<SEC-DOCUMENT>0001493152-25-008460.txt : 20250227
<SEC-HEADER>0001493152-25-008460.hdr.sgml : 20250227
<ACCEPTANCE-DATETIME>20250227081543
ACCESSION NUMBER:		0001493152-25-008460
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		95
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250227
DATE AS OF CHANGE:		20250227

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Imunon, Inc.
		CENTRAL INDEX KEY:			0000749647
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				521256615
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15911
		FILM NUMBER:		25673155

	BUSINESS ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648
		BUSINESS PHONE:		(609) 896-9100

	MAIL ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Celsion CORP
		DATE OF NAME CHANGE:	20071121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELSION CORP
		DATE OF NAME CHANGE:	19980515

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEUNG LABORATORIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>form10-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:IMNN="http://imunon.com/20241231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2024%2D(with%2DECD%2Dand%2DCYD) -->
<!-- Field: Set; Name: xdx; ID: xdx_038_IMNN_imunon.com_20241231 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20240101_20241231 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0000749647 -->
<!-- Field: Set; Name: xdx; ID: xdx_076_XDX_form10%2Dk.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_06A_sqrt_0_utr%2D%2Dsqft -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_Segment_0_Segment -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000004" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000005" name="dei:EntityCentralIndexKey">0000749647</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="AsOf2024-12-31" id="xdx2ixbrl0085" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2024-12-31" id="xdx2ixbrl0100" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2024-12-31" id="xdx2ixbrl0139" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-12-31" id="xdx2ixbrl0140" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-12-31" id="xdx2ixbrl0145" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl0146" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2024-12-31" id="xdx2ixbrl0186" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0229" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0232" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherNonoperatingExpense" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0235" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0244" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0272" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0305" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0308" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="IMNN:AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0311" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedInvestmentIncomeReceivable" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0317" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="IMNN:PaymentoffOfLoanAndAccruedEndoftermFees" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0350" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0368" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="IMNN:RecognitionOfRightUseAssetAndLiability" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0374" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0388" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0389" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0390" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0391" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0397" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0398" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0399" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0405" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-01-012024-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0406" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0407" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0408" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0413" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0414" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2024-01-012024-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0415" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0417" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0420" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-012024-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0422" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0423" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0424" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0430" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0458" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0459" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0460" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0461" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0467" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0468" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0469" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0475" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2023-01-012023-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0476" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0477" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0478" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0483" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0484" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2023-01-012023-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0485" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0487" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0490" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0492" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0493" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2024-12-31_srt_MinimumMember" id="xdx2ixbrl0543" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">P3Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_VaccineMember" id="xdx2ixbrl0611" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="AsOf2024-12-31" id="xdx2ixbrl0677" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2024-12-31_us-gaap_USTreasurySecuritiesMember" id="xdx2ixbrl0683" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="AsOf2024-12-31_us-gaap_USTreasurySecuritiesMember" id="xdx2ixbrl0685" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost" contextRef="AsOf2024-12-31" id="xdx2ixbrl0691" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue" contextRef="AsOf2024-12-31" id="xdx2ixbrl0693" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost" contextRef="AsOf2024-12-31" id="xdx2ixbrl0699" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue" contextRef="AsOf2024-12-31" id="xdx2ixbrl0701" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="IMNN:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" contextRef="AsOf2024-12-31" id="xdx2ixbrl0707" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" contextRef="AsOf2024-12-31" id="xdx2ixbrl0709" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="IMNN:AvailableForSaleSecuritiesUnrealizedLossFairValue" contextRef="AsOf2024-12-31" id="xdx2ixbrl0717" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="IMNN:AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths" contextRef="AsOf2024-12-31" id="xdx2ixbrl0719" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_USTreasurySecuritiesMember" id="xdx2ixbrl0740" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member_us-gaap_USTreasurySecuritiesMember" id="xdx2ixbrl0742" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member_us-gaap_USTreasurySecuritiesMember" id="xdx2ixbrl0744" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member_us-gaap_USTreasurySecuritiesMember" id="xdx2ixbrl0746" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member_us-gaap_USTreasurySecuritiesMember" id="xdx2ixbrl0752" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member_us-gaap_USTreasurySecuritiesMember" id="xdx2ixbrl0754" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0855" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0856" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0858" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0859" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0861" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0862" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0864" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0865" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0867" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0870" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0891" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="IMNN:EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0894" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="IMNN:EffectiveIncomeTaxRateReconciliationSaleAndExpiration" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0897" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0902" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2024-12-31" id="xdx2ixbrl0922" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" contextRef="AsOf2024-12-31" id="xdx2ixbrl1228" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="imnn-20241231.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-01-01to2024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-21">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-28_stpr_NJ_us-gaap_NewJerseyDivisionOfTaxationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_stpr_NJ_us-gaap_NewJerseyDivisionOfTaxationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-22_stpr_NJ_us-gaap_NewJerseyDivisionOfTaxationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_stpr_NJ_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_stpr_NJ_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_stpr_NJ_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OvationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:ClinicalResearchMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:OvationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OvationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:ClinicalResearchMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:OvationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_VaccineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:ClinicalResearchMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:VaccineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_VaccineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:ClinicalResearchMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:VaccineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OtherClinicalAndRegulatoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:ClinicalResearchMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:OtherClinicalAndRegulatoryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OtherClinicalAndRegulatoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:ClinicalResearchMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:OtherClinicalAndRegulatoryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:ClinicalResearchMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:ClinicalResearchMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_OvationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:NonClinicalRAndDAndCMCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:OvationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_OvationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:NonClinicalRAndDAndCMCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:OvationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_PlaCCineVaccineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:NonClinicalRAndDAndCMCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:PlaCCineVaccineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_PlaCCineVaccineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:NonClinicalRAndDAndCMCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:PlaCCineVaccineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_ManufacturingCMCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:NonClinicalRAndDAndCMCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:ManufacturingCMCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_ManufacturingCMCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:NonClinicalRAndDAndCMCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:ManufacturingCMCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:NonClinicalRAndDAndCMCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:NonClinicalRAndDAndCMCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_LeaseholdImprovementsMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_LeaseholdImprovementsMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-18_custom_SiliconValleyBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">IMNN:SiliconValleyBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-172021-06-18_custom_SiliconValleyBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">IMNN:SiliconValleyBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-17</xbrli:startDate>
        <xbrli:endDate>2021-06-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_SiliconValleyBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">IMNN:SiliconValleyBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-012020-08-31_custom_SiliconValleyBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">IMNN:SiliconValleyBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SiliconValleyBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">IMNN:SiliconValleyBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-21_custom_HorizonTechnologyFinanceCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">IMNN:HorizonTechnologyFinanceCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_stpr_NJ">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_FederalIncomeTaxMember_custom_NoExpirationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">IMNN:FederalIncomeTaxMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">IMNN:NoExpirationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_StateAndLocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_StateAndLocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_stpr_NJ">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_stpr_NJ_srt_MinimumMember_us-gaap_StateAndLocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_stpr_NJ_srt_MaximumMember_us-gaap_StateAndLocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-152024-05-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-15</xbrli:startDate>
        <xbrli:endDate>2024-05-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-152024-05-15_custom_AtTheMarketOfferingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-15</xbrli:startDate>
        <xbrli:endDate>2024-05-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-032024-09-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-03</xbrli:startDate>
        <xbrli:endDate>2024-09-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_AtTheMarketOfferingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AtTheMarketOfferingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-02-21_custom_AtTheMarketOfferingAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-302024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">IMNN:JulyTwoThousandTwentyFourOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-30</xbrli:startDate>
        <xbrli:endDate>2024-07-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">IMNN:JulyTwoThousandTwentyFourOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-302024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">IMNN:JulyTwoThousandTwentyFourOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-30</xbrli:startDate>
        <xbrli:endDate>2024-07-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">IMNN:JulyTwoThousandTwentyFourOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-05-15_custom_TwoThousandAndEighteenStockIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-05-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-05-14_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-05-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-05-14_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-05-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-15_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-15_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-10_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-10_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-14_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-14_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_TwoThousandAndEighteenStockIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_InducementOptionGrantsMember_srt_BoardOfDirectorsChairmanMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:InducementOptionGrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_InducementOptionGrantsMember_srt_BoardOfDirectorsChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:InducementOptionGrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_TwoThousandAndEighteenStockIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_EquityStockAwardsMember_custom_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">IMNN:EquityStockAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">IMNN:GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_InducementAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">IMNN:InducementAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">IMNN:EmployeeStockOptionAndRestrictedStockAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">IMNN:EmployeeStockOptionAndRestrictedStockAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">IMNN:EmployeeStockOptionAndRestrictedStockAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">IMNN:EmployeeStockOptionAndRestrictedStockAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">IMNN:EmployeeStockOptionAndRestrictedStockAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">IMNN:EmployeeStockOptionAndRestrictedStockAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_ExercisePriceOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">IMNN:ExercisePriceOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_ExercisePriceOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">IMNN:ExercisePriceOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_ExercisePriceTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">IMNN:ExercisePriceTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_ExercisePriceTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">IMNN:ExercisePriceTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_ExercisePriceThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">IMNN:ExercisePriceThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_ExercisePriceThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">IMNN:ExercisePriceThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31_custom_LeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:LeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-012023-08-31_custom_LeaseAgreementMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:LeaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-012023-08-31_custom_LeaseAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:LeaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-31_custom_LeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:LeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-01-31_custom_LeaseAgreementMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:LeaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-01-31_custom_LeaseAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:LeaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-11-16_custom_ConvertibleNotePurchaseAgreementMember_custom_TransomicTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:ConvertibleNotePurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">IMNN:TransomicTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-11-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="sqrt">
      <xbrli:measure>utr:sqft</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Segment">
      <xbrli:measure>IMNN:Segment</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_902_edei--DocumentType_c20240101__20241231_zoqnLTOsKgph"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000013" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Mark
One)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--DocumentAnnualReport_c20240101__20241231_znHVsaCDTune"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000014" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNUAL
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended <span id="xdx_900_edei--DocumentPeriodEndDate_c20240101__20241231_zkLW2ql2rfsb"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:datemonthdayyearen" id="Fact000015" name="dei:DocumentPeriodEndDate"><span id="xdx_90E_edei--CurrentFiscalYearEndDate_c20240101__20241231_zqTdT45IeQZ4"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:datemonthdayen" id="Fact000016" name="dei:CurrentFiscalYearEndDate">December 31</ix:nonNumeric></span>, <span id="xdx_901_edei--DocumentFiscalYearFocus_c20240101__20241231_zsfNcJnPn8Qi"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000017" name="dei:DocumentFiscalYearFocus">2024</ix:nonNumeric></span></ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>or</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--DocumentTransitionReport_c20240101__20241231_z545kFE75KSb"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000018" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSITION
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the transition period from _______ to _______</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMMISSION
FILE NO.: <b><span id="xdx_90E_edei--EntityFileNumber_c20240101__20241231_z1ZPz1tbaMO4"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000019" name="dei:EntityFileNumber">001-15911</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_901_edei--EntityRegistrantName_c20240101__20241231_zv98FyrjDDRi"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000020" name="dei:EntityRegistrantName">IMUNON,
INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in Its Charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="xdx_90B_edei--EntityIncorporationStateCountryCode_c20240101__20241231_zqfuxLOuC8pl"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt-sec:stateprovnameen" id="Fact000021" name="dei:EntityIncorporationStateCountryCode">delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20240101__20241231_zR2JCigMpsph"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000022" name="dei:EntityTaxIdentificationNumber">52-1256615</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
or other jurisdiction of <br/>
incorporation or organization)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityAddressAddressLine1_c20240101__20241231_zs6gGa29LiL4"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000023" name="dei:EntityAddressAddressLine1">997
                                            LENOX DRIVE</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressAddressLine2_c20240101__20241231_zScrOJelyPA7"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000024" name="dei:EntityAddressAddressLine2">SUITE 100</ix:nonNumeric></span>,</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressCityOrTown_c20240101__20241231_zoKLEwb7Ibpf"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000025" name="dei:EntityAddressCityOrTown">LAWRENCEVILLE</ix:nonNumeric></span>,
    <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20240101__20241231_zZAZDoA136aa"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000026" name="dei:EntityAddressStateOrProvince">NJ</ix:nonNumeric></span></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityAddressPostalZipCode_c20240101__20241231_zVzwf266Y41j"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000027" name="dei:EntityAddressPostalZipCode">08648</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of Principal Executive Offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <b><span id="xdx_90E_edei--CityAreaCode_c20240101__20241231_zmoHLn5NFTHh"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000028" name="dei:CityAreaCode">(609)</ix:nonNumeric></span> <span id="xdx_902_edei--LocalPhoneNumber_c20240101__20241231_z4Ol6Z38k0V6"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000029" name="dei:LocalPhoneNumber">896-9100</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--Security12bTitle_c20240101__20241231_zPHxhllSLXH9"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000030" name="dei:Security12bTitle">Common
    Stock, Par Value $0.01 Per Share</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--TradingSymbol_c20240101__20241231_zWO1pp29orAf"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000031" name="dei:TradingSymbol">IMNN</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
    <span id="xdx_909_edei--SecurityExchangeName_c20240101__20241231_z5oeZ7tARHy8"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt-sec:exchnameen" id="Fact000032" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to section 12(g) of the Act: <b>None</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744; <span id="xdx_904_edei--EntityWellKnownSeasonedIssuer_c20240101__20241231_z02NtiJobqJ6"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000033" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span>
&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes &#9744; <span id="xdx_90E_edei--EntityVoluntaryFilers_c20240101__20241231_zenlCR4JKIF1"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000034" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span>
&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2)
has been subject to such filing requirements for the past 90 days. <span id="xdx_905_edei--EntityCurrentReportingStatus_c20240101__20241231_z132VG9EtLye"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000035" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> &#9746;  No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant
was required to submit such files). <span id="xdx_90E_edei--EntityInteractiveDataCurrent_c20240101__20241231_zjscAWhDPk67"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000036" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> &#9746;  No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the Registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;,
&#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    Accelerated Filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    Filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityFilerCategory_c20240101__20241231_zTy4s2kLOZwe"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt-sec:entityfilercategoryen" id="Fact000037" name="dei:EntityFilerCategory">Non-accelerated
    Filer</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    Reporting Company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--EntitySmallBusiness_c20240101__20241231_zcwu1SYUlb5i"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000038" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    Growth Company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityEmergingGrowthCompany_c20240101__20241231_zbpyyn41Qwkb"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000039" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the Registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. <span id="xdx_907_edei--IcfrAuditorAttestationFlag_c20240101__20241231_zWjfG4w0x219"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000040" name="dei:IcfrAuditorAttestationFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. <span id="xdx_90D_edei--DocumentFinStmtErrorCorrectionFlag_c20240101__20241231_zRIcTfGGMbtf"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000041" name="dei:DocumentFinStmtErrorCorrectionFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934). Yes
&#9744; No <span id="xdx_908_edei--EntityShellCompany_dbF_c20240101__20241231_zB4rhimef9kf"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000042" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate market value of the common stock held by non-affiliates of the Registrant was approximately $<span id="xdx_90B_edei--EntityPublicFloat_iI_pn5n6_c20240628_zJ2C3hRctl5k"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2024-06-28" id="Fact000043" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">10.8</ix:nonFraction></span> million as of June 28, 2024
(the last business day of the Registrant&#8217;s most recently completed second fiscal quarter) based on the closing sale price of $1.16.
for the Registrant&#8217;s common stock on that date as reported by The Nasdaq Capital Market (&#8220;NASDAQ&#8221;). For purposes of
this calculation, shares of common stock held by directors, officers and stockholders who own greater than 10% of the Registrant&#8217;s
outstanding stock at June 30, 2024, were excluded. This determination of executive officers and directors as affiliates is not necessarily
a conclusive determination for any other purpose.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 21, 2025, <span id="xdx_902_edei--EntityCommonStockSharesOutstanding_iI_pid_c20250221_ztMXRHMyDpV7" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-02-21" id="Fact000045" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,620,732</ix:nonFraction></span> shares of the Registrant&#8217;s common stock were issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DOCUMENTS
INCORPORATED BY REFERENCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--DocumentsIncorporatedByReferenceTextBlock_c20240101__20241231_zuZKALdSG8Cg"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000046" name="dei:DocumentsIncorporatedByReferenceTextBlock">None</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IMUNON,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM
10-K</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
    I</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    1.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_001">BUSINESS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_002">FORWARD-LOOKING STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_003">OVERVIEW</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_004">THERAPLAS MODALITY: IMNN-001 DEVELOPMENT PROGRAM</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_005">Ovarian Cancer Overview</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_006">IMNN-001 Immunotherapy</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_007">OVATION I Study</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_008">OVATION 2 Study</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_009">PLACCINE DNA VACCINE TECHNOLOGY PLATFORM</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_010">COVID-19 Vaccine Overview</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_011">Our Next Generation Vaccine Initiative</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_012">BUSINESS STRATEGY AND DEVELOPMENT PLAN</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_013">RESEARCH AND DEVELOPMENT EXPENDITURES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_014">GOVERNMENT REGULATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_015">MANUFACTURING AND SUPPLY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_016">SALES AND MARKETING</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_017">PRODUCT LIABILITY AND INSURANCE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_018">COMPETITION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_019">INTELLECTUAL PROPERTY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_020">Patents and Proprietary Rights</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_021">EMPLOYEES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_022">COMPANY INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_023">AVAILABLE INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    1A.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_024">RISK FACTORS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    1B.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_025">UNRESOLVED STAFF COMMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>43</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    1C.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_026">CYBERSECURITY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    2.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_027">PROPERTIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    3.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_028">LEGAL PROCEEDINGS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    4.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_029">MINE SAFETY DISCLOSURES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IMUNON,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM
10-K</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b>&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#ar_030">PART II</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    5.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_031">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_032">Market for Our Common Stock</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_033">Record Holders</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_034">Dividend Policy</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_035">Unregistered Sales of Equity Securities</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_036">Issuer Purchases of Equity Securities</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    6.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_037">RESERVED</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    7.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_038">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_039">Overview</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ar_040">Business Plan</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_001">Financing Overview</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical Accounting Policies and Estimates</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#a_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Results of Operations</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#a_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Condition, Liquidity and Capital Resources</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#a_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Off-Balance Sheet Arrangements</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    7A.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><a href="#a_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    8.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><a href="#a_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    9.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><a href="#a_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    9A.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><a href="#a_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTROLS AND PROCEDURES</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    9B.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><a href="#a_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER INFORMATION</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    9C.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><a href="#a_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#a_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART III</b></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    10.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><a href="#a_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    11.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><a href="#a_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE COMPENSATION</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    12.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><a href="#a_015"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    13.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><a href="#a_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    14.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><a href="#a_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#a_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART IV</b></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    15.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><a href="#a_019"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_020">1. FINANCIAL STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_021">2. FINANCIAL STATEMENT SCHEDULES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_022">3. EXHIBITS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16.</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_023">FORM 10-K SUMMARY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_001"></span>ITEM
    1.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BUSINESS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_002"></span>FORWARD-LOOKING
STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Certain
of the statements contained in this Annual Report on Form 10-K (&#8220;Annual Report&#8221;) are forward-looking and constitute forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section
21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Forward-looking statements may relate to such
matters as anticipated financial performance, business prospects, technological developments, product pipelines, clinical trials and
research and development activities, the adequacy of capital reserves and anticipated operating results and cash expenditures, current
and potential collaborations, strategic alternatives and other aspects of our present and future business operations and similar matters.
These statements involve known and unknown risks, uncertainties, and other factors that may cause our or our industry&#8217;s actual
results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance,
or achievements expressed or implied by such forward-looking statements. Such factors include, among other things, unforeseen changes
in the course of research and development activities and in clinical trials; possible changes in cost, timing and progress of development,
preclinical studies, clinical trials and regulatory submissions; our collaborators&#8217; ability to obtain and maintain regulatory approval
of any of our drug candidates; possible changes in capital structure, financial condition, future working capital needs and other financial
items; uncertainties and assumptions regarding the potential worsening global economic conditions and the recent disruptions to, and
volatility in, financial markets in the U.S. and worldwide resulting from the Russian invasion of Ukraine and the unrest in the Middle
East on our business, operations, clinical trials, supply chain, strategy, goals and anticipated timelines, changes in approaches to
medical treatment; introduction of new products by others; success or failure of our current or future collaboration arrangements, risks
and uncertainties associated with possible acquisitions of other technologies, assets or businesses; our ability to obtain additional
funds for our operations; our ability to obtain and maintain intellectual property protection for our technologies and drug candidates
and our ability to operate our business without infringing the intellectual property rights of others; our reliance on third parties
to conduct preclinical studies or clinical trials; the rate and degree of market acceptance of any approved drug candidates; possible
actions by customers, suppliers, strategic partners, potential strategic partners, competitors and regulatory authorities; compliance
with listing standards of The Nasdaq Capital Market; and those listed under &#8220;Risk Factors&#8221; below and elsewhere in this Annual
Report.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>In
some cases, you can identify forward-looking statements by terminology such as &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221;
&#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;predict,&#8221; &#8220;may,&#8221; &#8220;should,&#8221;
&#8220;will,&#8221; &#8220;would&#8221; and words of similar import regarding the Company&#8217;s expectations. Forward-looking statements
are only predictions. Actual events or results may differ materially. Although we believe that our expectations are based on reasonable
assumptions within the bounds of our knowledge of our industry, business and operations, we cannot guarantee that actual results will
not differ materially from our expectations. In evaluating such forward-looking statements, you should specifically consider various
factors, including the risks outlined under &#8220;Risk Factors.&#8221; The discussion of risks and uncertainties set forth in this Annual
Report is not necessarily a complete or exhaustive list of all risks facing the Company at any particular point in time. We operate in
a highly competitive, highly regulated and rapidly changing environment and our business is in a state of evolution. Therefore, it is
likely that new risks will emerge, and that the nature and elements of existing risks will change over time. It is not possible for management
to predict all such risk factors or changes therein, or to assess either the impact of all such risk factors on our business or the extent
to which any individual risk factor, combination of factors, or new or altered factors, may cause results to differ materially from those
contained in any forward-looking statement. Except as required by law, we assume no obligation to revise or update any forward-looking
statement that may be made from time to time by us or on our behalf for any reason, even if new information becomes available in the
future. Unless the context requires otherwise or unless otherwise noted, all references in this Annual Report to &#8220;Imunon,&#8221;
&#8220;the Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, or &#8220;our&#8221; are to Imunon, Inc., a Delaware corporation and its
wholly owned subsidiary, CLSN Laboratories, Inc., also a Delaware corporation.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trademarks</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Imunon brand and product names contained in this document are trademarks, registered trademarks or service marks of Imunon, Inc. or its
subsidiary in the United States (the &#8220;U.S.&#8221;) and certain other countries. This document also contains references to trademarks
and service marks of other companies that are the property of their respective owners.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_003"></span>OVERVIEW</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon
is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body&#8217;s natural
mechanisms with the aim to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating
approach from conventional therapies. Imunon is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas&#174;,
is developed for the coding of proteins and cytokines in the treatment of solid tumors where an immunological approach is deemed promising.
The second modality, PlaCCine&#174;, is developed for the coding of viral antigens that can elicit a strong immunological response. This
technology may represent a promising platform for the development of vaccines in infectious diseases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer
that has completed Phase II development studies. IMNN-001 works by instructing the body to produce safe and durable levels of powerful
cancer-fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site. Additionally, the Company has entered into
a first-in-human study of its COVID-19 booster vaccine (IMNN-101). We will continue to leverage these modalities and to advance the technological
frontier of plasmid DNA to better serve patients with difficult-to-treat conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Technology
Platform</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon&#8217;s
technology platform is optimized for the delivery of DNA and mRNA therapeutics via synthetic non-viral carriers and is capable of providing
cell transfection for double-stranded DNA plasmids and large therapeutic RNA segments such as mRNA. There are two components to the system,
a backbone with plasmid DNA or mRNA payload encoding therapeutic proteins, or pathogen antigens or tumor associated antigens or cancer
neoantigens and a delivery system. The delivery system is designed to protect the DNA or mRNA from degradation and promote trafficking
into cells and through intracellular compartments. We designed the delivery system by chemically modifying the low molecular weight polymer
to improve its gene transfer activity without increasing toxicity. We believe that our non-viral DNA technology may be a viable alternative
to current approaches to gene delivery due to several distinguishing characteristics, including enhanced molecular versatility that allows
for complex modifications to potentially improve activity and safety.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
biocompatibility of these polymers reduces the risk of adverse immune response, thus allowing for repeated administration. Compared to
naked DNA or cationic lipids, we believe that our delivery systems are generally more efficient, cost effective and have a more favorable
safety profile. We believe that these advantages place Imunon in a position to capitalize on this technology platform.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_004"></span>THERAPLAS
MODALITY:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IMNN-001
DEVELOPMENT PROGRAM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_005"></span>Ovarian
Cancer Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ovarian
cancer is the most lethal of gynecological malignancies among women with more than 60% of women dying within five years of diagnosis.
This poor outcome is due in part to the lack of effective prevention and early detection strategies. There were approximately 20,000
new cases of ovarian cancer in the U.S. in 2021 with an estimated 13,000 deaths. Mortality rates for ovarian cancer declined very little
in the last 40 years due to the unavailability of detection tests and improved treatments. Most women with ovarian cancer are not diagnosed
until Stages III or IV, when the disease has spread outside the pelvis to the abdomen and areas beyond, causing swelling and pain. With
the five-year survival rates for Stages III and IV at 41% and 20%, respectively, there remains a need for a therapy that not only reduces
the recurrence rate but also meaningfully improves overall survival. Patients whose cancer recurs or progresses after initially responding
to surgery and first-line chemotherapy have been divided into one of the two groups based on the time from completion of platinum therapy
to disease recurrence or progression. This time period is referred to as platinum-free interval. The platinum-sensitive group has a platinum-free
interval of longer than six months. This group generally responds to additional treatment with platinum-based therapies. The platinum
resistant group has a platinum-free interval of shorter than six months and is resistant to additional platinum-based treatments. Pegylated
liposomal doxorubicin, topotecan, and bevacizumab are the only approved second-line therapies for platinum-resistant ovarian cancer.
The overall response rate for these therapies is 10% to 20% with median overall survival (&#8220;OS&#8221;) of 11 to 12 months. Additionally,
10% to 15% of ovarian cancer cases nationwide are a result of germline or somatic BRCA mutations. With cognizance of tumor genetics,
practice has shifted to include targeted agents in ovarian cancer treatment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Poly
(ADP-ribose) polymerase (&#8220;PARP&#8221;) enzymes are responsible for detecting and repairing single-stranded and double-stranded
DNA breaks during cell replication. BRCA1/2 mutations hinder the homologous recombination repair pathway, and tumor cells utilize PARP
enzymes to repair DNA. For this reason, these tumors are particularly sensitive to the mechanism of PARP inhibitors. PARP inhibitors
have expanded treatment options in ovarian cancer, but few treatment options are left for women who are not eligible to receive PARP
inhibitors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immunotherapy
is an attractive, novel approach for the treatment of ovarian cancer particularly since ovarian cancers are considered immunogenic tumors.
Interleukin-12 (&#8220;IL-12&#8221;) is one of the most active cytokines for the induction of potent anti-cancer immunity acting through
the induction of T-lymphocyte and natural killer cell proliferation. The precedence for a therapeutic role of IL-12 in ovarian cancer
is based on epidemiologic and clinical and preclinical data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_006"></span>IMNN-001
Immunotherapy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IMNN-001
is a DNA-based immunotherapeutic drug candidate for the localized treatment of ovarian cancer by intraperitoneally administering an IL-12
plasmid formulated with our proprietary TheraPlas delivery system. In this DNA-based approach, the immunotherapy is combined with a standard
chemotherapy drug, which can potentially achieve better clinical outcomes than with chemotherapy alone. We believe that increases in
IL-12 concentrations at tumor sites for several days after a single administration could create a potent immune environment against tumor
activity and that a direct killing of the tumor with concomitant use of cytotoxic chemotherapy could result in a more robust and durable
antitumor response than chemotherapy alone. We believe the rationale for local therapy with IMNN-001 is based on the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loco-regional
    production of the potent cytokine IL-12 avoids toxicities and poor pharmacokinetics associated with systemic delivery of recombinant
    IL-12;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Persistent
    local delivery of IL-12 lasts up to one week and dosing can be repeated; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Local
    therapy is ideal for long-term maintenance therapy.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="ar_007"></span>OVATION
1 Study</i></b>. In February 2015, we announced that the FDA accepted the Phase I dose-escalation clinical trial of IMNN-001 in combination
with the standard of care in neoadjuvant ovarian cancer (the &#8220;OVATION 1 Study&#8221;). The OVATION 1 Study was designed to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify
    a tolerable and therapeutically active dose of IMNN-001 within certain safety parameters by recruiting and maximizing an immune response;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enroll
    three to six patients per dose level and evaluate safety and efficacy; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">attempt
    to define an optimal dose for a follow-on Phase I/II study.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the OVATION 1 Study established a unique opportunity to assess how cytokine-based compounds such as IMNN-001 directly affect
ovarian cancer cells and the tumor microenvironment in newly diagnosed ovarian cancer patients. The study was designed to characterize
the nature of the immune response triggered by IMNN-001 at various levels of the patients&#8217; immune system, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Infiltration
    of cancer fighting T-cell lymphocytes into primary tumor and tumor microenvironment including peritoneal cavity, which is the primary
    site of metastasis of ovarian cancer;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    in local and systemic levels of immuno-stimulatory and immune-suppressive cytokines associated with tumor suppression and growth,
    respectively; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expression
    profile of a comprehensive panel of immune related genes in pre-treatment and IMNN-001-treated tumor tissue.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2016 and 2017, we announced data from the first 14 patients in the OVATION 1 Study. On October 3, 2017, we announced final translational
research and clinical data from the OVATION 1 Study.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
translational research findings from all evaluable patients were consistent with the earlier reports from partial analysis of the data
and are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    intraperitoneal treatment of IMNN-001 in conjunction with standard-of-care neoadjuvant chemotherapy (&#8220;NACT&#8221;) resulted
    in dose-dependent increases in IL-12 and Interferon-gamma (IFN&#947;) levels that were predominantly in the peritoneal fluid compartment
    with little to no changes observed in the patients&#8217; systemic circulation. These and other post-treatment changes including
    decreases in VEGF levels in peritoneal fluid were consistent with an IL-12 based immune mechanism;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consistent
    with the previous partial reports, the effects observed in the Immunohistochemistry analysis were pronounced decreases in the density
    of immunosuppressive T-cell signals (Foxp3, PD-1, PDL-1, IDO-1) and increases in CD8+ cells in the tumor microenvironment;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    ratio of CD8+ cells to immunosuppressive cells was increased in approximately 75% of patients, suggesting an overall shift in the
    tumor microenvironment from immunosuppressive to pro-immune stimulatory following treatment with IMNN-001. An increase in CD8+ to
    immunosuppressive T-cell populations was a leading indicator and believed to be a good predictor of improved OS; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Analysis
    of peritoneal fluid by cell sorting, not reported before, showed a treatment-related decrease in the percentage of immunosuppressive
    T-cell (Foxp3+), which was consistent with the reduction of Foxp3+ T-cells in the primary tumor tissue, and a shift in tumor na&#239;ve
    CD8+ cell population to more efficient tumor killing memory effector CD8+ cells.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also reported encouraging clinical data from the first 14 patients who completed treatment in the OVATION 1 Study. IMNN-001 plus
standard chemotherapy produced no dose-limiting toxicities and positive dose dependent efficacy signals which correlate well with positive
surgical outcomes as summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
    the 14 patients treated in the entire study, two patients demonstrated a complete response, 10 patients demonstrated a partial response,
    and two patients demonstrated stable disease, as measured by Response Evaluation Criteria in Solid Tumors (&#8220;RECIST&#8221;)
    criteria. This translated to a 100% disease control rate and an 86% objective response rate (&#8220;ORR&#8221;). Of the five patients
    treated in the highest dose cohort, there was a 100% ORR with one complete response and four partial responses;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14
    patients had successful resections of their tumors, with nine patients (64%) having a complete tumor resection (&#8220;R0&#8221;),
    which indicates a microscopically margin-negative resection in which no gross or microscopic tumor remains in the tumor bed. Seven
    out of eight (88%) patients in the highest two dose cohorts experienced a R0 surgical resection. All five patients treated at the
    highest dose cohort experienced a R0 surgical resection; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    patients experienced a clinically significant decrease in their CA-125 protein levels as of their most recent study visit. CA-125
    was used to monitor certain cancers during and after treatment. CA-125 was present in greater concentrations in ovarian cancer cells
    than in other cells.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 58.5pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 26, 2020, the Company announced with Medidata Solutions, a subsidiary of Dassault Syst&#232;mes, that examining matched patient
data provided by Medidata in a synthetic control arm (&#8220;SCA&#8221;) with results from the Company&#8217;s completed Phase Ib dose-escalating
OVATION 1 Study showed positive results in progression-free survival (&#8220;PFS&#8221;). The hazard ratio (&#8220;HR&#8221;) was 0.53
in the intent-to-treat (&#8220;ITT&#8221;) group, showing strong signals of efficacy. In its March 2019 discussion with the Company,
the FDA noted that preliminary findings from the Phase Ib OVATION 1 Study were exciting but lacked a control group to evaluate IMNN-001&#8217;s
independent impact on impressive tumor response, surgical results and PFS. The FDA encouraged the Company to continue its IMNN-001 development
program and consult with FDA with new findings that may have a bearing on designations such as Fast Track and Breakthrough Therapy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 29, 2021, the Company announced final PFS results from the OVATION 1 Study published in the Journal of Clinical Cancer Research.
Median PFS in patients treated per protocol (n=14) was 21 months and was 18.4 months for the ITT population (n=18) for all dose cohorts,
including three patients who dropped out of the study after 13 days or less, and two patients who did not receive full NACT and IMNN-001
cycles. Under the current standard of care, in women with Stage III/IV ovarian cancer undergoing NACT, their disease progresses within
about 12 months on average. The results from the OVATION 1 Study supported continued evaluation of IMNN-001 based on promising tumor
response, as reported in the PFS data, and the ability for surgeons to completely remove visible tumors at the time of interval debulking
surgery. IMNN-001 was well tolerated, and no dose-limiting toxicities were detected in the OVATION 1 Study. Intraperitoneal administration
of IMNN-001 was feasible with broad patient acceptance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="ar_008"></span>OVATION
2 Study. </i></b>The Company held an Advisory Board Meeting on September 27, 2017 with clinical investigators and scientific experts
including those from Roswell Park Cancer Institute, Vanderbilt University Medical School, and M.D. Anderson Cancer Center to review and
finalize clinical, translational research and safety data from the OVATION 1 Study to determine the next steps forward for our IMNN-001
immunotherapy program. On November 13, 2017, the Company filed its Phase I/II clinical trial protocol with the FDA for IMNN-001 for the
localized treatment of ovarian cancer. The protocol was designed with a single dose escalation phase to 100 mg/m&#178; to identify a
tolerable dose of IMNN-001 within certain safety parameters while maximizing an immune response. The Phase I portion of the study would
be followed by a continuation at the selected dose in approximately 110 patients randomized Phase II study.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the OVATION 2 Study, patients in the IMNN-001 treatment arm would receive IMNN-001 plus chemotherapy pre- and post-interval debulking
surgery (&#8220;IDS&#8221;). The OVATION 2 Study was designed to include up to 110 patients with Stage III/IV ovarian cancer, with 15
patients in the Phase I portion and up to 95 patients in Phase II. The sample size is consistent with a Phase II trial designed to inform
the design of a Phase III trial comparing IMNN-001 with neoadjuvant + adjuvant chemotherapy versus neoadjuvant + adjuvant chemotherapy
alone. As a Phase II study, the OVATION 2 Study was not powered for statistical significance. The primary endpoint is PFS and the primary
analysis would be conducted after at least 80 events had been observed or after all patients had been followed for at least 16 months,
whichever was later. Additional endpoints included objective response rate, chemotherapy response score, and surgical response.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, the Company announced encouraging initial clinical data from the first 15 patients enrolled in the Phase I portion of the
OVATION 2 Study for patients newly diagnosed with Stage III and IV ovarian cancer. The OVATION 2 Study was designed to combine IMNN-001,
the Company&#8217;s IL-12 gene-mediated immunotherapy, with standard-of-care NACT. Following NACT, patients undergo IDS, followed by
three additional cycles of chemotherapy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IMNN-001
plus standard-of-care NACT produced positive dose-dependent efficacy results, with no dose-limiting toxicities, which correlate well
with successful surgical outcomes as summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
    the 15 patients treated in the Phase I portion of the OVATION 2 Study, nine patients were treated with IMNN-001 at a dose of 100
    mg/m&#178; plus NACT and six patients were treated with NACT only. All 15 patients had successful resections of their tumors, with
    eight out of nine patients (88%) in the IMNN-001 treatment arm having an R0 resection. Only three out of six patients (50%) in the
    NACT only treatment arm had a R0 resection.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
    combining these results with the surgical resection rates observed in the Company&#8217;s OVATION 1 Study, a population of patients
    with inclusion criteria identical to the OVATION 2 Study, the data reflected the strong dose-dependent efficacy of adding IMNN-001
    to the current standard of care NACT:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">% of Patients R0 <br/> Resections</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">0, 36, 47 mg/m&#178; of IMNN-001 plus NACT</td><td style="width: 2%">&#160;</td>
    <td style="width: 16%; text-align: center">N =12</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">42</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">61, 79, 100 mg/m&#178; of IMNN-001 plus NACT</td><td>&#160;</td>
    <td style="text-align: center">N = 17</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    ORR as measured by RECIST criteria for the 0, 36, 47 mg/m&#178; dose IMNN-001 patients were comparable, as expected, to the higher
    (61, 79, 100 mg/m&#178;) dose IMNN-001 patients, with both groups demonstrating an approximate 80% ORR.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 23, 2020, the Company announced that the European Medicines Agency (the &#8220;EMA&#8221;) Committee for Orphan Medicinal Products
(&#8220;COMP&#8221;) had recommended that IMNN-001 be designated as an orphan medicinal product for the treatment of ovarian cancer.
IMNN-001 previously received orphan designation from the FDA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2021, the Company announced that it had received Fast Track designation from the FDA for IMNN-001 and also provided an update
on the OVATION 2 Study. The Company reported that approximately one-third, or 34 patients, of the anticipated 110 patients had been enrolled
into the OVATION 2 Study, of which 20 were in the treatment arm and 14 were in the control. Of the 34 patients enrolled in the trial,
27 patients have had their IDS with the following results:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80%
    of patients treated with IMNN-001 had a R0 resection.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58%
    of patients in the control arm had an R0 resection.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
    interim data represented a 38% improvement in R0 resection rates for IMNN-001 patients compared with control arm patients and was
    consistent with the reported improvement in resection scores noted in our Phase I OVATION 1 Study, the manuscript of which was submitted
    for peer review publication.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the Company announced that following a pre-planned interim safety review of 87 as treated patients (46 patients in the experimental
arm and 41 patients in the control arm) randomized in the OVATION 2 Study, the Data Safety Monitoring Board (&#8220;DSMB&#8221;) unanimously
recommended that the OVATION 2 Study continue treating patients with the dose of 100 mg/m2. The DSMB also determined that safety was
satisfactory, with an acceptable risk/benefit, and that patients tolerated IMNN-001 during a course of treatment that would last up to
six months. No dose-limiting toxicities were reported at this point in the OVATION 2 Study. Interim clinical data from patients who had
undergone IDS showed that the IMNN-001 treatment arm was continuing to show improvement in R0 surgical resection rates and CRS 3 chemotherapy
response scores over the control arm. The chemotherapy response score is a three-tier standardized scoring system for histological tumor
regression into complete/near complete (CRS 3), partial (CRS 2) and no/minimal (CRS 1) response based on omental examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2022, the Company announced that its Phase I/II OVATION 2 Study with IMNN-001 in advanced ovarian cancer had completed enrollment
with 113 patients. In September 2023, the Company announced interim PFS and OS data with IMNN-001 in its Phase I/II OVATION 2 Study.
Interim clinical data from the ITT population showed efficacy trends in PFS, demonstrating a delay in disease progression in the treatment
arm of approximately 33% compared with the control arm, with the hazard ratio nearing the required value. Preliminary OS data followed
a similar trend, showing an approximate 9-month improvement in the treatment arm over the control arm.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subgroup
analyses showed patients treated with a PARP inhibitor (&#8220;PARPi&#8221;) as maintenance therapy had longer PFS and OS if they were
also treated with IMNN-001 compared with patients treated with NACT only. This was not a pre-specified subgroup as PARP inhibitors were
approved after the OVATION 2 Study was initiated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    median PFS in the PARPi + NACT group and the PARPi + NACT + IMNN-001 group was 15.7 months and 23.7 months, respectively.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    median OS in the PARPi + NACT group was 45.6 months and has not yet been reached in the PARPi + NACT + IMNN-001 group.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon
also continues to see benefits in other secondary endpoints including an approximately 20% higher R0 tumor resection score and a doubling
of the CRS 3 chemotherapy response score to approximately 30% in the treatment arm versus 14% in the control arm. Chemotherapy response
score is considered a good prognostic indicator in ovarian cancer. The DSMB determined that safety analyses continue to show good tolerability
of IMNN-001 in this setting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2024, the Company announced database lock for the OVATION 2 Study. At that time, median OS and PFS had been reached, and all patients
in the open-label study had achieved treatment observation duration of 16 months, as required by protocol to evaluate efficacy. On July
11, 2024, a scientific advisory board with DSMB members, principal investigators, and scientific experts was held to review efficacy
and safety data from the OVATION 2 study.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2024, the Company announced positive topline results from the Phase II OVATION 2 Study. Highlights from patients treated with
IMNN-001 plus standard-of-care in a first-line treatment setting include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    11.1 month increase in median OS compared with standard-of-care alone in the ITT population.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    hazard ratio in the ITT population of 0.74, which indicates a 35% improvement in survival.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Among
    the approximately 90% of trial participants who received at least 20% of specified treatments per-protocol in both study arms, patients
    in the IMNN-001 arm had a 15.7 month increase in median OS, representing a further extension of life with a hazard ratio of 0.64,
    a 56% improvement in survival.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    nearly 40% of trial participants treated with a PARP inhibitor, the hazard ratio decreased further to 0.41, with median OS in the
    IMNN-001 treatment arm not yet reached at the time of database lock, compared with median OS of 37.1 months in the standard-of-care
    treatment arm.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PFS results, the trial&#8217;s primary endpoint, support the OS results with:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    three-month improvement in PFS compared with standard-of-care alone.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    hazard ratio in the intent-to-treat population of 0.79, indicating a 27% improvement in delaying progression for the IMNN-001 treatment
    arm.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">These
initial results from the OVATION 2 Study were presented in a late-breaking session at the </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Society
for Immunotherapy of Cancer <span style="background-color: white">(SITC) 39<sup>th</sup> Annual Meeting in </span>November 2024<span style="background-color: white">.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 11, 2024, a scientific advisory board was held with DSMB members, principal investigators, and scientific experts to discuss
and seek input on the protocol synopsis for the Phase III trial. A protocol synopsis was submitted along with a briefing document for
review and input at the End-of-Phase II (&#8220;EOP2&#8221;) meeting with the U.S. Food and Drug Administration focused on the Phase
III study. The EOP2 meeting was conducted in the fourth quarter of 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
                                            positive outcome of the EOP2 in-person meeting with the </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
                                            Food and Drug Administration <span style="background-color: white">(FDA), supported the advancement
                                            of IMNN-001 for the treatment of advanced ovarian cancer into a Phase 3 pivotal study. The
                                            interaction with the FDA included an extensive review of data generated to date, including
                                            positive results from the recently completed Phase 2 OVATION 2 Study, which assessed IMNN-001
                                            (100 mg/m<sup>2</sup> administered intraperitoneally weekly) plus neoadjuvant and adjuvant
                                            chemotherapy (NACT) of paclitaxel and carboplatin compared to standard-of-care NACT alone
                                            in 112 patients with newly diagnosed advanced ovarian cancer. Treatment was also generally
                                            well tolerated, with no reports of cytokine release syndrome or any other serious immune-related
                                            adverse events.</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
                                            Company also held a Type C Chemistry, Manufacturing, and Controls (CMC) meeting with the
                                            FDA regarding production of IMNN-001 for the treatment of women with newly diagnosed advanced
                                            ovarian cancer. The goal of the meeting was to seek alignment and agreement with the FDA
                                            on key CMC topics to support IMNN-001 production for the planned Phase 3 pivotal trial and
                                            a potential future new biologic license application (BLA) submission. The meeting with the
                                            FDA included a review of the Company&#8217;s current good manufacturing practice (cGMP) clinical-scale
                                            and commercial manufacturing process for IMNN-001, conducted at the company&#8217;s manufacturing
                                            facility based in </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Huntsville,
                                            Alabama<span style="background-color: white">. The Agency agreed that the Company&#8217;s
                                            potency assay which measures interferon-gamma (IFN-&#947;) is acceptable for the Phase 3
                                            clinical study and for use in a commercial setting for release of drug product. The FDA also
                                            agreed with the Company&#8217;s strategy to establish comparability of the core components
                                            of IMNN-001 produced by the Company with product previously produced through an external
                                            contract development and manufacturing organization.</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
December 2024, the Company announced additional clinical data from ongoing analyses of results from the Phase 2 OVATION 2 Study. The
updated results, based on an additional seven months of patient monitoring, showed the hazard ratio (HR) decreased from 0.74 to 0.69
in the ITT population, with an increase in median overall survival (OS) from 11.1 to 13 months following treatment with IMNN-001 plus
standard-of-care (SoC) neoadjuvant and adjuvant chemotherapy (NACT) versus SoC alone. More than one-third of patients in the trial survived
more than 36 months from the point of study enrollment, with 62% of those surviving patients from the IMNN-001 treatment arm and 38%
from the SoC arm. Over 10% of trial participants have reached 48 months or beyond.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company plans to present full OVATION 2 Study results at an upcoming medical conference and to submit the results for publication in
a peer-reviewed medical journal. The Phase 3 trial is anticipated to begin in the first quarter of 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>IMNN-001
in Combination with bevacizumab. </i></b>In February 2023, the Company and Break <i>Through</i> Cancer, a public foundation dedicated
to supporting translational research in the most difficult-to-treat cancers that partners with top cancer research centers, announced
the commencement of patient enrollment in a collaboration to evaluate IMNN-001 in combination with bevacizumab in patients with advanced
ovarian cancer in the frontline, neoadjuvant clinical setting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Phase I/II study, titled &#8220;Targeting Ovarian Cancer Minimal Residual Disease (MRD) Using Immune and DNA Repair Directed Therapies,&#8221;
is expected to enroll 50 patients with Stage III/IV advanced ovarian cancer and is being led by principal investigator Amir Jazaeri,
M.D., Vice Chair for Clinical Research and Director of the Gynecologic Cancer Immunotherapy Program in the Department of Gynecologic
Oncology and Reproductive Medicine at MD Anderson. Dana-Farber Cancer Institute, The Sidney Kimmel Comprehensive Cancer Center at Johns
Hopkins and Memorial Sloan Kettering Cancer Center will also be participating in the trial. In addition, The Koch Institute for Integrative
Cancer Research at the Massachusetts Institute of Technology (MIT) will provide artificial intelligence services including biomarker
and genomic analysis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patients
are being randomized 1:1 in a two-arm trial. In October 2023, the first patient began treatment at University of Texas MD Anderson Cancer
Center in the Phase I/II Clinical Trial Evaluating IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancer. The trial&#8217;s
primary endpoint is detection of minimal residual disease (MRD) by second look laparoscopy (SLL), and the secondary endpoint is PFS.
SLL data are expected within one year following the completion of enrollment and final PFS data are expected approximately three years
following the completion of enrollment. This trial will also include a wealth of translational endpoints aimed at understanding the clonal
evolution and immunogenomic features of the MRD phase of ovarian cancer that is currently undetectable by imaging or tumor markers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024, twelve patients were enrolled in the Phase I portion of this study at the University of Texas MD Anderson Cancer
Center. Memorial Sloan Kettering Cancer Center and John Hopkins Medicine Sidney Kimmel Cancer Care Center have been added as a clinical
site for this study.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="ar_009"></span>PLACCINE
DNA VACCINE MODALITY: IMNN-101</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2021, the Company announced the filing of a provisional U.S. patent application for a novel DNA-based, investigational vaccine
for preventing or treating infections from a broad range of infectious agents including the coronavirus disease using its PLACCINE DNA
vaccine modality (&#8220;PLACCINE&#8221;). The provisional patent covers a family of novel composition of multi-cistronic vectors and
polymeric nanoparticles that comprise the PLACCINE DNA vaccine platform technology for preventing or treating infectious agents that
have the potential for global pandemics, including the SARS-CoV-2 virus and its variations, using the Company&#8217;s TheraPlas platform
technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon&#8217;s
PLACCINE DNA vaccine modality is characterized by a single mono-cistronic or multi-cistronic DNA plasmid vector expressing single or
multiple pathogen antigens delivered with a synthetic delivery system. We believe it is adaptable to creating vaccines for a multitude
of pathogens, including emerging pathogens leading to pandemics as well as infectious diseases that have yet to be effectively addressed
with current vaccine technologies. This flexible vaccine platform is well supported by an established supply chain to produce any plasmid
vector and its assembly into a respective vaccine formulation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
need for new vaccine technologies is urgent. Since 1980, more than 80 pathogenic viruses have been discovered, yet fewer than 4% have
a commercially available prophylactic vaccine. We have engaged with the Biomedical Advanced Research and Development Authority (&#8220;BARDA&#8221;),
a division of the U.S. Department of Health and Human Services, to consider certain pathogens BARDA has identified as the most urgent
and the most important.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLACCINE
is an extension of the Company&#8217;s synthetic, non-viral TheraPlas delivery technology currently in development for the treatment
of late-stage ovarian cancer with IMNN-001. Imunon&#8217;s proprietary multifunctional DNA vaccine technology concept is built on the
flexible PLACCINE technology platform that is amenable to rapidly responding to the SARS-CoV-2 virus, as well as possible future mutations
of SARS-CoV-2, other future pandemics, emerging bioterrorism threats, and novel infectious diseases. Imunon&#8217;s extensive experience
with TheraPlas suggests that the PLACCINE-based nanoparticles are stable at storage temperatures of 4&#176;C to 25&#176;C, making vaccines
developed on this platform easily suitable for broad world-wide distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon&#8217;s
vaccine approach is designed to optimize the quality of the immune response dictating the efficiency of pathogen clearance and patient
recovery. Imunon has taken a multivalent approach in an effort to generate an even more robust immune response that not only results
in a strong neutralizing antibody response, but also a more robust and durable T-cell response. Delivered with Imunon&#8217;s synthetic
polymeric system, the proprietary DNA plasmid is protected from degradation and its cellular uptake is facilitated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_010"></span>COVID-19
Vaccine Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
data from the recent literature indicate that the quality of the immune response as opposed to its absolute magnitude is what dictates
SARS-CoV-2 viral clearance and recovery and that an ineffective or non-neutralizing enhanced antibody response might actually exacerbate
disease. The first-generation COVID-19 vaccines were developed for rapid production and deployment and were not optimized for generating
cellular responses that result in effective viral clearance. Though early data have indicated some of these vaccines to be over 95% effective,
these first-generation vaccines were primarily designed to generate a strong antibody response, and while they have been shown to provide
prophylactic protection against disease, the durability of this protection is currently unclear. Most of these vaccines have been specifically
developed to target the SARS-CoV-2 Spike (S) protein (antigen), though it is known that restricting a vaccine to a sole viral antigen
creates selection pressure that can serve to facilitate the emergence of viral resistance. Indeed, even prior to full vaccine rollout,
it has been observed that the S protein is a locus for rapid evolutionary and functional change as evidenced by the D614G, Y453F, 501Y.V2,
and VUI-202012/01 mutations/deletions. This propensity for mutation of the S protein leads to future risk of efficacy reduction over
time as these mutations accumulate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_011"></span>Our
Next Generation Vaccine Initiative</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon&#8217;s
vaccine candidate comprises a single plasmid vector containing the DNA sequence encoding multiple SARS-CoV-2 antigens. Delivery will
be evaluated intramuscularly, intradermally, or subcutaneously with a non-viral synthetic DNA delivery carrier that facilitates vector
delivery into the cells of the injected tissue and has potential immune adjuvant properties. Unique designs and formulations of Imunon
vaccine candidates may offer several potential key advantages. The synthetic polymeric DNA carrier is an important component of the vaccine
composition as it has the potential to facilitate the vaccine immunogenicity by improving vector delivery and, due to potential adjuvant
properties, attract professional immune cells to the site of vaccine delivery.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
vaccine technology will need to address viral mutations and the challenges of efficient manufacturing, distribution, and storage. We
believe the adaptation of our TheraPlas technology, PLACCINE, has the potential to meet these challenges. Our approach is described in
our provisional patent filing and is summarized as a DNA vaccine technology platform characterized by a single plasmid DNA with multiple
coding regions. The plasmid vector is designed to express multiple pathogen antigens. It is delivered via a synthetic delivery system
and has the potential to be easily modified to create vaccines against a multitude of infectious diseases, addressing:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viral
    Mutations</b>: PLACCINE may offer broad-spectrum and mutational resistance (variants) by targeting multiple antigens on a single
    plasmid vector.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Durable
    Efficacy</b>: PLACCINE delivers a DNA plasmid-based antigen that could result in durable antigen exposure and a robust vaccine response
    to viral antigens.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Storage
    &amp; Distribution</b>: PLACCINE allows for stability that is compatible with manageable vaccine storage and distribution.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Simple
    Dosing &amp; Administration</b>: PLACCINE is a synthetic delivery system that should require a simple injection that does not require
    viruses or special equipment to deliver its payload.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 2, 2021, the Company announced results from preclinical <i>in vivo</i> studies showing production of antibodies and cytotoxic
T-cell response specific to the spike antigen of SARS-CoV-2 when immunizing BALB/c mice with the Company&#8217;s next-generation PLACCINE
DNA vaccine platform. Moreover, the antibodies to SARS-CoV-2 spike antigen prevented the infection of cultured cells in a viral neutralization
assay. The production of antibodies predicts the ability of PLACCINE to protect against SARS-CoV-2 exposure, and the elicitation of cytotoxic
T-cell response shows the vaccine&#8217;s potential to eradicate cells infected with SARS-CoV-2. These findings demonstrated the potential
immunogenicity of Imunon&#8217;s PLACCINE DNA vaccine, which is intended to provide broad-spectrum protection and resistance against
variants by incorporating multiple viral antigens, to improve vaccine stability at storage temperatures of 4&#176;C and above, and to
facilitate cheaper and easier manufacturing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 31, 2022, the Company announced the initiation of a nonhuman primate (&#8220;NHP&#8221;) challenge study with Imunon&#8217;s
DNA-based approach for a SARS-CoV-2 vaccine. The NHP pilot study followed the generation of encouraging mouse data and will evaluate
the Company&#8217;s lead vaccine formulations for safety, immunogenicity and protection against SARS-CoV-2. In completed preclinical
studies, Imunon demonstrated a favorable safety profile and efficient immune responses including IgG response, neutralizing antibodies
and T-cell responses that parallel the activity of commercial vaccines following intramuscular (IM) administration of novel vaccine compositions
expressing a single viral antigen. In addition, vector development has shown promise of neutralizing activity against a range of SARS-CoV-2
variants. Imunon&#8217;s DNA-based vaccines have been based on a simple intramuscular injection that does not require viral encapsulation
or special equipment for administration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2022, the Company presented its PLACCINE platform technology at the 2022 World Vaccine Congress in an oral presentation during
a Session on Cancer and Immunotherapy. The presentation entitled: &#8220;<i>Novel DNA Approaches for Cancer Immunotherapies and Multivalent
Infectious Disease Vaccines</i>&#8221; highlighted the Company&#8217;s technology platform.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLACCINE
has demonstrated the potential to be a powerful platform that provides for rapid design capability for targeting two or more different
variants of a single virus in one vaccine. There is a clear public health need for vaccines today that address more than one strain of
viruses, like COVID-19, which have fast evolving variant capability to offer the widest possible protection. Murine model data has thus
far been encouraging and suggests that the Company&#8217;s approach provides not only flexibility, but also the potential for efficacy
comparable to benchmark COVID-19 commercial vaccines with durability to protect for more than six months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2022, the Company provided an update on the progress made in the development of a DNA-based vaccine using its PLACCINE platform
technology. The Company reported evidence of IgG, neutralizing antibody, and T-cell responses to its SARS-CoV-2 PLACCINE vaccines in
normal mice. In this murine model, the Company&#8217;s multivalent PLACCINE vaccine targeted against two different variants showed to
be immunogenic as determined by the levels of IgG, neutralizing antibodies, and T-cell responses. Additionally, our multivalent vaccine
was equally effective against two different variants of the COVID-19 virus while the commercial mRNA vaccine appeared to have lost some
activity against the newer variant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Final
data from its now completed proof-of-concept (&#8220;PoC&#8221;) mouse challenge study confirmed that a PLACCINE DNA-based vaccine can
produce robust levels of IgG, neutralizing antibodies, and T-cell responses. The data demonstrated the ability of the Company&#8217;s
PLACCINE vaccine to protect a SARS-CoV-2 mouse model in a live viral challenge. In the study, mice were vaccinated with a PLACCINE vaccine
expressing the SARS-CoV-2 spike antigen from the D614G variant or the Delta variant, or a combination vaccine expressing both the D614G
and Delta spike variants. The vaccination was administered by intramuscular injection on Day 0 and Day 14, followed by challenge with
live SARS-CoV-2 virus on Day 42. All three vaccines, including the single and dual antigen vaccines, were found to have a favorable safety
profile and elicited IgG responses and inhibited the viral load by 90-95%. The dual antigen vaccine was equally effective against both
variants of the SARS CoV-2 virus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2022, the Company reported partial results from an ongoing non-human primate study designed to examine the immunogenicity of
its proprietary PLACCINE vaccine which supported PLACCINE as a viable alternative to mRNA vaccines. The study examined a single plasmid
DNA vector containing the SARS-CoV-2 Alpha variant spike antigen formulated with a synthetic DNA delivery system and administered by
intramuscular injection. In the study, Cynomolgus monkeys were vaccinated with the PLACCINE vaccine or a commercial mRNA vaccine on Day
1, 28 and 84. Analysis of blood samples for IgG and neutralizing antibodies showed evidence of immunogenicity both in PLACCINE and mRNA
vaccinated subjects. Analysis of bronchoalveolar lavage for viral load by quantitative PCR showed viral clearance by &gt;90% of the non-vaccinated
controls. Viral clearance from nasal swab followed a similar pattern in a majority of vaccinated animals and a similar clearance profile
was observed when viral load was analyzed by the tissue culture infectious dose method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2023, the Company announced final results from the NHP study involving three vaccine-treated non-human primates. The final data
were consistent with the earlier data and showed excellent immunological response and viral clearance. More specifically, in this NHP
study, we examined PLACCINE activity against a more advanced SARS-CoV-2 variants and at a DNA dose that was not previously tested in
NHP and demonstrated robust IgG responses, neutralizing antibody responses and complete clearance of virus following the challenge as
seen in the previous study.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
a recent mouse study, a single dose of PLACCINE vaccine without a booster dose produced longer duration of IgG responses and higher T-cell
activation than an mRNA vaccine. A 12-month PLACCINE stability study demonstrated continued drug stability at 4&#176; C (standard refrigerated
temperature). These compelling data were presented at the Vaccine Technology Summit 2023 in Boston in March 2023. They showed robust
immunogenicity and protection in SARS-CoV-2 models, durable cellular or humoral responses detectable for more than 12 months, comparable
protection activity to a commercial mRNA vaccine in a booster-dose comparison and superior immune quality versus the mRNA vaccine in
a single-dose comparison.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2023, the Company filed with the FDA a pre-IND package in advance of beginning human testing of a SARS-CoV-2 seasonal booster vaccine.
In July 2023, the FDA confirmed in a written response our plug and play strategy agreeing that a platform approach to pre-clinical toxicology
testing with reference to updated SARS-CoV-2 genes that align with current variant of concern may be used without additional need for
toxicology studies. This demonstrated the flexibility and versatility of our platform, which allows for the rapid production and development
of any vaccine by simply changing the antigen coding cassette.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 18, 2024, the Company announced that it received clearance from the FDA to begin a Phase I clinical trial with a seasonal COVID-19
booster vaccine. The Company filed an Investigational New Drug (IND) application for IMNN-101 in late February. The primary objectives
of the Phase I study are to evaluate safety, tolerability, neutralizing antibody response, and the vaccine&#8217;s durability (duration
of immunogenicity) in healthy adults. Secondary objectives of the study include evaluating the ability of the IMNN-101 vaccine to elicit
binding antibodies and cellular responses and their associated durability. The Phase I study enrolled 24 subjects to evaluate three escalating
doses of IMNN-101. For this study, IMMN-101 has been designed to protect against the SARS-CoV-2 Omicron XBB1.5 variant, in accordance
with the FDA&#8217;s Vaccines and Related Biological Products Advisory Committee&#8217;s June 2023 announcement of the framework for
updated COVID-19 doses. Based on these results, we will advance discussions with potential partners to continue development of the platform.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the second quarter of 2024, the Company announced that DM Clinical Research in Philadelphia was the first clinical site activated for
patient recruitment for its Phase I study with IMNN-101 in a seasonal COVID-19 vaccine. DM Clinical Research is an integrated national
network of clinical trial sites focused on delivering advanced, preventive medicine to underserved communities. As of September 2024,
all 24 Phase I participants were inoculated with IMNN-101 at DM Clinical Research. Topline safety and immunogenicity data are anticipated
in the first half of 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Phase I trial is designed to establish PoC for IMNN-101 as an advancement in vaccine technology. At the conclusion of this trial, Imunon
intends to seek partnership and/or business development opportunities to develop the scientific and business case for IMNN-101 as a future
vaccine to address viral mutations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_012"></span>BUSINESS
STRATEGY AND DEVELOPMENT PLAN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not generated and do not expect to generate any revenue from product sales in the next several years, if at all. An element of our
business strategy has been to pursue, as resources permit, the research and development of a range of drug candidates for a variety of
indications. We may also evaluate licensing products from third parties to expand our current product pipeline. This is intended to allow
us to diversify the risks associated with our research and development expenditures. To the extent we are unable to maintain a broad
range of drug candidates, our dependence on the success of one or a few drug candidates would increase and would have a more significant
impact on our financial prospects, financial condition, and market value. We may also consider and evaluate strategic alternatives, including
investment in, or acquisition of, complementary businesses, technologies, or products. Drug research and development is an inherently
uncertain process and there is a high risk of failure at every stage prior to approval. The timing and the outcome of clinical results
are extremely difficult to predict. The success or failure of any preclinical development and clinical trial can have a disproportionately
positive or negative impact on our results of operations, financial condition, prospects, and market value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current business strategy includes the possibility of entering into collaborative arrangements with third parties to complete the development
and commercialization of our drug candidates. In the event that third parties are contracted to manage the clinical trial process for
one or more of our drug candidates, the estimated completion date would largely be under the control of that third party rather than
us. We cannot forecast with any degree of certainty which proprietary products or indications, if any, will be subject to future collaborative
arrangements, in whole or in part, and how such arrangements would affect our development plan or capital requirements. We may also apply
for subsidies, grants or government or agency-sponsored studies that could reduce our development costs. However, we cannot forecast
with any degree of certainty whether we will be selected to receive any subsidy, grant or governmental funding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024, the Company had $5.9 million in cash and cash equivalents to fund its operations. The Company&#8217;s primary sources
of cash have been proceeds from the issuance and sale of its common stock, including via its at-the-market (&#8220;ATM&#8221;) program
and other potential funding transactions. There can be no assurance that the Company will be able to do so in the future on a timely
basis on terms acceptable to the Company, or at all. The Company has not yet commercialized any of its product candidates. Even if the
Company commercializes one or more of its product candidates, it may not become profitable in the near term. The Company&#8217;s ability
to achieve profitability depends on several factors, including its ability to obtain regulatory approval for its product candidates,
successfully complete any post-approval regulatory obligations and successfully commercialize its product candidates alone or in partnership.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
conditions raise substantial doubts about the Company&#8217;s ability to continue as a going concern. Based on the above, management
has determined there is substantial doubt regarding our ability to continue as a going concern. The report of our independent registered
public accounting firm for the year ended December 31, 2024, includes an explanatory paragraph which expresses substantial doubt about
our ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&#8217;s
plan includes raising funds from outside investors via its ATM program and other potential funding sources. However, as mentioned above,
there is no assurance such funding will be available to the Company or that it will be obtained on terms favorable to the Company or
will provide the Company with sufficient funds to meet its objectives. The Company&#8217;s financial statements do not include any adjustments
relating to the recoverability and classification of assets, carrying amounts or the amount and classification of liabilities that may
be required should the Company be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the risks and uncertainties discussed in this Annual Report, among others, we are unable to estimate the duration and completion
costs of our research and development projects or when, if ever, and to what extent we will receive cash inflows from the commercialization
and sale of a product if one of our drug candidates receives regulatory approval for marketing, if at all. Our inability to complete
any of our research and development activities, preclinical studies or clinical trials in a timely manner or our failure to enter into
collaborative agreements when appropriate could significantly increase our capital requirements and could adversely impact our liquidity.
While our estimated future capital requirements are uncertain and could increase or decrease as a result of many factors, including the
extent to which we choose to advance our research and development activities, preclinical studies and clinical trials, or whether we
are in a position to pursue manufacturing or commercialization activities, we will need significant additional capital to progress our
drug candidates through development and clinical trials, obtain regulatory approvals and manufacture and commercialize approved products,
if any. We do not know whether we will be able to access additional capital when needed or on terms favorable to us or our stockholders.
Our inability to raise additional capital, or to do so on terms reasonably acceptable to us, would jeopardize the future success of our
business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
<b>Part II, Item 7 - Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</b> of this Annual Report
for additional information regarding the Company&#8217;s financial condition, liquidity and capital resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_013"></span>RESEARCH
AND DEVELOPMENT EXPENDITURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are engaged in a limited amount of research and development in our own facilities and have sponsored research programs in partnership
with various research institutions, including the NIH and the Wistar Institute. The majority of the spending in research and development
is for the funding of IMNN-001 clinical trials and, to a lesser extent, our next generation vaccine initiative. Research and development
expenses were approximately $11.6 million and $11.3 million for the years ended December 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
<b>Part II, Item 7 - Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations </b>of this Annual Report
for additional information regarding expenditures related to our research and development programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_014"></span>GOVERNMENT
REGULATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
authorities in the U.S., at the federal, state and local level, and in other countries extensively regulate, among other things, the
research, development, testing, quality control, approval, manufacturing, labeling, post-approval monitoring and reporting, recordkeeping,
packaging, promotion, storage, advertising, distribution, marketing and export and import of pharmaceutical products such as those we
are developing. The process of obtaining regulatory approvals and the subsequent compliance with appropriate federal, state, local and
foreign statutes and regulations require the expenditure of substantial time and financial resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Regulation
in the U.S.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the U.S., the FDA regulates drugs and biological products under the Federal Food, Drug, and Cosmetic Act (the &#8220;FDCA&#8221;), the
Public Health Service Act (the &#8220;PHSA&#8221;) and implementing regulations. Failure to comply with the applicable FDA requirements
at any time pre- or post-approval may result in a delay of approval or administrative or judicial sanctions. These sanctions could include
the FDA&#8217;s imposition of a clinical hold on trials, refusal to approve pending applications, withdrawal of an approval, issuance
of warning or untitled letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions,
fines, civil penalties or criminal prosecution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
and Development</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
vehicle by which FDA approves a new pharmaceutical product or a biologic product for sale and marketing in the U.S. is a New Drug Application
(&#8220;NDA&#8221;) or a Biologics License Application (&#8220;BLA&#8221;). A new drug or biological product cannot be marketed in the
U.S. without FDA&#8217;s approval of an NDA/BLA. The steps ordinarily required before a new drug can be marketed in the U.S. include
(a) completion of pre-clinical and clinical studies; (b) submission of an IND, which must become effective before human clinical trials
may commence; (c) completion of adequate and well-controlled human clinical trials to establish the safety and efficacy of the product
to support each of its proposed indications; (d) submission and FDA acceptance of an NDA/BLA; (e) completion of an FDA inspection and
potential audits of the facilities where the drug or biological product is manufactured to assess compliance with current Good Manufacturing
Practice (&#8220;cGMP&#8221;) and to assure adequate identity, strength, quality, purity, and potency; and (e) FDA review and approval
of the NDA/BLA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-clinical
tests include laboratory evaluations of product chemistry, toxicity, formulation and stability, as well as animal studies, to assess
the potential safety and efficacy of the product. Pre-clinical safety tests that support or are intended to support an IND or NDA/BLA
must be conducted by laboratories that comply with FDA regulations regarding good laboratory practice. The results of pre-clinical tests
are submitted to the FDA as part of an IND for review before the commencement of human clinical trials. The absence of FDA objection
to an IND does not necessarily mean that the FDA will ultimately approve an NDA/BLA or that a drug candidate otherwise will come to market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
trials involve the administration of the investigational product to human subjects under the supervision of a qualified principal investigator.
Clinical trials must be conducted in accordance with good clinical practices under protocols submitted to the FDA as part of an IND and
with informed consent from the patient. Also, each clinical trial must be approved by an Institutional Review Board (&#8220;IRB&#8221;)
and is subject to ongoing IRB monitoring.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
trials are typically conducted in three sequential phases, but the phases may overlap or be combined. Phase I clinical trials may be
conducted in patients or healthy volunteers to evaluate the product&#8217;s safety, dosage tolerance and pharmacokinetics and, if possible,
seek to gain an early indication of its effectiveness. Phase II clinical trials usually involve controlled trials in a larger but still
relatively small number of subjects from the relevant patient population to evaluate dosage tolerance and appropriate dosage; identify
possible short-term adverse effects and safety risks; and provide a preliminary evaluation of the efficacy of the drug for specific indications.
Phase III clinical trials are typically conducted in a significantly larger patient population and are intended to further evaluate safety
and efficacy, establish the overall risk-benefit profile of the product, and provide an adequate basis for physician labeling.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
limited circumstances when a patient has a serious or immediately life-threatening disease or condition and certain other conditions
apply, a therapeutic drug candidate being studied in clinical trials may be made available for treatment of individual patients. Pursuant
to the 21st Century Cures Act, the manufacturer of an investigational product for a serious disease or condition is required to make
available, such as by posting on its website, its policy on evaluating and responding to requests for individual patient access to such
investigational product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that any of our clinical trials will be completed successfully within any specified time period or at all. We may
suspend clinical trials at any time, or the FDA or IRB may suspend clinical trials at any time on various grounds, including among other
things, if we, the FDA, our independent DMC, or the IRB conclude that clinical subjects are being exposed to an unacceptable health risk.
The FDA inspects and reviews clinical trial sites, informed consent forms, data from the clinical trial sites (including case report
forms and record keeping procedures) and the performance of the protocols by clinical trial personnel to determine compliance with good
clinical practices. The conduct of clinical trials is complex and difficult, and there can be no assurance that the design or the performance
of the clinical trial protocols of any of our current or future drug candidates will be successful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>U.S.
Review and Approval Process</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of pre-clinical studies and clinical trials, if successful, are submitted to FDA in the form of an NDA or BLA. Among other things,
the FDA reviews an NDA to determine whether the product is safe and effective for its intended use and reviews a BLA to determine whether
the product is safe, pure, and potent, and in each case, whether the drug candidate is being manufactured in accordance with cGMP. The
testing, submission, and approval process requires substantial time, effort, and financial resources, including substantial application
user fees and annual program user fees. There can be no assurance that any approval will be granted for any product at any time, according
to any schedule, or at all. The FDA may refuse to accept or approve an application if it determines those applicable regulatory criteria
are not satisfied. The FDA may also require additional testing for safety and efficacy. Even if regulatory approval is granted, the approval
will be limited to specific indications. There can be no assurance that any of our current drug candidates will receive regulatory approvals
for marketing or, if approved, that approval will be for any or all of the indications that we request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA has agreed to certain performance goals in the review of NDAs and BLAs. The FDA has 60 days from its receipt of an NDA or BLA to
determine whether the application will be accepted for filing based on the agency&#8217;s threshold determination that it is sufficiently
complete to permit substantive review. Once the NDA/BLA is accepted for filing, the FDA seeks to complete its review of most standard
review applications within ten months of the date of acceptance for filing of an original BLA or an NDA for a new molecular entity; FDA
seeks to complete its review of most priority review applications for such an NDA or BLA within six months of the date or acceptance
for filing. Priority review is applied to a drug candidate that the FDA determines has the potential to treat a serious or life-threatening
condition and, if approved, would provide a significant improvement in safety or effectiveness compared to available therapies. The review
process for both standard and priority review may be extended by the FDA for three additional months to consider certain late-submitted
information, or information intended to clarify information already provided in the submission.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>FDA
Regulations Specific to Gene Therapy Products</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA regulates gene therapy products, including vaccines based on gene-therapy technologies, as biological products. While biological
products intended for therapeutic use may be regulated by either the Center for Biologics Evaluation and Research (&#8220;CBER&#8221;)
or the Center for Drug Evaluation and Research (&#8220;CDER&#8221;), gene-therapy products and vaccines are regulated by CBER. Biological
products are subject to extensive regulation under the FDCA, the PHSA, and implementing regulations. Each clinical trial of an investigational
gene therapy must be reviewed and approved by the Institutional Biosafety Committee (&#8220;IBC&#8221;) for each clinical site if they
receive any funding whatsoever from the NIH. IBCs were established under NIH Guidelines for Research Involving Recombinant or Synthetic
Nucleic Acid Molecules (&#8220;NIH Guidelines&#8221;) to provide local review and oversight of nearly all forms of research utilizing
recombinant or synthetic nucleic acid molecules. An IBC assesses biosafety issues, specifically, safety practices and containment procedures,
related to research involving recombinant or synthetic nucleic acid molecules. While compliance with the NIH Guidelines is only mandatory
for investigators at institutions receiving NIH funds for research involving recombinant or synthetic nucleic acid molecules, many companies
and other institutions not otherwise subject to the NIH Guidelines voluntarily follow them. Clinical trials subject to IBC oversight
nonetheless remain subject other applicable oversight, including by to FDA and IRBs, and only after the applicable submissions, authorizations,
or approvals are in place with regulatory authorities can the clinical trials proceed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Additional
Controls for Biological Products</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
help reduce the increased risk of the introduction of adventitious agents, the PHSA emphasizes the importance of manufacturing controls
for products whose attributes cannot be precisely defined. The PHSA also provides authority to the FDA or other components of HHS to
immediately suspend licenses in situations where there exists a danger to public health, to prepare or procure products in the event
of shortages and critical public health needs, and create and enforce regulations to prevent the introduction or spread of communicable
diseases in the U.S. and between states.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
a BLA is approved, the biological product may be subject to official lot release as a condition of approval. As part of the manufacturing
process, the manufacturer is required to perform certain tests on each lot of the product before it is released for distribution. If
the product is subject to official release by the FDA, the manufacturer submits samples of each lot of products to the FDA together with
a release protocol showing the results of the manufacturer&#8217;s tests performed on the lot. The FDA may also perform certain confirmatory
tests on lots of some products, such as viral vaccines, before releasing the lots for distribution by the manufacturer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the FDA conducts laboratory research related to the regulatory standards on the safety, purity, potency, and effectiveness
of biological products. As with drugs, after approval of biological products, manufacturers must address any safety issues that arise,
are subject to recalls or a halt in manufacturing, and are subject to periodic inspection after approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expedited
Development and Review Programs</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA has various programs, including Fast Track, priority review, accelerated approval and breakthrough therapy, which are intended to
facilitate and expedite the development and review of certain drug candidates, or provide for the approval of a drug candidate on the
basis of a surrogate or intermediate endpoint. In January 2021, the FDA granted Fast Track designation for IMNN-001 for the treatment
of ovarian cancer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if a drug candidate qualifies for one or more of these programs, the FDA may later decide that the drug candidate no longer meets the
conditions for qualification or that the time period for FDA review or approval will be lengthened. Generally, drug candidates that are
eligible for these programs are those for serious or life-threatening conditions, those with the potential to address unmet medical needs
and those that offer significant benefits over existing treatments. For example, Fast Track is a program designed to facilitate the development
and expedite the review of drug candidates that are intended to treat serious or life-threatening diseases or conditions and demonstrate
the potential to address unmet medical needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
Fast Track and priority review do not alter the standards for approval, the FDA will attempt to provide opportunities for frequent meetings
with a sponsor of a Fast Track-designated drug candidate and expedite review of the application for a drug candidate designated for priority
review. Accelerated approval is available for a new drug candidate that meets the following criteria: it is intended to treat a serious
or life-threatening disease or condition, generally provides a meaningful advantage over available therapies and demonstrates an effect
on a surrogate endpoint that is reasonably likely to predict clinical benefit or on a clinical endpoint that can be measured earlier
than irreversible morbidity or mortality (&#8220;IMM&#8221;) that is reasonably likely to predict an effect on IMM or other clinical
benefit. A surrogate endpoint is a laboratory measurement, physical sign or other measure that is thought to predict clinical benefit
but is not itself a measure of clinical benefit. As a condition of approval, the FDA may require that a sponsor of a drug candidate receiving
accelerated approval perform post-marketing clinical trials to verify and describe the predicted effect on irreversible morbidity or
mortality or other clinical benefit, and the drug may be subject to expedited withdrawal procedures if the sponsor fails to conduct a
required post-marketing study with due diligence, a required post-marketing study fails to verify and describe the predicted effect on
IMM or other clinical benefit, other evidence demonstrates that the product is not shown to be safe or effective, or the sponsor disseminates
false or misleading promotional materials with respect to the product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
sponsor may seek FDA designation of a drug candidate as a &#8220;breakthrough therapy&#8221; if the drug candidate is intended, alone
or in combination with one or more other therapeutics, to treat a serious or life-threatening disease or condition, and preliminary clinical
evidence indicates that the drug candidate may demonstrate substantial improvement over existing therapies on one or more clinically
significant endpoints, such as substantial treatment effects observed early in clinical development. A request for breakthrough therapy
designation should be submitted concurrently with, or as an amendment to, an IND, but ideally no later than the end-of-Phase II meeting.
If a drug receives breakthrough therapy designation, FDA will seek to ensure that the sponsor receives timely advice and interactive
communications to help the sponsor design and conduct a drug development program as efficiently as possible. Additionally, FDA seeks
to involve senior managers and experienced staff in the review of a breakthrough therapy-designated product. FDA may consider reviewing
parts of an NDA or BLA for a breakthrough therapy-designated product on a rolling basis before the sponsor submits the complete application.
Fast Track and breakthrough therapy designations may be rescinded if the drug candidate no longer meets the designation criteria. Fast
Track designation, priority review, accelerated approval, and breakthrough therapy designation do not change the standards for approval,
but depending on the type of designation, may expedite the development or approval process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Disclosure
of Clinical Trial Information</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsors
of clinical trials of FDA-regulated products are required to register and disclose certain clinical trial information to the NIH. Information
related to the product, patient population, phase of investigation, trial sites and investigators, and other aspects of the clinical
trial is then made public as part of the registration. Sponsors are also obligated to disclose the results of their clinical trials within
one year of completion, although disclosure of the results of these trials can be delayed in certain circumstances for up to two additional
years. Competitors may use this publicly available information to gain knowledge regarding the progress of development programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Orphan
Drug Designation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2005, the FDA granted orphan drug designation for IMNN-001 for the treatment of ovarian cancer. Orphan drug designation does not convey
any advantage in, or shorten the duration of, the regulatory review and approval process. However, if a product which has an orphan drug
designation subsequently receives the first FDA approval for a drug for the indication for which it has such designation, the product
is entitled to orphan drug exclusivity, which means the FDA may not approve any other application to market the same drug for the same
indication for a period of seven years, except in limited circumstances, such as a showing of clinical superiority to the product with
orphan exclusivity, consent by the holder of orphan drug exclusivity to the approval of another application before the expiration of
such exclusivity, or a finding by the FDA that the holder of exclusivity cannot ensure the availability of sufficient quantities of the
drug to meet the needs of persons with the designated disease or condition. Orphan drug designation can also provide opportunities for
grant funding towards clinical trial costs, tax advantages and a potential exemption from certain FDA user fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2021, the U.S. Court of Appeals for the Eleventh Circuit held in <i>Catalyst Pharmaceuticals, Inc. v. Becerra</i> that the
FDA had erred by limiting the scope of orphan drug exclusivity for FIRDAPSE&#174; (amifampridine) to the product&#8217;s approved indication,
an action that the FDA took in accordance with its regulations interpreting the Orphan Drug Act. The court held that under the Orphan
Drug Act, FIRDAPSE&#174;&#8217;s orphan drug exclusivity instead protected the rare disease or condition that received orphan drug designation.
Following this court decision in the Catalyst case, the FDA announced in January 2023 that it would continue to apply the FDA&#8217;s
regulations limiting the scope of orphan drug exclusivity to a product&#8217;s approved uses or indications. As a result of the FDA&#8217;s
announcement, the scope of orphan drug exclusivity and other issues relating to the FDA&#8217;s implementation of the Orphan Drug Act
with respect to previously approved and future products may be the subject of further litigation or legislation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hatch-Waxman
Exclusivity</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDCA provides a five-year period of non-patent data exclusivity within the U.S. upon the approval of an NDA for a drug, no active moiety
(as defined in FDA&#8217;s regulations) of which previously has been approved in an NDA. During the exclusivity period, the FDA generally
may not accept for review an abbreviated new drug application (ANDA) or a 505(b)(2) NDA submitted by another company for a drug product
containing the same active moiety, except that such applications may be submitted starting four years after approval of the product protected
by exclusivity if they contain a certification of patent invalidity, non-infringement or unenforceability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Biosimilars</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Biologics Price Competition and Innovation Act of 2009 created an abbreviated approval pathway for biological drug candidates that are
biosimilar to or interchangeable with an FDA-licensed reference product. The FDA may approve a biosimilar product if it finds, among
other requirements, that the product is highly similar to the reference product notwithstanding minor differences in clinically inactive
components and there are no clinically meaningful differences between the proposed biosimilar product and the reference product in terms
of safety, purity, and potency; the proposed conditions of use have been previously approved for the reference product; and the route
of administration, dosage form, and strength of the proposed biosimilar product are the same as those of the reference product. Biosimilarity
must be shown through analytical studies, an assessment of toxicity, and a clinical trial or trials, unless the FDA waives a required
element. A biosimilar drug candidate may be deemed interchangeable with a prior approved product if it meets the higher hurdle of demonstrating
that it not only is biosimilar to the reference product, but also can be expected to produce the same clinical results as the reference
product in any given patient, and, for products administered multiple times, alternating or switching between the biological product
and the reference product will not increase safety risks or risks of diminished efficacy relative to exclusive use of the reference product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA will not accept a biosimilar application until four years after the date of first licensure of a biological product licensed under
section 351(a) of the PHSA, and the FDA will not approve a biosimilar application until 12 years after such date of first licensure.
The first biological drug candidate submitted under the abbreviated approval pathway that is determined to be interchangeable with the
reference product has exclusivity against a finding by the FDA of interchangeability for other biological products with respect to the
same reference product for the lesser of (i) one year after first commercial marketing of the first interchangeable biosimilar, (ii)
18 months after the first interchangeable biosimilar is approved if there is no patent challenge brought under section 351(l)(6) of the
PHSA, (iii) 18 months after resolution of a lawsuit brought under section 351(l)(6) of the PHSA over the patents of the reference product,
or (iv) 42 months after the first interchangeable biosimilar&#8217;s application has been approved if a patent lawsuit brought under
section 351(l)(6) of the PHSA is ongoing within the 42-month period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Post-Approval
Requirements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
FDA approval of a product is obtained, we and our contract manufacturers are required to comply with various post-approval requirements,
including establishment registration and product listing, record-keeping requirements, reporting of adverse reactions and production
problems to the FDA, providing updated safety and efficacy information for drugs, or safety, purity, and potency for biological products,
and complying with requirements concerning advertising and promotional labeling. As a condition of approval of an NDA/BLA, the FDA may
require the applicant to conduct additional clinical trials or other post market testing and surveillance to further monitor and assess
the drug&#8217;s safety and efficacy. The FDA can also impose other post-marketing controls on us as well as our products including,
but not limited to, restrictions on sale and use, through the approval process, regulations and otherwise. The FDA also has the authority
to require the recall of our biological products or request a recall of our drug or biological products in the event of material deficiencies
or defects in manufacture. A governmentally mandated or requested recall, or a voluntary recall by us, could result from a number of
events or factors, including component failures, manufacturing errors, instability of product or defects in labeling.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, manufacturing establishments in the U.S. and abroad are subject to periodic inspections by the FDA and must comply with cGMP.
To maintain compliance with cGMP, manufacturers must expend funds, time and effort in the areas of production and quality control. The
manufacturing process must be capable of consistently producing quality batches of the drug candidate and the manufacturer must develop
methods for testing the quality, purity and potency of the drug candidate. Additionally, appropriate packaging must be selected and tested,
and stability studies must be conducted to demonstrate that the drug candidate does not undergo unacceptable deterioration over its proposed
shelf-life.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
Clinical Studies to Support an IND, NDA, or BLA</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA will accept as support for an IND, NDA, or BLA a well-designed, well-conducted, non-IND foreign clinical trial if it was conducted
in accordance with good clinical practice (&#8220;GCP&#8221;) and the FDA is able to validate the data from the trial through an on-site
inspection, if necessary. A sponsor or applicant who wishes to rely on a non-IND foreign clinical trial to support an IND must submit
supporting information to the FDA to demonstrate that the trial conformed to GCP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory
applications based solely on foreign clinical data meeting these criteria may be approved if the foreign data are applicable to the U.S.
population and U.S. medical practice, the trials have been performed by clinical investigators of recognized competence, and the data
may be considered valid without the need for an on-site inspection by FDA or, if FDA considers such an inspection to be necessary, FDA
is able to validate the data through an on-site inspection or other appropriate means. Failure of an application to meet any of these
criteria may result in the application not being approvable based on the foreign data alone.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>New
Legislation and Regulations</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, legislation is drafted, introduced, and passed in Congress that could significantly change the statutory provisions governing
the testing, approval, manufacturing and marketing of products regulated by the FDA. In addition to new legislation, FDA regulations
and policies are often revised or interpreted by the agency in ways that may significantly affect our business and our products, once
approved. It is impossible to predict whether further legislative changes will be enacted or whether FDA regulations, guidance, policies
or interpretations will be changed or what the effect of such changes, if any, may be.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Regulatory Matters</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing,
sales, promotion and other activities of drug candidates following product approval, where applicable, or commercialization are also
subject to regulation by numerous regulatory authorities in the U.S. in addition to the FDA, which may include the Centers for Medicare
&amp; Medicaid Services (&#8220;CMS&#8221;), other divisions of the HHS, the Department of Justice, the Drug Enforcement Administration,
the Consumer Product Safety Commission, the Federal Trade Commission, the Occupational Safety &amp; Health Administration, the Environmental
Protection Agency and state and local governments and governmental agencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FDA
regulations prohibit the promotion of an investigational product for unapproved use. The FDA distinguishes impermissible promotion of
an investigational product from the permissible exchange of scientific and medical information among healthcare professionals under certain
conditions, which may include company-sponsored scientific and educational activities. The FDA has issued Warning Letters and untitled
letters to sponsors and clinical investigators who have claimed, directly or indirectly, that an investigational product is safe and
effective for its intended use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Healthcare Laws</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthcare
providers, physicians, and third-party payors will play a primary role in the recommendation and prescription of any products for which
we obtain marketing approval. Our business operations and any current or future arrangements with third-party payors, healthcare providers
and physicians may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may constrain the business
or financial arrangements and relationships through which we develop, market, sell and distribute any drug candidates for which we obtain
marketing approval. In the U.S., these laws include, without limitation, state and federal anti-kickback, false claims, physician transparency,
and patient data privacy and security laws and regulations, including but not limited to those described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    federal Anti-Kickback Statute prohibits among other things, persons and entities from knowingly and willfully soliciting, offering,
    paying, receiving or providing any remuneration (including any kickback, bribe, or certain rebate), directly or indirectly, overtly
    or covertly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual for, or the purchase,
    order or recommendation of, any good or service, for which payment may be made, in whole or in part, under a federal healthcare program
    such as Medicare and Medicaid. A person or entity need not have actual knowledge of the federal Anti-Kickback Statute or specific
    intent to violate it in order to have committed a violation. Violations are subject to significant civil and criminal fines and penalties
    for each violation, imprisonment, and exclusion from government healthcare programs. In addition, the government may assert that
    a claim that includes items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent
    claim for purposes of the civil False Claims Act (&#8220;FCA&#8221;). </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    federal civil and criminal false claims laws, including the civil FCA, prohibit individuals or entities from, among other things,
    knowingly presenting, or causing to be presented, to the federal government, claims for payment or approval that are false, fictitious
    or fraudulent; knowingly making, using, or causing to be made or used, a false statement or record material to a false or fraudulent
    claim or obligation to pay or transmit money or property to the federal government; or knowingly concealing or knowingly and improperly
    avoiding or decreasing an obligation to pay money to the federal government. Manufacturers can be held liable under the FCA even
    when they do not submit claims directly to government payors if they are deemed to &#8220;cause&#8221; the submission of false or
    fraudulent claims. The FCA also permits a private individual acting as a &#8220;whistleblower&#8221; to bring actions on behalf of
    the federal government alleging violations of the FCA and to share in any monetary recovery. When an entity is determined to have
    violated the FCA, the government may impose civil fines and penalties for each false claim, plus treble damages, and exclude the
    entity from participation in Medicare, Medicaid and other federal healthcare programs. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    federal civil monetary penalties laws, which impose civil fines for, among other things, the offering or transfer or remuneration
    to a Medicare or state healthcare program beneficiary if the person knows or should know it is likely to influence the beneficiary&#8217;s
    selection of a particular provider, practitioner, or supplier of services reimbursable by Medicare or a state health care program,
    unless an exception applies. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;) imposes criminal and civil liability for knowingly
    and willfully executing a scheme, or attempting to execute a scheme, to defraud any healthcare benefit program, including private
    payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, willfully obstructing a criminal investigation
    of a healthcare offense, or falsifying, concealing or covering up a material fact or making any materially false statements in connection
    with the delivery of or payment for healthcare benefits, items or services.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HIPAA,
    as amended by the Health Information Technology for Economic and Clinical Health Act of 2009 (&#8220;HITECH&#8221;), and their respective
    implementing regulations, imposes, among other things, specified requirements on covered entities and their business associates relating
    to the privacy and security of individually identifiable health information including mandatory contractual terms and required implementation
    of technical safeguards of such information. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil
    and criminal penalties directly applicable to business associates in some cases, and gave state attorneys general new authority to
    file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#8217; fees
    and costs associated with pursuing federal civil actions.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Physician Payments Sunshine Act, enacted as part of the Patient Protection and Affordable Care Act, as amended by the Health Care
    and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;) imposed new annual reporting requirements for certain
    manufacturers of drugs, devices, biologics, and medical supplies for which payment is available under Medicare, Medicaid, or the
    Children&#8217;s Health Insurance Program, for certain payments and &#8220;transfers of value&#8221; provided to physicians (defined
    to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment
    interests held by physicians and their immediate family members. In addition, many states also require reporting of payments or other
    transfers of value, many of which differ from each other in significant ways and are often not pre-empted, thus further complicating
    compliance efforts. Effective January 1, 2022, these reporting obligations extended to include transfers of value made in the previous
    year to certain non-physician providers such as physician assistants and nurse practitioners.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal
    consumer protection and unfair competition laws broadly regulate marketplace activities and activities that potentially harm consumers.
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Analogous
    state and foreign laws and regulations, such as state anti-kickback and false claims laws, may apply to sales or marketing arrangements
    and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers,
    and may be broader in scope than their federal equivalents; state and foreign laws that require pharmaceutical companies to comply
    with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the
    federal government or otherwise restrict payments that may be made to healthcare providers; state and foreign laws that require drug
    manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers
    and restrict marketing practices or require disclosure of marketing expenditures and pricing information; and state and foreign laws
    that govern the privacy and security of health information in some circumstances. These data privacy and security laws may differ
    from each other in significant ways and often are not pre-empted by HIPAA, which may complicate compliance efforts. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform,
especially in light of the lack of applicable precedent and regulations. Federal and state enforcement bodies have recently increased
their scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions,
convictions and settlements in the healthcare industry. It is possible that governmental authorities will conclude that our business
practices do not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare
laws and regulations. If our operations are found to be in violation of any of these laws or any other related governmental regulations
that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, imprisonment, disgorgement,
exclusion from government funded healthcare programs, such as Medicare and Medicaid, reputational harm, additional oversight and reporting
obligations if we become subject to a corporate integrity agreement or similar settlement to resolve allegations of non-compliance with
these laws and the curtailment or restructuring of our operations. If any of the physicians or other healthcare providers or entities
with whom we expect to do business are found to be not in compliance with applicable laws, they may be subject to similar actions, penalties
and sanctions. Ensuring business arrangements comply with applicable healthcare laws, as well as responding to possible investigations
by government authorities, can be time- and resource-consuming, including requiring significant capital allocations, and can divert a
company&#8217;s attention from its business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the U.S., the collection and use of personal data is increasingly subject to various federal and state privacy and data security laws
and regulations, including oversight by various regulatory and other governmental bodies. Those laws and regulations continue to evolve
and are increasingly being enforced vigorously by both governmental and private causes of action. For example, following the enactment
of the California Consumer Privacy Act of 2018, which was subsequently amended by the Consumer Privacy Rights Act of 2020, other states
have established a broad range of privacy obligations for businesses, including robust notice and the right to opt-out from the selling
or sharing of personal information, access, correction, portability, deletion, and related obligations. While many of these statutes
specifically exempt protected health information that is subject to HIPAA and clinical trial regulations, these statutes have marked
the beginning of a trend towards a more stringent state privacy legislative regime in the U.S., which could increase our potential liability
and adversely affect our business both from a financial and reputational perspective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Insurance
Coverage and Reimbursement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the U.S. and markets in other countries, patients who are prescribed treatments for their conditions and providers performing the prescribed
services generally rely on third-party payors to reimburse all or part of the associated healthcare costs. Thus, even if a drug candidate
is approved, sales of the product will depend, in part, on the extent to which third-party payors, including government health programs
in the U.S. such as Medicare and Medicaid, commercial health insurers and managed care organizations, provide coverage, and establish
adequate reimbursement levels for, the product. In the U.S., the principal decisions about reimbursement for new medicines are typically
made by CMS, an agency within HHS. CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare
and private payors tend to follow CMS to a substantial degree. No uniform policy of coverage and reimbursement for drug products exists
among third-party payors. Therefore, coverage and reimbursement for drug products can differ significantly from payor to payor. The process
for determining whether a third-party payor will provide coverage for a product may be separate from the process for setting the price
or reimbursement rate that the payor will pay for the product once coverage is approved. Third-party payors are increasingly challenging
the prices charged, examining the medical necessity, and reviewing the cost-effectiveness of medical products and services and imposing
controls to manage costs. Third-party payors may limit coverage to specific products on an approved list, also known as a formulary,
which might not include all of the approved products for a particular indication.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure coverage and reimbursement for any product that might be approved for sale, a company may need to conduct expensive pharmacoeconomic
studies in order to demonstrate the medical necessity and cost-effectiveness of the product, in addition to the costs required to obtain
FDA or other comparable regulatory approvals. Additionally, companies may also need to provide discounts to purchasers, private health
plans or government healthcare programs. Nonetheless, drug candidates may not be considered medically necessary or cost effective. A
decision by a third-party payor not to cover a product could reduce physician utilization once the product is approved and have a material
adverse effect on sales, our operations and financial condition. Additionally, a third-party payor&#8217;s decision to provide coverage
for a product does not imply that an adequate reimbursement rate will be approved. Further, one payor&#8217;s determination to provide
coverage for a product does not ensure that other payors will also provide coverage and reimbursement for the product, and the level
of coverage and reimbursement can differ significantly from payor to payor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
containment of healthcare costs has become a priority of federal, state and foreign governments, and the prices of products have been
a focus in this effort. Governments have shown significant interest in implementing cost-containment programs, including price controls,
restrictions on reimbursement and requirements for substitution of generic products. Adoption of price controls and cost-containment
measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit a company&#8217;s
revenue generated from the sale of any approved products. Coverage policies and third-party payor reimbursement rates may change at any
time. Even if favorable coverage and reimbursement status is attained for one or more products for which a company or its collaborators
receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the federal level, for example, the Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;) was signed into law. Key provisions of the
IRA include the following, among others:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    IRA requires manufacturers to pay rebates for Medicare Part B and Part D drugs where price increases exceed inflation. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    IRA eliminates the &#8220;donut hole&#8221; under Medicare Part D beginning in 2025 by significantly lowering the beneficiary maximum
    out-of-pocket cost and requiring manufacturers to subsidize, through a newly established manufacturer discount program, 10% of Part
    D enrollees&#8217; prescription costs for brand drugs below the out-of-pocket maximum and 20% once the out-of-pocket maximum has
    been reached.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    IRA delays the rebate rule that would require pass through of pharmacy benefit manager rebates to beneficiaries.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    IRA directs CMS to engage in price-capped negotiation for certain Medicare Part B and Part D products. Specifically, the IRA&#8217;s
    Price Negotiation Program applies to high-expenditure single-source drugs and biologics that have been approved for at least 7 or
    11 years, respectively, among other negotiation selection criteria, beginning with ten high-cost drugs paid for by Medicare Part
    D starting in 2026, followed by 15 Part D drugs in 2027, 15 Part B or Part D drugs in 2028, and 20 Part B or Part D drugs in 2029
    and beyond. The negotiated prices will be capped at a statutorily determined ceiling price. There are certain statutory exemptions
    from the IRA&#8217;s Price Negotiation Program, such as for a drug that has only a single orphan drug designation and is approved
    only for an indication or indications within the scope of such designation. The IRA&#8217;s Price Negotiation Program is currently
    the subject of legal challenges.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturers
that fail to comply with the IRA may be subject to various penalties, including civil monetary penalties or a potential excise tax. The
IRA permits the Secretary of HHS to implement many of the IRA&#8217;s provisions through guidance, as opposed to regulation, for the
initial years. The effect of the IRA is anticipated to have significant effects on the pharmaceutical industry and may reduce the prices
pharmaceutical manufacturers can charge and reimbursement pharmaceutical manufacturers can receive for approved products, among other
effects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
implementation of the IRA and other state and federal healthcare reform measures may be adopted in the future, any of which may result
in additional reductions in Medicare and other healthcare funding and otherwise affect the prices we may obtain for any drug candidates
for which we may obtain regulatory approval or the frequency with which any such drug candidate is prescribed or used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outside
the U.S., ensuring coverage and adequate payment for a product also involves challenges, as the pricing of biological products is subject
to governmental control in many countries. For example, in the European Union, pricing and reimbursement schemes vary widely from country
to country. Some countries provide that products may be marketed only after a reimbursement price has been agreed. Some countries may
require the completion of additional studies that compare the cost effectiveness of a particular therapy to currently available therapies
or so-called health technology assessments, in order to obtain reimbursement or pricing approval. Other countries may allow companies
to fix their own prices for products but monitor and control product volumes and issue guidance to physicians to limit prescriptions.
Efforts to control prices and utilization of biological products will likely continue as countries attempt to manage healthcare expenditures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Current
and Future Healthcare Reform Legislation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the U.S. and some foreign jurisdictions, there have been, and likely will continue to be, a number of legislative and regulatory changes
and proposed changes regarding the healthcare system directed at broadening the availability of healthcare, improving the quality of
healthcare, and containing or lowering the cost of healthcare. For example, on May 30, 2018, the Right to Try Act was signed into law.
The law, among other things, provides a federal framework for certain patients to access certain IND products that have completed a Phase
I clinical trial and that are undergoing investigation for FDA approval or for which a marketing application has been submitted to the
FDA. Under certain circumstances, eligible patients can request access to such an investigational drug product for treatment use without
enrolling in clinical trials and without obtaining FDA permission under the FDA expanded access regulations. There is no obligation for
a drug manufacturer to make its drug products available to eligible patients as a result of the Right to Try Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
payment methodologies may be subject to changes in healthcare legislation and regulatory initiatives. For example, CMS may develop new
payment and delivery models, such as bundled payment models. In addition, recently there has been heightened governmental scrutiny over
the manner in which manufacturers set prices for their commercial products, which has resulted in several Congressional inquiries and
proposed and enacted state and federal legislation designed to, among other things, bring more transparency to product pricing, review
the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for pharmaceutical
products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 20, 2020, HHS Office of the Inspector General finalized a regulation with the goal of lowering prescription drug prices and
out-of-pocket spending for prescription drugs. Specifically, the final rule clarified and amended the discount safe harbor under the
federal Anti-Kickback Statute with the effect that rebates paid from drug manufacturers to Medicare Part D prescription drug plan sponsors,
or their pharmacy benefit managers (&#8220;PBMs&#8221;) would be excluded from liability protection under the discount safe harbor. The
rule also added a new safe harbor for point-of-sale reductions in price and another that protects certain fixed-fee service arrangements
between PBMs and drug manufacturers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Congress
has indicated that it will continue to seek new legislative and/or administrative measures to control drug costs. Any reduction in reimbursement
from Medicare and other government programs may result in a similar reduction in payments from private payers. Moreover, at the state
level, legislatures are increasingly passing legislation and implementing regulations designed to control biopharmaceutical and biologic
product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing
cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Regulation
Outside of the U.S.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to regulations in the U.S., we will be subject to a variety of regulations of other countries governing, among other things,
any clinical trials and commercial sales and distribution of our drug candidates. Whether or not we obtain FDA approval (clinical trial
or marketing) for a product, we must obtain the requisite approvals from regulatory authorities in countries outside of the U.S., such
as the EU and China, prior to the commencement of clinical trials or marketing of the products in those countries. The approval process
and requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement vary greatly from place to place,
and the time may be longer or shorter than that required for FDA approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the EU, before starting a clinical trial, it must be authorized by the competent authority of each EU Member State in which the sponsor
plans to conduct the clinical trial. Under the new EU Clinical Trials Regulation (EU) 536/2014, which took effect on 31 January 2022,
the sponsor must submit an application dossier to the relevant EU Member States through a central portal, known as the Clinical Trial
Information System (CTIS). Part I of the application contains the scientific aspects of the trial, including manufacturing, pre-clinical
and clinical data on the product. Part II of the application contains the ethical aspects of the trial. A single reporting Member State
assesses Part I and reaches a decision in consultation with the other concerned Member States. Each Member State assesses Part II of
the application through its own national ethics committee procedure and reaches its own decision. Clinical trials conducted in the EU
(or used for marketing authorization application in the EU) must be conducted in accordance with applicable standards of GCP, including
the ICH GCP guidelines. The investigational medicinal products used in clinical trials in the EU must have been manufactured in accordance
with EU standards of good manufacturing practice (&#8220;GMP&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
in the U.S., no medicinal product may be placed on the EU market unless a marketing authorization has been issued. In the EU, medicinal
products may be authorized under the centralized procedure administered by the EMA or one of the procedures administered by competent
authorities in the individual EU Member States (decentralized procedure, mutual recognition procedure, or if the product is to be approved
in only one member state, the national procedure). The centralized procedure provides for the grant of a single marketing authorization
by the European Commission that is valid for all EU Member States. The centralized procedure is compulsory for specific products, including
medicines produced by certain biotechnological processes, products designated as orphan medicinal products, advanced therapy medicinal
products and products with a new active substance indicated for the treatment of certain diseases, including products for the treatment
of cancer and products for the treatment of infectious diseases. For products with a new active substance indicated for the treatment
of other diseases and products that are highly innovative or for which a centralized process is in the interest of patients, the centralized
procedure is optional.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the centralized procedure in the EU, marketing authorization applications are submitted to the EMA, where they are reviewed by relevant
scientific committees, including the Committee for Medicinal Products for Human Use (&#8220;CHMP&#8221;). The EMA will forward the final
CHMP opinion to the European Commission, to use as the basis for deciding whether to grant a marketing authorization. The maximum timeframe
for the evaluation of a marketing authorization application by the CHMP is 210 days. However, this timeline excludes clock stops, when
additional written or oral information is to be provided by the applicant in response to questions asked by the CHMP, so the overall
process typically takes a year or more. Accelerated evaluation might be granted by the CHMP in exceptional cases, when a medicinal product
is expected to be of a major interest for public health and therapeutic intervention, defined by the absence or insufficiency of an appropriate
alternative therapeutic approach for the disease to be treated and anticipation of high therapeutic benefit of the new product. In this
circumstance, the EMA ensures that the opinion of the CHMP is given within 150 days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketing
authorization applications for generic of biosimilar medicinal products do not need to include the results of pre-clinical studies and
clinical trials, but instead can refer to the data included in the marketing authorization of a reference product for which regulatory
data exclusivity has expired. If a marketing authorization is granted for a medicinal product containing a new active substance, that
product benefits from eight years of data exclusivity, during which generic or biosimilar applications referring to the data of that
product will not be accepted by the regulatory authorities, and a further two years of market exclusivity, during which such generic
or biosimilar products may not be placed on the market. The two-year market exclusivity period may be extended to three years if during
the first eight years of the product&#8217;s authorization, a new therapeutic indication with significant clinical benefit over existing
therapies is approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the EU, a medicinal product may be designated as an orphan medicinal product if the sponsor can establish that it is intended for the
diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition affecting not more than five in 10 thousand
persons in the EU, or that, for the same purposes, it is unlikely that the marketing of the medicinal product would generate sufficient
return in the EU to justify the necessary investment; and in either case that there exists no satisfactory method of diagnosis, prevention
or treatment of the condition in question that has been authorized in the EU or, if such method exists, that the medicinal product will
be of significant benefit to those affected by that condition. Orphan medicinal product designation entitles the sponsor to financial
incentives such as reduction of fees or fee waivers and ten years of market exclusivity is granted following marketing authorization
for the orphan indication. During this period, the competent authorities may not accept or approve any similar medicinal product for
the same therapeutic indication, unless (i) the second medicinal product is safer, more effective or otherwise clinically superior to
the authorized orphan product; (ii) the marketing authorization holder for the authorized product consents to a second orphan medicinal
product application; or (iii) the marketing authorization holder for the authorized product cannot supply enough orphan medicinal product.
This period may be reduced to six years if the orphan medicinal product designation criteria are no longer met, including where it is
shown that the product is sufficiently profitable not to justify maintenance of orphan designation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the EU, the requirements for pricing, coverage and reimbursement of any drug candidates for which we obtain regulatory approval are provided
for by the national laws of EU Member States. Governments influence the price of pharmaceutical products through their pricing and reimbursement
rules and control of national health care systems that fund a large part of the cost of those products to consumers. The downward pressure
on healthcare costs in general, particularly prescription medicines, has become very intense. As a result, increasingly high barriers
are being erected to the entry of new products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_015"></span>MANUFACTURING
AND SUPPLY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company currently operates a current good manufacturing practice (cGMP) clinical-scale manufacturing facility for IMNN-001 based in </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Huntsville,
Alabama<span style="background-color: white">. </span>We do not currently own or operate manufacturing facilities for the final fill/finish
production of clinical or commercial quantities of any of our drug candidates. We contract with third-party contract manufacturing organizations
(&#8220;CMOs&#8221;) for our clinical trial supplies, and we expect to continue to do so to meet our clinical requirements of our drug
candidates. We have agreements for the supply of such drug materials with manufacturers or suppliers that we believe have sufficient
capacity to meet our demands. In addition, we believe that adequate alternative sources for such supplies exist. However, there is a
risk that, if supplies are interrupted, it would materially harm our business. We typically order raw materials and services on a purchase
order basis and do not enter into long-term dedicated capacity or minimum supply arrangements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
is subject to extensive regulations that impose various procedural and documentation requirements, which govern record keeping, manufacturing
processes and controls, personnel, quality control and quality assurance, among others. Medical product manufacturers and other entities
involved in the manufacture and distribution of approved drug or biologic products are required to register their establishments with
the FDA and certain state agencies and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance
with cGMP and other laws. cGMP is a regulatory standard for the production of pharmaceuticals that will be used in humans which is recognized
by FDA and many foreign regulatory authorities. Accordingly, manufacturers must continue to expend time, money, and effort in the area
of production and quality control to maintain GMP compliance. We use CMOs which manufacture our drug candidates under cGMP conditions.
In addition, changes to the manufacturing process or facility generally require prior FDA approval before being implemented and other
types of changes to the approved product, such as adding new indications and additional labeling claims, are also subject to further
FDA review and approval. The FDA has the authority to take a variety of actions to address violations, including suspending the review
of a pending application; refusing to approve or withdrawing approval of a marketing application; placing a study on clinical hold; issuing
warning or untitled letters; ordering or requesting a product recall; seizing product in distribution; seeking an injunction to stop
manufacture and distribution of a product; seeking restitution, disgorgement of profits, and fines; and debarring a company and its executives
individually from participation in any capacity in the drug approval process. In addition, the U.S. Department of Justice has the authority
to criminally prosecute companies and company executives for violations of the FDCA and the PHSA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_016"></span>SALES
AND MARKETING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current focus is on the development of our existing portfolio, the completion of clinical trials and, if and where appropriate, the registration
of our drug candidates. We currently do not have marketing, sales and distribution capabilities. If we receive marketing and commercialization
approval for any of our drug candidates, we intend to market the product either directly or through strategic alliances and distribution
agreements with third parties. The ultimate implementation of our strategy for realizing the financial value of our drug candidates is
dependent on the results of clinical trials for our drug candidates, the availability of regulatory approvals and the ability to negotiate
acceptable commercial terms with third parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_017"></span>PRODUCT
LIABILITY AND INSURANCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business exposes us to potential product liability risks that are inherent in the testing, manufacturing, and marketing of human therapeutic
products. We presently have product liability insurance limited to $10 million per incident, and if we were to be subject to a claim
in excess of this coverage or to a claim not covered by our insurance and the claim succeeded, we would be required to pay the claim
out of our own limited resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_018"></span>COMPETITION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Competition
in the discovery and development of new methods for treating and preventing disease is intense. We face, and will continue to face, competition
from pharmaceutical and biotechnology companies, as well as academic and research institutions and government agencies both in the U.S.
and abroad. We face significant competition from organizations pursuing the same or similar technologies used by us in our drug discovery
efforts and from organizations developing pharmaceuticals that are competitive with our drug candidates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
of our competitors, either alone or together with their collaborative partners, have substantially greater financial resources and larger
research and development staff than we do. In addition, most of these organizations, either alone or together with their collaborators,
have significantly greater experience than we do in developing products, undertaking preclinical testing and clinical trials, and manufacturing
and marketing products. Mergers and acquisitions in the pharmaceutical industry may result in even more resources being concentrated
among our competitors. These companies, as well as academic institutions, governmental agencies, and private research organizations,
also compete with us in recruiting and retaining highly qualified scientific personnel and consultants. Our ability to compete successfully
with other companies in the pharmaceutical and biotechnology field also depends on the status of our collaborations and on the continuing
availability of capital to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>IMNN-001
Immunotherapy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Studied
indications for IMNN-001 currently include newly diagnosed Stage III/IV ovarian cancer. In evaluating the competitive landscape for this
indication, neo-adjuvant and/or adjuvant chemotherapy to debulking surgery (carboplatin and paclitaxel for ovarian cancer) is the standard
of care. Bevacizumab, an angiogenesis inhibitor, can be used in conjunction with the adjuvant chemotherapy and prolonged until progression
(the maintenance phase of the treatment).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IMNN-001
is being studied as an adjuvant to both chemotherapy standard of care regimens, as well as anti-angiogenesis compounds. To support these
cases, we are conducting clinical studies in combination with chemotherapy, chemotherapy and bevacizumab for newly diagnosed ovarian
cancer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PLACCINE
DNA Vaccine Technology Platform</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face and will continue to encounter competition with an array of existing or development-stage drug approaches targeting diseases we
are pursuing. We are aware of various established enterprises, including major pharmaceutical companies, broadly engaged in vaccine/immunotherapy
research and development. These include Sanofi-Aventis, GlaxoSmithKline&#8239;plc, Merck, Pfizer, and AstraZeneca. There are also various
development-stage biotechnology companies involved in different vaccine and immunotherapy technologies including but not limited to Advaxis,
Bavarian Nordic, CureVac, Dynavax, Hookipa, Iovance, Nektar, Translate Bio, Zydus, and Vir Biotechnology. If these companies are successful
in developing their technologies, it could materially and adversely affect our business and our future growth prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
large number of companies are actively advancing COVID-19 vaccines through the clinic. Pfizer and BioNTech, Moderna Therapeutics, Novavax,
Zydus, and AstraZeneca have received conditional or complete approval for their COVID-19 vaccines from either the U.S., WHO, or European
regulatory authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also compete more specifically with companies seeking to utilize antigen-encoding DNA delivered with electroporation or other DNA delivery
technologies such as viral vectors or lipid vectors to induce <i>in vivo</i> generated antigen production and immune responses to prevent
or treat various diseases. These competitive technologies have shown promise, but they each also have their unique obstacles to overcome.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of our competitors develop products with efficacy or safety profiles significantly better than our drug candidates, we may not be
able to commercialize our products, if approved, and sales of any of our commercialized products, if any, could be harmed. Some of our
competitors and potential competitors have substantially greater product development capabilities and financial, scientific, marketing
and human resources than we do. Competitors may develop products earlier, obtain regulatory approvals for products more rapidly, or develop
products that are more effective than those under development by us. We will seek to expand our technological capabilities to remain
competitive; however, research and development by others may render our technologies or products obsolete or noncompetitive or result
in treatments or cures superior to ours.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
competitive position will be affected by the disease indications addressed by our drug candidates and those of our competitors, the timing
of market introduction for these products and the stage of development of other technologies to address these disease indications. For
us and our competitors, proprietary technologies, the ability to complete clinical trials on a timely basis and with the desired results,
and the ability to obtain timely regulatory approvals to market these drug candidates are likely to be significant competitive factors.
Other important competitive factors will include efficacy, safety, ease of use, reliability, availability and price of products and the
ability to fund operations during the period between technological conception and commercial sales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_019"></span>INTELLECTUAL
PROPERTY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_020"></span>Patents
and Proprietary Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the TheraPlas technology, we own five patents in U.S. and international patents and related applications with claims on methods and compositions
of matter that cover various aspects of TheraPlas and IMNN-001 technologies. The issued patents have expiration dates ranging from 2025
to 2028. Four new patents of the TheraPlas family were filed in 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the PlaCCine technology, we have filed three patent applications in the U.S. and abroad between 2021 and 2023 with claims on methods
and compositions of matter that cover various aspect of the Company&#8217;s prophylactic and therapeutic vaccine technologies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
mentioned above, the FDA granted orphan drug designation to IMNN-001 for the treatment of ovarian cancer. Orphan drug designation does
not convey any advantage in, or shorten the duration of, the regulatory review and approval process. However, if a product which has
an orphan drug designation subsequently receives the first FDA approval for the indication for which it has such designation, the product
is entitled to orphan drug exclusivity, which means the FDA may not approve any other application to market the same drug for the same
indication for a period of seven years, except in limited circumstances, such as a showing of clinical superiority to the product with
orphan exclusivity. Orphan drug designation can also provide opportunities for grant funding towards clinical trial costs, tax advantages
and FDA user-fee benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that an issued patent will remain valid and enforceable in a court of law through the entire patent term. Should
the validity of a patent be challenged, the legal process associated with defending the patent can be costly and time consuming. Issued
patents can be subject to oppositions, interferences and other third-party challenges that can result in the revocation of the patent
or maintenance of the patent in amended form (and potentially in a form that renders the patent without commercially relevant or broad
coverage). Competitors may be able to circumvent our patents. Development and commercialization of pharmaceutical products can be subject
to substantial delays, and it is possible that at the time of commercialization any patent covering the product has expired or will be
in force for only a short period of time following commercialization. We cannot predict with any certainty if any third-party U.S. or
foreign patent rights, other proprietary rights, will be deemed infringed by the use of our technology. Nor can we predict with certainty
which, if any, of these rights will or may be asserted against us by third parties. Should we need to defend ourselves and our partners
against any such claims, substantial costs may be incurred. Furthermore, parties making such claims may be able to obtain injunctive
or other equitable relief, which could effectively block our ability to develop or commercialize some or all of our products, if approved,
in the U.S. and abroad and could result in the award of substantial damages. In the event of a claim of infringement, we or our partners
may be required to obtain one or more licenses from a third party. There can be no assurance that we can obtain a license on a reasonable
basis should we deem it necessary to obtain rights to an alternative technology that meets our needs. The failure to obtain a license
may have a material adverse effect on our business, results of operations and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on our proprietary know-how and experience in the development and use of our product portfolio, which we seek to protect, in part,
through proprietary information agreements with employees, consultants and others. There can be no assurance that these proprietary information
agreements will not be breached, that we will have adequate remedies for any breach, or that these agreements, even if fully enforced,
will be adequate to prevent third-party use of the Company&#8217;s proprietary technology. Please refer to <b>Part I, Item 1A, Risk Factors
</b>of this Annual Report, including, but not limited to, &#8220;We rely on trade secret protection and other unpatented proprietary
rights for important proprietary technologies, and any loss of such rights could harm our business, results of operations and financial
condition.&#8221; Similarly, we cannot guarantee that technology rights licensed to us by others will not be successfully challenged
or circumvented by third parties, or that the rights granted will provide us with adequate protection. Please refer to <b>Part I, Item
1A, Risk Factors</b> of this Annual Report, including, but not limited to, &#8220;Our business depends on license agreements with third
parties to permit us to use patented technologies. The loss of any of our rights under these agreements could impair our ability to develop
and market our products, if approved.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_021"></span>EMPLOYEES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 21, 2025, we employed 25 full-time employees. We also maintain active independent contractor relationships with various individuals,
most of whom have month-to-month or annual consulting agreements. None of our employees are covered by a collective bargaining agreement,
and we consider our relationship with our employees to be good.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_022"></span>COMPANY
INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2022, Celsion Corporation announced a corporate name change to Imunon, Inc., reflecting the evolution of the Company&#8217;s
business focus and its commitment to developing cutting-edge immunotherapies and next-generation vaccines. The Company&#8217;s common
stock trades on the Nasdaq Stock Market under the ticker symbol &#8220;IMNN.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was founded in 1982 and is a Delaware corporation. Our principal executive offices are located at 997 Lenox Drive, Suite 100,
Lawrenceville, NJ 08648. Our telephone number is (609) 896-9100. The Company&#8217;s website is www.imunon.com. The information contained
in, or that can be accessed through, our website is not part of, and is not incorporated into, this Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_023"></span>AVAILABLE
INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
make available free of charge through our website, www.Imunon.com, our Annual Report, Quarterly Reports on Form 10-Q, Current Reports
on Form 8-K, and all amendments to those reports as soon as reasonably practicable after such material is electronically filed with or
furnished to the Securities and Exchange Commission (the &#8220;SEC&#8221;). In addition, our website, <i>www.imunon.com</i>, includes
other items related to corporate governance matters, including, among other things, our corporate governance principles, charters of
various committees of the Board of Directors, and our code of business conduct and ethics applicable to all employees, officers and directors.
We intend to disclose on our internet website any amendments to or waivers from our code of business conduct and ethics as well as any
amendments to its corporate governance principles or the charters of various committees of the Board of Directors. Copies of these documents
may be obtained, free of charge, from our website. The SEC also maintains an internet site that contains reports, proxy and information
statements and other information regarding issuers that file periodic and other reports electronically with the Securities and Exchange
Commission. The address of that site is <i>www.sec.gov</i>. The information available on or through our website is not a part of this
Annual Report and should not be relied upon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_024"></span>ITEM
    1A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISK
    FACTORS </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>We
are providing the following cautionary discussion of risk factors and uncertainties that we believe are relevant to our business. These
are factors that, individually or in the aggregate, we think could cause our actual results to differ materially from expected or historical
results and our forward-looking statements. We note these factors for investors as permitted by Section 21E of the Exchange Act and Section
27A of the Securities Act. You should understand that it is not possible to predict or identify all such factors. Consequently, you should
not consider the following to be a complete discussion of all potential risks or uncertainties that may impact our business. Moreover,
we operate in a competitive and rapidly changing environment. New factors emerge from time to time, and it is not possible to predict
the impact of all of these factors on our business, financial condition or results of operations. We undertake no obligation to publicly
update forward-looking statements, whether as a result of new information, future events, or otherwise.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
Factors Summary</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of some of the Company&#8217;s most important risks and uncertainties that could materially adversely affect our
business, financial condition, and results of operations. You should read this summary together with a more detailed description of each
risk factor. Additional discussion of the risks summarized in this Risk Factors Summary, and other risks that we face, can be found below
under the heading &#8220;Risk Factors&#8221; and should be carefully considered, together with other information in this Annual Report
on Form 10-K and our other filings with the SEC, before making an investment in our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risk
Related to Our Business and Operations</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have a history of significant losses from operations and expect to continue to incur significant losses for the foreseeable future
    and we may never achieve or maintain profitability. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    might not be able to continue as a going concern, which could cause our stockholders to lose most or all of their investment.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will need to raise additional capital to fund our planned future operations, and we may be unable to secure such capital without
    significant dilutive financing transactions. If we are not able to raise additional capital, we may not be able to complete the development,
    testing and commercialization of our drug candidates. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drug
    development is an inherently uncertain process with a high risk of failure at every stage of development.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we do not obtain or maintain FDA and foreign regulatory approvals for our drug candidates on a timely basis, or at all, or if the
    terms of any approval impose significant restrictions or limitations on use, we will be unable to sell those products and our business,
    results of operations and financial condition will be negatively affected.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    gene-based products for therapeutic applications are subject to extensive regulation by the FDA and comparable agencies in other
    countries. The precise regulatory requirements with which we will have to comply, now and in the future, are uncertain due to the
    novelty of the gene-based products we are developing.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise
    adversely affected.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    rely on third parties to conduct all of our clinical trials. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
    we rely on third-party manufacturing and supply partners, our supply of research and development, preclinical and clinical development
    materials may become limited or interrupted or may not be of satisfactory quantity or quality.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may seek Orphan Drug Designation for our drug candidates, but we may be unsuccessful or may be unable to maintain the benefits associated
    with Orphan Drug Designation, including the potential for market exclusivity.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fast
    Track designation may not actually lead to a faster development or regulatory review or approval process.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    relationships with healthcare providers and physicians and third-party payors will be subject to applicable false claims act, anti-kickback,
    transparency, fraud and abuse and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties,
    contractual damage, reputational harm and diminished profits and future earnings.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ongoing
    legislative and regulatory changes affecting the healthcare industry could have a material adverse effect on our business.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may fail to comply with evolving European and other privacy laws.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    success of our products, if approved may be harmed if the government, private health insurers and other third-party payers do not
    provide sufficient coverage or reimbursement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    commercial success of any current or future drug candidate will depend upon the degree of market acceptance by physicians, patients,
    payors and others in the medical community.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have no internal sales or marketing capability. If we are unable to create sales, marketing and distribution capabilities or enter
    into alliances with others possessing such capabilities to perform these functions, we will not be able to commercialize our products,
    if approved, successfully.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to hire or retain key officers or employees that we need to implement our business strategy and develop our drug
    candidates and business.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    success will depend in part on our ability to grow and diversify, which in turn will require that we manage and control our growth
    effectively.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    face intense competition and the failure to compete effectively could adversely affect our ability to develop and market our products,
    if approved.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may be subject to significant product liability claims and litigation.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    internal computer systems, or those of our clinical research organizations (&#8220;CROs&#8221;) or other contractors or consultants,
    may fail or suffer security breaches, which could result in a material disruption of our product development programs.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    employees, independent contractors, consultants, collaborators and contract research organizations may engage in misconduct or other
    improper activities, including non-compliance with regulatory standards and requirements, which could cause significant liability
    for us and harm our reputation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risks
Related to Intellectual Property</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    business depends on license agreements with third parties to permit us to use patented technologies. The loss of any of our rights
    under these agreements could impair our ability to develop and market our products, if approved.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    any of our pending patent applications do not issue, or are deemed invalid following issuance, we may lose valuable intellectual
    property protection.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    rely on trade secret protection and other unpatented proprietary rights for important proprietary technologies, and any loss of such
    rights could harm our business, results of operations and financial condition.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may incur substantial costs as a result of litigation or other proceedings relating to patent and other intellectual property rights</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risks
Related to Our Securities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    market price of our common stock may be significantly volatile.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    common stock may be delisted from The Nasdaq Capital Market if we fail to comply with continued listing standards.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
    sales of our common stock in the public market could cause our stock price to fall.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    stockholders may experience significant dilution as a result of future equity offerings or issuances and exercise of outstanding
    options and warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to use net operating losses to offset future taxable income is subject to certain limitations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have never paid cash dividends on our common stock and do not anticipate paying dividends in the foreseeable future. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATED TO OUR BUSINESS AND OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
have a history of significant losses from operations and expect to continue to incur significant losses for the foreseeable future, and
we may never achieve or maintain profitability.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception, our expenses have substantially exceeded our revenue, resulting in continuing losses and an accumulated deficit of $407
million at December 31, 2024. For the years ended December 31, 2024 and 2023, we incurred net losses of $18.6 million and $19.5 million,
respectively. We currently have no product revenue and do not expect to generate any product revenue for the foreseeable future. Because
we are committed to continuing our product research, development, clinical trial and commercialization programs, we will continue to
incur significant operating losses unless and until we complete the development of IMNN-001 and other new drug candidates and these drug
candidates have been clinically tested, approved by the FDA and successfully marketed. The amount of future losses is uncertain. Our
ability to achieve profitability, if ever, will depend on, among other things, the following, which we cannot guarantee: us or our collaborators
successfully developing drug candidates, obtaining regulatory approvals to market and commercialize drug candidates, manufacturing any
approved products on commercially reasonable terms, establishing a sales and marketing organization or suitable third-party alternatives
for any approved product, generating sufficient sales revenue from our drug candidates, and raising sufficient funds to finance business
activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
might not be able to continue as a going concern, which could cause our stockholders to lose most or all of their investment.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audited financial statements for the year ended December 31, 2024 were prepared under the assumption that we would continue as a going
concern. However, we have concluded that there is substantial doubt about our ability to continue as a going concern, therefore our independent
registered public accounting firm included a &#8220;going concern&#8221; explanatory paragraph in its report on our financial statements
for the year ended December 31, 2024, indicating that, without additional sources of funding, our cash at December 31, 2024 is not sufficient
for us to operate as a going concern for a period of at least one year from the date that the financial statements included in this Annual
Report on Form 10-K are issued. Management&#8217;s plans concerning these matters, including our need to raise additional capital, are
described in Note 2 of our financial statements included within this Annual Report on Form 10-K, however, management cannot assure you
that its plans will be successful. If we cannot continue as a viable entity, our stockholders would likely lose most or all of their
investment in us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
will need to raise additional capital to fund our planned future operations, and we may be unable to secure such capital without significant
dilutive financing transactions. If we are not able to raise additional capital, we may not be able to complete the development, testing
and commercialization of our drug candidates.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not generated significant revenue and have incurred significant net losses in each year since our inception. For the year ended
December 31, 2024, we incurred a net loss of $18.6 million. We have incurred approximately $407 million of cumulative net losses. As
of December 31, 2024, we had cash and cash equivalents of $5.9 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have substantial future capital requirements to continue our research and development activities and advance our drug candidates through
various development stages, including the Phase 3 registrational trial of IMNN-001 in advanced ovarian cancer. We are unable to estimate
the duration and completion costs of our research and development projects or when, if ever, and to what extent we will receive cash
inflows from the commercialization and sale of a product. Our inability to complete any of our research and development activities, preclinical
studies or clinical trials in a timely manner or our failure to enter into collaborative agreements when appropriate could significantly
increase our capital requirements and could adversely impact our liquidity. While our estimated future capital requirements are uncertain
and could increase or decrease as a result of many factors, including the extent to which we choose to advance our research, development
activities, preclinical studies and clinical trials, or if we are in a position to pursue manufacturing or commercialization activities,
we will need significant additional capital to develop our drug candidates through development and clinical trials, obtain regulatory
approvals and manufacture and commercialize approved products, if any. We do not know whether we will be able to access additional capital
when needed or on terms favorable to us or our stockholders. Our inability to raise additional capital, or to do so on terms reasonably
acceptable to us, would jeopardize the future success of our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we do not obtain or maintain FDA and foreign regulatory approvals for our drug candidates on a timely basis, or at all, or if the terms
of any approval impose significant restrictions or limitations on use, we will be unable to sell those products and our business, results
of operations and financial condition will be negatively affected.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
obtain regulatory approvals from the FDA and foreign regulatory agencies, we must conduct clinical trials demonstrating that our drug
candidates are safe and effective. We may need to amend ongoing trials, or the FDA and/or foreign regulatory agencies may require us
to perform additional trials beyond those we planned. The testing and approval process requires substantial time, effort and resources,
and generally takes a number of years to complete. The time to obtain approvals is also uncertain, and the FDA and foreign regulatory
agencies have substantial discretion, at any phase of development, to terminate clinical studies, require additional clinical studies
or other testing, delay or withhold approval, and mandate product withdrawals, including recalls. In addition, our drug candidates may
have undesirable side effects or other unexpected characteristics that could cause us or regulatory authorities to interrupt, delay or
halt clinical trials and could result in a more restricted label or the delay or denial of regulatory approval by regulatory authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if we receive regulatory approval of a product, the approval may limit the indicated uses for which the drug may be marketed. The failure
to obtain timely regulatory approval of drug candidates, the imposition of marketing limitations, or a product withdrawal would negatively
impact our business. Even if we receive approval, we will be subject to ongoing regulatory obligations and continued regulatory review,
which may result in significant additional expense and subject us to restrictions, withdrawal from the market, or penalties if we fail
to comply with applicable regulatory requirements or if we experience unanticipated problems with our drug candidates, when and if approved.
Finally, even if we obtain FDA approval of any of our drug candidates, we may never obtain approval or commercialize such products outside
of the U.S., given that we may be subject to additional regulatory burdens in other markets. This could limit our ability to realize
their full market potential.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Drug
development is an inherently uncertain process with a high risk of failure at every stage of development.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securing
FDA or comparable foreign regulatory approval requires the submission of extensive preclinical and clinical data and supporting information
for each therapeutic indication to establish the drug candidate&#8217;s safety and efficacy for its intended use. It takes years to complete
the testing of a new drug or biological product and development delays and/or failure can occur at any stage of testing. Any of our present
and future clinical trials may be delayed, halted, not authorized, or approval of any of our products may be delayed or may not be obtained
due to any of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">factors
    related to the ongoing effects of the COVID-19 pandemic, including regulators or institutional review boards, or IRBs, or ethics
    committees may not authorize us or our investigators to commence a clinical trial or conduct a clinical trial at a prospective trial
    site;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    preclinical test or clinical trial may fail to produce safety and efficacy results satisfactory to the FDA or comparable foreign
    regulatory authorities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">preclinical
    and clinical data can be interpreted in different ways, which could delay, limit, or prevent marketing approval;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">negative
    or inconclusive results from a preclinical test or clinical trial or adverse events during a clinical trial could cause a preclinical
    study or clinical trial to be repeated or a development program to be terminated, even if other studies relating to the development
    program are ongoing or have been completed and were successful;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    FDA or comparable foreign regulatory authorities can place a clinical hold on a trial if, among other reasons, it finds that subjects
    enrolled in the trial are or would be exposed to an unreasonable and significant risk of illness or injury;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    facilities that we utilize, or the processes or facilities of third-party vendors, including without limitation the contract manufacturers
    who will be manufacturing drug substance and drug product for us or any potential collaborators, may not satisfactorily complete
    inspections by the FDA or comparable foreign regulatory authorities; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    may encounter delays or rejections based on changes in FDA policies or the policies of comparable foreign regulatory authorities
    during the period in which we develop a drug candidate, or the period required for review of any final marketing approval before
    we are able to market any drug candidate.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, information generated during the clinical trial process is susceptible to varying interpretations that could delay, limit,
or prevent marketing approval. Moreover, early positive preclinical or clinical trial results may not be replicated in later clinical
trials. As more drug candidates within a particular class of drugs proceed through clinical development to regulatory review and approval,
the amount and type of clinical data that may be required by regulatory authorities may increase or change. Failure to demonstrate adequately
the quality, safety, and efficacy of any of our drug candidates would delay or prevent marketing approval. We cannot assure you that
if clinical trials are completed, either we or our potential collaborators will submit applications for required authorizations to manufacture
or market potential products or that any such application will be reviewed and approved by appropriate regulatory authorities in a timely
manner, if at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
gene-based products for therapeutic applications are subject to extensive regulation by the FDA and comparable agencies in other countries.
The precise regulatory requirements with which we will have to comply, now and in the future, are uncertain due to the novelty of the
gene-based products we are developing.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
regulatory approval process for novel drug candidates such as ours can be significantly more expensive and take longer than for other,
better-known or more extensively studied drug candidates. Limited data exist regarding the safety and efficacy of DNA-based therapeutics
compared with conventional therapeutics, and government regulation of DNA-based therapeutics is evolving. Regulatory requirements governing
gene and cell therapy products have changed frequently and may continue to change in the future. The FDA has established the Office of
Therapeutic Products within CBER, to consolidate the review of gene therapy and related products, and has established the Cellular, Tissue
and Gene Therapies Advisory Committee to advise CBER in its review. It is difficult to determine how long it will take or how much it
will cost to obtain regulatory approvals for our drug candidates in either the U.S. or the European Union or how long it will take to
commercialize our drug candidates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adverse
events or the perception of adverse events in the field of gene therapy generally, or with respect to our drug candidates specifically,
may have a particularly negative impact on public perception of gene therapy and result in greater governmental regulation, including
future bans or stricter standards imposed on gene-based therapy clinical trials, stricter labeling requirements and other regulatory
delays in the testing or approval of our potential products. For example, if we were to engage an NIH-funded institution to conduct a
clinical trial involving recombinant or nucleic acid molecules, we may be subject to review by an IBC and, in some cases, the NIH. Such
review can delay the initiation of a clinical trial, even if the FDA has reviewed the trial design and details and approved its initiation.
Conversely, the FDA can put an IND application on a clinical hold even if the IBC or the NIH has provided a favorable review. Such reviews
and any new guidelines may lengthen the regulatory review process, require us to perform additional studies, increase our development
costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and commercialization of our drug candidates
or lead to significant post-approval limitations or restrictions. Any increased scrutiny could delay or increase the costs of our product
development efforts or clinical trials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if our products receive regulatory approval, they may still face future development and regulatory difficulties. Government regulators
may impose ongoing requirements for potentially costly post-approval studies. This governmental oversight may be particularly strict
with respect to gene-based therapies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise
adversely affected.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have experienced and may experience difficulties in patient enrollment in our clinical trials for a variety of reasons. The timely completion
of clinical trials in accordance with their protocols depends, among other things, on our ability to enroll a sufficient number of patients
who remain in the trial until its conclusion. The enrollment of patients depends on many factors, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    patient eligibility and exclusion criteria defined in the protocol;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    size of the patient population required for analysis of the trial&#8217;s primary endpoints and the process for identifying patients;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    willingness or availability of patients to participate in our trials; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    proximity of patients to trial sites;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    design of the trial;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to recruit clinical trial investigators with the appropriate competencies and experience;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">clinicians&#8217;
    and patients&#8217; perceptions as to the potential advantages and risks of the drug candidate being studied in relation to other
    available therapies, including any new products that may be approved for the indications we are investigating;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    availability of competing commercially available therapies and other competing drug candidates&#8217; clinical trials;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to obtain and maintain patient informed consents; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risk that patients enrolled in clinical trials will drop out of the trials before completion.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
inability to enroll a sufficient number of patients for our clinical trials could result in significant delays or may require us to abandon
one or more clinical trials altogether. Enrollment delays in our clinical trials may result in increased development costs for our drug
candidates, delay or halt the development of and approval processes for our drug candidates and jeopardize our ability to achieve our
clinical development timeline and goals, including the dates by which we will commence, complete and receive results from clinical trials.
Enrollment delays may also delay or jeopardize our ability to commence sales and generate revenues from our drug candidates. Any of the
foregoing could cause the value of our company to decline and limit our ability to obtain additional financing, if needed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
rely on third parties to conduct all of our clinical trials. If these third parties are unable to carry out their contractual duties
in a manner that is consistent with our expectations, comply with budgets and other financial obligations or meet expected deadlines,
we may not receive certain development milestone payments or be able to obtain regulatory approval for or commercialize our drug candidates
in a timely or cost-effective manner.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not independently conduct clinical trials for our drug candidates. We rely, and expect to continue to rely, on third-party clinical
investigators, CROs, clinical data management organizations and consultants to design, conduct, supervise and monitor our clinical trials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we do not conduct our own clinical trials, we must rely on the efforts of others and have reduced control over aspects of these activities,
including the timing of such trials, the costs associated with such trials and the procedures that are followed for such trials. We do
not expect to significantly increase our personnel in the foreseeable future and may continue to rely on third parties to conduct all
of our future clinical trials. If we cannot contract with acceptable third parties on commercially reasonable terms or at all, if these
third parties are unable to carry out their contractual duties or obligations in a manner that is consistent with our expectations or
meet expected deadlines, if they do not carry out the trials in accordance with budgeted amounts, if the quality or accuracy of the clinical
data they obtain is compromised due to their failure to adhere to our clinical protocols or for other reasons, or if they fail to maintain
compliance with applicable government regulations and standards, our clinical trials may be extended, delayed or terminated or may become
significantly more expensive, we may not receive development milestone payments when expected or at all, and we may not be able to obtain
regulatory approval for or successfully commercialize our drug candidates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
our reliance on third parties to conduct our clinical trials, we are ultimately responsible for ensuring that each of our clinical trials
is conducted in accordance with the general investigational plan and protocols for the trial. Moreover, the FDA requires clinical trials
to be conducted in accordance with good clinical practices for conducting, recording and reporting the results of clinical trials and
that the rights, integrity and confidentiality of clinical trial participants are protected. We also are required to register ongoing
clinical trials and post the results of completed clinical trials on a government-sponsored database, <i>ClinicalTrials.gov</i>, within
certain timeframes. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions. Our reliance on third parties
that we do not control does not relieve us of these responsibilities and requirements. If we or a third party we rely on fails to meet
these requirements, we may not be able to obtain, or may be delayed in obtaining, marketing authorizations for our drug candidates and
will not be able to, or may be delayed in our efforts to, successfully commercialize our drug candidates. This could have a material
adverse effect on our business, financial condition, results of operations and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Because
we rely on third-party manufacturing and supply partners, our supply of research and development, preclinical and clinical development
materials may become limited or interrupted or may not be of satisfactory quantity or quality.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on third-party supply and manufacturing partners to supply the materials and components for, and manufacture, our research and development,
preclinical and clinical trial drug supplies. We do not own manufacturing facilities or supply sources for such components and materials.
There can be no assurance that our supply of research and development, preclinical and clinical development drugs and other materials
will not be limited, interrupted, or restricted in certain geographic regions or will be of satisfactory quality or will continue to
be available at acceptable prices. Suppliers and manufacturers must meet applicable manufacturing requirements and undergo rigorous facility
and process validation tests required by FDA and foreign regulatory authorities in order to comply with regulatory standards, such as
current cGMP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we or any of our third-party manufacturers or testing contractors fail to maintain regulatory compliance, this could cause the delay
of clinical trials, regulatory submissions, required approvals or commercialization of our drug candidates, cause us to incur higher
costs and prevent us from commercializing our products successfully. Furthermore, if our suppliers fail to meet contractual requirements,
and we are unable to secure one or more replacement suppliers capable of production at a substantially equivalent cost, our clinical
trials may be delayed, or we could lose potential revenue. In the event that any of our suppliers or manufacturers fails to comply with
such requirements or to perform its obligations to us in relation to quality, timing or otherwise, or if our supply of components or
other materials becomes limited or interrupted for other reasons, we may be forced to manufacture the materials ourselves, for which
we currently do not have the capabilities or resources, or enter into an agreement with another third party, which we may not be able
to do on reasonable terms, if at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
regulatory authorities also may, at any time following approval of a product for sale, inspect the manufacturing facilities of our third-party
manufacturers. If any such inspection or audit identifies a failure to comply with applicable regulations or if a violation of our product
specifications or applicable regulations occurs independent of such an inspection or audit, we or the relevant regulatory authority may
require remedial measures that may be costly and/or time-consuming for us or our third-party manufacturers to implement and that may
include the temporary or permanent suspension of a clinical trial or commercial sales or the temporary or permanent closure of a manufacturing
facility. Any such remedial measures imposed upon third parties with whom we contract could materially harm our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we fail to enter into and maintain successful strategic alliances for our drug candidates, we may have to reduce or delay our drug candidate
development or increase our expenditures. To the extent we are able to enter into strategic transactions, we will be exposed to risks
related to those collaborations and alliances.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
important element of our strategy for developing, manufacturing and commercializing our drug candidates is entering into strategic alliances
with pharmaceutical companies, research institutions or other industry participants to advance our programs and enable us to maintain
our financial and operational capacity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face significant competition in seeking appropriate alliances. We may not be able to negotiate alliances on acceptable terms, if at all.
In addition, these alliances may be unsuccessful. If we fail to create and maintain suitable alliances, we may have to limit the size
or scope of, or delay, one or more of our drug development or research programs. If we elect to fund drug development or research programs
on our own, we will have to increase our expenditures and will need to obtain additional funding, which may be unavailable or available
only on unfavorable terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may not successfully engage in future strategic transactions, which could adversely affect our ability to develop and commercialize drug
candidates, impact our cash position, increase our expenses and present significant distractions to our management.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the future, we may consider strategic alternatives intended to further the development of our business, which may include acquiring businesses,
technologies, or products, out- or in-licensing drug candidates or technologies or entering into a business combination with another
company. Any strategic transaction may require us to incur non-recurring or other charges, increase our near- and long-term expenditures
and pose significant integration or implementation challenges or disrupt our management or business. These transactions would entail
numerous operational and financial risks, including exposure to unknown liabilities, disruption of our business and diversion of our
management&#8217;s time and attention in order to manage a collaboration or develop acquired products, drug candidates or technologies,
incurrence of substantial debt or dilutive issuances of equity securities to pay transaction consideration or costs, higher than expected
collaboration, acquisition or integration costs, write-downs of assets or goodwill or impairment charges, increased amortization expenses,
difficulty and cost in facilitating the collaboration or combining the operations and personnel of any acquired business, impairment
of relationships with key suppliers, manufacturers or customers of any acquired business due to changes in management and ownership and
the inability to retain key employees of any acquired business. Accordingly, although there can be no assurance that we will undertake
or successfully complete any transactions of the nature described above, any transactions that we do complete may be subject to the foregoing
or other risks and have a material adverse effect on our business, results of operations, financial condition and prospects. Conversely,
any failure to enter any strategic transaction that would be beneficial to us could delay the development and potential commercialization
of our drug candidates and have a negative impact on the competitiveness of any drug candidate that reaches market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
have obtained Orphan Drug Designation for IMNN-001 and may seek Orphan Drug Designation for other drug candidates, but we may be unsuccessful
or may be unable to maintain the benefits associated with Orphan Drug Designation, including the potential for market exclusivity.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IMNN-001
has been granted orphan drug designation for ovarian cancer in both the U.S. and Europe. Regulatory authorities in some jurisdictions,
including the U.S. and Europe, may designate drugs or biologics for relatively small patient populations as orphan drugs. Under the Orphan
Drug Act, the FDA may designate a drug or biologic as an orphan drug if the disease or condition for which the drug is intended affects
fewer than 200,000 individuals in the U.S., or, if the drug is intended for a disease or condition affecting 200,000 or more people in
the U.S., there is no reasonable expectation that the cost of developing and making available in the U.S. the drug or biologic for the
disease or condition will be recovered from sales of the drug in the U.S.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
though we have obtained Orphan Drug Designation for IMNN-001 and may obtain such designation for other drug candidates in specific indications,
we may not be the first to obtain marketing approval of these drug candidates for the orphan-designated indication due to the uncertainties
associated with developing pharmaceutical products. In addition, exclusive marketing rights in the U.S. may be limited if we seek approval
for an indication broader than the orphan-designated indication or may be lost if the FDA later determines that the request for designation
was materially defective or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients
with the rare disease or condition. Further, even if we obtain orphan drug exclusivity for a product, that exclusivity may not effectively
protect the product from competition because different drugs with different active moieties can be approved for the same indication.
Even after an orphan product is approved, the FDA can subsequently approve a different sponsor&#8217;s application for the same drug
for the same indication if the FDA concludes that the later drug is safer, more effective or makes a major contribution to patient care.
Orphan Drug Designation neither shortens the development time or regulatory review time of a drug nor gives the drug any advantage in
the regulatory review or approval process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fast
Track designation may not actually lead to a faster development or regulatory review or approval process.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IMNN-001
received U.S. FDA Fast Track designation in 2021. However, we may not experience a faster development process, review, or approval compared
to a product that lacks Fast Track designation. The FDA may withdraw our Fast Track designation if the FDA believes that the designation
is no longer supported by data from our clinical or pivotal development program. Our Fast Track designation does not guarantee that we
will qualify for or be able to take advantage of the FDA&#8217;s expedited review procedures or that any application that we may submit
to the FDA for regulatory approval will be accepted for filing or ultimately approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
relationships with healthcare providers and physicians and third-party payors will be subject to applicable false claims act, anti-kickback,
transparency, fraud and abuse and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties,
contractual damages, administrative burdens, reputational harm and diminished profits and future earnings.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthcare
providers, physicians and third-party payors in the U.S. and elsewhere play a primary role in the recommendation and prescription of
biopharmaceutical products. Arrangements with third-party payors and customers can expose biopharmaceutical manufacturers to broadly
applicable fraud and abuse and other healthcare laws and regulations, including, without limitation, the federal Anti-Kickback Statute
and the federal False Claims Act, which may constrain the business or financial arrangements and relationships through which such companies
sell, market and distribute biopharmaceutical products. In particular, the research of our drug candidates, as well as the promotion,
sales and marketing of healthcare items and services, as well as certain business arrangements in the healthcare industry, are subject
to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict
or prohibit a wide range of pricing, discounting, marketing and promotion, structuring and commission(s), certain customer incentive
programs and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained
in the course of patient recruitment for clinical trials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
distribution of biopharmaceutical products is subject to additional requirements and regulations, including extensive record-keeping,
licensing, storage, and security requirements intended to prevent the unauthorized sale of biopharmaceutical products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform,
especially in light of the lack of applicable precedent and regulations. Ensuring business arrangements comply with applicable healthcare
laws, as well as responding to possible investigations by government authorities, can be time- and resource-consuming and can divert
a company&#8217;s attention from the business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is possible that governmental and enforcement authorities will conclude that our business practices may not comply with current or future
statutes, regulations or case law interpreting applicable fraud and abuse or other healthcare laws and regulations. If any such actions
are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant
impact on our business, including the imposition of significant civil, criminal and administrative penalties, damages, fines, disgorgement,
imprisonment, reputational harm, possible exclusion from participation in federal and state funded healthcare programs, contractual damages
and the curtailment or restricting of our operations, as well as additional reporting obligations and oversight if we become subject
to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws. Further, if any of the
physicians or other healthcare providers or entities with whom we expect to do business is found to be not in compliance with applicable
laws, they may be subject to significant criminal, civil or administrative sanctions, including exclusions from government funded healthcare
programs. Any action for violation of these laws, even if successfully defended, could cause a biopharmaceutical manufacturer to incur
significant legal expenses and divert management&#8217;s attention from the operation of the business. Prohibitions or restrictions on
sales or withdrawal of future marketed products could materially affect business in an adverse way.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ongoing
legislative and regulatory changes affecting the healthcare industry could have a material adverse effect on our business.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Political,
economic and regulatory influences are subjecting the healthcare industry to potential fundamental changes that could substantially affect
our results of operations by requiring, for example: (i) changes to our manufacturing arrangements; (ii) additions or modifications to
product labeling; (iii) the recall or discontinuation of our products, if approved; or (iv) additional record-keeping requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict what healthcare reform initiatives may be adopted in the future. Further, federal and state legislative and regulatory
developments are likely, and we expect ongoing initiatives in the U.S. to increase pressure on drug pricing. Such reforms could have
an adverse effect on anticipated revenues for any drug candidates that we may successfully develop and for which we may obtain regulatory
approval and may affect our overall financial condition and ability to develop drug candidates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may fail to comply with evolving European and other privacy laws.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to varying degrees of privacy regulation in the countries in which we operate, and the general trend is toward increasingly
stringent regulation and enforcement. We are, for example, subject to costly and complex U.S. and foreign laws governing the collection,
use, disclosure, and cross-border transfer of information about patients and other individuals that may materially adversely affect our
financial condition and business operations. Since we have conducted and may conduct clinical trials in the European Economic Area (&#8220;EEA&#8221;),
we are subject to additional data protection and clinical trial laws in the European Union. The General Data Protection Regulation, (EU)
2016/679 (&#8220;GDPR&#8221;), for example, governs the processing of personal data, and imposes numerous requirements on companies that
process personal data, including requirements relating to processing health and other sensitive data, obtaining consent of the individuals
to whom the personal data relates, providing notices to individuals regarding data processing activities, implementing safeguards to
protect the security and confidentiality of personal data, alerting data subjects and authorities about data breaches, and taking specific
measures when engaging third-party processors. The GDPR also imposes strict rules on the transfer of personal data to countries outside
the EEA, including the U.S., and confers on data subjects the right to lodge complaints with supervisory authorities, and seek certain
judicial review for violations of the GDPR. In addition, the GDPR includes restrictions on cross-border data transfers. Under the GDPR,
competent regulatory authorities have the power to impose fines up to EUR 20 million or 4% of the global annual turnover (whichever is
higher), depending on the nature of the violation (see Art. 83, GDPR). Further consequences of non-compliance could be cease and desist
claims by certain organizations/competitors, damage claims and reputational damage. <span style="background-color: white">F</span>urther,
Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for
human use and repealing Directive 2001/20/EC governs how we conduct clinical trials in the European Union together with Good Clinical
Practices. As a result of Brexit, moreover, we also have independent obligations, similar to those already imposed on us by GDPR, under
the United Kingdom&#8217;s Data Protection Act, 2018. Additionally, there are other local data protection laws, industry-specific requirements,
regulations, or applicable codes of conduct which may impact our operations. We have taken steps to implement privacy compliance programs
and controls, but our business remains subject to potential risks of controls imposed on cross border data flows, unauthorized access,
and loss of personal data through internal and external threats that could impact our business operations and research activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
success of our products, if approved, may be harmed if the government, private health insurers and other third-party payers do not provide
sufficient coverage or reimbursement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to commercialize our new cancer treatment systems successfully will depend in part on the extent to which reimbursement for the
costs of such products, if approved, and related treatments will be available from third-party payors, which include government authorities
such as Medicare, Medicaid, TRICARE, and the Veterans Administration, managed care providers, private health insurers, and other organizations.
Patients who are provided medical treatment for their conditions generally rely on third-party payors to reimburse all or part of the
costs associated with their treatment. Patients are unlikely to use our drug candidates unless coverage is provided, and reimbursement
is adequate to cover a significant portion of the cost. We cannot be sure that coverage and reimbursement will be available for, or accurately
estimate the potential revenue from, our drug candidates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
products, if approved, may not achieve sufficient acceptance by the medical community to sustain our business.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
commercial success of our products, if approved, will depend upon their acceptance by the medical community and third-party payors as
clinically useful, cost effective and safe. Any of our drug candidates or similar drug candidates being investigated by our competitors
may prove not to be effective in trial or in practice, cause adverse events or other undesirable side effects. Our testing and clinical
practice may not confirm the safety and efficacy of our drug candidates or even if further testing and clinical practice produce positive
results, the medical community may view these new forms of treatment as effective and desirable or our efforts to market our new products,
if approved, may fail. Market acceptance depends upon physicians and hospitals obtaining adequate reimbursement rates from third-party
payors to make our products, if approved, commercially viable. Any of these factors could have an adverse effect on our business, financial
condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
have no internal sales or marketing capability. If we are unable to create sales, marketing and distribution capabilities or enter into
alliances with others possessing such capabilities to perform these functions, we will not be able to commercialize our products, if
approved, successfully.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have no sales, marketing, or distribution capabilities. We intend to market our products, if and when such products are approved
for commercialization by the FDA and foreign regulatory agencies, either directly or through other strategic alliances and distribution
arrangements with third parties. If we decide to market our products directly, we will need to commit significant financial and managerial
resources to develop a marketing and sales force with technical expertise and with supporting distribution, administration, and compliance
capabilities, including providing adequate training on such topics. If we rely on third parties with such capabilities to market our
products, we will need to establish and maintain partnership arrangements, and there can be no assurance that we will be able to enter
into third-party marketing or distribution arrangements on acceptable terms or at all. To the extent that we do enter into such arrangements,
we will be dependent on our marketing and distribution partners. In entering into third-party marketing or distribution arrangements,
we expect to incur significant additional expenses and there can be no assurance that such third parties will establish adequate sales
and distribution capabilities or be successful in gaining market acceptance for our products and services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
success will depend in part on our ability to grow and diversify, which in turn will require that we manage and control our growth effectively.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business strategy contemplates growth and diversification. Our ability to manage growth effectively will require that we continue to
expend funds to improve our operational, financial and management controls, reporting systems and procedures. In addition, we must effectively
expand, train and manage our employees. We will be unable to manage our business effectively if we are unable to alleviate the strain
on resources caused by growth in a timely and successful manner. There can be no assurance that we will be able to manage our growth
and a failure to do so could have a material adverse effect on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
face intense competition and the failure to compete effectively could adversely affect our ability to develop and market our products,
if approved.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are many companies and other institutions engaged in research and development of various technologies for cancer treatment products that
seek treatment outcomes similar to those that we are pursuing. We believe that the level of interest by others in investigating the potential
of possible competitive treatments and alternative technologies will continue and may increase. Potential competitors engaged in all
areas of cancer treatment research in the U.S. and other countries include, among others, major pharmaceutical, specialized technology
companies, and universities and other research institutions. Most of our current and potential competitors have substantially greater
financial, technical, human and other resources, and may also have far greater experience than we do, both in pre-clinical testing and
human clinical trials of new products and in obtaining FDA and other regulatory approvals. One or more of these companies or institutions
could succeed in developing products or other technologies that are more effective than the products and technologies that we have been
or are developing, or which would render our technology and products obsolete and non-competitive. Furthermore, if we are permitted to
commence commercial sales of any of our products, we will also be competing, with respect to manufacturing efficiency and marketing,
with companies having substantially greater resources and experience in these areas.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may be subject to significant product liability claims and litigation.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business exposes us to potential product liability risks inherent in the testing, manufacturing and marketing of human therapeutic products.
We presently have product liability insurance limited to $10 million per incident and $10 million annually. If we were to be subject
to a claim in excess of this coverage or to a claim not covered by our insurance and the claim succeeded, we would be required to pay
the claim with our own limited resources, which could have a severe adverse effect on our business. Whether or not we are ultimately
successful in any product liability litigation, such litigation would harm the business by diverting the attention and resources of our
management, consuming substantial amounts of our financial resources and by damaging our reputation. Additionally, we may not be able
to maintain our product liability insurance at an acceptable cost, if at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
internal computer systems, or those of our CROs or other contractors or consultants, may fail or suffer security breaches, which could
result in a material disruption of our product development programs.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
internal computer systems and those of our CROs and other contractors and consultants are vulnerable to damage from computer viruses
and malicious software that could attack our networks and data centers or those of our service providers; unauthorized parties may attempt
to gain access to our systems, networks, or facilities, or those of third parties with whom we do business, through fraud, trickery,
or other forms of deceiving our employees or contractors, direct social engineering, phishing, credential stuffing, ransomware, denial
or degradation of service attacks and similar types of attacks against any or all of us, our patients and our services providers; inadvertent
security breaches or theft, misuse, unauthorized access or other improper actions by our employees, patients, service providers and other
business partners; natural disasters, terrorism, war and telecommunication and electrical failures. These extensive information security
and cybersecurity threats, which affect companies globally, pose a risk to the security and availability of our systems and networks,
and the confidentiality, integrity, and availability of our sensitive data. Such events could cause significant interruptions of our
operations. For instance, the loss of preclinical data or data from any clinical trial involving our drug candidates could result in
delays in our development and regulatory filing efforts and significantly increase our costs. To the extent that any disruption or privacy
or security breach were to result in a loss of, or damage to, our data, or inappropriate disclosure of confidential or proprietary information,
we could be subject to reputational harm, monetary fines, civil suits, civil penalties or criminal sanctions and requirements to disclose
the breach, and other forms of liability and the development of our drug candidates could be delayed. In addition, such interruptions
and cyber security incidents and faults can cause reputational damage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
employees, independent contractors, consultants, collaborators and contract research organizations may engage in misconduct or other
improper activities, including non-compliance with regulatory standards and requirements, which could cause significant liability for
us and harm our reputation.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are exposed to the risk that our employees, independent contractors, consultants, collaborators and contract research organizations may
engage in fraudulent conduct or other illegal activity. Misconduct by those parties could include intentional, reckless and/or negligent
conduct or disclosure of unauthorized activities to us that violates: (1) FDA regulations or similar regulations of comparable non-U.S.
regulatory authorities, including those laws requiring the reporting of true, complete and accurate information to such authorities,
(2) manufacturing standards, (3) federal and state healthcare fraud and abuse laws and regulations and similar laws and regulations established
and enforced by comparable non-U.S. regulatory authorities, and (4) laws that require the reporting of financial information or data
accurately. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations
intended to prevent fraud, misconduct, kickbacks, self- dealing, bribery and other abusive practices. These laws and regulations restrict
or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business
arrangements. Employee or collaborator misconduct could also involve the improper use of, including trading on, information obtained
in the course of clinical trials, which could result in regulatory sanctions and serious harm to our reputation. While we have a code
of conduct and business ethics, it is not always possible to identify and deter misconduct, and the precautions we take to detect and
prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental
investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws, standards or regulations. If
any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could
have a significant impact on our business and results of operations, including the imposition of civil, criminal and administrative penalties,
damages, monetary fines, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, additional
reporting requirements and/or oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations
of non-compliance with these laws, imprisonment, contractual damages, reputational harm, diminished profits and future earnings, and
curtailment of our operations, any of which could have a material adverse effect on our ability to operate our business and our results
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Litigation
and other legal proceedings against the Company, which may arise in the ordinary course of Company&#8217;s business, could be costly
and time consuming to defend.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is from time to time subject to legal proceedings and claims that arise in the ordinary course of business. From time to time,
third parties may in the future assert intellectual property rights to technologies that are important to the Company&#8217;s business
and may in the future demand that we license their technology. Litigation may result in substantial costs and may divert management&#8217;s
attention and resources, which may seriously harm the Company&#8217;s business, overall financial condition and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATED TO OUR INTELLECTUAL PROPERTY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
business depends on license agreements with third parties to permit us to use patented technologies. The loss of any of our rights under
these agreements could impair our ability to develop and market our products, if approved.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success will depend, in a substantial part, on our ability to maintain our rights under license agreements granting us rights to use
patented technologies. For instance, we are party to license agreements with Duke University, under which we have exclusive rights to
commercialize medical treatment products and procedures based on Duke&#8217;s thermo-sensitive liposome technology. The Duke University
license agreement contains a license fee, royalty and/or research support provisions, testing and regulatory milestones, and other performance
requirements that we must meet by certain deadlines. If we breach any provisions of the license and research agreements, we may lose
our ability to use the subject technology, as well as compensation for our efforts in developing or exploiting the technology. Any such
loss of rights and access to technology could have a material adverse effect on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
we cannot guarantee that any patent or other technology rights licensed to us by others will not be challenged or circumvented successfully
by third parties, or that the rights granted will provide adequate protection. We may be required to alter any of our potential products
or processes or enter into a license and pay licensing fees to a third party or cease certain activities. There can be no assurance that
we can obtain a license to any technology that we determine we need on reasonable terms, if at all, or that we could develop or otherwise
obtain alternate technology. If a license is not available on commercially reasonable terms or at all, our business, results of operations,
and financial condition could be significantly harmed, and we may be prevented from developing and commercializing the product. Litigation,
which could result in substantial costs, may also be necessary to enforce any patents issued to or licensed by us or to determine the
scope and validity of another&#8217;s claimed proprietary rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
any of our pending patent applications are not issued, or are deemed invalid following issuance, we may lose valuable intellectual property
protection.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
patent positions of pharmaceutical and biotechnology companies, such as ours, are uncertain and involve complex legal and factual issues.
We own various U.S. and international patents and have pending U.S. and international patent applications that cover various aspects
of our technologies. There can be no assurance that patents that have been issued will be held valid and enforceable in a court of law
through the entire patent term. Even for patents that are held valid and enforceable, the legal process associated with obtaining such
a judgment is time-consuming and costly. Additionally, issued patents can be subject to opposition, interferences or other proceedings
that can result in the revocation of the patent or maintenance of the patent in amended form (and potentially in a form that renders
the patent without commercially relevant or broad coverage). Further, our competitors may be able to circumvent and otherwise design
around our patents. Even if a patent is issued and enforceable because development and commercialization of pharmaceutical products can
be subject to substantial delays, patents may expire early and provide only a short period of protection, if any, following the commercialization
of products, if approved, encompassed by our patents. We may have to participate in interference proceedings declared by the U.S. Patent
and Trademark Office, which could result in a loss of the patent and/or substantial cost to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed patent applications, and plan to file additional patent applications, covering various aspects of our technologies and our
proprietary drug candidates. There can be no assurance that the patent applications for which we apply would actually issue as patents
or do so with commercially relevant or broad coverage. The coverage claimed in a patent application can be significantly reduced before
the patent is issued. The scope of our claim coverage can be critical to our ability to enter into licensing transactions with third
parties and our right to receive royalties from our collaboration partnerships. Since publication of discoveries in scientific or patent
literature often lags behind the date of such discoveries, we cannot be certain that we were the first inventor of inventions covered
by our patents or patent applications. In addition, there is no guarantee that we will be the first to file a patent application directed
to an invention.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
adverse outcome in any judicial proceeding involving intellectual property, including patents, could subject us to significant liabilities
to third parties, require disputed rights to be licensed from or to third parties or require us to cease using the technology in dispute.
In those instances where we seek an intellectual property license from another, we may not be able to obtain the license on a commercially
reasonable basis, if at all, thereby raising concerns on our ability to freely commercialize our technologies or products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
rely on trade secret protection and other unpatented proprietary rights for important proprietary technologies, and any loss of such
rights could harm our business, results of operations and financial condition.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on trade secrets and confidential information that we seek to protect, in part, by confidentiality agreements with our corporate
partners, collaborators, employees and consultants. We cannot assure you that these agreements are adequate to protect our trade secrets
and confidential information or will not be breached or, if breached, we will have adequate remedies. Furthermore, others may independently
develop substantially equivalent confidential and proprietary information or otherwise gain access to our trade secrets or disclose such
technology. Any loss of trade secret protection or other unpatented proprietary rights could harm our business, results of operations
and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may incur substantial costs as a result of litigation or other proceedings relating to patent and other intellectual property rights.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
commercial success depends on our ability to operate without infringing the patents and other proprietary rights of third parties. Although
we currently are not involved in any material litigation involving patents, a third-party patent holder may assert a claim of patent
infringement against us in the future. Alternatively, we may initiate litigation against the third-party patent holder to request that
a court declare that we are not infringing the third party&#8217;s patent and/or that the third party&#8217;s patent is invalid or unenforceable.
Any infringement action asserted against us, even if we are ultimately successful in defending against such action, would likely delay
the regulatory approval process of our products, harm our competitive position, be expensive and require the time and attention of our
key management and technical personnel. In addition, there is a risk that the court will decide that such patents are not valid and that
we do not have the right to stop the other party from using the inventions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATED TO OUR SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
market price of our common stock has been, and may continue to be volatile and fluctuate significantly, which could result in substantial
losses for investors and subject us to securities class action litigation.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading price for our common stock has been, and we expect it to continue to be, volatile. The price at which our common stock trades
depends upon a number of factors, some of these factors are beyond our control. Broad market fluctuations may lower the market price
of our common stock and affect the volume of trading in our stock, regardless of our financial condition, results of operations, business
or prospects. In addition to the factors discussed in this &#8220;Risk Factors&#8221; section and elsewhere in this Annual Report, these
factors include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclosure
    of actual or potential clinical results with respect to drug candidates we are developing;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
    developments in both the United States and abroad;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments
    concerning proprietary rights, including patents and litigation matters;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">public
    concern about the safety or efficacy of our drug candidates or technology, or related technology, or new technologies generally;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">concern
    about the safety or efficacy of our drug candidates or technology, or related technology, or new technologies generally;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">public
    announcements by our competitors or others; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    market conditions and comments by securities analysts and investors.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
common stock may be delisted from The Nasdaq Capital Market if we fail to comply with continued listing standards.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is currently traded on The Nasdaq Capital Market under the symbol &#8220;IMNN.&#8221; If we fail to comply with Nasdaq&#8217;s
continued listing standards, we may be delisted and our common stock will trade, if at all, only on the over-the-counter market, such
as the OTC Bulletin Board or OTCQX market, and then only if one or more registered broker-dealer market makers comply with quotation
requirements. In addition, delisting of our common stock could depress our stock price, substantially limit liquidity of our common stock
and materially adversely affect our ability to raise capital on terms acceptable to us, or at all. Further, delisting of our common stock
would likely result in our common stock becoming a &#8220;penny stock&#8221; under the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November <span style="background-color: white">26, 2024</span>, we received a notice from the staff of the Nasdaq Stock Market LLC (the
&#8220;Staff&#8221;) notifying us that, based upon the closing bid price of our common stock, for the 30 consecutive business days prior
to the notice, we no longer met the requirement to maintain a minimum closing bid price of $1.00 per share, as set forth in Nasdaq Listing
Rule 5550(a)(2). <span style="background-color: white">In accordance with Nasdaq Listing Rule 5810(c)(3)(A), w</span>e were granted 180
calendar days, or until May 27<span style="background-color: white">, 2025</span>, to regain compliance with the minimum bid price rule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">To
regain compliance, the closing bid price of our common stock must be $1.00 per share or more for a minimum of 10 consecutive business
days at any time before May 27, 2025. If we do not regain compliance with Rule 5550(a)(2) by May 27, 2025, we may be eligible for an
additional 180 calendar day compliance period. To qualify, we will be required to meet the continued listing requirement for market value
of publicly held shares and all other Nasdaq initial listing standards, except the bid price requirement, and would need to provide written
notice to Nasdaq of our intention to cure the deficiency during the second compliance period. If it appears to the Staff that we will
not be able to cure the deficiency, or if we are otherwise not eligible, Nasdaq would notify us that our securities will be subject to
delisting. In the event of such notification, we may appeal the Staff&#8217;s determination to delist our securities, but there can be
no assurance the Staff would grant our request for continued listing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our common stock were to be delisted by Nasdaq, it may be eligible for quotation on an over-the-counter quotation system or on the pink
sheets. Upon any such delisting, our common stock would become subject to the regulations of the SEC relating to the market for penny
stocks. A penny stock is any equity security not traded on a national securities exchange that has a market price of less than $5.00
per share. The regulations applicable to penny stocks may severely affect the market liquidity for our common stock and could limit the
ability of stockholders to sell securities in the secondary market. In such a case, an investor may find it more difficult to dispose
of or obtain accurate quotations as to the market value of our common stock, and there can be no assurance that our common stock will
be eligible for trading or quotation on any alternative exchanges or markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delisting
from Nasdaq could adversely affect our ability to raise additional financing through public or private sales of equity securities, would
significantly affect the ability of investors to trade our securities and would negatively affect the value and liquidity of our common
stock. Delisting could also have other negative results, including the potential loss of confidence by employees, the loss of institutional
investor interest and fewer business development opportunities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Future
sales of our common stock in the public market could cause our stock price to fall.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of a substantial number of shares of our common stock in the public market, or the perception that these sales might occur, could depress
the market price of our common stock and could impair our ability to raise capital through the sale of additional equity securities.
As of February 21, 2025, we had 14,620,732 shares of common stock outstanding, all of which, other than shares held by our directors
and certain officers, were eligible for sale in the public market, subject in some cases to compliance with the requirements of Rule
144, including the volume limitations and manner of sale requirements. In addition, all of the shares of common stock issuable upon exercise
of warrants will be freely tradable without restriction or further registration upon issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
stockholders may experience significant dilution as a result of future equity offerings or issuances and exercise of outstanding options
and warrants.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to raise additional capital or pursue strategic transactions, we may in the future offer, issue or sell additional shares of our
common stock or other securities convertible into or exchangeable for our common stock, including the issuance of common stock in relation
to the achievement, if any, of milestones triggering our payment of earn-out consideration in connection with the EGEN acquisition. Our
stockholders may experience significant dilution as a result of future equity offerings or issuances. Investors purchasing shares or
other securities in the future could have rights superior to existing stockholders. As of December 31, 2024, we had the following number
of securities convertible into, or allowing the purchase of, our common stock, including 5,155,060 shares of common stock issuable upon
exercise of warrants outstanding, 1,645,873 options to purchase shares of our common stock and restricted stock awards outstanding, and
420,000 shares of common stock reserved for future issuance under our stock incentive plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unstable
global market and economic conditions may have serious adverse consequences on our business, financial condition and share price.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
global economy, including credit and financial markets, has experienced extreme volatility and disruptions, including severely diminished
liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in unemployment rates, increases
in inflation rates and uncertainty about economic stability. For example, the COVID-19 pandemic resulted in widespread unemployment,
economic slowdown and extreme volatility in the capital markets. Similarly, the ongoing conflict between Ukraine and Russia and the unrest
in the Middle East has created extreme volatility in the global capital markets and is expected to have further global economic consequences,
including with respect to global supply chain and energy concerns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
such volatility may have adverse consequences on us or the third parties on whom we rely. If the equity and credit markets deteriorate,
including as a result of political unrest or war, it may make any necessary debt or equity financing more difficult to obtain in a timely
manner or on favorable terms, more costly or more dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
ability to use net operating losses to offset future taxable income is subject to certain limitations.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2017, the then President of the U.S. signed into law the Tax Reform Act. The Tax Reform Act significantly changed U.S. tax
law by, among other things, lowering corporate income tax rates, implementing a quasi-territorial tax system, providing a one-time transition
toll charge on foreign earnings, creating a new limitation on the deductibility of interest expenses and modifying the limitation on
officer compensation. The Tax Reform Act permanently reduced the U.S. corporate income tax rate from a maximum of 35% to a flat 21% rate,
effective January 1, 2018. We currently have significant net operating losses (&#8220;NOLs&#8221;) that may be used to offset future
taxable income. In general, under Section 382 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), a corporation
that undergoes an &#8220;ownership change&#8221; is subject to limitations on its ability to utilize its pre-change NOLs to offset future
taxable income. During 2022, 2021 and years prior, we performed analyses to determine if there were changes in ownership, as defined
by Section 382 of the Code, which would limit our ability to utilize certain net operating loss and tax credit carry forwards. We determined
we experienced ownership changes, as defined by Section 382, in connection with certain common stock offerings in 2011, 2013, 2015, 2017,
2018, 2020, 2021 and 2024. As a result, the utilization of our federal tax net operating loss carry-forwards generated prior to the ownership
changes is limited. Future changes in our stock ownership, some of which are outside of our control, could result in an ownership change
under Section 382 of the Code, which would significantly limit our ability to utilize NOLs to offset future taxable income. Future changes
in tax laws could also impair our corporate tax rate and/or our ability to utilize our NOLs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
have never paid cash dividends on our common stock in the past and do not anticipate paying cash dividends on our common stock in the
foreseeable future.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid cash dividends on our common stock. We do not anticipate paying any cash dividends on our common stock in
the foreseeable future. We currently intend to retain all available funds and any future earnings to fund the development and growth
of our business. As a result, capital appreciation, if any, of our common stock will be the sole source of gain for the foreseeable future
for holders of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anti-takeover
provisions in our charter documents and Delaware law could prevent or delay a change in control.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation and bylaws may discourage, delay or prevent a merger or acquisition that a stockholder may consider favorable
by authorizing the issuance of &#8220;blank check&#8221; preferred stock. This preferred stock may be issued by our Board of Directors
on such terms as it determines, without further stockholder approval. Therefore, our Board of Directors may issue such preferred stock
on terms unfavorable to a potential bidder in the event that our Board of Directors opposes a merger or acquisition. In addition, our
staggered Board of Directors may discourage such transactions by increasing the amount of time necessary to obtain majority representation
on our Board of Directors. Certain other provisions of our bylaws and of Delaware law may also discourage, delay or prevent a third party
from acquiring or merging with us, even if such action were beneficial to some, or even a majority, of <span id="xdx_904_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240101__20241231_z8itR2D0OLT5" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000047" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag">our</ix:nonNumeric></span> stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_025"></span>ITEM
    1B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNRESOLVED
    STAFF COMMENTS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_026"></span>ITEM
    1C.</b></span></td>
    <td id="xdx_980_ecyd--CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_iB_c20240101__20241231_gBFCRMPFAIAMT-_zI50fBsuEaK3" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" continuedAt="ConU000050-01" escape="true" id="Fact000050" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CYBERSECURITY</b></span></ix:nonNumeric></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C0E_gBFCRMPFAIAMT-_z2CyjHtuPA49"><ix:continuation continuedAt="ConU000050-02" id="ConU000050-01">&#160;</ix:continuation></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C00_gBFCRMPFAIAMT-_zShhPt6DLvq1"><ix:continuation id="ConU000050-02"><span id="xdx_908_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20240101__20241231_zFQsrNP64Zm8" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000051" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock">We
have <span id="xdx_904_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240101__20241231_zor46tLIquik" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000052" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag">processes for assessing, identifying and managing</ix:nonNumeric></span> cybersecurity risks, which are built into our information technology (&#8220;IT&#8221;)
function and are designed to help protect our information assets and operations from internal and external cyber threats, protect employee
and clinical trial information from unauthorized access or attack, as well as secure our networks and systems. Such processes include
physical, procedural and technical safeguards, response plans, and routine review of our policies and procedures to identify risks and
refine our practices.</ix:nonNumeric></span> We engage certain <span id="xdx_906_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240101__20241231_zcaOlp1kgktk" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000053" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag">external parties</ix:nonNumeric></span>, including a full-service managed IT service provider, to enhance our <span id="xdx_90B_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20240101__20241231_zdr41oCqFdl6" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000054" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">cybersecurity
oversight</ix:nonNumeric></span>.</ix:continuation></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240101__20241231_zSKv7jSIOAsl" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000055" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">Our
Audit Committee of the Board of Directors (the &#8220;Audit Committee&#8221;) is responsible for overseeing cybersecurity risk and periodically
updates our Board of Directors on such matters.</ix:nonNumeric></span> <span id="xdx_907_ecyd--CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240101__20241231_zmqiZLx7Jnvb" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000056" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">The Audit Committee receives periodic updates from management regarding cybersecurity
matters and is notified between such updates regarding any significant new cybersecurity threats or incidents. <span id="xdx_90C_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20240101__20241231_zDTe4N0EHe9b" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000057" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">We do <span id="xdx_90B_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240101__20241231_zZqnWGI7tySf" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000058" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">no</ix:nonNumeric></span>t believe that
there are currently any known risks from cybersecurity threats that are reasonably likely to materially affect us or our business strategy,
results of operations or financial condition.</ix:nonNumeric></span></ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_c20240101__20241231_zKCwq2xDTt55" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000059" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">Management
is <span id="xdx_901_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20240101__20241231_zYM4N2amO9C" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000060" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">responsible</ix:nonNumeric></span> for the operational oversight of company-wide cybersecurity strategy, policy, and standards across relevant departments
to assess and help prepare us to address cybersecurity risks</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
an effort to deter and detect cyber threats, <span id="xdx_901_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20240101__20241231_zbLRZnFMNe22" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000061" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">we annually provide all employees with cybersecurity and prevention training, which covers
timely and relevant topics, including social engineering, phishing, password protection, confidential data protection, and mobile security,
and educates employees on the importance of <span id="xdx_90C_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_dbT_c20240101__20241231_zGS6uaSSr8m1" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000062" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">reporting</ix:nonNumeric></span> all incidents immediately. We also use technology-based tools to mitigate cybersecurity
risks and to bolster our employee-based cybersecurity programs</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_027"></span>ITEM
    2.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPERTIES</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
own no real property and have no plans to acquire any real property in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lawrenceville,
NJ Lease</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2023, the Company renewed its Lawrenceville office lease for a 24-month agreement for 9,850 square feet with monthly rent payments
of approximately $22,983 and $23,394.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Huntsville,
AL Lease</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2023, the Company renewed its Huntsville facility lease for a 60-month lease agreement for 11,420 square feet with monthly rent
payments of approximately $28,550 to $30,903.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe our existing facilities are suitable and adequate to conduct our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
is a table of future payments and maturity of our operating lease liabilities as of December 31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ending<br/> December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">2025</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">543,009</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">362,976</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">370,235</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">2028 and thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">30,903</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Subtotal future lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,307,123</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less imputed interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(167,830</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Total lease liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,139,293</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Weighted average remaining life</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7 years </span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Weighted average discount rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">9.98</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
2024, operating lease expense was $651,681 and cash paid for operating leases included in operating cash flows was $659,161. For 2023,
operating lease expense was $646,633 and cash paid for operating leases included in operating cash flows was $644,593.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_028"></span>ITEM
    3.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEGAL
    PROCEEDINGS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not currently a party to any material legal proceedings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_029"></span>ITEM
    4.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MINE
    SAFETY DISCLOSURES</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
Applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_030"></span>PART
II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_031"></span>ITEM
    5. </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MARKET
    FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_032"></span>Market
for Our Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock trades on The Nasdaq Capital Market under the symbol &#8220;IMNN.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_033"></span>Record
Holders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 21, 2025, there were approximately 20,000 stockholders of record of our common stock. The actual number of stockholders may
be greater than this number of record stockholders and include stockholders who are beneficial owners but whose shares are held in street
name by brokers and other nominees. This number of stockholders of record also does not include stockholders whose shares may be held
in trust by other entities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_034"></span>Dividend
Policy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our common stock. We currently anticipate that we will retain all of our future earnings
for use in the operation of our business and to fund future growth and do not anticipate paying any cash dividends in the foreseeable
future. Any future determination to declare cash dividends will be made at the discretion of our Board of Directors, subject to applicable
law, and will depend on our financial condition, results of operations, capital requirements, general business conditions and other factors
that our Board of Directors may deem relevant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Performance
Graph</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_035"></span>Unregistered
Sales of Equity Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 7, 2024, we granted: (i) an inducement stock option to purchase 60,000 shares of the Company&#8217;s common stock with an exercise
price of $1.02 per share to one individual hired by the Company during the fourth quarter of 2024 and (ii) an inducement stock option
to purchase 50,000 shares of the Company&#8217;s common stock with an exercise price of $1.02 per share to Susan Eylward, our General
Counsel, in each case as an &#8220;inducement&#8221; grant pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. The grant of the
option was exempt from registration under the Securities Act, pursuant to Section 4(a)(2) thereof as a transaction by an issuer not involving
a public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_036"></span>Issuer
Purchases of Equity Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_037"></span>ITEM
    6.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RESERVED.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_038"></span>ITEM
    7.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MANAGEMENT&#8217;S
    DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following discussions should be read in conjunction with the financial statements and related notes thereto included in this Annual Report.
The following discussion contains forward-looking statements made pursuant to the safe harbor provisions of Section 27A of the Securities
Act and Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. These statements are based on the Company&#8217;s
beliefs and expectations about future outcomes and are subject to risks and uncertainties that could cause actual results to differ materially
from anticipated results. Factors that could cause or contribute to such differences include those described under <b>&#8220;Part I,
Item 1A - Risk Factors&#8221;</b> appearing in this Annual Report and factors described in other cautionary statements, cautionary language
and risk factors set forth in other documents that the Company files with the SEC. The Company undertakes no obligation to publicly update
forward-looking statements, whether as a result of new information, future events or otherwise.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_039"></span>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon
is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body&#8217;s natural
mechanisms with the aim to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating
approach from conventional therapies. Imunon is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas&#174;,
is developed for the coding of proteins and cytokines in the treatment of solid tumors where an immunological approach is deemed promising.
The second modality, PlaCCine&#174;, is developed for the coding of viral antigens that can elicit a strong immunological response. This
technology may represent a promising platform for the development of vaccines in infectious diseases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer
that has completed Phase II clinical development studies. IMNN-001 works by instructing the body to produce safe and durable levels of
powerful cancer-fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site. Additionally, the Company has entered
into a first-in-human study of its COVID-19 booster vaccine (IMNN-101). We will continue to leverage these modalities and to advance
the technological frontier of plasmid DNA to better serve patients with difficult-to-treat conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_040"></span>Business
Plan and Going Concern Risk</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a clinical-stage biopharmaceutical company, our business and our ability to execute our strategy to achieve our corporate goals are subject
to numerous risks and uncertainties. Material risks and uncertainties relating to our business and our industry are described in &#8220;<b>Part
I, Item 1A. Risk Factors</b>&#8221; in this Annual Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not generated and do not expect to generate any revenue from product sales in the next several years, if at all. An element of our
business strategy has been to pursue, as resources permit, the research and development of a range of drug candidates for a variety of
indications. We may also evaluate licensing products from third parties to expand our current product pipeline. This is intended to allow
us to diversify the risks associated with our research and development expenditures. To the extent we are unable to maintain a broad
range of drug candidates, our dependence on the success of one or a few drug candidates would increase and would have a more significant
impact on our financial prospects, financial condition, and market value. We may also consider and evaluate strategic alternatives, including
investment in, or acquisition of, complementary businesses, technologies, or products. Drug research and development is an inherently
uncertain process and there is a high risk of failure at every stage prior to approval. The timing and the outcome of clinical results
are extremely difficult to predict. The success or failure of any preclinical development and clinical trial can have a disproportionately
positive or negative impact on our results of operations, financial condition, prospects, and market value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current business strategy includes the possibility of entering into collaborative arrangements with third parties to complete the development
and commercialization of our drug candidates. In the event that third parties are contracted to manage the clinical trial process for
one or more of our drug candidates, the estimated completion date would largely be under the control of that third party rather than
us. We cannot forecast with any degree of certainty which proprietary products or indications, if any, will be subject to future collaborative
arrangements, in whole or in part, and how such arrangements would affect our development plan or capital requirements. We may also apply
for subsidies, grants or government or agency-sponsored studies that could reduce our development costs. However, we cannot forecast
with any degree of certainty whether we will be selected to receive any subsidy, grant or governmental funding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
inception, the Company has incurred substantial operating losses, principally from expenses associated with the Company&#8217;s research
and development programs, clinical trials conducted in connection with the Company&#8217;s drug candidates, and applications and submissions
to the FDA. The Company has not generated significant revenue and has incurred significant net losses in each year since our inception.
As of December 31, 2024, the Company has incurred approximately $407 million of cumulative net losses and had $5.9 million in cash and
cash equivalents to fund its operations. We have substantial future capital requirements to continue our research and development activities
and advance our drug candidates through various development stages. The Company believes these expenditures are essential for the commercialization
of its drug candidates and technologies. The Company&#8217;s primary sources of cash have been proceeds from the issuance and sale of
its common stock, including via its ATM program and other potential funding transactions. There can be no assurance that the Company
will be able to do so in the future on a timely basis on terms acceptable to the Company, or at all. The Company has not yet commercialized
any of its product candidates. Even if the Company commercializes one or more of its product candidates, it may not become profitable
in the near term. The Company&#8217;s ability to achieve profitability depends on several factors, including its ability to obtain regulatory
approval for its product candidates, successfully complete any post-approval regulatory obligations and successfully commercialize its
product candidates alone or in partnership.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
our development plans, we anticipate cash resources will not be sufficient to fund our operations for the next twelve months. The Company
has no committed sources of additional capital. As a result of the risks and uncertainties discussed in this Annual Report on Form 10-K,
among others, we are unable to estimate the duration and completion costs of our research and development projects or when, if ever,
and to what extent we will receive cash inflows from the commercialization and sale of a product. Our inability to complete any of our
research and development activities, preclinical studies or clinical trials in a timely manner or our failure to enter into collaborative
agreements when appropriate could significantly increase our capital requirements and could adversely impact our liquidity. While our
estimated future capital requirements are uncertain and could increase or decrease as a result of many factors, including the extent
to which we choose to advance our research, development activities, preclinical studies and clinical trials, or if we are in a position
to pursue manufacturing or commercialization activities, we will need significant additional capital to develop our drug candidates through
development and clinical trials, obtain regulatory approvals and manufacture and commercialized approved products, if any. We do not
know whether we will be able to access additional capital when needed or on terms favorable to us or our stockholders. Our inability
to raise additional capital, or to do so on terms reasonably acceptable to us, would jeopardize the future success of our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the above, management has determined there is substantial doubt regarding our ability to continue as a going concern. The report of
our independent registered public accounting firm for the year ended December 31, 2024 includes an explanatory paragraph which expresses
substantial doubt about our ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&#8217;s
plan includes raising funds from outside investors, including via its ATM program and other potential funding sources. However, as mentioned
above, there is no assurance such funding will be available to the Company or that it will be obtained on terms favorable to the Company
or will provide the Company with sufficient funds to meet its objectives. The Company&#8217;s financial statements do not include any
adjustments relating to the recoverability and classification of assets, carrying amounts or the amount and classification of liabilities
that may be required should the Company be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s ability to raise additional capital may also be adversely impacted by potential worsening global economic conditions
and the recent disruptions to, and volatility in, financial markets in the U.S. and worldwide resulting from the ongoing conflict between
Ukraine and Russia and the unrest in the Middle East. The specific impact, if any, is not readily determinable as of the date of the
financial statements included in this Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_001"></span><b><i>Financing
Overview</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Equity,
Debt and Other Forms of Financing</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
2018, the Company has annually submitted applications to sell a portion of the Company&#8217;s State of New Jersey net operating losses
(&#8220;NOLs&#8221;) as part of the Technology Business Tax Certificate Program (the &#8220;NOL Program&#8221;) sponsored by The New
Jersey Economic Development Authority. Under the program, emerging biotechnology companies with unused NOLs and unused research and development
credits are allowed to sell these benefits to other New Jersey-based companies. In 2018, 2019 and 2020, the Company sold cumulative NOLs
from 2011 to 2019 totaling $15 million and received net proceeds of $14 million. During 2021, the New Jersey State Legislature increased
the maximum lifetime benefit per company from $15 million to $20 million. As part of the expanded NOL Program, the Company sold $4.6
million of its New Jersey NOLs in 2021, 2022 and 2023 resulting in net proceeds to the Company of approximately $4.2 million. The Company
can participate in this funding program in future years for up to an additional $0.4 million in net operating losses under the $20 million
maximum lifetime limit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
more fully discussed in Note 8 to our financial statements included in this Annual Report, in June 2021, the Company entered into a $10
million loan facility with Silicon Valley Bank (the &#8220;SVB Loan Facility&#8221;). The Company immediately used $6 million from this
facility to retire all outstanding indebtedness with Horizon Technology Finance Corporation. The funding was in the form of money market
secured indebtedness bearing interest at a calculated WSJ Prime-based variable rate. The SVB Loan Facility was repaid in full during
the quarter ended June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2024 and 2023, we issued a total of 5.1 million shares and 1.9 million shares of common stock, respectively, as discussed below for approximately
$9.0 million and approximately $2.8 million, respectively, in net proceeds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 15, 2024, the Company filed with the SEC a shelf registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;)
for the offer and sale of up to $75 million of its securities. The 2024 Registration Statement was declared effective on May 22, 2024.
The 2024 Registration Statement is intended to provide the Company with flexibility to raise capital in the future for general corporate
purposes. However, the Company&#8217;s ability to offer and sell its securities in a primary offering on the 2024 Registration Statement
is limited by General Instruction I.B.6 of Form S-3 (the &#8220;Baby Shelf Limitation&#8221;), which limits the amount that the Company
can offer to up to one-third of its public float during any trailing 12-month period. The Company would no longer be subject to the Baby
Shelf Limitation if its public float exceeds $75 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">At
the Market Offering Agreement </span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 15, 2024, the Company amended its ATM Agreement with H.C. Wainwright &amp; Co., LLC (&#8220;Wainwright&#8221;)as sales agent pursuant
to which the Company may offer and sell, from time to time, through Wainwright, shares of the Company&#8217;s common stock having an
aggregate offering price of up to $5,500,000. The Company intends to use the net proceeds from the offering, if any, for general corporate
purposes, including research and development activities, capital expenditures and working capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2024, the Company notified Wainwright that it was suspending its use of and terminating the &#8220;at the market offering&#8221;
sales agreement prospectus (the &#8220;ATM Prospectus&#8221;), related to the potential issuance from time to time of the Company&#8217;s
common stock pursuant to the ATM Agreement, by and between the Company and Wainwright. Notwithstanding the termination of the ATM Prospectus,
the ATM Agreement remains in full force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 3, 2024, in connection with its intent to resume sales under the ATM Agreement, the Company filed a new prospectus supplement
to the 2024 Registration Statement with the SEC for an aggregate offering price of up to $5,500,000 related to the potential issuance
from time to time of the Company&#8217;s common stock pursuant to the ATM Agreement with Wainwright as sales agent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company sold 88,976 shares of common stock under the ATM Agreement for net proceeds of $99,506 during 2024. During 2023, the Company
sold 1,878,488 shares of common stock for net proceeds of $2,750,658.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">July
2024 Offering</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2024, the Company entered into the July 2024 Purchase Agreement with the Purchasers (as defined therein), pursuant to which
the Company issued, in a registered direct offering, an aggregate of 5,000,000 shares of the Company&#8217;s common stock at an offering
price of $2.00 per share for gross proceeds of $10.0 million before the deduction of the placement agent fees and offering expenses.
In a concurrent private placement (together with the registered direct offering, the &#8220;July 2024 Offering&#8221;) and also pursuant
to the July 2024 Purchase Agreement, the Company issued to the Purchasers unregistered warrants (the &#8220;Warrants&#8221;) to purchase
an aggregate of 5,000,000 shares of its common stock at a purchase price of $2.00 per share. The Warrants were exercisable immediately
after issuance for a term of five and one-half years following the date of issuance. The closing of the July 2024 Offering occurred on
August 1, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the July 2024 Offering, the Company entered into an engagement letter agreement with Wainwright pursuant to which the
Company agreed to pay Wainwright and any other placement agents for the July 2024 Offering a cash fee equal to 7% of the aggregate gross
proceeds raised from the sale of the securities sold in the July 2024 Offering and reimburse the placement agents for certain of their
expenses in an amount not to exceed $85,000. Brookline Capital Markets, a division of Arcadia Securities, LLC, acted as co-placement
agent in the July 2024 Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to Note 2 to our financial statements included in this Annual Report. Also refer to <b>Part I, Item 1A, Risk Factors</b>, in this
Annual Report, including, but not limited to<i>, &#8220;We will need to raise substantial additional capital to fund our planned future
operations, and we may be unable to secure such capital without significant dilutive financing transactions. If we are not able to raise
additional capital, we may not be able to complete the development, testing and commercialization of our drug candidates.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_002"></span>Critical
Accounting Policies and Estimates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
financial statements included in this Annual Report have been prepared in accordance with accounting principles generally accepted in
the U.S. (&#8220;GAAP&#8221;), which require that we make certain assumptions and estimates and, in connection therewith, adopt certain
accounting policies. Our significant accounting policies are set forth in Note 1 to our financial statements included in this Annual
Report. Of those policies, we believe that the policies discussed below may involve a higher degree of judgment and may be more critical
to an accurate reflection of our financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
and Development</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred. Supplies are consumable and recorded at cost and are charged to expense as they are
used in operations. Equipment and facilities acquired for research and development activities that have alternative future uses are
capitalized and charged to expense over their estimated useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrant
Accounting</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants&#8217; specific
terms and applicable authoritative guidance in ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221; (&#8220;ASC 480&#8221;),
and ASC 815 &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all
of the requirements for equity classification under ASC 815, including whether the warrants are indexed to our own ordinary shares and
whether warrant holders could potentially require &#8220;net cash settlement&#8221; in a circumstance outside of our control, among other
conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant
issuance and as of each subsequent quarterly period end-date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"></p>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
issued or modified warrants that meet all the criteria for equity classification, the warrants are required to be recorded as a component
of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants
are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of warrants classified as liabilities are recognized as a non-cash gain or loss on our statements
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the warrants issued upon our financings in 2024 meet the criteria for equity classification under ASC 815, those warrants were classified
as equity as of December 31, 2024. No warrants were issued in 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
review our financial reporting and disclosure practices and accounting policies on an ongoing basis to ensure that our financial reporting
and disclosure system provides accurate and transparent information relative to the current economic and business environment. As part
of the process, the Company reviews the selection, application and communication of critical accounting policies and financial disclosures.
The preparation of our financial statements in conformity with GAAP requires that our management make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period. We review our estimates and the methods by
which they are determined on an ongoing basis. However, actual results could differ from our estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="a_003"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Comparison
of Fiscal Year Ended December 31, 2024 and Fiscal Year Ended December 31, 2023.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2024, our net loss was $18.6 million compared to a net loss of $19.5 million for the year ended December
31, 2023. The Company recognized $1.3 million in tax benefits from the sale of its New Jersey NOLs under the NOL Program in the fourth
quarter of 2023. As of December 31, 2024, the Company had $5.9 million in cash and cash equivalents to fund its operations. The Company&#8217;s
primary sources of cash have been proceeds from the issuance and sale of its common stock, including via its ATM program and other funding
transactions. There can be no assurance that the Company will be able to do so in the future on a timely basis on terms acceptable to
the Company, or at all. The Company has not yet commercialized any of its product candidates. Even if the Company commercializes one
or more of its product candidates, it may not become profitable in the near term or at all. The Company&#8217;s ability to achieve profitability
depends on several factors, including its ability to obtain regulatory approval for its product candidates, successfully complete any
post-approval regulatory obligations and successfully commercialize its product candidates alone or in partnership.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Based on the above, management has
determined there is substantial doubt regarding our ability to continue as a going concern. The report of our independent registered
public accounting firm for the year ended December 31, 2024 includes an explanatory paragraph which expresses substantial doubt about
our ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&#8217;s
plan includes raising funds from the issuance and sale of its common stock, including via its ATM program and other funding transactions.
However, as mentioned above, there is no assurance such funding will be available to the Company or that it will be obtained on terms
favorable to the Company or will provide the Company with sufficient funds to meet its objectives. The Company&#8217;s financial statements
do not include any adjustments relating to the recoverability and classification of assets, carrying amounts or the amount and classification
of liabilities that may be required should the Company be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates in one segment for the research and development of our product candidates. The Company&#8217;s chief operating decision
maker (&#8220;CODM&#8221;) has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions
about allocating resources and assessing performance for the entire Company based on consolidated financial information. Consequently,
we view the entire organization as one reportable segment and the strategic purpose of all operating activities (including general &amp;
administrative expenses) is to support that one segment. As a pre-revenue research and development company, the CODM evaluates company-wide
performance and allocates resources based on non-financial research and development milestones achieved, and to a lesser extent, financial
measures of performance such as clinical development (research and development expenses) and general and administrative expenses incurred.
Our CODM does not generally evaluate our performance using asset or historical cash flow information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below provides a summary of the significant expense categories and consolidated net loss details provided to the CODM (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(In thousands)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Change Increase (Decrease)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating Expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Clinical Research</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; width: 36%">OVATION</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,386</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,197</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">189</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">15.8</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Vaccine</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,420</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,420</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Other clinical and regulatory</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,434</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,793</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">641</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">35.8</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,240</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,990</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Non-Clinical R&amp;D and CMC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">OVATION</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,819</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,504</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">315</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">PlaCCine Vaccine</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,554</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,511</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,957</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(43.4</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Manufacturing (CMC)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,026</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,283</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(257</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(11.3</td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,399</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,298</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,899</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(22.9</td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Research and development expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,639</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,288</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">351</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">General and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7,493</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">9,742</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,249</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(23.1</td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">19,132</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">21,030</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,898</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9.0</td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Loss from operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(19,132</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(21,030</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,898</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(9.0</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Research
and Development Expenses</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development (&#8220;R&amp;D&#8221;) expenses decreased $0.3 million to $11.6 million in 2024 from $11.3 million in 2023. Costs associated
with the OVATION 2 Study were $1.4 and $1.2 million in 2024 and 2023, respectively. Costs associated with the PlaCCine Vaccine Study
were $1.4 million in 2024. Other clinical and regulatory costs were $2.4 million in 2024 compared to $1.8 million in 2023. R&amp;D costs
associated with the development of IMNN-001 to support the OVATION 2 Study were $1.8 million in 2024, an increase from $0.3 million in
same period of 2023. The development of the PLACCINE DNA vaccine technology platform decreased to $2.6 million in 2024 compared to $4.5
million in 2023. CMC costs decreased to $2.0 million in 2024 compared to $2.3 million in 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">General
and Administrative Expenses</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses decreased to $7.5 million in 2024 compared to $9.7 million in 2023. This decrease is primarily attributable
to the decrease in legal expenses of $1.4 million, employee related costs of $0.4 million, non-cash stock compensation expenses of $0.3
million, insurance costs of $0.1 million, and franchise tax of $0.2 million offset by higher consulting fees of $0.2 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Investment
income and interest expense</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized interest expense of $0.2 million in 2023. As more fully discussed in Note 7 to our financial statements included in
this Annual Report, in June 2021, the Company entered into a $10 million loan facility with Silicon Valley Bank. The Company immediately
used $6 million from this facility to retire all outstanding indebtedness with Horizon Technology Finance Corporation. In connection
with the SVB Loan Facility, the Company incurred $0.2 million in interest expense in 2023. In connection with the termination of the
SVB Loan Facility in the second quarter of 2023, the Company paid early termination and end-of-term charges to SVB and recognized $0.3
million as a loss on debt extinguishment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
income from the Company&#8217;s short-term investments was $0.5 million in 2024 compared to $1.2 million in 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Income
Tax Benefit</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annually,
the State of New Jersey enables approved technology and biotechnology businesses with New Jersey NOLs the opportunity to sell these losses
through the NOL Program, thereby providing cash to companies to help fund their research and development and business operations. During
2021, the New Jersey State Legislature increased the maximum lifetime benefit per company from $15 million to $20 million, which will
allow the Company to participate in this innovative funding program in future years. After the cumulative NOL sales through 2023, the
Company has approximately $0.4 million remaining under the NOL Program.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement to sell the approved portion of the New Jersey NOLs applied for in 2023 for $1.3 million. At December
31, 2023, the Company evaluated the valuation reserve for its NOLs associated with its New Jersey NOLs and reduced the valuation reserve
and recognized $1.3 million as a deferred tax asset and an income tax benefit. The Company completed the sale of these NOLs in March
of 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_004"></span><b>Financial
Condition, Liquidity and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
inception, we have incurred significant losses and negative cash flows from operations. We have financed our operations primarily through
the net proceeds from the sales of equity, credit facilities and amounts received under our product licensing agreement with Yakult and
our technology development agreement with Hisun. The process of developing IMNN-001 and other drug candidates and technologies requires
significant research and development work and clinical trial studies, as well as significant manufacturing and process development efforts.
We expect these activities, together with our general and administrative expenses, to result in significant operating losses for the
foreseeable future. Our expenses have significantly and regularly exceeded our income, and we had an accumulated deficit of $407 million
at December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2024 we had total current assets of $8.0 million and current liabilities of $4.8 million, resulting in net working capital
of $3.2 million. On December 31, 2024, we had cash and cash equivalents of $5.9 million. On December 31, 2023, we had total current assets
of $18.2 million and current liabilities of $7.4 million, resulting in net working capital of $10.8 million. We have substantial future
capital requirements to continue our research and development activities and advance our drug candidates through various development
stages. The Company believes these expenditures are essential for the commercialization of its technologies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities for 2024 was $18.9 million. Our net loss of $18.6 million for 2024 included non-cash
transactions of $0.5 million in non-cash stock-based compensation expense. On December 31, 2024, we had cash and cash equivalents of
$5.9 million. See Financing Overview.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may seek additional capital through further public or private equity offerings, debt financing, additional strategic alliance
and licensing arrangements, collaborative arrangements, or some combination of these financing alternatives. If we raise additional funds
through the issuance of equity securities, the percentage ownership of our stockholders could be significantly diluted, and the newly
issued equity securities may have rights, preferences, or privileges senior to those of the holders of our common stock. If we raise
funds through the issuance of debt securities, those securities may have rights, preferences, and privileges senior to those of our common
stock. If we seek strategic alliances, licenses, or other alternative arrangements, such as arrangements with collaborative partners
or others, we may need to relinquish rights to certain of our existing or future technologies, drug candidates, or products we would
otherwise seek to develop or commercialize on our own, or to license the rights to our technologies, drug candidates, or products on
terms that are not favorable to us. The overall status of the economic climate could also result in the terms of any equity offering,
debt financing, or alliance, license, or other arrangement being even less favorable to us and our stockholders than if the overall economic
climate were stronger. We also will continue to look for government sponsored research collaborations and grants to help offset future
anticipated losses from operations and, to a lesser extent, interest income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
adequate funds are not available through either the capital markets, strategic alliances, or collaborators, we may be required to delay
or, reduce the scope of, or terminate our research, development, clinical programs, manufacturing, or commercialization efforts, or effect
additional changes to our facilities or personnel, or obtain funds through other arrangements that may require us to relinquish some
of our assets or rights to certain of our existing or future technologies, drug candidates, or products on terms not favorable to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
conditions raise substantial doubts about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plan includes
raising funds from the issuance and sale of its common stock via its ATM program and other funding transactions. However, as mentioned
above, there is no assurance such funding will be available to the Company or that it will be obtained on terms favorable to the Company
or will provide the Company with sufficient funds to meet its objectives. The Company&#8217;s financial statements do not include any
adjustments relating to the recoverability and classification of assets, carrying amounts or the amount and classification of liabilities
that may be required should the Company be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_005"></span><b>Off-Balance
Sheet Arrangements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not utilize off-balance sheet financing arrangements as a source of liquidity or financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>ITEM
    7A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QUANTITATIVE
    AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required
under this item.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_007"></span>ITEM
    8.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FINANCIAL
    STATEMENTS AND SUPPLEMENTARY DATA</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements, supplementary data and report of independent registered public accounting firm required to be filed pursuant to
this Item 8 are appended to this Annual Report beginning on page F-1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span id="a_008"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    9.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CHANGES
    IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_009"></span><b>ITEM
    9A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONTROLS
    AND PROCEDURES</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
    Controls and Procedures</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as such term
is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act under the supervision, and with the participation, of our management,
including our principal executive officer and principal financial officer. Based on that evaluation, our principal executive officer
and principal financial officer concluded that as of December 31, 2024, which is the end of the period covered by this Annual Report,
our disclosure controls and procedures were effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&#8217;s
    Report on Internal Control over Financial Reporting</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f)
and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is a process designed by, or under the supervision
of, our chief executive officer and chief financial officer, or persons performing similar functions, and effected by our Board of Directors,
management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with GAAP. Our internal control over financial reporting includes those policies
and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions
and disposition of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with GAAP and that receipts and expenditures of the Company are being made only in
accordance with authorization of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention
or timely detection of unauthorized acquisition, use, or disposition of the Company&#8217;s assets that could have a material effect
on the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
assessed the effectiveness of the Company&#8217;s internal control over financial reporting as of December 31, 2024. In making this assessment,
management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in the 2013 <i>Internal
Control-Integrated Framework</i>. Based on its evaluation, management has concluded that the Company&#8217;s internal control over financial
reporting is effective as of December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Regulation S-K Item 308(b), this Annual Report does not include an attestation report of the Company&#8217;s registered public accounting
firm regarding internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of
any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions
or that the degree of compliance with the policies or procedures may deteriorate. A control system, no matter how well designed and operated
can provide only reasonable, but not absolute, assurance that the control system&#8217;s objectives will be met. The design of a control
system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    in Internal Control over Financial Reporting</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no changes in our internal control over financial reporting in the fiscal quarter ended December 31, 2024 that were identified
in connection with our management&#8217;s evaluation required by paragraph (d) of rules 13a-15 and 15d-15 under the Exchange Act, that
have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_010"></span><b>ITEM
    9B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OTHER
    INFORMATION</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rule
10b5-1 Trading Plans</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2024, no directors or executive officers <span id="xdx_904_eecd--Rule10b51ArrAdoptedFlag_dbF_c20240101__20241231_z8yqc9bWjpi2" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><span id="xdx_90B_eecd--NonRule10b51ArrAdoptedFlag_dbF_c20240101__20241231_zMz3OXzyOTEc" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000063" name="ecd:Rule10b51ArrAdoptedFlag"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000064" name="ecd:NonRule10b51ArrAdoptedFlag">entered</ix:nonNumeric></ix:nonNumeric></span></span> into, <span id="xdx_90F_ecustom--Rule10b51ArrModifiedFlag_dbF_c20240101__20241231_zjYwkzp00Had" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA" title="Rule 10b5-1 Arrangement Modified"><span id="xdx_904_ecustom--NonRule10b51ArrModifiedFlag_dbF_c20240101__20241231_zcWPinme16If" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA" title="Non-Rule 10b5-1 Arrangement Modified"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000066" name="IMNN:Rule10b51ArrModifiedFlag"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000068" name="IMNN:NonRule10b51ArrModifiedFlag">modified</ix:nonNumeric></ix:nonNumeric></span></span> or <span id="xdx_907_eecd--Rule10b51ArrTrmntdFlag_dbF_c20240101__20241231_zrRghe0wKDdl" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><span id="xdx_905_eecd--NonRule10b51ArrTrmntdFlag_dbF_c20240101__20241231_zb3dDw4Slobi" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000069" name="ecd:Rule10b51ArrTrmntdFlag"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000070" name="ecd:NonRule10b51ArrTrmntdFlag">terminated</ix:nonNumeric></ix:nonNumeric></span></span>, contracts, instructions or
written plans for the sale or purchase of the Company&#8217;s securities that were intended to satisfy the affirmative defense conditions
of Rule 10b5-1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_011"></span><b>ITEM
    9C.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DISCLOSURE
    REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_012"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
III</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_013"></span><b>ITEM
    10.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DIRECTORS,
    EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors currently consists of six members and is divided into three classes of directors serving staggered three-year terms.
Directors for each class are elected at the Annual Meeting of Stockholders held in the year in which the term for their class expires
and hold office for a three-year term and until their successors are duly elected and qualified, or their earlier death, resignation
or removal. In accordance with our amended and restated certificate of incorporation and bylaws, our Board may fill any vacancy on the
Board by appointment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is certain information regarding our Company&#8217;s current directors, as well as our non-director executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAME</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGE</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>POSITION(S)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CLASS</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frederick
    J. Fritz</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christine
    Pellizzari</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    E. Dentzer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">II</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    R. Lindborg, Ph.D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Chief Executive Officer and Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">II</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald
    P. Braun, Ph.D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">III</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    H. Tardugno</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">III</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khursheed
    Anwer, Ph.D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Vice President and Chief Scientific Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Susan
    Eylward</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Counsel and Corporate Secretary</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas
    Faller, MD</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Medical Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Gaiero</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors
</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Class
I Directors (Term expires in 2026)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mr.
Frederick J. Fritz.</b> Mr. Fritz was appointed to our Board of Directors in July 2011. Mr. Fritz has served as CEO and Founder of NeuroDx,
a development stage diagnostic device company focused on the neurosurgery market, since 2006. Mr. Fritz joined NeuroDx from Valeo Medical,
a biotechnology company he founded in 2003 to develop the world&#8217;s first non-invasive diagnostic test for endometriosis. Prior to
that, Mr. Fritz was President and CEO of Songbird Hearing, Inc., a medical device company spun out of Sarnoff Corporation. Mr. Fritz
began his career in marketing management and new product development. He joined Schering Plough&#8217;s Wesley Jessen in 1985 as VP Marketing
and Sales in 1986. He was promoted to general manager of Schering&#8217;s Over the Counter pharmaceutical business in 1988 and of the
podiatric products business in 1990. He was President of Coleman North America from 1995 to 1997. Mr. Fritz holds a bachelor&#8217;s
degree in engineering (summa cum laude) from University of Illinois and an MBA degree from Harvard University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ms.
Christine A. Pellizzari. </b>Ms. Pellizzari was appointed to our Board of Directors in June 2021. Ms. Pellizzari most recently served
as the Chief Legal Officer and Human Resources Officer of Science 37 (formerly Nasdaq: SNCE), a developer of leading decentralized clinical
trial solutions, where she had global responsibility for both the legal and human resource functions and also oversaw quality and privacy
from 2021 through 2024. Immediately prior to joining Science 37, Ms. Pellizzari served as the General Counsel and Corporate Secretary
of Insmed, Inc., (Nasdaq: INSM) a publicly traded biotech company focused on serious and rare diseases, from 2013 to 2018 and as Chief
Legal Officer from 2018 to 2021. From 2007 through 2012 Ms. Pellizzari held various legal positions of increasing responsibility at Aegerion
Pharmaceuticals, most recently as Executive Vice President, General Counsel and Corporate Secretary. Prior to Aegerion, Ms. Pellizzari
was Senior Vice President, General Counsel and Secretary at Dendrite International, Inc., a formerly publicly traded company that provided
sales effectiveness, promotional and compliance solutions to the pharmaceutical industry. Ms. Pellizzari joined Dendrite from the law
firm of Wilentz, Goldman &amp; Spitzer, where she specialized in health care transactions and related regulatory matters. Ms. Pellizzari
has nearly three decades of relevant experience, including having served for over 25 years as Chief Legal Officer and General Counsel
of publicly traded companies in biopharmaceutical and related industries. Ms. Pellizzari also serves on the board of directors of Tempest
Therapeutics (Nasdaq: TPST), a public clinical-stage oncology company and Neurosense Therapeutics (Nasdaq: NRSN), a public clinical-stage
development company advancing treatments for severe neurodegenerative diseases. Ms. Pellizzari received her Bachelor of Arts, cum laude,
from the University of Massachusetts (Amherst) and her Juris Doctor degree from the University of Colorado School of Law. She is a member
of Global Leaders in Law, Executive Women in Bio, Women Corporate Directors, National Association of Corporate Directors, Association
of Corporate Counsel, Society for Corporate Governance and National Association of Stock Plan Professionals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Class
II Directors (Term expires in 2027)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mr.
James E. Dentzer. </b>Mr. Dentzer was appointed to our Board of Directors in September 2022. He has been President and Chief Executive
Officer and a member of the Board of Directors of Curis, Inc. (Nasdaq: CRIS) since September 2018. From March 2018 to September 2018,
Mr. Dentzer served as Curis&#8217; Chief Operating Officer and Chief Financial Officer. From March 2016 to March 2018, Mr. Dentzer served
as Curis&#8217; Chief Administrative Officer and Chief Financial Officer. Mr. Dentzer has also held the positions of secretary and treasurer
from March 2016 to March 2019. Prior to joining Curis, Mr. Dentzer served as Chief Financial Officer of Dicerna Pharmaceuticals, Inc.,
a formerly publicly traded biotechnology company, from December 2013 to December 2015. Prior to that, he was the Chief Financial Officer
of Valeritas, Inc., a formerly publicly traded medical technology company, from March 2010 to December 2013. Prior to joining Valeritas,
Inc., he was the Chief Financial Officer of Amicus Therapeutics, Inc. (Nasdaq: FOLD), a biotechnology company, from October 2006 to October
2009. In prior positions, he spent six years as Corporate Controller of Biogen Inc. (Nasdaq: BIIB), a biotechnology company, and six
years in various senior financial roles at E.I. du Pont de Nemours and Company, a chemical, petroleum and biotechnology company, in the
U.S. and Asia. Mr. Dentzer holds a B.A. degree in Philosophy from Boston College and an M.B.A. from the University of Chicago.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dr.
Stacy R. Lindborg</b>. Dr. Lindborg, a director since 2021, has served as President and Chief Executive Officer of the Company since
May 2024. Dr. Lindborg, a globally recognized biostatistician, brings to Imunon nearly 30 years of pharmaceutical and biotech industry
experience with a particular focus on R&amp;D, regulatory affairs, executive management and strategy. She has worked with biologics,
small molecules and cell therapies to address a broad range of diseases and disorders, including multiple Orphan drug products, along
with extensive experience in early-stage development having taken molecules from first-in-human studies into the clinic, through regulatory
approval and commercial launch. Prior to joining the Company, Dr. Lindborg held the position of co-Chief Executive Officer at Brainstorm
Cell Therapeutics (Nasdaq: BCLI), which she joined in 2020, and where she also currently serves as an independent director since May
2024. From 2012 to 2020, she held positions of increasing responsibility at Biogen and served as Vice President for Global Analytics
and Data Sciences. Prior to her time at Biogen, Dr. Lindborg had worked at Eli Lilly and Company (NYSE: LLY) since 1996 advancing through
the organization to serve from 2010 to 2012 as Head of R&amp;D Strategy with responsibility for characterizing the productivity of the
portfolio and advancing key R&amp;D strategy projects by connecting individual drug-development decisions to portfolio risk practices
and driving fundamental R&amp;D decisions to increase the number of drug launches. Dr. Lindborg received an M.A. and a Ph.D. in statistics
from Baylor University. She has authored more than 50 abstracts, 200 presentations and 40 manuscripts that have been published in peer-reviewed
journals. She has held numerous positions within the American Statistical Association and International Biometric Society and was elected
Fellow in 2008.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Class
III Directors (Term expires in 2025)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dr.
Donald P. Braun.</b> Dr. Braun was appointed to our Board of Directors in December 2015. Dr. Braun has over 35 years of research experience
in oncology, cancer immunology, cancer immunotherapy, and inflammatory diseases. He is the author of more than 120 published peer-reviewed
manuscripts, twenty-five reviews and book chapters, and co-editor of a book on the role of prostaglandins and other COX 2 metabolites
in cancer patient immunity and immunotherapy. He served from 2006 to 2014 as Vice President Clinical Research, after which he served
as Vice President Translational Research and Chief Science Officer at the Cancer Treatment Centers of America until his retirement in
May 2016. Prior to this role, he was the Scientific Director of the Cancer Center and Professor of Medicine and Immunology at Rush Medical
College in Chicago from 1978 to 1999, and the Administrative Director of the Cancer Institute and a Professor of Surgery with tenure
at the Medical College of Ohio from 1999 to 2006. He received his Ph.D. in Immunology and Microbiology from the University of Illinois
at the Medical Center in Chicago. Dr. Braun has served as an advisor to numerous public agencies and private corporations concerned with
cancer therapeutics and diagnostics. At the National Cancer Institute, Dr. Braun served as a member of the Experimental Therapeutics
Study Section; the Small Business Innovation Grant Review Study Section; and the Experimental Therapy program for &#8220;Molecular Targets
in Lung Cancer.&#8221; He served as a member of the Immunology and Immunotherapy Study Section of the American Cancer Society-National
Division; as a Member of the Ohio Cancer Incidence Surveillance System; as a Member of the Biomedical Research Technology Transfer Commission
for the State of Ohio; and as an advisor to the State of Arizona&#8217;s Disease Research Control Commission. Dr. Braun has also served
as a consultant to numerous pharmaceutical and biotechnology companies developing cancer treatments and diagnostics including Pfizer
Inc. (NYSE: PFE), Sterling Winthrop, Abbott Laboratories (NYSE: ABT), Boehringer Mannheim, Serono Corporation, Biomira Inc., Centocor
and Merck KGA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mr.
Michael H. Tardugno.</b> Mr. Tardugno was appointed President and Chief Executive Officer of the Company on January 3, 2007, and was
elected to the Board of Directors on January 22, 2007. In October of 2014, Mr. Tardugno was appointed by our Board of Directors as our
Chairman. Effective July 18, 2022, Mr. Tardugno transitioned from the roles of President, Chief Executive Officer and Chairman to the
position of Executive Chairman of the Board. From March 15, 2024, Mr. Tardugno served as interim Chief Executive Officer until the appointment
of Dr. Lindborg effective May 13, 2024. Prior to joining the Company and for the period from February 2005 to December 2006, Mr. Tardugno
served as Senior Vice President and General Manager of Mylan Technologies, Inc., a subsidiary of Mylan Inc. From 1998 to 2005, Mr. Tardugno
was Executive Vice President of Songbird Hearing, Inc., a medical device company spun out of Sarnoff Corporation. From 1996 to 1998,
he was Senior Vice President of Technical Operations worldwide for a division of Bristol-Myers Squibb (NYSE: BMY), and from 1977 to 1995,
he held increasingly senior executive positions including Senior Vice President of Worldwide Technology Development with Bausch &amp;
Lomb (NYSE, TSX: BLCO) and Abbott Laboratories (NYSE: ABT). Mr. Tardugno holds a B.S. degree from St. Bonaventure University and completed
the Harvard Business School Program for Management Development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Executive
Officers</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are the biographical summaries for each of our executive officers, other than Dr. Stacy R. Lindborg, whose biographical summary
is described above. Each executive officer is elected by and serves at the pleasure of our Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Khursheed
Anwer, Ph.D. </b>Dr. Anwer joined us in June 2014 as Executive Vice President and Chief Scientific Officer, in connection with our acquisition
of all the assets of EGWU, Inc. (formerly known as Egen, Inc.), an Alabama corporation (or &#8220;EGEN&#8221;). Before joining the Company,
Dr. Anwer served as EGEN&#8217;s President and Chief Scientific Officer, a position he held since 2009. He joined EGEN in July 2002 as
Vice President of Research and Development and directed EGEN&#8217;s clinical and research and development functions. Before joining
EGEN, Dr. Anwer was Director of Pre-Clinical Development at Valentis, Inc. from July 2000 to June 2002. From 1993 to 1999, he served
in several positions at GeneMedicine, Inc., where he led several research projects in the area of non-viral gene therapy. He has authored
more than 40 publications in the area of non-viral gene therapy, resulting from his active career in research and development. Dr. Anwer
holds a Ph.D. in physiology/pharmacology from Ohio University and received post-doctoral training from the University of Texas Health
Science Center at Houston. Dr. Anwer also has a master&#8217;s in business administration from the University of Alabama.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Susan
Eylward </b>Ms. Eylward joined the Company in October 2024 as General Counsel and Corporate Secretary. Prior to her position with the
Company, Ms. Eylward served as Senior Counsel at Science 37, Inc. (formerly Nasdaq: SNCE), a solutions organization focused on decentralized
clinical trials, from January 2022 through April 2024, where she was responsible for a variety of complex legal matters, including, among
others, corporate governance, securities compliance, executive compensation, and acquisitions. Prior to that, Ms. Eylward served as corporate
counsel and Vice President at the Allstate Corporation (NYSE: ALL) during 2021, at National General Holdings Corp. (formerly Nasdaq:
NGHC) from September 2014 through December 2020, and at Tower Group International, Ltd. (formerly Nasdaq: TWGP) from May 2009 through
September 2014, and at each of the foregoing, she had responsibility for various corporate legal matters including governance, securities
law, alternative investments and transactions. From 2004 through 2009, Ms. Eylward practiced law at Dewey &amp; LeBoeuf LLP, where she
represented public and private companies for equity and debt offerings, as well as mergers and acquisitions. Ms. Eylward received a Juris
Doctor from New York Law School and a Bachelor of Arts in Accounting from Boston College.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Douglas
Faller, MD</b> Dr. Faller, an internationally recognized oncologist/hematologist and scientist, has nearly 30 years of pharmaceutical
and biotech industry experience with a particular focus on clinical R&amp;D, discovery, regulatory affairs, and strategy development.
He has worked with small molecules, gene therapies, biologics and cell therapies to address a range of malignant and non-malignant diseases
and disorders, including rare and genetic diseases, and neurological and neuropsychiatric disorders. He has extensive experience in early-stage
development as well as global late-stage development and world-wide marketing approvals. He has taken molecules (including those discovered
in his own academic laboratories) from first-in-human studies in the clinic, through registrational trials, international regulatory
approvals and commercial launch. Prior to his position with the Company, Dr. Faller served as Chief Medical Officer of Skyhawk Therapeutics
beginning in 2024, where he led the development of splicing modulators for the treatment of oncological and neurological disorders. From
2022 through 2024, he served as Chief Medical Officer of Oryzon Genomics, leading the development of epigenetic-modifying small molecules
in oncology and neuropsychiatric disorders, and prior to that role, from 2015 through 2022, Dr. Faller was Executive Medical Director
at Takeda Pharmaceuticals, where he led multiple programs in hematologic oncology, solid tumor malignancies and rare diseases, from first-in-human
to global registrational trials and post-marketing trials. He was also extensively involved in Business Development for oncology, hematology
and rare diseases. Dr. Faller was the scientific founder and CMO/CSO of Viracta Therapeutics, which he joined in 2019 and remained through
2021, after it became publicly traded and launched a pivotal trial of his therapeutic. Dr. Faller is the scientific founder or co-founder
of four biopharma companies. Prior to working full-time in the biopharmaceutical industry, Dr. Faller was a professor at Harvard Medical
School, and an attending physician at Brigham and Women&#8217;s Hospital, Boston Children&#8217;s Hospital and Dana-Farber Cancer Institute.
He founded and directed the Comprehensive Cancer Center at Boston University, where he also served as the first Grunebaum Professor for
Cancer Research, Vice-Chairman of the Department of Medicine, and Professor of Medicine, Biochemistry, Pediatrics, Microbiology, Pathology
and Laboratory Medicine. Dr. Faller received a B.S. in biochemistry from the Massachusetts Institute of Technology, an MD from Harvard
Medical School, and a PhD from the Massachusetts Institute of Technology in cancer molecular biology. He has authored more than 300 abstracts,
230 presentations and 375 manuscripts that have been published in peer-reviewed journals. He is certified in Internal Medicine, Hematology
and Oncology, and is a Fellow of the American College of Physicians.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>David
Gaiero</b> Mr. Gaiero joined the Company in May 2024 as Chief Financial Officer pursuant to a professional agreement (the &#8220;Agreement&#8221;)
between the Company and Monomoy Advisors, LLC, a financial advisory services firm (&#8220;Monomoy&#8221;). He currently serves as a partner
with Monomoy. Prior to joining Monomoy in May 2024, Mr. Gaiero served as Chief Financial Officer of Cyteir Therapeutics, Inc. Prior
to joining Cyteir Therapeutics in December 2020, Mr. Gaiero served in various roles at Wave Life Sciences (Nasdaq: WVE) from July 2017
to December 2020, most recently serving as Interim Chief Financial Officer and prior to that, serving as Vice President and Corporate
Controller. Prior to joining Wave Life Sciences, from September 2015 to July 2017, Mr. Gaiero served as Vice President and Corporate
Controller of OvaScience, Inc. Prior to that, Mr. Gaiero held various positions of increasing responsibility and scope in finance and
accounting at iRobot Corporation. Mr. Gaiero began his career in public accounting at PricewaterhouseCoopers LLP. Mr. Gaiero received
a B.B.A. in Accounting from the University of Massachusetts, Amherst, and is a Certified Public Accountant in Massachusetts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delinquent
Section 16(a) Reports </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Exchange Act requires our executive officers, directors and persons who own more than 10% of our common stock to file reports
of ownership and reports of changes in ownership of common stock and other equity securities of the Company with the SEC. Executive officers,
directors and greater than 10% stockholders are required by SEC regulations to furnish us with copies of all Section 16(a) forms they
file.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have identified the following reports required to be filed by insiders under Section 16(a) of the Exchange Act that were not filed in
a timely manner: one late report by Stacy Lindborg relating to one transaction and one late report by Donald Braun relating to one transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
our knowledge, based solely on a review of the copies of reports furnished to us, we believe that during the year ended December 31,
2024, our executive officers, directors and greater than 10% stockholders complied with all Section 16(a) filing requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Ethics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Code of Ethics and Business Conduct is applicable to all employees, including the principal executive officer, principal financial officer
and principal accounting officer or controller, or persons performing similar functions. The Code of Ethics and Business Conduct is posted
on our website at <i><span style="text-decoration: underline">www.imunon.com</span></i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Governance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Audit
Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee consists of Mr. James A. Dentzer (Chair), Mr. Frederick J. Fritz and Ms. Christine Pellizzari. Our Audit Committee operates
under a written charter as amended and restated effective January 24, 2023. A copy of that charter, as may be amended from time to time,
is available on our web site, located at <i><span style="text-decoration: underline">http://www.imunon.com</span></i>. Additional copies of the charter are available upon written
request to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee assists our Board of Directors in fulfilling its responsibility to oversee management&#8217;s implementation of our financial
reporting process. In discharging its oversight role, the Audit Committee reviewed and discussed the audited financial statements contained
in our 2024 Annual Report on Form 10-K with our management and independent registered public accounting firm. Management is responsible
for the financial statements and the reporting process, including the system of internal controls. Our independent registered public
accounting firm is responsible for expressing an opinion on the conformity of those financial statements with accounting principles generally
accepted in the U.S.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has determined that all members of the Audit Committee meet the independence standards established by the SEC and Nasdaq. Our Board
has determined that Mr. Dentzer is qualified to serve as the &#8220;audit committee financial expert&#8221; as defined by Item 407(d)(5)
of Regulation S-K and that Mr. Fritz and Ms. Pellizzari meet the financial literacy requirements under applicable Nasdaq rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nomination
of Directors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no changes to the procedures by which stockholders may recommend nominees to our Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Insider
Trading Policy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has adopted an insider trading policy which governs the purchase, sales, and/or other dispositions of our securities
by directors, officers, and employees. Our insider trading policy is attached hereto as Exhibit 19 and incorporated herein. Our insider
trading policy is designed to promote compliance with insider trading laws, rules and regulations and, among other things, prohibits
our officers, directors, and employees from, among other things, engaging in short sales, transactions in derivative securities (including
put and call options) or other forms of hedging transactions (i.e., zero-cost collars, equity swaps, exchange funds and forward sale
contracts) that are designed to hedge or offset any decrease in the market value of equity securities (1) granted to the executive officer
or director by the Company as part of the compensation of such individual, or (2) held, directly or indirectly, by the executive officer
or director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72px"><span id="a_014"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    11.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXECUTIVE
    COMPENSATION</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
of Executive Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section discusses the material components of the executive compensation program for our executive officers who are named in the &#8220;2024
Summary Compensation Table&#8221; below. In 2024, our &#8220;named executive officers&#8221; and their positions were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.35in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    Lindborg, our President and Chief Executive Officer;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Tardugno, our Executive Chairman and former President and Chief Executive Officer; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corinne
    Le Goff, our former President and Chief Executive Officer;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khursheed
    Anwer, our Executive Vice President and Chief Scientific Officer;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Gaiero, our Chief Financial Officer; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    Church, our former Executive Vice President, Chief Financial Officer and Corporate Secretary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024
Summary Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding the total compensation for services rendered in all capacities during the years ended
December 31, 2024 and 2023, awarded to, paid to, or earned by each &#8220;Named Executive Officer.&#8221; All compensation awarded to,
earned by, or paid to IMUNON&#8217;s Named Executive Officers is included in the table below for the years ended December 31, 2024 and
2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left; font-weight: bold">Name and Principal Position</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Salary</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Bonus</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Stock<br/> Awards(1)</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Option<br/> Awards<br/> (2)</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non-Equity<br/> Incentive Plan<br/>
    Compensation<br/> (3)</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">All Other<br/> Compensation<br/> (4)</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total<br/> ($)</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 21%; font-weight: bold; text-align: left">Stacy Lindborg (5)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: center">2024</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">341,954</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">26,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">335,641</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">1,745</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">705,839</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">President &amp; CEO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Michael Tardugno (6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">336,639</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">213,072</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10,099</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">559,810</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Executive Chairman &amp; former interim CEO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Corinne Le Goff (7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">148,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">148,869</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Former President and CEO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">658,080</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">107,775</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">274,959</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">15,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,055,814</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Khursheed Anwer (8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">385,610</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">87.678</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">149,125</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">622,413</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Executive VP &amp; CSO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">412,760</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;&#160;&#160;-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">125,281</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">94,218</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">680,159</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">David Gaiero (9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">280,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">280,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>CFO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Jeffrey Church (10)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">251,337</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9,816</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"/><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">498,615</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">759,768</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Former Executive VP &amp; CFO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">441,296</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">115,726</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">75,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">679,922</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif"><td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    value reported for restricted stock awards is the aggregate grant date fair value of restricted stock granted to the Named Executive
    Officer in the year shown, determined in accordance with FASB ASC Topic 718.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    value reported for option awards is the aggregate grant date fair value of stock options granted to the Named Executive Officers
    in the years shown, determined in accordance with FASB ASC Topic 718, disregarding adjustments for forfeiture assumptions. The assumptions
    for making the valuation determinations are set forth in Note 11 to the Company&#8217;s financial statements for the years ended
    December 31, 2024 and December 31, 2023 included in the Company&#8217;s Annual Reports on Form 10-K for each of those years. With
    respect to Dr. Lindborg, the column includes the annual grant of options to Dr. Lindborg as part of the non-employee director compensation
    program.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Executives&#8217;
    bonuses under our annual incentive program are based on the achievement of specific performance measures established at the beginning
    of the fiscal year by our Compensation Committee. Historically, our Compensation Committee has awarded the annual incentive bonus
    for each year in the first quarter of the following year. Our Compensation Committee has not approved the amount and the payment
    of the incentive bonus for 2024 for each of the Named Executive Officers in the form of stock awards and Non-Equity (Cash) Incentive
    Plan Compensation.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            column includes other compensation as indicated below and matching and discretionary contributions
                                            made by the Company for the Named Executive Officers under our 401(k) plan. Our matching
                                            contribution is equal to 50% of the employee&#8217;s deferrals under the plan up to 6% of
                                            the employee&#8217;s compensation, subject to applicable IRS limitations, and are made in
                                            shares of our common stock.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
                                            Lindborg, a director since 2021, joined the Company as President and Chief Executive Officer,
                                            effective as of May 13, 2024. Dr. Lindborg became a Named Executive Officer for the first
                                            time in 2024. For Dr. Lindborg, the amount in the &#8220;Salary&#8221; column reflects $14,838
                                            that Dr. Lindborg received as her cash retainer for her service as a non-employee director
                                            prior to becoming the Company&#8217;s President and CEO in May 2024, as well as the base
                                            salary amount received by Dr. Lindborg during fiscal year 2024, which was pro-rated for the
                                            time served in her employee positions during fiscal year 2024. For Dr. Lindborg &#8220;All
                                            Other Compensation&#8221; for 2024 consists of a 401(k)-plan matching contribution of $1,745
                                            in our common stock.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Mr.
    Tardugno, the Company&#8217;s Executive Chairman, served as the Company&#8217;s interim Chief Executive Officer from March 15, 2024
    until May 13, 2024. For Mr. Tardugno, &#8220;All Other Compensation&#8221; for 2024 consists of a 401(k)-plan matching contribution
    of $10,099 in our common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Dr.
    Le Goff joined the Company as President and Chief Executive Officer and as a director, effective as of July 18, 2022, and stepped
    down from these positions, effective March 15, 2024. For Dr. Le Goff, the amount in the &#8220;Salary&#8221; column reflects the
    base salary amount received by Dr. Le Goff during fiscal year 2024, which was pro-rated for the time served in her employee positions
    during fiscal year 2024. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;For
    Dr. Anwer, &#8220;All Other Compensation&#8221; for 2024 consists of $133,000 for a retention bonus paid in July 2024, $5,775 for
    discretionary spending allowance and a 401(k)-plan matching contribution of $10,350 in our common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Gaiero joined the Company as Chief Financial Officer, effective as of June 1, 2024. For Mr. Gaiero, the amount in the &#8220;Salary&#8221;
    column reflects the pro-rated amount received by Monomoy Advisors, LLC for the time served by Mr. Gaiero in his position of CFO during
    fiscal year 2024. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Mr.
    Church retired from the positions of Executive Vice President and Chief Financial Officer, effective as of June 1, 2024. For Mr.
    Church, the amount in the &#8220;Salary&#8221; column reflects the base salary amount received by Mr. Church during fiscal year 2024,
    which was pro-rated for the time served in his employee positions during fiscal year 2024. For Mr. Church &#8220;All Other Compensation&#8221;
    for 2024 consists of $428,615 in severance paid, in connection with his retirement, and $70,000 for consulting services he provided
    in 2024 post-retirement.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Narrative
Disclosure to 2024 Summary Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Potential
Payments Upon Termination or Change in Control</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employment
Arrangements </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employment
Agreement with Stacy R. Lindborg, Ph.D.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and Dr. Lindborg entered into an employment agreement effective as of May 31, 2024, in connection with her appointment as President
and Chief Executive Officer. Pursuant to the Employment Agreement, the Company agreed to pay Dr. Lindborg an initial salary of $567,000
and a targeted annual performance bonus of 100% of her annual base salary (pro-rated for the year ended December 31, 2024). Dr. Lindborg
also received (i) an option to purchase 112,500 shares of the Company&#8217;s common stock and (ii) an additional option to purchase
112,500 shares of the Company&#8217;s common stock following the Company&#8217;s 2024 annual meeting of stockholders. Both stock options
will vest in equal fourths over four years, with the first 28,125 options vesting on the first anniversary of the date of grant and the
remaining three-fourths vesting in equal parts on subsequent anniversaries of the grant date. Dr. Lindborg is eligible to receive a sign-on
bonus from the Company of $200,000 subject to certain conditions. Dr. Lindborg&#8217;s initial term of employment pursuant to the Employment
Agreement is one year, to be extended automatically by an additional year at the end of such term and each subsequent one-year term absent
three months&#8217; prior written notice by Dr. Lindborg or the Company. Following the effective date of her employment with the Company,
Dr. Lindborg did not receive any additional compensation for her service on the Board. Dr. Lindborg&#8217;s employment agreement provides
that, upon a termination of Dr. Lindborg&#8217;s employment by the Company without &#8220;cause&#8221; or by Dr. Lindborg for &#8220;good
reason,&#8221; as each such term is defined in her employment agreement: (x) outside the Change in Control Protection Period (as defined
in the employment agreement), (i) Dr. Lindborg will be entitled to receive an amount equal to 12 months of her then-current base salary,
payable in equal monthly installments during the 12-month period following such termination and reimbursement of her COBRA premiums for
up to 12 months, and (ii) all of her options and similar awards would generally remain exercisable for the remainder of the original
term of the award, and (y) during the Change in Control Protection Period<b><i>, </i></b>(i) Dr. Lindborg will be entitled to receive
an amount equal to 24 months of her then-current base salary, payable in equal monthly installments during the 12-month period following
such termination and reimbursement of her COBRA premiums for up to 12 months, (ii) full acceleration of then-unvested portions of the
options awarded to Dr. Lindborg in connection with her appointment as CEO and (iii) all of her options and similar awards would generally
remain exercisable for the remainder of the original term of the award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employment
Agreement with Corinne Le Goff</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and Dr. Le Goff entered into an employment agreement effective as of July 18, 2022, in connection with her appointment as President
and Chief Executive Officer, Pursuant to the employment agreement, the Company agreed to pay Dr. Le Goff an initial salary of $624,000
and a signing bonus $50,000. Dr. Le Goff&#8217;s targeted annual performance bonus was 72% of her annual base salary (pro-rated for the
year ended December 31, 2022). Dr. Le Goff also received (i) an option to purchase 177,000 shares of the Company&#8217;s common stock
that vested with respect to 25% of the subject shares on July 18, 2023 and the remaining 75% percent to vest in equal quarterly installments
thereafter such that the stock option would be fully vested and exercisable as of the fourth anniversary of July 18, 2022, and (ii) a
restricted stock award of 53,000 restricted shares that vested on July 18, 2023. Dr. Le Goff did not receive any additional compensation
for her service on the Board. The agreement had no set term of employment and provided that in the event of termination by the Company
other than for cause, Dr. Le Goff would receive an amount equal to one year&#8217;s salary as severance payment. Effective March 15,
2024, Dr. Le Goff resigned from her positions as President, Chief Executive Officer and Director of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employment
Agreement with Michael H. Tardugno</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
July 18, 2022, Mr. Tardugno transitioned from his roles as Chairman, President and Chief Executive Officer to the position of Executive
Chairman of the Board. Mr. Tardugno and the Company entered into an employment agreement, effective as of July 18, 2022, that superseded
the previous employment agreement with Mr. Tardugno. The agreement has a term ending on December 31, 2024, with the option for a one-year
extension that was exercised. Under the agreement, the Company agreed to pay Mr. Tardugno a base salary of $500,000 (prorated to $240,000)
for 2022 and a base salary of $350,000 for 2023 and 2024, and to reimburse him for all reasonable business expenses. Mr. Tardugno remains
eligible for annual performance bonuses and equity awards and may participate in all compensation and benefit programs generally made
available to other senior executives. In the event of termination by the Company other than for cause, Mr. Tardugno will receive an amount
equal to one year&#8217;s salary as a severance payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Consulting
Agreement with Monomoy Advisors, LLC</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and Monomoy Advisors, LLC (&#8220;Monomoy&#8221;), a financial advisory services firm, entered into a professional consulting
agreement, effective as of June 1, 2024, in connection with the appointment of David Gaiero as the Company&#8217;s Chief Financial Officer.
Pursuant to the Agreement, the Company agreed to pay Monomoy $35,000 per month for Mr. Gaiero&#8217;s service as the Company&#8217;s
Chief Financial Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Retirement
and Consulting Agreement with Jeffrey Church</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
June 1, 2024, Mr. Church retired from his roles as Executive Vice President, Chief Financial Officer and Corporate Secretary. On May
17, 2024, the Company and Mr. Church entered into a retirement and consulting agreement (the &#8220;Retirement and Consulting Agreement&#8221;)
that superseded the previous employment agreement with Mr. Church, pursuant to which he agreed to provide the Company consulting services
for a term ending on December 31, 2024, with an option for an agreed upon extension (the &#8220;Consulting Period&#8221;). During the
Consulting Period, the Company agreed to pay Mr. Church a monthly retainer of $10,000, plus an additional $250 for each hour of services
performed in excess of 40 hours per month. In addition, pursuant to the Retirement and Consulting Agreement, Mr. Church received (i)
within 30 days following his Retirement Date, any accrued but unpaid salary and any unreimbursed business expenses incurred prior to
his Retirement Date and (ii) a retirement bonus in the amount of $428,615. Mr. Church also remained eligible to receive a pro-rated bonus
for 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employment
Offer Letter with Khursheed Anwer</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and Dr. Anwer entered into an employment offer letter effective as of June 20, 2014. Dr. Anwer&#8217;s employment with us is
&#8220;at-will&#8221;; however, subject to the retention and severance agreement between the Company and Dr. Anwer dated as of May 28,
2014, if we terminate Dr. Anwer&#8217;s employment without cause (as such term is defined in the retention and severance agreement),
he will be entitled to receive cash severance equal to 12 months of his base salary and reimbursement of his COBRA premiums for up to
12 months. Dr. Anwer&#8217;s right to receive these severance benefits is subject to his providing a release of claims in favor of the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>CIC
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into an amended and restated double-trigger change in control severance agreement (CIC Agreement) with Mr. Tardugno to provide
severance benefits to him should his employment terminate in certain circumstances in connection with a change in control of the Company
(a &#8220;CIC&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the amended and restated CIC Agreements, in the event that, on or within two years after a CIC, we terminate the executive&#8217;s employment
without cause or in the event that the executive terminates his employment for good reason, the executive would be entitled to receive
a cash lump sum payment equal to two (2) times the sum of (1) the executive&#8217;s annual base salary and (2) the executive&#8217;s
target annual bonus for the fiscal year in which the termination occurs. (For these purposes, the terms &#8220;cause,&#8221; &#8220;good
reason&#8221; and &#8220;change in control&#8221; are each defined in the CIC Agreement.) In addition, we will pay or reimburse the executive
for the cost of COBRA premiums and life insurance coverage for the executive and his eligible dependents, in each case for a period of
up to two years following the termination. The executive would also be entitled to full acceleration of his then-outstanding equity awards
granted to him by us. However, as to any equity award agreement that is subject to performance-based vesting requirements, the vesting
of such an award will continue to be governed by its terms. In the case of options or similar awards, the award would generally remain
exercisable for the remainder of the original term of the award (or, in the case of awards that vested after the date of the CIC, for
the lesser of 12 months following the last day such award would have been exercisable under the applicable award agreement and the remainder
of the original term). The benefits provided under the CIC Agreement are in addition to, and not in lieu of, any severance benefits the
executive may be entitled to receive in connection with the termination of his employment under any other agreement with the Company.
The executive&#8217;s right to benefits under the CIC Agreement is subject to his execution of a release of claims in favor of the Company
upon the termination of his employment. The CIC Agreements do not provide for any tax gross ups.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Material
Terms of Equity Grants During 2024</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the equity awards granted to the Named Executive Officers in 2024 was granted under, and is subject to, the terms of the IMUNON, INC.
2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;). The 2018 Plan is administered by the Compensation Committee, which has authority
to interpret the plan provisions and make all required determinations under the plan. This authority includes making required proportionate
adjustments to outstanding awards upon the occurrence of certain corporate events such as reorganizations, mergers, and stock splits,
and making provision to ensure that any tax withholding obligations incurred in respect of awards are satisfied. Awards granted under
the plan are generally only transferable to a beneficiary of a Named Executive Officer upon his death. Under the terms of the 2018 Plan,
if there is a change in control of the Company, each Named Executive Officer&#8217;s outstanding awards granted under the plan will generally
terminate, unless the Compensation Committee provides for the substitution, assumption, exchange or other continuation or settlement
(in cash, securities, or property) of the outstanding awards. The Compensation Committee has the discretion to provide for outstanding
awards to become vested in connection with a change in control. The Compensation Committee does not take material nonpublic information
into account when determining the timing and terms of equity awards. The Company does not time the disclosure of material nonpublic information
for the purpose of affecting the value of executive compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
option granted to the Named Executive Officers in 2024 was granted with a per-share exercise price equal to the closing price of our
common stock on the grant date. Each option is scheduled to vest in three installments, with one-half vesting on the date of grant and
one-fourth vesting on the first and second anniversary of the date of the grant, subject in each case to the executive&#8217;s continued
employment through the applicable vesting date and has a maximum term of ten years. However, vested options may terminate earlier in
connection with a change in control transaction or a termination of the Named Executive Officer&#8217;s employment. Subject to any accelerated
vesting that may apply in the circumstances, the unvested portion of the option will immediately terminate upon a termination of the
Named Executive Officer&#8217;s employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share of restricted stock granted to Dr. Lindborg in 2024 is scheduled to fully vest on the first anniversary of the grant date, subject
to the executive&#8217;s continued employment through the applicable vesting date. Subject to any accelerated vesting that may apply
in the circumstances, the unvested portion of the restricted stock will immediately terminate upon the termination of the Named Executive
Officer&#8217;s employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the stock options and restricted stock shares granted to our named executive officers in the 2024 fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Named Executive Officer</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024 Stock Options Granted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024 Restricted Stock Shares Granted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Stacy Lindborg</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">293,102</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">25,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Michael Tardugno</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">207,926</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Corinne Le Goff</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Khursheed Anwer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,653</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">David Gaiero</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Jeff Church</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024
Outstanding Equity Awards at Year-End</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the number of shares of the Company&#8217;s common stock underlying outstanding equity incentive plan awards
for each Named Executive Officer as of December 31, 2024. None of the Named Executive Officers held any other outstanding stock awards
as of December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Option Awards</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Grant Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> Number of Shares
    or Units of Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">No. of Securities<br/> Underlying<br/>
    Unexercised<br/> Options (#)<br/> Exercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">No. of Securities<br/> Underlying<br/>
    Unexercised<br/> Options (#)<br/> Unexercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
                                                                               Exercise<br/> Price</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Option<br/> Expiration<br/> Date</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: left">Michae H. Tardugno</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">10/3/2019</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"/><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">4,333</td><td style="width: 2%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">25.80</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center">10/3/2029</td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/04/2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4.60</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/04/2032</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/13/2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.93</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/13/2032</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/17/2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,333</td><td style="text-align: left"><sup>(1)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.32</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/17/2033</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/15/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,250</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.86</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/15/2034</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/12/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/12/2034</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">9/6/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,463</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,463</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.04</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">9/6/2034</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">12/18/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,250</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.83</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">12/18/2034</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stacy R. Lindborg PhD</td><td>&#160;</td>
    <td style="text-align: center">6/4/2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,666</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18.60</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/4/2031</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/4/2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4.60</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/4/2034</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/13/2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.93</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/13/2032</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/17/2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">667</td><td style="text-align: left"><sup>(1)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.32</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/17/2033</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/15/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,250</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.86</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/15/2034</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">5/13/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">112,500</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">5/13/2034</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/12/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">112,500</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/12/2034</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">9/6/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,801</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,801</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.04</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">9/6/2034</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">9/6/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">25,000</p></td><td style="text-align: left"><sup>(3)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left"><sup></sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Jeffrey Church</td><td>&#160;</td>
    <td style="text-align: center">10/3/2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,334</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25.80</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">10/3/2029</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/13/2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.93</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/13/2032</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/17/2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.32</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/17/2033</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/15/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.86</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/15/2034</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Khursheed Anwer</td><td>&#160;</td>
    <td style="text-align: center">10/3/2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,832</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25.80</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">10/3/2029</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/04/2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4.60</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/04/2032</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/13/2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.93</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/13/2032</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/17/2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,333</td><td style="text-align: left"><sup>(1)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.32</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/17/2033</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/15/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,500</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.86</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/15/2034</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/12/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,500</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/12/2034</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">9/6/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,327</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,327</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.04</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">9/6/2034</td>
    <td>&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    of these stock option grants vest in three equal installments, with one-third of the grant vesting each immediately, on the first
    anniversary, and on the second anniversary of the date of grant.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    of these stock option grants vest one half of the grant vesting on date of grant and one-fourth on the first and second anniversary
    of the date of grant.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Lindborg received a restricted stock grant, which vests fully on the first anniversary of date of the grant.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2024
Non-Employee Director Compensation Table</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the cash and non-cash compensation paid to the Company&#8217;s directors who were not employed by the Company
or any of its subsidiaries (&#8220;Non-Employee Directors&#8221;) for the year ended December 31, 2024. Other than as set forth in the
table, we did not pay any compensation, make any equity awards or non-equity awards to, or pay any other compensation to any of the Non-Employee
Directors in 2024. The compensation paid to any director who was also one of our employees during fiscal year 2024 is presented in the
&#8220;2024 Summary Compensation Table&#8221; and the information that follows that table. Such employee directors did not receive separate
compensation for their service on the Board of Directors or any of its Committees (other than Dr. Lindborg prior to her appointment as
CEO and President of the Company as described in Footnote (1) below).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name (1)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fees Earned<br/> ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Option Awards<br/> ($) (2)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total<br/> ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">James E. Dentzer</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">51,839</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">12,144</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">63,983</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Frederick J. Fritz</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">93,419</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,309</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,728</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Donald P. Braun</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,949</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12.651</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">71,600</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Christine A. Pellizzari</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,039</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54,495</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Lindborg did not participate in the non-employee director compensation program following her appointment as CEO and President of
    the Company. The compensation received by Dr. Lindborg during 2024, including the compensation received solely for her service as
    a non-employee director, is reported in the Summary Compensation Table above. Mr. Tardugno and Dr. Le Goff are not shown in this
    table because they were compensated as officers for the years shown and did not receive any additional director compensation.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    value reported for Option Awards is the aggregate grant date fair value of stock options granted to each Director in 2024, determined
    in accordance with FASB ASC Topic 718. The assumptions for making the valuation determinations are set forth in Note 11 to our financial
    statements. As of December 31, 2024, Mr. Dentzer had 17,301 option awards outstanding; Mr. Fritz had 32,070 option awards outstanding;
    Dr. Braun had 28,905 option awards outstanding; and Ms. Pellizzari had 23,630 option awards outstanding.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth stock option grants awarded to the Company&#8217;s Non-Employee Directors for the year ended December 31,
2024. Employee directors do not receive separate equity awards for service on the Board of Directors or any of the Board committees.
Dr. Lindborg did not participate in the non-employee director compensation program following her appointment as CEO and President of
the Company. Equity awards received by Dr. Lindborg during 2024 for her service as a non-employee director are reported in the Summary
Compensation Table above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non-Employee Director Stock Option and Grant Awards Table</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                                                               of<br/>
 Options Granted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(#)
                                            (1)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
                                                                               Price</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant
                                                                   Date</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiration
                                                                   Date</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant
                                            Date</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: left">James E. Dentzer</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">4,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0.86</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 14%; text-align: center">3/15/2024</td><td style="width: 2%">&#160;</td>
    <td style="width: 14%; text-align: center">3/15/2034</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0.79</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/12/2024</td><td>&#160;</td>
    <td style="text-align: center">6/12/2034</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.12</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,634</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.04</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">9/6/2024</td><td>&#160;</td>
    <td style="text-align: center">9/6/2034</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.99</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Frederick J. Fritz</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.86</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/15/2024</td><td>&#160;</td>
    <td style="text-align: center">3/15/2034</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.79</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/12/2024</td><td>&#160;</td>
    <td style="text-align: center">6/12/2034</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.12</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,737</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.04</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">9/6/2024</td><td>&#160;</td>
    <td style="text-align: center">9/6/2034</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.99</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Donald P. Braun</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.86</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/15/2024</td><td>&#160;</td>
    <td style="text-align: center">3/15/2034</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.79</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/12/2024</td><td>&#160;</td>
    <td style="text-align: center">6/12/2034</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.12</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,072</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.04</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">9/6/2024</td><td>&#160;</td>
    <td style="text-align: center">9/6/2034</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.99</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Christine A. Pellizzari</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.86</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/15/2024</td><td>&#160;</td>
    <td style="text-align: center">3/15/2034</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.79</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">6/12/2024</td><td>&#160;</td>
    <td style="text-align: center">6/12/2034</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.12</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,964</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.04</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">9/6/2024</td><td>&#160;</td>
    <td style="text-align: center">9/6/2034</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.99</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    of these stock option grants vests with one-half of the grant vesting on the date of grant and one fourth of the grant vesting on
    each of the first and second anniversary of the date of grant, subject to the applicable director&#8217;s continued service as a
    member of our Board through each applicable vesting date.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2024, each Non-Employee Director of the Company received annual cash compensation in the amount of $27,450
payable in quarterly installments, and an additional $1,980 for attendance at regular meetings of the Board of Directors and $1,080 for
each meeting of a committee of the Board of Directors that was not held in conjunction with a meeting of the Board of Directors. Each
Non-Employee director is reimbursed for the out-of-pocket costs of attending meetings of the Board of Directors and of committees of
the Board of Directors. In 2024, the Chairman of the Audit Committee received an additional annual cash fee of $12,150 and the Chairman
of the Compensation Committee received an additional annual cash fee of $9,450.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acting
on behalf of the Board of Directors, Mr. Fritz also received fees totaling $43,200 in 2024 for his role as a Board Liaison to our Board
of Directors. Mr. Fritz&#8217;s responsibilities as Board Liaison include the following: (i) serve as an initial sounding board for our
management regarding issues, matters, or communications to be brought or potentially to be brought before the Board of Directors; (ii)
provide input and feedback to management regarding strategic matters, business matters, major scientific, clinical, collaboration, or
corporate development matters, key personnel matters, or other items of significance regarding which management would like to obtain
initial or further Board guidance, including, but not limited to, guidance regarding timing and content of communications regarding such
matters or items with the full Board or any of its committees; (iii) remain accessible to management to provide guidance on business
or strategy issues or other issues of significance on an as-needed basis; (iv) participate in meetings and relevant discussions as requested
by management; (v) conduct general advisory or liaison services to the Board, including relaying to management requests from other members
of the Board regarding desired additional information or clarification or suggestions or feedback regarding improvement in Board processes
or communications; (vi) serve as a conduit for informal communications between management and the Board; and (vii) any other such services
established by the Board from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acting
on behalf of our Board of Directors, Dr. Braun also received fees totaling $22,500 in 2024 for his role as a strategic advisor to our
Executive Chairman and our Chief Executive Officer. Dr. Braun&#8217;s responsibilities as a strategic advisor include the following:
(i) provide strategic and tactical advice to our Chief Executive Officer; (ii) evaluate international subsidiary options; (iii) develop
strategies to secure business relationships other than in the U.S.; and (iv) having done both (ii) and (iii), develop high potential
ex-US market strategies that address the objectives for broad and profitable sales of its commercial products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Ownership Guidelines for Non-Employee and Executive Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors believes that, as a matter of sound corporate governance, non-employee and executive directors should have a significant
personal financial stake in our performance. Consequently, in February 2011, our Board of Directors adopted stock ownership guidelines
for non-employee and executive directors. Our corporate governance guidelines require that each non-employee director acquire and hold
shares of our common stock having an aggregate value equal to two times the director&#8217;s total compensation in the first year of
service and that our executive director acquire and hold shares of our common stock having an aggregate value equal to the executive
director&#8217;s total compensation in the first year of service. Each director is expected to satisfy the applicable ownership guideline
within three years after his or her appointment to the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of our common stock that count toward satisfaction of these ownership guidelines include, unless beneficial ownership therein is disclaimed:
(i) shares owned outright by the director or executive officer or their immediate family members residing in the same household, whether
held individually or jointly; (ii) shares held in a trust, family limited partnership or similar entity solely for the benefit of the
director or executive officer and/or their immediate family members; (iii) shares of restricted stock and restricted stock units awarded
under our equity incentive plans, including vested and unvested awards; and (iv) shares acquired upon stock option exercise, but not
shares underlying unexercised stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span id="a_015"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    12.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY
    OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table is furnished by the Company and sets forth certain information known to the Company regarding the beneficial ownership
of the Company&#8217;s common stock as of February 21, 2025 by:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person or group known by us to own beneficially more than 5% of the Company&#8217;s outstanding common stock;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of our directors, as well as each executive officer named in the Summary Compensation Table appearing under the heading &#8220;Executive
    Compensation;&#8221; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    directors and executive officers as a group.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
determine beneficial ownership in accordance with the rules of the SEC. Under SEC rules, beneficial ownership for purposes of this table
takes into account shares as to which the individual has voting or investment power (including shares held indirectly through the Imunon,
Inc. 401(k) Plan), as well as shares that may be acquired within 60 days of February 21, 2025. Shares of common stock subject to options
that are currently exercisable or that become exercisable within 60 days of February 21, 2025, are treated as outstanding and beneficially
owned by the holder of such options. However, these shares are not treated as outstanding for purposes of computing the percentage ownership
of any other person. Unless otherwise indicated or as to the interests of spouses, the persons included in the table have sole voting
and investment power with respect to all shares beneficially owned thereby. Percentage ownership calculations are based on 14,620,732
shares outstanding as of February 21, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">NAME OF BENEFICIAL OWNER</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">NUMBER OF<br/> SHARES OF<br/> COMMON
    STOCK<br/> BENEFICIALLY<br/> OWNED (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">PERCENT OF<br/> SHARES OF<br/> COMMON<br/>
    STOCK<br/> OUTSTANDING (2)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Ayrton Capital LLC (3)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">1,250,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">7.88</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James E. Dentzer<b>* </b>(4)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,109</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frederick J. Fritz<b>* </b>(5)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,843</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald P. Braun<b>* </b>(6)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,841</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christine Pellizzari<b>*</b>
    (7)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,773</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael H. Tardugno<b>* </b>(8)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">375,562</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.57</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stacy Lindborg* (9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72,898</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khursheed Anwer<b>* </b>(10)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">147,265</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.01</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Jeffrey Church* (11)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77,172</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Susan Eylward*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">**</p></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Douglas Faller MD*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">**</p></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">David Gaiero*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Corrine LeGoff* (12)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Directors and Executive Officers as a group (12 persons) (13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">842,463</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.76</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    address of each of the individuals named is c/o IMUNON, INC., 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than one percent.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
    Ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to
    securities. Except as indicated by footnote, and subject to community property laws where applicable, the persons named in the table
    above have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on 14,620,732 shares of common stock outstanding as of February 21, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on the Schedule 13G filed by Ayrton Capital, LLC (&#8220;Ayrton Capital&#8221;) on February 13, 2025, reporting beneficial ownership
    as of December 31, 2024 and represents shares of Common Stock issuable on the exercise of certain warrants held by the reporting
    persons. The Schedule 13G provides information only as of December 31, 2024, and, consequently, the beneficial ownership of the
    abovementioned reporting person may have changed between December 31, 2024 and February 21, 2025. Shares reported herein were held
    by Alto Opportunity Master Fund, SPC &#8211; Segregated Master Portfolio B, a Cayman Islands exempted company (the
    &#8220;Fund&#8221;). The Fund is a private investment vehicle for which Ayrton Capital LLC, a Delaware limited liability company
    (the &#8220;Investment Manager&#8221;), serves as the investment manager. Waqas Khatri serves as the managing member of the
    Investment Manager. The address of the principal business and office of Ayrton Capital LLC and its affiliates is 55 Post Rd West,
    2<sup>nd</sup> Floor, Westport Ct, 06880.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    12,109 shares of common stock underlying options currently exercisable or exercisable within 60 days of February 21, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    11,766 shares of common stock and 26,077 shares of common stock underlying options currently exercisable or exercisable within 60
    days of February 21, 20255.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    25,597 shares of common stock and 23,244 shares of common stock underlying options currently exercisable or exercisable within 60
    days of February 21, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    17,773 shares of common stock underlying options currently exercisable or exercisable within 60 days of February 21, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    69,141 shares of common stock and 306,421 shares of common stock underlying options currently exercisable or exercisable within 60
    days of February 21, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    28,056 shares of common stock and 44,842 shares of common stock underlying options currently exercisable or exercisable within 60
    days of February 21, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    12,855 shares of common stock and 134,410 shares of common stock underlying options currently exercisable or exercisable within 60
    days of February 21, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    2,338 shares of common stock and 74,834 shares of common stock underlying options currently exercisable or exercisable within 60
    days of February 21, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    53,000 shares of common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Includes
    202,753 of common stock and 639,710 shares of common stock underlying options currently exercisable or exercisable within 60 days
    of February 21, 2025. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Compensation Plan Information as of December 31, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Plan Category</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                                                               of<br/> securities to be<br/>
 issued upon<br/> exercise of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>outstanding<br/>
                                            options, warrants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and
                                            rights </b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-average<br/> exercise
    price<br/> of outstanding<br/> options, warrants<br/> and rights (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> Securities<br/>
 remaining<br/>
    available for<br/> future issuance<br/> under equity<br/>
 compensation<br/> plans (excluding<br/>
 securities reflected<br/>
 in first column)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Equity compensation plans approved by securityholders</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">1,555,073</td><td style="width: 1%; text-align: left"><sup>(2)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2.03</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">420,000</td><td style="width: 1%; text-align: left"><sup>(3)</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Equity compensation plans not approved by securityholders</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">130,500</td><td style="padding-bottom: 1pt; text-align: left"><sup>(4)</sup></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1.07</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,685,573</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1.95</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">420,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the weighted average exercise price of outstanding stock options and does not take into account restricted stock awards, which do
    not have an exercise price.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    both vested and unvested options to purchase common stock and unvested stock grants under the 2018 Plan. These awards have a weighted
    average remaining term of 8.7 years.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    shares available for award grant purposes under the 2018 Plan. Subject to certain express limits of the plan, shares available under
    the plan generally may be used for any type of award authorized under that plan including options, stock appreciation rights, restricted
    stock and other forms of awards granted or denominated in shares of our common stock or units of our common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    both vested and unvested options to purchase common stock and unvested stock grants under inducement grants provided certain employees
    as an inducement to accept employment with the Company. These awards have a weighted average remaining term of 9.5 years. These grants
    are similar to those granted under the 2018 Plan.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_016"></span>ITEM
    13.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTAIN
    RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Person Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Code of Ethics requires all of our directors, officers and employees to give their complete loyalty to the best interests of the Company
and to avoid any action that may involve, or that even may appear to involve, a conflict of interest with the Company. The Code of Ethics
also requires any of our directors, officers or employees who become aware of a conflict or potential conflict to bring it to the attention
of supervisor, manager or other appropriate personnel or consult the compliance procedures provided in the Code of Ethics. The Board
of Directors reviews and approves or ratifies all relationships and transactions between us and (i) any of our directors or executive
officers, (ii) any nominee for election as a director, (iii) any securityholder who is known to us to own beneficially or of record more
than five percent of our common stock or (iv) any member of the immediate family of any of the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the rules of the SEC and Nasdaq, the Company requires that at least a majority of the directors serving at any time on
the Board of Directors be independent. The Board has determined that of the six currently serving directors, four directors (Dr. Braun,
Messrs. Dentzer and Fritz and Ms. Pellizzari) are independent under applicable SEC and Nasdaq rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_017"></span>ITEM
    14.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRINCIPAL
    ACCOUNTANT FEES AND SERVICES</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Withum,
Brown + Smith PC (&#8220;Withum&#8221;) has served as our independent accountants since 2017 and has advised us that neither Withum nor
any of its members has, or has had in the past three years, any financial interest in the Company or any relation to the Company other
than as auditors and accountants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents fees as invoiced for professional audit services rendered for the fiscal years ended December 31, 2024 and December
31, 2023, and fees for other services rendered during those periods:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">FEE CATEGORY</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">AMOUNT</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% <br/> OF TOTAL</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">AMOUNT</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%<br/> OF TOTAL</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">Audit Fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">144,240</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">68</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">150,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">60</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Audit Related Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,705</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,272</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">All Other Fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">45,240</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">21</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">78,885</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">31</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Fees</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">211,952</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">252,340</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
fees consist of fees for professional services rendered by Withum for the audits of our annual financial statements in our Annual Reports
on Form 10-K and for reviews of the quarterly financial statements included in the Company&#8217;s Quarterly Reports on Form 10-Q. Audit-related
fees pertain to the work performed during our equity offerings in 2024 and 2023. Tax fees consist of fees for preparation of the Company&#8217;s
federal and state tax returns. All other fees consist of fees for attendance at the Company&#8217;s annual meetings, review of registration
statements and similar matters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Services
by Employees of Withum</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
part of Withum&#8217;s engagement to audit the Company&#8217;s financial statements for the years ended December 31, 2024 and 2023 was
attributable to work performed by persons other than Withum&#8217;s full-time, permanent employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee Policy on Approval of Audit and Non-Audit Services</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is the policy of the Audit Committee to pre-approve all audit and permissible non-audit services provided by our independent accountants,
in accordance with rules prescribed by the SEC. These services may include audit services, audit-related services, tax services, and
other services. Pre-approval is based on a written proposal, accompanied by a cost estimate, and estimated budget. The Audit Committee
has delegated to its chairman the authority to pre-approve audit and non-audit services with an estimated cost of up to $25,000, provided
the exercise of such authority is reported to the Audit Committee at its next regular meeting. The Audit Committee reserves the right,
from time to time, to delegate pre-approval authority to other of its members, so long as such members are independent directors. All
audit and permissible non-audit services during 2024 and 2023 were approved by the Audit Committee in accordance with its pre-approval
policy and the approval requirements of the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_018"></span>PART
IV</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span id="a_019"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    15. </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBITS
    AND FINANCIAL STATEMENT SCHEDULES</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The following documents are filed as part of this Annual Report:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="a_020"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a list of the consolidated financial statements of Imunon, Inc. filed with this Annual Report, together with the reports
of our independent registered public accountants and Management&#8217;s Report on Internal Control over Financial Reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 10px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REPORTS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_024">Reports of Independent Registered Public Accounting Firm</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FINANCIAL
    STATEMENTS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#me_001">Consolidated Balance Sheets</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#me_002">Consolidated Statements of Operations</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#me_003">Consolidated Statements of Comprehensive Loss</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#me_004">Consolidated Statements of Cash Flows</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#me_005">Consolidated Statements of Changes in Stockholders&#8217; Equity</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#me_006">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-11</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="a_021"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
FINANCIAL STATEMENT SCHEDULES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
financial statement schedules are omitted because the information is inapplicable or presented in the notes to the consolidated financial
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_022"></span>3.
EXHIBITS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following documents are included as exhibits to this report:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT
    NO.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DESCRIPTION</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000143774914014489/ex2-1.htm" style="-sec-extract: exhibit">Asset Purchase Agreement dated as of June 6, 2014, by and between Imunon, Inc. and EGEN, Inc., incorporated herein by reference to Exhibit 2.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2014 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315219004381/ex10-1.htm" style="-sec-extract: exhibit">Amendment to Asset Purchase Agreement between Celsion Corporation and EGWU, Inc., dated March 28, 2019 incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on April 1, 2019 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315223008888/ex3-1.htm" style="-sec-extract: exhibit">Amended and Restated Certificate of Incorporation of Imunon, dated March 24, 2023, incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K of the Company filed on March 24, 2023 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315224010195/ex3-1.htm" style="-sec-extract: exhibit">Amended and Restated Bylaws of the Company, effective on March 15, 2024, incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K of the Company, filed on March 18, 2024 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000143774917017965/ex_98287.htm" style="-sec-extract: exhibit">Form of Representative&#8217;s Common Stock Purchase Warrant, incorporated herein by reference to Exhibit 4.2 to the Current Report on Form 8-K of the Company, filed on October 31, 2017 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000143774917012481/ex4-4.htm" style="-sec-extract: exhibit">Form of Placement Agent Common Stock Purchase Warrant incorporated herein by reference to Exhibit 4.4 to the Current Report on Form 8-K of the Company, filed on July 11, 2017 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315220017312/ex4-1.htm" style="-sec-extract: exhibit">Form of Amended and Restated Warrant (issued under First Amendment of Venture Loan and Security Agreement, dated as of August 1, 2020, by and among Imunon, Inc., Horizon Funding I, LLC, Horizon Funding Trust 2019-1, and Horizon Technology Finance Corporation, as Collateral Agent), incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K of the Company, filed on September 4, 2020 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315220003910/ex4-1.htm" style="-sec-extract: exhibit">Form of Exchange Warrant, incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K of the Company, filed on March 13, 2020 (SEC File No. 001-15911).</a><sup></sup></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315219007214/ex4-1.htm" style="-sec-extract: exhibit">Warrant to purchase Shares of Common Stock of Celsion Corporation between Celsion Corporation and EGWU, Inc., dated March 28, 2019, incorporated herein by reference to Exhibit 4.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2019 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315224029697/ex4-1.htm" style="-sec-extract: exhibit">Form of Warrant, incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K of the Company filed on July 31, 2024 (SEC file No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-7.htm">Description of Securities of the Registrant</a></span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000143774917009400/ex10-1.htm" style="-sec-extract: exhibit">Imunon, Inc. 2007 Stock Incentive Plan, as amended, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on May 16, 2017 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000143774917019215/ex_99691.htm" style="-sec-extract: exhibit">Form Inducement Offer to Exercise Common Stock Purchase Warrants, incorporated herein by reference to Exhibit 10.3 to the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2017 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000143774918010040/ex_114605.htm" style="-sec-extract: exhibit">Imunon, Inc. 2018 Stock Incentive Plan, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed May 15, 2018 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4***
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000143774918010040/ex_114605.htm" style="-sec-extract: exhibit">First Amendment to the Imunon, Inc. 2018 Stock Incentive Plan, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on May 15, 2019 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315220011263/ex10-1.htm" style="-sec-extract: exhibit">Second Amendment to the Imunon, Inc. 2018 Stock Incentive Plan, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on June 16, 2020 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315221014023/ex10-1.htm" style="-sec-extract: exhibit">Third Amendment to the Celsion Corporation 2018 Stock Incentive Plan, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed with the Commission on June 10, 2021 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315224018795/ex10-1.htm" style="-sec-extract: exhibit">Form of Incentive Stock Option Grant Agreement under the 2018 Stock Incentive Plan, incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2024 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315224018795/ex10-2.htm" style="-sec-extract: exhibit">Form of Restricted Stock Agreement under the 2018 Stock Incentive Plan, incorporated herein by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2024 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315224034310/ex99-1.htm" style="-sec-extract: exhibit">Form
of Nonqualified Stock Option and Restricted Stock Grant Agreement for employment inducement awards, incorporated by reference to Exhibit
99.1 to the Company&#8217;s Registration Statement on Form S-8 filed on August 29, 2024 (No. 333-281833).</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72px; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000074964710000024/offerletter.htm" style="-sec-extract: exhibit">Employment Offer Letter, entered into on June 15, 2010, between the Company and Jeffrey W. Church, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on June 18, 2010 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000143774915004805/ex10-27.htm" style="-sec-extract: exhibit">Employment Offer Letter effective as of June 2, 2014, between the Company and Khursheed Anwer incorporated herein by reference to Exhibit 10.27 to the Annual Report of the Company for the year ended December 31, 2014 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315222019765/ex10-2.htm" style="-sec-extract: exhibit">Employment Agreement between the Company and Michael H. Tardugno, effective as of July 18, 2022, incorporated herein by reference to Exhibit 10.2 to the Current Report on Form 8-K of the Company filed with the Commission on July 19, 2022 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315222019765/ex10-1.htm" style="-sec-extract: exhibit">Employment Agreement between the Company Corporation and Corinne Le Goff, effective as of July 18, 2022 incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed with the Commission on July 19, 2022 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000143774916041670/ex10-1.htm" style="-sec-extract: exhibit">Amended and Restated Change in Control Agreement dated as of September 6, 2016, by and between the Company and Michael H. Tardugno, incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2016 (SEC File No. 001-15911).</a></span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315224018166/ex10-1.htm" style="-sec-extract: exhibit">Employment Agreement, dated as of May 3, 2024, between the Company and Stacy Lindborg, Ph.D., incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on May 8, 2024 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315224020543/ex10-1.htm" style="-sec-extract: exhibit">Retirement and Consulting Agreement, dated May 17, 2024, between Imunon, Inc. and Jeffrey Church, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on May 20, 2024 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315224020543/ex10-2.htm" style="-sec-extract: exhibit">Consulting Agreement, dated April 15, 2024, by and between Imunon, Inc. and Monomoy Advisors, LLC incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K of the Company filed on May 20, 2024 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315224039646/ex10-1.htm" style="-sec-extract: exhibit">Offer Letter of Employment, dated October 2, 2024, between Imunon, Inc. and Susan Eylward, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on October 7, 2024 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315224043931/ex10-5.htm" style="-sec-extract: exhibit">Separation Agreement, dated August 9, 2024 by and between the Company and S&#233;bastien Hazard, M.D., incorporated by reference to Exhibit 10.5 to the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2024 (SEC file No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000104746909003319/a2191931zex-10_15.htm" style="-sec-extract: exhibit">Development, Product Supply and Commercialization Agreement, effective December 5, 2008, by and between the Company and Yakult Honsha Co., Ltd., incorporated herein by reference to Exhibit 10.15 to the Annual Report of the Company for the year ended December 31, 2008 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000074964711000009/amend2yakult.htm" style="-sec-extract: exhibit">The 2nd Amendment to The Development, Product Supply and Commercialization Agreement, effective January 7, 2011, by and between the Company and Yakult Honsha Co., Ltd. incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on January 18, 2011 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000143774912008356/ex10-2.htm" style="-sec-extract: exhibit">Technology Development Agreement effective as of May 7, 2012, by and between Imunon, Inc. and Zhejiang Hisun Pharmaceutical Co. Ltd., incorporated herein by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2012 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000143774913005568/ex10-1.htm" style="-sec-extract: exhibit">Technology Development Contract dated as of January 18, 2013, by and between Imunon, Inc. and Zhejiang Hisun Pharmaceutical Co. Ltd., incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2013 (SEC File No. 001-15911).</a></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72px; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000074964711000106/exhibit99_1.htm" style="-sec-extract: exhibit">Lease Agreement, executed July 21, 2011, by and between Imunon, Inc. and Brandywine Operating Partnership, L.P., incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on July 25, 2011 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000143774917019215/ex_99690.htm" style="-sec-extract: exhibit">First Amendment to Lease Agreement, executed April 20, 2017, by and between Imunon, Inc. and Lenox Drive Office Park, LLC, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 10-Q of the Company filed on November 14, 2017 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
    26</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315219007214/ex10-1.htm" style="-sec-extract: exhibit">Second Amendment to Lease Agreement, dated January 9, 2019, by and between Celsion Corporation and Lenox Drive Office Park, LLC, successor in interest to Brandywine Operating Partnership, L.P., incorporated herein by reference to Exhibit 10-Q to the Current Report on Form 10-Q of the Company for the quarter ended March 31, 2019 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000143774918009535/ex_113795.htm" style="-sec-extract: exhibit">Lease Agreement dated January 15, 2018, by and between Imunon, Inc. and HudsonAlpha Institute of Biotechnology for office and lab space located in Huntsville, Alabama incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2018 (SEC File No. 001-15911).</a></span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 10px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315220011263/ex10-2.htm" style="-sec-extract: exhibit">Settlement Agreement and Release, by and between the plaintiff to the shareholder action captioned O&#8217;Connor v. Braun, et al., N.J. Super., Dkt. No. MERC-00068-19, William J. O&#8217;Connor, derivatively on behalf of Imunon, Inc. and individually on behalf of himself and all other similarly situated stockholders of Imunon, Inc. and defendants, incorporated herein by reference to Exhibit 10.2 to the Current Report on Form 8-K of the Company, filed on June 16, 2020 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315220003910/ex10-1.htm" style="-sec-extract: exhibit">Form of Exercise Agreement, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on March 13, 2020 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315222015061/ex10-1.htm" style="-sec-extract: exhibit">At the Market Offering Agreement, dated May 25, 2022 by and between Celsion Corporation and H.C. Wainwright &amp; Co. LLC, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on May 25, 2022, (SEC File NO. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315224019876/ex1-3.htm" style="-sec-extract: exhibit">Amendment No. 1, dated May 15, 2024, to At the Market Offering Agreement, by and between Imunon, Inc. and H.C. Wainwright &amp; Co. LLC, incorporated by reference to Exhibit 1.3 to the Company&#8217;s Registration Statement on Form S-3 (No. 333-279425) filed on May 15, 2024.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315224029697/ex10-1.htm" style="-sec-extract: exhibit">Form
of Securities Purchase Agreement, dated as of July 30, 2024, by and among the company and each purchaser party thereto, incorporated
by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on July 31, 2024 (SEC File o. 001-15911).</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">10.33***</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315223021447/ex10-1.htm" style="-sec-extract: exhibit">Imunon, Inc. 2018 Stock Incentive Plan, as amended as of June 14, 2023, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed with the Commission on June 15, 2023 (SEC File 001-15911).</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex19.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Insider Trading Policy</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex21-1.htm">Subsidiaries of Imunon, Inc.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex23-1.htm">Consent of WithumSmith+Brown, PC, independent registered public accounting firm for the Company.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex31-1.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex31-2.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1&#x5E;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-1.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2&#x5E;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-2.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/749647/000149315224011616/ex-97.htm" style="-sec-extract: exhibit">Compensation Recovery Policy, incorporated herein by reference to Exhibit 97 to the Annual Report of the Company for the year ended December 31, 2023 (SEC File No. 001-15911).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Instance Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Schema Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Label Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    following materials from the Company&#8217;s Annual Report for the fiscal year ended December 31, 2024, formatted in XBRL (Extensible
    Business Reporting Language): (i) the audited Consolidated Balance Sheets, (ii) the audited Consolidated Statements of Operations,
    (iii) the audited Consolidated Statements of Comprehensive Loss, (iv) the audited Consolidated Statements of Cash Flows, (v) the
    audited Consolidated Statements of Changes in Stockholders&#8217; Equity and (vi) Notes to Financial Statements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Portions
    of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act
    of 1934, amended, and the omitted material has been separately filed with the Securities and Exchange Commission.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#x5E;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furnished
    herewith.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    information is filed herewith.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
    contract or compensatory plan or arrangement.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_023"></span><b>ITEM
    16.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM
    10-K SUMMARY</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IMUNON,
    INC.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    27, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Stacy Lindborg, Ph.D.</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    Lindborg, Ph.D.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the
Registrant and in the capacities and on the dates indicated:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    MICHAEL H. TARDUGNO</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman of the Board</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    27, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Michael
    H. Tardugno)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    STACY R. LINDBORG, Ph.D.</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Chief Executive Officer and Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    27, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<i>Stacy
    R Lindborg, Ph.D.)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<i>(Principal
    Executive Officer)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    DAVID GAIERO</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    27, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(David
    Gaiero)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Principal
    Financial Officer and Principal Accounting Officer)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    FREDERICK J. FRITZ</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    27, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Frederick
    J. Fritz)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    JAMES E. DENTZER</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    27, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(James
    E. Dentzer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    DONALD BRAUN</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    27, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Donald
    Braun, Ph.D.)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    CHRISTINE PELLIZZARI</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    27, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<i>Christine
    A. Pellizzari)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_024"></span><i>Report
of Independent Registered Public Accounting Firm</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
of Directors and Stockholders of</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon
Inc.:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--AuditorOpinionTextBlock_c20240101__20241231_z60Jk3Cwn4P5"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000071" name="dei:AuditorOpinionTextBlock">We
have audited the accompanying consolidated balance sheets of Imunon Inc. as of December 31, 2024 and 2023, and the related consolidated
statements of operations, comprehensive loss, changes in stockholders&#8217; equity, and cash flows for each of the two years in the
period ended December 31, 2024, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion,
the consolidated financial statements present fairly, in all material respects, the financial position of Imunon Inc. as of December
31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024,
in conformity with accounting principles generally accepted in the United States of America.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Substantial
Doubt Regarding Going Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the entity will continue as a going concern. As discussed
in Note 2 to the consolidated financial statements, the entity has suffered recurring losses from operations, has negative cashflows
from operations, and has a significant accumulated deficit, that raise substantial doubt about its ability to continue as a going concern. Management&#8217;s
plans in regard to these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that
might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements are the responsibility of the entity&#8217;s management. Our responsibility is to express an opinion
on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting
Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to Imunon Inc. in accordance with
the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
Imunon Inc. is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing
an opinion on the effectiveness of the entity&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audits provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 79; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Audit Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements
that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are
material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The
communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole,
and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the
accounts or disclosures to which they relate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification
of Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Critical
Audit Matter Description</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 10 and 12 to the financial statements, in July 2024, the Company sold 5,000,000 shares of common stock at an
offering price of $2.00 per share and warrants to purchase up to 5,000,000 shares of common stock, at a exercise price of $2.00 per
share, for net proceeds of approximately $9 million. The Company determined that
the Warrants met all the criteria for equity classification and recorded them as a component of additional paid-in capital upon the
closing of the transaction in July 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
identified the determination of the financial statement classification of the Warrants as a critical audit matter. Our principal considerations
included the existence of accounting complexities related to certain provisions of the warrant agreement, including settlement provisions
and derivative elements in applying the accounting standard. Auditing these elements involved especially complex auditor judgment due
to the terms of the applicable agreement, including the extent of specialized knowledge and skills needed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>How
We Addressed the Matter in Our Audit</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluating
                                            the appropriateness of management&#8217;s application of the accounting guidance in determining
                                            the classification of the warrants in the financial statement by i) reviewing the relevant
                                            terms of the warrant agreement, (ii) evaluating the completeness and accuracy of the Company&#8217;s
                                            technical accounting analysis and the application of the relevant accounting literature.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utilizing
                                            personnel with specialized knowledge and skills in technical accounting to assist in: (i)
                                            evaluating the terms of the warrant agreement in relation to the relevant accounting literature,
                                            and (ii) assessing the appropriateness of conclusions reached by the Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
<span id="xdx_905_edei--AuditorName_c20240101__20241231_zimvpoHDFGp6"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000072" name="dei:AuditorName">WithumSmith+Brown, PC</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WithumSmith+Brown,
PC</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as Imunon Inc.&#8217;s auditor since 2017.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--AuditorLocation_c20240101__20241231_zY7nyOw4BwTi"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000073" name="dei:AuditorLocation">East
Brunswick, New Jersey</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
26, 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCAOB
ID Number <span id="xdx_909_edei--AuditorFirmId_c20240101__20241231_zcR6K7J2r84j"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000074" name="dei:AuditorFirmId">100</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 80; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="me_001"></span>IMUNON,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_111_z41E3r4t2HZc" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20241231_zFTika28b9Wi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20231231_zeirl4cUJlu4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; font-weight: bold">ASSETS</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AssetsCurrentAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets:</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_pp0p0_maACzhdw_z4N7Taxyg3qb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-12-31" id="Fact000082" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,872,767</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact000083" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,838,566</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_i02I_pp0p0_maACzhdw_zObpaVcdSawc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Investment in debt securities - available for sale, at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0085">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="AsOf2023-12-31" id="Fact000086" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,857,087</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--GrantsReceivableCurrent_i02I_pp0p0_maACzhdw_z6cqgiBCzeVk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Advances and deposits on clinical programs and other current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrantsReceivableCurrent" contextRef="AsOf2024-12-31" id="Fact000088" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,136,192</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrantsReceivableCurrent" contextRef="AsOf2023-12-31" id="Fact000089" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,545,051</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsCurrent_i02TI_pp0p0_mtACzhdw_maAz3Kr_zw2dHX72Izxa" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total current assets</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-12-31" id="Fact000091" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,008,959</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31" id="Fact000092" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,240,704</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentNet_i01I_pp0p0_maAz3Kr_zV7QexcsRMWb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Property and equipment (at cost, less accumulated depreciation and amortization)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-12-31" id="Fact000094" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">541,272</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31" id="Fact000095" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">751,906</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OtherAssetsAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other assets:</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredIncomeTaxAssetsNet_i02I_pp0p0_maOANzmc4_zpzArxP20vCd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred income tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0100">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2023-12-31" id="Fact000101" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,280,385</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OperatingLeaseRightOfUseAsset_i02I_pp0p0_maOANzmc4_zAbFrjsnofDe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating lease right-of-use assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-12-31" id="Fact000103" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,117,133</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-12-31" id="Fact000104" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,595,074</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DepositsAssetsNoncurrent_i02I_pp0p0_maOANzmc4_zuC5abEDUzxl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Deposits and other assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" contextRef="AsOf2024-12-31" id="Fact000106" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" contextRef="AsOf2023-12-31" id="Fact000107" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherAssetsNoncurrent_i02TI_pp0p0_mtOANzmc4_maAz3Kr_zZisJKzHZKs8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total other assets</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2024-12-31" id="Fact000109" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,167,133</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2023-12-31" id="Fact000110" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,925,459</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--Assets_i01TI_pp0p0_mtAz3Kr_zkxgW0mG8YR4" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-12-31" id="Fact000112" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,717,364</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-12-31" id="Fact000113" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,918,069</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 81; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IMUNON,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current liabilities:</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AccountsPayableTradeCurrent_i02I_pp0p0_maLCzgRU_zq3l3N4yMrAk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Accounts payable &#8211; trade</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" contextRef="AsOf2024-12-31" id="Fact000121" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,300,026</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" contextRef="AsOf2023-12-31" id="Fact000122" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,515,192</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_i02I_pp0p0_maLCzgRU_zKEfV8kgSgHf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-12-31" id="Fact000124" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,033,747</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000125" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,390,521</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_pp0p0_maLCzgRU_zquNUcuhNNSk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Operating lease liabilities - current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-12-31" id="Fact000127" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">452,358</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-12-31" id="Fact000128" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">485,421</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesCurrent_i02TI_pp0p0_mtLCzgRU_maLzFZ2_zjZW8D93uWX3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Total current liabilities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-12-31" id="Fact000130" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,786,131</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000131" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,391,134</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_pp0p0_maLzFZ2_zI8QC6zp1904" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Operating lease liabilities - non-current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-12-31" id="Fact000133" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">686,935</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-12-31" id="Fact000134" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,139,293</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--Liabilities_i01TI_pp0p0_mtLzFZ2_maLASEza80_z7ho6AfSRqCa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Total liabilities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-12-31" id="Fact000136" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,473,066</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-12-31" id="Fact000137" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,530,427</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--CommitmentsAndContingencies_i01I_pp0p0_maLASEza80_zKT9ulEPxUMa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Commitments and contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0139">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0140">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Stockholders&#8217; equity:</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--PreferredStockValue_i02I_pp0p0_maSEBTSzzS8_zKlueZMVjale" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Preferred Stock - $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20241231_znrnUK8BMoC" title="Preferred stock, par value"><span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_z58KJCcvwlPc" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-12-31" id="Fact000148" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000150" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></ix:nonFraction></span></span> par value (<span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_c20241231_z7rezq1KIF2e" title="Preferred stock, shares authorized"><span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231_zso7vwiLndL" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-12-31" id="Fact000152" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact000154" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, and <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_do_c20241231_zbhGx7VB4bKl" title="Preferred stock, shares issued"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20241231_z2i4ltUVAAOc" title="Preferred stock, shares outstanding"><span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_zN6bFYvf1zm4" title="Preferred stock, shares issued"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_zfzTTbgT6Bt9" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-12-31" id="Fact000156" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-12-31" id="Fact000158" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact000160" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact000162" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued or outstanding at December 31, 2024 and 2023)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0145">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0146">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CommonStockValue_i02I_pp0p0_maSEBTSzzS8_zYfDD7uEpRA4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Common stock - $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20241231_zxzWXrp3Exck" title="Common stock, par value"><span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zZXty2jpC14i" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-12-31" id="Fact000167" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000169" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></ix:nonFraction></span></span> par value (<span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20241231_zzZapfIZre95" title="Common stock, shares authorized"><span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_c20231231_zDpVWQTZWG37" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-12-31" id="Fact000171" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact000173" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">112,500,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_c20241231_z3FJpMvAhwZ9" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-12-31" id="Fact000175" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,500,707</ix:nonFraction></span> and <span id="xdx_907_eus-gaap--CommonStockSharesIssued_c20231231_pdd" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact000177" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,399,811</ix:nonFraction></span> shares issued at December 31, 2024 and 2023, respectively, and <span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20241231_zVioOIp8Feug" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-12-31" id="Fact000179" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,500,685</ix:nonFraction></span> and <span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_c20231231_pdd" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact000181" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,399,789</ix:nonFraction></span> shares outstanding at December 31, 2024 and 2023, respectively)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-12-31" id="Fact000164" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">145,007</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31" id="Fact000165" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">93,998</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AdditionalPaidInCapital_i02I_pp0p0_maSEBTSzzS8_zuNljLI8gQzf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-12-31" id="Fact000183" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">410,987,523</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-12-31" id="Fact000184" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">401,500,838</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_pp0p0_maSEBTSzzS8_z8PSIg5ZRRek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accumulated other comprehensive income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0186">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2023-12-31" id="Fact000187" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">60,796</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_pp0p0_maSEBTSzzS8_zyzWQy3gp3h2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-12-31" id="Fact000189" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">406,803,044</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31" id="Fact000190" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">388,182,802</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--StockholdersEquityBeforeTreasuryStock_i02TI_pp0p0_mtSEBTSzzS8_maSEznwM_zxOfS2SjHpk6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Total stockholders&#8217; equity before treasury stock</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityBeforeTreasuryStock" contextRef="AsOf2024-12-31" id="Fact000192" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,329,486</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityBeforeTreasuryStock" contextRef="AsOf2023-12-31" id="Fact000193" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,472,830</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--TreasuryStockValue_i02NI_pp0p0_di_msSEznwM_z56zzshwBcx1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Treasury stock, at cost (<span id="xdx_902_eus-gaap--TreasuryStockCommonShares_iI_c20241231_z8hhmcYPDwzk" title="Treasury stock, shares"><span id="xdx_903_eus-gaap--TreasuryStockCommonShares_iI_c20231231_zOclaYModdHa" title="Treasury stock, shares"><ix:nonFraction name="us-gaap:TreasuryStockCommonShares" contextRef="AsOf2024-12-31" id="Fact000198" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TreasuryStockCommonShares" contextRef="AsOf2023-12-31" id="Fact000200" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">22</ix:nonFraction></ix:nonFraction></span></span> shares at December 31, 2024 and 2023)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2024-12-31" id="Fact000195" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">85,188</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2023-12-31" id="Fact000196" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">85,188</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--StockholdersEquity_i02TI_pp0p0_mtSEznwM_maLASEza80_z7SzB7nGQX22" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total stockholders&#8217; equity</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31" id="Fact000202" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,244,298</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000203" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,387,642</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pp0p0_mtLASEza80_zJNKsufZ6ze" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders&#8217; equity</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-12-31" id="Fact000205" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,717,364</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000206" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,918,069</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 82; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="me_002"></span>IMUNON,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_113_zVh8er4ln2Gk" summary="xdx: Statement - Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20240101__20241231_z040ntC5f7sc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230101__20231231_zL8bx92qwYkl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingExpensesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_pp0p0_maOEzmij_zIV51aiwsNek" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Research and development</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-12-31" id="Fact000211" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,639,411</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-12-31" id="Fact000212" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,287,691</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--GeneralAndAdministrativeExpense_i01_pp0p0_maOEzmij_zkdAWl0x9R9k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">General and administrative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-01-01to2024-12-31" id="Fact000214" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,493,035</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31" id="Fact000215" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,742,739</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_pp0p0_mtOEzmij_msOILzByi_zAdR6jZ2agWk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-01-01to2024-12-31" id="Fact000217" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,132,446</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-12-31" id="Fact000218" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,030,430</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingIncomeLoss_iT_pp0p0_mtOILzByi_maILFCOzFCi_zplvcJDtQrZg" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Loss from operations</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-01-01to2024-12-31" id="Fact000220" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">19,132,446</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000221" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">21,030,430</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OtherIncomeAndExpensesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other income (expense):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--InvestmentIncomeNet_i01_pp0p0_maNIEz4fU_zNr0uqiuM7e2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Investment income, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2024-01-01to2024-12-31" id="Fact000226" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">512,204</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2023-01-012023-12-31" id="Fact000227" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,157,625</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i01_pp0p0_maNIEz4fU_zns3trXY6pb8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loss on debt extinguishment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0229">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2023-01-012023-12-31" id="Fact000230" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">329,158</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--InterestExpenseNonoperating_i01N_pp0p0_di_msNIEz4fU_zntxMA3URNvb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0232">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2023-01-012023-12-31" id="Fact000233" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">197,080</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--OtherNonoperatingExpense_i01N_pp0p0_di_msNIEz4fU_zh12Ktwp2nbg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0235">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherNonoperatingExpense" contextRef="From2023-01-012023-12-31" id="Fact000236" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">396,319</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--NonoperatingIncomeExpense_i01T_pp0p0_mtNIEz4fU_maILFCOzFCi_zAaiktpWlIof" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Total other income (expense), net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2024-01-01to2024-12-31" id="Fact000238" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">512,204</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-01-012023-12-31" id="Fact000239" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">235,068</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pp0p0_mtILFCOzFCi_maNILzhqT_zt3HA2loECL4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss before income tax benefit</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-01-01to2024-12-31" id="Fact000241" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">18,620,242</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-012023-12-31" id="Fact000242" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">20,795,362</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_msNILzhqT_znKSAWQ5Xjqc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Income tax benefit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0244">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="Fact000245" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,280,385</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetIncomeLoss_iT_pp0p0_mtNILzhqT_zzYFWiN0q9x6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-12-31" id="Fact000247" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">18,620,242</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000248" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">19,514,977</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss per common share - basic and diluted</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span id="xdx_906_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231_zKZT4gbVbLG7" title="Net loss per common share - Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231_zhgMlRvfTUDh" title="Net loss per common share - Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-01-01to2024-12-31" id="Fact000250" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-01-01to2024-12-31" id="Fact000252" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.62</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span id="xdx_90F_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zIaWPojiB0I2" title="Net loss per common share - Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_zcYE0EOgaIA5" title="Net loss per common share - Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-12-31" id="Fact000254" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-12-31" id="Fact000256" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">2.16</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Weighted average common shares outstanding - basic and diluted</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20241231_zATLcuBaZmq3" title="Weighted average common shares outstanding - Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20241231_zABqqPOD4p5a" title="Weighted average common shares outstanding - Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-01to2024-12-31" id="Fact000258" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-01to2024-12-31" id="Fact000260" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,508,159</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20231231_z8z7ua2JLC9a" title="Weighted average common shares outstanding - Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20231231_pdd" title="Weighted average common shares outstanding - Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-12-31" id="Fact000262" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-12-31" id="Fact000264" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,045,320</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 83; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="me_003"></span>IMUNON,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF COMPREHENSIVE LOSS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_zeHApcpMzfFj" summary="xdx: Statement - Consolidated Statements of Comprehensive Loss" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20240101__20241231_zMTPRAtsp1eb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230101__20231231_zOaPp3gDwQf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ComprehensiveIncomeNetOfTaxAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Other comprehensive loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Changes in:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_i02_pp0p0_maCINOTzyob_zZ32Vsgj07k" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Realized and unrealized gains on available for sale securities, net</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0272">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="From2023-01-012023-12-31" id="Fact000273" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">34,302</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_maCINOTzyob_zzKYFI0MLvMc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-12-31" id="Fact000275" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,620,242</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000276" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">19,514,977</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ComprehensiveIncomeNetOfTax_iT_pp0p0_mtCINOTzyob_zfZ7JoNxHv9c" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total comprehensive loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2024-01-01to2024-12-31" id="Fact000278" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">18,620,242</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2023-01-012023-12-31" id="Fact000279" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">19,480,675</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 84; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="me_004"></span>IMUNON,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_112_zjqtOjVbGe8l" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240101__20241231_z3pp7UzBYGU9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230101__20231231_zTKdYvkkFsuj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLoss_i01_pp0p0_maNCPBUzjVx_zkjZCF4jl5Lh" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Net loss</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-12-31" id="Fact000284" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">18,620,242</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000285" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">19,514,977</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Depreciation_i02_pp0p0_maNCPBUzjVx_zoDy8X9xDX2g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2024-01-01to2024-12-31" id="Fact000290" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">240,175</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-01-012023-12-31" id="Fact000291" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">248,154</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i02_pp0p0_maNCPBUzjVx_zrz1FxnIrFC9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Amortization of right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2024-01-01to2024-12-31" id="Fact000293" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">477,941</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2023-01-012023-12-31" id="Fact000294" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">471,851</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--GainLossOnInvestments_i02N_pp0p0_di_msNCPBUzjVx_zASDpjWmNQb9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Realized and unrealized (gains) and losses, net, on investment securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2024-01-01to2024-12-31" id="Fact000296" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">61,983</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2023-01-012023-12-31" id="Fact000297" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">34,302</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ShareBasedCompensation_i02_pp0p0_maNCPBUzjVx_zvaUIJ34Pj7c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-01-01to2024-12-31" id="Fact000299" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">477,256</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-12-31" id="Fact000300" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">759,013</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredIncomeTaxExpenseBenefit_i02_pp0p0_maNCPBUzjVx_zRt5niYiqobi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Realization of deferred income tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2024-01-01to2024-12-31" id="Fact000302" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,280,385</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="Fact000303" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">286,641</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i02N_pp0p0_di_msNCPBUzjVx_zBMhINtW3EC1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss on extinguishment of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0305">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2023-01-012023-12-31" id="Fact000306" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">329,158</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_i02_pp0p0_maNCPBUzjVx_zsdG5OvNFQ61" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Write-off of note receivable (Transomic)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0308">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" contextRef="From2023-01-012023-12-31" id="Fact000309" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">375,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable_i02_pp0p0_maNCPBUzjVx_z5zdGi5QQSX3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Amortization of deferred finance charges and debt discount associated with note payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0311">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="IMNN:AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable" contextRef="From2023-01-012023-12-31" id="Fact000312" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,122</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net changes in:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInAccruedInvestmentIncomeReceivable_i02N_pp0p0_di_msNCPBUzjVx_ztoXMmKAG137" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accrued interest receivable on investment securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0317">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedInvestmentIncomeReceivable" contextRef="From2023-01-012023-12-31" id="Fact000318" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">68,136</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInOtherCurrentAssets_i02N_pp0p0_di_msNCPBUzjVx_z8qV2MQq5VX1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Advances, deposits, and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" contextRef="From2024-01-01to2024-12-31" id="Fact000320" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">408,859</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" contextRef="From2023-01-012023-12-31" id="Fact000321" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">141,619</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i02_pp0p0_maNCPBUzjVx_zuDTP8jaIeFl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accounts payable and accrued liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2024-01-01to2024-12-31" id="Fact000323" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,057,361</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-01-012023-12-31" id="Fact000324" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,992,929</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_pp0p0_mtNCPBUzjVx_maCCERCzGZw_zzOY8nuIxfqe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-01-01to2024-12-31" id="Fact000326" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">18,854,970</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-012023-12-31" id="Fact000327" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">19,022,148</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--PaymentsToAcquireAvailableForSaleSecuritiesDebt_i01N_pp0p0_di_msNCPBUztGT_zisdGAypTed1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Purchases of investment securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="From2024-01-01to2024-12-31" id="Fact000332" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">57,174</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="From2023-01-012023-12-31" id="Fact000333" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,541,806</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_i01_pp0p0_maNCPBUztGT_zI4INsS6nlql" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from sale and maturity of investment securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" contextRef="From2024-01-01to2024-12-31" id="Fact000335" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,915,448</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" contextRef="From2023-01-012023-12-31" id="Fact000336" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_pp0p0_di_msNCPBUztGT_zSJMKcO15Ia" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Purchases of property and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2024-01-01to2024-12-31" id="Fact000338" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,541</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31" id="Fact000339" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">451,759</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_pp0p0_mtNCPBUztGT_maCCERCzGZw_zwInqmv1JOSa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash provided by investing activities</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2024-01-01to2024-12-31" id="Fact000341" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,828,733</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-01-012023-12-31" id="Fact000342" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,006,435</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_pp0p0_maNCPBUzHSu_zLjvSfWA1CD2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from sale of common stock equity, net of issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2024-01-01to2024-12-31" id="Fact000347" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,060,438</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-01-012023-12-31" id="Fact000348" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,781,438</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--PaymentoffOfLoanAndAccruedEndoftermFees_i01N_pp0p0_di_msNCPBUzHSu_zopCaH2pA1T5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Payoff of the SVB loan and accrued end-of-term fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0350">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="IMNN:PaymentoffOfLoanAndAccruedEndoftermFees" contextRef="From2023-01-012023-12-31" id="Fact000351" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,420,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_pp0p0_mtNCPBUzHSu_maCCERCzGZw_zNaevXhnIdI7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash (used in) provided by financing activities</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2024-01-01to2024-12-31" id="Fact000353" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,060,438</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact000354" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,638,562</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_pp0p0_mtCCERCzGZw_zatwfp07t2Yk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net change in cash, cash equivalents and restricted cash</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2024-01-01to2024-12-31" id="Fact000356" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">34,201</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-01-012023-12-31" id="Fact000357" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">11,654,275</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Cash, cash equivalents and restricted cash at beginning of year</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-12-31" id="Fact000359" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,838,566</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" id="Fact000360" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,492,841</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents end of year</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2024-12-31" id="Fact000362" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,872,767</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-12-31" id="Fact000363" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,838,566</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 85; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IMUNON,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--SupplementalCashFlowInformationAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental disclosure of cash flow information:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash paid for:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InterestPaidNet_i01_pp0p0_zV56v5kSdjL9" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; padding-bottom: 1pt">Interest</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0368">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-01-012023-12-31" id="Fact000369" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">179,542</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Non-Cash Investing and Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--RecognitionOfRightUseAssetAndLiability_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Recognition of right of use asset and liability</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0374">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="IMNN:RecognitionOfRightUseAssetAndLiability" contextRef="From2023-01-012023-12-31" id="Fact000375" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,911,049</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 86; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="me_005"></span>IMUNON,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>YEAR
ENDED DECEMBER 31, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_114_z99BsK6uhpde" summary="xdx: Statement - Consolidated Statements of Changes in Stockholders' Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zjATz5Apmf45" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BD_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zcQvu2iWpPMf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockCommonMember_zFcLTb0MiwP7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zAVXLGcCDII" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(Loss)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zVqsU9AnYUm1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BD_zlNZvEEAEImg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock Outstanding</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional<br/>
 Paid-in</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Treasury Stock</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accum. Other Compr. Income</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(Loss)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_432_c20240101__20241231_eus-gaap--StockholdersEquity_iS_zy2roR11jTO6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 28%; font-weight: bold">Balance at January 1, 2024</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zE16kzed3YTi" title="Balance, shares" style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000384" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,399,811</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000377" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,998</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000378" format="ixt:numdotdecimal" decimals="0" unitRef="USD">401,500,838</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zJqNTaQheIu3" title="Balance, shares" style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000386" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">22</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000379" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">85,188</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000380" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,796</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact000381" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">388,182,802</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000382" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,387,642</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_zocAtRGpyhXg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0388">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0389">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0390">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0391">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="Fact000392" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,620,242</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-12-31" id="Fact000393" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,620,242</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_z1wP8qqyaZlh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sale of equity through equity financing facilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzVBvtK6eiC2" title="Sale of equity through equity financing facilities, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="Fact000402" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,088,796</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="Fact000395" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,888</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000396" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,009,550</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0397">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0398">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0399">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-01to2024-12-31" id="Fact000400" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,060,438</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_z5BuYIDS7sU8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of stock upon vesting of restricted shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGRdRfLSFIGk" title="Issuance of stock upon vesting of restricted shares, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="Fact000411" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,100</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="Fact000404" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0405">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0406">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0407">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0408">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-01-01to2024-12-31" id="Fact000409" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_zFB8knrLq0W7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized and unrealized gains, net, on investment securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0413">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0414">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0415">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000416" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">60,796</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0417">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2024-01-01to2024-12-31" id="Fact000418" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">60,796</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zS4TzwvOihR1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left">Stock-based compensation expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0420">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000421" format="ixt:numdotdecimal" decimals="0" unitRef="USD">477,135</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0422">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0423">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0424">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-01to2024-12-31" id="Fact000425" format="ixt:numdotdecimal" decimals="0" unitRef="USD">477,135</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20240101__20241231_eus-gaap--StockholdersEquity_iE_zYO420K2mZpf" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left; font-weight: bold">Balance at December 31, 2024</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFVnvgECFTWe" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" id="Fact000434" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,500,707</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" id="Fact000427" format="ixt:numdotdecimal" decimals="0" unitRef="USD">145,007</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000428" format="ixt:numdotdecimal" decimals="0" unitRef="USD">410,987,523</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_z8ueeaYNAxc3" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000436" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">22</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000429" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">85,188</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0430">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember" id="Fact000431" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">406,803,044</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31" id="Fact000432" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,244,298</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 87; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IMUNON,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>YEAR
ENDED DECEMBER 31, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock Outstanding</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional<br/>
 Paid-in</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Treasury Stock</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accum. Other Compr. Income</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(Loss)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_432_c20230101__20231231_eus-gaap--StockholdersEquity_iS_zLexcNgI4xoc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 28%; font-weight: bold">Balance at January 1, 2023</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVVGfwrIsQq8" style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000444" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,436,219</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000438" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,362</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000439" format="ixt:numdotdecimal" decimals="0" unitRef="USD">397,980,023</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zYvNFLLvcJsj" title="Balance, shares" style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000446" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">22</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000440" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">85,188</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000441" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,494</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" id="Fact000442" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">368,667,825</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" id="Fact000443" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,327,866</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_439_c20230101__20231231_eus-gaap--StockholdersEquity_iS_zRmJb5aDYWd2" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; font-weight: bold">Balance</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxSVDKimig38" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000454" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,436,219</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000448" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,362</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000449" format="ixt:numdotdecimal" decimals="0" unitRef="USD">397,980,023</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zHOq0ZXaPr3l" title="Balance, shares" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000456" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">22</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000450" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">85,188</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000451" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,494</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" id="Fact000452" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">368,667,825</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" id="Fact000453" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,327,866</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_zghAZVtsyUOb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0458">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0459">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0460">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0461">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="Fact000462" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">19,514,977</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000463" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">19,514,977</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zUQC2ZHtuBze" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sale of equity through equity financing facilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsUV5ur15F5l" title="Sale of equity through equity financing facilities, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000472" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,904,142</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000465" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,041</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000466" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,762,397</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0467">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0468">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0469">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31" id="Fact000470" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,781,438</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_zxRpyTJYlq78" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of stock upon vesting of restricted shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zH3XoS2eIgXk" title="Issuance of stock upon vesting of restricted shares, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000481" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59,450</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000474" format="ixt:numdotdecimal" decimals="0" unitRef="USD">595</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0475">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0476">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0477">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0478">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2023-01-012023-12-31" id="Fact000479" format="ixt:numdotdecimal" decimals="0" unitRef="USD">595</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_zVmq30mhQGpk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized and unrealized gains, net, on investment securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0483">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0484">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0485">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000486" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,302</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0487">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2023-01-012023-12-31" id="Fact000488" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,302</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zKipvx57KlW3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left">Stock-based compensation expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0490">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000491" format="ixt:numdotdecimal" decimals="0" unitRef="USD">758,418</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0492">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0493">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0494">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31" id="Fact000495" format="ixt:numdotdecimal" decimals="0" unitRef="USD">758,418</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43B_c20230101__20231231_eus-gaap--StockholdersEquity_iE_zOv9ASKoGULg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; font-weight: bold">Balance at December 31, 2023</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCUkWOoNJiXh" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000504" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,399,811</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000497" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,998</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000498" format="ixt:numdotdecimal" decimals="0" unitRef="USD">401,500,838</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zftjCJ1ClHI" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000506" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">22</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000499" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">85,188</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000500" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,796</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact000501" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">388,182,802</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000502" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,387,642</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_43E_c20230101__20231231_eus-gaap--StockholdersEquity_iE_z8v74ujMmBok" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; font-weight: bold">Balance</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zb24KWLfJjdg" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000515" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,399,811</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000508" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,998</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000509" format="ixt:numdotdecimal" decimals="0" unitRef="USD">401,500,838</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zzJWNKOGhUvb" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000517" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">22</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000510" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">85,188</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000511" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,796</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact000512" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">388,182,802</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000513" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,387,642</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 88; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="me_006"></span>IMUNON,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER
31, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000519" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_z2M204phNIQ1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
<span id="xdx_820_zrtlyvz43qR6">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000521" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock"><p id="xdx_84D_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zvySlgYoTayb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zh5oy2eCD6x3">Description
of Business</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon,
Inc. (&#8220;Imunon&#8221; or the &#8220;Company&#8221;) is a clinical-stage biotechnology company focused on advancing a portfolio of
innovative treatments that harness the body&#8217;s natural mechanisms with the aim to generate safe, effective and durable responses
across a broad array of human diseases, constituting a differentiating approach from conventional therapies. Imunon is developing its
non-viral DNA technology across its modalities. The first modality, TheraPlas&#174;, is developed for the coding of proteins and cytokines
in the treatment of solid tumors where an immunological approach is deemed promising. The second modality, PlaCCine&#174;, is developed
for the coding of viral antigens that can elicit a strong immunological response. This technology may represent a promising platform
for the development of vaccines in infectious diseases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer
that has completed Phase II clinical studies. IMNN-001 works by instructing the body to produce safe and durable levels of powerful cancer-fighting
molecules, such as interleukin-12 and interferon gamma, at the tumor site. Additionally, the Company has entered a first-in-human study
of its COVID-19 booster vaccine (IMNN-101). The Company will continue to leverage these modalities and to advance the technological frontier
of plasmid DNA to better serve patients with difficult-to-treat conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000523" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zae6M2qgw8N9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zaJVUmFdjmi8">Basis
of Presentation</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements (&#8220;Financial Statements&#8221;) of Imunon have been prepared in accordance with accounting
principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and include the accounts of the Company and CLSN Laboratories,
Inc. The Company dissolved Celsion GmbH in 2023. All significant intercompany balances and transactions have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000525" name="us-gaap:SegmentReportingPolicyPolicyTextBlock"><p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zp7DGI3bhVRl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zI7u3z2jMAB2">Accounting
Standards Update: Improvements to Reportable Segment Disclosures</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU No. 2023-07, &#8220;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&#8221;.
The disclosure requirements are required on an annual and interim basis and are applicable to entities with a single reportable segment.
The amendments in the ASU require disclosures to include significant segment expenses that are regularly provided to the chief operating
decision maker (&#8220;CODM&#8221;), a description of other segment items by reportable segment, and any additional measures of a segment&#8217;s
profit or loss used by the CODM when deciding how to allocate resources. ASU 2023-07 is effective for fiscal years beginning after December
15, 2023 and interim periods for fiscal years beginning after December 31, 2024, with early adoption allowed. We adopted this guidance
as of January 1, 2024 on a retrospective basis and the adoption did not have a material impact on our consolidated financial statements.
Refer to Note 3, &#8220;<i>Segment Performance Measures and Expenses</i>,&#8221; for new disclosures resulting from the adoption of ASU
2023-07.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000527" name="us-gaap:UseOfEstimates"><p id="xdx_842_eus-gaap--UseOfEstimates_z1OUXqQnRFab" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zwIEi2FD2nra">Use
of Estimates</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the
reported amounts of expenses during the reporting period. Actual results could differ significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000529" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_843_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zKfScKLf3Bjh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_z6An9PGJcFY8">Revenue
Recognition</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not generate any revenue in 2024 or 2023 and there were <span id="xdx_907_eus-gaap--AccountsReceivableNet_iI_pdp0_do_c20241231_zQ3A5TpsjlMa" title="Accounts receivable"><span id="xdx_90E_eus-gaap--AccountsReceivableNet_iI_pdp0_do_c20231231_zvwPfGfAfP2d" title="Accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-12-31" id="Fact000531" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2023-12-31" id="Fact000533" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> accounts receivable as of December 31, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 89; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000535" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zOBhxFArpyd1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zzhY1d8iGIfc">Cash
and Cash Equivalents</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents include cash on hand and investments purchased with an original maturity of three months or less. A portion of these
funds are not covered by FDIC insurance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000537" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWVTmmcisM1e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zqyQ0nKKzRvl">Fair
Value of Financial Instruments</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of financial instruments approximate their respective fair values. Management believes that the carrying amounts of the
Company&#8217;s financial instruments, including cash and cash equivalents and accounts payable approximate fair value due to the short-term
nature of those instruments. Short-term investments are recorded at their estimated fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000539" name="us-gaap:InvestmentPolicyTextBlock"><p id="xdx_849_eus-gaap--InvestmentPolicyTextBlock_z8yuuJU4D5Pg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zOLBFKHY8BJ8">Short-Term
Investments</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies its investments in debt securities with readily determinable fair values as investments available-for-sale in accordance
with Accounting Standards Codification (&#8220;ASC&#8221;) 320, <i>Investments - Debt and Equity Securities</i>. Available-for-sale securities
consist of debt securities not classified as trading securities or as securities to be held to maturity. The Company has classified all
of its investments as available-for-sale. Unrealized holding gains and losses on available-for-sale securities are reported as a net
amount in accumulated other comprehensive gain or loss in stockholders&#8217; equity until realized. Gains and losses on the sale of
available-for-sale securities are determined using the specific identification method. The Company&#8217;s short-term investments consist
of corporate bonds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000541" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zug1ROyI6bp2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_z7ucnlguqE76">Property
and Equipment</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is provided over the estimated useful lives
of the related assets, ranging from <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20241231__srt--RangeAxis__srt--MinimumMember_zYE3fp0mEK27" title="Property plant and equipment useful life::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl0543">three</span></span> to <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20241231__srt--RangeAxis__srt--MaximumMember_zZIUtEY11Mi8" title="Property plant and equipment useful life"><ix:nonNumeric contextRef="AsOf2024-12-31_srt_MaximumMember" format="ixt-sec:durwordsen" id="Fact000545" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">seven years</ix:nonNumeric></span>, using the straight-line method. Amortization is recognized over the lesser
of the life of the asset or the lease term. Major renewals and improvements are capitalized at cost and ordinary repairs and maintenance
are charged against operating expenses as incurred. Depreciation expense was approximately $<span id="xdx_90C_eus-gaap--DepreciationAndAmortization_pp0p0_c20240101__20241231_zQVcdcMNWTh8" title="Depreciation expense"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2024-01-01to2024-12-31" id="Fact000547" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">240,000</ix:nonFraction></span> and $<span id="xdx_90D_eus-gaap--DepreciationAndAmortization_pp0p0_c20230101__20231231_z9WPieBxdnNc" title="Depreciation expense"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-01-012023-12-31" id="Fact000549" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">248,000</ix:nonFraction></span> for the years ended
December 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of
an asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the future net undiscounted cash flows
that the asset is expected to generate. If such asset is considered to be impaired, the impairment recognized is the amount by which
the carrying amount of the asset, if any, exceeds its fair value determined using a discounted cash flow model. There was <span id="xdx_90D_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pdp0_do_c20240101__20241231_zVfBHWUtMXA5" title="Impairment of property or equipment"><span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pdp0_do_c20230101__20231231_zm10zQPzzU8b" title="Impairment of property or equipment"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" contextRef="From2024-01-01to2024-12-31" id="Fact000551" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" contextRef="From2023-01-012023-12-31" id="Fact000553" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> impairment
of property or equipment during 2024 or 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000555" name="IMNN:AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock"><p id="xdx_840_ecustom--AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock_zgxMZgM0JY94" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zcieJVfHpkp">Advances
and Deposits on Clinical Programs and Other Current Assets</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplies
are consumable items kept on hand to support the Company&#8217;s R&amp;D and manufacturing operations which includes prepaid expense,
raw materials, clinical supplies and consumable items for clinical trials with alternate uses that are capitalized. Supplies are recorded
at cost and are charged to expense as they are used in operations. The Company regularly reviews the quality and utilization of supplies
to determine if future use of these supplies is probable. Due to the generic use of these supplies, they can be used in multiple projects
other than those currently being studied.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000557" name="IMNN:DepositsPolicyTextBlock"><p id="xdx_84D_ecustom--DepositsPolicyTextBlock_zv4VB1vNiPXh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zejGSx6DUqp2">Deposits</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits
include real property security deposits and other deposits which are contractually required and of a long-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<ix:exclude><!-- Field: Page; Sequence: 90; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000559" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock"><p id="xdx_84E_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zZQIAu9nUID1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zn5SgiHogNtg">Comprehensive
Income (Loss)</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
220, <i>Comprehensive Income</i>, establishes standards for the reporting and display of comprehensive income (loss) and its components
in the Company&#8217;s consolidated financial statements. The objective of ASC 220 is to report a measure of comprehensive income (loss)
of all changes in equity of an enterprise that result from transactions and other economic events in a period other than transactions
with owners. Comprehensive gains (losses) result from changes in unrealized gains and losses from investment in debt securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000561" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_z4pdAbEldQXh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zWZnZktlyHl1">Research
and Development</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred. Supplies are consumable and recorded at cost and are charged to expense as they are
used in operations. Equipment and facilities acquired for research and development activities that have alternative future uses are
capitalized and charged to expense over their estimated useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000563" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zPN17PhH7Lof" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zRxYNFxPrvH5">Net
Loss per Share of Common Stock</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
and diluted net loss per common share was computed by dividing net loss for the year by the weighted average number of shares of common
stock outstanding, both basic and diluted, during each period. The impact of common stock equivalents has been excluded from the computation
of diluted weighted average common shares outstanding in periods where there is a net loss, as their effect is anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2024 and 2023, the total number of shares of common stock issuable upon exercise of warrants and equity
awards was <span id="xdx_90C_ecustom--NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards_c20240101__20241231_zIdJ8NypOvke" title="Number of shares of common stock issuable upon exercise of warrants and equity awards"><ix:nonFraction name="IMNN:NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards" contextRef="From2024-01-01to2024-12-31" id="Fact000565" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,840,633</ix:nonFraction></span> and <span id="xdx_903_ecustom--NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards_c20230101__20231231_z8uqJsW68Whg" title="Number of shares of common stock issuable upon exercise of warrants and equity awards"><ix:nonFraction name="IMNN:NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards" contextRef="From2023-01-012023-12-31" id="Fact000567" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,255,642</ix:nonFraction></span>, respectively. For the years ended December 31, 2024 and 2023, diluted loss per common share is the
same as basic loss per common share as all options and all other warrants that were convertible into shares of the Company&#8217;s common
stock were excluded from the calculation of diluted earnings attributable to common stockholders per common share as their effect would
be anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000569" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zRaWOaQJvd1e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_z5YYICLMLxq5">Income
Taxes</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for
the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities
and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using
enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered
or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in results of operations in the
period that the tax rate change occurs. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount
expected to be realized. In accordance with ASC 740, <i>Income Taxes,</i> a tax position is recognized as a benefit only if it is &#8220;more
likely than not&#8221; that the tax position taken would be sustained in a tax examination, presuming that a tax examination will occur.
The Company recognizes interest and/or penalties related to income tax matters in the income tax expense category.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
more fully discussed in Note 10, on November 28, 2023, the Company received approval from the New Jersey Economic Development Authority
to sell $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231128__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_zyQUca0mGMrj" title="Net proceeds from sale of net operating losses"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-11-28_stpr_NJ_us-gaap_NewJerseyDivisionOfTaxationMember" id="Fact000571" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.3</ix:nonFraction></span> million of its New Jersey net operating losses (&#8220;NOLs&#8221;), recognizing a tax benefit for the year ended December
31, 2023 for the net proceeds (approximately $<span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_zQqFn3poljfg" title="Net proceeds from sale of net operating losses"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-12-31_stpr_NJ_us-gaap_NewJerseyDivisionOfTaxationMember" id="Fact000573" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.3</ix:nonFraction></span> million) by reducing the net operating loss valuation allowance. As more fully discussed
in Note 10, on November 28, 2023, the Company was notified by the New Jersey Economic Development Authority that its application was
approved and the Company entered into an agreement to sell this NOL. On March 22, 2024, the Company received approximately $<span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20240322__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_zVzov2i0QTOh" title="Net proceeds from sale of net operating losses"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2024-03-22_stpr_NJ_us-gaap_NewJerseyDivisionOfTaxationMember" id="Fact000575" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.3</ix:nonFraction></span> million
upon completion of the sale of the 2023 NOLs. During 2021, the New Jersey State Legislature increased the maximum lifetime benefit per
company from $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MinimumMember_zuvjJAWM4cA3" title="Net proceeds from sale of net operating losses"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-12-31_stpr_NJ_srt_MinimumMember" id="Fact000577" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">15</ix:nonFraction></span> million to $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MaximumMember_zscyKEF3T4t3" title="Net proceeds from sale of net operating losses"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-12-31_stpr_NJ_srt_MaximumMember" id="Fact000579" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">20</ix:nonFraction></span> million, which will allow the Company to participate in this innovative funding program in future years
for up to an additional $<span id="xdx_908_eus-gaap--DirectFinancingLeaseSellingLoss_pn5n6_c20210101__20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MaximumMember_znzYDjnuVgY7" title="Direct financing lease, selling loss"><ix:nonFraction name="us-gaap:DirectFinancingLeaseSellingLoss" contextRef="From2021-01-012021-12-31_stpr_NJ_srt_MaximumMember" id="Fact000581" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.4</ix:nonFraction></span> million in net operating losses under this maximum lifetime benefit (see Note 2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 91; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000583" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_84F_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zAuM5jvcHRGh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zmV0V4UKH7s4">Stock-Based
Compensation</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for all share-based payment awards granted to employees and non-employees as stock-based compensation expense at
grant date fair value. The Company&#8217;s share-based payments include stock options and grants of common stock, including common
stock subject to vesting. The measurement date for employee awards is the date of grant, and stock-based compensation costs are
recognized as expense over the employees&#8217; requisite service period, which is the vesting period, on a straight-line basis.
Prior to the adoption of Accounting Standards Update (&#8220;ASU&#8221;) No. 2018-07, <i>Compensation&#8212;Stock Compensation
(Topic 718): Improvements to Nonemployee Share-Based Payment Accounting</i> (&#8220;ASU No. 2018-07&#8221;) on January 1, 2020, the
measurement date for non-employee awards was generally the date the services were completed, resulting in financial reporting period
adjustments to stock-based compensation during the vesting terms for changes in the fair value of the awards. Since the adoption of
ASU 2018-07, the measurement date for non-employee awards is the date of grant without changes in the fair value of the award. There
was no material impact as a result of adopting this new standard. Stock-based compensation costs for non-employees are recognized as
expense over the vesting period on a straight-line basis. Stock-based compensation expense is classified in the accompanying
consolidated statements of operations based on the function to which the related services are provided. Forfeitures are recorded as
they occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. Since there is
limited historical data of the Company&#8217;s share price on the public market, the Company estimates its expected stock volatility
based on the historical volatility of a publicly traded set of representative companies and expects to continue to do so until such time
as it has adequate historical data regarding the volatility of its own traded stock price. The expected term of the Company&#8217;s stock
options has been determined utilizing the &#8220;simplified&#8221; method for awards that qualify as &#8220;plain-vanilla&#8221; options.
The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for
time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has
never paid cash dividends on common stock and does not expect to pay any cash dividends in the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000585" name="IMNN:WarrantAccountingPolicyTextBlock"><p id="xdx_84D_ecustom--WarrantAccountingPolicyTextBlock_zknejFqvE3v9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zubzMXlIwN6g">Warrant
Accounting</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants&#8217; specific
terms and applicable authoritative guidance in ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221; (&#8220;ASC 480&#8221;),
and ASC 815 &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all
of the requirements for equity classification under ASC 815, including whether the warrants are indexed to our own ordinary shares and
whether warrant holders could potentially require &#8220;net cash settlement&#8221; in a circumstance outside of our control, among other
conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant
issuance and as of each subsequent quarterly period end-date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
issued or modified warrants that meet all the criteria for equity classification, the warrants are required to be recorded as a component
of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants
are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of warrants classified as liabilities are recognized as a non-cash gain or loss on our statements
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the warrants issued upon our financings in 2024 meet the criteria for equity classification under ASC 815, those warrants were classified
as equity as of December 31, 2024. No warrants were issued in 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000587" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zDyZDNP766sh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zqPXVdyVEl3d">Recent
Accounting Pronouncements</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements are issued by the FASB and are adopted by the Company as of the specified effective date.
Unless otherwise discussed, the Company believes that the impact of recently issued accounting pronouncements will not have a material
impact on the Company&#8217;s consolidated financial position, results of operations, and cash flows, or do not apply to its operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU No. 2023-07, &#8220;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&#8221;.
The disclosure requirements are required on an annual and interim basis and are applicable to entities with a single reportable segment.
The amendments in the ASU require disclosures to include significant segment expenses that are regularly provided to the chief operating
decision maker (&#8220;CODM&#8221;), a description of other segment items by reportable segment, and any additional measures of a segment&#8217;s
profit or loss used by the CODM when deciding how to allocate resources. ASU 2023-07 is effective for fiscal years beginning after December
15, 2023 and interim periods for fiscal years beginning after December 31, 2024, with early adoption allowed. We adopted this guidance
as of January 1, 2024 on a retrospective basis and the adoption did not have a material impact on our consolidated financial statements.
Refer to Note 3, &#8220;<i>Segment Performance Measures and Expenses</i>,&#8221; for new disclosures resulting from the adoption of ASU
2023-07.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 92; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU No. 2023-09, <i>Improvements to Income Tax Disclosures</i>, which requires disclosure of disaggregated
income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income
tax-related disclosures. ASU No. 2023-09 is effective for fiscal years beginning after December 15, 2024 and allows for adoption on a
prospective basis, with a retrospective option. Early adoption is permitted. The Company is currently evaluating the impact of the ASU
on the income tax disclosures within the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2024, the FASB issued Accounting Standards Update No. 2024-03, Income Statement &#8211; Reporting Comprehensive Income &#8211;
Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses (&#8220;ASU 2024-03&#8221;). ASU 2024-03 will require
more detailed information about the types of expenses in commonly presented income statement captions such as &#8220;Cost of sales&#8221;
and &#8220;Selling, general and administrative expenses&#8221;. The new guidance is effective for annual reporting periods beginning
after December 15, 2026, and interim reporting periods beginning after December 15, 2027 with early adoption permitted. The Company is
currently evaluating the impact that this change will have on the Company&#8217;s disclosures.</span></p>

</ix:nonNumeric><p id="xdx_851_zczJowsXYUid" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000589" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_808_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zCnMSkstZca9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
<span id="xdx_821_zgDVjFnPoFXc">FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
inception, the Company has incurred substantial operating losses, principally from expenses associated with the Company&#8217;s research
and development programs, clinical trials conducted in connection with the Company&#8217;s drug candidates, and applications and submissions
to the FDA. The Company has not generated significant revenue and has incurred significant net losses in each year since inception. For
the year ended December 31, 2024, the Company had a net loss of $<span id="xdx_90F_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20240101__20241231_zfpK4dOpOVm9" title="Net loss"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-12-31" id="Fact000591" format="ixt:numdotdecimal" decimals="-5" scale="6" sign="-" unitRef="USD">18.6</ix:nonFraction></span> million and used $<span id="xdx_901_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20240101__20241231_ztZxwtxe5gUb" title="Fund operation"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-01-01to2024-12-31" id="Fact000593" format="ixt:numdotdecimal" decimals="-5" scale="6" sign="-" unitRef="USD">18.9</ix:nonFraction></span> million to fund operations. As of December
31, 2024, the Company has incurred approximately $<span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn6n6_di_c20241231_zpzS9gjb3sd" title="Cumulated net losses"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-12-31" id="Fact000595" format="ixt:numdotdecimal" decimals="-6" scale="6" sign="-" unitRef="USD">407</ix:nonFraction></span> million of cumulative net losses. As of December 31, 2024, the Company had $<span id="xdx_90D_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_pn5n6_c20241231_z9sVC6OiUSk8" title="Cash and cash equivalents, short-term investments"><ix:nonFraction name="us-gaap:CashCashEquivalentsAndShortTermInvestments" contextRef="AsOf2024-12-31" id="Fact000597" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">5.9</ix:nonFraction></span>
million in cash and cash equivalents and short-term investments. The Company has substantial future capital requirements to continue
its research and development activities and advance its drug candidates through various development stages. The Company believes these
expenditures are essential for the commercialization of its drug candidates and technologies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expects its operating losses to continue for the foreseeable future as it continues its product development efforts, and when
it undertakes marketing and sales activities. The Company&#8217;s ability to achieve profitability is dependent upon its ability to obtain
governmental approvals, manufacture, and market and sell its new drug candidates. There can be no assurance that the Company will be
able to commercialize its technology successfully or that profitability will ever be achieved. The Company expects that its operating
results will fluctuate significantly in the future and will depend on a number of factors, many of which are outside the Company&#8217;s
control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s ability to raise additional capital may be adversely impacted by potential worsening global economic conditions and the
recent disruptions to, and volatility in, financial markets in the U.S. and worldwide resulting from the Russian invasion of Ukraine
and the unrest in the Middle East. The Company continues to monitor its operating activities in light of these events, and it is possible
that these events could result in a variety of risks to the business. The specific impact, if any, is not readily determinable as of
the date of these consolidated Financial Statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has based its estimates on assumptions that may prove to be wrong. The Company may need to obtain additional funds sooner or
in greater amounts than it currently anticipates. Potential sources of financing include strategic relationships, public or private sales
of the Company&#8217;s shares or debt, the sale of the Company&#8217;s New Jersey NOLs and other sources. If the Company raises funds
by selling additional shares of common stock or other securities convertible into common stock, the ownership interest of existing stockholders
may be diluted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
actual amount of funds the Company will need to operate is subject to many factors, some of which are beyond the Company&#8217;s control.
These factors include the progress of research activities; the number and scope of research programs; the progress of preclinical and
clinical development activities; the progress of the development efforts of parties with whom the Company has entered into research and
development agreements; the costs associated with additional clinical trials of drug candidates; the ability to maintain current research
and development licensing arrangements and to establish new research and development and licensing arrangements; the ability to achieve
milestones under licensing arrangements; the costs involved in prosecuting and enforcing patent claims and other intellectual property
rights; and the costs and timing of regulatory approvals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 93; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements have been prepared on the going concern basis. In making this assessment, management conducted a comprehensive
review of the Company&#8217;s business plan including, but not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company&#8217;s financial position for the year ended December 31, 2024;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
    events and transactions the Company has entered into since December 31, 2024;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company&#8217;s cash flow and cash usage forecasts for the period one year from the issuance date of this Annual Report on Form 10-K;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company&#8217;s capitalization structure including common stock outstanding and common stock issuable on exercise of warrants and
    equity awards, and other common stock issuable under equity plans; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">continued
    support of the Company&#8217;s stockholders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the uncertainties involved in our business, we are unable to estimate the duration and completion costs of our research and
development projects or when, if ever, and to what extent we will receive cash inflows from the commercialization and sale of a product.
Our inability to complete our research and development projects in a timely manner or our failure to enter into collaborative agreements,
when appropriate, could significantly increase our capital requirements and could adversely impact our liquidity. These uncertainties
could force us to seek additional, external sources of financing from time to time in order to continue with our business strategy. Our
inability to raise additional capital, or to do so on terms reasonably acceptable to us, would jeopardize the future success of our business.
Our estimated future capital requirements are uncertain and could change materially as a result of many factors, including the progress
of our research, development, clinical, manufacturing, and commercialization activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
has determined the Company has suffered recurring losses from operations and has an accumulated deficit that raises substantial doubt
about our ability to continue as a going concern for the next twelve months from the issuance date of this Annual Report on Form 10-K.
The report of our independent registered public accounting firm for the year ended December 31, 2024 includes an explanatory paragraph,
which expresses substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments
that might result from the outcome of the uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
fundamental component of the ability to continue as a going concern is the Company&#8217;s ability to raise capital as required, as to
which no assurances can be provided. To address the additional funding requirements of the Company, management has undertaken the following
initiatives:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    has assessed its current expenditures and will be reducing the current spending requirements where necessary;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    will pursue additional capital funding in the public and private markets through equity sales and/or debt facilities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    will pursue possible partnerships and collaborations; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    will pursue potential out licensing for its drug candidates.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to continue as a going concern may depend on our ability to raise additional capital, attain further operating efficiencies,
reduce expenditures, and, ultimately, to generate revenue. There are no assurances that these future funding and operating efforts will
be successful. If management is unsuccessful in these efforts, our current capital is not expected to be sufficient to fund our operations
for the next twelve months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 94; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>
<!-- Field: Split-Segment; Name: 001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000599" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_803_eus-gaap--SegmentReportingDisclosureTextBlock_zzQTVrseoFp6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.
<span id="xdx_821_zukiTH0MiWai">SEGMENT PERFORMANCE MEASURES AND EXPENSES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates in <span id="xdx_901_eus-gaap--NumberOfOperatingSegments_pid_dc_uSegment_c20240101__20241231_zdHcMDCYRi69" title="Number of operating segment"><ix:nonFraction name="us-gaap:NumberOfOperatingSegments" contextRef="From2024-01-01to2024-12-31" id="Fact000601" format="ixt-sec:numwordsen" decimals="INF" unitRef="Segment">one</ix:nonFraction></span> segment for the research and development of our product candidates. The Company&#8217;s chief operating decision
maker (&#8220;CODM&#8221;) has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions
about allocating resources and assessing performance for the entire Company based on consolidated financial information. Consequently,
we view the entire organization as one reportable segment and the strategic purpose of all operating activities (including general &amp;
administrative expenses) is to support that one segment. As a pre-revenue research and development company, the CODM evaluates company-wide
performance and allocates resources based on non-financial research and development milestones achieved, and to a lesser extent, financial
measures of performance such as clinical development (research and development expenses) and general and administrative expenses incurred.
Our CODM does not generally evaluate our performance using asset or historical cash flow information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000603" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zlYQ79s71ut1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below provides a summary of the significant expense categories and consolidated net loss details provided to the CODM (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B1_zFMVxNtWuuRe" style="display: none">SCHEDULE
OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z9zuGKD5DL8g" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20230101__20231231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z4JR9kjY8526" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(In thousands)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Change Increase (Decrease)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating Expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Clinical Research</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OvationMember_z4e9KjHX7xFc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; width: 36%">OVATION</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OvationMember" id="Fact000605" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,386</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OvationMember" id="Fact000606" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,197</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zFtaV2ODW7J" style="width: 12%; text-align: right"><ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingCostAndExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OvationMember" id="Fact000607" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">189</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_905_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zl3kXxShCr7d"><ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OvationMember" id="Fact000608" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15.8</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--VaccineMember_z0OCox7LvAb2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Vaccine</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_VaccineMember" id="Fact000610" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,420</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0611">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--VaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zjRKddLokjw7" style="text-align: right"><ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingCostAndExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_VaccineMember" id="Fact000612" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,420</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--VaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zb0C42p2TNTc"><ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_VaccineMember" id="Fact000613" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OtherClinicalAndRegulatoryMember_zPYfOJ8X3dJd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Other clinical and regulatory</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OtherClinicalAndRegulatoryMember" id="Fact000615" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,434</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OtherClinicalAndRegulatoryMember" id="Fact000616" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,793</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OtherClinicalAndRegulatoryMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z3T2geOY6303" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingCostAndExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OtherClinicalAndRegulatoryMember" id="Fact000617" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">641</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OtherClinicalAndRegulatoryMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zw5gp35Sd7Md"><ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OtherClinicalAndRegulatoryMember" id="Fact000618" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">35.8</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember_zKd0FMmOdJp1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember" id="Fact000620" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,240</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember" id="Fact000621" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,990</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z452SWsVlj4g" style="text-align: right"><ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingCostAndExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember" id="Fact000622" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,250</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z4a7RGkHKSl3"><ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember" id="Fact000623" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75.3</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Non-Clinical R&amp;D and CMC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--OvationMember_zKDwOJJJJWU5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">OVATION</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_OvationMember" id="Fact000625" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,819</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_OvationMember" id="Fact000626" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,504</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z4DP2VlA9jT2" style="text-align: right"><ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingCostAndExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_OvationMember" id="Fact000627" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">315</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zrcBUfUtWYj9"><ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_OvationMember" id="Fact000628" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20.9</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--PlaCCineVaccineMember_zzqUozQSQxn1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">PlaCCine Vaccine</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_PlaCCineVaccineMember" id="Fact000630" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,554</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_PlaCCineVaccineMember" id="Fact000631" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,511</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--PlaCCineVaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zgHqSp0xeY9d" style="text-align: right">(<ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingCostAndExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_PlaCCineVaccineMember" id="Fact000632" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,957</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--PlaCCineVaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zTtNvCMJJ7d5">(<ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_PlaCCineVaccineMember" id="Fact000633" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">43.4</ix:nonFraction></span></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--ManufacturingCMCMember_zo4TRj9NNMz9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Manufacturing (CMC)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_ManufacturingCMCMember" id="Fact000635" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,026</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_ManufacturingCMCMember" id="Fact000636" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,283</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--ManufacturingCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zRx7aVJlZEMg" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingCostAndExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_ManufacturingCMCMember" id="Fact000637" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">257</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--ManufacturingCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z7iaC6rBWGH3">(<ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_ManufacturingCMCMember" id="Fact000638" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">11.3</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember_z6i4WbV7mvbj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember" id="Fact000640" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,399</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember" id="Fact000641" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,298</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zwSNi41ErFb1" title="Change Increase (Decrease), Subtotal" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingCostAndExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember" id="Fact000643" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,899</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zBowl8SqcpX4" title="Change Increase (Decrease), Subtotal, percentage">(<ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember" id="Fact000645" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">22.9</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr id="xdx_404_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_ztqM0GgOWf9l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Research and development expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember" id="Fact000647" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,639</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember" id="Fact000648" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,288</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--IncreaseDecreaseInResearchAndDevelopmentExpenses_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zYFMsCxY8myk" title="Change Increase (Decrease), Research and development expenses" style="text-align: right"><ix:nonFraction name="IMNN:IncreaseDecreaseInResearchAndDevelopmentExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember" id="Fact000650" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">351</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_ecustom--IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_ziAmP68chYk9" title="Change Increase (Decrease), Research and development expenses, percentage"><ix:nonFraction name="IMNN:IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember" id="Fact000652" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.1</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40D_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_zLS5FIlTy7Bi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">General and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember" id="Fact000654" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,493</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember" id="Fact000655" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,742</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--IncreaseDecreaseInGeneralAndAdministrativeExpenes_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zECrFD39e8Qh" title="Change Increase (Decrease), General and administrative expenses" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="IMNN:IncreaseDecreaseInGeneralAndAdministrativeExpenes" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember" id="Fact000657" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,249</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_ecustom--IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zyxAuV2CPhYa" title="Change Increase (Decrease), General and administrative expenses, percentage">(<ix:nonFraction name="IMNN:IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember" id="Fact000659" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">23.1</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingExpenses_pn3n3_zfgajMq7vzx4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember" id="Fact000661" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,132</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember" id="Fact000662" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,030</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--IncreaseDecreaseInOperatingExpenses_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z3A3fIYodV3f" title="Change Increase (Decrease), Operating expenses" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingExpenses" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember" id="Fact000664" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,898</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_ecustom--IncreaseDecreaseInOperatingExpensesPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zkeS1CfGQgA5" title="Change Increase (Decrease), Operating expenses, percentage">(<ix:nonFraction name="IMNN:IncreaseDecreaseInOperatingExpensesPercentage" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember" id="Fact000666" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">9.0</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingIncomeLoss_pn3n3_zEdiaCmAvLR4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Loss from operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember" id="Fact000668" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">19,132</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember" id="Fact000669" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">21,030</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--IncreaseDecreaseInLossFromOperations_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zWgXhZ2zDbN3" title="Change Increase (Decrease), Loss from operations" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="IMNN:IncreaseDecreaseInLossFromOperations" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember" id="Fact000671" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,898</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_ecustom--IncreaseDecreaseInLossFromOperationsPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zdAJmKiYcYVc" title="Change Increase (Decrease), Loss from operations, percentage">(<ix:nonFraction name="IMNN:IncreaseDecreaseInLossFromOperationsPercentage" contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember" id="Fact000673" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">9.0</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_z7LwPaQy3k1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000675" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"><p id="xdx_80F_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zSPdFfKASWO3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.
<span id="xdx_82C_zTpkOu60T2Wa">INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
in debt securities available for sale with a fair value of $<span id="xdx_90A_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_dxL_c20241231_zPGGVFNRdtag" title="Debt securities, available for sale, current::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0677">0</span></span> and $<span id="xdx_90E_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231_z8xrrKZwAmtd" title="Debt securities, available for sale, current"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="AsOf2023-12-31" id="Fact000679" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,857,087</ix:nonFraction></span> as of December 31, 2024 and 2023, respectively, consisted
of U.S. Treasury securities and corporate debt securities. These investments are valued at estimated fair value, with unrealized gains
and losses reported as a separate component of stockholders&#8217; equity in accumulated other comprehensive loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviews its debt securities classified as short-term investments on a regular basis for impairment. For debt securities in unrealized
loss positions, the Company determines whether any portion of the decline in fair value below the amortized cost basis is due to credit-related
factors if it neither intends to sell nor anticipates that it is more likely than not that it will be required to sell prior to recovery
of the amortized cost basis. The Company considers factors such as the extent to which the market value has been less than the cost,
any noted failure of the issuer to make scheduled payments, changes to the rating of the security and other relevant credit-related factors
in determining whether or not a credit loss exists. During fiscal 2024 and 2023, the Company did not recognize an allowance for credit-related
losses on any of our investments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 95; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000681" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock"><p id="xdx_891_eus-gaap--DebtSecuritiesAvailableForSaleTableTextBlock_zJhMhxVWqx8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the cost, fair value and maturities of the Company&#8217;s short-term investments is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zFMeTwAajRV5" style="display: none">SCHEDULE
OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Short-term investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%; text-align: left">U.S. Treasury securities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShortTermInvestments_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zop2FxWWLzPi" title="Short-term investments - Cost" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0683">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zEml1ZLOhUY9" title="Short-term investments - Fair Value" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0685">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShortTermInvestments_iI_pp0p0_c20231231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zDqeN0KHQiF5" title="Short-term investments - Cost" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2023-12-31_us-gaap_USTreasurySecuritiesMember" id="Fact000687" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,796,291</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_ziEbR6ujJHN8" title="Short-term investments - Fair Value" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="AsOf2023-12-31_us-gaap_USTreasurySecuritiesMember" id="Fact000689" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,857,087</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Short-term investment maturities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%">Within 3 months</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost_iI_pp0p0_c20241231_zQlUqIkK3kTj" title="Short-term investment maturities - Within 3 months, cost" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0691">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue_iI_pp0p0_c20241231_zbmS20GpWvpj" title="Short-term investment maturities - Within 3 months, fair value" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0693">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost_iI_pp0p0_c20231231_zkz8QPcho9p5" title="Short-term investment maturities - Within 3 months, cost" style="width: 12%; text-align: right"><ix:nonFraction name="IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost" contextRef="AsOf2023-12-31" id="Fact000695" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,467,518</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue_iI_pp0p0_c20231231_zvGVwKxRcQBc" title="Short-term investment maturities - Within 3 months, fair value" style="width: 12%; text-align: right"><ix:nonFraction name="IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue" contextRef="AsOf2023-12-31" id="Fact000697" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,490,775</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Between 3-12 months</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost_iI_pp0p0_c20241231_ztS153aL0mij" title="Short-term investment maturities - Between 3-12 months, cost" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0699">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue_iI_pp0p0_c20241231_zMqhyymOuDo5" title="Short-term investment maturities - Between 3-12 months, fair value" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0701">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost_iI_pp0p0_c20231231_zHMVpemb6uVd" title="Short-term investment maturities - Between 3-12 months, cost" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost" contextRef="AsOf2023-12-31" id="Fact000703" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,328,773</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue_iI_pp0p0_c20231231_zB8ZhcMRk2cj" title="Short-term investment maturities - Between 3-12 months, fair value" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue" contextRef="AsOf2023-12-31" id="Fact000705" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,366,312</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_iI_pp0p0_c20241231_zqaPVn5jycGb" title="Short-term investment maturities - Cost" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0707">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_iI_pp0p0_c20241231_z3BpHKtUrjA3" title="Short-term investment maturities - Fair value" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0709">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_iI_pp0p0_c20231231_zFRnRRpU0xai" title="Short-term investment maturities - Cost" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="IMNN:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" contextRef="AsOf2023-12-31" id="Fact000711" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,796,291</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_iI_pp0p0_c20231231_zvAMrI8mXcwd" title="Short-term investment maturities - Fair value" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" contextRef="AsOf2023-12-31" id="Fact000713" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,857,087</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zfvCdnXDTW6f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000715" name="us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock"><p id="xdx_89F_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_ztNRNPJJaSRi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the Company&#8217;s investment in debt securities available for sale gross unrealized gains (losses) and fair value
by investment category and length of time that individual securities have been in a continuous unrealized loss position at December 31,
2024 and 2023. The Company has reviewed individual securities to determine whether a decline in fair value below the amortizable cost
basis is other than temporary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BA_ztEDdfznwVke" style="display: none">SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES)</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Available for sale securities (all unrealized holding gains and losses are less than 12 months at date of measurement)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Unrealized Holding Gains (Losses)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Unrealized Holding Gains (Losses)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Investments in debt securities with unrealized gains</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--AvailableForSaleSecuritiesUnrealizedLossFairValue_iI_c20241231_zpqP4HgJM6Ri" title="Investments in debt securities with unrealized gains - Fair Value" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0717">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths_iI_c20241231_zZL6gqpCzoKi" title="Investments in debt securities with unrealized gains - Unrealized Holding Gains" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0719">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--AvailableForSaleSecuritiesUnrealizedLossFairValue_iI_c20231231_zFASLmzCc1kh" title="Investments in debt securities with unrealized gains - Fair Value" style="width: 12%; text-align: right"><ix:nonFraction name="IMNN:AvailableForSaleSecuritiesUnrealizedLossFairValue" contextRef="AsOf2023-12-31" id="Fact000721" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,857,087</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths_iI_c20231231_ziM6wy1neKGl" title="Investments in debt securities with unrealized gains - Unrealized Holding Gains (Losses)" style="width: 12%; text-align: right"><ix:nonFraction name="IMNN:AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths" contextRef="AsOf2023-12-31" id="Fact000723" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,796</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A0_zCigmoEY1tJb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000725" name="us-gaap:InvestmentIncomeTextBlock"><p id="xdx_897_eus-gaap--InvestmentIncomeTextBlock_zY581MyLYWEf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
income, net, which includes net realized losses on sales of available for sale securities and investment income interest and dividends,
is summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zlVNZnw7O8D" style="display: none">SCHEDULE
OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20240101__20241231_zljdSH3y5Laj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230101__20231231_zAr7TAvXzvm1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InvestmentIncomeInterestAndDividend_maIILNzUXt_zHteq5yzEnRc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Interest and dividends accrued and paid</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2024-01-01to2024-12-31" id="Fact000727" format="ixt:numdotdecimal" decimals="0" unitRef="USD">450,221</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2023-01-012023-12-31" id="Fact000728" format="ixt:numdotdecimal" decimals="0" unitRef="USD">725,824</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DebtSecuritiesAvailableForSaleRealizedGainLoss_maIILNzUXt_zadHWzORz6Xk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Realized losses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" contextRef="From2024-01-01to2024-12-31" id="Fact000730" format="ixt:numdotdecimal" decimals="0" unitRef="USD">61,983</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" contextRef="From2023-01-012023-12-31" id="Fact000731" format="ixt:numdotdecimal" decimals="0" unitRef="USD">431,801</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InvestmentIncomeNet_iT_pp0p0_mtIILNzUXt_zADW9BYCXPA6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Investment income, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2024-01-01to2024-12-31" id="Fact000733" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">512,204</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2023-01-012023-12-31" id="Fact000734" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,157,625</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A5_zbSaJ1z5LZx2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000736" name="us-gaap:DerivativesAndFairValueTextBlock"><p id="xdx_807_eus-gaap--DerivativesAndFairValueTextBlock_z90s5e0CXOkd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.
<span id="xdx_82A_z7ti2co9pHGk">FAIR VALUES OF FINANCIAL INSTRUMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FASB
ASC Section 820, <i>Fair Value Measurements and Disclosures,</i> establishes a three-level hierarchy for fair value measurements which
requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The
three levels of inputs that may be used to measure fair value are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1: Quoted prices (unadjusted) or identical assets or liabilities in active markets that the entity has the ability to access as of the
measurement date;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices
in markets that are not active; or other inputs that are observable or can be corroborated by observable market data; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3: Significant unobservable inputs that reflect a reporting entity&#8217;s own assumptions that market participants would use in pricing
an asset or liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents and accounts payable are reflected in the consolidated balance sheets at their approximate estimated fair values
primarily due to their short-term nature. The fair values of securities available for sale are determined by relying on the securities&#8217;
relationship to other benchmark quoted securities and classified its investments as Level 2 items in both 2024 and 2023. There were no
transfers of assets or liabilities between Level 1 and Level 2 and no transfers in or out of Level 3 during the years ended December
31, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 96; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000738" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zKZ4VOdG6wd6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
and liabilities measured at fair value are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zJnndAhHH5V" style="display: none">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Active Markets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for Identical</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assets/Liabilities (Level 1)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable Inputs</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 2)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs<br/> (Level 3)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Recurring items as of December 31, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%; text-align: left">U.S. treasury obligations, available for sale</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zceD1u3nzxuf" title="U.S. treasury obligations, available for sale - Fair Value" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0740">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zXXAxtFvvFm5" title="U.S. treasury obligations, available for sale - Fair Value" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zuTQGnUuLv9l" title="U.S. treasury obligations, available for sale - Fair Value" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0744">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zy4foxjilXN" title="U.S. treasury obligations, available for sale - Fair Value" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Recurring items as of December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">U.S. treasury obligations, available for sale</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zywdXOLBVdLj" title="U.S. treasury obligations, available for sale - Fair Value" style="text-align: right"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_USTreasurySecuritiesMember" id="Fact000748" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,857,087</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_z9PG169Tbm41" title="U.S. treasury obligations, available for sale - Fair Value" style="text-align: right"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member_us-gaap_USTreasurySecuritiesMember" id="Fact000750" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,857,087</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zZmBwQPrcrK3" title="U.S. treasury obligations, available for sale - Fair Value" style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0752">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zobKQnGwO3Ci" title="U.S. treasury obligations, available for sale - Fair Value" style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0754">-</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zKmnBLp5zFC1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000756" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zx45VJL7crtc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.
<span id="xdx_820_zbmBu1IrWYpj">PROPERTY AND EQUIPMENT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000758" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zmOlp6UwTvgd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment at December 31, 2024 and 2023 consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B8_zj3I9xNoiaZ1" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20241231_ztMynUkEH0mc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20231231_zcW0s8XAC9u1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zc7JeGc0Hj4f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Machinery and equipment (<span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4kNSSdpEdah" title="Estimated useful life" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonNumeric contextRef="AsOf2024-12-31_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact000763" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span>-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zfrXNENf7Ye" title="Estimated useful life" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonNumeric contextRef="AsOf2024-12-31_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact000765" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span> year life)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-12-31_us-gaap_MachineryAndEquipmentMember" id="Fact000760" format="ixt:numdotdecimal" decimals="0" unitRef="USD">951,192</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember" id="Fact000761" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,055,192</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z3CoxXI5hCNh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Furniture and fixtures (<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zvc0pSnWHmll" title="Estimated useful life" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonNumeric contextRef="AsOf2024-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact000770" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span>-<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zxpPcHQ1Kavj" title="Estimated useful life" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonNumeric contextRef="AsOf2024-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact000772" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span> year life)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-12-31_us-gaap_FurnitureAndFixturesMember" id="Fact000767" format="ixt:numdotdecimal" decimals="0" unitRef="USD">167,351</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember" id="Fact000768" format="ixt:numdotdecimal" decimals="0" unitRef="USD">191,932</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zyFZFZLvQfw9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Leasehold improvements (<span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MinimumMember_zlSnyGFwysfj" title="Estimated useful life" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonNumeric contextRef="AsOf2024-12-31_us-gaap_LeaseholdImprovementsMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact000777" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span>-<span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MaximumMember_zgD8FhAwgKs3" title="Estimated useful life" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonNumeric contextRef="AsOf2024-12-31_us-gaap_LeaseholdImprovementsMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact000779" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span> year life)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-12-31_us-gaap_LeaseholdImprovementsMember" id="Fact000774" format="ixt:numdotdecimal" decimals="0" unitRef="USD">619,024</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_us-gaap_LeaseholdImprovementsMember" id="Fact000775" format="ixt:numdotdecimal" decimals="0" unitRef="USD">607,054</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzwDA_zwGd7tMJa6Qj" style="vertical-align: bottom; background-color: White">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
    and equipment gross</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-12-31" id="Fact000781" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,737,567</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31" id="Fact000782" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,854,178</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzwDA_z7VL7Xxs8i8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-12-31" id="Fact000784" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,196,295</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-12-31" id="Fact000785" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,102,272</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzwDA_zvMBbyyWPvdb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-12-31" id="Fact000787" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">541,272</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31" id="Fact000788" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">751,906</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zs4m0rG6Ceu5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000790" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_803_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zx4KChnwTsM6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
<span id="xdx_82C_zjYEatQKrdc8">OTHER ACCRUED LIABILITIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000792" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zE0zruNMp2J7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
accrued liabilities at December 31, 2024 and 2023 include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zRjvPPOH0rWa" style="display: none">SCHEDULE OF OTHER ACCRUED LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20241231_zhcb6QF9v0Zd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20231231_zLaOpZh06MUk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ContractualObligation_iI_maCz80K_zoiVYfAmyVTc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Amounts due to contract research organizations and other contractual agreements</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ContractualObligation" contextRef="AsOf2024-12-31" id="Fact000794" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,048,036</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ContractualObligation" contextRef="AsOf2023-12-31" id="Fact000795" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,442,659</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_maCz80K_z4q7nyKo0cN9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued payroll and related benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2024-12-31" id="Fact000797" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,945,111</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000798" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,693,383</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedProfessionalFeesCurrent_iI_maCz80K_zqQm09ZloMo1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2024-12-31" id="Fact000800" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2023-12-31" id="Fact000801" format="ixt:numdotdecimal" decimals="0" unitRef="USD">234,479</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maCz80K_zurJLkpqUzK2" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2024-12-31" id="Fact000803" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000804" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtCz80K_zjIFJsOXJr6h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-12-31" id="Fact000806" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,033,747</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000807" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,390,521</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zCDHdYnOP6Dj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000809" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_809_eus-gaap--DebtDisclosureTextBlock_ze4EH12B2o1f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.
<span id="xdx_821_z0sB8LFTqFoi">NOTES PAYABLE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
SVB Loan Facility</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 18, 2021, the Company entered into a $<span id="xdx_908_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn6n6_c20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_z1dwh8NMbA7k" title="Line of credit facility, maximum borrowing capacity"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2021-06-18_custom_SiliconValleyBankMember" id="Fact000811" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">10</ix:nonFraction></span> million loan facility (the &#8220;SVB Loan Facility&#8221;) with Silicon Valley Bank (&#8220;SVB&#8221;).
Imunon immediately drew down $<span id="xdx_90C_eus-gaap--ProceedsFromLinesOfCredit_pn6n6_c20210617__20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_znGztfgxmSC2" title="Proceeds from lines of credit"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" contextRef="From2021-06-172021-06-18_custom_SiliconValleyBankMember" id="Fact000813" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">6</ix:nonFraction></span> million from the SVB Loan Facility and used the funds to retire all outstanding indebtedness with Horizon
Technology Finance Corporation pursuant to a loan agreement entered into on June 27, 2018, under which the Company had drawn down $<span id="xdx_904_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn6n6_c20200831__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_z5Ivv2YivX6j" title="Loan amount withdrawn"><ix:nonFraction name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" contextRef="AsOf2020-08-31_custom_SiliconValleyBankMember" id="Fact000815" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">10</ix:nonFraction></span>
million and repaid $<span id="xdx_900_eus-gaap--RepaymentsOfLinesOfCredit_pn6n6_c20200801__20200831__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zXatBAv4Au2c" title="Repayments of lines of credit"><ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" contextRef="From2020-08-012020-08-31_custom_SiliconValleyBankMember" id="Fact000817" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">5</ix:nonFraction></span> million in August 2020. Concurrently with this transaction, the Company used $<span id="xdx_901_eus-gaap--RestrictedCash_iI_pn5n6_c20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zsspH5qRUHAk" title="Restricted cash"><ix:nonFraction name="us-gaap:RestrictedCash" contextRef="AsOf2021-06-18_custom_SiliconValleyBankMember" id="Fact000819" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">6.0</ix:nonFraction></span> million of other available funds
to establish a restricted cash account which served as security for the SVB Loan Facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 97; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SVB Loan Facility was in the form of money market secured indebtedness bearing interest at a calculated WSJ Prime-based variable rate.
A final payment equal to <span id="xdx_90A_ecustom--FinalPaymentPercentage_iI_pid_dp_uPure_c20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zPJ6tk3znYmi" title="Final payment percentage"><ix:nonFraction name="IMNN:FinalPaymentPercentage" contextRef="AsOf2021-06-18_custom_SiliconValleyBankMember" id="Fact000821" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3</ix:nonFraction></span>% of the total $<span id="xdx_90C_eus-gaap--LineOfCredit_iI_pn6n6_c20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_z8V8IToQRU27" title="Long term line of credit"><ix:nonFraction name="us-gaap:LineOfCredit" contextRef="AsOf2021-06-18_custom_SiliconValleyBankMember" id="Fact000823" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">10</ix:nonFraction></span> million commitment amount was due upon maturity or prepayment of the SVB Loan Facility.
There was no facility commitment fee, and no stock or warrants were issued to SVB. <span id="xdx_90C_eus-gaap--DebtInstrumentDescription_c20210617__20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zwn8kYX2YmG9" title="Debt instrument, description"><ix:nonNumeric contextRef="From2021-06-172021-06-18_custom_SiliconValleyBankMember" id="Fact000825" name="us-gaap:DebtInstrumentDescription">Payments under the loan agreement were interest only
for the first 24 months after loan closing, followed by a 24-month amortization period of principal and interest through the scheduled
maturity date.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the SVB Loan Facility, the Company incurred financing fees and expenses totaling $<span id="xdx_90E_eus-gaap--InterestAndDebtExpense_c20210617__20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zfKBBCnACjIb" title="Financing fees and expenses"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2021-06-172021-06-18_custom_SiliconValleyBankMember" id="Fact000827" format="ixt:numdotdecimal" decimals="0" unitRef="USD">243,370</ix:nonFraction></span> which was recorded and classified
as debt discount and was amortized as interest expense using the effective interest method over the life of the loan. Also, in connection
with the SVB Loan Facility, the Company was required to pay an end-of-term fee equal to <span id="xdx_90C_ecustom--EndOfTermChargePercentage_pid_dp_uPure_c20210617__20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zcXJp5mYWeYh" title="End of term charge percentage"><ix:nonFraction name="IMNN:EndOfTermChargePercentage" contextRef="From2021-06-172021-06-18_custom_SiliconValleyBankMember" id="Fact000829" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.0</ix:nonFraction></span>% of the original loan amount at time of maturity.
Therefore, these amounts totaling $<span id="xdx_907_eus-gaap--InterestExpense_c20210617__20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zS0xSqYHWVAf" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-06-172021-06-18_custom_SiliconValleyBankMember" id="Fact000831" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span> were amortized as interest expense using the effective interest method over the life of the
loan. During the year ended December 31, 2023, the Company incurred interest expense of $<span id="xdx_90F_eus-gaap--InterestExpenseDebt_c20230101__20231231__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zw2Nknyzc4ni" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2023-01-012023-12-31_custom_SiliconValleyBankMember" id="Fact000833" format="ixt:numdotdecimal" decimals="0" unitRef="USD">197,080</ix:nonFraction></span> and amortized $<span id="xdx_901_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_pp0p0_c20230101__20231231__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zpMGmQFfQE43" title="Amortization of debt issuance costs"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="From2023-01-012023-12-31_custom_SiliconValleyBankMember" id="Fact000835" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">329,158</ix:nonFraction></span>, as interest
expense for debt discounts and end-of-term fee in connection with the SVB Loan Facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000837" name="us-gaap:ScheduleOfDebtTableTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zTIxlDJfvCCj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 21, 2023, the Company repaid the outstanding principal balance, an early termination fee and the end-of-term charges in full satisfaction
of the SVB Loan Facility. The following is a schedule of the amounts paid to SVB on April 21, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_ziCUQQAoOYna" style="display: none">SCHEDULE OF DEBT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td id="xdx_49C_20230421_zU6pXR4OSoea" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--LineOfCreditFacilityFairValueOfAmountOutstanding_iI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_maLOCzybh_zLiwc0vJ4Goh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Principal balance at April 21, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right"><ix:nonFraction name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" contextRef="AsOf2023-04-21_custom_HorizonTechnologyFinanceCorporationMember" id="Fact000839" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,000,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--EarlyTerminationFee_iI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_maLOCzybh_z5yGTfguhCj2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Early termination fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="IMNN:EarlyTerminationFee" contextRef="AsOf2023-04-21_custom_HorizonTechnologyFinanceCorporationMember" id="Fact000841" format="ixt:numdotdecimal" decimals="0" unitRef="USD">120,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--EndOfTermCharges_iI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_maLOCzybh_zEwkqVLLB0N7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">End of term charges</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="IMNN:EndOfTermCharges" contextRef="AsOf2023-04-21_custom_HorizonTechnologyFinanceCorporationMember" id="Fact000843" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LineOfCredit_iTI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_mtLOCzybh_zeo9YYC4MpS3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total payoff amount</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LineOfCredit" contextRef="AsOf2023-04-21_custom_HorizonTechnologyFinanceCorporationMember" id="Fact000845" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,420,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_z90niu9X332" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2023, the Company recorded a loss of $<span id="xdx_90F_eus-gaap--GainLossOnContractTermination_c20230101__20231231__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_znYufO5KRXu3" title="Gain (loss) on contract termination"><ix:nonFraction name="us-gaap:GainLossOnContractTermination" contextRef="From2023-01-012023-12-31_custom_SiliconValleyBankMember" id="Fact000847" format="ixt:numdotdecimal" decimals="0" unitRef="USD">329,158</ix:nonFraction></span> on the early termination of the SVB Loan Facility which represented
the early termination fee and the end of the term fees, net of previously amortized interest expense totaling $<span id="xdx_901_eus-gaap--InterestExpense_c20230101__20231231__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zqWFOwIY756i" title="Interest expense debt"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-01-012023-12-31_custom_SiliconValleyBankMember" id="Fact000849" format="ixt:numdotdecimal" decimals="0" unitRef="USD">334,212</ix:nonFraction></span> on the date of
its payoff.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000851" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_803_eus-gaap--IncomeTaxDisclosureTextBlock_zhjIeR0tTFSa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.
<span id="xdx_823_zUua3GGe1zig">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000853" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zEtZntAdjWO7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax benefit for the years ended December 31, 2024 and 2023 consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B5_zoT2mr4aedKc" style="display: none">SCHEDULE OF INCOME TAX PROVISION (BENEFIT)</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20240101__20241231_zJ13oxA4MKr5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230101__20231231_zGCtj1PfqiO6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CurrentFederalTaxExpenseBenefit_maITEBzpPN_zZSsqGTL5El5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0855">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maITEBzpPN_zROJEDZ4oFvg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0859">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_maITEBzpPN_zsNPOZ7Uj9G9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State and Local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0861">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0862">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maITEBzpPN_zaVkmcGmtLPi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0865">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maITEBzpPN_zSQn9EcAazQ5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; padding-bottom: 1pt">Deferred</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0867">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="Fact000868" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,280,385</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left; width: 1%">)</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzpPN_zGBNikyFsVOb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0870">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="Fact000871" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,280,385</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zKiDMzrlEQMf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000873" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zOcjI0HUYhUc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the Company&#8217;s statutory tax rate to the effective rate for the years ended December 31, 2024 and 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BB_zRHdyxfQieWh" style="display: none">SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20240101__20241231_z4MfqOJasFKd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230101__20231231_zLOUNGZp5s54" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maEIT001_zSnQ2rFZBM8j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Federal statutory rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2024-01-01to2024-12-31" id="Fact000875" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.00</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2023-01-012023-12-31" id="Fact000876" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maEIT001_zuGwNqWaxq7i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State taxes, net of federal tax benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2024-01-01to2024-12-31" id="Fact000878" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.40</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2023-01-012023-12-31" id="Fact000879" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.1</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--EffectiveIncomeTaxRateReconciliationPermanentDifferences_pid_dp_uPure_maEIT001_ze1NMFbfZjhc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Permanent differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="IMNN:EffectiveIncomeTaxRateReconciliationPermanentDifferences" contextRef="From2024-01-01to2024-12-31" id="Fact000881" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">2.74</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="IMNN:EffectiveIncomeTaxRateReconciliationPermanentDifferences" contextRef="From2023-01-012023-12-31" id="Fact000882" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">3.1</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--EffectiveIncomeTaxRateReconciliationTimeUp_pid_dp_uPure_maEIT001_zQ8X9rRHvpHf" style="vertical-align: bottom; background-color: White">
    <td>True-Up</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="IMNN:EffectiveIncomeTaxRateReconciliationTimeUp" contextRef="From2024-01-01to2024-12-31" id="Fact000884" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.07</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="IMNN:EffectiveIncomeTaxRateReconciliationTimeUp" contextRef="From2023-01-012023-12-31" id="Fact000885" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">105.0</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maEIT001_zCD6t8UiOWY1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2024-01-01to2024-12-31" id="Fact000887" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.11</ix:nonFraction></td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2023-01-012023-12-31" id="Fact000888" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">2.9</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_maEIT001_z6nLsLcjWhBf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Rate Change</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" contextRef="From2024-01-01to2024-12-31" id="Fact000890" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.57</ix:nonFraction></td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0891">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate_pid_dp_uPure_maEIT001_zhq7Gs2R3kN9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred vs statutory rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">(<ix:nonFraction name="IMNN:EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate" contextRef="From2024-01-01to2024-12-31" id="Fact000893" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.75</ix:nonFraction></p></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0894">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--EffectiveIncomeTaxRateReconciliationSaleAndExpiration_pid_dp_uPure_maEIT001_z6em4UqgIS94" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expiration of NOLs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">(<ix:nonFraction name="IMNN:EffectiveIncomeTaxRateReconciliationSaleAndExpiration" contextRef="From2024-01-01to2024-12-31" id="Fact000896" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">17.51</ix:nonFraction></p></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0897">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maEIT001_zDh2FHlNRLOe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Change in valuation allowance and deferred rate change, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2024-01-01to2024-12-31" id="Fact000899" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">9.01</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2023-01-012023-12-31" id="Fact000900" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">89.0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_uPure_mtEIT001_zMgG0RgSABza" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0902">-</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2023-01-012023-12-31" id="Fact000903" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.1</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A3_zcDlUH27oNY9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 98; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000905" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z1rYeM2k69Qk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of the Company&#8217;s deferred tax asset as of December 31, 2024 and 2023 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BA_zUDCXVSy1E43" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20241231_zS9srSO4cn8a" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20231231_zV03sdyHJfn6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzVBe_zy3iHYw1xYLd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Net operating loss carryforwards</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2024-12-31" id="Fact000907" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">66,141,490</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2023-12-31" id="Fact000908" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,310,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DeferredTaxAssetsLegalAct_iI_pp0p0_maDTAGzVBe_z3ljGiepV6i1" style="vertical-align: bottom; background-color: White">
    <td>Section 174</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="IMNN:DeferredTaxAssetsLegalAct" contextRef="AsOf2024-12-31" id="Fact000910" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,482,099</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="IMNN:DeferredTaxAssetsLegalAct" contextRef="AsOf2023-12-31" id="Fact000911" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,929,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGzVBe_zZxzEcf50Qek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Other deferred tax assets, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2024-12-31" id="Fact000913" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,010,744</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2023-12-31" id="Fact000914" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,016,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzVBe_maDTANzv9R_zqu8M1QiHnh6" style="vertical-align: bottom; background-color: White">
    <td>Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2024-12-31" id="Fact000916" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">74,634,333</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2023-12-31" id="Fact000917" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">74,255,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzv9R_z8M94y7oICYf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2024-12-31" id="Fact000919" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">74,634,333</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-12-31" id="Fact000920" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">72,974,615</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzv9R_zthyYaKwBNg6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0922">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-12-31" id="Fact000923" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,280,385</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A3_zKr4rlbtJGb6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
evaluation of the realizability of such deferred tax assets in future periods is made based upon a variety of factors that affect
the Company&#8217;s ability to generate future taxable income, such as intent and ability to sell assets and historical and
projected operating performance. As of December 31, 2024, based on the Company&#8217;s history of earnings and its assessment of
future earnings, management believes that it is more likely than not future taxable income will not be sufficient to realize the
deferred tax assets. Therefore, full valuation allowance has been applied to deferred tax assets. At December 31, 2023, after its
evaluation of its New Jersey NOLs as discussed more fully below, the Company reduced the valuation reserve and recognized $<span id="xdx_902_ecustom--ProceedsFromSaleOfNetOperatingLosses_pn5n6_c20230101__20231231__srt--StatementGeographicalAxis__stpr--NJ_zDUeJHDQX6b5" title="Deferred income tax asset"><ix:nonFraction name="IMNN:ProceedsFromSaleOfNetOperatingLosses" contextRef="From2023-01-012023-12-31_stpr_NJ" id="Fact000925" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.3</ix:nonFraction></span>
million as a deferred income tax asset. Such tax assets are available to be recognized and benefit future periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024, the Company had federal net operating loss carry forwards of approximately $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z6F017paUaJ6"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2024-12-31_us-gaap_DomesticCountryMember" id="Fact000926" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">303</ix:nonFraction></span> million. If unused, will <span id="xdx_90C_ecustom--OperatingLossCarryforwardsExpirationDescription_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zYskvG7Nntp2" title="Operating losses expiration description"><ix:nonNumeric contextRef="From2024-01-012024-12-31_us-gaap_DomesticCountryMember" id="Fact000928" name="IMNN:OperatingLossCarryforwardsExpirationDescription">expire
starting in 2025 through 2037</ix:nonNumeric></span>. The federal NOLs generated for the years ended after 2017 of approximately $<span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20181231__us-gaap--IncomeTaxAuthorityAxis__custom--FederalIncomeTaxMember__srt--StatementScenarioAxis__custom--NoExpirationMember_zDoxjcUP3DM5"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2018-12-31_custom_FederalIncomeTaxMember_custom_NoExpirationMember" id="Fact000929" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">101</ix:nonFraction></span> million can be carried
forward indefinitely. As of December 31, 2024, the Company had state net operating loss carryforwards of approximately $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zBErChhcPG16" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2024-12-31_us-gaap_StateAndLocalJurisdictionMember" id="Fact000931" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">40</ix:nonFraction></span> million, net
of net operating losses utilized in prior years, and, if unused, will <span id="xdx_90B_ecustom--OperatingLossCarryforwardsExpirationDescription_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_ztpLCKPm7UPh" title="Operating loss carryforwards expiration description"><ix:nonNumeric contextRef="From2024-01-012024-12-31_us-gaap_StateAndLocalJurisdictionMember" id="Fact000933" name="IMNN:OperatingLossCarryforwardsExpirationDescription">expire starting in 2029 through 2043</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be
sustained upon examination by taxing authorities. As of December 31, 2024, and 2023, there were <span id="xdx_901_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20241231_zAm0NJzZ1Zy7" title="Unrecognized tax benefits"><span id="xdx_909_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zRJ2LbEHfSB5" title="Unrecognized tax benefits"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2024-12-31" id="Fact000935" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2023-12-31" id="Fact000937" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> unrecognized tax benefits. The Company
recognizes accrued interest and penalties as income tax expense. <span id="xdx_90E_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_do_c20240101__20241231_z11G9gloEBb" title="Payment of interest and penalties"><span id="xdx_904_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_do_c20230101__20231231_ziLxq3m14KB7" title="Payment of interest and penalties"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" contextRef="From2024-01-01to2024-12-31" id="Fact000939" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" contextRef="From2023-01-012023-12-31" id="Fact000941" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">No</ix:nonFraction></ix:nonFraction></span></span> amounts were accrued for the payment of interest and penalties at
December 31, 2024 and 2023. The Company is currently not aware of any issues under review that could result in significant payments,
accruals or material deviation from its position in the next year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sections
382 and 383 of the Internal Revenue Code provide for a limitation on the annual use of NOL and tax credit carryforwards following certain
ownership changes that could limit the Company&#8217;s ability to utilize these carryforwards. The Company has completed an analysis
to determine if such ownership changes have occurred and concluded it was more likely than not that there were changes in ownership.
Due to the existence of full valuation allowance, limitations under Section 382 and 383 will not impact the Company&#8217;s effective
tax rate. Further analyses will be performed prior to recognizing the benefits of any losses or credits in the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
for tax years beginning after December 31, 2021, taxpayers are required to capitalize any expenses incurred that are considered incidental
to research and experimentation (&#8220;R&amp;E&#8221;) activities under IRC Section 174. While taxpayers historically had the option
of deducting these expenses under IRC Section 174, the December 2017 Tax Cuts and Jobs Act mandates capitalization and amortization of
R&amp;E expenses for tax years beginning after December 31, 2021. <span id="xdx_908_eus-gaap--IncomeTaxExaminationDescription_c20240101__20241231_zSMGtleefBc9" title="Income tax examination, description"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000943" name="us-gaap:IncomeTaxExaminationDescription">Expenses incurred in connection with R&amp;E activities in the US must
be amortized over a 5-year period if incurred, and R&amp;E expenses incurred outside the US must be amortized over a 15-year period.
R&amp;E activities are broader in scope than qualified research activities considered under IRC Section 41 (relating to the research
tax credit). For the year ended December 31, 2024, the Company performed an analysis based on available guidance and determined that
it will continue to be in a loss position even after the required capitalization and amortization of its R&amp;E expenses. The Company
will continue to monitor this issue for future developments, but it does not expect R&amp;E capitalization and amortization to require
it to pay cash taxes now or in the near future. The Company&#8217;s income tax returns for 2020 to 2023 are still open and subject to
audit. In addition, net operating losses arising from prior years are also subject to examination at the time they are utilized in future
years.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 99; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Sale
of New Jersey Net Operating Losses</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
2018, the Company has annually submitted applications to sell a portion of the Company&#8217;s New Jersey NOLs as part of the Technology
Business Tax Certificate Program sponsored by The New Jersey Economic Development Authority. Under the program, emerging biotechnology
companies with unused NOLs and unused research and development credits are allowed to sell these benefits to other New Jersey-based companies.
As part of the Technology Business Tax Certificate Program, the Company sold $<span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_z65s9wpCqj3b"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-12-31_stpr_NJ_us-gaap_NewJerseyDivisionOfTaxationMember" id="Fact000944" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.3</ix:nonFraction></span> million of its New Jersey NOLs in 2023. The sale of
these net operating losses resulted in net proceeds to the Company of approximately $<span id="xdx_90D_ecustom--NetProceedsFromSaleOfNetOperatingLosses_pn5n6_c20240101__20241231__srt--StatementGeographicalAxis__stpr--NJ_zM7tCMf6cXz2" title="Net operating losses"><ix:nonFraction name="IMNN:NetProceedsFromSaleOfNetOperatingLosses" contextRef="From2024-01-012024-12-31_stpr_NJ" id="Fact000946" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.3</ix:nonFraction></span> million in 2024. During 2021, the New Jersey
State Legislature increased the maximum lifetime benefit per company from $<span id="xdx_90F_ecustom--NetProceedsFromSaleOfNetOperatingLosses_pn6n6_c20210101__20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MinimumMember__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zr7Iqfone3x8" title="Proceeds from sale"><ix:nonFraction name="IMNN:NetProceedsFromSaleOfNetOperatingLosses" contextRef="From2021-01-012021-12-31_stpr_NJ_srt_MinimumMember_us-gaap_StateAndLocalJurisdictionMember" id="Fact000948" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">15</ix:nonFraction></span> million to $<span id="xdx_90B_ecustom--NetProceedsFromSaleOfNetOperatingLosses_pn6n6_c20210101__20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MaximumMember__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zWSsYfr7oaBh" title="Proceeds from sale"><ix:nonFraction name="IMNN:NetProceedsFromSaleOfNetOperatingLosses" contextRef="From2021-01-012021-12-31_stpr_NJ_srt_MaximumMember_us-gaap_StateAndLocalJurisdictionMember" id="Fact000950" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">20</ix:nonFraction></span> million, which will allow the Company to
participate in this funding program in future years for up to an additional $<span id="xdx_904_eus-gaap--OperatingIncomeLoss_pn5n6_c20210101__20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MaximumMember_z7TRyvVk9GJd" title="Operating losses"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-012021-12-31_stpr_NJ_srt_MaximumMember" id="Fact000952" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.3</ix:nonFraction></span> million in net operating losses under this maximum lifetime
benefit.</span></p>
<!-- Field: Split-Segment; Name: 002 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000954" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zhTTnRONoUD4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.
<span id="xdx_829_zzpPZQLH4vbb">STOCKHOLDERS&#8217; EQUITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 15, 2024, the Company filed with the SEC a shelf registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;)
for the offer and sale of up to $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20240515__20240515_zvrhV7PqeBY1" title="Stock issued during period, value, new issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-05-152024-05-15" id="Fact000956" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">75</ix:nonFraction></span> million of its securities. The 2024 Registration Statement was declared effective on May 22, 2024.
The 2024 Registration Statement is intended to provide the Company with flexibility to raise capital in the future for general corporate
purposes. However, the Company&#8217;s ability to offer and sell its securities in a primary offering on the 2024 Registration Statement
is limited by General Instruction I.B.6 of Form S-3 (the &#8220;Baby Shelf Limitation&#8221;), which limits the amount that the Company
can offer to up to one-third of its public float during any trailing 12-month period. The Company would no longer be subject to the Baby
Shelf Limitation if its public float exceeds $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20240515__20240515_zvWgFQF3PgR9" title="Stock issued during period, value, new issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-05-152024-05-15" id="Fact000958" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">75</ix:nonFraction></span> million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">At
the Market Offering Agreement</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 15, 2024, the Company amended the At the Market Offering Agreement, dated as of May 25, 2022 (the &#8220;ATM Agreement&#8221;) with
H.C. Wainwright &amp; Co., LLC (&#8220;Wainwright&#8221;) as sales agent. Pursuant to the terms of the amended ATM Agreement, the Company
may offer and sell, from time to time, through Wainwright, shares of the Company&#8217;s common stock having an aggregate offering price
of up to $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240515__20240515__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_zT8Y2tPrzHA" title="Stock issued during period, value, new issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-05-152024-05-15_custom_AtTheMarketOfferingAgreementMember" id="Fact000960" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,500,000</ix:nonFraction></span>. The Company intends to use the net proceeds from any offering under the amended ATM Agreement for general corporate
purposes, including research and development activities, capital expenditures and working capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2024, the Company notified Wainwright that it was suspending its use of and terminating the &#8220;at the market offering&#8221;
sales agreement prospectus (the &#8220;ATM Prospectus&#8221;), related to the potential issuance from time to time of the Company&#8217;s
common stock pursuant to the ATM Agreement, by and between the Company and Wainwright. Notwithstanding the termination of the ATM Prospectus,
the ATM Agreement remains in full force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 3, 2024, the Company filed a new prospectus supplement to the 2024 Registration Statement with the SEC for an aggregate offering
price of up to $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20240903__20240903_zy68mZFebLN" title="Issuance of common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2024-09-032024-09-03" id="Fact000962" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,500,000</ix:nonFraction></span> related to the potential issuance from time to time of the Company&#8217;s common stock pursuant to the ATM
Agreement with Wainwright as sales agent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company sold <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240101__20241231__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_z1hPCovJa3Gi" title="Number of shares sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-01-012024-12-31_custom_AtTheMarketOfferingAgreementMember" id="Fact000964" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">88,796</ix:nonFraction></span>
shares of common stock under the ATM Agreement for net proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20240101__20241231__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_zl9vGpzZwyYi" title="Proceeds from sale of stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2024-01-012024-12-31_custom_AtTheMarketOfferingAgreementMember" id="Fact000966" format="ixt:numdotdecimal" decimals="0" unitRef="USD">99,506</ix:nonFraction></span>
during 2024. During 2023, the Company sold <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_zXvhdIIv0hU" title="Number of shares sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-01-012023-12-31_custom_AtTheMarketOfferingAgreementMember" id="Fact000968" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,878,488</ix:nonFraction></span>
shares of common stock under the ATM Agreement for net proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_zGyO5DiQSK6a" title="Proceeds from sale of stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2023-01-012023-12-31_custom_AtTheMarketOfferingAgreementMember" id="Fact000970" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,750,658</ix:nonFraction></span>. The Company sold <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250101__20250221__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zDtCnA8pkbpg" title="Number of shares sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2025-01-012025-02-21_custom_AtTheMarketOfferingAgreementMember_us-gaap_SubsequentEventMember" id="Fact000972" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">120,047</ix:nonFraction></span> shares of common stock under the ATM Agreement for net proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20250101__20250221__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zzuAdJhf9ef8" title="Proceeds from sale of stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2025-01-012025-02-21_custom_AtTheMarketOfferingAgreementMember_us-gaap_SubsequentEventMember" id="Fact000974" format="ixt:numdotdecimal" decimals="0" unitRef="USD">105,693</ix:nonFraction></span> from January
1, 2025 through February 21, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">July
2024 Offering</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2024, the Company entered into the July 2024 Purchase Agreement with the Purchasers, pursuant to which the Company issued, in
a registered direct offering, an aggregate of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240730__20240730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--JulyTwoThousandTwentyFourOfferingMember_zZlgbMEa4p31" title="Stock issued, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-07-302024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember" id="Fact000976" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,000</ix:nonFraction></span> shares of the Company&#8217;s common stock at an offering price of $<span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20240730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--JulyTwoThousandTwentyFourOfferingMember_z3qBAl2xsjBe" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember" id="Fact000978" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.00</ix:nonFraction></span> per
share for gross proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20240730__20240730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--JulyTwoThousandTwentyFourOfferingMember_z4vAUXEzhxoe" title="Proceeds from issuance of common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2024-07-302024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember" id="Fact000980" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">10.0</ix:nonFraction></span> million before the deduction of placement agent fees and offering expenses. In a concurrent private
placement and also pursuant to the July 2024 Purchase Agreement, the Company issued to the Purchasers the Warrants to purchase an aggregate
of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240730__20240730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--JulyTwoThousandTwentyFourOfferingMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAPOFpmLpmj5" title="Stock issued, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-07-302024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember_us-gaap_WarrantMember" id="Fact000982" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,000</ix:nonFraction></span> shares of its common stock at an exercise price of $<span id="xdx_908_eus-gaap--SharePrice_iI_pid_c20240730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--JulyTwoThousandTwentyFourOfferingMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNXWFqZv9jOb" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember_us-gaap_WarrantMember" id="Fact000984" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.00</ix:nonFraction></span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants became exercisable immediately after issuance for a term of five and one-half years following the date of issuance. The closing
of the July 2024 Offering occurred on August 1, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 100; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000986" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p id="xdx_80F_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zKTW4wR9HPki" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.
<span id="xdx_82B_zl3f96Iow6oa">STOCK-BASED COMPENSATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has long-term compensation plans that permit the granting of equity-based awards in the form of stock options, restricted stock,
restricted stock units, stock appreciation rights, other stock awards, and performance awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the 2018 Annual Stockholders Meeting of the Company held on May 15, 2018, stockholders approved the Imunon, Inc. 2018 Stock Incentive
Plan (the &#8220;2018 Plan&#8221;). The 2018 Plan, as adopted, permits the granting of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20180515__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember_zisEblMdRbu7" title="Share-based payment award, shares authorized"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="AsOf2018-05-15_custom_TwoThousandAndEighteenStockIncentivePlanMember" id="Fact000988" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></span> shares of Imunon common stock as equity
awards in the form of incentive stock options, nonqualified stock options, restricted stock, restricted stock units, stock appreciation
rights, other stock awards, performance awards, or in any combination of the foregoing. At the 2019 Annual Stockholders Meeting of the
Company held on May 14, 2019, stockholders approved an amendment to the 2018 Plan whereby the Company increased the number of common
stock shares available by <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20190514__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MinimumMember_zQe6P0ftFbri" title="Share based payment award, shares granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2019-05-14_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MinimumMember" id="Fact000990" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">80,000</ix:nonFraction></span> to a total of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20190514__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zcrS350VE0jc" title="Share based payment award, shares granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2019-05-14_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MaximumMember" id="Fact000992" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">260,000</ix:nonFraction></span> under the 2018 Plan, as amended. At the 2020 Annual Stockholders Meeting of the
Company held on June 15, 2020, stockholders approved an amendment to the 2018 Plan, as previously amended, whereby the Company increased
the number of shares of common stock available by <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20200615__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MinimumMember_z5ervcvjoxj2" title="Share based payment award, shares granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2020-06-15_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MinimumMember" id="Fact000994" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">166,667</ix:nonFraction></span> to a total of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20200615__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zl7Rrti3C4qj" title="Share based payment award, shares granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2020-06-15_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MaximumMember" id="Fact000996" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">426,667</ix:nonFraction></span> under the 2018 Plan, as amended. At the 2021 Annual Stockholders
Meeting of the Company held on June 10, 2021, stockholders approved an amendment to the 2018 Plan, as previously amended, whereby the
Company increased the number of shares of common stock available by <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210610__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MinimumMember_zEKnldVWLYD7" title="Share based payment award, shares granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-06-10_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MinimumMember" id="Fact000998" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">513,333</ix:nonFraction></span> to a total of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210610__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zBG8HOp8pJQa" title="Share based payment award, shares granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-06-10_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MaximumMember" id="Fact001000" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">940,000</ix:nonFraction></span> under the 2018 Plan, as amended. At
the 2023 Annual Stockholders Meeting of the Company held on June 14, 2023, stockholders approved an amendment to the 2018 Plan, as previously
amended, whereby the Company increased the number of shares of common stock available by <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230614__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MinimumMember_zFh6RVbIO76h" title="Share based payment award, shares granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2023-06-14_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MinimumMember" id="Fact001002" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,030,000</ix:nonFraction></span> to a total of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230614__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zB7Y9Ae3EAka" title="Share based payment award, shares granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2023-06-14_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MaximumMember" id="Fact001004" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,970,000</ix:nonFraction></span> under the
2018 Plan, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has issued stock awards to employees and directors in the form of stock options and restricted stock. <span id="xdx_90B_ecustom--StockOptionsStrikePriceDescription_c20240101__20241231__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember_z5kmYKZC7jT1" title="Stock options, strike price description"><ix:nonNumeric contextRef="From2024-01-012024-12-31_custom_TwoThousandAndEighteenStockIncentivePlanMember" id="Fact001006" name="IMNN:StockOptionsStrikePriceDescription">Options are generally granted
with strike prices equal to the fair market value of a share of Imunon common stock on the date of grant. Incentive stock options may
be granted to purchase shares of common stock at a price not less than 100% of the fair market value of the underlying shares on the
date of grant, provided that the exercise price of any incentive stock option granted to an eligible employee owning more than 10% of
the outstanding stock of Imunon must be at least 110% of such fair market value on the date of grant. Only officers and key employees
may receive incentive stock options.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
and restricted stock awards vest upon terms determined by the Compensation Committee of the Board of Directors and are subject to accelerated
vesting in the event of a change of control or certain terminations of employment. The Company issues new shares to satisfy its obligations
from the exercise of options or the grant of restricted stock awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024, the Compensation Committee of the Board of Directors approved the grant of inducement stock options (the &#8220;Inducement
Option Grants&#8221;) to purchase a total of <span id="xdx_909_eus-gaap--SharesIssued_iI_c20241231__us-gaap--PlanNameAxis__custom--InducementOptionGrantsMember__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhH9UK2TxXmg" title="Shares, Issued"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2024-12-31_custom_InducementOptionGrantsMember_srt_BoardOfDirectorsChairmanMember_us-gaap_CommonStockMember" id="Fact001008" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">110,000</ix:nonFraction></span> shares of Imunon common stock. Each award has a grant date of the date of grant.
Each Inducement Option Grant has a weighted exercise price of $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20241231__us-gaap--PlanNameAxis__custom--InducementOptionGrantsMember__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zeJsIzeu9XPk" title="Exercise price per share"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2024-01-012024-12-31_custom_InducementOptionGrantsMember_srt_BoardOfDirectorsChairmanMember" id="Fact001010" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.02</ix:nonFraction></span> per share. Each Inducement Option Grant vests over four years, with
one-fourth vesting on the one-year anniversary of the employee&#8217;s first day of employment with the Company and one-fourth vesting
on the second, third and fourth anniversaries thereafter, subject to the new employee&#8217;s continued service relationship with the
Company on each such date. Each Inducement Option Grant has a ten-year term and is subject to the terms and conditions of the applicable
stock option agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024, there were a total of <span id="xdx_909_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20241231__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember_zNbo5GHMqnOk" title="Common stock, reserved for future issuance"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2024-12-31_custom_TwoThousandAndEighteenStockIncentivePlanMember" id="Fact001012" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,975,073</ix:nonFraction></span> shares of Imunon common stock reserved for issuance under the 2018 Plan, which
were comprised of <span id="xdx_900_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20241231__us-gaap--AwardTypeAxis__custom--EquityStockAwardsMember__srt--StatementScenarioAxis__custom--GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember_zJHHakkPzZba" title="Common stock, reserved for future issuance"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2024-12-31_custom_EquityStockAwardsMember_custom_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember" id="Fact001014" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,555,073</ix:nonFraction></span> shares of Imunon common stock subject to equity awards previously granted under the 2018 Plan and 2007 Plan
and <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20241231__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember_zLrj9bSYFSMk" title="Shares available for issuance"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2024-12-31_custom_TwoThousandAndEighteenStockIncentivePlanMember" id="Fact001016" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">420,000</ix:nonFraction></span> shares of Imunon common stock available for future issuance under the 2018 Plan. As of December 31, 2024, there are a total
of <span id="xdx_90A_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20241231__us-gaap--AwardTypeAxis__custom--InducementAwardsMember_zrqjMOEvC972" title="Common stock, reserved for future issuance"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2024-12-31_custom_InducementAwardsMember" id="Fact001018" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">130,500</ix:nonFraction></span> shares of Imunon common stock subject to outstanding inducement awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
compensation cost related to stock options and restricted stock awards was approximately $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240101__20241231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember_zZKr7Xbk0Ly7" title="Share based compensation"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-012024-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember" id="Fact001020" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.5</ix:nonFraction></span> million and $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20231231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember_zMm4JRhZcZMh" title="Share based compensation"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember" id="Fact001022" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.8</ix:nonFraction></span> million during 2024 and
2023, respectively. Of these amounts, $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240101__20241231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zvFiZ55Q4zy4" title="Share based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-012024-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember_us-gaap_ResearchAndDevelopmentExpenseMember" id="Fact001024" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.3</ix:nonFraction></span> million and $<span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20231231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zdMi7N3N3dGl" title="Share based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember_us-gaap_ResearchAndDevelopmentExpenseMember" id="Fact001026" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.2</ix:nonFraction></span> million were charged to research and development expenses during 2024 and
2023, respectively, and $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240101__20241231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zM6kUoHiDdr4" title="Share based compensation"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-012024-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001028" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.2</ix:nonFraction></span> million and $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20231231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_z59MNpv4F4Uh" title="Share based compensation"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001030" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.6</ix:nonFraction></span> million were charged to general and administrative expenses during 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 101; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001032" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z8l0Ay4zzcI7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of stock option awards as of December 31, 2024 and changes during the two-year period ended December 31, 2024 is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B2_zRT355IYq1Rk" style="display: none">SUMMARY OF STOCK OPTIONS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Stock Options</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average<br/>
 Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average<br/>
 Remaining<br/>
 Contractual<br/>
 Term (years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate<br/>

Intrinsic Value</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zNJMXarr63H6" title="Number Outstanding, Outstanding, Beginning balance" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001034" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">760,220</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z4eNJRRL00yl" title="Weighted Average Exercise Price, Outstanding, Beginning balance" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001036" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.55</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zjlUlgrQXE1b" title="Number Outstanding, Options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001038" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">432,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z86IZFDQBwmc" title="Weighted Average Exercise Price, Options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001040" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.23</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Options canceled or expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z0qzbteOkC7h" title="Number Outstanding, Options canceled or expired" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001042" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">129,238</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zjMKEcOzuJij" title="Weighted Average Exercise Price, Options canceled or expired" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001044" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.37</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z41s54Q7FPA" title="Number Outstanding, Outstanding, Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001046" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,063,482</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zZZKG3Pnf601" title="Weighted Average Exercise Price, Outstanding, Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001048" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.61</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGnmgQ5m4mDd" title="Number Outstanding, Options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2024-01-012024-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001050" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,051,835</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zB9aU3mYf3Ig" title="Weighted Average Exercise Price, Options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2024-01-012024-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001052" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Options canceled or expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zdk0cT81T7Y7" title="Number Outstanding, Options canceled or expired" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2024-01-012024-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001054" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">469,444</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zXIQ6eKuWvRd" title="Weighted Average Exercise Price, Options canceled or expired" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2024-01-012024-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001056" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.58</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Outstanding at December 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zB9YdanU429a" title="Number Outstanding, Outstanding, Ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001058" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,645,873</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zPgcGEuAWKs6" title="Weighted Average Exercise Price, Outstanding, Ending balance" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001060" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.95</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z7KqOTDF2zhh" title="Weighted Average Remaining Contractual Term (years), Outstanding, Ending balance"><ix:nonNumeric contextRef="From2024-01-012024-12-31_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear" id="Fact001062" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">8.8</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pp0p0_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z80FYQgd8joc" title="Aggregate Intrinsic Value, Outstanding, Ending balance" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2024-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001064" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,476</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Exercisable at December 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z34A130IUop3" title="Number Outstanding, Exercisable, Ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001066" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">907,723</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zbos3BQsD5nd" title="Weighted Average Exercise Price, Exercisable, Ending balance" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2024-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001068" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.58</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_ztNEf6U3r8Ya" title="Weighted Average Remaining Contractual Term (years), Exercisable, Ending balance"><ix:nonNumeric contextRef="From2024-01-012024-12-31_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear" id="Fact001070" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">8.3</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zzovtrSpQvGb" title="Aggregate Intrinsic Value, Exercisable, Ending balance" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2024-12-31_us-gaap_EmployeeStockOptionMember" id="Fact001072" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,299</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zCZImOcaKF7l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001074" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_z4CQpCRPhkib" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the status of the Company&#8217;s non-vested restricted stock awards as of December 31, 2024 and changes during the two-year
period ended December 31, 2024, is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zNlHSt0omjU6" style="display: none">SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Restricted Stock</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
                                                                               Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant Date</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Non-vested stock awards outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20231231_zrAa5r7ijF47" title="Number Outstanding, Non-vested stock awards, Outstanding, Beginning balance" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2022-12-31" id="Fact001076" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">69,650</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20231231_z4GTYcL6ZXYf" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Beginning balance" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2022-12-31" id="Fact001078" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.92</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231_z9Wjq5p9onjg" title="Number Outstanding, Non-vested stock awards, Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="From2023-01-012023-12-31" id="Fact001080" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">22,100</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231_zb9Og7xe4Mce" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-01-012023-12-31" id="Fact001082" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.92</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vested and issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20231231_zVQ1h5tySgp6" title="Number Outstanding, Non-vested stock awards, Vested and issued" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2023-01-012023-12-31" id="Fact001084" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59,450</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231_zrVzDHqAA35d" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Vested and issued" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-01-012023-12-31" id="Fact001086" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.91</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20230101__20231231_zLm1EdDMhxu7" title="Number Outstanding, Non-vested stock awards, Forfeited" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="From2023-01-012023-12-31" id="Fact001088" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20231231_z3EprKT964d5" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Forfeited" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="From2023-01-012023-12-31" id="Fact001090" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.60</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Non-vested stock awards outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20240101__20241231_zzlYQPS5wAod" title="Number Outstanding, Non-vested stock awards, Outstanding, Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2023-12-31" id="Fact001092" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">32,100</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20240101__20241231_zQvn5ShkEkNb" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2023-12-31" id="Fact001094" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.23</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240101__20241231_zqOa9UhzjXmk" title="Number Outstanding, Non-vested stock awards, Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="From2024-01-01to2024-12-31" id="Fact001096" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">39,700</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240101__20241231_zcYZqQzgWbq9" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2024-01-01to2024-12-31" id="Fact001098" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.99</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vested and issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20240101__20241231_zjd1ppaRNEB4" title="Number Outstanding, Non-vested stock awards, Vested and issued" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2024-01-01to2024-12-31" id="Fact001100" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,100</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20240101__20241231_zAvVVdZq9Mff" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Vested and issued" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="From2024-01-01to2024-12-31" id="Fact001102" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.84</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20240101__20241231_z0WgeoM8sAB4" title="Number Outstanding, Non-vested stock awards, Forfeited" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="From2024-01-01to2024-12-31" id="Fact001104" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20240101__20241231_zrr4LewQ5dU4" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Forfeited" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="From2024-01-01to2024-12-31" id="Fact001106" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.88</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Non-vested stock awards outstanding at December 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20240101__20241231_za3je5nz976l" title="Number Outstanding, Non-vested stock awards, Outstanding, Ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2024-12-31" id="Fact001108" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">39,700</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20240101__20241231_zT4qcQ0aRKma" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2024-12-31" id="Fact001110" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.99</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_z68OMfuXKA23" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001112" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z4uMi7arfhc6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of stock options outstanding at December 31, 2024 by price range is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_zFWKO5JmzFB2" style="display: none">SUMMARY OF STOCK OPTIONS OUTSTANDING</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options Exercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Range of Exercise Prices</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Contractual Term (in years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
                                                                               Average Remaining Contractual Term (in years)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">Up to $<span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zC2EgXvNdui6" title="Range of Exercise Prices, Upper"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2024-01-012024-12-31_custom_ExercisePriceOneMember" id="Fact001114" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.50</ix:nonFraction></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zOABDZXKzbz1" title="Options Outstanding, Number" style="width: 8%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-12-31_custom_ExercisePriceOneMember" id="Fact001116" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,250,252</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zBS2gZE4ARnl" title="Options Outstanding, Weighted Average Remaining Contractual Term (in years)"><ix:nonNumeric contextRef="From2024-01-012024-12-31_custom_ExercisePriceOneMember" format="ixt-sec:duryear" id="Fact001118" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">9.3</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zLwlTvB5X1Nc" title="Options Outstanding, Weighted Average Exercise Price" style="width: 8%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-12-31_custom_ExercisePriceOneMember" id="Fact001120" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.15</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zUyBq80VkaDg" title="Options Exercisable, Number" style="width: 8%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-12-31_custom_ExercisePriceOneMember" id="Fact001122" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">513,433</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zjg2C1U2Uqoj" title="Options Exercisable, Weighted Average Remaining Contractual Term (in years)"><ix:nonNumeric contextRef="From2024-01-012024-12-31_custom_ExercisePriceOneMember" format="ixt-sec:duryear" id="Fact001124" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">9.1</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zZPCgkp8keJe" title="Options Exercisable, Weighted Average Exercise Price" style="width: 8%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2024-12-31_custom_ExercisePriceOneMember" id="Fact001126" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.13</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>$<span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zVWu8UBrqpA1" title="Range of Exercise Prices, Lower"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2024-01-012024-12-31_custom_ExercisePriceTwoMember" id="Fact001128" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.51</ix:nonFraction></span> to $<span id="xdx_905_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_z8dizvnAXnRj" title="Range of Exercise Prices, Upper"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2024-01-012024-12-31_custom_ExercisePriceTwoMember" id="Fact001130" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.50</ix:nonFraction></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zJYbSSVN4667" title="Options Outstanding, Number" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-12-31_custom_ExercisePriceTwoMember" id="Fact001132" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">207,345</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zCIRvRAsVSl" title="Options Outstanding, Weighted Average Remaining Contractual Term (in years)"><ix:nonNumeric contextRef="From2024-01-012024-12-31_custom_ExercisePriceTwoMember" format="ixt-sec:duryear" id="Fact001134" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">7.5</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zz61uMkY9wL4" title="Options Outstanding, Weighted Average Exercise Price" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-12-31_custom_ExercisePriceTwoMember" id="Fact001136" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.93</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zTahOV2subqg" title="Options Exercisable, Number" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-12-31_custom_ExercisePriceTwoMember" id="Fact001138" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">206,289</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zaw6ZHbbKA8j" title="Options Exercisable, Weighted Average Remaining Contractual Term (in years)"><ix:nonNumeric contextRef="From2024-01-012024-12-31_custom_ExercisePriceTwoMember" format="ixt-sec:duryear" id="Fact001140" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">7.5</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zMVRzkiZWrSf" title="Options Exercisable, Weighted Average Exercise Price" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2024-12-31_custom_ExercisePriceTwoMember" id="Fact001142" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.93</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Above $<span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_z9j5NnQlDsN2" title="Range of Exercise Prices, Upper"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2024-01-012024-12-31_custom_ExercisePriceThreeMember" id="Fact001144" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.51</ix:nonFraction></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zsNUpLwp6gQ7" title="Options Outstanding, Number" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-12-31_custom_ExercisePriceThreeMember" id="Fact001146" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">188,276</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zNBVjGePI7t4" title="Options Outstanding, Weighted Average Remaining Contractual Term (in years)"><ix:nonNumeric contextRef="From2024-01-012024-12-31_custom_ExercisePriceThreeMember" format="ixt-sec:duryear" id="Fact001148" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">6.9</ix:nonNumeric></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zyB1BcHBruH9" title="Options Outstanding, Weighted Average Exercise Price" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-12-31_custom_ExercisePriceThreeMember" id="Fact001150" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.28</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_ztBKsnFquL5" title="Options Exercisable, Number" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-12-31_custom_ExercisePriceThreeMember" id="Fact001152" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">188,001</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zosgcMRbfIA8" title="Options Exercisable, Weighted Average Remaining Contractual Term (in years)"><ix:nonNumeric contextRef="From2024-01-012024-12-31_custom_ExercisePriceThreeMember" format="ixt-sec:duryear" id="Fact001154" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">6.9</ix:nonNumeric></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zwwVWasmmWVi" title="Options Exercisable, Weighted Average Exercise Price" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2024-12-31_custom_ExercisePriceThreeMember" id="Fact001156" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.27</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231_zJSATgPb4Zs2" title="Options Outstanding, Number" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-12-31" id="Fact001158" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,645,873</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231_zWWsWlE1Ojlk" title="Options Exercisable, Number" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-12-31" id="Fact001160" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">907,723</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zuLCI1C6AI73" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 102; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001162" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zRn1E7vsrxu" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair values of stock options granted were estimated at the date of grant using the Black-Scholes option pricing model. The Black-Scholes
model was originally developed for use in estimating the fair value of traded options, which have different characteristics from Imunon&#8217;s
stock options. The model is also sensitive to changes in assumptions, which can materially affect the fair value estimate. The Company
used the following assumptions for determining the fair value of options granted under the Black-Scholes option pricing model:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B6_znVN2aMnFbve" style="display: none">SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Year Ended December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20241231_zGTyUNEaqw6b" title="Risk-free interest rate, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2024-01-01to2024-12-31" id="Fact001164" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.72</ix:nonFraction></span>%
to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20241231_zOkmyCvW4FMc" title="Risk-free interest rate, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-01-01to2024-12-31" id="Fact001166" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.50</ix:nonFraction></span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231_zrRrmc9xZQkl" title="Risk-free interest rate, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2023-01-012023-12-31" id="Fact001168" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.39</ix:nonFraction></span>
% to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231_zpbW6ynBzo7j" title="Risk-free interest rate, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2023-01-012023-12-31" id="Fact001170" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.81</ix:nonFraction></span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20240101__20241231_zxlHAtQoGwc" title="Expected volatility, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2024-01-01to2024-12-31" id="Fact001172" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">101.7</ix:nonFraction></span>% to <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20240101__20241231_zYeGq2RjFJhi" title="Expected volatility, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2024-01-01to2024-12-31" id="Fact001174" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">115.8</ix:nonFraction></span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20231231_zsio7YMyPY4f" title="Expected volatility, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2023-01-012023-12-31" id="Fact001176" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100.0</ix:nonFraction></span>%
to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20231231_zTpLuGyWtvTi" title="Expected volatility, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2023-01-012023-12-31" id="Fact001178" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">113.6</ix:nonFraction></span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected life (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231__srt--RangeAxis__srt--MinimumMember_zk09D2exgTjh" title="Expected life (in years)"><ix:nonNumeric contextRef="From2024-01-012024-12-31_srt_MinimumMember" format="ixt-sec:duryear" id="Fact001180" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">7.5</ix:nonNumeric></span> to <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231__srt--RangeAxis__srt--MaximumMember_zFbDBv8hAmL6" title="Expected life (in years)"><ix:nonNumeric contextRef="From2024-01-012024-12-31_srt_MaximumMember" format="ixt-sec:duryear" id="Fact001182" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">10</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zVFdjiTdvoj9" title="Expected life (in years)"><ix:nonNumeric contextRef="From2023-01-012023-12-31_srt_MinimumMember" format="ixt-sec:duryear" id="Fact001184" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">7.5</ix:nonNumeric></span> to <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zwtWbIOu3Ywf" title="Expected life (in years)"><ix:nonNumeric contextRef="From2023-01-012023-12-31_srt_MaximumMember" format="ixt-sec:duryear" id="Fact001186" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">10</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Expected dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240101__20241231_zL7AaJc4Rar7" title="Expected dividend yield" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2024-01-01to2024-12-31" id="Fact001188" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231_zrkO6QxHlKh5" title="Expected dividend yield" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-01-012023-12-31" id="Fact001190" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><p id="xdx_8A2_zTr8D98efn3c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
volatilities utilized in the model are based on historical volatility of the Company&#8217;s stock price. As of December 31, 2024, there
was $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pn5n6_c20241231_zViXpu5K4stj" title="Unrecognized compensation cost related to non-vested stock-based compensation arrangements"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="AsOf2024-12-31" id="Fact001192" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.5</ix:nonFraction></span> million of total unrecognized compensation cost related to non-vested stock-based compensation arrangements. That cost is expected
to be recognized over a weighted-average period of <span id="xdx_905_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20240101__20241231_z6SnXkh9HZy9" title="Cost recognized over a weighted-average period"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt-sec:duryear" id="Fact001194" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">1.4</ix:nonNumeric></span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001196" name="IMNN:WarrantsTextBlock"><p id="xdx_800_ecustom--WarrantsTextBlock_zXIZYjpljPK1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.
<span id="xdx_822_zNB7aZ50AHzj">WARRANTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s
specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity (&#8220;ASC 480&#8221;),
and ASC 815, Derivatives and Hedging (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial
instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements
for equity classification under ASC 815, including whether the warrants are indexed to the Company&#8217;s own common stock, among other
conditions for equity classification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly
period end date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component
of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification,
the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter.
The Company has analyzed the Warrants issued in the July 2024 Offering and determined they are considered to be freestanding instruments
and do not exhibit any of the characteristics in ASC 480 and therefore are not classified as liabilities under ASC 480. The Warrants
meet all of the requirements for equity classification under ASC 815 and therefore are classified as equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001198" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zJ2ZnTFgCM0c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
is a summary of all warrant activity for the two years ended December 31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_z2F2T7VOb049" style="display: none">SUMMARY OF WARRANT ACTIVITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of<br/>
 Warrants Issued</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
                                                                               Average</b></span></p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
                                                                               Price</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Warrants outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20231231_fKg_____z34bE1wU0zL8" title="Number of Warrants Issued, Warrants outstanding, Beginning balance" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-12-31" id="Fact001200" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">168,519</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_zcKF45NV6RBd" title="Weighted Average Exercise Price, Warrants outstanding, Beginning balance" style="width: 16%; text-align: right"><ix:nonFraction name="IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31" id="Fact001202" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">19.78</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrants issued during 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20241231_zeMEUKZYq7Ba" title="Number of Warrants Issued, Warrants issued" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2024-01-01to2024-12-31" id="Fact001204" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice_c20240101__20241231_zgdqQZqWLjAf" title="Weighted Average Exercise Price, Warrants issued" style="text-align: right"><ix:nonFraction name="IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice" contextRef="From2024-01-01to2024-12-31" id="Fact001206" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.00</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Warrants expired during 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20230101__20231231_zYc1C5iqDFk7" title="Number of Warrants Issued, warrants expired" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2023-01-012023-12-31" id="Fact001208" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,459</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231_zkTJAkmi1rl8" title="Weighted Average Exercise Price, Warrants expired" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-12-31" id="Fact001210" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">37.29</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants outstanding and exercisable at December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20240101__20241231_fKg_____z5lebPFRBBci" title="Number of Warrants Issued, Warrants outstanding, Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2023-12-31" id="Fact001212" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">160,060</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20240101__20241231_zCdsBv4AEEE4" title="Weighted Average Exercise Price, Warrants outstanding, Beginning balance" style="text-align: right"><ix:nonFraction name="IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-12-31" id="Fact001214" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.86</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrants issued during 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20241231_zoyRFWBjB1p7" title="Number of Warrants Issued, Warrants issued" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2024-01-01to2024-12-31" id="Fact001216" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice_c20240101__20241231_zxLHC3wAQTI6" title="Weighted Average Exercise Price, Warrants issued" style="text-align: right"><ix:nonFraction name="IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice" contextRef="From2024-01-01to2024-12-31" id="Fact001218" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.00</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Warrants expired during 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20240101__20241231_zti0AXQom2y7" title="Number of Warrants Issued, Warrants expired" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2024-01-01to2024-12-31" id="Fact001220" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20241231_zLqFJVD2qeo4" title="Weighted Average Exercise Price, Warrants expired" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2024-01-01to2024-12-31" id="Fact001222" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.85</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Warrants outstanding and exercisable at December 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20240101__20241231_ztWbPxwDd6b6" title="Number of Warrants Issued, Warrants outstanding, Ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2024-12-31" id="Fact001224" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,155,060</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_c20240101__20241231_zys4QATDg5dk" title="Weighted Average Exercise Price, Warrants outstanding, Ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-12-31" id="Fact001226" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.51</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Aggregate intrinsic value of outstanding warrants at December 31, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iI_pp0p0_c20241231_zgqrkSeOdIW8" title="Aggregate intrinsic value of outstanding warrants"><span style="-sec-ix-hidden: xdx2ixbrl1228">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted average remaining contractual terms (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_fKg_____zwIguOVwLCRg" title="Weighted average remaining contractual terms (years)"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt-sec:duryear" id="Fact001230" name="IMNN:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2">5.0</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zf5qazZbbxV8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 103; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001232" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock"><p id="xdx_805_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zSjUR1FgFAL" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.
<span id="xdx_821_zYk7fPUfNDhh">IMUNON EMPLOYEE BENEFIT PLANS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon
maintains a defined-contribution plan under Section 401(k) of the Code. The plan covers substantially all employees over the age of twenty-one.
Participating employees may defer a portion of their pretax earnings, up to the IRS annual contribution limit. The Company makes a matching
contribution up to a maximum of <span id="xdx_906_eus-gaap--DefinedContributionPlanEmployerMatchingContributionPercent_pid_dp_uPure_c20240101__20241231_ztJDzsccaFW3" title="Maximum annual contributions per employee, percent"><ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" contextRef="From2024-01-01to2024-12-31" id="Fact001234" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3</ix:nonFraction></span>% of an employee&#8217;s annual salary. The Company&#8217;s total matching contributions for the year
ended December 31, 2024 and 2023 were $<span id="xdx_909_eus-gaap--DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_pp0p0_c20240101__20241231_z41gkPYRqotl" title="Matching contributions of employee"><ix:nonFraction name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount" contextRef="From2024-01-01to2024-12-31" id="Fact001236" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">62,000</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_pp0p0_c20230101__20231231_zgsDODgfjLLk" title="Matching contributions of employee"><ix:nonFraction name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount" contextRef="From2023-01-012023-12-31" id="Fact001238" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">142,000</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001240" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_809_eus-gaap--LesseeOperatingLeasesTextBlock_zr6s4i8EpNMk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.
<span id="xdx_823_zCqeCRmmZC83">LEASES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
New Jersey Lease</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2023, the Company renewed its Lawrenceville office lease for a <span id="xdx_903_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtM_c20230831_zcJCAZqi6Zbf" title="Operating lease, term"><ix:nonNumeric contextRef="AsOf2023-08-31" format="ixt-sec:durmonth" id="Fact001242" name="us-gaap:LesseeOperatingLeaseTermOfContract">24</ix:nonNumeric></span>-month agreement for <span id="xdx_901_eus-gaap--AreaOfLand_iI_pp0p0_usqrt_c20230831__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zcbWGLq8W29c" title="Area of land"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2023-08-31_custom_LeaseAgreementMember" id="Fact001244" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="sqrt">9,850</ix:nonFraction></span> square feet with monthly rent payments
of approximately $<span id="xdx_909_eus-gaap--PaymentsForRent_pp0p0_c20230801__20230831__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zPClH1MhBFOd" title="Payments for rent"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2023-08-012023-08-31_custom_LeaseAgreementMember_srt_MinimumMember" id="Fact001246" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,983</ix:nonFraction></span> to $<span id="xdx_906_eus-gaap--PaymentsForRent_pp0p0_c20230801__20230831__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zKwimQSDSEye" title="Payments for rent"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2023-08-012023-08-31_custom_LeaseAgreementMember_srt_MaximumMember" id="Fact001248" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,394</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Huntsville,
Alabama Lease</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2023, the Company renewed its Huntsville facility lease for a <span id="xdx_90D_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtM_c20230131_zKCXv94E01dk" title="Operating lease, term"><ix:nonNumeric contextRef="AsOf2023-01-31" format="ixt-sec:durmonth" id="Fact001250" name="us-gaap:LesseeOperatingLeaseTermOfContract">60</ix:nonNumeric></span>-month lease agreement for <span id="xdx_90B_eus-gaap--AreaOfLand_iI_pp0p0_usqrt_c20230131__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zHJP1JD2Jaeb" title="Area of land"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2023-01-31_custom_LeaseAgreementMember" id="Fact001252" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="sqrt">11,420</ix:nonFraction></span> square feet with monthly rent
payments of approximately $<span id="xdx_90D_eus-gaap--PaymentsForRent_pp0p0_c20230101__20230131__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zKoMycPK3NAl" title="Payments for rent"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2023-01-012023-01-31_custom_LeaseAgreementMember_srt_MinimumMember" id="Fact001254" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,550</ix:nonFraction></span> to $<span id="xdx_901_eus-gaap--PaymentsForRent_pp0p0_c20230101__20230131__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember__srt--RangeAxis__srt--MaximumMember_z16RY8z5Wusg" title="Payments for rent"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2023-01-012023-01-31_custom_LeaseAgreementMember_srt_MaximumMember" id="Fact001256" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,903</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001258" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><p id="xdx_89C_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zTtl57qOKdca" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a table of the lease payments and maturity of the Company&#8217;s operating lease liabilities as of December 31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zk0OYEyekFtj" style="display: none">SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20241231_zlwmB1L5fH14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ending December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzy9p_z8U9WnNpaBub" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">2025</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2024-12-31" id="Fact001260" format="ixt:numdotdecimal" decimals="0" unitRef="USD">543,009</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzy9p_zFGm5DMTnwre" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2024-12-31" id="Fact001262" format="ixt:numdotdecimal" decimals="0" unitRef="USD">362,976</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzy9p_zW6RfUsRkspe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2024-12-31" id="Fact001264" format="ixt:numdotdecimal" decimals="0" unitRef="USD">370,235</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter_iI_maLOLLPzy9p_z9aKaq1ytOM5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">2028 and thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="IMNN:LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter" contextRef="AsOf2024-12-31" id="Fact001266" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,904</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzy9p_maOLLz45C_maOLLzlbh_zotiXEslMm4f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Subtotal future lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2024-12-31" id="Fact001268" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,307,124</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zdcmyBRBBK01" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less imputed interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2024-12-31" id="Fact001270" format="ixt:numdotdecimal" decimals="0" unitRef="USD">167,831</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingLeaseLiability_iI_zv06nHSZ7uk6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Total lease liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2024-12-31" id="Fact001272" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,139,293</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Weighted average remaining life</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_z9wC3KQMMn5d" title="Operating lease, weighted average remaining lease term"><ix:nonNumeric contextRef="AsOf2024-12-31" format="ixt-sec:duryear" id="Fact001274" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">2.7</ix:nonNumeric></span> years </span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average discount rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20241231_zVcwOso1kwV3" title="Operating lease, weighted average discount rate, percent" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2024-12-31" id="Fact001276" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.98</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zLcEcZhZqQC7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discount rate used was the Company&#8217;s incremental borrowing rate, which is <span id="xdx_90B_ecustom--OperatingLeasesIncrementalBorrowingRate_iI_dp_uPure_c20241231_zQXoKyHKJ8n2" title="Incremental borrowing rate"><ix:nonFraction name="IMNN:OperatingLeasesIncrementalBorrowingRate" contextRef="AsOf2024-12-31" id="Fact001278" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.98</ix:nonFraction></span>%, as the Company could not determine the rate implicit
in the lease.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
2024, operating lease expense was $<span id="xdx_901_eus-gaap--OperatingLeaseCost_pp0p0_c20240101__20241231_zs0Fnfs0F3O3" title="Operating lease, cost"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2024-01-01to2024-12-31" id="Fact001280" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">652,166</ix:nonFraction></span> and cash paid for operating leases included in operating cash flows was $<span id="xdx_902_eus-gaap--OperatingLeasePayments_pp0p0_c20240101__20241231_z19S8IGFb7tf" title="Operating lease, payments"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2024-01-01to2024-12-31" id="Fact001282" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">659,646</ix:nonFraction></span>. For 2023,
operating lease expense was $<span id="xdx_907_eus-gaap--OperatingLeaseCost_pp0p0_c20230101__20231231_zqMsFXNBxCB4" title="Operating lease, cost"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2023-01-012023-12-31" id="Fact001284" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">646,633</ix:nonFraction></span> and cash paid for operating leases included in operating cash flows was $<span id="xdx_907_eus-gaap--OperatingLeasePayments_pp0p0_c20230101__20231231_zKm7azc4ONnc" title="Operating lease, payments"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2023-01-012023-12-31" id="Fact001286" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">644,593</ix:nonFraction></span>. Amortization expense
was approximately $<span id="xdx_904_eus-gaap--OtherDepreciationAndAmortization_c20240101__20241231_zPvyPlINkmCb" title="Amortization expense"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2024-01-01to2024-12-31" id="Fact001288" format="ixt:numdotdecimal" decimals="0" unitRef="USD">478,000</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--OtherDepreciationAndAmortization_c20230101__20231231_zdqTbMk9xpqc" title="Amortization expense"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2023-01-012023-12-31" id="Fact001290" format="ixt:numdotdecimal" decimals="0" unitRef="USD">472,000</ix:nonFraction></span> for the years ended December 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001292" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z8zBLQlNyDX5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15.
<span id="xdx_82E_zO8Yr3F9ZSD9">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not currently a party to any material legal proceedings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001294" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zteBUWcvnHK8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16.
<span id="xdx_82A_zbkpGyTOqKn">RELATED PARTY TRANSACTION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 16, 2022, the Company entered into a convertible note purchase agreement with Transomic Technologies, Inc. (&#8220;Transomic&#8221;)
whereby the Company purchased $<span id="xdx_908_eus-gaap--ConvertibleNotesPayable_iI_c20221116__us-gaap--TypeOfArrangementAxis__custom--ConvertibleNotePurchaseAgreementMember__dei--LegalEntityAxis__custom--TransomicTechnologiesIncMember_zRtQ0peERVej" title="Convertible notes and warrants"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2022-11-16_custom_ConvertibleNotePurchaseAgreementMember_custom_TransomicTechnologiesIncMember" id="Fact001296" format="ixt:numdotdecimal" decimals="0" unitRef="USD">375,000</ix:nonFraction></span> of convertible notes secured by certain assets held by Transomic and warrants. Imunon purchased
products from Transomic for research and development purposes &#8211; primarily delivery vectors for its vaccine program. As a result
of this investment in Transomic, Imunon&#8217;s executive chairman, Mr. Michael Tardugno, was appointed to the Board of Directors of
Transomic. The Company disclosed the notes receivable as a related party transaction. In December 2023, Transomic filed a formal certificate
of dissolution of the company resulting in a complete write-off of the convertible note and related warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001298" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_zIORMTUG7grh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.
<span id="xdx_827_zj9ZS1U4Yih4">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated its subsequent events from December 31, 2024, through the date these condensed consolidated financial statements
were issued, determining all subsequent events have been disclosed.</span></p>

</ix:nonNumeric><p id="xdx_812_ztZw0Bd1usx1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 104; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>














































</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.7
<SEQUENCE>2
<FILENAME>ex4-7.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
4.7</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
OF THE REGISTRANT&rsquo;S SECURITIES REGISTERED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
OF CAPITAL STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of the general terms and provisions of the capital stock of Imunon, Inc. (&ldquo;Imunon&rdquo;, &ldquo;we&rdquo;, &ldquo;our&rdquo;)
does not purport to be complete and is subject to, and qualified in its entirety by, reference to our Amended and Restated Certificate
of Incorporation (&ldquo;certificate of incorporation&rdquo;) our Amended and Restated Bylaws (&ldquo;bylaws&rdquo;) each of which is
incorporated by reference as an exhibit to our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission,
and applicable provisions of the Delaware General Corporation Law (the &ldquo;DGCL&rdquo;). Our common stock, par value $0.01 per share
is registered pursuant to Section 12(b) of the Securities and Exchange Act of 1934 and trades on the Nasdaq Capital Market under the
symbol IMNN. The summaries below do not purport to be complete statements of the relevant provisions of the certificate of incorporation,
the bylaws or the DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorized
Capital Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized capital stock consists of 112,500,000 shares of common stock, par value $0.01 per share and 100,000 shares of preferred stock,
par value $0.01 per share, all of which preferred stock is undesignated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of common stock are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders and do not
have cumulative voting rights. Subject to any preferential rights of any outstanding preferred stock, holders of common stock are entitled
to receive ratably such dividends, if any, as may be declared from time to time by our board of directors out of funds legally available
therefor. In the event of a dissolution, liquidation or winding-up of the Company, holders of common stock are entitled to share ratably
in all assets remaining after payment of liabilities and any preferential rights of any outstanding preferred stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of common stock have no preemptive or conversion rights or other subscription rights. There are no redemption or sinking fund provisions
applicable to our common stock. All outstanding shares of common stock are fully paid and non-assessable. The rights, preferences and
privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any
series of preferred stock which may be designated and issued in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is listed on the Nasdaq Capital Market under the symbol &ldquo;IMNN.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Transfer
Agent and Registrar</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our Common Stock is Equiniti Trust Company, LLC. Equiniti Trust Company, LLC is located at 6201 15<SUP>th
</SUP>Avenue, Brooklyn, NY 11219. Their telephone number is (888) 999-0032.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Undesignated
Preferred Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to our certificate of incorporation, our board of directors has the authority, without further action by the stockholders (unless such
stockholder action is required by applicable law or NASDAQ rules), to designate and issue shares of preferred stock in one or more series,
to establish from time to time the number of shares to be included in each such series, to fix the designations, powers (including voting),
privileges, preferences and relative participating, optional or other rights, if any, of the shares of each such series and the qualifications,
limitations or restrictions thereof and to increase or decrease the number of shares of any such series, but not below the number of
shares of such series then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will fix the designations, powers (including voting), privileges, preferences and relative participating, optional or other rights, if
any, of the preferred stock of each series, as well as the qualifications, limitations or restrictions thereof, in the certificate of
designation relating to that series. The certificate of designation will describe the terms of the series of preferred stock. This description
will include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    title and stated value;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of shares we are offering;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    liquidation preference per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    purchase price;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    dividend rate, period and payment date and method of calculation for dividends;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    procedures for any auction or remarketing, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    provisions for a sinking fund, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    provisions for redemption or repurchase, if applicable, and any restrictions on our ability to exercise those redemption and repurchase
    rights;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    listing of the preferred stock on any securities exchange or market;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the preferred stock will be convertible into or exchangeable for other securities and, if applicable, the conversion price, or how
    it will be calculated, and the conversion period;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">voting
    rights, if any, of the preferred stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">preemptive
    rights, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    on transfer, sale or other assignment, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">liability
    as to further calls or to assessment by the Company, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    discussion of any material United States federal income tax considerations applicable to the preferred stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    relative ranking and preferences of the preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our
    affairs;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    limitations on the issuance of any class or series of preferred stock ranking senior to or on a parity with the series of preferred
    stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other specific terms, preferences, rights or limitations of, or restrictions on, the preferred stock.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
DGCL provides that the holders of preferred stock will have the right to vote separately as a class or, in some cases, as a series on
an amendment to our certificate of incorporation if the amendment would change the par value or, unless our certificate of incorporation
provides otherwise, the number of authorized shares of the class or the powers, preferences or special rights of the class or series
so as to adversely affect the class or series, as the case may be. This right is in addition to any voting rights that may be provided
in the applicable certificate of designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of our common stock or other securities. Preferred stock could be issued quickly with terms designed
to delay or prevent a change in control of our Company or make removal of management more difficult. Additionally, the issuance of preferred
stock may have the effect of decreasing the market price of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anti-Takeover
Considerations and Special Provisions of Our Certificate of Incorporation, Our Bylaws and the Delaware General Corporation Law</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certificate
of Incorporation and Bylaws</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
number of provisions of our certificate of incorporation and bylaws concern matters of corporate governance and the rights of our stockholders.
Provisions that grant our board of directors the ability to issue shares of preferred stock and to set the voting rights, preferences
and other terms thereof may discourage takeover attempts that are not first approved by our board of directors, including takeovers that
may be considered by some stockholders to be in their best interests, such as those attempts that might result in a premium over the
market price for the shares held by stockholders. Certain provisions could delay or impede the removal of incumbent directors even if
such removal would be beneficial to our stockholders, such as the classification of our board of directors and the lack of cumulative
voting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our board of directors has the power to retain and discharge our officers, these provisions could also make it more difficult for existing
stockholders or another party to effect a change in management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions may have the effect of deterring hostile takeovers or delaying changes in our control or in our management. These provisions
are intended to enhance the likelihood of continued stability in the composition of our board of directors and in the policies they implement
and to discourage certain types of transactions that may involve an actual or threatened change of our control. These provisions are
designed to reduce our vulnerability to an unsolicited acquisition proposal. The provisions also are intended to discourage certain tactics
that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for
our shares and, as a consequence, they also may inhibit fluctuations in the market price of our shares that could result from actual
or rumored takeover attempts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions also could discourage or make more difficult a merger, tender offer or proxy contest, even if they could be favorable to the
interests of stockholders, and could potentially depress the market price of our common stock. Our board of directors believes that these
provisions are appropriate to protect our interests and the interests of our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Classification
of Board; No Cumulative Voting.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation and bylaws provide for our board of directors to be divided into three classes, with staggered three-year
terms. Only one class of directors is elected at each annual meeting of our stockholders, with the other classes continuing for the remainder
of their respective three-year terms. Because our stockholders do not have cumulative voting rights, our stockholders representing a
majority of the shares of common stock outstanding will be able to elect all of our directors due to be elected at each annual meeting
of our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Meetings
of and Actions by Stockholders.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws provide that annual meetings of our stockholders may take place at the time and place designated by our board of directors. A
special meeting of our stockholders may be called at any time by our board of directors, the chairman of our board of directors or the
president. Our bylaws provide that (i) our board of directors can fix separate record dates for determining stockholders entitled to
receive notice of a stockholder meeting and for determining stockholders entitled to vote at the meeting; (ii) we may hold a stockholder
meeting by means of remote communications; (iii) any stockholder seeking to have the stockholders authorize or take corporate action
by written consent shall, by written notice to the secretary of the Company, request that the board fix a record date and the board shall
adopt a resolution fixing the record date in all events within ten calendar days after a request is received; and (iv) a written consent
of stockholders shall not be effective unless a written consent signed by a sufficient number of stockholders to take such action is
received by us within 60 calendar days of the earliest dated written consent received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Advance
Notice Requirements for Stockholder Proposals and Director Nominations.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws provide that stockholders seeking to bring business before an annual meeting of stockholders or to nominate candidates for election
as directors at an annual meeting of stockholders must provide timely notice in writing. To be timely, a stockholder&rsquo;s notice must
be delivered to, or mailed and received by, the secretary of the Company at our principal executive offices not later than the close
of business on the 90th calendar day, nor earlier than the close of business on the 120th calendar day in advance of the date specified
in the Company&rsquo;s proxy statement released to stockholders in connection with the previous year&rsquo;s annual meeting of stockholders.
If the date of the annual meeting is more than 30 calendar days before or after such anniversary date, notice by the stockholder to be
timely must be so not earlier than the close of business on the 120th calendar day in advance of such date of annual meeting and not
later than the close of business on the later of the 90th calendar day in advance of such date of annual meeting or the tenth calendar
day following the date on which public announcement of the date of the meeting is made. In no event shall the public announcement of
an adjournment or postponement of an annual meeting commence a new time period (or extend any time period) for the giving of an advance
notice by any stockholder. Any stockholder that proposes director nominations or other business must be a stockholder of record at the
time the advance notice is delivered by such stockholder to us and entitled to vote at the meeting. Our bylaws also specify requirements
as to the form and content of a stockholder&rsquo;s notice. These provisions may preclude stockholders from bringing matters before an
annual meeting of stockholders or from making nominations for the election of directors at an annual meeting of stockholders. Unless
otherwise required by law, any director nomination or other business shall not be made or transacted if the stockholder (or a qualified
representative of the stockholder) does not appear at the meeting to present the director nominee or other proposed business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Filling
of Board Vacancies.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation and bylaws provide that the authorized size of our board of directors shall be determined by the board by
board resolution from time to time and that our board of directors has the exclusive power to fill any vacancies and newly created directorships
resulting from any increase in the authorized number of directors and the stockholders do not have the power to fill such vacancies.
Vacancies in our board of directors and newly created directorships resulting from any increase in the authorized number of directors
on our board of directors may be filled by a majority of the directors remaining in office, even though that number may be less than
a quorum of our board of directors, or by a sole remaining director. A director so elected to fill a vacancy shall serve for the remaining
term of the predecessor he or she replaced and until his or her successor is elected and has qualified, or until his or her earlier resignation,
removal or death.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Amendment
of the Certificate of Incorporation.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation may be amended, altered, changed or repealed at a meeting of our stockholders entitled to vote thereon by
the affirmative vote of a majority of the outstanding stock entitled to vote thereon and a majority of the outstanding stock of each
class entitled to vote thereon as a class, in the manner prescribed by the DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Amendment
of the Bylaws.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws may be amended or repealed, or new bylaws may be adopted, by either our board of directors or the affirmative vote of at least
66 2/3 percent of the voting power of our outstanding shares of capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Section
203 of the Delaware General Corporation Law</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to Section 203 of the DGCL, which prohibits a Delaware corporation from engaging in any business combination with any interested
stockholder for a period of three years after the date that such stockholder became an interested stockholder, with the following exceptions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">before
    such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in
    the stockholder becoming an interested stockholder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned
    at least 85 percent of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes
    of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares
    owned (i) by persons who are directors and also officers and (ii) pursuant to employee stock plans in which employee participants
    do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange
    offer; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting
    of the stockholders, and not by written consent, by the affirmative vote of at least 66 2/3 percent of the outstanding voting stock
    that is not owned by the interested stockholder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, Section 203 defines a business combination to include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    merger or consolidation involving the corporation and the interested stockholder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    sale, lease, transfer, pledge or other disposition of ten percent or more of the assets of the corporation to or with the interested
    stockholder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
    to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation
    to the interested stockholder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series
    of the corporation beneficially owned by the interested stockholder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    receipt by the interested stockholder of the benefit of any loss, advances, guarantees, pledges or other financial benefits by or
    through the corporation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, Section 203 of the DGCL defines an &ldquo;interested stockholder&rdquo; as an entity or person who, together with the entity&rsquo;s
or person&rsquo;s affiliates and associates, beneficially owns, or is an affiliate of the corporation and within three years prior to
the time of determination of interested stockholder status did own, 15 percent or more of the outstanding voting stock of the corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Delaware corporation may &ldquo;opt out&rdquo; of these provisions with an express provision in its certificate of incorporation. We
have not opted out of these provisions, which may as a result, discourage or prevent mergers or other takeover or change of control attempts
of us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19
<SEQUENCE>3
<FILENAME>ex19.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 19</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex19_001.jpg" ALT="" STYLE="width: 800px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="text-align: center; margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex19_002.jpg" ALT="" STYLE="width: 800px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="text-align: center; margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex19_003.jpg" ALT="" STYLE="width: 800px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="text-align: center; margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex19_004.jpg" ALT="" STYLE="width: 800px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex19_005.jpg" ALT="" STYLE="width: 800px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="text-align: center; margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex19_006.jpg" ALT="" STYLE="width: 800px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="text-align: center; margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>



<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>ex21-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
21.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsidiaries
of Imunon, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurisdiction
    of Incorporation</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLSN
    Laboratories, Inc.</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the incorporation by reference in the Registration Statements of Imunon, Inc. on Form S-1 (333-221543, 333-219414,
333-217156, 333-214353, 333-234603 and 333-281834), Form S-3 (Nos. 333-174960, 333-183286, 333-198786, 333-193936, 333-205608,
333-206789, 333-227236, 333-240271, 333-249420 and 333-279425) and on Form S-8 (Nos. 33 139784, 333-145680, 333-183288, 333-207864
and 333-281833) of Imunon, Inc. of our report dated February 27, 2025 (which includes an explanatory paragraph relating to Imunon,
Inc.&rsquo;s ability to continue as a going concern), relating to the consolidated financial statements as of and for the years
ended December 31, 2024 and 2023, which appear in this Form 10-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    WithumSmith+Brown, PC</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">East
    Brunswick, New Jersey</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    26, 2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
EXCHANGE ACT OF 1934 RULES 13a-14(a) AND 15d-14(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO</B> &sect;<B>302 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Stacy Lindborg, PhD, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have reviewed this Annual Report of Imunon, Inc.;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
    the period covered by this report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
    respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
    this report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
    (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
    Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
    supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
    the effectiveness of the Registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about
    the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
    in this report any change in the Registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
    or is reasonably likely to materially affect, the Registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
    reporting, to the Registrant&rsquo;s auditors and the audit committee of the Registrant&rsquo;s Board of Directors (or persons performing
    the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the Registrant&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    February 27, 2025</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stacy R. Lindborg, Ph.D.</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    R. Lindborg, Ph.D.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>ex31-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
OF THE CHIEF FINANCIAL OFFICER PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
EXCHANGE ACT OF 1934 RULES 13a-14(a) AND 15d-14(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO</B> &sect;<B>302 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
David Gaiero, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have reviewed this Annual Report of Imunon, Inc.;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
    the period covered by this report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
    respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
    this report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
    (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
    Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
    supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
    the effectiveness of the Registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about
    the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
    in this report any change in the Registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter (the Registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
    or is reasonably likely to materially affect, the Registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
    reporting, to the Registrant&rsquo;s auditors and the audit committee of the Registrant&rsquo;s board of directors (or persons performing
    the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the Registrant&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    February 27, 2025</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    David Gaiero</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Gaiero</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>ex32-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
OF THE CHIEF EXECUTIVE OFFICER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO 18 UNITED STATES CODE &sect; 1350</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&sect;
906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Annual Report of Imunon, Inc. (the &ldquo;Company&rdquo;) for the year ended December 31, 2024, as filed with the
Securities and Exchange Commission on or about February 27, 2025 (the &ldquo;Report&rdquo;), I, Stacy Lindborg, PhD, President and Chief
Executive Officer of the Company, certify, pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to &sect; 906 of the Sarbanes-Oxley
Act of 2002, that, to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
    of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    February 27, 2025</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stacy R. Lindborg, Ph.D.</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    R. Lindborg, Ph.D.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
certification accompanies each Report pursuant to &sect;906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required
by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of &sect;18 of the Securities Exchange Act of 1934, as
amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
signed original of this written statement required by &sect;906 has been provided to the Company and will be retained by the Company
and furnished to the Securities and Exchange Commission or its staff upon request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>ex32-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
32.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
OF THE CHIEF FINANCIAL OFFICER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO 18 UNITED STATES CODE &sect; 1350</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&sect;
906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Annual Report of Imunon, Inc. (the &ldquo;Company&rdquo;) for the year ended December 31, 2024, as filed with the
Securities and Exchange Commission on or about February 27, 2025 (the &ldquo;Report&rdquo;), I, David Gaiero, Chief Financial Officer
of the Company, certify, pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to &sect; 906 of the Sarbanes-Oxley Act of 2002, that,
to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
    of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    February 27, 2025</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    David Gaiero</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Gaiero</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
certification accompanies each Report pursuant to &sect;906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required
by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of &sect;18 of the Securities Exchange Act of 1934, as
amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
signed original of this written statement required by &sect;906 has been provided to the Company and will be retained by the Company
and furnished to the Securities and Exchange Commission or its staff upon request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex19_001.jpg
<TEXT>
begin 644 ex19_001.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____[@ .061O8F4 9
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MQ\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#   !$0(1 #\
M_?R@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@"%W*GMC'XTA6;?D)YA]JNP2DD*KD]<9J!\R%#$TRFAZG-!FAU!04 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 5+@[3D<FF95*CBK(\7^)OQSTGX5;$O9"]Q(/D@C7?(V<@87(QR,9->;6Q\
M:>[_ *^\^FR?ARKF"YDM.LG>W1_RON<_X2_:1TWQ#)'#<Q36,DIQ'YZ *2>@
MW!B 3V!-8T<RC-V_5?YG5C.&YT+N/O)=D^E_(^BX9/-&1_/->O>Y\HXN+)EJ
M4,=5""@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M/34.175:QXJ=Q] PH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M7?[WS?J:L9S5LTL/I % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MEZ6MY[6+*KL&*ENY$8V'4B@H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * $I6 AD8J>/\ ..O_ -:K6HSY?^(?Q#_X23Q3I_A&S?GF\U)E[6T62L)/
M0;W\L."#E&(!4G([H4+0<ON-HGT_ NP8_P _Y[?2O/D]3)DXH)%H * "@"C>
M0K< HXRI7!! ((.014S@IH(5)0DK>7YGY$?M/? *3X>73ZG91EM.GD)8*/\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M)P.@YP!R0H&23R?G[*.B_$\WEL;0&*SC'E^;N%Q:L H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * &GK0*YX!^TU\/)/BEX7O],A -PT8E@![RPG
M>B_5B-H/8L#VKTLOJJG-/[_P.JBM3^>F"7SUPP*.-JNAX*LG!4]P0>&[Y':O
MTOG6(A;I_P #Y]SUD[JQ]Z?!+]N74?A_#%8:U$;ZTC&U)PV)U7H%()PX4=
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M\'ZXXCM]8LF8\ -*$Y^K8%)X"JOLO[@]DSV*QUF+5%$ENZ21GHZ,&4_BI/\
M3J*XZE*<-&K/LTT8SBXO_AS1BF\T9%8J_4$2J2>M:#8ZD(C9B#0]BD9M]K$6
MFE1-(B;LXW,!G'IFM:=)U%HK^A2A<K'Q-9KUN(!TZR+QGIGD4>PGV?W,EP9L
MQR>8,CI7/JGJ*Q*#FM!"T@&DXJ;ZV\AD1D(/M2D[.QFF9'_"2VF2//AR#@CS
M%R".QYKH="?1/[F:\K%C\16LS!%FB+D@!1(I)SV SFFZ,H[I_<RI0:-F,EAS
M_G^=9&*)*104 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MZ8W;1]#7DYO0C2BVOT\_(5>*2_KS/Z*(5VC\?YU^?WN>&R:@04 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MO9A >V9)%_HIQ7S'$%3E7+Z?^W?Y'F8BHW_7J?MTB[:_/TOS/,'U0!0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MV_U/#K2NS[(1=HQ7CHYAU, H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H KRG!_"G>P7Z'G'BGXA0: WD0QO=7C?<MH 'D/\ O$E4C [E
MV QTSTK&<COPN YW>327=_+^OU/+Y?AKJ/Q0E$OB20+9J05TV%V\LD'(,[D
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M^8.7,_F>&?G#_P %,?$?V#PS9V"DAKN^4\>D*.WY;F4_7%?0Y/"\[]K?FO\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H HW]B-04H690>#M(!(],XR/PP?>H<;EPERNY0T_PW:Z4A2&,*&^
M]W+?[Q.2?J<FGREU*TJF[^[0TH[-4.<D_4_I]*TOI8Y*=-0\W?=ZOTOV'K;!
M#G)^G:LU$?)=WN_O)PNVK-!:0#2<5-];>0R-I,"F]"DC\-/^"F/B4ZIXHL[
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M9/T'2N7,9N-*5O/_ -)9E6E96/Z:HHMH'/0 5^4-7=SYV2U+"C%.]RF.H$%
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M%51@   >V*_(YKF=V>%)W98%0F0+5 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M0?R5L?C7RF=5.2/+WL_S_P CS<1+ET\KG[DITKX+9GELE6M"4[BT#"@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MPX/@+XLR"-&O^6(&;64 $Y//R],X'TKV:V:1LUZ]O\S2M74MNQ_1Q\$/#/\
MPA_AO2[ HR-!96Z.K @A_+4N""!_%GM7YYBJGM)M]V>94E<]6%<5K& M,84
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M^]>7=GH0Q"?]?\$\)EM7A8JRD$=3CH?0CL:]5UZ2V:^^)JZR&QP,Y"J&))P
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H \?\4_M"^#? UY)I^J^
M(-'L;V';YMM<ZC;0S)O4.N^.2177<K*RY RK!AP0: .?_P"&L?AY_P!#7X?_
M /!M9?\ QZ@ _P"&L?AY_P!#7X?_ /!M9?\ QZ@#T#P+\6/#WQ0\[^P=5T_4
M_L^SS_L5W#<^5YF[9YGDN^S=L;;NQNVMC.#@ ] H * "@ H * //_'7Q8\/?
M"_R?[>U73],^T;_(^VW<-MYOE[=_E^<Z;]N]-VW.W<N<9&0#S_\ X:Q^'G_0
MU^'_ /P;67_QZ@#Z H ^</C?^UUX(_9QN+>S\4:M'97-U&TL4(AGN)#&K;=[
M);Q2M&A;*HT@42%) A8QOM /7_ 'C_2_BGI=MK6BW,=YIUY&)()XR=K+D@@@
M@,KJP*21N%>-U:-U5U90 =A0 4 % !0 4 % !0 4 % !0 4 ?*'Q0_;F^&_P
M<N/L>L>(+-+D231/#;^9>R0R0,%D2=+-)V@=6.W;,(R2' !*/M #X7_MS?#?
MXQW'V/1_$%F]R9(8DAN/,LI)I)V*QI EXD#3NS#;MA$A!* @%TW 'T?XE\4V
M?@^!+F^D\J)[BUME;:S9FN[B.U@3"!C\\LL:;B-J[MS%4#, #H* "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@#/U;5K?0+>6\O)8X+:"-Y9II75(X
MXT4L[N[$*J*H+,S$!0"20!0!X?\ \-8_#S_H:_#_ /X-K+_X]0 ?\-8_#S_H
M:_#_ /X-K+_X]0!] 4 % 'S_ /\ #6/P\_Z&OP__ .#:R_\ CU '0>%OVA?!
MOCF\CT_2O$&CWU[-N\JVMM1MIIGV*7;9''(SMM569L X52QX!- 'L% !0 4
M% !0 4 % !0 4 % !0!Y_P".OBQX>^%_D_V]JNGZ9]HW^1]MNX;;S?+V[_+\
MYTW[=Z;MN=NY<XR,@'G_ /PUC\//^AK\/_\ @VLO_CU !_PUC\//^AK\/_\
M@VLO_CU '0>%OVA?!OCF\CT_2O$&CWU[-N\JVMM1MIIGV*7;9''(SMM569L
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M+ZM'>W-K&LLL)AGMY!&S;=ZI<11-(@;"NT881EXPY4R)N /H^@ H * "@ H
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MUE96P3AE*GD$4 =!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % 'RA\7OVXOAY\"-4;1?$.M1VNHI&DDD"6]U<-&L@R@D-M#*L;E<.(W*OL
M9)-NR1&8 ^G])U:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$@T
M :% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 9^K:M;Z!;
MRWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22 * /#_P#AK'X>?]#7X?\
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M0 4 % !0!GZMJUOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B H!)( H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M!+9L^=##+!;Q(LZ$#RY3Y)<Q9+1JZJ^R421H ?H_0 4 % !0 4 % !0 4 %
M!0!^&/\ P5E_;6U3X<7%KX*\*ZA)97;1K=:K<VL@2XB5F!MK9)HY/-@=@K33
MKMC=H6MMLAAEE1P#[/\ ^"=7[.&A_!OP-HVIVUM;R:OJNGQ7EUJ/DA;AUOEC
MN!;^8S.ZQ1+Y,?EHRQ2/%Y_E+)(U 'T_\8_@#X7_ &@+-;'Q/IEOJ$29\II
M5FAW,CMY,\92:'>8T$GE.GF*H1]R94@'\^/Q$_9T\2_LF_$OP5X<EU:\O_!]
MQXDT^YT6&6Z9HXVCOHC*CVNX11W$1N/FFCC5)A,9%V.\T,0!_3=0!Q_C_P ?
MZ7\+-+N=:UJYCL].LXS)//(3M5<@   %F=F(2.- SR.RQHK.RJ0#Y _X)_?M
M,:I^U?H.K^(=3CC@4:Y<6]G:QX*V]JEK:/'$9-JM*^Z1WDE8 N[MM6.()%&
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MRP.Z*S12&^MXB\9()1S'))&67!*2.F=K," ?S(_LG?\ )0_"G_8P:3_Z6PT
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M7%A::E<6[6-A<^9'-&T ECN)WMG \GS<PHI8++*L 9E\H0.X!^O] !0 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M$@G5'4(P!\@?$C_@K%K'P+UQ-#\8>![C2Y?W,DVW58[AOL\AYF@VVJPW& '
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M-?M87']D&"32-=\MI%LIY%DCG56<L+6<!#,Z1JLDL;QPN SE%ECAEE4 \?\
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MM9T_0[/3]<2YU*\M[.%Y;>T$:R7$JQ(7*WC,$#,"Q56(&<*3P0#]3Z "@ H
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M?>&O#&G^);J6\1M4CFEL]+$*/J#QP73VCNR)*T$2;XY&1IID$J1R",O*C1@
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M']D&"32-=\MI%LIY%DCG56<L+6<!#,Z1JLDL;QPN SE%ECAEE4 _0^@#Y_\
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M995 /T/H * "@#Y__:%_:=\+_LOZ<FH>);OR?.\T6MM&AEN+IXD+E(8U_P"
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M_P""U'A_PAJC6?AK2)-<L4C0F^>Z>P5Y&&66.&2UDE**"JEY!$2^\",HJ22
M'ZO?!?XO:7\>O#]CXET9I&L;^,O&)4,<B,CM')&Z\@/'(CQL5+(Q4LCNA5V
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MY(X98([6YMM16:.0-E_,)M8M@("JT+3@N)8V,;PLI ,__A]7\//^@;X@_P#
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MHOA71+77#(VK0Z78QWYEE$TANDMXUG+RAG$C^8&W2!F#G+;FSD@'\X7_  6
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MS;[&:6-KEL+\Z>2L?VGS5*B/R=TFZ'S48 _1_P#X+G?\RC_W&/\ VPH \?\
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MON /X\O"?BF\\#:C::KI\GDWMC<0W-M+M5]DT+B2-]KAD;:R@[6#*<8((R*
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M_A2WC*]U#^R-8UGS-'G@^S:/9_;+A-US:/YKQ[TQ$-FUGR<.\:X^;( /N_\
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MMI0!^OW_  14_P"2>:E_V,%S_P"D5C0 ?\%J_P#DGFF_]C!;?^D5]0!^0/\
MP2X_Y*]X>_[B/_IMNZ /ZS?B%XUM_AKHVH:Y>+(]MIMG<7DR1!3(T=O$TKA
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M+=!,L"5Q+;PON0JWR;<[&96 /ZW: /X<_P!HKX\ZI^TEXEO?$6J22%IY&%M
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * /X Z /Z??^"*G_)/-2_[&"Y_](K&@#]?Z "@#\ ?^"YW_ #*/_<8_]L*
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M-RJ0 ?WV4 ?R!?\ !4?_ )*]XA_[AW_IMM* /U^_X(J?\D\U+_L8+G_TBL:
M#_@M7_R3S3?^Q@MO_2*^H _('_@EQ_R5[P]_W$?_ $VW= '[_?\ !4?_ ))#
MXA_[AW_IRM* /Y@?V3O^2A^%/^Q@TG_TMAH _I^_X*C_ /)(?$/_ '#O_3E:
M4 ?S _LG?\E#\*?]C!I/_I;#0!_8[^T+_:/_  AOB#^R/M']I?V/J/V/[+O^
MT?:/LTGD^1Y?[SS=^WR]GS[\;?FQ0!_+%_QD+_U4#_RLT '_ !D+_P!5 _\
M*S0!_4[^SU_:/_"&^'_[7^T?VE_8^G?;/M6_[1]H^S1^=Y_F?O/-W[O,W_/O
MSN^;- '\L7_!4?\ Y*]XA_[AW_IMM* /?_\ @BI_R4/4O^Q?N?\ TML: /Z?
MJ "@ H _B"_:Q_Y*'XK_ .Q@U;_TMFH _I^_X)<?\DA\/?\ <1_].5W0!_,#
M^UC_ ,E#\5_]C!JW_I;-0!_3]_P2X_Y)#X>_[B/_ *<KN@ _X*C_ /)(?$/_
M '#O_3E:4 ?S _LG?\E#\*?]C!I/_I;#0!_;[0!_(%_P5'_Y*]XA_P"X=_Z;
M;2@#]CO^",.DW&G?#F[EGBDCCN=<NI8'=&598Q;6D1>,D .@DCDC++D!XW3.
MY6  /QQ_X*C_ /)7O$/_ '#O_3;:4 ?K]_P14_Y)YJ7_ &,%S_Z16- !_P %
MJ_\ DGFF_P#8P6W_ *17U 'Y _\ !+C_ )*]X>_[B/\ Z;;N@#]_O^"H_P#R
M2'Q#_P!P[_TY6E '\J7P0\:V_P -?%6B:Y>+(]MINJ6-Y,D04R-';W$<KA S
M*I<JI"AF4$XRP'( /[K* "@ H * "@#^ .@#^GW_ ((J?\D\U+_L8+G_ -(K
M&@#]?Z /X@OVL?\ DH?BO_L8-6_]+9J /Z?O^"7'_)(?#W_<1_\ 3E=T ?S
M_M8_\E#\5_\ 8P:M_P"ELU ']/W_  2X_P"20^'O^XC_ .G*[H ]_P#VL?\
MDGGBO_L7]6_](IJ /X@Z /[_ "@#^(+]K'_DH?BO_L8-6_\ 2V:@#^G[_@EQ
M_P DA\/?]Q'_ -.5W0!\ ?\ !<[_ )E'_N,?^V% 'S__ ,$5/^2AZE_V+]S_
M .EMC0!^O_\ P5'_ .20^(?^X=_Z<K2@#^8']D[_ )*'X4_[&#2?_2V&@#^W
MV@ H _ '_@N=_P RC_W&/_;"@#Y__P""*G_)0]2_[%^Y_P#2VQH ^_\ _@M7
M_P D\TW_ +&"V_\ 2*^H _('_@EQ_P E>\/?]Q'_ --MW0!^_P!_P5'_ .20
M^(?^X=_Z<K2@#^8']D[_ )*'X4_[&#2?_2V&@#^WV@#\\/VX_C1\+?@J@O/&
M&E:7K7B%K,G3[&>Q@N;J:-9"$5II(91;6_F.[;Y" 0MP88YY4:,@'P!?^/\
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M_P!.5I0!_,#^R=_R4/PI_P!C!I/_ *6PT ?T_?\ !4?_ ))#XA_[AW_IRM*
M/Y@?V3O^2A^%/^Q@TG_TMAH _M]H * "@#\\/VX_C1\+?@J@O/&&E:7K7B%K
M,G3[&>Q@N;J:-9"$5II(91;6_F.[;Y" 0MP88YY4:,@'P!?^/_B;^W9X5\1^
M*M1N9/#?@C3M+U6:ULK$F.34Y;>WNBL4D[#S9[=0PBO7^2UG,8BBMEF$LML
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M_P $\-3TO2?BIX:DU@1FV-XT:"2(RK]JEAECLB%"MAQ<M 8Y, 1.%E+($WJ
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M $VVE 'Z_?\ !%3_ ))YJ7_8P7/_ *16- 'Y _\ !4?_ )*]XA_[AW_IMM*
M/U^_X(J?\D\U+_L8+G_TBL: /T/_ &F])N-?\"^);.SBDGN9]#U.*&&)&>22
M1[2541$4%F=F(554$L2  2: /X<Z /[G)_CIH9UC2=#M)_MU[K%N]Y;BTQ.D
M=BD;.+Z>1"4BM)&"003$D3SRHD8<"1HP#V"@ H _&'_@L9^SA>?$30[#Q=I5
MMYUQHOG1Z@(H5,QL90'$SR!A(T5JZ,3&%D"+<S3DQ1QS,P!\W_\ !#[QK;V&
ML^)-#99#<WEG9WD;@+Y8CLI9(I QW;@Y:\B* *00LF64A0P!]_\ _!6SQK;^
M%?A7?6<ZR-)JMY8V<!0*561)A>DR$L"$\NUD4%0QWL@V[2S* ?DC_P $E/V<
M+SXF^-(O%-S;9T70O,D\Z6%9(9;XQ[8(4+L,2Q>8+L2(LA@:*'<(VFA>@#^A
MW]K'_DGGBO\ [%_5O_2*:@#^(.@#^WS]K'_DGGBO_L7]6_\ 2*:@#^(.@#^_
MR@ H * /SP_X*IZM;Z=\)-:BGECCDN9-/B@1W56ED%];RE(P2"[B..20JN2$
MC=\;58@ ^_\ 2=6M]?MXKRSECGMIXTEAFB=7CDC=0R.CJ2K(RD,K*2&!!!(-
M &A0!X_\=/@7H?[1>AS^'_$$'G6DWS(ZX6:WF4$)/ Y!V2IDX."K*6C=7B>2
M-@#^.+]IW]GK4?V7_%%WX:U!_.\G9);70B>)+JWE&Z.9 X^L<@5I$CGCEB$D
MGEEB ?V^T ?SP_\ !9O]G"\BU&S\>Z?;;[*2W2SU1X85'E31N1;W%PZMO?SE
MD%L)&3;%]GAB,I,L,8 /</\ @B/XUM[_ ,*ZYH:K(+FSU1+R1R%\LQWMND48
M4[MQ<-9REP5  :/#,2P4 /\ @MQXUM[#PKH>ALLAN;S5'O(W 7RQ'96[Q2!C
MNW!RUY$4 4@A9,LI"A@#P_\ X(R?LX7DNHWGCW4+;991V[V>EO-"I\V:1P+B
MXMW9MZ>2L9MC(J;9?M$T0E!BFC(!^C__  5'_P"20^(?^X=_Z<K2@#^8']D[
M_DH?A3_L8-)_]+8: /Z?O^"H_P#R2'Q#_P!P[_TY6E '\P/[)W_)0_"G_8P:
M3_Z6PT ?V^T % !0 4 ?R!?\%1_^2O>(?^X=_P"FVTH ]_\ ^"*G_)0]2_[%
M^Y_]+;&@#^GZ@ H * /XHOVUO"UYX/\ B5XHMKZ/RI7UB\N57<K9ANY6NH'R
MA8?/%+&^TG<N[:P5PR@ _H>_X)U_%70_A]\$-.U75+^WM[+2O[1%]*7#?9V-
M_/(L;JNY_-=98C'" 99?-B"(QE0, ?S)?&_QK;_$KQ5K>N6:R);:EJE]>0I*
M%$BQW%Q)*@<*S*'"L P5F .<,1R0#^JW_@EQ_P DA\/?]Q'_ -.5W0 ?\%1_
M^20^(?\ N'?^G*TH _ER_9DU:WT#QUX:O+R6."V@US3)9II75(XXTNXF=W=B
M%5%4%F9B H!)( H _N,H _C2_:Y\3O\ M-_%G5GT.*.:34=4ATZP$5Q')'<M
M"(M/@D2<[(MEP8EE4D[$$@'F,J^80#^JW]ECX*?\,[>"](\,-)YTMC;G[1(&
MWJ;B:1Y[CRV\N(F(2RR"'<BN(@@;+[B0#^8+_@J/_P E>\0_]P[_ --MI0!^
MOW_!%3_DGFI?]C!<_P#I%8T '_!:O_DGFF_]C!;?^D5]0!^0/_!+C_DKWA[_
M +B/_IMNZ /ZK?C7\+[?XU>&M4\.77EK'J5G-;B22%9UAD=3Y4XC8J&>&39-
M'\RD.BE71@& !_#GXL\+7G@;4;O2M0C\F]L;B:VN8MROLFA<QR)N0LC;64C<
MI93C()&#0!_6;_P3O_;$TO\ :2\-6NER3R#Q'I%G!#?PW,IEGN%B58OMZ2-\
MTR2M@S$Y>&9]DF0\,TX!]/Z9^T#HWB3Q*?"^DF34[NWCE?49[/RI;73"C-&D
M5[,9%$=Q+(DD<=M&);@&-WDBCA4R4 >X4 % !0!_ '0!_3[_ ,$5/^2>:E_V
M,%S_ .D5C0!^O] '\07[6/\ R4/Q7_V,&K?^ELU ']/W_!+C_DD/A[_N(_\
MIRNZ /Y@?VL?^2A^*_\ L8-6_P#2V:@#^G[_ ()<?\DA\/?]Q'_TY7= 'O\
M^UC_ ,D\\5_]B_JW_I%-0!_$'0!_?Y0!_+%_P5K_ &<+SX9>-)?%-M;8T77?
M+D\Z*%8X8KX1[9X7*,<RR^6;LR.L9G:6;:)&AF>@#];O^"2?C6W\5?"NQLX%
MD632KR^LYRX4*TCS&]!C(8DIY=U&I+!3O5QMVA68 ^ /^"X/C6WO]9\-Z&JR
M"YL[.\O)'(7RS'>RQQ1A3NW%PUG*7!4 !H\,Q+!0#Z0_X(Y_LX7GP[T._P#%
MVJVWDW&M>3'IXEA43"QB!<S)(6,BQ73NI$96,.MM#.#+')"R@'T__P %1_\
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M!<_^D5C0!^0/_!4?_DKWB'_N'?\ IMM* /U^_P""*G_)/-2_[&"Y_P#2*QH
M^L/VX_VN[?\ 9!\-#44BCNM6O9#;Z=:NZJID"EGGE4,LK6\(V^9Y0RSR0PEX
MO.$J 'QA^R'^S+X+_;9\+Q^.O',7]O>)M1N)UU&X^U26WDM;$6T$'D:>]M%%
MBVB@EPZ&5O.\PL4>,* ?=_PO_89^&_P<N/MFC^'[-+D20RI-<>9>R0R0,6C>
M![QYV@=6.[="8R2$))*)M /J^@ H * "@#^ .@#^WS]D[_DGGA3_ +%_2?\
MTBAH _('_@N=_P RC_W&/_;"@#Y__P""*G_)0]2_[%^Y_P#2VQH ^@/^"YW_
M #*/_<8_]L* /G__ ((J?\E#U+_L7[G_ -+;&@#^GZ@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M)/ Y!V2IDX."K*6C=7B>2-@#\@?%/_!#K3KN\D?2O$]Q;61V^5#<Z>EU,N%
M;?-'<6R/EMS+B)-JD*=Q4NP!]W_LJ_\ !//P=^RP\6HVJ2:CKJ1LIU.Z/S(9
M(T246T"_NH$8J^TXDN%262%KF2-B" ?;^K63ZC;RP1326TDD;HD\0C,D3,I
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MC*S32;FEE,B@'ZGZ3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550 H
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M:N>-?$&MZXEC!)YL&GVLMG%:Q2>6L9?!LGED? 8JT\DIC,DJQF-)&2@#Y_\
M '_!)/PA\+-4MM:T76_$EGJ-G()()X[JRW*V"""#8%61E)22-PR2(S1NK(S*
M0#]/])LGTZWB@EFDN9(XT1YY1&))650#(XB2.(.Q&YA&D: D[45<* #X@_:J
M_P"">?@[]J=Y=1NDDT[77C51J=J?F<QQND0N8&_=3HI9-QQ'<,D4<*W,<:@
M ^$/"W_!#K3K2\C?5?$]Q<V0W>;#;:>EK,V5(79-)<7*)AMK-F)]R@J-I8.H
M!^OWP+^!>A_LZ:'!X?\ #\'DVD/S.[8::XF8 //.X WRO@9. JJ%C14B2.-0
M#V"@ H ^</C1^SQ+\;[>^T^\\1ZY9Z7?QB*:QLCIT,?E[5#HLS6$EWLDVDRJ
MT[!P[Q$>2WET ?!__#E3X>?]!+Q!_P"!-E_\@T >X?!#_@G+I'[.%Q<77A7Q
M'XDL)+N-8[@";39HY%1MR%HI]-DB+J2VR3;O0/(JL%D<, ?;^I^&;J_TL:?'
MJ=Y!<B.)#J,:6ANBR%2TA22VDM-\FTB0"W" .WEI&0A4 _,#5O\ @C5X%U^X
MEO+S5_$D]S/(\LTTMY:/))([%G=W:R+,[,2S,Q)8DDDDT ?2'P>_8:L/@-H>
MH>'?#_B'Q!:6&H^8S[9-/\Z&:40H\\$XT\2QRF*$0@[BL:NTB*EP(YD /E__
M (<J?#S_ *"7B#_P)LO_ )!H ^X/V:_V7+7]EZS_ ++TK6=8O-+'F&*QOY+2
M6&%Y65F>)H[2*9.58^6)/(W2RR&(RN7H T/VA_V;X?VD[";1]3U?5+32;F.)
M+BQLQ8K'*T,PG20R3V4]PK[U3(CE1"(U&SERX!\'_P##E3X>?]!+Q!_X$V7_
M ,@T ?I?\+_AU=?#BW^RW&MZIK,:QPQQ'4C:/)$L2E<^;;VMO+*[@CS)+AIG
M8J&W!F<N =!X_P# &E_%/2[G1=:MH[S3KR,QSP2 [67(((((975@'CD0J\;J
MLB,KJK  _-#P+_P3/U/]G_49KSX<^-=0T2*ZMTBNH;NPM=2\YD=F#D,;>$;0
M0L9,+2QYEVS;)F0 &AX*_P""66C77B!O%?CK6+SQ5K#WAN9/.ABM[.8!%6..
M>V_?,Z1L,K&DL=OY:QVYM_(1DD /U/H ^8/VE/V7+7]J&S_LO5=9UBSTL^69
M;&PDM(H9GB9F5Y6DM)9GY93Y9D\C=%%((A*@>@#XOTG_ ((U>!= N(KRSU?Q
M)!<P2)+#-%>6B21R(P9'1UL@RNK ,K*05(!!!% 'ZG^%M&G\/V<=M<WMQJ$J
M;MUU<K;K-)N8L-XM8;>$;00B[(D^506W/N9@#H* /@#]H7_@GCHO[4&HIJ'B
M77?$$WD^:+6VCGL8K>U25RY2&-;'_=4R2&2>1(XUDED\M2 #S_X6_P#!*;PI
M\%M8M]>T'6O$%IJ5IYGD3^;ITNSS8WA?Y)M.>,Y1V7YE.,Y&& ( /</VF/V)
M]-_:N>-?$&MZXEC!)YL&GVLMG%:Q2>6L9?!LGED? 8JT\DIC,DJQF-)&2@#Y
M_P# '_!)/PA\+-4MM:T76_$EGJ-G()()X[JRW*V"""#8%61E)22-PR2(S1NK
M(S*0#Z _:._8GTW]J:WT^S\1:WKAMM/C4+#;RV<,<]P%*M=SH+(JUPRDKE0D
M,0+B&&(22[P#Y?TG_@C5X%T"XBO+/5_$D%S!(DL,T5Y:))'(C!D='6R#*ZL
MRLI!4@$$$4 ?J?X6T:?P_9QVUS>W&H2INW75RMNLTFYBPWBUAMX1M!"+LB3Y
M5!;<^YF /R!^.G_!&K0_B3KD^J^']6_L&TN?G?3UL!<PQS$DN8"+B#RHFX(@
MPRQMN",L1CAB /L_]G']@KP5^S-;ZA!IUO)?R:G&T%U/J7DW$CVKJ UIA8HX
MA;L06D39F8D>:TBQQ+& ?GAXI_X(=:==WDCZ5XGN+:R.WRH;G3TNIEPH#;YH
M[BV1\MN9<1)M4A3N*EV /U/_ &9_V5?#7[*&ER:9X>BD+3R>9=7EPRO=7# M
MY8ED1(UV1JQ6*-%1$!9]IEDE>0 Z_P".GP+T/]HO0Y_#_B"#SK2;YD=<+-;S
M*"$G@<@[)4R<'!5E+1NKQ/)&P!^0/A;_ ((=:=:7D;ZKXGN+FR&[S8;;3TM9
MFRI"[)I+BY1,-M9LQ/N4%1M+!U /V.TGX3V7@SP_%X<\./)H=I;1I';/9) T
MD*JX=BOVN&YB=Y#N\V2:.5Y#(\A;SF\P 'YP:M_P1J\"Z_<2WEYJ_B2>YGD>
M6::6\M'DDD=BSN[M9%F=F)9F8DL2222: /M#]FO]ERU_9>L_[+TK6=8O-+'F
M&*QOY+26&%Y65F>)H[2*9.58^6)/(W2RR&(RN7H ^C]6TFWU^WEL[R*.>VGC
M>*:&5%>.2-U*NCHP*LC*2K*P(8$@@@T ?EA8_P#!+>+X3:XOB#X;^)]0\-W9
M^TK*DMO%J4)AF*E8$21H<Q1X.!=&[9F6&3<LL0D8 +[_ ();Q?%G7&\0?$CQ
M/J'B2['V98DBMXM-A$,)8M Z1M-B*3(R+4VC*S32;FEE,B@'ZGZ3I-OH%O%9
MV<4<%M!&D4,,2*D<<:*%1$10%5%4!550 H    H ^</VE/V7+7]J&S_LO5=9
MUBSTL^69;&PDM(H9GB9F5Y6DM)9GY93Y9D\C=%%((A*@>@#X?_X<J?#S_H)>
M(/\ P)LO_D&@#Z@^/G[#5A^TQ9V-CXF\0^(+BWL-[*D<FGP++,S.?/F2+3TC
M>54?R8R%58XE.U1)+<23 'S?I/\ P1J\"Z!<17EGJ_B2"Y@D26&:*\M$DCD1
M@R.CK9!E=6 964@J0"""* /U/\+:-/X?LX[:YO;C4)4W;KJY6W6:3<Q8;Q:P
MV\(V@A%V1)\J@MN?<S '04 % 'XP_'3_ ((U:'\2=<GU7P_JW]@VES\[Z>M@
M+F&.8DES 1<0>5$W!$&&6-MP1EB,<,0!]G_LX_L%>"OV9K?4(-.MY+^34XV@
MNI]2\FXD>U=0&M,+%'$+=B"TB;,S$CS6D6.)8P#\\/%/_!#K3KN\D?2O$]Q;
M61V^5#<Z>EU,N% ;?-'<6R/EMS+B)-JD*=Q4NP!^I_[,_P"RKX:_90TN33/#
MT4A:>3S+J\N&5[JX8%O+$LB)&NR-6*Q1HJ(@+/M,LDKR 'G_ .TQ^Q/IO[5S
MQKX@UO7$L8)/-@T^UELXK6*3RUC+X-D\LCX#%6GDE,9DE6,QI(R4 ?-_A/\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * /PQ_X*V_"[Q+KFL^'_ !*VFR:WX/TB-FO;
M&W++)&PE,]ZT\D,9FAMY[>&*/[2"Z6YA=B(7=#. ??\ \'?VW_A;XQT:WETW
M6]+TNVACCA2PO)H-.DM@D2$0""5HUV1JRQAH/,M\JR1R.$. #T#5OVQ/ASHM
MO+=2^*M#:.&-Y'$6HVTTA5%+$)%%(\LCX'RQQJSN<*JLQ (!^6'C#]G[PY_P
M4&\?:=K/A;1?L?A.TS<:SKK6T]E#KK//O:WM8=MO)+*'6>&XO04E5GE\QB8+
M-;@ _=Z@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * /'_%/[/7@WQS>2:AJOA_1[Z]FV^;<W.G6TTS[%"+ODDC9V
MVJJJN2<*H4< "@#V"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * /'_%/[/7@WQS>2:AJOA_1[Z]FV^;<W.G6TTS[
M%"+ODDC9VVJJJN2<*H4< "@ \+?L]>#? UY'J&E>']'L;V'=Y5S;:=;0S)O4
MHVR2.-77<K,K8(RK%3P2* /8* "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H Y_P 4
M^+-.\#6<FH:K=V]C90[?-N;F9(84WL$7?)(51=S,JKDC+,%') H \?\ ^&L?
MAY_T-?A__P &UE_\>H ^@* ,^35K>&XCLVEC%S+')+'"742/'$T:R.J9W,B-
M+$KL 0IDC!(+KD T* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@#R_P :_&_PK\-;A;/7-;TO3;EXQ*D-
MY?6]O(T99E#A)9%8H65E# 8)5AG(. #H/!7Q"T;XE6[7FAZA9ZE;)(8GFL[B
M*XC60*K%"\3,H<*RL5)R RG&",@'07NK6^G/#%/+'')<R&*!'=5:601O*4C!
M(+N(XY)"JY(2-WQM5B #0H * "@ H * "@ H * "@ H * "@ H * "@ H *
M/+_!7QO\*_$JX:ST/6]+U*Y2,RO#9WUO<2+&&52Y2*1F"!F52Q& 649R1D ]
M0H * "@ H \OTSXW^%=:U0Z':ZWI<VK+)+$;".^MWNA)"&,J&!9#*'C".9%V
MY0*VX#:< 'J% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MJ7*12,P0,RJ6(P"RC.2,@'J% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M'T/4;(PD0)';R1ZC9+.JI:JL!<NNUY4#&0)&"[)''M /WNH * "@ H * "@
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M0 4 % !0!GZMI-OK]O+9WD4<]M/&\4T,J*\<D;J5='1@59&4E65@0P)!!!H
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M)_B5X>.@QW#RVNH6]S=O Q3RK&.5!>/*^5"Q-$S1.K'$WF"W =Y5C8 _L]H
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M!Y-W#X?N61URT-Q"U[9!)X'(&^)\'!P&5@T;JDJ21J ?T/4 % !0 4 % !0
M4 % !0 4 % !0!^8'_!6#X5:'X@^'&J>(+FPMWU?3_L M;[8%N(U:]BB,?FK
MAVB*W$W[ERT6]_,V>8JNH!_.#^R=_P E#\*?]C!I/_I;#0!_;[0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M_P#@H]\+?'.HVFE:?KOG7M]<0VUM%]@U!-\TSB.--SVRHNYF W,549R2!DT
M?5_C_P ?Z7\+-+N=:UJYCL].LXS)//(3M5<@   %F=F(2.- SR.RQHK.RJ0#
M^2+]N/\ ;CU3]KW5!'&)+/PY9R$V%@2-S-@K]JNMI*M<,I(5062W1C%&6+33
M3@'ZG_L%?MZ_#CX+?#C1M!U[6?LFI6GVWSX/L5[+L\V]N)D^>&W>,Y1T;Y6.
M,X.&!  /T^\;?M0>%?AWH=GXFU*ZN$T6_MXKF"]CT^^GA$,PB,3S-!;R?9_,
M\Z,1K<>4SLQ5065@H!X!_P /1_A#_P!##_Y3M2_^1* /O^@#R_XO?&CP_P#
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M;P-:7EG;:SI_B#1(KZW6Z@NM0TY4A:W=6:*=1!-/-)%*4*120Q2(S'.0@9E
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H _FA_X+:>*;R[\9:-I3R9LK;1Q<PQ;5&V:
MZN9XYGW ;SN6V@&UB579E0I9RP!^<'[)W_)0_"G_ &,&D_\ I;#0!_;[0 4
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M>1!"&))63*J I8 _0_\ X)&>*=<\4_#53K4EQ+%;:A/;:8\ZD?Z#%% $2)R
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M:,^/6F6K01O;>"=+CO[RX2UF61M0GE66RLY[H-&NR-6BO[9!O0D7<95P\PB
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M_8)^)>H_"_XE>'I]/?;]MU"WTZYC+.$EM[Z5()%=49-^W>)HPVY%GBBD*ML
M(!_9[0!_,#_P6K_Y*'IO_8OVW_I;?4 8'_!*3]FNS_:!US4)];_TC0M'^QW,
MNFM(PANKYC,MF\\&TQS11(+LE793ND6,B2"6XC8 Y_\ X*T_"K0_A-X^MH-
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MK< ^4/\ @J[\'=&^#GQ!2+0[>.SMK_2[6\>UACBAMX9-\UJ1!%$B*B,MLLC
M[BTSR/NPP50#U_\ X)4?!"W_ &CGO+/Q#<27/A[P[>0:C%HA5?LMUJ%[&\*S
MW7>5(H[,*L+AD8N1E8GN8KD T/\ @L9\!_#WPFU'P]J&@V-OIWV^WO8)[:T@
MAM[<_9'A=)1'#&G[UOM3+([%MR1Q* NPE@#0_P""(_C6XL/%6N:&JQFVO-+2
M\D<AO,$EE<)%&%.[:$*WDI<%225CPR@,& /Z3J /Y O^"H__ "5[Q#_W#O\
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M>21(8%C /VNH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M7$WCK2K-I9#;1:'%+'"78QI)+=W2R.J9VJ[K%$KL "PCC!)"+@ ]P_X(8_\
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MG-^WM_PU19OH6MKL\3:?;^;-(D>V&]MU9(S<@*-D4H9T6>+Y4+.LL(V,\-N
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MK[PT-.26.UU:RD-QIUTZ*RB0J5>"5@K2K;S#;YGE'*O'#,4E\D1. ?R!>/\
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M^EL- ']OM '\P/\ P6K_ .2AZ;_V+]M_Z6WU 'T!_P $,?\ F;O^X/\ ^W]
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M%TWQ5X:99%CL/%EZEN97CDD>U>SL)+61VBPA>2!XI& "E2Q4HC HH!]O^/\
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M<.B&-BSV[1++);,H!4 _1^@#^0+_ (*C_P#)7O$/_<._]-MI0!]O_P#!+_\
M9C_X73X-O=0_X2;Q1HWEZQ/!]FT?5/L=N^VVM'\UX_*?,IW[6?(RB1KCY<D
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M6_\ 2V:@#^G[_@EQ_P DA\/?]Q'_ -.5W0![_P#M8_\ )//%?_8OZM_Z134
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M4/\ @K9XUM_"OPKOK.=9&DU6\L;. H%*K(DPO29"6!">7:R*"H8[V0;=I9E
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MV% 'S_\ \$5/^2AZE_V+]S_Z6V- ']/U '\ = ']OG[)W_)//"G_ &+^D_\
MI%#0!_)%^V3\"Y?V=O'.K:'Y'D60N'N-. \UD-C.Q>W"23 /+Y:GR)'RX$\4
MJ>8Y0L0#]G_^".O[3NG:EH;> -1N]FJ6MQ<3Z9!(B(LMG(!-)%"ZX,LL<IN)
MY$D_>>5(&0O%%(( #]?OB1\4M'^$EFE]K-QY$4UQ#:P*L<DTT]Q.VR*"""!)
M)IY7.2(X4=]JL^-B,P //_VJOA;_ ,+I\#:]H*V_VNXN]/G^R0>9Y6^\B7SK
M/Y]Z*,7"1-\[",XQ)F,L" ?Q!T ?VV_LF?M V_[37@[3O$<1C%S+'Y5_#'M
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M0B* B@'\N7_!4?\ Y*]XA_[AW_IMM* /U^_X(J?\D\U+_L8+G_TBL: /U_H
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MFA>;R]^U]F[9MW;6VYSM.,$ _AS\?^/]4^*>J7.M:U<R7FHWDADGGD(W,V
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M_P!C!<_^D5C0!\ ?\%J_^2AZ;_V+]M_Z6WU 'T!_P0Q_YF[_ +@__M_0 ?\
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MC?:3N7=M8*X90 ?;] !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MTT@E*^>MY*CQ;FF?:\1EWR_Z\1HL5 '?_M8_\D\\5_\ 8OZM_P"D4U '\0=
M']=NF?LP>-?V;T-O\+=9LWT=Y)670?$*33VMHT\C2R26=Y;8NU1<(D=K)YB$
MR7%Q)*\[Y(!\@>"O^"26L_$7Q WB;XH>((]2N9KPS7EK9K*PNXPB[$-VXMVM
MTW#RS##!B.W18X9825,(!^WVDZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!51
M5 554 *    * /Q!_;$_X))7OQ8\2S^(?!E[9VJZE)+<:A:ZA+.%2ZD;>\MO
M)'#.Q29F9WB<*(GSY;&*18H #Z/_ &+O^"=4O[-?[[6M<N-54^3<+I,1EBTN
M"^78SW+0F5DO)8VCB^RSRQ1&,Q+/Y0F6!K< ^$/C%_P18UZYUFXG\)ZGI:Z3
M-))+#!>-=0R6RO*Y2V!6.\,R1Q^6HG=U>0[MT:XW, ?J?^Q=^RAJW[-FG;==
M\0ZAK=ZUO#!';O=7!TZPA1$S!:V\DK(VUEVK<,D;>2J)'#;@S+* <_\ MF_L
M<:Y^V#%#ILWB*WTW1;:X%S#:QZ29IFF$7E!YKEKY-^W?-Y:Q1P*%E*R"5D20
M 'R!\*O^"/FH_!O7+#Q#I7C'9>Z?<)/%G2757VGYHI/+U)':*5=T4R!E\R)W
M0G#&@#Z/_:W_ &%/$O[7KVD>I^+H[/3K..,I86VD-Y#77E[9KI]VH%F=F+B%
M6+"WA;RE+.T\TX!X!\%_^"1^J? 7Q!8^)=&\81K?6$A>,2Z()(W5T:.2-U_M
M $I)&[QL5*NH8LCHX5U /V>TF.XAMXEO)(Y;D1H)I(HVBC>0*-[)&TDK1H6R
M51I)"H(4R.1N(!H4 ?C#_P %+?V:[/XY>.? =M%Q>ZK<7%A>+'(R7#Z;:M'=
M32PF16M5^RQR73G<1-(\T:I%<A2L0!^QVDZ3;Z!;Q6=G%'!;01I%##$BI''&
MBA41$4!515 554 *    * -"@ H * /S \+?\$M_"&LZMK^N^,H?[7O=8UB^
MO8(TN+FWAM+>:XEDBC!@DA>25E<-.SY16"Q1KA&FG -#2?V6/B;^S\(H/ 'B
M^/4-)AD18M&\2PF:.. 6PAVB^MU-P$C=$:"V@2UA0=2V'$X!H>(_A]\?/B?$
M-+O];\+^'[*;S!<7VBPWTU\$:*10D2W>U%W,RGS(Y()XBHDCERI1P#U#]D3]
MASPU^R#;ROIQDO=6NHT2ZU&X"B0JJJ6B@11B"W:13+Y>9'8[!+--Y410 ^SZ
M /R0_;$_X)4:7^T%JD_B+P]>1Z-JD\<KW4#0%[6\NL9CE8HZM;.[9%S(B3"0
MD3>29O-:< ^0/A#_ ,$COB7X U1;B#Q39Z)')&\4]YI5S?&Z\LC>$""*S$B-
M(D>Y6F0 #S,,R*I /VN_9]_9KT/]F^SN;?2OM%Q=W]P]SJ&I7L@GOKV9F9@]
MQ.%3?MWL$4*J@L\A!EEFDD /<-6TFWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP*
MLC*2K*P(8$@@@T ?A#^T#_P1834;@W?@+4X[:.23+V&IM(8XE9I&)ANHHY)2
MB@Q1QPRQR.0'D>Z9L*0 ^"'_  2?\=>';>XTK6?&4FF:)/(IN-/T:XNWCO(Y
M5\NZ642_988W>)4B#M%=!P</&5C". ?M]X \ :7\+-+MM%T6VCL].LXQ'!!&
M#M5<DDDDEF=F)>21RSR.S2.S.S,0#R#]JK]F?2_VK_#4OA[4Y)(&$BW%G=1Y
M+6]TBND<ICW*LJ;9'22)B Z.VUHY0DL8!^,'@/\ X(Y^.O!GB!+NS\3V>FVT
M,DXAU.R:[74$C*.B,L"K"J/(I"2HMUA$=P))@,. ?5_QE_X)":'\0;.QM]*U
MBXLKN&XO[G4-2O;<:C?:E->-$P>XG$MK_JO+8(H7:3(\A'FO-)* '[-?_!,3
M7/V5M<_M_0/%UNUPUO);30W.A&2&6&0JQ1PNHI(,.D<BM&Z-N0 DQET8 _5_
MQ3;:C=V<B:5/;VUZ=OE37-N]U"N&!;?#'/;.^5W*N)4VL0QW!2C 'X@^+/\
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M_P!FO_@F)KG[*VN?V_H'BZW:X:WDMIH;G0C)#+#(58HX744D&'2.16C=&W(
M28RZ, ?I?XUT'Q+K6C+::5JMGI^K-&$FOVTUKF,,8F5Y+>U:\01OYA62(327
M2(%\MTGSN !^*/\ PXQ_ZF[_ ,H__P!WT ?K]^SA\+-<^"VAVV@:OJ]OJ]O8
M6\-M931Z>;*9(80RJDQ%U/'+M3RHXV1(6"QDR&:1RX /,/VN_P!ASPU^U];Q
M/J)DLM6M8W2UU&W"F0*RL5BG1AB>W61A+Y>8W4[Q%-#YLI< _'#_ (<S?$/P
MUJ/VG2-;T=?LUQYEG=?:+VVN!Y;[H9L1VLGDRC"OA)7\M^%D; 8@'ZW_ +,_
M[$"?!;5)/$?B/6KSQ7XC$?V>TU'4/,+6=J0Q:*W26>Y97=GDWR^9G8YC18P\
MYG /N^@#\D/VQ/\ @E1I?[06J3^(O#UY'HVJ3QRO=0- 7M;RZQF.5BCJUL[M
MD7,B),)"1-Y)F\UIP#Y ^$/_  2.^)?@#5%N(/%-GHD<D;Q3WFE7-\;KRR-X
M0((K,2(TB1[E:9  /,PS(JD _:[]GW]FO0_V;[.YM]*^T7%W?W#W.H:E>R">
M^O9F9F#W$X5-^W>P10JJ"SR$&66:20 /VC_A9KGQIT.YT#2-7M](M[^WFMKV
M:33S>S/#,%5DA)NH(XMR>;'(SI,Q60&,PR('(!^0/_#C'_J;O_*/_P#=] '[
M??#31=<\/Z<EMXAU&WU6]CVK]K@LC8^8JHJ[I8OM%PAE9@[NT1BB^8*D$87Y
M@#T"@#\<==_X)27&NZSJ?BNS\4WFB^([W7-2OH;FR1FC@L[N68I"NV2VG^T,
MD@,LJRK& SVXAD \]P#T_P#X5M^T/X@T?^P-0U[PO MQ^ZN=:M4O!JD<,DF9
M'@5(+>U$JQDQQE4@; !$T4V+A0#Z _9 _8RT/]CO3KBVTN:XN[V_^SM?7<Y
M\QH$*JL42_)%$&>5T4F24>:5>>4*FT X_P#;2_8+T;]L=+6XGNY-,U:RC>*"
M\B@BE5XWD1RERAV2S(@63R%6:(1/-))A]S*P!^,.E_L;V_P1^-W@_P (:1JL
M>I7<$EGJ>H3R!8E22UGGO7A$,9F:%S9V\1CCD=R[R+(7CAE7RP#^HV@ H ^<
M/C1\.?&OQ%M[[3]&\1V>B6EW&(XYHM)FFU"!2JB0I=?VE'$'8APLBVZ/$CC8
MPF19J /R0_X<8_\ 4W?^4?\ ^[Z /H_X(?\ !.KQO^SC;W%GX7^(DEE;74BR
MRPG08+B,R*NW>J7%W*L;E<*[1A3($C#EA&FT T/%/_!,"?XX7DE]\1?&>L:[
M*NW[(MM#;Z?#;94)+L@87<*^8(X2WD);Y9"\GFN^Y0#[?^"G[+'@O]G;S&\,
M:1;V,LVX27&9)K@J_E[H_M$[RS"(F)&\D.(@Z[PF\EB ?0% 'R!^UY^SEKG[
M4.CR>';;7;?2-(N/(:ZC_LPW=Q,T,AE"^>UY$B1;EA?:D0EWQ?Z\QNT5 'YP
M>$_^"+5YX&U&TU73_&7DWMC<0W-M+_8JOLFA<21OM>^9&VLH.U@RG&"",B@#
M]KM,LM9BTLPW5W9R:MY<H%U'9RQVHD);RF-HUW)*44%/,3[2#(58K)%N 0 _
M('XT?\$C]4^/7B"^\2ZSXPC:^OY \@BT01QHJ(L<<:+_ &@2$CC1(U+%G8*&
M=W<L[ 'U?^QE^QQKG['T4VFP^(K?4M%N;@W,UK)I)AF68Q>47AN5OGV;MD/F
M++'.I6(+&(F=Y" ??] !0!^(/[3O_!'.S\?:C=ZSX*O[?2FN-CKI,\+"S69G
M_?&*>(L]O$5)=(%@E59 41HH61( #S_]GK_@E)\0_AOJ+_:?%W]BZ;-Y377]
M@WEZMQ<^4XQ$VZ.UC3Y'FV3/Y_E.1^X=7; !^SWP+^!>A_LZ:'!X?\/P>3:0
M_,[MAIKB9@ \\[@#?*^!DX"JH6-%2)(XU #XZ? O0_VB]#G\/^((/.M)OF1U
MPLUO,H(2>!R#LE3)P<%64M&ZO$\D; 'X0_$O_@B7XAMM1?\ X1C6=/GTUMS1
M_P!HF:"XCR[;8F\B">.7:FS,P\G>Y;$$:@9 /K_X _\ !,O5M-_LP_$;Q)<:
M_I^FX>#P[YMQ-I<4T&8[4YN) )8HXB?W MX%RWDLTEN'2< _7^@#X@_;H_8R
ML_VP]#C@6;[)K6G>=)IERQ;R0TH3S(9T7.8I?+C!D53+"R+(@=1)#, ?F!\%
M/^"._C+PYJ,G]K^)+?3=-N+=K>\_L>:Y:XNK>1X_.M'\R*VC6*5 VYG\] ZQ
M[K:5<[0#]_O"?A:S\#:=::5I\?DV5C;PVUM%N9]D,*".--SEG;:J@;F+,<9)
M)R: /@#]LW_@F[H?[6EY#K$%U_8VM+A+F[CMA.MW"J[4$T7FPYECPJQSAPWE
M Q.LBK#Y(!Y__P *G_:,_P"$7_X1G^W/"^_[/]G_ +7\[4O[4V9^]]H^S^7Y
MNS]UY_E>?C][YGVG]_0!Z!^QE_P3=T/]DN\FUB>Z_MG6FREM=R6P@6TA9=KB
M&+S9L2R999)RY;RB(D6-6F\X _0_5H[B:WE6SDCBN3&XADEC:6-)"IV,\:R1
M-(@;!9%DC+ %1(A.X 'XP_&C_@D?JGQZ\07WB76?&$;7U_('D$6B".-%1%CC
MC1?[0)"1QHD:EBSL%#.[N6=@#ZO_ &,OV.-<_8^BFTV'Q%;ZEHMS<&YFM9-)
M,,RS&+RB\-RM\^S=LA\Q98YU*Q!8Q$SO(0#[_H ^$/VP_P!B6W_;%U30#J=Y
M)::3I4>I&Y6WVBZEDN1:B!8FD22)$!A=Y797.%6-8_WAEA /#_AI^S+\:_V:
M=FG>&/%.CZ]HJVZI';Z_%=Q_9W&U%6W$!N)5BCBB18D%RL"[Y<6H8"1@#H/A
MY^P#J/B[Q;#\0OB9K']J:_;W$4]G8V&^+3;+[/)(UO%&T@$TL49,4T: 6^)E
MD,YO/-D>0 _3^@ H Y_Q9X6L_'.G7>E:A'YUE?6\UM<Q;F3?#,ACD3<A5UW*
MQ&Y2K#.00<&@#^>'Q3_P1+\0G7)$TK6=/&@-<+Y4UR9C?1V[$%M\,< AEEC!
M95Q+$DY4,?L^\I& ?I?X3_X)[V&F^ [[P=K.K7FM7=W9O:0ZE>-,RV,:M&]K
M%96IN"+>WADM[:62".4"Z>!!*QA2&*$ _,#2?^",/CK0-9BGL]>TN"V@O$>&
M^BDNTO(XTE!2X2%80JW"J!(L:W "R *+@ >90!^]WP+^%,OP:T.#2KG5-0UF
M[7Y[G4-0N99YIIF #E1+))Y,0P!% A*HHRS22M)-( ?G!^TI_P $Q-<_:IUS
M^W]?\76ZW"V\=M##;:$8X8H8RS!$#:B\AR[R2,TCNVYR 1&$10#L/V1/^"=>
ML_L@:S+J>F>*8[NVNXTAO;*;2I5CEC659-Z>7J05;A5#QPS2),(A-+^Z<.00
M#S#XZ?\ !*77/VB]<G\0>(/&WG7<WRHBZ,5AMX5)*00(=0.R),G R69BTCL\
MKR2, >O_ +('_!/[7/V.]1N+G2_%%O=V5_\ 9UOK2?1B/,6!RRM%*NH;XI0K
MRHC$21#S2SP2E4V@'Z?T ?AC^U5_P1W3QUJDNL> [NSTU;J16FTNZ62.UB8A
MS+);2PI*T:%MFVU\K8A:0I+'$(K=0 ^$W_!+#Q?K[VEE\2?%$E_X<TZ2W>WT
M:UO;VX@D6&.2-8\W @6T1%*1J8(W=H7EC1[8[9* ./U__@C%J/COQ#K>H3ZQ
MI^D:;<ZA<3Z9;65H]SLMYII72*2,M9QP>6AC54B,R?>4%512X!^G_P"R'^RG
M/^REH\>D?\)!J&JVZ^>?LTT=O'9QO+('WV\>R2YAP!@Q_:G@:1YIO*$DN5 /
MK^@ H ^,/VBOV?\ QK\?]+O=!3Q39Z3I=Y(P<6FC3?:GM26_T6:X?5"K(RE1
M.T44!F"E"%ADDA8 _-#_ (<8_P#4W?\ E'_^[Z /J_X0_L)_$/X$:6NB^'OB
M1):Z<DCR1P/X?M;A8VD.7$9N;F5HT+9<QH53>SR;=\CLP!T'C7]C_P"*GC^W
M6UO/BG>1QI() ;/18;"3<%90#+97<$K)ACF-F*$[6*EE4@ \@_9N_P""1UO\
M!?%FF^)KK78]5CTZ2246<FE+&KR&)TB<.UW,$>*1DGC;8Q5XU*E6PR@'Z_:M
M'<36\JV<D<5R8W$,DL;2QI(5.QGC62)I$#8+(LD98 J)$)W  _&'XT?\$C]4
M^/7B"^\2ZSXPC:^OY \@BT01QHJ(L<<:+_:!(2.-$C4L6=@H9W=RSL ?3_[%
MO[$NL_L</=6\'B2/4])O9$EGLY=-EB9)$C= ]LXU!XH7<M'Y[-#*94ACCRFU
M64 \/_:4_P""8FN?M4ZY_;^O^+K=;A;>.VAAMM",<,4,99@B!M1>0Y=Y)&:1
MW;<Y (C"(H!Z!^R!_P $_M<_8[U&XN=+\46]W97_ -G6^M)]&(\Q8'+*T4JZ
MAOBE"O*B,1)$/-+/!*53: <_^U=_P3?US]K77#JNJ^,/)M(=Z:?IZ:26AM(6
M() )OQOE?"F><@-*P4!4B2&&( Y_]FO_ ()B:Y^RMKG]OZ!XNMVN&MY+::&Y
MT(R0RPR%6*.%U%)!ATCD5HW1MR $F,NC 'Z_T ?R!?\ !4?_ )*]XA_[AW_I
MMM* /L__ ()A_LP/\1_"MUXKT#6;SP]XHM-4N[&*_@2.YMY;5[>QD,-U93_N
MIT4M(T6&C*S.DK&0PPJ@!](?'S]BKXO_ +8=Y8V_C+7/#^G:+:;V^SZ2M[*H
MFVOMG-O<+'YTIR(@7N$6&(NT:AGE68 ^_P#]E']E'0_V2M#&E:4/.NYMCZAJ
M#H%FNYE! ) )V1)EA! "5B4L2SRO--* <_\ M>?LY:Y^U#H\GAVVUVWTC2+C
MR&NH_P"S#=W$S0R&4+Y[7D2)%N6%]J1"7?%_KS&[14 ?G!X3_P""+5YX&U&T
MU73_ !EY-[8W$-S;2_V*K[)H7$D;[7OF1MK*#M8,IQ@@C(H _;[PM;:C:6<:
M:K/;W-Z-WFS6UN]K"V6)79#)/<NF%VJV97W,"PVA@B@'R!^V;^POH?[8=G"T
M\G]G:U:86VU..$2L(=VYX)H]\?G1'+-&"Z-#*2Z,%>:.8 ^?_AO\#?CY\$M#
M?PMHVM>%[W3[?SH=-OM0%\;ZWMR-L 55B>%?*&'BBF^UI"3Y.^6WCC10 _91
M_P""7UG\&]<'B[Q9J7_"0:[\EQ&'B;R8+YR7GN3)+(\EW*'.8)Y5A*MNG,7G
MF)H #]7Z "@#\D/^"O?PA3XG>&M">U6-M;_MR"PTY'>1&G;459'MH\?N%=WB
MAE,ER8D1(' F5G$<H!^E_P *OAIIWP;T.P\/:4FRRT^W2"+*HK/M'S2R>6J(
MTLK;I9G"KYDKNY&6- 'H% 'C_P =/@7H?[1>AS^'_$$'G6DWS(ZX6:WF4$)/
M Y!V2IDX."K*6C=7B>2-@#\$?&O_  1'\56%PJZ'KFEWEL8P7DO$N+*02;FR
MHCB2\5D"[2',BDDLOE@*&8 ^W_V??^"9][IEO8#XD>(+SQ!!ITD4EIH(N9Y=
M'@:W66*(,EQS.BQM&4C6*U2/$D#K<0.P8 _6^@#X@_;-_87T/]L.SA:>3^SM
M:M,+;:G'")6$.[<\$T>^/SHCEFC!=&AE)=&"O-', ?D!_P .9OB'X:U'[3I&
MMZ.OV:X\RSNOM%[;7 \M]T,V([63R91A7PDK^6_"R-@,0#]?_P!G3]B2S^#.
MHKXBUW5]0\4^)DMS;1ZGJ4C2?9H2\K%+..1YG@W+)LD9I96/[SRS$D\T;@'0
M?MF?LM?\-<:3I6A2W7V.RM]8AO;V11F8V\5O<QM' "K)YKM*BAI/DC4M*5E*
M"&0 ^3_ ?[&'Q2_98N$B^'GBNSO]$,DY.D:_'.+>",L[0K&UN)FW[II))WMO
ML EF1'>.16,: &AJ_P"P#XA_:>UR+7OB[K%O<16>$L]$T3SHK%$!A9B9K@"8
M>>5D6Y55$[#RBEZB11PQ@'ZOT % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MCX*?\,[>"](\,-)YTMC;G[1(&WJ;B:1Y[CRV\N(F(2RR"'<BN(@@;+[B0#Z
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * /+_BAX]O\ P5;XTG1[S6M1DCF:"UMVA@CS&HP9[NYDB@A0
MN\:8#27#!GDBMIDAG,8!Y!^SC^S.GPFN-0\2ZS)'?^,-<D:;5+]?,:.)78,M
MA8^<S2QV4 "1QACOE$4;/M2."&  ^KZ "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H _D"_X*C_ /)7O$/_ '#O_3;:4 ?K?_P10U:WF\"ZK9K+&;F+7)99(0ZF
M1(Y;2U6-V3.Y4=HI51B &,<@!)1L '['4 % !0 4 % !0 4 % 'G_P 6-?U'
MPIX>U74-(M_M>I6FGW<]G;>6\OG7$4+O#%Y<9$C[W"KL0AVSM4AB#0!_*%\!
M_P!OSQSX:\96.J:UXFU!M-N=0@_M5)W:YMQ9R7,<EUY5J5DCAP@8)]DC22-,
MQP[5.T@'[7?!+Q:_[;OQ(C\>6!DC\'^$([S3])=FC22]U*ZC5;JX,)B,R6YM
MY$PDKHP*VTB@.]W!& ?J?0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!X_\ &/X$
M:#\?;-=/\10W%S9#.ZVCOKRUADRR./.CM9X4GVM&C1^<'\M@63:68D ^8/\
MAUQ\(?\ H7O_ "HZE_\ )= 'U?\ "_X/:3\'+?['H_VQ+81PQ)#<:C?7L<,<
M"E8T@2\N)U@15.W;"(P0$!!")M /4* "@ H * "@ H * "@ H * "@#X@_X=
MO?"C^T?[4_X1RW^T?:/M&SS[K[/OW^9M^R^?]F\K/'D>7Y&S]WY?E_+0!]GZ
M3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550 H    H T* "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H \O^+WP7\/_'K2VT;Q+8QW]BTB
M2B-RZ,DD9^5XY(V26-\%E+1LI9&>,DH[JP!YA\'/V+_A_P# *\;4/#NB6]M>
MG&VYD>:ZFCPKH?)DNI)G@W+(ZR>24\Q2%?<%4  ^GZ "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'QA^UA^TEXE_9ATNZ\0IX?L]
M4T2UDMT>5-8:WNE68K'YDEN]@R!!,RQ 13S.0Z2%%7S/* /+_P!EK]M#Q;^U
MMIUUJNB>%=/MK*UN!;&6]U^1/,F"+(Z1K#I4[_(KQEF<(I\Q0A<K($ /T?H
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M-X8\0+X2L(+S6O$?EB:73-.2)Y+:W*,_GW,]Q+;VENG" ++.LS&>WVQL)D)
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MQ&1 Z,DD9^9)(Y%26-\%6"R*I9&20 HZ,P!ZA0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^./_!9_XO/X0\':?X:@
M:1)-<O"\Q"1M&]K8;)'C9FRZ.9Y+21#&,D12*SJIV2 'W_\ LA?"%_@1X#T/
MP].LB7-K9J]U'(\<C1W5PS7-S&'B^1D2:61(RI8;%7YY#EV /H^@#\X/V@H?
M^%L_&'P1X8\JXFM-%M[WQ'J$?G>5;C:?(TV?:LJM++!=Q8V[#M2?'SQ/<!0#
M[_\ %/BS3O UG)J&JW=O8V4.WS;FYF2&%-[!%WR2%47<S*JY(RS!1R0* ,_3
M/B%HVM:6=<M=0LYM)6.64W\=Q$]J(X2PE<SJQB"1E'$C;L(5;<1M. #/\"_%
MCP]\4/._L'5=/U/[/L\_[%=PW/E>9NV>9Y+OLW;&V[L;MK8S@X /0* //_'7
MQ8\/?"_R?[>U73],^T;_ "/MMW#;>;Y>W?Y?G.F_;O3=MSMW+G&1D _*'_@L
M3\=(M/\  VE:-ID_FQ>)+@7'GP^5+;SV-HL<^!+EC\\LMG-$\(PZ1OF0(=L@
M!^EW[-?PA3X"^#M'\-*L:R6%G&EP8GDDC>Z?]Y=2(TN'*23O+(H(4*&"A$4!
M% .P\=?%CP]\+_)_M[5=/TS[1O\ (^VW<-MYOE[=_E^<Z;]N]-VW.W<N<9&0
M#H/^$LT[^SO[7^UV_P#9OV?[5]L\Y/L_V?9YGG^=GR_*V?/YF[9L^;.WF@ _
MX2S3O[._M?[7;_V;]G^U?;/.3[/]GV>9Y_G9\ORMGS^9NV;/FSMYH _.#1_V
ML8/VJ/BA8^$/"EQNT+P_Y^J:K?Q75Q!]O>!#;16]L;=E6>T2XN89)1,3!>>6
M=H:"-?M8!^G] 'E_C7XW^%?AK<+9ZYK>EZ;<O&)4AO+ZWMY&C+,H<)+(K%"R
MLH8#!*L,Y!P >@:3JUOK]O%>6<L<]M/&DL,T3J\<D;J&1T=259&4AE920P((
M)!H T* /+]3^-_A71=4&AW6MZ7#JS211"PDOK=+HR3!3$@@:02EY Z&-=N7#
M+M!W#(!^*/[:/_&5OQY\._#U_FTW2O)^V03_ +I)/,C&HW_E309G/FV<<$*;
MBFV="%\I2TS '[_4 % 'Y ?\%%?VT=8\'ZC:_#3P-_R,FK^1%-=QS1J]K]L?
MRH;:%BX\F[ERK&64Q_9X)(Y8R7F2:W /T/\ V=?@-I?[-OAJR\.Z7'&%@C4W
M,Z1E&N[HJHFNI 7D;?(RY"EW$2!(4(BC10 >X4 ?SP_\%7_'<OP6^)WA?Q5H
MU[_Q.K/3XW-H8Y45(8;J=HS)*CIYL5UYES;S0(RL(HG#MMG7 !_0]0!GZMJU
MOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B H!)( H \O\+?M"^#?'-Y'
MI^E>(-'OKV;=Y5M;:C;33/L4NVR..1G;:JLS8!PJECP": /8* /S _;-_;:L
M]&EA^'G@V\M[GQ9KUP-*^T1W#"'26N9?LC2336Y,B7:.2(XD_>P,IGD4!8H;
M@ _2_2=,31;>*UB,C1PQI&AEEDFD*HH4%Y96>61\#YI)&9W.69F8DD T* /'
M_"W[0O@WQS>1Z?I7B#1[Z]FW>5;6VHVTTS[%+MLCCD9VVJK,V <*I8\ F@#V
M"@#YP_:]^+S_  (\!ZYXA@:1+FULV2UDC2.1H[JX9;:VD*2_(R)-+&\@8,-B
MM\DAPC 'YX?\$IM#T/X ?#J3Q9K]]I^G?\)#J#K'=7-X(%:&T\R&&!_/9(A*
M)4O95$>YGB<%F.S9$ ?K]X6\6:=XYLX]0TJ[M[ZRFW>5<VTR30OL8HVR2,LC
M;65E;!.&4J>010!T% ''^-?B%HWPUMUO-<U"STVV>01)->7$5O&TA5F"!Y65
M2Y568*#DA6., X #P5\0M&^)5NUYH>H6>I6R2&)YK.XBN(UD"JQ0O$S*'"LK
M%2<@,IQ@C(!T&K:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22
M* ./\"_%CP]\4/._L'5=/U/[/L\_[%=PW/E>9NV>9Y+OLW;&V[L;MK8S@X -
M#PW\0M&\8W%W9Z9J%G>7-A)Y5[#;W$4TEM)N==DZ1LS1/NC==L@4Y1QC*G !
MV% !0!\X?%7]F?2_CGK-K?>)I)-0TFPCB>ST5\I9K?+*[O>W"HP-TYC\N".&
M?=;Q1_: 8Y/M+; #X_\ V\/V#_!7BGP5J.J:7IUGHFHZ)9W>H0S:?:0P+,L$
M)EDM[B.(1K(DBQX1S\\#X="4,T,P!G_\$;?%-YX@^&LMM<R;XM/UB[MK5=JK
MY<+16]T4RH!;,MQ,^YRS?/MSL554 ^H/VZ?VB_\ AF+P-?:S VW4I\66F<9Q
M>3JVR3F*6/\ <HLESME41R^3Y)8-(M 'E_\ P3*^$+_#[P'!K6HK(^M^)9'U
M6_N9WCFGF6=F-J6F7+LC0E;C;*\CI-<W!.QG9% /D#]L+QK<> /VD/ UY:K&
M\DEGIUF1(&*^7?WU_92D!64[UCG=HSG <*65E!4@'[G4 ?*%M^QWX:U[6;WQ
M%XJ@C\2:M=R3I%)J,2S6]I8M+NMK*VLWW6\:0(%!FV&XEF>XF:0?:'C !^0'
M_!6W]COPU\)[*R\9^'H(]-:ZO(M/NM/MXECM78P321W$2)M6!PL!25$79*66
M3$<HE:< _<[]GKQ3>>.?!OA_5=0D\Z]OM'TZYN9=JIOFFMHY)'VH%1=S,3M4
M*HS@ # H [#Q_P""K?XCZ7<Z/>-(MI>QF&Y6,JK2V[D": L58JDT>Z&1DVS*
MDC-%)%,$E0 \O^*OA/P-X&\%W^GZ_::?8^$8;=_M5L(5AMD1Y-_[N.$*5E:5
M@T/D 3FY9&B_?E#0!^8/_!$OX::CX?T/7?$-RGEV6JW%I!:;E=6D^PB?S95W
M*$:(M<")71F_>Q3HP4Q_, ?M]0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MV /PP_X)JV^N?'3QEXP\3:9K6GZ)K]];SLT;V!O/EU*Y:>>>UA>\A*_9I8H
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M_P!H7PM>>.?!OB#2M/C\Z]OM'U&VMHMRIOFFMI(XTW.51=S,!N8JHSDD#)H
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M5'26-9E29"OR2JZ@L &(!]?T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M_LS0-$N(=0T[2&DC>^FU2$NL=U?S6[RPQ16X):VMK6>83F3S;F4;?L:@'O\
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M6MGHUF=4DO;XQW"RZEJ"PP0K8VIEM&V0V44WG7$F9Y'G8-:M;I:SW!N #/\
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M_L92_M@Z'9PZ;-;VVM:;<-):S7)E$+0S!5N87,6_9NV12K)Y4K!H!& BRR.
M#Y _9BTG]I7X3:=:>%O[)T<Z?!O6"]UFZ2?[+"J92#=87K3-$I79"/)E:/>L
M>Y+=$$0!^E_P0_9_?X;7%QK>NZE)X@\47D:P7&KSP1VY6UC;,5I:VT1,5K;@
MXDE2(YGN"\\C,?+6, ^;_P#@J!\!/$?[1/@VRTKPQ9_;KV'6(+F2+SH(<0I;
M7<;/NGDB0X:5!M!+'=D# ) !ZA^RS\$M9\%Z-X>37(X]*;0]+2UATK3KR5K>
M6XFBC^U7FH"-8()[AG#;(0D\,$SW-Q]JNY9XGM@ _;C_ &1+?]K[PT-.26.U
MU:RD-QIUTZ*RB0J5>"5@K2K;S#;YGE'*O'#,4E\D1. :'PT^)GQ"L-.33O$/
MA6XGU>WVVW]I0:CIATZ\:-%3[=*?-ANK6*:3?*\45C/+#"1LAED_<  \?^#G
M[$.HWWBUOB'\2]0M];\1+C[#9V\;C3=,V2.8OLPEP\OEJ5:#?''Y,S2S-]HN
MBETH!^C] 'Y(?LB_LK^)_P!@35-8AALI/%.DZQ':F.ZT^2UM;J"2S#_+<6E_
M<P1!)3<R['AN9RHMP7C7S@$ /H#XJ_ KQ!^UY<6MOXD>31/!L$D4T^A)(CZA
MJDD;.2FH7%M*\%M;HZQ-##:RW1E0M*\MO<K +4 ^W])TFWT"WBL[.*."V@C2
M*&&)%2..-%"HB(H"JBJ JJH 4    4 ?CC_P4-_X)]:Y\5-<@\=> ?EUU?+:
M]B^VFWFDFMS!':3V;.%CBEC1292T\*[88FC4SES( >G_  OM/V@?BW;_ -B>
M+AI?AO3O+AAN]5M65M8FCVGS7LS;W-Q:0W$FS8\S1PBW\_SK>)GB5% /T?\
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M=6.E2-):^'M(BN!ILUP /+N[U[IO-G=0TD?V9D\D*JX?9-=0S 'Z'T % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % 'Y ?\ !8KXZ6?A#P6OA.&>W;4M9N+=IK5MS3)8P2&8SKM(6/-Q##$I
MER)5,XC5FC=X@#[ _8#T#3O#7PO\,P:7<?:;=M/2=Y/,23%Q<NT]U%NC 4>5
M<22P[#\\>SRW)D5B0#Z_H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * /#]6_9D\"Z_<2WEYX:T.>
MYGD>6::73+1Y))'8L[N[1%F=F)9F8DL2222: .@\%?!#PK\-;AKS0]$TO3;E
MXS$\UG8V]O(T996*%XHU8H656*DX)53C(& #U"@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M^%=4O+K6[K7+>Q%S):65Q=72W$-W(L(@CM%@+EUB2/R8$=@BC+,SEP#0\+?
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M_$=QHVI+;[;6%K:QGL7F5BVZ<36<UR/,!\HM%*%B 6002,KI* ?('_!/^_\
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MWXO?"_Q#JN@_\)/]H_LS4+NR\_\ LO38_-^S3/#YFS[,^S=LW;=S;<XW'&2
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M#X0_;QU:X\7:7IWP[TN62'5O&5X+-98W9&M]/MBMQJ=R>429$@7RI+4RQ/<)
M.RIYF&1@#^4+P!XUUG]GSQ+;:K:K)::MH]X&,,PEB99(6*RV]PBM'*$8!X;B
M+*%D:2-L9- ']OGP]\:V_P 2M&T_7+-9$MM2L[>\A24*)%CN(EE0.%9E#A6
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M.DNE6>D^";.?;]LW:AJ,2^:K-#&WEV:LP(B>)Y1<.T3!V$MM!)^[PA< \?\
M^"(7@7^T/$/B#7O.V_8M/@LO(V9W_;IC-YF_<-NS[%MV[6W^;G<NS#@']'U
M'X@_\%O? O\ :'A[P_KWG;?L6H3V7D;,[_MT(F\S?N&W9]BV[=K;_-SN79AP
M#Y?_ .",GQTE\+>*+SP?<SXLM7MWN+6%O-;_ $ZU 8B(*3%%YEL)FF=U!D^S
M0)Y@*JC@'ZO_ /!4?_DD/B'_ +AW_IRM* /P!_X)<?\ )7O#W_<1_P#3;=T
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M?^$TLXOASK/%[86\CZ7=/-DW%NC;C:D2N7,L"L3 L(*?8XF79$+;=, ?7_\
MS<+_ -T__P#<S0!]_P! !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M032 '[?4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % 'R!^W3\8Y?@WX&OI+%;B35]5QI.DQ6IE6X>^OE:.,P-"CNL
ML2^9<1@;3(\0B5UDD0T :'P]_8K\"^#M&T_3+SP_H=_<V=G;V\U[+I-IYES)
M#$L;SON21M\C*9&W.YRQR['D@'S_ /MN?L.>&O&?@/54\+^'=+M=;M8UN[-[
M*R6WG=K=@\L*?9(M\SRP^;%% P='F>(D*RI(@!_.#^R9^T#<?LR^,=.\1Q&0
MVT4GE7\,>XF>SEPLZ;!)$LCA?WL"R,(Q<1PNP(2@#^SW5O'^EZ+HTOB&6YC;
M28;-[Y[N(F:,VJ1&8S(8@YD3RQO7RPQ<8VALC(!^6'P+_P""O>A_&'Q;!X<N
M='N--M+^X^S6%\UP)VDFDD"6R3V\<0\GS<A2R2SK%*RJQ,6^= #]?Z "@ H
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M@ '84 ?Q!?M8_P#)0_%?_8P:M_Z6S4 ?U^_LG?\ )//"G_8OZ3_Z10T ?0%
M'\P/_!:O_DH>F_\ 8OVW_I;?4 ??_P#P14_Y)YJ7_8P7/_I%8T 8'_!7O]E&
M7XDZ/%XZTL;KW1+<Q7T(25WGL3)N5T"ED7[*TDLLA**#!)+(\P%NB, ?-_\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MHMA)#$JBOE5PX7<K 'YP>/\ _@DGX0^*>J7.M:UK?B2\U&\D,D\\EU9;F;
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ML[.LQV2B9YP#Z?H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /B#]HK]O7P]^S7
MXAL_#&H:?K%_J5_;PSVT>G6T,_F>?-+!'$JO<12-*SQ$!%1L[E )8D  \_\
M%/\ P4FT[P-9R:AJO@WQQ8V4.WS;FYT5(84WL$7?))=*B[F957)&68*.2!0!
MG^"O^"GFC?$JW:\T/PGXTU*V20Q/-9Z1%<1K(%5BA>*Z90X5E8J3D!E.,$9
M.P^%O_!13P]\4/%]OX'_ +'\0:9K5QYG[K4K.&V\KR[9[O\ >K]I>5-T293]
MV=VY#PIW  \/^)'_  4PO=.\=:'X,TKP_>6<>HZI86\UYK5M/:22VMQ=M:O)
M:6;>7*$8!7@N)F!!$D;V89<@ _6^@ H _+#]N?\ ;G\5?LP>*M"T/0]"CU&V
MU&-)'>1+AI+N1KCRC961BPJW"J%))6Z.;J#]P  )@#]3Z "@ H * "@ H *
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M<6+96"6WS(<[VN?.A='7R2<4 ?J_0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MWL_)UBYM+:" NVVW2&WFC$KNQ\R4><5>15B1\ B).10!]OT % !0 4 % !0
M4 % !0 4 % !0!\8?M@_MBI^R?8?:AH>J:O)Y:R-)!!)'I\"M,D*BZU QO%"
M[EF\J-%F<NJ*ZQ+-$[ '8?L9_&O4?VB? FE^)]5CMX;V^^U^;';*Z0CR;N>!
M=BR22N,K$I;+MEB2,#  !]/T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M.T^ZE\NZW_VB;BWO88/WZY6.#Y)<26VR1XID(^T.O% 'Z?T % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MU'Q9IVD7EKI]S=V\-[?>;]DMI)D2:X\E0\ODQL0\OEJ0TFP-L4AFP.: //\
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M$&CWU[-N\JVMM1MIIGV*7;9''(SMM569L X52QX!- 'L% '/_P#"6:=_:/\
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M-\<WD>GZ5X@T>^O9MWE6UMJ-M-,^Q2[;(XY&=MJJS-@'"J6/ )H ]@H Y_\
MX2S3O[1_LC[7;_VE]G^U?8_.3[1]GW^7Y_DY\SRM_P GF;=F_P"7.[B@#S__
M (:%\&_VC_9'_"0:/_:7VC[+]C_M&V^T?:-_E^1Y/F>9YN_Y/+V[]_RXW<4
M>P4 ?@#_ ,W>?Y_Z%R@#]_J .?T[Q9IVKWEUI]M=V\U[8^5]KMHYD>:W\Y2\
M7G1J2\7F*"T>\+O4%ER.: .@H \O\:_&_P *_#6X6SUS6]+TVY>,2I#>7UO;
MR-&690X2616*%E90P&"589R#@ [#PMXLT[QS9QZAI5W;WUE-N\JYMIDFA?8Q
M1MDD99&VLK*V"<,I4\@B@#0U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*
MH+,S$!0"20!0!Y?X6_:%\&^.;R/3]*\0:/?7LV[RK:VU&VFF?8I=MD<<C.VU
M59FP#A5+'@$T >P4 ?@#^P+_ ,G"^/?^X_\ ^GFWH _:[3/C?X5UK5#H=KK>
MES:LLDL1L([ZW>Z$D(8RH8%D,H>,(YD7;E K;@-IP >H4 ?@#_S=Y_G_ *%R
M@#]_J ./\:_$+1OAK;K>:YJ%GIML\@B2:\N(K>-I"K,$#RLJERJLP4')"L<8
M!P '@KXA:-\2K=KS0]0L]2MDD,3S6=Q%<1K(%5BA>)F4.%96*DY 93C!&0#L
M* "@#\P/VR_VN/\ A$O&7@_P'H5[LO[WQ!I3ZSY$F'ALS<P^7:RX0[?M6_S'
M59$D$$061&M[L;@#]/Z ,_5M6M] MY;R\EC@MH(WEFFE=4CCC12SN[L0JHJ@
MLS,0% )) % 'G_@KXW^%?B5<-9Z'K>EZE<I&97AL[ZWN)%C#*I<I%(S! S*I
M8C +*,Y(R >H4 % !0!X?JW[3?@70+B6SO/$NAP7,$CQ30RZG:))'(C%71T:
M4,KJP*LK %2"" 10![A0!^0'_!:O_DGFF_\ 8P6W_I%?4 ??_P"R=_R3SPI_
MV+^D_P#I%#0!^0/_ #=Y_G_H7* /W^H * "@#R_QK\;_  K\-;A;/7-;TO3;
MEXQ*D-Y?6]O(T99E#A)9%8H65E# 8)5AG(. #T#2=6M]?MXKRSECGMIXTEAF
MB=7CDC=0R.CJ2K(RD,K*2&!!!(- 'E_[0OBF\\#>#?$&JZ?)Y-[8Z/J-S;2[
M5?9-#;221OM<,C;64':P93C!!&10!^<'_!%3_DGFI?\ 8P7/_I%8T ?8'[6O
MPJT.?2;_ ,=26%N_B3PWH^I7.DW[H':WFAMY9H7,;9BF\J4>; MPDJPREI(P
MCLS$ ^/_ /@BI_R3S4O^Q@N?_2*QH _1_P 8? 'POX_US3O$NJ:9;W.KZ3G[
M%=.#NCR=RY (27RV)D@\U7^SREI8O+D8L0#T#PMXLT[QS9QZAI5W;WUE-N\J
MYMIDFA?8Q1MDD99&VLK*V"<,I4\@B@#H* /'_%/[0O@WP->2:?JOB#1[&]AV
M^;;7.HVT,R;U#KOCDD5UW*RLN0,JP8<$&@#U#2=6M]?MXKRSECGMIXTEAFB=
M7CDC=0R.CJ2K(RD,K*2&!!!(- &A0!X_X6_:%\&^.;R/3]*\0:/?7LV[RK:V
MU&VFF?8I=MD<<C.VU59FP#A5+'@$T >P4 <_J/BS3M(O+73[F[MX;V^\W[);
M23(DUQY*AY?)C8AY?+4AI-@;8I#-@<T <_\ \+8\/?VQ_P (]_:NG_VU_P!
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M#?'-Y'I^E>(-'OKV;=Y5M;:C;33/L4NVR..1G;:JLS8!PJECP": /8* .?\
M%/BS3O UG)J&JW=O8V4.WS;FYF2&%-[!%WR2%47<S*JY(RS!1R0* ./\%?&_
MPK\2KAK/0];TO4KE(S*\-G?6]Q(L895+E(I&8(&95+$8!91G)&0#H/'_ (_T
MOX6:7<ZUK5S'9Z=9QF2>>0G:JY    +,[,0D<:!GD=EC16=E4@'Q!_P3>^/.
MJ?M):#KWB+5))"T_B2\%M \@=;2U%K9F&UC(2-=D:M@L$0RN7F<&61V(!^A]
M 'E_C7XW^%?AK<+9ZYK>EZ;<O&)4AO+ZWMY&C+,H<)+(K%"RLH8#!*L,Y!P
M>@:3JUOK]O%>6<L<]M/&DL,T3J\<D;J&1T=259&4AE920P(()!H T* //_\
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M,"""0: /A#_@J/\ \DA\0_\ <._].5I0 ?\ !+C_ ))#X>_[B/\ Z<KN@#X
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MX\4>%[>32[G2Y(#+$)Y[F.ZCN9X;?:WVB:1HWC:02(\9P1YB/&Y='A /TO\
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MM ^TZ'I]O+;Z2;M#+8%3)&ED8(Y9)(I]]M]HGG10\4%W*[O';W+1JH!\G_\
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M[W.E3QV]T50Y\L3/%*T:%MI8Q;'8+L+^4TB. ?BC_P $,?\ F;O^X/\ ^W]
M'Z'_ /!0S]JI_P!ECP<]UITL::[J,@M=,#+'(4;[T]R8G=2R0QYPVV5%N)+9
M98VCD(( ? ;]@#P=\.M+C;7]+L]<\0W<<<NKZAJ*_P!HM/>,7DG>,W:$(ADD
M<!ECBDE18VG,DJ[Z /D#]DO]C#QY^S7\6=2NK!([+P+/)>$A;M98[FU8.UA
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ML\CLTCLSLS$ ["@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M," ?T_4 ?@#_ ,$,?^9N_P"X/_[?T ?K]^UC_P D\\5_]B_JW_I%-0!\0?\
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M2>>*_P#L7]6_](IJ /@#_@BI_P D\U+_ +&"Y_\ 2*QH ^@/^"H__)(?$/\
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M/_,W?]P?_P!OZ /?_P#@M7_R3S3?^Q@MO_2*^H ^_P#]D[_DGGA3_L7])_\
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MZ@#^='PWKS_\$[_CU=V%T\=OX7\22;\+Y<%M#:WLKM;2B);A884LK@26QDF
M*6BW,D<*B9!0!^E_P._XN[\5?%OB]>;+1+>W\*V$L?R+*\3_ &S4UFCDS*98
M+EHXXY5$4#Q,=@F(,@ /O^@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MUCJ.EVWA[PQ<?8M&^W+]KGU#3(_M+7#Q+NBB^UEUB"VZ.C2E)6\TJ\$1C^<
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M_B<UO%K45O)9Z3HML(WM-+A<J)[A&WS_ .EW.S#21RNPMW,3RNKI;V@!Y_\
M\%&?V"?^&J+--=T1MGB;3[?RH8WDVPWMNK/(+8ECLBE#.[02_*A9VBF.QDFM
MP#X0^$/[17[2'PE1?"[^&KS6)DO'A2\U6POKA@SR;=IU%)XH)+</N9;B61T5
M&R)_LZQA #]7_P!E;X(>(/#MQ?>,_'5Q'=>+=:CB22&-4-OI5G&S/'IUHWS,
M$#-ON=CM'+,J,3-)&UW< 'R!\+/B5\2/V9=>\2S:MX7US6O!^I^)-4ETXV/E
MW%U9A[J]=WAL!_I!M[EQ&^Z1K>W4$W$9D>Z'G !\7?A;JG_!1_Q+X;GNO#VJ
M:#X5T*2Z?4)-:C%I=7C2M:L]G!9QR^>J.D2*+O>B 23[2);=8YP#]CJ "@#Y
M_P#VI_@I_P -$^"]7\,+)Y,M];C[/(6V*+B&1)[?S&\N4B(RQ1B;:C.8BX3#
M[2 #X _X(W>*95\):QX9OY+A=2T;6)1+97"RJUG#/&@6,+( L>;B&\+PKADE
M$C.BM("X!^E_QH^$.E_'KP_?>&M961K&_C"2&)S'(C(ZR1R(W(#QR(DBA@R,
M5"NCH61@#^?'0/AQ\<O^"<^L7%CX8L[C7="N;B22-8+*2^L[K9&$6:6" M<V
M4N)$#@/#YLD(0274$ 8@'W_\(/AY\5?VH=8T7Q#\3(=/TC0-)N(M2M-#@B=+
MB:^AC9K.ZE_>230;#<$O%+.#OMA#+8#>TM 'TA^W'^R);_M?>&AIR2QVNK64
MAN-.NG1642%2KP2L%:5;>8;?,\HY5XX9BDODB)P#Y _9D_:7\>?L[Z,GA#QW
MX*\27L^D1P6]C>:-IRWL;VJQ#RXI9(I%MV>%-D8EADD+CY)52>*1Y@#K]>_9
MY\1_MQ^+=%\4>,-/_L+PGHN^6RT6[:"XOKUGDCF66[A$+1VT5PBP1W5I-)-+
M$;:2 1H9S<* >P?\%#O"_BKXM^$+SPAX8T"XU*74?LC27OVNQMK>!8;E9V7$
M]PDTDN8$7:(UBV3;Q.7C,1 #_@GCX7\5?"3PA9^$/$^@7&FRZ=]K:.]^UV-S
M;SK-<M.JX@N'FCES.Z[3&T6R'>9P\@B !\@?\%,_@-\0OVL=1TNV\/>&+C[%
MHWVY?M<^H:9']I:X>)=T47VLNL06W1T:4I*WFE7@B,?S@'Z_?#3Q5J?C#3DN
M=7TBXT6]^59;2>>UN,-L5F:*6TFE1XMS,B,XAE;86:",%<@'XH_MS_\ !/;Q
M+X:\03?$+X8/>?:[B2YN;^UM;AHKR">1)'GN+.0.LLB3@NKVT;-,))-D*20R
M^5;@&A\-/VG/VD_BALT*#PS;V5PUNL<FKZCI=U8^5G;"UVS3RI;/*I<3&&&W
MEW;6*6CQJ8P ?J?\)/V9]+^&W@Z7PA>22:I'?QW?]KWDV8[C49[[=]KFGDC8
M2EY YC5VD>9(5C0S.T8<@'X@>)/V9/BS_P $\?$MQJ?PY2\U?0KN2%0(8!>-
M-&&:5;:_LXP90\81XS>0)&-DO[N>VDN'@0 ^L/"?AOXS?MSP6EIX[LM/\.^#
MFN(9-2L?LTT%YJ<,-P)?)\J666ZM\26RKYGF6+>7/YR"Z4*@ /N_]N+X0ZI\
M=_AYK7A[15C?4;J.W>".1Q&LC6]U#<F,.?E5W6(I&7*IO9=[QIN=0#\\/^"?
M_BSXJZ1X<M? 7_"*7&E6EI<,K:_>[[)K6TNIWN)FBL[N!_M=V,W"V[(&MXY7
MM?M,!B5S, '_  4S^ WQ"_:QU'2[;P]X8N/L6C?;E^USZAID?VEKAXEW11?:
MRZQ!;='1I2DK>:5>"(Q_. ?K]\-/%6I^,-.2YU?2+C1;WY5EM)Y[6XPVQ69H
MI;2:5'BW,R(SB&5MA9H(P5R =AJVDV^OV\MG>11SVT\;Q30RHKQR1NI5T=&!
M5D92596!# D$$&@#\<?^"<7[%&L? CQ1K]QXCAN'M]'N)+709IO+%O-]J"FZ
MO[>'=*T4LMO%9QF6-QA))K21I)(9$A /V>H _''_ (*$_P#!/;5/BKJB>//
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'A_QB\2>()+>XT;P
MK:2-K%Q9R>1J,VR+3["2176&6>61)6F<,CLMO;079WK&MRMK!<1SL :'P!^#
MEG^S_P"%],\,6+;XM/MQ&TN&7SIF)DGFVN\A3S97DE\L.RQ[]BG8J@ 'L% !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M_ 'C_2_BGI=MK6BW,=YIUY&)()XR=K+D@@@@,KJP*21N%>-U:-U5U90 =A0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\H?M
M4_MD^&OV0;>QGU]+R:349)4MX+.%9)"L*J99"99(8E1#)$I!?>QD7:C*LC(
M?/\ J'CRP_;W\0>'5\*O)<^%?#FJ)K&IZJT$UJ&U"U1OL%C:FX16E?=(TU\O
MDA$MVAVW,<LBHX!^E] '/^*=?_X1BSDNQ;W%TR;0EO;1^9-*[L$1$!*HNYF4
M-)*T<$*YEFEBA2210#YP^%'PAU2X\8ZMX^\1+'%=WMG;:=I-BKB233]-CQ/+
M%<21;89+B>X)EE5?M*VY3RX;V>%L@ ^KZ "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M;Z<\TL$4<<ES()9W1%5I9!&D0>0@ NXCCCC#-DA(T3.U5  -"@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#C_&OP]T;XE6ZV
M>N:?9ZE;)()4AO+>*XC60*RAPDJLH<*S*& R S#."<@'0:3I-OH%O%9V<4<%
MM!&D4,,2*D<<:*%1$10%5%4!550 H    H T* "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /D
M#Q_^W3X&\!>(;#PI]N^WZU?ZA;V'V:Q"S_9I9YFM\W4NY8HO+E79-#O:Z3<K
M?9RIS0!]?T % !0 4 % !0!Q_C_Q_I?PLTNYUK6KF.STZSC,D\\A.U5R
M69V8A(XT#/([+&BL[*I ./\ ^%_>%_\ A%_^$T_M.W_X1[[/]H^W9.S9G;MV
MX\SS=_[GR-OG^?\ N/+\[Y* .@\+?%70_&FAQ^)K"_MY=%EMVN1>EPD*PH"9
M'D9]OE>7M83+)L:%D=9 C(P !Y__ ,-8_#S_ *&OP_\ ^#:R_P#CU !_PUC\
M//\ H:_#_P#X-K+_ ./4 '_#6/P\_P"AK\/_ /@VLO\ X]0![!X6\6:=XYLX
M]0TJ[M[ZRFW>5<VTR30OL8HVR2,LC;65E;!.&4J>010!T% !0 4 % !0 4 %
M &?JVK6^@6\MY>2QP6T$;RS32NJ1QQHI9W=V(545069F("@$D@"@#Y@^%7[:
M?@[XW^*KKPGX<N9+^YL[.6ZFNXH_]#Q#<);O$DK,K2OND1UDB1[=XV#).Q^6
M@#ZOH * "@ H * "@ H * "@ H * "@ H * "@#Q_P '_'[POX_US4?#6EZG
M;W.KZ3C[;:H3NCR=K8) 27RV(CG\IG^SRE8I?+D8*0 \'_'[POX_US4?#6EZ
MG;W.KZ3C[;:H3NCR=K8) 27RV(CG\IG^SRE8I?+D8*0#0D^+VEV/B"/PQ>-)
M::G<QR36*3H5COHH4C:9K68;HI'B+E9;=F2Z01O.8/LQCGD /4* "@ H * "
M@ H * /+_B;\:/#_ ,'D@;6[Z.VDNY%BM+<!YKJZD:2.():VL*R7%PX>6,,L
M$<A4.&8!>: /C#PY_P %1O UWKA\/:Y;ZQX:O1Y8/]M62VJJ\IC\M)=DLSP;
MED$OF3K% L0+M*H*[@#]'Z /'_%/[0O@WP->2:?JOB#1[&]AV^;;7.HVT,R;
MU#KOCDD5UW*RLN0,JP8<$&@#G_\ AK'X>?\ 0U^'_P#P;67_ ,>H /\ AK'X
M>?\ 0U^'_P#P;67_ ,>H ]0\%?$+1OB5;M>:'J%GJ5LDAB>:SN(KB-9 JL4+
MQ,RAPK*Q4G(#*<8(R =A0 4 >7^-?C?X5^&MPMGKFMZ7IMR\8E2&\OK>WD:,
MLRAPDLBL4+*RA@,$JPSD' !S]E^TWX%U%)I8/$NAR1VT8EG=-3M&6*,R)$'D
M(E(1#))'&&; +R(F=S*" 9__  UC\//^AK\/_P#@VLO_ (]0!V'@KXW^%?B5
M<-9Z'K>EZE<I&97AL[ZWN)%C#*I<I%(S! S*I8C +*,Y(R =AXI\6:=X&LY-
M0U6[M[&RAV^;<W,R0PIO8(N^20JB[F957)&68*.2!0!X_P#\-8_#S_H:_#__
M (-K+_X]0 ?\-8_#S_H:_#__ (-K+_X]0!ZAX*^(6C?$JW:\T/4+/4K9)#$\
MUG<17$:R!58H7B9E#A65BI.0&4XP1D ["@#Q_P 4_M"^#? UY)I^J^(-'L;V
M';YMM<ZC;0S)O4.N^.2177<K*RY RK!AP0: #PM^T+X-\<WD>GZ5X@T>^O9M
MWE6UMJ-M-,^Q2[;(XY&=MJJS-@'"J6/ )H ]@H ^4/BA^W-\-_@Y<?8]8\06
M:7(DFB>&W\R]DAD@8+(DZ6:3M ZL=NV81DD. "4?: 'PO_;F^&_QCN/L>C^(
M+-[DR0Q)#<>992323L5C2!+Q(&G=F&W;")""4! +IN /J^@#P_5OVF_ N@7$
MMG>>)=#@N8)'BFAEU.T22.1&*NCHTH975@596 *D$$ B@#T#P5\0M&^)5NUY
MH>H6>I6R2&)YK.XBN(UD"JQ0O$S*'"LK%2<@,IQ@C(!V% 'C_BG]H7P;X&O)
M-/U7Q!H]C>P[?-MKG4;:&9-ZAUWQR2*Z[E967(&58,."#0 >%OVA?!OCF\CT
M_2O$&CWU[-N\JVMM1MIIGV*7;9''(SMM569L X52QX!- 'L% !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M4AL+N=9VE74([:1K8WD9F(N'</&!=.ZX+R12[D-QY$0!^A] !0 4 % !0 4
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M1HJ*9)K:.65R% !>21WDD;J[LSL2S$D ^CZ "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H _ '_@L
M)\-?%%EI,&O:IXC^V:0^L+!9:)%8"VAM?-MYF65YA/(]S*JP%2\J\--,8A!&
MYA(!]O\ [%/PJ\=Z7HOA?5;[QC]LT Z/9R+HG]BVD6V&6Q400_;4<S'R"T9\
MPC=+Y6& WM0!\ ?\%)M?_P"$4^.O@W4/L]Q=_9+?19_LUK'YMQ-Y6K73^5!'
MD;Y7QMC3(W.0N1G- 'U?\>?V=?C3\:M+DU^W\4R:+J:QR3VGA?3G:VBA#%,6
MLFJPSQ&YN/+0$RS1FW%TTB1/!;/YH .@_P""5'[56J?M#^&KS3->EDNM4T*2
M",WCJ-T]K<*_V<RR;RTMPK0S+)(50N@A=FEF:9R >H?MB?M5ZC\.]1TWP#X/
MB\[QGX@V+:R21.]OI]O*[QF^F"QR>9L\N5P@61(DADN)U,<:PW !Y_\ $O\
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M^+-7_MG6F_>75RL$$$*,P'[F!(88<Q1XP))5,LK%I"(U9(8@#X \'_%O7/\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MFCMY)&@:WM[>UO9#$=C.ELT,[R'*H4B:02"+]Y0!_6;0!\ ?\$N/^20^'O\
MN(_^G*[H S_^"AG[%EO^U/X?>\TRVC/BK3XP=/F\Q83/&'W26DKE2K(REVMQ
M(4$5P5/G1127&\ _-#]FC]LV6;X>>)?A5XGAN(-7L/#^O0Z=+*)2[K;V5U)+
M97*R9>"6V576+.R(01"W*Q20H+@ _;[]D[_DGGA3_L7])_\ 2*&@#Z H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M]CTW5/[.B74Y!)]GAO$><06TSI$T<7GI+<2B6:2*.-+20DE=S( ?H_\ MO\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M+_._L'2M/TS[1L\_[%:0VWF^7NV>9Y*)OV[VV[L[=S8QDY /0* "@ H \_\
M'7PG\/?%#R?[>TK3]3^S[_(^VVD-SY7F;=_E^<C[-VQ-VW&[:N<X& #0\%?#
MW1OAK;M9Z'I]GIML\AE>&SMXK>-I"JJ7*1*JERJJI8C)"J,X P :'BGQ9IW@
M:SDU#5;NWL;*';YMS<S)#"F]@B[Y)"J+N9E5<D99@HY(% 'QA^W!X_?Q'X.@
M\.>&;F.;5O&LD.FZ6\)CGC>UN=KWET^T2,;);,R>==01RF$312#;E9% /L_P
MGX6L_ VG6FE:?'Y-E8V\-M;1;F?9#"@CC3<Y9VVJH&YBS'&22<F@#H* .?\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >?\ Q+\#S_$33GT^
M#5-0TCS=PDN=.:W2X*,C(R+)/!<>5G<&$D(CG1T5DE3!# 'R!^SU_P $\=%_
M9?U%]0\-:[X@A\[RA=6TD]C+;W21.'"31M8_[RB2,QSQI)(L<L?F,2 ??] !
M0 4 % !0 4 ?/_[2G[->A_M4Z'_8&O\ VA;=;B.YAFMI!'-%-&&4.A97C.4>
M2-ED1UVN2 ) CJ <A^S/^Q9X._9121O#]M(]]/'Y4^H74GFW4L?F-($R%2*-
M,E0RP1Q"01Q-()'C5Z /J^@ H * "@ H * "@ H * "@ H * /+Y/A#I=]X@
MC\3WBR7>IVT<D-B\[EH[&*9(UF6UA&V*-Y2A:6X97NG$CP&?[,(X(P#U"@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M[62U=,64$%D/FAN(F\CS9?*A+&&X)N)O._TD _4^@ H * "@ H * "@ H *
M"@ H S[+5K?47FB@ECDDMI!%.B.K-%(8TE"2 $E',<D<@5L$I(CXVLI(!H4
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MVGQ#N9+C5OMEP\(FN5N[B*U;9LCGN%+B1_,$TBGS)BL,D<>]=GDQ 'V?0 4
M% !0 4 % 'Y0?\%0/VO/%'[*W_"-?\(U);Q_;;B[FNO.@$OFI9_9L6YW'Y8I
M//;S3'LG^5/+FB^;< '_  5 _:\\4?LK?\(U_P (U);Q_;;B[FNO.@$OFI9_
M9L6YW'Y8I//;S3'LG^5/+FB^;< ?I_XIT#_A)[.2T%Q<6K/M*7%M)Y<T3HP=
M'0D,C;652T<JR03+F*:*6%Y(V /E#X0_M W^A^)5^&WC0QMXECLWN[/4X?)B
MM=7LT;9',L'F>;!>L%F-Q9JC1H;:>>*3[.4  /L^@ H * "@ H * "@ H *
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ? '_!4?_DD
M/B'_ +AW_IRM* /G_P#X(J?\D\U+_L8+G_TBL: /U_H _GA_X*3:!_PE?QU\
M&Z?]HN+3[7;Z+!]IM9/*N(?-U:Z3S8),'9*F=T;X.UP&P<8H _;[_A0/A?\
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M(P#W#_@HS\!M+^-7P^U:XO(XUOM%L[G4;&[,9:2%K9/.FC4AT.RXCB,+ABR
MF.8QN\$> #Y__P""/_[0-Q\4_!UQX<OC))<^')(HHIFW,&L[GS&MD+O([%XF
MBFB"A8XX[=;9$#$/@ ^</V!?^3A?'O\ W'__ $\V] 'ZG_MJ?#W1O&/@7Q!>
M:GI]G>7-AH>K2V4UQ;Q326TGV1VWP/(K-$^Z-&W1E3E$.<J, 'Q?_P $5/\
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MGA"<7 \-Z=<:C/\ V2MQ)]CN_P"S=32&RBOHV9OM<4'FF1$F+;I$7>71I4D
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M<85%W,S,V ,LQ8\DF@#H* "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@#X _P""H_\ R2'Q#_W#O_3E:4 ?/_\ P14_Y)YJ7_8P7/\
MZ16- 'Z_T ?@#^WU_P G"^ O^X!_Z>;B@#]_J /P!_X(8_\ ,W?]P?\ ]OZ
M#_@N=_S*/_<8_P#;"@#]_J /C#QY\%_A]^W587;:E8QSW-C>7VEO=QE(]0M+
MBQFGMROFQ,S! S-=06\^^%TEAGDMR6"@ _#'XL^ /%'_  2D\<V5_H]_<7'A
MZ^N!<0QK<"+[=;VS 365]$%:,RQI<%$N/*9!YRW,(CF#Q0@']3M !0!^ /\
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M5K/?;+)9RP0Q>;LE0@'])VDZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515
M554 *    * -"@ H * /G#]L35K?1?ASXJENI8X8VT/48@\CJBF2:VDBB0%B
M 7DD=(XUZN[*B@LP! /S _X(?>"KBPT;Q)KC-&;:\O+.SC0%O,$EE%)+(6&W
M:$*WD00AB25DRJ@*6 /W.H _#'_@N#X*N+_1O#>N*T8MK.\O+.1"6\PR7L4<
ML94;=I0+9RAR6!!:/"L"Q4 _3_\ 9,_:!M_VFO!VG>(XC&+F6/RK^&/:!!>1
M86=-@DE:-"W[V!9&,AMY(78 O0 ?'/XWW'PXU3PWH&EV\=WJWB'5$@6*1F18
MM/M@)]3N@?E1GA@XCB,B.SR*Z)-Y;0N ?BA^V/-J/[,W[0FF>-;N7[+I>H7&
MG3B\6%Y56S2&+3]1B8&)@TJQ+(S)#YDB13P.I65U"@']'U 'X0_\%5M%_P"%
M\^/O _@"S6X6]F\V2:=(/.6*WU">*$S!%<._D+97$\X;RT6)5;S,;S& <_\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MSPYXMTK0S9W>L:?>:TOEK%J+:3)'"RJ(PS3V<=^-\KXD8M#-;1!G7; %C*.
M? 'P8_X)V^*/@?XMN_&ECXRM[C5-0^U?;A<Z &AN?M<@FEWI%J$13]ZJ2KY+
M189 O^J+QL ?4'[;_P"RU_PUQX2?0HKK['>V]PE[92,,PFXBCEC6.<!6?RG6
M5U+1_/&Q64+*$,,@!X?^R9^R/X\^'-OIUGXY\31ZCI.C2;M/T6VB66W+1*/L
MLEQ=SP1W$J6[L[V]J5*030V<T<J_9XXD /TOH \_^*OPTT[XR:'?^'M53?9:
MA;O!+A49DW#Y98_,5T66)MLL+E6\N5$<#*B@#\L?^"3DEQ\)7\5_#76(XX=6
MT?5/M9/F,&N8YHTMVEAADCCE-NHMX)4GQB1+R$E8]R&0 _8Z@ H * /S@_:E
M_8O\6_M;:=:Z5K?BK3[:RM;@W(BLM D3S)@C1H\C3:K._P BO(%5"BGS&+AR
ML90 ] _9B_9I\6_LS:/:>'8/$FGZAI%K</(L<^AR)<+#+)YLT,4\6IJB[F:1
MTDEBG9'D.0\:I$H!]OT % 'Y(>-?^"=>L_"[QBOCCX1ZE9Z/<R2#[3I%XDJZ
M>\;[FN(PT D;[/(RQ8M/+ B?=+!<0&*WCB /4/%/[.7Q*_:;LY-$^(NL:/I^
M@/M\^S\.6\K37VUA+'YMUJ2R&V\B6*%T\A'\Y6ECDV_(P /L_2?ANGPX\/Q:
M%X06STJ.TC2.S$MM)<V\2APSEXDN+>65W!<M(9U=IG,TC2-N#@'YX?!C_@G;
MXH^!_BV[\:6/C*WN-4U#[5]N%SH :&Y^UR":7>D6H1%/WJI*ODM%AD"_ZHO&
MP!]O_M'_  LUSXTZ'<Z!I&KV^D6]_;S6U[-)IYO9GAF"JR0DW4$<6Y/-CD9T
MF8K(#&89$#D \ _8R_8XUS]CZ*;38?$5OJ6BW-P;F:UDTDPS+,8O*+PW*WS[
M-VR'S%ECG4K$%C$3.\A /I_XZ? O0_VB]#G\/^((/.M)OF1UPLUO,H(2>!R#
MLE3)P<%64M&ZO$\D; 'XH^&/^"3_ ,2_A5JDL/A?QE'8:3<26XN+JVN+ZRNI
M(T'S,]I;[HI'B+R^2C7.'!R9(?,8* ?J_P#LK?LD:7^RU;WSV]W>:GJVKR13
MZKJ-Y(6DN9T5B6"<A$,DDTHW&68F9A)<3;4*@'U?0!^2'[*GP&TO5OC+XX\<
M:;'&=+LKR33K8O&7;^UI4ADU:2-IG\Z%XI?-B)5!%*EXZPR>2A1@#];Z "@
MH * /S _X*S^.O[*^'X\-VT/VO4O$>H6=E:VL;YN&\J9+DR0P*K23_/%#;E4
M P]S&=VXJC@'UA^R9^S];_LR^#M.\.1",W,4?FW\T>TB>\EPT[[Q'$TB!OW4
M#2*)!;QPHQ)2@#Z/H X_Q_X TOXIZ7<Z+K5M'>:=>1F.>"0':RY!!!!#*ZL
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MWU?Q9/;P00W4^FQFQT^$,LMQ!;VUM)922><^?.N/,MVN!#9,\(%JL; 'R_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % &?JVIIHMO+=2B1H
MX8WD<11232%44L0D42O+(^!\L<:L[G"JK,0" ?SX_;-:_P"&AO\ A87_  C'
MBC_A'OM'D^?_ &%?;]G]F?V=]H\GRO,\K?\ OL8\_P CGR?._<T ?T':3J::
MU;Q740D6.:-)$$L4D,@5U# /%*J2QO@_-'(JNARK*K @ &A0 4 % !0 4 %
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MG)/J6G7&DZ@FU+NQG*R>3-L5V$5Q%F&YBPX*3PL5/,;K%<1S01 'H% !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 ?DA\//VM/C=XRUG4]%E^'\=O)YDB65U<
MR3VEG9*LK1>9<W,@>+4D0O$Y%@87GCCEDA1E<&( ^_\ ]GCX(6_[/OA^'1HK
MB2^N3)+<W^H3*HN+Z\N',D]S.1EF=F.U3(TLBPI'&TLA3>0#W"@ H * .?\
M%.O_ /",6<EV+>XNF3:$M[:/S)I7=@B(@)5%W,RAI)6C@A7,LTL4*22* ?('
MPM_9]USQ?XHM_B)X[N?^)I;V\B:1H5NY-GHBW =)@TRMB]NWB*I//M2+S#($
M66*.S:  ^WZ "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M@ H * ./^(7C6W^&NC:AKEXLCVVFV=Q>3)$%,C1V\32N$#,JERJD*&903C+
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M]\0ZEH-MI-Q8?9+=[NUGDG27S[=)DA)F157R)?WL+"-&N$YD'FCRU,H!^C]
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MW[ 'P^U_QC+XTO-+CGO)XW$UG*J/I\EP^0]V]JR%6N&4D,6)A9R;@PFZ/GT
M?7^DZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515 554 *    * -"@ H _
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MV-E#N\JVMH4AA3>Q=MD<85%W,S,V ,LQ8\DF@#H* "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /A#XC_M5/8?%OPQ\
M.M+EC*SQWMUK1"QNP46-Q):6P;>S1/NC^TS*41RAM620Q22HP!]WT <?X*^'
MNC?#6W:ST/3[/3;9Y#*\-G;Q6\;2%54N4B55+E552Q&2%49P!@ ["@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * /P!_X+G?\ ,H_]QC_VPH _?Z@
MH _,#_@KG\2]1^'?PU:#3W\K^U]0@TZYD#.KBW>*>>149&7'F?9Q#(&WH\$D
ML94[P5 /K_\ 9._Y)YX4_P"Q?TG_ -(H: /(/!__  3J^&O@W7-1UU-&M[EM
M1QBRNXHKBQM,G=)]DMGC*1>8P#'=O\H?NH/(A9HF /M^@ H * "@ H * "@
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M[4!(,A=V /H"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MC_TZ[C\QS=72/!YID>"%H[=(G(!\P?\ !)KXAZYX"\3>(_A7JLWVJWTC[5+
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M+^.O$?PPU'4I-4TG1([Q;62X#&2)M.NX+!5@W2.8;=XV!^S;G2(HGE%,RF4
M^S_^"H__ "2'Q#_W#O\ TY6E !_P2X_Y)#X>_P"XC_Z<KN@#[_H \O\ B]X9
M\0>+]+:S\-:O'H=\\B$WSV*7[)&IRRQPR2QQ!V(52\@E 3>!&'9)(P#\<?\
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M/^(7B2X\':-J&IV=I)?W-G9W%Q#91;O,N9(8FD2!-J2-OD91&NU'.6&$8\$
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M\N/$?@KQ#_9-DFCW6JM/'8F2XO+;[$T\,<,LLD3V6]26,JQ&YC?RV1HC&ZR
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MOA_HWDQ)8Z?.]K-JGFR31HUW*8%N&M+J".Y%Q:A[?RU>V0*TT<DY -_]H_\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H ^4/!6M^.OB5%=7]GJ>AV=LFJ:M9PP2Z+=W$BQV
M&HW-DA>9=8@5W=8 [%8HP"Q 7 Y ,_XL:O\ $/X7^'M5U[^U_#]Q_9FGW=[Y
M']@WL?F_9H7F\O?_ &X^S=LV[MK;<YVG&" ?7] !0 4 % '\@7P$_P",,OC;
M9VFJ\Q:5K$VGRSW/^A+]GNEDLUOG\S>(XO*G6\7+%'BQB4(PE !_7[0 4 9\
MFK6\-Q'9M+&+F6.26.$NHD>.)HUD=4SN9$:6)78 A3)&"077(!_/C^Q[\2_[
M/_:3\40:@]Q<7&IW&NZ=;2%O,V?9KH3QJ[.P98DM[(PQA=VS$4841@E #^AZ
M@#^>']L+X:?V?^TGX7GT]+BXN-3N-"U&YC"^9L^S71@D9%10RQ);V0FD+;MF
M)9"PC " '0?\%SO^91_[C'_MA0!^_P!0!^ /[ O_ "<+X]_[C_\ Z>;>@#[_
M /\ @J/_ ,DA\0_]P[_TY6E !_P2X_Y)#X>_[B/_ *<KN@ _X*C_ /)(?$/_
M '#O_3E:4 '_  2X_P"20^'O^XC_ .G*[H ^ -?\6?9OVMK?^T+O;;P>7:VW
MGS82/S]#/EP1;SM7S+B<[(UQOGF. 9)#D _?Z@#\ ?V!?^3A?'O_ ''_ /T\
MV] 'G_\ P53_ +'_ .%R>&/^$A_Y O\ 9^E_VC_K/^//^T[O[1_J?WO^JW_Z
MK]Y_<^;% 'Z?_P##KCX0_P#0O?\ E1U+_P"2Z .P^'7[$'PP^ NMV&LZ/ID=
MAJRR2Q6,CZA>.SR26\WF)''/<NDC^0)V*[6*HKR #864 _-#]OK_ ).%\!?]
MP#_T\W% '[_4 ?@#_P $,?\ F;O^X/\ ^W] !_P7._YE'_N,?^V% '[_ % '
MX _\W>?Y_P"A<H _9[XZ?'30_P!G30Y_$'B"?R;2'Y41<--<3,"4@@0D;Y7P
M<#(55#2.R1))(H!^>'PIT7XF_MV6\7B+7]7O/!GA>63S-.TS1F-OJ%W!MF\J
MXEOFS*B$21 90PWB1^<MI;@P3R 'RA_P39\+6?@;XZ^,M*T^/R;*QM]:MK:+
M<S[(8=6M8XTW.6=MJJ!N8LQQDDG)H _1_P#X*C_\DA\0_P#<._\ 3E:4 '_!
M+C_DD/A[_N(_^G*[H ^_Z "@#\ ?^"&/_,W?]P?_ -OZ /O_ /X*C_\ )(?$
M/_<._P#3E:4 '_!+C_DD/A[_ +B/_IRNZ /@#]OK_DX7P%_W /\ T\W% '[_
M % 'X _\$,?^9N_[@_\ [?T ?1__  6>U:XT[X<VD4$LD<=SKEK%.B.RK+&+
M:[E"2 $!T$D<<@5L@/&CXW*I !]@?L+>-;?Q_P##+PQ>6JR)''I=O9D2!0WF
M6 ^Q2D!68;&D@=HSG)0J656)4 !^W3X*M_'_ ,,O$]G=-(D<>EW%X#&5#>98
M#[;$"65AL:2!%D&,E"P5E8A@ ?'_ /P1ATFXT[X<W<L\4D<=SKEU+ [HRK+&
M+:TB+QD@!T$D<D99<@/&Z9W*P !\X?\ !#'_ )F[_N#_ /M_0!^_U 'X _L"
M_P#)POCW_N/_ /IYMZ /O_\ X*C_ /)(?$/_ '#O_3E:4 '_  2X_P"20^'O
M^XC_ .G*[H ^ /V^O^3A? 7_ ' /_3S<4 ?N=X_\?Z7\+-+N=:UJYCL].LXS
M)//(3M5<@   %F=F(2.- SR.RQHK.RJ0#\L/A[X[^(O_  40EN;W3;VX\&>
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MO^XC_P"G*[H ^ /V^O\ DX7P%_W /_3S<4 >_P#_  6K_P"2>:;_ -C!;?\
MI%?4 '[*O[!7PA^-/@;0=>;1OM=Q=Z?!]KG^VZE%OO(E\F\^3[0BC%PDJ_(H
MC.,QYC*D@'N&K?\ !,[X,:!;RWEYHD<%M!&\LTTNJ:@D<<:*6=W=KP*J*H+,
MS$!0"20!0!^A] !0!^ /[ O_ "<+X]_[C_\ Z>;>@#]_J /P1_X(:Z3<0V_B
MN\:*06TLFEQ1S%&$;R1+>-(BOC:SHLL3.H)*B2,D .N0#/\ ^;O/\_\ 0N4
M?O\ 4 ?@#_P0Q_YF[_N#_P#M_0!]W_MZ?L%V_P"V);VEY9W<>G:WIT<Z0S/
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M_@MIX3_MG4?!_P!AM/.U*\_M&U7R8=]Q/M>S\B ; 9),/-)Y48SAY7VC<[9
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M>XB%P4A62.=G:U2<F2@#[?\ ^"7'_)(?#W_<1_\ 3E=T ? '_-WG^?\ H7*
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M^X=_Z<K2@ _X)<?\DA\/?]Q'_P!.5W0!\ ?M]?\ )PO@+_N ?^GFXH ^C_\
M@L]JUQIWPYM(H)9(X[G7+6*=$=E66,6UW*$D (#H)(XY K9 >-'QN52 #[@_
M8[U:WUKX<^%9;66.:-=#TZ(O&ZNHDAMHXI4)4D!XY$>.1>J.K(P#*0 #\D/^
M"YW_ #*/_<8_]L* /W^H * /R _X+5_\D\TW_L8+;_TBOJ /O_\ 9._Y)YX4
M_P"Q?TG_ -(H: /@#_@M7_R3S3?^Q@MO_2*^H ^__P!D[_DGGA3_ +%_2?\
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M?3TN+BXU.XT+4;F,+YFS[-=&"1D5%#+$EO9":0MNV8ED+", ( =!_P %SO\
MF4?^XQ_[84 ?O]0!^ /[ O\ R<+X]_[C_P#Z>;>@#]_J /#_ -IO5KC0/ OB
M6\LY9(+F#0]3EAFB=DDCD2TE9'1U(975@&5E(*D @@B@#\P?^"(_C6WO_"NN
M:&JR"YL]42\D<A?+,=[;I%&%.[<7#6<I<%0 &CPS$L% /VNH _GA_P""7WPT
M_P"%=_&3QAI]BEQ+IND6^IZ<MS(N[&S4X$@6:1%6,2R);R,  F_RY&50J,%
M.@_;Z_Y.%\!?]P#_ -/-Q0!^_P!0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M6^+_ (LL?[,^TY70].E!2[2%K>.WBNKJ..>1891:#R9;>4NWVB6=C%;^3#O
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M76KV5Q)#_:*Q++I=K#>7,MQ]KOI/-@>/RE>X9+4$->&W6&*XCDG_ '(!S_\
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M!^Q_^S79_LK>$K70(/FNVQ<ZE,)&D66^DCC6=XRRIB(;%CA4(A\I$+@RF1V
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MK)&]K"A'VDQ>5$Z&V;<)S$',D2QM([,B@'A__!6S2]:^/NHZ+I_AK0/$%_\
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MZ]OM'U&VMHMRIOFFMI(XTW.51=S,!N8JHSDD#)H _"'_ ()H_M47GP-T[5O
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M*/#]S/KZQQZ[KVJ7NM:K!"X>WM[J^<$P0'DA(XTB5@7G'G"3;/)&4:@#ZOH
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * /A#]J;2;C]JFP7P+H<4DVG7&J6T7B'4BC1
M6]K9VDWGSI:7,@V7%Z9K<6X6VCO8[:99H;P6K[30!]WT % !0 4 % 'Y ?\
M!:O_ ))YIO\ V,%M_P"D5]0!]_\ [)W_ "3SPI_V+^D_^D4- 'T!0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MN*J0 >P4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'A^K?M-^!= N);.\\2Z'!<P2
M/%-#+J=HDD<B,5='1I0RNK JRL 5(((!% 'L&DZM;Z_;Q7EG+'/;3QI+#-$Z
MO')&ZAD='4E61E(964D,"""0: -"@ H * "@ H * "@ H * "@ H * "@ H
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M>!K.34-5N[>QLH=OFW-S,D,*;V"+ODD*HNYF55R1EF"CD@4 <_\ "WXI:/\
M&G1[?7M!N/M>FW?F>1/Y<D6_RI'A?Y)D208=&7YE&<9&5() //\ 0/VI_!?B
MGQ1<>"[+5[>77[;S!): 2#YH@&EC24H(998P29(8W>6/9+N1?)EV 'T!0 4
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M2=6M]?MXKRSECGMIXTEAFB=7CDC=0R.CJ2K(RD,K*2&!!!(- &A0 4 % !0
M4 % 'C^H_'[POI?B.U\(2:G;G7[SS?*L(R99E\J 7+><(PPM\Q'S(_M!B\U<
M^7OP: /8* "@ H * "@ H * "@ H S]6U:WT"WEO+R6."V@C>6::5U2..-%+
M.[NQ"JBJ"S,Q 4 DD 4 >?\ PJ^-'A_XWV]U>>'+Z._MK.\ELIIH@_E_:(51
MG5'9565-LB,LL1>%PP*.PH ]0H * "@ H * "@ H Y_3O%FG:O>76GVUW;S7
MMCY7VNVCF1YK?SE+Q>=&I+Q>8H+1[PN]067(YH -.\6:=J]Y=:?;7=O->V/E
M?:[:.9'FM_.4O%YT:DO%YB@M'O"[U!9<CF@#H* "@#Y__P"&L?AY_P!#7X?_
M /!M9?\ QZ@#W#4]6M]%02W4L<,;211!Y'5%,DTBQ1("Q +R2.D<:]7=E106
M8 @&A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '/Z!XLT
M[Q7]H_L^[M[O[)<26MSY$R2^3<18\R"783LE3(WQMAUR,@9% !H'BS3O%?VC
M^S[NWN_LEQ):W/D3)+Y-Q%CS()=A.R5,C?&V'7(R!D4 9]EX_P!+O]4FT1+F
M,:I!&)GLW)2<P$)_I$<;A6EM]TBQFXB#PB8/ 9!-'(B@'84 % !0!GZMJUOH
M%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B H!)( H \?\ @A^TCX3_ &C[
M>XNO"NI1W\=I(L=P!'+#)&SKN0M%.D<H1@&V2;=CE)%5BT;A0#W"@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * ,_5M
M)M]?MY;.\BCGMIXWBFAE17CDC=2KHZ,"K(RDJRL"&!(((- '\V/_  6#^ /A
M?X-WF@7WAW3+?39=4_M#[6ML#'"_V9;)(MD"GR8L!W+>2D?F,Q=]SG=0!^K_
M .RE^REX!N? /AN>?PWH]S<7.CV%S//<V$%S-)-<P)/*[RSH\AR[L54MM1<1
MH%C554 _$'_@IC^S%IWPF\;W?_"+6GD:>='@UF]@5T6&U\^_:P;R$.TK$TK0
M8A3?Y;2ML5+= D0!^YW_  3A_:!N/VA_A]9WE^9'U'39&TR\FDW$SR6Z1LDV
M]Y)'D=X9(6GD<J7N/.(0)MR ?=] 'S!^UY\8[SX-^%Y)-(7S-?U6X@TG0XLJ
MN_4KXF. [I$>%?*&^XQ<;89/*\IG7S : /YX?^"2WPJT/XL^/KF#7["WU&WM
M-'N;F&"Y02PB;S[: .\39CDPDT@59%=58B0 2(C* ?M=^V!^R+X%F^'WB.6S
MT'2]/N;72[J\ANK+3[2WN$DLT-T@658=RH[1".4+@M"[H&4MN !^4'_!(#]G
M7PU\9]4UO5/$-E'J#:1'9I:VUPJRVI:\%R)))874K*ZK"!$'RB%V?895B>,
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MT<S112I%,Z%?D\Y9 @:10 LD@8 ^3_\ @BI_R3S4O^Q@N?\ TBL: /U_H *
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M4-<\/K>?:;Z-H52XN/,CMK=Y1*T$ "*Q0LL0W7#3S 1)B0%I3( ?9] !0 4
M9^K:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22 * /'_V<OC?;
M_M'>&+3Q19V\EK;7LEV(8I65I!';W4UNC/M^57=8A(R*7$98H)) N]@#W"@
MH * "@#\L/\ @K)\&]$\3> =1\47D$DNK:5':1V,IN;@1P+/?V\<Q6W$HMR\
MB.5>1HR[!8P6_=1[ #U#_@EQ_P DA\/?]Q'_ -.5W0!]_P! !0 4 % !0 4
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ML_ VG6FE:?'Y-E8V\-M;1;F?9#"@CC3<Y9VVJH&YBS'&22<F@#H* "@ H *
M"@#/U;3$UJWEM93(L<T;QN8I9(9 KJ5)26)DEC?!^62-E=#AE96 ( /YT?A;
M\+='^"W[4MOH.@V_V33;3S/(@\R279YN@/,_SS.\AR[LWS,<9P,*   ?T?4
M% !0 4 % !0 4 % 'S_;_M"Z=J'CY_ %LGFWMOH[ZI=SK*A6#]_!#%;LBEG\
MUUE,[!_+V1&!E$HGS& >8?MZ?!O1/BKX%UBZUB"2XDT?2]3OK$"YN(HX[J*T
MD:.9HHI4BF="OR><L@0-(H 620, ?)__  14_P"2>:E_V,%S_P"D5C0!^O\
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M !0 4 % !0 4 % !0 4 % 'X _\ !#'_ )F[_N#_ /M_0 ?\$,?^9N_[@_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M]UG5M&M[S7+W2[ZYNHXYTFTF&6.S\N2)& B>6XN&N$W%F2X!B$L;(?(C(.X
M^,/B%\:OB=9_$ZV\!:!_PC\]I<Z?_:TUY<V-TC65B;J6W(=5U+_2I4V1JIC$
M(FEE&4MX@\B 'Z/T % 'YP:W^U7XA^/'BW5? ?PWBM[9M'_=ZMXBU"*:2&U<
M2-;S0VELL826[C8F2W-U(D$[6UROEO"JSL >7_'G4?CA^R;I<GB:UUZS\9V,
M$<@O[6YT6*S:TCRC"[1;*5)9D0*ZS'S (4;S6A= \MN ?<'[*O[3&E_M7^&H
MO$.F1R0,)&M[RUDR6M[I%1Y(A)M594VR(\<J@!T==RQRAXHP#\P/VD_^"A7Q
M#^&WCK1O#TN@R:+8RWEE</:1&UU/5=1L6NY83&@BDDMXGN$78MO&3<).@VWA
M1QD ]?\ B')^TSJFLZ9?Z5'H=GIUS)&9=,BD@FCLX_-5]NISW$:SROLD\J=]
M+=@P@=H8XW9#( ?K?0 4 ?*'[:?[3"?LH^#KGQ L<<]\\D=KI\$OF>7+=2[B
M-YC4D)'&DL[*6C$@B,(EC>1&H ^/])\,?'?XE>#HO%^E>,K--1U*S34;30HM
M'LA;K'<8FBMDO;A6<.(64*9D8";$;W!3==$ ]@_X)Y_MM7'[8NEZ@-3LX[35
MM*DA%RUON%K+'<F4P-$LCR2HX$+I*C,XRJR+)^\,4(!\(?\ !6S_ (6'_P (
M\G_"0_\ "/\ _"-_\) /[.^P_;?[1_U-Y]G^U>=_H_\ J=_G>5_RVV[/DS0!
M]?\ [)W_  N3_A'O"G_(G_\ "-_V?I/_ $$_[1_L[R8?^W?[7Y/_ &Q\[_8H
M \__ ."H_P#PL/\ X1#Q#_R+_P#PAG_$N_Y_?[8_X^;3_MT_X^?_ "7_ .FE
M ' ?L%?\+D_X5QHW_"*?\(?_ &+_ *;]F_M+^T_MG_'[<>;YOV?]U_K?,V;/
M^6>S/S9H ^S_ -NK]IGQ9^S1HDFJ>'M COK:&.)[K5+JYB6UM6DN(X8X_LB3
M)=W+ON(8IY21%XGWS 2I& =A^P5\4M8^-/PXT;7M>N/M>I7?VWSY_+CBW^5>
MW$*?)"B1C"(B_*HSC)RQ)(!^8'[?7_)PO@+_ +@'_IYN* /W.\?Z[?\ AG2[
MF\TO3Y-5OHHR;>QCFA@:>0D!5,UPZ11ID[I')8J@8I'*^V-P#\L/V-OVS?&G
M[0'Q3UOP[XAAM]-LM+T^^7^RH!')Y-S;:A!#NENOG>:5%D>%VB:.VDVB1(%)
MR0#]'_C]\8[/]G_POJ?B>^7?%I]N9%BRR^=,Q$<$.Y$D*>;*\<7F%&6/?O8;
M%8@ _.#X'7WQH_:R\+CQK8^,-/T+[?\ :/L&DP:-!/;C[,6MQYMS<^;<1>;-
M%(SX^U[$8.N<_9XP#L/V!OVVO$'QJUG5/ OC.SCB\1Z+'(9;FWV".46DL=I<
MK.J.R"X$S!]]O_H\H9PL<(B3S@#G_P#@J;??$:R\)ZK/IEQI=CX2BCM4O#'-
M<G5KM9Y5@DB/[D016[/,BR1JY>2*-MTQCF>UH Y#_@F]_P +3_X0GPY_9?\
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MP7IS^(M/\6Z?J5W;[KVYT!-%C6W9(T::2RLYT2:]N<LHMH WD3S(V\SQ2XR
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MT."?QLFGPZU-^\EMM/218;96 VPL\D\_FRKR99$81;CY:!U032@'L% !0 4
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MC1(U+%G8*&=W<L[ 'U?0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M ?.'[8FK6^B_#GQ5+=2QPQMH>HQ!Y'5%,DUM)%$@+$ O)(Z1QKU=V5%!9@"
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M6M7\0:=I_A?PV/[.E33&+W6KW >XLU1)Y#MB@B\V4SD>5!>1R6ZVSPA&DD<
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MW% '[O>+/"UGXYTZ[TK4(_.LKZWFMKF+<R;X9D,<B;D*NNY6(W*589R"#@T
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MA_[AW_IRM* #_@EQ_P DA\/?]Q'_ -.5W0 ?\%1_^20^(?\ N'?^G*TH /\
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M2V\?B6ZM[S5SYDEU+:Q&*W5I= >00P*Q+F*!66WCDD_>RI$)9 )'84 ?I_\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#^?'_@
MN5JUO-<>%+-98S<Q1ZI+)"'4R)'*UFL;LF=RH[12JC$ ,8Y "2C8 /UO_8O\
M6:=XK^'GAS^S[NWN_LFCZ;:W/D3)+Y-Q%90>9!+L)V2ID;XVPZY&0,B@#Y__
M .$LT[_AHS[+]KM_M'_"#_9?*\Y-_P!H_M+[7Y&W.[S?L_\ I'EXW^1^]QY?
MS4 ?7_Q^^#EG^T!X7U/PQ?-LBU"W,:RX9O)F4B2";:CQE_*E2.7RRZK)LV,=
MC," ?SP_\$S_ -G?7/&'CFXTS6Y+B/2/!VH&^O-.^TEK<:U$SV]J?+BG5/-1
MHI)/M"+,C):^0Y,<ZY /Z;M6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ
M"S,Q 4 DD 4 ?S!?\$8=6M].^(UW%/+'')<Z'=10([JK2R"YM)2D8)!=Q'')
M(57)"1N^-JL0 ?TV^+/"UGXYTZ[TK4(_.LKZWFMKF+<R;X9D,<B;D*NNY6(W
M*589R"#@T ?S@_L0^*;S_@GA\2M0\)^/9/[-LM4MXXOM&U6LY)DE_P!"O/M#
M!76T96N8O,&%CDDQ<I$896MP#^D[2=6M]?MXKRSECGMIXTEAFB=7CDC=0R.C
MJ2K(RD,K*2&!!!(- 'YP?M,?M%67Q[2/X9^ +V/5-4\0Q^5J&H:>T%Y:Z5I+
MR+'>W-P^XPL[1%X4@#QRYD!$D4SVBS@'Z/Z3I-OH%O%9V<4<%M!&D4,,2*D<
M<:*%1$10%5%4!550 H    H _/#_ (**^+-.\-?\()]NN[>VV^.-&NF\Z9(\
M6]MYOGSG>1B*+S(_-D/R1[TW$;ER ?H_0!Y_\5?AIIWQDT._\/:JF^RU"W>"
M7"HS)N'RRQ^8KHLL3;987*MY<J(X&5% '\^/[-?[,_B7]E#XY>'/#VL223Z6
M9-8N-+NEW"UN%?39DEECC+,L5QMC@2ZBR70I%EI(3;RR ']%WBSPM9^.=.N]
M*U"/SK*^MYK:YBW,F^&9#'(FY"KKN5B-RE6&<@@X- '\X/P4_M'_ ()/_$J2
MR\6_:)O#>L6[6\>H6^\6\J++&T5ZUN-^^6W^:.>WR9[=+B1XC.CQ?:@#^C[P
MMXLT[QS9QZAI5W;WUE-N\JYMIDFA?8Q1MDD99&VLK*V"<,I4\@B@#\4?^"A/
M[3#_ +3:)\+OAI')K]S=26\^J7-AY=Q:B!9$,4/G!60()FMY;BZ$D4-L42%Y
M6,EPD(!^C_[%G[,Z?LH^#K;P^TD<]\\DEUJ$\7F>7+=2[0=@D8D)'&D4"L%C
M$@B$QBC>1UH \/\ ^"BOBS3O#7_""?;KNWMMOCC1KIO.F2/%O;>;Y\YWD8BB
M\R/S9#\D>]-Q&Y<@'Z/T >?_ !5^&FG?&30[_P /:JF^RU"W>"7"HS)N'RRQ
M^8KHLL3;987*MY<J(X&5% '\^/[-?[,_B7]E#XY>'/#VL223Z69-8N-+NEW"
MUN%?39DEECC+,L5QMC@2ZBR70I%EI(3;RR '])U !0!_.#^TA\2+/X1?M+P:
MYXQ2X?0[3[&UL9H6G2*%M/"1SV\;YS%!>M).3 &9)XYGC5KE2I /K_\ X*3?
MM.^%_''PXUK1=!N_[9N)/[-,\VFH;RSLT:]21'O+R'=;0;S;-%'&TAG>1X\1
M>6QD4 Z#_@F3\=-#L_ GA3PG#/\ :]:N/[6::UML3-90Q7=U,9[[:?\ 18GW
MPQ1&7#32W$(C5E+N@!\@?\)9IW_#6WVK[7;_ &?[1]E\WSDV?:/[#^R>1NSM
M\W[1_H_EYW^?^ZQYGRT ?L?^V)JUOHOPY\52W4L<,;:'J,0>1U13)-;211("
MQ +R2.D<:]7=E1068 @'P!_P10U:WF\"ZK9K+&;F+7)99(0ZF1(Y;2U6-V3.
MY4=HI51B &,<@!)1L 'P_P#!GQ:G_!+KXO:IHNNF\/AR]C\E)E:1E^RRR++9
M7[QB*-;IX%$EO.84!C=KP0^84\F4 _4_]J3]LGP-K_P\UF/2-6M]6N]6T>]@
MM;*P=;B\_P!(LI6,LULI$MO%!$'GNGN%C\B.-PP\W;$P!\H?\$8?C)HEAH-W
MX0>>0ZW/JEU?););7#J+46MI'YTDZ1-!$F^-HQYLB$N40 M)&& /W.H ^(/^
M"D/]H_\ "J/$?]E_:/M'V>#?]GW[_L_VJ#[5N\OYO*^S^;Y^?D\CS-_[O=0!
M\8?\$S?VL_A]\.?AN--U/4;/2-1TN2[FU!+C9#)=F6266.>  E[Q_)5(-L8>
MX4PI%Y>PVYD /E_3/B]I<W[4)\0ZBTFCZ<LDJ-)JR'3F14T1K:.21+GRVB29
M@KP"4([)+%E$=M@ /O\ _P""@7Q>TOXF? W4M7M6D@MM4DLTT\7:&VENE34H
MF22&*3#LDT,#W< P':UQ,R( P4 ] _X)6:M;ZC\)-%B@ECDDMI-0BG1'5FBD
M-]<2A) "2CF.2.0*V"4D1\;64D _/#_@H)XLTZR_: \'3RW=ND6G_P!@_;9&
MF15M=NJ33MY[$XBQ$Z3'S-N(G60_(P) /Z'J /PA_P""MWP1O/ VHZ1\5_#J
M^3>V-Q;Q7TL<2OLFA<26%XZ^2R-M9?L\LER[*<6,"H1D4 ??_P"P3X6O)/"[
M>+]:CQK_ (NN)-7OG++)B&4D6$$+Y>1;2*U\IK>WEDE:W\V1,IDQJ ?;] !0
M!\(?$;]L2R^#'Q2M_"&OSQVVDZGH=O=6]Y-+!!;VEU'/?^;Y\DNP[+B.**-6
M,A"311HL1\^1U /G_P#X*^_"'PUKW@B3Q1?+'#KNG26T&GSAUCDN%FG426C
M\SHL;37*(/GB,<DB,L;7"R &!X\^$/B73/V8'T345DFU:WTN"[ECE=ED@M8;
MY+_R7^T>6R/:V:B-H,9C,)@B#[4# !_P3$_:W\%:)\/+/P]JFKV>EZCI,ERD
MT>H7$-JLJW-U/<QR6[RNJRIMDV. =\;H=Z*CPO* ?!__  5;_:"L_P!H;_A'
M+_1+:X;0(?[22SU:9&A2_F/V3[4+>"54F\JW(CC,[JJRSM-$B_Z.SN ?M_X]
M^)VF?M+?#'Q)?^$VN-1M[O1]7MK4K9W437$WV65-D$<T,<DV7/EAHE=6E#1
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M (H\0^!_'C7%M:-< ?:$%Q);V]Q;"0><MMY0E:*]B:(I<1Q[W1+4M&8F\R$
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M5_A;H.HV+211ZAK@GLHKE#;W%Q:P07L/VN."3$IMY \,L;E0?)N+=G5&E"4
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MGBN[=XM0_M[[%(LR,MUNU2&=?(8'$N8D>8>7NS$C2#Y%) !]?_\ !9+^T?\
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M:AX&\<6%Q;V4NH1M<GY=^G3&/9)/Y:1L]U%,HM6S'*5$$?G6ZSF4+( ?I_\
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MR. ?J?\ MG?M%67[.'@[4M1:]CMM6DLYTTJ+= ;B2Z;;#')%!.P$R02312W
M"R!(0S%&X1@#P_\ X)>_LX7G[/O@82:O;?9M7UBX:\N(I(5CN(80HCMK>9@S
M.VU5:X$;[&@>YDB:))%D+ 'P!_P3[\6:=>_M >,9XKNW>+4/[>^Q2+,C+=;M
M4AG7R&!Q+F)'F'E[LQ(T@^120 ?H?_P53U:WT[X2:U%/+'')<R:?% CNJM+(
M+ZWE*1@D%W$<<DA5<D)&[XVJQ  ?\$K-6M]1^$FBQ02QR26TFH13HCJS12&^
MN)0D@!)1S')'(%;!*2(^-K*2 ?GA_P %!/%FG67[0'@Z>6[MTBT_^P?MLC3(
MJVNW5)IV\]B<18B=)CYFW$3K(?D8$@'[/?M8_P#)//%?_8OZM_Z134 ?EC_P
M18^,6C6V@ZGX3GN(X=6;5&O((99(D:YCFM8U(MD+^;*\0LY'G"IB-&C;<=S;
M0#U__@J'\6'\8Z7;?"WPPD>J>(]?O(HY[.%XY);:"V,5X#*!,K6SNWD2)).G
MD_94N96:,(L@ /0/VMOA?<?!7X!W_AS0O,:33=+LK>22SA:!IHTN+?\ M"=H
MX2Q5)H_M$UWEF!1YC*[*78@'@'_!,W]K/X??#GX;C3=3U&STC4=+DNYM02XV
M0R79EDEECG@ )>\?R52#;&'N%,*1>7L-N9 #Y?TSXO:7-^U"?$.HM)H^G+)*
MC2:LATYD5-$:VCDD2Y\MHDF8*\ E".R2Q91';8 #[_\ ^"@7Q>TOXF? W4M7
MM6D@MM4DLTT\7:&VENE34HF22&*3#LDT,#W< P':UQ,R( P4 ] _X)6:M;ZC
M\)-%B@ECDDMI-0BG1'5FBD-]<2A) "2CF.2.0*V"4D1\;64D _/#_@H)XLTZ
MR_: \'3RW=ND6G_V#]MD:9%6UVZI-.WGL3B+$3I,?,VXB=9#\C D _H>H _"
M'_@K=\$;SP-J.D?%?PZODWMC<6\5]+'$K[)H7$EA>.ODLC;67[/+)<NRG%C
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M:_!#PK\2KA;S7-$TO4KE(Q$DUY8V]Q(L89F"!Y8V8(&9F"@X!9CC).0#C_\
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M@#2_$U_I^J7EM'+?:5)-)8W!!$D#3PO;S!6!!*21N0\;91BL;E=\4;( =A0
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ML>'[-[DR32O-;^992323L&D>=[-X&G=F&[=,9""7((+ON /3_@Y\ ?"_[/\
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M/^%3^'O['_X1[^RM/_L7_H'?9(?L?^L\[_CWV>5_K?WOW?\ 6?/][F@#S_\
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M-_[-WA/]H^WM[7Q5IL=_':2-);DR2PR1LZ[7"RP/'*$8!=\>[8Y2-F4M&A4
MS] _98\%^&/"]QX+M-(MTT"Z\PW%H3(_FM(0QD>5W:9I5*H8YB_FP^7%Y;IY
M4>T /A-^RQX+^!^G7NE:#I%O;V6I9%]%(9+G[2I0Q^7,UR\KO%M9@(6)B'F2
M$(#+(6 #_AD[X>?]"IX?_P#!39?_ !F@#L/$GP0\*^,;>TL]3T32[RVL(_*L
MH;BQMYH[:/:B[($DC98DVQHNV,*,(@QA1@ S_"W[/7@WP->1ZAI7A_1[&]AW
M>5<VVG6T,R;U*-LDCC5UW*S*V",JQ4\$B@#V"@#\\/V(=)M_B?JGBGXHO%&T
MGB'5);72[E44+)H^FA;2WEC5P;B%YWA8W4<I3S'@B<01JJ9 /T/H * "@ H
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M\7==62/4?%DDKZ?:S/.\MGIK3ETC:23RUD218[<6Y$6U+6"!XG"3M$@!^I]
M!0!Q_C7X>Z-\2K=;/7-/L]2MDD$J0WEO%<1K(%90X2564.%9E# 9 9AG!.0#
MS_2?V9/ N@7$5Y9^&M#@N8)$EAFBTRT22.1&#(Z.L0975@&5E(*D @@B@#L/
MB%\*M#^+,5M!K]A;ZC;VEQ]IA@N4$L(F\J6 .\39CDPDT@59%=58B0 2(C*
M?,'_  [>^%']H_VI_P (Y;_:/M'VC9Y]U]GW[_,V_9?/^S>5GCR/+\C9^[\O
MR_EH ^S])TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4    4 :%
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?FA\??\
M@GA<?&KQY#XXM?%FJ:3(D<$1AMPWGPQQJ8Y4L;I9HS:)+&SY7RY@)I9Y6$BR
MF( 'V_\ "'X0Z7\$M+72]+60J9'GN;F=S+=7EU*<S7=W,?FFN)6Y=S@8"HBI
M$B(H!ZA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M9R;9+DD/+:1J8TM8YE>>!4=6N9HVACMP#V"@ H * "@ H * "@ H * "@ H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MKF.\L9))XX[B(DQR-;S/;R%&P Z"2-PLBY20 .C,C*Q /S@_;G_88\5?M/\
MBK0M<T/78].MM.C2-TD>X62TD6X\TWMD(LJUPRE006M3FU@_?D$&$ _4^@ H
M * "@ H * "@ H * "@ H * "@ H * "@#R_XO>&?$'B_2VL_#6KQZ'?/(A-
M\]BE^R1J<LL<,DL<0=B%4O()0$W@1AV22, _''_@BUXLU'QS>>,M0U6[N+Z]
MF_L7S;FYF>:9]BWR+ODD+.VU555R3A5"C@ 4 ?N]0 4 % !0 4 % !0 4 %
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M6^A7EY#IYT>UMOL[.);6Z:5[F]68RW".%>-K;9';E#'NC:2,R2 'Z7?LG?\
M)//"G_8OZ3_Z10T ?0% !0 4 % '\Z/_  6)F\8^$+BPBO?$4ESHFLR7QATB
MWMOL=O;QVK6;(L[+-(U\Y9DDWSX$<RN\,<2R>6@!_1=0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M ./\?^,D^'VEW.J26UY>+;1EQ;6-M)=74S9 6.&&,%F=F(&3M1 2\CQQ*[J
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M=O-\GS?L36\L5PJ)'/%,B%D=0,X+ -"T,TP!_4[0!\@?LF_M9?\ #4O]M_\
M$DU#1_['U!K/_3%QYN-WRM\J^5=Q[?\ 2K7]Y]G\R']])YGR@'U_0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0!_-B?VAM4_X)T?&/Q7_;-E)>:3X@O&O'CA(C
M+07%TUS;W<#S0@S/!'-<V[0J\4+W'F(T_P"Y5P ?K?\ #7QWX+_;9OM!\9>'
M;W?>^&+BX:2"2.1+B%=1L)8);6:(NJ+N9HG%PHGB9[22*&5@96 !^>'_  5@
M\<7'BOQUX-\$K8R:A;>9;WDFGB]:VCU*2\N_LL=LS?*L#A8)8TNBQ,8NY"/+
M"L7 /N__ (:'^+W_ $3#_P NG3?_ (W0!\(?L9_LK?$KX4?%F3Q1<^'X]"\/
M:E)J8N[>*[TZ>.WM;@27%O:HL,A<)'.ELJM#'&<( 0L1=: ,_P#X+G?\RC_W
M&/\ VPH _<[P!X TOX6:7;:+HMM'9Z=9QB."",':JY))))+,[,2\DCEGD=FD
M=F=F8@'X0_\ !._2;?0/C[XWL[.*."V@CUV*&&)%2..--8ME1$10%5%4!550
M H    H ]P_X+$>'-<T:S\+^-M&.W_A'=0E9Y5C,C033M;26L[*8WB\I9;4(
MQF(4RRP1[7\P@ 'I_P "O^"CO@/]L"W?PGKT$FDWVKQR6+V%Q(S6]TMRLL9A
M@O8A&0[1A5_>K:N9IDB@,SX8@'Z'_"?P+_PJ_P /:5H/G?:/[,T^TLO/V>7Y
MOV:%(?,V;GV;MF[;N;;G&XXR0#\0?^"&/_,W?]P?_P!OZ /O_P#X*C_\DA\0
M_P#<._\ 3E:4 '_!+C_DD/A[_N(_^G*[H ^ /^"YW_,H_P#<8_\ ;"@#]_J
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MNL 4-$V0#XP_X(8_\S=_W!__ &_H ^__ /@J/_R2'Q#_ -P[_P!.5I0!G_\
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M0#^A[2=6M]?MXKRSECGMIXTEAFB=7CDC=0R.CJ2K(RD,K*2&!!!(- 'X _\
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M[CQ#X:T7Q'!YCQZ3>36\\:0LZK'?K'B>20'$2));1PC<N'>X0;U8*L@!]?\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M%8 'L'[3G['>G?M2:CHM]J&I:AI_]A_:I+9M.=(;C[1.]J\<RSNDGE^5]G)
M5-Y=U<2)Y960 \?_ .&,O'?BG3O^$?\ $OQ&U"_T"6W^S75O;Z5:6EY/"$VA
M&U!GN)CN(7SVD$K7,?F1R$^:S4 ?5][\"+*P\-0^%?#UW>>'-.@C,,9THP).
M(F5U=1+<P7+*[LYE:X3;=&8>;YX=G+ 'SA^SU_P3QT7]E_47U#PUKOB"'SO*
M%U;23V,MO=)$X<)-&UC_ +RB2,QSQI)(L<L?F,2 ?5_QH^$.E_'KP_?>&M96
M1K&_C"2&)S'(C(ZR1R(W(#QR(DBA@R,5"NCH61@#X _9D_X)CI\!;A'U#Q1J
MFIV,%Y!?0Z7 9+#3WNH&#I-=6ZW$XN'22*VEBP8@KVZ"03(=B@'J'[0O_!/'
M1?VH-134/$NN^()O)\T6MM'/8Q6]JDKERD,:V/\ NJ9)#)/(D<:R2R>6I !]
M?_#3P//\.].33Y]4U#5_*VB.YU%K=[@(J*BHTD$%OYN-I8R3"2=W=F>5\@*
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M-47Q'?*;BZM%AE,MO%:)<23M!;JQ;SXXY5>Y$LP,R!HA  =!^RS_ ,$_;?\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % '/\ BG69_#]G)<VUE<:A*FW;:VS6ZS2;F"G8;J:WA&T$
MNV^5/E4A=S[58 _.#XE_\%5O#/P;U%]*\0^'O%&GWJ;CY4]E9KO57:/S(F^W
M;)8BR.$FB+Q2;24=AS0!Z!_PWU_U(7Q _P#!!_\ =% '/V7_  4S\/?\)#IO
MAC4/#_BC2M2U6XM8+:/4=/AM?^/J;R(Y65[KS/*WY!=4;[K !F4B@#]'Z "@
M H * ./\?^,D^'VEW.J26UY>+;1EQ;6-M)=74S9 6.&&,%F=F(&3M1 2\CQQ
M*[J ?GA^RM^W]J/[3OQ#U3PQ_8_]DZ;IVGW4OEW6_P#M$W%O>PP?OURL<'R2
MXDMMDCQ3(1]H=>* /T_H * "@ H * "@ H S]6U--%MY;J42-'#&\CB**2:0
MJBEB$BB5Y9'P/ECC5G<X559B 0#\L/A]_P %'=1^*OQ2TWP);:!<:192_:?M
M9U:-XM2.W3VNXL6RL$MOF0YWM<^="Z.ODDXH _5^@ H * "@ H * "@ H *
M"@#\X/VW_P!OJ7]E*)[:QT'4+V[;9&E_<6\L&D1S2Q2R(@N2O^E2IL1WMX2J
MM&9%^U1RQ2(H!]G_  0\:W'Q*\*Z)KEXL:7.I:78WDR1!A&LEQ;QRN$#,S!
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MQI%E+]I^UG5HWBU([=/:[BQ;*P2V^9#G>USYT+HZ^23B@#]7Z "@ H * "@
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MAE920P(()!H -6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q 4 DD
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M35KC7_ OAJ\O)9)[F?0],EFFE=GDDD>TB9W=V)9G9B69F)+$DDDF@#W"@ H
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M[/\ 9_MV#OV8V[MN?+\W9^Y\_;Y_D?N/,\GY* .@_P"%L>'O['_X2'^U=/\
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MUO\ LR^#M.\.1",W,4?FW\T>TB>\EPT[[Q'$TB!OW4#2*)!;QPHQ)2@#Z/H
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M ;3@ ] TS5K?6D,MK+'-&LDL1>-U=1)#(T4J$J2 \<B/'(O5'5D8!E( !H4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '\P/_  6K_P"2AZ;_ -B_;?\
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MV]U+=0CRWG1(H$E999HG /I#_AW5\-?^$7_X1;^QK?9]G\G^T_*B_M3?G?\
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MJ7&F)JEG;R(T,7]H7GEW-F80"(HI(A%<) X/DM)'+#Y2+;", _6_]O3X:/\
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M"DH42+'<1+*@<*S*'"L P5F .<,1R0#L* /@#_@J/_R2'Q#_ -P[_P!.5I0
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MG<06.[!.   #Z?\ ^"U?_)/--_[&"V_](KZ@#H/V>OV*],^/W@WP_JGQ(/\
M;+#1].32;*&>ZM;/3K$6T8C"+#+$\MW<*$EOIY2P,@2")5A@0N ?&'[)'ANX
M_9!_:#N_A_I=W)=:3>QR0R^?N5C&+#^T[=V2-UB:XA/[CSBF&22X*11>=M0
M_2__ (*8VOBW5?AU=V/A"SN+RXO+B"WODM5D>Y6Q?<93"D3"1][B*&9%64&V
MEGW1^7OD0 Y_PG^P;X!LOAK::1XGT73]/NDT>%M5U'$"WEK<K$)KJ?\ M$[R
MOE2[WR9'MA&OE%6M?W9 /E#_ ((C>/\ 5-=TOQ#HMU<R2Z=ILEA)90.05@:[
M-V9Q&2-RH[1(YCSL#[Y%4/+*S@'/_P#!7_\ 9R\,>"=!C\7V5I(NNZEKD,5W
M>27=U.TD;VMTY0)--)$B PQ"-8T41(BQH%C&V@#[/_8I_8S\">#]%\+^-+'2
M_*U]]'L[EKO[7=MF:[L56=_*>=H?G$L@VA-J[OE"X7 !^C] &?JVDV^OV\MG
M>11SVT\;Q30RHKQR1NI5T=&!5D92596!# D$$&@#^7+X\?L\^'/V*OC#I4FL
M:?\ :_ UY<174,4[3RQ1PL?+F21A"QG^QRD7!M?W[36OV>*9W:X<D _I]_X1
M/3O[._LC[);_ -F_9_LOV/R4^S_9]GE^1Y./+\K9\GE[=FSY<;>* /RP_P""
M<G[.OAJXO==^)-I91E=1US5D\.RA52"'21.\:26MN%5K9W;SH&$BI*D,8C1(
MHI)/. #_ (*#_'#Q+J/BKPU\+/"5W>:9=ZY)!/?ZA:1,UQ%:O<&-&A>*5)52
M(0W%Q>8\HF&*,?:%A:X4@'V!IG["WPRTG2SH\?AC2S;&.6,O);B6ZVREBQ%[
M)NNPXW'RY!*'B 41L@1-H!^0'PO\47__  3$^+/_  A5Y?22>"M9DAE1[DPX
M2.Y!B@O2?-1('AF0V]Y,WEB:WA>8V_%J(P#/_P""TWPJT/P1J/A_5=+L+>SO
M=4_M0WTL""/[0T3VTBR2JN$:4M<2EYB/-DW .[!$"@']%VK:3;Z_;RV=Y%'/
M;3QO%-#*BO')&ZE71T8%61E)5E8$,"000: /YX? ?@#2_AA^U:FEZ-;1V=C'
M)/)';Q B.-KC0GN) BY(1#)(Y6-<)&"$15154 ']%U !0!\X?M>WOB6P\!ZX
M_A"&2?6S9LELD)83A794GDM_+>-_M$<+2RVXC)<S)&%21B(V /C_ /8F_86\
M-6GPWL;7QCX8LSK-_'=27QO+=7O%6>2180)3F:U<6_DXCB:%X)-S%8[GS#0!
M\@?\$J/$#^#OB7XK\':/J,EWX7ACU">T4RQS1S-;7UO;6]VLB*$+R0/AWAV)
M./+)5A'#L -#_@N=_P RC_W&/_;"@#[OU;_@FOX3^(MO+-XSN]4\1:[<1NKZ
MO<WDL4D#2*25LK:)A:V]NDK236]L\<Z1&0H3)& M 'YH?LHZQXA_8 ^+@^&V
MKWWF:!JUPB*S03>3.]Q$1875JF"8I9)1%9W#(9( PECD>3[-'/$ ??\ _P %
M<_B7J/P[^&K0:>_E?VOJ$&G7,@9U<6[Q3SR*C(RX\S[.(9 V]'@DEC*G>"H!
MV'@;]FOX.?M.^"HUT+1]+2QNK."(7%I':C4K*3R8I52:ZC\Z5+V(-&9UFDE+
MME9A,DCAP _9L_9/M=3^%.G^!/&UK)-'97FHI<01W%W:QSM#J=V8I,Q-;RRV
M[@I<0"0;) 89]FY8V4 _)#]D/]ESPA\4/C)XM\*:OI_VC1=,_MC[';?:;F/R
MOLVIPV\/[V.5)7VQ.R?.[;L[FRP! !^U_P :_AU>_ CX5ZIHGPRL)$N;6SF2
MPM899Y)XUN)B]U);R--Y[7")+//;A79_.6-420[8F /G_P#8F_86\-6GPWL;
M7QCX8LSK-_'=27QO+=7O%6>2180)3F:U<6_DXCB:%X)-S%8[GS#0!\@?\$J/
M$#^#OB7XK\':/J,EWX7ACU">T4RQS1S-;7UO;6]VLB*$+R0/AWAV)./+)5A'
M#L /0/\ @L]\-'M=!M/$;ZKJDJRZI:VB:6\\8TV%1:W;^=';I$K&X+*V9Y9)
M'VR/&"(A&D8!^IW[)W_)//"G_8OZ3_Z10T ?@C^VE\--4^&'QL\+P:;JMYK&
MK7<FE7=K/KLXFCCNI=4G$4)%K%"(;)9$5O(@11&'D\L#*J #]/\ Q_\ \$O/
M"?Q3TNY?6KF\O/%MY&6G\222R^:UUD$2"R$HM%MUP(8[5$41VJK"DJR*LX /
MG#_@B7\2]1\0:'KOAZY?S++2KBTGM-S.S1_;A/YL2[F*+$&MQ*J(J_O99W8L
M9/E /V^H * /R _X*C_LN>$/^$0\0^//[/\ ^*D_XEW^F_:;G_GYM+3_ %/F
M_9_]3^[_ -7_ +7W_FH X#]@K]@KX<?&GX<:-KVO:-]KU*[^V^?/]MO8M_E7
MMQ"GR0W"1C"(B_*HSC)RQ)(![?\ \%9/AH^O> =1UXZKJD,>G1VB+ID$\<>G
MW#37]NC2740B\V=U#*8@\NR)XT=$5FE,@!X!^Q!^P_X?_:/^&&F7OB^>\U!7
MCU"'284F>WCTB,WERLKVZ1-LFN)9MT\DURLH8+;P>5Y4'[P ]O\ CI_9W_!+
M7X53VW@W[0;V^U#R;:ZNMERPO+I"SW$P_=1#R[:V*0A(C'YL<!DAD#3,P!ZA
M^RU^QCX?B\-6.K>,]-CUSQ1JEG;7&J7FMP/=W0D92\<#)?-.87MXW6U?8(C(
M($,B JJH ?GA^V]\'+S_ ()[>*-/^)?P\;[#97]Q);WECA?L:3./--MY0=7:
MTNECD?R%4+:R0;XI82;5( #]#_VG_L7[4OPHN?$^DZSJEEIPT._U)(+&Y@B6
MY9;.0_9=0*),SI&PD@N;6.54+F1)-[QQM& ? '_!,/\ 9Y3]H7P+=6>NWLC^
M%XM<NVN-%@$D!O;K[)8^5)=7<4RRM;PC#Q6L2Q W 2:2641QQ* >/_MX? JP
M_P""?'C'PWXL\"O):K/)+-'8R23/'%)8^0)$\[S1/);W23[)X7?.#,HE,4JQ
MQ 'ZOZM_P3VT3XW6\NI?$AY-7\47D;B2]MKBXM[?3U92([738-_E"WMB2T37
M,<SSS&2XG#&9HE /A#_@E)J6H_";XA^+OAS]I^U:;9_;)-[!TS<:?>QV7G11
M>8T<7GI+F88=V\J!?,VQ?, ?O]0 4 >'_&_]G+PQ^T=;V]GXHM)+VVM9&EBA
M%W=6\8D9=N]DMYHED<+E4:0,8P\@0J)'W '\^/\ P2D_9<\(?M*?\)'_ ,)7
MI_V_[!_9OV;_ $FY@\OS_M?F_P#'O+%NW>5']_=C;QC)R ?2'_!7+X%V_P /
M?"&DWUCJ.J"QMKS3]+L]&>Y5M-MK>"RNA&\</EB5[@"/!N)Y9IBLCH6V;%0
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M!INJWFL:M=R:5=VL^NSB:..ZEU2<10D6L4(ALED16\B!%$8>3RP,JH /T_\
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MCX@T/7?#UR_F66E7%I/:;F=FC^W"?S8EW,46(-;B5415_>RSNQ8R?* ?M]0
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M\*ZE<*]YIT<DD,*W$4@DN+5)8X\6D5S%S;JCNZ,MT8DCAAC10#^C[X5)H?\
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M?;J=WMEC\Q4=HI5VRPN57S(G1P,,* /K^@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M(T/3=;OY+B/3#;Z?;0W4C16\DEP8FBB#JBPAQ+)E4 =8F;=-&C@'Y(?M]?\
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MJQCL+%9-#E,:%W9Y)-:N-SR22,\LCX"J&D9BJ*D8(1$50#]SOVL?^2>>*_\
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M=_Q=WXJ^+?%Z\V6B6]OX5L)8_D65XG^V:FLT<F93+!<M'''*HB@>)CL$Q!D
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M(J?\D\U+_L8+G_TBL: / /\ @N=_S*/_ '&/_;"@#]_J /P!_8%_Y.%\>_\
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MJ /O_P#9._Y)YX4_[%_2?_2*&@#\@?V^O^3A? 7_ ' /_3S<4 ?O]0!^ /\
MP0Q_YF[_ +@__M_0![A_P5<_9JN/&::3XVT&[CM?$.FR):0Q?:&@NKTF0SVL
M6GDR*&O89/.DA@A7[1<AW$;-+###( ?1_AS]MF_D\)'4K[PEXH_X22&WC5])
M70=0B6YN_+CWM!.(KB**T,K/AII/M"Q1LWD2/Y:2@'E__!._]C[Q!\(+W6?&
MWCCR_P#A*-<DE#1(R,T$<DYGN&D-N_V4O<RB.0)$K"!(D"R*9988P#]3Z "@
M#\@/^"U?_)/--_[&"V_](KZ@#[__ &3O^2>>%/\ L7])_P#2*&@#\@?V^O\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M\=_AYK7A[15C?4;J.W>".1Q&LC6]U#<F,.?E5W6(I&7*IO9=[QIN=0#\\/\
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MRNI:/YXV*RA90AAD /S0_9D^.7QI_9@MT\#ZSX(U37U@D@AT^<2,D=M'(HQ
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MSI%MYLNEWN@V?V_:)+B0NC,A1&BE;S)T$[17D.X+)"8Y8A  >G_&;X7>+/\
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M@'PL^(&O^*/#?B'P%J5O_:NG6]\EAI;10_:-\H"7EU$\\;VYB,+QQ3->-!!
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M=HY9E1B9I(VN[@ ^SZ "@#Y@_:N_91T/]K70SI6JCR;N'>^GZ@B!IK29@ 2
M2-\3X43P$A95"D,DJ0S1 'YH? _Q1\7OV $M/".L>&)/$WAE))3;7>B1R7$\
M*RR133E3''N9$:68I#>0VSS3,XCNOL\0P ?=_AS]K[6/B+*;+0_ OBB.]_=D
M/K5M'I%BB&6..1Y;IY)W^17,GEP07$\@0A8B S* >H?!#X(7'@VXN/$GB2XC
MU+Q;J4:I>7B*PM[6W#;TT[3D?YH;*)N>?WUU-FYG)D*K$ ?+_P#P4=_8<?\
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MVUJ(1=:?<+>M;0F)?LLD=UM5W6)"RW7V9(WF""61$>8 'YH?\*7^)W_"[_\
MA:/_  AUQ_9OVC;]D_M72OM'V?[!_9WF_P#'WY?F[/W_ ).[9O\ W'G[?W]
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MCBBE8 _0^@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MJP0N'M[>ZOG!,$!Y(2.-(E8%YQYPDVSR1E&H ^KZ "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /P1\0?
MM?ZI^R1\6?$FK^/_  ]>26FJR+9:5?P@$PZ;8AVC2Q\\F*5+@RVL][%%<0+%
M<,TCQ><!"H!]W_\ #T?X0_\ 0P_^4[4O_D2@#S_7_'__  \:@M]!T*PU"W\&
M+J$=QK.K7UO]GM]4L[.X)CLM. ;[1)]HFAW2W"M:R620XD!DE%NP!^G] !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % '\^/_  7*U:WFN/"EFLL9N8H]4EDA#J9$CE:S6-V3.Y4=HI51B &,
M<@!)1L '[_:3JUOK]O%>6<L<]M/&DL,T3J\<D;J&1T=259&4AE920P(()!H
MT* "@ H * "@ H * /SP\0?\%0_AOX0\2ZCX:U.ZO+233))89KU[.1[5[B%E
MCE@C\GS+@NKEU+-"D),3E9&4Q&0 ] _9/\ :H;_Q'XZURVDT^^\5WEO)!82
M));Z;8P^1IXN8<N8;UXV9[J,2R*I*+MA=9(E /L^@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#Y_\
M^&3OAY_T*GA__P %-E_\9H ]@\+>$].\#6<>GZ5:6]C90[O*MK:%(84WL7;9
M'&%1=S,S-@#+,6/))H Z"@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@#S_0/A/X>\*:C<:OI^E:?::E=^9]IO(+2&*XF\UQ))
MYLR()'WN [[F.YP&.6 - 'H% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!GZMI-OK]O+9WD4<]M/&
M\4T,J*\<D;J5='1@59&4E65@0P)!!!H \?TG]F3P+H%Q%>6?AK0X+F"1)89H
MM,M$DCD1@R.CK$&5U8!E92"I (((H ]PH * "@ H * "@ H * "@ H * "@
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^<'Q%_X*,:
M=\/?BA:_#9])N)?.N+&TFU 3HOEW%^B-"$MRI\R(>= ))&EB=<RE8G\M/. /
MT?H * /#_P!I'XWV_P"SAX3U+Q5=6\EW'81QD6\;*C2232I!$I=LA$,DB>8^
M'*)N98Y& 1@#@/V-OVJ;?]K[PT^OP6,FG20WDUG/;O*LRB2-8Y08Y0L9=#'-
M&26CC*OO3:RJLC@'U?0 4 % !0 4 % !0 4 % !0 4 % 'YH>*/^"HW@Y/%6
ME^$_#BR:W<W^J6EA-=Q-Y-G )[@V[NDK*S7+HVQU$2?9YHW#)=Y&V@#]+Z "
M@#\X/VQ/^"C&G?LA>(=-T&YTFXO_ +7;I=W4\<Z1>1;O,\(,*,K>?+^ZF8QN
MUNG$8\T^8QB /T/U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"
M20!0!^>'P^_X*8>%_C)X[TWP7X8M[B^BO?M/FZI(#;0IY-HUTODPR)YTN2CQ
M2>:MMY;*&3SD(- 'Z/T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M9])N)?.N+&TFU 3HOEW%^B-"$MRI\R(>= ))&EB=<RE8G\M/. /T?H * "@
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H X^]^'NC:CJD.N3Z?9R:M;1F*"_>WB:ZBC(<%(YRIE1")) 55@")'X
M^9L@'84 ?"'@O]JI_B/\8]1\#Z=+&^DZ+H<TET56-C+J7VJT5@)5=SLMXY3"
M8\1,MP;E)5?RXB@!]OZMI-OK]O+9WD4<]M/&\4T,J*\<D;J5='1@59&4E65@
M0P)!!!H S_"WA/3O UG'I^E6EO8V4.[RK:VA2&%-[%VV1QA47<S,S8 RS%CR
M2: .@H * "@ H * "@ H * "@ H * "@#\ ?V^O^3A? 7_< _P#3S<4 ?O\
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ML 1(_'S-D ["@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MG5-0UF[7Y[G4-0N99YIIF #E1+))Y,0P!% A*HHRS22M)-( ?F#\)_B;J/\
MP4K\6^(+&34KBR^'^C>3$ECI\[VLVJ>;)-&C7<I@6X:TNH([D7%J'M_+5[9
MK31R3D W_P!H_P#X)QV/PZT.YUWX2RZAX>U^QMYG>.QO;]VU&W 61[4$2RS"
M4F)6MUC^224"*1#OCF@ /4/V"_VFS^W!X.N[#Q \D>L:;)!!?R64]S8R31M^
M\M[I9K4P- \K12I+%;RX)B<E(X)TA !\H?\ !/CQSXA_X7)XJ\,:AKNL:KIN
ME6^K06T>HW\UU_QZZG;01RLKMY?F[,@NJ+]Y@ JL10!^E_[:/A ZUX*UG4[>
M_P!4TV^TG2[^\M+C3M1N;-A)!#YX$B0R+%,C&$1D3(Y1'D\IHG;> #Y?_P""
M1/Q"UGXE>!=0O-<U"\U*Y37+B))KRXEN)%C%I9L$#RLS! S,P4' +,<9)R ?
MJ?0 4 ?CC_P48\6^)?&_C7PC\-M/.J6>B:Y(O]I7%@S(UY!--]GNX=RQ-\EI
M;"2>X1FDA*7"23P[8HV(!Y_^W5^PSX8_9N\)R>.? +7GAW5M%DB)>UO+IFGC
MNY8[-E\R2=I874395XF 9#+$\;^8CQ 'Z'_L9_%K7/C[\,]+U^_EMUUJ[M[N
M,W!@)A,UO<3VT<TD"21;MWE+)-'&\*LQ<1F%2H0 _&#48/B+)^T%:^&7\4?V
MCK5GYL=KJ=Y:[+:U6[T<27,UOIT3FW25(23'&NV*XN8HFG.UY, 'Z'^'_P#@
ME_;^%_'FG>-X/%6N7$EG)%-.+V1;B^NI(E9 CWX,9%NT8C@EA:&0O;B6+S56
M1?* .?N?'.J?MZ?$'5O!T<EYI?@CPK)+!K*V\XAN-7NB\EM]DGDCE66.RE"7
M(V1[Q)#$YE:.:>V^R@'D'[9_['-A^QYHC_$/X87-YX?OM,DM([N&.]F>":VD
MN IRDPF>9VG>U\R":3[(\,3;H6?[X!^C_P"Q9^TPG[5W@ZV\0-''!?))):ZA
M!%YGEQ746TG89%!*21O%.JAI!&)1"99'C=J /J^@#R_XO>&?$'B_2VL_#6KQ
MZ'?/(A-\]BE^R1J<LL<,DL<0=B%4O()0$W@1AV22, _''_@BUXLU'QS>>,M0
MU6[N+Z]F_L7S;FYF>:9]BWR+ODD+.VU555R3A5"C@ 4 ?5__  4[F\8^%_!E
MYK_A_P 12:18V$=L)[2UMMEU=23WL$0;^T!,);=$#*52"-2X\U)))$E58@#Y
M@_8@^!?B#]IGX8:9I&K:C>:'X2@CU"*&/2KE$O-6DFO+GSY+N1HY%CLHUDDM
M5LBK&XD$MQ*1&MLI /G_ ,"^$]4_X)N_&[3/#6G7TE]HGB*2SC,!<(TEK>SR
MVMN;H>64^T6DP:19(@IE12H:W6ZFB0 _I.H * /+_B]X9\0>+]+:S\-:O'H=
M\\B$WSV*7[)&IRRQPR2QQ!V(52\@E 3>!&'9)(P#^?'_ ()FWOCGXYWGB>RM
MM2N(5U/^RSK?B&6Z:;4H;>%;J-+>S,N]_M=PI,<=VY9+*&%W56F^S+0!H?M;
M_L#7_P"PREI\0?A[JEYY&ER1_:GN9(3=6TDDGE1RH4CBBGMY#(MO-;M&QP_S
M+/!+*( #]K_V.?VA?^&G_!=AXDE2WAO9?-AO;>WE\Q8;B&1D8$$EXO,4)<)%
M(6=(IHP7D&)' /@#X3_$W4?^"E?BWQ!8R:E<67P_T;R8DL=/G>UFU3S9)HT:
M[E,"W#6EU!'<BXM0]OY:O;(%::.2<@&_^T?_ ,$X['X=:'<Z[\)9=0\/:_8V
M\SO'8WM^[:C;@+(]J")99A*3$K6ZQ_))*!%(AWQS0 'N'_!.+]L&X_:P\-3C
M5_+_ +=TB2."]:-659XY%)@NBH18HWE*2I)%&S /"T@2&.6*)0#Y@\#7&B?M
MX?%+QCX=\;/>7%CH4@AT?0A>7$=F%LIY+2ZOV^S" -<>8R%#(Y=8[R2']\D*
M-$ >GM^RQ+^SS\3O!4OAZ\U!?!TUQJ40T>:]EFL["^&E7TB/;QS3._\ I"FY
MD)VL8I%F)FVW$<2 'J'_  4]^/.J? /X?2W&C226]]J=Y#IT=W%($DMEE26:
M21#L8[VC@>%2IC>,RB9)%>-<@'/Z3_P3Y\ ^,]&BU_PK=:I9:WJ%FEU9>*4U
M"_.H/)=1!_MDJR31JSW"NQN4\N NDLJ+Y#$,@![!_P $^],U31?AUIUKKAD;
M5H;S68[\RRB:0W2:M>K.7E#.)'\P-ND#,'.6W-G) /D#X,ZA<?\ !4/5-4UC
M7?MEK\/=-D^PV.B1W+0+J-P0LSS:DUO,LK/"/L\R1#]S&[Q+%,QANFN@#P_]
ML3X,2_\ !-N?3?'7PSN[C3[*ZU!+;4-)FNI9[.9EMW:W0PL-\L15+PRM/.\L
M4DR-;&$_-& ??_Q2_;%\SX+W'Q)T%-MQ/I\?D)NS]EO)YTL7YF@VS?9+AV/S
M1".X\G Q'(' !X?^S7^QGX!_:%\':/XQO)-4O_$=]9QRS>('U._74(M0A_=.
M\3-(J![.:,Q6S-$Z;+>(DSCYW /</^"??@G7/AO8>*=(\1WEQJ.I6GBBXC>]
MN93+-<P_V?IQM9G8RS,/,MS"ZQM([1*1$Q#(0 #YP^*WC&P_:4^.$OPQ\43W
MD?ARRTO$6EP74T5OJFH-%#?[KK[.L;[(X6+Q))+L2:S1TD!G>&0 O_&[]B^#
MX#7_ (6U+P+<:AI^@)XHT-=9T1;^XDL9?-U"W6*^:.XN&+2K*MO"R 2[AY$B
MK%]GD>0 ]0_X*=S>,?"_@R\U_P /^(I-(L;".V$]I:VVRZNI)[V"(-_: F$M
MNB!E*I!&I<>:DDDB2JL0!V'_  2X_P"20^'O^XC_ .G*[H \_P#V^OVM-<^&
M6K:#X"\%S6]MXD\07%NOVRX0NMG#-<+;P,%>&6)O.E$BNQ$K0Q0R?N"\L,B
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MC_P1:\6:CXYO/&6H:K=W%]>S?V+YMS<S/-,^Q;Y%WR2%G;:JJJY)PJA1P *
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MX?+?K))J-];QVVG:>;^2262[NMFT274L: NXCCEN9B3")S&T8DC>5" #Y_\
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M]G_]@SQ!^S)X:U+1O#7C"2"^U*\@G-Y+I:3P6T<2D,+:RDNFB6XF.U9[B1I
M\*1QB!'C28 'YP?\$R?^$U^.[^*H;?69(&U"31UUG6IKF:;5DM4COD$=@TB2
M+]HD51"+J:0&RB&^**641^4 9_[<W[(MY^PO>:9\1/"6NZA)<2:@8YI[Z59K
MX7TRSSF8RK$D<\4R)*EQ',I+$D.;B.X=8@#]'T^"&L?\%"=#@UKQI?:AH&AZ
MA;V\NFZ!I-[&RM;N$F%SJ4[V[)=2S,(Y;>(1HEG$D?'VF2?: ?$'["5UKG['
MWQCOOA1<WG]H:;>>;]QBD*S+9B_@O!$ZNR2M;H()XD=5+.NZ6=;:$D _8_\
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M\+Z=J6L2>)I#>:5JEAID4:Z59^?_ &C.D%JD1FGB5\JT2WL[23".0+([JF2
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M\ZI\?/A]%<:S))<7VF7DVG27<L@>2Y6)(IHY'.Q3O6.=(6+&1Y#$9GD9Y&P
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H _%']M/_ ()AZIX_\07/
MCGP%?1VFK221W;V!Q:G[5"C,9[2ZBVB.XED2)P)0@-P\UP]XF0H /'_V9/\
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M?^X__P"GFWH _7[]K'_DGGBO_L7]6_\ 2*:@#X _X(J?\D\U+_L8+G_TBL:
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M_P!Q_P#]/-O0!^OW[6/_ "3SQ7_V+^K?^D4U 'P!_P $5/\ DGFI?]C!<_\
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M%Q)N8 ]PH * /P!_X(8_\S=_W!__ &_H ^__ /@J/_R2'Q#_ -P[_P!.5I0
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M\#_$"> ?BI!))(EY!9MJ%S)%#<6"E!&K7+D"*ZMR?*F-VT@?R7EN?.NU:)0
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M1/ L,:*9&E=[V12 6WXC55#!BX!]/_\ !:O_ ))YIO\ V,%M_P"D5]0!]_\
M[)W_ "3SPI_V+^D_^D4- 'Y _P#-WG^?^A<H _?Z@ H _GA_X(J?$O\ M#Q#
MXIT^^>XN-2U.WMM1:YD;S-_V::5)VFD=C(TKO>QL"0V_$C,P8*' /Z'J /YX
M?AU\-/\ A$OVK[J#3TN)[>*XOM1N9"N_R?[0TMYY&=D4*D0N+L0QEL8WQ1EG
MD8%@#H/^"YW_ #*/_<8_]L* /W^H * "@#\ ?^"&/_,W?]P?_P!OZ /O_P#X
M*C_\DA\0_P#<._\ 3E:4 '_!+C_DD/A[_N(_^G*[H ^ /V^O^3A? 7_< _\
M3S<4 ?O]0!^ /_!#'_F;O^X/_P"W] 'O_P#P6K_Y)YIO_8P6W_I%?4 ??_[)
MW_)//"G_ &+^D_\ I%#0!^0/_!;3PG_;.H^#_L-IYVI7G]HVJ^3#ON)]KV?D
M0#8#))AYI/*C&</*^T;G;(!H?\%RM6N(;?PI9K+(+:635)9(0["-Y(ELUC=D
MSM9T66548@E1)( 0';(!^WWP]\:V_P 2M&T_7+-9$MM2L[>\A24*)%CN(EE0
M.%9E#A6 8*S '.&(Y(!\ ?\ !6SP5;^*OA7?7D[2+)I5Y8WD 0J%:1YA9$2
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M_@'X2K>:C/J4EM%J>K_9KFUL+*SD,S2I-</Y4L3R" *ZM#)'<6SS01B6=A$
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M8RJ27*P09:,F54D1F /QA_X))Z7K7P"U'6M/\2Z!X@L/[8_LX6MS)HU\;</
M\Z%)I%A/DY^TJPDD"P*D<C22QX4. >__ /!:O_DGFF_]C!;?^D5]0 ?LQ_\
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MWUOJD5Y/+:Z3>2VL<:6LR ?:1%Y4KN;E=H@,H0QRK(T;JJ, ?9_[(GQ!7_A
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MD=0#0_8)_:ZO/C-X>\/>&]%T+4(FTRWM['4]6GB5]+AAL(45Q%,)8GEN[A1
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MN++X?Z-YTKWVH0/:S:IYLD,CK:1"=;AK2Z@CMC;W12W\M7N7+--'' 0#W_\
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M6GQ^396-O#;6T6YGV0PH(XTW.6=MJJ!N8LQQDDG)H Z"@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M H    H T* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@#\ ?^"&/_,W?]P?_P!OZ /W^H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H _(#_@M7_R3S3?^Q@MO_2*^H ^__P!D[_DGGA3_ +%_2?\ TBAH ^@*
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /PQ_9 _X*&>
M'X/$OB'_ (3][S2/$.JZH8D>]#FULK.V8166EN1L%L]M)-=M++);V\9+2S7$
MWFMB@#]3O^&L?AY_T-?A_P#\&UE_\>H ^4-0\>6'[>_B#PZOA5Y+GPKX<U1-
M8U/56@FM0VH6J-]@L;4W"*TK[I&FOE\D(ENT.VYCED5' /TOH * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H \/^+W[-?@[X](R^)='L[^1HTB%P\>RZ2..3S52.ZCV7$:;RQ*Q
MR*&#.I!5W# 'B'A;_@F]\*/!]Y'?6WARW>6+=M6YGNKN$[E*'?!=3RPOPQ*[
MT;:V'7#JK  ^S])TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4
M 4 :% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M#S3;#(AD\I'\M6#OM3+  ]@H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MT?X+?M2V^@Z#;_9--M/,\B#S))=GFZ \S_/,[R'+NS?,QQG PH  !_1]0 4
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M5I(T<S112I%,Z%?D\Y9 @:10 LD@8 ^3_P#@BI_R3S4O^Q@N?_2*QH _7^@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H \O
M^+WP;T3X[Z6VB^(8)+K3GD222!+FXMUD:,Y02&VEB:1 V'$;EDWJDFW?&C*
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M !0!Q_Q"\:V_PUT;4-<O%D>VTVSN+R9(@ID:.WB:5P@9E4N54A0S*"<98#D
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MW_!.:S_:HVZWH3V^G^)D\M))I=RV]["N% N3&CNLL2_ZJ=4=BBBWD5D\E[<
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M+>?:;&-862WN/+CN;=)3*L$X*,P0,THW6[03$2OF0E8C& ?9] !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0!_-C_ ,%FO@WHGP^U31M:TZ"1-1UN34Y-
M1GDN;B=IF@%F(0!/+(L:1K(R1QQ!$1-L84(B*H!_2=0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M;#;W.M:E<-':PW(E,*PPA6N9G$6S?MWQ1+'YL3%IQ("ZQ2(0#P_XO>&/CO\
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M^VFTO3=+@C5Y])TV.*^NK. EY#+=/=6LBRO"I6*ZDM)/) 3SUA6$2R@ ^_\
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M"P77EP1VZ/'+&[8:0R6\;QR20W#", S](^)/Q0^%'Q'\+>!_$M_I^JZ+JO\
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MD<.N:_>Q>;)#<&XV-!86C@K*ZK#<(S3IY,Q215DMP(+BX /F#]I?]H[XJ?\
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M2[U;XEZ_<>*+SP=+H<]S/)82ZG-K[WSR22.UXR/&]L2S.S&9IVE)+$H022U
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M^-6LZIX%\9V<<7B/18Y#+<V^P1RBTECM+E9U1V07 F8/OM_]'E#.%CA$2><
M?,'_  5WOOB-;:,'O[C2[7P?-JB6T%I937+WERQB>6%[]I(8XBBFW>588CLC
MD>,-]I>&.=0#[/\ V*?^%I_V+X7_ +4_X1?_ (1/^Q[/9]G_ +0_M3[/]A7[
M+N\S_1O-SY7GX^3'F;.=M 'Z/T ?*'[8GC[QK\)_#4_B'P9%I=TVFQRW&H6N
MH1S%GM8UWO+;R1W,"AX55G>)PQE3/EL)8UBG /F__@GQ^U;XR_:]BO-4U6;P
M_:V5A<+!+8VEM<F^??$S+*S27K);Q%BHB<QS^>8KF,"(QAR ?0'[;OQB\0_L
M]^$+OQ7H+Z>W]G^3Y]M>VDT_G_:+F"W3RY8;NW\G9YC.VY)O,^51Y>"6 /7_
M (%W'BV^T."?QLFGPZU-^\EMM/218;96 VPL\D\_FRKR99$81;CY:!U032@'
MR!K?[5?B'X\>+=5\!_#>*WMFT?\ =ZMXBU"*:2&U<2-;S0VELL826[C8F2W-
MU(D$[6UROEO"JSL >7_'G4?CA^R;I<GB:UUZS\9V,$<@O[6YT6*S:TCRC"[1
M;*5)9D0*ZS'S (4;S6A= \MN ?8'[/W[1Z?M=>#AKWA=X].OO,^SSQWMM)=Q
MVEU'Y;S1,D<UH;A#&X,4L<L8(D1W5762W4 ^3_V-OVU?&7QI^(>M^!_$]MH\
M?]C6]]YDNG17*[[BSO8+1MK3SOF([W(S&CG"D[>5(!]H?M2^+?%7PZ\-7VO^
M%Y=+$FE6=S>7%OJ-M<2K/' HE81RV]S"876-)2 T<PE<QH6@7=)0!X__ ,$]
M/VH-9_:S\*W>N:Y!9P7,&J36:)9I*D9C2WMI02)99FW[IF!(8# 7Y0020#[O
MH ^8/VL?C)XC^"'AZXU7PWH?]L2P6]U/<2R74%O;V4-O"TAGF5Y%FN,$ BWM
MP&D1) 9H7\L2 'YP?LK?M5_&']J_P]JD>A1:>FI?VA=,VLZA$8=.LK>6&$6]
MC8QP1RR7%W&[2S[[E9TAA6(7#3M<Q@ 'V?\ L;ZM\3] T;5;SXORV<"P2"6V
MF=[-)([=(BUP]P]F1:+;KA6C8D3*1<&4B(0T >7^#_CEXT_;AO-1E^'VIV_A
MOPGIEP+:+69;".^OM0NT7=*B6EPZQP6FR6.0-*JW&1"0<R7$%L >0:C^V'XY
M_8D\6VOA[XJ7-OK6@:GYLMMKMK9M!-"GF")-\<4<<+^4$66ZMHEFGB6Z1UN)
M\1P2 'T_^W?_ ,+#_P"$>US_ (1[_A'_ /A&_P#A'[[^T?MWVW^T?]3<?:/L
MOD_Z/_J=GD^;_P MMV_Y,4 ?G!_P2_\ ^%I_\(;>_P#"#_\ "+_V;_;$_F_V
MQ_:'VC[1]FM-VS[)^[\K9Y6W/S[_ #,_+MH _0_]KW]IGQY^S1X3AU2UT"SO
MKF&SM7U;5/M*KIMK=22PPM'#:-,E_<H[LX0_NA$KPNSS$3)& ?,'P;^.OQP_
M:5^'D%YX62SAOH([G[5K.HQQ13ZC<)=2O'%I4"1&S"1PI';2W%VB0R32/&K1
MO;2ST ?5_@#XQ^-/V?\ X7W_ (G^*ZV[ZOI_VB1(H3&KS*SK'9PW#6:26Z2R
MSN(A) C11P/"\H\Q9R #Y_\ @=??&C]K+PN/&MCXPT_0OM_VC[!I,&C03VX^
MS%K<>;<W/FW$7FS12,^/M>Q&#KG/V>, [#]@;]MKQ!\:M9U3P+XSLXXO$>BQ
MR&6YM]@CE%I+':7*SJCL@N!,P??;_P"CRAG"QPB)/. #_@HI^V%XW_9GLB=!
MT6.&QGDCM4UZZG@E7[1-!-)LMK%)#*'C"!UGNE\G?')&UM(C1R. ?=_[/7BF
M\\<^#?#^JZA)YU[?:/IUS<R[53?--;1R2/M0*B[F8G:H51G  &!0!^2/[2?_
M  44\;_"GQUHVAZKIL?A71&O+*ZNWE>#4;RXTPW<L4KN;<W$,*21(Q:"%9+J
M.2([+EU=0P!Z_P#'GQ5^T#XSTN3Q/X2AL]$TR*.2>WT8PK<:]-;DH%-U#<6\
M]NMQL5KA;6!TFC60VS?:+E%4@'L'_!.+]L&X_:P\-3C5_+_MW2)(X+UHU95G
MCD4F"Z*A%BC>4I*DD4;, \+2!(8Y8HE /T/H \?^-?\ PF7]G1_\(/\ V/\
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M]2T"^V*]U%;1);^2[();JVFMK2*9I;4G][;R1EG0E1$/.MK@ '[_ % !0 4
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M_:N\'6WB!HXX+Y))+74((O,\N*ZBVD[#(H)22-XIU4-((Q*(3+(\;M0!X_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MWZM^V#83?":7XF6?EQ*=+>>&*59I8TU DVZ6K[4BDD07N+9I5$:, 90Z1'>
M#T#]DSX0O\%?!VG:=>+)_:T\?VW5Y9GCEN)M2N\37;SSQ\3NLC&)96:1C#'&
MIEDVAR ?1] !0!^0'_!:O_DGFF_]C!;?^D5]0!]__LG?\D\\*?\ 8OZ3_P"D
M4- 'Y _\W>?Y_P"A<H _7[]K'_DGGBO_ +%_5O\ TBFH ^ /^"*G_)/-2_[&
M"Y_](K&@#Z0_;(\6?#+X'W&E>./&MC'=:S82&/2!$@DO)&#!F*1-)'%*EN6\
MY9+@[+61@\3)<S1B0 ^$/VTO&'Q5^+GPSUK5_$&G:?X7\-C^SI4TQB]UJ]P'
MN+-42>0[8H(O-E,Y'E07D<ENML\(1I)' /M__@EQ_P DA\/?]Q'_ -.5W0!\
M ?\ -WG^?^A<H _?Z@ H _ '_@N=_P RC_W&/_;"@#]_J /YT?VE/@[\2/V*
M/B#K'Q'\$V\EUH^H227-S.(X[P+'</\ ;;VWNX519H+<2P.QN(P@CMS"OVQ9
MV>@#Z_\ V5/^"COA/]J6ZTS3O%,$>D>)K2\1M.7S)3:W-U+:36SR0R !8G99
MKB)+6Z9P3-"L4MQ<$>6 ?K?0 4 ? '_!4?\ Y)#XA_[AW_IRM* #_@EQ_P D
MA\/?]Q'_ -.5W0!\ ?M]?\G"^ O^X!_Z>;B@#ZO_ ."POC6X\*_#(V<"QM'J
MNJ6=G.7#%EC02WH,9# !_,M8U)8,-C.-NXJR@'U!^PMIFEZ3\,O#$>CF,VQT
MNWD<QRF5?M4H\R]!8LV'%RTXDCR!$X:(*@38H!Q__!1OX:?\+0^%^O0(ENUQ
M96XU&&2=<^5]A<3S-$P5V25K=)X4*[=WFF-F6-W( /G_ /X(V^*;SQ!\-9;:
MYDWQ:?K%W;6J[57RX6BM[HIE0"V9;B9]SEF^?;G8JJH!\P?\$,?^9N_[@_\
M[?T ?O\ 4 % 'X _\W>?Y_Z%R@#]_J /YX?^"7V@?\*O^,GC#PQ8W%PVFV5O
MJ<"QR29\W[#J<$$$LRH$C>54>0!PB[?-D"A5=@0#H/\ F[S_ #_T+E '[_4
M?@#_ ,$,?^9N_P"X/_[?T '[?7_)PO@+_N ?^GFXH _?Z@#^?'P;IB?#[]K*
MYL=+,EM;7DES)<QI+)MF:ZT<W\PDRQW(UR?/$9RB.J%%41H% /H__@M7_P D
M\TW_ +&"V_\ 2*^H ^__ -D[_DGGA3_L7])_](H: /R!_;Z_Y.%\!?\ < _]
M/-Q0!^SW[0OBF\\#>#?$&JZ?)Y-[8Z/J-S;2[5?9-#;221OM<,C;64':P93C
M!!&10!^<'_!%3_DGFI?]C!<_^D5C0!^I_C7X>Z-\2K=;/7-/L]2MDD$J0WEO
M%<1K(%90X2564.%9E# 9 9AG!.0#R_\ :Q_Y)YXK_P"Q?U;_ -(IJ /@#_@B
MI_R3S4O^Q@N?_2*QH ^L/V__ (#)^T'\/M4L%CDDOK*-M1T\11R2R-=6J.PC
M2*-U,CSQF6V4$.%,PD$;NB"@#Y__ ."2'QY3XI^ UT*>21]1\.R?9I#)))*S
M6L[226;AF0*J*HDM8X5=S&EJI^1'C0 'J'[%W_%X-1\1?$RY_??VQJ$UAH<Y
MY1=#TYS# ;=)-UQ;?:)EFENX7,:R3QK-]GCX+ 'W_0 4 ?/_ .UC_P D\\5_
M]B_JW_I%-0!_-%\%?VG/%O[//PQ\C2(/+T75O$%]!>ZE;R21WT3+:Z:S06TY
MB>WLI98?-$%PZW,I/FR1PPM:B20 _IM_9KO?#6H^#M'G\(0QVVA26<;V<"%2
M8E;EXY2CR W"R%UN27D<W E\QVDW,0#/_:Q_Y)YXK_[%_5O_ $BFH ^ /^"*
MG_)/-2_[&"Y_](K&@#P#_@N=_P RC_W&/_;"@#]+_P#@H?XUN/ 'PK\2WEJL
M;R26:V9$@8KY=_-%92D!64[UCG=HSG <*65E!4@'C_\ P23TS2[#X5V,FGF,
MW,]Y?2:B$E+L+H3&-!(I9O*?[-':D1@("A27:3(78 ^S_P!H'X:?\+D\):UX
M>5+=Y=0T^Y@M_M*[H4N&C;[/*_RN5\J7RY5=59XV0.@WJM 'Y _\$.O%-Y=Z
M=XGTIY,V5M<:?<PQ;5&V:Z2XCF?<!O.Y;: ;6)5=F5"EG+ ''_M?Z3;_ +''
MQU\/>/8(H[;2=7D$M[*Z*T22-FSU1XX+8+-O6WGCNBS+(9;J9WS-\\2@'Z?_
M +<?C6XM/#0\)Z2L<VN^+Y#HMA"X9U6.Y4K>W<J1MYPM[:W,CR3QI*(':%I(
MS&6H _/#_@F'XIO/V?\ QSXG^$FJ2?NHKBXN;&2=5M7FFMV2)GB@8&23[7:^
M5=HHE=8X+<R('21Y0 ?;_P '_P#B^OQ0\1^*)_W^F^%MOA_16_Y9)>%!+K,G
MDRYD2[1S':_:8A#'-:GRP9U!< 'S_P#\%J_^2>:;_P!C!;?^D5]0!]__ +)W
M_)//"G_8OZ3_ .D4- 'Y _\ -WG^?^A<H _?Z@ H * "@#X0_;(\6?#+X'W&
ME>./&MC'=:S82&/2!$@DO)&#!F*1-)'%*EN6\Y9+@[+61@\3)<S1B0 ^$/VT
MO&'Q5^+GPSUK5_$&G:?X7\-C^SI4TQB]UJ]P'N+-42>0[8H(O-E,Y'E07D<E
MNML\(1I)' /M_P#X)<?\DA\/?]Q'_P!.5W0!\ ?\W>?Y_P"A<H _7[]K'_DG
MGBO_ +%_5O\ TBFH ^ /^"*G_)/-2_[&"Y_](K&@#R#]DK7_ /A:'[2?C+4-
M0M[=KBRM]2@MB(\^5]ANK338Y4+EV25K="LCJ5W>;*H"QN4 !^[U 'X _P#!
M#'_F;O\ N#_^W] '[_4 % 'X _\ !#'_ )F[_N#_ /M_0!]__P#!4?\ Y)#X
MA_[AW_IRM* #_@EQ_P DA\/?]Q'_ -.5W0!\ ?M]?\G"^ O^X!_Z>;B@#]OO
MBKX6T/QIH=_8>)H[>719;=S>BY8)"L*#>TCR$KY7E[?,68,C0L@E5T9 P /S
M0^%/[2VL_$JWB\.? GPU9P^'-(D^ROK.LF6#3U*K,Y2*")_M<SR_N9C.6>X#
MSYNK:,S"<@'RA_P39TZ\TCXZ^,K;4+K[=>PV^M1W-WY2P_:)DU:U62;RD)2+
MS&!?RU)5-VT' % 'T_\ \%J_^2>:;_V,%M_Z17U 'W_^R=_R3SPI_P!B_I/_
M *10T ?0% !0!_/#\ _(_8.^/U]X3;[1%H&O[+>Q#?:$A'VLI-8,J'SC=>3+
MYFF+.S<,\\K21XFCH _1_P#::_XO3XY\+?#O_7::/-\0>(+<<;[.R8)I\<PE
MS!<6D]X=EQ;;)I#Y<<F(542$ ^K_ (W^-;CX:^%=;URS6-[G3=+OKR%)0QC:
M2WMY)4#A65BA90&"LI(SA@>0 ?E#_P $1],TN+PKKEU"8_[6DU1([H"4F06L
M=NC6A:+<0B&22\V2;5,A$BEF\H! #]GM6TFWU^WEL[R*.>VGC>*:&5%>.2-U
M*NCHP*LC*2K*P(8$@@@T ?SP_P#!(ZRU3X5?$OQ3X.N)HVCMK.Y2\6(!HY+K
M3;Z*V21)'19=BB>X"CY XD!=-RKM .P_8%_Y.%\>_P#<?_\ 3S;T ?K]^UC_
M ,D\\5_]B_JW_I%-0!\ ?\$5/^2>:E_V,%S_ .D5C0!^O] 'S_\ M8_\D\\5
M_P#8OZM_Z134 ? '_!%3_DGFI?\ 8P7/_I%8T ?4'_!2'Q3>>#_A1XCN;&3R
MI7MX+9FVJV8;NZ@M9TPX8?/%+(FX#<N[<I5PK  ^(/V"O@S\1_%?PXT:]T'Q
MW_8VFR?;?(T_^P+*\\G;>W"O_I$SB1][AI/F V[]@^510!W_ ,=/^":GB_\
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MI_R3S4O^Q@N?_2*QH \ _P""YW_,H_\ <8_]L* /W^H * "@#\(?^"/&O_\
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M+]0\*?\ ".?;_L'V;_2?[2\CS//MHKC_ %7V27;M\W9]]L[=W&<  X#X3_\
M!93_ (6AXATK0?\ A%OL_P#:>H6EEY_]J^9Y7VF9(?,V?8DW[=^[;N7=C&X9
MR #]OJ "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M #]_M)U:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$@T ?SX_\
M!/OQ9IU[^T!XQGBN[=XM0_M[[%(LR,MUNU2&=?(8'$N8D>8>7NS$C2#Y%) !
M^A__  53U:WT[X2:U%/+'')<R:?% CNJM+(+ZWE*1@D%W$<<DA5<D)&[XVJQ
M  ?\$K-6M]1^$FBQ02QR26TFH13HCJS12&^N)0D@!)1S')'(%;!*2(^-K*2
M?G!_P4\\:V_PU^-GA/7+Q9'MM-L](O)DB"F1H[?5+J5P@9E4N54A0S*"<98#
MD '[W?\ "V/#W]C_ /"0_P!JZ?\ V+_T$?M</V/_ %GD_P#'QO\ *_UO[K[W
M^L^3[W% 'Y0_L%^&[S]HWXB^(_C+?V7V?3;K=9Z'YULH:15V6_VB-FED:.6*
MWMUMYY(]T4LMS<QQRJL4L5 'S_\ \%6]?_X13XI^$=0URWN+OPW:6]G/);-'
MYMO-Y6H2/?Q11RD6[RO"+=9D)&Y# LI"%#0!]_\ [3G[8W@OQ7X!UNVT*_\
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MW.^*OPTT[XR:'?\ A[54WV6H6[P2X5&9-P^66/S%=%EB;;+"Y5O+E1' RHH
M_G!_8R^&GBB7QI-\&M<3=H&FZP=9UFW50BR_V?'LBW"X5#=:?>2FP9H9(I/-
MB$$\2P_O)" ?T_4 % !0!^0'_!:O_DGFF_\ 8P6W_I%?4 ?0'[)'[4/A+4_!
MO@_1K#4K>]U>73]/T_\ LV"6/[8DUM;!;II8)'C>.*!8)YGE<*LD<8\CSY)K
M>.8 _.#_ (2S3O\ AK;[5]KM_L_VC[+YOG)L^T?V']D\C=G;YOVC_1_+SO\
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M&"07<1QR2%5R0D;OC:K$ !_P2LU:WU'X2:+%!+'));2:A%.B.K-%(;ZXE"2
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M/2M"NHXTU'RVN=0*1QHQNKAC(Z2-&\BRO"I2U$V]A(D"%=J;44 _&#_@C?\
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MJ:SHNHSR)J.MR:9'IT$=M<3M,T O#,28(I%C2-9%>224HB)ND+!$=E /0/\
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M-<NM0LX=):.*47\EQ$EJ8YBHB<3LPB*2%T$;;L.67:3N&0#\@?\ @GQX.O\
MX_\ Q!\2_&+4X)!IUW)/;:&]U:PK(\9<1+)$48^6]K;0)9221JXF,TZ?:'>.
M<, >'_\ !03Q9IUE^T!X.GEN[=(M/_L'[;(TR*MKMU2:=O/8G$6(G28^9MQ$
MZR'Y&!(!_0=JVK6^@6\MY>2QP6T$;RS32NJ1QQHI9W=V(545069F("@$D@"@
M#\ ?^"&NK6\-QXKLVEC%S+'I<L<)=1(\<37BR.J9W,B-+$KL 0IDC!(+KD _
MH.H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M[\OR_EH ^S])TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4    4
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M2M/TS[1L\_[%:0VWF^7NV>9Y*)OV[VV[L[=S8QDY //_ /AD[X>?]"IX?_\
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MDF@#T#P5\/=&^&MNUGH>GV>FVSR&5X;.WBMXVD*JI<I$JJ7*JJEB,D*HS@#
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#\H/C/\
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M@FDBC:*-Y HWLD;22M&A;)5&DD*@A3(Y&X@&A0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % 'YH?'W_@GA<?&KQY#XXM?%FJ:3(D<$1AMPWGPQQJ8Y4L;I9HS
M:)+&SY7RY@)I9Y6$BRF( 'V_\(?A#I?P2TM=+TM9"ID>>YN9W,MU>74IS-=W
M<Q^::XE;EW.!@*B*D2(B@'J% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^6'Q
M>_X)->#O&-ZVL^%[J\\+ZLLB30/9-OM8;A9_.,Z6Y*2QO@[8EMI[>& K$R1C
M8RN 9_A;_@G7XRM+R-]5^*7BBYLAN\V&VGN;69LJ0NR:2^N43#;6;,3[E!4;
M2P=0#[?_ &>OV8O"_P"R_ISZ?X:M/)\[RC=7,CF6XNGB0('FD;_@3".,1P1O
M)(T<4?F," ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MI#$$BCW$(BCB@#]/Z "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M,^RU:WU%YHH)8Y)+:013HCJS12&-)0D@!)1S')'(%;!*2(^-K*2 :% !0 4
M% !0 4 <?X_DUF+2[D^'H[.35O+(M%OI)8[42$@!IFACDE**"7V(H,A41^9%
MN\U #\<?V%_C]XY^*'QD\1Z1XNU/[1_9FGZE;_8[4M'IT4MMJ=O'N@APF_;O
MD2.>=6NFA(620XP #]OJ "@ H * "@ H * "@ H * "@ H * ,^RU:WU%YHH
M)8Y)+:013HCJS12&-)0D@!)1S')'(%;!*2(^-K*2 ?DA_P %2OC9\2O@II*W
M>AW6GZ;H%U<16(N+=Y7U>26:WN'DR7A$-M%A"$:!FNDDCCE6=/,:., _0_\
M9DU:XU_P+X:O+R62>YGT/3)9II79Y))'M(F=W=B69V8EF9B2Q))))H ]PH *
M "@ H * /E#]LCQ;XU\"^%;W4_!ATN*2RL[VZO;F_:9I(H(+=Y/]#@CB>*2X
MR"R-<,(5,:HT4JRDQ 'S?_P2@^*NN?&3P;JNJ^(;^XU"]?Q!=CS9W+;%:VLY
M/+B7[D409W*0Q!(H]Q"(HXH _3^@ H * "@ H * "@#\L/BC\+OC+JGQET_6
M-'U"1/!2261=!>HEK':HF+V">R/S37$K>?Y4OE3%3-;D7$/D_P"C 'ZGT %
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MX]:6NL^&KZ._L6D>(R('1DDC/S))'(J2QO@JP615+(R2 %'1F /S0_X+5_\
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MS))'(J2QO@JP615+(R2 %'1F .@\?^/]+^%FEW.M:U<QV>G6<9DGGD)VJN0
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MD^'M'>\&K0V<UU?6ES:2VTEBT$L$,EM<B4*/M"R3["L)F0&*7,@_=^8 ?5]
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MLC*0RLI(8$$$@T ?T'4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MY18TWQ,\IF0/-&^"+6,?O%*% #0_YN\_S_T+E '[_4 ?@#_P0Q_YF[_N#_\
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M >@?\$R]6N-:^$GAV6ZEDFD6.\B#R.SL(X;ZYBB0%B2$CC1(XUZ(BJB@*H
M./\ $?[)NHV7QC'Q8U+6[=- T_3Y&$%PSJUKMLY+62(,[>3%: /+>O-N7$KR
M(8/F:X(!\ ?\%6_VFO!?QX\/6=AX;E_M2]TS6-MQJ$-K(;>U5H;A# +QT5&^
MU-&)(A;M)%.EF\I;$498 _9[]D[_ ))YX4_[%_2?_2*&@#\@?V!?^3A?'O\
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M3@47"^;<>1)>/!+B2)6W6D4<<,\7SV_VR<AV;=$H!^SW_")Z=_9W]D?9+?\
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MSL(X;ZYBB0%B2$CC1(XUZ(BJB@*H  /N^@#Y_P#VL?\ DGGBO_L7]6_](IJ
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M])CBLI(Y)M4N(C<1&) JW"J%*2E6*E$ZA0* /WN_X4#X7_X1?_A"_P"S+?\
MX1[[/]G^PX.S9G=NW9\SS=_[[S]WG^?^_P#,\[YZ /QQ_P""&NK7$UOXKLVE
MD-M%)I<L<)=C&DDJWBR.J9VJ[K%$KL "PCC!)"+@ [#]LO4H/VI?C1X8^%L]
MS_Q);'_2]3@47"^;<>1)>/!+B2)6W6D4<<,\7SV_VR<AV;=$H!^SW_")Z=_9
MW]D?9+?^S?L_V7['Y*?9_L^SR_(\G'E^5L^3R]NS9\N-O% 'X _\$V?"UGX&
M^.OC+2M/C\FRL;?6K:VBW,^R&'5K6.--SEG;:J@;F+,<9))R: /Z'J "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M5_EBD\^WM?-DV;)Y<!'^02 '/_\ !<[_ )E'_N,?^V% '[_4 ?@#_P %SO\
MF4?^XQ_[84 ?O]0!^ /[ O\ R<+X]_[C_P#Z>;>@#[__ ."H_P#R2'Q#_P!P
M[_TY6E !_P $N/\ DD/A[_N(_P#IRNZ /A#4=6N/^"C'QCO_  7XBEDM?"OA
M22^E73+=V O9+&Z2S9YY048/*TI.Y1F"WWV\)2666[8 ]0_X+!>$].\#?#'2
M=/TJTM[&RA\00>5;6T*0PIOM=0=MD<85%W,S,V ,LQ8\DF@#]'OV3O\ DGGA
M3_L7])_](H: /R!_8%_Y.%\>_P#<?_\ 3S;T ?K]^UC_ ,D\\5_]B_JW_I%-
M0!\ ?\$5/^2>:E_V,%S_ .D5C0!\P?\ !8CPYKGP^\9>&_'NGGRXH+>&WMKA
M8S)]GOK&YENXS*'C:'YQ*&A1BQE\B?,>R,E@#]_O"?BFS\<Z=::KI\GG65];
MPW-M+M9-\,R"2-]KA77<K [6"L,X(!R* /R!_P""T6O_ -H>'O#OABVM[BXU
M+4]8\^UCAC\S?]FA: Q!5)D:5WO81$B(V_#C(8*' /7_ -N[P+_PJ_\ 9_N]
M!\[[1_9FGZ'9>?L\OS?LUW8P^9LW/LW;-VW<VW.-QQD@'H'_  2X_P"20^'O
M^XC_ .G*[H ^ /V^O^3A? 7_ ' /_3S<4 ?O]0 4 ?@#_P %SO\ F4?^XQ_[
M84 ?O]0!_.#_ ,$N9M1_9P^*NM^ -;E^SRW-O-!Y A<K<WEB_G02QN\2R+$U
MJUW/"[^5'-$Z,0SM"* /Z/J /PA^"&B_\+R_:<\0^)+-;B&R\/\ GQS,\&Y7
MN(;1-',)D5RD7F,+BX@+%GDB@8>6IWF( _=Z@#Y__:Q_Y)YXK_[%_5O_ $BF
MH ^ /^"*G_)/-2_[&"Y_](K&@ _X+5_\D\TW_L8+;_TBOJ /O_\ 9._Y)YX4
M_P"Q?TG_ -(H: /R!_YN\_S_ -"Y0!]__P#!4?\ Y)#XA_[AW_IRM* #_@EQ
M_P DA\/?]Q'_ -.5W0!\ ?\ !<[_ )E'_N,?^V% '[_4 ?SH_'KQ._[/G[3]
MGXAU6*..QO9+ QRRW$<4:VMU8C2I+IW^81I!()W990A80GE$=9: /Z+J /P!
M_8%_Y.%\>_\ <?\ _3S;T ?O]0 4 ?@#_P W>?Y_Z%R@#]_J /PQ_P""9GAA
M/B%\2_'OC^QED?29KR]MK*0V\B1W*W]\;S>LDFPJ\4<,)>$IO NHR_EX < Y
M_4=6N/\ @HQ\8[_P7XBEDM?"OA22^E73+=V O9+&Z2S9YY048/*TI.Y1F"WW
MV\)2666[8 ]0_P""P7A/3O WPQTG3]*M+>QLH?$$'E6UM"D,*;[74';9'&%1
M=S,S-@#+,6/))H _1[]D[_DGGA3_ +%_2?\ TBAH _(']@7_ ).%\>_]Q_\
M]/-O0!^_U 'X _L"_P#)POCW_N/_ /IYMZ /U^_:Q_Y)YXK_ .Q?U;_TBFH
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M/*R*2H)8 'Q__P $9/BE_P )7X&O-!FN/,N-&U!_+@\O;Y-G>*)HOG"!7WW
MO6Y9Y%Q@[8_*% 'ZG_$+QK;_  UT;4-<O%D>VTVSN+R9(@ID:.WB:5P@9E4N
M54A0S*"<98#D 'Y _P#!$_X7W'A[PUK7B.?S$CU:\AMX(WA9%:.P63,\<A.)
M4>2YDA.U<(]NXWLQ98P#]KJ /@#_ (*C_P#)(?$/_<._].5I0 ?\$N/^20^'
MO^XC_P"G*[H ^ /V^O\ DX7P%_W /_3S<4 ?O]0!^ /_  0Q_P"9N_[@_P#[
M?T =A^UOX_U3]JWXMVGP4DN9-+\.1R1R7[VQ#3WS)8_VEARP"JBJ!%#&1(B3
M?Z5(LY2&*( ^C_V^_A5H?P;^"&O:5X>L+?3[)/[,/E0(%WLM_91^9*WWY92J
M('FE+RR;07=CS0!Z!_P2X_Y)#X>_[B/_ *<KN@#T#]NG]G3_ (:=\#7VC0+N
MU*#%[IG.,WD"MLCYEBC_ 'R-);;I6,<7G><5+1K0!^,'[.'[2^H_M ?#JV^#
M$,UPNOW^H0Z=!=J[@PZ'\UW=3,[RXG^SQ0S6K6>^V62SE@AB\W9*A /Z3M)T
MFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4    4 :% 'S_P#M8_\
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MQH _>Z@#\(?^"6NB_P#"U/B'XW^(ULMQ#IMU<7<-JDT&/,_M&]-Z095=HQ+
MD,(EB0R?\?*-O5=OF '/_L"_\G"^/?\ N/\ _IYMZ /O_P#X*C_\DA\0_P#<
M._\ 3E:4 '_!+C_DD/A[_N(_^G*[H ^_Z /G_P#:Q_Y)YXK_ .Q?U;_TBFH
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M2W%Q_9=N[PI/<B;[ ]A-'8S6L1&_,1WQA%27R(?()C0^>[T <_\ M]?\G"^
MO^X!_P"GFXH _?Z@#X \;?LQ?#7_ (* Z'9^*)+3RY=2MXIXM3LWBAOER(@T
M5P\?G0S2Q"'[+(EP+C[.5ECC,;@L #\D/@I;>,?^"=GQ>TOP7=7LEWHVK7D,
M8@CGV6MW;ZC(+2*],#>:(+B.2-#(,+,3;M;K.UM()9 #^FZ@#R_XW^"KCXE>
M%=;T.S:-+G4M+OK.%Y2PC62XMY(D+E59@@9@6*JQ SA2>" ?C#_P19\>7&@7
M'B7P3J3R07,$D5[%I\L#))'(C&UU!G8H&5U864;12L"I!*(")C0!^]U 'X0_
M\$M=%_X6I\0_&_Q&MEN(=-NKB[AM4F@QYG]HWIO2#*KM&)8$AA$L2&3_ (^4
M;>J[?, .?_YN\_S_ -"Y0!^OW[6/_)//%?\ V+^K?^D4U 'P!_P14_Y)YJ7_
M &,%S_Z16- 'Z_T ?/\ ^UC_ ,D\\5_]B_JW_I%-0!\ ?\$5/^2>:E_V,%S_
M .D5C0 ?\%J_^2>:;_V,%M_Z17U 'W_^R=_R3SPI_P!B_I/_ *10T ?D#_S=
MY_G_ *%R@#Z?_P""K?[5VN?L[:'I^E>'S]FN]>^V(^H*Y$UM#;"$.( !\LLG
MG@"?.Z%58HHE:.:$ ^L/V5?V._#7[*&EQ6NF01SZH8V6\U:2)1=7#.4:10WS
M-%;[HT\NV5BB!%9C),7FD /RP_X(8_\ ,W?]P?\ ]OZ #_@N=_S*/_<8_P#;
M"@#]_J "@#X _P""H_\ R2'Q#_W#O_3E:4 '_!+C_DD/A[_N(_\ IRNZ /@#
M_@N=_P RC_W&/_;"@#]_J /P!_8%_P"3A?'O_<?_ /3S;T ??_\ P5'_ .20
M^(?^X=_Z<K2@ _X)<?\ )(?#W_<1_P#3E=T ?('_  6T^&FH^(-#T+Q#;)YE
MEI5Q=P7>U79H_MP@\J5MJE%B#6YB9W9?WLL"*&,GR@'Z??LJ_%+_ (73X&T'
M7FN/M=Q=Z?!]KG\ORM]Y$ODWGR;$48N$E7Y%$9QF/,94D ^4/^"MGC6W\*_"
MN^LYUD:35;RQLX"@4JLB3"])D)8$)Y=K(H*ACO9!MVEF4 /!7PON/@Y^SI=:
M/>>8+E/">K7$R2PM!)#)>V]S>/ \;$LKPM.86W8),98HA.Q0#R__ ((J?\D\
MU+_L8+G_ -(K&@#]?Z /P!_X(8_\S=_W!_\ V_H ]_\ ^"U?_)/--_[&"V_]
M(KZ@#[__ &3O^2>>%/\ L7])_P#2*&@#\@?^;O/\_P#0N4 ?3_\ P5;_ &KM
M<_9VT/3]*\/G[-=Z]]L1]05R)K:&V$(<0 #Y99// $^=T*JQ11*T<T(!]8?L
MJ_L=^&OV4-+BM=,@CGU0QLMYJTD2BZN&<HTBAOF:*WW1IY=LK%$"*S&28O-(
M ?EA_P $,?\ F;O^X/\ ^W] 'O\ _P %J_\ DGFF_P#8P6W_ *17U 'W_P#L
MG?\ )//"G_8OZ3_Z10T ?D#_ ,W>?Y_Z%R@#]/\ ]OCX::C\7?AGK^D:4GFW
MKV\4\405V:7[)<17;11K&KN\LBPLD*!?GE9%)4$L #X__P"",GQ2_P"$K\#7
MF@S7'F7&C:@_EP>7M\FSO%$T7SA K[[@7K<L\BXP=L?E"@#]3_B%XUM_AKHV
MH:Y>+(]MIMG<7DR1!3(T=O$TKA S*I<JI"AF4$XRP'( /R!_X(G_  ON/#WA
MK6O$<_F)'JUY#;P1O"R*T=@LF9XY"<2H\ES)"=JX1[=QO9BRQ@'E_P"P+_R<
M+X]_[C__ *>;>@#[_P#^"H__ "2'Q#_W#O\ TY6E !_P2X_Y)#X>_P"XC_Z<
MKN@#[_H * "@#\8?^"E?QTUS5_$VA?"/2I_[,M/$GV)=0U!,O,T-]>/9B ("
MF(AL9YP'#7*LL!:.+SEG /J_QQ^SKX:_9M^%'B?2_#ME' H\-ZFD]R54W5VR
M6=P1)=3!5:5]TDA4'"1!RD21Q!4 !\W_ /!%3_DGFI?]C!<_^D5C0!X!^WU_
MR<+X"_[@'_IYN* /W^H _ '_ ((8_P#,W?\ <'_]OZ ./^/7B=_V?/VG[/Q#
MJL4<=C>R6!CEEN(XHUM;JQ&E273O\PC2"03NRRA"PA/*(ZRT ?T74 ?@#^P+
M_P G"^/?^X__ .GFWH _?Z@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@#^;'XR?#E_BM^U#/I<%Y)I]R9+:XM;R...5K>ZL
M]$BN[:4Q2@I*BS0QF2)L"1 R;D+!U /T/\1_!OX[_%S21X9U_7/"^GZ;<V\E
MMJ.H:?:W-S?7$+V\D,B-#<1Q6W[XL#*T'V5HS\T155\IP#[?^!?P+T/]G30X
M/#_A^#R;2'YG=L--<3, 'GG< ;Y7P,G 55"QHJ1)'&H!\(?MP?\ !.NX_:'U
MF#Q?X5U*/2/$=M'"IW(T4<\D$JM#<&YMQY\-Q$FX"79.7$5M&OD",N0#L/AI
M^R7XT^(.R7XP>(_[<BM;A7M]'L1'!I=PJ[9 =1C2UM3>XE2.2*"1?*B,.2TR
M3R1* >7_ +$G_!,^]_9PN%U;6?$%XUV9(I)-.TJYGMM/D:%IA&+M_P!W+>H
MZ2+&R0(C^;$ZW$,C!@#W#]L3]@JS_:FU'3=?LM5N-"U_3=B1W\*--F&-WFB
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M3^$EY=)X+\76]K93^5NFCO-0TR:?8I(\Z&UCG3Y&>18\RR?*2WR%V0 'ZO\
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MN?M0Z/)X=MM=M](TBX\AKJ/^S#=W$S0R&4+Y[7D2)%N6%]J1"7?%_KS&[14
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M'\?WUG>>([:S^QV%GID4L.GZ?'^^1RCRMY]T\B3.V9PHB>>90L@6W:$ ^[Z
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MM*DF-LMQN%K+'<F(3K*T:22HX$*/$ZJXRK1M'^\$L(!V'[,7[/GC3P;]DO\
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M.DT+_A(;?2M%:X@G\F'3)I+B3RD(\JXF_M*.*:(RGS@GV=-KI"<EHM[ '/\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % &?JVIIHMO+=2B1HX8WD<11232%44L0D4
M2O+(^!\L<:L[G"JK,0" ?SX_;-:_X:&_X6%_PC'BC_A'OM'D^?\ V%?;]G]F
M?V=]H\GRO,\K?^^QCS_(Y\GSOW- ']!VDZFFM6\5U$)%CFC21!+%)#(%=0P#
MQ2JDL;X/S1R*KH<JRJP( !H4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % &?JVII
MHMO+=2B1HX8WD<11232%44L0D42O+(^!\L<:L[G"JK,0" ?SX_;-:_X:&_X6
M%_PC'BC_ (1[[1Y/G_V%?;]G]F?V=]H\GRO,\K?^^QCS_(Y\GSOW- ']!VDZ
MFFM6\5U$)%CFC21!+%)#(%=0P#Q2JDL;X/S1R*KH<JRJP( !H4 % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * /G#Q9\$+CXO:I8WOB:XC-CHVJ)J.EZ;9JRK]HMQ(E
MO/>W3_O9W4,)XX;=;.&%W>"8Z@B)*0#Z/H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M5X?O+./4=4L+>:\UJVGM));6XNVM7DM+-O+E", KP7$S @B2-[,,N0 ?K?0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'E_Q>^**?"#2VU-]/U35&
M$B1I9Z5927MU(SGJ(TPJHJAF:25HT &P,97C1P#XP_8'_;>U']LV\\0O<Z?;
MZ=9:;_9WV2&.1YIO])6X$OG3-L23YH T>R*'8K%6\PC>0#]'Z "@#\L/A=^W
M/XJ\<?&74/AY=:%'#I-K)>QB8)<"Z@CMDW17L[M^Z-O<D)Y0\N( 7=OMGEP/
M/ /U/H * "@ H \?^)?Q1OOAWO>#P]K&KV\5NT\DVG?8'QMW%HEAGOK>YEE
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M_MBI^R?8?:AH>J:O)Y:R-)!!)'I\"M,D*BZU QO%"[EF\J-%F<NJ*ZQ+-$[
M'8?L9_&O4?VB? FE^)]5CMX;V^^U^;';*Z0CR;N>!=BR22N,K$I;+MEB2,#
M !]/T ?.'[3?[1:?LV:,^J'2=4U>3RYW6*PM9)(XE@B,C2WEP%,5K;@[0\C[
MG 9G2&58I=@!Y?\ L%?M2ZC^USX>U#7M0M;>S\G6+FTMH("[;;=(;>:,2N['
MS)1YQ5Y%6)'P"(DY% 'V_0 4 % !0 4 % !0!\8?M@_MBI^R?8?:AH>J:O)Y
M:R-)!!)'I\"M,D*BZU QO%"[EF\J-%F<NJ*ZQ+-$[ '8?L9_&O4?VB? FE^)
M]5CMX;V^^U^;';*Z0CR;N>!=BR22N,K$I;+MEB2,#  !]/T % !0 4 % !0
M4 % !0 4 % !0 4 % !0!^6'[<_[<_BK]F#Q5H6AZ'H4>HVVHQI([R)<-)=R
M-<>4;*R,6%6X50I)*W1S=0?N  !, ?J?0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0!^2'Q(_X*87NG>.M#\&:5X?O+./4=4L+>:\UJVGM));6XNVM7DM+
M-O+E", KP7$S @B2-[,,N0 ?K?0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MXTBRE^T_:SJT;Q:D=NGM=Q8ME8);?,ASO:Y\Z%T=?))Q0!^K] !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MGG_8KN&Y\KS-VSS/)=]F[8VW=C=M;&<' !Z!0 4 % !0 4 % 'A^K?M-^!=
MN);.\\2Z'!<P2/%-#+J=HDD<B,5='1I0RNK JRL 5(((!% 'N% !0!X_X6_:
M%\&^.;R/3]*\0:/?7LV[RK:VU&VFF?8I=MD<<C.VU59FP#A5+'@$T >P4 %
M!0 4 ?@#_P %SO\ F4?^XQ_[84 ?O]0!S_BGQ9IW@:SDU#5;NWL;*';YMS<S
M)#"F]@B[Y)"J+N9E5<D99@HY(% 'YP?\%#?BQX>^*'PA\3_V#JNGZG]G_LOS
M_L5W#<^5YFI6VSS/)=]F[8VW=C=M;&<' !Z!_P $N/\ DD/A[_N(_P#IRNZ
M/O\ H ^?_P!K'_DGGBO_ +%_5O\ TBFH ^ /^"*G_)/-2_[&"Y_](K&@#]?Z
M /'_ !3^T+X-\#7DFGZKX@T>QO8=OFVUSJ-M#,F]0Z[XY)%==RLK+D#*L&'!
M!H ]@H Y_P 4^+-.\#6<FH:K=V]C90[?-N;F9(84WL$7?)(51=S,JKDC+,%'
M) H X_P5\;_"OQ*N&L]#UO2]2N4C,KPV=];W$BQAE4N4BD9@@9E4L1@%E&<D
M9 /4* .?\4^+-.\#6<FH:K=V]C90[?-N;F9(84WL$7?)(51=S,JKDC+,%')
MH _.#_@H;\6/#WQ0^$/B?^P=5T_4_L_]E^?]BNX;GRO,U*VV>9Y+OLW;&V[L
M;MK8S@X /0/^"7'_ "2'P]_W$?\ TY7= 'W_ $ >'_M%?'G2_P!FWPU>^(M4
MDC"P1L+:!Y"C7=T58PVL9"2-OD9<%@CB) \S@11NP /(/^">_C_5/BG\-=(U
MK6KF2\U&\DU*2>>0C<S?VC=    *J*H"1QH%2-%6-%5%50 ?9] 'C_BG]H7P
M;X&O)-/U7Q!H]C>P[?-MKG4;:&9-ZAUWQR2*Z[E967(&58,."#0![!0 4 %
M''^-?B%HWPUMUO-<U"STVV>01)->7$5O&TA5F"!Y652Y568*#DA6., X #0_
MB%HWB>WM;RPU"SNK:^D>*SFAN(I([F2-9&=('1BLKJL,S,J%BHBD) $;8 .P
MH \?\4_M"^#? UY)I^J^(-'L;V';YMM<ZC;0S)O4.N^.2177<K*RY RK!AP0
M: /8* .?U_Q9IWA3[/\ VA=V]I]KN([6V\^9(O.N)<^7!%O(WRO@[(UR[8.
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MA7XE7#6>AZWI>I7*1F5X;.^M[B18PRJ7*12,P0,RJ6(P"RC.2,@'J% !0 4
M<_XI\6:=X&LY-0U6[M[&RAV^;<W,R0PIO8(N^20JB[F957)&68*.2!0!Q_@K
MXW^%?B5<-9Z'K>EZE<I&97AL[ZWN)%C#*I<I%(S! S*I8C +*,Y(R >H4 <?
MXU^(6C?#6W6\US4+/3;9Y!$DUY<16\;2%68('E95+E59@H.2%8XP#@ /!7Q"
MT;XE6[7FAZA9ZE;)(8GFL[B*XC60*K%"\3,H<*RL5)R RG&",@'84 <_IWBS
M3M7O+K3[:[MYKVQ\K[7;1S(\UOYREXO.C4EXO,4%H]X7>H++D<T <?IGQO\
M"NM:H=#M=;TN;5EDEB-A'?6[W0DA#&5# LAE#QA',B[<H%;<!M. #U"@#S_Q
MU\6/#WPO\G^WM5T_3/M&_P C[;=PVWF^7MW^7YSIOV[TW;<[=RYQD9 .@TWQ
M9IVL_9OLUW;S?;+<W5KY<R/Y]NOEYGAVD^9$/.AS(F4'FQ\_.N0#H* /'_\
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MP5\;_"OQ*N&L]#UO2]2N4C,KPV=];W$BQAE4N4BD9@@9E4L1@%E&<D9 /4*
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M7A#2;B"/0]'G26.Q\X2/)%-+''.;>:[BA&+N.7[2L@OMI*VZPQ$ ^C_VQ/\
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M1^9$WWXI0KN$FB*2Q[B4=3S0!^(/_!#'_F;O^X/_ .W] !_P7._YE'_N,?\
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M#W&HQZ3<QJK(LUJTDIFA<3,([2YBBEE,:&=?/:-XROF7$D@!Y?\ MI?"._\
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M_%G6/#=]XAU622&UT[4;RT,&F:?#)MC@CL+HX@=I%D<,WFNT+1RB3S;BZ:4
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M\<:OH]IX)\*7#KI6FSZE#';ZI>"5XHKZ3S-L=[%LCED*!A'$DMO"%FBFNVN
M#G_^"@O@SX2IX<_X2?P%J?A_3_$VDW%E+;KHMY;I-,BSE"L4%I<(B2QM,MS]
MJ6)YU6V";@F&0 ^S_P!F;]LG5/BO\'-4\8W"1R:[H-GJ:7#20A+>XNK&U^TQ
M2>7%("4DC>$SA?('G&81I'&(Z / /^"8OA_X<_'/PFR:QIVEZIXM%Y?3ZJ^J
M16U[?W+/*KB[7[0TT_V?9-!$SXC0W(F)4R.TD@!]/_L>_LJI^RQXQ\96NG12
M)H6HQZ-=:86:20(O^GK/;&5T4,\,F<+NE=;>2V:61I)"2 ?H?0 4 ?@#_P %
M;/V7/"'PO\/)XKTC3_L^M:GX@'VRY^TW,GF_:8;RXF_=22O$FZ5%?Y$7;C:N
M%)! /K_]D[]@KX<?\(]X4\5_V-_Q.O[/TG4OM/VV]_X_/)AN/-\K[1Y7^M^?
M9L\O^'9MXH /^"H/[2FN?!;0]-T#PM]H77?$EQ+;036\9>9(8Q&LJ6Q1O,6[
MD>>".!D1V"M*4,<XA< 'T!\-/V&_ W@?3D@U#1]/UG4I-LNH:GJ-JMY<7EXR
M*+BY9[QKF2/SG4RF)9#&CNQ W,S, ?D!\6=(O/\ @E!\2K+5/#TMP?!VO8:Y
MLF*S9ABE NK5%:97DEMEE26RN)3$P\X0/+,HNC, ?;__  5.\%1>//AQ=^*;
M36]0-E;6]BUO96EU$-+O%NKVV GG5(R]S\KH\!,QBC*))&JEI#( >(?L0?L/
M^'_VC_AAIE[XOGO-05X]0ATF%)GMX](C-Y<K*]ND3;)KB6;=/)-<K*&"V\'E
M>5!^\ /U._9K_9KT/]E;0_[ T#[0UNUQ)<S37,@DFEFD"J7<JJ1C")'&JQHB
M[4!(,A=V /H"@#X _P""H_\ R2'Q#_W#O_3E:4 ?('[!7[&NC_'OX<:-?^,;
MW4-6TT_;18Z)]IDM=.M/+O;A?.\NV>.2:[+FY/VB1^(;CR/+*PQO0!\G_M4_
M!#6?^"8WC&Q\9^!;B1='OI)4CAD662.$_*\FG7;?=FMY5^>VWN+@B)V!$]JM
MVX!_0]JWQ>TO3O"LOC&)I+G28]+?54:)"));5;<W(*1R^60[1C*K)Y9!(#;>
M< 'Y8_L)?#R7]M2*^^(OQ+A_M=WU"6+1;"[BE.FV<*Q".X>TMI)&MI8I"RP$
MO%(RS67FM-)<EW4 T/\ @H9^PEHUOX??QKX)M(]$UOP]&+O9IJ16<<UO _FR
M2XC,*Q7%LN^XCGC_ 'SB,P[96-N80#T_]E'XBZ/_ ,%'_AT-/\9+]LO;&X2'
M5K:*XDLQ.\>7MKAX[.X1VBE7#$.$@:\AF:.%1!&5 /S _9#_ &7/"'Q0^,GB
MWPIJ^G_:-%TS^V/L=M]IN8_*^S:G#;P_O8Y4E?;$[)\[MNSN;+ $ '[?_%_X
M6Z/\%OA+XCT'0;?[)IMIX?UOR(/,DEV>;;W,S_/,[R'+NS?,QQG PH  !^4'
M_!+_ /9]E_:&\&WMAX@N=W@Z'6)WDTFW>6&6_OC;6F#>SQLC_9+=1%);P0LI
MENF,LS;;>%' /+_V\/@58?\ !/CQCX;\6>!7DM5GDEFCL9))GCBDL?($B>=Y
MHGDM[I)]D\+OG!F42F*58X@#^FZ@ H _F1_X*X_LY>&/@5<:%>:!:207.K2:
MK+J$TMW=74EQ(C6C*[O=33-OW32,S @N7)8L0, '[G_!3]C/P)^SMJ,FJ^&-
M+^PWLUNUM)+]KNYLPN\<C)MGGE09:)#N ##;@'!((!^,'Q2T[7-7_:EN+;PW
M=6]CJDWEQPW=Q$9DMU?0$6:98@0)98XC(\$;D1/.L:R'RB] 'UA^UO\ \$S?
M!%CX*U?6=.%Y#KNG6=QJ4NJ3W<]W/?26T+S3_:UFD\HO<D,SR1+$4F*R &,/
M!( >G_\ !(SXEZC\1/AJL&H/YO\ 9&H3Z=;2%G9S;I%!/&KL[-GR_M!AC"[$
M2".*,*-A+ '@'[1?QST[]I'XH-\-]>U?3]*\":)BXU9GU)+7^U;B)(G%HTYP
MH\JXD2)[171U\BZF,HN(K=;< T/VSOAM\#/'W@[4IM"OO"=CK=C9SW&GOIMU
M91R221[9F@^SVL\2W#SK%]GC\U93"92\:%B58 ]?_P""5'[56J?M#^&KS3->
MEDNM4T*2",WCJ-T]K<*_V<RR;RTMPK0S+)(50N@A=FEF:9R ?J?0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\8?!#PAXD^)7A71-<O/&&N)
M<ZEI=C>3)%;:$(UDN+>.5P@;2&8(&8A0S,0,98GD@&A\2/#OB#X7VUGJ47BK
M6+O_ (G&B6TEO<V^C>3+#>ZI:6DR.8-+AE&8IGVM'(C*V&!XP0#Z_H * "@
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M]DUV7,,S%A<6-Q-9+):F.0*3);RJ\4=O,\;.L(@<&T><NQ /@#X,_M7>/O\
M@GKXHB\">.S]IT-;BV5I+EYY_LUB1Y"76F3 ,[6BJJO]G\MP/(>W2*UN6GP
M=A_P57N;?P=\7/"FN:S927.B0V>GM<(8%DCN8[74;B6ZMU$NV&5_*D0/$S 8
MFCW[5D!(!^S^D_LR?#37[>*\L_#7AN>VGC26&:+3+%XY(W4,CHZQ%61E(964
MD,"""0: "T^'/PY^$&MZ7':Z1H>FZW?R7$>F&WT^VANI&BMY)+@Q-%$'5%A#
MB63*H ZQ,VZ:-' /R0_;Z_Y.%\!?]P#_ -/-Q0!^_P!0!^ /_!<[_F4?^XQ_
M[84 ?L=^TWI-QK_@7Q+9V<4D]S/H>IQ0PQ(SR22/:2JB(B@LSLQ"JJ@EB0 "
M30!^6/\ P1"\=?VAX>\0:#Y.W[%J$%[Y^_._[="8?+V;1MV?8MV[<V_S<;5V
M9< _;Z@#^?'_ ()=> [>P^+GC2\T!(W\.6$=_96TT4ZS1B.?44:R5'9W>9'A
MM9664%P0@+/ETW &A^P+_P G"^/?^X__ .GFWH _7[]K'_DGGBO_ +%_5O\
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M[!0!X?\ M-Z3<:_X%\2V=G%)/<SZ'J<4,,2,\DDCVDJHB(H+,[,0JJH)8D
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MB:=H^FZ_/I\MR8K*R@@N#8I-%&[R-#&I6)I6C"JY E=&*!_)D* 'Y _M]?\
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M;Q#XYUQ?ASXW7.H06\T5I=31S)?/<699I;:]#!@TJQ*Y\V00.#;,LIGN)MU
M'[?4 % 'Y ?\%J_^2>:;_P!C!;?^D5]0!]__ +)W_)//"G_8OZ3_ .D4- 'X
MH_\ !5?Q)<?"GXN>%/%36DD]M8V>GW$8.Z..XDL=1N+B2!9MC*'"M%OP',8E
MC8H0RA@#^BZ@#\4?^"W&F:7+X5T.ZF,?]K1ZH\=J#*1(;62W=KLK%N =!)'9
M[Y-K&,F-0R^:0X!Z?^V%X6O/ W[-YTK4(_)O;'1_#MM<Q;E?9-#<6$<B;D+(
MVUE(W*64XR"1@T >P?\ !+C_ ))#X>_[B/\ Z<KN@#[_ * "@#X _P""H_\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M_P!D'PT=.>6.ZU:]D%QJ-TB*JF0*%2")BJRM;PC=Y?FG+/)-,$B\XQ( ?9]
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M1&DF DM)P#]GM)TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4
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MSS+J_B+Q-=V^I>+->N));VY@C40Q*TKRLD#F**3]\[>=< +%$66&-80+<22
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M<_X3_P")S6\6M16\EGI.BVPC>TTN%RHGN$;?/_I=SLPTD<KL+=S$\KJZ6]H
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M::^&Y\.>([ZSE\3"3[=#>112Q6<%X))'2%$5M[6Z0RO8K+*))#&1=O"]P-M
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M7X6N/$%IKUQ>^6UN)1;M;ZE=BXBW7HC:*TEBE2-9_M*[$19#Q%)%<T ?I?\
M%V7Q]XE^'VI6$N@R7_B#Q%9W\)LK:]L$M-)CN4%O%!)<SO;O,\<+^;(T:7(F
MO%N%62WM7MA& >'_ /!,?X7>-OV;M)N_#'B?PY<6L5UJ$E[%J,=[I\\*;[>.
M-HYHH[HS+@VZ"-HDGWM,0ZPI&78 \@_X*9_ ;XA?M8ZCI=MX>\,7'V+1OMR_
M:Y]0TR/[2UP\2[HHOM9=8@MNCHTI25O-*O!$8_G /U^^&GBK4_&&G)<ZOI%Q
MHM[\JRVD\]K<8;8K,T4MI-*CQ;F9$9Q#*VPLT$8*Y /0* /QQ_X*_P#[.OB7
MXSZ7HFJ>'K*34%TB2\2ZMK=6ENBMX;81R10HI:5%:$B4)ET#J^PQ+*\8!]/_
M +/'QE^)'Q@MX=5\0^&)-!L[.SEE>W6>/[9JUX%,2PQ6MVD;6-N&6:7;<RQ2
M/(UD5NFM1<F4 ^$/^%+_ !._X7?_ ,+1_P"$.N/[-^T;?LG]JZ5]H^S_ &#^
MSO-_X^_+\W9^_P#)W;-_[CS]O[^@#]+_ -J6^\1>*?!5]I>A>'KR_P!1UO2[
MFU,)NM/MULFN81$WVJ22ZVLZ+*Y5;7[2DCPE#+&CI,0#Y/\ ^"8_PN\;?LW:
M3=^&/$_ARXM8KK4)+V+48[W3YX4WV\<;1S11W1F7!MT$;1)/O:8AUA2,NP!R
M'_!0G_@GMJGQ5U1/'G@-Y$\3));FYMA<"!IF@"1P75K/(Z+!<0JB;EWQHZ1B
M1"EPA%R ?/\ \%_VJ?VD+6WL?#T7A.2_GBC,:7VKZ9?022+&K.#<W<MQ:V^\
M(-@DD*O,0NYI9W+. ?K?^RU\ [SX*:==7.NWW]K>)M9N!>:SJ111YDVQ4CMX
M2$1_LENHV6\; *FZ1HXH$D$$8!]/T % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % 'RA^U3^V3X:_9!M[&?7TO)I-1DE2W@LX5DD*PJIED)EDAB5$,
MD2D%][&1=J,JR,@!\_ZAX\L/V]_$'AU?"KR7/A7PYJB:QJ>JM!-:AM0M4;[!
M8VIN$5I7W2--?+Y(1+=H=MS'+(J. ?I?0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % 'SA^V)JUOHOPY\52W4L<,;:'J,0>1U13)-;211("Q +R2.D<:]7=
ME1068 @'P!_P10U:WF\"ZK9K+&;F+7)99(0ZF1(Y;2U6-V3.Y4=HI51B &,<
M@!)1L '['4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!Q_C7X>Z-\2K=;
M/7-/L]2MDD$J0WEO%<1K(%90X2564.%9E# 9 9AG!.0#H-)TFWT"WBL[.*."
MV@C2*&&)%2..-%"HB(H"JBJ JJH 4    4 :% !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 >?^.OA/X>^*'D_V]I6GZG]GW^1]MM(;GRO,V[_+\Y'V;MB;
MMN-VU<YP, '/^%OV>O!O@:\CU#2O#^CV-[#N\JYMM.MH9DWJ4;9)'&KKN5F5
ML$95BIX)% 'L% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M_M:XDMH3,EONM8KB[4-;P2/O$I>0/#AHXY(5,R;Y$VS>4 ?9] !0 4 % !0
M4 >?_$OXJZ'\&].?5?$-_;Z?9)N'FSN%WLJ-)Y<2_?EE*HY2&(/+)M(1&/%
M'G_[.O[2FA_M0Z=>:KX>^T&RL]0FL/-GC$7G-$D4GFQ+N9_*=94*>:(I>H>)
M",4 ?0% !0 4 % !0!\@>/\ ]NGP-X"\0V'A3[=]OUJ_U"WL/LUB%G^S2SS-
M;YNI=RQ1>7*NR:'>UTFY6^SE3F@#V_XT?%[2_@+X?OO$NLM(MC81AY!$ADD=
MG=8XXT7@%Y)'2-2Q5%+!G=$#.H!Q_P"S7^TIH?[5.A_V_H'VA;=;B2VFAN8Q
M'-%-&%8HX5GC.4>.16C=UVN 2) Z* ?0% !0 4 % !0 4 % !0 4 % !0 4
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MWEX._9:UG3]#\0->?:;Z-9F>WM_,CMK=Y3$L\Y+JQ0LLIVVZSS 1/F,%HA(
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MH>)",4 ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H S]6TFWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP*LC*2K*P(8$@@@T ?S
MX^%O">G>!OVL8]/TJTM[&RAW>5;6T*0PIO\ #Q=MD<85%W,S,V ,LQ8\DF@#
M^AZ@ H * "@ H * "@ H * "@ H * "@ H _.#_@H)^T?>>!(-,\">&KG[-X
MJ\67$-G:W2S+']@AFN(X3<2[5DF3S2[0PR1H&7;/-'*LULJ. ?7_ ,"_@7H?
M[.FAP>'_  _!Y-I#\SNV&FN)F #SSN -\KX&3@*JA8T5(DCC4 Y_7_V6/!?B
MGQ1;^-+S2+>77[;RS'=DR#YH@5BD>(.(998P0(YI$>6/9%M=?)BV 'T!0 4
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M@OXZ:C9:KXDTBWO[W3\"WED,B_*'$@CF5'5+B(,"1#<"6(;Y $Q+(' /H"@
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ME1@ ^+_^"*G_ "3S4O\ L8+G_P!(K&@#]?Z "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MYK'[+VAZ;;>'9/L^KZO<2^7=-!',L-O:"-I]HE+)YKM+"B[XI4\HSGY)!$U
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MP$_X2A/VF;./QI]G.OQ>=#=R6V/)F\K0I(XKA N //B6.=@%BVM(1Y,&/)0
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MC[PU\?D^'&I^(9-4T1))R1+86$$CQOI3WT*N]O;QMOC9D5GC,8E,9;RT5S&
M#]+OVG?VA=._9?\ "]WXEU!/.\G9';6HE2)[JXE.V.%"Y^LDA59'C@CEE$<G
MEE2 ?"'P&^ _CS]JC2X_&/CGQ=KFD-JD<<^F:;X?O5L((+&4O-$TP1)%D=UD
M4Q[]]Q'"L8GN)928K< _.'XM>&_&/@GXV>"='\9W<>I7.GWFAV]AJ:\27VGC
M5':">X!=F%P&:2&7?\Y,6XO.3]JG /W>_;(\6^-? OA6]U/P8=+BDLK.]NKV
MYOVF:2*""W>3_0X(XGBDN,@LC7#"%3&J-%*LI,0!\W_\$H/BKKGQD\&ZKJOB
M&_N-0O7\078\V=RVQ6MK.3RXE^Y%$&=RD,02*/<0B*.* //_ /@J5\;/B5\%
M-)6[T.ZT_3= NKB*Q%Q;O*^KR2S6]P\F2\(AMHL(0C0,UTDD<<JSIYC1Q@&A
M\.?#GQ-_:^\%:0;?7KSP?I::7I\(N6@-QJVKSQPQ&XOY)OM$,UK;M*F+4I+Y
MUY$TL\W[F>%* /$/V$OCQXY^$7Q,OOA3X]OKC5)9O-,$TL[7K17$=N+I'2YE
MD$@M)[56<1LK.DIA_=6[M<Y /T__ &P/VE+/]E;PE=:_/\UVV;;383&TBRWT
MD<C0)(%9,1#8TDS%T/E(X0F4QHP!X?\ LN_#G7OCQX?M_&'CW5-4:^UF-;FT
MT_3]1NM+L[&Q=Y)+9(TTRZB,[R1R+(TUT\MP(S# ^'AD:0 ^0-3_ &F?BE\"
M_B&/A1:W^EZC'-)%_9&K^)H)X7DMY+56@B>XM'B%R_F(]J+CRY)KJ]WAF5F\
MJ( _8[X6_P#"0_V/;_\ "5_V?_;7[S[3_9OG?8_]8_E>5]H_>_ZKR]^__EIO
MQ\N* /0* /RP^*WQ:O\ X\_%F7X56NO7GAS2['2_M%Y)8F&WU#4+QA#<I!:7
M;F1XTCADCF;R461TBO8Y$>%EEC .?^+?PM\>?LV:EX7_ +#\5ZYJOA>_\2:1
M;:O!J4BW=Y$TUY"%?[<L"RQV4H1;>2$O$@D<)^^%Y(B 'N'_  4.\4>*OA)X
M0O/%_AC7[C39=.^R+)9?9+&YMYUFN5@9LSV[S1RYG1MPD:+9#L$ >0R@ ] _
M8*^*6L?&GX<:-KVO7'VO4KO[;Y\_EQQ;_*O;B%/DA1(QA$1?E49QDY8DD ^
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M/;P>,;#[:MM?2) 8IIK=V26":WMY8$FE@;+@6C(MQ:Q2$M$T)GF /SQ_:O\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M -L* /W^H _ ']@7_DX7Q[_W'_\ T\V] 'W_ /\ !4?_ ))#XA_[AW_IRM*
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MQ(\)?"SPO=ZAXU2WN-(^16LYX8[C[7,#YD,$5O+\DLI9 Z!L*FPS.T<<3R(
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MS?M!:=J'AK]]H7A/[!]JU:']];O]BGEO!@MY2_OKAFLXO+:;>D;WD?FP*P4
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MDC#N9)I/,NG6-YXTMU,4?D@$ _J-H _ ']@7_DX7Q[_W'_\ T\V] 'W_ /\
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M9W1%5I9!JLL0>0@ NXCCCC#-DA(T3.U5  /T/_X*C_\ )(?$/_<._P#3E:4
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M_LG?\D\\*?\ 8OZ3_P"D4- 'Y _M]?\ )PO@+_N ?^GFXH _?Z@#\ ?V!?\
MDX7Q[_W'_P#T\V] 'T?_ ,%GM6N-.^'-I%!+)''<ZY:Q3HCLJRQBVNY0D@!
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M_P#L7]6_](IJ /@#_@BI_P D\U+_ +&"Y_\ 2*QH _7^@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /Q1_X
M*:_\$\[CXM//XZ\)I)-K*QI_:.G@L[7D<,:QI+:J<D7$<:*C6Z\7"*#&HN5*
M70!Z_P#LN_\ !37PUXSM[?0/&L\FA>*+.-;:_.I(MO;S74"R+._FA8XK=R8M
MTD-PEL(YI1;Q><5R0#ZP\1_MD^!M(B'V#5K?6[V3S!;Z=HKKJE]<.D4DQ2*W
MM#*XRL3?O)/+@0X\R6,$&@#0^"'@KQ!<7%QXH\7M&NL7T:QVVF1%)+?1K/=O
M^R13A=TUQ*VR34;D$1W$T4"1H(+6 D _)#]NWX1:Q^R3\1;'XR>&;/S=+-Q%
M+JD<7EJ([B3,%RKJ(&$,5]$VPW1$SB\EF=F262V#@'Z?^%OV]OAKXGT./7CX
MAT^UB>W:=[2YN(H[Z+8#OB>S#M,TJE654B63SC@PF5'C9@#XP_9Q^'&L_M(?
M&#4/BU?07EIX<LHVM_#QN'E0W<;6PMXYX(;B%'%E+#+-><"$"XN4"/.4N2 #
MY/\ ^"TWQ5T/QOJ/A_2M+O[>\O=+_M07T4#B3[.TKVT:QRLN464-;RAX2?-C
MV@NBAT+ '[O>'/V@?"7BO0SXFM-:T]M%7RQ+>M<QQPPM((RL<[2,OD2_O8P8
M9MDJLZJR!B!0!^ /[#?Q^\+^'_CAXIUV^U.WM-+UC^VOL-W<DV\,GGZC%=Q;
MWE""'?%&[+YWE_,!%_K61& /T?\ ^"L'Q5T/P_\ #C5/#]S?VZ:OJ'V VMCO
M#7$BK>Q2F3RERZQ!;>;]\X6+>GE[_,948 /^"3_Q5T/Q!\.-+\/VU_;OJ^G_
M &\W5CO"W$:M>RRB3RFP[1%;B']\@:+>_E[_ #%9% /A#_@IYXDN/!WQL\)Z
MG9VDE_<V=GI%Q#91;O,N9(=4NI$@3:DC;Y&41KM1SEAA&/! /UO_ .&_/A?_
M &/_ &Y_PDVG_9/^>>]_MG^L\K_CPV_;?O<_ZG_5_OO]5\] 'R?_ ,$]?AQX
M@^(WB77OC'XE@DLI/$48ATFU9TW#3V:-E>15AC)18[>UBM9CY;SHDL[Q,LL,
MK@'S!_P57BU3X5?$OPIX_-A)<:381Z>%D#!(Y+JROKB\:U:0!S"[QLI1G0AQ
MYA02>3*% /J_XQ?MVZ'\?_ /B&V\$V.H:S</X?O7U']T+2'2H9H"DAO)[@I&
M\JH\SQ069NFN&MI55EC'G  ^8/\ @DG^T%9^$_#S^$;&VN-2U^^\0&=K6%&1
M+;37ALXI]0N+EU\E(H1'(!&&,TTYA@5!YRR* >/_ +<GQ^\+^(/CAX6UVQU.
MWN]+T?\ L7[==VQ-Q#'Y&HRW<NQX@XFV12(S>3YGS$Q?ZU710#]_O$?[0/A+
MPIH8\37>M:>NBMY@BO5N8Y(9FC$A:.!HV;SY?W4@$,.^5F1E5"P(H _"'_@B
MS\5=#\$:CX@TK5+^WL[W5/[+%C%.XC^T-$]S&T<3-A&E+7$02$'S9-Q*(P1R
MH!_0]XL\+6?CG3KO2M0C\ZROK>:VN8MS)OAF0QR)N0JZ[E8C<I5AG((.#0!_
M.#^QE^S[KGA3XN3?#K5+GS]%\-Z@=?EMI'*+--:1>5IM]"D32^7*_P!LM9Y(
M?-56B413^8T"1T ?TO4 % !0!^&/_!;GP!JFNZ7X>UJUMI)=.TV2_CO9T *P
M-=FT$!D .Y4=HG028V!]D;,'EB5P#ZO^%O\ P4FT/XX:=;Q>&-,U#5/%4]O)
M))H,*B/[,T:.6>XU"<16:6GF*D8N S2GSX0+7SF,"@'Y0?\ !*3]H*S^"_\
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M2XNKJ"ZN)6/WI)[B?39)IY7.6DFF=Y97)=W9V+$ ^@/A;_P69\/>$OL^E_\
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M%T*[EM[;Q,=0L[V^T:.Y2ZFL<6$QECFDB^0;6N8EC9MGVA298E9%<J ?H_\
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MU+K$US#92.$FFA>S@ >%6QYV/LTQD6+>T2H&D"*Z%@#Y/OGN/^"4GQ>N+_\
MLV2X\+ZI'-%:L P8Z?/)#-(EK(\SAKBSD2.)EN'WS(@9Q +J*9 #[_\ C?\
M\%"?"?QN\"ZWIO@Y+S5]6O-#OC<60MY;<Z?:M:2&ZNKN>5/LX2V0E2L,DQGN
M##;Q%O.$J@'D'_!&'XEO:Z#=^'$TK5)5EU2ZNWU1((QIL*BUM$\F2X>56-P6
M5<011R/MD20@1"1XP#]SJ "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * /+_&OP0\*_$JX6\US1-+U*Y2,1
M)->6-O<2+&&9@@>6-F"!F9@H. 68XR3D T/ OPG\/?"_SO[!TK3],^T;//\
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M_P *G\/?VQ_PD/\ 96G_ -M?]!'[)#]L_P!7Y/\ Q\;/-_U7[K[W^K^3[O%
M'H% !0!Q_C7X>Z-\2K=;/7-/L]2MDD$J0WEO%<1K(%90X2564.%9E# 9 9AG
M!.0#H-)TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4    4 :% !0
M!Y_XZ^$_A[XH>3_;VE:?J?V??Y'VVTAN?*\S;O\ +\Y'V;MB;MN-VU<YP, '
M0>%O">G>!K./3]*M+>QLH=WE6UM"D,*;V+MLCC"HNYF9FP!EF+'DDT :$FDV
M\UQ'>-%&;F*.2*.8HID2.5HVD17QN5':*)G4$!C'&2"47 !Y?X6_9Z\&^!KR
M/4-*\/Z/8WL.[RKFVTZVAF3>I1MDD<:NNY696P1E6*G@D4 >P4 % !0!Q_C7
MX>Z-\2K=;/7-/L]2MDD$J0WEO%<1K(%90X2564.%9E# 9 9AG!.0 TSX>Z-H
MNEG0[73[.'26CEB-A';Q):F.8L94,"J(BDA=S(NW#EFW [CD /!7P]T;X:V[
M6>AZ?9Z;;/(97AL[>*WC:0JJERD2JI<JJJ6(R0JC. , '84 % !0!S_BGPGI
MWCFSDT_5;2WOK*;;YMM<PI-"^Q@Z[XY R-M959<@X90PY - '/Z!\)_#WA33
MKC2-/TK3[33;OS/M-G!:0Q6\WFH(Y/-A1!&^] $?<IW( IRH H [#2=)M] M
MXK.SBC@MH(TBAAB14CCC10J(B* JHJ@*JJ %    % &A0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MND$:0"?[,9() #U"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M&F2H98(XA((XFD$CQJ] 'U?0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M/@622QO@J6:"2(R&.)9#(D:I0!]GT % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M.SN;^3RK*&XN(H9+F3<B[($D96E?=(B[8PQRZ#&6&0#L* "@ H * "@ H *
M,_3-6M]:0RVLL<T:R2Q%XW5U$D,C12H2I(#QR(\<B]4=61@&4@ &A0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >7^+OB]I?@K6]%\/732'4
M=>DNTLHT0E=ME;M<SR2.<*J*H1 ,EV>5-J%!*\8!ZA0 4 % !0 4 % !0 4
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M5&$E2;S)C* >?_\ !/7]DCQY^R=XEU[3M3NXYO"31@V961=MW=,T?EW4=O\
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M, >P4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!Q_C_7;_P ,Z7<W
MFEZ?)JM]%&3;V,<T,#3R$@*IFN'2*-,G=(Y+%4#%(Y7VQN ?S@S?&CXAZW^T
M':7^I^'XY_$>GQSV]GX?COK6%8K5["XFCB-_\\+NL5R]S)*Q)D<M&JQ I#$
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M%8]8UNVCG;5IT#PZ?:2).[16]O;RS"YU"X>T199(K:4F%Y[<_O&E^SJ >O\
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M?]D^WM]=\5:-X;U?0O,:.[.C/?QR0,R[83++<[Q"CR,H$GD3(2ODLT4DT)8
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MJ7^F?":QTNZL=*D6.Z\0ZO+<#39K@ ^9:626J^;.ZAHY/M*OY(56RFR:UFF
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MA9XM3P5J'@7_ (F]Q<0P6:KK8$-W]HD\JWE@FDL$1HI6^4.^S8P9)1%)'(B
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M1OV>KC3]',4FI>(]8D6'3-)MWB22625C% \\LK*EM;O-MA\Y]QR79(I1#-L
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M, 'O_P"W=H&H^%/V?[O3]7N/M>I6FGZ'!>7/F/+YUQ%=V*32^9(!(^]PS;W
M=L[F 8D4 >@?\$N/^20^'O\ N(_^G*[H ]__ &L?^2>>*_\ L7]6_P#2*:@#
MX _X(J?\D\U+_L8+G_TBL: / /\ @N=_S*/_ '&/_;"@#][M)TFWT"WBL[.*
M."V@C2*&&)%2..-%"HB(H"JBJ JJH 4    4 ?@C^P+_ ,G"^/?^X_\ ^GFW
MH ]__P""U?\ R3S3?^Q@MO\ TBOJ /O_ /9._P"2>>%/^Q?TG_TBAH _''_@
MHAI-OK_Q]\$6=Y%'/;3QZ%%-#*BO')&^L7*NCHP*LC*2K*P(8$@@@T ?T'4
M?@#_ ,$,?^9N_P"X/_[?T ?H?^U=\*OAOH6LZ1\3?'%U)93:%)#%;N)9/+GD
M65IK5&MXDDFE>&4R7"+;A20)&G$MO&50 ^$/VTOVFO%'[1?PSUJYTWPM<:5X
M1/\ 9TIU;5I1%<W437%F\:VMB@8_/++$Z77FRVKVT4P#"=E1 #[?_P""7'_)
M(?#W_<1_].5W0!\ ?\W>?Y_Z%R@#]_J /P!_X(8_\S=_W!__ &_H ]0_X+8?
M%"X\/>&M%\.0>8D>K7DUQ/(DS(K1V"QX@DC Q*CR7,<PW-A'MT.QF*M& ?K]
M\/?!5O\ #71M/T.S:1[;3;.WLX7E*F1H[>)8D+E552Y506*JH)SA0.  ?EA_
MP6;^%O\ PE?@:SUZ&W\RXT;4$\R?S-ODV=XIAE^0N%??<"R7A7D7&1MC\TT
M>@?#?XEZC\7?V<;S5]5?S;U_"^MP2REG9I?LD5W:++(TC.[RR+"KS.6^>5G8
M!00H /,/^"*&DV\/@75;Q8HQ<RZY+%),$42/'%:6K1HSXW,B-+*R*20IDD(
M+MD \/\ ^"YW_,H_]QC_ -L* /W^H * "@#\(?@%K7_"_P#]IK7M3O6N(_\
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MMO\ TBOJ /O_ /9._P"2>>%/^Q?TG_TBAH _*'X!:U_PO_\ ::U[4[UKB/\
MX1VWU"&QA\_S$7[&T>E,/F3Y8I//N+KRH]FR>7)=_G,@!^[U '\X/Q%AU']E
M_P#::M9]*B^RVGB#4+$^69G=+JWU=D@O7=5EW?\ 'W]HFCCEPD<\,4@B,2Q
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MS=1-<6;QK:V*!C\\LL3I=>;+:O;13 ,)V5$ /M__ ()<?\DA\/?]Q'_TY7=
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M5RT/XN[?#OQ#T^WL6OLVTEV@$FERK-YJLEU%.S/;Q%3'"S,US$Y=Y)3;P@X
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M\=?C3XG\6,D<ECX6LX/#NG2FSD :Z+/-?,L\QP+BVD,]L_DJ ]O<QG<$;?<
M'Z7T ?S0_LZV]G_P3I^.5YHFO/Y.D7UO-9VFHW#LB):74D5Q9W$DGD(DGS0)
M:7,BB.WAG,[F41P-D _I>H _#']B'23^U!\9?%/Q1>*.32;&26UTNY5+F%9)
M"BVEO+&K@!W%A&QNHY2#&]W$X@3<GE ''_M]?\G"^ O^X!_Z>;B@#]_J "@
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M0OQ_JGPP^&&O:IHUS)9WT<=K''<1$"2-;B\@MY"C8)1S'(X61</&2'1E=58
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M 'C7WABQN-/E?'FK'J6H-#-M5T7SH)+IX9M@D<Q^:C^6S%TVOA@ <_\ $O\
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MU!-"U 6,-W,EFA$\R")\RG>VX@JK,6D*^;)-)( ?;_[/7[,7A?\ 9?TY]/\
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MI\*M#^#>G)I7AZPM]/LDVGRH$"[V5%C\R5OORRE40/-*7EDV@N['F@#0\?\
M@#2_BGI=SHNM6T=YIUY&8YX) =K+D$$$$,KJP#QR(5>-U61&5U5@ ?G!IG_!
M'KX96&J'4)!JD]L9)7&G27@%J%<,%C#QQ1W>R/<#&3<%R47S'D!<, ?H_IG@
M#2] TLZ+IUM'8:<8Y8U@L0;)8UF+&0PFV,30N6=G\R(HZN3(&#_-0!\H?\.Y
M/AC_ &C_ &O_ &3<?VE]H^U?;/[7U7[1]HW^9Y_G?;/,\W?\_F;M^_YL[N:
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@#\T/\ @H'^S1XZ_:WLK?0-
M'&AVFDVMXEX+BZO+LW4TBP-$H\J.R:*%%,TX8>9.91Y3AH</&P!]0?LM>$O%
M7PZ\-6.@>*(M+$FE6=M9V]QIUS<2K/' IB4R17%M"876-(@2LDPE<R.%@7;'
M0!]'T % !0 4 % !0!^6'B#]F+XTW/CS4=:TSQW'9:%>R2^2CQ-=-;6[*K11
M1Z7-$;$/&R)";A98YI$#W#-YDLL+ 'W_ /"'X0Z7\$M+72]+60J9'GN;F=S+
M=7EU*<S7=W,?FFN)6Y=S@8"HBI$B(H!ZA0 4 % !0 4 % !0 4 % !0 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M9R6FDZ5'IHMFN-HNI9+D71G:58WDB1 842)%9SA6D:3]X(H0#[OH * "@ H
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M*U^'FGR76DS1H9C'9)<QSW1N-KP7LK9-K;B/R<2[K0$2SM]H/E9@ /U/H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MQQI-O'!::MH=W;ZBD:JB_P!H?;+.5)R#)DO<QB3S/+C5 ]NTLCM-<DD ^SZ
M/B#Q3_P4A^%'@^\DL;GQ';O+%MW-;075W"=RAQLGM8)87X8!MCMM;*-AU90
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MG!9 &4D ^K])U:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$@T
M>7_&/X_>%_V?[-;[Q/J=OI\3Y\I9"6FFVLB-Y,$8>:;89$,GE(_EJP=]J98
M'(?&_P#:Z\$?LXW%O9^*-6CLKFZC:6*$0SW$AC5MN]DMXI6C0ME4:0*)"D@0
ML8WV@'?_  A^-'A_X]:6NL^&KZ._L6D>(R('1DDC/S))'(J2QO@JP615+(R2
M %'1F .P\4^+-.\#6<FH:K=V]C90[?-N;F9(84WL$7?)(51=S,JKDC+,%')
MH ^,-)_X*:?"36KB*UB\11K)-(D:&6SOH8PSL%!>66V2*-,GYI)&5$&69E4$
M@ ^W])U:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$@T >7^/\
MX_>%_A?J-AI&KZG;V^I:G<6]O9V>3)<2O<NT<+>3&'D2)G1D\]U6!7&UI Q
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M%RD@ =&9&5B =A0!GZMJUOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B
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MWEKXGU>WL99MICM\237!5_,VR?9X$EF$1,3KYQ01!UV%]Y"D [#X0_&CP_\
M'K2UUGPU?1W]BTCQ&1 Z,DD9^9)(Y%26-\%6"R*I9&20 HZ,P!ZA0!\0>*?^
M"D/PH\'WDEC<^([=Y8MNYK:"ZNX3N4.-D]K!+"_# -L=MK91L.K* #Z_\+>+
M-.\<V<>H:5=V]]93;O*N;:9)H7V,4;9)&61MK*RM@G#*5/((H Z"@ H _(#_
M ()-_ O_ (4__P )K_IGVKR?$$FB_P"I\K=_9'F?O_\ 6/CSOM?^JY\OR_\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M'P99_9KOQ$L=O=,T\PW726DQ@Q*\3Q"V$9M\K#+<F=_,DMXUA /?_B7^V?\
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M;SNBQP743N[(D\1\D-+&X!^E] !0!\__ +6/_)//%?\ V+^K?^D4U 'Y _\
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MA\/?]Q'_ -.5W0!\8?\ !9[X-Z)8:#:>+T@D.MSZI:V+W+W-PZBU%K=R>3'
M\K01)OC60^5&A+EW)+22%@#ZO_9!_9.\/:QX-T76/%-O;^)-2O\ 1]+9)M2M
M89TL[-+93:V-G#(KQP10H_[QT DNIVDN)6+.J1@'YX? +P5;_LS_ +3<WA7P
MXTD.DSQSPO#(5E;[/-I8U+R!(ZEPD<Z1^6V?.V1JKR2;I"X!]W_\%1_A/X>_
MX5QXA\0_V5I_]M?\2[_B8_9(?MG_ !^VD/\ Q\;/-_U7[K[W^K^3[O% &?\
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M9A;)B,)MSY- 'YX?\$.O%-Y=Z=XGTIY,V5M<:?<PQ;5&V:Z2XCF?<!O.Y;:
M;6)5=F5"EG+ 'H&M>*;/]M_XY-X3O)/M'A7P=;SW,FG2*S6]_J5O(EO*\T9$
M)_<RW(B"R?:872UD"@PWTN0#[O\ VL/V9+?]H'P'=>$-.2SLI$CMSIC/ OD6
MLEJRF)8U09@1HU:V+Q F*&5\1R+F)P#G_P!@W]G'6?V6O!R^']<U".^N?MEQ
M<(L+2O;VT<FP""!I0K%"RM<-B.(":>0;&(,L@!^4'P\_;(\&?%3XI:GXO^(>
ML1G2=#DDA\)69L+V2W"M.VR_6.-)"EP(X8Y'-S&7>:>-T\G['!'$ =!_P4;_
M &D_@_\ M)^$YI-'U".Y\46DEJUC*FG7,,\L:RE)+>2YGM%/V=8YYYQ%YD8,
MR(PR<HX!]_\ _!,+X\ZI\?/A]%<:S))<7VF7DVG27<L@>2Y6)(IHY'.Q3O6.
M=(6+&1Y#$9GD9Y&P ?H?0!^*/_!0?QC?_'_X@^&O@[ID\@TZ[D@N=<2UNH5D
M>,N96CE#J?+>UMH'O8XY&<3&:!_L[O' 6 /U^TSX>Z-HNEG0[73[.'26CEB-
MA';Q):F.8L94,"J(BDA=S(NW#EFW [CD _GAUN^3_@EW\:8[>PN)(O!^L1V\
M]S:>=)*([&X:6'=*#"[L]G.DTUOL$EP]NJPFX+W$^0#]#_\ @J/\)_#W_"N/
M$/B'^RM/_MK_ (EW_$Q^R0_;/^/VTA_X^-GF_P"J_=?>_P!7\GW>* .?_P""
M</[/7@WQS\+="U#5?#^CWU[-]O\ -N;G3K::9]FH7*+ODDC9VVJJJN2<*H4<
M "@#Z@_;0^$_A[Q7X-\1ZOJ&E:?=ZE:>']2^S7D]I#+<0^5;3R1^5,Z&1-CD
MNFUAM<EAAB30!^>'_!(GX(>%?B5X%U"\US1-+U*Y37+B))KRQM[B18Q:6;!
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M6]L_W6@:/J%SI=O#-/;V]O-;V4GD.+>WDCA?R@@6)9$=8T+HH5))%8 ^7_\
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M)#X>_P"XC_Z<KN@#[_H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M48EM1<%L>1Y,:PW3J+KAB&AC<6\8!\ ?\$,?^9N_[@__ +?T '_!<[_F4?\
MN,?^V% '[_4 ?A#^UKH'_"T/VD_!NGZ?<6[7%E;Z;/<@R9\K[#=7>I21.$#L
MDK6Z!HT8+N\V)B5C<. #G_\ @N=_S*/_ '&/_;"@#]_J /PA_:UT#_A:'[2?
M@W3]/N+=KBRM]-GN09,^5]ANKO4I(G"!V25K= T:,%W>;$Q*QN' !Y?_ ,%<
M;W5/A5\2_"WC&WAC:.VL[9[-I2&CDNM-OI;EXWC1UEV*)[<L?D#B0A'W*VT
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M_P#P5'_Y)#XA_P"X=_Z<K2@ _P""7'_)(?#W_<1_].5W0!\ ?M]?\G"^ O\
MN ?^GFXH _7[]K'_ ))YXK_[%_5O_2*:@#X _P""*G_)/-2_[&"Y_P#2*QH
M]P_X*IZM;Z=\)-:BGECCDN9-/B@1W56ED%];RE(P2"[B..20JN2$C=\;58@
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MYW+;3G<H*KLPQ4L@8 _5[]D[_DGGA3_L7])_](H: #]K'_DGGBO_ +%_5O\
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M <(V[RI H9D8  ^W_P#@J/\ \DA\0_\ <._].5I0 ?\ !+C_ ))#X>_[B/\
MZ<KN@#X _P""YW_,H_\ <8_]L* /W^H _$'XC_%77/V_/B5>?##2;^XT#PSH
MGVT:S)"Y2\U%;>46=U&"FY/*=I?*BAD)B,;/=3I,ZPVD8!S_ /P5(^ /A?\
M9_\ ACI]CX8TRWT^)_$%KYK1@M--MM=1=?.GD+S3;#(XC\UW\M6*)M3"@ _5
M[]D[_DGGA3_L7])_](H: /R!_8%_Y.%\>_\ <?\ _3S;T ??_P#P5'_Y)#XA
M_P"X=_Z<K2@#Q_\ 8]\+7GCG]F\:5I\?G7M]H_B*VMHMRIOFFN+^.--SE47<
MS ;F*J,Y) R: / /^")?QCLY=.UGP6Z[+V.X.K0MECYL,B06LPP$V)Y+1P'+
M/NE^T?*@$3L0#]SM6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q 4
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % 'P!^V-\)OB'^TCX<O\ PGIMKX?LK*\N
M(LWEQJ=[+,]O!.L\>($TU$AE=HXB_P"]N$1?,C&\LLJ@'E_[$O[.'Q+_ &/-
M&O-#:W\-ZI;7-Y]LC<:I?6LD<CQ)%(&/]ESK(A6*(H L90B3+2!U$8!^I] '
MXP_M#_L9?%/XZ>/M,\=Q-X7L9='^P_8K1KW4+A?]#G:Z7SY!8PF3=*[Y\M8<
M1%4'SJ97 /T^\1ZEXR?0P^FV.CKK[^8IAN-1N6L8>)!'*)DL%FN,$1,\/E6V
MX-(HG78KN ?G!^P-^QE\0_V-=1OOM+>'[_3=6^R+=>7>WL=Q#]G=\2P[K$QR
M82:;,+^7YC^7^_A56W@'TA^W'^PYI?[7NEB2,QV?B.SC(L+\@[67);[+=;06
M:W9B2K ,]N[&6,,&FAG /S ^$/P"_:;^!"+X8\/31VNCI>.(YWGTNXM8UDDP
M\\8N1+=QVYYG,21*^6=_L_GR.K 'Z_\ [*W[.-Q\#[>^U/7-0DU;Q5KLD5QK
M6H,S>6\D2L(H+>/"JEO KM'%A$+ _<BB$-O  ?5] !0!X_\ '3X%Z'^T7H<_
MA_Q!!YUI-\R.N%FMYE!"3P.0=DJ9.#@JREHW5XGDC8 _+'X<? KXX?L/W$&E
M>$WL_&/A4R.WV*:2*RDA#-#),4^T2JUL[MYRPB*:[MP3+<2VPED (!]G^'/B
MK\7/'<ILV\':?X<SY;?VCJ&M1:E"BB6,2JMG8)'+-*8C(T2M-;1;E^>=>$<
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M;*;P_'X6L_$\EE&+?3M?&K16JW,:0(D,]Y:7<[W$EQO!>[Q-")'+I&^T+<2
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MZ21,0'1VVM'*$EC /@_]GJ/XZ?LK:<_A:]\-V_B[3[/RETV]AUNVM/*AV M
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MC,8]LJ)CS%FS$&0_.PE0 _9Z@ H ^0/VZ?V=/^&G? U]HT"[M2@Q>Z9SC-Y
MK;(^98H_WR-);;I6,<7G><5+1K0!X?\ \$D_&MOXJ^%=C9P+(LFE7E]9SEPH
M5I'F-Z#&0Q)3R[J-26"G>KC;M"LP!]W_ !8\"_\ "T/#VJZ#YWV?^T]/N[+S
M]GF>5]IA>'S-FY-^W?NV[EW8QN&<@ _&']CO]G3X\_L\_P!I>%+)='T[1;JX
M>4ZK=&.[\I_DMWN;"*&42O*\02:**_B2 ^0JN(&>19 #U#]N/]B#Q_\ M87&
MEVMB^AV6DZ''<0V1N=2U"ZO)UE:-?-N99+-CO:."'*%IG$GFL]S/O!4 _2[P
MYJ7C)-#+ZE8Z.VOIY:B&WU&Y6QFXC$DIF>P::WR3*R0^5<[0L:F=M[.@!^8/
M[/'[&7Q3^!?C[4_'<K>%[Z76/MWVVT6]U"W7_3)UNF\B0V,QCVRHF/,6;,09
M#\["5 #[_P#VKOV4=#_:UT,Z5JH\F[AWOI^H(@::TF8 $@$C?$^%$\!(650I
M#)*D,T0!^*'PY_99_:/_ &47O-*\'-&]C/)'*\EO<Z=+:RR>6,O%'J6R6-\$
M12L(HC(8U!,B1Q-0!^M_[+7[,FN?#_4;KQAX[U;^V_&-];BR:>(E+.UL4=72
MWMHA' GSLBS2OY48\PD(@8SS7(!]OT % !0 4 <?X_\  &E_%/2[G1=:MH[S
M3KR,QSP2 [67(((((975@'CD0J\;JLB,KJK  _''2/V0_BY^P]>2R?"R_M]?
MT*[N#)+H]_Y43*S+,BO)YDD,9\M!")+BUGM9;B41A[4P1   ^S],^-7Q@\3.
M;-/ %GI4DL<HCOK[Q';3VL$@C8QM-#9P/<2)O"KLB"EB0#)$N9$ /;_A-\"_
M^$'U&]\1:Q>?VOXDU#,<VH-#Y"06:N6AL+&W,DWV6TCX9T\R22XGW3S2R.4\
ML [#XT?"'2_CUX?OO#6LK(UC?QA)#$YCD1D=9(Y$;D!XY$210P9&*A71T+(P
M!^6/[/OPP^-'[#<MSX>T_2[?QIX9;?+8[-2@L&M7:5NGVLEXO,4>;/;(LT"R
MR*\5QO-QYH!Z_P",/V9?%O[;5YIUW\2(K?0?#VG7!N(O#EE=275S<L5\MAJ%
MY&Z6PP4#0/:QM*MM=3P^9!,3+0!]8?M2^$O%7Q%\-7V@>%XM+,FJV=S9W%QJ
M-S<1+!'.HB8QQ6]M,9G:-Y0"TD(B<1N5G7='0!\O_P#!/S]FCQU^R197&@:P
M-#N])NKQ[PW%K>78NH9&@6)AY4EDL4R,88 H\R Q#S7+392-0#R_]OG]C+XA
M_ME:C8_9F\/V&FZ3]K6U\R]O9+B;[0Z9EFVV(CCRD,.(4\SRW\S]_,K+L /T
M?\.:EXR30R^I6.CMKZ>6HAM]1N5L9N(Q)*9GL&FM\DRLD/E7.T+&IG;>SH ?
MF#^SQ^QE\4_@7X^U/QW*WA>^EUC[=]MM%O=0MU_TR=;IO(D-C,8]LJ)CS%FS
M$&0_.PE0 W_^"U?_ "3S3?\ L8+;_P!(KZ@ _9C\6_%SX-^$M$L;'PY;^+]%
MFT?3[O3[U=5BTZY@6ZC,[VET+R2;S/(\Q(;<PK'$MM'%_$S10 'L'[/7[*GB
M'6/%[_%#XD2VY\2&WBAT[3;&68V>FQ&V$4H_>2/F4[YE:*-Y+5)))YU>9YD:
M  ] _;E^#OC+]HGPY<>$_#J:/#97WV9KJ\O[NY28>3.)_*B@AM)4&6BA/G/*
MV5,L?D [)0 '[#7P=\9?L[>'+?PGXB31YK*Q^TM:WEA=W+S'SIS/Y4L$UI$A
MPTLQ\Y)5PHBC\@G?*0#Y?_;Y_8R^(?[96HV/V9O#]AIND_:UM?,O;V2XF^T.
MF99MMB(X\I##B%/,\M_,_?S*R[ #]/\ X:7/B&YTY/\ A)X-/@U)=JR?V=<3
M3V\F$7=*OGP021;GWXA/G;$"YGD8G: ?C#\9OV*_B9\#?B5+X]^%I_M%=2N+
MF[NH)9[>'8UQ+YMS:7*32P)<6DK-NB,9\V/:,^7-!#<R@'8?M;_LD?%3]ISP
M5:7VJW<<_B..\CN3X<M)(;;3;:!X?*9(WDW-<WJ-B5YKBZ,,:R74-MD%#. ?
M3_[*7P[^)O@[P_9W7B/[&E]IFEPZ1I?AY+HV]F((7A1KW4+J%+\R7KQPKY/D
MJ\,,890L;W<_D@'SA^SQ^QE\4_@7X^U/QW*WA>^EUC[=]MM%O=0MU_TR=;IO
M(D-C,8]LJ)CS%FS$&0_.PE0 ^O\ ]N7X.^,OVB?#EQX3\.IH\-E??9FNKR_N
M[E)AY,XG\J*"&TE09:*$^<\K94RQ^0#LE  ?L-?!WQE^SMX<M_"?B)-'FLK'
M[2UK>6%W<O,?.G,_E2P36D2'#2S'SDE7"B*/R"=\I /@#]J[_@F#KGA_7#XO
M^$<WV&X;>[Z=!=&QFAFE(C<Z?,#'''$Z22-) \D*Q*KI$SQR1V\0!V'@K]FG
MX[_M(6[6'Q*\2R:-HAD*W%G9BR%Y=Q[522(OIZ)"+>6*69#YTLP$B*7LI%V,
M #];O%/PJT/QIH<GAF_L+>719;=;8V00)"L* "-(U3;Y7E[5,+1[&A9$:,HR
M*0 ?@#K7_!.KXK_LI>*&UCX6W7VRW?SXX)EGM8KB.W<(?)OH;SR[:;)/R&,2
MHSP+<&.VD\I% /M_X _LR?$SXKZCIFO_ !DU;SXM&N!>Z9HMN;>/;?1N1'<7
MK6,<<+^4$62W1'G)\TAGB3S[>X /U?H * /F#]J[]E'0_P!K70SI6JCR;N'>
M^GZ@B!IK29@ 2 2-\3X43P$A95"D,DJ0S1 'Q_\ "7PS\;?V1+.+P_%I^G^.
M="@\^.P>/4%T^^M84:,6Z3/>#R_*V;_+MXQ<M"28Q=+!%#&P ?%KPS\;?VN[
M.7P_+I^G^!M"G\B._>34%U"^NH7:07"0O9CR_*V;/,MY!;-,0(S=-!+-&H!]
MH?LS_LJ^&OV4-+DTSP]%(6GD\RZO+AE>ZN&!;RQ+(B1KLC5BL4:*B("S[3+)
M*\@!S_[6?@KQK\5?#^H^&_"JZ7;QZG9_9Y;^\O9DDC65RMS$+5-/N4=)(-T0
ME\Z-T,K,JJT:,P!\?_L2_LP?%?\ 8ZM[S3"WAO5=)NY/M"VQO[RVDBNBJ1M*
MLXTR8LCQQJKQ.K#*1NC1_O1, ?8'[6?@KQK\5?#^H^&_"JZ7;QZG9_9Y;^\O
M9DDC65RMS$+5-/N4=)(-T0E\Z-T,K,JJT:,P!\?_ +$O[,'Q7_8ZM[S3"WAO
M5=)NY/M"VQO[RVDBNBJ1M*LXTR8LCQQJKQ.K#*1NC1_O1, ?<'[4OA+Q5\1?
M#5]H'A>+2S)JMG<V=Q<:C<W$2P1SJ(F,<5O;3&9VC>4 M)"(G$;E9UW1T ?+
M_P#P3\_9H\=?LD65QH&L#0[O2;J\>\-Q:WEV+J&1H%B8>5)9+%,C&& */,@,
M0\URTV4C4 ^D/VKOV4=#_:UT,Z5JH\F[AWOI^H(@::TF8 $@$C?$^%$\!(65
M0I#)*D,T0!^.'PO_ &8OVE/V=+C_ (1_PS>QKI+20H+G[79W.GPJ[&1Y(H+Y
M6N(45YI&N!!;*\KJS!)\1D@'ZO\ [*W[,&J?!^XOO$/BS69/$/BC5(XHYKN1
M ([. ,TSV=D6RZ6YGDD<J@@A<)!MM(#'\P!X?^WM_P $YK/]JC;K>A/;Z?XF
M3RTDFEW+;WL*X4"Y,:.ZRQ+_ *J=4=BBBWD5D\E[< ^,/@O\*OVIO"%O8^'+
M.ZCTO2[:,Q0S7LNDW4=O&BLR(SJEY=L@XBB55D$8*(!'"GR 'Z__  "^ 2?L
MT^&IM,TR:35-4GDGOKR\OIY$;4-2F4>9--)BX:%)&1%^59F1 '87$V]Y0#\\
M/^&,OBG_ ,+7_P"%I[O"_P!H^T;OL'VW4-GV?[+]A\KS?L.[S?L__+;;L\_]
M[Y'E_N* /V.TF2XFMXFO(XXKDQH9HXI&EC20J-ZI(T<32(&R%=HXRP 8QH3M
M !H4 % !0!^&/_!4/PD_[1_Q!\$?#S3Q)'?21W5Q-.5C,<=K=.@>50TL9D>&
M.PN9GB)0N!&D;,[[5 /VN\)^%K/P-IUII6GQ^396-O#;6T6YGV0PH(XTW.6=
MMJJ!N8LQQDDG)H Z"@#Y _;?_9:_X:X\)/H45U]CO;>X2]LI&&83<11RQK'.
M K/Y3K*ZEH_GC8K*%E"&&0 ^(/V/_A_^T!X6L[7P=K9M]&T"VPPU:5[2_P!2
M@MXVC(L;,+/<0G< T<;W<$J6T+/M8^5;6] 'C_PA_8K^+GP"^)6KWGAXVYT_
M5?MEI_PD>HSQ7LL=I=2I<_:V@\V&:?4%,:*1+";>2ZW;\V[>< #[_P#VN?V?
MO&7Q=\%IX#\.RZ?+9/;V,5UJFL7]RU]+]DD5^4ALW1Y9&AADDN7D^<M,OV=2
M4E !T'[#7P=\9?L[>'+?PGXB31YK*Q^TM:WEA=W+S'SIS/Y4L$UI$APTLQ\Y
M)5PHBC\@G?*0#Y _:'_8R^*?QT\?:9X[B;PO8RZ/]A^Q6C7NH7"_Z'.UTOGR
M"QA,FZ5WSY:PXB*H/G4RN ?I]XL^'G_"[_"]WH7BNUMX?[1MYH+F&UG^UI%N
M)$4L$UQ:PYECQ'-&[VX\J=00'V!V /Q1^&7[,/Q\_8AU2>T\$"SUW1)Y&G:)
MYK=+65L20QM+!<SV\]O<;!'))]ED*,1#&]Q<+%L4 [#]K[]A+XJ_M/7FB7>I
M7VGW-^WVY+I()7@T72H46$VP@24/>S2W++*UQ/Y<K%S#"5CM[>.1@#]COA#X
M1UOP5I:VOB'6I->U$R.\EZ]I;V2[2<)''!;*%5%4#)=I79R[;PA2*, ]0H X
M_P"(7@JW^)6C:AH=XTB6VI6=Q9S/$5$BQW$31.4+*RAPK$J65@#C*D<$ _#'
MX!_LV_'G]C+7+[2/"<&GZIH%W<(HN+Z>-;'YB@%\;9;J.\@E2/Y+A(EDWA2H
M6Z\JVD !H?M5?L/_ !/3QKH/C/P_/)XNOK*.QFGFOIK.U5+RPF$@1+4-9Q0V
M4AVND,#R2!S<M)+O=99 #]CO@IX/USPGITC^)=1_M+5[ZX:[NC&"EG;,Z1H+
M2PC;YTM(5C54,A,LTAEN9,23,J@'L% 'XP_M#_L9?%/XZ>/M,\=Q-X7L9='^
MP_8K1KW4+A?]#G:Z7SY!8PF3=*[Y\M8<1%4'SJ97 /U^\+7.HW=G&^JP6]M>
MG=YL-M</=0KAB%V3206SOE=K-F)-K$J-P4.P!^&/[8/_  2KU2'6?^$J^%GE
MV\GF+<-I:3BTD@NEE0K+ITI*11IDF;RGDA%N8SY#,KQ6\(!V'@7X&_M#?M ^
M=HOQ"UK^R/#<^R/4%B&F?;+JW;<9(;9[")]F[8L4IFDC3RYC^[ND$D# 'Z'_
M +2/P\\/Z3\,M2\/W6IR>'-"MM+CM!>QR.S6UO"$CBB.YC+<(X5+>2#<9KM)
M&MU;S)0: /R@TG_@GO\ 'C3+>*#3?&DEI8Q1HEK;2ZUJ4$D$"J!%$\-JMQ;Q
M.B!4:.":>&,@K'-*@5V -#_AB3]HSPI_Q,+7QK]KN+3]_%;?VYJ4OG/%\ZQ>
M7=P"V?>0%V7!$#9VR$1EC0!]?_"?^V/V^_A?KGA3QI_Q+=:L]0FT6^N;?RWW
M7FG/;W"SM$O[K_6[$GBA<1R[)&AD@65!" ?,'[*GP6_:$^ 'F^#+5-/M] FN
M)535KJ6&]33U/F>9=6$"W"3-YIQ+%;W$)B,Y5I(K?S;IR 9_C7]C#XJ?##XP
M+XT\))'KT<D@D34M8NX2(VN;9K2X%Y%";.79"'=H8[.)DCMQ!'&K,C0@ ^S_
M -I3]FWQ]\3? G_"!Z;?Z?J/VORY=2UO5[F>*YEF^UM>2)!:6MI)%#$)1$+<
M>:ZP6P-J(3L2>@#T#]AKX.^,OV=O#EOX3\1)H\UE8_:6M;RPN[EYCYTYG\J6
M":TB0X:68^<DJX411^03OE(!]OT % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MS1"1D4K$KB20I&"P /@#_@BY\5=#L_#-_P"&9K^WBUJ76)KF&RD<)--"]G
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MV=0LJH9(R\9#$ ^OZ "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#Q_XQ_%G_A5UFOV2
MRN-6U>YRNGZ7:C,UP^Y$+NY!2VM(VEC^U7LV(+973<6DDABD /$/V8/V;=4^
M'6J:SXQ\7W-G?>+=?D07,EG"%M;2U@&R"UM'DC6<H46(S-)@R&* ,))(3<3
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M47%]>7#F2>YG(RS.S':ID:6184CC:60IO(![A0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MRI,X50L3LLP#1*TH0J<32 YH ^KZ "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MX-\/ZKJ$GG7M]H^G7-S+M5-\TUM')(^U J+N9B=JA5&<  8% 'L% !0 4 %
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M 4 <?9?#W1M.U2;7(-/LX]6N8Q%/?I;Q+=2Q@( DDX42N@$<8"LQ $:<?*N
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ML[F_D\V]FM[>*&2YDW.V^=XU5I7W2.VZ0L<NYSECD ["@ H * "@ H * "@
MH * "@ H * "@ H * "@ H _ ']OK_DX7P%_W /_ $\W% '[_4 % !0 4 %
M'X _L"_\G"^/?^X__P"GFWH _7[]K'_DGGBO_L7]6_\ 2*:@#X _X(J?\D\U
M+_L8+G_TBL: /U_H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@#X0_;Q_:8U3X$:7IVD^&(XYO%7B2\&GZ2DF-L;,51[@>8OD,Z/+!'&D
M[HF^996$L4,L; 'G]E_P2N\$:U93'Q1/JFOZ[=1@3ZW=W\XNA(($A#0J',02
M,IO@2Y6Z*#$;R31JJ@ \0_X);6OQ5\$:CJGAGQC9ZA'H%A;A;:34%<^3<Q.D
M$<%C,[8EM#$DAQ!YUM'Y431M%YY^T '?_M-_M*ZYX[^)FD_"#PG??V9]IPVN
M:C$2EVD+6\EQ+:VLDD$BPRBT'G17$0=OM$L"B6W\F;> >@>*?^"77@35;.27
M3_[0L_$GRS0^(C?W<U\M\C"07L@:<1/*\H\R;8L1)9S$T#['0 ^</V /VHO%
M7A+QC?\ PC\?W$EWJ-K)=?8+Z=KB2XDDAS*\1DECWS6\L.^[M;B?RR(5V!I$
MEMXX@#R_]IG5-:^!?QP\)Z#HVO\ B :1J5QHD\]C<:S?7,/[W46MI8AY\SN\
M4BPAG29I<M)(,B,K&@!^[WBGPU!XPLY+&Y>X2*7;N:VNKBTF&U@XV3VLD4R<
MJ VQUW+E&RC,I /Q!_X)\>.?$/\ PN3Q5X8U#7=8U73=*M]6@MH]1OYKK_CU
MU.V@CE97;R_-V9!=47[S !58B@#L/^"O\WC'PAH,>IVOB*2WT*\O(=/.CVMM
M]G9Q+:W32O<WJS&6X1PKQM;;([<H8]T;21F20 Z_X1_LK:Q^USX!T./QIJFH
M:1H::/IEOINC:3=1JL]O#!"1>ZE(\,J7$MPT<<]O;A0EC$L8RUR\Y4 ^8/V$
MKK7/V/OC'??"BYO/[0TV\\W[C%(5F6S%_!>")U=DE:W003Q(ZJ6==TLZVT)(
M!^A__!3WX\ZI\ _A]+<:-));WVIWD.G1W<4@22V65)9I)$.QCO:.!X5*F-XS
M*)DD5XUR <_I/_!/GP#XST:+7_"MUJEEK>H6:75EXI34+\Z@\EU$'^V2K)-&
MK/<*[&Y3RX"Z2RHOD,0R 'L'_!/O3-4T7X=:=:ZX9&U:&\UF._,LHFD-TFK7
MJSEY0SB1_,#;I S!SEMS9R0#Y ^#.H7'_!4/5-4UC7?MEK\/=-D^PV.B1W+0
M+J-P0LSS:DUO,LK/"/L\R1#]S&[Q+%,QANFN@#P_]L3X,2_\$VY]-\=?#.[N
M-/LKK4$MM0TF:ZEGLYF6W=K=#"PWRQ%4O#*T\[RQ23(UL83\T8!^SWP!^,=G
M^T!X7TSQ/8KLBU"W$C199O)F4F.>'<Z1E_*E22+S BK)LWJ-C*2 ?C#_ ,$,
M?^9N_P"X/_[?T ?O]0 4 ?D!_P %F_BE_P (IX&L]!AN/+N-9U!/,@\O=YUG
M9J9I?G*%4V7!LFX9)&S@;H_-% 'V!^P'X%_X5W\+_#-EYWG^;IZ7N_9LQ_:#
MM?>7C<V?+^T>7NR-^S?M3=L4 \__ ."@_P"S_%\7/"6KZE=ZQK%M;Z5H]]<I
MIMI<116-Q-;1M=(]W&8&DG^>*+"M)MC";HA%(TCN ?G!_P $O_V8_P#A=/@V
M]U#_ (2;Q1HWEZQ/!]FT?5/L=N^VVM'\UX_*?,IW[6?(RB1KCY<D ^G_ /@M
M7_R3S3?^Q@MO_2*^H /A'^RMK'[7/@'0X_&FJ:AI&AIH^F6^FZ-I-U&JSV\,
M$)%[J4CPRI<2W#1QSV]N%"6,2QC+7+SE0#Y@_82NM<_8^^,=]\*+F\_M#3;S
MS?N,4A69;,7\%X(G5V25K=!!/$CJI9UW2SK;0D@'Z/\ [>O[4NL? 2STK0O"
M]K]H\3>)[A[+2Y',8A@<-#&9")6"-*6N(E@63$ 8M+,Q2+R9@#C]3_X)7>"/
M&>EB/Q#/JFI^(9(XA=^(9+^<WTTB%<L$F>>W5-BB"-'CE,=N%7S&E7SB ?.'
M_!.W]KCQ#IGBW4/A1XVO?[2O;2XOXK'4'DFGF>XLY'^T6QE=-\L15)IX)9S&
M\:QM"2PD@BA /V^H * /'_A#\%-.^"W]K_V?)<2?VSK%YK%SY[(VRXO-GF)%
MLC3$0V#8K;W&3F1N, !\(?@IIWP6_M?^SY+B3^V=8O-8N?/9&V7%YL\Q(MD:
M8B&P;%;>XR<R-Q@ _.#_ (+5_P#)/--_[&"V_P#2*^H ^@/^"7'_ "2'P]_W
M$?\ TY7= 'W_ $ % 'Y8?'7XQ>(/V@/B0GPA\-7%YHMG8QQWWB'6+61([S[.
M(XITALWWAHD9IK>)Y5#3&27F$VL,RW0!P'[4O_!.CPQ\*O#5]XL^'QO/#NNZ
M'9W-Y%-;:E=*LD<:AK@.\C3S*_V=9TA$#P!WEVRLT9^4 ]__ ."<7[8-Q^UA
MX:G&K^7_ &[I$D<%ZT:LJSQR*3!=%0BQ1O*4E22*-F >%I D,<L42@'RA^SE
M\0[S_@I3XYUB]U::X'@/1/L[VOA^2542XFE9?LQOXH8PEW%NLY;IX)Y)5@G:
M*%&F@,P< [_]O[X:3_LL:'%X\^&2?\(]>V5Q!!J<>G+;P6,]G*)HHY;JP9?L
M]S+%/.D<+^6\B"X9B&$4;P 'T!^PM?>+_B1H]CXPUKQA_;VFZGIYVZ?_ &-;
M6/V:\$BK-_I$6V27R'BGM_N+'+GS5^4)D ^,-/\ #=[^W'\:?$6@>-;?5/\
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M:&NLZ(M_<26,OFZA;K%?-'<7#%I5E6WA9 )=P\B15B^SR/( ?H?^TC\;[?\
M9P\)ZEXJNK>2[CL(XR+>-E1I))I4@B4NV0B&21/,?#E$W,L<C (P!\(? O\
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MU6/5(?!MM9K<WMM;R2Q6]_&L1N_M,[1QKFW-RL%CEF<1S1/Y,L%S,=H!X_\
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M]IXU^&-_>6OAQ+R/[?H+S75Q8QSR1^5YTJ,[*]O.J+#(\[+-#<-#Y,V9(1;
M'Z?^'_'FJ?M7^ ].UOP9JT>@7.IQQ2O=/8C4&MVC9DNK:..=K9&=)D: SNCH
MZ*[1QYDCEC /Q0_X)F^'/%O[2UYXG2?Q)J%E:3_V7)J^H07$AUJX:);I+*&"
M\E\SR8AAFN)"&E9(8;9 (I9BH!^I_P"QO_P3]M_V/-9U74[/6[R^MK^,0PV3
MQK#''&LID1[C:[+<W"+B..94MP@>XQ%B?$8!X!X"MKC_ (*@:SK%_JM[>6WP
M[TB\6QT_3K*=H(]8DBECN))K\G;.4*+ ZQ-%$8A/&(9HYX+B28 \/_;-_8YU
M;]EG4=&\3?!6PUBUE;S;?4(]-EN+S!1XI[<R0LT\TD4I1Q.DGF6;>1"KQJ[_
M +X _5_XG?'R\^ 7PZ;QAXFL=VI6FGV<E[86SJ%%]<>3"T*2%Y56);B7:T@:
M8K$"ZB9@%< ^/_@7^R=!^USH<'C3XL?:-7U#6/\ 3;#3_M=Q;V.EV<P'DQV<
M5K<@#SXEAEE9V,A B61?M"3RS 'R!+\3=1_X)9?$JV\*'4KB_P# E_;VDJV]
M[.\[V5O/+(DUS&(H%6*6.X6YF:*WB9+F!E5P;@I)" ?T/4 >7_%[X:/\6M+;
M2TU75-'5Y$=[G2IX[>Z*H<^6)GBE:-"VTL8MCL%V%_*:1' /YPOV+?V;+?7_
M (N>*/"=GK.N:3;:3'JL4-WIEZMK>21VNHP6Z)-*L15D92'D540-(B, H7;0
M!^YWQ?\  '_"K_A+XCTC[?J&I_9_#^M_Z9J5Q]IO)?,M[F3][-M3?MW[$^4;
M8U1><9(!^4'_  2_\ >*/C%X-O=#M+^XT'PVNL3W%[J>GW CU2ZN#;6@CLK5
M]K?9(HMB3W-P0SSAXK:,!#<M0!X_^T#\'KS_ ()4^.=#\1^&-0N+K2[[?_HT
MLBI<2PV[0?;;.Y=8?)>*82(T4HBW1.0PB$MM%-( ?T7?%[PSX@\7Z6UGX:U>
M/0[YY$)OGL4OV2-3EECADECB#L0JEY!* F\",.R21@'XX_\ !%KQ9J/CF\\9
M:AJMW<7U[-_8OFW-S,\TS[%OD7?)(6=MJJJKDG"J%'  H ^S_P#@I[\>=4^
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M]_[C_P#Z>;>@#]?OVL?^2>>*_P#L7]6_](IJ /@#_@BI_P D\U+_ +&"Y_\
M2*QH _7^@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M(Y=9S*LBLQ,;AHR%V[0 ?BC_ ,$,?^9N_P"X/_[?T ?O]0 4 ?@#_P %SO\
MF4?^XQ_[84 ?K]^R=_R3SPI_V+^D_P#I%#0 ?M8_\D\\5_\ 8OZM_P"D4U '
MP!_P14_Y)YJ7_8P7/_I%8T '_!:O_DGFF_\ 8P6W_I%?4 ??_P"R=_R3SPI_
MV+^D_P#I%#0!^0/_ #=Y_G_H7* //_\ @JG_ &/_ ,+D\,?\)#_R!?[/TO\
MM'_6?\>?]IW?VC_4_O?]5O\ ]5^\_N?-B@#]/_\ AUQ\(?\ H7O_ "HZE_\
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M)H[B)+>3;#@-L@:WBWR L,W,:D(=ID /W.H * /@#_@I#XL_XM#XCNM+N_\
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M_MA0!^_U 'X _MM^$_M/[1G@K^S[3=<3_P!AW5SY$.7D\C4I_,GEV#<WEV\
MWR-G9!",D1QC: >__P#!:O\ Y)YIO_8P6W_I%?4 ??\ ^R=_R3SPI_V+^D_^
MD4- 'X _ GX6^$/C3\?/%>@^,;?[7;W>H:_]A@\RYBWWD5\9OOVSHPQ;I<M^
M\81G&.9#&" ?K_\ \.N/A#_T+W_E1U+_ .2Z /</@/\ LY>"/V<;B_L_"5I'
M97-U':RWL(NY[B0QJUPML[)<32M&A;[0J, HD*2#+&,[0#\D/V!?^3A?'O\
MW'__ $\V] 'W_P#\%1_^20^(?^X=_P"G*TH /^"7'_)(?#W_ '$?_3E=T ?
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MV^D6<SW%G;,\%E&$C>54>XB%P4A62.=G:U2<F2@#[?\ ^"7'_)(?#W_<1_\
M3E=T ? '_!$OQ9_;.H^,/MUWYVI7G]G73>=-ON)]KWGGSG>3))AYH_-D.</*
MFX[G7(!^OW[6/_)//%?_ &+^K?\ I%-0!\ ?\$5/^2>:E_V,%S_Z16- '@'[
M?7_)PO@+_N ?^GFXH _?Z@#\ ?\ @AC_ ,S=_P!P?_V_H ]__P""U?\ R3S3
M?^Q@MO\ TBOJ /O_ /9._P"2>>%/^Q?TG_TBAH _('_F[S_/_0N4 ?O]0!^
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MO#<7=MJ,OVO4(<3),TD2;8YXHCBVEMSNB!4[L$^8'  /M_\ X=<?"'_H7O\
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MQ1_X*W^/]+^)_P +=*U31KF.\L9/$BQQW$1)CD:W@U*WD*-@!T$D;A9%RD@
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M16- 'Z_T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M6_AYXSTNVGDEO(M;N(P!H<-E=75T]T256UMY(X?(F>5\+;L7C#AX_,$#%T0
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M5=4_9X\-7FIZ]%):ZIKLD$ALW8;H+6W5_LXECV!HKAFFF:2,LY1#"C+%,LR
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M**V\+6>M:CJ6J/=7]_;65[J@!**+>U$]K<[X;>*'9)9V=WMN+>WN$<QHDR9
M.P_X;Z_:%_Z$+_R@:S_\D4 ?=_[$O[>*?M07%YX>UC3I-'\4:7'NN[0B0QR+
M$R0W$BAU#V[I.VQ[68L\8>/$LY$WE 'Y _LT?&;5/^"5_C'5_#WC/2Y);2_C
MA,TMKAY&6W\[[+=6;2-%%/;R&21'5S&ZGJ8YK>6V< Z__@K'KWBWXDV?AG7]
M7T7^R-%;[>EE#(\DE]&TS1,O]I 1K;VDL\,44D-FCS2QE+D22ED*1 '['^ ?
MVJKWQ9HUSXON=!U2#P]/'!_8=K%8SWFL7S>5-+--);6HFBM[>4B.*R>614?:
M9Y)DBN;<4 ?FA_P23TO6O@%J.M:?XET#Q!8?VQ_9PM;F31KXVX>!YT*32+"?
M)S]I5A)(%@5(Y&DECPH< _?Z@ H S]6TFWU^WEL[R*.>VGC>*:&5%>.2-U*N
MCHP*LC*2K*P(8$@@@T ?@CXZ_8Y\6_L'^.8?'7PUL+C6] &_[3I44LC7$<,S
M+')9LB,9KF++K+:RJEPT#Q+)<Q/]F$TX!]?_  T_X*X_#/QAIR7.KW5QHM[\
MJRVD]K<7&&V*S-%+:12H\6YF1&<0RML+-!&"N0#V#5_B1KG[4L46G>#4U#2/
M#UU@WOBB:$VDTMHT4,HCT6"?;<F6<3>6NH30QV]NL<LD!N)A$5 /I_\ X5;H
M_P#PCW_"*?9_^)+_ &?_ &;]F\R3_CS\G[/Y7F[_ #?]5\F_?YG\6_=S0!^$
M/P+U_P 0_P#!*/Q1>:%XMM[B[\$ZK<0B/688YFMXI2)!%<)&"\:2LB,M]:<W
M6R!)8FGBAB%R ?9_QK_;&L/VG?#6J>%?A9;7GB35M3LYK.25+*:"QLH[A2DA
MO+F\-FD+R0?:?LARX>XB"LIR$< ^H/V+/V9T_91\'6WA]I(Y[YY)+K4)XO,\
MN6ZEV@[!(Q(2.-(H%8+&)!$)C%&\CK0!^('P"^)>J?\ !*+QCK.C^*M*O+C0
MM3D,45_' $DN%LO,:VN;3?+]GE1TN5^TP>:7@,J!I%DA>&4 ^H/VW_C-XL_:
M.^&&IZU9:7)H/@Q8]/N8Y;_RGU#6%FO+:.%$MXV<6-O'(6N#,SR/=(MH8<03
M38 /H_\ X)M7OBWX>^!(-*\2>'+C2=-TFWO)8KJ6222^NVDN[B=D328[<W*;
M 6 #GS9CY)@AF68F, ^(/MFM?\-#?\+"_P"$8\4?\(]]H\GS_P"PK[?L_LS^
MSOM'D^5YGE;_ -]C'G^1SY/G?N: /U?_ &N_B"O_  @.J6UEIVL:A=ZYH]Y;
MV5M9Z5>S3;KJ#RE-P@A'V39YZO(ET89=J2JD;RQF.@#XP_X))-J7PJT&]\*^
M(-%US3+ZXU26\@ENM)O(K62-[6%"/M)B\J)T-LVX3F(.9(EC:1V9% +^J_M7
MZC^S9\4O&']MV&H2^!IKC3#-J-MI[S0V&HR:?I<)>>X7:%B:)D\V/]]-N6W\
MF+=(XE /,/VT/'&B?\%';+1_#7PWCDUC5(-462XU(V%Q!:Z9:O!,KBZN[B&-
MHDF8+(L<8<SFT*A6F6".0 _2_P")W[+6G?$7X=-\.5NKBWLDT^SLK>Z(229/
ML/DM;R2#:B2?-!&9E41>8N]4:(LK* ?@#\+_ (X?$7_@EAK$WA_7--^TZ'+<
M7,GV=E\JWO)C'"OVNQU#R&=MJK;[T(=41VCEMX;EMT0!]_\ A/XL>+?^"GL%
MII4GA_\ L#P-]HAN=9N[B:2X_M2&WN T=C92B&U(W2PL+B6 EH=@)FC91;W8
M!H?\%;6U+XJZ#9>%?#^BZYJ=];ZI%>3RVNDWDMK'&EK,@'VD1>5*[FY7:(#*
M$,<JR-&ZJC 'V_\ L7>+SK7@K1M,N+#5--OM)TNPL[NWU'3KFS8200^03&\T
M:Q3(QA,@,+N41X_-6)VV  ^KZ "@ H _#'_@LKJU_P",[CPCX)TF6.:YU*\F
ME.GAX1(]PS0VM@[,Y#1(S374:,S)"Y\PL28<H ?L=\)_ O\ PJ_P]I6@^=]H
M_LS3[2R\_9Y?F_9H4A\S9N?9NV;MNYMN<;CC) /0* /PQ_X+<^ -4UW2_#VM
M6MM)+IVFR7\=[.@!6!KLV@@,@!W*CM$Z"3&P/LC9@\L2N ?=_P"S%^UU>?M7
M_9+O2]"U#3-+6W>:^OKZ)?L\LW^J6TTZ595-QB42M+=&/;$EMY+VZ2W:/  ?
MGA^TW\%_%7[%/Q(?XM>$+&34M$O))Y]5LH#<9B$L9DOA=;6D;[/(RO>17!#6
M]K<*@D@58;<3@'V_I/\ P5 ^'GBJWB&C/JFJZM/&CQZ+9:7=2Z@S%0\D:KL6
MW9X4WO*5G9-D;E'D^7< <?\ L"_LEZY\,M6U[Q[XTAM[;Q)X@N+AOL=NY=;.
M&:X:XG4LDTL3>=*(V1096ABAC_?EY9HT /T_H ^4/VT?%YT7P5K.F6]AJFI7
MVK:7?V=I;Z=IUS>,9)X?(!D>&-HH44S"0F9T+HDGE+*Z[" ?$'_!))M2^%6@
MWOA7Q!HNN:9?7&J2WD$MUI-Y%:R1O:PH1]I,7E1.AMFW"<Q!S)$L;2.S(H ?
M\%;6U+XJZ#9>%?#^BZYJ=];ZI%>3RVNDWDMK'&EK,@'VD1>5*[FY7:(#*$,<
MJR-&ZJC 'V?^R)\05_X0'2[:]T[6-/N]#T>SM[VVO-*O89MUK!Y3&W0PG[7O
M\AGC2U,TNUXE>-)9!'0!^4'VS6O^&AO^%A?\(QXH_P"$>^T>3Y_]A7V_9_9G
M]G?:/)\KS/*W_OL8\_R.?)\[]S0!^K_[7?Q!7_A =4MK+3M8U"[US1[RWLK:
MSTJ]FFW74'E*;A!"/LFSSU>1+HPR[4E5(WEC,= 'QA_P22;4OA5H-[X5\0:+
MKFF7UQJDMY!+=:3>16LD;VL*$?:3%Y43H;9MPG,0<R1+&TCLR* >'_\ !<[_
M )E'_N,?^V% 'V?9?\%.O"?@6RFLO'"WFC^*M-C$>H:2;&4M+=) DCFS>-IX
M#;S.Q%I)-<('39(S")EE8 X_]E[X)^(?C'\1=1^+WB^UN-/B7S[3PYI=XDT-
MW;VZYMUGE@:9A;YB,H:!MZ37%S<72I$GD22@'(?\%;6U+XJZ#9>%?#^BZYJ=
M];ZI%>3RVNDWDMK'&EK,@'VD1>5*[FY7:(#*$,<JR-&ZJC 'V_\ L7>+SK7@
MK1M,N+#5--OM)TNPL[NWU'3KFS8200^03&\T:Q3(QA,@,+N41X_-6)VV  _-
M#_@HY^Q=XHM/%$7Q3\#_ &B^OUN+*6XLXH1/<6]Q:"*.VN;:$(WGQ?NHO-B*
MR/&X,I$EN\@M@#C_ (+_ /!8WQ+KEO8Z++X3D\0:[Y91Y+*Y:.2[:-68R+9Q
M64Y5_+7?*(SLRKR*D4>(T /TO_9R\!:M\&=.UCQIXY'F^)O$%Q;W.IQZ;:7%
MU]FAB1;>RL8K>T%P\WV968/+$CL=[^9-<)"+EP#\P/V.KS6OAM\7_$7B_6?#
M'BBSTC7?[6\B5M"OI&@^U7L=Y%Y\<$4KC*Q&,^2)L2LO_+/=(H!]_P#_  4W
MUFZ\0>!-0\*:5I6L:IJFI?8C$MAIEW<PQI'=I.SRW$<1A7 MV3RP[3[I(F,0
MB8R* '_!,C6;KP_X$T_PIJNE:QI>J:;]M,JW^F7=M#(DEV\ZO%<21"%LBX5/
M++K/NCE81&)1(P!\ ?MBWFM?$GXO^'?%^C>&/%%YI&A?V3Y\JZ%?1M/]EO9+
MR7R(YXHG.%E$8\X0YE5O^6>V1@#]SM9T^P^/7AJ\L7^V0V.KV=U9R&2VFLKI
M(YEDMY"(;R%)8WP6,9EBPPVN%=&!8 _FRMD^(O\ P26\43LD'V[P[=W%N)KC
M[/ML]3A03^3']H*2/:7:JT[>2KEDD7>R75J$:4 ^W] _:[\<_P#!1;3KCPIX
M8\._V#IM_P"9:ZKK\\S7MO;V90"Z@B!MK>-KN1)41(P[2;)"P$*G[7;@'O\
M_P %"]/71OAG+\/_  SHVL7UQ);Z9;V4%AIU[>0P6UI<1.IEN@CQ_*EKY>PR
M27)9XG:/RW,H .@_X)D:S=>'_ FG^%-5TK6-+U33?MIE6_TR[MH9$DNWG5XK
MB2(0MD7"IY9=9]T<K"(Q*)& /@#]L6\UKXD_%_P[XOT;PQXHO-(T+^R?/E70
MKZ-I_LM[)>2^1'/%$YPLHC'G"',JM_RSVR, ?L]\7$E^-/@'7+?1H+AKC4]'
MU.VM(+FWEL9GFD@F@1'BO4@DBW/@*TRHI4B3/ED,0#\0?^":/[5%Y\#=.U;P
M$OAG6-4U\ZA-=06]K&J[)F2&T>*_,Q0V,44L42RW+B18_-;S(T\H"4 _1_\
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MI=)O+?POHVAV=A->/:SW-Y?:E!Y%JW]GV=DMQ++90A)?.N"NYY'50D8M;HT
M?"'['5YK7PV^+_B+Q?K/ACQ19Z1KO]K>1*VA7TC0?:KV.\B\^."*5QE8C&?)
M$V)67_EGND4 ^_\ _@IOK-UX@\":AX4TK2M8U35-2^Q&);#3+NYAC2.[2=GE
MN(XC"N!;LGEAVGW21,8A$QD4 /\ @F1K-UX?\":?X4U72M8TO5--^VF5;_3+
MNVAD22[>=7BN)(A"V1<*GEEUGW1RL(C$HD8 _.#XV> ?%'_!-7XE77COPQI?
MVGPG?;VE5(P;>*WN983<6,KQ0JMAMN-GV%PNS8($#7!6Y@(!]0>.?V]+S]JS
MX>:[#X2\.:A$QT>_&K7]^JKI=G#'9-)>QPW,3E[F[VNL5K#Y<+,94N942&.1
M" 9__!("'QCX0T&33+KP[);Z%>7DVH#6+JY^SLXEM;58DMK)H3+<(X5)%N=\
M=N4,FV1I(Q'( ?M=0!X?^TC\$+?]H_PGJ7A6ZN)+2._CC N(U5VCDAE2>)BC
M8#H)(T\Q,H73<JR1L0Z@'\Z7PO\ CA\1?^"6&L3>']<TW[3H<MQ<R?9V7RK>
M\F,<*_:['4/(9VVJMOO0AU1':.6WAN6W1 'W_P"$_BQXM_X*>P6FE2>'_P"P
M/ WVB&YUF[N)I+C^U(;>X#1V-E*(;4C=+"PN)8"6AV F:-E%O=@&A_P5M;4O
MBKH-EX5\/Z+KFIWUOJD5Y/+:Z3>2VL<:6LR ?:1%Y4KN;E=H@,H0QRK(T;JJ
M, ?9_P"R)\05_P"$!TNVO=.UC3[O0]'L[>]MKS2KV&;=:P>4QMT,)^U[_(9X
MTM3-+M>)7C2601T ?E!]LUK_ (:&_P"%A?\ ",>*/^$>^T>3Y_\ 85]OV?V9
M_9WVCR?*\SRM_P"^QCS_ ".?)\[]S0!^G_[9/Q8?_A!M6TW2-)UC5-2UC1WB
MM;:#2=2/R7ZFW+2RK9O'!+"CO,]K<&*?]V(V6-I%- 'PA_P2Z\<ZO^SOHVH^
M&O%7ACQ)81RWCZA;WPT34IXW:2*"![=HX+625' A61'PR.#(K&)D03 'ZW?'
M[X.6?[0'A?4_#%\VR+4+<QK+AF\F92)()MJ/&7\J5(Y?++JLFS8QV,P(!^,/
M[)G[06K?\$Z[RX^'WQ0MKBTT5KBXETS6%2XN+8,%1Y$@VJWFVDFY)0+=!+;W
M,S"XA#32&W /?_VFOC/+^WSX<E\&?"ZTN-4M[ZXM1J.M7%K+::9:PPSI+)&+
MBX,,ANXW%K*\,<,[-:22-&CR#Y #[@\&Z#IG[%_@;3](@M]0U"+3;?RECTZP
MNKRXNKEEDGF=88O/,/GR^8X,LB6T+R+$9HTV4 ?E!_P23TO6O@%J.M:?XET#
MQ!8?VQ_9PM;F31KXVX>!YT*32+"?)S]I5A)(%@5(Y&DECPH< _?Z@#^8'XA_
M!GQS_P $JO%LWB?PM%_:>@36\L2WD]LTT*V\TD8^S:@8O+,$J2^08Y4>%+EE
M0H?FN+6, ^P- _;N^)7[:FG7&D> /"7]F_:/,MKG7)[^5K>S21!'(T4Z0VFR
M[A\^*X3RVGG5%+K:2\%0#]#_ !Y^R)HWBOX;O\-;.62QTX6<%O#<(D1D$EO(
MDZ3RHJQI(\DT8EN=HB,Y>4AXW?>H!^"/PO\ CA\1?^"6&L3>']<TW[3H<MQ<
MR?9V7RK>\F,<*_:['4/(9VVJMOO0AU1':.6WAN6W1 'W_P"$_BQXM_X*>P6F
ME2>'_P"P/ WVB&YUF[N)I+C^U(;>X#1V-E*(;4C=+"PN)8"6AV F:-E%O=@'
M[/4 % '\T/@WXGWG[$WQ\\0W>O:-J%RNNW&HQVD-HBR7$T.HWRW-G-:Q[@ES
MYC1)#Y:R(RNTBD^="T! /U?^.?Q:U;Q%\-=7:]T+6%U#Q!I^I6^EZ1:Z9<75
MY!#/%]F@-^]OYT,$K"07<J2- T,;M:+'<7%K(\P!\X?\$DFU+X5:#>^%?$&B
MZYIE]<:I+>02W6DWD5K)&]K"A'VDQ>5$Z&V;<)S$',D2QM([,B@'A_\ P5LT
MO6OC[J.BZ?X:T#Q!?_V/_:(NKF/1KX6Y>=X$"0R-"/.Q]F9C)&&@9)(VCEDR
MP0 _7[_AHFQ_X1[_ (2'^R_$']S^SO[#O_[1\_R?.\G[/Y/_ &R^T[OL/G?)
M]J[T ?D#_P $D]+UKX!:CK6G^)= \06']L?V<+6YDT:^-N'@>="DTBPGR<_:
M5822!8%2.1I)8\*' /N__@HUXR\2_#[2/#FJ>$+:2\UNV\20O;6T=LUTTR_V
M;J(GC,,8+LC0F42&/:Z(6=7C90Z@&>__  4J^&?BVSGTS4%U#^TIOM%G-X;N
M=)N);Z:;<\!L7A6.6V:68CRUA>;:3((Y3&V]5 ./_P""5'[*NJ?L\>&KS4]>
MBDM=4UV2"0V;L-T%K;J_V<2Q[ T5PS33-)&6<HAA1EBF69  ?J?0!\8?M@?%
M2*'PKXC\/V>FZYJ&J76EW5G##9:+J-Q&\EY;F-"MTMO]D9$\T/*5F)4(Z!6F
M7RB ?F!_P2I&K_LT7&OP>*O#WB2RCU*.Q>WG&@ZE/'NM6N \;""WDE#L+A60
M["F$DW.C;%< _?[2=336K>*ZB$BQS1I(@EBDAD"NH8!XI526-\'YHY%5T.59
M58$  T* /P1_:;^"_BK]BGXD/\6O"%C)J6B7DD\^JV4!N,Q"6,R7PNMK2-]G
MD97O(K@AK>UN%020*L-N)P#[?TG_ (*@?#SQ5;Q#1GU35=6GC1X]%LM+NI=0
M9BH>2-5V+;L\*;WE*SLFR-RCR?+N ./_ &!?V2]<^&6K:]X]\:0V]MXD\07%
MPWV.W<NMG#-<-<3J62:6)O.E$;(H,K0Q0Q_OR\LT: 'Q!^V+>:U\2?B_X=\7
MZ-X8\47FD:%_9/GRKH5]&T_V6]DO)?(CGBB<X641CSA#F56_Y9[9& /W>_X6
M78_V/_;GE:A]D_YY_P!EW_VS_6>5_P >'V?[;][G_4_ZO]]_JOGH _"']CJ\
MUKX;?%_Q%XOUGPQXHL](UW^UO(E;0KZ1H/M5['>1>?'!%*XRL1C/DB;$K+_R
MSW2* ?M=^TC\$+?]H_PGJ7A6ZN)+2._CC N(U5VCDAE2>)BC8#H)(T\Q,H73
M<JR1L0Z@'\\7PJ^/OQ!_X)67]UX9UW1H[O1[B\EF4.'BCN9%A1&GT^_$95D9
M3:M,LD<QC"K$8[6=Y: /T.\$^+_'/_!0R\TDZSX;_L#X?P7$&H70N+AI)M4>
MW4S6T 26.-+G3YVEMI71[4P2+!(R7GG+'&H!^O\ 0!_.C_P4"_9$N$^+.B2>
M'99+-?&TDEO.;1&:2"3"6^ISF&%8LV[VTXGN=TC&8F]:9TB;- ']#VDZ3;Z!
M;Q6=G%'!;01I%##$BI''&BA41$4!515 554 *    * /C#]M[]LW_AC73M/O
MO[&N-6^WW$D.Y9?L]O#Y:;\2S^5-B63.88MG[Q(YWWKY.UP#U_\ 9K_:"L_V
MD-#_ +5@MKBPN[>XDLM2T^Y1EFLKZ *9[=RRIOV[U*N I*L Z12B2&, ^@*
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M+$PN]K\\ELN^.1@#[OH * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * ./\?^/]+^%FEW.M:U<QV>G6<9DGGD)VJN0
M  "S.S$)'&@9Y'98T5G95(!\ ?L\_"[5/CKX\O?BSXJTV\TM;:,:?X7TZ\(A
MNK>U19HKBXN[=(T8/*TLK0I,\A03SC$D26=P0#]+Z "@ H * "@ H * "@ H
M * "@ H * "@ H _ '_@N=_S*/\ W&/_ &PH _?Z@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@#P_XQ?%6X\(V]QI^@6LFI^)GLY);"QCB9XQ(5
M<0/>S%X8+6W9T<AKB>W-P(9XK8S7">70!G_LL?!3_AG;P7I'AAI/.EL;<_:)
M V]3<32//<>6WEQ$Q"6600[D5Q$$#9?<2 ?0% !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M"1QI$K O./.$FV>2,HU 'U?0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!GZMI-OK]O+9WD
M4<]M/&\4T,J*\<D;J5='1@59&4E65@0P)!!!H S_  MX6L_!5G'I^GQ^3:0[
MA#"&9EB5F+".,,3LB3.R&%,101!(8D2)$10#H* "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H ^4/BA^PS\-_C'<?;-8\/V;W)DFE>:W\RRDFDG8-(\
M[V;P-.[,-VZ8R$$N007?< 'PO_89^&_P<N/MFC^'[-+D20RI-<>9>R0R0,6C
M>![QYV@=6.[="8R2$))*)M /J^@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * ./\2> -+\8W%I=:C;1W4EA)YU
MJ)@9(X9PR,MPD3$Q"XC*#R;C;YT :58I$6:4. =A0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0!\@?$O\ 8-^'OQDU%]5\0Z;<:A>ON'FSZIJ;;%9VD\N)
M?M>R*(,[E(8@D4>XA$4<4 >__#3X8Z9\(M.32M(6X2RBVB**>\NKORE5%C6.
M)KN:9XXE5%"0H5B3DJ@+,2 >@4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MQJS!I$# 'L&DZM;Z_;Q7EG+'/;3QI+#-$ZO')&ZAD='4E61E(964D,"""0:
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M;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!0!Y_\*OC1X?\
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M'J&E7=O?64V[RKFVF2:%]C%&V21ED;:RLK8)PRE3R"* .@H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MV]]!H#WDTFHR1/<3WDRR2%85811@11PQ*B&21@0F]C(VYV58U0 ^KZ "@ H
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M'[./[!O@[]EK6=0USP^MY]IOHVA5+BX\R.VMWE$K00 (K%"RQ#=<-/,!$F)
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M-O#;6T6YGV0PH(XTW.6=MJJ!N8LQQDDG)H Z"@ H * "@ H * "@ H * "@
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MXOV7B3XA:I#')XCU37+B":[S([1VJP6LT=I"97D:.WC:3:B!LE(X4=G$$.P
M-:_X)AIX9^)ND>-?!E]'H^EPWBW>H6*>8K(R'<\-D(]J_9[M2T,T#LB6Z/)Y
M8FA9;6, Y#_@GS\0K/\ :W^(OC+Q[?VWF7%E]@MM#,VXM8V,WVQ-D<;2RQQ2
MRI$K3M&2/-EN?+*QW$JN ;_[9O\ P2LL_P!H#7(?$'AFYM](N[NX']L)(C&&
M56.9+R%(Q_Q]_P#/2(F.*Z8B1I891+). ??_ .S7^S7H?[*VA_V!H'VAK=KB
M2YFFN9!)-+-(%4NY54C&$2.-5C1%VH"09"[L ?0% !0 4 % !0 4 % !0 4
M% !0!\__ +3O[0NG?LO^%[OQ+J">=Y.R.VM1*D3W5Q*=L<*%S]9)"JR/'!'+
M*(Y/+*D _&']EKX3:Q_P5&U&Z\7_ !)O;B71=)N!;:?86ACM[=I7=;FXMP%)
ME2)(C#')(1]JN$DB_P!-W6M 'Z__ /#%/PU_L[^R_P#A%]'^S_9_L^_['%]H
MV;/+W?:MOVGS<<^?YGG[_P!YYGF?-0!^8'B[]F_4?V*OBAX,UG39[C4/!D^L
M/ING:?/>.?[)N-926&6*)9"^8CO>Y1T7?+Y)AN'$@2YG /H__@K)\&]$\3>
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MM];L]3U6._MKZ\C>RAA$JQQQPJZ_:'20[8[BX5D6:.,.$%O$/M$XQY8!^A]
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M']K+2_V1?#_]K7BQW5]-(L=CIQG,,EVP=!,5<1S%$BC8R/(R; ?+B+*\T88
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M5+SQ=I?A_498P]OHMII-O=VL3"!-L<UW<"6:-S+N$Y3[:B'+Q/*A6)0#R_\
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M\VB_:(A/:Z7:B:SM]OEJJ7!NK=+U(KALJ9%G.V1C&)8&>W5@#]?O@#\8[/\
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M-M##]JM).1*A0SIL(54N(9;64 _7[]K'_DGGBO\ [%_5O_2*:@#X _X(J?\
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MC@'Y _"'_@I-XT\2?$/5]$UK3,RP6]Y8Z9X9L%CD>758KU%19K\APOE1>?\
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M_EGOQ\V* /K^@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M^(>C236-E''!"K1+:WD%K"R6R-;R*!;WMNB03")NMS(<_;]BT ?N]^SWX_\
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M[+ BAC)\H!^KWP!^,=G^T!X7TSQ/8KLBU"W$C199O)F4F.>'<Z1E_*E22+S
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M_P#@M7_R3S3?^Q@MO_2*^H ^_P#]D[_DGGA3_L7])_\ 2*&@#\@?V^O^3A?
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M7Q,N?WW]L:A-8:'.>470].<PP&W23=<6WVB99I;N%S&LD\:S?9X^"P!]_P!
M!0!^$/[>W[-'Q \!?$!?BG\.X;BZN'MX_M!@2&ZN+:X$(T\^79O$S2Q26[1X
MV+<NCBXE?R8UC- '0?L[?\%4_#GQY6/0_B1;6^DW N+.XM[V)YQ8S7-O>I/;
MAQEI+3RG2WD+S2R6T@CF::2&/;$X!]?_ /!4?_DD/B'_ +AW_IRM* #_ ()<
M?\DA\/?]Q'_TY7= 'P!^WU_R<+X"_P"X!_Z>;B@#ZO\ ^"POC6X\*_#(V<"Q
MM'JNJ6=G.7#%EC02WH,9# !_,M8U)8,-C.-NXJR@'U!^PMIFEZ3\,O#$>CF,
MVQTNWD<QRF5?M4H\R]!8LV'%RTXDCR!$X:(*@38H!Q__  4;^&G_  M#X7Z]
M B6[7%E;C489)USY7V%Q/,T3!79)6MTGA0KMW>:8V98W<@ ^ /V'O%-YX@_9
MS\86US)OBT^W\0VUJNU5\N%M-6Z*94 MF6XF?<Y9OGVYV*JJ >O_ /!%3_DG
MFI?]C!<_^D5C0 ?\%J_^2>:;_P!C!;?^D5]0!]__ +)W_)//"G_8OZ3_ .D4
M- 'Y _L"_P#)POCW_N/_ /IYMZ /J_\ X+"^-;CPK\,C9P+&T>JZI9V<Y<,6
M6-!+>@QD, '\RUC4E@PV,XV[BK* ?8'['>DV^B_#GPK%:Q1PQMH>G2E(T5%,
MDUM'+*Y"@ O)([R2-U=V9V)9B2 ?DA_P7._YE'_N,?\ MA0!^_U !0!^ /[?
M7_)PO@+_ +@'_IYN* /W^H _GQ\&Z8GP^_:RN;'2S);6UY)<R7,:2R;9FNM'
M-_,),L=R-<GSQ&<HCJA15$:!0#0_X*7ZQK'B/XR>!M!LK[[%L_LV6QG\B.;[
M+>7FIM"USL8#SL?9K=O*D;RSY6 %WN6 /O\ _P"&>/B]_P!%/_\ +6TW_P".
M4 >/_ C_ ()FWGPD^($/Q U#Q/\ VK>BXOKFYB_LM;7SYKV&>.1]R73I'\TY
MDVK'MXV *"" #]7Z /C#_@H?XUN/ 'PK\2WEJL;R26:V9$@8KY=_-%92D!64
M[UCG=HSG <*65E!4@'G_ /P2LTFWT[X2:++!%'')<R:A+.Z(JM+(+ZXB#R$
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M?V!?^3A?'O\ W'__ $\V] '[_4 % 'X _M]?\G"^ O\ N ?^GFXH _?Z@#\
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MY_\ 2*QH /\ @M7_ ,D\TW_L8+;_ -(KZ@#[_P#V3O\ DGGA3_L7])_](H:
M/F#]J7XG_#K]F#Q1:^)IM&_M3X@:E;FUT^VLDWWDP8-%$\B;BD7F,%LUNA')
M>/&6@B2:&*6- #\\/^"EM[\3?%?@JSU3QM#I>CZ<=<5+/1;,FYN@SPWOER7M
MWO>$O%%%B,6N$G%R[RI$\21* ?M=^R=_R3SPI_V+^D_^D4- 'Y _L"_\G"^/
M?^X__P"GFWH ^_\ _@J/_P DA\0_]P[_ -.5I0 ?\$N/^20^'O\ N(_^G*[H
M ^(/^"+OBF\\<ZCXYU74)/.O;ZXTRYN9=JIOFF?49)'VH%1=S,3M4*HS@ #
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M&GRV7D?8/LVWS)H)O,W_ &J;./)V[=HSNSN&,$ ^0/\ F[S_ #_T+E '[_4
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MO/A)\0(?B!J'B?\ M6]%Q?7-S%_9:VOGS7L,\<C[DNG2/YIS)M6/;QL 4$$
M'S!_P7._YE'_ +C'_MA0!^_U !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MF !^I_Q]^/'A[XA?#SQM-I=];W-A9Z/>VC:A'/"UG)>7-D^RUAE$A\R4>=;
M[1Y;27,<$<DEPL\4(!\H?\$4-6MYO NJV:RQFYBUR662$.ID2.6TM5C=DSN5
M':*548@!C'( 24; !\__ /!<K5K>:X\*6:RQFYBCU262$.ID2.5K-8W9,[E1
MVBE5&( 8QR $E&P ?O=_PEFG?V=_:_VNW_LW[/\ :OMGG)]G^S[/,\_SL^7Y
M6SY_,W;-GS9V\T ?@C_P0UU:WAN/%=FTL8N98]+ECA+J)'CB:\61U3.YD1I8
ME=@"%,D8)!=<@'Z?_ML?M,/^RCINB>(&CDGL7UR*UU""+R_,EM9;.])V&12
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M2TA_/T\7$T$%VK(T-UY#>5++ R,Q:)95EA#N$\QHFDC#V[PS2@'H% '\\/\
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M_:^\-#3DECM=6LI#<:==.BLHD*E7@E8*TJV\PV^9Y1RKQPS%)?)$3@'Y@?\
M!.O]JI/V3[C4OAI\2)9-(DMKQ#8FZ61HX)9V"S0/*'>*&W<M'=02JJVI$ES<
M/<;98RP!^_VDZM;Z_;Q7EG+'/;3QI+#-$ZO')&ZAD='4E61E(964D,"""0:
M/D#4_C%<?M%ZH- \#W$<FBVTD1U[Q##(S0",A9#IFF3P.IDO9XR!/=0R :;#
M)O5_MK0K& >?_P#!5/5K?3OA)K44\L<<ES)I\4".ZJTL@OK>4I&"07<1QR2%
M5R0D;OC:K$ !_P $K-6M]1^$FBQ02QR26TFH13HCJS12&^N)0D@!)1S')'(%
M;!*2(^-K*2 ?GA_P4$\6:=9?M >#IY;NW2+3_P"P?MLC3(JVNW5)IV\]B<18
MB=)CYFW$3K(?D8$@'['_ +8FK6^B_#GQ5+=2QPQMH>HQ!Y'5%,DUM)%$@+$
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MT6YCO-.O(Q)!/&3M9<D$$$!E=6!22-PKQNK1NJNK* #L* "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M#/U;2;?7[>6SO(HY[:>-XIH945XY(W4JZ.C JR,I*LK A@2""#0!\H>%OV!_
MAGX*UR/Q'I^@6\.I0W#7,+B6X:&*9B2'CM6E-LFPG="J1!8&"-$$9$*@'Y@?
M\W>?Y_Z%R@#][M6TFWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP*LC*2K*P(8$@@
M@T ?*'A;]@?X9^"M<C\1Z?H%O#J4-PUS"XEN&ABF8DAX[5I3;)L)W0JD06!@
MC1!&1"H!Z_K_ , ?"_BOQ#;^*]0TRWN]:M+>.WMKF<&7R4BF-Q&T43DQ)*DI
M+I.J"=<E1(%)% 'L% 'S!\8_V+_A_P#'V\74/$6B6]S>C.ZYC>:UFDRJ(/.D
MM9(7GVK&BQ^<7\M053:&8$ [_P"#GP!\+_L_V;6/AC3+?3XGQYK1@M--M9W7
MSIY"\TVPR.(_-=_+5BB;4PH -#Q]\%/#7Q5N+:ZU_2[/4Y+..>.W%Y"MQ'&M
MPT+2D12AHM[&"+$A4N@#*K*LD@8 ^</"W_!-[X4>#[R.^MO#EN\L6[:MS/=7
M<)W*4.^"ZGEA?AB5WHVUL.N'56 !]OT ?*&K?L,_#?7_ !!+XGO/#]G/JD\C
MRS-+YCV\DCH4=WLV<VC.V2[,T1+3$SDF8^90!Z_XU^"'A7XE7"WFN:)I>I7*
M1B))KRQM[B18PS,$#RQLP0,S,%!P"S'&2<@!X*^"'A7X:W#7FAZ)I>FW+QF)
MYK.QM[>1HRRL4+Q1JQ0LJL5)P2JG&0, 'H&K:3;Z_;RV=Y%'/;3QO%-#*BO'
M)&ZE71T8%61E)5E8$,"000: /B#5O^"9?PDUJXENI?#L:R32/(XBO+Z&,,[%
MB$BBN4BC3)^6.-51!A555   /L_PMX3T[P-9QZ?I5I;V-E#N\JVMH4AA3>Q=
MMD<85%W,S,V ,LQ8\DF@#S_Q3^SUX-\<WDFH:KX?T>^O9MOFW-SIUM-,^Q0B
M[Y)(V=MJJJKDG"J%'  H T/#?P0\*^#K>[L],T32[.VOX_*O8;>QMX8[F/:Z
M[)TCC594VR.NV0,,.XQACD X_P#X9.^'G_0J>'__  4V7_QF@#L/%GP4\->.
MK*QTS4]+L[K3M-D22SLI(5-K$T<$EM&!;X\ED2*5UCC961#M=5#QHR@'SA_P
M[>^%']H_VI_PCEO]H^T?:-GGW7V??O\ ,V_9?/\ LWE9X\CR_(V?N_+\OY:
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MZ?\ X1K3X]2DQ;Z-'IMI%;7DVJ7*M!9QQ+;&"2YVO)YSVW[T-'$\GD2M$HH
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M_P#\%-E_\9H ]PTG2;?0+>*SLXHX+:"-(H88D5(XXT4*B(B@*J*H"JJ@!0
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M@*P-TYC^27[49A./]:)* /7]3^'NC:UI8T.ZT^SFTE8XHA826\3VHCA*F)!
MRF()&40QKMPA5=H&T8 /+_\ AD[X>?\ 0J>'_P#P4V7_ ,9H ] \=?"?P]\4
M/)_M[2M/U/[/O\C[;:0W/E>9MW^7YR/LW;$W;<;MJYS@8 .?\+?L]>#? UY'
MJ&E>']'L;V'=Y5S;:=;0S)O4HVR2.-77<K,K8(RK%3P2* /8* /F#XQ_L7_#
M_P"/MXNH>(M$M[F]&=US&\UK-)E40>=):R0O/M6-%C\XOY:@JFT,P(!W_P '
M/@#X7_9_LVL?#&F6^GQ/CS6C!::;:SNOG3R%YIMAD<1^:[^6K%$VIA0 >P4
M?&&I_P#!/#X5ZMJ@UB3PU9BY$D4@2-IHK7=$%"@V4<JVA0[1YD9B*2DL9%<N
M^X ^O])TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4    4 >/_&_
M]F[PG^T?;V]KXJTV._CM)&DMR9)89(V==KA98'CE", N^/=L<I&S*6C0J =A
M\-/A5H?P;TY-*\/6%OI]DFT^5 @7>RHL?F2M]^64JB!YI2\LFT%W8\T <_\
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M39?_ !F@#L/&OP0\*_$JX6\US1-+U*Y2,1)->6-O<2+&&9@@>6-F"!F9@H.
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M_P!G;S&\,:1;V,LVX27&9)K@J_E[H_M$[RS"(F)&\D.(@Z[PF\EB ?0% !0
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MI*2QD5R[[@#Z_P!)TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H S]6CN)K>5;.2.*Y,;B&26-I8TD
M*G8SQK)$TB!L%D62,L 5$B$[@ ?EA_P[M\4?\+ _X63_ ,)E;_V[]H\[']@#
M[/L\G[-]G\O^T-WE?9_]'SO\_9\_G>?^]H _4_28[B&WB6\DCEN1&@FDBC:*
M-Y HWLD;22M&A;)5&DD*@A3(Y&X@&A0 4 % !0 4 % !0 4 % !0 4 % !0
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MN;ZYWRM,WF2$*B[F8&3RDC\XQQO+YDB!Z /I^@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@#\T/C[_P $\+CXU>/(?'%KXLU3
M29$C@B,-N&\^&.-3'*EC=+-&;1)8V?*^7,!-+/*PD64Q  ^W_A#\(=+^"6EK
MI>EK(5,CSW-S.YENKRZE.9KN[F/S37$K<NYP,!414B1$4 ]0H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M^V;^W1H?['EG"L\?]HZU=X:VTR.81,8=VUYYI-DGDQ##+&2CM-*"B*52:2$
M^?\ X2_L_P#Q0_:/LXM>^(GBK6- 6?SY;31-$9-,FMDG:-HOM,RJSMM565;:
MX6>>%2A>X28W$- !\6OV?_BA^SA9RZ]\._%6L:^L'D2W>B:VR:G-<I TC2_9
MIF577<K*K6UNL$\RAREP\PMX: /</V'/VX]+_:]TLQR".S\1V<8-_8 G:RY"
M_:K7<2S6[,0&4EGMW812%@T,TX!]WT ?E!\./'W_  W_ .-/%.ES:I<?\(-H
M'D6D>FV4GV==5>XCNH)9[F]M9O.EM"4F,<$4B07$1M9)$5HY4F /E#XJ_L??
M$']BGQC:ZY\(?MEYH^I7D2MIJ,\L<4GSA;;4$+JLMEMDD$-Y,RFU#-YD\,ZQ
M74X!]G^(?C/>?M)_%J?X=:3K%QI^@:%IYN]7;3V6.XO[N*XM]UHE_#*9K:*,
MRQ1SF P7&];RV?[T<D0!\8?M@_\ !/;7OV>KC_A+/@Z^J6T$D:VU[IVG7%T;
MR)69!O@>-S<7%N[JC30LTCQ2 2C=!D6H!]O_ /!-']DCQ+^RIHVH)XCNXVDU
M22UGCTZ&1I8[-DB(D9WXB-Q(76*;R0R8MHB+B92HC /TOH * "@ H * "@ H
M * "@ H ^$/C?^T#X@U[QC;_  U\!&SCUA[-KW5]5N=D\>E6;?NU:.V616EO
M=TD4L<4H\O$EN71X)Y);< ^K_AI\-[/X6:<FGVCW%PWRM<7EW,UQ>7<P18S/
M=7#_ #RRE41,G"I&D<,:QPQ1QH ?FA^V#_P4=?P9K/\ P@'P_@CU+Q1=2+8_
M:S)&+>ROIY4BCA59!Y4]PI9@_F.EO;3>6)3,5N((P#L/ O[$7CGQ7YVH^//B
M#X@.I7&S_1] O6L+.'R]R?*/*$;[T$3'R[:UVR>;N\]G\R@#S_\ :/T?XN?L
M<Z'<ZKX2U^X\2:%!;S)-!JUO%=ZEIJN%<WXNE"27OE/YI/G!HK6%D#VT\$;R
MP@'V!^SIK,_QY^&OAJ^L=<U"VN&T^T%S?P+;R7$UQ;1&VNTE.HVMTK_Z0DA>
M0)OD= ZRF-CO /R ^)?[3/Q>^'?Q0B^&W_"9>?YNH:79?VA_8NFIC^T$MV\S
M[/Y39\O[1C;YHW[,[DW?* ?I_P#\,\?%[_HI_P#Y:VF__'* /+_#A^,'PA^)
M7AW2?$OB./7?"^L2:A$)8M,MK5O,M].EN%2Y\NVQ [2*S0+'<2&9+>1B% =
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\ ?\%1_^20^(?\
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M.VU5)VJ&8XP 3@4 ?G!H'[>WB_XI:=<>(?!WP]U#5/#T?F>3>3ZG;6=Q/Y*
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M>8I#'RSE  ?9^K:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22
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MXFZ7^T=HEGXGM8(WMOME^=/D=2[!;>XNK!+J/S(XWB>:$.Q7:KQI.\#%AN+
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MC?9E6^PR?+$D8PB/;;0TDA^S>=(VZ89 /T_H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@#X _X*C_ /)(?$/_ '#O_3E:
M4 ?G!_P2_P#V8_\ A=/@V]U#_A)O%&C>7K$\'V;1]4^QV[[;:T?S7C\I\RG?
MM9\C*)&N/ER0#ZO7]C*X^"OQ6\&^*EU_5-:MI9+[39!K-TUW>12'3-2N(_*F
MV*IMRJRYC(4Q2?,#*)F$(!^M] 'X _\ !#'_ )F[_N#_ /M_0!]__P#!4?\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M_'_C_2_A9I=SK6M7,=GIUG&9)YY"=JKD    LSLQ"1QH&>1V6-%9V52 <_\
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MYN=R[,. ?T?4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M$T_X27Q1_P )#]H^T?;OM=COWXV[=OV#R_*V?N?(V^1Y'[CR_)^2@#[_ /\
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M]E%)&\/VTCWT\?E3ZA=2>;=2Q^8T@3(5(HTR5#+!'$)!'$T@D>-7H ]_\?\
M@#2_BGI=SHNM6T=YIUY&8YX) =K+D$$$$,KJP#QR(5>-U61&5U5@ ?BCXI_X
M(=:==WDCZ5XGN+:R.WRH;G3TNIEPH#;YH[BV1\MN9<1)M4A3N*EV /U/_9G_
M &5?#7[*&ER:9X>BD+3R>9=7EPRO=7# MY8ED1(UV1JQ6*-%1$!9]IEDE>0
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M<6_V6XUO5-9C6.&.(ZD;1Y(EB4KGS;>UMY97<$>9)<-,[%0VX,SEP#U"@ H
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M\G5=\?$LL?[E%CMMT3".7R?."AI&H ^OZ "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M-+R?R(IK%LB-+B6X(C\Z(Y'VN2Y=Y0H^T"4LDD<X!_2]0 4 % !0 4 % 'Y
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MU/\ X))_"N_TL:?'8WD%R(XD.HQWTQNBR%2TA20R6F^3:1(!;A ';RTC(0J
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M_CWXZ^&OBK6]#L_%OB1[;3=4OK.%Y=7NS(T=O<21(7*R*I<JH+%54$YPH'
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MG]K/PK=ZYKGC;QI!<P:I-9HEGKDJ1F-+>VE!(E29M^Z9@2& P%^4$$D \O\
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M_M7^&H-3M98QJD$<4>K6:J4:WNBOS%8V>1OL\C*[6TFYPZ HS":.9(P#Y/\
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MS_BGPU!XPLY+&Y>X2*7;N:VNKBTF&U@XV3VLD4R<J VQUW+E&RC,I /YL?\
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M%^&EC\._.^Q2ZA+Y^S?]MU2_U#&S=CR_MUQ<>5G<=WE[-^%W;MB;0#T"@#\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M2Q?#C7YK>*R?S&T6X?\ =L+B67>UB2%V/YS222P/(R.)=UN&E,UO'$ ?H_\
M\W"_]T__ /<S0!]_T ?Q!?M8_P#)0_%?_8P:M_Z6S4 ?U7?##XQ:-\"OA'X=
MUS7+B."V@\-Z:R(TD227$B:<DHM[<2O&LEQ(L;"*(,"Y'8 D ''_ +'O_&2G
MPA']K_N?^$D_X2+[9]E^3R_[1U*_\[R/,\W;M\UO+W^9C W;^<@'O_[6/_)/
M/%?_ &+^K?\ I%-0!_(%^R=_R4/PI_V,&D_^EL- ']OM '\P/_!:O_DH>F_]
MB_;?^EM]0!]__P#!%3_DGFI?]C!<_P#I%8T >@?\%>? O_"6_"^XO?.\K^R-
M0LKW9LW>=O=K'R\[ALQ]K\S=A\^7LVC?O4 _#'_@FO\ %Y_A!\3='<M(+;5)
M/[*N4C2-VD6]*I #YF-J+<BWED9"'"1L!O!,;@']1O[6/_)//%?_ &+^K?\
MI%-0!_(%^R=_R4/PI_V,&D_^EL- ']/WQE^.EG??%GP1X)LY[>:XAN-3U#48
MEW--;,ND7<=FK,#Y:^8D]P[1,#+M$$GR1NAE /K_ ,5?#33O&&IZ1J]RG^FZ
M+<3SVDJJFX?:+6:TEB9F5G\IUE#LB,FZ6&!F)$>T@'H% '\V.C_L.)^T=\#=
M!\3Z29!XCTBSU0)"HDE6^M8M2OIOLJQ(&87 9I&MFC4F1W,$@(>.6W /S@_9
M5_:8U3]E#Q+%XATR..=3&UO>6LF MQ:NR/)$)-K-$^Z-'CE4$HZ+N62(O%(
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M6"LK$, #^RV@#Y0_;I\%6_C_ .&7B>SNFD2./2[B\!C*AO,L!]MB!+*PV-)
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M_%7A_4/!EY)'YFCR"YL09(Q(UK=N[3(L0179(9\N\S-(<WD<9\M5C# '[74
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MQ>?X[^ ]#\0SM(]S=6:I=22)'&TEU;LUM<R!(OD5'FBD>,*%&QE^2,Y10#X
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M (*P>%KSP_\ %?5+FYCV1:A;V%S:MN5O,A6UBM2^%)*XEMYDVN%;Y-V-C*S
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M;;2@#]#_ -DG_@G9X(_:/^$EAJ=U;R6GB&_CO0-5CGG=HY(;ZXCB8VS3"W=
MD:1R)L0NF[;)'*1*H!]7_P#!*GX::C\&_#/B'P]JJ;+W3_%%[!+A757VV=CM
MEC\Q4=HI5VRPN57S(G1P,,* .?\ ^"R7A:\\0?#6*YMH]\6GZQ:7-TVY5\N%
MHKBU#X8@MF6XA3:@9OGW8V*S* ?C#_P2X_Y*]X>_[B/_ *;;N@#^OV@#Y_\
MVL?^2>>*_P#L7]6_](IJ /XH_"?A:\\<ZC::5I\?G7M]<0VUM%N5-\TSB.--
MSE47<S ;F*J,Y) R: /[7/VL?^2>>*_^Q?U;_P!(IJ /XX_V>M _X2OQEX?T
M_P"T7%I]KUC3H/M-K)Y5Q#YMS&GFP28.R5,[HWP=K@-@XQ0!]O\ _!3#X2^+
M?@7K%OINH:[K&L>&;[%QI9U+4Y+Q_.MXT2X$L;;$26-ICL=8PI@F11(S^<J
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MG7//\BR%PEOJ)/FLAL9V"7!>.$AY?+4^?&F' GBB?RW*!2 ?VNT % 'Y ?\
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M/NC1XY5!*.B[EDB+Q2 ']-W_  2X_P"20^'O^XC_ .G*[H ^_P"@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M7?;B6-!*S,)D9)-_F&6*( _L-H * /Y@?^"U?_)0]-_[%^V_]+;Z@#[_ /\
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MU#!71'#(H!_5;0!_(%_P5'_Y*]XA_P"X=_Z;;2@#]_O^"7'_ "2'P]_W$?\
MTY7= 'V_HWA:S\/SWMS;1[)=0N%N;IMS-YDRV\-J'PQ(7$5O"FU J_)NQO9F
M8 Y_XJ_#33OC)H=_X>U5-]EJ%N\$N%1F3</EEC\Q7198FVRPN5;RY41P,J*
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MK_Y)YIO_ &,%M_Z17U 'P!_P14_Y*'J7_8OW/_I;8T ?T_4 % '\ = ']_E
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M*[H ^_Z "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MN\JVMH4AA3>Q=MD<85%W,S,V ,LQ8\DF@#H* /E#X\_L1^ _VCGDNM=TJ/\
MM%XY$&H6S-;W09XTC61WC(6=XEC3R1=+.D87:$V,ZL ?/^I_\$P]&UK2QH=U
MXL\:3:2L<40L)-7B>U$<)4Q((&M3$$C*(8UVX0JNT#:, 'U?\%/V6/!?[.WF
M-X8TBWL99MPDN,R37!5_+W1_:)WEF$1,2-Y(<1!UWA-Y+$ ^@* /C#QK_P $
M^_AU\2KA;S7-.O-2N4C$237FLZM<2+&&9@@>6]9@@9F8*#@%F.,DY /?_A?\
M'M)^#EO]CT?[8EL(X8DAN-1OKV.&.!2L:0)>7$ZP(JG;MA$8(" @A$V@'J%
M'C]O\"]#L?%K^-H(/)UJ;3WT^YECPJW,+202(TRX^:6/R%2.4$-Y1,;[U2$1
M '0>.OAI8_$3R?MDNH1>1OV?8M4O]/SOVY\S[#<6_FXVC;YF_9EMNW>^X ^0
M/^'7'PA_Z%[_ ,J.I?\ R70![_\ "W]F+PU\%OLZZ"FH6EO:>9Y%I_;&J2V:
M>;OW_P"AS7;VQR79_FC.)#Y@Q( P /H"@#Y_^*7[,7AKXT_:%UY-0N[>[\OS
M[3^V-4BLW\K9L_T.&[2V&"B/\L8S(/,.9"6(!X!_PZX^$/\ T+W_ )4=2_\
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M ^,-6_X)G?"G7[B6\O-$DGN9Y'EFFEU34WDDD=BSN[M>%F=F)9F8DL2222:
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M/CF\DU#5=)N+Z]FV^;<W.KZK-,^Q0B[Y)+QG;:JJJY)PJA1P * .@\"_L(^
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M0?&O]C/P)^T3J,>J^)]+^W7L-NMM'+]KNX<0H\DBIM@GB0X:5SN(+'=@G
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M@._U2+6M";5/#.HQR7$AGT2^:V8M<##!1(LZP(JET2.U$"!)'C*E-BJ 9_\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M^TUX5U/7/$<T<MR-<NH84BB2*."W%O:RI @4;F1&E<*TK23$$;Y'(S0!^A]
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M&U[7KC[7J5W]M\^?RXXM_E7MQ"GR0HD8PB(ORJ,XR<L22 ?7] !0 4 % !0
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MEW)<)9ZO<2VMY<72VS6Y>2"V1Y8K9,N5Q=+*\L,J.$MIE94 /VNH * "@ H
M* "@ H X_P ?^/\ 2_A9I=SK6M7,=GIUG&9)YY"=JKD    LSLQ"1QH&>1V6
M-%9V52 ?F!9?M\>-?VC-4FT[X3>&([O3H+P1'Q!JK3)8-$H196,2B!HW#2QS
M+&LTUT;8;S9!W*1 'L&K?$7XY_"RWEU/5= \-^([:.-\V6A7=[;7BE5,AE'V
MV.59D"HT?V>%&N)))(]BD*P(!T'['G[;5O\ MBZIKXTRSDM-)TJ/31;-<;1=
M2R7(NC.TJQO)$B PHD2*SG"M(TG[P10@'W?0 4 % !0 4 % !0 4 % !0 4
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M[I;KYWFE19'A=HFCMI-HD2!2<D _7^@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M+)]H\V!PVQF19/+E7[\4H5T+PRA)8]P#HIXH _,#_@M7_P D\TW_ +&"V_\
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M^,?[:'P_^ 5XNG^(M;M[:].=UM&DUU-'A4<>=':QS/!N61&C\X)YBDLFX*Q
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MV_VC[1]GW^1=?9]^_P O=]J\C[-Y6>?/\SR-G[SS/+^:@#\X/V!?^3A?'O\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M47 !]O\ P$^'NC?$KX:>$K/7-/L]2MDT/2)4AO+>*XC606,:APDJLH<*S*&
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MOCO\'+/X^Z#-X=U!L65S<6,ERN&/F0VMY!=20Y1XW3SEA,/F*P:/?Y@#%0I
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M1/$W@'4?%%Y!)+JVE1VD=C*;FX$<"SW]O',5MQ*+<O(CE7D:,NP6,%OW4>P
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MA#S"-[>+4;=;)V28[V=(965&F!F422 D%WR ?5__  6K_P"2>:;_ -C!;?\
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MV]A<21>#]8CMY[FT\Z241V-PTL.Z4&%W9[.=)IK?8)+A[=5A-P7N)\@'W_\
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M#^@[X6_"W1_@MH]OH.@V_P!DTVT\SR(/,DEV>;(\S_/,[R'+NS?,QQG PH
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M]@#X?:_X?ET*\TN.>:>-Q-K,JH^L27#N97NWU!D,S7#2DRL6S"V3$83;GR:
M/SP_X(=>*;R[T[Q/I3R9LK:XT^YABVJ-LUTEQ',^X#>=RVT VL2J[,J%+.6
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M!^Q+X2N-.N(O%%G;^)-7U#S'U/6+^WC:\N)I4$;F&0#?91(H6.U@M6C6UC1
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M$C1,[54  _8[]K'_ ))YXK_[%_5O_2*:@#X _P""*G_)/-2_[&"Y_P#2*QH
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'Q!_P4A\+7GC#X4>([:QC\
MV5+>"Y9=RKB&TNH+J=\N5'R112/M!W-MVJ&<JI /D#_@B7XIL[OP;K.E))F]
MMM8-S-%M8;8;JV@CA?<1L.YK:<;5)9=F6"AD+ '[/4 ?"'_!1VR3Q5X!D\-+
M-'#?>(M4TC2M/,HD\MKJ:_@D =HTD*((X99&8C&$*C<[(C 'W?0!^ /[ O\
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MHEE6[(1?,:+,C>6/-&\ ^_\ _@J/_P DA\0_]P[_ -.5I0 ?\$N/^20^'O\
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MQ>TOP5K>B^'KII#J.O27:64:(2NVRMVN9Y)'.%5%4(@&2[/*FU"@E>, ]0H
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MDZ]XK;_A)/&;[);G5KZ22Z\N5/*,2VHN"V/(\F-8;IU%UPQ#0QN+>, ^ /\
M@AC_ ,S=_P!P?_V_H /^"YW_ #*/_<8_]L* /W^H _ ']@7_ ).%\>_]Q_\
M]/-O0!^YWQ"\%6_Q*T;4-#O&D2VU*SN+.9XBHD6.XB:)RA964.%8E2RL <94
MC@@'\^/[!W[1?_#"6L>*O ?C=O(M[/[5>P8&SS+RTC^>.W\Z*)I/MUND4EFT
M\D,;^5"L:^9=C(!^O_[#7PTU'X=>"[>?7$VZ_K=Q<ZSK#%71GO-0D,O[R%UC
M$$J1>3%-#'''''+&X53R[ 'U_0 4 ?A#_P %Q?"UY=Z=X8U5(\V5M<:A;32[
ME&V:Z2WDA3:3O.Y;:<[E!5=F&*ED# 'Z_? 'XQV?[0'A?3/$]BNR+4+<2-%E
MF\F928YX=SI&7\J5)(O,"*LFS>HV,I(!G_&+XWV_PEN-%L!;R7NHZ[JEO86M
MK"R^8(V8-=WCK\S_ &>TA#2S.B,%)B5VB20RH ?B#_P5QO=4^%7Q+\+>,;>&
M-H[:SMGLVE(:.2ZTV^EN7C>-'678HGMRQ^0.)"$?<K;0#^A[2=6M]?MXKRSE
MCGMIXTEAFB=7CDC=0R.CJ2K(RD,K*2&!!!(- 'XP_P#!;C4]+B\*Z':S"/\
MM:35'DM28B9!:QV[K=A9=I"(9)+/?'N4R$1L%;RB4 .?_P""GG@JX^&OP3\)
MZ'>-&]SIMYI%G,\18QM);Z7=1.4+*K%"RDJ6521C*@\  _4[]D[_ ))YX4_[
M%_2?_2*&@#\@?V^O^3A? 7_< _\ 3S<4 ?K]^UC_ ,D\\5_]B_JW_I%-0!\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H S]6TFWU^WEL[R*.>VGC>*:&5
M%>.2-U*NCHP*LC*2K*P(8$@@@T ?C#+^P_\ $']C[Q+?^)/@_/9W>DW4:[]
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M!#-H][KNNV]['JMY=7-[!9VOVM1%Y-A:I#<LT45N6@B)>VS)&M[+'//<7*L
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MI^TREN/#^LC2[.V$>T:WJ;07MY!'MCA A6RN66YN$7=<1F]C832!Q/<D,JT
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M'T]O9RG3[T6/A32]D4,U_%')]@N+V^-S*7_>L)!:+-]DW16DTC!TFBH T/\
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M7&+<VP!^C] !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MX8M[B^BO?M/FZI(#;0IY-HUTODPR)YTN2CQ2>:MMY;*&3SD(- 'Z/T % !0
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 <?X_\ '^E_"S2[G6M:
MN8[/3K.,R3SR$[57(   !9G9B$CC0,\CLL:*SLJD ^,/V=?^"@^A_M0^,KSP
MQX>L[@V5GI\UW_:4["+SFBN8H-L5MM9_*=94E265XI>J/;(1F@#[_H * /S0
M_:B_X*C>#OV>+BXTFR637-;MI&BFM;=O*MX)$:/>D]VRLH<*SC; EP4FB>&8
M0-R #]+Z "@ H * "@ H * "@ H * "@ H \O^+WQH\/_ 72VUGQ+?1V%BLB
M1"1P[L\DA^5(XXU>61\!F*QJQ5%>0@(CLH!\X?L@_MO:=^V->:VFE:?<6=EI
M/V'RIKF1/.G^U+,6WPQ[TA\MH&5<2S>8I#'RSE  ?;] !0 4 <?\0O&MO\-=
M&U#7+Q9'MM-L[B\F2(*9&CMXFE<(&95+E5(4,R@G&6 Y !\@?L.?MQV_[:%O
MJC+I<FEW.ER6XDC-PMS&\=RLGELLGEPMOW0RAT,>%'EL)'+LL8!]WT % !0
M4 % 'YH>*/\ @J-X.3Q5I?A/PXLFMW-_JEI837<3>39P">X-N[I*RLURZ-L=
M1$GV>:-PR7>1MH _2^@#\X/V._\ @HQIW[7OB'4M!MM)N+#[);O=VL\DZ2^?
M;I,D),R*J^1+^]A81HUPG,@\T>6IE /T?H * "@#\T/VHO\ @J-X._9XN+C2
M;)9-<UNVD:*:UMV\JW@D1H]Z3W;*RAPK.-L"7!2:)X9A W( /TOH * /E#]L
MG]JFW_9!\-)K\]C)J,DUY#9P6Z2K"IDD624F24K(401PR$%8Y"S[$VJK-(@!
MW_[-WQOM_P!H_P )Z;XJM;>2TCOXY";>1E=HY(97@E4.N Z"2-_+?"%TVLT<
M;$HH!\@?M1?\%1O!W[/%Q<:39+)KFMVTC136MNWE6\$B-'O2>[964.%9QM@2
MX*31/#,(&Y !^E] 'YP?#K_@HQIWQ"^*%U\-DTFXB\FXOK2'4#.C>9<6".TP
M>W"CRXCY,XCD665VQ$6B3S'\D _1^@ H * "@ H * "@#/U;5K?0+>6\O)8X
M+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!0!^>'Q#_;]O(-#F\5>"_"NH>(O
M#=IYIN=6:9=/A*QB/?):P2QRWMQ%&S2)<3&WBBA:"4[W1)'C /4/V1/VX_#7
M[7UO*FG"2RU:UC1[K3K@J9 K*H:6!U.)[=9&,7F8C=3L,L,/FQ!P#[/H * "
M@ H * "@ H \O^+WQH\/_ 72VUGQ+?1V%BLB1"1P[L\DA^5(XXU>61\!F*QJ
MQ5%>0@(CLH!\X?L@_MO:=^V->:VFE:?<6=EI/V'RIKF1/.G^U+,6WPQ[TA\M
MH&5<2S>8I#'RSE  ?;] !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M1/NC1MT94Y1#G*C !V% !0 4 % !0 4 % !0 4 ?@#_S=Y_G_H7* /W^H *
M"@ H * "@ H * "@ H * "@ H * /A#P7^U4_P 1_C'J/@?3I8WTG1=#FDNB
MJQL9=2^U6BL!*KN=EO'*83'B)EN#<I*K^7$4 /N^@ H * "@ H S]6U:WT"W
MEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q 4 DD 4 ?&'["G[2EY^U3I.N:_
M/\MHOB"ZMM-A,:QM%8QV]JT"2!6?,IWM),Q=QYKN$(B$:* ?+_\ P6K_ .2>
M:;_V,%M_Z17U 'W_ /LG?\D\\*?]B_I/_I%#0!] 4 % !0 4 % !0!^4'_!5
M/]L"\_9^T.VT#P_=?9]=UC>7FC*F:UL5!5Y$(D$D,LKD1V\VQAMCNBCQSQ1N
MH ?\$M/V1].^%WA*R\4ZG96\FOZM_IMO<R1H\UI9RQE+>.&3?($\V)VFD:,0
MR,MR()E/D*  ?J_0!^4%E^RC%^S%\8]"\1>$Q]DT+Q+_ &E8:G9*D7DP3"SE
MOHXX Q\Q(IGM?.$<2A;=K=HQ(L$T=N@!^K] !0 4 % !0 4 % !0 4 % !0
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M!PRAAR : -#2=)M] MXK.SBC@MH(TBAAB14CCC10J(B* JHJ@*JJ %    %
M'X(_\%SO^91_[C'_ +84 ?O]0!Q]E\/=&T[5)M<@T^SCU:YC$4]^EO$MU+&
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MW_<'_P#;^@#]_J "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M$:CJGAGQC9ZA'H%A;A;:34%<^3<Q.D$<%C,[8EM#$DAQ!YUM'Y431M%YY^T
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MYX#US7=%@DGU&TLV, C4,T+.RQFZ*F.562V5S=2*Z%"D+!RB%G4 _.#]D_\
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M\'1R7FE^"/"LDL&LK;SB&XU>Z+R6WV2>2.598[*4)<C9'O$D,3F5HYI[;[*
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MEXBTN"ZFBM]4U!HH;_==?9UC?9'"Q>)))=B36:.D@,[PR %_XW?L7P? :_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!_/#_ ,%)O%-GX&^.O@W5=0D\
MFRL;?1;FYEVL^R&'5KJ21]J!G;:JD[5#,<8 )P* /Z'J ./UWQ_I?AF_T_2[
MRYCBOM5DFCL;<DF2=H(7N)BJ@$A(XT)>1L(I:-"V^6-7 /P1_8]^)?\ 9_[2
M?BB#4'N+BXU.XUW3K:0MYFS[-=">-79V#+$EO9&&,+NV8BC"B,$H ?T/4 ?S
MP_MA?#3^S_VD_"\^GI<7%QJ=QH6HW,87S-GV:Z,$C(J*&6)+>R$TA;=LQ+(6
M$8 0 Z#_ (+G?\RC_P!QC_VPH _?Z@#\ ?V!?^3A?'O_ ''_ /T\V] 'W_\
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MP5\<Z=::KI^A>=97UO#<VTOV_5$WPS()(WVO<JZ[E8':P5AG! .10!V&C?\
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M"U&YC"^9L^S71@D9%10RQ);V0FD+;MF)9"PC " '0?\ !<[_ )E'_N,?^V%
M'[_4 ?@#^P+_ ,G"^/?^X_\ ^GFWH ^__P#@J/\ \DA\0_\ <._].5I0 ?\
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M98#[%*0%9AL:2!VC.<E"I958E0 '[=/@JW\?_#+Q/9W32)''I=Q> QE0WF6
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M0 ?\$N/^20^'O^XC_P"G*[H ^ /^"YW_ #*/_<8_]L* /W^H _ '_F[S_/\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MA,\:Q'RUF9TC8.EK<0;K22WB\I60PH;@ [#]IN74?^"FL6D^'_!%M<)X5@U
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M3P_\0/M&A:E::/I[6SM93RVU[8R1D64]J]L;IG_T=(OM!D$0%R98U4-')'$
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MXOUGPQXHL](UW^UO(E;0KZ1H/M5['>1>?'!%*XRL1C/DB;$K+_RSW2* ??\
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MZ:&*"XB=8$ /F2CS@XBR&D5&5-\ICC< ^8/V$_\ @H=>>.M#TKP+I_AZXO\
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M%]O\%?#6E^'+7RVCTVSAMS)'"L"S2(H\V<QJ6"O-)OFD^9B7=BSLQ+$ ]0H
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M &?_  OIGABQ;?%I]N(VEPR^=,Q,D\VUWD*>;*\DOEAV6/?L4[%4  ]@H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H _ ']OK_DX7P%_W /_ $\W% '[_4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\
M_P#Q9_:G\%_ O4;+2O$FKV]A>ZA@V\4@D;Y2XC$DS(C);Q%B0)K@Q1'9(0^(
MI"@!\X7FK6_[5_Q(T:;1Y8[_ ,*^$(Y[RZO8G6YT^[UBYC6.TMDY$+W%E$WV
MQ;J$W/V=Y1"?L\K@L ?H?0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'Q!XI_X)R?#'QS>2:A
MJNDW%]>S;?-N;G5]5FF?8H1=\DEXSMM555<DX50HX % 'U_X6\-0>#[..QMG
MN'BBW;6N;JXNYCN8N=\]U)+,_+$+O=MJX1<(JJ #H* "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0!\X?&_]D7P1^T=<6]YXHTF.]N;6-HH
MIA-/;R"-FW;&>WEB:1 V619"PC+R% ID?< >W^%O">G>!K./3]*M+>QLH=WE
M6UM"D,*;V+MLCC"HNYF9FP!EF+'DDT =!0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % &?JVK
M6^@6\MY>2QP6T$;RS32NJ1QQHI9W=V(545069F("@$D@"@#Q_2?VF_ NOW$5
MG9^)=#GN9Y$BAABU.T>221V"HB(LI9G9B%55!+$@ $F@#V"]U:WTYX8IY8XY
M+F0Q0([JK2R"-Y2D8)!=Q'')(57)"1N^-JL0 :% !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >/\ PT^/WA?X
MR7FH6/AW4[?4I=+^S_:VMB9(4^TJSQ;)U'DRY".&\EY/+92C[7&V@#V"@ H
MY_Q3XLT[P-9R:AJMW;V-E#M\VYN9DAA3>P1=\DA5%W,RJN2,LP4<D"@#Y@^&
MG[?'PS^+NHII6D:_;O>R[1%%/%<6GFLSK&L<37<4*22LSJ$A0M*_)5"%8@ ^
MOZ "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M:@UG]K/PK=ZYKD%G!<P:I-9HEFDJ1F-+>VE!(EEF;?NF8$A@,!?E!!) //\
M_@H'^TOXZ_9(LK?7]'.AW>DW5XEF+>ZL[L74,C0-*I\V.]6*9&,,Y8^7 8AY
M2!9LO(H!]O\ P0\:W'Q*\*Z)KEXL:7.I:78WDR1!A&LEQ;QRN$#,S! S$*&9
MB!C+$\D ]0H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M ?\ !<[_ )E'_N,?^V% '[_4 ?@#^P+_ ,G"^/?^X_\ ^GFWH ^__P#@J/\
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M\CDMUMGA"-)(X!]O_P#!+C_DD/A[_N(_^G*[H ^ /^;O/\_]"Y0!^OW[6/\
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MKM5?+A;35NBF5 +9EN)GW.6;Y]N=BJJ@'K__  14_P"2>:E_V,%S_P"D5C0
M?\%J_P#DGFF_]C!;?^D5]0!]_P#[)W_)//"G_8OZ3_Z10T ?0% !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M_+N%TY86DLV\PI<*J/ KW#7%O,(W9VLXHW\V7RV /K__ (*%Z3<:!\']>L]
MBD@6"SM8DALD9!'9I<P+<(J0@;;=;82+*H C6W#A@(@U 'R!_P $S?VL_A]\
M.?AN--U/4;/2-1TN2[FU!+C9#)=F6266.>  E[Q_)5(-L8>X4PI%Y>PVYD /
ME_3/B]I<W[4)\0ZBTFCZ<LDJ-)JR'3F14T1K:.21+GRVB29@KP"4([)+%E$=
MM@ /O_\ X*!?%[2_B9\#=2U>U:2"VU22S33Q=H;:6Z5-2B9)(8I,.R30P/=P
M# =K7$S(@#!0#T#_ ()6:M;ZC\)-%B@ECDDMI-0BG1'5FBD-]<2A) "2CF.2
M.0*V"4D1\;64D _/#_@H)XLTZR_: \'3RW=ND6G_ -@_;9&F15M=NJ33MY[$
MXBQ$Z3'S-N(G60_(P) /Z'J /YT?^"BG@;5/V./B1IOQ3\*QQQQW\CO*&@#V
MZ7XC,=S'*J1(BI>0.SY\PW,LWVV97C94=0#]G_V3/A"_P5\':=IUXLG]K3Q_
M;=7EF>.6XFU*[Q-=O//'Q.ZR,8EE9I&,,<:F63:'(!]'T % '\X/[2'Q(L_A
M%^TO!KGC%+A]#M/L;6QFA:=(H6T\)'/;QOG,4%ZTDY, 9DGCF>-6N5*D ^O_
M /@I-^T[X7\<?#C6M%T&[_MFXD_LTSS::AO+.S1KU)$>\O(=UM!O-LT4<;2&
M=Y'CQ%Y;&10#H/\ @F3\=-#L_ GA3PG#/]KUJX_M9IK6VQ,UE#%=W4QGOMI_
MT6)]\,41EPTTMQ"(U92[H ?('_"6:=_PUM]J^UV_V?[1]E\WSDV?:/[#^R>1
MNSM\W[1_H_EYW^?^ZQYGRT ?L?\ MB:M;Z+\.?%4MU+'#&VAZC$'D=44R36T
MD42 L0"\DCI'&O5W944%F (!\ ?\$4-6MYO NJV:RQFYBUR662$.ID2.6TM5
MC=DSN5':*548@!C'( 24; !\?_'*2X_X)X_'4>+Y([RYT+6I+J]=8I&5IH[W
M>+V!F,<<,KV]PPN8[8EAL%EYDR2/YJ '['_\-Y?#J]T?^U]/UJWU!G^6VTZU
M.[5+J9I/)C@@TY]ETTLLF$C#1HI#"4LL.9  ?CA_P1E^,FB?#[5-9T749Y$U
M'6Y-,CTZ".VN)VF: 7AF),$4BQI&LBO))*41$W2%@B.R@'])U !0!_-C^P)\
M:/#X^/'B347OHX[3Q!)J\6ERR!XUN)+K4H;BW0;U4QO+&C>6LH0L^V$#SG1&
M /Z+O%GA:S\<Z==Z5J$?G65];S6US%N9-\,R&.1-R%77<K$;E*L,Y!!P: /Y
MX?V,O&/_  [F^)6L^"O&1^R:;JWE);ZG-%Y:2>1+*+&Z+B5HXK2=)9EE;]]Y
M$^Q)7A6&Y90#][OC%\8M&^!6C7&N:Y<1P6T$<C(C21))<2)$\HM[<2O&LEQ(
ML;"*(,"Y'8 D 'YH?\$G_@SK%I9ZS\0_$T6-4\47 E@DEMHXYFMV9YY;E&3!
M2*[EEW"(1Q(RVT,RAXGA*@'S!_PEFG?\-;?:OM=O]G^T?9?-\Y-GVC^P_LGD
M;L[?-^T?Z/Y>=_G_ +K'F?+0!_0]0 4 % '\Z/\ P44\#:I^QQ\2--^*?A6.
M..._D=Y0T >W2_$9CN8Y52)$5+R!V?/F&YEF^VS*\;*CJ ?L_P#LF?"%_@KX
M.T[3KQ9/[6GC^VZO+,\<MQ-J5WB:[>>>/B=UD8Q+*S2,88XU,LFT.0#C_P!N
MG]G3_AIWP-?:- N[4H,7NF<XS>0*VR/F6*/]\C26VZ5C'%YWG%2T:T ?$'_!
M)C]I2S31S\,M:_T#7](N+P6MK-&T+S0F1YIXSYC$F[@E:?S8=L3+ $94?RKE
MT /?_P#@IC\=(O G@N[\-:9/YGB3Q!Y&GVEA;^5/=O#>2-'*QMF)E,4L4<]J
MDL<;M]HDC5-K_.@!H?"?]EV_^%7P1N_!L%O&^NWNAZGY\:+#$TFH7\$N(I)!
M(T4CQ%X[07#2;'2%&W)&%50#X0_X)"_M0^$OAQX>U/PSKNI6^EWO]H2:A')>
MRQV]O+#)#;0%8YI'5/-1HLM$VUF1U:/S LWE &?_ ,%5OVF-+^.?A6WL?#,<
MFH:38:Y&EYK292S6^6WNT2RMV=0;IS'YD\DT&ZWBC^SD22?:5V 'Z?\ [!?Q
MDT3XJ^!='M='GDN)-'TO3+&^)MKB*..ZBM(UDA666)(IG0K\_DM($#1L2%DC
M+ 'M_@_X_>%_'^N:CX:TO4[>YU?2<?;;5"=T>3M;!("2^6Q$<_E,_P!GE*Q2
M^7(P4@'L% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M_P#@Y\ ?"_[/]FUCX8TRWT^)\>:T8+33;6=U\Z>0O--L,CB/S7?RU8HFU,*
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?
M('[7G[.6N?M0Z/)X=MM=M](TBX\AKJ/^S#=W$S0R&4+Y[7D2)%N6%]J1"7?%
M_KS&[14 '[(?[.6N?LO:/'X=N==M]7TBW\]K6/\ LPVEQ"TT@E*^>MY*CQ;F
MF?:\1EWR_P"O$:+%0!]?T % !0 4 % !0 4 ?GA^V1^P?<?M5:SI6N6?B2\T
M6YTJ,K"B1-/&D@E$J7%N%GMVM[C< ))59C((K?&PPY< ^G_@A\ M+^!-O<)9
MS7E_?7LBR7VJ:C.;K4+QHUV0B>X(4LD,>(H8U"I&@)"[WD=P#W"@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@#\\/VR/V#[C]JK6=*UR
MS\27FBW.E1E842)IXTD$HE2XMPL]NUO<;@!)*K,9!%;XV&'+@'T_\$/@%I?P
M)M[A+.:\O[Z]D62^U349S=:A>-&NR$3W!"EDACQ%#&H5(T!(7>\CN >X4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M0+JXBL1<6[ROJ\DLUO</)DO"(;:+"$(T#-=))''*LZ>8T<8!^A_[,FK7&O\
M@7PU>7DLD]S/H>F2S32NSR22/:1,[N[$LSLQ+,S$EB22230![A0!GZM'<36\
MJV<D<5R8W$,DL;2QI(5.QGC62)I$#8+(LD98 J)$)W  _(']N/\ ;(^)?[%]
MQI:LWAO5+;5([@QR#3KZVD22V:/S%:/^TIEV;9HBCB3+'S%,:!%:0 ]/^%7Q
M"_: ^+.AV&OP6W@>TM]1MTN8(;G^U/.$,HW1.X@EFC'F(5D50Y95<!PD@9%
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MN8Q0%%)9-EN8-@D)E:(QR.SL_F, ?7] !0 4 % !0 4 % !0 4 % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M9'P&8K&K%45Y" B.R@'RA_P\7\.>'_WOB?1?%'ABR/RQWNL:+/%;R3'E8$:
MW#F5E#R*"H79%(2P( 8 ]P\0?M6^&/!GAK3?%FK/>6>DZG9P7D<QL+JX6&.X
M6)HQ=/9Q7$5NY,\:*)' D<E8VDVG !U_P4^/?AS]HG3I-5\,7GVZRAN&MI)?
M)GAQ,B1R,FV>.)SA94.X J=V <@@ ' ?&/\ ;)\$_L_WBV/B>^N-/E?/E-)I
MNH-#-M5';R9X[5X9M@D02>4[^6S!'VOE0 >WZ3X_TO6M&B\0Q7,:Z3-9I?)=
MRDPQBU>(3"9S*$,:>6=[>8%*#.X+@X /E#2?^"B/PZUS5M3TVVU/?;Z/I\U_
M>ZD$Q8HL-PEJT4<A(DN)6>6/R?L\<L5P)$6&621@A .?^!W_  4G\#?M ^*!
MX4T@:@MW+]H^RW$]LJ6]U]G#.?**R/*FZ)'F3[1%#\B%6V2E8V /H_XW_M#^
M'_V?;>WEUF:0W-](T.GV%M$]Q>7UP%R(+:",%F=F*1AFV0K)+$CR(9$R ?,&
MD_\ !3#P=#K,6A^(['7/"US<1I)"^NZ?]CC<22B),E996C0MO/GRK';J(I-\
MRE<$ _0^@ H * "@#\<?VJOV9]+_ &K_ (PR^'M3DD@8> UN+.ZCR6M[I-7=
M(Y3'N594VR.DD3$!T=MK1RA)8P#X_P#^"?G[56J?LA>);CX<?$*633M+$CQQ
M)=*"NG7SLK*?.W[8[*X5F=I%\RWWO%=*T<,MS.X!_2=0!\ ?L\?\E>^)_P#W
M*W_IMDH ^[]6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q 4 DD 4
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M?3+I;S4=;O(VEL]&TRV>\U"XC1L.Z0IA515$DFZ9XPZ0S>67:)E !X_\+_\
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M[5W[:_A?]DNS/]J3?:-7EMWFLM+BSYUQA@BEW"LEO$6)S++C<L<WE)/)$8B
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MQ7EG+'/;3QI+#-$ZO')&ZAD='4E61E(964D,"""0: /P1_X(8_\ ,W?]P?\
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M+_X*Y_#7X=ZB^GP-J&K^5N$ESIT$3VX=79&19)Y[?S<;0PDA$D#HZLDKY(4
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M=27#0>8+A1%,[0B.,O0!]GT ?@#_ ,$,?^9N_P"X/_[?T ?O]0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M'OBW\'+KQQ%IMN;VYT_1Y[*\N+6$WT%O=7EK(L0F&]X_EG<.D<A3+R %@Q)
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M,&>X6&.Y>(PF5W<OYDL+W,L@"-*\B+()/(C>@#S#_@M?X TN7PKI7B$VT?\
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M?PIXDTO1-7U2!+Q+_3;V)?(O_*349+G:S($$S2WD8:1H8G2&0H%B$:@'])U
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M#'7=/N;"W:TTS1[NYL(501K:S6-K(UL\ CV^5Y>T(%3:IB+0L#$[HP!\G_\
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M@']-U 'X _\ !#'_ )F[_N#_ /M_0!^_U !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MXTZ<7BPO*JV:0Q:?J,3 Q,&E6)9&9(?,D2*>!U*RNH4 _H^H _"'_@JMHO\
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MYCV1DL ?O]X3\4V?CG3K35=/D\ZROK>&YMI=K)OAF021OM<*Z[E8':P5AG!
M.10!^0/_  6BU_\ M#P]X=\,6UO<7&I:GK'GVL<,?F;_ +-"T!B"J3(TKO>P
MB)$1M^'&0P4. ?J]\)_ O_"K_#VE:#YWVC^S-/M++S]GE^;]FA2'S-FY]F[9
MNV[FVYQN.,D ] H _ '_ (+G?\RC_P!QC_VPH _7[]D[_DGGA3_L7])_](H:
M /<-3TFWUI!%=11S1K)%*$D17420R++$X# @/'(B21MU1U5U(900 >/^"OCS
MI?Q(\2ZKX=T>2.Z;0HXAJDZR';#=7#.(K6,!"LKJL,YNFWH+=Q%"!+*UPMJ
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MM<77F+)K-Y<:D(I(6B:*-Q';Q8W$F1)8[=+B.3"ADF7:&4!W /C#_@J-\/\
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M@#\ ?^"&/_,W?]P?_P!OZ /?_P#@M7_R3S3?^Q@MO_2*^H ^P/A/XZ_X5?\
M!O2M>\G[1_9G@^TO?(W^7YOV;3$F\O?M?9NV;=VUMN<[3C! /SP_8&^%]O\
MMQW^J?%/X@^7K%Y'>2:;9:9-"K:?:QI#'+\D$A=715N=D,;@A'\VYD,]U*)H
M@#C_ -OK_DX7P%_W /\ T\W% '[_ % 'X _\$,?^9N_[@_\ [?T ?O\ 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MZ]XKC@\'QR-</8Z3<3BZDD\Q)/(CNWMH+BSMY'4O/]EF4N#*BHKW,DZ@''^
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M?\3^*+<^$X[A)FT6RC^TK=J6,DUM+<7=O%);VDCJGVBVB$D5W%+=1NL1F=Y
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MH[J&UMXY"]O:B.2[$,L48.'5XMD[&225&>60L ?0'_#/'Q>_Z*?_ .6MIO\
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MYX8UZWT74M*T=;33O,M!=>9<%K[S1-YF8X8BERD8D$=R_P TC")6B3S #/\
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M]X3\0?VU\,==CTR,R3/%'<3W5M<6*N@7RX+RW6:69&#S)EQ$Z0[(W>X9GDH
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M#UWK5GJ;6-G':Z9='2FMVA6)72+[5&E\RW*(ODHJQFU=DB.^5Y9#*H!\7_\
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M*\J(Q$D0\TL\$I5-H!^G] !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MK^L__(] !_PP+^T+_P!#[_Y7]9_^1Z #_A@7]H7_ *'W_P K^L__ "/0 ?\
M# O[0O\ T/O_ )7]9_\ D>@ _P"&!?VA?^A]_P#*_K/_ ,CT '_# O[0O_0^
M_P#E?UG_ .1Z #_A@7]H7_H??_*_K/\ \CT '_# O[0O_0^_^5_6?_D>@ _X
M8%_:%_Z'W_ROZS_\CT '_# O[0O_ $/O_E?UG_Y'H /^&!?VA?\ H??_ "OZ
MS_\ (] !_P ,"_M"_P#0^_\ E?UG_P"1Z #_ (8%_:%_Z'W_ ,K^L_\ R/0
M?\,"_M"_]#[_ .5_6?\ Y'H /^&!?VA?^A]_\K^L_P#R/0 ?\,"_M"_]#[_Y
M7]9_^1Z #_A@7]H7_H??_*_K/_R/0 ?\,"_M"_\ 0^_^5_6?_D>@ _X8%_:%
M_P"A]_\ *_K/_P CT '_  P+^T+_ -#[_P"5_6?_ )'H /\ A@7]H7_H??\
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M%@^%^G/J$]KJ%[MW".VTZQN+ZXE<(SJBQP(^S=L*B28Q0*[*KRIN!(!^(/\
MP23TO6O@%J.M:?XET#Q!8?VQ_9PM;F31KXVX>!YT*32+"?)S]I5A)(%@5(Y&
MDECPH< _?Z@ H * "@ H * /F#]KSXG^+?A%X7DU/P7HW]MZH+B",V^R27RH
M7)WS?9X66:XP0L?EQ,K)YOGL3%#(I /E_P $VOCG]N&STF/QQH/_  C.@6-Q
M!?7]O)*SS:W<6S$1VKV,R VVG^:C3W$-ZL[S*+40L?FN5 /T_H * "@ H *
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M+?\ 9]\/PZ-%<27UR9);F_U"95%Q?7EPYDGN9R,LSLQVJ9&ED6%(XVED*;R
M>X4 % !0 4 % !0 4 % !0 4 <_XLU&\TC3KNYT^U^W7L-O-);6GFK#]HF1"
MT</FN"D7F, GF,"J;MQ& : /R@^$W[0'QK_:2TZ]\/7WA7_A'KBZS!)XAD6[
MT]-/MYT*M+!9SM]INKM DODO;SHD<[VQE$48+R 'Z?\ PJ^&FG?!O0[#P]I2
M;++3[=((LJBL^T?-+)Y:HC2RMNEF<*OF2N[D98T >@4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M_M<^'M0U[4+6WL_)UBYM+:" NVVW2&WFC$KNQ\R4><5>15B1\ B).10!]OT
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H Y_Q9XIL_ VG7>JZA)Y-E8V\US<R[6?9#"ADD?:@9VVJI.U
M0S'& "<"@#\\/%O[2WQ2^(?AH^,/A_X:LTTE8VF@MM8,[ZMJ%OMB83VUE:ND
M4:9,QC5[F6:[B5)(8QYD23 &A^P?_P %![/]K_S]*O+/^S]?L[=9Y(HV:2WN
M(5\N.6>%BN8L2N ;>0NRH\96:?\ >F( _1^@ H * "@ H * "@ H * "@ H
M* "@ H S]6U--%MY;J42-'#&\CB**2:0JBEB$BB5Y9'P/ECC5G<X559B 0#\
ML/A]_P %'=1^*OQ2TWP);:!<:192_:?M9U:-XM2.W3VNXL6RL$MOF0YWM<^=
M"Z.ODDXH _5^@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M@?%CP]XKU&XTC3]5T^[U*T\S[39P7<,MQ#Y3B.3S84<R)L<A'W*-KD*<,0*
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M?^3A?'O_ ''_ /T\V] '[7:G\;_"NBZH-#NM;TN'5FDBB%A)?6Z71DF"F)!
MT@E+R!T,:[<N&7:#N&0#U"@#/U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*
MJ*H+,S$!0"20!0!Y_P""OC?X5^)5PUGH>MZ7J5RD9E>&SOK>XD6,,JERD4C,
M$#,JEB, LHSDC(!ZA0 4 % '\J7Q&\;W'_!2SXRV>BI>2+X>:\DM[!/,9%CT
M^V0RW4\(:#*7%U' \R>=$SJ[0V\KF*!2H!_4[I.DV^@6\5G9Q1P6T$:10PQ(
MJ1QQHH5$1% 5450%55 "@   "@#G_'_@#2_BGI=SHNM6T=YIUY&8YX) =K+D
M$$$$,KJP#QR(5>-U61&5U5@ ?*'["GP4U']G;2=<\,7<EQ-96/B"Z_LF29G<
M'3IK>UGA\MFCB0X:603^2BPB\%R%R=Q(!]OT >/_ /#0O@W^T?[(_P"$@T?^
MTOM'V7['_:-M]H^T;_+\CR?,\SS=_P GE[=^_P"7&[B@#V"@#G_%/BS3O UG
M)J&JW=O8V4.WS;FYF2&%-[!%WR2%47<S*JY(RS!1R0* ,_QK\0M&^&MNMYKF
MH6>FVSR"))KRXBMXVD*LP0/*RJ7*JS!0<D*QQ@' !H>%O%FG>.;./4-*N[>^
MLIMWE7-M,DT+[&*-LDC+(VUE96P3AE*GD$4 <?J?QO\ "NBZH-#NM;TN'5FD
MBB%A)?6Z71DF"F)! T@E+R!T,:[<N&7:#N&0#U"@#G]1\6:=I%Y:Z?<W=O#>
MWWF_9+:29$FN/)4/+Y,;$/+Y:D-)L#;%(9L#F@#S_P 4_M"^#? UY)I^J^(-
M'L;V';YMM<ZC;0S)O4.N^.2177<K*RY RK!AP0: /8* .?\ %/BS3O UG)J&
MJW=O8V4.WS;FYF2&%-[!%WR2%47<S*JY(RS!1R0* ./\%?&_PK\2KAK/0];T
MO4KE(S*\-G?6]Q(L895+E(I&8(&95+$8!91G)&0#U"@#G_\ A+-._M'^R/M=
MO_:7V?[5]C\Y/M'V??Y?G^3GS/*W_)YFW9O^7.[B@#C]3^-_A71=4&AW6MZ7
M#JS211"PDOK=+HR3!3$@@:02EY Z&-=N7#+M!W#(!ZA0 4 % !0 4 % !0 4
M <_XI\6:=X&LY-0U6[M[&RAV^;<W,R0PIO8(N^20JB[F957)&68*.2!0!S_@
M7XL>'OBAYW]@ZKI^I_9]GG_8KN&Y\KS-VSS/)=]F[8VW=C=M;&<' !Z!0 4
M% !0!Q_C7XA:-\-;=;S7-0L]-MGD$237EQ%;QM(59@@>5E4N55F"@Y(5CC .
M #/\"_%CP]\4/._L'5=/U/[/L\_[%=PW/E>9NV>9Y+OLW;&V[L;MK8S@X /0
M* /+_&OQO\*_#6X6SUS6]+TVY>,2I#>7UO;R-&690X2616*%E90P&"589R#@
M ] TG5K?7[>*\LY8Y[:>-)89HG5XY(W4,CHZDJR,I#*RDA@002#0 :MJUOH%
MO+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B H!)( H X_7_BQX>\*:=;ZOJ&
MJZ?::;=^7]FO)[N&*WF\U#)'Y4SN(WWH"Z;6.Y 6&5!- &AX*^(6C?$JW:\T
M/4+/4K9)#$\UG<17$:R!58H7B9E#A65BI.0&4XP1D ^8/V[?VHK?]ESP==WL
M5Q''K=Y&]OI$)9?,:X;"M.J-'*K);*_GOYB^2Q6.!G5IX]P!Z_\ LR:M<:_X
M%\-7EY+)/<SZ'IDLTTKL\DDCVD3.[NQ+,[,2S,Q)8DDDDT >X4 % 'Y0?\%D
MO%-YX?\ AK%;6TFR+4-8M+:Z7:K>9"L5Q=!,L"5Q+;PON0JWR;<[&96 /M_]
MD[_DGGA3_L7])_\ 2*&@#H/!_P  ?"_@#7-1\2Z7IEO;:OJV/MMT@.Z3!W-@
M$E(O,8"2?RE3[1*%EE\R10P -#QK\;_"OPUN%L]<UO2]-N7C$J0WE];V\C1E
MF4.$ED5BA964,!@E6&<@X /0-)U:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*L
MC*0RLI(8$$$@T :% 'G_ /PMCP]_8_\ PD/]JZ?_ &+_ -!'[7#]C_UGD_\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M UWJ/D>#M/N(KG4(8GF6^NDO!(!ID4P?9;:?*T$DMWY(2=R\D2OMNIG0 /\
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M$:M,36OAIJ]K*9%CFUR\C<Q2R0R!7L;)24EB9)8WP?EDC970X965@" #X/\
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M?%CPW'+J-U>1PVPU*$7$"L&E:Y6UBN'F5[>-1:Q6MP/,00IY4$[()@0#YO\
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MVR_;@\!F#Q/#9ZCJ-I(+75[6>"!HIF1A+;7+6Q,B[)%56W,D:&ZAN/*C1(E
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MQ@T_X2V,]Y:>'+*-;CQ"+=)4-W&UL;B2">:WF1Q92PRPV?)A N+ERZ3E+8
M^S_%/[!/PU\3Z')H(\/:?:Q/;K EW;6\4=]%L V2I>%&F:52JLSRM)YQR)A*
MCR*P!^8'["7Q=UC]DGXBWWP;\37GFZ6;B6+2Y)?+41W$F)[9D8SL(8KZ)MXM
M09G%Y+"BJDLER7 /+_\ @LU\-'\'ZIHVJ2:KJE^VJ2:FXMKR>-[6R6$686.R
MACBB6%"K@2$[WE,:/([R[W< _4_Q9_P3R\.?&C[7J'CR>XUS7[OSE748Y)[)
M+*%LB""PLTGEABBMP=Z"?[4TL[2S3-+YK( #\H/V#M!\6Z+XR\5?"71-:^QZ
M6EQ='4-05)%O(X=/N?L<LFF)YCPVMW=B2..29Q(T,:I*CM+;1*X![A_P43_X
M)V>"/A/X(N/%'A>WDTNYTN2 RQ">>YCNH[F>&WVM]HFD:-XVD$B/&<$>8CQN
M71X0#]'_ -AWQ_JGQO\ A7HNHZC<R1ZC/9W%JUY&0\^ZVFFLX[DFY$ZR7!6)
M99&E61'F+,8RA\N@#\4/^%8:YX&_:-_X1_PWK-Q-JB_NX=8UISJ%PBS:)OFF
MDPJ">6&)Y/LD;A8B\<$<A\K>: /T?^.G_!)CPAX\T.==#-Q;>)C^^&K7EY<W
M37EP 3(;X.[I_I#$O-+!&CQRD2*C(K6\@!Y!_P $<_VG=1\?6=_X*UF[^T-I
M5O#/I*NCM,MF&,4\1FY0Q0,ULL"/B15E9$+0Q(D !V'QF^!WB7X__'S2T\1:
M-)>>!])L_.@=]QL'7[.SEI<R&)KAKXQQ26X"O-;00F6"2V5I& /#_P#@K1\"
M_"7P4T[0_$WAF"WT+7UU!(88].\NS\R&-))S<K#"$/FV\HA N8MK)YRK(S?Z
M/Y8!^M_PY2_^.?PYTAKS4KRSOM7T/3Y;G4+$PP72R7%M%),\),+Q0NY9AN2,
M&(,6B,3JCH ?@A^R'\,-<U3XR>+?#>B:S<6:C^V+74-6F<RZHUC%J<*RO;S;
M0@U"=EC0W3KB(2S7"(9DB6@#Z0_X*)_\$[/!'PG\$7'BCPO;R:7<Z7) 98A/
M/<QW4=S/#;[6^T32-&\;2"1'C."/,1XW+H\(!]__ +(MZG[6'P?TE/%\,>HQ
MW]G-:7BRF1S.MI<RVR3/([M+]H80),TX<.+C,T9C8+M /QA^$/P,\/\ [,'Q
MU7PCXQTZ/4M)NY'M])DO4>:(B]_X\)WC-N(KIR<V4N8Q;PW3RRAQ]E#  _I-
M^*J:'_8=_+XF@M[C1;>W>YO8[FW%S#Y-L//9WA*2>9L\OS%4*S;E!4%@* /@
M#_@EI^S%IWP@\%V7B2:TV:_KMOY\]Q(Z2,MG)(7M8H2F1%%)$(;B1,^8TK 2
MG]U%'" ?I_0 4 % &?JVK6^@6\MY>2QP6T$;RS32NJ1QQHI9W=V(545069F(
M"@$D@"@#\(?V<?B[X5_;$\0:AXZ^*FI:'!;64C67A_P[J%_;K;VL;H&N)Y+6
MY"+<NZM$BW+9$DRS'R8Q;V:P 'E_[?UKX!^$4^C^._A/J^CV.OV^H>7/;Z-=
M02;E>W.R;[/#,\,,48@:&:-8!%=?:V$Q;)60 _0]_A-X:_X*<?#?3=>U6TCL
MM9O;,+'J45NJW%K=6LDT,BH?,=Y++SQ.5MI92'AD#YBN=LL8!\ ?\$NOB';_
M +./C'4?A]XOTRSTK6YY'2VOYXU2\-P_D#^SC.%97MYU1+BUQ(D,D@_=FX:Z
M@V@'U!X5_9,\'?MV^*IOB+-IT<'A)HYK6RMH/]%DUJY2XN!<ZK=?9Q%-"AE=
MXXD=A=W!A2:8PQ@02@'Z7>+-?\/?LQ>%[O4/L]OIVBZ3;S3_ &:UCAMT')?R
MH(\Q1>;-*VV-,IYL\@7.Y\T ?G!^Q7\"[/\ :WLS\5?B-!;ZUJNIW$ZZ;;2[
MI+&QL;=I;80)9./*_P!;Y[ 2_:1@0W 87;SR. >8?M7?L">+-*^(.D>*/A'9
M6>DQ^7")I;::*TCL[J-VC>>2W;"&WD@>-9(K:.83".X$MNS2_OP#[/\ ^"C/
M[5UY^RIX22YT<V_]M:E<?9+3S74M"OEN\MVD# ^=Y6$0!AY22SPM)O7]S* >
M'_"'X8_ SPSX:73O$NK^$]:UF]C>76-3N]4LKJZGO+E?]*>&\D=+B--Y;R&C
M,4B@"8G[2TDK@'Q!^S;\<[?]DWXRW/@WPYJ,>J>"-:U2&&&.V=;F".2^2/[*
M]O(;AQOMY)8[2YF\QS-#$[/$TT<*Q 'T!_P6>^&CVN@VGB-]5U259=4M;1-+
M>>,:;"HM;M_.CMTB5C<%E;,\LDC[9'C!$0C2, ]O_9Z_8KTSX_>#?#^J?$@_
MVRPT?3DTFRAGNK6STZQ%M&(PBPRQ/+=W"A);Z>4L#($@B588$+@'YP2P:C_P
M2J^+5MI]KJWF>&]3^R37?FH\F[2YKB2)C<Q1*,W=KLF:*6 $M@,$"7$UI0!]
M(?\ !7_]G+PQX)T&/Q?96DBZ[J6N0Q7=Y)=W4[21O:W3E DTTD2(##$(UC11
M$B+&@6,;: /L_P#8I_8S\">#]%\+^-+'2_*U]]'L[EKO[7=MF:[L56=_*>=H
M?G$L@VA-J[OE"X7 !^C] !0!^ /_  5L_9<\(?"_P\GBO2-/^SZUJ?B ?;+G
M[3<R>;]IAO+B;]U)*\2;I45_D1=N-JX4D$ ^O_V3OV"OAQ_PCWA3Q7_8W_$Z
M_L_2=2^T_;;W_C\\F&X\WROM'E?ZWY]FSR_X=FWB@ _X*@_M*:Y\%M#TW0/"
MWVA==\27$MM!-;QEYDAC$:RI;%&\Q;N1YX(X&1'8*TI0QSB%P ?0'PT_8;\#
M>!].2#4-'T_6=2DVRZAJ>HVJWEQ>7C(HN+EGO&N9(_.=3*8ED,:.[$#<S,P!
M^0'Q9TB\_P""4'Q*LM4\/2W!\':]AKFR8K-F&*4"ZM45IE>26V65);*XE,3#
MSA \LRBZ,P!]O_\ !4[P5%X\^'%WXIM-;U V5M;V+6]E:740TN\6ZO;8">=4
MC+W/RNCP$S&*,HDD:J6D,@!XA^Q!^P_X?_:/^&&F7OB^>\U!7CU"'284F>WC
MTB,WERLKVZ1-LFN)9MT\DURLH8+;P>5Y4'[P _4[]FO]FO0_V5M#_L#0/M#6
M[7$ES--<R"2:6:0*I=RJI&,(D<:K&B+M0$@R%W8 ^@* /D#]OCXEZC\(OAGK
M^KZ4_E7J6\4$4H9U:+[7<16C2QM&R.DL:S,\+AODE5&(8 J0#Y?_ &'OA!\)
M?CS\.M.@AT71[J]33U@U998K>34HKA_,BFEEF5GNH/.D2:6T?S(W6'RS$(@B
MI& >P?L._LT?\*$T7Q1X1U"'[3IK>(+S[-]H3S$N].N;&R\OS-\4<<V4)@N=
MJ>29TGB&54T ?FAX#\ :7\,/VK4TO1K:.SL8Y)Y([>($1QM<:$]Q($7)"(9)
M'*QKA(P0B*J*J@ _>[XE_"K0_C)ISZ5XAL+?4+)]Q\J= VQF1H_,B;[\4H5W
M"31%)8]Q*.IYH _$'_@AC_S-W_<'_P#;^@#Z?_;5^*MY\8/&FA_!?0[_ .R)
MJ^Z7Q'/"ZK,MB(VG:SCE7S6BEEMXII'CDA D62T5G-M-.K 'N'Q"_P"">_@/
M4?!VH>'=#T#2[:[DL[A+"[EC8W$5TVZ2"1[XB2\*+,5+ O(#"##L:']T0#R_
M_@E]\#OB!\!-#U+2_&@^SV7VB(Z58M<0W#09$C73JT+2(D4K/&5C$AQ*D\GE
M1F4O, ? 'Q2T[7-7_:EN+;PW=6]CJDWEQPW=Q$9DMU?0$6:98@0)98XC(\$;
MD1/.L:R'RB] 'UA^UO\ \$S?!%CX*U?6=.%Y#KNG6=QJ4NJ3W<]W/?26T+S3
M_:UFD\HO<D,SR1+$4F*R &,/!( >G_\ !(SXEZC\1/AJL&H/YO\ 9&H3Z=;2
M%G9S;I%!/&KL[-GR_M!AC"[$2".*,*-A+ 'Z?T % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M1HXH_,8$ _?[]K'_ ))YXK_[%_5O_2*:@#X _P""*G_)/-2_[&"Y_P#2*QH
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M#/!&Z?:[<;89I)4 ,22I*8V<HT:2?: ([>-87) /F#_F[S_/_0N4 ?O]0!^
M/_!#'_F;O^X/_P"W] ''_%OQK;_!#]J:+7-<62VTZ:2T5+B0+''Y=UI*Z>+C
MS)6C3[/',S">4,0@AF^\\92@#^BZ@#R^3XO:6GBJ/P<&D;5GTN3564(?+2U2
MXCME+2' +R2.P14W$"*0OY>8O, /Q1_YN\_S_P!"Y0!^OW[6/_)//%?_ &+^
MK?\ I%-0!\ ?\$5/^2>:E_V,%S_Z16- 'Z_T % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MV\ND>#/!GB2PU:XC=$U#7;6+2[.Q613&+PO*;D7+P2/')]D2-GFC60@'858
M[#]C+]E&+]C#PE-:*/[3UJYS=W[VZ1(T\RQXCM+9YC#F*/!6 W,B*9999C]G
M69HXP#X _P"%+_$[_A=__"T?^$.N/[-^T;?LG]JZ5]H^S_8/[.\W_C[\OS=G
M[_R=VS?^X\_;^_H _<[2;U]1MXIY89+:22-'>"4QF2)F4$QN8GDB+J3M8QO(
MA(.UV7#$ _#']J;X+_$[XS?$[1?'.E>#KA;+0O[-\J"YU72HYKG['=/>-O\
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M-S2-$N#-A5$IY8Q( ?M]X6UF?Q!9QW-S97&GRONW6MRUNTT>UBHWFUFN(3N
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M('@W1[C7M%U>X=KB&%?M,TBWS_:;NUDCAB-Q;[9HC)!<)&\4:_9DDEF9I8'
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M'[+GAJQT3QOX/\2:I8O&\FF76GQQW]U;VX6#RK*XM$(EMT0-(R&ZE29!BU2
M) 1$ =_H_P #M4_:^^*6E_$C6-&O-"\/:'9VZ6-KJ>(M0O;JWGN)8Y'MHI-]
MHD,\GF8F9A.D4)"217,@@ -#_@IQ\+O&W[2.DVGACPQX<N+J*UU".]EU&2]T
M^"%]EO)&L<,4ET)FR;AQ(TJ0;&A 19DD#J ?8'[(AU[2/"6EZ)XBT2XT>]TC
M3[.R8R7-G<PW'D1^2)(7M9Y7&5B1Y%F2+8THC1I@C24 ?GA_P4#_ &/O&,7B
MRW^*/PW\PZM!&C7L-NW^E"2VB95N8DE<I<(\"K:RV<:9D"JH@N?M$VP ]/\
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MKQ;K4<220QJAM]*LXV9X].M&^9@@9M]SL=HY9E1B9I(VN[@ ^SZ "@#\,?\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * ./\:_#W1OB5;K
M9ZYI]GJ5LD@E2&\MXKB-9 K*'"2JRAPK,H8#(#,,X)R >?Z3^S)X%T"XBO+/
MPUH<%S!(DL,T6F6B21R(P9'1UB#*ZL RLI!4@$$$4 >X4 % !0 4 % !0 4
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M- 'N&DZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515 554 *    * -"@ H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H \_P#B7\5=#^#>
MG/JOB&_M]/LDW#S9W"[V5&D\N)?ORRE4<I#$'EDVD(C'B@#S_P#9U_:4T/\
M:ATZ\U7P]]H-E9ZA-8>;/&(O.:)(I/-B7<S^4ZRH4\T12]0\2$8H \P\9?MY
M>#O OCRV^'EVUY_:UQ);0F9+?=:Q7%VH:W@D?>)2\@>'#1QR0J9DWR)MF\H
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* ,_5M6M] MY;R\EC@MH(WEFFE=4CCC12SN[L0JHJ@LS,0% )) % 'P!\6/^
M"F'@[X5(EY]AUS4])DD>&/5['3\Z;)<))-&\$-W<RV\5PX,$C;K<RPNH)21M
MKA0#Z_\ A#\:/#_QZTM=9\-7T=_8M(\1D0.C))&?F22.14EC?!5@LBJ61DD
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * /E#]M3X>Z-XQ\"^(+S4]/
ML[RYL-#U:6RFN+>*:2VD^R.V^!Y%9HGW1HVZ,J<HASE1@ ^+_P#@BI_R3S4O
M^Q@N?_2*QH ^_P#7_P!ECP7XI\46_C2\TBWEU^V\LQW9,@^:(%8I'B#B&66,
M$".:1'ECV1;77R8M@!] 4 % !0 4 % &?JVDV^OV\MG>11SVT\;Q30RHKQR1
MNI5T=&!5D92596!# D$$&@#^?'PMX3T[P-^UC'I^E6EO8V4.[RK:VA2&%-_A
MXNVR.,*B[F9F; &68L>230!_0]0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M&2YDW63;YWC56E?=([;I"QR[G.6.0#^BZ@ H * "@ H * "@ H * "@ H *
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MF&2[!D/S2@++(D1<PQ2R $231HDLF^7<[>=+O /H"@ H * "@ H * ./\?\
M@#2_BGI=SHNM6T=YIUY&8YX) =K+D$$$$,KJP#QR(5>-U61&5U5@ <_\(?@O
MX?\ @+I:Z-X:L8["Q61Y3&A=V>20_,\DDC/+(^ JAI&8JBI&"$1%4 ]0H S]
M6TFWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP*LC*2K*P(8$@@@T ?SX^%O">G>!
MOVL8]/TJTM[&RAW>5;6T*0PIO\/%VV1QA47<S,S8 RS%CR2: /Z'J "@ H *
M "@ H \?^/WQCL_V?_"^I^)[Y=\6GVYD6+++YTS$1P0[D20IYLKQQ>8498]^
M]AL5B #0^"'C6X^)7A71-<O%C2YU+2[&\F2(,(UDN+>.5P@9F8(&8A0S,0,9
M8GD@'J% !0!\H?!']IA/C9XQ\7>'[../[#X9DL+59QYGF374GVH7FX.J!4BD
MA$"*JL&,<DPE=)8UC /J^@ H * "@ H * /E#X(_M,)\;/&/B[P_9QQ_8?#,
MEA:K./,\R:ZD^U"\W!U0*D4D(@155@QCDF$KI+&L8!\__P#!5/X>Z-J/PUUK
M7)]/LY-6MH]/B@OWMXFNHHSJ-N"D<Y4RHA$D@*JP!$C\?,V0#L/^"7'_ "2'
MP]_W$?\ TY7= 'W_ $ % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MYXQ^$=QH^AZ_J<FMZ)#)J4^A:E=2>9J!CG:V-Q:WCEMTCV[+$4E*X=)OE=5
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M7D\,>(=<O-9\.)X;NKG1IIXU1F5;RQA*7<L<4:W5[ H"O,[2N4F6?]R;N2(
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M0W[07Q2\-?%SPIX7UR_L[#3KS5-)N4LM%EG\M[:;49+<1W=S+%!/.[(&CGC
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MQ3KGC3X>Z;?^)I+B76I;C5!>FY4I,LR:G=HT;QD+Y7E[?+6$*BPJ@B5$5 H
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M, _1_P#:%^*/CZW^'B>)O"]II^EWHT>74M3CU1IVN+!5LC.\%O"+<)+=QL6
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MOB^\\O\ MK59%V6=I]E9(_\ 3Y8%66Y^SQ,\3_O5^S2/%;Q^?<,]HH!^6/\
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MU9JUQK_[,T5Y>2R3W,^A^&I9II79Y))'GT]G=W8EF=F)9F8DL2222: /</\
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M]OK_ ).%\!?]P#_T\W% 'Z_?M8_\D\\5_P#8OZM_Z134 ? '_!%3_DGFI?\
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M3VK6^M?#GQ9+:RQS1KH>MQ%XW5U$D-M<12H2I(#QR(\<B]4=61@&4@ 'P?\
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MX5^)5PMYKGB+Q9J5RD8B2:\U*WN)%C#,P0/+9LP0,S,%!P"S'&2<@'ZGT %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MKC3&O/LZ3SE&E^RS68G= \4*R/)%.L^8YX/,4_NF57AE,T0!H?\ !6?XS/\
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M'\5=#O/#-AX9AO[>76HM8AN9K*-P\T,*6<X+S*N?)S]IA,:R[&E5RT8=4<J
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MW\+^*+B32[G2Y)Q%*8)[F.ZCN9YKC<OV>&1HWC:0QND@P1Y;I(Y=TA /F_\
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M+V< #PJV/.Q]FF,BQ;VB5 T@170L ?/_ /P6F^*NA^-]1\/Z5I=_;WE[I?\
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MGL +R339LR+!*AA65KV$>7)]C#[8))+V")KJ5HFE /7_ -CO_@HSX5^,7AJ
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MM6M--\Q6>&V:"6X5KB[59(524,K()$:&2%IIK8 _8Z@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M*D-Y;Q7$:R!64.$E5E#A690P&0&89P3D S_ OPG\/?"_SO[!TK3],^T;//\
ML5I#;>;Y>[9YGDHF_;O;;NSMW-C&3D ] H \O\2?!#PKXQM[2SU/1-+O+:PC
M\JRAN+&WFCMH]J+L@22-EB3;&B[8PHPB#&%& #L/"WA/3O UG'I^E6EO8V4.
M[RK:VA2&%-[%VV1QA47<S,S8 RS%CR2: .@H \O\%?!#PK\-;AKS0]$TO3;E
MXS$\UG8V]O(T996*%XHU8H656*DX)53C(& #L-.\)Z=I%Y=:A;6EO#>WWE?:
M[F.%$FN/)4I%YTB@/+Y:DK'O+;%)5<#B@#H* "@ H \O\:_!#PK\2KA;S7-$
MTO4KE(Q$DUY8V]Q(L89F"!Y8V8(&9F"@X!9CC).0#T#2=)M] MXK.SBC@MH(
MTBAAB14CCC10J(B* JHJ@*JJ %    % 'Q!^VM;:-J.EZA9:=I-GK'CJ_P!+
MDT_3H(XHGU**VU$R63W)F$;RVME$)YVDGF,-H6W0-/&\PR ?5_PG\"_\*O\
M#VE:#YWVC^S-/M++S]GE^;]FA2'S-FY]F[9NV[FVYQN.,D ] H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M=JKDDDDDLSLQ+R2.6>1V:1V9V9B =A0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 9^IZ3;ZT@BNHHYHUDBE"2(KJ)(9%EB<!@0
M'CD1)(VZHZJZD,H( -"@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H Y_Q3HT_B"SDMK:]N-/E?;MNK9;=IH]K!CL%U#<0
MG< 4;?$_RL2NU]K* ?@#^W]^U%\3OV2?%L6B:5XKN+JRN=/@O8C<Z;I1FCWR
M30M&[QV:))\T#.K!(\*XC*L4,C@'Z/\ _#/'Q>_Z*?\ ^6MIO_QR@#R_XQ?"
M3X[^!=&N-3T/Q['J]S:QR3/9-X>LK>26.*)Y"EOY4-VTMPS*L<4)1 Y?_6J0
M P!]W_L]>*;SQSX-\/ZKJ$GG7M]H^G7-S+M5-\TUM')(^U J+N9B=JA5&<
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M:AJMW<7U[-_8OFW-S,\TS[%OD7?)(6=MJJJKDG"J%'  H _=Z@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H _+#XH_L,>*O''QET_X
MAVNNQPZ3:R64AA+W NH([9-LME B_NC;W)#^:?,B %W<;H)<'SP#]'_'^E:I
MKNEW-KHM['INHRQE(+V2V%VL#$@&00&2)9'"Y\L.VP/M9TE0-$X!^&/_  3X
MUO7-4^.OBJV\0ZK<:Q>Z?I^K6/VN?*[EM]6MEQ%%N9+>(L7=+>(B*+>508H
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MK;Q#JMQK%[I^GZM8_:Y\KN6WU:V7$46YDMXBQ=TMXB(HMY5!B@#]_J "@ H
M* "@ H * "@ H _G1_X+$S>,?"%Q817OB*2YT369+XPZ1;VWV.WMX[5K-D6=
MEFD:^<LR2;Y\".97>&.)9/+0 _HNH * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M<3:1H&AZIXJUVWCBDN++3())8[-9F!B%]/%',;=Y8Q))!&(Y7<1@LL<<D<K
M'G_[$O\ P4,TO]L6XO-,.GR:5JUI']H6V,QN8Y;4,D;2K.(H0KI)(JO$ZJ</
M&Z-)^]$(!]'_ +0O[3OA?]E_3DU#Q+=^3YWFBUMHT,MQ=/$A<I#&O_ 5,DAC
M@C>2-9)8_,4D ^4/ O\ P4KTOQ_X5O/$-GI%Y+?-JEYIVB:) QN=0U1K:WAN
M?,$4,;&%%CF#W143I;(O$D[O%'( >7_#3_@K39ZAXH3PSXU\/W'A-GVHT]W<
MLWD32!7A%U%+:VSP12*P/GME4W1LZK"SS1@'Z_T ?@#_ ,$,?^9N_P"X/_[?
MT ?O=JVK6^@6\MY>2QP6T$;RS32NJ1QQHI9W=V(545069F("@$D@"@#X0_X;
M4UCXF_O_ (;>$-0\3::GW]3N+B/1K.7/ ^Q/?)YEUL=)HKC$<?D21@?.LB-0
M!G_"'_@HIHWC'Q*O@CQ/IMYX9\4>8\+VMV\4EJ;C=^Y@ANU*F1YXRLD#-%'#
M,6"122EX#, >H?M2_MF:3^R/]EEUW2M8N+*\RL=[90V\MN)AN)@D:2YB=)=J
M^8H90LB;C&SF*81@'0?LU_M1VO[4-G_:FE:-K%GI9\P17U_':10S/$RJR1+'
M=RS/RS#S!'Y&Z*6,RB5"E &?^U!^USIO[)EO!?ZYIFJ3Z=/(D*7EFMF\8N'6
M5Q 4EO(9]^R%G+"(PX*CS"Y*@ ]_\ >+'\=:7;:G)8WFFM=1B06=\D<=U$I)
MVB:..258W*X;RRV] P218Y0Z* ?*'CO]L:>XUR]\,> M!N/%FKZ5Y9U/RKNW
MLK&TW%U,+WL^Y&NU95!MU0\></,$EM/$@!Q_PA_X*!6_B/Q*O@SQIHEYX2\0
MSR.MG#=R++:W0#>7&(;K9"'>619D@*HUO,8PL5S)+*D1 /O_ %;5K?0+>6\O
M)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!0!^>#_MR^(_'MG/K?@+P/J'
MB#P]!]H4:C+?0:>URULSB1K.S=)KFYB(5?+94$KRE[?R%FB9* /8/V6OVS=#
M_:?^U6,,-QI>OZ;A=0T>] 2XA9=J2M'T,L4<I:%F*QRHX7S8(?-B#@'C_P#P
MH&#_ (:"_P"$I_LRX^S_ /"+_:/[0Q<?9_[4\_[!M\S/D^;]A^3R.FS]]Y?F
M?O* /J_X^_'W2_V==+AU/4X;RZ:ZO(+&SL[& W%U=75P3Y<,,>54N55V^9D#
M!"BEI61' /E#Q3^V_P"*O@M9R:QX]\!:AI.BQ[4-W8:G8ZJR32,%C$L2-!Y4
M3?,OGL^T2F*+:6F7 !]O_"?QU_PM#P]I6O>3]G_M/3[2]\C?YGE?:84F\O?M
M3?MW[=VU=V,[1G  /0* ,_5M6M] MY;R\EC@MH(WEFFE=4CCC12SN[L0JHJ@
MLS,0% )) % 'YX?#[_@IAX7^,GCO3?!?ABWN+Z*]^T^;JD@-M"GDVC72^3#(
MGG2Y*/%)YJVWELH9/.0@T ?H_0!\8>/_ -LBW@U2Y\-^"]*O/%GB&SD,5W;V
M96"QLI  Q2]U*8?9X'9%F$:KYI-Q ]LXBEXH \/U_P#X*/S_  1U&WT_XF^%
M-0\-?;?+-G<P75OJMNR;RD[RR0>5M\G,;/'"+B?8X8Q+NB$H!^E^DZM;Z_;Q
M7EG+'/;3QI+#-$ZO')&ZAD='4E61E(964D,"""0: /YH?^"4'[0_A_\ 9]M_
M$TNLS2&YOI-)AT^PMHGN+R^N M^1!;01@LSLQ2,,VR%9)8D>1#(F0#[@TG_@
MKDGA768M+\>^$M4\,1SQHZ2RM)+(JO*(Q*]O+:VLOV< 2EI(O.?,91(9&)V@
M'Z_:3JUOK]O%>6<L<]M/&DL,T3J\<D;J&1T=259&4AE920P(()!H T* "@#\
MP/'_ /P5<\#>'O$-AX>TA_[3^T:A;VMYJ/FK;:=9Q23-#--]HD4^=Y6%ERBB
MUDA;>MX,$4 <?\0_^"K">$M9TRTL?"&N7>DZK)&EE?RQ26DE^K2JOF:9:R0,
M;Q&CDAD@!D@>0S)&Z0Y#, ?H?\=/CIH?[.FAS^(/$$_DVD/RHBX::XF8$I!
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MW[6VDWNMZ5:W%K96VH-91"Y*":39;V\S2.D;.D?S3LBJ'DRJ"0LI<QH ?3]
M!0 4 % 'SA\;_P!J;P_\"KBWTRZ6\U'6[R-I;/1M,MGO-0N(T;#ND*85451)
M)NF>,.D,WEEVB90 ?+_C7]N/QG\$[==7\;?#Z\TS0ED$=Q>V>L66I20LZL(B
M8(EC 1I D9DDDB12ZC<TC1Q2 'V?\"_CIH?[1>AP>(/#\_G6DWRNC86:WF4
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M'T?X_P#'^E_"S2[G6M:N8[/3K.,R3SR$[57(   !9G9B$CC0,\CLL:*SLJD
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M: /T?\ >/]+^*>EVVM:+<QWFG7D8D@GC)VLN2""" RNK I)&X5XW5HW575E
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MHQ !^C_]LS_V=]M^Q7'VC[/YWV'=;_:-^S=]GW>=]F\W/[O/G^1OY\[R_GH
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MP^UO39;>2YN8;.:\L$AC62X^V6J-+ ( 4D;?(R^0PC D>&:2)64R9H ^$/\
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M\J+8 >/_ /!<K2;>&X\*7BQ1BYECU2*28(HD>.)K-HT9\;F1&EE9%)(4R2$
M%VR ?M]\;_!5Q\2O"NMZ'9M&ESJ6EWUG"\I81K)<6\D2%RJLP0,P+%58@9PI
M/! /P!_8-_X*-6_[+]@O@3QK97D-M9WEPD=TJ+YEB9)D\RWN+3RXYMD<K7,T
MLFZ:X4MY"V[!5"@'[?\ P5\-^'_$>J:C\0?#EW'=6GBFSTS>\>\J\FGBYB\T
MEW)1S')';R6_EQ&%[9MZF9Y H!^2'[?7_)PO@+_N ?\ IYN* /W^H _GQ_81
MTFWU']HGQM+/%'));2>()8'=%9HI#JL41>,D$HYCDDC++@E)'3.UF! /V>_:
M*^ VE_M)>&KWP[JD<96>-C;3O&7:TN@K"&ZC >-M\;-DJ'02H7A<F*1U(!^4
M/_!#[QK<7^C>)-#98Q;6=Y9WD;@-YADO8I(I QW;2@6SB* *""TF68%0H!Q_
M[?7_ "<+X"_[@'_IYN* /W^H _ ']@7_ ).%\>_]Q_\ ]/-O0!^OW[6/_)//
M%?\ V+^K?^D4U 'P!_P14_Y)YJ7_ &,%S_Z16- !_P %J_\ DGFF_P#8P6W_
M *17U 'W_P#LG?\ )//"G_8OZ3_Z10T ?D#^WU_R<+X"_P"X!_Z>;B@#]OOB
MQXZ_X5?X>U77O)^T?V9I]W>^1O\ +\W[-"\WE[]K[-VS;NVMMSG:<8(!^"/_
M  3,^(7C?PUHVM:QH'@^3Q/<ZGJA_M#5I=?@M)'DBB258GBN@[.ZM<R3-<#F
M4W!5F8QC ![!^VUX#^*W[9&C6>F-\/(]-N;*\^T1WIUW3+J01F)XY(%YA9$D
M8Q2/A\,8(\H2%*@'M_BGX%^-/$O[.DGA/5X,>)+33U7[*/+E8PZ;?":W@C^Q
MB5996M+>**$)N:24H)&#L[@ ^8/V'O\ @JSH?@O0].\*>-8[BV_L^W6V@U:-
M!/"T,0D\I)H((UEB\N)8+:-HUNFF;,DIC^9R ?L=\$?AEI?@ :M?Z-/'/8^(
MM4?6XS$QDCW7EM;+(R2^9()4FDB>Y5U*H!.(T0(BD@'N% !0 4 % 'X0_P#!
M..^B_:;^*OC+XD7+>9Y&V*PBN+:(310WCO';.&C8K%+#:68M7*;VE6:3=,?G
M,H!^YVK:3;Z_;RV=Y%'/;3QO%-#*BO')&ZE71T8%61E)5E8$,"000: /YT?^
M"?\ J]Y^S%\;=9^'D45Q_9NH7%]:*MR%28+8+/=6%VY\D,^^W#A1'Y,4JW0G
M&Y4C6@#L/^"B&DV^O_'WP19WD4<]M/'H44T,J*\<D;ZQ<JZ.C JR,I*LK A@
M2""#0!_0=0 4 % 'P!_P4T^"G_"Z?AKJ6R3R[C1LZQ#EMJ/]CBE\Y'Q&['-N
M\_EJNS,XBW2+'OR 9_\ P2X^+S_%KX9:>D[2/<Z/))I4KND:*5MPCVXC\O[R
M);2V\19PKLZ.6W']XX!^8'[:_P 1G^%'Q@_X65X7LY)+31+RPTW5[SS(S;W>
MI&VF^T6<4C&<*_V!1:7!CC#6DR,SQI,T3R@'[7_'O]I2S^%_PZO/'NF_Z7;_
M -GPW.GDQMME:]\M+-Y(W:&01%YHFF7*2K%OP/, 4@'7_LW?"JX^"OA/3=#O
M;J2]OH8Y);ZZDE:9IKRZE>ZNW$KI&[H9YI3&TBB0IMWEGW,0#\0?V,? &E^.
MOVB?%\FIVT=TVFWFNWUF) 2L5U'JL<<<P7.UG197,>X,$?;*H$L:.H!^C_\
MP53TFWU'X2:U+/%'));2:?+ [HK-%(;ZWB+QD@E',<DD99<$I(Z9VLP(!H?\
M$N/^20^'O^XC_P"G*[H ^ /^;O/\_P#0N4 ?J_\ MH?&.\^ 7P_UOQ%IZYO;
M:W2.V;*CRYKJ:.UCFPZ2(_DM,)O+92LFSRR5#%@ ?/\ _P $G_"UGX?^%&EW
M-M'LEU"XO[FZ;<S>9,MU+:A\,2%Q%;PIM0*OR;L;V9F /4/VCOV#?!W[4NLZ
M?KGB!;S[38QK"R6]QY<=S;I*95@G!1F"!FE&ZW:"8B5\R$K$8P#C_P#@J/\
M\DA\0_\ <._].5I0!Q__  2;\ :7X9^&&G:I9VT<5]JLEW)?7 !,D[07EQ;P
MAF))"1QH D:X12TCA=\LC. ?$'[=VDV^G?M$^"98(HXY+F3P_+.Z(JM+(-5E
MB#R$ %W$<<<89LD)&B9VJH !_0=0 4 % '\Z/[&/@#2_'7[1/B^34[:.Z;3;
MS7;ZS$@)6*ZCU6...8+G:SHLKF/<&"/ME4"6-'4 _1__ (*IZ3;ZC\)-:EGB
MCDDMI-/E@=T5FBD-];Q%XR02CF.22,LN"4D=,[68$ T/^"7'_)(?#W_<1_\
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M^2GV?[/L\OR/)QY?E;/D\O;LV?+C;Q0!^$/_  0Q_P"9N_[@_P#[?T ?O]0
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MTHW6[03$2OF0E8C& <?_ ,%1_P#DD/B'_N'?^G*TH /^"7'_ "2'P]_W$?\
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MXWL[.*."V@CUV*&&)%2..--8ME1$10%5%4!550 H    H _H.H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M9_#*V75UD\NQO+BST^:02[IK.,1LA#R,PD2*1Y;6,Q[8XTMU@"AHFR ?I?0
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M &;=1U3P7XQF_LNRN+@20M=(T?V;4E=+6:&<"$O%YBA#))</'#:_9#N"F5V
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MYU"__L_PGJ']G7.JR1NL#,L]_) [S32;HQ% D/G1JZ^4LN9I1(8X?* /T?\
MVA?"VA_!+X2^(-*T^.WTW2[7P_J-M;1;@B!IK>2.--SG+RS2R ;F+2SSR9)>
M60E@#XP_X(SZM;Z+\.=0ENI8X8V\221!Y'5%,DUMI\42 L0"\DCI'&O5W944
M%F (!\__ /!1#5K?0/C[X(O+R6."V@CT*6::5U2..--8N6=W=B%5%4%F9B H
M!)( H _?[5M6M] MY;R\EC@MH(WEFFE=4CCC12SN[L0JHJ@LS,0% )) % '\
M^/\ P39\4V?CGXZ^,M5T^3SK*^M]:N;:7:R;X9M6M9(WVN%==RL#M8*PS@@'
M(H ^G_\ @M7_ ,D\TW_L8+;_ -(KZ@#[P_9AU:WT7X<^$Y;J6.&-M#T2(/(Z
MHIDFMK>*) 6(!>21TCC7J[LJ*"S $ _)#_F[S_/_ $+E 'Z_?M8_\D\\5_\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MN]3^&OB^\\-VU]'MN+*:QAU2/(E>1 GGR1KLC5A'"94EN$'FYN6$SB@#Z \
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M;[4-2U#3_P"P_M4ELVG.D-Q]HG>U>.99W23R_*^SD@*F\NZN)$\LK( >/_\
M#&7COQ3IW_"/^)?B-J%_H$MO]FNK>WTJTM+R>$)M"-J#/<3'<0OGM()6N8_,
MCD)\UFH ^[_ '@#2_A9I=MHNBVT=GIUG&(X((P=JKDDDDDLSLQ+R2.6>1V:1
MV9V9B =A0 4 ?@C9:3<:C^US-+!%))';1B6=T1F6*,^'TB#R$ A$,DD<89L
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MT-E!=6-M:Z;!',%W/_9\0>*2XR&#32,P93%F+?;PR( ?=] !0 4 ?G!\2/\
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M6[L86@\@[HO($%A&D&QLR#R53]ZS2_ZQV8@'V_\ \(;??V/_ &9_;.H?:_\
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MNL>'/M]Q>:OK^GS6NJ:_>;KB\NII;9K9)9-\A<Q0*VVWMO-VQQC;YC2/+-(
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M9>L_[+TK6=8O-+'F&*QOY+26&%Y65F>)H[2*9.58^6)/(W2RR&(RN7H ^?\
MXU_\$S] _:)U&/5?$^O>(+Z]AMUMHY=^F0XA1Y)%3;!IL2'#2N=Q!8[L$X
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M$1\ ]+CT:WU;5-3L;>..*TCU%[:5K:-"^$CDAMH)63#!0LS2B-(XXXA&B[2
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M&RDSWCW)CN \UHMBLAA4 ]PH * "@ H * "@ H * "@ H * "@ H * "@ H
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M)'>1@H5%+%41$"HH!ZA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
2% !0 4 % !0 4 % !0 4 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex19_002.jpg
<TEXT>
begin 644 ex19_002.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[@ .061O8F4 9       _]L 0P " @(%
M @4'!04'" <&!P@)"0@("0D+"@H*"@H+# L+"PL+"PP,# P,#@X,# P,# P/
M# P,# P,# \,# P,# P,_\  "P@,Y GV 0 1 /_$ !\   $% 0$! 0$!
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M"WE$UY*IE:U:#S+1HKL*'8Q+,\>?\=_VJ/$O[&KVFH>,[:SUGPY?2"W^WZ1
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MEO+@*8K6W!VAY'W. S.D,JQ2[/+_ -@K]J74?VN?#VH:]J%K;V?DZQ<VEM!
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M$E]:S-,TUY&I\R_CR@>XFMA$&<(D"(A\K/F2S?O=\"_B)XO\>_;/^$K\+_\
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MHL_A!HUOXJEM?+6ZU5KR!-+MYI-D@@B=IH1?2^42TPMYE6U,D&]G=FA7Q_\
M82_X*'ZC^T)KE]X0\86%OI>OP>:]NL2O;K)Y!"3VKP7,KS+=Q'?(54MNB2;<
MD/V<M+]H?M-_M%I^S9HSZH=)U35Y/+G=8K"UDDCB6"(R-+>7 4Q6MN#M#R/N
M<!F=(95BEV?!_P $/^"D&N?';P]?'1]&M[[QC<:A>Q:1HMM(0D%C##;R+>:G
M<32HB11M,8O,S;"]G"6\*1,9'B\PTG_@IWXU^"?C&+P]\6]"L]*M)(T,DME%
M,9(5EQY=TK?:;J*ZMP0Z2K 2ZD/M+30-;2?M=_PEFG?V=_:_VNW_ +-^S_:O
MMGG)]G^S[/,\_P [/E^5L^?S-VS9\V=O-?F!\)OVM?B=^U_]MU7X>Z7X?T_0
M+.X-HDNO374EQ<3+F0LJV)Q%B)[<O$P=5=R$N9_G$70?LJ?M_:C\1?%$OP]\
M=Z/_ &+XLA\T*(=[6]P\0DF= A,C0XMPLL4GFSP7*!Y$E0/!'+[A^V#^V*G[
M)]A]J&AZIJ\GEK(TD$$D>GP*TR0J+K4#&\4+N6;RHT69RZHKK$LT3M\W_"?]
MO?Q1\:O"%E)X8T*WU[QG/;W4U_;6TPM-.TQ!<W%O:/<RW,QS++Y:2)8B99YH
M5FF#P1B,OR'[,_\ P4<\2ZWX\D\ ?$G2K/2-1DD^SV[P!H%BNE5G6*;[1<3+
M*ERNP6LL#D2.T019DN5DB^K_ -LW]JS7/V2[.'6(/#?]LZ*V$N;N/4# UI,S
M;4$T7V2;$4F56.<.5\TF)UC9H?.Z#]D/]HW7/VH='C\17.A6^D:1<>>MK)_:
M9N[B9H9!$6\A;.)$BW+,FYY1+OB_U!C=9:S_ -K_ /:@UG]ERWL;ZST&/6[:
M_O(-/ABBOY8;QKR=9G2-+9;&=9$*Q *RR^8TCA!#@;V^G_ &JZIKNEVUUK5E
M'INHRQAY[*.Y%VL#$DB,SB.)9'"X\PHNP/N5'E0+*_85Q_C_ ,9)\/M+N=4D
MMKR\6VC+BVL;:2ZNIFR L<,,8+,[,0,G:B EY'CB5W7\D? '_!5?4?B!XRO_
M  ]!X:N%\NWN(-,TLA_[4N]4CN51([ASMM[")83)+>"57%F()G-Q+A8F]O\
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M8_\ ;"OW^K\ ?^;O/\_]"Y7W_P#\%1_^20^(?^X=_P"G*TH_X)<?\DA\/?\
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M^_\ ]D[_ ))YX4_[%_2?_2*&O@#_ (+5_P#)/--_[&"V_P#2*^K[_P#V3O\
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MN@_X+G?\RC_W&/\ VPK]_J**_(#_ (+5_P#)/--_[&"V_P#2*^K[_P#V3O\
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MQ_X(:Z3;S7'BN\:*,W,4>EQ1S%%,B1RM>-(BOC<J.T43.H(#&.,D$HN/H_\
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M3\+6?@;3K32M/C\FRL;>&VMHMS/LAA01QIN<L[;54#<Q9CC)).37X0_M]?\
M)PO@+_N ?^GFXKW_ /X+5_\ )/--_P"Q@MO_ $BOJ^__ -D[_DGGA3_L7])_
M](H:_(']OK_DX7P%_P!P#_T\W%?K]^UC_P D\\5_]B_JW_I%-7P!_P $5/\
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M^GS^5]DGM8[Z-WMYKC4-0$!BO%4G?:'[)"'1$#E'F&7W*%^__P#C(7_JG_\
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MB+*5?S/'_P#@N5JUO-<>%+-98S<Q1ZI+)"'4R)'*UFL;LF=RH[12JC$ ,8Y
M"2C8_?[2=6M]?MXKRSECGMIXTEAFB=7CDC=0R.CJ2K(RD,K*2&!!!(-:%%?D
M!_P6K_Y)YIO_ &,%M_Z17U?:'[+?C_2[+X<^#I#<QR+<Z7I5C"(29FDNEMDC
MDA58@[%XFBF-Q@8MD@GEF,<4$SI^6'[?7_)PO@+_ +@'_IYN*_?ZOP!_X(8_
M\S=_W!__ &_KS_\ X*:^%M<_9L^*&G?$W1([@17/V24W3L3;_;K5#"]FWDF.
M1(IK6&/?&[ W"/=*CLBR)%^M_P (?^"@7PY^+^EKJ::U9Z6QD>-[/5;FVLKJ
M-D/4QO,59&4JRR1-(A!V%A*DB(?!G]H>X_:%\:ZH/#TT<_@S1+/['+=B)MM[
MK$LRNQM;C#)-;VT$91BC1Y>Y$FVX@DMIE^SZ\?\ C]\'+/\ : \+ZGX8OFV1
M:A;F-9<,WDS*1)!-M1XR_E2I'+Y9=5DV;&.QF!_GQ_8M\6ZI_P $[/B;=>$O
M&QCL-.U:-(9[EV M2R%S8W\<QB+-;LQE@))A2(SN]SY;VKHG]+VDZM;Z_;Q7
MEG+'/;3QI+#-$ZO')&ZAD='4E61E(964D,"""0:\?^-_QOM_@[;V\45O)J6M
MZE(T&D:1 RBXOK@+N8!F^6&WB7]Y=74G[FVA^=LL8XY-!_A[>>._"4^@>)[G
MS+O4]/N+;4IK3:JHUY&ZSI:%HAB*+S&CM6F1Y?*2,SF:7S'?\,?^"8?BU/V4
M?B#XA^'GB@QVE]?R06\$[M)''+=6;RB&*(21(62[CN3-;2R&(2!8D17>YC6O
MZ#O%GBFS\#:==ZKJ$GDV5C;S7-S+M9]D,*&21]J!G;:JD[5#,<8 )P*_''_@
MDMX O?&M[XF^*6L6T<-SKUY-':,@GC7;).US?F*-R4:W:8P1QR;YG5[::(LI
M5_,\O_YN\_S_ -"Y7Z_?M8_\D\\5_P#8OZM_Z135\ ?\$5/^2>:E_P!C!<_^
MD5C7@'_!<[_F4?\ N,?^V%?O]7\\/_!#KQ39VFH^)]*>3%[<V^GW,,6UCNAM
M7N(YGW ;!M:Y@&UB&;?E0P5ROZ?_ /!17XQV?P;^&NLR7*^9+JMO+I-K%EEW
MS7T4D9.Y4<+Y47G7&'VK)Y7E;U>131_P3N^!<OP"^'6F6-Y!]GU*]WZA?H?-
M#":YP8UD28*T4L=NMO#-$JJJRQ/]YBTC_EA_P2:\?Z7\4_'FNZUXNN8[SQE>
M1Q2:9/=$^:R[9A?"V&!"KK$($6.,*\=JLD<*K;+.HS_^"TWQ5T/QOJ/A_2M+
MO[>\O=+_ +4%]% XD^SM*]M&L<K+E%E#6\H>$GS8]H+HH="W]!VE>/\ 2]=U
M2]T6UN8Y=1TV.VDO8$)+0+=B0P"0@;5=UB=Q'G>$V2,H26)G_#'_ ((8_P#,
MW?\ <'_]OZ]__P""U?\ R3S3?^Q@MO\ TBOJ^_\ ]D[_ ))YX4_[%_2?_2*&
MOS1_X+"_ JXFL--^)&CO)!J.B20V]U-%(T<B6[S;K2='\U=CP7+[5\E#,QNA
M(75+<8]O_P""?VOZC^TQ>:C\6-?M_L][=6\&B:= L;I#%9VBQS7DD#DCSHKF
M]:1AY@EDMF@:W%S( X'Z?T45^&/_  6Y\?ZIH6E^'M%M;F2+3M2DOY+V!" L
M[6AM# )"!N9$:5W$>=A?9(REXHF3]+_!OQ5^'7P;\#:?JNEW^GZ?X12WQ8RA
M]J.%621HT5OWTMV2DIDA(>\DG64.C3[Q7XX?\$</'^E_"S2_'&M:U<QV>G6<
M>D23SR$[57-^   "S.S$)'&@9Y'98T5G95/['_&']I2S^"WBWPQH&I?+:>)/
MMUM%,L;.R7T<EDMHC%6^6*3SY8V;8Y$K0$F.(2N/F_\ X*,_L=^&OC%X5U;Q
M*8([+7=*L[G4%OX(E$ERMK;[FM[K&TS(T<*QQ.Y+VY5&0^7YL,V?_P $AO[8
M_P"%7V_]I_\ 'I_:%[_9?^K_ .//>N_[GS?\??VS_7?O/3]UY5?I_17\^.IZ
MM;Z+^UR);J6.&-I(H@\CJBF2;P^L42 L0"\DCI'&O5W944%F /[O>/\ Q_I?
MPLTNYUK6KF.STZSC,D\\A.U5R    69V8A(XT#/([+&BL[*I_*'_ ()<?#*X
M\6ZEXE^+%_9QVJ^)KRZ.EH+AI9([>2\FEO%8*%0H9EAC1W59B;:1A'%%(IE^
M3_\ @IKX6US]FSXH:=\3=$CN!%<_9)3=.Q-O]NM4,+V;>28Y$BFM88]\;L#<
M(]TJ.R+(D7ZW_"'_ (*!?#GXOZ6NIIK5GI;&1XWL]5N;:RNHV0]3&\Q5D92K
M+)$TB$'86$J2(A\&?VA[C]H7QKJ@\/31S^#-$L_L<MV(FVWNL2S*[&UN,,DU
MO;01E&*-'E[D2;;B"2VF7\T/V^O^3A? 7_< _P#3S<5^_P!7X _\$,?^9N_[
M@_\ [?U[_P#\%J_^2>:;_P!C!;?^D5]7W_\ LG?\D\\*?]B_I/\ Z10U^*/B
M#X\?"3]HGQ9J/B[7]>O/"FHV=Y+9Z3=:'#?07UY8QQ+$M[=W*VLZEYE9XXHU
MBM;B"W!MYWN4$)B]@\2?&7X!_$O6;36O&/C#5/$TEA'LM+74K*X2SB;S4E,G
MV:QTJSBD=B@203"1)H\1RI(J1!/V.^&GQ5T/XR:<FJ^'K^WU"R?:/-@<-L9D
M63RY5^_%*%="\,H26/< Z*>*] HKY_\ VL?^2>>*_P#L7]6_](IJ^ /^"*G_
M "3S4O\ L8+G_P!(K&OH#_@IC\"[SX\_#J[MM,@N+O4M.N(-0M+:WV[IFBW1
M2J48%I,6\T[I%&1+)*D:IO8^6_Q!_P $SO\ @H7H>E:':>"/%][]CN[/SUL;
M^Z<):-:(%DB@FN99CLE3,L<(98K<6\4$"MYNQ'^W_P!H+]LG3KBSMO#WP[U;
M3]4\7:[<)9:;]D=-0AM-S+Y][=_9S*(HK>(O*"ZR?,N\P3017&SY0_X+8?"^
MX\0^&M%\1P>8\>DWDUO/&D+.JQWZQXGDD!Q$B26T<(W+AWN$&]6"K)]__L=_
MM5:7^U?X:@U.UEC&J01Q1ZM9JI1K>Z*_,5C9Y&^SR,KM;2;G#H"C,)HYDC_)
M#]MOQ39^*?VA?!1LI/-6VN-#MI'"L$\Z+69Q*B.0$E\MB8I&C+K'.DMNQ6:&
M6-/J_P#X+/:3<:C\.;26"*22.VURUEG=$9EBC-M=Q!Y" 0B&22.,,V 7D1,[
MF4'ZP_8R^*NA^(_ACH6H6U_;M::9H]I;7\S.(UM9K&UC6Y2<R;?*\O:7+/M4
MQ%9E)B=';\8/VO/CIH?Q)^.OA+6;&?&D:?<:/"VI38BLYUM=6F:>YMYW(26T
MC8R0FY!$1D@FVLT:K(W[?_M$>+-.\<_#'Q/J&E7=O?64WA_6/*N;:9)H7V6L
MZ-LDC+(VUE96P3AE*GD$5\/_ /!%3_DGFI?]C!<_^D5C7T!_P5'_ .20^(?^
MX=_Z<K2C_@EQ_P DA\/?]Q'_ -.5W1_P4Q^!=Y\>?AU=VVF07%WJ6G7$&H6E
MM;[=TS1;HI5*,"TF+>:=TBC(EDE2-4WL?+?X@_X)G?\ !0O0]*T.T\$>+[W[
M'=V?GK8W]TX2T:T0+)%!-<RS'9*F98X0RQ6XMXH(%;S=B/\ ;_[07[9.G7%G
M;>'OAWJVGZIXNUVX2RTW[(Z:A#:;F7S[V[^SF4116\1>4%UD^9=Y@F@BN-GY
MH?MW1W_[)GQPT?XCF21M.U&2VG8Q1PM(([6**QU&U1))#N=K8JRRN(1FZ"HX
M>%I!^[W@KXU^&OB+HS>(=*U2SN=)CC,DUVLRB.!5B69Q<%B#;ND;*\L<PC>(
M'YU6OP!_8.^-?AK3OC9XP\0WFJ6=GI.HQZS):7=Y,MI'*MQJEO-$ ;@QD.T8
M+B-@' #94;6Q_2=117\^/[".K6^G?M$^-HIY8XY+F3Q!% CNJM+(-5BE*1@D
M%W$<<DA5<D)&[XVJQ'W_ /M__"=/VL/A]JEIHCR7%]HEXUU D22%)[JR1TN+
M9-L,AN'$<L\"K;Y OT%L\B/#<1KX_P#\$@OCSI?C/P1'X2$D<6K:))<EK<R$
MR36MQ.UPMTJE%&Q9)V@=4,AC*1NY3[1$I^@/^"E'Q>3X0?#+6'#1BYU2/^RK
M9)$D=9&O0R3@>7C:ZVPN)8V<A \:@[R1&^A_P3N^!<OP"^'6F6-Y!]GU*]WZ
MA?H?-#":YP8UD28*T4L=NMO#-$JJJRQ/]YBTC_;]?CC_ ,%K]6MX? NE6;2Q
MBYEUR*6.$NHD>.*TNED=4SN9$:6)78 A3)&"077/W_\ L=ZM;ZU\.?"LMK+'
M-&NAZ=$7C=7420VT<4J$J2 \<B/'(O5'5D8!E('Y ?\ !5?Q^DOQ+\*>'O$5
MS)_PA\<>GWVH6@,@C*R7UQ#=3,( )G<6\91-I9XP9/)"O+)O_2_]KOXJ^$OA
MO\,=4@^WZ?:6FH^'[RVT6"%X]MRLMKY%NEE%%GS(AYT W0J8HHG61BD0W#XP
M_P""0WC_ $OX??#FYDU2YCMEO/%GV&V#D[IKJZMK".&&-0"S.S')P"$17E<K
M%&[K\?\ QYO=4_8 ^.LGBM(;P:)JEY)=L[$.M[:WNQ]2A3RWA1W@FD=H()F!
MC>.SEE#J4DD_;_3/VZ?AEJVEG6(_$^EBV$<LA22X$5UMB+!@+*3;=ESM/EQB
M(O*"IC5PZ;N?_9)\?ZI\<[C7O&DES(WA[4;Q;/P]:$CRUL=-:6%[U1A'5[R=
MY6>.>)+B(0QQL\L2P[/S0_8%_P"3A?'O_<?_ /3S;U^OW[6/_)//%?\ V+^K
M?^D4U? '_!%3_DGFI?\ 8P7/_I%8T?\ !:O_ ))YIO\ V,%M_P"D5]7W_P#L
MG?\ )//"G_8OZ3_Z10U^./\ P40U:WT#X^^"+R\EC@MH(]"EFFE=4CCC36+E
MG=W8A515!9F8@* 22 *_8[]H7XI?\(/X>\0?V;<>7K5CX?U'4H=L?F^1Y,,G
MD2R[D>)-TJ'R4FQ]H\F?8DBV\_E_EC_P1AU;P_K]OKUY=2QS^-9[R26ZFG=W
MO)-/=86#AY"=R-<F5KAHR7:0P&<G-M7A_P"UQ\5=#^+/[0'@N?0+^WU&WM+C
M0+::>V<2PB;^U'G*)*N8Y,)-&6:-G56)C)$B.J_L?^T+X_TOQUX \<QZ9<QW
M3:;I>LV-X8R2L5U'I[220EL;6=%E02;2P1]T3$2QNB_"'_!&;Q9IVC?#S6_M
M-W;P_8]8N+JZ\R9$\BW:RM<3S;B/+B/DS8D?"'RI.?D;'C__  5_^&FHW,OA
M[XEZ&FH(L%ND%Q<JKV[6.V47&GRM$RQW5M*TD\RL\@7RI4@B80S,HD^[_P!F
M3_@I#X*^-VC)/JVIV>BZM;1P)?07\T-E&\[1 R269EG<26_F"14!<S(%7S43
M?&TG8:/^T[_PNGX@6/AWP5=V][HNEV\][XCOXD\ZW?S83%865M=IOB,IE<W,
MH7;E("B3EHKJW/V_17QA_P %"_'^J?##X8:]JFC7,EG?1QVL<=Q$0)(UN+R"
MWD*-@E',<CA9%P\9(=&5U5A\O_\ !)/5O!V@?#>6\LY;.#5()+B7Q',[[)(P
MDDS6SW#RD;;=;8!HV4BW4BX((F%S7R!X#\?Z7\3_ -JU-4T:YCO+&22>..XB
M),<C6^A/;R%&P Z"2-PLBY20 .C,C*Q_?[P'X_TOXGV":IHUS'>6,DD\<=Q$
M28Y&MYGMY"C8 =!)&X61<I( '1F1E8]A7'_$+P5;_$K1M0T.\:1+;4K.XLYG
MB*B18[B)HG*%E90X5B5+*P!QE2.#_-C^P#^TI+^PCXHUCPAX_P#M&F:?-S.C
MQRS?9+Z$ I($A9QY5Q$=K301S&?;9.K_ &=3)7[7_&+]OKX??"G1KC4XM=TO
M4KE(Y/LME9WJ7$EQ<")Y(HC]E%PT*2,GEFXD3R8RR[FR5#?-_P"T;^RUXH^+
MOP2BTS7+JXU#Q=89UN0$ M+>,T\TUD$@6X$GEQ7,UK:QV^R-Y8K<)Y4'[L9_
M_!(+X\Z7XS\$1^$A)'%JVB27):W,A,DUK<3M<+=*I11L62=H'5#(8RD;N4^T
M1*?H#_@I1\7D^$'PRUAPT8N=4C_LJV21)'61KT,DX'EXVNML+B6-G(0/&H.\
MD1OH?\$[O@7+\ OAUIEC>0?9]2O=^H7Z'S0PFN<&-9$F"M%+';K;PS1*JJLL
M3_>8M(_YP?\ !#'_ )F[_N#_ /M_7O\ _P %J_\ DGFF_P#8P6W_ *17U??_
M .R=_P D\\*?]B_I/_I%#7Y _P#-WG^?^A<K]?OVL?\ DGGBO_L7]6_](IJ_
M.'_@B7XIL[OP;K.E))F]MM8-S-%M8;8;JV@CA?<1L.YK:<;5)9=F6"AD+>G_
M /!6SXFIHO@B+PE;P27>K>*+RWMK.WB61I"MM/#<.Z*D;B1_,%O L.4=S<!T
MW^6RG0^.^@:C^QM^S_-I^AW'V'4M,T^Q@DN;61VQ<7=W E_+!)*/,7S'GN&C
M<"-XMX:(0LB!./\ ^"2>K>#M ^&\MY9RV<&J027$OB.9WV21A))FMGN'E(VV
MZVP#1LI%NI%P01,+FOD#P'X_TOXG_M6IJFC7,=Y8R23QQW$1)CD:WT)[>0HV
M '021N%D7*2 !T9D96/W_P#\%"_'^E_$_P""6O:IHUS'>6,DEK''<1$F.1K?
M6(+>0HV '021N%D7*2 !T9D96/8?\$N/^20^'O\ N(_^G*[KX _;Z_Y.%\!?
M]P#_ -/-Q7[_ %?@#_P5&^'^H_L[>--$^+OAT^7+)<0PW>7<*;RWC_="3;.L
MC175K&]O-%"L<8BMW#N7N>?T/_8.TFX\7:7J/Q$U2*2'5O&5X;QHI$9&M]/M
MBUOIEL.$29$@7S8[H11/<).K/YF%=OL_Q3X3T[QS9R:?JMI;WUE-M\VVN84F
MA?8P==\<@9&VLJLN0<,H8<@&O'_^&3OAY_T*GA__ ,%-E_\ &:]0\%?#W1OA
MK;M9Z'I]GIML\AE>&SMXK>-I"JJ7*1*JERJJI8C)"J,X Q^&/[ O_)POCW_N
M/_\ IYMZ_<[XA>"K?XE:-J&AWC2);:E9W%G,\142+'<1-$Y0LK*'"L2I96 .
M,J1P?YHOV%/VH+C]@+Q+JWA/QW!>6EC/)$L\(1I6L[Q611<!!*$-O) Y>:6W
M2>2X2.U:+S$"[OW>\?\ [<?PY^'VEW.J2>(M+O%MHRXMK&]MKJZF;("QPPQR
MEF=F(&3M1 2\CQQ*[KY_X@U/Q+KOP1UF^\7B--;N_#>M75S#'$T*P+<07,T%
ML8I%5T>"%XH)%DW.'C8-)*V97^;_ /@BI_R3S4O^Q@N?_2*QKYP_X*K^/TE^
M)?A3P]XBN9/^$/CCT^^U"T!D$962^N(;J9A !,[BWC*)M+/&#)Y(5Y9-_P"E
M_P"UW\5?"7PW^&.J0?;]/M+34?#]Y;:+!"\>VY66U\BW2RBBSYD0\Z ;H5,4
M43K(Q2(;A\8?\$AO'^E_#[X<W,FJ7,=LMYXL^PVP<G=-=75M81PPQJ 69V8Y
M. 0B*\KE8HW=?'_^"B&K6^@?'WP1>7DL<%M!'H4LTTKJD<<::Q<L[N[$*J*H
M+,S$!0"20!7[??$*RTOXEV^H>#KJ:02:CI=PERL /F16MRK6WF&0H\4+N6D%
MN)N9C#.8TE6WGV?SA?L*?M07'[ 7B75O"?CN"\M+&>2)9X0C2M9WBLBBX""4
M(;>2!R\TMND\EPD=JT7F(%W?N]X__;C^'/P^TNYU23Q%I=XMM&7%M8WMM=74
MS9 6.&&.4LSLQ R=J("7D>.)7=?B#]L/X7^,?CU\"K?4?$/EIXAL)/\ A(+N
MUCA\E4M_])8VI68Q-"]I9W(\Q7$LS/:M#F:63S6[_P#X)@?M9Z-\3O!VF>%[
MW48QXCTN,V?V6?RH9)[>+S&MC:JI'GI%;1K'*5!F0PN\RX=)9?B#_@MSX_TO
M7=4\/:+:W,<NHZ;'?R7L"$EH%NQ:& 2$#:KNL3N(\[PFR1E"2Q,_[_>"OB%H
MWQ*MVO-#U"SU*V20Q/-9W$5Q&L@56*%XF90X5E8J3D!E.,$9["BBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOG_P#:%_9B\+_M0:<FG^);3SO)
M\TVMS&YBN+5Y4*%X9%_X"QCD$D$CQQM)%)Y:@?('PT_X)&?#7X=ZBFH3KJ&K
M^5M,=MJ,\3VX=75U=HX(+?S<;2ICF,D#H[*\3Y!7[O\ B]\&]$^.^EMHOB&"
M2ZTYY$DD@2YN+=9&C.4$AMI8FD0-AQ&Y9-ZI)MWQHRGPA^#>B? C2UT7P]!)
M:Z<DCR1P/<W%PL;2'+B,W,LK1H6RYC0JF]GDV[Y'9O(/BA^Q'X&^-5Q]J\1V
M5YJ4BR321BXU?5'CA:=@T@@B^V>5 C%5_=PJB *BA0JJ!Z?\'/@1H/P"LVT_
MP[#<6UD<;;:2^O+J&/#.Y\F.ZGF2#<TCM)Y(3S&(9]Q52/,/VF/V+/!W[5R1
MMX@MI$OH(_*@U"UD\JZBC\Q9"F2KQ2)D,%6>.41B25HQ&\C/7C_P&_X)A?#[
MX!ZI'K-O%>:G?6\D<MI)J,R2K;2('P\<<,4$3/E@P:993&\<<D1C==Q_0^OS
MP^//_!,+X??'S5)-9N(KS3+ZXDDENY-.F2);F1PF7DCFBGB5\J6+0K$9'DDD
ME,CMN'T!^S]^R9X._9EMQ%X<TZ.*Y,?ES7\O[V\G!6,/OG8;E1VB21H(O+MQ
M("Z0H37?_%[X+^'_ (]:6VC>);&._L6D241N71DDC/RO')&R2QO@LI:-E+(S
MQDE'=6^(/A#_ ,$G_AS\)=475'CO-89(W1+;56MKBU#.,>884MHED<+N"B7>
MBEMX3S5C=/<-8_86\#>*_%]]XUUFQ_M34KWR/W-Z5ELX?)MA:_N[;:(WWH%9
MOM/G[9%5XO*85]'^/_ &E_%/2[G1=:MH[S3KR,QSP2 [67(((((975@'CD0J
M\;JLB,KJK#X@^ W_  3"^'WP#U2/6;>*\U.^MY(Y;2349DE6VD0/AXXX8H(F
M?+!@TRRF-XXY(C&Z[CZA\2_V#?A[\9-1?5?$.FW&H7K[AYL^J:FVQ6=I/+B7
M[7LBB#.Y2&()%'N(1%'%>_\ PT^&.F?"+3DTK2%N$LHMHBBGO+J[\I518UCB
M:[FF>.)510D*%8DY*H"S$^@5X?\ "O\ 9X\/_!K5-=UC1X9([OQ%>"\OV>5Y
M%,@#'$:L2$0R23S$<G?.ZAA"L,47N%>7_%[X+^'_ (]:6VC>);&._L6D241N
M71DDC/RO')&R2QO@LI:-E+(SQDE'=6_/#PM_P1M^&OA^\CN;F76-0B3=NM;F
M[B6&3<I4;S:V]O,-I(==DJ?,H#;DW*WZGZ3I-OH%O%9V<4<%M!&D4,,2*D<<
M:*%1$10%5%4!550 H    K0HKR_XO?!?P_\ 'K2VT;Q+8QW]BTB2B-RZ,DD9
M^5XY(V26-\%E+1LI9&>,DH[JWQAX6_X)GZ'X4LX]*B\3>,&T5=RR:2=8$=C-
M#(Q::"2&""+]U-N<3",HS!W(8,=U?;_PT^%6A_!O3DTKP]86^GV2;3Y4"!=[
M*BQ^9*WWY92J('FE+RR;07=CS7B'Q0_8C\#?&JX^U>([*\U*19)I(Q<:OJCQ
MPM.P:001?;/*@1BJ_NX51 %10H55 Z#X0_LF>$?@*ZMX:MKRPC61Y3;IJNI/
M:O))'Y3/):R73V\C[ H#21L5*HP(9$*\_P#%#]B/P-\:KC[5XCLKS4I%DFDC
M%QJ^J/'"T[!I!!%]L\J!&*K^[A5$ 5%"A54#H/A#^R9X1^ KJWAJVO+"-9'E
M-NFJZD]J\DD?E,\EK)=/;R/L"@-)&Q4JC AD0KG_ !C_ &-O!/[0%XM]XGL;
MC4)4SY2R:EJ"PP[E1&\F".Z2&'>(T,GE(GF,H=]SY8]_\'/@1H/P"LVT_P .
MPW%M9'&VVDOKRZACPSN?)CNIYD@W-([2>2$\QB&?<54C0^+WP7\/_'K2VT;Q
M+8QW]BTB2B-RZ,DD9^5XY(V26-\%E+1LI9&>,DH[JWPA\-/^"1GPU^'>HIJ$
MZZAJ_E;3';:C/$]N'5U=7:.""W\W&TJ8YC) Z.RO$^05_2_2=)M] MXK.SBC
M@MH(TBAAB14CCC10J(B* JHJ@*JJ %    %?,'[3'[%G@[]JY(V\06TB7T$?
ME0:A:R>5=11^8LA3)5XI$R&"K/'*(Q)*T8C>1GKQ_P" W_!,+X?? /5(]9MX
MKS4[ZWDCEM)-1F25;:1 ^'CCAB@B9\L&#3+*8WCCDB,;KN/U?\8_@1H/Q]LU
MT_Q%#<7-D,[K:.^O+6&3+(X\Z.UGA2?:T:-'YP?RV!9-I9B> ^#G[&W@G]G^
M\:^\,6-QI\KX\U8]2U!H9MJNB^=!)=/#-L$CF/S4?RV8NFU\,/I^BBOE#]IC
M]BSP=^U<D;>(+:1+Z"/RH-0M9/*NHH_,60IDJ\4B9#!5GCE$8DE:,1O(SUY_
MI/\ P3[\/S7$4OB/6/$GBFVMY$FAL-=U5[RS2XC8%)S J1+(X7?'ME\R%HY9
M$>-@W'V_I.DV^@6\5G9Q1P6T$:10PQ(J1QQHH5$1% 5450%55 "@   "OD#Q
MK_P3[^'7Q*N%O-<TZ\U*Y2,1)->:SJUQ(L89F"!Y;UF"!F9@H. 68XR3GU_X
M0_LZ^'?@0BP>'H[RUMDC>..U?4]0N+6-9)/-<QVUS<RP1N7RQD1%?+/\V)'#
M>X45X_\ '3X%Z'^T7H<_A_Q!!YUI-\R.N%FMYE!"3P.0=DJ9.#@JREHW5XGD
MC;P#]FO_ ()[^!OV7KS^U-*@N+S5!Y@BOK^599H4E559(EC2*%.%8>8(_/VR
MRQF4Q.4H\4_\$Y/ACXYO)-0U72;B^O9MOFW-SJ^JS3/L4(N^22\9VVJJJN2<
M*H4< "O?_$?P+T7Q;H8\.7QU";3?W@=&U;4?.F642!XY[H70N;B)A*ZF&:22
M(KM79MCC"^0?#3]@WX>_!O44U7P]IMQI]ZFT>;!JFIKO5763RY5^U[)8BR(7
MAE#Q2;0'1AQ7T?X_\ :7\4]+N=%UJVCO-.O(S'/!(#M9<@@@@AE=6 >.1"KQ
MNJR(RNJL/S0_X<V_#7^T?MOFZQ]G^T>=]A^UQ?9]F_=]GW?9_M/E8_=Y\_S]
MG/G>9\]?I?X \ :7\+-+MM%T6VCL].LXQ'!!&#M5<DDDDEF=F)>21RSR.S2.
MS.S,>PHKQ_XQ_ 'PO^T!9K8^)],M]0B3/E-("LT.YD=O)GC*30[S&@D\IT\Q
M5"/N3*GXP\%?\$P]&^&MNUGH?BSQIIML\AE>&SU>*WC:0JJERD5JJERJJI8C
M)"J,X Q]?_"?]GCP_P#!YWO+*&2YU:>-([O5[Z5[S4KH+'#&?.NYBTNQA!$W
MD1F.W5E!2%.E>X5\H?M,?L6>#OVKDC;Q!;2)?01^5!J%K)Y5U%'YBR%,E7BD
M3(8*L\<HC$DK1B-Y&>O/])_X)]^'YKB*7Q'K'B3Q3;6\B30V&NZJ]Y9I<1L"
MDY@5(ED<+OCVR^9"T<LB/&P;C[/_ .$6LXM._LJ"/[-9"W^S1Q6K-:^5"$\M
M4@: QO!L7 C:$HT6 4*E01\@?\.Y/AC_ &C_ &O_ &3<?VE]H^U?;/[7U7[1
M]HW^9Y_G?;/,\W?\_F;M^_YL[N:]O^)O[.OAWXQZ7!HNNQWEWIT$:QB ZGJ"
M+,JF,J;HQW*-=NK1(ZR71F=7!D#!W=FY#X.?L;>"?V?[QK[PQ8W&GROCS5CU
M+4&AFVJZ+YT$ET\,VP2.8_-1_+9BZ;7PPY_XE_L&_#WXR:B^J^(=-N-0O7W#
MS9]4U-MBL[2>7$OVO9%$&=RD,02*/<0B*.*]_P#AI\,=,^$6G)I6D+<)91;1
M%%/>75WY2JBQK'$UW-,\<2JBA(4*Q)R50%F)_G!_X)9_LUZ'^TA9^);?5?M%
MO=V%QHESI^I64@@OK*96O6+V\Y5]F[8H=2K*2J2 "6*&2/\ 9_X>?L">%_!N
MN0^)=4N]8\2ZO:>5]BNM=OC>M:>49&7R0$B0X:4R+YJR^5*JRQ>5("S?;]?G
M!\=/^"6O@'X\ZY/X@N6U#3KN[^:Y33Y8(H9ILDO.R2V\V)9,CS2A19&'F,IE
M>21_0/C5_P $]_ WQKT/2/#TL%QIMEH7F#3_ .SY5C:-)@/.1O.2=)/-9$EE
MDD5IWE7>9<R2^9Z!X6_8\\(>$?"4?@JVMKA-(&XW"Q7ES:S7KR1F*9[R:TD@
M>X\U6*R1O^X*A$6)8XH4CY_X:?L&_#WX-ZBFJ^'M-N-/O4VCS8-4U-=ZJZR>
M7*OVO9+$61"\,H>*3: Z,.*Z#XQ_L;>"?V@+Q;[Q/8W&H2IGREDU+4%AAW*B
M-Y,$=TD,.\1H9/*1/,90[[GRQ[_X.? C0?@%9MI_AV&XMK(XVVTE]>74,>&=
MSY,=U/,D&YI':3R0GF,0S[BJD>0?MY>.O^$(^'6M1Q0_:KW5;<Z196BOMFN+
MC4O]$5($"N\TJ+(\XAC4O(L3 ;1EU]?^ /P<L_V?_"^F>&+%M\6GVXC:7#+Y
MTS$R3S;7>0IYLKR2^6'98]^Q3L50/8***\?^.GP+T/\ :+T.?P_X@@\ZTF^9
M'7"S6\R@A)X'(.R5,G!P592T;J\3R1M\X?LS_P#!.OP5^RUJDFM:6+R]U$Q^
M7#/J$D,K6RL&$AMQ%#"J/(IV/(0SA 8T9$DF63G_ (0_\$POA]\&/$J^)K&*
M\N)X9'EL[6[F2:UM)&;=&\*^4LK/"/E@:>28H<2DM.B2K] ?'C]D_P )_M,7
M%A/XJM9+V/38[I+> 7$L$>ZZ:W+R,8&CE+J+=50;PF'DW(S;&3Y_TG_@FYX?
MAMXM,U/Q!XLU?1(HTB.C7NLN=/>.)0(4:&WC@8)"RI)$L;H%>-."H*G[_P!)
MTFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4    5H45\P?M"_L<^"
M_P!I_9+XDL/-O8;>6WM[V&62&XA63)!#(P27RV)DB2X6:)'9R(\22!_'_"?_
M  3E\+Z-]D@U?4_$'B'3;#R39Z5K&I&XTZ!X,"%TM8XX8SY:!H5C?? 89)(V
MB92,??\ 7'^/_ &E_%/2[G1=:MH[S3KR,QSP2 [67(((((975@'CD0J\;JLB
M,KJK#\T/^'-OPU_M'[;YNL?9_M'G?8?M<7V?9OW?9]WV?[3Y6/W>?/\ /V<^
M=YGSU^E_@#P!I?PLTNVT71;:.STZSC$<$$8.U5R222269V8EY)'+/([-([,[
M,Q^4/%/_  3D^&/CF\DU#5=)N+Z]FV^;<W.KZK-,^Q0B[Y)+QG;:JJJY)PJA
M1P *]_\ $?P+T7Q;H8\.7QU";3?W@=&U;4?.F642!XY[H70N;B)A*ZF&:22(
MKM79MCC"^0?#3]@WX>_!O44U7P]IMQI]ZFT>;!JFIKO5763RY5^U[)8BR(7A
ME#Q2;0'1AQ70?&/]C;P3^T!>+?>)[&XU"5,^4LFI:@L,.Y41O)@CNDAAWB-#
M)Y2)YC*'?<^6)8^$_"'[#WA?4=0LDN+/1;"W>=[9]0N;A%V%W$5K'?7+112S
MRRE52,Q?:)Y$5BS;"/F_P!^QIX(_:DTNV\;>+= L_P"T]=C&H"*SGGMXH;>[
M)GMT8VOV0W%P8W62[N9UDFDNI)@L@MEMX8NP_P"'7'PA_P"A>_\ *CJ7_P E
MUX?^R?\  +2_@'\8_$>E^$)KQM"MM#MSJEO-.6CMM2O+K[19P(K!&F1+-7,,
MI^T-&))4DN/,D93^M]%>/_&/X$:#\?;-=/\ $4-Q<V0SNMH[Z\M89,LCCSH[
M6>%)]K1HT?G!_+8%DVEF)X#X.?L;>"?V?[QK[PQ8W&GROCS5CU+4&AFVJZ+Y
MT$ET\,VP2.8_-1_+9BZ;7PP^GZ_/#X\_\$POA]\?-4DUFXBO-,OKB226[DTZ
M9(EN9'"9>2.:*>)7RI8M"L1D>2224R.VX>P?LS_L6>#OV44D;P_;2/?3Q^5/
MJ%U)YMU+'YC2!,A4BC3)4,L$<0D$<32"1XU>OI_5M)M]?MY;.\BCGMIXWBFA
ME17CDC=2KHZ,"K(RDJRL"&!(((-?F!J?_!'KX97^J#4(QJD%L)(G.G1W@-J5
M0*&C+R127>R3:3(1<!P7;RWC 0+\@?MR:3;Z!\??A[9V<4<%M!'X=BAAB14C
MCC36+A41$4!515 554 *    *_=[Q_X TOXIZ7<Z+K5M'>:=>1F.>"0':RY!
M!!!#*ZL \<B%7C=5D1E=58?GAX6_X)&?#7PMKD>M!=0N8HKAITTRYGBEL>22
MD3H8!-+%&2NU)9G\P(%F,R-(K_0'C_\ 86\#?%#Q#8>(=7L?M']F:?;V%GIV
M5CTZ**VF::$_9XU3?MWM%Y+LUJT)V-;G (]/^)O[.7ACXO:7!H>K6DC:3;1K
M%'86UW=65KY:&,QH\%G-!%(D9BC,*R*PA*_NPF3GD/@Y^QMX)_9_O&OO#%C<
M:?*^/-6/4M0:&;:KHOG0273PS;!(YC\U'\MF+IM?##?^-?[+_A7]HGRU\3VM
MQ?10[3';_P!H7T-N&3S-LGV>"XBA,H$KKYQ0RE&V%]@"@^"G[+_A7]G;S%\,
M6MQ8Q3;C);_VA?36Y9_+W2?9Y[B6$2D1(OG!!*$78'V$J?H"OSP^//\ P3"^
M'WQ\U236;B*\TR^N)));N33IDB6YD<)EY(YHIXE?*EBT*Q&1Y)))3([;A[!^
MS/\ L6>#OV44D;P_;2/?3Q^5/J%U)YMU+'YC2!,A4BC3)4,L$<0D$<32"1XU
M>O7_ (O?!?P_\>M+;1O$MC'?V+2)*(W+HR21GY7CDC9)8WP64M&RED9XR2CN
MK?"'PT_X)&?#7X=ZBFH3KJ&K^5M,=MJ,\3VX=75U=HX(+?S<;2ICF,D#H[*\
M3Y!7Z \ ?L+>!O 7B&_\5_8?M^M7^H7%_P#:;XK/]FEGF6XQ:Q;5BB\N5=\,
MVQKI-S+]H*G%?7]%%?GA\7O^"87P^^,_B5O$U]%>6\\TB2WEK:3)#:W<BMND
M>9?*:57F'RSM!)"7.905G=Y6^W_ '@#2_A9I=MHNBVT=GIUG&(X((P=JKDDD
MDDLSLQ+R2.6>1V:1V9V9C\@?%#_@G=X.^(?B#_A*K*;5/#^MM)-+->Z+>?9)
M)I)D$;NVZ.58W*[][0"$S&65IC*SY'8?#3]B/POX"U%-:U"34/$FM0[1;:EK
M]T=1N+9$=98TM]ZK%%Y<JF6*18Q.CR2XEVN5KZ_HKY0^*'[$?@;XU7'VKQ'9
M7FI2+)-)&+C5]4>.%IV#2""+[9Y4",57]W"J( J*%"JH'0?"']DSPC\!75O#
M5M>6$:R/*;=-5U)[5Y)(_*9Y+62Z>WD?8% :2-BI5&!#(A4_:8_95\-?M7Z7
M'IGB&*0-!)YEK>6[*EU;L2OF"*1TD79(JA98W5T<!7VB6.)X_+_@/_P3W\#?
M #3M5T^R@N+W^V;>6TO;F]E5KAK.5-DEK') D'E1-RS>6%D=RK-(WE0B+/\
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M=&!5D92596!# D$$&OS0\+?\$C/AKX6UR/6@NH7,45PTZ:9<SQ2V/))2)T,
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M>_!O44U7P]IMQI]ZFT>;!JFIKO5763RY5^U[)8BR(7AE#Q2;0'1AQ70?&/\
M8V\$_M 7BWWB>QN-0E3/E+)J6H+##N5$;R8([I(8=XC0R>4B>8RAWW/ECU_P
MR_9U\._!S2Y]%T*.\M-.GC:,P#4]0=858R%C:F2Y=K1V:5W:2U,+ER)"Q=$9
M?$/^'<GPQ_M'^U_[)N/[2^T?:OMG]KZK]H^T;_,\_P [[9YGF[_G\S=OW_-G
M=S7J'[3>F)HOPT\2VL1D:.'PWJ<:&662:0JEC*H+RRL\LCX'S22,SN<LS,Q)
M/XX?\$T/V3-#^/\ X(?59[C4-)UK3O$%XMMJVDW M+Y89+"T5X#-L?,1WL0"
M-R%G",BS3+)^K_P4_8C\+_!;6)/$GF:AK/B&3</[7UBZ-Y>(C1QP[$;:D8PB
M;%DV&<1O)#YODMY8^K]6TFWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP*LC*2K*P
M(8$@@@U^:'A;_@D9\-?"VN1ZT%U"YBBN&G33+F>*6QY)*1.A@$TL49*[4EF?
MS @68S(TBOZ!\<?^";'@;]H'Q0?%>KG4%NY?L_VJW@N52WNOLX5!YH:-Y4W1
M(D+_ &>6'Y$#+LE+2-[A\5?V2?!GQJM[6RURPDFL;*.*.UL8KV]M;.%85=(B
MEI:SPVZNB2-&L@CWB,B/=L55%_X*?LO^%?V=O,7PQ:W%C%-N,EO_ &A?36Y9
M_+W2?9Y[B6$2D1(OG!!*$78'V$J?(/%/_!.3X8^.;R34-5TFXOKV;;YMS<ZO
MJLTS[%"+ODDO&=MJJJKDG"J%'  KZ_\ "WAJ#P?9QV-L]P\46[:US=7%W,=S
M%SOGNI)9GY8A=[MM7"+A%51\0?\ !1+_ (K?PYI_@2#F]\7:Q8:>A3]Y-;V\
M4Z7=U?"V'SSQ6ZPKY^&B2-95=Y4  ;[?\)^%K/P-IUII6GQ^396-O#;6T6YG
MV0PH(XTW.6=MJJ!N8LQQDDG)KH**Y_Q3X:@\86<EC<O<)%+MW-;75Q:3#:P<
M;)[62*9.5 ;8Z[ERC91F4_('A;_@G)\,? UY'J&E:3<6-[#N\JYMM7U6&9-Z
ME&V21WBNNY696P1E6*G@D5]OU\H?M,?L6>#OVKDC;Q!;2)?01^5!J%K)Y5U%
M'YBR%,E7BD3(8*L\<HC$DK1B-Y&>O'_@-_P3"^'WP#U2/6;>*\U.^MY(Y;23
M49DE6VD0/AXXX8H(F?+!@TRRF-XXY(C&Z[C]7_&/X$:#\?;-=/\ $4-Q<V0S
MNMH[Z\M89,LCCSH[6>%)]K1HT?G!_+8%DVEF)X#X.?L;>"?V?[QK[PQ8W&GR
MOCS5CU+4&AFVJZ+YT$ET\,VP2.8_-1_+9BZ;7PPT/VF/V5?#7[5^EQZ9XABD
M#02>9:WENRI=6[$KY@BD=)%V2*H66-U=' 5]HECB>/R_X#_\$]_ WP T[5=/
MLH+B]_MFWEM+VYO95:X:SE39):QR0)!Y43<LWEA9'<JS2-Y4(BS_ -F?_@G7
MX*_9:U236M+%Y>ZB8_+AGU"2&5K96#"0VXBAA5'D4['D(9P@,:,B23+)V'[4
MO[$'A+]KC[++KJ7%O>V>5CO;)XXK@PG<3!(TD4J/%N;S%#*6C?<8V02S"3O_
M -GK]F+PO^R_ISZ?X:M/)\[RC=7,CF6XNGB0('FD;_@3".,1P1O)(T<4?F,#
MR'[3'[%G@[]JY(V\06TB7T$?E0:A:R>5=11^8LA3)5XI$R&"K/'*(Q)*T8C>
M1GKQ_P" W_!,+X?? /5(]9MXKS4[ZWDCEM)-1F25;:1 ^'CCAB@B9\L&#3+*
M8WCCDB,;KN/Z'U^8'Q+_ ."1GPU^(FHOJ$"ZAI'F[C);:=/$EN79V=G6.>"X
M\K.X*(X3' B(JI$F"6]0\3?\$V_AOXGM](T]M.D@TO1Y+Z6.Q@N)$CN9+Y8A
M(]U-DW<KKY,1B83H5")$2T*K&/L_PMX3T[P-9QZ?I5I;V-E#N\JVMH4AA3>Q
M=MD<85%W,S,V ,LQ8\DFN@HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHKS_XEW/B&VTY_^$8@T^?4FW+'_:-Q-!;QY1MLK>1!
M/)+M?9F$>3O0MB>-@,_F!^P-^QE\0_V-=1OOM+>'[_3=6^R+=>7>WL=Q#]G=
M\2P[K$QR82:;,+^7YC^7^_A56W_K_1111117S!^UY\,/%OQ=\+R:9X+UG^Q-
M4-Q!(;C?)%YL*$[X?M$*M-;Y)63S(E9G\KR& BFD8>/_  !_93\46W]F7WQ.
M\0?\))=Z/A],L5C L[2X3,:7DLI2.74+M8@AAGND#VTDD[KYDKK.OW_11111
M11111111111111117E_QH^$.E_'KP_?>&M961K&_C"2&)S'(C(ZR1R(W(#QR
M(DBA@R,5"NCH61ORAT3_ ()W?$W]FRXD/PN\9QPV-S)<-)9ZE&5CB5VB\MO+
M\F]MY[@I&J27(@M7 C 4;)&1/7_#'[-'QP\=)+9^,_B!':6+26Y*Z):Q)=2Q
MK)OE5;Q;6QEM'PJJCH)PP9Q)&4!CE^__ (0_"'2_@EI:Z7I:R%3(\]S<SN9;
MJ\NI3F:[NYC\TUQ*W+N<# 5$5(D1%]0HHHHHHHHK\8?VA_V,OBG\=/'VF>.X
MF\+V,NC_ &'[%:->ZA<+_H<[72^?(+&$R;I7?/EK#B(J@^=3*_Z_>%KG4;NS
MC?58+>VO3N\V&VN'NH5PQ"[)I(+9WRNUFS$FUB5&X*';H***************
M**********************************************^</VI?"7BKXB^&
MK[0/"\6EF35;.YL[BXU&YN(E@CG41,8XK>VF,SM&\H!:2$1.(W*SKNCKY?\
M^"?G[-'CK]DBRN- U@:'=Z3=7CWAN+6\NQ=0R- L3#RI+)8ID8PP!1YD!B'F
MN6FRD:_I?1111117Q!^V]\$/'WQMT[3X/ GB'^PY;>XD>[3SY[3[0K)B,_:K
M5'F7RCN'D;?*F\WS'8/!$&Z#X%_LY:QH%Y!XD\>ZQ_PDGB:"W\FUF^SQV]II
MJ2J#<I9PQ*B-+*VY);YDCGFMTBAV0H)$D^OZ************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M***************************_.#_@HQ\.OBA\0M.TE/AM=7$/E7$YU"&T
MODL+B3<BBW<3,\.8H\3+)&)1N>6)O*DV;X?N_P"'MEJFG:-I\&N31W.K1V=N
ME_/$ (Y;I8E$\B )& C2!F4!(P 1\B_='8444445GV6K6^HO-%!+'));2"*=
M$=6:*0QI*$D )*.8Y(Y K8)21'QM92="BBBBBBBBBBL_3-6M]:0RVLL<T:R2
MQ%XW5U$D,C12H2I(#QR(\<B]4=61@&4@:%%%%%%%%%%%%%%%%9^IZM;Z*@EN
MI8X8VDBB#R.J*9)I%BB0%B 7DD=(XUZN[*B@LP!T*_+#]ACX7?&7P/XJUVZ^
M(>H276DS1N(1)>I<QSW1N-R3V42Y-K;B/SLQ;;0$2P+]G/E8@_4^BBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBOD#1_VZ? WBOQ?8^"M&OO[4U*]\_\ ?6066SA\
MFV-U^\N=PC?>@95^S>?MD5DE\IA7S?X__P""O_PY\"ZI<Z9''JFI+:R&,WEC
M#;26LK #<89)+J)I$#97S NQRI>-I(BCM^C_ ( \?Z7\4]+MM:T6YCO-.O(Q
M)!/&3M9<D$$$!E=6!22-PKQNK1NJNK*/G#Q_^W3X&\!>(;#PI]N^WZU?ZA;V
M'V:Q"S_9I9YFM\W4NY8HO+E79-#O:Z3<K?9RIS7A_C7_ (*S?#+P9K*Z0MS>
M7T?F".;4+.W$EG"WFM&Y+M(DLR(%\PR6L=PDD;*8FE8[1^A_BGQ9IW@:SDU#
M5;NWL;*';YMS<S)#"F]@B[Y)"J+N9E5<D99@HY(%?"&K?\%(_#\-O+J>F>'_
M !9J^B11O*-9LM&<Z>\<2DS.LUQ) P2%E>.5I$0*\;\E0&/T_P#!#]I'PG^T
M?;W%UX5U*._CM)%CN (Y89(V==R%HITCE", VR3;L<I(JL6C<+@?M _M9^#O
MV9;<R^(]1CBN3'YD-A%^]O)P5D*;(%.Y4=HGC6>7R[<2 (\R$UZ_\/?&MO\
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M[-6G7VC:?=>?XN>W"VUM"H;[&UPC>7=7#NCPKY0Q,+=@\LNZ',2P3&9? /\
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MID:.WTZ2)"Y554N54%BJJ"<X4#@?%_\ P14_Y)YJ7_8P7/\ Z16-?K_17/\
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M+_9:M[Y[>[O-3U;5Y(I]5U&\D+27,Z*Q+!.0B&22:4;C+,3,PDN)MJ%?E_\
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M1BT$*R74<D1V7+JZAO7_ (\^*OV@?&>ER>)_"4-GHFF11R3V^C&%;C7IK<E
MINH;BWGMUN-BM<+:P.DT:R&V;[1<HJGV#_@G%^V#<?M8>&IQJ_E_V[I$D<%Z
MT:LJSQR*3!=%0BQ1O*4E22*-F >%I D,<L42_,'_  45_;K^(?[/UQ'IFDZ3
M'HMI=R7"6>KW$MK>7%TMLUN7D@MD>6*V3+E<72RO+#*CA+:965/VNK\\/CS^
MTQXE\3>+)/AG\-([/_A(X;.2ZU34=1W+:Z= \2&+RT"LT]P6GMW#".>&,O&K
MQ3!K@VOS!^UC\0_C!^PY9:=XEG\76?B6QFO&LYK*ZT6VLU\R2"62(_Z*1*Z
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MMP/,FM]]TX,DK1[%63;'%'%^_P!\"_\ A8?^F?\ ">?\(_\ \L?L7]B_;?\
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M0O+'^0/['G[?_P 0?V@GU^-;"/4=6FDTV#2+6&U>'2=-,D=U]INK^[ DE2W
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M_P![_JO,V;/^6FS/RYK^<'_BX?\ PT;_ ,R__P )G_V^_P!C_P#($_\  O\
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M;_T]^3Y'V3_MKYOF?],]O\5?T??"W_A(?['M_P#A*_[/_MK]Y]I_LWSOL?\
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MR:?JMI;WUE-M\VVN84FA?8P==\<@9&VLJLN0<,H8<@&C_A$]._L[^R/LEO\
MV;]G^R_8_)3[/]GV>7Y'DX\ORMGR>7MV;/EQMXK\H/A[^T'9Z-+<_#_]G[PW
M;WJ6%QNO=6N9F72(&EEB5IWF,K7-_N FC4B193';A[5;RVB"CY ^%NG:YI?[
M4MO'XENK>\U<^9)=2VL1BMU:70'D$,"L2YB@5EMXY)/WLJ1"60"1V%?M]^UC
M_P D\\5_]B_JW_I%-7P!_P $5/\ DGFI?]C!<_\ I%8UX!_P7._YE'_N,?\
MMA7[_5^ /_!(#Q'9_$_QEXT\3:B+=-?OMEQ'''(R8AO;F:>^$,+2,6B65;0%
MV\QHLQKY@\T[_P!_J_G!_9R\.7GP"_:<OO#]H;>WM+VXU17@MHU$(L;FT?5+
M6!%,:^5Y>VVW"(*%:(QJS1$[_0/V^O\ DX7P%_W /_3S<5^_U?@#_P $,?\
MF;O^X/\ ^W]>X?\ !3/]E7Q9XVUG1?B%X'BDNM6T6,":!&B:2-;.5[RUGM[>
M1,3NLC2K)%NE>4FW2.W?]Z:\/^#'_!4^#Q3%=^"OC#8?9HI;>ZL+Z_BCN(FX
MB$$L%Y9Q*9HI9")UDEMMGERNB+:PHKRI^]VDZM;Z_;Q7EG+'/;3QI+#-$ZO'
M)&ZAD='4E61E(964D,"""0:T**_!'_@K3X ?X0>)?#/Q2T>VC-S#>0QW;.(Q
M!)=63+<V!EC0QSR/(D<\<DF\@0V\,0:(A-_ZG_'']I2S^'G@8^+-(_T^74+>
MW&@VXC9GOKN_5?L,:6[-#-)N+K+)"F+@0)*53>FVOQP_8JLM4_8-^,#_  ^U
MF:-[37;.U1[A@+>WDNOLQN+>2W>9-\Z+.USIL05HA/-)N9!-&L"_I?K_ /Q?
MCXPV^ER?O]%\$:?'?SQCA!KFH$BS%Q%+E9O*M US:30(&MIV;-P&;RJ/^"H_
M_)(?$/\ W#O_ $Y6E'_!+C_DD/A[_N(_^G*[KX _X+G?\RC_ -QC_P!L*_?Z
MOP!_YN\_S_T+E?K]^UC_ ,D\\5_]B_JW_I%-7P!_P14_Y)YJ7_8P7/\ Z16-
M?K_7S_\ M8_\D\\5_P#8OZM_Z135\ ?\$5/^2>:E_P!C!<_^D5C1_P %J_\
MDGFF_P#8P6W_ *17U??_ .R=_P D\\*?]B_I/_I%#7Y _P#-WG^?^A<KH/\
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MX_:%\>?M/V\$?PQT2S\->#TC>UBUG5HU,@2-88?^)=IUN_E![8F80JYGLIC
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M6E'_  2X_P"20^'O^XC_ .G*[KX _P""YW_,H_\ <8_]L*_?ZOP!_P""&/\
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M;FVN+G]V5O\ _!%3_DGFI?\ 8P7/_I%8UX!^WU_R<+X"_P"X!_Z>;BOW^K\
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M;G8JJOS!_P $,?\ F;O^X/\ ^W]>_P#_  6K_P"2>:;_ -C!;?\ I%?5]_\
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M"D7E[#;F3Y?TSXO:7-^U"?$.HM)H^G+)*C2:LATYD5-$:VCDD2Y\MHDF8*\
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M&YD@_&'_ (2S3O\ AK;[5]KM_L_VC[+YOG)L^T?V']D\C=G;YOVC_1_+SO\
M/_=8\SY:_8_]L35K?1?ASXJENI8X8VT/48@\CJBF2:VDBB0%B 7DD=(XUZN[
M*B@LP!^ /^"*&K6\W@75;-98S<Q:Y++)"'4R)'+:6JQNR9W*CM%*J,0 QCD
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M +GRG7R=/-G9^5.LT<N[[0L@N!+7[?5_+%KPUS_@E;\5;C58],\S0KW[>MC
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MDY__  4F\4V?@;XZ^#=5U"3R;*QM]%N;F7:S[(8=6NI)'VH&=MJJ3M4,QQ@
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M2QU>ZFCPKH?)DNH)G@W+(ZR>24\Q2%?<%4#Z?_X>C_"'_H8?_*=J7_R)7/\
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MX?\ _"8E_P#E=78>-?VV/V=_B5<+>:Y-I>I7*1B))KS0+JXD6,,S! \MBS!
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M37H'@K_@H)\"/AK;M9Z'J-GIML\AE>&ST:]MXVD*JI<I%9*I<JJJ6(R0JC.
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MC]G?P=;W=GIDVEV=M?Q^5>PV^@74,=S'M==DZ1V*K*FV1UVR!AAW&,,<\?\
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MSR/+--+X:G>221V+.[NVGEF=F)9F8DL2222:S_\ AI;]E[_GU\/_ /A,2_\
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M+_\ *ZM#4_VK/V9M:<2W46AS2+'%$'D\-3NPCAC6*) 6T\D)'&B1QKT1%5%
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MYDK??EE*H@>:4O+)M!=V/->@5\__ !K_ &6/!?[1/EMXGTBWOI8=HCN,R0W
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M ."FR_\ C->X:3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550 H
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M_P )OV6/!?P/TZ]TK0=(M[>RU+(OHI#)<_:5*&/RYFN7E=XMK,!"Q,0\R0A
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M3]5M+>^LIMOFVUS"DT+[&#KOCD#(VUE5ER#AE##D UX__P ,G?#S_H5/#_\
MX*;+_P",T?\ #)WP\_Z%3P__ ."FR_\ C-'_  R=\//^A4\/_P#@ILO_ (S1
M_P ,G?#S_H5/#_\ X*;+_P",T?\ #)WP\_Z%3P__ ."FR_\ C-'_  R=\//^
MA4\/_P#@ILO_ (S1_P ,G?#S_H5/#_\ X*;+_P",T?\ #)WP\_Z%3P__ ."F
MR_\ C-'_  R=\//^A4\/_P#@ILO_ (S1_P ,G?#S_H5/#_\ X*;+_P",T?\
M#)WP\_Z%3P__ ."FR_\ C-'_  R=\//^A4\/_P#@ILO_ (S1_P ,G?#S_H5/
M#_\ X*;+_P",T?\ #)WP\_Z%3P__ ."FR_\ C-'_  R=\//^A4\/_P#@ILO_
M (S1_P ,G?#S_H5/#_\ X*;+_P",T?\ #)WP\_Z%3P__ ."FR_\ C-'_  R=
M\//^A4\/_P#@ILO_ (S1_P ,G?#S_H5/#_\ X*;+_P",T?\ #)WP\_Z%3P__
M ."FR_\ C-'_  R=\//^A4\/_P#@ILO_ (S1_P ,G?#S_H5/#_\ X*;+_P",
MT?\ #)WP\_Z%3P__ ."FR_\ C-'_  R=\//^A4\/_P#@ILO_ (S1_P ,G?#S
M_H5/#_\ X*;+_P",T?\ #)WP\_Z%3P__ ."FR_\ C-'_  R=\//^A4\/_P#@
MILO_ (S1_P ,G?#S_H5/#_\ X*;+_P",T?\ #)WP\_Z%3P__ ."FR_\ C-'_
M  R=\//^A4\/_P#@ILO_ (S1_P ,G?#S_H5/#_\ X*;+_P",T?\ #)WP\_Z%
M3P__ ."FR_\ C-'_  R=\//^A4\/_P#@ILO_ (S1_P ,G?#S_H5/#_\ X*;+
M_P",T?\ #)WP\_Z%3P__ ."FR_\ C-'_  R=\//^A4\/_P#@ILO_ (S1_P ,
MG?#S_H5/#_\ X*;+_P",T?\ #)WP\_Z%3P__ ."FR_\ C-'_  R=\//^A4\/
M_P#@ILO_ (S1_P ,G?#S_H5/#_\ X*;+_P",T?\ #)WP\_Z%3P__ ."FR_\
MC-'_  R=\//^A4\/_P#@ILO_ (S1_P ,G?#S_H5/#_\ X*;+_P",T?\ #)WP
M\_Z%3P__ ."FR_\ C-'_  R=\//^A4\/_P#@ILO_ (S1_P ,G?#S_H5/#_\
MX*;+_P",T?\ #)WP\_Z%3P__ ."FR_\ C-'_  R=\//^A4\/_P#@ILO_ (S1
M_P ,G?#S_H5/#_\ X*;+_P",T?\ #)WP\_Z%3P__ ."FR_\ C-'_  R=\//^
MA4\/_P#@ILO_ (S1_P ,G?#S_H5/#_\ X*;+_P",T?\ #)WP\_Z%3P__ ."F
MR_\ C-'_  R=\//^A4\/_P#@ILO_ (S1_P ,G?#S_H5/#_\ X*;+_P",T?\
M#)WP\_Z%3P__ ."FR_\ C-'_  R=\//^A4\/_P#@ILO_ (S1_P ,G?#S_H5/
M#_\ X*;+_P",T?\ #)WP\_Z%3P__ ."FR_\ C-'_  R=\//^A4\/_P#@ILO_
M (S1_P ,G?#S_H5/#_\ X*;+_P",T?\ #)WP\_Z%3P__ ."FR_\ C-'_  R=
M\//^A4\/_P#@ILO_ (S1_P ,G?#S_H5/#_\ X*;+_P",T?\ #)WP\_Z%3P__
M ."FR_\ C-'_  R=\//^A4\/_P#@ILO_ (S1_P ,G?#S_H5/#_\ X*;+_P",
MT?\ #)WP\_Z%3P__ ."FR_\ C-'_  R=\//^A4\/_P#@ILO_ (S1_P ,G?#S
M_H5/#_\ X*;+_P",T?\ #)WP\_Z%3P__ ."FR_\ C-'_  R=\//^A4\/_P#@
MILO_ (S1_P ,G?#S_H5/#_\ X*;+_P",T?\ #)WP\_Z%3P__ ."FR_\ C-'_
M  R=\//^A4\/_P#@ILO_ (S1_P ,G?#S_H5/#_\ X*;+_P",T?\ #)WP\_Z%
M3P__ ."FR_\ C-'_  R=\//^A4\/_P#@ILO_ (S1_P ,G?#S_H5/#_\ X*;+
M_P",T?\ #)WP\_Z%3P__ ."FR_\ C-'_  R=\//^A4\/_P#@ILO_ (S1_P ,
MG?#S_H5/#_\ X*;+_P",U0U/]COX<ZL@CD\*Z&%$D4@,>G6T3;HI%D4%HXU8
MH64"2,DI*A:*17B=T:__ ,,G?#S_ *%3P_\ ^"FR_P#C-'_#)WP\_P"A4\/_
M /@ILO\ XS1_PR=\//\ H5/#_P#X*;+_ .,T?\,G?#S_ *%3P_\ ^"FR_P#C
M-'_#)WP\_P"A4\/_ /@ILO\ XS1_PR=\//\ H5/#_P#X*;+_ .,T?\,G?#S_
M *%3P_\ ^"FR_P#C-'_#)WP\_P"A4\/_ /@ILO\ XS1_PR=\//\ H5/#_P#X
M*;+_ .,T?\,G?#S_ *%3P_\ ^"FR_P#C-'_#)WP\_P"A4\/_ /@ILO\ XS1_
MPR=\//\ H5/#_P#X*;+_ .,T?\,G?#S_ *%3P_\ ^"FR_P#C-'_#)WP\_P"A
M4\/_ /@ILO\ XS7F'QH_8+\"_%;P_?:-9Z/I>CW-U&!#J%EIEI'<6\B.LB,I
M6-6*%E"RHK(9(6>,21EMZ_-_[-?_  22\)?!:\_M+7Y_^$DNU\Q88KFUCCL4
M5U50SVC-/YLJ_O-K22-$ X80"6-)1]O_ /#)WP\_Z%3P_P#^"FR_^,T?\,G?
M#S_H5/#_ /X*;+_XS1_PR=\//^A4\/\ _@ILO_C-'_#)WP\_Z%3P_P#^"FR_
M^,T?\,G?#S_H5/#_ /X*;+_XS1_PR=\//^A4\/\ _@ILO_C-'_#)WP\_Z%3P
M_P#^"FR_^,T?\,G?#S_H5/#_ /X*;+_XS1_PR=\//^A4\/\ _@ILO_C-'_#)
MWP\_Z%3P_P#^"FR_^,T?\,G?#S_H5/#_ /X*;+_XS1_PR=\//^A4\/\ _@IL
MO_C-'_#)WP\_Z%3P_P#^"FR_^,T?\,G?#S_H5/#_ /X*;+_XS1_PR=\//^A4
M\/\ _@ILO_C-'_#)WP\_Z%3P_P#^"FR_^,T?\,G?#S_H5/#_ /X*;+_XS1_P
MR=\//^A4\/\ _@ILO_C-'_#)WP\_Z%3P_P#^"FR_^,T?\,G?#S_H5/#_ /X*
M;+_XS1_PR=\//^A4\/\ _@ILO_C-'_#)WP\_Z%3P_P#^"FR_^,T?\,G?#S_H
M5/#_ /X*;+_XS1_PR=\//^A4\/\ _@ILO_C-'_#)WP\_Z%3P_P#^"FR_^,T?
M\,G?#S_H5/#_ /X*;+_XS1_PR=\//^A4\/\ _@ILO_C-'_#)WP\_Z%3P_P#^
M"FR_^,T?\,G?#S_H5/#_ /X*;+_XS1_PR=\//^A4\/\ _@ILO_C-'_#)WP\_
MZ%3P_P#^"FR_^,T?\,G?#S_H5/#_ /X*;+_XS1_PR=\//^A4\/\ _@ILO_C-
M'_#)WP\_Z%3P_P#^"FR_^,T?\,G?#S_H5/#_ /X*;+_XS1_PR=\//^A4\/\
M_@ILO_C-'_#)WP\_Z%3P_P#^"FR_^,T?\,G?#S_H5/#_ /X*;+_XS1_PR=\/
M/^A4\/\ _@ILO_C-'_#)WP\_Z%3P_P#^"FR_^,T?\,G?#S_H5/#_ /X*;+_X
MS1_PR=\//^A4\/\ _@ILO_C-'_#)WP\_Z%3P_P#^"FR_^,T?\,G?#S_H5/#_
M /X*;+_XS7H'@7X3^'OA?YW]@Z5I^F?:-GG_ &*TAMO-\O=L\SR43?MWMMW9
MV[FQC)SZ!111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111117'Z[X_TOPS?Z?I=Y<QQ
M7VJR31V-N23).T$+W$Q50"0D<:$O(V$4M&A;?+&K\_\ %[PSX@\7Z6UGX:U>
M/0[YY$)OGL4OV2-3EECADECB#L0JEY!* F\",.R21_CC_P $6O%FH^.;SQEJ
M&JW=Q?7LW]B^;<W,SS3/L6^1=\DA9VVJJJN2<*H4< "OW>HHHHHKY@_:N_:N
MT/\ 9*T,ZKJI\Z[FWII^GHX6:[F4 D D'9$F5,\Y!6)2H"O*\,,OYX?"'3_B
MS_P4 1?$UYXBD\*>#+F\>2RLM*<+?M';2?9VC%S$L<H1@)U:6XD<?:8_-&G^
M080GT_JW[&GBSP3;RW7@SX@>)$U8QNJ#7;B+5K.1=I81F*6#$#M(L?\ I2+*
M\4?F*(G\PBO+_P!A']I3Q;\4?'/BW0_'W^@ZY:V]@;?1XXY$M[>&V:9+F2'+
M2H?,:YMI#,TLC7*21M$[VT<8C_5^BBBBBBBBBBBBBBBBBBBBBBBBBBOS@_X*
M,?L=^(?VO=.TFVT'4K>T^P7$\D]K=O,EO/YJ*J3$PI+^]AVLD8:(_)<2D21X
M*R_=_P /?#=QX.T;3],O+N2_N;.SM[>:]EW>9<R0Q+&\[[GD;?(RF1MSN<L<
MNQY)KOC_ $OPS?Z?I=Y<QQ7VJR31V-N23).T$+W$Q50"0D<:$O(V$4M&A;?+
M&K\_\7O#/B#Q?I;6?AK5X]#OGD0F^>Q2_9(U.66.&26.(.Q"J7D$H";P(P[)
M)'^./_!%KQ9J/CF\\9:AJMW<7U[-_8OFW-S,\TS[%OD7?)(6=MJJJKDG"J%'
M  K]WJ***X_P'X_TOXGV":IHUS'>6,DD\<=Q$28Y&MYGMY"C8 =!)&X61<I(
M '1F1E8_@#_P6)F\8^$+BPBO?$4ESHFLR7QATBWMOL=O;QVK6;(L[+-(U\Y9
MDDWSX$<RN\,<2R>6G]%U%%%%%%%%%%%%%%<?X_TK5-=TNYM=%O8]-U&6,I!>
MR6PNU@8D R" R1+(X7/EAVV!]K.DJ!HG_#'_ ()\:WKFJ?'7Q5;>(=5N-8O=
M/T_5K'[7/E=RV^K6RXBBW,EO$6+NEO$1%%O*H,5]O_\ !1C]COQ#^U[IVDVV
M@ZE;VGV"XGDGM;MYDMY_-1528F%)?WL.UDC#1'Y+B4B2/!67[O\ A[X;N/!V
MC:?IEY=R7]S9V=O;S7LN[S+F2&)8WG?<\C;Y&4R-N=SECEV/)["BBBBBBBBB
MBBBBBBBBBORP^*/[#'BKQQ\9=/\ B':Z['#I-K)92&$O<"Z@CMDVRV4"+^Z-
MO<D/YI\R( 7=QN@EP?/_ %/KCY/'^EQ:S'X>-S'_ &M)9R7RV@),@M8Y8X6F
M8 $(ADD5$WE3(1)L#>5+L\O_ &I_A-J/QT\%ZOX;TJ]_L^]O[<1Q7!+A?ED1
MVAD,9#B*=5:WF(#XBE<F.49C?S#]@W]G'6?V6O!R^']<U".^N?MEQ<(L+2O;
MVT<FP""!I0K%"RM<-B.(":>0;&(,LGV?1111111111111117XH_\%?YO&/A#
M08]3M?$4EOH5Y>0Z>='M;;[.SB6UNFE>YO5F,MPCA7C:VV1VY0Q[HVDC,DGZ
M7?LG?\D\\*?]B_I/_I%#7T!111117'^$_'^E^.GOH],N8[IM-O'L;PQDE8KJ
M...22$MC:SHLJ"3:6"/NB8B6-T7L***********X_P ?Z5JFNZ7<VNBWL>FZ
MC+&4@O9+87:P,2 9! 9(ED<+GRP[; ^UG25 T3_AC_P3XUO7-4^.OBJV\0ZK
M<:Q>Z?I^K6/VN?*[EM]6MEQ%%N9+>(L7=+>(B*+>508K]_J****X_P 9>/\
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MZP]V]ND4VN"TN(=-L5N@8R\=ZNS?=KOC$)C(BCFE0F9I87MF\@_X)O?M.?\
M"->"?#GAC_A&?%%SNN)X/[5M]+\S2Q]IU"<^:UUYHQ%%YF)WV?NRD@P=O/C_
M /P7._YE'_N,?^V%?=_[17[?Z?"-[V#PYX=U3Q.VER,FJ7=I'(FFV311M)<1
M37R0W"BX@7RVGCV;(ED.^9)8WB'H'[%O[:6E_MDZ7=75K:R6&HV$B)>V3N9E
MC68N8)(YPD:R)(L;Y&U'1T=639Y4LOT_X_\ '^E_"S2[G6M:N8[/3K.,R3SR
M$[57(   !9G9B$CC0,\CLL:*SLJGX U/]N#QOJ>ECQ)X>^&^J:CX>FCBEM+B
M34((;Z>.0JH<:;#%=7&PN28V3S!);[;G*Q-E?J#]F?\ :J\-?M7Z7)J?AZ60
M-!)Y=U9W"JEU;L2WEF6-'D79(JEHI$9T<!DW"6.5(_H^OG_]H7]IWPO^R_IR
M:AXEN_)\[S1:VT:&6XNGB0N4AC7_ ("IDD,<$;R1K)+'YBD_,'PO_P""DVA_
M$7P]-K_]F:AYLFL7.FZ7I%FHOM4U%;>&&X>>.V0($\N*;S+A=[Q0!<?:)'DB
M5_+_ (._\%4T\7^,;?P=XJ\,WGAN[NY([>(S3232)=3[/LT4]N]I;RQ),'4+
M+\P!>,LHA9YH_8/VBOV_T^$;WL'ASP[JGB=M+D9-4N[2.1--LFBC:2XBFODA
MN%%Q OEM/'LV1+(=\R2QO$/0/V+?VTM+_;)TNZNK6UDL-1L)$2]LG<S+&LQ<
MP21SA(UD218WR-J.CHZLFSRI9?K_ %;5K?0+>6\O)8X+:"-Y9II75(XXT4L[
MN[$*J*H+,S$!0"20!7YX/^W+XC\>V<^M^ O ^H>(/#T'VA1J,M]!I[7+6S.)
M&L[-TFN;F(A5\ME02O*7M_(6:)DKV#]EK]LW0_VG_M5C##<:7K^FX74-'O0$
MN(67:DK1]#+%'*6A9BL<J.%\V"'S8@_K_P =/CIH?[.FAS^(/$$_DVD/RHBX
M::XF8$I! A(WRO@X&0JJ&D=DB221?B#_ (;V\7_V/_PEW_"O=0_X1#_CX_M#
M^T[;[9_9WF;?M?\ 9OE^;_JOW^W?Y/E_O?M/V?\ TBOB#_@FSXIL_'/QU\9:
MKI\GG65];ZU<VTNUDWPS:M:R1OM<*Z[E8':P5AG! .17Z7_M5?\ !0SP=^RP
M\NG73R:CKJ1JPTRU'S(9(W>(W,[?NH$8JFX9DN%26.9;:2-@3]7_  G\=?\
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MX6/VO?Y"1D+'$D<C3(9"]N4D^S_'_C_2_A9I=SK6M7,=GIUG&9)YY"=JKD
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MWPBURV\':)I]QXC\77FSR=+M)$C6+>58?:[AMPM\Q%YQ\DFR)/-F\B"1)C\
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M1HOO_P +?%70_&FAQ^)K"_MY=%EMVN1>EPD*PH"9'D9]OE>7M83+)L:%D=9
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M+^U!J+Z?X:T+Q!-Y/E&ZN9(+&*WM4E<('FD:^_WF$<8DGD2.1HXI/+8#ZO\
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M-$7\8/\ @J5X 3]FSXC:!X\T.VLX6O)%OC#B3;-J6G7*32S31*44)*LMMO\
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M3>QD;<[*L:I^6'[ O_)POCW_ +C_ /Z>;>OU^_:Q_P"2>>*_^Q?U;_TBFKX
M_P""*G_)/-2_[&"Y_P#2*QKYP_X*(:3;Z_\ 'WP19WD4<]M/'H44T,J*\<D;
MZQ<JZ.C JR,I*LK A@2""#7]!U?@#^WU_P G"^ O^X!_Z>;BOW^K\ ?V!?\
MDX7Q[_W'_P#T\V]?K]^UC_R3SQ7_ -B_JW_I%-7P!_P14_Y)YJ7_ &,%S_Z1
M6->(?\%8/'%QXK\=>#?!*V,FH6WF6]Y)IXO6MH]2DO+O[+';,WRK X6"6-+H
ML3&+N0CRPK%_N_\ X:'^+W_1,/\ RZ=-_P#C=?"'[&?[*WQ*^%'Q9D\47/A^
M/0O#VI2:F+NWBN].GCM[6X$EQ;VJ+#(7"1SI;*K0QQG" $+$76N/_:T^*.N?
ML-_'2;QS]D^V:;K>GHHA5C$MQ"EM#;20-</;R+'+%<6\%RPA#MY1@5F59V6O
MT/\ !?QP\!_\%$K6QATF[DAU31-4T[6TL[J)H[JW:QNQ\WEI+Y,R2Q>9"SQR
M7"6XNHGD19O+CK]#Z*X_XA>"K?XE:-J&AWC2);:E9W%G,\142+'<1-$Y0LK*
M'"L2I96 .,J1P?S0^%?BKP-_P3#T/_A#9]7N-?U^\U!ISIUA;++?2W%P+:*.
M*.T21A;YB,#QI<S![@^8\)?<L*_$'PM\87GC_P#:EM]4OM.N-)EN?,=;*Z*F
MXCA_L!Q 9U3(BEDB$<LD!):W=S S,\;$_I__ ,%1_P#DD/B'_N'?^G*TKC_^
M"3?@#2_#/PPT[5+.VCBOM5DNY+ZX )DG:"\N+>$,Q)(2.- $C7"*6D<+OED9
M_B#]N[2;?3OVB?!,L$4<<ES)X?EG=$56ED&JRQ!Y" "[B...,,V2$C1,[54#
M]7_VR?V5K?\ :^\-)H$]])ITD-Y#>07"1+,HDC62(B2(M&70QS2 !9(RK['W
M,JM&_A^E?MF^$OAK%I_@+P)#J'C+4M/T^&UMX],$<\*+!%!#;O>W_P"[MHXG
M,D:S74(EBMV\SS4C95C;X@_X(8_\S=_W!_\ V_KW_P#X+5_\D\TW_L8+;_TB
MOJ^__P!D[_DGGA3_ +%_2?\ TBAK\@?^"HWP_P!1_9V\::)\7?#I\N62XAAN
M\NX4WEO'^Z$FV=9&BNK6-[>:*%8XQ%;N'<O<\_M=JWQ>TO3O"LOC&)I+G28]
M+?54:)"));5;<W(*1R^60[1C*K)Y9!(#;><> ?L&^"KC0/!RZY?M&=1\5WEQ
MXDO$A+&WCDU39*D< =0ZHL(A#([2E9O,Q*Z;37YX?\%-M7US]G;XE>$_B=8Q
M>;96UNMDP4$9:*6X>>WED>&2*+[5;74D<+C?*-D\BHIA5C]'^$_VJO ?_!2C
MPU?>!Y)9-+UC4[-P+&Z5BR3PK'.L]M)&\:7203 2K$7AFF2WD:2W2#>:^S_V
ML?\ DGGBO_L7]6_](IJ^ /\ @BI_R3S4O^Q@N?\ TBL:P/\ @L1X<US1K/PO
MXVT8[?\ A'=0E9Y5C,C033M;26L[*8WB\I9;4(QF(4RRP1[7\P@>G_ K_@H[
MX#_; MW\)Z]!)I-]J\<EB]A<2,UO=+<K+&88+V(1D.T85?WJVKF:9(H#,^&/
MZ'_"?P+_ ,*O\/:5H/G?:/[,T^TLO/V>7YOV:%(?,V;GV;MF[;N;;G&XXR?0
M*^$/VX_V-]&_:KM]+O-9U632+;0I+B>XF B\MK.58VN@SRE5@<+ C)<,7CA
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MNK"[<^2&??;APHC\F*5;H3C<J1K7H'[?7_)PO@+_ +@'_IYN*_?ZOYT?V,?
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M9[J^UYO-^?3K-(0+7Y,JIEGN)H/EW/)'!\[0>7/'/']/U\__ +6/_)//%?\
MV+^K?^D4U? '_!%3_DGFI?\ 8P7/_I%8UX!_P7._YE'_ +C'_MA7[_5^ /[
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MR:GHUQ&;F*.#^T+(,YDL[B6(2&)O,CB:1 V^-+A4$,QCDV,2CA<_Q%^T+O\
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MB[Q_X_TOX6:7<ZUK5S'9Z=9QF2>>0G:JY    +,[,0D<:!GD=EC16=E4^?\
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MK_ '@#2_A9I=MHNBVT=GIUG&(X((P=JKDDDDDLSLQ+R2.6>1V:1V9V9B>/\
MP!I?Q3TNYT76K:.\TZ\C,<\$@.UER""""&5U8!XY$*O&ZK(C*ZJP_.#X<_\
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M3V,MO=)$X<)-&UC_ +RB2,QSQI)(L<L?F,3\_P#_  6K_P"2>:;_ -C!;?\
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M)FJ7&DI&D<BV6FVMAJ#+$H\LKJ>^>X5]ZH99&\QYTWH['S&:OK_X0_!?P_\
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MU.Q@O(+Z'2X#)8:>]U P=)KJW6XG%PZ216TL6#$%>W02"9#L7[O^.GP+T/\
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MX:4>8DADV1!YHTA".@B^D/ O[(L7@?P]-I4&NZPFKZAL;6/$,4L3:IJ#+"T
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M6(^C])U:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$@U\8>*?\
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MQ_8%_P"3A?'O_<?_ /3S;U^OW[6/_)//%?\ V+^K?^D4U? '_!%3_DGFI?\
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MTC3]*T^TTV[_ +#^TV<%I#%;S>;JT\<GFPH@C?>@"/N4[D 4Y4 5^[UCX/\
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M0>3K4VH0Z?<RQX5;F%K>>1&F7'S2Q^0J1R@AO*)C?>J0B+]7OV3O^2>>%/\
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M-EHVGN]O:ATM83Y,>VWM8SM*1>8PCMX556PSHB(QVJ?S@_X)8?#2?QWIU_\
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M'VJ>'-=ETN":#2VET;32Z)<1W"(\&GO:6T1$RHLH\H-$HA6$3)(1;B85X_\
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M3^(+7S6C!::;;:ZBZ^=/(7FFV&1Q'YKOY:L43:F%'ZO?LG?\D\\*?]B_I/\
MZ10U^0/[ O\ R<+X]_[C_P#Z>;>OU^_:Q_Y)YXK_ .Q?U;_TBFKX _X(J?\
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M\(W>7YIRSR33!(O.,2?FA_P7._YE'_N,?^V%?O\ 5^ /[ O_ "<+X]_[C_\
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M\NZC4E@IWJXV[0K-Y?\ \%J_^2>:;_V,%M_Z17U??_[)W_)//"G_ &+^D_\
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M#X>_[B/_ *<KNOO^BOP!_P""YW_,H_\ <8_]L*_?ZOP!_8%_Y.%\>_\ <?\
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MU_\ A:>[PO\ :/M&[[!]MU#9]G^R_8?*\W[#N\W[/_RVV[//_>^1Y?[BOO\
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M<$RSVL5Q';N$/DWT-YY=M-DGY#&)49X%N#';2>4B_;_P!_9D^)GQ7U'3-?\
MC)JWGQ:-<"]TS1;<V\>V^C<B.XO6L8XX7\H(LENB/.3YI#/$GGV]QZA^VA\
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M22'[1;^=!!);R00+ DL3SM'#);R11B*XMY2Q)9@5F@F=(.O^,?[/OQ<_:O\
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MUU?('[67_"T/^))_PK7^S_\ D(+_ &I]LV?ZCY=F[?\ \NG^L^U?9_\ 3O\
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M6OV9-<^'^HW7C#QWJW]M^,;ZW%DT\1*6=K8HZNEO;1".!/G9%FE?RHQYA(1
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M?!=UX<U2\CDC@(NK?:9[B2X4^4MC:,H%TADV0%_.B/G">-8V:$"7V#]G_P
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M+)%&F2Q5IY(A((Y5C,CQLE=?^RY\=/\ AI3PAI_BO[']@^W_ &G_ $;SO/\
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M:9I]G9W-_)YM[-;V\4,ES)N=M\[QJK2OND=MTA8Y=SG+'/844444445^ /\
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M!*5U_P"SUXIO/'/@WP_JNH2>=>WVCZ=<W,NU4WS36T<DC[4"HNYF)VJ%49P
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M-M9:QJ!B:^GNY?+LI'%R18^=$T<RPQ",_98F\B.+<)H_U?HHK\$?V4OAD?\
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M_#&_O+7PXEY']OT%YKJXL8YY(_*\Z5&=E>WG5%AD>=EFAN&A\F;,D(MOT_\
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M,GV=8 [2E;B9O.>1I<OLW^2JQ+@?\$WOV8_^$E\$^'/$_P#PDWBBVVW$\_\
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MC/I>MZ7XAO9-072)+-[6YN&:6Z*WAN3)'+,[%I45H08B^70.R;S$L21_!_\
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M:5((E+MD(ADD3S'PY1-S+'(P"-\(? O]DZ#]KG0X/&GQ8^T:OJ&L?Z;8:?\
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M^RCX.N?$"QQSWSR1VNGP2^9Y<MU+N(WF-20D<:2SLI:,2"(PB6-Y$:OC_P"
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M;".V$]I:VVRZNI)[V"(-_: F$MNB!E*I!&I<>:DDDB2JL78?\$N/^20^'O\
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MN^+WPT?XM:6VEIJNJ:.KR([W.E3QV]T50Y\L3/%*T:%MI8Q;'8+L+^4TB/\
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MSC',AC!_7_\ X=<?"'_H7O\ RHZE_P#)=>P?!W]ESX?_  0_M72/#VGV\/\
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M/M%[']J'D>19B0_;HY]T2+#]FN&,DC7$AD/VDJ%6.W./L_\ 8 TFXUWP_?\
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M_P#[?UX_\=_"WASQS^T]-I7BR/SM(OKBQMI8MTZ;YIM(@CM$W6Y65=URT(W
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MQ]/ZMI-QH'P"EL[R*2"Y@\!O%-#*C))'(FCE71T8!E=6!5E8 J000"*^;_\
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MB6UG3#A3\DL4B;@-K;=RED*L?;_'_C_2_A9I=SK6M7,=GIUG&9)YY"=JKD
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M ']@7_DX7Q[_ -Q__P!/-O7O_P#P6K_Y)YIO_8P6W_I%?5]__LG?\D\\*?\
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M'_!335KC1?A)XBEM99(9&CLXB\;LC&.:^MHI4)4@E)(W>.1>CHS(P*L0?/\
M_@DGXUM_%7PKL;.!9%DTJ\OK.<N%"M(\QO08R&)*>7=1J2P4[U<;=H5F^_\
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M.\"+<>)/$-U<6;VD,&FW(^Q[+F,27DLUU##';1!&:W>?<-OVD*^V%Y77[?\
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M,MQ]KOI/-@>/RE>X9+4$->&W6&*XCDG_ '/M_P#P4\_8^UGXOI8^-O"'F?\
M"0Z''AXH&E6ZGMXY//A:T*O@7%M(99$2-5FG$K!9&EB@ADZ#X0_\%6_!FH:6
ML?CB63P]XCM9'MM0L'LKV15GA.UWC\N&5HT+9!AF(FA=7B;S BS2\?X;^!.N
M?M=_%6R^).OZ3<:+X;T6WMETJSU",V^I74UN\LB-/;QW#M!Y-V\DX:38LT*6
MJ""5)9I%_7^BOE#]M'Q>=%\%:SIEO8:IJ5]JVEW]G:6^G:=<WC&2>'R 9'AC
M:*%%,PD)F="Z))Y2RNNP_$'_  22;4OA5H-[X5\0:+KFF7UQJDMY!+=:3>16
MLD;VL*$?:3%Y43H;9MPG,0<R1+&TCLR+U_[1O[0^N?LY?%H:E!IFH:EX9/A>
MU;7A8V)NGMUAN-6>UG\S=&D&QO,W&618F@,[%6>.-H^ _;#_ &EO"'[:GA"Y
M\'>!%N/$GB&ZN+-[2&#3;D?8]ES&)+R6:ZAACMH@C-;O/N&W[2%?;"\KK]/W
M7P4_X9V^!&J>&&D\Z6Q\+ZO]HD#;U-Q-;7$]QY;>7$3$)99!#N17$00-E]Q/
MC_P3_P""E6F>$='M=-^+"ZAX?\30VZ-.;O2;J%+U6DF1)X(X8Y7&5B7SRT<$
M1G9UA78I6/@/V9/@/_PM_P",>K?%FSL;C3O#*Y?2&E@^QMJ-Q<V<<$MXEN\>
M][299+BY$[>2\TLT+_,XNHX_#_VX/#_B7]D_XP0?%RPTZ35-)>.&6=_*86\#
M"V72YK:6:-G,+O&R/;SRJB&:=46.?R)%;[?\%?MH:W^V#;M:_#/1[RR@:0VU
M[XAU9;=+?3695??;VL<TQU"X$>_;"&C2&9K5I\P2G'P!_P $=H?&/A"XOY;+
MP[)<Z)K,EB)M7N+G[';V\=JUXKM K0R-?.69X]D&!',J)-)$LGF)]0?\%3OV
M'-4^/21>,?#IDNM4TVS%M/IH +7%K')+,'M0!N:X1I9"T)W&=,"+$T:Q7'R_
M\(?^"OGC'P@B^'/$OAV37/$*7CVP9)/L%T\C2;%MI+..SD!N%D+1 1K$2-B&
M(RJ\DGZ?_LK> /$OC+6;[XF>-K:.PU;5+.*QTK2E#"32])25IQ#<-E1)<3R%
M)I?,3S82F,P>8]I;_=]%?E!^T;^T/KG[.7Q:&I0:9J&I>&3X7M6UX6-B;I[=
M8;C5GM9_,W1I!L;S-QED6)H#.Q5GCC:/@/VP_P!I;PA^VIX0N?!W@1;CQ)XA
MNKBS>TA@TVY'V/9<QB2\EFNH88[:((S6[S[AM^TA7VPO*Z_H]^RQ\%/^&=O!
M>D>&&D\Z6QMS]HD#;U-Q-(\]QY;>7$3$)99!#N17$00-E]Q/X _\$^?C?>?L
M1>*-?\)>(?#VL7>J7WV=/L>G0+<WB360GDPMOO031213O,)XI&7RXUD19(I?
M,3ZP_P""JWP7\8_%OP=H'BB6QC$VCQWT^KV4!WR64=[]GD4#:TBW"6BP^3=7
M$; .1]K6"*W,@M_;_P!G3_@H=KG[5FG+IOACP]N\30VY.HW5W*8=#LV*2B*8
MS1^?=2>;(B>79"-965I5%SLMWN#^<'_!+_XGZY\)=1\2^%-(T:XN_%6I?9([
M>*X0PV=@UD]S'<S:JQ99H8H#.I:-$:6:1?LJF.:6,GZP_P""W/@#5-=TOP]K
M5K;22Z=ILE_'>SH 5@:[-H(#( =RH[1.@DQL#[(V8/+$K_=_[,7[75Y^U?\
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M5/++K/NCE81&)1(WB'_!4[]AS5/CTD7C'PZ9+K5--LQ;3Z: "UQ:QR2S![4
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M<67P_P!&\Z5[[4('M9M4\V2&1UM(A.MPUI=01VQM[HI;^6KW+EFFCC@/O_\
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MBBBBBBL_5M6M] MY;R\EC@MH(WEFFE=4CCC12SN[L0JHJ@LS,0% )) %>/\
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M4A:+6-1-NKJS);7=O)!:V\[D+;I=B"X/E+/))!#-L'SA^R'_ ,%+=<URSO\
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MVU/&FJ^-+[X;_$T?\3K]ZUI*\$<,RS0QB1[4K:Q"W>)X0]U!<?*I56Q+.L\
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MC]L72]0&IV<=IJVE20BY:WW"UECN3*8&B61Y)4<"%TE1F<959%D_>&*'S_\
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MI\=_/&.$&N:@2+,7$4N5F\JT#7-I- @:VG9LW 9O*K[_ **_ '_@N=_S*/\
MW&/_ &PK]_J_ '_F[S_/_0N5^OW[6/\ R3SQ7_V+^K?^D4U? '_!%3_DGFI?
M]C!<_P#I%8UY!^R5K_\ PM#]I/QEJ&H6]NUQ96^I06Q$>?*^PW5IIL<J%R[)
M*UNA61U*[O-E4!8W*#]WJ_ '_@AC_P S=_W!_P#V_H_;Z_Y.%\!?]P#_ -/-
MQ7[_ %?@#^P+_P G"^/?^X__ .GFWKW_ /X+5_\ )/--_P"Q@MO_ $BOJ^__
M -D[_DGGA3_L7])_](H:_(']OK_DX7P%_P!P#_T\W%?O]7X@_P#!9'X.2VUG
MH_Q$TIKB'4M+N(K.>>W$NZ.%F>>UN#*CA;?R+@,B2!0SRW<8,H9(E/W?JW[8
M-A-\)I?B99^7$ITMYX8I5FEC34"3;I:OM2*21!>XMFE41HP!E#I$=X] _9,^
M$+_!7P=IVG7BR?VM/']MU>69XY;B;4KO$UV\\\?$[K(QB65FD8PQQJ99-H<_
M1]%?@#_S=Y_G_H7*_?ZOP!_8%_Y.%\>_]Q__ -/-O7[_ %?@#_P2 \1V?Q/\
M9>-/$VHBW37[[9<1QQR,F(;VYFGOA#"TC%HEE6T!=O,:+,:^8/-._P#?ZOYP
M?V<O#EY\ OVG+[P_:&WM[2]N-45X+:-1"+&YM'U2U@13&OE>7MMMPB"A6B,:
MLT1._P! _;Z_Y.%\!?\ < _]/-Q7[_5^ /\ P0Q_YF[_ +@__M_7O_\ P6K_
M .2>:;_V,%M_Z17U??\ ^R=_R3SPI_V+^D_^D4-?0%? '_!4?_DD/B'_ +AW
M_IRM*/\ @EQ_R2'P]_W$?_3E=U\ ?\%SO^91_P"XQ_[85^_U?@#^P+_R<+X]
M_P"X_P#^GFWH_P""E^L:QXC^,G@;0;*^^Q;/[-EL9_(CF^RWEYJ;0M<[& \[
M'V:W;RI&\L^5@!=[EOO_ /X9X^+W_13_ /RUM-_^.5X_\"/^"9MY\)/B!#\0
M-0\3_P!JWHN+ZYN8O[+6U\^:]AGCD?<ETZ1_-.9-JQ[>-@"@@C]7Z*_ '_@A
MC_S-W_<'_P#;^O?_ /@M7_R3S3?^Q@MO_2*^K[__ &3O^2>>%/\ L7])_P#2
M*&OR!_YN\_S_ -"Y7T__ ,%DO%-YX?\ AK%;6TFR+4-8M+:Z7:K>9"L5Q=!,
ML"5Q+;PON0JWR;<[&96/V>O@3\4M7\&^'[G3_B+]ALIM'TZ2VM/^$;T^;[/"
M]M&T</FO('E\M2$\Q@&?;N(R37 ?&O\ X)5^(_VB=1CU7Q/X[^W7L-NMM'+_
M &#!#B%'DD5-L%W$APTKG<06.[!.  //_P#@H[K_ /PEOQD^'OAB^M[>?38K
MC3YVCDCW^=_:&IK!/%,KDQO$4M(P$*#.^0,75E"_N]7X _\ -WG^?^A<K[__
M ."H_P#R2'Q#_P!P[_TY6E'_  2X_P"20^'O^XC_ .G*[K0_;(\6?#+X'W&E
M>./&MC'=:S82&/2!$@DO)&#!F*1-)'%*EN6\Y9+@[+61@\3)<S1B3X0_;2\8
M?%7XN?#/6M7\0:=I_A?PV/[.E33&+W6KW >XLU1)Y#MB@B\V4SD>5!>1R6ZV
MSPA&DD?[?_X)<?\ )(?#W_<1_P#3E=U]_P!%%>?_ !5\+:'XTT._L/$T=O+H
MLMNYO1<L$A6%!O:1Y"5\KR]OF+,&1H602JZ,@8?FA\*?VEM9^)5O%X<^!/AJ
MSA\.:1)]E?6=9,L&GJ569RD4$3_:YGE_<S&<L]P'GS=6T9F$Y^4/^";.G7FD
M?'7QE;:A=?;KV&WUJ.YN_*6'[1,FK6JR3>4A*1>8P+^6I*INV@X K^AZBOY@
M=;\)_%#_ ()7:YJNH>'[3[1X5NKCBYFA2\MI[>,LEI]MDA$4UK*ANPO6T2>Y
M#*GGPK@_J_\ LE_MT>"_VN-1M)7C_LOQ=!;W]O#I\TTDF;:1[>:8V\P2.&?>
M+>"0HRK<Q^1,5C\A7ED^(/\ @I?K&L>(_C)X&T&ROOL6S^S9;&?R(YOLMY>:
MFT+7.Q@/.Q]FMV\J1O+/E8 7>Y;[_P#^&>/B]_T4_P#\M;3?_CE>/_ C_@F;
M>?"3X@0_$#4/$_\ :MZ+B^N;F+^RUM?/FO89XY'W)=.D?S3F3:L>WC8 H((\
M _8J\4WGC#]HSQU<WTGFRI;ZM;*VU5Q#::E9VL"80*/DBBC3<1N;;N8LY9C^
MYVK:3;Z_;RV=Y%'/;3QO%-#*BO')&ZE71T8%61E)5E8$,"000:S_  MX3T[P
M-9QZ?I5I;V-E#N\JVMH4AA3>Q=MD<85%W,S,V ,LQ8\DFOPA_P""&/\ S-W_
M '!__;^OO_\ X*C_ /)(?$/_ '#O_3E:4?\ !+C_ ))#X>_[B/\ Z<KNO@#_
M )N\_P _]"Y7[_5^ /[?7_)PO@+_ +@'_IYN*_?ZOP!_X(8_\S=_W!__ &_K
M]?OVL?\ DGGBO_L7]6_](IJ^ /\ @BI_R3S4O^Q@N?\ TBL:\ _X*7ZQK'B/
MXR>!M!LK[[%L_LV6QG\B.;[+>7FIM"USL8#SL?9K=O*D;RSY6 %WN6^__P#A
MGCXO?]%/_P#+6TW_ ..5X_\  C_@F;>?"3X@0_$#4/$_]JWHN+ZYN8O[+6U\
M^:]AGCD?<ETZ1_-.9-JQ[>-@"@@CP#]O;]FCX@> OB OQ3^'<-Q=7#V\?V@P
M)#=7%M<"$:>?+LWB9I8I+=H\;%N71Q<2OY,:QFN@_9V_X*I^'/CRL>A_$BVM
M])N!<6=Q;WL3SBQFN;>]2>W#C+26GE.EO(7FEDMI!',TTD,>V)_V^HKY_P#V
MG?"W@OQ/X7NSX_CMWT"UV7,[SM(GE-&<(\3PE9EE8MY2+ ?-F\PVZA_-,;?&
M'PX_:%\>?M/V\$?PQT2S\->#TC>UBUG5HU,@2-88?^)=IUN_E![8F80JYGLI
MC (GE@='A/RA_P $,?\ F;O^X/\ ^W]>_P#_  6K_P"2>:;_ -C!;?\ I%?5
M]_\ [)W_ "3SPI_V+^D_^D4-?D#_ ,W>?Y_Z%ROU^_:=\+>"_$_A>[/C^.W?
M0+79<SO.TB>4T9PCQ/"5F65BWE(L!\V;S#;J'\TQM\8?#C]H7QY^T_;P1_#'
M1+/PUX/2-[6+6=6C4R!(UAA_XEVG6[^4'MB9A"KF>RF, B>6!T>$_*'_  0Q
M_P"9N_[@_P#[?T?\%SO^91_[C'_MA7[_ %?SP_'SR/V#OC]8^+%^T1:!K^^X
MOBOVA(1]K+PWZLX\XW7DR^7J;0*O#/!$D<>(9*_2_P#;GU:X\5V^A?#ZPEDC
MN?%^J):W8A=HK@:/;+]HU66"8D0JZQ!$:.7S//AEDB6"4DA?M_2=)M] MXK.
MSBC@MH(TBAAB14CCC10J(B* JHJ@*JJ %    %?AC^WM^S1\0/ 7Q 7XI_#N
M&XNKA[>/[08$ANKBVN!"-//EV;Q,TL4ENT>-BW+HXN)7\F-8S70?L[?\%4_#
MGQY6/0_B1;6^DW N+.XM[V)YQ8S7-O>I/;AQEI+3RG2WD+S2R6T@CF::2&/;
M$_U__P %1_\ DD/B'_N'?^G*TH_X)<?\DA\/?]Q'_P!.5W7W_17X _\ !4KQ
M'9^*?BGX(\,Z\+== A^R7%W))(T/[G4-0$%X)IO,41Q+%:(0Z^6T>Z1C)]W9
M^_U?A#_P6]^&GVG3O#_B>)+=?(N)].N)-N+B3ST$]LNX+\T4?D71PSC8\V44
M^9(5]_\ VPO%-YXY_9O.JZA)YU[?:/X=N;F7:J;YIKBPDD?:@5%W,Q.U0JC.
M  ,"O8/^"7'_ "2'P]_W$?\ TY7=??\ 17YP?M2_$_X=?LP>*+7Q--HW]J?$
M#4K<VNGVUDF^\F#!HHGD3<4B\Q@MFMT(Y+QXRT$230Q2QI^>'_!2V]^)OBOP
M59ZIXVATO1]..N*EGHMF3<W09X;WRY+V[WO"7BBBQ&+7"3BY=Y4B>)(E_:[]
MD[_DGGA3_L7])_\ 2*&OR!_8%_Y.%\>_]Q__ -/-O7W_ /\ !4?_ ))#XA_[
MAW_IRM*/^"7'_)(?#W_<1_\ 3E=U]_T44444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444444444444444444445_/C_P4U_8<U3PKJD_Q0\'&0*)$N]2@M@(I
M[*>(*3J-N80K%"RB:Y89FAF+W9=XGE:V_2_]D?\ ;I\+_M.Z=90+?6\'B1K>
M/[9IC@P.;@(YF^RI(S>?%^ZDE7RI)GB@*&?RW)6OI_XE_%70_@WISZKXAO[?
M3[)-P\V=PN]E1I/+B7[\LI5'*0Q!Y9-I"(QXKS#X(7OB7X@7%QXGU^&32[2Y
MC6+1]%<LMQ;6I;>]SJ*J_E&]N2(F\@JYTZ&,0+)YT][O_&#]K'P1<?L*?&73
MOB9:6<DWA[4;QKBX=8VD6.XNDEBU&!2TX)N)(WFO+;S&AA+R&-$:*VE _>[P
MM\5=#\::''XFL+^WET66W:Y%Z7"0K"@)D>1GV^5Y>UA,LFQH61UD",C ?D#\
M)M%G_;*^/-[XW1?M/A/PKFSL+F2"WEMYKBWC*)'!(CE9,7$T^I0W"^<\:"VW
M>29K<)Y?_P %RM6MYKCPI9K+&;F*/5)9(0ZF1(Y6LUC=DSN5':*548@!C'(
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M^ZY\4/A'/X3\6W/V_P 0ZEI]Q+<37+F-8M2GE>]@1VMFD416EPT42B'="T4
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M-'M=-LKB&34)VD4,L:VC.DL;X.93<"%+5 \MR\$,4LB?DA_P0Q_YF[_N#_\
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MJ-RELT,C%P5CFF\J*Y3*%@\))"-&98X'?RQ^.'_#37ART_:-_P"$ZOI;BQT
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MVY>,Q/-9V-O;R-&65BA>*-6*%E5BI."54XR!CC_^&3OAY_T*GA__ ,%-E_\
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M_2YWTG0=4UC4?L<MPDT-C/)IMHJ''FW]T@"JBJ))3%&2Y6+$C6R2QS'\P/\
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MW^G6H#$1!28HO,MA,TSNH,GV:!/,!54?V#_@K9\??^$]\/)X>_L'Q!8?8/$
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M\0O&MO\ #71M0UR\61[;3;.XO)DB"F1H[>)I7"!F52Y52%#,H)QE@.1^0/\
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M_@A]XUN+_1O$FALL8MK.\L[R-P&\PR7L4D4@8[MI0+9Q% %!!:3+,"H7C_\
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MLZ/X=D\17VB1WEG8V#ZNEFMI':/'ITES'+.HB*2%YV-KM(5[UY!N>,RG[?\
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M/%7C+XGS6\EK'J-Y<6]K&)HY(PUY<?;[N)OE65GA'V,)+MB1Q))A6;(BX_\
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M8%<20VKNS[(4S^_VK:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@*
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MT74&=W=B%5%4%F9B H!)( K0_P""YW_,H_\ <8_]L*_?ZOP!_8%_Y.%\>_\
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MG:M;Z!\&-$O+R6."V@CU26::5U2..--0O&=W=B%5%4%F9B H!)( K\P/V_\
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M;$=-\)_$;4+/18_+%K:ZAI5IJLT"I%'%Y:W,SIB(;/W4,4<442G:$+;Y'T/
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M4OS!DGC*_-^UVDZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515 554 *
M*_,#]JK_ ()4>&OVA]4EU[3+R30M4NI%>\,<"W%K.V'\R4V^^%DN)&*&2190
MCE&=H6FE>8FN?\$QT\:>&+K2]?\ %&J:WKL\:1V^K:F9+R/3U%U'/*;&SEN"
M87GCAB@GD,[NP4E62-Y(7^H/V9_V+/!W[**2-X?MI'OIX_*GU"ZD\VZEC\QI
M F0J11IDJ&6".(2".)I!(\:O7U?7Y ?\%J_^2>:;_P!C!;?^D5]6A^SM^RAX
MLTKPKH6H^"?&UYX?L=1T/2KB?39["+5K>.ZDMQ-/+:B[E MDFDE>66*-<-,S
MMNV>5%#]@?LV_LD:7^ST]SJ<EW>:UXCU".%+_6M1D,UU*L<<:>5&S;FBM]T8
M81EI'P(TDFE$,.SZ?U;2;?7[>6SO(HY[:>-XIH945XY(W4JZ.C JR,I*LK A
M@2""#7XH_$O_ ((EZ'X@U%[GP]KMQI5E)N;[)/:"^\MF=FVQ2^?;N(E4HB+*
M)9?E+//(6^7[O_9$_8<\-?L@V\KZ<9+W5KJ-$NM1N HD*JJEHH$48@MVD4R^
M7F1V.P2S3>5$4/VF/V)]-_:N>-?$&MZXEC!)YL&GVLMG%:Q2>6L9?!LGED?
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M78>-?B%HWPUMUO-<U"STVV>01)->7$5O&TA5F"!Y652Y568*#DA6., X\O\
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M9Z-\//#,N-4\47!BGCBN8XYFMV9((K9U?!2*[EEVF4R1(RVTT+%XGF"_I?\
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MEZ!?VUG>:)X2L_[4U,.()VDOK\M'8V$JY6>! D#7LB9DM[I!#'<0%3 [<?\
M\%4_VG=1_9[\)6UEH5W]CU?6KAX$D5'\Z.SBC)NI8)1\D4H9[>,.3YBK,SQ
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M"[3Q+J<'F>)/$'GZA=W]QY4]V\-Y(LD2BY4&4Q2Q1P73Q22.WVB21GVO\B>
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M?$G1OVY_A]IU[XCL;/5+FUD^SZA#>6L4\8U"V0*9PDD"0AY8I5G'DKLA%PT
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M?Z/I;)-J5K#.EG9I;*;6QLX9%>."*%'_ 'CH!)=3M)<2L6=4C_/#X!>"K?\
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MRMIHD\2/8K>/9VRRWT\; BYE\ITAMTF!CM0)I$4RS;X_+_\ @JG\'=&_9?\
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MYF9FP!EF+'DDU^C_ /P5'_Y)#XA_[AW_ *<K2C_@EQ_R2'P]_P!Q'_TY7=?
M'_!<[_F4?^XQ_P"V%?O]7X _\$,?^9N_[@__ +?U]_\ _!4?_DD/B'_N'?\
MIRM*/^"7'_)(?#W_ '$?_3E=U\ ?M]?\G"^ O^X!_P"GFXKZ?_X+)>%KSQ!\
M-8KFVCWQ:?K%I<W3;E7RX6BN+4/AB"V9;B%-J!F^?=C8K,OT!_P3D^)?_"T/
MA?H,[O;M<65N=.FC@;/E?87,$*RJ6=DE:W2"9PVW=YHD55C= .P_;IU/2])^
M&7B>36!&;8Z7<1H)(C*OVJ4>79$*%;#BY: QR8 B<+*60)O7Y?\ ^"/7@JX\
M*_#(7D[1M'JNJ7EY $+%EC0161$@*@!_,M9& 4L-C(=VXLJ_*'_!#'_F;O\
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M2Q( !)K\P?\ @B/XUM[_ ,*ZYH:K(+FSU1+R1R%\LQWMND484[MQ<-9REP5
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M+-9$MM2L]&O(4E"B18[B]LI4#A690X5@&"LP!SAB.3V'_!+C_DD/A[_N(_\
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M L0"\DCI'&O5W944%F /Q_\ \$>O!5QX5^&0O)VC:/5=4O+R (6++&@BLB)
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M72>"K>/Q9X/OY)7.G2WT-E<0L$012N\X2*.XR?*:2W$J74,),L,#_9A![?\
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M#D;_ &?2O.GAL_/C9;>UFE,2PG?=1RW-[;OE9FC*QK-+:Q%6\/\ VS?!,O\
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MQGTO6]+\0WLFH+I$EF]K<W#-+=%;PW)DCEF=BTJ*T(,1?+H'9-YB6)(_E_\
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MYOM&KZ5;I-;7;;VFN[,,(G,[;2AE@9H4,K.)+A959D:2*::3]?Z^0/VWM/\
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M$U6SDET_^T+/Q)\LT/B(W]W-?+?(PD%[(&G$3RO*/,FV+$26<Q- ^QT^</V
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M'E63R8A@3WUQ()'NQ*ELHV-=-7E_[1W[./B#_@EUX@T_QMX)U"2;1YI%M?\
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MY']OT%YKJXL8YY(_*\Z5&=E>WG5%AD>=EFAN&A\F;,D(MOT_\/\ CS5/VK_
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M:?XV\$ZA)-H\TBVO^E,C2>8R&22SO(XQ$MQ;SK$\B/&J&,IC]S/#;W$O[_>
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M#S3(\$+1VZ1.?F#_ ()-?$/7/ 7B;Q'\*]5F^U6^D?:I8&64M#;36EX+6Z2
M/&LABG>990"8U1HV<0B2XE:N?_X*I^&?&7P"O+;Q7X<\2^(+?2-5N'AN;1=6
MN5AM+PJ94$"_: XBG59G$2H8[=HF576.6&&/]?OV7I]'U3PEINH:'>ZAJ%E?
MV\5P+G4K^2_NV=HT219I'FF2.560K/! 4@BN!*JQH=PKX@\8_#"_^)OQK.C:
M=XA\06F@6&CQ:GK-M9:QJ!B:^GNY?+LI'%R18^=$T<RPQ",_98F\B.+<)H_U
M?HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK\ ?^;O/\_P#0N5^_
MU?@#_P $,?\ F;O^X/\ ^W]>_P#_  6K_P"2>:;_ -C!;?\ I%?5]_\ [)W_
M "3SPI_V+^D_^D4-?D#_ ,W>?Y_Z%ROV._:;U:XT#P+XEO+.62"Y@T/4Y89H
MG9)(Y$M)61T=2&5U8!E92"I (((K\P?^"(_C6WO_  KKFAJL@N;/5$O)'(7R
MS'>VZ11A3NW%PUG*7!4 !H\,Q+!?VNK^>'_@E]\-/^%=_&3QAI]BEQ+IND6^
MIZ<MS(N[&S4X$@6:1%6,2R);R,  F_RY&50J,%Z#_F[S_/\ T+E?O]7X _M]
M?\G"^ O^X!_Z>;BOW^K\ ?\ @AC_ ,S=_P!P?_V_KW__ (+5_P#)/--_[&"V
M_P#2*^K[_P#V3O\ DGGA3_L7])_](H:^(/%/[7GBC]ISQ;)X+^$<EO%I]EM_
MMCQ5+ +F&W_> _Z&CGR9<A)(H]ZR?;&9VB\FW@-Z?S1_X*B?LZ)\!;?PN]QJ
MVJ:[JUY'?I>:CJ=U)/(ZVZV92*%'9A#;K)-<2QQYD=3.X>:7"E?ZC:_ '_@A
MC_S-W_<'_P#;^O?_ /@M7_R3S3?^Q@MO_2*^K[__ &3O^2>>%/\ L7])_P#2
M*&OQA^(OQ+_X1+]J^UGU![B>WBN+'3K:,-O\G^T-+2"-45V"I$+B[,T@7&-\
ML@5Y&(;^AZOYX?\ @M7\-/[0\0^%M0L4N+C4M3M[G3EMHU\S?]FFB>!88T4R
M-*[WLBD MOQ&JJ&#%_I__@M7_P D\TW_ +&"V_\ 2*^K[_\ V3O^2>>%/^Q?
MTG_TBAK\@?\ F[S_ #_T+E?O]1117\\/[-FKR_L'?'+4_!5W%]FT#Q'<+%8@
M"5T"S2.^DNDDD+S3;#(^GR$.(A/)*\DTGV;=7Z/_  ^_XO3\8=;UL_O--\(Z
M?#HMB3_I%N^HWA^TW\]O)Q';W<"!+&[BC#S%&42R1KB(Z'_!335KC1?A)XBE
MM99(9&CLXB\;LC&.:^MHI4)4@E)(W>.1>CHS(P*L0?/_ /@DGXUM_%7PKL;.
M!9%DTJ\OK.<N%"M(\QO08R&)*>7=1J2P4[U<;=H5F^__ (A>"K?XE:-J&AWC
M2);:E9W%G,\142+'<1-$Y0LK*'"L2I96 .,J1P?Q!_X(:Z3<0V_BN\:*06TL
MFEQ1S%&$;R1+>-(BOC:SHLL3.H)*B2,D .N<_P#X(8_\S=_W!_\ V_K[_P#^
M"H__ "2'Q#_W#O\ TY6E'_!+C_DD/A[_ +B/_IRNZ^_Z^8/VKOVKM#_9*T,Z
MKJI\Z[FWII^GHX6:[F4 D D'9$F5,\Y!6)2H"O*\,,OR?\./@%\0?VJ[>#7/
MBAK-YI.G7,;[?"FDE["-K>585:/491(T[I.B2B:TE9YH1,=MQ;.9;9/E#_@A
MC_S-W_<'_P#;^C_@N=_S*/\ W&/_ &PK]_J_FA^._A;PYXY_:>FTKQ9'YVD7
MUQ8VTL6Z=-\TVD01VB;K<K*NZY:$;@549RY$>\U^K_\ PZX^$/\ T+W_ )4=
M2_\ DNO4/@S^R3\//V<-9-UX:L([#5KNSFC -[=3226J2P-,5BN)Y 460V^^
M15RA>-2P\P!OJ^OG_P#:Q_Y)YXK_ .Q?U;_TBFKX _X(J?\ )/-2_P"Q@N?_
M $BL:]P_X*IZ3;ZC\)-:EGBCDDMI-/E@=T5FBD-];Q%XR02CF.22,LN"4D=,
M[68'H/\ @F7I-QHOPD\.Q744D,C1WDH21&1C'-?7,L3@, 2DD;I)&W1T974E
M6!/YX?\ !#'_ )F[_N#_ /M_7['?M-ZM<:!X%\2WEG+)!<P:'J<L,T3LDD<B
M6DK(Z.I#*ZL RLI!4@$$$5^8/_!$?QK;W_A77-#59!<V>J)>2.0OEF.]MTBC
M"G=N+AK.4N"H #1X9B6"_M=7\\/_  2^^&G_  KOXR>,-/L4N)=-TBWU/3EN
M9%W8V:G D"S2(JQB61+>1@ $W^7(RJ%1@O0?\W>?Y_Z%ROU^_:Q_Y)YXK_[%
M_5O_ $BFKX _X(J?\D\U+_L8+G_TBL:\ _;Z_P"3A? 7_< _]/-Q7[_5^ /_
M  0Q_P"9N_[@_P#[?U^OW[6/_)//%?\ V+^K?^D4U?"'_!&'2;C3OAS=RSQ2
M1QW.N74L#NC*LL8MK2(O&2 '021R1EER \;IG<K ?.'_ #=Y_G_H7*_?ZOP!
M_P""&/\ S-W_ '!__;^C_@N=_P RC_W&/_;"OM_PG_P3A^"OCG3K35=/T+SK
M*^MX;FVE^WZHF^&9!)&^U[E77<K [6"L,X(!R*[#1O\ @GO\)/A9>V>M0:1'
M9W-G>6LEK/)J5]M6Z\^,6P ENBC.TQC2.-@PD=ECVL6"G\\-?\6?9OVMK?\
MM"[VV\'EVMMY\V$C\_0SY<$6\[5\RXG.R-<;YYC@&20Y_?ZOP!_8%_Y.%\>_
M]Q__ -/-O7[_ %%?@#_S=Y_G_H7*_?ZOP!_YN\_S_P!"Y7[_ %?SP_L>_$O^
MS_VD_%$&H/<7%QJ=QKNG6TA;S-GV:Z$\:NSL&6)+>R,,87=LQ%&%$8)3^AZO
MYX?VPOAI_9_[2?A>?3TN+BXU.XT+4;F,+YFS[-=&"1D5%#+$EO9":0MNV8ED
M+", )T'[?7_)PO@+_N ?^GFXK]_J_ '_ ((8_P#,W?\ <'_]OZ]__P""U?\
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MF=H)XSM/R2Q(QCD'RRQ*Q = 1^E_["WC6W\?_#+PQ>6JR)''I=O9D2!0WF6
M^Q2D!68;&D@=HSG)0J656)4'[=/@JW\?_#+Q/9W32)''I=Q> QE0WF6 ^VQ
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MH,JM(CZ181BXMXKZR8*?LE]+)'$CW.V-)XE'E2RC8OZ/T5\__M8_\D\\5_\
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MLM8NHG\P0VEOH]^U](Z"3"&S:!)H=YC*I)<K!!EHR9521&;\8?\ @DGI>M?
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MS4-+6/QQ+)X>\1VLCVVH6#V5[(JSPG:[Q^7#*T:%L@PS$30NKQ-Y@19I>/\
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MEFQ@$:AFA9V6,W14QRJR6RN;J170H4A8.40LZ_%_["W[=GPZO?"]CH=SJO\
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M6=XG#&5,^6PEC6*?]KJ****_.#]CO_@G/IW[(7B'4M>MM6N+_P"UV[VEK!)
MD7D6[S),1,ZLWGR_NH5$B+;IQ(?*/F*(OT?KR_X:?%[2_BT^JII;2.NCZI/I
M5R[H44W5O'$\PCS\S(C2^46(4,Z.4W1;)'[#Q9XIL_ VG7>JZA)Y-E8V\US<
MR[6?9#"ADD?:@9VVJI.U0S'& "<"L_X>^-;?XE:-I^N6:R);:E9V]Y"DH42+
M'<1+*@<*S*'"L P5F .<,1R>PHHHHHHKG_%/AJ#QA9R6-R]PD4NW<UM=7%I,
M-K!QLGM9(IDY4!MCKN7*-E&93_-#_P %(==\3?LO>,H=*\/>*_% LKS3TO\
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MOB>GPPUGPU'IU]YDZ2746JB[C"QV;WD<B+]CA+I+&J%0S1N@D&]%=6C''_\
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M46C'VB!$@BD>2UBWP23!F!ED6.'>;<F6WD^O_P!BGXJ^.]4T7POI5]X.^QZ
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M];Z_J_\ 9]A+JUZUQ';Z78WUQ##/)9Q":>)[N5%9Q-'%.#9%X!*\DC/$O/\
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MOD 3$L@<_:Q_Y)YXK_[%_5O_ $BFKX _X(J?\D\U+_L8+G_TBL:\ _X+G?\
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M_P#]/-O7T_\ \%DO"UYX@^&L5S;1[XM/UBTN;IMRKY<+17%J'PQ!;,MQ"FU
MS?/NQL5F7Z@_8)^)>G?%#X:^'I]/?=]BT^WTZYC+(7BN+&)()%=49]F[8)HP
MVUV@EBD*KO 'Y@?M.?\ %2_M->&;?PQ\NI6W]E_VJ8/]&<^6TMS=>;(?+$V=
M,**^&?S(,6HW,/*'[_45^(/_  61^#DMM9Z/\1-*:XAU+2[B*SGGMQ+NCA9G
MGM;@RHX6W\BX#(D@4,\MW&#*&2)3^IW@#X\Z7XQ\%6WCB>2.#3I-+&HW1CD-
MRMLJ0F2YC+1)ND>W99(I J!]\;+Y8<%!^ /[*GQ&U3]FCXKZ9=75G'I^C_$.
M-+J'2;602I:VNJWDRZ7\J&" /"ZIM;:YBLII56))W:&/];_VP_\ B\FN>&OA
M>OSV6LW#ZCKPC_>,FEZ85F2&9$VRP17ER(X([Q9(3'+$43S2S1U[_P#M8_\
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M_P!.5I1_P2X_Y)#X>_[B/_IRNZ^_Z*_ '_@AC_S-W_<'_P#;^OO_ /X*C_\
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M$2AB!&E?&'[ O_)POCW_ +C_ /Z>;>OW^HHHK^8'_@M7_P E#TW_ +%^V_\
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M7S_^UC_R3SQ7_P!B_JW_ *135^0/_!#'_F;O^X/_ .W]>_\ _!:O_DGFF_\
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MB-9 JL4+Q,RAPK*Q4G(#*<8(SV%%?@#^P+_R<+X]_P"X_P#^GFWK]?OVL?\
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M\=G+*'4I))^W_@#]N/X<_$'2[;5(_$6EV:W,8<VU]>VUK=0MDAHYH9)0RNK
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MPSX8M[BXUF>W.8;Z_NO/L[2R.X1N\42I/>)<0M<6DS"/(#I!*/R0^/-[JG[
M'QUD\5I#>#1-4O)+MG8AUO;6]V/J4*>6\*.\$TCM!!,P,;QV<LH=2DDG[?\
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M_HJ&PM?$'BR'0FDE)T*/67333;S2,\MH8EC$IMY [I(/-\YU9BTQD8R'[?\
M '@#2_A9I=MHNBVT=GIUG&(X((P=JKDDDDDLSLQ+R2.6>1V:1V9V9C\@?M,?
M\$Z_!7[4NJ1ZUJ@O++41'Y<T^GR0Q-<JH41FX$L,RN\:C8D@"N4(C=G2.%8_
MH_X;_ 'PO\)-#?PUHVF6\&D3>=Y]JP,RS^>-LOGF<R//O7$9\YG_ '2K%_JT
M51\0>%O^"1GPU\+:Y'K074+F**X:=-,N9XI;'DDI$Z& 32Q1DKM269_,"!9C
M,C2*_H'QQ_X)L>!OV@?%!\5ZN=06[E^S_:K>"Y5+>Z^SA4'FAHWE3=$B0O\
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M8Y "2C8T****_)#PW^TKX\_;?\07=G\-KB/P_P"#]-DV2^([BQ6ZN+J=4?\
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M])U:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$@UH4445^4&O\
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M_P"!?QTT/]HO0X/$'A^?SK2;Y71L+-;S* 7@G0$[)4R,C)5E*R(SQ/'(W/\
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MNI& 4J=ZH=VT,K'C_P ?Z7\+-+N=:UJYCL].LXS)//(3M5<@   %F=F(2.-
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MJD,6\O\ C7^T[X7^ GEP:O=[M2N=HL]*M4-SJ-V\GF"%(+6/,A\UXVACD?9
M9L1M*K$5\X2?\%+?"?AFXC@\5:7XD\+1S1R/;SZSI$L,<[1-&'CB$#7$K.!(
MK$[ BC[SJS(K_?\ I.K6^OV\5Y9RQSVT\:2PS1.KQR1NH9'1U)5D92&5E)#
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M3[/=:AHGBBTT6[N(X;;6Y]),6G3)+EH[B*1Y1*\3Q SH%B,[0@D0E@4K[O\
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M;_A+]KC[5%H3W%O>V>&DLKU(XK@PG:!/&L<LJ/%N;RV*L6C?:)%02PF3Y_\
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M^8CM)Y=NB??_ .PS\4+CXQ_#?P_K%YYAN7L_L\SRS-/)-)92/9O.\C ,SS-
M9FW9(,A4NY&]ORP_8%_Y.%\>_P#<?_\ 3S;U^I_[:GP]T;QCX%\07FIZ?9WE
MS8:'JTME-<6\4TEM)]D=M\#R*S1/NC1MT94Y1#G*C'P!_P $4/ &EQ>%=5\0
MBVC_ +6DU26Q:[()D%K';VLRPJ22$0R2,[[ ID(CWEO*BV?K]X*^'NC?#6W:
MST/3[/3;9Y#*\-G;Q6\;2%54N4B55+E552Q&2%49P!CL***_EB_;"_M'_AI
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M,V4MO',P:W=+199XXY97MPS2NFW9$+R-E8M,X']1M?@#_P $,?\ F;O^X/\
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MEU9_;$>^L[N"-;R&6*("$RA(0\L4K&4!3)(+>'Y@L1!S_P#F[S_/_0N5]_\
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M_?LG?\D\\*?]B_I/_I%#7L'BSQ39^!M.N]5U"3R;*QMYKFYEVL^R&%#)(^U
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M:IJWPK\2QZ.9!<BS61S'*(F^RQ3127H+%ERAMEG$D>294+1!7+[&^0/V"/\
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M]0M-8U;0-!\BYNM$T^UBN7O+[R)+T.ELQ(N8O*>WBG6;!C@%X(PGF-))]O\
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MD&F6]X&;S+C4(D=]21D;:R) SV\*?(4D(DE2:57"Q?DA^P+_ ,G"^/?^X_\
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M;&BVGB"W\3S.ML96MYM-@<$LZLFR*X_<VS-*65)3 T8#,\<_];M? '_!4?\
MY)#XA_[AW_IRM*/^"7'_ "2'P]_W$?\ TY7=? '[?7_)PO@+_N ?^GFXK]#_
M /@HI^TQJG[+7@HZIHL<9U&]O(]/@FDPRVS2PS2FX$94K*ZK"1&CX0.RNXD1
M&ADX_P#X)^?LHZ'\//#VG^,+L?VKXFUVWAU6XU6[027$37L)D,<#N7>/Y9W6
M>4-YMT[.\C;#'#%\0?L"_P#)POCW_N/_ /IYMZ]__P""U?\ R3S3?^Q@MO\
MTBOJ^_\ ]D[_ ))YX4_[%_2?_2*&O,/'GP7^'W[=5A=MJ5C'/<V-Y?:6]W&4
MCU"TN+&:>W*^;$S,$#,UU!;S[X726&>2W)8*/PQ^+/@#Q1_P2D\<V5_H]_<7
M'AZ^N!<0QK<"+[=;VS 365]$%:,RQI<%$N/*9!YRW,(CF#Q0_P!1NK:M;Z!;
MRWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22 *_-#]DWX":3\>/[;^(_B
M_2[?49?%6H-<:9!JEA;R/:Z1;;H-/!BD@(BEDB +O')-'/ MK+YC.79OK_\
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MYAN71B&$HM9/+#(?-7]SJ***^ /^"H__ "2'Q#_W#O\ TY6E?/\ _P $5/\
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MA7WW WF9DCRB1K'!;CS1(?\ !4?_ ))#XA_[AW_IRM*/^"7'_)(?#W_<1_\
M3E=UH?\ !13]IC5/V6O!1U318XSJ-[>1Z?!-)AEMFEAFE-P(RI65U6$B-'P@
M=E=Q(B-#)Q__  3\_91T/X>>'M/\878_M7Q-KMO#JMQJMV@DN(FO83(8X'<N
M\?RSNL\H;S;IV=Y&V&.&+X@_8%_Y.%\>_P#<?_\ 3S;U[_\ \%J_^2>:;_V,
M%M_Z17U??_[)W_)//"G_ &+^D_\ I%#7Y _\W>?Y_P"A<K]?OVL?^2>>*_\
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MD,9$,:.BRK(QB_''_F[S_/\ T+E?O]17Y ?\%J_^2>:;_P!C!;?^D5]7W_\
MLG?\D\\*?]B_I/\ Z10U^0/_ #=Y_G_H7*_7[]K'_DGGBO\ [%_5O_2*:O@#
M_@BI_P D\U+_ +&"Y_\ 2*QKX@\%?$O_ (8Y_:.UO^V7M_L6K:A=074X;Y8+
M?5Y8[^VE+RM D?E,]M]J=]Z1Q"XV"0B-S_2=I.K6^OV\5Y9RQSVT\:2PS1.K
MQR1NH9'1U)5D92&5E)# @@D&O'_AU\;[?XG>(-?T:QMY#;:!):6TNH;E:WGO
M)4DDN;:(IN7?:*(5N 6$B32M&\481'E^</&W[,7PU_X* Z'9^*)+3RY=2MXI
MXM3LWBAOER(@T5P\?G0S2Q"'[+(EP+C[.5ECC,;@L/R0^"EMXQ_X)V?%[2_!
M=U>R7>C:M>0QB".?9:W=OJ,@M(KTP-YH@N(Y(T,@PLQ-NUNL[6T@ED_H.^(>
MO^'M9U&R\':];V]U_;5O=SP6UW'#+;S_ -GO;.\1CF)\R4><D\:*CX2"64E/
M*!/XP_MK_P#!,&S^%.G3>-OAQ-<6,ND_Z;<6+73?N8;9%<W%C<.?.26$QM.Z
M2RR,^6,+QO''!+[!^SW^W1KFF_ ;4?&%]'_:6K^'[C^S5FNIBWVIGDM5@GG*
M(KGREO(UD4L9;CR"[7"R3,Z;_P#P3@_9ZT[XFZ8OQ8\5O_;OB;6[B:9)[R)'
M6R^R730H;=""BRAK=6CE4)]GB6*W@2%$D,W@'_-WG^?^A<K]7_VT/^$7_P"%
M?ZW_ ,)G]H_L+[.GVC[+G[1O\Z/[-Y&/E\W[1Y/E^;^XWX\[]QYE?)_[&WP*
M^*_[+6EOHN-#U31&DFN+2"]U"\M+^V:8QD1N8;;4+2)!MD>6WMS,@N999$O)
M5^:3L/V??V(=1T+QI<_$WQUJ%OJ'BJYW^3!81O#8V6Z-K4>6S;9+C%J(X8_-
M1/+!D+_:9MEPO'_\%A?!5QXJ^&1O(&C6/2M4L[R<.6#-&XEL@(P%(+^9=1L0
MQ4;%<[MP56[#_@F7^TOIWQI\#:;I#S6\>M:-;BQFLPZ+*]O9K%'#=)"97E,1
MB>!))F5$-T)55578#]7_ +0_QOM_V??#\VLRV\E]<F2*VL-/A91<7UY<.(X+
M: '+,[,=S"-99%A2218I"FP^X44444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444445S_BFVU&[LY$TJ>WMKT[?*FN;=[J%<,"V^&.>V=\KN5<2IM8ACN"E
M&_*#]I3_ ()B:Y^U3KG]OZ_XNMUN%MX[:&&VT(QPQ0QEF"(&U%Y#EWDD9I'=
MMSD B,(B_H_\-/#GBWP_LC\0ZQI^JQ1VZQ[X-)DL;B29=H\Z5_M]Q"=P#EXX
MH(EWL"AC1?+;U#5M)M]?MY;.\BCGMIXWBFAE17CDC=2KHZ,"K(RDJRL"&!((
M(-?B#X;_ .";GQ-_9HUF[NOA=XKL[>QO8]L@U!"LFU97:..2+[+>6\SQIMVW
M06%\R3*L42.P?U_]H;_@F9<?%_1K>$:U)J/B.?5+6?4]=U8L\D=FD5P)[?3K
M>)-EO;B:X:XAL4:.,DA'N2(H2GV!\#?V:[W]GCPT='TG7;R^U$QVJ)=ZP9[Z
MU@6!43RK:P2YMUM[?:)/+CCE#H70233I#&@^3_@Q_P $[?%'P/\ %MWXTL?&
M5O<:IJ'VK[<+G0 T-S]KD$TN](M0B*?O525?):+#(%_U1>-OJ#]KS]G+7/VH
M='D\.VVNV^D:1<>0UU'_ &8;NXF:&0RA?/:\B1(MRPOM2(2[XO\ 7F-VBH_9
M#_9RUS]E[1X_#MSKMOJ^D6_GM:Q_V8;2XA::02E?/6\E1XMS3/M>(R[Y?]>(
MT6*OE_XS_P#!.WQ1\</%MIXTOO&5O;ZII_V7["+;0 L-M]DD,T6Q)=0E+_O6
M>5O.:7+.5_U02-?T??P;+XMT.?1O$SV]_P#;;>XMKTVT,MG#-#.'1D2,W-Q+
M%F)MC,)V8MEU*9"K^8'PW_89^)7[(]X__"MO$VGW>D75Q--<:7KD$J0CY=D!
MWVRRN\NUOWTL'V'S&@AWI)&!%'] >$_V0]6^)'B&T\9?%"_M]2U33O);2M+T
MW[1;Z7IDT,PE\^(O()KF60Q1.YG"J#OB=9XH[;R?M_Q3;:C=V<B:5/;VUZ=O
ME37-N]U"N&!;?#'/;.^5W*N)4VL0QW!2C?F!\&/^"=OBCX'^+;OQI8^,K>XU
M34/M7VX7.@!H;G[7()I=Z1:A$4_>JDJ^2T6&0+_JB\;?;_[1_P +-<^-.AW.
M@:1J]OI%O?V\UM>S2:>;V9X9@JLD)-U!'%N3S8Y&=)F*R QF&1 Y\ _8R_8X
MUS]CZ*;38?$5OJ6BW-P;F:UDTDPS+,8O*+PW*WS[-VR'S%ECG4K$%C$3.\A^
MG_C]X/USQ_X7U/2_#6H_V3J]S;E+6]P3Y;9!(W+EXO,4-%Y\8,MOO\^-6DC4
M'X _8RC\?? _QO-\/O&6N?V]]I\/G7?-DDGN6M9A?_8EAANK@B5XGB ED5T5
M4EP(U7$LEQ^K]<?XULM9O[=5T.[L[.Y$@+R7EG+>QF/:V5$<5W9LKEMI#F1@
M &7RR6#+^4/CS_@EQX@^(/C%_'5SXTCCULWD%Y%)%H2".&2VV?9@D;WSJ4B6
M*-%$OF%P@,C2,79OU.\"Z;XAT_SO[>OM/O=VSR/L6G36.S&[?YGG7][YF[*;
M=OE;-K9W[AL^8/VS?V%]#_;#LX6GD_L[6K3"VVIQPB5A#NW/!-'OC\Z(Y9HP
M71H9271@KS1S<?\ LJ_L>^,?V6$BTZU\91ZCH22,QTRZT;Y4$DB/*;:=;_S8
M'8*^T9DMU>629K:21B3S_P"W'_P3BTO]JUQK6F3QZ7XCCC*O.8RT%\J1D0QW
M04AE=6"(MTHD=(<QM%.$@6+Y0^&G_!-#XIW.S2/$_CFX@\-K;K;R6>G:EJ$_
MF6XVQM:+#.L%O%$T.] Q69$PJFVD0D+^UW@#P!I?PLTNVT71;:.STZSC$<$$
M8.U5R222269V8EY)'+/([-([,[,Q_&'Q;_P2M\5?"CQ*=?\ A-XACTJ.21F%
MO=2W$36\8:*5;?S8X[D7MN9$):*YC4;$B23[4V^2O0/CI_P3D\8_M$Z-IQ\3
M>*(]3\1QWEMYMU)#]GL[#3S%)]LBLK2V1$N;AYFC<W$ZV[W$=O!&6M@A#_?_
M .S)^SHG[-FC)I8U;5-7D\N!&EO[J22.)8(A&L5G;EC%:VX.XI&FYP&5'FE6
M*+9^>'[2_P#P2YU;Q!XHF\:?#G6_['U2[N'GGBFFN(/+FN!+]JGM[RW\R9/-
M+@&W*%?WDVV98MENN_\ %+]A'XB_'_PA<6GC3Q1;ZMKZ^6VEVRQ_8]+LYOM*
M>=/*]K;QR7<K6JM%"9;<+;&>=%5O,$R_4'[*G[&TO[*NCRV=IX@U#4KUK>6*
MW^UO*=+M6>224/!I:7"HNYF1IR9C+(5?RYK<32 _/_\ P[M\4?\ "P/^%D_\
M)E;_ -N_:/.Q_8 ^S[/)^S?9_+_M#=Y7V?\ T?._S]GS^=Y_[VOU/TF.XAMX
MEO)(Y;D1H)I(HVBC>0*-[)&TDK1H6R51I)"H(4R.1N/XH_";_@FQ\1?V=O%%
M[-X*\76^EZ!>91II(/M=X85!>$364L(LY98Y"8A.LL;"-I)$6/S7MC]7_M/_
M ++?C7Q1X:T;0OAUXCDT=M.D<WCS7$UM/?LZY-U<7MG&9FN&E,LUPNP)=S7,
MEQ(1+%'N[#]@[QWKGBG0]7TKQ!>_VG=^&_$&H:$FH-&4FNX;$1!)IP7?,IWD
M%LEF55+M)+YDTGV_7E_QO\%7'Q*\*ZWH=FT:7.I:7?6<+REA&LEQ;R1(7*JS
M! S L55B!G"D\'X0\"_L,^*/V5/.?X7>)O\ 1)=DDNBZ_ +BSN+CYHVF:YM%
MAEML1,C 01;Y9((EED>+:L6AX_\ @C\9_P!H?2[GP[XEUOPWH6EW49$\^AV]
M_<74ZY -K(+J6%4MY%+&5HW#N$$)#0RRJ?L_X%_ O0_V=-#@\/\ A^#R;2'Y
MG=L--<3, 'GG< ;Y7P,G 55"QHJ1)'&OP!\9_P#@G;XH^.'BVT\:7WC*WM]4
MT_[+]A%MH 6&V^R2&:+8DNH2E_WK/*WG-+EG*_ZH)&OW_P"(_#GBW5=#%G::
MQI]GK3>8LNHKI,DD*JPD"M!9R7YV2IF-@TTUS$61MT!60(GQ!^R!_P $_M<_
M8[U&XN=+\46]W97_ -G6^M)]&(\Q8'+*T4JZAOBE"O*B,1)$/-+/!*53;Q_[
M<'_!-V]^.OB"#QGX,U"/3/$/F0F[-Q//'&S6Z*MO=02PI++!<1B.--J*$<*D
M@,4L;FXT/'?[!?BWX^^"[VT\=^(_[3\6/Y;Z<Z-)#I%BUO(YCQ:VZ6T<TLZ2
M213WDUN\L,<JI%$P@S/V'[$W[%_B7X(6]BGC+6([^/0Y+HZ%IUBS+9VK7:R"
MXNIG,-O+<W#">>*)9PZ6T<LQ0LTP$'YP?&3X<O\ %;]J&?2X+R33[DR6UQ:W
MD<<<K6]U9Z)%=VTIBE!25%FAC,D38$B!DW(6#K^A_B/X-_'?XN:2/#.OZYX7
MT_3;FWDMM1U#3[6YN;ZXA>WDAD1H;B.*V_?%@96@^RM&?FB*JOE/]O\ P+^!
M>A_LZ:'!X?\ #\'DVD/S.[8::XF8 //.X WRO@9. JJ%C14B2.-? /VS?V%]
M#_;#LX6GD_L[6K3"VVIQPB5A#NW/!-'OC\Z(Y9HP71H9271@KS1S?GA\(?\
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M1^'KO6K/4VL;..UTRZ.E-;M"L2ND7VJ-+YEN41?)15C-J[)$=\KRR&5?B_\
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M^+-6\-Z1HEU&\=Z^A6UU<7EU;RJ8IK0'4088$EBDD/VE%>:*1(]J,I<5]/\
MPA^ VE_L]>&E\.^%(X[18XW*3SQF=I;IEQ]JNPCP-.[,%+JKPC8JPQF&)(U3
MX0_X=V^*/^%@?\+)_P"$RM_[=^T>=C^P!]GV>3]F^S^7_:&[ROL_^CYW^?L^
M?SO/_>U]0?M5_LT:C^U)X7B\-7.HZ?;;O*DNKIM*>X?[1$8V$UB&OD^R9Q-&
MX=KIS!,T7F#YFD\__91_9*\6_LJ68T>V\5V^I:+]H27[)=Z/)NA4L6G2TE34
MAY/FY+$.D\22_O5AW/-YOR!^U;X+^+7[.NK:Y\4(O%WGZ'87$%Q9:2SW!AD2
MXN+>U6RGL 4M4BCCF=3<1N\\K1+.!%<S&6']OJ*^ /CQ^RQXY^/W]E?:_%VG
MV']CZA%J5K]B\/,,WD'^HED^TZI<[O*R^U!MC;S&\Q),)L^O_ NF^(=/\[^W
MK[3[W=L\C[%ITUCLQNW^9YU_>^9NRFW;Y6S:V=^X;/ /&'[%WA[QI\1=.^(T
M_%[86Y1[7R83#<7"?+:W4I*%S+ K,%8DONBLV1XA;%9OH_QK9:S?VZKH=W9V
M=R) 7DO+.6]C,>ULJ(XKNS97+;2',C  ,OEDL&7\H?'G_!+CQ!\0?&+^.KGQ
MI''K9O(+R*2+0D$<,EML^S!(WOG4I$L4:*)?,+A 9&D8NS?I=8^!=6\4Z=J.
ME>+[K3]3LK^W>V:*RL+C3_W,R/'.DC/J%V[;U8!6C,+1X8Y8LI3\D?AS_P $
MW/B;^SCXEO)_ 'BNST_1+R2.-Y+A#/=&U#!LRV;VLEI+<0Y=8I \1D!;#6RS
MR1KT'[1?_!+[7M7\2Z3XH\!ZO&FHV4=J]S<ZW=75U=2WUDRF"]::2.[65V54
M5X?+AMXQ @2,I(4C^O\ XE_L;W'C/X>:IX.359+G5M<O+2[U36;P,S37"W5H
M]Q,L"'9$B06RPVEG$8X8TBAA,B_/.?/_  -\*/CG\$;*/0-%U;PGK.DV4<$-
MC<:K;7MK=);Q011+ 8K$&()&4(5GDFF<'>\GS"./Z _99_96M_V;DU2\GOI-
M5UW7;Q[S5M2>);=9Y#)*Z".UC9HH44S2,0I8L\CG<(_*BB^+_P!JO_@GSXM\
M:_$"+XB> -:M].U1_*>?[6\D?DS6\,=NA@:&WG$D4L2;)X)UVGYPS2Q3F*+]
M#_@A\*+_ .&MO<3:YJTFO:W>R*UWJ<MM#:EHXEV6]O#!"-L-O$NYUB#.#<3W
M5QPUPX'P!XU_X)UZS\+O&*^./A'J5GH]S)(/M.D7B2KI[QON:XC#0"1OL\C+
M%BT\L")]TL%Q 8K>.+U#Q3^SE\2OVF[.31/B+K&CZ?H#[?/L_#EO*TU]M82Q
M^;=:DLAMO(EBA=/(1_.5I8Y-OR,/N_P!X TOX6:7;:+HMM'9Z=9QB."",':J
MY))))+,[,2\DCEGD=FD=F=F8_DC^TO\ \$N=6\0>*)O&GPYUO^Q]4N[AYYXI
MIKB#RYK@2_:I[>\M_,F3S2X!MRA7]Y-MF6+9;KO_ !2_81^(OQ_\(7%IXT\4
M6^K:^OEMI=LL?V/2[.;[2GG3RO:V\<EW*UJK10F6W"VQGG15;S!,OUA^Q]^Q
MTG[)]A]E.N:IJ\GEM&L<\\D>GP*TSS,;73Q(\4+N67S9':9RZNR-$LTJ-Y?^
MV;_P3XL_VC[R'Q-H%Y_8?BRTPZ7L:L%N6A7-MYS1,LD4L;K&([R/?+%$"IBF
M"0"'0TGPC\?]:MXM,U'6O">G1^6B2ZO96EW=Z@&C4'S%MKA8;%WE90LHVQHB
M2.\2*RHH^@/V9_V5?#7[*&ER:9X>BD+3R>9=7EPRO=7# MY8ED1(UV1JQ6*-
M%1$!9]IEDE>3XO\ C/\ \$[?%'QP\6VGC2^\96]OJFG_ &7["+;0 L-M]DD,
MT6Q)=0E+_O6>5O.:7+.5_P!4$C7[_P#$?ASQ;JNABSM-8T^SUIO,6745TF22
M%582!6@LY+\[)4S&P:::YB+(VZ K($3X@_9 _P""?VN?L=ZC<7.E^*+>[LK_
M .SK?6D^C$>8L#EE:*5=0WQ2A7E1&(DB'FEG@E*IMX_]M;X*_%)-;U#QSH/C
M"33O#VDZ7)?)I\<D\;))I]O)/Y)M4'V6[2:6,&26Z;(29HFAEBMXXY/T?^"'
MC6X^)7A71-<O%C2YU+2[&\F2(,(UDN+>.5P@9F8(&8A0S,0,98GD^H5\P?'[
MX1^+?C)IVIZ)8Z]I^EZ7J5N;9O\ B327-XD,B!)T\]]12%O-'F)N%LK1QR84
MB55FKX__ &8_^"=OBC]DN\GN?#OC*W,5YY?VNUN= $L-QY2RK%O*Z@DR>69G
M=?)EBW-@/O0;3ZA^UO\ L:>)?VN[*TTO4?$UG9:=:21W!AMM$8M+=+!Y32O)
M)J+,$#-.88DVA$FV2-</&DU?0'P&^$_B7X.>&H_#UWK5GJ;6-G':Z9='2FMV
MA6)72+[5&E\RW*(ODHJQFU=DB.^5Y9#*OQ?_ ,.[?%'_  L#_A9/_"96_P#;
MOVCSL?V /L^SR?LWV?R_[0W>5]G_ -'SO\_9\_G>?^]K[?\ CW\"_P#AHGP7
M>>$]5O/)EOK>%9;RVAV*+B&2.=94@DDE(B,L2EH3*SF(F,3A\2CX _91_81^
M(OPPLQX?\3^*+<^$X[A)FT6RC^TK=J6,DUM+<7=O%);VDCJGVBVB$D5W%+=1
MNL1F=Y/N#]J[]E'0_P!K70SI6JCR;N'>^GZ@B!IK29@ 2 2-\3X43P$A95"D
M,DJ0S1?DAX*_X)=?%SX:W#:?H?C2/3=$>\+NUG?ZC;R-&65#<&SB183<&)5)
MC,^"56+[1M D'ZW_ +/O[,=G^S?H=S9Z5/\ :-=O]\^H:U>QM/->WS!B)[A1
M*DCQ*[LR6XF4A6?,QGEFN)/C_P#X=V^*/^%@?\+)_P"$RM_[=^T>=C^P!]GV
M>3]F^S^7_:&[ROL_^CYW^?L^?SO/_>U^I^DQW$-O$MY)'+<B-!-)%&T4;R!1
MO9(VDE:-"V2J-)(5!"F1R-Q_+#XS_P#!.WQ1\</%MIXTOO&5O;ZII_V7["+;
M0 L-M]DD,T6Q)=0E+_O6>5O.:7+.5_U02-?O_P 1^'/%NJZ&+.TUC3[/6F\Q
M9=1729)(55A(%:"SDOSLE3,;!IIKF(LC;H"L@1/B#]D#_@G]KG['>HW%SI?B
MBWN[*_\ LZWUI/HQ'F+ Y96BE74-\4H5Y41B)(AYI9X)2J;?J#]J[]E'0_VM
M=#.E:J/)NX=[Z?J"(&FM)F !(!(WQ/A1/ 2%E4*0R2I#-%^2'@K_ ()=?%SX
M:W#:?H?C2/3=$>\+NUG?ZC;R-&65#<&SB183<&)5)C,^"56+[1M D'Z__LS_
M +,^E_LTZ7):VLDE[JE[)]HU;5KC+76H73%F:65F9F"!F?RHMS! S,S23233
M2_!_[5?_  3Y\6^-?B!%\1/ &M6^G:H_E//]K>2/R9K>&.W0P-#;SB2*6)-D
M\$Z[3\X9I8IS%%^A_P $/A1?_#6WN)M<U:37M;O9%:[U.6VAM2T<2[+>WA@A
M&V&WB7<ZQ!G!N)[JXX:X<#W"O@#]LW]CC7/VP8H=-F\16^FZ+;7 N8;6/23-
M,TPB\H/-<M?)OV[YO+6*.!0LI602LB2#W#X#?"?Q+\'/#4?AZ[UJSU-K&SCM
M=,NCI36[0K$KI%]JC2^9;E$7R458S:NR1'?*\LAE7XO_ .'=OBC_ (6!_P +
M)_X3*W_MW[1YV/[ 'V?9Y/V;[/Y?]H;O*^S_ .CYW^?L^?SO/_>U]H?'GX3^
M)?C'X:D\/6FM6>F-?6<EKJ=T-*:X:9951)?LL;WRK;(Z^<C+(;IU24;)4EC$
MK>'_ +&7['&N?L?13:;#XBM]2T6YN#<S6LFDF&99C%Y1>&Y6^?9NV0^8LL<Z
ME8@L8B9WD/0?MF_L+Z'^V'9PM/)_9VM6F%MM3CA$K"'=N>":/?'YT1RS1@NC
M0RDNC!7FCF_.#X6_\$T/C)X2^SZ7_P )S_9&BQ>9\FFZEJ;^3NWR?NK7;:1'
M?*<O^\CQO>3YV&UOV>^!?P+T/]G30X/#_A^#R;2'YG=L--<3, 'GG< ;Y7P,
MG 55"QHJ1)'&OYP? /\ 8Y^+7[(6G1V?A#7O#]_;W?F3W^GZI:7$5O!>.ENI
MDM[BVW7,_$1C!D-O'L ?[.9)/W7TA\*?V5M9U+QC%\1_']]9WGB.VL_L=A9Z
M9%+#I^GQ_OD<H\K>?=/(DSMF<*(GGF4+(%MVA/VO_P!D75/VF-9\-:GIFL1Z
M+)X=DN[J*Y-J+N3[4TME);;8'>.(HIMW9VD8@$1IY4BNY3S_ %;X4?'/XIZ-
M+X7\1:MX3M-.OK-[.^U.RMKVXU!HVB*2%8)1;VA>?F.4J(1&DKO"J.D8'TA_
MPR'X7_X5_P#\*V\NX_L+[/Y.?//VC?YWVG[1YF-OF_:/](QL\C?\GD^1^ZK\
MX/V??^">7Q5^!5Y<Z-8^,+>Q\)WUPYO39;S?/"%9!);QSVSQV5W*FQ'F@G+0
MD(^^X-O$IT/&O_!,SQ5X8^)"^,OA]K5GI5L\@E:6\-Q>WEM)/&T%\X%TETMZ
M\BO+.&N)HBTDS1YC"+,?H_\ :;^ W@N/P7I/P\U%M0O+N\U '1XUNY'U*ZU)
MY));J]GG,5QB(?:+B?4KJ2"6&WAED=(?-^S1'X@_X<8_]3=_Y1__ +OH_P"'
M,WB'X=_\33PIXR\K6H/^/9_LLVGXW_NY?]*M[FXEBS$T@^2-]^?+.U7++^G_
M .QG\2+S]I;X9Z7JOB9+>[N-1M[NWO5,*^3<+%<3VC&2$YC/FI'F9 !$S.X6
M-(R$7\T/BA_P2$U[PGX@_MKX8Z['ID9DF>*.XGNK:XL5= OEP7ENLTLR,'F3
M+B)TAV1N]PS/)7U?^S%^P+JWA+4;3Q'\2=>N/%&KZ?O;3;:>XN+JST^9G^:>
M)[IM\LI5(60F*%89 6VRR1P31?I_11111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111111117/\ BG^T39R#2OLXO6VK$USO,,>Y@&E=
M(\/+Y:EI%A#1>>RB$SVX<SQ^7_"CX(6_PUO]6UR:XDO=;UZ2VEU.[95BC8VL
M(A@AM[=/EAMXEWB)7:>X(?\ ?75PP#CW"BBBBBBBBBBBBBBBBBO/_'6G:YK/
MDVVD75O81/O^U7;Q&XN$7Y5"6L3%85E8,[K<W!GB@>)%:QNTF;R<_P""_P (
M=+^ OA^Q\-:,LBV-A&4C,KF21V=VDDD=N 7DD=Y&"A44L51$0*B^H4444444
M445GZMJ::+;RW4HD:.&-Y'$44DTA5%+$)%$KRR/@?+'&K.YPJJS$ _SX_;-:
M_P"&AO\ A87_  C'BC_A'OM'D^?_ &%?;]G]F?V=]H\GRO,\K?\ OL8\_P C
MGR?._<U_0=I.IIK5O%=1"18YHTD02Q20R!74, \4JI+&^#\T<BJZ'*LJL"!H
M44444444445X?\8OASJGQ?M[C03>1V&A7MG);WTD,8EU"=9U=)(H'E!M[5 F
MT-*\5X\Z32(BV4D,=Q)ZAX3\+6?@;3K32M/C\FRL;>&VMHMS/LAA01QIN<L[
M;54#<Q9CC)).370444444444444444444445GZMJ::+;RW4HD:.&-Y'$44DT
MA5%+$)%$KRR/@?+'&K.YPJJS$ _SX_;-:_X:&_X6%_PC'BC_ (1[[1Y/G_V%
M?;]G]F?V=]H\GRO,\K?^^QCS_(Y\GSOW-?T':3J::U;Q740D6.:-)$$L4D,@
M5U# /%*J2QO@_-'(JNARK*K @:%?SP_MBWFM?$GXO^'?%^C>&/%%YI&A?V3Y
M\JZ%?1M/]EO9+R7R(YXHG.%E$8\X0YE5O^6>V1OW^\+>)8/&%G'?6R7"12[M
MJW-K<6DPVL4.^"ZCBF3E25WHNY<.N496/05\X?&3X(7'[0J3Z)KUQ'%X7>2V
M=[*U5OM5Z8)(KC%S=/Q!;M(I1K>UC%P1%',NHQB62U7Z/HHHHHHHHHHHHK\@
M/VFOV??BYX2^(LOQ&^'=S;ZE]JM[6R;3;AX@T-M'L>:W NV6(6DDMNLKO;S0
M7(EN9 B+\\[4-)_X*,_$N&WB6\^%.N2W(C0321+?11O(%&]DC;3I6C0MDJC2
M2%00ID<C<?;YOA]\1?VNO-TSQ_ING^'/!S7$,D^E07/VS5+T6WE2I#+>0L;>
M*TDG'F/) L-X! (%"K(;AOT?HHHHHHHHHKYP^,GP0N/VA4GT37KB.+PN\EL[
MV5JK?:KTP217&+FZ?B"W:12C6]K&+@B*.9=1C$LEJOT?1111111111111111
M11117SAXL^"%Q\7M4L;WQ-<1FQT;5$U'2]-LU95^T6XD2WGO;I_WL[J&$\<-
MNMG#"[O!,=01$E/T?111111111111111111111111117SA\9/@A<?M"I/HFO
M7$<7A=Y+9WLK56^U7I@DBN,7-T_$%NTBE&M[6,7!$4<RZC&)9+5?H^BBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBORP_;K_9Q^)'B_P 2Z3XZ^'FH1F^T
M:SEMX=/E:,,DD[/'+/;"Z#V;/+#,4G\[R2$MHRKS/Y:1\!IG_!0+XK^&D-EK
M7PNU2[U&"26.>>Q6\2U=ED8 P@6=XK(%P/,2XF24@R(P1U4>OQWGQ9_:TMY-
M,U31K/P9X5U*SCBOVGG%]K$UO<+(9TM5"K#;.\6VWE6]MUFMO->5!)*GE1_H
M?X3\+6?@;3K32M/C\FRL;>&VMHMS/LAA01QIN<L[;54#<Q9CC)).37044444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444444444445Q_C_P 9)\/M+N=4DMKR\6VC+BVL;:2ZNIFR L<,,8+,
M[,0,G:B EY'CB5W7\\/V5OV_M1_:=^(>J>&/['_LG3=.T^ZE\NZW_P!HFXM[
MV&#]^N5C@^27$EMLD>*9"/M#KQ7Z?T4444444445Y?\ %[XHI\(-+;4WT_5-
M482)&EGI5E)>W4C.>HC3"JBJ&9I)6C0 ; QE>-'^,/V!_P!M[4?VS;SQ"]SI
M]OIUEIO]G?9(8Y'FF_TE;@2^=,VQ)/F@#1[(H=BL5;S"-Y_1^BBBBL_5M331
M;>6ZE$C1PQO(XBBDFD*HI8A(HE>61\#Y8XU9W.%568@'\L/A]_P4=U'XJ_%+
M3? EMH%QI%E+]I^UG5HWBU([=/:[BQ;*P2V^9#G>USYT+HZ^23BOU?HHHHHH
MHHHHHHHHHHHHHHHHHHHHHKYP_:;_ &BT_9LT9]4.DZIJ\GESNL5A:R21Q+!$
M9&EO+@*8K6W!VAY'W. S.D,JQ2[/+_V"OVI=1_:Y\/:AKVH6MO9^3K%S:6T$
M!=MMND-O-&)7=CYDH\XJ\BK$CX!$2<BO#_BC^W/XJ\#_ !ET_P"'EKH4<VDW
M4EE&9BEP;J>.Y3=+>P.O[H6]L2_FCRY01:7&Z>+)\C]3Z*************_+
M#X7?MS^*O''QEU#X>76A1PZ3:R7L8F"7 NH([9-T5[.[?NC;W)">4/+B %W;
M[9Y<#S_U/HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKYP_:;_:+3]FS1GU0Z
M3JFKR>7.ZQ6%K))'$L$1D:6\N IBM;<':'D?<X#,Z0RK%+L\O_8*_:EU']KG
MP]J&O:A:V]GY.L7-I;00%VVVZ0V\T8E=V/F2CSBKR*L2/@$1)R*^WZ*****^
M,/VP?VQ4_9/L/M0T/5-7D\M9&D@@DCT^!6F2%1=:@8WBA=RS>5&BS.75%=8E
MFB=NP_8S^->H_M$^!-+\3ZK';PWM]]K\V.V5TA'DW<\"[%DDE<96)2V7;+$D
M8& /I^BBBBBBBO#_ (^_'W2_V==+AU/4X;RZ:ZO(+&SL[& W%U=75P3Y<,,>
M54N55V^9D#!"BEI61'^ /VE?VL/C'^SC;VGB:_\ #FA_\(Y+);_:K6"XNKN\
ML0ZQ[HKJ[7R8$>1R\<5Q%!/;QR;(V:4M$;C[@_95_:8TO]J_PU%XATR.2!A(
MUO>6LF2UO=(J/)$)-JK*FV1'CE4 .CKN6.4/%']'T444444444444445S_BS
MQ39^!M.N]5U"3R;*QMYKFYEVL^R&%#)(^U SMM52=JAF., $X%?GAXM_:6^*
M7Q#\-'QA\/\ PU9II*QM-!;:P9WU;4+?;$PGMK*U=(HTR9C&KW,LUW$J20QC
MS(DFT/V#_P#@H/9_M?\ GZ5>6?\ 9^OV=NL\D4;-);W$*^7'+/"Q7,6)7 -O
M(794>,K-/^],7Z/T44444445^6'[<_[<_BK]F#Q5H6AZ'H4>HVVHQI([R)<-
M)=R-<>4;*R,6%6X50I)*W1S=0?N  !-^I]%%>7_%[XHI\(-+;4WT_5-482)&
MEGI5E)>W4C.>HC3"JBJ&9I)6C0 ; QE>-'^,/V!_VWM1_;-O/$+W.GV^G66F
M_P!G?9(8Y'FF_P!)6X$OG3-L23YH T>R*'8K%6\PC>?T?HHHHHHHHHHK\D/V
MV_\ @IA>_LX7#:3HWA^\:[,DL<>HZK;3VVGR-"T)D-HG[N6]0!WC:17@1'\J
M5&N(9%+?I_\ $+Q)<>#M&U#4[.TDO[FSL[BXALHMWF7,D,32) FU)&WR,HC7
M:CG+#",>#\(?\$Y_VQ/$/[7NG:M<Z]IMO:?8+B"."ZM$F2WG\U&9X0)GE_>P
M[4>0K*?DN(@8X\!I?T?HHHHHHHHHHK\L/V&/VY_%7[3_ (JUW0]<T*/3K;3H
MWD1XTN%DM)%N/*%E>F7*M<,I8@A;4YM9_P!P02(?U/HK\X/VW_V^I?V4HGMK
M'0=0O;MMD:7]Q;RP:1'-+%+(B"Y*_P"E2IL1WMX2JM&9%^U1RQ2(OV?\$/&M
MQ\2O"NB:Y>+&ESJ6EV-Y,D081K)<6\<KA S,P0,Q"AF8@8RQ/)]0HHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHK\X/VW_ -OJ7]E*)[:QT'4+V[;9&E_<6\L&D1S2
MQ2R(@N2O^E2IL1WMX2JM&9%^U1RQ2(OV?\$/&MQ\2O"NB:Y>+&ESJ6EV-Y,D
M081K)<6\<KA S,P0,Q"AF8@8RQ/)]0HHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHK\ ?V!?^3A?'O_ ''_ /T\V]?M=IGQO\*ZUJAT.UUO2YM6626(
MV$=];O="2$,94,"R&4/&$<R+MR@5MP&TX]0HKQ__ (:%\&_VC_9'_"0:/_:7
MVC[+]C_M&V^T?:-_E^1Y/F>9YN_Y/+V[]_RXW<5[!6?JVK6^@6\MY>2QP6T$
M;RS32NJ1QQHI9W=V(545069F("@$D@"O+_"W[0O@WQS>1Z?I7B#1[Z]FW>5;
M6VHVTTS[%+MLCCD9VVJK,V <*I8\ FO8*Y_4?%FG:1>6NGW-W;PWM]YOV2VD
MF1)KCR5#R^3&Q#R^6I#2; VQ2&; YKG_ /A;'A[^V/\ A'O[5T_^VO\ H'?:
MX?MG^K\[_CWW^;_JOWOW?]7\_P!WFO0*\?\ "W[0O@WQS>1Z?I7B#1[Z]FW>
M5;6VHVTTS[%+MLCCD9VVJK,V <*I8\ FOQA_X(8_\S=_W!__ &_K]_J***\/
MU;]IOP+H%Q+9WGB70X+F"1XIH9=3M$DCD1BKHZ-*&5U8%65@"I!! (KW"OP!
M_P";O/\ /_0N5^UWC7XW^%?AK<+9ZYK>EZ;<O&)4AO+ZWMY&C+,H<)+(K%"R
MLH8#!*L,Y!QZA7/^*?%FG>!K.34-5N[>QLH=OFW-S,D,*;V"+ODD*HNYF55R
M1EF"CD@5Q_@KXW^%?B5<-9Z'K>EZE<I&97AL[ZWN)%C#*I<I%(S! S*I8C +
M*,Y(SZA7Y@?!;]KC_AH'XUZGHVCWOG^&](\/SI#Y,FZWNKS[79>==#")OV[S
M;1-NFCV1O-"X2Z?=^G]%<_XI\6:=X&LY-0U6[M[&RAV^;<W,R0PIO8(N^20J
MB[F957)&68*.2!7/^.OBQX>^%_D_V]JNGZ9]HW^1]MNX;;S?+V[_ "_.=-^W
M>F[;G;N7.,C/H%>7^-?C?X5^&MPMGKFMZ7IMR\8E2&\OK>WD:,LRAPDLBL4+
M*RA@,$JPSD''H&DZM;Z_;Q7EG+'/;3QI+#-$ZO')&ZAD='4E61E(964D,"""
M0:T*\_\ '7Q8\/?"_P G^WM5T_3/M&_R/MMW#;>;Y>W?Y?G.F_;O3=MSMW+G
M&1GH/"WBS3O'-G'J&E7=O?64V[RKFVF2:%]C%&V21ED;:RLK8)PRE3R"*Z"N
M?T#Q9IWBO[1_9]W;W?V2XDM;GR)DE\FXBQYD$NPG9*F1OC;#KD9 R*X_P5\;
M_"OQ*N&L]#UO2]2N4C,KPV=];W$BQAE4N4BD9@@9E4L1@%E&<D9Z#QK\0M&^
M&MNMYKFH6>FVSR"))KRXBMXVD*LP0/*RJ7*JS!0<D*QQ@'&AX6\6:=XYLX]0
MTJ[M[ZRFW>5<VTR30OL8HVR2,LC;65E;!.&4J>01705Y?IGQO\*ZUJAT.UUO
M2YM6626(V$=];O="2$,94,"R&4/&$<R+MR@5MP&TX] TS5K?6D,MK+'-&LDL
M1>-U=1)#(T4J$J2 \<B/'(O5'5D8!E(&A116?JVK6^@6\MY>2QP6T$;RS32N
MJ1QQHI9W=V(545069F("@$D@"OD#X]_&_P *_$KP+XML]#UO2]2N4\-ZO*\-
MG?6]Q(L8M)%+E(I&8(&95+$8!91G)&?D_P#X(J?\D\U+_L8+G_TBL:_5_7_%
MFG>%/L_]H7=O:?:[B.UMO/F2+SKB7/EP1;R-\KX.R-<NV#@'!KH*\_\ '7Q8
M\/?"_P G^WM5T_3/M&_R/MMW#;>;Y>W?Y?G.F_;O3=MSMW+G&1GH--\6:=K/
MV;[-=V\WVRW-U:^7,C^?;KY>9X=I/F1#SH<R)E!YL?/SKGH*\/U;]IOP+H%Q
M+9WGB70X+F"1XIH9=3M$DCD1BKHZ-*&5U8%65@"I!! (KW"BBBN?\4^+-.\#
M6<FH:K=V]C90[?-N;F9(84WL$7?)(51=S,JKDC+,%') KG_#GQ8\/>,+,ZAI
MNJZ?>60N([4W-O=PRPBXE:-(X#(CLGFNTL2I'G>S2QJ 2Z@^@5Y?J?QO\*Z+
MJ@T.ZUO2X=6:2*(6$E];I=&28*8D$#2"4O('0QKMRX9=H.X9] LM6M]1>:*"
M6.22VD$4Z(ZLT4AC24)( 24<QR1R!6P2DB/C:RDY^H^+-.TB\M=/N;NWAO;[
MS?LEM),B37'DJ'E\F-B'E\M2&DV!MBD,V!S705S_ (I\6:=X&LY-0U6[M[&R
MAV^;<W,R0PIO8(N^20JB[F957)&68*.2!7/^!?BQX>^*'G?V#JNGZG]GV>?]
MBNX;GRO,W;/,\EWV;MC;=V-VUL9P<>@5S_\ PEFG?VC_ &1]KM_[2^S_ &K[
M'YR?:/L^_P OS_)SYGE;_D\S;LW_ "YW<5Q^I_&_PKHNJ#0[K6]+AU9I(HA8
M27UNET9)@IB00-()2\@=#&NW+AEV@[AGU"BBO+_&OQO\*_#6X6SUS6]+TVY>
M,2I#>7UO;R-&690X2616*%E90P&"589R#CT#2=6M]?MXKRSECGMIXTEAFB=7
MCDC=0R.CJ2K(RD,K*2&!!!(-:%<?;?$+1KVWO;R+4+-[;39)XK^9;B(QVDEN
MNZ=+APVV%XE^:59"IC'+ "CP5\0M&^)5NUYH>H6>I6R2&)YK.XBN(UD"JQ0O
M$S*'"LK%2<@,IQ@C.AXI\6:=X&LY-0U6[M[&RAV^;<W,R0PIO8(N^20JB[F9
M57)&68*.2!7/^!?BQX>^*'G?V#JNGZG]GV>?]BNX;GRO,W;/,\EWV;MC;=V-
MVUL9P<>@4445S^H^+-.TB\M=/N;NWAO;[S?LEM),B37'DJ'E\F-B'E\M2&DV
M!MBD,V!S7G_BG]H7P;X&O)-/U7Q!H]C>P[?-MKG4;:&9-ZAUWQR2*Z[E967(
M&58,."#7L%<_XI\6:=X&LY-0U6[M[&RAV^;<W,R0PIO8(N^20JB[F957)&68
M*.2!7/\ ASXL>'O&%F=0TW5=/O+(7$=J;FWNX981<2M&D<!D1V3S7:6)4CSO
M9I8U )=0?0**Y_Q3XLT[P-9R:AJMW;V-E#M\VYN9DAA3>P1=\DA5%W,RJN2,
MLP4<D"N/\%?&_P *_$JX:ST/6]+U*Y2,RO#9WUO<2+&&52Y2*1F"!F52Q& 6
M49R1GU"N?_X2S3O[1_LC[7;_ -I?9_M7V/SD^T?9]_E^?Y.?,\K?\GF;=F_Y
M<[N*X_4_C?X5T75!H=UK>EPZLTD40L)+ZW2Z,DP4Q((&D$I>0.AC7;EPR[0=
MPSZA6?JVK6^@6\MY>2QP6T$;RS32NJ1QQHI9W=V(545069F("@$D@"OD#X]_
M&_PK\2O OBVST/6]+U*Y3PWJ\KPV=];W$BQBTD4N4BD9@@9E4L1@%E&<D9^3
M_P#@BI_R3S4O^Q@N?_2*QK]?Z*X_QK\0M&^&MNMYKFH6>FVSR"))KRXBMXVD
M*LP0/*RJ7*JS!0<D*QQ@'!X*^(6C?$JW:\T/4+/4K9)#$\UG<17$:R!58H7B
M9E#A65BI.0&4XP1GH-6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q
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M0O@WQS>1Z?I7B#1[Z]FW>5;6VHVTTS[%+MLCCD9VVJK,V <*I8\ FO8*\_\
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MU3]I+0=>\1:I)(6G\27@MH'D#K:6HM;,PVL9"1KLC5L%@B&5R\S@RR.Q\/\
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MAW0] TNVNY+.X2PNY8V-Q%=-ND@D>^(DO"BS%2P+R P@P[&A_='R_P#X)??
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MBCPMYMQ!$/$%XVG7H"M*;2>QLC;SHTT AEEC!V2'R7MQ=12Q[71"#^8'PM\
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ME^*WP[']B7NF7$"WL%FD4-O&K_N([J.+*HNYFCMKBW1)(KE)M[Q*!<M-]O\
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MQ%OO@WXFO/-TLW$L6ER2^6HCN),3VS(QG80Q7T3;Q:@S.+R6%%5)9+DOX?\
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M_P"QGX$_:)\&WNJ^)]+^W7L.L3VT<OVN[AQ"EM:2*FV">)#AI7.X@L=V"<
M?3__  6K_P"2>:;_ -C!;?\ I%?5T'[/7[%>F?'[P;X?U3XD'^V6&CZ<FDV4
M,]U:V>G6(MHQ&$6&6)Y;NX4)+?3RE@9 D$2K# A?XP_9(\-W'[(/[0=W\/\
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MQ8EQ=>$-)N((]#T>=)8['SA(\D4TL<<YMYKN*$8NXY?M*R"^VDK;K#$?H_\
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MKF ;6(9M^5#!7*_L]^UC_P D\\5_]B_JW_I%-7P!_P $5/\ DGFI?]C!<_\
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MT'>-JW,!W, K;\*6*N%Y_P#X(8_\S=_W!_\ V_K[_P#^"H__ "2'Q#_W#O\
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M'_\ T\V]??\ _P %1_\ DD/B'_N'?^G*TH_X)<?\DA\/?]Q'_P!.5W7YP?\
M!#KQ39VFH^)]*>3%[<V^GW,,6UCNAM7N(YGW ;!M:Y@&UB&;?E0P5RO[/?M8
M_P#)//%?_8OZM_Z135\ ?\$5/^2>:E_V,%S_ .D5C7Z_U^2'_!9[2;C4?AS:
M2P1221VVN6LL[HC,L49MKN(/(0"$0R21QAFP"\B)G<R@_6'[ ?CK_A8GPO\
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M .GFWK]?OVL?^2>>*_\ L7]6_P#2*:O@#_@BI_R3S4O^Q@N?_2*QH_X+5_\
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M_P#)/--_[&"V_P#2*^K[_P#V3O\ DGGA3_L7])_](H:_('_F[S_/_0N5Q_\
MP57N;?P=\7/"FN:S927.B0V>GM<(8%DCN8[74;B6ZMU$NV&5_*D0/$S 8FCW
M[5D!/[/Z3^S)\--?MXKRS\->&Y[:>-)89HM,L7CDC=0R.CK$59&4AE920P((
M)!HM/AS\.?A!K>EQVND:'INMW\EQ'IAM]/MH;J1HK>22X,311!U180XEDRJ
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MPO:>&M/?SO)WR7-T8DB>ZN)3NDF<(/I'&&:1XX(XHC))Y88_BC\//AY\3?\
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M_A#KC^S?M&W[)_:NE?:/L_V#^SO-_P"/OR_-V?O_ "=VS?\ N//V_OZ_2_\
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MF]MK<K?>)=2LIAYA9)4B:STN1+9'NRWER2,97LX]DC- HE@MC\0?\$^?AO\
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M ."FR_\ C->X:3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550 H
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M (E_%70_@WISZKXAO[?3[)-P\V=PN]E1I/+B7[\LI5'*0Q!Y9-I"(QXKS_\
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MC:Y#\./!,UQ!>G[*U]<67G+?/<3D/;V-N4577<K0RN\#.\YE2W#($GCF^_\
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M;=(6.7<YRQS_ $7444445S_BSQ39^!M.N]5U"3R;*QMYKFYEVL^R&%#)(^U
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MU^W\4R:+J:QR3VGA?3G:VBA#%,6LFJPSQ&YN/+0$RS1FW%TTB1/!;/YHT/\
M@E]^T[K'[3/A+4M%UF[N#J^C>5 NIJD9F:WNHY!;2L\WG)-=Q-#-N>6$HZK
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M]WAF5F\J+]COA;_PD/\ 8]O_ ,)7_9_]M?O/M/\ 9OG?8_\ 6/Y7E?:/WO\
MJO+W[_\ EIOQ\N*] K\$?^"AGQM^*W['6J:>=,\6R7>DZK',;9;C3M,-U%);
M"(3K*T=C'$Z$S(\3JJ'#-&T?[L2S?L=:^%KGQ3H=G'8^)=0;=MN$UBW72Y)K
MN&0,Z YL'LC$5="CPP(S*D9\PYD,GY0_LK?'GXA>)OBUJG@+QCXGN!%I7VIK
M9/[/TRR?46M;B$QKL>T>3RKBU,ESM@<2^1^]CG"*9#^MWQB<6&C7%_+J]YHE
MM81R7EU>6<5M-(+>")WE!2ZM+Q60+\Y$<7G$HH5L%E;Y ^ ;_%G5OA]:ZX=7
MTO6?$>M1VEY;)J40M-/L;.9/-48T^T2>YN'1E$@=HXT=AL8B!C=_.'_!)3X_
M>*/V@+SQ;?>)]3N-0E3^R/*60A88=RWB-Y,$82&'>(T,GE(GF,H=]SY8[_\
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MWX5:%K?PHT:Z?QGXCCUJ2*26Y?49;*WTR.WM5B0E'2)C$$C*22M,Y!PY!PJ
MU\ ?!GXH^+/^"CKZI>6>I7GA3P597GV6 :<(DU:_81K*?,O3)*UF\+""4K;Q
M;)(KF2U,L^QI1P'[4W@_XD?L+6"^+O"'BK5-9T2*2V&K6>OSQZA(A\[9$T;R
MHC"WE:58)TMC#<*2DGF2+\UK^EW[,7[0NG?M0>%[3Q+IZ>3YV^.YM3*DKVMQ
M$=LD+E#])(RRQO)!)%*8X_,"CZ K\@/^"L'PU\4:SX0U36O^$C\GP]9_8#_8
M,-@$\]VN8H=]Q>^>9),/-YHC\L0#RH?W7G)]H.!_P3>^%7CO5/!/AS5;'QC]
MCT 7$\C:)_8MI+NABU"<3P_;7<3#SRLA\P#=%YN%!V+7C_\ P7._YE'_ +C'
M_MA7U_\ $OX3_%7]K'3GU6S\07'@BU?=+I>B)"\=XRHC""75+VWF2:WEG+DS
M6D8GBM8_)#1RW44E>0?\$N?VE_%'B#5M;^'/C2:XN]4T?SIHIYW%Q-'Y%Q]G
MO+>>Z\US-LEDC-N0)/E,R^=Y2VZ+]/\ [8G[5>H_#O4=-\ ^#XO.\9^(-BVL
MDD3O;Z?;RN\9OI@L<GF;/+E<(%D2)(9+B=3'&L-QY_\ $O\ 8J\:6&G/K'A[
MQ]XHG\36^Z\\F>ZC.G7ES&C2?9XK'=#;VL4T^Q4CE>>VAA)B>*5.1H?\$XOV
MXW_:MTN?3-:$<?B/2XXS.ZF-%OH&)474<((975@%NE1?)1Y(G0H)U@B_2^OR
MP_X+"^-;CPK\,C9P+&T>JZI9V<Y<,66-!+>@QD, '\RUC4E@PV,XV[BK+YA_
MP1+\+6=IX-UG54CQ>W.L&VFEW,=T-K;020IM)V#:US.=R@,V_#%@J!?V>HKG
M_P#B7> M._Y=[#3;"W_V(+>VMX$_X#'%%&B_[*(B]E%?EA\&?BCXL_X*.OJE
MY9ZE>>%/!5E>?98!IPB35K]A&LI\R],DK6;PL()2MO%LDBN9+4RS[&E' ?M3
M>#_B1^PM8+XN\(>*M4UG1(I+8:M9Z_/'J$B'SMD31O*B,+>5I5@G2V,-PI*2
M>9(OS6OW_P#"']HJX_:;\!KXF\'0V:ZM/&\2V=_<MY%K>(VR1+E[9))2B@B>
M-0D4EQ"T)(MO.W1_E!^SK^TW\6?&7Q0\2Z3.\>LZM96=_806*3BUT2RFBU."
M(WDD9,<LMO;AI '5)M2GB*0[OF:2+0_;4^$?QA_9RLQX\M_'FH:M%;7$!OHT
M!TZ&W^:**W<6"3R6<\3R;8YXQ&-S.K/%,DD[Q_5_@#XJ^//V^?#5M+X=N9/!
MVG&S$>H:PUFLL]]?E3%<P:7";C=#91-YC?;C,MSYPBBBV/!<M7R!\)OBI\0?
MV+/B]:>"?&.LWFO:3K<EO!!+/.]VSQW,DD%E=0B><O:N)\QW419AL$I"7.RU
MFK]OOB])XJ32V'@Z/2WU9I$"MJLEPEJD><R,5MHWED? "*@:( MYAD/E^5)^
M&/[ _P"T[\4/V@KSQ#80W=Q>:IJ']G#^U[I$;3=$MXUN$GN$M$V0M=RCRA:V
MD2(ES,CSW#>5!,6S_P!H[P!\8_V"KC3_ !99^+-4\2Z/!(OVIKJ6Z>WBD9B@
MBO+.2YG4V\RL$2X5P5F.T-;S_9I)?V^_9N^-]O\ M'^$]-\56MO):1W\<A-O
M(RNT<D,KP2J'7 =!)&_EOA"Z;6:.-B47\H?V<?'?B#_@I/XE\17EQXFUS0?#
MVCR1C3+'1Y4TZ<QWC2")KF9/.,CK':;I$<S 33.89(8@8Y,^R^+_ (Y_8C^+
M6F^!-0UJX\3>'M>N+4VPU&5I;R"+4+C[)&[7+JT@E@>$YC5C:SQ[G$5O-.3!
M^E_[9'BWQKX%\*WNI^##I<4EE9WMU>W-^TS21006[R?Z'!'$\4EQD%D:X80J
M8U1HI5E)B_-#]@KXQ_%#]I/P]J&GV.HW%M=R:Q<W5]XIOH4O(K6)X;=HK#3K
M21A$\KRB1I8@(K6QM7W*OFW$ 7Q_XC^,/B5_P37\<Z3<Z]XDU#Q)X;O^&-Q/
M+/Y]NC1"]1;2XN7\B[AWH\$BRA'W1@RE'N;=?V/_ &Q-(\;R^&I]1\ ZK)8:
MMIT<MP;5;."[6_C1=S0*LEO/*MQA?]&\H8D<F%T/F)+!\7_\$OOCSXJ_:=BU
M+4O$GB>XN[C3+B*,Z3'I]C!"89XI/+FFG2T$C[W$GEQP20M$UL6E,D<RI7U!
M_P %!O'.O?"3P)?^)_#NJW&G7NF_9]L<<-G-#/\ :;NV@/G+=6T[_(KN8_)>
M'YF)?S % ]_^!?A7Q'X0T."W\6:O_;.M-^\NKE8(((49@/W,"0PPYBCQ@22J
M996+2$1JR0Q>P5\__M._M"Z=^R_X7N_$NH)YWD[([:U$J1/=7$IVQPH7/UDD
M*K(\<$<LHCD\LJ?D#X5?"+QI^UQH=AXK\8>*M8T3^T+=+FRTGPY+'IL-M#*/
ME>6<-=2W?GQ+!<HLS!K5I)8P!N*)\P?$OX_?$#_@F[XMT^Q\1:G<>)_ U]]H
M^R-<F&34A$)%>7?.P6:2[MC*@7SG-K<0N$3[.QVV?Z/_ +6/Q#\6Z)X-N-?\
M 3:.\46GW5_/?W4LDN+2.V:9)+".&.2&>5Q^\BDG?[.-BAHYDE+1?G!^P5\8
M_BA^TGX>U#3['4;BVNY-8N;J^\4WT*7D5K$\-NT5AIUI(PB>5Y1(TL0$5K8V
MK[E7S;B +X_\1_&'Q*_X)K^.=)N=>\2:AXD\-W_#&XGEG\^W1HA>HMI<7+^1
M=P[T>"190C[HP92CW-NO]'U%?DA_P4'_ &F?$&@>*O#7PU\,7\FCW.OR0+?:
MDD"221V]_<&QA%NQ<,KJPGED*"*92EN8KF,F2N _;!^"/C']D?P__P )QX1\
M<^)+AM+D47EKK-_]OCDCNG2U1HHGB\AG1Y1E)XW!#>:DD4L"K+^A_P"RY\=-
M1_:(^'^G^*_L=O%J5Y;W/^C><Z6[7%O-+;_ZWRY9(HI7BW_<G>%'V_OV3+_D
M!J/[5WQ5\+_&JUT#7C_:MQ8>:D>@Z"[P6-S-=Z6'A#O.$D>)7>*>>>],JV86
M>:-1&FT^P?M@?L]?&;3M#NO&B^.+B6[LK<W%YI.F&;2K2WMD$DUP+:2.X7[3
M]GW$(]RB7,]NG,C2I' _V?\ L&_M#W_[6?P^6_OYI(-8@DN-.O+R&*%";A$1
MTN8$<30[_*FA=@\0A^T"0"W$ 53^<%S\>_BW\/?BS9?#KQ5XPDM[&ZO((XM1
MAT6Q!NH+@9MC CV3!7FDVVC2?OH;6X\S<TR0.6_>[^QI_P"SOL7VVX^T?9_)
M^W;;?[1OV;?M&WR?LWFY_>8\CR-_'D^7\E?GA^QKK?C[XE>)?$MYK?B62[\/
M:#KFI:-:6)L[!)[F2V; ENIH;.$JB1R1LH@*&68DMY<4?ES_ *7T5^./[/6N
M7_\ P4<?6]<N/%NN:+8V&J26^F:1HMS#IL\%FT:-%/?,@N)9WG PN]C'%-#=
M>2Y1S'%Z_P#!'2_'GPU^*\GACQ#KEYK/AQ/#=U<Z--/&J,RK>6,)2[ECBC6Z
MO8% 5YG:5RDRS_N3=R1#L/VV_P!L>\_9YETCP[X9M+?4O%FO7$<5E;3R*(8E
M:5(E>=!+%)^^=O)MR6BB++-(TP%N8Y,_5OV'?$'BNWEN-3^(OBPZW+&X-Q97
M*:?IXD"E8673;<!515">:D<R&=P\GF1M(2OSA^RU^VOXO\$_$"Z^%_Q3FM[C
M4GN!'9ZE%]FA196A66&%O+6"-XKE"C6IV+=+/*L$D;-*%MOM_P#;-_:E_P"&
M8-#AFL;7^TM?U2X%EH^GJ=S37#C_ %C1(PFEBC)0,L(+O+)!!NB\X2IX?9?L
M.^,?%UE->>)?B+XD'B&XC!#:5<_8M-MY! B*HLXP@F1)%9F>,V9N%.3'#*SR
M-XA_P2V_:K\<_%74=4\(>+HKB[_LBW#?;[B)H[BUEB=+;[#=GRQOE?$DBO.1
M=%X;GS&GS^X\O_:&_:"^*7AKXN>%/"^N7]G8:=>:II-REEHLL_EO;3:C);B.
M[N98H)YW9 T<\8"6DH6-_LZOD#][J_#']G'QWX@_X*3^)?$5Y<>)M<T'P]H\
MD8TRQT>5-.G,=XT@B:YF3SC(ZQVFZ1',P$TSF&2&(&.3/LOB_P".?V(_BUIO
M@34-:N/$WA[7KBU-L-1E:6\@BU"X^R1NURZM()8'A.8U8VL\>YQ%;S3DP?J]
M^UC_ ,D\\5_]B_JW_I%-7P!_P14_Y)YJ7_8P7/\ Z16-?K_7'^/Y-9BTNY/A
MZ.SDU;RR+1;Z26.U$A( :9H8Y)2B@E]B*#(5$?F1;O-3\(?V=?VF_BSXR^*'
MB729WCUG5K*SO[""Q2<6NB64T6IP1&\DC)CEEM[<-( ZI-J4\12'=\S21:'[
M:GPC^,/[.5F/'EOX\U#5HK:X@-]&@.G0V_S116[BP2>2SGB>3;'/&(QN9U9X
MIDDG>/ZO\ ?%7QY^WSX:MI?#MS)X.TXV8CU#6&LUEGOK\J8KF#2X3<;H;*)O
M,;[<9EN?.$446QX+EJ^0/A-\5/B#^Q9\7K3P3XQUF\U[2=;DMX()9YWNV>.Y
MDD@LKJ$3SE[5Q/F.ZB+,-@E(2YV6LU?O=XL\4V?@;3KO5=0D\FRL;>:YN9=K
M/LAA0R2/M0,[;54G:H9CC !.!7Y@?";4_%'_  40^V^(9-7UCPKX,CN#;Z-9
MZ7(+/4;MX,B2]N+TQ/F([VB-O TD'G(4)\RS,USX!\2_C/XT_P""9?BW3[;6
M=8U#Q7X,U?[1*/M[1R7T)614D2*=Y7E>6WB^S/AS!9W!FE5(8)&::+]3_P!H
M?]IO1OV??!TWC&5X[ZV,<1L(X9X@+Z2XQY"P2$E61E/G,\8E*VZ23+'($VGX
M?^ WP'\>?M4:7'XQ\<^+M<TAM4CCGTS3?#]ZMA!!8REYHFF")(LCNLBF/?ON
M(X5C$]Q+*3%;_G#\6O#?C'P3\;/!.C^,[N/4KG3[S0[>PU->)+[3QJCM!/<
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M8\"_\+0\/:KH/G?9_P"T]/N[+S]GF>5]IA>'S-FY-^W?NV[EW8QN&<C\4?\
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M_=MW+NQC<,Y'XH_\$-=6N)K?Q79M+(;:*32Y8X2[&-))5O%D=4SM5W6*)78
M%A'&"2$7&?\ L"_\G"^/?^X__P"GFWK[_P#^"H__ "2'Q#_W#O\ TY6E'_!+
MC_DD/A[_ +B/_IRNZ^ /V^O^3A? 7_< _P#3S<5^_P!7X _\$,?^9N_[@_\
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MYCMXE2)"44MOG::<D-*57]WOVL?^2>>*_P#L7]6_](IJ^ /^"*G_ "3S4O\
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M\ ?V^O\ DX7P%_W /_3S<5^OW[6/_)//%?\ V+^K?^D4U? '_!%3_DGFI?\
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M[N\N8[=9HU6UM&46BVZX@CEC7:()$=(;RX\J6!?E#_@FSH'_  BGQU\9:?\
M:+B[^R6^M0?:;J3S;B;RM6M4\V>3 WROC=(^!N<EL#.*_7_]LGX%Q?M$^!M6
MT/R//O3;O<:<!Y2N+Z!2]N$DF!2+S&'D2/E"8)94\Q Y8?"'_!'']H&W\9^$
MYO!DYCCOM#DDE@0;5::SNI7E+@&1GD>*=Y$F942.-);5<L[L3]'_ + O_%Q;
M/7OB--\TOBW6+B:U=OEF32]/9K+3[>>)/W*2PB.8$Q&0R*ZM)-(_W?O^BOY\
M?^"-7CRW\9^*O%UYJSQS>(]2CAO1,8%$CQM<3-?LKH@2)&FFM6>)2@<^650B
M'Y/Z#J_G1^$_ANX^%7[5=WIT%W(\=[>:G<3[-T2R1W^G2ZF()$#L)$BD>/&X
MX=X4FV(P55[#]OK_ ).%\!?]P#_T\W%?O]7X _\ !#'_ )F[_N#_ /M_1_P7
M._YE'_N,?^V%?O\ 5^"/_!6GP _P@\2^&?BEH]M&;F&\ACNV<1B"2ZLF6YL#
M+&ACGD>1(YXY)-Y AMX8@T1";_L_]J_XZ1?%3X7V#>%Y]DOCNXT_1=/F?RG2
M%M3?;<17A4S"/;$ES;3^2)I89_E4!UWI]_\ A/PM9^!M.M-*T^/R;*QMX;:V
MBW,^R&%!'&FYRSMM50-S%F.,DDY-=!7S_P#M8_\ )//%?_8OZM_Z135\ ?\
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MVPN+GQ9'<7-M;::()]MPUS=R3I.;F**:.&TB28O=2N/-AB@N)%MY0L8E^?\
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M+>W+QK>6\"Q)'=/<W.(C<2%RLL1F>:1XY;@(L;;(_G#Q)\'-#_:)_:"T[4_
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M/_%70_$'PXTOP_;7]N^KZ?\ ;S=6.\+<1JU[+*)/*;#M$5N(?WR!HM[^7O\
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MH&YBS'&22<FN@HK^='XH>%[_ /X)B?%G_A-;.QDD\%:S)-$Z6PAPD=R!+/9
M>4B0/#,@N+.%?+$UO"D(N.+HQ_K_ *G^W3\,M)TL:Q)XGTLVQCBD"1W ENML
MI4*#91[KL.-P\R,Q!X@&,BH$?;\?_P#!/CX'^)=1\5>)?BGXMM+S3+O7))X+
M#3[N5FN(K5[@2.LR2Q)*J1"&WM[//E$PQ2'[.L+6['X0_;D^/WA?Q!\</"VN
MV.IV]WI>C_V+]NN[8FXAC\C49;N78\0<3;(I$9O)\SYB8O\ 6JZ+^_WB/]H'
MPEX4T,>)KO6M/716\P17JW,<D,S1B0M' T;-Y\O[J0"&'?*S(RJA8$5^$/\
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M(OQK,CPQZCI>HQA$=S-':ZA:QS(_F1['VPWL2[HB)1.;4SN0DT,T<DOZ7?\
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M=X@UI?\ EDEX4,6C1^=%F1+M',EU]FE,,<UJ?,(G4!!]_P!%%?@#_P %SO\
MF4?^XQ_[85^SWBG]GKP;XYO)-0U7P_H]]>S;?-N;G3K::9]BA%WR21L[;555
M7).%4*. !7L%%>/^*?V>O!OCF\DU#5?#^CWU[-M\VYN=.MIIGV*$7?))&SMM
M555<DX50HX %>H:3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550 H
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MAL[>*WC:0JJERD2JI<JJJ6(R0JC. ,=A117G]C\6/#VI_P!H^1JNGR_V1O\
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M32YM662*47\EC;O="2$*(G$[1F4/&$01MNR@5=I&T8[#_A$]._M'^U_LEO\
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M/_[2G[->A_M4Z'_8&O\ VA;=;B.YAFMI!'-%-&&4.A97C.4>2-ED1UVN2 )
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M444445Q_C7XA:-\-;=;S7-0L]-MGD$237EQ%;QM(59@@>5E4N55F"@Y(5CC
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M/)\[?'<VIE25[6XB.V2%RA^DD998WD@DBE,<?F!1\X?M'?MF:IX3\8Z?\-O
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MCG0X_$FE7'V[2YK=KB*:VCDF9T0$LJ0QHTS2J59&@"&<2J83'YH*5^4.H_\
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M1^(G@W2M>\FW;4M0T>TO?(WO!;FXN+9)O+W[;B2*(NVW=MF=$YVR,,-\ ?\
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M'4*\,DWS?^VW_P %,+W]G"X;2=&\/WC79DECCU'5;:>VT^1H6A,AM$_=RWJ
M.\;2*\"(_E2HUQ#(I;T#XQ?M<>//$=O<7GPG\,QZ[I-E)(LNM7$JM;W36ZO]
MICT^T2>"XO$5]J1W4#2)--'/##%+A)3Y_P#LK?\ !4[2_BEX?OKCQ5%'::[8
M21)%8V(,DFJM<NR6T6FVCRO<27&\+#)'ET0M',TR1R.L'F'[07[?_P 8?V=K
MRVU'7_!NGZ;H%U<)''&]R;R8[%5I83?6MP88I9 )&@,EL,*&Q'/Y,I/Z_?"K
MXEZ=\9-#L/$.E/OLM0MTGBRR,R;A\T4GELZ++$VZ*9 S>7*CH3E37Y@?%[_@
MJ-+X/\9:1X8M=$N-+LKG4+-+S4M?AEL,V,ER\$UQ;VTGE.D6U1+%=W#J%VRI
M): J2#XZ?MI_%6QLY_%?@GPK;S>"8;?SHM1U!':YN858AKU;..[@N8K1AB2+
M?"6^S#[8[)$Y2+Z0_8<_;CTO]KW2S'(([/Q'9Q@W]@"=K+D+]JM=Q+-;LQ 9
M26>W=A%(6#0S3G[9'[9C_LZ7&E>'M#L(]6\4:](8;"T>YCACA:1A#!+< L'*
M23NJ1H3"DHCN/])A,7/S_P#&_P#:?^,_[)]O;Z[XJT;PWJ^A>8T=V=&>_CD@
M9EVPF66YWB%'D90)/(F0E?)9HI)H2WZ'_"WXXZ/\8/"]OXOTHW#Z;<6\DZK]
MGD:X7R2Z31>1$LDDDJ/&\>R$2^8Z_NC*K(S?FBO_  5<1O'UMX>U'29/#FA0
M1W4FIW&M))%J"JE@UU %M4.(':10B1YNWNDDB\I8Y'"'/_:4_;D^,/PJL_\
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M$D/A]98G 8$!XY$22-NJ.JNI#*"/V._:Q_Y)YXK_ .Q?U;_TBFKX _X(J?\
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MP:58EC57F\R1(IYT8+*[%?0/^"YW_,H_]QC_ -L*_?ZBBOP!_8%_Y.%\>_\
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M_0__ (*C_P#)(?$/_<._].5I1_P2X_Y)#X>_[B/_ *<KNOSP_P""B&DV^O\
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M11S1K)%*$D17420^'UEB<!@0'CD1)(VZHZJZD,H(_8[]K'_DGGBO_L7]6_\
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M=:A;10,AAM;_ %.(&V2&0P,MQ;V=P(569LK<1#S9)L.\GL'Q-^#O@[]LKPU
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M?QDTY-5\/7]OJ%D^T>; X;8S(LGERK]^*4*Z%X90DL>X!T4\5^(/_-WG^?\
MH7*_7[]K'_DGGBO_ +%_5O\ TBFKX _X(J?\D\U+_L8+G_TBL:^4/@=X_P!+
M^(/[2&L2>.KF.YEL[S4;'P\+LGRH;JUOA'8PPJ (5=8A,8-X >Z82J6OI(W;
MW#_@M'\5=#O/#-AX9AO[>76HM8AN9K*-P\T,*6<X+S*N?)S]IA,:R[&E5RT8
M=4<K^A_[*?C_ $N+PKX1\/&YC_M:3PGIM\MH"3(+6.WM86F8 $(ADD5$WE3(
M1)L#>5+L_*#]A'5K?3OVB?&T4\L<<ES)X@B@1W56ED&JQ2E(P2"[B..20JN2
M$C=\;58C[O\ ^"B/PT_X:A^'6IV^@)<:AJ&BZ@D\$-LO$UQ:YANHD+KBY\J*
M>X5DMF+_ &R$VN3<12V]?('_  3._P""A>AZ5H=IX(\7WOV.[L_/6QO[IPEH
MUH@62*":YEF.R5,RQPAEBMQ;Q00*WF[$?[?_ &@OVR=.N+.V\/?#O5M/U3Q=
MKMPEEIOV1TU"&TW,OGWMW]G,HBBMXB\H+K)\R[S!-!%<;/@#_@L1X%UCP%XA
M\-_$G2YMGV7R;)'V1G[->6LTM]:R8D9O-\S=*=IB,:?9L.S><J5^QWP&_:*\
M-?M):7'JGAV]CG4QQO/;%E%U:,Y<".ZA#,T3[HY I.4E"%XGDB*N?PATSXU^
M&M6_:A/B6/5+,:())8SJ,DRQ6NZ+1&M&(FD*H4,RF..0$I*2K1LZNC-_1]I.
MK6^OV\5Y9RQSVT\:2PS1.KQR1NH9'1U)5D92&5E)# @@D&M"OP!_YN\_S_T+
ME?O]7\R/QYO=4_8 ^.LGBM(;P:)JEY)=L[$.M[:WNQ]2A3RWA1W@FD=H()F!
MC>.SEE#J4DD_;_P!^W'\.?B#I=MJD?B+2[-;F,.;:^O;:UNH6R0T<T,DH975
M@1D;D< /&\D3([9_[+?QQU']HV\UWQ# <>$?M$%EX?WV[P37'V57^W7I\Q<O
M%-+(L4!##:MLR/!!.LWF?E!_P0Z\4V=IJ/B?2GDQ>W-OI]S#%M8[H;5[B.9]
MP&P;6N8!M8AFWY4,%<K^G_\ P45^,=G\&_AKK,EROF2ZK;RZ3:Q99=\U]%)&
M3N5'"^5%YUQA]JR>5Y6]7D4T?\$[O@7+\ OAUIEC>0?9]2O=^H7Z'S0PFN<&
M-9$F"M%+';K;PS1*JJLL3_>8M(_YP?\ -WG^?^A<K]_J_EB^%/Q"O/\ @EW\
M5=4T_5;;4/\ A'IOM,1A^66:ZL=\C:=>1 2V]M+*"JHTAXB62\A"1S;D3]_O
M^&UOAK_9W]J?\)1H_P!G^S_:-GVR+[1LV>9M^R[OM/FXX\CR_/W_ +OR_,^6
MC]DSXD:Y\9=#N/$NL)Y%IJFH7%QHMLT)AFAT@!(K03H<YEE\M[HNLDT;K.K1
MR"(I''S_ .S1\9]#_;B\#0WU]:6]VK[+;5K&XM0UNM] L4LB+%,94>+<T<T#
M%I"$:/<5F5T3\<-9_9G?]EK]H;PUI?@F20PWLD&H)#)Y;-;6,KW,6H6XDF8^
M:BVT-R8W;%P$944R7"+-)H?\%-?"VN?LV?%#3OB;HD=P(KG[)*;IV)M_MUJA
MA>S;R3'(D4UK#'OC=@;A'NE1V19$B_6_X0_\% OAS\7]+74TUJSTMC(\;V>J
MW-M974;(>IC>8JR,I5EDB:1"#L+"5)$0^#/[0]Q^T+XUU0>'IHY_!FB6?V.6
M[$3;;W6)9E=C:W&&2:WMH(RC%&CR]R)-MQ!);3+^:'_-WG^?^A<K]?OVL?\
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M[XFZ)'<"*Y^R2FZ=B;?[=:H87LV\DQR)%-:PQ[XW8&X1[I4=D61(OUO^$/\
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M6$JQ33)$K*J2K(DL+\,H\PQ^?MBBC$HB0)70?LZ?L+>!OV8ML^C6/GZDN?\
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M5Y9RQSVT\:2PS1.KQR1NH9'1U)5D92&5E)# @@D&M"O'_P#AH7P;_:/]D?\
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MXTEAFB=7CDC=0R.CJ2K(RD,K*2&!!!(-?DA_P6K_ .2>:;_V,%M_Z17U??\
M^R=_R3SPI_V+^D_^D4-?0%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%>'
MW/ASPK^S+HVK:YIFCV>GVUK9RWEZFFV=O;R3QV<4DN,1B)9'"[Q&)& !<_,H
M8FOPA^)GQBT;_@JC\0=%T%KB/P]X<TV.5HYKV2*+4+V2Z>V22W@7?)!]HD=8
MHK:(&0JBS7)\X[;1?Z3J******_,#_@HS^P3_P -46::[HC;/$VGV_E0QO)M
MAO;=6>06Q+'9%*&=V@E^5"SM%,=C)-;_ (H_!#]KOX@_L :S<>';^*26VM)%
MANM$OW<QP@2^<SV;*Q6!Y5D=DFB$EO,)EG:*X B8?T7?LH_MK^%_VM+,?V7-
M]GU>*W2:]TN7/G6^6*,4<JJ7$08#$L6=JR0^:D$DHB'G_P#P4QM?%NJ_#J[L
M?"%G<7EQ>7$%O?):K(]RMB^XRF%(F$C[W$4,R*LH-M+/NC\O?(G/^$_V#? -
ME\-;32/$^BZ?I]TFCPMJNHX@6\M;E8A-=3_VB=Y7RI=[Y,CVPC7RBK6O[L_*
M'_!$;Q_JFNZ7XAT6ZN9)=.TV2PDLH'(*P-=F[,XC)&Y4=HD<QYV!]\BJ'EE9
M^/\ ^"MG[+GA#X7^'D\5Z1I_V?6M3\0#[9<_:;F3S?M,-Y<3?NI)7B3=*BO\
MB+MQM7"D@_7_ .R=^P5\./\ A'O"GBO^QO\ B=?V?I.I?:?MM[_Q^>3#<>;Y
M7VCRO];\^S9Y?\.S;Q6?_P %*_VI=4^%":1X.\.WUGINJ>(Y&BGU*>Y$3:;:
MF2.$3L0"T"2M)(/MAYA2WN#$IF"RP&D_"C]F_3O#\7AV6[\)W,$<:(]W+J=B
M-0E97$AD>^BECN [.,L(WC0(3"J+!B(?&'_!,3]H:\^&7CF\^%;:A_:^@/<:
MC'I-S&JLBS6K22F:%Q,PCM+F**64QH9U\]HWC*^9<22>H?M3>.;W]J'XUZ7\
M)+J22S\.6<B/J$44\^W4U^R1:J\=RD<L*[-L*00'YGMW:2Y5V++$GZ?_ +17
M[.NE_&WP5>^$TLK,*+-DTE'4Q06=U%"R6<D?DKNA2)MJD1*1Y)>(H\3O&WY
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M ,S=_P!P?_V_K]_J**_%'^WKW]OGXO:SX3U-[P> _#,=S!=:<GGP07UU%(D
M6\FMKA<N;E7N;3<Q'DV0"VZ2/<O7V?\ '3_@GQX!^,NASZ5;:1I^C7;?/;:A
MI]C!!-#,H(0L(EC\Z(Y(E@<A74Y5HY5CFC^(/^"6'[2^L:?J-_\ "GQ?-_I^
MD>9'IJRO&SI]C=HKJP\X2GSO*P'MDC639!'<?O1;PPHGR?\ MI?#35/AA\;/
M"\&FZK>:QJUW)I5W:SZ[.)HX[J75)Q%"1:Q0B&R61%;R($41AY/+ RJC]/\
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M*OBQX;CEU&ZO(X;8:E"+B!6#2M<K:Q7#S*]O&HM8K6X'F((4\J"=D$P/S?\
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MXA:!]IT/3[>6WTDW:&6P*F2-+(P1RR213[[;[1/.BAXH+N5W>.WN6C5?D_\
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MUFTDNM1T?0]3ET]S=W21V\D=O),'6WCF6 N75"[-&QD"1HY9(T5?S0_X)?\
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M':/J,EWX7ACU">T4RQS1S-;7UO;6]VLB*$+R0/AWAV)./+)5A'#LZ#_@K_\
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MR7UQXAU]?WL>ERRJ-+L"?(*HMM $ADEQ HN@G^ASEF5H;C8+F3Y _P""&/\
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M4ZS1B.?44:R5'9W>9'AM9664%P0@+/ETW:'_ #=Y_G_H7*_?ZOP!_P";O/\
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M6\WT!_PW9>:7^XU#P!XX2]B^2Y2UTE;NW69>)!!=).J7$08$1SJJK*F) H#
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MAMHL("ZSJUTDD<D30)YBR1T/^"A/_!/;5/BKJB>// ;R)XF22W-S;"X$#3-
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M,\8?%*&WTNRT?$^D>'[>+"2W<D9VZA>Q327#QRPK)MMXY&6X@G0N$M2L@N_
M/^"F?P&^(7[6.HZ7;>'O#%Q]BT;[<OVN?4-,C^TM</$NZ*+[676(+;HZ-*4E
M;S2KP1&/Y_U>\.?$/6M0T,ZE?>'-0M=23RU?25N=.FF=B(][03B\2V>)2[X:
M:2VE=8F;R%9HT?\ (']EGX+_ !.^#/Q.UKQSJO@ZX:RUW^TO-@MM5TJ2:V^V
M727B[/,NX4GVM&L39,.58RCE1$_U_P#MJZ/\0$\6^#-8\ V-Q?2Z;_:CZC#'
M/#;0S6<DFG"2UFFN"(1YX4^6K!Y%:,W$:%[?>G'_ !"_:H\0?'OPKJ'AG3/
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M@Z!HC(C.)X_WN\+:S/X@LX[FYLKC3Y7W;K6Y:W::/:Q4;S:S7$)W !UV2O\
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M:G<OJUA?1W1C8>5!#$9+B*4V4 C>.TC;S!"/,17Z@=?_ ,/J_B'_ - WP_\
M^ U[_P#)U:'CG]J7XV?'Q]!U6X\&27-CI=Y#J]C';:+JAM;FX6,_9+EY$F:6
M1(@YEA$,L<,A?,JSIM4>X?\ #?7[0O\ T(7_ )0-9_\ DBC_ (;Z_:%_Z$+_
M ,H&L_\ R11_PWU^T+_T(7_E UG_ .2*/^&^OVA?^A"_\H&L_P#R11_PWU^T
M+_T(7_E UG_Y(H_X;Z_:%_Z$+_R@:S_\D4?\-]?M"_\ 0A?^4#6?_DBC_AOK
M]H7_ *$+_P H&L__ "11_P -]?M"_P#0A?\ E UG_P"2*/\ AOK]H7_H0O\
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M4#6?_DBC_AOK]H7_ *$+_P H&L__ "11_P -]?M"_P#0A?\ E UG_P"2*/\
MAOK]H7_H0O\ R@:S_P#)%'_#?7[0O_0A?^4#6?\ Y(H_X;Z_:%_Z$+_R@:S_
M /)%'_#?7[0O_0A?^4#6?_DBC_AOK]H7_H0O_*!K/_R11_PWU^T+_P!"%_Y0
M-9_^2*/^&^OVA?\ H0O_ "@:S_\ )%'_  WU^T+_ -"%_P"4#6?_ )(H_P"&
M^OVA?^A"_P#*!K/_ ,D4?\-]?M"_]"%_Y0-9_P#DBC_AOK]H7_H0O_*!K/\
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MQ3\1^"_$^M?VM9:-;ZE'&WV&TM=\UGJ%O:K-B")77<K.?++NHW\EBH:OO_\
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M[,7[0NG?M0>%[3Q+IZ>3YV^.YM3*DKVMQ$=LD+E#])(RRQO)!)%*8X_,"CZ
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M7[_5^ /[?7_)PO@+_N ?^GFXK]_J_ '_ ((8_P#,W?\ <'_]OZ]__P""U?\
MR3S3?^Q@MO\ TBOJ^_\ ]D[_ ))YX4_[%_2?_2*&OD#XI?M9?9O'-QX,^%FB
M:?JOB^\\O^VM5D799VGV5DC_ -/E@59;G[/$SQ/^]7[-(\5O'Y]PSVB_EC_P
M5$^&/BSP);^%[KQGXBDU[5KN._5PD$5M9VJPK9L8[>*)(P[F2:3S+IUC>>-+
M=3%'Y(!_J-K\ ?\ @AC_ ,S=_P!P?_V_KW__ (+5_P#)/--_[&"V_P#2*^K[
M_P#V3O\ DGGA3_L7])_](H:_''XH^/+>Z_:KT^+Q"\<MC8265E8I) LBQR3Z
M=YMHH"(27^WW0DCE?)A=E?>B1*4_H.K^='_@M-X;N/"'BKPUXJL[N2&YFLY;
M>$1;HY+>33K@7"3I,K[@Y:\&W:%,9A#!V+X3ZO\ ^"U?_)/--_[&"V_](KZO
MO_\ 9._Y)YX4_P"Q?TG_ -(H:_('_F[S_/\ T+E?O]117YP?M2_M9:=\)/%%
MKH7A+1+?Q!\1=0MS9QJBHKVENX:>);JX"^9Y6_;<M:^9"@@5[F6:V0Q22_GA
M_P %+?ACX\T?P59ZUX[\11ZA<R:XL<&DZ? L&FV:S0WLA(<HD]VZI%"D$EP
M]NK7$>Z8RM*?VN_9._Y)YX4_[%_2?_2*&OR!_P""&/\ S-W_ '!__;^OUO\
MVQ-)M]:^'/BJ*ZBCFC70]1E"2(KJ)(;:26)P&! >.1$DC;JCJKJ0R@C\L/\
M@FSXIO/ WP*\9:KI\GDWMC<:U<VTNU7V30Z3:R1OM<,C;64':P93C!!&178?
M\$1]3TN7PKKEK"(_[6CU1)+HB(B0VLENBV@:7: Z"2.\V1[F,9,C%5\T%_VN
MK^='_@E1X;N/A3\7/%?A5;N2>VL;/4+>0C=''<26.HV]O'.T.]E#A6EV9+F,
M2R*'(9BW8?L"_P#)POCW_N/_ /IYMZ_7[]K'_DGGBO\ [%_5O_2*:O@#_@BI
M_P D\U+_ +&"Y_\ 2*QKP#]OK_DX7P%_W /_ $\W%?O]117Y ?\ !:O_ ))Y
MIO\ V,%M_P"D5]7W_P#LG?\ )//"G_8OZ3_Z10U^0/\ S=Y_G_H7*_7[]K'_
M ))YXK_[%_5O_2*:O@#_ ((J?\D\U+_L8+G_ -(K&OB#X'^#?^%X_'SQCI^H
M>(=8TBX>XUE+:YT[4?LEY/\ 9KZ-([-9'61I(DMXRP@4?)';*PVQPD#]3]6_
MX)WV^OV\MG>>-_'D]M/&\4T,NNJ\<D;J5='1K8JR,I*LK A@2""#7J'[*7[%
M7A[]C[^T?[!N=0N/[3^S>?\ ;989-OV;SMGE^3!#C/G-NW;LX7&,'/U_17\V
M/_!;CP5<6'BK0]<9HS;7FEO9QH"WF"2RN'ED+#;M"%;R((0Q)*R950%+?L_^
MPMXUM_'_ ,,O#%Y:K(D<>EV]F1(%#>98#[%*0%9AL:2!VC.<E"I958E1]7T5
M^$/_  7%\4WEIIWAC2DDQ97-QJ%S-%M4[IK5+>.%]Q&\;5N9QM4A6WY8,50K
M^UWP]U/2]:T;3[K0Q&NDS6=O)8"*(PQBU>)6@"1%4,:>65VQE5*#"[5Q@?GA
M_P %>? O_"6_"^XO?.\K^R-0LKW9LW>=O=K'R\[ALQ]K\S=A\^7LVC?O7C_V
M?-6N-:_9BN9;J62:1?#?B*(/([.PCA-_%$@+$D)'&B1QKT1%5% 50!G_ /!%
M3_DGFI?]C!<_^D5C7@'_  7._P"91_[C'_MA7[_5^ /[ O\ R<+X]_[C_P#Z
M>;>OO_\ X*C_ /)(?$/_ '#O_3E:4?\ !+C_ ))#X>_[B/\ Z<KNOF#_ (+:
M>%K.[\&Z-JKQYO;;6!;0R[F&V&ZMIY)DV@[#N:V@.Y@679A2H9PWV_\ "/Q3
MH?@OX0:'?^)I+>+18O"^F"]-RH>%H7LH4:-XR&\WS-WEK"%=IF<1*CLX4_)_
MPI^+?Q(_;$MXI? ,5GX%\%6<GV>UOI[2.[O+F.W6:-5M;1E%HMNN((Y8UVB"
M1'2&\N/*E@7Y0_X)LZ!_PBGQU\9:?]HN+O[);ZU!]INI/-N)O*U:U3S9Y,#?
M*^-TCX&YR6P,XKZ?_P""U?\ R3S3?^Q@MO\ TBOJ^_\ ]D[_ ))YX4_[%_2?
M_2*&OR!_YN\_S_T+E?M]\5?AIIWQDT._\/:JF^RU"W>"7"HS)N'RRQ^8KHLL
M3;987*MY<J(X&5%?BC_P2$^+#_#75-=^%NMI':ZC%>3W4"EXRS75N%MKZV,@
MF*RNJPQR0K C@I'=2M(45,?=_P"S=_Q=OXB^-/&DOS1:;<1^%=,#_)- FGXF
MU%2D?[MXIKJ1)8)9&DGVAE(A3]V?O^BOS@_:E_:RT[X2>*+70O"6B6_B#XBZ
MA;FSC5%17M+=PT\2W5P%\SRM^VY:U\R%! KW,LULABDE_/#_ (*6_#'QYH_@
MJSUKQWXBCU"YDUQ8X-)T^!8--LUFAO9"0Y1)[MU2*%()+@![=6N(]TQE:4_M
M=^R=_P D\\*?]B_I/_I%#7Y _L"_\G"^/?\ N/\ _IYMZ^__ /@J/_R2'Q#_
M -P[_P!.5I1_P2X_Y)#X>_[B/_IRNZ^(/^"+OBF\\<ZCXYU74)/.O;ZXTRYN
M9=JIOFF?49)'VH%1=S,3M4*HS@ # K]7OVL?^2>>*_\ L7]6_P#2*:O@#_@B
MI_R3S4O^Q@N?_2*QK]?Z*_ ']OK_ ).%\!?]P#_T\W%?O]7X _\ !#'_ )F[
M_N#_ /M_7O\ _P %J_\ DGFF_P#8P6W_ *17U??_ .R=_P D\\*?]B_I/_I%
M#7X _P#!+_X7?\-%:CXE^W>*?$&DZD?LETW]EZK]EN+[S'N?/GN-Z2R7'ENT
M>9#]Q[@[B6F6OU?\4_\ !-G3O'-G)I^J^,O'%]93;?-MKG6DFA?8P==\<EJR
M-M959<@X90PY -?2'[+_ .R_HW[)FC3Z'H<]Y/;3WCWCO>/$\@D>**(@&**%
M=FV%2 5)R6^8@@#Z/KY__:Q_Y)YXK_[%_5O_ $BFKX _X(J?\D\U+_L8+G_T
MBL:\ _X+G?\ ,H_]QC_VPK]_J_ ']@7_ ).%\>_]Q_\ ]/-O7W__ ,%1_P#D
MD/B'_N'?^G*TH_X)<?\ )(?#W_<1_P#3E=U\ ?\ !<[_ )E'_N,?^V%?O]7\
M\/[</A:S\/\ [1G@^YMH]DNH7'AZYNFW,WF3+J36H?#$A<16\*;4"K\F[&]F
M9M#_ (*B^/+>P^+G@NSU]XW\.6$=A>W,,L"S1B.?476]9T5'>9'AM8E:(AP0
MA"IEWW?T'5^(/_!;WP+_ &AX>\/Z]YVW[%J$]EY&S._[=")O,W[AMV?8MNW:
MV_S<[EV8?T_]JS5KC7_V9HKR\EDGN9]#\-2S32NSR22//I[.[NQ+,[,2S,Q)
M8DDDDU[A_P $N/\ DD/A[_N(_P#IRNZ/^"H__)(?$/\ W#O_ $Y6E'_!+C_D
MD/A[_N(_^G*[K0_;(_:F\-?LY7&E/+I<>O>,))"FBZ=$BF\1;EA!+(DWE32V
MZ2@>2HC1GNY (51D29X?A#]M+X??%#Q!\,]:\1>/];M[6)/[.EA\-Z3"BVT;
MO<6<(^U7;;YIMADG9[823P?:5AGCN&2-(U^W_P#@EQ_R2'P]_P!Q'_TY7=?
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M[R?$,>H1VEC>I:;=EXT;VC"ZA8^9:W;N[P-);H(_])>)XK6%'9^__P""U?\
MR3S3?^Q@MO\ TBOJ^_\ ]D[_ ))YX4_[%_2?_2*&OR!_;Z_Y.%\!?]P#_P!/
M-Q7T?_P6>U:XT[X<VD4$LD<=SKEK%.B.RK+&+:[E"2 $!T$D<<@5L@/&CXW*
MI'W!^QWJUOK7PY\*RVLL<T:Z'IT1>-U=1)#;1Q2H2I(#QR(\<B]4=61@&4@>
M_P"K:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22 *_)#_@M7_R
M3S3?^Q@MO_2*^K[_ /V3O^2>>%/^Q?TG_P!(H:_('_F[S_/_ $+E?O\ 45\
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M_P 9G^-B>%M1M=+O+31&CU-].O[ORXFU!6DMU>6&U#-/%;[(X98)+E87N$N
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M-A\5O"$/^GZ1Y<FI-$D;.GV-UEM;_P DQ'SO*P4N7D:39!';_NA;PS.GV_\
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MG<R;'BN)H[99)1;3)'U__!5/]C^\_:!T.VU_P_:_:-=T?>'AC"B:ZL6!9XT
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MS?\ AF:_MXM:EUB:YALI'"330O9P /"K8\['V:8R+%O:)4#2!%="WW_^W/\
M%70_AOX!UZ#5[^WM+C4='U*VLH)''G7,TL!@5(8AF23#S1"1D4K$KB20I&"P
M^ /^"+GQ5T.S\,W_ (9FO[>+6I=8FN8;*1PDTT+V< #PJV/.Q]FF,BQ;VB5
MT@170M\__P#!:;XJZ'XWU'P_I6EW]O>7NE_VH+Z*!Q)]G:5[:-8Y67*+*&MY
M0\)/FQ[0710Z%OW>\.?M ^$O%>AGQ-::UI[:*OEB6]:YCCAA:01E8YVD9?(E
M_>Q@PS;)59U5D#$"OP!_8;^/WA?P_P#'#Q3KM]J=O::7K']M?8;NY)MX9//U
M&*[BWO*$$.^*-V7SO+^8"+_6LB-^A_\ P5_\ :IXZ^',<FF6TETNFZI#?7@C
M +16L=M=1R3%<[F1&E0R;0Q1-TK 11NZ\?\ L9?\%%?"^L>$M"\-+:ZA-XFM
M+>TTN'1[6 SS7?V:..$7$,[>5:I%Y:F>8W,T'V=8Y\ED1)9?@#]D/]H*S^#?
MQD\6ZSXGMKBTO;_^V((]+M4:_N'U*?4X95T^ P+LEE+(\,<A,<,C@9= PK[P
M_P""N46J>*?A1I-]=6$EK<IJFGW.H6R,+A;)I+.ZC=))XQL9$FE2 3?*DCL@
M7F10?3_V*?VU/#GQ!\/>%_".A"XN]?M]/L[2]M7@GC2SALH5BN;N:Y6*6$1$
M18M@K,TT\]K!)]G\V62#\X/VY/C]X7\0?'#PMKMCJ=O=Z7H_]B_;KNV)N(8_
M(U&6[EV/$'$VR*1&;R?,^8F+_6JZ+_1=IFK:-\5]+,MK+9ZKI-['+$7C>*ZM
M;B,EHI4)4O%(F0\<B_,,AD8=17\^/PFU>\_X)0?$J]TOQ#%<'P=KV5MKU0LV
M88I2;6Z=EA5Y);997BO;>(1,/.,Z13*+43?K_P#$O]N3P-X'TYY]/UC3]9U*
M3=%I^F:==+>7%Y>,C&WME2S6YDC\YU$0E:,QH[J"=S*K?+__  3G^#%Y^R]X
M7U;Q?X_N_P"S]0U^X@N;Q]1NE3R85+"![MYPICNYI;F5I5DD=OG@1A'<>;'7
MP!^PW\?O"_A_XX>*==OM3M[32]8_MK[#=W)-O#)Y^HQ7<6]Y0@AWQ1NR^=Y?
MS 1?ZUD1OT?_ ."L'Q5T/P_\.-4\/W-_;IJ^H?8#:V.\-<2*M[%*9/*7+K$%
MMYOWSA8MZ>7O\QE1C_@D_P#%70_$'PXTOP_;7]N^KZ?]O-U8[PMQ&K7LLHD\
MIL.T16XA_?(&BWOY>_S%9%_3^BOYX?\ @J#K_P#PJ_XR>#_$]];W#:;96^F3
MM)''GS?L.ISSSQ0LY2-Y51XR4+KM\V,L55U)_7_X3?M$>'/VK_MMMH,?]J:!
M';F&^N[BVGBMY9I\K]B2*Y@47&(@SW>XJL236JA9_M$GD?C!\)M7O/\ @E!\
M2KW2_$,5P?!VO96VO5"S9ABE)M;IV6%7DEMEE>*]MXA$P\XSI%,HM1-^O_Q+
M_;D\#>!].>?3]8T_6=2DW1:?IFG72WEQ>7C(QM[94LUN9(_.=1$)6C,:.Z@G
M<RJWS_\ \$OOV:]<^"VAZEK_ (I^T+KOB2XBN9X;B0O,D,8D:)[D.OF+=R//
M/).KN[!6B#B.<3(/T_HK^:'X'_''1_V4OCYXQOO%YN+"TO+C68%E-O(_E_:+
MZ.\@E>-%,IBEBC!C>-)-WFQ/CRF:1?U/_:)_:B\/ZS\+==U2]N(].MM:TO5;
M?0H[EGCN]1C> VT4\=H\:3!)995DCVB0+9R6]W,\(EDBA^4/^"+GQ5T.S\,W
M_AF:_MXM:EUB:YALI'"330O9P /"K8\['V:8R+%O:)4#2!%="WS_ /\ !:;X
MJZ'XWU'P_I6EW]O>7NE_VH+Z*!Q)]G:5[:-8Y67*+*&MY0\)/FQ[0710Z%OV
MO\02^&OVSO!6HV.D7]G?:=JMG+;"Y15N5MIY(5DB>2!BK)<0,\4XAD\J:)U0
MGRW (_GQ^!?Q\\6_\$L_%%YX4\2V/VC2[FXAFNHE>1MT($D8O=,9G2%O-&TR
M>8@:7[.EK(UM+$QB_0_5O^"CC_M9V\O@[X7:5JB^(=2C>$WMZ([6WTVU=2D]
M^TUK<32H\091$1M(F="OFRB.VG_5[X>^"K?X:Z-I^AV;2/;:;9V]G"\I4R-'
M;Q+$A<JJJ7*J"Q55!.<*!P.PHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHKG_%/A/3O'-G)I^JVEO?64VWS;:YA2:%]
MC!UWQR!D;:RJRY!PRAAR :X_P5\$/"OPUN&O-#T32]-N7C,3S6=C;V\C1EE8
MH7BC5BA958J3@E5.,@8]0HHHHHHHKR_QK\$/"OQ*N%O-<T32]2N4C$237EC;
MW$BQAF8('EC9@@9F8*#@%F.,DYZ#QK\/=&^)5NMGKFGV>I6R2"5(;RWBN(UD
M"LH<)*K*'"LRA@,@,PS@G/0:3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%
M4!550 H    KC_\ A4_A[^V/^$A_LK3_ .VO^@C]DA^V?ZOR?^/C9YO^J_=?
M>_U?R?=XKT"BBO#]6_9D\"Z_<2WEYX:T.>YGD>6::73+1Y))'8L[N[1%F=F)
M9F8DL2222:]PHHHHHHKS_P =?"?P]\4/)_M[2M/U/[/O\C[;:0W/E>9MW^7Y
MR/LW;$W;<;MJYS@8T-3^'NC:UI8T.ZT^SFTE8XHA826\3VHCA*F)! RF()&4
M0QKMPA5=H&T8T/"WA/3O UG'I^E6EO8V4.[RK:VA2&%-[%VV1QA47<S,S8 R
MS%CR2:S_ !K\/=&^)5NMGKFGV>I6R2"5(;RWBN(UD"LH<)*K*'"LRA@,@,PS
M@G)X*^'NC?#6W:ST/3[/3;9Y#*\-G;Q6\;2%54N4B55+E552Q&2%49P!CL*Y
M_P 4^$].\<V<FGZK:6]]93;?-MKF%)H7V,'7?'(&1MK*K+D'#*&'(!KC_!7P
M0\*_#6X:\T/1-+TVY>,Q/-9V-O;R-&65BA>*-6*%E5BI."54XR!CU"N/\:_#
MW1OB5;K9ZYI]GJ5LD@E2&\MXKB-9 K*'"2JRAPK,H8#(#,,X)R:9\/=&T72S
MH=KI]G#I+1RQ&PCMXDM3',6,J&!5$120NYD7;ARS;@=QST&DZ3;Z!;Q6=G%'
M!;01I%##$BI''&BA41$4!515 554 *    *Y_P :_#W1OB5;K9ZYI]GJ5LD@
ME2&\MXKB-9 K*'"2JRAPK,H8#(#,,X)ST&DZ3;Z!;Q6=G%'!;01I%##$BI''
M&BA41$4!515 554 *    *T**S]6TFWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP
M*LC*2K*P(8$@@@US_@KX>Z-\-;=K/0]/L]-MGD,KPV=O%;QM(552Y2)54N55
M5+$9(51G &.PHHHKQ_PM^SUX-\#7D>H:5X?T>QO8=WE7-MIUM#,F]2C;)(XU
M==RLRM@C*L5/!(KV"BBBN?\ %/A/3O'-G)I^JVEO?64VWS;:YA2:%]C!UWQR
M!D;:RJRY!PRAAR :\OTG]F3P+H%Q%>6?AK0X+F"1)89HM,M$DCD1@R.CK$&5
MU8!E92"I (((KW"BO+_&OP0\*_$JX6\US1-+U*Y2,1)->6-O<2+&&9@@>6-F
M"!F9@H. 68XR3GL/"WA/3O UG'I^E6EO8V4.[RK:VA2&%-[%VV1QA47<S,S8
M RS%CR2:Z"BBBBO@#_@J/_R2'Q#_ -P[_P!.5I7G_P#P3R^$_A[XH?"'PQ_;
MVE:?J?V?^U/(^VVD-SY7F:E<[_+\Y'V;MB;MN-VU<YP,?H_X6\)Z=X&LX]/T
MJTM[&RAW>5;6T*0PIO8NVR.,*B[F9F; &68L>23705Y?X*^"'A7X:W#7FAZ)
MI>FW+QF)YK.QM[>1HRRL4+Q1JQ0LJL5)P2JG&0,:'_"I_#W]L?\ "0_V5I_]
MM?\ 01^R0_;/]7Y/_'QL\W_5?NOO?ZOY/N\5Z!117'^)/B%HW@ZXM+/4]0L[
M.YOY/*LH;BXBADN9-R+L@21E:5]TB+MC#'+H,989^,/C!_Q?7XH>'/"\'[_3
M?"V[Q!K2_P#+)+PH8M&C\Z+,B7:.9+K[-*88YK4^81.H"#[_ ***\_\ '7PG
M\/?%#R?[>TK3]3^S[_(^VVD-SY7F;=_E^<C[-VQ-VW&[:N<X&-#4_A[HVM:6
M-#NM/LYM)6.*(6$EO$]J(X2IB00,IB"1E$,:[<(57:!M&-#PMX3T[P-9QZ?I
M5I;V-E#N\JVMH4AA3>Q=MD<85%W,S,V ,LQ8\DFN@HHKG_%/A/3O'-G)I^JV
MEO?64VWS;:YA2:%]C!UWQR!D;:RJRY!PRAAR :Y_0/A/X>\*:=<:1I^E:?::
M;=^9]ILX+2&*WF\U!')YL*((WWH C[E.Y %.5 %=AI.DV^@6\5G9Q1P6T$:1
M0PQ(J1QQHH5$1% 5450%55 "@   "M"BN/\ &OP]T;XE6ZV>N:?9ZE;)()4A
MO+>*XC60*RAPDJLH<*S*& R S#."<]!I.DV^@6\5G9Q1P6T$:10PQ(J1QQHH
M5$1% 5450%55 "@   "M"BBL_5M)M]?MY;.\BCGMIXWBFAE17CDC=2KHZ,"K
M(RDJRL"&!(((->?^"O@AX5^&MPUYH>B:7IMR\9B>:SL;>WD:,LK%"\4:L4+*
MK%2<$JIQD#'J%%%%%%%%%?@#_P %SO\ F4?^XQ_[85^SWBG]GKP;XYO)-0U7
MP_H]]>S;?-N;G3K::9]BA%WR21L[;5557).%4*. !7L%%>/^*?V>O!OCF\DU
M#5?#^CWU[-M\VYN=.MIIGV*$7?))&SMM555<DX50HX %>H:3I-OH%O%9V<4<
M%M!&D4,,2*D<<:*%1$10%5%4!550 H    K0HHKS_P "_"?P]\+_ #O[!TK3
M],^T;//^Q6D-MYOE[MGF>2B;]N]MN[.W<V,9.=#QK\/=&^)5NMGKFGV>I6R2
M"5(;RWBN(UD"LH<)*K*'"LRA@,@,PS@G)IGP]T;1=+.AVNGV<.DM'+$;".WB
M2U,<Q8RH8%41%)"[F1=N'+-N!W')X*^'NC?#6W:ST/3[/3;9Y#*\-G;Q6\;2
M%54N4B55+E552Q&2%49P!CL****\OTSX(>%=%U0ZY:Z)I<.K-)+*;^.QMTNC
M),&$KF=8Q*7D#N)&W9<,VXG<<^H5GZMI-OK]O+9WD4<]M/&\4T,J*\<D;J5=
M'1@59&4E65@0P)!!!KS_ ,%?!#PK\-;AKS0]$TO3;EXS$\UG8V]O(T996*%X
MHU8H656*DX)53C(&/4***Y_Q3X3T[QS9R:?JMI;WUE-M\VVN84FA?8P==\<@
M9&VLJLN0<,H8<@&N/\%?!#PK\-;AKS0]$TO3;EXS$\UG8V]O(T996*%XHU8H
M656*DX)53C(&/4*****\_P#$?PG\/>,+,:?J6E:?>60N)+H6UQ:0RPBXE:1Y
M)Q&Z,GFNTLK/)C>S2R,22[$Z'@KX>Z-\-;=K/0]/L]-MGD,KPV=O%;QM(552
MY2)54N555+$9(51G &.PKR_3/@AX5T75#KEKHFEPZLTDLIOX[&W2Z,DP82N9
MUC$I>0.XD;=EPS;B=QSV'_")Z=_:/]K_ &2W_M+[/]E^V>2GVC[/O\SR/.QY
MGE;_ )_+W;-_S8W<UT%>?^.OA/X>^*'D_P!O:5I^I_9]_D?;;2&Y\KS-N_R_
M.1]F[8F[;C=M7.<#'8:3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550
M H    K0HHHHHHHHHHHHKR_QK\$/"OQ*N%O-<T32]2N4C$237EC;W$BQAF8(
M'EC9@@9F8*#@%F.,DY[#PMX3T[P-9QZ?I5I;V-E#N\JVMH4AA3>Q=MD<85%W
M,S,V ,LQ8\DFN@HHHHHHHKR_P5\$/"OPUN&O-#T32]-N7C,3S6=C;V\C1EE8
MH7BC5BA958J3@E5.,@8T/^%3^'O[8_X2'^RM/_MK_H(_9(?MG^K\G_CXV>;_
M *K]U][_ %?R?=XKL-6TFWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP*LC*2K*P(
M8$@@@US_ (*^'NC?#6W:ST/3[/3;9Y#*\-G;Q6\;2%54N4B55+E552Q&2%49
MP!CL**Y_Q3X3T[QS9R:?JMI;WUE-M\VVN84FA?8P==\<@9&VLJLN0<,H8<@&
MN/\ !7P0\*_#6X:\T/1-+TVY>,Q/-9V-O;R-&65BA>*-6*%E5BI."54XR!CU
M"BBBBBN/\:_#W1OB5;K9ZYI]GJ5LD@E2&\MXKB-9 K*'"2JRAPK,H8#(#,,X
M)ST&DZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515 554 *    *S_%/A/3O
M'-G)I^JVEO?64VWS;:YA2:%]C!UWQR!D;:RJRY!PRAAR :X_P5\$/"OPUN&O
M-#T32]-N7C,3S6=C;V\C1EE8H7BC5BA958J3@E5.,@8]0HHKS_7_ (3^'O%>
MHV^KZAI6GW>I6GE_9KR>TAEN(?*<R1^5,Z&1-CDNFUAM<EAAB37H%%%%<?XU
M^'NC?$JW6SUS3[/4K9)!*D-Y;Q7$:R!64.$E5E#A690P&0&89P3D\%?#W1OA
MK;M9Z'I]GIML\AE>&SMXK>-I"JJ7*1*JERJJI8C)"J,X QV%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?,'[2
MG[+EK^U#9_V7JNLZQ9Z6?+,MC826D4,SQ,S*\K26DLS\LI\LR>1NBBD$0E0/
M1^S7^RY:_LO6?]EZ5K.L7FECS#%8W\EI+#"\K*S/$T=I%,G*L?+$GD;I99#$
M97+U]/T444445\0?M2_L ^$OVMM1M=5UN74+:]M;<VPELIXT\R$.TB)(LT,Z
M?(SR%60(Q\Q@Y<+&$^C_ (0_!?P_\!=+71O#5C'86*R/*8T+NSR2'YGDDD9Y
M9'P%4-(S%45(P0B(J^H444444444444444444444444444445\ ?M"_\$\=%
M_:@U%-0\2Z[X@F\GS1:VT<]C%;VJ2N7*0QK8_P"ZIDD,D\B1QK)+)Y:D?7_P
MT\#S_#O3DT^?5-0U?RMHCN=1:W>X"*BHJ-)!!;^;C:6,DPDG=W9GE?("^@44
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444444444444444444444444444444444445S__  EFG?VC_9'VNW_M
M+[/]J^Q^<GVC[/O\OS_)SYGE;_D\S;LW_+G=Q70444444444444444444444
M444444444444444444444444444444445S_BGQ9IW@:SDU#5;NWL;*';YMS<
MS)#"F]@B[Y)"J+N9E5<D99@HY(%9_@KXA:-\2K=KS0]0L]2MDD,3S6=Q%<1K
M(%5BA>)F4.%96*DY 93C!&>PHHHHHHHHHHHHHHKG]1\6:=I%Y:Z?<W=O#>WW
MF_9+:29$FN/)4/+Y,;$/+Y:D-)L#;%(9L#FN@HHHKG_%/BS3O UG)J&JW=O8
MV4.WS;FYF2&%-[!%WR2%47<S*JY(RS!1R0*Z"BBBBBBBBBBBBBBBBO/_ !U\
M6/#WPO\ )_M[5=/TS[1O\C[;=PVWF^7MW^7YSIOV[TW;<[=RYQD9-?\ BQX>
M\*:=;ZOJ&JZ?::;=^7]FO)[N&*WF\U#)'Y4SN(WWH"Z;6.Y 6&5!->@445S^
M@>+-.\5_:/[/N[>[^R7$EK<^1,DODW$6/,@EV$[)4R-\;8=<C(&170444444
M45Q_@KXA:-\2K=KS0]0L]2MDD,3S6=Q%<1K(%5BA>)F4.%96*DY 93C!&>PH
MHKG_ !3XLT[P-9R:AJMW;V-E#M\VYN9DAA3>P1=\DA5%W,RJN2,LP4<D"N@K
MC[+XA:-J.J3:'!J%G)JUM&)9[!+B)KJ*,A"'D@#&5$(DC(9E (D3GYESV%%%
M%%%%%%%%>?\ CKXL>'OA?Y/]O:KI^F?:-_D?;;N&V\WR]N_R_.=-^W>F[;G;
MN7.,C/8:3JUOK]O%>6<L<]M/&DL,T3J\<D;J&1T=259&4AE920P(()!K0HHH
MHHHHHKG_ !3XLT[P-9R:AJMW;V-E#M\VYN9DAA3>P1=\DA5%W,RJN2,LP4<D
M"N@HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHK\T/^"@?_!0-/V14M])TFWCO/$=Y&EPB7"2?9;>U\QD\V78T;2/(T<D<
M44;J5*M+(RA8X[CR#X+_ /!.^]^.-O8^)_B_K.J:W=W$9NX]%EEGM[>R:\5G
MDA=<I+&^# S06JV26\T)@(GA5:]O\4_\$[=,\#V<ES\+]0U#PEK2;98_(O[J
M6QO)H6#PIJ,$[S^;$O[Q% &U!/(SPW*_N6X__@F+XU\07X\7Z'XR6\'BJSUQ
M;S4WN0F"+VVCB@$91MI0+9L8Q&HMQ;M;^0S1$!?U/HHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHKR_P ,_%[2_%_B#5_#5FTCWVAQV+WQ*%8T
M:_262&-6."[B.,2.5&P"6-0[.)$C]0HKG_%GBFS\#:==ZKJ$GDV5C;S7-S+M
M9]D,*&21]J!G;:JD[5#,<8 )P*S_ (>^-;?XE:-I^N6:R);:E9V]Y"DH42+'
M<1+*@<*S*'"L P5F .<,1R>PHKC_ !_X3?QUI=SID=]>::UU&8S>6+QQW42D
MC<89)(Y5C<KE?,"[T#%XVCE".OX(_P#!-G0/^$4^.OC+3_M%Q=_9+?6H/M-U
M)YMQ-Y6K6J>;/)@;Y7QND? W.2V!G%?T/4444444444445Y?X9^+VE^+_$&K
M^&K-I'OM#CL7OB4*QHU^DLD,:L<%W$<8D<J-@$L:AV<2)'ZA111111111111
M1111111111111117E_P;^+VE_'?1(/$.BM(^G74ERD$DB&-I%M[B6V,@0_,J
M.T1>,.%?8R[TC?<B^H4444444445S_BSQ39^!M.N]5U"3R;*QMYKFYEVL^R&
M%#)(^U SMM52=JAF., $X%?E!^PIING?MO1:YX\\:6W]K2MK%U9Z;IVHE+RQ
MTRS\JUF$=K;O&L*RL&CCFN!&))1"K?*\DYEX#1/^"=7BC]G3XJZ5KWP\NO*\
M,W%QNOUEG :UL]ZO<V,JR;GNHIE&VT<+)(DHC,S1/ EZ_P"WU%%%%%%%%%%%
M%%9^K63ZC;RP1326TDD;HD\0C,D3,I D02I)$74G<HD21"0-R,N5/\Z/PM\
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M_P 0]%T.^\.74D5N;S0IYXY(KB1G<J$O9"\KK##,_E^5%"Y:,?;(R&6OT_\
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M_LO6:^(?$^C^%]6T"#/VXZ3<7=O-#O9(8,O>,Q^>65,>5!<_*CA_)RLE??\
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MLTJV\PW>7YHRKQS0AY?),K_FA_P5L^(GB_Q#X>33=7\+_P!F:+;^(!]CU?\
MM6VN?MGEPWB0_P"B1J)8?-B+3?.3Y>WRVRQ!KZ__ &3OC-\1_P#A'O"FF_\
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M4WA_XE>#F\::&MYJ5FD9+V=G;/<:@MP-H-H;6+<PN S*""?)",MQYWV4B<_
M'PT_X*N)XP\7ZKIFJ:3)I>EV%G.MM9.DDVMWNI)>Q6T-I';@HHN)5EVFR"R-
M%*CN]UY*.R<?^T%^W_\ &']G:\MM1U_P;I^FZ!=7"1QQO<F\F.Q5:6$WUK<&
M&*60"1H#);#"AL1S^3*3^IVD_&D>/O!T7BSPK92:PUW9I<65BEQ;0R22/@>1
M+-)+Y$+Q/N2Y^=S"8Y55)95$;?@#-\:/B'K?[0=I?ZGX?CG\1Z?'/;V?A^.^
MM85BM7L+B:.(W_SPNZQ7+W,DK$F1RT:K$"D,7[?V7[0GB#PSX:FUSQ5X1U2R
MODO!;P:1I3IKEU/&RHPG#6JI%&F3*&\YHPHB^^7EBC?P_P#8'_;>U']LV\\0
MO<Z?;Z=9:;_9WV2&.1YIO])6X$OG3-L23YH T>R*'8K%6\PC>?I_]IW]H73O
MV7_"]WXEU!/.\G9';6HE2)[JXE.V.%"Y^LDA59'C@CEE$<GEE3\0?\+R^/GB
M7PO_ ,)II&B^%VL+FW^W6>E9OKG5#9R'?#_JY8[>:4PE9=J,DD@^58%N"+8?
M2'[%O[:6E_MDZ7=75K:R6&HV$B)>V3N9EC68N8)(YPD:R)(L;Y&U'1T=639Y
M4LOYH?\ !<[_ )E'_N,?^V%?O=JVIIHMO+=2B1HX8WD<11232%44L0D42O+(
M^!\L<:L[G"JK,0#^6'P^_P""CNH_%7XI:;X$MM N-(LI?M/VLZM&\6I';I[7
M<6+96"6WS(<[VN?.A='7R2<5]O\ [0OCOQ?X)TY/^$+\/_V]J4_FJ/,O+:TM
M[7"'9+-YTL<DV7*XABV[T63=/ PC\S\(?^":/QM\=Q:CXMU71?#G_"57NJ7%
MG<ZE+_:5IIGE32/>R;]LL>Q_.:24[8@JQ;,8 90/T?\ VH?V]_%'[*<6G7>L
M>"]]EJ%O WVB/6 RP7C1!Y[&8I9.BRQ-O$;JS1W,2&6-LK-'#]?_ +.'Q3US
MXTZ';:_J^D6^D6]_;PW-E#'J!O9GAF#,KS 6L$<6Y/*DC5'F8K(1((9$*'Q#
M]I?]K'Q+\!?$&D:%IWA>/79->DFCTP6^J-#<.UND+3F>)[%HH44S$^9Y\B+#
M&\TK0J"%^W])DN)K>)KR..*Y,:&:.*1I8TD*C>J2-'$TB!LA7:.,L &,:$[1
MH5\H?M'?M=Z-^SU<:?HYBDU+Q'K$BPZ9I-N\222R2L8H'GEE94MK=YML/G/N
M.2[)%*(9MGA_BGX@_'SPM9R:\=$\+W-E%MN7T2VFOI=7^SE@SVR3#%K+=QQE
ME9XE=))$)AAF+1POZ!^QE^W1H?[8=G,L$?\ 9VM6F6N=,DF$K"'=M2>&39'Y
MT1RJR$(C0RD(ZA7ADF_.#_@K9\1/%_B'P\FFZOX7_LS1;?Q /L>K_P!JVUS]
ML\N&\2'_ $2-1+#YL1:;YR?+V^6V6(-?7_[)WQF^(_\ PCWA33?^$$_XDO\
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M7['"726-4*AFC=!(-Z*ZM&/O_P ?^/\ 2_A9I=SK6M7,=GIUG&9)YY"=JKD
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M6MP)-\ULDZRI$\,6+F6=D1OVNK\ ?^"&/_,W?]P?_P!OZ_?ZBOR _P""U?\
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M_P D\U+_ +&"Y_\ 2*QKZP_X*'^-;CP!\*_$MY:K&\DEFMF1(&*^7?S164I
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ME)5E8$,"000:_H.K\ ?^"&/_ #-W_<'_ /;^O?\ _@M7_P D\TW_ +&"V_\
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M'P]_W$?_ $Y7=? '_-WG^?\ H7*_?ZOP!_X(8_\ ,W?]P?\ ]OZ_6_\ :J^
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M][% ZE3'\W[7:3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550 H
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MR$LJD 1OS\K8_:ZBOP!_X+G?\RC_ -QC_P!L*_?ZOP!_8%_Y.%\>_P#<?_\
M3S;U]_\ _!4?_DD/B'_N'?\ IRM*/^"7'_)(?#W_ '$?_3E=U^<'Q(\4V?P?
M_:J36?$$G]GZ;+Y)2[N%9(66?1?L22!R-OE?:,PO-GRHV23>Z+'(5_;[XQ_'
M30_@99K<ZO/_ *1-E;*PAQ+?7\VY(U@LK8$27$K/+$F$&U#(K2-''EQ^&/\
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M_6-/DAL-,*93P]9W2 A+=+F+_D*_<DN[Z6(2+/&L$21V\.V3\X/V6OBEJ/\
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MDM;G4I+:QN#&8@TNDR0WDEI"6B'RH]M%:"3!65TW13DF2=&_0_\ 83\6>!O
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MW9*2F2$A[R2=90Z-/O%?CA_P1P\?Z7\+-+\<:UK5S'9Z=9QZ1)//(3M5<WX
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MQSJB/A%58 (1^C^DZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515 554 *
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M<_"75%U1X[S6&2-T2VU5K:XM0SC'F&%+:)9'"[@HEWHI;>$\U8W3W#6/V%O
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M<_\ I;8U_2]XL\4V?@;3KO5=0D\FRL;>:YN9=K/LAA0R2/M0,[;54G:H9CC
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MED;:RLK8)PRE3R"*T-6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q
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M'K_A;XJZ'XTT./Q-87]O+HLMNUR+TN$A6% 3(\C/M\KR]K"99-C0LCK($9&
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MB)B=?.*"(.NPOO(4GP4_:G\%_M$^8OAC5[>^EAW&2WQ)#<!4\O=)]GG2*8Q
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MSH[6.9X-RR(T?G!/,4EDW!6(]?\ "WQ5T/QIH<?B:PO[>719;=KD7I<)"L*
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M;MN=NY<XR,Z'@KXA:-\2K=KS0]0L]2MDD,3S6=Q%<1K(%5BA>)F4.%96*DY
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M;>*2&>:2"&=G>$IY7^M_>*H4*C %0,#'X@_\*G\/?\-2_P#"/?V5I_\ 8O\
MT#OLD/V/_D >=_Q[[/*_UO[W[O\ K/G^]S7[W>&_A[X5^"%O=WFF:?I>B6QC
M\V]FM[>WLH_+@5VWSO&L:[(U9VW2'" N<@$U^2/_  3QTV?]L#Q;XA^*?BJV
M^U+#<16>AQ7)M[F&QV2?:_+@5HP\<MHOV7RKA%@WM/<2G?-)*R?H?^V)^RKI
M?[5_AJ?3+J*,:I!'+)I-XS%&M[HK\H:14D;[/(RHMS'M<.@#JHFCA>/\\/\
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M^.OC72-0TK3[O3;3^W/LUG/:0RV\/E:M!''Y4+H8TV(2B;5&U"5&%)%?J?\
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MM.T+2O"_V=[*/4'DU"*:2.+8S(([>[+,I<Q0*UR)4A+2MYR%;><KF/L/V_\
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MS1_PT;X&N?L</FZUI&Z^T_8FZ638O^D6J[8I96\Z('9#'L\VZCM=S!4KG_\
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MG\/?\-2_\(]_96G_ -B_] [[)#]C_P"0!YW_ ![[/*_UO[W[O^L^?[W-?O\
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M /[3GARS^)O[37AG3]%-O'>V?]EW&IL8VBW36+2ZBX=Q'^]E-DD"1O\ ,O\
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M[B/_ *<KNO@#_F[S_/\ T+E?O]7X _\ !#'_ )F[_N#_ /M_7O\ _P %J_\
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MOZ]__P""U?\ R3S3?^Q@MO\ TBOJ^_\ ]D[_ ))YX4_[%_2?_2*&OC#XZ_\
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M_G_H7*_?ZOP!_;Z_Y.%\!?\ < _]/-Q7[_5^ /\ P0Q_YF[_ +@__M_7O_\
MP6K_ .2>:;_V,%M_Z17U??\ ^R=_R3SPI_V+^D_^D4-?E#\-/%FH_P#!5_Q;
MJ O;NXTWX?Z%]G\S1(IGCFU+SI&>#[8T1V'<UMYDF&;[,JI#;_OI);ZO'_\
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M +C_ /Z>;>OW^HK\\/VA/V'/ ?[:Z7&M1F2SUCS+BT.J6H9&:>PDGLFCN8)
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M"PCD(!"-C]OOA[XUM_B5HVGZY9K(EMJ5G;WD*2A1(L=Q$LJ!PK,H<*P#!68
MYPQ')_#']OK_ ).%\!?]P#_T\W%?O]17X _\%SO^91_[C'_MA7[_ %?@#^P+
M_P G"^/?^X__ .GFWKC_ /@KC>ZI\*OB7X6\8V\,;1VUG;/9M*0T<EUIM]+<
MO&\:.LNQ1/;EC\@<2$(^Y6V_T/:3JUOK]O%>6<L<]M/&DL,T3J\<D;J&1T=2
M59&4AE920P(()!K\8?\ @MQJ>EQ>%=#M9A'_ &M)JCR6I,1,@M8[=UNPLNTA
M$,DEGOCW*9"(V"MY1*>O_ML>"KCX:_L[S:'>-&]SINEZ!9S/$6,;26]U8Q.4
M+*K%"RDJ6521C*@\#U#_ ()<?\DA\/?]Q'_TY7=??]%? '_!4?\ Y)#XA_[A
MW_IRM*/^"7'_ "2'P]_W$?\ TY7=?.'_  6OU:WA\"Z59M+&+F77(I8X2ZB1
MXXK2Z61U3.YD1I8E=@"%,D8)!=<^O_M9_"'5-%_9^N?#2K'<7VE:'I27!B<"
M,KI;6LEU(C2^62BQV\LB@A7<*%";R$/'_P#!'WXQV?CGX?\ _".HNR]\/W$L
M<RY9M\-[--=0S9**B[F:>'RU:1AY'F,5$J+7Z?\ BSQ39^!M.N]5U"3R;*QM
MYKFYEVL^R&%#)(^U SMM52=JAF., $X%9_P]\:V_Q*T;3]<LUD2VU*SM[R%)
M0HD6.XB65 X5F4.%8!@K, <X8CD]A1111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111116?JTEQ#;RM9QQRW(C<PQRR-%&\@4[%>18Y6C0M@,ZQR%02P
MC<C:?QQ_X8R^*?\ PM?_ (6GN\+_ &C[1N^P?;=0V?9_LOV'RO-^P[O-^S_\
MMMNSS_WOD>7^XK]3O&M[XJ31E;0[32VUN2,!X[R\N%LX)&B;+"2*T::Y1)=H
M"&.U,T>YO,@;"U^:'[ W[&7Q#_8UU&^^TMX?O]-U;[(MUY=[>QW$/V=WQ+#N
ML3')A)ILPOY?F/Y?[^%5;?ZA_P % _V:/'7[6]E;Z!HXT.TTFUO$O!<75Y=F
MZFD6!HE'E1V310HIFG##S)S*/*<-#AXV^@/@'X;\=?"[P=:Z'J=GH=QJ.DV=
MI9V3V^I7<=O=1P?NLSF33W>V=(50YC6Y$\V_Y;9" OYP:M^PK\8YOB1+\3+/
M4O#<6J&\>>&*6>ZEC2W,9MTM7VZ=%YB"VQ;-*HCF8 RATF.\?L]X*O=9O[=F
MURTL[.Y$A"1V=Y+>QF/:N&,DMI9LKEMP*"-@ %;S"6*K^4/QY_8?\8_"OQK)
M\2OA)/&;ZYDDFU'2+F;:MS)/,C7"(TK+%);SDM--#-+"8'C\RVEW_9X[?W_5
MO&/QE^-5O+HD7AFS\'1W4;QW&L7.LIJ$D,$BF*0V4.G^3*MZ@D\^WDD=(082
MK,K.C#W#]FO]FNS_ &2O"7]@:!_IEW^\N9IKF1H5N[YXU4NY59_LT3>7'&JQ
MI*8HE!(GEWO+\ ?\,9?%/_A:_P#PM/=X7^T?:-WV#[;J&S[/]E^P^5YOV'=Y
MOV?_ );;=GG_ +WR/+_<5^QVDR7$UO$UY''%<F-#-'%(TL:2%1O5)&CB:1 V
M0KM'&6 #&-"=H_'']H?]C+XI_'3Q]IGCN)O"]C+H_P!A^Q6C7NH7"_Z'.UTO
MGR"QA,FZ5WSY:PXB*H/G4RO^GWB/4O&3Z&'TVQT==??S%,-QJ-RUC#Q((Y1,
ME@LUQ@B)GA\JVW!I%$Z[%=_S@_8&_8R^(?[&NHWWVEO#]_INK?9%NO+O;V.X
MA^SN^)8=UB8Y,)--F%_+\Q_+_?PJK;_4/^"@?[-'CK]K>RM] T<:'::3:WB7
M@N+J\NS=32+ T2CRH[)HH44S3AAYDYE'E.&AP\;?4'[+7A+Q5\.O#5CH'BB+
M2Q)I5G;6=O<:=<W$JSQP*8E,D5Q;0F%UC2($K),)7,CA8%VQU^0'AO\ 8X^,
M'[$/C&[O/AE%'K6B74?W+JXMHXY8SO\ +BO()+BU8W%NQ+)<6Y4,&R&C6:XM
M5[#]N_\ 82^)GQQL]%U9;[_A(-:C^TI?V,<MO9V-F)V$L8TV*80YBCP8)I[F
M:2\N ELY7:K)#^I_[.OAOQC%;S:WXYNXSK&I1VV[2K3C3],CA5]L4(+R-)<.
MTCO>7!DD#OY<,;&"WB=_R0_9L_9+^-O['?BC4['PI#H]WI%_MC;4=1=19R+
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MY4.P%H UTHFEBC)"1"2&)H=KQJTEOY C]@T3]E3Q#\>/%NE>//B1+;VS:/\
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M<0V\K6<<<MR(W,,<LC11O(%.Q7D6.5HT+8#.L<A4$L(W(VG\<?\ AC+XI_\
M"U_^%I[O"_VC[1N^P?;=0V?9_LOV'RO-^P[O-^S_ /+;;L\_][Y'E_N*_4[Q
MK>^*DT96T.TTMM;DC >.\O+A;."1HFRPDBM&FN427: ACM3-'N;S(&PM?FA^
MP-^QE\0_V-=1OOM+>'[_ $W5OLBW7EWM['<0_9W?$L.ZQ,<F$FFS"_E^8_E_
MOX55M_J'_!0/]FCQU^UO96^@:.-#M-)M;Q+P7%U>79NII%@:)1Y4=DT4**9I
MPP\R<RCRG#0X>-OH#X!^&_'7PN\'6NAZG9Z'<:CI-G:6=D]OJ5W';W4<'[K,
MYDT]WMG2%4.8UN1/-O\ EMD("_G!JW["OQCF^)$OQ,L]2\-Q:H;QYX8I9[J6
M-+<QFW2U?;IT7F(+;%LTJB.9@#*'28[Q^SW@J]UF_MV;7+2SL[D2$)'9WDM[
M&8]JX8R2VEFRN6W H(V  5O,)8JOYH?MF_L):YXP\1P_$CX<WWV#Q9;X>>*2
M4JMT8(/+B,+.'C25D1;62";;9W$3#S6B F-QZAI/QA^.'B6WBL!X'TO2]1>-
M ^J7NMQ3Z>DB*&D9K.S\R[V2;62)$ED,3NA>1T1V/H'[+/[)"?LG:7JDEK=R
M:YXCU61[F]O[V22!;N=#*T"/C[4T*;I7,LV+B9WEEE;>/*AC^,/^&,OBG_PM
M?_A:>[PO]H^T;OL'VW4-GV?[+]A\KS?L.[S?L_\ RVV[//\ WOD>7^XK]CM)
MDN)K>)KR..*Y,:&:.*1I8TD*C>J2-'$TB!LA7:.,L &,:$[1^./[0_[&7Q3^
M.GC[3/'<3>%[&71_L/V*T:]U"X7_ $.=KI?/D%C"9-TKOGRUAQ$50?.IE?\
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M;Q%?_P!I^+-=S]IEB\U+2TAD,<CV=JLLDDDD2/&B12S$,+>&"-(H )!+\O\
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MRH=@+0!KI1-+%&2$B$D,30[7C5I+?R!'[!HG[*GB'X\>+=*\>?$B6WMFT?\
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M_AKHVH:Y>+(]MIMG<7DR1!3(T=O$TKA S*I<JI"AF4$XRP'(_+#]GWX8R_\
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MY&ER1_:GN9(3=6TDDGE1RH4CBBGMY#(MO-;M&QP_S+/!+*(/VO\ V.?VA?\
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M*V\XAN-7NB\EM]DGDCE66.RE"7(V1[Q)#$YE:.:>V^R^0?MG_L<V'['FB/\
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M#]I9/!T6O:Y=Z%').Z6=[JEU=1[9M&>\$;"61A(D4CXB,F]P$0L[R R'[?\
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M49+R)B\/E7 ++.(854;O]3)!OM9?D#_@AC_S-W_<'_\ ;^OW^KG_ !9XIL_
MVG7>JZA)Y-E8V\US<R[6?9#"ADD?:@9VVJI.U0S'& "<"OR!_9DBU'_@IK%J
MWB#QO<W">%8-0-I8>&[*[>WMFVQ1RR#4&ACBFN]A:TF@D,R[;E)V6*&%EB//
M_M>?L:W7[*.CR>-?A%>ZAH?]G^1+JFF6]S=SQ744,A*7+([S>9Y'F,T\5QOM
M3:^8Y$>R5;G[?_9K_:#U']LOX=?VMH]U;Z-K[^997,PM7NX;.\CVEY(X97A$
MFZ)TGA5I)8X6E2.1KCRI$?\ (#]F/2O'/Q3^,GB;0IO$UPUW!;ZIIVH:RX87
MBZ=!J<0E72X]SQ64LLNU80,PV4<TTL2F6.(']+_@%_P3>M_@!X\F\:6OB/5+
MR.2.<&UN-IGN)+A1YK7UVK 72&3?.$\F(^<()&D9H29?TOK\T/\ @IW-XQ\+
M^#+S7_#_ (BDTBQL([83VEK;;+JZDGO8(@W]H"82VZ(&4JD$:EQYJ222)*JQ
M?('[)/[(&J?M5_"2PM=:\0WFGZ/Y=[%I.GZ<0D#,+ZXD>YU5) ?MC_:5'E0(
MT20PP(R2+//*R?;_ (3\-V__  3$^%=]-=7=YK\>FR/<!3M@4R7<T<,4$$;/
M*+:W\QT>7YIB'>XN%1V<0UY?\"_V3H/VN=#@\:?%C[1J^H:Q_IMAI_VNXM['
M2[.8#R8[.*UN0!Y\2PRRL[&0@1+(OVA)Y9OD"7XFZC_P2R^)5MX4.I7%_P"!
M+^WM)5M[V=YWLK>>61)KF,10*L4L=PMS,T5O$R7,#*K@W!22'V#_ (*I^!_%
M?PBL[;QCX1USQ!:63W#PZM;0ZOJ+0Q/.Q>"XCC\QDMXBQ>!P'C@1FM(H85+.
M3^GW[+T^CZIX2TW4-#O=0U"RO[>*X%SJ5_)?W;.T:)(LTCS3)'*K(5G@@*01
M7 E58T.X5\@?M2>![KXJ?$70O"WA[7/$&D7MS;SZIKLMAJ]W###I<.RWA,=H
M\@MQ+/.ODQO:D&%C)/<6MR'5T/\ @I+9>+?A[X$GU7PWXCN-)TW2;>SBEM8H
MY)+Z[:2[MX%=]6DN#<IL!4DH/-F/G">:99@(_0/^"7'_ "2'P]_W$?\ TY7=
M<?\ MH?M ^()O$NC_"?P>9++6?$4:RW.KC9NLM/9IEF>U4R1DW"QV\\C-NC=
M$0+ 6N94DM\_XE_\$LO"&LZ<]UH+ZA9^+(=UU;:V^IW+7$^HHC-'/>2/YRCS
M+@K//);113!QF(H,H?,/^"8?[8E[^TOI=]X+\43R3:I8V>Z&\26>.ZNK%CY,
MC23Q;62X@9XE%RLJ7$HE20 S0S3R?)_[8#Z_^RI\3M'MKGQ3XH_X0S4KBTNY
MO-U34RL-M]JV7UHD\<YEF\J(!P4/VE(IX5;?)B:7]WO'7P5L?'>G0Z>][K%G
M]FMW@M[FRUB_MKA-R*@EDD2?_2I4V*RO>BY^?<S!O,D#_D#_ ,$L?&>M>(/%
MOB+0O&NL:Q=Z_H^W[/:7.JWUQ#'Y$D]IJ&]%G>SFV226ZKYOF?,1+#]UG7]#
M_P!NW4[7PSX.N]1,^J1ZMY;V6BQ:9J%W:7$^I7V(;5$@M;F 7CK)ME\IUG98
M8YF2)LNCFN:RG[!?PWNM4U.\U3Q)/IT:27%Q>74DMQ=W5Q)';H T\DHMK?S'
M0"./>(80S[;B<NTWS?\  O\ 9.@_:YT.#QI\6/M&KZAK'^FV&G_:[BWL=+LY
M@/)CLXK6Y 'GQ+#+*SL9"!$LB_:$GEF^0)?B;J/_  2R^)5MX4.I7%_X$O[>
MTE6WO9WG>RMYY9$FN8Q% JQ2QW"W,S16\3)<P,JN#<%)(?T?_P""@_[5>H_L
MW:'9V7AV+[1XFUZX:TTR,1/,R8"B2>.)8W2:5&DACA@<C?+,C[)DBDB;R_P5
M_P $KO#&MZ,S>/9[S7O%5Y&3>:RU_=>9%(8EC1;?>^V1+=541/=1RF0KN>-8
MBMM%^>'P$\'ZY\/_ -IFSTKQ'J/]KZE:>=$^H$$-<0KH4@M7D!^;S?L_DB8L
M9&,H<M-,Q,S_ -+U9^K1W$UO*MG)'%<F-Q#)+&TL:2%3L9XUDB:1 V"R+)&6
M *B1"=P_GQ^'UUXHTO\ :9TW0O$^O7&ORZ;]I\J>2(6T*_:-":5O)LXW:&WR
M"BR>5CS6C$KY=C7[G?%[PSX@\7Z6UGX:U>/0[YY$)OGL4OV2-3EECADECB#L
M0JEY!* F\",.R21_SX_\$S;WQS\<[SQ/96VI7$*ZG_99UOQ#+=--J4-O"MU&
MEO9F7>_VNX4F..[<LEE#"[JK3?9EH_;F_9%O/V%[S3/B)X2UW4)+B34#'-/?
M2K-?"^F6><S&58DCGBF1)4N(YE)8DAS<1W#K%_0]\)_'7_"T/#VE:]Y/V?\
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M;XP_\$O99-6T:]^V>&1<*99(B9;&3S90JB\L9#OMI95@ACDN(ON"5+>._+N
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M)[>*XOM1N9"N_P G^T-+>>1G9%"I$+B[$,9;&-\499Y&!;H/V^O^3A? 7_<
M_P#3S<5^_P!7X _\$,?^9N_[@_\ [?U[_P#\%J_^2>:;_P!C!;?^D5]7W_\
MLG?\D\\*?]B_I/\ Z10U^(/_  53_L?_ (7)X8_X2'_D"_V?I?\ :/\ K/\
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M&F9'T+3HUUCQ2899(PZ\KINFO+"S!7FDS=36\ZQ.UO'%<6\RR1@CX@_X)?\
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MWC12"VEDTN*.8HPC>2);QI$5\;6=%EB9U!)421D@!USG_L"_\G"^/?\ N/\
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M _\ -WG^?^A<K]_J*_ '_F[S_/\ T+E?O]7X _\ !#'_ )F[_N#_ /M_7O\
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M7A]K74[B.\UO4;RYU/6;R)62.XU"\??,Z(<*J*H2%?+2%'$8E\F)G91\7_\
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MA_\ L#P-]HAN=9N[B:2X_M2&WN T=C92B&U(W2PL+B6 EH=@)FC91;W??_\
M!5/]C^\_:!T.VU_P_:_:-=T?>'AC"B:ZL6!9XT C,DTL3@26\.]1MDN@B23R
MQHWD'[.G_!66\O=OAGQ?X<UB[\36V;=ETJU6:XNIH/-\\RV#F![>6-8P94C\
MQ2XF;R[9%6,?+^G3_$63]H*Z\3)X7_M'6K/RI+K3+.ZV6UJMWHYCMH;C494-
MNDJ0D"21ML5Q<Q2K -KQX_I.TF2XFMXFO(XXKDQH9HXI&EC20J-ZI(T<32(&
MR%=HXRP 8QH3M!JVIIHMO+=2B1HX8WD<11232%44L0D42O+(^!\L<:L[G"JK
M,0#_ #X_;-:_X:&_X6%_PC'BC_A'OM'D^?\ V%?;]G]F?V=]H\GRO,\K?^^Q
MCS_(Y\GSOW-?N=XU^*]KX)T9=::TU2[CEC#PVMGIEW/>2,T32I&;98O-@=@N
MPFZ$"12%8Y7B8XK\4?\ @DGI>M? +4=:T_Q+H'B"P_MC^SA:W,FC7QMP\#SH
M4FD6$^3G[2K"20+ J1R-)+'A0_N'_!6UM2^*N@V7A7P_HNN:G?6^J17D\MKI
M-Y+:QQI:S(!]I$7E2NYN5VB RA#'*LC1NJHWV_\ L7>+SK7@K1M,N+#5--OM
M)TNPL[NWU'3KFS8200^03&\T:Q3(QA,@,+N41X_-6)VV#ZOKX _X*C_\DA\0
M_P#<._\ 3E:5\0?L!?MN:/\ L]>!-)T7QU'<:793?VA/HVIK:R36EU;K=D2Q
M,]NT\OVM+E[C<AAC1+=8&8YEC:;L/'MC>_\ !43Q5HZ:=;WEO\-M%D:YNKN\
MAGMH]7G6XDB9+15F4S(T<)BBFQ#-9"6[,NV5XH)/T/\ VT/@Y>?'WX?ZWX=T
M]L7MS;I);+A3YDUK-'=1PY=XT3SFA$/F,P6/?YA#!2I_(#]BC_@H%_PR[H\/
MPY\7^'M874K*X\NP@M+3-Y)]ND:X$,]K<RPR"4O,# 8PWG1RHOEJR;Y_/_\
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MGQ9^S1HDFJ>'M COK:&.)[K5+JYB6UM6DN(X8X_LB3)=W+ON(8IY21%XGWS
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MAG_$N_Y_?[8_X^;3_MT_X^?_ "7_ .FE<!^P5_PN3_A7&C?\(I_PA_\ 8O\
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M^+'[1/[-/E>*M0O='FT7[1$)[72[436=OM\M52X-U;I>I%<-E3(LYVR,8Q+
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M\T>_\60V^H6^I76KM=-:2+;WMM#(8/LJI(,.D2VZ;(XDMP4$:!41?V_^+_\
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M^5XJU"]T>;1?M$0GM=+M1-9V^WRU5+@W5NEZD5PV5,BSG;(QC$L#/;JWZG^
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M +5-G'D[=NT9W9W#&#\@?M]?\G"^ O\ N ?^GFXK]_J_ '_@AC_S-W_<'_\
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M14_Y)YJ7_8P7/_I%8UX!_P %SO\ F4?^XQ_[85^_U?@#^P+_ ,G"^/?^X_\
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M ()FWGPD^($/Q U#Q/\ VK>BXOKFYB_LM;7SYKV&>.1]R73I'\TYDVK'MXV
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M ((=>*;R[T[Q/I3R9LK:XT^YABVJ-LUTEQ',^X#>=RVT VL2J[,J%+.6Y_\
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M8X+K[+#_ &1)>2IY$FQ)O,:>X&Z4ED\[(.(T4?H__P ,\?%[_HI__EK:;_\
M'*\__8J_X)O?\,?>(;G7O[=_M/[1I\MEY'V#[-M\R:";S-_VJ;./)V[=HSNS
MN&,'Y _YN\_S_P!"Y7[_ %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%?"'[,'[8EE\5=>\1>#]4GCAUO1]<U*UMA++ C7UJMU=-#]FB&QW>VAA
M\N=0CD(D<[RLTSB/\T/^"DW[-=F_Q*\,CP-_H?BKQ%<22W*6\C+Y,T4L)AU-
MD@5IK?),\L]P@VM]EDN OG)<2/\ 3_\ P6K_ .2>:;_V,%M_Z17U?6'[ OQB
MT;XK?#[0HM,N(WN=-TNRL[VU\R(W%O);H;7,L4;NT:2M;O);F3:9(=K[0<JO
MPA\9[B+]OKXPZ#HFBI;ZCX5\([+S4]11(KNSE:X,=P]N9!.T,T4X@@M%CP)5
MD-Z[130P-MY__@N+_:/]G>&/*^T?V;]HU#[1MW_9_M&RW^S>;C]WYNS[5Y.[
MY]GG[/E\ROO_ ,&_MR_#J[\/:?<Z#<>>TUOY=CX>TZV\[5%,$,C_ &1=-M@[
MP^6L#('8)9J%5A<>2\<C?D!_P24^.FA_ RS\6W.KS_Z1-_9"V5A#B6^OYMUY
M&L%E; B2XE9Y8DP@VH9%:1HX\N/J#_@L9^S%J/CZSL/&NC6GVAM*MYH-69'=
MIELPPE@E$/*&*!FN6G=,2*LJNX:&)W@[_P#9P_X*X^"_$.AVT/C*ZN--UJVM
MX8[N:2UDFAO)@&5YH391/LW;!+)&\4"QM*(XS*J%Z]0^#?Q>3]MWQY!XAT5K
MR+PEX0CN4@DD22!=0U>\66V,@0^9'+;PV1+QAQ;7D#W:[T\N9D'YH?MF^!-<
M_8@^+D/Q+TNR_P")+>:@+N)XY"ZR3318U*TF>5)?L\MSNNGC.UE6*4O!\T#Q
MP?I?X _X*R?##Q-I=M>:IJ,FE7TL8-Q8R6EY.T$@)#*)K>W>*1,C=&X*ED*E
MXXGW1H>"OB]XL\8^$/''Q,=KS3+.YTN>7PMI]TD1:VM=/LIY(K_9\R%[R:1I
MF25&.R*(":YM?L[#Z0_9T_:%\/?MB^%UOH$MV^TVYCU/2998;E[?S#+"\-S&
M"<Q2^7(8C*B?:(,.8URR+^2'[*/P"3P!^T1J]KX,FD'AK0HYOMI$\DL>VYM5
M7^SVEC#+(\5XYV0W#;P+&1F>2XMR3^M_Q(_;0^'_ ,(M<3PWKFMV]IJC^3F%
MDF98O/.(_/F2-H;?((<^>\>R)EF;;$RN?I^BOQ!_X+&?LQ:CX^L[#QKHUI]H
M;2K>:#5F1W:9;,,)8)1#RAB@9KEIW3$BK*KN&AB=X.__ &</^"N/@OQ#H=M#
MXRNKC3=:MK>&.[FDM9)H;R8!E>:$V43[-VP2R1O% L;2B.,RJA>O4/@W\7D_
M;=\>0>(=%:\B\)>$([E())$D@74-7O%EMC($/F1RV\-D2\8<6UY ]VN]/+F9
M!\ ?M8^"+C]A3XRZ=\3+2SDF\/:C>-<7#K&TBQW%TDL6HP*6G!-Q)&\UY;>8
MT,)>0QHC16TH'[W>%OBKH?C30X_$UA?V\NBRV[7(O2X2%84!,CR,^WRO+VL)
MEDV-"R.L@1D8#\@?A-HL_P"V5\>;WQNB_:?"?A7-G87,D%O+;S7%O&42."1'
M*R8N)I]2AN%\YXT%MN\DS6X3R_\ X+E:M;S7'A2S66,W,4>J2R0AU,B1RM9K
M&[)G<J.T4JHQ #&.0 DHV/W^TG5K?7[>*\LY8Y[:>-)89HG5XY(W4,CHZDJR
M,I#*RDA@002#7\^/_!/OQ9IU[^T!XQGBN[=XM0_M[[%(LR,MUNU2&=?(8'$N
M8D>8>7NS$C2#Y%)'W_\ \%8/%-GX?^%&J6US)LEU"XL+:U7:S>9,MU%=%,J"
M%Q%;S/N<JOR;<[V56S_^"3?C_2_$WPPT[2[.YCEOM*DNX[ZW!(D@:>\N+B$L
MI )22-P4D7*,5D0-OBD5.@_X*IZM;Z=\)-:BGECCDN9-/B@1W56ED%];RE(P
M2"[B..20JN2$C=\;58@_X)6:M;ZC\)-%B@ECDDMI-0BG1'5FBD-]<2A) "2C
MF.2.0*V"4D1\;64G\\/^"D?@[4?V8OBAHOQ6T\7$UI=W%J]RJ2O%BXLD2*2U
M,R1;88KNT0(JLTSRXO<H8E"5^I_@K_@H1\,O&VC-K2Z_9VD<49>:UO)!!>1L
ML2RO&+9CYL[J&V VHG260-'$\K#%?C!^Q;^T)HG@#XV>*-:UP7FG1ZQ)JL%K
M:RV5Q+>?:KO5()8K1[:UCGE6XPK(R $"13'N+%0?4/\ @J]\"]<^&GBVR^*G
MAZ#9;I]A:ZNX\S-;ZE:R;;:>:*4/&D3(EM%&0#"98BDJK)-'Y_V?\(?^"NOP
M\\:Z6MUXAGDT'41(Z263PW5ZNT'*21SVUL59&4C(=8G5PZ["@263V#]G'XO:
MI^T[XJU#Q98->6W@BRLVTS28YD$<>JW37 >ZU)$.R54B$*6T(E608>4JT$WV
MNW'YH?\ !03Q9IUE^T!X.GEN[=(M/_L'[;(TR*MKMU2:=O/8G$6(G28^9MQ$
MZR'Y&!/]!VK:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22 *_
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MW'[0_@Y;W2;>2YUO0Y&N+6&)6>2>WEVK=P(GF*I<JL<ZX669S;B")-TYR?\
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MB'P/X\:XMK1K@#[0@N)+>WN+82#SEMO*$K17L31%+B./>Z):EHS$WF0_;_\
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MK6=%\-:UJMVTBZ3J%Y"MA"YE"F2V61;JXC1E$120O#"98RQ=[5XWQY"Y^O\
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M47RY\OMF=IK9'_4_]L[]HJR_9P\':EJ+7L=MJTEG.FE1;H#<273;88Y(H)V
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M?6_]F_9VGMI$GA_TS]RT\<5FSR)'/+,B$P(K_O>H.W)'YX?\$M?A-JDR:_\
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MMH4.T>9&8BDI+&17+ON^O])TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ
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M8BDI+&17+ON^O])TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4
M 5G^*?">G>.;.33]5M+>^LIMOFVUS"DT+[&#KOCD#(VUE5ER#AE##D U\8:3
M_P $R_A)HMQ%=1>'8VDAD21!+>7TT99&# /%+<O%(F1\T<BLCC*LK*2#]OZ3
MI-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550 H    KQ_5OV9/ NOW$M
MY>>&M#GN9Y'EFFETRT>221V+.[NT19G9B69F)+$DDDFN@LO@AX5T[2YM#@T3
M2X])N9!+/8)8VZVLL@*$/) (Q$[@QQD,RD@QIS\JXX__ (9.^'G_ $*GA_\
M\%-E_P#&:Z#Q3^SUX-\<WDFH:KX?T>^O9MOFW-SIUM-,^Q0B[Y)(V=MJJJKD
MG"J%'  K/TG]F3P+H%Q%>6?AK0X+F"1)89HM,M$DCD1@R.CK$&5U8!E92"I
M(((KH/&OP0\*_$JX6\US1-+U*Y2,1)->6-O<2+&&9@@>6-F"!F9@H. 68XR3
MD\%?!#PK\-;AKS0]$TO3;EXS$\UG8V]O(T996*%XHU8H656*DX)53C(&.P\4
M^$].\<V<FGZK:6]]93;?-MKF%)H7V,'7?'(&1MK*K+D'#*&'(!KY@^&G[ _P
MS^$6HIJND:!;I>Q;3%+/+<7?E,KK(LD2W<LR1RJR*4F0+*G(5P&8'U_P!\ ?
M"_POU&_U?2-,M[?4M3N+BXO+S!DN)7N7629?.D+R)$SHK^0C+ KC<L88DGU#
M5M)M]?MY;.\BCGMIXWBFAE17CDC=2KHZ,"K(RDJRL"&!(((-?&'_  [>^%']
MH_VI_P (Y;_:/M'VC9Y]U]GW[_,V_9?/^S>5GCR/+\C9^[\OR_EK[/TG2;?0
M+>*SLXHX+:"-(H88D5(XXT4*B(B@*J*H"JJ@!0   !7A_P#PR=\//^A4\/\
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M.?2O$-A;ZA9/N/E3H&V,R-'YD3??BE"NX2:(I+'N)1U/->0?!S]B_P"'_P
MKQM0\.Z);VUZ<;;F1YKJ:/"NA\F2ZDF>#<LCK)Y)3S%(5]P50._^#GP!\+_L
M_P!FUCX8TRWT^)\>:T8+33;6=U\Z>0O--L,CB/S7?RU8HFU,*/8***X^3P!I
M<NLQ^(3;1_VM'9R6*W8!$AM9)8YFA8@@.@DC5TWAC&3)L*^;+O["O/\ P?\
M"K0_A_>:CJ&E6%O:7>KW N=0FB0*UQ,%VAW(_P"!.5&%,LDTQ!EFF=^PU;2;
M?7[>6SO(HY[:>-XIH945XY(W4JZ.C JR,I*LK A@2""#7A__  R=\//^A4\/
M_P#@ILO_ (S7N&DZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515 554 *
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MI?[+5O8I<6EYJ>K:O)+!I6G6<9:2YG15 4OR$0R20Q':)9B9E,=O-M<+\O\
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M (:>.)_B)IR:A/I>H:1YNTQVVHK;I<%&175VC@GN/*SN*F.8QSHZ,KQ)@%O
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M(F?E#Q3^V;X[\%6<FOZA\.=0A\-P[9YKLZK:-?16+,"9Y-,5#*DJ1'S)K=W
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MAG@[]EAY=.NGDU'74C5AIEJ/F0R1N\1N9V_=0(Q5-PS)<*DL<RVTD; GZO\
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M_MB:3;ZU\.?%45U%'-&NAZC*$D17420VTDL3@," \<B))&W5'574AE!'P?\
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MT6]M>']TL(4XM/LIE'[UJ^S_ /@M7_R3S3?^Q@MO_2*^K[__ &3O^2>>%/\
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M7W'Q'^&5S<6OF-)HUY;ZD8HX6E:6-!);RYVD&-(H[A[B23#!4A;<%4ET\_\
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MULU>ZCD>.1H[JX9KFYC#Q?(R)-+(D94L-BK\\AR[?1]?@#_P7._YE'_N,?\
MMA7J'_!0S]D2X^&]P_Q?^'\LFFZWIL@NM1AMD8B8%MLMY&BJRAPK,;])%^SW
M%OYTTN&$_P!J^[_V*/VKK/\ :T\+PZIFWBU>W_=:I90NQ^SS98(X5P'$4ZKY
ML1S(JY>#SI9()2/C_P#X+5_\D\TW_L8+;_TBOJ^__P!D[_DGGA3_ +%_2?\
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M^]TFK6\-Q'9M+&+F6.26.$NHD>.)HUD=4SN9$:6)78 A3)&"077.A17X _\
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MIWQ"\;WFO:$)(II-,M=-M=)6XDAD5T2YGMB\LEO@-NA4QG?Y<RRI)"AKZ/\
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M8<\-?L@V\KZ<9+W5KJ-$NM1N HD*JJEHH$48@MVD4R^7F1V.P2S3>5$4]O\
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M]0LGVCS8'#;&9%D\N5?OQ2A70O#*$ECW .BGBOS _P""U?\ R3S3?^Q@MO\
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MH_M'^R_^$CM_M'VC[/O\BZ^S[]_E[OM7D?9O*SSY_F>1L_>>9Y?S5]OU\_\
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MK'& <>?Z3^TWX%U^XBL[/Q+H<]S/(D4,,6IVCR22.P5$1%E+,[,0JJH)8D
MDUZ!XU^(6C?#6W6\US4+/3;9Y!$DUY<16\;2%68('E95+E59@H.2%8XP#C/\
M"_%CP]\4/._L'5=/U/[/L\_[%=PW/E>9NV>9Y+OLW;&V[L;MK8S@X] KY_\
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M&5$&69E4$CZOU_XL>'O"FG6^KZAJNGVFFW?E_9KR>[ABMYO-0R1^5,[B-]Z
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M%5W^H?\ !3C]E72_C=X.OO$*Q1Q:[H-G+=07>XH7M8,S7%M*51S(GEB5[=2
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MV?AR60>');/4);*$/,(WMXM1MULG9)CO9TAE94:8&91)("07?/U?_P %J_\
MDGFF_P#8P6W_ *17U??_ .R=_P D\\*?]B_I/_I%#7T!7Y ?\%J_^2>:;_V,
M%M_Z17U'_!%3_DGFI?\ 8P7/_I%8U^O]%9^K:M;Z!;RWEY+'!;01O+--*ZI'
M'&BEG=W8A515!9F8@* 22 *_%'_@GCIL_P"V!XM\0_%/Q5;?:EAN(K/0XKDV
M]S#8[)/M?EP*T8>.6T7[+Y5PBP;VGN)3OFDE9/T/_;$_95TO]J_PU/IEU%&-
M4@CEDTF\9BC6]T5^4-(J2-]GD946YCVN'0!U431PO'^>'_!(W]H^7XLZ'J'P
M^UNYN);BPMS)82":5)AIKA8)(8YH522'[,[)Y,GG><JW")"(X[5=OR?IGP"T
MOPA^TB?!WAV:\T/3A'+'#+8SDW5NLV@M-*89[H7+*[L\@\P[GC#DQ-&ZQNGZ
M?_M;_L0?#Z+X<ZN+'1+/3Y]'TNXO+.[M(4BNA)8VSO&)KC:9;A'"[)Q.TAD#
M&0L)U29/E#_@E?\ ".+X^^$DN?%<_P#:NBZ#J%W::3H4\$1L89I8TN)[N=-O
M^F2G[6Z6XN0ZVH:9H\M*AA\/_P""J?P=T;]E_P 2^&?%7@ZWCTF^N9)IC%;Q
MQ+:QW&F-:/;SQ6VPQ(Y,@\U0/)D,:L8][3/+_0]X_P# =A\3]+N=&U1))+&\
MC,5Q''/-;M)&2-R&2W>.4(P&V10P$B%HW#(S*?YL?V0_V?;/QE\9/%OA&VN;
MC3M MO[8@NK6W=@]WIMOJ<,0T]KEF,T44A$(GD1O.E@22#>OGM(OZ?\ [;7_
M  3X\)?$CPE>7/A_2+?3-:TRWN+NR_LJQCC:Z:.,N;22"!4\_P [8$B.#+%*
M59,J989O/_\ @CG\=+SXD^$K_P /ZC/<7-QH-Q"MN\NTK'8W,9%O CY\QO+>
M"XP)!B.)H8T8QJL<78? 3]E7Q9HOQI\3^//%$5G/8S1S1Z1=;HGD*RM"EN8H
MU0-$]O9Q&TN))!&[EV"-<I)+*?S@_P""LOQ"\':UXET+7/!>H6<VNK'++?W^
MEW&]@86A%@[3P,8A<1E)@K*WVA$6'>1&MMC^A[XO?!O1/COI;:+XA@DNM.>1
M))($N;BW61HSE!(;:6)I$#8<1N63>J2;=\:,O\\/_!([X(6_QLN-=BU:XDDT
M2SDTJ>ZT@*OV?4+A6NVM#=M]Z2WMV620VI_<W$S0O+N6 1O[A_P5Z_9>\)?#
MCP]IGB;0M-M]+O?[0CT^2.RBCM[>6&2&YG#20QHJ>:C1865=K,CLLGF!8?*_
M6_X<Z3;_ +1?PYTB+Q5%'J4>M:'I\NH)(BJLTD]M%*[@1A!&_F'S(VBV&)PK
MQE&12/Q@_P""=]B_[)GQEUGX>:I;QSW-Y'+;6U\(8_/"VZ&^A<,)G\BWNK8>
M=-"#*_G+:H^TQ.1^O_[;_C6W\'?#[6XI5DFN=4LYM)L+6$*]Q<WFHHUK!%!$
M65I7W2>8R1[I/)CD=4<IM/7_ ++WP+L_V=/"6F^'[:"WAN(;>)K][?<RW%\T
M:"YG+R 2/O<'87 *Q".-52-$C7L/C7\4+?X*^&M4\1W7EM'IMG-<".298%FD
M13Y4 D8,%>:39#'\K$NZA49B%/YH?\$P?@I_PF]G-\7/%$G]J>)M;N+K[-=R
MMO-O;QL;5]D?EHD,KM'+$/+W)'9K#!#Y*--$WD'_  6C^!>AV.DV'C:"#R=:
MFU"'3[F6/"K<PM;SR(TRX^:6/R%2.4$-Y1,;[U2$1?J]^R=_R3SPI_V+^D_^
MD4-?EC\'9!^WO\:=:U368X]2\)>%([BVTZU:2VN]/:25C:Q2&)HRLZ72Q7-Z
M)%5BCQVR-<-'# K_ *W?'3X%Z'^T7H<_A_Q!!YUI-\R.N%FMYE!"3P.0=DJ9
M.#@JREHW5XGDC;\8?^"6?QLU'X1>+=6^$6OW7GK!<7D>G;7>2&*\LI)?MD,&
M80XBG59+@&1HHT:!B(_.NGS[!K7BFS_;?^.3>$[R3[1X5\'6\]S)ITBLUO?Z
ME;R);RO-&1"?W,MR(@LGVF%TM9 H,-]+G[O_ &L/V9+?]H'P'=>$-.2SLI$C
MMSIC/ OD6LEJRF)8U09@1HU:V+Q F*&5\1R+F)^/_8C_ &6M1_9Y\#2>%/$]
MU;ZM]HN+IY+<!YK.*WN%5&M4$ZC?$^'FD4Q1H9+B52C<R2?G!_P0Q_YF[_N#
M_P#M_7W?_P %4])M]1^$FM2SQ1R26TFGRP.Z*S12&^MXB\9()1S'))&67!*2
M.F=K,#S_ /P3W\!V'Q/^!ND:-JB226-Y'J45Q''/-;M)&=2NMR&2W>.4(P&V
M10P$B%HW#(S*?S _8W^ 6E^+_C#XT\()->6.B01ZO;O;6DY1KBQM]7MH_L,T
M[B2?[/(BK'.8I(KB1 4,X5Y _P!P?\%._P!DCP5HGP\O/$.EZ19Z7J.DR6SP
MR:?;PVJRK<W4%M)'<)$BK*FV3>A(WQN@V.J/,DN__P $^O@;9?&_P1HWB?QL
M8_$4BV<FGZ597UK ]GIEC:3M;!(;?88I+B4VZ-+>2*;AHUA@W!8W:7XP^.?P
MTT[]E;]H?PK_ ,(BGV"+5+C39Y8%5&AB_M"\GL+N*!&4B**2(/A!GR6D;R3$
MBQ)'^YW[2GQ>3X"^#M8\2LT:R6%G(]N)4DDC>Z?]W:QNL6'*23O%&Q!4*&+%
MT4%U_'']A+]KOX<?#:SOO%/C?7O.\<Z[<2OJ%S+I][)-!;JP2&U22&&6$1$1
M+,%@$2!6A@*;;2(+\P?MW_M ^"Y_%NB^-OA1J/D:U']I:_EM;.2S43"021SN
MLUM#Y\MQY]PET9#,LT2)'(NTL)/V._:;\*:)^U+\(W\4:Q92>9'X;GUNQMQ>
M7 CMKJ33C<1LRQ/#%</$3M1YHV !D 15ED5OA#_@DM^SUIWQ=\,W.I>(G_M+
M2['6+E;31)XD>Q6\>SMEEOIXV!%S+Y3I#;I,#':@32(IEFWQ^7_\%4_@[HW[
M+_B7PSXJ\'6\>DWUS)-,8K>.);6.XTQK1[>>*VV&)')D'FJ!Y,AC5C'O:9Y?
MZ#O'7PG\/?%#R?[>TK3]3^S[_(^VVD-SY7F;=_E^<C[-VQ-VW&[:N<X&/P!_
MX(U_"?P]\4/^$I_M[2M/U/[/_97D?;;2&Y\KS/MN_P OSD?9NV)NVXW;5SG
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MVNWM(XXVA_<ZAJ!GLS##Y:B.)8K1P4;RVCW1J(_O;#_F[S_/_0N5^OW[6/\
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M:Z-);+Y<NE6\6DW466;9-8Q1Q@[F1 WFQ>3<83<L?F^5O9XV-?1_QH^+VE_
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M5PQ"[)I$MG?*[6;,2;6)4;@H=OPA_P"'H_Q>_P"AA_\ *=IO_P B5^[WBGX
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MUMNF>W9U2Y@@2*9.5E>)K>YD4^0#*4\P0O\ 7_[!_P#P4'L_VO\ S]*O+/\
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M_&;_ (47^SQIVIQ2^5>S>%]*LK(K<_9IOM%W9PPK) XRYE@5GN@L?SE8&(9
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M?!#X@V-F3(^G:])%IEU"NXCS)W"VDP3S(TWQS,JF1Q(4MY;D(A=Q7]=M>?\
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MSB^'.L\7MA;R/I=T\V3<6Z-N-J1*Y<RP*Q,"P@I]CB9=D0MMTWU__P W"_\
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M_.#_ (+5_P#)0]-_[%^V_P#2V^K[_P#^"*G_ "3S4O\ L8+G_P!(K&OU_KX
M_8%_YGW_ +*!K_\ [;U[_P#M8_\ )//%?_8OZM_Z135_(%^R=_R4/PI_V,&D
M_P#I;#7]GOQ5^)>G?!O0[_Q#JK[++3[=YY<,BL^T?+%'YC(C2RMMBA0LOF2N
MB Y85_%'\"_@7KG[1>N0>'_#\'G7<WS.[96&WA4@//.X!V1)D9."S,5C17E>
M.-O[G*_@#K^_RBBOX@OVL?\ DH?BO_L8-6_]+9J_K]_9._Y)YX4_[%_2?_2*
M&OYXO^"M?[1]Y\3?&DOA:VN<Z+H7EQ^3%,LD,M\8]T\SA%&)8O,-H8W:0P-%
M-M,;33)7Z7?\$<?A"G@KP'-XA=8S<Z]>2.)$>0M]ELF>VBCD1L(KK,+MP8P2
MR2IN<D!(_P!;ZY_Q9X6L_'.G7>E:A'YUE?6\UM<Q;F3?#,ACD3<A5UW*Q&Y2
MK#.00<&N?^$_@7_A5_A[2M!\[[1_9FGVEEY^SR_-^S0I#YFS<^S=LW;=S;<X
MW'&3Z!7Y ?\ !:O_ ))YIO\ V,%M_P"D5]7P!_P14_Y*'J7_ &+]S_Z6V-?T
M_5_.CXC_ &''_:MTOQMJ>BF./Q'I?CSQ(($81HM] QMF-K),0&5U8%K5G;R4
M>25'""=IXORP_9B_:%U']E_Q1:>)=/3SO)WQW-J97B2ZMY1MDA<H?I)&661(
MYXXI3')Y84_U??%SXEZ=\9/A!KGB'2GWV6H>%]3GBRR,R;K*;=%)Y;.BRQ-N
MBF0,WERHZ$Y4UW_[)W_)//"G_8OZ3_Z10U\ ?\%J_P#DGFF_]C!;?^D5]7P!
M_P $5/\ DH>I?]B_<_\ I;8U^U_Q@^/*:3\2O!G@>UDD%S>R7^HWH221%^RQ
M:=?1P1R*$V3)+-OE WDQ/9HS1Y>)U]?OO#&E_"75-?\ '%U+';VUQI=F=0*6
MYW!=*%[(]U(T>YYW,,Z1!=A=4MD52X*HG\6?Q5^)>H_&37+_ ,0ZJ^^]U"X>
M>7#.RIN/RQ1^8SNL42[8H4+-Y<2(@.%%?V^?"?P+_P *O\/:5H/G?:/[,T^T
MLO/V>7YOV:%(?,V;GV;MF[;N;;G&XXR?0*_A3^(7ANX^"'BK4-,L[N0W.B:I
M<6\-[%N@D\RRN&C2=-KLT3[HQ(NUR4.,.2,U_9Y^S7\7D^/7@[1_$JM&TE_9
MQO<"))(XTND_=W4:++EPD<Z2QJ26#!0P=U(=OY<O^"H__)7O$/\ W#O_ $VV
ME?O]_P $N/\ DD/A[_N(_P#IRNZ_.#_@N+XIL[O4?#&E))F]MK?4+F:+:PVP
MW3V\<+[B-AW-;3C:I++LRP4,A;T#_@AUX6O+33O$^JO'BRN;C3[:&7<IW36J
M7$DR;0=XVK<P'<P"MOPI8JX7[?\ ^"H__)(?$/\ W#O_ $Y6E?C#_P %>_@7
M%\,/',6N64'DV7B"W-PY'E*AOH6V702.,*Z[E:WGD>0,99YY7$C'<J?9_P#P
M18^/*:MI>I^![J20W-E(VHV0>21U^RRF..>.-2FR%(IMDI&\&5[QV6/*2NWV
M_P#MLZM<>-GT#X:V<LEK)XQO)HKRZ1VB:/2M/C6ZU%(I5+%;B:/;#&KQ302H
M\T<H16#5_/C_ ,%1_P#DKWB'_N'?^FVTK]_O^"7'_)(?#W_<1_\ 3E=U]_U^
M$/\ P51_M'X^RZEI.C?:'LO NGPZCJRQ;W62\U&6%((7@^3_ (][(7-Z;Q!/
M''$TT+^02['\\/\ @F/^T#<?!#X@V-F3(^G:])%IEU"NXCS)W"VDP3S(TWQS
M,JF1Q(4MY;D(A=Q7]=M>?^./AIIWQ$GTN?4$\W^R-074;:,JC(;A+>>"-G5U
M;/E_:#-&5V.D\<4@8;"&] K^ .O[_*\_\#_#33OAW/JD^GIY7]KZ@VHW,85%
M07#V\$$C(J*N/,^SB:0MO=YY)9"QW@+_ #@_\%J_^2AZ;_V+]M_Z6WU??_\
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MX<:-J_\ PEOC#3/M'VW_ $/3=8^S6<7EWMQ'^ZA\E]F[9O?YCND9VXS@>/\
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M7]4$EA'J.I'2+JZ:321'97%XLOV:W5,P7#1J\BR9D#RM(C!%G,L7[W?LG?\
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M"U?_ "3S3?\ L8+;_P!(KZO@#_@BI_R4/4O^Q?N?_2VQK^GZO@#]@7_F??\
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M^K?^D4U?R!?LG?\ )0_"G_8P:3_Z6PU_;[7P!^SQ_P E>^)__<K?^FV2OO\
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MKO\ LC[1-<>(-8F^Q_:M[O#;RRGR?/\ +\]DBMK<+YFSS$@@A.W,<8K^OWX
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MDOEAV6/?L4[%4#^6+_@J/_R5[Q#_ -P[_P!-MI7[_?\ !+C_ ))#X>_[B/\
MZ<KNL_\ :UU-/B]XQ\)?#.(2/'/>)KVM 122V_\ 9NG>8T5O=Q;1#+;WEPGD
MDR.5AFCA+0R-)"#]'_\ #)WP\_Z%3P__ ."FR_\ C-?CC_P5V_9(TOP5I>E^
M*O"^D6=A;6TCVFJ"QMS"NV8JUI,\4*"!45Q+$\[;'9Y[:(F0;!'X?_P2$_:7
M_P"%9>*)?".H3;=-U['V;>^$BU&,?N\;Y4C3[0F8&VH\T\ZV40PH-?T_45_
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MGP \>3OIUE'9Z)JT:7=@D"R"!&VJEU"NY0BNLP:7R(BR0PSVX C5EC7];O\
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M4U'[)W_)//"G_8OZ3_Z10UT'QT^!>A_M%Z'/X?\ $$'G6DWS(ZX6:WF4$)/
MY!V2IDX."K*6C=7B>2-OY0O 7P+US]G3XO\ AOP_X@@\F[A\0:0R.N6AN(6O
M8@D\#D#?$^#@X#*P:-U25)(U_K=^*7PMT?XTZ/<:#KUO]KTV[\OSX/,DBW^5
M(DR?/"Z2##HC?*PSC!RI(/R!_P .N/A#_P!"]_Y4=2_^2Z]_^!?[+GA#]FO[
M9_PBFG_8/M_D_:?])N9_,\CS/*_X^)9=NWS9/N;<[N<X&/R!_P""YW_,H_\
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MJ_P@^)M[HNCV4@MM4DAN]*MH5C=I%O3@PV\-NHVHMR)[>W@V!PD<8 <%7?\
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M3V_XE_"Z^^(F](/$.L:1;RV[020Z=]@3.[<&E6:>QN+F*4A@H>&6/9L5D"2
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M:^*/L_V?[/OW:1]HV;/+W?:O[*^T^;CGS_,\_?\ O/,\SYJ^'_\ ARI\//\
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MP0J2J"$('$GZ?Z3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550 H
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MC\"-+71?#WBSQ):Z<DCR1P.=)N%C:0Y<1FYTN5HT+9<QH53>SR;=\CLWE_\
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MG]J:5!<7FJ#S!%?7\JRS0I*JJR1+&D4*<*P\P1^?MEEC,IB<I7V_7YX?&_\
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M&2LHC^SZ********S]6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q
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M5I;*:XMXII+:3[([;X'D5FB?=&C;HRIRB'.5&/B__@BI_P D\U+_ +&"Y_\
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MHHHHHHHHHHHHHHHHK\4?^"SWP]T;3O"%IKD&GV<>K7.N6L4]^EO$MU+&+*[
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MJ?V1Y2R$+##N6\1O)@C"0P[Q&AD\I$\QE#ON?+'?_P""L'PU\4:SX0U36O\
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M ,$O_CWXC_:)\&WNJ^)[S[=>PZQ/;1R^3!#B%+:TD5-L$<2'#2N=Q!8[L$X
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M ,$V/BCKWQ[\+GQ-KWB.XU:[-Q<VD]C]BL[6WM'C,;(-T-K'+-*8BDOF++Y
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MSZ?%"MDSW[V\(CLA(\!2)XO/,8\M)7=RZ[G=W_H-^!?P[\7^ OMG_"5^*/\
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M'<R32>9=.L;SQI;J8H_) /\ 4;7X _\ !#'_ )F[_N#_ /M_7O\ _P %J_\
MDGFF_P#8P6W_ *17U?4'A/Q3>>!O@5::KI\GDWMCX'AN;:7:K[)H=)$D;[7#
M(VUE!VL&4XP01D5\O_\ !%3_ ))YJ7_8P7/_ *16-?0'_!4?_DD/B'_N'?\
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M/_,W?]P?_P!OZ^__ /@J/_R2'Q#_ -P[_P!.5I1_P2X_Y)#X>_[B/_IRNZ^
M/^"YW_,H_P#<8_\ ;"OV._:;U:XT#P+XEO+.62"Y@T/4Y89HG9)(Y$M)61T=
M2&5U8!E92"I (((K\0?^"77[/-O\;_"NHRKXK\2:/<VVJ.LEAHVK+:1^6]O
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MCR&._P#!46EZ-<:0'@:*UME?3[2-[Z-83,UQ>V#,Q(N1,X+/+;P6?VJV>/\
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M.>\GMI[Q[QWO'B>02/%%$0#%%"NS;"I *DY+?,00!^2'[ O_ "<+X]_[C_\
MZ>;>OW^K^<'XJ_L9?%7]B[7+_P 0_"^:XET6XN'DCM=.+SS10L=D,-UI\_F_
M;/*^T21PR 7;*L;73BW8\?9_[#W_  4BTO\ :<U2TT7Q#I\=GXM:.]2UN+>
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MU6S#=W4%K.F'##YXI9$W ;EW;E*N%8<__P $N/\ DD/A[_N(_P#IRNZ^?_\
M@M7_ ,D\TW_L8+;_ -(KZOO_ /9._P"2>>%/^Q?TG_TBAK\@?V!?^3A?'O\
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M.T.]E#A6EV9+F,2R*'(9BW]%U?/_ .UC_P D\\5_]B_JW_I%-7P!_P $5/\
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MQ>/$^+WAB.,Z<UY;W,P@C:);6Z"I'*EVL+HSV]\P;SIE9!,]Q+!+M>2)[CZ
M\ ?\%K_"LNEVQ\0Z5JD>K>6!=K8Q6\EJ9 2"T+374<H1@ ^QU)C+&/S)=OFO
M]?\ [-UQJGA^WUSXD?$-X]!GUZ2SV65W>!;?2]-ME,5C#*TX007$DEQ-).FY
M5::93Y-O.\T*_DA^PW\?O"_A_P".'BG7;[4[>TTO6/[:^PW=R3;PR>?J,5W%
MO>4((=\4;LOG>7\P$7^M9$;^EZOY@?\ @GS^T%9_L%>*-?\ #/C^VN-,:\^S
MI/.4:7[+-9B=T#Q0K(\D4ZSYCG@\Q3^Z95>&4S1:'_!6?XS/\;$\+:C:Z7>6
MFB-'J;Z=?W?EQ-J"M);J\L-J&:>*WV1PRP27*PO<)<!A"JH&?]K_  O^VOX7
M\1:=?^))IOL/A.V\N.SUJ]S;)J5P$FDNH;*VE5;F7R!$J A"]Q/Y\,4;&W9G
M_(#_ ((L_%70_!&H^(-*U2_M[.]U3^RQ8Q3N(_M#1/<QM'$S81I2UQ$$A!\V
M3<2B,$<K_1]17\P/_!/G]H*S_8*\4:_X9\?VUQIC7GV=)YRC2_99K,3N@>*%
M9'DBG6?,<\'F*?W3*KPRF:+0_P""L_QF?XV)X6U&UTN\M-$:/4WTZ_N_+B;4
M%:2W5Y8;4,T\5OLCAE@DN5A>X2X#"%50,_[7^%_VU_"_B+3K_P 233?8?"=M
MY<=GK5[FV34K@)-)=0V5M*JW,OD")4!"%[B?SX8HV-NS/^0'_!%GXJZ'X(U'
MQ!I6J7]O9WNJ?V6+&*=Q']H:)[F-HXF;"-*6N(@D(/FR;B41@CE?H#_@M'\5
M=#O/#-AX9AO[>76HM8AN9K*-P\T,*6<X+S*N?)S]IA,:R[&E5RT8=4<K]O\
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M)EVQMH?LS_M5>&OVK]+DU/P]+(&@D\NZL[A52ZMV);RS+&CR+LD52T4B,Z.
MR;A+'*D?T?7C_P ?O@Y9_M >%]3\,7S;(M0MS&LN&;R9E(D@FVH\9?RI4CE\
MLNJR;-C'8S _@#^PS^V)_P ,%7FI^ /'NFW%G$=0$SSQIOFM;B18(7,R!\2V
MAB1)XY;;>Y4%HTN4GC,7H'_!4#]JO1_VC?!ME'X4BN+[1;;6(&N=9:*2VMTO
M#;78BL8H[B..6:4Q&2>9T41P)Y +,UP GZ7_ +&GQWLKCX<Z7=:M:7F@Z=I&
MEZ5:/J&L""RM;EA;0Q^=;.\Y9K=F,?ESR+$DIE18R[B18_R0_8;^/WA?P_\
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M4Z[?:G;VFEZQ_;7V&[N2;>&3S]1BNXM[RA!#OBC=E\[R_F B_P!:R(WZ/_\
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MH C[E.Y %.5 %=AI.DV^@6\5G9Q1P6T$:10PQ(J1QQHH5$1% 5450%55 "@
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MY- ^$_A[PIJ-QJ^GZ5I]IJ5WYGVF\@M(8KB;S7$DGFS(@D?>X#ON8[G 8Y8
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M(8_\S=_W!_\ V_K[?_;$_P""<^G?M>^(=-UZYU:XL/LENEI=01P)+Y]NDSS
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M6^@>*D\I8VAG62SN9IP)8H!B2802M%)#Y0,TZSR;TW13&*W?ZP_:8_:8TO\
M9ITN.ZNHY+W5+V3[/I.DV^6NM0NF*JL42JK,$#,GFR[6"!E55DFDAAE^/_B%
M\7_C_P"#/#^H>*I=&\)VEI9QW%T^ERS7=QJ$-K"[$[Y8ITLYG2%?.9HY$,B
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MIVA1:'>:;ISWEL;_ %'6K2YMY&T\W$D,\]I8A5G*%%\V">3YR5DB:RWCC?\
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M#1I(Y7L+77);HZE?QH6:&XC6!HK>!+A"BQ1S28W R_:&MI(I3T'[)'[>EO\
M'75+OPAXCM(]%\8:=))!-9B=98+J2V&RZ-JXR \<B2%K?=*5A D2>X19FB]0
M_:-_:6O/AKK&C^#_  U96^I>*M?^T?98;BZ6"WLX88V8WEV%W3-$I5F6*-5:
MX2"Y2.431JC_ "_\=/VI/B_^RAH<^L>)]"\/ZK;R_NH;O1Y[U(=/F8%8WOXK
ME&DEBD=D5#$\"AD,3S))/!7ZOT5\X?M,?M5>&OV4-+CU/Q#+(6GD\NUL[=5>
MZN&!7S#%&[QKLC5@TLCLB("J;C+)$DGS_JWB[X_ZU;RZGIVB^$].C\MWBTB]
MN[N[U -&I'EM<V[0V+O*REHCNC1$D1)75E=@?LD?\%#-+_:5U2[\.:GI\GA[
MQ':R2*FG7,QD:981B94=HH&%Q"ROYULT8=47S%,@2<09_P"V_P#M]2_LI1/;
M6.@ZA>W;;(TO[BWE@TB.:6*61$%R5_TJ5-B.]O"55HS(OVJ.6*1%Y^#]L[QI
M\6_#UE)\-_#UOK^K_P!GV$NK7K7$=OI=C?7$,,\EG$)IXGNY45G$T<4X-D7@
M$KR2,\2\_P#L)?\ !0_4?VA-<OO"'C"PM]+U^#S7MUB5[=9/((2>U>"YE>9;
MN([Y"JEMT23;DA^SEI?U?KC_ !_KM_X9TNYO-+T^35;Z*,FWL8YH8&GD) 53
M-<.D4:9.Z1R6*H&*1ROMC?\ G!F^-'Q#UO\ :#M+_4_#\<_B/3XY[>S\/QWU
MK"L5J]A<31Q&_P#GA=UBN7N9)6),CEHU6(%(8OZ#O@IXS\1^.=.DN?$^@_\
M"/7JW#1QVGV^#4-\(2-EF\V!51=S,Z>61N'E[B<.*_GQ_P""4'QOM_@[;^)H
MHK>34M;U*328-(TB!E%Q?7 6_9@&;Y8;>)?WEU=2?N;:'YVRQCCD^H/B-_P4
MC^)O[./B6S@\?^%+/3]$O)))$CMW,]T;4,5Q%>)=26DMQ#E&EC*1&0%<K;+/
M'(O[?:3JUOK]O%>6<L<]M/&DL,T3J\<D;J&1T=259&4AE920P(()!KX@\?\
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M ,%1_B)XO_X1#Q#HW_"+_P#%-_\ $N_XJ#^U;;_GYM)?^0?M^T?Z[_1OO?\
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MOW^K/U;4TT6WENI1(T<,;R.(HI)I"J*6(2*)7ED? ^6.-6=SA55F(!_(%?\
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MY9QZCJEA;S7FM6T]I)+:W%VUJ\EI9MY<H1@%>"XF8$$21O9AER/UOKX0\?\
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MG\:]1_:)\":7XGU6.WAO;[[7YL=LKI"/)NYX%V+))*XRL2ELNV6)(P, <_\
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MT/7?#UR_F66E7%I/:;F=FC^W"?S8EW,46(-;B5415_>RSNQ8R?+Y_P#L"_\
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MI?Q+J.H12%M!L[^VTY'N))%MVLIH--=XP-BA)5ENI3"5*(]R[?-*!*?W.K\
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M+4"*-Q&H9O*3[3'=$QD(2Y>7:1(';]3Z*_ '_@AC_P S=_W!_P#V_K[_ /\
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MJWF\?_P7._YE'_N,?^V%?O\ 5^ /[ O_ "<+X]_[C_\ Z>;>OO\ _P""H_\
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M+Y)2[N%9(66?1?L22!R-OE?:,PO-GRHV23>Z+'(5_;[XQ_'30_@99K<ZO/\
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M\S=_W!__ &_K]_J*_ '_ )N\_P _]"Y7Z_?M8_\ )//%?_8OZM_Z135\ ?\
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MC;)(RR-M965L$X92IY!%:'_!*S5K?4?A)HL4$L<DEM)J$4Z(ZLT4AOKB4)(
M24<QR1R!6P2DB/C:RD_.'_!3_6O^&A]3\/\ PB\.-;W.OW6H?;KG=/L6R2&U
MFV>?\C#YXI9K@JK&=8H%*P2?:8=WZ_>$_"UGX&TZTTK3X_)LK&WAMK:+<S[(
M84$<:;G+.VU5 W,68XR23DU^$/\ P0Q_YF[_ +@__M_7W_\ \%1_^20^(?\
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M".(2".)I!(\:O7T_JVDV^OV\MG>11SVT\;Q30RHKQR1NI5T=&!5D92596!#
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M+WQ'>?VA;Z_=W%K<1ZI:7LD%Q9M:1V\40M0 85P+<-ODBEE#R2,LBXB\K0\
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M\4_:+/Q#X_T^QLIK>1/.TZPAFN-SX7"G['8/#\I=A/%,)8W5=BY.]/N_X(?
M+2_@3;W"6<UY?WU[(LE]JFHSFZU"\:-=D(GN"%+)#'B*&-0J1H"0N]Y'?W"B
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOS0_X*!_LT>.OVM[*W
MT#1QH=II-K>)>"XNKR[-U-(L#1*/*CLFBA13-.&'F3F4>4X:'#QM]0?LM>$O
M%7PZ\-6.@>*(M+$FE6=M9V]QIUS<2K/' IB4R17%M"876-(@2LDPE<R.%@7;
M'7T?11111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111117YX?M@_\ !0/2_P!G2X_X1K1[>36?&%S&JVEA ADC
MAGF9%MUNMC"4O('\R*VA#32@(I,"3PS'C_ OP[_: ^*'G:GKWBC3_"7F[/(T
MNRTJTU+RMNY'\QYF?9NV),NVYNMWFL#Y&P1#C_CS\??B]^Q-I<E]K$.E^+M'
M$<D,6KQP26-U!=2E#!+J5M"6@%N'9X$2WV"4)$)+F">5%E^__P!FCQ^_Q3\%
M:!K4]S'>7-YI=G)=3QF/:UUY*BY!$0"*ZS"1)(U"B-U:/:I4J/<*********
M***********_*#_@E_\ M>>*/VJ?^$E_X262WD^Q7%I-:^3 (O*2\^TYMQM/
MS11^0OE&3?/\S^9-+\NW]7Z*********_(#_ (*E?&SXE?!325N]#NM/TW0+
MJXBL1<6[ROJ\DLUO</)DO"(;:+"$(T#-=))''*LZ>8T<?Z'_ +,FK7&O^!?#
M5Y>2R3W,^AZ9+--*[/))(]I$SN[L2S.S$LS,26))))-?$'Q1^%WQEU3XRZ?K
M&CZA(G@I)+(N@O42UCM43%[!/9'YIKB5O/\ *E\J8J9K<BXA\G_1OU/HHHHH
MHHK/U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!6A111111
M11111111117Y8?L,?"[XR^!_%6NW7Q#U"2ZTF:-Q")+U+F.>Z-QN2>RB7)M;
M<1^=F+;: B6!?LY\K$'ZGT444444445GZ3JUOK]O%>6<L<]M/&DL,T3J\<D;
MJ&1T=259&4AE920P(()!K0HK\L/BC\+OC+JGQET_6-'U"1/!2261=!>HEK':
MHF+V">R/S37$K>?Y4OE3%3-;D7$/D_Z-^I]%%%%%%%%%%%%9][JUOISPQ3RQ
MQR7,AB@1W56ED$;RE(P2"[B..20JN2$C=\;58C0HHHHHHHHHHK\L/VY_A=\9
M?''BK0KKX>:A):Z3#&@F$=ZEM'!="XW//>Q-@W5N8_)Q%MNP!%.OV<>;B?\
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M]^'/VB=.DU7PQ>?;K*&X:VDE\F>'$R)'(R;9XXG.%E0[@"IW8!R"![!7S_\
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M+^*NA_!O3GU7Q#?V^GV2;AYL[A=[*C2>7$OWY92J.4AB#RR;2$1CQ7QAJ?\
MP4C\/Z*@O[KP_P"+(=":2(#79-&=---O-(J178E:02FWD#H\9\KSG5E"PF1A
M&?K_ .$/QH\/_'K2UUGPU?1W]BTCQ&1 Z,DD9^9)(Y%26-\%6"R*I9&20 HZ
M,WB'[1?[=/@;]F+=!K-]Y^I+C_B6606>\&?*/[Q-RQP?)*LJ_:9(?-C#&+S&
M&VOK^OG_ /:%_:=\+_LOZ<FH>);OR?.\T6MM&AEN+IXD+E(8U_X"IDD,<$;R
M1K)+'YBD_$'QV_;QT/Q3X9U[P_JND>(/#=WJ?A_6ET]]=T\6,-W,EFX,$+F5
M\RG>NT$*K,5C#>;)#')S_P#P14_Y)YJ7_8P7/_I%8U]P?M!?M>>%_P!G"6VL
M=4DN+K5[[9]BTFP@-S?7.^585\N,%47<S$1^:\?G&.1(O,D0I7A^D_\ !3#P
M=#K,6A^(['7/"US<1I)"^NZ?]CC<22B),E996C0MO/GRK';J(I-\RE<'[_U;
M5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!7RAX _;I\#?%#Q
M#?\ A[2+[[1_9FGW%_>:CA8].BBMIEAF'VB1DW[=ZR^<BM:M"=ZW!P0/F_4_
M^"POPRL-4&GQG5)[8R1(=1CLP+4*X4M(4DECN]D>XB0"W+DHWEI("A;]/])U
M:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$@UX?^T+^T[X7_9?T
MY-0\2W?D^=YHM;:-#+<73Q(7*0QK_P !4R2&."-Y(UDEC\Q2?F#4?^"G/A?P
M?>6MMXGT3Q1X;BN_-\JZU;23!"?*4,V!'++,_+(A\J*3:TB%]J$L/T/TG5K?
M7[>*\LY8Y[:>-)89HG5XY(W4,CHZDJR,I#*RDA@002#7@'QO_:F\/_ JXM],
MNEO-1UN\C:6ST;3+9[S4+B-&P[I"F%5%422;IGC#I#-Y9=HF4>/_  O_ ."B
M/@[XA^(/^$5O8=4\/ZVTD,4-EK5G]DDFDF0R(B[9)5C<KLV+.83,98EA$K/@
M?=]%>?\ Q+^*NA_!O3GU7Q#?V^GV2;AYL[A=[*C2>7$OWY92J.4AB#RR;2$1
MCQ7QAJ?_  4C\/Z*@O[KP_XLAT)I(@-=DT9TTTV\TBI%=B5I!*;>0.CQGRO.
M=64+"9&$9^O_ (0_&CP_\>M+76?#5]'?V+2/$9$#HR21GYDDCD5)8WP58+(J
MED9) "CHS?BC_P %;/VH_"'Q0\/)X4TC4/M&M:9X@'VRV^S7,?E?9H;RWF_>
MR1)$^V5U3Y';=G<N5!(^O_V3OV]?AQ_PCWA3PI_;/_$Z_L_2=-^S?8KW_C\\
MF&W\KS?L_E?ZWY-^_P O^+?MYK]/Z\O^+WQH\/\ P%TMM9\2WT=A8K(D0D<.
M[/)(?E2..-7ED? 9BL:L517D("([+^$/P1_X*)^'_$OQCU;QKXEN)-+T1]#?
M3-+26!YY$C2ZMI41Q:0R-OD9;BX;=Y@B+F$3.J1D_K?\7_BEH_QI^$OB/7M!
MN/M>FW?A_6_(G\N2+?Y5O<PO\DR)(,.C+\RC.,C*D$_GA_P2R^-'A_X"_"C5
M-9\2WT=A8KXDFB$CAW9Y)+.QVI''&KRR/@,Q6-6*HKR$!$=E^K_@7_P5*\ _
M'G7(/#]LNH:==W?RVSZA%!%#--D!(%>*XFQ+)D^4'"+(P\M6,KQQO^C]?*'Q
M>_;&\/\ PHU1M @MM4U[78XTFGTK1;)[ZZM[=QQ/. 4BC3)C!5I!-B>!_+,<
MBO7/_ +]O+P=^T'JDV@6K7FF:[#)/&=*U2W^S73&W \W:%>2(NI+AH/,%PHB
MF=H1'&7K[/HK^8'_ (*M_M1^$/VE/^$<_P"$4U#[?]@_M+[3_HUS!Y?G_9/*
M_P"/B*+=N\J3[F[&WG&1G]O_ (6_MZ_#CXTZQ;Z#H.L_:]2N_,\B#[%>Q;_*
MC>9_GFMTC&$1F^9AG&!EB 3Q_P#MT^!O 7B&P\*?;OM^M7^H6]A]FL0L_P!F
MEGF:WS=2[EBB\N5=DT.]KI-RM]G*G->'^-?^"LWPR\&:RND+<WE]'Y@CFU"S
MMQ)9PMYK1N2[2)+,B!?,,EK'<))&RF)I6.T?5_[0O[3OA?\ 9?TY-0\2W?D^
M=YHM;:-#+<73Q(7*0QK_ ,!4R2&."-Y(UDEC\Q2?F#4?^"G/A?P?>6MMXGT3
MQ1X;BN_-\JZU;23!"?*4,V!'++,_+(A\J*3:TB%]J$L/N_4_'EAIVEC64>2[
ML7CBECDL8)K]I8YBOEO#'9I-+,C!U;=$K@)F0D("P\0^"G[9G@3]HG49-*\,
M:I]NO8;=KF2+[)=PXA1XXV?=/!$APTJ#:"6.[(& 2._^,?QWT'X!6:ZAXBFN
M+:R.=US'8WEU#'AD0>=):P3)!N:1%C\XIYC$JFXJP!\%/CWX<_:)TZ35?#%Y
M]NLH;AK:27R9X<3(D<C)MGCB<X65#N *G=@'(('/_M"_M.^%_P!E_3DU#Q+=
M^3YWFBUMHT,MQ=/$A<I#&O\ P%3)(8X(WDC626/S%)^(/CM^WCH?BGPSKWA_
M5=(\0>&[O4_#^M+I[Z[IXL8;N9+-P8(7,KYE.]=H(568K&&\V2&.3D/^"-6I
MIHOPTU>ZE$C1PZY>2.(HI)I"J6-DQ"11*\LCX'RQQJSN<*JLQ /V_P" _P!M
M_P  _$KQ GA73-3D?6WDGB%E+I]_;R+);H\DR/\ :+:-8W18WW+(5(*E<;L
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M_BS5]$BC>4:S9:,YT]XXE)F=9KB2!@D+*\<K2(@5XWY*@,?I_P""'[2/A/\
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M9TK5+?[-=,;<#S=H5Y(BZDN&@\P7"B*9VA$<9>O3_P!K'_DGGBO_ +%_5O\
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MU3Q#K5U;1RZCIL=A'93N"6@6[%V)S&"=JNZQ(ADQO";XU8)+*K_N=K]EX>^
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M%JMY;V!MU\PB-=06*XL,*]QAWM9)T@-Q*97-NURZIYDNT?9__!:O_DGFF_\
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MQ;HU]!C2-/N-8F738<16<ZVNK0K!;7$" )+:1L8YA;$"(R00[E:-6C;]+_\
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M^"=^DV^@?'WQO9V<4<%M!'KL4,,2*D<<::Q;*B(B@*J*H"JJ@!0   !7ZO\
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MY)-?H]^R=_R3SPI_V+^D_P#I%#7Y _L"_P#)POCW_N/_ /IYMZ^__P#@J/\
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M??#\VLRV\E]<F2*VL-/A91<7UY<.(X+: '+,[,=S"-99%A2218I"FP^X45\
M>-OV8OAK_P % =#L_%$EIY<NI6\4\6IV;Q0WRY$0:*X>/SH9I8A#]ED2X%Q]
MG*RQQF-P6'Y(?!2V\8_\$[/B]I?@NZO9+O1M6O(8Q!'/LM;NWU&06D5Z8&\T
M07$<D:&0868FW:W6=K:02R?=_P#P6K_Y)YIO_8P6W_I%?5]__LG?\D\\*?\
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M%Q_[?7_)PO@+_N ?^GFXK]?OVL?^2>>*_P#L7]6_](IJ^ /^"*G_ "3S4O\
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M;!BATV;Q%;Z;HMM<"YAM8]),TS3"+R@\URU\F_;OF\M8HX%"RE9!*R)(/?\
M]G#X6:Y\%M#MM U?5[?5[>PMX;:RFCT\V4R0PAE5)B+J>.7:GE1QLB0L%C)D
M,TCEQ\0?&?\ X)V^*/CAXMM/&E]XRM[?5-/^R_81;: %AMOLDAFBV)+J$I?]
MZSRMYS2Y9RO^J"1K^G_A:VU&TLXTU6>WN;T;O-FMK=[6%LL2NR&2>Y=,+M5L
MRON8%AM#!%_*#]M?_@E99_'W49O$?A2YM]*U>X^:[MID86=W,SKNG+Q!GMY2
MID:4I%*MQ($8K%(TTTF!\-/^"8WB;QSL_P"%L>+=0UNR@N%FBTF#4+R>W=DV
M[9)9[O:Z[E:>%TABCE".'2[0EDK]GJ_.#_@J;X6L_'/P_32FC\[5[[6-,MM"
MBW,F_4IIO+";LK$NZV:Z&ZX*PC.<B3RS7V?\%/A?;_!7PUI?ARU\MH]-LX;<
MR1PK LTB*/-G,:E@KS2;YI/F8EW8L[,2Q]0HK\\/^"AG[$MQ^V+I>GG3+R.T
MU;2I)C;+<;A:RQW)B$ZRM&DDJ.!"CQ.JN,JT;1_O!+#V'[,7[/GC3P;]DO\
MXA>)/[?O;"W>&QM4AC^SVC-^Z:Y-RT4=Q=W;0*L:W,RI+$D][%NF%R\C>?\
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MWMQ-<-<0V*-'&20CW)$4)3[ ^!O[-=[^SQX:.CZ3KMY?:B8[5$N]8,]]:P+
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MS%^P+JWA+4;3Q'\2=>N/%&KZ?O;3;:>XN+JST^9G^:>)[IM\LI5(60F*%89
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M"OPA_P""+OBF\\<ZCXYU74)/.O;ZXTRYN9=JIOFF?49)'VH%1=S,3M4*HS@
M# K]?OBS\ ?"_P =?L7_  DNF6^H_P!G7 N+7S@?D?C*G:1OB?"^;!)O@FV)
MYD;[%QV'C7XA:-\-;=;S7-0L]-MGD$237EQ%;QM(59@@>5E4N55F"@Y(5CC
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M?$*]U33M&U"?0X8[G5H[.X>P@E($<MTL3&"-R7C 1I JL2\8 )^=?O#\H?\
M@F[^Q_;W?AK4-9^(OAR.YUW4]4GE\S6[5;BZ:W54P[1W8=X7>=KEG9ECFG!2
M1S)'Y#5\O_LU6UO^SW^T?=^#O"%[(/#EU)<0W-L)UN(V,6G27?D,QW?/:7(>
M%&)-Q$$DADD8O/YGU_\ \%4_V<O#&H^#-:\<3VDDGB&VCT^*"[>[NF6*,WMO
M"4CMS,;=$*22958P"\CRX\UF<\A_P3>_8S\">,/!/ASQI?:7YNOI<3W*W?VN
M[7$UIJ$ZP/Y23K#\@BC&TIM;;\P;+9^3_P!J7X:/\,/C[X,@EU75-8DN[S1;
MMY]3GCFDC:76)0881%%#%#;J4W1P1HJ1EWV@*0H_I.K\4?[>O?V^?B]K/A/4
MWO!X#\,QW,%UIR>?!!?744B0!;R:VN%RYN5>YM-S$>39 +;I(]R]?9_QT_X)
M\> ?C+H<^E6VD:?HUVWSVVH:?8P030S*"$+")8_.B.2)8'(5U.5:.58YH_B#
M_@EA^TOK&GZC?_"GQ?-_I^D>9'IJRO&SI]C=HKJP\X2GSO*P'MDC639!'<?O
M1;PPHGR?^VE\--4^&'QL\+P:;JMYK&K7<FE7=K/KLXFCCNI=4G$4)%K%"(;)
M9$5O(@11&'D\L#*J/T_\?_\ !+SPG\4]+N7UJYO+SQ;>1EI_$DDLOFM=9!$@
MLA*+1;=<"&.U1%$=JJPI*LBK./G#_@B7\2]1\0:'KOAZY?S++2KBTGM-S.S1
M_;A/YL2[F*+$&MQ*J(J_O99W8L9/E_;ZBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBOP!_P""&/\ S-W_ '!__;^OO_\ X*C_ /)(?$/_
M '#O_3E:4?\ !+C_ ))#X>_[B/\ Z<KNO@#]OK_DX7P%_P!P#_T\W%?O]7X
M_P#!#'_F;O\ N#_^W]?1_P#P6>TFXU'X<VDL$4DD=MKEK+.Z(S+%&;:[B#R$
M A$,DD<89L O(B9W,H/UA^P'XZ_X6)\+_#-[Y/D>5IZ66S?OS_9[M8^9G:N/
M,^S^9MP=F_9N?;O;0_;ITS2]6^&7B>/6#&+8:7<2(9)3$OVJ(>99 ,&7+FY6
M 1QY(E<K$5</L;Y/_P""-OA:\\/_  UEN;F/9%J&L7=S:MN5O,A6*WM2^%)*
MXEMYDVN%;Y-V-C*S?,'_  0Q_P"9N_[@_P#[?U^_U?@#^P+_ ,G"^/?^X_\
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MQ-'K5P+KR[!+IHB78M%O8P)YA\O!!;:JY&/V._X8%_ZGWX@?^#__ .YZ\_\
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M7L;BVD$K-)*L;JGT!^V1^V8_[.EQI7A[0["/5O%&O2&&PM'N8X8X6D80P2W
M+!RDD[JD:$PI*([C_283%S\__&_]I_XS_LGV]OKOBK1O#>KZ%YC1W9T9[^.2
M!F7;"99;G>(4>1E D\B9"5\EFBDFA+??_@#XSI\;_"=MXH\(11W:WT8>VAOI
M9+)=RRF*>.:2."Z9'B9)5S'',CN@"N8G$U?*'[*W[?%Y^T3XRU3P7J'A[^QK
MW2;>ZDN6_M%;S$UK<PVLD.$MXD.&E)\Q7=3LX#!@P^G_ -H_XIZY\%M#N=?T
MC2+?5[>PMYKF]ADU V4R0PA69X0;6>.7:GFR2*[PL%C C$TCA!P'[%7[5O\
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M6K),+<NZ0-^($WQH^(>M_M!VE_J?A^.?Q'I\<]O9^'X[ZUA6*U>PN)HXC?\
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MOB>GPPUGPU'IU]YDZ2746JB[C"QV;WD<B+]CA+I+&J%0S1N@D&]%=6C'U?\
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M'!\DN)+;9(\4R$?:'7BOT/\ '_C_ $OX6:7<ZUK5S'9Z=9QF2>>0G:JY
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M/!&J17-M))]B2PT^[AC>.*W:6:2\%R96L[>%A&'NW9A*)V\FWD-G=$'[//\
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MO^T_Z-YWG^7Y%S+;_P"M\N+=N\K?]Q<;MO.,GP#]J7]M[_A4FL6O@OPEI_\
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MBQOD;4='1U9-GE2R_E!X_P#'^E_"S]JBYUK6KF.STZSC,D\\A.U5_P"$<
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MM:T6YCO-.O(Q)!/&3M9<D$$$!E=6!22-PKQNK1NJNK*/PQ_X(8_\S=_W!_\
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MPOCW_N/_ /IYMZ_7[]K'_DGGBO\ [%_5O_2*:O@#_@BI_P D\U+_ +&"Y_\
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M]E_XV?M9Z-!H>N3^"X+:"\2\1[-]420R)%+$ 3+%,NS;,Q("@Y"_, "#]_\
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M8S(WRES(8X5=V2WB+$$PVXBB.R,%,11A/R!_;Z_Y.%\!?]P#_P!/-Q7[_5^
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M_P"GFWK]?OVL?^2>>*_^Q?U;_P!(IJ^ /^"*G_)/-2_[&"Y_](K&O /V^O\
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M ."POC6X\*_#(V<"QM'JNJ6=G.7#%EC02WH,9# !_,M8U)8,-C.-NXJR\_\
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M/]+\,_##P=I=Y<QQ7VJR:O'8VY),D[07E[<3%5 )"1QH2\C812T:%M\L:O\
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M'(%;!*2(^-K*3^A]%%%? '_!4?\ Y)#XA_[AW_IRM*/^"7'_ "2'P]_W$?\
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M_:@TY-/\2VGG>3YIM;F-S%<6KRH4+PR+_P !8QR"2"1XXVDBD\M0/G#X#?\
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M_P!XU]X8L;C3Y7QYJQZEJ#0S;5=%\Z"2Z>&;8)',?FH_ELQ=-KX8<_\ $O\
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M ,:_V7_"O[1/EKXGM;B^BAVF.W_M"^AMPR>9MD^SP7$4)E E=?.*&4HVPOL
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MPO\ !N\;5XX[C5=?DQYNN:M.;[4GVJ\:XGD&(L1/]G/V=8O,A5$D\S:#7?\
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MZK#,F]2C;)([Q77<K,K8(RK%3P2*]?\ C7^R_P"%?VB?+7Q/:W%]%#M,=O\
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MB=0ATW]V$1=6U'SH5B$82."Z-T;FWB41(HAADCB"[EV;9) W@'A;_@G)\,?
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M#;AD\S;)]G@N(H3*!*Z^<4,I1MA?8 H/@I^R_P"%?V=O,7PQ:W%C%-N,EO\
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MCWX<_:)TZ35?#%Y]NLH;AK:27R9X<3(D<C)MGCB<X65#N *G=@'((' ?&/\
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M75]:7-I+;26+02P0R6UR)0H^T+)/L*PF9 8I<R#]WYGU?17S_P#&O]IWPO\
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ME?\ 'Q%%NW>5)]S=C;SC(SZAX_\ '^E_"S2[G6M:N8[/3K.,R3SR$[57(
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MBGF,2J;BK 'P4^/?AS]HG3I-5\,7GVZRAN&MI)?)GAQ,B1R,FV>.)SA94.X
MJ=V <@@<!\8_VR?!/[/]XMCXGOKC3Y7SY32:;J#0S;51V\F>.U>&;8)$$GE.
M_ELP1]KY4>WZ3X_TO6M&B\0Q7,:Z3-9I?)=RDPQBU>(3"9S*$,:>6=[>8%*#
M.X+@X^4-)_X*(_#K7-6U/3;;4]]OH^GS7][J03%BBPW"6K11R$B2XE9Y8_)^
MSQRQ7 D1899)&"'G_@=_P4G\#?M ^*!X4T@:@MW+]H^RW$]LJ6]U]G#.?**R
M/*FZ)'F3[1%#\B%6V2E8V^_Z*^(/%/[??A>RO)+'P[::QXNEM]OVMO#EB=1A
MM?,4/%YLZND+>:-X3R7EPT4J/L=-IZ#X'?MR^"_CSJ(T.RN+BQU\?:!)H^HV
MTEK>1-;.R2QMD-"TJA3(88Y9)5C#,R+Y<HC[_P"-?[4'A7]G;RV\3W5Q8Q3;
M1'<?V??36Y9_,VQ_:(+>6$2D1.WDEQ*$7>4V$,3X*?M0>%?VB?,;PQ=7%]%#
MN$EQ_9]]#;AD\O=']HGMXH3*!*C>2',I1MX38"P\P\:_\%!/AU\-;A;/7-1O
M--N7C$J0WFC:M;R-&690X26R5BA964,!@E6&<@X^K_"WB6#QA9QWULEPD4N[
M:MS:W%I,-K%#O@NHXIDY4E=Z+N7#KE&5CX!:_MB^#KG7+/PRT^H0ZU?[3:V5
MQHNK6\TBL6'F!9K-,1#9(7F;$2+'(S.JHY7G_'_[=/@;P%XAL/"GV[[?K5_J
M%O8?9K$+/]FEGF:WS=2[EBB\N5=DT.]KI-RM]G*G->7_ !Y_X*>_#[X!ZI)H
MUQ+>:G?6\DD5W'IT*2K;2($RDDDTL$3/EBI6%I3&\<D<HC==I^K_ (%_'30_
MVB]#@\0>'Y_.M)OE=&PLUO,H!>"= 3LE3(R,E64K(C/$\<C>P45\0?$/]OOP
MOX-UR;PUI=IK'B75[3S?MMKH5B;UK3RC&K><2\2'#2B-O*:7RI5:*7RI %;0
M^ 7[>7@[]H/5)M M6O-,UV&2>,Z5JEO]FNF-N!YNT*\D1=27#0>8+A1%,[0B
M.,O7V?7Q!\0_V^_"_@W7)O#6EVFL>)=7M/-^VVNA6)O6M/*,:MYQ+Q(<-*(V
M\II?*E5HI?*D 5M#X!?MY>#OV@]4FT"U:\TS789)XSI6J6_V:Z8VX'F[0KR1
M%U)<-!Y@N%$4SM"(XR]?7^K:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!
M9F8@* 22 *_/"Z_X*<^%[N*\OM&T3Q1K>D6.[S]6T_22]BNR)9I=TD\L#Q^4
MK@R^<D>T#?S&5=OI_P#9Z_:=\+_M0:<^H>&KOSO)\H75M(ABN+5Y4#A)HV_X
M$HDC,D$CQR+'+)Y;$>@?$OXJZ'\&].?5?$-_;Z?9)N'FSN%WLJ-)Y<2_?EE*
MHY2&(/+)M(1&/%?&&I_\%(_#^BH+^Z\/^+(=":2(#79-&=---O-(J178E:02
MFWD#H\9\KSG5E"PF1A&?K_X0_&CP_P#'K2UUGPU?1W]BTCQ&1 Z,DD9^9)(Y
M%26-\%6"R*I9&20 HZ,WB"?MY?#W^W(/#,NI7%OK5Q<6]M'97.EZG;3>=<E!
M"CK/:1^7O\Q"K2;5VL&)"G-?3_BGQ+!X/LY+ZY2X>*+;N6VM;B[F.Y@@V06L
M<LS\L"VQ&VKEVPBLP\ ^"G[9G@3]HG49-*\,:I]NO8;=KF2+[)=PXA1XXV?=
M/!$APTJ#:"6.[(& 2-#]H']K/P=^S+;F7Q'J,<5R8_,AL(OWMY."LA39 IW*
MCM$\:SR^7;B0!'F0FO+_ (K?\%"/ WP;T/2]:U2>X\W6=/MM1LM,BB62^>WN
M!&59T#^3%@.<F69$D,4RQ-*\96N@_9:_;?\ "7[7'VJ+0GN+>]L\-)97J1Q7
M!A.T">-8Y94>+<WEL58M&^T2*@EA,GC_ .W3_P % -#_ &:M.OM&T^Z\_P 7
M/;A;:VA4-]C:X1O+NKAW1X5\H8F%NP>67=#F)8)C,O@'_!-[]LSP)X/\$^'/
M!=]JGE:^]Q/;+:?9+MLS7>H3M GFI T/SB6,[B^U=WS%<-C]GJ*^8/C'^UYX
M7^#=XND227&JZ_)GRM#TF WVI/M5)&S!&<18B?[0/M#1>9"KO'YFTBO']%_X
M*2>"TU%=*\20:QX4O9?(-O%KVG26GG+.[QB161IDCB5D(>:X,,2\D.0DA3[O
MU;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!7QAI/_!1'X=:
MYJVIZ;;:GOM]'T^:_O=2"8L46&X2U:*.0D27$K/+'Y/V>.6*X$B+#+)(P0\_
M\#O^"D_@;]H'Q0/"FD#4%NY?M'V6XGME2WNOLX9SY161Y4W1(\R?:(H?D0JV
MR4K&WW_7P!^W?^U'X0^%_A[7/"FKZA]GUK4_#]]]CMOLUS)YOVF&XMX?WL<3
MQ)NE1D^=UVXW-A2"?S@_X)?_ +9G@3]G;P;>Z5XGU3[#>S:Q/<QQ?9+N;,+V
MUI&K[H()4&6B<;20PVY(P03^_P!X3\4V?CG3K35=/D\ZROK>&YMI=K)OAF02
M1OM<*Z[E8':P5AG! .17S!\2_P!MSPOX"U%]%T^/4/$FM0[C<Z;H%J=1N+9$
M=HI'N-C+%%Y<JB*6-I!.CR19BVN&KG_AI_P4%\%_$#6$\.7G]H:!K\MPMO'I
M>LV4EI<,SQK+$<@R0IYH<+"DDJ2ROM58SYD7F?3_ ,2_BKH?P;TY]5\0W]OI
M]DFX>;.X7>RHTGEQ+]^64JCE(8@\LFTA$8\5\@1?\%,?AT?#USXFDN[B*RBU
M"[T^UC>#_2+^:UACG+6L*LS^4ZRQ!9;G[.L;R(L_D%USZA^RM^V3X:_:^M[Z
M?0$O(9-.DB2X@O(5CD"S*QBD!BDFB9',<B@!]ZF-MR*K1L_U?7XP_P#!2S_@
MH!H?AC0]4\#>';K[7KMWYEA?O$H,-E"0HN8W>1&CEED1GMC'"2T#&9GDAGA2
M-_?_ -BG]LSP)XPT7POX+L=4\W7TT>SMFM/LEVN)K2Q5IT\UX%A^012'<'VM
MM^4ME<_$'_-WG^?^A<KZ_P#B7_P5S^&OP[U%]/@;4-7\K<)+G3H(GMPZNR,B
MR3SV_FXVAA)")('1U9)7R0OZ'^ /'^E_%/2[;6M%N8[S3KR,203QD[67)!!!
M 975@4DC<*\;JT;JKJRCR_\ :%_:=\+_ ++^G)J'B6[\GSO-%K;1H9;BZ>)"
MY2&-?^ J9)#'!&\D:R2Q^8I/S!J/_!3GPOX/O+6V\3Z)XH\-Q7?F^5=:MI)@
MA/E*&; CEEF?ED0^5%)M:1"^U"6'V_XI^*NA^"]#D\37]_;Q:+%;K<F]#AX6
MA< QO&R;O-\S<HA6/>TS.BQAV=0?P1\4?\%$_#_Q'^->@:[/<26G@_P]'J,$
M-Q) [M+)<VD\4ET(HH6N%29_L\4<3[RJ1K*R0O)-&G[G?!3X]^'/VB=.DU7P
MQ>?;K*&X:VDE\F>'$R)'(R;9XXG.%E0[@"IW8!R"![!7/^*?%FG>!K.34-5N
M[>QLH=OFW-S,D,*;V"+ODD*HNYF55R1EF"CD@5\(:M_P4C\/PV\NIZ9X?\6:
MOHD4;RC6;+1G.GO'$I,SK-<20,$A97CE:1$"O&_)4!C]/_!#]I'PG^T?;W%U
MX5U*._CM)%CN (Y89(V==R%HITCE", VR3;L<I(JL6C<+^>'_!4?]J/PA_PB
M'B'P'_:'_%2?\2[_ $+[-<_\_-I=_P"N\K[/_J?WG^L_V?O_ "UP'[!7[>OP
MX^"WPXT;0=>UG[)J5I]M\^#[%>R[/-O;B9/GAMWC.4=&^5CC.#A@0/V^HKY
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M26S0QIY9\UI)-J)#F5F6,%A[_P"/_'^E_"S2[G6M:N8[/3K.,R3SR$[57(
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ME^UMJ-UI6B1:A;7MK;BY,5[!&GF0AUC=XVAFG3Y&>,,KE&/F*4#A9"GV_7Y
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MJ@!0   !7['?M8_\D\\5_P#8OZM_Z135\ ?\$5/^2>:E_P!C!<_^D5C7(?\
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M.'[8OP]T;X:_'WP+9Z'I]GIML\F@RO#9V\5O&TAUB=2Y2)54N555+$9(51G
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M7J'[2WC6W_:0^._AKX:WZR'1-&D-Y>6[!?+N[P63Z@@EC=I89K<1)##AXDD
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MMY46S]?O!7P]T;X:V[6>AZ?9Z;;/(97AL[>*WC:0JJERD2JI<JJJ6(R0JC.
M,=A7Y ?\%J_^2>:;_P!C!;?^D5]7W_\ LG?\D\\*?]B_I/\ Z10U^(/Q2^&]
MG\7?VI;C0]0>X2RN_+6Y%O,T#RPKH"/) TB8<13JI@G"E6>"21 RE@P_7_\
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MSD2.B^5]?Z3^W);Z!;Q6=G\/?'D%M!&D4,,7AU4CCC10J(B+<!515 554 *
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M6!(81+$AD_X^4;>J[?,Y_P#YN\_S_P!"Y7Z_?M8_\D\\5_\ 8OZM_P"D4U?
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MM51MN4-LLT[RH)D):.,O"\;++^2'_-WG^?\ H7*_7[]K'_DGGBO_ +%_5O\
MTBFKX _X(J?\D\U+_L8+G_TBL:_7^OG_ /:Q_P"2>>*_^Q?U;_TBFKX _P""
M*G_)/-2_[&"Y_P#2*QH_X+5_\D\TW_L8+;_TBOJ^_P#]D[_DGGA3_L7])_\
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MYBR:S>7&I"*2%HFBC<1V\6-Q)D26.W2XCDPH9)EVAE =_C#_ ((8_P#,W?\
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M"V^&.>V=\KN5<2IM8ACN"E&_,#X,?\$[?%'P/\6W?C2Q\96]QJFH?:OMPN=
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M2]%USQ!ISVWA[4;?2KV3<OVN>R-]Y:LC+NBB^T6Z"56*.C2F6+Y2KP2!OE^
M/V0/^"?VN?L=ZC<7.E^*+>[LK_[.M]:3Z,1YBP.65HI5U#?%*%>5$8B2(>:6
M>"4JFWT#]LW]CC7/VP8H=-F\16^FZ+;7 N8;6/23-,TPB\H/-<M?)OV[YO+6
M*.!0LI602LB2#W#X#?"?Q+\'/#4?AZ[UJSU-K&SCM=,NCI36[0K$KI%]JC2^
M9;E$7R458S:NR1'?*\LAE7XO_P"'=OBC_A8'_"R?^$RM_P"W?M'G8_L ?9]G
MD_9OL_E_VAN\K[/_ */G?Y^SY_.\_P#>U]@?M*?LQV?[5/A+_A'-?GVW:^7/
M#?6T;1K%?1QL@G2W:5\Q'?(K6\DKGRG*B82A)U^$/V5?V&?BE\*DB\/Z]XKC
M@\'QR-</8Z3<3BZDD\Q)/(CNWMH+BSMY'4O/]EF4N#*BHKW,DZ\?X _X)@>+
M?A%XYO\ 4/#'B"WT?PSJ'VBWD:U\QM4BTVX996M8//AF2.561(8[P3F9 @N@
M-^;<_;_[6?[&5G\?_ -OX-TJ;^SO[)^SR:3N+20JUI ]O##.S;Y3$8G9#("T
MJ-ME(FV-%)Y?^R9^R/X\^'-OIUGXY\31ZCI.C2;M/T6VB66W+1*/LLEQ=SP1
MW$J6[L[V]J5*030V<T<J_9XXDX_XS_\ !.WQ1\</%MIXTOO&5O;ZII_V7["+
M;0 L-M]DD,T6Q)=0E+_O6>5O.:7+.5_U02-?T_\ "UMJ-I9QIJL]O<WHW>;-
M;6[VL+98E=D,D]RZ87:K9E?<P+#:&"+^:'[3'_!.NX\5^)8_'OPZU*/P]XHC
MD\Z161A:W-P64/.S(',+O&THN5\F>&\)"R1J9+B67T#5OA1\8_C7;RZ'XLU;
MPWI&B74;QWKZ%;75Q>75O*IBFM =1!A@26*20_:45YHI$CVHREQ7T_\ "'X#
M:7^SUX:7P[X4CCM%CC<I//&9VENF7'VJ["/ T[LP4NJO"-BK#&88DC5/A#_A
MW;XH_P"%@?\ "R?^$RM_[=^T>=C^P!]GV>3]F^S^7_:&[ROL_P#H^=_G[/G\
M[S_WM?:'QY^$_B7XQ^&I/#UIK5GIC7UG):ZG=#2FN&F65427[+&]\JVR.OG(
MRR&Z=4E&R5)8Q*WA_P"QE^QQKG['T4VFP^(K?4M%N;@W,UK)I)AF68Q>47AN
M5OGV;MD/F++'.I6(+&(F=Y#]_P!>/_&;P=XA\=Z=+I^@ZM;Z1]IM[F">Y>RF
MN;A/.38DMK)#?6?D2QY9E=A-\^Q@%V$/^>'[,_\ P3;\2_LH:I)J?A[QG&5G
MC\NZL[C16>UN% ;RS+&FI1MOC9BT4B,CH2R;C%)*DGZOZ3'<0V\2WDD<MR(T
M$TD4;11O(%&]DC:25HT+9*HTDA4$*9'(W'\H/&O_  3KUGX7>,5\<?"/4K/1
M[F20?:=(O$E73WC?<UQ&&@$C?9Y&6+%IY8$3[I8+B Q6\<7J'BG]G+XE?M-V
M<FB?$76-'T_0'V^?9^'+>5IK[:PEC\VZU)9#;>1+%"Z>0C^<K2QR;?D8?9^D
M_#=/AQX?BT+P@MGI4=I&D=F);:2YMXE#AG+Q)<6\LKN"Y:0SJ[3.9I&D;<'_
M #P^#'_!.WQ1\#_%MWXTL?&5O<:IJ'VK[<+G0 T-S]KD$TN](M0B*?O525?)
M:+#(%_U1>-OU?HHK\D/VOO@-I?[0?QC\%V$<<<EW96<VHZX)8S+&VDVMU&UI
M&\4KK#(D]P;FV81AY5$QDEC>%$%?K?6?JVDV^OV\MG>11SVT\;Q30RHKQR1N
MI5T=&!5D92596!# D$$&OR0T#]@'QE^R[XHN-=^$VL:?'IM]Y@N=&UG[2;=4
MP#"GF0"62X\MVE:&1O(GA0+$TMPLMP9/8-?_ &2O%O[4/V>/XL:IIYTNSN(Y
MXM$T"&2*WFFBR%GN+V[#7GSQRSV\MO#Y2[/*E29)0U??_P#PB>G?V=_9'V2W
M_LW[/]E^Q^2GV?[/L\OR/)QY?E;/D\O;LV?+C;Q7XH^&_P#@FY\3?V:-9N[K
MX7>*[.WL;V/;(-00K)M65VCCDB^RWEO,\:;=MT%A?,DRK%$CL']?_:&_X)F7
M'Q?T:WA&M2:CXCGU2UGU/7=6+/)'9I%<">WTZWB39;VXFN&N(;%&CC)(1[DB
M*$I]@? W]FN]_9X\-'1])UV\OM1,=JB7>L&>^M8%@5$\JVL$N;=;>WVB3RXX
MY0Z%T$DTZ0QH/D_X,?\ !.WQ1\#_ !;=^-+'QE;W&J:A]J^W"YT -#<_:Y!-
M+O2+4(BG[U4E7R6BPR!?]47C;]7Z*X_Q_P" -+^*>EW.BZU;1WFG7D9CG@D!
MVLN00000RNK /'(A5XW59$9756'Y8?";]BKXG?L?:C>Q?#O7-'O] OLR&RUY
M;I/)FWD*ZK9JP:58ECC>X1H%N,D/:CR8"GN$7[&>J?'75+#Q!\6;^SU2;39&
MDL=#TZV$6DV[. L@DDG5KN]27R;><QS-&B2K)"5FMW*']#Z^(/VV_P!C*S_;
M!L](AEF^S7&FZA'(TP+!FL9F1;^&,_/&DK(B2PR212@2P)&0D<LCC[/TG2;?
M0+>*SLXHX+:"-(H88D5(XXT4*B(B@*J*H"JJ@!0   !7Q!X]_8JM_&OQ9T?X
MCE[,6UA9LMU9M:JTEQ>1"1+2X+YVLZ+*K"5P9(#96RIO#AK;[OK\H/C/_P $
M[?%'QP\6VGC2^\96]OJFG_9?L(MM "PVWV20S1;$EU"4O^]9Y6\YI<LY7_5!
M(U^__$?ASQ;JNABSM-8T^SUIO,6745TF22%582!6@LY+\[)4S&P:::YB+(VZ
M K($3X@_9 _X)_:Y^QWJ-Q<Z7XHM[NRO_LZWUI/HQ'F+ Y96BE74-\4H5Y41
MB)(AYI9X)2J;?T_KG_%GA:S\<Z==Z5J$?G65];S6US%N9-\,R&.1-R%77<K$
M;E*L,Y!!P:_%'X<_\$W/B;^SCXEO)_ 'BNST_1+R2.-Y+A#/=&U#!LRV;VLE
MI+<0Y=8I \1D!;#6RSR1KT'[1?\ P2^U[5_$ND^*/ >KQIJ-E':O<W.MW5U=
M74M]9,I@O6FDCNUE=E5%>'RX;>,0($C*2%(_T^^%7P0M_ .C76FZG<2:W<ZI
M)+/K-W>JKB_N)XDAF+6YW0Q6_E1I!%:QCR8K>-(OG(9W_('XH?\ !(37O"?B
M#^VOACKL>F1F29XH[B>ZMKBQ5T"^7!>6ZS2S(P>9,N(G2'9&[W#,\E?9_P"S
M%^P++\+M8M/&'C'7M0\2>*K6W>&":>XE>WM%ECVO'$9F>:;89+E4>1HXF2<O
M]DCF <?7_P =/@7H?[1>AS^'_$$'G6DWS(ZX6:WF4$)/ Y!V2IDX."K*6C=7
MB>2-OQ1\,?\ !)_XE_"K5)8?"_C*.PTFXDMQ<75M<7UE=21H/F9[2WW12/$7
ME\E&N<.#DR0^8P7]7_V5OV2-+_9:M[Y[>[O-3U;5Y(I]5U&\D+27,Z*Q+!.0
MB&22:4;C+,3,PDN)MJ%>/_;-_87T/]L.SA:>3^SM:M,+;:G'")6$.[<\$T>^
M/SHCEFC!=&AE)=&"O-'-Y?X \!?M">'-+MM#N]8\)R1QQBW?5Y%U"ZU)(R2O
MGA7CAM[BXB0@Q^>H$S(OGN[-)(WT!^SC^R)HW[/5QJ&L"634O$>L2--J>K7"
M1))+)*PEG2"*)52VMWFW3>2FXY**\LHAAV>/_MZ?L%V_[8EO:7EG=QZ=K>G1
MSI#,\"O'<QNNY+>X=<3*BR@-'(ID$ DN"+>5I?E\_P#A?^R%\3?&=O\ V3\4
M?%\E[H4$<*1V&DS&*2]55,<D6HWOV2WNI;=XBT<T9>1[DR&5IHY(E:3C_A#_
M ,$N9?!_C+5_$]UK=QI=E<ZA>/9Z;H$TMAFQDN4GAM[BYC\ITBVJ8I;2W10N
MV)X[L%0!] ?MF_L<:Y^V#%#ILWB*WTW1;:X%S#:QZ29IFF$7E!YKEKY-^W?-
MY:Q1P*%E*R"5D20>X? ;X3^)?@YX:C\/7>M6>IM8V<=KIET=*:W:%8E=(OM4
M:7S+<HB^2BK&;5V2([Y7ED,J_%__  [M\4?\+ _X63_PF5O_ &[]H\[']@#[
M/L\G[-]G\O\ M#=Y7V?_ $?._P _9\_G>?\ O:^W_CW\"_\ AHGP7>>$]5O/
M)EOK>%9;RVAV*+B&2.=94@DDE(B,L2EH3*SF(F,3A\2CX _91_81^(OPPLQX
M?\3^*+<^$X[A)FT6RC^TK=J6,DUM+<7=O%);VDCJGVBVB$D5W%+=1NL1F=Y/
MU_HK\D/&O_!.O6?A=XQ7QQ\(]2L]'N9)!]ITB\25=/>-]S7$8: 2-]GD98L6
MGE@1/NE@N(#%;QQ>H>*?V<OB5^TW9R:)\1=8T?3] ?;Y]GX<MY6FOMK"6/S;
MK4ED-MY$L4+IY"/YRM+')M^1A]GZ3\-T^''A^+0O""V>E1VD:1V8EMI+FWB4
M.&<O$EQ;RRNX+EI#.KM,YFD:1MP?\\/@Q_P3M\4? _Q;=^-+'QE;W&J:A]J^
MW"YT -#<_:Y!-+O2+4(BG[U4E7R6BPR!?]47C;]7Z*^8/VG?@IXA^/NCW?A_
M3]<M]'TV_MTAN6&GS3WAQ)OD"3IJ%M&L4J 0R1-#)NC:52Y60*GR_P#LM?L(
M>+?V1_M46A>,;>XLKS#265[HDDMN)AM GC6/5(G27:OEL58+(FT2*YBA,?Z7
MZMI-OK]O+9WD4<]M/&\4T,J*\<D;J5='1@59&4E65@0P)!!!K\D- _8!\9?L
MN^*+C7?A-K&GQZ;?>8+G1M9^TFW5, PIYD EDN/+=I6AD;R)X4"Q-+<++<&3
MV#7_ -DKQ;^U#]GC^+&J:>=+L[B.>+1- ADBMYIHLA9[B]NPUY\\<L]O+;P^
M4NSRI4F24-7TA\>?@KJGQ*\-2>%?#NHV>@:=<6<EC.!I@NF6U94C$-JHN;>&
MW3RA)"V8Y2$<>48'C5SX?^QE^QQKG['T4VFP^(K?4M%N;@W,UK)I)AF68Q>4
M7AN5OGV;MD/F++'.I6(+&(F=Y#]_T5\@?MO_ ++7_#7'A)]"BNOL=[;W"7ME
M(PS";B*.6-8YP%9_*=974M'\\;%90LH0PR?/_P"S%^R%\1?A_IUI8>+?%5O>
M66D;SI.DQVWVJS6:-/\ 0IKN>5+6ZN(K61VDALMR+%)!:2Q7,9@C2/G_ /AW
M;XH_X6!_PLG_ (3*W_MW[1YV/[ 'V?9Y/V;[/Y?]H;O*^S_Z/G?Y^SY_.\_]
M[7VA\>?A/XE^,?AJ3P]::U9Z8U]9R6NIW0TIKAIEE5$E^RQO?*MLCKYR,LAN
MG5)1LE26,2MX?^QE^QQKG['T4VFP^(K?4M%N;@W,UK)I)AF68Q>47AN5OGV;
MMD/F++'.I6(+&(F=Y#X?^W!_P3=O?CKX@@\9^#-0CTSQ#YD)NS<3SQQLUNBK
M;W4$L*2RP7$8CC3:BA'"I(#%+&YN-#QW^P7XM^/O@N]M/'?B/^T_%C^6^G.C
M20Z18M;R.8\6MNEM'-+.DDD4]Y-;O+#'*J11,(,S]A^Q-^Q?XE^"%O8IXRUB
M._CT.2Z.A:=8LRV=JUVL@N+J9S#;RW-PPGGBB6<.EM'+,4+-,!!Y?^U7_P $
M^?%OC7X@1?$3P!K5OIVJ/Y3S_:WDC\F:WACMT,#0V\XDBEB39/!.NT_.&:6*
M<Q1?H?\ !#X47_PUM[B;7-6DU[6[V16N]3EMH;4M'$NRWMX8(1MAMXEW.L09
MP;B>ZN.&N' ]PKY@_:N_91T/]K70SI6JCR;N'>^GZ@B!IK29@ 2 2-\3X43P
M$A95"D,DJ0S1?)_PA^#/QX^ &EKX=TO5/">K:79R.EA/JO\ :7VI+4'$,1$"
MA515&5C+SF$-Y*3-#'$J_0'P0_8SLOAQX@N/&NOW\GB'QA=QK'+JD]M!;1Q*
MB>2#:VD"[(':!8H99"TCL$?:T:33(^?^UY^RWXA_:MTZ30O^$AM]*T5KB"?R
M8=,FDN)/*0CRKB;^THXIHC*?."?9TVND)R6BWMS_ .RC^R5XM_94LQH]MXKM
M]2T7[0DOV2[T>3="I8M.EI*FI#R?-R6(=)XDE_>K#N>;S?O^BOPQU;_@F)XU
M^"?C&7Q#\)-=L]*M)(W$<5[+,9(5ESYEJR_9KJ*ZMP0CQ-."ZD)N#30+<R=A
M^UK_ ,$N=6^-EGI=YINM_;?$D'G)JE_J\UP%O%E8S#R(XO/BLHH)6D6WL[>%
M8A%,=TI>+=+^A_[.OP9U3X;6\VI>)M4DUGQ1J<=L-3O3A+=5ME<06MI BQQ1
M6\)EE8,L://-+-<2!3((H_H^OS _:_\ ^"?VN?MB:C;W.J>*+>TLK#[0MC:0
M:,3Y:SN&9I96U#?+*52)'8".(^4&2"(L^[[_ /AIHNN>'].2V\0ZC;ZK>Q[5
M^UP61L?,545=TL7VBX0RLP=W:(Q1?,%2",+\W/\ QT^!>A_M%Z'/X?\ $$'G
M6DWS(ZX6:WF4$)/ Y!V2IDX."K*6C=7B>2-OQ!T[_@E)\4_A)>72>"_%UO:V
M4_E;IH[S4-,FGV*2/.AM8YT^1GD6/,LGRDM\A=D'ZO\ [+7[(=G^SK]JU*^O
M[C7_ !-J&%OM<O=S7$D*;5B@C\R29XXE5(]P,CM*Z*S-LC@BA^?_ -K_ /X)
M_:Y^V)J-O<ZIXHM[2RL/M"V-I!HQ/EK.X9FEE;4-\LI5(D=@(XCY09((BS[O
MM_0/AYJ.L^'KC0?&-[;ZU]JMY+2YG@M'T_S[>6$0R"5$N9L2R9D9Y(&@0;P(
MXHM@)_)'X<_\$W/B;^SCXEO)_ 'BNST_1+R2.-Y+A#/=&U#!LRV;VLEI+<0Y
M=8I \1D!;#6RSR1KT'[1?_!+[7M7\2Z3XH\!ZO&FHV4=J]S<ZW=75U=2WUDR
MF"]::2.[65V545X?+AMXQ @2,I(4C_4[X*?";_A4>G203WMQJ>I7MPUYJ>HW
M!P]W>2)'&\BQ F.WB5(HX8+>+$<$$4<8W,&=_P H?A-_P38^(O[.WBB]F\%>
M+K?2] O,HTTD'VN\,*@O")K*6$6<LL<A,0G66-A&TDB+'YKVQ^C_ -H[]@/5
M/CYHVG^&(_$L=CH6FR+/'&VE"XO+FZ\HK)=WUY]LB$]Q)))<SR/'%;B22YD>
M59I L@^K_P!G#X6:Y\%M#MM U?5[?5[>PMX;:RFCT\V4R0PAE5)B+J>.7:GE
M1QLB0L%C)D,TCEQ] 5\ ?##]A>S^&GQ5UGXAQ26[VFH6[M;6C0L\UO?73JU[
M.LLCOLW;'*F/!*WD\ 6**%?/^_Z^8/VKOV4=#_:UT,Z5JH\F[AWOI^H(@::T
MF8 $@$C?$^%$\!(650I#)*D,T7Y(>"O^"77Q<^&MPVGZ'XTCTW1'O"[M9W^H
MV\C1EE0W!LXD6$W!B528S/@E5B^T;0)!^O\ ^S/^S/I?[-.ER6MK))>ZI>R?
M:-6U:XRUUJ%TQ9FEE9F9@@9G\J+<P0,S,TDTDTTOT?6?JVDV^OV\MG>11SVT
M\;Q30RHKQR1NI5T=&!5D92596!# D$$&OR0T#]@'QE^R[XHN-=^$VL:?'IM]
MY@N=&UG[2;=4P#"GF0"62X\MVE:&1O(GA0+$TMPLMP9/8-?_ &2O%O[4/V>/
MXL:IIYTNSN(YXM$T"&2*WFFBR%GN+V[#7GSQRSV\MO#Y2[/*E29)0U?9_C7P
M?JAT9=+\)WEGH<D<8@AE;3Q=1V\"Q-&BV]NL]M$CQGRS%O\ -A4)L:W=6^7X
M0_9 _P""?VN?L=ZC<7.E^*+>[LK_ .SK?6D^C$>8L#EE:*5=0WQ2A7E1&(DB
M'FEG@E*IM_3^BOB#]KS]EOQ#^U;ITFA?\)#;Z5HK7$$_DPZ9-)<2>4A'E7$W
M]I1Q31&4^<$^SIM=(3DM%O;G_P!E']DKQ;^RI9C1[;Q7;ZEHOVA)?LEWH\FZ
M%2Q:=+25-2'D^;DL0Z3Q)+^]6'<\WF^@?M>?LY:Y^U#H\GAVVUVWTC2+CR&N
MH_[,-W<3-#(90OGM>1(D6Y87VI$)=\7^O,;M%1^R'^SEKG[+VCQ^';G7;?5]
M(M_/:UC_ +,-I<0M-()2OGK>2H\6YIGVO$9=\O\ KQ&BQ4?M>?LY:Y^U#H\G
MAVVUVWTC2+CR&NH_[,-W<3-#(90OGM>1(D6Y87VI$)=\7^O,;M%1^R'^SEKG
M[+VCQ^';G7;?5](M_/:UC_LPVEQ"TT@E*^>MY*CQ;FF?:\1EWR_Z\1HL5>O_
M !T^!>A_M%Z'/X?\00>=:3?,CKA9K>900D\#D'9*F3@X*LI:-U>)Y(V_$'3O
M^"4GQ3^$EY=)X+\76]K93^5NFCO-0TR:?8I(\Z&UCG3Y&>18\RR?*2WR%V0?
MJ_\ LM?LAV?[.OVK4KZ_N-?\3:AA;[7+W<UQ)"FU8H(_,DF>.)52/<#([2NB
MLS;(X(H?E_XS_P#!.WQ1\</%MIXTOO&5O;ZII_V7["+;0 L-M]DD,T6Q)=0E
M+_O6>5O.:7+.5_U02-?O_P 1^'/%NJZ&+.TUC3[/6F\Q9=1729)(55A(%:"S
MDOSLE3,;!IIKF(LC;H"L@1/B#]D#_@G]KG['>HW%SI?BBWN[*_\ LZWUI/HQ
M'F+ Y96BE74-\4H5Y41B)(AYI9X)2J;>@_;P_P""?%G^U_Y&JV5Y_9^OV=NT
M$<LBM);W$*^9)%!,H;,6)7)%Q&'94>0-#/\ NA%Y_P#!S]CWXJZE9MH7Q$\9
M_;/#?"SV%FSS7-_"[/)+!<:G/!!>Q1,VQ) CRM-;-+;!H$VFL_\ 8D_X)GWO
M[.%PNK:SX@O&NS)%))IVE7,]MI\C0M,(Q=O^[EO4 =)%C9($1_-B=;B&1@WZ
MWT4444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444444445^:'Q]_:C^*7PR\>0Z)H/@F36?#SQP!+F,3[KB292NXWJ![
M6Q2.4A)$NHV(2)IFDCBGC>/Z _9_^$.J66J:EXX\5+&GB/6XX(A91N)XM(L(
M 3%803MEF=F/G7SQ&.VFNOGCA 02R?5]%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%>
M7_%[XHI\(-+;4WT_5-482)&EGI5E)>W4C.>HC3"JBJ&9I)6C0 ; QE>-'^,/
MV!_VWM1_;-O/$+W.GV^G66F_V=]DACD>:;_25N!+YTS;$D^: -'LBAV*Q5O,
M(WG]'Z*********^8/CI^TRWP"BGO+[PWX@O=-M^7O\ 3X;*YA"B(S/(T8O5
MN8HHPKK+--#%$K+]\JT;/\O^!?\ @JGX>^*'G?V#X8\8:G]GV>?]BTN&Y\KS
M-VSS/)NWV;MC;=V-VUL9P<=AJW_!1"WT"WEO+SP1X\@MH(WEFFET)4CCC12S
MN[M<A515!9F8@* 22 *^@/V7_P!J#1OVL]&GUS0X+R"V@O'LW2\2))#(D44I
M($4LR[-LR@$L#D-\H !/T?111111117QA^V#^V*G[)]A]J&AZIJ\GEK(TD$$
MD>GP*TR0J+K4#&\4+N6;RHT69RZHKK$LT3MV'[&?QKU']HGP)I?B?58[>&]O
MOM?FQVRND(\F[G@78LDDKC*Q*6R[98DC P!]/T45^2'Q(_X*87NG>.M#\&:5
MX?O+./4=4L+>:\UJVGM));6XNVM7DM+-O+E", KP7$S @B2-[,,N1^M]%%%%
M%%%%%%%%%%?EA\+OVY_%7CCXRZA\/+K0HX=)M9+V,3!+@74$=LFZ*]G=OW1M
M[DA/*'EQ "[M]L\N!Y_ZGT44444444444445Y?\ %[XHI\(-+;4WT_5-482)
M&EGI5E)>W4C.>HC3"JBJ&9I)6C0 ; QE>-'^,/V!_P!M[4?VS;SQ"]SI]OIU
MEIO]G?9(8Y'FF_TE;@2^=,VQ)/F@#1[(H=BL5;S"-Y_1^BBBBBBOG_\ :G^+
M.H_ OP7J_B32K+^T+VPMQ)%;D.5^:1$::01@N8H%9KB8 IF*)P9(AF1/,/V#
M?VCM9_:E\'+X@US3X[&Y^V7%NC0K*EO<QQ[")X%E+,$#,UNV))09H)#O4DQ1
M_9]%%%%%?DA^VW_P4PO?V<+AM)T;P_>-=F26./4=5MI[;3Y&A:$R&T3]W+>H
M [QM(KP(C^5*C7$,BEOUOHHHHKR_XO?%%/A!I;:F^GZIJC"1(TL]*LI+VZD9
MSU$:85450S-)*T: #8&,KQH_QA^P/^V]J/[9MYXA>YT^WTZRTW^SOLD,<CS3
M?Z2MP)?.F;8DGS0!H]D4.Q6*MYA&\_H_1111117Y8?"[]N?Q5XX^,NH?#RZT
M*.'2;62]C$P2X%U!';)NBO9W;]T;>Y(3RAY<0 N[?;/+@>?^I]%%%%%%%%%%
M%%%%%%%%%%%%%?&'[>7[1VL_LM>#F\0:'I\=]<_;+>W=IEE>WMHY-Y,\ZQ%6
M*%E6W7,D0$T\9WL0(I/3_P!ECXLZC\=/!>D>)-5LO[/O;^W,DMN X7Y9'19H
MQ( XBG55N(02^(I4 DE&)'^@****************_.#]M_\ ;ZE_92B>VL=!
MU"]NVV1I?W%O+!I$<TL4LB(+DK_I4J;$=[>$JK1F1?M4<L4B+]G_  0\:W'Q
M*\*Z)KEXL:7.I:78WDR1!A&LEQ;QRN$#,S! S$*&9B!C+$\GU"BBORP^%W[<
M_BKQQ\9=0^'EUH4<.DVLE[&)@EP+J".V3=%>SNW[HV]R0GE#RX@!=V^V>7 \
M_P#4^BBBO#_C[\?=+_9UTN'4]3AO+IKJ\@L;.SL8#<75U=7!/EPPQY52Y57;
MYF0,$**6E9$?X _:5_:P^,?[.-O:>)K_ ,.:'_PCDLEO]JM8+BZN[RQ#K'NB
MNKM?)@1Y'+QQ7$4$]O')LC9I2T1N/N#]E7]IC2_VK_#47B'3(Y(&$C6]Y:R9
M+6]TBH\D0DVJLJ;9$>.50 Z.NY8Y0\4?T?1111111111117S_P#M3_%G4?@7
MX+U?Q)I5E_:%[86XDBMR'*_-(B--((P7,4"LUQ, 4S%$X,D0S(GF'[!O[1VL
M_M2^#E\0:YI\=C<_;+BW1H5E2WN8X]A$\"REF"!F:W;$DH,T$AWJ28H_L^BB
MBBBBBORP^*/[<_BKP/\ &73_ (>6NA1S:3=2649F*7!NIX[E-TM[ Z_NA;VQ
M+^:/+E!%I<;IXLGR/U/HHHHKC_B%XUM_AKHVH:Y>+(]MIMG<7DR1!3(T=O$T
MKA S*I<JI"AF4$XRP'(^4/V>/VWM.^.G@'4_'<NGW%C%H_V[[;:+(EPW^AP+
M=-Y$A\D2;HG3'F+#B4LA^11*_8?L;?M4V_[7WAI]?@L9-.DAO)K.>W>59E$D
M:QR@QRA8RZ&.:,DM'&5?>FUE59'^KZ*_+#]AC]N?Q5^T_P"*M=T/7-"CTZVT
MZ-Y$>-+A9+21;CRA97IERK7#*6((6U.;6?\ <$$B']3Z*****^(/C?\ MO:=
M\$O'WA[P)/I]Q<2ZYY&^[21%6W^USO:VN(SS+F5&\_+1>3%M=//<F)3XW_MO
M:=\$O'WA[P)/I]Q<2ZYY&^[21%6W^USO:VN(SS+F5&\_+1>3%M=//<F)?M^B
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBN?\ %/BS3O UG)J&JW=O8V4.
MWS;FYF2&%-[!%WR2%47<S*JY(RS!1R0*Y_P+\6/#WQ0\[^P=5T_4_L^SS_L5
MW#<^5YF[9YGDN^S=L;;NQNVMC.#CT"N?_P"$LT[^T?[(^UV_]I?9_M7V/SD^
MT?9]_E^?Y.?,\K?\GF;=F_Y<[N*Y_0/BQX>\5ZC<:1I^JZ?=ZE:>9]ILX+N&
M6XA\IQ')YL*.9$V.0C[E&UR%.&(%>@45X?JW[3?@70+B6SO/$NAP7,$CQ30R
MZG:))'(C%71T:4,KJP*LK %2"" 17N%<_P"*?%FG>!K.34-5N[>QLH=OFW-S
M,D,*;V"+ODD*HNYF55R1EF"CD@5G^-?B%HWPUMUO-<U"STVV>01)->7$5O&T
MA5F"!Y652Y568*#DA6., XT/"WBS3O'-G'J&E7=O?64V[RKFVF2:%]C%&V21
MED;:RLK8)PRE3R"*Z"BBBO/_ !U\6/#WPO\ )_M[5=/TS[1O\C[;=PVWF^7M
MW^7YSIOV[TW;<[=RYQD9Z#PMXLT[QS9QZAI5W;WUE-N\JYMIDFA?8Q1MDD99
M&VLK*V"<,I4\@BN@KG] \6:=XK^T?V?=V]W]DN)+6Y\B9)?)N(L>9!+L)V2I
MD;XVPZY&0,BN/\%?&_PK\2KAK/0];TO4KE(S*\-G?6]Q(L895+E(I&8(&95+
M$8!91G)&?4*X_P :_$+1OAK;K>:YJ%GIML\@B2:\N(K>-I"K,$#RLJERJLP4
M')"L<8!P>"OB%HWQ*MVO-#U"SU*V20Q/-9W$5Q&L@56*%XF90X5E8J3D!E.,
M$9["BL_5M6M] MY;R\EC@MH(WEFFE=4CCC12SN[L0JHJ@LS,0% )) %>?^"O
MC?X5^)5PUGH>MZ7J5RD9E>&SOK>XD6,,JERD4C,$#,JEB, LHSDC/J%?@#_P
M0Q_YF[_N#_\ M_7[_5Y?IGQO\*ZUJAT.UUO2YM6626(V$=];O="2$,94,"R&
M4/&$<R+MR@5MP&TX] TS5K?6D,MK+'-&LDL1>-U=1)#(T4J$J2 \<B/'(O5'
M5D8!E(!JVK6^@6\MY>2QP6T$;RS32NJ1QQHI9W=V(545069F("@$D@"O/_!7
MQO\ "OQ*N&L]#UO2]2N4C,KPV=];W$BQAE4N4BD9@@9E4L1@%E&<D9]0HHHH
MKY__ &L?^2>>*_\ L7]6_P#2*:OR!_X(8_\ ,W?]P?\ ]OZ_>[4]6M]%02W4
ML<,;211!Y'5%,DTBQ1("Q +R2.D<:]7=E1068 ^7_"?X.6?PBGUR2Q;]UK6L
M3:LT6&_=37%O;QSC<[N7\R6&2XR-BIYWE*@2-2?0/^$LT[^T?[(^UV_]I?9_
MM7V/SD^T?9]_E^?Y.?,\K?\ )YFW9O\ ESNXKG] ^+'A[Q7J-QI&GZKI]WJ5
MIYGVFS@NX9;B'RG$<GFPHYD38Y"/N4;7(4X8@5H>-?B%HWPUMUO-<U"STVV>
M01)->7$5O&TA5F"!Y652Y568*#DA6., XS_ OQ8\/?%#SO[!U73]3^S[//\
ML5W#<^5YF[9YGDN^S=L;;NQNVMC.#CT"BBBN?\4^+-.\#6<FH:K=V]C90[?-
MN;F9(84WL$7?)(51=S,JKDC+,%') K\X/^"AOQ8\/?%#X0^)_P"P=5T_4_L_
M]E^?]BNX;GRO,U*VV>9Y+OLW;&V[L;MK8S@X] _X)<?\DA\/?]Q'_P!.5W7W
M_117X _M]?\ )PO@+_N ?^GFXK]_JY_Q3XLT[P-9R:AJMW;V-E#M\VYN9DAA
M3>P1=\DA5%W,RJN2,LP4<D"N?\"_%CP]\4/._L'5=/U/[/L\_P"Q7<-SY7F;
MMGF>2[[-VQMN[&[:V,X./0*Y_0/%FG>*_M']GW=O=_9+B2UN?(F27R;B+'F0
M2["=DJ9&^-L.N1D#(KC_  5\;_"OQ*N&L]#UO2]2N4C,KPV=];W$BQAE4N4B
MD9@@9E4L1@%E&<D9] U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$
M!0"20!7YP?L/?M17'[4?C'QS>Q7$DFB6<FE6^D0EF\M;=?MRM.J-'$RO<LGG
MOYB^<H:.!G98(]OZ7T5S^O\ BS3O"GV?^T+NWM/M=Q':VWGS)%YUQ+GRX(MY
M&^5\'9&N7;!P#@US_CKXL>'OA?Y/]O:KI^F?:-_D?;;N&V\WR]N_R_.=-^W>
MF[;G;N7.,C/8:3JUOK]O%>6<L<]M/&DL,T3J\<D;J&1T=259&4AE920P(()!
MKS_3/C?X5UK5#H=KK>ES:LLDL1L([ZW>Z$D(8RH8%D,H>,(YD7;E K;@-IQZ
MA7/ZCXLT[2+RUT^YN[>&]OO-^R6TDR)-<>2H>7R8V(>7RU(:38&V*0S8'-=!
M7E^I_&_PKHNJ#0[K6]+AU9I(HA827UNET9)@IB00-()2\@=#&NW+AEV@[AGT
M"RU:WU%YHH)8Y)+:013HCJS12&-)0D@!)1S')'(%;!*2(^-K*3H445GZMJUO
MH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B H!)( KS_PW\;_"OC&WN[S3
M-;TN\MK"/S;V:WOK>:.VCVNV^=XY&6)-L;MND*C".<X4X]0KC_&OQ"T;X:VZ
MWFN:A9Z;;/((DFO+B*WC:0JS! \K*I<JK,%!R0K'& <'@KXA:-\2K=KS0]0L
M]2MDD,3S6=Q%<1K(%5BA>)F4.%96*DY 93C!&>PHKC_&OQ"T;X:VZWFN:A9Z
M;;/((DFO+B*WC:0JS! \K*I<JK,%!R0K'& <9_@7XL>'OBAYW]@ZKI^I_9]G
MG_8KN&Y\KS-VSS/)=]F[8VW=C=M;&<''H%?@#_P0Q_YF[_N#_P#M_7[_ %>7
MZ9\;_"NM:H=#M=;TN;5EDEB-A'?6[W0DA#&5# LAE#QA',B[<H%;<!M./0-,
MU:WUI#+:RQS1K)+$7C=7420R-%*A*D@/'(CQR+U1U9& 92 :MJUOH%O+>7DL
M<%M!&\LTTKJD<<:*6=W=B%5%4%F9B H!)( KS_P5\;_"OQ*N&L]#UO2]2N4C
M,KPV=];W$BQAE4N4BD9@@9E4L1@%E&<D9]0HHKG] \6:=XK^T?V?=V]W]DN)
M+6Y\B9)?)N(L>9!+L)V2ID;XVPZY&0,BM#5M6M] MY;R\EC@MH(WEFFE=4CC
MC12SN[L0JHJ@LS,0% )) %<_J?Q"T;1=+&N76H6<.DM'%*+^2XB2U,<Q41.)
MV81%)"Z"-MV'++M)W#)X*^(6C?$JW:\T/4+/4K9)#$\UG<17$:R!58H7B9E#
MA65BI.0&4XP1GL*\O\:_&_PK\-;A;/7-;TO3;EXQ*D-Y?6]O(T99E#A)9%8H
M65E# 8)5AG(..P\+>+-.\<V<>H:5=V]]93;O*N;:9)H7V,4;9)&61MK*RM@G
M#*5/((K\(?\ @N=_S*/_ '&/_;"OW^HHHHKQ_P +?M"^#?'-Y'I^E>(-'OKV
M;=Y5M;:C;33/L4NVR..1G;:JLS8!PJECP":_&'_@AC_S-W_<'_\ ;^OW^KQ_
M_AH7P;_:/]D?\)!H_P#:7VC[+]C_ +1MOM'VC?Y?D>3YGF>;O^3R]N_?\N-W
M%>P5Q_C7XA:-\-;=;S7-0L]-MGD$237EQ%;QM(59@@>5E4N55F"@Y(5CC .#
M0_B%HWB>WM;RPU"SNK:^D>*SFAN(I([F2-9&=('1BLKJL,S,J%BHBD) $;8[
M"BN?U'Q9IVD7EKI]S=V\-[?>;]DMI)D2:X\E0\ODQL0\OEJ0TFP-L4AFP.:Z
M"N?T#Q9IWBO[1_9]W;W?V2XDM;GR)DE\FXBQYD$NPG9*F1OC;#KD9 R*X_P5
M\;_"OQ*N&L]#UO2]2N4C,KPV=];W$BQAE4N4BD9@@9E4L1@%E&<D9]0KC_&O
MQ"T;X:VZWFN:A9Z;;/((DFO+B*WC:0JS! \K*I<JK,%!R0K'& <9_@7XL>'O
MBAYW]@ZKI^I_9]GG_8KN&Y\KS-VSS/)=]F[8VW=C=M;&<''H%<?XU^(6C?#6
MW6\US4+/3;9Y!$DUY<16\;2%68('E95+E59@H.2%8XP#@\%?$+1OB5;M>:'J
M%GJ5LDAB>:SN(KB-9 JL4+Q,RAPK*Q4G(#*<8(SV%<_IWBS3M7O+K3[:[MYK
MVQ\K[7;1S(\UOYREXO.C4EXO,4%H]X7>H++D<US_ (%^+'A[XH>=_8.JZ?J?
MV?9Y_P!BNX;GRO,W;/,\EWV;MC;=V-VUL9P<=!IWBS3M7O+K3[:[MYKVQ\K[
M7;1S(\UOYREXO.C4EXO,4%H]X7>H++D<UY_X6_:%\&^.;R/3]*\0:/?7LV[R
MK:VU&VFF?8I=MD<<C.VU59FP#A5+'@$U[!6?JVK6^@6\MY>2QP6T$;RS32NJ
M1QQHI9W=V(545069F("@$D@"O/\ P5\;_"OQ*N&L]#UO2]2N4C,KPV=];W$B
MQAE4N4BD9@@9E4L1@%E&<D9]0KG]1\6:=I%Y:Z?<W=O#>WWF_9+:29$FN/)4
M/+Y,;$/+Y:D-)L#;%(9L#FN?_P"%L>'O[8_X1[^U=/\ [:_Z!WVN'[9_J_._
MX]]_F_ZK][]W_5_/]WFN@\4^+-.\#6<FH:K=V]C90[?-N;F9(84WL$7?)(51
M=S,JKDC+,%') KC_  5\;_"OQ*N&L]#UO2]2N4C,KPV=];W$BQAE4N4BD9@@
M9E4L1@%E&<D9] U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"2
M0!7YP?L/?M17'[4?C'QS>Q7$DFB6<FE6^D0EF\M;=?MRM.J-'$RO<LGGOYB^
M<H:.!G98(]OZ7US_ (6\6:=XYLX]0TJ[M[ZRFW>5<VTR30OL8HVR2,LC;65E
M;!.&4J>011XI\6:=X&LY-0U6[M[&RAV^;<W,R0PIO8(N^20JB[F957)&68*.
M2!6?XU^(6C?#6W6\US4+/3;9Y!$DUY<16\;2%68('E95+E59@H.2%8XP#C0\
M+>+-.\<V<>H:5=V]]93;O*N;:9)H7V,4;9)&61MK*RM@G#*5/((KH*\?\4_M
M"^#? UY)I^J^(-'L;V';YMM<ZC;0S)O4.N^.2177<K*RY RK!AP0:]@HHKG_
M !3XLT[P-9R:AJMW;V-E#M\VYN9DAA3>P1=\DA5%W,RJN2,LP4<D"N?\.?%C
MP]XPLSJ&FZKI]Y9"XCM3<V]W#+"+B5HTC@,B.R>:[2Q*D>=[-+&H!+J#Z!11
M17G_ (Z^+'A[X7^3_;VJZ?IGVC?Y'VV[AMO-\O;O\OSG3?MWINVYV[ESC(SH
M>"OB%HWQ*MVO-#U"SU*V20Q/-9W$5Q&L@56*%XF90X5E8J3D!E.,$9_+#_@M
M7_R3S3?^Q@MO_2*^K[@_9W\6:=X&^&/AC4-5N[>QLH?#^C^;<W,R0PIOM8$7
M?)(51=S,JKDC+,%') KV_P %?$+1OB5;M>:'J%GJ5LDAB>:SN(KB-9 JL4+Q
M,RAPK*Q4G(#*<8(SV%%<_J/BS3M(O+73[F[MX;V^\W[);23(DUQY*AY?)C8A
MY?+4AI-@;8I#-@<UT%<_IWBS3M7O+K3[:[MYKVQ\K[7;1S(\UOYREXO.C4EX
MO,4%H]X7>H++D<UQ^F?&_P *ZUJAT.UUO2YM6626(V$=];O="2$,94,"R&4/
M&$<R+MR@5MP&TX]0K\(?^"@?BF\N_CK\.]*>3-E;7&D7,,6U1MFNM6,<S[@-
MYW+;0#:Q*KLRH4LY;]SM6TFWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP*LC*2K*
MP(8$@@@UY_\ "'X+^'_@+I:Z-X:L8["Q61Y3&A=V>20_,\DDC/+(^ JAI&8J
MBI&"$1%7/\+?M"^#?'-Y'I^E>(-'OKV;=Y5M;:C;33/L4NVR..1G;:JLS8!P
MJECP":]@KG]?\6:=X4^S_P!H7=O:?:[B.UMO/F2+SKB7/EP1;R-\KX.R-<NV
M#@'!KG]?^+'A[PIJ-OI&H:KI]IJ5WY?V:SGNX8KB;S7,<?E0NXD?>X*)M4[G
M!498$5T'BGQ9IW@:SDU#5;NWL;*';YMS<S)#"F]@B[Y)"J+N9E5<D99@HY(%
M9_C7XA:-\-;=;S7-0L]-MGD$237EQ%;QM(59@@>5E4N55F"@Y(5CC .-#PMX
MLT[QS9QZAI5W;WUE-N\JYMIDFA?8Q1MDD99&VLK*V"<,I4\@BN/U/XW^%=%U
M0:'=:WI<.K-)%$+"2^MTNC),%,2"!I!*7D#H8UVY<,NT'<,^H5S_ (I\6:=X
M&LY-0U6[M[&RAV^;<W,R0PIO8(N^20JB[F957)&68*.2!7'^"OC?X5^)5PUG
MH>MZ7J5RD9E>&SOK>XD6,,JERD4C,$#,JEB, LHSDC/J%?F!\%OVN/\ AH'X
MUZGHVCWOG^&](\/SI#Y,FZWNKS[79>==#")OV[S;1-NFCV1O-"X2Z?=^G]<_
MH'BS3O%?VC^S[NWN_LEQ):W/D3)+Y-Q%CS()=A.R5,C?&V'7(R!D5T%>7^-?
MC?X5^&MPMGKFMZ7IMR\8E2&\OK>WD:,LRAPDLBL4+*RA@,$JPSD''H&DZM;Z
M_;Q7EG+'/;3QI+#-$ZO')&ZAD='4E61E(964D,"""0:-6U:WT"WEO+R6."V@
MC>6::5U2..-%+.[NQ"JBJ"S,Q 4 DD 5S^I_$+1M%TL:Y=:A9PZ2T<4HOY+B
M)+4QS%1$XG9A$4D+H(VW8<LNTG<,G@KXA:-\2K=KS0]0L]2MDD,3S6=Q%<1K
M(%5BA>)F4.%96*DY 93C!&>PHKG]?\6:=X4^S_VA=V]I]KN([6V\^9(O.N)<
M^7!%O(WRO@[(UR[8. <&N@KG_P#A+-._M'^R/M=O_:7V?[5]C\Y/M'V??Y?G
M^3GS/*W_ ">9MV;_ )<[N*X_4_C?X5T75!H=UK>EPZLTD40L)+ZW2Z,DP4Q(
M(&D$I>0.AC7;EPR[0=PSZA17E_QO\%7'Q*\*ZWH=FT:7.I:7?6<+REA&LEQ;
MR1(7*JS! S L55B!G"D\'\L?^"='P4U'Q!\"-:T^*2W$OB?^VOL19G"Q^;;#
M35\\B,E<2V[L?+$O[HJPRY*+Z?\ \$>O!5QX5^&0O)VC:/5=4O+R (6++&@B
MLB) 5 #^9:R, I8;&0[MQ95T/VR_VN/^$2\9>#_ >A7NR_O?$&E/K/D28>&S
M-S#Y=K+A#M^U;_,=5D2001!9$:WNQN_3^N?_ .$LT[^T?[(^UV_]I?9_M7V/
MSD^T?9]_E^?Y.?,\K?\ )YFW9O\ ESNXKH*X^V^(6C7MO>WD6H6;VVFR3Q7\
MRW$1CM)+==TZ7#AML+Q+\TJR%3&.6 %<_P""OC?X5^)5PUGH>MZ7J5RD9E>&
MSOK>XD6,,JERD4C,$#,JEB, LHSDC/J%>7^-?C?X5^&MPMGKFMZ7IMR\8E2&
M\OK>WD:,LRAPDLBL4+*RA@,$JPSD''H$>K6\UQ)9K+&;F*..62$.ID2.5I%C
M=DSN5':*548@!C'( 24;'XX_MG_!34?&'QW^'>H026ZQ7'E[ [.&']B7,FI7
M60(V'SQ2JL&"=TH97\I ')^V?\%-1\8?'?X=ZA!);K%<>7L#LX8?V)<R:E=9
M C8?/%*JP8)W2AE?RD <_L]17QA^W;^U%;_LN>#KN]BN(X];O(WM](A++YC7
M#85IU1HY59+97\]_,7R6*QP,ZM/'N]?_ &9-6N-?\"^&KR\EDGN9]#TR6::5
MV>221[2)G=W8EF=F)9F8DL2222:]PKQ_PM^T+X-\<WD>GZ5X@T>^O9MWE6UM
MJ-M-,^Q2[;(XY&=MJJS-@'"J6/ )KV"BBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBN/^(7C6W^&NC:AKEXLCVVFV=Q>3)$%,C1V\32N$#,JERJD*&903C+ <C\D?
MV$OAY+^VI%??$7XEP_VN[ZA+%HMA=Q2G3;.%8A'</:6TDC6TL4A98"7BD99K
M+S6FDN2[KH?\%#/V$M&M_#[^-?!-I'HFM^'HQ=[--2*SCFMX'\V27$9A6*XM
MEWW$<\?[YQ&8=LK&W,/M_P"QE\?I_P!N+X=36U[J=Q8:_!FQU.ZT\V]O=KGY
MH[J ,)Q#Y\7R&8118N$NC;K#Y4;)^4'[(?P'_P"$_P#C)XM\+3ZKJ']FP_VQ
M%J;F7=>:K9PZG#&]M<70V2)]H?RWO)8MLDT8FA!19V9?V/\ A#_P3D\!_ SQ
M8OB[1(;R&YAC=+6T>Z:2UMFDB\F22,.#.SLAD!$\TR S.512L7E_=]? '_!3
M&U\6ZK\.KNQ\(6=Q>7%Y<06]\EJLCW*V+[C*84B82/O<10S(JR@VTL^Z/R]\
MB<_X3_8-\ V7PUM-(\3Z+I^GW2:/"VJZCB!;RUN5B$UU/_:)WE?*EWODR/;"
M-?**M:_NS\H?\$1O'^J:[I?B'1;JYDET[39+"2R@<@K UV;LSB,D;E1VB1S'
MG8'WR*H>65G^?_\ @LU\-'\'ZIHVJ2:KJE^VJ2:FXMKR>-[6R6$686.RACBB
M6%"K@2$[WE,:/([R[W?]/]6_X)[:)\;K>74OB0\FK^*+R-Q)>VUQ<6]OIZLI
M$=KIL&_RA;VQ):)KF.9YYC)<3AC,T2_"'_!*34M1^$WQ#\7?#G[3]JTVS^V2
M;V#IFXT^]CLO.BB\QHXO/27,PP[MY4"^9MB^;G_^"O?[']GX6\KX@Z#:^4MS
M<&+6TB#%/.EYAO-BQE(O,8-%<R,Z+).]N0C3332/^O\ ^QM?>%]<\#:3J7A#
M3K?3--O;=)6MH$(V7$:BWG665TCDN)8WA,+W4@+W'E"3<RE2?A_Q!^R]X2^/
M/QWNY'TVWDTWP_H]K<:M#%%'!#-K5Y<S7, O(]BM=^;;N;B1UWI(T:13R,N^
M!_J#_@H1^TI>?LO>!I]5TOC5+RXBL+&4QK*D,TJO(TKJS*/DBBE,>1*OG^4'
MB>(N*X_]EK]C'P_%X:L=6\9Z;'KGBC5+.VN-4O-;@>[NA(REXX&2^:<PO;QN
MMJ^P1&00(9$!553\\/VWO@Y>?\$]O%&G_$OX>-]ALK^XDM[RQPOV-)G'FFV\
MH.KM:72QR/Y"J%M9(-\4L)-JD'Z'_M/_ &+]J7X47/B?2=9U2RTX:'?ZDD%C
M<P1+<LMG(?LNH%$F9TC8207-K'*J%S(DF]XXVC_/#_@E_P#L^R_M#>#;VP\0
M7.[P=#K$[R:3;O+#+?WQMK3!O9XV1_LENHBDMX(64RW3&69MMO"C^7_MX? J
MP_X)\>,?#?BSP*\EJL\DLT=C)),\<4ECY D3SO-$\EO=)/LGA=\X,RB4Q2K'
M%_0]\:_BA;_!7PUJGB.Z\MH]-LYK@1R3+ LTB*?*@$C!@KS2;(8_E8EW4*C,
M0I_(']DCQ'X%^-Z7?Q!^+.L>&[[Q#JLDD-KIVHWEH8-,T^&3;'!'871Q [2+
M(X9O-=H6CE$GFW%TTOR_^UUXK\-?LB^-='\9_![5=+W7<=TNH:?I]RMU:[EF
M21UN$CN'5+>Y6942VC6!(3:B2 I*JM%_1]\/?&MO\2M&T_7+-9$MM2L[>\A2
M4*)%CN(EE0.%9E#A6 8*S '.&(Y/85^$-C\<_#W[9/Q*U$>.-7T>T\$^%+AU
MTK39]2ACM]4O!*\45])YFV.]BV1RR% PCB26WA"S137;7'/_ /!07P9\)4\.
M?\)/X"U/P_I_B;2;BREMUT6\MTFF19RA6*"TN$1)8VF6Y^U+$\ZK;!-P3#)^
MC_\ P3W_ &E+S]J'P-!JNJ<ZI9W$MA?2B-8DFFB5)%E159A\\4L1DP(E\_S0
MD21!!7YP?\$,?^9N_P"X/_[?U]?_ /!7/XEZC\._AJT&GOY7]KZA!IUS(&=7
M%N\4\\BHR,N/,^SB&0-O1X))8RIW@KV'@;]FOX.?M.^"HUT+1]+2QNK."(7%
MI':C4K*3R8I52:ZC\Z5+V(-&9UFDE+ME9A,DCA_4/V#?AIJ/P;^'NF^'M539
M>Z?<:I!+A757VZG=[98_,5':*5=LL+E5\R)T<##"OS@L?CGX>_;)^)6HCQQJ
M^CVG@GPI<.NE:;/J4,=OJEX)7BBOI/,VQWL6R.60H&$<22V\(6:*:[:XY_\
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MU*YLIY$'G6TT4!G5X91B2/+PQ&148+*J".0/&2I^/_\ @BI_R3S4O^Q@N?\
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M7B&PM]0LGW'RIT#;&9&C\R)OOQ2A7<)-$4ECW$HZGFOQ!_X(8_\ ,W?]P?\
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MN<L[;54#<Q9CC)).37ZO_MS_  JT/XD> =>GU>PM[NXT[1]2N;*>1!YUM-%
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M;#Q!<[O!T.L3O)I-N\L,M_?&VM,&]GC9'^R6ZB*2W@A93+=,99FVV\*/Y?\
MMX? JP_X)\>,?#?BSP*\EJL\DLT=C)),\<4ECY D3SO-$\EO=)/LGA=\X,RB
M4Q2K'%_1=\5?B7IWP;T._P#$.JOLLM/MWGEPR*S[1\L4?F,B-+*VV*%"R^9*
MZ(#EA7Y@?L5_ NS_ &M[,_%7XC06^M:KJ=Q.NFVTNZ2QL;&W:6V$"63CRO\
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M  BECXAUA)3\C:U<3K=:IY,FB>;.%N'10LK1-);03A=UL#'(JL\2Y_6_P_\
M\$O/AOX0\2Z=XETRUO+233)(IH;)+R1[5[B%FDBGD\[S+@NKE&"K,D),2!HV
M4RB3P#XS? [Q+\?_ (^:6GB+1I+SP/I-GYT#ON-@Z_9V<M+F0Q-<-?&.*2W
M5YK:"$RP26RM(WA__!6CX%^$O@IIVA^)O#,%OH6OKJ"0PQZ=Y=GYD,:23FY6
M&$(?-MY1"!<Q;63SE61F_P!'\O\ 2_2O@WHG[8_@7PO=>.8)-3DDTNPOG N;
MBUC>ZN+2)I)FBLY8(F?+/LRI$0>18PBR.&_%#_@E)^RYX0_:4_X2/_A*]/\
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M>ZEY3_1=X3T#_A%-.M-/^T7%W]DMX8/M-U)YMQ-Y2!/-GDP-\KXW2/@;G);
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M(%%T$_T.<LRM#<;!<R?('_!#'_F;O^X/_P"W]'_!<[_F4?\ N,?^V%?O]7X
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ME5W*V8;M;RZ@?*%A\\4L;[2=R[MK!7#*.?\ ^"*G_)/-2_[&"Y_](K&O /\
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MV\C12633+>6ZI= RI<$2*[1(A)2VF:3;Y(S^]W_#)WP\_P"A4\/_ /@ILO\
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M^ /^"*G_ "3S4O\ L8+G_P!(K&O /V^O^3A? 7_< _\ 3S<5^QW[3>DW&O\
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M,P,GE)'YQCC>7S)$#U^SW[)W_)//"G_8OZ3_ .D4-?D#_P $,?\ F;O^X/\
M^W]??_\ P5'_ .20^(?^X=_Z<K2C_@EQ_P DA\/?]Q'_ -.5W7P!_P %SO\
MF4?^XQ_[85^_U?@#^P+_ ,G"^/?^X_\ ^GFWK[/_ ."HW[-5O\=_!RZBMW9V
M.HZ'(T]O/>W"VUO)'/MCEM6FEDC@B>9Q!Y4LP(\Z-(=\2322*?LN_M:ZO8>#
MK>U\9>'?%D>NZ99K'(?[!U*<ZBT7F+&8I=LQ:X>..+[1)=M;(UQ*S*PCW%/+
M_P!CO]F+Q1XS^(&I?%[QY:?V?=W>\Z3ILC@W$"3PI%&\WD^4J^3:'[&(YX_/
MD<R2S10RQHTGZ_T5^>'[8/[!WAK]M.X^VC49+'7=-C6Q:X@*W$:+N2Z6&ZM2
MRG>L<[21;)+=\7*2.9HQ$E?D#I/Q0^*7_!*/68M$U;R]2T2YC1H;=YIY=/EC
M$HEG.GRL$:UN%:21)@8\;Y5FEMIU-M(?N_\ X*_^*;/QS\+-#U73Y/.LK[6+
M"YMI=K)OAFT^]DC?:X5UW*P.U@K#." <BOT>_9._Y)YX4_[%_2?_ $BAK\@?
MV^O^3A? 7_< _P#3S<5]'_\ !9[2;C4?AS:2P1221VVN6LL[HC,L49MKN(/(
M0"$0R21QAFP"\B)G<R@_6'[!/Q+T[XH?#7P]/I[[OL6GV^G7,99"\5Q8Q)!(
MKJC/LW;!-&&VNT$L4A5=X ]O^-'Q>TOX"^'[[Q+K+2+8V$8>01(9)'9W6..-
M%X!>21TC4L512P9W1 SK^:'_  6K_P"2>:;_ -C!;?\ I%?5]_\ [)W_ "3S
MPI_V+^D_^D4-?D#_ ,W>?Y_Z%ROW^HK\ ?\ F[S_ #_T+E?O]7X _P#!#'_F
M;O\ N#_^W]>__P#!:O\ Y)YIO_8P6W_I%?5]_P#[)W_)//"G_8OZ3_Z10U^0
M/[?7_)PO@+_N ?\ IYN*_?ZOYT?^"+/B2X\(>*O$OA6\M)(;F:SBN)C+NCDM
MY-.N#;O \+)N#EKP[MQ4QF$J48OE/Z+J_GQ^%W@.WNOVJ]0E\/)'+8V$E[>W
MSQSK(L<D^G>5=L2[DE_M]T8Y(DR879DV(D3!-#]OK_DX7P%_W /_ $\W%?O]
M7X _\%SO^91_[C'_ +85^_U?@#^P+_R<+X]_[C__ *>;>OO_ /X*C_\ )(?$
M/_<._P#3E:4?\$N/^20^'O\ N(_^G*[KY_\ C-^T[XH_:;\<R_"WX9W?]E)8
M_:1K^N.@$L21-]GN4M4?$@\IY!&LD6R>6Z*&*6WMHGNI?F#_ (*4_LA^%_V<
M/ -O?:7'<76KWWB"'[;JU_.;F^N=\&H3-YDA"HNYF!D\I(_.,<;R^9(@>OV>
M_9._Y)YX4_[%_2?_ $BAK\@?V!?^3A?'O_<?_P#3S;U^OW[6/_)//%?_ &+^
MK?\ I%-7P!_P14_Y)YJ7_8P7/_I%8U\H?\%5_$EQ\*?BYX4\5-:23VUC9Z?<
M1@[HX[B2QU&XN)(%FV,H<*T6_ <QB6-BA#*&_HNK\4?^"W&F:7+X5T.ZF,?]
MK1ZH\=J#*1(;62W=KLK%N =!)'9[Y-K&,F-0R^:0_'_\%)O"UYX&^!7@W2M0
MC\F]L;C1;:YBW*^R:'2;J.1-R%D;:RD;E+*<9!(P:_5[]D[_ ))YX4_[%_2?
M_2*&OR!_YN\_S_T+E?O]17X _M]?\G"^ O\ N ?^GFXK]_J_ ']@7_DX7Q[_
M -Q__P!/-O7W_P#\%1_^20^(?^X=_P"G*TH_X)<?\DA\/?\ <1_].5W7W_11
M17X _M]?\G"^ O\ N ?^GFXK]_J_ ']@7_DX7Q[_ -Q__P!/-O7Z_?M8_P#)
M//%?_8OZM_Z135\ ?\$5/^2>:E_V,%S_ .D5C7T!_P %1_\ DD/B'_N'?^G*
MTK0_X)Z:8_PP^#^@OK)CLXX[.ZOI))98Q'':W%S/>1S/)N*(A@D25MQ!C!(<
M*RL!\ ?M _\ !'JXT"X.N_#+4I(+F"3[3#IUS,R21R(TDR?8KY<,KJPABMTN
M,%2#+)? BNP_X)P?M[>(?'.N+\.?&ZYU""WFBM+J:.9+Y[BS+-+;7H8,&E6)
M7/FR"!P;9EE,]Q-NK]OJ***_(#_@M7_R3S3?^Q@MO_2*^K[_ /V3O^2>>%/^
MQ?TG_P!(H:_%'_@BSXDN/"'BKQ+X5O+22&YFLXKB8R[HY+>33K@V[P/"R;@Y
M:\.[<5,9A*E&+Y3^BZOY\?A=X#M[K]JO4)?#R1RV-A)>WM\\<ZR+')/IWE7;
M$NY)?[?=&.2),F%V9-B)$P3^@ZBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBL_5M)
MM]?MY;.\BCGMIXWBFAE17CDC=2KHZ,"K(RDJRL"&!(((-?A#X!^"GCS_ ()G
M>,;FZT#2[SQ1X(U:2".X%G"L^H*B^<T1,40\T7%L#+F0*ME<I(JLUO-+&+7Z
MO^*OQ=\:?M<:'?\ A3P?X5UC1/[0MWMKW5O$<4>FPVT,H^9(H"MU+=^?$L]L
M[0J&M6DBD)&X.GU!\"_@G:_L?^"X-#T:UN-7EM?WD_V=+2"YOKB:0>;,?/FM
MX1M! 033%TMH8X?,F=%W_F!^RS\%_B=\&?B=K7CG5?!UPUEKO]I>;!;:KI4D
MUM]LNDO%V>9=PI/M:-8FR8<JQE'*B)_W>HK\H/\ @JW^RCKG[1.AZ?JOA\?:
M;O0?MCOIZH3-<PW(A+F @_-+'Y (@QNF5F",95CAF/V=/CK\9OC[IRZ'?:'_
M ,(S>VUN5OO$NI64P\PLDJ1-9Z7(ELCW9;RY)&,KV<>R1F@42P6Q^(/^"?/P
MW^*OP5U'7_"UEH%QI5UJWV>.37K^%_L>FK9/.DLT*&,PZC*PG(M8XYO*>0)*
MQDM1*R_0'_!3/X#?$+]K'4=+MO#WABX^Q:-]N7[7/J&F1_:6N'B7=%%]K+K$
M%MT=&E*2MYI5X(C'\_ZO>'/B'K6H:&=2OO#FH6NI)Y:OI*W.G33.Q$>]H)Q>
M);/$I=\--);2NL3-Y"LT:/\ D#^RS\%_B=\&?B=K7CG5?!UPUEKO]I>;!;:K
MI4DUM]LNDO%V>9=PI/M:-8FR8<JQE'*B)_W>K\$?^"A_['UO\2OBSX3:S\S=
MXLD,&I1Q,J2+'I@A^TW223NT8<63 +$L8 -J&"32S%3^]U?/_P"T[^SUIW[4
M'A>[\-:@_D^=LDMKH1)*]K<1'=',@<?6.0*T;R022Q"2/S"P_,']E3XA_$7]
MAN"7P1XN\*:QK.D6WFRZ7>Z#9_;]HDN)"Z,R%$:*5O,G03M%>0[@LD)CEB$'
MI_QF^%WBS_@HZ^EV=YIMYX4\%65Y]JG.HF)-6OV$;1#R[(1RM9O"PGB#7$NR
M2*YCNA%/L6(?8'[4NE:M!X*OO#/A+P_)J,E_I=SIMO%;36-E:V4<D(MUW_:)
MH2J)'(S0QP1R F'RF,"LKU\G_P#!,?X7>-OV;M)N_#'B?PY<6L5UJ$E[%J,=
M[I\\*;[>.-HYHH[HS+@VZ"-HDGWM,0ZPI&7;R#_@IG\!OB%^UCJ.EVWA[PQ<
M?8M&^W+]KGU#3(_M+7#Q+NBB^UEUB"VZ.C2E)6\TJ\$1C^?]7M ,_P :?#UQ
M9>)]$N-+^VV\EI?:?/<V\N])H0LXBN+&=\Q'>\:2$P3G:7,464S^ /C']E'X
MJ_L >*#J_P /!J&K:')<1-&MLCW'GKB7;:ZG80$/+Y:F1/M"QB(>8DL4MM<R
M".+ZP\%:C\;OVYK=M!\5:?'X0\+S2%-4NX;6>SU"Y@15+V4$5W/+*$G$BAIO
M*6'8DB-),!):3_L]I.DV^@6\5G9Q1P6T$:10PQ(J1QQHH5$1% 5450%55 "@
M   "M"OP1_;G_P"">WB7PUX@F^(7PP>\^UW$ES<W]K:W#17D$\B2//<6<@=9
M9$G!=7MHV:822;(4DAE\JWT/AI^TY^TG\4-FA0>&;>RN&MUCDU?4=+NK'RL[
M86NV:>5+9Y5+B8PPV\N[:Q2T>-3&/TO\!_#JZ_9-\')IVAV%YXHU8R3SW4HE
MM+:XO[^XWS2W=W/=31@(T@6(N6NKF.'R5VW'E,]?GA_P3,^ WQ"_9.U'5+;Q
M#X8N/L6L_85^UP:AIDGV9K=Y5W2Q?:P[1%;AW=HB\J^4%2"4R?)]?_\ !0[P
MMXT\3Z+H1\ 1W#Z_:^((+F!X&C3RECL;X.\KS%85B8-Y3K.?*F\P6[!_-$;9
M^F?MQ>()4-C=?#KQ9'KOF2P"".V2333<"1HX@=58QQ"W8A#)=>488U9G7S8U
M#N?\$XOV/KC]D_PU.=7\O^W=7DCGO5C9F6".-2(+4L':*1XB\KR2QJH+S-&'
MFCBBE;X@_;G_ .">WB7PUX@F^(7PP>\^UW$ES<W]K:W#17D$\B2//<6<@=99
M$G!=7MHV:822;(4DAE\JWT/AI^TY^TG\4-FA0>&;>RN&MUCDU?4=+NK'RL[8
M6NV:>5+9Y5+B8PPV\N[:Q2T>-3&/UN_9X^"%O^S[X?AT:*XDOKDR2W-_J$RJ
M+B^O+AS)/<SD99G9CM4R-+(L*1QM+(4WGS#]DWXP>.?BS_;?_":>'/[ ^Q:@
MT-C\S'SHOFW)\Q/G>5A/].AVVMWYO[E%\I\_7]%%?('[56M>)?$OA[7O#>@^
M&-0U&XO]/GLH+O[7I=O9G[7#Y3R;IKT7(\H2,=K6Z^9)'L#+&XF'YP?\$[_@
MO\3OV.;S4TU7P=<7EEJWV7S9K;5=*\Z#[*MR5V0R7:)-YC3JK9EA\M06'F'"
M']SM)O7U&WBGEADMI)(T=X)3&9(F903&YB>2(NI.UC&\B$@[79<,<_Q3K,_A
M^SDN;:RN-0E3;MM;9K=9I-S!3L-U-;PC:"7;?*GRJ0NY]JM^(/[+/P7^)WP9
M^)VM>.=5\'7#66N_VEYL%MJNE236WVRZ2\79YEW"D^UHUB;)ARK&4<J(G_=Z
MOYL?A%X*^*7_  31\8ZC9Z9X>O/%.B7L:>8]E:3M'=1Q^;]EE6>&&X:TN(F=
MUEMY!(,,XVR*UM=#L/\ @I3\#_BK\9;/P_KE_IWVO'VQ#HND6KW3:49V22,3
MW"/)+>2R1(L=Q/'%#9Q2VX6-1YRO-^K_ ,.--\4?M%^'M6?QK;?V)8>(-/\
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M9;K[,D;S!!+(B/,/S0_X4O\ $[_A=_\ PM'_ (0ZX_LW[1M^R?VKI7VC[/\
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MCJ.EVWA[PQ<?8M&^W+]KGU#3(_M+7#Q+NBB^UEUB"VZ.C2E)6\TJ\$1C^?\
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M#*9)-ID?]KO"?]H_V=:?VO\ 9_[2^SP_;/LN_P"S_:-@\[R/,_>>5OW>7O\
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M#]Y+9K'->:=>VFC:+=R0QW:/?30Q6MW?7$4,KO*%,$^Y5LF'ES&W5@P'T_\
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ME"?M,V<?C3[.=?B\Z&[DML>3-Y6A21Q7"!< >?$L<[ +%M:0CR8,>2GZG_\
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M3OL%O++K'B!H8+YK9HO+;9:V[SI$^V5X[.X$HDE66:4"&+[*97/B7^QGXT\
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MN]D\)Z39QZA'<ZX]LMQ<W\]Q>7+>1I\9DC,5O#'+F:^#I-]K"PP;?(G<^?\
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MQX%_X6AX>U70?.^S_P!IZ?=V7G[/,\K[3"\/F;-R;]N_=MW+NQC<,Y'XH_\
M!#75KB:W\5V;2R&VBDTN6.$NQC225;Q9'5,[5=UBB5V !81Q@DA%QG_L"_\
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M=_R3SPI_V+^D_P#I%#7T!17X _L"_P#)POCW_N/_ /IYMZ_7[]K'_DGGBO\
M[%_5O_2*:O@#_@BI_P D\U+_ +&"Y_\ 2*QK _;V_8,\6^.?%"_$'X<W/D:N
M;>..ZABNY+.\>9 +836UPTBQ+NMF$4L9>V41P$J9I)V6O#_@;_P5'U3PA>GP
MQ\9]-D+126KBZ?3Q#=6\XG2XBEO;-A&NR-6BGADMHDFC$$;K#<2R"1/V._:Q
M_P"2>>*_^Q?U;_TBFKX _P""*G_)/-2_[&"Y_P#2*QKP#_@N=_S*/_<8_P#;
M"OW^K\ ?V!?^3A?'O_<?_P#3S;U[A_P61^ VJ?$KPUIOB+3(Y+A= DNC>01Q
MAF6UNEB,ET3O#;(&MT$BJCD)*TS&.*!V/V_^R[^U;HW[07@ZW\1R7EG!<P6:
MRZS#YT2"QD3S%F>5#-(UO;LT,LMNT[ M;A78@AL?F!^RCI-Q^U?\=]7^)^G1
M20^'--DFB@NBC&.[D6R73H44R"%T>2$F]=?+<VX\N&4 S1R-^]U%?@#^WU_R
M<+X"_P"X!_Z>;BOW^K\ ?V!?^3A?'O\ W'__ $\V]?O]17PA^V1^U-X:_9RN
M-*>72X]>\822%-%TZ)%-XBW+""61)O*FEMTE \E1&C/=R 0JC(DSP_"'[:7P
M^^*'B#X9ZUXB\?ZW;VL2?V=+#X;TF%%MHW>XLX1]JNVWS3;#).SVPDG@^TK#
M/'<,D:1K]O\ _!+C_DD/A[_N(_\ IRNZ^$/VL_V'_B#\+/&.H_$7X73R!;N3
M[7<6EG,ZWBR'-Q= Q2LR7MO+-"LQM@7,DDRVZV3Q1ACV'[(__!37_A.]8LO"
M/Q)T[R?$,>H1VEC>I:;=EXT;VC"ZA8^9:W;N[P-);H(_])>)XK6%'9_V^HK\
MD+G]J;5/BWX@U;P=\#=+TM2LDMSJOB>9 FGK=3)(LDR+!$1<7#R+&(;J3SQ<
MO%*?LTUI&;D?"'[1_P /M8^'?QU\#PZ]K=QK^I7%QH4\]Y-#';(/^)M+$D5O
M:PYCMXE2)"44MOG::<D-*57^EZBOP!_;Z_Y.%\!?]P#_ -/-Q7[_ %?SXZ9I
M-OHO[7)BM8HX8VDEE*1HJ*9)O#[2RN0H +R2.\DC=7=F=B68D_J?^V;^T%X2
M_9UT.'5?$UM;ZA=Q7 GT?3Y$C>:6^@&8Y83(K^1Y._,EV!F!7 7?+)%#+\8?
M%?0OBS\<_!7B#Q%XIU"/PMH1T._N8?#EC"&OI8XH;F>*/4+N9/-@=@MNMS'"
M0+BW,D$EO9R-*M7_ /@BI_R3S4O^Q@N?_2*QK _;V_8,\6^.?%"_$'X<W/D:
MN;>..ZABNY+.\>9 +836UPTBQ+NMF$4L9>V41P$J9I)V6O#_ (&_\%1]4\(7
MI\,?&?39"T4EJXNGT\0W5O.)TN(I;VS81KLC5HIX9+:))HQ!&ZPW$L@D3]CO
MVL?^2>>*_P#L7]6_](IJ^ /^"*G_ "3S4O\ L8+G_P!(K&NP_P""BG[#^L_M
M#W&F^*O"$\=MXCTB-UPTTL$D\<3&XMA;S*VR&XBFW^42(@YGW27,8@0'X0^&
M_P#P4,\:?LY7C^#?C)I5QJ.FFWF@E^T6T9OGAV_9UPTC);:C:.8I4>5R[3F2
M27[7,J")_P"A[PGXIL_'.G6FJZ?)YUE?6\-S;2[63?#,@DC?:X5UW*P.U@K#
M." <BN@K\@/^"U?_ "3S3?\ L8+;_P!(KZOO_P#9._Y)YX4_[%_2?_2*&OQQ
M_P""HOCRWL/BYX+L]?>-_#EA'87MS#+ LT8CGU%UO6=%1WF1X;6)6B(<$(0J
M9=]W]!U?B#_P6]\"_P!H>'O#^O>=M^Q:A/9>1LSO^W0B;S-^X;=GV+;MVMO\
MW.Y=F']/_:LU:XU_]F:*\O)9)[F?0_#4LTTKL\DDCSZ>SN[L2S.S$LS,26))
M))->X?\ !+C_ ))#X>_[B/\ Z<KNOO\ HK\ ?V^O^3A? 7_< _\ 3S<5^_U?
MS@_''3?^%D?M/'2-0UK4-)MS]GM;:\M+W[+<6WF:0LD<%K,X98O/N)2GEJO[
MU[B10#),2?T__P"&!?\ J??B!_X/_P#[GK0_9?\ ^">GA7]DS69]<T.[U2>Y
MGLWLW2\FMWC$;RQ2D@16T+;]T*@$L1@M\I)!'YX?\$2_%G]LZCXP^W7?G:E>
M?V==-YTV^XGVO>>?.=Y,DF'FC\V0YP\J;CN=<_O]7Y(?\%A?'[V'PY-CI]S&
M5GURSL=1C0QNP46TM^D,F0S1/NCM9QC8Y0H<F*0AOL#]A;4]+U;X9>&)-'$8
MMAI=O&XCB,2_:HAY=Z2I5<N;E9S))@B5RTH9P^]L_P#;\\"_\+$^%_B:R\[R
M/*T][W?LWY_L]UOO+QN7'F?9_+W9.S?OVOMV-\G_ /!&'5KC4?AS=Q3RR21V
MVN744".[,L49MK24I&"2$0R222%5P"\COC<S$_.'_!#'_F;O^X/_ .W]>_\
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MZ*,8[N1;)=.A13((71Y(2;UU\MS;CRX90#-'(W[W45^ /_-WG^?^A<K]_J_
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MXT4L[N[$*J*H+,S$!0"20!7Y(?\ !:O_ ))YIO\ V,%M_P"D5]7W_P#LG?\
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MC/\ XQV^-NEZ?JO[Z6QUB[T>4VWSJ;B99]-5T,GE$Q"6569B%<1 L(R^$/\
M7[117\^/[*'CRW\0_M+^)Y=>>.:^DDUFRTQW@4LLEG,D42QE$Q$Z6%M-&93L
M+H'1G9YB)/Z#J_G1_:U\-W'PX_:7\.ZC:W<BR:S>:#<'R]T311O,NF2P%U<F
M1)8[=_,X4,DS0LC*"S]A_P %SO\ F4?^XQ_[85^_U?@#^P+_ ,G"^/?^X_\
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MP?%70_#_ ,.-4\/W-_;IJ^H?8#:V.\-<2*M[%*9/*7+K$%MYOWSA8MZ>7O\
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M<Z7;1W'AS4+RZ:&. -;6I@NB[R:7,D1VPO$OSVN0\+F"*X2)C!-;P_<&D_\
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MCR]A_P $G_BKH?B#X<:7X?MK^W?5]/\ MYNK'>%N(U:]EE$GE-AVB*W$/[Y
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MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBO/\
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M&?+0+,TB;X##)'(LK*3CW_\ 9Z_:=\+_ +4&G/J'AJ[\[R?*%U;2(8KBU>5
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MX]:6NL^&KZ._L6D>(R('1DDC/S))'(J2QO@JP615+(R2 %'1F_%'_F[S_/\
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M'8B10L;2%'AFCD$;H5KH/V9_VT_!W[5R2+X?N9$OH(_-GT^ZC\JZBC\QHP^
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M<BHT+B2O8(OVW/ </A.P\9WVJQV.EZE&SVR7*L+IVCE$$\:6L8DFE>&4[)C
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M  2X_P"20^'O^XC_ .G*[K[/\?\ C_2_A9I=SK6M7,=GIUG&9)YY"=JKD
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M[:-M3L'.YEBC,D<5U"2TA"(9)(988XXP"\EU([[F4'/_ &^O^3A? 7_< _\
M3S<5^_U%?/\ ^UC_ ,D\\5_]B_JW_I%-7P!_P14_Y)YJ7_8P7/\ Z16-'_!:
MO_DGFF_]C!;?^D5]7UA^P7\(=+^&G@71[ZS622^UC2],N[Z\G<RW$K&TC\F$
MR'D6]M&1!:P+A(85P 7:1W_+#X;^%K/X/_M5/HWA^/\ L_39?.#VENS)"RSZ
M+]M>,H#M\K[1B9(<>5&R1[$18XPOT_\ \%C/CI>?#;PE8>'].GN+:XUZXF6X
M>+:%DL;:,"X@=\^8OF//;Y$8Q)$LT;L(V:.7T#X5?M7Z=\&]#L/#VE?#_P"(
M"66GVZ019\/(K/M'S2R>7,B-+*VZ69PJ^9*[N1EC7YX>!K+Q?I/QUC\8^%_"
MGB32]$U?5($O$O\ 3;V)?(O_ "DU&2YVLR!!,TMY&&D:&)TAD*!8A&O])U%?
M@#_P0Q_YF[_N#_\ M_7W_P#\%(OV:/\ AHWP-<_8X?-UK2-U]I^Q-TLFQ?\
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MZ^S_ /@JG\/=&U'X:ZUKD^GV<FK6T>GQ07[V\37449U&W!2.<J940B20%58
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MIFEV'PKL9-/,9N9[R^DU$)*7870F,:"12S>4_P!FCM2(P$!0I+M)D+M\0?\
M!972;?P+XJ\(^+%BCN[DQS126EVBRV<L>G7$-Q&DL6%9TD:[E2=2^'C"J AW
M,WZG_M#ZYI/['WPZU_5?#MC;Z5Y-N[6ZZ?9V\2K?77EVEO.T.U(GVRO"92X8
MF*/&V3:J'\T/^">W[0UO\'O";WC^%/&FMZMK5Y<7FHZO::2M[%=2"5XT$=V9
M$EF1 K,XE+E;J2Z(;YR*\?\ ^"@6I:]^TQK.B>(?"7@WQIIVK:;')'-=W&DW
M4$FV.5)K,P&!Y@CQ2-</Y@$;Y=/F;:NS[?\ V^_#EOX]^"DOBS7M'LX?%#:7
MHC2S/9JEU:237=HT]O&\P:XA17FF0Q%\J&=6R6?/0?\ !)OX0Z7H/@'3O% 6
M2;5M1CNX&GG<R&WM8;^X"VEJ#Q!;M(K7,J)S+<2/([-MB6/XP_:\\+6?PK_:
M,\)7.A1_V?+JEQH]S>M;LT?G376I36MR[!2 //B79.J@+-ND:0,\LK/^C_\
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MY_[_ ,SSOGK\<?\ @AKJUQ-;^*[-I9#;12:7+'"78QI)*MXLCJF=JNZQ1*[
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M**************************_F!_9I_P"3H;K_ +&#Q/\ ^BM1K^GZO/\
MQWXIT/X36=[XFUB2WLK>"WC%W>NH#&&)G,49909),/,X@A7<S2S,L:&27#<_
MX6^,=GJ_A*/QE?K]BTV33VU0Y+3-%8F,W$;R*B;O-^S[7FAC$HCE+Q1R7"JL
MLGY8_M,_L6>(/VW["_\ '-U;2:7K8LX(/#FB2R)%)]CAF>8G5&=75+VY6:4Q
M6\;0QV9,,4\[MYS1^O\ _!-/]L&X^,-A)X*\3?;!XMT*.47+W:MYEQ;Q3"+=
M*2BLEQ SQV\Z3YFD(68R2R/.(O8/^"BG[3&J?LM>"CJFBQQG4;V\CT^":3#+
M;-+#-*;@1E2LKJL)$:/A [*[B1$:&3C_ /@GY^RCH?P\\/:?XPNQ_:OB;7;>
M'5;C5;M!)<1->PF0QP.Y=X_EG=9Y0WFW3L[R-L,<,7Q!^P+_ ,G"^/?^X_\
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M.?5#&RWFK21*+JX9RC2*&^9HK?=&GEVRL40(K,9)B\TGY8?\$,?^9N_[@_\
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M<7UY<.(X+: '+,[,=S"-99%A2218I"FP_GA_P6K_ .2>:;_V,%M_Z17U??\
M^R=_R3SPI_V+^D_^D4-> ?\ !4?_ ))#XA_[AW_IRM*/^"7'_)(?#W_<1_\
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M\:V_PUT;4-<O%D>VTVSN+R9(@ID:.WB:5P@9E4N54A0S*"<98#D?D#_P1/\
MA?<>'O#6M>(Y_,2/5KR&W@C>%D5H[!9,SQR$XE1Y+F2$[5PCV[C>S%EC\O\
MV!?^3A?'O_<?_P#3S;U^_P!7X _L"_\ )POCW_N/_P#IYMZ^_P#_ (*C_P#)
M(?$/_<._].5I1_P2X_Y)#X>_[B/_ *<KNO@#]OK_ ).%\!?]P#_T\W%?K?\
MM<_&^X_9Q\$:MXHL[>.ZN;*.$0Q2LRQF2XGBMT9]OS,B-*)&12AD"E!)&6WK
M\'_\$X/V>M.^)NF+\6/%;_V[XFUNXFF2>\B1ULOLETT*&W0@HLH:W5HY5"?9
MXEBMX$A1)#-X!_S=Y_G_ *%ROO\ _P""H_\ R2'Q#_W#O_3E:4?\$N/^20^'
MO^XC_P"G*[KX _X+G?\ ,H_]QC_VPK]_J_G!_P""7,VH_LX?%76_ &MR_9Y;
MFWF@\@0N5N;RQ?SH)8W>)9%B:U:[GA=_*CFB=&(9VA%?T?5^$/P0T7_A>7[3
MGB'Q)9K<0V7A_P ^.9G@W*]Q#:)HYA,BN4B\QA<7$!8L\D4##RU.\Q<_^WU_
MR<+X"_[@'_IYN*_?ZOP!_P""&/\ S-W_ '!__;^OW^HK\4?^"ROPON$TO0_'
M6E^9#?:/>?9Y;BVA83I',1+;SO=1D/$EO/%LASP)KS*/&[8D]?\  GQ-3_@H
M/X@\,W]E!(GA?P['%K.I$K)Y9\1;-MKIRRO';2L]@'>Y>: RVTX>..:)1)$3
M\@?&_4T_X)__ !ZM_%$8DC\/>)HVDU$F*3RU6ZEVWX65EN'E>&=(M2>. (^)
M([552)U+_H_^P!I-QKOA^_\ &VHQ21:CXOU2ZU4I.C&X@LRYAL+0W#@//;Q0
MQB2U;;'&(9\11*AW/^:'_!8CPYKGP^\9>&_'NGGRXH+>&WMKA8S)]GOK&YEN
MXS*'C:'YQ*&A1BQE\B?,>R,EOW^\)^*;/QSIUIJNGR>=97UO#<VTNUDWPS()
M(WVN%==RL#M8*PS@@'(K\@?^"T6O_P!H>'O#OABVM[BXU+4]8\^UCAC\S?\
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M[%;>-/B#<:EIMI<"8VL.BVUENSA7(,,_E^;LW)%++%/Y.]RJ%7D5_I#]K?\
M9E\0?M-):6-GXCCT?2;>2.>:R.EI>K>7$4GF1FZ\VY2*:W0JI6U>)H6<%Y?.
MQ"(?J_[-J/\ 9WE>?;_VE]GV_:/L[_9_M&S'F_9O/\SRM_S>3]HW[/D\_=^\
MK\H/%/\ P3$US7/&DGCVP\76^CZT]PMR#IVA&&%)A&$D<1OJ,N[SL,URLAD6
MX:6;S RR,I^T/V@?V7D_:D\''PWXHNXVOED^T07]E;R6T<-TGF+#*MK)<W!9
M!'(8I8I)F$@9V1H',;1?$'[*O[#/Q2^%21>']>\5QP>#XY&N'L=)N)Q=22>8
MDGD1W;VT%Q9V\CJ7G^RS*7!E145[F2=>/\ ?\$P/%OPB\<W^H>&/$%OH_AG4
M/M%O(UKYC:I%IMPRRM:P>?#,D<JLB0QW@G,R!!= ;\VY^W_VD/V2=1^-/A>#
MP/HNLV^A^&X;>S@:W_LY[VX=+,@PQ_:9;U,1#9 <>69R\.6N&21XST'[(?[.
M6N?LO:/'X=N==M]7TBW\]K6/^S#:7$+32"4KYZWDJ/%N:9]KQ&7?+_KQ&BQ5
M\O\ QG_X)V^*/CAXMM/&E]XRM[?5-/\ LOV$6V@!8;;[)(9HMB2ZA*7_ 'K/
M*WG-+EG*_P"J"1K]_P#B/PYXMU70Q9VFL:?9ZTWF++J*Z3))"JL) K06<E^=
MDJ9C8---<Q%D;= 5D")\0?L@?\$_M<_8[U&XN=+\46]W97_V=;ZTGT8CS%@<
MLK12KJ&^*4*\J(Q$D0\TL\$I5-OR!_P7._YE'_N,?^V%?9]E\(/C=\*;*;PY
MX5UGPW=Z)!&+?2+O589TU*TM5@2*"(K:0?9)'M]ORRRQS&9AYDBA7\B/W#]E
M[]D#3OV=9=1U>YN/[7\3:Q<3SZEK$ENENTGG2F8Q0P(62WB+$/(B,?-E 9CL
M2"*'S_\ ;-_8XUS]L&*'39O$5OINBVUP+F&UCTDS3-,(O*#S7+7R;]N^;RUB
MC@4+*5D$K(D@]_\ V</A9KGP6T.VT#5]7M]7M["WAMK*:/3S93)#"&54F(NI
MXY=J>5'&R)"P6,F0S2.7'D'[9O["^A_MAV<+3R?V=K5IA;;4XX1*PAW;G@FC
MWQ^=$<LT8+HT,I+HP5YHYOS@^%O_  30^,GA+[/I?_"<_P!D:+%YGR:;J6IO
MY.[?)^ZM=MI$=\IR_P"\CQO>3YV&UOV>^!?P+T/]G30X/#_A^#R;2'YG=L--
M<3, 'GG< ;Y7P,G 55"QHJ1)'&OYP? /]CGXM?LA:='9^$->\/W]O=^9/?Z?
MJEI<16\%XZ6ZF2WN+;=<S\1&,&0V\>P!_LYDD_=?2'PI_96UG4O&,7Q'\?WU
MG>>([:S^QV%GID4L.GZ?'^^1RCRMY]T\B3.V9PHB>>90L@6W:'[OHK\L/VF/
M^"==QXK\2Q^/?AUJ4?A[Q1')YTBLC"UN;@LH>=F0.87>-I1<KY,\-X2%DC4R
M7$LOH&K?"CXQ_&NWET/Q9JWAO2-$NHWCO7T*VNKB\NK>53%-: ZB## DL4DA
M^THKS12)'M1E+BOI_P"$/P&TO]GKPTOAWPI'':+'&Y2>>,SM+=,N/M5V$>!I
MW9@I=5>$;%6&,PQ)&J?GA\<?^"9'B'X]^*#XNU#QK]FU)?L_V;[)I4T:6GV8
M+Y?V7?JDDD.'!G^5^)WDE&&8U^E_POT'Q+X>M_(\1ZK9ZM(D<*1SV^FM82,R
M*1))./MES$[R':V(4MT0[\(595C]0KC_ (A>"K?XE:-J&AWC2);:E9W%G,\1
M42+'<1-$Y0LK*'"L2I96 .,J1P?R!_9Q_P""=WQ-^!UQJ&CV_C./3O"][(S2
MC3XS)>3KN$>Z-;B'9IUQ) 3NN;>69XI$A&)Q$CI]/_M;_L1:I^U'96F@PZ[9
MZ+X<TZ2.2STZVT8.RM%!Y$8>;[;&NR-6E$,<,4"*DFQUE,:.OT!\!OA/XE^#
MGAJ/P]=ZU9ZFUC9QVNF71TIK=H5B5TB^U1I?,MRB+Y**L9M79(COE>60RK\7
M_P##NWQ1_P + _X63_PF5O\ V[]H\[']@#[/L\G[-]G\O^T-WE?9_P#1\[_/
MV?/YWG_O:_1_Q3\/+/XFZ')H?B:&WU&WN[=8KU!$T4,K8!9XT,DDD.''F0D2
MO+ P1EF,B"2OPQU;_@D=XZ^%FLRWGP\\4QVEM+&Z":6YN]/O%C:4L+=WLHI5
MF0*D+-)F$22 G[/&$7/Z'_LH_L22_!R\'B;Q?J]QXF\6?9T@BO;N269;"$J3
M+!:-<.\AR[R@W#>6S1-M6& 27 F^_P"BOQ!^$W_!-CXB_L[>*+V;P5XNM]+T
M"\RC320?:[PPJ"\(FLI819RRQR$Q"=98V$;22(L?FO;']CO '@JW^'6EVVE6
MK221VT84S3%6GGD)+2W%PZJHDN)Y"\UQ+@&6:221OF8U^:'_  4_^#EG^T!/
MX,\,0-LU_4-8FCM9<,WDZ:MN9-4FVEXX7\H):R^6[K-)LV0GYI ?U/TG2;?0
M+>*SLXHX+:"-(H88D5(XXT4*B(B@*J*H"JJ@!0   !6A7\L7_!+SX6>*/%<N
MO:[X)U*WT_7]+_LR)([V(26-Y9W4LTEU;7!$<DT6XVD+)+!B0!7B!7S1-#^K
MWB?]DKQ]^U->6L7Q4U31U\/6-Q!<KHVA0SA;N:-;A2\UW=!;F#B58V6)G62(
ML%%O,%G/Z7Z3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550 H    K\
MD/VU_P#@E99_'W49O$?A2YM]*U>X^:[MID86=W,SKNG+Q!GMY2ID:4I%*MQ(
M$8K%(TTTG(?"_P#X)N>/_%EQY'Q.\9WFIZ$)(7ETFWU/4+F.^5&,GESO<&$0
MHLB0ME$E=QOV/;R*DM?H?^U!^SU_PO#P)=>"M*>WTV*X_L^&)A%B&VM[:[MY
M6$<,84?)%$RPQ#RT+!$+Q(2Z_-_@;X4?'/X(V4>@:+JWA/6=)LHX(;&XU6VO
M;6Z2WB@BB6 Q6(,02,H0K/)-,X.]Y/F$<?T!^RS^RM;_ +-R:I>3WTFJZ[KM
MX]YJVI/$MNL\ADE=!':QLT4**9I&(4L6>1SN$?E11?5]<?X_\ :7\4]+N=%U
MJVCO-.O(S'/!(#M9<@@@@AE=6 >.1"KQNJR(RNJL/RP^$W[%7Q._8^U&]B^'
M>N:/?Z!?9D-EKRW2>3-O(5U6S5@TJQ+'&]PC0+<9(>U'DP%/<(OV,]4^.NJ6
M'B#XLW]GJDVFR-)8Z'IUL(M)MV<!9!)).K7=ZDODV\YCF:-$E62$K-;N4/U?
M\9O!WB'QWITNGZ#JUOI'VFWN8)[E[*:YN$\Y-B2VLD-]9^1+'EF5V$WS[& 7
M80_YX?LS_P#!-OQ+^RAJDFI^'O&<96>/R[JSN-%9[6X4!O+,L::E&V^-F+12
M(R.A+)N,4DJ2?J_I,=Q#;Q+>21RW(C03211M%&\@4;V2-I)6C0MDJC22%00I
MD<C<="O'_CI\"]#_ &B]#G\/^((/.M)OF1UPLUO,H(2>!R#LE3)P<%64M&ZO
M$\D;?B#IW_!*3XI_"2\ND\%^+K>ULI_*W31WFH:9-/L4D>=#:QSI\C/(L>99
M/E);Y"[(/U?_ &6OV0[/]G7[5J5]?W&O^)M0PM]KE[N:XDA3:L4$?F23/'$J
MI'N!D=I7169MD<$4/U_7P!\,/V%[/X:?%76?B'%);O::A;NUM:-"SS6]]=.K
M7LZRR.^S=L<J8\$K>3P!8HH5\_[_ *^8/VKOV4=#_:UT,Z5JH\F[AWOI^H(@
M::TF8 $@$C?$^%$\!(650I#)*D,T7Y(>"O\ @EU\7/AK<-I^A^-(]-T1[PN[
M6=_J-O(T994-P;.)%A-P8E4F,SX)58OM&T"0?K?^S[^S'9_LWZ'<V>E3_:-=
MO]\^H:U>QM/->WS!B)[A1*DCQ*[LR6XF4A6?,QGEFN)/C_\ X=V^*/\ A8'_
M  LG_A,K?^W?M'G8_L ?9]GD_9OL_E_VAN\K[/\ Z/G?Y^SY_.\_][7VA\>?
MA/XE^,?AJ3P]::U9Z8U]9R6NIW0TIKAIEE5$E^RQO?*MLCKYR,LANG5)1LE2
M6,2MX?\ L9?L<:Y^Q]%-IL/B*WU+1;FX-S-:R:289EF,7E%X;E;Y]F[9#YBR
MQSJ5B"QB)G>0_/\ ^U7_ ,$^?%OC7X@1?$3P!K5OIVJ/Y3S_ &MY(_)FMX8[
M=# T-O.)(I8DV3P3KM/SAFEBG,47Z'_!#X47_P -;>XFUS5I->UN]D5KO4Y;
M:&U+1Q+LM[>&"$;8;>)=SK$&<&XGNKCAKAP/SP^ ?['/Q:_9"TZ.S\(:]X?O
M[>[\R>_T_5+2XBMX+QTMU,EO<6VZYGXB,8,AMX]@#_9S))^Z^D/A3^RMK.I>
M,8OB/X_OK.\\1VUG]CL+/3(I8=/T^/\ ?(Y1Y6\^Z>1)G;,X41//,H60+;M#
M]WT5X_\ '[X.6?[0'A?4_#%\VR+4+<QK+AF\F92)()MJ/&7\J5(Y?++JLFS8
MQV,P/(?LF?L_6_[,O@[3O#D0C-S%'YM_-'M(GO)<-.^\1Q-(@;]U TBB06\<
M*,24KR_]NW]D#_AL+0['38+BWL;VRU"*=+N6W\UEMW!BNHD8%77<K+,$!"32
MV\,;F,$31?9^DZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515 554 *    *
M^$/VS?V.-<_;!BATV;Q%;Z;HMM<"YAM8]),TS3"+R@\URU\F_;OF\M8HX%"R
ME9!*R)(/</@-\)_$OP<\-1^'KO6K/4VL;..UTRZ.E-;M"L2ND7VJ-+YEN41?
M)15C-J[)$=\KRR&5?B__ (=V^*/^%@?\+)_X3*W_ +=^T>=C^P!]GV>3]F^S
M^7_:&[ROL_\ H^=_G[/G\[S_ -[7J'[6_P"QIXE_:[LK32]1\36=EIUI)'<&
M&VT1BTMTL'E-*\DFHLP0,TYAB3:$2;9(UP\:35]'_LX?"S7/@MH=MH&KZO;Z
MO;V%O#;64T>GFRF2&$,JI,1=3QR[4\J.-D2%@L9,AFD<N,#]J[]E'0_VM=#.
ME:J/)NX=[Z?J"(&FM)F !(!(WQ/A1/ 2%E4*0R2I#-%^4'PW_P""6OQ3^'5X
M^G:;XW_LG0'N)I#)I]WJ$<S_ "[8YFL4,$/FN$B64?:3Y:]))?+4-^M_P"_9
MGTO]ESPU-X>\*R2*TDD]P+J^S<LUU*H199HXS;*R(J1)Y4)MPR1CYA*SRM\7
M_P##NWQ1_P + _X63_PF5O\ V[]H\[']@#[/L\G[-]G\O^T-WE?9_P#1\[_/
MV?/YWG_O:^T/CS\)_$OQC\-2>'K36K/3&OK.2UU.Z&E-<-,LJHDOV6-[Y5MD
M=?.1ED-TZI*-DJ2QB5O#_P!C+]CC7/V/HIM-A\16^I:+<W!N9K6323#,LQB\
MHO#<K?/LW;(?,66.=2L06,1,[R'[_HKX@_;;_8RL_P!L&STB&6;[-<:;J$<C
M3 L&:QF9%OX8S\\:2LB)+#))%*!+ D9"1RR./L_2=)M] MXK.SBC@MH(TBAA
MB14CCC10J(B* JHJ@*JJ %    %?$'CW]BJW\:_%G1_B.7LQ;6%FRW5FUJK2
M7%Y$)$M+@OG:SHLJL)7!D@-E;*F\.&MON^OB#]LW]A?0_P!L.SA:>3^SM:M,
M+;:G'")6$.[<\$T>^/SHCEFC!=&AE)=&"O-'-Y?X \!?M">'-+MM#N]8\)R1
MQQBW?5Y%U"ZU)(R2OGA7CAM[BXB0@Q^>H$S(OGN[-)(WT!^SC^R)HW[/5QJ&
ML"634O$>L2--J>K7"1))+)*PEG2"*)52VMWFW3>2FXY**\LHAAV>/_MZ?L%V
M_P"V);VEY9W<>G:WIT<Z0S/ KQW,;KN2WN'7$RHLH#1R*9! )+@BWE:7Y?/_
M (7_ +(7Q-\9V_\ 9/Q1\7R7NA01PI'8:3,8I+U54QR1:C>_9+>ZEMWB+1S1
MEY'N3(96FCDB5I./^$/_  2YE\'^,M7\3W6MW&EV5SJ%X]GIN@32V&;&2Y2>
M&WN+F/RG2+:IBEM+=%"[8GCNP5 'T!^V;^QQKG[8,4.FS>(K?3=%MK@7,-K'
MI)FF:81>4'FN6ODW[=\WEK%' H64K()61)![_P#LX?"S7/@MH=MH&KZO;ZO;
MV%O#;64T>GFRF2&$,JI,1=3QR[4\J.-D2%@L9,AFD<N/F#]O#_@GQ9_M?^1J
MME>?V?K]G;M!'+(K26]Q"OF2103*&S%B5R1<1AV5'D#0S_NA%Y_\'/V/?BKJ
M5FVA?$3QG]L\-\+/86;/-<W\+L\DL%QJ<\$%[%$S;$D"/*TULTML&@3::S_V
M)/\ @F?>_LX7"ZMK/B"\:[,D4DFG:5<SVVGR-"TPC%V_[N6]0!TD6-D@1'\V
M)UN(9&#?K?7G_P 2]%USQ!ISVWA[4;?2KV3<OVN>R-]Y:LC+NBB^T6Z"56*.
MC2F6+Y2KP2!OE^ /V0/^"?VN?L=ZC<7.E^*+>[LK_P"SK?6D^C$>8L#EE:*5
M=0WQ2A7E1&(DB'FEG@E*IM^@/VO/V<M<_:AT>3P[;:[;Z1I%QY#74?\ 9AN[
MB9H9#*%\]KR)$BW+"^U(A+OB_P!>8W:*C]D/]G+7/V7M'C\.W.NV^KZ1;^>U
MK'_9AM+B%II!*5\];R5'BW-,^UXC+OE_UXC18J^?_P!K_P#X)_:Y^V)J-O<Z
MIXHM[2RL/M"V-I!HQ/EK.X9FEE;4-\LI5(D=@(XCY09((BS[OL^R\#>);KPU
M-H^KZGI>IZC+&(#=SZ,PM9H"J)*MW8+?[9GE7S=_ERV\.9% MPB%)/@#]F?_
M ()M^)?V4-4DU/P]XSC*SQ^7=6=QHK/:W"@-Y9EC34HVWQLQ:*1&1T)9-QBD
ME23[_P#B]\!M+_:%\--X=\5QQW:R1H7G@C,#172KC[5:!WG:!U8L45GF&QFA
MD,T3R*_XHZ=_P2D^*?PDO+I/!?BZWM;*?RMTT=YJ&F33[%)'G0VL<Z?(SR+'
MF63Y26^0NR#]7_V6OV0[/]G7[5J5]?W&O^)M0PM]KE[N:XDA3:L4$?F23/'$
MJI'N!D=I7169MD<$4/R_\9_^"=OBCXX>+;3QI?>,K>WU33_LOV$6V@!8;;[)
M(9HMB2ZA*7_>L\K><TN6<K_J@D:_I_X6MM1M+.--5GM[F]&[S9K:W>UA;+$K
MLADGN73"[5;,K[F!8;0P1>?^+']C_P#"/:K_ ,)#_P @7^S[O^T?]9_QY^2_
MVC_4_O?]5O\ ]5^\_N?-BOA#_@E/\!G^#?P^AO[R.-;[7Y!J+$1QB1;5T5;.
M-I4=S(GE@W*!BIB-U)&8U<2%OTOHKY@_;&_X1>]\%W^G^+OM#Z?J'E6L5M9Y
M:^NKQI%>T@L8UYENS*B-#&0T9*%IA]G64C\H/^''7VS][_PD_P!EW_-]G_L_
M[5Y.>?*^T_:+7S]GW?.^SVWFXW^1#N\M3_AR7J/AK_3M(\8;=2MOWUFW]G/;
M8N(_GA/GQWDDD.'"GS41WC^^J,P"G]#_ /@GQX_\2^+_  UJ6F>*[F.^U3PY
MKE[H;WB%F:X6R6']Y)(X5I7W2,HE94>1%1Y TQD=_C#]I3_@D;+K>N?\)'\.
M-0M]&N&N(Y_L,IE@AMIE+.T]G<6ZR20X<1M';B(+$Q=HYHXUB@7O_@7_ ,$Y
MO$VH7D%Y\6/$UQXDM+*X\^WT5KR\O+%YD4"&>=KLIOV[YE-N(0KC;OF>)YK=
M_L#]KS]G+7/VH='D\.VVNV^D:1<>0UU'_9AN[B9H9#*%\]KR)$BW+"^U(A+O
MB_UYC=HJ/V0_V<M<_9>T>/P[<Z[;ZOI%OY[6L?\ 9AM+B%II!*5\];R5'BW-
M,^UXC+OE_P!>(T6*OE_XS_\ !.WQ1\</%MIXTOO&5O;ZII_V7["+;0 L-M]D
MD,T6Q)=0E+_O6>5O.:7+.5_U02-?TOTS0+C4]+-AXA:SU&2:.6*[\NT:&UGC
MD+*4-M-/='88R$D5Y9!(=QPJML7\0?BA_P $A->\)^(/[:^&.NQZ9&9)GBCN
M)[JVN+%70+Y<%Y;K-+,C!YDRXB=(=D;O<,SR5]7_ +,7[ NK>$M1M/$?Q)UZ
MX\4:OI^]M-MI[BXNK/3YF?YIXGNFWRRE4A9"8H5AD!;;+)'!-%Z!^V;^QQKG
M[8,4.FS>(K?3=%MK@7,-K'I)FF:81>4'FN6ODW[=\WEK%' H64K()61)![_^
MSA\+-<^"VAVV@:OJ]OJ]O86\-M931Z>;*9(80RJDQ%U/'+M3RHXV1(6"QDR&
M:1RX\@_;H_8RL_VP]#C@6;[)K6G>=)IERQ;R0TH3S(9T7.8I?+C!D53+"R+(
M@=1)#-\__LZ?L3>/M/TY?#GQ&\2_;O"MG;F"UTC3;F>+SUD26(Q7EZL-I>-:
M1QR%8[02/$_[M6V0VZPR>0?LV?\ !,#Q;\)M1U/2]4\06_\ PAVJ;5U"VL/,
MCO-3AMW?[/!,[0J]G%(LDGVH6UP[/&SVVYED\Z/V_P#;Y_8&UG]I76=+\5>%
M=4CT_6]/CCMR+B26&-8X99+B&>":WCDFCN(Y9&[$,"C*\31$3?6'[/7P;\1^
M"M^J^-=<_P"$@U^:WB@65;6"VM[*'B2:"U6*-"WFRX,]PPC:Z2"S#PI]F05\
MW_MQ_P#!.+2_VK7&M:9/'I?B..,J\YC+07RI&1#'=!2&5U8(BW2B1TAS&T4X
M2!8OE#X:?\$T/BG<[-(\3^.;B#PVMNMO)9Z=J6H3^9;C;&UHL,ZP6\430[T#
M%9D3"J;:1"0O[7> / &E_"S2[;1=%MH[/3K.,1P01@[57)))))9G9B7DD<L\
MCLTCLSLS'L*_,#]K_P#X)_:Y^V)J-O<ZIXHM[2RL/M"V-I!HQ/EK.X9FEE;4
M-\LI5(D=@(XCY09((BS[OM_PYX<\6Z5H9L[O6-/O-:7RUBU%M)DCA95$89I[
M.._&^5\2,6AFMH@SKM@"QE'^ /@Q_P $[?%'P/\ %MWXTL?&5O<:IJ'VK[<+
MG0 T-S]KD$TN](M0B*?O525?):+#(%_U1>-OJ#]KS]G+7/VH='D\.VVNV^D:
M1<>0UU'_ &8;NXF:&0RA?/:\B1(MRPOM2(2[XO\ 7F-VBH_9#_9RUS]E[1X_
M#MSKMOJ^D6_GM:Q_V8;2XA::02E?/6\E1XMS3/M>(R[Y?]>(T6*OB#]H7_@F
MCXAE\<IX[^&6K6^DW\UQ+>7*W<TR^5>2,3)) Z0W'F17&^3S[>9?+&70;[>8
M00[_ .T%_P $XO$/Q^\)6QU?7_[2\<Q7"7$EY=R31Z:B/&L4UE:6L"B&VBPD
M4IN$M3/<S0[I!&LVV#Z@_8__ &9-<^#EG:W?C#5O[6UJST\:59) 2EC8:;&T
M96"!!'#YTLODP-<74T?G,(H80=L)DF^0/%G_  3H\<^$OB5=^-/ 'B2WTNWU
M.XFGNY+A6DN(?MLI>\B6W\A[:[B!/FP).T6'$:L1)"MTWZ??#?X1Q>$-#?2=
M5G_MJXO?.?5KNZ@B!U":X&V8S1*OE^5LVV\,!WK#9Q06H9HXEK\<?BA_P2$U
M[PGX@_MKX8Z['ID9DF>*.XGNK:XL5= OEP7ENLTLR,'F3+B)TAV1N]PS/)7U
M?^S%^P+JWA+4;3Q'\2=>N/%&KZ?O;3;:>XN+JST^9G^:>)[IM\LI5(60F*%8
M9 6VRR1P31>@?MF_L<:Y^V#%#ILWB*WTW1;:X%S#:QZ29IFF$7E!YKEKY-^W
M?-Y:Q1P*%E*R"5D20>__ +.'PLUSX+:';:!J^KV^KV]A;PVUE-'IYLIDAA#*
MJ3$74\<NU/*CC9$A8+&3(9I'+C@/VO/V<M<_:AT>3P[;:[;Z1I%QY#74?]F&
M[N)FAD,H7SVO(D2+<L+[4B$N^+_7F-VBH_9#_9RUS]E[1X_#MSKMOJ^D6_GM
M:Q_V8;2XA::02E?/6\E1XMS3/M>(R[Y?]>(T6*OB#]H7_@FCXAE\<IX[^&6K
M6^DW\UQ+>7*W<TR^5>2,3)) Z0W'F17&^3S[>9?+&70;[>800[_[07_!.+Q#
M\?O"5L=7U_\ M+QS%<)<27EW)-'IJ(\:Q365I:P*(;:+"12FX2U,]S-#ND$:
MS;8/I#]E7]F#Q+\(M+BN/$FLQZCXCM-+;2=,*HS:;IMBA3RHX[=/LC7+NT-N
M]U/+Y=Q*L,5NLJ"(S2^'_P##NWQ1_P + _X63_PF5O\ V[]H\[']@#[/L\G[
M-]G\O^T-WE?9_P#1\[_/V?/YWG_O:_4_28[B&WB6\DCEN1&@FDBC:*-Y HWL
MD;22M&A;)5&DD*@A3(Y&XZ%?F!^U_P#\$_M<_;$U&WN=4\46]I96'VA;&T@T
M8GRUG<,S2RMJ&^64JD2.P$<1\H,D$19]WW?X*T'Q+HNC-::KJMGJ&K+&4AOU
MTUK:,L(E5)+BU6\<2/Y@:240R6J.&\M$@QN/YX?\.[?%'_"P/^%D_P#"96_]
MN_:/.Q_8 ^S[/)^S?9_+_M#=Y7V?_1\[_/V?/YWG_O:^T/CS\)_$OQC\-2>'
MK36K/3&OK.2UU.Z&E-<-,LJHDOV6-[Y5MD=?.1ED-TZI*-DJ2QB5O#_V,OV.
M-<_8^BFTV'Q%;ZEHMS<&YFM9-),,RS&+RB\-RM\^S=LA\Q98YU*Q!8Q$SO(?
M/_'_ .QSXYL?B!K7Q)\':]I]EJ5[]C@AT^[M&EM[FSBAL5FCNK@;I(-[VSG%
MO$TFQ8PMQ$TK^5H>+/V5O'7[5+V-G\4[[0X]"TZ\2\_LW08KO=?R".1 +BZN
MV$MNB!MH%N"94FF!:*18)4]P_:\_9RUS]J'1Y/#MMKMOI&D7'D-=1_V8;NXF
M:&0RA?/:\B1(MRPOM2(2[XO]>8W:*C]D/]G+7/V7M'C\.W.NV^KZ1;^>UK'_
M &8;2XA::02E?/6\E1XMS3/M>(R[Y?\ 7B-%BK/_ &TOV+=+_;)TNUM;JZDL
M-1L)'>RO40S+&LQ03QR0%XUD218TP=R.CHC*^SS8I?D#]G[]C'XT^!+<:!JO
MCF.S\."/84L"U[>+'MCA-O:W%[:QO8H(580R0R,+:0*Z6Y+,P/@7_P $IS\-
M?%6HZ[+KEYING/>7(L-.T6[N;>1M/-Q'-!!=WQ99RA1?*G@C^<E8Y5O=XX_5
M[Q_X TOXIZ7<Z+K5M'>:=>1F.>"0':RY!!!!#*ZL \<B%7C=5D1E=58?A#JW
M_!([QU\+-9EO/AYXICM+:6-T$TMS=Z?>+&TI86[O912K,@5(6:3,(DD!/V>,
M(N?T/_91_8DE^#EX/$WB_5[CQ-XL^SI!%>W<DLRV$)4F6"T:X=Y#EWE!N&\M
MFB;:L, DN!-]_P!>?_$O1=<\0:<]MX>U&WTJ]DW+]KGLC?>6K(R[HHOM%N@E
M5BCHTIEB^4J\$@;Y?@#]D#_@G]KG['>HW%SI?BBWN[*_^SK?6D^C$>8L#EE:
M*5=0WQ2A7E1&(DB'FEG@E*IM^@/VO/V<M<_:AT>3P[;:[;Z1I%QY#74?]F&[
MN)FAD,H7SVO(D2+<L+[4B$N^+_7F-VBH_9#_ &<M<_9>T>/P[<Z[;ZOI%OY[
M6L?]F&TN(6FD$I7SUO)4>+<TS[7B,N^7_7B-%BKY?^,__!.WQ1\</%MIXTOO
M&5O;ZII_V7["+;0 L-M]DD,T6Q)=0E+_ +UGE;SFERSE?]4$C7[?\>^!?&7C
M#0SI=MKNGV-[<6]W!=WT.E7(8><"L4MDJZJKVLL*DG>\ESNE"R*(@-A^$/V9
M_P#@FWXE_90U234_#WC.,K/'Y=U9W&BL]K<* WEF6--2C;?&S%HI$9'0EDW&
M*25)/U?TF.XAMXEO)(Y;D1H)I(HVBC>0*-[)&TDK1H6R51I)"H(4R.1N/Y0>
M-?\ @G7K/PN\8KXX^$>I6>CW,D@^TZ1>)*NGO&^YKB,- )&^SR,L6+3RP(GW
M2P7$!BMXXO4/%/[.7Q*_:;LY-$^(NL:/I^@/M\^S\.6\K37VUA+'YMUJ2R&V
M\B6*%T\A'\Y6ECDV_(P^S])^&Z?#CP_%H7A!;/2H[2-([,2VTES;Q*'#.7B2
MXMY97<%RTAG5VF<S2-(VX/\ GA\&/^"=OBCX'^+;OQI8^,K>XU34/M7VX7.@
M!H;G[7()I=Z1:A$4_>JDJ^2T6&0+_JB\;?I_XIMM1N[.1-*GM[:].WRIKFW>
MZA7# MOACGMG?*[E7$J;6(8[@I1OS ^#'_!.WQ1\#_%MWXTL?&5O<:IJ'VK[
M<+G0 T-S]KD$TN](M0B*?O525?):+#(%_P!47C;Z@_:\_9RUS]J'1Y/#MMKM
MOI&D7'D-=1_V8;NXF:&0RA?/:\B1(MRPOM2(2[XO]>8W:*C]D/\ 9RUS]E[1
MX_#MSKMOJ^D6_GM:Q_V8;2XA::02E?/6\E1XMS3/M>(R[Y?]>(T6*OE_XS_\
M$[?%'QP\6VGC2^\96]OJFG_9?L(MM "PVWV20S1;$EU"4O\ O6>5O.:7+.5_
MU02-?N_Q_P#!A/C?X3N?"_B^6.[6^C*7,UC%)9+N642P20QR3W3(\3)$V)))
MD=T)9#$YAK\L?V??^">7Q5^!5Y<Z-8^,+>Q\)WUPYO39;S?/"%9!);QSVSQV
M5W*FQ'F@G+0D(^^X-O$IT/&O_!,SQ5X8^)"^,OA]K5GI5L\@E:6\-Q>WEM)/
M&T%\X%TETMZ\BO+.&N)HBTDS1YC"+,?O_P ?_LD:7XS^'ES\/([N\BMKB,DW
MTTANKI[HW0OFNKAI/]<\MSF:X4&,.'D2,P H4^+_ -E']A'XB_#"S'A_Q/XH
MMSX3CN$F;1;*/[2MVI8R36TMQ=V\4EO:2.J?:+:(217<4MU&ZQ&9WD] _:__
M ."?VN?MB:C;W.J>*+>TLK#[0MC:0:,3Y:SN&9I96U#?+*52)'8".(^4&2"(
ML^[[_P#AIHNN>'].2V\0ZC;ZK>Q[5^UP61L?,545=TL7VBX0RLP=W:(Q1?,%
M2",+\WQ!^V;_ ,$^+/\ :/O(?$V@7G]A^++3#I>QJP6Y:%<VWG-$RR12QNL8
MCO(]\L40*F*8) (=#2?"/Q_UJWBTS4=:\)Z='Y:)+J]E:7=WJ :-0?,6VN%A
ML7>5E"RC;&B)([Q(K*BCZ _9G_95\-?LH:7)IGAZ*0M/)YEU>7#*]U<,"WEB
M61$C79&K%8HT5$0%GVF625Y/B_XS_P#!.WQ1\</%MIXTOO&5O;ZII_V7["+;
M0 L-M]DD,T6Q)=0E+_O6>5O.:7+.5_U02-?O_P 1^'/%NJZ&+.TUC3[/6F\Q
M9=1729)(55A(%:"SDOSLE3,;!IIKF(LC;H"L@1/B#]D#_@G]KG['>HW%SI?B
MBWN[*_\ LZWUI/HQ'F+ Y96BE74-\4H5Y41B)(AYI9X)2J;?T_HKQ_X_?!RS
M_: \+ZGX8OFV1:A;F-9<,WDS*1)!-M1XR_E2I'+Y9=5DV;&.QF!Y#]DS]GZW
M_9E\':=X<B$9N8H_-OYH]I$]Y+AIWWB.)I$#?NH&D42"WCA1B2E>7_MV_L@?
M\-A:'8Z;!<6]C>V6H13I=RV_FLMNX,5U$C JZ[E99@@(2:6WAC<Q@B:+[/TG
M2;?0+>*SLXHX+:"-(H88D5(XXT4*B(B@*J*H"JJ@!0   !7E_P =/@7H?[1>
MAS^'_$$'G6DWS(ZX6:WF4$)/ Y!V2IDX."K*6C=7B>2-OSP^"'[,'QG_ &3[
M>XT+PKK/AO5]"\Q9+0:RE_') S+NF$45MO$*/(S$Q^?,A*^<JQ233!OH#P!^
MQF^L^);;QY\0;^/7?$UK&%LX8;:.WTW3EW&:..WBVF:X>VEDG^SW5RY<J\<C
M1+<1)*O8?MF_L@:=^V)H<.EW-Q]@O;2X$]I?+;I.T>1MEB96*.T4JX+(DD69
M8X)&+"+8WQ_\"_V-?C#HEG!X9\3>-OLOA6VM_+CCT64C4AL8-##%?3V,<T$2
M'N)),0H+18UA?,5!O^"4:-X^N?$.G:M)X<T*".UCTRWT5Y(M054L%M9RUTXQ
M [2*7>3%V]TDDOFM'(Y<_7_[4W[+^L_M#^'U\)V.O1Z5HC1VRW"RV$NHWDYM
MGWH'O)[Y6*%EA=B4:X>2(L]RZR/&=#]D/]G+7/V7M'C\.W.NV^KZ1;^>UK'_
M &8;2XA::02E?/6\E1XMS3/M>(R[Y?\ 7B-%BK/_ &TOV+=+_;)TNUM;JZDL
M-1L)'>RO40S+&LQ03QR0%XUD218TP=R.CHC*^SS8I?D#]G[]C'XT^!+<:!JO
MCF.S\."/84L"U[>+'MCA-O:W%[:QO8H(580R0R,+:0*Z6Y+,P/@7_P $IS\-
M?%6HZ[+KEYING/>7(L-.T6[N;>1M/-Q'-!!=WQ99RA1?*G@C^<E8Y5O=XX_8
MZBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOP!_X*V:7K7Q]U'1=/\-:!X@O
M_P"Q_P"T1=7,>C7PMR\[P($AD:$>=C[,S&2,- R21M'+)E@G[??#3XBP?%#3
MDU""UU"RW;1);:C8W%C<1.45V1HYT3?MWA3)"98&=65)7VDCT"BBBBBBBBBB
MBBBBBBBBBBBBBBBBOSP_;(_:2^(WP,UG2H/"/A.37M)FC,M]/%#<W,C,LH#V
MR"UR;5Q'AEGG29)3*-D9^SRJ_H'PA^&7B#XA>)5^('C:SCTR^M[-[#2-"2X2
M]33XW;-S>27 'E&]N2/+#VHB"602&5IG9A%]GUY_\2_B+!\+].?4)[74+W;N
M$=MIUC<7UQ*X1G5%C@1]F[85$DQB@5V57E3<"?Q!_P""2>EZU\ M1UK3_$N@
M>(+#^V/[.%K<R:-?&W#P/.A2:183Y.?M*L)) L"I'(TDL>%#_O\ 44444444
M444444444444444444444444444444444444444444444444444444444444
M444444445X_\?O&&N> /"^IZIX:T[^UM7MK<O:V62/,;(!.U</+Y:EI?(C(E
MN-GD1LLDBD?GAX*\5_%+]N#P^WAGQ-X>D\)Z=<R&/6-7$D]K<36R.LCVEAI\
MX\^-[A&C@DN9WGM#"+L%)'*VX_5_2=)M] MXK.SBC@MH(TBAAB14CCC10J(B
M* JHJ@*JJ %    %:%%?GA_P4"_9Q\8_'.WT34_!FH1P:CX>O)-0BLIFVQW-
MPBI);2)O#P&XB>(QPK<((2+F7=-$@<2?.'AS]M[XS?"^(Z1XJ^'.H:QJ5OY:
MM>Z>LRPRJ8HR&9K6VO;:25B6>5K>2.)6;RA!$T; ^W^&_C+\:?V@4MUTKPQ9
M^#+&>.83ZCK$[7EU&/,6$-;6(2VE2XC'FS1I>0FWN J9D1"OG?;_ ,%_A#I?
MP%\/V/AK1ED6QL(RD9E<R2.SNTDDCMP"\DCO(P4*BEBJ(B!47U"BBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBN/\ B%XDN/!VC:AJ=G:27]S9V=Q<
M0V46[S+F2&)I$@3:DC;Y&41KM1SEAA&/!^$/^"<_[8GB']KW3M6N=>TVWM/L
M%Q!'!=6B3);S^:C,\($SR_O8=J/(5E/R7$0,<> TOZ/T44445^<'[;_[?4O[
M*43VUCH.H7MVVR-+^XMY8-(CFEBED1!<E?\ 2I4V([V\)56C,B_:HY8I$7[/
M^"'C6X^)7A71-<O%C2YU+2[&\F2(,(UDN+>.5P@9F8(&8A0S,0,98GD^H444
M5Q_C_P 9)\/M+N=4DMKR\6VC+BVL;:2ZNIFR L<,,8+,[,0,G:B EY'CB5W7
M\\/V5OV_M1_:=^(>J>&/['_LG3=.T^ZE\NZW_P!HFXM[V&#]^N5C@^27$EML
MD>*9"/M#KQ7Z?T4445X?\;_VA_#_ .S[;V\NLS2&YOI&AT^PMHGN+R^N N1!
M;01@LSLQ2,,VR%9)8D>1#(F?(/BA^TYK/P&\*_V_XB\/WEQJ,\<TZZ7I,4MY
M'I\<5N'8:CJ040*BN"9KA8U""0I#!=I:RW,F?^P5^U+J/[7/A[4->U"UM[/R
M=8N;2V@@+MMMTAMYHQ*[L?,E'G%7D58D? (B3D5]OT44444444444444445G
MZMJ::+;RW4HD:.&-Y'$44DTA5%+$)%$KRR/@?+'&K.YPJJS$ _EA\/O^"CNH
M_%7XI:;X$MM N-(LI?M/VLZM&\6I';I[7<6+96"6WS(<[VN?.A='7R2<5^K]
M%?G!^V_^WU+^RE$]M8Z#J%[=MLC2_N+>6#2(YI8I9$07)7_2I4V([V\)56C,
MB_:HY8I$7[/^"'C6X^)7A71-<O%C2YU+2[&\F2(,(UDN+>.5P@9F8(&8A0S,
M0,98GD^H4444444445Q_C_QDGP^TNYU22VO+Q;:,N+:QMI+JZF;("QPPQ@LS
MLQ R=J("7D>.)7=?SP_96_;^U']IWXAZIX8_L?\ LG3=.T^ZE\NZW_VB;BWO
M88/WZY6.#Y)<26VR1XID(^T.O%?I_111117YP?MO_M]2_LI1/;6.@ZA>W;;(
MTO[BWE@TB.:6*61$%R5_TJ5-B.]O"55HS(OVJ.6*1%^S_@AXUN/B5X5T37+Q
M8TN=2TNQO)DB#"-9+BWCE<(&9F"!F(4,S$#&6)Y/P!\4?VY_%7@?XRZ?\/+7
M0HYM)NI+*,S%+@W4\=RFZ6]@=?W0M[8E_-'ER@BTN-T\63Y'ZGT4445Q_P 0
MO$EQX.T;4-3L[22_N;.SN+B&RBW>9<R0Q-(D";4D;?(RB-=J.<L,(QX/PA_P
M3G_;$\0_M>Z=JUSKVFV]I]@N((X+JT29+>?S49GA F>7][#M1Y"LI^2XB!CC
MP&E_1^BBBBBOG#]IO]HM/V;-&?5#I.J:O)Y<[K%86LDD<2P1&1I;RX"F*UMP
M=H>1]S@,SI#*L4NSR_\ 8*_:EU']KGP]J&O:A:V]GY.L7-I;00%VVVZ0V\T8
ME=V/F2CSBKR*L2/@$1)R*^WZ*****\?^,?C#7/A]9KJND:=_;%O;Y-[I\)*W
MSPED+361.8YI8D$I^Q.(VNBRB.YBDC$-ST'PT^*NA_&33DU7P]?V^H63[1YL
M#AMC,BR>7*OWXI0KH7AE"2Q[@'13Q7H%%%<?X_\ &2?#[2[G5)+:\O%MHRXM
MK&VDNKJ9L@+'##&"S.S$#)VH@)>1XXE=U_/#]E;]O[4?VG?B'JGAC^Q_[)TW
M3M/NI?+NM_\ :)N+>]A@_?KE8X/DEQ);;)'BF0C[0Z\5^G]%%%%%%?G@/VG_
M !K^T%I=UJWPIT:SDTZUDD6&_P!=>:W75&A,RR1Z=:Q;6*%EA"75W/:H'=X'
MB5XYFA\O_8K_ ."DTOQYUP^"_%FF?V3XD'GK'Y2RB&::W,KSP/!*&EM)8HDR
M1*\BR-'-EH7\J%_U?HKXP_;!_;%3]D^P^U#0]4U>3RUD:2""2/3X%:9(5%UJ
M!C>*%W+-Y4:+,Y=45UB6:)V[#]C/XUZC^T3X$TOQ/JL=O#>WWVOS8[972$>3
M=SP+L6225QE8E+9=LL21@8 ^+_VV_P#@IA>_LX7#:3HWA^\:[,DL<>HZK;3V
MVGR-"T)D-HG[N6]0!WC:17@1'\J5&N(9%+?K?11111117S_^U/\ %G4?@7X+
MU?Q)I5E_:%[86XDBMR'*_-(B--((P7,4"LUQ, 4S%$X,D0S(GF'[!O[1VL_M
M2^#E\0:YI\=C<_;+BW1H5E2WN8X]A$\"REF"!F:W;$DH,T$AWJ28H_L^BBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBN?T[Q9IVKWEUI]M=V\U[8^5]KMHYD>:W\Y2\7G1J2\7F*"
MT>\+O4%ER.:Z"N/TSXA:-K6EG7+74+.;25CEE-_'<1/:B.$L)7,ZL8@D91Q(
MV["%6W$;3C/\"_%CP]\4/._L'5=/U/[/L\_[%=PW/E>9NV>9Y+OLW;&V[L;M
MK8S@X] KS_QU\6/#WPO\G^WM5T_3/M&_R/MMW#;>;Y>W?Y?G.F_;O3=MSMW+
MG&1G0\%?$+1OB5;M>:'J%GJ5LDAB>:SN(KB-9 JL4+Q,RAPK*Q4G(#*<8(S^
M6'_!:O\ Y)YIO_8P6W_I%?5]_P#[)W_)//"G_8OZ3_Z10U] 4445X_\ \-"^
M#?[1_LC_ (2#1_[2^T?9?L?]HVWVC[1O\OR/)\SS/-W_ ">7MW[_ )<;N*_&
M']@7_DX7Q[_W'_\ T\V]?O\ 5X_XI_:%\&^!KR33]5\0:/8WL.WS;:YU&VAF
M3>H==\<DBNNY65ER!E6##@@U[!16?JVK6^@6\MY>2QP6T$;RS32NJ1QQHI9W
M=V(545069F("@$D@"OR0_83U^?\ :^\<^(?BKJEO_HECC1O#@>.W7R+?=)-+
MN0&65;M8I8B\PDV-]LNHD9HL1P_?_P"UC_R3SQ7_ -B_JW_I%-7YX_\ !&K5
MK?0/AIJ]Y>2QP6T&N7DLTTKJD<<:6-DSN[L0JHJ@LS,0% )) %?J=X%^+'A[
MXH>=_8.JZ?J?V?9Y_P!BNX;GRO,W;/,\EWV;MC;=V-VUL9P<>@4445^8'C7]
MKC_A+?C?X:\!Z%>[["R_M)]9\B3*37@L+KR[67"#=]EV>8ZK(\9GE"R(MQ:#
M;^G]%%%%%%<_XI\6:=X&LY-0U6[M[&RAV^;<W,R0PIO8(N^20JB[F957)&68
M*.2!7/\ @7XL>'OBAYW]@ZKI^I_9]GG_ &*[AN?*\S=L\SR7?9NV-MW8W;6Q
MG!QZ!1117X _\W>?Y_Z%ROW^KC_&OQ"T;X:VZWFN:A9Z;;/((DFO+B*WC:0J
MS! \K*I<JK,%!R0K'& <?D#_ ,%=OB%HWQ*^&FGWFAZA9ZE;)XDMXGFL[B*X
MC606-XQ0O$S*'"LK%2<@,IQ@C/Z7?LG?\D\\*?\ 8OZ3_P"D4-?0%9^K:M;Z
M!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22 *Y_4_B%HVBZ6-<NM0L
MX=):.*47\EQ$EJ8YBHB<3LPB*2%T$;;L.67:3N&3P5\0M&^)5NUYH>H6>I6R
M2&)YK.XBN(UD"JQ0O$S*'"LK%2<@,IQ@C/85Y_XZ^+'A[X7^3_;VJZ?IGVC?
MY'VV[AMO-\O;O\OSG3?MWINVYV[ESC(ST'A;Q9IWCFSCU#2KNWOK*;=Y5S;3
M)-"^QBC;)(RR-M965L$X92IY!%9_C_Q_I?PLTNYUK6KF.STZSC,D\\A.U5R
M   69V8A(XT#/([+&BL[*I^(/^";WQYU3]I+0=>\1:I)(6G\27@MH'D#K:6H
MM;,PVL9"1KLC5L%@B&5R\S@RR.Q_0^BOP!_8%_Y.%\>_]Q__ -/-O7[7:9\;
M_"NM:H=#M=;TN;5EDEB-A'?6[W0DA#&5# LAE#QA',B[<H%;<!M./4**\?\
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M0_X*C_\ )(?$/_<._P#3E:4?\$N/^20^'O\ N(_^G*[KX _X+G?\RC_W&/\
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M&JLBS6K22F:%Q,PCM+F**64QH9U\]HWC*^9<22?T/5^<'_!5KXE_\*[^%]_
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M[G2IX[>Z*H<^6)GBE:-"VTL8MCL%V%_*:1'_ !1_X(8_\S=_W!__ &_KZ/\
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MW.]65?'_ /@M7_R3S3?^Q@MO_2*^K[__ &3O^2>>%/\ L7])_P#2*&OH"OR
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M<RQ. P!*21NDD;='1E=258$_=]?@#^WU_P G"^ O^X!_Z>;BOW^K\ ?V!?\
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M*M3\'Z<]SI&D7&M7OS+%:03VMOEMC,K2RW<T2)%N54=D$TJ[PRP2 -C\@?\
M@F9\!OB%^R=J.J6WB'PQ<?8M9^PK]K@U#3)/LS6[RKNEB^UAVB*W#N[1%Y5\
MH*D$ID^3Z_\ ^"AWA?Q5\6_"%YX0\,:!<:E+J/V1I+W[78VUO L-RL[+B>X2
M:27,"+M$:Q;)MXG+QF(G_!/'POXJ^$GA"S\(>)] N--ET[[6T=[]KL;FWG6:
MY:=5Q!</-'+F=UVF-HMD.\SAY!$/B#]J;X+_ !.^,WQ.T7QSI7@ZX6RT+^S?
M*@N=5TJ.:Y^QW3WC;_+NYD@W-(T2X,V%42GEC$GZW>/_ (=67[37A.YT3Q%8
M7EC;:E&4FM9)8!=0-'*'BD$EK-<P;U>..>,!Y4(VK*A!DBK\$= ^''QR_P""
M<^L7%CX8L[C7="N;B22-8+*2^L[K9&$6:6" M<V4N)$#@/#YLD(0274$ 8_?
M_P (/AY\5?VH=8T7Q#\3(=/TC0-)N(M2M-#@B=+B:^AC9K.ZE_>230;#<$O%
M+.#OMA#+8#>TM'_!3CX7>-OVD=)M/#'ACPY<745KJ$=[+J,E[I\$+[+>2-8X
M8I+H3-DW#B1I4@V-" BS)('7[ _9$.O:1X2TO1/$6B7&CWND:?9V3&2YL[F&
MX\B/R1)"]K/*XRL2/(LR1;&E$:-,$:2OS0_;@_9U\>?##XD0?%KP!92:G((X
M7NH55;F2.=(UL6C%HJK-);SVY128#+-&?M,I>W58G'T_X*^)GQ2_:[MVM?[%
MD\ Z/YA@U"\NI9VUB6-E5R-*22VMUMWV@PO=3HX3SQ+;[I[9UKY _P""6'[/
MOQ2^$%Q=7LUA9Z3HFIR6AO?[5BG_ +0DCM6NEVVEM'+$T+EG*L]X$ 22*>*.
M=5*/]'_\%)OV*]<^/,NF>+/!9QXDTG;%Y:SFWFFA$HE@>"=Y4BAEMI6DE!/E
MM(LC'SM\,,3\A^S]^UU\;O&UN-$OO LCZL(\)K%^L^DV<:[8XA/=0RPXG=9&
M,\T5F\3RQ[E@MT\LM7S_ /LF_LV?%[P%\2_$/B"SBLUCFO-1LKO6=:M)(8[M
M'OH9I;JTL;>6&5WE"B>#:RV3#S(1<*P4C]+_ -NC]C*S_;#T..!9OLFM:=YT
MFF7+%O)#2A/,AG1<YBE\N,&15,L+(LB!U$D,WY ?"/XJ?M#_ +(D4_AQ?#NH
M:O;Q>0(4N[&\U.&U58E"QVEU93>7Y6SRU,*R210LFU$BD,P;]7_V:_@YXT\6
MZY_PG_Q.:WBUJ*WDL])T6V$;VFEPN5$]PC;Y_P#2[G9AI(Y786[F)Y75TM[3
M[_KY_P#VI_@I_P -$^"]7\,+)Y,M];C[/(6V*+B&1)[?S&\N4B(RQ1B;:C.8
MBX3#[2/@#_@C=XIE7PEK'AF_DN%U+1M8E$ME<+*K6<,\:!8PL@"QYN(;PO"N
M&242,Z*T@+_I_P#%CP+_ ,+0\/:KH/G?9_[3T^[LO/V>9Y7VF%X?,V;DW[=^
M[;N7=C&X9R/QA_9,N_B+_P $\HKCPSK_ (-U#6=%O=0N+F+4-#'VZ962)(6?
MR8R<Q2^7;F%;G[%*JF9L2LIBC]_\?_#+Q1_P4.U&P76M-N/#?@'3;BWO5L]2
M@"ZIJUPCM'-'+#%.LMA$L1GB1MZN1*EPJW D06GZ/^+/AIIWBOP]=^&-GV33
M;O3YM.\NU5(O)MY83!M@7:8TV(<1C847 &TJ,5^"/[..K?%[_@G5<:AX<N/!
M]YXBTFYD:YB_L]))(Q/N$'VB.[M[>X(26.$;K:XC290(9-D&YUF]0_;U^!?Q
M5^/_ (>T^]U2#?>S:Q;0V/AO2-\UO9P7$-PS7.IW+ )+=QL8K5[D&*PMD61T
M;%VY7]+_ -C?PEXU\"^%;+3/&8TN*2RL[*ULK:P69I(H(+=(_P#3)Y)7BDN,
M@*ZVZB%3&SK+*LH$7Y8?M5_#?Q]\"_C?%\2]!T"XU^RG\J2*.TAGN/E2PCT^
MYAG\B-GMY2I9X)&5XCO1P)C'/"G['?!#5?%GBBWN-3\664>CSSR*EKI$5S%>
M"U@B7!DFN8XU$EQ/(9&8(S0I;K:HJ).+EI?<**_%'X!?\$[W\$_&G6=?OK6,
M>'M.D.HZ,%@CCMY)[YI&ACBB"RQ!+ B9<!X)HIH[*X2-8I5%?K=\5?AIIWQD
MT._\/:JF^RU"W>"7"HS)N'RRQ^8KHLL3;987*MY<J(X&5%?FA_P2C_9,O_@)
MI>K:MXCTZ2RUV[O'LT6;R69+.U(&8F0,ZI-/YA<[S'<)!;3(IC\N63]7]6TF
MWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP*LC*2K*P(8$@@@U^$/@'X*>//^"9WC
M&YNM TN\\4>"-6D@CN!9PK/J"HOG-$3%$/-%Q; RYD"K97*2*K-;S2QBU^K_
M (J_%WQI^UQH=_X4\'^%=8T3^T+=[:]U;Q'%'IL-M#*/F2* K=2W?GQ+/;.T
M*AK5I(I"1N#I]?\ [,7[/6G?LO\ A>T\-:>_G>3ODN;HQ)$]U<2G=),X0?2.
M,,TCQP1Q1&23RPQ_%'X>?#SXF_\ !-+QCJ9T+PY>>)/"^IR2)&ELIN))X(-S
M6DDDUM \MK<1"<I()8%AG)N!&D@6*>+Z _:V\+_%+]IOX>7^K:E8R:3:>793
MZ=X6TX3W>I7,DEU;HYU5A$I9(8_,N8K6"-"C2(]SMFL@I^C_ -@/X:_$7X#>
M$$TKQ3::>EEI]O<M8Z;:'S=4EFDN9IV6>Y:Z6P7=NQ J':PE0RSVYB<2?('_
M  I?XG?\+O\ ^%H_\(=<?V;]HV_9/[5TK[1]G^P?V=YO_'WY?F[/W_D[MF_]
MQY^W]_7[7:MH=O\ $K1I;#5;61+;4K-X;NSE=1(L=Q$4E@=[>1E#A69&:&5@
M#DI(1M8_SX_#WP3\9O\ @FOKES8Z-I-QXF\-WEQNV6T$UQ#.L9B+3HEN9)=/
MNVB(A8S*T3L#\MXEM%(OJ'[;_A_XL_M=^%=)F?PW)I5L^J6B6VA1L+V\EDGM
MYS_:%[<!(EL+>%62W$,RQ%))IWNFC"0"OT__ &-_"7C7P+X5LM,\9C2XI+*S
MLK6RMK!9FDB@@MTC_P!,GDE>*2XR KK;J(5,;.LLJR@1?5]?E!_P4X^%WC;]
MI'2;3PQX8\.7%U%:ZA'>RZC)>Z?!"^RWDC6.&*2Z$S9-PXD:5(-C0@(LR2!U
M^L/V6K[Q%X6\%6.EZ[X>O+#4=$TNVM1"+K3[A;UK:$Q+]EDCNMJNZQ(66Z^S
M)&\P02R(CS#\T/\ A2_Q._X7?_PM'_A#KC^S?M&W[)_:NE?:/L_V#^SO-_X^
M_+\W9^_\G=LW_N//V_OZ_4_]H?X#67[67@Z;0=5CDL)+N.*>%Y(X)KBPNDPZ
M-\KR1%U):&?R9<20O-$EP%D\ROS0_94^(?Q%_8;@E\$>+O"FL:SI%MYLNEWN
M@V?V_:)+B0NC,A1&BE;S)T$[17D.X+)"8Y8A!Z?\9OA=XL_X*.OI=G>:;>>%
M/!5E>?:ISJ)B35K]A&T0\NR$<K6;PL)X@UQ+LDBN8[H13[%B'Z'_ !8^&G_"
M5^#=5\,:0EO:?:]'N].LX]OE6\/FVSP0KMC4[(DRHPB':@PJG %?BC^P-J'Q
M>_9YM]4\#VG@J222:\DN(]1U!Y+.SM)RL=I)+)-L>*^MU*0RK%9.)I(TF:)I
ME96B_?[2;)].MXH)9I+F2.-$>>41B25E4 R.(DCB#L1N81I&@).U%7"C0K\(
M=7^"7Q%_8L^)VO?$'0-"_P"$JT75OM<DT=M)Y=RJZC=+.84A4RW'FPS+'NDC
MAN8GMLN1"S/]F^G_ (E_%3QI^V%IS^$_"GAW6/#EEJ&ZVUO6/$-C':_9[&9&
M$B6=JTS/=2S*)(F9,"'* F(SI<V_V?\ LZ_ ;2_V;?#5EX=TN.,+!&IN9TC*
M-=W151-=2 O(V^1ER%+N(D"0H1%&BC\X?^"A/_!/;5/BKJB>// ;R)XF22W-
MS;"X$#3- $C@NK6>1T6"XA5$W+OC1TC$B%+A"+GY_P#@O^U3^TA:V]CX>B\)
MR7\\49C2^U?3+Z"218U9P;F[EN+6WWA!L$DA5YB%W-+.Y9_UO_9:^ =Y\%-.
MNKG7;[^UO$VLW O-9U(HH\R;8J1V\)"(_P!DMU&RWC8!4W2-'% D@@C^GZ_*
M#_@IQ\+O&W[2.DVGACPQX<N+J*UU".]EU&2]T^"%]EO)&L<,4ET)FR;AQ(TJ
M0;&A 19DD#K]@?LB'7M(\):7HGB+1+C1[W2-/L[)C)<V=S#<>1'Y(DA>UGE<
M96)'D69(MC2B-&F"-)7Y@?M3?!?XG?&;XG:+XYTKP=<+9:%_9OE07.JZ5'-<
M_8[I[QM_EW<R0;FD:)<&;"J)3RQB3]GO^$ROO['_ +3_ +&U#[7_ - OS+#[
M9_K-GW_MGV+[O[[_ (^?]7Q_K?W5?C#^RS\%_B=\&?B=K7CG5?!UPUEKO]I>
M;!;:KI4DUM]LNDO%V>9=PI/M:-8FR8<JQE'*B)_M_P#X*'>%_%7Q;\(7GA#P
MQH%QJ4NH_9&DO?M=C;6\"PW*SLN)[A)I)<P(NT1K%LFWB<O&8B?\$\?"_BKX
M2>$+/PAXGT"XTV73OM;1WOVNQN;>=9KEIU7$%P\T<N9W7:8VBV0[S.'D$0^(
M/VIO@O\ $[XS?$[1?'.E>#KA;+0O[-\J"YU72HYKG['=/>-O\N[F2#<TC1+@
MS851*>6,2?K]XC^(>M:?H8U*Q\.:A=:D_F*FDM<Z=#,C 2;&GG-X]LD3%$RT
M,ES*BRJWD,RR(GY0_P#!,SX#?$+]D[4=4MO$/ABX^Q:S]A7[7!J&F2?9FMWE
M7=+%]K#M$5N'=VB+RKY05()3)\GZ'_MQ?"'5/CO\/-:\/:*L;ZC=1V[P1R.(
MUD:WNH;DQAS\JNZQ%(RY5-[+O>--SK^>'_!/_P 6?%72/#EKX"_X12XTJTM+
MAE;7[W?9-:VEU.]Q,T5G=P/]KNQFX6W9 UO'*]K]I@,2N9O?_P#@HS^P3_PU
M19IKNB-L\3:?;^5#&\FV&]MU9Y!;$L=D4H9W:"7Y4+.T4QV,DUO\(?"']HK]
MI#X2HOA=_#5YK$R7CPI>:K87UPP9Y-NTZBD\4$EN'W,MQ+(Z*C9$_P!G6,)^
MK_[*WP0\0>';B^\9^.KB.Z\6ZU'$DD,:H;?2K.-F>/3K1OF8(&;?<[':.694
M8F:2-KNX_.#]J+]EWX@_LU_$&X^)OPRMY+RVO)&N+RSMU>>023O&+J">U,C3
M7=O<RL;C_1P3;DNP2V%M!.?8/$?QA^+W[4G@76-./A*3PT/[+O$OKVX$DEQ>
MM':%I++3]+EA2X5[QW6*.9VG2&%IU226[2.K_P#P2U^"?Q*^"FDM::Y:Z?IN
M@75Q+?&WN$E?5Y)9K>W2/ 280VT6$!=9U:Z22.2)H$\Q9(_U_KR_XW^"KCXE
M>%=;T.S:-+G4M+OK.%Y2PC62XMY(D+E59@@9@6*JQ SA2>#^(/[ VH?%[]GF
MWU3P/:>"I)))KR2XCU'4'DL[.TG*QVDDLDVQXKZW4I#*L5DXFDC29HFF5E:+
M]+_VS?V.(OVK?"4.CM=XUK3L2V&I7$<6Z281[)$N3#$FR*XX:<6R1JLJ12B%
MUA6!OE#]F3]I?QY^SOHR>$/'?@KQ)>SZ1'!;V-YHVG+>QO:K$/+BEDBD6W9X
M4V1B6&20N/DE5)XI'FZ_7OV>?$?[<?BW1?%'C#3_ .PO">B[Y;+1;MH+B^O6
M>2.99;N$0M';17"+!'=6DTDTL1MI(!&AG-POZOU^&/\ P5LLKWXT^)?!OP]T
M2:1]1O)+B>6TQ/Y"K.T<-O=S"-'4I$L5ZSNJR/;PK,Y54?Y_V>^'O@JW^&NC
M:?H=FTCVVFV=O9PO*5,C1V\2Q(7*JJERJ@L5503G"@<#L*_#'_@IQ\%/&J>.
MO#GQ"\+Z7)J\>FQV<:P6\,UU(EU97<UY&9[>$"4V\@<+YD;8!1T=HF>$R?H?
M\(_BEX[\;6<_B+7?#5QI=NMO MAH,%W:3WUTTS*\MU</<BSC@\M#&D-N\L$J
M$7OGQ22&T6/\X/V6?@O\3O@S\3M:\<ZKX.N&LM=_M+S8+;5=*DFMOMETEXNS
MS+N%)]K1K$V3#E6,HY41/]O_ /!0[POXJ^+?A"\\(>&- N-2EU'[(TE[]KL;
M:W@6&Y6=EQ/<)-)+F!%VB-8MDV\3EXS$3_@GCX7\5?"3PA9^$/$^@7&FRZ=]
MK:.]^UV-S;SK-<M.JX@N'FCES.Z[3&T6R'>9P\@B'PA^W/\ \$]O$OAKQ!-\
M0OA@]Y]KN)+FYO[6UN&BO()Y$D>>XLY ZRR)."ZO;1LTPDDV0I)#+Y5OH?#3
M]IS]I/XH;-"@\,V]E<-;K')J^HZ7=6/E9VPM=LT\J6SRJ7$QAAMY=VUBEH\:
MF,?K=^SQ\$+?]GWP_#HT5Q)?7)DEN;_4)E47%]>7#F2>YG(RS.S':ID:6184
MCC:60IO/N%?G!_P4.\/^-OC3X7O/!WA3P]<7?VNXM/M%]-<:?%;O;Q%;D_9]
M]^EP)1,D,9\Z (4$VW.8Y#S_ /P3_L/B%\"?#EKX/\5>%+B.WM+AEM+^TO=,
ME58;F=YI6NXVOQ(/*>1F#6ZRM)$=@@$D6Z?W#]N/]D2W_:^\-#3DECM=6LI#
M<:==.BLHD*E7@E8*TJV\PV^9Y1RKQPS%)?)$3_('[,G[2_CS]G?1D\(>._!7
MB2]GTB."WL;S1M.6]C>U6(>7%+)%(MNSPILC$L,DA<?)*J3Q2/-U^O?L\^(_
MVX_%NB^*/&&G_P!A>$]%WRV6BW;07%]>L\D<RRW<(A:.VBN$6".ZM)I)I8C;
M20"-#.;A?8/^"AWA?Q5\6_"%YX0\,:!<:E+J/V1I+W[78VUO L-RL[+B>X2:
M27,"+M$:Q;)MXG+QF(G_  3Q\+^*OA)X0L_"'B?0+C39=.^UM'>_:[&YMYUF
MN6G5<07#S1RYG==IC:+9#O,X>01#Y _X*9_ ;XA?M8ZCI=MX>\,7'V+1OMR_
M:Y]0TR/[2UP\2[HHOM9=8@MNCHTI25O-*O!$8_G_ %^^&GBK4_&&G)<ZOI%Q
MHM[\JRVD\]K<8;8K,T4MI-*CQ;F9$9Q#*VPLT$8*Y_)']KO]COQ9\+_&\7Q:
M^&$$=U?)(]Q?Z9Y460X@9)Y8HAY9N$NH]ZW$49^VFXE:6%I'FS;_ $_I/[<7
MB#Q7;Q6^F?#KQ8=;EC0BWO;9-/T\2!0TRMJ5P0JHJA_*>2%#.X2/RXVD 70_
M8D_8XO/V>9=7\1>)KNWU+Q9KUQ)+>W,$:B&)6E>5D@<Q12?OG;SK@!8HBRPQ
MK"!;B23[OU;2;?7[>6SO(HY[:>-XIH945XY(W4JZ.C JR,I*LK A@2""#7XX
M_P#!.+]@6\_9_P#%&OZUX@BWRZ?<2:;HTLD:KYT+!9)-012L@3S8GBBB:&=F
MCWWUK,N]2!]__MD_ N+]HGP-JVA^1Y]Z;=[C3@/*5Q?0*7MPDDP*1>8P\B1\
MH3!+*GF('+#P_P#X)E?LZO\  #P' ^HV4EGK>K2/=WZ3K&)T7<R6L+;5#JBP
MA9?(E+/#-/< B-F:-?</VNSKVK^$M4T3P[HEQK%[J^GWEDICN;.VAM_/C\DR
M3/=3Q.<+*[QK"DN]HC&[0AUDKX__ ."8_P +O&W[-VDW?ACQ/X<N+6*ZU"2]
MBU&.]T^>%-]O'&T<T4=T9EP;=!&T23[VF(=84C+L?\%./A=XV_:1TFT\,>&/
M#EQ=16NH1WLNHR7NGP0OLMY(UCABDNA,V3<.)&E2#8T("+,D@=?K#]EJ^\1>
M%O!5CI>N^'KRPU'1-+MK40BZT^X6]:VA,2_99([K:KNL2%ENOLR1O,$$LB(\
MP_-#_A2_Q._X7?\ \+1_X0ZX_LW[1M^R?VKI7VC[/]@_L[S?^/OR_-V?O_)W
M;-_[CS]O[^ON_P#;X^'.J?'/X;SV%I>1Z))/)8S7,%[&)3*OF(5L&-H+I_M!
MG,/E"R%R]Q<1I:Q>8MQNK\\/^,O/\_\ "-T?\)_^U?\ "_\ XF^I6']IVEO_
M *RS^SZ7<^;YG[M?W.F,EZ^UG#_N6&W;N?,0D!_8[]F[XWV_[1_A/3?%5K;R
M6D=_'(3;R,KM')#*\$JAUP'021OY;X0NFUFCC8E%\P_9-^,'CGXL_P!M_P#"
M:>'/[ ^Q:@T-C\S'SHOFW)\Q/G>5A/\ 3H=MK=^;^Y1?*?/U_11111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111117P!\2_@7>? OQ0_Q)\%07$JW&[_A)_#]IM']J0X;_
M $RUB8%#J$#,9_*7RVO,2(DL4T\XN_L_P!X_TOXIZ7;:UHMS'>:=>1B2">,G
M:RY((((#*ZL"DD;A7C=6C=5=64=A11111111111111111111111111111111
M11111111111111111111111111111111117E_P 7OB]I?P2TMM4U1I"ID2"V
MMH$,MU>74IQ#:6D(^::XE;A$&!@,[LD2.Z_*'[-GP$US6O%&I_$OQ_9V]OK]
MYMMM)TX3&[_L:QB#QE$F$CP^;< [Y&@50-TKJ8_MEQ;Q_?\ 111111111111
M11111111111111111117XX_\%&_BIXE^#7C'POXDDT*36/!^AQS7LBJ66W.I
M2[[:-[J3;/%"]N7MI;&62%6\Z698I6<MY7M_A;_@K!\*/$%G'<W.J7&GRONW
M6MS87331[6*C>;6*XA.X .NR5_E8!MK[E4U+]O.S^.GVGP]\++;4-8U>>W$<
M6K+:-!I>F33^8JS7TUW'O3R5C>X2/[/*MT46WC+R.RI]?_ 'X.6?[/\ X7TS
MPQ8MOBT^W$;2X9?.F8F2>;:[R%/-E>27RP[+'OV*=BJ![!11111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111116?9:3;Z<\TL$4<<ES()9W1%5I9!&D0>0@ NXCCCC#-
MDA(T3.U5 T**************************************************
M*****************SY-)MYKB.\:*,W,4<D4<Q13(D<K1M(BOC<J.T43.H(#
M&.,D$HN-"BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBO#]6_9D\"Z_<2WEYX:
MT.>YGD>6::73+1Y))'8L[N[1%F=F)9F8DL2222:]@TG2;?0+>*SLXHX+:"-(
MH88D5(XXT4*B(B@*J*H"JJ@!0   !6A11111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
6111111111111111111111111117_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex19_003.jpg
<TEXT>
begin 644 ex19_003.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[@ .061O8F4 9       _]L 0P " @(%
M @4'!04'" <&!P@)"0@("0D+"@H*"@H+# L+"PL+"PP,# P,#@X,# P,# P/
M# P,# P,# \,# P,# P,_\  "P@,Y GV 0 1 /_$ !\   $% 0$! 0$!
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M7QA^WI\-'^(/@76)QJNJ:='INEZG=M!83QP1WC1VDA6&\)B>62WP&5X$>-)
M[;PS+$T?R?\ \$5/^2>:E_V,%S_Z16-?K_11111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111111111111111111111111117PA^V1^V8_[.EQ
MI7A[0["/5O%&O2&&PM'N8X8X6D80P2W +!RDD[JD:$PI*([C_283%S\__&_]
MI_XS_LGV]OKOBK1O#>KZ%YC1W9T9[^.2!F7;"99;G>(4>1E D\B9"5\EFBDF
MA+?H_P#!?XO:7\>O#]CXET9I&L;^,O&)4,<B,CM')&Z\@/'(CQL5+(Q4LCNA
M5V]0HHHHHHK^8'_@BI_R4/4O^Q?N?_2VQK]G_P#@H/\ '30_@UX!U>VU6?;=
MZSI]]I^GVR8::::>!HBP0D8BB\Q7GE)"HI51NEDACD_-#_@BQ\!M4LKW4_'%
MU')!ITMFVG61>,!;MGGCDGDC8N&V0-;I$3L*2/(ZK('MY4K^@ZOSPE_:I\5?
M'[5+_3/A-8Z7=6.E2+'=>(=7EN!ILUP ?,M+)+5?-G=0T<GVE7\D*K939-:S
M3>7^%O\ @H#KGP?\6Q^"_B]IVGZ1<7>Z2SU:PG)L6A:0PV[RQR22R112O%,?
MM$KQM&#%YUK#&))U^W_VG?VA=._9?\+W?B74$\[R=D=M:B5(GNKB4[8X4+GZ
MR2%5D>.".641R>65/SAJWQ%^.?A&WEU^[T#PW>Z=%&]PVA65W>G6!&RDK MP
M8Y+26XAR#+Y4;"X\MTMT+R1"O8/V<OCQK/[0G@&T\6V=A9C4;Z2[,-E+=2P6
MZQQ7\UNBO<K;W+[UAC!9U@(EF!Q'"CXC\/\ V5OV^+S]HGQEJG@O4/#W]C7N
MDV]U)<M_:*WF)K6YAM9(<);Q(<-*3YBNZG9P&#!A]/\ [1_Q3USX+:'<Z_I&
MD6^KV]A;S7-[#)J!LIDAA"LSP@VL\<NU/-DD5WA8+&!&)I'"#@/V*OVK?^&P
M?#USKW]G?V9]GU"6R\C[3]IW>7#!-YF_R8<9\[;MVG&W.XYP/S _;Z_Y.%\!
M?]P#_P!/-Q7[7?%[Q=K?@K2VNO#VBR:]J)D1([)+NWLEVDY>22>Y8*J*H. B
MRNSE%V!"\L?\\/[*?QH^(=S\8_$VL-X?CUWQ0]G=VNH:=%?6NG1VRV]U:0'9
M-)YL3I 8(K=5#2/(")3+(0[M^]S_ !MG\#>"Y_%OC33O["EL[>XGN]/%Y;W3
M)Y<CK%%'<*8H99;@"/R4!7,LR0YWU\P>$_BY\:_B;IUIXKTG1?"\.BWEO#>V
M^D7%[=OJDMNR!Q&MVB)9)+<+\\#2($@$L:SKN205[!^QG^TGJ/[3^DZKJFI:
M9_8\MCK$VG"Q9G>:'R+>V:19V=(B91++*"/+BV*%C*ET9W^OZS]6U:WT"WEO
M+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q 4 DD 5^>&@?M:^+?VH?M$GPGTO3
MSI=G<202ZWK\TD5O--%@M!;V5H6O/GCE@N(KB;REV>;$\*2A:\O\2?\ !0+Q
M5^R]X@M- ^*^B6<5M>R;HM=T>2X:S^SE$!*6\Z232O#*<7($D<R1LKI;2 PF
MY^__ (J_$G6]%T:UU3P9H\?BF2ZDB*11:E;V<9M98GD%TEQ*'BD3(C"JF2XE
M#@[5.?Y\?V0_B)XO\/?&3Q;J6D>%_P"T]:N/[8^V:1_:MM;?8_,U.%YO]+D4
MQ3>5*%A^0#S-WF+A017]#WP4\9^(_'.G27/B?0?^$>O5N&CCM/M\&H;X0D;+
M-YL"JB[F9T\LC</+W$X<5[!7C_QT^.FA_LZ:'/X@\03^3:0_*B+AIKB9@2D$
M"$C?*^#@9"JH:1V2)))%^,++XG?'_P ?64VM:9X=\-Z1;&,26FDZK/=RZE(O
MD)( 7A>&!'D<LBQW(M'A8>7,J!?-;0_8/_X*#V?[7_GZ5>6?]GZ_9VZSR11L
MTEO<0KY<<L\+%<Q8E< V\A=E1XRLT_[TQ?$'[?7_ "<+X"_[@'_IYN*_<[Q_
MXR3X?:7<ZI);7EXMM&7%M8VTEU=3-D!8X88P69V8@9.U$!+R/'$KNOYX?LK?
MM_:C^T[\0]4\,?V/_9.FZ=I]U+Y=UO\ [1-Q;WL,'[]<K'!\DN)+;9(\4R$?
M:'7BO</VP?VQ4_9/L/M0T/5-7D\M9&D@@DCT^!6F2%1=:@8WBA=RS>5&BS.7
M5%=8EFB=OF_X3_M[^*/C5X0LI/#&A6^O>,Y[>ZFO[:VF%IIVF(+FXM[1[F6Y
MF.99?+21+$3+/-"LTP>",1E^0_9G_P""CGB76_'DG@#XDZ59Z1J,DGV>W> -
M L5TJLZQ3?:+B994N5V"UE@<B1VB"+,ERLD7W_\ M-_M%I^S9HSZH=)U35Y/
M+G=8K"UDDCB6"(R-+>7 4Q6MN#M#R/N<!F=(95BEV>7_ +!7[4NH_M<^'M0U
M[4+6WL_)UBYM+:" NVVW2&WFC$KNQ\R4><5>15B1\ B).17O_P =/CIH?[.F
MAS^(/$$_DVD/RHBX::XF8$I! A(WRO@X&0JJ&D=DB221?C"R^)WQ_P#'UE-K
M6F>'?#>D6QC$EII.JSW<NI2+Y"2 %X7A@1Y'+(L=R+1X6'ES*@7S6T/V#_\
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M\*7%O<Z*UQ?3VTEK)#);C[3>3SRQ0-;@1"**622&-$_U:((R2RDG\8?V!?\
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M&C'E%*_;[]K'_DGGBO\ [%_5O_2*:O@#_@BI_P D\U+_ +&"Y_\ 2*QK@/\
M@I_\//%O@+Q;X?\ BIX6AN+K^R+?RKI88I&6V6TDFNM]R89%E-I/%-/%<D".
M)(HV228?:$6M#X5?\%'?!7[8^C77@KQ_!'H<^HV<L,MR\D/]GNRQ(?-BFN 1
M:W DWS6R3K*D3PQ8N99V1&_:ZBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOYT?VE?'^E^)OVC[32_'US'+X
M4TJ2WCAM[LD6<#3Z='<(954!2DEX\1GDFRC1JJ3M]EBVI]W_ /!6#XJZ'X?^
M'&J>'[F_MTU?4/L!M;'>&N)%6]BE,GE+EUB"V\W[YPL6]/+W^8RHVA_P36\?
MZ7X9^&'@[2[RYCBOM5DU>.QMR29)V@O+VXF*J 2$CC0EY&PBEHT+;Y8U?]#_
M /A+-._M'^R/M=O_ &E]G^U?8_.3[1]GW^7Y_DY\SRM_R>9MV;_ESNXKH***
M***_F!_X(J?\E#U+_L7[G_TML:_?[]IW]GK3OVH/"]WX:U!_)\[9);70B25[
M6XB.Z.9 X^L<@5HWD@DEB$D?F%A_/E^QO^TQ>_\ !.[QCJO@OQ?')_9,EX(;
MQT\\BTGCRJ7]O"ZJ9+>>,HTA$2S36XMYH]WE+!+^]W[4_P -XOVEOAUJ^E::
M_P!K_M'3Q<:>UM-%MN)HMEW9A)GS$8I98X@SY"M$Y(D3(=?Q@_X)G_MOV?[/
M/VCP!XW>XL8CJ!6SFN$94L)GWK=079EE!MHO-1"H6(+%/+<RSLB%G3]7_CI^
MW9X2^'^ASS^']5T_7-=G_P!&TK3=/GCU":XOI@5MT:"UE\SRM^#*VY"5'EH6
MG>*-]#XP_M#W'[)GASPM?^+YHYVGO++3M=O(8F<"1["Y>6Y@1!#\GVF%'8"(
MG[.9!';F4QJ.@_:J_8[\-?M7Z7+:ZG!'!J@C5;/5HXE-U;LA=HU+?*TMOND?
MS+9F".'9E,<P2:/\\/\ @B%_;'_"/>(/._Y O]H0?8_]7_Q^>2?MO3][_JOL
M/W_W?_//YO.KQ_\ 9#\4V?PK_:,\6VVNR?V?+JEQK%M9+<*T?G376I0W5LBE
M@ //B7? S$+-NC6,L\L2O^G_ .W?\=-#^'7@W7-&N9_.U?4]'OH;73;?$UXZ
MS6UPIN6@4[TM(5CFFGN7"Q1QPR?,TFV-OC#_ ((P_$+1M.\(7>ASZA9QZM<Z
MY=2P6#W$2W4L8LK0EXX"PE= (Y"652 (WY^5L>7_ +?7_)PO@+_N ?\ IYN*
M_?ZOY\?V$=6M]._:)\;13RQQR7,GB"*!'=5:60:K%*4C!(+N(XY)"JY(2-WQ
MM5B/UO\ V@?VE+/X/^%=1\46G^EV^D:A9VUYMC9@RF^MK>]2!BT4<LL22RQA
MED,4=Y&T$I$D,\2Z'Q-^#O@[]LKPU =2MX[VQO[-9M/OA'Y=U!'=+'*D]K)(
MGFP.P6)V5E <*(YHW3=&?R0_X)-^!=8^%_Q#\:Z##-]HT73/,LKR?9''YMY;
M7LD-E)L+/*FZ)+YMJ,T:YQ(Q80D_O]7PA_P4>_9^N/VA_A]>6=@)'U'39%U.
MSACW$SR6Z2*\.Q(Y'D=X9)E@C0*7N/)!<)NS\_\ _!(+X\Z7XS\$1^$A)'%J
MVB27):W,A,DUK<3M<+=*I11L62=H'5#(8RD;N4^T1*?H#_@I1\7D^$'PRUAP
MT8N=4C_LJV21)'61KT,DX'EXVNML+B6-G(0/&H.\D1OH?\$[O@7+\ OAUIEC
M>0?9]2O=^H7Z'S0PFN<&-9$F"M%+';K;PS1*JJLL3_>8M(_Y@?\ !/OQ9IU[
M^T!XQGBN[=XM0_M[[%(LR,MUNU2&=?(8'$N8D>8>7NS$C2#Y%)']#U%?@C_P
M65^$.J:=>Z'\0M'6\#64?V2[NX'"K9-%.)K"92F)HG:6:=?/W%%=;= 8Y73S
M?N_]G#_@HKX&^,FAVUSJ>LZ?I6KQV\/]HVMY*MBJ7#!ED^SFXDV2Q%D9X_+E
ME>.)HA-Y<C;:/"'Q^_X:;^(MM:>#]3\WPSX8M[BXUF>W.8;Z_NO/L[2R.X1N
M\42I/>)<0M<6DS"/(#I!*/@#]OK_ ).%\!?]P#_T\W%?O]7X _L"_P#)POCW
M_N/_ /IYMZ^__P#@J/\ \DA\0_\ <._].5I1_P $N/\ DD/A[_N(_P#IRNZ^
M /V^O^3A? 7_ ' /_3S<5^OW[6/_ "3SQ7_V+^K?^D4U? '_  14_P"2>:E_
MV,%S_P"D5C7B'_!97X0ZIIU[H?Q"T=;P-91_9+N[@<*MDT4XFL)E*8FB=I9I
MU\_<45UMT!CE=/-^[_V</^"BO@;XR:';7.IZSI^E:O';P_VC:WDJV*I<,&63
M[.;B39+$61GC\N65XXFB$WER-MH\(?'[_AIOXBVUIX/U/S?#/ABWN+C69[<Y
MAOK^Z\^SM+([A&[Q1*D]XEQ"UQ:3,(\@.D$H_-#]I7Q_I?B;]H^TTOQ]<QR^
M%-*DMXX;>[)%G T^G1W"&55 4I)>/$9Y)LHT:JD[?98MJ?=__!6#XJZ'X?\
MAQJGA^YO[=-7U#[ ;6QWAKB15O8I3)Y2Y=8@MO-^^<+%O3R]_F,J-H?\$UO'
M^E^&?AAX.TN\N8XK[59-7CL;<DF2=H+R]N)BJ@$A(XT)>1L(I:-"V^6-7^,/
M^;O/\_\ 0N5^_P!17X _\%SO^91_[C'_ +85^YT7C_2[I["."YCG;5(VFLC
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MM/+R#?'*),Q/!]W_ + ?]L?\*O\ #/\ ;G_'W_9Z>7_J_P#CSWM]@_U7R_\
M'I]GZ_O/^>O[W?7O_@7XL>'OBAYW]@ZKI^I_9]GG_8KN&Y\KS-VSS/)=]F[8
MVW=C=M;&<''H%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%?('[4O[$'A+]KC[++KJ7%O>V>5CO;)XXK@PG<3!
M(TD4J/%N;S%#*6C?<8V02S"3G_!__!/?P-X*\%ZCX'@@N'LM6P;Z\>5?MTSQ
MR>9;N9D1$_T=@I@C$?D AB\4AEG,O0?LM?L0>$OV1_M4NA)<7%[>862]O7CE
MN!"-I$$;1Q1(D6Y?,8*H:1]ID9Q%"(^@_P"&0_"__"P/^%D^7<?V[]G\G'GG
M[/O\G[-]H\O&[S?L_P#H^-_D;/G\GS_WM?3]%%%%>/\ Q+^!>B_%W>NKG4'B
MEMVMI;>#5M1M+>6%MVY);>TNH89-P=E=G1F=,(Q**JCP#PM_P3D^&/@:\CU#
M2M)N+&]AW>5<VVKZK#,F]2C;)([Q77<K,K8(RK%3P2*^O_"WAJ#P?9QV-L]P
M\46[:US=7%W,=S%SOGNI)9GY8A=[MM7"+A%51XA\;_V1?!'[1UQ;WGBC28[V
MYM8VBBF$T]O((V;=L9[>6)I$#99%D+",O(4"F1]U_P""G[+_ (5_9V\Q?#%K
M<6,4VXR6_P#:%]-;EG\O=)]GGN)81*1$B^<$$H1=@?82I\@_:4_X)[^!OVH;
MS^U-5@N+/5#Y8EOK"58IIDB5E5)5D26%^&4>88_/VQ11B41($H_9K_X)[^!O
MV7KS^U-*@N+S5!Y@BOK^599H4E559(EC2*%.%8>8(_/VRRQF4Q.4KV_X[_L\
M>'_VD[*TTSQ+#)<V-I>"\%NDKPK+(L$\"B1XRLNQ1.T@$;QDNB98IO1_F#3/
M^";GA_14-A:^(/%D.A-)*3H4>LNFFFWFD9Y;0Q+&)3;R!W20>;YSJS%IC(QD
M/V_X \ :7\+-+MM%T6VCL].LXQ'!!&#M5<DDDDEF=F)>21RSR.S2.S.S,?E#
M]I3_ ()[^!OVH;S^U-5@N+/5#Y8EOK"58IIDB5E5)5D26%^&4>88_/VQ11B4
M1($K0^%W[!7@KX0>&M0\.:9;R!M4L[VRO-4D\E]2D@O5V2(+CR@JHJA/+B6,
M0AHUD:)Y2[OZ!^S]^R9X._9EMQ%X<TZ.*Y,?ES7\O[V\G!6,/OG8;E1VB21H
M(O+MQ("Z0H37E_BG_@G)\,?'-Y)J&JZ3<7U[-M\VYN=7U6:9]BA%WR27C.VU
M555R3A5"C@ 5]?\ A;PU!X/LX[&V>X>*+=M:YNKB[F.YBYWSW4DLS\L0N]VV
MKA%PBJH^$/B]_P $POA]\9_$K>)KZ*\MYYI$EO+6TF2&UNY%;=(\R^4TJO,/
MEG:"2$N<R@K.[RM]'^)?V8O"_B7P@G@3[)]F\/+]E'V2W<QY2VN8[K8TG,A\
MUX_W\F[SY-\C^:)F\T?.%E_P3<\/^%7F7PUX@\6>';&:02G3]*UEX;59/+2-
MG DCFE9W$:EFDD<Y^4%45$7Z_P#A#\%_#_P%TM=&\-6,=A8K(\IC0N[/)(?F
M>221GED? 50TC,514C!"(BKZA17PA\4/^"=W@[XA^(/^$JLIM4\/ZVTDTLU[
MHMY]DDFDF01N[;HY5C<KOWM (3,996F,K/D=A\-/V(_"_@+44UK4)-0\2:U#
MM%MJ6OW1U&XMD1UEC2WWJL47ERJ98I%C$Z/)+B7:Y6OH_P :^![7Q_;K:WDE
MY'&D@D!L[^[L)-P5E ,ME-!*R88YC9BA.UBI95(^0-)_X)G?"G0+B*\L]$D@
MN8)$EAFBU34TDCD1@R.CK>!E=6 964@J0"""*^S_  MX:@\'V<=C;/</%%NV
MM<W5Q=S'<Q<[Y[J269^6(7>[;5PBX154=!6?JVDV^OV\MG>11SVT\;Q30RHK
MQR1NI5T=&!5D92596!# D$$&OS U/_@CU\,K_5!J$8U2"V$D3G3H[P&U*H%#
M1EY(I+O9)M)D(N X+MY;Q@(%_0_X:?"K0_@WIR:5X>L+?3[)-I\J! N]E18_
M,E;[\LI5$#S2EY9-H+NQYKY@\4_\$Y/ACXYO)-0U72;B^O9MOFW-SJ^JS3/L
M4(N^22\9VVJJJN2<*H4< "OI_P#X5I8_V/\ V'YNH?9/^>G]J7_VS_6>;_Q_
M_:/MOWN/]=_J_P!S_JODKY@\+?\ !.3X8^!KR/4-*TFXL;V'=Y5S;:OJL,R;
MU*-LDCO%==RLRM@C*L5/!(KU_P"-?[+_ (5_:)\M?$]K<7T4.TQV_P#:%]#;
MAD\S;)]G@N(H3*!*Z^<4,I1MA?8 H/@I^R_X5_9V\Q?#%K<6,4VXR6_]H7TU
MN6?R]TGV>>XEA$I$2+YP02A%V!]A*GR#Q3_P3D^&/CF\DU#5=)N+Z]FV^;<W
M.KZK-,^Q0B[Y)+QG;:JJJY)PJA1P *]?\=?LQ>&OB;H\.@ZRFH7FFP[_ -Q+
MK&J-YN^19O\ 27^U^9=;'16B^TM+Y& (MB\5@?!S]C;P3^S_ 'C7WABQN-/E
M?'FK'J6H-#-M5T7SH)+IX9M@D<Q^:C^6S%TVOAA]'ZMI-OK]O+9WD4<]M/&\
M4T,J*\<D;J5='1@59&4E65@0P)!!!K\P-3_X(]?#*_U0:A&-4@MA)$YTZ.\!
MM2J!0T9>2*2[V2;29"+@."[>6\8"!?T/^&GPJT/X-Z<FE>'K"WT^R3:?*@0+
MO946/S)6^_+*51 \TI>63:"[L>:\ _:E_8@\)?M<?99==2XM[VSRL=[9/'%<
M&$[B8)&DBE1XMS>8H92T;[C&R"682<_X/_X)[^!O!7@O4? \$%P]EJV#?7CR
MK]NF>.3S+=S,B(G^CL%,$8C\@$,7BD,LYET/V<?V#?!W[,-OJ$6CK>37.I1M
M#/?W%QB\6W90#!!/;);M;IN'F;H=DQDV.9"88/*S_P#AW)\,?[1_M?\ LFX_
MM+[1]J^V?VOJOVC[1O\ ,\_SOMGF>;O^?S-V_?\ -G=S7V?I.F)HMO%:Q&1H
MX8TC0RRR32%44*"\LK/+(^!\TDC,[G+,S,23H5\X?M,?LJ^&OVK]+CTSQ#%(
M&@D\RUO+=E2ZMV)7S!%(Z2+LD50LL;JZ. K[1+'$\?'_ +/O[#7@O]FNSN8-
M$M[@W=[;O;76I2W,@OI(79FV)/"8?LV-R@-:+;L3%#(Q:6))!S__  [D^&/]
MH_VO_9-Q_:7VC[5]L_M?5?M'VC?YGG^=]L\SS=_S^9NW[_FSNYK[/TG3$T6W
MBM8C(T<,:1H999)I"J*%!>65GED? ^:21F=SEF9F))^,/%/_  3D^&/CF\DU
M#5=)N+Z]FV^;<W.KZK-,^Q0B[Y)+QG;:JJJY)PJA1P *^K],\!V&G:6=&=)+
MNQ>.6*2.^GFOVECF+>8DTEX\TLR,'9=LK. F(P @"C\\/"W_  2,^&OA;7(]
M:"ZA<Q17#3IIES/%+8\DE(G0P":6*,E=J2S/Y@0+,9D:17] ^./_  38\#?M
M ^*#XKU<Z@MW+]G^U6\%RJ6]U]G"H/-#1O*FZ)$A?[/+#\B!EV2EI&^C_B;^
MSEX8^+VEP:'JUI(VDVT:Q1V%M=W5E:^6AC,:/!9S012)&8HS"LBL(2O[L)DY
MY#X.?L;>"?V?[QK[PQ8W&GROCS5CU+4&AFVJZ+YT$ET\,VP2.8_-1_+9BZ;7
MPPY_X^?L->"_VE]1DU7Q);W$]Z=/CL+>6.YDB^RK&]Q()850A&E+7!)^T">+
M]U&!$!Y@DX_2?^"??A^:XBE\1ZQXD\4VUO(DT-AKNJO>6:7$; I.8%2)9'"[
MX]LOF0M'+(CQL&X^S_%GA:S\<Z==Z5J$?G65];S6US%N9-\,R&.1-R%77<K$
M;E*L,Y!!P:_''X5_L@:-^RQ\9?#>G>#K[5+B1]+U6]UZ*ZGBVII[(+>S;]U#
M;K*CWA&Z(&9U>**8I&J!S^UU%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%9^K63ZC;RP1326TDD;HD
M\0C,D3,I D02I)$74G<HD21"0-R,N5/'^!?A;H_PW\YM-M]MQ<[/M-W+))<W
MESY>[ROM-Y</+<W'EABD7G2/Y4>(TVQ@*/0*************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M**********************_)#XD?\%,+W3O'6A^#-*\/WEG'J.J6%O->:U;3
MVDDMK<7;6KR6EFWERA& 5X+B9@01)&]F&7(_6^BBBBBBBBBOE#XR_M9:7\&/
M&/ACPE>+&\GB*2>-I1.?,M&^2.S+6Z1R.Z74[&!)&,2(4D<LRQR;?J^BBBBB
MOG_]J?XLZC\"_!>K^)-*LO[0O;"W$D5N0Y7YI$1II!&"YB@5FN)@"F8HG!DB
M&9$\P_8-_:.UG]J7P<OB#7-/CL;G[9<6Z-"LJ6]S''L(G@64LP0,S6[8DE!F
M@D.]23%']GT444444445\8?M@_MBI^R?8?:AH>J:O)Y:R-)!!)'I\"M,D*BZ
MU QO%"[EF\J-%F<NJ*ZQ+-$[=A^QG\:]1_:)\":7XGU6.WAO;[[7YL=LKI"/
M)NYX%V+))*XRL2ELNV6)(P, ?3]%%%%%?&'QY_;/A_9Q22ZUWPQXD_LY))$&
MH6T%C<6I5)$C61WCORT"2M(GDBZ6!Y"VT)O5U7Q_P5_P4\T;XE6[7FA^$_&F
MI6R2&)YK/2(KB-9 JL4+Q73*'"LK%2<@,IQ@C.AXI_X*3:=X&LY-0U7P;XXL
M;*';YMS<Z*D,*;V"+ODDNE1=S,JKDC+,%') KZ0^'7[2$/Q?\)V'B[P]I&J7
M]M?R2I':(;&&ZC6&6:%Y)!<WL,&S?"0 DSN0Z'9C?L^/_'__  5L\(?"S5+G
M1=:T3Q)9ZC9R&.>"2ULMRM@$$$7Y5D92'CD0LDB,LB,R,K'U#_AOK_J0OB!_
MX(/_ +HH^%O_  4Z^%_Q0^SQ?VO_ &9=W'F?Z/J43VWE>7O/[VY^>R3<J;D_
MT@[MR)Q*?+'W_117RA\,?VLM+^)GCSQ%X$@6,7.AQP21SQSF9;I2J"\!"QA(
M'M9I8[>2-I7=G9OE4QR*OU?111117E_QH^+VE_ 7P_?>)=9:1;&PC#R")#)(
M[.ZQQQHO +R2.D:EBJ*6#.Z(&=?@#]H']I;XQ^"?#Y\9Z)X:TNWT1(_,EL+\
MW5QK$%OOD(N[J"![>&W3RA$\ULCW,UKN9I7VI-Y'L'[+/[??A_\ :1\-:IK\
M\,FE2:%&\VK6[E[A8+<++*D\<L<2F9&CAD)58UF5XW3RROE22^?^+?VEOBE\
M0_#1\8?#_P -6::2L;306VL&=]6U"WVQ,)[:RM72*-,F8QJ]S+-=Q*DD,8\R
M))M#]@__ (*#V?[7_GZ5>6?]GZ_9VZSR11LTEO<0KY<<L\+%<Q8E< V\A=E1
MXRLT_P"],7Z/T44445\__M3_ !9U'X%^"]7\2:59?VA>V%N)(K<AROS2(C32
M",%S% K-<3 %,Q1.#)$,R)YA^P;^T=K/[4O@Y?$&N:?'8W/VRXMT:%94M[F.
M/81/ LI9@@9FMVQ)*#-!(=ZDF*/[/HHHHHHHHK/U;4TT6WENI1(T<,;R.(HI
M)I"J*6(2*)7ED? ^6.-6=SA55F(!_+#X??\ !1W4?BK\4M-\"6V@7&D64OVG
M[6=6C>+4CMT]KN+%LK!+;YD.=[7/G0NCKY).*_5^BBBBBBO@#]H7_@HSX2^!
MNHIH%DEQX@U^;S8H[#2_+FV7:N88K6XD#DQ2R2@QF*-)[B/:2T'S1++GZ3^U
M1\3YK>+4;SX8WD6G&-)YC%K=G+>);E0[E+!HHIY+@)G;:L(YFD A.QSQH?#C
M_@HKX7^+/B/2/"FEVNH1ZOJ%Q?PWMI>P&UFTS[#!/*PN%.]'ED:$(D43ML4N
MTKQ21B&3[_HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK
M\ ?V^O\ DX7P%_W /_3S<5^UWC7XW^%?AK<+9ZYK>EZ;<O&)4AO+ZWMY&C+,
MH<)+(K%"RLH8#!*L,Y!QZA111111117\D7[=>D:Y\9-WQ8FE\_0-5UB]TK22
M"51+&R^2RD2.69IH_M)BO7DB,40CGBEE*K]JC6OZ7?V6/C7_ ,-$^"](\3M'
MY,M];G[1&%V*+B&1X+CRU\R4B(RQ2&'<[.8BA;#[@/H"BO#])_:;\"Z_<16=
MGXET.>YGD2*&&+4[1Y))'8*B(BREF=F(554$L2  2:]PK\P/@M^UQ_PT#\:]
M3T;1[WS_  WI'A^=(?)DW6]U>?:[+SKH81-^W>;:)MTT>R-YH7"73[OT_KG]
M \6:=XK^T?V?=V]W]DN)+6Y\B9)?)N(L>9!+L)V2ID;XVPZY&0,BN@KR_P :
M_&_PK\-;A;/7-;TO3;EXQ*D-Y?6]O(T99E#A)9%8H65E# 8)5AG(./0-)U:W
MU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$@UH5Q^F?$+1M:TLZY:
MZA9S:2L<LIOX[B)[41PEA*YG5C$$C*.)&W80JVXC:<9_@7XL>'OBAYW]@ZKI
M^I_9]GG_ &*[AN?*\S=L\SR7?9NV-MW8W;6QG!QZ!7E^I_&_PKHNJ#0[K6]+
MAU9I(HA827UNET9)@IB00-()2\@=#&NW+AEV@[AGT"RU:WU%YHH)8Y)+:013
MHCJS12&-)0D@!)1S')'(%;!*2(^-K*3H5\ ?\%1_^20^(?\ N'?^G*TKG_\
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MA=+C0_&,*R-&\;Z5=,7C\M&1GN;0+'Q*7D#WA=OF0"*,'RV(\S]'_P#@FO\
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M[BWU3Q9K=P]SJ&I1V_E;?.V2RVT/.WROM'F2ETCMO.S'OA40Q*GH'[7GQ/\
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M=HOCG2O!UPMEH7]F^5!<ZKI4<US]CNGO&W^7=S)!N:1HEP9L*HE/+&)/O_\
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MV=G+*]NL\?VS5KP*8EABM;M(VL;<,LTNVYEBD>1K(K=-:BY,OPA_PI?XG?\
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MZN==OO[6\3:S<"\UG4BBCS)MBI';PD(C_9+=1LMXV 5-TC1Q0)(((_I^N/\
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M=TE>/_\ !/3]J#6?VL_"MWKFN06<%S!JDUFB6:2I&8TM[:4$B669M^Z9@2&
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M@?XIO/&'[,MQ<WTGFRIX7UVV5MJKB&T6\M8$P@4?)%%&FXC<VW<Q9RS'G_\
M@BI_R3S4O^Q@N?\ TBL:\ _X+G?\RC_W&/\ VPK]_J*_ '_@J5XCL_%/Q3\$
M>&=>%NN@0_9+B[DDD:']SJ&H""\$TWF*(XEBM$(=?+:/=(QD^[L_?ZOPA_X+
M>_#3[3IWA_Q/$ENOD7$^G7$FW%Q)YZ">V7<%^:*/R+HX9QL>;**?,D*_?_BS
MQ3>>.?@5=ZKJ$GG7M]X'FN;F7:J;YIM),DC[4"HNYF)VJ%49P !@5\O_ /!%
M3_DGFI?]C!<_^D5C7Z_T5^ /_-WG^?\ H7*_7[]K'_DGGBO_ +%_5O\ TBFK
MX _X(J?\D\U+_L8+G_TBL:^0/@K:^+_C3\?/&W]B^(O[#U*'^TXFO?[-MKW?
M9V=];6D-MY,NR,81(/WO,A\GYBS2.Q_1_P 6?LG_ !2\<Z==Z5J'Q+\ZROK>
M:VN8O^$8T]-\,R&.1-R3*Z[E8C<I5AG((.#70?L,?L,?\,7?VO\ \3?^U?[5
M^Q_\N?V7ROLOVC_IXGW[O/\ ]G;M_BW<?"'_  5I\ /\(/$OAGXI:/;1FYAO
M(8[MG$8@DNK)EN; RQH8YY'D2.>.23>0(;>&(-$0F_\ 4_XX_M*6?P\\#'Q9
MI'^GRZA;VXT&W$;,]]=WZK]AC2W9H9I-Q=99(4Q<"!)2J;TVU^.'[%5EJG[!
MOQ@?X?:S-&]IKMG:H]PP%O;R77V8W%O);O,F^=%G:YTV(*T0GFDW,@FC6!?T
MOU__ (OQ\8;?2Y/W^B^"-/COYXQP@US4"19BXBERLWE6@:YM)H$#6T[-FX#-
MY5??]%?@#_S=Y_G_ *%ROT?_ ."D/BF\\'_"CQ'<V,GE2O;P6S-M5LPW=U!:
MSIAPP^>*61-P&Y=VY2KA6'Q!^P5\&?B/XK^'&C7N@^._[&TV3[;Y&G_V!97G
MD[;VX5_](F<2/O<-)\P&W?L'RJ*[_P".G_!-3Q?^TI]C_P"$K\?_ &_[!YWV
M;_BGK:#R_/\ +\W_ (][J+=N\J/[^[&WC&3GY@_X*VZ=>?"3P;X"\%I=>?96
MMO+',WE*GGS:9;6EK#-@EWC^6><^6KE?WGS%RB,/Z'JX^R^'NC:=JDVN0:?9
MQZM<QB*>_2WB6ZEC 0!))PHE= (XP%9B (TX^5<?AC_P7._YE'_N,?\ MA7[
M_5^ /[ O_)POCW_N/_\ IYMZ]_\ ^"U?_)/--_[&"V_](KZOO_\ 9._Y)YX4
M_P"Q?TG_ -(H:_('_F[S_/\ T+E=A_P7!\:W%AHWAO0U6,VUY>7EY(Y#>8)+
M**.*,*=VT(5O)2X*DDK'AE 8-^SWP]TS2]%T;3[70S&VDPV=O'8&*4S1FU2)
M5@*2EG,B>6%VR%F+C#;FSD_FA_P6*^&G_"8?#I=7C2W\W1=0MYWED7]\+>XS
M:/%"P5C\\LML\B%D1EA#$EXXU/T!_P $WO%-YXP^%'ARYOI/-E2WGME;:JXA
MM+J>U@3"!1\D44:;B-S;=S%G+,?S@_X(8_\ ,W?]P?\ ]OZ/^"I7B.S\4_%/
MP1X9UX6ZZ!#]DN+N221H?W.H:@(+P33>8HCB6*T0AU\MH]TC&3[NS]_J_"'_
M (+>_#3[3IWA_P 3Q);KY%Q/IUQ)MQ<2>>@GMEW!?FBC\BZ.&<;'FRBGS)"O
MH'[=WAS7/C[\ ]!US/VJ]MK?1]:U$B,AY%>Q9+B5(X8]@VM<^?)Q'%' DKY4
M(%/U_P#\$ZOC'9_&3X:Z-);+Y<NE6\6DW466;9-8Q1Q@[F1 WFQ>3<83<L?F
M^5O9XV-?G!\??^,E/VD]!L?#W[[_ (1O^S_[1G^_!'_9UU)?W'SP^;MV^:EG
M^]$>+X_9WV<.?W>\6>%K/QSIUWI6H1^=97UO-;7,6YDWPS(8Y$W(5==RL1N4
MJPSD$'!K\(?^"9?BF7]FOXB^)/A3JLEPWGW$IT]Y5EB62:Q\PF1+4B18_MEI
MMN1,753%;PH'FWPD??\ K_\ Q?CXPV^ER?O]%\$:?'?SQCA!KFH$BS%Q%+E9
MO*M US:30(&MIV;-P&;RJ^_Z*^0/VS;7X=:1H</B#XBV=O=VFD7 FLDD7=-+
M<D96VA0,GG^=L'F6TA-M(L8DN%$4)DC^,/BO\9OB;^TSX*\0:MINEV?AKP5)
MH=_.ESJ&;C5K^U6&YDW6\",(;=+F*..)_/4F.*X-S;7%S^[*W_\ @BI_R3S4
MO^Q@N?\ TBL:\ _;Z_Y.%\!?]P#_ -/-Q7[_ %?@#_P0Q_YF[_N#_P#M_70?
MLE:__P +0_:3\9:AJ%O;M<65OJ4%L1'GROL-U::;'*A<NR2M;H5D=2N[S95
M6-R@_=ZOP!_X(8_\S=_W!_\ V_K[O_X*4>,;A/"=IX0TR>.'5O&&J6>C6S-=
M- R1S2J9Y66-7EDM\!+:Y"C 2Z&[=N$4GW?X3\+6?@;3K32M/C\FRL;>&VMH
MMS/LAA01QIN<L[;54#<Q9CC)).37X0_LQ^([/XF_M->)M0UH6\=[9_VI;Z8H
MD:+=-8M%IR%$,G[V4V23O(GS+_K9EC01KY?[_5_.#^T'X<O/@7^TUHVH:<;>
MV76M0TFXC6"-?]3?L-.OA*C1A!+.RW;NZ[F/G";S!,3L] _X+G?\RC_W&/\
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M@U+X=>/8Y-+@N;Q&62;RUCL;XH$9IW"Y-O<QB#;<B1[>,1QR@>1/+<)]W_\
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M,B-+$KL 0IDC!(+KG[__ &.]6M]:^'/A66UECFC70].B+QNKJ)(;:.*5"5)
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M4%F9B H!)( K\ ?^"&NK6\-QXKLVEC%S+'I<L<)=1(\<37BR.J9W,B-+$KL
M0IDC!(+KGS_XY27'_!/'XZCQ?)'>7.A:U)=7KK%(RM-'>[Q>P,QCCAE>WN&%
MS';$L-@LO,F21_-3]C_^&\OAU>Z/_:^GZU;Z@S_+;:=:G=JEU,TGDQP0:<^R
MZ:663"1AHT4AA*66',@_'#_@C+\9-$^'VJ:SHNHSR)J.MR:9'IT$=M<3M,T
MO#,28(I%C2-9%>224HB)ND+!$=E_2_\ ?_&KX\_\O TWP%H__3NB?VIK,?\
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MZA'(1(YWE9IG$?YH?\%)OV:[-_B5X9'@;_0_%7B*XDEN4MY&7R9HI83#J;)
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MKP]86^GV2;3Y4"!=[*BQ^9*WWY92J('FE+RR;07=CS7G_P#PR=\//^A4\/\
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MD0J\;JLB,KJK#H-)TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4
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M^(Z2+J?A^SEDFO)[V:X3S(;J6XGDEEE:2ZA>.X="\SD1-(85&Q515BB"=?\
M!3]ECP7^SMYC>&-(M[&6;<)+C,DUP5?R]T?VB=Y9A$3$C>2'$0==X3>2Q^@*
M^(/%/_!-[X4>,+R2^N?#ENDLNW<MM/=6D(VJ$&R"UGBA3A06V(NYLNV79F/U
M_P"%O">G>!K./3]*M+>QLH=WE6UM"D,*;V+MLCC"HNYF9FP!EF+'DDUXA\1?
MV0O ?Q:>_GUO0[.[N=2DBDNKIU871:&.&*,1W*,L\"!((U,<#QHPW[E)EE+Y
M_P '/V+_ (?_  "O&U#P[HEO;7IQMN9'FNIH\*Z'R9+J29X-RR.LGDE/,4A7
MW!5 ]/\ B]\%_#_QZTMM&\2V,=_8M(DHC<NC))&?E>.2-DEC?!92T;*61GC)
M*.ZM\(?\$\?A;H_A36/&FM>%+?[-X3O=0M+'2%,DDOG?V7'+%=W4,SO*LUI+
M<2R?9YDFDW;9%*Q% E?I_111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111117R!^UY^SEK
MG[4.CR>';;7;?2-(N/(:ZC_LPW=Q,T,AE"^>UY$B1;EA?:D0EWQ?Z\QNT5'[
M(?[.6N?LO:/'X=N==M]7TBW\]K6/^S#:7$+32"4KYZWDJ/%N:9]KQ&7?+_KQ
M&BQ5]?T44444444444444444444444444444444444444444444444444444
M444445\H?M,?L6>#OVKDC;Q!;2)?01^5!J%K)Y5U%'YBR%,E7BD3(8*L\<HC
M$DK1B-Y&>OB#3/\ @EUXJ\&(;'P]\2]<TS28Y)3:64:7 6&-Y&D"GR=0@B9\
ML3(Z11"1RS^6N[ ^G_A-^P!X?\#ZI:>(_$%_JGBKQ#9QVX@OM8NGN%MY(A(2
MUM"20B&21I8TG:Y-NX1XY%E#2-H?MO?L9?\ #96G:?8_VS<:3]@N))MJQ?:+
M>;S$V9E@\V',L>,0R[_W:23IL;SMR>@?L]?LO6?P+WWUWJ.H:_K\]O%;W&L:
MI.UQ<>2F'-M;[RQM[0REYA &=B[CS)9O+C*?3]%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%<?XU\ :7\1[=;/6+:.]M%D$C6TP+V\K*K!1/"3Y4Z*6
MWK',LB+,L<P4311.G8444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444445Q_C_7;_P ,Z7<WFEZ?)JM]%&3;V,<T,#3R$@*IFN'2*-,G=(Y+
M%4#%(Y7VQO\ EA^QM^V;XT_: ^*>M^'?$,-OIMEI>GWR_P!E0".3R;FVU""'
M=+=?.\TJ+(\+M$T=M)M$B0*3D_K_ $44445\X?&CXC>-?AU;WVH:-X<L];M+
M2,21PQ:M-#J$ZA5,@2U_LV2(NI+E8UN'>5$&Q3,ZPU\?_LS_ /!472_C5XED
M\)^(=*D\-:H9/(M4N+DRK+=*S)):2[X+=K>XW +$CJ1*X:+<DWE1S?J?7C_Q
M+\1^+?#^^3P]H^GZK%';M)LGU:2QN))EW'R8D^P7$)W ($DEGB7>Q#B-%\QO
M /V8OVEO%O[3.CVGB*#PWI^GZ1=7#QK)/KDCW#0Q2>5--%!%IC(VUED1(Y98
M&=XSDI&R2M]OT4444444445^6'[#'Q1^,OCCQ5KMK\0]/DM=)AC<PF2R2VC@
MNA<;4@LI5P;JW,?G9EW78 B@;[0/-S/^I]%%%%?EA\4?BC\9=+^,NGZ/H^GR
M/X*>2R#N+)'M9+5TS>SSWI^:&XB;S_*B\V$L8;<"WF\[_2?U/HHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHKC_B%>ZIIVC:A/H<,=SJT=G</802D".6Z6)C!&Y+Q@
M(T@56)>, $_.OWA\(?\ !.?XB_%#XA:=JS_$FUN(?*N(!I\UW8I87$FY&-PA
MA5(<Q1XA:.0Q#<\LJ^;)LV0_H_11111111111111111117Y8?"[XH_&75/C+
MJ&CZQI\B>"DDO0CFR1+6.U1,V4\%Z/FFN)6\CS8O-F*F:X!MX?)_T;]3Z**_
M+#]N?XH_&7P/XJT*U^'FGR76DS1H9C'9)<QSW1N-KP7LK9-K;B/R<2[K0$2S
MM]H/E9@_4^BN/^(5[JFG:-J$^APQW.K1V=P]A!*0(Y;I8F,$;DO& C2!58EX
MP 3\Z_>'PA_P3G^(OQ0^(6G:L_Q)M;B'RKB :?-=V*6%Q)N1C<(852',4>(6
MCD,0W/+*OFR;-D/Z/T4444444444444444444444444444444444445^6'Q1
M^*/QETOXRZ?H^CZ?(_@IY+(.XLD>UDM73-[//>GYH;B)O/\ *B\V$L8;<"WF
M\[_2?U/HHHK\L/BC\4?C+I?QET_1]'T^1_!3R60=Q9(]K):NF;V>>]/S0W$3
M>?Y47FPEC#;@6\WG?Z3^I]%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%9^K:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A5
M15!9F8@* 22 *^,/^'D/PH_M'^R_^$CM_M'VC[/O\BZ^S[]_E[OM7D?9O*SS
MY_F>1L_>>9Y?S5^<'[ O_)POCW_N/_\ IYMZ_?ZBBBBBBOY8OC/^RUJ/B:#Q
MM\3-!NKB/4M \<:TD\$0?>+>&XAF2ZMGA7S(Y;=YFEE9B$$"F8/$UN1-^OW_
M  3F_;7_ .&JM#>RUF:W7Q-IORW,:?(UU;@($OA%M5%W,QCG2$LD<H5]L*7$
M,0_1^O@#_@EQ_P DA\/?]Q'_ -.5W7V_XI\6:=X&LY-0U6[M[&RAV^;<W,R0
MPIO8(N^20JB[F957)&68*.2!7R!X6_X*0_"CQA>1V-MXCMTEEW;6N8+JTA&U
M2YWSW4$4*<*0N]UW-A%R[*I^WZ\O^)OQH\/_  >2!M;OH[:2[D6*TMP'FNKJ
M1I(X@EK:PK)<7#AY8PRP1R%0X9@%YKG_  E^T;X8\9ZH-#ANY+;5FC66.PU"
MTNM-NIHV$IWV\%_#;RW" 02EVA601A#O*\9]PKG_ !3XLT[P-9R:AJMW;V-E
M#M\VYN9DAA3>P1=\DA5%W,RJN2,LP4<D"OD#PM_P4A^%'C"\CL;;Q';I++NV
MM<P75I"-JESOGNH(H4X4A=[KN;"+EV53]GZ3JUOK]O%>6<L<]M/&DL,T3J\<
MD;J&1T=259&4AE920P(()!K\4?VR_P!NS0_%/C+P?X5T'5;>72[;Q!I5_K=_
M%.!9[8KF&2&+[2LHAEBC!:XN=RO%'(EN1*LL,R)^OW@7XL>'OBAYW]@ZKI^I
M_9]GG_8KN&Y\KS-VSS/)=]F[8VW=C=M;&<''/Z!\?O"_BOQ#<>%-/U.WN]:M
M+>2XN;: F7R4BF%O(LLJ Q)*DI"/ SB=<AC&%(->P5\0>*?^"D/PH\'WDEC<
M^([=Y8MNYK:"ZNX3N4.-D]K!+"_# -L=MK91L.K*/I_X:?%70_C)IR:KX>O[
M?4+)]H\V!PVQF19/+E7[\4H5T+PRA)8]P#HIXKX0_P""BW[:VE_ 3PU?Z+I>
MH1GQ5>QFUA@@D+3V2RJADN9C%(CVKK#)OM6)#M,T4B1R1),R>P?L=_&_PKK7
MA#PKH=KK>ES:LNAZ=$;".^MWNA)#91F5# LAE#QA',B[<H%;<!M./;_'_P ?
MO"_POU&PTC5]3M[?4M3N+>WL[/)DN)7N7:.%O)C#R)$SHR>>ZK KC:T@8@'V
M"O/_ (E_%70_@WISZKXAO[?3[)-P\V=PN]E1I/+B7[\LI5'*0Q!Y9-I"(QXK
MYP\%?\%#_A7X_N&M;/Q+9QR)&9";Q9K"/:&52!+>Q01,^6&(U8N1N8*55B/L
M^O']1^/WA?2_$=KX0DU.W.OWGF^581DRS+Y4 N6\X1AA;YB/F1_:#%YJY\O?
M@UY!\2_V^/AG\(M1?2M7U^W2]BW"6*"*XN_*97:-HY6M(IDCE5D8/"Y65."R
M ,I/U?I.K6^OV\5Y9RQSVT\:2PS1.KQR1NH9'1U)5D92&5E)# @@D&O+_C'\
M?O"_[/\ 9K?>)]3M]/B?/E+(2TTVUD1O)@C#S3;#(AD\I'\M6#OM3+#S#P-^
MW-\-_B.D;:9X@LY9)KR"RAMW\R&ZEN)Y(HHECM9DCN'0O,@,JQF%1O9G58I2
MGU?17/\ BGQ9IW@:SDU#5;NWL;*';YMS<S)#"F]@B[Y)"J+N9E5<D99@HY(%
M?&&D_P#!33X2:U<16L7B*-9)I$C0RV=]#&&=@H+RRVR11ID_-)(RH@RS,J@D
M?;^DZM;Z_;Q7EG+'/;3QI+#-$ZO')&ZAD='4E61E(964D,"""0:X_P")?Q5T
M/X-Z<^J^(;^WT^R3</-G<+O94:3RXE^_+*51RD,0>63:0B,>*^</!7_!0_X5
M^/[AK6S\2V<<B1F0F\6:PCVAE4@2WL4$3/EAB-6+D;F"E58C[/KQ_4?C]X7T
MOQ':^$)-3MSK]YYOE6$9,LR^5 +EO.$886^8CYD?V@Q>:N?+WX->0?$O]OCX
M9_"+47TK5]?MTO8MPEB@BN+ORF5VC:.5K2*9(Y59&#PN5E3@L@#*3]7Z3JUO
MK]O%>6<L<]M/&DL,T3J\<D;J&1T=259&4AE920P(()!K/\4^+-.\#6<FH:K=
MV]C90[?-N;F9(84WL$7?)(51=S,JKDC+,%') KXPTG_@II\)-:N(K6+Q%&LD
MTB1H9;.^AC#.P4%Y9;9(HTR?FDD94099F502/M_2=6M]?MXKRSECGMIXTEAF
MB=7CDC=0R.CJ2K(RD,K*2&!!!(->7_&/X_>%_P!G^S6^\3ZG;Z?$^?*60EII
MMK(C>3!&'FFV&1#)Y2/Y:L'?:F6' ?!S]M#X?_'V\;3_  [K=O<WHQMMI$FM
M9I,J[GR8[J.%Y]JQNTGDA_+4!GVAE)^C]6U:WT"WEO+R6."V@C>6::5U2..-
M%+.[NQ"JBJ"S,Q 4 DD 5X!;?M>^ [O1KWQ"NN68TFPO)[&:[9F2-KJ"+SGA
MMRR@W3F/YXOLHF$X_P!49*O_  F_:G\%_'#3KW5=!U>WN++3<F^ED$EM]F4(
M9/,F6Y2)TBVJQ$S 1'RY ')BD"Z'A/\ :4\'>-M+OM<LM8LVTG3;Q[*[OY)/
M(M8[A#&"HGF\N)T)FB$<L;-#*778[9K@/A#^W%\//COJBZ+X>UJ.ZU%XWDC@
M>WNK=I%C&7$9N88ED<+ES&A9]BO)MV1NR_5]>/\ PT^/WA?XR7FH6/AW4[?4
MI=+^S_:VMB9(4^TJSQ;)U'DRY".&\EY/+92C[7&VO0/%/BS3O UG)J&JW=O8
MV4.WS;FYF2&%-[!%WR2%47<S*JY(RS!1R0*\?A_:G\%R^%XO&C:O;PZ!/YP@
MNYQ)!YK0F57CBBF1)I)<P2A(41I9=A\M'XS0^"'[77@C]HZXN+/POJT=[<VL
M:RRPF&>WD$;-MWJEQ%$TB!L*[1AA&7C#E3(F[Z/KP_Q;^T;X8\&:H=#FNY+G
M5EC:62PT^TNM2NH8U$1WW$%A#<2VZ$3Q%&F6,2!QL+<XZ#X9?&CP_P#&%)VT
M2^CN9+21HKNW(>&ZM9%DDB*75K,L=Q;N7BD"K/'&6"%E!7FO4**Y_P 4^+-.
M\#6<FH:K=V]C90[?-N;F9(84WL$7?)(51=S,JKDC+,%') KXPTG_ (*:?"36
MKB*UB\11K)-(D:&6SOH8PSL%!>66V2*-,GYI)&5$&69E4$C[?TG5K?7[>*\L
MY8Y[:>-)89HG5XY(W4,CHZDJR,I#*RDA@002#6?XI\6:=X&LY-0U6[M[&RAV
M^;<W,R0PIO8(N^20JB[F957)&68*.2!7QAI/_!33X2:U<16L7B*-9)I$C0RV
M=]#&&=@H+RRVR11ID_-)(RH@RS,J@D?;^DZM;Z_;Q7EG+'/;3QI+#-$ZO')&
MZAD='4E61E(964D,"""0:X_XE_%70_@WISZKXAO[?3[)-P\V=PN]E1I/+B7[
M\LI5'*0Q!Y9-I"(QXKQ#X9?MS?#?XO//%I/B"S:2VC:61+GS+)O+2.261T%X
MD!D2..*229H]PA1=\A12">_T/]I3P=K_ (?M?%2ZQ9P:)?2/%;7MY)]BCDD1
MY(V0?:_);?NAEPI +!&8 J,UV'@7XL>'OBAYW]@ZKI^I_9]GG_8KN&Y\KS-V
MSS/)=]F[8VW=C=M;&<'&?XU^-_A7X:W"V>N:WI>FW+QB5(;R^M[>1HRS*'"2
MR*Q0LK*& P2K#.0<=AX6\6:=XYLX]0TJ[M[ZRFW>5<VTR30OL8HVR2,LC;65
ME;!.&4J>017G^H_'[POI?B.U\(2:G;G7[SS?*L(R99E\J 7+><(PPM\Q'S(_
MM!B\U<^7OP:]@KY ^)?[?'PS^$6HOI6KZ_;I>Q;A+%!%<7?E,KM&T<K6D4R1
MRJR,'A<K*G!9 &4GV_P#\:_#7Q5N+FUT#5+/4Y+.."2X-G,MQ'&MPTRQ RQ%
MHM[&"3,88N@"LRJLD9;/^,?Q^\+_ +/]FM]XGU.WT^)\^4LA+33;61&\F",/
M--L,B&3RD?RU8.^U,L/4-6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S
M,Q 4 DD 5^*/C7]NS0_B3\;_  U8VFJV\7A70?[2-Q?2SB"SGOI;"ZB,GFO*
M(98HP4AMIBJ$R2W'EO+#-&[?L=X*^(6C?$JW:\T/4+/4K9)#$\UG<17$:R!5
M8H7B9E#A65BI.0&4XP1GC_AI\?O"_P 9+S4+'P[J=OJ4NE_9_M;6Q,D*?:59
MXMDZCR9<A'#>2\GELI1]KC;7L%?,'QC_ &T/A_\  *\73_$6MV]M>G.ZVC2:
MZFCPJ./.CM8YG@W+(C1^<$\Q263<%8CK_A#^TIX.^/2*WAK6+._D:-Y3;I)L
MNDCCD\IGDM9-EQ&F\J TD:A@R,"5="WL&K:M;Z!;RWEY+'!;01O+--*ZI''&
MBEG=W8A515!9F8@* 22 *\?\)_M*>#O&VEWVN66L6;:3IMX]E=W\DGD6L=PA
MC!43S>7$Z$S1".6-FAE+KL=LUP'PA_;B^'GQWU1=%\/:U'=:B\;R1P/;W5NT
MBQC+B,W,,2R.%RYC0L^Q7DV[(W9?J^BBBO'] ^/WA?Q7XAN/"FGZG;W>M6EO
M)<7-M 3+Y*13"WD665 8DE24A'@9Q.N0QC"D&O$-3_X*'_"O2=4&CR>);,W)
MDBC#QK-+:[I0I4F]CB:T"#</,D,H2(AA(R%'V_1_Q+^*NA_!O3GU7Q#?V^GV
M2;AYL[A=[*C2>7$OWY92J.4AB#RR;2$1CQ7F'P0_:Z\$?M'7%Q9^%]6CO;FU
MC666$PSV\@C9MN]4N(HFD0-A7:,,(R\8<J9$W?1]?,'QC_;0^'_P"O%T_P 1
M:W;VUZ<[K:-)KJ:/"HX\Z.UCF>#<LB-'YP3S%)9-P5B._P#@Y\?O"_[0%FU]
MX8U.WU"),>:L9*S0[F=%\Z"0)-#O,;F/S43S%4NFY,,?0/%/BS3O UG)J&JW
M=O8V4.WS;FYF2&%-[!%WR2%47<S*JY(RS!1R0*\ U']M#X?Z1X<M?%ESK=O#
MI%]YOV261)DFN/)G%O+Y-HT8NI?+D($FR)MBD2-B/YZ]/^$/QH\/_'K2UUGP
MU?1W]BTCQ&1 Z,DD9^9)(Y%26-\%6"R*I9&20 HZ,W'ZE^U!X5LM1N=*@NKC
M4+VRP+R+2]/OM4^RLSR1B.X;3[>Y2"7=#(##*4E&PDH!@GT#X:?%70_C)IR:
MKX>O[?4+)]H\V!PVQF19/+E7[\4H5T+PRA)8]P#HIXKT"OF#XQ_MH?#_ . 5
MXNG^(M;M[:].=UM&DUU-'A4<>=':QS/!N61&C\X)YBDLFX*Q'?\ P<^/WA?]
MH"S:^\,:G;ZA$F/-6,E9H=S.B^=!($FAWF-S'YJ)YBJ73<F&/0?$OXJZ'\&]
M.?5?$-_;Z?9)N'FSN%WLJ-)Y<2_?EE*HY2&(/+)M(1&/%>0>/_VT/A_\+].L
M-4U?6[>WM]3M[>ZLTV327$MO<HTD,_V6.-[E(F",/,>-45QY;$2$*?3])^-?
MAK6O#\7BJ+5+-="FC21-0EF6&W"NXC =Y2@C?S#Y31R;72;,3*L@*CP#P5_P
M4/\ A7X_N&M;/Q+9QR)&9";Q9K"/:&52!+>Q01,^6&(U8N1N8*55B/J_PGXI
ML_'.G6FJZ?)YUE?6\-S;2[63?#,@DC?:X5UW*P.U@K#." <BN@HKY@^,?[:'
MP_\ @%>+I_B+6[>VO3G=;1I-=31X5''G1VL<SP;ED1H_.">8I+)N"L1U_P (
M?VE/!WQZ16\-:Q9W\C1O*;=)-ETD<<GE,\EK)LN(TWE0&DC4,&1@2KH6]@U;
M5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!7@%M^U[X#N]&O?
M$*ZY9C2;"\GL9KMF9(VNH(O.>&W+*#=.8_GB^RB83C_5&2M_X(?M(^$_VC[>
MXNO"NI1W\=I(L=P!'+#)&SKN0M%.D<H1@&V2;=CE)%5BT;A?<*\?\?\ Q^\+
M_"_4;#2-7U.WM]2U.XM[>SL\F2XE>Y=HX6\F,/(D3.C)Y[JL"N-K2!B ?8*\
M_P#B7\5=#^#>G/JOB&_M]/LDW#S9W"[V5&D\N)?ORRE4<I#$'EDVD(C'BOG#
MP5_P4/\ A7X_N&M;/Q+9QR)&9";Q9K"/:&52!+>Q01,^6&(U8N1N8*55B/L^
MO'_'_P ?O"_POU&PTC5]3M[?4M3N+>WL[/)DN)7N7:.%O)C#R)$SHR>>ZK K
MC:T@8@'V"O'] ^/WA?Q7XAN/"FGZG;W>M6EO)<7-M 3+Y*13"WD665 8DE24
MA'@9Q.N0QC"D&O$-3_X*'_"O2=4&CR>);,W)DBC#QK-+:[I0I4F]CB:T"#</
M,D,H2(AA(R%'V_7^K:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@*
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M#6>AZWI>I7*1F5X;.^M[B18PRJ7*12,P0,RJ6(P"RC.2,Z'CKXL>'OA?Y/\
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M(+OGW#_@L9\)_#WA3P;:ZOI^E:?::E=^((OM-Y!:0Q7$WFVU[))YLR()'WN
M[[F.YP&.6 -?=_['?P0\*Z+X0\*ZY:Z)I<.K-H>G2F_CL;=+HR3648E<SK&)
M2\@=Q(V[+AFW$[CG\@/VI?@WHGP5^/O@RUT."2&.]O-%OKHRW-Q=2374VL2K
M+,\MU+-*SN(UW9;!(+8W,Q/]'VK:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A
M515!9F8@* 22 *_%'_@GCIL_[8'BWQ#\4_%5M]J6&XBL]#BN3;W,-CLD^U^7
M K1AXY;1?LOE7"+!O:>XE.^:25D_0_\ ;$_95TO]J_PU/IEU%&-4@CEDTF\9
MBC6]T5^4-(J2-]GD946YCVN'0!U431PO'^>'_!(W]H^7XLZ'J'P^UNYN);BP
MMS)82":5)AIKA8)(8YH522'[,[)Y,GG><JW")"(X[5=OQ_\ \,^V?A;]HW_A
M#?"=S<>'K(?)%/:NTMQ!#+HGGW8@EN&D=)95>9(YR7:V>42HI,2+7ZG_ +6_
M[$'P^B^'.KBQT2ST^?1]+N+RSN[2%(KH26-L[QB:XVF6X1PNR<3M(9 QD+"=
M4F3C_P#@C;XIO/$'PUEMKF3?%I^L7=M:KM5?+A:*WNBF5 +9EN)GW.6;Y]N=
MBJJ^ ?%+]HBS^!/[2%QJ7C6/9I$>CQV>FWLULQ^QPR6Z3_:+<1022S[[G[7:
M&1/F7[1,AE$<315]W_'[X%:-^TW-X7\:^'7L[Z^T;7-,N([^UDBE6YT^&^47
MD'GK*L3)"?,N%SYKH\,L,2*]Q)G[OHK\8=:\4V?[;_QR;PG>2?:/"O@ZWGN9
M-.D5FM[_ %*WD2WE>:,B$_N9;D1!9/M,+I:R!08;Z7/W?^UA^S);_M ^ [KP
MAIR6=E(D=N=,9X%\BUDM64Q+&J#,"-&K6Q>($Q0ROB.1<Q/Q_P"Q'\!]1_8\
M\#2:7XGU6WG\BXNKV202N+.QMRJEHTEGV8B&Q[F1BD*+)-+E3@RR?$'_  3Q
MTV?]L#Q;XA^*?BJV^U+#<16>AQ7)M[F&QV2?:_+@5HP\<MHOV7RKA%@WM/<2
MG?-)*R?H?^V)^RKI?[5_AJ?3+J*,:I!'+)I-XS%&M[HK\H:14D;[/(RHMS'M
M<.@#JHFCA>/\\/\ @D;^T?+\6=#U#X?:W<W$MQ86YDL)!-*DPTUPL$D,<T*I
M)#]F=D\F3SO.5;A$A$<=JNWX_P#^&?;/PM^T;_PAOA.YN/#UD/DBGM7:6X@A
MET3S[L02W#2.DLJO,D<Y+M;/*)44F)%K]3_VM_V(/A]%\.=7%CHEGI\^CZ7<
M7EG=VD*170DL;9WC$UQM,MPCA=DXG:0R!C(6$ZI,G'_\$;?%-YX@^&LMM<R;
MXM/UB[MK5=JKY<+16]T4RH!;,MQ,^YRS?/MSL557@-:\4V?[;_QR;PG>2?:/
M"O@ZWGN9-.D5FM[_ %*WD2WE>:,B$_N9;D1!9/M,+I:R!08;Z7/W?^UA^S);
M_M ^ [KPAIR6=E(D=N=,9X%\BUDM64Q+&J#,"-&K6Q>($Q0ROB.1<Q/Y_P#L
M<_!F]_8B^'US:^+-4CN8[*2]U&9X?/EM[*U5 [QP;E$KH!')<L$BC)FFD58W
M;]Y)^8'[&_[9'@R_\0:K\0_BCK$8\43R"UTN V%[+'IUBJ$M]D,*3Q1I(96A
M"D"X41S.TLAO)V?C_P#@I-^T#\,_C#%IGB+P+J/_ !5EIJ"M+<6MG<64TD/E
M#;/+<26T,DDMN]O;I;$2[HE>3:I&&3[O\2+8?MI? 5/%GBBVDGU&QT/5KJ(B
MZFCC_M"QBN+?[8T-NT$#N[P&5$DC=(!+)"F49S)X!_P2)_9U\-?$WPKJ&M:_
M91ZK)%JEQ:6]K?*MS9VZFWLY99H;:56B6XF/E)+.0SF."&-2B^8)/J_]H7]@
MKX<>!?AYX@_LW1OL_P!BT_4=2AVWMZ?],@LI/(EEW7!\[RL'R4F\R.'S9]B+
M]HG\SY _X)+?L]:=\7?#-SJ7B)_[2TNQUBY6TT2>)'L5O'L[99;Z>-@1<R^4
MZ0VZ3 QVH$TB*99M\?E__!5/X.Z-^R_XE\,^*O!UO'I-]<R33&*WCB6UCN-,
M:T>WGBMMAB1R9!YJ@>3(8U8Q[VF>7]_OB]\&]$^.^EMHOB&"2ZTYY$DD@2YN
M+=9&C.4$AMI8FD0-AQ&Y9-ZI)MWQHR_BC_P0Q_YF[_N#_P#M_7U?_P %9/@W
MHGB;P#J/BB\@DEU;2H[2.QE-S<".!9[^WCF*VXE%N7D1RKR-&78+&"W[J/9P
M'_!-7]F31O'_ (!TG7O%"1ZZICOH-,L+Z"*6STVW^WS&<0P.&1[B>9#++=2
MS>6(;9-D41\WY/\ CG\--._96_:'\*_\(BGV"+5+C39Y8%5&AB_M"\GL+N*!
M&4B**2(/A!GR6D;R3$BQ)'^Q_P"W%\7M4^!'P\UKQ#HK1IJ-K';I!)(@D6-K
MBZAMC($/RLZ+*7C#ADWJN])$W(WS?_P2.^&FG>#_ (9VNKVR?Z;K5Q=3W<K*
MFX_9[B6TBB5E57\I%B+JCL^V6:=E($FT?"'_  6$\ :7X&\:^&_%EU;1W=MJ
M$9CU"P0&V:Z73IHF<R749+[YX;A+82;=\*0(59AM5/W.^"GP$\.?L[:=)I7A
MBS^PV4UPUS)%YT\V9G2.-GW3R2N,K$@V@A1MR!DDGV"OS _X*;_LU^-/VGM.
MT+2O"_V=[*/4'DU"*:2.+8S(([>[+,I<Q0*UR)4A+2MYR%;><KF/L/V_]6^'
MV@?#[5/#FNRZ7!-!I;2Z-II=$N([A$>#3WM+:(B9464>4&B40K")DD(MQ,*\
M?_X(PZM<:C\.;N*>622.VURZB@1W9EBC-M:2E(P20B&2220JN 7D=\;F8GD-
M:\4V?[;_ ,<F\)WDGVCPKX.MY[F33I%9K>_U*WD2WE>:,B$_N9;D1!9/M,+I
M:R!08;Z7/W?^UA^S);_M ^ [KPAIR6=E(D=N=,9X%\BUDM64Q+&J#,"-&K6Q
M>($Q0ROB.1<Q/Q_[$?P'U']CSP-)I?B?5;>?R+BZO9)!*XL[&W*J6C26?9B(
M;'N9&*0HLDTN5.#+)\0?L ^#O^&S/%&L?%[Q8/M;VFH?9-"LI9?-33_* G \
MORHXV^SI/"+:08S.;BZ>(7)CF'T?_P %9/ &E^)OAAJ.J7EM'+?:5):26-P0
M1) T]Y;V\P5@02DD;D/&V48K&Y7?%&R=!_P3.TFWU_X,:)9WD4<]M/'JD4T,
MJ*\<D;ZA>*Z.C JR,I*LK A@2""#7PA_P0Q_YF[_ +@__M_7W?\ \%4])M]1
M^$FM2SQ1R26TFGRP.Z*S12&^MXB\9()1S'))&67!*2.F=K,"?\$SM,36O@QH
MEK*9%CFCU2-S%+)#(%?4+Q24EB9)8WP?EDC970X965@"/S0^%OPMT?X+?M2V
M^@Z#;_9--M/,\B#S))=GFZ \S_/,[R'+NS?,QQG PH '[W?&_4]4T7PKK=UH
M8D;5H=+OI+ 11":0W26\C0!(BKB1_,"[8RK!SA=K9P?RA_X),_M1>#K#PG;>
M#;JXL],UV.\N,1R-Y3:B9Y8_*E$C1QQ/<$S):1V_F2W#);*RKY8"I]O_ +._
M[+MO^SQXQ\67NDV\=MHFN1Z3<6L,2JD<%Q%]M6[@1/,9@@9HYUPL4*"X$$2;
M8#C\@/\ @LU\&]$^'VJ:-K6G02)J.MR:G)J,\ES<3M,T LQ" )Y9%C2-9&2.
M.((B)MC"A$15_HN\4^$].\<V<FGZK:6]]93;?-MKF%)H7V,'7?'(&1MK*K+D
M'#*&'(!K^>'_ (5/X>_X:E_X1[^RM/\ [%_Z!WV2'['_ ,@#SO\ CWV>5_K?
MWOW?]9\_WN:_;[Q3^RQX+\6Z')X9ETBWM]%FN%N9K*P,FG0S3* %>5;%[?S<
M;4.V3<I:.)B-T497\@?^"&/_ #-W_<'_ /;^OM__ (*A?M'WG[/O@8QZ1<_9
MM7UBX6SMY8YECN(80IDN;B%2K.VU56W,B;&@>YCE65)%C#>X?L8_LZV7[.'@
M[3=.6RCMM6DLX'U67; ;B2Z;=-)'+/ H$R0232Q6Y+2!(0JAVY=ORP_X*D_!
M3_AG+6-+^*W@V3^R=2FU PWK0MMWWDD;RQW"0^68SYJ1W"7P=O+GRFZ%VFN7
M?[/^.R^&/VU?@Y+XQNK:218-#U'4K.$75TD=KJ$%K,K[D1H$N7MYHY(DDFB9
M"!(8P(IFW_&'_!);]GK3OB[X9N=2\1/_ &EI=CK%RMIHD\2/8K>/9VRRWT\;
M BYE\ITAMTF!CM0)I$4RS;X_+_\ @JG\'=&_9?\ $OAGQ5X.MX])OKF2:8Q6
M\<2VL=QIC6CV\\5ML,2.3(/-4#R9#&K&/>TSR_TG445Q_C_P'8?$_2[G1M42
M22QO(S%<1QSS6[21DC<ADMWCE",!MD4,!(A:-PR,RG^<']C?X!:7XO\ C#XT
M\()->6.B01ZO;O;6DY1KBQM]7MH_L,T[B2?[/(BK'.8I(KB1 4,X5Y _W!_P
M4[_9(\%:)\/+SQ#I>D6>EZCI,EL\,FGV\-JLJW-U!;21W"1(JRIMDWH2-\;H
M-CJCS)+O_P#!/KX&V7QO\$:-XG\;&/Q%(MG)I^E65]:P/9Z98VD[6P2&WV&*
M2XE-NC2WDBFX:-88-P6-VE^,/CG\--._96_:'\*_\(BGV"+5+C39Y8%5&AB_
MM"\GL+N*!&4B**2(/A!GR6D;R3$BQ)'^M_[??[0]Q^S/X#O=8TZ:.'5IY(;/
M3FDB:5?M$S9<A0"@>.!)YHS-^YWQJK+)N$3_  A^Q1^UW\(?V>_"\*ZAKWF>
M)-3_ --UV\DT_4I+B>\F+2&.:;R9O,\CS#$&5S'(XDN H>XD+? 'QG_:2\+_
M  4^*MIXS^$\^=+:WM6O[.V@.GVTFUS'<V*0R6L82*:*&&5G,4NRYD-PC>:B
M"/\ 6[_@K)\&]$\3> =1\47D$DNK:5':1V,IN;@1P+/?V\<Q6W$HMR\B.5>1
MHR[!8P6_=1[. _X)S?LF>#OB-\,++4O$&G1ZM<ZI'>PL][^^-I;Q7EW$L%@2
M UFFYI9V:W*3-<322F3(B$=__@H%:V?[%?PE;0_ UG;Z;9:OJ!T^Z&UIG,-Y
M;W+W+>9,SN\LBPK!YLID:. [(]ACA:+[ _8)^&FG?"_X:^'H-/3;]MT^WU&Y
MD*H'EN+Z))Y&=D5-^W>(8RVYU@BBC+-L!/XX?M>?!?P_X<_:&TJUU2QCU#2?
M%$EA+<6$9>R5)+YY-.9S+;L'=Q/']OD8>69G=HW/S-*WZ?\ [57C6P_X)_\
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M'_!<[_F4?^XQ_P"V%?O]7X _\$,?^9N_[@__ +?U]_\ _!4?_DD/B'_N'?\
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MO.NGZ/%%'!8P323RSEGOS;->R^8S+EC&%MQ),H@N,0E/F#_AC+XI_P#"U_\
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MGEQWE\LMPR21ZA8Q+#:"&.-%8H66UG4,[H3!="5E5H(9?U/KY@_:N_91T/\
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MURMJA42,LDJ;"4.YD0/(GU!^S_\ "'5++5-2\<>*EC3Q'K<<$0LHW$\6D6$
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MU/X+\+>*+?P7>:O;Q:_<^6([0B0_-*"T4;RA##%+( #'#(Z2R;XMJ-YT6_Z
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M^*TL=S'J,D=O:W0MXXE620NMI/:M:V\8N+>ZDQ WFH#$Y!=[=H+F)OV>\?\
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M/QHUOXJ\)WMP,ZS#8I9WB[HP'MA'#(MM%+&5:>*.57^U1[PMRA$@M/T>\?\
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MK^&%D\F6^MQ]GD+;%%Q#(D]OYC>7*1$98HQ-M1G,1<)A]I'X _"W]K+XH?\
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MLGEL1^,/_"6:=_PUM]J^UV_V?[1]E\WSDV?:/[#^R>1NSM\W[1_H_EYW^?\
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M/<N%BCCAD^9I-L;?N]7QA^WW^SQ<?M,> [W1].ACFU:"2&\TY9)6B7[1"V'
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M1!EL[K5+VX6[NH;=29;?RH852WN[4&$6\A6(6P1MQ^W_ /AD[X>?]"IX?_\
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M**\?\4_L]>#?'-Y)J&J^']'OKV;;YMS<Z=;33/L4(N^22-G;:JJJY)PJA1P
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MZYI]GJ5LD@E2&\MXKB-9 K*'"2JRAPK,H8#(#,,X)SY?_P ,G?#S_H5/#_\
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MKF#R_/\ ,\K_ (^(HMV[RI/N;L;><9&> T?]NGP-XK\7V/@K1K[^U-2O?/\
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M"_#'A>W\:7>KVZ:!=>6+>[ D?S6D)41I$B-,TJE7$D(3S8?+E\Q$\J3;\P?
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MT2#Q#HK2/IUU)<I!)(AC:1;>XEMC($/S*CM$7C#A7V,N](WW(OF'_#7GA?\
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M  EN-%L!;R7NHZ[JEO86MK"R^8(V8-=WCK\S_9[2$-+,Z(P4F)7:))#*F?\
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M^+'CK_A5_A[5=>\G[1_9FGW=[Y&_R_-^S0O-Y>_:^S=LV[MK;<YVG&#^./[
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M2FA^-K.ZUCP%%_9VM#,HTT2 6-T=TCR)&'_X]97WJL(5TLT$:1>3"KM/'O\
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MB,M,[]!_P[M\4?\ "P/^%D_\)E;_ -N_:/.Q_8 ^S[/)^S?9_+_M#=Y7V?\
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M  AVJ;5U"VL/,CO-3AMW?[/!,[0J]G%(LDGVH6UP[/&SVVYED\Z/W_\ :_\
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MC\?[!#I<FM>$Y[8R2Q#6I+2[&I"!Y&VW(M(UCL/M$:,#' <PED5))) 7E;Z
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MT=Q-;RK9R1Q7)C<0R2QM+&DA4[&>-9(FD0-@LBR1E@"HD0G</RP_X=V^*/\
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M************************************************_!'PGX ^.O[
MM[?2:9;1^,?#ES>/?7@C'FW5Q+<SQQR3%<_V@MZ\<2&3:+ZUA$K2L)RCNOT?
MX6_;X^)7C"\CL;;X4:PDLN[:US>2VD(VJ7.^>ZTZ*%.%(7>Z[FPBY=E4_0'P
M<^#GBWQYK&G>-/B6VGIJ^EV\T>D:9I8D6WLC>QJMW-<2.\CSW;KBV,:R26<2
M1F2,RR2B2/[?KG_%/B6#P?9R7UREP\46W<MM:W%W,=S!!L@M8Y9GY8%MB-M7
M+MA%9A^ /['5YK7PV^+_ (B\7ZSX8\46>D:[_:WD2MH5](T'VJ]CO(O/C@BE
M<96(QGR1-B5E_P"6>Z1?Z'J***********^</%GP0N/B]JEC>^)KB,V.C:HF
MHZ7IMFK*OVBW$B6\][=/^]G=0PGCAMULX87=X)CJ"(DI^CZ*************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M******************************************************\_\1?%
M+1_"FL:7H-Y<>7J6L_:O[/@\N1O.^QQB:X^=4,:;$(;]XR;LX7<W%>@44444
M444444445\@?M%_MT^!OV8MT&LWWGZDN/^)99!9[P9\H_O$W+'!\DJRK]IDA
M\V,,8O,8;:^OZ*********^0-'_;I\#>*_%]CX*T:^_M34KWS_WUD%ELX?)M
MC=?O+G<(WWH&5?LWG[9%9)?*85]?T444444444444444445S_BGQ9IW@:SDU
M#5;NWL;*';YMS<S)#"F]@B[Y)"J+N9E5<D99@HY(%> ?L]_M>>%_VH;S5;;P
MQ)<7$6D?9/-NI(###-]K61E\D2%9OD,3I)YL47S %-Z$-7T_111111111111
M1117QAX-_;R\'>.O'ES\/+1KS^UK>2YA$SV^VUEN+12UQ!&^\RAXPDV6DCCA
M8POLD?=#YOV?111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111117\J7_!17]H'Q!XK^(,>OV)DM=.\.:I<:9H[
MML8#4-(>WFO9C;M),F_SIH2)#&B3VZVR.C/%(J_TV_"KXEZ=\9-#L/$.E/OL
MM0MTGBRR,R;A\T4GELZ++$VZ*9 S>7*CH3E37H%%%%%%%%%%%%%?SH_\%JOA
M[HW@ZX\.7FF:?9V=S?R:Q+>S6]O%#)<R;K)M\[QJK2OND=MTA8Y=SG+'/]%U
M%%%%%%%%9^K:3;Z_;RV=Y%'/;3QO%-#*BO')&ZE71T8%61E)5E8$,"000:_G
MQ\+>$].\#?M8QZ?I5I;V-E#N\JVMH4AA3?X>+MLCC"HNYF9FP!EF+'DDU_0]
M1111111111117RA^VG^TPG[*/@ZY\0+''/?/)':Z?!+YGERW4NXC>8U)"1QI
M+.REHQ((C")8WD1J^KZ****X_P :_#W1OB5;K9ZYI]GJ5LD@E2&\MXKB-9 K
M*'"2JRAPK,H8#(#,,X)S^&/_  0Q_P"9N_[@_P#[?U^_U%%%%%%%%%%%%%%%
M?/\ H'[+'@OPMXHN/&EEI%O%K]SYADNP9#\TH"RR)$7,,4L@!$DT:)+)OEW.
MWG2[_H"BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBOS0_;Y_;)U3X)W&E^#O!J1S>,-<DC2!9H0T<,%RTEM#(DDDD<(N
M&N HA$GFPJ(I3.BH8_,]P_X94NO['\O_ (2CQ!_PDG^N_MK^T;OROMGF>=O_
M +)\_P#LW[)O_=_8?)\O[+^YW[_WU?GA^RM^V3\9_P!HNXOM!LT\)V^K:+'$
MEW%K$-_;7DS*S0RR&"WD(#QR(!=!8H4BDEC0(N]4'[G4444445\X?M9_%Y_@
MKX.U'4;-I/[6GC^Q:1%"D<MQ-J5WF&T2""3B=UD82M$JR,88Y&$4FTH?B_\
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M!<6ME#?V>DZ)J<EV++^RI9_[0DCM6M6W7=S)%$T+EG#*EF4 226"62=5#O\
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MO*=EDC6%E60( 6C\U_V>\4Z-/X@LY+:VO;C3Y7V[;JV6W::/:P8[!=0W$)W
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M)Y\]W]G54Q(?M5TB3-YIVCR-OE0^5YB,7GE"_G!_P0Q_YF[_ +@__M_7T?\
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M,$1R#[49?*FW^5L0BOV.^+TGBI-+8>#H]+?5FD0*VJR7"6J1YS(Q6VC>61\
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MEMCXACCM;02 7:V,EX+%M/U!""T+31O<75O:NP?8ZRN]Q9F/S&F3S1_6;7X
M_M]?\G"^ O\ N ?^GFXK]_J_ '_@AC_S-W_<'_\ ;^C_ (+G?\RC_P!QC_VP
MK]_J_ ']@7_DX7Q[_P!Q_P#]/-O1_P %SO\ F4?^XQ_[85^_U?@#_P W>?Y_
MZ%ROU^_:=^)'A+X6>%[O4/&J6]QI'R*UG/#'<?:Y@?,A@BMY?DEE+('0-A4V
M&9VCCB>1/C#X<:Y\6?VU+>#66NH_ OA*[C?RH+9!<ZQ>6\BPJ9!<3QJMLCKY
M[6=W"L,T>4D^SW$9AN#\H?\ !#'_ )F[_N#_ /M_1_P7._YE'_N,?^V%?O\
M45\__M._$CPE\+/"]WJ'C5+>XTCY%:SGACN/M<P/F0P16\OR2RED#H&PJ;#,
M[1QQ/(GQA\.-<^+/[:EO!K+74?@7PE=QOY4%L@N=8O+>185,@N)XU6V1U\]K
M.[A6&:/*2?9[B,PW!^4/^"&/_,W?]P?_ -OZ/^"YW_,H_P#<8_\ ;"OW^K\
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M3K&\\:6ZF*/R0#_4;7X _P#!#'_F;O\ N#_^W]?O]7X _L"_\G"^/?\ N/\
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MH+HH="W[_?#3XJZ'\9-.35?#U_;ZA9/M'FP.&V,R+)Y<J_?BE"NA>&4)+'N
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M-M959<@X90PY -'A;PGIW@:SCT_2K2WL;*'=Y5M;0I#"F]B[;(XPJ+N9F9L
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M$N-374HKV2S6X7]U)<6,4"7$:;RB2B01O&6\O8]P8X)/C#_@AC_S-W_<'_\
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M_P#3E=U\ ?M]?\G"^ O^X!_Z>;BOW^HK\ ?^"YW_ #*/_<8_]L*_>[2=)M]
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M,;GQ=IODV5C;G5K"T^TVC^=-#;3M=CS;9IW3>L%JF9 RKC<B$^9G?_X([_\
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M<DA5<D)&[XVJQ'PA_P W>?Y_Z%ROU^_:Q_Y)YXK_ .Q?U;_TBFKX _X(J?\
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M;ZI.8_%NJ'PY>2,+[2(%DM&OK4"01VMW<P72K*FV0I,P@0R(\HC%N9 R=?\
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MM]1\3^+;S_A(3(TLR)$)]'M5D7#VVG63-#+"BA($\]YF>X\DS2Q^;+^[S_\
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MKJ*2&1H[R4)(C(QCFOKF6)P& )22-TDC;HZ,KJ2K G\\/V^O^3A? 7_< _\
M3S<5^_U?@#_P0Q_YF[_N#_\ M_7O_P#P6K_Y)YIO_8P6W_I%?5]__LG?\D\\
M*?\ 8OZ3_P"D4->0?MF_MFV?[,-G#I^GP_VGXLU/$>E:5&&D9FD;RTFF2/\
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MUOXP2WE.J!(H[C)/DW!"AB?)G;R_+EMM#_@G-_P3XO/V697\3:Y>;M:OM/\
MLSZ?$JF&T625)G1Y@S>?+^ZA!:/9%&PF53<*8Y1^K]%%%%%%%%>7_&CXO:7\
M!?#]]XEUEI%L;",/((D,DCL[K''&B\ O)(Z1J6*HI8,[H@9U]0HHHHK\,?\
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M:17@1'\J5&N(9%+?K?111111117E_P :_BA;_!7PUJGB.Z\MH]-LYK@1R3+
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M_.W2(K_Z1,#&FQ"TGS [MFP?,PK^<'_A8GB__AHW^V?^$7_XJ3_H7_[5MO\
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M#2PTNZU'38S-J.J:I<L;&)8U FB6*T;SF=)9;>!G#,Z7'G1/;!(VN%\OU_\
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MGH=PVFK<23"*5I([N!9)5CDDLV=FMI[3,5P\:1!(I[AWD%V%+$_N?^S;X_\
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MAO\ L?45N/$FIN;.V:%([I;AK*VVF6[WQ0/'"RLC0W,D8NH(41@Y_P $5/\
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M_*^W]_M)U:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$@U^"/\
MP2U_XG_Q3\;ZIX>^7PFWVORDA_<6_P"_U R:;BU.QABW2Y$7[L>0A>,^69 K
M=A_P7!\:W%AHWAO0U6,VUY>7EY(Y#>8)+**.*,*=VT(5O)2X*DDK'AE 8-]?
MZ3I/Q]T"WBL[.+X=P6T$:10PQ)K"1QQHH5$1% 5450%55 "@   "OE"#]@KX
MI^)?BA9?$C5]0\/VUPNH6$]Y'IMSJ$>;>V2&":*)9+<L?-MXVC='EV2;W1B(
MV('[?45^ /[ O_)POCW_ +C_ /Z>;>OO_P#X*C_\DA\0_P#<._\ 3E:5G_\
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M)P&! >.1$DC;JCJKJ0R@C]COVL?^2>>*_P#L7]6_](IJ^ /^"*G_ "3S4O\
ML8+G_P!(K&O /V^O^3A? 7_< _\ 3S<5^_U%?D!_P6K_ .2>:;_V,%M_Z17U
M?>'['>DV^B_#GPK%:Q1PQMH>G2E(T5%,DUM'+*Y"@ O)([R2-U=V9V)9B3^,
M'_!83PP_PE\:^&_'&D2QV^HW$9(*6\>X76E312174C-N6=RL\4061"%2V127
M0A$_2_\ X*C_ /)(?$/_ '#O_3E:4?\ !+C_ ))#X>_[B/\ Z<KNM#]J[X5?
M#?0M9TCXF^.+J2RFT*2&*W<2R>7/(LK36J-;Q))-*\,IDN$6W"D@2-.);>,J
MGPA^VE^TUXH_:+^&>M7.F^%KC2O")_LZ4ZMJTHBN;J)KBS>-;6Q0,?GEEB=+
MKS9;5[:*8!A.RHGV_P#\$N/^20^'O^XC_P"G*[K\\-3TFWUK]KD1744<T:R1
M2A)$5U$D/A]98G 8$!XY$22-NJ.JNI#*"/V._:Q_Y)YXK_[%_5O_ $BFKX _
MX(J?\D\U+_L8+G_TBL:^</VZK'QK^R)\5)/BKX>MY+O3KVSB%Q(\,S6,3"&.
MP:UO?L\RL4++;W$+2F%'N&C5!(]NQKZO^"W[='@']N9;/1M;C_L36K/4-/U"
MS@N9H&5[NUO5>W6QNI$&^5\)%+%Y<%P\5S-%#YBB25?U?HHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK\ ?\
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M)6'B#3H+BYN-!N)FN$BVE8[&YC!N)W3'F-Y;P6^3&<1Q--(ZF-6DBT/V$O\
M@I#X:^(/A^TT7Q9J<>G:[IMFB7%UJ$RP6]XL;F))$N9YW,EQY8A>Y$IC>29Y
M)(D:-7,?T!XY_:SM_'OB70?"'P]U&SU*^N[R&\U:[MMMY:VFCVK%[H/<0F2*
M*XN"JVT(8/M,OS-;/+:S'[OHK\ ?V!?^3A?'O_<?_P#3S;U]_P#_  5'_P"2
M0^(?^X=_Z<K2C_@EQ_R2'P]_W$?_ $Y7=? '[?7_ "<+X"_[@'_IYN*_?ZBO
MYP?^"FOA;7/V;/BAIWQ-T2.X$5S]DE-T[$V_VZU0PO9MY)CD2*:UACWQNP-P
MCW2H[(LB1?K_ /#3]O;X:_%#3DU"#Q#I]ENVB2VU&XBL;B)RBNR-'.Z;]N\*
M9(3+ SJRI*^TD<?^SO\ &BX_:@\8ZKXDT6^D?P5I=G'I5B@#)'?:A/Y-Y=W;
M1R+#/$]LGDVJ+-'(C"222&5-\Z-^8'_!)KQ_I?Q3\>:[K7BZYCO/&5Y'%)ID
M]T3YK+MF%\+88$*NL0@18XPKQVJR1PJMLLZC/_X+3?%70_&^H^']*TN_M[R]
MTO\ M07T4#B3[.TKVT:QRLN464-;RAX2?-CV@NBAT+?T':5X_P!+UW5+W1;6
MYCEU'38[:2]@0DM MV)# )"!M5W6)W$>=X39(RA)8F?\$?\ @AUXIL[34?$^
ME/)B]N;?3[F&+:QW0VKW$<S[@-@VM<P#:Q#-ORH8*Y7]/_\ @HK\8[/X-_#7
M69+E?,EU6WETFUBRR[YKZ*2,G<J.%\J+SKC#[5D\KRMZO(IH_P""=WP+E^ 7
MPZTRQO(/L^I7N_4+]#YH837.#&LB3!6BECMUMX9HE5566)_O,6D?\X/V!?\
MDX7Q[_W'_P#T\V]?K]^UC_R3SQ7_ -B_JW_I%-7YP_\ !&;Q9IVC?#S6_M-W
M;P_8]8N+JZ\R9$\BW:RM<3S;B/+B/DS8D?"'RI.?D;'S_P#\%0?BE!K_ ,0_
M!^D:[<7"^#&M],U*]LY([B#Y)[V>.YEFA5$NQ*+9-@1E$\&9%C2.224-^G_[
M7?Q5\)?#?X8ZI!]OT^TM-1\/WEMHL$+Q[;E9;7R+=+**+/F1#SH!NA4Q11.L
MC%(AN'QA_P $AO'^E_#[X<W,FJ7,=LMYXL^PVP<G=-=75M81PPQJ 69V8Y.
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M&K:\L(UD>4VZ:KJ3VKR21^4SR6LET]O(^P* TD;%2J,"&1"OT?7RA\4/V(_
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MKX:_:OTN/3/$,4@:"3S+6\MV5+JW8E?,$4CI(NR15"RQNKHX"OM$L<3Q\_\
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MY/AC_:/]K_V3<?VE]H^U?;/[7U7[1]HW^9Y_G?;/,\W?\_F;M^_YL[N:]O\
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M  WK-Q-JB_NX=8UISJ%PBS:)OFFDPJ">6&)Y/LD;A8B\<$<A\K>:^\/VM_\
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M8R:1J-U9RV9O(KJ>XDCCE9')1+V2Y@WJ\<;J7B<90!E9"RM^.'PM\ ?\*O\
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MVJ2:KJE^VJ2:FXMKR>-[6R6$686.RACBB6%"K@2$[WE,:/([R[W?^A[Q_P"
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MR+9POE1?Z+>6_F&2%TA.%^T3(/8/^&!?^I]^('_@_P#_ +GK\4?VCO .J?\
M!.7XLZ?XBL);S4;221=0M[J\D$MQ>+(#%J5O<7+6PB-Q(7F#NB2/%#<P3$^<
MP(_J-\)^*;/QSIUIJNGR>=97UO#<VTNUDWPS()(WVN%==RL#M8*PS@@'(KH*
MS]6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q 4 DD 5^$/[0/_!'J
MXT"X.N_#+4I(+F"3[3#IUS,R21R(TDR?8KY<,KJPABMTN,%2#+)? BNP_P""
M<'[>WB'QSKB_#GQNN=0@MYHK2ZFCF2^>XLRS2VUZ&#!I5B5SYL@@<&V993/<
M3;J\_P#V^O\ DX7P%_W /_3S<5^_U?SX_#SP1K/_  3\^+.ICP]9WGB'PK>1
MR?;-/T2.6_N[".8-/9175J)]T-Q$VU+>XNV(N;.2XDB8RO-'#]/_ +<&N^*O
MVN+"#P#X%T?5!;7LD-QJNJZE87&EV<=O%,NV#.H6\4TCB7RKF3[.IF$<(6)+
M@/.D7Z'_  !^#EG^S_X7TSPQ8MOBT^W$;2X9?.F8F2>;:[R%/-E>27RP[+'O
MV*=BJ!^,/_-WG^?^A<K]?OVL?^2>>*_^Q?U;_P!(IJ^ /^"*G_)/-2_[&"Y_
M](K&O /V^O\ DX7P%_W /_3S<5^_U?@#_P W>?Y_Z%ROW^K\ ?V!?^3A?'O_
M ''_ /T\V]?1_P#P6>TFXU'X<VDL$4DD=MKEK+.Z(S+%&;:[B#R$ A$,DD<8
M9L O(B9W,H/UA^P3\2].^*'PU\/3Z>^[[%I]OIUS&60O%<6,202*ZHS[-VP3
M1AMKM!+%(57> /;_ (T?%[2_@+X?OO$NLM(MC81AY!$ADD=G=8XXT7@%Y)'2
M-2Q5%+!G=$#.OQA^W;^V;>? ^6Q\&^%(?M/C/7O*CL=X40VJW,IMXIBTN(GE
M>4,D$;'RD96EG(C5(KCQ_P"(O["5GH7@WQ#XN\=7UQXG\8Q^']4E^U74K/9V
M4PMKR7986V$1(HVF)B$BE8Y(UG@AM&/EJ?\ !%3_ ))YJ7_8P7/_ *16-> ?
MM]?\G"^ O^X!_P"GFXK]_J_ '_@AC_S-W_<'_P#;^C_@N=_S*/\ W&/_ &PK
M]_J*^</VJOVF-+_90\-2^(=3CDG8R+;V=K'D-<73J[QQ&3:RQ)MC=Y)6!"(C
M;5DE*12?!_P3_9>US]M+3K7Q?\7M1N+RRO=EYI?ARTG-MIT5M*DS02SK;D.T
MI6XW0,)/M,<*HEQ<3%Y((OG#_@G?I-OH'Q]\;V=G%'!;01Z[%##$BI''&FL6
MRHB(H"JBJ JJH 4    5G_\ !4'7_P#A5_QD\'^)[ZWN&TVRM],G:2.//F_8
M=3GGGBA9RD;RJCQDH77;YL98JKJ3_0=I.K6^OV\5Y9RQSVT\:2PS1.KQR1NH
M9'1U)5D92&5E)# @@D&O/_%WQ>TOP5K>B^'KII#J.O27:64:(2NVRMVN9Y)'
M.%5%4(@&2[/*FU"@E>/\0?\ @AKJUO#<>*[-I8Q<RQZ7+'"742/'$UXLCJF=
MS(C2Q*[ $*9(P2"ZY_8[]K'_ ))YXK_[%_5O_2*:O@#_ ((J?\D\U+_L8+G_
M -(K&O /^;O/\_\ 0N5^_P!7X _\$,?^9N_[@_\ [?T?\%SO^91_[C'_ +85
M^_U?E!^V!_P39T/]K6\NO%6@:G]DUV7,,S%A<6-Q-9+):F.0*3);RJ\4=O,\
M;.L(@<&T><NQ^ /@S^U=X^_X)Z^*(O GCL_:=#6XME:2Y>>?[-8D>0EUIDP#
M.UHJJK_9_+<#R'MTBM;EI\?J_P#\%1_^20^(?^X=_P"G*TH_X)<?\DA\/?\
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M;?Y=W,D&YI&B7!FPJB4\L8D_9[_A,K[^Q_[3_L;4/M?_ $"_,L/MG^LV??\
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MP2"[B..20JN2$C=\;58@_P""5FK6^H_"318H)8Y)+:34(IT1U9HI#?7$H20
MDHYCDCD"M@E)$?&UE)_0^BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBN/\:^+'\(6ZRPV-YJ,\D@CBM;-(S([;6<DR3R0V\**B,QDN)H4)"Q*S3RPQ
M2>(?L[?!34?A]>:_XA\026\VO^(]0^T7!MF=X;>SME\G3[)':. 3>1%G=<>1
M!)*TA#B38LC?3]%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%>?^.OA/X>^*'D_V]I6G
MZG]GW^1]MM(;GRO,V[_+\Y'V;MB;MN-VU<YP,'@7X3^'OA?YW]@Z5I^F?:-G
MG_8K2&V\WR]VSS/)1-^W>VW=G;N;&,G/H%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%>?^.OA/X>^*'D_V]I6GZG]GW^1]MM(;GRO,V[_+\Y'V;MB;MN-VU<YP,<_X
M6_9Z\&^!KR/4-*\/Z/8WL.[RKFVTZVAF3>I1MDD<:NNY696P1E6*G@D5[!11
M11111111111111111111111111111117E_C7X(>%?B5<+>:YHFEZE<I&(DFO
M+&WN)%C#,P0/+&S! S,P4' +,<9)R>"O@AX5^&MPUYH>B:7IMR\9B>:SL;>W
MD:,LK%"\4:L4+*K%2<$JIQD#'J%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%<_XI\6:=X&LY-0U6[M[&RAV^
M;<W,R0PIO8(N^20JB[F957)&68*.2!70444444444445S^O^+-.\*?9_[0N[
M>T^UW$=K;>?,D7G7$N?+@BWD;Y7P=D:Y=L' .#70444444444445Y?X*^-_A
M7XE7#6>AZWI>I7*1F5X;.^M[B18PRJ7*12,P0,RJ6(P"RC.2,^H4444445S_
M (I\6:=X&LY-0U6[M[&RAV^;<W,R0PIO8(N^20JB[F957)&68*.2!6?X*^(6
MC?$JW:\T/4+/4K9)#$\UG<17$:R!58H7B9E#A65BI.0&4XP1GL*****X^]^(
M6C:=JD.ASZA9QZM<QF6"P>XB6ZEC <EXX"PE= (Y"652 (WY^5L=A7/Z=XLT
M[5[RZT^VN[>:]L?*^UVT<R/-;^<I>+SHU)>+S%!:/>%WJ"RY'-'BGQ9IW@:S
MDU#5;NWL;*';YMS<S)#"F]@B[Y)"J+N9E5<D99@HY(%:&DZM;Z_;Q7EG+'/;
M3QI+#-$ZO')&ZAD='4E61E(964D,"""0:T**X^]^(6C:=JD.ASZA9QZM<QF6
M"P>XB6ZEC <EXX"PE= (Y"652 (WY^5L=A1111111111111111111111117'
M^&_B%HWC&XN[/3-0L[RYL)/*O8;>XBFDMI-SKLG2-F:)]T;KMD"G*.,94X["
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBN/O?B%HVG:I#H<^H6<>K7,9E@L
M'N(ENI8P')>. L)70".0EE4@"-^?E;'84444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444445
M_-C_ ,%FOAH_@_5-&U235=4OVU234W%M>3QO:V2PBS"QV4,<42PH5<"0G>\I
MC1Y'>7>[_P!)U%%%%%%%>/\ Q+^"MC\4-[SWNL65PUNT$<VG:Q?V/E9W%95A
M@G2V>52Y8/-%+NVJKAXU"#^=+_@GIJ/BK]K/Q5=Z'KGC'Q9!;0:7->(]GK5P
MDAD2XMH@"93,NS;,Q("@Y"_, "#]G_M>?"SX@?L7:/)XS\'>-?$%_:0^1;7U
MKK$\.H^4D\A7[2AN1Y7^M^S0JD=LTZ^9(_G>49%'U?\ \$_/VXT_:[TNXAU0
M6=IXCLI',UG;F15EM25\NZBCE+,$#-Y,JB28HZJ[F,7$,=?F!^U+\-'^&'Q]
M\&02ZKJFL27=YHMV\^ISQS21M+K$H,,(BBABAMU*;HX(T5(R[[0%(4?TG444
M44444445^0!^(=G^V5\:[[P;>37$WA7PQI\KR::LK)9ZAJ5K=VRRF^@,:&>*
M&5PB02&2%I+1959H9Y8Y.0_;@_X)E/KEQ!XL^%T$>G:S;20F33K5X[*-VC91
M'=6;[HHK:XB(5G4-&D@7S5*7*L+K]?OA[9:IIVC:?!KDT=SJT=G;I?SQ ".6
MZ6)1/(@"1@(T@9E 2, $?(OW1V%%%%%<_P"+/%-GX&TZ[U74)/)LK&WFN;F7
M:S[(84,DC[4#.VU5)VJ&8XP 3@5^4'["FFZ=^V]%KGCSQI;?VM*VL75GING:
MB4O+'3+/RK681VMN\:PK*P:..:X$8DE$*M\KR3F7@-$_X)U>*/V=/BKI6O?#
MRZ\KPS<7&Z_66<!K6SWJ]S8RK)N>ZBF4;;1PLDB2B,S-$\"7K_M]11117YP?
M$7_@G/IWQ"^*%K\27U:XB\FXL;N;3Q C>9<6"(L)2X+#RXCY,!DC:*5VQ*%E
M3S$\G[/^+WPT?XM:6VEIJNJ:.KR([W.E3QV]T50Y\L3/%*T:%MI8Q;'8+L+^
M4TB/^*/_  0Q_P"9N_[@_P#[?U^I_P"V3^RM;_M?>&DT">^DTZ2&\AO(+A(E
MF421K)$1)$6C+H8YI  LD95]C[F56C?O_P!F[X(6_P"SAX3TWPK:W$EW'81R
M W$BJC2232O/*P1<A$,DC^6F7*)M5I)&!=N@^-'Q>TOX"^'[[Q+K+2+8V$8>
M01(9)'9W6..-%X!>21TC4L512P9W1 SKZA7YP?$7_@G/IWQ"^*%K\27U:XB\
MFXL;N;3Q C>9<6"(L)2X+#RXCY,!DC:*5VQ*%E3S$\G]'Z**************
M**********_.#]CO_@G/IW[(7B'4M>MM6N+_ .UV[VEK!) D7D6[S),1,ZLW
MGR_NH5$B+;IQ(?*/F*(OT?HHHHHHHHHHHHHHHHHHHHHHHKR_XT?%[2_@+X?O
MO$NLM(MC81AY!$ADD=G=8XXT7@%Y)'2-2Q5%+!G=$#.OJ%%%%%%%%%>7_!OX
MO:7\=]$@\0Z*TCZ==27*022(8VD6WN);8R!#\RH[1%XPX5]C+O2-]R+\8?$7
M_@G/IWQ"^*%K\27U:XB\FXL;N;3Q C>9<6"(L)2X+#RXCY,!DC:*5VQ*%E3S
M$\G]'Z******************************************************
M************************************************************
M************************************************************
M*********************************_ '_@N=_P RC_W&/_;"OW^HHHHH
MHHHK^8'_ ((J?\E#U+_L7[G_ -+;&OW?_;6\4V?@_P"&OBBYOI/*B?1[RV5M
MK-F:[B:U@3"!C\\LL:;B-J[MS%4#,/Q _P"")?A:\N_&6LZJD>;*VT<VTTNY
M1MFNKF"2%-I.\[EMISN4%5V88J60-[!^WU_R<+X"_P"X!_Z>;BOW^K\L-%_;
M,\:_M+^)=7T7X66&A_V=H,C1W6K:Q<S2P73,WEPFV2Q;<J.T5R\<F9TEA1)&
M:W=EBDS_ (:?M_>(?!GCE/AY\4-'M]/U*[N%BL-1T[SC9S^>RQVFV*4RR-%,
MXD47*R?NY"L,UO"T=P\?VA^TW^T6G[-FC/JATG5-7D\N=UBL+622.)8(C(TM
MY<!3%:VX.T/(^YP&9TAE6*79\/\ [//_  4EU3XX:-</9:''J?BB;5+J/3M!
MLK@0F/38(K>4W5_>7!:*%%,S0K.R1+=7'EPPP*3(8_,/"?\ P4H\<_"WQS:>
M%/BMHFGZ3;W?DHTUONB\C[0P6&Z:>6[GMI;13N2=D=?*Q(V\R6[P/^UVK:M;
MZ!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22 *_.#P'^T!\5_VF[!/
M$O@73?#>F^'IY)XK0:[/>2WERL$SQFY*V(\J!&*^7Y#EW22.1A))$T3GU#]E
M/]J37/C]KGB31]<T+_A'[CP__9\3VCSFYF,UR;MG<RA(HVB9(H6@,:%64M*L
MTL<L>S[?KQ_XU^,_$?@;3H[GPQH/_"0WK7"QR6GV^#3]D)21FF\V=61MK*B>
M6!N/F;@<(:_GA_9#^(GB_P /?&3Q;J6D>%_[3UJX_MC[9I']JVUM]C\S4X7F
M_P!+D4Q3>5*%A^0#S-WF+A017]#WP4\9^(_'.G27/B?0?^$>O5N&CCM/M\&H
M;X0D;+-YL"JB[F9T\LC</+W$X<5\X>/_ -LQ]9\2W/@/X?6$>N^)K6,M>337
M,=OING+N$,DEQ+N,UP]M+)!]HM;9"Y5Y(UE6XB>)?#_C'^U)\7_V2[-=<\8:
M%X?UG16S%(^B3WL#6DS,@B>Y>Z2;$4F7C4K$5\THK31LT4<WW?\ "']H?P_\
M<?#2^*M$FDN+'RW::)(GDNH)(EWRV\EM"))3<*",11B0RAD:'S4DB=_S1U'_
M (*RRP>.[7P[+X<U#3=-7S5N8;RUE;6KB:2T$EE!;V,9"PRRW!2&,2-.LR31
M2%K9=Q'I_A_]IWXTW/CS3M%U/P)'9:%>R1><Z2M=-;6[*RRRR:I#*;$/&R/,
M+=HHYI$"6ZKYDL4S?J?7P!^W?\1/%_A[P]KFFZ1X7_M/1;CP_??;-7_M6VMO
ML?F0W"3?Z)(IEF\J(+-\A'F;O+7# FOS@_X)?_%7QWX&\&WMMX8\'?\ "0V3
M:Q/))=_VU::?LF-M:*T/E3HSMM54?S =I\S:!E#7[?>*?BY%\,O"4GBKQ-!_
M9WV33UN[VT$\4K13>6&:TCE+1Q32F4_9X2&19Y2@7&\5\ ?#?]HWXU_M&Z&_
MB_PEH_A>TTB;SOL%CJ%Q=S7UQ]G'ER;986@M_GG26.+SA:[2OS_N]L\GJ'[$
MO[>*?M07%YX>UC3I-'\4:7'NN[0B0QR+$R0W$BAU#V[I.VQ[68L\8>/$LY$W
ME?5_QT^.FA_LZ:'/X@\03^3:0_*B+AIKB9@2D$"$C?*^#@9"JH:1V2)))%^,
M++XG?'_Q]93:UIGAWPWI%L8Q)::3JL]W+J4B^0D@!>%X8$>1RR+'<BT>%AY<
MRH%\UM#]@_\ X*#V?[7_ )^E7EG_ &?K]G;K/)%&S26]Q"OEQRSPL5S%B5P#
M;R%V5'C*S3_O3%Y?\2/^"F%[IWCK0_!FE>'[RSCU'5+"WFO-:MI[226UN+MK
M5Y+2S;RY0C *\%Q,P((DC>S#+D?K?7X _P#!#'_F;O\ N#_^W]?I?^V#^V*G
M[)]A]J&AZIJ\GEK(TD$$D>GP*TR0J+K4#&\4+N6;RHT69RZHKK$LT3MV'[&?
MQKU']HGP)I?B?58[>&]OOM?FQVRND(\F[G@78LDDKC*Q*6R[98DC P!^('_!
M63XR>._%?]F:5KVA_P!@: ]Q<3V,4EU:7=Q>36_[OSYFMI)!!LBN$ MU)4/+
M(3-<;8S#^W_P4^*OCOQSJ,EMXG\'?\(]9+;M)'=_VU::AOF#QJL/E0(KKN5G
M?S"=H\O:1EQ7Q?\ $C_@IA>Z=XZT/P9I7A^\LX]1U2PMYKS6K:>TDEM;B[:U
M>2TLV\N4(P"O!<3,"")(WLPRY'ZWU\(>/_VJ=9\9>);GP3\,[&SU35K",MJN
MJWTLJ:3I<@8;;>8P*9;BX<+)'Y4+(89<$^9Y%VEO\_\ B3]NOQK^RQX@M-,^
M+6DZ7'I.IR;+35]%EF:-%B1#<2-;3/+<2I&\\"N"MLZA97B2[^13^C_C_P",
M6C?#KPU<^++JXCDTFVLS>":&2)EGC*AHA;NSK%(\Y*);C>!*\D:JWS"OC#PG
M\7/C7\3=.M/%>DZ+X7AT6\MX;VWTBXO;M]4EMV0.(UNT1+));A?G@:1 D EC
M6==R2"O8/V,_VD]1_:?TG5=4U+3/['EL=8FTX6+,[S0^1;VS2+.SI$3*)990
M1Y<6Q0L94NC._P!?UGZMJUOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B
M H!)( K\\- _:3^(?[3'VC4/AEIFCV_AZWN)((-4\0M>K_:FW"M+9V]JBR11
M1NLBL\Q;S=R*!%-%<0Q\_P#L]?\ !0&\U7Q0_P /OB3IUOH'BI/*6-H9UDL[
MF:<"6* 8DF$$K120^4#-.L\F]-T4QBMWT/VN_P!NOQ+^R#<1/J/A&.]TFZD=
M+74;?5V$9968K%.C:?F"X:-1+Y>9$8;Q%--Y4I3ZO^!?Q=U'XV^$H/$L5II\
M<M];^?96\.I/<PG,8*Q7-R+.,P2I+O@N4CAN/(:-L&1P8U^8/A3^V-XY^,FN
M:IHNE^"K?RM&U"YTZ]U.776CL4N+<R!E1SIGG2Y*# BA=XQ+"TJQ)(&H_;?_
M &^I?V4HGMK'0=0O;MMD:7]Q;RP:1'-+%+(B"Y*_Z5*FQ'>WA*JT9D7[5'+%
M(B\?-^V5X\^+V@Z7+\,="L]<U06=C-KUW+(L6FVMU<VJ3/86QEN[=IKB-G#3
MA)I!9J8XI=\TI\GC_P!C+_@IQ+\6]<F\(^/;2WT;76N##9F..6"%YE.QK*:.
MXDDDANPX81[F"S,3!MCG6-;C[_\ VG?VA=._9?\ "]WXEU!/.\G9';6HE2)[
MJXE.V.%"Y^LDA59'C@CEE$<GEE3\0?\ "\OCYXE\+_\ "::1HOA=K"YM_MUG
MI6;ZYU0V<AWP_P"KECMYI3"5EVHR22#Y5@6X(MA](?L6_MI:7^V3I=U=6MK)
M8:C82(E[9.YF6-9BY@DCG"1K(DBQOD;4='1U9-GE2R_+_P"VW_P4PO?V<+AM
M)T;P_>-=F26./4=5MI[;3Y&A:$R&T3]W+>H [QM(KP(C^5*C7$,BEO0/C%^U
MQX\\1V]Q>?"?PS'KNDV4DBRZU<2JUO=-;J_VF/3[1)X+B\17VI'=0-(DTT<\
M,,4N$E.A_P $^/V\/^&O[.\LM5@M[/7]/VR2QP-MAN+>1F"S0122/,OE';'<
M ET5GA<2?OQ%%]/_ +3O[0NG?LO^%[OQ+J">=Y.R.VM1*D3W5Q*=L<*%S]9)
M"JR/'!'+*(Y/+*GYPU;XB_'/PC;RZ_=Z!X;O=.BC>X;0K*[O3K C925@6X,<
MEI+<0Y!E\J-A<>6Z6Z%Y(A7J'P(_:AE^)OPXA\?7VG7!:;[=(NG:;!+>W#+%
M>SV\$,4:#?+*52-7D(BBWEYF%O"&\OY__96_;^U']IWXAZIX8_L?^R=-T[3[
MJ7R[K?\ VB;BWO88/WZY6.#Y)<26VR1XID(^T.O%?I?JVK6^@6\MY>2QP6T$
M;RS32NJ1QQHI9W=V(545069F("@$D@"OSPT#]K7Q;^U#]HD^$^EZ>=+L[B2"
M76]?FDBMYIHL%H+>RM"UY\\<L%Q%<3>4NSS8GA24+7E_B3_@H%XJ_9>\06F@
M?%?1+.*VO9-T6NZ/)<-9_9RB E+>=))I7AE.+D"2.9(V5TMI 83<_H?\2/C/
M9_#_ $--?MK34-<MY_)-M#HMJVH37"S#<DD0B/E^5LS)YSND14 *[2/&C_FC
M^SM_P5-N/C4^LK)H\9OO,L(/#NA6DS27U[<3QW!G$UP^R);>(PB:>Z,,,-G;
ML?,\U_+$GG_Q&_X*1_$W]G'Q+9P>/_"EGI^B7DDDB1V[F>Z-J&*XBO$NI+26
MXARC2QE(C("N5MEGCD7]OM)U:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0
MRLI(8$$$@UH5X_\ '3XZ:'^SIH<_B#Q!/Y-I#\J(N&FN)F!*00(2-\KX.!D*
MJAI'9(DDD7Y0TGXK_&/XUV\6N>$])\-Z1HEU&DEDFNW-U<7EU;RJ)8;LC3B8
M8$EBDC'V9V>:*1)-SLI0UQ_[/7_!1C_A,/%#^ _'>D_\(UXDB\J!=T^^WNKS
M WQIE1Y/FY62R'F7$=PCA4N'=H/M'N'[8/[8J?LGV'VH:'JFKR>6LC20021Z
M? K3)"HNM0,;Q0NY9O*C19G+JBNL2S1.WR!X#_X* ?$'XR^"$U7PAX5CUC6[
M:.=M6G0/#I]I(D[M%;V]O+,+G4+A[1%EDBMI287GMS^\:7[.OW?^R'\3_%OQ
M=\+QZGXTT;^Q-4-Q/&+?9)%YL*$;)OL\S--;Y):/RY69G\KSU(BFC4?3]?*'
M[1W[5-O\#[C3]#TRQDUWQ5JTBKI^BV\JQ2/'N/F7$\I5UMK=%5SYLBD,4?I%
M%<30?'_Q;_:(^.?[/'A^+Q=XCTKPG/I<,EH=0L[.2]6\@CG=4*EY)F@#AV6
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MST.X;35N))A%*TD=W LDJQR26;.S6T]IF*X>-(@D4]P[R"["EB?W/_9M\?\
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MWBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4    5^"/[ O_)POCW_N/_\
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M'9E,<P2:/\\/^"(7]L?\(]X@\[_D"_VA!]C_ -7_ ,?GDG[;T_>_ZK[#]_\
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M+:Z7<JES"LDA1;2WEC5P [BPC8W4<I!C>[B<0)N3RN/_ &^O^3A? 7_< _\
M3S<5^_U?@#_P0Q_YF[_N#_\ M_7[?>.OBQX>^%_D_P!O:KI^F?:-_D?;;N&V
M\WR]N_R_.=-^W>F[;G;N7.,C/H%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?('Q+_ &#?A[\9
M-1?5?$.FW&H7K[AYL^J:FVQ6=I/+B7[7LBB#.Y2&()%'N(1%'%>__#3X8Z9\
M(M.32M(6X2RBVB**>\NKORE5%C6.)KN:9XXE5%"0H5B3DJ@+,3Y!_P ,A^%_
M^%@?\+)\NX_MW[/Y.///V??Y/V;[1Y>-WF_9_P#1\;_(V?/Y/G_O:^GZ****
M*\?^)?P+T7XN[UU<Z@\4MNUM+;P:MJ-I;RPMNW)+;VEU##)N#LKLZ,SIA&)1
M54> >%O^"<GPQ\#7D>H:5I-Q8WL.[RKFVU?589DWJ4;9)'>*Z[E9E;!&58J>
M"17U_P"%O#4'@^SCL;9[AXHMVUKFZN+N8[F+G?/=22S/RQ"[W;:N$7"*JCH*
M^(/%/_!.3X8^.;R34-5TFXOKV;;YMS<ZOJLTS[%"+ODDO&=MJJJKDG"J%'
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MS*]Q>7UP%P9[F>0EF=F+R%5V0K)+*Z1H9'S[A7'^-? ]KX_MUM;R2\CC202
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M &D[*TTSQ+#)<V-I>"\%NDKPK+(L$\"B1XRLNQ1.T@$;QDNB98IO1_F#3/\
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M[_N#_P#M_7[_ %9^K:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@*
M22 *_GA_;?\ C?HWC'XV>!KRQUNSO-$L)-(EEFAOHIK.VD_M21KEW=)&AB?R
MHX6F8E3Y:1%SM5,?N]X*^-_A7XE7#6>AZWI>I7*1F5X;.^M[B18PRJ7*12,P
M0,RJ6(P"RC.2,\?JWQ2\#?L[2Z9X8:XT_29;ZXAM].TJVC5&+WDKB-DM;="8
MHI)1(&G9$@$I(:0.W/T!7C^@?'[POXK\0W'A33]3M[O6K2WDN+FV@)E\E(IA
M;R++*@,22I*0CP,XG7(8QA2#7B&I_P#!0_X5Z3J@T>3Q+9FY,D48>-9I;7=*
M%*DWL<36@0;AYDAE"1$,)&0H^W[/KY_^-?[4_@O]G;RU\3ZO;V,LVTQV^))K
M@J_F;9/L\"2S"(F)U\XH(@Z["^\A3@?!S]M#X?\ Q]O&T_P[K=O<WHQMMI$F
MM9I,J[GR8[J.%Y]JQNTGDA_+4!GVAE)^GZ\/\%?M*>#OB*^JKI.L6=W'HD<4
MNHW$<F;6".:-Y4<W1Q;N@2.0R-'(XB*,LA1@17F'A;]OCX9^-=<C\.:?K]O-
MJ4UPUM"@BN%AEF4D!([IHA;/O(VPLDA6=BBQ%V= WU_7C_QC^/WA?]G^S6^\
M3ZG;Z?$^?*60EIIMK(C>3!&'FFV&1#)Y2/Y:L'?:F6'D'PT_;X^&?Q=U%-*T
MC7[=[V7:(HIXKBT\UF=8UCB:[BA225F=0D*%I7Y*H0K$?5^K:M;Z!;RWEY+'
M!;01O+--*ZI''&BEG=W8A515!9F8@* 22 *\_P#A5\:/#_QOM[J\\.7T=_;6
M=Y+9331!_+^T0JC.J.RJLJ;9$998B\+A@4=A6A\2_BKH?P;TY]5\0W]OI]DF
MX>;.X7>RHTGEQ+]^64JCE(8@\LFTA$8\5Y_XV_:G\%_#?0[/Q'J^KV]IINHV
M\5S9/()/.N891$5>&U"&YDP)HFD5(BT2N&D"*"1H?!#]I'PG^T?;W%UX5U*.
M_CM)%CN (Y89(V==R%HITCE", VR3;L<I(JL6C<+[A7S_J7[4'A6RU&YTJ"Z
MN-0O;+ O(M+T^^U3[*S/)&([AM/M[E()=T,@,,I24;"2@&"?0/AI\5=#^,FG
M)JOAZ_M]0LGVCS8'#;&9%D\N5?OQ2A70O#*$ECW .BGBO0**_-#_ (*C?M17
M'[/'@Y;+2;B2VUO7)&M[6:)F22"WBVM=SH_ELH<*T<"X:*9#<">)]T!Q]?\
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MOR=>\5M_PDGC-]DMSJU]))=>7*GE&);47!;'D>3&L-TZBZX8AH8W%O'\ ?\
M!#'_ )F[_N#_ /M_7/\ Q%U__A5_[5]KJ&H6]PMO>W%C!;$1X\W[=I::;'*A
M<HKQ+<.5D=2VWRI5 :1"A_H>K\ ?V!?^3A?'O_<?_P#3S;US_P#P5!U__A5_
MQD\'^)[ZWN&TVRM],G:2.//F_8=3GGGBA9RD;RJCQDH77;YL98JKJ3_0]7X
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M\3)+/PYH@D,5UH^D@&XU:W959DN+U;NY:UMRP6)EMG6:XA>ZAD$:M%(? /\
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MOY(O'7@7QS_P2_\ ',-W:3?WS97H1OL>IV>Y?,AFCW?[@N+<MYD$GERQR?\
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MT=@+&WL$B>!RD,:SS[]WGJIDD)G9(8UDEEVJ5_=_X*?"KQWX&U&2Y\3^,?\
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M[5_:&H?V!92_;_-D#6_^CLXCM_(0&/\ =D^=G>V&%?B!_P $I/AWXO\ 'O\
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MP=<>'+XR27/AR2***9MS!K.Y\QK9"[R.Q>)HIH@H6...W6V1 Q#X^</V^O\
MDX7P%_W /_3S<5^_U?SH_L0:\_\ P3\^)NM>!O%SQV>G:I'FWU.Z\NVBD6S,
M[V=UYKW'DQV]Q$TZ,H,SK=>5;DHZ3 ?9_P#P5G^,=GI?A >!K1?MFO\ B.XL
MX[>QA+/<+#'<I*)A$B.7\R6%+:*,E&E>1VC,GD2)7V!^Q?\ !R\^ 7P_T3P[
MJ#9O;:W>2Y7"CRYKJ:2ZDARCR(_DM,8?,5BLFSS %#!1^4'_ #=Y_G_H7*_7
M[]K'_DGGBO\ [%_5O_2*:O@#_@BI_P D\U+_ +&"Y_\ 2*QKP#]OK_DX7P%_
MW /_ $\W%?O]7X _\W>?Y_Z%ROW^K\ ?^;O/\_\ 0N5]'_\ !9[5KC3OAS:1
M02R1QW.N6L4Z([*LL8MKN4)( 0'021QR!6R \:/C<JD?<'['>K6^M?#GPK+:
MRQS1KH>G1%XW5U$D-M'%*A*D@/'(CQR+U1U9& 92![_JVK6^@6\MY>2QP6T$
M;RS32NJ1QQHI9W=V(545069F("@$D@"O#_VG?B1X2^%GA>[U#QJEO<:1\BM9
MSPQW'VN8'S(8(K>7Y)92R!T#85-AF=HXXGD3XP^'&N?%G]M2W@UEKJ/P+X2N
MXW\J"V07.L7EO(L*F07$\:K;(Z^>UG=PK#-'E)/L]Q&8;@_*'_!#'_F;O^X/
M_P"W]'_!<[_F4?\ N,?^V%?O]7X _L"_\G"^/?\ N/\ _IYMZ/\ @N=_S*/_
M '&/_;"OW^HHK\ =?_XQ&_::MY8/W>F^+?+\R&#]\[?VJQA;S3/@QYU.$73^
M2YV085/E)MZ^[_VR+)_VB=9TKX1VLTD$&HQG5_$$\0C\R'2;.4"%$$R;2]S>
M"-%DA9I;<PAY()8'93\H?\$@/B7J/AN7Q#\--<?9>Z-<//;VS,\K1;93;ZA$
MLJL]NL44_DLJ1E=\MQ/*IE#,4^O_ -@7_BXMGKWQ&F^:7Q;K%Q-:NWRS)I>G
MLUEI]O/$G[E)81',"8C(9%=6DFD?[OP!_P %SO\ F4?^XQ_[85^_U?D!_P %
MJ_\ DGFF_P#8P6W_ *17U??_ .R=_P D\\*?]B_I/_I%#7Y _P#-WG^?^A<K
M]#_^"FFK7&B_"3Q%+:RR0R-'9Q%XW9&,<U];12H2I!*21N\<B]'1F1@58@_$
M'_!/W]EJW^,/P\TW4H/&?BRPD$EY%/8:5K2P6MK(EU*0@@$+F%WC:.=E8Y8S
M>;C;(M?1_CK_ ()6>'OBAY/]O>)_&&I_9]_D?;=4AN?*\S;O\OSK1]F[8F[;
MC=M7.<#'J'[2?BCQ5^R9X%T:S^'FER:Y<V,EEI@AEM+B]D%G#:2J)G2R,+;]
MT,*M)A8\N1L!9<?GA_PWU^T+_P!"%_Y0-9_^2*Z#]N[XS^+?&'P&TJ^\0VG]
MD:IK&L);:I8_99+?$,,E[+"GE71DFBW&TMIMVX,V.#Y3E#^E_P"PMJ>EZM\,
MO#$FCB,6PTNWC<1Q&)?M40\N])4JN7-RLYDDP1*Y:4,X?>V?^WYX%_X6)\+_
M !-9>=Y'E:>][OV;\_V>ZWWEXW+CS/L_E[LG9OW[7V[&^3_^",.K7&H_#F[B
MGEDDCMM<NHH$=V98HS;6DI2,$D(ADDDD*K@%Y'?&YF)^</\ @AC_ ,S=_P!P
M?_V_K]_J_ '_ ((8_P#,W?\ <'_]OZ_9[X_?!RS_ &@/"^I^&+YMD6H6YC67
M#-Y,RD203;4>,OY4J1R^6759-FQCL9@?YX?^+Y?\$QO^G[PW'_UTO]'&[_OU
M<6/[ZZ_Z<_M5PO\ R\(O/[7_ +&?[6_AK]K.RO[[1;22PU&&2V?5K:2-0QGF
M@6-)1/'\MPA6W,$<C[)MENH>&)/*!^SZ****************************
M************************************************************
M************************************************************
M************************************************************
M***********************************************_G!_X+3?%70_&
M^H^']*TN_M[R]TO^U!?10.)/L[2O;1K'*RY190UO*'A)\V/:"Z*'0M^[WAS]
MH'PEXKT,^)K36M/;15\L2WK7,<<,+2",K'.TC+Y$O[V,&&;9*K.JL@8@5^ /
M[#?Q^\+^'_CAXIUV^U.WM-+UC^VOL-W<DV\,GGZC%=Q;WE""'?%&[+YWE_,!
M%_K61&_=[]I3]I30_P!E;0_[?U_[0UNUQ';0PVT8DFEFD#,$0,R1C"))(S2.
MB[4(!,A1&]@\)^*;/QSIUIJNGR>=97UO#<VTNUDWPS()(WVN%==RL#M8*PS@
M@'(KH****^?_ -K'_DGGBO\ [%_5O_2*:OA#]C']N"P\&:-IO@GXBP2>$];T
M^S@M[3^TH9K.WO+.")HXI_,N%58'"P-')YS+'+, 879I&MX/I#XZ?\%!_ /P
M:T.?5;;5]/UF[7Y+;3]/OH)YIIF!*!C$TGDQ#!,L[@JBC"K)*T<,GA__  2H
M_95U3]GCPU>:GKT4EKJFNR02&S=AN@M;=7^SB6/8&BN&::9I(RSE$,*,L4RS
M(/SP_;D^/WA?Q!\</"VNV.IV]WI>C_V+]NN[8FXAC\C49;N78\0<3;(I$9O)
M\SYB8O\ 6JZ+_1]X6\6:=XYLX]0TJ[M[ZRFW>5<VTR30OL8HVR2,LC;65E;!
M.&4J>017\X/C;]MF\^&VN:M!\4O ?]L:E<:A/<6,&L7*M#86)(@BM["*6RFM
MC$#"P>]M%C%^RB21I6C1AH>"O^"L'A7X:W#7FA_#;2]-N7C,3S6=U;V\C1EE
M8H7BTQ6*%E5BI."54XR!C];_ -EK]OKPE^T_IUU<PR_V7>Z;;BXU"TO9(T\F
M%45I;F.7<$EM(V+(TY$;)A6EBA$L6_\ (#_A?WA?_AI[_A*?[3M_["^T?9_[
M0R?L^_\ LC[!N\S&WROM'R>?_J-G[[S/(_>5^Q_[:/QK\->%OASK,EWJEFBZ
MQH=_'I@$RNUZUQ;>7$;54+-.A:>$M)&&2-'$KLL67'PA_P $7/BKH=GX9O\
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ML_6_[37@[4?#DHC%S+'YMA-)M @O(LM ^\QRM&A;]U.T:F0V\DR*07K\L/\
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M%%%%%%%%%<_XL\4V?@;3KO5=0D\FRL;>:YN9=K/LAA0R2/M0,[;54G:H9CC
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MM_PE^UQ]JBT)[BWO;/#265ZD<5P83M GC6.65'BW-Y;%6+1OM$BH)83)\_\
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MV>6TM]2BU_\ LG[;::A"EQ;'[3+)I+;8B%'R11)-%YGF;;D>8=R 1C[_ /\
M@H1\2(OV3OA?/!X73^QY;NXBT_3_ .SH8H$MFN'>XN&55V"'?%'<@2PJ95GD
M61=K_O4\ _8V_:/T[X">!M)TC3_ _CBYW6Z75S>6^A))%=W%RHDDGCF26/SH
MCD);2,N\VJ0*2=H-?%_[3NI>+_%_Q-LOB+X%\&^++&Y@CM)+@7NDWJ-<75N6
MC8.MN\G^CR6RPVTL:/$)$$JLH+L[_P!-U%?AC^V]JQ_:@^,OA;X7)+')I-C)
M%=:I;,]S"LDA1KNXBD9" [BPC46LD0!C>[E0SIN?ROW.K^:']HJXL_\ @G3\
M<K/6]!3R=(OK>&\N].MT9$2TNI);>\MXX_/1)/F@:[MHV,=O#.8$$0C@7/ZO
M_P#!4?\ Y)#XA_[AW_IRM*/^"7'_ "2'P]_W$?\ TY7=??\ 17YX?M)?L;ZS
M\<_B-X3\70:K'#I.@R0RSV,HE9EDMKG[4'MD!\HO<D1P3LQB,20QR9N,+$GS
M!_P4J_:P\!_%+P1JWAK1[J/6]6@DL9U>SMVNK>R43PEKLWH4VZ(4D^QEX9'?
MSKI;8J-\NWZO_P""7'_)(?#W_<1_].5W7RA_P3^\:V_[77Q-\7?$.^61I-/C
MM;/1890I6TL[DW"J51VF,-P8[?\ >&"18R]U>X4K/\OW_P#MD_LK6_[7WAI-
M GOI-.DAO(;R"X2)9E$D:R1$21%HRZ&.:0 +)&5?8^YE5HW\_P!6CM_^"<_P
M?E6SDDU!M"LW$,DL:XFO+RY.QGC62/;;_:;D%D60R);@J))95W/Y_P#\$I/!
M5OIWP\B\1NTEQJWB*\O;S4;N<K)/+)%=36Z!I2HE= (VEQ*TA$T]PX8>85&A
M^V)_P3GT[]KWQ#INO7.K7%A]DMTM+J".!)?/MTF>8"%V9?(E_>S*9'6X3F,^
M4/+82^?_ /!7OXZ2_##P-%H=E/Y-[X@N#;N!YJN;&%=]T4DC*HNYFMX)$D+"
M6">5!&PW,GW?^S7\(4^ O@[1_#2K&LEA9QI<&)Y)(WNG_>74B-+ARDD[RR*"
M%"A@H1% 1?R1_P""R/P<L_"D6C_$32F^PZTNH16<\]N&CFF81//:W!E1UV2V
MWV9D20*965XP90MO$M>O_M0?&O\ X:)_9MNO$[1^3+?6^G_:(PNQ1<0ZK;P7
M'EKYDI$1EBD,.YV<Q%"V'W ?0'_!+C_DD/A[_N(_^G*[KX _X+G?\RC_ -QC
M_P!L*_<[QK\/=&^)5NMGKFGV>I6R2"5(;RWBN(UD"LH<)*K*'"LRA@,@,PS@
MG/\ /#_P1E^$.E_$/5-9U34UDG;1I-,GL[9G/V473B\$=W)#]V2XMU5Q:NV1
M 9I75?-*/']0?\%K_ &ER^%=*\0FVC_M:/5(K%;L B0VLEO=3-"Q! =!)&KI
MO#&,F385\V7?^GW[,FK7&O\ @7PU>7DLD]S/H>F2S32NSR22/:1,[N[$LSLQ
M+,S$EB22237XX_L"_P#)POCW_N/_ /IYMZ_4_P#;4^'NC>,? OB"\U/3[.\N
M;#0]6ELIKBWBFDMI/LCMO@>16:)]T:-NC*G*(<Y48^+_ /@BI_R3S4O^Q@N?
M_2*QKD/^"SWP]T;3O"%IKD&GV<>K7.N6L4]^EO$MU+&+*[ 22<*)70".,!68
M@"-./E7'V_\ L%_"'2_AIX%T>^LUDDOM8TO3+N^O)W,MQ*QM(_)A,AY%O;1D
M06L"X2&%< %VD=_RP^&_A:S^#_[53Z-X?C_L_39?.#VENS)"RSZ+]M>,H#M\
MK[1B9(<>5&R1[$18XPOV?_P5_P#'^J>!?AS''IES):KJ6J0V-X8R TMK);74
MDD);&Y4=HD$FTJ73=$Q,4CHWU!^PMIFEZ3\,O#$>CF,VQTNWD<QRF5?M4H\R
M]!8LV'%RTXDCR!$X:(*@38OY(?MB^$].\'_M'>'9Y;2WU*+7_P"R?MMIJ$*7
M%L?M,LFDMMB(4?)%$DT7F>9MN1YAW(!&/W^\+>$].\#6<>GZ5:6]C90[O*MK
M:%(84WL7;9'&%1=S,S-@#+,6/))KH*_%'_@L]\/=&T[PA::Y!I]G'JUSKEK%
M/?I;Q+=2QBRNP$DG"B5T CC 5F( C3CY5Q]W_L/?"W1_ ?@C1M0T^WV7NKZ/
MI%Q?W+R2333NMA"D:F29W=8HE^6"!"L$"EEBC0,P/XP77P.T=/VDKSP5IXN-
M+T#4-R7EGI]Q):K-;R:4NH7%FQC8$6D\J[98$VHL1V1>5MC*?L_^V;\*M#\1
M_#'7=/N;"W:TTS1[NYL(501K:S6-K(UL\ CV^5Y>T(%3:IB+0L#$[HWR?_P1
MAU:XU'X<W<4\LDD=MKEU% CNS+%&;:TE*1@DA$,DDDA5< O([XW,Q/SA^W'\
M9XO'GQHT;PGJ%IK&K:!H/D7-UHFGVL5R]Y?>1)>ATMF)%S%Y3V\4ZS8,< O!
M&$\QI)/M_P 6?MHV?CG3KO2M0^'WQ FLKZWFMKF+^PF3?#,ACD3<ETKKN5B-
MRE6&<@@X-?&'_!('PYXZ^%FLZOH>N:/JFGZ)=6?VQ'OK.[@C6\AEBB A,H2$
M/+%*QE 4R2"WA^8+$0<_]@7_ ).%\>_]Q_\ ]/-O7Z_?M8_\D\\5_P#8OZM_
MZ135^6/_  1A^$.EZIH-WXJNEDGU&TU2ZM+(2N6@LU>UM&GFMHC\L=Q<*R13
MS\NT,,<2E$,HD\O_ ."T?A:S\":YX9\3:5']BUJ[^V&>]MV:*9VL39FUD+(1
MB6+S&"3#$NT1J7*Q1!/T_P#^"B/QTE^ 7PZU.^LY_L^I7NS3[!QYH837.1(T
M;PE6BECMUN)H969566)/O,5C?/\ ^":_PA3X0?#+1T*QBYU2/^U;EXWD=9&O
M0KP$^9C:ZVPMXI%0! \;$;R3(_S_ /\ !7WX#:7XS\$2>+3''%JVB26P6X$9
M,DUK<3K;M:LP=1L62=9T9Q(8RDB($^T2L=#]G7]M^6]^!MYXPU%\ZIX>MYM/
MDFN$EE2ZOHHXEL6D*RR32>>9[1;F5FB)G>=_W40#@_X),?!RSTOP@?'-VWVS
M7_$=Q>27%],&>X6&.Y>(PF5W<OYDL+W,L@"-*\B+()/(C>O,/^"U_@#2Y?"N
ME>(3;1_VM'JD5BMV 1(;62WNIFA8@@.@DC5TWAC&3)L*^;+O_2[]D[_DGGA3
M_L7])_\ 2*&OQ!_8%_;?L_V4KS7O"'Q%>X@N)-8N+B:^V->-'?!6BOA>2QRR
MR2[GMX5B>".8M*\KR2>60Z_L?X2^%6C>)_'47Q-\/W5G=6U]H=SIEW-:RQ21
MW,D=W;-;S(\*%97589[>>1Y6*B*VB5 (WQ]'Z_X3T[Q7]G_M"TM[O[)<1W5M
MY\*2^3<19\N>+>#LE3)V2+AUR<$9-=!11111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111117\X/[8\VH_LS?M":9XUNY?LNEZA<:=.+Q87E5;-(8M/U
M&)@8F#2K$LC,D/F2)%/ ZE974+_1]7X0_P#!5;1?^%\^/O _@"S6X6]F\V2:
M=(/.6*WU">*$S!%<._D+97$\X;RT6)5;S,;S'^[U%%%%%%?F!\'_ (8:3^UM
MXY\1^/\ 6[6WU;0(-N@^'H;RVMY[>2&S8->7D0:*2.>)[KS!9W22NQ1[F)U3
M:B)]?_\ #)WP\_Z%3P__ ."FR_\ C-?@#_P4]^",7[*OCG1_%GA5;?3HK[9<
MVMO!%$B6M]IC0Y>.W6%85B8-;RA6\TR3FX+@(54_T7?!3XH6_P :O#6E^([7
MRUCU*SAN#'',LZPR.H\V R*%#/#)OAD^52'1@R(P*CU"O+_C?X*N/B5X5UO0
M[-HTN=2TN^LX7E+"-9+BWDB0N55F"!F!8JK$#.%)X/X@_P#!%C]H&WTY]3\!
M79CCDN9&U.P<[5:601QQ74)+2 NXCCAEACCC)"1W4COM50/WN\6>*;/P-IUW
MJNH2>396-O-<W,NUGV0PH9)'VH&=MJJ3M4,QQ@ G KXP\0?$;5/B_P#!'6?$
M.L6<=A<ZEX;UJZ2UCD$JQVLT%R]EF0$[G:V,#R-A"79LQ0G]TGS?_P $5/\
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MD[_DGGA3_L7])_\ 2*&OR!_YN\_S_P!"Y7Z_?M8_\D\\5_\ 8OZM_P"D4U?
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M/ 2%E4*0R2I#-%\G_"'X,_'CX :6OAW2]4\)ZMI=G(Z6$^J_VE]J2U!Q#$1
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MAO)29H8XE7Z ^"'[&=E\./$%QXUU^_D\0^,+N-8Y=4GMH+:.)43R0;6T@79
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MYE=X8XED\M/M_P"*'[ U_P#MDV_]M_$#5+S3M8,<W]G:58R0RZ?I$<BCRHI
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MOD#]O+X,_P#"]/AUK6F11>;>PVYO;(+;?:9OM%I^^6.!!AQ+.JO:AH_G"SL
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MA_[AW_IRM*/^"7'_ "2'P]_W$?\ TY7=?F!_P53_ +'_ .%R>&/^$A_Y O\
M9^E_VC_K/^//^T[O[1_J?WO^JW_ZK]Y_<^;%?I__ ,.N/A#_ -"]_P"5'4O_
M )+KL/AU^Q!\,/@+K=AK.CZ9'8:LLDL5C(^H7CL\DEO-YB1QSW+I(_D"=BNU
MBJ*\@ V%E_-#]OK_ ).%\!?]P#_T\W%?O]7Y0?M[?\$U?^&IM17Q)H-[;V&M
M"WC@GAGBQ;W>QP$EDFA4RI*D19"[)<>8D=O"!"L9<_"'PO\ V]/B1^P_K/\
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M.T$+W$Q50"0D<:$O(V$4M&A;?+&K_AC^P+_R<+X]_P"X_P#^GFWK]?OVL?\
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MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOP!_X+G?\
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M_P"$8\4?\(]]H\GS_P"PK[?L_LS^SOM'D^5YGE;_ -]C'G^1SY/G?N:_8_\
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MMCI^FV]K#\KW$L.GSVK$X4())?*@9MD:AI7&R.,NRH?B#_@FM^UU>7OA"Q\
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M.ERQF73XM4U;^S]0O8Q$KATMH[*[@B25RR6[372"5 LY,<,B.?/],_X*E?#
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M^#O_  533Q?XQM_!WBKPS>>&[N[DCMXC--)-(EU/L^S13V[VEO+$DP=0LOS
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MWQM5B-"OG_\ :Q_Y)YXK_P"Q?U;_ -(IJ^ /^"*G_)/-2_[&"Y_](K&O /\
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M:M\+R>&_[3N-*W7$$_G0KYB2>42?*N(=\?G1'.\)O3;.D,V3Y6QO?_">@?\
M"*:=::?]HN+O[);PP?:;J3S;B;RD">;/)@;Y7QND? W.2V!G%=!1117G_P 6
M/ O_  M#P]JN@^=]G_M/3[NR\_9YGE?:87A\S9N3?MW[MNY=V,;AG(^,(_\
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M6^O_ !]^'MY9RQSVT\?AV6&:)U>.2-]8N&1T=259&4AE920P(()!K^@ZO/\
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M0!7'Z_\ %CP]X4TZWU?4-5T^TTV[\O[->3W<,5O-YJ&2/RIG<1OO0%TVL=R
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MIV][X0U&WLI-2L+&X%_"L(=X9X1(UU)YEVGEO=6\CR1-$UP(2/L[2+-]8?\
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MMK*1K+P_X=U"_MUM[6-T#7$\EK<A%N7=6B1;ELB299CY,8M[-8/+_P!OZU\
M_"*?1_'?PGU?1['7[?4/+GM]&NH)-RO;G9-]GAF>&&*,0-#-&L BNOM;"8MD
MK)^M_P -O$#_ +<?PWTK4QJ.J:#)J,:O=S:3+':7'GVTCPW$<4KK=/';M/$S
M(499FA"([A7FB;\4/^"4G[/MG^T-_P )'8:W<W#:!#_9KWFDPNT*7\Q^U_93
M<3Q,DWE6Y$D@@1E66=H97;_1U1_VO_9Q_8-\'?LM:SJ&N>'UO/M-]&T*I<7'
MF1VUN\HE:" !%8H66(;KAIY@(DQ("TID^SZ^</VL_P!H&W_9E\':CXCE,9N8
MH_*L(9-I$]Y+E8$V&2)I$#?O9UC82"WCF=02E?)_['_['^A^--#M?'/CFUM_
M$7BGQ%;B_NKJ_ NX5ANQ'+;116TL:V\7EPK"ORQ%H6,L,4OV7RXQX G[#7C3
MX2?&V#Q'X%M[?3/"=S<6\MT\-S&D*6C*AU"SDM7)D/FO'(T$<43V\+2VS(]N
M8<V_O_\ P5!_:4USX+:'IN@>%OM"Z[XDN);:":WC+S)#&(UE2V*-YBW<CSP1
MP,B.P5I2ACG$+CZ ^&G[#?@;P/IR0:AH^GZSJ4FV74-3U&U6\N+R\9%%Q<L]
MXUS)'YSJ93$LAC1W8@;F9F_(#XLZ1>?\$H/B59:IX>EN#X.U[#7-DQ6;,,4H
M%U:HK3*\DMLLJ2V5Q*8F'G"!Y9E%T9O8/^"Q'@J+5?#.G>+[;6]0O+2\U"RA
MMK%;J)](6%[.ZE2Y@BBC&^5\%A<O)*QCE9%;RO+1/H_X&_L3Z)\>?"'A[4_'
MTLFNJ-#TE=*LU>XL;73;7[%#F...WN=TUQ*WS75U*Q,I2)$B@BB5*_.#X,^"
MO$O[+'QKU3X;^!]5CC74H_LHO+^)I5@@:T745N?L\;I#/>VL1DCMVE7R979P
MT<,4[A/N#]K?_@F;X(L?!6KZSIPO(==TZSN-2EU2>[GNY[Z2VA>:?[6LTGE%
M[DAF>2)8BDQ60 QAX)/3_P#@D9\2]1^(GPU6#4'\W^R-0GTZVD+.SFW2*">-
M79V;/E_:##&%V(D$<484;"6^</\ @L]\-'M=!M/$;ZKJDJRZI:VB:6\\8TV%
M1:W;^=';I$K&X+*V9Y9)'VR/&"(A&D?M_P"SU^Q7IGQ^\&^']4^)!_MEAH^G
M)I-E#/=6MGIUB+:,1A%AEB>6[N%"2WT\I8&0)!$JPP(7_."6#4?^"57Q:MM/
MM=6\SPWJ?V2:[\U'DW:7-<21,;F*)1F[M=DS12P EL!@@2XFM*_7_P#X*8VO
MBW5?AU=V/A"SN+RXO+B"WODM5D>Y6Q?<93"D3"1][B*&9%64&VEGW1^7OD3G
M_"?[!O@&R^&MII'B?1=/T^Z31X6U74<0+>6MRL0FNI_[1.\KY4N]\F1[81KY
M15K7]V?E#_@B-X_U37=+\0Z+=7,DNG:;)8264#D%8&NS=F<1DC<J.T2.8\[
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MPV=_I%VL-Q)J]ZD<EZ(KD6SA?*B_T6\M_,,D+I"<+]HF0>P?\,"_]3[\0/\
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M34HO#NAW-S#9PV=^\VFV,EQ]LM46*<SD)(V^1E\]3(1(\,T<K*IDQ7T!X_\
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M &M;RZ\5:!J?V379<PS,6%Q8W$UDLEJ8Y I,EO*KQ1V\SQLZPB!P;1YR['X
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MT=U<,US<QAXOD9$FED2,J6&Q5^>0Y=OH^O'_ (Z?#?0_C3H<_A7Q ^VTU?\
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MNJ0;[V;6+:&Q\-Z1OFM[."XAN&:YU.Y8!);N-C%:O<@Q6%LBR.C8NW*_H?\
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M>F:3I,>BVEW)<)9ZO<2VMY<72VS6Y>2"V1Y8K9,N5Q=+*\L,J.$MIE94]_\
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M ,60V^H6^I76KM=-:2+;WMM#(8/LJI(,.D2VZ;(XDMP4$:!41?Z'O#7BG5O
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M8P1(CNJNLENOP!X#_;9^*^M?$]/AAK-OX;TZ^\R=)+J*SO+N,+'9O>1R(O\
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MX!TSQ+K+1M?7\FH/((D$<:*E_<QQQHO)"1QHD:EBSL%#.[N6=OQ0_9P^+/\
MPJ/XZ^.)X+*XU/4KVXUVSTS3K<8>[O)-6BD2-I2#';Q*D4DT]Q+B.""*20[F
M"H_T!^U7\6/VB?V:?*\5:A>Z/-HOVB(3VNEVHFL[?;Y:JEP;JW2]2*X;*F19
MSMD8QB6!GMU;]?O@#\8[/]H#POIGB>Q79%J%N)&BRS>3,I,<\.YTC+^5*DD7
MF!%639O4;&4G\T?A7^T=X\_;Q\2Z[;^"]>L_#/AS0I D%TFFK?W5^MPS);R2
M1W@141EMII@%$#PB5(72X.98\_PG^UY\0/V;?B5:?#OXB26^N6FK7$*Z=JMO
M!#;W!2\E%O:2M%$4B$0E21)X703QNTDB3W$4<*S??_[6/QD\1_!#P]<:KX;T
M/^V)8+>ZGN)9+J"WM[*&WA:0SS*\BS7&" 1;VX#2(D@,T+^6)/S@_96_:K^,
M/[5_A[5(]"BT]-2_M"Z9M9U"(PZ=96\L,(M[&QC@CEDN+N-VEGWW*SI#"L0N
M&G:YC ^K_P!F#Q_\0_A9X:UG6OC=<V=G;6<B26\[&U\]8MN)!(+ &!D9S&EK
M&@:ZDF:6,JP:W4\?\-_''Q,_;5LW\3>'=9M_!GAMKB:/25_LVWU.^OH8V\J2
M:\\Z4Q6^V6)Q%'#ALM*KF1(X+B;S_P"#/[:GBWX.>.8OAE\5Q;W%[=?9DT_6
MK*"1$N)KMLQ"1?*A22)F<6BSP0Q+#/ R2K(#+<1?6'[8O[3%[\"$T/2=!CLY
MO$?B35(-/TY+[S_LL:M)&DUQ-Y"[F1&EACV!T?,PE42B%XV\/^*NF?&C]F[0
M[_Q/;>*=/\6+86[RW&G7^BP6"I;QCS)KF*6TN(W>6)4)\IW5'B,I4/,L*-]O
M_L]>*;SQSX-\/ZKJ$GG7M]H^G7-S+M5-\TUM')(^U J+N9B=JA5&<  8%>0?
MLF_\+0_XG?\ PLK^S_\ D(-_9?V/9_J/FW[=G_+I_J_LOVC_ $[_ %WVC_EE
M7U_111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111117XX_\%,_V5?%GC;6=%^(7@>*2ZU;18P)H$:)I(ULY7O+6>WMY$Q.Z
MR-*LD6Z5Y2;=([=_WIKP_P"#'_!4^#Q3%=^"OC#8?9HI;>ZL+Z_BCN(FXB$$
ML%Y9Q*9HI9")UDEMMGERNB+:PHKRI^]VDZM;Z_;Q7EG+'/;3QI+#-$ZO')&Z
MAD='4E61E(964D,"""0:T*******_)#]M;QQJWQ(^(/AGPGX5L9-<N?#<B^)
M=3TV&]L;,&2%XTL ]U<>8T;QM(SS0;%,MO=1,N2RRP>X?\-#_%[_ *)A_P"7
M3IO_ ,;K\,?V5?$]U^P_\98K'7XI-'MI)&L+^WFN+2Y:&UOT26U^T7:^7!LC
M=K2>XN(O*(2.0[ "T!_K-HHK\ ?^;O/\_P#0N5^_U?SP_P#!+[0/^%7_ !D\
M8>&+&XN&TVRM]3@6.23/F_8=3@@@EF5 D;RJCR .$7;YL@4*KL#T'[?7_)PO
M@+_N ?\ IYN*_?ZOP!^+WB.S^('[5&D:?KPMTLM(^QV]HQD:'=,MD^HV9=_,
M&Z4WMPB1HNU9<10F-RS>9^_U?S@_\%?_  Y>?";Q]X>\;:4;>VN)[=&AECC4
MS&^TN<2">96C,<F$FM4C+F0LL)C91&B!OH#_ (+:?#34?$&AZ%XAMD\RRTJX
MNX+O:KLT?VX0>5*VU2BQ!K<Q,[LO[V6!%#&3Y?U>^ /QCL_V@/"^F>)[%=D6
MH6XD:++-Y,RDQSP[G2,OY4J21>8$59-F]1L92?QA^ __ !D;^TOJOB[0?WNB
MZ1YOGW1^:*39I_\ 92>3+#YL3>=*&GM]SIYMK')*,,ACKW__ (+5_P#)/--_
M[&"V_P#2*^K[_P#V3O\ DGGA3_L7])_](H:/VG?"W@OQ/X7NSX_CMWT"UV7,
M[SM(GE-&<(\3PE9EE8MY2+ ?-F\PVZA_-,;?&'PX_:%\>?M/V\$?PQT2S\->
M#TC>UBUG5HU,@2-88?\ B7:=;OY0>V)F$*N9[*8P")Y8'1X3\H?\$,?^9N_[
M@_\ [?T?\%SO^91_[C'_ +85^_U?@#^P+_R<+X]_[C__ *>;>OO_ /X*C_\
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MO&/]IZE;:A87L_\ Q)H[;S_L+0[(_P!S=B./*0I'N6,X^\59LY_7^BOY(O\
M@K!X6O/#_P 5]4N;F/9%J%O87-JVY6\R%;6*U+X4DKB6WF3:X5ODW8V,K-_5
M[X3\4V?CG3K35=/D\ZROK>&YMI=K)OAF021OM<*Z[E8':P5AG! .17045^ /
M_!4KQ'9^*?BGX(\,Z\+== A^R7%W))(T/[G4-0$%X)IO,41Q+%:(0Z^6T>Z1
MC)]W9^_U?A#_ ,%O?AI]IT[P_P")XDMU\BXGTZXDVXN)//03VR[@OS11^1='
M#.-CS913YDA7W_\ ;"\4WGCG]F\ZKJ$GG7M]H_AVYN9=JIOFFN+"21]J!47<
MS$[5"J,X  P*]@_X)<?\DA\/?]Q'_P!.5W7P!^WU_P G"^ O^X!_Z>;BOW^K
M\ ?^"&/_ #-W_<'_ /;^O?\ _@M7_P D\TW_ +&"V_\ 2*^K[_\ V3O^2>>%
M/^Q?TG_TBAK\8?\ @M7H'_")>(?"WB>QN+B#4I;>Y@62.39Y/]GS13P2PL@$
MB2A[N0EPYQLC*A&5BW[/?M.^%O!?B?PO=GQ_';OH%KLN9WG:1/*:,X1XGA*S
M+*Q;RD6 ^;-YAMU#^:8V^,/AQ^T+X\_:?MX(_ACHEGX:\'I&]K%K.K1J9 D:
MPP_\2[3K=_*#VQ,PA5S/93& 1/+ Z/"?E#_@AC_S-W_<'_\ ;^C_ (+G?\RC
M_P!QC_VPK]_J_ ']@7_DX7Q[_P!Q_P#]/-O7Z7_M_P#P&3]H/X?:I8+'))?6
M4;:CIXBCDED:ZM4=A&D4;J9'GC,MLH(<*9A((W=$%?/_ /P20^/*?%/P&NA3
MR2/J/AV3[-(9)))6:UG:22S<,R!515$EK'"KN8TM5/R(\:#U#]B[_B\&H^(O
MB9<_OO[8U":PT.<\HNAZ<YA@-NDFZXMOM$RS2W<+F-9)XUF^SQ\%OO\ KY__
M &I_@I_PT3X+U?PPLGDRWUN/L\A;8HN(9$GM_,;RY2(C+%&)MJ,YB+A,/M(_
M 'X6_M9?%#_@F]]G\+>*]$\W18_,^S6MPJ0_>WW$OV+4;=9(IOWMU&]QO^U^
M7@0C[.Q./W?_ &8?CIX+_: M;_6?",^^6ZN(+C5()/,2XAN6M(($$T3DA<16
M\<(> M;2/!)Y<DCK*Q^GZ\O^-_C6X^&OA76]<LUC>YTW2[Z\A24,8VDM[>25
M X5E8H64!@K*2,X8'D?E#_P1'TS2XO"NN74)C_M:35$CN@)29!:QVZ-:%HMQ
M"(9)+S9)M4R$2*6;R@$_9[5M)M]?MY;.\BCGMIXWBFAE17CDC=2KHZ,"K(RD
MJRL"&!(((-?SP_\ !(ZRU3X5?$OQ3X.N)HVCMK.Y2\6(!HY+K3;Z*V21)'19
M=BB>X"CY XD!=-RKM] _X*T^ '^$'B7PS\4M'MHS<PWD,=VSB,0275DRW-@9
M8T,<\CR)'/'))O($-O#$&B(3?^I_QQ_:4L_AYX&/BS2/]/EU"WMQH-N(V9[Z
M[OU7[#&ENS0S2;BZRR0IBX$"2E4WIMK\</V*K+5/V#?C _P^UF:-[37;.U1[
MA@+>WDNOLQN+>2W>9-\Z+.USIL05HA/-)N9!-&L"_I?K_P#Q?CXPV^ER?O\
M1?!&GQW\\8X0:YJ!(LQ<12Y6;RK0-<VDT"!K:=FS<!F\JC_@J/\ \DA\0_\
M<._].5I1_P $N/\ DD/A[_N(_P#IRNZ^ /V^O^3A? 7_ ' /_3S<5^_U%?$'
M_!0C]FN\_:A\#3Z5I?.J6=Q%?V,1D6))IHE>-HG9E8?/%+*(\F)?/\HO*D0<
MU^2'P=_X*(>//V,+BW\'?$/1I)K&RCC@A5HEM;R"UA9+9&MY% M[VW1()A$W
M6YD.?M^Q:_=[]GOQ_P"$_B5HAU'P9<QW6ERWE[([(90RW5Q<27-T)(YP)HG:
M69I1&ZH DB-&HA://XX_L"_\G"^/?^X__P"GFWK[_P#^"H__ "2'Q#_W#O\
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M>L_$226.35O%&J2O=Q(ZLUC;V)-O8:?)L*HSPP8E$QB@FF2X1I%?".WZ'U^
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M^H?\%F?$<5W\/-$BG'V6]N=8M[A;*:2(W"JEE="8%8I)$?R6FCCE>)I(E=T
MD8.A;]#_ -CO5K?6OASX5EM98YHUT/3HB\;JZB2&VCBE0E20'CD1XY%ZHZLC
M ,I _'#_ (2S3O\ AK;[5]KM_L_VC[+YOG)L^T?V']D\C=G;YOVC_1_+SO\
M/_=8\SY:^W_^"J?[,6H_M">$K:]T*T^V:OHMP\Z1J[^=)9RQD744$0^264LE
MO($(\QEA9(B9'$4ORA^PE_P5,\/^%?#]IX7\</)8MI5FD-KJ8C>>.XCC<I%
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M7_#_ ./MXNH>(M$M[F]&=US&\UK-)E40>=):R0O/M6-%C\XOY:@JFT,P._\
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MSMK^/RKV&WL;>&.YCVNNR=(XU65-LCKMD###N,88YX__ (9.^'G_ $*GA_\
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MD\%?!#PK\-;AKS0]$TO3;EXS$\UG8V]O(T996*%XHU8H656*DX)53C(&./\
M^&3OAY_T*GA__P %-E_\9KL+WX(>%=1TN'0Y]$TN32;:0RP6#V-NUK%(2Y+Q
MP&,Q(Y,DA+*H),C\_,V>?TG]F3P+H%Q%>6?AK0X+F"1)89HM,M$DCD1@R.CK
M$&5U8!E92"I (((K\\/^"U?_ "3S3?\ L8+;_P!(KZO4/A9^P[\//COX0\+:
MUXAT6.ZU%_#>BQR3I<75NTBQV400R"VFB61PN$$CAGV*D>[9&BK]W_#3X5:'
M\&].32O#UA;Z?9)M/E0(%WLJ+'YDK??EE*H@>:4O+)M!=V/-:'C_ , :7\4]
M+N=%UJVCO-.O(S'/!(#M9<@@@@AE=6 >.1"KQNJR(RNJL/(/@A^R+X(_9QN+
MB\\+Z3'97-U&L4LQFGN)#&K;MBO<2RM&A;#.L942%(RX8QIMS_AO^Q?\/_A%
MKC^)-#T2WM-4?SL3*\S+%YYS)Y$+R-#;Y!*#R$CV1,T*[8F9#U^K?LR>!=?N
M);R\\-:'/<SR/+--+IEH\DDCL6=W=HBS.S$LS,26))))-=!9?!#PKIVES:'!
MHFEQZ3<R"6>P2QMUM99 4(>2 1B)W!CC(9E)!C3GY5QQ_P#PR=\//^A4\/\
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M58?9^K:3;Z_;RV=Y%'/;3QO%-#*BO')&ZE71T8%61E)5E8$,"000:_)#P?\
MLN>$/AW\:-#M? >G_8_^$?T^_OO$$OVFYN8A]O@:TT^UW2RW'E79W2W'DR"#
M?:GS5:7 5?U_HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK/U:.XFMY5LY(XKDQN(9)8VEC20J=
MC/&LD32(&P619(RP!42(3N'Y8?\ #NWQ1_PL#_A9/_"96_\ ;OVCSL?V /L^
MSR?LWV?R_P"T-WE?9_\ 1\[_ #]GS^=Y_P"]K]3])CN(;>);R2.6Y$:":2*-
MHHWD"C>R1M)*T:%LE4:20J"%,CD;CH444445\0?M*?\ !/?P-^U#>?VIJL%Q
M9ZH?+$M]82K%-,D2LJI*LB2POPRCS#'Y^V**,2B) E?*&D_\$S/'6@6\5G9_
M%37(+:"-(H88HKM(XXT4*B(BZH%5%4!550 H    K[/^"G[$?A?X+:Q)XD\S
M4-9\0R;A_:^L71O+Q$:..'8C;4C&$38LFPSB-Y(?-\EO+'U_111111111111
M1111111111117G_Q+T77/$&G/;>'M1M]*O9-R_:Y[(WWEJR,NZ*+[1;H)58H
MZ-*98OE*O!(&^7X _9 _X)_:Y^QWJ-Q<Z7XHM[NRO_LZWUI/HQ'F+ Y96BE7
M4-\4H5Y41B)(AYI9X)2J;?T_HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKX _
M;-_8XUS]L&*'39O$5OINBVUP+F&UCTDS3-,(O*#S7+7R;]N^;RUBC@4+*5D$
MK(D@]_\ V</A9KGP6T.VT#5]7M]7M["WAMK*:/3S93)#"&54F(NIXY=J>5'&
MR)"P6,F0S2.7'T!1111117YH?'W_ ()X7'QJ\>0^.+7Q9JFDR)'!$8;<-Y\,
M<:F.5+&Z6:,VB2QL^5\N8":6>5A(LIB'V_\ "'X0Z7\$M+72]+60J9'GN;F=
MS+=7EU*<S7=W,?FFN)6Y=S@8"HBI$B(OJ%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%9^K:8FM6\MK*9%CFC>-S%+)#(%=2I*2Q,DL;X/RR1LKH<,K*P!&?X
M6\)Z=X&LX]/TJTM[&RAW>5;6T*0PIO8NVR.,*B[F9F; &68L>23704444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444444444444444444444444444444444445^8&I?MO>(?CKXH
MN?"GPBT_3]133L-?Z_J4DW]EIQ(#%&+;$C[W")!,COYQ29D@>V3[6-#QK^UA
M\0?V6K=;[XC^'+.^T?S!Y^L>&[AWCMA(K+#%)97NV8N95 >X:6*W GB16:<>
M7)]0?LD_&^X_:/\ !EAXJNK>.TDOY+TBWC9G6..&]N((E+M@NXCC3S'P@=]S
M+'&I"+]'T444445Y?\7O%VM^"M+:Z\/:+)KVHF1$CLDN[>R7:3EY))[E@JHJ
M@X"+*[.478$+RQ_GA_P3-_:\\4?M:7GB>Y\126XBL_[+^R6MM (H;?S5NEEV
M%B\S^884=O.EEVMD)L0[1^K]%%%%%%%<?X_UV_\ #.EW-YI>GR:K?11DV]C'
M-# T\A("J9KATBC3)W2.2Q5 Q2.5]L;_ )8?L;?MF^-/V@/BGK?AWQ##;Z;9
M:7I]\O\ 94 CD\FYMM0@AW2W7SO-*BR/"[1-';2;1(D"DY/W_P#M3Z_XH\+>
M"]7O/!=O]IU^*W!M(Q&)6YD02O'$Q EECB,DD,9#^9*B)Y4V[RG\P_8-\9>/
M/'7@Y;OXAVTEOJWVRX2$S6RVEQ+:KLV23VZA!&_F&:-1Y<):&..38V_SI?L^
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOQ1_X*L?MK:7H?A^
M;P/X=U".XU:_D,.IFVD+BTM8G99[>26*11'<2R((9+=A(?L_VA)HX_,A+_J]
MX*^-_A7XE7#6>AZWI>I7*1F5X;.^M[B18PRJ7*12,P0,RJ6(P"RC.2,^H444
M4445X_\ M"_VC_PAOB#^R/M']I?V/J/V/[+O^T?:/LTGD^1Y?[SS=^WR]GS[
M\;?FQ7X@_P#!'O\ :NT/P-%/X!U4_9+O4=0:[T^Z=QY,\TL4,)M#D#RY3Y*M
M 22L[.T(V2B%)_Z#M6TFWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP*LC*2K*P(8
M$@@@UX!^R9\(7^ OA&V\-,LBQV%YJJ6YE>.21[5]2NI+61VBPA>2!XI& "E2
MQ4HC HOYH?ME_MV:'XI\9>#_  KH.JV\NEVWB#2K_6[^*<"SVQ7,,D,7VE91
M#+%&"UQ<[E>*.1+<B5989D3]?O OQ8\/?%#SO[!U73]3^S[//^Q7<-SY7F;M
MGF>2[[-VQMN[&[:V,X.#XE_%70_@WISZKXAO[?3[)-P\V=PN]E1I/+B7[\LI
M5'*0Q!Y9-I"(QXKYP\%?\%#_ (5^/[AK6S\2V<<B1F0F\6:PCVAE4@2WL4$3
M/EAB-6+D;F"E58C[/KS_ .)?Q5T/X-Z<^J^(;^WT^R3</-G<+O94:3RXE^_+
M*51RD,0>63:0B,>*^8/"W_!2'X4>,+R.QMO$=NDLN[:US!=6D(VJ7.^>Z@BA
M3A2%WNNYL(N795/V_7X _P#!#'_F;O\ N#_^W]?L]XI_:%\&^!KR33]5\0:/
M8WL.WS;:YU&VAF3>H==\<DBNNY65ER!E6##@@UT'@7XL>'OBAYW]@ZKI^I_9
M]GG_ &*[AN?*\S=L\SR7?9NV-MW8W;6QG!QZ!7/^*?%FG>!K.34-5N[>QLH=
MOFW-S,D,*;V"+ODD*HNYF55R1EF"CD@5\H>"O^"A_P *_']PUK9^);..1(S(
M3>+-81[0RJ0);V*")GRPQ&K%R-S!2JL1]7^$_%-GXYTZTU73Y/.LKZWAN;:7
M:R;X9D$D;[7"NNY6!VL%89P0#D5Y?X*_:4\'?$5]572=8L[N/1(XI=1N(Y,V
ML$<T;RHYNCBW= D<AD:.1Q$499"C BO(/ '_  4+^&'Q/U2VT;2]>CDOKR01
M6\<EK>6ZR2$':@DN((X@[$;8U+ R.5C0,[*I^SZ_ ']@7_DX7Q[_ -Q__P!/
M-O7[W:MJUOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B H!)( KS_ .%7
MQH\/_&^WNKSPY?1W]M9WDME--$'\O[1"J,ZH[*JRIMD1EEB+PN&!1V%?E#_P
M58_;6TO0_#\W@?P[J$=QJU_(8=3-M(7%I:Q.RSV\DL4BB.XED00R6["0_9_M
M"31Q^9"7_5[P5\;_  K\2KAK/0];TO4KE(S*\-G?6]Q(L895+E(I&8(&95+$
M8!91G)&?,/C'^VA\/_@%>+I_B+6[>VO3G=;1I-=31X5''G1VL<SP;ED1H_."
M>8I+)N"L1U_PX_:4\'?%^X@L_#^L6>HW,]F]ZL-O)ODCMT:%6:=!\UNX:XB7
MRK@1S$EP$)BEV:'Q9^/WA?X%?8O^$EU.WT[^T;@6]KYQ/SOQECM!V1)E?-GD
MV00[T\R1-ZY]@HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK^<'_@LI
M\)_#WPO_ .$6_L'2M/TS[1_:OG_8K2&V\WR_L6SS/)1-^W>VW=G;N;&,G/[W
M>"O@AX5^&MPUYH>B:7IMR\9B>:SL;>WD:,LK%"\4:L4+*K%2<$JIQD#'J%%%
M%%%%%?SX_MV_\$I[@7%WXH^'L,9MC&\]UHB!A(L@8%CIR*I5D92TGV4E#&4*
M6_F"2*VB^8/V7?\ @I9XQ_9?N+?PWXECDO\ 1+"1;2:SN(MFH6,<+2(\4#L8
MVWQLP'D7>\*D*6T;6J_,O])OPM^)&A_M,^%[?6;%/M.D:M;R*T%U"/F4EX)X
M)XGW(VUEDAD +Q/@[6DC96;\(?VV_A/X>\*?'7P5I&GZ5I]IIMW_ &']ILX+
M2&*WF\W5IXY/-A1!&^] $?<IW( IRH K][O#?P]\*_!"WN[S3-/TO1+8Q^;>
MS6]O;V4?EP*[;YWC6-=D:L[;I#A 7.0":_)'_@GCIL_[8'BWQ#\4_%5M]J6&
MXBL]#BN3;W,-CLD^U^7 K1AXY;1?LOE7"+!O:>XE.^:25D_0_P#;$_95TO\
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MLVBYU+PY_:U['SC?9G4+G[='\TJ1C"(ESN*R2'[-Y,:[ICGZ_P#^"0G[2_\
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M[LT2.\FD%L=3*V]SN9XD\F.*)'01%9)9_-CN80D;>7_MB:+XY_X)]_V;XO\
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M@'_IYN*^C_\ @L]JUQIWPYM(H)9(X[G7+6*=$=E66,6UW*$D (#H)(XY K9
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MM^Q:A/9>1LSO^W0B;S-^X;=GV+;MVMO\W.Y=F'^S]6U:XU_X!2WEY+)/<S^
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MX7B\7:?#NU+0<_:=B9>73I#^\SLB>1_L[XG7<Z0P0->RG+$5] ?\$W?V:/\
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MO[S0-4NM1U"358)M,TQ8;R2SN+C5('<33M+! +>%U,4ETSI""48[4;(_6_\
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M63[1YL#AMC,BR>7*OWXI0KH7AE"2Q[@'13Q7H%%?E!_P53_8_O/V@=#MM?\
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M%K/QSIUWI6H1^=97UO-;7,6YDWPS(8Y$W(5==RL1N4JPSD$'!KG_ (3^!?\
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M*,K>?+^ZF8QNUNG$8\T^8QB_1^BBBBBBOS@_;$_X*,:=^R%XATW0;G2;B_\
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M\8=(M[;[';V\=JUFR+.RS2-?.69)-\^!',KO#'$LGEI_0=XLT#_A*].N]/\
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M-H_].NX_,<W5TCP>:9'@A:.W2)S\P?\ !)KXAZYX"\3>(_A7JLWVJWTC[5+
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MFB=7CDC=0R.CJ2K(RD,K*2&!!!(-:%?/_P"UC_R3SQ7_ -B_JW_I%-7YP_\
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M=Y_G_H7*_7[]K'_DGGBO_L7]6_\ 2*:O@#_@BI_R3S4O^Q@N?_2*QK]?Z*_
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M:[S]J'P-/I6E\ZI9W$5_8Q&18DFFB5XVB=F5A\\4LHCR8E\_RB\J1!S7R_\
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M;_TBOJ^__P!D[_DGGA3_ +%_2?\ TBAK\@?^;O/\_P#0N5^OW[6/_)//%?\
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M_P )U*DC^#_$MY,EW=\2"-;]A-=Q2E+=GC>"<?;+>.-=]Q;P+"LSN+G9]?\
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M /\ F[S_ #_T+E?K]^UC_P D\\5_]B_JW_I%-7P!_P $5/\ DGFI?]C!<_\
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M"GACP[_8.FW_ )EKJNOSS->V]O9E +J"(&VMXVNY$E1$C#M)LD+ 0J?M=O\
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M_=Q?Z5<-<119E:,?/&^_/EC:SAE_3_Q3IVA_\%"?AG)%I]U<6VFZ];JT,YB
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M+';7 N+))W#M<+*L<%U>V\\D =8689__  WU^T+_ -"%_P"4#6?_ )(KZO\
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M:+Q[J^G7$ND7'E/;O&5'VB'^S(]/N3"QRAE@9F8P.8V;$>YHHYXYC^Q_AO\
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M]<&[6M0VW>H);)+<-##!&QAM$2$R_:)8]TS,;>,M)+,84\]8XI'^ /MFM?\
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MS\KB.1$E%M MAYL[J&?:<1V[/%)"US'(I _0^BBBBBBOY@?^"*G_ "4/4O\
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MWA_Q9X.CTS1!'/(;N,2%;9=HDMP;[S9+2^<[D@DCMEC?>[3;8U@FB'Z7T5\
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M9Q(HN5D_=R%89K>%H[AX_P!+_'_C_2_A9I=SK6M7,=GIUG&9)YY"=JKD
MLSLQ"1QH&>1V6-%9V53\ >$OCM\8_P!H5!K/A#0=#T7P]-&KV,GB*6Z>ZO8V
MDEVW"QV+9@1HUB;RY5((=9(KBYB<,O/_ +(7_!12X^+_ (EF\!>,=-CTOQ1;
MR74(:U=I;6>XM&F-Q!MS*8'CCC)5C-/#.8Y6$D1,,4GYX?\ !63XR>._%?\
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MSQ7_ -B_JW_I%-7P!_P14_Y)YJ7_ &,%S_Z16-'_  6K_P"2>:;_ -C!;?\
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M2]1\0:'KOAZY?S++2KBTGM-S.S1_;A/YL2[F*+$&MQ*J(J_O99W8L9/E\O\
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M-AH>DQ7L-O<1326TGV1%V3I&S-$^Z-UVR!3E'&,J<?EA^P+_ ,G"^/?^X_\
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MP]XF\8:)93W$EQ]BT[6!!;HSX&%7R&=MJJD8>5I)2B*'D<C-?7_P<^ /A?\
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M:RLUG.DSB>WG*PF+L-)TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH
M4    5H44444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444445X_\ $OXHWWP[
MWO!X>UC5[>*W:>2;3OL#XV[BT2PSWUO<RR@*&"0Q2;]ZJA>0E%^$/!7_  5I
M\*_$JX:ST/P[XLU*Y2,RO#9Z;;W$BQAE4N4BO&8(&95+$8!91G)&>PU__@IA
MH?@;[/+XA\,^,-$LI[B.W^VZCHX@MT9\G+-Y[.VU5>0I$LDI1&*1N1BOK_X.
M?'[PO^T!9M?>&-3M]0B3'FK&2LT.YG1?.@D"30[S&YC\U$\Q5+IN3#'V"BBB
MBBOG#]IO]HM/V;-&?5#I.J:O)Y<[K%86LDD<2P1&1I;RX"F*UMP=H>1]S@,S
MI#*L4NSR_P#8*_:EU']KGP]J&O:A:V]GY.L7-I;00%VVVZ0V\T8E=V/F2CSB
MKR*L2/@$1)R*^WZ*************************_.#_ (*,?MB>(?V0M.TF
MYT'3;>[^WW$\<]U=I,]O!Y2*R0D0O%^]FW,\9:4?);R@1R9+1?=_P]\27'C'
M1M/U.\M)+"YO+.WN)K*7=YEM)-$LCP/N2-M\;,8VW(ARIRBG@=A11111117'
M^/\ QDGP^TNYU22VO+Q;:,N+:QMI+JZF;("QPPQ@LSLQ R=J("7D>.)7=?SP
M_96_;^U']IWXAZIX8_L?^R=-T[3[J7R[K?\ VB;BWO88/WZY6.#Y)<26VR1X
MID(^T.O%?I_11111111111111111111111111111111117Y(?MM_\%,+W]G"
MX;2=&\/WC79DECCU'5;:>VT^1H6A,AM$_=RWJ .\;2*\"(_E2HUQ#(I;]/\
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MEU2UM$TMYXQIL*BUNW\Z.W2)6-P65LSRR2/MD>,$1"-(_P!3OV3O^2>>%/\
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M_:LT.*TN9MGB;3[>-=2MY-BM/M"H;Z$(J(T4K8,B(J_9I7$3+L:"2;[_ *_
M'_@AC_S-W_<'_P#;^OW^K\ ?^"&/_,W?]P?_ -OZ^_\ _@J/_P DA\0_]P[_
M -.5I1_P2X_Y)#X>_P"XC_Z<KNO@#_F[S_/_ $+E?O\ 5^$/_!/SPM>7?QU^
M(FJI'FRMKC5[::7<HVS76K"2%-I.\[EMISN4%5V88J60-S_[?7_)PO@+_N ?
M^GFXK]COVF])N-?\"^);.SBDGN9]#U.*&&)&>221[2541$4%F=F(554$L2
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M&U&0-%Y 4NR1-;I!($D>25&=@[!OD3[?HK\@/^"U?_)/--_[&"V_](KZOO\
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M,WERHZ$Y4UG_ !1^+VE_"!-/?4VD#:IJEEI5FD:%VDNKV39&#T5450\LC,0
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M:5&)1-X)<Q_A#^QM^S#\9_V0?$KZ_!X0CU&.:SFLY[=]6T^%C'(T<H,<HN9
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MOE\D(ENT.VYCED5'_2^BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOA#XO?\
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M*K12^5( K?C!_P %3/VE-#_:0L_#4^E?:+>[L+C6[;4--O8Q!?64RM9*$N(
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M/[6?@[]F6W,OB/48XKDQ^9#81?O;R<%9"FR!3N5':)XUGE\NW$@"/,A-?/\
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M8A1]0>."Z>T=V1)6@B3?'(R--,@E2.01EY4:,=AX._X*(_#KQ3X7'BRXU/\
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MAZC8QR:3:2:N\5@A>&UQ:ZU;&"*2"%DBFMT*J1;2J]N2B9B.Q,?H_P#\%9/
M&E^)OAAJ.J7EM'+?:5):26-P01) T]Y;V\P5@02DD;D/&V48K&Y7?%&R9_\
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M66*.:X2ZM_*N8F) 6WMO.6+;+(Z_=_\ P4$_XN1H^F?#:T_Y"7C#4(;>-_\
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M]0N-.G%XL+RJMFD,6GZC$P,3!I5B61F2'S)$BG@=2LKJ%_H^K\(?^"JVB_\
M"^?'W@?P!9K<+>S>;)-.D'G+%;ZA/%"9@BN'?R%LKB><-Y:+$JMYF-YC]?\
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M]NGQK;^ /AEXGO+I9'CDTNXLP(PI;S+\?8HB0S*-BR3HTASD(&*JS *?G_\
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M"_\ )POCW_N/_P#IYMZ^K_\ @L+X*N/%7PR-Y T:QZ5JEG>3ARP9HW$MD!&
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MW$,DL;2QI(5.QGC62)I$#8+(LD98 J)$)W#\L/\ AW;XH_X6!_PLG_A,K?\
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M;.U:[607%U,YAMY;FX83SQ1+.'2VCEF*%FF @\O_ &J_^"?/BWQK\0(OB)X
MUJWT[5'\IY_M;R1^3-;PQVZ&!H;><212Q)LG@G7:?G#-+%.8HOT/^"'PHO\
MX:V]Q-KFK2:]K=[(K7>IRVT-J6CB79;V\,$(VPV\2[G6(,X-Q/=7'#7#@?EC
M^TI_P2-EUO7/^$C^'&H6^C7#7$<_V&4RP0VTREG:>SN+=9)(<.(VCMQ$%B8N
MT<T<:Q0+W_P+_P""<WB;4+R"\^+'B:X\26EE<>?;Z*UY>7EB\R*!#/.UV4W[
M=\RFW$(5QMWS/$\UN_V!^UY^SEKG[4.CR>';;7;?2-(N/(:ZC_LPW=Q,T,AE
M"^>UY$B1;EA?:D0EWQ?Z\QNT5'[(?[.6N?LO:/'X=N==M]7TBW\]K6/^S#:7
M$+32"4KYZWDJ/%N:9]KQ&7?+_KQ&BQ4?M>?LY:Y^U#H\GAVVUVWTC2+CR&NH
M_P"S#=W$S0R&4+Y[7D2)%N6%]J1"7?%_KS&[14?LA_LY:Y^R]H\?AVYUVWU?
M2+?SVM8_[,-I<0M-()2OGK>2H\6YIGVO$9=\O^O$:+%7A_\ P4#_ ."?B?M=
M);ZMI-Q'9^([.-+='N'D^RW%KYC/Y4NQ9&C>-I))(I8T8L6:*16#1R6_/^$_
MV(?&OQ/\-7VB_%+Q3)J;&S>STR"SEF%K VV,Q7MZ46RFU*XCEBC>..[,B*4>
M1GDEG+0\?^Q=_P $^?%OP6_T#Q9K5O+H%MJ$.JVVDZ:\@2XU*+9Y<]Y.]O;S
M-%"889([4,\,LZ1RN%\DI-T'QG_X)V^*/CAXMM/&E]XRM[?5-/\ LOV$6V@!
M8;;[)(9HMB2ZA*7_ 'K/*WG-+EG*_P"J"1K^G_A:VU&TLXTU6>WN;T;O-FMK
M=[6%LL2NR&2>Y=,+M5LRON8%AM#!%Z"O@#]LW]CC7/VP8H=-F\16^FZ+;7 N
M8;6/23-,TPB\H/-<M?)OV[YO+6*.!0LI602LB2#W#X#?"?Q+\'/#4?AZ[UJS
MU-K&SCM=,NCI36[0K$KI%]JC2^9;E$7R458S:NR1'?*\LAE7XO\ ^'=OBC_A
M8'_"R?\ A,K?^W?M'G8_L ?9]GD_9OL_E_VAN\K[/_H^=_G[/G\[S_WM?H_X
MI^'EG\3=#DT/Q-#;ZC;W=NL5Z@B:*&5L L\:&222'#CS(2)7E@8(RS&1!)7Y
M@?";]BKXG?L?:C>Q?#O7-'O] OLR&RUY;I/)FWD*ZK9JP:58ECC>X1H%N,D/
M:CR8"GN$7[&>J?'75+#Q!\6;^SU2;39&DL=#TZV$6DV[. L@DDG5KN]27R;>
M<QS-&B2K)"5FMW*'Z/\ VC_A9KGQIT.YT#2-7M](M[^WFMKV:33S>S/#,%5D
MA)NH(XMR>;'(SI,Q60&,PR('/@'[&7['&N?L?13:;#XBM]2T6YN#<S6LFDF&
M99C%Y1>&Y6^?9NV0^8LL<ZE8@L8B9WD/G_[7_P#P3^US]L34;>YU3Q1;VEE8
M?:%L;2#1B?+6=PS-+*VH;Y92J1([ 1Q'R@R01%GW??\ \--%USP_IR6WB'4;
M?5;V/:OVN"R-CYBJBKNEB^T7"&5F#N[1&*+Y@J01A?F] HHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKQ_X]_#C4?BWX<O-%TK5KC0
MKVY\GRM2MMYF@\N>.5MGERP/\ZHT38D7Y7.=PRI_.#_AW%\0_P#HK/B#_OF]
M_P#EK1_P[B^(?_16?$'_ 'S>_P#RUH_X=Q?$/_HK/B#_ +YO?_EK1_P[B^(?
M_16?$'_?-[_\M:/^'<7Q#_Z*SX@_[YO?_EK1_P .XOB'_P!%9\0?]\WO_P M
M:/\ AW%\0_\ HK/B#_OF]_\ EK1_P[B^(?\ T5GQ!_WS>_\ RUH_X=Q?$/\
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M'JBHNYF9FP!EF+'DDUO_ /#N+XA_]%9\0?\ ?-[_ /+6C_AW%\0_^BL^(/\
MOF]_^6M'_#N+XA_]%9\0?]\WO_RUH_X=Q?$/_HK/B#_OF]_^6M'_  [B^(?_
M $5GQ!_WS>__ "UH_P"'<7Q#_P"BL^(/^^;W_P"6M'_#N+XA_P#16?$'_?-[
M_P#+6C_AW%\0_P#HK/B#_OF]_P#EK1_P[B^(?_16?$'_ 'S>_P#RUH_X=Q?$
M/_HK/B#_ +YO?_EK1_P[B^(?_16?$'_?-[_\M:/^'<7Q#_Z*SX@_[YO?_EK1
M_P .XOB'_P!%9\0?]\WO_P M:/\ AW%\0_\ HK/B#_OF]_\ EK1_P[B^(?\
MT5GQ!_WS>_\ RUH_X=Q?$/\ Z*SX@_[YO?\ Y:T?\.XOB'_T5GQ!_P!\WO\
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M'_T5GQ!_WS>__+6C_AW%\0_^BL^(/^^;W_Y:T?\ #N+XA_\ 16?$'_?-[_\
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MX5\/Z+KFIWUOJD5Y/+:Z3>2VL<:6LR ?:1%Y4KN;E=H@,H0QRK(T;JJ-]O\
M[%WB\ZUX*T;3+BPU33;[2=+L+.[M]1TZYLV$D$/D$QO-&L4R,83(#"[E$>/S
M5B=M@^KZ****************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M**************************************************_)#XD?\%,+
MW3O'6A^#-*\/WEG'J.J6%O->:U;3VDDMK<7;6KR6EFWERA& 5X+B9@01)&]F
M&7(_6^BOS@_;?_;ZE_92B>VL=!U"]NVV1I?W%O+!I$<TL4LB(+DK_I4J;$=[
M>$JK1F1?M4<L4B+]G_!#QK<?$KPKHFN7BQI<ZEI=C>3)$&$:R7%O'*X0,S,$
M#,0H9F(&,L3R?@#XH_MS^*O _P 9=/\ AY:Z%'-I-U)91F8I<&ZGCN4W2WL#
MK^Z%O;$OYH\N4$6EQNGBR?(_4^BBBBORP_;G_;G\5?LP>*M"T/0]"CU&VU&-
M)'>1+AI+N1KCRC961BPJW"J%))6Z.;J#]P  )OU/HHHKP_X^_'W2_P!G72X=
M3U.&\NFNKR"QL[.Q@-Q=75U<$^7##'E5+E5=OF9 P0HI:5D1_@#]I7]K#XQ_
MLXV]IXFO_#FA_P#".2R6_P!JM8+BZN[RQ#K'NBNKM?)@1Y'+QQ7$4$]O')LC
M9I2T1N/N#]E7]IC2_P!J_P -1>(=,CD@82-;WEK)DM;W2*CR1"3:JRIMD1XY
M5 #HZ[ECE#Q1_1]%%%%%%%%%%%%?/_[4_P 6=1^!?@O5_$FE67]H7MA;B2*W
M(<K\TB(TT@C!<Q0*S7$P!3,43@R1#,B>8?L&_M':S^U+X.7Q!KFGQV-S]LN+
M=&A65+>YCCV$3P+*68(&9K=L22@S02'>I)BC^SZ***********S]6U--%MY;
MJ42-'#&\CB**2:0JBEB$BB5Y9'P/ECC5G<X559B ?RP^'W_!1W4?BK\4M-\"
M6V@7&D64OVG[6=6C>+4CMT]KN+%LK!+;YD.=[7/G0NCKY).*_5^BBBBBBBBB
MBBBBBBBBBBBBBL_5M331;>6ZE$C1PQO(XBBDFD*HI8A(HE>61\#Y8XU9W.%5
M68@'\L/A]_P4=U'XJ_%+3? EMH%QI%E+]I^UG5HWBU([=/:[BQ;*P2V^9#G>
MUSYT+HZ^23BOU?HHHHHK\X/VW_V^I?V4HGMK'0=0O;MMD:7]Q;RP:1'-+%+(
MB"Y*_P"E2IL1WMX2JM&9%^U1RQ2(OV?\$/&MQ\2O"NB:Y>+&ESJ6EV-Y,D08
M1K)<6\<KA S,P0,Q"AF8@8RQ/)]0HHHHHHK\L/BC^W/XJ\#_ !ET_P"'EKH4
M<VDW4EE&9BEP;J>.Y3=+>P.O[H6]L2_FCRY01:7&Z>+)\C]3Z***********
M***********^0/'?[2>HZIXCO? _@G3/[1U^QMXY;Z\O6>VTC3OM$#R6_P!H
MF1))IY7/DE+:"/\ >QR.1<1^1.8OA"/_ (*9^*O@!XQD\*_%C1;.TA,D834-
M,%P(TMV\P"[2.5YVN[=V"<QF&:$),K0R7"&W7]#_ (L_M)_\(3XALO!NBZ9<
M:QXDO[<7:P*WV>SM;,3")[J^O"DGDQ#$NSRHKB1Y(UA\M7G@\S\\/B;_ ,%"
MOB-^R/XE@TSXD:#I=QI=U&K0WFC&YC61=T?FR0274DBRO"I99+61;9R[1.98
MX7C>7]CO"?BFS\<Z=::KI\GG65];PW-M+M9-\,R"2-]KA77<K [6"L,X(!R*
MZ"OC#]O+]H[6?V6O!S>(-#T^.^N?MEO;NTRRO;VT<F\F>=8BK%"RK;KF2(":
M>,[V($4GI_[+'Q9U'XZ>"](\2:K9?V?>W]N9);<!PORR.BS1B0!Q%.JK<0@E
M\12H!)*,2/\ 0%%%%%%%%%%?$&I_M)^(?BUJ.KZ%\-M,MY[C1;B2TO=9UIIK
M?2TO(GB$EK!' CW-W* 9EEQ]GC@*1R^9+'-")?E#]G[_ (*9ZS-XQ'@+XE:+
M'I&L2WGV2*:U$HC2XE\M;:&6!WG8I,S$QWD4SPL)(&$8@+W(_8ZBN/\ '_C)
M/A]I=SJDEM>7BVT9<6UC;275U,V0%CAAC!9G9B!D[40$O(\<2NZ_GA^RM^W]
MJ/[3OQ#U3PQ_8_\ 9.FZ=I]U+Y=UO_M$W%O>PP?OURL<'R2XDMMDCQ3(1]H=
M>*_3^BBBBBBOS0^+W_!3SPUX2U1O#WA*QO/%^MF-'ABTK;+:R,1YDD8N(O.=
MWCA#2L8()T!'ELZ,LWE=A_PU)\1_#7^EZ]\-=0ATV/\ U\FFZO9:K>#=\J>5
M8PB.2;+E ^UAY<9>4Y5"#T'P#_;V\+_M,^(8]!\-+<3?\2>34KJ>:,P_9G6:
MWA%F48'S)1YS-+)&Q@3:@CDGWL8OM^BBBBBBBBBBBBBBBBBBBBBBBBBOR0^)
M'_!3"]T[QUH?@S2O#]Y9QZCJEA;S7FM6T]I)+:W%VUJ\EI9MY<H1@%>"XF8$
M$21O9AER/UOHHHK/U;4TT6WENI1(T<,;R.(HI)I"J*6(2*)7ED? ^6.-6=SA
M55F(!_+#X??\%'=1^*OQ2TWP);:!<:192_:?M9U:-XM2.W3VNXL6RL$MOF0Y
MWM<^="Z.ODDXK]#_ (O?%%/A!I;:F^GZIJC"1(TL]*LI+VZD9SU$:85450S-
M)*T: #8&,KQH_P 8?L#_ +;VH_MFWGB%[G3[?3K+3?[.^R0QR/--_I*W E\Z
M9MB2?- &CV10[%8JWF$;S^C]%%%%?DA^VW_P4PO?V<+AM)T;P_>-=F26./4=
M5MI[;3Y&A:$R&T3]W+>H [QM(KP(C^5*C7$,BEOT_P#B%XDN/!VC:AJ=G:27
M]S9V=Q<0V46[S+F2&)I$@3:DC;Y&41KM1SEAA&/!^$/^"<_[8GB']KW3M6N=
M>TVWM/L%Q!'!=6B3);S^:C,\($SR_O8=J/(5E/R7$0,<> TOZ/T44444445Y
M?\7OBBGP@TMM3?3]4U1A(D:6>E64E[=2,YZB-,*J*H9FDE:- !L#&5XT?XP_
M8'_;>U']LV\\0O<Z?;Z=9:;_ &=]DACD>:;_ $E;@2^=,VQ)/F@#1[(H=BL5
M;S"-Y_1^BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MN?U'Q9IVD7EKI]S=V\-[?>;]DMI)D2:X\E0\ODQL0\OEJ0TFP-L4AFP.:\_\
M4_M"^#? UY)I^J^(-'L;V';YMM<ZC;0S)O4.N^.2177<K*RY RK!AP0:]@HH
MHK\ ?V^O^3A? 7_< _\ 3S<5^UWC7XW^%?AK<+9ZYK>EZ;<O&)4AO+ZWMY&C
M+,H<)+(K%"RLH8#!*L,Y!QZA7Y ?\%J_^2>:;_V,%M_Z17U??_[)W_)//"G_
M &+^D_\ I%#7L&O^+-.\*?9_[0N[>T^UW$=K;>?,D7G7$N?+@BWD;Y7P=D:Y
M=L' .#705S_BGQ9IW@:SDU#5;NWL;*';YMS<S)#"F]@B[Y)"J+N9E5<D99@H
MY(%<?X*^-_A7XE7#6>AZWI>I7*1F5X;.^M[B18PRJ7*12,P0,RJ6(P"RC.2,
M^H45S_BGQ9IW@:SDU#5;NWL;*';YMS<S)#"F]@B[Y)"J+N9E5<D99@HY(%=!
M7/\ _"6:=_:/]D?:[?\ M+[/]J^Q^<GVC[/O\OS_ "<^9Y6_Y/,V[-_RYW<5
MQ^I_&_PKHNJ#0[K6]+AU9I(HA827UNET9)@IB00-()2\@=#&NW+AEV@[AGU"
MOPA_X*!^*;R[^.OP[TIY,V5M<:1<PQ;5&V:ZU8QS/N WG<MM -K$JNS*A2SE
MOW.U;2;?7[>6SO(HY[:>-XIH945XY(W4JZ.C JR,I*LK A@2""#7G_PA^"_A
M_P" NEKHWAJQCL+%9'E,:%W9Y)#\SR22,\LCX"J&D9BJ*D8(1$5<_P#X:%\&
M_P!H_P!D?\)!H_\ :7VC[+]C_M&V^T?:-_E^1Y/F>9YN_P"3R]N_?\N-W%>P
M5S_BGQ9IW@:SDU#5;NWL;*';YMS<S)#"F]@B[Y)"J+N9E5<D99@HY(%<_P".
MOBQX>^%_D_V]JNGZ9]HW^1]MNX;;S?+V[_+\YTW[=Z;MN=NY<XR,]!XI\6:=
MX&LY-0U6[M[&RAV^;<W,R0PIO8(N^20JB[F957)&68*.2!6?XU^(6C?#6W6\
MUS4+/3;9Y!$DUY<16\;2%68('E95+E59@H.2%8XP#C0\+>+-.\<V<>H:5=V]
M]93;O*N;:9)H7V,4;9)&61MK*RM@G#*5/((KC]3^-_A71=4&AW6MZ7#JS211
M"PDOK=+HR3!3$@@:02EY Z&-=N7#+M!W#/J%<_XI\6:=X&LY-0U6[M[&RAV^
M;<W,R0PIO8(N^20JB[F957)&68*.2!7'^"OC?X5^)5PUGH>MZ7J5RD9E>&SO
MK>XD6,,JERD4C,$#,JEB, LHSDC/J%?F!\%OVN/^&@?C7J>C:/>^?X;TCP_.
MD/DR;K>ZO/M=EYUT,(F_;O-M$VZ:/9&\T+A+I]WZ?US^@>+-.\5_:/[/N[>[
M^R7$EK<^1,DODW$6/,@EV$[)4R-\;8=<C(&1705Y?XU^-_A7X:W"V>N:WI>F
MW+QB5(;R^M[>1HRS*'"2R*Q0LK*& P2K#.0<>@:3JUOK]O%>6<L<]M/&DL,T
M3J\<D;J&1T=259&4AE920P(()!K0KC],^(6C:UI9URUU"SFTE8Y93?QW$3VH
MCA+"5S.K&()&4<2-NPA5MQ&TXS_ OQ8\/?%#SO[!U73]3^S[//\ L5W#<^5Y
MF[9YGDN^S=L;;NQNVMC.#CT"BN?\4^+-.\#6<FH:K=V]C90[?-N;F9(84WL$
M7?)(51=S,JKDC+,%') KG_'7Q8\/?"_R?[>U73],^T;_ "/MMW#;>;Y>W?Y?
MG.F_;O3=MSMW+G&1GT"O'_\ AH7P;_:/]D?\)!H_]I?:/LOV/^T;;[1]HW^7
MY'D^9YGF[_D\O;OW_+C=Q7L%?@#_ ,W>?Y_Z%ROW^KC_ !K\0M&^&MNMYKFH
M6>FVSR"))KRXBMXVD*LP0/*RJ7*JS!0<D*QQ@'!X*^(6C?$JW:\T/4+/4K9)
M#$\UG<17$:R!58H7B9E#A65BI.0&4XP1GL****\?\4_M"^#? UY)I^J^(-'L
M;V';YMM<ZC;0S)O4.N^.2177<K*RY RK!AP0:]0TG5K?7[>*\LY8Y[:>-)89
MHG5XY(W4,CHZDJR,I#*RDA@002#1JVK6^@6\MY>2QP6T$;RS32NJ1QQHI9W=
MV(545069F("@$D@"N?U/XA:-HNEC7+K4+.'26CBE%_)<1):F.8J(G$[,(BDA
M=!&V[#EEVD[AD\%?$+1OB5;M>:'J%GJ5LDAB>:SN(KB-9 JL4+Q,RAPK*Q4G
M(#*<8(SY_P#M%?'G2_V;?#5[XBU22,+!&PMH'D*-=W15C#:QD)(V^1EP6".(
MD#S.!%&[#R#_ ()[^/\ 5/BG\-=(UK6KF2\U&\DU*2>>0C<S?VC=    *J*H
M"1QH%2-%6-%5%51]GT5^8'P6_:X_X:!^->IZ-H][Y_AO2/#\Z0^3)NM[J\^U
MV7G70PB;]N\VT3;IH]D;S0N$NGW?I_7'^-?B%HWPUMUO-<U"STVV>01)->7$
M5O&TA5F"!Y652Y568*#DA6., X/!7Q"T;XE6[7FAZA9ZE;)(8GFL[B*XC60*
MK%"\3,H<*RL5)R RG&",]A17Y@?\%0OVN/\ AG[PN=&T>]\CQ)J^U(?)DVW%
MK9Y/G70PC[-VPVT3;H9-\CS0N7M7V_I_7X _\W>?Y_Z%ROVN\:_&_P *_#6X
M6SUS6]+TVY>,2I#>7UO;R-&690X2616*%E90P&"589R#CU"BO'_"W[0O@WQS
M>1Z?I7B#1[Z]FW>5;6VHVTTS[%+MLCCD9VVJK,V <*I8\ FO8**_(#_@M7_R
M3S3?^Q@MO_2*^K[0^ GQ"T;X:_#3PE>:YJ%GIML^AZ1$DUY<16\;2&QC8('E
M95+E59@H.2%8XP#CZ/\ "WBS3O'-G'J&E7=O?64V[RKFVF2:%]C%&V21ED;:
MRLK8)PRE3R"*Z"BBBO+]3^-_A71=4&AW6MZ7#JS211"PDOK=+HR3!3$@@:02
MEY Z&-=N7#+M!W#/H%EJUOJ+S102QR26T@BG1'5FBD,:2A) "2CF.2.0*V"4
MD1\;64G/U_Q9IWA3[/\ VA=V]I]KN([6V\^9(O.N)<^7!%O(WRO@[(UR[8.
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MT/"WBS3O'-G'J&E7=O?64V[RKFVF2:%]C%&V21ED;:RLK8)PRE3R"*Z"O/\
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MXO,4%H]X7>H++D<UH:MJUOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B
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M(II+:22-T2>(1F2)F4@2()4DB+J3N42)(A(&Y&7*G^9'_A6&N>!OVC?^$?\
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M5OAV/[$O=,N(%O8+-(H;>-7_ '$=U'%E47<S1VUQ;HDD5RDV]XE N6F_4_\
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M:%?>$['6[&SGN-/?3;JRCDDDCVS-!]GM9XEN'G6+[/'YJRF$REXT+$JWK_\
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MVO+2._U&S\-WDNFZA%=S^7Y<-O/=6SHL$RP2IOD,BLRN'# $LF!7YX?\$O\
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MUQ%"SE?(4K*/U?TG2;?0+>*SLXHX+:"-(H88D5(XXT4*B(B@*J*H"JJ@!0
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MDODC^RO;R&X<;[>26.TN9O,<S0Q.SQ--'"L7W?\ MJ_%6\^,'C30_@OH=_\
M9$U?=+XCGA=5F6Q$;3M9QRKYK12RV\4TCQR0@2+):*SFVFG5O</B%_P3W\!Z
MCX.U#P[H>@:7;7<EG<)87<L;&XBNFW202/?$27A19BI8%Y 808=C0_NC\_\
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M ()<?\DA\/?]Q'_TY7=? '[?7_)PO@+_ +@'_IYN*_?ZBOP!_P""YW_,H_\
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M?\RC_P!QC_VPK]_J_ '_ )N\_P _]"Y7Z_?M8_\ )//%?_8OZM_Z135\ ?\
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M ,D\TW_L8+;_ -(KZOO_ /9._P"2>>%/^Q?TG_TBAK\@?V^O^3A? 7_< _\
M3S<5^YWC_3-+U_2[G3M:,8TZ_C-C.LDIA61;TBV$(D#(P>5I1%'L8.SNJH=Y
M6OP!^//_  2C\2_ AY/$_P ,M6O+AK..21;8.T&K1KY:1R"UGM@BW+NK3LT:
MK;/Y0$"+<ROAOL__ ()J_M[:C^U-]MT'Q(MN-:L+>*>&>"-T^UVXVPS22H 8
MDE24QLY1HTD^T 1V\:PN3\P?M]?\G"^ O^X!_P"GFXK]_J_ ']@7_DX7Q[_W
M'_\ T\V]??\ _P %1_\ DD/B'_N'?^G*TH_X)<?\DA\/?]Q'_P!.5W7Y(?\
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M*0Q22+^&/_!<K2;B:W\*7BQ2&VBDU2*28(QC225;-HT9\;5=UBE9%)!81R$
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M,C-#*P!R4D(VL?YT?&/[*/Q5_8 \4'5_AX-0U;0Y+B)HUMD>X\]<2[;74["
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M2ZE93#S"R2I$UGI<B6R/=EO+DD8RO9Q[)&:!1+!;'X@_X)\_#?XJ_!74=?\
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MN(VCT^2&\L(7D8SB.Y,BW0C1G(%O'(D+D1HH2:Z=G8M.N/W.KY0_;(\6^-?
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MS!XY^/VAQZ_XL\9>(-%U^_MVFM[#2)6T^QTY)@9;>WGM-B33RPE\7!EDCG(
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MM\*OA]+]DUUMEQK&LRVIN(=+M!&MQA(G1HY99$:-0\N+<--#;B03S&2T\?\
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M^([WFJPZK>006US/.]S)')<N(+>ZM;B<[IK*5L++$Q4Q%794CN([BWF^K_\
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MH4=QY>I!OW@-A<16,D3-Y:-<H[,)4N)@MQD2&5I3*OD_5_\ P4(_:4O/V7O
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M:A;I/%ED9DW#YHI/+9T66)MT4R!F\N5'0G*FO0*_.#]IO]K;6-.\::3\+O!
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M9)'VH%1=S,3M4*HS@ # K]7OVL?^2>>*_P#L7]6_](IJ^ /^"*G_ "3S4O\
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MW[6/_)//%?\ V+^K?^D4U? '_!%3_DGFI?\ 8P7/_I%8T?\ !:O_ ))YIO\
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M ,%SO^91_P"XQ_[85^_U?@#_ ,W>?Y_Z%ROU^_:Q_P"2>>*_^Q?U;_TBFKX
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M*D$I)&[QR+T=&9&!5B#S_P#P2LU:WU'X2:+%!+'));2:A%.B.K-%(;ZXE"2
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MGA3_ +%_2?\ TBAK\@?^;O/\_P#0N5^K_P"V3\"XOVB? VK:'Y'GWIMWN-.
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MCV2 +:7%M=O%M\G,L082IY4<<-N+8;&DK[?^'?Q/O/\ @H9XHT;48M&U#3O
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MT.\\,V'AF&_MY=:BUB&YFLHW#S0PI9S@O,JY\G/VF$QK+L:57+1AU1ROW_\
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M^'&J>'[F_MTU?4/L!M;'>&N)%6]BE,GE+EUB"V\W[YPL6]/+W^8RHQ_P2?\
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M48KN+>\H00[XHW9?.\OY@(O]:R(WZ/\ _!6#XJZ'X?\ AQJGA^YO[=-7U#[
M;6QWAKB15O8I3)Y2Y=8@MO-^^<+%O3R]_F,J,?\ !)_XJZ'X@^'&E^'[:_MW
MU?3_ +>;JQWA;B-6O991)Y38=HBMQ#^^0-%O?R]_F*R+^:%\]Q_P2D^+UQ?_
M -FR7'A?5(YHK5@&#'3YY(9I$M9'F<-<6<B1Q,MP^^9$#.(!=13)]_\ QO\
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M-\#7D>H:5X?T>QO8=WE7-MIUM#,F]2C;)(XU==RLRM@C*L5/!(KV"BBBN?\
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M"BBBBBBBBBBL_5M6M] MY;R\EC@MH(WEFFE=4CCC12SN[L0JHJ@LS,0% ))
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M6%?$'A/XN?&OXFZ=:>*])T7PO#HMY;PWMOI%Q>W;ZI+;L@<1K=HB622W"_/
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MDNO374EQ<3+F0LJV)Q%B)[<O$P=5=R$N9_G$70?LJ?M_:C\1?%$OP]\=Z/\
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MU;Q1KTAAL+1[F.&.%I&$,$MP"P<I).ZI&A,*2B.X_P!)A,7/S_\ &_\ :?\
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M*,:C\,?%L?@;XJZ3;Z)>MN"ZS;3N=-FWR$6TR1S*7BM)%!1KAII/*F4B:.W
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MXTN77M,\.QZ[I=K&KWACU%K>Z@7+^9*;?[',KV\:A#)(LI= [.T*PQ/,./\
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M;>'P+JMXL48N9=<EBDF"*)'CBM+5HT9\;F1&EE9%)(4R2$ %VSX?_P %SO\
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M6/#* P;Z_P!)TGX^Z!;Q6=G%\.X+:"-(H88DUA(XXT4*B(B@*J*H"JJ@!0
M !7RA!^P5\4_$OQ0LOB1J^H>'[:X74+">\CTVYU"/-O;)#!-%$LEN6/FV\;1
MNCR[)-[HQ$;$#S__ (+G?\RC_P!QC_VPK]_J*^4/VYOBA<?!SX;^(-8L_,%R
MEG]GA>*9H)(9+V1+-)TD4%E>%IQ,NW!)C"AT)WK\_P#_  23\%6_A7X5V-Y
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M3;Z_\??!%G>11SVT\>A130RHKQR1OK%RKHZ,"K(RDJRL"&!(((-?T'5^ /\
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M%^'/A6*UBCAC;0].E*1HJ*9)K:.65R% !>21WDD;J[LSL2S$G\D/^;O/\_\
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M;4W-S#:MAS(DJ301%)U8@F9)LPI"T6_\4/\ @H'^RC%^SMX^\-:K\/A]FO\
M7M0WV.GJD0AMM2MI[8Q& RGREBDEGC(@E'DPLK ,+=DAA]P_X+*_"'5-.O=#
M^(6CK>!K*/[)=W<#A5LFBG$UA,I3$T3M+-.OG[BBNMN@,<KIYOV_^S)_P4A\
M%?&[1DGU;4[/1=6MHX$OH+^:&RC>=H@9)+,RSN)+?S!(J N9D"KYJ)OC:3L-
M'_:=_P"%T_$"Q\.^"KNWO=%TNWGO?$=_$GG6[^;"8K"RMKM-\1E,KFYE"[<I
M 42<M%=6Y_*#_@IKX6US]FSXH:=\3=$CN!%<_9)3=.Q-O]NM4,+V;>28Y$BF
MM88]\;L#<(]TJ.R+(D7Z_P#PT_;V^&OQ0TY-0@\0Z?9;MHDMM1N(K&XB<HKL
MC1SNF_;O"F2$RP,ZLJ2OM)''_L[_ !HN/VH/&.J^)-%OI'\%:79QZ58H R1W
MVH3^3>7=VT<BPSQ/;)Y-JBS1R(PDDDAE3?.C?FA^R'XIL_A7^T9XMMM=D_L^
M75+C6+:R6X5H_.FNM2ANK9%+  >?$N^!F(6;=&L99Y8E?]/_ -N_XZ:'\.O!
MNN:-<S^=J^IZ/?0VNFV^)KQUFMKA3<M IWI:0K'--/<N%BCCAD^9I-L;?&'_
M  1A^(6C:=X0N]#GU"SCU:YURZE@L'N(ENI8Q96A+QP%A*Z 1R$LJD 1OS\K
M8\O_ .;O/\_]"Y7[_5^ /[?7_)PO@+_N ?\ IYN*_?ZOY\?V$=6M]._:)\;1
M3RQQR7,GB"*!'=5:60:K%*4C!(+N(XY)"JY(2-WQM5B/UO\ VDO%-GXI^'GC
M(V4GFK;:/K5M(X5@GG164HE1'("2^6Q,4C1EUCG26W8K-#+&GP__ ,$5/^2>
M:E_V,%S_ .D5C7B'_!97X0ZIIU[H?Q"T=;P-91_9+N[@<*MDT4XFL)E*8FB=
MI9IU\_<45UMT!CE=/-^W_P!F3_@I#X*^-VC)/JVIV>BZM;1P)?07\T-E&\[1
M R269EG<26_F"14!<S(%7S43?&TG8:/^T[_PNGX@6/AWP5=V][HNEV\][XCO
MXD\ZW?S83%865M=IOB,IE<W,H7;E("B3EHKJW/H'P\_:4L_%OCOQ'X"G^34M
M'^S7-L%C8+-8S6EF[NTFYE,L=Q<,K*1$#%)!L$C+,R_CA_P5M_8[\-?">RLO
M&?AZ"/36NKR+3[K3[>)8[5V,$TD=Q$B;5@<+ 4E1%V2EEDQ'*)6G_>[X3_VQ
M_P (]I7_  D/_(:_L^T_M'_5_P#'YY*?:/\ 4_NO];O_ -5^[_N?+BO0*_FQ
M^-.@I^PI^T#9>+;]))-"U6\N+\7#>81&NH++;W^62WP[VLD[SBWB$KFW:V1G
M\R7</Z/M)U:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$@U^(,>
MDG]KK]I*2\6*.XT3P3''%),$N8A]HLS(T:,^,-<)J,LK(I,4,UO:2$"95;S?
M0/\ @M?JUO#X%TJS:6,7,NN12QPEU$CQQ6ETLCJF=S(C2Q*[ $*9(P2"ZY^_
M_P!CO5K?6OASX5EM98YHUT/3HB\;JZB2&VCBE0E20'CD1XY%ZHZLC ,I ^CZ
M*_GQ_81U:WT[]HGQM%/+'')<R>((H$=U5I9!JL4I2,$@NXCCDD*KDA(W?&U6
M(_6_]I+Q39^*?AYXR-E)YJVVCZU;2.%8)YT5E*)41R DOEL3%(T9=8YTEMV*
MS0RQI\/_ /!%3_DGFI?]C!<_^D5C7@'_  7._P"91_[C'_MA7W__ ,%,?@7>
M?'GX=7=MID%Q=ZEIUQ!J%I;6^W=,T6Z*52C M)BWFG=(HR)9)4C5-['RW^(/
M^"9W_!0O0]*T.T\$>+[W['=V?GK8W]TX2T:T0+)%!-<RS'9*F98X0RQ6XMXH
M(%;S=B/]O_M!?MDZ=<6=MX>^'>K:?JGB[7;A++3?LCIJ$-IN9?/O;O[.91%%
M;Q%Y0763YEWF":"*XV??]%?S0_\ !1_]E'7/V=_%K?$_PR/^);-J$-^TL:&5
MM.U+S%D\R993*K137 \V.0CR5ED-JT<:_9Q/^[W[.'[1^A_M,:';:OI%S;M<
M-;PR7ME',))K&:0,&AF4JD@PZ2I'(\:+.J&6,&,@U[AJVK6^@6\MY>2QP6T$
M;RS32NJ1QQHI9W=V(545069F("@$D@"O /@A\3=4^-UQ<:^D$EEX7:-8]&$J
MA+C4E9MTFI2Q/'YL%NP5%TY-\;RPM/<3Q$2V@A_$#XTZ"G["G[0-EXMOTDDT
M+5;RXOQ<-YA$:Z@LMO?Y9+?#O:R3O.+>(2N;=K9&?S)=P_H^TG5K?7[>*\LY
M8Y[:>-)89HG5XY(W4,CHZDJR,I#*RDA@002#7X@QZ2?VNOVDI+Q8H[C1/!,<
M<4DP2YB'VBS,C1HSXPUPFHRRLBDQ0S6]I(0)E5O-X_\ X+G?\RC_ -QC_P!L
M*_?ZOP!_8%_Y.%\>_P#<?_\ 3S;U]_\ _!4?_DD/B'_N'?\ IRM*/^"7'_)(
M?#W_ '$?_3E=U^<'_!2;Q39^!OCKX-U74)/)LK&WT6YN9=K/LAAU:ZDD?:@9
MVVJI.U0S'& "<"OZ'J_$']C338/VI?C1XG^*4%M_Q);'_1-,G8W"^;<>1'9I
M/%F.)6W6D4DDT$OSV_VR %&;;*OA_P"TKX_TOQ-^T?::7X^N8Y?"FE26\<-O
M=DBS@:?3H[A#*J@*4DO'B,\DV4:-52=OLL6U/N__ (*P?%70_#_PXU3P_<W]
MNFKZA]@-K8[PUQ(JWL4ID\I<NL06WF_?.%BWIY>_S&5&T/\ @FMX_P!+\,_#
M#P=I=Y<QQ7VJR:O'8VY),D[07E[<3%5 )"1QH2\C812T:%M\L:O\8?\ -WG^
M?^A<K]?OVL?^2>>*_P#L7]6_](IJ^ /^"*G_ "3S4O\ L8+G_P!(K&OU?\6>
M%K/QSIUWI6H1^=97UO-;7,6YDWPS(8Y$W(5==RL1N4JPSD$'!K^7+X8Q^,?@
M'XE\1? JUDD>/Q'>0:<;I8_.:VMYF3S=0CM%DEB"3Z;([72;DFC01.US$UH0
M?ZC?"?A:S\#:=::5I\?DV5C;PVUM%N9]D,*".--SEG;:J@;F+,<9))R:Z"BO
MYX?^$LT[_AK;[5]KM_L_VC[+YOG)L^T?V']D\C=G;YOVC_1_+SO\_P#=8\SY
M:_H>K^:']G6WL_\ @G3\<KS1->?R=(OK>:SM-1N'9$2TNI(KBSN))/(1)/F@
M2TN9%$=O#.9W,HC@;/\ 2]7X8_L0Z2?VH/C+XI^*+Q1R:38R2VNEW*I<PK)(
M46TMY8U< .XL(V-U'*08WNXG$";D\KC_ -OK_DX7P%_W /\ T\W%?O\ 45\_
M_M8_\D\\5_\ 8OZM_P"D4U? '_!%3_DGFI?]C!<_^D5C7@'_  7._P"91_[C
M'_MA7[_5^ /[ O\ R<+X]_[C_P#Z>;>OU^_:@^-?_#.WA6Z\3M'YT5C<:?\
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MS!(V8%XS]J#X%R_!_P#9TNO"MG!YMQI^GZ>UTMMYLZM,E];W6H3H7'F>5O\
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MSELX-4@DN)?$<SOLDC"23-;/</*1MMUM@&C92+=2+@@B87-?('@/Q_I?Q/\
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M%)+@176V(L& LI-MV7.T^7&(B\H*F-7#IN^3YM UC]NKP7X[U1;BXETC6_\
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MP_.#3/\ @CU\,K#5#J$@U2>V,DKC3I+P"U"N&"QAXXH[O9'N!C)N"Y*+YCR
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M38YD)A@\K/\ ^'<GPQ_M'^U_[)N/[2^T?:OMG]KZK]H^T;_,\_SOMGF>;O\
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MP41PF.!$152),$M]?_L]?LQ>%_V7].?3_#5IY/G>4;JYD<RW%T\2! \TC?\
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MJ=QJ$J?V1Y2R$+##N6\1O)@C"0P[Q&AD\I$\QE#ON?+']GJ****_!'_@J?\
MM!?%+X07%K90W]GI.B:G)=BR_LJ6?^T)([5K5MUW<R11-"Y9PRI9E $DE@ED
MG50[_M]\0K+5-1T;4(-#FCMM6DL[A+">4 QQ731,()'!20%%D*LP*2 @'Y&^
MZ?A#_@G/\.OBA\/=.U9/B3=7$WFW$!T^&[ODO[B/:C"X<S*\V(I,PK'&93M>
M*5O*CW[YOT?HHHHHHHK/U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,
MS$!0"20!1JTEQ#;RM9QQRW(C<PQRR-%&\@4[%>18Y6C0M@,ZQR%02PC<C:?P
MQ^'WQ^^)6J?M!:;X0\7:G;B*S^T^;8:298M-;S=':Y7(D"S7&"(Y!]J,OE3;
M_*V(17[O444444444444444444444445GZMJUOH%O+>7DL<%M!&\LTTKJD<<
M:*6=W=B%5%4%F9B H!)( K0KY_\ VE/V@K/]F_0_[5GMKB_N[BXCLM-T^V1F
MFO;Z<,8+="JOLW;&+.0Q"J0B2RF.&0^"F@>*+SS-=\7W'E7]WN-OHUO(#9Z5
M;OY9%NTB!?MMW^[5I[N7>B2&2*T6&W>0W'T!17RA\>=6\0?!1Y/&>ERR7^BV
ML<DVO:+(Z%C;1QIOOM-EE(,5Q;QQ;WLBZVEVGFLBPWKF:?V_X5?$O3OC)H=A
MXATI]]EJ%ND\661F3</FBD\MG198FW13(&;RY4="<J:] HHHHKY0_;3_ &F$
M_91\'7/B!8XY[YY([73X)?,\N6ZEW$;S&I(2.-)9V4M&)!$81+&\B-7R_P#M
M _LF_$WQ[X?.KV/C/5$\81Q[WT^PNCI^CNN^20V=JD0AE5T$@CAN[R25YO*4
M3F)) UMT'_!-3]I7QC\?M+U>S\9VDBWVBWBVQOGM_LS32.9#+;2PK''$EQ:E
M560(%(26$21*X,DWZ7T44444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444445^ /\ S=Y_G_H7*^O_ (E_\%<_AK\.]1?3X&U#5_*W"2YTZ")[
M<.KLC(LD\]OYN-H820B2!T=625\D+^A_@#Q_I?Q3TNVUK1;F.\TZ\C$D$\9.
MUER0000&5U8%)(W"O&ZM&ZJZLH\0_:"_:\\+_LX2VUCJDEQ=:O?;/L6DV$!N
M;ZYWRK"OEQ@JB[F8B/S7C\XQR)%YDB%*\/TG_@IAX.AUF+0_$=CKGA:YN(TD
MA?7=/^QQN))1$F2LLK1H6WGSY5CMU$4F^92N#^A]?&'C_P#;E\/^$]4N=&TG
M3M<\37VGR&+48]!TY[Y;&3 V)<2%HX@[$2*%C:0H\,T<@C="M=!\&?VS_"?Q
MXUD^'M'>\&K0V<UU?6ES:2VTEBT$L$,EM<B4*/M"R3["L)F0&*7,@_=^9]7T
M5\0?$/\ ;[\+^#=<F\-:7::QXEU>T\W[;:Z%8F]:T\HQJWG$O$APTHC;RFE\
MJ56BE\J0!6T/@%^WEX._:#U2;0+5KS3-=ADGC.E:I;_9KIC;@>;M"O)$74EP
MT'F"X413.T(CC+U]GT5Y?\7OC1X?^ NEMK/B6^CL+%9$B$CAW9Y)#\J1QQJ\
MLCX#,5C5BJ*\A 1'9?D#P_\ \%)_#5^^G2:IHWB30]+U22*.VUC5=.6VTTM-
M&TD)-T)Y%V2*N5D 9 O[UV2%7D7X0_X(8_\ ,W?]P?\ ]OZ_3_\ :+_;I\#?
MLQ;H-9OO/U)<?\2RR"SW@SY1_>)N6.#Y)5E7[3)#YL88Q>8PVU]?U\8+^W_\
M/KWQ/;>%;+5([VYFCNI9KRW9&T^TCM;5KQWGO&=82AB5_F@,XC='68PD5Y?X
M3_X*H?#KQSXHM/"^GOJ$S7UQ#;6VH?9-EF\TP C3#NMTNZ1A!N:W51(=Q(AS
M-7V?\7OC1X?^ NEMK/B6^CL+%9$B$CAW9Y)#\J1QQJ\LCX#,5C5BJ*\A 1'9
M?C#4?^"G/A?P?>6MMXGT3Q1X;BN_-\JZU;23!"?*4,V!'++,_+(A\J*3:TB%
M]J$L/T/TG5K?7[>*\LY8Y[:>-)89HG5XY(W4,CHZDJR,I#*RDA@002#7SA^T
M%^UYX7_9PEMK'5)+BZU>^V?8M)L(#<WUSOE6%?+C!5%W,Q$?FO'YQCD2+S)$
M*5X?I/\ P4P\'0ZS%H?B.QUSPM<W$:20OKNG_8XW$DHB3)665HT+;SY\JQVZ
MB*3?,I7!^C_VA?VG?"_[+^G)J'B6[\GSO-%K;1H9;BZ>)"Y2&-?^ J9)#'!&
M\D:R2Q^8I/XP_L1?\%!O#FE^*/&WB?QS?_V;+K]QITEI%]GGN-L-L+J-(=UI
M;$'R(F@B\QTC:7&\AG+FOW^\)^*;/QSIUIJNGR>=97UO#<VTNUDWPS()(WVN
M%==RL#M8*PS@@'(KH*^?_C7^T[X7^ GEP:O=[M2N=HL]*M4-SJ-V\GF"%(+6
M/,A\UXVACD?9 9L1M*K$5\X2?\%+?"?AFXC@\5:7XD\+1S1R/;SZSI$L,<[1
M-&'CB$#7$K.!(K$[ BC[SJS(K_?^DZM;Z_;Q7EG+'/;3QI+#-$ZO')&ZAD='
M4E61E(964D,"""0:^0%_;_\ A]>^)[;PK9:I'>W,T=U+->6[(VGVD=K:M>.\
M]XSK"4,2O\T!G$;HZS&$BO+_  G_ ,%4/AUXY\46GA?3WU"9KZXAMK;4/LFR
MS>:8 1IAW6Z7=(P@W-;JHD.XD0YFK]'ZY_Q3XLT[P-9R:AJMW;V-E#M\VYN9
MDAA3>P1=\DA5%W,RJN2,LP4<D"O /V>_VO/"_P"U#>:K;>&)+BXBTC[)YMU)
M 889OM:R,ODB0K-\AB=)/-BB^8 IO0AJT/V@?VL_!W[,MN9?$>HQQ7)C\R&P
MB_>WDX*R%-D"G<J.T3QK/+Y=N) $>9":\O\ BM_P4(\#?!O0]+UK5)[CS=9T
M^VU&RTR*)9+Y[>X$95G0/Y,6 YR99D20Q3+$TKQE:Z#]EK]M_P )?M<?:HM"
M>XM[VSPTEE>I'%<&$[0)XUCEE1XMS>6Q5BT;[1(J"6$R?7]? &I?\%&O"]YJ
M-SI_AK3/$'BK[%@75SH.FF\MX79Y$"-(TD6[=Y3,DD8>"5,-'*^&"_E!^T-\
M=-#_ &B_C3\._$'A^?SK2;^P%=&PLUO,NL3EX)T!.R5,C(R592LB,\3QR-_0
M]\2_BKH?P;TY]5\0W]OI]DFX>;.X7>RHTGEQ+]^64JCE(8@\LFTA$8\5Y_\
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M#A)HV_X$HDC,D$CQR+'+)Y;$>H>/_'^E_"S2[G6M:N8[/3K.,R3SR$[57(
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M'_CUI:ZSX:OH[^Q:1XC(@=&22,_,DD<BI+&^"K!9%4LC)( 4=&8^+WQH\/\
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M.\#6<FH:K=V]C90[?-N;F9(84WL$7?)(51=S,JKDC+,%') KP#]GO]KSPO\
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MC4(;60V]JK0W"& 7CHJ-]J:,21"W:2*=+-Y2V(HRW[/?LG?\D\\*?]B_I/\
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MZI9:3H$9U.S2ZM+B&=XVAN);R&V%T8XBBFW618T\L+-<2/(_[T%>O_X)0?\
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MZ7\-/ NCWUFLDE]K&EZ9=WUY.YEN)6-I'Y,)D/(M[:,B"U@7"0PK@ NTCO\
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M<B1T7ROK_2?VY+?0+>*SL_A[X\@MH(TBAAB\.JD<<:*%1$1;@*J*H"JJ@!0
M  !7YP?\$^?"7B_X4?%FZ^P>'-<TGP?K,FH1F/4+&]BCM[6,37-@9'<F(7$9
M1+=9)7F.)ID5F>7?7U?_ ,%J_P#DGFF_]C!;?^D5]7W_ /LG?\D\\*?]B_I/
M_I%#7XH_\%JOA[HW@ZX\.7FF:?9V=S?R:Q+>S6]O%#)<R;K)M\[QJK2OND=M
MTA8Y=SG+'/[_ 'Q"\:V_PUT;4-<O%D>VTVSN+R9(@ID:.WB:5P@9E4N54A0S
M*"<98#D?EA_P2@_XNW%XH^)&J_O=?U?6)+660_,L%O%%!.L%LTF^:.+,ZQ^6
M973RK:U0 >2"?I#]N/\ 8<M_VT+?2U;5)-+N=+DN#'(+=;F-X[E8_,5H_,A;
M?NAB*.),*/,4QN75H_H^R^ _A[_A'M-\,:A8V^JZ;I5O:P6T>HP0W7_'K#Y$
M<K*\?E^;LR"ZHOWF "JQ%?C#_P $,?\ F;O^X/\ ^W]?I?\ MY?LXZS^U+X.
M;P_H>H1V-S]LM[AUF:5+>YCCW@P3M$&8(&9;A<QR@S01C8I(ECY_Q!\=O ?[
M+V@Z;X UW4(]6U&WTN#2QI-M:->75\T5K%"L#V<?G+$]VKH(8;IT242X$C('
M<?GA_P $,?\ F;O^X/\ ^W]'_!<[_F4?^XQ_[85^_P!17Y0?\%>_CI+\,/ T
M6AV4_DWOB"X-NX'FJYL85WW122,JB[F:W@D20L)8)Y4$;#<R?=_[-?PA3X"^
M#M'\-*L:R6%G&EP8GDDC>Z?]Y=2(TN'*23O+(H(4*&"A$4!%_)'_ (+(_!RS
M\*1:/\1-*;[#K2ZA%9SSVX:.:9A$\]K<&5'79+;?9F1) IE97C!E"V\2U]7^
M+O%&C?M=?!&Y\9ZII=G-?+X;U>6)Y[2)VM+R&":*X>T,AF>%#/;[X6#^846)
MG(=<+X!_P10\ :7%X5U7Q"+:/^UI-4EL6NR"9!:QV]K,L*DDA$,DC.^P*9"(
M]Y;RHMGZ_>"OA[HWPUMVL]#T^STVV>0RO#9V\5O&TA55+E(E52Y554L1DA5&
M< 8["OPQ_P""M/Q>?4=>\,_#T-JATZ]DAN]7M-.2-I[V"6Z6&VAMP<M+<*T-
MPT<#J(6F:V<B1T7ROK_2?VY+?0+>*SL_A[X\@MH(TBAAB\.JD<<:*%1$1;@*
MJ*H"JJ@!0   !7YP?\$^?"7B_P"%'Q9NOL'AS7-)\'ZS)J$9CU"QO8H[>UC$
MUS8&1W)B%Q&42W625YCB:9%9GEWU] >!?&MO^UG^T7>17ZR-IW@JSO%TRUD"
MF,WEK<0VL]Q)$[3)O\Z9Y(98O)DQ;6+MM>$J?T^_:1^"%O\ M'^$]2\*W5Q)
M:1W\<8%Q&JNT<D,J3Q,4; =!)&GF)E"Z;E62-B'7Y0\%?#2S_P""8_PJUN:/
M4/M]Q;_:K\7%Q;LL,E].D=M:1""%GD2)G2VB?,K'<TDAEBC.(O/_ /@D/\-Y
M=(\%W?BR_?[1J7B;4)[B6Z::66:6&VD>%1/YGR^;]H^V2EUW-(LREY&8!(_<
M/^"C/P&TOXU?#[5KB\CC6^T6SN=1L;LQEI(6MD\Z:-2'0[+B.(PN&+("8YC&
M[P1X^8/^"5'Q5M_VB_ =YX,\1VL>I1Z%)!%LNXEN()K.=GEM$D$[RAW@D@D1
M%V)'%#':J@+*Q'Q?^R'\"]#^)/QU\6Z-?08TC3[C6)ETV'$5G.MKJT*P6UQ
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M2M(L+?2[*Y_L,RQ:<@L,M)JT\;2*UIY3I+M50)D*RKM4JX*J1^[W_"@?"_\
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MK=271#?.17C_ /P4"U+7OVF-9T3Q#X2\&^--.U;38Y(YKNXTFZ@DVQRI-9F
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MO^UU\3?%WQ#OED:33X[6ST6&4*5M+.Y-PJE4=IC#<&.W_>&"18R]U>X4K/\
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M'H=O'H=M?1Z,KOI,<5E)')-JEQ$;B(Q(%6X50I24JQ4HG4*!7[W?\*!\+_\
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MCL+G4HY+I+6.02K':S2N]EF0$[G:V,#R-A"79LQ0G]TGXX_\$,?^9N_[@_\
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M\$,?^9N_[@__ +?U[_\ \%J_^2>:;_V,%M_Z17U??_[)W_)//"G_ &+^D_\
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M\0O&MO\ #71M0UR\61[;3;.XO)DB"F1H[>)I7"!F52Y52%#,H)QE@.1^0/\
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MM2L8Y[FQO+[2WNXRD>H6EQ8S3VY7S8F9@@9FNH+>??"Z2PSR6Y+!1^&/Q9\
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M+ _X63_PF5O_ &[]H\[']@#[/L\G[-]G\O\ M#=Y7V?_ $?._P _9\_G>?\
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M=^,-6_M;6K/3QI5DD!*6-AIL;1E8($$</G2R^3 UQ=31^<PBAA!VPF2;Y?\
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MM)(BQ^:]L?V.\ >"K?X=:7;:5:M))';1A3-,5:>>0DM+<7#JJB2XGD+S7$N
M99I))&^9C785^6'[3'_!.NX\5^)8_'OPZU*/P]XHCD\Z161A:W-P64/.S(',
M+O&THN5\F>&\)"R1J9+B67T#5OA1\8_C7;RZ'XLU;PWI&B74;QWKZ%;75Q>7
M5O*IBFM =1!A@26*20_:45YHI$CVHREQ7T_\(?@-I?[/7AI?#OA2..T6.-RD
M\\9G:6Z9<?:KL(\#3NS!2ZJ\(V*L,9AB2-4^$/\ AW;XH_X6!_PLG_A,K?\
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MM<27,TUS())I9I JEW*JD8PB1QJL:(NU 2#(7=O@#]JO_@GSXM\:_$"+XB>
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MO:/'X=N==M]7TBW\]K6/^S#:7$+32"4KYZWDJ/%N:9]KQ&7?+_KQ&BQ5X?\
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MPY+U'PU_IVD>,-NI6W[ZS;^SGML7$?SPGSX[R22'#A3YJ([Q_?5&8!3^A_\
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MZYHVG/=^'K6WO[V#=)]@GE-O]K4(W[F*YPR6\I8HR22QRQ-L,+B$2_:8.?\
M@Y\=-#^.=FUSI$_^D0X6]L)L17UA-N>-H+VV),EO*KQ2IAQM<QLT;21X<^P4
M444444445Y?\7OBBGP@TMM3?3]4U1A(D:6>E64E[=2,YZB-,*J*H9FDE:- !
ML#&5XT?XP_8'_;>U']LV\\0O<Z?;Z=9:;_9WV2&.1YIO])6X$OG3-L23YH T
M>R*'8K%6\PC>?T?HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK\\!^T_XU_:"TNZ
MU;X4Z-9R:=:R2+#?ZZ\UNNJ-"9EDCTZUBVL4++"$NKN>U0.[P/$KQS-#Y?\
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MPK#G_P#@EQ_R2'P]_P!Q'_TY7=?3_P#PH'PO_P )1_PFG]F6_P#PD/V?[/\
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M]0L]2MDD,3S6=Q%<1K(%5BA>)F4.%96*DY 93C!&>PK\8?\ @K_\%-1^+/\
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M-2_[&"Y_](K&OH#_ (*C_P#)(?$/_<._].5I1_P2X_Y)#X>_[B/_ *<KNOR
M_P""DW[*&C_LS>+=,\3Z?I?F^%=2N%>\TZ.22&%;B*027%JDL<>+2*YBYMU1
MW=&6Z,21PPQHO]'WPJ30_P"P["7PS!;V^BW%NES91VUN+:'R;D>>KI"$C\O?
MYGF,I56W,2P#$U^8'[-?[+WA+QK\5_%WBZTTVW&EZ#J%II^CQ0Q1P6<.I6MK
M&NHL+0(A\VWE"&*4J(3)*\\?FRK'+%^O]<?X_P#";^.M+N=,COKS36NHS&;R
MQ>..ZB4D;C#))'*L;E<KY@7>@8O&T<H1U_G!_8W^%>J:O\8?&GAS2]=O+%DC
MU>VN=4<"XU*6UCU>V28QW!:-8KV91S>F.4QLSR)#YI1X_H#_ (*)_P#!.SP1
M\)_!%QXH\+V\FEW.ER0&6(3SW,=U'<SPV^UOM$TC1O&T@D1XS@CS$>-RZ/#[
M?^RQ\(+K]NKP7I&M_$VX_M/2X;<VVF:7!/=PJSVDCVLFIZC,LPFN=0D,3HOS
M^1%$TD@3S;J01_&&O_#)/V"OC_X?L?"L\G]G:U)9@VLS2%8K74[N2SEM699
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MQ\/Q>&K'5O&>FQZYXHU2SMKC5+S6X'N[H2,I>.!DOFG,+V\;K:OL$1D$"&1
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M?VCOB/K/[2'Q@T_X2V,]Y:>'+*-;CQ"+=)4-W&UL;B2">:WF1Q92PRPV?)A
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MX6_#.[_LI+'[2-?UQT EB2)OL]REJCXD'E/((UDBV3RW10Q2V]M$]U+\P?\
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M?AZ=9$N;6S5[J.1XY&CNKAFN;F,/%\C(DTLB1E2PV*OSR'+M]'T5^ /[ O\
MR<+X]_[C_P#Z>;>OO_\ X*C_ /)(?$/_ '#O_3E:4?\ !+C_ ))#X>_[B/\
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M*K.KAV]0K\L/VM_VP?$$WBRT^%7PU\M/%=U)&;O4+E4$%E'Y7VHJBS(Z2/Y
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M (*C_P#)(?$/_<._].5I1_P2X_Y)#X>_[B/_ *<KNO@#]@7_ ).%\>_]Q_\
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MNKF1S+<73Q)IZ!YI&_X$PCC$<$;R2-'%'YC _P!/U?@#_P $,?\ F;O^X/\
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M=1M8[.35(-/M8;=D6<3&T%P88U4N565TC8ET1Q(55)D9_P <?V!?^3A?'O\
MW'__ $\V]?O]7XH_M1?\$H]+^/EQ<>+? ^K1P7>K2-?/%<.9]/N6NFCD,T%Q
M$'EA1PTL_2Z21Y$2,6\(&/'_ -BS]N/QK\*/&-M\,?B.))3)>26GVF],TNH6
M]U/M-M&TRF47-O+(0D3L"-ERDRW7V2)$KG_BOXDN/A5^U7::C/:2/'>WFF6\
M&_=$LD=_IT6F&>-RC"1(I'DSM&'>%X=Z,&9?Z+J_GQ_X+*^ [?QGXJ\(V>DI
M'-XCU*.:R,(G42/&UQ"M@K([A(D:::Z5)6"!SY@9R(?D_0__ (*C_P#)(?$/
M_<._].5I1_P2X_Y)#X>_[B/_ *<KNO@#]OK_ ).%\!?]P#_T\W%?O]17\Z/[
M)7B2X^''[2_B+3KJTD636;S7K<>9NB:*-YFU.*<(R$R)+';IY?*ADF69790%
M?^BZOY\?VK_ =OXA_:7\,1:"D<U]))HU[J:).I99+.9Y96D#OB)TL+:&01#8
M70(ZHSS R:'_  7._P"91_[C'_MA7[_45X?^TWI-QK_@7Q+9V<4D]S/H>IQ0
MPQ(SR22/:2JB(B@LSLQ"JJ@EB0 "37XP_P#!('PYX%^*>C:OH>N:/I>H:W:W
MGVQ'OK.TGD:SFBBB A,H>8I%+$QE 41QFXA^8M*0/V._X9.^'G_0J>'_ /P4
MV7_QFO,/B9J?AK5OA#XDD\("S&B#0]?CMA8Q+%:[HH[N.<PK&JH4,RRGS(P4
ME),JLZN';Y/_ ."*G_)/-2_[&"Y_](K&O /^"YW_ #*/_<8_]L*_?ZOP!_X(
M8_\ ,W?]P?\ ]OZ^_P#_ (*C_P#)(?$/_<._].5I1_P2X_Y)#X>_[B/_ *<K
MNO@#_@N=_P RC_W&/_;"OW^K\8?^"Q/P<O+O1]*\?:0WD7OA^X$=Q<0A8KA8
M9Y(_LTPN Z2_Z/<A5BC0.RO=O,IC"2,VA\1_V@;?]M_P'X0\.6IC-]XRU2WM
M=8MH=J2VUOI3)=ZO+;LTDL4#QF.&:WCN6DFEM9XR()'?Y?V.HHHK^='XK^)+
MCX5?M5VFHSVDCQWMYIEO!OW1+)'?Z=%IAGC<HPD2*1Y,[1AWA>'>C!F7^BZO
MY\?^"RO@.W\9^*O"-GI*1S>(]2CFLC")U$CQM<0K8*R.X2)&FFNE25@@<^8&
M<B'Y/H__ (+5_P#)/--_[&"V_P#2*^K[_P#V3O\ DGGA3_L7])_](H:^@**_
MF1_X(U:3<:!\2]7L[R*2"Y@T.\BFAE1DDCD2^LE='1@&5U8%65@"I!! (K^F
MZOP!_P";O/\ /_0N5^_U?A#_ ,$_/"UY=_'7XB:JD>;*VN-7MII=RC;-=:L)
M(4VD[SN6VG.Y0579ABI9 W[O5_,C^T'I-QK7[4EM%:Q232+KGAV4I&C.PCAM
MK"65R%!(2.-'DD;HB*SL0JDC^FZO@#_@J/\ \DA\0_\ <._].5I7/_\ !)_Q
M39^(/A1I=M;2;Y=/N+^VNEVLOES-=2W03+ !LQ7$+[D++\^W.]65?'_^"U?_
M "3S3?\ L8+;_P!(KZOO_P#9._Y)YX4_[%_2?_2*&OR!_P";O/\ /_0N5^YW
MC_3-+U_2[G3M:,8TZ_C-C.LDIA61;TBV$(D#(P>5I1%'L8.SNJH=Y6OP!^//
M_!*/Q+\"'D\3_#+5KRX:SCDD6V#M!JT:^6D<@M9[8(MR[JT[-&JVS^4! BW,
MKX;[/_X)J_M[:C^U-]MT'Q(MN-:L+>*>&>"-T^UVXVPS22H 8DE24QLY1HTD
M^T 1V\:PN3\8?LH>-;?X0_M(>)[/6EDM)-9O-9L[4S!8E\RYODO;8L960[+B
M.(+;E YF>: (K+(&']%U>7^&?B]I?B_Q!J_AJS:1[[0X[%[XE"L:-?I+)#&K
M'!=Q'&)'*C8!+&H=G$B1_BC^P+_R<+X]_P"X_P#^GFWKZ/\ ^"SVDW&H_#FT
ME@BDDCMM<M99W1&98HS;7<0>0@$(ADDCC#-@%Y$3.YE!^L/V _'7_"Q/A?X9
MO?)\CRM/2RV;]^?[/=K'S,[5QYGV?S-N#LW[-S[=[:'[=.F:7JWPR\3QZP8Q
M;#2[B1#)*8E^U1#S+(!@RY<W*P"./)$KE8BKA]C?'_\ P2#TQ_ 'PMNM4U4Q
MVEC<ZI?7T=Q++&L?V6&""WDF=MV(D22VG#>;L($9?&PJQ\ _:!_X(]7&@7!U
MWX9:E)!<P2?:8=.N9F22.1&DF3[%?+AE=6$,5NEQ@J099+X$5V'_  3@_;V\
M0^.=<7X<^-USJ$%O-%:74T<R7SW%F6:6VO0P8-*L2N?-D$#@VS+*9[B;=7S?
M^T)<Z-X)_:;%YXQLHY="NY+)6%[!$UK)'/I<=E'<.+G;"UO#<9:64DB(P2D9
MDBVU^YW_  R=\//^A4\/_P#@ILO_ (S1X.\'^ ?AAXA&E:)IVCZ;K\^GRW)B
MLK*""X-BDT4;O(T,:E8FE:,*KD"5T8H'\F0I] 5^"/\ P7*TFXFM_"EXL4AM
MHI-4BDF",8TDE6S:-&?&U7=8I61206$<A (1L?M=\)_'7_"T/#VE:]Y/V?\
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M\7Q9T.>SUG3KBTM]1M[BVN["YDB\X0RAX71Y+*XFC'F(2RM#,657'*2 JO\
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M/T,:E8^'-0NM2?S%326N=.AF1@)-C3SF\>V2)BB9:&2YE195;R&99$3\H?\
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M;?2[+1\3Z1X?MXL)+=R1G;J%[%-)</'+"LFVWCD9;B"="X2U*R"[\ _X*9_
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M>>#O"GAZXN_M=Q:?:+Z:XT^*W>WB*W)^S[[]+@2B9(8SYT 0H)MN<QR'G_\
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M  AUQ_9OVC;]D_M72OM'V?[!_9WF_P#'WY?F[/W_ ).[9O\ W'G[?W]?H?\
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M(!K\$?\ @G?I-OH'Q]\;V=G%'!;01Z[%##$BI''&FL6RHB(H"JBJ JJH 4
M  5_0=6?JVDV^OV\MG>11SVT\;Q30RHKQR1NI5T=&!5D92596!# D$$&OY\?
M"WA/3O W[6,>GZ5:6]C90[O*MK:%(84W^'B[;(XPJ+N9F9L 99BQY)-?N=\7
MO@OX?^/6EMHWB6QCO[%I$E$;ET9)(S\KQR1LDL;X+*6C92R,\9)1W5N@\ >
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M:W\.?&DUQ=ZIH_G313SN+B:/R+C[/>6\]UYKF;9+)&;<@2?*9E\[REMT7?\
M^"H_P[\7_P#"(>(=9_X2C_BF_P#B7?\ %/\ ]E6W_/S:1?\ (0W?:/\ 7?Z3
M]W_IC]SFN _8*^#/Q'\5_#C1KW0?'?\ 8VFR?;?(T_\ L"RO/)VWMPK_ .D3
M.)'WN&D^8#;OV#Y5%?I]^T[^T+IW[+_A>[\2Z@GG>3LCMK42I$]U<2G;'"A<
M_620JLCQP1RRB.3RRI^0/A5\(O&G[7&AV'BOQAXJUC1/[0MTN;+2?#DL>FPV
MT,H^5Y9PUU+=^?$L%RBS,&M6DEC &XHGS!\2_C]\0/\ @F[XMT^Q\1:G<>)_
M U]]H^R-<F&34A$)%>7?.P6:2[MC*@7SG-K<0N$3[.QVV?Z/_M8_$/Q;HG@V
MXU_P!-H[Q1:?=7\]_=2R2XM([9IDDL(X8Y(9Y7'[R*2=_LXV*&CF24M%^:'[
M$'B#XL_M=^%=6A3Q))I5L^J7;W.NR*+V\EDGMX!_9]E;EXEL+>%6>X,T+1%)
M)H$M5C"3FO8-(^'WQS_98\"Z[>7'B'2]7N8H[F]::_N;V\DLK:VM':1K-YK?
M=-<2MADBN"+2W-LIV3&\F\GS_P#8/^*/Q4_:.\*WL%EJ4EO/<ZY>S7GB>]$-
MZ+1%M[-TL+#3GD +R2.S,&2&RM;=I/)WSNJ1>'_$?QA\2O\ @FOXYTFYU[Q)
MJ'B3PW?\,;B>6?S[=&B%ZBVEQ<OY%W#O1X)%E"/NC!E*/<VZ_?\ \2_A/\5?
MVL=.?5;/Q!<>"+5]TNEZ(D+QWC*B,()=4O;>9)K>6<N3-:1B>*UC\D-'+=12
M5Y!_P2Y_:7\4>(-6UOX<^-)KB[U31_.FBGG<7$T?D7'V>\MY[KS7,VR62,VY
M D^4S+YWE+;HOU__ ,%"/VE+S]E[P-/JNE\:I>7$5A8RF-94AFE5Y&E=691\
MD44ICR)5\_R@\3Q%Q7R_X3_9$\6_&3P-:>)(/B!XHB\3:QI\.I1C^T9+?2TF
MNU%RL'V6 ;XH@KB#="^V,CSDM]@%K78?\$NOVP?$'[4>EZK9^)?+GOM'DMB+
MY%2)KB.\,Y59(8T2)7B,+*'C"AT9 8PZ/)+^:'_!6SX:^*/!VHZ+J'B7Q'_;
M?V_^T1:VT=@+&WL$B>!RD,:SS[]WGJIDD)G9(8UDEEVJ5_<_X5?"_P"(?@"X
MNKO7/%T?B:,V<J6MA+I-KI4?VK<C12/=6HGE5,*T; 1R "0R;'9%4_FA\/OC
M]\2M4_:"TWPAXNU.W$5G]I\VPTDRQ::WFZ.URN1(%FN,$1R#[49?*FW^5L0B
MOW.U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!7Y0?!GXH^
M+/\ @HZ^J7EGJ5YX4\%65Y]E@&G")-6OV$:RGS+TR2M9O"P@E*V\6R2*YDM3
M+/L:4<!^U-X/^)'["U@OB[PAXJU36=$BDMAJUGK\\>H2(?.V1-&\J(PMY6E6
M"=+8PW"DI)YDB_-:_?\ \(?VBKC]IOP&OB;P=#9KJT\;Q+9W]RWD6MXC;)$N
M7MDDE**")XU"127$+0DBV\[='^2'P"_:N^*OB3XIZ]HMR?[:U>&WU#3+6RA=
MX=#L9X=0C!O;A5"/]DMU$RB9UDO[A6AM/,\R92O0?MJ?"/XP_LY68\>6_CS4
M-6BMKB WT: Z=#;_ #116[BP2>2SGB>3;'/&(QN9U9XIDDG>/]?OV6/C7_PT
M3X+TCQ.T?DRWUN?M$878HN(9'@N/+7S)2(C+%(8=SLYB*%L/N ^@*^ /^"@_
MPU\4>._"6KSZ7XC_ +(TBST>^GO;"*P$DU_Y,;3M$]X9T>&)UC$12*,;E>82
MF>-Q$GYP?\$O_A5X[\<^#;VY\,>,?^$>LEUB>.2T_L6TU#?,+:T9IO-G=77<
MK(GE@;1Y>X'+FOU/_;C_ &N[?]D'PT-12*.ZU:]D-OIUJ[JJF0*6>>50RRM;
MPC;YGE#+/)#"7B\X2IY_I/[)OBSXLV\6K^,_&?B2PU:XC1WT_0KJ+2[.Q611
M(;,)$+D7+P2/)']K>1GFC6,$G8&;Y \'?M9^-_V,?B#!X#^)FHQZQHEY':QV
M&JMY$,D-N[M!!>S2$JQ0LK)?B\=YD,;3I/*JYN_W.HK\4?\ A;7B#]M7XO:S
MX%M=>U3P]X:T".Y8KI92TOKFXL9$LY2UVID<(T]P[J/FA>WAA#6R7!,R>7_M
M)^/_ !S_ ,$T/%&F7EIXBU#Q+X;U?<S:?K-RUS<?Z&$6>+[0Z'R<_:5DAFMQ
M'E]J3P3) OG_ +7?%Z3Q4FEL/!T>EOJS2(%;59+A+5(\YD8K;1O+(^ $5 T0
M!;S#(?+\J3\,?V!_VG?BA^T%>>(;"&[N+S5-0_LX?VO=(C:;HEO&MPD]PEHF
MR%KN4>4+6TB1$N9D>>X;RH)BV?\ M8Z3\7OV$]4T[QC_ ,)A>:_IUQ>,)5N'
MDBM?M4@ED:UETW[1)#]GDB60Q-;[!"58(+5X[9W_ &?\97>M_'GP5;:IX'U2
M30]1U"SMM0T^:>WMYE*S0B5+>[CDCN55'5P'>'<\3A74RHK0R_F!_P $Z_VC
M/'W[0_BK4M'\7^)KRVN=(C2;^R5TJP@DG,5P(KE+B5K+="D3;(981Y5PYGW1
MRQF!\_J=^U)J&I^'_!NLZKI&HW&FWNEZ?>W\4L$=K)YC6UM+(L4JW=O<(8F8
M*7V".7Y0%E4%@W ?L2CQ?K/A*SUWQEK?]KWNL6]O>P1I;6UO#:6\T8DBC!@@
MA>25E<-.SY16"Q1KA&FG^OZ\_P#BK\2].^#>AW_B'57V66GV[SRX9%9]H^6*
M/S&1&EE;;%"A9?,E=$!RPK\X/@='XT_X* Z./%&M:YJ'A;0)KBX73-,T"2.V
MN)%@D:-+JXU$F69^6GMI;?RK>*1X(KE8D^7=XA^T=XI^)'_!."_T_6++7;SQ
M+X*NKQ4FM=8FCN+P7#0G?;O=M'YZHZ1/-;208ABD1EFMVZW?Z'^,&UC]KCPE
MIVH>!?$W_"/66IVYFFN4LH[R[*2Q[#;B1;I4M986,BSF(O/'<1JJ31&)Q)^(
M'_!*3X=^+_'O_"1_\(IXH_X1OR?[-^T_\2JVU'[3O^U^5_Q\,OE>7MD^YG?Y
MG/W!7ZO_ /!1O3KS2/@AJUMJ%U]NO8;?2([F[\I8?M$R7]FLDWE(2D7F,"_E
MJ2J;MH. *^4/V(-*\>?'#X8:9X=\-WLGA/2;./4([G7'MEN+F_GN+RY;R-/C
M,D9BMX8Y<S7P=)OM86&#;Y$[GS_X3?%3X@_L6?%ZT\$^,=9O->TG6Y+>""6>
M=[MGCN9)(+*ZA$\Y>U<3YCNHBS#8)2$N=EK-7[??&CXO:7\!?#]]XEUEI%L;
M",/((D,DCL[K''&B\ O)(Z1J6*HI8,[H@9U^ /A#\/O&/[;&EKXQ\3^(=<\-
M6-](\NBZ-H=S]@:WLR=BO=SO;^;=O,(UFB9AY81C-$52Z\B#P#P=^TYXL_85
M^(,'P^\?:M)KWAZ]CM39:Q=F**X@6Y=A]JEDDFD<VZSF:"=;N9GCAA6>$I$@
M@F]/_P""I7QL^)7P4TE;O0[K3]-T"ZN(K$7%N\KZO)+-;W#R9+PB&VBPA"-
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M>\;2:SX>>.<O;2&?=<23*&VBR<O:V*1RDO&]K(Q"1+"L<<4\B1^0?L]:Y?\
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M<ZUK5S)-;:79F2>>0P)/<-&H   %O ;B=\)'&@A1YI%C14#*H_/#X'1^-/\
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M2.T+)'&D/FVX";C%MS%-!OC5\RS'Q#_:E\1_&?XBS?"_X?7-OIWV"WEEUCQ
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M@)EFC-N+II$B>"V?S1Y!^PY^V3X\_:)\-'P?IZ23>([6012^)+F%9+6PTUE
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MNDDCCE6=/,:./ T_X1?&;]I_P#HVI6GBK_A'W_L_3FLK%)9O.O%2!$-_?ZM
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M_<._].5I1_P2X_Y)#X>_[B/_ *<KNO@#_@N=_P RC_W&/_;"OW^K\ ?V!?\
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MSW$9AN#\H?\ !#'_ )F[_N#_ /M_1_P7._YE'_N,?^V%?O\ 5^ /_-WG^?\
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MJPK9L8[>*)(P[F2:3S+IUC>>-+=3%'Y(!_J-K\ ?^"&/_,W?]P?_ -OZ]_\
M^"U?_)/--_[&"V_](KZOO_\ 9._Y)YX4_P"Q?TG_ -(H:_&']M6UB_8G^-NA
M_$2TL_\ B6ZENN+I56(AYMK6FIB"%&A82FWFCN \S;9+R=I&D=?,1?T/_;,U
M:W^,[^#? MG+'<6/BW5$NKIU=3:W>CZ7&M_<Q+<1%I5>8>0]M);[=Y4@SQ(2
M6_0^BOR@_P""R7BF\\/_  UBMK:39%J&L6EM=+M5O,A6*XN@F6!*XEMX7W(5
M;Y-N=C,K?6'["VIZ7JWPR\,2:.(Q;#2[>-Q'$8E^U1#R[TE2JY<W*SF23!$K
MEI0SA][9_P"WYX%_X6)\+_$UEYWD>5I[WN_9OS_9[K?>7C<N/,^S^7NR=F_?
MM?;L;Y/_ .",.K7&H_#F[BGEDDCMM<NHH$=V98HS;6DI2,$D(ADDDD*K@%Y'
M?&YF)^</^"&/_,W?]P?_ -OZ^_\ _@J/_P DA\0_]P[_ -.5I1_P2X_Y)#X>
M_P"XC_Z<KNO@#]OK_DX7P%_W /\ T\W%?1__  6>U:XT[X<VD4$LD<=SKEK%
M.B.RK+&+:[E"2 $!T$D<<@5L@/&CXW*I!^S1^QU;_$7P5H&JVOCKQI''<Z79
ML8;'7E6U@D$*K+;PHL#"-() \/E9)B,9C;YE-=!XU_X)+>%?B5<+>:YXB\6:
ME<I&(DFO-2M[B18PS,$#RV;,$#,S!0< LQQDG/'_ /!:O_DGFF_]C!;?^D5]
M7W_^R=_R3SPI_P!B_I/_ *10U] 45^ /[ O_ "<+X]_[C_\ Z>;>OW>\6>%K
M/QSIUWI6H1^=97UO-;7,6YDWPS(8Y$W(5==RL1N4JPSD$'!K\(?^"&/_ #-W
M_<'_ /;^O'_@?X-_X7C\?/&.GZAXAUC2+A[C64MKG3M1^R7D_P!FOHTCLUD=
M9&DB2WC+"!1\D=LK#;'"0/U/U;_@G?;Z_;RV=YXW\>3VT\;Q30RZZKQR1NI5
MT=&MBK(RDJRL"&!(((->H?LI?L5>'OV/O[1_L&YU"X_M/[-Y_P!MEADV_9O.
MV>7Y,$.,^<V[=NSA<8P<_F!^P+_R<+X]_P"X_P#^GFWK]_J_G!^*O[&7Q5_8
MNUR_\0_"^:XET6XN'DCM=.+SS10L=D,-UI\_F_;/*^T21PR 7;*L;73BW8\?
M9_[#W_!2+2_VG-4M-%\0Z?'9^+6CO4M;BW@+6LL&$N)(HG=Y)[=V2$/+&Y:&
M0VJR>=YC10)\P?%'QY;W7[5>GQ>(7CEL;"2RLK%)(%D6.2?3O-M% 1"2_P!O
MNA)'*^3"[*^]$B4I_0=7\Z/_  6F\-W'A#Q5X:\56=W)#<S6<MO"(MT<EO)I
MUP+A)TF5]P<M>#;M"F,PA@[%\)]7_P#!:O\ Y)YIO_8P6W_I%?5]_P#[)W_)
M//"G_8OZ3_Z10U^0/_-WG^?^A<K]_J***_F!_:6_Y.AM?^Q@\,?^BM.K^GZO
MP!_X(8_\S=_W!_\ V_KW_P#X+5_\D\TW_L8+;_TBOJ^__P!D[_DGGA3_ +%_
M2?\ TBAKZ KY_P#VG?B1X2^%GA>[U#QJEO<:1\BM9SPQW'VN8'S(8(K>7Y)9
M2R!T#85-AF=HXXGD3XP^'&N?%G]M2W@UEKJ/P+X2NXW\J"V07.L7EO(L*F07
M$\:K;(Z^>UG=PK#-'E)/L]Q&8;@_*'_!#'_F;O\ N#_^W]=!K/BF\\0?M;65
MM<R;XM/MVMK5=JKY<+:'-=%,J 6S+<3/N<LWS[<[%55_=ZOP!_8%_P"3A?'O
M_<?_ /3S;UT'_!0/Q3>7?QU^'>E/)FRMKC2+F&+:HVS76K&.9]P&\[EMH!M8
ME5V94*6<M^[U?@#_ ,W>?Y_Z%ROO_P#X*C_\DA\0_P#<._\ 3E:4?\$N/^20
M^'O^XC_Z<KNO@#]OK_DX7P%_W /_ $\W%?O]7X _\W>?Y_Z%ROT?_P""D/BF
M\\'_  H\1W-C)Y4KV\%LS;5;,-W=06LZ8<,/GBED3<!N7=N4JX5AY?\ \$D]
M3TN_^%=C'IXC%S!>7T>HE(BC&Z,QD0R,57S7^S26H$@+@($BW QE%^[_ (L>
M!?\ A:'A[5=!\[[/_:>GW=EY^SS/*^TPO#YFS<F_;OW;=R[L8W#.1^*/_!#7
M5KB:W\5V;2R&VBDTN6.$NQC225;Q9'5,[5=UBB5V !81Q@DA%QG_ + O_)PO
MCW_N/_\ IYMZ^_\ _@J/_P DA\0_]P[_ -.5I1_P2X_Y)#X>_P"XC_Z<KNOO
M^BBOP!_;Z_Y.%\!?]P#_ -/-Q7[_ %?@#_S=Y_G_ *%ROW^HKS_XJ_#33OC)
MH=_X>U5-]EJ%N\$N%1F3</EEC\Q7198FVRPN5;RY41P,J*_%'_@D)\6'^&NJ
M:[\+=;2.UU&*\GNH%+QEFNK<+;7UL9!,5E=5ACDA6!'!2.ZE:0HJ8^[_ -F[
M_B[?Q%\:>-)?FBTVXC\*Z8'^2:!-/Q-J*E(_W;Q374B2P2R-)/M#*1"G[L^/
M_P#!9+Q3>>'_ (:Q6UM)LBU#6+2VNEVJWF0K%<703+ E<2V\+[D*M\FW.QF5
MOK#]A;4]+U;X9>&)-'$8MAI=O&XCB,2_:HAY=Z2I5<N;E9S))@B5RTH9P^]L
M_P#;\\"_\+$^%_B:R\[R/*T][W?LWY_L]UOO+QN7'F?9_+W9.S?OVOMV-^:'
M[".K7&H_L[>-HIY9)([:/Q!% CNS+%&=*BE*1@DA$,DDDA5< O([XW,Q/M__
M  14_P"2>:E_V,%S_P"D5C1_P6K_ .2>:;_V,%M_Z17U??\ ^R=_R3SPI_V+
M^D_^D4-?0%?@#_P7._YE'_N,?^V%?O\ 5_/C^W=I-OIW[1/@F6"*..2YD\/R
MSNB*K2R#598@\A !=Q'''&&;)"1HF=JJ!T'_  7*U:XAM_"EFLL@MI9-4EDA
M#L(WDB6S6-V3.UG19951B"5$D@! =L_;^D_L-V^OV\5Y9_$+QY/;3QI+#-%X
MB5XY(W4,CHZVY5D92&5E)# @@D&N?T;_ ();>%=.\2V?BRZUKQ)J.K6=Y:W@
MFOKZWN&EDM&C:(3.UH)70"-$QO!" *K+@8^,-?\ %GV;]K:W_M"[VV\'EVMM
MY\V$C\_0SY<$6\[5\RXG.R-<;YYC@&20Y_?ZL^35K>&XCLVEC%S+')+'"742
M/'$T:R.J9W,B-+$KL 0IDC!(+KG\ ?\ @C5X\M_&?BKQ=>:L\<WB/4HX;T3&
M!1(\;7$S7[*Z($B1IIK5GB4H'/EE4(A^3^@ZOYT?A/X;N/A5^U7=Z=!=R/'>
MWFIW$^S=$LD=_ITNIB"1 ["1(I'CQN.'>%)MB,%5>P_;Z_Y.%\!?]P#_ -/-
MQ7[_ %?@#_P0Q_YF[_N#_P#M_7O_ /P6K_Y)YIO_ &,%M_Z17U??_P"R=_R3
MSPI_V+^D_P#I%#7X _\ !+_X7?\ #16H^)?MWBGQ!I.I'[)=-_9>J_9;B^\Q
M[GSY[C>DLEQY;M'F0_<>X.XEIEK]7_%/_!-G3O'-G)I^J^,O'%]93;?-MKG6
MDFA?8P==\<EJR-M959<@X90PY -?2'[+_P"R_HW[)FC3Z'H<]Y/;3WCWCO>/
M$\@D>**(@&**%=FV%2 5)R6^8@@#Z/KX0_;(_:F\-?LY7&E/+I<>O>,))"FB
MZ=$BF\1;EA!+(DWE32VZ2@>2HC1GNY (51D29X?A#]M+X??%#Q!\,]:\1>/]
M;M[6)/[.EA\-Z3"BVT;O<6<(^U7;;YIMADG9[823P?:5AGCN&2-(U^W_ /@E
MQ_R2'P]_W$?_ $Y7=?&'_!8SP5<>"KCPQ\1]):.#4=.O%LS.2SR>8C->V!6%
MU> I$\5TSE@"QDC5EE0?N_O_ ./7[3#Z+\/K/Q!X<CD.K>)X["U\.P2^6DAO
MM60&UWEEFMT>)&:=EF;[.YA,)E&]6/Y0? /PW<?\$\/CA:^$)+N1]$UZSM+<
MS3;B+J2>+;#.D%N[")_[1CEMH?/$A@MY9=SE7-R?TOT[_B\GQMNI)/FLO FC
MQ0Q1R?(R:IK:F1KB$Q_ZV(V2>1(+A@(Y<&.$DF:OK_XJ^*=#\%Z'?W_B:2WB
MT6*W<7IN5#PM"XV-&\9#>;YF[RUA"NTS.(E1V<*?S0^%/Q;^)'[8EO%+X!BL
M_ O@JSD^SVM]/:1W=Y<QVZS1JMK:,HM%MUQ!'+&NT02(Z0WEQY4L"_*'_!-G
M0/\ A%/CKXRT_P"T7%W]DM]:@^TW4GFW$WE:M:IYL\F!OE?&Z1\#<Y+8&<5]
M/_\ !:O_ ))YIO\ V,%M_P"D5]7W_P#LG?\ )//"G_8OZ3_Z10U^2/\ P7*U
M:XAM_"EFLL@MI9-4EDA#L(WDB6S6-V3.UG19951B"5$D@! =L_;^D_L-V^OV
M\5Y9_$+QY/;3QI+#-%XB5XY(W4,CHZVY5D92&5E)# @@D&N?T;_@EMX5T[Q+
M9^++K6O$FHZM9WEK>":^OK>X:62T:-HA,[6@E= (T3&\$( JLN!C]+Z*_ ']
M@7_DX7Q[_P!Q_P#]/-O7Z_?M8_\ )//%?_8OZM_Z135\ ?\ !%3_ ))YJ7_8
MP7/_ *16-> ?\%SO^91_[C'_ +85^_U%?G!_P5+^!<7Q@^'5[?10>;J6A?\
M$PMG7RE984P+U6>0;O*^S[YFBC9&DEMX,;V18VY_]@G]K;3O$OPE;4+P?Z1X
M/T^2#4+: )YIM["W+V\L<;3%CYMO&%#R&%)+J.X50L:9'N'[ G@JX\,^ [+4
M]1:.75O$4DVO:C<1EML]QJ;>>DA0JB1OY!@CDCA1(5=&VALEW_,#_@J+X\M[
M#XN>"[/7WC?PY81V%[<PRP+-&(Y]1=;UG14=YD>&UB5HB'!"$*F7?=_0=7X@
M_P#!;WP+_:'A[P_KWG;?L6H3V7D;,[_MT(F\S?N&W9]BV[=K;_-SN79A^/\
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MG7_B2:;[#X3MO+CL]:O<VR:E<!)I+J&RMI56YE\@1*@(0O<3^?#%&QMV9_R
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MV\6M2ZQ-<PV4CA)IH7LX 'A5L>=C[-,9%BWM$J!I BNA;[__ &Y_BKH?PW\
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M5\*?B(?[$O=,N)VLI[QXH;>-7_?R6LDN%1=S-)<V]P[R17*3;$E4"V6;W_\
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MF>XE@EVO)$]Q] > /^"U_A672[8^(=*U2/5O+ NUL8K>2U,@)!:%IKJ.4(P
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M4TZ/3=+TRT6>_@C@CO&CM(PTUF!*\LEO@*R3ND:2!UV%F658_L^OPQ_X+<^
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MH=YX9L/#,-_;RZU%K$-S-91N'FAA2SG!>95SY.?M,)C678TJN6C#JCE?O_\
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M9%VX<LVX'<<]!I.DV^@6\5G9Q1P6T$:10PQ(J1QQHH5$1% 5450%55 "@
M"M"O+_!7P0\*_#6X:\T/1-+TVY>,Q/-9V-O;R-&65BA>*-6*%E5BI."54XR!
MCU"BBBBBBBBBBBBO+_&OP0\*_$JX6\US1-+U*Y2,1)->6-O<2+&&9@@>6-F"
M!F9@H. 68XR3GL/"WA/3O UG'I^E6EO8V4.[RK:VA2&%-[%VV1QA47<S,S8
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M! \L;,$#,S!0< LQQDG/H&DZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515
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M22(NI.Y1(DB$@;D9<J?YT?A;X _X5?\ M2V^D?;]0U/[/YG^F:E<?:;R7S-
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MS6$\%^!]+_X2/QC+;RSO:+,L5OI\(C+1SWTK%47<S1%+<O"TB.N9H6FM?/\
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MO^91_P"XQ_[85^]VDZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515 554 *
M   *_!']@7_DX7Q[_P!Q_P#]/-O70?\ !4K6O^%J?$/P1\.;EKB'3;JXM)KI
MX9\>9_:-Z+($1,C1B6!(9C%*XD_X^778J[O,_=ZOP1_X+3> [C0+CPUXVTU)
M(+F"26REU"*=DDCD1A=:>J*'#*ZL+V198E!4@!W!$(KZ?_;8\:W'Q*_9WFUR
M\6-+G4M+T"\F2(,(UDN+JQE<(&9F"!F(4,S$#&6)Y/H'_!*S2;?3OA)HLL$4
M<<ES)J$L[HBJTL@OKB(/(0 7<1QQQAFR0D:)G:J@?"'[?7_)PO@+_N ?^GFX
MK]_J*_"'X!:U_P +_P#VFM>U.]:XC_X1VWU"&QA\_P Q%^QM'I3#YD^6*3S[
MBZ\J/9LGER7?YS)^[U?S@_$6'4?V7_VFK6?2HOLMIX@U"Q/EF9W2ZM]79(+U
MW59=W_'W]HFCCEPD<\,4@B,2Q _7_P#P6K_Y)YIO_8P6W_I%?5]__LG?\D\\
M*?\ 8OZ3_P"D4-?0%%?DAIOB3X;_ /!.2_U3P[X0M-4USQ5K$BW']B6?F7EP
MB)#/-;0%E3;#;Q+O8Y%Q?B&=9Y$N(MC+\(?M'^(O%'BOXZ^![WQ7I=OHUW)<
M:%]GT^&Z%X\-NNK2J/M%P@$3RO*)I!Y("+ \*-^]62OW>_:Q_P"2>>*_^Q?U
M;_TBFK\\?^"*&DV\/@75;Q8HQ<RZY+%),$42/'%:6K1HSXW,B-+*R*20IDD(
M +MGP_\ X+G?\RC_ -QC_P!L*_>[5M)M]?MY;.\BCGMIXWBFAE17CDC=2KHZ
M,"K(RDJRL"&!(((-?SX_L5747[$_QMUSX=W=Y_Q+=2VV]JS-$0\VU;O3#/,Z
MPL)3;S26Y2%=LEY.L:QNOENOZ/\ [8?_ !>37/#7PO7Y[+6;A]1UX1_O&32]
M,*S)#,B;98(KRY$<$=XLD)CEB*)YI9HZ^_Z*_(#_ (+5_P#)/--_[&"V_P#2
M*^K[_P#V3O\ DGGA3_L7])_](H:_''4])M]:_:Y$5U%'-&LD4H21%=1)#X?6
M6)P&! >.1$DC;JCJKJ0R@C]COVL?^2>>*_\ L7]6_P#2*:O@#_@BI_R3S4O^
MQ@N?_2*QKZ0_:N^%7PWT+6=(^)OCBZDLIM"DABMW$LGESR+*TUJC6\2232O#
M*9+A%MPI($C3B6WC*I\(?MI?M->*/VB_AGK5SIOA:XTKPB?[.E.K:M*(KFZB
M:XLWC6UL4#'YY98G2Z\V6U>VBF 83LJ)]O\ _!+C_DD/A[_N(_\ IRNZ^ /^
M;O/\_P#0N5^E_P#P4/\ &MQX ^%?B6\M5C>22S6S(D#%?+OYHK*4@*RG>L<[
MM&<X#A2RLH*GX _X)^Z3\7-.^'FFR^#HO!<>DW,EY*KWZ:BM]+(+J6*1[DVP
M$3N#&(XV&2+>.%"?EP-#]JW]BKXR?M@_V=_;USX/M_[,^T^1]BEU./=]I\G?
MYGG039QY*;=NW&6SG(Q[_P#MW:!J/A3]G^[T_5[C[7J5II^AP7ESYCR^=<17
M=BDTOF2 2/O<,V]P';.Y@&)%>@?\$N/^20^'O^XC_P"G*[KW_P#:Q_Y)YXK_
M .Q?U;_TBFKX _X(J?\ )/-2_P"Q@N?_ $BL:^L/VTO@%X#^+6EVNM>/II+7
M3O#TCW1G2=H5,4A02VT@4,SI.R1(%A"W3.$C@D1Y"K_)_P ;?VP]<_:(\)>)
M8O _AJXE\-_V/J*W'B34W-G;-"D=TMPUE;;3+=[XH'CA961H;F2,74$*(P<_
MX(J?\D\U+_L8+G_TBL:\ _;Z_P"3A? 7_< _]/-Q7[_45\ ?\%1_^20^(?\
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M%U6\6*,7,NN2Q23!%$CQQ6EJT:,^-S(C2RLBDD*9)" "[9\/_P""YW_,H_\
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MR1YT5S>M(P\P2R6S0-;BYD <#]/Z*_(#_@M7_P D\TW_ +&"V_\ 2*^K[_\
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MD93(VYW.6.78\GL*_ ']OK_DX7P%_P!P#_T\W%?O]7X _L"_\G"^/?\ N/\
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M659575+91)&6 WQ/C?#,F8IXBDT3O$Z.W0?\$N/^20^'O^XC_P"G*[K\T/\
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M5XCLKS4I%DFDC%QJ^J/'"T[!I!!%]L\J!&*K^[A5$ 5%"A54#H/A#^R9X1^
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ML0>$OV1_M4NA)<7%[>862]O7CEN!"-I$$;1Q1(D6Y?,8*H:1]ID9Q%"(^/\
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M4< "OH_X7_![2?@Y;_8]'^V);".&)(;C4;Z]CAC@4K&D"7EQ.L"*IV[81&"
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M9_\ PBUG%IW]E01_9K(6_P!FCBM6:U\J$)Y:I T!C>#8N!&T)1HL H5*@CY
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MRPH4DC>")T,KB*9 &:7]'])TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ
MJJH 4    5H4444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444445GWNK6^G/#%/+'')<R&*!'
M=5:601O*4C!(+N(XY)"JY(2-WQM5B//_ (O2>*DTMAX.CTM]6:1 K:K)<):I
M'G,C%;:-Y9'P BH&B +>89#Y?E2?EC_P24^/WBC]H"\\6WWB?4[C4)4_LCRE
MD(6&'<MXC>3!&$AAWB-#)Y2)YC*'?<^6/[/44444444444445^0'_!4KXV?$
MKX*:2MWH=UI^FZ!=7$5B+BW>5]7DEFM[AY,EX1#;180A&@9KI)(XY5G3S&CC
M_0_]F35KC7_ OAJ\O)9)[F?0],EFFE=GDDD>TB9W=V)9G9B69F)+$DDDFO<*
M_/#_ (*)_%;X@_!CPQ<:YX1ETNSTZTC@-Y=S[YM0$DUU#"BVMN\+6@0;@)7G
M:0NDC[(XGB5Y.P_X)P^+-1\<_"W0M0U6[N+Z]F^W^;<W,SS3/LU"Y1=\DA9V
MVJJJN2<*H4< "O#_ -N?X7?&7QQXJT*Z^'FH26NDPQH)A'>I;1P70N-SSWL3
M8-U;F/R<1;;L 13K]G'FXG_4^BBBBBBBBBBBBBBBBBBBBBBBBBBBBBOG_P#:
M4_:"L_V;]#_M6>VN+^[N+B.RTW3[9&::]OIPQ@MT*J^S=L8LY#$*I")+*8X9
M#X*:!XHO/,UWQ?<>5?W>XV^C6\@-GI5N_ED6[2(%^VW?[M6GNY=Z)(9(K18;
M=Y#<>(?M,_M#ZSI'BS0/AOX1FL[;7=?CN9I[Z[BEF73[..*8B>&$!8IKAC#.
MT"R.8P]N(YH_+G61/C#]M'X-?%#]F_\ XKKP5XL\0:G:6_G2ZG:7MPES]G\S
M?ON8[,1)9/:*KD-$MN/L>U9T!B#-:_I]^RQ\6=1^.G@O2/$FJV7]GWM_;F26
MW <+\LCHLT8D <13JJW$()?$4J 22C$C_0%%%%%%%%%%%%%%%%%%%%%%?D!_
MP5*^-GQ*^"FDK=Z'=:?IN@75Q%8BXMWE?5Y)9K>X>3)>$0VT6$(1H&:Z22..
M59T\QHX_T/\ V9-6N-?\"^&KR\EDGN9]#TR6::5V>221[2)G=W8EF=F)9F8D
ML2222:]PHHHHHK/O=6M].>&*>6..2YD,4".ZJTL@C>4I&"07<1QR2%5R0D;O
MC:K$>?\ Q>D\5)I;#P='I;ZLTB!6U62X2U2/.9&*VT;RR/@!%0-$ 6\PR'R_
M*D_+'_@DI\?O%'[0%YXMOO$^IW&H2I_9'E+(0L,.Y;Q&\F",)##O$:&3RD3S
M&4.^Y\L?V>HHHHHHHHHHHHHHHHK\X/\ @HQ\.OBA\0M.TE/AM=7$/E7$YU"&
MTODL+B3<BBW<3,\.8H\3+)&)1N>6)O*DV;X?K]+?Q;I'A*"&)]/O?%D>GV\<
MDUR\D-C+?"-%FF<P0>9Y6_?*L<<41D $8-N&WQ_E#^PO\?O'/Q0^,GB/2/%V
MI_:/[,T_4K?[':EH].BEMM3MX]T$.$W[=\B1SSJUTT)"R2'&!^WU%?@C^T-^
MT%\4O#7Q<\*>%]<O[.PTZ\U32;E++199_+>VFU&2W$=W<RQ03SNR!HYXP$M)
M0L;_ &=7R!^]U%%%%%%%%%%%%%%%%?EA^PQ\+OC+X'\5:[=?$/4)+K29HW$(
MDO4N8Y[HW&Y)[*)<FUMQ'YV8MMH")8%^SGRL0?J?117Y8?%'X7?&75/C+I^L
M:/J$B>"DDLBZ"]1+6.U1,7L$]D?FFN)6\_RI?*F*F:W(N(?)_P!&_4^L^35K
M>&XCLVEC%S+')+'"742/'$T:R.J9W,B-+$KL 0IDC!(+KGP_]J?0/%'BGP7J
M]EX+N/LVORVX%I()!$W$B&5(Y6!$4LD0DCAD)3RY71_-AV^:GF'[!O@WQYX%
M\'+:?$.YDN-6^V7#PB:Y6[N(K5MFR.>X4N)'\P32*?,F*PR1Q[UV>3%]GT44
M44444445X_\ '[XQV?[/_A?4_$]\N^+3[<R+%EE\Z9B(X(=R)(4\V5XXO,*,
ML>_>PV*Q'P@?@K\0?VL/!5KXEN/&%YHVNZA9QWVF66CR/8Z3!'<PPR10W.P&
M^N'=5W22O,XMI9G$,,D<9%QQ_P#P3?\ V@OB+XAUS6? 7CVVN)KC0[>-C?3I
MB:W93%%':SRHICN//0M<V]PSF698YI?-N8W5XOU_K/DU:WAN([-I8Q<RQR2Q
MPEU$CQQ-&LCJF=S(C2Q*[ $*9(P2"ZY^8/VR/%OC7P+X5O=3\&'2XI+*SO;J
M]N;]IFDB@@MWD_T.".)XI+C(+(UPPA4QJC12K*3%\W_\$H/BKKGQD\&ZKJOB
M&_N-0O7\078\V=RVQ6MK.3RXE^Y%$&=RD,02*/<0B*.*_3^BBBBL_3-6M]:0
MRVLL<T:R2Q%XW5U$D,C12H2I(#QR(\<B]4=61@&4@:%%%%%%%%%%%%%%%%%%
M%%%%%%%%?@C_ ,%3_P!H+XI?""XM;*&_L])T34Y+L67]E2S_ -H21VK6K;KN
MYDBB:%RSAE2S* ))+!+).JAW_>ZBBBBBBL_4]6M]%02W4L<,;211!Y'5%,DT
MBQ1("Q +R2.D<:]7=E1068 \_P"/Y-9BTNY/AZ.SDU;RR+1;Z26.U$A( :9H
M8Y)2B@E]B*#(5$?F1;O-3\<?V%_C]XY^*'QD\1Z1XNU/[1_9FGZE;_8[4M'I
MT4MMJ=O'N@APF_;OD2.>=6NFA(620XP/V^HHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHKY ^-?[;GA?X+:Q'X;\O4-9\0R;3_9&CVIO+Q$
M:.2;>Z[DC&$3>T>\SB-XYO*\EO,''_"__@HCX.^(?B#_ (16]AU3P_K;20Q0
MV6M6?V22:29#(B+MDE6-RNS8LYA,QEB6$2L^!]G^*?%FG>!K.34-5N[>QLH=
MOFW-S,D,*;V"+ODD*HNYF55R1EF"CD@5\H?#K]OOP'\3[?7]1LKV2/2?#D=I
M)>:C<0M#;R+=+(4$"/BX=P\;0^6T*/),42%9=ZD^'^%O^"N?PU\4ZY'HH;4+
M:*6X:!-3N8(HK'@D)*[F<S112$+M>6%/+#AIA"BR,GZ?U\__ !K_ &G?"_P$
M\N#5[O=J5SM%GI5JAN=1NWD\P0I!:QYD/FO&T,<C[(#-B-I58BOG"3_@I;X3
M\,W$<'BK2_$GA:.:.1[>?6=(EACG:)HP\<0@:XE9P)%8G8$4?>=69%?[/\4_
M%70_!>AR>)K^_MXM%BMUN3>AP\+0N 8WC9-WF^9N40K'O:9G18P[.H/X(^*/
M^"B?A_XC_&O0-=GN)+3P?X>CU&"&XD@=VEDN;2>*2Z$44+7"I,_V>*.)]Y5(
MUE9(7DFC3]SO@I\>_#G[1.G2:KX8O/MUE#<-;22^3/#B9$CD9-L\<3G"RH=P
M!4[L Y! _#'_ ((X>/\ 2_A9I?CC6M:N8[/3K./2))YY"=JKF_   !9G9B$C
MC0,\CLL:*SLJG[O\+?\ !7/X:^*=<CT4-J%M%+<- FIW,$45CP2$E=S.9HHI
M"%VO+"GEAPTPA19&3]/Z^</C?^U-X?\ @5<6^F72WFHZW>1M+9Z-IEL]YJ%Q
M&C8=TA3"JBJ))-TSQATAF\LNT3*/'_A?_P %$?!WQ#\0?\(K>PZIX?UMI(8H
M;+6K/[))-),AD1%VR2K&Y79L6<PF8RQ+")6? ^K_ (E_%70_@WISZKXAO[?3
M[)-P\V=PN]E1I/+B7[\LI5'*0Q!Y9-I"(QXKY B_X*8_#H^'KGQ-)=W$5E%J
M%WI]K&\'^D7\UK#'.6M859G\IUEB"RW/V=8WD19_(+KGU#]E;]LGPU^U];WT
M^@)>0R:=)$EQ!>0K'(%F5C%(#%)-$R.8Y% #[U,;;D56C9_J^OD#]HO]NGP-
M^S%N@UF^\_4EQ_Q++(+/>#/E']XFY8X/DE65?M,D/FQAC%YC#;7'_M,?\%%/
M!7[+6J1Z+JAO+W43'YDT&GQPRM;*P4QBX,LT*H\BG>D8+.$ D=422%I/8/V9
M_P!JKPU^U?I<FI^'I9 T$GEW5G<*J75NQ+>698T>1=DBJ6BD1G1P&3<)8Y4C
MX_XE_MY?#WX-ZB^E>(=2N-/O4W'RI]+U-=ZJ[1^9$WV39+$61PDT1>*3:2CL
M.:^K]6U--%MY;J42-'#&\CB**2:0JBEB$BB5Y9'P/ECC5G<X559B ?F#P'^V
M_P" ?B5X@3PKIFIR/K;R3Q"RET^_MY%DMT>29'^T6T:QNBQON60J05*XW8!^
M+_\ @M7_ ,D\TW_L8+;_ -(KZNPT;]O7P5^RQX \(6NK7$EYJ+Z'I"/I^G^3
M/=0+_9\$GF7"/+$L*%7CV"1E>42!HT=%D9/J#]F?]M/P=^U<DB^'[F1+Z"/S
M9]/NH_*NHH_,:,/@,\4B9"EF@DE$8DB60QO(J5Y?_P %1_\ DD/B'_N'?^G*
MTH_X)<?\DA\/?]Q'_P!.5W7H'[1?[=/@;]F+=!K-]Y^I+C_B6606>\&?*/[Q
M-RQP?)*LJ_:9(?-C#&+S&&VOK^OG_P#:%_:=\+_LOZ<FH>);OR?.\T6MM&AE
MN+IXD+E(8U_X"IDD,<$;R1K)+'YBD_,&H_\ !3GPOX/O+6V\3Z)XH\-Q7?F^
M5=:MI)@A/E*&; CEEF?ED0^5%)M:1"^U"6'Z'Z3JUOK]O%>6<L<]M/&DL,T3
MJ\<D;J&1T=259&4AE920P(()!K0K/U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[
MN[$*J*H+,S$!0"20!7YX77_!3GPO=Q7E]HVB>*-;TBQW>?JVGZ27L5V1+-+N
MDGE@>/RE<&7SDCV@;^8RKM]/_L]?M.^%_P!J#3GU#PU=^=Y/E"ZMI$,5Q:O*
M@<)-&W_ E$D9D@D>.18Y9/+8CT#XE_%70_@WISZKXAO[?3[)-P\V=PN]E1I/
M+B7[\LI5'*0Q!Y9-I"(QXKXPU/\ X*1^']%07]UX?\60Z$TD0&NR:,Z::;>:
M14BNQ*T@E-O('1XSY7G.K*%A,C",_7_PA^-'A_X]:6NL^&KZ._L6D>(R('1D
MDC/S))'(J2QO@JP615+(R2 %'1F\0_:+_;I\#?LQ;H-9OO/U)<?\2RR"SW@S
MY1_>)N6.#Y)5E7[3)#YL88Q>8PVUS_[2G_!0CP-^R]>?V7JL]Q>:H/+,MC81
M++-"DJLRO*TCQ0IPJGRS)Y^V6*01&)P]>@?L^_M@>$OVD-#N=?TJZ^SV]AO.
MH0WIC@FLE4,PDN )'C2)D1I$F#M$55P7$D4R1_)^I_\ !87X96&J#3XSJD]L
M9(D.HQV8%J%<*6D*22QW>R/<1(!;ER4;RTD!0M^G^DZM;Z_;Q7EG+'/;3QI+
M#-$ZO')&ZAD='4E61E(964D,"""0:^4/'_[=/@;P%XAL/"GV[[?K5_J%O8?9
MK$+/]FEGF:WS=2[EBB\N5=DT.]KI-RM]G*G->/\ QT_X*E> ?@-KD_A^Y74-
M1N[3Y;E]/B@EAAFR0\#/+<0YECP/-"!UC8^6S"5)(T^O_@7\=-#_ &B]#@\0
M>'Y_.M)OE=&PLUO,H!>"= 3LE3(R,E64K(C/$\<C<_\ M"_M.^%_V7].34/$
MMWY/G>:+6VC0RW%T\2%RD,:_\!4R2&."-Y(UDEC\Q2?F#4?^"G/A?P?>6MMX
MGT3Q1X;BN_-\JZU;23!"?*4,V!'++,_+(A\J*3:TB%]J$L/T/TG5K?7[>*\L
MY8Y[:>-)89HG5XY(W4,CHZDJR,I#*RDA@002#7RAH_[=/@;Q7XOL?!6C7W]J
M:E>^?^^L@LMG#Y-L;K]Y<[A&^] RK]F\_;(K)+Y3"OG_ .)?_!7/X:_#O47T
M^!M0U?RMPDN=.@B>W#J[(R+)//;^;C:&$D(D@='5DE?)"_?_ (6^*6C^.=#C
M\2:5<?;M+FMVN(IK:.29G1 2RI#&C3-*I5D: (9Q*IA,?F@I7RAI/_!3'X4Z
M_<16=GK<D]S/(D4,,6EZF\DDCL%1$1;,LSLQ"JJ@EB0 "37V?_PDL']G?VIL
MN/L_V?[1L^RW'VC9L\S;]E\O[3YN./(\OS]_[OR_,^6O /AO^V3X)^+>N/X:
MT:^N)]7A\[S[5M-U"%H/(.V7SS/:QI!L;$9\YD_>LL7^L=5/T_17X8_#OXCV
M_P"VK^T-]H2>.;0O!]G=2:=$R+/!<R0NEN]RF)I(0[7%PMQ!=1#+PVMGE%D4
M.G['?%+XI:/\%M'N->UZX^R:;:>7Y\_ER2[/-D2%/DA1Y#EW1?E4XSDX4$C^
M<'_AJ/PA_P -&_\ ">?VA_Q3?_/[]FN?^@)]D_U/E?:/]=^[_P!7_M?<^:OW
M^^!?[4?A#]I3[9_PBFH?;_L'D_:?]&N8/+\_S/*_X^(HMV[RI/N;L;><9&>@
M^,?Q^\+_ +/]FM]XGU.WT^)\^4LA+33;61&\F",/--L,B&3RD?RU8.^U,L/E
M"]_X*1^'_"KPMXE\/^+/#MC-(8AJ&JZ,\-JLGEO(J$QR32L[B-@JQQN<_,0J
M*[K]O^ /'^E_%/2[;6M%N8[S3KR,203QD[67)!!! 975@4DC<*\;JT;JKJRC
MYP\?_MT^!O 7B&P\*?;OM^M7^H6]A]FL0L_V:6>9K?-U+N6*+RY5V30[VNDW
M*WV<J<UX?XU_X*S?#+P9K*Z0MS>7T?F".;4+.W$EG"WFM&Y+M(DLR(%\PR6L
M=PDD;*8FE8[1^E]%?&'C_P#;E\/^$]4N=&TG3M<\37VGR&+48]!TY[Y;&3 V
M)<2%HX@[$2*%C:0H\,T<@C="M=!^S/\ MI^#OVKDD7P_<R)?01^;/I]U'Y5U
M%'YC1A\!GBD3(4LT$DHC$D2R&-Y%2M#XQ_MD^"?V?[Q;'Q/?7&GROGRFDTW4
M&AFVJCMY,\=J\,VP2()/*=_+9@C[7RH[_P"#GQWT'X^V;:AX=FN+FR&-MS)8
MWEK#)EG0^3)=00I/M:-UD\DOY; *^TLH/B&I_P#!03X=:+J@T.ZU&\AU9I(H
MA82:-JR71DF"F)! UD)2\@=#&NW+AEV@[AGZO_X2FSBT[^U9Y/LUD+?[3)+=
M*UKY4(3S&>=9Q&\&Q<F19@C18(<*5('P!=?\%.?"]W%>7VC:)XHUO2+'=Y^K
M:?I)>Q79$LTNZ2>6!X_*5P9?.2/:!OYC*NWT_P#L]?M.^%_VH-.?4/#5WYWD
M^4+JVD0Q7%J\J!PDT;?\"421F2"1XY%CED\MB.@^,?Q^\+_L_P!FM]XGU.WT
M^)\^4LA+33;61&\F",/--L,B&3RD?RU8.^U,L/ +O_@H1X&TCP78>.-0GN+.
MRU3[6+"SEB5KZX>TDECD1(87E09:+ D>18$,D(EEB,BBL_\ 9G_X**>"OVI=
M4DT72S>66HB/S(8-0CAB:Y50QD%N8IIE=XU&]XR5<H3(BND<S1\_\>?^"GOP
M^^ >J2:-<2WFIWUO))%=QZ="DJVTB!,I))-+!$SY8J5A:4QO')'*(W7:?J_X
M%_'30_VB]#@\0>'Y_.M)OE=&PLUO,H!>"= 3LE3(R,E64K(C/$\<C>0?M%_M
MT^!OV8MT&LWWGZDN/^)99!9[P9\H_O$W+'!\DJRK]IDA\V,,8O,8;:X_]IC_
M (**>"OV6M4CT75#>7NHF/S)H-/CAE:V5@IC%P99H51Y%.](P6<(!(ZHDD+2
M>P?LS_M5>&OVK]+DU/P]+(&@D\NZL[A52ZMV);RS+&CR+LD52T4B,Z. R;A+
M'*D?P?\ \%J_^2>:;_V,%M_Z17U??_[)W_)//"G_ &+^D_\ I%#78?%[XT>'
M_@+I;:SXEOH["Q61(A(X=V>20_*D<<:O+(^ S%8U8JBO(0$1V7XPU'_@ISX7
M\'WEK;>)]$\4>&XKOS?*NM6TDP0GRE#-@1RRS/RR(?*BDVM(A?:A+#]#])U:
MWU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$@UH45Q_C_ ,?Z7\+-
M+N=:UJYCL].LXS)//(3M5<@   %F=F(2.- SR.RQHK.RJ?P!\4?\%$_#_P 1
M_C7H&NSW$EIX/\/1ZC!#<20.[2R7-I/%)="**%KA4F?[/%'$^\JD:RLD+R31
MI^YWP4^/?AS]HG3I-5\,7GVZRAN&MI)?)GAQ,B1R,FV>.)SA94.X J=V <@@
M?AC_ ,$</'^E_"S2_'&M:U<QV>G6<>D23SR$[57-^   "S.S$)'&@9Y'98T5
MG95/W?X6_P""N?PU\4ZY'HH;4+:*6X:!-3N8(HK'@D)*[F<S112$+M>6%/+#
MAIA"BR,GZ?U\X?&_]J;P_P# JXM],NEO-1UN\C:6ST;3+9[S4+B-&P[I"F%5
M%422;IGC#I#-Y9=HF4>/_"__ (*(^#OB'X@_X16]AU3P_K;20Q0V6M6?V22:
M29#(B+MDE6-RNS8LYA,QEB6$2L^!]WT5\@>/_P!NGP-X"\0V'A3[=]OUJ_U"
MWL/LUB%G^S2SS-;YNI=RQ1>7*NR:'>UTFY6^SE3FO'_CI_P5*\ _ ;7)_#]R
MNH:C=VGRW+Z?%!+##-DAX&>6XAS+'@>:$#K&Q\MF$J21I]?_  +^.FA_M%Z'
M!X@\/S^=:3?*Z-A9K>90"\$Z G9*F1D9*LI61&>)XY&] \4^+-.\#6<FH:K=
MV]C90[?-N;F9(84WL$7?)(51=S,JKDC+,%') KX0U;_@I'X?AMY=3TSP_P"+
M-7T2*-Y1K-EHSG3WCB4F9UFN)(&"0LKQRM(B!7C?DJ Q^G_@A^TCX3_:/M[B
MZ\*ZE'?QVDBQW $<L,D;.NY"T4Z1RA& ;9)MV.4D56+1N%Z#XO?&CP_\!=+;
M6?$M]'86*R)$)'#NSR2'Y4CCC5Y9'P&8K&K%45Y" B.R_*'_  \7\.>'_P![
MXGT7Q1X8LC\L=[K&BSQ6\DQY6!&@-PYE90\B@J%V12$L" &^S_A[XUM_B5HV
MGZY9K(EMJ5G;WD*2A1(L=Q$LJ!PK,H<*P#!68 YPQ')^8/'_ .W+X?\ ">J7
M.C:3IVN>)K[3Y#%J,>@Z<]\MC)@;$N)"T<0=B)%"QM(4>&:.01NA6N@^#/[9
M_A/X\:R?#VCO>#5H;.:ZOK2YM);:2Q:"6"&2VN1*%'VA9)]A6$S(#%+F0?N_
M,Z#]H']K/P=^S+;F7Q'J,<5R8_,AL(OWMY."LA39 IW*CM$\:SR^7;B0!'F0
MFO7_ (>^-;?XE:-I^N6:R);:E9V]Y"DH42+'<1+*@<*S*'"L P5F .<,1R?P
M1_8N\6:=X&^/7Q!U#5;NWL;*'^W?-N;F9(84WZW:HN^20JB[F957)&68*.2!
M7V?IG_!87X97^J'3Y#JD%L))4&HR68-J50,5D"1RR7>R3:!&#;AP77S$C <K
M^G^DZM;Z_;Q7EG+'/;3QI+#-$ZO')&ZAD='4E61E(964D,"""0:_!']OK_DX
M7P%_W /_ $\W%?O]7SA\;_VIO#_P*N+?3+I;S4=;O(VEL]&TRV>\U"XC1L.Z
M0IA515$DFZ9XPZ0S>67:)E'C_P +_P#@HCX.^(?B#_A%;V'5/#^MM)#%#9:U
M9_9))I)D,B(NV258W*[-BSF$S&6)81*SX'W?17S_ /M"_M.^%_V7].34/$MW
MY/G>:+6VC0RW%T\2%RD,:_\  5,DAC@C>2-9)8_,4GY@U'_@ISX7\'WEK;>)
M]$\4>&XKOS?*NM6TDP0GRE#-@1RRS/RR(?*BDVM(A?:A+#]#])U:WU^WBO+.
M6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$@UX?^T+^T[X7_ &7].34/$MWY
M/G>:+6VC0RW%T\2%RD,:_P# 5,DAC@C>2-9)8_,4GY@U'_@ISX7\'WEK;>)]
M$\4>&XKOS?*NM6TDP0GRE#-@1RRS/RR(?*BDVM(A?:A+#]#])U:WU^WBO+.6
M.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$@U\X?&/]KSPO\ !N\72))+C5=?
MDSY6AZ3 ;[4GVJDC9@C.(L1/]H'VAHO,A5WC\S:17C]U_P %)/!?ARSO)O$$
M&L:!?VMNURFE:MITEK?74.Y8T>U0LT4OF2L8D7S58&.:1Q';Q23+[AX@_:M\
M,>#/#6F^+-6>\L])U.S@O(YC875PL,=PL31BZ>SBN(K=R9XT42.!(Y*QM)M.
M.O\ @I\>_#G[1.G2:KX8O/MUE#<-;22^3/#B9$CD9-L\<3G"RH=P!4[L Y!
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M3\:B>XBTC3=0FTY&EB5)KZXCC25%LX2^]_.616C$ODNJAWF6&..1U\_^!?\
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MI24JQ4HG4*!7[W?\*!\+_P#"+_\ "%_V9;_\(]]G^S_8<'9LSNW;L^9YN_\
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MY)M4N(C<1&) JW"J%*2E6*E$ZA0*_>[_ (4#X7_X1?\ X0O^S+?_ (1[[/\
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M^M_[%^O^(?$OP_T2?Q7;W%MK2V[P7,=U'-'<'[--)!%+.MP3*998HXYI'?\
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MP11SK:WB>)]6,J+)''I]CYEO%"\,H5)TO)I6MF".[PA3(\$D39'Z'T5^ /\
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MD\N C_().?\ ^"YW_,H_]QC_ -L*_?ZOP!_8%_Y.%\>_]Q__ -/-O7W_ /\
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M2218I"FP^H>+/%-GX&TZ[U74)/)LK&WFN;F7:S[(84,DC[4#.VU5)VJ&8XP
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M+MW>%)[D3?8'L)H[&:UB(WYB.^,(J2^1#Y!,:'SW>N?_ &^O^3A? 7_< _\
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M]GB6*W@2%$D,W@'_ #=Y_G_H7*^__P#@J/\ \DA\0_\ <._].5I1_P $N/\
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M^E_\)S_9&BQ>9\FFZEJ;^3NWR?NK7;:1'?*<O^\CQO>3YV&UOU^^&_[/6G?
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MM@Q0Z;-XBM]-T6VN!<PVL>DF:9IA%Y0>:Y:^3?MWS>6L4<"A92L@E9$D'O\
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M#]OS_@G[_P *1T=_B-HGB'6+O4M/N+:2\GU2[\^\;,D-O:S6]U%%%(LL+F,
M.3^[PR21M"J2_K_^Q?\ &.\^/OP_T3Q%J"XO;FW>.Y;*GS)K6:2UDFPB1HGG
M-"9O+50L>_RP6"AC^*'[:6K^// 'Q<\+Z=J6L2>)I#>:5JEAID4:Z59^?_:,
MZ06J1&:>)7RK1+>SM),(Y LCNJ9/V?\ '3_@F!>?M%V<^O>(/$%Q-XVFM_DV
M[5T6W96+I9P0&$W*6B F(2^896<M>O$\KR0MYA_P2T_:;\0:=K-Y\)_%CQF;
M28[E+%YIT-Q%)92K%-IR$%EN41?,DAV,3##!*JF2W$8M_;_^"L'QC\6_#O0]
M&TCPFNH0W&M:@89+VP,@F#1!#!91M$AD66Z=]\?E21RNMM)$%ECDE"\A^T5_
MP3-\$?#3P5>ZSX7%YI6N^'[-M2@U1+N>2>633X6F/F*9%BC>4IN$ELL!AFV2
M(/+5H']O_P""6OQTUSX\^ 6N?$$_VN[T[4)=/2Y;/G30Q06\J-.Y)\R4><4,
MN TBHK/OE,DC_FA^VEJ_CSP!\7/"^G:EK$GB:0WFE:I8:9%&NE6?G_VC.D%J
MD1FGB5\JT2WL[23".0+([JF3]O\ QY_X)K:I^TEI<FI>(O$MY/XM,<DL$(<#
M0;2=RA-M:VIB:>*WV1QP-.',TK(+N6.20M">0_X)"?&;4?C)X2UCPGK$MQ-%
MHWV>*VN1<O',EG>QRHEM')%Y<T?D&!S#*LIDC65(XS$EO&*^/_'\WB']FOXP
MV'A;Q;XP\42^$[FXMYH[DZW-"\EG<%DB-Q(+E5BBCN%:&\ES!(8(IIXDB+Q
M?T??\(U!_9W]E[[C[/\ 9_L^_P"U7'VC9L\O=]J\S[3YN.?/\SS]_P"\\SS/
MFK\T/V#? >I>+-9\0^+KSQ!KE_H\&N:I8>'[.;4[RXT^2SAE*+>(\L\BWR%6
M,$+L7C1XI9"TL^QH/U/K^<'P!K'_  S7^U#?V4M]BTUC4+B*X?R,^9_;,2WU
MM;8 E9=MW+:Q^:I3/E[W,<32(/Z/J**_(#_@K!^S_%X@\(:IXON=8UAVT_[
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MB)K&SAGMYI&2TMXX(_)_X]85+;F:0+OE,LI,E?;_ .Q3^S'_ ,(UHOA?Q/\
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MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK^0+X"?\89?&VSM-5YBTK6)M/EGN?\
M0E^SW2R6:WS^9O$<7E3K>+EBCQ8Q*$82C^OVBL^35K>&XCLVEC%S+')+'"74
M2/'$T:R.J9W,B-+$KL 0IDC!(+KG^?']CWXE_P!G_M)^*(-0>XN+C4[C7=.M
MI"WF;/LUT)XU=G8,L26]D88PN[9B*,*(P2G]#U?SP_MA?#3^S_VD_"\^GI<7
M%QJ=QH6HW,87S-GV:Z,$C(J*&6)+>R$TA;=LQ+(6$8 3H/\ @N=_S*/_ '&/
M_;"OW^K\ ?V!?^3A?'O_ ''_ /T\V]??_P#P5'_Y)#XA_P"X=_Z<K2C_ ()<
M?\DA\/?]Q'_TY7=? '[?7_)PO@+_ +@'_IYN*_?ZOP!T#PG]F_:VN/[/M-MO
M!YEU<^1#A(_/T,>9/+L&U?,N)QOD;&^>89)DD&?T?_;-_;-L_P!F&SAT_3X?
M[3\6:GB/2M*C#2,S2-Y:33)'^\\K?\D<:8ENI088B )IH/E#XK_LQ^,?'O@K
MQ!XH^)OB"\FNTT._NHO#>GR_9=)M)(8;FY@BN%A8B]>"0P2)(QRLL 1Y[V%4
M<W_^"*G_ "3S4O\ L8+G_P!(K&O /V^O^3A? 7_< _\ 3S<5^_U?@#_P0Q_Y
MF[_N#_\ M_7T_P#\%>_@7+\3_ T6N64'G7OA^X-PY'FLXL9EV702.,,C;66W
MGD>0*(H()7$BC<KY]E^VW<?$?X%3>(;9I)?%$T8T 102M#=2ZQ/LMUDM/+AC
M+W!CF744@M$.T;H5=3$[I^C_ ,%/A?;_  5\-:7X<M?+:/3;.&W,D<*P+-(B
MCS9S&I8*\TF^:3YF)=V+.S$L?4*_F!_:6_Y.AM?^Q@\,?^BM.K^GZBBO@#_@
MJ/\ \DA\0_\ <._].5I1_P $N/\ DD/A[_N(_P#IRNZ^ /\ @N=_S*/_ '&/
M_;"OW^K\ ?V!?^3A?'O_ ''_ /T\V]>/_'?PMX<\<_M/3:5XLC\[2+ZXL;:6
M+=.F^:;2(([1-UN5E7=<M"-P*J,Y<B/>:_5__AUQ\(?^A>_\J.I?_)=>H?!G
M]DGX>?LX:R;KPU81V&K7=G-& ;VZFDDM4E@:8K%<3R HLAM]\BKE"\:EAY@#
M?5]%?@#_ ,$,?^9N_P"X/_[?U^A__!335KC1?A)XBEM99(9&CLXB\;LC&.:^
MMHI4)4@E)(W>.1>CHS(P*L0?/_\ @DGXUM_%7PKL;.!9%DTJ\OK.<N%"M(\Q
MO08R&)*>7=1J2P4[U<;=H5F^_P#XA>"K?XE:-J&AWC2);:E9W%G,\142+'<1
M-$Y0LK*'"L2I96 .,J1P?Q!_X(:Z3<0V_BN\:*06TLFEQ1S%&$;R1+>-(BOC
M:SHLL3.H)*B2,D .N<_]@7_DX7Q[_P!Q_P#]/-O7Z_?M8_\ )//%?_8OZM_Z
M135^(/\ P2V_9<^''[2GA[5/^$DT_P"WZU8:@-W^DWL'EV<\*?9_]1+%$VZ6
M*ZZ;I!M^;"F//Z?_ /#KCX0_]"]_Y4=2_P#DNNP^(7[+/A_QU\,-0^'WA5H[
M73C'<1602Y>6.*\M[QKC9+-)]IDV+>QLEROSR(!+$H1U 7X _P""<O[45O\
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M +1_UG_'G_:=W]H_U/[W_5;_ /5?O/[GS8K]/_\ AUQ\(?\ H7O_ "HZE_\
M)==A\.OV(/AA\!=;L-9T?3([#5EDEBL9'U"\=GDDMYO,2..>Y=)'\@3L5VL5
M17D &PLOS?\ M[?\$U?^&IM17Q)H-[;V&M"WC@GAGBQ;W>QP$EDFA4RI*D19
M"[)<>8D=O"!"L9<_"'PO_;T^)'[#^L_\(Q\4+2\U*V\N%U6XGCDO(8Y92[7$
M%X/,6^0JTJ>7+*P$D20+<6PAEC/]'VDZM;Z_;Q7EG+'/;3QI+#-$ZO')&ZAD
M='4E61E(964D,"""0:T*_,#]H7]LW7/$?BA/AM\*8;>_\1'S5U/4I@7L]*4
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M2Z220O--L,CZ?(0XB$\DKR32?9MU?H_\/O\ B]/QAUO6S^\TWPCI\.BV)/\
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M +?U[_\ \%J_^2>:;_V,%M_Z17U??_[)W_)//"G_ &+^D_\ I%#7Y _M]?\
M)PO@+_N ?^GFXK]OOBK\--.^,FAW_A[54WV6H6[P2X5&9-P^66/S%=%EB;;+
M"Y5O+E1' RHK^='Q_P#L;_%G_@GP]SXD\%ZK)>:3#&9;NXLP$81QQA2][ILQ
MEBE2,SS&-E^UB!$>Y<VV,C]7_P!@O]O2W_;$M[NSO+2/3M;TZ.!YH4G5X[F-
MUVO<6Z-B9464%9(V$@@$EN#<2M+\OPA^WU_R<+X"_P"X!_Z>;BOW^HK\@/\
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M)YXK_P"Q?U;_ -(IJ^ /^"*G_)/-2_[&"Y_](K&C_@M7_P D\TW_ +&"V_\
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MOQU\-?Z=J_@3;IMM^^O&_L;5K;%O'\\Q\^262.'"!CYKHZ1_?9&4%3^I_P
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M\$U?B5=>._#&E_:?"=]O:54C!MXK>YEA-Q8RO%"JV&VXV?87"[-@@0-<%;F
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M -4\=?#F.33+:2Z73=4AOKP1@%HK6.VNHY)BN=S(C2H9-H8HFZ5@(HW=<_\
M8)_:ZO/C-X>\/>&]%T+4(FTRWM['4]6GB5]+AAL(45Q%,)8GEN[A1 B6^U6M
MC=&X87$-JRS_ "!^V+>:U\2?B_X=\7Z-X8\47FD:%_9/GRKH5]&T_P!EO9+R
M7R(YXHG.%E$8\X0YE5O^6>V1OV^\1_&JQ\/Z&->6RUBZB?S!#:6^CW[7TCH)
M,(;-H$FAWF,JDERL$&6C)E5)$9OQA_X))Z7K7P"U'6M/\2Z!X@L/[8_LX6MS
M)HU\;</ \Z%)I%A/DY^TJPDD"P*D<C22QX4/[A_P5._8<U3X])%XQ\.F2ZU3
M3;,6T^F@ M<6L<DLP>U &YKA&ED+0G<9TP(L31K%<?+_ ,(?^"OGC'P@B^'/
M$OAV37/$*7CVP9)/L%T\C2;%MI+..SD!N%D+1 1K$2-B&(RJ\DGZ?_LK> /$
MOC+6;[XF>-K:.PU;5+.*QTK2E#"32])25IQ#<-E1)<3R%)I?,3S82F,P>8]I
M;_=]%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%?@#^WU_R<+X"_[@'_IYN*_?ZBBBBBBBOD"Q_;\^%^H?VCL\3:>/[,W_
M &C>[Q[]F_/V7>J_;?\ 5MM^Q?:-^4VY\V/?G_L4^ -4T?2]3\3^(;:2TUOQ
M3JEQJD]M< /=6=JQ$=C82SD[Y$MX5#1(ZPFW$S0>1$R.#]GU\@?M7?M!7GPW
MLSX?\*VUQJ?C/4[=QIME:(LC6JR,(!J5V75XH+2&5UP]P!%+*/+)$8GEAZ#]
MC_\ 9KL_V5O"5KH$'S7;8N=2F$C2++?21QK.\994Q$-BQPJ$0^4B%P93([=?
M\8OBK<>$;>XT_0+634_$SV<DMA8QQ,\8D*N('O9B\,%K;LZ.0UQ/;FX$,\5L
M9KA/+K/_ &6/@I_PSMX+TCPPTGG2V-N?M$@;>IN)I'GN/+;RXB8A++((=R*X
MB"!LON)^@********************_+#_@J5\;[CX5:7H&GSV]XWA[5M45-?
MFM69&DT^$HT^G;QL*O>1O(5VSP.Z6\L66BDEV_2'PT_;V^&OQ0TY-0@\0Z?9
M;MHDMM1N(K&XB<HKLC1SNF_;O"F2$RP,ZLJ2OM)!XZ_;R^'7@CR8H]:M]5O;
MK>MI9:0?[2N+B9=H2!%M/,1)96=8X1.T2R.<!L*Y70_8Y^$.J?"CP_<SZ^L<
M>NZ]JE[K6JP0N'M[>ZOG!,$!Y(2.-(E8%YQYPDVSR1E&KZOHHHHHHKX _P""
MF/QCUSX*?#J[O?#ZW"7=U<06;WMN2&L89MQ>X+!'V;M@M4DS$T<MS&Z2K*L8
M8_9P_;L^%7BO0[:STO5;?1;?3K>&VCL-6G2TFAAB#0PH))Y6CG^2(,6BFG95
M9/-*2/MKU#QK^W3\,O %NMU>>)]+DC>01@6=P+^3<59@3%9>?*J84YD90@.U
M2P9E!Y_]D_P!JAO_ !'XZURVDT^^\5WEO)!82 ));Z;8P^1IXN8<N8;UXV9[
MJ,2R*I*+MA=9(E^SZ*****************_ ']@7_DX7Q[_W'_\ T\V]?O\
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M_P":/Q:\2>,=9^-G@FS\=6D<&MZ9>:'9274/_'OJ,::H\D=_ -B*$E67:RH
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M,CQH"1N=5RP_#'4?^"DWC3PY\4K7P_XHTS^Q=-M/-6YT6Q6/5+ZZFN-/$EE
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MRA_P4F\4V?@;XZ^#=5U"3R;*QM]%N;F7:S[(8=6NI)'VH&=MJJ3M4,QQ@ G
MKZO^//BK]H'QGI<GB?PE#9Z)ID4<D]OHQA6XUZ:W)0*;J&XMY[=;C8K7"VL#
MI-&LAMF^T7**I]@_X)Q?M@W'[6'AJ<:OY?\ ;ND21P7K1JRK/'(I,%T5"+%&
M\I25)(HV8!X6D"0QRQ1+^A]>7_%[Q=K?@K2VNO#VBR:]J)D1([)+NWLEVDY>
M22>Y8*J*H. BRNSE%V!"\L?YX?\ !,W]KSQ1^UI>>)[GQ%);B*S_ ++^R6MM
M (H;?S5NEEV%B\S^884=O.EEVMD)L0[1[A^W5^TSXL_9HT235/#V@1WUM#'$
M]UJEU<Q+:VK27$<,<?V1)DN[EWW$,4\I(B\3[Y@)4C^8/V<OVGOB;^T]X(M+
M7PH;.;Q#%'=C6?$&JPF"SMY7GF6UM;2*V@V3WJP-!<LPB>U@C$2S"66YV+Y_
M\!OVQ_B1\&_B;'\/_BM+'<QZC)';VMT+>.)5DD+K:3VK6MO&+BWNI,0-YJ Q
M.07>W:"YB;]3OCI_PL/_ $/_ (0/_A'_ /EM]M_MK[;_ -,_)\C[)_VU\WS/
M^F>W^*OP!_X)2?\ "P_^*C_X0/\ X1__ )AOVW^VOMO_ $]^3Y'V3_MKYOF?
M],]O\5?T??"W_A(?['M_^$K_ +/_ +:_>?:?[-\[['_K'\KROM'[W_5>7OW_
M /+3?CY<5\ >#_VFO%O[;5YJ-I\-Y;?0?#VG7 MY?$=[:R75S<L5\Q3I]G(B
M6PP4*SI=2-*MM=03>7!,1%7F'Q]^+GQE_882'6M1OK/QKX<ED@6\GDTY-/GL
MF$A!C LWVQI<*RI'=2BY1)@L9BC+1K=?H=X6^/D7Q4\%Q^,/"-C<:O\ :K=I
M+.P+Q6DTDRR&%H9)+AUBB\N576:0-(NV-WA%QF-9/RA^$/[?WQ0^*GQ#U?PU
M'H]O]KAM[RRM=)38UG87D-ZB&]U2^4O*\5O%YL<QMF6.ZD$,4$"2SJX^G_@Q
M_P - >'_ !I=R>+_ .S]0\,I;W4WEV7V15D=HQ)!;Z<7^SW0E60K #J+)!Y2
MS%YF?R9F^<%_X*(>/+;XK6WAK7]&DTNQLX[I[O0]-B75]0N6;3&N;>/SH0XD
M?S DD9MQ;)&DA6Y<I&\B]!^U5XS_ &C?!&ER^+[:;2]-TN"-7GTG38XKZZLX
M"7D,MT]U:R+*\*E8KJ2TD\D!//6%81+*/7_@O^WCKW[4?A^QM?!6G6<GC!HR
MVKF[%TFCZ4L;LJR32JHEE>\"?Z':V[3/'ND:64I:R&3Y0OOVN_BY^QEXYT[3
M?BE>6^I:!?;%>ZBMHDM_)=D$MU;36UI%,TMJ3^]MY(RSH2HB'G6UP/W>\6>*
M;/P-IUWJNH2>396-O-<W,NUGV0PH9)'VH&=MJJ3M4,QQ@ G K\D?V<?BI\5/
MV\[?4/$NE>)+/PAI-M>-8VUC;Z5#J4CLBB=GGDNRIWK'/!'OB*I*5=OLUOC,
MM_\ 94_;-\::9\0)?A/\1X;>ZU=/-6WU*T$:[V2&2]#3JFR)HI;;:8&BB@EC
MVHDT#222/#](?MX7WQ&L/#6HS^#+C2]/TZVTN[N=0O9IKD:D%A4RNE@L<+0Q
M/Y4;*)G<N6E_=_9GB69OS0_X)?\ _"T_^$-O?^$'_P"$7_LW^V)_-_MC^T/M
M'VC[-:;MGV3]WY6SRMN?GW^9GY=M>X?\%%?VZ_B'^S]<1Z9I.DQZ+:7<EPEG
MJ]Q+:WEQ=+;-;EY(+9'EBMDRY7%TLKRPRHX2VF5E3]KJ^ /C'^UYJS^-%^&G
M@*PM[WQ(+<W%Y>ZA]H33=.41I.HG%O&TLOF1,J!U:**.:XM4\R5VDBC\_P#B
M7X*^.GP6TY]?TCQ5;^+I;/<\NBSZ#;6GVB'8P8Q-:2":66,E9$@1XFEVD*TC
M[;>;V#]A?]LVS_;#T.2=H?LFM:=Y,>IVRAO)#2A_+F@=LYBE\N0B-F,L+(T;
M%U$<TWPA^TG_ ,%%/&_PI\=:-H>JZ;'X5T1KRRNKMY7@U&\N-,-W+%*[FW-Q
M#"DD2,6@A62ZCDB.RY=74-Z_\>?%7[0/C/2Y/$_A*&ST33(HY)[?1C"MQKTU
MN2@4W4-Q;SVZW&Q6N%M8'2:-9#;-]HN453[!_P $XOVP;C]K#PU.-7\O^W=(
MDC@O6C5E6>.128+HJ$6*-Y2DJ211LP#PM($ACEBB7]#Z\_\ B7;>(;G3G_X1
MB?3X-27<T?\ :-O-/;R81ML3>1/!)%N?9F8>=L0-B"1B-OP!_P $WOVU?$/[
M8/\ ;O\ ;UMI]O\ V9]@\C[%%-'N^T_:M_F>=/-G'DIMV[<9;.<C'L'[<OQB
M\9?L[>'+CQ9X=?1YK*Q^S+=6=_:7+S'SIQ!YL4\-W$APTL(\EXEPHED\\G9$
M>P_9)^.^J?'?X>6'B[4;2-]1NH[UVM+$"-9&M[JXACCA%S/M5W6)1F694WL2
M7C3[OYH:C_P4F\:>'/BE:^'_ !1IG]BZ;:>:MSHMBL>J7UU-<:>)+* 7$899
M99+AH?LXMA;*#.(YV949U[#]JKQG^T;X(TN7Q?;3:7INEP1J\^DZ;'%?75G
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MFU2\\7:7X?U&6,/;Z+::3;W=K$P@3;'-=W EFC<R[A.4^VHAR\3RH5B7S_\
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MQQHH5$1% 5450%55 "@   "OP1_;Z_Y.%\!?]P#_ -/-Q7Z_?M8_\D\\5_\
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MM&8Y,)-:I&7,A983&RB-$#?7_P#P6K_Y)YIO_8P6W_I%?5]__LG?\D\\*?\
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M^&/[?7_)PO@+_N ?^GFXK]_J_ '_ ((8_P#,W?\ <'_]OZ_?ZBOP!_X(8_\
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M?'O_ ''_ /T\V]?O]7X _P#-WG^?^A<K]?OVL?\ DGGBO_L7]6_](IJ^ /\
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M ))YJ7_8P7/_ *16-> ?M]?\G"^ O^X!_P"GFXK]_J_ ']@7_DX7Q[_W'_\
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MG2Y*-</)+AA).\2CRHHR?Z7J_ '_ ((8_P#,W?\ <'_]OZ_?ZOP!_P""&/\
MS-W_ '!__;^C_@I?K&L>(_C)X&T&ROOL6S^S9;&?R(YOLMY>:FT+7.Q@/.Q]
MFMV\J1O+/E8 7>Y;[_\ ^&>/B]_T4_\ \M;3?_CE>/\ P(_X)FWGPD^($/Q
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MS&LN&;R9E(D@FVH\9?RI4CE\LNJR;-C'8S _C#_P2V^-?_#.6L:I\*?&4?\
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MCN76W:.&=G] _P""U^K6\/@72K-I8Q<RZY%+'"742/'%:72R.J9W,B-+$KL
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MNE:#I%O;V6I9%]%(9+G[2I0Q^7,UR\KO%M9@(6)B'F2$(#+(6/\ AD[X>?\
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MQ&2%49P!C\(=6TFWU_\ :TEL[R*.>VGC>*:&5%>.2-_#15T=&!5D92596!#
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M47BC:3Q#JDMKI=RJ*%DT?30MI;RQJX-Q"\[PL;J.4IYCP1.((U5,_H?17/\
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MZOI&F6]OJ6IW%Q<7EY@R7$KW+K),OG2%Y$B9T5_(1E@5QN6,,23[!7QAJ?\
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MK%'#&TDLI2-%13)-X?:65R% !>21WDD;J[LSL2S$G^@ZBOP!_;Z_Y.%\!?\
M< _]/-Q7ZW_M>_%Y_@1X#USQ# TB7-K9LEK)&D<C1W5PRVUM(4E^1D2:6-Y
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M60P6ZZEHUQ;K-=-N69[&>0PF!=H*R8N)H95$N!$HG,;*TCI+V'PA\:W'C_\
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MLK>9Y1_H>TG5K?7[>*\LY8Y[:>-)89HG5XY(W4,CHZDJR,I#*RDA@002#7X
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M)&:,M*@+A(E@BC5#]/\ [*O_  3S\'?LL/%J-JDFHZZD;*=3NC\R&2-$E%M
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MW_X)I:+\)-<?Q+HWB7Q1!J\WG>?=-=V,S3^>=TOGB>PD2?>V)#YRO^]59?\
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K444444444444444444444444444444444444444444444444444445__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex19_004.jpg
<TEXT>
begin 644 ex19_004.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[@ .061O8F4 9       _]L 0P " @(%
M @4'!04'" <&!P@)"0@("0D+"@H*"@H+# L+"PL+"PP,# P,#@X,# P,# P/
M# P,# P,# \,# P,# P,_\  "P@,Y GV 0 1 /_$ !\   $% 0$! 0$!
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M?SH[=(E8W!96S/+)(^V1XP1$(TC_ %._9._Y)YX4_P"Q?TG_ -(H:^@*\?\
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M7A_QB^"$7Q6M[@Q:AJFFZB]G);VMU9ZGJ-O';R%7\J<VEK=V\$SQN^\^8N9
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MU75-.CTW2]3NV@L)XX([QH[20K#>$Q/+);X#*\"/&D@=MX9EB:/Y/_X(J?\
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M?#+3-'M_#UO<200:IXA:]7^U-N%:6SM[5%DBBC=9%9YBWF[D4"*:*XACY_\
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MQVTL>0/J#]E']J[0_P!K70QJNE'R;N'8FH:>[AIK29@2 2 -\3X8P3@!95#
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M&FMW#GQ_XJ_ML_$;]CVXM7^(^@:7J&DW\D21:CH$US'';L&<SQ2)>*YDN/+
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MR0 ZY_=_]CO5K?6OASX5EM98YHUT/3HB\;JZB2&VCBE0E20'CD1XY%ZHZLC
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M.9ITF+EVEMS!))$KR-^UW[)W_)//"G_8OZ3_ .D4-?D#^P+_ ,G"^/?^X_\
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M1_:)\;2SQ1R26TGB"6!W16:*0ZK%$7C)!*.8Y)(RRX)21TSM9@?T/_X*C_\
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MCKDD=Y=RRR223K#;PS(7+L07\RZN':3&^0R'>S;5V_1__!4?_DD/B'_N'?\
MIRM*/^"7'_)(?#W_ '$?_3E=U\8?\$I?$Z?'7QKX[\<7L4@U&YDM1 9+B29K
M>UO9KF0VH8[5=(UM;6*-B@*) JQB-"R']3OVL?\ DGGBO_L7]6_](IJ^ /\
M@BI_R3S4O^Q@N?\ TBL:\ _;Z_Y.%\!?]P#_ -/-Q7[_ %?@#^P+_P G"^/?
M^X__ .GFWK]?OVL?^2>>*_\ L7]6_P#2*:O@#_@BI_R3S4O^Q@N?_2*QKR#_
M (*E:U_PM3XA^"/AS<M<0Z;=7%I-=/#/CS/[1O19 B)D:,2P)#,8I7$G_'RZ
M[%7=YG[O5^"/_!:;P'<:!<>&O&VFI)!<P22V4NH13LDD<B,+K3U10X975A>R
M++$H*D .X(A%?3_[;'C6X^)7[.\VN7BQI<ZEI>@7DR1!A&LEQ=6,KA S,P0,
MQ"AF8@8RQ/)] _X)6:3;Z=\)-%E@BCCDN9-0EG=$56ED%]<1!Y" "[B...,,
MV2$C1,[54#X0_;Z_Y.%\!?\ < _]/-Q7[7?&CX0Z7\>O#]]X:UE9&L;^,)(8
MG,<B,CK)'(C<@/'(B2*&#(Q4*Z.A9&_/#X:_M2:'\,K.T^'WP<T+4/&/]DYB
MGGCG%O8Q%VNI)7FU*=#$9998WEC*HEG.)"+:;Y5@KY _X)L_VC_PO7QE_:_V
M?^TOL^M?;/LN_P"S_:/[6M?.\CS/WGE;]WE[_GV8W?-FOI__ (+5_P#)/--_
M[&"V_P#2*^K[_P#V3O\ DGGA3_L7])_](H:^@**_DB_X)?\ PA_X73XRO=/_
M +7UC1O+T>>?[3H]Y]CN'VW-HGE/)L?,1W[F3 RZ1MGY<'H/VI?AIJ/[$?Q0
MM=8UY/\ A,--N<W,#ZRKW/VVWV-;/;74LRO&]W;ILVNHD2/_ $2X,*JPME_I
M]^%7Q+T[XR:'8>(=*??9:A;I/%ED9DW#YHI/+9T66)MT4R!F\N5'0G*FL_XW
M^-;CX:^%=;URS6-[G3=+OKR%)0QC:2WMY)4#A65BA90&"LI(SA@>1^$/_!+K
M2?B7#X5U&\\"Q>$Q;2ZH\5S-JZ7PO'DBMX&5 ]H-K6Z++NB5R2LDDY  ?GZ@
M_:@_9?\ C9^UGHT&AZY/X+@MH+Q+Q'LWU1)#(D4L0!,L4R[-LS$@*#D+\P (
M/K^K?LD>);[X$2_#J_NX[O78;-Q%)%(TT<K6UZ;RSM4DN?LY5#''#:*S[$MQ
MC :.,!OS@_9=_P""F>L_LIV]OX)\>Z+>-;:;&L2/B6+4[>-EDFC26WO'594V
MR01VZAK406JJ0)AL6OW._9[NO"7B"UU'7/!UY;WEEK6H?VA<FW:/9'=RVEJD
MBM&BH\,KK''//%./M'GS2/)@N%7\@?\ F[S_ #_T+E?O]7X _P#!#'_F;O\
MN#_^W]?O]7X _L"_\G"^/?\ N/\ _IYMZ^O_ /@KG\2]1^'?PU:#3W\K^U]0
M@TZYD#.KBW>*>>149&7'F?9Q#(&WH\$DL94[P5^L/V.])M]%^'/A6*UBCAC;
M0].E*1HJ*9)K:.65R% !>21WDD;J[LSL2S$F_K_[+'@OQ3XHM_&EYI%O+K]M
MY9CNR9!\T0*Q2/$'$,LL8($<TB/+'LBVNODQ;/@#_@M7_P D\TW_ +&"V_\
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MG_H7*_7[]K'_ ))YXK_[%_5O_2*:O@#_ ((J?\D\U+_L8+G_ -(K&OU_HK\
M?V^O^3A? 7_< _\ 3S<5^_U?@#^P+_R<+X]_[C__ *>;>OU^_:Q_Y)YXK_[%
M_5O_ $BFKX _X(J?\D\U+_L8+G_TBL:\ _;Z_P"3A? 7_< _]/-Q7[_5^ /_
M  7._P"91_[C'_MA7[_5_/CJ>DV^M?M<B*ZBCFC62*4)(BNHDA\/K+$X# @/
M'(B21MU1U5U(901^QW[6/_)//%?_ &+^K?\ I%-7P!_P14_Y)YJ7_8P7/_I%
M8U\@?#37_&7Q0_:"\7:AX8M_#[:U9?;X(SJT=R;>*WL9[?35EA,!>5+MHD17
M<%49);E0%5P@_0_XA>"OC[\2M&U#0[QO :6VI6=Q9S/$=8$BQW$31.4+*RAP
MK$J65@#C*D<$_P""<?[('BK]D2WUFS\07UG=6U]):2VD-G/<21Q21K,MPY2:
M&%4>13 I9 Q<1*&($:5\8?L"_P#)POCW_N/_ /IYMZ_?ZBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBOP1_X*&?MD7_ ,3/$#_";PK>V>FVSR"V
MUG5[F]AM[=B4W36QN"^V&WB7<EX/^/B>97LEBP&BN_H_]C+P1\(/V/+.9H/%
M_A_4=:N\K<ZG)J-E$QAW;D@AC^TR>3$,*T@#NTTH#NQ5(8X?T?\  OQ8\/?%
M#SO[!U73]3^S[//^Q7<-SY7F;MGF>2[[-VQMN[&[:V,X.#0/BQX>\5ZC<:1I
M^JZ?=ZE:>9]ILX+N&6XA\IQ')YL*.9$V.0C[E&UR%.&(%>@44445_,#_ ,%J
M_P#DH>F_]B_;?^EM]7]-VDZM;Z_;Q7EG+'/;3QI+#-$ZO')&ZAD='4E61E(9
M64D,"""0:_/#]L#_ (*1>%_V<K.ZL=*N;?5O$R9BBL8F,D-O+NDC9KR6/Y$\
MEHV$EJ'%TS;$*Q)(9X_B#_@G!^P+KEWKB_$7Q[%<0W$-Q--9V5]&6N[B[8L&
MO;Q;A3(FQRTD&X"XDN MSN2-(S<^_P#_  6,^!=Y\2?"5AX@TZ"XN;C0;B9K
MA(MI6.QN8P;B=TQYC>6\%ODQG$<332.IC5I(M#]A+_@I#X:^(/A^TT7Q9J<>
MG:[IMFB7%UJ$RP6]XL;F))$N9YW,EQY8A>Y$IC>29Y)(D:-7,?T!XY_:SM_'
MOB70?"'P]U&SU*^N[R&\U:[MMMY:VFCVK%[H/<0F2**XN"JVT(8/M,OS-;/+
M:S'U#4/VE+/P_P#$J+X?7WR2ZAH\-_IKK&S>9,LM\+J*5PQ"XBMXY8<HJ_).
M&EWM#&WYX?\ !5[]COPU+X8O/'VG01Z=JUA)$UT+>)4COUN[I(V:=5VC[0LD
MYE^T\O(-\<HDS$\'M_PT_MC_ (9LE_MS_C[_ .$/U3R_]7_QY_9;C[!_JOE_
MX]/L_7]Y_P ]?WN^O/\ _@BI_P D\U+_ +&"Y_\ 2*QK[ _;I_:"L_V</ U]
MJES;6]]+=8L+6RND9[>YFN58&.=55@T2Q+-+)&YC69(S!YB/(IK\P/@I\2_@
MO\ O,;P]\1_$&F_:-SSVEK9SMIPED\O>T%G?Z5?>7_JT2-Y9)[I85$;W4OSL
M_O\ ^RI\9?V?_A!J,O\ 87B#S]=U/S?M>LZP+M;BXR\ER_G7EW!!;1;C][;Y
M/VATA\SSIPC'[_\ VL?^2>>*_P#L7]6_](IJ^ /^"*G_ "3S4O\ L8+G_P!(
MK&O /^"YW_,H_P#<8_\ ;"OTO_X*%^/]4^&'PPU[5-&N9+.^CCM8X[B(@21K
M<7D%O(4;!*.8Y'"R+AXR0Z,KJK#Y?_X))ZMX.T#X;RWEG+9P:I!)<2^(YG?9
M)&$DF:V>X>4C;;K; -&RD6ZD7!!$PN:^0/ ?C_2_B?\ M6IJFC7,=Y8R23QQ
MW$1)CD:WT)[>0HV '021N%D7*2 !T9D96/W_ /\ !0OQ_I?Q/^"6O:IHUS'>
M6,DEK''<1$F.1K?6(+>0HV '021N%D7*2 !T9D96)_P35\?Z7X<^#&DW5Q<Q
M^7927T-P(R99$GDU"9HK?RH@\K7$HFA\BW56FF,T*QQNTL8;XP_;Z_Y.%\!?
M]P#_ -/-Q7[G?$+P5;_$K1M0T.\:1+;4K.XLYGB*B18[B)HG*%E90X5B5+*P
M!QE2.#^ /_!,/Q:G[*/Q!\0_#SQ08[2^OY(+>"=VDCCENK-Y1#%$)(D+)=QW
M)FMI9#$) L2(KO<QK7]!WBSQ39^!M.N]5U"3R;*QMYKFYEVL^R&%#)(^U SM
MM52=JAF., $X%?CC_P $EO %[XUO?$WQ2UBVCAN=>O)H[1D$\:[9)VN;\Q1N
M2C6[3&"..3?,ZO;31%E*OYGE_P#S=Y_G_H7*_7[]K'_DGGBO_L7]6_\ 2*:O
M@#_@BI_R3S4O^Q@N?_2*QK]?Z^?_ -J?X*?\-$^"]7\,+)Y,M];C[/(6V*+B
M&1)[?S&\N4B(RQ1B;:C.8BX3#[2/RA_X(W?&.S\*1:Q\.]57[#K2ZA+>007!
M:.:9A$D%U;B)T79+;?9E=XRQE97D(B"V\K5^MW[2GQ>3X"^#M8\2LT:R6%G(
M]N)4DDC>Z?\ =VL;K%ARDD[Q1L05"ABQ=%!=?A#_ ()"? N7X8>!I=<O8/)O
M?$%P+A"?-5S8PKLM0\<@5%W,UQ/&\882P3Q.9&&U4^0/^$LT[_AK;[5]KM_L
M_P!H^R^;YR;/M']A_9/(W9V^;]H_T?R\[_/_ '6/,^6OZ'J*_/#_ (*._L?7
M'[6'AJ Z1Y?]NZ1))/9+(S*L\<B@3VH8NL4;RE(GCED5@'A6,O#'++*OR!_P
M2:_:BM_#5A=?#?Q1<1Z=J.G7C+ID-XRVTCFXF*SV(1XX_P#2([EBPCD=[B4W
M+1I&$MCC]SJ^8/B1\8[S6-<3P5X47SM7_<RZQ>@KY.BV,ISYLC.DL;:A,@;^
MS[1DD#-BZGC^R1D3>/\ _!3'X%WGQY^'5W;:9!<7>I:=<0:A:6UOMW3-%NBE
M4HP+28MYIW2*,B625(U3>Q\M_B#_ ()G?\%"]#TK0[3P1XOO?L=W9^>MC?W3
MA+1K1 LD4$US+,=DJ9ECA#+%;BWB@@5O-V(_V_\ M!?MDZ=<6=MX>^'>K:?J
MGB[7;A++3?LCIJ$-IN9?/O;O[.91%%;Q%Y0763YEWF":"*XV?/\ _P %J_\
MDGFF_P#8P6W_ *17U??_ .R=_P D\\*?]B_I/_I%#7@'_!4?_DD/B'_N'?\
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M2>>*_P#L7]6_](IJ^ /^"*G_ "3S4O\ L8+G_P!(K&O /^"YW_,H_P#<8_\
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M[$.DG]J#XR^*?BB\4<FDV,DMKI=RJ7,*R2%%M+>6-7 #N+"-C=1RD&-[N)Q
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MZ'/J%G'JUSKEU+!8/<1+=2QBRM"7C@+"5T CD)95( C?GY6QY?\ M]?\G"^
MO^X!_P"GFXK]_J_GQ_81U:WT[]HGQM%/+'')<R>((H$=U5I9!JL4I2,$@NXC
MCDD*KDA(W?&U6(_6_P#:2\4V?BGX>>,C92>:MMH^M6TCA6">=%92B5$<@)+Y
M;$Q2-&76.=);=BLT,L:?#_\ P14_Y)YJ7_8P7/\ Z16->(?\%I_V?KC44TSQ
M[:"22.VC73+]!N98HS))+:S +&0B&22:*:220 O):QHFYF)_7[]G7X\Z7^TE
MX:LO$6ER1E9XU%S DA=K2Z"J9K60E(VWQLV Q1!*A29 8I$8_F#_ ,%8]3O?
MC#JGA3X6Z((Y=1U.\^W2JT4Y:%0'MK>9I(U91;A6O9+G:DCQI;B4A$'[SZ/_
M ."C?A:S\#?!#5M*T^/R;*QM](MK:+<S[(8;^SCC3<Y9VVJH&YBS'&22<FN@
M_P""7'_)(?#W_<1_].5W7P!^WU_R<+X"_P"X!_Z>;BOJ_P#X*_\ C_5/ OPY
MCCTRYDM5U+5(;&\,9 :6UDMKJ22$MC<J.T2"3:5+INB8F*1T;U#]A/Q9X&\#
M?"K2M0TR[T^QT^&W@_M>YDF6%4U1TB2Z^UR3E2LK2LJIYA ,36ZP_P"CF 5^
M:'_!._Q_I>M?&SQOXABN8UTF:SUV^2[E)AC%J^J6TPF<RA#&GEG>WF!2@SN"
MX./I#_@K_P"*;/QS\+-#U73Y/.LK[6+"YMI=K)OAFT^]DC?:X5UW*P.U@K#.
M" <BOT>_9._Y)YX4_P"Q?TG_ -(H:^@**_F!_P""*G_)0]2_[%^Y_P#2VQK]
M_OVG?V>M._:@\+W?AK4'\GSMDEM="))7M;B([HYD#CZQR!6C>2"26(21^86'
M\^7[&_[3%[_P3N\8ZKX+\7QR?V3)>"&\=//(M)X\JE_;PNJF2WGC*-(1$LTU
MN+>:/=Y2P2_TF^+- T[XT^'KO3_M'F:;K.GS0?:;61&WV]Y"4\V"3#QG*/NC
M?#H<AL,O!_FR_84_:@N/V O$NK>$_'<%Y:6,\D2SPA&E:SO%9%%P$$H0V\D#
MEYI;=)Y+A([5HO,0+N_=[Q_^W'\.?A]I=SJDGB+2[Q;:,N+:QO;:ZNIFR L<
M,,<I9G9B!D[40$O(\<2NZ^?W_P ??$OP3^%-OXU\8PQOJRR65UJ%M% R&&UO
M]3B!MDAD,#+<6]G<"%5F;*W$0\V2;#O)[!\3?@[X._;*\-0'4K>.]L;^S6;3
M[X1^7=01W2QRI/:R2)YL#L%B=E90'"B.:-TW1G\D/^"3?@76/A?\0_&N@PS?
M:-%TSS+*\GV1Q^;>6U[)#92;"SRINB2^;:C-&N<2,6$).?J>K6^B_M<B6ZEC
MAC:2*(/(ZHIDF\/K%$@+$ O)(Z1QKU=V5%!9@#^]VG>*;/5[RZL()/,N++RA
M<A58K$TRETC:3'E^;LVR-"&,L<4L$KHL=Q"TGX0_\$,?^9N_[@__ +?U^_U?
M@#^P+_R<+X]_[C__ *>;>OO_ /X*8_ N\^//PZN[;3(+B[U+3KB#4+2VM]NZ
M9HMT4JE&!:3%O-.Z11D2R2I&J;V/EO\ &'_!,K]O_P /Z=X:@\'>,-4CL;ZP
MD>+3[B[9T@EL]K2HDEU([11O 0\*+(;>,0_9881(X8#ZO_:*_:JT[XG?8_ /
MP\UZWG\2>(+B&W^V:=.D_P#9U@?-DO;U9E_T=I8X8)%%NL\-V/,6:(JXB+>/
M_P#!:O\ Y)YIO_8P6W_I%?5]H?LM^/\ 2[+X<^#I#<QR+<Z7I5C"(29FDNEM
MDCDA58@[%XFBF-Q@8MD@GEF,<4$SI^6'[?7_ "<+X"_[@'_IYN*_7[]J?X*?
M\-$^"]7\,+)Y,M];C[/(6V*+B&1)[?S&\N4B(RQ1B;:C.8BX3#[2/RA_X(W?
M&.S\*1:Q\.]57[#K2ZA+>007!:.:9A$D%U;B)T79+;?9E=XRQE97D(B"V\K5
M^MW[2GQ>3X"^#M8\2LT:R6%G(]N)4DDC>Z?]W:QNL6'*23O%&Q!4*&+%T4%U
M^$/^"0GP+E^&'@:77+V#R;WQ!<"X0GS5<V,*[+4/'(%1=S-<3QO&&$L$\3F1
MAM5/F#]@7_DX7Q[_ -Q__P!/-O7W_P#\%1_^20^(?^X=_P"G*TH_X)<?\DA\
M/?\ <1_].5W7J'P)^/NE_M)GQ-X>O(8Y+O1-4U#2]2M)(";>6U-S<PVK8<R)
M*DT$12=6()F2;,*0M%O_ !0_X*!_LHQ?L[>/O#6J_#X?9K_7M0WV.GJD0AMM
M2MI[8Q& RGREBDEGC(@E'DPLK ,+=DAA_I.U;5K?0+>6\O)8X+:"-Y9II75(
MXXT4L[N[$*J*H+,S$!0"20!1I.K6^OV\5Y9RQSVT\:2PS1.KQR1NH9'1U)5D
M92&5E)# @@D&M"BOY@?V;_\ C7W\<I](US_B7Z+=_;+&.\O^=VG3R&2PNA-%
MMB'F2V]NDTQ7R8<W"RK"T;F'^GZOF#]J[]I2S_9OT,SK_I&NW^^VT/34C:>:
M]OF 6)!!&R2/$KO&9V5E(5EC0F>6&.3K_P!FOX0I\!?!VC^&E6-9+"SC2X,3
MR21O=/\ O+J1&EPY22=Y9%!"A0P4(B@(OXX_M]?\G"^ O^X!_P"GFXK]_J_
M'_@AC_S-W_<'_P#;^C_@N=_S*/\ W&/_ &PK]SHO'^EW3V$<%S'.VJ1M-9&
MF99H$C$C7"M$&46X5HQ]H8B'?-;Q>9YMQ"DGX8_\W>?Y_P"A<K]?OVL?^2>>
M*_\ L7]6_P#2*:O@#_@BI_R3S4O^Q@N?_2*QK]?Z*_GA_P""@GBS3K+]H#P=
M/+=VZ1:?_8/VV1ID5;7;JDT[>>Q.(L1.DQ\S;B)UD/R,"?Z'J_GA_9#\4V?P
MK_:,\6VVNR?V?+JEQK%M9+<*T?G376I0W5LBE@ //B7? S$+-NC6,L\L2O\
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MD:17[_XX_ GX!_M ^*#XKU?Q7IZW<OV?[5;P:_8I;W7V<*@\T,7E3=$B0O\
M9Y8?D0,NR4M(WV!XI^+GP@\::')X9O\ 7/"\NBRVZVQLAJ=DD*PH (TC5)E\
MKR]JF%H]C0LB-&49%(^,/@-^SG^SW\ ]4CUFW\3:7J=];R1RVDFHZYI\JVTB
M!\/''"8(F?+!@TRRF-XXY(C&Z[CU_BGX*_LW^.;R34-5U71[Z]FV^;<W/BVX
MFF?8H1=\DFI,[;5557).%4*. !7V!X6_:+^&O@^SCL;;Q;H[Q1;MK7/B"*[F
M.YBYWSW5U+,_+$+O=MJX1<(JJ/F_]ICP[\#/VKDC;Q!XBT-+Z"/RH-0M=:LH
MKJ*/S%D*9,CQ2)D,%6>.41B25HQ&\C/7G^D_"SX.37$4OB/XAR>*;:WD2:&P
MUWQ7:WEFEQ&P*3F!7B61PN^/;+YD+1RR(\;!N/M#_AHCX8Q:=_94'B?P_;60
MM_LT<5KK%K:^5"$\M4@:">-X-BX$;0E&BP"A4J"/C_\ X4K^S?\ VC_:_P#:
MNC_VE]H^U?;/^$MN/M'VC?YGG^=_:7F>;O\ G\S=OW_-G=S7N'Q-\3_!KXQZ
M7!HNN^)M+N].@C6,0'Q2Z+,JF,J;HQWZ-=NK1(ZR71F<.#(&#N[-Q_P<T?X#
M?L_WC7WAC7='T^5\>:L?BF1H9MJNB^=!)?O#-L$CF/S4?RV8NFU\,/I__AK'
MX>?]#7X?_P#!M9?_ !ZC_AK'X>?]#7X?_P#!M9?_ !ZOC#X^_#[X&?M!ZI#K
M]UXITO3-=AD@D&JZ7KUE;73&W!\K<6>2(NI*%9_+%PHBA19A'&$K/\+?#7X*
M65Y'?>(O&UOXNEM]WV1?$?B6TU&&U\Q2DOE0,Z0MYHV%_.27#11.FQTW'[ \
M4_M%_#7QA9R6-SXMT=(I=NYK;Q!%:3#:P<;)[6ZBF3E0&V.NY<HV49E/Q?JW
M[/\ ^S-K]Q+>7E_H<]S/(\LTTOBJ=Y))'8L[N[:B69V8EF9B2Q))))K[ \%?
M'GX9> +=K6S\7Z7)&\AD)O/$HOY-Q55($M[>3RJF%&(U8(#N8*&9B>O_ .&L
M?AY_T-?A_P#\&UE_\>H_X:Q^'G_0U^'_ /P;67_QZOD#]HOP/\ _VG=T^LZY
MX?@U)L?\3.RU>Q@O#CRA^\?S&CG^2)8E^TQS>5&6$7EL=U>?^$_A9\,?!_V2
M*#XN:P;*S\E8[+_A-+6*W,,6 L&V#RG2+:HCQ"T3*G",A (^P/AI\7/A!\&]
M.32O#VN>%]/LDVGRH-3LEWLJ+'YDK>=OEE*H@>:4O+)M!=V/-=__ ,-8_#S_
M *&OP_\ ^#:R_P#CU?GC\>?V<_V>_CYJDFLW'B;2],OKB226[DT[7-/B6YD<
M)EY(YC/$KY4L6A6(R/)))*9';</7_P!F?P[\#/V44D;P_P"(M#>^GC\J?4+K
M6K*6ZEC\QI F1(D4:9*AE@CB$@CB:02/&KUH?&/1_@-^T!>+?>)]=T?4)4SY
M2R>*9%AAW*B-Y,$=^D,.\1H9/*1/,90[[GRQ] ^#GCKX/? *S;3_  [XET>V
MLCC;;2>)!=0QX9W/DQW5[,D&YI':3R0GF,0S[BJD=AX_^.7PH^*>EW.BZUXA
M\-WFG7D9CG@DU:SVLN0001,&5U8!XY$*O&ZK(C*ZJP^(/@-^SG^SW\ ]4CUF
MW\3:7J=];R1RVDFHZYI\JVTB!\/''"8(F?+!@TRRF-XXY(C&Z[CO_M,?!OX#
M_M2ZI'K6J>*M+LM1$?ES3Z?K6FQ-<JH41FX$HF5WC4;$D 5RA$;LZ1PK'H:_
M\*/@'KO@:W\ #Q)H]OIMO<1W:W,&MV*WC7BJ4>ZED+M'++(C/&_F1M&L;!(H
MXEB@$78?!#0?@C\ /#]QX>T?Q1I:QWDBR7E\/$4%OJ%PR/OB#7=G/;2HD8^1
M(X3$FPR95FFG:7C_  M\%?V;_ UY'J&E:KH]C>P[O*N;;Q;<0S)O4HVR2/4E
M==RLRM@C*L5/!(KZ ^,?CKX/?'VS73_$7B71[FR&=UM'XD%K#)ED<>=':WL*
M3[6C1H_.#^6P+)M+,3Y_\'-'^ W[/]XU]X8UW1]/E?'FK'XID:&;:KHOG027
M[PS;!(YC\U'\MF+IM?##G_B7\/OV>_C)J+ZKXAUG1]0O7W#S9_%<S;%9VD\N
M)?[1V11!G<I#$$BCW$(BCBOH#X:?&+X5?"+3DTK2/%.CI91;1%%/XB2[\I51
M8UCB:[NYGCB544)"A6).2J LQ/?_ /#6/P\_Z&OP_P#^#:R_^/5\H?%#PI\
M_C5<?:O$>O:7J4BR321BX\6W#QPM.P:001?VEY4",57]W"J( J*%"JH'E_\
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MZ/K4O'E+JVM:;<0Q?*Z-B"/R89-P?)^T)-L9$>/RW!8_H]_PUC\//^AK\/\
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MOV@+Q;[Q/KNCZA*F?*63Q3(L,.Y41O)@COTAAWB-#)Y2)YC*'?<^6/J'PO\
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MH]M9'&VVD\2"ZACPSN?)CNKV9(-S2.TGDA/,8AGW%5(]?_X:Q^'G_0U^'_\
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M (<J?#S_ *"7B#_P)LO_ )!H_P"'*GP\_P"@EX@_\";+_P"0:/\ ARI\//\
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ME_\ (-'_  Y4^'G_ $$O$'_@39?_ "#1_P .5/AY_P!!+Q!_X$V7_P @T?\
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M>AW6GZ;H%U<16(N+=Y7U>26:WN'DR7A$-M%A"$:!FNDDCCE6=/,:./\ 0_\
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M_P""</BS4?'/PMT+4-5N[B^O9OM_FW-S,\TS[-0N47?)(6=MJJJKDG"J%'
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M(PC/U_\ "'XT>'_CUI:ZSX:OH[^Q:1XC(@=&22,_,DD<BI+&^"K!9%4LC)(
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MQ_X_TOX6:7<ZUK5S'9Z=9QF2>>0G:JY    +,[,0D<:!GD=EC16=E4_"&O\
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M+E79-#O:Z3<K?9RIS7C_ ,=/^"I7@'X#:Y/X?N5U#4;NT^6Y?3XH)889LD/
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M]X7_ &?[-;[Q/J=OI\3Y\I9"6FFVLB-Y,$8>:;89$,GE(_EJP=]J98> 7?\
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M#^EWQK\/=&^)5NMGKFGV>I6R2"5(;RWBN(UD"LH<)*K*'"LRA@,@,PS@G/X
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M#]@OX0Z7\-/ NCWUFLDE]K&EZ9=WUY.YEN)6-I'Y,)D/(M[:,B"U@7"0PK@
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M_!3SPDG[*/Q!\/?$/PN([2^OY)[B>!%DCCENK-XC-+*8Y4+)=QW(AN8HQ$)
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MQ%^QM)JJGY7^6*3S[>U\V39LGEP$?Y!)S_\ P7._YE'_ +C'_MA7[_5^ /\
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M_P!(KZOO_P#9._Y)YX4_[%_2?_2*&OR!_;Z_Y.%\!?\ < _]/-Q7[_5^ /\
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MOX8_MQ_L 7'[(B#Q]\/;^\M+&VD(ND%TT=U8&YD,,;6MPACE>W(F6V9&9[A
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ME/@IIGB73[;9L_LW7KFU!>9X[>:TD614*1_/Y/VH22.RQ(((I925VA3] ?\
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M ).%\!?]P#_T\W%?H?\ \%%/VF-4_9:\%'5-%CC.HWMY'I\$TF&6V:6&:4W
MC*E97582(T?"!V5W$B(T,G'_ /!/S]E'0_AYX>T_QA=C^U?$VNV\.JW&JW:"
M2XB:]A,AC@=R[Q_+.ZSRAO-NG9WD;88X8OB#]@7_ ).%\>_]Q_\ ]/-O7O\
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M8UZWT74M*T=;33O,M!=>9<%K[S1-YF8X8BERD8D$=R_S2,(E:)/,S_'G[/\
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M*(]3\1QWEMYMU)#]GL[#3S%)]LBLK2V1$N;AYFC<W$ZV[W$=O!&6M@A#_?\
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MXNW^GW&FV'F^1X?T3[9!8RS,H5+RYN)9$N7E4/(BQ(%6,*C)*%EN8IOT?K\
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M 87<HCQ^:L3ML'U?11111111111111111111111111111111111117X(^$_
M'QU_8%O;Z33+:/QCX<N;Q[Z\$8\VZN);F>..28KG^T%O7CB0R;1?6L(E:5A.
M4=U^C_"W[?'Q*\87D=C;?"C6$EEW;6N;R6TA&U2YWSW6G10IPI"[W7<V$7+L
MJGZ ^#GP<\6^/-8T[QI\2VT]-7TNWFCTC3-+$BV]D;V-5NYKB1WD>>[=<6QC
M622SB2,R1F62421_;]%%%%%%%%%%%%%%%%%%%%%?SP_MBWFM?$GXO^'?%^C>
M&/%%YI&A?V3Y\JZ%?1M/]EO9+R7R(YXHG.%E$8\X0YE5O^6>V1OW^\+>)8/&
M%G'?6R7"12[MJW-K<6DPVL4.^"ZCBF3E25WHNY<.N496/044444444444444
M4444444444444444444444444444444445^6'B#]M'XC?#_QYJ.EZIX$U2[\
M*V\DL5M<Z58W-Y=.H53#<B8-]DF27JT \E[<2['D:6W=)?8/V*?V<-4^#]QX
MF\2Z\D=MJWBO5&U"2QAN1<QV<#-)/';O)Y,0:XCDNKB.9XS)"X2)HR/F+?=]
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%?EA\4?VY_%7@?XRZ?\ #RUT*.;2;J2RC,Q2X-U/'<IN
MEO8'7]T+>V)?S1Y<H(M+C=/%D^1^I]%%%%?EA^W/^W/XJ_9@\5:%H>AZ%'J-
MMJ,:2.\B7#27<C7'E&RLC%A5N%4*22MT<W4'[@  3?J?1111111111111111
M11111117'_$+Q)<>#M&U#4[.TDO[FSL[BXALHMWF7,D,32) FU)&WR,HC7:C
MG+#",>#\(?\ !.?]L3Q#^U[IVK7.O:;;VGV"X@C@NK1)DMY_-1F>$"9Y?WL.
MU'D*RGY+B(&./ :7]'Z******S]6U--%MY;J42-'#&\CB**2:0JBEB$BB5Y9
M'P/ECC5G<X559B ?RP^'W_!1W4?BK\4M-\"6V@7&D64OVG[6=6C>+4CMT]KN
M+%LK!+;YD.=[7/G0NCKY).*_5^BORP^%W[<_BKQQ\9=0^'EUH4<.DVLE[&)@
MEP+J".V3=%>SNW[HV]R0GE#RX@!=V^V>7 \_]3Z*********************
M*****_)#]MO_ (*87O[.%PVDZ-X?O&NS)+''J.JVT]MI\C0M"9#:)^[EO4 =
MXVD5X$1_*E1KB&12WZWT445S_BGQ9IW@:SDU#5;NWL;*';YMS<S)#"F]@B[Y
M)"J+N9E5<D99@HY(%?FAIG_!3)_B_JATOX:^$M4\3-#)*ES<R2QZ=:QJ Q@D
M$TBS*B3K'*8Q=_9')54"/*Q1/0-3_;@UOX2(+KXB^"M4T#3I)(D74+.YM]8M
M85:18Y)+U[;8UJBM)%Y8VRO<%G6-&>/:WT!^S1^TQI?[4MEJ6J:+'(-.LM4E
MT^":3*M<K%!;RFX$94-$C-,1&CY<HJNXC=VAC^CZ*_/#X\_\%/?A]\ ]4DT:
MXEO-3OK>22*[CTZ%)5MI$"9222:6")GRQ4K"TIC>.2.41NNT^P?LS_MI^#OV
MKDD7P_<R)?01^;/I]U'Y5U%'YC1A\!GBD3(4LT$DHC$D2R&-Y%2OJ^BBBBBO
MD#QW^TGJ.J>([WP/X)TS^T=?L;>.6^O+UGMM(T[[1 \EO]HF1))IY7/DE+:"
M/]['(Y%Q'Y$YB^$(_P#@IGXJ^ 'C&3PK\6-%L[2$R1A-0TP7 C2W;S +M(Y7
MG:[MW8)S&89H0DRM#)<(;=?VNHKC_'_C)/A]I=SJDEM>7BVT9<6UC;275U,V
M0%CAAC!9G9B!D[40$O(\<2NZ_GA^RM^W]J/[3OQ#U3PQ_8_]DZ;IVGW4OEW6
M_P#M$W%O>PP?OURL<'R2XDMMDCQ3(1]H=>*_3^BORP^%W[<_BKQQ\9=0^'EU
MH4<.DVLE[&)@EP+J".V3=%>SNW[HV]R0GE#RX@!=V^V>7 \_]3Z***\_\=>,
MK[PEY/V+1M0U?S=^_P"Q26">3MVX\S[=>6F=^3M\OS,;&W;,IN_/#3/^"M/A
M76M4.AVOAWQ9-JRR2Q&PCTVW>Z$D(8RH8%O#*'C".9%VY0*VX#:<=AJ/_!3G
MPOX/O+6V\3Z)XH\-Q7?F^5=:MI)@A/E*&; CEEF?ED0^5%)M:1"^U"6'V_\
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M)&68*.2!7'^"OC?X5^)5PUGH>MZ7J5RD9E>&SOK>XD6,,JERD4C,$#,JEB,
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M_<?_ /3S;U^]VK:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22
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MGD?-YGF?NJ_1[]K'_DGGBO\ [%_5O_2*:OR!_P""&/\ S-W_ '!__;^OK_\
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MK9/$EO$\UG<17$:R"QO&*%XF90X5E8J3D!E.,$9_2[]D[_DGGA3_ +%_2?\
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M!^,NASZ5;:1I^C7;?/;:AI]C!!-#,H(0L(EC\Z(Y(E@<A74Y5HY5CFC^(/\
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MD9-L\\J#+1(=P 8;< X)!^ /AS^SQKGQM^.7B77/B%H'VG0]/MY;?23=H9;
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M]4UW2_$.BW5S)+IVFR6$EE Y!6!KLW9G$9(W*CM$CF/.P/OD50\LK/\ /_\
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MEBN!?1M]FM[*]B=G=8HEV6EOM"&W="\ZRR7%U=K^_P!17Q!_P4(_:4O/V7O
MT^JZ7QJEY<16%C*8UE2&:57D:5U9E'R112F/(E7S_*#Q/$7%<?\ LM?L8^'X
MO#5CJWC/38]<\4:I9VUQJEYK<#W=T)&4O' R7S3F%[>-UM7V"(R"!#(@*JJ?
MGA^V]\'+S_@GMXHT_P")?P\;[#97]Q);WECA?L:3./--MY0=7:TNECD?R%4+
M:R0;XI82;5(/U?U[X3_#_P#;XT/1?$.JV7]I61MWGL<W4T30?:1'Y\4GV.X5
M/-1HEBF0M)Y4L3H""&S^('_!*3]ESPA^TI_PD?\ PE>G_;_L']F_9O\ 2;F#
MR_/^U^;_ ,>\L6[=Y4?W]V-O&,G/]'WPM^%NC_!;1[?0=!M_LFFVGF>1!YDD
MNSS9'F?YYG>0Y=V;YF.,X&%  [#5M,36K>6UE,BQS1O&YBEDAD"NI4E)8F26
M-\'Y9(V5T.&5E8 C^9']KS]ESPA\+_C)X2\*:1I_V?1=3_L?[9;?:;F3S?M.
MIS6\W[V25Y4W1(J?(Z[<;EPQ)/[_ 'P+_9<\(?LU_;/^$4T_[!]O\G[3_I-S
M/YGD>9Y7_'Q++MV^;)]S;G=SG Q^$/[.'@_7/'_QU\<:7HFH_P!DK<W&NIJ%
M[&";R.Q_M:(RBP;E(KN1A'$D[@BWC>6=%::.('W#_@HG_P $[/!'PG\$7'BC
MPO;R:7<Z7) 98A//<QW4=S/#;[6^T32-&\;2"1'C."/,1XW+H\/Z/_L.^/\
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M*D9=]H"D*/Z/M6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q 4 DD
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M$<;7&A/<2!%R0B&21RL:X2,$(BJBJH_>[XE_"K0_C)ISZ5XAL+?4+)]Q\J=
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MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK\ ?^;O/\_\
M0N5^_P!7\T/P%LO#VE_M#^)=(\;:;;SQ:MJ&KP646HVL+PK<7%X+NTE*W6 /
M/B4I;.BN\K7,*H"DVZOW>_X9.^'G_0J>'_\ P4V7_P 9K0^&&C>"O!FJ:GHO
MA>STNQU&UCLY-4@T^UAMV19Q,;07!AC52Y5972-B71'$A54F1G_,']J+_@E'
MI?Q\N+CQ;X'U:."[U:1KYXKAS/I]RUTT<AF@N(@\L*.&EGZ722/(B1BWA QX
M_P#L6?MQ^-?A1XQMOAC\1Q)*9+R2T^TWIFEU"WNI]IMHVF4RBYMY9"$B=@1L
MN4F6Z^R1(E:'_!<[_F4?^XQ_[85^_P!7X _\W>?Y_P"A<K]_J_ ']OK_ ).%
M\!?]P#_T\W%?H?\ \%--)N-:^$GB**UBDFD6.SE*1HSL(X;ZVEE<A02$CC1Y
M)&Z(BL[$*I(\O_X)'?$O3O&'PSM=(MG_ --T6XNH+N)F3</M%Q+=Q2JJLS^4
MZRE%=U3=+#.J@B/<?T?\6>*;/P-IUWJNH2>396-O-<W,NUGV0PH9)'VH&=MJ
MJ3M4,QQ@ G KYP^-_C6W^)7PCUO7+-9$MM2\)WUY"DH42+'<:=)*@<*S*'"L
M P5F .<,1R?B_P#X(J?\D\U+_L8+G_TBL:\ _P""YW_,H_\ <8_]L*_?ZOYT
M?^"+/B2X\(>*O$OA6\M)(;F:SBN)C+NCDMY-.N#;O \+)N#EKP[MQ4QF$J48
MOE/Z+J_GQ^%W@.WNOVJ]0E\/)'+8V$E[>WSQSK(L<D^G>5=L2[DE_M]T8Y(D
MR879DV(D3!-#]OK_ ).%\!?]P#_T\W%?O]7X _\ !#'_ )F[_N#_ /M_7Z7_
M +7?[)'AK]LJWBTO4;N2UU;2XWGM9;>16D@6\5HU:>W;(DMY9+<'_ED[FV=(
MKB/][G\0?$_AOXI?\$F-4BNK*[CO_#U[)<+%GSY--GD<;5%U;;XS;WICBBF4
MQOEE0Q)<SQ1W*#^BWX _&.S_ &@/"^F>)[%=D6H6XD:++-Y,RDQSP[G2,OY4
MJ21>8$59-F]1L92?8*_G1^+?C6W^"'[4T6N:XLEMITTEHJ7$@6./R[K25T\7
M'F2M&GV>.9F$\H8A!#-]YXRE?T75Y?)\7M+3Q5'X.#2-JSZ7)JK*$/EI:I<1
MVREI#@%Y)'8(J;B!%(7\O,7F?A#_ ,$6?$EQX0\5>)?"MY:20W,UG%<3&7='
M);R:=<&W>!X63<'+7AW;BIC,)4HQ?*?T75_/C\+O =O=?M5ZA+X>2.6QL)+V
M]OGCG618Y)].\J[8EW)+_;[HQR1)DPNS)L1(F":'[?7_ "<+X"_[@'_IYN*_
M?ZOP!_X(8_\ ,W?]P?\ ]OZ/^"YW_,H_]QC_ -L*_?ZOQAT[X_>*/^"B?BVZ
MT+P/J=QH'@;2/*_M/5+<B'4KW?(6C^S,P\ZV\TP.L&W9LA$LMUO:2.PKX?\
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MYGN&D-N_V4O<RB.0)$K"!(D"R*9988^/_P""U?\ R3S3?^Q@MO\ TBOJ^_\
M]D[_ ))YX4_[%_2?_2*&O(/VZ/VS;/\ 8\T..=8?M>M:CYT>F6S!O)+1!/,F
MG=<8BB\R,F-6$LS.L:%%,DT/C_PB_82O/B5]C\3?&2^N/$.OK^]CTN651I=@
M3Y!5%MH D,DN(%%T$_T.<LRM#<;!<R?('_!#'_F;O^X/_P"W]'_!<[_F4?\
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M#)<R1QNZ01&,22LJDB-#*\<0=B-JF1XT!(W.JY8?AC_PI?XG?\+O_P"%H_\
M"'7']F_:-OV3^U=*^T?9_L']G>;_ ,??E^;L_?\ D[MF_P#<>?M_?U^YVDWK
MZC;Q3RPR6TDD:.\$IC,D3,H)C<Q/)$74G:QC>1"0=KLN&/Y _P#!0G_@GMJG
MQ5U1/'G@-Y$\3));FYMA<"!IF@"1P75K/(Z+!<0JB;EWQHZ1B1"EPA%S\_\
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M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?GA_P53U:WT[X2:U%/+'')<R:?%
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MK]SO'\>LRZ7<CP])9QZMY9-HU]'+):F0$$+,L,D<H1@"F]&)C+"3RY=OE/\
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M_B]/P7T:RU[_ $NWN]/O=-G3_5;[.*>XL4BS#L88MT2/>I$AQO+F0ES\ ?\
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M@-YW+;0#:Q*KLRH4LY;G_P#@AC_S-W_<'_\ ;^OO_P#X*C_\DA\0_P#<._\
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M  &__P %J_\ DGFF_P#8P6W_ *17U??_ .R=_P D\\*?]B_I/_I%#7T!17X
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M=*FF,7NM7N ]Q9JB3R';%!%YLIG(\J"\CDMUMGA"-)(_V_\ \$N/^20^'O\
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MK_\ MJ[U'P_J#16VF127<T,,L B:>]2-3]ABA^T(\QO# RJLBA7E0QU\@?\
M!)/XZ:'\.O!KZ-<S^=J^I^*##:Z;;XFO'6:VLU-RT"G>EI"L<TT]RX6*..&3
MYFDVQMY__P %!/%FG67[0'@Z>6[MTBT_^P?MLC3(JVNW5)IV\]B<18B=)CYF
MW$3K(?D8$_T':MJUOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B H!)(
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M5CX=U*WU:XO+>2Z*6DL;M:VT:H3-=HSK)!\\L,(A=?M)EE_U'EPW,D'XP_\
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M9IU[^T!XQGBN[=XM0_M[[%(LR,MUNU2&=?(8'$N8D>8>7NS$C2#Y%)'Z/_\
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M)^)=&2#QS/)I6K6D<$3SF&6YCOV$0$ERHL[;$#M(KL\!140/'Y<DGSK%[_\
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MMI0/WN\+?%70_&FAQ^)K"_MY=%EMVN1>EPD*PH"9'D9]OE>7M83+)L:%D=9
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M,&1T=8@RNK ,K*05(!!!%=AXZ^$_A[XH>3_;VE:?J?V??Y'VVTAN?*\S;O\
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MK-)E40>=):R0O/M6-%C\XOY:@JFT,P/K_P -/A5H?P;TY-*\/6%OI]DFT^5
M@7>RHL?F2M]^64JB!YI2\LFT%W8\UQ^K?LR>!=?N);R\\-:'/<SR/+--+IEH
M\DDCL6=W=HBS.S$LS,26))))-=!9?!#PKIVES:'!HFEQZ3<R"6>P2QMUM99
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M%?FA\??^">%Q\:O'D/CBU\6:II,B1P1&&W#>?#'&ICE2QNEFC-HDL;/E?+F
MFEGE82+*8A]O_"'X0Z7\$M+72]+60J9'GN;F=S+=7EU*<S7=W,?FFN)6Y=S@
M8"HBI$B(OJ%%%%%%%%%%%9^K1W$UO*MG)'%<F-Q#)+&TL:2%3L9XUDB:1 V"
MR+)&6 *B1"=P\?\ A5^S]HWPIN+K4XQ)?:W?22O>ZS>^5)J%P)&0^4TT<<:Q
MVZ+'%'%;0)%;QI$FV(,"S>X4444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M5\(?\%#/VJG_ &6/!SW6G2QIKNHR"UTP,L<A1OO3W)B=U+)#'G#;946XDMEE
MC:.0@^/_ +0/_!,:P^-OA\M<ZK>7GC6./<NN7L\S1SR;Y)6MVM [P6EDSRN(
MHK2-3:C8P\_;*EQT'_!-2]^)MOI>KZ7\18;P+IUXL-A<WY+W4S$R&Z7SF=FN
M;=&\HV]Q\Z.)'2.>6*-4A^[_ !UX-OO%OD_8M9U#2/*W[_L4=@_G;MN/,^W6
M=WC9@[?+\O.]MV_";?Y\? _[3WQG\?\ Q-D^&]KXOC22/5+^Q-])I.GA?+L#
M,99A"MLQWM' [1Q;\%RL;3*I,@_3_5OV?/C/#;RM9_$R.6Y$;F&.7PUI\4;R
M!3L5Y%,K1H6P&=8Y"H)81N1M/R!XD_X*%?$W]D76;32/BCH-G<V,D>R/4-/)
MCDNUBE2.2\C?S'MY'V!I&M#'8N#-"6%JC*K?L]X \?Z7\4]+MM:T6YCO-.O(
MQ)!/&3M9<D$$$!E=6!22-PKQNK1NJNK*/S@_;G_88\5?M/\ BK0M<T/78].M
MM.C2-TD>X62TD6X\TWMD(LJUPRE006M3FU@_?D$&']3Z********X_P'X_TO
MXGV":IHUS'>6,DD\<=Q$28Y&MYGMY"C8 =!)&X61<I( '1F1E8]A11111111
M11117Y0?#CQ]_P -_P#C3Q3I<VJ7'_"#:!Y%I'IME)]G757N([J"6>YO;6;S
MI;0E)C'!%(D%Q$;621%:.5)OE#XJ_L??$']BGQC:ZY\(?MEYH^I7D2MIJ,\L
M<4GSA;;4$+JLMEMDD$-Y,RFU#-YD\,ZQ74_]!U<?X_\ '^E_"S2[G6M:N8[/
M3K.,R3SR$[57(   !9G9B$CC0,\CLL:*SLJGH-6CN)K>5;.2.*Y,;B&26-I8
MTD*G8SQK)$TB!L%D62,L 5$B$[A_/C\/KKQ1I?[3.FZ%XGUZXU^73?M/E3R1
M"VA7[1H32MY-G&[0V^0463RL>:T8E?+L:_H>HHHHHKC_ !_X_P!+^%FEW.M:
MU<QV>G6<9DGGD)VJN0   "S.S$)'&@9Y'98T5G95/XP^&_VHOB1_P44UF[TS
MX>7$?A3PY81^7J%[,T<UY)'=RO''(F(V>*X\F.22&*V>,12)+OU#+6Y7Z_TG
M]@_5-%MXI8OB%XT;5H8T9)Y=2$UF;I%!$CV,J.)+?S!N:UDF8/'F)I6R7/S!
M'\=OB;\'_BIX5\'_ ! U".31)+R\6VU6UM# NLM<PS06:W*P917AFGAC:V1(
MTA=HYYC,HM[L_M=11111111111111111111117YP>#_B?KG[;6N:C;:-=?V7
MX!T;4!:S7]E<E=2UB[M3YDD-O<VTO^BZ>^^%WFB(N)X0BQSJ+F=+7/\ ^"@7
M[$NL_M/:-HFE>%;RSTVVTB20'3YO-@LVC,21PL@MTD57MU1HH4\K CGE"R1@
M%)?O_P"'OANX\':-I^F7EW)?W-G9V]O->R[O,N9(8EC>=]SR-OD93(VYW.6.
M78\GL*****S]6CN)K>5;.2.*Y,;B&26-I8TD*G8SQK)$TB!L%D62,L 5$B$[
MA_/C\/KKQ1I?[3.FZ%XGUZXU^73?M/E3R1"VA7[1H32MY-G&[0V^0463RL>:
MT8E?+L:_H>HHHHK\T/\ @IW-XQ\+^#+S7_#_ (BDTBQL([83VEK;;+JZDGO8
M(@W]H"82VZ(&4JD$:EQYJ222)*JQ=A_P2X_Y)#X>_P"XC_Z<KNO+_P!AC]AC
MQ5^S!XJUW7-<UV/4;;48WC1(WN&DNY&N/-%[>B7"K<*H8 !KHYNI_P!^ "9O
MU/HHHHHHHHHHHHHHHHHHHHHHHHHHHHHKY _;>T_Q1)X-U.^\-:[_ &'_ &?I
M^H7=TT=F)[BY2&VD<00SM,GV3.&)GC1YU?RWC>/8RR_)_P#P1JU:XU_P+J]Y
M>2R3W,_B2\EFFE=GDDD>TLF=W=B69V8EF9B2Q))))K];Z*************\?
M^,?PF_X6C9K]DO;C2=7MLMI^J6IQ-;ON1RCH2$N;21HH_M5E-F"Y5$W!9(X9
M8_(/V9/VG)?BY>:MX9\006^F^+-!N#!>V44DI6XA58P-1M5GBBD^R3.Q,2_O
M6CB:!GD(N(B_U_1117Y0?M7?\%![S1M</P[^&MG_ &QXLN-]L;E&5H;&Y)&4
M",ICFEB02O.TC1VUFRJ9C*([F&/T#PY^Q%XH\3Q&^\8?$'Q1)J\_EM,NBWHT
MRQBQ%&ABB@6)D;:RN?.5+?S@0[0)(79OG#XW^+OBS_P3R-OJL6IR>,O!0D:.
M9=1C!O+,2W.]5GO$S.SLA\F&\D,ENLCF-K./_1(W_4[X%_'30_VB]#@\0>'Y
M_.M)OE=&PLUO,H!>"= 3LE3(R,E64K(C/$\<C=AX_P#'^E_"S2[G6M:N8[/3
MK.,R3SR$[57(   !9G9B$CC0,\CLL:*SLJGH-6CN)K>5;.2.*Y,;B&26-I8T
MD*G8SQK)$TB!L%D62,L 5$B$[A_/C\/KKQ1I?[3.FZ%XGUZXU^73?M/E3R1"
MVA7[1H32MY-G&[0V^0463RL>:T8E?+L:_H>HHHHHHHHHK^='_@L3-XQ\(7%A
M%>^(I+G1-9DOC#I%O;?8[>WCM6LV19V6:1KYRS))OGP(YE=X8XED\M/Z+J**
M***_+#]AC]ACQ5^S!XJUW7-<UV/4;;48WC1(WN&DNY&N/-%[>B7"K<*H8 !K
MHYNI_P!^ "9OU/HHHHHHHHHKC_"?C_2_'3WT>F7,=TVFWCV-X8R2L5U'''))
M"6QM9T65!)M+!'W1,1+&Z+V%%%%>7_%[PSX@\7Z6UGX:U>/0[YY$)OGL4OV2
M-3EECADECB#L0JEY!* F\",.R21_CC_P1:\6:CXYO/&6H:K=W%]>S?V+YMS<
MS/-,^Q;Y%WR2%G;:JJJY)PJA1P *_=ZN/\:^&;KQ5;K!9ZG>:5(L@<SV:6CR
M,H5@8R+VVNHMA)#$JBOE5PX7<K?@#\8?VGOBMX!^+/\ PKBS\7R-;3:IIUG#
M>2Z3IC21QZB+=T+HMLBR/$MP%8J8A,4+!80^U?TO_P"&>/B]_P!%/_\ +6TW
M_P".5\X?M1>'OCO\ /#]QXCTSQO'K-M8QM+>P_V#96]PD>^-=\21P72R(BL\
MMPTC0B&&)GRXSM_8ZBBBBBBBOD#]M[3_ !1)X-U.^\-:[_8?]GZ?J%W=-'9B
M>XN4AMI'$$,[3)]DSAB9XT>=7\MXWCV,LOR?_P $:M6N-?\  NKWEY+)/<S^
M)+R6::5V>221[2R9W=V)9G9B69F)+$DDDFOUOHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKYP^-_[4WA_P"!5Q;Z9=+>:CK=
MY&TMGHVF6SWFH7$:-AW2%,*J*HDDW3/&'2&;RR[1,H^7_&O[<?C/X)VZZOXV
M^'UYIFA+(([B]L]8LM2DA9U81$P1+& C2!(S)))$BEU&YI&CBD^S_@7\=-#_
M &B]#@\0>'Y_.M)OE=&PLUO,H!>"= 3LE3(R,E64K(C/$\<C?SP_\%6_C[_P
MO'_A'/\ B0^(-$^R?VE_R&M/^Q>?YOV3_4?O)/,V>7^]Z;-\?7=Q^W_PM_:\
M_P"%H:Q;Z1_PB7C#3/M'F?Z9J6C_ &:SB\N-Y/WLWG/LW;-B?*=TC(O&<CZ_
MHK^8']FG_DZ&Z_[&#Q/_ .BM1K^GZOF#]LGX%Q?M$^!M6T/R//O3;O<:<!Y2
MN+Z!2]N$DF!2+S&'D2/E"8)94\Q Y8?B!_P1D^.DOA;Q1>>#[F?%EJ]N]Q:P
MMYK?Z=:@,1$%)BB\RV$S3.Z@R?9H$\P%51_TO_:B_P""HW@[]GBXN-)LEDUS
M6[:1HIK6W;RK>"1&CWI/=LK*'"LXVP)<%)HGAF$#<C]']6U:WT"WEO+R6."V
M@C>6::5U2..-%+.[NQ"JBJ"S,Q 4 DD 5^8"_P#!6_P'J/B>VT6R:1M),=U)
M>:W<;K:WB6&U:Y000/&;BX=W5K?RV2!S-L$*W'F*">'_ /@I?<:UX\T[P9/X
M,URPCU.2)8);U&@OA'(K W#Z>8B!;QR))YLJW#!+>*6?ED:$?9_[07[2FA_L
MWV=M/JOVBXN[^X2VT_3;*,3WU[,S*I2W@+)OV[U+L65062,$RRPQR?('CK]O
M;Q?\#O)O?&_P]U#3=%;?Y]]9:G;:GY&-JIYBPQQQ1[Y9(HU\^>#?N8Q^8R%#
M^A_@#Q_I?Q3TNVUK1;F.\TZ\C$D$\9.UER0000&5U8%)(W"O&ZM&ZJZLH^0/
MB/\ MLO!X@G\)^!= O/%NLV4B)J!MYH[73[)BDS&*>_D62)+@&';Y;JJ%R\0
MF^TQ/!7E^B_\%*8O!_BA?"?Q'\/W'A&]F\@V]Q)>17MF5F#XDFN$2)$BW*L0
MFB\^)9#()GMQ!(P/^"B/[8&K?!30]3TK0-'UA[M[=(IM<%I<0Z;8K= QEX[U
M=F^[7?&(3&1%'-*A,S2PO;-Y!_P3>_:<_P"$:\$^'/#'_",^*+G=<3P?VK;Z
M7YFEC[3J$Y\UKKS1B*+S,3OL_=E)!@[>?U.^+WQH\/\ P%TMM9\2WT=A8K(D
M0D<.[/)(?E2..-7ED? 9BL:L517D("([+\@:M^UO\0[NWEU31OAGJEQI*1O)
M&U[J5K8:@RQ*?,#:9LGN%?>KB*-?,>=-CHI\Q5KU#]EK]M_PE^UQ]JBT)[BW
MO;/#265ZD<5P83M GC6.65'BW-Y;%6+1OM$BH)83)Q_[57_!0SP=^RP\NG73
MR:CKJ1JPTRU'S(9(W>(W,[?NH$8JFX9DN%26.9;:2-@3X?\ $7_@J=9^&?#U
MKKFB^'=0UE3;V,NISP,RZ7ITUU"DCV<NI""1'NX6F@C>/RD7,H5G296@'UAI
M/[6^EQ?#>+XE:S:7FF6+6:7,EH\9>X#/((8TB'RB1)Y"GV:9O*22&6*=_)1F
MV>/ZM^V1XS\'V\NO:S\/-4M?"\,;W$EZFHV4VH1VI4M'++I>4EC?!0W,32YM
M$\UW9A"V?I_]G+XWV_[1WABT\46=O):VU[)=B&*5E:01V]U-;HS[?E5W6(2,
MBEQ&6*"20+O;W"L_5M6M] MY;R\EC@MH(WEFFE=4CCC12SN[L0JHJ@LS,0%
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MK6KF.STZSCU*2>>0G:J_VE=    LSLQ"1QH&>1V6-%9V53V'[.O_  4'T/\
M:A\97GACP]9W!LK/3YKO^TIV$7G-%<Q0;8K;:S^4ZRI*DLKQ2]4>V0C->_\
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M>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!7YX/^W+XC\>V<^M^ O
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M5>&OVK]+DU/P]+(&@D\NZL[A52ZMV);RS+&CR+LD52T4B,Z. R;A+'*D?/\
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M^3%*MT)QN5(UKT#_ (+G?\RC_P!QC_VPK]_J**_F!_9I_P"3H;K_ +&#Q/\
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M._:EUG3]<\0+>?:;&-862WN/+CN;=)3*L$X*,P0,THW6[03$2OF0E8C'Q_\
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M0#:Q*KLRH4LY;^EZOR _X+5_\D\TW_L8+;_TBOJ^_P#]D[_DGGA3_L7])_\
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M/^"U^DV\W@72KQHHS<Q:Y%%',44R)'+:732(KXW*CM%$SJ" QCC)!*+C[O\
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MR Z"2-"T;920 HZLC,I_9_\ ;$TFWUKX<^*HKJ*.:-=#U&4)(BNHDAMI)8G
M8$!XY$22-NJ.JNI#*"/@_P#X(J?\D\U+_L8+G_TBL:^4- ^+7B#Q[^T-X@UG
M1_#LGB*^T2.\L[&P?5TLUM([1X].DN8Y9U$120O.QM=I"O>O(-SQF4_;_P :
M_&_Q6^-7AK5/#EU\,(UCU*SFMQ))XCTR=89'4^5.(V10SPR;)H_F4AT4JZL
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M5<LZN[AMI_=I\(?\$,?^9N_[@_\ [?U[_P#\%J_^2>:;_P!C!;?^D5]7W_\
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M <BOR@_X+5_\D\TW_L8+;_TBOJ^__P!D[_DGGA3_ +%_2?\ TBAK\@?V^O\
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MG\'+SXN_#6ZDL6_>Z+<)JS187][#;Q31SC<[H$\N*:2XR-[/Y/E*A>12,_\
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M]X+O/V,OBAH_Q5T&WS97UQYEW$BJB?:U0QWD);[.T4/VZV9F61O-N'G-[<
MHI'Z/_L)_P#%T/\ A(?B>WR?\)?J ^R0#Y?*T[2?,L+/SD^?9=MLE:XV2RPM
M^[,?E_,@X_\ X*S?"^X^(_PRN;BU\QI-&O+?4C%'"TK2QH)+>7.T@QI%'</<
M2288*D+;@JDNGG__  2X_;*TOXF>&M/\&:I>1Q^(].CDMK:!P5:ZL;94,+QD
M11P[XXF\DPAY+ADM7NGR"[+]H?M5_M"_\*$T>(:>EO=^)-6N(K'0M-FE\O[7
M>3R1Q#/(Q%%Y@DE9FBC/R0F>%YHVK\\/^"V'PON/$/AK1?$<'F/'I-Y-;SQI
M"SJL=^L>)Y) <1(DEM'"-RX=[A!O5@JR?7_["7[96E_M1>'[2WFO(V\46EFA
MU6T(*R%D<PFZ4>5#$Z2E5F=;<,EL9XX6()3=ZA\;_P!H7_A7VN>'O"FD);WF
MOZYJ$"M:/+M:WTN,O+?WQ7*CY(HI4@1W0RR[FC6?R)(6W]:^,>AZEXMF^'>J
MK;_:+S1XKR""X(=;^&:2[@NK<1.GEMY:0*[QEF::*60B+RX)6K\<?^"FO_!/
M/P_\.]$G\=>$TCTV.UD3^T=/!<P2"ZN%C26U4[A"ZR3*C6Z[+?R<&-86B*7'
MZO\ [#/C76?B'\-_#^I:^L@U&6SVN\HE$DT<4CQ6]PYF9G=YX4BG:4DB8R&5
M<(Z@?"'_  6T\4V=IX-T;2GDQ>W.L"YABVL=T-K;3QS/N V#:US -K$,V_*A
M@KE?M_\ 8#\"_P#"N_A?X9LO.\_S=/2]W[-F/[0=K[R\;FSY?VCR]V1OV;]J
M;MB_7]%<_P"+/"UGXYTZ[TK4(_.LKZWFMKF+<R;X9D,<B;D*NNY6(W*589R"
M#@U_,E^RS'<?\$]?C2VC>)Y([33KJ.YL&U"ZC:..6SF;S+.\B*2.D:2S6\"R
M.[21VX:>.5HWBD>+^HVOB#_@H'^T?9_L[>!M0D^T^5J^I6\UGI<4<S0W!FE4
M1O<0LBLZ_95D^T&3Y%#K'%YL<DT1/QA_P1W_ &7;CP!I=WXXU:WD@N]6C6WT
MY)%9&_L_*2O. ),%+F01^7YD:N$MUEC=H;D$^7_\%SO^91_[C'_MA7[W7NK6
M^G/#%/+'')<R&*!'=5:601O*4C!(+N(XY)"JY(2-WQM5B/P1_P";O/\ /_0N
M5^OW[6/_ "3SQ7_V+^K?^D4U? '_  14_P"2>:E_V,%S_P"D5C7PAX@\>7'[
M!O[0VHZC?/(=)U2\EEO)7@:-9-/U9UN)'C^2=Y$M)SRT WSO9O"#'O=%_H^\
M >/]+^*>EVVM:+<QWFG7D8D@GC)VLN2""" RNK I)&X5XW5HW575E'B'P$_:
M%_X: UCQ"=+2WF\-Z3<6UC8ZE#+YGVV\6-I;_'(Q%%YEM'$RJ8Y?GFCGF1PL
M7Y0?\W>?Y_Z%ROW^HK\P/^"N?PTU'XB?#5I]/3S?[(U"#4;F,*[.;=(IX)&1
M45L^7]H$TA;8B01RR%AL ;T#_@FG\=+/XR_#K2[99[=M2T:WCT^]MHMRM"L&
MZ*T9T<ECYMO'&YE4F)Y1,J;6C>./\\/^"Y6K6\UQX4LUEC-S%'JDLD(=3(D<
MK6:QNR9W*CM%*J,0 QCD )*-C]7_ -N;X7W'QC^&_B#1[/S#<O9_:(4BA:>2
M:2RD2\2!(U(9GF: 0KMR09 P1R-C?F!_P20_;*TO2M+7X?\ B"\CMKE;S&AF
M0%5F6Z,DDEJ&6((KK,&>-IY2\[W2P1C,:(?U^_:*^/.E_LV^&KWQ%JDD86"-
MA;0/(4:[NBK&&UC(21M\C+@L$<1('F<"*-V'(>*_VA?^%*:+X9OO&J6^GW&K
MW%I8ZG)YNVWL;R>QGG?Y@9E,0N(1;[FD\N-)//><QQL6^?\ ]L#_ ()N^%_V
MC;.ZOM*MK?2?$SYEBOHE,<-Q+NDD9;R*/Y'\YI&,ET$-TK;'+2I&8)/G#_@B
M?XUUG6O#6M:5=K(VDZ?>0M83.)2HDN5D:ZMXW9C$$C*0S&*,*4>Z>1\^>N/+
M_P!@7_DX7Q[_ -Q__P!/-O7[7?&OQKHWPZ\-:IJOB%8Y-)MK.9KN&01,L\94
MJ;<),RQ2/.2(8XG($KR+'_%7XP_LF^'-!^#SMXG\,?$'PWX;MM=C@NKGPS?2
MVNJ+;KY<A@MIKN2[T^[WP>>S;56%XWQ!+)=B(S2_1_PT^&_P\\1^.4\9>)_'
M.C^*O$[W"QZ5;I>64-G:[F46L-G8BYN9&EB<OY!,KYDE\XQM>#[2WZOU^ /_
M  0Q_P"9N_[@_P#[?U[_ /\ !:O_ ))YIO\ V,%M_P"D5]7UA\/?&MQ\-?@G
MI^N6:QO<Z;X+M[R%)0QC:2WTM94#A65BA90&"LI(SA@>1\(?\$E] T[XSSZY
M\1=?N/[3\9G4'@::>1'>VMY+>,I+%" /)\W,UNC@!%@MS;0"*,3H_E_[=VK6
M^H_M$^"8H)8Y)+:3P_%.B.K-%(=5EE"2 $E',<D<@5L$I(CXVLI/Z_\ [4FK
M6^H^ /&,4$L<DEMH>JQ3HCJS12'3WE"2 $E',<D<@5L$I(CXVLI/P?\ \$5/
M^2>:E_V,%S_Z16-?,'_!7;3KSPWXA\)?$O0;KS8FMXH[2ZAB6:WBFM)C?6<P
MGS)#)YXG=XHV7:Z6SN#*A8)^Q_[,G[47A_\ :FT9-3T:XC-S%'!_:%D&<R6=
MQ+$)#$WF1Q-(@;?&EPJ"&8QR;&)1PN?XB_:%W_$#2_ FBI;WEQ]GNK[7F\WY
M].LTA M?DRJF6>XF@^7<\D<'SM!Y<\<\?XP>!/%,O[&W[1VK-XCDM[/3=>N-
M0+WLRRB$6FIRF]M9(Y"$48N$AMIYF#V\3+<JSA8S,G]%VK:M;Z!;RWEY+'!;
M01O+--*ZI''&BEG=W8A515!9F8@* 22 *_!'_@AC_P S=_W!_P#V_K]_J*_F
M!_:6_P"3H;7_ +&#PQ_Z*TZOZ?JX_P ?^/\ 2_A9I=SK6M7,=GIUG&9)YY"=
MJKD    LSLQ"1QH&>1V6-%9V53\@>*OBK<?'#X.>)?$LMK)96VHZ'KDMA:S1
M-'<)9K:SQP/.2[*[SJGVM6C"QK#/'$IF$?VF?YO_ ."*G_)/-2_[&"Y_](K&
MO /^"YW_ #*/_<8_]L*_?ZOP!_8%_P"3A?'O_<?_ /3S;U]__P#!4?\ Y)#X
MA_[AW_IRM*S_ /@E9JUOJ/PDT6*"6.22VDU"*=$=6:*0WUQ*$D )*.8Y(Y K
M8)21'QM92?G#_@L1XCB\8:=X;\!:>/M&OZKK$-Q;6ZR1+A0DMI&)2\BF/SI;
MD+"[ 1-Y4^9%\H@_=_QO\%6_PU^$>MZ'9M(]MIOA.^LX7E*F1H[?3I(D+E55
M2Y506*JH)SA0.!\7_P#!%3_DGFI?]C!<_P#I%8U\X?\ !9[X9:IX<UG0?']A
M/)%''''IWF1,(I+6Z@EFO+:1)%D$I>0/,5*(!";8$R;I4 _<[X5?$O3OC)H=
MAXATI]]EJ%ND\661F3</FBD\MG198FW13(&;RY4="<J:_)'_ (+&>)W\7V_A
MCP!ID4=SJVK:HMS%&+B-)$95:SMD:-\!4N)+IPDTCQH#;R#YOG,?Z_?#WP5;
M_#71M/T.S:1[;3;.WLX7E*F1H[>)8D+E552Y506*JH)SA0.!_/#\4"__  3$
M^-/_  D%K:R-X7UJ.:3R((XU!M;E@;FUA+0QPH]K<+'/%!"RD6XM89)T$[M7
MZ_\ [!O@JXT#P<NN7[1G4?%=Y<>)+Q(2QMXY-4V2I' '4.J+"(0R.TI6;S,2
MNFTUX_\ \%9OA?<?$?X97-Q:^8TFC7EOJ1BCA:5I8T$EO+G:08TBCN'N)),,
M%2%MP5273S__ ()<?ME:7\3/#6G^#-4O(X_$>G1R6UM X*M=6-LJ&%XR(HX=
M\<3>280\EPR6KW3Y!=E^T/VJ_P!H7_A0FCQ#3TM[OQ)JUQ%8Z%ILTOE_:[R>
M2.(9Y&(HO,$DK,T49^2$SPO-&U?DA_P6,\,:I\/?%7ACQ_IDLB20QK;12"W#
MQVUU87#7EL[2/OB9Y3,Y2&1,$6LA_>*7"?K_ /LR?M1>'_VIM&34]&N(S<Q1
MP?VA9!G,EG<2Q"0Q-YD<32(&WQI<*@AF,<FQB4<+G^(OVA=_Q TOP)HJ6]Y<
M?9[J^UYO-^?3K-(0+7Y,JIEGN)H/EW/)'!\[0>7/'/'H6/Q-\-?&O6_$/@'5
M(+.YN=*DM3-IUTJSK=6LMO:W<=UY,L>QD2:7RF4>:8GBBD<H9X5K\(/^"D7[
M#]A^R:^G^,_!D\EA8R7D%N+033&>TO$C>:*>UN&9I=C"!G;>_F0S -&[)($M
M_P"B[X3Z_J/BOP]I6H:O;_9-2N]/M)[RV\MXO)N)84>:+RY"9$V.678Y+KC:
MQ+ FO0******************************************************
M*************************************************^,/VN_V'/#7
M[7UO$^HF2RU:UC=+74;<*9 K*Q6*=&&)[=9&$OEYC=3O$4T/FRE_/])_9(^(
M=W;Q:7K/Q,U2XTE(TCD6RTVUL-098E'EE=3WSW"OO5#+(WF/.F]'8^8S5]?_
M  A^"_A_X"Z6NC>&K&.PL5D>4QH7=GDD/S/))(SRR/@*H:1F*HJ1@A$15^,/
MC7_P3/T#]HG48]5\3Z]X@OKV&W6VCEWZ9#B%'DD5-L&FQ(<-*YW$%CNP3@ #
MZ?\ @7\!6^ UG!IEMKNL:CIMI;_9[:TU!K*585W!D*RQ6<-R?+ ,<2/,\4<1
M\M8PJ1[/H"O/_'7@V^\6^3]BUG4-(\K?O^Q1V#^=NVX\S[=9W>-F#M\OR\[V
MW;\)M_.#_AT!X-_M'^U_[<\4?VE]H^U?;/M]M]H^T;_,\_SOL7F>;O\ G\S=
MOW_-G=S7J&K?\$[[?7[>6SO/&_CR>VGC>*:&775>.2-U*NCHUL59&4E65@0P
M)!!!KV#X#?L1^ _V<7CNM"TJ/^T4CC0ZA<LUQ=%DC>-I$>0E8'E61_.%JL"2
M!MI38J*OU?7P!^T+_P $\=%_:@U%-0\2Z[X@F\GS1:VT<]C%;VJ2N7*0QK8_
M[JF20R3R)'&LDLGEJ1]7^"OAU=>#-&;2&UO5+Z3RS'#J%X;22\A7REC0AUM4
MBF="OF"2ZCN'DD9C*TJG:/C#_AVEHO\ PE'_  FG_"2^*/\ A(?M'VC[=]KL
M=^_&W;M^P>7Y6S]SY&WR/(_<>7Y/R5^A^DV3Z=;Q02S27,D<:(\\HC$DK*H!
MD<1)'$'8C<PC2- 2=J*N%'@'[3'[*OAK]J_2X],\0Q2!H)/,M;RW94NK=B5\
MP12.DB[)%4++&ZNC@*^T2QQ/'^6'A;_@AUIUI>1OJOB>XN;(;O-AMM/2UF;*
MD+LFDN+E$PVUFS$^Y05&TL'7]KO '@#2_A9I=MHNBVT=GIUG&(X((P=JKDDD
MDDLSLQ+R2.6>1V:1V9V9C^<'[57_  2H\-?M#ZI+KVF7DFA:I=2*]X8X%N+6
M=L/YDIM]\+)<2,4,DBRA'*,[0M-*\QZ#]EW_ ()<^#OV>+BWU:]:37-;MI%E
MANKA?*MX)$:38\%HK,H<*R'=.]P4FB2:$P-P/M_XT?"'2_CUX?OO#6LK(UC?
MQA)#$YCD1D=9(Y$;D!XY$210P9&*A71T+(WP!^S)_P $QT^ MPCZAXHU34[&
M"\@OH=+@,EAI[W4#!TFNK=;B<7#I)%;2Q8,05[=!()D.Q?N_XZ? O0_VB]#G
M\/\ B"#SK2;YD=<+-;S*"$G@<@[)4R<'!5E+1NKQ/)&WQ!\-_P!ACQW\#K-]
M'\)_$6XL=%6XFEM;2XT.TOF@65MVP2S3?\"<1)#$\K22B%&D?/UA\$/V6?#_
M ,"KBXU.U:\U'6[R-8KS6=3N7O-0N(T;*(\SX5451''MA2,.D,/F!VB5AY_^
MTQ^Q/IO[5SQKX@UO7$L8)/-@T^UELXK6*3RUC+X-D\LCX#%6GDE,9DE6,QI(
MR5Z_\!O@B/@'I<>C6^K:IJ=C;QQQ6D>HO;2M;1H7PD<D-M!*R88*%F:41I''
M'$(T7:>0_:M_9:T[]K;2;+1-5NKBULK;4%O93;!!-)LM[B%8T>172/YIU=F*
M295#&%4N)$\/TS]DCXAZ2ATR/XF:H=$,DJF*33;674OLLLC,T8U:1VG%P$8K
M'=!08F"O'$BHD:_5_P "_@7H?[.FAP>'_#\'DVD/S.[8::XF8 //.X WRO@9
M. JJ%C14B2.-?8*S]6TFWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP*LC*2K*P(8
M$@@@U^8'AO\ X)MW_P $-9N]3^&OB^\\-VU]'MN+*:QAU2/(E>1 GGR1KLC5
MA'"94EN$'FYN6$SBOH#P!^QO;P:I;>)/&FJWGBSQ#9R"6TN+P+!8V4@!4/9:
M;"?L\#LBPF1F\TFX@2Y0Q2\U[?\ &;X2-\9M.ETJ35=0TZRN;>YMKN*R6R/V
MF&Y3RW21KNTN73"[@K0&%AO8DL0A3XP^$/\ P2\\.? 75%UGPUK_ (DL+Y8W
MB,B7%@ZO'(/F22.33WBD3(5@LBL%=4D #HC+^C^DV3Z=;Q02S27,D<:(\\HC
M$DK*H!D<1)'$'8C<PC2- 2=J*N%&A7QA^VE^Q;I?[9.EVMK=74EAJ-A([V5Z
MB&98UF*">.2 O&LB2+&F#N1T=$97V>;%+G_LU_L7?\* L_\ 2/$6L:MJBZ?)
MIUK>3S?N=/MW93MTZRF-S#!Q#:[A+]I0M;1X5(B\)\__ .':6B_\)1_PFG_"
M2^*/^$A^T?:/MWVNQW[\;=NW[!Y?E;/W/D;?(\C]QY?D_)7T_P#&/X"M\:]#
M7P_>Z[K%K:/;FWO7LVLH9KY2$#&X<V;[-VQO,2U%M%(LLL;QM$PC7S#]F?\
M8GTW]E%Y%\/ZWKCV,\GFSZ?=2V<MK+)Y;1A\"R26-\%2S021&0QQ+(9$C5*]
M _:8_95\-?M7Z7'IGB&*0-!)YEK>6[*EU;L2OF"*1TD79(JA98W5T<!7VB6.
M)X_RP\+?\$.M.M+R-]5\3W%S9#=YL-MIZ6LS94A=DTEQ<HF&VLV8GW*"HVE@
MZ_M=X \ :7\+-+MM%T6VCL].LXQ'!!&#M5<DDDDEF=F)>21RSR.S2.S.S,>P
MHK\X/VB_^"9_A?XTZBWB+1KBX\.>)#<"Z_M"R)*/<!XF\^2WWIB4;&99+:2V
M<SR-/*9GZ]!X3_9I^*7A_P"R03_$VXGLK?R4D3_A']/-Q)#'@,/M4[W#F5E!
M'GS+.V\^8ZRG(;Z?^$?P.T?X+Q3_ -GBXGO;SR#?ZC>W$EW?7KP1+#&]Q<3,
MSMM5?DC39!$6?RHHP[ ^P5^8&M?\$UHO!_BAO%GPX\07'A&]F\\7%O'9Q7MF
M5F"9CAMW>)$BW*TIAE\^)9#&84MQ!&H]0TG]B9_&UQ%>?$K7[SQC):R(]K9R
MPQZ?I4;1,&BE?3K5O*GN%+3(TDS.DL$QA>%E137U?\2_ \_Q$TY]/@U34-(\
MW<)+G3FMTN"C(R,BR3P7'E9W!A)"(YT=%9)4P0WR!^SU_P $\=%_9?U%]0\-
M:[X@A\[RA=6TD]C+;W21.'"31M8_[RB2,QSQI)(L<L?F,3V'[3'[$^F_M7/&
MOB#6]<2Q@D\V#3[66SBM8I/+6,O@V3RR/@,5:>24QF258S&DC)7I_P '/@*W
MP4T-O#]EKNL75HEN+>R>\:RFFL5 <*;=Q9IOV[U\M+H7,4:Q11I&L2F-OF#_
M (=I:+_PE'_":?\ "2^*/^$A^T?:/MWVNQW[\;=NW[!Y?E;/W/D;?(\C]QY?
MD_)7TA^TW9/IWPT\2P2S27,D?AO4T>>41B25EL909'$21Q!V(W,(TC0$G:BK
MA1^,'_!,O]G'5/B+X0G\0^%_$5YX:UNWURXMYIXHQ>6MW:K96YCBN;&61()'
MB>XE>"5@3&99,JS>2\/Z?_#C]B9X/$$'BSQUK]YXMUFRD=]/%Q#':Z?9,4A4
M2P6$;21)< P[O,1E0N4E,/VF))Z^O_'_ ( TOXIZ7<Z+K5M'>:=>1F.>"0':
MRY!!!!#*ZL \<B%7C=5D1E=58?E#\,O^"1J?#?5)S'XMU0^'+R1A?:1 LEHU
M]:@2".UN[F"Z594VR%)F$"&1'E$8MS(&3K_B1_P2MT[Q!XT3Q9X9URX\+Q?N
M?,L]+M4MVCVQ^1-]BG@DA%KYT7#9BF_>O+(WF))Y2_2'Q5_8=T'XG^'[7PC%
M?ZIH_AJTCB1-)TR2UAMY&B=Y!),\MK-<3.SOYD@DE9))D2X9#< RGL/V:_V7
M+7]EZS_LO2M9UB\TL>88K&_DM)887E969XFCM(IDY5CY8D\C=++(8C*Y>OG_
M .)'_!-+1?BWKB>)=9\2^*)]7A\GR+I;NQA:#R#NB\@06$:0;&S(/)5/WK-+
M_K'9C]_^%M&G\/V<=M<WMQJ$J;MUU<K;K-)N8L-XM8;>$;00B[(D^506W/N9
MOA#_ (*;Z3;^,?!%MX<:*-]1U[7-*TS2II44QVUY/.&$SOAGB3R8YXFDA623
M$I384=\?;_P]\%6_PUT;3]#LVD>VTVSM[.%Y2ID:.WB6)"Y554N54%BJJ"<X
M4#@=A17R!^W3^SI_PT[X&OM&@7=J4&+W3.<9O(%;9'S+%'^^1I+;=*QCB\[S
MBI:-:X__ ()T_%Y/B-X#L-+NFCBUOP]&-*U.PV20SVC6C/!;B:&7YU=X8D+M
M]QIA,B[&BDBCZ#]IC]B?3?VKGC7Q!K>N)8P2>;!I]K+9Q6L4GEK&7P;)Y9'P
M&*M/)*8S)*L9C21DKU_X#?!$? /2X]&M]6U34[&WCCBM(]1>VE:VC0OA(Y(;
M:"5DPP4+,THC2...(1HNT_*'Q(_X)I:+\6]<3Q+K/B7Q1/J\/D^1=+=V,+0>
M0=T7D""PC2#8V9!Y*I^]9I?]8[,?K_Q'\+K[Q)H8T5O$.L02GS!-J=O]@BOI
M4D$@*%UL?)BP'&R2VA@G0Q1L)0^]G^8/V>O^">.B_LOZB^H>&M=\00^=Y0NK
M:2>QEM[I(G#A)HVL?]Y1)&8YXTDD6.6/S&)^G_CI\"]#_:+T.?P_X@@\ZTF^
M9'7"S6\R@A)X'(.R5,G!P592T;J\3R1M^2.F?\$/M&BU0S77B2\DTGS)2+6.
MSBCNA&0WE*;MI)(BZDIYC_9@) K!8XMP*?K=\-_@7H?P6T-_#_A6#^R+1O.9
M7M\23)-,,&<O="?S95^78;@3*%2.,J8D6,?('_#M+1?^$H_X33_A)?%'_"0_
M:/M'V[[78[]^-NW;]@\ORMG[GR-OD>1^X\OR?DK]#])LGTZWB@EFDN9(XT1Y
MY1&))650#(XB2.(.Q&YA&D: D[45<*/R!U;_ ()&IX5UF75/ 7BW5/#$<\;H
M\42R2R*KRF0Q)<175K+]G $06.7SGS&'>:1B-OM_Q0_X)G^%_'7AZ'P]8W%Q
M9>9K%MJFK:C(3>:CJ;Q0S0R&:XF?Y99//DE#A6@BF>1UM?WK@_3_ .SU^S%X
M7_9?TY]/\-6GD^=Y1NKF1S+<73Q($#S2-_P)A'&(X(WDD:.*/S&!^,/VJO\
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M6:CJ&NZ19V_ESMJ,=O=7$T,BQVJ6C"&W@2X\UF"%[H,SO,S3W'EY9/A#2?\
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M]G"\I4R-';Q+$A<JJJ7*J"Q55!.<*!P.PK\<?CS_ ,$;O#7Q*U234_#NI2:
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MJF \\K@R-0U;_@BAX%FMY5L]5UR*Y,;B&266TEC20J=C/&MK$TB!L%D62,L
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MI))P(^PU/7?VA/#*"\?3_!>JQQ21&2QL9M0@NIXS(HD6&:\=+>-]A9M\I8*
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M/J>FV]N_]I[+NVN;>*WD1]_VK#O&D3(DF[S<(R*^<J&Q^$/[9/Q8\/:G\9/
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M^H1)CS5C)6:'<SHOG02!)H=YC<Q^:B>8JETW)AC[!7S!\8_VT/A_\ KQ=/\
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M%WR2%47<S*JY(RS!1R0*Y_X6_%+1_C3H]OKV@W'VO3;OS/(G\N2+?Y4CPO\
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MT;L3A7S7PA_P2)^"'A7XE>!=0O-<T32]2N4URXB2:\L;>XD6,6EFP0/+&S!
MS,P4' +,<9)S^WVDZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515 554 *
M  *-6TFWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP*LC*2K*P(8$@@@U_.C^VW\)
M_#WA3XZ^"M(T_2M/M--N_P"P_M-G!:0Q6\WFZM/')YL*((WWH C[E.Y %.5
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M/A]%<:S))<7VF7DVG27<L@>2Y6)(IHY'.Q3O6.=(6+&1Y#$9GD9Y&Q^A]?S
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M;1ZA8^%+.^U+6TE!>V#7PA2PM7\LL/M#20"Z:UN!&DUH"W[Y&>,_I?7XP_\
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MK<->:'HFEZ;<O&8GFL[&WMY&C+*Q0O%&K%"RJQ4G!*J<9 Q^"/Q2\'WGC_\
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M<>5/=O#>2+)$HN5!E,4L4<%T\4DCM]HDD9]K_(G@'_!6?]FNS31Q\3=%_P!
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M,-]+G[O_ &L/V9+?]H'P'=>$-.2SLI$CMSIC/ OD6LEJRF)8U09@1HU:V+Q
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M?34=8\0WD>J>*-8D)N[M=TJQQB1G*QW$R+<2/.Y$UT[[!(ZQ+Y9,'G2^'_\
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MLM/MYXD_<I+"(Y@3$9#(KJTDTC_=^?\ _@M7_P D\TW_ +&"V_\ 2*^K[_\
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MQ:3WAWV]SOFD/ER1YA53&?O^BOP!_P""YW_,H_\ <8_]L*_?ZOP!_P";O/\
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M_P#8P6W_ *17U??_ .R=_P D\\*?]B_I/_I%#7Y _P#-WG^?^A<K]?OVL?\
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MZEXR?0P^FV.CKK[^8IAN-1N6L8>)!'*)DL%FN,$1,\/E6VX-(HG78KO^<'[
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MXABUZ31;&6\O;=+N46NIZKJ-BUW%,)',L<EO$]PB[VN) ;A)T.ZS*.<_I?\
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MXJUK5H_$WAZ.2(ZI;R:E+=*L?F+!&H>^C2X@>1[C]V]F)!O16N(WB14?[?\
M^"@?[-'CK]K>RM] T<:'::3:WB7@N+J\NS=32+ T2CRH[)HH44S3AAYDYE'E
M.&AP\;?2'[.'A?QE\-/"5MH6N6VCR7NDZ?#:6,EG?7/DW7V>-HXA<"6R#VWR
MI"LDD?VK>QEE6*,!(3\ ?\,9?%/_ (6O_P +3W>%_M'VC=]@^VZAL^S_ &7[
M#Y7F_8=WF_9_^6VW9Y_[WR/+_<5[?_P4,_8VU3]KKPUI]U9O'!XCT>.:6*R6
M8/:W#7"Q&XMEGDCA;?NA7[-.ZQ(Q!66.(2^;;\?^SIX)^.GCO3E\.^.[S^P-
M+M+<Q-J=I+;3ZY?ATEC2(70ENX8?+#*\EWY27C-'%LD:62>X3Y@_8R_8K^+G
MP5U'6?#TIM]$T/5_*2^URWGBFO##9O*JC2MLN^"6X69PL]U K6\9\Y52YC2)
M_J__ (*B_L?>(/VH]+TJ\\->7/?:/)<@V+LD37$=X8 S1S2.D2O$858I(5#H
MSD2!T2.7W#]F+2/BKXB^R:A\29=/M%L[=UAL+$N+BXN6_<FZU&2&9K5ML:N\
M5O;[K9GNO.>*&:UMUC^0/V^O^"7O_"Z+R7Q3X)%O;:O+YDFH6,C>5#>N%9A-
M"P!2*[D8!) ^R"=G$SR0R+,]QY_\-/AA^U'XPV:'J^L_V+I?V=8);Z=]-N+@
M0_+$WE2VBRWCW?ELTB2O+"S.A9KN.4JY_7[X6_ O0_A)X7M_!]C!YVD06\EN
MT-UB?SUF+M.9PXV/YS22-(@58OG*+&D>U!^*-E^P_P#&#]BSQ+-?_"V>/5=)
MNY!N@EFMD9[>)DDCBOX;EH(F?+21)<6CB;8)F5K/S_+KU#]JG]E3XP_M7^'M
M+DUV73TU+^T+55T;3Y3#IUE;RPS&XOKZ2>262XNXW:*#9;-.D,*RFW6=KF0C
M]'_V3O@WXC^"'AZWTKQ)KG]L2P6]K!;Q1VL%O;V4-O"L8@A9(UFN,$$&XN"&
MD1(R(87\PR?3]9^K:3;Z_;RV=Y%'/;3QO%-#*BO')&ZE71T8%61E)5E8$,"0
M00:_(&V_8.\:_LE^(+WQ'\(=1LY;&ZCG,WA_5#,(W54W00)*K8G=9&D^SRS2
M6CP#;')<3)+<N_O^I_'+XUZZ@M=.^'MGIMS+)$BWM]X@M+NU@4R*)))H+;RI
MY$";N(FW@X8)*1Y3\?\ LU_\$\/^$6US_A._B'?_ /"0>,7N))]P;=8P/E1!
M)&CQ1N\L2I^Y)6."V#(D-NK6T,]?H_XIN=1M+.1]*@M[F]&WRH;FX>UA;+ -
MOFC@N73"[F7$3[F 4[0Q=?Q1U;]A7XQS?$B7XF6>I>&XM4-X\\,4L]U+&EN8
MS;I:OMTZ+S$%MBV:51',P!E#I,=X_8[0-2\0W.G7$NH6.GP:DOF?9K>#49I[
M>3" Q^;<O8021;GRK[;>;8@#CS&)C7\@?VD/V&?BU\>_','C>"^\/Z=<6'V/
M^S(/M=Q<?9/LC"9/G.E1K-FX,D_[V-L>9Y1W1HHK];OA?>^*KJWV^*K32[>Y
M2.$"33;RXN(YI-I\YO+N+2W:W3<%,:>9<G#%6DR@:3\L?VA_V,OBG\=/'VF>
M.XF\+V,NC_8?L5HU[J%PO^ASM=+Y\@L83)NE=\^6L.(BJ#YU,K_K=IEE<>*M
M+-OXALK-9+F.6*[LXYFO;5HW+(4+S6]N94>,CS%>%1EFCPZC<WX0_%[_ ()K
M^//V?_$K>(_@[=R"VDD3R[1+Q8+JW4MYKPR-<LD%W9*\46$GD=Y R1RPS"-Y
MW^C_ (5?LI_%?X[2V%[\7O$'_$KM+A)V\/01VK+>>5+Y@BU$6J)9R1>9!;R*
MC"]W1-(@-K*6:OU/\?\ @#2_BGI=SHNM6T=YIUY&8YX) =K+D$$$$,KJP#QR
M(5>-U61&5U5A_/CK7_!.KXK_ +*7BAM8^%MU]LMW\^."99[6*XCMW"'R;Z&\
M\NVFR3\AC$J,\"W!CMI/*1?M_P" /[,GQ,^*^HZ9K_QDU;SXM&N!>Z9HMN;>
M/;?1N1'<7K6,<<+^4$62W1'G)\TAGB3S[>X[#_@H'^S1XZ_:WLK?0-'&AVFD
MVMXEX+BZO+LW4TBP-$H\J.R:*%%,TX8>9.91Y3AH</&WU!^RUX2\5?#KPU8Z
M!XHBTL2:59VUG;W&G7-Q*L\<"F)3)%<6T)A=8TB!*R3"5S(X6!=L=?/_ .VA
M\ O&OQ:\2^$-:\%S6=K<^'I-0NI)[V>:& M(UD$MG%L&G=)T29)54*C0B6-Y
M$,B*_'^+/%GQH^-_AZ[\*7?@G3](N-5T^:RNM7N-<@ELXO.A*3R+:6PFN1Y@
M+I H>;RI'C:1I8T<M]?_ +,7[/6G?LO^%[3PUI[^=Y.^2YNC$D3W5Q*=TDSA
M!](XPS2/'!'%$9)/+#'Z KYP_:J_9GTO]J_PU+X>U.22!A(MQ9W4>2UO=(KI
M'*8]RK*FV1TDB8@.CMM:.4)+'\'_ +/4?QT_96TY_"U[X;M_%VGV?E+IM[#K
M=M:>5#L!: -=*)I8HR0D0DAB:':\:M);^0(_8-$_94\0_'CQ;I7CSXD2V]LV
MC_O-)\.Z?+-)#:N)%N(9KNY:0)+=QL1'<"UC2"=K:V;S'A5H&]P_:S\%>-?B
MKX?U'PWX572[>/4[/[/+?WE[,DD:RN5N8A:II]RCI)!NB$OG1NAE9E56C1F^
M/_V)?V8/BO\ L=6]YIA;PWJNDW<GVA;8W]Y;21715(VE6<:9,61XXU5XG5AE
M(W1H_P!Z)OUOHK\<?^"C'['WC?XG^*M#\=>!?+N=1TV.W@%L6@BD@DM;B6[@
MNE:Z=8)4WR;'B?!4K&0DR22>3]G_  CL?B=/9SZYXK71WUI[>"*PT6TN;JTL
M;=799+E[NXVWOF7;96,%8KB*$6VV"95O+ES\0?L\?L9?%/X%^/M3\=RMX7OI
M=8^W?;;1;W4+=?\ 3)UNF\B0V,QCVRHF/,6;,09#\["5/K_]N7X.^,OVB?#E
MQX3\.IH\-E??9FNKR_N[E)AY,XG\J*"&TE09:*$^<\K94RQ^0#LE!^PU\'?&
M7[.WARW\)^(DT>:RL?M+6MY87=R\Q\Z<S^5+!-:1(<-+,?.25<*(H_()WRGY
M _;Z_P""7O\ PNB\E\4^"1;VVKR^9)J%C(WE0WKA6830L 4BNY& 20/L@G9Q
M,\D,BS/<>?\ PT^&'[4?C#9H>KZS_8NE_9U@EOIWTVXN!#\L3>5+:++>/=^6
MS2)*\L+,Z%FNXY2KG]CO@O\ "'2_@+X?L?#6C+(MC81E(S*YDD=G=I))';@%
MY)'>1@H5%+%41$"HOJ%9^K:3;Z_;RV=Y%'/;3QO%-#*BO')&ZE71T8%61E)5
ME8$,"000:_&'7/V#O'G[)>LW7B/X,ZC'+:74B&X\/WA4!XEEC9(!+.WE3HI:
M?$LDEI=06^Z..XFFE=W^K_"?QV^,=W]DMM0^'5O'*_DQW-W_ ,))9QVZL<+)
M-Y21W,R1 Y?RU-Q*J?*#*X&[V#X:? O46UA/%OC2\M]3\0QVZPV<=M"\.G:2
MDD:BZ2PBEDED:69PWG7TI$\L(CA5+>$-$WI_QH^$.E_'KP_?>&M961K&_C"2
M&)S'(C(ZR1R(W(#QR(DBA@R,5"NCH61ORQ_9]^&'QH_8;EN?#VGZ7;^-/#+;
MY;'9J4%@UJ[2MT^UDO%YBCS9[9%F@6617BN-YN/-]?\ &'[,OBW]MJ\TZ[^)
M$5OH/A[3K@W$7ARRNI+JYN6*^6PU"\C=+88*!H'M8VE6VNIX?,@F)EKZP_:E
M\)>*OB+X:OM \+Q:69-5L[FSN+C4;FXB6".=1$QCBM[:8S.T;R@%I(1$XC<K
M.NZ.OE__ ()^?LT>.OV2+*XT#6!H=WI-U>/>&XM;R[%U#(T"Q,/*DLEBF1C#
M %'F0&(>:Y:;*1KY?^WS^QE\0_VRM1L?LS>'[#3=)^UK:^9>WLEQ-]H=,RS;
M;$1QY2&'$*>9Y;^9^_F5EV?H_P"'-2\9)H9?4K'1VU]/+40V^HW*V,W$8DE,
MSV#36^2962'RKG:%C4SMO9T_,']GC]C+XI_ OQ]J?CN5O"]]+K'V[[;:+>ZA
M;K_IDZW3>1(;&8Q[943'F+-F(,A^=A*GT_\ \%1_^20^(?\ N'?^G*TKX@_8
M"USXH?"?P)I-UX=T:W\6:!J?]H3K;-J":?=Z;<1W9MS$LMU(\+VD@A>=4AB#
M_:)IRY3:IN/I_P &_LR^+?VA_&6G^/?B=%;Z;%HOS:)X>LKJ2;R)DN9)(Y[V
M57:%I5"PL3:D+=>7!YJPI"]M+] ?MO\ [+7_  UQX2?0HKK['>V]PE[92,,P
MFXBCEC6.<!6?RG65U+1_/&Q64+*$,,GQ!^Q_\/\ ]H#PM9VO@[6S;Z-H%MAA
MJTKVE_J4%O&T9%C9A9[B$[@&CC>[@E2VA9]K'RK:WKQ_X0_L5_%SX!?$K5[S
MP\;<Z?JOVRT_X2/49XKV6.TNI4N?M;0>;#-/J"F-%(EA-O)=;M^;=O.'U?\
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M4_P4_P"&B?!>K^&%D\F6^MQ]GD+;%%Q#(D]OYC>7*1$98HQ-M1G,1<)A]I'
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M2+"W\.^$]*N))H]#MK]KJ\O93'"%-S/ WV;RL^<$EC$5U%&TT"HIF%VOZ/\
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M#_AC+XI_\+7_ .%I[O"_VC[1N^P?;=0V?9_LOV'RO-^P[O-^S_\ +;;L\_\
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M#W!]OTG_ (+*^!=?N(K.STCQ)/<SR)%##%9VCR22.P5$1%O2S.S$*JJ"6)
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M+^*NA_!O3GU7Q#?V^GV2;AYL[A=[*C2>7$OWY92J.4AB#RR;2$1CQ7QAJ?\
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MZ;5-/CLS92QPD:D\5LKE949%CN/MA?S9"RLEQO:1E<,1_7;7E_Q>^-'A_P"
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M_8P7/_I%8U^M^K:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22
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MCU;6YM+O433K2W:^:*>)91YDSHK00/9O$UU.)9$FMDMS,$W",-Y?_P $5/\
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M-FOZ7T5^0'_!:O\ Y)YIO_8P6W_I%?5] ?\ !+C_ ))#X>_[B/\ Z<KNOO\
MKXP_X*'^"KCQ_P#"OQ+9VK1I)'9K>$R%@OEV$T5[* 55CO:.!UC&,%RH9E4E
MA\8?\$??VE].\0^%_P#A![V:WM]2TRXE^PQ,Z1O>6]R9KMO*5I3)-+$XN#-Y
M<:I' 8"<L7:OU>^*OQ+T[X-Z'?\ B'57V66GV[SRX9%9]H^6*/S&1&EE;;%"
MA9?,E=$!RPKX0_X*">)+CQC\"-1U.\M)+"YO+/1KB:REW>9;237ME(\#[DC;
M?&S&-MR(<J<HIX'8?\$N/^20^'O^XC_Z<KNO?_VL?^2>>*_^Q?U;_P!(IJ^
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MPC_M"V1_^F)BG;O9W/[_ /IM\ >/]+^*>EVVM:+<QWFG7D8D@GC)VLN2"""
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MG:,X'H%%%?S _M+?\G0VO_8P>&/_ $5IU?T_5^ /_!#'_F;O^X/_ .W]>_\
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M*G_)/-2_[&"Y_P#2*QH_X+5_\D\TW_L8+;_TBOJ^_P#]D[_DGGA3_L7])_\
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MK?\ I%-7P!_P14_Y)YJ7_8P7/_I%8UX!_P %SO\ F4?^XQ_[85^E_P#P4/\
M!5QX_P#A7XEL[5HTDCLUO"9"P7R[":*]E *JQWM' ZQC&"Y4,RJ2P^,/^"/O
M[2^G>(?"_P#P@][-;V^I:9<2_88F=(WO+>Y,UVWE*TIDFEB<7!F\N-4C@,!.
M6+M7ZO?%7XEZ=\&]#O\ Q#JK[++3[=YY<,BL^T?+%'YC(C2RMMBA0LOF2NB
MY85^&/\ P6#BU3Q[X5\$>*+BPDL8WCG%Y;RL/,M+J_M[6X2U=7$<I=1;W"LW
MEJ%,1#B-F53^WWP4^*%O\:O#6E^([7RUCU*SAN#'',LZPR.H\V R*%#/#)OA
MD^52'1@R(P*C\4?V^O\ DX7P%_W /_3S<5^_U%?@#_P7._YE'_N,?^V%?O\
M5^ /[ O_ "<+X]_[C_\ Z>;>OO\ _P""H_\ R2'Q#_W#O_3E:4?\$N/^20^'
MO^XC_P"G*[K[_HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKY@_:<_9
M#\+_ +6EG!;>(H[@2V?F?9+JVG,4UOYK1-+L#!X7\P0HC>=%+M7)38YW#\P/
M"W_!#K3K2\C?5?$]Q<V0W>;#;:>EK,V5(79-)<7*)AMK-F)]R@J-I8.O[7>
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M=7]P8E1/.D:WF2.:]A\U_M3S5X?_ ,.[?%'_  L#_A9/_"96_P#;OVCSL?V
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M]D^WN-"\*ZSX;U?0O,62T&LI?QR0,R[IA%%;;Q"CR,Q,?GS(2OG*L4DTP;Z
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MF1R-Q_+#XS_\$[?%'QP\6VGC2^\96]OJFG_9?L(MM "PVWV20S1;$EU"4O\
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M+Z'^V'9PM/)_9VM6F%MM3CA$K"'=N>":/?'YT1RS1@NC0RDNC!7FCF\O\ >
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MP_8^&M&61;&PC*1F5S)([.[222.W +R2.\C!0J*6*HB(%1?4*\?^.GP+T/\
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M;W_Y:T?\.XOB'_T5GQ!_WS>__+6C_AW%\0_^BL^(/^^;W_Y:T?\ #N+XA_\
M16?$'_?-[_\ +6C_ (=Q?$/_ **SX@_[YO?_ ):T?\.XOB'_ -%9\0?]\WO_
M ,M:/^'<7Q#_ .BL^(/^^;W_ .6M'_#N+XA_]%9\0?\ ?-[_ /+6C_AW%\0_
M^BL^(/\ OF]_^6M'_#N+XA_]%9\0?]\WO_RUH_X=Q?$/_HK/B#_OF]_^6M'_
M  [B^(?_ $5GQ!_WS>__ "UH_P"'<7Q#_P"BL^(/^^;W_P"6M'_#N+XA_P#1
M6?$'_?-[_P#+6C_AW%\0_P#HK/B#_OF]_P#EK1_P[B^(?_16?$'_ 'S>_P#R
MUH_X=Q?$/_HK/B#_ +YO?_EK1_P[B^(?_16?$'_?-[_\M:/^'<7Q#_Z*SX@_
M[YO?_EK1_P .XOB'_P!%9\0?]\WO_P M:/\ AW%\0_\ HK/B#_OF]_\ EK1_
MP[B^(?\ T5GQ!_WS>_\ RUH_X=Q?$/\ Z*SX@_[YO?\ Y:T?\.XOB'_T5GQ!
M_P!\WO\ \M:/^'<7Q#_Z*SX@_P"^;W_Y:T?\.XOB'_T5GQ!_WS>__+6C_AW%
M\0_^BL^(/^^;W_Y:T?\ #N+XA_\ 16?$'_?-[_\ +6C_ (=Q?$/_ **SX@_[
MYO?_ ):T?\.XOB'_ -%9\0?]\WO_ ,M:/^'<7Q#_ .BL^(/^^;W_ .6M'_#N
M+XA_]%9\0?\ ?-[_ /+6C_AW%\0_^BL^(/\ OF]_^6M'_#N+XA_]%9\0?]\W
MO_RUH_X=Q?$/_HK/B#_OF]_^6M'_  [B^(?_ $5GQ!_WS>__ "UH_P"'<7Q#
M_P"BL^(/^^;W_P"6M'_#N+XA_P#16?$'_?-[_P#+6C_AW%\0_P#HK/B#_OF]
M_P#EK1_P[B^(?_16?$'_ 'S>_P#RUH_X=Q?$/_HK/B#_ +YO?_EK1_P[B^(?
M_16?$'_?-[_\M:/^'<7Q#_Z*SX@_[YO?_EK1_P .XOB'_P!%9\0?]\WO_P M
M:/\ AW%\0_\ HK/B#_OF]_\ EK1_P[B^(?\ T5GQ!_WS>_\ RUH_X=Q?$/\
MZ*SX@_[YO?\ Y:T?\.XOB'_T5GQ!_P!\WO\ \M:/^'<7Q#_Z*SX@_P"^;W_Y
M:U\@?M>?LA>// FCR:?_ ,)=XP\87%SY!_LN'2M4N;-T\PMON+C[7<6R^68M
MPCQ)/YGDMY2QMYR'[(?[(7CSQWH\>G_\)=XP\'W%MYY_LN;2M4MK-$\P-OM[
MC[7;VS>89=QCQ'/YGG-Y31KYS_7_ /P[B^(?_16?$'_?-[_\M:/^'<7Q#_Z*
MSX@_[YO?_EK1_P .XOB'_P!%9\0?]\WO_P M:/\ AW%\0_\ HK/B#_OF]_\
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M:F.8J(G$[,(BDA=!&V[#EEVD[AD\%?$+1OB5;M>:'J%GJ5LDAB>:SN(KB-9
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MXW+AB2?W?^"G[&?@3]G;49-5\,:7]AO9K=K:27[7=S9A=XY&3;//*@RT2'<
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M2(P1VJQY_P#P4"_X)]7_ (DN-$USX5Z-9V6HV4DBW2:?)#IL@*LDMI<1C=!
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M**********************************************************_
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M2/*_M/5+<B'4KW?(6C^S,P\ZV\TP.L&W9LA$LMUO:2.PKX?_ ."I/[,7A?\
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M^.GPWT/XTZ'/X5\0/MM-7_T=%680S/-&#=(8"?O2Q^0;@)M=2L+%XWB$BG\
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M'M/!4DDDUY)<1ZCJ#R6=G:3E8[2262;8\5];J4AE6*R<321I,T33*RM%]/\
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M8?V8?C/\2OB1_P +'L_"$=G<I>:=>0V<NK:?<1K)81VZ('=;F!G1V@#,%$9
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M?=JR1#SI[*WD,MK< >4-[&)R\3Q1S7%LK^9]W_"KPW\5?VVI;"7XDV5OX?\
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MH-@NL1ZIJ&KZE;RQO);E($;3[.TFBCWRS_9MDEUO9+:!Y&V"X-L7/VIO@O\
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MAIDGV9K=Y5W2Q?:P[1%;AW=HB\J^4%2"4R?)]?\ _!0[POXJ^+?A"\\(>&-
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M@'[/?[7GA?\ :AO-5MO#$EQ<1:1]D\VZD@,,,WVM9&7R1(5F^0Q.DGFQ1?,
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MX>^-;?XE:-I^N6:R);:E9V]Y"DH42+'<1+*@<*S*'"L P5F .<,1R>PKY_\
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M;P]KUQ:FV&HRM+>01:A<?9(W:Y=6D$L#PG,:L;6>/<XBMYIR8/U>_:G^-?\
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MM;N19-9O-!N#Y>Z)HHWF73)8"ZN3(DL=N_F<*&29H61E!9^P_P""YW_,H_\
M<8_]L*_?ZOP!_8%_Y.%\>_\ <?\ _3S;U]__ /!4?_DD/B'_ +AW_IRM*/\
M@EQ_R2'P]_W$?_3E=U\ ?M]?\G"^ O\ N ?^GFXK]_J_GA\->%K/P?\ M;/;
M6,?E1/<75RR[F;,UWH<EU.^7+'YY99'V@[5W;5"H%4?J_P#MF_M!>$OV==#A
MU7Q-;6^H7<5P)]'T^1(WFEOH!F.6$R*_D>3OS)=@9@5P%WRR10R_&'Q7T+XL
M_'/P5X@\1>*=0C\+:$=#O[F'PY8PAKZ6.*&YGBCU"[F3S8'8+;K<QPD"XMS)
M!);V<C2K5_\ X(J?\D\U+_L8+G_TBL:\ _;Z_P"3A? 7_< _]/-Q7[_5^ /_
M  0Q_P"9N_[@_P#[?U[!_P %F_@7%XI\+V?C"V@S>Z1<);W4R^4O^@W1*@RE
M@)9?+N3"L*(Q$?VF=_+(9G3W^Z_;?B\1_!*\^(EH_E:E%I[6\JVZ1.;75W9;
M1289)956);B6.X1)F>0V;QR-&[.$;ZO_ &:_A"GP%\':/X:58UDL+.-+@Q/)
M)&]T_P"\NI$:7#E))WED4$*%#!0B* B^X45_.#\5?V,OBK^Q=KE_XA^%\UQ+
MHMQ</)':Z<7GFBA8[(8;K3Y_-^V>5]HDCAD NV58VNG%NQX^S_V'O^"D6E_M
M.:I::+XAT^.S\6M'>I:W%O 6M98,)<211.[R3V[LD(>6-RT,AM5D\[S&B@3X
MP^..F_\ "R/VGCI&H:UJ&DVY^SVMM>6E[]EN+;S-(62."UF<,L7GW$I3RU7]
MZ]Q(H!DF)/Z?_P## O\ U/OQ _\ !_\ _<]:'[+_ /P3T\*_LF:S/KFAW>J3
MW,]F]FZ7DUN\8C>6*4D"*VA;?NA4 EB,%OE)((_/#_@B7XL_MG4?&'VZ[\[4
MKS^SKIO.FWW$^U[SSYSO)DDP\T?FR'.'E3<=SKG]_J^</VI-6M]1\ >,8H)8
MY)+;0]5BG1'5FBD.GO*$D )*.8Y(Y K8)21'QM92?@__ ((J?\D\U+_L8+G_
M -(K&C_@M7_R3S3?^Q@MO_2*^K[_ /V3O^2>>%/^Q?TG_P!(H:_(']@7_DX7
MQ[_W'_\ T\V]?O\ 5^ /_-WG^?\ H7*_7[]K'_DGGBO_ +%_5O\ TBFKX _X
M(J?\D\U+_L8+G_TBL:/^"U?_ "3S3?\ L8+;_P!(KZOO_P#9._Y)YX4_[%_2
M?_2*&OQ!^..F_P#"R/VGCI&H:UJ&DVY^SVMM>6E[]EN+;S-(62."UF<,L7GW
M$I3RU7]Z]Q(H!DF)/Z?_ /# O_4^_$#_ ,'_ /\ <]:'[+__  3T\*_LF:S/
MKFAW>J3W,]F]FZ7DUN\8C>6*4D"*VA;?NA4 EB,%OE)((^ /VL_V'_B#\+/&
M.H_$7X73R!;N3[7<6EG,ZWBR'-Q= Q2LR7MO+-"LQM@7,DDRVZV3Q1ACV'[(
M_P#P4U_X3O6++PC\2=.\GQ#'J$=I8WJ6FW9>-&]HPNH6/F6MV[N\#26Z"/\
MTEXGBM84=G_;ZBOP!_YN\_S_ -"Y7[_5_/C_ ,$:O'EOXS\5>+KS5GCF\1ZE
M'#>B8P*)'C:XF:_971 D2---:L\2E Y\LJA$/R?T'5_.C\)_#=Q\*OVJ[O3H
M+N1X[V\U.XGV;HEDCO\ 3I=3$$B!V$B12/'C<<.\*3;$8*J]A^WU_P G"^ O
M^X!_Z>;BOW^HHK\ ?^"&/_,W?]P?_P!OZ]__ ."U?_)/--_[&"V_](KZOO\
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MU^_U%?D!_P %J_\ DGFF_P#8P6W_ *17U??_ .R=_P D\\*?]B_I/_I%#7Y
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M=R^9;SC?&V-\$PR#'(,Y_P#P2LU:WU'X2:+%!+'));2:A%.B.K-%(;ZXE"2
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M7Z_?M8_\D\\5_P#8OZM_Z135\ ?\$5/^2>:E_P!C!<_^D5C7@'_!<[_F4?\
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M.V0?\3:6)(K>UAS';Q*D2$HI;?.TTY(:4JO[O?M8_P#)//%?_8OZM_Z135\
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M%_W /_3S<5^_U%? '_!4?_DD/B'_ +AW_IRM*/\ @EQ_R2'P]_W$?_3E=U\
M?\%SO^91_P"XQ_[85^_U?@#^P+_R<+X]_P"X_P#^GFWK]_J*_ '_ (*%_P#&
M*WQA\+_$FV_=V][L^W"'][<2_8REM>XCG_<KYEC/#;Q;'3YU=_W4F)6_1_\
M;>\4WFKZ=I_P_P!'D\K5_&EQ)IRR[5;[/IL:>9JMUME BE\NV)C\GS(9G\[?
M"QDCQ7YX?\$^-6N/V7/BSXE^%5Y+(FG7,D\NFQ3NTTC20 3VS@P'[/&]QI[&
M:X9DC+&"",F-T$+?=_[-W_%V_B+XT\:2_-%IMQ'X5TP/\DT":?B;45*1_NWB
MFNI$E@ED:2?:&4B%/W9^?_\ @M7_ ,D\TW_L8+;_ -(KZOO_ /9._P"2>>%/
M^Q?TG_TBAK\@?^;O/\_]"Y7W_P#\%1_^20^(?^X=_P"G*TH_X)<?\DA\/?\
M<1_].5W7P!K_ (L^S?M;6_\ :%WMMX/+M;;SYL)'Y^AGRX(MYVKYEQ.=D:XW
MSS' ,DAS^_U9\FK6\-Q'9M+&+F6.26.$NHD>.)HUD=4SN9$:6)78 A3)&"07
M7/X(_P#-WG^?^A<K]?OVL?\ DGGBO_L7]6_](IJ^ /\ @BI_R3S4O^Q@N?\
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MB7J/P;^'NI>(=*?9>Z?<:7/%EG57VZG:;HI/+9':*5=T4R!E\R)W0G#&N?\
MAI^W)\-?CKX>2?4-8T>T^UVZQ:AIFHW446QY85-Q;,EXL'VF)?,,1E6,P388
M G#*/A#_ ()8? 9++Q?XH\<:1')!X5EDO=.T$O'(%N[5[T2"2-IW$^R!+>*(
MF1"9'D=3();>9*_<ZOG#]K/]GZW_ &FO!VH^')1&+F6/S;":3:!!>19:!]YC
ME:-"W[J=HU,AMY)D4@O7Y8?\$ZOVKHOV=?M7PI^(A_L2]TRXG:RGO'BAMXU?
M]_):R2X5%W,TES;W#O)%<I-L250+99O?_P!N7]H^S^,_ARX\!_#FY_X2#Q#K
M/V:.1-(F:9;:Q><"::>Z@5[9(F*+:7$<TT(6*Z$DI$)P_P!0?"32=#_82^'6
MEZ;XBU.WM+?3K=A<7$TPVR7<OFW=Q';#9')-ES-]FA2,W#Q(J['D#$_D!_P1
M9^*NA^"-1\0:5JE_;V=[JG]EBQBG<1_:&B>YC:.)FPC2EKB()"#YLFXE$8(Y
M7^CZBOQ!_P""T?Q5T.\\,V'AF&_MY=:BUB&YFLHW#S0PI9S@O,JY\G/VF$QK
M+L:57+1AU1ROW?\ L7?&OPUXI^'.C26FJ6;KH^AV$>I@S*C636]MY<INE<JT
M"!H)BLD@5)$0RHS18<_CA_PO[PO_ ,-/?\)3_:=O_87VC[/_ &AD_9]_]D?8
M-WF8V^5]H^3S_P#4;/WWF>1^\K]3_P#@H'^S._[97@JW?PY)9SZC:2)J&G3?
MNV6[@>%@]O#=!ML:7"M'*CY,,KPPARB$31?F!^Q]_P %1;C]G"P_X0[QUIUY
M-;:3&UM;20(QU"&2.9]UM=1W<\:[(U;R8@AA-LD"0F*0-NB^[_!/Q\O/^"B&
MN:2OAVQU#3O!FA:A!J6JW]TZV\UW?6A,UGI\4<3SQ2Q++Y-S<JY8[1&VZUD2
MW:Y^(/\ @M-\5=#\;ZCX?TK2[^WO+W2_[4%]% XD^SM*]M&L<K+E%E#6\H>$
MGS8]H+HH="W[_?#3XJZ'\9-.35?#U_;ZA9/M'FP.&V,R+)Y<J_?BE"NA>&4)
M+'N =%/%>@5GZMI-OK]O+9WD4<]M/&\4T,J*\<D;J5='1@59&4E65@0P)!!!
MK^='X3:O>?\ !*#XE7NE^(8K@^#M>RMM>J%FS#%*3:W3LL*O)+;+*\5[;Q")
MAYQG2*91:B;]?_B7^W)X&\#Z<\^GZQI^LZE)NBT_3-.NEO+B\O&1C;VRI9K<
MR1^<ZB(2M&8T=U!.YE5OG_\ X)??LUZY\%M#U+7_ !3]H77?$EQ%<SPW$A>9
M(8Q(T3W(=?,6[D>>>2=7=V"M$'$<XF0?6'[7OPA?X[^ ]<\/0+(]S=6;/:QQ
MO'&TEU;LMS;1EY?D5'FBC20L5&QF^>,X=?S _P""2?PGU3QUI=CXG\0O(^G>
M'I+ZU\*P%!"L37I)U.Y)6%&N4=F$$+/+,B.+I/+1XXV7T_\ X+)_!3_A.?!=
MKXGCDVR^'KCYXV;"O;ZA)# ^U1&Q:595MBN7C01>>3O?RQ7U!_P3W^'MYX/\
M#0:KJES]JU3Q/<2^(;Z4;0AFU)4D78JQ1!/W2Q&1 "JSF4(QBV >/_\ !6#X
MJZ'X?^'&J>'[F_MTU?4/L!M;'>&N)%6]BE,GE+EUB"V\W[YPL6]/+W^8RHQ_
MP2?^*NA^(/AQI?A^VO[=]7T_[>;JQWA;B-6O991)Y38=HBMQ#^^0-%O?R]_F
M*R+^<'[<GQ^\+^(/CAX6UVQU.WN]+T?^Q?MUW;$W$,?D:C+=R['B#B;9%(C-
MY/F?,3%_K5=%_H^\+>+-.\<V<>H:5=V]]93;O*N;:9)H7V,4;9)&61MK*RM@
MG#*5/((KH*_FA\&_%G_AAGX^>(=0\7V5Q;V&LW&HJLX&[99W]\MU!?(J!O/B
M_=!9$C/F)F5=K7$#6[>H?\%1?VCK?]H#P+IUQX?T^\F\.#7$V:[.JVUO<7$=
MI.!%:V\I6[E3]Y.LMP\4,,<UL\2M*6)3]#_V$/V@K/XJ>'M#T;1;:XN;+2/#
M]C!J6J,C0V\.I0PV\7]GQ"55>XE"B6::2(&&%!!\[FY79^2'QR\ >)?^"9OQ
M-'CG2[:.X\.:A>730QP!K:U,%T7>32YDB.V%XE^>UR'A<P17"1,8)K>'[@TG
M_@L9HWC.WBM- \,:YJ7B.:-"FF1+$T;R!0]PJ3PM-.Z1H)'5Q:Y<("T<(+%/
MI_X7?LFO-\,M0\,>(6C;6_$T=[?:U<R01RJFK:B/,:80)(T&^T<0K']G:*)G
MMEGC$3/D?C#^S_\ M >)?^"6'B74O"?BO39+O3KN2"5TBG8*%#%/M]AO'DS)
M+%N5T987E>&&*2:W>WDC'W?XI_;CG_;LLY/ WP\T;6(UU;;9:MK-S!;^3I=G
M<,!-(\:R3Q2>;;)=HJR36LA8 0-),5"_1_[<'[%EO\;_ (?0:!X=MHTU'08X
M3HB-(H/EP(L+6AN)ED?9)"H #21A[B*V>:8(C-7@'_!//]NW1K?P^G@KQM=Q
MZ)K?AZ,VF_4GBLXYK>!_*CBS((5BN+9=EO)!)^^<1B;=*QN!#G_MV_$.7]M2
M*Q^'7PTF_M=WU"*76K^TEE.FV<*Q&2W2[N8XVMI8I"S3@)+(RS67E+#)<E$7
MZO\ VMOV?KC4_@U?^#/#PDN)+#2[**T23=)//'I;V\H0"&,F2XECMRD:HBB2
M9E7"*<K\ ?\ !.S_ (*)^"/A/X(M_"_BBXDTNYTN2<12F">YCNH[F>:XW+]G
MAD:-XVD,;I(,$>6Z2.7=(?F__@JW\3]<^+O_  CFIWVC7&B:0?[2CTVWU!#%
MJDK)]D^U375N&9+>(L8X[:,LTKB*6=B(YH5'ZW_M$_M0:-J7PMUV]UF"\\.3
M:II>JV>GZ?K*16VH74C0&W!BLXY9IMGFS(I+!2B?OW5+=DF;Y0_X(N?%70[/
MPS?^&9K^WBUJ76)KF&RD<)--"]G  \*MCSL?9IC(L6]HE0-($5T+?/\ _P %
MIOBKH?C?4?#^E:7?V]Y>Z7_:@OHH'$GV=I7MHUCE9<HLH:WE#PD^;'M!=%#H
M6_?[X:?%70_C)IR:KX>O[?4+)]H\V!PVQF19/+E7[\4H5T+PRA)8]P#HIXK^
M<'_@E_\ M->'/V2=1\2Z;XUEN-*ENOLBJ9+6=_+FLGN4F@FCB1YHY<SC :/:
M/+D5V1PBO_2=X \27'C'2[;4;JTDL)+J,3"UFW">&.0EHDN%9$,=QY93[1#A
MA!-YD*RS*@E?L*_ ']NWX1:Q^R3\1;'XR>&;/S=+-Q%+JD<7EJ([B3,%RKJ(
M&$,5]$VPW1$SB\EF=F262V#_ *?^%OV]OAKXGT./7CXAT^UB>W:=[2YN(H[Z
M+8#OB>S#M,TJE654B63SC@PF5'C9OC#]G'X<:S^TA\8-0^+5]!>6GARRC:W\
M/&X>5#=QM;"WCG@AN(4<64L,LUYP(0+BY0(\Y2Y(^3_^"TWQ5T/QOJ/A_2M+
MO[>\O=+_ +4%]% XD^SM*]M&L<K+E%E#6\H>$GS8]H+HH="W[_?#3XJZ'\9-
M.35?#U_;ZA9/M'FP.&V,R+)Y<J_?BE"NA>&4)+'N =%/%>@5X_\ M"^%KSQS
MX-\0:5I\?G7M]H^HVUM%N5-\TUM)'&FYRJ+N9@-S%5&<D@9-?A#_ ,$T?VU/
M#G[+.G:MX/\ &HN-)E34)KM;B2">3$VR&VFM)H(HGFAEC, 8%E*M^\1_*>-!
M-Q_[9WQF>_\ C/X0\2Z]I=YH&G6D>A7*K?>6UT;&._DN)+B:WMFG:!U8S1_9
MB7N (0S(CR>4OZG_ !\_:NT/Q'\,?$>HZ@?[)M-6T_5+3P^+QQ'<ZO#):K#%
M=V]IC[0L4DT^(PZ[A;>5>2^3%,-GS!_P1<^*NAV?AF_\,S7]O%K4NL37,-E(
MX2::%[. !X5;'G8^S3&18M[1*@:0(KH6^?\ _@M-\5=#\;ZCX?TK2[^WO+W2
M_P"U!?10.)/L[2O;1K'*RY190UO*'A)\V/:"Z*'0M^_WPT^*NA_&33DU7P]?
MV^H63[1YL#AMC,BR>7*OWXI0KH7AE"2Q[@'13Q7P!_P5<_9T_P"%T^!GUFT7
M.I>'/-O8^<;[,JOVZ/YI4C&$1+G<5DD/V;R8UW3')_P2LT#4=:\)7/C77;C[
M;J_B.X0/>-([S26>EQC3[5)P0J>:C17#&0;Y)ED5Y99)"0GZ?T5^&/\ P6Y\
M :IKNE^'M:M;:273M-DOX[V= "L#79M! 9 #N5':)T$F-@?9&S!Y8E?ZO^%O
M_!2;0_CAIUO%X8TS4-4\53V\DDF@PJ(_LS1HY9[C4)Q%9I:>8J1BX#-*?/A
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M\)3_ &G;_P!A?:/L_P#:&3]GW_V1]@W>9C;Y7VCY//\ ]1L_?>9Y'[ROT/\
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M^WEUJ+6(;F:RC</-#"EG."\RKGR<_:83&LNQI5<M&'5'*_3_ ,'/%FG?M ?
M]M"\,7=OJ&J)X/&FRVD<R+-#>-ISVBQ3)(4,.^6-UC>79'(JF5':+#G\X/\
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M5E#A690P&0&89P3GH-)TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH
M4    5H444444445GZ3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550
MH    HU/2;?6D$5U%'-&LD4H21%=1)#(LL3@," \<B))&W5'574AE!&A1111
M117E^F?!#PKHNJ'7+71-+AU9I)93?QV-NET9)@PE<SK&)2\@=Q(V[+AFW$[C
MGU"BBBBBBBBN/\:_#W1OB5;K9ZYI]GJ5LD@E2&\MXKB-9 K*'"2JRAPK,H8#
M(#,,X)R>"OA[HWPUMVL]#T^STVV>0RO#9V\5O&TA55+E(E52Y554L1DA5&<
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M5M @S]N.DW%W;S0[V2&#+WC,?GEE3'E07/RHX?R<K)7V!X<_:6B^,'@L^+/
M-E_;]PWEK'IC745C,LWF1K/!/)+OC@EA1S*0VY9%53&SQRQ2-^$'_"Q/%_\
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MC9<Q7$>G6LL-W:V[;)6CEN%83PO;R?N#(L;_ &!\;/VJ;?X >&K#4]:L9/\
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MA?2K[P=]CT :/9QKK?\ ;5I+NABL5,$WV)$$P\\K&/+)W1>;EB=C5^C]<?\
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M2ND=R&A#_1__  5'_P"20^(?^X=_Z<K2C_@EQ_R2'P]_W$?_ $Y7=>?^._\
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M?^$UA9ZI-ILBQWVN:C<B+2;=G!:,QQP,UW>I+Y-Q )(5C1)5CF#36[ASX_\
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M/85>*.&8),'W@74@3R\$O^YU?@#_ ,W>?Y_Z%ROO_P#X*C_\DA\0_P#<._\
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M][<:E/J5MIUS>CS?MR3/Y2QRVZ*\2W#Q2!)9&V^4KY:1%)\?_P""YW_,H_\
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M0U] 5\(?\%--6N-%^$GB*6UEDAD:.SB+QNR,8YKZVBE0E2"4DC=XY%Z.C,C
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MKYWD>9^\\K?N\O?\^S&[YLU]/_\ !:O_ ))YIO\ V,%M_P"D5]7W_P#LG?\
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MZYX+\5WOV?3;K;:&Y:.(0M,KK+IUW.X>1K>*2WFD) =EA:Y7[1M6)I(?V?\
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MNB1W BN?LDING8FW^W6J&%[-O),<B136L,>^-V!N$>Z5'9%D2+];_A#_ ,%
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MI)<&)Y)(WNGLII+J1&EPY22=Y9%!"A0P4(B@(OS?_P $5/\ DGFI?]C!<_\
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MSQAKFN7$>AVU]'K+(FK2164D<DVJ6\HMY1*X5;A5#!X@S%2C]0I->H?\%B/
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M^CW[)W_)//"G_8OZ3_Z10U^0/_-WG^?^A<K]?OVL?^2>>*_^Q?U;_P!(IJ^
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M ,:_V7_"O[1/EKXGM;B^BAVF.W_M"^AMPR>9MD^SP7$4)E E=?.*&4HVPOL
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ML+>!OV8ML^C6/GZDN?\ B9WI6>\&?-'[M]JQP?)*T3?9HX?-C"B7S&&ZN_\
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MKQ!XL\.V,T@E.GZ5K+PVJR>6D;.!)'-*SN(U+-)(YS\H*HJ(OU_\(?@OX?\
M@+I:Z-X:L8["Q61Y3&A=V>20_,\DDC/+(^ JAI&8JBI&"$1%7S#]LGXZ1?L[
M>!M6USS_ "+T6[V^G$>4SF^G4I;E(YB$E\MCY\B8<B"*5_+<(5/E_P#P3S_9
M5?\ 98\'):ZC%&FNZC(;K4RK1R%&^[!;"5$4LD,>,KNE1;B2Y:*1HY 3]WT5
M\8?'W]@WP=^T'JD.OW2WFF:[#)!(-5TNX^S73&W!\K<622(NI*%9_+%PHBA1
M9A'&$K/\+?L">%[*\COO$5WK'BZ6WW?9%\1WQU&&U\Q2DOE0,B0MYHV%_.27
M#11.FQTW'[/U;3$UJWEM93(L<T;QN8I9(9 KJ5)26)DEC?!^62-E=#AE96 (
M^,/%/_!.3X8^.;R34-5TFXOKV;;YMS<ZOJLTS[%"+ODDO&=MJJJKDG"J%'
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M'B99(Q*-SRQ-Y4FS?#]W_#VRU33M&T^#7)H[G5H[.W2_GB $<MTL2B>1 $C
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MWTRZ6\U'6[R-I;/1M,MGO-0N(T;#ND*85451))NF>,.D,WEEVB91X_\ "_\
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MUS1=;U"\M;6STK5-,EMKJ9;N>.WCN5.6@%N'9]S-*KX@F"QLP19/M_5M6M]
MMY;R\EC@MH(WEFFE=4CCC12SN[L0JHJ@LS,0% )) %?"'_#Q?PY=_P"F6.B^
M*+[0!\S>(+?19VTM84_U\[2N4F\JW(D6<B$LIBDVJ^%+?1_P(_:'\/\ [2=E
M=ZGX:FDN;&TO#9FX>)X5ED6""=C&D@678HG6,F1(R71\*4V._N%9^K:M;Z!;
MRWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22 *^$/^'B_AR[_ -,L=%\4
M7V@#YF\06^BSMI:PI_KYVE<I-Y5N1(LY$)93%)M5\*6]P^&/[5OACXQZ-?\
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M@MH(P69V8I&&;9"LDL2/(AD3/S!I/_!3#P=#K,6A^(['7/"US<1I)"^NZ?\
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MM<?:HM">XM[VSPTEE>I'%<&$[0)XUCEE1XMS>6Q5BT;[1(J"6$R:'Q>_;?\
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MVN?2-,\0>(=-L/.%YJNCZ:;C3H'@R9D>ZDDAC/EH%F:1-\!ADCD65E)Q[_\
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M8),,2[1&I<K%$$_9[]K'_DGGBO\ [%_5O_2*:O@#_@BI_P D\U+_ +&"Y_\
M2*QKS#_@K3\7GU'7O#/P]#:H=.O9(;O5[33DC:>]@ENEAMH;<'+2W"M#<-'
MZB%IFMG(D=%\KZ_TG]N2WT"WBL[/X>^/(+:"-(H88O#JI''&BA41$6X"JBJ
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M\??&=CK*R36-O>:U=R68<K;W;0ZQ#Y<-W'TGMUD9)S WR/-#"7#HK(WZ/_\
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M2RM[FS>=Y& 9GF: S-NR09"I=R-[>7_\$5/^2>:E_P!C!<_^D5C1_P %J_\
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M+E\*Z5XA-M'_ &M'JD5BMV 1(;62WNIFA8@@.@DC5TWAC&3)L*^;+O\ T/\
MA/8ZC\4/A9I4']HW%OJ6I^%[1/[3WO)<17%SIZ#[5OWI(\JN_F[O,5V<9WAC
MN'R_^S'X8T?_ ()D^!GLO'FNZ?#<7FH7%[B(R/G<MM;>7;1[/M-UL"122M'
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ME^)OAAJ.J7EM'+?:5):26-P01) T]Y;V\P5@02DD;D/&V48K&Y7?%&R>@?\
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MSM4L=8OK>TFDDD=;=)K.P,K0PLYABED "23HBSO$!"TAB^2O'_\ @M'X6L_
MFN>&?$VE1_8M:N_MAGO;=FBF=K$V9M9"R$8EB\Q@DPQ+M$:ERL403]OOAO\
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MX5OX[J+ST5U6,^3,JM7Z'UY?\;],U36O"NMVNAF1=6FTN^CL#%*(9!=/;R+
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MAAB14CCC36+941$4!515 554 *    *_0_\ X*C_ /)(?$/_ '#O_3E:4?\
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M11111111111111111111111111111117X _\W>?Y_P"A<K]?OVL?^2>>*_\
ML7]6_P#2*:O@#_@BI_R3S4O^Q@N?_2*QKP#_ (+G?\RC_P!QC_VPK]KOC?X*
MN/B5X5UO0[-HTN=2TN^LX7E+"-9+BWDB0N55F"!F!8JK$#.%)X/X8_\ !&O]
MI?3O"G]H^!]5FM[3[7<)?:=+*Z1>=<2^3:2VNZ24;Y7Q;FVABC+MBX)8X1:_
MH.U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!7QAXV^+/\
MPO3X,Z_XD6RN-/BO_#^NR6]O<C$WV=8;I+>9Q@ >?$L=PH4N@64!))4VR/\
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M+C4(D=]21D;:R) SV\*?(4D(DE2:57"Q?DA^P+_R<+X]_P"X_P#^GFWK[_\
M^"H__)(?$/\ W#O_ $Y6E'_!+C_DD/A[_N(_^G*[K[_KY_\ VL?^2>>*_P#L
M7]6_](IJ^ /^"*G_ "3S4O\ L8+G_P!(K&O8/^"L'BFS\/\ PHU2VN9-DNH7
M%A;6J[6;S)ENHKHIE00N(K>9]SE5^3;G>RJV?X*^%]Q\'/V=+K1[SS!<IX3U
M:XF26%H)(9+VWN;QX'C8EE>%IS"V[!)C+%$)V+Y?_P $5/\ DGFI?]C!<_\
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M+)*DTT2_N+I)'F$TDJ[+B<*BBZ5*_.#_ ()[>,?&/[,GQ4?X4:_/)/:21W$
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M;3KO5=0D\FRL;>:YN9=K/LAA0R2/M0,[;54G:H9CC !.!7Y8?M;?$;5/B_\
MLZW_ (AUBSCL+G4H[*Z2UCD$JQVLVKV[V69 3N=K8P/(V$)=FS%"?W2>X?\
M!+C_ ))#X>_[B/\ Z<KNOSP_X+E:M;S7'A2S66,W,4>J2R0AU,B1RM9K&[)G
M<J.T4JHQ #&.0 DHV/Z#J_ '_@AC_P S=_W!_P#V_K]_J_ ']@7_ ).%\>_]
MQ_\ ]/-O7W__ ,%1_P#DD/B'_N'?^G*TH_X)<?\ )(?#W_<1_P#3E=U\ ?\
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M31=<\/Z<EMXAU&WU6]CVK]K@LC8^8JHJ[I8OM%PAE9@[NT1BB^8*D$87YOS
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M8:!!?1Z='#JD=Y/</$TS"..UNH@(X@T8=S)-&"&DC"IO?<S*L;^?Z9X1^/\
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M4[ZXUOQ)>6\%O=:M=I$C"&)5_P!&M((42*TM#*&G,$8+/*^^:6=U1U]0\?\
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M&E\RW*(ODHJQFU=DB.^5Y9#*OQ?_ ,.[?%'_  L#_A9/_"96_P#;OVCSL?V
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M2;3O'-G'J&E>#?'%]93;O*N;;14FA?8Q1MDD=TR-M965L$X92IY!%=!\"_\
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M;CQ_C7_@IYHWPUMUO-<\)^---MGD$237FD16\;2%68('ENE4N55F"@Y(5CC
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M"$1%7/\ ^&A?!O\ :/\ 9'_"0:/_ &E]H^R_8_[1MOM'VC?Y?D>3YGF>;O\
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M,N"P1Q$@>9P(HW8>0?\ !/?Q_JGQ3^&ND:UK5S)>:C>2:E)//(1N9O[1N@
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M;;F1MK+/,Z30N@ECM)%)*.M?L=I.DV^@6\5G9Q1P6T$:10PQ(J1QQHH5$1%
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MHFLZKX.+1MI+V<NJJI0>8ETDMK;,5D&"4DC=0ZON ,493R\R^9V'_-WG^?\
MH7*_?ZO+_&OQO\*_#6X6SUS6]+TVY>,2I#>7UO;R-&690X2616*%E90P&"58
M9R#CL/"WBS3O'-G'J&E7=O?64V[RKFVF2:%]C%&V21ED;:RLK8)PRE3R"*Z"
MN/TSXA:-K6EG7+74+.;25CEE-_'<1/:B.$L)7,ZL8@D91Q(V["%6W$;3C/\
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M\*>#+SQ;X<@CT.YL8[:WN[;3XEM[74+6:]@"Q7$,7EIOCF:.=)<,6,01U<K
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M@EB0 "37Y8_\$0O'7]H>'O$&@^3M^Q:A!>^?OSO^W0F'R]FT;=GV+=NW-O\
M-QM79E_V^K^?'_@EUX#M[#XN>-+S0$C?PY81W]E;313K-&(Y]11K)4=G=YD>
M&UE9907!" L^73=H?L"_\G"^/?\ N/\ _IYMZ_?ZBOG_ /:Q_P"2>>*_^Q?U
M;_TBFKX _P""*G_)/-2_[&"Y_P#2*QKZP_:[_9(\-?ME6\6EZC=R6NK:7&\]
MK+;R*TD"WBM&K3V[9$EO+);@_P#+)W-LZ17$?[W/X@^)_#?Q2_X),:I%=65W
M'?\ AZ]DN%BSY\FFSR.-JBZMM\9M[TQQ13*8WRRH8DN9XH[E!_1;\ ?C'9_M
M >%],\3V*[(M0MQ(T66;R9E)CGAW.D9?RI4DB\P(JR;-ZC8RD^P5_.C\6_&M
MO\$/VIHM<UQ9+;3II+14N) L<?EW6DKIXN/,E:-/L\<S,)Y0Q""&;[SQE*_H
MNKR^3XO:6GBJ/P<&D;5GTN3564(?+2U2XCME+2' +R2.P14W$"*0OY>8O,_"
M']DKQ)<?#C]I?Q%IUU:2+)K-YKUN/,W1-%&\S:G%.$9"9$ECMT\OE0R3+,KL
MH"O_ $75_/C^U?X#M_$/[2_AB+04CFOI)-&O=31)U++)9S/+*T@=\1.EA;0R
M"(;"Z!'5&>8&30_;Z_Y.%\!?]P#_ -/-Q7[_ %?@#_P0Q_YF[_N#_P#M_7/^
M)?%-GX/_ &MDN;Z3RHGN+6V5MK-F:[T..U@3"!C\\LL:;B-J[MS%4#,/Z'J_
M ']@7_DX7Q[_ -Q__P!/-O1_P7._YE'_ +C'_MA7[_5^ /\ S=Y_G_H7*T/^
M"Y6DW$UOX4O%BD-M%)JD4DP1C&DDJV;1HSXVJ[K%*R*2"PCD(!"-C]KOA5\2
M].^,FAV'B'2GWV6H6Z3Q99&9-P^:*3RV=%EB;=%,@9O+E1T)RIK/^*/Q>TOX
M0)I[ZFT@;5-4LM*LTC0NTEU>R;(P>BJBJ'ED9B $C8+OE*1O^*/_  7._P"9
M1_[C'_MA7[_5_,C_ ,$FO#GA74?$NN^$_&>CV=QJTL<36<.J6=O(T4EDTRWE
MNJ70,J7!$BNT2(24MIFDV^2,_O=_PR=\//\ H5/#_P#X*;+_ .,UY!\4$\):
M?\-_'>G^$(-/M[>PT_6K:^AT^WC@A2^73=TJ,(D2-Y51XDE9=Q1E\EB)(G1/
MD#_@B7XIL[OP;K.E))F]MM8-S-%M8;8;JV@CA?<1L.YK:<;5)9=F6"AD+?3_
M /P5'_Y)#XA_[AW_ *<K2C_@EQ_R2'P]_P!Q'_TY7=??]? '_!4?_DD/B'_N
M'?\ IRM*/^"7'_)(?#W_ '$?_3E=U\__ /!:O_DGFF_]C!;?^D5]70?MA>%K
MSP-^S>=*U"/R;VQT?P[;7,6Y7V30W%A'(FY"R-M92-REE.,@D8->P?\ !+C_
M ))#X>_[B/\ Z<KNO@#_ (+G?\RC_P!QC_VPK]_J_ '_ ((8_P#,W?\ <'_]
MOZ_?ZOQ1_:B_X)1Z7\?+BX\6^!]6C@N]6D:^>*X<SZ?<M=-'(9H+B(/+"CAI
M9^ETDCR(D8MX0,>/_L6?MQ^-?A1XQMOAC\1Q)*9+R2T^TWIFEU"WNI]IMHVF
M4RBYMY9"$B=@1LN4F6Z^R1(E:'[?7_)PO@+_ +@'_IYN*_?ZOP!_8%_Y.%\>
M_P#<?_\ 3S;U]O\ [=O[9MY\#Y;'P;X4A^T^,]>\J.QWA1#:K<RFWBF+2XB>
M5Y0R01L?*1E:6<B-4BN/'_B+^PE9Z%X-\0^+O'5]<>)_&,?A_5)?M5U*SV=E
M,+:\EV6%MA$2*-IB8A(I6.2-9X(;1CY:G_!%3_DGFI?]C!<_^D5C7@'[?7_)
MPO@+_N ?^GFXK]_J_ '_ ((8_P#,W?\ <'_]OZ/^"YW_ #*/_<8_]L*_?ZBO
M@#_@J/\ \DA\0_\ <._].5I1_P $N/\ DD/A[_N(_P#IRNZ_-#XK^)+CX5?M
M5VFHSVDCQWMYIEO!OW1+)'?Z=%IAGC<HPD2*1Y,[1AWA>'>C!F7^BZOY\?\
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M7>)MA 0[-Q.Y5!_,#_A@7]H7_H??_*_K/_R/7Z_?LN> /$/PO\(:?I'BN_\
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M\7M+^ OA^^\2ZRTBV-A&'D$2&21V=UCCC1> 7DD=(U+%44L&=T0,Z_EC\%/
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M*0RLI(8$$$@UY_XN^+VE^"M;T7P]=-(=1UZ2[2RC1"5VV5NUS/)(YPJHJA$
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MG1+7PW#%JUE%/';QW96?4I(D3S5D:6XA8K*JVT<MPH<0X5;O$G/_ +1OQ/\
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MS^(+..YN;*XT^5]VZUN6MVFCVL5&\VLUQ"=P ==DK_*P#;7W*OXX_P#!0/\
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MHHHKG_%/BS3O UG)J&JW=O8V4.WS;FYF2&%-[!%WR2%47<S*JY(RS!1R0*\
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MN8(XI9I8]T@#^4CK([26WQ!_P5/_ &@OBE\(+BULH;^STG1-3DNQ9?V5+/\
MVA)':M:MNN[F2*)H7+.&5+,H DDL$LDZJ'?][J_ '_F[S_/_ $+E?K]^UC_R
M3SQ7_P!B_JW_ *135\ ?\$5/^2>:E_V,%S_Z16-?K_17\T/[.&H^+;+XZ^.(
M_!=KI]QJD]QKL9EU*62.SM81JT4CS2K"/.ER46W2.+#"2=)6/E12 ^X?M-_
MWXT_LP6[^.-&\;ZIKZP23S:A 8V2.VCD4YG73Y)KJTDMTW/O58T%H!'*D8BC
M>2W_ $O_ &(/VI?^&N/"2:[+:_8[VWN'LKV-3F$W$4<4C20$LS^4ZRHP63YX
MV+1%I0@FD\?_ &@OVFM<\6^-+;X5?#Z7[)KK;+C6-9EM3<0Z7:"-;C"1.C1R
MRR(T:AY<6X::&W$@GF,EIX_^T?\ LQ^-/V>]#N?&'@KQSXHNKO1K>:YGLM6O
M8]0AGA 42N%G\JW7R83/,5DBN6D94$0CE52WUA^PY^UW;_M?>&CJ+Q1VNK64
M@M]1M4=642%0R3Q*6:5;>8;O+\T95XYH0\ODF5_L^OD#]LW]J7_AF#0X9K&U
M_M+7]4N!9:/IZG<TUPX_UC1(PFEBC)0,L(+O+)!!NB\X2IX?9?L.^,?%UE->
M>)?B+XD'B&XC!#:5<_8M-MY! B*HLXP@F1)%9F>,V9N%.3'#*SR-XA_P2V_:
MK\<_%74=4\(>+HKB[_LBW#?;[B)H[BUEB=+;[#=GRQOE?$DBO.1=%X;GS&GS
M^X\?_;Z_Y.%\!?\ < _]/-Q7[_5^4&@_M#>(_P!N/Q;K7A?P?J']A>$]%V17
MNM6BP7%]>L\DD+16DQF:.VBN$6>2UNX8YI8C;1SF1#.+=>?_ &C_ -GOX@?L
MTZ'<^*_ /C3Q!?2V%O-)J-IK=Y#J"M9H%EDFMEN(?)26$1EV#(9)(BZQR*X\
MFX^L/V'/VN[?]K[PT=1>*.UU:RD%OJ-JCJRB0J&2>)2S2K;S#=Y?FC*O'-"'
ME\DRO\OZ-X[O_P!MOX@^*O"X\3:IX>T?PS)%!:V6E2PV.H7=Q"\MO=W4ES^^
MF>WCE#1^4@$+)-9NZ13H1+T%KX,\>? CXE>$-$?Q'JFL^"KZ34=@O=LEU'=0
MZ==R^3?7J0HURCLS3VJ2OC$3*(1]BCE;[ _:J_:8TO\ 90\-2^(=3CDG8R+;
MV=K'D-<73J[QQ&3:RQ)MC=Y)6!"(C;5DE*12?)_A;]F#QS\?M#CU_P 6>,O$
M&BZ_?V[36]AI$K:?8Z<DP,MO;SVFQ)IY82^+@RR1SD 6QF;R5N'\@_9:_; \
M1_"CX@77PC^(=U]OECN!;:5K$I@BE8"%7M4N<2$2?:XO+>)F>6\%U,()3.\N
M;?Z/_;Q_:[O_ (%)IWA?PK%'<^,/$4@M]/5GAVVHDD6%)Y(Y& +R2/Y=KYH%
MNSI*\CLD#0R\?_PQ%XY_L?\ M+_A8/B#_A,_^/K/VUO[#^V>9YWD_8?*_P"/
M3_ECC'E[?WGV/R_]#KX0_P""8=[JFH_&SQ9/KD,=MJTEGJ[W\$1!CBNFU2U,
M\:$/("BR%E4AY 0!\[?>/]%U%?AC^SCX[\0?\%)_$OB*\N/$VN:#X>T>2,:9
M8Z/*FG3F.\:01-<S)YQD=8[3=(CF8":9S#)#$#')GV7Q?\<_L1_%K3? FH:U
M<>)O#VO7%J;8:C*TMY!%J%Q]DC=KEU:02P/"<QJQM9X]SB*WFG)@^W_^"@_P
MU\4>._"6KSZ7XC_LC2+/1[Z>]L(K 237_DQM.T3WAG1X8G6,1%(HQN5YA*9X
MW$2?G!_P2_\ A5X[\<^#;VY\,>,?^$>LEUB>.2T_L6TU#?,+:T9IO-G=77<K
M(GE@;1Y>X'+FOZ'JX_Q_I6J:[I=S:Z+>QZ;J,L92"]DMA=K Q(!D$!DB61PN
M?+#ML#[6=)4#1/\ S1:9\*?%FD_M%'0H_%,A\1F260^(9-/BE;=+I#7+ 64D
MC0A!$QM8XPX2) IC5 B1K_1;\%/!GB/P-ITEMXGU[_A(;UKAI([O[!!I^R$I
M&JP^5 S(VUE=_,)W'S-I&$%?SP_\$I-?\4-_PD>A>$K?R[_4_P"S1)K,T8DL
M])MX?M8EN'C)'VB[;S56QM.$ED#RRL+>WE#>H?M8Z3\7OV$]4T[QC_PF%YK^
MG7%XPE6X>2*U^U2"61K673?M$D/V>2)9#$UOL$)5@@M7CMG?]_OA[XUM_B5H
MVGZY9K(EMJ5G;WD*2A1(L=Q$LJ!PK,H<*P#!68 YPQ')_-#P?\6]<_X*':YJ
M-MX;U34/#W@'2<6\M_9*;?4M6NV/F*;>YDB;[)%%L5W1"+@PR(L\>+P):>(?
MM':EX\_X)M7^G^)-.\1:IXG\+W]XMO>6&M3K<21LD)9(ENG9I5>8?:I4EMH8
M4B,$2W"W("J_['?"KXEZ=\9-#L/$.E/OLM0MTGBRR,R;A\T4GELZ++$VZ*9
MS>7*CH3E37H%?G!^T%^TUKGBWQI;?"KX?2_9-=;9<:QK,MJ;B'2[01K<82)T
M:.661&C4/+BW#30VXD$\QDM/'_VC_P!F/QI^SWH=SXP\%>.?%%U=Z-;S7,]E
MJU['J$,\("B5PL_E6Z^3"9YBLD5RTC*@B$<JJ6^H/V,OVO\ _AKCPE-JEM;V
M\6OV.8+NQ:X\N$W'E[HI591/-#:3G(5WCD>-DGC47'D;Y/S U']J[XJ^%_C5
M:Z!KQ_M6XL/-2/0=!=X+&YFN]+#PAWG"2/$KO%///>F5;,+/-&HC3:?8/VP/
MV>OC-IVAW7C1?'%Q+=V5N;B\TG3#-I5I;VR"2:X%M)'<+]I^S[B$>Y1+F>W3
MF1I4C@?[?_X)[_M*7G[4/@:#5=4YU2SN);"^E$:Q)--$J2+*BJS#YXI8C)@1
M+Y_FA(DB""O'_P!L3]J[Q';^*--^%WPX-NOBK4MDMQ?S/ \5A" \Q0QN)0)3
M%$T\HEC9EM2GDPS37$;1&O\ ['?CGX5:=;ZUX0\:^(-7\2:?Y<S6.LW[3Z7J
M6U"L]O\ 9W(\GS<GR3)-)Y1VKYT;E;R'Y _X(8_\S=_W!_\ V_K]_JS]6U:W
MT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q 4 DD 5^4'P9^*/BS_@HZ^J
M7EGJ5YX4\%65Y]E@&G")-6OV$:RGS+TR2M9O"P@E*V\6R2*YDM3+/L:4<!^U
M-X/^)'["U@OB[PAXJU36=$BDMAJUGK\\>H2(?.V1-&\J(PMY6E6"=+8PW"DI
M)YDB_-:_=_PT^,<_[9GP_36/"&H_\(_J5WMC:8PV^H/I]Q!,IGA>%V$;[T!\
MLR"-S!/%<>6C,J#\0/\ A7?B_P#X:-_L;_A*/^*D_P"A@_LJV_Z GF_\@_=]
MG_U/^C?>_P"FWW^*_?[X%_#OQ?X"^V?\)7XH_P"$D\[R?LW_ !*K;3OLVSS/
M-_X]V;S?,W1_?QL\OC[YKZ KYP_:J_:8TO\ 90\-2^(=3CDG8R+;V=K'D-<7
M3J[QQ&3:RQ)MC=Y)6!"(C;5DE*12?)_A;]F#QS\?M#CU_P 6>,O$&BZ_?V[3
M6]AI$K:?8Z<DP,MO;SVFQ)IY82^+@RR1SD 6QF;R5N'\@_9:_; \1_"CX@77
MPC^(=U]OECN!;:5K$I@BE8"%7M4N<2$2?:XO+>)F>6\%U,()3.\N;?S_ /;;
M^-'Q._95\6Z18KXQN(O#.L>7MU&YTK2IYK7RY$CO=\5O:(\_DJ\=PNV.'S%E
M$";WC=S^WWA;1I_#]G';7-[<:A*F[==7*VZS2;F+#>+6&WA&T$(NR)/E4%MS
M[F;\\/&MUXY\6_%)?"WACQ?>0Z3;68U'70VG:7.+!9IV^SV-O<"T8K<31\Q1
M7J[X[=/M?FWNXPK[!^VE^UNG[+>EVL=E:2:EXCUB1[;1K!(Y'66<%%+R>7\S
M(C2Q 0QGSKAW2)-H,DT/C^I_L.^,?&VEBZU3XB^)+?Q1-'$;B6QN?)TF.12H
M98=/MQ:G8(QY>\20F67-R\:EVAKS_P#8 _;CUOXE:S?_  ]\?"-?%&G2702Z
M!MXQ<M;2E+BU:.$K$UQ"=S(ULK)+;QR.P4P-+/\ ,'[67[2?Q>\!?$OP]X?O
M);-8YKS3KVTT;1;N2&.[1[Z:&*UN[ZXBAE=Y0I@GW*MDP\N8VZL& ^G_ (A_
MLE_&[QEK.F:U%\0([>3S(WO;6VCGM+.R595E\NVMHR\6I(A>5 ;\0O/''%',
M[*Y$7S!^UO\ 'OXM_LL>-;31;[QA)'X<U*2.2VU9]%L96@M6F\N<2I'9(L]Q
M:J=\D<!S*C0R!83.(D_>[PMHT_A^SCMKF]N-0E3=NNKE;=9I-S%AO%K#;PC:
M"$79$GRJ"VY]S-^<'PJO_B%XK^*^O^'V\5W$GAGPQ_9DD\4UEIAO+QKZU6X2
M$RPV$2)%N67S9$"RB,)'& \AN(?T_KS_ .*7AW6/%>CW%EH.J?V-J4GE^1J'
MV6.\\G;(C/\ Z/,1&^] T?S$;=^\?,HK^<'_ (5WXO\ ^&C?[&_X2C_BI/\
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M^2!;[4D@222.WO[@V,(MV+AE=6$\LA013*4MS%<QDR5P'[8/P1\8_LC^'_\
MA./"/CGQ)<-I<BB\M=9O_M\<D=TZ6J-%$\7D,Z/*,I/&X(;S4DBE@59?T?\
MV1?C?<?M'>"-)\47EO':W-[',)HHF9HQ);SRV[LF[YE1VB,BHQ<QA@ADD*[V
M_(#]K+]I/XO> OB7X>\/WDMFL<UYIU[::-HMW)#'=H]]-#%:W=]<10RN\H4P
M3[E6R8>7,;=6# ?3_P 0_P!DOXW>,M9TS6HOB!';R>9&][:VT<]I9V2K*LOE
MVUM&7BU)$+RH#?B%YXXXHYG97(B_.']J_P"%/BSP?\9_#%CJGBF35-;OY-&D
MMM6?3XH5LF>_>WA$=D)'@*1/%YYC'EI*[N77<[N_]!OP+^'?B_P%]L_X2OQ1
M_P ))YWD_9O^)5;:=]FV>9YO_'NS>;YFZ/[^-GE\??-?$'@_XMZY_P %#M<U
M&V\-ZIJ'A[P#I.+>6_LE-OJ6K7;'S%-O<R1-]DBBV*[HA%P89$6>/%X$M/$/
MVCM2\>?\$VK_ $_Q)IWB+5/$_A>_O%M[RPUJ=;B2-DA+)$MT[-*KS#[5*DMM
M#"D1@B6X6Y 57^W_ (Y?'GQ+XJ^'(\:?#:32Q;/I=UJ-Q<ZA(SSV\$5L\C1V
M\%NDT#WL;AU<3RF&&:$PO','8Q? '[$'B#XL_M=^%=6A3Q))I5L^J7;W.NR*
M+V\EDGMX!_9]E;EXEL+>%6>X,T+1%))H$M5C"3FOT/\ V(?@AX^^"6G:A!X[
M\0_VY+<7$;VB>?/=_9U5,2'[5=(DS>:=H\C;Y4/E>8C%YY0OV_7X(_\ !4_]
MH+XI?""XM;*&_L])T34Y+L67]E2S_P!H21VK6K;KNYDBB:%RSAE2S* ))+!+
M).JAW_<[Q9IUYJ^G7=MI]U]AO9K>:.VN_*6;[/,Z%8YO*<A)?+8A_+8A7V[2
M<$U_-#^UY\._%_A[XR>$M-U?Q1_:>M7']C_8]7_LJVMOL?F:G,D/^B1L8IO*
ME#3?.1YF[RVPH!K]W_@I\*O'?@;49+GQ/XQ_X2&R:W:..T_L6TT_9,7C99O-
M@=G;:JNGED;3YFXG*"OI^OSP_P""B?Q6^(/P8\,7&N>$9=+L].M(X#>7<^^;
M4!)-=0PHMK;O"UH$&X"5YVD+I(^R.)XE>3L/^"</BS4?'/PMT+4-5N[B^O9O
MM_FW-S,\TS[-0N47?)(6=MJJJKDG"J%'  KY?_X*E?&SXE?!325N]#NM/TW0
M+JXBL1<6[ROJ\DLUO</)DO"(;:+"$(T#-=))''*LZ>8T<>A\.?#GQ-_:^\%:
M0;?7KSP?I::7I\(N6@-QJVKSQPQ&XOY)OM$,UK;M*F+4I+YUY$TL\W[F>%*\
M0_82^/'CGX1?$R^^%/CV^N-4EF\TP32SM>M%<1VXND=+F602"TGM59Q&RLZ2
MF']U;NUSG]WJ************************************************
M***********************************************************_
MD"_8S_XQV^-NEZ?JO[Z6QUB[T>4VWSJ;B99]-5T,GE$Q"6569B%<1 L(R^$/
M]?M%%%?$'_!0CQMXM\&^!IX_!5GJ%UJ^H7$5FLNG122W%I"ZO)-<*L44KC*Q
M&W$B^6T3SK*DJR(@;XP\ ?MO>+_A9I=MHNB_!S7+/3K.,1P01F]VJN2223I1
M9G9B7DD<L\CLTCLSLS'\\/VG/VC_ !#\1OBGX9\2ZAX2U#2=2T[^R_LVBSF;
M[1>_9]0EGC\K?:12?OG8P)MAD^=#C>V4']%W[+_QKUGX[Z-/J>N>'KSPU<Q7
MCVZ65X93))&L44@G'FV]LVQFD:,80C,;?.3D+]'U^ /_  7._P"91_[C'_MA
M7[_5_/C^W=I-OIW[1/@F6"*..2YD\/RSNB*K2R#598@\A !=Q'''&&;)"1HF
M=JJ!T'_!<K5KB&W\*6:RR"VEDU262$.PC>2);-8W9,[6=%EE5&()422 $!VS
M]OZ3^PW;Z_;Q7EG\0O'D]M/&DL,T7B)7CDC=0R.CK;E61E(964D,"""0:Y_1
MO^"6WA73O$MGXLNM:\2:CJUG>6MX)KZ^M[AI9+1HVB$SM:"5T C1,;P0@"JR
MX&/C#_@N=_S*/_<8_P#;"OW^K^?'_@C5X\M_&?BKQ=>:L\<WB/4HX;T3&!1(
M\;7$S7[*Z($B1IIK5GB4H'/EE4(A^3^@ZOYT?A/X;N/A5^U7=Z=!=R/'>WFI
MW$^S=$LD=_ITNIB"1 ["1(I'CQN.'>%)MB,%5?K_ /X+'?"%/&O@.'Q"BQBY
MT&\C<R.\@;[+>LEM+'&BY1G:8VCDR %4B?:X)*2?0'@#]L&WMO@U;?$C5/,F
MD@TL&X$BK$USJ$+FR90+=)%B2XO%VQN$V1I(LCQQJK*OY >(?#?B#_@G[\1O
M"?C'7;N3S/$4;7'B2>39Y7VB[N6;5H!;V+Y=+6.>WFCP)(9;I%FB1E46\7ZW
M_''_ (N[\5?"7A!N;+1+>X\57\4GR+*\3_8],:&2/,IE@N6DDDB8Q0/$PW&8
M@1C[_HHHHHKY_P#VL?\ DGGBO_L7]6_](IJ_('_@AC_S-W_<'_\ ;^OW^K\
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M _%-Y=_'7X=Z4\F;*VN-(N88MJC;-=:L8YGW ;SN6V@&UB579E0I9RW[O5^
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M7Z_?M8_\D\\5_P#8OZM_Z135\ ?\$5/^2>:E_P!C!<_^D5C7Z_T5^ /[ O\
MR<+X]_[C_P#Z>;>OWNU;2;?7[>6SO(HY[:>-XIH945XY(W4JZ.C JR,I*LK
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MJNVWS3;#).SVPDG@^TK#/'<,D:1K]O\ _!+C_DD/A[_N(_\ IRNZ^ /V^O\
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M"7A30QXFN]:T]=%;S!%>K<QR0S-&)"T<#1LWGR_NI (8=\K,C*J%@17X0_\
M!%GXJZ'X(U'Q!I6J7]O9WNJ?V6+&*=Q']H:)[F-HXF;"-*6N(@D(/FR;B41@
MCE?L_P#X*2_&[Q+\']4T.X_L2\U+P5;1W$^L+#<-#:WLLH-M#:7\D44C1V\;
M21N8;C=:ZB9_L[Q2>2V/SP_X>._#S_HDWA__ +ZLO_E57WA\!O\ @LCX:^)6
MJ1Z9XBTV30%N)(XX+PW2W5JK,'R;J0Q6[6Z;A&JR!94!<O*T$4;.?V.HKYP_
M:]^$+_'?P'KGAZ!9'N;JS9[6.-XXVDNK=EN;:,O+\BH\T4:2%BHV,WSQG#K^
M8'_!)/X3ZIXZTNQ\3^(7D?3O#TE]:^%8"@A6)KTDZG<DK"C7*.S""%GEF1'%
MTGEH\<;+Z?\ \%D_@I_PG/@NU\3QR;9?#UQ\\;-A7M]0DA@?:HC8M*LJVQ7+
MQH(O/)WOY8KZ@_X)[_#V\\'^!H-5U2Y^U:IXGN)?$-]*-H0S:DJ2+L58H@G[
MI8C(@!59S*$8Q; /'_\ @K!\5=#\/_#C5/#]S?VZ:OJ'V VMCO#7$BK>Q2F3
MRERZQ!;>;]\X6+>GE[_,948_X)/_ !5T/Q!\.-+\/VU_;OJ^G_;S=6.\+<1J
MU[+*)/*;#M$5N(?WR!HM[^7O\Q61?@#_ (+3?%70_&^H^']*TN_M[R]TO^U!
M?10.)/L[2O;1K'*RY190UO*'A)\V/:"Z*'0M^[WAS]H'PEXKT,^)K36M/;15
M\L2WK7,<<,+2",K'.TC+Y$O[V,&&;9*K.JL@8@5^ /[#?Q^\+^'_ (X>*==O
MM3M[32]8_MK[#=W)-O#)Y^HQ7<6]Y0@AWQ1NR^=Y?S 1?ZUD1OK#_@L1^R[<
M>/\ 2[3QQI-O)/=Z3&UOJ*1JSM_9^7E2<@R8"6TAD\SRXV<I<-+(ZPVQ([_X
M#?\ !7WP1XSTN,^+9)-$U:*.,7"BVGN+6:0EPS6K6ZSRJF%5V2=4,9D$:R7&
MQI3^>'_"[[S3OVC?^$KOO#VL)*?G71;>!;K5/)DT3RH"UNCJ%E:)H[F> MNM
M@9(V9GB;/Z__ +>W[,4_[7/@94L[3R?$-GY=[I\,[VZ2J[*!<64DR^=&/,0E
M2(Y1 ]U%;LT_DIOKYP_X)Y_MVZ-;^'T\%>-KN/1-;\/1FTWZD\5G'-;P/Y4<
M69!"L5Q;+LMY()/WSB,3;I6-P(<_]NWXAR_MJ16/PZ^&DW]KN^H12ZU?VDLI
MTVSA6(R6Z7=S'&UM+%(6:<!)9&6:R\I89+DHB_K=\/?!5O\ #71M/T.S:1[;
M3;.WLX7E*F1H[>)8D+E552Y506*JH)SA0.!^*/\ P5V^&FL:%XA\)>._#R7#
MZDEQ%IT1C6.;;>0S&[TU8;8JTDLLCM<Y&V6-O*C0JK,!+^KW[-?P4_X4?H?V
M:YD^T:OJ%Q)J6M70;<MSJEV%:[EC CB1(MRA(42*(")$+)YA=F_"'XZ?LI7G
M_"]Y_!]I>^5IOC?_ $^\8LIF^PO<G4;V(.;=ECE%QI\K6NU7&U;=)92KSU_2
M]117X0_\%=OAIK&A>(?"7COP\EP^I)<1:=$8UCFVWD,QN]-6&V*M)++([7.1
MMEC;RHT*JS 2_J]^S7\%/^%'Z']FN9/M&KZA<2:EK5T&W+<ZI=A6NY8P(XD2
M+<H2%$BB B1"R>879OPA^.G[*5Y_PO>?P?:7OE:;XW_T^\8LIF^PO<G4;V(.
M;=ECE%QI\K6NU7&U;=)92KSU_2]7\X/_  6F^*NA^-]1\/Z5I=_;WE[I?]J"
M^B@<2?9VE>VC6.5ERBRAK>4/"3YL>T%T4.A;][O!7QK\-?$71F\0Z5JEG<Z3
M'&9)KM9E$<"K$LSBX+$&W=(V5Y8YA&\0/SJM?SX_\+^\+_\ #3W_  E/]IV_
M]A?:/L_]H9/V??\ V1]@W>9C;Y7VCY//_P!1L_?>9Y'[ROV/_;1^-?AKPM\.
M=9DN]4LT76-#OX], F5VO6N+;RXC:JA9IT+3PEI(PR1HXE=EBRX^$/\ @BY\
M5=#L_#-_X9FO[>+6I=8FN8;*1PDTT+V< #PJV/.Q]FF,BQ;VB5 T@170M^WU
M%?S@_"[XD6?[%?Q\\4W_ (Y2XTVRU?\ M5K6X\EID,-Y?)=VT^(=[O%(L+1Y
MB61HYSY4BH8YC%^G_P"T+^VUI-AIR:-X O+?Q#XNUGS;32;;2[BWNO(F*'-W
M<.#+#%%;@^<1.-LFP[ML"7$T'8?L%?LSO^RQX*M])NI)'U&\D_M#4$?R]L%U
M/#$CV\?ELZE(EB2,OOD$KJ\JE4=8T_*#_@H3\!O$O[,7CQ/B]X8CC.G->6]S
M,((VB6UN@J1RI=K"Z,]O?,&\Z9603/<2P2[7DB>X^@/ '_!:_P *RZ7;'Q#I
M6J1ZMY8%VMC%;R6ID!(+0M-=1RA& #['4F,L8_,EV^:_V_\ LB^&_$NLOK'C
MCQ=;R:?JGB.2U^SZ2TS2+IVFV<;K9PLKJ&BN&::>:Y0$*7D#F&VF::%?L^OR
M0_X*K_L=ZI^T%I=GXA\.P1SZIHT<ZSVJ1#[5>6KE'"Q2#YI'MV61X[8@F033
M>4?.*Q3_ #A^SA_P64T[PQH=MI?C33M0GO;*WA@6^LW2Y:\\L,IEN%NIHG27
M:L9D<23^?*TLF(1M0_9_[/&M:I^V!XQA^(>JZ1>:1H6AV<MOX:@O%"R74NH9
M,^I@KY;!&LQ!"(F%U:DRL\-PTD3L?S0_;D^/WA?Q!\</"VNV.IV]WI>C_P!B
M_;KNV)N(8_(U&6[EV/$'$VR*1&;R?,^8F+_6JZ+_ $7:9JVC?%?2S+:RV>JZ
M3>QRQ%XWBNK6XC):*5"5+Q2)D/'(OS#(9&'45_/C\)M7O/\ @E!\2KW2_$,5
MP?!VO96VO5"S9ABE)M;IV6%7DEMEE>*]MXA$P\XSI%,HM1-^O_Q+_;D\#>!]
M.>?3]8T_6=2DW1:?IFG72WEQ>7C(QM[94LUN9(_.=1$)6C,:.Z@G<RJWS_\
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M)SZ!11117E_C7X(>%?B5<+>:YHFEZE<I&(DFO+&WN)%C#,P0/+&S! S,P4'
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M[HWPU^&GBVST/3[/3;9]#U>5X;.WBMXVD-C(I<I$JJ7*JJEB,D*HS@#'Q?\
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M.4<8RIQV%%%9^K:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22
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M%UB<:KJFG1Z;I>IW;06$\<$=XT=I(5AO"8GEDM\!E>!'C20.V\,RQ-'\G_\
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M(DN[R#1_+N9O$$=I<26S7;/8S7,5A,ZQJYMS"JF<12E)DNRA\N>W1T/VX_\
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M**?"#2VU-]/U35&$B1I9Z5927MU(SGJ(TPJHJAF:25HT &P,97C1_C#]@?\
M;>U']LV\\0O<Z?;Z=9:;_9WV2&.1YIO])6X$OG3-L23YH T>R*'8K%6\PC>?
M4/VP?VQ4_9/L/M0T/5-7D\M9&D@@DCT^!6F2%1=:@8WBA=RS>5&BS.75%=8E
MFB=OF_X3_M[^*/C5X0LI/#&A6^O>,Y[>ZFO[:VF%IIVF(+FXM[1[F6YF.99?
M+21+$3+/-"LTP>",1E^0_9G_ ."CGB76_'DG@#XDZ59Z1J,DGV>W> - L5TJ
MLZQ3?:+B994N5V"UE@<B1VB"+,ERLD7['45^ /\ P5L^(GB_Q#X>33=7\+_V
M9HMOX@'V/5_[5MKG[9Y<-XD/^B1J)8?-B+3?.3Y>WRVRQ!KZ_P#V3OC-\1_^
M$>\*:;_P@G_$E_L_2;?^U_[?LO\ CS\F%/MOV39YO^J_??9\^9_RSSNYKC_V
MV_\ @IA>_LX7#:3HWA^\:[,DL<>HZK;3VVGR-"T)D-HG[N6]0!WC:17@1'\J
M5&N(9%+?J_JVIIHMO+=2B1HX8WD<11232%44L0D42O+(^!\L<:L[G"JK,0#^
M0*_\%7$;Q];>'M1TF3PYH4$=U)J=QK221:@JI8-=0!;5#B!VD4(D>;M[I)(O
M*6.1PAS_ -I3]N3XP_"JS_X22T\%V^F^&3Y:K-J;&ZNQYS,89;F&TNXGLMZF
M-'AF1O)N#Y+3L\B)7Z/?LQ?M"Z=^U!X7M/$NGIY/G;X[FU,J2O:W$1VR0N4/
MTDC++&\D$D4ICC\P*/G#]H[]LS5/"?C'3_AMX'L+/4?%&H1K(\UY<A;.Q7F4
MBXCB83.XMXY9WCW0ND;021K<F40UX?\ %G]M7XG?L?:C92_$30]'O] OL1B]
MT%KI/)FW@LC->,P:58EDD2W=8%N,@I=#R9PGZGZ3X\L-?T:+7[-Y)].GLTO8
M7B@F>22W>(3(R6ZH9V=D(*Q+&9F)"!"YVU^4*_\ !5Q&\?6WA[4=)D\.:%!'
M=2:G<:TDD6H*J6#74 6U0X@=I%")'F[>Z22+RECD<(<_]I3]N3XP_"JS_P"$
MDM/!=OIOAD^6JS:FQNKL><S&&6YAM+N)[+>IC1X9D;R;@^2T[/(B5^CW[,7[
M0NG?M0>%[3Q+IZ>3YV^.YM3*DKVMQ$=LD+E#])(RRQO)!)%*8X_,"CD/VCOV
MJ;?X'W&GZ'IEC)KOBK5I%73]%MY5BD>/<?,N)Y2KK;6Z*KGS9%(8H_2**XF@
M^/\ XM_M$?'/]GCP_%XN\1Z5X3GTN&2T.H6=G)>K>01SNJ%2\DS0!P[+ 7A-
MV$D=9!'-"KL/K#X*?ME:/\;O TGC6PLM0E^R[HKO3+6VDN[Q;Q%C+6T"1(/M
M&[S8VCE&R/RY \QM]DRQ?/\ ^RM^W]J/[3OQ#U3PQ_8_]DZ;IVGW4OEW6_\
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M7KNJR[O^/O[1-''+A(YX8I!$8EB!^O\ _@M7_P D\TW_ +&"V_\ 2*^K[_\
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M,$T42R6Y8^;;QM&Z/+LDWNC$1L0/V^HK\ ?V!?\ DX7Q[_W'_P#T\V]?J_\
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M/_!<[_F4?^XQ_P"V%?O]7\^.IZ3;ZU^UR(KJ*.:-9(I0DB*ZB2'P^LL3@,"
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MQ6)IE+I&TF/+\W9MD:$,98XI8)718[B%I/PA_P""&/\ S-W_ '!__;^O?_\
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M;NOE_P"WU_R<+X"_[@'_ *>;BOW^K\ ?^"&/_,W?]P?_ -OZ_9[X_?!RS_:
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M^_\ _@H7X_TOXG_!+7M4T:YCO+&22UCCN(B3'(UOK$%O(4; #H)(W"R+E)
MZ,R,K$_X)J^/]+\.?!C2;JXN8_+LI+Z&X$9,LB3R:A,T5OY40>5KB430^1;J
MK33&:%8XW:6,-^>'_!37PMKG[-GQ0T[XFZ)'<"*Y^R2FZ=B;?[=:H87LV\DQ
MR)%-:PQ[XW8&X1[I4=D61(OUO^$/_!0+X<_%_2UU--:L]+8R/&]GJMS;65U&
MR'J8WF*LC*599(FD0@["PE21$/@S^T/<?M"^-=4'AZ:.?P9HEG]CENQ$VV]U
MB6978VMQADFM[:",HQ1H\O<B3;<026TR_FA^WU_R<+X"_P"X!_Z>;BOW^K\
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MQ_I?PLTOQQK6M7,=GIUG'I$D\\A.U5S?@   LSLQ"1QH&>1V6-%9V53]7_\
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M_B*&XN;(9W6T=]>6L,F61QYT=K/"D^UHT:/S@_EL"R;2S$\!\'/V-O!/[/\
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M_M)V5IIGB6&2YL;2\%X+=)7A6618)X%$CQE9=BB=I (WC)=$RQ3>C_,&F?\
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MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKR_XO?&CP_\
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M$;S401_U>UQ_C7X>Z-\2K=;/7-/L]2MDD$J0WEO%<1K(%90X2564.%9E# 9
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M^.],LHUD20VFL3Q+)YCJZH+*:8*IB"1E'MVGD*N3+:P9D41K'^SWP4^*%O\
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MQ0P(DB2!)[2\D#&,L(9(OO\ K/U;2;?7[>6SO(HY[:>-XIH945XY(W4JZ.C
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MM?NO/6"XO(].VN\D,5Y922_;(8,PAQ%.JR7 ,C11HT#$1^==/GH/BE^T19_
MG]I"XU+QK'LTB/1X[/3;V:V8_8X9+=)_M%N(H))9]]S]KM#(GS+]HF0RB.)H
MJ^[_ (_? K1OVFYO"_C7PZ]G?7VC:YIEQ'?VLD4JW.GPWRB\@\]95B9(3YEP
MN?-='AEAB17N),]!^WW^T/<?LS^ [W6-.FCAU:>2&STYI(FE7[1,V7(4 H'C
M@2>:,S?N=\:JRR;A$_PA^Q1^UW\(?V>_"\*ZAKWF>)-3_P!-UV\DT_4I+B>\
MF+2&.:;R9O,\CS#$&5S'(XDN H>XD+? 'QG_ &DO"_P4^*MIXS^$\^=+:WM6
MO[.V@.GVTFUS'<V*0R6L82*:*&&5G,4NRYD-PC>:B"/]3O\ @J5\6=4F30/A
MKX>NX[74?%EXMO=2?: C):R2);1Q3(D;S);W,LQWRIM+):S0;9DDE0??_P (
M?V=?#7P2\-+X3TNRC.EF-TN4G596O&E79-)=Y7;,\J_*X*A-@6)$2%$C7\(?
M@W\(=+^!'[4,'A[15D33K62Y>".1S(T:W&B2W)C#GYF1&E*1ERS[%7>\C[G;
M^DZBOP1^ O[3VE_!SXW>.D\>F.QN=3O!;6.I74)B:&"WG$-I;Y2#]W;W%LUM
M,US(\4+):Q32O(765?T/\8_LZ:=XR^(7A/XFZ MO(T?VI-1N;<H5N[.XTRX2
MSNC()0DOEL8X4:-)))8KB,EQ#;(%\?\ ^"J?[3NH_L]^$K:RT*[^QZOK5P\"
M2*C^='9Q1DW4L$H^2*4,]O&')\Q5F9X@)$$L7G_P+_:X^ GP,\)0>$;;6+>:
MT^S^7?EM(U';?S2QA+F:>.2VEW>=@@QNTBI%M@4^5&BC\\?@;\?]+^$'QU(\
M 7,EQX2\0ZI:VKVRJ;6"1;_8/EA>W3RTLKF=S;*(D<0QF 2^7-([_5__  5N
M^ __  BFHZ1\4M-L;>[^R7%O!J]M-!YMO-Y3A[26ZC2,;XGP;.Y>:4;D-G;H
M!DFOV>^%7Q+T[XR:'8>(=*??9:A;I/%ED9DW#YHI/+9T66)MT4R!F\N5'0G*
MFOC#0O %E^T7\6=0\37MM9W&F>#(X=)TV0""<S:LP2\NIVD0K*KV(E2W2WG$
MT45P\D\+0W*2@?.'_!6#]HR7PS+HW@&WU7^R;36LOKUTEO++-!ILDJ0H1LQO
MB?%TT\$1\Z98%A+)%,R3>GZ3^VY^SYHOA^+PK%>V;:%#&D::?+I%_-;E4<2
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M%#]3U32?A7XEDT<2&Y-FL;B.(2M]EEFBCO25*MA!;-.9), Q(&E#(4WKX?\
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MO!7P]T;X:V[6>AZ?9Z;;/(97AL[>*WC:0JJERD2JI<JJJ6(R0JC. ,?S@_\
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M_P"T#X#NO"&G)9V4B1VYTQG@7R+62U93$L:H,P(T:M;%X@3%#*^(Y%S$_/\
M[!O[..L_LM>#E\/ZYJ$=]<_;+BX186E>WMHY-@$$#2A6*%E:X;$<0$T\@V,0
M99/QP_9P^$W_  NOXZ^.-'GO;BTTV6XUUM3AMSL>^LQJT0>Q:8$20Q2N8_/>
M(B22!)+<,BS,Z_:'_!3O]DCP5HGP\O/$.EZ19Z7J.DR6SPR:?;PVJRK<W4%M
M)'<)$BK*FV3>A(WQN@V.J/,DOU?_ ,$WO%-YXP^%'ARYOI/-E2WGME;:JXAM
M+J>U@3"!1\D44:;B-S;=S%G+,?RP^'G[9'@SXJ?%+4_%_P 0]8C.DZ'))#X2
MLS87LEN%:=ME^L<:2%+@1PQR.;F,N\T\;IY/V.".+H/^"C?[2?P?_:3\)S2:
M/J$=SXHM)+5K&5-.N89Y8UE*26\ES/:*?LZQSSSB+S(P9D1ADY1_J_\ 8M_;
M)O-2^#-_XK\1O]IN_#?VRV>>YN51K]K>&.>U1Y3'\LLGGPV:LPFEFE42L9)9
M2M<__P $P?@I_P )O9S?%SQ1)_:GB;6[BZ^S7<K;S;V\;&U?9'Y:)#*[1RQ#
MR]R1V:PP0^2C31-Y!_P6C^!>AV.DV'C:"#R=:FU"'3[F6/"K<PM;SR(TRX^:
M6/R%2.4$-Y1,;[U2$1?J?^S)I-OK_P -/#5G>11SVT_AO3(IH945XY(WL8E=
M'1@59&4E65@0P)!!!K\D/^"&/_,W?]P?_P!OZ^[_ /@JGI-OJ/PDUJ6>*.22
MVDT^6!W16:*0WUO$7C)!*.8Y)(RRX)21TSM9@=#_ ()<?\DA\/?]Q'_TY7=?
M '_-WG^?^A<K]COVE/B\GP%\':QXE9HUDL+.1[<2I))&]T_[NUC=8L.4DG>*
M-B"H4,6+HH+K^./["7[7?PX^&UG?>*?&^O>=XYUVXE?4+F73[V2:"W5@D-JD
MD,,L(B(B68+ (D"M# 4VVD07Y@_;O_:!\%S^+=%\;?"C4?(UJ/[2U_+:V<EF
MHF$@DCG=9K:'SY;CS[A+HR&99HD2.1=I82?I]^W3^V3>>#?A+I>MZ0_]G:OX
MKM[(VZQW*_:+2&YMUNKF2$F,/+Y:E;8S(L+1/<1S*\<@C5OK#]CO]E72_P!E
M#PU!IEK%&=4GCBDU:\5B[7%T%^8+(R1M]GC9G6VCVH$0EV4S23/)^*'[3/P+
MT/X#?M >$[;P_!]DM-1U#1-0>V7'DPS2ZHT3K @ \N(^2'$62L;.RILB$<:?
MTO4444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444445_*%\:]%G_8"^.4>
MK1+Y.FC4%U2W6U@MQG2[V21+FW@@+F--B&ZLHPQA/[L3((5:-E_J]HK^6+X>
MZ+_PWU\?KG4HUMY](CU#[=,Q@S#+I>F&*"W\RWN75V^U+';0S*02K7#R& 1H
MT:_L]_P5'_Y)#XA_[AW_ *<K2C_@EQ_R2'P]_P!Q'_TY7=? '_!<[_F4?^XQ
M_P"V%?O]7X _L"_\G"^/?^X__P"GFWKG_P#@JWJ-Y\)/BGX1\:/:^?96MO9R
M0KYJIY\VF:A)=30Y =X_EG@'F,A7]Y\H<HZC]_O"?BFS\<Z=::KI\GG65];P
MW-M+M9-\,R"2-]KA77<K [6"L,X(!R*X_P 7?%[2_!6MZ+X>NFD.HZ])=I91
MHA*[;*W:YGDD<X5450B 9+L\J;4*"5X_Q1_;Z_Y.%\!?]P#_ -/-Q7[_ %>'
M_M*?"%/CUX.UCPTRQM)?V<B6YE>2.-+I/WEK([19<)'.D4C !@P4J4=24;\4
M?V ?VWXOA9\+]8T9G^U:_I5QMT#32D3/=MJ3A;:"W@26*YN]EXTLUV$!E2"5
M?+9ODC3H/V]?V*O^%>?"/2M0>Y\_5] N'NM8N7EWF^N-8EA2^G,GD++<2BY%
MNL$DYC<6:,LADD5!7N'P]_:!M_V^/$O@&S0Q^7I-G/XEUZT^6-%U"T;[#9B$
MQ233H\5TSW*03/&DEE-#)+YK,(A^AW[6/_)//%?_ &+^K?\ I%-7P!_P14_Y
M)YJ7_8P7/_I%8U^E_P 6-)\/^,[)/#GB.*.YM-<D>R2VD1V6:18)KO:&09B=
M([:2:.7=&8WB4HZS>7G\0?VJO^"35Q\.$E\5?#.ZO&GLI%NDTK<S74121Y-^
MGW*%96>$>5Y,#AKAA&[+<RSF.)_</V0_VE/$?[;7PQ\9:!J7^G>)+;3[RVBF
M6."V6Y74;6X6T1BK)$)1*DL;-L@B6+R"2SF5Z\__ .")?QCLY=.UGP6Z[+V.
MX.K0MECYL,B06LPP$V)Y+1P'+/NE^T?*@$3L?W>KR_X-_%[2_COHD'B'16D?
M3KJ2Y2"21#&TBV]Q+;&0(?F5':(O&'"OL9=Z1ON1?4***_ '_@AC_P S=_W!
M_P#V_KW_ /X+5_\ )/--_P"Q@MO_ $BOJ^__ -D[_DGGA3_L7])_](H:_('_
M )N\_P _]"Y7T_\ \%DO"UYX@^&L5S;1[XM/UBTN;IMRKY<+17%J'PQ!;,MQ
M"FU S?/NQL5F7Z _X)U?&.S^,GPUT:2V7RY=*MXM)NHLLVR:QBCC!W,B!O-B
M\FXPFY8_-\K>SQL:^C_C1\7M+^ OA^^\2ZRTBV-A&'D$2&21V=UCCC1> 7DD
M=(U+%44L&=T0,Z^H45^ /[ O_)POCW_N/_\ IYMZ_7[]K'_DGGBO_L7]6_\
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M',"8C(9%=6DFD?[OS_\ \%J_^2>:;_V,%M_Z17U??_[)W_)//"G_ &+^D_\
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M4?\ Y)#XA_[AW_IRM*/^"7'_ "2'P]_W$?\ TY7=?F!_P2(\=?\ "EO'.O>
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MHHHHHHHHHHHHHHHHHHHHHKY@_:N_91T/]K70SI6JCR;N'>^GZ@B!IK29@ 2
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ML48"0GX _P"&,OBG_P +7_X6GN\+_:/M&[[!]MU#9]G^R_8?*\W[#N\W[/\
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MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKY_\
MVA?VG?"_[+^G)J'B6[\GSO-%K;1H9;BZ>)"Y2&-?^ J9)#'!&\D:R2Q^8I/(
M?L@?M4V_[7>C7VN6=C)8VUKJD]C"DLJR22QQQ0RI,X50L3LLP#1*TH0J<32
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MP_\  72VUGQ+?1V%BLB1"1P[L\DA^5(XXU>61\!F*QJQ5%>0@(CLOP!\;/\
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M$NMC1S1HZ_=]%%%%?/\ ^UC_ ,D\\5_]B_JW_I%-7P!_P14_Y)YJ7_8P7/\
MZ16-?K_111111111117P!_P5'_Y)#XA_[AW_ *<K2C_@EQ_R2'P]_P!Q'_TY
M7=??]%%%%%%%%%%%%%%%? '_  5'_P"20^(?^X=_Z<K2C_@EQ_R2'P]_W$?_
M $Y7=??]%%%%%%%?@#^P+_R<+X]_[C__ *>;>OW^HK\ ?^"YW_,H_P#<8_\
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M  0Q_P"9N_[@_P#[?U]__P#!4?\ Y)#XA_[AW_IRM*/^"7'_ "2'P]_W$?\
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M-)INB"SL;@06MHT5U>K>W5N(I?MS2I/:HJ2(RQ1Q1NP,L<S.L@2+Y@_9)_9
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M]O:KJ&I_9_[*\C[;=S7/E>9]MW^7YSOLW;$W;<;MJYS@8^G_ /@IOHUUX?\
M FH>*]*U76-+U33?L0B:PU.[MH9$DNT@9);>.40MD7#/Y@19]T<2F4Q*8V]
M_P""</BS4?'/PMT+4-5N[B^O9OM_FW-S,\TS[-0N47?)(6=MJJJKDG"J%'
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MJ&L?Z;8:?]KN+>QTNSF \F.SBM;D >?$L,LK.QD($2R+]H2>6;Y E^)NH_\
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M4CC6.*/#%_WNU;3$UJWEM93(L<T;QN8I9(9 KJ5)26)DEC?!^62-E=#AE96
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M6\FSC=H;?(*+)Y6/-:,2OEV-?T/5^ /_  0Q_P"9N_[@_P#[?U]__P#!4?\
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M7'_)(?#W_<1_].5W7O\ ^UC_ ,D\\5_]B_JW_I%-7P!_P14_Y)YJ7_8P7/\
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M-+BCF*,(WDB6\:1%?&UG198F=025$D9( =<Y_P#P7._YE'_N,?\ MA7[_5^
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MMULRD4*.S"&W62:XECCS(ZF=P\TN%*_U&U^ /_!#'_F;O^X/_P"W]?O]17X
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MN;J^U*Z:[O+F9M6EB#RRL%'R110PHJ*BB.)."^YV_=[]K'_DGGBO_L7]6_\
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M_G_H7*_?ZOP!_P""&/\ S-W_ '!__;^OO_\ X*C_ /)(?$/_ '#O_3E:4?\
M!+C_ ))#X>_[B/\ Z<KNOO\ HK\ ?^"&/_,W?]P?_P!OZ_7[]K'_ ))YXK_[
M%_5O_2*:OQ!_X);?LN?#C]I3P]JG_"2:?]OUJPU ;O\ 2;V#R[.>%/L_^HEB
MB;=+%==-T@V_-A3'G]/_ /AUQ\(?^A>_\J.I?_)=?('_  4Z\-:/\'_@]IN@
M^$'^SZ*GB 6K0074DR-M&H33P2N\DC2;+N,L\<C-Y<\0&%:)0OZ'_L+>-;?Q
M_P##+PQ>6JR)''I=O9D2!0WF6 ^Q2D!68;&D@=HSG)0J656)4'[=/@JW\?\
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M-2_[&"Y_](K&O /^"YW_ #*/_<8_]L*_?ZBOP!_X+G?\RC_W&/\ VPK]_J_
M'_F[S_/_ $+E?K]^UC_R3SQ7_P!B_JW_ *135\ ?\$5/^2>:E_V,%S_Z16-?
M 'P)^%OA#XT_'SQ7H/C&W^UV]WJ&O_88/,N8M]Y%?&;[]LZ,,6Z7+?O&$9QC
MF0Q@_K__ ,.N/A#_ -"]_P"5'4O_ )+KW#X#_LY>"/V<;B_L_"5I'97-U':R
MWL(NY[B0QJUPML[)<32M&A;[0J, HD*2#+&,[?H^OG_]K'_DGGBO_L7]6_\
M2*:O@#_@BI_R3S4O^Q@N?_2*QKZ _P""H_\ R2'Q#_W#O_3E:4?\$N/^20^'
MO^XC_P"G*[KX _X+G?\ ,H_]QC_VPK]_J^0/VS?V0-._;$T.'2[FX^P7MI<"
M>TOEMTG:/(VRQ,K%':*5<%D22+,L<$C%A%L;\0+76OC#_P $KKRS74F^W^%7
MN%C$"SFXTV?Y6FDA@=T\ZPE)FE<'RX//FB:0QW<,+ _O]^S%^T+IW[4'A>T\
M2Z>GD^=OCN;4RI*]K<1';)"Y0_22,LL;R0212F./S H_('_@AC_S-W_<'_\
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M4'MESYTT,4%Q$ZP( ?,E'G!Q%D-(J,J;Y3'&_P P?L)_\%#KSQUH>E>!=/\
M#UQ?^)+"W@M(6BE6#3?L-L(H1=WERWG2VOEQ<2!(+@33*BQ8>Y2"/X__ &8_
MB?KG[/\ \:_$PU?1KC4O$VJ?VI:Q:?IR&.*:^N;N*\5U>[9'AT]UC:473B0Q
MVK+<,C(&8?:'_!4%O$?Q5\(:1X5M]%U34_$-O>6MYJ<NEZ3?RZ;'(EE(DH@N
M7BQ*CR7/[D(92BQR+,T<JA&^[_V1/B"O_" Z7;7NG:QI]WH>CV=O>VUYI5[#
M-NM8/*8VZ&$_:]_D,\:6IFEVO$KQI+((Z_*#[9K7_#0W_"PO^$8\4?\ "/?:
M/)\_^PK[?L_LS^SOM'D^5YGE;_WV,>?Y'/D^=^YK[O\ ^"D/BN;QU\/+OP]H
MNDZYJ6HZQ'I\T$=KH]\ZQ1"ZCN2URY@58'"P%&MW/VI'>/? J%G70_X)D:S=
M>'_ FG^%-5TK6-+U33?MIE6_TR[MH9$DNWG5XKB2(0MD7"IY9=9]T<K"(Q*)
M&^ /VQ;S6OB3\7_#OB_1O#'BB\TC0O[)\^5="OHVG^RWLEY+Y$<\43G"RB,>
M<(<RJW_+/;(WZO\ [4_@*7]JWX9ZOI>C"XCN+ZW$EI'<VDMI-)-9W"3I"\-Z
M+:2'SG@$2R3!%59!/AX\;OR@_8H_X*!?\,NZ/#\.?%_A[6%U*RN/+L(+2TS>
M2?;I&N!#/:W,L,@E+S P&,-YT<J+Y:LF^?S_ /X*9:)\1?B_>>&)=9TK[-=W
MW]J1Z;X;L/\ B8W-NMLMJT\TMS;J?M$L^3)Y<*^5;VT$1R96N"/U?_:$\#^-
M/VIOA1K&E7>C6^C:_>>4UOIIU*.[RMK=0SA7N4BCA2680N(U!>)=T1DGCW2"
M'\X/V _V]+SX2Z.GPRN_#FH7VOV=Q<P:5:VJK$\DTDDTTL%_]H=3:^3*7\VX
M"NL4&YI(4^SL\WE_C7XAZS\"OVCU\1^+],DDN9) 8K31XY;DW$=SIS6-FMF;
ME;9KIPQ2&9PL8>XCG$<8($0_0_\ ;E\4^)O''PMN/#M_H&H3>*=8^S2FQTBQ
MO-0MK.%=0%Q&D]\D7V=I8X8%AN!&Q9[EA)'"+5UD7T#_ ()D:S=>'_ FG^%-
M5TK6-+U33?MIE6_TR[MH9$DNWG5XKB2(0MD7"IY9=9]T<K"(Q*)&_1^BOY8O
M^"7G[17_  S9+KVJ:K9W$OAF;^S(-1OK:'SFL+B269;.6=1*KK:,K70E=(YG
M\U;>-1OD1)?T/_:/_:F/[:VEOX!^$JWFHSZE);1:GJ_V:YM;"RLY#,TJ37#^
M5+$\@@"NK0R1W%L\T$8EG81#]+O@#\'+/]G_ ,+Z9X8L6WQ:?;B-I<,OG3,3
M)/-M=Y"GFRO)+Y8=ECW[%.Q5 _GQ^ 7Q+U3_ ()1>,=9T?Q5I5Y<:%J<ABBO
MXX DEPMEYC6US:;Y?L\J.EROVF#S2\!E0-(LD+PR_4'[;_QF\6?M'?##4]:L
MM+DT'P8L>GW,<M_Y3ZAK"S7EM'"B6\;.+&WCD+7!F9Y'ND6T,.()IL?3_P#P
M3$A\8^%_!EGH'B#P[)I%C81W)@N[JYV75U)/>SRE?[/,(EMT0,P9YY%+CRGC
MCD25FB^$+:37/^"??Q?\3>-/$6AZA?>&]5^WO_:.GQF6&&'4;U+B M(X2(2B
M5$MI8)I(&#/YB-*AA\_[?^)?[:B_M&:<_AGX/BXU?5]2W6EQJ@@O;.ST6&9&
M!N[BY>*)TEVK(;01Y8R1LP\R1([:X^H/V/\ ]FNS_96\)6N@0?-=MBYU*82-
M(LM])'&L[QEE3$0V+'"H1#Y2(7!E,CM^4'_!6S2]:^/NHZ+I_AK0/$%__8_]
MHBZN8]&OA;EYW@0)#(T(\['V9F,D8:!DDC:.63+!/V>\.?&JQ\0:&=>:RUBU
MB3RQ-:7&CWZWT;N(\H+-8'FFV&0*\ELL\&5D(E9(W9?Q!_8ZO-:^&WQ?\1>+
M]9\,>*+/2-=_M;R)6T*^D:#[5>QWD7GQP12N,K$8SY(FQ*R_\L]TB_M=^TC\
M$+?]H_PGJ7A6ZN)+2._CC N(U5VCDAE2>)BC8#H)(T\Q,H73<JR1L0Z_SQ?"
MKX^_$'_@E9?W7AG7=&CN]'N+R690X>*.YD6%$:?3[\1E61E-JTRR1S&,*L1C
MM9WEK]#O!/B_QS_P4,O-).L^&_[ ^'\%Q!J%T+BX:2;5'MU,UM $ECC2YT^=
MI;:5T>U,$BP2,EYYRQQK^O\ 6?JVIIHMO+=2B1HX8WD<11232%44L0D42O+(
M^!\L<:L[G"JK,0#_ #X_;-:_X:&_X6%_PC'BC_A'OM'D^?\ V%?;]G]F?V=]
MH\GRO,\K?^^QCS_(Y\GSOW-?T':3J::U;Q740D6.:-)$$L4D,@5U# /%*J2Q
MO@_-'(JNARK*K @?AC_P4<_8N\46GBB+XI^!_M%]?K<64MQ9Q0B>XM[BT$4=
MM<VT(1O/B_=1>;$5D>-P92)+=Y!;<?\ !?\ X+&^)=<M['19?"<GB#7?+*/)
M97+1R7;1JS&1;.*RG*OY:[Y1&=F5>14BCQ&GZ'_!70=6_9YTG5_&WC>WN+_Q
M9XDN([B^M-%L+B\:);>W*V.FQ16_FQ_N45T^U2&.(RRB.6[F"QW$GP!_P23T
MO6O@%J.M:?XET#Q!8?VQ_9PM;F31KXVX>!YT*32+"?)S]I5A)(%@5(Y&DECP
MH?\ 8[]I'X(6_P"T?X3U+PK=7$EI'?QQ@7$:J[1R0RI/$Q1L!T$D:>8F4+IN
M59(V(=?YTOA?\</B+_P2PUB;P_KFF_:=#EN+F3[.R^5;WDQCA7[78ZAY#.VU
M5M]Z$.J([1RV\-RVZ+[_ /"?Q8\6_P#!3V"TTJ3P_P#V!X&^T0W.LW=Q-)<?
MVI#;W :.QLI1#:D;I86%Q+ 2T.P$S1LHM[OR_P#X*P> /$O@/Q?H'Q2TRVCN
M=.T>.QC=B&=8+JUO9;F$W4:E&%O*TJ1K(K@;P8F:)Y(/-]OU?]L/7/VV/ .O
M0>!O#5PO_$GNX=2N;]SY*320+YEEIJ6JRRZA=O$\PBW+:+&WV>25?WZ0M\X?
M\$COC-JD&C3>#] TN2YNVUQ+_4=0GPFGV6FR16\<N75C+)>RBWDCM;<(%+MY
M[.88)UKW#X,_ML2_L]ZUXFTWQS:ZA:^%7\4:RNBZTNFRM9QL]]?RW,$MQ&,R
MYE1O)$4<\JR-.LC+#&OE>?\ [27AG1_^"G7BWPRO@N&XN=(L/M*:]KXM)+.%
M+<R6[_8X[FY@#RW<:F1X8#&Z(UVDG^K:Y>+]'_VW_P!EK_AKCPD^A177V.]M
M[A+VRD89A-Q%'+&L<X"L_E.LKJ6C^>-BLH64(89/PQ^!7[;_ (\_X)[%_!WB
MO19+BQMHY/L=A<;;*2!FN96>:"Z2"47-O+(9QO/G(Y5##,B(RR?I=\(->\6_
MM]:QHOB+7M%_X1[P=H5Q%J=I:3O)+<:IJ0C9K.YBE\NV<6D"RI,CJODS.3&?
MM2NWV3]7Z*_GANO!OB'_ ()3^/KSQ#9:?<:E\/\ 5-PG^R^<RVEN\Z^4DN^1
MD6[M6D6*VDNF*7<4DB)+%---]G_0_5O^"B_ACQU;RV'P\%YXE\1RQNMI9VVF
MW0CBD92D5Q>O<+:)%9+,T*7$OF@H) >!N9<__@GQ^RC+^QKX2O+O7!NUK4-M
MWJ"6R2W#0PP1L8;1$A,OVB6/=,S&WC+22S&%//6.*1_S@_;/U3Q7\1OBUI/C
M#0?"/B"^TWP__9?D/_9>HP?;?LEP;Y^)K-9(/GE:W^9)/]7YHW*X0?O=\+_B
MO:_%6W\^WM-4LI$CA>6#4M,N["2-I5)\O-Q$D4SH5*R&W>9$./G*NC-ZA7C_
M ,9OBXOPDTZ6YCL-0U*]-O<R6EI96%[=>?-"FY(9);2VN$MO,8JBR3A5Y9@&
M$;X_#'_@EUJ'B/\ 9<U35;/Q+X4\206.L1VQ%\FC7\JV\EF)RJR0QVSRLDHF
M90\88HZH#&4=Y(OW>\:_%>U\$Z,NM-::I=QRQAX;6STR[GO)&:)I4C-LL7FP
M.P783="!(I"L<KQ,<5^*/_!)/2]:^ 6HZUI_B70/$%A_;']G"UN9-&OC;AX'
MG0I-(L)\G/VE6$D@6!4CD:26/"A_</\ @K:VI?%70;+PKX?T77-3OK?5(KR>
M6UTF\EM8XTM9D ^TB+RI7<W*[1 90ACE61HW54;[/_9$^(*_\(#I=M>Z=K&G
MW>AZ/9V][;7FE7L,VZU@\IC;H83]KW^0SQI:F:7:\2O&DL@CK\H/MFM?\-#?
M\+"_X1CQ1_PCWVCR?/\ ["OM^S^S/[.^T>3Y7F>5O_?8QY_D<^3YW[FO</\
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M%PJ>676?='*PB,2B1OE#_@MSX U37=+\/:U:VTDNG:;)?QWLZ %8&NS:" R
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M%J.M:?XET#Q!8?VQ_9PM;F31KXVX>!YT*32+"?)S]I5A)(%@5(Y&DECPH?\
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M4?\ "/?:/)\_^PK[?L_LS^SOM'D^5YGE;_WV,>?Y'/D^=^YK]7_VN_B"O_"
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MFUBX:XUB]%Q+.DS))*8 C3)$YPLK22.ZF5YY92TCH(@GYH?MP>'_ !+^R?\
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M\])-\2K"VZ)50?1^DZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515 554 *
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M+XR\>W]MYEQ9?8+;0S-N+6-C-]L39'&TLL<4LJ1*T[1DCS9;GRRL=Q*K]?\
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M+M9-\,R"2-]KA77<K [6"L,X(!R*_"'_ ((8_P#,W?\ <'_]OZ]__P""U?\
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M68K#!)BW=9I4\V10PBFB='\HE)83-Y?Z'? 3X^1?'WP79^,+"QN%^UV\T@L
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MS%W;V5[;S?9[RZ^RR9C>^F2.56279\TR%1&YY9HD^@/^"H__ "2'Q#_W#O\
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MK.J>!?&=G'%XCT6.0RW-OL$<HM)8[2Y6=4=D%P)F#[[?_1Y0SA8X1$GG<?\
M\%J_^2>:;_V,%M_Z17U??_[)W_)//"G_ &+^D_\ I%#7T!7S!^UC\9/$?P0\
M/7&J^&]#_MB6"WNI[B62Z@M[>RAMX6D,\RO(LUQ@@$6]N TB)(#-"_EB3\X/
MV5OVJ_C#^U?X>U2/0HM/34O[0NF;6=0B,.G65O+#"+>QL8X(Y9+B[C=I9]]R
MLZ0PK$+AIVN8P/L_]C?5OB?H&C:K>?%^6S@6"02VTSO9I)';I$6N'N'LR+1;
M=<*T;$B92+@RD1"&O+_!_P <O&G[<-YJ,OP^U.W\-^$],N!;1:S+81WU]J%V
MB[I42TN'6."TV2QR!I56XR(2#F2X@MO(-1_;#\<_L2>+;7P]\5+FWUK0-3\V
M6VUVULV@FA3S!$F^.*..%_*"++=6T2S3Q+=(ZW$^(X)/N_\ ;3_:83]E'P=<
M^(%CCGOGDCM=/@E\SRY;J7<1O,:DA(XTEG92T8D$1A$L;R(U>/ZM\-_CAX:M
MY=<M/%>EZIJ*1O.OAQ]&B@T]Y'4EK6*^$T=WLCW$6TLK1F5XXOM#HCRL.@_9
ML^*OC7]H/X8:?XEL;G2XO$-[)J,I%Y9S26;+'>7<<-L%M[B&6%%"0QB<FY=8
MT9GCGE8O7E__  3>_;5\0_M@_P!N_P!O6VGV_P#9GV#R/L44T>[[3]JW^9YT
M\V<>2FW;MQELYR,>P?MR_&+QE^SMX<N/%GAU]'FLK'[,MU9W]I<O,?.G$'FQ
M3PW<2'#2PCR7B7"B63SR=D1] _8S^->H_M$^!-+\3ZK';PWM]]K\V.V5TA'D
MW<\"[%DDE<96)2V7;+$D8& /R@_;Z_Y.%\!?]P#_ -/-Q7[7?%Z3Q4FEL/!T
M>EOJS2(%;59+A+5(\YD8K;1O+(^ $5 T0!;S#(?+\J3^=']D"Z^)US\7_$ZZ
M;>:/?^+(;?4+?4KK5VNFM)%M[VVAD,'V54D&'2);=-D<26X*"- J(O[O^+/C
M'JW[/_P_N_$_CE=/?5-/MYI)XM--PMG-,TQCLX8FE229/-+P1/(Z,L<CNY'E
M+D?-_P /= ^,OQ>T;3_&,/B_2["34;.WU"#04T1)-/VR1++#;RWDDK7RI,NP
MW+IN>%Y)1"65(R?4/V%/C7XH^.&DZY<^+X[>WU33_$%UIKVMLH6&V^R6]JKQ
M(1)*7_>M*[.TLN6<A7\H1JOV_11117\J7_!(GXA:-\-?'6H7FN:A9Z;;/H=Q
M$DUY<16\;2&[LV"!Y652Y568*#DA6., X_HM_P"&L?AY_P!#7X?_ /!M9?\
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M^D5C7@'[?7_)PO@+_N ?^GFXK]_J*_(#_@M7_P D\TW_ +&"V_\ 2*^K[_\
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M;H,\-[Y<E[=[WA+Q118C%KA)Q<N\J1/$D2_M=^R=_P D\\*?]B_I/_I%#7Y
M_L"_\G"^/?\ N/\ _IYMZ^__ /@J/_R2'Q#_ -P[_P!.5I1_P2X_Y)#X>_[B
M/_IRNZ^(/V*O%-YXP_:,\=7-])YLJ6^K6RMM5<0VFI6=K F$"CY(HHTW$;FV
M[F+.68_N=JVDV^OV\MG>11SVT\;Q30RHKQR1NI5T=&!5D92596!# D$$&L_P
MMX3T[P-9QZ?I5I;V-E#N\JVMH4AA3>Q=MD<85%W,S,V ,LQ8\DFOPA_8%_Y.
M%\>_]Q__ -/-O7[??%7PMH?C30[^P\31V\NBRV[F]%RP2%84&]I'D)7RO+V^
M8LP9&A9!*KHR!A^:'PI_:6UGXE6\7ASX$^&K.'PYI$GV5]9UDRP:>I59G*10
M1/\ :YGE_<S&<L]P'GS=6T9F$Y^4/^";.G7FD?'7QE;:A=?;KV&WUJ.YN_*6
M'[1,FK6JR3>4A*1>8P+^6I*INV@X KZ?_P""U?\ R3S3?^Q@MO\ TBOJ^_\
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MNP!"F2,$@NN?H#_@M?JUO#X%TJS:6,7,NN12QPEU$CQQ6ETLCJF=S(C2Q*[
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M?\%K]6MX? NE6;2QBYEUR*6.$NHD>.*TNED=4SN9$:6)78 A3)&"077/W_\
ML=ZM;ZU\.?"LMK+'-&NAZ=$7C=7420VT<4J$J2 \<B/'(O5'5D8!E('XX?\
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MQR(\<B]4=61@&4@?1]?.'[8FK6^B_#GQ5+=2QPQMH>HQ!Y'5%,DUM)%$@+$
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MZCXY\-'[7::=J%FD4RO%Y-_#%J=M;7@@DQ-B*3-Q:"=HPVY&GA5XC;SR>O\
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M,<VK020WFG+)*T2_:(6PX# A"\D#SPQB;]SOD5F:/:)4_)#_ ()]?\%#;/\
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MOT'BGPGIWCFSDT_5;2WOK*;;YMM<PI-"^Q@Z[XY R-M959<@X90PY ->/_\
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M2DTHE/GA4\Q62.W20PVB*MK$J0PI&O7_ /#)WP\_Z%3P_P#^"FR_^,U\@?\
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MSMK^/RKV&WL;>&.YCVNNR=(XU65-LCKMD###N,88YX__ (9.^'G_ $*GA_\
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M6TFWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP*LC*2K*P(8$@@@U\P?"']AWX>?
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M;3O-"W['44444444444444444444444444444444445^6'[<_P"PQXJ_:?\
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M$&%U#;N&W2/;LK;TECMYB@,@A CF$6?_ ,%1_P#DD/B'_N'?^G*TH_X)<?\
M)(?#W_<1_P#3E=U]/_'3XZ:'^SIH<_B#Q!/Y-I#\J(N&FN)F!*00(2-\KX.!
MD*JAI'9(DDD7XP\:_MP>-_AY;KK>I?#?5(O#AD#O=KJ$$MY#9E6E-Q<:?%$[
MVSI"K/+'/)''#(/)DN$)#'[/^!?QTT/]HO0X/$'A^?SK2;Y71L+-;S* 7@G0
M$[)4R,C)5E*R(SQ/'(WXP_\ -WG^?^A<K];_ -IC]I:R_9:TN/6M4TW5+W3C
M)Y<T^GQ02K;,Q41FX$MQ"R)(QV)( R!P(W9'DA63S_\ 9G_;8TW]JYY&\/Z)
MKB6,$GE3ZA=16<5K%)Y;2!,B]>61\!0RP1RF,R1-((TD5Z]/_:+_ &A+7]FG
M1VU[4M.U"\TV''VF>R^R-]GWR10Q>8EQ=6\C>8\H5?)67;AB^Q<%N@^!?QAB
M^/.AP>(+;3]0TZTN_FMDU".**::' *3JD4TV(I,GRBY1I%'F*IB>.1_8*^,/
MVF/VV--_91>-O$&B:X]C/)Y4&H6L5G+:RR>6LA3)O4EC?!8*L\<1D,<K1B1(
MV>O0/@5^TA#^T+X??Q+I.D:I'8M'(]F+@V*27K1/+&\<"I>R!'$D)CS=&V0E
MD8.4W.OS_P",O^"C6D?#[Q+;>$-4\.>)+;6[R2VCMK9X=-VS-=,(X3'.-1,#
M(SGRS()"B.KH[*T;A?N_^V9_[.^V_8KC[1]G\[[#NM_M&_9N^S[O.^S>;G]W
MGS_(W\^=Y?SU\P>#_P!L:P\4>(]1\,W.BZQIEQHUN+G5KN]&GK8V$+0?:(WN
M+J&_FC'F(045-[8#LP6.&=X_'_A]_P %,/"_QD\=Z;X+\,6]Q?17OVGS=4D!
MMH4\FT:Z7R89$\Z7)1XI/-6V\ME#)YR$&OI_]H7XZR_ O3DN;30]8U^]G\U;
M>TTNREN/F1"P:XE1&2WB+%$+$/*=Y:."81R;/Q!_X)\_MDZC9:YXR\0ZKHGB
M#7[W7+BPGE_L6Q>^6UV&\VQ/YD^^*(*ZQ6J%GQ%"4! C&?J#_@K_ *__ ,)7
M\+-#U#[/<6GVO6+"?[-=1^5<0^;I]Z_E3QY.R5,[9$R=K@KDXS7I_A7]L5/@
M_P"!?#6D:!H>J>*M=M_#>AR7%EID$DL=FLUI 8A?3Q1S&W>6,2201B.5W$8+
M+'')'*WH'[$O_!0S2_VQ;B\TPZ?)I6K6D?VA;8S&YCEM0R1M*LXBA"NDDBJ\
M3JIP\;HTG[T0_H?17Y@>/_\ @JYX&\/>(;#P]I#_ -I_:-0M[6\U'S5MM.LX
MI)FAFF^T2*?.\K"RY11:R0MO6\&"*X_XA_\ !5A/"6LZ9:6/A#7+O2=5DC2R
MOY8I+22_5I57S-,M9(&-XC1R0R0 R0/(9DC=(<AF_0_XZ?'30_V=-#G\0>()
M_)M(?E1%PTUQ,P)2"!"1OE?!P,A54-([)$DDB_&'C7]N#QO\/+==;U+X;ZI%
MX<,@=[M=0@EO(;,JTIN+C3XHG>V=(59Y8YY(XX9!Y,EPA(8_9_P+^.FA_M%Z
M'!X@\/S^=:3?*Z-A9K>90"\$Z G9*F1D9*LI61&>)XY&\0^)O[6%_IOB"\\)
M^#/#EYXFUO3([>;4E%Q#I]G:QW*%XT:\N<JUPRF-TA1"'C:1A+N@FC7C_ W[
M<T^K^+]*\ :]X9U#1/$E_P"=)/%-/;SV<5NEM<W"36]W"Q^U[_(2,A8XDCD:
M9#(7MRDFA^U5_P %#/!W[+#RZ==/)J.NI&K#3+4?,ADC=XC<SM^Z@1BJ;AF2
MX5)8YEMI(V!/'^._^"@<NF:3I,WAGPUJ'B76KW3]/U#4--T[S95TN&_MQ/"M
MU<PVTV)9,_N8C$C21*TS>4IB$I^QE_P4BT/]K2\FT>>U_L;6ER]M:27(G6[A
M5=SF&7RH<RQX9I("@;R@)4:15F\G]#]6U:WT"WEO+R6."V@C>6::5U2..-%+
M.[NQ"JBJ"S,Q 4 DD 5^>#_MR^(_'MG/K?@+P/J'B#P]!]H4:C+?0:>URULS
MB1K.S=)KFYB(5?+94$KRE[?R%FB9*]@_9:_;-T/]I_[58PPW&EZ_IN%U#1[T
M!+B%EVI*T?0RQ1REH68K'*CA?-@A\V(/Z_\ '3XZ:'^SIH<_B#Q!/Y-I#\J(
MN&FN)F!*00(2-\KX.!D*JAI'9(DDD7X@\6?MR?$#PUH]WXE_X5IJ"Z%;>=)Y
MUUJD-M>"WCD*>=/I_P!GDN8< >9(-KI''F7S&@'G'Z ^$W[;GA?XW>%[WQ/H
M4>H7?]GY%SI4-J9]45R2(4%K TN[SL9BD5S!C>9)8_)N/*_'#5_VS=9\:_'?
M2M8U/0-<CMM%CO+>RT"&UEDU/RY[*X/GO92.BBXE65)IO+VA;6.)=\PA$LG[
MW?!3XO?\+ITZ34/[(UC1O+N&@^S:Q9_8[A]J1OYJ1[WS$=^U7R,NDBX^7)]@
MK^<'_@JG^V!JWQ!L[;PK::/K&D:+)</++=ZE:7%@VI-;,55((I-F^T7?'<,)
ME\TRM;EH;=H1YO[/_!3]IS_A=.HR:?\ \(SXHT;R[=I_M.L:7]CMWVO&GE))
MYKYE._<J8&421L_+@Z'QO_:F\/\ P*N+?3+I;S4=;O(VEL]&TRV>\U"XC1L.
MZ0IA515$DFZ9XPZ0S>67:)E'R_XU_;C\9_!.W75_&WP^O-,T)9!'<7MGK%EJ
M4D+.K"(F")8P$:0)&9))(D4NHW-(T<4GV?\  OXZ:'^T7H<'B#P_/YUI-\KH
MV%FMYE +P3H"=DJ9&1DJRE9$9XGCD;V"OG_]H7XZR_ O3DN;30]8U^]G\U;>
MTTNREN/F1"P:XE1&2WB+%$+$/*=Y:."81R;/Q!_X)\_MDZC9:YXR\0ZKHGB#
M7[W7+BPGE_L6Q>^6UV&\VQ/YD^^*(*ZQ6J%GQ%"4! C&?T?_ ."C>O\ _"5_
M!#5M0^SW%I]KM](G^S74?E7$/FW]F_E3QY.R5,[9$R=K@KDXS7@'['O[4-G\
M"_A#X<L;33M0U_7Y[?5KBWT?2X&N+CR4U*[07-QL#&WM#*4A,Y5V+N?+BF\N
M0)Z_^RI_P4OL_P!H3Q1+X/U?1+C0-7_>K;PR3-<>9-;B1KF"8&W@>WEC6-F
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M7)K-QI.J:G8V\<DMW)IR6TK6T:%,O)'-<P2LF&+%H5E$:1R22F-%W' _9?\
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M[%_2?_2*&OR!_P""&/\ S-W_ '!__;^OO_\ X*C_ /)(?$/_ '#O_3E:4?\
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M'J4EY=_98[9F^58'"P2QI=%B8Q=R$>6%8O\ =_\ PT/\7O\ HF'_ )=.F_\
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M3;P^!=5O%BC%S+KDL4DP11(\<5I:M&C/C<R(TLK(I)"F20@ NV?V.HK\(?\
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M'#_8#B SJF1%+)$(Y9("2UN[F!F9XV)_3_\ X*C_ /)(?$/_ '#O_3E:4?\
M!+C_ ))#X>_[B/\ Z<KNOS0T#XM>(/'O[0WB#6='\.R>(K[1([RSL;!]72S6
MTCM'CTZ2YCEG41%)"\[&UVD*]Z\@W/&93]O_ !K\;_%;XU>&M4\.77PPC6/4
MK.:W$DGB/3)UAD=3Y4XC9%#/#)LFC^92'12KJP##/_X)6_ 3QW^SMIVN:5XN
ML_L-E-<6MS81>=:39F=)([M]UM)*XRL5J-LA"C;E!DR$_J_7XX_\%G_B\_A#
MP=I_AJ!I$DUR\+S$)&T;VMALD>-F;+HYGDM)$,8R1%(K.JG9)^GWP4^%]O\
M!7PUI?ARU\MH]-LX;<R1PK LTB*/-G,:E@KS2;YI/F8EW8L[,2Q_*'_@M/\
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M:;2; >?)<)/"\2RV#>4PEN+>87"0H _G30R26\FYE\Z?]#O^"U?_ "3S3?\
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MKO2>WFF=8[:6*0H4MR#%%*)3)^6'[ O_ "<+X]_[C_\ Z>;>OO\ _P""H_\
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M_"06MK(WA?6HYI/(@CC4&UN6!N;6$M#'"CVMPL<\4$+*1;BUADG03NU?K_\
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MSY&WR/(_<>7Y/R5^A^DV3Z=;Q02S27,D<:(\\HC$DK*H!D<1)'$'8C<PC2-
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M<LO$_CW7KCQ9J^E>8-,\VTM[*QM-Q1A,EE!N1KM65B+AG/'DGRQ);02I\O\
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M#^)O!7B"X\)L^YU@M+9F\B:0,DQM98KJV>"*16(\A<JFZ149862&/L/V@/\
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M?^D5]6A^SM^RAXLTKPKH6H^"?&UYX?L=1T/2KB?39["+5K>.ZDMQ-/+:B[E
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M/_@A]HTNJ":U\27D>D^9$3:R6<4ET8P%\U1=K)'$'8A_+?[,1&&4-'+M)?\
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MBBBBO+_B]XNUOP5I;77A[19->U$R(D=DEW;V2[2<O))/<L%5%4' 1979RB[
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M'Q#_ -P[_P!.5I1_P2X_Y)#X>_[B/_IRNZ]__P"&L?AY_P!#7X?_ /!M9?\
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MKR#XE_M\?#/X1:B^E:OK]NE[%N$L4$5Q=^4RNT;1RM:13)'*K(P>%RLJ<%D
M92?H_4_B%HVBZ6-<NM0LX=):.*47\EQ$EJ8YBHB<3LPB*2%T$;;L.67:3N&?
M /A#^W%\//COJBZ+X>UJ.ZU%XWDC@>WNK=I%C&7$9N88ED<+ES&A9]BO)MV1
MNR_5]?/_ ,:_VI_!?[.WEKXGU>WL99MICM\237!5_,VR?9X$EF$1,3KYQ01!
MUV%]Y"D^"G[4_@O]HGS%\,:O;WTL.XR6^)(;@*GE[I/L\Z13&(&5%\X(8B[;
M ^\%1[!XI\6:=X&LY-0U6[M[&RAV^;<W,R0PIO8(N^20JB[F957)&68*.2!7
MC\/[4_@N7PO%XT;5[>'0)_.$%W.)(/-:$RJ\<44R)-)+F"4)"B-++L/EH_&:
M'P0_:Z\$?M'7%Q9^%]6CO;FUC666$PSV\@C9MN]4N(HFD0-A7:,,(R\8<J9$
MW;_QY_:*\-?LVZ7)JGB*]C@41R/!;!E-U=LA0&.UA+*TK[I(PQ&$B#AY7CB#
M./SA_P"";W[76C:UH.O:KXQU[2[#5M3\27EXT-WJ$4#".2ULUC$*7,QE%O&$
M,, )8(D0C#'9Q^IWQ+^*NA_!O3GU7Q#?V^GV2;AYL[A=[*C2>7$OWY92J.4A
MB#RR;2$1CQ70>$_%-GXYTZTU73Y/.LKZWAN;:7:R;X9D$D;[7"NNY6!VL%89
MP0#D5H:MJUOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B H!)( KXP_X>
M0_"C^T?[+_X2.W^T?:/L^_R+K[/OW^7N^U>1]F\K//G^9Y&S]YYGE_-7U_X6
M\6:=XYLX]0TJ[M[ZRFW>5<VTR30OL8HVR2,LC;65E;!.&4J>017G_P 8_C]X
M7_9_LUOO$^IV^GQ/GRED)::;:R(WDP1AYIMAD0R>4C^6K!WVIEAS_P :_P!J
M?P7^SMY:^)]7M[&6;:8[?$DUP5?S-LGV>!)9A$3$Z^<4$0==A?>0I[#X0_&C
MP_\ 'K2UUGPU?1W]BTCQ&1 Z,DD9^9)(Y%26-\%6"R*I9&20 HZ,WJ%?$'BG
M_@I#\*/!]Y)8W/B.W>6+;N:V@NKN$[E#C9/:P2POPP#;';:V4;#JRCZ_\+>+
M-.\<V<>H:5=V]]93;O*N;:9)H7V,4;9)&61MK*RM@G#*5/((H\4^+-.\#6<F
MH:K=V]C90[?-N;F9(84WL$7?)(51=S,JKDC+,%') KY0\ ?\%"_AA\3]4MM&
MTO7HY+Z\D$5O'):WENLDA!VH)+B".(.Q&V-2P,CE8T#.RJ?S0_X(8_\ ,W?]
MP?\ ]OZ_?ZN?\4^+-.\#6<FH:K=V]C90[?-N;F9(84WL$7?)(51=S,JKDC+,
M%') K\8?@M^W9H?Q=^->IZK=ZK;V'AFQ\/SV&E2WTXLXI6-W922R[;B4()9V
M5RN!%*]K# )(E>)@/U^_X6QX>_L?_A(?[5T_^Q?^@C]KA^Q_ZSR?^/C?Y7^M
M_=?>_P!9\GWN*\@U']M#X?Z1X<M?%ESK=O#I%]YOV261)DFN/)G%O+Y-HT8N
MI?+D($FR)MBD2-B/YZ]/^$/QH\/_ !ZTM=9\-7T=_8M(\1D0.C))&?F22.14
MEC?!5@LBJ61DD *.C-\X>*?^"D/PH\'WDEC<^([=Y8MNYK:"ZNX3N4.-D]K!
M+"_# -L=MK91L.K*/I_X:?%70_C)IR:KX>O[?4+)]H\V!PVQF19/+E7[\4H5
MT+PRA)8]P#HIXKT"OB#Q3_P4A^%'@^\DL;GQ';O+%MW-;075W"=RAQLGM8)8
M7X8!MCMM;*-AU91^:&DZM;Z_^UI%>6<L<]M/&DL,T3J\<D;^&@R.CJ2K(RD,
MK*2&!!!(-?O=XI\6:=X&LY-0U6[M[&RAV^;<W,R0PIO8(N^20JB[F957)&68
M*.2!7/\ PM^*6C_&G1[?7M!N/M>FW?F>1/Y<D6_RI'A?Y)D208=&7YE&<9&5
M()Y_XQ_'[PO^S_9K?>)]3M]/B?/E+(2TTVUD1O)@C#S3;#(AD\I'\M6#OM3+
M#G_C7^U/X+_9V\M?$^KV]C+-M,=OB2:X*OYFV3[/ DLPB)B=?.*"(.NPOO(4
M]A\(?C1X?^/6EKK/AJ^CO[%I'B,B!T9)(S\R21R*DL;X*L%D52R,D@!1T9O4
M*^8+K]LGP3%%>7,%]<7UE8;OM=]I^FZAJ%C%LB6=]U[96L]K\D;J\N)3Y0.'
MVD$#W_PMXLT[QS9QZAI5W;WUE-N\JYMIDFA?8Q1MDD99&VLK*V"<,I4\@BN@
MHKQ_4?C]X7TOQ':^$)-3MSK]YYOE6$9,LR^5 +EO.$886^8CYD?V@Q>:N?+W
MX->(>/\ _@H7\,/AAJESHVJ:]''?6<ABN(X[6\N%CD &Y#);P21%U)VR*&)C
M<-&X5U91]?Z3JUOK]O%>6<L<]M/&DL,T3J\<D;J&1T=259&4AE920P(()!HU
M;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!7QA_P\A^%']H_
MV7_PD=O]H^T?9]_D77V??O\ +W?:O(^S>5GGS_,\C9^\\SR_FK[/TG5K?7[>
M*\LY8Y[:>-)89HG5XY(W4,CHZDJR,I#*RDA@002#7E^H_'[POI?B.U\(2:G;
MG7[SS?*L(R99E\J 7+><(PPM\Q'S(_M!B\U<^7OP:\PTG]N;X;Z_X@B\,6?B
M"SGU2>1(H5B\Q[>21T#HB7BH;1G;(1564EIB( #,?+KT_P ?_'[PO\+]1L-(
MU?4[>WU+4[BWM[.SR9+B5[EVCA;R8P\B1,Z,GGNJP*XVM(&(!]@KS_XE_%70
M_@WISZKXAO[?3[)-P\V=PN]E1I/+B7[\LI5'*0Q!Y9-I"(QXKYP\%?\ !0_X
M5^/[AK6S\2V<<B1F0F\6:PCVAE4@2WL4$3/EAB-6+D;F"E58C[/KQ_XQ_'[P
MO^S_ &:WWB?4[?3XGSY2R$M--M9$;R8(P\TVPR(9/*1_+5@[[4RP_-']MC]K
MKP1^T=\*?%-GX7U:.]N;6/3)983#/;R"-M3M%WJEQ%$TB!L*[1AA&7C#E3(F
M[Z/_ ."7'_)(?#W_ '$?_3E=U]_T45^(/[9?[=FA^*?&7@_PKH.JV\NEVWB#
M2K_6[^*<"SVQ7,,D,7VE91#+%&"UQ<[E>*.1+<B5989D3]?O OQ8\/?%#SO[
M!U73]3^S[//^Q7<-SY7F;MGF>2[[-VQMN[&[:V,X./Q!_8%_Y.%\>_\ <?\
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M[T^[\66FH/:R_9IEEN(;.))OM$%SY1*ILN#%LCN,2*YF\H &YK];_@;I-O\
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M\=?&ND:AI6GW>FVG]N?9K.>TAEMX?*U:"./RH70QIL0E$VJ-J$J,*2*^S_\
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M'PU\/7<=KJ/BR\6WNI/M 1DM9)$MHXID2-YDM[F68[Y4VEDM9H-LR22H/O\
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M<DEPN@26HLYY) S+:W2RB.U V!MD#6[F-F=R$E6%1'% BG]CJ_F!_P""U?\
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MV._:1^-]O^SAX3U+Q5=6\EW'81QD6\;*C2232I!$I=LA$,DB>8^'*)N98Y&
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M(4.-D@8HRJ&_9[]K'_DGGBO_ +%_5O\ TBFKX _X(J?\D\U+_L8+G_TBL:\
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MHNYFGA\M6D8>1YC%1*BU^G_BSQ39^!M.N]5U"3R;*QMYKFYEVL^R&%#)(^U
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MV6]+36=E:72/-';QVSXA;(N&D:-H_L]O(52VB3RC/-\P?L"_\G"^/?\ N/\
M_IYMZY__ (*@Z_\ \*O^,G@_Q/?6]PVFV5OID[21QY\W[#J<\\\4+.4C>54>
M,E"Z[?-C+%5=2?Z'J_ '_F[S_/\ T+E??_\ P5'_ .20^(?^X=_Z<K2C_@EQ
M_P DA\/?]Q'_ -.5W7P!_P %SO\ F4?^XQ_[85^_U?@#^P+_ ,G"^/?^X_\
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M -(H:_(']@7_ ).%\>_]Q_\ ]/-O7W__ ,%1_P#DD/B'_N'?^G*TH_X)<?\
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M>+WCT?2?#\EY]BTRUDCDGU"2[,KM+J,\4L\1MX#<2_9[>(QEYMLTJ_Z-"9>
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M*^6PU"\C=+88*!H'M8VE6VNIX?,@F)EK[_\ B7<^(;;3G_X1B#3Y]2;<L?\
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M$4!515 554 *    *-6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q
M4 DD 5_-C_PO[PO_ ,-/?\)3_:=O_87VC[/_ &AD_9]_]D?8-WF8V^5]H^3S
M_P#4;/WWF>1^\K^D[2=6M]?MXKRSECGMIXTEAFB=7CDC=0R.CJ2K(RD,K*2&
M!!!(-:%%%%%%%%%%%%%%?*%Y\(=4^,_B#1O$7B58[*QT.2>YL-#1Q=&2ZE15
M@O-0D/\ HXN+9"XAM[9)A:W&Z:+4YT?8/J^BBBBBBBBBBBBBBBBBBBBBBOS
M_P""L'Q5T/P_\.-4\/W-_;IJ^H?8#:V.\-<2*M[%*9/*7+K$%MYOWSA8MZ>7
MO\QE1C_@D_\ %70_$'PXTOP_;7]N^KZ?]O-U8[PMQ&K7LLHD\IL.T16XA_?(
M&BWOY>_S%9%_3^BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOG_\ :%_:=\+_ ++^G)J'
MB6[\GSO-%K;1H9;BZ>)"Y2&-?^ J9)#'!&\D:R2Q^8I/(?L@?M4V_P"UWHU]
MKEG8R6-M:ZI/8PI+*LDDL<<4,J3.%4+$[+, T2M*$*G$T@.:^KZ******_.#
M]CO_ (*,:=^U[XAU+0;;2;BP^R6[W=K/).DOGVZ3)"3,BJOD2_O86$:-<)S(
M/-'EJ9?T?HHHHHHKR_XO?&CP_P# 72VUGQ+?1V%BLB1"1P[L\DA^5(XXU>61
M\!F*QJQ5%>0@(CLOSA^R#^V]IW[8UYK::5I]Q9V6D_8?*FN9$\Z?[4LQ;?#'
MO2'RV@95Q+-YBD,?+.4'V_111111111111117'^/_'^E_"S2[G6M:N8[/3K.
M,R3SR$[57(   !9G9B$CC0,\CLL:*SLJGXP_9U_X*#Z'^U#XRO/#'AZSN#96
M>GS7?]I3L(O.:*YB@VQ6VUG\IUE25)97BEZH]LA&:^_Z*****_-#]J+_ (*C
M>#OV>+BXTFR637-;MI&BFM;=O*MX)$:/>D]VRLH<*SC; EP4FB>&80-R/TOK
M\X/AU_P48T[XA?%"Z^&R:3<1>3<7UI#J!G1O,N+!':8/;A1Y<1\F<1R++*[8
MB+1)YC^3^C]%%%%>'_M(_&^W_9P\)ZEXJNK>2[CL(XR+>-E1I))I4@B4NV0B
M&21/,?#E$W,L<C (W ?L;?M4V_[7WAI]?@L9-.DAO)K.>W>59E$D:QR@QRA8
MRZ&.:,DM'&5?>FUE59'^KZ*****^4/VF/VT_!W[**1KX@N9'OIX_-@T^UC\V
MZEC\Q8R^"R11IDL5:>2(2".58S(\;)77_LN?'3_AI3PAI_BO[']@^W_:?]&\
M[S_+\BYEM_\ 6^7%NW>5O^XN-VWG&3] 444444444444444445^<'['?_!1C
M3OVO?$.I:#;:3<6'V2W>[M9Y)TE\^W29(29D55\B7]["PC1KA.9!YH\M3+^C
M]%%%%%%%%%%?G!^QW_P48T[]KWQ#J6@VVDW%A]DMWN[6>2=)?/MTF2$F9%5?
M(E_>PL(T:X3F0>:/+4R_H_111116?JVK6^@6\MY>2QP6T$;RS32NJ1QQHI9W
M=V(545069F("@$D@"OSP^'W_  4P\+_&3QWIO@OPQ;W%]%>_:?-U20&VA3R;
M1KI?)AD3SI<E'BD\U;;RV4,GG(0:_1^BBBBBBBBBBBBBBBBBBBBBBBBOF#XE
M_M2Z=X2UA_"FB6MQK_BP6[3C2+(HGDIY;.DE[=S,EM:1$B-"7=IQ]H@9+>42
MQAOC_P "_P#!5+3K;Q1-X2\>:'<>%+^.X2W\R6Z2YMXW8,=US+Y<'E1-^Z\J
M>,3P.DHF:2*W7S3^K]%%%%%%%%%%%%%%%?"'[<?[<=O^Q?;Z6S:7)JESJDEP
M(XQ<+;1I';+'YC-)Y<S;]TT01!'AAYC&1"BK)]7^$_B7IWBOP]:>)]_V33;O
M3X=1\RZ9(O)MY81/NG;<8TV(<R'>47!.XJ,U\0?#[_@IAX7^,GCO3?!?ABWN
M+Z*]^T^;JD@-M"GDVC72^3#(GG2Y*/%)YJVWELH9/.0@U^C]%?FA^U%_P5&\
M'?L\7%QI-DLFN:W;2-%-:V[>5;P2(T>])[ME90X5G&V!+@I-$\,P@;D?I?11
M1117'^/_ !_I?PLTNYUK6KF.STZSC,D\\A.U5R    69V8A(XT#/([+&BL[*
MI^,/V=?^"@^A_M0^,KSPQX>L[@V5GI\UW_:4["+SFBN8H-L5MM9_*=94E265
MXI>J/;(1FOO^BBBBBBBBBBBBBBBBBBBBBBBBOS@^'7_!1C3OB%\4+KX;)I-Q
M%Y-Q?6D.H&=&\RXL$=I@]N%'EQ'R9Q'(LLKMB(M$GF/Y/Z/T44444444445\
M_P#Q9_:4T/X2:C9:'+]HO]?U/!L='L8Q->3KO"-)\S1PP1(-\C374L$7EPSL
MKMY+@?"&I_\ !4U_A+XE'AWXB^%+SPXS1Q.)X[R/45"RLH64B.*)9+<+YADD
MMGN'5XFA$+RAU3]7])U:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8
M$$$@UH444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444445\(>"_VJG^(_QCU'P/ITL;Z3HNAS27158V,NI?:K16 E5W.RWCE,)C
MQ$RW!N4E5_+B*>W_ +6/_)//%?\ V+^K?^D4U? '_!%3_DGFI?\ 8P7/_I%8
MU^O]%%%%%%<?X;^'NC>#KB[O-,T^SL[F_D\V]FM[>*&2YDW.V^=XU5I7W2.V
MZ0L<NYSECGL********_ '_@AC_S-W_<'_\ ;^OW^HKX0\%_M5/\1_C'J/@?
M3I8WTG1=#FDNBJQL9=2^U6BL!*KN=EO'*83'B)EN#<I*K^7$4^[Z********
M****_ ']@7_DX7Q[_P!Q_P#]/-O7[_444445^ /_  7._P"91_[C'_MA7[_5
MQ]E\/=&T[5)M<@T^SCU:YC$4]^EO$MU+& @"23A1*Z 1Q@*S$ 1IQ\JX["BB
MBBL_5M)M]?MY;.\BCGMIXWBFAE17CDC=2KHZ,"K(RDJRL"&!(((-9_A;PGIW
M@:SCT_2K2WL;*'=Y5M;0I#"F]B[;(XPJ+N9F9L 99BQY)->(?M9_M V_[,O@
M[4?$<IC-S%'Y5A#)M(GO)<K FPR1-(@;][.L;"06\<SJ"4KK_P!GKQ3>>.?!
MOA_5=0D\Z]OM'TZYN9=JIOFFMHY)'VH%1=S,3M4*HS@ # KV"BBBO@#_ (*C
M_P#)(?$/_<._].5I1_P2X_Y)#X>_[B/_ *<KNOO^BBBBBBBBBBBBBBBOA#]K
MC]JI_@YKWA'PKI<L8U37]<T^.Y!6.1H=--U'',2I?=&]PS>3#(8W5D2ZV-'-
M&CK]WUQ_AOX>Z-X.N+N\TS3[.SN;^3S;V:WMXH9+F3<[;YWC56E?=([;I"QR
M[G.6.>PHHHHHHHHHHKC_  W\/=&\'7%W>:9I]G9W-_)YM[-;V\4,ES)N=M\[
MQJK2OND=MTA8Y=SG+'/844445\(?\%#/VJG_ &6/!SW6G2QIKNHR"UTP,L<A
M1OO3W)B=U+)#'G#;946XDMEEC:.0@_=]?@#_ ,W>?Y_Z%ROW^HHHHHHHHHHH
MHHHHHHKX0_X*&?M5/^RQX.>ZTZ6--=U&06NF!ECD*-]Z>Y,3NI9(8\X;;*BW
M$ELLL;1R$'[OHHHHHK\0?^"0WQ+U'XR:YX]\0ZJ^^]U"XTJ>7#.RIN-_MBC\
MQG=8HEVQ0H6;RXD1 <**_0_]H[]BSP=^U/<:?>>(K:0W.GR*5FMY/)DGMPQ9
MK2=PI9K=F);"E)HB7,,T1DEW_5]%%%%9^K:M;Z!;RWEY+'!;01O+--*ZI''&
MBEG=W8A515!9F8@* 22 *^,/V%/VE+S]JG2=<U^?Y;1?$%U;:;"8UC:*QCM[
M5H$D"L^93O:29B[CS7<(1$(T7[?HHHHHHHHKC_&OP]T;XE6ZV>N:?9ZE;)()
M4AO+>*XC60*RAPDJLH<*S*& R S#."<]A7X _P#-WG^?^A<K]_J*_ '_ (+G
M?\RC_P!QC_VPK]_J******_ ']@7_DX7Q[_W'_\ T\V]?O\ 444444444444
M4445GZMJUOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B H!)( KXP_84_
M:4O/VJ=)US7Y_EM%\075MIL)C6-HK&.WM6@20*SYE.]I)F+N/-=PA$0C1?M^
MBBBBOA#_ (*&?M5/^RQX.>ZTZ6--=U&06NF!ECD*-]Z>Y,3NI9(8\X;;*BW$
MELLL;1R$'[OKC[+X>Z-IVJ3:Y!I]G'JUS&(I[]+>);J6,! $DG"B5T CC 5F
M( C3CY5QV%%%%%%%%%%%%?B#^R5\2]1^*'[1GC*?4'W?8M/U+3K:,,Y2*WL=
M2M((U179]F[89I NU&GEED"KO('Z7_M,?LJ^&OVK]+CTSQ#%(&@D\RUO+=E2
MZMV)7S!%(Z2+LD50LL;JZ. K[1+'$\?M_A/PM9^!M.M-*T^/R;*QMX;:VBW,
M^R&%!'&FYRSMM50-S%F.,DDY-=!111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111111117X8Z?X;O?VX_C3XBT#QK;ZI_P (IX<C?[/I7G3P
MV?GQLMO:S2F)83ONHY;F]MWRLS1E8UFEM8BK>'_MF^"9?^"9?BC1O$'PXO+B
MPLM7\UKC1Y)99K-VL!$A6;?*7GBE6Z;"RDRV\ADDAG0O&(/V/_;1\('6O!6L
MZG;W^J:;?:3I=_>6EQIVHW-FPD@A\\"1(9%BF1C"(R)D<HCR>4T3MO'R_P#\
M$B?B%K/Q*\"ZA>:YJ%YJ5RFN7$237EQ+<2+&+2S8('E9F"!F9@H. 68XR3G@
M/^"MJZE\*M!LO%7A_6M<TR^N-4BLYXK75KR*UDC>UF<'[,)?*B=#;+M, B#F
M25I%D=E=?L_P%X*O/CS\,?#=M<ZWK&G7%WH^D7%S?Z?=+%?3-]EBD<-<RQS2
M#S'(>5T*2R$;6D,;R(_X8_L6_LV6^O\ Q<\4>$[/6=<TFVTF/58H;O3+U;6\
MDCM=1@MT2:58BK(RD/(JH@:1$8!0NVOW.^+_ ( _X5?\)?$>D?;]0U/[/X?U
MO_3-2N/M-Y+YEO<R?O9MJ;]N_8GRC;&J+SC)_*#_ ()?^ /%'QB\&WNAVE_<
M:#X;76)[B]U/3[@1ZI=7!MK01V5J^UOLD46Q)[FX(9YP\5M& AN6KQ_]H'X/
M7G_!*GQSH?B/PQJ%Q=:7?;_]&ED5+B6&W:#[;9W+K#Y+Q3"1&BE$6Z)R&$0E
MMHII/Z7O%GBFS\#:==ZKJ$GDV5C;S7-S+M9]D,*&21]J!G;:JD[5#,<8 )P*
M_(']F2+4?^"FL6K>(/&]S<)X5@U VEAX;LKM[>V;;%'+(-0:&.*:[V%K2:"0
MS+MN4G98H866(\_^UY^QK=?LHZ/)XU^$5[J&A_V?Y$NJ:9;W-W/%=10R$I<L
MCO-YGD>8S3Q7&^U-KYCD1[)5N?M_]FO]H/4?VR_AU_:VCW5OHVOOYEE<S"U>
M[AL[R/:7DCAE>$2;HG2>%6DECA:5(Y&N/*D1_P @/V8]*\<_%/XR>)M"F\37
M#7<%OJFG:AK+AA>+IT&IQ"5=+CW/%92RR[5A S#91S32Q*98X@?O_P  ?\$R
M+SX.^*+_ ,5>&_&&H0WMU;W$<+WMLMY+YUT%$TUZXFA2^^8R7$4;QQJMT+::
M0SB!XY_F#_@GQK>N:I\=?%5MXAU6XUB]T_3]6L?M<^5W+;ZM;+B*+<R6\18N
MZ6\1$46\J@Q7Z_?M0>"=<^)'A6ZTCPY>7&G:E=W&GQI>VTIBFMH?MUN;J9&$
ML+'R[<3.T:R(TJ@Q*2S@'Y@_X87_ .$:T[[3J_Q%\<+]FM_,O+K^WOLUN/+3
M=--B2.3R8AAGP\K^6G#2-@L?RP_9QTWQ?^UE\0=0TCPYXR\60^#].D:234)M
M6O9;B2U1Q'&$?9!%'<79#20QS1H8(1*2MP]LRR_M?^V_^U+_ ,,C^$GUV*U^
MV7MQ<)964;'$(N)8Y9%DG(97\I%B=BL?SR,%B#1!S-'\_P#A;_@G'H_Q8T..
M^^)LNH:QXNOK=GNKZ6]D1M/><&3[+9Q0RM9K%:R2.8UV2P-*7<(('2!/E#]F
MW]H+6?V0?BI<_"/7;^34O#TMY#::7-<RRSSV0GAC;38D<1 E)(WM[:: (EO!
M,?.B:*)9?/\ ?_VM_C1XJ^-/CRT^#_@6^DTJ3RX[K7=8@%P)[2,+YXB5XU0Q
MIY9A;S$D47$UQ;V;3VZ^>LG8:_\ \$P?#G@K3K>\^'LUQH7B[3?+EL=7>ZGF
M\Z:-"C)>1,7A\JX!99Q#"JC=_J9(-]K+\@?\$,?^9N_[@_\ [?U^_P!7E_Q>
M^&C_ !:TMM+35=4T=7D1WN=*GCM[HJASY8F>*5HT+;2QBV.P787\II$?^<+]
MBW]FRWU_XN>*/"=GK.N:3;:3'JL4-WIEZMK>21VNHP6Z)-*L15D92'D540-(
MB, H7;7[W>+/$EG^Q?\ #^[U"^O=0U>+1[>:1;C4KEKB\NIIICY$,MPD3'YY
M98[=)#&5AC*%AL1FKX?_ &9?@Q+^WSX<B\9_%&[N-4M[ZXNCIVBV]U+::9:P
MPSO%'(;>W$,ANXW%U$DTDT[-:21K([R#Y/$/VM_@GKW_  3Q>T\:_#&_O+7P
MXEY']OT%YKJXL8YY(_*\Z5&=E>WG5%AD>=EFAN&A\F;,D(MOV.^ /QCL_P!H
M#POIGB>Q79%J%N)&BRS>3,I,<\.YTC+^5*DD7F!%639O4;&4GV"OYT?^"Q,W
MC'PA<6$5[XBDN=$UF2^,.D6]M]CM[>.U:S9%G99I&OG+,DF^? CF5WACB63R
MT^__ (Q?L'ZI^UE;W%QXY\07EK=M)(VGZ9I<P?1[!45TM6>*>".6]N '=[BY
M/V5Y/-:WC$,*1FOSP_8%^(?Q%\&:MKWP>T>:WDN+2XN%74II?-MM$6VN&@O[
MJVMI(UDN_-=T-M;LT40N2LTD0CENC70?M^?\$_?^%(Z._P 1M$\0ZQ=ZEI]Q
M;27D^J7?GWC9DAM[6:WNHHHI%EA<Q@!R?W>&22-H527]?_V+_C'>?'WX?Z)X
MBU!<7MS;O'<ME3YDUK-):R381(T3SFA,WEJH6/?Y8+!0Q_/#]HZ36?VF?CAI
M_P -=5CU2'P;;6:W-[;6\DL5O?QK$;O[3.T<:YMS<K!8Y9G$<T3^3+!<S';X
M_P#M\_LU6'["=OI?CKX:W=YH%R;R/3[BVAN)I8Y@RR7:.[3R2,R;K8)-;2^;
M;S@1$QH8W\[]OO@AXUN/B5X5T37+Q8TN=2TNQO)DB#"-9+BWCE<(&9F"!F(4
M,S$#&6)Y/XH_L"_\G"^/?^X__P"GFWKZ_P#VE-&UK]JW7/[#^'FJZAI<NCW$
M<.NZ]!J=]!8P;2V_38+6WE$-YJ"B7S[A@(_LXBAMIKI'E$<7V?\ "'X$6OP@
M12FIZYJER(WC>YU75[N]:17D\S)@>06BNN%19(H(W"#!8EY"_P  7/CG5/V]
M/B#JW@Z.2\TOP1X5DE@UE;><0W&KW1>2V^R3R1RK+'92A+D;(]XDAB<RM'-/
M;?9?(/VS_P!CFP_8\T1_B'\,+F\\/WVF26D=W#'>S/!-;27 4Y283/,[3O:^
M9!-)]D>&)MT+/]_]'_V+/VF$_:N\'6WB!HXX+Y))+74((O,\N*ZBVD[#(H)2
M2-XIU4-((Q*(3+(\;M7U?7X _P#!<[_F4?\ N,?^V%?O=JT=Q-;RK9R1Q7)C
M<0R2QM+&DA4[&>-9(FD0-@LBR1E@"HD0G</Y\?A]=>*-+_:9TW0O$^O7&ORZ
M;]I\J>2(6T*_:-":5O)LXW:&WR"BR>5CS6C$KY=C7[W>/]*U37=+N;71;V/3
M=1EC*07LEL+M8&) ,@@,D2R.%SY8=M@?:SI*@:)_YX?V5K_X@^*/C#XLTRUU
MN.]UVVL]3TTZQJ0=EM;:+5[=9;BULE$D1=27DM;#?#:(\GS/Y:&.7L/V_/\
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M";6-8O[NXUA;:*SN[B)K&SAGMYI&2TMXX(_)_P"/6%2VYFD"[Y3+*3)7V_\
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MOPQO[RU\.)>1_;]!>:ZN+&.>2/RO.E1G97MYU189'G99H;AH?)FS)"+;]/\
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MP4_GA^Q)XL^T_M&>-?[0N]UQ/_;EK;>?-EY/(U*#RX(MYW-Y=O =D:YV00G
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M]C!<_P#I%8T?\%J_^2>:;_V,%M_Z17U??_[)W_)//"G_ &+^D_\ I%#7X _
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M\=GDDMYO,2..>Y=)'\@3L5VL517D &PLOYH?M]?\G"^ O^X!_P"GFXK]_J_
M'_@AC_S-W_<'_P#;^O?_ /@M7_R3S3?^Q@MO_2*^K[__ &3O^2>>%/\ L7])
M_P#2*&OQA_X(J?$O^T/$/BG3[Y[BXU+4[>VU%KF1O,W_ &::5)VFD=C(TKO>
MQL"0V_$C,P8*'_H>K^>'X=?#3_A$OVK[J#3TN)[>*XOM1N9"N_R?[0TMYY&=
MD4*D0N+L0QEL8WQ1EGD8%N@_;Z_Y.%\!?]P#_P!/-Q7[_5^ /_!#'_F;O^X/
M_P"W]?=_[>G[!=O^V);VEY9W<>G:WIT<Z0S/ KQW,;KN2WN'7$RHLH#1R*9!
M )+@BWE:7Y?R@\-_M%?%G_@F9JEOH?B^&35=":.9;.VFN0\$L<06&-["^V2R
MP)&(XB+210(X9?FM(9)TE7]K_BY\2].^,GP@USQ#I3[[+4/"^ISQ99&9-UE-
MNBD\MG198FW13(&;RY4="<J:^/\ _@BI_P D\U+_ +&"Y_\ 2*QH_P""U?\
MR3S3?^Q@MO\ TBOJ^_\ ]D[_ ))YX4_[%_2?_2*&L#]J[]J[0_V2M#.JZJ?.
MNYMZ:?IZ.%FNYE ) )!V1)E3/.05B4J KRO##+\G_#CX!?$']JNW@USXH:S>
M:3IUS&^WPII)>PC:WE6%6CU&42-.Z3HDHFM)6>:$3';<6SF6V3Y0_P""&/\
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M\*W5Q):1W\<8%Q&JNT<D,J3Q,4; =!)&GF)E"Z;E62-B'7^=+X7_ !P^(O\
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MWF6#\X/@'_P4X\:_L^6]KX%\0>%Y-1OK&.TL;"VQ-I^H*NW$$,L)MYC,[1O
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MTZTU73Y/.LKZWAN;:7:R;X9D$D;[7"NNY6!VL%89P0#D5T%%%%%%%%>/^/\
MX_>%_A?J-AI&KZG;V^I:G<6]O9V>3)<2O<NT<+>3&'D2)G1D\]U6!7&UI Q
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M2WAC97+F%7D2WC/G>7^^VG-O#=?/_P >;?XX?LP:7)XLM?%5GXIL=.CDEO\
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MAI-M>-8VUC;Z5#J4CLBB=GGDNRIWK'/!'OB*I*5=OLUOC,M_]E3]LWQIIGQ
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M%TVT\U;G1;%8]4OKJ:XT\264 N(PRRRR7#0_9Q;"V4&<1SLRHSKT'[3OB?\
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MY=1\.II5M:?:(=A^T)9W<,8FEEC)W0#RHFEV[O)D?%G-\@?\$,?^9N_[@_\
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MDG(E0H9TV$*J7$,MK+]__P#!4?\ Y)#XA_[AW_IRM*/^"7'_ "2'P]_W$?\
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M!(Y'66<%%+R>7\S(C2Q 0QGSKAW2)-H,DT/A_P#PKO\ : _L?_A(?^$HT_\
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MMJ>--5\:7WPW^)H_XG7[UK25X(X9EFAC$CVI6UB%N\3PA[J"X^52JMB6=9X
MGW_^UC\9/$?P0\/7&J^&]#_MB6"WNI[B62Z@M[>RAMX6D,\RO(LUQ@@$6]N
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MLBR?O#%#^4'_  5HOOB,EQI*>+[C2XM)N9+U].T[2IKF2-&@9 9;M[B&$S7
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MLWB233[1-3T^5Y/.BAMI;@QA"P6*>));F8B> ;ML\(G6)VCA7\X/V^O^3A?
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M;?0+>*SLXHX+:"-(H88D5(XXT4*B(B@*J*H"JJ@!0   !7X(_P#!#'_F;O\
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M/_<._P#3E:4?\$N/^20^'O\ N(_^G*[KY0_X+<>"K>_\*Z'KC-(+FSU1[.-
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M+9_9LMC/Y$<WV6\O-3:%KG8P'G8^S6[>5(WEGRL +O<M]_\ _#/'Q>_Z*?\
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M/U"WMY;?2+=8+8&/=G9I<^I1RN'+*98[BX+1NH39Y<3 "1"[?N]7X _L"_\
M)POCW_N/_P#IYMZ/^"E^L:QXC^,G@;0;*^^Q;/[-EL9_(CF^RWEYJ;0M<[&
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M9Y;G==/&=K*L4I>#YH'C@_2_P!_P5D^&'B;2[:\U349-*OI8P;BQDM+R=H)
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M?&3QKXF\0S_V)93V^N3>7J.(+A&?4X)_LS0Y9VNU57!MHO,E+HRHKD5]8?\
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M6^GV2;3Y4"!=[*BQ^9*WWY92J('FE+RR;07=CS7H%?GA^U/I-O\ 'KQYX0\
M3Q1W5C:R3>)=9B9%+);V:M;V(;S@89;>XN)9(+F!4EF9,']RF7;]#Z*^8/C'
M^Q?\/_C[>+J'B+1+>YO1G=<QO-:S295$'G26LD+S[5C18_.+^6H*IM#,#W_P
M<^ /A?\ 9_LVL?#&F6^GQ/CS6C!::;:SNOG3R%YIMAD<1^:[^6K%$VIA1[!7
MQ!XI_P"";WPH\87DE]<^'+=)9=NY;:>ZM(1M4(-D%K/%"G"@ML1=S9=LNS,?
MK_PMX3T[P-9QZ?I5I;V-E#N\JVMH4AA3>Q=MD<85%W,S,V ,LQ8\DFO/_&'P
M!\+^/]<T[Q+JFF6]SJ^DY^Q73@[H\G<N0"$E\MB9(/-5_L\I:6+RY&+'V"BB
MN/\ &OP]T;XE6ZV>N:?9ZE;)()4AO+>*XC60*RAPDJLH<*S*& R S#."<^?Z
M3^S)X%T"XBO+/PUH<%S!(DL,T6F6B21R(P9'1UB#*ZL RLI!4@$$$5[A7C_B
MG]GKP;XYO)-0U7P_H]]>S;?-N;G3K::9]BA%WR21L[;5557).%4*. !7/_\
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M4VWS;:YA2:%]C!UWQR!D;:RJRY!PRAAR :\?_P"&3OAY_P!"IX?_ /!39?\
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M<>3NW;AG=C:,9/Z7ZM^SY\9X;>5K/XF1RW(C<PQR^&M/BC>0*=BO(IE:-"V
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MTC_A$O&&F?:/,_TS4M'^S6<7EQO)^]F\Y]F[9L3Y3ND9%XSD?F!_P5L^/O\
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M7)!!! 975@4DC<*\;JT;JKJRC\,?^;O/\_\ 0N5^_P!7X _\$,?^9N_[@_\
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M*M=M_#>AR7%EID$DL=FLUI 8A?3Q1S&W>6,2201B.5W$8++'')'*WH'[$O\
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MU>>$)+N1([.^EN8[S3Y&*!W+W:1PQ*B&2!&DA-PD3RGSVMEC9J^O_CS\;A\
M]+DUFXTG5-3L;>.26[DTY+:5K:-"F7DCFN8)63#%BT*RB-(Y))3&B[CY!^S/
M^VQIO[5SR-X?T37$L8)/*GU"ZBLXK6*3RVD"9%Z\LCX"AE@CE,9DB:01I(KU
M]'_$OQQ/\.].?4(-+U#5_*W&2VTY;=[@(J,[.L<\]OYN-H41PF2=W=52)\DK
MX!\)OVU?#WQ2\+WOC2:VU#1O#UEG-]JD4,23[25?[.L,\\DNU]L(PH\V=A!%
MYLRR(GG_ .SK_P %!]#_ &H?&5YX8\/6=P;*ST^:[_M*=A%YS17,4&V*VVL_
ME.LJ2I+*\4O5'MD(S7W_ %\ 77[:^I_$2\O+?X:>%[CQ9::;<-;7NI?VA:Z=
M8F;:K!+.>??]KQEA*R*BH!%(IEBN(I&T/V9_V\=+^.^J2>&-6TZ\\-^*H8_,
M?2=0!5I%PTF+=W6)Y'$/ESO')%"^QR\:S1122KG_ +0O_!0[1?V7]133_$NA
M>((?.\TVMS'!8RV]TD3E"\,BWW^ZQCD$<\:21M)%'YB@_1_@;XSR_$+PU'XE
ML=$U0QW,<$UG9.^G+=7-O.L4D<\?^G&W1"DFXK/-#,!&X,>[8'^8-,_X*-:1
MJWBP^!X_#GB0>(Q)+&;&2'38FW11-.Q$DFHK"4,2F6.0.4E0JT;.'0M]W^*=
M9G\/V<ES;65QJ$J;=MK;-;K-)N8*=ANIK>$;02[;Y4^52%W/M5O /@/^U':_
M'_4=5T^RT;6++^QKB6TO;F]CM%MUO(GV26L<D%W/YLJ\LWEAHT0*S2+YL(D^
MGZ**Y_PGX6L_ VG6FE:?'Y-E8V\-M;1;F?9#"@CC3<Y9VVJH&YBS'&22<FOY
MH?\ @M7_ ,E#TW_L7[;_ -+;ZOZ?JY_1O"UGX?GO;FVCV2ZA<+<W3;F;S)EM
MX;4/AB0N(K>%-J!5^3=C>S,WRAX__;(MX-4N?#?@O2KSQ9XALY#%=V]F5@L;
M*0 ,4O=2F'V>!V19A&J^:3<0/;.(I>*\/U__ (*/S_!'4;?3_B;X4U#PU]M\
MLV=S!=6^JV[)O*3O+)!Y6WR<QL\<(N)]CAC$NZ(2_I?I.K6^OV\5Y9RQSVT\
M:2PS1.KQR1NH9'1U)5D92&5E)# @@D&M"BBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBOY O^"7'_)7O#W_<1_\ 3;=U_7[117X0^ +Z+]J;
M]IJ_NKEMUEX2M[A+6WN+:)LMI[+:$*5;C;>W,U[!._F2KLC&V,[1#^[U?S8Z
M>7_8L_:2^P:/:R1:3K5Y;6JP-''#&]KK!A+?9R(=HM[:\/[I80IQ:?93*/WK
M5ZA_P7._YE'_ +C'_MA7[O>%O">G>!K./3]*M+>QLH=WE6UM"D,*;V+MLCC"
MHNYF9FP!EF+'DDU_/#^PW\*M#UO]H#Q3!/86[6^C7&M7.FP! L-M-!JD4$#Q
MQ+B,>4DC"%2I6)@DB!9(XV7]+_\ @JGI-OJ/PDUJ6>*.22VDT^6!W16:*0WU
MO$7C)!*.8Y)(RRX)21TSM9@=#_@EQ_R2'P]_W$?_ $Y7=?G!_P %)O"UGXY^
M.O@W2M0C\ZROK?1;:YBW,F^&;5KJ.1-R%77<K$;E*L,Y!!P:_?[_ (1/3O[.
M_LC[);_V;]G^R_8_)3[/]GV>7Y'DX\ORMGR>7MV;/EQMXK^>']E#PM+^R]^T
MA?\ A.RCMQ97G]H6R(&EE\FQEM_[5M41Y"K^:BQ6\4C2>:/]: 7)66OK_P#X
M+5_\D\TW_L8+;_TBOJ^__P!D[_DGGA3_ +%_2?\ TBAK\@?^;O/\_P#0N5^Y
MWQ"\%6_Q*T;4-#O&D2VU*SN+.9XBHD6.XB:)RA964.%8E2RL <94C@_FA\*_
M%7@;_@F'H?\ PAL^KW&OZ_>:@TYTZPMEEOI;BX%M%'%':)(PM\Q&!XTN9@]P
M?,>$ON6%?B#X6^,+SQ_^U+;ZI?:=<:3+<^8ZV5T5-Q'#_8#B SJF1%+)$(Y9
M("2UN[F!F9XV)_3_ /X*C_\ )(?$/_<._P#3E:5Q_P#P2;\ :7X9^&&G:I9V
MT<5]JLEW)?7 !,D[07EQ;PAF))"1QH D:X12TCA=\LC/\0?MW:3;Z=^T3X)E
M@BCCDN9/#\L[HBJTL@U66(/(0 7<1QQQAFR0D:)G:J@?=_\ P53^,=Y\(OAK
M=1V*_O=:N$TEI<K^ZAN(II)SM='#^9%#);X&QD\[S5</&H/T!^Q3X6L_!_PU
M\+VUC'Y43Z/9W++N9LS7<2W4[Y<L?GEED?:#M7=M4*@51Q_C+]@WP=XZ\>6W
MQ#NUO/[6MY+:8PI<;;66XM%"V\\B;#*'C"0X6.2.%C"F^-]TWF_G!_P5@\<7
M'BOQUX-\$K8R:A;>9;WDFGB]:VCU*2\N_LL=LS?*L#A8)8TNBQ,8NY"/+"L7
M^[_^&A_B]_T3#_RZ=-_^-U\(?L9_LK?$KX4?%F3Q1<^'X]"\/:E)J8N[>*[T
MZ>.WM;@27%O:HL,A<)'.ELJM#'&<( 0L1=:_>ZOR0_X+/:3<:C\.;26"*22.
MVURUEG=$9EBC-M=Q!Y" 0B&22.,,V 7D1,[F4'/_ ."*G_)/-2_[&"Y_](K&
MOU_KY_\ VL?^2>>*_P#L7]6_](IJ_!'_ ((H:3<3>.M5O%BD-M%H<L4DP1C&
MDDMW:M&C/C:KNL4K(I(+".0@$(V/</\ @N=_S*/_ '&/_;"OW^K\@/\ @M7_
M ,D\TW_L8+;_ -(KZOO_ /9._P"2>>%/^Q?TG_TBAKX _P""U?\ R3S3?^Q@
MMO\ TBOJ^_\ ]D[_ ))YX4_[%_2?_2*&OS!^ 7CK_AH3]I/7KW4X?^1:T_4+
M+2TW_P"H^QW4=B\F46/S/-^T7DFV82>7]HV!F\F)U_6[XT?"'2_CUX?OO#6L
MK(UC?QA)#$YCD1D=9(Y$;D!XY$210P9&*A71T+(WB'@3X2Z'^P-X!U;^P(KB
M[M].M]0U:87,X\ZZFB@+D/(L8CCRD,<*F.(*JH'*/(79_P D/^"9GQ"\;^&M
M&UK6- \'R>)[G4]4/]H:M+K\%I(\D422K$\5T'9W5KF29K@<RFX*LS&,8]@_
M;:\!_%;]LC1K/3&^'D>FW-E>?:([TZ[IEU((S$\<D"\PLB2,8I'P^&,$>4)"
ME?J_0/"WB/P-^S[J&E>+(_)U>Q\+ZS;2Q;H'V0PP74=HFZW+1-MMEA&X%F.,
MN3)O->(?\$4-)MX? NJWBQ1BYEUR6*28(HD>.*TM6C1GQN9$:65D4DA3)(0
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M^V)I-OK7PY\51744<T:Z'J,H21%=1)#;22Q. P(#QR(DD;=4=5=2&4$?!_\
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M^%]O\*OAEH%O!Y;R7MG'J4\J0K$TDE^!<#S,%C(\4;QVXD8Y=(4X10J+X_\
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M^K[0_8<\ :7\/OASX=CTNVCMEO-+LKZY* [IKJZMHI)II&)+,[,<#)(1%2)
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M=U^>'_!1#5K?0/C[X(O+R6."V@CT*6::5U2..--8N6=W=B%5%4%F9B H!)(
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M'BOPM;6^BZEIEO->W,,*F.SNK>WA#21B!,QV\JI$7B:%$220NLREI1/#[?\
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MQ'')(57)"1N^-JL1\(?\W>?Y_P"A<K]_J_ '_@AC_P S=_W!_P#V_K]_J*_
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MSQ7_ -B_JW_I%-7P!_P14_Y)YJ7_ &,%S_Z16-'_  6K_P"2>:;_ -C!;?\
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MI[SK(ESK$DFJRH[QNH6X");F/R_NH]M%;RE7+.KNX;:?W:?H?7P!_P %1_\
MDD/B'_N'?^G*TH_X)<?\DA\/?]Q'_P!.5W7P!_P7._YE'_N,?^V%?O=I.K6^
MOV\5Y9RQSVT\:2PS1.KQR1NH9'1U)5D92&5E)# @@D&OYX? ?C_2_B?^U:FJ
M:-<QWEC))/''<1$F.1K?0GMY"C8 =!)&X61<I( '1F1E8_I?_P %1_\ DD/B
M'_N'?^G*TH_X)<?\DA\/?]Q'_P!.5W7O_P"UC_R3SQ7_ -B_JW_I%-7P!_P1
M4_Y)YJ7_ &,%S_Z16-4/^"RNK6^O_#32+RSECGMI]<LY89HG5XY(WL;UD='4
ME61E(964D,"""0:_0[]D[_DGGA3_ +%_2?\ TBAK\@?^;O/\_P#0N5ZA_P %
ML/A?<>(?#6B^(X/,>/2;R:WGC2%G58[]8\3R2 XB1)+:.$;EP[W"#>K!5D^O
M_P!A+]LK2_VHO#]I;S7D;>*+2S0ZK:$%9"R.83=*/*AB=)2JS.MN&2V,\<+$
M$IN]0^-_[0O_  K[7/#WA32$M[S7]<U"!6M'EVM;Z7&7EO[XKE1\D44J0([H
M99=S1K/Y$D+?E!_P7._YE'_N,?\ MA7[_445^ /_  0Q_P"9N_[@_P#[?U^W
MWQ8\"_\ "T/#VJZ#YWV?^T]/N[+S]GF>5]IA>'S-FY-^W?NV[EW8QN&<C^>'
M_@EM^UI9_LVZCJG@OQC-_9=E<7 DA:Z1H_LVI*Z6LT,X$)>+S%"&22X>.&U^
MR'<%,KL/Z+O'_C_2_A9I=SK6M7,=GIUG&9)YY"=JKD    LSLQ"1QH&>1V6-
M%9V53Y_^S=\1M4^+_A/3?$.L6<=A<ZE')=):QR"58[6:5WLLR G<[6Q@>1L(
M2[-F*$_ND_,'_@L+\"KB:PTWXD:.\D&HZ))#;W4T4C1R);O-NM)T?S5V/!<O
MM7R4,S&Z$A=4MQCV_P#97\=?\-E>-)/B.L/E:1H^CV^E6$$C_:%35+N..\U.
M6'S%B>WEMUDCT^258<7D1#I-Y8,0_3^OP!_8%_Y.%\>_]Q__ -/-O7V?_P %
M9OA?<?$?X97-Q:^8TFC7EOJ1BCA:5I8T$EO+G:08TBCN'N)),,%2%MP5273S
M_P#X)<?ME:7\3/#6G^#-4O(X_$>G1R6UM X*M=6-LJ&%XR(HX=\<3>280\EP
MR6KW3Y!=E^T/VJ_VA?\ A0FCQ#3TM[OQ)JUQ%8Z%ILTOE_:[R>2.(9Y&(HO,
M$DK,T49^2$SPO-&U?3]?S(_L]_$Z_P#^"?GQ!\7>!;.PDO+G4I$L]#CD,,LD
MEYO;^Q3<R"XMH5MYHKL/=%=LBED 6$K(H_4_Q9^Q!%>_!Z[\&3I_:&OO;S:E
M)=[XFGNM?8&X:;[5/$A;S9<VOGS!)S8MY3RKRX_-#]AGXL:I^U&_@SX?7B22
MVWA35)]<N+P.!*MKI\:_V7&))IGWHMS<M;31)""MK]E6(H(YG7^DZBBBBOY@
M?^"U?_)0]-_[%^V_]+;ZOZ?J^8/VT/@Y>?'WX?ZWX=T]L7MS;I);+A3YDUK-
M'=1PY=XT3SFA$/F,P6/?YA#!2I_/#_@BQ\8K?6O#6I^$Y[B1K[3[QKR"&612
MHL[E8U(MD+EPD<Z2/.%18T>ZC;<7G;'ZO?&OXH6_P5\-:IXCNO+:/3;.:X$<
MDRP+-(BGRH!(P8*\TFR&/Y6)=U"HS$*?S!_X(P?"%_"'@[4/$LZR))KEX$A!
M>-HWM;#?&DBJN71S/)=QN)#DB*-E15.^3]CJ************************
M************************************************************
M***********************X_P ?^ -+^*>EW.BZU;1WFG7D9CG@D!VLN000
M00RNK /'(A5XW59$9756'YH:1_P3(O/@_KDNK_#?QAJ'AJWGRTMD]LNH0LV9
M@JE9)HHY8HDE*0+=1W$L;!I?/:1@5^@-(_94\1^+8I;/Q]XSU#Q!IKY'V"TM
M(-$AF5XIH98[N2P87-Q$PE#"%9H8BR?O$F4A5^S])TFWT"WBL[.*."V@C2*&
M&)%2..-%"HB(H"JBJ JJH 4    5X!^TQ^RKX:_:OTN/3/$,4@:"3S+6\MV5
M+JW8E?,$4CI(NR15"RQNKHX"OM$L<3Q_+_@#]B[XA^!-+MO#T?Q*O!HD$8MS
M!#HUJETMJ20T5O?233SP.J$I;R@N;8"/RU"QH@^O_@A^SQX?_9]M[B+1H9#<
MWTBS:A?W,KW%Y?7 7!GN9Y"69V8O(579"LDLKI&AD?/SA^T+_P $\=%_:@U%
M-0\2Z[X@F\GS1:VT<]C%;VJ2N7*0QK8_[JF20R3R)'&LDLGEJ1]/^'/A=?>&
M]#.BKXAUB>4>6(=3N/L$M]$D8C 0.UCY,N0AWR7,,\[F61C*7V,GR!\-_P#@
MFEHOPDUQ_$NC>)?%$&KS>=Y]TUW8S-/YYW2^>)["1)][8D/G*_[U5E_UB*P^
M@/VE/V7+7]J&S_LO5=9UBSTL^69;&PDM(H9GB9F5Y6DM)9GY93Y9D\C=%%((
MA*@>C]FO]ERU_9>L_P"R]*UG6+S2QYABL;^2TEAA>5E9GB:.TBF3E6/EB3R-
MTLLAB,KEZ_(#_@I-X6L_'/QU\&Z5J$?G65];Z+;7,6YDWPS:M=1R)N0JZ[E8
MC<I5AG((.#7W_P#\,:_$#R/[(_X6;K']A?:-WE_8H?[4^S_:/.\K^V/-^T^;
MCY/.V[,?+Y'D?N*^O_@7\"]#_9TT.#P_X?@\FTA^9W;#37$S !YYW &^5\#)
MP%50L:*D21QKXA^TQ^Q/IO[5SQKX@UO7$L8)/-@T^UELXK6*3RUC+X-D\LCX
M#%6GDE,9DE6,QI(R5Z?\'/@*WP4T-O#]EKNL75HEN+>R>\:RFFL5 <*;=Q9I
MOV[U\M+H7,4:Q11I&L2F-OF#_AVEHO\ PE'_  FG_"2^*/\ A(?M'VC[=]KL
M=^_&W;M^P>7Y6S]SY&WR/(_<>7Y/R5]O^*?AIIWQ!T.3P]KZ?VK97%NL%U]I
M5 UQM _>OY*Q(DNY1*KP+%Y4H#Q"(JFW\L?AE_P2-3X;ZI.8_%NJ'PY>2,+[
M2(%DM&OK4"01VMW<P72K*FV0I,P@0R(\HC%N9 R=?\2/^"5NG>(/&B>+/#.N
M7'A>+]SYEGI=JENT>V/R)OL4\$D(M?.BX;,4W[UY9&\Q)/*7Z0^*O[#N@_$_
MP_:^$8K_ %31_#5I'$B:3IDEK#;R-$[R"29Y;6:XF=G?S)!)*R23(EPR&X!E
M/8?LU_LN6O[+UG_9>E:SK%YI8\PQ6-_):2PPO*RLSQ-':13)RK'RQ)Y&Z660
MQ&5R]?/_ ,2/^":6B_%O7$\2ZSXE\43ZO#Y/D72W=C"T'D'=%Y @L(T@V-F0
M>2J?O6:7_6.S'[_\+:-/X?LX[:YO;C4)4W;KJY6W6:3<Q8;Q:PV\(V@A%V1)
M\J@MN?<S?DC\>?\ @C=X:^)6J2:GX=U*30%N))))[,6JW5JK,$P+6,2V[6Z;
MA(S1EI4!<)$L$4:H?I_]E7_@GGX._98>+4;5)-1UU(V4ZG='YD,D:)*+:!?W
M4",5?:<27"I+)"US)&Q!^O\ Q_X TOXIZ7<Z+K5M'>:=>1F.>"0':RY!!!!#
M*ZL \<B%7C=5D1E=58?BCXI_X(=:==WDCZ5XGN+:R.WRH;G3TNIEPH#;YH[B
MV1\MN9<1)M4A3N*EV_4_]F?]E7PU^RAI<FF>'HI"T\GF75Y<,KW5PP+>6)9$
M2-=D:L5BC141 6?:99)7D^CZ*^4/VF/V+/!W[5R1MX@MI$OH(_*@U"UD\JZB
MC\Q9"F2KQ2)D,%6>.41B25HQ&\C/7C^F?LK_ !/\*H;/2_B=>+8I)*;=;[1+
M/4;I8WD9U6:\N)?-G=0VW>0HP $CC0+&O0? W_@GYX:^$^J'Q'JUQ>>)O$<D
M=KOU'6'6Y:.>W"'SK9'5FB?=''Y;R23S0)&D<<P'F&3[OK\X/C7_ ,$S] _:
M)U&/5?$^O>(+Z]AMUMHY=^F0XA1Y)%3;!IL2'#2N=Q!8[L$X  ^G_@7\!6^
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ME'_":?\ "2^*/^$A^T?:/MWVNQW[\;=NW[!Y?E;/W/D;?(\C]QY?D_)7T_\
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M]FB1HI"V_P""36EZ=XQO==L]=O+/0M1DG^UZ)9Q&T$MK<?/+IYN;>:,"R:0
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M2_A9I=MHNBVT=GIUG&(X((P=JKDDDDDLSLQ+R2.6>1V:1V9V9CV%?G!\2/\
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M6[/YK/&T&2A^L/VF/V)]-_:N>-?$&MZXEC!)YL&GVLMG%:Q2>6L9?!LGED?
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M9(_(DC)^=9'6ON_2=)M] MXK.SBC@MH(TBAAB14CCC10J(B* JHJ@*JJ %
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M9FYA\NUEPAV_:M_F.JR)(((@LB-;W8W?I_7/_P#"6:=_:/\ 9'VNW_M+[/\
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M!U'7CJNJ0QZ=':(NF03QQZ?<--?VZ-)=1"+S9W4,IB#R[(GC1T16:4R>H?\
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M@PQJI<JLKI&Q+HCB0JJ3(S_CC^P+_P G"^/?^X__ .GFWK]?OVL?^2>>*_\
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M$QV"8@R _P""H_\ R2'Q#_W#O_3E:4?\$N/^20^'O^XC_P"G*[KX _X+G?\
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M  0Z\+7EIIWB?57CQ97-QI]M#+N4[IK5+B29-H.\;5N8#N8!6WX4L5<+S_\
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M_P#<8_\ ;"OW^HKY_P#VL?\ DGGBO_L7]6_](IJ^ /\ @BI_R3S4O^Q@N?\
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M34HO#NAW-S#9PV=^\VFV,EQ]LM46*<SD)(V^1E\]3(1(\,T<K*IDQ7T!X_\
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M)C_&?Q1\"_#-W>QZ#J'B'PS>ZQ) Z:2@GOK"\BLXY'E-J(P\T5RK6T8<SI'
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MH<_A_P 00>=:3?,CKA9K>900D\#D'9*F3@X*LI:-U>)Y(V^0/V8O^"8O@O\
M9[^R:A>1_P!M:_9W#W$>HSB2)(VZ1"*S$KPKY0PZ/)YTJSYF61,1)%^C]%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?BC_ ,+:
M\0?MJ_%[6? MKKVJ>'O#6@1W+%=+*6E]<W%C(EG*6NU,CA&GN'=1\T+V\,(:
MV2X)F3R_]I/Q_P".?^":'BC3+RT\1:AXE\-ZON9M/UFY:YN/]#"+/%]H=#Y.
M?M*R0S6XCR^U)X)D@7S_ -KOB])XJ32V'@Z/2WU9I$"MJLEPEJD><R,5MHWE
MD? "*@:( MYAD/E^5)^&/[ _[3OQ0_:"O/$-A#=W%YJFH?V</[7ND1M-T2WC
M6X2>X2T39"UW*/*%K:1(B7,R//<-Y4$Q;/\ VL=)^+W[">J:=XQ_X3"\U_3K
MB\82K</)%:_:I!+(UK+IOVB2'[/)$LAB:WV"$JP06KQVSO\ L_XRN];^//@J
MVU3P/JDFAZCJ%G;:AI\T]O;S*5FA$J6]W')'<JJ.K@.\.YXG"NIE16AE_,#_
M ()U_M&>/OVA_%6I:/XO\37EM<Z1&DW]DKI5A!).8K@17*7$K66Z%(FV0RPC
MRKAS/NCEC,#Y_4[]J34-3\/^#=9U72-1N--O=+T^]OXI8([63S&MK:618I5N
M[>X0Q,P4OL$<OR@+*H+!N _8E'B_6?"5GKOC+6_[7O=8M[>]@C2VMK>&TMYH
MQ)%&#!!"\DK*X:=GRBL%BC7"--/]?T5_*E_P2)^(6C?#7QUJ%YKFH6>FVSZ'
M<1)->7$5O&TAN[-@@>5E4N55F"@Y(5CC ./TN_;:_;VT?Q%I-YX$\ +_ ,)1
MK^LV]Q92+81R74,%O-;DS21O "+F7RG;RUMV=(621YV7R?(FT/\ @F'^PKJG
M[-"7WB'Q1''#K=]']EAM4E$C6MJLF^3S)(I&@=YW2)PJAS$D28E#3311_J?X
ML\4V?@;3KO5=0D\FRL;>:YN9=K/LAA0R2/M0,[;54G:H9CC !.!7Y@?";4_%
M'_!1#[;XADU?6/"O@R.X-OHUGI<@L]1NW@R)+VXO3$^8CO:(V\#20><A0GS+
M,S7/@'Q+^,_C3_@F7XMT^VUG6-0\5^#-7^T2C[>T<E]"5D5)$BG>5Y7EMXOL
MSX<P6=P9I52&"1FFB^[_ -O+]JI_V?/A\WB'0)8YKO4Y+>UTJ[C6.XMU:Y1Y
MA<YWA'001R/ P$J-,8=T<D)>N/\ ^&2O$=QIW_"0>&OB+X@NM?GM_M-K<7%W
M!<:'<33IN+KIZPR0I:2AV\A8S,MJKQR1B;R55M#]FQ_'GQC^%.GN=;DT?Q1/
M>:C]NO[S3EO+B)HM3NUDA%K*\,4+J46$(Z,D$*M"D*$1M%^0/[%OPI\63_%S
MQ1HFA^*9--U:QCU6.ZUB73XK^2]6#48(I2\-U(P5YI-L[2%W<%2NYMS-7[/?
M':[^)OP:^'TL^E:II>JZMIUGJ-UJ>LW]N;60P1)-,GV.QMHY+<W"H55&F<0Y
MA7?%+Y[&+X _8@\0?%G]KOPKJT*>))-*MGU2[>YUV11>WDLD]O /[/LK<O$M
MA;PJSW!FA:(I)- EJL82<U]?_L__  5^,_P.\-:E;W6NZ7K^MW5Y UD-5N[^
MXM;2!5/GR&X,/VN9Y?D1;7]U#"4^T+*S22POXA_P24^/WBC]H"\\6WWB?4[C
M4)4_LCRED(6&'<MXC>3!&$AAWB-#)Y2)YC*'?<^6/Z/?M._M"Z=^R_X7N_$N
MH)YWD[([:U$J1/=7$IVQPH7/UDD*K(\<$<LHCD\LJ?D#X>?LP>.?CO9P^)/'
M7C+Q!I=[?V\4T.D:%*VDPZ>DC23"WF5D=YI462-&,J+/$R-"\UR%20?.'[$7
M[0_Q!\'?$V^^%?B.:\UVQM)+Z,7UW$ZW5M';F66*]DD822O;W0:)4%Q)( )[
M40SA (Y_D_\ X*V?#7Q1X.U'1=0\2^(_[;^W_P!HBUMH[ 6-O8)$\#E(8UGG
MW[O/53)(3.R0QK)++M4K^[_P4^%7COP-J,ESXG\8_P#"0V36[1QVG]BVFG[)
MB\;+-YL#L[;55T\LC:?,W$Y05\?^#_BWKG_!0[7-1MO#>J:AX>\ Z3BWEO[)
M3;ZEJUVQ\Q3;W,D3?9(HMBNZ(1<&&1%GCQ>!+3Q#]H[4O'G_  3:O]/\2:=X
MBU3Q/X7O[Q;>\L-:G6XDC9(2R1+=.S2J\P^U2I+;0PI$8(EN%N0%5_U^\ ?&
M+1OB+X:MO%EK<1QZ3<V8O#--)$JP1A2THN'5VBC> ATN!O(B>.16;Y37Y8_"
M;QMXT_X*3ZQ>ZI::MJ'A7X?Z=<&WMX]-GCM]4N[F.,D&2X0.\?RSI+.A+6P'
MDP1QSS+)>1_)_P#P4T^#OC'X&:#!83ZU>>(/!]YJEO<03ZK<?:-2LM0CM;B,
MP&8E3);SQF25=J;(VBV[(7W27G[G?LG?\D\\*?\ 8OZ3_P"D4-?0%? '_!4?
M_DD/B'_N'?\ IRM*_.#_ ()?_MF>!/V=O!M[I7B?5/L-[-K$]S'%]DNYLPO;
M6D:ON@@E09:)QM)##;DC!!/W?X__ ."LGPP\,Z7<WFEZC)JM]%&3;V,=I>0-
M/(2 JF:XMTBC3)W2.2Q5 Q2.5]L;_7_[,FK7&O\ @7PU>7DLD]S/H>F2S32N
MSR22/:1,[N[$LSLQ+,S$EB22237XX_M.?M'_ !5\$?%/PSX=U>YMX+*XU#2[
MR+2M F<?:()-0EA6WN+J[6T>:615:&6-V@L),12-%$=Q7Z/^//[.OQI^-6ER
M:_;^*9-%U-8Y)[3POISM;10ABF+63589XC<W'EH"99HS;BZ:1(G@MG\T>0?L
M.?MD^//VB?#1\'Z>DDWB.UD$4OB2YA62UL--90$N;C,A:\U/<LD=M R(MP52
M>>200W;OX_\ M8Z3\7OV$]4T[QC_ ,)A>:_IUQ>,)5N'DBM?M4@ED:UETW[1
M)#]GDB60Q-;[!"58(+5X[9W_ 'N\)^.O^%B>'K37M(AW?VAI\-[9P73^1G[1
M")H8YWC6X\K.Y5D9%FV<E5DP WX0ZC^U=\5?"_QJM= UX_VK<6'FI'H.@N\%
MC<S7>EAX0[SA)'B5WBGGGO3*MF%GFC41IM/L'[3O[*/QK&G7?BS3_&FH7NJM
MLGN="TI[NQMXD"?O(M."71\[RL 1HT44]TBM(2]VPCE^G_\ @F[^V;>?M::'
M=0:Q#MUK1OLT=W<H%6&[6<2^5,$7'ERGR7$\:J(MP62,JLGDP_$'[?7_ "<+
MX"_[@'_IYN*_?ZOR@T']H;Q'^W'XMUKPOX/U#^PO">B[(KW6K18+B^O6>22%
MHK28S-';17"+/):W<,<TL1MHYS(AG%NO/_M'_L]_$#]FG0[GQ7X!\:>(+Z6P
MMYI-1M-;O(=05K- LLDULMQ#Y*2PB,NP9#))$76.17'DW'T!^RU^T[/^W)X&
MNIM-N_[ \26^+:YD@2WN?L]QM5XKF.WN/-W6DV" DP5_EN($F+Q"ZKX _9O_
M &@/BEXR^*$_P[\:>++C3I;;[8@%KI.GA[N:W0N@@DFT\B**2(-=QSRQ;98$
M"JJO/&R_N]XIT:?Q!9R6UM>W&GROMVW5LMNTT>U@QV"ZAN(3N *-OB?Y6)7:
M^UE^ /\ @G!XH\=_%[PXOC#QAK_]H6^H>='86$=I:0+"L$[0R3320V\4C2L\
M3K'&K>4D678R22*MN?M!?M-:YXM\:6WPJ^'TOV376V7&L:S+:FXATNT$:W&$
MB=&CEED1HU#RXMPTT-N)!/,9+3Q_]H_]F/QI^SWH=SXP\%>.?%%U=Z-;S7,]
MEJU['J$,\("B5PL_E6Z^3"9YBLD5RTC*@B$<JJ6^L/V'/VN[?]K[PT=1>*.U
MU:RD%OJ-JCJRB0J&2>)2S2K;S#=Y?FC*O'-"'E\DRO\ -_@_XMZY_P %#M<U
M&V\-ZIJ'A[P#I.+>6_LE-OJ6K7;'S%-O<R1-]DBBV*[HA%P89$6>/%X$M/$/
MVCM2\>?\$VK_ $_Q)IWB+5/$_A>_O%M[RPUJ=;B2-DA+)$MT[-*KS#[5*DMM
M#"D1@B6X6Y 57_8[X5?$O3OC)H=AXATI]]EJ%ND\661F3</FBD\MG198FW13
M(&;RY4="<J:] K\$?^"I_P"T%\4OA!<6ME#?V>DZ)J<EV++^RI9_[0DCM6M6
MW7=S)%$T+EG#*EF4 226"62=5#O]?_&+X*?%G]I>WN+RW\0R>"H8Y)/[-T6W
M :X<0JZ0RZAJ=E<;HWN&8M);VYN;>"'R#MGN(W)^,/V)/VQ_B+9RZO\ #:_M
M+C7?%EI<216$UW)YL-DT<KQWSZM?+*\CVEN^UXC&)99F)M(Y@)+4(?MJ?"/X
MP_LY68\>6_CS4-6BMKB WT: Z=#;_-%%;N+!)Y+.>)Y-L<\8C&YG5GBF22=X
M_P!;_P!F[XO/^TUX#TWQ"C26-SJ5G(DLD*1AH+J-GMIY+=)OM*;%FC=[<3"4
M%/+\U"2Z5^<'@/\ :&\?>&OC\GPXU/Q#)JFB)).2);"P@D>-]*>^A5WM[>-M
M\;,BL\9C$IC+>6BN8Q^MWQ+\*ZGXPTY[;2-7N-%O?F:*[@@M;C#;&55EBNX9
M4>+<RNZH896V!5GC!;/Y@?\ !*3]J/Q?^TI_PD?_  E>H?;_ +!_9OV;_1K:
M#R_/^U^;_P >\46[=Y4?W]V-O&,G/J'[7'QYOY?'GAGX7Z;JTGA^/6XY9]3U
M.-(1.;>19XK>ULYY6(AN)Y(98EE6/SHYGM'A=V\R%_(/VL_@;X\_9H\':CK?
M@GQGXDOHTC_XFMMJ<ZZC<?93F,S6,_V?S;1X1(\D[QF,^2#/YT;6J!_H_P#X
M*#_#7Q1X[\):O/I?B/\ LC2+/1[Z>]L(K 237_DQM.T3WAG1X8G6,1%(HQN5
MYA*9XW$2?G!_P2_^%7COQSX-O;GPQXQ_X1ZR76)XY+3^Q;34-\PMK1FF\V=U
M==RLB>6!M'E[@<N:_H>HK^:']G#4?%ME\=?'$?@NUT^XU2>XUV,RZE+)'9VL
M(U:*1YI5A'G2Y*+;I'%AA).DK'RHI ?</VF_@;\:?V8+=_'&C>-]4U]8))YM
M0@,;)';1R*<SKI\DUU:26Z;GWJL:"T CE2,11O);_I?^Q!^U+_PUQX2379;7
M['>V]P]E>QJ<PFXBCBD:2 EF?RG65&"R?/&Q:(M*$$TGC_[07[36N>+?&EM\
M*OA]+]DUUMEQK&LRVIN(=+M!&MQA(G1HY99$:-0\N+<--#;B03S&2T\?_:/_
M &8_&G[/>AW/C#P5XY\475WHUO-<SV6K7L>H0SP@*)7"S^5;KY,)GF*R17+2
M,J"(1RJI;ZP_8<_:[M_VOO#1U%XH[75K*06^HVJ.K*)"H9)XE+-*MO,-WE^:
M,J\<T(>7R3*_V?7S_P#M1_ O_AI3PAJ'A3[9]@^W_9O])\GS_+\BYBN/]5YD
M6[=Y6S[ZXW;N<8)^U'\"_P#AI3PAJ'A3[9]@^W_9O])\GS_+\BYBN/\ 5>9%
MNW>5L^^N-V[G&#[AJTEQ#;RM9QQRW(C<PQRR-%&\@4[%>18Y6C0M@,ZQR%02
MPC<C:?Y\=1_:N^*OA?XU6N@:\?[5N+#S4CT'07>"QN9KO2P\(=YPDCQ*[Q3S
MSWIE6S"SS1J(TVGV#]IW]E'XUC3KOQ9I_C34+W56V3W.A:4]W8V\2!/WD6G!
M+H^=Y6 (T:**>Z16D)>[81R_3_\ P3=_;-O/VM-#NH-8AVZUHWV:.[N4"K#=
MK.)?*F"+CRY3Y+B>-5$6X+)&563R8?A#]K+]I/XO> OB7X>\/WDMFL<UYIU[
M::-HMW)#'=H]]-#%:W=]<10RN\H4P3[E6R8>7,;=6# ?3_Q#_9+^-WC+6=,U
MJ+X@1V\GF1O>VMM'/:6=DJRK+Y=M;1EXM21"\J WXA>>..*.9V5R(O</VQ/V
MJ]1^'>HZ;X!\'Q>=XS\0;%M9)(G>WT^WE=XS?3!8Y/,V>7*X0+(D20R7$ZF.
M-8;CS_XE_L5>-+#3GUCP]X^\43^)K?=>>3/=1G3KRYC1I/L\5CNAM[6*:?8J
M1RO/;0PDQ/%*G(T/^"<7[<;_ +5NESZ9K0CC\1Z7'&9W4QHM] Q*BZCA!#*Z
ML MTJ+Y*/)$Z%!.L$7Z7T5^8'Q5^,?BC]IKQI?\ PV\ ZC_8EEI%N[:]XACA
M%TPEEC\M+&T*-LBE#.0[M+;W2RP7!C:,V;+<_.'[;7PP\8_L7Z-9^,?"/C+Q
M9?-!>?9[R'4[O^TK=([B)U2=T>,0*BN!%^_BE#33PE'BE1?,_4[]ECXLZC\=
M/!>D>)-5LO[/O;^W,DMN X7Y9'19HQ( XBG55N(02^(I4 DE&)'_ "!_X(8_
M\S=_W!__ &_K];_VJOVF-+_90\-2^(=3CDG8R+;V=K'D-<73J[QQ&3:RQ)MC
M=Y)6!"(C;5DE*12?)_A;]F#QS\?M#CU_Q9XR\0:+K]_;M-;V&D2MI]CIR3 R
MV]O/:;$FGEA+XN#+)'.0!;&9O)6X?R#]EK]L#Q'\*/B!=?"/XAW7V^6.X%MI
M6L2F"*5@(5>U2YQ(1)]KB\MXF9Y;P74P@E,[RYM^O_X*#_M,^(- \5>&OAKX
M8OY-'N=?D@6^U)($DDCM[^X-C"+=BX975A/+(4$4RE+<Q7,9,E<!^V#\$?&/
M[(_A_P#X3CPCXY\27#:7(HO+76;_ .WQR1W3I:HT43Q>0SH\HRD\;@AO-22*
M6!5E_0_]ESXZ:C^T1\/]/\5_8[>+4KRWN?\ 1O.=+=KBWFEM_P#6^7+)%%*\
M6_[D[PH^W]^R9?\ (#4?VC_C-_PNJU\*7-SI]UJ5KYL<.EV<TUKHNZZTL2B:
MX+*MS<Q6X9;R2.8R2[XY8K8QM(E?9_A_]DOXO:)X\T[7[KX@2:CH\<D4NH0O
M');+*J*R/;1Z7&9+#9(BHIGWQO&\CW"QF>)6E[#]H+]IK7/%OC2V^%7P^E^R
M:ZVRXUC69;4W$.EV@C6XPD3HT<LLB-&H>7%N&FAMQ()YC):>/_M'_LQ^-/V>
M]#N?&'@KQSXHNKO1K>:YGLM6O8]0AGA 42N%G\JW7R83/,5DBN6D94$0CE52
MWU!^QE^VCIW[3_A*;7;[[/IM[I>4UB-ID6&'9'YGVI2[EXK210[*TV-C1SQ;
MY1"9G^0/A-XV\:?\%)]8O=4M-6U#PK\/].N#;V\>FSQV^J7=S'&2#)<('>/Y
M9TEG0EK8#R8(XYYEDO(_D_\ X*:?!WQC\#-!@L)]:O/$'@^\U2WN()]5N/M&
MI66H1VMQ&8#,2IDMYXS)*NU-D;1;=D+[I+S]SOV3O^2>>%/^Q?TG_P!(H:/A
MW\"_^$"\7^*/%?VSSO\ A)/[*_T;R=GV;^SK9K?_ %OF-YOF;M_W(]F-OS]:
M/AW\"_\ A O%_BCQ7]L\[_A)/[*_T;R=GV;^SK9K?_6^8WF^9NW_ '(]F-OS
M]:^@*S]6LGU&WE@BFDMI)(W1)XA&9(F92!(@E22(NI.Y1(DB$@;D9<J?PQ\?
M_&CXG?"_XPV'@#5_&-Q;Z%J=Q;M9WW]E:5)<2V]R66&+;':.J2M<(UCYSHJ*
MX^UM ("$/[G:39/IUO%!+-)<R1QHCSRB,22LJ@&1Q$D<0=B-S"-(T!)VHJX4
M?G!\*+KQSX[^)&K6%GXOO+OP?X=DMHKMI=.TOS+J_:,/+81W=O:+$R0G'VUU
M$%S 7%J(5<K>#Y _X*G_ +07Q2^$%Q:V4-_9Z3HFIR78LO[*EG_M"2.U:U;=
M=W,D430N6<,J690!))8)9)U4._[W5^*/_"VO$'[:OQ>UGP+:Z]JGA[PUH$=R
MQ72REI?7-Q8R)9REKM3(X1I[AW4?-"]O#"&MDN"9D\O_ &D_'_CG_@FAXHTR
M\M/$6H>)?#>K[F;3]9N6N;C_ $,(L\7VAT/DY^TK)#-;B/+[4G@F2!?/_?ZB
MO@#]L3]JO4?AWJ.F^ ?!\7G>,_$&Q;622)WM]/MY7>,WTP6.3S-GERN$"R)$
MD,EQ.ICC6&X\_P#B7^Q5XTL-.?6/#WC[Q1/XFM]UYY,]U&=.O+F-&D^SQ6.Z
M&WM8II]BI'*\]M#"3$\4J<@_X)\?MT7G[4^AWFG7\=N?%FDVZL0\RV\.HJ0R
MQSX1))(<.%CO#'#)%$TD4D:XF6VC^,%_:;^+.F_&VV\.:T\>J7.GQW130=%G
M%GI]S)-H[3QJTMX8FD0-Y<SO>-,8'$IMXV.R)_4/VP/V>OC-IVAW7C1?'%Q+
M=V5N;B\TG3#-I5I;VR"2:X%M)'<+]I^S[B$>Y1+F>W3F1I4C@?O_ -F+]J+X
M@?MH^%[33]$;^R-2M-\>N>*9K&&6W5XSN@AT^T,ACN+N=#&UX7$,%HAD9(PT
M]H%^0/B/XP^)7_!-?QSI-SKWB34/$GAN_P"&-Q/+/Y]NC1"]1;2XN7\B[AWH
M\$BRA'W1@RE'N;=?Z/J_#']G'QWX@_X*3^)?$5Y<>)M<T'P]H\D8TRQT>5-.
MG,=XT@B:YF3SC(ZQVFZ1',P$TSF&2&(&.3/LOB_XY_8C^+6F^!-0UJX\3>'M
M>N+4VPU&5I;R"+4+C[)&[7+JT@E@>$YC5C:SQ[G$5O-.3!^E_P"V1XM\:^!?
M"M[J?@PZ7%)96=[=7MS?M,TD4$%N\G^AP1Q/%)<9!9&N&$*F-4:*5928OF__
M ()0?%77/C)X-U75?$-_<:A>OX@NQYL[EMBM;6<GEQ+]R*(,[E(8@D4>XA$4
M<5Y__P %J_\ DGFF_P#8P6W_ *17U??_ .R=_P D\\*?]B_I/_I%#7T!7S_^
MUC_R3SQ7_P!B_JW_ *135^*/_!-7PW\0?B5X%U/0/"]W9Z#H\^J77VW77WSZ
M@LDMI:CRM/MXWC6-T6-1-<32(0EVKV[+/;DD^*OC'XO?\$TO$%K>W^M7GBOP
MO>R1!I;UY)(YV1'\RU9IGN9;"X 9Y(FBD*3A$D83B&:VB_9_QE=ZW\>?!5MJ
MG@?5)-#U'4+.VU#3YI[>WF4K-")4M[N.2.Y54=7 =X=SQ.%=3*BM#+^8'_!.
MO]HSQ]^T/XJU+1_%_B:\MKG2(TF_LE=*L())S%<"*Y2XE:RW0I$VR&6$>5<.
M9]T<L9@?/ZG?M2:AJ?A_P;K.JZ1J-QIM[I>GWM_%+!':R>8UM;2R+%*MW;W"
M&)F"E]@CE^4!95!8-P'[$H\7ZSX2L]=\9:W_ &O>ZQ;V][!&EM;6\-I;S1B2
M*,&""%Y)65PT[/E%8+%&N$::?Z_K\@/^"L'PU\4:SX0U36O^$C\GP]9_8#_8
M,-@$\]VN8H=]Q>^>9),/-YHC\L0#RH?W7G)]H.!_P3>^%7CO5/!/AS5;'QC]
MCT 7$\C:)_8MI+NABU"<3P_;7<3#SRLA\P#=%YN%!V+7C_\ P7._YE'_ +C'
M_MA7U_\ $OX3_%7]K'3GU6S\07'@BU?=+I>B)"\=XRHC""75+VWF2:WEG+DS
M6D8GBM8_)#1RW44E>0?\$N?VE_%'B#5M;^'/C2:XN]4T?SIHIYW%Q-'Y%Q]G
MO+>>Z\US-LEDC-N0)/E,R^=Y2VZ+]G_MI?M;I^RWI=K'96DFI>(]8D>VT:P2
M.1UEG!12\GE_,R(TL0$,9\ZX=TB3:#)-#X_J?[#OC'QMI8NM4^(OB2W\431Q
M&XEL;GR=)CD4J&6'3[<6IV",>7O$D)EES<O&I=H:\_\ V /VX];^)6LW_P /
M?'PC7Q1ITET$N@;>,7+6TI2XM6CA*Q-<0G<R-;*R2V\<CL%,#2S_ *WU^6'_
M  6%\:W'A7X9&S@6-H]5U2SLYRX8LL:"6]!C(8 /YEK&I+!AL9QMW%67S#_@
MB7X6L[3P;K.JI'B]N=8-M-+N8[H;6V@DA3:3L&UKF<[E 9M^&+!4"_L]16?I
M.DV^@6\5G9Q1P6T$:10PQ(J1QQHH5$1% 5450%55 "@   "ORPT']H;Q'^W'
MXMUKPOX/U#^PO">B[(KW6K18+B^O6>22%HK28S-';17"+/):W<,<TL1MHYS(
MAG%NO/\ [1_[/?Q _9IT.Y\5^ ?&GB"^EL+>:34;36[R'4%:S0++)-;+<0^2
MDL(C+L&0R21%UCD5QY-Q]0?L9?M?_P##7'A*;5+:WMXM?L<P7=BUQY<)N/+W
M12JRB>:&TG.0KO'(\;)/&HN/(WR?F@O[3?Q9TWXVVWAS6GCU2YT^.Z*:#HLX
ML]/N9)M':>-6EO#$TB!O+F=[QIC XE-O&QV1/ZA^V!^SU\9M.T.Z\:+XXN);
MNRMS<7FDZ89M*M+>V0237 MI([A?M/V?<0CW*)<SVZ<R-*D<#]_^S%^U%\0/
MVT?"]II^B-_9&I6F^/7/%,UC#+;J\9W00Z?:&0QW%W.AC:\+B&"T0R,D8:>T
M"_('Q'\8?$K_ ()K^.=)N=>\2:AXD\-W_#&XGEG\^W1HA>HMI<7+^1=P[T>"
M190C[HP92CW-NO\ 0=X_DUF+2[D^'H[.35O+(M%OI)8[42$@!IFACDE**"7V
M(H,A41^9%N\U/P1^ 7[5WQ5\2?%/7M%N3_;6KPV^H:9:V4+O#H=C/#J$8-[<
M*H1_LENHF43.LE_<*T-IYGF3*5Z#]J[]GKXS?L[69\::5XXUC7DMKA[K4(4,
MULMLH82"86(N)[:6T4[A/"$6*&+;F!K83&']/_V(/VI?^&N/"2:[+:_8[VWN
M'LKV-3F$W$4<4C20$LS^4ZRHP63YXV+1%I0@FD_,#_F[S_/_ $+E?M=\7I/%
M2:6P\'1Z6^K-(@5M5DN$M4CSF1BMM&\LCX 14#1 %O,,A\ORI/RQ_P""2GQ^
M\4?M 7GBV^\3ZG<:A*G]D>4LA"PP[EO$;R8(PD,.\1H9/*1/,90[[GRQ^O\
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MU=Z-;S7,]EJU['J$,\("B5PL_E6Z^3"9YBLD5RTC*@B$<JJ6^L/V'/VN[?\
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M  KJ,J^*_$FCW-MJCK)8:-JRVD?EO;P&.XE@\N1M\C++&)3@.(-@R8FK[_\
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MO<6<(^U7;;YIMADG9[823P?:5AGCN&2-(U^W_P#@EQ_R2'P]_P!Q'_TY7=?
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M7Q3>>!O!OB#5=/D\F]L='U&YMI=JOLFAMI)(WVN&1MK*#M8,IQ@@C(K\L?\
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MXDFF^P^$[;RX[/6KW-LFI7 2:2ZALK:55N9?($2H"$+W$_GPQ1L;=F?\@/\
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MX>*==OM3M[32]8_MK[#=W)-O#)Y^HQ7<6]Y0@AWQ1NR^=Y?S 1?ZUD1ON_\
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M([".VN-2U_5O[-31M)MT;?>S0_:_,#3E3#;11B59)YYV58H!)*%D\LH?0/\
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MQ>/$^+WAB.,Z<UY;W,P@C:);6Z"I'*EVL+HSV]\P;SIE9!,]Q+!+M>2)[CZ
M\ ?\%K_"LNEVQ\0Z5JD>K>6!=K8Q6\EJ9 2"T+374<H1@ ^QU)C+&/S)=OFO
M]O\ [(OAOQ+K+ZQXX\76\FGZIXCDM?L^DM,TBZ=IMG&ZV<+*ZAHKAFFGFN4!
M"EY YAMIFFA7[/KY_P#VG?V>M._:@\+W?AK4'\GSMDEM="))7M;B([HYD#CZ
MQR!6C>2"26(21^86'XX_L@?&R]_X)M7]]X#^)-A)8:3=WD]U9ZU%#/-;R3I#
M"C[&1";BW>-8-K0IYUM,XCGB'F-]F_6_Q3^VM\-?!]G)?7/BC1WBBV[EMKR*
M[F.Y@@V06K2S/RP+;$;:N7;"*S#\@-1^%OBC_@K+XMM?$ES;W&B_#^S\VWM)
MI) 9I8HI 96AA9W3[7<,0DDZ(;6%81"TEU-:;)OWNU/5M&^%&EB6ZEL]*TFR
MCBB#R/%:VMO&"L42 L4BC3)2.-?E&2J*.@K^:+5OVJO#6B_M'R^.)99&T*&\
M>U>YB59@533CIAN4\IW$EOY@\Y6C+.]OAUC:0B(_TFZ!\6/#WBO3KC5]/U73
M[O3;3S/M-Y!=PRV\/E())/-F1S&FQ"'?<PVH0QPI!K^<']N[]I?P]K/QKT'Q
M#I\WV_3?#W]C_:9[1X9TG^SW;7\GV5TE,<F$F$7S-'B=)$.%4.?Z+OA?\:_#
M7QJM_M7AS5+/4HUCADD%O,KR0K.I:,3Q9\V!V"M^[F5'!5U*AE8#^?']N3X_
M>%_$'QP\+:[8ZG;W>EZ/_8OVZ[MB;B&/R-1ENY=CQ!Q-LBD1F\GS/F)B_P!:
MKHO]%VF:MHWQ7TLRVLMGJNDWL<L1>-XKJUN(R6BE0E2\4B9#QR+\PR&1AU%?
MS):!J/BW_@D-XYN%O+7^U=(U&WDCC(EDMK?4(48-%,A E2*[MV(62.1)FA2:
M5%)CN8KEOT/U;_@JD/C;;RZ'\,O#VN7WB.ZC>.%Y8K:..S$BF)+URLEVA2&:
M2$L+A8K?#'S)XP,-]'_$C]A>SU_X1I\--,DMUN+.WA:TO;B%F7[='+Y\LX#/
M+);_ &EVG1S&SF"*YD1%DC'E-^0'[)G[<VN?L$7EQX#\;:9<-IMG<7#2PJ2U
M]9S2*C*L DG%L]HY!E"H460W+7:3R*0DOWAJ?[6+_P#!1U!X'\#Z=JEGI=S)
M%_PDNK731VK6FF^8K/#;-!+<*UQ=JLD*I*&5D$B-#)"TTUMQ_P#P6C^*NAWG
MAFP\,PW]O+K46L0W,UE&X>:&%+.<%YE7/DY^TPF-9=C2JY:,.J.5^_\ ]ACX
MJZ'\2/ .@P:1?V]W<:=H^FVU[!&X\ZVFB@$#)-$<21Y>&41LZA950R1EXR&/
MU_1111111111111111111111111111111111111111111111111111111111
M11111111111111111111111111111111111111111111111117E_C7X(>%?B
M5<+>:YHFEZE<I&(DFO+&WN)%C#,P0/+&S! S,P4' +,<9)ST'C7X>Z-\2K=;
M/7-/L]2MDD$J0WEO%<1K(%90X2564.%9E# 9 9AG!.>@TG2;?0+>*SLXHX+:
M"-(H88D5(XXT4*B(B@*J*H"JJ@!0   !6A16?JVK6^@6\MY>2QP6T$;RS32N
MJ1QQHI9W=V(545069F("@$D@"OF#]HK]HJR\'> [WQ#X>O8[ZYO(VLM#DL&@
MO&N=2N&:VMDMDW,ERZ39>2)!*VR&;]TY0H>__9K^$*? 7P=H_AI5C62PLXTN
M#$\DD;W3_O+J1&EPY22=Y9%!"A0P4(B@(ON%%%%%%%<?XU^'NC?$JW6SUS3[
M/4K9)!*D-Y;Q7$:R!64.$E5E#A690P&0&89P3D\%?#W1OAK;M9Z'I]GIML\A
ME>&SMXK>-I"JJ7*1*JERJJI8C)"J,X QT%[I-OJ+PRSQ1R26TAE@=T5FBD,;
MQ%XR02CF.22,LN"4D=,[68'R_P#X9Z\&_P!H_P!K_P#"/Z/_ &E]H^U?;/[.
MMOM'VC?YGG^=Y?F>;O\ G\S=OW_-G=S7L%>?Z_\ "?P]XKU&WU?4-*T^[U*T
M\O[->3VD,MQ#Y3F2/RIG0R)L<ETVL-KDL,,2:] HHHHKR_QK\$/"OQ*N%O-<
MT32]2N4C$237EC;W$BQAF8('EC9@@9F8*#@%F.,DY]0KG_%/A/3O'-G)I^JV
MEO?64VWS;:YA2:%]C!UWQR!D;:RJRY!PRAAR :/"WA/3O UG'I^E6EO8V4.[
MRK:VA2&%-[%VV1QA47<S,S8 RS%CR2:/%/A/3O'-G)I^JVEO?64VWS;:YA2:
M%]C!UWQR!D;:RJRY!PRAAR :Y_P+\)_#WPO\[^P=*T_3/M&SS_L5I#;>;Y>[
M9YGDHF_;O;;NSMW-C&3GT"O/_'7PG\/?%#R?[>TK3]3^S[_(^VVD-SY7F;=_
ME^<C[-VQ-VW&[:N<X&-"Y^'NC7MO96<NGV;VVFR02V$+6\1CM)+==L#VZ%=L
M+Q+\L31A3&.%(%=A11111111117X _\ -WG^?^A<K]GO"W[/7@WP->1ZAI7A
M_1[&]AW>5<VVG6T,R;U*-LDCC5UW*S*V",JQ4\$BO8***Y_Q3X3T[QS9R:?J
MMI;WUE-M\VVN84FA?8P==\<@9&VLJLN0<,H8<@&N/\%?!#PK\-;AKS0]$TO3
M;EXS$\UG8V]O(T996*%XHU8H656*DX)53C(&/4*\/\0?M'>%=%\-:CXL@U.S
MO])TR.5IYK*ZMYU,D:JPMT<2B(W$A>-(HF=2[RQ+QO7/F'[#7PTU'X=>"[>?
M7$VZ_K=Q<ZSK#%71GO-0D,O[R%UC$$J1>3%-#'''''+&X53R[?7]%>/^%OV>
MO!O@:\CU#2O#^CV-[#N\JYMM.MH9DWJ4;9)'&KKN5F5L$95BIX)%>P5S_BGP
MGIWCFSDT_5;2WOK*;;YMM<PI-"^Q@Z[XY R-M959<@X90PY -<_X%^$_A[X7
M^=_8.E:?IGVC9Y_V*TAMO-\O=L\SR43?MWMMW9V[FQC)SZ!1111117/^*?">
MG>.;.33]5M+>^LIMOFVUS"DT+[&#KOCD#(VUE5ER#AE##D UG^"OA[HWPUMV
ML]#T^STVV>0RO#9V\5O&TA55+E(E52Y554L1DA5&< 8T/"WA/3O UG'I^E6E
MO8V4.[RK:VA2&%-[%VV1QA47<S,S8 RS%CR2:-2\)Z=K/VG[3:6\WVRW%K=>
M9"C^?;KYF()MP/F1#SIL1OE!YLG'SMGC_!7P0\*_#6X:\T/1-+TVY>,Q/-9V
M-O;R-&65BA>*-6*%E5BI."54XR!CU"O/] ^$_A[PIJ-QJ^GZ5I]IJ5WYGVF\
M@M(8KB;S7$DGFS(@D?>X#ON8[G 8Y8 UZ!17/^*?">G>.;.33]5M+>^LIMOF
MVUS"DT+[&#KOCD#(VUE5ER#AE##D US_ (%^$_A[X7^=_8.E:?IGVC9Y_P!B
MM(;;S?+W;/,\E$W[=[;=V=NYL8R<^@45X_X6_9Z\&^!KR/4-*\/Z/8WL.[RK
MFVTZVAF3>I1MDD<:NNY696P1E6*G@D5[!11117X _P#-WG^?^A<K]GO"W[/7
M@WP->1ZAI7A_1[&]AW>5<VVG6T,R;U*-LDCC5UW*S*V",JQ4\$BO8****\?_
M .&>O!O]H_VO_P (_H_]I?:/M7VS^SK;[1]HW^9Y_G>7YGF[_G\S=OW_ #9W
M<U[!116?JVDV^OV\MG>11SVT\;Q30RHKQR1NI5T=&!5D92596!# D$$&N/\
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M?_\ !39?_&:]PTG2;?0+>*SLXHX+:"-(H88D5(XXT4*B(B@*J*H"JJ@!0
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MR_ 'PW_X)I:+\)-<?Q+HWB7Q1!J\WG>?=-=V,S3^>=TOGB>PD2?>V)#YRO\
MO567_6(K#]'Z************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M**Y_PMXLT[QS9QZAI5W;WUE-N\JYMIDFA?8Q1MDD99&VLK*V"<,I4\@BN@HH
MHHHHHHHHHHHHHHHHHK/U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S
M$!0"20!1I.K6^OV\5Y9RQSVT\:2PS1.KQR1NH9'1U)5D92&5E)# @@D&M"BB
MBBBBBBBBBBBBN?\ ^$LT[^T?[(^UV_\ :7V?[5]C\Y/M'V??Y?G^3GS/*W_)
MYFW9O^7.[BN@HHHHHHHHHHHHKG] \6:=XK^T?V?=V]W]DN)+6Y\B9)?)N(L>
M9!+L)V2ID;XVPZY&0,BN@HHHHHHHHHHHHHHK/U;5K?0+>6\O)8X+:"-Y9II7
M5(XXT4L[N[$*J*H+,S$!0"20!1I.K6^OV\5Y9RQSVT\:2PS1.KQR1NH9'1U)
M5D92&5E)# @@D&M"BBBBBBBBBBBBBBBBBBBN?T[Q9IVKWEUI]M=V\U[8^5]K
MMHYD>:W\Y2\7G1J2\7F*"T>\+O4%ER.:Z"BBBBBBBBL_5M6M] MY;R\EC@MH
M(WEFFE=4CCC12SN[L0JHJ@LS,0% )) %&DZM;Z_;Q7EG+'/;3QI+#-$ZO')&
MZAD='4E61E(964D,"""0:T******X_PW\0M&\8W%W9Z9J%G>7-A)Y5[#;W$4
MTEM)N==DZ1LS1/NC==L@4Y1QC*G'845GZMJUOH%O+>7DL<%M!&\LTTKJD<<:
M*6=W=B%5%4%F9B H!)( HTG5K?7[>*\LY8Y[:>-)89HG5XY(W4,CHZDJR,I#
M*RDA@002#6A7/^*?%FG>!K.34-5N[>QLH=OFW-S,D,*;V"+ODD*HNYF55R1E
MF"CD@5H:3JUOK]O%>6<L<]M/&DL,T3J\<D;J&1T=259&4AE920P(()!K0HHH
MHHHHHHHHHHHHHK/DU:WAN([-I8Q<RQR2QPEU$CQQ-&LCJF=S(C2Q*[ $*9(P
M2"ZYT**S]6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q 4 DD 5H44
M4444444445S_ /PEFG?VC_9'VNW_ +2^S_:OL?G)]H^S[_+\_P G/F>5O^3S
M-NS?\N=W%9_C7XA:-\-;=;S7-0L]-MGD$237EQ%;QM(59@@>5E4N55F"@Y(5
MCC ..PHHHHHHHHHHKG_"WBS3O'-G'J&E7=O?64V[RKFVF2:%]C%&V21ED;:R
MLK8)PRE3R"*Z"BBBBBBBBBBBBBO+_!7QO\*_$JX:ST/6]+U*Y2,RO#9WUO<2
M+&&52Y2*1F"!F52Q& 649R1GU"BBBBBBBBBN?T#Q9IWBO[1_9]W;W?V2XDM;
MGR)DE\FXBQYD$NPG9*F1OC;#KD9 R*Z"BBBBBBBN?T#Q9IWBO[1_9]W;W?V2
MXDM;GR)DE\FXBQYD$NPG9*F1OC;#KD9 R*Z"BBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBORP_X*R?#1]>\ ZCKQU75(8].
MCM$73()XX]/N&FO[=&DNHA%YL[J&4Q!Y=D3QHZ(K-*9/4/\ @EQ_R2'P]_W$
M?_3E=U]_T44444444445Y?\ %'XO:7\($T]]3:0-JFJ66E6:1H7:2ZO9-D8/
M1515#RR,Q "1L%WRE(W]0HHHHHHK\,?^"SWPT>UT&T\1OJNJ2K+JEK:)I;SQ
MC385%K=OYT=ND2L;@LK9GEDD?;(\8(B$:1_J=^R=_P D\\*?]B_I/_I%#7T!
M11111111111117'^/_";^.M+N=,COKS36NHS&;RQ>..ZB4D;C#))'*L;E<KY
M@7>@8O&T<H1U_!'_ ()LZ!_PBGQU\9:?]HN+O[);ZU!]INI/-N)O*U:U3S9Y
M,#?*^-TCX&YR6P,XK^AZBBBBBBBBBBBOC#]O3X:/\0? NL3C5=4TZ/3=+U.[
M:"PGC@CO&CM)"L-X3$\LEO@,KP(\:2!VWAF6)H_D_P#X(J?\D\U+_L8+G_TB
ML:_7^BBBBBBBBBBBO+_BC\7M+^$":>^IM(&U35++2K-(T+M)=7LFR,'HJHJA
MY9&8@!(V"[Y2D;^H45^&/_!9[X:/:Z#:>(WU75)5EU2UM$TMYXQIL*BUNW\Z
M.W2)6-P65LSRR2/MD>,$1"-(_P!3OV3O^2>>%/\ L7])_P#2*&OH"BBBBBBB
MBBBBBBBBBBBO+_B]\-'^+6EMI::KJFCJ\B.]SI4\=O=%4.?+$SQ2M&A;:6,6
MQV"["_E-(C_BC_P0Q_YF[_N#_P#M_7[_ %%%>7_&CXO:7\!?#]]XEUEI%L;"
M,/((D,DCL[K''&B\ O)(Z1J6*HI8,[H@9U]0HHHHK\,?^"SWPT>UT&T\1OJN
MJ2K+JEK:)I;SQC385%K=OYT=ND2L;@LK9GEDD?;(\8(B$:1_J=^R=_R3SPI_
MV+^D_P#I%#7T!111117YP?L=_P#!.?3OV0O$.I:];:M<7_VNW>TM8)($B\BW
M>9)B)G5F\^7]U"HD1;=.)#Y1\Q1%^C]>7_#3XO:7\6GU5-+:1UT?5)]*N7="
MBFZMXXGF$>?F9$:7RBQ"AG1RFZ+9(_Y _P#!9[X:/:Z#:>(WU75)5EU2UM$T
MMYXQIL*BUNW\Z.W2)6-P65LSRR2/MD>,$1"-(_U._9._Y)YX4_[%_2?_ $BA
MKZ KY0_;)_96M_VOO#2:!/?2:=)#>0WD%PD2S*)(UDB(DB+1ET,<T@ 62,J^
MQ]S*K1OW_P"S=\$+?]G#PGIOA6UN)+N.PCD!N)%5&DDFE>>5@BY"(9)'\M,N
M43:K22,"[>X44445Y?XN^+VE^"M;T7P]=-(=1UZ2[2RC1"5VV5NUS/)(YPJH
MJA$ R79Y4VH4$KQ^H4444444445\0?MB?M%ZC\.?[-\)>$&MY?&?B*X2VL8Y
M \GV*W?>)=3FBCBE_=0[3CS!L^62;9/':SQ'V_X(?!"W^#MO<2RW$FI:WJ4B
MSZOJ\ZJ+B^N NU257Y8;>)?W=K:Q_N;:'Y%RQDDD_-'X_?$/XJ_M;>*-3\*?
M#*;^RO#NC7!L-0UKS7M?,OH@)98_M'E_:D\F2/[-Y=BKD[_,GD:UNHMGQ_\
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MZ=':(NF03QQZ?<--?VZ-)=1"+S9W4,IB#R[(GC1T16:4R>H?\$N/^20^'O\
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MMGIOAC[;J0^R-H^D6UP48PA9/M\]]J4ZK;111E8A$?*B9I;B&W"RLQE3Z/\
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M22.U>6*-#$\MNDX:8AX[:6/('U!^RC^U=H?[6NAC5=*/DW<.Q-0T]W#36DS
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M<W<CPV5E"\2R2R+$TF]_,8,MNK!(YIHTF,1FB_=.7 .?_:'Q:_L?^V/*\/\
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MQ_X(:Z3;S7'BN\:*,W,4>EQ1S%%,B1RM>-(BOC<J.T43.H(#&.,D$HN/H_\
MX+5_\D\TW_L8+;_TBOJ^P/A/XZ_X5?\ !O2M>\G[1_9G@^TO?(W^7YOV;3$F
M\O?M?9NV;=VUMN<[3C!^,/\ @C#IB:GX5U[Q#<&2;5M1UR2.\NY99)))UAMX
M9D+EV(+^9=7#M)C?(9#O9MJ[?H__ (*C_P#)(?$/_<._].5I1_P2X_Y)#X>_
M[B/_ *<KNOO^O+_C1\(=+^/7A^^\-:RLC6-_&$D,3F.1&1UDCD1N0'CD1)%#
M!D8J%='0LC?GA\-?VI-#^&5G:?#[X.:%J'C'^R<Q3SQSBWL8B[74DKS:E.AB
M,LLL;RQE42SG$A%M-\JP5\@?\$V?[1_X7KXR_M?[/_:7V?6OMGV7?]G^T?VM
M:^=Y'F?O/*W[O+W_ #[,;OFS7T__ ,%J_P#DGFF_]C!;?^D5]7WA^QWI-OHO
MPY\*Q6L4<,;:'ITI2-%13)-;1RRN0H +R2.\DC=7=F=B68D_DA_S=Y_G_H7*
M^[_^"G'[/UO\;_A]?7@$::CH,<NIVLS;0?+@0M=PE_+D?9)"K,(T,8>XBMB[
MA$-9_P#P2T^.D7Q@^'5E8RS^;J6A?\2^Y1O*5EA3)LF5(SN\K[/LA6614:26
MWGSO9&D;H/V5_P#B]OBWQ-\2+CYHA<2>'="9?FA.EZ?('FN8)TV1W45Y=%I0
MY20P-$T*7#IN5?O^BOP!_;Z_Y.%\!?\ < _]/-Q7[_5^ /\ P0Q_YF[_ +@_
M_M_7[_5^2&F^)/AO_P $Y+_5/#OA"TU37/%6L2+<?V)9^9>7"(D,\UM 65-L
M-O$N]CD7%^(9UGD2XBV,OPA^T?XB\4>*_CKX'O?%>EV^C7<EQH7V?3X;H7CP
MVZZM*H^T7" 1/*\HFD'D@(L#PHW[U9*_:_\ ;F^*%Q\'/AOX@UBS\P7*6?V>
M%XIF@DADO9$LTG21065X6G$R[<$F,*'0G>OA_P#P2?\ "UGX?^%&EW-M'LEU
M"XO[FZ;<S>9,MU+:A\,2%Q%;PIM0*OR;L;V9F\?_ ."U?_)/--_[&"V_](KZ
MOK#X>^-;CX:_!/3]<LUC>YTWP7;WD*2AC&TEOI:RH'"LK%"R@,%921G# \C\
MH/\ @EUI/Q+A\*ZC>>!8O"8MI=4>*YFU=+X7CR16\#*@>T&UK=%EW1*Y)622
M<@ /S]0?M0?LO_&S]K/1H-#UR?P7!;07B7B/9OJB2&1(I8@"98IEV;9F) 4'
M(7Y@ 0?O_P#9%^%6L_!#P1I/AS7[J.\U&PCFB>:*66:/R_/E:W1'F2-]D<+1
M1*I50@0(HV*M?1]?SX_\%$-)M]?^/O@BSO(HY[:>/0HIH945XY(WUBY5T=&!
M5D92596!# D$$&OZ#J_G1^ OAA_V?/VG[SP]I4L<=C>R7XDBBMXXHUM;JQ.J
MQVJ)\PC2"00(K1%"PA'"([15V'_!<[_F4?\ N,?^V%?O]7X _P#!4K7]1\6_
M%/P1X8MK?3Y_*^R3VL=]&[V\UQJ&H" Q7BJ3OM#]DA#HB!RCS#+[E"_?_P#Q
MD+_U3_\ \K-?,'[-/[!7Q#^%_P 4&\?ZUJ&CK;WMQJ4^I6VG7-Z/-^W),_E+
M'+;HKQ+</%($ED;;Y2OEI$4GC_V5O&MQ\8?VD/%EYJZQS2:39ZG9Z>"&=;6.
MSOK>R0P"1G,+O&TK2F,H&>XN"%59F6OV>\?^ -+^*>EW.BZU;1WFG7D9CG@D
M!VLN00000RNK /'(A5XW59$9756'/_"'X+^'_@+I:Z-X:L8["Q61Y3&A=V>2
M0_,\DDC/+(^ JAI&8JBI&"$1%7\4?V!?^3A?'O\ W'__ $\V]?5__!87QK<>
M%?AD;.!8VCU75+.SG+ABRQH);T&,A@ _F6L:DL&&QG&W<59>?_9HTGXV:+X*
MT"+P]%X#ATEM+LY;1)DU1)S'-"LH>X$($1N)"YDN&3AYFD?)W9/B'[17[!7Q
MD_:4\0V?B?4-0\+V&I6%O#!;2:=<ZG!Y?D32SQRJSV\LBRJ\I(=77&U2 &!)
M_0_]M+X!> _BUI=KK7CZ:2UT[P](]T9TG:%3%(4$MM(%#,Z3LD2!80MTSA(X
M)$>0J_R?\;?VP]<_:(\)>)8O _AJXE\-_P!CZBMQXDU-S9VS0I'=+<-96VTR
MW>^*!XX65D:&YDC%U!"B,'/^"*G_ "3S4O\ L8+G_P!(K&O /V^O^3A? 7_<
M _\ 3S<5^_U?SP_M%:_XA^(G[2]GI^BV^CRZEI%O#!IHU2.9K,[-/EU+S;@1
M%I#+&]Q*UN\039)';M@,C.WZ/_\ &0O_ %3_ /\ *S7S_P#\$\/V"O&7[(WB
M&_U#6M0T^;3;S3V@:VLKFY?=<+-$\,LD<MO#&?+03JKY+IYK*HVNYKS#_@E+
MXG3XZ^-?'?CB]BD&HW,EJ(#)<23-;VM[-<R&U#':KI&MK:Q1L4!1(%6,1H60
M_J=^UC_R3SQ7_P!B_JW_ *135\ ?\$5/^2>:E_V,%S_Z16-?K_17X _\$,?^
M9N_[@_\ [?U[_P#\%J_^2>:;_P!C!;?^D5]7WA^QWI-OHOPY\*Q6L4<,;:'I
MTI2-%13)-;1RRN0H +R2.\DC=7=F=B68D_DA_P W>?Y_Z%ROO_\ X*C_ /)(
M?$/_ '#O_3E:4?\ !+C_ ))#X>_[B/\ Z<KNO@#_ (+G?\RC_P!QC_VPK]OO
MBQX%_P"%H>'M5T'SOL_]IZ?=V7G[/,\K[3"\/F;-R;]N_=MW+NQC<,Y'\X/[
M-?[:OBW_ ()XR_\ "$^,]#N&TU;B2812M)'=P+)*L<DEFSLUM/:9BN'C2()%
M/<.\@NPI8G]S_P!FWQ_X*^.-Q>^-?"ES')=ZM9Z='J=L#"EQ UJUT(#=PH#*
MEP1))"9)&=)8;>'R&:% [_EA^WU_R<+X"_[@'_IYN*_?ZBOR _X+5_\ )/--
M_P"Q@MO_ $BOJ^__ -D[_DGGA3_L7])_](H:_&'_ (+$>'(OA-XM\+^-M&/V
M;6I_-9Y5CB*F;2Y+:2UG93&?,E'G!&,QD5HH8(]H5"&^S_\ @L+XUN/"OPR-
MG L;1ZKJEG9SEPQ98T$MZ#&0P ?S+6-26##8SC;N*LO/_LT:3\;-%\%:!%X>
MB\!PZ2VEV<MHDR:HDYCFA64/<"$"(W$A<R7#)P\S2/D[LGQ#]HK]@KXR?M*>
M(;/Q/J&H>%[#4K"WA@MI-.N=3@\OR)I9XY59[>6195>4D.KKC:I # D_N]7E
M_P ;_&MQ\-?"NMZY9K&]SINEWUY"DH8QM);V\DJ!PK*Q0LH#!64D9PP/(_-#
M_@C-_P 3GP;K>KW/[[4KSQ!<?:KR3Y[B?;;6L@\Z9LR28>:9QO8X>61OO.Q/
MZ'_&_P#9N\)_M'V]O:^*M-COX[21I+<F26&2-G7:X66!XY0C +OCW;'*1LRE
MHT*_&'_!5#QU_P *9^%3Z9I4/V:+4;BTTB(6S_9EMK<(\S(B1K@Q-%;-:M"-
MB&*8@Y13&_TA^PMX*M_ 'PR\,6=JTCQR:7;WA,A4MYE^/MLH!55&Q9)W6,8R
M$"AF9@6/E_\ P4Z^%O\ PM#X7ZOY5O\ :+O3/*U*W_>>7Y7V9_\ 29>717VV
MCW7R-NW9^1#*(\>?_P#!(SXEZC\1/AJL&H/YO]D:A/IUM(6=G-ND4$\:NSLV
M?+^T&&,+L1((XHPHV$M\@?\ !#'_ )F[_N#_ /M_7O\ _P %J_\ DGFF_P#8
MP6W_ *17U?>'['>DV^B_#GPK%:Q1PQMH>G2E(T5%,DUM'+*Y"@ O)([R2-U=
MV9V)9B3^2'_-WG^?^A<K]?OVL?\ DGGBO_L7]6_](IJ_/'_@BAI-O#X%U6\6
M*,7,NN2Q23!%$CQQ6EJT:,^-S(C2RLBDD*9)" "[9[__ (*^_"^W\9_#>36&
M\M+G0[RVN(W,*O(\=Q(MG) LF0T2,TT4SXW!S;QJ4SM=/</^";WBF\\8?"CP
MY<WTGFRI;SVRMM5<0VEU/:P)A H^2**--Q&YMNYBSEF/YP?\$,?^9N_[@_\
M[?UV'_!<'QK<6&C>&]#58S;7EY>7DCD-Y@DLHHXHPIW;0A6\E+@J22L>&4!@
MWU_I.D_'W0+>*SLXOAW!;01I%##$FL)''&BA41$4!515 554 *    *^4(/V
M"OBGXE^*%E\2-7U#P_;7"ZA83WD>FW.H1YM[9(8)HHEDMRQ\VWC:-T>79)O=
M&(C8@>?_ /!<[_F4?^XQ_P"V%?O]7\T/_!.O7_B'\4/$/B_Q/X0M_"ZZE>W$
M,]_)JT=Z/*^W374YBLFMB\B1,Z$S)([;O*MSEF3(^_\ X]_!3XZ_M$^'+SPQ
MJLG@>&ROO)\V2V;5DF'DSQSKL:2.5!EHE#91LJ2!@X(Y#1O OBK_ ()]_ KQ
M+;:O>1W=]').-/>QO+@+:1ZC]FLT:&22&-XGAGEEN]D:J&<DB17D9U]O_P""
M3_A:S\/_  HTNYMH]DNH7%_<W3;F;S)ENI;4/AB0N(K>%-J!5^3=C>S,WC__
M  6K_P"2>:;_ -C!;?\ I%?5]_\ [)W_ "3SPI_V+^D_^D4-?0%?&'[?_P !
MD_:#^'VJ6"QR27UE&VHZ>(HY)9&NK5'81I%&ZF1YXS+;*"'"F82"-W1!7A__
M  24^,W_  LWX=1:9/+OO=!N)+)P]SYTS6[?OK60H?GBB"NUK IW)MM&", I
MCC_.#]NWQUJ.E_$"7XI^%H;>VM/#>L6>@/<AW1]0U2VAFN+I9HHUAE,4<0_L
M^X+OB>!8UBEDB9A#^Q_[0G[3#^&OAD/%OAZ.0ZCK-G9+H=L_E_:GNM4$8MEC
MAVSK/<1+*9S;()1*(73.S+CV_P" /P<L_P!G_P +Z9X8L6WQ:?;B-I<,OG3,
M3)/-M=Y"GFRO)+Y8=ECW[%.Q5 _&']@7_DX7Q[_W'_\ T\V]?K]^UC_R3SQ7
M_P!B_JW_ *135\ ?\$5/^2>:E_V,%S_Z16-'_!:O_DGFF_\ 8P6W_I%?5]X?
ML=Z3;Z+\.?"L5K%'#&VAZ=*4C144R36T<LKD* "\DCO)(W5W9G8EF)/Y(?\
M-WG^?^A<K[__ ."H_P#R2'Q#_P!P[_TY6E'_  2X_P"20^'O^XC_ .G*[KX
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MJQNR9VLZ++*J,02HDD (#MG^FZOG_P#:Q_Y)YXK_ .Q?U;_TBFKX _X(J?\
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M%U6\6*,7,NN2Q23!%$CQQ6EJT:,^-S(C2RLBDD*9)" "[9\/_P""YW_,H_\
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M^',<>F7,EJNI:I#8WAC(#2VLEM=220EL;E1VB02;2I=-T3$Q2.C>H?L)^+/
MW@;X5:5J&F7>GV.GPV\']KW,DRPJFJ.D277VN2<J5E:5E5/,(!B:W6'_ $<P
M"OS0_P""=_C_ $O6OC9XW\0Q7,:Z3-9Z[?)=RDPQBU?5+:83.90AC3RSO;S
MI09W!<''TA_P5_\ %-GXY^%FAZKI\GG65]K%A<VTNUDWPS:?>R1OM<*Z[E8'
M:P5AG! .17Z/?LG?\D\\*?\ 8OZ3_P"D4-?D#_S=Y_G_ *%ROW^K^7+QC>^)
M?^":GQ-UK1?"<,D]MK]FZ:3;(6D;;>%Q8210E[GSKBRN0]O&+E)'N428;(Q=
MAU_HM^ /P<L_V?\ POIGABQ;?%I]N(VEPR^=,Q,D\VUWD*>;*\DOEAV6/?L4
M[%4#V"BOY\?^"B&K6^@?'WP1>7DL<%M!'H4LTTKJD<<::Q<L[N[$*J*H+,S$
M!0"20!7[W?\ "4V9U'^RA)NO1;_:6B56;RX2_EH\K %(O,8.(5D*M/Y4YB#B
MWG,?X0_\$,?^9N_[@_\ [?U^SW[0OBF\\#>#?$&JZ?)Y-[8Z/J-S;2[5?9-#
M;221OM<,C;64':P93C!!&17Y(_\ !&'5O#^OV^O7EU+'/XUGO));J:=W>\DT
M]UA8.'D)W(UR96N&C)=I# 9R<VU>'_M<?%70_BS^T!X+GT"_M]1M[2XT"VFG
MMG$L(F_M1YRB2KF.3"31EFC9U5B8R1(CJOZW_M2>&[?]K?P'XI\,^'+N.XOK
M:3[*XCVLHU"R:WOOL9=WCB#L1'!(^\I;O(P?YX9(Q\ ?\$B/VL]&M_#Y\"ZW
MJ,=MJ-M>.VE1W'E0QS6]TZ8MX),KYMQ]IDE?RGS,XG01>8D;K#T'_!:_Q_I<
M7A72O#QN8_[6DU2*^6T!)D%K';W4+3, "$0R2*B;RID(DV!O*EV?9_[-M[X>
M^/?PLT_PQ!J5O<[O"]CIVIQV5U#)<6GVG3Q ZR*/,\F48D"B5.'1@5.UA7XH
M_L*?M07'[ 7B75O"?CN"\M+&>2)9X0C2M9WBLBBX""4(;>2!R\TMND\EPD=J
MT7F(%W?N]X__ &X_AS\/M+N=4D\1:7>+;1EQ;6-[;75U,V0%CAACE+,[,0,G
M:B EY'CB5W7O_P!F[4_$NN^$]-OO%XC36[N.2ZN88XFA6!;B5YH+8Q2*KH\$
M+Q02+)N</&P:25LRO[A7\\/_  4F\4V?@;XZ^#=5U"3R;*QM]%N;F7:S[(8=
M6NI)'VH&=MJJ3M4,QQ@ G K^AZOQ!_8TTV#]J7XT>)_BE!;?\26Q_P!$TR=C
M<+YMQY$=FD\68XE;=:122302_/;_ &R %&;;*OG_ /P7._YE'_N,?^V%?O\
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M.-+@Q/))&]T_[RZD1I<.4DG>6100H4,%"(H"+^./_!#'_F;O^X/_ .W]>_\
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MRK<:I;S1 &X,9#M&"XC8!P V5&UL?9__  6K_P"2>:;_ -C!;?\ I%?5]_\
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M:8N-/NK\7FG2:;9K8P#39(8(_LL;%H8?*DAFB1(BS^7Y2QG#E6+*L83Z_P#
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M"1GPU^(FHOJ$"ZAI'F[C);:=/$EN79V=G6.>"X\K.X*(X3' B(JI$F"6^O\
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MR0!;J9E9_*=992T5M]G6-Y':#R"[9^O_ (:?"K0_@WIR:5X>L+?3[)-I\J!
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M@WX>_&347U7Q#IMQJ%Z^X>;/JFIML5G:3RXE^U[(H@SN4AB"11[B$11Q7O\
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M]CS1K/7%N/#>J6US>?8Y$.EWUK)'(\3RQE1_:DZR(5BE#DM&4(CPL@=C'G_
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MV(^ /^"U?_)/--_[&"V_](KZOO\ _9._Y)YX4_[%_2?_ $BAK\@?V^O^3A?
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M"JL 1(_'S-GX0\1_LFZC9?&,?%C4M;MTT#3]/D807#.K6NVSDM9(@SMY,5H
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M1[J/6]6@DL9U>SMVNK>R43PEKLWH4VZ(4D^QEX9'?SKI;8J-\NWZO_X)<?\
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M; Y\[RL";[/)A'V>8NZXBA1_VNU;2;?7[>6SO(HY[:>-XIH945XY(W4JZ.C
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M94H.!7U?_P %J_\ DGFF_P#8P6W_ *17U??_ .R=_P D\\*?]B_I/_I%#7Y
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M-M'_ &M'JD5BMV 1(;62WNIFA8@@.@DC5TWAC&3)L*^;+O\ T/\ A/\ $O\
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MU%%?@#_P0Q_YF[_N#_\ M_7W_P#\%1_^20^(?^X=_P"G*TH_X)<?\DA\/?\
M<1_].5W7P!^WU_R<+X"_[@'_ *>;BOJ__@L+X*N/%7PR-Y T:QZ5JEG>3ARP
M9HW$MD!& I!?S+J-B&*C8KG=N"JW8?\ !,O]I?3OC3X&TW2'FMX]:T:W%C-9
MAT65[>S6*.&Z2$RO*8C$\"23,J(;H2JJJNP'ZO\ VA_C?;_L^^'YM9EMY+ZY
M,D5M8:?"RBXOKRX<1P6T .69V8[F$:RR+"DDBQ2%-A]PHK\ ?V!?^3A?'O\
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MW7_8P>)__16HU_3]6?I.DV^@6\5G9Q1P6T$:10PQ(J1QQHH5$1% 5450%55
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M@MO_ $BOJ^__ -D[_DGGA3_L7])_](H:_(']OK_DX7P%_P!P#_T\W%?O]7X
M_P#!#'_F;O\ N#_^W]?7_P#P4I^#FA_'^+P_X9D:X7Q9?7%XOA]H@#"HCB26
M^:\\QTC%H$2(R,F^\1@C6\%P!-;R>@>'- ^.&A>$CH;/X7EUJ*WCMK76FO\
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M\:_/I7AO[-_9F@#Y[-?M33%/.)QYV/LP>XW(/M<AC5]EI"MHV?\ \%N-)M]
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MW[4'A>RU>":W_M+[/'_:=G$Z;[6XR\;[H1++)%%*\4CVOFMOD@VL?FW =?\
M&+XWV_PEN-%L!;R7NHZ[JEO86MK"R^8(V8-=WCK\S_9[2$-+,Z(P4F)7:))#
M*F?\0[7PE\;=1NO 7B&SM[Z6/3X-2^SW*QG,-R]U:>=;'=YR2PF-U>>(1M!]
MHAV2AY,+^&/[<?[ %Q^R(@\??#V_O+2QMI"+I!=-'=6!N9##&UK<(8Y7MR)E
MMF1F>X0$,TDZ22M!^U_[%_QCO/C[\/\ 1/$6H+B]N;=X[ELJ?,FM9I+62;")
M&B><T)F\M5"Q[_+!8*&/Y0?\$,?^9N_[@_\ [?U]_P#_  5'_P"20^(?^X=_
MZ<K2C_@EQ_R2'P]_W$?_ $Y7='_!4?\ Y)#XA_[AW_IRM*/^"7'_ "2'P]_W
M$?\ TY7=?G!_P5V_M'X3?$/PEXXMOL\GDV\7V6*3>V;C2KTW9\Y5V?NF^U0@
M;) [8D'R85F_=[X5?$O3OC)H=AXATI]]EJ%ND\661F3</FBD\MG198FW13(&
M;RY4="<J:\P\7?&^XL/'FB^"=,MX[B2YL[O4]7E=F5K/3XE:"V>,':LCSWA2
M,[6D>)(W+0[9%FB_)#]OK_DX7P%_W /_ $\W%?I?_P %#_!5QX_^%?B6SM6C
M22.S6\)D+!?+L)HKV4 JK'>T<#K&,8+E0S*I+#XP_P""/O[2^G>(?"__  @]
M[-;V^I:9<2_88F=(WO+>Y,UVWE*TIDFEB<7!F\N-4C@,!.6+M7ZO?%7XEZ=\
M&]#O_$.JOLLM/MWGEPR*S[1\L4?F,B-+*VV*%"R^9*Z(#EA7X8_\%@XM4\>^
M%?!'BBXL)+&-XYQ>6\K#S+2ZO[>UN$M75Q'*746]PK-Y:A3$0XC9E4_M]\%/
MBA;_ !J\-:7XCM?+6/4K.&X,<<RSK#(ZCS8#(H4,\,F^&3Y5(=&#(C J/Q1_
M;Z_Y.%\!?]P#_P!/-Q7[_45^0'_!:O\ Y)YIO_8P6W_I%?5] ?\ !+C_ ))#
MX>_[B/\ Z<KNON_5M)M]?MY;.\BCGMIXWBFAE17CDC=2KHZ,"K(RDJRL"&!(
M((->/R?'G2[KQC'X(L9([G5H[.2_U!!(0+.U7RTCW81PUQ+)-"4MR8R+<R7#
MNO\ H\=U^./_ #=Y_G_H7*_7[]K'_DGGBO\ [%_5O_2*:O@#_@BI_P D\U+_
M +&"Y_\ 2*QKP#_@N=_S*/\ W&/_ &PK]_J_ ']@7_DX7Q[_ -Q__P!/-O7[
MO>+/%-GX&TZ[U74)/)LK&WFN;F7:S[(84,DC[4#.VU5)VJ&8XP 3@5^./_!$
M_P"%]QX>\-:UXCG\Q(]6O(;>"-X616CL%DS/'(3B5'DN9(3M7"/;N-[,66/R
M_P#YN\_S_P!"Y7Z?_M\?#34?B[\,]?TC2D\V]>WBGBB"NS2_9+B*[:*-8U=W
MED6%DA0+\\K(I*@EA\?_ /!&3XI?\)7X&O-!FN/,N-&U!_+@\O;Y-G>*)HOG
M"!7WW O6Y9Y%Q@[8_*%?J?\ $+QK;_#71M0UR\61[;3;.XO)DB"F1H[>)I7"
M!F52Y52%#,H)QE@.1^0/_!$_X7W'A[PUK7B.?S$CU:\AMX(WA9%:.P63,\<A
M.)4>2YDA.U<(]NXWLQ98S_@L+\"KB:PTWXD:.\D&HZ))#;W4T4C1R);O-NM)
MT?S5V/!<OM7R4,S&Z$A=4MQCK_@1\:_^'@OBCPOJ21[+#PGI[:CK4++_ *.^
MN78>UMH4MI)&QY'DSWUE>*URT:.(F^SW#-7Z_P!?S(_\$V/C%;_LB?$'7O!G
MB6XL[>VNI)K.XOVD6.WBO-*><(3/.\*I;R*;A 60R/,ULH6,%Z_INK\P/VF_
M'7_#7'PC\;2:-#Y%E87$Z6MW,^8=0M]'EM[NYNK9XE='BD:&Y@MF1I$D:)2[
MQ%I$A\@_X(^_M+Z=XA\+_P#"#WLUO;ZEIEQ+]AB9TC>\M[DS7;>4K2F2:6)Q
M<&;RXU2. P$Y8NU?J]\5?B7IWP;T._\ $.JOLLM/MWGEPR*S[1\L4?F,B-+*
MVV*%"R^9*Z(#EA6A\/?$EQXQT;3]3O+22PN;RSM[B:REW>9;231+(\#[DC;?
M&S&-MR(<J<HIX'85\8>//@O\/OVZK"[;4K&.>YL;R^TM[N,I'J%I<6,T]N5\
MV)F8(&9KJ"WGWPNDL,\EN2P4?AC\6? 'BC_@E)XYLK_1[^XN/#U]<"XAC6X$
M7VZWMF FLKZ(*T9EC2X*)<>4R#SEN81','BA_9[_ (*C_P#)(?$/_<._].5I
M1_P2X_Y)#X>_[B/_ *<KNO@#]OK_ ).%\!?]P#_T\W%?H?\ \%%/VF-4_9:\
M%'5-%CC.HWMY'I\$TF&6V:6&:4W C*E97582(T?"!V5W$B(T,G'_ /!/S]E'
M0_AYX>T_QA=C^U?$VNV\.JW&JW:"2XB:]A,AC@=R[Q_+.ZSRAO-NG9WD;88X
M8OB#]@7_ ).%\>_]Q_\ ]/-O7O\ _P %J_\ DGFF_P#8P6W_ *17U??_ .R=
M_P D\\*?]B_I/_I%#7Y _M]?\G"^ O\ N ?^GFXK]_J*_(#_ (+5_P#)/--_
M[&"V_P#2*^K[_P#V3O\ DGGA3_L7])_](H:_+'_@JUX83XZ^-? G@>RED&HW
M,ET9Q';R3-;VM[-;1BZ*C:KI&MK=2R*'!1(&:0QH5<_9_P#P5'_Y)#XA_P"X
M=_Z<K2C_ ()<?\DA\/?]Q'_TY7=>?_\ !7/X::C\1/AJT^GIYO\ 9&H0:C<Q
MA79S;I%/!(R*BMGR_M FD+;$2".60L-@#>@?\$Q?BE_PM#X7Z1YMQ]HN],\W
M3;C]WY?E?9G_ -&BX1%?;:/:_.N[=GYW,HDQZA^W3XUM_ 'PR\3WETLCQR:7
M<68$84MYE^/L41(9E&Q9)T:0YR$#%59@%/S_ /\ !)GX7W'PX^&5M<77F+)K
M-Y<:D(I(6B:*-Q';Q8W$F1)8[=+B.3"ADF7:&4!W^4/^"MWP1O/ VHZ1\5_#
MJ^3>V-Q;Q7TL<2OLFA<26%XZ^2R-M9?L\LER[*<6,"H1D5]7_!WQK;_MA?$B
MW\86"R2>'/#6AQQV32A5*:QK$:37/ER6[21RO#9%+6]@EE;[+<$!8<L)C^E]
M?@#^P+_R<+X]_P"X_P#^GFWKZ?\ ^"R7A:\\0?#6*YMH]\6GZQ:7-TVY5\N%
MHKBU#X8@MF6XA3:@9OGW8V*S+](?\$]_BA;_ !5^&6@7$'EI)96<>FSQ),LK
M1R6 %N/,P%,;RQI'<"-AE$F3EU*NWYH?\%SO^91_[C'_ +85^E__  4/\%7'
MC_X5^);.U:-)([-;PF0L%\NPFBO90"JL=[1P.L8Q@N5#,JDL/C#_ ((^_M+Z
M=XA\+_\ "#WLUO;ZEIEQ+]AB9TC>\M[DS7;>4K2F2:6)Q<&;RXU2. P$Y8NU
M?J]\5?B7IWP;T._\0ZJ^RRT^W>>7#(K/M'RQ1^8R(TLK;8H4++YDKH@.6%:'
MP]\27'C'1M/U.\M)+"YO+.WN)K*7=YEM)-$LCP/N2-M\;,8VW(ARIRBG@=A7
MX _\W>?Y_P"A<K]_J_ '_@AC_P S=_W!_P#V_KW_ /X+5_\ )/--_P"Q@MO_
M $BOJ^L/A[X*N/B5\$]/T.S:-+G4O!=O9PO*6$:R7&EK$A<JK,$#,"Q56(&<
M*3P?RP_X(U_M+Z=X4_M'P/JLUO:?:[A+[3I972+SKB7R;26UW22C?*^+<VT,
M49=L7!+'"+7]!VK:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22
M *\O^ GQ9_X7IX<L_$BV5QI\5_YTEO;W(Q-]G6>1+>9Q@ >?$L=PH4N@64!)
M)4VR/[!11111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111117
MYP?MF_\ !/BS_:/O(?$V@7G]A^++3#I>QJP6Y:%<VWG-$RR12QNL8CO(]\L4
M0*F*8) (=#2?"/Q_UJWBTS4=:\)Z='Y:)+J]E:7=WJ :-0?,6VN%AL7>5E"R
MC;&B)([Q(K*BCZ _9G_95\-?LH:7)IGAZ*0M/)YEU>7#*]U<,"WEB61$C79&
MK%8HT5$0%GVF625Y/B_]J7_@G/XA_:YU&UU#7O%MO#]CMS!!;6FC3);KN=G>
M41S:K-B63*+(ZD;TBB4CY :^W_@7\/?%OPVLX-.\0>(+?7K>VM_*2X;39+:^
MD8,-CSW!OIXY=J9C)\E99#MD>9I!(TOT!17X@_";_@FQ\1?V=O%%[-X*\76^
MEZ!>91II(/M=X85!>$364L(LY98Y"8A.LL;"-I)$6/S7MC]G_'W]CS5/BYX3
MA\#Z9K\>FZ((X/MCS::+V_O9XI3/)-<77VJW0O/-LN;AU@6:6Y$DC3%9GC/8
M?LA_LY:Y^R]H\?AVYUVWU?2+?SVM8_[,-I<0M-()2OGK>2H\6YIGVO$9=\O^
MO$:+%7R_\9_^"=OBCXX>+;3QI?>,K>WU33_LOV$6V@!8;;[)(9HMB2ZA*7_>
ML\K><TN6<K_J@D:_I?IF@7&IZ6;#Q"UGJ,DT<L5WY=HT-K/'(64H;::>Z.PQ
MD)(KRR"0[CA5;8OX@_%#_@D)KWA/Q!_;7PQUV/3(S),\4=Q/=6UQ8JZ!?+@O
M+=9I9D8/,F7$3I#LC=[AF>2OJ_\ 9B_8%U;PEJ-IXC^).O7'BC5]/WMIMM/<
M7%U9Z?,S_-/$]TV^64JD+(3%"L,@+;99(X)HOT_HK^8'X)?"S6/B?\</&Y\.
M:E_9.OZ;<>(;W2[MHHYH1<?VB+4QSQRQR@Q217,T995+Q,RS*LGE^4_Z?_$#
M]G+XM?M/P#0?'.L>'],\-R;&O8-!M[B:XO/+N()DB9[]3]GV^4S)-$QVN0)(
M+A#A/O\ \+?#RS^&6AQZ'X9AM].M[2W:*R0Q-+#$V"5>1!)')-ESYDQ,J2SL
M79IA(YDK\X/^'=OBC_A8'_"R?^$RM_[=^T>=C^P!]GV>3]F^S^7_ &AN\K[/
M_H^=_G[/G\[S_P![7ZGZ3'<0V\2WDD<MR(T$TD4;11O(%&]DC:25HT+9*HTD
MA4$*9'(W'XP_;-_87T/]L.SA:>3^SM:M,+;:G'")6$.[<\$T>^/SHCEFC!=&
MAE)=&"O-'-^<'PM_X)H?&3PE]GTO_A.?[(T6+S/DTW4M3?R=V^3]U:[;2([Y
M3E_WD>-[R?.PVM^SWP+^!>A_LZ:'!X?\/P>3:0_,[MAIKB9@ \\[@#?*^!DX
M"JH6-%2)(XU]@HK\@/VU_P#@E99_'W49O$?A2YM]*U>X^:[MID86=W,SKNG+
MQ!GMY2ID:4I%*MQ($8K%(TTTF!\-/^"8WB;QSL_X6QXMU#6[*"X6:+28-0O)
M[=V3;MDEGN]KKN5IX72&*.4(X=+M"62OU>^)>BZYX@TY[;P]J-OI5[)N7[7/
M9&^\M61EW11?:+=!*K%'1I3+%\I5X) WR_ '[('_  3^US]CO4;BYTOQ1;W=
ME?\ V=;ZTGT8CS%@<LK12KJ&^*4*\J(Q$D0\TL\$I5-OZ'^/_ &E_%/2[G1=
M:MH[S3KR,QSP2 [67(((((975@'CD0J\;JLB,KJK#\(=6_X)'>.OA9K,MY\/
M/%,=I;2QN@FEN;O3[Q8VE+"W=[**59D"I"S29A$D@)^SQA%S^A_[*/[$DOP<
MO!XF\7ZO<>)O%GV=((KV[DEF6PA*DRP6C7#O(<N\H-PWELT3;5A@$EP)O#_V
MX/\ @F[>_'7Q!!XS\&:A'IGB'S(3=FXGGCC9K=%6WNH)84EE@N(Q'&FU%".%
M20&*6-S<:'CO]@OQ;\??!=[:>._$?]I^+'\M].=&DATBQ:WD<QXM;=+:.:6=
M))(I[R:W>6&.54BB809GZ#]CS]BKQ;\%].MHO$VN6]U+HGVS_A'+*V61].LI
MKQ)!+>7*A;*:]E)GFC2*5@L$,DPCE#S@V_/_ /#NWQ1_PL#_ (63_P )E;_V
M[]H\[']@#[/L\G[-]G\O^T-WE?9_]'SO\_9\_G>?^]K]3])CN(;>);R2.6Y$
M:":2*-HHWD"C>R1M)*T:%LE4:20J"%,CD;C^./[0O_!-'Q#+XY3QW\,M6M])
MOYKB6\N5NYIE\J\D8F22!TAN/,BN-\GGV\R^6,N@WV\P@AW_ -H+_@G%XA^/
MWA*V.KZ__:7CF*X2XDO+N2:/341XUBFLK2U@40VT6$BE-PEJ9[F:'=((UFVP
M?0'[-'[+?BWX3Z/#/K6NV]YXFM-/32M-=H))]+TW38Y(CY$5K$^GO<2S+!$9
MKJ5DFS'!'ED@8W'C_P &/^"=OBCX'^+;OQI8^,K>XU34/M7VX7.@!H;G[7()
MI=Z1:A$4_>JDJ^2T6&0+_JB\;?4'[7G[.6N?M0Z/)X=MM=M](TBX\AKJ/^S#
M=W$S0R&4+Y[7D2)%N6%]J1"7?%_KS&[14?LA_LY:Y^R]H\?AVYUVWU?2+?SV
MM8_[,-I<0M-()2OGK>2H\6YIGVO$9=\O^O$:+%7A_P"W'_P3BTO]JUQK6F3Q
MZ7XCCC*O.8RT%\J1D0QW04AE=6"(MTHD=(<QM%.$@6+Y@^%__!+KQUK]O_8W
MCWQI>-X<CCAB32M-O[N>.2.)3Y:8O$2"!(72!HU$%P&"E0(2J/7[7>$_"UGX
M&TZTTK3X_)LK&WAMK:+<S[(84$<:;G+.VU5 W,68XR23DU^,/[2G_!(V76]<
M_P"$C^'&H6^C7#7$<_V&4RP0VTREG:>SN+=9)(<.(VCMQ$%B8NT<T<:Q0+W_
M ,"_^"<WB;4+R"\^+'B:X\26EE<>?;Z*UY>7EB\R*!#/.UV4W[=\RFW$(5QM
MWS/$\UN_Z/\ Q^\'ZYX_\+ZGI?AK4?[)U>YMREK>X)\ML@D;ER\7F*&B\^,&
M6WW^?&K21J"? 'P?KG@#POIFE^)=1_M;5[:W"75[@CS&R2!N;#R^6I6+SY )
M;C9Y\BK)(P'L%>?^.M-\0ZAY/]@WVGV6W?Y_VW3IK[?G;L\OR;^R\O;AMV[S
M=^Y<;-IW_E#X:_X)5^(_!_BA_&ECX[\K7WN+JY:[_L&!LS78D6=_*>[:'YQ+
M(-H3:N[Y0N%Q^MW@JRUFPMV77+NSO+DR$I)9V<ME&(]JX4QRW=XS.&W$N)%!
M!5?+!4LW85\0?MF_L+Z'^V'9PM/)_9VM6F%MM3CA$K"'=N>":/?'YT1RS1@N
MC0RDNC!7FCF\O\ > OVA/#FEVVAW>L>$Y(XXQ;OJ\BZA=:DD9)7SPKQPV]Q<
M1(08_/4"9D7SW=FDD;Z _9Q_9$T;]GJXU#6!+)J7B/6)&FU/5KA(DDEDE82S
MI!%$JI;6[S;IO)3<<E%>640P[/F_]K__ ()_:Y^V)J-O<ZIXHM[2RL/M"V-I
M!HQ/EK.X9FEE;4-\LI5(D=@(XCY09((BS[ON_P %:#XET71FM-5U6SU#5EC*
M0WZZ:UM&6$2JDEQ:K>.)'\P-)*(9+5'#>6B08W'\\/\ AW;XH_X6!_PLG_A,
MK?\ MW[1YV/[ 'V?9Y/V;[/Y?]H;O*^S_P"CYW^?L^?SO/\ WM?J?I,=Q#;Q
M+>21RW(C03211M%&\@4;V2-I)6C0MDJC22%00ID<C<?R@\:_\$Z]9^%WC%?'
M'PCU*ST>YDD'VG2+Q)5T]XWW-<1AH!(WV>1EBQ:>6!$^Z6"X@,5O'%ZAXI_9
MR^)7[3=G)HGQ%UC1]/T!]OGV?ARWE::^VL)8_-NM260VWD2Q0NGD(_G*TL<F
MWY&'W?X \ :7\+-+MM%T6VCL].LXQ'!!&#M5<DDDDEF=F)>21RSR.S2.S.S,
M>/\ C]\'+/\ : \+ZGX8OFV1:A;F-9<,WDS*1)!-M1XR_E2I'+Y9=5DV;&.Q
MF!Y#]DS]GZW_ &9?!VG>'(A&;F*/S;^:/:1/>2X:=]XCB:1 W[J!I%$@MXX4
M8DI7E_[=O[('_#86AV.FP7%O8WMEJ$4Z7<MOYK+;N#%=1(P*NNY668("$FEM
MX8W,8(FB^S])TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4    5\
M(?MF_L<:Y^V#%#ILWB*WTW1;:X%S#:QZ29IFF$7E!YKEKY-^W?-Y:Q1P*%E*
MR"5D20>__LX?"S7/@MH=MH&KZO;ZO;V%O#;64T>GFRF2&$,JI,1=3QR[4\J.
M-D2%@L9,AFD<N/B#XS_\$[?%'QP\6VGC2^\96]OJFG_9?L(MM "PVWV20S1;
M$EU"4O\ O6>5O.:7+.5_U02-?O\ \1^'/%NJZ&+.TUC3[/6F\Q9=1729)(55
MA(%:"SDOSLE3,;!IIKF(LC;H"L@1/B#]D#_@G]KG['>HW%SI?BBWN[*_^SK?
M6D^C$>8L#EE:*5=0WQ2A7E1&(DB'FEG@E*IMY_\ ;-_9:\+_ +:7BV'1K2ZN
M+?Q-ING@W]]"#-:65FTGF6T-W%MV/=S-)*UK;K-:2&W:XNY9)$AMH)_F#_AQ
MC_U-W_E'_P#N^N/\>?L<>-?^":M@_CSPIXHCN[2RD@?4[*6":UCN5:9+:"-[
M=)IXKI";F3<9'@>W!,D#^<0R?T75S_BSPM9^.=.N]*U"/SK*^MYK:YBW,F^&
M9#'(FY"KKN5B-RE6&<@@X-?BC\.?^";GQ-_9Q\2WD_@#Q79Z?HEY)'&\EPAG
MNC:A@V9;-[62TEN(<NL4@>(R MAK99Y(UZ#]HO\ X)?:]J_B72?%'@/5XTU&
MRCM7N;G6[JZNKJ6^LF4P7K321W:RNRJBO#Y<-O&($"1E)"D?V?XD_93UR\\)
M7OAK3_$GEW>N?:7\0:M>:>;RYO9KF.*&4V\?VN"WLHO)C^RQP)'*L-L(EB:.
M6(SOS_[&7['&N?L?13:;#XBM]2T6YN#<S6LFDF&99C%Y1>&Y6^?9NV0^8LL<
MZE8@L8B9WD/G_P"U_P#\$_M<_;$U&WN=4\46]I96'VA;&T@T8GRUG<,S2RMJ
M&^64JD2.P$<1\H,D$19]WW_\--%USP_IR6WB'4;?5;V/:OVN"R-CYBJBKNEB
M^T7"&5F#N[1&*+Y@J01A?F\ _;\_L?\ X5?XF_MS_CT_L]_+_P!9_P ?F]?L
M'^J^;_C[^S]?W?\ SU_=;ZT/V(_@,_[./@/2M"NHXTU'RVN=0*1QHQNKAC(Z
M2-&\BRO"I2U$V]A(D"%=J;47ZOHKY _;?_9:_P"&N/"3Z%%=?8[VWN$O;*1A
MF$W$4<L:QS@*S^4ZRNI:/YXV*RA90AAD\/\ V3/V1_'GPYM].L_'/B:/4=)T
M:3=I^BVT2RVY:)1]EDN+N>".XE2W=G>WM2I2":&SFCE7[/'$G'_&?_@G;XH^
M.'BVT\:7WC*WM]4T_P"R_81;: %AMOLDAFBV)+J$I?\ >L\K><TN6<K_ *H)
M&OZ?^%K;4;2SC359[>YO1N\V:VMWM86RQ*[(9)[ETPNU6S*^Y@6&T,$7\L/V
MX/\ @F[>_'7Q!!XS\&:A'IGB'S(3=FXGGCC9K=%6WNH)84EE@N(Q'&FU%".%
M20&*6-S<:'CO]@OQ;\??!=[:>._$?]I^+'\M].=&DATBQ:WD<QXM;=+:.:6=
M))(I[R:W>6&.54BB809G[#]B;]B_Q+\$+>Q3QEK$=_'H<ET="TZQ9EL[5KM9
M!<74SF&WEN;AA//%$LX=+:.68H6:8"#C_P!M3_@FS+\>=<'C3PGJ?]D^)!Y#
M2>:THAFFMS$D$Z3Q%I;26*), Q)(LC1PX6%_-F?/MOV)_B;\3_"M[H7Q!\71
MZG&MG/%IVG6X*6\ETEOLL+G4-06WAO+A(ICYTD#I*))HH+B229E:(^H?L0?L
M"R_LI1)<WVO:A>W;;Y'L+>XE@TB.:6**-W-L&_TJ5-CHEQ,%5HS&WV6.6*-U
M] _;-_87T/\ ;#LX6GD_L[6K3"VVIQPB5A#NW/!-'OC\Z(Y9HP71H9271@KS
M1S?G!\+?^":'QD\)?9]+_P"$Y_LC18O,^33=2U-_)W;Y/W5KMM(COE.7_>1X
MWO)\[#:WZ_?#?]GK3O@7X2?PMX/?^RV^SS+#?-$EQ-]LDCVB^G5@J7$H8(Y1
MML95%A58X51$_.']G7PY\3OV5_'?A[0/&'B3^W;?Q7_:T<EO)<75ZMLNF6B7
M,4T,]UY<D<KO(\<D:IY1B +&60Q&W_9ZBOPQU;_@F)XU^"?C&7Q#\)-=L]*M
M)(W$<5[+,9(5ESYEJR_9KJ*ZMP0CQ-."ZD)N#30+<R=A^UK_ ,$N=6^-EGI=
MYINM_;?$D'G)JE_J\UP%O%E8S#R(XO/BLHH)6D6WL[>%8A%,=TI>+=+^A_[.
MOP9U3X;6\VI>)M4DUGQ1J<=L-3O3A+=5ME<06MI BQQ16\)EE8,L://-+-<2
M!3((H_H^OB#]IW]FGQ;^TSH]WX=G\2:?I^D75PDC1P:'(]PT,4GFPPRSRZFR
M-M98W>2**!G>,8"1L\3>?_LM?L7^+?V2=.NM*T3Q5I]S975P+DQ7N@2/Y<Q1
M8W>-H=5@?YU2,,KEU'EJ4"%I"_Z'ZMI-OK]O+9WD4<]M/&\4T,J*\<D;J5='
M1@59&4E65@0P)!!!K\<?^'0O_"$^*/\ A)/!?BJXT'R+CS[&'[#]K>UR,-%Y
MS74?G1'+ILF1M\#>3,9\N\GZ767PFN/&?AJ;PYX[N+/Q#'<1B&>1+%K)9HPJ
M8>2,7,X6X\Q3,)K=H!&Y0Q10M&K'\8=6_P""1WCKX6:S+>?#SQ3':6TL;H)I
M;F[T^\6-I2PMW>RBE69 J0LTF81)("?L\81<_H?^RC^Q)+\'+P>)O%^KW'B;
MQ9]G2"*]NY)9EL(2I,L%HUP[R'+O*#<-Y;-$VU88!)<";G_VEOV.?%'Q4\<V
M_CSPQKUOHNI:5HZVFG>9:"Z\RX+7WFB;S,QPQ%+E(Q(([E_FD81*T2>9G^//
MV?\ XK_M-V#^&O'6I>&]-\/3R02W9T*"\EO+E8)DD%L&OCY4",5\SST#NDD<
M:F.2)I4/Z'^$_"UGX&TZTTK3X_)LK&WAMK:+<S[(84$<:;G+.VU5 W,68XR2
M3DU^,/PF_P"";'Q%_9V\47LW@KQ=;Z7H%YE&FD@^UWAA4%X1-92PBSEECD)B
M$ZRQL(VDD18_->V/V?\ 'W]CS5/BYX3A\#Z9K\>FZ((X/MCS::+V_O9XI3/)
M-<77VJW0O/-LN;AU@6:6Y$DC3%9GC/8?LA_LY:Y^R]H\?AVYUVWU?2+?SVM8
M_P"S#:7$+32"4KYZWDJ/%N:9]KQ&7?+_ *\1HL5'[7G[.6N?M0Z/)X=MM=M]
M(TBX\AKJ/^S#=W$S0R&4+Y[7D2)%N6%]J1"7?%_KS&[14?LA_LY:Y^R]H\?A
MVYUVWU?2+?SVM8_[,-I<0M-()2OGK>2H\6YIGVO$9=\O^O$:+%7K_P =/@7H
M?[1>AS^'_$$'G6DWS(ZX6:WF4$)/ Y!V2IDX."K*6C=7B>2-OQ1\,?\ !)_X
ME_"K5)8?"_C*.PTFXDMQ<75M<7UE=21H/F9[2WW12/$7E\E&N<.#DR0^8P7]
M7_V5OV2-+_9:M[Y[>[O-3U;5Y(I]5U&\D+27,Z*Q+!.0B&22:4;C+,3,PDN)
MMJ%?E_\ ;Y_8&UG]I76=+\5>%=4CT_6]/CCMR+B26&-8X99+B&>":WCDFCN(
MY9&[$,"C*\31$3?6'[/7P;\1^"M^J^-=<_X2#7YK>*!95M8+:WLH>))H+58H
MT+>;+@SW#"-KI(+,/"GV9!7YP?M*?\$C9=;US_A(_AQJ%OHUPUQ'/]AE,L$-
MM,I9VGL[BW622'#B-H[<1!8F+M'-'&L4"]_\"_\ @G-XFU"\@O/BQXFN/$EI
M97'GV^BM>7EY8O,B@0SSM=E-^W?,IMQ"%<;=\SQ/-;O^E_QH^$.E_'KP_?>&
MM961K&_C"2&)S'(C(ZR1R(W(#QR(DBA@R,5"NCH61OR!^$__  3N^+W[..J/
M!X.\9V=KHDTB>:TD<C,5D$/GS#3)H;FT^T+Y82-Q,KR(BJ9H5D=5[#Q__P $
MJ-1^('C*P\0S^);A?+M[>?4]4!?^U+O5([EG>2W0;;>PB6$QQ69B9Q9B"%!;
MRX:5OUN\ >#4^'VEVVEQW-Y>+;1A#<WUS)=74S9):2::0EF=F).!M1 0D:1Q
M*B+V%?FA^U!^Q'XQ_:SMX+#7/&%G!IT$B3)9V?A_9&;A%E03EY=2FGW[)F0J
M)1#@*?+#@L>?^$/["?Q#^!&EKHOA[XD26NG)(\D<#^'[6X6-I#EQ&;FYE:-"
MV7,:%4WL\FW?([-ZA_PSQ\7O^BG_ /EK:;_\<K0_9)_8NN/V5+?7IUUV35M;
MUV199+Z[MF\M9(EE,;RP_:&FG<RSRR3L;A#,"J@Q,&D?P_\ X=V^*/\ A8'_
M  LG_A,K?^W?M'G8_L ?9]GD_9OL_E_VAN\K[/\ Z/G?Y^SY_.\_][7VA\>?
MA/XE^,?AJ3P]::U9Z8U]9R6NIW0TIKAIEE5$E^RQO?*MLCKYR,LANG5)1LE2
M6,2MX?\ L9?L<:Y^Q]%-IL/B*WU+1;FX-S-:R:289EF,7E%X;E;Y]F[9#YBR
MQSJ5B"QB)G>0^?\ [7__  3^US]L34;>YU3Q1;VEE8?:%L;2#1B?+6=PS-+*
MVH;Y92J1([ 1Q'R@R01%GW??_P --%USP_IR6WB'4;?5;V/:OVN"R-CYBJBK
MNEB^T7"&5F#N[1&*+Y@J01A?F_G!^"7PLUCXG_'#QN?#FI?V3K^FW'B&]TN[
M:*.:$7']HBU,<\<L<H,4D5S-&652\3,LRK)Y?E/^G_Q _9R^+7[3\ T'QSK'
MA_3/#<FQKV#0;>XFN+SR[B"9(F>_4_9]OE,R31,=KD"2"X0X3[_\+?#RS^&6
MAQZ'X9AM].M[2W:*R0Q-+#$V"5>1!)')-ESYDQ,J2SL79IA(YDK\X/\ AW;X
MH_X6!_PLG_A,K?\ MW[1YV/[ 'V?9Y/V;[/Y?]H;O*^S_P"CYW^?L^?SO/\
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MQ;:>-+[QE;V^J:?]E^PBVT +#;?9)#-%L274)2_[UGE;SFERSE?]4$C7]/\
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M=I);KNG2X<-MA>)?FE60J8QRP H\%?$+1OB5;M>:'J%GJ5LDAB>:SN(KB-9
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M4DB+J3N42)(A(&Y&7*G\4/A;X _X5?\ M2V^D?;]0U/[/YG^F:E<?:;R7S-
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M0*V0'C1\;E4C/_X(J?\ )/-2_P"Q@N?_ $BL:_7^OG_]K'_DGGBO_L7]6_\
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M\*>#+SQ;X<@CT.YL8[:WN[;3XEM[74+6:]@"Q7$,7EIOCF:.=)<,6,01U<K
M]O\ 5_\ P2X_Y)#X>_[B/_IRNZ^(+'XY^'OVR?B5J(\<:OH]IX)\*7#KI6FS
MZE#';ZI>"5XHKZ3S-L=[%LCED*!A'$DMO"%FBFNVN.?_ ."@O@SX2IX<_P"$
MG\!:GX?T_P 3:3<64MNNBWENDTR+.4*Q06EPB)+&TRW/VI8GG5;8)N"89/J_
M]F:;1/\ @I?\/K"Z\>6DE_=Z3>3VMR%GN+.WENHT1EN1%:7$:.Y@FCRSJHCF
M>Y6&.*%\-^:'_!*3]ESPA^TI_P )'_PE>G_;_L']F_9O])N8/+\_[7YO_'O+
M%NW>5']_=C;QC)S^K_\ P4%\&^(?#?PJ_P"$;\ :?<3Q#[%ITUO:^=+<Q:7&
MA0K"%D\Z7)2"WF!$Y>VEG,BE-\B'A/\ 8-\ V7PUM-(\3Z+I^GW2:/"VJZCB
M!;RUN5B$UU/_ &B=Y7RI=[Y,CVPC7RBK6O[L_*'_  1&\?ZIKNE^(=%NKF27
M3M-DL)+*!R"L#79NS.(R1N5':)',>=@??(JAY96?Y_\ ^"S7PT?P?JFC:I)J
MNJ7[:I)J;BVO)XWM;)819A8[*&.*)84*N!(3O>4QH\CO+O=_Z3J_ '_F[S_/
M_0N5^UWQ>^&C_%K2VTM-5U31U>1'>YTJ>.WNBJ'/EB9XI6C0MM+&+8[!=A?R
MFD1_Q1_X(8_\S=_W!_\ V_KZO_X*R?#1]>\ ZCKQU75(8].CM$73()XX]/N&
MFO[=&DNHA%YL[J&4Q!Y=D3QHZ(K-*9/$/V"OV5(/VC?AQHTGCB7[=X>MOMJZ
M/HUO+<6T2.;VX,]]>R0R1R379<RP6Z!A!!:Y(5IKB4I\WZ_\,D_8*^/_ (?L
M?"L\G]G:U)9@VLS2%8K74[N2SEM699 TZ1-'Y]NTN2KK 9!,\)DE_;_]KGXW
MW'[./@C5O%%G;QW5S91PB&*5F6,R7$\5NC/M^9D1I1(R*4,@4H)(RV]?C_\
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M\??AUJ=C9P?:-2LMFH6"#S2QFMLF18TA#-++);M<0PQ,K*TLJ?=8+(GYX?\
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M^#EG^T!X7U/PQ?-LBU"W,:RX9O)F4B2";:CQE_*E2.7RRZK)LV,=C,#^2/\
MP3E^*.O?LZV][X1U_3]4U70A>/)I6N:-976L:8%*R?:!'<VGG!K=Y(T,4=O"
MSQW4MR+E8I/,$?0?%WX*>)?^"AOQ!TZXO]+O-*\ :!(\>[4X6M+C4&#Q27)A
MMF$%]&EVHAACD<JD4,+S!DNM]H?VNHK\ ?\ @N=_S*/_ '&/_;"OW^K\ ?\
MF[S_ #_T+E?K]^UC_P D\\5_]B_JW_I%-7P!_P $5/\ DGFI?]C!<_\ I%8U
M\0? 6R\/:7^T/XETCQMIMO/%JVH:O!91:C:PO"MQ<7@N[24K=8 \^)2ELZ*[
MRM<PJ@*3;J_=[_AD[X>?]"IX?_\ !39?_&:T/AAHW@KP9JFIZ+X7L]+L=1M8
M[.35(-/M8;=D6<3&T%P88U4N565TC8ET1Q(55)D9_<*^ /\ @J/_ ,DA\0_]
MP[_TY6E'_!+C_DD/A[_N(_\ IRNZ^?\ _@M7_P D\TW_ +&"V_\ 2*^KZ0\2
M_&^W_87^%&B7GB.WD:^LM+TW3DL8V5FEU!+,#R#,GF1(@,,C2399 D;%!*YC
MCD^;_@G^R]KG[:6G6OB_XO:C<7EE>[+S2_#EI.;;3HK:5)F@EG6W(=I2MQN@
M82?:8X51+BXF+R01?.'_  3OTFWT#X^^-[.SBC@MH(]=BAAB14CCC36+941$
M4!515 554 *    *^C_^"U?_ "3S3?\ L8+;_P!(KZOO_P#9._Y)YX4_[%_2
M?_2*&O@#_@M7_P D\TW_ +&"V_\ 2*^K[_\ V3O^2>>%/^Q?TG_TBAK\@?V^
MO^3A? 7_ ' /_3S<5^QW[3>DW&O^!?$MG9Q23W,^AZG%##$C/))(]I*J(B*"
MS.S$*JJ"6)  )-?EC_P1+^)>G7/A[6?#&_;J4&H'4?+9D'F6\\,$&Z)=WF-Y
M;P8F.P(GG0#<6DPO[?5^6'[<7Q>TOX[_  &UKQ#HK2/IUU);I!)(AC:1;?6H
M;8R!#\RH[1%XPX5]C+O2-]R+ZA_P2X_Y)#X>_P"XC_Z<KNO@#_@N=_S*/_<8
M_P#;"OW^K\ ?^"&/_,W?]P?_ -OZ_1_]NC]LVS_8\T..=8?M>M:CYT>F6S!O
M)+1!/,FG=<8BB\R,F-6$LS.L:%%,DT/C_P (OV$KSXE?8_$WQDOKCQ#KZ_O8
M]+EE4:78$^051;: )#)+B!1=!/\ 0YRS*T-QL%S)\@?\$,?^9N_[@_\ [?T?
M\%SO^91_[C'_ +85^_U?.'[3'P"\-?M1Z7'X5\0S21LTGVZU%O.L5TK6Q6.2
M:)7#JZ*MR(9=\<B*+A>%E,3K^"'Q(_9L^)7_  2]O$\5^'-3^WZ&+B$7,D2R
MI#)A=J)JECO9/*=I9H89%EEV,0RRVUS+"#^Y_P"Q9^TPG[5W@ZV\0-''!?))
M):ZA!%YGEQ746TG89%!*21O%.JAI!&)1"99'C=J^KZ_G1^*_B2X^%7[5=IJ,
M]I(\=[>:9;P;]T2R1W^G1:89XW*,)$BD>3.T8=X7AWHP9E_HNK^?'_@LKX#M
M_&?BKPC9Z2D<WB/4HYK(PB=1(\;7$*V"LCN$B1IIKI4E8('/F!G(A^3]#_\
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M*W\4?\)#]H^S_9O*']E[_M'E;O[7V^7Y6S]YY_D>1GCS/)_TBM#]@[]D2_\
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M]$\1:)<:/>Z1I]G9,9+FSN8;CR(_)$D+VL\KC*Q(\BS)%L:41HTP1I*^?_\
M@J5\"]<^//@%;;P_!]KN].U"+4'MESYTT,4%Q$ZP( ?,E'G!Q%D-(J,J;Y3'
M&_'_ +$'Q"^)OC'1M$\/:KX9D\/:9HT<-M=ZK<N8;BY@L8E$-O;Z?<P-*KS#
MR$N+EBT)A6\\EX+DPB#YP_:F^"_Q.^,WQ.T7QSI7@ZX6RT+^S?*@N=5TJ.:Y
M^QW3WC;_ "[N9(-S2-$N#-A5$IY8Q)^WWA;69_$%G'<W-E<:?*^[=:W+6[31
M[6*C>;6:XA.X .NR5_E8!MK[E7^?'X\_L.>//V-?$LGB_P"$)O)=.DCD!@M@
MMS=6BS,B-:O;2"1KZW+,LD+>7.\0CWS /;I=2^X:!XD_:"_;1TZXT34-.T_P
MCHMSYEMJ%Y/83PW$MO(@BN+>*UO)9Y7W13ETD5+=&>(QB]B8,I_1_P"/?[-=
MG\4/AU>> M-_T2W_ +/AMM/!D;;$UEY;V:22.LTAB#PQ+,V'E:+?@^80P_*#
M]E'XN?&']D:S'@/4/ >H:S%#<(+"2(F&&W^U,99$>_A@N;.6(R2^89'D3[.S
M3+++L54@Y_\ ;X_91^*OQJO/#TUZ/[:UJ[_M%)+32T>+1=,A@6W:()+=%-DM
MQ^]EFGNI$:9Q';1J5MXM_P"Q^F>)O'G@SPT;K6M,L]=\1M)*$LM#=;2U1=K&
M$23ZI<JQ0LH\V9%+H90J6LHB:5_S0_X)F? ;XA?LG:CJEMXA\,7'V+6?L*_:
MX-0TR3[,UN\J[I8OM8=HBMP[NT1>5?*"I!*9/D]?_P""K?[*.N?M$Z'I^J^'
MQ]IN]!^V.^GJA,US#<B$N8"#\TL?D B#&Z968(QE6.&8_9T^.OQF^/NG+H=]
MH?\ PC-[;6Y6^\2ZE93#S"R2I$UGI<B6R/=EO+DD8RO9Q[)&:!1+!;'X@_X)
M\_#?XJ_!74=?\+66@7&E76K?9XY->OX7^QZ:MD\Z2S0H8S#J,K"<BUCCF\IY
M DK&2U$K+] ?\%,_@-\0OVL=1TNV\/>&+C[%HWVY?M<^H:9']I:X>)=T47VL
MNL06W1T:4I*WFE7@B,?S_K]\-/%6I^,-.2YU?2+C1;WY5EM)Y[6XPVQ69HI;
M2:5'BW,R(SB&5MA9H(P5S\0?MJZ/\0$\6^#-8\ V-Q?2Z;_:CZC#'/#;0S6<
MDFG"2UFFN"(1YX4^6K!Y%:,W$:%[?>G'_$+]JCQ!\>_"NH>&=,\ >+(-;UG2
M[BS O;-+/3X9+BW9)BU_</&NR-6=HC)'$;AU2+;$THV_4'[%G[,Z?LH^#K;P
M^TD<]\\DEUJ$\7F>7+=2[0=@D8D)'&D4"L%C$@B$QBC>1UKZOK\T/^"CO[#C
M_M6Z7!J>BF./Q'I<<@@1A&BWT#$,;628@,KJP+6K.WDH\DJ.$$[3Q<_\(?VW
M_&/A?2UT[QWX&\67&NV<CV\]UI6D?:+6Z$1VB<,)(X@[$'=]G,ENY'G1.L<B
MQ1:'P\_9:\1_&?XBP_%#X@VUOIWV"WBBT?P^LT%\ULT7F+ONKA($B?;*\EY;
MF(R2K+-$3-%]E$3]!_P4.\/^-OC3X7O/!WA3P]<7?VNXM/M%]-<:?%;O;Q%;
MD_9]]^EP)1,D,9\Z (4$VW.8Y#S_ /P3_L/B%\"?#EKX/\5>%+B.WM+AEM+^
MTO=,E58;F=YI6NXVOQ(/*>1F#6ZRM)$=@@$D6Z?]/Z*_#'_@IQ\%/&J>.O#G
MQ"\+Z7)J\>FQV<:P6\,UU(EU97<UY&9[>$"4V\@<+YD;8!1T=HF>$R?=_@7X
MQ_$?Q-ITWB*_\(7%IFW2/3= BU&R-Q/+*C3-=W\]T+;[+$NV"VCA3-U"\EV\
M]I-B#R?B#_@F9\!OB%^R=J.J6WB'PQ<?8M9^PK]K@U#3)/LS6[RKNEB^UAVB
M*W#N[1%Y5\H*D$ID^3U__@IQ\+O&W[2.DVGACPQX<N+J*UU".]EU&2]T^"%]
MEO)&L<,4ET)FR;AQ(TJ0;&A 19DD#K]@?LB'7M(\):7HGB+1+C1[W2-/L[)C
M)<V=S#<>1'Y(DA>UGE<96)'D69(MC2B-&F"-)7Y8?MS_ /!/;Q+X:\03?$+X
M8/>?:[B2YN;^UM;AHKR">1)'GN+.0.LLB3@NKVT;-,))-D*20R^5;Z'PT_:<
M_:3^*&S0H/#-O97#6ZQR:OJ.EW5CY6=L+7;-/*EL\JEQ,88;>7=M8I:/&IC'
MZW?L\?!"W_9]\/PZ-%<27UR9);F_U"95%Q?7EPYDGN9R,LSLQVJ9&ED6%(XV
MED*;S[A7XX_\%?\ ]G7Q+\9]+T35/#UE)J"Z1)>)=6UNK2W16\-L(Y(H44M*
MBM"1*$RZ!U?88EE>/Z?_ &>/C+\2/C!;PZKXA\,2:#9V=G+*]NL\?VS5KP*8
MEABM;M(VL;<,LTNVYEBD>1K(K=-:BY,OPA_PI?XG?\+O_P"%H_\ "'7']F_:
M-OV3^U=*^T?9_L']G>;_ ,??E^;L_?\ D[MF_P#<>?M_?U^YVDWKZC;Q3RPR
M6TDD:.\$IC,D3,H)C<Q/)$74G:QC>1"0=KLN&/\ /C\1_A/\2OV)_BU>>-?#
M&E7'B+3=<N+VXE2TM)9M]O=W N+BRG\I)I+66-]C07 RDFQ' =?M-HOH'[=O
M@GXJ_M1> ;'6I])^QVZ:A%<)X7M('N]2CA> Q)=7<Y*2/*KNX%G;6R-##<[[
M@M)!((/M_P#83OO'.NZ'I1\0:=_8&D:5H\&EV^FSHS7U[<6XBB;4)_,2)[2)
M5A,=O:[2\AEFF=VC6U9OS0\4?L^_%+_@GIXQOM<^'%A)JWAS4)"L=I!%/>1^
M7)YKPVUU:1RF[WVF"(KQ6P04W3J;F:V/N'[4?BSXJ_M9_#C4"/"EQX>T]?LT
MC6#;]0U356%[%&D,5L((9K.* J]U-))'YLHC@$0^SO.]?5__  3L^%/Q!^#'
MABWT/Q=%I=GIUI'.+.T@WS:@))KJ:9VNKA)FM @W$Q) LA=)$WR1/$R2?FA^
MT7^P3XY_9+\0MXK^$K:A)IK8?R;*1I+RT_?1-]ED@RTE_:,X1U4I/^[1END*
MQ>?-] >!?C-^T/\ M2>=H$FC6_A.RGV17>M/87EG<6D,FXN]JMW=;Y92J-&I
M@0M&[H3-:EDN$_1_Q3HEY^RY\.I++P+I7]IW>C:>L=A9':K3LN!)-(L*Q^=*
M<R74T<026[E#HA6692/G_P#8R_:Z\6_%O5IO#/CW0O[&UIM/.K6?EQ20*]BM
MQ]C836]Q+)<0RB8,8RV!-$2VR-5C>X_1^BBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOYX?^"@GBS3K+]H#P=/+=VZ1:?_8/
MVV1ID5;7;JDT[>>Q.(L1.DQ\S;B)UD/R,"?Z'J**********************
M*********************************************_-#PW_P5C^&_BFX
MN[.V;5&N89/*L85T^2235)&9UC2Q2(R-OD946-;L6I)FC!"GS/+^@/V.?A#J
MGPH\/W,^OK''KNO:I>ZUJL$+A[>WNKYP3! >2$CC2)6!><><)-L\D91J^KZ*
M*******************************************************_+#_@
MJ5K7B71-+T"?3M(DUCPY::HNH>(+>-6998+ I<16]TJ^8OV*15G>=YH988WA
M@9BA"++H?#3_ (*X_#/QAIR7.KW5QHM[\JRVD]K<7&&V*S-%+:12H\6YF1&<
M0RML+-!&"N>PD_X*4>$_&-Q'IG@:TU3Q9JTT<C);6%G+#'"P:..-KR>\6 6]
MN\DJ*]R%E2 ;GD"_('^@/V6?@A<? KP^UKJ=Q'>:WJ-Y<ZGK-Y$K)'<:A>/O
MF=$.%5%4)"OEI"CB,2^3$SLH^CZ*********_/#_ (*IZM;Z=\)-:BGECCDN
M9-/B@1W56ED%];RE(P2"[B..20JN2$C=\;58@_X)6:M;ZC\)-%B@ECDDMI-0
MBG1'5FBD-]<2A) "2CF.2.0*V"4D1\;64G]#Z***********************
M******************************Y_Q3K_ /PC%G)=BWN+IDVA+>VC\R:5
MW8(B("51=S,H:25HX(5S+-+%"DDB_.'PH^$.J7'C'5O'WB)8XKN]L[;3M)L5
M<22:?IL>)Y8KB2+;#)<3W!,LJK]I6W*>7#>SPMD?5]%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?/\ _P ,G?#S_H5/#_\
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M(###-]K61E\D2%9OD,3I)YL47S %-Z$-7T_1111111111111111111117/\
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M117QA^T=^WEX._9:UG3]#\0->?:;Z-9F>WM_,CMK=Y3$L\Y+JQ0LLIVVZSS
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MOP,\4?M=^"XO&FL^/?%%IJ^K?:O(33[L6=C;?9Y'LXMUG J))\T!EE\EK7S
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M5^_U?@#_ ,$,?^9N_P"X/_[?U[__ ,%J_P#DGFF_]C!;?^D5]7TAI.K7&@?
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M0<,H8<@&OI#]E_\ 9?T;]DS1I]#T.>\GMI[Q[QWO'B>02/%%$0#%%"NS;"I
M*DY+?,00!]'U^ /_  7._P"91_[C'_MA7[_5^ /_ #=Y_G_H7*_?ZOP!_8%_
MY.%\>_\ <?\ _3S;U]__ /!4?_DD/B'_ +AW_IRM*/\ @EQ_R2'P]_W$?_3E
M=U\ ?M]?\G"^ O\ N ?^GFXK]_J_ '_@AC_S-W_<'_\ ;^O?_P#@M7_R3S3?
M^Q@MO_2*^K[_ /V3O^2>>%/^Q?TG_P!(H:_('_F[S_/_ $+E?=__  4]^ VJ
M?'SX?2V^C1R7%]IEY#J,=I%&'DN5B26&2-!O4[UCG>90HD>0Q"%(V>1<9_\
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MN]^UC_R3SQ7_ -B_JW_I%-7P!_P14_Y)YJ7_ &,%S_Z16-> ?M]?\G"^ O\
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M /[ O_)POCW_ +C_ /Z>;>OW^HK\ ?\ F[S_ #_T+E?O]7X _P#!#'_F;O\
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M?_2*QKP#]OK_ ).%\!?]P#_T\W%?O]7X _\ !<[_ )E'_N,?^V%?O]7X _\
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MI=K)OAF021OM<*Z[E8':P5AG! .1705^ /\ P7._YE'_ +C'_MA7[_5^ /\
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M'7BB+X=7%Y\.X;C4;W4/LR176F.)9HK.XPS75L(UD>?>NV)&M_WD2S_:T=1
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M;"XN?%D=Q<VUMIH@GVW#7-W).DYN8HIHX;2))B]U*X\V&*"XD6WE"QB7Y_\
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M%/J%Q<NODI%"(Y (PQFFG,,"H/.61?'_ -N3X_>%_$'QP\+:[8ZG;W>EZ/\
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M@C4?$&E:I?V]G>ZI_98L8IW$?VAHGN8VCB9L(TI:XB"0@^;)N)1&".5^S_\
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M8%61E)5E8$,"000:_G!_9@^ 6J67Q-UGX17<T@\*Z=JB:Y=V=Q.)&N[6Q/\
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M&9F"@X!9CC).?0-)TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4
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MLX+VS,EM+IUK-!-(5#B6\C6<H45I(Y8K::&0[4$N?,,?ZGT5^>%]^W5?^/\
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MS7-S+_PD^GOLAA0R2/M2%G;:JD[5#,<8 )P*\?\ @7_P4K\7_M*?;/\ A%/
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MESXZ?\-*>$-/\5_8_L'V_P"T_P"C>=Y_E^1<RV_^M\N+=N\K?]Q<;MO.,GZ
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M>_[B/_IRNZ^[]6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q 4 DD
M5\8?\/(?A1_:/]E_\)';_:/M'V??Y%U]GW[_ "]WVKR/LWE9Y\_S/(V?O/,\
MOYJ^S])U:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$@UH45\ ?
M\%1_^20^(?\ N'?^G*TH_P""7'_)(?#W_<1_].5W7U?\:_BA;_!7PUJGB.Z\
MMH]-LYK@1R3+ LTB*?*@$C!@KS2;(8_E8EW4*C,0I_.#_@D)I-QKGAK7?%^J
M12?VMX@UR>6>\=&C6[CC57#QH L.Q;B>\!:%%&_?&3^Z54^@/^"E'PA3XO\
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MD@BMXY+6\MUDD(.U!)<01Q!V(VQJ6!D<K&@9V53]GU^ /[ O_)POCW_N/_\
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M*7,QE%O&$,, )8(D0C#'9Q?_ ."U?_)/--_[&"V_](KZOJ#X8_'[PO\ L_\
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M1+#0;3Q>D$AUN?5+6Q>Y>YN'46HM;N3R8X'E:")-\:R'RHT)<NY):20M]/\
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M-$MD@58FLVB79#):87;"\2_*@"E-A:)T>%WC;\<?^"&/_,W?]P?_ -OZ\O\
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MNZ/^"H__ "2'Q#_W#O\ TY6E'_!+C_DD/A[_ +B/_IRNZ]__ &L?^2>>*_\
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M&^(]7U#2M/N]2M/#^I?9KR>TAEN(?*MIY(_*F=#(FQR73:PVN2PPQ)K\\/\
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M=S@,<L :^[_V._@AX5T7PAX5URUT32X=6;0].E-_'8VZ71DFLHQ*YG6,2EY
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M98(HXY+F3P_+.Z(JM+(-5EB#R$ %W$<<<89LD)&B9VJH']!U?SX_\$[])M]
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MTC3K2VU#2/MU[#;PQW-W]LU"'[1,B!9)O*2[*1>8P+^6I*INV@X KS_X_?\
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M'_F;O^X/_P"W]??_ /P5'_Y)#XA_[AW_ *<K2C_@EQ_R2'P]_P!Q'_TY7=?
M'[?7_)PO@+_N ?\ IYN*_>[5M)M]?MY;.\BCGMIXWBFAE17CDC=2KHZ,"K(R
MDJRL"&!(((-?A#^QO\,O$_[,_BK5;_X?V<GC+P'J4@MC=17%K92![6X*F1&O
M1 MZ]LK7,2R6;K87AD#"XCD1HK?W_P#:._9R\;_MX^(-/LM8M)/#'@K2I%E=
M)KN";4+^25#YCI!9S75HCQ;/(A:9LPI/+.#/YCVL?ZOZ3I-OH%O%9V<4<%M!
M&D4,,2*D<<:*%1$10%5%4!550 H    K0K\@/^"U?_)/--_[&"V_](KZOO\
M_9._Y)YX4_[%_2?_ $BAK\H?^"P^@?\ "T/$/@3PQ8W%NNI7MQ>0+'))CROM
MTUC!!+,J!Y$B9TD <(V[RI H9D8#[?\ ^"H__)(?$/\ W#O_ $Y6E'_!+C_D
MD/A[_N(_^G*[KYP_:W_:*\2_&'XAVGP7\'7LF@S221OJ6LAF6?:+7[>8[4PL
M'5%A 9B&B>XFQ;EX+<2O.?MC?LF>#OV9?@QX@B\.:='%<F/38YK^7][>3@ZA
M8!]\[#<J.T22-!%Y=N) 72%":^C_ /@EQ_R2'P]_W$?_ $Y7=? '_-WG^?\
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M5A^)UQ')=^(K.*";2K-4^PZ3'&K^6+02_: UZ))#<373M,!<) D6Z&UA=_S
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M9Q216LTK"0N8.@_84^!WQ0^&^AV5AXD%OIEEX>^WG3-(BN$#:G<78F</JEW
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M#_\ X#Q?_*:C_A3?[4/_ $.?A_\ \!XO_E-1_P *;_:A_P"AS\/_ /@/%_\
M*:C_ (4W^U#_ -#GX?\ _ >+_P"4U'_"F_VH?^AS\/\ _@/%_P#*:C_A3?[4
M/_0Y^'__  'B_P#E-1_PIO\ :A_Z'/P__P" \7_RFH_X4W^U#_T.?A__ ,!X
MO_E-1_PIO]J'_H<_#_\ X#Q?_*:C_A3?[4/_ $.?A_\ \!XO_E-1_P *;_:A
M_P"AS\/_ /@/%_\ *:C_ (4W^U#_ -#GX?\ _ >+_P"4U'_"F_VH?^AS\/\
M_@/%_P#*:C_A3?[4/_0Y^'__  'B_P#E-1_PIO\ :A_Z'/P__P" \7_RFH_X
M4W^U#_T.?A__ ,!XO_E-1_PIO]J'_H<_#_\ X#Q?_*:C_A3?[4/_ $.?A_\
M\!XO_E-7PA\5[7]HC]E'6]7\0/+)<R:M'!+J.KZ=86MY:RQZ=;A4>13:9M$A
MCD9"TL-L)"DC@RJADKP#2?\ @IC\9]?N(K.SUN2>YGD2*&&+2]/>221V"HB(
MMF69V8A5502Q( !)K[/T7X0_M(?M=Z.J^(+^WL--2X@N([36+:WM?M3P2/M6
M:S@L9))(D>-7:"_C6";,,BQS* R_3_\ PIO]J'_H<_#_ /X#Q?\ RFH_X4W^
MU#_T.?A__P !XO\ Y34?\*;_ &H?^AS\/_\ @/%_\IJ/^%-_M0_]#GX?_P#
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MK6^@6\MY>2QP6T$;RS32NJ1QQHI9W=V(545069F("@$D@"OSP^'W_!3#PO\
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M:7+&5GCO;K6B%C=@HL;B2TM@V]FB?=']IF4HCE#:LDABDE1ON^OP!_X(8_\
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MD$J321#R&5@AMTA81I(TI?[OHHHHHHHHHK\@/^"U?_)/--_[&"V_](KZOO\
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M/X/,EEK/B*-9;G5QLW66GLTRS/:J9(R;A8[>>1FW1NB(%@+7,J26^?\ $O\
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MGAR-_L^E>=/#9^?&RV]K-*8EA.^ZCEN;VW?*S-&5C6:6UB*MX?\ MF^"9?\
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MW_)//"G_ &+^D_\ I%#7Y _\%M/"?]LZCX/^PVGG:E>?VC:KY,.^XGVO9^1
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MX/U"^>XETW2+?3-1:VC;=C9J<[SM#&[+&)9$MXU))3?Y<:LP5%*_T/5^*/\
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M[T(=41VCEMX;EMT7W_X3^+'BW_@I[!::5)X?_L#P-]HAN=9N[B:2X_M2&WN
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MRSVLB+''*GF_?_\ P3]^,VJ?%SPUHL=II<EIX<TO0[:PDOKS"3WNI6RPP/\
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MT$2;XUD/E1H2Y=R2TDA;]3OV3O\ DGGA3_L7])_](H:^@********X_Q_P"
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M .$A_P"$HT_^VO\ C[_X1?\ LJT^Q_ZSS/[/_M'=YO\ JOW6_=_K/D^V;?\
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M#YQM(IPT2!;81R7:N)?0/^"<W[>W_#5%F^A:VNSQ-I]OYLTB1[8;VW5DC-R
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MMJ>--5\:7WPW^)H_XG7[UK25X(X9EFAC$CVI6UB%N\3PA[J"X^52JMB6=9X
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MET9I&L;^,O&)4,<B,CM')&Z\@/'(CQL5+(Q4LCNA5V_%']@7_DX7Q[_W'_\
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M:=FS<!F\JC_@J/\ \DA\0_\ <._].5I1_P $N/\ DD/A[_N(_P#IRNZ^ /\
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M$NL9>2-]^-Y7=&RJ0_O_ /P2LTFWT[X2:++!%'')<R:A+.Z(JM+(+ZXB#R$
M%W$<<<89LD)&B9VJH'A__!:O_DGFF_\ 8P6W_I%?5]0>$_%-YX&^!5IJNGR>
M3>V/@>&YMI=JOLFATD21OM<,C;64':P93C!!&17Y@?\ !+_X5>._'/@V]N?#
M'C'_ (1ZR76)XY+3^Q;34-\PMK1FF\V=U==RLB>6!M'E[@<N:^O_ (U_\$_?
M'?[1.G1Z5XG^(?VZRAN%N8XO^$<M(<3(DD:ON@N8G.%E<;22IW9(R 1[!>_
MO_AFOX&ZUX4^V?;_ +!X?U__ $GR?(\SSX[NX_U7F2[=OF[/OMG;NXS@?/\
M_P $5/\ DGFI?]C!<_\ I%8UX!_P4OUC6/$?QD\#:#97WV+9_9LMC/Y$<WV6
M\O-3:%KG8P'G8^S6[>5(WEGRL +O<M]__P##/'Q>_P"BG_\ EK:;_P#'*\?^
M!'_!,V\^$GQ A^(&H>)_[5O1<7US<Q?V6MKY\U[#/'(^Y+ITC^:<R;5CV\;
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MPK]_J_ ']@7_ ).%\>_]Q_\ ]/-O7W__ ,%1_P#DD/B'_N'?^G*TH_X)<?\
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M!_P5'_Y)#XA_[AW_ *<K2C_@EQ_R2'P]_P!Q'_TY7=? '[?7_)PO@+_N ?\
MIYN*_?ZOP!_8%_Y.%\>_]Q__ -/-O7W_ /\ !4?_ ))#XA_[AW_IRM*/^"7'
M_)(?#W_<1_\ 3E=U\ ?\W>?Y_P"A<K]_J_ '_@AC_P S=_W!_P#V_KW_ /X+
M5_\ )/--_P"Q@MO_ $BOJ^__ -D[_DGGA3_L7])_](H:^@*^ /\ @J/_ ,DA
M\0_]P[_TY6E'_!+C_DD/A[_N(_\ IRNZ^4/^"W'@JWO_  KH>N,T@N;/5'LX
MT!7RS'>V[RR%AMW%PUG$$(8 !I,JQ*E?K_5M6N-?^ 4MY>2R3W,_@-Y9II79
MY))'T<L[N[$LSLQ+,S$EB22237S?_P $5/\ DGFI?]C!<_\ I%8U]0?\%(?%
M-YX/^%'B.YL9/*E>W@MF;:K9AN[J"UG3#AA\\4LB;@-R[MRE7"L/B#]@KX,_
M$?Q7\.-&O=!\=_V-ILGVWR-/_L"RO/)VWMPK_P"D3.)'WN&D^8#;OV#Y5%=_
M\=/^":GB_P#:4^Q_\)7X_P#M_P!@\[[-_P 4];0>7Y_E^;_Q[W46[=Y4?W]V
M-O&,G/SA_P %:8[CX0>!? W@59([FV@CQ)<F-DDDDTFT@M(V5?,9421;J5W0
M^801&!( K;_W^TG2;?0+>*SLXHX+:"-(H88D5(XXT4*B(B@*J*H"JJ@!0
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M#_@KM^T5X:^)OA73]%T"]CU62+5+>[N+JQ9;FSMU-O>110S7,3-$MQ,?,>*
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MA_P5V_:*\-?$WPKI^BZ!>QZK)%JEO=W%U8LMS9VZFWO(HH9KF)FB6XF/F/%
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M3_V.?@Y>?!#P78:;JK>9K4_FWVK3L%,TM]>2-/,9Y5>7[1+'N6W-P7<RK"K
MA=JKX?\ \%4]6M].^$FM13RQQR7,FGQ0([JK2R"^MY2D8)!=Q'')(57)"1N^
M-JL0?\$K-6M]1^$FBQ02QR26TFH13HCJS12&^N)0D@!)1S')'(%;!*2(^-K*
M3^>'_!2;Q39^!OCKX-U74)/)LK&WT6YN9=K/LAAU:ZDD?:@9VVJI.U0S'& "
M<"OV^\"_'CP]\4M1FT_P_?6^J_9K=)[JYLIX;BWM_-=D@BDDCD.99?+F94C#
M[$A9IC#YML)_Q!_X)]^+-.O?V@/&,\5W;O%J']O?8I%F1ENMVJ0SKY# XES$
MCS#R]V8D:0?(I(_0_P#X*IZM;Z=\)-:BGECCDN9-/B@1W56ED%];RE(P2"[B
M..20JN2$C=\;58@_X)6:M;ZC\)-%B@ECDDMI-0BG1'5FBD-]<2A) "2CF.2.
M0*V"4D1\;64G\\/^$LT[_AK;[5]KM_L_VC[+YOG)L^T?V']D\C=G;YOVC_1_
M+SO\_P#=8\SY:_H.U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0
M"20!7X _\$-=6MX;CQ79M+&+F6/2Y8X2ZB1XXFO%D=4SN9$:6)78 A3)&"07
M7/T!_P %K]6MX? NE6;2QBYEUR*6.$NHD>.*TNED=4SN9$:6)78 A3)&"077
M/W_^QWJUOK7PY\*RVLL<T:Z'IT1>-U=1)#;1Q2H2I(#QR(\<B]4=61@&4@?1
M]? '_!4?_DD/B'_N'?\ IRM*\O\ ^"2?QBT;Q5\/+'PY!<1KJVE27RSVCR1"
M=HWNC<"XCB#F4V^+J.(RLJCSE=.RLWD'_!0K7G_:]\2Z#\)?"SQW;)>&_P!:
MO+?R[A=.6%I+-O,*7"JCP*]PUQ;S"-V=K.*-_-E\MOT/_:M_L[P-\,?$D"_9
M[&RA\/W]K;QC9#"F^U>"W@C7Y47<S1PPQKC+,D:#)45\(?\ !%#5K>;P+JMF
MLL9N8M<EEDA#J9$CEM+58W9,[E1VBE5&( 8QR $E&Q^CW[2GPA3X]>#M8\-,
ML;27]G(EN97DCC2Z3]Y:R.T67"1SI%(P 8,%*E'4E&_GQ_8A_:\O/V ]8U#P
M-XXL+BWLI=0C:Y/R[].F,>R2?RTC9[J*91:MF.4J((_.MUG,H63]/_B7_P %
M)?#GC73GT;X:3W&N^+M2W6FEVT%G/#Y,TB-_I<KWMND/E6X!F<,&4[1YGEP>
M;-%Y!_P4]_9:U'Q#\-='U!;JXU/4O"%NB7<[AV>\MY(H8;RZ9-LTAE#PQ7+L
M\H2.#[4\CR,%->G_ +%/_!1GP=\0O#6GZ9XAU:/3-=L+.."[.J7.Q;DVZQQ&
MZ6\FVQ2/.2)&B=Q<!_.^22./SW_.#]M+]H?P_P"+_C9X7\1VTTAT329-*674
M#$YM[B.RU2>2YN+0H&:YMT;S(1+$I$DT$PC\Q0CO]_\ _!13X.G]M/X?:;XF
M\'6\FH7-C(]Y:;H[FWN)]/F0K<"WMIDC:1Y&CMYX@Z!YH8LV[.942;P#]A+_
M (*F>'_"OA^T\+^.'DL6TJS2&UU,1O/'<1QN4B@:"U@WPO%#Y4:-B43"*1Y)
M$E*B7Z__ .&L$_:X\2Z-X>^&]U>/I=G>6VI^(M9CMY((([6W9Y(M-(N%AF9[
MR6-4D,94B$-A;F'[7'%\8?\ !<[_ )E'_N,?^V%?K]X$_:A\)?%6\LK'P[J5
MOJUQ>6\ET4M)8W:UMHU0F:[1G62#YY881"Z_:3++_J/+AN9(/YXM>&N?\$K?
MBK<:K'IGF:%>_;UL8$G(AN]-F??% +J6*>1);9Q;&<$&;=$H+-!<)++^OW_#
MV#X4?V=]M_M2X^T?9_.^P_8+K[1OV;OL^[ROLWFY_=Y\_P C?SYWE_/7T!^R
M9_PE&JZ'<:UXN^T0:AK6H7&H1:;<8W:79R!(K2Q&W:/DBB25\QP2>;-)YT0N
M/-9OR _X)]^+-.O?V@/&,\5W;O%J']O?8I%F1ENMVJ0SKY# XES$CS#R]V8D
M:0?(I(_H>K^>'_@GWXLTZ]_: \8SQ7=N\6H?V]]BD69&6ZW:I#.OD,#B7,2/
M,/+W9B1I!\BDC]#_ /@JGJUOIWPDUJ*>6..2YDT^*!'=5:607UO*4C!(+N(X
MY)"JY(2-WQM5B#_@E9JUOJ/PDT6*"6.22VDU"*=$=6:*0WUQ*$D )*.8Y(Y
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MWQ\N*1H+&V62XNOM$TGG"6WCE,AE9I-LJSK'^<'[$GQTT/P-\9/&OB;Q#/\
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MAW1+>VO3C;<R/-=31X5T/DR74DSP;ED=9/)*>8I"ON"J!]/U\H>"OV&?AO\
M#S66U_3?#]G%J)D,J.WF2QPR&59@]O;RN\%LZ.JF)H(XS"!LC*(2I^KZ^(/%
M/_!-[X4>,+R2^N?#ENDLNW<MM/=6D(VJ$&R"UGBA3A06V(NYLNV79F/U_P"%
MO">G>!K./3]*M+>QLH=WE6UM"D,*;V+MLCC"HNYF9FP!EF+'DDUX_P#\,G?#
MS_H5/#__ (*;+_XS7L'A;PGIW@:SCT_2K2WL;*'=Y5M;0I#"F]B[;(XPJ+N9
MF9L 99BQY)->7ZM^S)X%U^XEO+SPUH<]S/(\LTTNF6CR22.Q9W=VB+,[,2S,
MQ)8DDDDUT%E\$/"NG:7-H<&B:7'I-S()9[!+&W6UED!0AY(!&(G<&.,AF4D&
M-.?E7''_ /#)WP\_Z%3P_P#^"FR_^,UV'C7X(>%?B5<+>:YHFEZE<I&(DFO+
M&WN)%C#,P0/+&S! S,P4' +,<9)R>"O@AX5^&MPUYH>B:7IMR\9B>:SL;>WD
M:,LK%"\4:L4+*K%2<$JIQD#''_\ #)WP\_Z%3P__ ."FR_\ C->@?\*G\/?V
M/_PCW]E:?_8O_0.^R0_8_P#6>=_Q[[/*_P!;^]^[_K/G^]S7G_\ PR=\//\
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M_:C,)Q_K1)7O^DZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515 554 *
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M]C!UWQR!D;:RJRY!PRAAR :^,-)_X)E_"31;B*ZB\.QM)#(DB"6\OIHRR,&
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M-/U6TM[ZRFV^;;7,*30OL8.N^.0,C;6567(.&4,.0#7C_P#PR=\//^A4\/\
M_@ILO_C-=AXU^"'A7XE7"WFN:)I>I7*1B))KRQM[B18PS,$#RQLP0,S,%!P"
MS'&2<G@KX(>%?AK<->:'HFEZ;<O&8GFL[&WMY&C+*Q0O%&K%"RJQ4G!*J<9
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M<%E8.T>8[2WMY?.@6WMS^XA>)^8I8XUFC'R*X3Y:]PHK\ ?V^O\ DX7P%_W
M/_3S<5^C_P#P[>^%']H_VI_PCEO]H^T?:-GGW7V??O\ ,V_9?/\ LWE9X\CR
M_(V?N_+\OY:^S])TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4
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M1\1RF,W,4?E6$,FTB>\ERL";#)$TB!OWLZQL)!;QS.H)2OB_2OV)+/\ ;!\
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M(F?E#Q3^V;X[\%6<FOZA\.=0A\-P[9YKLZK:-?16+,"9Y-,5#*DJ1'S)K=W
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MN'4]3AO+IKJ\@L;.SL8#<75U=7!/EPPQY52Y57;YF0,$**6E9$?Y0\4_MO\
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M-<R)YT_VI9BV^&/>D/EM RKB6;S%(8^6<H/E_P#X+5_\D\TW_L8+;_TBOJ/
M7[>4'@3P1X;TCP;HFH>,M7L-'TB'5+?38K@PV&;"(@3W,5M<(968%%B16VM%
M<+(\4D/EO[A^Q]_P4=\-?M87']D&"32-=\MI%LIY%DCG56<L+6<!#,Z1JLDL
M;QPN SE%ECAEE7Z/_:%_:=\+_LOZ<FH>);OR?.\T6MM&AEN+IXD+E(8U_P"
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MX_\ \%RM)MX;CPI>+%&+F6/5(I)@BB1XXFLVC1GQN9$:65D4DA3)(0 7;/\
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MWU'X2:U+/%'));2:?+ [HK-%(;ZWB+QD@E',<DD99<$I(Z9VLP.A_P $N/\
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M>*O%UKKHD_X2B2.&1C=Q2&\"QW$RZB)99%+HYGDM?/CD97DD"L58Q,4^W_\
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MSVT\;Q30R^)M,>.2-U*NCHT15D92596!# D$$&OE#_@EM^RY\1_V:_$.J?\
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M_P#!<K2;>&X\*7BQ1BYECU2*28(HD>.)K-HT9\;F1&EE9%)(4R2$ %VS]O\
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M#+XFTQXY(W4JZ.C1%61E)5E8$,"000:^4/\ @EM^RY\1_P!FOQ#JG_"2:?\
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M? ^IW.C:AHD1N-"CM;?4D6*\EA35I<S2VZLQM\RF:-(W9F>.))\A)E4?J?\
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MYHUT/490DB*ZB2&VDEB<!@0'CD1)(VZHZJZD,H(^#_\ @BI_R3S4O^Q@N?\
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MY<QQ7VJR6D=C;DDR3M!>6]Q,54 D)'&A+R-A%+1H6WRQJ_8?\$N/^20^'O\
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MLN-)M(Q;3WDW]@>7YKR7^GZ7<V\AE\L(9A<7$MM=+!;M%$X)AB92,W$G'_\
M!'7XZ6?B_P %MX3FGMUU+1KBX:&U7<LSV,\@F$[;B5DQ<331,8L")1 )%5I$
M>6A_P6OU:WA\"Z59M+&+F77(I8X2ZB1XXK2Z61U3.YD1I8E=@"%,D8)!=<_H
M=^R=_P D\\*?]B_I/_I%#7T!7P!_P5'_ .20^(?^X=_Z<K2C_@EQ_P DA\/?
M]Q'_ -.5W7P!^WU_R<+X"_[@'_IYN*_?ZOP!_P""&/\ S-W_ '!__;^OW^HK
M\ ;W3?!'QB^(&I>._"GBW1_ FH:9J%S9K<SSV%W_ &K-Y/EW&HQ64\D,,,4H
MFD1)TDNEO>;@QVMPLC3>_P#Q9\-^#?VF-1LI/'WQ+\/WNBV&)(]&TNYMM-MY
M;@."9KB234KV63=$7@(1HGC1R89(&:8S?J_X3_L[^SK3^R/L_P#9OV>'[']E
MV?9_L^P>3Y'E_N_*V;?+V?)LQM^7%?SH_L#!_P!C7XTZIX&URZD2.\CDT^!O
M,CCMYY]T=SI]Q+'YS(KS0;DMT!EF2:[6WP&DDQ_2=7X0_LKV,7[3'[0GB;QS
M;K_Q+=$\R*WGM[F*6&6;R1I=NY;;NDBN+>&ZN4,0VQL(U,S+M\[P_4 _[%G[
M27V_6+J2+2=:O+FZ:=9(X8WM=8,P7[0#-M%O;7A_>M,5.+3[4(A^Z6OZ3J_"
M'Q_8Q?M3?M-6%K;+NLO"5O;O=7%O<Q-EM/9KL%@R\;;VYALIX$\R5=DAW1G<
M8?+_ -K34[W]EC]HC3?'%^(TTG49+.07+13R1I:_94TR_!V*I:XACWS".(RE
M1);.RMYGE'^A[2=6M]?MXKRSECGMIXTEAFB=7CDC=0R.CJ2K(RD,K*2&!!!(
M-?@#_P $[]6M]?\ C[XWO+.6.>VGCUV6&:)U>.2-]8MF1T=259&4AE920P((
M)!K^@ZBOP!_YN\_S_P!"Y7[_ %?SX_\ !./5K?\ ;.^(.L^-/'$L=[KVF1VD
MND6;.HM[:-GF#/;VK%FV6C"(1-EA%-<?:)"]W)'.#_@N5JUO-<>%+-98S<Q1
MZI+)"'4R)'*UFL;LF=RH[12JC$ ,8Y "2C8_?Z/5K>:XDLUEC-S%''+)"'4R
M)'*TBQNR9W*CM%*J,0 QCD )*-C\$?\ @AC_ ,S=_P!P?_V_KW__ (+5_P#)
M/--_[&"V_P#2*^K[P_9AU:WT7X<^$Y;J6.&-M#T2(/(ZHIDFMK>*) 6(!>21
MTCC7J[LJ*"S '\D/V^O^3A? 7_< _P#3S<5^_P!7X _\$,?^9N_[@_\ [?U^
M_P!7G_Q8\"_\+0\/:KH/G?9_[3T^[LO/V>9Y7VF%X?,V;DW[=^[;N7=C&X9R
M/PA_X(=>*;.TU'Q/I3R8O;FWT^YABVL=T-J]Q',^X#8-K7, VL0S;\J&"N5_
MH>K\ ?\ F[S_ #_T+E?O]17\V/[?^IZI^R7\<+#Q_9B2:.\CM;Q08A'&ZPQ#
M3[RR6=UF1G>",%Y%3? +N,A RQR/^_WPA^-'A_X]:6NL^&KZ._L6D>(R('1D
MDC/S))'(J2QO@JP615+(R2 %'1F\P\'_ +0O_"Q_'VH^%M&2WNM+T/3PVK7R
M2[FBU2>?;!8A<J/DBBN7G=/."R[87:"6%TE^GZ***^?_ -K'_DGGBO\ [%_5
MO_2*:O@#_@BI_P D\U+_ +&"Y_\ 2*QKP#_@N=_S*/\ W&/_ &PK]7_VT/@Y
M>?'WX?ZWX=T]L7MS;I);+A3YDUK-'=1PY=XT3SFA$/F,P6/?YA#!2I_/#_@B
MQ\8K?6O#6I^$Y[B1K[3[QKR"&612HL[E8U(MD+EPD<Z2/.%18T>ZC;<7G;'Z
MO?&OXH6_P5\-:IXCNO+:/3;.:X$<DRP+-(BGRH!(P8*\TFR&/Y6)=U"HS$*?
MS!_X(P?"%_"'@[4/$LZR))KEX$A!>-HWM;#?&DBJN71S/)=QN)#DB*-E15.^
M3P_]@7_DX7Q[_P!Q_P#]/-O7[W66K6^HO-%!+'));2"*=$=6:*0QI*$D )*.
M8Y(Y K8)21'QM92="OP!_:A\6?\ #1OQ[T[X;>*[ORO"-C<0;+2.;[,MQ<2Z
M<+I/.D)R\LTLBV<>THZQ2&.#RYYI)9/M_P#X*>_V=X/^#FJZ?%]GLXC_ &9:
MV5LNR)3Y5Y;NL$$8VCY(HG81QCY8HF8 (A(T/^"8NK6^G?"3PQ%/+'')<R:E
M% CNJM+(+Z^E*1@D%W$<<DA5<D)&[XVJQ'L&A>)/!W[9UAK&A:K:6=\VD:I?
MZ??:?-^]DMI()KBUAN48I&\3S0AI89X<&(O+$DYEAD(_"']K;]F>]_8&^(.@
MZ[X&DDFCU&\:;2; >?)<)/"\2RV#>4PEN+>87"0H _G30R26\FYE\Z?^HVBO
MY\=3U:WT7]KD2W4L<,;211!Y'5%,DWA]8HD!8@%Y)'2.->KNRHH+, ?W^U;5
MK?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!7XH_P#!+7PM%\3?
M&7C?XFPQW$5E?ZA=VVG^8T0W+=W)O[A)HE+NLL2_8L,&\K][(H,I&8_+_!&K
M6_[9GQ_U+2?'DL=QIOAV35(M%TIG6.UDDLKM(E1H7)-P[QJ]U<KDF8P .#90
M_9U^@/\ @M?JUO#X%TJS:6,7,NN12QPEU$CQQ6ETLCJF=S(C2Q*[ $*9(P2"
MZY^__P!E/5K>'P+X1LVEC%S+X;TV6.$NHD>.*TM5D=4SN9$:6)78 A3)&"07
M7/Y(?L"_\G"^/?\ N/\ _IYMZ_?ZOP!_YN\_S_T+E?O='JUO-<26:RQFYBCC
MEDA#J9$CE:18W9,[E1VBE5&( 8QR $E&QH5_.#_P4 TB\_9B^-NC?$.66X_L
MW4+BQNV:V*I,%L%@M;^T0><&??;A"QD\F*5;HP'<J2-7]%VDZM;Z_;Q7EG+'
M/;3QI+#-$ZO')&ZAD='4E61E(964D,"""0:_#'_@HY8Q?M-_%7P;\-[9?,\C
M=+?RV]S$)HH;QTDN4*R*5BEAM+,W2!][2K-'MA/R"7[?_P""H_\ R2'Q#_W#
MO_3E:4?\$N/^20^'O^XC_P"G*[K[_HK^?'_@G'JUO^V=\0=9\:>.)8[W7M,C
MM)=(LV=1;VT;/,&>WM6+-LM&$0B;+"*:X^T2%[N2.<'_  7*U:WFN/"EFLL9
MN8H]4EDA#J9$CE:S6-V3.Y4=HI51B &,<@!)1L?O]'JUO-<26:RQFYBCCEDA
M#J9$CE:18W9,[E1VBE5&( 8QR $E&QH5X?X]^/.E_#7Q+H?AW4Y([=M?COA9
MSR2%5:ZM6M!':@;"N^=;AS&S.@+Q+"HDEG11^:/_  4#_P"";OA?5_#VH>*_
M"UM;Z+J6F6\U[<PPJ8[.ZM[>$-)&($S';RJD1>)H41))"ZS*6E$\/G_[/^B^
M(?VE?V:M8T6[6X,MI]HCTEQ!-/->6^G/!?0PQAGS+F5)-/A,/R1+&D2QL\+(
MQ_P2$_:XTZ#1Y? >NWMO:W%M<!]&\^1(OM"7<G[RUBRB*\JW#^8BM))/-]J*
MQIY=N<?J?^U%^T#;_L^^'[B\C,<^MSQM%HVF_*]Q?7CO'!"D5L)(YKA%EFB:
MX6 F182Q4%BH//\ QOLM4T[X1ZW!KDT=SJT?A.^2_GB $<MTNG2">1 $C 1I
M S* D8 (^1?NCXO_ ."*G_)/-2_[&"Y_](K&O /^"YW_ #*/_<8_]L*^S_\
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M>9);;PI9P2:C/#+ %6?3YI;I I+/O1;FYM;2XC"B97\]-J",RKZ?_P %J_\
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M /;^O?\ _@M7_P D\TW_ +&"V_\ 2*^K[_\ V3O^2>>%/^Q?TG_TBAK\P?\
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M_DGGBO\ [%_5O_2*:O@#_@BI_P D\U+_ +&"Y_\ 2*QK[PL?B;X:^->M^(?
M.J06=S<Z5):F;3KI5G6ZM9;>UNX[KR98]C(DTOE,H\TQ/%%(Y0SPK7X0?\%(
MOV'[#]DU]/\ &?@R>2PL9+R"W%H)IC/:7B1O-%/:W#,TNQA SMO?S(9@&C=D
MD"6_]%WPGU_4?%?A[2M0U>W^R:E=Z?:3WEMY;Q>3<2PH\T7ER$R)L<LNQR77
M&UB6!->@5_-CJ ?]BS]I+[?K%U)%I.M7ES=-.LD<,;VNL&8+]H!FVBWMKP_O
M6F*G%I]J$0_=+7])U?A#X_L8OVIOVFK"UMEW67A*WMWNKBWN8FRVGLUV"P9>
M-M[<PV4\">9*NR0[HSN,/K__  6K_P"2>:;_ -C!;?\ I%?5]_\ [)W_ "3S
MPI_V+^D_^D4-?0%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%9^K6
M3ZC;RP1326TDD;HD\0C,D3,I D02I)$74G<HD21"0-R,N5/YX?\ #M+1?^$H
M_P"$T_X27Q1_PD/VC[1]N^UV._?C;MV_8/+\K9^Y\C;Y'D?N/+\GY*^G_C'\
M!6^->AKX?O==UBUM'MS;WKV;64,U\I"!C<.;-]F[8WF):BVBD666-XVB81KY
MA^S/^Q/IO[*+R+X?UO7'L9Y/-GT^ZELY;663RVC#X%DDL;X*EF@DB,ACB60R
M)&J5Q_[0O_!/'1?VH-134/$NN^()O)\T6MM'/8Q6]JDKERD,:V/^ZIDD,D\B
M1QK)+)Y:D?7_ ,-/ \_P[TY-/GU34-7\K:([G46MWN BHJ*C2006_FXVEC),
M))W=V9Y7R OYP?&;_@EC9^,/%$OB_P )^(M0\-:I=7%S<W+Q*T^)K@8D>V=)
M[::#S"TS2J9)5;SBB"&)1&?0->_X)PZ/K/A#4]%.HW$_B36K>RAU+Q-?"2^O
M)_LES#<8V2SCRXCY*1+%'(N(XX/->=X%<^X?LS_L6>#OV44D;P_;2/?3Q^5/
MJ%U)YMU+'YC2!,A4BC3)4,L$<0D$<32"1XU>OG]O^">U_P"$M9U'Q-X1\8ZI
MHFMZKJEW?7A$$-SI\D=Q+<ND+6#E%D>);@*DL\DP#K)*D,;2+Y7J'@3]CF>X
MURR\3^/=>N/%FKZ5Y@TSS;2WLK&TW%&$R64&Y&NU96(N&<\>2?+$EM!*GJ'[
M57[,^E_M7^&I?#VIR20,)%N+.ZCR6M[I%=(Y3'N594VR.DD3$!T=MK1RA)8_
MG_\ 9/\ V $_9O>UGU#Q%JFMMITEP^G6CR26VFVC3QM&\L=B)IE^T;9KI3(7
MV%;E_P!R)0)3^A]9^K:3;Z_;RV=Y%'/;3QO%-#*BO')&ZE71T8%61E)5E8$,
M"000:_,#3/\ @F:_P@U0ZI\-?%NJ>&6FDE>YMI(H]1M9%(801B&1H5=(%DE$
M9N_M;@LKATE4N_T!\+_V,[+0]9_X2OQ??R>+/%'EPQQW][;01V]HMO*9(386
M4:F*U<'8S2!G?SEDEC:(SS*_V?7YX?M@_P#!.+PU^UA<?VN)Y-(UWRUC:]@C
M62.=59 INH"4,SI&K1Q2))"X#(':6.&*)? /@-_P1N\-?#75(]3\1:E)KZV\
MD<D%F;5;6U9E#Y%U&9;AKA-QC98PT2$H4E6>*1D'['45^6'[3'_!+K2_C5XE
MC\6>'M5D\-:H9//NGM[8RK+=*RO'=Q;)[=K>XW M*Z,1*X67:DWFR3:'Q(_X
M)?:'\2/"2:-<ZE<2^)/M$-U<^)[J(7E]=3)'Y+I,99/-^R>5A(;5)T6(QP.S
MS.DC3?0'[*/[(=G^S/9AKF_N-;UK[.EG_:=WNW16,3%H+&TC>2;[+:1\,84<
MB27YV.U88X?F_P#:J_X)4>&OVA]4EU[3+R30M4NI%>\,<"W%K.V'\R4V^^%D
MN)&*&2190CE&=H6FE>8FN?\ !,=/&GABZTO7_%&J:WKL\:1V^K:F9+R/3U%U
M'/*;&SEN"87GCAB@GD,[NP4E62-Y(7^H/V9_V+/!W[**2-X?MI'OIX_*GU"Z
MD\VZEC\QI F0J11IDJ&6".(2".)I!(\:O7/_ +7?[#GAK]KZWB?43)9:M:QN
MEKJ-N%,@5E8K%.C#$]NLC"7R\QNIWB*:'S92_G^D_LD?$.[MXM+UGXF:I<:2
MD:1R+9:;:V&H,L2CRRNI[Y[A7WJAED;S'G3>CL?,9J^O_A#\%_#_ ,!=+71O
M#5C'86*R/*8T+NSR2'YGDDD9Y9'P%4-(S%45(P0B(J_AC_P4F\+6?CGXZ^#=
M*U"/SK*^M]%MKF+<R;X9M6NHY$W(5==RL1N4JPSD$'!K[_\ ^&-?B!Y']D?\
M+-UC^POM&[R_L4/]J?9_M'G>5_;'F_:?-Q\GG;=F/E\CR/W%?7_P+^!>A_LZ
M:'!X?\/P>3:0_,[MAIKB9@ \\[@#?*^!DX"JH6-%2)(XU\0_;2_8MTO]LG2[
M6UNKJ2PU&PD=[*]1#,L:S%!/') 7C61)%C3!W(Z.B,K[/-BE/V5?V.D_9O2*
M>]US5->U&&S:Q@DO)Y!:VEJ9$8PV5F9)%MT98;59,O*2;=/+,2%HR?M=_L.>
M&OVOK>)]1,EEJUK&Z6NHVX4R!65BL4Z,,3VZR,)?+S&ZG>(IH?-E+_"'PT_X
M(EZ'X?U%+GQ#KMQJME'M;[)!:"Q\QE=6VRR^?<.8F4.CK$(I?F#)/&5^;]KM
M)TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4    5^2'QC_X)":'X
MKUQ=?\(ZQ<>&;C[0;DPPVXFAAF!1HWL@DMM):[75Y-H>159E$(@CC5*[#QU_
MP2UTOXCZ-9V.K:_JFH:LMY9S7VM7[&\O);6WBF22PLVE<BRMWDGDG0'[05D*
MF7[3LCV?9_[/7[,7A?\ 9?TY]/\ #5IY/G>4;JYD<RW%T\2! \TC?\"81QB.
M"-Y)&CBC\Q@?H"OF#]I3]ERU_:AL_P"R]5UG6+/2SY9EL;"2TBAF>)F97E:2
MTEF?EE/EF3R-T44@B$J!Z/V:_P!ERU_9>L_[+TK6=8O-+'F&*QOY+26&%Y65
MF>)H[2*9.58^6)/(W2RR&(RN7KY_^)'_  32T7XMZXGB76?$OBB?5X?)\BZ6
M[L86@\@[HO($%A&D&QLR#R53]ZS2_P"L=F/U_P"(_A=?>)-#&BMXAUB"4^8)
MM3M_L$5]*D@D!0NMCY,6 XV26T,$Z&*-A*'WL_S!^SU_P3QT7]E_47U#PUKO
MB"'SO*%U;23V,MO=)$X<)-&UC_O*)(S'/&DDBQRQ^8Q/W_7/^+/%-GX&TZ[U
M74)/)LK&WFN;F7:S[(84,DC[4#.VU5)VJ&8XP 3@5^0/A;_@F=X!_:>LX_&+
M6FH>'+?5]UU9Z;83P*JVDS%[>:42+>1K+.C"?R;8P6]K%)%:" R023S[_P#P
MY4^'G_02\0?^!-E_\@T?L5?!6\_96^)VN>"=*U>XU3PW_8ZZE/$T:[;&^FNE
MCM8)V0NJ7;6B,Y8"V-W%MD-OLAB*?6'[7?[#GAK]KZWB?43)9:M:QNEKJ-N%
M,@5E8K%.C#$]NLC"7R\QNIWB*:'S92_G^D_LD?$.[MXM+UGXF:I<:2D:1R+9
M:;:V&H,L2CRRNI[Y[A7WJAED;S'G3>CL?,9J^O\ X0_!?P_\!=+71O#5C'86
M*R/*8T+NSR2'YGDDD9Y9'P%4-(S%45(P0B(J\!^TQ^RKX:_:OTN/3/$,4@:"
M3S+6\MV5+JW8E?,$4CI(NR15"RQNKHX"OM$L<3Q_+_@#]B[XA^!-+MO#T?Q*
MO!HD$8MS!#HUJETMJ20T5O?233SP.J$I;R@N;8"/RU"QH@^O_@A^SQX?_9]M
M[B+1H9#<WTBS:A?W,KW%Y?7 7!GN9Y"69V8O(579"LDLKI&AD?.!^TQ^RKX:
M_:OTN/3/$,4@:"3S+6\MV5+JW8E?,$4CI(NR15"RQNKHX"OM$L<3Q_!_P4_X
M)1R_#3S+'4/&>L76@3[FN='L3+IEO=,_EI(MULNIQ)%+$AAF55CE="N)TV '
MT#P!_P $H_ WA[Q#?^(=73^T_M&H7%U9Z=Y2VVG6<4DRS0P_9XV/G>5AHL.P
MM9(6V-9C -?I_7/^*=&G\06<EM;7MQI\K[=MU;+;M-'M8,=@NH;B$[@"C;XG
M^5B5VOM9?S0U;_@DGX0UK69?$,NM^)%U::\>^>[BNK*&073RF8S(8K!!&_F'
M>OEA0AQM"X&/T?\ !7AFZ\*V[07FIWFJR-(7$]XEHDBJ54","RMK6+8""P+(
MSY9LN5VJOY8?$O\ X)+6>H>*'\3>"O$%QX39]SK!:6S-Y$T@9)C:RQ75L\$4
MBL1Y"Y5-TBHRPLD,?8?M ?\ !*CPU\7=+TVTTN\DTO4;&2=[G4Y8%O;K4FN2
M'FEOY2\$T]PTH\Q)#)LB#S1I"$=!%](>!?V18O _AZ;2H-=UA-7U#8VL>(8I
M8FU34&6%H K7%W%=O#%&K 6JPE9;8(I2?S&FDF\__9Z_X)XZ+^R_J+ZAX:UW
MQ!#YWE"ZMI)[&6WNDB<.$FC:Q_WE$D9CGC2218Y8_,8GW#]JK]F?2_VK_#4O
MA[4Y)(&$BW%G=1Y+6]TBND<ICW*LJ;9'22)B Z.VUHY0DL?S_P#LG_L )^S>
M]K/J'B+5-;;3I+A].M'DDMM-M&GC:-Y8[$33+]HVS72F0OL*W+_N1*!*<_XD
M?\$TM%^+>N)XEUGQ+XHGU>'R?(NEN[&%H/(.Z+R!!81I!L;,@\E4_>LTO^L=
MF/U_XC^%U]XDT,:*WB'6()3Y@FU.W^P17TJ2"0%"ZV/DQ8#C9);0P3H8HV$H
M?>S_ #!^SU_P3QT7]E_47U#PUKOB"'SO*%U;23V,MO=)$X<)-&UC_O*)(S'/
M&DDBQRQ^8Q/W_17XH^)_"2?L2?'6+Q;,([7PEXOCN+>\OYUD,%I?7/[^2)IO
M-?RWEN;>*?S9@ENL,]PB*L=J\L7[/:M9/J-O+!%-);221NB3Q",R1,RD"1!*
MDD1=2=RB1)$) W(RY4_GA_P[2T7_ (2C_A-/^$E\4?\ "0_:/M'V[[78[]^-
MNW;]@\ORMG[GR-OD>1^X\OR?DK[OU;PF^M:-+I$M]>+)-9O:OJ$3QPW@9XC&
M;E'BC2*.XR?,5HXU1),%8U4!1XA^R'^S9_PREX7C\-_VG<:KMN)Y_.F7RTC\
MT@^5;P[Y/)B&-Y3>^Z=YILCS=B]_\=/@7H?[1>AS^'_$$'G6DWS(ZX6:WF4$
M)/ Y!V2IDX."K*6C=7B>2-OR!_X<=:=_:/F_\)/<?V;]HW?9_P"ST^T?9]^?
M*^T_:/+\W9\OG?9]F_Y_(V_NZ_7[X%_ O0_V=-#@\/\ A^#R;2'YG=L--<3,
M 'GG< ;Y7P,G 55"QHJ1)'&OD'_#)O\ Q=#_ (65_;>H?\@_['_9>[]Q]S9M
MW[O^/3_EX^R[/^/[_2O._P"65<_^V]^QE_PV5IVGV/\ ;-QI/V"XDFVK%]HM
MYO,39F6#S8<RQXQ#+O\ W:23IL;SMR<__P $Y;J\3POJ>GM>7&H:1I?B#4M/
MT"\G99/.TBU,<=LT5PBJEQ$&$J)*F8UVF&/;'$D:??\ 7A_QY^"(^/FER:-<
M:MJFF6-Q')%=QZ<]M$US&Y3*2236T\JIA2I6%HA(DDD<HD1MH\@_9G_8GTW]
ME%Y%\/ZWKCV,\GFSZ?=2V<MK+)Y;1A\"R26-\%2S021&0QQ+(9$C5*X_]H7_
M ()XZ+^U!J*:AXEUWQ!-Y/FBUMHY[&*WM4E<N4AC6Q_W5,DADGD2.-9)9/+4
MCZ_^&G@>?X=Z<FGSZIJ&K^5M$=SJ+6[W 145%1I((+?S<;2QDF$D[N[,\KY
M7X@^-?\ P3GT[QKXHC\<>$M6N/"WB1;A9Y+BW@2>WE?$@ED:V+1?O9MRB<^8
M8)T$@EMY'GED;H/^&*]8^)O[CXD^+]0\3::GW-,M[>/1K.7/)^VI8OYEUL=(
M9;?,D?D21D_.LCK7W?I.DV^@6\5G9Q1P6T$:10PQ(J1QQHH5$1% 5450%55
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M+R+X?UO7'L9Y/-GT^ZELY;663RVC#X%DDL;X*EF@DB,ACB60R)&J5Q_[0O\
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M1N^S_P!GI]H^S[\^5]I^T>7YNSY?.^S[-_S^1M_=U^OWP+^!>A_LZ:'!X?\
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M.CK$(I?F#)/&5^;]KM)TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH
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MX=(HTR=TCDL50,4CE?;&_P"6'[&W[9OC3]H#XIZWX=\0PV^FV6EZ??+_ &5
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M7^T?[.\,>5]H_LW[1J'VC;O^S_:-EO\ 9O-Q^[\W9]J\G=\^SS]GR^97Z?\
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MHBBGBN+3S69UC6.)KN*%))69U"0H6E?DJA"L1]?T5^:'_!1;]M;2_@)X:O\
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MI&OV[WLNT113Q7%IYK,ZQK'$UW%"DDK,ZA(4+2OR50A6(^OZ*\?\?_'[PO\
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M-.\<V<>H:5=V]]93;O*N;:9)H7V,4;9)&61MK*RM@G#*5/((KS_XQ_'[PO\
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M#"F]@B[Y)"J+N9E5<D99@HY(%<_\+?BEH_QIT>WU[0;C[7IMWYGD3^7)%O\
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MC'&2"47'V_\  WP'8?$_X4>'M&U1))+&\\-Z3%<1QSS6[21FSAW(9+=XY0C
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M4\&VNKZ?I6GVFI7?B"+[3>06D,5Q-YMM>R2>;,B"1][@.^YCN<!CE@#7W?\
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M!^Q+X2N-.N(O%%G;^)-7U#S'U/6+^WC:\N)I4$;F&0#?91(H6.U@M6C6UC1
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MX3\6>*=3$EK?>,8UBT!+C=$UEI6GRK+I:.)(YW@2[GB6[OEMGF@N$>.>$([
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M -K'_DGGBO\ [%_5O_2*:O@#_@BI_P D\U+_ +&"Y_\ 2*QKP#_@N=_S*/\
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M2*\.Q(Y'D=X9)E@C0*7N/)!<)NS^:'P9_:TO/C;\'HOAOI\W_%8W5Q;>&[5
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M+/XG^,O!?AG3C;IK]]OMY))(V3$-[<PP6)FF6-BT2RK=D(OF-%F1O+'FC?\
M?_\ P5'_ .20^(?^X=_Z<K2C_@EQ_P DA\/?]Q'_ -.5W7W_ $5^ /\ S=Y_
MG_H7*_7[]K'_ ))YXK_[%_5O_2*:O@#_ ((J?\D\U+_L8+G_ -(K&O /^"YW
M_,H_]QC_ -L*_<[XA>-;?X:Z-J&N7BR/;:;9W%Y,D04R-';Q-*X0,RJ7*J0H
M9E!.,L!R/QA_9Q\&WO\ P5#O]0\8^.KF3_A%+*\:TT_PQ;W,\=NL\<(833M&
M8BSQQW6?/3;-/,[@F"UB2VD\O_;1\)Z=X&^/7P^T_2K2WL;*'^PO*MK:%(84
MWZW=.VR.,*B[F9F; &68L>237[/?M8_\D\\5_P#8OZM_Z135\ ?\$5/^2>:E
M_P!C!<_^D5C7S!_P5;U&\^$GQ3\(^-'M?/LK6WLY(5\U4\^;3-0DNIH<@.\?
MRSP#S&0K^\^4.4=1^_WA/Q39^.=.M-5T^3SK*^MX;FVEVLF^&9!)&^UPKKN5
M@=K!6&<$ Y%<?XN^+VE^"M;T7P]=-(=1UZ2[2RC1"5VV5NUS/)(YPJHJA$ R
M79Y4VH4$KQ_BC^WU_P G"^ O^X!_Z>;BOW^K\ ?V^O\ DX7P%_W /_3S<5^_
MU?A#\-/%FH_\%7_%NH"]N[C3?A_H7V?S-$BF>.;4O.D9X/MC1'8=S6WF289O
MLRJD-O\ OI);ZO'_ /@L'\*M#^#>G>#M*\/6%OI]DG]K'RH$"[V5--C\R5OO
MRRE40/-*7EDV@N['FOZ/J_ '_@AC_P S=_W!_P#V_K]_J*_ '_F[S_/_ $+E
M?K]^UC_R3SQ7_P!B_JW_ *135\ ?\$5/^2>:E_V,%S_Z16-?('[/GB.\^!?[
M36LZ?J(M[9=:U#5K>1IY%_U-^QU&Q,3K($$L[+:(B-N8^<8?+$Q&S^CZOP!_
M:<\.6?Q-_::\,Z?HIMX[VS_LNXU-C&T6Z:Q:747#N(_WLILD@2-_F7_50M(@
MC;RS_@N=_P RC_W&/_;"OW^K\ ?V!?\ DX7Q[_W'_P#T\V]>_P#_  6K_P"2
M>:;_ -C!;?\ I%?5]_\ [)W_ "3SPI_V+^D_^D4-?E#_ ,%A] _X6AXA\">&
M+&XMUU*]N+R!8Y),>5]NFL8()9E0/(D3.D@#A&W>5(%#,C >O_\ !:O_ ))Y
MIO\ V,%M_P"D5]7W_P#LG?\ )//"G_8OZ3_Z10U^0/[?7_)PO@+_ +@'_IYN
M*^__ /@J/_R2'Q#_ -P[_P!.5I1_P2X_Y)#X>_[B/_IRNZ^</^"U^K6\/@72
MK-I8Q<RZY%+'"742/'%:72R.J9W,B-+$KL 0IDC!(+KG]/O@AX*N/AKX5T30
M[QHWN=-TNQLYGB+&-I+>WCB<H656*%E)4LJDC&5!X'XH_P#!#'_F;O\ N#_^
MW]??_P#P5'_Y)#XA_P"X=_Z<K2C_ ()<?\DA\/?]Q'_TY7=?F!^TAXZ_X9B_
M:7@\5ZU#MTV?['*LF_.+.?3QIDUSMB663]RZSOY6P22^3M4!9$DK^CZO#[+X
MWV^K>-9O!EI;R3R66EB_O[U&5H+6269([6SDV[BMQ-'YUP$D,9$,:.BRK(QB
M]PHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MK\0?VJ_V2_B9X=^*\7Q-^'L-OJ4LOE2&&1[>+[.T-K'920S+<S1"6*XB#8DA
M995WR+B%XXII/T/\-Z)\2]$T:[O;R30[_P 57LFU(?M%]:Z/8V\<3K (D\JX
MFN'\TF>X++;33^>T!N1%:6N/B_\ 8&_8R^(?[&NHWWVEO#]_INK?9%NO+O;V
M.XA^SN^)8=UB8Y,)--F%_+\Q_+_?PJK;_4/^"@?[-'CK]K>RM] T<:'::3:W
MB7@N+J\NS=32+ T2CRH[)HH44S3AAYDYE'E.&AP\;?4'[+7A+Q5\.O#5CH'B
MB+2Q)I5G;6=O<:=<W$JSQP*8E,D5Q;0F%UC2($K),)7,CA8%VQU^4'[8/_!*
MO5(=9_X2KX6>7;R>8MPVEI.+22"Z65"LNG2DI%&F29O*>2$6YC/D,RO%;P]A
MX%^!O[0W[0/G:+\0M:_LCPW/LCU!8AIGVRZMVW&2&V>PB?9NV+%*9I(T\N8_
MN[I!) W[/>$_"UGX&TZTTK3X_)LK&WAMK:+<S[(84$<:;G+.VU5 W,68XR23
MDUT%>/\ QT^!>A_M%Z'/X?\ $$'G6DWS(ZX6:WF4$)/ Y!V2IDX."K*6C=7B
M>2-OS!^!WP?^-O[#>-&TBTT_QEX9>XN'BMA>K97%JHW;2CW91+?SV=9I($%]
M$KQR[6B>5II?H^]^,/QP\7O#9Z9X'TO0Y'D)DOM5UN*_M4C6-SM,-AY=P'9P
MBJZB4 \-&%8R1^X?LV?LV?\ "B/[3U#4-3N-;\0ZW<+/JFJ3KY7G>5O6WBBM
MU=XX(H4<JB*3C)4%85AAA]_\6?VC_9UW_9'V?^TOL\WV/[5O^S_:-A\GS_+_
M 'GE;]OF;/GV9V_-BO /V0_^%@?\(O'_ ,+)^S_V[]HGQY/D[_L^1Y?VC[-_
MHWFYWX^S_)Y'D[_W_FUX?^VU^Q_JG[5VL^&WL-3DT6/1H]2N?[1BC$LD5TTN
MGFV1$6XMY5<B.:59D)$9A .UG0T:3\2/CA\-;>*PU7PII?BJY6-"=3TS68M.
MC8!0A6:"]A5C<%E:61X4CMR)45(T*,!Y?XP_9=\<_MJZYIU_\1EM]$\(V69E
M\,VEZUS<R7"'9F[N8HTA;S1N(EA=GAMF\B)(9YKBX'ZOU\@?LF_\+0_XG?\
MPLK^S_\ D(-_9?V/9_J/FW[=G_+I_J_LOVC_ $[_ %WVC_EE7U_17XP_LM>
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MK),)7,CA8%VQUX_^W'^PYI?[7NEB2,QV?B.SC(L+\@[67);[+=;06:W9B2K
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MO[8.AV<.FS6]MK6FW#26LUR91"T,P5;F%S%OV;MD4JR>5*P: 1@(LLCCY_\
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M7Q+\)7.A:';:/'>ZMI\UI?27E]<^3:_:(UCE%N(K(O<_*\RQR2?9=C"*5HI
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M9$S\(?%S_@IAJ?[.NN06'C3P5J&F:;=>>]M=I?VMU-+#&65"(HA]F\W/E^?
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MJQF1XV2NO_9<^.G_  TIX0T_Q7]C^P?;_M/^C>=Y_E^1<RV_^M\N+=N\K?\
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M'Z************************X_Q_X_TOX6:7<ZUK5S'9Z=9QF2>>0G:JY
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MBBBBN/\ !7P]T;X:V[6>AZ?9Z;;/(97AL[>*WC:0JJERD2JI<JJJ6(R0JC.
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M%%%%%%%%%%%%%%%9^K1W$UO*MG)'%<F-Q#)+&TL:2%3L9XUDB:1 V"R+)&6
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MJ=QK6FZG<1+8:G=FYDE#W" 6DL#RB61HIG"VL\.YX+>Z#LDX6*X:?L/^"O\
M-XQ\(:#'J=KXBDM]"O+R'3SH]K;?9V<2VMTTKW-ZLQEN$<*\;6VR.W*&/=&T
MD9DDZ_X1_LK:Q^USX!T./QIJFH:1H::/IEOINC:3=1JL]O#!"1>ZE(\,J7$M
MPT<<]O;A0EC$L8RUR\Y7Y@_82NM<_8^^,=]\*+F\_M#3;SS?N,4A69;,7\%X
M(G5V25K=!!/$CJI9UW2SK;0D_P!#U%%%?S _LT_\G0W7_8P>)_\ T5J-?O\
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MCY_^W5^PSX8_9N\)R>.? +7GAW5M%DB)>UO+IFGCNY8[-E\R2=I874395XF
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MFP^8'52DEU9C];_V\/@K9?'OP5J.O#7=4&G66AW=];6>GW<"Z;>M%";R&:X
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MXBU!<7MS;O'<ME3YDUK-):R381(T3SFA,WEJH6/?Y8+!0Q^GZ^ /^"@_[/\
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MQ]\8[[X47-Y_:&FWGF_<8I"LRV8OX+P1.KLDK6Z"">)'52SKNEG6VA)_5_\
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M0_ODA1HO3V_98E_9Y^)W@J7P]>:@O@Z:XU*(:/->RS6=A?#2KZ1'MXYIG?\
MTA3<R$[6,4BS$S;;B.)/U?HK\@/$GQVUS]KOXJWOPVT#5KC1?#>BV]RVJWFG
MR&WU*ZFMWBC=8+B2W=H/)NWC@*Q[%FA2Z<SRI+#&OH'Q+_X)=>%;73GN?A[]
MH\,>)K?=)8ZE!?WQPQ1D:&4M/(Z12J[(\D($J9#8E0/!+Q__  3#_;!UGXOI
M?>"?%_F?\)#H<>4EG65;J>WCD\B9;L,F!<6TABC=Y&6:<2J6C:6*>:3\\/\
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MNN_)TVS_ +&NF\Z;9;P;M6E\^<[R(X\I#'YLAQE(DW':BX_?ZOP!_P";O/\
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M[_45^ /[ O\ R<+X]_[C_P#Z>;>OU^_:Q_Y)YXK_ .Q?U;_TBFKX _X(J?\
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M_P!(KZOO#]F35K?0/AIX:O+R6."V@\-Z9+--*ZI''&EC$SN[L0JHJ@LS,0%
M)) %?!]C^T'XY_;YUC4=)^'=U_PCO@RSWP7'B5[5GO+F4QNICM4=X_+W^9'(
MH3RKJVC1+A[B"2:.T;X@_:/^#%G\#_CKX'L;:[U#4);BXT*YNK[4KIKN\N9F
MU:6(/+*P4?)%%#"BHJ*(XDX+[G;]WOVL?^2>>*_^Q?U;_P!(IJ^ /^"*G_)/
M-2_[&"Y_](K&O /^"YW_ #*/_<8_]L*^_P#_ (*C_P#)(?$/_<._].5I7/\
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M[2AY<D]C='Y6M+VX9IGB@ A6>)B9)I 67Y__ ."U?_)/--_[&"V_](KZOO\
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M82.RQ[6+!3S_ .WI^P7;_MB6]I>6=W'IVMZ='.D,SP*\=S&Z[DM[AUQ,J+*
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MDM9Y-2OMJW7GQBV $MT49VF,:1QL&$CLL>UBP4_GA_P7._YE'_N,?^V%?O\
M445^ /\ P0Q_YF[_ +@__M_7Z_?M8_\ )//%?_8OZM_Z135^(/\ P2V_9<^'
M'[2GA[5/^$DT_P"WZU8:@-W^DWL'EV<\*?9_]1+%$VZ6*ZZ;I!M^;"F//Z?_
M /#KCX0_]"]_Y4=2_P#DNO/_ -M#PUH_P6^!.MZ5X-?[)IMILM8UM[J279YN
MK1Q7T#3-(\AR[W$,\;N<9D@8!04'H'_!+C_DD/A[_N(_^G*[KY__ ."U?_)/
M--_[&"V_](KZOO\ _9._Y)YX4_[%_2?_ $BAK\@?^"&/_,W?]P?_ -OZ^_\
M_@J/_P DA\0_]P[_ -.5I1_P2X_Y)#X>_P"XC_Z<KNO@#_F[S_/_ $+E?O\
M5^ /_!#'_F;O^X/_ .W]?K]^UC_R3SQ7_P!B_JW_ *135^(/_!+;]ESX<?M*
M>'M4_P"$DT_[?K5AJ W?Z3>P>79SPI]G_P!1+%$VZ6*ZZ;I!M^;"F//Z?_\
M#KCX0_\ 0O?^5'4O_DNNP^)G@/P_\,/A#XDT;PND<>DV>AZ_%%''.]PL<@CN
M_M"&21Y'+K.95D5F)C<-&0NW:/D__@BI_P D\U+_ +&"Y_\ 2*QKP#_@N=_S
M*/\ W&/_ &PK]_J_ ']@7_DX7Q[_ -Q__P!/-O7G_P#P53_L?_A<GAC_ (2'
M_D"_V?I?]H_ZS_CS_M.[^T?ZG][_ *K?_JOWG]SYL5^G_P#PZX^$/_0O?^5'
M4O\ Y+KL/AU^Q!\,/@+K=AK.CZ9'8:LLDL5C(^H7CL\DEO-YB1QSW+I(_D"=
MBNUBJ*\@ V%E_-#]OK_DX7P%_P!P#_T\W%?O]7X _P#!#'_F;O\ N#_^W]'_
M  7._P"91_[C'_MA7[_5^*/[:?\ P3#U3Q_X@N?'/@*^CM-6DDCNWL#BU/VJ
M%&8SVEU%M$=Q+(D3@2A ;AYKA[Q,A1X_^S)_P4=\6? _Q G@'XJ0222)>06;
M:A<R10W%@I01JURY BNK<GRIC=M('\EY;GSKM6B4?T'45_/#_P $5/B7_:'B
M'Q3I]\]Q<:EJ=O;:BUS(WF;_ +--*D[32.QD:5WO8V!(;?B1F8,%#_T/5_/#
M\.OAI_PB7[5]U!IZ7$]O%<7VHW,A7?Y/]H:6\\C.R*%2(7%V(8RV,;XHRSR,
M"W0?\%SO^91_[C'_ +85^_U%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%9^K:FFBV\MU*)&CAC>1Q%%)-(512Q"11*\LCX'RQQJSN<*JLQ /\
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MSQ#9:?<:E\/]4W"?[+YS+:6[SKY22[Y&1;NU:18K:2Z8I=Q22(DL4TTWV?\
M0_5O^"B_ACQU;RV'P\%YXE\1RQNMI9VVFW0CBD92D5Q>O<+:)%9+,T*7$OF@
MH) >!N9<_P#X)\?LHR_L:^$KR[UP;M:U#;=Z@ELDMPT,,$;&&T1(3+]HECW3
M,QMXRTDLQA3SUCBD?X ^V:U_PT-_PL+_ (1CQ1_PCWVCR?/_ +"OM^S^S/[.
M^T>3Y7F>5O\ WV,>?Y'/D^=^YK^@[2=336K>*ZB$BQS1I(@EBDAD"NH8!XI5
M26-\'YHY%5T.5958$#^?']L6\UKXD_%_P[XOT;PQXHO-(T+^R?/E70KZ-I_L
MM[)>2^1'/%$YPLHC'G"',JM_RSVR-^WWB/XU6/A_0QKRV6L743^8(;2WT>_:
M^D=!)A#9M DT.\QE4DN5@@RT9,JI(C-^,/\ P23TO6O@%J.M:?XET#Q!8?VQ
M_9PM;F31KXVX>!YT*32+"?)S]I5A)(%@5(Y&DECPH?W#_@K:VI?%70;+PKX?
MT77-3OK?5(KR>6UTF\EM8XTM9D ^TB+RI7<W*[1 90ACE61HW54;[?\ V+O%
MYUKP5HVF7%AJFFWVDZ786=W;ZCIUS9L)((?()C>:-8ID8PF0&%W*(\?FK$[;
M!^$/[-'QFU3_ ()7^,=7\/>,]+DEM+^.$S2VN'D9;?SOLMU9M(T44]O(9)$=
M7,;J>ICFMY;9^O\ ^"L>O>+?B39^&=?U?1?[(T5OMZ64,CR27T;3-$R_VD!&
MMO:2SPQ120V:/-+&4N1)*60I%^Y_[.OQFU3X^6\VOMI<FE^'KF.V.C"[PNH7
M*E7:>ZFB1GBAMW+1+9J'=Y$CDN"?*G@ _!#_ ()\_&^\_8B\4:_X2\0^'M8N
M]4OOLZ?8].@6YO$FLA/)A;?>@FBDBG>83Q2,OEQK(BR12^8GV!_P4NO_ !-\
M:/!ND^'8O#^L7.OKJ$.HWT5CI5Y/9V2FVFVVOVQ5DANI8Q=)"TUJSQ2R03R,
MMKN2W'Z'_L7>+SK7@K1M,N+#5--OM)TNPL[NWU'3KFS8200^03&\T:Q3(QA,
M@,+N41X_-6)VV#X__P""GG['VL_%]+'QMX0\S_A(=#CP\4#2K=3V\<GGPM:%
M7P+BVD,LB)&JS3B5@LC2Q00R=!\(?^"K?@S4-+6/QQ+)X>\1VLCVVH6#V5[(
MJSPG:[Q^7#*T:%L@PS$30NKQ-Y@19I>/\-_ G7/VN_BK9?$G7])N-%\-Z+;V
MRZ59ZA&;?4KJ:W>61&GMX[AV@\F[>2<-)L6:%+5!!*DLTBT/^"MK:E\5=!LO
M"OA_1=<U.^M]4BO)Y;72;R6UCC2UF0#[2(O*E=S<KM$!E"&.59&C=51OL_\
M9$^(*_\ " Z7;7NG:QI]WH>CV=O>VUYI5[#-NM8/*8VZ&$_:]_D,\:6IFEVO
M$KQI+((Z_*#[9K7_  T-_P +"_X1CQ1_PCWVCR?/_L*^W[/[,_L[[1Y/E>9Y
M6_\ ?8QY_D<^3YW[FOVN^-'QL3X2>#K[Q?%87E_':68NDLTADAN&5]N/-CE0
M2VZ(&\RY:2/?;0I*[1%HS&=#X _%G_A>OA?3/$OV*XT[^T;<3?9;@?.G)7*G
M WQ/CS()=J>= \<NQ-^T>P5Y_P".OB78_#OR?MD6H2^?OV?8M+O]0QLVY\S[
M#;W'E9W#;YFS?AMN[8^W^;+X0Z=XJ\ ?&6;XAW7@[Q8^DR:IK-X(8]%N#=>7
M?I=+$"C!8MZF=/,'F8 #;6; S^_WC']I2ST+1I]3L-,UR^N1'=?9;(:%K$4D
M]Q!$LBQ-NL"T"2M(D:7$J"$DR;6<PRA/Q@_X)=:AXC_9<U35;/Q+X4\206.L
M1VQ%\FC7\JV\EF)RJR0QVSRLDHF90\88HZH#&4=Y(OZ'M)U--:MXKJ(2+'-&
MDB"6*2&0*ZA@'BE5)8WP?FCD570Y5E5@0-"OPQ_X+<^ -4UW2_#VM6MM)+IV
MFR7\=[.@!6!KLV@@,@!W*CM$Z"3&P/LC9@\L2O\ ;_[/'[9MQ^TK;PZK8:!J
MFG:/;V<MUJ-[=6K3QS2(IC%GI7V=S->/YJS,\R0L5%L+<VHGO(S!^:'VS6O^
M&AO^%A?\(QXH_P"$>^T>3Y_]A7V_9_9G]G?:/)\KS/*W_OL8\_R.?)\[]S7Z
MO_M=_$%?^$!U2VLM.UC4+O7-'O+>RMK/2KV:;==0>4IN$$(^R;//5Y$NC#+M
M254C>6,QU\8?\$DFU+X5:#>^%?$&BZYIE]<:I+>02W6DWD5K)&]K"A'VDQ>5
M$Z&V;<)S$',D2QM([,B^7_\ !1S]B[Q1:>*(OBGX'^T7U^MQ92W%G%")[BWN
M+011VUS;0A&\^+]U%YL161XW!E(DMWD%MQ_P7_X+&^)=<M['19?"<GB#7?+*
M/)97+1R7;1JS&1;.*RG*OY:[Y1&=F5>14BCQ&GZG_LE?!S7/!,6J>)O&#6[>
M+/$MQ#<ZBML"(;6&"(16=BF'>-_LZ;PTJY9V<JTUR(TN)/K^OR _X+5_\D\T
MW_L8+;_TBOJ/V8_^"@OASX0^$M$\/_$#[1H6I6FCZ>UL[64\MM>V,D9%E/:O
M;&Z9_P#1TB^T&01 7)EC50T<D<5#X>^"-9_;N^)&G_$74[.\TWP5H$=O)H=I
M?QRV]Q>7!C6X6Y2))V0()F28W49\FYA@M+?9-B=H?;_^"F^LW7B#P)J'A32M
M*UC5-4U+[$8EL-,N[F&-([M)V>6XCB,*X%NR>6':?=)$QB$3&13_ ()D:S=>
M'_ FG^%-5TK6-+U33?MIE6_TR[MH9$DNWG5XKB2(0MD7"IY9=9]T<K"(Q*)&
M_/#]N"+Q+^R#\9X/BLMA'>Z3=20B!MS",LNGK97%K*ZC,%PT:RRV[$2(PVR
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MT:(TLTB_95,<TL9/Z/\ _!5/]C^\_:!T.VU_P_:_:-=T?>'AC"B:ZL6!9XT
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MHHHHHHHHHHHHHHHHHHHHHHKX _X*C_\ )(?$/_<._P#3E:4?\$N/^20^'O\
MN(_^G*[K[_HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK\@/\
M@M7_ ,D\TW_L8+;_ -(KZOO_ /9._P"2>>%/^Q?TG_TBAKZ HHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKY@^,?[&W@
MG]H"\6^\3V-QJ$J9\I9-2U!88=RHC>3!'=)##O$:&3RD3S&4.^Y\L>_^#GP(
MT'X!6;:?X=AN+:R.-MM)?7EU#'AG<^3'=3S)!N:1VD\D)YC$,^XJI'L%%%%%
M%%%%%%%%%%%%%%%%%%%%?/\ \:_V7_"O[1/EKXGM;B^BAVF.W_M"^AMPR>9M
MD^SP7$4)E E=?.*&4HVPOL 4'P4_9?\ "O[.WF+X8M;BQBFW&2W_ +0OIK<L
M_E[I/L\]Q+")2(D7S@@E"+L#["5/T!111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111117S!\8_V-O!/[0%XM]XGL;C4)4SY2R:EJ"PP[E1&\F".Z2&
M'>(T,GE(GF,H=]SY8]_\'/@1H/P"LVT_P[#<6UD<;;:2^O+J&/#.Y\F.ZGF2
M#<TCM)Y(3S&(9]Q52/8*****************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M*Y_Q3XLT[P-9R:AJMW;V-E#M\VYN9DAA3>P1=\DA5%W,RJN2,LP4<D"N@HHH
MHHHHHHHHKG_"WBS3O'-G'J&E7=O?64V[RKFVF2:%]C%&V21ED;:RLK8)PRE3
MR"*Z"BBBBBBBBBBBBBBBBBBL_5M6M] MY;R\EC@MH(WEFFE=4CCC12SN[L0J
MHJ@LS,0% )) %&DZM;Z_;Q7EG+'/;3QI+#-$ZO')&ZAD='4E61E(964D,"""
M0:T********Y_4?%FG:1>6NGW-W;PWM]YOV2VDF1)KCR5#R^3&Q#R^6I#2;
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MW&H2I_9'E+(0L,.Y;Q&\F",)##O$:&3RD3S&4.^Y\L?V>HHHHHHHHHK\,?\
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M2()AYY6,>63NB\W+$[&K\\/'_C_2_A9^U1<ZUK5S'9Z=9QF2>>0G:J_\(X
M  69V8A(XT#/([+&BL[*I^D/VE/VY/C#\*K/_A)+3P7;Z;X9/EJLVIL;J['G
M,QAEN8;2[B>RWJ8T>&9&\FX/DM.SR(E?H]^S%^T+IW[4'A>T\2Z>GD^=OCN;
M4RI*]K<1';)"Y0_22,LL;R0212F./S HY#]H[]JFW^!]QI^AZ98R:[XJU:15
MT_1;>58I'CW'S+B>4JZVUNBJY\V12&*/TBBN)H/D_P",?[1OQK_9>LU\0^)]
M'\+ZMH$&?MQTFXN[>:'>R0P9>\9C\\LJ8\J"Y^5'#^3E9*^__@7\=-#_ &B]
M#@\0>'Y_.M)OE=&PLUO,H!>"= 3LE3(R,E64K(C/$\<C>P5\P?MH?!R\^/OP
M_P!;\.Z>V+VYMTDMEPI\R:UFCNHX<N\:)YS0B'S&8+'O\PA@I4_SX_L/_P#!
M0/5/V.+B?PQXHM[RYT*.296L]@%YIUTK-YBQ1S-& C2 K<6TC1A)"TZ%9/.C
MN/Z;?AI\5=#^,FG)JOAZ_M]0LGVCS8'#;&9%D\N5?OQ2A70O#*$ECW .BGBM
M#X>^"K?X:Z-I^AV;2/;:;9V]G"\I4R-';Q+$A<JJJ7*J"Q55!.<*!P/F#XW_
M +5-QX=\06_@7P98QZUXMNHVDFC>5H[/2K<I\MWJ,B*S! S1O]F3;-+&P >.
M2:T6X^7_ (J_MA?%+]D2XM;_ .(>BZ'?>'+J2*W-YH4\\<D5Q(SN5"7LA>5U
MAAF?R_*BA<M&/MD9#+7Z?^ /'^E_%/2[;6M%N8[S3KR,203QD[67)!!! 975
M@4DC<*\;JT;JKJRCX0U+]K7Q;\=-8N=*^$FEZ??Z?I]P(+WQ)JDTBZ7YPCD>
M2"WC@*S7&"(0+B$RJ"X)A^SRPW3^(:W_ ,%%/%7[,?C&/PO\5]-TM;:YCMYH
MM3T5[@QQ6\OFH9V@G,LTR"5/+=0+>:,12ND=R&A#_1_[9O[8^N?L?10ZE-X=
MM]2T6YN!;0W4>K&&99C%YH2:V:Q?9NV3>6T4DZE8BTAB9TC/U_\ "?QU_P +
M0\/:5KWD_9_[3T^TO?(W^9Y7VF%)O+W[4W[=^W=M7=C.T9P/@#QW_P % =<^
M$WC[2? 6O^%[>&XU:XT^.&\MM9-Q"8;V<6XF16T^&0^6XD5HY!"S-&<'RV21
MOK#]IO\ :+3]FS1GU0Z3JFKR>7.ZQ6%K))'$L$1D:6\N IBM;<':'D?<X#,Z
M0RK%+L^ /@7_ ,%&_&/[1.C:B/#/A>/4_$<=Y<^5:QS?9[.PT\Q1_8Y;V[N7
M1+FX>9I$%O UN]Q';SR!;8("_K_[/_[8'CJ_\-:EK?C[P=JEO/;7D$%C;:5I
MEVUU>"52T@%E.[2QI !O:ZEDCMY1)Y*?OXRDNA^P/^V]J/[9MYXA>YT^WTZR
MTW^SOLD,<CS3?Z2MP)?.F;8DGS0!H]D4.Q6*MYA&\_('_!6OXR>.TT.71FT/
M^S/"=QJ$=M)J4MU:3S:BT8^T0(D$4CR6L6^"28,P,LBQP[S;DRV\GU_^Q3\5
M?'>J:+X7TJ^\'?8] &CV<:ZW_;5I+NABL5,$WV)$$P\\K&/+)W1>;EB=C5Y?
M\2/^"F%[IWCK0_!FE>'[RSCU'5+"WFO-:MI[226UN+MK5Y+2S;RY0C *\%Q,
MP((DC>S#+D?K?7QA\;_VJ;CP[X@M_ O@RQCUKQ;=1M)-&\K1V>E6Y3Y;O49$
M5F"!FC?[,FV:6-@ \<DUHMQ\O_%7]L+XI?LB7%K?_$/1=#OO#EU)%;F\T*>>
M.2*XD9W*A+V0O*ZPPS/Y?E10N6C'VR,AEK]+_"WQ5T/QIH<?B:PO[>719;=K
MD7I<)"L* F1Y&?;Y7E[6$RR;&A9'60(R,!\(> _V@/BO^TW8)XE\"Z;X;TWP
M]/)/%:#79[R6\N5@F>,W)6Q'E0(Q7R_(<NZ21R,))(FB<^H?LI_M2:Y\?M<\
M2:/KFA?\(_<>'_[/B>T><W,QFN3=L[F4)%&T3)%"T!C0JREI5FECECV?;]%?
MS _\$5/^2AZE_P!B_<_^EMC7]/U?/_P%^.EG\>6UVYTR>WN]-T[6&T^TN;?=
MMF6*RLY96+L2LF+B:=$EC BDB2-DWJ?,?Q#]L']K'Q+^R?;_ -KCPO'J^A>8
ML;7L&J-') S*@4W4!L7$*/(S1Q2)),A*H':*2:*)O0/V/OVDKC]JKP__ ,)&
MUE9V-L\C11PP:BU[<))&[K(ETGV6W6W?:(I8E#2F2&9'(C!7?X?:?MC>.=7\
M:7_@?3_!5O>7NE_9#?WD6NLMC;I=QQ21N\TVF1.<++DQI&T[B.8Q12B-C7W_
M /VU_8VG?;M7:WL_)M_.O&\_=;P;$WS'SY$AS%'ACYKI%E!O9$Y4?GAHG[3_
M ,1OVE;B2Z^&.C:7!X:ADN(XM;\0/<I'J+1-$F;6VM]EQ&F\S;9'61) A5VM
MKB-[>O/_ (3_ /!136?#WCQ_AO\ $K3;.SU9KQ+6WOM+>5[5I+A839HT+F64
M).)-RS[P4,L,<MM#MFDCS_\ @M7_ ,D\TW_L8+;_ -(KZM#X;?M,^+-1\"Z%
MH_PLT"/Q%?:;H>CP:A?SW,4&GV=U]DMV:T'F30&\N%CW?:$AE06;O )&9V>%
M=#]A+_@H?J/[0FN7WA#QA86^EZ_!YKVZQ*]NLGD$)/:O!<RO,MW$=\A52VZ)
M)MR0_9RTOV_^T[^T+IW[+_A>[\2Z@GG>3LCMK42I$]U<2G;'"A<_620JLCQP
M1RRB.3RRI^(/^%Y?'SQ+X7_X332-%\+M87-O]NL]*S?7.J&SD.^'_5RQV\TI
MA*R[49))!\JP+<$6P^D/V+?VTM+_ &R=+NKJUM9+#4;"1$O;)W,RQK,7,$D<
MX2-9$D6-\C:CHZ.K)L\J67Y?_;;_ ."F%[^SA<-I.C>'[QKLR2QQZCJMM/;:
M?(T+0F0VB?NY;U '>-I%>!$?RI4:XAD4MZ!\8OVN/'GB.WN+SX3^&8]=TFRD
MD676KB56M[IK=7^TQZ?:)/!<7B*^U([J!I$FFCGAABEPDIT/^"?'[>'_  U_
M9WEEJL%O9Z_I^V26.!ML-Q;R,P6:"*21YE\H[8[@$NBL\+B3]^(HOJ_]H?\
M:!T;]F7P_-XCUPR&VBDBB2&'RC<3R2N%"0)+)$LCA=TK*&!$,<CX(0UXA\-/
M'/Q.^-OAY/$UF/#^B+J%NMSI>EW=O=:BYA>%7@>ZOK>\M$C\]B7VQVLC00/'
MN#S"2-?#_!O_  5)LM=O;G0;KPEXD?Q'I\ES'J&G:5!!JJP-;SF!R)HYHFD0
M-L#2>4J!VV*SC:[_ '_J?Q>TOPQX:'BK6FDTC3A9Q7<XOD,4]LLJJPAFB&YA
M<!F$7D)O=IB(D#N5!^(-,^.WQC^.&EGQ-X*T'0[#1I(Y7L+77);HZE?QH6:&
MXC6!HK>!+A"BQ1S28W R_:&MI(I3T'[)'[>EO\==4N_"'B.TCT7QAITDD$UF
M)UE@NI+8;+HVKC(#QR)(6M]TI6$"1)[A%F:+]#Z**_)#2_A"G[<Z>/\ Q'=+
M'(M]'<>&O#+N\BVHM=-D$\5['=6^T7-O<:BJ7!;RYC";=[=99XB\=?&'_!';
MXQR_#;Q1JO@'5UN+>74<R6]O,95\B^L1)]IA-N4(BEDB#-+(YB(^Q)"P=VC5
M?Z/J\?\ CI\=-#_9TT.?Q!X@G\FTA^5$7#37$S E(($)&^5\' R%50TCLD22
M2+\867Q.^/\ X^LIM:TSP[X;TBV,8DM-)U6>[EU*1?(20 O"\,"/(Y9%CN1:
M/"P\N94"^:Q^Q+_P44M_VK;>\L+C39(/$>G6?VIK.V=7COHT5$D>V>8Q)"YF
M<((+B4!!)$?M,H$S1?F!^UQ\:/B'XI^*_A%/$/A^.PN;"\T^ZT;0DOK69IFF
MO(U/F7\>4#W$UL(@SA$@1$/E9\R6;][O@7\1/%_CW[9_PE?A?_A&_)\G[-_Q
M-;;4?M._S/-_X]U7RO+VQ_?SO\SC[AKZ KQ_XZ?'30_V=-#G\0>()_)M(?E1
M%PTUQ,P)2"!"1OE?!P,A54-([)$DDB_*&D_%?XQ_&NWBUSPGI/AO2-$NHTDL
MDUVYNKB\NK>51+#=D:<3# DL4D8^S.SS12))N=E*&N/_ &>O^"C'_"8>*'\!
M^.])_P"$:\21>5 NZ??;W5Y@;XTRH\GS<K)9#S+B.X1PJ7#NT'VCT#]N_P"(
MGB_P]X>US3=(\+_VGHMQX?OOMFK_ -JVUM]C\R&X2;_1)%,LWE1!9OD(\S=Y
M:X8$U^<'_!+_ .*OCOP-X-O;;PQX._X2&R;6)Y)+O^VK33]DQMK16A\J=&=M
MJJC^8#M/F;0,H:_?[PGJ-YJ^G6ESJ%K]AO9K>&2YM/-6;[/,Z!I(?-0!)?+8
ME/,4!7V[@,$5T%%?@#^WU_R<+X"_[@'_ *>;BOW^K^?'_@I7X_3P9\;/!5UJ
M=S)'I.F1Z3?2@F1XX5&J3-<S+$@8[VC@3?Y:EY!%&N&VH!_0=7X _P#!9G_B
MW?B'P;XKTO\ <:U%]JV7/W\?V?-;7%K^ZDW1'RY;B5^4._?M?>JJ%_?ZO'_C
MI\9M.^ ^ASZQJ$MNC#]U9PW%REJMU>2 BWMA-)E(O,8?/*X\N"(27$I6&*1U
M^</V ?V2-+_9;\-"2UNX]2U'6([>YO;^"0O:RJ%9H$M,?*UNBRN4FQON"[2M
MM0Q0P_=]?GAX#LG_ &Q/&*>+Y9I!X/\ #%Y/;:+9$1R6^IZE!OBEUG=L:*2W
MB+^5I[QR3,)H6G62U?SH9?A#]@7_ ).%\>_]Q_\ ]/-O7[_445Y?\7OBBGP@
MTMM3?3]4U1A(D:6>E64E[=2,YZB-,*J*H9FDE:- !L#&5XT?XP_8'_;>U']L
MV\\0O<Z?;Z=9:;_9WV2&.1YIO])6X$OG3-L23YH T>R*'8K%6\PC>?/_ /@I
MU\9/'?@_POJ]CHFA^5H#V\4&H:_-=6C9ANSY$L%O9>8TWSF6.$W#KN7=-LA7
M$5V. _X)O?%7QWI?@GPYI5CX.^V: ;B>-M;_ +:M(ML,NH3F>;[$Z&8^06D'
ME@[I?*RI&]:_9ZBOS@TG]I;Q]^T?>:FWPQLO#ZZ+I&H3:>^IZS=3S+J$T:HS
M-9QZ?G9$F=PED=UN(IH'38PFC3H/@9^U)XM\8^/I_ /BG0K?2KO3]'EO9[J&
M>2>&_99[6&*XLMZ1^7:/YD[;',\JMMA=XY8)D;W#]IC]IC2_V:=+CNKJ.2]U
M2]D^SZ3I-OEKK4+IBJK%$JJS! S)YLNU@@9559)I(89?D_XE_&3X[_"[3G\3
MW6A^%Y](M]UW>:;!=7)U&TL8T:>99;F22.U>6*-#$\MNDX:8AX[:6/('TA^S
M/^V#X?\ VF_#4FOZ=YD<]G'G4M.57N+JUD"LQ58H4,MPCA6-L\49-P 4$:SK
M+!'\(:C_ ,%998/'=KX=E\.:AINFKYJW,-Y:RMK5Q-):"2R@M[&,A899;@I#
M&)&G69)HI"ULNXCO[7]J'XY/XTL]'G\ V]OI=YM.&N9)5A0QLK//K%N9K./;
M(C2F,VQG:+;"D3RRQ.Y_P\2\4?\ "P/^%;?\(;;_ -N_:/)S_;X^S[/)^T_:
M/,_L_=Y7V?\ TC&SS]GR>3Y_[JOU/TF2XFMXFO(XXKDQH9HXI&EC20J-ZI(T
M<32(&R%=HXRP 8QH3M'Q!X8_:C\8Z]X\E\#/X5LR;..WGU'4[;7?M%K:6\Z[
MD+@Z?'*+A@&$-K*L,TI'FC;:9NA[!^TQ^TQI?[-.EQW5U')>ZI>R?9])TFWR
MUUJ%TQ55BB559@@9D\V7:P0,JJLDTD,,OR?\2_C)\=_A=IS^)[K0_"\^D6^Z
M[O--@NKDZC:6,:-/,LMS))':O+%&AB>6W2<-,0\=M+'D#Z@_91_:NT/]K70Q
MJNE'R;N'8FH:>[AIK29@2 2 -\3X8P3@!95# JDJ30Q>/^*OVEO%OQ/\4:OX
M1^&EEH\TOA_[-_:FK:M=2-9B:82?Z'#!9;IFE4J0\K,JQ207,$D2OY3OS_A?
M]J3Q]X<\=Z!\/_&&A:?;W&I_:Y6UFQGGDL;J&"TN+C99Q2HLD4L;K!'.)I)&
M #.(1'<6\B_H_17Y8:+^V9XU_:7\2ZOHOPLL-#_L[09&CNM6UBYFE@NF9O+A
M-LEBVY4=HKEXY,SI+"B2,UN[+%)G_#3]O[Q#X,\<I\//BAH]OI^I7=PL5AJ.
MG><;.?SV6.TVQ2F61HIG$BBY63]W(5AFMX6CN'C_ $?^*OQ+T[X-Z'?^(=5?
M99:?;O/+AD5GVCY8H_,9$:65ML4*%E\R5T0'+"OB#PG\7/C7\3=.M/%>DZ+X
M7AT6\MX;VWTBXO;M]4EMV0.(UNT1+));A?G@:1 D EC6==R2"O8/V,_VD]1_
M:?TG5=4U+3/['EL=8FTX6+,[S0^1;VS2+.SI$3*)9901Y<6Q0L94NC._U_7G
M_P 5?B7IWP;T._\ $.JOLLM/MWGEPR*S[1\L4?F,B-+*VV*%"R^9*Z(#EA7Y
MP?#?]HWXU_M&Z&_B_P ):/X7M-(F\[[!8ZA<7<U]<?9QY<FV6%H+?YYTECB\
MX6NTK\_[O;/)ZA^Q+^WBG[4%Q>>'M8TZ31_%&EQ[KNT(D,<BQ,D-Q(H=0]NZ
M3ML>UF+/&'CQ+.1-Y6?^V_\ M]2_LI1/;6.@ZA>W;;(TO[BWE@TB.:6*61$%
MR5_TJ5-B.]O"55HS(OVJ.6*1%Y^#]L[QI\6_#UE)\-_#UOK^K_V?82ZM>M<1
MV^EV-]<0PSR6<0FGB>[E16<31Q3@V1> 2O)(SQ+S_P"PE_P4/U']H37+[PAX
MPL+?2]?@\U[=8E>W63R"$GM7@N97F6[B.^0JI;=$DVY(?LY:7]7Z*_/#]H[]
MLS5/"?C'3_AMX'L+/4?%&H1K(\UY<A;.Q7F4BXCB83.XMXY9WCW0ND;021K<
MF40UX?\ %G]M7XG?L?:C92_$30]'O] OL1B]T%KI/)FW@LC->,P:58EDD2W=
M8%N,@I=#R9PGZ/\ B7XEWE[X73Q%X0T_^WY;FWM;FPM/M"V'VJ&X,;!_-N5Q
M%B)S-MD4,=OEX#MQ_/#_ ,+$\7_\-&_VS_PB_P#Q4G_0O_VK;?\ 0$\K_D(;
M?L_^I_TG[O\ TQ^_S7[O_#CXJ^._$VG:M<ZUX._LF]L[?S--M/[:M+K^T9MD
MK>3YL2!+;YDB3S)05_?;L8C;/X0?M>?$3Q?XA^,GA+4M7\+_ -F:U;_V/]CT
MC^U;:Y^V>7J<SP_Z7&HBA\V4M#\X/E[?,;*D"OW/^%7QG\;Z_<71\6>#)- T
MZVLY;@746JP:M)))&R8@2TLHC.SLAD==BN6,8C5&>117R?\ #[_@H[J/Q5^*
M6F^!+;0+C2+*7[3]K.K1O%J1VZ>UW%BV5@EM\R'.]KGSH71U\DG%?H?\7OBB
MGP@TMM3?3]4U1A(D:6>E64E[=2,YZB-,*J*H9FDE:- !L#&5XT?\L?V>_P#@
MJ1KGQ]O-5L]-\,?;=2'V1M'TBVN"C&$+)]OGOM2G5;:**,K$(CY43-+<0VX6
M5F,J>O\ [.W[5OQ.U&77V^(7@^XM+32+?=#)IEA=--<7(E\H6MM TMQ]N\WE
MDN+=Q;0+'OFE$4R2IYA\-/\ @JXGC#Q?JNF:II,FEZ786<ZVUDZ23:W>ZDE[
M%;0VD=N"BBXE67:;(+(T4J.[W7DH[)Q_[07[?_QA_9VO+;4=?\&Z?IN@75PD
M<<;W)O)CL56EA-]:W!ABED D: R6PPH;$<_DRD_7^O\ [;$_Q%TZW3X6Z5_P
MD^M7.GQWLT)NK>&WTI+A"(5U"8R^5]K\WY3IT<JSLD5PQDB5$=_G#]F?_@HY
MXEUOQY)X ^).E6>D:C))]GMW@#0+%=*K.L4WVBXF65+E=@M98'(D=H@BS)<K
M)%^OVK:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22 *_+#X3?M
M:_$[]K_[;JOP]TOP_I^@6=P;1)=>FNI+BXF7,A95L3B+$3VY>)@ZJ[D)<S_.
M(N@_94_;^U'XB^*)?A[X[T?^Q?%D/FA1#O:WN'B$DSH$)D:'%N%EBD\V>"Y0
M/(DJ!X(Y>?\ ^"G7QD\=^#_"^KV.B:'Y6@/;Q0:AK\UU:-F&[/D2P6]EYC3?
M.98X3<.NY=TVR%<178X#_@F]\5?'>E^"?#FE6/@[[9H!N)XVUO\ MJTBVPRZ
MA.9YOL3H9CY!:0>6#NE\K*D;UKK_ -MO_@IA>_LX7#:3HWA^\:[,DL<>HZK;
M3VVGR-"T)D-HG[N6]0!WC:17@1'\J5&N(9%+?J?XIN=1M+.1]*@M[F]&WRH;
MFX>UA;+ -OFC@N73"[F7$3[F 4[0Q=?S ^#'_!1+Q1\</%MWX+L?!MO;ZII_
MVK[<;G7PL-M]DD$,N]XM/E+_ +UDB7R5ERSAO]4'D7]3]6DN(;>5K...6Y$;
MF&.61HHWD"G8KR+'*T:%L!G6.0J"6$;D;3\8? ?]I[Q1\8_%&JZ#<>&+>SL-
M$N);6^U:+61>6YN$&5@M@MG'YTIRK2QLT3VJ$BX$5QLMY.P_:._:IM_@?<:?
MH>F6,FN^*M6D5=/T6WE6*1X]Q\RXGE*NMM;HJN?-D4ABC](HKB:#Y/\ C'^T
M;\:_V7K-?$/B?1_"^K:!!G[<=)N+NWFAWLD,&7O&8_/+*F/*@N?E1P_DY62O
MO_X%_'30_P!HO0X/$'A^?SK2;Y71L+-;S* 7@G0$[)4R,C)5E*R(SQ/'(WL%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?S _\%J_^
M2AZ;_P!B_;?^EM]7TA_P4,_83UGPWX.?6=,\3>)-=MM+D%S>Z?J]]+?@Q_ZO
M[3;B.-51X%=VF,BD?9VED\V(1%)O?_\ @DM^T=HWQ)\-/X7@T^STO5M'CA:=
M;98HEU",JL(OC&")7N (XX[V1@X+M"_F#SUAB_6^OP!_YN\_S_T+E?O]7X _
M\$,?^9N_[@__ +?T?\%SO^91_P"XQ_[85^_U?S0_\$Z]?^(?Q0\0^+_$_A"W
M\+KJ5[<0SW\FK1WH\K[=-=3F*R:V+R)$SH3,DCMN\JW.69,C[_\ CW\%/CK^
MT3X<O/#&JR>!X;*^\GS9+9M628>3/'.NQI(Y4&6B4-E&RI(&#@CZ _8!_9U\
M0_LO>$I?#WB*\M[R4:A//:_9III88;>6.']TGG11%/WJS2LB+LW2E\EW>OM^
MBOP!_P""YW_,H_\ <8_]L*_?ZOP1_P""Y6DW$UOX4O%BD-M%)JD4DP1C&DDJ
MV;1HSXVJ[K%*R*2"PCD(!"-C][J_(#_@M7_R3S3?^Q@MO_2*^K0_:LTFXT#]
MF:*SO(I(+F#0_#44T,J,DD<B3Z>KHZ, RNK JRL 5(((!%>X?\$N/^20^'O^
MXC_Z<KNOD#_@MI\--.N?#VC>)]FW4H-0&G>8JH/,MYX9Y]LK;?,;RW@S"-X1
M/.G.TM)E?U>_9Z\4WGCGP;X?U74)/.O;[1].N;F7:J;YIK:.21]J!47<S$[5
M"J,X  P*]@K\$?\ @JI^Q];^"$_X6GX5\RPOH+R!]46W98E$DD@$6HQ,'1X[
MCSS$DODAC*\BW.(W2XEE_6[PG\:_^+>6GCC5X_\ F7X=8O(K5?\ IR%W,D"R
M2?[PC5Y/0-)U:O@#_A]7\//^@;X@_P# :R_^3J^P/V4OVU?#W[8/]H_V#;:A
M;_V9]F\_[;%#'N^T^=L\OR9YLX\EMV[;C*XSDX^OZ_ '_@AC_P S=_W!_P#V
M_K]_J*_(#_@M7_R3S3?^Q@MO_2*^K[__ &3O^2>>%/\ L7])_P#2*&OR!_;Z
M_P"3A? 7_< _]/-Q7Z_?M8_\D\\5_P#8OZM_Z135^>/_  10TFWA\"ZK>+%&
M+F77)8I)@BB1XXK2U:-&?&YD1I96122%,DA !=L^'_\ !<[_ )E'_N,?^V%?
MJ?\ MS?%"X^#GPW\0:Q9^8+E+/[/"\4S020R7LB6:3I(H+*\+3B9=N"3&%#H
M3O7P_P#X)/\ A:S\/_"C2[FVCV2ZA<7]S=-N9O,F6ZEM0^&)"XBMX4VH%7Y-
MV-[,S>/_ /!:O_DGFF_]C!;?^D5]7UA\/?&MQ\-?@GI^N6:QO<Z;X+M[R%)0
MQC:2WTM94#A65BA90&"LI(SA@>1^4'_!+K2?B7#X5U&\\"Q>$Q;2ZH\5S-JZ
M7PO'DBMX&5 ]H-K6Z++NB5R2LDDY  ?GZ@_:@_9?^-G[6>C0:'KD_@N"V@O$
MO$>S?5$D,B12Q $RQ3+LVS,2 H.0OS  @^_VWPJUGX(? 75?#FOW4=YJ-AX;
MUR)YHI99H_+\J[:W1'F2-]D<+11*I50@0(HV*M>'_P#!%3_DGFI?]C!<_P#I
M%8U^O]%?D!_P6K_Y)YIO_8P6W_I%?5]__LG?\D\\*?\ 8OZ3_P"D4-?CCJ>D
MV^M?M<B*ZBCFC62*4)(BNHDA\/K+$X# @/'(B21MU1U5U(901^QW[6/_ "3S
MQ7_V+^K?^D4U? '_  14_P"2>:E_V,%S_P"D5C7R!\--?\9?%#]H+Q=J'ABW
M\/MK5E]O@C.K1W)MXK>QGM]-66$P%Y4NVB1%=P51DEN5 57"#]#_ (A>"OC[
M\2M&U#0[QO :6VI6=Q9S/$=8$BQW$31.4+*RAPK$J65@#C*D<$_X)Q_L@>*O
MV1+?6;/Q!?6=U;7TEI+:0V<]Q)'%)&LRW#E)H851Y%,"ED#%Q$H8@1I7Z7T5
M\ ?M>?\ !.[PO^U;YFH?\@KQ"WD#^U(4,GF)%E=EQ;^9''-E#M$F4G79"OFF
M&+R6_GQ\:_"?XF_\$W/$"ZE"\EG(8Q#%JUFAGT^X6X1F-N6GA$3N#&S&WN(P
MZO"MPL>U89C_ $_?LF?M V_[37@[3O$<1C%S+'Y5_#'M @O(L+.FP22M&A;]
M[ LC&0V\D+L 7K\,/^"=>O\ Q#^*'B'Q?XG\(6_A==2O;B&>_DU:.]'E?;IK
MJ<Q636Q>1(F="9DD=MWE6YRS)D??_P >_@I\=?VB?#EYX8U63P/#97WD^;);
M-JR3#R9XYUV-)'*@RT2ALHV5) P<$<!#X \9?L ? ;Q):WM_;SZE%<-]AEM;
MBY=+2WU"2TM&\AF6WDAE1Y+BXC\L!$G<2G>S.I^C_P#@E9I-OIWPDT66"*..
M2YDU"6=T15:607UQ$'D( +N(XXXPS9(2-$SM50/H_P"+/[+'@OXZ:C9:KXDT
MBWO[W3\"WED,B_*'$@CF5'5+B(,"1#<"6(;Y $Q+('^ /^"U?_)/--_[&"V_
M](KZOO\ _9._Y)YX4_[%_2?_ $BAK\@?V^O^3A? 7_< _P#3S<5^OW[6/_)/
M/%?_ &+^K?\ I%-7P!_P14_Y)YJ7_8P7/_I%8U^O]?@#_P $,?\ F;O^X/\
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M2W_H._9U^&6E_"OPU96FESQWRSQK=W.IHQ=M4NKA5>;49)3),TKW+?O QDE
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M +?U^_U%?DA_P6>TFXU'X<VDL$4DD=MKEK+.Z(S+%&;:[B#R$ A$,DD<89L
MO(B9W,H/UA^QE\5=#\1_#'0M0MK^W:TTS1[2VOYF<1K:S6-K&MRDYDV^5Y>T
MN6?:IB*S*3$Z.WXP?M>?'30_B3\=?"6LV,^-(T^XT>%M2FQ%9SK:ZM,T]S;S
MN0DMI&QDA-R"(C)!-M9HU61OV_\ VB/%FG>.?ACXGU#2KNWOK*;P_K'E7-M,
MDT+[+6=&V21ED;:RLK8)PRE3R"*^'_\ @BI_R3S4O^Q@N?\ TBL:\ _X+G?\
MRC_W&/\ VPK]7_VT/@Y>?'WX?ZWX=T]L7MS;I);+A3YDUK-'=1PY=XT3SFA$
M/F,P6/?YA#!2I_-#_@D1^UGHUOX?/@76]1CMM1MKQVTJ.X\J&.:WNG3%O!)E
M?-N/M,DK^4^9G$Z"+S$C=8>@_P""U_C_ $N+PKI7AXW,?]K2:I%?+: DR"UC
MM[J%IF !"(9)%1-Y4R$2; WE2[/L_P#9MO?#WQ[^%FG^&(-2M[G=X7L=.U..
MRNH9+BT^TZ>('611YGDRC$@42IPZ,"IVL*_%']A3]J"X_8"\2ZMX3\=P7EI8
MSR1+/"$:5K.\5D47 02A#;R0.7FEMTGDN$CM6B\Q N[]WO'_ .W'\.?A]I=S
MJDGB+2[Q;:,N+:QO;:ZNIFR L<,,<I9G9B!D[40$O(\<2NZ^?^(-3\2Z[\$=
M9OO%XC36[OPWK5U<PQQ-"L"W$%S-!;&*15='@A>*"19-SAXV#22MF5_F_P#X
M(J?\D\U+_L8+G_TBL:_7^BOR _X+5_\ )/--_P"Q@MO_ $BOJ^T/V6_'^EV7
MPY\'2&YCD6YTO2K&$0DS-)=+;)')"JQ!V+Q-%,;C Q;)!/+,8XH)G3\L/^;O
M/\_]"Y7Z_?M8_P#)//%?_8OZM_Z135\ ?\$5/^2>:E_V,%S_ .D5C7PA\>;W
M5/V /CK)XK2&\&B:I>27;.Q#K>VM[L?4H4\MX4=X)I':""9@8WCLY90ZE))/
MV_\  '[<?PY^(.EVVJ1^(M+LUN8PYMKZ]MK6ZA;)#1S0R2AE=6!&1N1P \;R
M1,CMG_LM_''4?VC;S7?$,!QX1^T067A_?;O!-<?95?[=>GS%R\4TLBQ0$,-J
MVS(\$$ZS>9]?U\0?\%&_%-YX&^&.K:KI\GDWMC<:1<VTNU7V30ZK9R1OM<,C
M;64':P93C!!&17O_ ,"_CIH?[1>AP>(/#\_G6DWRNC86:WF4 O!.@)V2ID9&
M2K*5D1GB>.1O$/\ @H1JWA_3OAEK\7B*6.."YLY(K1'=U:74 #+8I&(R'=Q/
M''(5&4"1N\H\A92/#_\ @D9\--1^'?PU6?4$\K^U]0GU&VC*NKBW>*""-G5U
M7'F?9S-&5WH\$D4@8[R%_*'X4_$*\_X)=_%75-/U6VU#_A'IOM,1A^66:ZL=
M\C:=>1 2V]M+*"JHTAXB62\A"1S;D3]_O^&UOAK_ &=_:G_"4:/]G^S_ &C9
M]LB^T;-GF;?LN[[3YN./(\OS]_[OR_,^6OF^ZTGQ!^VY\)O$DFHQ21KKTEU=
M>&K)42UN$L[8Q2:7%<><"@>XFMA/+)YDD;PW.Z*>.(QB'X _X)A_MIV'P#2^
M\!>.;F33(X[S-@]W',%MKAY/*NK2<LQ%J@DVR@/'%#&YO))YE9E!_2_]HO\
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M"B&K6^@?'WP1>7DL<%M!'H4LTTKJD<<::Q<L[N[$*J*H+,S$!0"20!7[W?\
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MX_AS\0=+MM4C\1:79K<QAS;7U[;6MU"V2&CFADE#*ZL",C<C@!XWDB9';/\
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M@@9F8*#@%F.,DY]_^%_P>TGX.6_V/1_MB6PCAB2&XU&^O8X8X%*QI EY<3K
MBJ=NV$1@@(""$3;ZA7S!\8_V+_A_\?;Q=0\1:);W-Z,[KF-YK6:3*H@\Z2UD
MA>?:L:+'YQ?RU!5-H9@?7_AI\*M#^#>G)I7AZPM]/LDVGRH$"[V5%C\R5OOR
MRE40/-*7EDV@N['FNPU;2;?7[>6SO(HY[:>-XIH945XY(W4JZ.C JR,I*LK
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MW,T]]=Q2S+I]G'%,1/#" L4UPQAG:!9',8>W$<T?ESK(GQA^VC\&OBA^S?\
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MA*D@/'(CQR+U1U9& 92!^$/_  5/_:"^*7P@N+6RAO[/2=$U.2[%E_94L_\
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M"L_3-6M]:0RVLL<T:R2Q%XW5U$D,C12H2I(#QR(\<B]4=61@&4@?A#_P5/\
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MKJRCG_B]\:/#_P !=+;6?$M]'86*R)$)'#NSR2'Y4CCC5Y9'P&8K&K%45Y"
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M/H_PMXLT[QS9QZAI5W;WUE-N\JYMIDFA?8Q1MDD99&VLK*V"<,I4\@BN@KY
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M+0L#$[HWR?\ \$8=6N-1^'-W%/+))';:Y=10([LRQ1FVM)2D8)(1#)))(57
M+R.^-S,3\X?'O]HV\_8^_:$O/$&OQ7%QHM_H\-O"D96>9;%H8R#:(T\:0_\
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M(_ACKNGW-A;M::9H]W<V$*H(UM9K&UD:V> 1[?*\O:$"IM4Q%H6!B=T;Y/\
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MF65+E+AK2V:=9P6+7;QR^7Y3$+]G_L$_#33OA?\ #7P]!IZ;?MNGV^HW,A5
M\MQ?1)/(SLBIOV[Q#&6W.L$4499M@)\?^(O_  3GT[XA?%"U^)+ZM<1>3<6-
MW-IX@1O,N+!$6$I<%AY<1\F R1M%*[8E"RIYB>3\0?\ !<[_ )E'_N,?^V%?
MO]7X _\ -WG^?^A<K[/_ ."J?P]T;4?AKK6N3Z?9R:M;1Z?%!?O;Q-=11G4;
M<%(YRIE1")) 55@")'X^9LY__!+'X5:';_"BTN?L%N\NN_;AJC2()/M:QW5S
M:I','W!HEB78(<>5\TC;-\LK/[A^U9\$/"L'PYUR)-$TM8]*T/69=.06-N%L
MI'MI97>U CQ [2*LC-%M)=0Y.X U\G_\$5/^2>:E_P!C!<_^D5C1_P %J_\
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MW#Q;0LEC;1@7$#OGS%\QY[?(C&)(EFC=A&S1R^@?"K]J_3O@WH=AX>TKX?\
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MF,DQ>:3\L/\ @AC_ ,S=_P!P?_V_H_X+G?\ ,H_]QC_VPK]_J_ '_F[S_/\
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M ,%SO^91_P"XQ_[85^_U?@#_ ,W>?Y_Z%ROU^_:Q_P"2>>*_^Q?U;_TBFKX
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M)#XA_P"X=_Z<K2C_ ()<?\DA\/?]Q'_TY7=? '_!<[_F4?\ N,?^V%?O]7X
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MSQ7_ -B_JW_I%-7P!_P14_Y)YJ7_ &,%S_Z16-'_  6K_P"2>:;_ -C!;?\
MI%?5]_\ [)W_ "3SPI_V+^D_^D4-?D#_ ,W>?Y_Z%ROTO_X*'^"KCQ_\*_$M
MG:M&DD=FMX3(6"^78317LH!56.]HX'6,8P7*AF526'QA_P $??VE].\0^%_^
M$'O9K>WU+3+B7[#$SI&]Y;W)FNV\I6E,DTL3BX,WEQJD<!@)RQ=J_5[XJ_$O
M3O@WH=_XAU5]EEI]N\\N&16?:/EBC\QD1I96VQ0H67S)71 <L*X^\^-]OX3\
M)V/BKQ#;R:7'<QZ6;NWF95:QDU&6W@*W#S>0%2WDN!]H=PA1(Y&\O<-E?$'[
M47_!*?P=\8[>XO?#4,>@ZWY;&'[./+T^:0+&J+/;*K+$FV,KOM!$5>5YY([E
MAL;YP_X)+_&;Q1IOB'7/AMXDEN+C^R[=WA2>Y$WV![":.QFM8B-^8COC"*DO
MD0^03&A\]WK]WJ^?_P!K'_DGGBO_ +%_5O\ TBFKX _X(J?\D\U+_L8+G_TB
ML:P/^"E?QTUS5_$VA?"/2I_[,M/$GV)=0U!,O,T-]>/9B ("F(AL9YP'#7*L
ML!:.+SEG^K_''[.OAK]FWX4>)]+\.V4<"CPWJ:3W)53=7;)9W!$EU,%5I7W2
M2%0<)$'*1)'$%0?-_P#P14_Y)YJ7_8P7/_I%8U]@?MY?!G_A>GPZUK3(HO-O
M8;<WMD%MOM,WVBT_?+' @PXEG57M0T?SA9V 5P3&_P"4'[,7[1>H_'OX7VGP
MGT=KAO$ES</I=U<$/<_9/#\C[[G4',T0MQ%%#(=-CM?/24?NC"ZN88Z]0_X*
MG_ 9/A)I?A?QQX5CDM;GPO)9:=&4CDN5AM;<F33Y)&F>1%2WF3R@94<W#W2+
M)(Q5$;W_ /93^)J?MG^/)_'J021:7H>AV6G64,JR30+J6H*+K49+:66.%8KB
MV7;83F)"UQ"T<ID6&2.-OT/^)WQ+T[X1:8VKZJ_E627%G!+*615B^UW4-HLL
MC2,B)%&TRO,Y;Y(E=@&("G\\/VHO^"4_@[XQV]Q>^&H8]!UORV,/V<>7I\T@
M6-46>V566)-L97?:"(J\KSR1W+#8WSA_P27^,WBC3?$.N?#;Q)+<7']EV[O"
MD]R)OL#V$T=C-:Q$;\Q'?&$5)?(A\@F-#Y[O7[O5\_\ [6/_ "3SQ7_V+^K?
M^D4U? '_  14_P"2>:E_V,%S_P"D5C7H'_!7/X::C\1/AJT^GIYO]D:A!J-S
M&%=G-ND4\$C(J*V?+^T":0ML1((Y9"PV -Z!_P $Q?BE_P +0^%^D>;<?:+O
M3/-TVX_=^7Y7V9_]&BX1%?;:/:_.N[=GYW,HDQZA^W3XUM_ 'PR\3WETLCQR
M:7<68$84MYE^/L41(9E&Q9)T:0YR$#%59@%/S_\ \$F?A?<?#CX96UQ=>8LF
MLWEQJ0BDA:)HHW$=O%C<29$ECMTN(Y,*&29=H90'?XP_X(8_\S=_W!__ &_K
M]_J*_(#_ (+5_P#)/--_[&"V_P#2*^K[_P#V3O\ DGGA3_L7])_](H:_(']O
MK_DX7P%_W /_ $\W%?O]7X _\$,?^9N_[@__ +?U^OWQ#M?"7QMU&Z\!>(;.
MWOI8]/@U+[/<K&<PW+W5IYUL=WG)+"8W5YXA&T'VB'9*'DPOX8_MQ_L 7'[(
MB#Q]\/;^\M+&VD(ND%TT=U8&YD,,;6MPACE>W(F6V9&9[A 0S23I)*T'Z7Z!
M\8[SX^_L^ZAXBU!<7MSX7UF.Y;*GS)K6"ZM9)L(D:)YS0F;RU4+'O\L%@H8^
M/_\ !%3_ ))YJ7_8P7/_ *16-?,'_!5O4;SX2?%/PCXT>U\^RM;>SDA7S53S
MYM,U"2ZFAR [Q_+/ /,9"O[SY0Y1U']!VDZM;Z_;Q7EG+'/;3QI+#-$ZO')&
MZAD='4E61E(964D,"""0:_!'_F[S_/\ T+E=A_P7!\%7%_HWAO7%:,6UG>7E
MG(A+>89+V*.6,J-NTH%LY0Y+ @M'A6!8K^E_[(_[2^G?M0>%[+5X)K?^TOL\
M?]IV<3IOM;C+QONA$LLD44KQ2/:^:V^2#:Q^;<!U_P 8OC?;_"6XT6P%O)>Z
MCKNJ6]A:VL++Y@C9@UW>.OS/]GM(0TLSHC!28E=HDD,J?CC_ ,%SO^91_P"X
MQ_[85^_U%%?@#^P+_P G"^/?^X__ .GFWK]?OVL?^2>>*_\ L7]6_P#2*:O@
M#_@BI_R3S4O^Q@N?_2*QK[P_:Y^-]Q^SCX(U;Q19V\=U<V4<(ABE9EC,EQ/%
M;HS[?F9$:42,BE#(%*"2,MO7X/\ ^"<'[/6G?$W3%^+'BM_[=\3:W<33)/>1
M(ZV7V2Z:%#;H0464-;JT<JA/L\2Q6\"0HDAF\ _YN\_S_P!"Y70?\%Q?"UY=
MZ=X8U5(\V5M<:A;32[E&V:Z2WDA3:3O.Y;:<[E!5=F&*ED#?L=\%/BA;_&KP
MUI?B.U\M8]2LX;@QQS+.L,CJ/-@,BA0SPR;X9/E4AT8,B,"H_%']OK_DX7P%
M_P!P#_T\W%?K]^UC_P D\\5_]B_JW_I%-7P!_P $5/\ DGFI?]C!<_\ I%8T
M?\%J_P#DGFF_]C!;?^D5]7W_ /LG?\D\\*?]B_I/_I%#7Y _\W>?Y_Z%ROU?
M_;0_X1?_ (5_K?\ PF?VC^POLZ?:/LN?M&_SH_LWD8^7S?M'D^7YO[C?CSOW
M'F5\G_L;? KXK_LM:6^BXT/5-$:2:XM(+W4+RTO[9IC&1&YAMM0M(D&V1Y;>
MW,R"YEED2\E7YI.P_9]_8AU'0O&ES\3?'6H6^H>*KG?Y,%A&\-C9;HVM1Y;-
MMDN,6HCAC\U$\L&0O]IFV7"_H_17X _M]?\ )PO@+_N ?^GFXK]_J_ '_F[S
M_/\ T+E?O]17P!_P5'_Y)#XA_P"X=_Z<K2C_ ()<?\DA\/?]Q'_TY7=? '_!
M<[_F4?\ N,?^V%?O]7X _L"_\G"^/?\ N/\ _IYMZY__ (*[?VC\)OB'X2\<
M6WV>3R;>+[+%)O;-QI5Z;L^<J[/W3?:H0-D@=L2#Y,*S?N=\'?C%HWQUT:WU
MS0[B.>VGCC9T62)Y+>1XDE-O<")Y%CN(UD42Q%B4)[@@GG_%WQOM_#7BS1?"
M$%O)=WVJQW=S.T3*5L+.VB8BYN5&YU2:?R[: L$C=VD_>[XUBE_'']OK_DX7
MP%_W /\ T\W%?O\ 5_-#X*^)?_#'/[1VM_VR]O\ 8M6U"Z@NIPWRP6^KRQW]
MM*7E:!(_*9[;[4[[TCB%QL$A$;G^D[2=6M]?MXKRSECGMIXTEAFB=7CDC=0R
M.CJ2K(RD,K*2&!!!(->/_#KXWV_Q.\0:_HUC;R&VT"2TMI=0W*UO/>2I))<V
MT13<N^T40K< L)$FE:-XHPB/+[A7P!_P5'_Y)#XA_P"X=_Z<K2C_ ()<?\DA
M\/?]Q'_TY7=>_P#Q#M?"7QMU&Z\!>(;.WOI8]/@U+[/<K&<PW+W5IYUL=WG)
M+"8W5YXA&T'VB'9*'DPOX8_MQ_L 7'[(B#Q]\/;^\M+&VD(ND%TT=U8&YD,,
M;6MPACE>W(F6V9&9[A 0S23I)*T'[7_L7_&.\^/OP_T3Q%J"XO;FW>.Y;*GS
M)K6:2UDFPB1HGG-"9O+50L>_RP6"AC]/U^&/[6_C_5/VK?BW:?!22YDTOPY'
M)')?O;$-/?,EC_:6'+ *J*H$4,9$B)-_I4BSE(8HOH_]OOX5:'\&_@AKVE>'
MK"WT^R3^S#Y4"!=[+?V4?F2M]^64JB!YI2\LFT%W8\UZ!_P2X_Y)#X>_[B/_
M *<KNO@#_F[S_/\ T+E?K]^UC_R3SQ7_ -B_JW_I%-7P!_P14_Y)YJ7_ &,%
MS_Z16-?K_111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111117Y0?MJ?
M\$V9?CSK@\:>$]3_ +)\2#R&D\UI1#--;F)()TGB+2VDL428!B219&CAPL+^
M;,^?;?L3_$WXG^%;W0OB#XNCU.-;.>+3M.MP4MY+I+?987.H:@MO#>7"13'S
MI('2423107$DDS*T1]0_8@_8%E_92B2YOM>U"]NVWR/86]Q+!I$<TL44;N;8
M-_I4J;'1+B8*K1F-OLL<L4;KZ!^V;^POH?[8=G"T\G]G:U:86VU..$2L(=VY
MX)H]\?G1'+-&"Z-#*2Z,%>:.;\X/A;_P30^,GA+[/I?_  G/]D:+%YGR:;J6
MIOY.[?)^ZM=MI$=\IR_[R/&]Y/G8;6_7[X:? *S_ &?_  NGASP5]GL&BVLM
MS=V[7?G3$KYT]TD4UH\TLBJ5RLD2Q_NU11#$D(_/'5O^"7?B74?&,OCN+QW)
M;:[)>/=I/%I+$1,V0(4$NHR$VZQG[.L$AD0VX$#!H\J?U>\%66LV%NRZY=V=
MY<F0E)+.SELHQ'M7"F.6[O&9PVXEQ(H(*KY8*EF^ /VX_P#@G%I?[5KC6M,G
MCTOQ''&5><QEH+Y4C(ACN@I#*ZL$1;I1(Z0YC:*<) L7RA\-/^":'Q3N=FD>
M)_'-Q!X;6W6WDL].U+4)_,MQMC:T6&=8+>*)H=Z!BLR)A5-M(A(7]+_BA^S;
M<:MX._X0;P=>V?AS1WLYK*9?[.:]D^SRX#K$S74*H\BF87$LJW$TIF:4/'./
M-;R_]C+]CC7/V/HIM-A\16^I:+<W!N9K6323#,LQB\HO#<K?/LW;(?,66.=2
ML06,1,[R'S_]K_\ X)_:Y^V)J-O<ZIXHM[2RL/M"V-I!HQ/EK.X9FEE;4-\L
MI5(D=@(XCY09((BS[OK#Q'\,/$OBKP+K'AK5=3L]2U:^TN\L8;Y;-K"-FGM#
M CW$:S70WF0M)*\(1,-M2V79AOC_ .%/[-WQC_9:L(O#_A'7/#>L:)%'F!-9
ML[JTDMI'FFEF6(61D:1':0.7GF<@_(D<2KF3Z _9W_96N/AUX@U7QUXFOH]2
M\6ZW'''<R6T36]G:6X2'_1+:,L6E16AC07,_[Z2.&(E(Y#.TW8?M7?LHZ'^U
MKH9TK51Y-W#O?3]01 TUI,P ) )&^)\*)X"0LJA2&25(9HOR0\%?\$NOBY\-
M;AM/T/QI'INB/>%W:SO]1MY&C+*AN#9Q(L)N#$JDQF?!*K%]HV@2#]?_ -F?
M]F?2_P!FG2Y+6UDDO=4O9/M&K:M<9:ZU"Z8LS2RLS,P0,S^5%N8(&9F:2:2:
M:7Z/KYP_:J_9GTO]J_PU+X>U.22!A(MQ9W4>2UO=(KI'*8]RK*FV1TDB8@.C
MMM:.4)+'\ ?LJ_L,_%+X5)%X?U[Q7'!X/CD:X>QTFXG%U))YB2>1'=O;07%G
M;R.I>?[+,I<&5%17N9)UX_P!_P $P/%OPB\<W^H>&/$%OH_AG4/M%O(UKYC:
MI%IMPRRM:P>?#,D<JLB0QW@G,R!!= ;\VY]__;#_ &:_!?QIB\-?#J'[1#K5
MG;N-(6VDD<:=IL42Q2W-]O6;-H/)ACB\TQS7EXD-M'=0+)=7$7R!_P .,?\
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M%^*7BF34V-F]GID%G+,+6!ML9BO;THME-J5Q'+%&\<=V9$4H\C/)+.6AX_\
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M4>#P=XSL[71)I$\UI(Y&8K((?/F&F30W-I]H7RPD;B97D1%4S0K(ZKV'C_\
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M^^(O[77FZ9X_TW3_  YX.:XADGTJ"Y^V:I>BV\J5(9;R%C;Q6DDX\QY(%AO
M(! H59#<-^C]%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?DA\//VM/C=XRUG4]%E
M^'\=O)YDB65U<R3VEG9*LK1>9<W,@>+4D0O$Y%@87GCCEDA1E<&+[_\ V>/@
MA;_L^^'X=&BN)+ZY,DMS?ZA,JBXOKRX<R3W,Y&69V8[5,C2R+"D<;2R%-Y]P
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK
M\L/VZ_V<?B1XO\2Z3XZ^'FH1F^T:SEMX=/E:,,DD[/'+/;"Z#V;/+#,4G\[R
M2$MHRKS/Y:1\!IG_  4"^*_AI#9:U\+M4N]1@DECGGL5O$M799& ,(%G>*R!
M<#S$N)DE(,B,$=5'K\=Y\6?VM+>33-4T:S\&>%=2LXXK]IYQ?:Q-;W"R&=+5
M0JPVSO%MMY5O;=9K;S7E022IY4?Z'^$_"UGX&TZTTK3X_)LK&WAMK:+<S[(8
M4$<:;G+.VU5 W,68XR23DUT%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%?EA\+OVY_%7CCXRZA\/+K0HX=)M9+V,3!+@74$=LFZ
M*]G=OW1M[DA/*'EQ "[M]L\N!Y_ZGT44445^6'[<_P"W/XJ_9@\5:%H>AZ%'
MJ-MJ,:2.\B7#27<C7'E&RLC%A5N%4*22MT<W4'[@  3?J?17SA^TW^T6G[-F
MC/JATG5-7D\N=UBL+622.)8(C(TMY<!3%:VX.T/(^YP&9TAE6*79Y?\ L%?M
M2ZC^USX>U#7M0M;>S\G6+FTMH("[;;=(;>:,2N['S)1YQ5Y%6)'P"(DY%?;]
M%%%%%%%%%%%%%>7_ !>^**?"#2VU-]/U35&$B1I9Z5927MU(SGJ(TPJHJAF:
M25HT &P,97C1_C#]@?\ ;>U']LV\\0O<Z?;Z=9:;_9WV2&.1YIO])6X$OG3-
ML23YH T>R*'8K%6\PC>>/_;G_;G\5?LP>*M"T/0]"CU&VU&-)'>1+AI+N1KC
MRC961BPJW"J%))6Z.;J#]P  )OU/HHHHHHHHHHKXP_;!_;%3]D^P^U#0]4U>
M3RUD:2""2/3X%:9(5%UJ!C>*%W+-Y4:+,Y=45UB6:)V[#]C/XUZC^T3X$TOQ
M/JL=O#>WWVOS8[972$>3=SP+L6225QE8E+9=LL21@8 ^GZ**_+#X7?MS^*O'
M'QEU#X>76A1PZ3:R7L8F"7 NH([9-T5[.[?NC;W)">4/+B %W;[9Y<#S_P!3
MZ*********^8/CI^TRWP"BGO+[PWX@O=-M^7O]/ALKF$*(C,\C1B]6YBBC"N
MLLTT,42LOWRK1L_A_P $/^"C6D?M'W%Q:^%?#GB2_DM(UDN"(=-ACC5VVH&E
MGU&.(.Q#;(]V]PDC*I6-ROW_ *3>OJ-O%/+#);221H[P2F,R1,R@F-S$\D1=
M2=K&-Y$)!VNRX8Z%%<?\0O$EQX.T;4-3L[22_N;.SN+B&RBW>9<R0Q-(D";4
MD;?(RB-=J.<L,(QX/PA_P3G_ &Q/$/[7NG:M<Z]IMO:?8+B"."ZM$F2WG\U&
M9X0)GE_>P[4>0K*?DN(@8X\!I?T?HHHHHK\D/B1_P4PO=.\=:'X,TKP_>6<>
MHZI86\UYK5M/:22VMQ=M:O):6;>7*$8!7@N)F!!$D;V89<C];Z******^8/V
ME/VP/"7[*UGY^OW6Z[;RS#IML8Y+Z59&91(D#2)B(;)"TTC)%E#&',I2-OF_
MP5^VC\0_BO;MJ?ASX:WEQI+R'[)<WFLVNG27$#*LD4P@N(02DD;HP>)IH<ED
M2:38QK/\=_\ !4;0_A19WL'B31-8TCQ):6\;Q:1=P@+>3,SQ-]DO8_,BDM$E
MC8&\=8UEB'F013.#"/T_HHHHHHHHHHHHHHHHHHHHK\D/'_\ P5ETOX6>/+GP
MCK6A7EGIUG>&UGU.24^:J[1BY%B(2S6[,1)&R2L\EJRW"1L[+ ?UOHHHHHHH
MHHHK\D/B1_P4PO=.\=:'X,TKP_>6<>HZI86\UYK5M/:22VMQ=M:O):6;>7*$
M8!7@N)F!!$D;V89<C];Z_+#]AC]N?Q5^T_XJUW0]<T*/3K;3HWD1XTN%DM)%
MN/*%E>F7*M<,I8@A;4YM9_W!!(A_4^BBBBBBBBO+_B]\44^$&EMJ;Z?JFJ,)
M$C2STJRDO;J1G/41IA515#,TDK1H -@8RO&C_&'[ _[;VH_MFWGB%[G3[?3K
M+3?[.^R0QR/--_I*W E\Z9MB2?- &CV10[%8JWF$;S^C]%%%%%%%%%%%%%%%
M?DA\2/\ @IA>Z=XZT/P9I7A^\LX]1U2PMYKS6K:>TDEM;B[:U>2TLV\N4(P"
MO!<3,"")(WLPRY'ZWT444444444444444445\X?M-_M%I^S9HSZH=)U35Y/+
MG=8K"UDDCB6"(R-+>7 4Q6MN#M#R/N<!F=(95BEV>7_L%?M2ZC^USX>U#7M0
MM;>S\G6+FTMH("[;;=(;>:,2N['S)1YQ5Y%6)'P"(DY%?;]%%%%%%%%%%%%%
M%?&'[8/[8J?LGV'VH:'JFKR>6LC20021Z? K3)"HNM0,;Q0NY9O*C19G+JBN
ML2S1.W8?L9_&O4?VB? FE^)]5CMX;V^^U^;';*Z0CR;N>!=BR22N,K$I;+ME
MB2,# 'T_1111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111111111117/ZCXLT[2+RUT^YN[>&]OO-^R6TDR)-<>2H>
M7R8V(>7RU(:38&V*0S8'-=!7/Z=XLT[5[RZT^VN[>:]L?*^UVT<R/-;^<I>+
MSHU)>+S%!:/>%WJ"RY'-<?IGQO\ "NM:H=#M=;TN;5EDEB-A'?6[W0DA#&5#
M LAE#QA',B[<H%;<!M./4*\_\=?%CP]\+_)_M[5=/TS[1O\ (^VW<-MYOE[=
M_E^<Z;]N]-VW.W<N<9&>@TWQ9IVL_9OLUW;S?;+<W5KY<R/Y]NOEYGAVD^9$
M/.AS(F4'FQ\_.N3Q3XLT[P-9R:AJMW;V-E#M\VYN9DAA3>P1=\DA5%W,RJN2
M,LP4<D"N@K/U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!7
MR!\>_C?X5^)7@7Q;9Z'K>EZE<IX;U>5X;.^M[B18Q:2*7*12,P0,RJ6(P"RC
M.2,_)_\ P14_Y)YJ7_8P7/\ Z16-?K_7C_\ PT+X-_M'^R/^$@T?^TOM'V7[
M'_:-M]H^T;_+\CR?,\SS=_R>7MW[_EQNXKV"N?U'Q9IVD7EKI]S=V\-[?>;]
MDMI)D2:X\E0\ODQL0\OEJ0TFP-L4AFP.:Y__ (6QX>_MC_A'O[5T_P#MK_H'
M?:X?MG^K\[_CWW^;_JOWOW?]7\_W>:] KP_]HKX\Z7^S;X:O?$6J21A8(V%M
M \A1KNZ*L8;6,A)&WR,N"P1Q$@>9P(HW8>0?\$]_'^J?%/X:Z1K6M7,EYJ-Y
M)J4D\\A&YF_M&Z    5450$CC0*D:*L:*J*JCZO\4^+-.\#6<FH:K=V]C90[
M?-N;F9(84WL$7?)(51=S,JKDC+,%') KG_'7Q8\/?"_R?[>U73],^T;_ "/M
MMW#;>;Y>W?Y?G.F_;O3=MSMW+G&1GT"O#])_:;\"Z_<16=GXET.>YGD2*&&+
M4[1Y))'8*B(BREF=F(554$L2  2:]PHKQ_PM^T+X-\<WD>GZ5X@T>^O9MWE6
MUMJ-M-,^Q2[;(XY&=MJJS-@'"J6/ )K\8?\ @AC_ ,S=_P!P?_V_K]WO%/BS
M3O UG)J&JW=O8V4.WS;FYF2&%-[!%WR2%47<S*JY(RS!1R0*Z"N?_P"$LT[^
MT?[(^UV_]I?9_M7V/SD^T?9]_E^?Y.?,\K?\GF;=F_Y<[N*X_4_C?X5T75!H
M=UK>EPZLTD40L)+ZW2Z,DP4Q((&D$I>0.AC7;EPR[0=PSZA17C_A;]H7P;XY
MO(]/TKQ!H]]>S;O*MK;4;::9]BEVV1QR,[;55F; .%4L> 37L%%%<?XU^(6C
M?#6W6\US4+/3;9Y!$DUY<16\;2%68('E95+E59@H.2%8XP#C/\"_%CP]\4/.
M_L'5=/U/[/L\_P"Q7<-SY7F;MGF>2[[-VQMN[&[:V,X./D#_ (*C_P#)(?$/
M_<._].5I1_P2X_Y)#X>_[B/_ *<KNON_5M6M] MY;R\EC@MH(WEFFE=4CCC1
M2SN[L0JHJ@LS,0% )) %>7^%OVA?!OCF\CT_2O$&CWU[-N\JVMM1MIIGV*7;
M9''(SMM569L X52QX!->P5S^H^+-.TB\M=/N;NWAO;[S?LEM),B37'DJ'E\F
M-B'E\M2&DV!MBD,V!S705S^G>+-.U>\NM/MKNWFO;'ROM=M',CS6_G*7B\Z-
M27B\Q06CWA=Z@LN1S7'Z9\;_  KK6J'0[76]+FU99)8C81WUN]T)(0QE0P+(
M90\81S(NW*!6W ;3CL/%/BS3O UG)J&JW=O8V4.WS;FYF2&%-[!%WR2%47<S
M*JY(RS!1R0*S_!7Q"T;XE6[7FAZA9ZE;)(8GFL[B*XC60*K%"\3,H<*RL5)R
M RG&",]A11117S_^UC_R3SQ7_P!B_JW_ *135^0/_!#'_F;O^X/_ .W]?I?^
MW;^U%;_LN>#KN]BN(X];O(WM](A++YC7#85IU1HY59+97\]_,7R6*QP,ZM/'
MN]?_ &9-6N-?\"^&KR\EDGN9]#TR6::5V>221[2)G=W8EF=F)9F8DL2222:]
MPHKG].\6:=J]Y=:?;7=O->V/E?:[:.9'FM_.4O%YT:DO%YB@M'O"[U!9<CFN
M@KR_P5\;_"OQ*N&L]#UO2]2N4C,KPV=];W$BQAE4N4BD9@@9E4L1@%E&<D9]
M TG5K?7[>*\LY8Y[:>-)89HG5XY(W4,CHZDJR,I#*RDA@002#6A7QA^W;^U%
M;_LN>#KN]BN(X];O(WM](A++YC7#85IU1HY59+97\]_,7R6*QP,ZM/'N]?\
MV9-6N-?\"^&KR\EDGN9]#TR6::5V>221[2)G=W8EF=F)9F8DL2222:_'']OK
M_DX7P%_W /\ T\W%?M]XZ^+'A[X7^3_;VJZ?IGVC?Y'VV[AMO-\O;O\ +\YT
MW[=Z;MN=NY<XR,]AI.K6^OV\5Y9RQSVT\:2PS1.KQR1NH9'1U)5D92&5E)#
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M89(FD0-^]G6-A(+>.9U!*5\G_L?_ +'^A^--#M?'/CFUM_$7BGQ%;B_NKJ_
MNX5ANQ'+;116TL:V\7EPK"ORQ%H6,L,4OV7RXQX G[#7C3X2?&V#Q'X%M[?3
M/"=S<6\MT\-S&D*6C*AU"SDM7)D/FO'(T$<43V\+2VS(]N8<V_C_ /P5[_8_
ML_"WE?$'0;7REN;@Q:VD08IYTO,-YL6,I%YC!HKF1G19)WMR$::::1_U_P#V
M-K[POKG@;2=2\(:=;Z9IM[;I*UM A&RXC46\ZRRND<EQ+&\)A>ZD!>X\H2;F
M4J3\/^(/V7O"7QY^.]W(^FV\FF^']'M;C5H8HHX(9M:O+F:Y@%Y'L5KOS;=S
M<2.N])&C2*>1EWP/^O\ 6?JVF)K5O+:RF18YHWC<Q2R0R!74J2DL3)+&^#\L
MD;*Z'#*RL 1_,C^UY^RYX0^%_P 9/"7A32-/^SZ+J?\ 8_VRV^TW,GF_:=3F
MMYOWLDKRINB14^1UVXW+AB2?W^^!?[+GA#]FO[9_PBFG_8/M_D_:?])N9_,\
MCS/*_P"/B67;M\V3[FW.[G.!C\ ?^"4GPFU'XU_\)'H[7OV3PW+_ &:VMPPE
MTO+Y!]K$-BDRD>3:2YE^W.A$\D:);QLB33.OH'_!2[]BOPY^RSIVD^,/!1N-
M)E34(;1K>.>>3$VR:YANX9Y97FAEC,!4A6*M^[=/*>-S-^]WP0\:W'Q*\*Z)
MKEXL:7.I:78WDR1!A&LEQ;QRN$#,S! S$*&9B!C+$\G\H?V&/V8=4^)7B7QA
MXJ^+'AN.74;J\CAMAJ4(N(%8-*URMK%</,KV\:BUBM;@>8@A3RH)V03 _-_Q
M:T#3OV5OVA]"M? EQ]@BU2XTQ-4L[>1&AB_M"\\NYLS" 1%%)$(KA('!\EI(
MY8?*1;81_N=\;_V<O#'[1UO;V?BBTDO;:UD:6*$7=U;QB1EV[V2WFB61PN51
MI QC#R!"HD?=_/C_ ,$I/V7/"'[2G_"1_P#"5Z?]O^P?V;]F_P!)N8/+\_[7
MYO\ Q[RQ;MWE1_?W8V\8R<_TO>$_"UGX&TZTTK3X_)LK&WAMK:+<S[(84$<:
M;G+.VU5 W,68XR23DUG^/_ =A\3]+N=&U1))+&\C,5Q''/-;M)&2-R&2W>.4
M(P&V10P$B%HW#(S*?YL?^&7/"'_#1O\ P@?]G_\ %-_\^7VFY_Z GVO_ %WF
M_:/]=^\_UG^S]SY:_<^R_8Y\/^$/#4WA7PK<ZIX9L;F\%Y/+I5ZZW3R;40@7
M-T+J6-&$46X0F,D1[=VQY4D_##_@E)^S[9_M#?\ "1V&MW-PV@0_V:]YI,+M
M"E_,?M?V4W$\3)-Y5N1)(($95EG:&5V_T=4?]?\ X9_L-:'^R3_PD'B+P';W
M%SK]UI]U'I]K>W(>WC8YFBM(^8#Y3RI C/<2O*$C7_2$W2N_SA_P3=_8_M[O
MPUJ&L_$7PY'<Z[J>J3R^9K=JMQ=-;JJ8=H[L.\+O.URSLRQS3@I(YDC\AJ^7
M_P!FJVM_V>_VC[OP=X0O9!X<NI+B&YMA.MQ&QBTZ2[\AF.[Y[2Y#PHQ)N(@D
MD,DC%Y_,_4__ (*$?M*7G[+W@:?5=+XU2\N(K"QE,:RI#-*KR-*ZLRCY(HI3
M'D2KY_E!XGB+BO/_ -E'_@GYX>^'FAB[\8:?;Z[XFU79=ZK<:K##>M%<2 N\
M$9D,Z?(SN)9U9GNI=TK.4\F.+\H/CA^S[9_LV?'7P=HVEW-Q-I<NH:-=V-M.
M[2?8(9M6DW6D3LS%HEE669"0K?OCO\R7?-+^[_[8W[0O_#,'@N_\21);S7L7
ME0V5O<2^6LUQ-(J*  0\OEJ7N'BC*N\4,@#QC,B? '[*.F_"S4-#'B3XB:UX
M7UOQ=K^R^U*;5;W3[AH-X)@M8X;@*+7R8BB2PHB[)0T(9H(;=(_A_P 7?&'0
M_P!@3XJQ7OP[U.WO?"&HV]E)J5A8W OX5A#O#/")&NI/,NT\M[JWD>2)HFN!
M"1]G:19OO#_@KE\6$\')X2T74TDE\.:CJC76M00/(D]S:Z?):EK92DT2E'6=
MWVL0?.CMY%DB,>X^_P#QB_8I^'/[3'@ZX3PKI^AP3S1R2:7JFEQVT,?VJ+>B
M![BTC<26_F!HKB/$@QN*JL\<;I]/_LR:3<:!X%\-6=Y%)!<P:'ID4T,J,DD<
MB6D2NCHP#*ZL"K*P!4@@@$5[A7X8_P#!9[X:/:Z#:>(WU75)5EU2UM$TMYXQ
MIL*BUNW\Z.W2)6-P65LSRR2/MD>,$1"-(_?_ (&_L3Z)\>?"'A[4_'TLFNJ-
M#TE=*LU>XL;73;7[%#F...WN=TUQ*WS75U*Q,I2)$B@BB5*_.#X,^"O$O[+'
MQKU3X;^!]5CC74H_LHO+^)I5@@:T745N?L\;I#/>VL1DCMVE7R979PT<,4[A
M/N#]K?\ X)F^"+'P5J^LZ<+R'7=.L[C4I=4GNY[N>^DMH7FG^UK-)Y1>Y(9G
MDB6(I,5D ,8>"3T__@D9\2]1^(GPU6#4'\W^R-0GTZVD+.SFW2*">-79V;/E
M_:##&%V(D$<484;"6\__ ."@7PD\6_'WQ]X+\/II=Q>^#!<17&H/"TB0EA/B
M\%VZ2JL7EVBC[*["*5FN+B."261C&F!_P5(_9>\ ^$_A_-KECINGZ/JEC<6Z
MV)LHH+/[4UQ-&DL$D<:*+C$0DG4 &6/R6=66+SUD^G_V,_\ C*'X.:7#XT_X
MG"ZA;W=O=FY^9IDM[R>&)G==K^:BQ1E9P1/YJ"?S/._>5^./PA^!GA_]F#XZ
MKX1\8Z='J6DW<CV^DR7J/-$1>_\ 'A.\9MQ%=.3FRES&+>&Z>64./LH8?TF_
M%5-#_L._E\306]QHMO;O<WL=S;BYA\FV'GL[PE)/,V>7YBJ%9MR@J"P%? '_
M  2T_9BT[X0>"[+Q)-:;-?UVW\^>XD=)&6SDD+VL4)3(BBDB$-Q(F?,:5@)3
M^ZBCA_3^OG_]K'_DGGBO_L7]6_\ 2*:OQA_X)?\ [+UG^T+X-O6\0ZCJ$N@1
M:Q/&=!MYVM;.YF^S6CO->O"5FN,$6S6\>^-;>2W+@OY\BUS_ .W;^QE+^Q5>
M6/Q&^&\UQI]I;7$4<L"&69K&9E*+,)9/-W6DV##/'=,R^;*L.98KD0P_M]\
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MKU-/6#5EEBMY-2BN'\R*:6696>Z@\Z1)I;1_,C=8?+,0B"*D?J'[&'[*5O\
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M-.T?3=?GT^6Y,5E9007!L4FBC=Y&AC4K$TK1A5<@2NC% _DR%/R!_P";O/\
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MR1-;I!($D>25&=@[!OD3[?HK\ ?V^O\ DX7P%_W /_3S<5^_U?@#_P $,?\
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MIJS:WJ<SSW&3>6$+B%69EB3;&5C+&6X2&1X#<O$=M?9__!+C_DD/A[_N(_\
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MSC'&\OF2('K]GOV3O^2>>%/^Q?TG_P!(H:_(']@7_DX7Q[_W'_\ T\V]??\
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M#_A2_P 3O^%W_P#"T?\ A#KC^S?M&W[)_:NE?:/L_P!@_L[S?^/OR_-V?O\
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M@:,M_INA7FHZC)&"FF+<6,$D<C1,X6XGEN1 J*X6*5X'NBI;='',@)K\D?\
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M:-'#;7>JW+F&XN8+&)1#;V^GW,#2J\P\A+BY8M"85O/)>"Y,(@^</VIO@O\
M$[XS?$[1?'.E>#KA;+0O[-\J"YU72HYKG['=/>-O\N[F2#<TC1+@S851*>6,
M2?K]XC^(>M:?H8U*Q\.:A=:D_F*FDM<Z=#,C 2;&GG-X]LD3%$RT,ES*BRJW
MD,RR(GY0_P#!,SX#?$+]D[4=4MO$/ABX^Q:S]A7[7!J&F2?9FMWE7=+%]K#M
M$5N'=VB+RKY05()3)\GO_P#P49_8)_X:HLTUW1&V>)M/M_*AC>3;#>VZL\@M
MB6.R*4,[M!+\J%G:*8[&2:W^$/A#^T5^TA\)47PN_AJ\UB9+QX4O-5L+ZX8,
M\FW:=12>*"2W#[F6XED=%1LB?[.L83]7_P!E;X(>(/#MQ?>,_'5Q'=>+=:CB
M22&-4-OI5G&S/'IUHWS,$#-ON=CM'+,J,3-)&UW<?9]%?BC\;_\ @GGX@^#W
MC&W^(?P?2S6Y@D::31)RB1^9+^YF2U\S9"+>6*67S86DMS;@/]FE!:&*#V_X
M:?\ !0/Q#<Z<G_"3_#OQA!J2[5D_L[2)I[>3"+NE7SS!)%N??B$^=L0+F>1B
M=OL&KZ/XH_:SBBM-2L;CPSX.FP]Y;3SA=:U6!HH76UECMRZ:;:.SRQW:^>]]
M*D7D%+199#7U_P#\(GIW]G?V1]DM_P"S?L_V7['Y*?9_L^SR_(\G'E^5L^3R
M]NS9\N-O%?ACX!^"GCS_ ()G>,;FZT#2[SQ1X(U:2".X%G"L^H*B^<T1,40\
MT7%L#+F0*ME<I(JLUO-+&+7ZO^*OQ=\:?M<:'?\ A3P?X5UC1/[0MWMKW5O$
M<4>FPVT,H^9(H"MU+=^?$L]L[0J&M6DBD)&X.GU!\"_@G:_L?^"X-#T:UN-7
MEM?WD_V=+2"YOKB:0>;,?/FMX1M! 033%TMH8X?,F=%W_F!^RS\%_B=\&?B=
MK7CG5?!UPUEKO]I>;!;:KI4DUM]LNDO%V>9=PI/M:-8FR8<JQE'*B)_M_P#X
M*'>%_%7Q;\(7GA#PQH%QJ4NH_9&DO?M=C;6\"PW*SLN)[A)I)<P(NT1K%LFW
MB<O&8B?\$\?"_BKX2>$+/PAXGT"XTV73OM;1WOVNQN;>=9KEIU7$%P\T<N9W
M7:8VBV0[S.'D$0^(/VIO@O\ $[XS?$[1?'.E>#KA;+0O[-\J"YU72HYKG['=
M/>-O\N[F2#<TC1+@S851*>6,2?M]X6UF?Q!9QW-S97&GRONW6MRUNTT>UBHW
MFUFN(3N #KLE?Y6 ;:^Y5_F"_P""7GQ'\4?""77M;T;2;C7M(C_LRWU;3[+!
MOE\^6;R+VWB\IWN/(5+E'MT>+<;A)'(CB>6']'OCSXC\:?M^V:^"M"\-ZQX;
MT*>XM)-8U?7;>.T80HTLODPV3[I)_GB@D62WF5O-589A!!(9F^_W_9ZT[2_
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MB?PY<6L5UJ$E[%J,=[I\\*;[>.-HYHH[HS+@VZ"-HDGWM,0ZPI&7;YP_;@^
M?Q!^#WQ/@^*_@FUDU=KB2']Q;VCW4EO)%9K:213P1[G>WGA1Q]HCV&,N\>Z"
M46\LOJ'[1DGQ5_;&^&>JW"Z'_P (]:#[.\>@O&]UJ^I"VN-\Y+RBV^RQ+MCE
M@@6W>\NI+=E1A%-$LW7_ /!-6V^(-IX?TG0M1TF3P]HF@R7WVI[Z)Q>:M)=/
M--%%#;S1Q-:V\#7 EEN/WAGDBABB8+]J5/U/\6>%K/QSIUWI6H1^=97UO-;7
M,6YDWPS(8Y$W(5==RL1N4JPSD$'!K\4?^"3_ .S._P ,O%7C+4YI))H])O+C
MP[:W(\N..X:&X\R[9H-TDJ.!#9LGS; )I$#2LI,?[G45Y_\ %CP+_P +0\/:
MKH/G?9_[3T^[LO/V>9Y7VF%X?,V;DW[=^[;N7=C&X9R/QA_9,N_B+_P3RBN/
M#.O^#=0UG1;W4+BYBU#0Q]NF5DB2%G\F,G,4OEVYA6Y^Q2JIF;$K*8H_?_'_
M ,,O%'_!0[4;!=:TVX\-^ =-N+>]6SU* +JFK7".T<T<L,4ZRV$2Q&>)&WJY
M$J7"K<"1!:?J?I.DV^@6\5G9Q1P6T$:10PQ(J1QQHH5$1% 5450%55 "@
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MOG_]I3]I30_V5M#_ +?U_P"T-;M<1VT,-M&))I9I S!$#,D8PB22,TCHNU"
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MB;')=-K#:Y+##$FO0***************************************\_\
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F%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ex19_005.jpg
<TEXT>
begin 644 ex19_005.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[@ .061O8F4 9       _]L 0P " @(%
M @4'!04'" <&!P@)"0@("0D+"@H*"@H+# L+"PL+"PP,# P,#@X,# P,# P/
M# P,# P,# \,# P,# P,_\  "P@,Y GV 0 1 /_$ !\   $% 0$! 0$!
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MP+K$XU75-.CTW2]3NV@L)XX([QH[20K#>$Q/+);X#*\"/&D@=MX9EB:/Y/\
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M6WA[4=)D\.:%!'=2:G<:TDD6H*J6#74 6U0X@=I%")'F[>Z22+RECD<(>?\
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M"_CIH?[1>AP>(/#\_G6DWRNC86:WF4 O!.@)V2ID9&2K*5D1GB>.1OG#Q_\
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M&ZI;S(B++%'&D5L)610UPK+(S_N=\"_CIH?[1>AP>(/#\_G6DWRNC86:WF4
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M[PE+X>\17EO>2C4)Y[7[---+##;RQP_ND\Z*(I^]6:5D1=FZ4ODN[U]OT5^
M/_!<[_F4?^XQ_P"V%?O]7X(_\%RM)N)K?PI>+%(;:*35(I)@C&-))5LVC1GQ
MM5W6*5D4D%A'(0"$;'[W5^0'_!:O_DGFF_\ 8P6W_I%?5H?M6:3<:!^S-%9W
MD4D%S!H?AJ*:&5&22.1)]/5T=& 975@596 *D$$ BO</^"7'_)(?#W_<1_\
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M\0O!7Q]^)6C:AH=XW@-+;4K.XLYGB.L"18[B)HG*%E90X5B5+*P!QE2."?\
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M &PK][M)TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4    5^"/[
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M $BFK\\?^"*&DV\/@75;Q8HQ<RZY+%),$42/'%:6K1HSXW,B-+*R*20IDD(
M+MGP_P#X+G?\RC_W&/\ VPK]_J*_ ']OK_DX7P%_W /_ $\W%?O]7\^/_!#7
M2;>:X\5WC11FYBCTN*.8HID2.5KQI$5\;E1VBB9U! 8QQD@E%Q]'_P#!:O\
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M9))R:_"']OK_ ).%\!?]P#_T\W%>_P#_  6K_P"2>:;_ -C!;?\ I%?5]_\
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M:+;-"89H=( 2*T$Z'.99?+>Z+K)-&ZSJT<@B*1Q_3]%?@#_P7._YE'_N,?\
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M_2_B?^U:FJ:-<QWEC))/''<1$F.1K?0GMY"C8 =!)&X61<I( '1F1E8_K_\
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MKO\ N?-_Q]_;/]=^\]/W7E5^G]? '_!4?_DD/B'_ +AW_IRM*X__ ()J^/\
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MNR5/F4!MR;E;]3])TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4
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MY]ZY$C3%VER2Y8L2?S@\+?\ !(SX:^%M<CUH+J%S%%<-.FF7,\4MCR24B=#
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MJIA1B-6" [F"AF8GL*^?_BE^S%X:^-/VA=>34+NWN_+\^T_MC5(K-_*V;/\
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MS=QDMM.GB2W+L[.SK'/!<>5G<%$<)C@1$54B3!+?7_[/7[,7A?\ 9?TY]/\
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M]X?U72/$'AN[U/P_K2Z>^NZ>+&&[F2S<&"%S*^93O7:"%5F*QAO-DACDY_\
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MRY\0^&G[>7P]^,FHII7A[4KC4+U]I\J#2]3;8K.L?F2M]DV11!G0/-*4BCW
MNZCFN_\ C7^U!X5_9V\MO$]U<6,4VT1W']GWTUN6?S-L?VB"WEA$I$3MY)<2
MA%WE-A#'H/@Y\=]!^/MFVH>'9KBYLAC;<R6-Y:PR99T/DR74$*3[6C=9/)+^
M6P"OM+*#Y!H_[=/@;Q7XOL?!6C7W]J:E>^?^^L@LMG#Y-L;K]Y<[A&^] RK]
MF\_;(K)+Y3"OF_Q__P %?_ASX%U2YTR./5-26UD,9O+&&VDM96 &XPR27432
M(&ROF!=CE2\;21%';]'_  !X_P!+^*>EVVM:+<QWFG7D8D@GC)VLN2""" RN
MK I)&X5XW5HW575E'S O[?\ \/KWQ/;>%;+5([VYFCNI9KRW9&T^TCM;5KQW
MGO&=82AB5_F@,XC='68PD5Y?X3_X*H?#KQSXHM/"^GOJ$S7UQ#;6VH?9-EF\
MTP C3#NMTNZ1A!N:W51(=Q(AS-7V?\7OC1X?^ NEMK/B6^CL+%9$B$CAW9Y)
M#\J1QQJ\LCX#,5C5BJ*\A 1'9?C#4?\ @ISX7\'WEK;>)]$\4>&XKOS?*NM6
MTDP0GRE#-@1RRS/RR(?*BDVM(A?:A+#]#])U:WU^WBO+.6.>VGC26&:)U>.2
M-U#(Z.I*LC*0RLI(8$$$@U\P?%[]L;P_\*-4;0(+;5->UV.-)I]*T6R>^NK>
MW<<3S@%(HTR8P5:038G@?RS'(KUS_P .OV[O"?Q&UNP\+I%JECXCO9)4?2+^
MPEM;JT6.WFNO,N=_[E4>*)6C$4DKL)X24 ,AC]_^+WQH\/\ P%TMM9\2WT=A
M8K(D0D<.[/)(?E2..-7ED? 9BL:L517D("([+\H?\/%_#GA_][XGT7Q1X8LC
M\L=[K&BSQ6\DQY6!&@-PYE90\B@J%V12$L" &^S_ (>^-;?XE:-I^N6:R);:
ME9V]Y"DH42+'<1+*@<*S*'"L P5F .<,1R?PQ_X(8_\ ,W?]P?\ ]OZ_4_XO
M?MO^ ?@+JC:-XEU.2POEC241OI]^ZO'(/E>.2.V>*1,AE+1LP5U>,D.CJOI_
MP<^.^@_'VS;4/#LUQ<V0QMN9+&\M89,LZ'R9+J"%)]K1NLGDE_+8!7VEE!X#
MXQ_MD^"?V?[Q;'Q/?7&GROGRFDTW4&AFVJCMY,\=J\,VP2()/*=_+9@C[7RH
M^C])U--:MXKJ(2+'-&DB"6*2&0*ZA@'BE5)8WP?FCD570Y5E5@0-"OG_ /:%
M_:=\+_LOZ<FH>);OR?.\T6MM&AEN+IXD+E(8U_X"IDD,<$;R1K)+'YBD_,&H
M_P#!3GPOX/O+6V\3Z)XH\-Q7?F^5=:MI)@A/E*&; CEEF?ED0^5%)M:1"^U"
M6'W?J?CRPT[2QK*/)=V+QQ2QR6,$U^TL<Q7RWACLTFEF1@ZMNB5P$S(2$!8>
M(?!3]LSP)^T3J,FE>&-4^W7L-NUS)%]DNX<0H\<;/NG@B0X:5!M!+'=D# )'
M?_&/X[Z#\ K-=0\137%M9'.ZYCL;RZACPR(/.DM8)D@W-(BQ^<4\QB53<58#
M/^%7[2/A/XU:-=>(=#U*.;2;*26.ZNY8Y;6.%H8DFE+FZ2$JB1R*[2$; "?F
M^5L?B#^UQ_P43\/_ !?\:^$;/1[B3_A%]#US3]3O[YX'59Y(YHSOCA:'[4$M
MHC.IX4SO*X$+"*&23]KO@7^U'X0_:4^V?\(IJ'V_[!Y/VG_1KF#R_/\ ,\K_
M (^(HMV[RI/N;L;><9&?QQ_8;U:WT#X^_$*\O)8X+:"/Q%+--*ZI''&FL6[.
M[NQ"JBJ"S,Q 4 DD 5]?ZG_P6%^&5AJ@T^,ZI/;&2)#J,=F!:A7"EI"DDL=W
MLCW$2 6Y<E&\M) 4+?I_I.K6^OV\5Y9RQSVT\:2PS1.KQR1NH9'1U)5D92&5
ME)# @@D&O+_C'\?O"_[/]FM]XGU.WT^)\^4LA+33;61&\F",/--L,B&3RD?R
MU8.^U,L/E"]_X*1^'_"KPMXE\/\ BSP[8S2&(:AJNC/#:K)Y;R*A,<DTK.XC
M8*L<;G/S$*BNZ_;_ ( \?Z7\4]+MM:T6YCO-.O(Q)!/&3M9<D$$$!E=6!22-
MPKQNK1NJNK*/G#Q_^W3X&\!>(;#PI]N^WZU?ZA;V'V:Q"S_9I9YFM\W4NY8H
MO+E79-#O:Z3<K?9RIS7A_C7_ (*S?#+P9K*Z0MS>7T?F".;4+.W$EG"WFM&Y
M+M(DLR(%\PR6L=PDD;*8FE8[1[AX_P#VZ? W@+Q#8>%/MWV_6K_4+>P^S6(6
M?[-+/,UOFZEW+%%Y<J[)H=[72;E;[.5.:^OZ^ /^'H_PA_Z&'_RG:E_\B4?\
M/1_A#_T,/_E.U+_Y$KZ_^%OQ2T?XTZ/;Z]H-Q]KTV[\SR)_+DBW^5(\+_),B
M2##HR_,HSC(RI!/SAX__ &Y?#_A/5+G1M)T[7/$U]I\ABU&/0=.>^6QDP-B7
M$A:.(.Q$BA8VD*/#-'((W0K70?LS_MI^#OVKDD7P_<R)?01^;/I]U'Y5U%'Y
MC1A\!GBD3(4LT$DHC$D2R&-Y%2OI_5M6M] MY;R\EC@MH(WEFFE=4CCC12SN
M[L0JHJ@LS,0% )) %?GA=?\ !3GPO=Q7E]HVB>*-;TBQW>?JVGZ27L5V1+-+
MNDGE@>/RE<&7SDCV@;^8RKM^>'@#Q_I?Q3_:HMM:T6YCO-.O(Q)!/&3M9?\
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M=2",7E]#;1VL3$':9I([J5HT+87S"NQ"P>1HX@[K^I]?@#_P0Q_YF[_N#_\
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MGI=[?6Q<'=#=6MM+)#-&P(975A@X(#HSQ.&BD=&^+_\ @BI_R3S4O^Q@N?\
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M_P""[WQ)#:;]?T*W\^"XC=(V:SCD#W44Q? EBCB,UQ&F?,652(C^]ECFT/\
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M1111111111111111111111111111111111111111111111117\T/_!*/0/\
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MXL>!?^%7_!O5=!\[[1_9G@^[LO/V>7YOV;3'A\S9N?9NV;MNYMN<;CC)^/\
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MRH$"[V6_LH_,E;[\LI5$#S2EY9-H+NQYKT#_ ()<?\DA\/?]Q'_TY7=? '[
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MVDZM;Z_;Q7EG+'/;3QI+#-$ZO')&ZAD='4E61E(964D,"""0:_!'_F[S_/\
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M?M=^UC_R3SQ7_P!B_JW_ *135\ ?\$5/^2>:E_V,%S_Z16-?K_7S_P#M8_\
M)//%?_8OZM_Z135\ ?\ !%3_ ))YJ7_8P7/_ *16->P?\%8/%-GX?^%&J6US
M)LEU"XL+:U7:S>9,MU%=%,J"%Q%;S/N<JOR;<[V56]P_89^%]Q\'/AOX?T>\
M\P7*6?VB9)86@DADO9'O'@>-B65X6G,+;L$F,L40G8OY8?\ !#'_ )F[_N#_
M /M_7[7?&_P5<?$KPKK>AV;1I<ZEI=]9PO*6$:R7%O)$A<JK,$#,"Q56(&<*
M3P?PQ_X(U_M+Z=X4_M'P/JLUO:?:[A+[3I972+SKB7R;26UW22C?*^+<VT,4
M9=L7!+'"+7]!VK:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22
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M77F+)K-Y<:D(I(6B:*-Q';Q8W$F1)8[=+B.3"ADF7:&4!W^,/V!?^3A?'O\
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MP0$)-+;PQN8P1-%]GZ3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550
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MMI$=\IR_[R/&]Y/G8;6_9[X%_ O0_P!G30X/#_A^#R;2'YG=L--<3, 'GG<
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M:9I8L/#S6>G20QQ16GF6C36L$<950@MH9[4[!&"D:I+&(SM.&5=C?FA\&/\
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M /'(A5XW59$9756'@'P&TGQ!\%'C\&:I%)?Z+:QQPZ#K4:(6-M'&^RQU**(
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M_#7X7Z<FGP>'M/O=NTR7.HV\5]<2N$5&=I)T?9NV!C'"(H%=F9(DW$'\,?\
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MY?+4AI-@;8I#-@<US_\ PMCP]_;'_"/?VKI_]M?] [[7#]L_U?G?\>^_S?\
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MGDWMCH^HW-M+M5]DT-M))&^UPR-M90=K!E.,$$9%?G!_P14_Y)YJ7_8P7/\
MZ16-?H_XP^ /A?Q_KFG>)=4TRWN=7TG/V*Z<'='D[ER 0DOEL3)!YJO]GE+2
MQ>7(Q8^@>%O%FG>.;./4-*N[>^LIMWE7-M,DT+[&*-LDC+(VUE96P3AE*GD$
M5T%>'ZM^TWX%T"XEL[SQ+H<%S!(\4T,NIVB21R(Q5T=&E#*ZL"K*P!4@@@$5
M[A7'^-?B%HWPUMUO-<U"STVV>01)->7$5O&TA5F"!Y652Y568*#DA6., XS_
M  +\6/#WQ0\[^P=5T_4_L^SS_L5W#<^5YF[9YGDN^S=L;;NQNVMC.#CT"OS
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M<8DF\+^ 8_GEVQ_9Y->=DF,,4\4JRL\(^RO<(V]8)K-K>6%!<AY?U/K\T/\
M@K9X*M_%7PKOKR=I%DTJ\L;R (5"M(\PLB) 5)*>7=2, I4[U0[MH96T/^"4
MOQ+_ .%B?"^P@=[B6XTBXN=.FDG;=G8XGA6)BS,8H[>X@A0-LV>68U41HA;]
M'Z_(#_@J/^RYX0_X1#Q#X\_L_P#XJ3_B7?Z;]IN?^?FTM/\ 4^;]G_U/[O\
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M%X--U6\UC5KN32KNUGUV<31QW4NJ3B*$BUBA$-DLB*WD0(HC#R>6!E5'Z?\
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MVVGQ7DDTNRU$4^]8US';FV5Y)$C01?9_PG_8_L_V?OB_<Z_X?M?L^A:QX?O
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MG;QW&DR:HGVMHYI);>33=+6.WEF^T6ZY1+J. "!U*J)KF&(3<K*?Z+?VL?\
MDGGBO_L7]6_](IJ^ /\ @BI_R3S4O^Q@N?\ TBL:_7^OP!_X(8_\S=_W!_\
MV_K]?OVL?^2>>*_^Q?U;_P!(IJ^ /^"*G_)/-2_[&"Y_](K&OF#_ (*@Z_\
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M]E_3O">G^&K3R?._M,W5S(YEN+IXDT] \TC?\"81QB."-Y)&CBC\Q@?Z?J_
M']@7_DX7Q[_W'_\ T\V]?K]^UC_R3SQ7_P!B_JW_ *135\ ?\$5/^2>:E_V,
M%S_Z16-?*'Q7\27'PJ_:KM-1GM)'CO;S3+>#?NB62._TZ+3#/&Y1A(D4CR9V
MC#O"\.]&#,O]%U?SX_\ !97P';^,_%7A&STE(YO$>I1S61A$ZB1XVN(5L%9'
M<)$C3372I*P0.?,#.1#\GT?_ ,%J_P#DGFF_]C!;?^D5]7W_ /LG?\D\\*?]
MB_I/_I%#7Y _\W>?Y_Z%ROW^HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHKX0_;C_8<TO]KW2Q)&8[/Q'9QD6%^0=K+DM]ENMH+-;LQ)5@&>W=C+&&
M#30S^'_"7]H#XH?LX6<6@_$3PKK&OK!Y\5IK>B*FIS7*0-&L7VF%65UW*S,M
MS<-!/,H0/;O,+B:CXM?M ?%#]H^SET'X=^%=8T!9_(BN];UM4TR:V2=I%E^S
M0LS.VU55FN;=IYX5+A+=)C;S5] ?L9?L+Z'^QY9S-!)_:.M7>5N=3DA$3&'=
MN2"&/?)Y,0PK2 .[32@.[%4ACAZ#]LFY\5>(/"^K>'?"FA7&I7NJ:>]LMT9K
M&.SC6Y)AN$?S[ZWN!*L!D>-DBDB\QHLE@)$7X@_X)X>!_B=^R7IU_H.O>$+B
MXTVXN&O8)[*_TIKA+ADBA>.1)M0BC:)DB1E965XW5@5E64&']/OC-XRU[PEI
MTO\ PC>C7&KZE+;W/V79)9I;PW"I^X^U?:;RTD,3N1N^S^8X1'SL8IN_''_@
MGG\$OBM^QUJFH#4_"4EWI.JQPBY:WU'3#=126PE,#1+)?1Q.A,SI*C,APRR+
M)^[,4WZ?_M2WWB+Q3X*OM+T+P]>7^HZWI=S:F$W6GVZV37,(B;[5))=;6=%E
M<JMK]I21X2AEC1TF/R?_ ,$Q_A=XV_9NTF[\,>)_#EQ:Q76H27L6HQWNGSPI
MOMXXVCFBCNC,N#;H(VB2?>TQ#K"D9=OH#]NC]C*S_;#T..!9OLFM:=YTFF7+
M%O)#2A/,AG1<YBE\N,&15,L+(LB!U$D,WY0?!GXJ?M'?LV^5X.C\.W&J10_9
MK:T%[8RW5O;*W*)'J-I-%"8@)55FGN)(K5(UB!@2)U'ZG_LK?!#QC9ZS?>.O
MB/<6<WB.^LXK&SMK-=L>FZ>96NWM"R;4E?SI A9OM#H+=2M[.)6Q\P?\%"?^
M">VJ?%75$\>> WD3Q,DEN;FV%P(&F: )'!=6L\CHL%Q"J)N7?&CI&)$*7"$7
M/S_\%_VJ?VD+6WL?#T7A.2_GBC,:7VKZ9?022+&K.#<W<MQ:V^\(-@DD*O,0
MNYI9W+/^I_P#^#FI_LZ:'?:EJC7'B;Q9JUPEYJ\]N+6.:XF(2)+>V>Y>TC%I
M:IGR(Y9(U5?-:**$2);+^<'[+/P7^)WP9^)VM>.=5\'7#66N_P!I>;!;:KI4
MDUM]LNDO%V>9=PI/M:-8FR8<JQE'*B)_W>HK\H/^"K?[*.N?M$Z'I^J^'Q]I
MN]!^V.^GJA,US#<B$N8"#\TL?D B#&Z968(QE6.&8_9T^.OQF^/NG+H=]H?_
M  C-[;6Y6^\2ZE93#S"R2I$UGI<B6R/=EO+DD8RO9Q[)&:!1+!;'X@_X)\_#
M?XJ_!74=?\+66@7&E76K?9XY->OX7^QZ:MD\Z2S0H8S#J,K"<BUCCF\IY DK
M&2U$K+^C_P#P5*^!>N?'GP"MMX?@^UW>G:A%J#VRY\Z:&*"XB=8$ /F2CS@X
MBR&D5&5-\ICC?C_V(/B%\3?&.C:)X>U7PS)X>TS1HX;:[U6Y<PW%S!8Q*(;>
MWT^Y@:57F'D)<7+%H3"MYY+P7)A$'ZGU\P?M=G7M7\):IHGAW1+C6+W5]/O+
M)3'<V=M#;^?'Y)DF>ZGB<X65WC6%)=[1&-VA#K)7Q_\ \$Q_A=XV_9NTF[\,
M>)_#EQ:Q76H27L6HQWNGSPIOMXXVCFBCNC,N#;H(VB2?>TQ#K"D9=N@_X*,_
ML$_\-46::[HC;/$VGV_E0QO)MAO;=6>06Q+'9%*&=V@E^5"SM%,=C)-;_"'P
MA_:*_:0^$J+X7?PU>:Q,EX\*7FJV%]<,&>3;M.HI/%!);A]S+<2R.BHV1/\
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M-J)%(9@WZO\ [-?P<\:>+=<_X3_XG-;Q:U%;R6>DZ+;"-[32X7*B>X1M\_\
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MQYX,\-&ZUK3+/7?$;22A++0W6TM47:QA$D^J7*L4+*/-F12Z&4*EK*(FE?\
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M6ER6=OI-GHM\L<@M+[3K9+9H9&*$-)##Y45RF4"E)@2$:0120._F#X@_8?\
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MRDDAM;RVAEC@OQ;1;Y'='53&\L:->0S*D5O/"^%B@(B6?R#_ (**_MU_$/\
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MU#Q+I7B2S\(:3;7C6-M8V^E0ZE([(HG9YY+LJ=ZQSP1[XBJ2E7;[-;XS+?\
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MX _L"_\ )POCW_N/_P#IYMZ_<[Q_X_TOX6:7<ZUK5S'9Z=9QF2>>0G:JY
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MA**.U2\,<UR=6NUGE6"2(_N1!%;L\R+)&KEY(HVW3&.9[6N0_P"";W_"T_\
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MR]MMN$04*T1C5FB)W^@?M]?\G"^ O^X!_P"GFXK]_J**_ '_ ((8_P#,W?\
M<'_]OZZ#_@N+XIO+33O#&E))BRN;C4+F:+:IW36J6\<+[B-XVK<SC:I"MORP
M8JA7[?\ ^&>/B]_T4_\ \M;3?_CE?/\ !_P2\UC6?'-EX\U[QC_:>I6VH6%[
M/_Q)H[;S_L+0[(_W-V(X\I"D>Y8SC[Q5FSGP#_@N=_S*/_<8_P#;"OW^K\@/
M^"U?_)/--_[&"V_](KZOO_\ 9._Y)YX4_P"Q?TG_ -(H:_('_F[S_/\ T+E?
MK]^UC_R3SQ7_ -B_JW_I%-7P!_P14_Y)YJ7_ &,%S_Z16-> ?M]?\G"^ O\
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M;6(Q6ZM+H#R"&!6)<Q0*RV\<DG[V5(A+(!(["OZ/J*_ ']OK_DX7P%_W /\
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M_DGGA3_L7])_](H:^@*^ /\ @J/_ ,DA\0_]P[_TY6E'_!+C_DD/A[_N(_\
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M?]C!<_\ I%8UZA_P5L\%6_BKX5WUY.TBR:5>6-Y $*A6D>861$@*DE/+NI&
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M/)_L^:*>"6%D D24/=R$N'.-D94(RL6_1_\ X*C_ /)(?$/_ '#O_3E:4?\
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MU_X3\+6?@;3K32M/C\FRL;>&VMHMS/LAA01QIN<L[;54#<Q9CC)).37\X/\
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MV6ZEDFD6.\B#R.SL(X;ZYBB0%B2$CC1(XUZ(BJB@*H _/#_@AC_S-W_<'_\
M;^O?_P#@M7_R3S3?^Q@MO_2*^K[_ /V3O^2>>%/^Q?TG_P!(H:^8/VI?B?\
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M_P $,?\ F;O^X/\ ^W]?O]7X _L"_P#)POCW_N/_ /IYMZ_?ZOP!_P""&/\
MS-W_ '!__;^N@_X+B^*;RTT[PQI228LKFXU"YFBVJ=TUJEO'"^XC>-JW,XVJ
M0K;\L&*H5_=ZN/LOA[HVG:I-KD&GV<>K7,8BGOTMXENI8P$ 22<*)70".,!6
M8@"-./E7'X(_&N?Q'\2_VGH]*TK6/[)O;.W6VTZ^^QP77V6'^R)+R5/(DV)-
MYC3W W2DLGG9!Q&BC]'_ /AGCXO?]%/_ /+6TW_XY7G_ .Q5_P $WO\ AC[Q
M#<Z]_;O]I_:-/ELO(^P?9MOF303>9O\ M4V<>3MV[1G=G<,8/R!^WU_R<+X"
M_P"X!_Z>;BOW^HK/U;2;?7[>6SO(HY[:>-XIH945XY(W4JZ.C JR,I*LK A@
M2""#7Y(?#W]H.ST:6Y^'_P"S]X;M[U+"XW7NK7,S+I$#2RQ*T[S&5KF_W 31
MJ1(LICMP]JMY;1!1\@?"W3M<TO\ :EMX_$MU;WFKGS)+J6UB,5NK2Z \@A@5
MB7,4"LMO'))^]E2(2R 2.PK]OOVL?^2>>*_^Q?U;_P!(IJ^ /^"*G_)/-2_[
M&"Y_](K&OU_HK\ ?V!?^3A?'O_<?_P#3S;U]/_\ !9+Q3>>'_AK%;6TFR+4-
M8M+:Z7:K>9"L5Q=!,L"5Q+;PON0JWR;<[&96/V>O@3\4M7\&^'[G3_B+]ALI
MM'TZ2VM/^$;T^;[/"]M&T</FO('E\M2$\Q@&?;N(R37 ?&O_ ()5^(_VB=1C
MU7Q/X[^W7L-NMM'+_8,$.(4>214VP7<2'#2N=Q!8[L$X  ^W_P!LVU^'6D:'
M#X@^(MG;W=II%P)K))%W32W)&5MH4#)Y_G;!YEM(3;2+&)+A1%"9(_C#XK_&
M;XF_M,^"O$&K:;I=GX:\%2:'?SI<ZAFXU:_M5AN9-UO C"&W2YBCCB?SU)CB
MN#<VUQ<_NRM__@BI_P D\U+_ +&"Y_\ 2*QKR#]O;]FCX@> OB OQ3^'<-Q=
M7#V\?V@P)#=7%M<"$:>?+LWB9I8I+=H\;%N71Q<2OY,:QFN@_9V_X*I^'/CR
ML>A_$BVM])N!<6=Q;WL3SBQFN;>]2>W#C+26GE.EO(7FEDMI!',TTD,>V)_K
M_P#X*C_\DA\0_P#<._\ 3E:4?\$N/^20^'O^XC_Z<KNOO^BOP!_8%_Y.%\>_
M]Q__ -/-O7[W:MI-OK]O+9WD4<]M/&\4T,J*\<D;J5='1@59&4E65@0P)!!!
MK\$?^">G_&*WQA\4?#:Y_=V][O\ L)F_>W$OV,O<V69(/W*^98SS7$N]$^=4
M3]U)F)O?_P#@HYHNH_M23R> ?#Z^;_PC^GW'B+59(X'N7^T);S1Z;IL(A<XN
M[K?*Y@F5',!CN(3+L:&3L/\ @FG^U%;^*_A;)-KEQ'&WA*.6WNW#*\@T^V@$
MUO.UO#&'5%A#6Z861YS:2/O>4NJ^X?L$^%KR3PNWB_6H\:_XNN)-7OG++)B&
M4D6$$+Y>1;2*U\IK>WEDE:W\V1,IDQK^<'[,?B.S^)O[37B;4-:%O'>V?]J6
M^F*)&BW36+1:<A1#)^]E-DD[R)\R_P"MF6-!&OE_O]7\X/[0?AR\^!?[36C:
MAIQM[9=:U#2;B-8(U_U-^PTZ^$J-&$$L[+=N[KN8^<)O,$Q.S^CZBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOYL=$L4_P""7?QIDN+^WDB\
M'ZQ'<06UWY,DHCL;AHIML1$SNSV<Z0PW&\R7#VZM,+<O<09_H>U/XA:-HNEC
M7+K4+.'26CBE%_)<1):F.8J(G$[,(BDA=!&V[#EEVD[AG\@?^"?'@Z_^/_Q!
M\2_&+4X)!IUW)/;:&]U:PK(\9<1+)$48^6]K;0)9221JXF,TZ?:'>.<-X?\
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MEO[+[/IMUNL]#\ZV4-(J[+?[1&S2R-'+%;VZV\\D>Z*66YN8XY56*6*O#_\
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M_P""&NK6\-QXKLVEC%S+'I<L<)=1(\<37BR.J9W,B-+$KL 0IDC!(+KGL/\
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M5V> HJ('C\N23YUB]_\ AE^T/<?M<>-[.X\(37B>"O#T=Q)?WYB:&WU;4+B
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MW^S_ &C[+YOG)L^T?V']D\C=G;YOVC_1_+SO\_\ =8\SY:_9[]K'_DGGBO\
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M@_X)^?MM:'^T!X>T_1KN\\GQ-8V\-I<6UW<![B^:&$YNX'<A[GS%B>:< -+
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M_"7Q'KFGI<)97?A_6VMC<0M \L*V]RD<ZQOAQ%.JB> L%9X)(W*J6*C\T/\
M@DW^TIX.^$'@76+/Q!K%GIUS!JD]ZT-Q)LDDMWM+=5:!#\UPY:WE7RK<23 A
M 4!EBW_N]I-Z^HV\4\L,EM))&CO!*8S)$S*"8W,3R1%U)VL8WD0D':[+ACH5
M_/#_ ,$^_%FG7O[0'C&>*[MWBU#^WOL4BS(RW6[5(9U\A@<2YB1YAY>[,2-(
M/D4D?J?^WW^SQ<?M,> [W1].ACFU:"2&\TY9)6B7[1"V' 8$(7D@>>&,3?N=
M\BLS1[1*GY(?\$^O^"AMG^S=9_\ " ^.H+BRM+*XO?*O6C8M9,6#M9SVD<'V
MC_7?:&,I,LJ2RK"T2Q*7B^[_ (F_MLV'[3:0>"?A3?7ESK.KR+'=:K;6LT"Z
M-IZR1_:[US=1P%G\MC'"(FC?>V4GBN?LR3?&'_!5O7_^$4^*?A'4-<M[B[\-
MVEO9SR6S1^;;S>5J$CW\44<I%N\KPBW69"1N0P+*0A0U]_\ [3G[8W@OQ7X!
MUNVT*_\ [:N]1\/Z@T5MID4EW-##+ (FGO4C4_88H?M"/,;PP,JK(H5Y4,=?
M('_!)/XZ:'\.O!KZ-<S^=J^I^*##:Z;;XFO'6:VLU-RT"G>EI"L<TT]RX6*.
M.&3YFDVQM]W^#_VQ+*U^)_B+X>:Y/';R026,VD3S2P11R+<6=B&L$#>6[W!G
MF::$ S/,))4_=K!&K_"'_!9'X%Z'=Q:/K^G0?\59J6H1:>+>WP9M0A\I\,;=
M09)I8G%O DL8W!9XX7WC[,L?T_\ MW:!J/A3]G^[T_5[C[7J5II^AP7ESYCR
M^=<17=BDTOF2 2/O<,V]P';.Y@&)%>?_ /!.?]J'PEX,^%NCZ5-J5N^M6]Q<
MVJZ2LL:WT]S=:A(UM#!#,\?F>;]HA FR+:,LQEGB6&=H_P!?Z*_G!_9'^*NA
M_";]H#QI/K]_;Z=;W=QK]M#/<N(H3-_:B3A'E;$<>4AD*M(R*S 1@F1T5OW^
M^&_Q+T[XLV;ZEI#^?IXN)H(+M61H;KR&\J66!D9BT2RK+"'<)YC1-)&'MWAF
ME_$'_@JOHNH_ #QSX:^)^@KY=P<0SLD#QQ-<6;;T%U/"Z-+]JMY&MFB8H[VM
MJ\8=X\K%^K_[+7P<O/AMIUUJVNMYOB;Q#<#4M9<A3Y$TB*(]/A</,YM+)?W%
MNK33*/WCQLB2"-?P@^(GP%\4?#+XM:S\-O#D_P!BTWQSM*F#$,46ES7!NYGC
MMHKF./\ T1(+RS$<A4SVHN(XXD6[05_3=I.DV^@6\5G9Q1P6T$:10PQ(J1QQ
MHH5$1% 5450%55 "@   "OYX?VL?!%Q^PI\9=.^)EI9R3>'M1O&N+AUC:18[
MBZ26+48%+3@FXDC>:\MO,:&$O(8T1HK:4#][O"WQ5T/QIH<?B:PO[>719;=K
MD7I<)"L* F1Y&?;Y7E[6$RR;&A9'60(R,!^0/PFT6?\ ;*^/-[XW1?M/A/PK
MFSL+F2"WEMYKBWC*)'!(CE9,7$T^I0W"^<\:"VW>29K<)^WU%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%>?_ !+^%6A_&33GTKQ#86^H63[C
MY4Z!MC,C1^9$WWXI0KN$FB*2Q[B4=3S7S!X6_P"";WPH\'WD=];>'+=Y8MVU
M;F>ZNX3N4H=\%U/+"_#$KO1MK8=<.JL/M^OG_P#X9.^'G_0J>'__  4V7_QF
MO8/"WA/3O UG'I^E6EO8V4.[RK:VA2&%-[%VV1QA47<S,S8 RS%CR2:Z"BOE
M#5OV&?AOK_B"7Q/>>'[.?5)Y'EF:7S'MY)'0H[O9LYM&=LEV9HB6F)G),Q\R
MOJ^OD#XE_L#_  S^+NHOJNKZ!;O>R[C++!+<6GFLSM(TDJVDL*22LSL7F<-*
M_ 9R%4#W_P"&GPJT/X-Z<FE>'K"WT^R3:?*@0+O946/S)6^_+*51 \TI>63:
M"[L>:X_5OV9/ NOW$MY>>&M#GN9Y'EFFETRT>221V+.[NT19G9B69F)+$DDD
MFO0/!7P]T;X:V[6>AZ?9Z;;/(97AL[>*WC:0JJERD2JI<JJJ6(R0JC. ,<?X
MI_9Z\&^.;R34-5\/Z/?7LVWS;FYTZVFF?8H1=\DD;.VU555R3A5"C@ 5H>&_
M@AX5\'6]W9Z9HFEV=M?Q^5>PV]C;PQW,>UUV3I'&JRIMD==L@88=QC#'/'_\
M,G?#S_H5/#__ (*;+_XS78>)/@AX5\8V]I9ZGHFEWEM81^590W%C;S1VT>U%
MV0))&RQ)MC1=L8481!C"C&?X6_9Z\&^!KR/4-*\/Z/8WL.[RKFVTZVAF3>I1
MMDD<:NNY696P1E6*G@D5S_\ PR=\//\ H5/#_P#X*;+_ .,UZ!_PJ?P]_8__
M  CW]E:?_8O_ $#OLD/V/_6>=_Q[[/*_UO[W[O\ K/G^]S7G_P#PR=\//^A4
M\/\ _@ILO_C-=AXU^"'A7XE7"WFN:)I>I7*1B))KRQM[B18PS,$#RQLP0,S,
M%!P"S'&2<G@KX(>%?AK<->:'HFEZ;<O&8GFL[&WMY&C+*Q0O%&K%"RJQ4G!*
MJ<9 QY!\7OV'?AY\=]4;6O$.BQW6HO&D<DZ7%U;M(L8PAD%M-$LCA<()'#/L
M5(]VR-%7K_BS^RQX+^.&G66E:]I%O<66FX%C%&9+;[,H01^7"UL\3I%M5 85
M(B/EQDH3%&5]0\ > -+^%FEVVBZ+;1V>G6<8C@@C!VJN22222S.S$O)(Y9Y'
M9I'9G9F/B'Q(_8O^'_Q=UQ/$FN:);W>J)Y.9F>95E\@YC\^%)%AN, !#YZ2;
MXE6%MT2J@[_7_P!GKP;XK^S_ -H>']'N_LEO':VWGZ=;2^3;Q9\N"+?&=D29
M.R-<(N3@#)K0\%?!#PK\-;AKS0]$TO3;EXS$\UG8V]O(T996*%XHU8H656*D
MX)53C(&/0-6TFWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP*LC*2K*P(8$@@@U\0
M:M_P3+^$FM7$MU+X=C62:1Y'$5Y?0QAG8L0D45RD4:9/RQQJJ(,*JJH 'V?X
M6\)Z=X&LX]/TJTM[&RAW>5;6T*0PIO8NVR.,*B[F9F; &68L>237G_BG]GKP
M;XYO)-0U7P_H]]>S;?-N;G3K::9]BA%WR21L[;5557).%4*. !6AX;^"'A7P
M=;W=GIFB:79VU_'Y5[#;V-O#'<Q[779.D<:K*FV1UVR!AAW&,,<\?_PR=\//
M^A4\/_\ @ILO_C->X:3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550
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MDR%A;YB/ER?9Q%YJX\S?@5T'Q"^%6A_%F*V@U^PM]1M[2X^TPP7*"6$3>5+
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MGKP;X&O(]0TKP_H]C>P[O*N;;3K:&9-ZE&V21QJZ[E9E;!&58J>"17L%?/\
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MM1F$X_UHDKW_ $G2;?0+>*SLXHX+:"-(H88D5(XXT4*B(B@*J*H"JJ@!0
M!6A7/^*?">G>.;.33]5M+>^LIMOFVUS"DT+[&#KOCD#(VUE5ER#AE##D U\@
M?\.WOA1_:/\ :G_".6_VC[1]HV>?=?9]^_S-OV7S_LWE9X\CR_(V?N_+\OY:
M^S])TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4    5H5^>'[4^D
MV_QZ\>>$/ $\4=U8VLDWB768F12R6]FK6]B&\X&&6WN+B62"Y@5)9F3!_<IE
MV_0^BBO+_B]\%_#_ ,>M+;1O$MC'?V+2)*(W+HR21GY7CDC9)8WP64M&RED9
MXR2CNK<_\,OV:_!WP>TN?1M$T>SMK&[C:*[C,?G-=1L9,I=23>9+<(!+(JK.
MT@5',:@)\M9__#)WP\_Z%3P__P""FR_^,UV'B3X(>%?&-O:6>IZ)I=Y;6$?E
M64-Q8V\T=M'M1=D"21LL2;8T7;&%&$08PHQG^%OV>O!O@:\CU#2O#^CV-[#N
M\JYMM.MH9DWJ4;9)'&KKN5F5L$95BIX)%>@>*?">G>.;.33]5M+>^LIMOFVU
MS"DT+[&#KOCD#(VUE5ER#AE##D U\@>%O^";WPH\'WD=];>'+=Y8MVU;F>ZN
MX3N4H=\%U/+"_#$KO1MK8=<.JL/M^BBO/_B7\*M#^,FG/I7B&PM]0LGW'RIT
M#;&9&C\R)OOQ2A7<)-$4ECW$HZGFOD#_ (=<?"'_ *%[_P J.I?_ "77V_X6
M\)Z=X&LX]/TJTM[&RAW>5;6T*0PIO8NVR.,*B[F9F; &68L>23705\P?&/\
M8O\ A_\ 'V\74/$6B6]S>C.ZYC>:UFDRJ(/.DM9(7GVK&BQ^<7\M053:&8'?
M^"G[+'@O]G;S&\,:1;V,LVX27&9)K@J_E[H_M$[RS"(F)&\D.(@Z[PF\ECZA
MXU^'NC?$JW6SUS3[/4K9)!*D-Y;Q7$:R!64.$E5E#A690P&0&89P3GS_ $G]
MF3P+H%Q%>6?AK0X+F"1)89HM,M$DCD1@R.CK$&5U8!E92"I (((K0\4_L]>#
M?'-Y)J&J^']'OKV;;YMS<Z=;33/L4(N^22-G;:JJJY)PJA1P *T/#?P0\*^#
MK>[L],T32[.VOX_*O8;>QMX8[F/:Z[)TCC594VR.NV0,,.XQACGC_P#AD[X>
M?]"IX?\ _!39?_&:H?M-Z3;Z!\-/$MG9Q1P6T'AO4XH88D5(XXTL951$10%5
M%4!550 H    K\H/^"8?[-WA/]H_X:75KXJTV._CM/$EW);DR2PR1L]C8JX6
M6!XY0C +OCW;'*1LREHT*_K=\%/V6/!?[.WF-X8TBWL99MPDN,R37!5_+W1_
M:)WEF$1,2-Y(<1!UWA-Y+'U#QK\/=&^)5NMGKFGV>I6R2"5(;RWBN(UD"LH<
M)*K*'"LRA@,@,PS@G/G^D_LR>!= N(KRS\-:'!<P2)+#-%IEHDD<B,&1T=8@
MRNK ,K*05(!!!%:'BG]GKP;XYO)-0U7P_H]]>S;?-N;G3K::9]BA%WR21L[;
M5557).%4*. !70>!?A/X>^%_G?V#I6GZ9]HV>?\ 8K2&V\WR]VSS/)1-^W>V
MW=G;N;&,G/F'QO\ V1?!'[1UQ;WGBC28[VYM8VBBF$T]O((V;=L9[>6)I$#9
M9%D+",O(4"F1]U_7_P!ECP7XG\+V_@N[TBW?0+7RS;V@,B>4T9+"1)4=9EE8
MLYDF#^;-YDOF._FR;N@^&_P!\+_"30W\-:-IEO!I$WG>?:L#,L_GC;+YYG,C
MS[UQ&?.9_P!TJQ?ZM%4<_P#\,G?#S_H5/#__ (*;+_XS78>)/@AX5\8V]I9Z
MGHFEWEM81^590W%C;S1VT>U%V0))&RQ)MC1=L8481!C"C&?X6_9Z\&^!KR/4
M-*\/Z/8WL.[RKFVTZVAF3>I1MDD<:NNY696P1E6*G@D5Z!XI\)Z=XYLY-/U6
MTM[ZRFV^;;7,*30OL8.N^.0,C;6567(.&4,.0#7S!\-/V!_AG\(M135=(T"W
M2]BVF*6>6XN_*97619(ENY9DCE5D4I,@65.0K@,P/U_7C_QC^ /A?]H"S6Q\
M3Z9;ZA$F?*:0%9H=S([>3/&4FAWF-!)Y3IYBJ$?<F5/ ?!S]B_X?_ *\;4/#
MNB6]M>G&VYD>:ZFCPKH?)DNI)G@W+(ZR>24\Q2%?<%4#Z?HHKYP^+W[(7@/X
M[NT_B'0[.ZN7D222Z16M[J1HX_*027-LT4\B!,*(W=DPJ?+F-"OG_@K_ ()X
M?"OP!<-=6?AJSDD>,QD7C37\>TLK$B*]EGB5\J,2*H<#<H8*S _9]>?^.OA/
MX>^*'D_V]I6GZG]GW^1]MM(;GRO,V[_+\Y'V;MB;MN-VU<YP,>?_ /#)WP\_
MZ%3P_P#^"FR_^,UZ!K_PG\/>*].M](U#2M/N]-M/+^S6<]I#+;P^4ACC\J%T
M,:;$)1-JC:A*C"DBO/\ _AD[X>?]"IX?_P#!39?_ !FNPO?@AX5U'2X=#GT3
M2Y-)MI#+!8/8V[6L4A+DO' 8S$CDR2$LJ@DR/S\S9Y_2?V9/ N@7$5Y9^&M#
M@N8)$EAFBTRT22.1&#(Z.L0975@&5E(*D @@BO<*^0/B7^P/\,_B[J+ZKJ^@
M6[WLNXRRP2W%IYK,[2-)*MI+"DDK,[%YG#2OP&<A5 ^G_"WA/3O UG'I^E6E
MO8V4.[RK:VA2&%-[%VV1QA47<S,S8 RS%CR2:T-6TFWU^WEL[R*.>VGC>*:&
M5%>.2-U*NCHP*LC*2K*P(8$@@@U\8?\ #M[X4?VC_:G_  CEO]H^T?:-GGW7
MV??O\S;]E\_[-Y6>/(\OR-G[OR_+^6OL_2=)M] MXK.SBC@MH(TBAAB14CCC
M10J(B* JHJ@*JJ %    %>'_ /#)WP\_Z%3P_P#^"FR_^,U[!X6\)Z=X&LX]
M/TJTM[&RAW>5;6T*0PIO8NVR.,*B[F9F; &68L>237045\@>%OV!_AGX*UR/
MQ'I^@6\.I0W#7,+B6X:&*9B2'CM6E-LFPG="J1!8&"-$$9$*]!\2/V+_ (?_
M !=UQ/$FN:);W>J)Y.9F>95E\@YC\^%)%AN, !#YZ2;XE6%MT2J@^GZ^4/!7
M[#/PW^'FLMK^F^'[.+43(94=O,ECAD,JS![>WE=X+9T=5,301QF$#9&40E3]
M7US_ (I\)Z=XYLY-/U6TM[ZRFV^;;7,*30OL8.N^.0,C;6567(.&4,.0#7C_
M /PR=\//^A4\/_\ @ILO_C-?0%?,'QC_ &+_ (?_ !]O%U#Q%HEO<WHSNN8W
MFM9I,JB#SI+62%Y]JQHL?G%_+4%4VAF![_X.? 'PO^S_ &;6/AC3+?3XGQYK
M1@M--M9W7SIY"\TVPR.(_-=_+5BB;4PHT/B]\%_#_P >M+;1O$MC'?V+2)*(
MW+HR21GY7CDC9)8WP64M&RED9XR2CNK<?\)OV6/!?P/TZ]TK0=(M[>RU+(OH
MI#)<_:5*&/RYFN7E=XMK,!"Q,0\R0A 99"U#X(?LB^"/V<;BXO/"^DQV5S=1
MK%+,9I[B0QJV[8KW$LK1H6PSK&5$A2,N&,:;3XB_LA> _BT]_/K>AV=W<ZE)
M%)=73JPNBT,<,48CN499X$"01J8X'C1AOW*3+*7S_@Y^Q?\ #_X!7C:AX=T2
MWMKTXVW,CS74T>%=#Y,EU),\&Y9'63R2GF*0K[@J@?1^K:3;Z_;RV=Y%'/;3
MQO%-#*BO')&ZE71T8%61E)5E8$,"000:^</@Y^Q?\/\ X!7C:AX=T2WMKTXV
MW,CS74T>%=#Y,EU),\&Y9'63R2GF*0K[@J@?3]%?,'Q(_8O^'_Q=UQ/$FN:)
M;W>J)Y.9F>95E\@YC\^%)%AN, !#YZ2;XE6%MT2J@^C])TFWT"WBL[.*."V@
MC2*&&)%2..-%"HB(H"JBJ JJH 4    5S_C+P!I?Q!2VCU2VCN5L[RVOK8N#
MNANK6020S1L"&5U88." Z,\3AHI'1NPKS_4?A5H>KZY:^)I["WDUJRMY;:VO
M60&:*&8@NBM_WT%8Y:-99U0JMQ,)/0*Y_P 4^$].\<V<FGZK:6]]93;?-MKF
M%)H7V,'7?'(&1MK*K+D'#*&'(!KXPTG_ ()E_"31;B*ZB\.QM)#(DB"6\OIH
MRR,& >*6Y>*1,CYHY%9'&5964D'[?TG2;?0+>*SLXHX+:"-(H88D5(XXT4*B
M(B@*J*H"JJ@!0   !6A11111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111111111111111111111111111111117Y0?&?\
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M<?\ @BUXLU'QS>>,M0U6[N+Z]F_L7S;FYF>:9]BWR+ODD+.VU555R3A5"C@
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M*^(/^";/BFS\<_'7QEJNGR>=97UOK5S;2[63?#-JUK)&^UPKKN5@=K!6&<$
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M.\F]\;_#W4--T5M_GWUEJ=MJ?D8VJGF+#''%'OEDBC7SYX-^YC'YC(4/Z'^
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M/_,W?]P?_P!OZ^__ /@J/_R2'Q#_ -P[_P!.5I1_P2X_Y)#X>_[B/_IRNZ^
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M5BM8HX8VT/3I2D:*BF2:VCEE<A0 7DD=Y)&ZN[,[$LQ)\/\ ^"H__)(?$/\
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MY=VY2KA6'R__ ,$5/^2>:E_V,%S_ .D5C7Z_U^ /_!#'_F;O^X/_ .W]??\
M_P %1_\ DD/B'_N'?^G*TH_X)<?\DA\/?]Q'_P!.5W7P!_P7._YE'_N,?^V%
M?O\ 45_-#_P1+\4WEIXRUG2DDQ97.CFYFBVJ=TUK<P1PON(WC:MS.-JD*V_+
M!BJ%?Z7J^?\ ]K'_ ))YXK_[%_5O_2*:OS1_X(H> -+B\*ZKXA%M'_:TFJ2V
M+79!,@M8[>UF6%220B&21G?8%,A$>\MY46SQ_P#X+E:3;PW'A2\6*,7,L>J1
M23!%$CQQ-9M&C/C<R(TLK(I)"F20@ NV?U__ &O?B\_P(\!ZYXA@:1+FULV2
MUDC2.1H[JX9;:VD*2_(R)-+&\@8,-BM\DAPC?'__  2"^%]OX,^&\>L+Y;W.
MN7ES<2.(521([>1K..!I,EI45H99DSM"&XD4)G<[_4'[;_P=M_C?\/M;TV6W
MDN;F&SFO+!(8UDN/MEJC2P" %)&WR,OD,(P)'AFDB5E,F:^$/^"+?QCO/&'A
M?4_#%RNZ+0KB*2UERHQ#J!GD,.U44_)+%-+YCN[-]HV81(E!_9ZO@#_@J/\
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M+!;FV@$48G1_+_V[M6M]1_:)\$Q02QR26TGA^*=$=6:*0ZK+*$D )*.8Y(Y
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MYY"=JKD    LSLQ"1QH&>1V6-%9V53^&/_!#'_F;O^X/_P"W]'_!<[_F4?\
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MYK^N:A K6CR[6M]+C+RW]\5RH^2**5($=T,LNYHUG\B2%OR@_P""YW_,H_\
M<8_]L*_?ZBBOP!_YN\_S_P!"Y7[W1ZM;S7$EFLL9N8HXY9(0ZF1(Y6D6-V3.
MY4=HI51B &,<@!)1L?@C_P $,?\ F;O^X/\ ^W]>_P#_  6K_P"2>:;_ -C!
M;?\ I%?5]@?"?P+_ ,+0^#>E:#YWV?\ M/P?:67G[/,\K[3IB0^9LW)OV[]V
MW<N[&-PSD?C!_P $MOVM+/\ 9MU'5/!?C&;^R[*XN!)"UTC1_9M25TM9H9P(
M2\7F*$,DEP\<-K]D.X*978?T7>/_ !_I?PLTNYUK6KF.STZSC,D\\A.U5R
M  69V8A(XT#/([+&BL[*I\__ &;OB-JGQ?\ ">F^(=8LX["YU*.2Z2UCD$JQ
MVLTKO99D!.YVMC \C80EV;,4)_=)[A7\^/\ P40U:WT#X^^"+R\EC@MH(]"E
MFFE=4CCC36+EG=W8A515!9F8@* 22 *_H.K\,?V:=,LOVD_VB/$OCC33))I.
MB1B.&YCE@,<MT;5-,0_*TAEMYHXKV:"2(@$)"[LF[RGX_P#X+G?\RC_W&/\
MVPK]_J_GQ_X)QZM;_MG?$'6?&GCB6.]U[3([272+-G46]M&SS!GM[5BS;+1A
M$(FRPBFN/M$A>[DCG!_P7*U:WFN/"EFLL9N8H]4EDA#J9$CE:S6-V3.Y4=HI
M51B &,<@!)1L?O\ 1ZM;S7$EFLL9N8HXY9(0ZF1(Y6D6-V3.Y4=HI51B &,<
M@!)1L?@C_P $,?\ F;O^X/\ ^W]>_P#_  6K_P"2>:;_ -C!;?\ I%?5]_\
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M/%$OB_PGXBU#PUJEU<7-S<O$K3XFN!B1[9TGMIH/,+3-*IDE5O.*((8E$9]
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M_AIX'G^'>G)I\^J:AJ_E;1'<ZBUN]P$5%14:2""W\W&TL9)A).[NS/*^0%]
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M\27D>D^9$3:R6<4ET8P%\U1=K)'$'8A_+?[,1&&4-'+M)?\ 4[]GK]F+PO\
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M5-0U?RMHCN=1:W>X"*BHJ-)!!;^;C:6,DPDG=W9GE?("_,'_  41^)$OP_\
MAUJ=M9IY^I:YLT6PMA#+,UQ-J&8I(HTA^;S?L_VAX=Q"F5$7#LRQOT'["W[.
MG_#,7@:QT:==NI3YO=3YSB\G5=\?$LL?[E%CMMT3".7R?."AI&KZ_KP_X\_!
M$?'S2Y-&N-6U33+&XCDBNX].>VB:YC<IE)))K:>54PI4K"T0D222.42(VT>0
M?LS_ +$^F_LHO(OA_6]<>QGD\V?3[J6SEM99/+:,/@622QO@J6:"2(R&.)9#
M(D:I7'_M"_\ !/'1?VH-134/$NN^()O)\T6MM'/8Q6]JDKERD,:V/^ZIDD,D
M\B1QK)+)Y:D?7_PT\#S_  [TY-/GU34-7\K:([G46MWN BHJ*C2006_FXVEC
M),))W=V9Y7R OQ!\:_\ @G/IWC7Q1'XX\):M<>%O$BW"SR7%O D]O*^)!+(U
ML6B_>S;E$Y\PP3H)!+;R//+(W0?\,5ZQ\3?W'Q)\7ZAXFTU/N:9;V\>C6<N>
M3]M2Q?S+K8Z0RV^9(_(DC)^=9'6ON_2=)M] MXK.SBC@MH(TBAAB14CCC10J
M(B* JHJ@*JJ %    %:%>7_&CX0Z7\>O#]]X:UE9&L;^,)(8G,<B,CK)'(C<
M@/'(B2*&#(Q4*Z.A9&^ /V9/^"8Z? 6X1]0\4:IJ=C!>07T.EP&2PT][J!@Z
M375NMQ.+ATDBMI8L&(*]N@D$R'8OJ'[0O_!/'1?VH-134/$NN^()O)\T6MM'
M/8Q6]JDKERD,:V/^ZIDD,D\B1QK)+)Y:D?7_ ,-/ \_P[TY-/GU34-7\K:([
MG46MWN BHJ*C2006_FXVEC),))W=V9Y7R OS!^V;^POH?[8=G"T\G]G:U:86
MVU..$2L(=VYX)H]\?G1'+-&"Z-#*2Z,%>:.;R_X5?\$U-+T'1KK2_%^KWGBF
M1[.6PTZ6[4^7I%K+$D9_LVWN)+N*WN 40K<#)010I&D:K)YV?^RC_P $T+/]
MG:\%SJNMW&O6]M<)>:?8/"UM8VU\%,9OC;&XGCENU3:D$Q"F$;F :00O#[A^
MUW^PYX:_:^MXGU$R66K6L;I:ZC;A3(%96*Q3HPQ/;K(PE\O,;J=XBFA\V4O\
M_P#P&_X)CI\-4CL?$7BC5-?T2WDCD@T(F2UTEF61YB+JS-Q<)<)YQCG6,>4A
ME0F59UD91T'[+O\ P2Y\'?L\7%OJUZTFN:W;2++#=7"^5;P2(TFQX+1690X5
MD.Z=[@I-$DT)@;@?4'[3'[*OAK]J_2X],\0Q2!H)/,M;RW94NK=B5\P12.DB
M[)%4++&ZNC@*^T2QQ/'^6'A;_@AUIUI>1OJOB>XN;(;O-AMM/2UF;*D+LFDN
M+E$PVUFS$^Y05&TL'7]KO '@#2_A9I=MHNBVT=GIUG&(X((P=JKDDDDDLSLQ
M+R2.6>1V:1V9V9C^<'PX_P""<NM_ "W@C\"^.]4TF1XW_M!+BSM[^SN)W6$&
M:"RD:.*W<F+&]S<3>7LB$P57\WZ0^#G[)47@G7&\8>)M4N/$OBQK<6RZC<PQ
M00VL(+C98V<0\NUWH^V5@SL[&9U,8N;A)/K^L_5M)M]?MY;.\BCGMIXWBFAE
M17CDC=2KHZ,"K(RDJRL"&!(((-?D#9?\$C4\&>)9M8\*^+=4T#3IY #:62R)
M=):LR/+:I?K=*Q0LO[II8I2@$1D%P\9=^O\ CQ_P2DT/X@:CI6I>$-0_X1.7
M2[>*%1:68DW-;OO@N1(DUO,+M23YES))-++MB;<KQLTGU!K7[&>DW_A=O"-E
MJNL:=I]SY[:I+:S6YO-5FN2C3SW]W<6T\TDLI0B4QM"LD;M RM;B.),_]F?]
MB?3?V47D7P_K>N/8SR>;/I]U+9RVLLGEM&'P+))8WP5+-!)$9#'$LAD2-4K[
M/K\L/VJO^"5'AK]H?5)=>TR\DT+5+J17O#' MQ:SMA_,E-OOA9+B1BADD64(
MY1G:%II7F)^RK_P2H\-?L\:I%KVIWDFNZI:R,]F9(%M[6!L)Y<HM]\S/<1L'
M,<C2E$+JZPK-$DP_4^BOS@^)'_!-+1?BWKB>)=9\2^*)]7A\GR+I;NQA:#R#
MNB\@06$:0;&S(/)5/WK-+_K'9C]?^(_A=?>)-#&BMXAUB"4^8)M3M_L$5]*D
M@D!0NMCY,6 XV26T,$Z&*-A*'WL_S!^SU_P3QT7]E_47U#PUKOB"'SO*%U;2
M3V,MO=)$X<)-&UC_ +RB2,QSQI)(L<L?F,3V'[3'[$^F_M7/&OB#6]<2Q@D\
MV#3[66SBM8I/+6,O@V3RR/@,5:>24QF258S&DC)7I_P<_9[M?A%H;>&I-1U#
M6M(^SBUBM=6^R7"Q6^'5H 8[6%Y(F5_+,=PTR)$B11B.,%3^>-E_P2-3P9XE
MFUCPKXMU30-.GD -I9+(ETEJS(\MJE^MTK%"R_NFEBE* 1&07#QEWZ_X\?\
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M-0\2Z[X@F\GS1:VT<]C%;VJ2N7*0QK8_[JF20R3R)'&LDLGEJ1]?_#3P//\
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MN>(YHY;D:Y=0PI%$D4<%N+>UE2! HW,B-*X5I6DF((WR.1FOT/HHHHK\X/\
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M&S&\NPNZ9HE*LRQ1JK7"07*1RB:-4?X0_:[^)?QP_8]N(O%":Q9^(?#CR/\
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M\1:W;VUZ<[K:-)KJ:/"HX\Z.UCF>#<LB-'YP3S%)9-P5B/Q0_P""N'QH\/\
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M^"D/PH\87D=C;>([=)9=VUKF"ZM(1M4N=\]U!%"G"D+O==S81<NRJ?M^O/\
MXE_%70_@WISZKXAO[?3[)-P\V=PN]E1I/+B7[\LI5'*0Q!Y9-I"(QXKY@\+?
M\%(?A1XPO([&V\1VZ2R[MK7,%U:0C:I<[Y[J"*%.%(7>Z[FPBY=E4_3_ ,2_
MBKH?P;TY]5\0W]OI]DFX>;.X7>RHTGEQ+]^64JCE(8@\LFTA$8\5^2/[#W[;
M.C?$KQCXY\1^(]6L]*MKV32HM*AU"\BM2MG;?;EC1$GG90X5EEN5A9HQ<3R.
M !(,_L]I.K6^OV\5Y9RQSVT\:2PS1.KQR1NH9'1U)5D92&5E)# @@D&OG#XQ
M_MH?#_X!7BZ?XBUNWMKTYW6T:374T>%1QYT=K',\&Y9$:/S@GF*2R;@K$=?\
M(?VE/!WQZ16\-:Q9W\C1O*;=)-ETD<<GE,\EK)LN(TWE0&DC4,&1@2KH6]@U
M;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!7@%M^U[X#N]&O
M?$*ZY9C2;"\GL9KMF9(VNH(O.>&W+*#=.8_GB^RB83C_ %1DK?\ @A^TCX3_
M &C[>XNO"NI1W\=I(L=P!'+#)&SKN0M%.D<H1@&V2;=CE)%5BT;A?<**^(/%
M/_!2'X4>#[R2QN?$=N\L6W<UM!=7<)W*'&R>U@EA?A@&V.VULHV'5E'U?X*^
M(6C?$JW:\T/4+/4K9)#$\UG<17$:R!58H7B9E#A65BI.0&4XP1G/^)?Q5T/X
M-Z<^J^(;^WT^R3</-G<+O94:3RXE^_+*51RD,0>63:0B,>*\@\?_ +:'P_\
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MI>(G_M+2['6+E;31)XD>Q6\>SMEEOIXV!%S+Y3I#;I,#':@32(IEFWQ^7_\
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M6]PK\4?^"@_C&_\ C_\ $'PU\'=,GD&G7<D%SKB6MU"LCQES*T<H=3Y;VMM
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MYD1I96122%,DA !=L_T'5_/CIFDV^B_M<F*UBCAC:264I&BHIDF\/M+*Y"@
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M]&\3ZAI&GZA%<6[2117MK'=_99F(CNX8VN(5/R2Q&)I%1%F\I7 *;#7XP?\
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M_: UCPA\._+^TRW&L1ZQJ,09@D.D6$<T=P;AH3YT'V@S?9[23:L<DX:/SHG
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MV5*/^".OQ+_X3#X=-I$CV_FZ+J%Q D4;?OA;W&+M)9E+,?GEEN4C<*B,L)4
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MNUW-;PZ?;R9,$"W-JS31_:3%]I6R$#IN2>[FGA\^TCG\?_X8%_:%_P"A]_\
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M]#_LJ"YN+^[N+B2]U+4+EV::]OIPHGN'#,^S=L4*@+$*H+O+*9)I/R1\:_\
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M/MG^S?H?]E07-Q?W=Q<27NI:A<NS37M].%$]PX9GV;MBA4!8A5!=Y93)-)]
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MY4BPW'DODD^1*RQ2>8L6]F#0^=$&D!\,/VO/"_Q=\6ZSX+TR2X.J:)O^T&2
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M>?M4Z3KFOS_+:+X@NK;383&L;16,=O:M D@5GS*=[23,7<>:[A"(A&B_+_\
MP6K_ .2>:;_V,%M_Z17U??\ ^R=_R3SPI_V+^D_^D4-?0%%%%?"'_!0S]JI_
MV6/!SW6G2QIKNHR"UTP,L<A1OO3W)B=U+)#'G#;946XDMEEC:.0@_=]%>?\
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MG*F5$(DD!56 (D?CYFSV%%%%%?/_ .UC_P D\\5_]B_JW_I%-7P!_P $5/\
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M;1/$.L7>I:?<6TEY/JEWY]XV9(;>UFM[J***1987,8 <G]WADDC:%4E_6_\
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MKB\T6SL8X[[Q#K%K(D=Y]G$<4Z0V;[PT2,TUO$\JAIC)+S";6&9;K@/VI?\
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MX+>Z#LDX6*X:?U__ (*C_ +_ (I#Q#XN_M[Q!_S#O^)-_:'_ !)_^/FTMO\
MCS\O_MO]_P#X^/WO^S7 ?L%?LA_\+0^'&C:O_P );XPTS[1]M_T/3=8^S6<7
MEWMQ'^ZA\E]F[9O?YCND9VXS@?7_ .W?\ O^$]\/:YXA_M[Q!8?8/#]]_P 2
MZQU#R-.N?(AN)O\ 2K?RV\WS-WE3?,N^%53C&:_.#_@E_P#LQ_\ "Z?!M[J'
M_"3>*-&\O6)X/LVCZI]CMWVVUH_FO'Y3YE._:SY&42-<?+D_O]X3T#_A%-.M
M-/\ M%Q=_9+>&#[3=2>;<3>4@3S9Y,#?*^-TCX&YR6P,XKH*_FQ_;2U?QYX
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M7_8P7/\ Z16-> ?\%SO^91_[C'_MA7[_ %%?@#_P7._YE'_N,?\ MA7[_5^
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M?(<1DJ-C)(%Q)N;W"OP!_P""YW_,H_\ <8_]L*_?ZOP!_8%_Y.%\>_\ <?\
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M  23\:V_BKX5V-G LBR:5>7UG.7"A6D>8WH,9#$E/+NHU)8*=ZN-NT*S??\
M\0O!5O\ $K1M0T.\:1+;4K.XLYGB*B18[B)HG*%E90X5B5+*P!QE2.#^(/\
MP0UTFXAM_%=XT4@MI9-+BCF*,(WDB6\:1%?&UG198F=025$D9( =<Y_[ O\
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M #=Y_G_H7*_?ZBO@#_@J/_R2'Q#_ -P[_P!.5I1_P2X_Y)#X>_[B/_IRNZ^
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MQ8VTL6Z=-\TVD01VB;K<K*NZY:$;@549RY$>\U^K_P#PZX^$/_0O?^5'4O\
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M-0\*:5I6L:IJFI?8C$MAIEW<PQI'=I.SRW$<1A7 MV3RP[3[I(F,0B8R*?\
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M?R:O<)BY6T:\A>WMK6)BP=[>RA94C@::5(W\Y8IS$RM7Y(?L=_M=7G_!.?\
MM+P7X_T+4+>*6X>^@:&)?M'G'9:N0)I8X9[1Q;YBN('*[XWVF=)0T/J'_!2K
M6O'GQP\*Z9?7ND2:-I,VN6MMI6BNJW.JW\]S;W3PW=PL63:N(]L$>G+OF\^6
MX$S'R[?/Z?\ [&_B/Q+I/@6RC\5:#)HL>D:7906Z"=KV\NHK:T0/,UE!;^;
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MWIVH1:@]LN?.FAB@N(G6! #YDH\X.(LAI%1E3?*8XW^8/V$_^"AUYXZT/2O
MNG^'KB_\26%O!:0M%*L&F_8;810B[O+EO.EM?+BXD"07 FF5%BP]RD$?Q_\
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M8^S,QDC#0,DD;1RR98)^SWASXU6/B#0SKS66L6L2>6)K2XT>_6^C=Q'E!9K
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MJW[8GPYT6WENI?%6AM'#&\CB+4;::0JBEB$BBD>61\#Y8XU9W.%568@'Y_\
M >II^U[X\TGQQI8D_P"$2\,V=]'I=\\4EL^HZE?JL%V8XYEWR65O"OE&0I;-
M]M#JC3QQN$_0^BBBBBBBBBBOP!_;Z_Y.%\!?]P#_ -/-Q7[_ %%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%9^K:8F
MM6\MK*9%CFC>-S%+)#(%=2I*2Q,DL;X/RR1LKH<,K*P!'QA_P[D^&/\ :/\
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M111111111111111111111111111111111111111111111111111111117/\
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M[I$#>_\ PA^-'A_X]:6NL^&KZ._L6D>(R('1DDC/S))'(J2QO@JP615+(R2
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M*********************************************_+#_@K)\&]$\3>
M=1\47D$DNK:5':1V,IN;@1P+/?V\<Q6W$HMR\B.5>1HR[!8P6_=1[/4/^"7'
M_)(?#W_<1_\ 3E=U]_UY?\:/A#I?QZ\/WWAK65D:QOXPDAB<QR(R.LD<B-R
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M9&L;^,)(8G,<B,CK)'(C<@/'(B2*&#(Q4*Z.A9&X_P#9K_9KT/\ 96T/^P-
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MSCR=NW:,[L[AC!_3^ORP_P""POC6X\*_#(V<"QM'JNJ6=G.7#%EC02WH,9#
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M=+L_#7@J30[^=+G4,W&K7]JL-S)NMX$80VZ7,4<<3^>I,<5P;FVN+G]V5O\
M_!%3_DGFI?\ 8P7/_I%8UY!^R5K_ /PM#]I/QEJ&H6]NUQ96^I06Q$>?*^PW
M5IIL<J%R[)*UNA61U*[O-E4!8W*#]WJ_ '_@AC_S-W_<'_\ ;^C]F/Q'9_$W
M]IKQ-J&M"WCO;/\ M2WTQ1(T6Z:Q:+3D*(9/WLILDG>1/F7_ %LRQH(U\O\
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M"^ O^X!_Z>;BOW^K\ ?^"&/_ #-W_<'_ /;^O?\ _@M7_P D\TW_ +&"V_\
M2*^KZ@\)^*;SP-\"K35=/D\F]L? \-S;2[5?9-#I(DC?:X9&VLH.U@RG&"",
MBOS _P""7_PJ\=^.?!M[<^&/&/\ PCUDNL3QR6G]BVFH;YA;6C--YL[JZ[E9
M$\L#:/+W Y<U]?\ QK_X)^^._P!HG3H]*\3_ !#^W64-PMS'%_PCEI#B9$DC
M5]T%S$YPLKC:25.[)&0"/8+WX%_\,U_ W6O"GVS[?]@\/Z__ *3Y/D>9Y\=W
M<?ZKS)=NWS=GWVSMW<9P/G__ ((J?\D\U+_L8+G_ -(K&O /^"YW_,H_]QC_
M -L*_2__ (*'^-;CP!\*_$MY:K&\DEFMF1(&*^7?S164I 5E.]8YW:,YP'"E
ME905/G__  2LTFWT[X2:++!%'')<R:A+.Z(JM+(+ZXB#R$ %W$<<<89LD)&B
M9VJH'A__  6K_P"2>:;_ -C!;?\ I%?5]_\ [)W_ "3SPI_V+^D_^D4-?D#^
MP+_R<+X]_P"X_P#^GFWK[_\ ^"H__)(?$/\ W#O_ $Y6E'_!+C_DD/A[_N(_
M^G*[KX _;Z_Y.%\!?]P#_P!/-Q7Z/_\ !2'Q3>>#_A1XCN;&3RI7MX+9FVJV
M8;NZ@M9TPX8?/%+(FX#<N[<I5PK#X@_8*^#/Q'\5_#C1KW0?'?\ 8VFR?;?(
MT_\ L"RO/)VWMPK_ .D3.)'WN&D^8#;OV#Y5%=_\=/\ @FIXO_:4^Q_\)7X_
M^W_8/.^S?\4];0>7Y_E^;_Q[W46[=Y4?W]V-O&,G/H'[=W@7_A5_[/\ =Z#Y
MWVC^S-/T.R\_9Y?F_9KNQA\S9N?9NV;MNYMN<;CC)] _X)<?\DA\/?\ <1_]
M.5W7P!^WU_R<+X"_[@'_ *>;BOU^_:Q_Y)YXK_[%_5O_ $BFKX _X(J?\D\U
M+_L8+G_TBL:_7^BOP!_X) >([/XG^,O&GB;41;IK]]LN(XXY&3$-[<S3WPAA
M:1BT2RK: NWF-%F-?,'FG?\ O]7\X/[.7AR\^ 7[3E]X?M#;V]I>W&J*\%M&
MHA%C<VCZI:P(IC7RO+VVVX1!0K1&-6:(G?Z!^WU_R<+X"_[@'_IYN*_?ZBBO
MP!_X(8_\S=_W!_\ V_KW_P#X+5_\D\TW_L8+;_TBOJ^__P!D[_DGGA3_ +%_
M2?\ TBAK\@?^;O/\_P#0N5]7_P#!87QK<>%?AD;.!8VCU75+.SG+ABRQH);T
M&,A@ _F6L:DL&&QG&W<59?J#]A;3-+TGX9>&(]',9MCI=O(YCE,J_:I1YEZ"
MQ9L.+EIQ)'D")PT05 FQ>/\ ^"C?PT_X6A\+]>@1+=KBRMQJ,,DZY\K["XGF
M:)@KLDK6Z3PH5V[O-,;,L;N1^6'[/GQ>U30/V8O%3AHYEL[RYTJV21!MCM=1
M-FDX'E[&9PU_<2QLY8J[*#NB01U^C_\ P2LTFWT[X2:++!%'')<R:A+.Z(JM
M+(+ZXB#R$ %W$<<<89LD)&B9VJH'A_\ P6K_ .2>:;_V,%M_Z17U??\ ^R=_
MR3SPI_V+^D_^D4-?D#^P+_R<+X]_[C__ *>;>OW^K\ ?^"&/_,W?]P?_ -OZ
M_7[]K'_DGGBO_L7]6_\ 2*:O@#_@BI_R3S4O^Q@N?_2*QKR#_@H'XIO+OXZ_
M#O2GDS96UQI%S#%M4;9KK5C',^X#>=RVT VL2J[,J%+.6_=ZN/\ #?P]T;P=
M<7=YIFGV=G<W\GFWLUO;Q0R7,FYVWSO&JM*^Z1VW2%CEW.<L<_"'[4OQ/^'7
M[,'BBU\33:-_:GQ U*W-KI]M9)OO)@P:*)Y$W%(O,8+9K=".2\>,M!$DT,4L
M:?GA_P %+;WXF^*_!5GJGC:'2]'TXZXJ6>BV9-S=!GAO?+DO;O>\)>**+$8M
M<).+EWE2)XDB7]KOV3O^2>>%/^Q?TG_TBAK\@?V!?^3A?'O_ ''_ /T\V]?K
M]^UC_P D\\5_]B_JW_I%-7P!_P $5/\ DGFI?]C!<_\ I%8UX!_P5*\1V?BG
MXI^"/#.O"W70(?LEQ=R22-#^YU#4!!>":;S%$<2Q6B$.OEM'ND8R?=V?O]7X
M0_\ !;WX:?:=.\/^)XDMU\BXGTZXDVXN)//03VR[@OS11^1='#.-CS913YDA
M7W_]L+Q3>>.?V;SJNH2>=>WVC^';FYEVJF^::XL))'VH%1=S,3M4*HS@ # K
MV#_@EQ_R2'P]_P!Q'_TY7=? '[?7_)PO@+_N ?\ IYN*_?ZBOP!^+WB.S^('
M[5&D:?KPMTLM(^QV]HQD:'=,MD^HV9=_,&Z4WMPB1HNU9<10F-RS>9^_U?S@
M_P#!7_PY>?";Q]X>\;:4;>VN)[=&AECC4S&^TN<2">96C,<F$FM4C+F0LL)C
M91&B!OK_ /X+5_\ )/--_P"Q@MO_ $BOJ^__ -D[_DGGA3_L7])_](H:^@**
M_ ']@7_DX7Q[_P!Q_P#]/-O7Z_?M8_\ )//%?_8OZM_Z135\ ?\ !%3_ ))Y
MJ7_8P7/_ *16-> ?\%SO^91_[C'_ +85^C__  4A\4WG@_X4>([FQD\J5[>"
MV9MJMF&[NH+6=,.&'SQ2R)N W+NW*5<*P^(/V"O@S\1_%?PXT:]T'QW_ &-I
MLGVWR-/_ + LKSR=M[<*_P#I$SB1][AI/F V[]@^517?_'3_ ()J>+_VE/L?
M_"5^/_M_V#SOLW_%/6T'E^?Y?F_\>]U%NW>5']_=C;QC)S^G_P )_ O_  J_
MP]I6@^=]H_LS3[2R\_9Y?F_9H4A\S9N?9NV;MNYMN<;CC)] K\ ?V^O^3A?
M7_< _P#3S<5^_P!7\\/PZT#_ (5?^U?=:?I]Q<+;WMQ?3W(,F/-^W:6^I21.
M$"*\2W#AHT8-M\J)B6D0.>@_;Z_Y.%\!?]P#_P!/-Q7[_5^2%S\;?#7P#\0:
MMX&^"_A:/5O%=U)+<Z@+=UAT^VE1)-PGN)),!+:0QI]BC-O:QO.]O'-!=,\)
M^$/VC].\6V7QU\#R>-+K3[C5)[C0I!%IL4D=G:PC5I8TAB:8^=+DHUP\DN&$
MD[Q*/*BC)_I>K\ ?^"&/_,W?]P?_ -OZ]_\ ^"U?_)/--_[&"V_](KZOO_\
M9._Y)YX4_P"Q?TG_ -(H:^@*^?\ ]IWPMX+\3^%[L^/X[=] M=ES.\[2)Y31
MG"/$\)6996+>4BP'S9O,-NH?S3&WQA\./VA?'G[3]O!'\,=$L_#7@](WM8M9
MU:-3($C6&'_B7:=;OY0>V)F$*N9[*8P")Y8'1X3\H?\ !#'_ )F[_N#_ /M_
M1_P7._YE'_N,?^V%?O\ 5^ /[ O_ "<+X]_[C_\ Z>;>N@\<:_\ \+$_:OTO
M3]0M[>6WTBW6"V!CW9V:7/J4<KARRF6.XN"T;J$V>7$P D0NW[O5^ /[ O\
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M%OVQOA5\0)8_$WQ'T76+[QFUPTSWNF!+&&W$4I-G';-:W]G*WD1+$$GNO.O
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M6_LOL^FW6ZST/SK90TBKLM_M$;-+(T<L5O;K;SR1[HI9;FYCCE58I8J^?_\
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MNP!"F2,$@NN?H#_@M?JUO#X%TJS:6,7,NN12QPEU$CQQ6ETLCJF=S(C2Q*[
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M (S70:C^SUX-U>SM=/N?#^CS65CYOV2VDTZV>&W\Y@\ODQM&4B\Q@&DV!=[
M,V3S1X6_9Z\&^!KR/4-*\/Z/8WL.[RKFVTZVAF3>I1MDD<:NNY696P1E6*G@
MD5[!7QAJ?_!/#X5ZMJ@UB3PU9BY$D4@2-IHK7=$%"@V4<JVA0[1YD9B*2DL9
M%<N^[Z_TG2;?0+>*SLXHX+:"-(H88D5(XXT4*B(B@*J*H"JJ@!0   !7A_\
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MP-9QZ?I5I;V-E#N\JVMH4AA3>Q=MD<85%W,S,V ,LQ8\DFN@KR_XO?!?P_\
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M4D][!$&_M 3"6W1 RE4@C4N/-2221)56+L/^"7'_ "2'P]_W$?\ TY7=??\
M11116?JT=Q-;RK9R1Q7)C<0R2QM+&DA4[&>-9(FD0-@LBR1E@"HD0G</Y\?A
M]=>*-+_:9TW0O$^O7&ORZ;]I\J>2(6T*_:-":5O)LXW:&WR"BR>5CS6C$KY=
MC7]#U%%%<?X#\?Z7\3[!-4T:YCO+&22>..XB),<C6\SV\A1L .@DC<+(N4D
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M<?I7C_2]=U2]T6UN8Y=1TV.VDO8$)+0+=B0P"0@;5=UB=Q'G>$V2,H26)G^
M/^"G<WC'POX,O-?\/^(I-(L;".V$]I:VVRZNI)[V"(-_: F$MNB!E*I!&I<>
M:DDDB2JL78?\$N/^20^'O^XC_P"G*[K[_HHHHHHHHK^=']J6;QCX8^-G@S1O
M$?B*36+:?5-%U"&WBMOL-G;%]4EB1$M5FF5WC4.JW,K/<-&XC>1@N3_1=111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111111111111111111111111111111111111117SA\;_P!J
M;P_\"KBWTRZ6\U'6[R-I;/1M,MGO-0N(T;#ND*85451))NF>,.D,WEEVB91\
MO^-?VX_&?P3MUU?QM\/KS3-"601W%[9ZQ9:E)"SJPB)@B6,!&D"1F222)%+J
M-S2-'%)]G_ OXZ:'^T7H<'B#P_/YUI-\KHV%FMYE +P3H"=DJ9&1DJRE9$9X
MGCD;XP\4?\%1O!R>*M+\)^'%DUNYO]4M+":[B;R;. 3W!MW=)65FN71MCJ(D
M^SS1N&2[R-M<_P#'G_@IPGPU22^\.^%]4U_1+>22.?70)+72699$A!M;P6]P
MEPGG&2!I#Y2&5 (FG616'V!^RK^TQI?[5_AJ+Q#ID<D#"1K>\M9,EK>Z14>2
M(2;565-LB/'*H ='7<L<H>*/Z/KY_P#VA?CK+\"].2YM-#UC7[V?S5M[32[*
M6X^9$+!KB5$9+>(L40L0\IWEHX)A')L_$'_@GS^V3J-EKGC+Q#JNB>(-?O=<
MN+">7^Q;%[Y;78;S;$_F3[XH@KK%:H6?$4)0$",9_1__ (*-Z_\ \)7\$-6U
M#[/<6GVNWTB?[-=1^5<0^;?V;^5/'D[)4SMD3)VN"N3C-> ?L>_M0V?P+^$/
MARQM-.U#7]?GM]6N+?1]+@:XN/)34KM!<W&P,;>T,I2$SE78NY\N*;RY GK_
M .RI_P %+[/]H3Q1+X/U?1+C0-7_ 'JV\,DS7'F36XD:Y@F!MX'MY8UC9@'4
MJVR1&:.18TE_3^O@"Z_;7U/XB7EY;_#3PO<>++33;AK:]U+^T+73K$S;58)9
MSS[_ +7C+"5D5%0"*13+%<12-H?LS_MXZ7\=]4D\,:MIUYX;\50Q^8^DZ@"K
M2+AI,6[NL3R.(?+G>.2*%]CEXUFBBDE7[OHK\ ?^;O/\_P#0N5^_U?FAX;_;
M[UOXW7%V_P -O!EYXBTFRD\B74;C4+?2HWGW.=L"7".9$\L1R\E)D$J"6WAW
M(9.P_94_X*#Z'^TCJ,OAV\L[C0?$UOYHDTR[8'>T+R++'!(5C=Y8E0//#)%#
M*F7VI*D,LB^?_P#!1']L#5O@IH>IZ5H&CZP]V]ND4VN"TN(=-L5N@8R\=ZNS
M?=KOC$)C(BCFE0F9I87MF\@_X)O?M.?\(UX)\.>&/^$9\47.ZXG@_M6WTOS-
M+'VG4)SYK77FC$47F8G?9^[*2#!V\_I]\=/CIH?[.FAS^(/$$_DVD/RHBX::
MXF8$I! A(WRO@X&0JJ&D=DB221?C#QK^W!XW^'ENNMZE\-]4B\.&0.]VNH02
MWD-F5:4W%QI\43O;.D*L\L<\D<<,@\F2X0D,?K_X0_M%>&OC;X:7Q7I=[&-+
M$;O<O.RQ-9M$N^:.[RVV%XE^9R6*;"LJ.\+I(WQ O_!6_P !ZCXGMM%LFD;2
M3'=27FMW&ZVMXEAM6N4$$#QFXN'=U:W\MD@<S;!"MQYB@GA__@I?<:UX\T[P
M9/X,URPCU.2)8);U&@OA'(K W#Z>8B!;QR))YLJW#!+>*6?ED:$?J?6?JVK6
M^@6\MY>2QP6T$;RS32NJ1QQHI9W=V(545069F("@$D@"OA#_ (;4UCXF_O\
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MS/$SE4;S2ODK)(GSA^SU_P %#M%_:@U%]/\ #6A>()O)\HW5S)!8Q6]JDKA
M\TC7W^\PCC$D\B1R-'%)Y; ?5_QB^)P^#FC7&N2V%Y?VUG')-=)9FV\R&WAB
M>66<BZN+961%3!6-GF)9=L;#<5X#]F?]I:R_:ETN36M+TW5++3A)Y<,^H101
M+<LI82&W$5Q,SI&PV/(0J%R8T9WCF6/S_P")O[6%_IOB"\\)^#/#EYXFUO3(
M[>;4E%Q#I]G:QW*%XT:\N<JUPRF-TA1"'C:1A+N@FC7C_ W[<T^K^+]*\ :]
MX9U#1/$E_P"=)/%-/;SV<5NEM<W"36]W"Q^U[_(2,A8XDCD:9#(7MRDGW_17
MPA\7OVV7\,>+&\!^$= O/$OB:&-)[NW2:.QM;:!HO-+27<RLH<*T&,H(6-PD
M8N/M'[@^7Z+_ ,%*8O!_BA?"?Q'\/W'A&]F\@V]Q)>17MF5F#XDFN$2)$BW*
ML0FB\^)9#()GMQ!(P^W_ (U_%[_A2VG1ZA_9&L:SYEPL'V;1[/[9<)N21_->
M/>F(ALVL^3AWC7'S9'\\/[(?Q]_X0+XR>+?$/]@^(+_[?_;'_$NL=/\ /U&V
M\_4X9O\ 2K?S%\KR]OE3?,VR9E3G.:_<^R_:O2Z\-3>(W\,>+(FBO!:)I;Z-
M(=2F8JC^=';H[*+<*S9GEDC3=&\8)E,:2?C!^SE^V;K.L_&/7O%6N:!KEW<O
MI<^GIHVEVLM[<Z='#=6H$;PRO&T:(T;?:& C!NYF;R8S*57^@[X6^/\ _A:&
MCV^K_8-0TS[1YG^AZE;_ &:\B\N1X_WL.Y]F[9O3YCNC9&XS@?(%U^VOJ?Q$
MO+RW^&GA>X\66FFW#6U[J7]H6NG6)FVJP2SGGW_:\982LBHJ 12*98KB*1M#
M]F?]O'2_COJDGAC5M.O/#?BJ&/S'TG4 5:1<-)BW=UB>1Q#Y<[QR10OL<O&L
MT44DJG[57_!0SP=^RP\NG73R:CKJ1JPTRU'S(9(W>(W,[?NH$8JFX9DN%26.
M9;:2-@3X?\1?^"IUGX9\/6NN:+X=U#65-O8RZG/ S+I>G374*2/9RZD()$>[
MA::"-X_*1<RA6=)E: ??_P  ?BS_ ,+U\+Z9XE^Q7&G?VC;B;[+<#YTY*Y4X
M&^)\>9!+M3SH'CEV)OVCL/'_ (R3X?:7<ZI);7EXMM&7%M8VTEU=3-D!8X88
MP69V8@9.U$!+R/'$KNO\\.K_ +9NL^-?COI6L:GH&N1VVBQWEO9:!#:RR:GY
M<]E<'SWLI'11<2K*DTWE[0MK'$N^80B63][O@I\7O^%TZ=)J']D:QHWEW#0?
M9M8L_L=P^U(W\U(][YB._:KY&721<?+D_@C_ ,$C_B]I?P2TOQAJFJ-(5,FB
M06UM AENKRZE.H"&TM(1\TUQ*W"(,# 9W9(D=U^P+W_@KDG@SQ+#H_BKPEJF
M@:=/(2+N]:1+I+5F=(KI[!K56*%E_>K%+*4 E$9N'C"/^QU?('QC_:UB\$ZX
MO@_PSI=QXE\6-;FY;3K::*"&UA!0[[Z\E/EVN]'W1*5=G8PHPC%S;O)X?I/_
M  43?P3X@B\/?$GPU>>$)+N1([.^EN8[S3Y&*!W+W:1PQ*B&2!&DA-PD3RGS
MVMEC9J_2^BOC#]H[]LBW^"&LZ?X3TK2KS7O%6JQK+9:;;E88_+,I3?/=2!EB
M3;'.^Y4E""!VF,$1$M?/_B3_ (*27_P0UFTTSXE>$+SPW;7T>ZWO8;Z'5(\B
M5(W+^1'&NR-6,DPB>6X0>5BV83(:_3_2=6M]?MXKRSECGMIXTEAFB=7CDC=0
MR.CJ2K(RD,K*2&!!!(-?&'[07[;VG?"+7+;P=HFGW'B/Q=>;/)TNTD2-8MY5
MA]KN&W"WS$7G'R2;(D\V;R()$F/P!^WK^UKK&J>"=9\(>-?#%QX8U+4K>RGT
MEOMD>HV]Y]GU"W>YB\^WC6.*6-%$FQBWR'YS$SVZS_;_ /P2X_Y)#X>_[B/_
M *<KNO</C?\ M3>'_@5<6^F72WFHZW>1M+9Z-IEL]YJ%Q&C8=TA3"JBJ))-T
MSQATAF\LNT3*/E_QK^W'XS^"=NNK^-OA]>:9H2R".XO;/6++4I(6=6$1,$2Q
M@(T@2,R221(I=1N:1HXI/L_X%_'30_VB]#@\0>'Y_.M)OE=&PLUO,H!>"= 3
MLE3(R,E64K(C/$\<C?&'BC_@J-X.3Q5I?A/PXLFMW-_JEI837<3>39P">X-N
M[I*RLURZ-L=1$GV>:-PR7>1MKC_CI_P4]E^&TL]WX?\ "FH:]X;MOD?Q"KRV
MVFR3"4P.(+@6D\4L2RXA$_F*LDVY45D$<DOV!^RC^U=H?[6NAC5=*/DW<.Q-
M0T]W#36DS D D ;XGPQ@G "RJ&!5)4FAB_&#_@JG^V!JWQ!L[;PK::/K&D:+
M)</++=ZE:7%@VI-;,55((I-F^T7?'<,)E\TRM;EH;=H1YO['_"K]K*W^)5Q=
M17GA[Q)X>MK.SEO)K_7=.6PLUCA9 X,[3,H<*QDPV (XY'+ )SX?\/O^"F'A
M?XR>.]-\%^&+>XOHKW[3YNJ2 VT*>3:-=+Y,,B>=+DH\4GFK;>6RAD\Y"#7Z
M/U\8>/\ ]LBW@U2Y\-^"]*O/%GB&SD,5W;V96"QLI  Q2]U*8?9X'9%F$:KY
MI-Q ]LXBEXKP_7_^"C\_P1U&WT_XF^%-0\-?;?+-G<P75OJMNR;RD[RR0>5M
M\G,;/'"+B?8X8Q+NB$OW_P"*?BKH?@O0Y/$U_?V\6BQ6ZW)O0X>%H7 ,;QLF
M[S?,W*(5CWM,SHL8=G4'X0^&G_!4;P=\3]>U6R@62TT+1]+GOY]9NV\I9##=
M16P2&U"O*R2B:-H"S)<2.P@^R"0KGR#XF_\ !6FX^%6J00ZIX&URPTFXD417
M6H[K*ZDC01_:&CM)(&BD>(OP@N<.#&7DA\S"_K=X3\4V?CG3K35=/D\ZROK>
M&YMI=K)OAF021OM<*Z[E8':P5AG! .170445\8?M'?MD6_P0UG3_  GI6E7F
MO>*M5C66RTVW*PQ^692F^>ZD#+$FV.=]RI*$$#M,8(B):^?_ !)_P4DO_@AK
M-IIGQ*\(7GANVOH]UO>PWT.J1Y$J1N7\B.-=D:L9)A$\MP@\K%LPF0U^A_BG
MXJZ'X+T.3Q-?W]O%HL5NMR;T.'A:%P#&\;)N\WS-RB%8][3,Z+&'9U!^$/AI
M_P %1O!WQ/U[5;*!9+30M'TN>_GUF[;RED,-U%;!(;4*\K)*)HV@+,EQ(["#
M[()"N?(/B;_P5IN/A5JD$.J>!M<L-)N)%$5UJ.ZRNI(T$?VAH[22!HI'B+\(
M+G#@QEY(?,POV?\ %G]LK1_ FG64^B66H>)-2U73QJ.GZ9I=M)+</9N@,5W<
M)L\RUM'=XXC*\;2;W(2"5HY53Y__ &5/^"E]G^T)XHE\'ZOHEQH&K_O5MX9)
MFN/,FMQ(US!,#;P/;RQK&S .I5MDB,T<BQI+^G]?$'CO]L:>XUR]\,> M!N/
M%FKZ5Y9U/RKNWLK&TW%U,+WL^Y&NU95!MU0\></,$EM/$G'_  A_X*!6_B/Q
M*O@SQIHEYX2\0SR.MG#=R++:W0#>7&(;K9"'>619D@*HUO,8PL5S)+*D1]@_
M:8_;3\'?LHI&OB"YD>^GC\V#3[6/S;J6/S%C+X+)%&F2Q5IY(A((Y5C,CQLE
M>'Z#_P %%;/Q!X0TS7+30]0U#7]6M[VXM_#VEAK^XCAM;F:T%S<2)$AAM'EC
M2,SF(MOD*QQ3^5)MY_\ 94_X*7V?[0GBB7P?J^B7&@:O^]6WADF:X\R:W$C7
M,$P-O ]O+&L;, ZE6V2(S1R+&DOZ?U^<%U_P4 G^(NN7FA?#/PW<>+FTS=]O
MO5OK>PL4Y58_(N9A(D^]O-49\KS!"TL'VB'=*OY _P#!3O\ :3_X7O\ V)I^
MH:9<:)XAT2XU:#5-+G;S?)\W[$UO+%<*B1SQ3(A9'4#."P#0M#--_2;\7OC1
MX?\ @+I;:SXEOH["Q61(A(X=V>20_*D<<:O+(^ S%8U8JBO(0$1V7X@^#_\
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M=^RBD:^(+F1[Z>/S8-/M8_-NI8_,6,O@LD4:9+%6GDB$@CE6,R/&R5X?H/\
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M$WQM\1;L22W,,D$>F">*!6@M;LSQQ%E16V7$=M:0VWF1ODH]PKM,92]?I_\
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M6U1'D*OYJ+%;Q2-)YH_UH!<E9:] _P""YW_,H_\ <8_]L*_?ZOP!_P";O/\
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M-];Q%XR02CF.22,LN"4D=,[68'0_X)<?\DA\/?\ <1_].5W7W_117YP?$O\
M9V\)?!OXCO\ &GQ#K_\ 9\26[)]DG\M4>[6R:U_=/_K)<VJ.4LXHWN))U,B2
MLG[BOSP_X*6_M76_[2G@JS.A:1JBZ%#KBD:W>0K;6MU(D-[#$MDK,9;A'"W#
MR.5B-L8DCEC$DP5/VN_9._Y)YX4_[%_2?_2*&OQA_8D\)Z=XK_:%\:_VA:6]
MW]DN-<NK;SX4E\FXBUF#RYXMX.R5,G9(N'7)P1DU^A__  53TFWU'X2:U+/%
M'));2:?+ [HK-%(;ZWB+QD@E',<DD99<$I(Z9VLP//\ _!)OP!I?AGX8:=JE
MG;1Q7VJR7<E]< $R3M!>7%O"&8DD)'&@"1KA%+2.%WRR,_Q!^W=I-OIW[1/@
MF6"*..2YD\/RSNB*K2R#598@\A !=Q'''&&;)"1HF=JJ!^K_ .W-\4+CX.?#
M?Q!K%GY@N4L_L\+Q3-!)#)>R)9I.DB@LKPM.)EVX),84.A.]?S0_X)X^/?'?
MPT^']G'X8\ ?VM97EQ=W,FI?\)#:6OVJ;SF@9_LTZN\/EK EOM&%?R?- S(2
M>/\ VX_@3\5OVR[C2[Q? 4>D7.GQW$4DPUK3+F2XCE:-HT9]T#!(665D4EP#
M/(0%);=]G_MW?VQ_PS_=_P#"0_\ (:_L_0_[1_U?_'Y]KL?M'^I_=?ZW?_JO
MW?\ <^7%:'_!)OP!I?AGX8:=JEG;1Q7VJR7<E]< $R3M!>7%O"&8DD)'&@"1
MKA%+2.%WRR,_Q!^W=I-OIW[1/@F6"*..2YD\/RSNB*K2R#598@\A !=Q'''&
M&;)"1HF=JJ!]_P#_  5'^+S_  E^&6H) TB7.L21Z5$Z)&ZA;@.]P)/,^ZCV
MT5Q$&0,ZNZ%=I_>)ZA^P3\--.^%_PU\/0:>FW[;I]OJ-S(50/+<7T23R,[(J
M;]N\0QEMSK!%%&6;8"?RP_X+E:3;PW'A2\6*,7,L>J123!%$CQQ-9M&C/C<R
M(TLK(I)"F20@ NV?Z#J_GA_X(A>$].U>\\2:A<VEO->V/]F?9+F2%'FM_.6_
M27R9&!>+S% 6385WJ K9'%?2'_!:_2;>;P+I5XT49N8M<BBCF**9$CEM+II$
M5\;E1VBB9U! 8QQD@E%Q]O\ [#G@#2_A]\.?#L>EVT=LMYI=E?7)0'=-=75M
M%)--(Q)9G9C@9)"(J1(%BC1%_*#3-)M]%_:Y,5K%'#&TDLI2-%13)-X?:65R
M% !>21WDD;J[LSL2S$G]7_VYOBA<?!SX;^(-8L_,%REG]GA>*9H)(9+V1+-)
MTD4%E>%IQ,NW!)C"AT)WK^:'_!/'Q[X[^&GP_LX_#'@#^UK*\N+NYDU+_A(;
M2U^U3><T#/\ 9IU=X?+6!+?:,*_D^:!F0D\?^W'\"?BM^V7<:7>+X"CTBYT^
M.XBDF&M:9<R7$<K1M&C/N@8)"RRLBDN 9Y" I+;OL_\ ;N_MC_AG^[_X2'_D
M-?V?H?\ :/\ J_\ C\^UV/VC_4_NO];O_P!5^[_N?+BM#_@DWX TOPS\,-.U
M2SMHXK[59+N2^N "9)V@O+BWA#,22$CC0!(UPBEI'"[Y9&?X@_;NTFWT[]HG
MP3+!%'')<R>'Y9W1%5I9!JLL0>0@ NXCCCC#-DA(T3.U5 _0_P#X*C_\DA\0
M_P#<._\ 3E:4?\$N/^20^'O^XC_Z<KNOO^N/^(7C6W^&NC:AKEXLCVVFV=Q>
M3)$%,C1V\32N$#,JERJD*&903C+ <C\@?^".?AA_%]OXG\?ZG+'<ZMJVJ-;2
MR&WC21&55O+EUD3 5+B2Z0O#&D: V\9^;Y!'^MWQ5^&FG?&30[_P]JJ;[+4+
M=X)<*C,FX?++'YBNBRQ-MEA<JWERHC@945^&/_!&'XFZIX<UG7O %_!)%'''
M)J/ERJ(I+6Z@EAL[F-XVC$I>0/"&#N!";8@1[I7(-3TFWUK]KD1744<T:R12
MA)$5U$D/A]98G 8$!XY$22-NJ.JNI#*"/Z#J*^?_ -K'_DGGBO\ [%_5O_2*
M:OSA_P""*GA/3O\ A#=2U?[);_VE_;%S:_;/)3[1]G^S6,GD>=CS/*W_ #^7
MNV;_ )L;N:\/_P""Y6DV\-QX4O%BC%S+'JD4DP11(\<36;1HSXW,B-+*R*20
MIDD( +MG]WO '@#2_A9I=MHNBVT=GIUG&(X((P=JKDDDDDLSLQ+R2.6>1V:1
MV9V9C^$/_!._2;?0/C[XWL[.*."V@CUV*&&)%2..--8ME1$10%5%4!550 H
M   KT#_@K!XD?XJ>*O!OPPAN)+6/4;RWN+J0PQR1AKRX^P6DJ_,LK/"/MA>+
M=$CB2/+,V#%^WVDZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515 554 *
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M_9Y/)MY?M4L>]LW&E7HM!Y+-L_=-]JF)WQAVQ&?DPRMT'[?7_)PO@+_N ?\
MIYN*_?ZOR0^&?A3X??\ !)NWUJ75?$,EU<ZO)%+;V!C1KS[- MR;6-8(B69V
M8SQO>R_9[1Y!&F+8@[_A#]H_XGWGQ=^.O@?4[G1M0T2(W&A1VMOJ2+%>2PIJ
MTN9I;=68V^93-&D;LS/'$D^0DRJ/W>_:Q_Y)YXK_ .Q?U;_TBFK\T?\ @BAX
M TN+PKJOB$6T?]K2:I+8M=D$R"UCM[6985))"(9)&=]@4R$1[RWE1;/'_P#@
MN5I-O#<>%+Q8HQ<RQZI%),$42/'$UFT:,^-S(C2RLBDD*9)" "[9_H.HK\(?
MVJ+Z+]IC]H3PSX&N&_XENB>7+<07%M%+#+-Y)U2X0+NW217%O#:VSB4[8V$C
M"%EW>=^[U?S8_M\E_P!C7XTZ7XYT.UD2.\CCU"=?+CCMYY]TEMJ%O%)Y+(KS
M0;7N'(EF2:[:XR&DCQ]G_P#!:O\ Y)YIO_8P6W_I%?5]X?L=Z3;Z+\.?"L5K
M%'#&VAZ=*4C144R36T<LKD* "\DCO)(W5W9G8EF)/T?11111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111111111117\V/[ P?]C7XTZIX&URZD2.\CDT^!O,CCMYY
M]T=SI]Q+'YS(KS0;DMT!EF2:[6WP&DDQ_2=7X0_LKV,7[3'[0GB;QS;K_P 2
MW1/,BMY[>YBEAEF\D:7;N6V[I(KBWANKE#$-L;"-3,R[?.Y_]OK_ ).%\!?]
MP#_T\W%?O]7X _\ !#'_ )F[_N#_ /M_7[_45^ /_!#'_F;O^X/_ .W]?=__
M  4TU:WUKX.^(I;66.:-9+.(O&ZNHDAU:VBE0E20'CD1XY%ZHZLC ,I T/\
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MO/\ /_0N5^_U%?/_ .UC_P D\\5_]B_JW_I%-7P!_P $5/\ DGFI?]C!<_\
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M\$5/^2>:E_V,%S_Z16-?0'_!4?\ Y)#XA_[AW_IRM*/^"7'_ "2'P]_W$?\
MTY7=?EA^W_J>J?LE_'"P\?V8DFCO([6\4&(1QNL,0T^\LEG=9D9W@C!>14WP
M"[C(0,L<C_T'?#3XJZ'\9-.35?#U_;ZA9/M'FP.&V,R+)Y<J_?BE"NA>&4)+
M'N =%/%> ?"SXZ7GQO\ '.I1:%/;W'@[1M/BMY+N+;*E[J]VT=P#;749DBEB
MM;9?+E16BDCGN")(Y5,+Q_EA_P $X]6M_P!L[X@ZSXT\<2QWNO:9':2Z19LZ
MBWMHV>8,]O:L6;9:,(A$V6$4UQ]HD+W<D<X/^"Y6K6\UQX4LUEC-S%'JDLD(
M=3(D<K6:QNR9W*CM%*J,0 QCD )*-C]_H]6MYKB2S66,W,4<<LD(=3(D<K2+
M&[)G<J.T4JHQ #&.0 DHV/P1_P""&/\ S-W_ '!__;^ON_\ X*::M;ZU\'?$
M4MK+'-&LEG$7C=7420ZM;12H2I(#QR(\<B]4=61@&4@:'_!+C_DD/A[_ +B/
M_IRNZ_,#_@H!I%Y^S%\;=&^(<LMQ_9NH7%C=LUL528+8+!:W]H@\X,^^W"%C
M)Y,4JW1@.Y4D:OZ+M)U:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8
M$$$@U^&/_!1RQB_:;^*O@WX;VR^9Y&Z6_EM[F(310WCI)<H5D4K%+#:69ND#
M[VE6:/;"?D$OK_\ P6K_ .2>:;_V,%M_Z17U??\ ^R=_R3SPI_V+^D_^D4-?
MD#_S=Y_G_H7*_?ZBOYL=0#_L6?M)?;]8NI(M)UJ\N;IIUDCAC>UU@S!?M ,V
MT6]M>']ZTQ4XM/M0B'[I:_I.K\(?']C%^U-^TU86MLNZR\)6]N]U<6]S$V6T
M]FNP6#+QMO;F&RG@3S)5V2'=&=QAY_\ X+G?\RC_ -QC_P!L*_?ZBBOP!_X(
M8_\ ,W?]P?\ ]OZ^[_\ @IIJUOK7P=\12VLL<T:R6<1>-U=1)#JUM%*A*D@/
M'(CQR+U1U9& 92!H?\$N/^20^'O^XC_Z<KNO@#]OK_DX7P%_W /_ $\W%?9_
M_!6;X7W'Q'^&5S<6OF-)HUY;ZD8HX6E:6-!);RYVD&-(H[A[B23#!4A;<%4E
MT\__ ."7'[96E_$SPUI_@S5+R./Q'IT<EM;0."K75C;*AA>,B*.'?'$WDF$/
M)<,EJ]T^079?M#]JO]H7_A0FCQ#3TM[OQ)JUQ%8Z%ILTOE_:[R>2.(9Y&(HO
M,$DK,T49^2$SPO-&U?3]%?SXZGJUOHO[7(ENI8X8VDBB#R.J*9)O#ZQ1("Q
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M^99Z7:I;M'MC\B;[%/!)"+7SHN&S%-^]>61O,23RE^W_ !3^S%X7\3^"Y/
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MUC$MNUNFX2,T9:5 7"1+!%&J'W_]C[_@G%X:_9/N/[7,\FKZ[Y;1K>SQK''
MK,X8VL +F%WC98Y9'DF<A7"-%'-+$WZ'T5_.#\4OAO9_%O\ :EN-&OGN(8I_
M+99[69H+B":'0$G@G@E3E)898XYHR0R[T&Y73<I_0^]_8?\ &_CBRAT/Q1\2
M-4OM"2,Q3VUII\%A=7$?D/"$FOA+-+,C!\SK<K<"X&=X,A65?O\ \ > -+^%
MFEVVBZ+;1V>G6<8C@@C!VJN22222S.S$O)(Y9Y'9I'9G9F/PA\2/^":6B_%O
M7$\2ZSXE\43ZO#Y/D72W=C"T'D'=%Y @L(T@V-F0>2J?O6:7_6.S'[OTSP@!
MI9TK5)Y-8CDCEBN)+Z*V+7$<I;<DT=O!!;LFQO*VB)0R !PS%F;\H;+_ ()&
MIX,\2S:QX5\6ZIH&G3R &TLED2Z2U9D>6U2_6Z5BA9?W32Q2E (C(+AXR[]?
M\>/^"4FA_$#4=*U+PAJ'_")RZ7;Q0J+2S$FYK=]\%R)$FMYA=J2?,N9))I9=
ML3;E>-FD^H-:_8STF_\ "[>$;+5=8T[3[GSVU26UFMS>:K-<E&GGO[NXMIYI
M)92A$IC:%9(W:!E:W$<29_[,_P"Q/IO[*+R+X?UO7'L9Y/-GT^ZELY;663RV
MC#X%DDL;X*EF@DB,ACB60R)&J5Q_[0O_  3QT7]J#44U#Q+KOB";R?-%K;1S
MV,5O:I*Y<I#&MC_NJ9)#)/(D<:R2R>6I'U_\-/ \_P .].33Y]4U#5_*VB.Y
MU%K=[@(J*BHTD$%OYN-I8R3"2=W=F>5\@+Z!7C_QT^!>A_M%Z'/X?\00>=:3
M?,CKA9K>900D\#D'9*F3@X*LI:-U>)Y(V^(/AO\ L,>._@=9OH_A/XBW%CHJ
MW$TMK:7&AVE\T"RMNV"6:;_@3B)(8GE:240HTCY^L/@A^RSX?^!5Q<:G:M>:
MCK=Y&L5YK.IW+WFH7$:-E$>9\*J*HCCVPI&'2&'S [1*P\__ &F/V)]-_:N>
M-?$&MZXEC!)YL&GVLMG%:Q2>6L9?!LGED? 8JT\DIC,DJQF-)&2O7_@-\$1\
M ]+CT:WU;5-3L;>..*TCU%[:5K:-"^$CDAMH)63#!0LS2B-(XXXA&B[3[A11
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111117S!\2/@IJ-EKB>,/!LEO:ZX_DPZI:W#/'8ZQ9H=H2Z,4
M<KQ7=NI)L[Y(Y)(QFVD26V?;']'Z3>OJ-O%/+#);221H[P2F,R1,R@F-S$\D
M1=2=K&-Y$)!VNRX8Z%%>/_&/_A*-1LUT_P *?9[:]NLJ^J76'AL(@R*\J6XR
M]S=[79K6%@EJ6C=IYT"QPW'/_L^_LUZ'^S?9W-OI7VBXN[^X>YU#4KV03WU[
M,S,P>XG"IOV[V"*%506>0@RRS22?0%%%%%%%%%%%%%%%>/\ Q^_X2C_A%]3_
M .$+^S_\)#]G/V'[1C9OR-VW=^[\W9O\CSOW'G^7YW[G?7P!\-/@Y\7/VC]'
M3P_\76T^UT!;A9+V* 1?VIJ@@D6XAAEEM':SM[0R%=\EN(;PBV$8"><UP?U?
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK\(?VIO@O\3OC-\3M%\<Z5X.
MN%LM"_LWRH+G5=*CFN?L=T]XV_R[N9(-S2-$N#-A5$IY8Q)^WWA;69_$%G'<
MW-E<:?*^[=:W+6[31[6*C>;6:XA.X .NR5_E8!MK[E7H***********\/\-_
M!"W@U2W\1:W<2:OKMM'-';74RK'!9)<A?/CL+2/]U C%2HFD-Q?F$^1-?3QJ
M!7N%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%9^K7KZ=;RSQ0R7,D<;ND$1C$DK*I(
MC0RO'$'8C:ID>- 2-SJN6'X8_P#"E_B=_P +O_X6C_PAUQ_9OVC;]D_M72OM
M'V?[!_9WF_\ 'WY?F[/W_D[MF_\ <>?M_?U^YVDWKZC;Q3RPR6TDD:.\$IC,
MD3,H)C<Q/)$74G:QC>1"0=KLN&.A11111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M117'^/\ Q_I?PLTNYUK6KF.STZSC,D\\A.U5R    69V8A(XT#/([+&BL[*I
M\ ^ WQ5\0?M#O'XD2UDT7PH\<;Z=;7,2?VEJ):-P]Q<8>6*VLLNIMHXLW%PT
M27)N([5Q!<<_^UW^W'X:_9!MXDU$27NK74;O:Z=;E1(556"RSNQQ!;M(HB\S
M$CL=YBAF\J4)^>'A;_@N+IUW>1IJOABXMK([O-FMM02ZF7"DKLADM[9'RVU6
MS*FU26&XJ$;]KO 'C_2_BGI=MK6BW,=YIUY&)()XR=K+D@@@@,KJP*21N%>-
MU:-U5U91\X?$OXXZC^S/J+WOBH_:/!EQN,>KPV[M<:7<,[,MOJ$,"MYMI)N6
M"SNX(E>)UCM[I99)1>2?7]%%%%%%%%%%%%?,'[6/QD\1_!#P]<:KX;T/^V)8
M+>ZGN)9+J"WM[*&WA:0SS*\BS7&" 1;VX#2(D@,T+^6)/#_^":O[0_B#]IKP
MKJ>N>(YHY;D:Y=0PI%$D4<%N+>UE2! HW,B-*X5I6DF((WR.1FOT/HHHHHHK
M\X/^"C'Q%^*'P]T[27^&UK<3>;<3C4)K2Q2_N(]J*;=!"R38BDS,TD@B.UXH
ME\V/?LF^[_A[>ZIJ.C:?/KD,=MJTEG;O?P1$&.*Z:)3/&A#R HLA95(>0$ ?
M.WWCV%%%%%%%%%%%%%%?BC\9_P!NOXAZ#\2_#?@Z728_#=CJ&J:87666UOKR
M[L9[Y[8EY(GFM[=)4&&ACW7$4D9*W3(PS^UU%%%%%%%%%%%%>?\ Q5^)>G?!
MO0[_ ,0ZJ^RRT^W>>7#(K/M'RQ1^8R(TLK;8H4++YDKH@.6%? &KZQ\:/VA/
M"47B[PO?:?X:EN+<7>FZ&L$%]-=V\L<+QFZU&Z!ABED DDMXX[>)$66*.YE5
MR[6_/_\ !/#]NW7/VA-1O_!_B^Q\C7]+MVE:X2(P>8MN\5M.EU YS%=B5PS"
M-4B;<Z>3;^2HE_5^BBBBBBBBOQ1^,_[=?Q#T'XE^&_!TNDQ^&['4-4TPNLLM
MK?7EW8SWSVQ+R1/-;VZ2H,-#'NN(I(R5NF1AG]KJ******^$-7_:!\0?&SQ9
MK'@?P(;.SCT2.--6\1W&R\6VN+B*8);V=C'(@FN$D4;I+B00PO!<Q2V[LL2S
M?F!^T5^U]\</V+M4O=#UV\L]4@OXV_LK5Y=.BC7RU#*9;9;<0Q+<(9$,]O=+
M<B)UCPKP2+)<?J_^P;XR\>>.O!RW?Q#MI+?5OMEPD)FMEM+B6U79LDGMU""-
M_,,T:CRX2T,<<FQM_G2_/_\ P44_;"\;_LSV1.@Z+'#8SR1VJ:]=3P2K]HF@
MFDV6UBDAE#QA ZSW2^3OCDC:VD1HY'^[_P!GKQ3>>.?!OA_5=0D\Z]OM'TZY
MN9=JIOFFMHY)'VH%1=S,3M4*HS@ # KX0^*/Q1^,NE_&73]'T?3Y'\%/)9!W
M%DCVLEJZ9O9Y[T_-#<1-Y_E1>;"6,-N!;S>=_I/ZGT44444444445\@?M&_M
M+7GPUUC1_!_AJRM]2\5:_P#:/LL-Q=+!;V<,,;,;R["[IFB4JS+%&JM<)!<I
M'*)HU1_A#]KOXE_'#]CVXB\4)K%GXA\./(_VB'^R(K>WLY)F98HI4B=KL6XW
M(+>X^UDF95BG;+Q_:?T^_9N^-]O^T?X3TWQ5:V\EI'?QR$V\C*[1R0RO!*H=
M<!T$D;^6^$+IM9HXV)1?<**_%'XS_MU_$/0?B7X;\'2Z3'X;L=0U33"ZRRVM
M]>7=C/?/;$O)$\UO;I*@PT,>ZXBDC)6Z9&&?VNHHHHHHKX0_:F_;[\/_ +.-
MPNAV<,FN>*I9+:.'1;4N)";EOD\V58I5C<K@QP*LEQ(9(,0B*7SE\_\ !7CW
M]H3XE6[:G%H_A/0[::0M:V6K-J#7BV[JLD1E^RR,H<*WEN)$MYA(C[K:$;0?
M+_CI_P %'_%'[,=G/IOB[PI]EU^2WQI-W;W0N-(OY48Q3W!;]W-!$AV3):$R
M71CDCCF:VWI,WZ_T44444444444444444445^<'_  3Y_;>U']LG^W_[0T^W
ML?[,N+=K;R)';-O=^?Y<4N_[TL?D'?,OEI+O&((=AW_H_111111111111111
M111117E_Q>\7:WX*TMKKP]HLFO:B9$2.R2[M[)=I.7DDGN6"JBJ#@(LKLY1=
M@0O+'^>'_!,W]KSQ1^UI>>)[GQ%);B*S_LO[):VT BAM_-6Z6786+S/YAA1V
M\Z67:V0FQ#M'ZOT4444444444444444444444444445\(?M1?M1^,?V8["XU
MR;PK9ZCHD$C![NWUW9)%&TT<-NT]O-IZ,'E:51LMVNA&0^Z0*%=_#_@I_P %
M O'?[1.G2:KX8^'GVZRAN&MI)?\ A([2'$R)'(R;9[:)SA94.X J=V <@@>@
M>*?VK?BOX/LY+ZY^%MP\46W<MMK]K=S'<P0;(+6VEF?E@6V(VU<NV$5F'T_^
MRY\=/^&E/"&G^*_L?V#[?]I_T;SO/\OR+F6W_P!;Y<6[=Y6_[BXW;><9/T!1
M11111111117YP?'?_@I]X+^#5G%<VL.H:Q]K^W)9S6UK)%8S36;"-@E]<".*
M:(RG8T]D+Q4 +%3F,2?;_P )_'7_  M#P]I6O>3]G_M/3[2]\C?YGE?:84F\
MO?M3?MW[=VU=V,[1G ] KX0^(_[;+P>()_"?@70+SQ;K-E(B:@;>:.UT^R8I
M,QBGOY%DB2X!AV^6ZJA<O$)OM,3P5V'P<_:UB\;:XW@_Q-I=QX:\6+;BY73K
MF:*>&ZA)<[[&\B/EW6Q$W2J%1D83(HD%M</']?T45\@?M7?MK^%_V2[,_P!J
M3?:-7EMWFLM+BSYUQA@BEW"LEO$6)S++C<L<WE)/)$8CX_X<^(/Q\^)\1U2P
MT3POX?LIO+-O8ZU-?37P1HHV+RM:;47<S,/+DC@GB*F.2+*AW\_U'_@H=KG[
M.FK6NA_%OP]_9OVGS?)UK2Y3<V-P%N!&)4MVS*D21$23+YLMXH\MC9K]H1%_
M4_2=6M]?MXKRSECGMIXTEAFB=7CDC=0R.CJ2K(RD,K*2&!!!(-:%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?C#^VC\0Y?VB_BAX=^#ME-C2
MUN(;OQ#"9984NE1!?&T=HXUD^2UB,L9CD,3SW,6[RI;99$_9ZOB#X8?LQ?V]
MXMUGQWXVM+>[U>34'@T..1_M$.GZ792*+*6&*3>D%W,R&[D=&8HT@9!;22W,
M1]?_ &C_ -G#0_VF-#N=(U>VMVN&MYH[*]DA$DUC-(%*S0L&208=(GDC21%G
M5!%(3&2*_*'_ ((=?VC_ &=XG\W[1_9OVC3_ +/NW_9_M&RX^T^5G]WYNS[+
MYVWY]GD;_E\NOVN\?^ -+^*>EW.BZU;1WFG7D9CG@D!VLN00000RNK /'(A5
MXW59$9756'Y8?\$N?C9J-I+K?PL\177VK5/"]Q-':2AWD5K.WE^R2PQLT*'R
MK>4)Y)F;S&BN4B2-(K;:OZ_UY_\ $OXJZ'\&].?5?$-_;Z?9)N'FSN%WLJ-)
MY<2_?EE*HY2&(/+)M(1&/%?DC^P]^VSHWQ*\8^.?$?B/5K/2K:]DTJ+2H=0O
M(K4K9VWVY8T1)YV4.%99;E86:,7$\C@ 2#/Z?:G^TWX%T5Q%=>)=#AD:.*4)
M)J=HC&.:-98G :4$I)&Z21MT=&5U)5@3T'AOXW^%?&-O=WFF:WI=Y;6$?FWL
MUO?6\T=M'M=M\[QR,L2;8W;=(5&$<YPIQQ__  UC\//^AK\/_P#@VLO_ (]7
ML'_"6:=_9W]K_:[?^S?L_P!J^V><GV?[/L\SS_.SY?E;/G\S=LV?-G;S7G_A
M;]H7P;XYO(]/TKQ!H]]>S;O*MK;4;::9]BEVV1QR,[;55F; .%4L> 37H'BG
MQ9IW@:SDU#5;NWL;*';YMS<S)#"F]@B[Y)"J+N9E5<D99@HY(%?('A;_ (*0
M_"CQA>1V-MXCMTEEW;6N8+JTA&U2YWSW4$4*<*0N]UW-A%R[*I^S])U:WU^W
MBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$@UH5\_P#[6/\ R3SQ7_V+
M^K?^D4U?FC_P23\?Z7\+/A1K>M:U<QV>G6>N74D\\A.U5^QV    +,[,0D<:
M!GD=EC16=E4_H?\ !S]M#X?_ !]O&T_P[K=O<WHQMMI$FM9I,J[GR8[J.%Y]
MJQNTGDA_+4!GVAE)]O\ &OQ"T;X:VZWFN:A9Z;;/((DFO+B*WC:0JS! \K*I
M<JK,%!R0K'& <9_@7XL>'OBAYW]@ZKI^I_9]GG_8KN&Y\KS-VSS/)=]F[8VW
M=C=M;&<'&?XU^-_A7X:W"V>N:WI>FW+QB5(;R^M[>1HRS*'"2R*Q0LK*& P2
MK#.0<=AX6\6:=XYLX]0TJ[M[ZRFW>5<VTR30OL8HVR2,LC;65E;!.&4J>017
MC_QK_:G\%_L[>6OB?5[>QEFVF.WQ)-<%7\S;)]G@2681$Q.OG%!$'787WD*:
M'PZ_:]\!_%I["#1-<L[NYU*26.UM49A=%H8YI9#);.JSP($@D823I&C#9M8F
M6(/Z?\2_BKH?P;TY]5\0W]OI]DFX>;.X7>RHTGEQ+]^64JCE(8@\LFTA$8\5
MT'A/Q39^.=.M-5T^3SK*^MX;FVEVLF^&9!)&^UPKKN5@=K!6&<$ Y%>?^/\
MX_>%_A?J-AI&KZG;V^I:G<6]O9V>3)<2O<NT<+>3&'D2)G1D\]U6!7&UI Q
M/ ?&/]M#X?\ P"O%T_Q%K=O;7ISNMHTFNIH\*CCSH[6.9X-RR(T?G!/,4EDW
M!6(]O\ >/]+^*>EVVM:+<QWFG7D8D@GC)VLN2""" RNK I)&X5XW5HW575E'
M0:MJUOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B H!)( KXP_P"'D/PH
M_M'^R_\ A([?[1]H^S[_ "+K[/OW^7N^U>1]F\K//G^9Y&S]YYGE_-7V?I.K
M6^OV\5Y9RQSVT\:2PS1.KQR1NH9'1U)5D92&5E)# @@D&O#_ (U_M3^"_P!G
M;RU\3ZO;V,LVTQV^))K@J_F;9/L\"2S"(F)U\XH(@Z["^\A30^'7[7O@/XM/
M80:)KEG=W.I22QVMJC,+HM#'-+(9+9U6>! D$C"2=(T8;-K$RQ!_?]6U:WT"
MWEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q 4 DD 5\@:9_P4/\ A7JVJ'1X
M_$MF+D22QEY%FBM=T08L1>R1+:%#M/ER"4I*2HC9RZ;OI_P'X_TOXGV":IHU
MS'>6,DD\<=Q$28Y&MYGMY"C8 =!)&X61<I( '1F1E8]A17R!\2_V^/AG\(M1
M?2M7U^W2]BW"6*"*XN_*97:-HY6M(IDCE5D8/"Y65."R ,I/Y(?M=^/]+^*?
MQQ^'.M:+<QWFG7D?A^2">,G:R_VU<@@@@,KJP*21N%>-U:-U5U91_0]JVK6^
M@6\MY>2QP6T$;RS32NJ1QQHI9W=V(545069F("@$D@"OB#5O^"FGPDT6XEM9
M?$4;20R/&YBL[Z:,LC%24EBMGBD3(^62-F1QAE9E()^S_"WBS3O'-G'J&E7=
MO?64V[RKFVF2:%]C%&V21ED;:RLK8)PRE3R"*\OU;]IOP+H%Q+9WGB70X+F"
M1XIH9=3M$DCD1BKHZ-*&5U8%65@"I!! (KT#P5\0M&^)5NUYH>H6>I6R2&)Y
MK.XBN(UD"JQ0O$S*'"LK%2<@,IQ@C/G^K?M-^!= N);.\\2Z'!<P2/%-#+J=
MHDD<B,5='1I0RNK JRL 5(((!%>P:MJUOH%O+>7DL<%M!&\LTTKJD<<:*6=W
M=B%5%4%F9B H!)( KY TS_@H?\*]6U0Z/'XELQ<B26,O(LT5KNB#%B+V2);0
MH=I\N02E)25$;.73=]/^ _'^E_$^P35-&N8[RQDDGCCN(B3'(UO,]O(4; #H
M)(W"R+E)  Z,R,K'L*Y_Q3XLT[P-9R:AJMW;V-E#M\VYN9DAA3>P1=\DA5%W
M,RJN2,LP4<D"OC#2?^"FGPDUJXBM8O$4:R32)&AEL[Z&,,[!07EEMDBC3)^:
M21E1!EF95!(^W])U:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$
M@U^,/_!7_P"-^C:UX*CT/2-;LYKY=<ABU"PM;Z)YQ'##=%TN8(Y"X2.=(BRR
M+A)ECR ZKC[/_9._:%\&_P#"&^%-(_X2#1_[2_L?2;7['_:-M]H^T?9H8_(\
MGS/,\W?\GE[=^_Y<;N*\/_X*"_M5>&OV;-&UFUT*6SC\;ZW'':RFT51>1*(E
M47-Y+ \<T3PV\O\ H+2L7$CQ-'&\*S%/H#]COXW^%=:\(>%=#M=;TN;5ET/3
MHC81WUN]T)(;*,RH8%D,H>,(YD7;E K;@-IQ]'_$OXJZ'\&].?5?$-_;Z?9)
MN'FSN%WLJ-)Y<2_?EE*HY2&(/+)M(1&/%> ?#3]OCX9_%W44TK2-?MWO9=HB
MBGBN+3S69UC6.)KN*%))69U"0H6E?DJA"L1]?U\_^'?VJO WBO\ M1K+7M/D
MM]&^R_VA=^>JV</VS/V?_3&Q;/O(*?NY'VR#RVVR?+5#X(?M=>"/VCKBXL_"
M^K1WMS:QK++"89[>01LVW>J7$432(&PKM&&$9>,.5,B;OH^OS0_X*+?MK:7\
M!/#5_HNEZA&?%5[&;6&""0M/9+*J&2YF,4B/:NL,F^U8D.TS12)')$DS)[!^
MQW\;_"NM>$/"NAVNMZ7-JRZ'IT1L([ZW>Z$D-E&94,"R&4/&$<R+MR@5MP&T
MX_-#]OK_ ).%\!?]P#_T\W%?J_\ &/\ ;0^'_P  KQ=/\1:W;VUZ<[K:-)KJ
M:/"HX\Z.UCF>#<LB-'YP3S%)9-P5B/;_  !X_P!+^*>EVVM:+<QWFG7D8D@G
MC)VLN2""" RNK I)&X5XW5HW575E'0:MJUOH%O+>7DL<%M!&\LTTKJD<<:*6
M=W=B%5%4%F9B H!)( KXP_X>0_"C^T?[+_X2.W^T?:/L^_R+K[/OW^7N^U>1
M]F\K//G^9Y&S]YYGE_-7V?I.K6^OV\5Y9RQSVT\:2PS1.KQR1NH9'1U)5D92
M&5E)# @@D&M"O/\ QU\6/#WPO\G^WM5T_3/M&_R/MMW#;>;Y>W?Y?G.F_;O3
M=MSMW+G&1G\$?^"0/QOT;P=<>+KSQ5K=G9W-_)ILHFU*^BADN9-U\TS[[B16
ME?=(K2-ECEP6.6&?W>O=6\*_$72X=<GETO4=)LY#?P7[O;W%K!):%P;J.<EH
MHW@(D!F5@8B'^9<-1\*OC1X?^-]O=7GAR^CO[:SO);*::(/Y?VB%49U1V55E
M3;(C++$7A<,"CL*_-#_@M7_R3S3?^Q@MO_2*^K[_ /V3O^2>>%/^Q?TG_P!(
MH:Z#Q_\ '[PO\+]1L-(U?4[>WU+4[BWM[.SR9+B5[EVCA;R8P\B1,Z,GGNJP
M*XVM(&(!]@KQ_0/C]X7\5^(;CPII^IV]WK5I;R7%S;0$R^2D4PMY%EE0&))4
ME(1X&<3KD,8PI!KQ#4_^"A_PKTG5!H\GB6S-R9(HP\:S2VNZ4*5)O8XFM @W
M#S)#*$B(82,A1]OV?7G_ ,2_BKH?P;TY]5\0W]OI]DFX>;.X7>RHTGEQ+]^6
M4JCE(8@\LFTA$8\5Y_IO[4'A6]U&VTJ>ZN-/O;W(LXM4T^^TO[4RO'&8[=M0
MM[9)Y=TT8$,1>4[P0A&2/H"BBO'_ (Q_'[PO^S_9K?>)]3M]/B?/E+(2TTVU
MD1O)@C#S3;#(AD\I'\M6#OM3+#S#X7_MS?#?XQW'V/1_$%F]R9(8DAN/,LI)
MI)V*QI EXD#3NS#;MA$A!* @%TW?1_BGQ9IW@:SDU#5;NWL;*';YMS<S)#"F
M]@B[Y)"J+N9E5<D99@HY(%?SXWOQOT;4?VH8=<GUNSDT*VC,4%^]]$UC%&=$
M<%(YS(840W$D@*JP!N)'X\QFS^[WAOXA>%?C?;W=GIFH:7K=L(_*O8;>XM[V
M/RYU==DZ1M(NR15==L@PX#C! ->@:3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$
M10%5%4!550 H    K\X/^"BW[:VE_ 3PU?Z+I>H1GQ5>QFUA@@D+3V2RJADN
M9C%(CVKK#)OM6)#M,T4B1R1),R>P?L=_&_PKK7A#PKH=KK>ES:LNAZ=$;".^
MMWNA)#91F5# LAE#QA',B[<H%;<!M./S0_;Z_P"3A? 7_< _]/-Q7ZO_ !C_
M &T/A_\  *\73_$6MV]M>G.ZVC2:ZFCPJ./.CM8YG@W+(C1^<$\Q263<%8CV
M_P  >/\ 2_BGI=MK6BW,=YIUY&)()XR=K+D@@@@,KJP*21N%>-U:-U5U91T&
MK:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22 *^,/^'D/PH_M'
M^R_^$CM_M'VC[/O\BZ^S[]_E[OM7D?9O*SSY_F>1L_>>9Y?S5]GZ3JUOK]O%
M>6<L<]M/&DL,T3J\<D;J&1T=259&4AE920P(()!K0KY__:G^-?\ PSMX+U?Q
M.L?G2V-N/L\97>IN)I$@M_,7S(B8A++&9MKJXB#E,OM!_$'_ (([?!R7XD^*
M-5\?:NUQ<2Z=F.WN)A*WGWU\)/M,QN"X$LL<1998W$I/VU)F*.L;-_1]7A_[
M17P&TO\ :2\-7OAW5(XRL\;&VG>,NUI=!6$-U& \;;XV;)4.@E0O"Y,4CJ=#
M]GKPM>>!O!OA_2M0C\F]L='TZVN8MROLFAMHXY$W(61MK*1N4LIQD$C!KH/B
M7\5=#^#>G/JOB&_M]/LDW#S9W"[V5&D\N)?ORRE4<I#$'EDVD(C'BOG#P5_P
M4/\ A7X_N&M;/Q+9QR)&9";Q9K"/:&52!+>Q01,^6&(U8N1N8*55B/L^O']
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MYAXU_;F^&_P\UE= U+Q!9Q:B9!$Z+YDL<,AE:$I<7$2/!;.CJPE6>2,P@;Y
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M=I%C&7$9N88ED<+ES&A9]BO)MV1NR_5]%? '_!4?_DD/B'_N'?\ IRM*^?\
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M*"UCM)-'DDTR=(8EBBDDA"2B90'<L\L<T<EQ(VPR733OL"E2>?\ C_X TO\
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MH?#[6[FXEN+"W,EA()I4F&FN%@DACFA5)(?LSLGDR>=YRK<(D(CCM5V_'_\
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M?+OYI;V($LJG>L<Z+(,8#A@K,H#'\T/^"&/_ #-W_<'_ /;^OO\ _P""H_\
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M@L(Y" 0C8_;[X>^-;?XE:-I^N6:R);:E9V]Y"DH42+'<1+*@<*S*'"L P5F
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M)W_)//"G_8OZ3_Z10U^0/[?7_)PO@+_N ?\ IYN*_?ZOP!_X(8_\S=_W!_\
MV_KS_P#:0\=?\,Q?M+P>*]:AVZ;/]CE63?G%G/IXTR:YVQ++)^Y=9W\K8))?
M)VJ LB25_1]7E\GQ>TM/%4?@X-(VK/I<FJLH0^6EJEQ';*6D. 7DD=@BIN($
M4A?R\Q>9ZA17X _\$,?^9N_[@_\ [?U^OW[6/_)//%?_ &+^K?\ I%-7P!_P
M14_Y)YJ7_8P7/_I%8T?\%J_^2>:;_P!C!;?^D5]7W_\ LG?\D\\*?]B_I/\
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M,;=-^W?)9W+)Y-K'/)/([E+4$?J?^PQI-QXKM]=^(-_%)'<^+]4>ZM#,C17
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M\DGA/6;P&,L5\N_ANKV($LJG>L<Z+(,8#A@K,H#'C_\ @BI_R3S4O^Q@N?\
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MCN8KRZD197A=TEG64J"T802#"*JB,?GA_P .,?\ J;O_ "C_ /W?7W?\%?V
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M+>'[_3=6^R+=>7>WL=Q#]G=\2P[K$QR82:;,+^7YC^7^_A56W_K_ $5\(?\
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M')YTBLC"UN;@LH>=F0.87>-I1<KY,\-X2%DC4R7$LNA\-/C=\>_#^G);>(?
M-OJM['M7[7!KFG6/F*J*NZ6+?<(968.[M$8HOF"I!&%^;W _"'Q+^T.]K/\
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MSE!]OT44445GZMJUOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B H!)(
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MVYNAY93[1:3!I%DB"F5%*AK=;J:)/Z3J**_ ']OK_DX7P%_W /\ T\W%?O\
M5^ /_!17_BI?CKX$TB^_TG36_L;=9S?O+<_:=6ECGS"^8SYJ1QI+E?WB(BME
M54#]_J_!'_@MQJUQH%QX+O+.62"Y@DU66&:)V22.1&T]D='4AE=6 964@J0"
M""*_>ZBBOY O^">/[05G^S#K6N^)KRVN+Q;?P_.D<$",=\TM]8I$)90K);Q%
MB \\GRKD*JRS/%#)^K__  39\=Z'^TWKFI^-O$%[]N\?+N1+26,1PZ9II)5!
MI<1=\Q'>4FGR)D9S&Z@W$EQ?_L]117C_ ,?OC'9_L_\ A?4_$]\N^+3[<R+%
MEE\Z9B(X(=R)(4\V5XXO,*,L>_>PV*Q'YX? _P#9"3]KW2[3QU\6)KS5;S58
MY;JRT<74D&FZ=:W)B-O]ECMIMZN\,4;LQE4LLH6XB>ZC:=O / WP7^(/[)7Q
MECT;P/8ZHW@6_O()7CF+W&FK:7*1?;7:0L(HKBW,4BV[2LMXZP01L;E)]MQ]
MO_\ !1W]L&X_9/\ #4 TCR_[=U>22"R:1698(XU!GN@I1HI'B+Q)'%(R@O,L
MA2:.*6)C2?\ @G1X8\=6\5_\0S>>)?$<L:-=WESJ5T(XI&4/+;V26[6B162S
M-,]O%Y0*"0C@;57X N?B3XJ_X)@_$&RT/5M5O-8\!ZE'!';/?-<2BSLT?ROW
M)".J7%BI!E@M5,=Q;M#F&&26 6WU_P#\%-?ACXCT[PU/XQ\'ZOKEC?6$B2ZA
M;VFJ7Z02V>U8G>.UC=HHW@(29VC%O&(?M4TQD<*1[!_P3IUVP\;> [#6;?4]
M4U.^N8Q%J<FI:E->RQWD#/YJ"-YI8K9,ONA5%BDEM6MI)@[D-7'_ +>FC77B
M>\\.:#X?U76-,\3:]J"VUO+8:G=VT,5A:*\^H7,MLLJ6L_DQN&V;K>[F8Q!)
MG2)H&^@/BEX]L_V+_A_<:K,=0U>+1[>-0UU=M<7EU--,D*-/<S%C\\LJF1@"
ML,9(B@V)'!7Q_P# O]DZ#]KG0X/&GQ8^T:OJ&L?Z;8:?]KN+>QTNSF \F.SB
MM;D >?$L,LK.QD($2R+]H2>6;Y E^)NH_P#!++XE6WA0ZE<7_@2_M[25;>]G
M>=[*WGED2:YC$4"K%+'<+<S-%;Q,ES RJX-P4DA]P_X*_P WC'PAH,>IVOB*
M2WT*\O(=/.CVMM]G9Q+:W32O<WJS&6X1PKQM;;([<H8]T;21F20\,_L#ZI^U
MC\.=!E\1^)[RVF_LO2VTNQM%#:3:6L5M&ENTUHY1[F]>%I&GN?.B*2SF) UO
M BR=!^U[\+/&/[,7PDAA\/\ B^\AL?#]G:P3A;?;?7LDU]"@*WXG\VTMX1(J
M6UO N4MT-O)/.C+L^C_^"7'_ "2'P]_W$?\ TY7=?FA_P6)F\8^$+BPBO?$4
MESHFLR7QATBWMOL=O;QVK6;(L[+-(U\Y9DDWSX$<RN\,<2R>6GW?\2_V'-8_
M;#TY[_Q]K.H:;?S;I;+1+">.72]+PC+;+-&T?^G7<?F.;JZ1X/-,CP0M';I$
MY^8/^"37Q#USP%XF\1_"O59OM5OI'VJ6!EE+0VTUI>"UND@#QK(8IWF64 F-
M4:-G$(DN)6KZO_X*:?M@W_[+7A^TM=#\R+6]8DD%I>!87CMH[1X'N&9)DD61
MW61840I@!Y)?,5HD63U#X:?L+>%[/P\EEXOL;?Q!KMW;K_:VK7Y-[>37#PK%
M)Y-[,JW,44841VOEF%XHT1^)R\C?FA\+O'_Q/MOB;J'PE?QO>:5':27ITN>^
ML+/6KJYC!^UVZS3N@8O)9NUQOED41A!;B.-MD2_O=X3TZ\TC3K2VU"Z^W7L-
MO#'<W?E+#]HF1 LDWE(2D7F,"_EJ2J;MH. *S_'_ (3?QUI=SID=]>::UU&8
MS>6+QQW42DC<89)(Y5C<KE?,"[T#%XVCE".O\T6F?LV6^B_M%'P9:ZSKD,;2
M2RG5H[U4U8R3:0U]*YNUB +R2.Z2-LR\3,K$LQ<_T6_!3X0_\*6TZ33_ .U]
M8UGS+AI_M.L7GVRX3<D:>4DFQ,1#9N5,'#O(V?FP/YX?^"4F@>*/'?\ PD>A
M:#<?V987O]FG5M9CD O+6WC^U@6]A&0=MW=;V5+MLI9QQ2RA6N#;BN@_;F_9
M%O/V%[S3/B)X2UW4)+B34#'-/?2K-?"^F6><S&58DCGBF1)4N(YE)8DAS<1W
M#K%_0]\)_'7_  M#P]I6O>3]G_M/3[2]\C?YGE?:84F\O?M3?MW[=VU=V,[1
MG _+'X,ZA<?\%0]4U36-=^V6OP]TV3[#8Z)'<M NHW!"S/-J36\RRL\(^SS)
M$/W,;O$L4S&&Z:Z\/_;$^#$O_!-N?3?'7PSN[C3[*ZU!+;4-)FNI9[.9EMW:
MW0PL-\L15+PRM/.\L4DR-;&$_-'^SWP!^,=G^T!X7TSQ/8KLBU"W$C199O)F
M4F.>'<Z1E_*E22+S BK)LWJ-C*3[!7X _P#!6SX!?\(%X>3Q#_;WB"_^W^(!
M_P 2Z^U#S].MO/AO)O\ 1;?RU\KR]OE0_,VR%F3G.:^O_P!D[]D/_BGO"GB'
M_A+?&'_(/TF^_L[^V/\ B7?ZF&;[+]G\G_CT_P"67D[O]3\F[O7PA_P6)F\8
M^$+BPBO?$4ESHFLR7QATBWMOL=O;QVK6;(L[+-(U\Y9DDWSX$<RN\,<2R>6G
M]%U?BCX&N-$_;P^*7C'P[XV>\N+'0I!#H^A"\N([,+93R6EU?M]F$ :X\QD*
M&1RZQWDD/[Y(4:+T]OV6)?V>?B=X*E\/7FH+X.FN-2B&CS7LLUG87PTJ^D1[
M>.:9W_TA3<R$[6,4BS$S;;B.)/K#]M/]IA/V4?!USX@6..>^>2.UT^"7S/+E
MNI=Q&\QJ2$CC26=E+1B01&$2QO(C5\W_  \_X)QZ/\0[.'6_BG+J'B/Q->6\
M3W8N[V2.&Q=VDF>UM$LI41(HVF*%0\D!9/,@2!)#'7SA^Q%X ^)O[.WQ-OO!
MPMM4D\!PR7P26^!DM8[53+-93VDX*0"XE>6(3Q6W+F:8RVZR0;[?T#_@HQXM
M\2^-_&OA'X;:>=4L]$UR1?[2N+!F1KR":;[/=P[EB;Y+2V$D]PC-)"4N$DGA
MVQ1L?/\ ]NK]AGPQ^S=X3D\<^ 6O/#NK:+)$2]K>73-/'=RQV;+YDD[2PNHF
MRKQ, R&6)XW\Q'B_1_\ 8=^+VJ?'?X>:+XAUIHWU&ZCN$GDC01K(UO=36PD*
M#Y5=UB#R! J;V;8D:;47\L/^;O/\_P#0N5^_U%?FA^W/^T]XE\&:SH7P]\!&
M-/%&OR([74D+3"RM?-V++Y9@FB9',<[3R%93;6]O,YAS)%+'T&D_\$T?!DMO
M%=:S-JFI^*%C0R>)'U*]34#=(H$=U%^_:*-X"$^S*RRB-(HE<S%6=_A#_@GK
MK>N:A\</$EAX@U6XUF[T?1[[24O+C(9X=/U&SMT(4L^S=L,CC<S/+))*[R2R
M22.?\%;-4UKX!:CHNH>&M?\ $%A_;']HFZMH]9OC;AX'@</#&TQ\G/VEE,<9
M6!4CC6.*/#%_WNU;3$UJWEM93(L<T;QN8I9(9 KJ5)26)DEC?!^62-E=#AE9
M6 (_"'P'XFU[P!^TLG@Z+7M<N]"CDG=+.]U2ZNH]LVC/>"-A+(PD2*1\1&3>
MX"(6=Y 9#]W_ /!3'XQZY\%/AU=WOA];A+NZN(+-[VW)#6,,VXO<%@C[-VP6
MJ29B:.6YC=)5E6,-\_\ A/\ X);^$/BAX&M)]7AU"W\7ZGI\-W>:M=7%S)>1
M:C<J+B8SVTDB1/ME=HI(WC69HP0THN";@4/^"0'[17B7XSZ7K>E^(;V34%TB
M2S>UN;AFENBMX;DR1RS.Q:5%:$&(OET#LF\Q+$D?R_\ \%B9O&/A"XL(KWQ%
M)<Z)K,E\8=(M[;[';V\=JUFR+.RS2-?.69)-\^!',KO#'$LGEI]?_&__ ()F
MZI^TW;V^H^)_%MY_PD)D:69$B$^CVJR+A[;3K)FAEA10D">>\S/<>29I8_-E
M_=_*'_!5?]E^+X9>&=-\03:_X@UF[74+?3XDU6\BGABA:SE+-&D=O#ME?[)#
MYLN2T[!I)?,E8R5]_P#[%/[,?_"-:+X7\3_\)-XHN=VCV<_]E7&J>9I8^TV*
MCREM?*&(HO,S F_]V4C.3MYX_P".OQB\0?M ?$A/A#X:N+S1;.QCCOO$.L6L
MB1WGV<1Q3I#9OO#1(S36\3RJ&F,DO,)M89ENN _:E_X)T>&/A5X:OO%GP^-Y
MX=UW0[.YO(IK;4KI5DCC4-<!WD:>97^SK.D(@> .\NV5FC/R^G_L0_M5ZY^V
M;X&U"T2^M]-\7:=Y=M-?_8S<IMF7]S??9B8(?-<).OE+(T23P^<T(@D2V/YP
M?LQZ5XY^*?QD\3:%-XFN&NX+?5-.U#67#"\73H-3B$JZ7'N>*REEEVK"!F&R
MCFFEB4RQQ _I?\ O^";UO\ /'DWC2U\1ZI>1R1S@VMQM,]Q)<*/-:^NU8"Z0
MR;YPGDQ'SA!(TC-"3+^E]?BC_P %?YO&/A#08]3M?$4EOH5Y>0Z>='M;;[.S
MB6UNFE>YO5F,MPCA7C:VV1VY0Q[HVDC,DGZ7?LG?\D\\*?\ 8OZ3_P"D4-?A
MC^VEJ_CSP!\7/"^G:EK$GB:0WFE:I8:9%&NE6?G_ -HSI!:I$9IXE?*M$M[.
MTDPCD"R.ZID_;_QY_P"":VJ?M):7)J7B+Q+>3^+3')+!"' T&TG<H3;6MJ8F
MGBM]D<<#3AS-*R"[ECDD+0G _P""-WQYU3XE>&M2\.ZG))<+H$EJ+.>20,RV
MMTLHCM0-@;9 UNYC9G<A)5A41Q0(I_8ZO/\ XE_#J#XH:<^GSW6H66[<8[G3
MKZXL;B)RC(KK) Z;]N\L(YA+ SJK/$^T ?A#^Q;XBU_1/C-?^"/&WB+Q!??8
MOMD>FQW.H:G$MS<VDT<\$SPK<%3%+:1S3K'.TEM+$P4F7?'N_0__ (*"_"O4
MCX.UGQ-X9U+7+'6[&..\_P!#UJ\M[=K>WVK<@VS7 ME1;<23D0)%-)-$I#.S
MNDN?_P $M_&"_$7X?PZK<:CJ&I:N;BXMM4EO;V]NMDT,TDD*1K=2/%'_ *-/
M 6:V"K)E1(6DC(4_:L\'KX^\7^'_  OHNM>(-*U?5KB2^U.?3-4O=EMI%E;.
MCE[477V>T^TS^1!!<?9_+:<2LQDD#13>(?\ !973$T7X::1:Q&1HX=<LXT,L
MLDTA5+&]4%Y96>61\#YI)&9W.69F8DF_\(_V5M8_:Y\ Z''XTU34-(T--'TR
MWTW1M)NHU6>WA@A(O=2D>&5+B6X:..>WMPH2QB6,9:Y><K\P?L)76N?L??&.
M^^%%S>?VAIMYYOW&*0K,MF+^"\$3J[)*UN@@GB1U4LZ[I9UMH2?N_P#X*=S>
M,?"_@R\U_P /^(I-(L;".V$]I:VVRZNI)[V"(-_: F$MNB!E*I!&I<>:DDDB
M2JL78?\ !+C_ ))#X>_[B/\ Z<KNN?\ VU?CIKCZYH?PM\'3_9-=\2[FN]07
M/G:=IH+"6> ,8HVE9(KE@5E$T:V[+&JSS6\T?G_Q8_X)4^"[WPOJO]GV^H:A
MXJ>WN[BVU.ZU&1KRZOF+SQB<NR6;>;)B&1VB0F-BYD6;,XZ#_@E]K_Q*U+0]
M2M/B!;Z@D5K<1#3;C5(Y4OI?,$CW*.9R)I8HR8C#)(O622)972(1P? 'Q2U'
M7-+_ &I;B3PU:V]YJY\N.UBNI3%;JTN@)&9IV4%S% K-<21Q_O94B,49$CJ:
M]P_;6_X)K/J_AK4/&$_B75-5\1Z;9R7=U+J3QFUE@@62XN8;6&*(-9IN:22U
M@5Y88S^XP YGC^O_ /@F%\>=4^/GP^BN-9DDN+[3+R;3I+N60/)<K$D4T<CG
M8IWK'.D+%C(\AB,SR,\C8_0^O@#_ (*#_L_Q?%SPEJ^I7>L:Q;6^E:/?7*:;
M:7$45C<36T;72/=QF!I)_GBBPK2;8PFZ(12-([_G!_P2_P#V8_\ A=/@V]U#
M_A)O%&C>7K$\'V;1]4^QV[[;:T?S7C\I\RG?M9\C*)&N/ER?I_\ X+5_\D\T
MW_L8+;_TBOJ/A'^RMK'[7/@'0X_&FJ:AI&AIH^F6^FZ-I-U&JSV\,$)%[J4C
MPRI<2W#1QSV]N%"6,2QC+7+SE?F#]A*ZUS]C[XQWWPHN;S^T--O/-^XQ2%9E
MLQ?P7@B=79)6MT$$\2.JEG7=+.MM"3^UW[2/QOM_V</">I>*KJWDNX[".,BW
MC94:22:5((E+MD(ADD3S'PY1-S+'(P"-\(? O]DZ#]KG0X/&GQ8^T:OJ&L?Z
M;8:?]KN+>QTNSF \F.SBM;D >?$L,LK.QD($2R+]H2>6;Y E^)NH_P#!++XE
M6WA0ZE<7_@2_M[25;>]G>=[*WGED2:YC$4"K%+'<+<S-%;Q,ES RJX-P4DA_
MH>KC_'^E:IKNEW-KHM['INHRQE(+V2V%VL#$@&00&2)9'"Y\L.VP/M9TE0-$
M_P#.C^S'K?Q%U[XR>)M*LM5_M+7([?5-*DUN_P"4T^TAU.(RWD-D69&VLI%K
MI\96W2>X0MBVCESZA^V)_P $OG^$^ES^./!FKZI=:IILDNI:@^H749NG6,^>
M]Y;W4<<#"XA96F<.6>49>.031K'/^A__  3F_:NO/VJ_"3W.L&W_ +:TVX^R
M7?E.H:9?+1XKMX% \GS<NA"CRGE@F:/8O[F+X _YN\_S_P!"Y7[G?$+Q)<>#
MM&U#4[.TDO[FSL[BXALHMWF7,D,32) FU)&WR,HC7:CG+#",>#^*/["7[,NF
M?ML:'?>-OBA%J&MZE<ZA+;V4MW=74,*6D0$A-HL#PJ(C<37"%$)MXVB\N*.)
MEE#<_P#LJ:WKG[*?QOE^$MEJMQJ'AE_-6."[RWD*UA)JD30*&V12AG,<[1A(
MKG<\K0*_E>3]G_\ !3N;QCX7\&7FO^'_ !%)I%C81VPGM+6VV75U)/>P1!O[
M0$PEMT0,I5((U+CS4DDD255B^8/V(/@7X@_:9^&&F:1JVHWFA^$H(]0BACTJ
MY1+S5I)KRY\^2[D:.18[*-9)+5;(JQN)!+<2D1K;*?G_ ,"^$]4_X)N_&[3/
M#6G7TE]HGB*2SC,!<(TEK>SRVMN;H>64^T6DP:19(@IE12H:W6ZFB3^DZBOY
MX?\ @J#X9\5_LQWFFZOX8\2^*(=(U/S89;=M6U&:&TN(5C*A;F2X=_\ 2%+N
ML4K,X:&=D=H\1P_M=X?\%:%\1_#6G+8W6J2Z3-'%>V=PFK:K#=2QSJTL;277
MVF.^="LV1%/(0HV*47RD"?CC^RMJFM>%/CEJG@;Q=K_B"[M[3[4=&@NM9OI?
M.>*2&\LWG^S3"%]]B))9(YP(&R8I(A(5BK]COVBM3T3PUX:O=7\0SWD&G:9&
MUW(;+4+C3YW9%94A26VN;5G>5G$<4#R!)9FB&-X0CP#]F?P;KWP&^',FMZI<
MZYXC\1SZ7_:<UGJ%S=/.)UMFFCTVW@E,[0.K'R'(1II9B6=2%A@B^$/V$OV9
M=,_;8T.^\;?%"+4-;U*YU"6WLI;NZNH84M(@)";18'A41&XFN$*(3;QM%Y<4
M<3+*&Y_]E36]<_93^-\OPELM5N-0\,OYJQP7>6\A6L)-4B:!0VR*4,YCG:,)
M%<[GE:!7\KR?U?\ VT/C'>? +X?ZWXBT]<WMM;I';-E1Y<UU-':QS8=)$?R6
MF$WELI639Y9*ABP^+_V:_P!C/P#^T+X.T?QC>2:I?^([ZSCEF\0/J=^NH1:A
M#^Z=XF:14#V<T9BMF:)TV6\1)G'SO[A_P3[\$ZY\-[#Q3I'B.\N-1U*T\47$
M;WMS*99KF'^S].-K,[&69AYEN876-I':)2(F(9"!]_T44444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444444444444444444444444444444444445_/#_P $5/B7_:'B'Q3I
M]\]Q<:EJ=O;:BUS(WF;_ +--*D[32.QD:5WO8V!(;?B1F8,%#_T/5_/#\.OA
MI_PB7[5]U!IZ7$]O%<7VHW,A7?Y/]H:6\\C.R*%2(7%V(8RV,;XHRSR,"W0?
MM]?\G"^ O^X!_P"GFXK]_J*X_P ?^/\ 2_A9I=SK6M7,=GIUG&9)YY"=JKD
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MY(HH845%11'$G!?<[?N]^UC_ ,D\\5_]B_JW_I%-7P!_P14_Y)YJ7_8P7/\
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MY7=?5][\+[>Z\56GBI?+2YM]+O--D A7S)H[BXM+B/=-D-L@:WEV1D,,W,C
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MB6UG3#A3\DL4B;@-K;=RED*L?;_'_C_2_A9I=SK6M7,=GIUG&9)YY"=JKD
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M[>[U#7_L,'F7,6^\BOC-]^V=&&+=+EOWC",XQS(8P?U__P"'7'PA_P"A>_\
M*CJ7_P EU[A\!_V<O!'[.-Q?V?A*TCLKFZCM9;V$7<]Q(8U:X6V=DN)I6C0M
M]H5& 42%)!EC&=OY(?L"_P#)POCW_N/_ /IYMZ_?ZBOR _X+5_\ )/--_P"Q
M@MO_ $BOJ^__ -D[_DGGA3_L7])_](H:_(']OK_DX7P%_P!P#_T\W%?O]7X
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MM7_R3S3?^Q@MO_2*^K[_ /V3O^2>>%/^Q?TG_P!(H:_('_F[S_/_ $+E??\
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M'?\ A[54WV6H6[P2X5&9-P^66/S%=%EB;;+"Y5O+E1' RHK^='Q_^QO\6?\
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M.^M]4BO)Y;72;R6UCC2UF0#[2(O*E=S<KM$!E"&.59&C=51OL_\ 9$^(*_\
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MVB:6\\8TV%1:W;^=';I$K&X+*V9Y9)'VR/&"(A&D?ZG?LG?\D\\*?]B_I/\
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M%;2:GJWB#2[.]O=;NY//U87%Q;0NK0WLJM+&D $<<$0S#Y4825)O,F,OG_\
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MPPQ2X24Z'_!/C]O#_AK^SO++58+>SU_3]LDL<#;8;BWD9@LT$4DCS+Y1VQW
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M/QC+;RSO:+,L5OI\(C+1SWTK%47<S1%+<O"TB.N9H6FM?/\ E_X^?M:_%_\
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MT*D\I5]OW?\ %[XHI\(-+;4WT_5-482)&EGI5E)>W4C.>HC3"JBJ&9I)6C0
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MYX6LY->.B>%[FRBVW+Z);37TNK_9RP9[9)ABUENXXRRL\2NDDB$PPS%HX7]
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M]DG]GNR\*ZK<_:M4N;A=(EN[:[F*QV[S7%VJ(\D:221?98%L6A(C01.4&Z)
MC_H_^Q3X6L_!_P -?"]M8Q^5$^CV=RR[F;,UW$MU.^7+'YY99'V@[5W;5"H%
M4?E!_P %SO\ F4?^XQ_[85^_U%%%?DAIOB3X;_\ !.2_U3P[X0M-4USQ5K$B
MW']B6?F7EPB)#/-;0%E3;#;Q+O8Y%Q?B&=9Y$N(MC+\(?M'^(O%'BOXZ^![W
MQ7I=OHUW)<:%]GT^&Z%X\-NNK2J/M%P@$3RO*)I!Y("+ \*-^]62OW>_:Q_Y
M)YXK_P"Q?U;_ -(IJ^ /^"*G_)/-2_[&"Y_](K&O /\ @N=_S*/_ '&/_;"O
MWNTG2;?0+>*SLXHX+:"-(H88D5(XXT4*B(B@*J*H"JJ@!0   !7X(_L"_P#)
MPOCW_N/_ /IYMZ[#_@N#XUN+#1O#>AJL9MKR\O+R1R&\P2644<484[MH0K>2
MEP5))6/#* P;Z_TG2?C[H%O%9V<7P[@MH(TBAAB36$CCC10J(B* JHJ@*JJ
M%    %?*$'[!7Q3\2_%"R^)&KZAX?MKA=0L)[R/3;G4(\V]LD,$T42R6Y8^;
M;QM&Z/+LDWNC$1L0//\ _@N=_P RC_W&/_;"OWNTG2;?0+>*SLXHX+:"-(H8
M8D5(XXT4*B(B@*J*H"JJ@!0   !7X(_L"_\ )POCW_N/_P#IYMZ[#_@IGXG3
MXA?$OP%X OHI'TF:\LKF]C%Q(D=RM_?"SV-''L*O%'#,$F#[P+J0)Y>"7_<Z
MOP!_YN\_S_T+E=A_P7!\:W%AHWAO0U6,VUY>7EY(Y#>8)+**.*,*=VT(5O)2
MX*DDK'AE 8-]?Z3I/Q]T"WBL[.+X=P6T$:10PQ)K"1QQHH5$1% 5450%55 "
M@   "OE"#]@KXI^)?BA9?$C5]0\/VUPNH6$]Y'IMSJ$>;>V2&":*)9+<L?-M
MXVC='EV2;W1B(V(&?\7/$Z?&3]I_0/#VH12-8Z!&IAB-Q(8VNDL9=52Z5%V"
M-_,-LCJ"PE%K'YA9#Y2_N=7X _L"_P#)POCW_N/_ /IYMZ_?ZBOPA_X)4ZU_
MPOGQ]XX\?WC7"WLWE1PP//YRQ6^H3RS"$NR!W\A;*W@@*^6BQ*R^7C8(_P!W
MJ_G!_8XAU']F;]H34_!5I%]ETO4+C48#9M,\JK9I#+J&G2J1*P:58EC57F\R
M1(IYT8+*[%?0/V^O^3A? 7_< _\ 3S<5^_U%?/\ ^UC_ ,D\\5_]B_JW_I%-
M7P!_P14_Y)YJ7_8P7/\ Z16-> ?\%SO^91_[C'_MA7[W:3I-OH%O%9V<4<%M
M!&D4,,2*D<<:*%1$10%5%4!550 H    K\$?V!?^3A?'O_<?_P#3S;U]G_\
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M9J$=K#-@EWC^6><^6KE?WGS%RB,.@_;Z_P"3A? 7_< _]/-Q7[_5^ /[ O\
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M&BA41$4!515 554 *    *_!']@7_DX7Q[_W'_\ T\V]>_\ _!:O_DGFF_\
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MX>\17,G_  A\<>GWVH6@,@C*R7UQ#=3,( )G<6\91-I9XP9/)"O+)O\ TO\
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MQA;7,FR74+CQ#;6J[6;S)EU);HIE00N(K>9]SE5^3;G>RJW[??'[XQV?[/\
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M7_VF^*S_ &:6>9;C%K%M6*+RY5WPS;&NDW,OV@J<5\G_ /!0C]C;P'=66O\
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ME+7!)^T">+]U&!$!Y@DX_2?^"??A^:XBE\1ZQXD\4VUO(DT-AKNJO>6:7$;
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MBXU.U:\U'6[R-8KS6=3N7O-0N(T;*(\SX5451''MA2,.D,/F!VB5AZ_X_P#
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M/+#%(O.D?RH\1IMC 4>@444444444444444444444444444444444445Y_\
M$NY\0VVG/_PC$&GSZDVY8_[1N)H+>/*-ME;R()Y)=K[,PCR=Z%L3QL!G\P/V
M!OV,OB'^QKJ-]]I;P_?Z;JWV1;KR[V]CN(?L[OB6'=8F.3"339A?R_,?R_W\
M*JV_]?Z*****************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M*********************************^4/VR/%OC7P+X5O=3\&'2XI+*SO
M;J]N;]IFDB@@MWD_T.".)XI+C(+(UPPA4QJC12K*3%\W_P#!*#XJZY\9/!NJ
MZKXAO[C4+U_$%V/-G<ML5K:SD\N)?N11!G<I#$$BCW$(BCBOT_HHHHHHHHHH
MHHKX ^('Q[USXC_$H?#+PI>6^FK8Z>FHZYJ;0F:\B4RP,MK8QSQM:^:\<L.^
M:9;F)8[EF51-;>7+\ ?M5^'/BK^P/J,7BOPWXDUC7?#+>5%<)JUP^H?9V+QD
MQ7:/A!%.RA8[NW6WE3>UL9(G>.2Y_;[X<>.O^$XTZSGN8?L.I3Z?97MUIDCY
MN+/[6A(CF1E208=)H@SQQ[WAD&T,C*OH%%%%%%%%%%%?D!_P5*^-GQ*^"FDK
M=Z'=:?IN@75Q%8BXMWE?5Y)9K>X>3)>$0VT6$(1H&:Z22..59T\QHX_T/_9D
MU:XU_P "^&KR\EDGN9]#TR6::5V>221[2)G=W8EF=F)9F8DL2222:]PHHHHH
MK/O=6M].>&*>6..2YD,4".ZJTL@C>4I&"07<1QR2%5R0D;OC:K$<_P#$*RU3
M4=&U"#0YH[;5I+.X2PGE ,<5TT3""1P4D!19"K,"D@(!^1ONGX0_X)S_  Z^
M*'P]T[5D^)-U<3>;<0'3X;N^2_N(]J,+AS,KS8BDS"L<9E.UXI6\J/?OF_1^
MBBBBBBBBBBBOS ^$_CS7/^"@O]N7=IK=QH/@ZRU";3K Z*3!JEZT/V>874]W
M<PL]O$5*M%#;QPRL+B2&=F6']_\ *'PN\?\ Q>_9 ^)NF^!_$-S>>)]$UN\*
M6MQ.9)VE@D,:R7D,[B:>%[1%$MU:.[PQ)YK8"S17I_>ZL_4]6M]%02W4L<,;
M211!Y'5%,DTBQ1("Q +R2.D<:]7=E1068 \_X_DUF+2[D^'H[.35O+(M%OI)
M8[42$@!IFACDE**"7V(H,A41^9%N\U/QQ_87^/WCGXH?&3Q'I'B[4_M']F:?
MJ5O]CM2T>G12VVIV\>Z"'";]N^1(YYU:Z:$A9)#C _;ZBBBBBBBBOSP_X*)_
M%;X@_!CPQ<:YX1ETNSTZTC@-Y=S[YM0$DUU#"BVMN\+6@0;@)7G:0NDC[(XG
MB5Y.P_X)P^+-1\<_"W0M0U6[N+Z]F^W^;<W,SS3/LU"Y1=\DA9VVJJJN2<*H
M4< "OM^BBBBBBBBBBORP^%WPN^,NE_&74-8UC4)'\%/)>E$-ZCVLEJZ8LH(+
M(?-#<1-Y'FR^5"6,-P3<3>=_I/ZGU\ ?$#X]ZY\1_B4/AEX4O+?35L=/34=<
MU-H3->1*98&6UL8YXVM?->.6'?-,MS$L=RS*HFMO+E^ /VJ_#GQ5_8'U&+Q7
MX;\2:QKOAEO*BN$U:X?4/L[%XR8KM'P@BG90L=W;K;RIO:V,D3O')<_N=\/?
M$EQXQT;3]3O+22PN;RSM[B:REW>9;231+(\#[DC;?&S&-MR(<J<HIX'84444
M44444444444444444444445GV6K6^HO-%!+'));2"*=$=6:*0QI*$D )*.8Y
M(Y K8)21'QM92="BBBBBBN/\?R:S%I=R?#T=G)JWED6BWTDL=J)"0 TS0QR2
ME%!+[$4&0J(_,BW>:GXX_L+_ !^\<_%#XR>(](\7:G]H_LS3]2M_L=J6CTZ*
M6VU.WCW00X3?MWR)'/.K730D+)(<8'T__P %&/AU\4/B%IVDI\-KJXA\JXG.
MH0VE\EA<2;D46[B9GAS%'B99(Q*-SRQ-Y4FS?#]W_#VRU33M&T^#7)H[G5H[
M.W2_GB $<MTL2B>1 $C 1I S* D8 (^1?NCL********SX]6MYKB2S66,W,4
M<<LD(=3(D<K2+&[)G<J.T4JHQ #&.0 DHV-"BBBBBBBBBBBBBBBBBBBBBBBB
MBBBBL_2=6M]?MXKRSECGMIXTEAFB=7CDC=0R.CJ2K(RD,K*2&!!!(-?F!\4?
MA=\9=4^,NGZQH^H2)X*22R+H+U$M8[5$Q>P3V1^::XE;S_*E\J8J9K<BXA\G
M_1OU/HHHHHHHHHHHK\P/A/X\US_@H+_;EW::W<:#X.LM0FTZP.BDP:I>M#]G
MF%U/=W,+/;Q%2K10V\<,K"XDAG9EA_?_ "A\+O'_ ,7OV0/B;IO@?Q#<WGB?
M1-;O"EK<3F2=I8)#&LEY#.XFGA>T11+=6CN\,2>:V LT5Z?L^R^+>N?M:>-/
M$?A#0M4_L7PWX<\NUU&^LE(U>[NYX[B*2&WEN(FBM(HI4D5YDC>X\RV1X)]E
MQOA_-#]JK3_C3^QOJDNG:1XBUS5M"\0R+:Z?=2.U]=>9('5+,-(LLMM>X=O+
M>T,)N@JS18DB:*V_7_\ 8-\&^// O@Y;3XAW,EQJWVRX>$37*W=Q%:MLV1SW
M"EQ(_F":13YDQ6&2./>NSR8OL^BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOG_P#:%_:=\+_LOZ<F
MH>);OR?.\T6MM&AEN+IXD+E(8U_X"IDD,<$;R1K)+'YBD_$'QV_;QT/Q3X9U
M[P_JND>(/#=WJ?A_6ET]]=T\6,-W,EFX,$+F5\RG>NT$*K,5C#>;)#')S_\
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M7X8^*/\ @HGX?^(_QKT#79[B2T\'^'H]1@AN)('=I9+FTGBDNA%%"UPJ3/\
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MGB61PNR3=%YD+1RQNDC!N/4/V>OVQO!?[3^^+PW?^;>PV\5Q<64T4D-Q"LF
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M#-?Z%I3WEFEQ&Q#P"=GB61PNR3=%YD+1RQNDC!N/4/V>OVQO!?[3^^+PW?\
MFWL-O%<7%E-%)#<0K)@$%74)+Y;$1RO;M-$CL@,F)(R_C_[=_P"U'X0^%_A[
M7/"FKZA]GUK4_#]]]CMOLUS)YOVF&XMX?WL<3Q)NE1D^=UVXW-A2"?S@_P""
M7_[9G@3]G;P;>Z5XGU3[#>S:Q/<QQ?9+N;,+VUI&K[H()4&6B<;20PVY(P03
M^O\ \1_VS/ GPDT[2=5UK5/LUEKMO]ITV7[)=R>?"$BDW[8H'>/Y9XCME"-\
MV,95@/P@_P""4G[4?A#]FO\ X2/_ (2O4/L'V_\ LW[-_HUS/YGD?:_-_P"/
M>*7;M\V/[^W.[C.#C]_H?VI_!<OA>+QHVKV\.@3^<(+N<20>:T)E5XXHID2:
M27,$H2%$:678?+1^,G[.O[2FA_M0Z=>:KX>^T&RL]0FL/-GC$7G-$D4GFQ+N
M9_*=94*>:(I>H>)",5[AJVK6^@6\MY>2QP6T$;RS32NJ1QQHI9W=V(545069
MF("@$D@"OSPNO^"G/A>[BO+[1M$\4:WI%CN\_5M/TDO8KLB6:7=)/+ \?E*X
M,OG)'M W\QE7;Z?_ &>OVG?"_P"U!ISZAX:N_.\GRA=6TB&*XM7E0.$FC;_@
M2B2,R02/'(L<LGEL1ZAX_P#'^E_"S2[G6M:N8[/3K.,R3SR$[57(   !9G9B
M$CC0,\CLL:*SLJGX0U__ (*<^%_"GV>ZU#1/%%IHMW<1PVVMSZ28M.F27+1W
M$4CRB5XGB!G0+$9VA!(A+ I7W?X \?Z7\4]+MM:T6YCO-.O(Q)!/&3M9<D$$
M$!E=6!22-PKQNK1NJNK*/F!?V_\ X?7OB>V\*V6J1WMS-'=2S7ENR-I]I':V
MK7CO/>,ZPE#$K_- 9Q&Z.LQA(KR_PG_P50^'7CGQ1:>%]/?4)FOKB&VMM0^R
M;+-YI@!&F'=;I=TC"#<UNJB0[B1#F:OT?HHKX0U;_@IC\*= N);.\UN2"Y@D
M>*:&72]322.1&*NCHUF&5U8%65@"I!! (K[/\+>)8/&%G'?6R7"12[MJW-K<
M6DPVL4.^"ZCBF3E25WHNY<.N496/SAI/[;G@;6O$$7A6*]O%UV:1(TT^72-4
MAN SH) 726S0QIY9\UI)-J)#F5F6,%A]/ZMJUOH%O+>7DL<%M!&\LTTKJD<<
M:*6=W=B%5%4%F9B H!)( KX@U;_@H)X?FN)8O#FC^)/%-M;R/#-?Z%I3WEFE
MQ&Q#P"=GB61PNR3=%YD+1RQNDC!N/4/V>OVQO!?[3^^+PW?^;>PV\5Q<64T4
MD-Q"LF 05=0DOEL1'*]NTT2.R R8DC+GQC_;)\$_L_WBV/B>^N-/E?/E-)IN
MH-#-M5';R9X[5X9M@D02>4[^6S!'VOE1[_X3\4V?CG3K35=/D\ZROK>&YMI=
MK)OAF021OM<*Z[E8':P5AG! .17S G[>7P]_MR#PS+J5Q;ZU<7%O;1V5SI>I
MVTWG7)00HZSVD?E[_,0JTFU=K!B0IS7O_P 2_BKH?P;TY]5\0W]OI]DFX>;.
MX7>RHTGEQ+]^64JCE(8@\LFTA$8\5\@1?\%,?AT?#USXFDN[B*RBU"[T^UC>
M#_2+^:UACG+6L*LS^4ZRQ!9;G[.L;R(L_D%USZA^RM^V3X:_:^M[Z?0$O(9-
M.DB2X@O(5CD"S*QBD!BDFB9',<B@!]ZF-MR*K1L_U?111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111117X8_L<1V'[:?Q>\4>/M3DCO[3
M09((-"A>.;RDC>29;.ZC2:3,3I';/,8FCQ]JNGN52":-:_1_]N/P!I?Q!^'/
MB*/5+:.Y6STN]OK8N#NANK6VEDAFC8$,KJPP<$!T9XG#12.C?%__  14_P"2
M>:E_V,%S_P"D5C7L'B/]DW4;+XQCXL:EK=NF@:?I\C""X9U:UVV<EK)$&=O)
MBM 'EO7FW+B5Y$,'S-<'X _X*M_M->"_CQX>L[#PW+_:E[IFL;;C4(;60V]J
MK0W"& 7CHJ-]J:,21"W:2*=+-Y2V(HRW['_LR:3;Z_\ #3PU9WD4<]M/X;TR
M*:&5%>.2-[&)71T8%61E)5E8$,"000:_'#]D.WO/V$OC;?\ P_NWQHNN_N[6
M>X=8Q(H62?3)A*\$?G2G,E@\</EQ/>2R*ID:&-3^K_[=/CK_ (13P-?:;!#]
MIU+Q%C0-,MM_E^=>:HK6Z+YI4QIL0R39E,<;>5Y9E1G4U[?\%/A?;_!7PUI?
MARU\MH]-LX;<R1PK LTB*/-G,:E@KS2;YI/F8EW8L[,2Q_#'X=?M;?\ #'/Q
MF\<6GC87!LM9U!2;A1]JF@19B^G.Q$W%HME<DM&BRSQJD$21*4:,_J?'X3\-
M?M+^(O"OQ(\,7UG>-HTEY#//"Z[GM;S3Y@+>4",S+<0RSP2);SM"8$FN2T?F
MNJG[/HK\T/A;^S'<?LZ?$;Q7\3O%'B"S_LG48Y(K>2YE:)H8[NY@D5+B:X81
M1);F**SME5Y!*A0@6^U83^4/_!5;]H3PG^T7<:!J/A4274=O'?07&IFREMXY
MF#6[I:++/''+*]N&:5TV[(A>1LK%IG _J-K\ ?V!?^3A?'O_ ''_ /T\V]?O
M]7X _P#!#'_F;O\ N#_^W]>__P#!8SXZ7GPV\)6'A_3I[BVN->N)EN'BVA9+
M&VC N('?/F+YCSV^1&,21+-&["-FCE] ^%7[5^G?!O0[#P]I7P_^("66GVZ0
M19\/(K/M'S2R>7,B-+*VZ69PJ^9*[N1EC7YX>!K+Q?I/QUC\8^%_"GB32]$U
M?5($O$O]-O8E\B_\I-1DN=K,@03-+>1AI&AB=(9"@6(1KT'_  6J^'NC>#KC
MPY>:9I]G9W-_)K$M[-;V\4,ES)NLFWSO&JM*^Z1VW2%CEW.<L<_N=:_L_>$K
M;0[/PRVBZ?-HMAM-K97%M'<0QLH8>8%F5\RG?(7F;,KM)(S.S.Y/L%%?EA^R
MU\#$_P"">-OXG\0^/?$EG+'J]Y&R7<KR"29;9;J82.9299;VX$LKM:Q"=\QG
M9+<,YV?G!^T'\6_#_P </CQX-USPU%)]AGO-!4WKVCVJW\D>I-&UQ'YBI+,B
M!5LS+(JG?:O$,I$A/[_?M*?%Y/@+X.UCQ*S1K)86<CVXE222-[I_W=K&ZQ8<
MI).\4;$%0H8L71077X0_X),?!RSTOP@?'-VWVS7_ !'<7DEQ?3!GN%ACN7B,
M)E=W+^9+"]S+( C2O(BR"3R(WKS#_@M?X TN7PKI7B$VT?\ :T>J16*W8!$A
MM9+>ZF:%B" Z"2-73>&,9,FPKYLN_P#0_P#9Z\4V?@;X6>']5U"3R;*Q\+Z=
M<W,NUGV0PZ?')(^U SMM52=JAF., $X%?GA_P2<TR]^,.J>*_BEK9CEU'4[S
M[#$RRSEH5 2YN(5CD9E%N%:RCMMSR/&EN8@40?O/T^_:*^ VE_M)>&KWP[JD
M<96>-C;3O&7:TN@K"&ZC >-M\;-DJ'02H7A<F*1U/XX_\$;OC7_PF%GK'PWU
M>/[99"WEOK:.9?-A%O*R07MK(LDC)Y3M+%(D*1;&:6[>1B74'Q_Q3\"]#\2_
MM,R>$XH/[.T6;:LEKIV+)3#_ &$)IH!Y 39%<?/%<B/8TD4TP#*S[Q^]WQ>_
M9U\-?&WPTWA/5+*,:6(T2V2!5B:S:)=D,EIA=L+Q+\J *4V%HG1X7>-OQA_X
M(Y^)]4^'OBKQ/X U.*1)(8VN98S<!X[:ZL+A;.Y18TWQ,\IF0/-&^"+6,?O%
M*%-#_F[S_/\ T+E?N=XU^'NC?$JW6SUS3[/4K9)!*D-Y;Q7$:R!64.$E5E#A
M690P&0&89P3G\,?^"&/_ #-W_<'_ /;^OI__ (*]_'27X8>!HM#LI_)O?$%P
M;=P/-5S8PKONBDD95%W,UO!(DA82P3RH(V&YD^[_ -FOX0I\!?!VC^&E6-9+
M"SC2X,3R21O=/^\NI$:7#E))WED4$*%#!0B* B_DC_P61^#EGX4BT?XB:4WV
M'6EU"*SGGMPT<TS")Y[6X,J.NR6V^S,B2!3*RO&#*%MXEK]+_@=XHT;]M/P'
MHVN:]I=G>1W<?FRVMW:130)>6[26L[PQ3&<*GF+,(&+&3R7&XAF=:_&#_@C+
M\(=+^(>J:SJFIK).VC2:9/9VS.?LHNG%X([N2'[LEQ;JKBU=LB S2NJ^:4>/
MZ@_X+7^ -+E\*Z5XA-M'_:T>J16*W8!$AM9+>ZF:%B" Z"2-73>&,9,FPKYL
MN_\ 3[]F35KC7_ OAJ\O)9)[F?0],EFFE=GDDD>TB9W=V)9G9B69F)+$DDDF
MO<*_%'_@K3X_O?&M[X9^%NCW,<-SKUY#)=JYGC7;).MM8"61 4:W:8SR21[)
MG5[:&4*I5/,_8[PGX6L_ VG6FE:?'Y-E8V\-M;1;F?9#"@CC3<Y9VVJH&YBS
M'&22<FOY\?\ @IYX23]E'X@^'OB'X7$=I?7\D]Q/ BR1QRW5F\1FEE,<J%DN
MX[D0W,48B$@65W9WN9&K]?\ XW^-;?XE?"/6]<LUD2VU+PG?7D*2A1(L=QIT
MDJ!PK,H<*P#!68 YPQ')^+_^"*G_ "3S4O\ L8+G_P!(K&OU_HK\ ?V^O^3A
M? 7_ ' /_3S<5^_U?S8_LM?"'2_C/\??&=CK*R36-O>:U=R68<K;W;0ZQ#Y<
M-W'TGMUD9)S WR/-#"7#HK(WZ/\ _!63P!I?B;X8:CJEY;1RWVE26DEC<$$2
M0-/>6]O,%8$$I)&Y#QME&*QN5WQ1LGH'_!,O5KC6OA)X=ENI9)I%CO(@\CL[
M".&^N8HD!8DA(XT2.->B(JHH"J /RP_9?_:FB\=?$KQ)\0=2T7Q1XEE3_1M$
M33]-BO?[,L9Y9C&DJ*X%M+Y2"*-H7Q)YE\7,KRO(WT!^W+\9Y?VJ?!=QH%GX
M#\<+J2W%M<V$USHDL<,4T<@61W,,SL<V[W$:JR.NYP<!@KK]7_\ !,*Y\50_
M#Z+3?%EE>65SI=Y-9VB7L%Q#</9JD4L187'S,B-+)!$4"QK#"D2KF-B?T/K\
M4?\ @L]\/=&T[PA::Y!I]G'JUSKEK%/?I;Q+=2QBRNP$DG"B5T CC 5F( C3
MCY5Q]O\ [!?PATOX:>!='OK-9)+[6-+TR[OKR=S+<2L;2/R83(>1;VT9$%K
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M*Z_5_P#P3"N?%4/P^BTWQ997EE<Z7>36=HE[!<0W#V:I%+$6%Q\S(C2R01%
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M3Q#X2\&^--.U;38Y(YKNXTFZ@DVQRI-9F P/,$>*1KA_, C?+I\S;5V?H_\
MMC?M0:S\(_@Y;:Y<026/B/7+.RL]D:2PFRO+VU,MR<-*D\#PHEP(#N>2*X6'
M>K .1[A^P3\--.^%_P -?#T&GIM^VZ?;ZC<R%4#RW%]$D\C.R*F_;O$,9;<Z
MP111EFV GQ_XB_\ !.?3OB%\4+7XDOJUQ%Y-Q8W<VGB!&\RXL$182EP6'EQ'
MR8#)&T4KMB4+*GF)Y/Q!_P %SO\ F4?^XQ_[85^_U?@#_P W>?Y_Z%RO?_\
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M=!+':2*24=:_8[2=)M] MXK.SBC@MH(TBAAB14CCC10J(B* JHJ@*JJ %
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M'7YG^SVD(:69T1@I,2NT22&5/QQ_X+G?\RC_ -QC_P!L*_?ZBO/_ (L>.O\
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M[A7Y ?\ !:O_ ))YIO\ V,%M_P"D5]7W_P#LG?\ )//"G_8OZ3_Z10U^0/\
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M=_F$:02"=V64(6$)Y1'66OZ+J_ ']@7_ ).%\>_]Q_\ ]/-O7O\ _P %J_\
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MIXT'EM-+.]JBJFYQ7]+U?.'[,7QON/VAM+O=?%O'#I,FJ7<&BRHS%KO3[8K
MMU('VO&\LZ7!$3QQ/&@1"C8\Z7\D/^"&/_,W?]P?_P!OZY__ (+$>'-<^'WC
M+PWX]T\^7%!;PV]M<+&9/L]]8W,MW&90\;0_.)0T*,6,OD3YCV1DM^_WA/Q3
M9^.=.M-5T^3SK*^MX;FVEVLF^&9!)&^UPKKN5@=K!6&<$ Y%?D#_ ,%HM?\
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MIQK9SQ:=IUN"EO)=);[+"YU#4%MX;RX2*8^=) Z2B2:*"XDDF96B/J'[$'[
MLO[*427-]KVH7MVV^1["WN)8-(CFEBBC=S;!O]*E38Z)<3!5:,QM]ECEBC=?
M /VA?^":/B&7QRGCOX9:M;Z3?S7$MY<K=S3+Y5Y(Q,DD#I#<>9%<;Y//MYE\
ML9=!OMYA!#O_ +07_!.+Q#\?O"5L=7U_^TO',5PEQ)>7<DT>FHCQK%-96EK
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MU&XN=+\46]W97_V=;ZTGT8CS%@<LK12KJ&^*4*\J(Q$D0\TL\$I5-OZ'^/\
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MN;>69XI$A&)Q$CI^SVDZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515 554
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M8E@G(1#))-*-QEF)F827$VU"NA^U=^RCH?[6NAG2M5'DW<.]]/U!$#36DS
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M6T$!=MMND-O-&)7=CYDH\XJ\BK$CX!$2<BOM^BBBBBBBBBBBBOF#XL_M)_\
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M-'Q>TOX"^'[[Q+K+2+8V$8>01(9)'9W6..-%X!>21TC4L512P9W1 SK\ ?M
M_M+?&/P3X?/C/1/#6EV^B)'YDMA?FZN-8@M]\A%W=00/;PVZ>4(GFMD>YFM=
MS-*^U)O(^</A!_P5Q\0_&[QSHNA:?X<MXM-U"XBMKF$3375XN]F$ERDR)%&L
M4*$32(UN_P"[AE)FC5P\7[O44444445^6'Q1_;G\5>!_C+I_P\M="CFTFZDL
MHS,4N#=3QW*;I;V!U_="WMB7\T>7*"+2XW3Q9/D?J?111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111111111116?JVK6^@6\MY>2QP6T$;RS32NJ1QQ
MHI9W=V(545069F("@$D@"O+_  M^T+X-\<WD>GZ5X@T>^O9MWE6UMJ-M-,^Q
M2[;(XY&=MJJS-@'"J6/ )KV"N?\ %/BS3O UG)J&JW=O8V4.WS;FYF2&%-[!
M%WR2%47<S*JY(RS!1R0*Y_P+\6/#WQ0\[^P=5T_4_L^SS_L5W#<^5YF[9YGD
MN^S=L;;NQNVMC.#CT"L_5M6M] MY;R\EC@MH(WEFFE=4CCC12SN[L0JHJ@LS
M,0% )) %>?\ @KXW^%?B5<-9Z'K>EZE<I&97AL[ZWN)%C#*I<I%(S! S*I8C
M +*,Y(SZA7X _P#-WG^?^A<K]_JY_3O%FG:O>76GVUW;S7MCY7VNVCF1YK?S
ME+Q>=&I+Q>8H+1[PN]067(YKH*X_3/B%HVM:6=<M=0LYM)6.64W\=Q$]J(X2
MPE<SJQB"1E'$C;L(5;<1M.,_P+\6/#WQ0\[^P=5T_4_L^SS_ +%=PW/E>9NV
M>9Y+OLW;&V[L;MK8S@X] KS_ ,=?%CP]\+_)_M[5=/TS[1O\C[;=PVWF^7MW
M^7YSIOV[TW;<[=RYQD9Z#PMXLT[QS9QZAI5W;WUE-N\JYMIDFA?8Q1MDD99&
MVLK*V"<,I4\@BN@HHKG_ !3XLT[P-9R:AJMW;V-E#M\VYN9DAA3>P1=\DA5%
MW,RJN2,LP4<D"N?\"_%CP]\4/._L'5=/U/[/L\_[%=PW/E>9NV>9Y+OLW;&V
M[L;MK8S@X] K\(=9\4WGB#]K:RMKF3?%I]NUM:KM5?+A;0YKHIE0"V9;B9]S
MEF^?;G8JJO[7>/\ P!I?Q3TNYT76K:.\TZ\C,<\$@.UER""""&5U8!XY$*O&
MZK(C*ZJP_"']L32;?X<?&'X9>$-(BCM-"TJ31Y;*SC10L4ESJ[).Y<@RR/*+
M>(R-(SEG5I"?,DE9_P!_M6TFWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP*LC*2K
M*P(8$@@@UY_\(?@OX?\ @+I:Z-X:L8["Q61Y3&A=V>20_,\DDC/+(^ JAI&8
MJBI&"$1%7U"O/_\ A;'A[^Q_^$A_M73_ .Q?^@C]KA^Q_P"L\G_CXW^5_K?W
M7WO]9\GWN*/ OQ8\/?%#SO[!U73]3^S[//\ L5W#<^5YF[9YGDN^S=L;;NQN
MVMC.#CT"O/\ QU\6/#WPO\G^WM5T_3/M&_R/MMW#;>;Y>W?Y?G.F_;O3=MSM
MW+G&1GH/"WBS3O'-G'J&E7=O?64V[RKFVF2:%]C%&V21ED;:RLK8)PRE3R"*
MZ"O/_P#A;'A[^Q_^$A_M73_[%_Z"/VN'['_K/)_X^-_E?ZW]U][_ %GR?>XK
MH/"WBS3O'-G'J&E7=O?64V[RKFVF2:%]C%&V21ED;:RLK8)PRE3R"*- \6:=
MXK^T?V?=V]W]DN)+6Y\B9)?)N(L>9!+L)V2ID;XVPZY&0,BN@KQ_Q3^T+X-\
M#7DFGZKX@T>QO8=OFVUSJ-M#,F]0Z[XY)%==RLK+D#*L&'!!KV"BO'_%/[0O
M@WP->2:?JOB#1[&]AV^;;7.HVT,R;U#KOCDD5UW*RLN0,JP8<$&OQA_YN\_S
M_P!"Y7[_ %%%>/\ A;]H7P;XYO(]/TKQ!H]]>S;O*MK;4;::9]BEVV1QR,[;
M55F; .%4L> 37L%<_P#\)9IW]H_V1]KM_P"TOL_VK['YR?:/L^_R_/\ )SYG
ME;_D\S;LW_+G=Q7'ZG\;_"NBZH-#NM;TN'5FDBB%A)?6Z71DF"F)! T@E+R!
MT,:[<N&7:#N&?4*S]6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q 4
M DD 5\@?'OXW^%?B5X%\6V>AZWI>I7*>&]7E>&SOK>XD6,6DBERD4C,$#,JE
MB, LHSDC/R?_ ,$5/^2>:E_V,%S_ .D5C7ZO^*?%FG>!K.34-5N[>QLH=OFW
M-S,D,*;V"+ODD*HNYF55R1EF"CD@5S_ASXL>'O&%F=0TW5=/O+(7$=J;FWNX
M981<2M&D<!D1V3S7:6)4CSO9I8U )=0?0**\/\-_ ;2]-\07?BR_CCO]=N),
M07<L98V-K&CQ0VMBLCRFV3RW=KEHF4W5Q-<2L$C>."'X0_X*X_ O0_%_@2Z\
M63P;=:T;[*MM=1X5GAGNXH7@FX/F1#SFEC!PT4H)1E629)?J#]@?PMKG@KX9
MZ!I_B..XAU*&WE#PW+%IHH6N)6M8W!)9-EN846%L- H$+(C(47X@_P""G/Q+
M_P"$Y\3>$OA/ON(++6]0T^?5I86V,]O/>?9((HVW,C;66>9TFA=!+':2*24=
M:_8[2=)M] MXK.SBC@MH(TBAAB14CCC10J(B* JHJ@*JJ %    %?CC\!_/_
M &4OCSJO@2'[1#X;\36\NI:79)]G-O'<-'Y[RK&FS[-$GV>^M$1%#LD=JLB2
M(D4R_L]16?JVK6^@6\MY>2QP6T$;RS32NJ1QQHI9W=V(545069F("@$D@"OD
M#X]_&_PK\2O OBVST/6]+U*Y3PWJ\KPV=];W$BQBTD4N4BD9@@9E4L1@%E&<
MD9^3_P#@BI_R3S4O^Q@N?_2*QK]7_%/BS3O UG)J&JW=O8V4.WS;FYF2&%-[
M!%WR2%47<S*JY(RS!1R0*X_P5\;_  K\2KAK/0];TO4KE(S*\-G?6]Q(L895
M+E(I&8(&95+$8!91G)&?4****X_QK\0M&^&MNMYKFH6>FVSR"))KRXBMXVD*
MLP0/*RJ7*JS!0<D*QQ@'!H?Q"T;Q/;VMY8:A9W5M?2/%9S0W$4D=S)&LC.D#
MHQ65U6&9F5"Q412$@"-L=A17'^-?B%HWPUMUO-<U"STVV>01)->7$5O&TA5F
M"!Y652Y568*#DA6., XS_ OQ8\/?%#SO[!U73]3^S[//^Q7<-SY7F;MGF>2[
M[-VQMN[&[:V,X./0*_"']BKQ3>>,/VC/'5S?2>;*EOJULK;57$-IJ5G:P)A
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M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?C#H+V?_  4N^(NM6>JS_:_
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MFAWDMK=W,UG.#=S[ R6_FM#=)Y)8E7N/.DD4-(\DO[??!3X0_P#"EM.DT_\
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M;0I'MX7.2#Y$31VZE0B%8@4CB3;&G]+U%?B#^T7\<]._:1^*#?#?7M7T_2O
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M_P#^"MG[+GA#X7^'D\5Z1I_V?6M3\0#[9<_:;F3S?M,-Y<3?NI)7B3=*BO\
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M%7Q8\-QRZC=7D<-L-2A%Q K!I6N5M8KAYE>WC46L5K<#S$$*>5!.R"8'YO\
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M:;JMYK&K7<FE7=K/KLXFCCNI=4G$4)%K%"(;)9$5O(@11&'D\L#*J/T_\?\
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M92>(HS-JUTJ)N&GLTBLD;--&2BQV]U+=0CRWG1(H$E999HG^D/\ AW5\-?\
MA%_^$6_L:WV?9_)_M/RHO[4WYW_:/MOE^9YN_P"?'^HQ^Y\G[-^XK\L/^"8?
MANX\'?&SQ9IEY=R7]S9V>KV\U[+N\RYDAU2UC>=]SR-OD93(VYW.6.78\GV#
M_@L]\-'M=!M/$;ZKJDJRZI:VB:6\\8TV%1:W;^=';I$K&X+*V9Y9)'VR/&"(
MA&D?ZG?LG?\ )//"G_8OZ3_Z10U^ /\ P5;_ &7/"'[-?_".?\(II_V#[?\
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MRR@N"$!9\NF[0_YN\_S_ -"Y7[_5^ /_  0Q_P"9N_[@_P#[?U]__P#!4?\
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MT1Q(55)D9_QQ_8%_Y.%\>_\ <?\ _3S;U]__ /!4?_DD/B'_ +AW_IRM*/\
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M)J47AW0[FYALX;._>;3;&2X^V6J+%.9R$D;?(R^>ID(D>&:.5E4R8KZ \?\
MP-^%'PLTNYUK6O#WANSTZSC,D\\FDV>U5R   (2S.S$)'&@9Y'98T5G95/U?
M17\Z/_!%GQ)<>$/%7B7PK>6DD-S-9Q7$QEW1R6\FG7!MW@>%DW!RUX=VXJ8S
M"5*,7RG]%U?SX_"[P';W7[5>H2^'DCEL;"2]O;YXYUD6.2?3O*NV)=R2_P!O
MNC')$F3"[,FQ$B8)]'_\%J_^2>:;_P!C!;?^D5]7W_\ LG?\D\\*?]B_I/\
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M,NUGV0PZM=22/M0,[;54G:H9CC !.!7]#U?@#_S=Y_G_ *%ROO\ _P""H_\
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MH6[VU[JWB.*/38;:&4?,D4!6ZEN_/B6>V=H5#6K212$C<'3Z@^!?P3M?V/\
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M&M8U_0+[^T+C3+S1(!>36VR[,4EE<VJI$4_>K<7*W$DS[UF2) WER+!Z_/\
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MR(R@B=85D9$G,L7ZW>$_"UGX&TZTTK3X_)LK&WAMK:+<S[(84$<:;G+.VU5
MW,68XR23DUT%?EAX_P!=_:(\"^-;F\TO3]+U_P +RR$V]C'-:VRQ6PF 53-<
M/;W2WIBCW2.3=6BO.Q2-PJQQ=A\0/AM\0/VU='&@^)["W\%Z$]PC:C!'>PZM
MJ-\D$D$T44+QQ);6D1(=C,6GG\Z*,&#R"XF^[_ '@#2_A9I=MHNBVT=GIUG&
M(X((P=JKDDDDDLSLQ+R2.6>1V:1V9V9CY!^U5^S/I?[5_AJ7P]J<DD#"1;BS
MNH\EK>Z172.4Q[E65-LCI)$Q =';:T<H26/YO3XB?'GP_9P:$?"^CZAJB?9X
M7\2'58UTV3<R;[B33PMO>#;&6681;/WRO+#"T7EP-[!^R'^RU_PSK9W]]J5U
M_:'B;7[C[;KE\HV0R7#-))Y<$2JB)%&TTI#;$>5G9RL:>5!#]?T5^"/[47[+
MOQ!_9K^(-Q\3?AE;R7EM>2-<7EG;J\\@DG>,74$]J9&FN[>YE8W'^C@FW)=@
MEL+:"<^P>(_C#\7OVI/ NL:<?"4GAH?V7>)?7MP))+B]:.T+266GZ7+"EPKW
MCNL4<SM.D,+3JDDMVD=7_P#@EK\$_B5\%-):TURUT_3= NKB6^-O<)*^KR2S
M6]ND> DPAMHL("ZSJUTDD<D30)YBR1_,'Q'^$_Q*_8G^+5YXU\,:5<>(M-UR
MXO;B5+2TEFWV]W<"XN+*?RDFDM98WV-!<#*2;$<!U^TVB^@?MV^"?BK^U%X!
ML=:GTG[';IJ$5PGA>T@>[U*.%X#$EU=SDI(\JN[@6=M;(T,-SON"TD$@@^W_
M -A.^\<Z[H>E'Q!IW]@:1I6CP:7;Z;.C-?7MQ;B*)M0G\Q(GM(E6$QV]KM+R
M&6:9W:-;5F^G_C]\'+/]H#POJ?AB^;9%J%N8UEPS>3,I$D$VU'C+^5*D<OEE
MU639L8[&8'\T?^",'PA?PAX.U#Q+.LB2:Y>!(07C:-[6PWQI(JKET<SR7<;B
M0Y(BC9453OD_8ZOQQ^%GQ*^)'[,NO>)9M6\+ZYK7@_4_$FJ2Z<;'R[BZLP]U
M>N[PV _T@V]RXC?=(UO;J";B,R/=#SCXN_"W5/\ @H_XE\-SW7A[5-!\*Z%)
M=/J$FM1BTNKQI6M6>S@LXY?/5'2)%%WO1 ))]I$MNL<_['45_-C\(O!7Q2_X
M)H^,=1L],\/7GBG1+V-/,>RM)VCNHX_-^RRK/##<-:7$3.ZRV\@D&&<;9%:V
MNAV'_!2GX'_%7XRV?A_7+_3OM>/MB'1=(M7NFTHSLDD8GN$>26\EDB18[B>.
M*&SBEMPL:CSE>;]7_A7\2?'>KZ=)XFU[0;A%U#[*MAX;LGM&O+"%4E:2ZO;F
M^GL$>6=F0&W7:UK&D"F+SFNRGY8?LQ?!+XS_  1^(U[XYU'PE'<QZU)=C4X(
M-1T]62.]N5N96M ]\0'CD12B2LP= T1D1G$\?[W>%M9G\06<=S<V5QI\K[MU
MK<M;M-'M8J-YM9KB$[@ Z[)7^5@&VON5?YX?V,O#/Q5_8=\4:SX?@\&7&NKJ
M'E1M/'(]K9LUH)9(9H=2EB:U\IXY9,QRA)3(8XR8ID>!_P!?_C7^RU_PU!X&
MC\-^+KK_ (FORW?VVU'[JUU';)S!'MB\VTB\V2WCCG'G26N#)+]K_P!)'XH?
M#+_A?_[!%[/HNGZ->:SIQC800"VN]4TU5\^0B>U-JZM;.[>8[1,87=91)/;[
M_*9/TO\ @#\//B+^T=K&F>,/BE#;Z79:/B?2/#]O%A);N2,[=0O8II+AXY85
MDVV\<C+<03H7"6I607?@'_!3/X#?$+]K'4=+MO#WABX^Q:-]N7[7/J&F1_:6
MN'B7=%%]K+K$%MT=&E*2MYI5X(C'\_Z_?#3Q5J?C#3DN=7TBXT6]^59;2>>U
MN,-L5F:*6TFE1XMS,B,XAE;86:",%<^@45_/#IO@CXE?LC?&O6M>TOPM<>(+
M37KB]\MK<2BW:WU*[%Q%NO1&T5I+%*D:S_:5V(BR'B*2*YK[/_:P\.?$KXT_
M#RZ\.#P[)=:QKDEO<3+#J&G)8Z5!'=+-'9K+++#/<W");P_:&,;0O<7$\D-S
MY$<-JOJ'_!/'POXJ^$GA"S\(>)] N--ET[[6T=[]KL;FWG6:Y:=5Q!</-'+F
M=UVF-HMD.\SAY!$/B#]J;X+_ !.^,WQ.T7QSI7@ZX6RT+^S?*@N=5TJ.:Y^Q
MW3WC;_+NYD@W-(T2X,V%42GEC$G[//I\7Q9T.>SUG3KBTM]1M[BVN["YDB\X
M0RAX71Y+*XFC'F(2RM#,657'*2 JO\\/C']E'XJ_L >*#J_P\&H:MH<EQ$T:
MVR/<>>N)=MKJ=A 0\OEJ9$^T+&(AYB2Q2VUS((XOK#P5J/QN_;FMVT'Q5I\?
MA#PO-(4U2[AM9[/4+F!%4O9017<\LH2<2*&F\I8=B2(TDP$EI/\ L]I.DV^@
M6\5G9Q1P6T$:10PQ(J1QQHH5$1% 5450%55 "@   "M"OQ1_X*!_L?>,8O%E
MO\4?AOYAU:"-&O8;=O\ 2A);1,JW,22N4N$>!5M9;.-,R!5407/VB;9Z?\'/
MVE_C-\>[-M&?PA_PCM^V([CQ#>+-!;6BR,Y$UOI=W'YMU*D2%(XUGEB%R8GG
M,=NY2OG#_@EA^S[\4OA!<75[-86>DZ)J<EH;W^U8I_[0DCM6NEVVEM'+$T+E
MG*L]X$ 22*>*.=5*/Q_Q'^$_Q*_8G^+5YXU\,:5<>(M-URXO;B5+2TEFWV]W
M<"XN+*?RDFDM98WV-!<#*2;$<!U^TVB^@?MV^"?BK^U%X!L=:GTG[';IJ$5P
MGA>T@>[U*.%X#$EU=SDI(\JN[@6=M;(T,-SON"TD$@@^W_V$[[QSKNAZ4?$&
MG?V!I&E:/!I=OILZ,U]>W%N(HFU"?S$B>TB583';VNTO(99IG=HUM6;X _:K
M^&_C[X%_&^+XEZ#H%QK]E/Y4D4=I#/<?*EA'I]S#/Y$;/;RE2SP2,KQ'>C@3
M&.>%/T_@^&VL?M1>%]6TWXC6']DV^K;(8M(MKV.X>SBMRKQW#7<405[M[@&;
M ,EJL$=I&T/F?:Q-^*&B?";XW?\ !.SQ!)'X9M+S7-&EDN/*2WMY[W3[M62(
M>=/96\AEM;@#RAO8Q.7B>*.:XME?S/N_X5>&_BK^VU+82_$FRM_#_A.RN$O)
M-+BMGBFUB:"7,5O>6UU+<2+:1O%YDD<ZQK.K(4BE+17-K^O]%?BC^UW^QWXL
M^%_C>+XM?#"".ZODD>XO],\J+(<0,D\L40\LW"74>];B*,_;3<2M+"TCS9M_
MI_2?VXO$'BNWBM],^'7BPZW+&A%O>VR:?IXD"AIE;4K@A515#^4\D*&=PD?E
MQM( NA^Q)^QQ>?L\RZOXB\37=OJ7BS7KB26]N8(U$,2M*\K) YBBD_?.WG7
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M(8_\S=_W!_\ V_KW_P#X+5_\D\TW_L8+;_TBOJ^__P!D[_DGGA3_ +%_2?\
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MEM\[33DAI2J_N]^UC_R3SQ7_ -B_JW_I%-7P!_P14_Y)YJ7_ &,%S_Z16->
M?\%SO^91_P"XQ_[85^_U%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?SH_%#PO?\
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M:^>L%Q9R:CN1Y(8KRRDB^QS3XF#B*=5CMR(UBC1H%!D\ZZ3/U_\ #3_@K/\
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MNAV?AF_\,S7]O%K4NL37,-E(X2::%[. !X5;'G8^S3&18M[1*@:0(KH6^?\
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M(7<R+MPY9MP.XYZ#2=)M] MXK.SBC@MH(TBAAB14CCC10J(B* JHJ@*JJ %
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M9Y?DV%[YF[+;MWE;-JXW[CL_*'PU_P %5/$?C#Q0_@NQ\">;KZ7%U;-:?V]
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MZ_;)\$Q17ES!?7%]96&[[7?:?INH:A8Q;(EG?=>V5K/:_)&ZO+B4^4#A]I!
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M;9/L\"2S"(F)U\XH(@Z["^\A3^2/_!3S]I'PG^T?\-+6Z\*ZE'?QVGB2TCN
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MU@5S%&1& *^$/@+_ ,$Z]9^!_P 6;SQG9ZE9V_AR22_DAL+5)89'CO 2EE+
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M:O\ 9FADDBMWMVDC6625!OB541;6#'S_ /\ !'SX%Z'\8;S7[G7X/M]OIO\
M9[0V$^)+&2:=;V,3SVS QS2Q()$MS(&6(3S,%\PHZ?M?HO[#OP\\-)J\=AHL
M=HNN1M#J!M[BZA9X&D\Q[>)HYE:VMW; EM[8PPRHJQ/&T2*@_)#_ ()L^%K/
MP-\=?&6E:?'Y-E8V^M6UM%N9]D,.K6L<:;G+.VU5 W,68XR23DU^Q_[6?[/U
MO^TUX.U'PY*(Q<RQ^;832;0(+R++0/O,<K1H6_=3M&ID-O),BD%Z^ /^"/7Q
M5MW\/ZEX%O+6.PUO1+R:6:$Q+!<3QS/M=YT9_.DN+>53;SLT:"&'[%"26KZO
M_;M\_P ;Z'8^!-/^SG4/%VH1:>#+]GD:WLX@;N^ODMI^)_L\4/&QHI(Y987B
ME2X$(;W]_AI_PK[PE/X>\$I;Z5+;Z?<0:3E<PV]PT;^3+)N64O\ O6$LSNLK
MRL7=Q*[-N^(/^">'P.G_ &+O U_<^.!I^CW=UJ#3W$\MQ;CRK<+%;VT5S=!O
M*_UOFO$@ED1?M( *RR2(/SP_9[U;P_IW[39B\#2QQ^'KF2]B"63NMK*!I<DM
MPB#(5[<7D;21*F;<&.)X!Y2PD?H?_P %1_A/X>_X5QXA\0_V5I_]M?\ $N_X
MF/V2'[9_Q^VD/_'QL\W_ %7[K[W^K^3[O%9__!,OX(>%=:^&OAW7+K1-+FU9
M9+R47\EC;O="2'4;D1.)VC,H>,(@C;=E J[2-HQ\ ?\ !9KX-Z)\/M4T;6M.
M@D34=;DU.349Y+FXG:9H!9B$ 3RR+&D:R,D<<01$3;&%"(BK_2=7\\.H^$].
M_P""?GQ^M=0N;2W3PSX@\W[)<R0HL>G_ &TA)?)D86UO;?9I\+)L,GD:3.%;
M<\N*_H.U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!7PA^P
ME\*HI+.^^(^HV%O;:[XPN)=1 1(MUKIMPP>TM1)#B-]Z!+J>81PS7$LBFY5I
MX=P_/#X\_M/^&/BE\99-)\=:I&G@7PK)(8;$V5U+!>ZG"B12+=1Q*SR/%.\P
M5W1[5H;8PK&4NYI)O8/VSOVO/@I^T?X.U+3FU2.YU:.SG?2I?[,NQ<1W2[9H
MXXIY[(B%)Y(8HK@AHP\)92Z\.O0?\$;OCSJGQ*\-:EX=U.22X70)+46<\D@9
MEM;I91':@; VR!K=S&S.Y"2K"HCB@13^QU9^K:3;Z_;RV=Y%'/;3QO%-#*BO
M')&ZE71T8%61E)5E8$,"000:_FA_;3_X)3ZS\,[BYUSP-#)J6B/)&5TV(2SZ
MA:F5F#*B!6:YMT;8%<,UPJ2#S(W6&6Z8_95_X*[^(/AP\6G>.!)K6DI&RBZC
M1/[2B*QHL0+,\45RF4/F&8BX9I6F:YDV")_Z+O\ A:6C_P#"/?\ "5_:/^)+
M_9_]I?:?+D_X\_)^T>;Y6SS?]5\^S9YG\.S=Q7X(_L;_ +9'@R_\0:K\0_BC
MK$8\43R"UTN V%[+'IUBJ$M]D,*3Q1I(96A"D"X41S.TLAO)V?C_ /@I-^T#
M\,_C#%IGB+P+J/\ Q5EIJ"M+<6MG<64TD/E#;/+<26T,DDMN]O;I;$2[HE>3
M:I&&3]7_ (6_MB^7\%[?XDZ\FZX@T^3STW8^U7D$[V*<PP;8?M=PB'Y8C';^
M=@YCC+GR_P#X)F_"^W\8^'Q\3/$'EZKXJUZ\N[AM2N(5-Q;1PO+8K! Q++$F
MV.4_Z.L \F5+8H8H(L<_^VM_P3KUG]HCQKIGBSPUJ5GI$D<=O'?3;)8KI)+:
M8M'>PO ,SW"QLJ()'MR@MH5$^UAY.!_P6OTFWF\"Z5>-%&;F+7(HHYBBF1(Y
M;2Z:1%?&Y4=HHF=00&,<9()1<?H=^R=_R3SPI_V+^D_^D4-?CC^W=I-OIW[1
M/@F6"*..2YD\/RSNB*K2R#598@\A !=Q'''&&;)"1HF=JJ!^G_[>GP;T3XJ^
M!=8NM8@DN)-'TO4[ZQ N;B*..ZBM)&CF:**5(IG0K\GG+($#2* %DD#?G!_P
M2)_9U\-?$WPKJ&M:_91ZK)%JEQ:6]K?*MS9VZFWLY99H;:56B6XF/E)+.0SF
M."&-2B^8)/TOT[]@KX<:1H=UX;MM&\G2[ZXBN+N&.]O4:X>$$1+-,MP)I8HR
M2\<#NT"2DS+&)?GK\P/^"&/_ #-W_<'_ /;^O0/^"QGPG\/>%/!MKJ^GZ5I]
MIJ5WX@B^TWD%I#%<3>;;7LDGFS(@D?>X#ON8[G 8Y8 U]W_L=_!#PKHOA#PK
MKEKHFEPZLVAZ=*;^.QMTNC)-91B5S.L8E+R!W$C;LN&;<3N.?R _:E^#>B?!
M7X^^#+70X)(8[V\T6^NC+<W%U)-=3:Q*LLSRW4LTK.XC7=EL$@MC<S$_T7>+
M/%-GX&TZ[U74)/)LK&WFN;F7:S[(84,DC[4#.VU5)VJ&8XP 3@5_/C^QO^V1
MX,O_ !!JOQ#^*.L1CQ1/(+72X#87LL>G6*H2WV0PI/%&DAE:$*0+A1',[2R&
M\G9^/_X*3?M _#/XPQ:9XB\"ZC_Q5EIJ"M+<6MG<64TD/E#;/+<26T,DDMN]
MO;I;$2[HE>3:I&&3[O\ '_QU\0?&?]FNY\30))_:UWI9M[PQQI,TD<=X+'49
MRBQ*D:2P)<3R;$46J.Q5QY0D'8?\$]OVB_ WQ<\#:5X-5M/@U*#3_L5YHDH4
M?:,+,LTBQR11QW7VE(Y+NZ6(3>7YS"=BQ+O] ?L>_LZ?\,Q6OB#1H%VZ;/X@
MN+W3.<XLY[2SV1\RRR?N762VW2L))?)\XJ%D6OK^BBBBOY0OAW_PD/\ PT3J
M7_"*?V?_ &U_PD'B/[-_:7G?8^E]YOF_9_WO^J\S9L_Y:;,_+FOV^_XR%_ZI
M_P#^5FO/_P!AK_A.?^$Y\>_\+ _Y"O\ Q)O)\O=]C^Q[M2\C[!N_Y=/O;,_O
M/,\WS_\ 2_/K[?\ CI\"]#_:+T.?P_X@@\ZTF^9'7"S6\R@A)X'(.R5,G!P5
M92T;J\3R1M^&/[$OQ>U3_@GQXQO/AO\ $%H[#2;Z3S[>Z* VXNI-D45VMR=A
M^Q7$<7EN[JP@FCC$BVNR\(^__A3\%-+_ &R]9B^*WBS2XVM)K/['X?T>\A+A
M;!)9BM[J$<H,4MQ<&626WC0-;0V[Q2*]S,4GB^O_ -I3XO)\!?!VL>)6:-9+
M"SD>W$J221O=/^[M8W6+#E))WBC8@J%#%BZ*"Z_CC^PE^UW\./AM9WWBGQOK
MWG>.==N)7U"YET^]DF@MU8)#:I)##+"(B(EF"P") K0P%-MI$%^8/V[_ -H'
MP7/XMT7QM\*-1\C6H_M+7\MK9R6:B82"2.=UFMH?/EN//N$NC(9EFB1(Y%VE
MA)^EW[=W[;=QX(^%NCZCI+2:=K?B^SMI;412L9+.WD@BN+MTF\G:SHLL=LK#
MR)@9Q<1%6A('W?\ LX?LX:'^S/H=MI&D6UNMPMO#'>WL<(CFOIHPQ::9BSR'
M+O*\<;R.L"N8HR(P!7PA\!?^"=>L_ _XLWGC.SU*SM_#DDE_)#86J2PR/'>
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M^"XOA:\N].\,:JD>;*VN-0MII=RC;-=);R0IM)WG<MM.=R@JNS#%2R!OU^^
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M28>5Z!_P5'_Y)#XA_P"X=_Z<K2C_ ()<?\DA\/?]Q'_TY7=? '_!<[_F4?\
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M";.79"'=H8[.)DCMQ!'&K,C0C]'_ (T?LP:I\4OAA?>!Y=9DO=6NHQ(^J7J
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M;ZK!;VUZ=WFPVUP]U"N&(79-)!;.^5VLV8DVL2HW!0[?AC^V#_P2KU2'6?\
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MSIIUTEYJ=QKNM:C<"?4-7NU_TBX\M%AMXBS/++Y4,2A8TDEEVN\K*463RU^
M/V^O^"7O_"Z+R7Q3X)%O;:O+YDFH6,C>5#>N%9A-"P!2*[D8!) ^R"=G$SR0
MR+,]QY_\-/AA^U'XPV:'J^L_V+I?V=8);Z=]-N+@0_+$WE2VBRWCW?ELTB2O
M+"S.A9KN.4JY_4_0_A5>_L^>#K7PU\/K:SEDLHWBMSJUY/'&K2>9(]S*T%O,
M\SM._F/ @MD8.ZQR0*J)7P?^P-^QE\0_V-=1OOM+>'[_ $W5OLBW7EWM['<0
M_9W?$L.ZQ,<F$FFS"_E^8_E_OX55M_Z_U^,/[+7@'XV_L9Z';:.-!T_Q-IMQ
MYURMI%K"VUWILTH@8P/+=?Z-Y6?.8Q6J3*;AII?M 5E\WV_P1^S-X@^.'Q!L
M_B;X^L+/26TNSCM]*T**=+^1)(WG(GOKC9Y#.CRM<6WV894M;LSQ2VSB?]+Z
MX_XA>"K?XE:-J&AWC2);:E9W%G,\142+'<1-$Y0LK*'"L2I96 .,J1P?PQ^
M?[-OQY_8RUR^TCPG!I^J:!=W"*+B^GC6Q^8H!?&V6ZCO()4C^2X2)9-X4J%N
MO*MI!H?M5?L/_$]/&N@^,_#\\GBZ^LH[&:>:^FL[54O+"82!$M0UG%#92':Z
M0P/)('-RTDN]UED^_P#QU\(OB-K/@K4]#2]TO4M;\11W@U*YO;BYM['3ENH8
MK<VNF6T-K,[V\<(=(VFDB<W&;R43-/+"OG__  3\_9H\=?LD65QH&L#0[O2;
MJ\>\-Q:WEV+J&1H%B8>5)9+%,C&& */,@,0\URTV4C7R_P#;Y_8R^(?[96HV
M/V9O#]AIND_:UM?,O;V2XF^T.F99MMB(X\I##B%/,\M_,_?S*R[/TO\ !5EK
M/B?1FL_&=EI?VF6,P74-G-+=V=S&\2K*2EU;PLB2,9%-NXG"Q[09Y2S8_$&R
M_8?^,'[%GB6:_P#A;/'JNDW<@W02S6R,]O$R21Q7\-RT$3/EI(DN+1Q-L$S*
MUGY_EUZA^U3^RI\8?VK_  ]I<FNRZ>FI?VA:JNC:?*8=.LK>6&8W%]?23R2R
M7%W&[10;+9ITAA64VZSM<R$?H_\ LG?!OQ'\$/#UOI7B37/[8E@M[6"WBCM8
M+>WLH;>%8Q!"R1K-<8((-Q<$-(B1D0POYAD^GZ**********************
M************************************************************
M*************************************\?^/>C>*/$'AR\MO!=[;Z?K
M[^3]DNKE0T,>V>-I=X:&X!W1"1%S$_S,#\OWE_.#_A3?[4/_ $.?A_\ \!XO
M_E-1_P *;_:A_P"AS\/_ /@/%_\ *:C_ (4W^U#_ -#GX?\ _ >+_P"4U'_"
MF_VH?^AS\/\ _@/%_P#*:C_A3?[4/_0Y^'__  'B_P#E-1_PIO\ :A_Z'/P_
M_P" \7_RFH_X4W^U#_T.?A__ ,!XO_E-1_PIO]J'_H<_#_\ X#Q?_*:C_A3?
M[4/_ $.?A_\ \!XO_E-1_P *;_:A_P"AS\/_ /@/%_\ *:OD#XU^ /VD/@MX
MAC\7>?\ VSJ4FGKI?V_1[*WO-ENTTES]G>T^Q)(,.GF-<?9R@WQQ_:-S>6/D
M#_AZ/\7O^AA_\IVF_P#R)7V?X3\+?M,_M;Z7?:3JEY)I6DW$;PW#:I:0:6TP
M!C+0*MO9B^*2*^&8(MO*BS0O(?FB;Z@TGX"_M,Z!;Q6=GXM\-P6T$:10PQ6D
M"1QQHH5$1%T4*J*H"JJ@!0   !5__A3?[4/_ $.?A_\ \!XO_E-1_P *;_:A
M_P"AS\/_ /@/%_\ *:C_ (4W^U#_ -#GX?\ _ >+_P"4U'_"F_VH?^AS\/\
M_@/%_P#*:OD#XU^ /VD/@MXAC\7>?_;.I2:>NE_;]'LK>\V6[327/V=[3[$D
M@PZ>8UQ]G*#?'']HW-Y8^0/^'H_Q>_Z&'_RG:;_\B5]G^$_"W[3/[6^EWVDZ
MI>2:5I-Q&\-PVJ6D&EM, 8RT"K;V8OBDBOAF"+;RHLT+R'YHF^H-)^ O[3.@
M6\5G9^+?#<%M!&D4,,5I D<<:*%1$1=%"JBJ JJH 4    5?_P"%-_M0_P#0
MY^'_ /P'B_\ E-1_PIO]J'_H<_#_ /X#Q?\ RFH_X4W^U#_T.?A__P !XO\
MY34?\*;_ &H?^AS\/_\ @/%_\IJ/^%-_M0_]#GX?_P# >+_Y34?\*;_:A_Z'
M/P__ . \7_RFH_X4W^U#_P!#GX?_ / >+_Y34?\ "F_VH?\ H<_#_P#X#Q?_
M "FH_P"%-_M0_P#0Y^'_ /P'B_\ E-1_PIO]J'_H<_#_ /X#Q?\ RFH_X4W^
MU#_T.?A__P !XO\ Y34?\*;_ &H?^AS\/_\ @/%_\IJ/^%-_M0_]#GX?_P#
M>+_Y34?\*;_:A_Z'/P__ . \7_RFH_X4W^U#_P!#GX?_ / >+_Y34?\ "F_V
MH?\ H<_#_P#X#Q?_ "FH_P"%-_M0_P#0Y^'_ /P'B_\ E-1_PIO]J'_H<_#_
M /X#Q?\ RFH_X4W^U#_T.?A__P !XO\ Y34?\*;_ &H?^AS\/_\ @/%_\IJ/
M^%-_M0_]#GX?_P# >+_Y34?\*;_:A_Z'/P__ . \7_RFH_X4W^U#_P!#GX?_
M / >+_Y34?\ "F_VH?\ H<_#_P#X#Q?_ "FH_P"%-_M0_P#0Y^'_ /P'B_\
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M_P# >+_Y34?\*;_:A_Z'/P__ . \7_RFH_X4W^U#_P!#GX?_ / >+_Y34?\
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M_P#X#Q?_ "FH_P"%-_M0_P#0Y^'_ /P'B_\ E-1_PIO]J'_H<_#_ /X#Q?\
MRFH_X4W^U#_T.?A__P !XO\ Y34?\*;_ &H?^AS\/_\ @/%_\IJ/^%-_M0_]
M#GX?_P# >+_Y34?\*;_:A_Z'/P__ . \7_RFH_X4W^U#_P!#GX?_ / >+_Y3
M4?\ "F_VH?\ H<_#_P#X#Q?_ "FH_P"%-_M0_P#0Y^'_ /P'B_\ E-1_PIO]
MJ'_H<_#_ /X#Q?\ RFH_X4W^U#_T.?A__P !XO\ Y34?\*;_ &H?^AS\/_\
M@/%_\IJ/^%-_M0_]#GX?_P# >+_Y34?\*;_:A_Z'/P__ . \7_RFH_X4W^U#
M_P!#GX?_ / >+_Y34?\ "F_VH?\ H<_#_P#X#Q?_ "FH_P"%-_M0_P#0Y^'_
M /P'B_\ E-1_PIO]J'_H<_#_ /X#Q?\ RFH_X4W^U#_T.?A__P !XO\ Y34?
M\*;_ &H?^AS\/_\ @/%_\IJ/^%-_M0_]#GX?_P# >+_Y34?\*;_:A_Z'/P__
M . \7_RFH_X4W^U#_P!#GX?_ / >+_Y34?\ "F_VH?\ H<_#_P#X#Q?_ "FH
M_P"%-_M0_P#0Y^'_ /P'B_\ E-1_PIO]J'_H<_#_ /X#Q?\ RFH_X4W^U#_T
M.?A__P !XO\ Y34?\*;_ &H?^AS\/_\ @/%_\IJ/^%-_M0_]#GX?_P# >+_Y
M34?\*;_:A_Z'/P__ . \7_RFH_X4W^U#_P!#GX?_ / >+_Y34?\ "F_VH?\
MH<_#_P#X#Q?_ "FH_P"%-_M0_P#0Y^'_ /P'B_\ E-1_PIO]J'_H<_#_ /X#
MQ?\ RFH_X4W^U#_T.?A__P !XO\ Y34?\*;_ &H?^AS\/_\ @/%_\IJ/^%-_
MM0_]#GX?_P# >+_Y34?\*;_:A_Z'/P__ . \7_RFH_X4W^U#_P!#GX?_ / >
M+_Y34?\ "F_VH?\ H<_#_P#X#Q?_ "FH_P"%-_M0_P#0Y^'_ /P'B_\ E-1_
MPIO]J'_H<_#_ /X#Q?\ RFH_X4W^U#_T.?A__P !XO\ Y35^I_P]LM4T[1M/
M@UR:.YU:.SMTOYX@!'+=+$HGD0!(P$:0,R@)& "/D7[H["BBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBOG_ /:%_:=\+_LOZ<FH>);OR?.\T6MM&AEN
M+IXD+E(8U_X"IDD,<$;R1K)+'YBD\A^R!^U3;_M=Z-?:Y9V,EC;6NJ3V,*2R
MK))+''%#*DSA5"Q.RS -$K2A"IQ-(#FO#_B+_P %&-.^'OQ0M?AL^DW$OG7%
MC:3:@)T7R[B_1&A"6Y4^9$/.@$DC2Q.N92L3^6GG?H_11111111111111111
M111117R!XR_:UBN-1U#P_P""-+N/%>OZ9Q?6]M-%:6=HV^-?+N=0N2L*RL&E
MV0P"XE\RWFCD2+RY&3Y__9K_ ."H.A_&G7/^$6U_3;CPWKK7$EO#!<RB2%YD
M*H+9Y6C@DBNV?S$6"2%5+((Q*9Y$A/Z?T5Q_C_Q_I?PLTNYUK6KF.STZSC,D
M\\A.U5R    69V8A(XT#/([+&BL[*I^,/V=?^"@^A_M0^,KSPQX>L[@V5GI\
MUW_:4["+SFBN8H-L5MM9_*=94E265XI>J/;(1FOO^BBBBBBOC#]H?]OOP'^S
M/<3:=K%[)/JT,<4C:=9PM-<;96 4%SLMXWV'SC'--&_D[7"MYD0?C_\ AX;H
M^C?O]>\->,-!TU?]?J>I:')'9P9X3S7ADFD'F.4B3;&V9'0'"DL/</AQ^UGX
M.^,.LP:'X=U&/4KF;2WU1GM_FCAMQ+#$J3DD-%<,TP/V=E\Z,(_G+"3$)/H^
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBL_5M6M] MY;R\EC@MH(WEFFE=4CCC1
M2SN[L0JHJ@LS,0% )) %?GA\/O\ @IAX7^,GCO3?!?ABWN+Z*]^T^;JD@-M"
MGDVC72^3#(GG2Y*/%)YJVWELH9/.0@U^C]%%%%<?\0O&MO\ #71M0UR\61[;
M3;.XO)DB"F1H[>)I7"!F52Y52%#,H)QE@.1\@?L.?MQV_P"VA;ZHRZ7)I=SI
M<EN)(S<+<QO'<K)Y;+)Y<+;]T,H=#'A1Y;"1R[+']WT44444444444444444
M45\(>*/VV7\0V]]/\.= O/&4>ER%+ZYMIH[2S5D64R16TTJO+?7"A(W$=E#.
MCQSQ,LQ:2-).?_8^_P""COAK]K"X_L@P2:1KOEM(ME/(LD<ZJSEA:S@(9G2-
M5DEC>.%P&<HLL<,LJ_H?111111117PA^U5_P4,\'?LL/+IUT\FHZZD:L-,M1
M\R&2-WB-S.W[J!&*IN&9+A4ECF6VDC8$_5_PG\=?\+0\/:5KWD_9_P"T]/M+
MWR-_F>5]IA2;R]^U-^W?MW;5W8SM&<#T"BBBBBN/\?\ C_2_A9I=SK6M7,=G
MIUG&9)YY"=JKD    LSLQ"1QH&>1V6-%9V53^>'QK_X*':Q\-M'C\5Z7X+U"
M_P#"<VT1ZO<7<=EYF^21(IEM!%<W,=I,%C>"XN4M_,\Z-?+4R1&7Z@_9]_;
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M;3)W2?9+9XRD7F, QW;_ "A^Z@\B%FB;[?HHHHHHHHHHHHHHHHHHHHK\ ?\
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M8\T1_B'\,+F\\/WVF26D=W#'>S/!-;27 4Y283/,[3O:^9!-)]D>&)MT+/\
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M\4WFA>%]4DMFT:6[MX-::WCN(1!!;PB=9)TMQ=0FR@B>2,0H!,^X%YI?T/\
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M*'N$ M)8'E$LC13.%M9X=SP6]T'9)PL5PT_K_P#P5'^ 7_%(>(?%W]O>(/\
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MM0\_3K;SX;R;_1;?RU\KR]OE0_,VR%F3G.:^O_V3OV0_^*>\*>(?^$M\8?\
M(/TF^_L[^V/^)=_J89OLOV?R?^/3_EEY.[_4_)N[UXA_P5_F\8^$-!CU.U\1
M26^A7EY#IYT>UMOL[.);6Z:5[F]68RW".%>-K;9';E#'NC:2,R2?I=^R=_R3
MSPI_V+^D_P#I%#7PAXQ\0:I^WOX\UKP+9:C>:5X*\-1O!J]QITHANM1OIE>W
M-I(TJAEMU872%!%/;RBVD:1G\^T:#R#]MK_@G[:_!K1K/Q+\(]-U2SUVRO-D
MPTR\NY;@VMQ$\;R(K2R7!=7,<>+8@^3-,TJ/&N^+]3OV6-?\4>*?!>D7GC2W
M^S:_+;DW<9C$3<2.(GDB4D12R1".2:,!/+E=T\J';Y2?GC\&=0N/^"H>J:IK
M&N_;+7X>Z;)]AL=$CN6@74;@A9GFU)K>996>$?9YDB'[F-WB6*9C#=-=>'_M
MB?!B7_@FW/IOCKX9W=QI]E=:@EMJ&DS74L]G,RV[M;H86&^6(JEX96GG>6*2
M9&MC"?FC^W_C!\4M<_:$^$O_  FO@S6_[ B_L>^O[Q([0W%Q(UO;RB:RANI&
M@-OY<L<T9NXH3*SI'-"\:*1+\ ?\$Z_@AKG[5?@W6(-8\0ZA9:!/K%X]TFGS
MF/4=1OKFVMA<F^NIDE#VGE,!Y&UC<S3RR3-^YA#?3]A\%;S_ ()<?"_Q7JFG
MZO<:O>S>0UMNC6VM[2:9X[..>*W<W2&56F$LQ8E;E((("J!"[:'[-?[&?@']
MH7P=H_C&\DU2_P#$=]9QRS>('U._74(M0A_=.\3-(J![.:,Q6S-$Z;+>(DSC
MYW]P_P""??@G7/AO8>*=(\1WEQJ.I6GBBXC>]N93+-<P_P!GZ<;69V,LS#S+
M<PNL;2.T2D1,0R$#[_KQ_P"/WQCL_P!G_P +ZGXGOEWQ:?;F18LLOG3,1'!#
MN1)"GFRO'%YA1ECW[V&Q6(_.#]F7X,2_M\^'(O&?Q1N[C5+>^N+HZ=HMO=2V
MFF6L,,[Q1R&WMQ#(;N-Q=1)-)-.S6DD:R.\@^3Q#]K?X)Z]_P3Q>T\:_#&_O
M+7PXEY']OT%YKJXL8YY(_*\Z5&=E>WG5%AD>=EFAN&A\F;,D(MOT_P##_CS5
M/VK_  'IVM^#-6CT"YU..*5[I[$:@UNT;,EU;1QSM;(SI,C0&=T='17:./,D
M<L?XH?\ !,WPYXM_:6O/$Z3^)-0LK2?^RY-7U""XD.M7#1+=)90P7DOF>3$,
M,UQ(0TK)##;(!%+,5_4_]C?_ ()^V_['FLZKJ=GK=Y?6U_&(8;)XUACCC64R
M(]QM=EN;A%Q'',J6X0/<8BQ/B/\ 0^O@#_@H/^U7J/[-VAV=EX=B^T>)M>N&
MM-,C$3S,F HDGCB6-TFE1I(8X8'(WRS(^R9(I(F\O\%?\$KO#&MZ,S>/9[S7
MO%5Y&3>:RU_=>9%(8EC1;?>^V1+=541/=1RF0KN>-8BMM%^>'P$\'ZY\/_VF
M;/2O$>H_VOJ5IYT3Z@00UQ"NA2"U>0'YO-^S^2)BQD8RARTTS$S/^E__  4[
MF\8^%_!EYK_A_P 12:18V$=L)[2UMMEU=23WL$0;^T!,);=$#*52"-2X\U))
M)$E58NP_X)<?\DA\/?\ <1_].5W7YH?\%B9O&/A"XL(KWQ%)<Z)K,E\8=(M[
M;[';V\=JUFR+.RS2-?.69)-\^!',KO#'$LGEI]?_ !O_ ."9NJ?M-V]OJ/B?
MQ;>?\)"9&EF1(A/H]JLBX>VTZR9H9844) GGO,SW'DF:6/S9?W?0?M2?&+Q!
MX:U3PY\%O!]Q>+K.L6=NMSX@N9$ENH-/02137",7B,MZ8[:>>:7,3@+^XS<S
M(]OH?$O_ ()9>$-9TY[K07U"S\60[KJVUM]3N6N)]11&:.>\D?SE'F7!6>>2
MVBBF#C,1090^?_\ !*S]M?4?C[9W/A3Q'-]HU?2K=)K:[;>TUW9AA$YG;:4,
ML#-"AE9Q)<+*K,C21332>@?M!?%77/CO\1;;X2>%[^XTJTMK=-1\2:K9.8KZ
M&%=LD=K;N_E^7O\ ,M=\T!G8FZ0,OE074,WD'[37_!,CPY\/_!<NI?#[3]07
MQ9I'V6YM+FWO9VN[AK>1/-<HS^7YNS?<(MHD,IN(XUA !\E_;_V5?"?CSX]?
M#*+3/'E]KF@:BEXT<-Y:NMEJUQ8VX3RC<R31RS1N9=ZM)M@N)XH8W=I$FE>X
M_*']BW]FRWU_XN>*/"=GK.N:3;:3'JL4-WIEZMK>21VNHP6Z)-*L15D92'D5
M40-(B, H7;7[/?M _%E/V ?AN;A;N\UJ^BD^RZ?+J]Q)<W%S=7,DDP^TSQQJ
M62&/S7"GR@T,"VXE1V1Z\?\ @I^QS8?M.^&M+\5?%.YO/$FK:G9PWD<3WLT%
MC91W"AXQ9VUF+-(7D@^S?:QAP]Q$65CDN_R!^T!;>*O^"6GB73=8\,7MY?\
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M"&  :3*L2I7Z_P!6TFXT#X!2V=Y%)!<P> WBFAE1DDCD31RKHZ, RNK JRL
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M_DD/A[_N(_\ IRNZ^ /V^O\ DX7P%_W /_3S<5^_U?@#_P $,?\ F;O^X/\
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MU!X7M/$NGIY/G;X[FU,J2O:W$1VR0N4/TDC++&\D$D4ICC\P*/R!_P""&/\
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M=G/"GV?_ %$L43;I8KKIND&WYL*8\_I__P .N/A#_P!"]_Y4=2_^2Z[#XF>
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M)-QVHN/W^K\ ?^;O/\_]"Y7W_P#\%1_^20^(?^X=_P"G*TH_X)<?\DA\/?\
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M1QQHH5$1% 5450%55 "@   "M"OG_P#:Q_Y)YXK_ .Q?U;_TBFKX _X(J?\
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MN_91T/\ :UT,Z5JH\F[AWOI^H(@::TF8 $@$C?$^%$\!(650I#)*D,T7Y(?
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M*T0ZCX,N8[K2Y;R]D=D,H9;JXN)+FZ$D<X$T3M+,THC=4 21&C40M'G\$?\
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M>$_*'_!#'_F;O^X/_P"W]'_!<[_F4?\ N,?^V%?O]7X _L"_\G"^/?\ N/\
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M=R22-#^YU#4!!>":;S%$<2Q6B$.OEM'ND8R?=V?O]7X0_P#!;WX:?:=.\/\
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M1%)"\,)EC+%WM7C?'D+GX0UX:Y_P2M^*MQJL>F>9H5[]O6Q@2<B&[TV9]\4
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M%?BJWM+6X\-6:1V4?EQ&W::UD9=J+F>6WEBEN7P@_>7#2ODNV[=(Y;V_X.?
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M7@WP->1ZAI7A_1[&]AW>5<VVG6T,R;U*-LDCC5UW*S*V",JQ4\$BL_5OV9/
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MAB23Q3^SUX-\<WDFH:KX?T>^O9MOFW-SIUM-,^Q0B[Y)(V=MJJJKDG"J%'
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M'[#'BK]F#Q5KNN:YKL>HVVHQO&B1O<-)=R-<>:+V]$N%6X50P #71S=3_OP
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M7GB'Q1=V;7T5A \=M;Q6J2^69KJ]G_=0(Q618L+(6F1(F$9FA9_#[K]O?4_
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M,OV^O&_PHTNV\1>*/AS>:?H4LEL)[I-7@GGMX[@C#26@MTEC?!VA+DVX\XI
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M3_A*)(X9&-W%(;P+'<3+J(EED4NCF>2U\^.1E>20*Q5C$Q3[?_X*V:9I=_\
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M.OVB?%\FIVT=TVFWFNWUF) 2L5U'JL<<<P7.UG197,>X,$?;*H$L:.OZ/_\
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MMYO NE7C11FYBUR**.8HID2.6TNFD17QN5':*)G4$!C'&2"47'V_\$/&MO\
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M/K^H^*_#VE:AJ]O]DU*[T^TGO+;RWB\FXEA1YHO+D)D38Y9=CDNN-K$L":]
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M0>1U13)-;:?%$@+$ O)(Z1QKU=V5%!9@#X?^WU_R<+X"_P"X!_Z>;BOW^K\
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M,'PA?PAX.U#Q+.LB2:Y>!(07C:-[6PWQI(JKET<SR7<;B0Y(BC9453OD\/\
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M-_%7P;\-[9?,\C=+?RV]S$)HH;QTDN4*R*5BEAM+,W2!][2K-'MA/R"7]/\
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M#7Q+H?AW4Y([=M?COA9SR2%5:ZM6M!':@;"N^=;AS&S.@+Q+"HDEG11^:/\
MP4#_ .";OA?5_#VH>*_"UM;Z+J6F6\U[<PPJ8[.ZM[>$-)&($S';RJD1>)H4
M1))"ZS*6E$\/M_\ P29\:ZSXS^&5LNKK)Y=C>7%GI\T@EW36<8C9"'D9A(D4
MCRVL9CVQQI;K %#1-GXP_8%_Y.%\>_\ <?\ _3S;U^]UEJUOJ+S102QR26T@
MBG1'5FBD,:2A) "2CF.2.0*V"4D1\;64G0K^9'Q!X\N/V#?VAM1U&^>0Z3JE
MY++>2O T:R:?JSK<2/'\D[R):3GEH!OG>S>$&/>Z+_1]IGQ"T;6M+.N6NH6<
MVDK'+*;^.XB>U$<)82N9U8Q!(RCB1MV$*MN(VG'R!X*\2:I^V'9>.($N(X/"
MM['/H.A7"PAVD9()[>_U%65MEU;R33*EL\4P1TMBI2"42M)^<'_!'OQR_P +
M/$OB3X>ZW));ZBT@>"T>>-H%NK!I8;Z.,"4JUPRF-B8%<20VKNS[(4S^_P!J
MVK6^@6\MY>2QP6T$;RS32NJ1QQHI9W=V(545069F("@$D@"OQ!_X)/\ AM_B
MIXJ\9?$^:WDM8]1O+BWM8Q-')&&O+C[?=Q-\JRL\(^QA)=L2.)),*S9$7'_\
MW>?Y_P"A<K]_J_ '_@AC_P S=_W!_P#V_KV#_@LK\=-<^&VAZ3X?TJ?[-::]
M]O74'3(FDAMA;@0!P?EBD\]O/ &Z156,L(FFCE_1[X%_#?PE^SIX2@MO#[V\
M.A0V_P!L>_::-EN%:,2/?3W(Q&^] ',V1$L054"0)&B_CC_P1'U:WT"W\:7E
MY+'!;01Z5+--*ZI''&BZ@SN[L0JHJ@LS,0% )) %:'_!<[_F4?\ N,?^V%?O
M]7A_CWX\Z7\-?$NA^'=3DCMVU^.^%G/)(55KJU:T$=J!L*[YUN',;,Z O$L*
MB26=%'YH_P#!0/\ X)N^%]7\/:AXK\+6UOHNI:9;S7MS#"ICL[JWMX0TD8@3
M,=O*J1%XFA1$DD+K,I:43P^W_P#!)GQKK/C/X96RZNLGEV-Y<6>GS2"7=-9Q
MB-D(>1F$B12/+:QF/;'&ENL 4-$V?TOHKS_XL>!?^%H>'M5T'SOL_P#:>GW=
MEY^SS/*^TPO#YFS<F_;OW;=R[L8W#.1_/#_P2V_:TL_V;=1U3P7XQF_LNRN+
M@20M=(T?V;4E=+6:&<"$O%YBA#))</'#:_9#N"F5V']%WC_Q_I?PLTNYUK6K
MF.STZSC,D\\A.U5R    69V8A(XT#/([+&BL[*I_/#X_:CKG[3W[/^IZK?6M
MOIM[?:>=66V\TR(EC;78OX!YB!]\LEE#&<D1AIWPR6X+)'Q__!(+X\Z7XS\$
M1^$A)'%JVB27):W,A,DUK<3M<+=*I11L62=H'5#(8RD;N4^T1*<#_@M?JUO#
MX%TJS:6,7,NN12QPEU$CQQ6ETLCJF=S(C2Q*[ $*9(P2"ZY^C_\ FWK_ +I_
M_P"X:OG#_@BAJUO-X%U6S66,W,6N2RR0AU,B1RVEJL;LF=RH[12JC$ ,8Y "
M2C8Y_P#X+7^/]+B\*Z5X>-S'_:TFJ17RV@),@M8[>ZA:9@ 0B&2143>5,A$F
MP-Y4NS]+OV3O^2>>%/\ L7])_P#2*&OR!_8%_P"3A?'O_<?_ /3S;U^OW[6/
M_)//%?\ V+^K?^D4U? '_!%3_DGFI?\ 8P7/_I%8U^K_ /Q+O'NG?\N]_IM_
M;_[$]O<V\Z?\"CEBD1O]I'1NZFOYDO"_Q-U3_@E'X\\3Z%Y$EWIU[9R'3C(H
M996"R2:3=2,8[=IDC9Y+6\6W>%-[7)0R/;QH?Z#?V6/@I_PSMX+TCPPTGG2V
M-N?M$@;>IN)I'GN/+;RXB8A++((=R*XB"!LON)^@**^<+'XF^&OC7K?B'P#J
MD%G<W.E26IFTZZ59UNK66WM;N.Z\F6/8R)-+Y3*/-,3Q12.4,\*U^$'_  4B
M_8?L/V37T_QGX,GDL+&2\@MQ:":8SVEXD;S13VMPS-+L80,[;W\R&8!HW9)
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MI/!_.#_@C5\7D\)/KGP]UAH[+41>?:[2TG22*ZDG6,PW\+!\+O@6W@;R-JS
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M\L<<ES)I\4".ZJTL@OK>4I&"07<1QR2%5R0D;OC:K$:'_!+C_DD/A[_N(_\
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M?@O]B;P]>RZ5!]CLH+<W6IWLGF3W$RVD)+S3, SMM57D$,*K$KO(8H$,C _
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M_B+<6.BK<32VMI<:':7S0+*V[8)9IO\ @3B)(8GE:240HTCY^L/@A^RSX?\
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M2C_A-/\ A)?%'_"0_:/M'V[[78[]^-NW;]@\ORMG[GR-OD>1^X\OR?DK[/\
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M'\3>"O$%QX39]SK!:6S-Y$T@9)C:RQ75L\$4BL1Y"Y5-TBHRPLD,?8?M ?\
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M(-;UQ+&"3S8-/M9;.*UBD\M8R^#9/+(^ Q5IY)3&9)5C,:2,E>O_  &^"(^
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M/C]X7_: LVOO#&IV^H1)CS5C)6:'<SHOG02!)H=YC<Q^:B>8JETW)AC\P?\
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M3DU7P]?V^H63[1YL#AMC,BR>7*OWXI0KH7AE"2Q[@'13Q7PA_P %%OVUM+^
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MSA_X)O?M=:-K6@Z]JOC'7M+L-6U/Q)>7C0W>H10,(Y+6S6,0I<S&46\80PP
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M%FG>!OACJVH:K=V]C90^()_-N;F9(84WVNGHN^20JB[F957)&68*.2!7W?\
M"']N+X>?'?5%T7P]K4=UJ+QO)' ]O=6[2+&,N(S<PQ+(X7+F-"S[%>3;LC=E
M^KZ^?_C7^U/X+_9V\M?$^KV]C+-M,=OB2:X*OYFV3[/ DLPB)B=?.*"(.NPO
MO(4GP4_:G\%_M$^8OAC5[>^EAW&2WQ)#<!4\O=)]GG2*8Q RHOG!#$7;8'W@
MJ/H"BO'_ !_\?O"_POU&PTC5]3M[?4M3N+>WL[/)DN)7N7:.%O)C#R)$SHR>
M>ZK KC:T@8@'@/C'^VA\/_@%>+I_B+6[>VO3G=;1I-=31X5''G1VL<SP;ED1
MH_.">8I+)N"L1Z_X6^*NA^--#C\36%_;RZ++;M<B]+A(5A0$R/(S[?*\O:PF
M638T+(ZR!&1@/ /"W[?'PS\:ZY'X<T_7[>;4IKAK:%!%<+#+,I("1W31"V?>
M1MA9)"L[%%B+LZ!OK^OG_P"-?[4_@O\ 9V\M?$^KV]C+-M,=OB2:X*OYFV3[
M/ DLPB)B=?.*"(.NPOO(4X'P<_;0^'_Q]O&T_P .ZW;W-Z,;;:1)K6:3*NY\
MF.ZCA>?:L;M)Y(?RU 9]H92?I^OG_P ._M5>!O%?]J-9:]I\EOHWV7^T+OSU
M6SA^V9^S_P"F-BV?>04_=R/MD'EMMD^6J'P0_:Z\$?M'7%Q9^%]6CO;FUC66
M6$PSV\@C9MN]4N(HFD0-A7:,,(R\8<J9$W?DA^P+_P G"^/?^X__ .GFWK]K
MO&OQO\*_#6X6SUS6]+TVY>,2I#>7UO;R-&690X2616*%E90P&"589R#@\%?&
M_P *_$JX:ST/6]+U*Y2,RO#9WUO<2+&&52Y2*1F"!F52Q& 649R1G/\ C'\?
MO"_[/]FM]XGU.WT^)\^4LA+33;61&\F",/--L,B&3RD?RU8.^U,L. ^#G[:'
MP_\ C[>-I_AW6[>YO1C;;2)-:S295W/DQW4<+S[5C=I/)#^6H#/M#*3U_P >
M?VBO#7[-NER:IXBO8X%$<CP6P93=7;(4!CM82RM*^Z2,,1A(@X>5XX@SC\X?
M^";W[76C:UH.O:KXQU[2[#5M3\27EXT-WJ$4#".2ULUC$*7,QE%O&$,, )8(
MD0C#'9Q^QU%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%9^K:3;Z
M_;RV=Y%'/;3QO%-#*BO')&ZE71T8%61E)5E8$,"000:_G1_;;^$_A[PI\=?!
M6D:?I6GVFFW?]A_:;."TABMYO-U:>.3S8401OO0!'W*=R *<J *_>[P5\$/"
MOPUN&O-#T32]-N7C,3S6=C;V\C1EE8H7BC5BA958J3@E5.,@8_)'XLZU/^V5
M\>;+P0[?:?"?A7%Y?VT<]O+;S7%O&'>2>-T*R8N)H--FMV\YXT%SM\DS7!3]
M?O%/PJT/QIH<GAF_L+>719;=;8V00)"L* "-(U3;Y7E[5,+1[&A9$:,HR*1^
M"/[)WC>X_84^,NH_#.[O))O#VHWBV]NC2-(L=Q=)%+IT[!8 3<21O#9W/EK#
M"7D$CNT5M$1S_P#P6:^#>B?#[5-&UK3H)$U'6Y-3DU&>2YN)VF: 68A $\LB
MQI&LC)''$$1$VQA0B(J_K_>_\$^OAOKFEPZ9J>C1W\D<AFFU&>20:E=W#EVE
MGN[^%HKB=Y'D>1U9_)W%=L:K'$J?FA_P6)_9>L]$T[2O%^@Z;;VT5KC3]2-M
M$R8A"1II[-'&GDI%"(WMO-;8P\RTMQO18EB_:[X*?%"W^-7AK2_$=KY:QZE9
MPW!CCF6=89'4>; 9%"AGADWPR?*I#HP9$8%1^"/[/_BG0_V6?VCM8TB"2WET
MW5KBXTR"2V41PVDU_+!=16R10"5?W-PJZ:R Q+&V9'\E8VB'[??M._&O_A0G
MA>[U>"/[3J3;+72K,+YCW>HW)\NU@2$21R39<AY(X6\XP)*R LN*Y#X0_L_7
M'P%^'*^&?#0L[#75TMP;I-SP/K$EMM:[D:2-WD3SPK R1MMA5(A"(T2)?F__
M ()X? Z?]B[P-?W/C@:?H]W=:@T]Q/+<6X\JW"Q6]M%<W0;RO];YKQ()9$7[
M2 "LLDB#\\/V>]6\/Z=^TV8O TL<?AZYDO8@ED[K:R@:7)+<(@R%>W%Y&TD2
MIFW!CB> >4L)'W__ ,%9/@WHGB;P#J/BB\@DEU;2H[2.QE-S<".!9[^WCF*V
MXE%N7D1RKR-&78+&"W[J/9P'_!.;]DSP=\1OAA9:EX@TZ/5KG5([V%GO?WQM
M+>*\NXE@L"0&LTW-+.S6Y29KB:24R9$0C^C_ (_:CH?_  3W^%^IR>$+6WTU
MES'81>:-[WUXXC$VZY$SW4L*YN/+D\PM!;>5E(8\Q\__ ,$W?V:[/X8>%[;Q
M9??Z9XF\2VZW]]J,LC3RF&[/VB*)9)%5UW*T<MUG<TMUN+2RI'!L_,#_ (+*
M_ O0_AMKFD^(-*@^S7>O?;VU!$P(9)K8VY$X0#Y99//;SR#MD95D*B5II)?Z
M7J*_$']OOXO_ /"HOC-X&U/Q!;^?X9L+<RH98,PQ7%Q-+#=7*.(9'EEM56RN
MA$N]T:*$H(GF$A^K_P!J+X9>&O\ @H/\/KBX\-3V>J7UM&T^D7<+*TD5T$CF
M:T<M)$8'N(RD,T-R4$)DBFEBWP1[?M_XA66J:CHVH0:'-';:M)9W"6$\H!CB
MNFB802."D@*+(59@4D! /R-]T_GA_P $\/@=/^Q=X&O[GQP-/T>[NM0:>XGE
MN+<>5;A8K>VBN;H-Y7^M\UXD$LB+]I !6621!^>'[/>K>']._:;,7@:6./P]
M<R7L02R=UM90-+DEN$09"O;B\C:2)4S;@QQ/ /*6$C]3_P#@J/\ \DA\0_\
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M]()#K<^J6MB]R]S<.HM1:W<GDQP/*T$2;XUD/E1H2Y=R2TDA;Z?_ &;OV(_
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MA>";@^9$/.:6,'#12@E&59)DE]@_X)<?\DA\/?\ <1_].5W7PA\#M3?]J/\
M:0UBY\1B.5?"D>HQZ7 D48B5=/OA:VYD#J[.ZM<R78DW!UNMCHR11I$OZ/\
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M')D'FJ!Y,AC5C'O:9Y?W>_:*^ VE_M)>&KWP[JD<96>-C;3O&7:TN@K"&ZC
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M*;>.]L_[+N-38QM%NFL6EU%P[B/][*;)($C?YE_U4+2((V\L_P""YW_,H_\
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MU^^WV\DDD;)B&]N88+$S3+&Q:)95NR$7S&BS(WECS1O]_P#^"U?_ "3S3?\
ML8+;_P!(KZOO_P#9._Y)YX4_[%_2?_2*&OR!_P";O/\ /_0N5]__ /!4?_DD
M/B'_ +AW_IRM*/\ @EQ_R2'P]_W$?_3E=U\ ?\%SO^91_P"XQ_[85^_U?E!_
MP4,_:NUSP?JVE?#+PB?L6N^)/LR'59'*+:PWEPUI&(60/(DK.C^9.%W6\0#0
MJ\[K);]!XE_8H\+_ +/?P\\4:@L/]I^))/#^L27FNWN9KR>XDLKKSIHS(TGV
M?S/.D5A$0\D959Y+AP9&\_\ ^"*G_)/-2_[&"Y_](K&OD#X!>.O^&<OVD]>L
MM<A\K^W=0U"RC??N\O\ M.ZCOK"3$2R[O.Q;Q[24\K[1OE9/*=*_H^KP_P"'
M7QOM_B=X@U_1K&WD-MH$EI;2ZAN5K>>\E222YMHBFY=]HHA6X!82)-*T;Q1A
M$>7\<?V!?^3A?'O_ ''_ /T\V]?N=X\U/2].L'361&]C=R06,D<L1FCE:_F2
MSCA>/:X9)9)DB;<-@#DN0@8C\8?VHO\ @CCI>IV]QJ?P^FDM+N.-G32+B0RV
M\[*L8$<%S*_FP.P65LW#3I),Z)OM8067L/\ @EM^UYXH^*&HZIX'\9R7%QJ6
MF6XFMY;B 1W$26SI:7-O=L2DCRJ[PE3+&T[.;DS3%A&H_9ZOYH?^")?A:\N_
M&6LZJD>;*VT<VTTNY1MFNKF"2%-I.\[EMISN4%5V88J60-_2]7S_ /M8_P#)
M//%?_8OZM_Z135\ ?\$5/^2>:E_V,%S_ .D5C1_P6K_Y)YIO_8P6W_I%?5]_
M_LG?\D\\*?\ 8OZ3_P"D4-?D#_S=Y_G_ *%ROT__ &W_ -J7_AD?PD^NQ6OV
MR]N+A+*RC8XA%Q+'+(LDY#*_E(L3L5C^>1@L0:(.9H_E_P#9'_8RL_B;IUE\
M0/B5-_PE6OZO;QWELMZ6FL[*TND>:.WCMGQ"V1<-(T;1_9[>0JEM$GE&>;Y@
M_8%_Y.%\>_\ <?\ _3S;U[__ ,%J_P#DGFF_]C!;?^D5]7W_ /LG?\D\\*?]
MB_I/_I%#7T!7R!^V_P#M2_\ #(_A)]=BM?ME[<7"65E&QQ"+B6.619)R&5_*
M18G8K'\\C!8@T0<S1_+_ .R/^QE9_$W3K+X@?$J;_A*M?U>WCO+9;TM-9V5I
M=(\T=O';/B%LBX:1HVC^SV\A5+:)/*,\WS!^P+_R<+X]_P"X_P#^GFWKW_\
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M](KZOJ#PGX6O/'/P*M-*T^/SKV^\#PVUM%N5-\TVDB.--SE47<S ;F*J,Y)
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M_50M(@C;R_?_ /@M7_R3S3?^Q@MO_2*^K[__ &3O^2>>%/\ L7])_P#2*&O
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M6;>MU*@41)C[O^&GBFS_ &L?B@GBK2Y/MOAGPKHZPZ?<E6C1M7U9%EN)+=U
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M]O[>]\2"W%O9V6G_ &A--TY1&\#& W$C2R^9$S.498HHYKBZ?RY7:.6/C_\
M@H'^S1XZ_:WLK?0-'&AVFDVMXEX+BZO+LW4TBP-$H\J.R:*%%,TX8>9.91Y3
MAH</&WTA^SAX7\9?#3PE;:%KEMH\E[I.GPVEC)9WUSY-U]GC:.(7 EL@]M\J
M0K))']JWL995BC 2$_ '_#&7Q3_X6O\ \+3W>%_M'VC=]@^VZAL^S_9?L/E>
M;]AW>;]G_P"6VW9Y_P"]\CR_W%??_P"U'\%-1_:4^'^H>&?,M[#4K^WMFSN>
M>WCN()HKGRO,\N*1HF>+RO.\I7"-YOD%AY1^ /V*/@M\;?!&CP^#=;33]%\,
MV]QNDG:59-4:VFD:>XM;&6PN"D7F,'1[B8QW-N+MI;>5GAB6+?\ V^?V,OB'
M^V5J-C]F;P_8:;I/VM;7S+V]DN)OM#IF6;;8B./*0PXA3S/+?S/W\RLNS]/_
M (:7/B&YTY/^$G@T^#4EVK)_9UQ-/;R81=TJ^?!!)%N??B$^=L0+F>1B=OYH
M?\%(OV'_ !!\=;W3_&?@R>3_ (2'3(X+<6@F2W9HXYWFBGM;AFC$5Q#)*SMO
M=0Z -&\<L02XT-)^$WQH_:6\):GI'CN]M_#['3YK2VM[ P+-J=PT:%)]2N8C
M>)%:%E*2P6*P/.LMPK(D*QQR^8?\$^?V8?BI\++=M U\1^'_  ]#JD6KRF":
M&;4-0G58E%D)8)YHH;(FWB:ZRB33)_HZLT4\QB]O_;V_X)S6?[5&W6]">WT_
MQ,GEI)-+N6WO85PH%R8T=UEB7_53JCL446\BLGDO;_*'PA^#O[3^M(OA_4]:
MDT;23&ZS7]W<6-[=".63$HAGA-Q?-<!9'> M-"$$81;F#;%C]?OV>/@A;_L^
M^'X=&BN)+ZY,DMS?ZA,JBXOKRX<R3W,Y&69V8[5,C2R+"D<;2R%-Y_)&]_9+
M^+GP"^+6I>+/ D.GZA9:W<7,DEQ=O$EO'#J-QYTL-U"9DNO]'D"2^9:;VD2.
M,@$O+:C[?_:!_9]\6_%?X6ZCX;N;FWOO$^KW%G+<RJ\D-C"QU"VD=(%E9VBM
M+6WC" (HEN!"UPT+WEQ()./\#?$+XX?"6RCT/4_!]GXGDLHX(8]7M-?BM5N8
MT@B7?,M^'N)+C>',\S+")')VQ;0))/0/V.OV1+CX%7NN>*/$,MG<^*/$5Y/<
M7;6:-]EM8Y)Y)C!:23*+@I([B2;>0&*0)L8P>=+Z!^W3XUM_ 'PR\3WETLCQ
MR:7<68$84MYE^/L41(9E&Q9)T:0YR$#%59@%/S?_ ,$H_P!G3_A2W@9-9NUQ
MJ7B/RKV3G.RS"M]AC^65XSE'>YW!8Y!]I\F1=T(Q^G]>?_%CP+_PM#P]JN@^
M=]G_ +3T^[LO/V>9Y7VF%X?,V;DW[=^[;N7=C&X9R/QA_8[_ &=/CS^SS_:7
MA2R71].T6ZN'E.JW1CN_*?Y+=[FPBAE$KRO$$FBBOXD@/D*KB!GD63Z?_;M_
M95\;_M.Z38^%M#.CVVBZ?<17"75_J-_/?3M%;F%!)FTEV[?-F$CR374MP?+E
M:2-O,1OJ#]G#POXR^&GA*VT+7+;1Y+W2=/AM+&2SOKGR;K[/&T<0N!+9![;Y
M4A622/[5O8RRK%& D)^ /^&,OBG_ ,+7_P"%I[O"_P!H^T;OL'VW4-GV?[+]
MA\KS?L.[S?L__+;;L\_][Y'E_N*^S_VR?V7[C]K[P4FB3SQZ=JT,D-]!L=IK
M47D<,D9ADD,4<KVY$TB"58XY%.R;R6VM;O\ &'['_P /_P!H#PM9VO@[6S;Z
M-H%MAAJTKVE_J4%O&T9%C9A9[B$[@&CC>[@E2VA9]K'RK:WKQ_X0_L5_%SX!
M?$K5[SP\;<Z?JOVRT_X2/49XKV6.TNI4N?M;0>;#-/J"F-%(EA-O)=;M^;=O
M.'W?^W1^R1JGQY^'-KX:T6[DN=1T>2UN8&OI \^H-:VTMN4FN#L47$JRF3SG
M 1Y@%?RDD:6/C_V-OA_\8;/3M)T?QN=/TO0M$V1I# Y;5+U+5 +.&6:SG-LE
MHA*;RI$]P+06\\<L%S.\OZ?U\@?MO_LM?\-<>$GT**Z^QWMO<)>V4C#,)N(H
MY8UCG 5G\IUE=2T?SQL5E"RA##)\0?L?_#_]H#PM9VO@[6S;Z-H%MAAJTKVE
M_J4%O&T9%C9A9[B$[@&CC>[@E2VA9]K'RK:WKQ_X0_L5_%SX!?$K5[SP\;<Z
M?JOVRT_X2/49XKV6.TNI4N?M;0>;#-/J"F-%(EA-O)=;M^;=O.'U?^VM^R1X
MZ_:,T'3/"&CSZ6-)TJ2WE&HZIJ%W+J5Y)!:FW5YQ'8F)')DG,S;IC.QCD!@^
M>-OL#]EKPEXJ^'7AJQT#Q1%I8DTJSMK.WN-.N;B59XX%,2F2*XMH3"ZQI$"5
MDF$KF1PL"[8ZZ_XZ? O0_P!HO0Y_#_B"#SK2;YD=<+-;S*"$G@<@[)4R<'!5
ME+1NKQ/)&WX(^&_V'_CO^R!K-V?A]/'=VUW'M>ZMYK)8Y8UE?RA/::BP5;A5
M&_*+,(A,\<=RX>4']+_V8OV9/&EYK%IXW^*VK?VEK]C;O%I-E 8X[?3UN8\7
M+RK;QPPR7;!V@<HLD01 WG7&+<VWZ/UGZMI-OK]O+9WD4<]M/&\4T,J*\<D;
MJ5='1@59&4E65@0P)!!!K\ ;+]A_XP?L6>)9K_X6SQZKI-W(-T$LULC/;Q,D
MD<5_#<M!$SY:2)+BT<3;!,RM9^?Y=>H?M4_LJ?&']J_P]I<FNRZ>FI?VA:JN
MC:?*8=.LK>6&8W%]?23R2R7%W&[10;+9ITAA64VZSM<R$?H_^R=\&_$?P0\/
M6^E>)-<_MB6"WM8+>*.U@M[>RAMX5C$$+)&LUQ@@@W%P0TB)&1#"_F&3\L/V
MP?\ @E7JD.L_\)5\+/+MY/,6X;2TG%I)!=+*A673I24BC3),WE/)"+<QGR&9
M7BMX>P\"_ W]H;]H'SM%^(6M?V1X;GV1Z@L0TS[9=6[;C)#;/81/LW;%BE,T
MD:>7,?W=T@D@;]/OBQ\+?^+>:KX4\/6__,OW>FZ=;>9_TY/;V\7FS/\ [B;Y
M7_VG?J:^(/@G'\;?V5M'M?"T_AO3_%UE9VZ+9WMIK:VCQ+YDQ,$[:@H>7RU,
M:0"*&**&!4C#2'(C]0_9W_95U1?&^J_%/QG%9P:[J<<<=EIELPN(].@\B&+,
MEQ(@+WHCC%O));[8<&X*M)'<B.'YP_:'_8R^*?QT\?:9X[B;PO8RZ/\ 8?L5
MHU[J%PO^ASM=+Y\@L83)NE=\^6L.(BJ#YU,K_K]X6N=1N[.-]5@M[:].[S8;
M:X>ZA7#$+LFD@MG?*[6;,2;6)4;@H=OP!T/]AOXA^)9;[4OACX\N)/#MYJ%Y
M*MW<:G>VK7EP)6BGG#67VA+O#1^2][(+=[J6&21(/LIMYIN@_P"&!?VA?^A]
M_P#*_K/_ ,CU]/\ ['?Q4^*'@SQ#J7PW\>1V^H:E::.^IZ3?272#SX()DL8T
MFGABED:*9QY@GGB^W1XD>:*9I$2/@/\ AC+XI_\ "U_^%I[O"_VC[1N^P?;=
M0V?9_LOV'RO-^P[O-^S_ /+;;L\_][Y'E_N*^_\ ]H_POXR^)?A*YT+0[;1X
M[W5M/FM+Z2\OKGR;7[1&L<HMQ%9%[GY7F6.23[+L812M%("\(^;_ /@GY^S1
MXZ_9(LKC0-8&AW>DW5X]X;BUO+L74,C0+$P\J2R6*9&,, 4>9 8AYKEILI&N
M?^WM_P $YK/]JC;K>A/;Z?XF3RTDFEW+;WL*X4"Y,:.ZRQ+_ *J=4=BBBWD5
MD\E[?XP^"_PJ_:F\(6]CX<L[J/2]+MHS%#->RZ3=1V\:*S(C.J7EVR#B*)56
M01@H@$<*?)^QW[-?[/MG^S?H?]E07-Q?W=Q<27NI:A<NS37M].%$]PX9GV;M
MBA4!8A5!=Y93)-)^2/QB_P""?GQ#^ ?C&X\8_!VXC$=Y))BRC>UMY+9;G>\T
M/DW"I8S62,J&!&^>,F$"%FMQ<GU#X]_!;XV_M3>!+R+Q(FGV-VODO9^'])E6
M-KN87<:L=2N+BXEM_*AA62>W@@F*R2O')*PEMXXC]7_L*_LS>+/V:-$CTOQ#
MK\=];0QRI:Z7:VT2VMJTEQ)-))]K>%+NY=]P*A_*2(O*FR8")X_N^OG#]KGX
M(7'[1W@C5O"]G<1VMS>QPF&656:,26\\5PBOM^94=HA&SJ',88N(Y"NQOSP_
M8H^"WQM\$:/#X-UM-/T7PS;W&Z2=I5DU1K::1I[BUL9;"X*1>8P='N)C'<VX
MNVEMY6>&)8OK_P#;H_8RL_VP]#C@6;[)K6G>=)IERQ;R0TH3S(9T7.8I?+C!
MD53+"R+(@=1)#-X?\(?B%\=_A+I:Z'K?@^/Q//92/##JZ:_96K7-NAVQ/(LP
M>61\ D32+#-(A3SHO/$LDGJ'P<_9#U9_&C?$OQ[?V][XD%N+>SLM/^T)ING*
M(W@8P&XD:67S(F9RC+%%'-<73^7*[1RQ_?\ 6?JTEQ#;RM9QQRW(C<PQRR-%
M&\@4[%>18Y6C0M@,ZQR%02PC<C:?QQ_X8R^*?_"U_P#A:>[PO]H^T;OL'VW4
M-GV?[+]A\KS?L.[S?L__ "VV[//_ 'OD>7^XK[__ &C_  OXR^)?A*YT+0[;
M1X[W5M/FM+Z2\OKGR;7[1&L<HMQ%9%[GY7F6.23[+L812M%("\(^;_\ @GY^
MS1XZ_9(LKC0-8&AW>DW5X]X;BUO+L74,C0+$P\J2R6*9&,, 4>9 8AYKEILI
M&N?^WM_P3FL_VJ-NMZ$]OI_B9/+22:7<MO>PKA0+DQH[K+$O^JG5'8HHMY%9
M/)>W^,/@O\*OVIO"%O8^'+.ZCTO2[:,Q0S7LNDW4=O&BLR(SJEY=L@XBB55D
M$8*(!'"GR?L=^S7^S[9_LWZ'_94%S<7]W<7$E[J6H7+LTU[?3A1/<.&9]F[8
MH5 6(507>64R32?DC\8O^"?GQ#^ ?C&X\8_!VXC$=Y))BRC>UMY+9;G>\T/D
MW"I8S62,J&!&^>,F$"%FMQ<GU#X]_!;XV_M3>!+R+Q(FGV-VODO9^'])E6-K
MN87<:L=2N+BXEM_*AA62>W@@F*R2O')*PEMXXC]7_L*_LS>+/V:-$CTOQ#K\
M=];0QRI:Z7:VT2VMJTEQ)-))]K>%+NY=]P*A_*2(O*FR8")X_A#XG?L=^,OB
M;XT\2:S\,?&MQ$LVH>7J[2W]S:K%>1QJXL$GLC*]S]D67:$DAACLXI(;1)9Y
MH[I8.?\ ^&!?VA?^A]_\K^L__(]>X?LP>,?BS^SGXWTOX?\ Q!GCUG2];CO1
MIFI&Z$\BR6<#7L[+,ZK=RI^\$#I>HI!\LP2"&(I+Z?\ M[?\$YK/]JC;K>A/
M;Z?XF3RTDFEW+;WL*X4"Y,:.ZRQ+_JIU1V**+>163R7M_C#X+_"K]J;PA;V/
MARSNH]+TNVC,4,U[+I-U';QHK,B,ZI>7;(.(HE59!&"B 1PI\G['?LU_L^V?
M[-^A_P!E07-Q?W=Q<27NI:A<NS37M].%$]PX9GV;MBA4!8A5!=Y93)-)] 5\
MX?M5?LSZ7^U?X:E\/:G)) PD6XL[J/):WND5TCE,>Y5E3;(Z21,0'1VVM'*$
MEC^#_P!GJ/XZ?LK:<_A:]\-V_B[3[/RETV]AUNVM/*AV M &NE$TL49(2(20
MQ-#M>-6DM_($?L&B?LJ>(?CQXMTKQY\2);>V;1_WFD^'=/EFDAM7$BW$,UW<
MM($ENXV(CN!:QI!.UM;-YCPJT#>@?MR_!WQE^T3X<N/"?AU-'ALK[[,UU>7]
MW<I,/)G$_E100VDJ#+10GSGE;*F6/R =DH/V&O@[XR_9V\.6_A/Q$FCS65C]
MI:UO+"[N7F/G3F?RI8)K2)#AI9CYR2KA1%'Y!.^4_;]%?G!^W;^PE+^TW+8^
M(O#M]_9GBS3/*2VN7EECA>&.4RH"\0>2"6%W>:">%2VXM&ZD&.2WS_ 'QA^.
M\6EVVF:GX'LY-6\L02:Q-K=E':B0DJEU<65MYDI105DN(K9P9"LGDI%N2-/4
M/V9/V0Y?A)KFK>-O$5__ &GXLUW/VF6+S4M+2&0QR/9VJRR2221(\:)%+,0P
MMX8(TB@ D$OA_P"WI^S!\1OVP+>TT>P;0].TFRO)[C$M_<RR73;?+MI75=,!
MMW2-IMT22S(3,06?RD<_0'[)G@KXC?"/1M.\-^*ET.]M+"/[/%?V=[<I<):Q
M1!;:(VKZ>D4SH56(R^="3#M9EDF1VFX_]N7X*^/OVEM#N/"N@?V/9:;/<6TD
MUU<WTYFN(8@)3"]LNFR+#BX$;K)'<,S+" 0%E>->?_8H^"OQ._9CT>'PQJ__
M  C^IZ1#<;K>6&^NH;BTAFD:2Y4*=-*7/S.TL2N\+!V=&G\MHQ#H?MH? +QK
M\6O$OA#6O!<UG:W/AZ34+J2>]GFA@+2-9!+9Q;!IW2=$F255"HT(EC>1#(BO
MQ_BSQ9\:/C?X>N_"EWX)T_2+C5=/FLKK5[C7();.+SH2D\BVEL)KD>8"Z0*'
MF\J1XVD:6-'+?7_[,7[/6G?LO^%[3PUI[^=Y.^2YNC$D3W5Q*=TDSA!](XPS
M2/'!'%$9)/+#'\D?VP?^"5>J0ZS_ ,)5\+/+MY/,6X;2TG%I)!=+*A673I24
MBC3),WE/)"+<QGR&97BMX>P\"_ W]H;]H'SM%^(6M?V1X;GV1Z@L0TS[9=6[
M;C)#;/81/LW;%BE,TD:>7,?W=T@D@;]7O%GP<L]7\&W?@O3V^PV4VCS:3;-A
MIOL\+VQM8SAW#R^6I!PSAGV\ODEJ_(']CO\ 9T^//[//]I>%+)='T[1;JX>4
MZK=&.[\I_DMWN;"*&42O*\02:**_B2 ^0JN(&>19/W.TG3$T6WBM8C(T<,:1
MH999)I"J*%!>65GED? ^:21F=SEF9F))Y_XA>"K?XE:-J&AWC2);:E9W%G,\
M142+'<1-$Y0LK*'"L2I96 .,J1P?PQ^ ?[-OQY_8RUR^TCPG!I^J:!=W"*+B
M^GC6Q^8H!?&V6ZCO()4C^2X2)9-X4J%NO*MI!H?M5?L/_$]/&N@^,_#\\GBZ
M^LH[&:>:^FL[54O+"82!$M0UG%#92':Z0P/)('-RTDN]UED^_P#QU\(OB-K/
M@K4]#2]TO4M;\11W@U*YO;BYM['3ENH8K<VNF6T-K,[V\<(=(VFDB<W&;R43
M-/+"OG__  3\_9H\=?LD65QH&L#0[O2;J\>\-Q:WEV+J&1H%B8>5)9+%,C&&
M */,@,0\URTV4C7R_P#;Y_8R^(?[96HV/V9O#]AIND_:UM?,O;V2XF^T.F99
MMMB(X\I##B%/,\M_,_?S*R[/T_\ AI<^(;G3D_X2>#3X-27:LG]G7$T]O)A%
MW2KY\$$D6Y]^(3YVQ N9Y&)V_.'_  4(\%:-XV^&6OKK31Q1VEG)>6LSF)6C
MO( 6MA&\JL%>:3%J0F))4G>!&#2BL_\ X)W? N7X!?#K3+&\@^SZE>[]0OT/
MFAA-<X,:R),%:*6.W6WAFB55598G^\Q:1_M^BOC#]N/]D2W_ &OO#0TY)8[7
M5K*0W&G73HK*)"I5X)6"M*MO,-OF>4<J\<,Q27R1$_PA^SIX0_:5^"6WPM';
M:/=Z1;9M[2]U6X2:WMX8/-*&)K2=+]HI?E2))X9&A00QB.VC5PO/Z=_P3Q^)
MD?Q2NO%5KXA^S>1Y3IXBO(K>[N;J:XT\Q71M]/&8DB24R6\<$[0K;VS1"%I_
M)!/[/>*?AIIWQ!T.3P]KZ?VK97%NL%U]I5 UQM _>OY*Q(DNY1*KP+%Y4H#Q
M"(JFW\ =:_X)U?%?]E+Q0VL?"VZ^V6[^?'!,L]K%<1V[A#Y-]#>>7;39)^0Q
MB5&>!;@QVTGE(OV_\ ?V9/B9\5]1TS7_ (R:MY\6C7 O=,T6W-O'MOHW(CN+
MUK&..%_*"+);HCSD^:0SQ)Y]O<?8'[5W[*.A_M:Z&=*U4>3=P[WT_4$0--:3
M, "0"1OB?"B> D+*H4ADE2&:+\</A?\ LQ?M*?LZ7'_"/^&;V-=):2%!<_:[
M.YT^%78R/)%!?*UQ"BO-(UP(+97E=68)/B,G]7_V5OV8-4^#]Q?>(?%FLR>(
M?%&J1Q1S7<B 1V< 9IGL[(METMS/)(Y5!!"X2#;:0&/YOC#]H?\ 8R^*?QT\
M?:9X[B;PO8RZ/]A^Q6C7NH7"_P"ASM=+Y\@L83)NE=\^6L.(BJ#YU,K_ *_>
M%KG4;NSC?58+>VO3N\V&VN'NH5PQ"[)I(+9WRNUFS$FUB5&X*';XP_;C_8<T
MO]KW2Q)&8[/Q'9QD6%^0=K+DM]ENMH+-;LQ)5@&>W=C+&&#30S_F!\(?@%^T
MW\"$7PQX>FCM='2\<1SO/I=Q:QK))AYXQ<B6[CMSS.8DB5\L[_9_/D=6_7_]
ME;]G&X^!]O?:GKFH2:MXJUV2*XUK4&9O+>2)6$4%O'A52W@5VCBPB%@?N11"
M&W@_*#PW^QQ\8/V(?&-W>?#**/6M$NH_N75Q;1QRQG?Y<5Y!)<6K&XMV)9+B
MW*A@V0T:S7%JO8?MW_L)?$SXXV>BZLM]_P )!K4?VE+^QCEM[.QLQ.PEC&FQ
M3"',4>#!-/<S27EP$MG*[59(?N^+X9>//&G@7Q-+XHGCG\2^(-#N+:#1K1EC
MT_3V^R3QPV\)DD<-<2R3%KRYDF9&?RXD?[/;1R/X?\$X_C;^RMH]KX6G\-Z?
MXNLK.W1;.]M-;6T>)?,F)@G;4%#R^6IC2 10Q10P*D8:0Y$?J'[._P"RKJB^
M-]5^*?C.*S@UW4XXX[+3+9A<1Z=!Y$,69+B1 7O1'&+>22WVPX-P5:2.Y$</
M0?MQ_L.:7^U[I8DC,=GXCLXR+"_(.UER6^RW6T%FMV8DJP#/;NQEC#!IH9_S
M ^$/P"_:;^!"+X8\/31VNCI>.(YWGTNXM8UDDP\\8N1+=QVYYG,21*^6=_L_
MGR.K?K_^RM^SC<? ^WOM3US4)-6\5:[)%<:UJ#,WEO)$K"*"WCPJI;P*[1Q8
M1"P/W(HA#;P?5]?$'[<OP=\9?M$^'+CPGX=31X;*^^S-=7E_=W*3#R9Q/Y44
M$-I*@RT4)\YY6RIEC\@'9*#]AKX.^,OV=O#EOX3\1)H\UE8_:6M;RPN[EYCY
MTYG\J6":TB0X:68^<DJX411^03OE/R_^WS^QE\0_VRM1L?LS>'[#3=)^UK:^
M9>WLEQ-]H=,RS;;$1QY2&'$*>9Y;^9^_F5EV?H_X<U+QDFAE]2L=';7T\M1#
M;ZC<K8S<1B24S/8--;Y)E9(?*N=H6-3.V]G3\P?V>/V,OBG\"_'VI^.Y6\+W
MTNL?;OMMHM[J%NO^F3K=-Y$AL9C'ME1,>8LV8@R'YV$J?L]17X@_M5_LE_$S
MP[\5XOB;\/8;?4I9?*D,,CV\7V=H;6.RDAF6YFB$L5Q$&Q)"RRKOD7$+QQ32
M?7_C;X7_ !3\9^$M6TV[F\/W.N>(+>>SN6^TZA;Z;IMFT8@2.SM_)G>XED62
MYFEN)3;R+-+%&WVFVMH8UX__ ()^?LT>.OV2+*XT#6!H=WI-U>/>&XM;R[%U
M#(T"Q,/*DLEBF1C# %'F0&(>:Y:;*1KY?^WS^QE\0_VRM1L?LS>'[#3=)^UK
M:^9>WLEQ-]H=,RS;;$1QY2&'$*>9Y;^9^_F5EV?I?X*LM9\3Z,UGXSLM+^TR
MQF"ZALYI;NSN8WB5924NK>%D21C(IMW$X6/:#/*6;'X8_&O_ ()@^-/@AXHC
M\4?".;?%'<++:6WVJ.*\LF82>8F^Z*PW%H !'B61I9(YO(EAG199I/H#X:?L
MR?&/]I/99_&+5O)\,Q7"RSZ1 ;..XOVAVO"DLNG1JBVC,Q9P9FEWPC;#&_DW
M47[/45^,/[0_[&7Q3^.GC[3/'<3>%[&71_L/V*T:]U"X7_0YVNE\^06,)DW2
MN^?+6'$15!\ZF5_T^\1ZEXR?0P^FV.CKK[^8IAN-1N6L8>)!'*)DL%FN,$1,
M\/E6VX-(HG78KO\ G!^P-^QE\0_V-=1OOM+>'[_3=6^R+=>7>WL=Q#]G=\2P
M[K$QR82:;,+^7YC^7^_A56W^H?\ !0/]FCQU^UO96^@:.-#M-)M;Q+P7%U>7
M9NII%@:)1Y4=DT4**9IPP\R<RCRG#0X>-OJ#]EKPEXJ^'7AJQT#Q1%I8DTJS
MMK.WN-.N;B59XX%,2F2*XMH3"ZQI$"5DF$KF1PL"[8Z_(#PW^QQ\8/V(?&-W
M>?#**/6M$NH_N75Q;1QRQG?Y<5Y!)<6K&XMV)9+BW*A@V0T:S7%JO8?MW_L)
M?$SXXV>BZLM]_P )!K4?VE+^QCEM[.QLQ.PEC&FQ3"',4>#!-/<S27EP$MG*
M[59(?T/\ Z)\4K+1KG6]1DTNX\5:I' JZ5+<3VVCZ1'%%-Y8C$,5Y-<W!ED#
MWI\Q1-Q#%<I%:PO)\G_L#?L9?$/]C74;[[2WA^_TW5OLBW7EWM['<0_9W?$L
M.ZQ,<F$FFS"_E^8_E_OX55M_ZO\ BFYU&TLY'TJ"WN;T;?*AN;A[6%LL V^:
M."Y=,+N9<1/N8!3M#%U_(']GC]C+XI_ OQ]J?CN5O"]]+K'V[[;:+>ZA;K_I
MDZW3>1(;&8Q[943'F+-F(,A^=A*GK_\ P4/_ &*=6_:X^P?V):Z/;WMGMSJU
MW=W$5P83YN^S,$-G*CQ;FCFCE>4M&_FHD2"61Y/H#]F+0/B=X!TZTT;QJ^CZ
MJMOO1M6@O[HWC0JG[D2P2V"I<2A@$>=IXF:,AW6697>;\T/VP?\ @E7JD.L_
M\)5\+/+MY/,6X;2TG%I)!=+*A673I24BC3),WE/)"+<QGR&97BMX>P\"_ W]
MH;]H'SM%^(6M?V1X;GV1Z@L0TS[9=6[;C)#;/81/LW;%BE,TD:>7,?W=T@D@
M;]7O%GP<L]7\&W?@O3V^PV4VCS:3;-AIOL\+VQM8SAW#R^6I!PSAGV\ODEJ_
M(']CO]G3X\_L\_VEX4LET?3M%NKAY3JMT8[ORG^2W>YL(H91*\KQ!)HHK^)(
M#Y"JX@9Y%D_<[2=,31;>*UB,C1PQI&AEEDFD*HH4%Y96>61\#YI)&9W.69F8
MDG0HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK/U;5K?0+>6\O)8X+:"-
MY9II75(XXT4L[N[$*J*H+,S$!0"20!7YX>,/AAKG[;6N:=<ZS:_V7X!T;4#=
M0V%[;%=2UB[M3Y<<UQ;7,7^BZ>^^9$AE N)X0[20*+F![7]'Z***********
M********************^</VO?!7B#XC^ ]<T?PNT:ZM>V;0Q+(4598W91<0
M!I%9%>:#S88V;:%>16,D6/-3\L/A%_P43US]DO3K/PK\3_"FH6$6GV_V&PO+
M2$K]H6P2"W"A;F18;C #/)=VUP8FWQ!(-C^8?H_PQ_P5)LOB^DL'@?PEXDUO
M44DMXQ&8((+6-IY-JFZO(YKE;5"HD99)4V$H=S(@>1/J#]G_ .$.J66J:EXX
M\5+&GB/6XX(A91N)XM(L( 3%803MEF=F/G7SQ&.VFNOGCA 02R?5]%%%%%%%
M%%%%%%%%%%%%%%%%%<?\0K+5-1T;4(-#FCMM6DL[A+">4 QQ731,()'!20%%
MD*LP*2 @'Y&^Z?PA^ '[6OC'_@GQI=MX2^(?A*\BT*RD:*#4K5-S"2Y-Q>E/
M.,C6-X[-( JPSP&!(Y=PED1D'U?H'_!6WP]\1/M%MX8\->*-7U**WDFCM8+*
M%\[<*IE,%Q<211%V1'E$4FS>"$=B%;Z0^$/PR\0?$+Q*OQ \;6<>F7UO9O8:
M1H27"7J:?&[9N;R2X \HWMR1Y8>U$02R"0RM,[,(OL^BBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBOF#]KS]I/_ (92\+R>)/[,N-5VW$$'DPMY:1^:2/-N)MDG
MDQ#&P/L?=.\,.!YN]?C^R^)]Y_P4RT?3=*LM&U#2?#,EQ:W?B&[OD46]Y#:R
M;CIFG2QL);GS+F(B6\C-HUJEOEE+S+;M^K]%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%<?X_P#'^E_"S2[G6M:N8[/3K.,R3SR$[57(   !9G9B$CC0,\CLL:*SLJGX
MP_9U_P""@^A_M0^,KSPQX>L[@V5GI\UW_:4["+SFBN8H-L5MM9_*=94E265X
MI>J/;(1FOO\ HHHHHHHHHHK/U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J
M*H+,S$!0"20!7YX?$/\ ;]O(-#F\5>"_"NH>(O#=IYIN=6:9=/A*QB/?):P2
MQRWMQ%&S2)<3&WBBA:"4[W1)'C]0_9$_;C\-?M?6\J:<)++5K6-'NM.N"ID"
MLJAI8'4XGMUD8Q>9B-U.PRPP^;$'^SZ********X_P"(7C6W^&NC:AKEXLCV
MVFV=Q>3)$%,C1V\32N$#,JERJD*&903C+ <CY _8<_;CM_VT+?5&72Y-+N=+
MDMQ)&;A;F-X[E9/+99/+A;?NAE#H8\*/+82.798_N^BBBBBBBBBBBBBBBBBB
MBOS@^(O_  48T[X>_%"U^&SZ3<2^=<6-I-J G1?+N+]$:$);E3YD0\Z 22-+
M$ZYE*Q/Y:>=^C]%>'_M(_&^W_9P\)ZEXJNK>2[CL(XR+>-E1I))I4@B4NV0B
M&21/,?#E$W,L<C (W ?L;?M4V_[7WAI]?@L9-.DAO)K.>W>59E$D:QR@QRA8
MRZ&.:,DM'&5?>FUE59'^KZ*******^?_ /AH73M?\0_\(QX?3^U[^#YM3EMY
M4^QZ8BS>4Z7MP"^R[;9,+>RC22=Y(2)A:VY:Y3Z KP_QE^TIX.\ :I;:'J.L
M6<>K7=Y;645@DGG77VBZ ,"R00[Y84<,I$LJI" Z9<;TS[A7A_B3XWV_@/Q!
M::'K=O)9PZI)Y6E:EN5[.XN-B$64K_*UM>NWFFWA=6AN8XU\JX>X9[6+W"BB
MBBBBBBBBBBBBBBBBBOS0\4?\%1O!R>*M+\)^'%DUNYO]4M+":[B;R;. 3W!M
MW=)65FN71MCJ(D^SS1N&2[R-M?I?1111111117PA^U5_P4,\'?LL/+IUT\FH
MZZD:L-,M1\R&2-WB-S.W[J!&*IN&9+A4ECF6VDC8$_5_PG\=?\+0\/:5KWD_
M9_[3T^TO?(W^9Y7VF%)O+W[4W[=^W=M7=C.T9P/0********************
M**_.#XB_\%&-.^'OQ0M?AL^DW$OG7%C:3:@)T7R[B_1&A"6Y4^9$/.@$DC2Q
M.N92L3^6GG?H_111111111117PAXH_;9?Q#;WT_PYT"\\91Z7(4OKFVFCM+-
M6193)%;32J\M]<*$C<1V4,Z/'/$RS%I(TDY_]C[_ (*.^&OVL+C^R#!)I&N^
M6TBV4\BR1SJK.6%K. AF=(U626-XX7 9RBRQPRRKZAXR_:UBN-1U#P_X(TNX
M\5Z_IG%];VTT5I9VC;XU\NYU"Y*PK*P:79# +B7S+>:.1(O+D9/B#2?^"S6A
MV=GJ<>OZ!J&F:[8^<L.G&02K--&R1B"29HX9+:4.TAF$D!6**%R&DG*6[?=_
M[&W[5-O^U]X:?7X+&33I(;R:SGMWE691)&L<H,<H6,NACFC)+1QE7WIM9561
M_J^BBBBBBBBBBBBBBBBN/\?^/]+^%FEW.M:U<QV>G6<9DGGD)VJN0   "S.S
M$)'&@9Y'98T5G95/QA^SK_P4'T/]J'QE>>&/#UG<&RL]/FN_[2G81><T5S%!
MMBMMK/Y3K*DJ2RO%+U1[9",UH?MQ_MQV_P"Q?;Z6S:7)JESJDEP(XQ<+;1I'
M;+'YC-)Y<S;]TT01!'AAYC&1"BK)]?\ P]\:V_Q*T;3]<LUD2VU*SM[R%)0H
MD6.XB65 X5F4.%8!@K, <X8CD]A1111111111111117YH>*/^"HW@Y/%6E^$
M_#BR:W<W^J6EA-=Q-Y-G )[@V[NDK*S7+HVQU$2?9YHW#)=Y&VOTOHHHHHHH
MKR_XO?&CP_\  72VUGQ+?1V%BLB1"1P[L\DA^5(XXU>61\!F*QJQ5%>0@(CL
MOSA^R#^V]IW[8UYK::5I]Q9V6D_8?*FN9$\Z?[4LQ;?#'O2'RV@95Q+-YBD,
M?+.4'V_11111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111117X _L"_\G"^/?^X__P"GFWK]_J**********_,#_
M (*Y_$O4?AW\-6@T]_*_M?4(-.N9 SJXMWBGGD5&1EQYGV<0R!MZ/!)+&5.\
M%?K_ /9._P"2>>%/^Q?TG_TBAKD/@S^Q9X.^ ?B75/%&@6TEM=ZI'Y1@$F+6
MVC9EDE2UA55$:2R(DC*QD$90) ((<QGZOHHHHHHHHHKC_!7P]T;X:V[6>AZ?
M9Z;;/(97AL[>*WC:0JJERD2JI<JJJ6(R0JC. ,9_Q5^)>G?!O0[_ ,0ZJ^RR
MT^W>>7#(K/M'RQ1^8R(TLK;8H4++YDKH@.6%>(?L0?%[5/CUX!TSQ+K+1M?7
M\FH/((D$<:*E_<QQQHO)"1QHD:EBSL%#.[N6=OJ^BBBBBBBBBBBBBBBBBN/O
M?A[HVHZI#KD^GV<FK6T9B@OWMXFNHHR'!2.<J940B20%58 B1^/F;/85\(>"
M_P!JI_B/\8]1\#Z=+&^DZ+H<TET56-C+J7VJT5@)5=SLMXY3"8\1,MP;E)5?
MRXBGV_JVDV^OV\MG>11SVT\;Q30RHKQR1NI5T=&!5D92596!# D$$&L_PMX3
MT[P-9QZ?I5I;V-E#N\JVMH4AA3>Q=MD<85%W,S,V ,LQ8\DFN@HHHHHHK\\/
M^"CO[3%[\"/#4&DZ#')-XC\222:?IR0^?Y\:LH2:XM_(7<UPC2PQVZ!T?SIH
MY5$HA>-OI_\ 9U^ VE_LV^&K+P[I<<86"-3<SI&4:[NBJB:ZD!>1M\C+D*7<
M1($A0B*-%'H'C_P'8?$_2[G1M4222QO(S%<1QSS6[21DC<ADMWCE",!MD4,!
M(A:-PR,RG^?']KCX5:'\)OV@/!<&@6%OIUO=W&@7,T%L@BA,W]J/ 72)<1QY
M2&,,L:HK,#(09'=F_H^KS_XJ_#33OC)H=_X>U5-]EJ%N\$N%1F3</EEC\Q71
M98FVRPN5;RY41P,J*^ /V ?CCJ-GJ.L?";Q"=VI>$?W&GW)MWMGO=+@<012O
M#M,:;$-LT;^83<07$3 2-'+<2_I_1111111111117PA\1_VJGL/BWX8^'6ER
MQE9X[VZUHA8W8*+&XDM+8-O9HGW1_:9E*(Y0VK)(8I)4;[OHHHHK\ ?V^O\
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M4DR-;&$_-'^SWP!^,=G^T!X7TSQ/8KLBU"W$C199O)F4F.>'<Z1E_*E22+S
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MVSM[.%Y2ID:.WB6)"Y554N54%BJJ"<X4#@?GA^T+^V;KGB/Q0GPV^%,-O?\
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M_P DA\/?]Q'_ -.5W7P!_P %SO\ F4?^XQ_[85^_U?@#_P $,?\ F;O^X/\
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M!_8%_P"3A?'O_<?_ /3S;U^OW[6/_)//%?\ V+^K?^D4U? '_!%3_DGFI?\
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M#^S3_P G0W7_ &,'B?\ ]%:C7]/U%?@#^WU_R<+X"_[@'_IYN*_?ZBOY@?\
M@M7_ ,E#TW_L7[;_ -+;ZOZ?J*_GQ^*&@ZI_P3T^-/\ PG4J2/X/\2WDR7=W
MQ((UOV$UW%*4MV>-X)Q]LMXXUWW%O L*S.XN=GU_^V)^VGX?\7^"I]#\#W,?
MB/7?$UG+:V=AI\;WDZ6\T.;J6X@A836[I;M(4CE43";&Z!HXKCR_</\ @GO^
MS7>?LO>!H-*U3C5+RXEO[Z(2+*D,TJI&L2,JJ/DBBB$F#*OG^:4E>(H:_.#]
MOK_DX7P%_P!P#_T\W%?O]7Y@?M"_MFZYXC\4)\-OA3#;W_B(^:NIZE,"]GI2
M@%'8D90RP,RO*SB6**0):>1<W4K01?"'_!2W]F.X^%'@JSUS7?$&J>)-=GUQ
M8C<WDK):V\=Q#>S2I96*LT5JDACMQ(H9QFW3RA#&3%7[7?LG?\D\\*?]B_I/
M_I%#7Y _L"_\G"^/?^X__P"GFWK[_P#^"H__ "2'Q#_W#O\ TY6E'_!+C_DD
M/A[_ +B/_IRNZ^ /^;O/\_\ 0N5]_P#_  5'_P"20^(?^X=_Z<K2OB#_ ()X
M_L9_"W]HGX?V>JZKI?V[5X;B[MM1E^UZA#B9)FDB3;'/%$<6TMN=T0*G=@GS
M X'V_P#\.N/A#_T+W_E1U+_Y+K\X/^"P[V?A_P />!-*T&?_ (D M[PVD4-P
MTMO)#;PV,=G(&WN)MD4CB*9B[;)7(<^8Q;^@[2=6M]?MXKRSECGMIXTEAFB=
M7CDC=0R.CJ2K(RD,K*2&!!!(-?@C^WU_R<+X"_[@'_IYN*_?ZBOP!_X+G?\
M,H_]QC_VPK]_J_GA_P""*GQ+_M#Q#XIT^^>XN-2U.WMM1:YD;S-_V::5)VFD
M=C(TKO>QL"0V_$C,P8*'_H>K^>'X=?#3_A$OVK[J#3TN)[>*XOM1N9"N_P G
M^T-+>>1G9%"I$+B[$,9;&-\499Y&!;^AZOG_ /:Q_P"2>>*_^Q?U;_TBFKX
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MAB2PN#+'Y+K;V^FB&XE@.UXR[F_F>WDYDF@>9MR%("B_T'45^"/QI^(/QC^
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M]3M[?4M3N+>WL[/)DN)7N7:.%O)C#R)$SHR>>ZK KC:T@8@'V"BBL_5M6M]
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M%EMFED,?[?>+/%-GX&TZ[U74)/)LK&WFN;F7:S[(84,DC[4#.VU5)VJ&8XP
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M3:I>>+M+\/ZC+&'M]%M-)M[NUB80)MCFN[@2S1N9=PG*?;40Y>)Y4*Q+Y_\
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M=O9+M)R\DD]RP5450<!%E=G*+L"%Y8_SP_X)F_M>>*/VM+SQ/<^(I+<16?\
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M\0_%_P +V7B37KK1Y_[3MXYX(=*@F5+?)</%+--=3^;*OR)*BI#]GG2:$F;
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MTR-_+M JV;RM-/+)(TEP[2+%(D;O;QBV1HI',TAK^HVOP!_X(8_\S=_W!_\
MV_K[_P#^"H__ "2'Q#_W#O\ TY6E'_!+C_DD/A[_ +B/_IRNZ^ /B]XCL_B!
M^U1I&GZ\+=++2/L=O:,9&AW3+9/J-F7?S!NE-[<(D:+M67$4)C<LWF?O]7\X
M/_!7_P .7GPF\?>'O&VE&WMKB>W1H98XU,QOM+G$@GF5HS')A)K5(RYD++"8
MV41H@;Z__P""U?\ R3S3?^Q@MO\ TBOJ^_\ ]D[_ ))YX4_[%_2?_2*&OR!_
MYN\_S_T+E?O]17X _P#!(#Q'9_$_QEXT\3:B+=-?OMEQ'''(R8AO;F:>^$,+
M2,6B65;0%V\QHLQKY@\T[_W^K^<']G+PY>? +]IR^\/VAM[>TO;C5%>"VC40
MBQN;1]4M8$4QKY7E[;;<(@H5HC&K-$3O] _X+G?\RC_W&/\ VPK]_J*X_P"(
M7@JW^)6C:AH=XTB6VI6=Q9S/$5$BQW$31.4+*RAPK$J65@#C*D<'^:+P5\0_
MBS_P2LN&T[4M,CG\.3WAD<-&'L[F1V5#);W\2AX;B2&T;RH9R3'&?.DL22*_
M:[]DC]J[P7^U3+-JND'[-XDDT^T34]/E>3SHH;:6X,80L%BGB26YF(G@&[;/
M")UB=HX5_.#]OK_DX7P%_P!P#_T\W%?O]7X _L"_\G"^/?\ N/\ _IYMZZ#_
M (*!^*;R[^.OP[TIY,V5M<:1<PQ;5&V:ZU8QS/N WG<MM -K$JNS*A2SEOW>
MKC_#?P]T;P=<7=YIFGV=G<W\GFWLUO;Q0R7,FYVWSO&JM*^Z1VW2%CEW.<L<
M_AC^WU_R<+X"_P"X!_Z>;BOW^K\ ?^"&/_,W?]P?_P!OZ_?ZBOP!_P""&/\
MS-W_ '!__;^OO_\ X*C_ /)(?$/_ '#O_3E:4?\ !+C_ ))#X>_[B/\ Z<KN
MO@#]OK_DX7P%_P!P#_T\W%?5_P#P6%\:W'A7X9&S@6-H]5U2SLYRX8LL:"6]
M!C(8 /YEK&I+!AL9QMW%67[ _8[TFWT7X<^%8K6*.&-M#TZ4I&BHIDFMHY97
M(4 %Y)'>21NKNS.Q+,2?R0_X+G?\RC_W&/\ VPK]_J_ '_@AC_S-W_<'_P#;
M^OV^^*OPTT[XR:'?^'M53?9:A;O!+A49DW#Y98_,5T66)MLL+E6\N5$<#*BO
MQA_X)(_&Z\\#:CJ_PH\1-Y-[8W%Q+8Q22J^R:%S'?V:-YS(VUE^T11VR,IQ?
M3LY&#7W?HEZGQ[^+,E]%#'+I/@6SN+*&\S("^MZF(OM2121NT$R6UK'Y%Q%)
MLEM[B=@T39B>/V_]K'_DGGBO_L7]6_\ 2*:O@#_@BI_R3S4O^Q@N?_2*QKR#
M_@H[K_\ PEOQD^'OAB^M[>?38KC3YVCDCW^=_:&IK!/%,KDQO$4M(P$*#.^0
M,75E"_N]7X _\W>?Y_Z%RO?_ /@M7_R3S3?^Q@MO_2*^K[__ &3O^2>>%/\
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M;5]%UN]L]*U:6\^U_:KQH;:.XM1%%%'"+F1E#/#)YKB!RI G:2(/_I!C\O\
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M;R9E(D@FVH\9?RI4CE\LNJR;-C'8S _C#_P2V^-?_#.6L:I\*?&4?]DZE-J
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MO>++;&0(?,CEMX;(EXPXMKR![M=Z>7,R#X0_X*">+-.LOV@/!T\MW;I%I_\
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MNU!@AV6[FXE]0TG_ (+*_#30+>*SL](UR"V@C2*&&*SL4CCC10J(B+>A515
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MA+J)'CB:\61U3.YD1I8E=@"%,D8)!=<_?_\ P53U:WT[X2:U%/+'')<R:?%
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MHGRV\3Z1;WTL.T1W&9(;@*GF;8_M$#Q3&(&5V\DN8B[;RF\!AT'P<^ /A?\
M9_LVL?#&F6^GQ/CS6C!::;:SNOG3R%YIMAD<1^:[^6K%$VIA1[!7S!\8_P!B
M_P"'_P ?;Q=0\1:);W-Z,[KF-YK6:3*H@\Z2UDA>?:L:+'YQ?RU!5-H9@=_X
M*?LL>"_V=O,;PQI%O8RS;A)<9DFN"K^7NC^T3O+,(B8D;R0XB#KO";R6/J'C
M7X>Z-\2K=;/7-/L]2MDD$J0WEO%<1K(%90X2564.%9E# 9 9AG!.?/\ 2?V9
M/ N@7$5Y9^&M#@N8)$EAFBTRT22.1&#(Z.L0975@&5E(*D @@BM#Q3^SUX-\
M<WDFH:KX?T>^O9MOFW-SIUM-,^Q0B[Y)(V=MJJJKDG"J%'  K0\-_!#PKX.M
M[NSTS1-+L[:_C\J]AM[&WACN8]KKLG2.-5E3;(Z[9 PP[C&&.>/_ .&3OAY_
MT*GA_P#\%-E_\9KYP_X*8Z3;Z!\&-;L[.*."V@CTN*&&)%2..--0LU1$10%5
M%4!550 H    KP#]B?\ 9%\$?M'?"GPM>>*-)CO;FUCU.**833V\@C;4[MMC
M/;RQ-(@;+(LA81EY"@4R/N_2[X.? 'PO^S_9M8^&-,M]/B?'FM&"TTVUG=?.
MGD+S3;#(XC\UW\M6*)M3"CV"OF#XQ_L7_#_X^WBZAXBT2WN;T9W7,;S6LTF5
M1!YTEK)"\^U8T6/SB_EJ"J;0S ]_\'/@#X7_ &?[-K'PQIEOI\3X\UHP6FFV
ML[KYT\A>:;89'$?FN_EJQ1-J84:'C7X(>%?B5<+>:YHFEZE<I&(DFO+&WN)%
MC#,P0/+&S! S,P4' +,<9)R>"O@AX5^&MPUYH>B:7IMR\9B>:SL;>WD:,LK%
M"\4:L4+*K%2<$JIQD#''_P##)WP\_P"A4\/_ /@ILO\ XS78:G\%/#6K:(/#
M4FEV8T0212#3HX5BM=T5PMVH,,85"AF4221D%)266175W5OG#Q3_ ,$WOA1X
MPO)+ZY\.6Z2R[=RVT]U:0C:H0;(+6>*%.%!;8B[FR[9=F8_7_A;PGIW@:SCT
M_2K2WL;*'=Y5M;0I#"F]B[;(XPJ+N9F9L 99BQY)-?.'Q>_8=^'GQWU1M:\0
MZ+'=:B\:1R3I<75NTBQC"&06TT2R.%P@D<,^Q4CW;(T5>O\ BS^RQX+^.&G6
M6E:]I%O<66FX%C%&9+;[,H01^7"UL\3I%M5 85(B/EQDH3%&5]0\ > -+^%F
MEVVBZ+;1V>G6<8C@@C!VJN22222S.S$O)(Y9Y'9I'9G9F/@&K?L,_#?7_$$O
MB>\\/V<^J3R/+,TOF/;R2.A1W>S9S:,[9+LS1$M,3.29CYE>O^-?@AX5^)5P
MMYKFB:7J5RD8B2:\L;>XD6,,S! \L;,$#,S!0< LQQDG)X*^"'A7X:W#7FAZ
M)I>FW+QF)YK.QM[>1HRRL4+Q1JQ0LJL5)P2JG&0,>@:MI-OK]O+9WD4<]M/&
M\4T,J*\<D;J5='1@59&4E65@0P)!!!KX@U;_ ()E_"36KB6ZE\.QK)-(\CB*
M\OH8PSL6(2**Y2*-,GY8XU5$&%554 #[/\+>$].\#6<>GZ5:6]C90[O*MK:%
M(84WL7;9'&%1=S,S-@#+,6/))KS_ ,4_L]>#?'-Y)J&J^']'OKV;;YMS<Z=;
M33/L4(N^22-G;:JJJY)PJA1P *T/#?P0\*^#K>[L],T32[.VOX_*O8;>QMX8
M[F/:Z[)TCC594VR.NV0,,.XQACGC_P#AD[X>?]"IX?\ _!39?_&:]PTG2;?0
M+>*SLXHX+:"-(H88D5(XXT4*B(B@*J*H"JJ@!0   !6A7G_Q+^%6A_&33GTK
MQ#86^H63[CY4Z!MC,C1^9$WWXI0KN$FB*2Q[B4=3S7S!X6_X)O?"CP?>1WUM
MX<MWEBW;5N9[J[A.Y2AWP74\L+\,2N]&VMAUPZJP^WZ^?_\ AD[X>?\ 0J>'
M_P#P4V7_ ,9KL/!7P0\*_#6X:\T/1-+TVY>,Q/-9V-O;R-&65BA>*-6*%E5B
MI."54XR!CU"N?\6>%K/QSIUWI6H1^=97UO-;7,6YDWPS(8Y$W(5==RL1N4JP
MSD$'!KY0\:_\$\/A7X_N%NKSPU9QR)&(P+-IK"/:&9@3%92P1,^6.9&4N1M4
ML550/H_X:?"K0_@WIR:5X>L+?3[)-I\J! N]E18_,E;[\LI5$#S2EY9-H+NQ
MYH^)?PJT/XR:<^E>(;"WU"R?<?*G0-L9D:/S(F^_%*%=PDT126/<2CJ>:\P^
M"'[(O@C]G&XN+SPOI,=E<W4:Q2S&:>XD,:MNV*]Q+*T:%L,ZQE1(4C+AC&FW
MK_ 'P!\+_"_4;_5](TRWM]2U.XN+B\O,&2XE>Y=9)E\Z0O(D3.BOY",L"N-R
MQAB2?8*^,-3_ .">'PKU;5!K$GAJS%R)(I D;316NZ(*%!LHY5M"AVCS(S$4
ME)8R*Y=]WU_I.DV^@6\5G9Q1P6T$:10PQ(J1QQHH5$1% 5450%55 "@   "O
M#_\ AD[X>?\ 0J>'_P#P4V7_ ,9KL+WX(>%=1TN'0Y]$TN32;:0RP6#V-NUK
M%(2Y+QP&,Q(Y,DA+*H),C\_,V>?TG]F3P+H%Q%>6?AK0X+F"1)89HM,M$DCD
M1@R.CK$&5U8!E92"I (((KW"N/\ &OP]T;XE6ZV>N:?9ZE;)()4AO+>*XC60
M*RAPDJLH<*S*& R S#."<^?Z3^S)X%T"XBO+/PUH<%S!(DL,T6F6B21R(P9'
M1UB#*ZL RLI!4@$$$5T'C7X(>%?B5<+>:YHFEZE<I&(DFO+&WN)%C#,P0/+&
MS! S,P4' +,<9)R>"O@AX5^&MPUYH>B:7IMR\9B>:SL;>WD:,LK%"\4:L4+*
MK%2<$JIQD#''_P##)WP\_P"A4\/_ /@ILO\ XS7L'A;PGIW@:SCT_2K2WL;*
M'=Y5M;0I#"F]B[;(XPJ+N9F9L 99BQY)-?,'Q+_8'^&?Q=U%]5U?0+=[V7<9
M98);BT\UF=I&DE6TEA225F=B\SAI7X#.0J@=_P"(OV5? WBO^RUO-!T^2WT;
M[5_9]IY"K9P_;,?:/]#7%L^\@/\ O(WVR#S%VR?-7J'C7X>Z-\2K=;/7-/L]
M2MDD$J0WEO%<1K(%90X2564.%9E# 9 9AG!.?/\ 2?V9/ N@7$5Y9^&M#@N8
M)$EAFBTRT22.1&#(Z.L0975@&5E(*D @@BO<*\_^)'PJT/XP6::?X@L+?4+2
M*XAN4AN$#JLT#;D< _BCK]V2)Y(7#Q22(WH%>?\ CKX3^'OBAY/]O:5I^I_9
M]_D?;;2&Y\KS-N_R_.1]F[8F[;C=M7.<#'/^%OV>O!O@:\CU#2O#^CV-[#N\
MJYMM.MH9DWJ4;9)'&KKN5F5L$95BIX)%>H:MI-OK]O+9WD4<]M/&\4T,J*\<
MD;J5='1@59&4E65@0P)!!!KY TS_ ()X?"O2=4.L1^&K,W)DED*2--+:[I0P
M8"RDE:T"#<?+C$02(A3&J%$V^WZ=\ ?"^E^([KQ?'IEN=?O/*\V_D!EF7RH#
M;+Y)D+"WS$?+D^SB+S5QYF_ KU#5M)M]?MY;.\BCGMIXWBFAE17CDC=2KHZ,
M"K(RDJRL"&!(((-?*'A;]@?X9^"M<C\1Z?H%O#J4-PUS"XEN&ABF8DAX[5I3
M;)L)W0JD06!@C1!&1"OK^O\ P!\+^*_$-OXKU#3+>[UJTMX[>VN9P9?)2*8W
M$;11.3$DJ2DNDZH)UR5$@4D5ZAJVDV^OV\MG>11SVT\;Q30RHKQR1NI5T=&!
M5D92596!# D$$&OF#X0_L._#SX$:HNM>'M%CM=12-XXYWN+JX:-9!AS&+F:5
M8W*Y0R(%?8SQ[MDCJVA_PQ?\/_\ A*/^$S_L2W_MW[1]J^T;YMGVC&//^S>9
M]F\W/[WS/*W^?_I&?/\ WE=_XI_9Z\&^.;R34-5\/Z/?7LVWS;FYTZVFF?8H
M1=\DD;.VU555R3A5"C@ 5T'@7X3^'OA?YW]@Z5I^F?:-GG_8K2&V\WR]VSS/
M)1-^W>VW=G;N;&,G/Y@?M^?LL>"[N!X]&TBW7QSXTU"VLK.93(VUA<0W-[?/
M;AW$,4<4#&]O+:!I5\XF4E;B9F_7^BL_5M)M]?MY;.\BCGMIXWBFAE17CDC=
M2KHZ,"K(RDJRL"&!(((-?$&K?\$R_A)K5Q+=2^'8UDFD>1Q%>7T,89V+$)%%
M<I%&F3\L<:JB#"JJJ !]G^%O">G>!K./3]*M+>QLH=WE6UM"D,*;V+MLCC"H
MNYF9FP!EF+'DDUY_XI_9Z\&^.;R34-5\/Z/?7LVWS;FYTZVFF?8H1=\DD;.V
MU555R3A5"C@ 5T'@7X3^'OA?YW]@Z5I^F?:-GG_8K2&V\WR]VSS/)1-^W>VW
M=G;N;&,G/H%%?FA^W/\ L\:SJ>LZ%\3O"4,EUK?AF1&NK"&66*XU'3XY?-:W
M@=2RAPK7"-$(F>YAN9$_>M'%;R_;_@#QKHW[0?AJVU6U6.[TG6+,,89A%*K1
MS*5EM[A%:2(NI+PW$67"NLD;9P:X_P#X9.^'G_0J>'__  4V7_QFC_AD[X>?
M]"IX?_\ !39?_&:]0\%?#W1OAK;M9Z'I]GIML\AE>&SMXK>-I"JJ7*1*JERJ
MJI8C)"J,X Q\P?MV_'E/@KX.N[>SDD;Q#K4;Z=HEI;22+>375SB'S+80H\N^
MW$HF!4*#((H1(DL\6>@_8L_9G3]E'P=;>'VDCGOGDDNM0GB\SRY;J7:#L$C$
MA(XTB@5@L8D$0F,4;R.M?5]<?XU^'NC?$JW6SUS3[/4K9)!*D-Y;Q7$:R!64
M.$E5E#A690P&0&89P3GS_2?V9/ N@7$5Y9^&M#@N8)$EAFBTRT22.1&#(Z.L
M0975@&5E(*D @@BM#Q3^SUX-\<WDFH:KX?T>^O9MOFW-SIUM-,^Q0B[Y)(V=
MMJJJKDG"J%'  KH/ OPG\/?"_P [^P=*T_3/M&SS_L5I#;>;Y>[9YGDHF_;O
M;;NSMW-C&3GG_C'\ ?"_[0%FMCXGTRWU"),^4T@*S0[F1V\F>,I-#O,:"3RG
M3S%4(^Y,J> ^#G[%_P /_@%>-J'AW1+>VO3C;<R/-=31X5T/DR74DSP;ED=9
M/)*>8I"ON"J!Z_XZ^$_A[XH>3_;VE:?J?V??Y'VVTAN?*\S;O\OSD?9NV)NV
MXW;5SG QS_A;]GKP;X&O(]0TKP_H]C>P[O*N;;3K:&9-ZE&V21QJZ[E9E;!&
M58J>"17J&K:3;Z_;RV=Y%'/;3QO%-#*BO')&ZE71T8%61E)5E8$,"000:^0-
M,_X)X?"O2=4.L1^&K,W)DED*2--+:[I0P8"RDE:T"#<?+C$02(A3&J%$V^WZ
M=\ ?"^E^([KQ?'IEN=?O/*\V_D!EF7RH#;+Y)D+"WS$?+D^SB+S5QYF_ KG_
M -H7X">"_CAIR-XUL[>XLM-\VY6XFFDMOLRA#YSFXBDB=(MJAI59Q$?+1W!,
M2,O@'_!.7PG_ &-X7U/5X+3[!IOB'Q!J6L:59F'R'@TZX,<=JCP@"./*0AXU
MA:2$P/$R2%6P/O\ HKY ^)?[ _PS^+NHOJNKZ!;O>R[C++!+<6GFLSM(TDJV
MDL*22LSL7F<-*_ 9R%4#O_$7[*O@;Q7_ &6MYH.GR6^C?:O[/M/(5;.'[9C[
M1_H:XMGWD!_WD;[9!YB[9/FKU#QK\/=&^)5NMGKFGV>I6R2"5(;RWBN(UD"L
MH<)*K*'"LRA@,@,PS@G/G^D_LR>!= N(KRS\-:'!<P2)+#-%IEHDD<B,&1T=
M8@RNK ,K*05(!!!%=!XU^"'A7XE7"WFN:)I>I7*1B))KRQM[B18PS,$#RQLP
M0,S,%!P"S'&2<G@KX(>%?AK<->:'HFEZ;<O&8GFL[&WMY&C+*Q0O%&K%"RJQ
M4G!*J<9 QZA7S!\8_P!B_P"'_P ?;Q=0\1:);W-Z,[KF-YK6:3*H@\Z2UDA>
M?:L:+'YQ?RU!5-H9@>_^#GP!\+_L_P!FUCX8TRWT^)\>:T8+33;6=U\Z>0O-
M-L,CB/S7?RU8HFU,*/8*^,-3_P"">'PKU;5!K$GAJS%R)(I D;316NZ(*%!L
MHY5M"AVCS(S$4E)8R*Y=]WU_I.DV^@6\5G9Q1P6T$:10PQ(J1QQHH5$1% 54
M50%55 "@   "O'_C?^S=X3_:/M[>U\5:;'?QVDC26Y,DL,D;.NUPLL#QRA&
M7?'NV.4C9E+1H5T/#G[/WA+PIH9\,VFBZ>NBMY9ELFMHY(9FC$862=9%;SY?
MW49,TV^5F169RP!KG_\ AD[X>?\ 0J>'_P#P4V7_ ,9KZ KX _;Z_P"+BV>@
M_#F'YI?%NL6\-TB_+,FEZ>RWNH7$$K_N4EA$<) E$AD5V6.&1_N_=^DZ3;Z!
M;Q6=G%'!;01I%##$BI''&BA41$4!515 554 *    *T***^(/%/_  3>^%'C
M"\DOKGPY;I++MW+;3W5I"-JA!L@M9XH4X4%MB+N;+MEV9C]/_#3X5:'\&].3
M2O#UA;Z?9)M/E0(%WLJ+'YDK??EE*H@>:4O+)M!=V/-9_C7X(>%?B5<+>:YH
MFEZE<I&(DFO+&WN)%C#,P0/+&S! S,P4' +,<9)R>"O@AX5^&MPUYH>B:7IM
MR\9B>:SL;>WD:,LK%"\4:L4+*K%2<$JIQD#'J%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?E!\9_^"=OB
MCXX>+;3QI?>,K>WU33_LOV$6V@!8;;[)(9HMB2ZA*7_>L\K><TN6<K_J@D:_
MI_X6MM1M+.--5GM[F]&[S9K:W>UA;+$KLADGN73"[5;,K[F!8;0P1>@HHHHH
MHK\D/AY_P2G3PEK.IW=]XOUR[TG59)'O;"*62TDOU:5F\O4[J.=C>(T<DT<Y
M$<#R&9Y$>')5OU?TG2;?0+>*SLXHX+:"-(H88D5(XXT4*B(B@*J*H"JJ@!0
M  !6A111111117S_ /M'_"S7/C3H=SH&D:O;Z1;W]O-;7LTFGF]F>&8*K)"3
M=01Q;D\V.1G29BL@,9AD0.? /V,OV.-<_8^BFTV'Q%;ZEHMS<&YFM9-),,RS
M&+RB\-RM\^S=LA\Q98YU*Q!8Q$SO(?O^BBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBOD#]KS]G+7/VH='D\.VVNV^D:1<>0UU'_ &8;NXF:&0RA?/:\B1(M
MRPOM2(2[XO\ 7F-VBH_9#_9RUS]E[1X_#MSKMOJ^D6_GM:Q_V8;2XA::02E?
M/6\E1XMS3/M>(R[Y?]>(T6*OK^BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBN/\-^ -+\(W%W>65M''=W\GF7E
MS@O<7#!G*"69RTLB1!V2WC9BEO#MAA6.%51>PHHHHHHHHHKP_P -_!"W\!^(
M+O7-$N)+.'5)/-U73=JO9W%QL<&]B3Y6MKUV\H7$R,T-S'&WFV[W#)=1>X44
M5\_^!?V>M.\/:Q-XGU5_[7\23[/^)C<Q)_H:+&T?V;3(L-]BM/WDQ\M7DGD\
MYS<7-TYWU] 4444444444445Q_B3P!I?C&XM+K4;:.ZDL)/.M1,#)'#.&1EN
M$B8F(7$90>3<;?.@#2K%(BS2A^PHHHHHHHHHHHHHHHHHKX@_;>_8R_X;*T[3
M['^V;C2?L%Q)-M6+[1;S>8FS,L'FPYECQB&7?^[22=-C>=N3T#]GK]EZS^!>
M^^N]1U#7]?GMXK>XUC5)VN+CR4PYMK?>6-O:&4O,( SL7<>9+-Y<93Z?HHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK\L/A=^PQXJ\#_&74/B
M'=:['-I-U)>R"$/<&ZGCN4VQ64Z-^Z%O;$IY1\R4$6EOM@BR/(_4^BBBBOS0
M_P""G<WC'POX,O-?\/\ B*32+&PCMA/:6MMLNKJ2>]@B#?V@)A+;H@92J01J
M7'FI))(DJK%V'_!+C_DD/A[_ +B/_IRNZ\O^%W[#'BKP/\9=0^(=UKL<VDW4
ME[((0]P;J>.Y3;%93HW[H6]L2GE'S)01:6^V"+(\C]3Z*******S]6U:WT"W
MEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q 4 DD 5S^D^)$\?Z-%J>AW$9CO
M[-+BPN989'CVSQ"2"5X"T$K)AE9HBT+D93=&W(_!'X?77BC2_P!IG3="\3Z]
M<:_+IOVGRIY(A;0K]HT)I6\FSC=H;?(*+)Y6/-:,2OEV-?T/444445Q_C_2M
M4UW2[FUT6]CTW498RD%[);"[6!B0#((#)$LCA<^6';8'VLZ2H&B?\,?^"?&M
MZYJGQU\56WB'5;C6+W3]/U:Q^USY7<MOJULN(HMS);Q%B[I;Q$11;RJ#%?O]
M1111117'R>/]+BUF/P\;F/\ M:2SDOEM 29!:QRQPM,P (1#)(J)O*F0B38&
M\J79\X?MO:?XHD\&ZG?>&M=_L/\ L_3]0N[IH[,3W%RD-M(X@AG:9/LF<,3/
M&CSJ_EO&\>QEE^3_ /@C5JUQK_@75[R\EDGN9_$EY+--*[/))(]I9,[N[$LS
MLQ+,S$EB22237ZWT44444444444444444445Q_@/Q_I?Q/L$U31KF.\L9))X
MX[B(DQR-;S/;R%&P Z"2-PLBY20 .C,C*Q_.#]N?]ACQ5^T_XJT+7-#UV/3K
M;3HTC=)'N%DM)%N/--[9"+*M<,I4$%K4YM8/WY!!A_4^BBBBBBBBBBBOR@^'
M'C[_ (;_ /&GBG2YM4N/^$&T#R+2/3;*3[.NJO<1W4$L]S>VLWG2VA*3&."*
M1(+B(VLDB*T<J3?*'Q5_8^^(/[%/C&UUSX0_;+S1]2O(E;349Y8XI/G"VVH(
M759;+;)((;R9E-J&;S)X9UBNI_J_X<>/O^&__&GBG2YM4N/^$&T#R+2/3;*3
M[.NJO<1W4$L]S>VLWG2VA*3&."*1(+B(VLDB*T<J3?&'[0/[#_Q!_95\0&\^
M$,^J'1]=D^S-:V<S^9:22I)&L=R2VUK=%ED:UOYB#9DYDFBG2*YG_0__ ()S
M_L=^(?V0M.U:VU[4K>[^WW$$D%K:/,]O!Y2,KS S)%^]FW(D@6(?);Q$R29"
MQ?H_11111111111111116?JT=Q-;RK9R1Q7)C<0R2QM+&DA4[&>-9(FD0-@L
MBR1E@"HD0G</Y\?A]=>*-+_:9TW0O$^O7&ORZ;]I\J>2(6T*_:-":5O)LXW:
M&WR"BR>5CS6C$KY=C7ZG_MY?LXZS^U+X.;P_H>H1V-S]LM[AUF:5+>YCCW@P
M3M$&8(&9;A<QR@S01C8I(EC]/_98^$VH_ OP7I'AO5;W^T+VPMS'+< N5^:1
MW6&,R$N8H%9;>$D)F*)"(XAB-/H"BBBBBBBN/D\?Z7%K,?AXW,?]K26<E\MH
M"3(+6.6.%IF !"(9)%1-Y4R$2; WE2[.PHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHK/U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!7YX?#[_@
MIAX7^,GCO3?!?ABWN+Z*]^T^;JD@-M"GDVC72^3#(GG2Y*/%)YJVWELH9/.0
M@U]G_%[XT>'_ ("Z6VL^);Z.PL5D2(2.'=GDD/RI''&KRR/@,Q6-6*HKR$!$
M=E^(/@__ ,%//#7Q9M]=U$6-Y:V.E2:=!8HVV74-4NM06<1VEO91;A]H:2!D
MB1)I0Z'SG:!$DV>07O\ P5R3P9XEAT?Q5X2U30-.GD)%W>M(ETEJS.D5T]@U
MJK%"R_O5BEE* 2B,W#QA'_8ZOB#]H+]M[3OA%KEMX.T33[CQ'XNO-GDZ7:2)
M&L6\JP^UW#;A;YB+SCY)-D2>;-Y$$B3'X _;U_:UUC5/!.L^$/&OABX\,:EJ
M5O93Z2WVR/4;>\^SZA;O<Q>?;QK'%+&BB38Q;Y#\YB9[=9_L_P#X)G:M;Z!\
M&-$O+R6."V@CU26::5U2..--0O&=W=B%5%4%F9B H!)( K/^'W_!3#PO\9/'
M>F^"_#%O<7T5[]I\W5) ;:%/)M&NE\F&1/.ER4>*3S5MO+90R><A!K[/^+WQ
MH\/_  %TMM9\2WT=A8K(D0D<.[/)(?E2..-7ED? 9BL:L517D("([+\ ?##_
M (*N>&OB@^IBUTG5':VDLX],L+=%NM6U-IXYI+@Q6,1*QI:K [RR>?(GE%2S
M1RO'"_H'[&_[>%Q^U5K.JZ'>>&[S1;G2HPTSO*T\:2"4Q/;W!:"W:WN-P)CB
M96,@BN,[##A^P\=_MC3W&N7OACP%H-QXLU?2O+.I^5=V]E8VFXNIA>]GW(UV
MK*H-NJ'CSAY@DMIXDX_X0_\ !0*W\1^)5\&>--$O/"7B&>1ULX;N19;6Z ;R
MXQ#=;(0[RR+,D!5&MYC&%BN9)94B/W_JVK6^@6\MY>2QP6T$;RS32NJ1QQHI
M9W=V(545069F("@$D@"OSPTC]N7Q'\7)99_AYX'U#7M%BRJZI=WT&D0W#"6:
M(M:"Z1O/B_=9+!EEC8^7-!"P7?T'[*G_  4'T/\ :1U&7P[>6=QH/B:W\T2:
M9=L#O:%Y%EC@D*QN\L2H'GADBAE3+[4E2&61?D#_ (*E_M@:MI&AWOA/2-'U
MBTM+JX^Q7NN7-I<6EI*H D:WL93L\_SMDL4KOB*2WCF$:7$4PFC^G_V*?VG/
M^$ET7POX8_X1GQ1;;='LX/[5N-+\O2S]FL5/FK=>:<Q2^7B!]G[PO&,#=Q\0
M?\W>?Y_Z%ROUO_:8_:6LOV6M+CUK5--U2]TXR>7-/I\4$JVS,5$9N!+<0LB2
M,=B2 ,@<"-V1Y(5D\_\ V9_VV--_:N>1O#^B:XEC!)Y4^H745G%:Q2>6T@3(
MO7ED? 4,L$<IC,D32"-)%>O3_P!HO]H2U_9IT=M>U+3M0O--AQ]IGLOLC?9]
M\D4,7F)<75O(WF/*%7R5EVX8OL7!;H/@7\88OCSH<'B"VT_4-.M+OYK9-0CB
MBFFAP"DZI%--B*3)\HN4:11YBJ8GCD?V"BBOYL?V8_C1X?\ @+\<?'VL^);Z
M.PL5DUR(2.'=GDDUJWVI''&KRR/@,Q6-6*HKR$!$=E^P/$__  5IN/AIJD4/
MBCP-KFCZ3<27 M[JYW174L<0^5DM+B"")GRT7G(MRPA$F1))A0_ZG>%OB7IW
MQ!T./Q#H#_VK97%NT]K]F9 UQM!_=)YS1(DNY3$R3M%Y4H*2F(J^WX \+?\
M!5;PSXTUR/PS8>'O%$NM2W#6PLC96:3+,A(D217OE\KR]K&9I-BPJCM(45&(
M_1_^V9_[.^V_8KC[1]G\[[#NM_M&_9N^S[O.^S>;G]WGS_(W\^=Y?SU\H?!/
M]MC3?CMXEO\ POIVB:Y!=Z5)-%J4]Q%9BULY(F>,I+-#>S!G>2-HXEB$AD*L
MX'DQRR)]GUY?\7OBBGP@TMM3?3]4U1A(D:6>E64E[=2,YZB-,*J*H9FDE:-
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M4'U,6NDZH[6TEG'IEA;HMUJVIM/'-)<&*QB)6-+58'>63SY$\HJ6:.5XX7]
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M*************************************_ '_F[S_/\ T+E?O]7X _\
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MOOQ0M_!GPWDT=O+>YUR\MK>-#,J2)';R+>23K'@M*BM#%"^-H0W$;%\[4?[
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MXA_[AW_IRM*/^"7'_)(?#W_<1_\ 3E=U\ ?\%SO^91_[C'_MA7[_ %?SX_\
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M>.15,31*-I^4/V>O^">.B_LOZB^H>&M=\00^=Y0NK:2>QEM[I(G#A)HVL?\
M>421F.>-))%CEC\QB?L_Q_X TOXIZ7<Z+K5M'>:=>1F.>"0':RY!!!!#*ZL
M\<B%7C=5D1E=58?C#J?_  0^T:75!-:^)+R/2?,B)M9+.*2Z,8"^:HNUDCB#
ML0_EO]F(C#*&CEVDO^IW[/7[,7A?]E_3GT_PU:>3YWE&ZN9',MQ=/$@0/-(W
M_ F$<8C@C>21HXH_,8'H/CI\"]#_ &B]#G\/^((/.M)OF1UPLUO,H(2>!R#L
ME3)P<%64M&ZO$\D;?D#_ ,..M._M'S?^$GN/[-^T;OL_]GI]H^S[\^5]I^T>
M7YNSY?.^S[-_S^1M_=U^MWPA_9^T;X"^&E\,^&A)80+&X-TGE/=/<2+M:[D:
M2-XI+C(5@9(VA4*D0A$")$ORA_P[2T7_ (2C_A-/^$E\4?\ "0_:/M'V[[78
M[]^-NW;]@\ORMG[GR-OD>1^X\OR?DK]#])LGTZWB@EFDN9(XT1YY1&))650#
M(XB2.(.Q&YA&D: D[45<*-"BOS UK_@FM%X/\4-XL^''B"X\(WLWGBXMX[.*
M]LRLP3,<-N[Q(D6Y6E,,OGQ+(8S"EN((U'J&D_L3/XVN(KSXE:_>>,9+61'M
M;.6&/3]*C:)@T4KZ=:MY4]PI:9&DF9TE@F,+PLJ*:^K_ (E^!Y_B)ISZ?!JF
MH:1YNX27.G-;I<%&1D9%DG@N/*SN#"2$1SHZ*R2I@AOD#]GK_@GCHO[+^HOJ
M'AK7?$$/G>4+JVDGL9;>Z2)PX2:-K'_>421F.>-))%CEC\QB?O\ HKQ_XZ?
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MYKFH6>FVSR"))KRXBMXVD*LP0/*RJ7*JS!0<D*QQ@''E_P#PUC\//^AK\/\
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M1I(X@EK:PK)<7#AY8PRP1R%0X9@%YKXP\.?\%1O UWKA\/:Y;ZQX:O1Y8/\
M;5DMJJO*8_+279+,\&Y9!+YDZQ0+$"[2J"N[]'Z*************^4/VJ?VR
M?#7[(-O8SZ^EY-)J,DJ6\%G"LDA6%5,LA,LD,2HADB4@OO8R+M1E61D^C_"?
MBFS\<Z=::KI\GG65];PW-M+M9-\,R"2-]KA77<K [6"L,X(!R*Z"BBBBBBBB
MBBBBBOD#]HO]NGP-^S%N@UF^\_4EQ_Q++(+/>#/E']XFY8X/DE65?M,D/FQA
MC%YC#;7T_P"+/%-GX&TZ[U74)/)LK&WFN;F7:S[(84,DC[4#.VU5)VJ&8XP
M3@5\X?LK?MD^&OVOK>^GT!+R&33I(DN(+R%8Y LRL8I 8I)HF1S'(H ?>IC;
M<BJT;/\ 5]%%%%%%%%%?"'Q6_P""B/@[X9V\M]:PZIKVG6TGE7FHZ-9_:M/M
M9"L+(DM^\D5H7?SXP%AEE*N=D@C<JK>W_L]?M.^%_P!J#3GU#PU=^=Y/E"ZM
MI$,5Q:O*@<)-&W_ E$D9D@D>.18Y9/+8CZ HHHHHHKXP\&_MY>#O'7CRY^'E
MHUY_:UO)<PB9[?;:RW%HI:X@C?>90\82;+21QPL87V2/NA\WZO\ %/BS3O U
MG)J&JW=O8V4.WS;FYF2&%-[!%WR2%47<S*JY(RS!1R0*\ _9[_:\\+_M0WFJ
MVWAB2XN(M(^R>;=20&&&;[6LC+Y(D*S?(8G23S8HOF *;T(:OI^BBBBBBBBB
MBBO/_B7\5=#^#>G/JOB&_M]/LDW#S9W"[V5&D\N)?ORRE4<I#$'EDVD(C'BO
M/_V=?VE-#_:ATZ\U7P]]H-E9ZA-8>;/&(O.:)(I/-B7<S^4ZRH4\T12]0\2$
M8KZ HHKQ_P",?Q^\+_L_V:WWB?4[?3XGSY2R$M--M9$;R8(P\TVPR(9/*1_+
M5@[[4RP/@)\:]._:)\.6?B?2H[B&ROO.\J.Y5$F'DSR0-O6.25!EHF*X=LJ0
M3@Y ]@HHHHHHHHHHHHHHHHHHHHHHKQ_XQ_'[PO\ L_V:WWB?4[?3XGSY2R$M
M--M9$;R8(P\TVPR(9/*1_+5@[[4RP/@)\:]._:)\.6?B?2H[B&ROO.\J.Y5$
MF'DSR0-O6.25!EHF*X=LJ03@Y ]@HHHHHHHHHHHKQ_XQ_'[PO^S_ &:WWB?4
M[?3XGSY2R$M--M9$;R8(P\TVPR(9/*1_+5@[[4RP/@)\:]._:)\.6?B?2H[B
M&ROO.\J.Y5$F'DSR0-O6.25!EHF*X=LJ03@Y ]@HHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHKYP_:!_:S\'?LRVYE\1ZC'%<F/S(;"+][>3@K(4V0*=RH[1
M/&L\OEVXD 1YD)KU_P"'OC6W^)6C:?KEFLB6VI6=O>0I*%$BQW$2RH'"LRAP
MK ,%9@#G#$<GL*************S]6U:WT"WEO+R6."V@C>6::5U2..-%+.[N
MQ"JBJ"S,Q 4 DD 5\P?"K]M/P=\;_%5UX3\.7,E_<V=G+=37<4?^AXAN$MWB
M25F5I7W2(ZR1(]N\;!DG8_+7U?1111111111111111111111111111111111
M1111111111111111111111111111111111111111111111111111116?JVDV
M^OV\MG>11SVT\;Q30RHKQR1NI5T=&!5D92596!# D$$&OY,OVY/V8O\ AB?Q
MS::AI]I;W'AZZN%O=+MKM_M43_9FA>XLKJ-MDCQ*[A<,6\RUDC4SR3"8K_4;
M\%_B]I?QZ\/V/B71FD:QOXR\8E0QR(R.T<D;KR \<B/&Q4LC%2R.Z%7;@/VL
M_BK;_"+P=J-Y+:QZA<W4?V"PTV2);@7]Y>9@@M?LQ=&N4=FW3PQDR-;I,55B
MN*\/_8%_8HT[]E/0XKNYAW^)M0MXVU*XDV,T&X*YL82C.BQ1-@2.C-]IE02L
MVQ8(X?O^BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOS0_P""J?P]
MT;4?AKK6N3Z?9R:M;1Z?%!?O;Q-=11G4;<%(YRIE1")) 55@")'X^9L]A_P2
MX_Y)#X>_[B/_ *<KNOO^BBBBBBBBBBBBBOQ1_9U^)K_'7]I#Q+<:A!&5T'2[
M_3M.5UCD:W6ROH+9Y(Y!&C!Y6ENG).71+E[?S&B S]G_ +9O["^A_MAV<+3R
M?V=K5IA;;4XX1*PAW;G@FCWQ^=$<LT8+HT,I+HP5YHYOJ_X>^"K?X:Z-I^AV
M;2/;:;9V]G"\I4R-';Q+$A<JJJ7*J"Q55!.<*!P.PHHHHHHHHHHHHKP_XW_L
MW>$_VC[>WM?%6FQW\=I(TEN3)+#)&SKM<++ \<H1@%WQ[MCE(V92T:%?8-)T
MFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ JJH 4    5H4444444444444
M5_.C_P %JOA[HW@ZX\.7FF:?9V=S?R:Q+>S6]O%#)<R;K)M\[QJK2OND=MTA
M8Y=SG+'/]#VK:3;Z_;RV=Y%'/;3QO%-#*BO')&ZE71T8%61E)5E8$,"000:\
M?^"'[-WA/]G"WN+7PKIL=A'=R+)<$22S22,B[4#2SO)*44%MD>[8A>1E4-(Y
M;W"BBOE#]M/]IA/V4?!USX@6..>^>2.UT^"7S/+ENI=Q&\QJ2$CC26=E+1B0
M1&$2QO(C5]7T4445^<'_  53^,=Y\(OAK=1V*_O=:N$TEI<K^ZAN(II)SM='
M#^9%#);X&QD\[S5</&H/T!^REX3TZ7X8^&]/:TMS97/A^P^T6QA0PR_:K5'N
M/,CQL?SFDD:;<#YK.[-N+,3X_P#LR?\ !/C0_P!EGQ;JWB;1[RX:WOK<VUII
M[J"MI#))'-*AF9FDG^>)! S;&CB#+(;B0^:/O^BBBBBBOG_0/V6/!?A;Q1<>
M-++2+>+7[GS#)=@R'YI0%ED2(N88I9 "))HT263?+N=O.EW^H>-?A[HWQ*MU
ML]<T^SU*V202I#>6\5Q&L@5E#A)590X5F4,!D!F&<$Y_#'_@AC_S-W_<'_\
M;^OW^HHHHHHHHHHHKY0_;4^'NC>,? OB"\U/3[.\N;#0]6ELIKBWBFDMI/LC
MMO@>16:)]T:-NC*G*(<Y48^+_P#@BI_R3S4O^Q@N?_2*QK]?Z*^4/@C^TPGQ
ML\8^+O#]G'']A\,R6%JLX\SS)KJ3[4+S<'5 J120B!%56#&.282NDL:Q_/\
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MVY+11%EFD:8"W,<F?JW[#OB#Q7;RW&I_$7Q8=;EC<&XLKE-/T\2!2L++IMN
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MVMR5KR^3]HKXF_\ !-SQC'H_C:]O/$GA>[DDDBN)V,TEQ WEJ9[6>=FECN(
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M]BGX5>.]+T7POJM]XQ^V: ='LY%T3^Q;2+;#+8J((?MJ.9CY!:,^81NE\K#
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MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOYP?\
M@MI\--.\/ZYH7B&V3R[W5;>[@N]JHJR?83!Y4K;5#M*5N#$SNS?NHH$4*(_F
M_;[]D[_DGGA3_L7])_\ 2*&OH"OY\?BCX\M[K]JO3XO$+QRV-A)965BDD"R+
M')/IWFVB@(A)?[?="2.5\F%V5]Z)$I3^@ZOYT?\ @M-X;N/"'BKPUXJL[N2&
MYFLY;>$1;HY+>33K@7"3I,K[@Y:\&W:%,9A#!V+X3L/^"YW_ #*/_<8_]L*_
M?ZOP!_YN\_S_ -"Y7W__ ,%1_P#DD/B'_N'?^G*TH_X)<?\ )(?#W_<1_P#3
ME=U]_P!%?C#^WM^P9XM\<^*%^(/PYN?(U<V\<=U#%=R6=X\R 6PFMKAI%B7=
M;,(I8R]LHC@)4S23LM>'_ W_ (*CZIX0O3X8^,^FR%HI+5Q=/IXANK><3I<1
M2WMFPC79&K13PR6T231B"-UAN)9!(GZ'_P#!4?\ Y)#XA_[AW_IRM*/^"7'_
M "2'P]_W$?\ TY7=?,'_  6T\+6=WX-T;57CS>VVL"VAEW,-L-U;3R3)M!V'
M<UM =S LNS"E0SAO/_VX?%-YX?\ V<_!]M;2;(M0M_#UM=+M5O,A736N@F6!
M*XEMX7W(5;Y-N=C,K?I?^PMJ>EZM\,O#$FCB,6PTNWC<1Q&)?M40\N])4JN7
M-RLYDDP1*Y:4,X?>V?\ M^>!?^%B?"_Q-9>=Y'E:>][OV;\_V>ZWWEXW+CS/
ML_E[LG9OW[7V[&_-#]A'5KC4?V=O&T4\LDD=M'X@B@1W9EBC.E12E(P20B&2
M220JN 7D=\;F8GV__@BI_P D\U+_ +&"Y_\ 2*QH_P""U?\ R3S3?^Q@MO\
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MX[WCQ/()'BBB(!BBA79MA4@%2<EOF(( _)#]@7_DX7Q[_P!Q_P#]/-O7W_\
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M,);J62:18XH@\CL[".'Q L42 L20D<:)'&O1$544!5 'W?\ \$N/^20^'O\
MN(_^G*[KX _X+G?\RC_W&/\ VPK]_J_ '_@AC_S-W_<'_P#;^OW^HK\@/^"U
M?_)/--_[&"V_](KZOO\ _9._Y)YX4_[%_2?_ $BAK\@?V^O^3A? 7_< _P#3
MS<5^_P!7X _\$,?^9N_[@_\ [?U[_P#\%J_^2>:;_P!C!;?^D5]7W_\ LG?\
MD\\*?]B_I/\ Z10U^0/_ #=Y_G_H7*_7[]K'_DGGBO\ [%_5O_2*:O@#_@BI
M_P D\U+_ +&"Y_\ 2*QKP#_@N=_S*/\ W&/_ &PK]COVF]6N- \"^);RSED@
MN8-#U.6&:)V22.1+25D='4AE=6 964@J0"""*_$'_@EU^SS;_&_PKJ,J^*_$
MFCW-MJCK)8:-JRVD?EO;P&.XE@\N1M\C++&)3@.(-@R8FK[_ /&O_!,/1OB5
M;K9ZYXL\::E;)()4AO-7BN(UD"LH<)+:LH<*S*& R S#."<_.'_!1?X>Q?LK
M?!+3O!^@7-PVFMK$5M,USY4DTL,C7FHE'=8D48N$C96C5&VH$)*E]WZ??LG?
M\D\\*?\ 8OZ3_P"D4-?D#_P7._YE'_N,?^V%?O\ 5^ /_!#'_F;O^X/_ .W]
M?K]^T[\2/"7PL\+W>H>-4M[C2/D5K.>&.X^US ^9#!%;R_)+*60.@;"IL,SM
M''$\B?&'PXUSXL_MJ6\&LM=1^!?"5W&_E06R"YUB\MY%A4R"XGC5;9'7SVL[
MN%89H\I)]GN(S#<'Y0_X(8_\S=_W!_\ V_H_X+G?\RC_ -QC_P!L*_?ZOY@?
M^"7_ ,+O^&BM1\2_;O%/B#2=2/V2Z;^R]5^RW%]YCW/GSW&])9+CRW:/,A^X
M]P=Q+3+7ZO\ BG_@FSIWCFSDT_5?&7CB^LIMOFVUSK230OL8.N^.2U9&VLJL
MN0<,H8<@&OI#]E_]E_1OV3-&GT/0Y[R>VGO'O'>\>)Y!(\441 ,44*[-L*D
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MFAO9"0Y1)[MU2*%()+@![=6N(]TQE:4_M=^R=_R3SPI_V+^D_P#I%#7Y _\
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MO[1_L&YU"X_M/[-Y_P!MEADV_9O.V>7Y,$.,^<V[=NSA<8P<_7]? '_!4?\
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MMKMCJ=O=Z7H_]B_;KNV)N(8_(U&6[EV/$'$VR*1&;R?,^8F+_6JZ+^_WB/\
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M_P#9HUC3]1L/BMX0A_T_2/+DU)HDC9T^QNLMK?\ DF(^=Y6"ER\C2;(([?\
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M/_:&3]GW_P!D?8-WF8V^5]H^3S_]1L_?>9Y'[ROM_P#X+$?\5A\,=.U#3?\
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M?\+>$].\#6<>GZ5:6]C90[O*MK:%(84WL7;9'&%1=S,S-@#+,6/))KH*\_\
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MX-\<WDFH:KX?T>^O9MOFW-SIUM-,^Q0B[Y)(V=MJJJKDG"J%'  KU#2=)M]
MMXK.SBC@MH(TBAAB14CCC10J(B* JHJ@*JJ %    %?DA_P6K_Y)YIO_ &,%
MM_Z17U?6'P$^"'A7XE>!?"5YKFB:7J5RGAO2(DFO+&WN)%C%I&P0/+&S! S,
MP4' +,<9)S]?Z3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550 H
MK0HHKQ__ (9Z\&_VC_:__"/Z/_:7VC[5]L_LZV^T?:-_F>?YWE^9YN_Y_,W;
M]_S9W<U[!117E^I_!#PKK6J#7+K1-+FU99(I1?R6-N]T)(0HB<3M&90\81!&
MV[*!5VD;1CL-1\)Z=J]Y:ZA<VEO->V/F_9+F2%'FM_.4)+Y,C O%YB@+)L*[
MU 5LCBN@HHHKC_&OP]T;XE6ZV>N:?9ZE;)()4AO+>*XC60*RAPDJLH<*S*&
MR S#."<Y_P#PJ?P]_8__  CW]E:?_8O_ $#OLD/V/_6>=_Q[[/*_UO[W[O\
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M1111111111111111111117'V7Q"T;4=4FT.#4+.35K:,2SV"7$37449"$/)
M&,J(1)&0S* 1(G/S+GL*********Y_0/%FG>*_M']GW=O=_9+B2UN?(F27R;
MB+'F02["=DJ9&^-L.N1D#(KH*****Y_4?%FG:1>6NGW-W;PWM]YOV2VDF1)K
MCR5#R^3&Q#R^6I#2; VQ2&; YKH**********X^R^(6C:CJDVAP:A9R:M;1B
M6>P2XB:ZBC(0AY( QE1")(R&90")$Y^9<]A1111111111111117E_C7XW^%?
MAK<+9ZYK>EZ;<O&)4AO+ZWMY&C+,H<)+(K%"RLH8#!*L,Y!QZA1111111111
M111111111111111111111111111111111111111111111111111111111111
M111111117X8_\%GOAH]KH-IXC?5=4E675+6T32WGC&FPJ+6[?SH[=(E8W!96
MS/+)(^V1XP1$(TC_ %._9._Y)YX4_P"Q?TG_ -(H:^@**************^,/
MV]/AH_Q!\"ZQ.-5U33H]-TO4[MH+">.".\:.TD*PWA,3RR6^ RO CQI(';>&
M98FC^3_^"*G_ "3S4O\ L8+G_P!(K&OU_HKR_P"&GQ>TOXM/JJ:6TCKH^J3Z
M5<NZ%%-U;QQ/,(\_,R(TOE%B%#.CE-T6R1_4****S]6LGU&WE@BFDMI)(W1)
MXA&9(F92!(@E22(NI.Y1(DB$@;D9<J?YT?A;X _X5?\ M2V^D?;]0U/[/YG^
MF:E<?:;R7S- >3][-M3?MW[$^4;8U1><9/\ 1]111117RA^V3^RM;_M?>&DT
M">^DTZ2&\AO(+A(EF421K)$1)$6C+H8YI  LD95]C[F56C?O_P!F[X(6_P"S
MAX3TWPK:W$EW'81R W$BJC2232O/*P1<A$,DC^6F7*)M5I)&!=O<********
M***************\/_:1^"%O^T?X3U+PK=7$EI'?QQ@7$:J[1R0RI/$Q1L!T
M$D:>8F4+IN59(V(=> _8V_96M_V0?#3Z!!?2:C)->37D]P\2PJ9)%CB CB#2
M%$$<,8(:20L^]]RJRQI]7T4444444445X_\ '[XQV?[/_A?4_$]\N^+3[<R+
M%EE\Z9B(X(=R)(4\V5XXO,*,L>_>PV*Q'P!^Q+\"]#_:9\"1^+/'4'_"1:UX
M@^VK<W6I8G:VACN[J%(-/X7[!$N7E46OE,DLC%654A2+@/V5/V$O&G[)?Q0E
METB^\WP-<6\K7$DDL8>X79(+:UFMP"3=P2LL@N$6.)H!(5EB:>2S/[/44444
M4445Y?\ #3XO:7\6GU5-+:1UT?5)]*N7="BFZMXXGF$>?F9$:7RBQ"AG1RFZ
M+9(_J%%%%%?G!\1?^"<^G?$+XH6OQ)?5KB+R;BQNYM/$"-YEQ8(BPE+@L/+B
M/DP&2-HI7;$H65/,3R?T?HHKR_XO?#1_BUI;:6FJZIHZO(CO<Z5/';W15#GR
MQ,\4K1H6VEC%L=@NPOY32(_XH_\ !#'_ )F[_N#_ /M_7[_4444444444444
M444445^6'_!63X:/KW@'4=>.JZI#'IT=HBZ9!/''I]PTU_;HTEU$(O-G=0RF
M(/+LB>-'1%9I3)ZA_P $N/\ DD/A[_N(_P#IRNZ^_P"O+_B]\-'^+6EMI::K
MJFCJ\B.]SI4\=O=%4.?+$SQ2M&A;:6,6QV"["_E-(C_BC_P0Q_YF[_N#_P#M
M_7ZG_MD_LK6_[7WAI- GOI-.DAO(;R"X2)9E$D:R1$21%HRZ&.:0 +)&5?8^
MYE5HW[_]F[X(6_[.'A/3?"MK<27<=A'(#<2*J-))-*\\K!%R$0R2/Y:9<HFU
M6DD8%V]PHHHKP_\ :1^"%O\ M'^$]2\*W5Q):1W\<8%Q&JNT<D,J3Q,4; =!
M)&GF)E"Z;E62-B'7@/V-OV5K?]D'PT^@07TFHR37DUY/</$L*F218X@(X@TA
M1!'#&"&DD+/O?<JLL:?5]%%<_P"+/%-GX&TZ[U74)/)LK&WFN;F7:S[(84,D
MC[4#.VU5)VJ&8XP 3@5^4'["FFZ=^V]%KGCSQI;?VM*VL75GING:B4O+'3+/
MRK681VMN\:PK*P:..:X$8DE$*M\KR3F7@-$_X)U>*/V=/BKI6O?#RZ\KPS<7
M&Z_66<!K6SWJ]S8RK)N>ZBF4;;1PLDB2B,S-$\"7K_M]111111111117/^+/
M%-GX&TZ[U74)/)LK&WFN;F7:S[(84,DC[4#.VU5)VJ&8XP 3@5G_  ]\:V_Q
M*T;3]<LUD2VU*SM[R%)0HD6.XB65 X5F4.%8!@K, <X8CD_"'Q%_X)SZ=\0O
MBA:_$E]6N(O)N+&[FT\0(WF7%@B+"4N"P\N(^3 9(VBE=L2A94\Q/)_1^BBB
MBBBBOC#]O3X:/\0? NL3C5=4TZ/3=+U.[:"PGC@CO&CM)"L-X3$\LEO@,KP(
M\:2!VWAF6)H_D_\ X(J?\D\U+_L8+G_TBL:_7^BBBBBBBBBBBBBBBBO+_C1\
M7M+^ OA^^\2ZRTBV-A&'D$2&21V=UCCC1> 7DD=(U+%44L&=T0,Z^H444444
M4444444444445^<'PZ_X)SZ=\/?BA=?$E-6N)?.N+Z[AT\P(OEW%^CK,7N Q
M\R(>=.8XUBB=<Q!I7\M_._1^BBBBBBBOC#]O3X:/\0? NL3C5=4TZ/3=+U.[
M:"PGC@CO&CM)"L-X3$\LEO@,KP(\:2!VWAF6)H_D_P#X(J?\D\U+_L8+G_TB
ML:_7^BBBL_5K)]1MY8(II+:22-T2>(1F2)F4@2()4DB+J3N42)(A(&Y&7*G^
M='X6^ /^%7_M2V^D?;]0U/[/YG^F:E<?:;R7S- >3][-M3?MW[$^4;8U1><9
M/]'U%%%%%%%%%?G!\.O^"<^G?#WXH77Q)35KB7SKB^NX=/,"+Y=Q?HZS%[@,
M?,B'G3F.-8HG7,0:5_+?SOT?HHKR^3XO:6GBJ/P<&D;5GTN3564(?+2U2XCM
ME+2' +R2.P14W$"*0OY>8O,]0HHHHHHHHHHK\T/^"HW[45Q^SQX.6RTFXDMM
M;UR1K>UFB9DD@MXMK7<Z/Y;*'"M' N&BF0W GB?= <=A\2_^";O@;XA>%WT$
M6WDZE\TJZ^ZK-JDEXQ9WN;RY.V2[\UW=IXI&$;!L1"!D@>'C_P#@FI\ O'G[
M.>EZOHOB^:,Z='>*-(@2=9U509#<SQ$#=';W#-$\<4A1PZS2-;PO(S2_I?11
M111111111111111111111111111111111111111111111111111111111111
M111111111111117Y@:E^V]XA^.OBBY\*?"+3]/U%-.PU_K^I23?V6G$@,48M
ML2/O<(D$R._G%)F2![9/M8_/#_@II\9O&LN@P>#O'^EV<&HC5+?4=/U+2O..
MFW=JEK<0SQ@W#&9;B&6= P."5?)CC00RW7[G?LG?\D\\*?\ 8OZ3_P"D4->(
M>/\ ]JG6?&7B6Y\$_#.QL]4U:PC+:KJM]+*FDZ7(&&VWF,"F6XN'"R1^5"R&
M&7!/F>1=I;_/_B3]NOQK^RQX@M-,^+6DZ7'I.IR;+35]%EF:-%B1#<2-;3/+
M<2I&\\"N"MLZA97B2[^13^I__"6:=_9W]K_:[?\ LW[/]J^V><GV?[/L\SS_
M #L^7Y6SY_,W;-GS9V\U\ :!^TG\0_VF/M&H?#+3-'M_#UO<200:IXA:]7^U
M-N%:6SM[5%DBBC=9%9YBWF[D4"*:*XACY_\ 9Z_X* WFJ^*'^'WQ)TZWT#Q4
MGE+&T,ZR6=S-.!+% ,23""5HI(?*!FG6>3>FZ*8Q6[]!^V_^WU+^RE$]M8Z#
MJ%[=MLC2_N+>6#2(YI8I9$07)7_2I4V([V\)56C,B_:HY8I$7GX/VSO&GQ;\
M/64GPW\/6^OZO_9]A+JUZUQ';Z78WUQ##/)9Q":>)[N5%9Q-'%.#9%X!*\DC
M/$OF'[*/_!4Y/&-QJ^E_$J*S\/WVF1S3B4"2WC*P,L<UHUO<2R7!O5<DI#%Y
MCS 2((HWA'G9_P"TI^W)\8?A59_\)):>"[?3?#)\M5FU-C=78\YF,,MS#:7<
M3V6]3&CPS(WDW!\EIV>1$K]'OV8OVA=._:@\+VGB73T\GSM\=S:F5)7M;B([
M9(7*'Z21EEC>2"2*4QQ^8%%#]IC]IC2_V:=+CNKJ.2]U2]D^SZ3I-OEKK4+I
MBJK%$JJS! S)YLNU@@9559)I(89?D_XE_&3X[_"[3G\3W6A^%Y](M]UW>:;!
M=7)U&TL8T:>99;F22.U>6*-#$\MNDX:8AX[:6/('U!^RC^U=H?[6NAC5=*/D
MW<.Q-0T]W#36DS D D ;XGPQ@G "RJ&!5)4FAB\?_:E_;>_X5)K%KX+\):?_
M ,)!XSU#*QV*2;8K3?&S12W3#_@,S0[H<6JO/+/;1F)Y?G#]JCXS?%?X0^%=
M53QUI>AWNA:KI>HZ<UWX?^V&2PNKJW:*TDNEO& -O)(_E,4 "E@3)YGDP7-_
M_@BI_P D\U+_ +&"Y_\ 2*QK]?Z^(/VVOC)X[^%.AWDO@O0_M?E:?<7-SK,M
MU:)#IZQ L[I:2R>;=2I$DD@4J(E;R3BZS) OY@?\$O\ XJ^._ W@V]MO#'@[
M_A(;)M8GDDN_[:M-/V3&VM%:'RIT9VVJJ/Y@.T^9M RAK]OOCI\=-#_9TT.?
MQ!X@G\FTA^5$7#37$S E(($)&^5\' R%50TCLD222+\H:3\5_C'\:[>+7/">
MD^&](T2ZC22R37;FZN+RZMY5$L-V1IQ,,"2Q21C[,[/-%(DFYV4H:X_]GK_@
MHQ_PF'BA_ ?CO2?^$:\21>5 NZ??;W5Y@;XTRH\GS<K)9#S+B.X1PJ7#NT'V
MC]/Z*_G!^*7Q(L_A)^U+<:S?)<310>6JP6L+3W$\TV@)!!!!$G+RS2R1PQ@E
M5WN-S(FYA]0?'']N3XP_"'/B>?P7;VG@PW%OY?VMB=1%O+MV_:O(NW^Q2R\K
M^^MBEK-)';OYT@'F_?\ ^RC^U=H?[6NAC5=*/DW<.Q-0T]W#36DS D D ;XG
MPQ@G "RJ&!5)4FABT/VF/VF-+_9ITN.ZNHY+W5+V3[/I.DV^6NM0NF*JL42J
MK,$#,GFR[6"!E55DFDAAE^3_ (E_&3X[_"[3G\3W6A^%Y](M]UW>:;!=7)U&
MTL8T:>99;F22.U>6*-#$\MNDX:8AX[:6/('U!^RC^U=H?[6NAC5=*/DW<.Q-
M0T]W#36DS D D ;XGPQ@G "RJ&!5)4FAB^GZ^,/VP?VQ4_9/L/M0T/5-7D\M
M9&D@@DCT^!6F2%1=:@8WBA=RS>5&BS.75%=8EFB=NP_8S^->H_M$^!-+\3ZK
M';PWM]]K\V.V5TA'DW<\"[%DDE<96)2V7;+$D8& /B_]MO\ X*87O[.%PVDZ
M-X?O&NS)+''J.JVT]MI\C0M"9#:)^[EO4 =XVD5X$1_*E1KB&12WH'QB_:X\
M>>([>XO/A/X9CUW2;*219=:N)5:WNFMU?[3'I]HD\%Q>(K[4CNH&D2::.>&&
M*7"2G0_X)\?MX?\ #7]G>66JP6]GK^G[9)8X&VPW%O(S!9H(I)'F7RCMCN 2
MZ*SPN)/WXBB_1^N/\?\ C)/A]I=SJDEM>7BVT9<6UC;275U,V0%CAAC!9G9B
M!D[40$O(\<2NZ_E#\-/^"KB>,/%^JZ9JFDR:7I=A9SK;63I)-K=[J27L5M#:
M1VX**+B59=IL@LC12H[O=>2CLGG_ ,;_ -OKXT_LXW%OJ'BCPAI=EHEU>,D2
MB5KB0QJV_P"SM>6]W+#'<&+(222!1(4DE2W98WC7];O@7\=-#_:+T.#Q!X?G
M\ZTF^5T;"S6\R@%X)T!.R5,C(R592LB,\3QR-XA\;_VS++X<>(+?P5H%A)XA
M\87<;21:7!<P6T<2HGG$75W.VR!V@62:*,+([!$W+&DT+OX?\2_C5\</V>].
M?Q'KVD>%]:TBSW-?6VC2:C%>1P[&_?[[D.BQ1-L:8K%,RQ[F*I&))HOJ#]E'
M]J[0_P!K70QJNE'R;N'8FH:>[AIK29@2 2 -\3X8P3@!95# JDJ30Q>?_&/]
MI;7'\6K\// 5EI][XA&GG4+R[U"Z*6.G0B1%59XK?=<RRR!E B7RFC%Q:S_O
M86D\OQ_Q3^U)\3O@=JV@:'XOT+1[C^W]8L;*+6M*GNOL,"SW$4<MO);W">;]
MK\KS9(G:6.)PRLJ2_9[A#]__ !5^)>G?!O0[_P 0ZJ^RRT^W>>7#(K/M'RQ1
M^8R(TLK;8H4++YDKH@.6%?$'A/XN?&OXFZ=:>*])T7PO#HMY;PWMOI%Q>W;Z
MI+;L@<1K=HB622W"_/ TB!(!+&LZ[DD%>P?L9_M)ZC^T_I.JZIJ6F?V/+8ZQ
M-IPL69WFA\BWMFD6=G2(F42RR@CRXMBA8RI=&=\_XW_M4W'AWQ!;^!?!EC'K
M7BVZC:2:-Y6CL]*MRGRW>HR(K,$#-&_V9-LTL; !XY)K1;CY?^*O[87Q2_9$
MN+6_^(>BZ'?>'+J2*W-YH4\\<D5Q(SN5"7LA>5UAAF?R_*BA<M&/MD9#+7Z7
M^%OBKH?C30X_$UA?V\NBRV[7(O2X2%84!,CR,^WRO+VL)EDV-"R.L@1D8#X0
M\!_M ?%?]INP3Q+X%TWPWIOAZ>2>*T&NSWDMY<K!,\9N2MB/*@1BOE^0Y=TD
MCD8221-$Y]0_93_:DUSX_:YXDT?7-"_X1^X\/_V?$]H\YN9C-<F[9W,H2*-H
MF2*%H#&A5E+2K-+'+'LZ#]HW]I:\^&NL:/X/\-65OJ7BK7_M'V6&XNE@M[.&
M&-F-Y=A=TS1*59EBC56N$@N4CE$T:H_R_P#'3]J3XO\ [*&ASZQXGT+P_JMO
M+^ZAN]'GO4AT^9@5C>_BN4:26*1V14,3P*&0Q/,DD\%?:'[3?[1:?LV:,^J'
M2=4U>3RYW6*PM9)(XE@B,C2WEP%,5K;@[0\C[G 9G2&58I=GE_[!7[4NH_M<
M^'M0U[4+6WL_)UBYM+:" NVVW2&WFC$KNQ\R4><5>15B1\ B).17U?X_\?Z7
M\+-+N=:UJYCL].LXS)//(3M5<@   %F=F(2.- SR.RQHK.RJ?A#PM^T;\2OV
MF[./6_AUH^CZ?H#[O(O/$=Q*TU]M8Q2>5:Z:TAMO(EBF1_/=_.5HI(]OSJ//
M_"W_  48U'X8^+8_ WQ5TFWT2];<%UFVG<Z;-OD(MIDCF4O%:2*"C7#32>5,
MI$T=N!.+;[0_:;_:+3]FS1GU0Z3JFKR>7.ZQ6%K))'$L$1D:6\N IBM;<':'
MD?<X#,Z0RK%+L^'_ -GG_@I+JGQPT:X>RT./4_%$VJ74>G:#97 A,>FP16\I
MNK^\N"T4**9FA6=DB6ZN/+AA@4F0Q^8>$_\ @I1XY^%OCFT\*?%;1-/TFWN_
M)1IK?=%Y'VA@L-TT\MW/;2VBG<D[(Z^5B1MYDMW@?]OJ*^</VF/VJO#7[*&E
MQZGXAED+3R>7:V=NJO=7# KYABC=XUV1JP:61V1$!5-QEDB23Y_U;Q=\?]:M
MY=3T[1?">G1^6[Q:1>W=W=Z@&C4CRVN;=H;%WE92T1W1HB2(DKJRNP/V2/\
M@H9I?[2NJ7?AS4]/D\/>([6214TZYF,C3+",3*CM% PN(65_.MFC#JB^8ID"
M3B#P_P#X*C_$3Q?_ ,(AXAT;_A%_^*;_ .)=_P 5!_:MM_S\VDO_ "#]OVC_
M %W^C?>_Z;?<XK@/V"OC-\1_"GPXT:RT'P)_;.FQ_;?(U#^W[*S\[=>W#/\
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MT2'3UB!9W2TED\VZE2))) I41*WDG%UF2!?S _X)?_%7QWX&\&WMMX8\'?\
M"0V3:Q/))=_VU::?LF-M:*T/E3HSMM54?S =I\S:!E#7[??'3XZ:'^SIH<_B
M#Q!/Y-I#\J(N&FN)F!*00(2-\KX.!D*JAI'9(DDD7XPU/XG?'_Q+I8\0:+X=
M\-VD,\<4D&AWT]V^K(K%5(FD+V=HKGF?RW:%XHB(74W",A]0_8R_;HT/]L.S
MF6"/^SM:M,M<Z9),)6$.[:D\,FR/SHCE5D(1&AE(1U"O#)-\H?'3_@JP?AKX
MJT[0HM#O--TY[RV-_J.M6ES;R-IYN)(9Y[2Q"K.4*+YL$\GSDK)$UEO'&_\
M$/\ :\^--EK.F-HWP]D&B:A)&(H[DM->21F5?FN9+>;R=)=XI(P4O8W%M()6
M:258W5#XD?\ !3"]T[QUH?@S2O#]Y9QZCJEA;S7FM6T]I)+:W%VUJ\EI9MY<
MH1@%>"XF8$$21O9AER/UOK\L-%_;,\:_M+^)=7T7X66&A_V=H,C1W6K:Q<S2
MP73,WEPFV2Q;<J.T5R\<F9TEA1)&:W=EBDS_ (:?M_>(?!GCE/AY\4-'M]/U
M*[N%BL-1T[SC9S^>RQVFV*4RR-%,XD47*R?NY"L,UO"T=P\?ZOU^ /\ P0Q_
MYF[_ +@__M_7[_5GZMJ::+;RW4HD:.&-Y'$44DTA5%+$)%$KRR/@?+'&K.YP
MJJS$ _D"O_!5Q&\?6WA[4=)D\.:%!'=2:G<:TDD6H*J6#74 6U0X@=I%")'F
M[>Z22+RECD<(<_\ :4_;D^,/PJL_^$DM/!=OIOAD^6JS:FQNKL><S&&6YAM+
MN)[+>IC1X9D;R;@^2T[/(B5^CW[,7[0NG?M0>%[3Q+IZ>3YV^.YM3*DKVMQ$
M=LD+E#])(RRQO)!)%*8X_,"CD/VCOVN]&_9ZN-/T<Q2:EXCUB18=,TFW>)))
M9)6,4#SRRLJ6UN\VV'SGW')=DBE$,VSP_P 4_$'X^>%K.37CHGA>YLHMMR^B
M6TU]+J_V<L&>V288M9;N.,LK/$KI)(A,,,Q:.%_0/V,OVZ-#_;#LYE@C_L[6
MK3+7.F23"5A#NVI/#)LC\Z(Y59"$1H92$=0KPR3?-_[;?_!3"]_9PN&TG1O#
M]XUV9)8X]1U6VGMM/D:%H3(;1/W<MZ@#O&TBO B/Y4J-<0R*6] ^,7[7'CSQ
M';W%Y\)_#,>NZ3922++K5Q*K6]TUNK_:8]/M$G@N+Q%?:D=U TB331SPPQ2X
M24Z'_!/C]O#_ (:_L[RRU6"WL]?T_;)+' VV&XMY&8+-!%)(\R^4=L=P"716
M>%Q)^_$47Z/T5^<'[;_[?4O[*43VUCH.H7MVVR-+^XMY8-(CFEBED1!<E?\
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M21YE\H[8[@$NBL\+B3]^(HN@_;O^(GB_P]X>US3=(\+_ -IZ+<>'[[[9J_\
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M)LQV4D,\3C[.VZ*3S5>XV& )$\M>_P#[+GQT_P"&E/"&G^*_L?V#[?\ :?\
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MF:S.S3Y=2\VX$1:0RQO<2M;O$$V21V[8#(SM^C__ !D+_P!4_P#_ "LU\_\
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MAJ @,5XJD[[0_9(0Z(@<H\PR^Y0OW_\ \9"_]4__ /*S7S!^S3^P5\0_A?\
M%!O'^M:AHZV][<:E/J5MIUS>CS?MR3/Y2QRVZ*\2W#Q2!)9&V^4KY:1%)\?_
M &^O^3A? 7_< _\ 3S<5^_U?@#^WU_R<+X"_[@'_ *>;BOW^K\D--\2?#?\
MX)R7^J>'?"%IJFN>*M8D6X_L2S\R\N$1(9YK: LJ;8;>)=['(N+\0SK/(EQ%
ML9?A#]H_Q%XH\5_'7P/>^*]+M]&NY+C0OL^GPW0O'AMUU:51]HN$ B>5Y1-(
M/) 18'A1OWJR5_2]7X _\$,?^9N_[@__ +?U^_U%?SXZGI-OK7[7(BNHHYHU
MDBE"2(KJ)(?#ZRQ. P(#QR(DD;=4=5=2&4$?L=^UC_R3SQ7_ -B_JW_I%-7P
M!_P14_Y)YJ7_ &,%S_Z16->0? +6O^%__M-:]J=ZUQ'_ ,([;ZA#8P^?YB+]
MC:/2F'S)\L4GGW%UY4>S9/+DN_SF3]WJ_G!^(L.H_LO_ +35K/I47V6T\0:A
M8GRS,[I=6^KLD%Z[JLN[_C[^T31QRX2.>&*01&)8@?0/^"YW_,H_]QC_ -L*
M_>[2=)M] MXK.SBC@MH(TBAAB14CCC10J(B* JHJ@*JJ %    %?@C^P+_R<
M+X]_[C__ *>;>OM_X]_\%0/!O[.WB.\\,:K9:Q->V/D^;);06SPGSH(YUV-)
M=Q.<+*H;*+A@0,C!/'_#W_@KMX%^)6LZ?H=GI^N)<ZE>6]G"\MO:"-9+B58D
M+E;QF"!F!8JK$#.%)X/'_P#!:O\ Y)YIO_8P6W_I%?5]X?L=Z3;Z+\.?"L5K
M%'#&VAZ=*4C144R36T<LKD* "\DCO)(W5W9G8EF)/XP?\%A/##_"7QKX;\<:
M1+';ZC<1D@I;Q[A=:5-%)%=2,VY9W*SQ1!9$(5+9%)="$3ZO_P""U?\ R3S3
M?^Q@MO\ TBOJ^_\ ]D[_ ))YX4_[%_2?_2*&OR!_;Z_Y.%\!?]P#_P!/-Q7W
M_P#\%1_^20^(?^X=_P"G*TH_X)<?\DA\/?\ <1_].5W7R!_P6T^&FG7/A[1O
M$^S;J4&H#3O,54'F6\\,\^V5MOF-Y;P9A&\(GG3G:6DROZO?L]>*;SQSX-\/
MZKJ$GG7M]H^G7-S+M5-\TUM')(^U J+N9B=JA5&<  8%?C#_ ,$,?^9N_P"X
M/_[?U]__ /!4?_DD/B'_ +AW_IRM*/\ @EQ_R2'P]_W$?_3E=U\8>/?&MQ\2
MOVIM'T/4UCFT[0XV6RMV#/&LC:3)J'V@QR,R"X$S(1+&J$"WMOXX0Y_;[5M)
MM]?MY;.\BCGMIXWBFAE17CDC=2KHZ,"K(RDJRL"&!(((->/_  0_9N\)_LX6
M]Q:^%=-CL([N19+@B26:21D7:@:6=Y)2B@MLCW;$+R,JAI'+>X5\_P#[6/\
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M!$(HI9)(8T3_ %:((R2RDG\8?^;O/\_]"Y7Z_?M8_P#)//%?_8OZM_Z135\
M?\$5/^2>:E_V,%S_ .D5C7@'_!<[_F4?^XQ_[85^]VDZ3;Z!;Q6=G%'!;01I
M%##$BI''&BA41$4!515 554 *    *_!']@7_DX7Q[_W'_\ T\V]??\ _P %
M1_\ DD/B'_N'?^G*TK/_ ."5FDV^G?"3198(HXY+F34)9W1%5I9!?7$0>0@
MNXCCCC#-DA(T3.U5 ^0/^"W'POM[K1M#\5+Y:7-O>/IL@$*^9-'<1/<1[ILA
MMD#6\NR,AAFYD8%#N$GW?XL\4WGCGX%7>JZA)YU[?>!YKFYEVJF^:;23)(^U
M J+N9B=JA5&<  8%?+__  14_P"2>:E_V,%S_P"D5C7N'_!3C]GZW^-_P^OK
MP"--1T&.74[69MH/EP(6NX2_ER/LDA5F$:&,/<16Q=PB&L__ ():?'2+XP?#
MJRL99_-U+0O^)?<HWE*RPIDV3*D9W>5]GV0K+(J-)+;SYWLC2-T'[*__ !>W
MQ;XF^)%Q\T0N)/#NA,OS0G2]/D#S7,$Z;([J*\NBTH<I(8&B:%+ATW*OW_17
MX _\W>?Y_P"A<K][M6TFWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP*LC*2K*P(8
M$@@@U^ /_!+JR?X5?%SQIX.L)I&TFVCOTVRB-I)&TW44MK:1Y%13O6.>8,$V
M(YD)*?*FWZ _X+'?L_6_C/PG#XS@$<=]H<D<4[G:K36=U*D00D1L\CQ3O&\*
MLZ1QI+=-AG=0?M_]DS]HJR^-7P^T[Q1>7L?F06>S5YYF@B$-U:(!=R3B-O*@
M1BIN5#>6!;R1R%(U8*//_P!@[2;CQ=I>H_$35(I(=6\97AO&BD1D:WT^V+6^
MF6PX1)D2!?-CNA%$]PDZL_F85V^[Z*_GQ^-^II_P3_\ CU;^*(Q)'X>\31M)
MJ),4GEJMU+MOPLK+</*\,Z1:D\< 1\21VJJD3J7_ %?_ &T_BA<?#7P=<PZ9
MYC:WK<D>BZ,D4S6\C:AJ.Z&%DN -L+Q+ON%>1HD)A">;&SJP]O\ A5\--.^#
M>AV'A[2DV66GVZ0195%9]H^:63RU1&EE;=+,X5?,E=W(RQK\0?\ F[S_ #_T
M+E?O]7X _P#!#'_F;O\ N#_^W]?O]7X _L"_\G"^/?\ N/\ _IYMZ^__ /@J
M/_R2'Q#_ -P[_P!.5I1_P2X_Y)#X>_[B/_IRNZ^ /^"YW_,H_P#<8_\ ;"OT
MO_X*'^-;CP!\*_$MY:K&\DEFMF1(&*^7?S164I 5E.]8YW:,YP'"EE905/P!
M_P $_=)^+FG?#S39?!T7@N/2;F2\E5[]-16^ED%U+%(]R;8")W!C$<;#)%O'
M"A/RX&A^U;^Q5\9/VP?[._MZY\'V_P#9GVGR/L4NIQ[OM/D[_,\Z";./)3;M
MVXRV<Y&/U^^$^@:CX4\/:5I^KW'VO4K33[2"\N?,>7SKB*%$FE\R0"1][AFW
MN [9W, Q(KT"OPA_X)4ZU_POGQ]XX\?WC7"WLWE1PP//YRQ6^H3RS"$NR!W\
MA;*W@@*^6BQ*R^7C8(_W>K^<']CB'4?V9OVA-3\%6D7V72]0N-1@-FTSRJMF
MD,NH:=*I$K!I5B6-5>;S)$BGG1@LKL5] _X+G?\ ,H_]QC_VPK]_J*******
M************************************************************
M**********^8/VT/@Y>?'WX?ZWX=T]L7MS;I);+A3YDUK-'=1PY=XT3SFA$/
MF,P6/?YA#!2I_-#_ ()$?M9Z-;^'SX%UO48[;4;:\=M*CN/*ACFM[ITQ;P29
M7S;C[3)*_E/F9Q.@B\Q(W6'H/^"U_C_2XO"NE>'C<Q_VM)JD5\MH"3(+6.WN
MH6F8 $(ADD5$WE3(1)L#>5+L^S_V;;WP]\>_A9I_AB#4K>YW>%['3M3CLKJ&
M2XM/M.GB!UD4>9Y,HQ(%$J<.C J=K"OQ1_84_:@N/V O$NK>$_'<%Y:6,\D2
MSPA&E:SO%9%%P$$H0V\D#EYI;=)Y+A([5HO,0+N_=[Q_^W'\.?A]I=SJDGB+
M2[Q;:,N+:QO;:ZNIFR L<,,<I9G9B!D[40$O(\<2NZ_'_P"U!\'?&/[2OP/@
MEURWDG\6Q2)K26%G'Y)4O+*1:&"5!*7M[&Y:,P#-PUQ J>9<2$^=XA_P3._X
M*%Z'I6AVG@CQ?>_8[NS\];&_NG"6C6B!9(H)KF68[)4S+'"&6*W%O%! K>;L
M1_M_]H+]LG3KBSMO#WP[U;3]4\7:[<)9:;]D=-0AM-S+Y][=_9S*(HK>(O*"
MZR?,N\P3017&SY__ ."U?_)/--_[&"V_](KZOO\ _9._Y)YX4_[%_2?_ $BA
MK\@?^;O/\_\ 0N5^OW[6/_)//%?_ &+^K?\ I%-7P!_P14_Y)YJ7_8P7/_I%
M8U\@?\%-?"VN?LV?%#3OB;HD=P(KG[)*;IV)M_MUJAA>S;R3'(D4UK#'OC=@
M;A'NE1V19$B_6_X0_P#!0+X<_%_2UU--:L]+8R/&]GJMS;65U&R'J8WF*LC*
M599(FD0@["PE21$/@S^T/<?M"^-=4'AZ:.?P9HEG]CENQ$VV]UB6978VMQAD
MFM[:",HQ1H\O<B3;<026TR_CA^Q5X[B_X)]_%77/!?BN]^SZ;=;;0W+1Q"%I
ME=9=.NYW#R-;Q26\TA(#LL+7*_:-JQ-)#^S_ .V;\5=#\.?#'7=0N;^W6TU/
M1[NVL)E<2+=37UK(MLD!CW>;YFX.&3<HB#3,1$CNOPA_P1A^(6C:=X0N]#GU
M"SCU:YURZE@L'N(ENI8Q96A+QP%A*Z 1R$LJD 1OS\K8_:ZOG_\ :Q_Y)YXK
M_P"Q?U;_ -(IJ_.'_@C-XLT[1OAYK?VF[MX?L>L7%U=>9,B>1;M96N)YMQ'E
MQ'R9L2/A#Y4G/R-CQ_\ X+(_!&7Q79Z/\1M/6X:W6WBL+V.2*6-H89&>>TE>
M%X5D@^>66&X^T,C+*]K"(A(7K]COV=?CSI?[27AJR\1:7)&5GC47,"2%VM+H
M*IFM9"4C;?&S8#%$$J%)D!BD1C^8/_!6/4[WXPZIX4^%NB".74=3O/MTJM%.
M6A4![:WF:2-646X5KV2YVI(\:6XE(1!^\_8[PGX6L_ VG6FE:?'Y-E8V\-M;
M1;F?9#"@CC3<Y9VVJH&YBS'&22<FN@K^?'4]6M]%_:Y$MU+'#&TD40>1U13)
M-X?6*) 6(!>21TCC7J[LJ*"S ']WO'_C_2_A9I=SK6M7,=GIUG&9)YY"=JKD
M    LSLQ"1QH&>1V6-%9V53^4/\ P2X^&5QXMU+Q+\6+^SCM5\37ET=+07#2
MR1V\EY-+>*P4*A0S+#&CNJS$VTC".**13+\G_P#!37PMKG[-GQ0T[XFZ)'<"
M*Y^R2FZ=B;?[=:H87LV\DQR)%-:PQ[XW8&X1[I4=D61(OUO^$/\ P4"^'/Q?
MTM=336K/2V,CQO9ZK<VUE=1LAZF-YBK(RE662)I$(.PL)4D1#X,_M#W'[0OC
M75!X>FCG\&:)9_8Y;L1-MO=8EF5V-K<89)K>V@C*,4:/+W(DVW$$EM,OV?7P
M!_P5'_Y)#XA_[AW_ *<K2C_@EQ_R2'P]_P!Q'_TY7=? '_!<[_F4?^XQ_P"V
M%?O]7X _L"_\G"^/?^X__P"GFWK]_J*_GA_8>\4V?A_]HSQA;7,FR74+CQ#;
M6J[6;S)EU);HIE00N(K>9]SE5^3;G>RJW[??'[XQV?[/_A?4_$]\N^+3[<R+
M%EE\Z9B(X(=R)(4\V5XXO,*,L>_>PV*Q'P!_P2$^!<OPP\#2ZY>P>3>^(+@7
M"$^:KFQA79:AXY J+N9KB>-XPPE@GB<R,-JI\ ?LZV]G_P $Z?CE>:)KS^3I
M%];S6=IJ-P[(B6EU)%<6=Q))Y"))\T"6ES(HCMX9S.YE$<#9_I>K\,?V(=)/
M[4'QE\4_%%XHY-)L9);72[E4N85DD*+:6\L:N '<6$;&ZCE(,;W<3B!-R>5^
ME_P\_:4L_%OCOQ'X"G^34M'^S7-L%C8+-8S6EF[NTFYE,L=Q<,K*1$#%)!L$
MC+,R_CA_P5M_8[\-?">RLO&?AZ"/36NKR+3[K3[>)8[5V,$TD=Q$B;5@<+ 4
ME1%V2EEDQ'*)6G_6_P")'QKUC]G;X9V?B?Q%'YVJ6-OHG]LQA8W8O-<6D&H^
M6L,D4)E EF,.QU@$H0\Q<'L/B;\'?!W[97AJ ZE;QWMC?V:S:??"/R[J".Z6
M.5)[621/-@=@L3LK* X41S1NFZ,_DA_P2;\"ZQ\+_B'XUT&&;[1HNF>997D^
MR./S;RVO9(;*386>5-T27S;49HUSB1BPA)^8/A3\0KS_ ()=_%75-/U6VU#_
M (1Z;[3$8?EEFNK'?(VG7D0$MO;2R@JJ-(>(EDO(0D<VY$_?[_AM;X:_V=_:
MG_"4:/\ 9_L_VC9]LB^T;-GF;?LN[[3YN./(\OS]_P"[\OS/EKR_X=_'WQ+K
M?PY\1_$&\ACC5H]6U3P]9SP-$T6FVUM_H*W<8(9GF:!KEV2:19$N%:*98C''
M%[!H=SX._;>\'6M_/91ZEHFI1O)'%>08DBD'F6\F/XH;B)O.B$\#Y4[FAF*E
M7;\8/V0/@A?_ +./[1%]X7T&XDNM+LK.<WTLJPK(=/N+6&XA5\_>=+F6RC9X
M CR%2_EQPM(B_L?J'[2EGX?^)47P^OODEU#1X;_376-F\R99;X744KAB%Q%;
MQRPY15^2<-+O:&-OSP_X*O?L=^&I?#%YX^TZ"/3M6L)(FNA;Q*D=^MW=)&S3
MJNT?:%DG,OVGEY!OCE$F8G@]O^&G]L?\,V2_VY_Q]_\ "'ZIY?\ J_\ CS^R
MW'V#_5?+_P >GV?K^\_YZ_O=]>?_ /!%3_DGFI?]C!<_^D5C6A_P6 _9^N/B
MGX.M_$=B))+GPY)+++"NY@UG<^6MRX1(W8O$T4,I8M''';K<NY8A,?0'_!.;
MX\Z7\:OA]I-O9R1K?:+9VVG7UH)"TD+6R>3#(P*(=EQ'$)D*AD!,D(D=X),>
M'_\ !7CXD2Z1X+M/"=@GVC4O$VH06\5JL,LLTL-M(DS&#R_E\W[1]CB"-N:1
M9F"1LP+Q^X:[\(4^ OP,U/PTJQK)8>$]22X,3R21O=/93274B-+ARDD[RR*"
M%"A@H1% 1?F__@BI_P D\U+_ +&"Y_\ 2*QKP#_@N=_S*/\ W&/_ &PK]_J*
M_G1_X*;?#BX_9\^)NB?%&""2\L;F\L+B>,NRJMYIAAQ 9!"4A2>"&,P[C-(S
MQW3[-D:K7[_> /'^E_%/2[;6M%N8[S3KR,203QD[67)!!! 975@4DC<*\;JT
M;JKJRC\8?VUM)/[7'QI\,_#Z"*.ZT[1(UNM7&RYC,<=PT=Q=Q2S1CY4>VBM$
MMY(]@%Q=+$TZNP$7U_\ \%4]6M].^$FM13RQQR7,FGQ0([JK2R"^MY2D8)!=
MQ'')(57)"1N^-JL0?\$K-6M]1^$FBQ02QR26TFH13HCJS12&^N)0D@!)1S')
M'(%;!*2(^-K*3^A]%?@#_P W>?Y_Z%ROU^_:Q_Y)YXK_ .Q?U;_TBFKX _X(
MJ?\ )/-2_P"Q@N?_ $BL:\ _X+G?\RC_ -QC_P!L*_9[]H7Q3>>!O!OB#5=/
MD\F]L='U&YMI=JOLFAMI)(WVN&1MK*#M8,IQ@@C(K\D?^",.K>']?M]>O+J6
M.?QK/>22W4T[N]Y)I[K"P</(3N1KDRM<-&2[2& SDYMJ\/\ VN/BKH?Q9_:
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MWO\ JOL/W_W?_//YO.KS_P#YN\_S_P!"Y7Z_?M8_\D\\5_\ 8OZM_P"D4U?
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M;>"?V?[QK[PQ8W&GROCS5CU+4&AFVJZ+YT$ET\,VP2.8_-1_+9BZ;7PP]O\
M'_@#2_BGI=SHNM6T=YIUY&8YX) =K+D$$$$,KJP#QR(5>-U61&5U5A^:'_#F
MWX:_VC]M\W6/L_VCSOL/VN+[/LW[OL^[[/\ :?*Q^[SY_G[.?.\SYZ_2_P
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M^A^%+./2HO$WC!M%7<LFDG6!'8S0R,6F@DA@@B_=3;G$PC*,P=R&#'=7V_\
M#3X5:'\&].32O#UA;Z?9)M/E0(%WLJ+'YDK??EE*H@>:4O+)M!=V/-> ?$O]
M@WX>_&347U7Q#IMQJ%Z^X>;/JFIML5G:3RXE^U[(H@SN4AB"11[B$11Q7K_A
MSX%Z+X2T,^'+$ZA#IO[L(BZMJ/G0K$(PD<%T;HW-O$HB11##)'$%W+LVR2!O
M /"W_!.3X8^!KR/4-*TFXL;V'=Y5S;:OJL,R;U*-LDCO%==RLRM@C*L5/!(K
M[?HK\@/^"U?_ "3S3?\ L8+;_P!(KZN@^!/[!VA^*?#.@^(-*U?Q!X;N]3\/
MZ*VH)H6H"QANYDLT(GF01/F4[VW$%59BTA7S9)I)/M_]GK]F+PO^R_ISZ?X:
MM/)\[RC=7,CF6XNGB0('FD;_ ($PCC$<$;R2-'%'YC ^H>/_  !I?Q3TNYT7
M6K:.\TZ\C,<\$@.UER""""&5U8!XY$*O&ZK(C*ZJP_/#PM_P2,^&OA;7(]:"
MZA<Q17#3IIES/%+8\DE(G0P":6*,E=J2S/Y@0+,9D:17^@/'_P"PMX&^*'B&
MP\0ZO8_:/[,T^WL+/3LK'IT45M,TT)^SQJF_;O:+R79K5H3L:W. 1]/_ /")
MZ=_9W]D?9+?^S?L_V7['Y*?9_L^SR_(\G'E^5L^3R]NS9\N-O%? '_#KSP7X
M?U'^TO#%_P"(/#$IM_L\@T?5)(O,4OO8O).EQ,=Q";D$@B_=1L(PX+-]7_!#
M]GCP_P#L^V]Q%HT,AN;Z19M0O[F5[B\OK@+@SW,\A+,[,7D*KLA6265TC0R/
MGL/B7\,=,^+NG/I6KK</92[A+%!>75IYJLC1M'*UI-"\D3*[!X7+1/P60E5(
M\ ^&G[!OP]^#>HIJOA[3;C3[U-H\V#5-37>JNLGERK]KV2Q%D0O#*'BDV@.C
M#BN_^-?[+_A7]HGRU\3VMQ?10[3';_VA?0VX9/,VR?9X+B*$R@2NOG%#*4;8
M7V *#X*?LO\ A7]G;S%\,6MQ8Q3;C);_ -H7TUN6?R]TGV>>XEA$I$2+YP02
MA%V!]A*GU#Q_X TOXIZ7<Z+K5M'>:=>1F.>"0':RY!!!!#*ZL \<B%7C=5D1
ME=58?G!IG_!'KX96&J'4)!JD]L9)7&G27@%J%<,%C#QQ1W>R/<#&3<%R47S'
MD!<-^E_A;PGIW@:SCT_2K2WL;*'=Y5M;0I#"F]B[;(XPJ+N9F9L 99BQY)-=
M!7C_ ,8_@1H/Q]LUT_Q%#<7-D,[K:.^O+6&3+(X\Z.UGA2?:T:-'YP?RV!9-
MI9B> ^#G[&W@G]G^\:^\,6-QI\KX\U8]2U!H9MJNB^=!)=/#-L$CF/S4?RV8
MNFU\,.?^)?[!OP]^,FHOJOB'3;C4+U]P\V?5-3;8K.TGEQ+]KV11!G<I#$$B
MCW$(BCBO7_#GP+T7PEH9\.6)U"'3?W81%U;4?.A6(1A(X+HW1N;>)1$BB&&2
M.(+N79MDD#> >%O^"<GPQ\#7D>H:5I-Q8WL.[RKFVU?589DWJ4;9)'>*Z[E9
ME;!&58J>"17M_P 7OV=?#OQW1H/$,=Y=6SQI'):IJ>H6]K(L<GFH9+:VN8H)
M'#X82.C/E4^;$:!?(/!7_!/OX=?#6X:\T/3KS3;EXS$\UGK.K6\C1EE8H7BO
M58H656*DX)53C(&/L^OA#XH?\$[O!WQ#\0?\)593:IX?UMI)I9KW1;S[))-)
M,@C=VW1RK&Y7?O: 0F8RRM,96?([#X:?L1^%_ 6HIK6H2:AXDUJ':+;4M?NC
MJ-Q;(CK+&EOO58HO+E4RQ2+&)T>27$NURM>O_&/X$:#\?;-=/\10W%S9#.ZV
MCOKRUADRR./.CM9X4GVM&C1^<'\M@63:68G@/@Y^QMX)_9_O&OO#%C<:?*^/
M-6/4M0:&;:KHOG0273PS;!(YC\U'\MF+IM?##O\ XQ_ C0?C[9KI_B*&XN;(
M9W6T=]>6L,F61QYT=K/"D^UHT:/S@_EL"R;2S$\!\'/V-O!/[/\ >-?>&+&X
MT^5\>:L>I:@T,VU71?.@DNGAFV"1S'YJ/Y;,73:^&'/_ !+_ &#?A[\9-1?5
M?$.FW&H7K[AYL^J:FVQ6=I/+B7[7LBB#.Y2&()%'N(1%'%>O^'/@7HOA+0SX
M<L3J$.F_NPB+JVH^="L0C"1P71NC<V\2B)%$,,D<07<NS;)(&\ \+?\ !.3X
M8^!KR/4-*TFXL;V'=Y5S;:OJL,R;U*-LDCO%==RLRM@C*L5/!(KZO\?^ -+^
M*>EW.BZU;1WFG7D9CG@D!VLN00000RNK /'(A5XW59$9756'PA\"_P#@EKX!
M^ VN0>(+9M0U&[M/FMDU"6"6&&;(*3JD5O#F6/!\HN76-CYBJ)4CD30U;_@F
M%\/M?\8R^,KR*\GFGO'O9M.EF1]/DN'RSL\31&9D:4F=HFF,+.3&4-N?(KZO
M^.GP+T/]HO0Y_#_B"#SK2;YD=<+-;S*"$G@<@[)4R<'!5E+1NKQ/)&W@'[-?
M_!/?P-^R]>?VII4%Q>:H/,$5]?RK+-"DJJK)$L:10IPK#S!'Y^V66,RF)RE'
MBG_@G)\,?'-Y)J&JZ3<7U[-M\VYN=7U6:9]BA%WR27C.VU555R3A5"C@ 5]?
M^%O#4'@^SCL;9[AXHMVUKFZN+N8[F+G?/=22S/RQ"[W;:N$7"*JCY0^/O[!O
M@[]H/5(=?NEO-,UV&2"0:KI=Q]FNF-N#Y6XLDD1=24*S^6+A1%"BS".,)6?X
M6_8$\+V5Y'?>(KO6/%TMON^R+XCOCJ,-KYBE)?*@9$A;S1L+^<DN&BB=-CIN
M/V?JVF)K5O+:RF18YHWC<Q2R0R!74J2DL3)+&^#\LD;*Z'#*RL 1\8?\.Y/A
MC_:/]K_V3<?VE]H^U?;/[7U7[1]HW^9Y_G?;/,\W?\_F;M^_YL[N:]O^)O[.
MOAWXQZ7!HNNQWEWIT$:QB ZGJ"+,JF,J;HQW*-=NK1(ZR71F=7!D#!W=FY#X
M.?L;>"?V?[QK[PQ8W&GROCS5CU+4&AFVJZ+YT$ET\,VP2.8_-1_+9BZ;7PP^
MGZ\?^,?P(T'X^V:Z?XBAN+FR&=UM'?7EK#)ED<>=':SPI/M:-&C\X/Y; LFT
MLQ/ ?!S]C;P3^S_>-?>&+&XT^5\>:L>I:@T,VU71?.@DNGAFV"1S'YJ/Y;,7
M3:^&'/\ Q+_8-^'OQDU%]5\0Z;<:A>ON'FSZIJ;;%9VD\N)?M>R*(,[E(8@D
M4>XA$4<5V$?[*'A:+1I/#P75/[)DCCA:T.NZN8Q!'%)"MNH-Z2EN8Y&1[="L
M,@$>^-O*BV<?\-/V#?A[\&]135?#VFW&GWJ;1YL&J:FN]5=9/+E7[7LEB+(A
M>&4/%)M =&'%=!\8_P!C;P3^T!>+?>)[&XU"5,^4LFI:@L,.Y41O)@CNDAAW
MB-#)Y2)YC*'?<^6/?_!SX$:#\ K-M/\ #L-Q;61QMMI+Z\NH8\,[GR8[J>9(
M-S2.TGDA/,8AGW%5(\P_:8_8L\'?M7)&WB"VD2^@C\J#4+63RKJ*/S%D*9*O
M%(F0P59XY1&))6C$;R,]>?Z3_P $^_#\UQ%+XCUCQ)XIMK>1)H;#7=5>\LTN
M(V!2<P*D2R.%WQ[9?,A:.61'C8-Q]OZ3I-OH%O%9V<4<%M!&D4,,2*D<<:*%
M1$10%5%4!550 H    K0KQ_X'? O0_V=M'&A^'H/(LA<7%Q@X9RT\C/AY,!Y
M?+4I!&\I>4011(\CE-QT/C1\(=+^/7A^^\-:RLC6-_&$D,3F.1&1UDCD1N0'
MCD1)%#!D8J%='0LC=AX3\+6?@;3K32M/C\FRL;>&VMHMS/LAA01QIN<L[;54
M#<Q9CC)).37C_P :_P!E_P *_M$^6OB>UN+Z*':8[?\ M"^AMPR>9MD^SP7$
M4)E E=?.*&4HVPOL 4'P4_9?\*_L[>8OABUN+&*;<9+?^T+Z:W+/Y>Z3[//<
M2PB4B)%\X()0B[ ^PE3Y!XI_X)R?#'QS>2:AJNDW%]>S;?-N;G5]5FF?8H1=
M\DEXSMM555<DX50HX %?7_A;PU!X/LX[&V>X>*+=M:YNKB[F.YBYWSW4DLS\
ML0N]VVKA%PBJHZ"OG#]IC]E7PU^U?I<>F>(8I T$GF6MY;LJ75NQ*^8(I'21
M=DBJ%EC=71P%?:)8XGCY_P#9G_8L\'?LHI(WA^VD>^GC\J?4+J3S;J6/S&D"
M9"I%&F2H98(XA((XFD$CQJ]'[3'[%G@[]JY(V\06TB7T$?E0:A:R>5=11^8L
MA3)5XI$R&"K/'*(Q)*T8C>1GKS_2?^"??A^:XBE\1ZQXD\4VUO(DT-AKNJO>
M6:7$; I.8%2)9'"[X]LOF0M'+(CQL&X^W])TFWT"WBL[.*."V@C2*&&)%2..
M-%"HB(H"JBJ JJH 4    5H45\ ?\%$O^*W\.:?X$@YO?%VL6&GH4_>36]O%
M.EW=7PMA\\\5NL*^?AHDC657>5  &^W_  GX6L_ VG6FE:?'Y-E8V\-M;1;F
M?9#"@CC3<Y9VVJH&YBS'&22<FN@KXP^/O[!O@[]H/5(=?NEO-,UV&2"0:KI=
MQ]FNF-N#Y6XLDD1=24*S^6+A1%"BS".,)6?X6_8$\+V5Y'?>(KO6/%TMON^R
M+XCOCJ,-KYBE)?*@9$A;S1L+^<DN&BB=-CIN/V_7YX?'G_@F%\/OCYJDFLW$
M5YIE]<222W<FG3)$MS(X3+R1S13Q*^5+%H5B,CR222F1VW#T!OV"O!5MX(N?
M =E;R65C>QVJ7E[;^2NH7+6LZW*23W#Q.)'\P-PR%(TD>.%(DVJOM_P<^ /A
M?]G^S:Q\,:9;Z?$^/-:,%IIMK.Z^=/(7FFV&1Q'YKOY:L43:F%'L%>'_ !W_
M &>/#_[2=E::9XEADN;&TO!>"W25X5ED6">!1(\9678HG:0"-XR71,L4WH_S
M!IG_  3<\/Z*AL+7Q!XLAT)I)2="CUETTTV\TC/+:&)8Q*;>0.Z2#S?.=68M
M,9&,A^S_  M\+='\#:''X;TJW^PZ7#;M;Q0VTDD+(C@AF2:-UF65BS.TX<3F
M5C,9/-)>OF#_ (=R?#'^T?[7_LFX_M+[1]J^V?VOJOVC[1O\SS_.^V>9YN_Y
M_,W;]_S9W<U[?\3?V=?#OQCTN#1==CO+O3H(UC$!U/4$695,94W1CN4:[=6B
M1UDNC,ZN#(&#N[-R'P<_8V\$_L_WC7WABQN-/E?'FK'J6H-#-M5T7SH)+IX9
MM@D<Q^:C^6S%TVOAAS_Q+_8-^'OQDU%]5\0Z;<:A>ON'FSZIJ;;%9VD\N)?M
M>R*(,[E(8@D4>XA$4<5Z_P"'/@7HOA+0SX<L3J$.F_NPB+JVH^="L0C"1P71
MNC<V\2B)%$,,D<07<NS;)(&\ \+?\$Y/ACX&O(]0TK2;BQO8=WE7-MJ^JPS)
MO4HVR2.\5UW*S*V",JQ4\$BN?_X*C_\ )(?$/_<._P#3E:5\@?L-_L6Z'\6_
MA[X=\307^L:!K36^I6US>Z)>"QFNX?[3N"B7+>7)YFSRU"L-K%517+K%"(OT
M?_9]_9#\+_LX2W-]I<=Q=:O?;_MNK7\YN;ZYWRM,WF2$*B[F8&3RDC\XQQO+
MYDB!Z[_XQ_ C0?C[9KI_B*&XN;(9W6T=]>6L,F61QYT=K/"D^UHT:/S@_EL"
MR;2S$\!\'/V-O!/[/]XU]X8L;C3Y7QYJQZEJ#0S;5=%\Z"2Z>&;8)',?FH_E
MLQ=-KX8?3]?G!\6/"UG^T+\9O#^ERQ^9:>"M/FUFYFC9G7[=>30K96<QC*?9
MI4^SI?QB1G-S$I4P>5N<_H_117S!^T+^QSX+_:?V2^)+#S;V&WEM[>]AEDAN
M(5DR00R,$E\MB9(DN%FB1V<B/$D@?Q_PG_P3E\+Z-]D@U?4_$'B'3;#R39Z5
MK&I&XTZ!X,"%TM8XX8SY:!H5C?? 89)(VB92,??]%?G!X&\+6?QQ^-NL^*VC
MW6_@[3[71;*=&:2&>^N%GGNW$J%8UEM4N)+.>U83%&E65C%($4?H_1117A_P
M"_9X\/\ [,^ES:/X<ADAM)[R>\=9)7E;S)B!@,Y)"1QI'#&.NR-6=I)FDE?V
M#5M,36K>6UE,BQS1O&YBEDAD"NI4E)8F26-\'Y9(V5T.&5E8 CXP_P"'<GPQ
M_M'^U_[)N/[2^T?:OMG]KZK]H^T;_,\_SOMGF>;O^?S-V_?\V=W-?1_C7X/:
M3\0]&70-2^V2Z<(Q$Z+J-]%)-&(FA*7%Q%<)/<HZ,PE6>203$[Y [@,/$/AI
M^P;\/?@WJ*:KX>TVXT^]3:/-@U34UWJKK)Y<J_:]DL19$+PRAXI-H#HPXKZ_
MK\\/B]_P3"^'WQG\2MXFOHKRWGFD26\M;29(;6[D5MTCS+Y32J\P^6=H)(2Y
MS*"L[O*WV?X6^%6A^"]#C\,V%A;Q:+%;M;"R*!X6A<$2)(K[O-\S<QF:3>TS
M.[2%V=B?SPU/_@CU\,K_ %0:A&-4@MA)$YTZ.\!M2J!0T9>2*2[V2;29"+@.
M"[>6\8"!?I#XN?L+>!OC3_8L&I6/DZ;H?VW[-IED5L[-_MNPR^8ENJ2##H)5
M\F2',A8OYBL5/T_X6\)Z=X&LX]/TJTM[&RAW>5;6T*0PIO8NVR.,*B[F9F;
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MR?!/[0%XUCX8OKC4)4QYK1Z;J"PP[E=U\Z>2U2&'>(W$?FNGF,I1-SX4]_\
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M%Z7"0K"@)D>1GV^5Y>UA,LFQH61UD",C ?@C^UQ_P43\/_%_QKX1L]'N)/\
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M57AK]J_2Y-3\/2R!H)/+NK.X54NK=B6\LRQH\B[)%4M%(C.C@,FX2QRI&?M
M_M9^#OV9;<R^(]1CBN3'YD-A%^]O)P5D*;(%.Y4=HGC6>7R[<2 (\R$UZ_\
M#WQK;_$K1M/URS61+;4K.WO(4E"B18[B)94#A690X5@&"LP!SAB.3\X>/_VZ
M? W@+Q#8>%/MWV_6K_4+>P^S6(6?[-+/,UOFZEW+%%Y<J[)H=[72;E;[.5.:
M\?\ CI_P5*\ _ ;7)_#]RNH:C=VGRW+Z?%!+##-DAX&>6XAS+'@>:$#K&Q\M
MF$J21I]?_ OXZ:'^T7H<'B#P_/YUI-\KHV%FMYE +P3H"=DJ9&1DJRE9$9XG
MCD;V"O'_ (Q_'?0?@%9KJ'B*:XMK(YW7,=C>74,>&1!YTEK!,D&YI$6/SBGF
M,2J;BK <!\'/VR?!/[0%XUCX8OKC4)4QYK1Z;J"PP[E=U\Z>2U2&'>(W$?FN
MGF,I1-SX4Y_Q0_;<\#?!6X^R^([V\TV1I)HXS<:1JB1S- P60P2_8_*G12R_
MO(6="&1@Q5E)]O\ AI\3M,^+NG)JND-</92[3%+/9W5IYJLBR+)$MW#"\D3*
MZE)D#1/R%<E6 \@\=?MB^#OAIJ,.E:O/J%K>W-P]M:Q/HNK'[5,CK&4M66S*
M7/S.@5K<R*^]"I8.I//_ +1?[=/@;]F+=!K-]Y^I+C_B6606>\&?*/[Q-RQP
M?)*LJ_:9(?-C#&+S&&VOH_Q_X_TOX6:7<ZUK5S'9Z=9QF2>>0G:JY    +,[
M,0D<:!GD=EC16=E4_@#XH_X*)^'_ (C_ !KT#79[B2T\'^'H]1@AN)('=I9+
MFTGBDNA%%"UPJ3/]GBCB?>52-962%Y)HT_<[X*?'OPY^T3ITFJ^&+S[=90W#
M6TDODSPXF1(Y&3;/'$YPLJ'< 5.[ .00/PQ_X(X>/]+^%FE^.-:UJYCL].LX
M](DGGD)VJN;\   %F=F(2.- SR.RQHK.RJ?N_P +?\%<_AKXIUR/10VH6T4M
MPT":G<P116/!(25W,YFBBD(7:\L*>6'#3"%%D9/T_HK\8?\ @I9_P4 T/PQH
M>J>!O#MU]KUV[\RPOWB4&&RA(47,;O(C1RRR(SVQCA):!C,SR0SPI&_O_P"Q
M3^V9X$\8:+X7\%V.J>;KZ:/9VS6GV2[7$UI8JTZ>:\"P_((I#N#[6V_*6RN?
MB#]OK_DX7P%_W /_ $\W%?=_QY_X*>_#[X!ZI)HUQ+>:G?6\DD5W'IT*2K;2
M($RDDDTL$3/EBI6%I3&\<D<HC==I^K_@7\=-#_:+T.#Q!X?G\ZTF^5T;"S6\
MR@%X)T!.R5,C(R592LB,\3QR-V'C_P ?Z7\+-+N=:UJYCL].LXS)//(3M5<@
M   %F=F(2.- SR.RQHK.RJ?A#7_^"G/A?PI]GNM0T3Q1::+=W$<-MK<^DF+3
MIDERT=Q%(\HE>)X@9T"Q&=H02(2P*5]W^ /'^E_%/2[;6M%N8[S3KR,203QD
M[67)!!! 975@4DC<*\;JT;JKJRCYPT?]NGP-XK\7V/@K1K[^U-2O?/\ WUD%
MELX?)MC=?O+G<(WWH&5?LWG[9%9)?*85\_\ Q+_X*Y_#7X=ZB^GP-J&K^5N$
MESIT$3VX=79&19)Y[?S<;0PDA$D#HZLDKY(7Z_U_]J?P7X8\+V_C2[U>W30+
MKRQ;W8$C^:TA*B-(D1IFE4JXDA">;#Y<OF(GE2;?F#X%_P#!4KP#\>=<@\/V
MRZAIUW=_+;/J$4$4,TV0$@5XKB;$LF3Y0<(LC#RU8RO'&_Z/T445_,#_ ,%J
M_P#DH>F_]B_;?^EM]7]/U>/Z9XCT/XZ?VEIZC[3%HNL6]O.PD&S[=8?9-10H
M\,A)\B5HDD1]I$\,L,D90'?Y!\2_V\OA[\&]1?2O$.I7&GWJ;CY4^EZFN]5=
MH_,B;[)LEB+(X2:(O%)M)1V'-?5^K:FFBV\MU*)&CAC>1Q%%)-(512Q"11*\
MLCX'RQQJSN<*JLQ /S!X#_;?\ _$KQ GA73-3D?6WDGB%E+I]_;R+);H\DR/
M]HMHUC=%C?<LA4@J5QNP#Z?\8_C]X7_9_LUOO$^IV^GQ/GRED)::;:R(WDP1
MAYIMAD0R>4C^6K!WVIEA\H:[_P %/?A]X:\,:?XENI;Q&U2.:6STL0H^H/'!
M=/:.[(DK01)OCD9&FF02I'((R\J-&./UK_@K7\.K3PNVOVDMQ+J#^>EOHLD?
MEWC31% !,R>=#!$PD203EW5H_,$:RW$,ENOR!_P3K_;U\(?"_P /:Q_PG&L_
M9]:U/Q!>:E+_ *%<R>;]IAMMTO\ HEN\2;I4E^0;=N.$"E<^_P#_  6K_P"2
M>:;_ -C!;?\ I%?5ZAHW[:?@[]E'X<^$%\07,CWT_AO2)8-/M8_-NI8_LT$9
M?!9(HTR6*M/)$)!'*L9D>-DKW#]EK]M_PE^UQ]JBT)[BWO;/#265ZD<5P83M
M GC6.65'BW-Y;%6+1OM$BH)83)]?U\ >+/\ @HUX7T;[7/I&F>(/$.FV'G"\
MU71]--QIT#P9,R/=220QGRT"S-(F^ PR1R+*RDX]_P#V>OVG?"_[4&G/J'AJ
M[\[R?*%U;2(8KBU>5 X2:-O^!*)(S)!(\<BQRR>6Q' ?M%_MT^!OV8MT&LWW
MGZDN/^)99!9[P9\H_O$W+'!\DJRK]IDA\V,,8O,8;:\O^//_  4]^'WP#U23
M1KB6\U.^MY)(KN/3H4E6VD0)E)))I8(F?+%2L+2F-XY(Y1&Z[3]W^$_%-GXY
MTZTU73Y/.LKZWAN;:7:R;X9D$D;[7"NNY6!VL%89P0#D5T%%<?X_\?Z7\+-+
MN=:UJYCL].LXS)//(3M5<@   %F=F(2.- SR.RQHK.RJ?C#_ (>+^'+3_3+[
M1?%%CH!^9?$%QHLZZ6T+_P"HG65"\WE7!,:P$PAF,L>Y4RQ7ZO\ @W\7M+^.
M^B0>(=%:1].NI+E())$,;2+;W$ML9 A^94=HB\8<*^QEWI&^Y%X#XW_M3>'_
M (%7%OIETMYJ.MWD;2V>C:9;/>:A<1HV'=(4PJHJB23=,\8=(9O++M$RCQ_X
M7_\ !1'P=\0_$'_"*WL.J>'];:2&*&RUJS^R2323(9$1=LDJQN5V;%G,)F,L
M2PB5GP/N^OB#XA_M]^%_!NN3>&M+M-8\2ZO:>;]MM="L3>M:>48U;SB7B0X:
M41MY32^5*K12^5( K:'P"_;R\'?M!ZI-H%JUYIFNPR3QG2M4M_LUTQMP/-VA
M7DB+J2X:#S!<*(IG:$1QEZ[#XQ_MD^"?V?[Q;'Q/?7&GROGRFDTW4&AFVJCM
MY,\=J\,VP2()/*=_+9@C[7RH]_\ "?BFS\<Z=::KI\GG65];PW-M+M9-\,R"
M2-]KA77<K [6"L,X(!R*^8$_;R^'O]N0>&9=2N+?6KBXM[:.RN=+U.VF\ZY*
M"%'6>TC\O?YB%6DVKM8,2%.:]_\ B7\5=#^#>G/JOB&_M]/LDW#S9W"[V5&D
M\N)?ORRE4<I#$'EDVD(C'BOD"+_@IC\.CX>N?$TEW<1646H7>GVL;P?Z1?S6
ML,<Y:UA5F?RG66(++<_9UC>1%G\@NN=#X1?\%'OA]\6M&U'7&O)-(MM+D2.X
M34U2&0F6*66+R1%),L[R+!.(X(6>X8PO^YP8R_M_[.O[2FA_M0Z=>:KX>^T&
MRL]0FL/-GC$7G-$D4GFQ+N9_*=94*>:(I>H>)",5^</_  4L_P""@&A^&-#U
M3P-X=NOM>NW?F6%^\2@PV4)"BYC=Y$:.661&>V,<)+0,9F>2&>%(W]__ &*?
MVS/ GC#1?"_@NQU3S=?31[.V:T^R7:XFM+%6G3S7@6'Y!%(=P?:VWY2V5S[!
MX_\ VZ? W@+Q#8>%/MWV_6K_ %"WL/LUB%G^S2SS-;YNI=RQ1>7*NR:'>UTF
MY6^SE3FOK^OG#XW_ +4WA_X%7%OIETMYJ.MWD;2V>C:9;/>:A<1HV'=(4PJH
MJB23=,\8=(9O++M$RCQ_X7_\%$?!WQ#\0?\ "*WL.J>'];:2&*&RUJS^R232
M3(9$1=LDJQN5V;%G,)F,L2PB5GP/M_5M6M] MY;R\EC@MH(WEFFE=4CCC12S
MN[L0JHJ@LS,0% )) %?"'_#Q?PY=_P"F6.B^*+[0!\S>(+?19VTM84_U\[2N
M4F\JW(D6<B$LIBDVJ^%+?1_P(_:'\/\ [2=E=ZGX:FDN;&TO#9FX>)X5ED6"
M"=C&D@678HG6,F1(R71\*4V._N%%?('Q+_;<\+^ M1?1=/CU#Q)K4.XW.FZ!
M:G4;BV1':*1[C8RQ1>7*HBEC:03H\D68MKAJY_X:?\%!?!?Q UA/#EY_:&@:
M_+<+;QZ7K-E):7#,\:RQ'(,D*>:'"PI)*DLK[56,^9%YGO\ \:_CWX<_9VTZ
M/5?$]Y]ALIKA;:.7R9YLS.DDBIM@CE<96)SN("C;@G) /\\/[(?[4?A#X7_&
M3Q;XKU?4/L^BZG_;'V.Y^S7,GF_:=3AN(?W4<3RINB1G^=%VXVMAB ?Z'O@I
M\>_#G[1.G2:KX8O/MUE#<-;22^3/#B9$CD9-L\<3G"RH=P!4[L Y! ]@K\X/
MVZ?^"@&A_LU:=?:-I]UY_BY[<+;6T*AOL;7"-Y=U<.Z/"OE#$PMV#RR[H<Q+
M!,9E\ _X)O?MF>!/!_@GPYX+OM4\K7WN)[9;3[)=MF:[U"=H$\U(&A^<2QG<
M7VKN^8KAL>/_ +?7_)PO@+_N ?\ IYN*^[_CS_P4]^'WP#U231KB6\U.^MY)
M(KN/3H4E6VD0)E)))I8(F?+%2L+2F-XY(Y1&Z[3]7_ OXZ:'^T7H<'B#P_/Y
MUI-\KHV%FMYE +P3H"=DJ9&1DJRE9$9XGCD;L/'_ (_TOX6:7<ZUK5S'9Z=9
MQF2>>0G:JY    +,[,0D<:!GD=EC16=E4_"&O_\ !3GPOX4^SW6H:)XHM-%N
M[B.&VUN?23%ITR2Y:.XBD>42O$\0,Z!8C.T()$)8%*^[_ 'C_2_BGI=MK6BW
M,=YIUY&)()XR=K+D@@@@,KJP*21N%>-U:-U5U91V%?*'[;GQY?\ 9Q\!ZKKM
MK)&FH^6MMIX>2-&-U<,(T>-9$D65X5+W1AV,)$@<-M3<Z_DA_P $4_@7%JMY
MJWC:\@W?8]NGZ=*WE,JS2+YEXRJ094E2(VZ+*I13%<SQ_O,N$_H>KS_XJ_#3
M3OC)H=_X>U5-]EJ%N\$N%1F3</EEC\Q7198FVRPN5;RY41P,J*S_ ((>"KCX
M:^%=$T.\:-[G3=+L;.9XBQC:2WMXXG*%E5BA925+*I(QE0>!YA\8_P!KSPO\
M&[Q=(DDN-5U^3/E:'I,!OM2?:J2-F",XBQ$_V@?:&B\R%7>/S-I%>/Z+_P %
M)/!::BNE>)(-8\*7LOD&WBU[3I+3SEG=XQ(K(TR1Q*R$/-<&&)>2'(20I]WZ
MMJUOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B H!)( KY0\ ?MT^!OBA
MXAO_  ]I%]]H_LS3[B_O-1PL>G116TRPS#[1(R;]N]9?.16M6A.];@X('S?J
M?_!87X96&J#3XSJD]L9(D.HQV8%J%<*6D*22QW>R/<1(!;ER4;RTD!0M]@?&
M_P#:S\'?L^Z-;ZYK.HQFVOHVDT]+;_2)+X"+S1]F$9*LC*4 G9DMU,L6^9!(
MA/C_ .S/_P %%/!7[4NJ2:+I9O++41'YD,&H1PQ-<JH8R"W,4TRN\:C>\9*N
M4)D172.9H_L_Q3XLT[P-9R:AJMW;V-E#M\VYN9DAA3>P1=\DA5%W,RJN2,LP
M4<D"OE#X=?M]^ _B?;Z_J-E>R1Z3X<CM)+S4;B%H;>1;I9"@@1\7#N'C:'RV
MA1Y)BB0K+O4GY_\  '_!7_X<^.M4MM,DCU335NI!&+R^AMH[6)B#M,TD=U*T
M:%L+YA78A8/(T<0=U_4^OB#XA_M]^%_!NN3>&M+M-8\2ZO:>;]MM="L3>M:>
M48U;SB7B0X:41MY32^5*K12^5( K:'P"_;R\'?M!ZI-H%JUYIFNPR3QG2M4M
M_LUTQMP/-VA7DB+J2X:#S!<*(IG:$1QEZ^C_ (E_%70_@WISZKXAO[?3[)-P
M\V=PN]E1I/+B7[\LI5'*0Q!Y9-I"(QXKYP\)_M]^ _$_AJ^\7R7LEEHEEJCZ
M6+FZA96N9U6.16MH(_,GD1TD$BJ8UF5%D>2&-8W(\O\ @7_P5*\ _'G7(/#]
MLNH:==W?RVSZA%!%#--D!(%>*XFQ+)D^4'"+(P\M6,KQQO\ 5_QO_:-\,?LX
MV]O>>*+N2RMKJ1HHIA:75Q&9%7=L9[>&58W*Y9%D*F0)(4#"-]O(?!S]LGP3
M^T!>-8^&+ZXU"5,>:T>FZ@L,.Y7=?.GDM4AAWB-Q'YKIYC*43<^%/?\ QC^.
M^@_ *S74/$4UQ;61SNN8[&\NH8\,B#SI+6"9(-S2(L?G%/,8E4W%6 T/A#\9
M-$^.^EKK7AZ>2ZTYY'CCG>VN+=9&C.',8N8HFD0-E#(@9-ZO'NWQNJ^H5GZM
MJUOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B H!)( KX@U;_ (*">'YK
MB6+PYH_B3Q3;6\CPS7^A:4]Y9I<1L0\ G9XED<+LDW1>9"T<L;I(P;CU#]GK
M]L;P7^T_OB\-W_FWL-O%<7%E-%)#<0K)@$%74)+Y;$1RO;M-$CL@,F)(RY\8
M_P!LGP3^S_>+8^)[ZXT^5\^4TFFZ@T,VU4=O)GCM7AFV"1!)Y3OY;,$?:^5'
M7_#+]HKP[\8]+GUK0I+R[TZ"-I#.-,U!%F53(&%J)+9&NW5HG1H[43.K@1E0
M[HK>0:G_ ,%!/AUHNJ#0[K4;R'5FDBB%A)HVK)=&28*8D$#60E+R!T,:[<N&
M7:#N&?J__A)8/[._M39<?9_L_P!HV?9;C[1LV>9M^R^7]I\W''D>7Y^_]WY?
MF?+7B'@K]K/PC\0?$#>%;"YO#K<<9EELIM*U*VDAC"+)OG^T6L2PH5=-K2E
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M,WEEVB91X_HW_!0[PG=7MGH^IV6N:+K>H7EK:V>E:IIDMM=3+=SQV\=RIRT
MMP[/N9I5?$$P6-F"+)]WU\0>*?V^_"]E>26/AVTUCQ=+;[?M;>'+$ZC#:^8H
M>+S9U=(6\T;PGDO+AHI4?8Z;3T'P._;E\%_'G41H=E<7%CKX^T"31]1MI+6\
MB:V=DEC;(:%I5"F0PQRR2K&&9D7RY1'[_P#$OXJZ'\&].?5?$-_;Z?9)N'FS
MN%WLJ-)Y<2_?EE*HY2&(/+)M(1&/%?.'A/\ ;[\!^)_#5]XODO9++1++5'TL
M7-U"RM<SJL<BM;01^9/(CI()%4QK,J+(\D,:QN1Y?\"_^"I7@'X\ZY!X?MEU
M#3KN[^6V?4(H(H9IL@) KQ7$V)9,GR@X19&'EJQE>.-_T?KX0U;_ (*">'YK
MB6+PYH_B3Q3;6\CPS7^A:4]Y9I<1L0\ G9XED<+LDW1>9"T<L;I(P;CV#X#_
M +6'A/\ :8N+^#PK=27L>FQVKW$YMY8(]UTUP$C43K'*746[,YV!,/'M=FWJ
MGT?7/^*?%FG>!K.34-5N[>QLH=OFW-S,D,*;V"+ODD*HNYF55R1EF"CD@5\H
M?#K]OOP'\3[?7]1LKV2/2?#D=I)>:C<0M#;R+=+(4$"/BX=P\;0^6T*/),42
M%9=ZD^'^%O\ @KG\-?%.N1Z*&U"VBEN&@34[F"**QX)"2NYG,T44A"[7EA3R
MPX:80HLC)](?M,?MI^#OV44C7Q!<R/?3Q^;!I]K'YMU+'YBQE\%DBC3)8JT\
MD0D$<JQF1XV2L_\ 9:_;?\)?M<?:HM">XM[VSPTEE>I'%<&$[0)XUCEE1XMS
M>6Q5BT;[1(J"6$R?5^K:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@
M* 22 *_/"Z_X*<^%[N*\OM&T3Q1K>D6.[S]6T_22]BNR)9I=TD\L#Q^4K@R^
M<D>T#?S&5=OI_P#9Z_:=\+_M0:<^H>&KOSO)\H75M(ABN+5Y4#A)HV_X$HDC
M,D$CQR+'+)Y;$>8>/_\ @H1\-?A9JESHNM:O)9ZC9R&.>"33=1W*V 001:E6
M1E(>.1"R2(RR(S(RL?H_X:?$[3/B[IR:KI#7#V4NTQ2SV=U:>:K(LBR1+=PP
MO)$RNI29 T3\A7)5@/$/&O[;G@;X=:ROA[5;V\MM6DD$<-HVD:H9)V:5H4-N
M%LR+A'D5DBDA,B2D?(S5]7T5_/CJVK6^@?M:2WEY+'!;01O+--*ZI''&GAHL
M[N[$*J*H+,S$!0"20!7V?XI_X*Y_#7PMKDFBEM0N8HKA8'U.V@BEL>2 \J.)
MQ-+%&2VYXH7\P(6A$R-&S_H?X \?Z7\4]+MM:T6YCO-.O(Q)!/&3M9<D$$$!
ME=6!22-PKQNK1NJNK*#Q_P"/]+^%FEW.M:U<QV>G6<9DGGD)VJN0   "S.S$
M)'&@9Y'98T5G95/PAK__  4Y\+^%/L]UJ&B>*+31;NXCAMM;GTDQ:=,DN6CN
M(I'E$KQ/$#.@6(SM""1"6!2ON_P!X_TOXIZ7;:UHMS'>:=>1B2">,G:RY(((
M(#*ZL"DD;A7C=6C=5=64=A11111111111111111111111111111111111111
M1111111111111111111111111111111111111117G_Q5^&FG?&30[_P]JJ;[
M+4+=X)<*C,FX?++'YBNBRQ-MEA<JWERHC@945^*/_!*WQ;JGP%\8^(?A-KYC
MBDCDENK<,PB#W4'EQR_9UEBCFN$NK?RKF)B0%M[;SEBVRR.OW?\ \%!/^+D:
M/IGPVM/^0EXPU"&WC?\ Y]K.PDCOKZ]PVV.7R$B0?9S+#)+YF8RS(4/V?JVI
MZ7\*-&ENI1'9:3I5F\CB*(B.WM;6(L0D42DA(XT^6.-2<*%5>@K\@?\ @DYI
ME[\8=4\5_%+6S'+J.IWGV&)EEG+0J ES<0K'(S*+<*UE';;GD>-+<Q H@_>?
MI]^T5\!M+_:2\-7OAW5(XRL\;&VG>,NUI=!6$-U& \;;XV;)4.@E0O"Y,4CJ
M?R!_X(L?M W&HIJ?@*[,DD=M&VIV#G<RQ1F2.*ZA):0A$,DD,L,<<8!>2ZD=
M]S*#G_L"_P#)POCW_N/_ /IYMZ_7[]K'_DGGBO\ [%_5O_2*:O@#_@BI_P D
M\U+_ +&"Y_\ 2*QKXP_;Q^"GAK3OC9X/\/6>EV=GI.HQZ-'=VEG"MI'*MQJE
MQ#*2+<1D.T8"&12' "X8;5Q_0=??"?P]J?\ 9WGZ5I\O]D;/[,WVD+?8=FS9
M]ERA^S[?*CV^5LV^6F,;%QZ!7'^-?A[HWQ*MUL]<T^SU*V202I#>6\5Q&L@5
ME#A)590X5F4,!D!F&<$Y_ '_ ((C> -+UW5/$.M75M'+J.FQV$=E.X):!;L7
M8G,8)VJ[K$B&3&\)OC5@DLJO^YVOV7A[X":=K?B>#3;>VVV]QJ.IR65K#'<7
M?V9)9W:1AY?G2G,A4ROR[L2PW,:_#'_@GK^T@^@/KWC'6O#_ (L\3^(]7O!#
M/J>FZ5'>P1P11QN+=)0T30N6<&2W3]RL,5D$C01J*Z#_ (**>,;W]K[1M-@T
M;P+XTAU;3KQW2>\T6>.,6LT1%Q&!#),&=Y([9@63*B-MKKN97]P^.^O^(?$O
M[,,T_BNWN+;6EM[&"YCNHYH[@_9M7@@BEG6X)E,LL4<<TCO_ *QW,@ 5@!]/
M_P#!+C_DD/A[_N(_^G*[K/\ ^"@7[&^L_MAV^B6>F:K'86UC>2/>PS"5HY(Y
ME1?M")&=LEQ;JKK#'($#BXE'VB 9\SG_ -N/]K#P'_PC7B+P:]U'JVMS:7>H
MFG6ENU\T4\2RCS)G16@@>S>)KJ<2R)-;);F8)N$8;R__ ((J?\D\U+_L8+G_
M -(K&O /V^O^3A? 7_< _P#3S<5^YWC7X>Z-\2K=;/7-/L]2MDD$J0WEO%<1
MK(%90X2564.%9E# 9 9AG!.?PQ_X(8_\S=_W!_\ V_KZ?_X*]_'27X8>!HM#
MLI_)O?$%P;=P/-5S8PKONBDD95%W,UO!(DA82P3RH(V&YD^[_P!FOX0I\!?!
MVC^&E6-9+"SC2X,3R21O=/\ O+J1&EPY22=Y9%!"A0P4(B@(OY(_\%D?@Y9^
M%(M'^(FE-]AUI=0BLYY[<-'-,PB>>UN#*CKLEMOLS(D@4RLKQ@RA;>):^K_%
MWBC1OVNO@C<^,]4TNSFOE\-ZO+$\]I$[6EY#!-%</:&0S/"AGM]\+!_,*+$S
MD.N%^8/^",/PATO5-!N_%5TLD^HVFJ75I9"5RT%FKVMHT\UM$?ECN+A62*>?
MEVAACB4HAE$GE_\ P6C\+6?@37/#/B;2H_L6M7?VPSWMNS13.UB;,VLA9",2
MQ>8P288EVB-2Y6*()^YWQOTS5-:\*ZW:Z&9%U:;2[Z.P,4HAD%T]O(L!24L@
MC?S"NV0LH0X;<N,C\4?^"9W_  4(\+_#KPY:>!_%,_\ 9TMM<3BRO&B(M'BN
M9UD5)Y@[F.7S9YR9'CAM8[=%+RJX);]7_@W\%-.\%^*/$/B[19+=]-\56^DW
M2^0R,C7$(NO.GC\J-8S%.DT$XDWRO-.]Q*Q"LF?R@_X+G?\ ,H_]QC_VPK]G
MOAO\"]#^&.AOX?MH/M-I<^<U^]YBYFU&:Y&+F>^>0'[1+/D^<7&TKB-56)4C
M7\4?^":FF)X ^-GC7P]IAD@TFVCU:.*T$LC1[;/5(8;8L'9C(\4;NB22%G D
MD^;YWS[!_P %GOA[HVG>$+37(-/LX]6N=<M8I[]+>);J6,65V DDX42N@$<8
M"LQ $:<?*N/TN_9._P"2>>%/^Q?TG_TBAK\,?V\?@[HV@?&SP?H>AV\>AVU]
M'HRN^DQQ64D<DVJ7$1N(C$@5;A5"E)2K%2B=0H%?O=_PH'PO_P (O_PA?]F6
M_P#PCWV?[/\ 8<'9LSNW;L^9YN_]]Y^[S_/_ '_F>=\]?A#^PM8WG[*/QYU3
MP%MN#97OVVTC22Y4_N8HVU"PNYEB7RI93;)M Q$T7VN3_5D/"W]'U9^K:3;Z
M_;RV=Y%'/;3QO%-#*BO')&ZE71T8%61E)5E8$,"000:_ '_@F]'<?LH?%GQ'
M\,]5DC+7D>+>4QMYEQ)9!KBU9?*DECA2:RGGN724DH5CB\Q904D^S_\ @K?X
M<L_%/PZCMI#<-J3:Q8+H]M;QM(UW?2>9%Y!1(W8YMWN70 H6E2-0Q8B.3L/^
M"8_[0-O\;_A]8V9,::CH,<6F74*[0?+@0+:3!/,D?9)"JJ9'$8>XBN0B!$%=
M!\--3?X__$W5=? C?1/!\<^@Z<7BC=GU:<Q2:K<1LZI/ \*)#9$$/%,CO)#,
M%>9&_,#_ (+5?#W1O!UQX<O-,T^SL[F_DUB6]FM[>*&2YDW63;YWC56E?=([
M;I"QR[G.6.?Z+J_ '_F[S_/_ $+E?O\ 5_-C_P $9?A#I?Q#U36=4U-9)VT:
M33)[.V9S]E%TXO!'=R0_=DN+=5<6KMD0&:5U7S2CQ_4'_!:_P!I<OA72O$)M
MH_[6CU2*Q6[ (D-K);W4S0L00'021JZ;PQC)DV%?-EW_ *??LR:M<:_X%\-7
MEY+)/<SZ'IDLTTKL\DDCVD3.[NQ+,[,2S,Q)8DDDDU[A7Y ?\%J_^2>:;_V,
M%M_Z17U??_[)W_)//"G_ &+^D_\ I%#7XP_\%)M _P"$K^.O@W3_ +1<6GVN
MWT6#[3:R>5<0^;JUTGFP28.R5,[HWP=K@-@XQ7[??\*!\+_\(O\ \(7_ &9;
M_P#"/?9_L_V'!V;,[MV[/F>;O_?>?N\_S_W_ )GG?/7XX_\ !#75KB:W\5V;
M2R&VBDTN6.$NQC225;Q9'5,[5=UBB5V !81Q@DA%QG_MQ_&>+QY\:-&\)ZA:
M:QJV@:#Y%S=:)I]K%<O>7WD27H=+9B1<Q>4]O%.LV#' +P1A/,:23[?\6?MH
MV?CG3KO2M0^'WQ FLKZWFMKF+^PF3?#,ACD3<ETKKN5B-RE6&<@@X-?$'_!)
M?P-XR\%ZCKGACQ/H6H6_AO4M/>>2/4["YCMVN%>.!HD6=5MSY\,SB="C/,D$
M0)V1$'R_5O@OX?U;]IV7PJ+&.UT2>-XGLK(O8Q^7)X>,DB+]C:%D21BWFJA4
M2AW5PRR.&_8_]LWX5:'XC^&.NZ?<V%NUIIFCW=S80J@C6UFL;61K9X!'M\KR
M]H0*FU3$6A8&)W1O@#_@C;\-[/Q+X>E\3:@]Q>7NEZA=Z?I<=Q,TEOIT,L-O
M/<-90M\D$MPTQ%Q*OS.BA1M#S>;X_P#\%H_"UGX$USPSXFTJ/[%K5W]L,][;
MLT4SM8FS-K(60C$L7F,$F&)=HC4N5BB"?T/4445_,#_P6K_Y*'IO_8OVW_I;
M?5^O_P#PSQ\7O^BG_P#EK:;_ /'*Y_\ X)I?#?7/A)HOB71O$K^=J\'BB[:Z
MG\XS^>TUC83B?S6^=_.619LR!9?G_>*DFY1\0?\ !<[_ )E'_N,?^V%?O]7X
M _\ -WG^?^A<K[/_ ."J?P]T;4?AKK6N3Z?9R:M;1Z?%!?O;Q-=11G4;<%(Y
MRIE1")) 55@")'X^9LY__!+'X5:';_"BTN?L%N\NN_;AJC2()/M:QW5S:I',
M'W!HEB78(<>5\TC;-\LK/]0?M$>$].\#?#'Q/I^E6EO8V4/A_6/*MK:%(84W
MVL[MLCC"HNYF9FP!EF+'DDU\/_\ !%3_ ))YJ7_8P7/_ *16-'_!:O\ Y)YI
MO_8P6W_I%?5]8?L%_"'2_AIX%T>^LUDDOM8TO3+N^O)W,MQ*QM(_)A,AY%O;
M1D06L"X2&%< %VD=_P L/AOX6L_@_P#M5/HWA^/^S]-E\X/:6[,D++/HOVUX
MR@.WROM&)DAQY4;)'L1%CC"_3_\ P6,^.EY\-O"5AX?TZ>XMKC7KB9;AXMH6
M2QMHP+B!WSYB^8\]OD1C$D2S1NPC9HY?0/A5^U?IWP;T.P\/:5\/_B EEI]N
MD$6?#R*S[1\TLGES(C2RMNEF<*OF2N[D98U^>'@:R\7Z3\=8_&/A?PIXDTO1
M-7U2!+Q+_3;V)?(O_*349+G:S($$S2WD8:1H8G2&0H%B$:]!_P %JOA[HW@Z
MX\.7FF:?9V=S?R:Q+>S6]O%#)<R;K)M\[QJK2OND=MTA8Y=SG+'/[G6O[/WA
M*VT.S\,MHNGS:+8;3:V5Q;1W$,;*&'F!9E?,IWR%YFS*[22,SLSN3[!117Y8
M?\%A=,U2_P#AD9-/,@MH-4LY-1"2A%-J1+&@D4LOFI]IDM2(P'(<)+M C+KV
M'[-'_!0CP-^U-IT.BZO/;VFM7=NEO>:;?1+%;W<LJ1131VOF/+%-%++*T4-L
M\ANI$#;H"H+'W#X0^"K?]BSX>36=TTES8^'X]9O 8RLD[V:W5U>Q EE@1KCR
M&19!B./SMP5MF&K\@/\ @GK^T@^@/KWC'6O#_BSQ/XCU>\$,^IZ;I4=[!'!%
M'&XMTE#1-"Y9P9+=/W*PQ602-!&HKH/^"BGC&]_:^T;38-&\"^-(=6TZ\=TG
MO-%GCC%K-$1<1@0R3!G>2.V8%DRHC;:Z[F5_H#XG?M0>*O@Y^S]8:EKD%Y9^
M*K^,Z*CS)<0W,,FZXB%W.994N4N&M+9IUG!8M=O'+Y?E,0OV?^P3\--.^%_P
MU\/0:>FW[;I]OJ-S(50/+<7T23R,[(J;]N\0QEMSK!%%&6;8"?'_ (B_\$Y]
M.^(7Q0M?B2^K7$7DW%C=S:>($;S+BP1%A*7!8>7$?)@,D;12NV)0LJ>8GD^/
M_P#!:O\ Y)YIO_8P6W_I%?5]_P#[)W_)//"G_8OZ3_Z10U^0/[?7_)PO@+_N
M ?\ IYN*_4_]M3X>Z-XQ\"^(+S4]/L[RYL-#U:6RFN+>*:2VD^R.V^!Y%9HG
MW1HVZ,J<HASE1CX _P""*'@#2XO"NJ^(1;1_VM)JDMBUV03(+6.WM9EA4DD(
MADD9WV!3(1'O+>5%L^S_ -I_]GKP;HWP\\1?9O#^CP_8]'UBZM?+TZV3R+AK
M(YGAVQCRY3Y,.9$PY\J/GY%Q\O\ _!%3_DGFI?\ 8P7/_I%8T?\ !:O_ ))Y
MIO\ V,%M_P"D5]7W_P#LG?\ )//"G_8OZ3_Z10U^*/[8OP]T;X:_'WP+9Z'I
M]GIML\F@RO#9V\5O&TAUB=2Y2)54N555+$9(51G &/W^^(7C6W^&NC:AKEXL
MCVVFV=Q>3)$%,C1V\32N$#,JERJD*&903C+ <C\ ?^">O[2#Z ^O>,=:\/\
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M!_P4FT#_ (2OXZ^#=/\ M%Q:?:[?18/M-K)Y5Q#YNK72>;!)@[)4SNC?!VN
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MQX\&ZYX:BD^PSWF@J;U[1[5;^2/4FC:XC\Q4EF1 JV9ED53OM7B&4B0G]O\
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MM]JEO]IETFXTBZLE>23R8[@KJ"+.8 XAEEC!)@DE1WMV+/$8W8L?I#_@M?X
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M_8OZ3_Z10U^0/[?7_)PO@+_N ?\ IYN*_?ZOPQ^$?AA/C)^T_K_B'3Y9&L=
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MLEQ$'6W>24^8XA7(3 1?RP_X+G?\RC_W&/\ VPK]_J_ '_F[S_/_ $+E?O\
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M3+>.\UO4;RVTS1K.5F2.XU"\?9"CN,*J*H>9O,>%'$9B\Z)G5A\'_P#!:O\
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M/AQ\,K:XNO,636;RXU(120M$T4;B.WBQN),B2QVZ7$<F%#),NT,H#O\ &'[
MO_)POCW_ +C_ /Z>;>OW^HKX _X*C_\ )(?$/_<._P#3E:4?\$N/^20^'O\
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M+)F>.0G$J/)<R0G:N$>W<;V8LL?E_P"P+_R<+X]_[C__ *>;>OO_ /X*C_\
M)(?$/_<._P#3E:4?\$N/^20^'O\ N(_^G*[KX _;Z_Y.%\!?]P#_ -/-Q7[_
M %?@#_P0Q_YF[_N#_P#M_7ZO_MK>*;/P?\-?%%S?2>5$^CWELK;6;,UW$UK
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M8)PRE3R"*\OLOC?;ZMXUF\&6EO)/)9:6+^_O496@M9)9DCM;.3;N*W$T?G7
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M-KMO#JMQJMV@DN(FO83(8X'<N\?RSNL\H;S;IV=Y&V&.&+X@_8%_Y.%\>_\
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MN/(^)WC.\U/0A)"\NDV^IZA<QWRHQD\N=[@PB%%D2%LHDKN-^Q[>14EK[?\
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M(?,66.=2L06,1,[R'T#]M_\ 9:_X:X\)/H45U]CO;>X2]LI&&83<11RQK'.
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MN:-;A2\UW=!;F#B58V6)G62(L%%O,%G/Z'ZMX TO6M&E\/2VT:Z3-9O8O:1
MPQBU>(PF%!$4,:>6=B^65*#&TK@8_&'X<_\ !-SXF_LX^);R?P!XKL]/T2\D
MCC>2X0SW1M0P;,MF]K):2W$.76*0/$9 6PULL\D:]!^T7_P2^U[5_$ND^*/
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M6BB5ON^OA#P%^Q5;^"OBSK'Q'#V9MK^S5;6S6U59+>\E$:7=P'SM5W6)F,J
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M[_\ $?ASQ;JNABSM-8T^SUIO,6745TF22%582!6@LY+\[)4S&P:::YB+(VZ
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M^!-+\3ZK';PWM]]K\V.V5TA'DW<\"[%DDE<96)2V7;+$D8& /I^BBBBBN?\
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ME6UMJ-M-,^Q2[;(XY&=MJJS-@'"J6/ )K\8?^"&/_,W?]P?_ -OZ_?ZOG_\
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M"6+5K/1=&U"..;Q'J;7L=O(EJWF/)8&5U9+5Y((]P$@)N3<6T3;+9Y1<=?\
M$OX1_L\>//#SZ':W_@_3Y4MVCL[Z"_LUN()EA:*&:66.YBFN]A82/'<2NL[J
M&D+/AQXA_P $=_VJM4\=)=^ ]8EDNETVS6ZTN9E!:*UCD2&6VDE+[F1&E@^R
MKL8HGFQF011V\2Z&MZ1>?\%'OBKJOA_59;B+P)X+N-DUE&5A-U?([0$3%9C(
M?->.Z\N=!F*SB,:K:W%T\K>__MO?L2^$K_P;J>LZ#9V_A[5-&T_4+N*YTNWC
MM?/A%M)]IM+A(!$)8KB(-"2QW1[SC=$\\,_G_P#P14_Y)YJ7_8P7/_I%8U^O
M]?"'[>G[.7ACXK>%=8U_6;22ZU'1]#U.73W-W=)';R1V\DP=;>.98"Y=4+LT
M;&0)&CEDC15_-#_@E_\ L9^!/VB?!M[JOB?2_MU[#K$]M'+]KNX<0I;6DBIM
M@GB0X:5SN(+'=@G  'V__P %0?VE-<^"VAZ;H'A;[0NN^)+B6V@FMXR\R0QB
M-94MBC>8MW(\\$<#(CL%:4H8YQ"X^@/AI^PWX&\#Z<D&H:/I^LZE)MEU#4]1
MM5O+B\O&11<7+/>-<R1^<ZF4Q+(8T=V(&YF9OR ^+.D7G_!*#XE66J>'I;@^
M#M>PUS9,5FS#%*!=6J*TRO)+;+*DME<2F)AYP@>691=&;^B[2=6M]?MXKRSE
MCGMIXTEAFB=7CDC=0R.CJ2K(RD,K*2&!!!(-:%?S@_%+P?>>/_VI;C2['4;C
M29;GRT:]M0IN(X?[ 0SB!GR(I9(A)%'. 6MW<3JK/&H/V_\ '3_@DQX0\>:'
M.NAFXMO$Q_?#5KR\N;IKRX )D-\'=T_TAB7FE@C1XY2)%1D5K>3S#_@D3^T/
MK.OIJGP^\232?:]#C1K"WN(I5NH;>.1H+JWE=A@);2&W2**7;-&)6B7=#$J0
M=!^WS^T,_BGQCI?PEBU:ST71M0CCF\1ZFU[';R):MYCR6!E=62U>2"/<!(";
MDW%M$VRV>47'7_$OX1_L\>//#SZ':W_@_3Y4MVCL[Z"_LUN()EA:*&:66.YB
MFN]A82/'<2NL[J&D+/AQXA_P1W_:JU3QTEWX#UB62Z73;-;K2YF4%HK6.1(9
M;:24ON9$:6#[*NQBB>;&9!%';Q+^YU?D!_P6K_Y)YIO_ &,%M_Z17U=!^SU^
MP9X<^+_@WP_J?CFYU#Q'+-H^G26EO<7<]M9Z="]M'LALK>TDB"?NE@CN)':1
MKB2 3D(\CJ?SPN="UG_@E'\4K**WU"1O"6L20&>::&5XY=/\_9,LZQH%>]LE
M8R*]OE\/&_EK'=26A_H>^-?Q0M_@KX:U3Q'=>6T>FV<UP(Y)E@6:1%/E0"1@
MP5YI-D,?RL2[J%1F(4_D#^R1XC\"_&]+OX@_%G6/#=]XAU622&UT[4;RT,&F
M:?#)MC@CL+HX@=I%D<,WFNT+1RB3S;BZ:7Y?_:Z\5^&OV1?&NC^,_@]JNE[K
MN.Z74-/T^Y6ZM=RS)(ZW"1W#JEO<K,J);1K D)M1) 4E56B^[_\ @I%I,7QH
M^%!\=6FIZQ;61T_3+FWTE9HHK.9;^ZM6#WT*([S2HLB%%,[10R1*T8!,C2\!
M^P5^RI!^T;\.-&D\<2_;O#UM]M71]&MY;BVB1S>W!GOKV2&2.2:[+F6"W0,(
M(+7)"M-<2E/F_7_ADG[!7Q_\/V/A6>3^SM:DLP;69I"L5KJ=W)9RVK,L@:=(
MFC\^W:7)5U@,@F>$R2_M?^V-^T+_ ,,P>"[_ ,21);S7L7E0V5O<2^6LUQ-(
MJ*  0\OEJ7N'BC*N\4,@#QC,B? '[*.F_"S4-#'B3XB:UX7UOQ=K^R^U*;5;
MW3[AH-X)@M8X;@*+7R8BB2PHB[)0T(9H(;=(_A_Q=\8=#_8$^*L5[\.]3M[W
MPAJ-O92:E86-P+^%80[PSPB1KJ3S+M/+>ZMY'DB:)K@0D?9VD6;[_P#^"H_[
M+GA#_A$/$/CS^S_^*D_XEW^F_:;G_GYM+3_4^;]G_P!3^[_U?^U]_P":N _8
M*_8*^''QI^'&C:]KVC?:]2N_MOGS_;;V+?Y5[<0I\D-PD8PB(ORJ,XR<L23G
M_P#!9[X:/:Z#:>(WU75)5EU2UM$TMYXQIL*BUNW\Z.W2)6-P65LSRR2/MD>,
M$1"-(_U._9._Y)YX4_[%_2?_ $BAKX ^,?BS_AM?XJK\+8[O_BD="MS?>((8
M)O+;4+B!T M?.A,A>*&6:VCEA/V9TE6[);SX+5T]0_:P_P"">_AKQGX#NM)\
M&Z!I=KK=K';OITR1K;SNUNRAXY+H#?,\L/F1@W3NCS.DLKJRB9.@_8V^!?C?
M0?AD_A7QIJ-YIU\TDT-G+97,#WUAI^(TC@2Y\N>)7RLWE,IF>"WEB6*2%XD2
M#\\/^";.@?\ "*?'7QEI_P!HN+O[);ZU!]INI/-N)O*U:U3S9Y,#?*^-TCX&
MYR6P,XK][OB%>ZIIVC:A/H<,=SJT=G</802D".6Z6)C!&Y+Q@(T@56)>, $_
M.OWA^4/_  3=_8_M[OPUJ&L_$7PY'<Z[J>J3R^9K=JMQ=-;JJ8=H[L.\+O.U
MRSLRQS3@I(YDC\AJ^7_V:K:W_9[_ &C[OP=X0O9!X<NI+B&YMA.MQ&QBTZ2[
M\AF.[Y[2Y#PHQ)N(@DD,DC%Y_,_2_P#X*C_\DA\0_P#<._\ 3E:4?\$N/^20
M^'O^XC_Z<KNO@#]OK_DX7P%_W /_ $\W%?L]\=/@7H?[1>AS^'_$$'G6DWS(
MZX6:WF4$)/ Y!V2IDX."K*6C=7B>2-OP!_X)L^ ='^$7Q5U/P;XRTNWGU^#<
MNEW,T<DBQ7%DYN"]M%+" //B47=M>N(G2*!1&?\ 2L']G_V]DT.+X:^(;G7H
M+>:*#3[@VC3VXG\J^FB>ULY(AL<QR^;.B),H4Q;RQ=$W,#]B7]F+3OV8?"5G
M916GV?5[RWMY]8D=TEF>\,8,D1ECRAB@9GC@2,F-5W."\DLLLGU_7S_^U/\
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M]GC*[U-Q-(D%OYB^9$3$)98S-M=7$0<IE]H/PA^PY^QW9>/-+/Q#^(L$>O\
MB/Q-&+HC48H+F"WM9"&M_+B_>0[Y(EBD#;4-M"8[2.* 1S"7\X?^"L'[,^E_
ML^ZII=UH,DD&EZS)J%P-)&?LMG=(+5;B6U7=MC2X5H=T04",PA5;R1##!_1[
M\7OAH_Q:TMM+35=4T=7D1WN=*GCM[HJASY8F>*5HT+;2QBV.P787\II$?\4?
M^"&/_,W?]P?_ -OZ^K_^"LGPT?7O .HZ\=5U2&/3H[1%TR">./3[AIK^W1I+
MJ(1>;.ZAE,0>79$\:.B*S2F3Q#]@K]E2#]HWX<:-)XXE^W>'K;[:NCZ-;RW%
MM$CF]N#/?7LD,D<DUV7,L%N@8006N2%::XE*?-^O_#)/V"OC_P"'['PK/)_9
MVM268-K,TA6*UU.[DLY;5F60-.D31^?;M+DJZP&03/"9)?V__:Y^-]Q^SCX(
MU;Q19V\=U<V4<(ABE9EC,EQ/%;HS[?F9$:42,BE#(%*"2,MO7X__ ."5?PR2
M;PG_ ,)]JD\FI^(_$,DXFU&Z:2:Z2UM93:1VOG2R2,R;K;S68>66!BC<.+:%
MA\8?\%)M#E_9F\?:9X@T>^U#0]%\3;6UI-#O);6[N9K.<&[GV!DM_-:&Z3R2
MQ*O<>=)(H:1Y)?V^^"GPA_X4MITFG_VOK&L^9<-/]IUB\^V7";DC3RDDV)B(
M;-RI@X=Y&S\V![!7X8_\%GOAH]KH-IXC?5=4E675+6T32WGC&FPJ+6[?SH[=
M(E8W!96S/+)(^V1XP1$(TC_4[]D[_DGGA3_L7])_](H:_!']M+X::I\,/C9X
M7@TW5;S6-6NY-*N[6?79Q-''=2ZI.(H2+6*$0V2R(K>1 BB,/)Y8&54?I_X_
M_P""7GA/XIZ7<OK5S>7GBV\C+3^)))9?-:ZR")!9"46BVZX$,=JB*([55A25
M9%6<?.'_  1+^)>H^(-#UWP]<OYEEI5Q:3VFYG9H_MPG\V)=S%%B#6XE5$5?
MWLL[L6,GR_M]7A_QO_9R\,?M'6]O9^*+22]MK61I8H1=W5O&)&7;O9+>:)9'
M"Y5&D#&,/($*B1]W\^/_  2D_9<\(?M*?\)'_P )7I_V_P"P?V;]F_TFY@\O
MS_M?F_\ 'O+%NW>5']_=C;QC)S^K_P#P4;\+6?@;X(:MI6GQ^396-OI%M;1;
MF?9##?V<<:;G+.VU5 W,68XR23DU\P?L%?LJ0?M&_#C1I/'$OV[P];?;5T?1
MK>6XMHD<WMP9[Z]DADCDFNRYE@MT#"""UR0K37$I3YOU_P"&2?L%?'_P_8^%
M9Y/[.UJ2S!M9FD*Q6NIW<EG+:LRR!ITB:/S[=I<E76 R"9X3)+^U_P"V-^T+
M_P ,P>"[_P 21);S7L7E0V5O<2^6LUQ-(J*  0\OEJ7N'BC*N\4,@#QC,B?
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MXMO#=U;V.J3>7'#=W$1F2W5] 19IEB! EECB,CP1N1$\ZQK(?*+U]8?M;_\
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M/_;X^)>H_"+X9Z_J^E/Y5ZEO%!%*&=6B^UW$5HTL;1LCI+&LS/"X;Y)51B&
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M  "$LSLQ"1QH&>1V6-%9V53\7_\ !:O_ ))YIO\ V,%M_P"D5]7W_P#LG?\
M)//"G_8OZ3_Z10U^0/\ S=Y_G_H7*_7[]K'_ ))YXK_[%_5O_2*:O@#_ ((J
M?\D\U+_L8+G_ -(K&OC#]H2YT;P3^TV+SQC91RZ%=R62L+V")K62.?2X[*.X
M<7.V%K>&XRTLI)$1@E(S)%MK]SO^&3OAY_T*GA__ ,%-E_\ &:/!W@_P#\,/
M$(TK1-.T?3=?GT^6Y,5E9007!L4FBC=Y&AC4K$TK1A5<@2NC% _DR%/QA_X(
M=>*;.TU'Q/I3R8O;FWT^YABVL=T-J]Q',^X#8-K7, VL0S;\J&"N5_9[]K'_
M ))YXK_[%_5O_2*:O@#_ ((J?\D\U+_L8+G_ -(K&OU_KY__ &L?^2>>*_\
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M?_P5'_Y)#XA_[AW_ *<K2C_@EQ_R2'P]_P!Q'_TY7=? '[?7_)PO@+_N ?\
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M/B'_ +AW_IRM*/\ @EQ_R2'P]_W$?_3E=U\ ?M]?\G"^ O\ N ?^GFXKZ/\
M^"SVDW&H_#FTE@BDDCMM<M99W1&98HS;7<0>0@$(ADDCC#-@%Y$3.YE!] _8
M@^&'PT^-_P /M$U*+P[H=S<PV<-G?O-IMC)<?;+5%BG,Y"2-OD9?/4R$2/#-
M'*RJ9,5] >/_ (&_"CX6:7<ZUK7A[PW9Z=9QF2>>32;/:JY   $)9G9B$CC0
M,\CLL:*SLJGZOHK^0+PM_P 8'?&V..Y_=66CZPT+27/^D,-+NU,8N'%KC=*;
M*X$ZA%R)2 T.0T-?U^T5S_\ PE-F=1_LH2;KT6_VEHE5F\N$OY:/*P!2+S&#
MB%9"K3^5.8@XMYS'_/C^R5XDN/AQ^TOXBTZZM)%DUF\UZW'F;HFBC>9M3BG"
M,A,B2QVZ>7RH9)EF5V4!7_HNK^?']J_P';^(?VE_#$6@I'-?22:->ZFB3J66
M2SF>65I [XB=+"VAD$0V%T".J,\P,FA_P7._YE'_ +C'_MA7[_5^ /[ O_)P
MOCW_ +C_ /Z>;>OO_P#X*C_\DA\0_P#<._\ 3E:4?\$N/^20^'O^XC_Z<KNO
M@#]OK_DX7P%_W /_ $\W%?O]7X0Z-X6O/$'[6U[<VT>^+3[=;FZ;<J^7"VAP
MVH?#$%LRW$*;4#-\^[&Q69?H_P#:W_;!\03>++3X5?#7RT\5W4D9N]0N5006
M4?E?:BJ+,CI(_D#SIGV2A(?W<4<UU)BW\ _;&_8?\/\ P0^&'B#Q%>3WFO>*
MGCTU9M;U.9Y[C)O+"%Q"K,RQ)MC*QEC+<)#(\!N7B.VOL_\ X)<?\DA\/?\
M<1_].5W7P!^WU_R<+X"_[@'_ *>;BOW^K\ ?^"&/_,W?]P?_ -OZ^S_^"K'P
M&?XR?#Z:_LXXVOM D.HJ3'&9&M41EO(UE=T,:>61<N%+&4VL<8C9S&5^8/#'
M[9EQ\9_@5+ID<D=UXPNY+?PF+>=F9[NXU#]Q%,SM.S*\UGYTGVJZ>&%[V"XX
M**$;]GOA[X*M_AKHVGZ'9M(]MIMG;V<+RE3(T=O$L2%RJJI<JH+%54$YPH'
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M6K:AJ\%E%J-K"\*W%Q>"[M)2MU@#SXE*6SHKO*US"J I-NK]WO\ AD[X>?\
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M<M=/TW0+JXEOC;W"2OJ\DLUO;I'@),(;:+" NLZM=))')$T">8LD?Z_UY?\
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M\'+/]H#POJ?AB^;9%J%N8UEPS>3,I$D$VU'C+^5*D<OEEU639L8[&8'\T?\
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MAW&C+H?A*\MK;2X[LO)>:CI*222730Y41Q7TJA$6!2',A+F1E\M!&&D_0_\
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MAJ<ZOY?]NZO)'/>K&S,L$<:D06I8.T4CQ%Y7DEC507F:,/-'%%*WZ'U\(?\
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MJLH<*S*& R S#."<]!I.DV^@6\5G9Q1P6T$:10PQ(J1QQHH5$1% 5450%55
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MR\EDGN9]#TR6::5V>221[2)G=W8EF=F)9F8DL2222:_'']OK_DX7P%_W /\
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M2_\ CWXC_:)\&WNJ^)[S[=>PZQ/;1R^3!#B%+:TD5-L$<2'#2N=Q!8[L$X
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MT[[!;RRZQX@:&"^:V:+RVV6MN\Z1/ME>.SN!*))5EFE AB^RF5SXE_L9^-/
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M;<EHHBRS2-,!;F.3/U;]AWQ!XKMY;C4_B+XL.MRQN#<65RFGZ>) I6%ETVW
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M/ E_XG\.ZK<:=>Z;]GVQQPV<T,_VF[MH#YRW5M._R*[F/R7A^9B7\P!0/?\
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MV<\K$0W$\D,L2RK'YT<SVCPN[>9"_D'[6?P-\>?LT>#M1UOP3XS\27T:1_\
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M4KC3]-6WTQVN8[G[/]A\_4YTGO(9'S';RJD4;&<CY?)C9LK&H'Z/_P## O\
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ME(P20B&2220JN 7D=\;F8GYP_8%_Y.%\>_\ <?\ _3S;U^_U%?D!_P %J_\
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MI_:[]D[_ ))YX4_[%_2?_2*&OR!_X(8_\S=_W!__ &_K[_\ ^"H__)(?$/\
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MB6S\676M>)-1U:SO+6\$U]?6]PTLEHT;1"9VM!*Z 1HF-X(0!59<#'Z7T5^
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M*D J3DM\Q! 'Y(?\$,?^9N_[@_\ [?U[_P#\%J_^2>:;_P!C!;?^D5]7W_\
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MDM8-4N?$,\8)\/6-A/>7WF*3YJPNJ);S(B*\^_S(R;=2S1I+F$?EA_PL_7/
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MIX2TD89(T<2NRQ9<?"'_  1<^*NAV?AF_P##,U_;Q:U+K$US#92.$FFA>S@
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M3[.TKVT:QRLN464-;RAX2?-CV@NBAT+?O]\-/BKH?QDTY-5\/7]OJ%D^T>;
MX;8S(LGERK]^*4*Z%X90DL>X!T4\5Z!7X@_\%H_BKH=YX9L/#,-_;RZU%K$-
MS-91N'FAA2SG!>95SY.?M,)C678TJN6C#JCE?N_]B[XU^&O%/PYT:2TU2S==
M'T.PCU,&94:R:WMO+E-TKE6@0-!,5DD"I(B&5&:+#G\</^%_>%_^&GO^$I_M
M.W_L+[1]G_M#)^S[_P"R/L&[S,;?*^T?)Y_^HV?OO,\C]Y7ZO_M[?LUQ?MC>
M!E;0OL]UJEMY=_HUPDD02=74>9$MP5<>5<1'<FUXXI)TM7DE6)"P^</^">?[
M=NC6_A]/!7C:[CT36_#T9M-^I/%9QS6\#^5'%F00K%<6R[+>2"3]\XC$VZ5C
M<"'/_;M^(<O[:D5C\.OAI-_:[OJ$4NM7]I+*=-LX5B,ENEW<QQM;2Q2%FG 2
M61EFLO*6&2Y*(OU?^U+X@\-?LV_"B^\.7>HQP*/#=SI6F1W,JFZNV2S%G$$C
M15:5]TD/G-'&$B#^8_EQ D?&'_!%SXJZ'9^&;_PS-?V\6M2ZQ-<PV4CA)IH7
MLX 'A5L>=C[-,9%BWM$J!I BNA;Y_P#^"TWQ5T/QOJ/A_2M+O[>\O=+_ +4%
M]% XD^SM*]M&L<K+E%E#6\H>$GS8]H+HH="W[_?#3XJZ'\9-.35?#U_;ZA9/
MM'FP.&V,R+)Y<J_?BE"NA>&4)+'N =%/%>@45_,C^SY\=;#]GKX\>,M6UA)%
MTF2\UZWOKQ(YI5LHWU)7CGD2"*9V1YXX+4<* ]RA+\!6_5_]J+]O?PUX&\/W
M%OX1U>SUCQ1J$;6VCVFFRK?2&ZE>.%'Q!'<Q!XS*)HX9PHNC&84W$MM[#_@G
MO^S7>?LO>!H-*U3C5+RXEO[Z(2+*D,TJI&L2,JJ/DBBB$F#*OG^:4E>(H:_)
M#0/B:G[!7Q_\07WBJ"3^SM:DO"+J%9"L5KJ=W'>172JT8:=(FC\BX6+)5UG$
M9F>$1R_=_P"T+^V5!\>_!OB"P^'=E<:M:'1]1.HZW<6UQ:Z7:6\=M(UW"LDJ
M1RS:@8C&(+=$V W$<[R&*&9*\0_X(P_$M[70;OPXFE:I*LNJ75V^J)!&--A4
M6MHGDR7#RJQN"RKB"*.1]LB2$"(2/'Y?^T%K_P#PS#^TE;>-?$UO<6^@7FPP
M7B1^:KH=*73Y7 0DGR)6W3QC,ZQ;76)_-A$GZ?\ Q(_X*!^!O">AIJFC:A;Z
M_J%YY,>FZ1I\RRWUU<7 _<0M;J&FM\D@2F:,/&?W?EO<-'!)Q_\ P3W_ &9]
M;^"=AJWB#Q9))_PE'B:\:ZU. _9_+A:.:X*;3;,\3/*9I)W9&5%$D<*Q(8F:
M3\T/^"TWQ5T/QOJ/A_2M+O[>\O=+_M07T4#B3[.TKVT:QRLN464-;RAX2?-C
MV@NBAT+?O=X*^-?AKXBZ,WB'2M4L[G28XS)-=K,HC@58EF<7!8@V[I&RO+',
M(WB!^=5K^?'_ (7]X7_X:>_X2G^T[?\ L+[1]G_M#)^S[_[(^P;O,QM\K[1\
MGG_ZC9^^\SR/WE?O]\5? NG?M$^$K_2%FMYK+6=/=+>Z")=0CSH]UO=1C<$E
M\MC'<0LK+ED1T=3M8?SI?L__ +0'B7_@EAXEU+PGXKTV2[TZ[D@E=(IV"A0Q
M3[?8;QY,R2Q;E=&6%Y7AABDFMWMY(Q]W^*?VXY_V[+.3P-\/-&UB-=6VV6K:
MS<P6_DZ79W# 32/&LD\4GFVR7:*LDUK(6 $#23%0OZ_>$_"UGX&TZTTK3X_)
MLK&WAMK:+<S[(84$<:;G+.VU5 W,68XR23DUH:MJUOH%O+>7DL<%M!&\LTTK
MJD<<:*6=W=B%5%4%F9B H!)( K^;'_A?WA?_ (:>_P"$I_M.W_L+[1]G_M#)
M^S[_ .R/L&[S,;?*^T?)Y_\ J-G[[S/(_>5_0=XU^-?AKX=:,OB'5=4L[;29
M(Q)#=M,ICG5HFF06Y4DW#O&K/%'")'E ^16K\$?^"+/Q5T/P1J/B#2M4O[>S
MO=4_LL6,4[B/[0T3W,;1Q,V$:4M<1!(0?-DW$HC!'*_0'_!:/XJZ'>>&;#PS
M#?V\NM1:Q#<S64;AYH84LYP7F5<^3G[3"8UEV-*KEHPZHY7[?_9!_:!\)7_P
MUT6Y&M:>D6D:/I=MJ32W,</V.98EM=ER)60P[Y8W2)I JS8#1%T96/XHZM^U
M5X:T7]H^7QQ++(VA0WCVKW,2K,"J:<=,-RGE.XDM_,'G*T99WM\.L;2$1'^E
MWP5\0M&^)5NUYH>H6>I6R2&)YK.XBN(UD"JQ0O$S*'"LK%2<@,IQ@C/X _%#
MPO?_ /!,3XL_\)K9V,DG@K69)HG2V$.$CN0)9[(#RD2!X9D%Q9PKY8FMX4A%
MQQ=&/]?]3_;I^&6DZ6-8D\3Z6;8QQ2!([@2W6V4J%!LH]UV'&X>9&8@\0#&1
M4"/M^/\ _@GQ\#_$NH^*O$OQ3\6VEYIEWKDD\%AI]W*S7$5J]P)'69)8DE5(
MA#;V]GGRB88I#]G6%K=C\(?MR?'[POX@^.'A;7;'4[>[TO1_[%^W7=L3<0Q^
M1J,MW+L>(.)MD4B,WD^9\Q,7^M5T7^C[PMXLT[QS9QZAI5W;WUE-N\JYMIDF
MA?8Q1MDD99&VLK*V"<,I4\@BOYX?^"TWQ5T/QOJ/A_2M+O[>\O=+_M07T4#B
M3[.TKVT:QRLN464-;RAX2?-CV@NBAT+?N]X<_:!\)>*]#/B:TUK3VT5?+$MZ
MUS''#"T@C*QSM(R^1+^]C!AFV2JSJK(&(%?@#^PW\?O"_A_XX>*==OM3M[32
M]8_MK[#=W)-O#)Y^HQ7<6]Y0@AWQ1NR^=Y?S 1?ZUD1OT?\ ^"L'Q5T/P_\
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M7$=M/K4EFVBVDS.M]>6<=]$ZWS6CQK+;V\PMKB2WD?,<EN(',B3S_9H_3_\
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MNA^"-1\0:5JE_;V=[JG]EBQBG<1_:&B>YC:.)FPC2EKB()"#YLFXE$8(Y7Z
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MBO'_ !3^SUX-\<WDFH:KX?T>^O9MOFW-SIUM-,^Q0B[Y)(V=MJJJKDG"J%'
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M"'A76M4&N76B:7-JRR12B_DL;=[H20A1$XG:,RAXPB"-MV4"KM(VC'J%>?\
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M<O&8GFL[&WMY&C+*Q0O%&K%"RJQ4G!*J<9 QZA1111117G_CKX3^'OBAY/\
M;VE:?J?V??Y'VVTAN?*\S;O\OSD?9NV)NVXW;5SG QH:G\/=&UK2QH=UI]G-
MI*QQ1"PDMXGM1'"5,2"!E,02,HAC7;A"J[0-HQH>%O">G>!K./3]*M+>QLH=
MWE6UM"D,*;V+MLCC"HNYF9FP!EF+'DDUT%%%<_XI\)Z=XYLY-/U6TM[ZRFV^
M;;7,*30OL8.N^.0,C;6567(.&4,.0#7/Z!\)_#WA33KC2-/TK3[33;OS/M-G
M!:0Q6\WFH(Y/-A1!&^] $?<IW( IRH KL-)TFWT"WBL[.*."V@C2*&&)%2..
M-%"HB(H"JBJ JJH 4    5H4444444444444444444444444444444444444
M44444444444444444444444444444444444444444444444444444444445^
M:'@K_@DS\,O!FLMJ[6UY?1^89(=/O+@26<+>:LB (L:2S(@7RQ'=27"21LPE
M65CN'Z7T4444444444444444444444444444444444444444444444444444
M4444444444444444444445S_ (IT:?Q!9R6UM>W&GROMVW5LMNTT>U@QV"ZA
MN(3N *-OB?Y6)7:^UE^ /AO_ ,$TM%^$FN/XET;Q+XH@U>;SO/NFN[&9I_/.
MZ7SQ/82)/O;$A\Y7_>JLO^L16'Z/T4444444444444444444444444444444
M4444444444444444444445\__M*?LUZ'^U3H?]@:_P#:%MUN([F&:VD$<T4T
M890Z%E>,Y1Y(V61'7:Y( D".O(?LS_L6>#OV44D;P_;2/?3Q^5/J%U)YMU+'
MYC2!,A4BC3)4,L$<0D$<32"1XU>OJ^BBBBBBBBBBBBBBBBBBBBBBOE#X\_L1
M^ _VCGDNM=TJ/^T7CD0:A;,UO=!GC2-9'>,A9WB6-/)%TLZ1A=H38SJWQ_I/
M_!&'X<Z=<13RW>N7,<<B.\$MU;".558$QN8K2.4(P&UC&\;@$[75L,/T/^#G
MP!\+_L_V;6/AC3+?3XGQYK1@M--M9W7SIY"\TVPR.(_-=_+5BB;4PH]@HHHH
MHKY@_:4_9<M?VH;/^R]5UG6+/2SY9EL;"2TBAF>)F97E:2TEF?EE/EF3R-T4
M4@B$J!Z/V:_V7+7]EZS_ ++TK6=8O-+'F&*QOY+26&%Y65F>)H[2*9.58^6)
M/(W2RR&(RN7KZ?HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHK\P/$/QGO/VD_BU/\.M)UBXT_0-"T\W>KMI[+'<7]W%<6^ZT2_AE,
MUM%&98HYS 8+C>MY;/\ >CDB^0/VJ_V"?$/[,&HQ>-?@RVH0(OE176F6<DT]
MQ'AXR&C1C))>6DCHC7%K-YVQQO*R6Q9;7]SOA[>ZIJ.C:?/KD,=MJTEG;O?P
M1$&.*Z:)3/&A#R HLA95(>0$ ?.WWCV%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%<?X3\?Z7XZ>^CTRYCNFTV\>QO#&25BNHXXY)(2V-K.BR
MH)-I8(^Z)B)8W1?R!_X*_P WC'PAH,>IVOB*2WT*\O(=/.CVMM]G9Q+:W32O
M<WJS&6X1PKQM;;([<H8]T;21F23]+OV3O^2>>%/^Q?TG_P!(H:^@******X_
MQ_X_TOX6:7<ZUK5S'9Z=9QF2>>0G:JY    +,[,0D<:!GD=EC16=E4]!JT=Q
M-;RK9R1Q7)C<0R2QM+&DA4[&>-9(FD0-@LBR1E@"HD0G</Y\?A]=>*-+_:9T
MW0O$^O7&ORZ;]I\J>2(6T*_:-":5O)LXW:&WR"BR>5CS6C$KY=C7]#U%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?BC_P %?YO&/A#08]3M?$4EOH5Y>0Z>
M='M;;[.SB6UNFE>YO5F,MPCA7C:VV1VY0Q[HVDC,DGZ7?LG?\D\\*?\ 8OZ3
M_P"D4-?0%%%%%%%%%?('[;VG^*)/!NIWWAK7?[#_ +/T_4+NZ:.S$]Q<I#;2
M.((9VF3[)G#$SQH\ZOY;QO'L99?D_P#X(U:M<:_X%U>\O)9)[F?Q)>2S32NS
MR22/:63.[NQ+,[,2S,Q)8DDDDU^M]%%%%%%9^K1W$UO*MG)'%<F-Q#)+&TL:
M2%3L9XUDB:1 V"R+)&6 *B1"=P_GQ^'UUXHTO]IG3="\3Z]<:_+IOVGRIY(A
M;0K]HT)I6\FSC=H;?(*+)Y6/-:,2OEV-?T/45^*/_!7^;QCX0T&/4[7Q%);Z
M%>7D.GG1[6V^SLXEM;II7N;U9C+<(X5XVMMD=N4,>Z-I(S))^EW[)W_)//"G
M_8OZ3_Z10U] 4445_.C^U+-XQ\,?&SP9HWB/Q%)K%M/JFBZA#;Q6WV&SMB^J
M2Q(B6JS3*[QJ'5;F5GN&C<1O(P7)_HNHHHHKCY/'^EQ:S'X>-S'_ &M)9R7R
MV@),@M8Y8X6F8 $(ADD5$WE3(1)L#>5+L["BBOS@_P""C'['?B']KW3M)MM!
MU*WM/L%Q/)/:W;S);S^:BJDQ,*2_O8=K)&&B/R7$I$D>"LOW?\/?#=QX.T;3
M],O+N2_N;.SM[>:]EW>9<R0Q+&\[[GD;?(RF1MSN<L<NQY/844445^8'B'XS
MWG[2?Q:G^'6DZQ<:?H&A:>;O5VT]ECN+^[BN+?=:)?PRF:VBC,L4<Y@,%QO6
M\MG^]')%\@?M5_L$^(?V8-1B\:_!EM0@1?*BNM,LY)I[B/#QD-&C&22\M)'1
M&N+6;SMCC>5DMBRVO[G?#V]U34=&T^?7(8[;5I+.W>_@B(,<5TT2F>-"'D!1
M9"RJ0\@( ^=OO'L**********S]6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ
M"JBJ"S,Q 4 DD 5G^$_%-GXYTZTU73Y/.LKZWAN;:7:R;X9D$D;[7"NNY6!V
ML%89P0#D5T%%%%%%?('[;VG^*)/!NIWWAK7?[#_L_3]0N[IH[,3W%RD-M(X@
MAG:9/LF<,3/&CSJ_EO&\>QEE^3_^"-6K7&O^!=7O+R62>YG\27DLTTKL\DDC
MVEDSN[L2S.S$LS,26))))-=!\4?V&/%7CCXRZ?\ $.UUV.'2;62RD,)>X%U!
M';)MELH$7]T;>Y(?S3YD0 N[C=!+@^?^I]%%%%%%%?/_ .U/\)M1^.G@O5_#
M>E7O]GWM_;B.*X)<+\LB.T,AC(<13JK6\Q ?$4KDQRC,;^8?L&_LXZS^RUX.
M7P_KFH1WUS]LN+A%A:5[>VCDV 00-*%8H65KAL1Q 33R#8Q!ED^SZ****X_Q
MEX_TOX?);2:I<QVRWEY;6-L')W375U((X88U +,[,<G (1%>5RL4;NO/_%[P
MSX@\7Z6UGX:U>/0[YY$)OGL4OV2-3EECADECB#L0JEY!* F\",.R21_CC_P1
M:\6:CXYO/&6H:K=W%]>S?V+YMS<S/-,^Q;Y%WR2%G;:JJJY)PJA1P *_=ZBB
MBBBO'_CI\=-#_9TT.?Q!X@G\FTA^5$7#37$S E(($)&^5\' R%50TCLD222+
M^2/PY^)/Q9_X*3O>7V@ZK'X+\'Q21V<@MV%Q?&XBC%PYBF1(+AGWM")2);*$
M6\BHJW#K<"3[/_X8BUCPU_I>@_$'QA#J4?\ J)-2O8]5LQN^5_-L9HHXYLH6
M";F'ER%)1ED /SA^SA^T/\08OB\G@OXES1V\\.AW-O816L3I:ZE<+)#/_:&5
M!21Y8+>X*R$0PPE);=(+:=YH6_8ZBBBBBBBBBBBBBBBBBBBOQA_X*]?'[Q1\
M$/\ A%?^$;U.XT[SKB^N)O((7S7M/LODK+D'S(AYTF^!]T$N1YD;[$V_L]11
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111111111111111111117C_QK^+W_"EM.CU#^R-8
MUGS+A8/LVCV?VRX3<DC^:\>],1#9M9\G#O&N/FR/YX?V0_C[_P (%\9/%OB'
M^P?$%_\ ;_[8_P")=8Z?Y^HVWGZG#-_I5OYB^5Y>WRIOF;9,RISG-?T/?!3X
MO?\ "Z=.DU#^R-8T;R[AH/LVL6?V.X?:D;^:D>]\Q'?M5\C+I(N/ER?,/B]^
MUOI?P\U1O#&D6EYXA\5>6CC2-.C+M"LPQ%+?7+8@L[?>T2RR2,7A2>*<PM$X
M8_-_CK_@H/KWP \FY^(G@;4-&TVYWQV]U9:C9ZINN%VL(9 GD1Q;D\QU+RAW
M\M@D;JLC1??_ (6^*NA^--#C\36%_;RZ++;M<B]+A(5A0$R/(S[?*\O:PF63
M8T+(ZR!&1@/SP7_@K?X#U'Q/;:+9-(VDF.ZDO-;N-UM;Q+#:M<H(('C-Q<.[
MJUOY;) YFV"%;CS%!/#_ /P4ON-:\>:=X,G\&:Y81ZG)$L$MZC07PCD5@;A]
M/,1 MXY$D\V5;A@EO%+/RR-"/U/KX0_:8_X* Z#^RAJD>F>(=(UPK/'YEK>6
M]O:O:W"@+Y@BD>[C;?&S!98W5'0E7VF*2)Y/?_@-\;A\?-+CUFWTG5-,L;B.
M.6TDU%+:)KF-R^'CCAN9Y53"A@TRQ"1)(Y(C(C;AY!^T-^VQIO[-6J66E:MH
MFN7,FIR&+3I+&*SN%O)%$.](8Q>K<;U>>.+;)%&7<D1B1<,?K_2;U]1MXIY8
M9+:22-'>"4QF2)F4$QN8GDB+J3M8QO(A(.UV7#'Y \?_ +9%O!JESX;\%Z5>
M>+/$-G(8KNWLRL%C92 !BE[J4P^SP.R+,(U7S2;B![9Q%+Q7A^O_ /!1^?X(
MZC;Z?\3?"FH>&OMOEFSN8+JWU6W9-Y2=Y9(/*V^3F-GCA%Q/L<,8EW1"7[O\
M:_$X>&M&77--L+S7K9XQ,B:2;:>1[<Q-*)XA+<0+.C*%"+ TLTID3RXW!)'B
M'[*7[:OA[]L'^T?[!MM0M_[,^S>?]MBACW?:?.V>7Y,\V<>2V[=MQE<9R<=!
M^TI^U':_LO6?]J:KHVL7FECRQ+?6$=I+#"\K,JI*LEW%,G*J/,,?D;I8HQ*9
M7"5W_P !/C7IW[1/ARS\3Z5'<0V5]YWE1W*HDP\F>2!MZQR2H,M$Q7#ME2"<
M'('D'_#67_%T/^%:_P!B:A_R#_MG]J;?W'W-^[9M_P"/3_EW^U;_ /C^_P!%
M\G_EK7U_17C_ ,=/CIH?[.FAS^(/$$_DVD/RHBX::XF8$I! A(WRO@X&0JJ&
MD=DB221?B#Q9^W)\0/#6CW?B7_A6FH+H5MYTGG76J0VUX+>.0IYT^G_9Y+F'
M 'F2#:Z1QYE\QH!YQ^L/V9_VJO#7[5^ER:GX>ED#02>7=6=PJI=6[$MY9EC1
MY%V2*I:*1&=' 9-PECE2,^-_[4WA_P"!5Q;Z9=+>:CK=Y&TMGHVF6SWFH7$:
M-AW2%,*J*HDDW3/&'2&;RR[1,H^7_&O[<?C/X)VZZOXV^'UYIFA+(([B]L]8
MLM2DA9U81$P1+& C2!(S)))$BEU&YI&CBD^O_A#^T5X:^-OAI?%>EWL8TL1N
M]R\[+$UFT2[YH[O+;87B7YG)8IL*RH[PNDC?('A3_@J-X.^(OC.R\+Z(LD]C
M-'>2W>M7+?8[6".ULGO"Z),HE= (Y(YFG%J(BF]3,AS7E_QK_P""KDOPT\N^
MT_P9K%UH$^U;;6+X2Z9;W3/YCQM:[[6<212Q()H69HY70MF!-A)_2_X+_%[2
M_CUX?L?$NC-(UC?QEXQ*ACD1D=HY(W7D!XY$>-BI9&*ED=T*NW ?M ?M'6_P
M.?3=.@T^\U?7=;DGATG3+15#3R01AW>:>0B*WMT+1^?,Q8Q(YF\IXXI2GR?\
M2_\ @H/KW[/>G/?>._ VH:5Y^Z/36MM1L]0MY[A49_)N9XMGV3.%*'9.\B"9
MTC;R&5OT_KX NOVU]3^(EY>6_P -/"]QXLM--N&MKW4O[0M=.L3-M5@EG//O
M^UXRPE9%14 BD4RQ7$4C:'[,_P"WCI?QWU23PQJVG7GAOQ5#'YCZ3J *M(N&
MDQ;NZQ/(XA\N=XY(H7V.7C6:**25?K_Q_P"/]+^%FEW.M:U<QV>G6<9DGGD)
MVJN0   "S.S$)'&@9Y'98T5G95/Q!IG[:7B?XKH=1^'O@B\U[0A)+#'J=UJ5
MKI*W$D,C([VT%R'EDM\!=LS",[_,A:))(7%9_P ./^"DVA_%SQII'@O2M,U"
M.[OOMZZA]O46DVG36<<[B"2 "7S96^SL9 '185DCRSR^=##ZA^TQ^VQIO[*+
MQMX@T37'L9Y/*@U"UBLY;663RUD*9-ZDL;X+!5GCB,ACE:,2)&SU]/\ P]\:
MV_Q*T;3]<LUD2VU*SM[R%)0HD6.XB65 X5F4.%8!@K, <X8CD_&&N?\ !0[1
M?!_BVQ\%:SH7B#3=7U"XLX(%N(+%H3]LD6**4307TJ/%N8J[P^9M9)$QYD;(
M/O\ KX NOVU]3^(EY>6_PT\+W'BRTTVX:VO=2_M"UTZQ,VU6"6<\^_[7C+"5
MD5%0"*13+%<12-H?LS_MXZ7\=]4D\,:MIUYX;\50Q^8^DZ@"K2+AI,6[NL3R
M.(?+G>.2*%]CEXUFBBDE7T#]IC]M/P=^RBD:^(+F1[Z>/S8-/M8_-NI8_,6,
MO@LD4:9+%6GDB$@CE6,R/&R5X?H/_!16S\0>$-,URTT/4-0U_5K>]N+?P]I8
M:_N(X;6YFM!<W$B1(8;1Y8TC,YB+;Y"L<4_E2;>?_94_X*7V?[0GBB7P?J^B
M7&@:O^]6WADF:X\R:W$C7,$P-O ]O+&L;, ZE6V2(S1R+&DON'[8G[55[^S?
MI<[Z3H.J:QJ/V.6X2:&QGDTVT5#CS;^Z0!515$DIBC)<K%B1K9)8YC^8'_!-
M7]K*X^&OA74XKSP]XL\0W-YKEU>37^F:<U_&TDUO:AQ-.TRL;@LIDD#9)$B.
M6)?CZ/\ ^"U?_)/--_[&"V_](KZOO#]F2]?3OAIX:GBADN9(_#>F.D$1C$DK
M+8Q$1H97CB#L1M4R/&@)&YU7+#Y/\+?\%5O#/C37(_#-AX>\42ZU+<-;"R-E
M9I,LR$B1)%>^7RO+VL9FDV+"J.TA148C]'_[9G_L[[;]BN/M'V?SOL.ZW^T;
M]F[[/N\[[-YN?W>?/\C?SYWE_/7RA\$_VV--^.WB6_\ "^G:)KD%WI4DT6I3
MW$5F+6SDB9XRDLT-[,&=Y(VCB6(2&0JS@>3'+(GV?117\X/_  53_; U;X@V
M=MX5M-'UC2-%DN'EEN]2M+BP;4FMF*JD$4FS?:+OCN&$R^:96MRT-NT(\W]G
M_@I^TY_PNG49-/\ ^$9\4:-Y=NT_VG6-+^QV[[7C3RDD\U\RG?N5,#*)(V?E
MP?R0U;5K?0/VM);R\EC@MH(WEFFE=4CCC3PT6=W=B%5%4%F9B H!)( KZ/\
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MI+67*C$.H&>0P[513\DL4TOF.[LWVC9A$B4'Q_\ X(8_\S=_W!__ &_K[_\
M^"H__)(?$/\ W#O_ $Y6E'_!+C_DD/A[_N(_^G*[KX _YN\_S_T+E?K?^U[\
M7G^!'@/7/$,#2)<VMFR6LD:1R-'=7#+;6TA27Y&1)I8WD#!AL5ODD.$;Y/\
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MXOM_$_C_ %.6.YU;5M4:VED-O&DB,JK>7+K(F J7$ETA>&-(T!MXS\WR"/\
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M &Q-)M]:^'/BJ*ZBCFC70]1E"2(KJ)(;:26)P&! >.1$DC;JCJKJ0R@CX/\
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M<M$VVV6$;@68XRY,F\U]/U_(%_P5'_Y*]XA_[AW_ *;;2OZ_:**_''_@L_\
M%Y_"'@[3_#4#2))KEX7F(2-HWM;#9(\;,V71S/):2(8QDB*16=5.R3]/O@I\
M+[?X*^&M+\.6OEM'IMG#;F2.%8%FD11YLYC4L%>:3?-)\S$N[%G9B6/Y0_\
M!:?X.V^M>&M,\606\C7VGWBV<\T4:E19W*R,#<N$+A(YTC2 LZQH]U(NTO.N
M/H_0/C'>?'W]GW4/$6H+B]N?"^LQW+94^9-:P75K)-A$C1/.:$S>6JA8]_E@
ML%#'P#_@BIX3T[_A#=2U?[);_P!I?VQ<VOVSR4^T?9_LUC)Y'G8\SRM_S^7N
MV;_FQNYKP_\ X+E:3;PW'A2\6*,7,L>J123!%$CQQ-9M&C/C<R(TLK(I)"F2
M0@ NV?W>\ > -+^%FEVVBZ+;1V>G6<8C@@C!VJN22222S.S$O)(Y9Y'9I'9G
M9F/X0_\ !._2;?0/C[XWL[.*."V@CUV*&&)%2..--8ME1$10%5%4!550 H
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MC_DD/A[_ +B/_IRNZ^ /V^O^3A? 7_< _P#3S<5^OW[6/_)//%?_ &+^K?\
MI%-7P!_P14_Y)YJ7_8P7/_I%8U0_X+*ZM;Z_\--(O+.6.>VGURSEAFB=7CDC
M>QO61T=259&4AE920P(()!K]#OV3O^2>>%/^Q?TG_P!(H:H?M9_L_6_[37@[
M4?#DHC%S+'YMA-)M @O(LM ^\QRM&A;]U.T:F0V\DR*07K\ ?V7?B;JGQA\/
MV_[/VI026TEUKBB>:91#):Z;:O)J.H6J+Y>^*]2>V8PM.EPK&>6&00+%&U?U
M&T445^ /_!<[_F4?^XQ_[85^]U[JUOISPQ3RQQR7,AB@1W56ED$;RE(P2"[B
M..20JN2$C=\;58C\$?\ F[S_ #_T+E?K]^UC_P D\\5_]B_JW_I%-7P!_P $
M5/\ DGFI?]C!<_\ I%8U\8:@'_8L_:2^WZQ=21:3K5Y<W33K)'#&]KK!F"_:
M 9MHM[:\/[UIBIQ:?:A$/W2U_2=7X0^/[&+]J;]IJPM;9=UEX2M[=[JXM[F)
MLMI[-=@L&7C;>W,-E/ GF2KLD.Z,[C#^KVM?&/0]2\6S?#O55M_M%YH\5Y!!
M<$.M_#-)=P75N(G3RV\M(%=XRS--%+(1%Y<$K5^./_!37_@GGX?^'>B3^.O"
M:1Z;':R)_:.G@N8)!=7"QI+:J=PA=9)E1K==EOY.#&L+1%+CZO\ [%\0_M3?
MLW^3JBW UJXT?SD'D337%W_9MQYUJ=DCF666]BM8CYH+>8]QYZ(RLL9^</\
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M!UWP-))-'J-XTVDV \^2X2>%XEEL&\IA+<6\PN$A0!_.FADDMY-S+YT_O_\
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MZR.CJ2K(RD,K*2&!!!(-?H=^R=_R3SPI_P!B_I/_ *10U0L?B;X:^->M^(?
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MO_L7]6_](IJ^ /\ @BI_R3S4O^Q@N?\ TBL:_7^BOP!_8%_Y.%\>_P#<?_\
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MQ'9M+&+F6.26.$NHD>.)HUD=4SN9$:6)78 A3)&"077/X(_\$,?^9N_[@_\
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MT>*2Z73;-K75(58%HK6.1YHKF.()N9$:6?[4V]BB>5((Q%'<2K]?_P#!,?\
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MNC@*^T2QQ/'\O^ /V+OB'X$TNV\/1_$J\&B01BW,$.C6J72VI)#16]])-//
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M_AIX'G^'>G)I\^J:AJ_E;1'<ZBUN]P$5%14:2""W\W&TL9)A).[NS/*^0%]
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M2-%(6W_!)K2].\8WNNV>NWEGH6HR3_:]$LXC:"6UN/GET\W-O-&!9-( #"L
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MH8#!*L,Y!P>"OC?X5^)5PUGH>MZ7J5RD9E>&SOK>XD6,,JERD4C,$#,JEB,
MLHSDC//ZM^TWX%T"XEL[SQ+H<%S!(\4T,NIVB21R(Q5T=&E#*ZL"K*P!4@@@
M$5ZAX6\6:=XYLX]0TJ[M[ZRFW>5<VTR30OL8HVR2,LC;65E;!.&4J>017C_Q
MK_:G\%_L[>6OB?5[>QEFVF.WQ)-<%7\S;)]G@2681$Q.OG%!$'787WD*<#X.
M?MH?#_X^WC:?X=UNWN;T8VVTB36LTF5=SY,=U'"\^U8W:3R0_EJ S[0RD_3]
M?('Q+_;X^&?PBU%]*U?7[=+V+<)8H(KB[\IE=HVCE:TBF2.561@\+E94X+(
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MD@ =&9&5CV%9^K:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22
M*^0-,_X*'_"O5M4.CQ^);,7(DEC+R+-%:[H@Q8B]DB6T*':?+D$I24E1&SET
MW?3_ (#\?Z7\3[!-4T:YCO+&22>..XB),<C6\SV\A1L .@DC<+(N4D #HS(R
ML<_XE_%70_@WISZKXAO[?3[)-P\V=PN]E1I/+B7[\LI5'*0Q!Y9-I"(QXKP#
MX:?M\?#/XNZBFE:1K]N][+M$44\5Q:>:S.L:QQ-=Q0I)*S.H2%"TK\E4(5B/
M?_B7\5=#^#>G/JOB&_M]/LDW#S9W"[V5&D\N)?ORRE4<I#$'EDVD(C'BOR1_
M8>_;9T;XE>,?'/B/Q'JUGI5M>R:5%I4.H7D5J5L[;[<L:(D\[*'"LLMRL+-&
M+B>1P )!G]GM)U:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0RLI(8$$$@U
MH5_.C_P60^-^C?$JW\-6?A_6[/4K9)-1ENX;&^BN(UD"VJV[S)#(RAPK3K$S
MC(#3!3@OG]OM,_:;\"ZTYBM?$NAS2+'+*4CU.T=A'#&TLKD+*2$CC1Y)&Z(B
ML[$*I(S_ (;_ !8^'E[>/I_AG5?#[WNH7$UU);:?=V3375PR[YIVC@??+*53
M=+(0SE4W,<+D>H>-?B%HWPUMUO-<U"STVV>01)->7$5O&TA5F"!Y652Y568*
M#DA6., XS_ OQ8\/?%#SO[!U73]3^S[//^Q7<-SY7F;MGF>2[[-VQMN[&[:V
M,X..?^,?Q^\+_L_V:WWB?4[?3XGSY2R$M--M9$;R8(P\TVPR(9/*1_+5@[[4
MRPX#XQ_MH?#_ . 5XNG^(M;M[:].=UM&DUU-'A4<>=':QS/!N61&C\X)YBDL
MFX*Q'R__ ,% /V[-#^$?A*ZL/#^JV]SXAU6W6*R%G.)6MX;F-'-X\D$JM!_H
M\HDLY-VZ25X9426%963W#]COXW^%=:\(>%=#M=;TN;5ET/3HC81WUN]T)(;*
M,RH8%D,H>,(YD7;E K;@-IQ^:'_-WG^?^A<K]/\ XE_M\?#/X1:B^E:OK]NE
M[%N$L4$5Q=^4RNT;1RM:13)'*K(P>%RLJ<%D 92?J_2=6M]?MXKRSECGMIXT
MEAFB=7CDC=0R.CJ2K(RD,K*2&!!!(-9_BGQ9IW@:SDU#5;NWL;*';YMS<S)#
M"F]@B[Y)"J+N9E5<D99@HY(%?('A;_@I#\*/&%Y'8VWB.W267=M:Y@NK2$;5
M+G?/=010IPI"[W7<V$7+LJG[?KP^V_:4\'7NLWN@1:Q9OJ.FV<][?HLF8[2W
MMY?)G:XN!^XA>)^)8I)%FC'SL@3YJY#X;_MH?#_XNZX_AO0];M[O5$\[$*I,
MJR^0<2>1,\:PW& "X\AY-\2M,NZ)6<?3]%?$'BG_ (*0_"CP?>26-SXCMWEB
MV[FMH+J[A.Y0XV3VL$L+\, VQVVME&PZLH^G_AI\5=#^,FG)JOAZ_M]0LGVC
MS8'#;&9%D\N5?OQ2A70O#*$ECW .BGBOQ!_X+G?\RC_W&/\ VPK];_C?^UUX
M(_9QN+>S\4:M'97-U&TL4(AGN)#&K;=[);Q2M&A;*HT@42%) A8QOM]/^&GQ
M5T/XR:<FJ^'K^WU"R?:/-@<-L9D63RY5^_%*%="\,H26/< Z*>*] KY@^,?[
M:'P_^ 5XNG^(M;M[:].=UM&DUU-'A4<>=':QS/!N61&C\X)YBDLFX*Q'7_"'
M]I3P=\>D5O#6L6=_(T;RFW239=)'')Y3/):R;+B--Y4!I(U#!D8$JZ%N@\:_
M&_PK\-;A;/7-;TO3;EXQ*D-Y?6]O(T99E#A)9%8H65E# 8)5AG(.#P5\;_"O
MQ*N&L]#UO2]2N4C,KPV=];W$BQAE4N4BD9@@9E4L1@%E&<D9T/'7Q8\/?"_R
M?[>U73],^T;_ "/MMW#;>;Y>W?Y?G.F_;O3=MSMW+G&1G0\%?$+1OB5;M>:'
MJ%GJ5LDAB>:SN(KB-9 JL4+Q,RAPK*Q4G(#*<8(SXA\8_P!M#X?_  "O%T_Q
M%K=O;7ISNMHTFNIH\*CCSH[6.9X-RR(T?G!/,4EDW!6([_X.?'[PO^T!9M?>
M&-3M]0B3'FK&2LT.YG1?.@D"30[S&YC\U$\Q5+IN3#'V"BBBOYH?^"G'[-=Y
M^S3XMM/B3X9_<6E[J$=RTC2+*UOK0DDNMZQ2J<Q2^7YZJ?.195G1A%$;>)OW
M/_9,_:!M_P!IKP=IWB.(QBYEC\J_ACV@07D6%G38))6C0M^]@61C(;>2%V +
MU\W_ +6?G_M2:Y;_  CTW[0FGG[/J'BK4K?[.ZVEFI>6UL3YFXQW=S+%%*GW
M9(XA'.(KFW:=4_0_2=)M] MXK.SBC@MH(TBAAB14CCC10J(B* JHJ@*JJ %
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MU^>'_!(GX(>%?B5X%U"\US1-+U*Y37+B))KRQM[B18Q:6;! \L;,$#,S!0<
MLQQDG)_P6>^#>B6&@VGB]()#K<^J6MB]R]S<.HM1:W<GDQP/*T$2;XUD/E1H
M2Y=R2TDA;]3OV3O^2>>%/^Q?TG_TBAK\<?CS^T_X8^*7QEDTGQUJD:>!?"LD
MAAL3974L%[J<*)%(MU'$K/(\4[S!7='M6AMC"L92[FDF]@_;._:\^"G[1_@[
M4M.;5([G5H[.=]*E_LR[%Q'=+MFCCBGGLB(4GDABBN"&C#PEE+KPZ]!_P1N^
M/.J?$KPUJ7AW4Y)+A= DM19SR2!F6UNEE$=J!L#;(&MW,;,[D)*L*B.*!%/A
M_P#P3+_:TT/X?WGB32/'<UOI'B34M8EO+B]O4%JUQ,RR&XM[AO)CBM?L\L<C
MI'-)&IENWBBB5PP?]+_#G[+MOX ^*\_CC2;>."TU;0[NWU%(U5%_M#[99RI.
M09,E[F,2>9Y<:H'MVED=IKDD_9]<_P"+/%-GX&TZ[U74)/)LK&WFN;F7:S[(
M84,DC[4#.VU5)VJ&8XP 3@5_/C^QO^V1X,O_ !!JOQ#^*.L1CQ1/(+72X#87
MLL>G6*H2WV0PI/%&DAE:$*0+A1',[2R&\G9^/_X*3?M _#/XPQ:9XB\"ZC_Q
M5EIJ"M+<6MG<64TD/E#;/+<26T,DDMN]O;I;$2[HE>3:I&&3]7_A)ING?\%"
M/A'I;>,+;S6O[=EFE4H)DO+266T-] RQHD,KM&\H14\M5E:W9982ZR?FA^Q+
M\7M4_P""?'C&\^&_Q!:.PTF^D\^WNB@-N+J39%%=K<G8?L5Q'%Y;NZL()HXQ
M(MKLO"/O_P"%/P4TO]LO68OBMXLTN-K2:S^Q^']'O(2X6P268K>ZA'*#%+<7
M!EDEMXT#6T-N\4BO<S%)XOL_X_?&.S_9_P#"^I^)[Y=\6GVYD6+++YTS$1P0
M[D20IYLKQQ>8498]^]AL5B/A#_@F;\+[?QCX?'Q,\0>7JOBK7KR[N&U*XA4W
M%M'"\MBL$#$LL2;8Y3_HZP#R94MBAB@BQS_[:W_!.O6?VB/&NF>+/#6I6>D2
M1QV\=]-LEBNDDMIBT=["\ S/<+&RH@D>W*"VA43[6'D]A_P53_:=U']GOPE;
M66A7?V/5]:N'@214?SH[.*,FZE@E'R12AGMXPY/F*LS/$!(@EB\_^!?[7'P$
M^!GA*#PC;:Q;S6GV?R[\MI&H[;^:6,)<S3QR6TN[SL$&-VD5(ML"GRHT4?GC
M\#?C_I?P@^.I'@"YDN/"7B'5+6U>V53:P2+?[!\L+VZ>6EE<SN;91$CB&,P"
M7RYI'?O_ /@LU\&]$^'VJ:-K6G02)J.MR:G)J,\ES<3M,T LQ" )Y9%C2-9&
M2..((B)MC"A$15_8_0/V)?"5QIUQ%XHL[?Q)J^H>8^IZQ?V\;7EQ-*@C<PR
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MKEW]0_;F7PQ^U-\&%^)ZVTAU&*SL_L9-U=&.SDEU""WO8EA+102.'\V![@P
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M;MN-VU<YP,?T7:3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550 H
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MMHUF2%REYJ*V\HL[J,%-R>4[2^5%#(3$8V>ZG29UAM(^?_X*D? 'PO\ L_\
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M4?\ N,?^V%?O]7X0_M:Z!_PM#]I/P;I^GW%NUQ96^FSW(,F?*^PW5WJ4D3A
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M&T6Z:Q:747#N(_WLILD@2-_F7_50M(@C;RS]OK_DX7P%_P!P#_T\W%?O]7X
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M  9^$GQ%^!'@V+2H]5T_7]7BM[:VM(KU?L&G:=#!;>6B1M:6DMU>[) H9IS
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MKLD5QK6H,S>6\D2L(H+>/"JEO KM'%A$+ _<BB$-O!]7U\ ?\%1_^20^(?\
MN'?^G*TKX@_8"USXH?"?P)I-UX=T:W\6:!J?]H3K;-J":?=Z;<1W9MS$LMU(
M\+VD@A>=4AB#_:)IRY3:IN/I_P &_LR^+?VA_&6G^/?B=%;Z;%HOS:)X>LKJ
M2;R)DN9)(Y[V57:%I5"PL3:D+=>7!YJPI"]M+^C_ (L\+6?CG3KO2M0C\ZRO
MK>:VN8MS)OAF0QR)N0JZ[E8C<I5AG((.#7XX_"K]FKXJ?L$^(+I/!5O'XL\'
MW\DKG3I;Z&RN(6"((I7><)%'<9/E-);B5+J&$F6&!_LP@]O^)'P?^(O[<=FF
MC^++2W\%^&TN(9;JTM[W^T=3O6@;=L,L)CLH[1UDW()4GEBN[:.4PR(4V_;^
MO^']6^'WAZWTKP/::>9;.WCM+.+4;JXBM[>&*$QPLS1PW,T_EE8@8B8FE3<3
M<HX!;\X/V!OV,OB'^QKJ-]]I;P_?Z;JWV1;KR[V]CN(?L[OB6'=8F.3"339A
M?R_,?R_W\*JV_P"H/VY?@[XR_:)\.7'A/PZFCPV5]]F:ZO+^[N4F'DSB?RHH
M(;25!EHH3YSRME3+'Y .R4'[#7P=\9?L[>'+?PGXB31YK*Q^TM:WEA=W+S'S
MIS/Y4L$UI$APTLQ\Y)5PHBC\@G?*<_\ ;C_8<TO]KW2Q)&8[/Q'9QD6%^0=K
M+DM]ENMH+-;LQ)5@&>W=C+&&#30S_G!\(?@7^T_\,'7PUIFHQVFDPR/'#>W=
MS8WEK''#'Y<7D^='=7T=NRQ(L$"PH(RX+0PYE(_5_P#9Q_9QN/V;=&U '4)/
M$7B._D:XNM3U!FADNY(HA%:023XNITMXD147>UT8B\TB)AQ"/A#_ (8R^*?_
M  M?_A:>[PO]H^T;OL'VW4-GV?[+]A\KS?L.[S?L_P#RVV[//_>^1Y?[BOU^
M_LW_ (273OLVKVUNWVFW\N\M<_:;<^8FV:',D<?G1'+)EXD\Q.6C7)4?@#\:
M_P#@F#XT^"'BB/Q1\(YM\4=PLMI;?:HXKRR9A)YB;[HK#<6@ $>)9&EDCF\B
M6&=%EFD^@/AI^S)\8_VD]EG\8M6\GPS%<++/I$!LX[B_:':\*2RZ=&J+:,S%
MG!F:7?"-L,;^3=1?5_\ P4!^ 7B7]HK0=(TSPK-':ZC:ZY;WPO))VMUM5M[6
M[VS"2,-,'$K1+'Y*NZNZOA45W3G],^,/QPB0Z9=>!]+DOO,E@&L1ZW%'IH)D
M98KHV3>9?&W52DDD6\7$BJVU(G81IZ!^PY^R);_L@^&CISRQW6K7L@N-1ND1
M54R!0J01,565K>$;O+\TY9Y)I@D7G&)/L^OA#_@H#\ O$O[16@Z1IGA6:.UU
M&UURWOA>23M;K:K;VMWMF$D8:8.)6B6/R5=U=U?"HKNG/Z9\8?CA$ATRZ\#Z
M7)?>9+ -8CUN*/303(RQ71LF\R^-NJE))(MXN)%5MJ1.PC3T#]AS]D2W_9!\
M-'3GECNM6O9!<:C=(BJID"A4@B8JLK6\(W>7YIRSR33!(O.,2?&'[?7_  2]
M_P"%T7DOBGP2+>VU>7S)-0L9&\J&]<*S":%@"D5W(P"2!]D$[.)GDAD69[CS
M_P"&GPP_:C\8;-#U?6?[%TO[.L$M].^FW%P(?EB;RI;19;Q[ORV:1)7EA9G0
MLUW'*5<_L=\%_A#I?P%\/V/AK1ED6QL(RD9E<R2.SNTDDCMP"\DCO(P4*BEB
MJ(B!47\4?V;/V2_C;^QWXHU.Q\*0Z/=Z1?[8VU'4746<BP!Y+>9H8)OM\4HW
MR0F-%DB$DK9,L:QW"_N=X \-W'A'2[:RO+N2_NXXQ]IO)-P:XN')>:4(7<0H
M\C,T=NA\FW0K!$JPQHJ]A7XP_MO?L5?$[]LW4=/N7D\/Z;9:=;R1PVG]H75S
M^^F?=--YHTJ!_G5($\M@RIY.Y2#(^?T>^!9\?6-G!9^-H]'FN(;?;+J.GWD[
M-<S*P"LUG)8P1Q;DRTK),5\T?) D;A(OSQ_;@_8?\8Z_XQ@^)7PUGCBUN*.'
M[1;^=Y-Q)<0[8$EB>=C;,C6Y$5Q;RF"%H8&!6X:X=*]?\%?#OXL_M,V[6WQ,
MDL_#FB"0Q76CZ2 ;C5K=E5F2XO5N[EK6W+!8F6V=9KB%[J&01JT4A\ _X)U?
ML*?$/]GZXDU/5M6CT6TNY+=[S2+>*UO+BZ6V:X"1SW+I+%;)EPV;5I7EAE="
M]M,JLG7_ +?/[&7Q#_;*U&Q^S-X?L--TG[6MKYE[>R7$WVATS+-ML1''E(8<
M0IYGEOYG[^9679^G_P -+GQ#<Z<G_"3P:?!J2[5D_LZXFGMY,(NZ5?/@@DBW
M/OQ"?.V(%S/(Q.WY0_X**?LSZI^U+X*.EZ+)&-1LKR/4((9,*MRT4,T1MQ(6
M"Q.RS$QN^4+JJ.8T=IH_'_V3/ ?QITW1M.TGQ6FEV&EZ''LMK59V34-0-I$/
ML%O<7=B\\$%DKF,2R1H]Q*EIY,]O<0W$YF\P_P"&,OBG_P +7_X6GN\+_:/M
M&[[!]MU#9]G^R_8?*\W[#N\W[/\ \MMNSS_WOD>7^XK[_P#VC_"_C+XE^$KG
M0M#MM'CO=6T^:TOI+R^N?)M?M$:QRBW$5D7N?E>98Y)/LNQA%*T4@+PCYO\
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M[7P=K9M]&T"VPPU:5[2_U*"WC:,BQLPL]Q"=P#1QO=P2I;0L^UCY5M;UX_\
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M7Q-^'L-OJ4LOE2&&1[>+[.T-K'920S+<S1"6*XB#8DA995WR+B%XXII/T/\
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M/%>OZ9Q?6]M-%:6=HV^-?+N=0N2L*RL&EV0P"XE\RWFCD2+RY&3Y_P#V:_\
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M1E)5E8$,"000:S_"WA/3O UG'I^E6EO8V4.[RK:VA2&%-[%VV1QA47<S,S8
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MVUE5ER#AE##D UH:3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550 H
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M959<@X90PY -:&DZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515 554 *
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M9^!M.N]5U"3R;*QMYKFYEVL^R&%#)(^U SMM52=JAF., $X%?DC\"OA)<?\
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M]QBD*S+9B_@O!$ZNR2M;H()XD=5+.NZ6=;:$G]7_ -M[3_%$G@W4[[PUKO\
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M<^5W+;ZM;+B*+<R6\18NZ6\1$46\J@Q7Z_?M8_\ )//%?_8OZM_Z135\ ?\
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M:9X:TZ^DOM$\126<9@+A&DM;V>6UMS=#RRGVBTF#2+)$%,J*5#6ZW4T2?O\
M?%[PSX@\7Z6UGX:U>/0[YY$)OGL4OV2-3EECADECB#L0JEY!* F\",.R21_C
MC_P1:\6:CXYO/&6H:K=W%]>S?V+YMS<S/-,^Q;Y%WR2%G;:JJJY)PJA1P *^
MK_\ @IW-XQ\+^#+S7_#_ (BDTBQL([83VEK;;+JZDGO8(@W]H"82VZ(&4JD$
M:EQYJ222)*JQ?,'[$'P+\0?M,_##3-(U;4;S0_"4$>H10QZ5<HEYJTDUY<^?
M)=R-'(L=E&LDEJMD58W$@EN)2(UME/S_ .!?">J?\$W?C=IGAK3KZ2^T3Q%)
M9QF N$:2UO9Y;6W-T/+*?:+28-(LD04RHI4-;K=31)^Q_P"V]I_BB3P;J=]X
M:UW^P_[/T_4+NZ:.S$]Q<I#;2.((9VF3[)G#$SQH\ZOY;QO'L99?D_\ X(U:
MM<:_X%U>\O)9)[F?Q)>2S32NSR22/:63.[NQ+,[,2S,Q)8DDDDUP'_!7^;QC
MX0T&/4[7Q%);Z%>7D.GG1[6V^SLXEM;II7N;U9C+<(X5XVMMD=N4,>Z-I(S)
M)W_PV_9)U3]JKP+H4'B_6KRPT)=#T>+3M)T6Y"1RP):6\AN=3>XMB+BX>14:
M. )Y-D(E\N2:2224_"'[,FM>.?V*OB9JWPLT-K?6Y;W,=K%/.UM8QW#V\=W#
MJ4JE'D7RK7/VNV@97F"^4LTSPV['Z0_;6_X)K/J_AK4/&$_B75-5\1Z;9R7=
MU+J3QFUE@@62XN8;6&*(-9IN:22U@5Y88S^XP YGC^O_ /@F%\>=4^/GP^BN
M-9DDN+[3+R;3I+N60/)<K$D4T<CG8IWK'.D+%C(\AB,SR,\C8_.#_@L3-XQ\
M(7%A%>^(I+G1-9DOC#I%O;?8[>WCM6LV19V6:1KYRS))OGP(YE=X8XED\M/Z
M+J_-#0OV*/$OC74M8U;Q!XV\66,=YJE_)8:=INJ-;QVMK]LN! -Y>Y1TD@\B
M2.-$MS;@F)E9AA/S@_;QN;W]GC5-.\+^#O&GC35O$=U(/M-M)KL]PT"R!1;0
MB&WAC9KBX9PT:"3>B(I,+"YA<?L?\&/"6H_LC^ ;N[\6:QJ'B&]LK>ZU34;B
M69[EAY4 >2WLS<,K^4BQ8C$K)YDK/*1")?+C^/\ ]GWX8R_\%%K.Y\;_ !&6
MXDT*[N'BT'P[%>2Q6-O#;,T?VQS;31R379<SP&258FP)F"&"6V2W^8/VA(M1
M_P""4'BW2M0\'7-Q/X5UG[7+<:%=7;R0F6.2/[0J#R\18B>T6UNB9[H-$ZS-
M+#NCF_?[PGXIL_'.G6FJZ?)YUE?6\-S;2[63?#,@DC?:X5UW*P.U@K#." <B
ML_Q_X3?QUI=SID=]>::UU&8S>6+QQW42DC<89)(Y5C<KE?,"[T#%XVCE".O\
MT6F?LV6^B_M%'P9:ZSKD,;22RG5H[U4U8R3:0U]*YNUB +R2.Z2-LR\3,K$L
MQ<_T6_!3X0_\*6TZ33_[7UC6?,N&G^TZQ>?;+A-R1IY22;$Q$-FY4P<.\C9^
M; _GA_X)2:!XH\=_\)'H6@W']F6%[_9IU;68Y +RUMX_M8%O81D';=W6]E2[
M;*6<<4LH5K@VXKH/VYOV1;S]A>\TSXB>$M=U"2XDU QS3WTJS7POIEGG,QE6
M)(YXID25+B.926)(<W$=PZQ?T/?"?QU_PM#P]I6O>3]G_M/3[2]\C?YGE?:8
M4F\O?M3?MW[=VU=V,[1G _+'X,ZA<?\ !4/5-4UC7?MEK\/=-D^PV.B1W+0+
MJ-P0LSS:DUO,LK/"/L\R1#]S&[Q+%,QANFNO#_VQ/@Q+_P $VY]-\=?#.[N-
M/LKK4$MM0TF:ZEGLYF6W=K=#"PWRQ%4O#*T\[RQ23(UL83\T?[/? 'XQV?[0
M'A?3/$]BNR+4+<2-%EF\F928YX=SI&7\J5)(O,"*LFS>HV,I/L%?S8_MI3?$
M'PQ\7/"^C7GB*/6+F>\TK4--MY;9['2K:Y?49XK9'M8)IF=(V!5KEF>[:!S&
M9&*@G[?^(?\ P2N?XDZSIGB&^\::Y-JUM)')>W<HC:1F259L:88S$-,19#,\
M$8%TD!D38O[L^9\@?\%B9O&/A"XL(KWQ%)<Z)K,E\8=(M[;[';V\=JUFR+.R
MS2-?.69)-\^!',KO#'$LGEI_1=7XH^!KC1/V\/BEXQ\.^-GO+BQT*00Z/H0O
M+B.S"V4\EI=7[?9A &N/,9"AD<NL=Y)#^^2%&B]/;]EB7]GGXG>"I?#UYJ"^
M#IKC4HAH\U[+-9V%\-*OI$>WCFF=_P#2%-S(3M8Q2+,3-MN(XDY__@M7_P D
M\TW_ +&"V_\ 2*^KZ@\!?$O1_A9\(/#=WK+W'E7'A_2+2"WLVD%]=W%Q91)%
M:V(@9)FNY3D0^2R.A!E\R)(VD3Q_]GW]C?Q7<7ESK?C?Q'X@BBN+AYK+P]:>
M(]1DAM+>569;>[O!(DT\L)=4!@=$W0>89KA)BB?I?I.F)HMO%:Q&1HX8TC0R
MRR32%44*"\LK/+(^!\TDC,[G+,S,23H5^4'[3?[2NN>._B9I/P@\)WW]F?:<
M-KFHQ$I=I"UO)<2VMK))!(L,HM!YT5Q$';[1+ HEM_)FW^@>*?\ @EUX$U6S
MDET_^T+/Q)\LT/B(W]W-?+?(PD%[(&G$3RO*/,FV+$26<Q- ^QT^</V /VHO
M%7A+QC?_  C\?W$EWJ-K)=?8+Z=KB2XDDAS*\1DECWS6\L.^[M;B?RR(5V!I
M$EMXXO+_ /@K9\ O^$"\/)XA_M[Q!?\ V_Q /^)=?:AY^G6WGPWDW^BV_EKY
M7E[?*A^9MD+,G.<U]?\ [)W[(?\ Q3WA3Q#_ ,);XP_Y!^DWW]G?VQ_Q+O\
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M[7/$&D7MS;SZIKLMAJ]W###I<.RWA,=H\@MQ+/.ODQO:D&%C)/<6MR'5T/\
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MH[11,Z@@,8XR02BX^G]6TFXT#X!2V=Y%)!<P> WBFAE1DDCD31RKHZ, RNK
MJRL 5(((!%?-_P#P14_Y)YJ7_8P7/_I%8T?\%J_^2>:;_P!C!;?^D5]7W_\
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MVHR_:]0AQ,DS21)MCGBB.+:6W.Z(%3NP3Y@<#[?_ .'7'PA_Z%[_ ,J.I?\
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MO_2*:O@#_@BI_P D\U+_ +&"Y_\ 2*QH_P""U?\ R3S3?^Q@MO\ TBOJ^_\
M]D[_ ))YX4_[%_2?_2*&OR!_YN\_S_T+E?K]^UC_ ,D\\5_]B_JW_I%-7P!_
MP14_Y)YJ7_8P7/\ Z16->X?MZ?L%V_[8EO:7EG=QZ=K>G1SI#,\"O'<QNNY+
M>X=<3*BR@-'(ID$ DN"+>5I?E_*#PW^T5\6?^"9FJ6^A^+X9-5T)HYEL[::Y
M#P2QQ!88WL+[9++ D8CB(M)% CAE^:TADG25?Z+OA5\2].^,FAV'B'2GWV6H
M6Z3Q99&9-P^:*3RV=%EB;=%,@9O+E1T)RIKT"OR _P""U?\ R3S3?^Q@MO\
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M%_Y.%\>_]Q__ -/-O7W_ /\ !4?_ ))#XA_[AW_IRM*/^"7'_)(?#W_<1_\
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M4$L<DEM)J$4Z(ZLT4AOKB4)( 24<QR1R!6P2DB/C:RD^'_\ !:O_ ))YIO\
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MP?J%\]Q+IND6^F:BUM&V[&S4YWG:&-V6,2R);QJ22F_RXU9@J*5_H>K\4?\
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M\E9+6WCN(;V:5+*Q5FBM4D,=N)%#.,VZ>4(8R8J_:[]D[_DGGA3_ +%_2?\
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M&EV4W]H3Z-J:VLDUI=6ZW9$L3/;M/+]K2Y>XW(88T2W6!F.98VF[#Q[8WO\
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M*/\ A'OM'D^?_85]OV?V9_9WVCR?*\SRM_[[&//\CGR?._<U^K_[7?Q!7_A
M=4MK+3M8U"[US1[RWLK:STJ]FFW74'E*;A!"/LFSSU>1+HPR[4E5(WEC,=?&
M'_!))M2^%6@WOA7Q!HNN:9?7&J2WD$MUI-Y%:R1O:PH1]I,7E1.AMFW"<Q!S
M)$L;2.S(O['5X_\ M"^%KSQSX-\0:5I\?G7M]H^HVUM%N5-\TUM)'&FYRJ+N
M9@-S%5&<D@9-?A#_ ,$T?VJ+SX&Z=JW@)?#.L:IKYU":Z@M[6-5V3,D-H\5^
M9BAL8HI8HEEN7$BQ^:WF1IY0$OU!_P %5UUKXG^&=-\)Z7I&L:QJ]MJ%O=WM
MS8:+?"Q'EV<J,8Y"LJ'S&N08XXI;GR@DD<LJR( _V_\ LB?$%?\ A =+MKW3
MM8T^[T/1[.WO;:\TJ]AFW6L'E,;=#"?M>_R&>-+4S2[7B5XTED$=?E!]LUK_
M (:&_P"%A?\ ",>*/^$>^T>3Y_\ 85]OV?V9_9WVCR?*\SRM_P"^QCS_ ".?
M)\[]S7ZO_M=_$%?^$!U2VLM.UC4+O7-'O+>RMK/2KV:;==0>4IN$$(^R;//5
MY$NC#+M254C>6,QU\8?\$DFU+X5:#>^%?$&BZYIE]<:I+>02W6DWD5K)&]K"
MA'VDQ>5$Z&V;<)S$',D2QM([,B]?^T;^T/KG[.7Q:&I0:9J&I>&3X7M6UX6-
MB;I[=8;C5GM9_,W1I!L;S-QED6)H#.Q5GCC:/@/VP_VEO"'[:GA"Y\'>!%N/
M$GB&ZN+-[2&#3;D?8]ES&)+R6:ZAACMH@C-;O/N&W[2%?;"\KK^CW[+'P4_X
M9V\%Z1X8:3SI;&W/VB0-O4W$TCSW'EMY<1,0EED$.Y%<1! V7W$_0%?BC_P5
M%\47?[0OA73M#\+Z%XDO[E-42\E<>']4@CBCAMYXL,;BUB8N[3@H(U<8CDWL
MAV!_;_\ @G/X^?X=>!-'\*:YI'B#3M4MKBY@*W&A:D(7^TW<D\<HN$MGACBQ
M.$=YWA\MDD9@L061OT_KG_%GA:S\<Z==Z5J$?G65];S6US%N9-\,R&.1-R%7
M7<K$;E*L,Y!!P:_ 'X%Z_P"(?^"4?BB\T+Q;;W%WX)U6XA$>LPQS-;Q2D2"*
MX2,%XTE9$9;ZTYNMD"2Q-/%#$+G[/^-?[8UA^T[X:U3PK\++:\\2:MJ=G-9R
M2I9306-E'<*4D-Y<WALTA>2#[3]D.7#W$05E.0C_ $!^RK\#;7]B'P'%IMV9
M+JY61KK4I;&UN[MI;JX9(SY-O"DT[I&@AAW1Q(&2(W#Q1%I=OY8?L=7FM?#;
MXO\ B+Q?K/ACQ19Z1KO]K>1*VA7TC0?:KV.\B\^."*5QE8C&?)$V)67_ )9[
MI%_6_P#;1\7G1?!6LZ9;V&J:E?:MI=_9VEOIVG7-XQDGA\@&1X8VBA13,)"9
MG0NB2>4LKKL/Q!_P22;4OA5H-[X5\0:+KFF7UQJDMY!+=:3>16LD;VL*$?:3
M%Y43H;9MPG,0<R1+&TCLR+[?_P %(OV,KS]K30[6?1YMNM:-]IDM+9RJPW:S
MB+S82[8\N4^2A@D9A%N#1R!5D\Z'\T/@'_P4X\:_L^6]KX%\0>%Y-1OK&.TL
M;"VQ-I^H*NW$$,L)MYC,[1O EOLBA=D568SO+OK]/_V9_"/C'XP^)9/B)\0-
M,CTF2WL_L?AW2O,\UK6WN6:>>[FC?>8;UXVAM'E3[+,R1S136D:^6*^_]6TF
MWU^WEL[R*.>VGC>*:&5%>.2-U*NCHP*LC*2K*P(8$@@@U_/#^QO^R)<?#[XX
M:KX?>62?1/#,@U(*Z-<6\TCQ$:3]H8K%"E[%%>O<1R>62DT%P(!M)E7^BZOS
M _:4_P""DW_#.WC3_A$V\,ZA?Q16\=U<7D<GEL;?RVGN)[2#R7%Q%!$DA>1I
M8$$L-Q&QC2%I3^C_ (3\4V?CG3K35=/D\ZROK>&YMI=K)OAF021OM<*Z[E8'
M:P5AG! .17045^ /Q#_8KU;4?C]-:6)N++PWXAMY=3U)[:>XC6XL28QJEE._
MFP,_VF[*++##)*((KVWF\L(HC3]SM6\ :7K6C2^'I;:-=)FLWL7M(@88Q:O$
M83"@B*&-/+.Q?+*E!C:5P,?B#_P3/_9-O? OCSQ!)K#7CVWA"\N;/2Q-!/!!
M+=7J^7+>Q*9/+5WLHH"\>)@\-W;2E\1V[M^YWBGQ+!X/LY+ZY2X>*+;N6VM;
MB[F.Y@@V06L<LS\L"VQ&VKEVPBLP_ ']CJ\UKX;?%_Q%XOUGPQXHL](UW^UO
M(E;0KZ1H/M5['>1>?'!%*XRL1C/DB;$K+_RSW2+]_P#_  4WUFZ\0>!-0\*:
M5I6L:IJFI?8C$MAIEW<PQI'=I.SRW$<1A7 MV3RP[3[I(F,0B8R+S_\ P3Q\
M?/\ "_X<6>A:]I'B#3[_ $C[69XYM"U)O-2>]:1'MS#;2>=_Q](IC7]^OES2
MF(6\9F/Q!^QU>:U\-OB_XB\7ZSX8\46>D:[_ &MY$K:%?2-!]JO8[R+SXX(I
M7&5B,9\D38E9?^6>Z1?UO_;1\7G1?!6LZ9;V&J:E?:MI=_9VEOIVG7-XQDGA
M\@&1X8VBA13,)"9G0NB2>4LKKL/Q!_P22;4OA5H-[X5\0:+KFF7UQJDMY!+=
M:3>16LD;VL*$?:3%Y43H;9MPG,0<R1+&TCLR+]G_ +;_ .RU_P -<>$GT**Z
M^QWMO<)>V4C#,)N(HY8UCG 5G\IUE=2T?SQL5E"RA##)^&/P*_;?\>?\$]B_
M@[Q7HLEQ8VT<GV.PN-ME) S7,K/-!=)!*+FWED,XWGSD<JAAF1$99/TN^$&O
M>+?V^M8T7Q%KVB_\(]X.T*XBU.TM)WDEN-4U(1LUG<Q2^7;.+2!94F1U7R9G
M)C/VI7;[)^K]>?\ Q5^&FG?&30[_ ,/:JF^RU"W>"7"HS)N'RRQ^8KHLL3;9
M87*MY<J(X&5%?SH_ CX^^,?^"5^J7?A7Q?HTESH5W>&1)8AL5I%$"37=A<M&
M$ND,'E;[:0QE7$*L]G)YZ/ZA_P %%/C?KG[5?@W1Y]'\/:A9:!/K%FEJ^H0&
M/4=1OKFVN3;"QM87E#VGE,3Y^YC<S3Q1PK^YF+?J_P#L0ZAXHD\&Z98^)="_
ML/\ L_3]/M+59+P3W%RD-M&AGF@6%/LF<*!!([SJ_F)(D>Q6E_#'XK? WQY_
MP2Y\52^)?"1DN]"ECV+?O:K/&+5KB%FLM1PF(':188_.C,!N 0T$D4AEAA^S
M_ O_  4N\<_M7>=H/@/PE]DU*;9#_:TMXUU9Z;YNX_:+D?8DC&$25HA(QWR(
M L-RP^SR?1_[0_PON/V9?@DNA>%?,EU'2)-$^Q/%"TLD^H#6+.;S4MY#/EYK
MEFE6W_>("XB52@"T>!O^"H'@RPLH[7QP]YX<\1P1P)J&GW>EWJ,)V@BD>2%(
MTN66W=G/D"9EF* ,R ,K-Y!_P3\_9QN/AQKWBOXE:CIEYHMC?R7\>D:2UJT=
MU%I[737+^9IT,4DJ.!#!%:P0DNP64+"Z/;2/\W_;-:_X:&_X6%_PC'BC_A'O
MM'D^?_85]OV?V9_9WVCR?*\SRM_[[&//\CGR?._<U^]VK:G>ZUHTMUH8C6^F
MLWDL!?Q3PQB=XBT NHBJ7$:;ROG1E5F0;EVJXP/YX?A)^T!\<_V;;"7P_IW@
M^/4FCO+N6\U%=.O=2DN[R69FN7N+^PNF@N;A'S;RMN:2(P_9Y2)864>H?\-]
M?M"_]"%_Y0-9_P#DBOT/_96_;WT3]IGP_?:P+.\L[O2Y(DO["&"XU&1%N'9;
M>2#[+;F6X1PK;@D0>$I(700JDTGYH?L=7FM?#;XO^(O%^L^&/%%GI&N_VMY$
MK:%?2-!]JO8[R+SXX(I7&5B,9\D38E9?^6>Z1?O_ /X*;ZS=>(/ FH>%-*TK
M6-4U34OL1B6PTR[N88TCNTG9Y;B.(PK@6[)Y8=I]TD3&(1,9%/\ @F1K-UX?
M\":?X4U72M8TO5--^VF5;_3+NVAD22[>=7BN)(A"V1<*GEEUGW1RL(C$HD;\
MX/VU/V5_&G[*7C2?XH>!I+BYM[FXOKZ6>.WCN9M-FN8YGNS-$T;QFT*/,8[A
MDVPKF.4K(L4UQ[!\-/\ @KAXM^,FS1?#W@G^T-?>W4>9!>2-;I,VV+[3+!]G
MS%:"5T+^;<HL:,$>Z7_6U^A_PN_9$M].\!ZAX4\42QZA?>(9+V\UZ\A10LNH
M7S;WN+=)5:*-X"(A;NL4:!X([@01NQ4?C!\"/C[XQ_X)7ZI=^%?%^C27.A7=
MX9$EB&Q6D40)-=V%RT82Z0P>5OMI#&5<0JSV<GGH_J'_  44^-^N?M5^#='G
MT?P]J%EH$^L6:6KZA 8]1U&^N;:Y-L+&UA>4/:>4Q/G[F-S-/%'"O[F8M^K_
M .Q#J'BB3P;IECXET+^P_P"S]/T^TM5DO!/<7*0VT:&>:!84^R9PH$$CO.K^
M8DB1[%:7Z_KXP_X*%^ -4^)_PPU[2]&MI+R^DCM9([>( R2+;WD%Q($7(+N(
MXW*QKEY" B*SLJG\\/\ @FM^UU>7OA"Q\ Z'H6H76KV5Q)#_ &BL2RZ7:PWE
MS+<?:[Z3S8'C\I7N&2U!#7AMUABN(Y)_W/8?M_\ [+OBKPEXQL/BYX MY+O4
M;62U^WV,"W$EQ))#B))1'%)OFMY8=EI=6\'ED0KO*R)+<21>_P#@#_@JW\//
M&>EVT\DMY%K=Q& -#ALKJZNGNB2JVMO)'#Y$SROA;=B\8</'Y@@8NB<?^S)^
MS5KGCOXF:M\7_%EC_9GVG*Z'ITH*7:0M;QV\5U=1QSR+#*+0>3+;REV^T2SL
M8K?R8=_ZOUS_ (I\2P>#[.2^N4N'BBV[EMK6XNYCN8(-D%K'+,_+ ML1MJY=
ML(K,/P!_8ZO-:^&WQ?\ $7B_6?#'BBSTC7?[6\B5M"OI&@^U7L=Y%Y\<$4KC
M*Q&,^2)L2LO_ "SW2+]__P#!3?6;KQ!X$U#PII6E:QJFJ:E]B,2V&F7=S#&D
M=VD[/+<1Q&%<"W9/+#M/NDB8Q")C(I_P3(UFZ\/^!-/\*:KI6L:7JFF_;3*M
M_IEW;0R))=O.KQ7$D0A;(N%3RRZS[HY6$1B42-\ ?MBWFM?$GXO^'?%^C>&/
M%%YI&A?V3Y\JZ%?1M/\ 9;V2\E\B.>*)SA91&/.$.95;_EGMD;]OO$?QJL?#
M^AC7ELM8NHG\P0VEOH]^U](Z"3"&S:!)H=YC*I)<K!!EHR9521&;\8?^"2>E
MZU\ M1UK3_$N@>(+#^V/[.%K<R:-?&W#P/.A2:183Y.?M*L)) L"I'(TDL>%
M#_;_ /P4WUFZ\0>!-0\*:5I6L:IJFI?8C$MAIEW<PQI'=I.SRW$<1A7 MV3R
MP[3[I(F,0B8R*?\ !,C6;KP_X$T_PIJNE:QI>J:;]M,JW^F7=M#(DEV\ZO%<
M21"%LBX5/++K/NCE81&)1(WP!^V+>:U\2?B_X=\7Z-X8\47FD:%_9/GRKH5]
M&T_V6]DO)?(CGBB<X641CSA#F56_Y9[9&_4_]JCXJ1:M\/M5BT[3=<OKG6M+
MU&SLK6WT743<>9(C6N9XI+=&M45I!)FY\HRPJ[P+,0%;Y _X))-J7PJT&]\*
M^(-%US3+ZXU26\@ENM)O(K62-[6%"/M)B\J)T-LVX3F(.9(EC:1V9%/^"MK:
ME\5=!LO"OA_1=<U.^M]4BO)Y;72;R6UCC2UF0#[2(O*E=S<KM$!E"&.59&C=
M51OL_P#9$^(*_P#" Z7;7NG:QI]WH>CV=O>VUYI5[#-NM8/*8VZ&$_:]_D,\
M:6IFEVO$KQI+((Z_*#[9K7_#0W_"PO\ A&/%'_"/?:/)\_\ L*^W[/[,_L[[
M1Y/E>9Y6_P#?8QY_D<^3YW[FOU?_ &N_B"O_  @.J6UEIVL:A=ZYH]Y;V5M9
MZ5>S3;KJ#RE-P@A'V39YZO(ET89=J2JD;RQF.OC#_@DDVI?"K0;WPKX@T77-
M,OKC5);R"6ZTF\BM9(WM84(^TF+RHG0VS;A.8@YDB6-I'9D7P_\ X*V:7K7Q
M]U'1=/\ #6@>(+_^Q_[1%U<QZ-?"W+SO @2&1H1YV/LS,9(PT#))&T<LF6"?
ML]H'QD@\2^'KCQ#!INL+]FMY)I-.GTVXMM1+QPB9K>*WG6/SI3D1(86>"2;*
M),V"1_/#Y?B;XU?%#_A.?B-X'\47.D1<P:/;Z->7:!84V6MLWVA[=!$K$W,^
M 8KB?S%:U$=RX3]?_P#AOK_J0OB!_P""#_[HK/\ V7+;6?VC_"_C%O&.DWGA
M^3Q)JE["UH\4L$\=G)I5C8QO&;F,%W$<9!F,?EO,KL(E7]TOXXVR?$7_ ()+
M>*)V2#[=X=N[BW$UQ]GVV>IPH)_)C^T%)'M+M5:=O)5RR2+O9+JU"-+]OZ!^
MUWXY_P""BVG7'A3PQX=_L'3;_P RUU77YYFO;>WLR@%U!$#;6\;7<B2HB1AV
MDV2%@(5/VNW_ &>\)^%K/P-IUII6GQ^396-O#;6T6YGV0PH(XTW.6=MJJ!N8
MLQQDDG)KH*_G!_:K\87G[)?[0T7CW5].N)=(N/*>W>,J/M$/]F1Z?<F%CE#+
M S,Q@<QLV(]S11SQS']C_#?[2%[>:-=^)M2\/ZY96)D\G3=+_LJ>?6+AHHG>
M266WMFF%NDL@:WMTG$*)Y*SR7.R]A2'\L/\ @DGI>M? +4=:T_Q+H'B"P_MC
M^SA:W,FC7QMP\#SH4FD6$^3G[2K"20+ J1R-)+'A0_N'_!6UM2^*N@V7A7P_
MHNN:G?6^J17D\MKI-Y+:QQI:S(!]I$7E2NYN5VB RA#'*LC1NJHWV_\ L7>+
MSK7@K1M,N+#5--OM)TNPL[NWU'3KFS8200^03&\T:Q3(QA,@,+N41X_-6)VV
M#\(?BM\#?'G_  2Y\52^)?"1DN]"ECV+?O:K/&+5KB%FLM1PF(':188_.C,!
MN 0T$D4AEAA^S_ O_!2[QS^U=YV@^ _"7V34IMD/]K2WC75GIOF[C]HN1]B2
M,81)6B$C'?(@"PW+#[/)^KWP!^#EG^S_ .%],\,6+;XM/MQ&TN&7SIF)DGFV
MN\A3S97DE\L.RQ[]BG8J@>P5_/#^V+>:U\2?B_X=\7Z-X8\47FD:%_9/GRKH
M5]&T_P!EO9+R7R(YXHG.%E$8\X0YE5O^6>V1OW^\+>)8/&%G'?6R7"12[MJW
M-K<6DPVL4.^"ZCBF3E25WHNY<.N496/X0_\ !6S2]:^/NHZ+I_AK0/$%_P#V
M/_:(NKF/1KX6Y>=X$"0R-"/.Q]F9C)&&@9)(VCEDRP3]OOAI\18/BAIR:A!:
MZA9;MHDMM1L;BQN(G**[(T<Z)OV[PIDA,L#.K*DK[21^4/P9_;8E_9[UKQ-I
MOCFUU"U\*OXHUE=%UI=-E:SC9[Z_EN8);B,9ES*C>2(HYY5D:=9&6&-?*\__
M &DO#.C_ /!3KQ;X97P7#<7.D6'VE->U\6DEG"EN9+=_L<=S<P!Y;N-3(\,!
MC=$:[23_ %;7+Q>H?\%;6U+XJZ#9>%?#^BZYJ=];ZI%>3RVNDWDMK'&EK,@'
MVD1>5*[FY7:(#*$,<JR-&ZJC?1_P9M=,^,GPEB\*^(M+UBR6S\/VUAJ5M=Z1
M=17"-!;^5YMFDMO(ES*K0?:+;[,MQ+&_V<M$DS+'7YP?L)>-/&_['^N7WAF[
M\.>(-1\&7>H2LFH)H%_%-$V1"E^(3"93%+%'$9[9M\L:A6BS(DD5Q^_WA;Q+
M!XPLX[ZV2X2*7=M6YM;BTF&UBAWP74<4R<J2N]%W+AURC*QZ"OQ1_;__ &7?
M%7A+QC8?%SP!;R7>HVLEK]OL8%N)+B22'$22B.*3?-;RP[+2ZMX/+(A7>5D2
M6XDB]_\  '_!5OX>>,]+MIY);R+6[B, :'#975U=/=$E5M;>2.'R)GE?"V[%
MXPX>/S! Q=$X_P#9D_9JUSQW\3-6^+_BRQ_LS[3E=#TZ4%+M(6MX[>*ZNHXY
MY%AE%H/)EMY2[?:)9V,5OY,._P P_P""K^M:O\:M&L/"_AG0-<U*2WU22YO+
MB+2-26.%K6*2W1$9[017"3&XD99H)'0"$$;UE5A]?_L0?&6;5?"NB>'=8T/7
M-%U:PLX=/:.\TJ^2WD6RMU5;@7AMEMXTE1,A)GC=9MT($G[J2;[OKR_XW^"K
MCXE>%=;T.S:-+G4M+OK.%Y2PC62XMY(D+E59@@9@6*JQ SA2>#_/C^PS^UU>
M?L+WFI_#OQ;H6H27$FH"2&"QB6:^%],L$ A$32I'/%,B1/;R0L2Q(*"XCN$:
M+/\ VZ?&OB7P9\5_"7C'QKI4>GVUO'I-U%;6,K7C)!9WAN+BV>YD2W@FO8W=
MRZPXA1);8>8P;SG_ %?^,WQ?U[Q+\.==.I^'M4CO-?L]1MM$TJRL+J]ODM9[
M9+>%]3,*/!:7#/*]S)"TBF*W(@7S[J&53X!_P22;4OA5H-[X5\0:+KFF7UQJ
MDMY!+=:3>16LD;VL*$?:3%Y43H;9MPG,0<R1+&TCLR*?\%;6U+XJZ#9>%?#^
MBZYJ=];ZI%>3RVNDWDMK'&EK,@'VD1>5*[FY7:(#*$,<JR-&ZJC?;_[%WB\Z
MUX*T;3+BPU33;[2=+L+.[M]1TZYLV$D$/D$QO-&L4R,83(#"[E$>/S5B=M@_
M-#_@HY^Q=XHM/%$7Q3\#_:+Z_6XLI;BSBA$]Q;W%H(H[:YMH0C>?%^ZB\V(K
M(\;@RD26[R"VX_X+_P#!8WQ+KEO8Z++X3D\0:[Y91Y+*Y:.2[:-68R+9Q64Y
M5_+7?*(SLRKR*D4>(T_4_P#9*^#FN>"8M4\3>,&MV\6>);B&YU%;8$0VL,$0
MBL[%,.\;_9TWAI5RSLY5IKD1I<2?DAI_QA^.?[-?B#Q%%;>%K/6M1U+5'NK^
M_MK*]U0 E%%O:B>UN=\-O%#LDL[.[VW%O;W".8T29,]A_P -]?M"_P#0A?\
ME UG_P"2*^[_ -B7]O%/VH+B\\/:QITFC^*-+CW7=H1(8Y%B9(;B10ZA[=TG
M;8]K,6>,/'B6<B;ROS0_;4_97\:?LI>-)_BAX&DN+FWN;B^OI9X[>.YFTV:Y
MCF>[,T31O&;0H\QCN&3;"N8Y2LBQ37'L'PT_X*X>+?C)LT7P]X)_M#7WMU'F
M07DC6Z3-MB^TRP?9\Q6@E="_FW*+&C!'NE_UM?H?\+OV1+?3O >H>%/%$L>H
M7WB&2]O->O(44++J%\V][BW256BC> B(6[K%&@>".X$$;L5'XP? CX^^,?\
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MW3\,O %NMU>>)]+DC>01@6=P+^3<59@3%9>?*J84YD90@.U2P9E!Y_\ 9/\
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MA\*_']PMU>>&K..1(Q&!9M-81[0S,"8K*6")GRQS(RER-JEBJJ!Z!\(?V0O
M?P(=9_#VAV=K<I(\D=TZM<74;21^4XCN;EI9XT*94QHZIAG^7,CEOH^BBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBOE#XH?L,_#?XQW'VS6/#]F]R9)I7FM_,LI)I)V#2/.]F\#3
MNS#=NF,A!+D$%WW'PO\ V&?AO\'+C[9H_A^S2Y$D,J37'F7LD,D#%HW@>\>=
MH'5CNW0F,DA"22B;?J^BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBN?\
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M5\RO!$QC$WF)] 5\8?LX_L&^#OV6M9U#7/#ZWGVF^C:%4N+CS([:W>42M!
MBL4++$-UPT\P$28D!:4R?9]%%%%%?EA_P5D^#>B>)O .H^*+R"275M*CM([&
M4W-P(X%GO[>.8K;B46Y>1'*O(T9=@L8+?NH]GJ'_  2X_P"20^'O^XC_ .G*
M[K[_ ******S]6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q 4 DD
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M3]2N[?=>W.@)HL:V[)&C3265G.B37MSEE%M &\B>9&WF>*7&?8/V%_VS;/\
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M=/LXXIB)X80%BFN&,,[0+(YC#VXCFC\N=9$^;_VG?$_QH_9 \+W>O1^(]/\
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MU,Z?]OO+F\?SDE@6"Z\N".W1XY8W;#2&2WC>.22&X81Y^D?$GXH?"CXC^%O
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M<>$DUV6U^QWMO</97L:G,)N(HXI&D@)9G\IUE1@LGSQL6B+2A!-)^>'[2?\
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M1111111111111111111111111111111111111111111111111111111117X
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M99-H<_1]%?DA<_&WPU\ _$&K>!O@OX6CU;Q7=22W.H"W=8=/MI423<)[B23
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M=Y4B>)(E_:[]D[_DGGA3_L7])_\ 2*&OR!_8%_Y.%\>_]Q__ -/-O7W_ /\
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M/]O_ /!+C_DD/A[_ +B/_IRNZ^ /^;O/\_\ 0N5^_P!7X _M]?\ )PO@+_N
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M1_\ DD/B'_N'?^G*TH_X)<?\DA\/?]Q'_P!.5W7P!_P7._YE'_N,?^V%?O\
M5\__ +3OA;P7XG\+W9\?QV[Z!:[+F=YVD3RFC.$>)X2LRRL6\I%@/FS>8;=0
M_FF-OC#X<?M"^//VG[>"/X8Z)9^&O!Z1O:Q:SJT:F0)&L,/_ !+M.MW\H/;$
MS"%7,]E,8!$\L#H\)^4/^"&/_,W?]P?_ -OZ/^"YW_,H_P#<8_\ ;"OW^K\
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M3[./5KF,13WZ6\2W4L8" )).%$KH!'& K,0!&G'RKC\,?^"YW_,H_P#<8_\
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M3&8ERB*3]7U_/C_P7*U:WFN/"EFLL9N8H]4EDA#J9$CE:S6-V3.Y4=HI51B
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MK&H>!O'%A<6]E+J$;7)^7?ITQCV23^6D;/=13*+5LQRE1!'YUNLYE"R?I_\
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M:RQFYBUR662$.ID2.6TM5C=DSN5':*548@!C'( 24;'A_P#P7._YE'_N,?\
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M'_@AKJUO#<>*[-I8Q<RQZ7+'"742/'$UXLCJF=S(C2Q*[ $*9(P2"ZY^@/\
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M_:]:N/[6::UML3-90Q7=U,9[[:?]%B??#%$9<--+<0B-64NZ?('_  EFG?\
M#6WVK[7;_9_M'V7S?.39]H_L/[)Y&[.WS?M'^C^7G?Y_[K'F?+7]#U?SP_\
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M9/(W9V^;]H_T?R\[_/\ W6/,^6OZ'J*^ /\ @J/_ ,DA\0_]P[_TY6E?/_\
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MU"?$.HM)H^G+)*C2:LATYD5-$:VCDD2Y\MHDF8*\ E".R2Q91';8/L__ (*
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M#6X:\T/1-+TVY>,Q/-9V-O;R-&65BA>*-6*%E5BI."54XR!CC_\ AD[X>?\
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M$MW+,D<JLBE)D"RIR%<!F!^OZ*_/#X-:3;_&_P"+/B?QG+%'-;>&XX/#6DW
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M[J+ZKJ^@6[WLNXRRP2W%IYK,[2-)*MI+"DDK,[%YG#2OP&<A5 ^G_"WA/3O
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M=W&Z"7!\_P#4^BBL_5H[B:WE6SDCBN3&XADEC:6-)"IV,\:R1-(@;!9%DC+
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MYB@R1)<+#*Z*Y$>8Y GT?\'?B</C'HUOKD5A>6%M>1QS6J7AMO,FMYHDEBG
MM;BY54=7P%D9)E*MNC4;2WB'Q+_:\3X6:YI_AZ\\->()KW5[BX@TS[,NFS+=
M_9BOF2IMU'?%$%=)6>Y6#9$2\@0))L\/_:B_X*C>#OV>+BXTFR637-;MI&BF
MM;=O*MX)$:/>D]VRLH<*SC; EP4FB>&80-R/TOK\ ?\ F[S_ #_T+E?O]7X
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MX8\!:#<>+-7TKRSJ?E7=O96-IN+J87O9]R-=JRJ#;JAX\X>8)+:>)./^$/\
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MIQ7GA[Q9XAN;S7+J\FO],TYK^-I)K>U#B:=IE8W!93)(&R2)$<L2_'[O>/\
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M+ZS'<ME3YDUK!=6LDV$2-$\YH3-Y:J%CW^6"P4,?'_\ @BI_R3S4O^Q@N?\
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MMZW))K6LO+"UO(VH:CMFF5[<G;"\2[+=DC6)"82_E1L[*/RP_;Z_Y.%\!?\
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MR)'*UXTB*^-RH[11,Z@@,8XR02BX_H.K\ ?V!?\ DX7Q[_W'_P#T\V]??_\
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M4>ZCD>.1H[JXM+BYN8P\7R,B32R)&5+#8J_/(<NWA_\ P14_Y)YJ7_8P7/\
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M#?(GR_\ \%J_^2>:;_V,%M_Z17U??_[)W_)//"G_ &+^D_\ I%#7Y _M]?\
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MG>$V2,H26)G_ *+J_ '_ ((8_P#,W?\ <'_]OZ_?ZOP!_8%_Y.%\>_\ <?\
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M+^U!J*:AXEUWQ!-Y/FBUMHY[&*WM4E<N4AC6Q_W5,DADGD2.-9)9/+4CZ_\
MAIX'G^'>G)I\^J:AJ_E;1'<ZBUN]P$5%14:2""W\W&TL9)A).[NS/*^0%] H
MKS_XJ_#33OC)H=_X>U5-]EJ%N\$N%1F3</EEC\Q7198FVRPN5;RY41P,J*Y_
MX _!RS_9_P#"^F>&+%M\6GVXC:7#+YTS$R3S;7>0IYLKR2^6'98]^Q3L50.
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MP2-3X;ZI.8_%NJ'PY>2,+[2(%DM&OK4"01VMW<P72K*FV0I,P@0R(\HC%N9
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M]DMWN[6>2=)?/MTF2$F9%5?(E_>PL(T:X3F0>:/+4R_H_11111117YH>*/\
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M/'>F^"_#%O<7T5[]I\W5) ;:%/)M&NE\F&1/.ER4>*3S5MO+90R><A!K[O\
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M444444445^>'P.TFWU_XK?%2SO(HY[:>/PS%-#*BO')&^F2JZ.C JR,I*LK
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MN)K>5;.2.*Y,;B&26-I8TD*G8SQK)$TB!L%D62,L 5$B$[A_-CJ.M_$7PO\
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M%-B1!H&39&@=)/FW?&'[/7Q^\9?LD?%!_ACX[U.XUK3=3N(EL-3NS<R2A[A
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MKSQ%'K%S/>:5J&FV\ML]CI5M<OJ,\5LCVL$TS.D; JURS/=M YC,C%03]O\
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MQ_YF[_N#_P#M_7[_ %%? '_!4?\ Y)#XA_[AW_IRM*/^"7'_ "2'P]_W$?\
MTY7=?/\ _P %J_\ DGFF_P#8P6W_ *17U:'[5FDW&@?LS16=Y%)!<P:'X:BF
MAE1DDCD2?3U='1@&5U8%65@"I!! (KQ#_@GC^QG\+?VB?A_9ZKJNE_;M7AN+
MNVU&7[7J$.)DF:2)-L<\41Q;2VYW1 J=V"?,#@?;_P#PZX^$/_0O?^5'4O\
MY+K[/^'NF:7HNC:?:Z&8VTF&SMX[ Q2F:,VJ1*L!24LYD3RPNV0LQ<8;<V<G
ML*_)#_@L]JUQIWPYM(H)9(X[G7+6*=$=E66,6UW*$D (#H)(XY K9 >-'QN5
M2/N#]CO5K?6OASX5EM98YHUT/3HB\;JZB2&VCBE0E20'CD1XY%ZHZLC ,I _
M)#_@N=_S*/\ W&/_ &PK[_\ ^"H__)(?$/\ W#O_ $Y6E?$'_!/']C/X6_M$
M_#^SU75=+^W:O#<7=MJ,OVO4(<3),TD2;8YXHCBVEMSNB!4[L$^8' ^W_P#A
MUQ\(?^A>_P#*CJ7_ ,EU^:'_  6,TS2]%T;P#:Z&8VTF&SU".P,4IFC-JD6F
MK 4E+.9$\L+MD+,7&&W-G)_0_P )_P#!.'X*^.=.M-5T_0O.LKZWAN;:7[?J
MB;X9D$D;[7N5==RL#M8*PS@@'(KL-&_X)[_"3X67MGK4&D1V=S9WEK):SR:E
M?;5NO/C%L );HHSM,8TCC8,)'98]K%@I_/#_ (+G?\RC_P!QC_VPK]_J_ ']
M@7_DX7Q[_P!Q_P#]/-O7W_\ \%1_^20^(?\ N'?^G*TH_P""7'_)(?#W_<1_
M].5W7Y ? GX6^$/C3\?/%>@^,;?[7;W>H:_]A@\RYBWWD5\9OOVSHPQ;I<M^
M\81G&.9#&#^O_P#PZX^$/_0O?^5'4O\ Y+H\1_ CPA^REX-\:_\ "#0_V5J3
M>'[FZG\F^N9+B/RK:]^QSCS9Y)(<.)_*D39N='P2T7R_.'_!%#5K>;P+JMFL
ML9N8M<EEDA#J9$CEM+58W9,[E1VBE5&( 8QR $E&Q]'_ /!4?_DD/B'_ +AW
M_IRM*/\ @EQ_R2'P]_W$?_3E=U]_T5^ /_!<[_F4?^XQ_P"V%?O]7\\/_!%3
MXE_VAXA\4Z??/<7&I:G;VVHM<R-YF_[--*D[32.QD:5WO8V!(;?B1F8,%#_T
M/5_/#\.OAI_PB7[5]U!IZ7$]O%<7VHW,A7?Y/]H:6\\C.R*%2(7%V(8RV,;X
MHRSR,"W]#U%?@#^WU_R<+X"_[@'_ *>;BOW^K^:'X[^%O#GCG]IZ;2O%D?G:
M1?7%C;2Q;ITWS3:1!':)NMRLJ[KEH1N!51G+D1[S7ZO_ /#KCX0_]"]_Y4=2
M_P#DNO4/@S^R3\//V<-9-UX:L([#5KNSFC -[=3226J2P-,5BN)Y 460V^^1
M5RA>-2P\P!O@#]M/_@F'JGC_ ,07/CGP%?1VFK221W;V!Q:G[5"C,9[2ZBVB
M.XED2)P)0@-P\UP]XF0H\?\ V9/^"COBSX'^($\ _%2"221+R"S;4+F2*&XL
M%*"-6N7($5U;D^5,;MI _DO+<^==JT2CZ/\ ^"U?_)/--_[&"V_](KZOO_\
M9._Y)YX4_P"Q?TG_ -(H:_(']OK_ ).%\!?]P#_T\W%?O]7Y ?\ !:O_ ))Y
MIO\ V,%M_P"D5]7W_P#LG?\ )//"G_8OZ3_Z10U^,/\ P0Z\4V=IJ/B?2GDQ
M>W-OI]S#%M8[H;5[B.9]P&P;6N8!M8AFWY4,%<K_ $/5Q_A/Q_I?CI[Z/3+F
M.Z;3;Q[&\,9)6*ZCCCDDA+8VLZ+*@DVE@C[HF(EC=%_#']@7_DX7Q[_W'_\
MT\V]?O\ 45\__M8_\D\\5_\ 8OZM_P"D4U? '_!%3_DGFI?]C!<_^D5C1_P6
MK_Y)YIO_ &,%M_Z17U??_P"R=_R3SPI_V+^D_P#I%#7Y _\ -WG^?^A<H_X+
MG?\ ,H_]QC_VPK[?\)_\$X?@KXYTZTU73]"\ZROK>&YMI?M^J)OAF021OM>Y
M5UW*P.U@K#." <BNPT;_ ()[_"3X67MGK4&D1V=S9WEK):SR:E?;5NO/C%L
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ML?#^AC7ELM8NHG\P0VEOH]^U](Z"3"&S:!)H=YC*I)<K!!EHR9521&;\8?\
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MXHUE=%UI=-E:SC9[Z_EN8);B,9ES*C>2(HYY5D:=9&6&-?*\_P#VDO#.C_\
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MXBU.TM)WDEN-4U(1LUG<Q2^7;.+2!94F1U7R9G)C/VI7;[)^K]%?@C_P5@\
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M>5ABOPQ^V:U_PT-_PL+_ (1CQ1_PCWVCR?/_ +"OM^S^S/[.^T>3Y7F>5O\
MWV,>?Y'/D^=^YK]SO&OQ7M?!.C+K36FJ7<<L8>&UL],NY[R1FB:5(S;+%YL#
ML%V$W0@2*0K'*\3'%?BC_P $D]+UKX!:CK6G^)= \06']L?V<+6YDT:^-N'@
M>="DTBPGR<_:5822!8%2.1I)8\*'_2__ (*%^ -4^)_PPU[2]&MI+R^DCM9(
M[>( R2+;WD%Q($7(+N(XW*QKEY" B*SLJG\\/^":W[75Y>^$+'P#H>A:A=:O
M97$D/]HK$LNEVL-Y<RW'VN^D\V!X_*5[ADM00UX;=88KB.2?]S^[U?S@Z_\
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MEMHOB&"2ZTYY$DD@2YN+=9&C.4$AMI8FD0-AQ&Y9-ZI)MWQHR_BC_P $,?\
MF;O^X/\ ^W]?O]1111111111111117S_ .._VA=.\$^+_#_@O9Y^I:]]LDPL
MJ#[+;VEM+-YTJ9,A\UX_*A&U4?;.WF!H/+D^@*******************\O\
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MBBBBBBBBBBBL_5M6M] MY;R\EC@MH(WEFFE=4CCC12SN[L0JHJ@LS,0% ))
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M5'VMLC1TC,;A+A ;F_\ \%J_^2>:;_V,%M_Z17U??_[)W_)//"G_ &+^D_\
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MZO\ CSXJ_:!\9Z7)XG\)0V>B:9%')/;Z,85N->FMR4"FZAN+>>W6XV*UPMK
MZ31K(;9OM%RBJ?8/^"<7[8-Q^UAX:G&K^7_;ND21P7K1JRK/'(I,%T5"+%&\
MI25)(HV8!X6D"0QRQ1+Z!^UO^UW;_L]I::-I<4>I>,-:DCM]'TLNJJ9)Y/)C
MGNF+(([?S#M7+(9W!C1T1)YX/#_B7X"^//@O3G\1:?XMT_4KNWW7MSH":+&M
MNR1HTTEE9SHDU[<Y91;0!O(GF1MYGBEQGL/V5OVTKW]K[P=?7&@6MG#XPTZ.
M**XM+QYX]/$\VX17(EB2:5K=Q'(X@'[Y7C:W:14:.[?\D(;KXG/^T-%!=WFC
MWGC&W\Y;?SVNCH\,,NF2W @B5%2X2*."9P@"[FN"9)&E9Y)7_H>^"G_"9?V=
M)_PG']C_ -I?:&\K^Q_M/V?[/LCV[_M?[SS=_F[L?)L\O'S;J_GA_P""4GQ9
MU'P/_P )'H_AVR_M#Q)J_P#9JZ?#('6S@2#[6+B^OYE'[NTM_.BWHI\^XDDB
MMX5+R;X_H#X^?M)?'G]C+7+'5_%D^GZIH%W<.QM[&"-;'YBY-B+EK6.\@E2/
MY[=Y6DWA0Q:Z\JYC'[O>$_%-GXYTZTU73Y/.LKZWAN;:7:R;X9D$D;[7"NNY
M6!VL%89P0#D5^>$O[3/B#]K#Q+?^%_A=?V=AI.D1K_:OB>2!+UA<2,3#%IML
M[K%,C&&6-[B4-"Z>:\3)LMGN_$/BS^T3\4/V!M8LKGQI?V_B[PGJ5P(3=0V"
M65Y;>7&&< 0K';1RN9&>**66X^TQVCA7M"9&7[?_ &A?VC=8\$^#4\5^"]'_
M +>MY]/EU 7,EQ':6]K9BV-PEU-%,T=S-D%7%M$BR.BR*TL$@C$GP!^RM^U7
M\8?VK_#VJ1Z%%IZ:E_:%TS:SJ$1ATZRMY881;V-C'!'+)<7<;M+/ON5G2&%8
MA<-.US&!]O\ [$/_  M?^SM0_P"%I_9_M'VB/[!M^R_:-FS][YOV'_1O*SL\
MG_EOO\_S/W?D5]OT5^<&M_M5^(?CQXMU7P'\-XK>V;1_W>K>(M0BFDAM7$C6
M\T-I;+&$ENXV)DMS=2)!.UM<KY;PJL[>7_'G4?CA^R;I<GB:UUZS\9V,$<@O
M[6YT6*S:TCRC"[1;*5)9D0*ZS'S (4;S6A= \MO]H?LU_M2Z=^T]X2_X2?1[
M6X,L7F17.G IYR7D4:R/;1RRM##)N#H896>*-ED0R&!Q(D?Y@:C_ ,%#OB9'
M\4K7PK=>'OLWD>:C^';.6WN[FZFN-/$MJ+C4#F)(DE,=Q)/ L*V]LTIF6?R2
M#]'^'[+]HVU\>:<^J3:'+X9EDB>_2R$0L88 K)-&GGHNJ&X(7S8B#)#]HDB#
MN+<2QQ_J?7S!^UC\9/$?P0\/7&J^&]#_ +8E@M[J>XEDNH+>WLH;>%I#/,KR
M+-<8(!%O;@-(B2 S0OY8D_/#]D#]N#X@_M'Z-?66E06>H>*GU2>8S7<+V^CZ
M1IABA:%)GMU\Z9Y9?/@LX5:6Z;;)/-+Y4!\SR^^_:[^+G[&7CG3M-^*5Y;ZE
MH%]L5[J*VB2W\EV02W5M-;6D4S2VI/[VWDC+.A*B(>=;7 _?ZOS \'_M->+?
MVVKS4;3X;RV^@^'M.N!;R^([VUDNKFY8KYBG3[.1$MA@H5G2ZD:5;:Z@F\N"
M8B*O,/C[\7/C+^PPD.M:C?6?C7PY+) MY/)IR:?/9,)"#&!9OMC2X5E2.ZE%
MRB3!8S%&6C6Z^[[7XQZM\=_!=GXD^&BZ?+<:AM:$ZT;B"&%4D9+A98[9))))
M4>-H-J.D1;,RSR1HJS?A!^R!=?$ZY^+_ (G73;S1[_Q9#;ZA;ZE=:NUTUI(M
MO>VT,A@^RJD@PZ1+;ILCB2W!01H%1%_H^^%O_"0_V/;_ /"5_P!G_P!M?O/M
M/]F^=]C_ -8_E>5]H_>_ZKR]^_\ Y:;\?+BO0*_+#]H[]K#Q+KWQ(T_X2^!;
MJSTZ^N8U?4-7N+=KB2T;RS>F."&11 [BUCW9<3)*;E(@]J\3RCR#]H[XR_&#
M]@JXT_7-6UJS\7^'+N1;6=)M/MM.DBN"QE*(+;YU=X8I!#.6GA4^;YMME8#+
M^OWP]\:V_P 2M&T_7+-9$MM2L[>\A24*)%CN(EE0.%9E#A6 8*S '.&(Y/84
M5^ /_!<[_F4?^XQ_[85^K_[._BS3O WPQ\,:AJMW;V-E#X?T?S;FYF2&%-]K
M B[Y)"J+N9E5<D99@HY(%?@#^TY?:C_P4V^)2?\ "!Z=<36%G;V^F_VA*CI;
MA%EN9OMERVS_ $6)]\OE1R9GE2(;8_M#_9D_IM^'O@JW^&NC:?H=FTCVVFV=
MO9PO*5,C1V\2Q(7*JJERJ@L5503G"@<#Y@_:W_:[M_V>TM-&TN*/4O&&M21V
M^CZ6755,D\GDQSW3%D$=OYAVKED,[@QHZ(D\\'A_Q+\!?'GP7IS^(M/\6Z?J
M5W;[KVYT!-%C6W9(T::2RLYT2:]N<LHMH WD3S(V\SQ2XS[!^PO^V;9_MAZ'
M).T/V36M.\F/4[90WDAI0_ES0.V<Q2^7(1&S&6%D:-BZB.:;R^;XR^,?VI?&
M/B+POX'UJS\.Z7X7DMH;K4SI_P!OO+F\?SDE@6"Z\N".W1XY8W;#2&2WC>.2
M2&X81Y^D?$GXH?"CXC^%O _B6_T_5=%U7^T)DUB&R2UO+S[+97$TEO<0+*\4
M'DRO 08(U\V-83YS,UU$./\ ^"IM]\1K+PGJL^F7&EV/A**.U2\,<UR=6NUG
ME6"2(_N1!%;L\R+)&KEY(HVW3&.9[6N0_P"";W_"T_\ A"?#G]E_\(O_ ,(G
M]HGW_:/[0_M3[/\ VA/]JV^7_HWFY\WR,_)CR]_.ZL__ (**_MU_$/\ 9^N(
M],TG28]%M+N2X2SU>XEM;RXNEMFMR\D%LCRQ6R9<KBZ65Y894<);3*RIW_QO
M\2?M$?$.WM];\%6EGH^G32-]GTI_LIU@6[K^[EU$:@C6D3_N]_V>WD$T'V@0
MRK*\3O'Y!^W3^W7\5/V?K>PTPZ39Z+/=QLG]KK+#>"ZGMEMC<R6-LSRBVM_,
M=UC%\LLTMO+&Y2VG5U3]SJ_/#X\_M,>)?$WBR3X9_#2.S_X2.&SDNM4U'4=R
MVNG0/$AB\M K-/<%I[=PPCGAC+QJ\4P:X-K\P?M8_$/XP?L.66G>)9_%UGXE
ML9KQK.:RNM%MK-?,D@EDB/\ HI$KH!'(S%9H"KI$-LR/(%^O[3XS^-?VG_ >
ME^(?AM%I>FW.J1W N)-8EF=K1HFDMF%LEO!*DSB9'>.:<*FR--]JYF9(?R _
MX)=ZM\2]?N/%%YX.ET.>YGDL)=3FU][YY))':\9'C>V)9G9C,T[2DEB4()):
MOWN^)'QTL_V=/"2>(/&\]O#<0V\*W*6>YEN+YH\O!8I*1(^]P_DB0@K$#)*R
M1I)(OR!X6M?C1^TCH<?BRQ\1:?X36_MVGTO1HM-@OU>WD!ELY+R^G\QTEE5T
M$AAB9$B"2?9TF:6!<_\ 9(_;@UG7O%EW\,?B%!'#XHLI)(;6\MH98X+\6T6^
M1W1U4QO+&C7D,RI%;SPOA8H"(EG^@/VTOVMT_9;TNUCLK234O$>L2/;:-8)'
M(ZRS@HI>3R_F9$:6("&,^=<.Z1)M!DFA\/\ ^%=_M ?V/_PD/_"4:?\ VU_Q
M]_\ "+_V5:?8_P#6>9_9_P#:.[S?]5^ZW[O]9\GVS;_IE?"'_!,/Q)<>,?C9
MXLU.\M)+"YO+/5[B:REW>9;23:I:R/ ^Y(VWQLQC;<B'*G**>!_1=17\P/\
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MX9^*D=OJ&@7/FBV\1VMJT,TZ-("EP\43&$^0&6*ZM(HDGB4I*K7/[LW?T_\
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M<LL2V\'F2L7,TP:.WMY(V^S_ -C>R^->G:SJL'Q,FL[G28XPEE.@M!)+.LI
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M.N_&4%YI]EI2[)I-&L(K>^N--MRF6,TD]D?.\K ^U2PRRH'9YD1+128OL_\
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M9U3P+XSLXXO$>BQR&6YM]@CE%I+':7*SJCL@N!,P??;_ .CRAG"QPB)/./\
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M$8=6N-1^'-W%/+))';:Y=10([LRQ1FVM)2D8)(1#)))(57 +R.^-S,3\X?\
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MILDG>1/F7_6S+&@C7R_W^K^<']H/PY>? O\ ::T;4-.-O;+K6H:3<1K!&O\
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M<J[>P_YN\_S_ -"Y7[_45\__ +6/_)//%?\ V+^K?^D4U? '_!%3_DGFI?\
M8P7/_I%8UX!_P7._YE'_ +C'_MA7Z7_\%#_&MQX ^%?B6\M5C>22S6S(D#%?
M+OYHK*4@*RG>L<[M&<X#A2RLH*GQ_P#X))Z9I=A\*[&33S&;F>\OI-1"2EV%
MT)C&@D4LWE/]FCM2(P$!0I+M)D+M]G_M _#3_A<GA+6O#RI;O+J&GW,%O]I7
M="EPT;?9Y7^5ROE2^7*KJK/&R!T&]5K\@?\ @AUXIO+O3O$^E/)FRMKC3[F&
M+:HVS727$<S[@-YW+;0#:Q*KLRH4LY;G_P!@7_DX7Q[_ -Q__P!/-O7[_45^
M<'[4OQ/^'7[,'BBU\33:-_:GQ U*W-KI]M9)OO)@P:*)Y$W%(O,8+9K=".2\
M>,M!$DT,4L:?GA_P4MO?B;XK\%6>J>-H=+T?3CKBI9Z+9DW-T&>&]\N2]N][
MPEXHHL1BUPDXN7>5(GB2)?VN_9._Y)YX4_[%_2?_ $BAKZ HK\ ?^"YW_,H_
M]QC_ -L*[";_ ()B>$_BM\*-+U3P]9R6GBJ?0['4(YDN976[NFLTE>WDCN9_
M(C2X=B Z>2(7*/DQ(\,GG_\ P2K_ &P;CP+>_P#"K/%7EV4<4DZ:6UPK03Q7
MC3DRZ=*I0 O)(\KQ><8Y%F#6V96EMXHOZ#J_GA^-<_B/XE_M/1Z5I6L?V3>V
M=NMMIU]]C@NOLL/]D27DJ>1)L2;S&GN!NE)9/.R#B-%'Z/\ _#/'Q>_Z*?\
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M$_:OTO3]0M[>6WTBW6"V!CW9V:7/J4<KARRF6.XN"T;J$V>7$P D0NW[O5^
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MAC]AC_AB[^U_^)O_ &K_ &K]C_Y<_LOE?9?M'_3Q/OW>?_L[=O\ %NX^</\
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M@MY"C8=&26"9PLB\@.'1@P5A\8?L%?!GXC^*_AQHU[H/CO\ L;39/MOD:?\
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M<59?J#]A;3-+TGX9>&(]',9MCI=O(YCE,J_:I1YEZ"Q9L.+EIQ)'D")PT05
MFQ>/_P""C?PT_P"%H?"_7H$2W:XLK<:C#).N?*^PN)YFB8*[)*UND\*%=N[S
M3&S+&[D?/_\ P1M\4WGB#X:RVUS)OBT_6+NVM5VJOEPM%;W13*@%LRW$S[G+
M-\^W.Q55?F#_ ((8_P#,W?\ <'_]OZ]__P""U?\ R3S3?^Q@MO\ TBOJ^_\
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MJ;%0!?+PI2-E :-"OZ__ +,_[:?@[]JY)%\/W,B7T$?FSZ?=1^5=11^8T8?
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M5%!9@#\ ?\$4-6MYO NJV:RQFYBUR662$.ID2.6TM5C=DSN5':*548@!C'(
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MY"IGM1<1QQ(MV@K^F[2=)M] MXK.SBC@MH(TBAAB14CCC10J(B* JHJ@*JJ
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MPZFR0*TUODF>6>X0;6^RR7 7SDN)'_1__@J/_P DA\0_]P[_ -.5I7S_ /\
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MSA4Q&C1MN.YMOK__  5#^+#^,=+MOA;X82/5/$>OWD4<]G"\<DMM!;&*\!E
MF5K9W;R)$DG3R?LJ7,K-&$60?H?\*O NG?L[>$K#2&FMX;+1M/1+BZ*):PGR
M8]UQ=2#<4B\QA)<3,S-AG=V=CN8_BC_P0UU:WAN/%=FTL8N98]+ECA+J)'CB
M:\61U3.YD1I8E=@"%,D8)!=<_;__  5&_9=N/VA_!RWNDV\ESK>AR-<6L,2L
M\D]O+M6[@1/,52Y58YUPLLSFW$$2;ISD_P""8_[56E_&[P=8^'FECBUW0;.*
MUGM-I0O:P8AM[F(,[F1/+$27# @I<%LQQQRV_F>7_P#!4_XES^.].L/AAX5?
M[?XAUK4(Q=6%LUO*Z6]NBW(2Y#-YEKO=[>Y21A&GD032/*D*MO\ TO\ @I\+
M[?X*^&M+\.6OEM'IMG#;F2.%8%FD11YLYC4L%>:3?-)\S$N[%G9B6/XX_P#!
M6[X(WG@;4=(^*_AU?)O;&XMXKZ6.)7V30N)+"\=?)9&VLOV>62Y=E.+&!4(R
M*^__ -@GPM>2>%V\7ZU'C7_%UQ)J]\Y99,0RDBP@A?+R+:16OE-;V\LDK6_F
MR)E,F-?;_P!I3X0I\>O!VL>&F6-I+^SD2W,KR1QI=)^\M9':++A(YTBD8 ,&
M"E2CJ2C?SX_L0_M>7G[ >L:AX&\<6%Q;V4NH1M<GY=^G3&/9)/Y:1L]U%,HM
M6S'*5$$?G6ZSF4+)^G_Q+_X*2^'/&NG/HWPTGN-=\7:ENM-+MH+.>'R9I$;_
M $N5[VW2'RK< S.&#*=H\SRX/-FBX_\ X*(?L?:S\4OASHT.G>9K?B'PS'$'
MN':7[5>VXMA%>M'$7D$MQ-)%!<%'9YF$;I'(\K^7-X!^PE_P5,\/^%?#]IX7
M\</)8MI5FD-KJ8C>>.XCC<I% T%K!OA>*'RHT;$HF$4CR2)*5$OU_P#\-8)^
MUQXET;P]\-[J\?2[.\MM3\1:S';R001VMNSR1::1<+#,SWDL:I(8RI$(;"W,
M/VN.+Z0^)'[:'P_^$6N)X;US6[>TU1_)S"R3,L7GG$?GS)&T-OD$.?/>/9$R
MS-MB97/T_117\Z/CSQ_I?PP_:M?5-9N8[.QCD@CDN)21'&UQH26\9=L$(ADD
M0-(V$C!+NRHK,/U_\<#PU^VYX:U_PSI]U'>:<\:6K:G;R+/:I?;5N8O*:&9&
MG>U8VMQ*H*V[F18/-=UNHH?RP_X);?&O_AG+6-4^%/C*/^R=2FU 362S+MWW
MDD:126[S>88SYJ1V[V)1?+GR^V9VFMD?]3_VSOVBK+]G#P=J6HM>QVVK26<Z
M:5%N@-Q)=-MACDB@G8"9())HI;@!9 D(9BC<(WA__!+W]G"\_9]\#"35[;[-
MJ^L7#7EQ%)"L=Q#"%$=M;S,&9VVJK7 C?8T#W,D31)(LA;]'Z*_FA_;-\":Y
M^Q!\7(?B7I=E_P 26\U 7<3QR%UDFFBQJ5I,\J2_9Y;G==/&=K*L4I>#YH'C
M@_2_P!_P5D^&'B;2[:\U349-*OI8P;BQDM+R=H) 2&436]N\4B9&Z-P5+(5+
MQQ/NC3U#]EOXEZQ\2XM=^(6OO<:5X=U#R#HMC?M'$MKI=E$[-J$C!@B?:VED
MFD,@RD449%Q<6HMW'/\ P4U+3OVT=8D\;RW/VSP]HVH-!X<T\A%B6X@CC\W5
MKN(2/(;LN[K81W20/:6H2Y6W6:Y$J_GA^WI\,M4_85\8VGQ6\#SR0QZM>3IJ
M5O*PDMS=3?Z0\3J9!++;W@265H\8MIH3)'-$S6JP_L=\-_B7X7_;$\)/=Z>_
MVS2-4MYK2\MV8QS1^;'LN+6<1MOBE"O@[&Y5EEBD:-XY&_G2_9_^+OB#_@E;
MXUU+1O%&G23VE[' ES' Z*LL:3'R-0M))(LSHL;7*I#NMP[R-',T4T)6/]CO
M%/\ P5.^'%O9R?\ "/W=QKNKOMCL=+MK&]CFN[B1@D4*/+;*B[F8;C\S[<[(
MY9-D3_3_ ,!+'6/AMX+LY/&VH^=JD5O->ZM=W+QQK \TDEW-&[J[0K%:B0P*
MR,L BA!18XMJ+^./_!#75K>&X\5V;2QBYECTN6.$NHD>.)KQ9'5,[F1&EB5V
M (4R1@D%US^]WBSPM9^.=.N]*U"/SK*^MYK:YBW,F^&9#'(FY"KKN5B-RE6&
M<@@X-?S!?LV?%G6/^"67CG4]%\965P]A>6ZK.MH(W\[RF<V=]:O*(_.B.9HM
MGF08\V3S5^T6WD#]7OB7_P %5O EIISQ>$;BXUW7[G=;Z=90:==G==R(PMS*
MLRVQ>(R^7&Z0,UPV\".-N2OH'C/P!_PSW\#=8TC5[_S[N+P_JOVR\N+C?Y^H
MZA'/)-MFD6-I/-N[AD@WJ)I-\:MOE8EOG#_@BAJUO-X%U6S66,W,6N2RR0AU
M,B1RVEJL;LF=RH[12JC$ ,8Y "2C8^G_ (C?MB67P8^*5OX0U^>.VTG4]#M[
MJWO)I8(+>TNHY[_S?/DEV'9<1Q11JQD(2:*-%B/GR.OS_P#\%??A#X:U[P1)
MXHOECAUW3I+:#3YPZQR7"S3J)+1@>9T6-IKE$'SQ&.21&6-KA9/4/A;^S7JW
MC?X#6_@CQ#\^J76CR");J2X3[/,TCW6FQSDJ)H_LA^S1R0[66/R# $DB4*WY
M0?L0_M>7G[ >L:AX&\<6%Q;V4NH1M<GY=^G3&/9)/Y:1L]U%,HM6S'*5$$?G
M6ZSF4+)^G_Q+_P""DOASQKISZ-\-)[C7?%VI;K32[:"SGA\F:1&_TN5[VW2'
MRK< S.&#*=H\SRX/-FB_0_X>^&[CP=HVGZ9>7<E_<V=G;V\U[+N\RYDAB6-Y
MWW/(V^1E,C;G<Y8Y=CR>PKX@_P""D/\ :/\ PJCQ'_9?VC[1]G@W_9]^_P"S
M_:H/M6[R_F\K[/YOGY^3R/,W_N]U?&'_  3-_:S^'WPY^&XTW4]1L](U'2Y+
MN;4$N-D,EV99)98YX "7O'\E4@VQA[A3"D7E[#;F3Y?TSXO:7-^U"?$.HM)H
M^G+)*C2:LATYD5-$:VCDD2Y\MHDF8*\ E".R2Q91';8/O_\ X*!?%[2_B9\#
M=2U>U:2"VU22S33Q=H;:6Z5-2B9)(8I,.R30P/=P# =K7$S(@#!?0/\ @E9J
MUOJ/PDT6*"6.22VDU"*=$=6:*0WUQ*$D )*.8Y(Y K8)21'QM92?SP_X*">+
M-.LOV@/!T\MW;I%I_P#8/VV1ID5;7;JDT[>>Q.(L1.DQ\S;B)UD/R,"?Z'J*
MY_Q9X6L_'.G7>E:A'YUE?6\UM<Q;F3?#,ACD3<A5UW*Q&Y2K#.00<&OYX?V,
MO&/_  [F^)6L^"O&1^R:;JWE);ZG-%Y:2>1+*+&Z+B5HXK2=)9EE;]]Y$^Q)
M7A6&Y9?WN^,7QBT;X%:-<:YKEQ'!;01R,B-)$DEQ(D3RBWMQ*\:R7$BQL(H@
MP+D=@"1^:'_!)_X,ZQ:6>L_$/Q-%C5/%%P)8));:..9K=F>>6Y1DP4BNY9=P
MB$<2,MM#,H>)X2OR!\3OB7IWPB_:J;5]5?RK)+BS@EE+(JQ?:]%AM%ED:1D1
M(HVF5YG+?)$KL Q 4_N]\2_CQX>^%'AY_$^H7UO_ &;]G:>VD2>'_3/W+3QQ
M6;/(D<\LR(3 BO\ O>H.W)'YX?\ !+7X3:I,FO\ Q*\0VD=KJ/BR\:XM8_LX
M1DM9)'N9)87>1YDM[F68;(GVEDM89]TR21./E#_@I-XIL_ WQU\&ZKJ$GDV5
MC;Z+<W,NUGV0PZM=22/M0,[;54G:H9CC !.!7[?>!?CQX>^*6HS:?X?OK?5?
MLUND]U<V4\-Q;V_FNR01221R',LOES,J1A]B0LTQA\VV$_X@_P#!/OQ9IU[^
MT!XQGBN[=XM0_M[[%(LR,MUNU2&=?(8'$N8D>8>7NS$C2#Y%)'ZO_MT_LZ?\
M-.^!K[1H%W:E!B]TSG&;R!6V1\RQ1_OD:2VW2L8XO.\XJ6C6OB#_ (),?M*6
M::.?AEK7^@:_I%Q>"UM9HVA>:$R/-/&?,8DW<$K3^;#MB98 C*C^5<NGO_\
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M@\"_"?P]\+_._L'2M/TS[1L\_P"Q6D-MYOE[MGF>2B;]N]MN[.W<V,9.>?\
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M'PT_8'^&?PBU%-5TC0+=+V+:8I9Y;B[\IE=9%DB6[EF2.5612DR!94Y"N S
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M/LYM)6.*(6$EO$]J(X2IB00,IB"1E$,:[<(57:!M&/+_ /AD[X>?]"IX?_\
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MY)LRRF23]+Z*******************_&'_A?WBC_ (:>_P"$6_M.X_L+[/\
M9_[/R/L^S^R/M^[R\;?-^T?/Y_\ K]G[GS/(_=U^SU%%%%?F!^V)^U=XCM_%
M&F_"[X<&W7Q5J6R6XOYG@>*PA >8H8W$H$IBB:>42QLRVI3R89IKB-HNPTG]
MAWQ!X4MXKC3/B+XL&MQ1H!<7MRFH:>9"H69FTVX!5D92_E)),Y@<I)YDC1@M
MX_\ LK_%[XFZW\5[GPG\0FCB;2?#<YB2U0QVM\QO+-%U/^[,\J[E5E6-(#YL
M2V]M*;F,_K?7'^ _'^E_$^P35-&N8[RQDDGCCN(B3'(UO,]O(4; #H)(W"R+
ME)  Z,R,K'L******_G1_:EF\8^&/C9X,T;Q'XBDUBVGU31=0AMXK;[#9VQ?
M5)8D1+59IE=XU#JMS*SW#1N(WD8+D_T74445Q_C_ ,?Z7\+-+N=:UJYCL].L
MXS)//(3M5<@   %F=F(2.- SR.RQHK.RJ?R!\&_M#_$C_@HGJES;^")I/!W@
M^TCN;>[U5XH[FZN)) ?*6,D(8[CRS&QCM94-F'>5[R1WM$;Z?U/]@_5+!!/H
MOQ"\:0:C%)%)!)?:D-0M0R2*Q$UF4@6=&4%?+=PA)&]9$#1M\X?!S]O;Q1\#
M/%K> /C.MO!*<"TUV.,10R^9(_E33%0D+6DHQ''<1QP?9FB*748?[1);_L]1
M117'Z[X_TOPS?Z?I=Y<QQ7VJR31V-N23).T$+W$Q50"0D<:$O(V$4M&A;?+&
MKGQ"\-W'C'1M0TRSNY+"YO+.XMX;V+=YEM)-$T:3IM>-M\;,)%VNARHPZGD?
M"'_!.?\ 8[\0_LA:=JUMKVI6]W]ON()(+6T>9[>#RD97F!F2+][-N1) L0^2
MWB)DDR%B_1^BBBBBBBOR _X*'^./'O[)OAZPU[0?%^H3>=J"V4\%[8:/+GS8
M99DDC>'3X-FWR&5E99-_F*0T?ED2'[+FE_%[]I3PAI_BO_A8GV#[?]I_T;_A
M'--G\OR+F6W_ -;F+=N\K?\ <7&[;SC)\0U/_@HU\0?V//$H\)_$RRL]9CAC
MB=]0L4>VGFCN&63[1"7CAM[A(D,MOY:06H>:(HUP&CD=_P!COB1I^L?$W0T_
MX0_7;?2I;KR9H=46SCU)6MV&\&!&F2%O-&S$K>:GE%MJ;V26/\@?^"+7BS4?
M'-YXRU#5;NXOKV;^Q?-N;F9YIGV+?(N^20L[;5557).%4*. !7[O44444444
M4444445Q_C_Q_I?PLTNYUK6KF.STZSC,D\\A.U5R    69V8A(XT#/([+&BL
M[*I["BBBBBBBBBBBBBN/\)^/]+\=/?1Z9<QW3:;>/8WAC)*Q74<<<DD);&UG
M194$FTL$?=$Q$L;HOPA_P48_8[\0_M>Z=I-MH.I6]I]@N)Y)[6[>9+>?S454
MF)A27][#M9(PT1^2XE(DCP5E^[_A[X;N/!VC:?IEY=R7]S9V=O;S7LN[S+F2
M&)8WG?<\C;Y&4R-N=SECEV/)["BBORP_88_88\5?LP>*M=US7-=CU&VU&-XT
M2-[AI+N1KCS1>WHEPJW"J&  :Z.;J?\ ?@ F;]3Z******X_P'X_TOXGV":I
MHUS'>6,DD\<=Q$28Y&MYGMY"C8 =!)&X61<I( '1F1E8]A11117Y8?MS_L,>
M*OVG_%6A:YH>NQZ=;:=&D;I(]PLEI(MQYIO;(195KAE*@@M:G-K!^_((,/ZG
MT44445Q_A/Q_I?CI[Z/3+F.Z;3;Q[&\,9)6*ZCCCDDA+8VLZ+*@DVE@C[HF(
MEC=%_('_ (*_S>,?"&@QZG:^(I+?0KR\AT\Z/:VWV=G$MK=-*]S>K,9;A'"O
M&UMLCMRACW1M)&9)/TN_9._Y)YX4_P"Q?TG_ -(H:^@******S]6U:WT"WEO
M+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q 4 DD 5^*.M?MW>-/VQO%#>$/@Z;
M?3(K3S[F;6K[RV\^VA"1A_L\UO,8(FED"JHCFN9-T#L+5%N$'T_X6_X)^:C:
M6<::K\1/'%S>C=YLUMJ[VL+98E=D,@N73"[5;,K[F!8;0P1?E#]HCXR_%G]E
M+6="L/%FM1W_ (2N=<TZXN/$5OIXM;@V\,L4ESI\\=KN6)-L<DOEHCS7<(=5
MGDC^T6L?[G44444444444444444445X_^T+XIO/ W@WQ!JNGR>3>V.CZC<VT
MNU7V30VTDD;[7#(VUE!VL&4XP01D5\0?\$EOBKKGQ9\ W,^OW]QJ-Q::Q<VT
M,]RYEF$/D6TX1Y6S))AYI"K2,[*I$8(C1%7]/Z**********************
M************************************************************
M*********************_F!_9I_Y.ANO^Q@\3_^BM1K^GZO'[3QUIWCOQ#J
M?A=X;>Y_LBWTB]F8NDVRXN9KJ6&-X2I\J6'['!=1LQW_ +Z*153:COYA^TQ^
MVGX._912-?$%S(]]/'YL&GVL?FW4L?F+&7P62*-,EBK3R1"01RK&9'C9*\/T
M'_@HK9^(/"&F:Y::'J&H:_JUO>W%OX>TL-?W$<-K<S6@N;B1(D,-H\L:1F<Q
M%M\A6.*?RI-O/_LJ?\%+[/\ :$\42^#]7T2XT#5_WJV\,DS7'F36XD:Y@F!M
MX'MY8UC9@'4JVR1&:.18TES_ (\_\%.$^&J27WAWPOJFOZ);R21SZZ!):Z2S
M+(D(-K>"WN$N$\XR0-(?*0RH!$TZR*P^P/V5?VF-+_:O\-1>(=,CD@82-;WE
MK)DM;W2*CR1"3:JRIMD1XY5 #HZ[ECE#Q1^/_M5?\%#/!W[+#RZ==/)J.NI&
MK#3+4?,ADC=XC<SM^Z@1BJ;AF2X5)8YEMI(V!/'^._\ @H'+IFDZ3-X9\-:A
MXEUJ]T_3]0U#3=.\V5=+AO[<3PK=7,-M-B63/[F(Q(TD2M,WE*8A*?L9?\%(
MM#_:TO)M'GM?[&UI<O;6DER)UNX57<YAE\J',L>&:2 H&\H"5&D59O)Z#_@J
M/_R2'Q#_ -P[_P!.5I1_P2X_Y)#X>_[B/_IRNZ^K_B]\:/#_ ,!=+;6?$M]'
M86*R)$)'#NSR2'Y4CCC5Y9'P&8K&K%45Y" B.R_(&K?M;_$.[MY=4T;X9ZI<
M:2D;R1M>ZE:V&H,L2GS VF;)[A7WJXBC7S'G38Z*?,5:]0_9:_;?\)?M<?:H
MM">XM[VSPTEE>I'%<&$[0)XUCEE1XMS>6Q5BT;[1(J"6$R>/_'3_ (*;^&?V
M=-<G\/\ B#1O$$-W#\R.MM9M#<0L2$G@<WHWQ/@X. RL&C=4E22-?M_X:>.)
M_B)IR:A/I>H:1YNTQVVHK;I<%&175VC@GN/*SN*F.8QSHZ,KQ)@%OF#XA?MR
MV'PW\6VW@FY\/>()]:O?FLHK:/3Y5N83)+&LZ,-0'EQ'R9'8W A:*)3),L2@
MD?9^K:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22 *_/!_VY?$
M?CVSGUOP%X'U#Q!X>@^T*-1EOH-/:Y:V9Q(UG9NDUS<Q$*OELJ"5Y2]OY"S1
M,E>P?LM?MFZ'^T_]JL88;C2]?TW"ZAH]Z EQ"R[4E:/H98HY2T+,5CE1POFP
M0^;$']?^.GQTT/\ 9TT.?Q!X@G\FTA^5$7#37$S E(($)&^5\' R%50TCLD2
M22+\8>-?VX/&_P /+==;U+X;ZI%X<,@=[M=0@EO(;,JTIN+C3XHG>V=(59Y8
MYY(XX9!Y,EPA(8_9_P "_CIH?[1>AP>(/#\_G6DWRNC86:WF4 O!.@)V2ID9
M&2K*5D1GB>.1O8**^ /VA?\ @H=HO[+^HII_B70O$$/G>:;6YC@L9;>Z2)RA
M>&1;[_=8QR".>-)(VDBC\Q0?N_5KU].MY9XH9+F2.-W2"(QB25E4D1H97CB#
ML1M4R/&@)&YU7+#X@\!_\% =!\;>-T^'LND:YINNM)/&\=[;VJ1QM! ]R2SQ
M7<Q9'CCW121JZ2AD=6,;!Z] _:8_;3\'?LHI&OB"YD>^GC\V#3[6/S;J6/S%
MC+X+)%&F2Q5IY(A((Y5C,CQLE>'Z#_P45L_$'A#3-<M-#U#4-?U:WO;BW\/:
M6&O[B.&UN9K07-Q(D2&&T>6-(S.8BV^0K'%/Y4FWG_V5/^"E]G^T)XHE\'ZO
MHEQH&K_O5MX9)FN/,FMQ(US!,#;P/;RQK&S .I5MDB,T<BQI+^G]?G!=?\%
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M?$X?!S1KC7);"\O[:SCDFNDLS;>9#;PQ/++.1=7%LK(BI@K&SS$LNV-AN*^
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M4'U,6NDZH[6TEG'IEA;HMUJVIM/'-)<&*QB)6-+58'>63SY$\HJ6:.5XX7]
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M_#;P9>>(M)LI/(EU&XU"WTJ-Y]SG; EPCF1/+$<O)29!*@EMX=R&3L/V5/\
M@H/H?[2.HR^';RSN-!\36_FB33+M@=[0O(LL<$A6-WEB5 \\,D4,J9?:DJ0R
MR+Y__P %$?VP-6^"FAZGI6@:/K#W;VZ13:X+2XATVQ6Z!C+QWJ[-]VN^,0F,
MB*.:5"9FEA>V;R#_ ()O?M.?\(UX)\.>&/\ A&?%%SNN)X/[5M]+\S2Q]IU"
M<^:UUYHQ%%YF)WV?NRD@P=O/ZW>/_'^E_"S2[G6M:N8[/3K.,R3SR$[57(
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MK90+)::%H^ESW\^LW;>4LAANHK8)#:A7E9)1-&T!9DN)'80?9!(5SY!\3?\
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M*M=M_#>AR7%EID$DL=FLUI 8A?3Q1S&W>6,2201B.5W$8++'')'*WH'[$O\
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M:';6<+7DBWQAQ)MFU+3KE)I9IHE**$E66VW^4ZM*ZS2,%E<RR?J?_P %1_\
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M%Q\'/AOX@UBS\P7*6?V>%XIF@DADO9$LTG21065X6G$R[<$F,*'0G>OYH?\
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M"WPZ_@N?PO)9/_:6Z'5K?4(YHL:A< 8FM9Y$GWMYC',5OY2[%_>DLXY_1?\
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M\021@8E1Y+F.8;FPCVZ'8S%6C^C_  G\7OBEX&TZTTK3_A9Y-E8V\-M;1?\
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MUCOE_>Z+</I*RY7][#;Q0R0':B($\N*:.WP=[/Y/FLY>1@/@#]B3PGIWBO\
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M)84U:7,TMNK,;?,IFC2-V9GCB2?(295'[O?M8_\ )//%?_8OZM_Z135^:/\
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MJ[)#NC.XP\__ ,%SO^91_P"XQ_[85^_U?@#^P+_R<+X]_P"X_P#^GFWK[_\
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M++)"'4R)'+:6JQNR9W*CM%*J,0 QCD )*-CT_P#X*X_$O3O!_P ,[K2+E_\
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M$<>V%(PZ0P^8':)6'K_C_P  :7\4]+N=%UJVCO-.O(S'/!(#M9<@@@@AE=6
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M(((((975@'CD0J\;JLB,KJK#\4?%/_!#K3KN\D?2O$]Q;61V^5#<Z>EU,N%
M;?-'<6R/EMS+B)-JD*=Q4NWZG_LS_LJ^&OV4-+DTSP]%(6GD\RZO+AE>ZN&!
M;RQ+(B1KLC5BL4:*B("S[3+)*\GT?17P!^T+_P $\=%_:@U%-0\2Z[X@F\GS
M1:VT<]C%;VJ2N7*0QK8_[JF20R3R)'&LDLGEJ1]/^'/A=?>&]#.BKXAUB>4>
M6(=3N/L$M]$D8C 0.UCY,N0AWR7,,\[F61C*7V,GR!\-_P#@FEHOPDUQ_$NC
M>)?%$&KS>=Y]TUW8S-/YYW2^>)["1)][8D/G*_[U5E_UB*P^@/VE/V7+7]J&
MS_LO5=9UBSTL^69;&PDM(H9GB9F5Y6DM)9GY93Y9D\C=%%((A*@>C]FO]ERU
M_9>L_P"R]*UG6+S2QYABL;^2TEAA>5E9GB:.TBF3E6/EB3R-TLLAB,KEZ^GZ
MY_Q9X6L_'.G7>E:A'YUE?6\UM<Q;F3?#,ACD3<A5UW*Q&Y2K#.00<&OR@^$W
M_!)&S^&FHWN[Q5K$F@7N5GTFU9K'[5"'.R"_GAF(N8O*>6&4)%;L_FL\;09*
M'ZP_:8_8GTW]JYXU\0:WKB6,$GFP:?:RV<5K%)Y:QE\&R>61\!BK3R2F,R2K
M&8TD9*]/^#GP%;X*:&WA^RUW6+JT2W%O9/>-9336*@.%-NXLTW[=Z^6ET+F*
M-8HHTC6)3&WS!_P[2T7_ (2C_A-/^$E\4?\ "0_:/M'V[[78[]^-NW;]@\OR
MMG[GR-OD>1^X\OR?DK[_ /\ A'(KW3O[-U _VA$]O]GN3=1Q-]J5DV2&>-(T
MA;S1GS$6-(CN*B-4PH_&'XE_\$2]#\0:B]SX>UVXTJRDW-]DGM!?>6S.S;8I
M?/MW$2J41%E$LOREGGD+?+]W_LB?L.>&OV0;>5].,E[JUU&B76HW 42%552T
M4"*,06[2*9?+S(['8)9IO*B*?9]%%?"'[57_  3S\'?M3O+J-TDFG:Z\:J-3
MM3\SF.-TB%S W[J=%+)N.([ADBCA6YCC4 <?X6_92^*_@^SCL;;XI7#Q1;MK
M7.@6MW,=S%SOGNKF69^6(7>[;5PBX154?5_PR^ 6E_#6]GU@S7FIZW=1M#/J
MNHSFXNF@,\EP+>, )!:VZO(<6]G%;PD)&6C9D5A[A7Y@:U_P36B\'^*&\6?#
MCQ!<>$;V;SQ<6\=G%>V968)F.&W=XD2+<K2F&7SXED,9A2W$$:CU#2?V)G\;
M7$5Y\2M?O/&,EK(CVMG+#'I^E1M$P:*5].M6\J>X4M,C23,Z2P3&%X65%-?9
M_BG1I_$%G);6U[<:?*^W;=6RV[31[6#'8+J&XA.X HV^)_E8E=K[67X ^&__
M  32T7X2:X_B71O$OBB#5YO.\^Z:[L9FG\\[I?/$]A(D^]L2'SE?]ZJR_P"L
M16'T!^TI^RY:_M0V?]EZKK.L6>EGRS+8V$EI%#,\3,RO*TEI+,_+*?+,GD;H
MHI!$)4#T?LU_LN6O[+UG_9>E:SK%YI8\PQ6-_):2PPO*RLSQ-':13)RK'RQ)
MY&Z660Q&5R]?/_Q(_P"":6B_%O7$\2ZSXE\43ZO#Y/D72W=C"T'D'=%Y @L(
MT@V-F0>2J?O6:7_6.S'[_P#"VC3^'[..VN;VXU"5-VZZN5MUFDW,6&\6L-O"
M-H(1=D2?*H+;GW,W\R7_  2W^ 5Q\94\17FD:S>>']=TR32&LM2M2SJ(Y)+E
MY[>YM3(D5U;RF")FBD.-\49.Z/S8I?U^L?V%;_Q_JEOJ/Q*\4WGBV"QDAEM-
M,-I#I^F^9$)L/=6<+217#@R_*V(R54PRF>!_*'W_ *MI-OK]O+9WD4<]M/&\
M4T,J*\<D;J5='1@59&4E65@0P)!!!K\@;+_@D:G@SQ+-K'A7Q;JF@:=/( ;2
MR61+I+5F1Y;5+];I6*%E_=-+%*4 B,@N'C+OU_QX_P""4FA_$#4=*U+PAJ'_
M  B<NEV\4*BTLQ)N:W??!<B1)K>87:DGS+F22:67;$VY7C9I/J#6OV,])O\
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M4-OYJRM%O"Z>\S^8871?)BEVM@OL0[A^G_VG4?[.\WR+?^TOL^[[/]H?[/\
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MOD#XE_M\?#/X1:B^E:OK]NE[%N$L4$5Q=^4RNT;1RM:13)'*K(P>%RLJ<%D
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MY'I^E>(-'OKV;=Y5M;:C;33/L4NVR..1G;:JLS8!PJECP":Z#QU\6/#WPO\
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MZ^G_ !_\?O"_POU&PTC5]3M[?4M3N+>WL[/)DN)7N7:.%O)C#R)$SHR>>ZK
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M  4/^%>DZH-'D\2V9N3)%&'C6:6UW2A2I-['$UH$&X>9(90D1#"1D*/M]O\
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MBUI6K^'IM0A\/7GE7,B(F_-FUQMO],625O+NMB(CIYK"2+S;5G?SD2Z?]?\
M_@J/_P DA\0_]P[_ -.5I1_P2X_Y)#X>_P"XC_Z<KNOE#_@H/XQO_C_\0?#7
MP=TR>0:==R07.N):W4*R/&7,K1RAU/EO:VT#WL<<C.)C- _V=WC@+?K]IGP]
MT;1=+.AVNGV<.DM'+$;".WB2U,<Q8RH8%41%)"[F1=N'+-N!W'/\\.MWR?\
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M5('TV.&VT+2]5OM,M;626TM8+I;::59OLUL\4$CA]S+YJ. 9)< ":4/\W_\
M!%3_ ))YJ7_8P7/_ *16-'_!6#XS:Q:6>C?#SPS+C5/%%P8IXXKF..9K=F2"
M*V=7P4BNY9=IE,D2,MM-"Q>)Y@OZ7_!WX.Z-\"M&M]#T.WC@MH(XU=UCB22X
MD2)(C<7!B2-9+B18U,LI4%R.P  _!']LWP=_P[F^)6C>-?!H^R:;JWFO<:9#
M+Y:2>1+$;ZU"&)HXK2=)86B7]]Y$^]XDA6&V5?L__@IQX#\,?%_X83>/8DDN
MKF"ST^72+HSW21QV]]>6NYUM&=(0\L4N':2'SB!&K$&*,)@?\$U?V9-&\?\
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MM\#Y_P#VV_A/X>\*?'7P5I&GZ5I]IIMW_8?VFS@M(8K>;S=6GCD\V%$$;[T
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MXX_\$,?^9N_[@_\ [?U^_P!17Y ?\%J_^2>:;_V,%M_Z17U>P?L@_L;>!O\
MA#=%U?4M)M]8U+5-'TN>YNM51;]^;96BBB%P'C@BA1Q;Q)"L?[B*%',C1AJ_
M+#X^_#)_^"8GQ2T;Q#X?GO(?#6HR"1HHVCDD-JD\?]HZ;MDDS.BQM$\#W 0@
MR0XE:XMFN:_9_P#;M_9=M_VH_!UW916\<FMV<;W&D3%5\Q;A<,T"NTD2JERJ
M>0_F-Y*EHYV1F@CV_('_  1@^*MOXG\':AX<6UC@N='O!+)-%$J"YCOM[1O,
M^\M+<*T,L3,50+;I:H"Q5L>W_MU>%K/]H#6/"'P[\O[3+<:Q'K&HQ!F"0Z18
M1S1W!N&A/G0?:#-]GM)-JQR3AH_.B< G]#])TFWT"WBL[.*."V@C2*&&)%2.
M.-%"HB(H"JBJ JJH 4    5H444444444444444444444444444444444444
M444444444444444444444444444444444444444445\0?\%(?"UYXP^%'B.V
ML8_-E2W@N67<JXAM+J"ZG?+E1\D44C[0=S;=JAG*J?G_ /X(^_&.S\<_#_\
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M@^&L5S;1[XM/UBTN;IMRKY<+17%J'PQ!;,MQ"FU S?/NQL5F7Z _X)R?$O\
MX6A\+]!G=[=KBRMSITT<#9\K["Y@A652SLDK6Z03.&V[O-$BJL;H!V'[=.IZ
M7I/PR\3R:P(S;'2[B-!)$95^U2CR[(A0K8<7+0&.3 $3A92R!-Z_+_\ P1Z\
M%7'A7X9"\G:-H]5U2\O( A8LL:"*R(D!4 /YEK(P"EAL9#NW%E7Y0_X(8_\
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M9[]K'_DGGBO_ +%_5O\ TBFKX _X(J?\D\U+_L8+G_TBL:\ _P""YW_,H_\
M<8_]L*_?ZBBBOG_]K'_DGGBO_L7]6_\ 2*:OR!_X(8_\S=_W!_\ V_K]_J_
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MR#(,HCJX=E$;E?Z#J_ ']@7_ ).%\>_]Q_\ ]/-O1_P7._YE'_N,?^V%?O\
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M*.6YU&.2;Q# &*+_ &;I\D16XG-NGGQO<(TUC%<2,%=X[>!)(C&6K]KJ\?\
MCI\"]#_:+T.?P_X@@\ZTF^9'7"S6\R@A)X'(.R5,G!P592T;J\3R1M^"/AO]
MA_X[_L@:S=GX?3QW=M=Q[7NK>:R6.6-97\H3VFHL%6X51ORBS"(3/''<N'E!
M_2_]F+]F3QI>:Q:>-_BMJW]I:_8V[Q:390&..WT];F/%R\JV\<,,EVP=H'*+
M)$$0-YUQBW-MV'[<?[#FE_M>Z6)(S'9^([.,BPOR#M9<EOLMUM!9K=F)*L S
MV[L98PP::&?\P/A#\ OVF_@0B^&/#TT=KHZ7CB.=Y]+N+6-9),//&+D2W<=N
M>9S$D2OEG?[/Y\CJWZ__ +*W[.-Q\#[>^U/7-0DU;Q5KLD5QK6H,S>6\D2L(
MH+>/"JEO KM'%A$+ _<BB$-O!]7T5^8'[2WP.^)5W\2K?Q_X#&GG^S/#ZVAM
MKZXEC34'>6^=[7RX63?MWP2+]HDMX!.8'\P^5(8\_P",FB?%3]LC1)_!FH^%
MK/PGIU[);/>:G=:Q#J3"""XBE,=M;V:*QN"RJZF5EA9(Y(R\;R1R+]GO^SUI
MVE^ 9_ &E/\ 9+)]'N-+BG,2,R^? \+7$B1B%))69VGF(\OS96=B5+$U^4/[
M'?[.GQY_9Y_M+PI9+H^G:+=7#RG5;HQW?E/\EN]S810RB5Y7B"3117\20'R%
M5Q SR+)^G_[2G[*FC_M*^$O^$4OI;B%8/+DL;LRR3S07$,;1132-+(7N?E=T
MF$SL\JN[>8DVR9/A_P#9ZC^.G[*VG/X6O?#=OXNT^S\I=-O8=;MK3RH=@+0!
MKI1-+%&2$B$D,30[7C5I+?R!'[!HG[*GB'X\>+=*\>?$B6WMFT?]YI/AW3Y9
MI(;5Q(MQ#-=W+2!);N-B([@6L:03M;6S>8\*M WW?X_\ :7\4]+N=%UJVCO-
M.O(S'/!(#M9<@@@@AE=6 >.1"KQNJR(RNJL/P!U;]@#XP?LF>();WX5W\EWI
MUQ(Y39=6T4@C5"L:ZA;7ACM+AU\Z58743#*M/Y=J[H@^[_@#^RG\0/%>L:9X
ML^+'B#^T;C3L36>A0QP_8X;CRSY-Q<"-([9KNW,\X#0Q.ZR)#(E\\:".M#_@
MH'^S1XZ_:WLK?0-'&AVFDVMXEX+BZO+LW4TBP-$H\J.R:*%%,TX8>9.91Y3A
MH</&WT!\!O /BKPEX*C\+^*+'0[R2PTN/3[=8+NXDM;^..%X5CNX[BQS C1K
M%',RB[$A:5Q"BA86_/#]GW]A/XI_LP^+;G7O#-SX?M](O+AS/HCZCJ$L+V9D
M9HK<S/8%S+ K;8+LJ9%;<65XY9H9/V>\+7.HW=G&^JP6]M>G=YL-M</=0KAB
M%V3206SOE=K-F)-K$J-P4.W05S_BSPM9^.=.N]*U"/SK*^MYK:YBW,F^&9#'
M(FY"KKN5B-RE6&<@@X-?CC\*OV:OBI^P3X@ND\%6\?BSP??R2N=.EOH;*XA8
M(@BE=YPD4=QD^4TEN)4NH82988'^S"#V_P")'P?^(O[<=FFC^++2W\%^&TN(
M9;JTM[W^T=3O6@;=L,L)CLH[1UDW()4GEBN[:.4PR(4V_H_X3\+6?@;3K32M
M/C\FRL;>&VMHMS/LAA01QIN<L[;54#<Q9CC)).37\P7_  2\A\<Z'+KVO>"(
MK?4I;+^S(+W1+F9H%O;>YEF9I8)C+'#'=P"!EB>=9$6*XN" S@0S?I]\4/AA
M\4/VX_)T#Q/I=OX,\)QW%M/?K'J27^HWOE^<3%"]L?LWE9\DE+F,>5,L=RIN
M#'Y"_I_X3\+6?@;3K32M/C\FRL;>&VMHMS/LAA01QIN<L[;54#<Q9CC)).37
MX@WO[)?Q<^ 7Q:U+Q9X$AT_4++6[BYDDN+MXDMXX=1N/.EANH3,EU_H\@27S
M+3>TB1QD EY;4??_ ,1_A?\ $/Q'X&O- AFT>]UW7;>]CU6\NKF]@L[7[6HB
M\FPM4AN6:**W+01$O;9DC6]ECGGN+E6\O_X)^?LT>.OV2+*XT#6!H=WI-U>/
M>&XM;R[%U#(T"Q,/*DLEBF1C# %'F0&(>:Y:;*1K]0?M5?LSZ7^U?X:E\/:G
M)) PD6XL[J/):WND5TCE,>Y5E3;(Z21,0'1VVM'*$EC^#_V>H_CI^RMIS^%K
MWPW;^+M/L_*73;V'6[:T\J'8"T :Z432Q1DA(A)#$T.UXU:2W\@1^P:)^RIX
MA^/'BW2O'GQ(EM[9M'_>:3X=T^6:2&U<2+<0S7=RT@26[C8B.X%K&D$[6ULW
MF/"K0-Z!^W+\'?&7[1/ARX\)^'4T>&ROOLS75Y?W=RDP\F<3^5%!#:2H,M%"
M?.>5LJ98_(!V2@_8:^#OC+]G;PY;^$_$2:/-96/VEK6\L+NY>8^=.9_*E@FM
M(D.&EF/G)*N%$4?D$[Y3\@?M#_L9?%/XZ>/M,\=Q-X7L9='^P_8K1KW4+A?]
M#G:Z7SY!8PF3=*[Y\M8<1%4'SJ97_7[PM<ZC=V<;ZK!;VUZ=WFPVUP]U"N&(
M79-)!;.^5VLV8DVL2HW!0[=!17\P/P2TCQ;=_'#QO?>"9;?^VM-N/$-W%971
MD%MJ"_VB(&M)C'-#C/G":$NWE"Y@@W[%S+'^E_Q6MOC+^U?82^$Y/#UGX,TF
M^CV:EJ,^K)J%PT'G0EHK5+%HR':,2K+'.IAN(6>)IH,Y?[_^"_PATOX"^'['
MPUHRR+8V$92,RN9)'9W:221VX!>21WD8*%12Q5$1 J+^6/[0_P"QE\4_CIX^
MTSQW$WA>QET?[#]BM&O=0N%_T.=KI?/D%C"9-TKOGRUAQ$50?.IE?]3M9\)7
M'Q5\-7FC>(8H[.34[.ZL[M+&Y:X6..X62$F&XFMH"S^6P;+P (Y*[9%7<WXH
M_ /]FWX\_L9:Y?:1X3@T_5- N[A%%Q?3QK8_,4 OC;+=1WD$J1_)<)$LF\*5
M"W7E6T@T/VJOV'_B>GC70?&?A^>3Q=?64=C-/-?36=JJ7EA,) B6H:SBALI#
MM=(8'DD#FY:27>ZRR??_ (Z^$7Q&UGP5J>AI>Z7J6M^(H[P:E<WMQ<V]CIRW
M4,5N;73+:&UF=[>.$.D;321.;C-Y*)FGEA7S_P#X)^?LT>.OV2+*XT#6!H=W
MI-U>/>&XM;R[%U#(T"Q,/*DLEBF1C# %'F0&(>:Y:;*1KY?^WS^QE\0_VRM1
ML?LS>'[#3=)^UK:^9>WLEQ-]H=,RS;;$1QY2&'$*>9Y;^9^_F5EV?I_\-+GQ
M#<Z<G_"3P:?!J2[5D_LZXFGMY,(NZ5?/@@DBW/OQ"?.V(%S/(Q.WP#]DW_A:
M'_$[_P"%E?V?_P A!O[+^Q[/]1\V_;L_Y=/]7]E^T?Z=_KOM'_+*OK^BOE#]
MI3PWXZ^)6C:QX=T"ST-+;4K.2S2^O=2NQ(L=Q%Y=P6M(=/90X5I%B(N6 .R5
ME(W0'X0_8I_8R^*?[&5Y>O;-X7U&RU+R/M<,E[J$,W^C+.(O)F6Q=(_FG+2;
MXIMZJ%7RR=X_7[[3J/\ 9WF^1;_VE]GW?9_M#_9_M&S/E?:?(\SRM_R^=]GW
M[/G\C=^[K\D?VX_V-_B7^VA<:6S+X;TNVTN.X$<8U&^N9'DN6C\QFD_LV%=F
MV&((@CRI\QC(X=5C^S_V7O"_Q#^&6DZ;X>\36WA^:RT^WBM([S3[Z]69;>VM
MTBA#6L]ELEE+)^]D$\";7RL64VR?+_[9O["6N>,/$</Q(^'-]]@\66^'GBDE
M*K=&"#RXC"SAXTE9$6UD@FVV=Q$P\UH@)C<>H:3\8?CAXEMXK >!]+TO47C0
M/JE[K<4^GI(BAI&:SL_,N]DFUDB1)9#$[H7D=$=CZA^R'^R'9_LJ6=^S7]QJ
M^M:O<?:-3U.XW*UPRM(T8$;22[=OFR,[L\DLLLDCM(5,<<7U_7Y@?L%_L$_\
M,HZYXCU6[;S6FN&LM'D,F]O[+RD_F2,A1&EE;RHIE:",Q2VCM$S0S@M]G_M*
M?"%/CUX.UCPTRQM)?V<B6YE>2.-+I/WEK([19<)'.D4C !@P4J4=24;R#]@3
M]GBX_9G\!V6CZC#'#JT\DUYJ*QRM*OVB9L("Q)0/' D$,@A_<[XV96DW&5_I
M_P ?^ -+^*>EW.BZU;1WFG7D9CG@D!VLN00000RNK /'(A5XW59$9756'\^.
MM?\ !.KXK_LI>*&UCX6W7VRW?SXX)EGM8KB.W<(?)OH;SR[:;)/R&,2HSP+<
M&.VD\I%^W_@#^S)\3/BOJ.F:_P#&35O/BT:X%[IFBVYMX]M]&Y$=Q>M8QQPO
MY019+=$><GS2&>)//M[C]7Z_+#]M[]@VX_:8\:^%O$$"QS6,$D5GKL$UPT2_
MV?#,UR#$(T$I>0/<6[E)-^^2V*K&BSSI^I]>/_'3X%Z'^T7H<_A_Q!!YUI-\
MR.N%FMYE!"3P.0=DJ9.#@JREHW5XGDC;\$?#?[#_ ,=_V0-9NS\/IX[NVNX]
MKW5O-9+'+&LK^4)[346"K<*HWY19A$)GCCN7#R@_I?\ LQ?LR>-+S6+3QO\
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MI>%;JXDM([^.,"XC57:.2&5)XF*-@.@DC3S$RA=-RK)&Q#K^2/[*GP6_:$^
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H44444444444444444444444444444444444444444444444445__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ex19_006.jpg
<TEXT>
begin 644 ex19_006.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[@ .061O8F4 9       _]L 0P " @(%
M @4'!04'" <&!P@)"0@("0D+"@H*"@H+# L+"PL+"PP,# P,#@X,# P,# P/
M# P,# P,# \,# P,# P,_\  "P@,Y GV 0 1 /_$ !\   $% 0$! 0$!
M       ! @,$!08'" D*"__$ +40  (! P,"! ,%!00$   !?0$" P $$042
M(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V
M-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KA
MXN/DY>;GZ.GJ\?+S]/7V]_CY^O_:  @!    /P#]_*******************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************X_PW\0M&\8W%W9Z9J%G>7-A)Y5[#;W$4TEM)
MN==DZ1LS1/NC==L@4Y1QC*G'84444444444444445S_BGQ9IW@:SDU#5;NWL
M;*';YMS<S)#"F]@B[Y)"J+N9E5<D99@HY(%9_@KXA:-\2K=KS0]0L]2MDD,3
MS6=Q%<1K(%5BA>)F4.%96*DY 93C!&>PHHHHHHHHHHHHHHHHK/U;5K?0+>6\
MO)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!6?X6\6:=XYLX]0TJ[M[ZRF
MW>5<VTR30OL8HVR2,LC;65E;!.&4J>01704444444444444444444445Q_B3
MXA:-X.N+2SU/4+.SN;^3RK*&XN(H9+F3<B[($D96E?=(B[8PQRZ#&6&>PHHH
MHHHHHHHHHHHHHKG]?\6:=X4^S_VA=V]I]KN([6V\^9(O.N)<^7!%O(WRO@[(
MUR[8. <&N@HHHHHHHHHHHHHKG].\6:=J]Y=:?;7=O->V/E?:[:.9'FM_.4O%
MYT:DO%YB@M'O"[U!9<CFN@HHHHHHHHHHHK/U;5K?0+>6\O)8X+:"-Y9II75(
MXXT4L[N[$*J*H+,S$!0"20!1I.K6^OV\5Y9RQSVT\:2PS1.KQR1NH9'1U)5D
M92&5E)# @@D&M"BBBBBBN?T#Q9IWBO[1_9]W;W?V2XDM;GR)DE\FXBQYD$NP
MG9*F1OC;#KD9 R*Z"BBBBBBBN/\ &OQ"T;X:VZWFN:A9Z;;/((DFO+B*WC:0
MJS! \K*I<JK,%!R0K'& <=A11111111117/ZCXLT[2+RUT^YN[>&]OO-^R6T
MDR)-<>2H>7R8V(>7RU(:38&V*0S8'-=!17'^)/B%HW@ZXM+/4]0L[.YOY/*L
MH;BXBADN9-R+L@21E:5]TB+MC#'+H,989["BBBBBBBBBBBBBBBBBBN?U'Q9I
MVD7EKI]S=V\-[?>;]DMI)D2:X\E0\ODQL0\OEJ0TFP-L4AFP.:Z"BBBBBBBB
MBBBBBBBBBN/\:_$+1OAK;K>:YJ%GIML\@B2:\N(K>-I"K,$#RLJERJLP4')"
ML<8!QV%%%9^K:M;Z!;RWEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22 *S
M_"WBS3O'-G'J&E7=O?64V[RKFVF2:%]C%&V21ED;:RLK8)PRE3R"*Z"BBBBB
MBBBBBBBBBO/_ !U\6/#WPO\ )_M[5=/TS[1O\C[;=PVWF^7MW^7YSIOV[TW;
M<[=RYQD9[#2=6M]?MXKRSECGMIXTEAFB=7CDC=0R.CJ2K(RD,K*2&!!!(-:%
M%%<_XI\6:=X&LY-0U6[M[&RAV^;<W,R0PIO8(N^20JB[F957)&68*.2!7045
MQ_C7XA:-\-;=;S7-0L]-MGD$237EQ%;QM(59@@>5E4N55F"@Y(5CC ..PHHH
MHHHHHHHHKG_%/BS3O UG)J&JW=O8V4.WS;FYF2&%-[!%WR2%47<S*JY(RS!1
MR0*Z"N/LOB%HVHZI-H<&H6<FK6T8EGL$N(FNHHR$(>2 ,940B2,AF4 B1.?F
M7/8444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444445^<'['?_!.?3OV0O$.I:];
M:M<7_P!KMWM+6"2!(O(MWF28B9U9O/E_=0J)$6W3B0^4?,41?H_117E_PT^+
MVE_%I]532VD=='U2?2KEW0HINK>.)YA'GYF1&E\HL0H9T<INBV2/ZA111111
M11117/\ BSQ39^!M.N]5U"3R;*QMYKFYEVL^R&%#)(^U SMM52=JAF., $X%
M?E!^PIING?MO1:YX\\:6W]K2MK%U9Z;IVHE+RQTRS\JUF$=K;O&L*RL&CCFN
M!&))1"K?*\DYEX#1/^"=7BC]G3XJZ5KWP\NO*\,W%QNOUEG :UL]ZO<V,JR;
MGNHIE&VT<+)(DHC,S1/ EZ_[?4444444444444445Y?)\7M+3Q5'X.#2-JSZ
M7)JK*$/EI:I<1VREI#@%Y)'8(J;B!%(7\O,7F<_^TC\$+?\ :/\ ">I>%;JX
MDM([^.,"XC57:.2&5)XF*-@.@DC3S$RA=-RK)&Q#KP'[&W[*UO\ L@^&GT""
M^DU&2:\FO)[AXEA4R2+'$!'$&D*((X8P0TDA9][[E5EC3ZOHHHHHHHHHHHHH
MHHHHHHHHK\X/VQ/^"<^G?M>^(=-UZYU:XL/LENEI=01P)+Y]NDSS 0NS+Y$O
M[V93(ZW"<QGRAY;"7]'Z**************Y_Q9XIL_ VG7>JZA)Y-E8V\US<
MR[6?9#"ADD?:@9VVJI.U0S'& "<"L_X>^-;?XE:-I^N6:R);:E9V]Y"DH42+
M'<1+*@<*S*'"L P5F .<,1R?YX?VI?AH_P ,/C[X,@EU75-8DN[S1;MY]3GC
MFDC:76)0881%%#%#;J4W1P1HJ1EWV@*0H_I.HHHHHHHHHHHHKR_XO?#1_BUI
M;:6FJZIHZO(CO<Z5/';W15#GRQ,\4K1H6VEC%L=@NPOY32(_XH_\$,?^9N_[
M@_\ [?U^_P!111111111117X8_\ !9[X:/:Z#:>(WU75)5EU2UM$TMYXQIL*
MBUNW\Z.W2)6-P65LSRR2/MD>,$1"-(_U._9._P"2>>%/^Q?TG_TBAKZ HHHH
MHKXP_;T^&C_$'P+K$XU75-.CTW2]3NV@L)XX([QH[20K#>$Q/+);X#*\"/&D
M@=MX9EB:/Y/_ ."*G_)/-2_[&"Y_](K&OU_HHHHHHHKX0_;C_8<M_P!M"WTM
M6U232[G2Y+@QR"W6YC>.Y6/S%:/S(6W[H8BCB3"CS%,;EU:/Z_\ A[X*M_AK
MHVGZ'9M(]MIMG;V<+RE3(T=O$L2%RJJI<JH+%54$YPH' ["BBBBBBBBL_5K)
M]1MY8(II+:22-T2>(1F2)F4@2()4DB+J3N42)(A(&Y&7*G^='X6^ /\ A5_[
M4MOI'V_4-3^S^9_IFI7'VF\E\S0'D_>S;4W[=^Q/E&V-47G&3_1]17YP?MB?
M\$Y]._:]\0Z;KUSJUQ8?9+=+2Z@C@27S[=)GF A=F7R)?WLRF1UN$YC/E#RV
M$OZ/T444445Y?\-/B]I?Q:?54TMI'71]4GTJY=T**;JWCB>81Y^9D1I?*+$*
M&='*;HMDC^H45S_BSQ39^!M.N]5U"3R;*QMYKFYEVL^R&%#)(^U SMM52=JA
MF., $X%9_P /?&MO\2M&T_7+-9$MM2L[>\A24*)%CN(EE0.%9E#A6 8*S '.
M&(Y/844445S_ (L\4V?@;3KO5=0D\FRL;>:YN9=K/LAA0R2/M0,[;54G:H9C
MC !.!7/^$_%,7Q;\/6FJZ?)<6<6K:?#<VTNV+[1 MU")(WVN)X?-0.#M831;
MQ@B1,@_@#\+? '_"K_VI;?2/M^H:G]G\S_3-2N/M-Y+YF@/)^]FVIOV[]B?*
M-L:HO.,G^CZBBBBBBBBBBBBBBBBBOA#]N/\ 8<M_VT+?2U;5)-+N=+DN#'(+
M=;F-X[E8_,5H_,A;?NAB*.),*/,4QN75H_K_ .'O@JW^&NC:?H=FTCVVFV=O
M9PO*5,C1V\2Q(7*JJERJ@L5503G"@<#L**\/_:1^"%O^T?X3U+PK=7$EI'?Q
MQ@7$:J[1R0RI/$Q1L!T$D:>8F4+IN59(V(=> _8V_96M_P!D'PT^@07TFHR3
M7DUY/</$L*F218X@(X@TA1!'#&"&DD+/O?<JLL:?5]%%%%%%%%%%%%%?('[=
M/[1?_#,7@:^UF!MNI3XLM,XSB\G5MDG,4L?[E%DN=LJB.7R?)+!I%KP_X-?L
M6>#OC+\.;"7Q%;2:GJWB#2[.]O=;NY//U87%Q;0NK0WLJM+&D $<<$0S#Y48
M25)O,F,OG_\ P3U_9(\>?LG>)=>T[4[N.;PDT8-F5D7;=W3-'Y=U';_.]LZ0
MJ\5TK,@=S$JFZCA2:/\ 6^BO+_@W\7M+^.^B0>(=%:1].NI+E())$,;2+;W$
MML9 A^94=HB\8<*^QEWI&^Y%_ '_ (+-?#1_!^J:-JDFJZI?MJDFIN+:\GC>
MULEA%F%CLH8XHEA0JX$A.]Y3&CR.\N]W_I.HKX0_;C_8<M_VT+?2U;5)-+N=
M+DN#'(+=;F-X[E8_,5H_,A;?NAB*.),*/,4QN75H_K_X>^"K?X:Z-I^AV;2/
M;:;9V]G"\I4R-';Q+$A<JJJ7*J"Q55!.<*!P.PHHHKQ_XE_!6Q^*&]Y[W6+*
MX:W:".;3M8O['RL[BLJPP3I;/*I<L'FBEW;55P\:A!_.E_P3TU'Q5^UGXJN]
M#USQCXL@MH-+FO$>SUJX20R)<6T0!,IF79MF8D!0<A?F !!^S_VO/A9\0/V+
MM'D\9^#O&OB"_M(?(MKZUUB>'4?*2>0K]I0W(\K_ %OV:%4CMFG7S)'\[RC(
MH^K_ /@GY^W&G[7>EW$.J"SM/$=E(YFL[<R*LMJ2OEW44<I9@@9O)E423%'5
M7<QBXACK]#Z**_FQ_P""S7PT?P?JFC:I)JNJ7[:I)J;BVO)XWM;)819A8[*&
M.*)84*N!(3O>4QH\CO+O=_Z3J_.#X=?\$Y].^'OQ0NOB2FK7$OG7%]=PZ>8$
M7R[B_1UF+W 8^9$/.G,<:Q1.N8@TK^6_G?H_1111111117Y8?\%'/AI-\/O!
MFJ>,="U[Q)IFHV<D4ABMM<OOLLS7=[;PL'@DFD6-(UD<PQVOV=$+8*LBHB^0
M?\$NO"]W^T+X5U'7/%&N^)+^Y35'LXD/B#5((XHX;>"7*BWNHF+NTY#F1G&(
MX]BH=Y?]KJ**************************************************
M*****************************^?_ -H_XIZY\%M#N=?TC2+?5[>PMYKF
M]ADU V4R0PA69X0;6>.7:GFR2*[PL%C C$TCA!X!^QE^V/KG[8,4VI0^';?3
M=%MK@VTUU)JQFF:81>:4AMEL4W[=\/F-+) H64-&961XQ]7_ !B\8:IX T:X
MU32K.SO9+2.2>:*\U :='Y$43R.PN&@GB5\JH'G>3" S.]Q&J<^ ?!#]J76?
MB/X.N/&FL^&+S3;/RUET^SM))=3U"_C/ >*UCM861)&*"!F.'0M<.8;4)/)X
M?^RM^W]J/[3OQ#U3PQ_8_P#9.FZ=I]U+Y=UO_M$W%O>PP?OURL<'R2XDMMDC
MQ3(1]H=>*^L/VF_VBT_9LT9]4.DZIJ\GESNL5A:R21Q+!$9&EO+@*8K6W!VA
MY'W. S.D,JQ2[/@#X%_\%&_&/[1.C:B/#/A>/4_$<=Y<^5:QS?9[.PT\Q1_8
MY;V[N71+FX>9I$%O UN]Q';SR!;8("_/_P##8WQUU3P5K.IS^"(]/N;6.Y?^
MU)&^PK9P0PI++*-,U!VGN71/,:.16,+/M3R93%)')X?_ ,$O_BKX[\#>#;VV
M\,>#O^$ALFUB>22[_MJTT_9,;:T5H?*G1G;:JH_F [3YFT#*&OM_]K__ (*
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M%:.00LS1G!\MDD;]+]6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"S,Q
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M\)_%SXU_$W3K3Q7I.B^%X=%O+>&]M](N+V[?5);=D#B-;M$2R26X7YX&D0)
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M/)INK^%_[,T6W\0#['J_]JVUS]L\N&\2'_1(U$L/FQ%IOG)\O;Y;98@U]?\
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MV&!9[B*.6WDM[A/-^U^5YLD3M+'$X965)?L]PA_3^BBOY@?^"*G_ "4/4O\
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MAJ5A;PP6TFG7.IP>7Y$TL\<JL]O+(LJO*2'5UQM4@!@2?7_^"U?_ "3S3?\
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MWT^?ROLD]K'?1N]O-<:AJ @,5XJD[[0_9(0Z(@<H\PR^Y0OW_P#\9"_]4_\
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M(WUBY5T=&!5D92596!# D$$&OZ#J_ '_ ((8_P#,W?\ <'_]OZ]__P""U?\
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MKRWO++6M0_M"Y-NT>R.[EM+5)%:-%1X976..>>*<?://FD>3!<*OY _L"_\
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M12A)$5U$D/A]98G 8$!XY$22-NJ.JNI#*"/V._:Q_P"2>>*_^Q?U;_TBFKX
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MH$"O;!XTGM4NKI;BXGMG"?.L;&,LOG2_-_\ P6K_ .2>:;_V,%M_Z17U??\
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M91_[C'_MA7[W:3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550 H
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MX9\,6]Q<:S/;G,-]?W7GV=I9'<(W>*)4GO$N(6N+29A'D!T@E'P!_P %SO\
MF4?^XQ_[85^_U?*'P)^/NE_M)GQ-X>O(8Y+O1-4U#2]2M)(";>6U-S<PVK8<
MR)*DT$12=6()F2;,*0M%O_%#_@H'^RC%^SMX^\-:K\/A]FO]>U#?8Z>J1"&V
MU*VGMC$8#*?*6*26>,B"4>3"RL PMV2&'W#_ (+*_"'5-.O=#^(6CK>!K*/[
M)=W<#A5LFBG$UA,I3$T3M+-.OG[BBNMN@,<KIYOV_P#LR?\ !2'P5\;M&2?5
MM3L]%U:VC@2^@OYH;*-YVB!DDLS+.XDM_,$BH"YF0*OFHF^-I.PT?]IW_A=/
MQ L?#O@J[M[W1=+MY[WQ'?Q)YUN_FPF*PLK:[3?$93*YN90NW*0%$G+175N?
MM^BOYT?^"FWPXN/V?/B;HGQ1@@DO+&YO+"XGC+LJK>:88<0&00E(4G@AC,.X
MS2,\=T^S9&JU^_W@#Q_I?Q3TNVUK1;F.\TZ\C$D$\9.UER0000&5U8%)(W"O
M&ZM&ZJZLH_&']M;23^UQ\:?#/P^@BCNM.T2-;K5QLN8S''<-'<7<4LT8^5'M
MHK1+>2/8!<72Q-.KL!%Z?_P6K_Y)YIO_ &,%M_Z17U??_P"R=_R3SPI_V+^D
M_P#I%#7T!17Y ?\ !:O_ ))YIO\ V,%M_P"D5]7VA^RWX_TNR^'/@Z0W,<BW
M.EZ58PB$F9I+I;9(Y(56(.Q>)HIC<8&+9()Y9C'%!,Z?EA^WU_R<+X"_[@'_
M *>;BOW^K\ ?^"&/_,W?]P?_ -OZ]_\ ^"U?_)/--_[&"V_](KZOO_\ 9._Y
M)YX4_P"Q?TG_ -(H:_)'_@M/^S]<:BFF>/;0221VT:Z9?H-S+%&9));68!8R
M$0R2313222 %Y+6-$W,Q/Z_?LZ_'G2_VDO#5EXBTN2,K/&HN8$D+M:7053-:
MR$I&V^-FP&*()4*3(#%(C'\P?^"L>IWOQAU3PI\+=$$<NHZG>?;I5:*<M"H#
MVUO,TD:LHMPK7LESM21XTMQ*0B#]YT'_  5R\ )X8^%&DZ=I%M(-.TC5-/C"
MH))5MK6*SNK:(R2,68(&:*(22,2SNBEB[C/V?^QE\5=#\1_#'0M0MK^W:TTS
M1[2VOYF<1K:S6-K&MRDYDV^5Y>TN6?:IB*S*3$Z.WXP?M>?'30_B3\=?"6LV
M,^-(T^XT>%M2FQ%9SK:ZM,T]S;SN0DMI&QDA-R"(C)!-M9HU61OW>^*O[1^A
M_#?P7?\ C>"YM]1TVTMWD@DMIA+#<S>9Y$4*30+,H\RX*P-(%=8F)9P%1L?B
MC\!OB=\'_ KQ^)HO&NJ>&-=U&..XU/3-$LKF+28KAXWW0+9W-AJ$4B0F614W
MR30K*7EMTMXS%%%](?!3XU_L_P#@KQ1)XD_X26XU;Q3J-PP_M?6(+O?%]H$<
M.Q&^Q6UE:Q*J[%DV1^1 \D/FI:_NU_8[2=6M]?MXKRSECGMIXTEAFB=7CDC=
M0R.CJ2K(RD,K*2&!!!(-?@C_ ,$,?^9N_P"X/_[?U[__ ,%J_P#DGFF_]C!;
M?^D5]7W_ /LG?\D\\*?]B_I/_I%#7T!17S!\//VE+/Q;X[\1^ I_DU+1_LUS
M;!8V"S6,UI9N[M)N93+'<7#*RD1 Q20;!(RS,OXX?\%;?V._#7PGLK+QGX>@
MCTUKJ\BT^ZT^WB6.U=C!-)'<1(FU8'"P%)41=DI99,1RB5I_H#_@J-I/B#4?
M@QX>EUJ*235K:\TJ7671$98K@V%Q%.\A@!A1#<2",,F(2\B(A^9 ?N_]C+XJ
MZ'XC^&.A:A;7]NUIIFCVEM?S,XC6UFL;6-;E)S)M\KR]I<L^U3$5F4F)T=OQ
M@_:\^.FA_$GXZ^$M9L9\:1I]QH\+:E-B*SG6UU:9I[FWG<A);2-C)";D$1&2
M";:S1JLC?I__ ,%"/AO%^UC\+YY_"[_VQ+:7$6H:?_9TT4Z7+6[O;W"JR[Q-
MLBDN2(H6$K3QK&NY_P!T_P H?\$ROV__  _IWAJ#P=XPU2.QOK"1XM/N+MG2
M"6SVM*B274CM%&\!#PHLAMXQ#]EAA$CA@/J_]HK]JK3OB=]C\ _#S7K>?Q)X
M@N(;?[9ITZ3_ -G6!\V2]O5F7_1VECA@D46ZSPW8\Q9HBKB(MX__ ,%J_P#D
MGFF_]C!;?^D5]7W_ /LG?\D\\*?]B_I/_I%#7Y _\W>?Y_Z%ROW^HKX _P""
MH_\ R2'Q#_W#O_3E:5S_ /P2?\4V?B#X4:7;6TF^73[B_MKI=K+Y<S74MT$R
MP ;,5Q"^Y"R_/MSO5E7P#_@J_J\OQ?O/"_PKT:+SM:U34([\L1+MMX56>UCD
MD"0OF([[F6:1"6MXK1W>,JZL/O\ _:%\+6?@;X6>(-*T^/R;*Q\+ZC;6T6YG
MV0PZ?)'&FYRSMM50-S%F.,DDY-?#_P#P14_Y)YJ7_8P7/_I%8U\X?\%5_'Z2
M_$OPIX>\17,G_"'QQZ??:A: R",K)?7$-U,P@ F=Q;QE$VEGC!D\D*\LF_\
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MT*QQNTL8;XP_X+G?\RC_ -QC_P!L*_?ZOP!_8%_Y.%\>_P#<?_\ 3S;U[_\
M\%J_^2>:;_V,%M_Z17U??_[)W_)//"G_ &+^D_\ I%#6!\//VE+/Q;X[\1^
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MGPQK?BCPW%=^5YMKI.K&"$^4I5<F2*69^6=QYLLFUI'";4(4?3_P4_9B\+_
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MJZ?907%[_;-O+:7MS>RJUPUG*FR2UCD@2#RHFY9O+"R.Y5FD;RH1%G_LS_\
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MOX?^/6EMHWB6QCO[%I$E$;ET9)(S\KQR1LDL;X+*6C92R,\9)1W5OSP\+?\
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M#\ K-M/\.PW%M9'&VVDOKRZACPSN?)CNIYD@W-([2>2$\QB&?<54CP#XL?\
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MZMX:MKRPC61Y3;IJNI/:O))'Y3/):R73V\C[ H#21L5*HP(9$*_1]%<?X_\
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MGF,0S[BJD> ?%C_@GUX+^,&L7OB.\_M"WU^[N+6XCU2TO9(+BS:TCMXHA:@
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MSXAMM.?_ (1B#3Y]2;<L?]HW$T%O'E&VRMY$$\DNU]F81Y.]"V)XV S^8'[
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M:./^E[Q3XLT[P-9R:AJMW;V-E#M\VYN9DAA3>P1=\DA5%W,RJN2,LP4<D"O
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MXATVP\X7FJZ/IIN-.@>#)F1[J22&,^6@69I$WP&&2.1964G'O_[/7[3OA?\
M:@TY]0\-7?G>3Y0NK:1#%<6KRH'"31M_P)1)&9()'CD6.63RV(^@**\?^,?Q
M^\+_ +/]FM]XGU.WT^)\^4LA+33;61&\F",/--L,B&3RD?RU8.^U,L/ +O\
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M6OO<3VRVGV2[;,UWJ$[0)YJ0-#\XEC.XOM7=\Q7#8\?_ ."YW_,H_P#<8_\
M;"OT?_:4_P""A'@;]EZ\_LO59[B\U0>69;&PB66:%)59E>5I'BA3A5/EF3S]
MLL4@B,3AZ]0_9G_:J\-?M7Z7)J?AZ60-!)Y=U9W"JEU;L2WEF6-'D79(JEHI
M$9T<!DW"6.5(_?\ 5M6M] MY;R\EC@MH(WEFFE=4CCC12SN[L0JHJ@LS,0%
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M)?01^;/I]U'Y5U%'YC1A\!GBD3(4LT$DHC$D2R&-Y%2ORP_X+G?\RC_W&/\
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M["L)F0&*7,@_=^9]/ZMJUOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B
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M$/PN([2^OY)[B>!%DCCENK-XC-+*8Y4+)=QW(AN8HQ$) LKNSO<R-7W_ /\
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M?SP_YN\_S_T+E?O]17\P/_!:O_DH>F_]B_;?^EM]7[_?LG?\D\\*?]B_I/\
MZ10U] 45\0?\%$?CI+\ OAUJ=]9S_9]2O=FGV#CS0PFN<B1HWA*M%+';K<30
MRLRJLL2?>8K&^?\ \$U_A"GP@^&6CH5C%SJD?]JW+QO(ZR->A7@)\S&UUMA;
MQ2*@"!XV(WDF1_G_ /X*^_ ;2_&?@B3Q:8XXM6T22V"W C)DFM;B=;=K5F#J
M-BR3K.C.)#&4D1 GVB5CZA^PMX_T[]M'X:V/_"5V%OJMQI5P;&Y^WVZ722W%
MK$OE70^T-.SRM;SQ^=,^UVG:XPJQL,_G!_P1A^%NC^/[S7;[5+?[3+I-QI%U
M9*\DGDQW!74$6<P!Q#++&"3!)*CO;L6>(QNQ8_2'_!:_P!I<OA72O$)MH_[6
MCU2*Q6[ (D-K);W4S0L00'021JZ;PQC)DV%?-EW_ '?^Q#\-[/PGX-TS6=]Q
M>:OK^GZ?J&J:E>3-<7EU-+;1LBR3OES% K>3;Q9VQQC^*1Y9)/R@^&_A:S^#
M_P"U4^C>'X_[/TV7S@]I;LR0LL^B_;7C* [?*^T8F2''E1LD>Q$6.,+^]WC7
MX>Z-\2K=;/7-/L]2MDD$J0WEO%<1K(%90X2564.%9E# 9 9AG!.?YX?^",OP
MATOXAZIK.J:FLD[:-)ID]G;,Y^RBZ<7@CNY(?NR7%NJN+5VR(#-*ZKYI1X_T
M/_X*E_LQ:=\7_!=[XDAM-^OZ%;^?!<1ND;-9QR![J*8O@2Q1Q&:XC3/F+*I$
M1_>RQS:'_!)GXH7'Q'^&5M;W7F-)HUY<::)9)FE:6-!'<18W &-(H[A+>./+
M!4A7:54A$Y_]EKX&)_P3QM_$_B'Q[XDLY8]7O(V2[E>023+;+=3"1S*3++>W
M EE=K6(3OF,[);AG.S\X/V@_BWX?^.'QX\&ZYX:BD^PSWF@J;U[1[5;^2/4F
MC:XC\Q4EF1 JV9ED53OM7B&4B0G]O_VU/A[HWC'P+X@O-3T^SO+FPT/5I;*:
MXMXII+:3[([;X'D5FB?=&C;HRIRB'.5&/S@_X(P_"'2]4T&[\572R3ZC::I=
M6ED)7+06:O:VC3S6T1^6.XN%9(IY^7:&&.)2B&42>7_\%H_"UGX$USPSXFTJ
M/[%K5W]L,][;LT4SM8FS-K(60C$L7F,$F&)=HC4N5BB"?N]\5?AIIWQDT._\
M/:JF^RU"W>"7"HS)N'RRQ^8KHLL3;987*MY<J(X&5%?BC_P2M\6ZI\!?&/B'
MX3:^8XI(Y);JW#,(@]U!Y<<OV=98HYKA+JW\JYB8D!;>V\Y8MLLCK]W_ /!0
M3_BY&CZ9\-K3_D)>,-0AMXW_ .?:SL)([Z^O<-MCE\A(D'V<RPR2^9F,LR%#
M]WZ3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550 H    K0HK^<']@7
M]M^S_92O->\(?$5[B"XDUBXN)K[8UXT=\%:*^%Y+'++)+N>WA6)X(YBTKRO)
M)Y9#K^Q_A+X5:-XG\=1?$WP_=6=U;7VAW.F7<UK+%)'<R1W=LUO,CPH5E=5A
MGMYY'E8J(K:)4 C?'YP?\%:?B\^HZ]X9^'H;5#IU[)#=ZO::<D;3WL$MTL-M
M#;@Y:6X5H;AHX'40M,ULY$CHOE?7^D_MR6^@6\5G9_#WQY!;01I%##%X=5(X
MXT4*B(BW 5450%55 "@   "OS@_X)\^$O%_PH^+-U]@\.:YI/@_69-0C,>H6
M-[%';VL8FN; R.Y,0N(RB6ZR2O,<33(K,\N^OH#P+XUM_P!K/]HN\BOUD;3O
M!5G>+IEK(%,9O+6XAM9[B2)VF3?YTSR0RQ>3)BVL7;:\)4_I]^TC\$+?]H_P
MGJ7A6ZN)+2._CC N(U5VCDAE2>)BC8#H)(T\Q,H73<JR1L0Z_(&C_LK6_P"R
M#\&/%N@07TFHR3:7KEY/</$L*F22P:(".(-(401PQ@AI)"S[WW*K+&GE_P#P
M14_Y)YJ7_8P7/_I%8T?\%J_^2>:;_P!C!;?^D5]7WA^S)I-OK_PT\-6=Y%'/
M;3^&],BFAE17CDC>QB5T=&!5D92596!# D$$&OQ U/X*>&M6_:A'AJ32[,:(
M)(I!IT<*Q6NZ+1%NU!AC"H4,RB22,@I*2RR*ZNZM_0=XC^$_A[QA>#4-2TK3
M[R]%O):BYN+2&686\JR)) )'1G\IUEE5X\[&6612"'8'\(?"WA/3O W[6,>G
MZ5:6]C90[O*MK:%(84W^'B[;(XPJ+N9F9L 99BQY)-?T/5^ /_!#'_F;O^X/
M_P"W]?9__!5/X>Z-J/PUUK7)]/LY-6MH]/B@OWMXFNHHSJ-N"D<Y4RHA$D@*
MJP!$C\?,V>P_X)<?\DA\/?\ <1_].5W7P!^W'\9XO'GQHT;PGJ%IK&K:!H/D
M7-UHFGVL5R]Y?>1)>ATMF)%S%Y3V\4ZS8,< O!&$\QI)/M_Q9^VC9^.=.N]*
MU#X??$":ROK>:VN8O["9-\,R&.1-R72NNY6(W*589R"#@U\8?\$@?#GCKX6:
MSJ^AZYH^J:?HEU9_;$>^L[N"-;R&6*("$RA(0\L4K&4!3)(+>'Y@L1!S_CW^
MT;>?L??M"7GB#7XKBXT6_P!'AMX4C*SS+8M#&0;1&GC2'_B86LF])"H*M<2"
M,M*DA_0_Q*G@[]N^UT36?"^I6=[=^'=<TW4XI ?+GACBNQ]HAGCDA-U"D\4,
MK11LL(GF@MY"YA3=7W?17Y ?\%J_^2>:;_V,%M_Z17U?8'[#'PJT/X;^ =!G
MTBPM[2XU'1]-N;V>-!YUS-+ )V>:4YDDP\TIC5V*Q*YCC"1@*/Q@_;L^$MG^
MP=\2O#WC;PQ%]GT^[N#>?V?!.T&)K26,WMO&5CQ!:7$4R((P95'F7$8B6W$4
M-?N?^UG^S];_ +37@[4?#DHC%S+'YMA-)M @O(LM ^\QRM&A;]U.T:F0V\DR
M*07K\\/^".WQCO+O1]5\ ZNOD7OA^X,EO;S%8KA89Y)/M,)MRB2_Z/<AFED<
MNRO=I"PC"1JWT?\ M:Z3;_'[QCX2^'@BCG6UO$\3ZL9462./3['S+>*%X90J
M3I>32M;,$=WA"F1X)(FR/T/HKC_B%X;N/&.C:AIEG=R6%S>6=Q;PWL6[S+:2
M:)HTG3:\;;XV82+M=#E1AU/(_/#]F/PQH_\ P3)\#/9>/-=T^&XO-0N+W$1D
M?.Y;:V\NVCV?:;K8$BDE:. >5YI#+Y:>:_YX?!OQEI?Q#_:A@U?1;:2UTZ]D
MN9X!);&U:99-$E8W8B(5MEVQ-W&[A7F2=9G4/(P'[/\ [:GP]T;QCX%\07FI
MZ?9WES8:'JTME-<6\4TEM)]D=M\#R*S1/NC1MT94Y1#G*C'YP?\ !&'X0Z7J
MF@W?BJZ62?4;35+JTLA*Y:"S5[6T:>:VB/RQW%PK)%//R[0PQQ*40RB3R_\
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M"F-Y8TCN!&PRB3)RZE7;\T/^"YW_ #*/_<8_]L*_?ZOP!_X(8_\ ,W?]P?\
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MRP0Q>;LE0_TG:3I-OH%O%9V<4<%M!&D4,,2*D<<:*%1$10%5%4!550 H
MK0HK\ ?^"YW_ #*/_<8_]L*_?ZOPQ_:*\,)\=?VE_#6G:?+(6T&SL+G472WD
MD6W:RFGU)$D)V*$E66UB$P8HCW*+\TH,1/\ @N#X*N+_ $;PWKBM&+:SO+RS
MD0EO,,E[%'+&5&W:4"V<H<E@06CPK L5_2_]D?\ :7T[]J#PO9:O!-;_ -I?
M9X_[3LXG3?:W&7C?=")99(HI7BD>U\UM\D&UC\VX#K_C%\;[?X2W&BV MY+W
M4==U2WL+6UA9?,$;,&N[QU^9_L]I"&EF=$8*3$KM$DAE3W"BOYX?^"Q'AS7/
MA]XR\-^/=//EQ06\-O;7"QF3[/?6-S+=QF4/&T/SB4-"C%C+Y$^8]D9+?O\
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M-2_[&"Y_](K&J'_!:_5K>'P+I5FTL8N9=<BECA+J)'CBM+I9'5,[F1&EB5V
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MSCOQOE?$C%H9K:(,Z[8 L91_@#X,?\$[?%'P/\6W?C2Q\96]QJFH?:OMPN=
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MH_X6!_PLG_A,K?\ MW[1YV/[ 'V?9Y/V;[/Y?]H;O*^S_P"CYW^?L^?SO/\
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M/MKRR>ZEDM_,8)<+YCV<L-O(.;2.7[3,]J(;F2X\RX:"#0_X<8_]3=_Y1_\
M[OKZ/_8ET7QK^S=XZO/AAXBU>/6=)70_[6TR0M,\EO!%=I801+YO,"-&I+VB
MM-#"5C\F0;IC+^M]>'_M(_!"W_:/\)ZEX5NKB2TCOXXP+B-5=HY(94GB8HV
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MVQ-1M[G5/%%O:65A]H6QM(-&)\M9W#,TLK:AOEE*I$CL!'$?*#)!$6?=]O\
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MU]JMT+SS;+FX=8%FEN1)(TQ69XSV'[(?[.6N?LO:/'X=N==M]7TBW\]K6/\
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M4444444444444444444444444444444444444445_,#^S3_R=#=?]C!XG_\
M16HU_3]7A_Q@^&6E_&HV-A//&M]HNJ:3K<(#%I(6MKEF1FB61#LN(XKNV1Y
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M>:E_V,%S_P"D5C7ZWZMJUOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B
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M4KOR_LUG/=PQ7$WFN8X_*A=Q(^]P43:IW."HRP(KT"O'_P#AH7P;_:/]D?\
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M))(]I$SN[L2S.S$LS,26))))-?CC^WU_R<+X"_[@'_IYN*_;[QU\6/#WPO\
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M?BQX>^*'G?V#JNGZG]GV>?\ 8KN&Y\KS-VSS/)=]F[8VW=C=M;&<''H%>?\
MCKXL>'OA?Y/]O:KI^F?:-_D?;;N&V\WR]N_R_.=-^W>F[;G;N7.,C/0>%O%F
MG>.;./4-*N[>^LIMWE7-M,DT+[&*-LDC+(VUE96P3AE*GD$5T%%?S _M+?\
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MT****\/U;]IOP+H%Q+9WGB70X+F"1XIH9=3M$DCD1BKHZ-*&5U8%65@"I!!
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M;OSKNYE@G$MU<$9C@)\F&WA:1!"\DKS'X_\ B7\,KW]@KXW:58_#V>/=K4<
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M.R212MY.)&D'ERJDR? '_!$>YT:_T;7(ELHQK=G>(TE^8(O,-G>Q(([=9_\
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M7Q39^.?A9X@U73Y/.LK[POJ-S;2[63?#-I\DD;[7"NNY6!VL%89P0#D5\/\
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M^+88]7L;.SCNK!+N".XC6U@FC1[:;S2PD2*1[=[-3&QB D7S%2*WC3P_PM\
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M*]9HI)IXG.\S)YB_:&EDDF,LNQT^?_\ @BI_R3S4O^Q@N?\ TBL:\0_X*_\
M[.7ACP3H,?B^RM)%UW4M<ABN[R2[NIVDC>UNG*!)II(D0&&(1K&BB)$6- L8
MVU]G_L4_L9^!/!^B^%_&ECI?E:^^CV=RUW]KNVS-=V*K._E/.T/SB60;0FU=
MWRA<+CX _P""DW]H_P#"]?!O]D?9_P"TOL^B_8_M6_[/]H_M:Z\GS_+_ 'GE
M;]OF;/GV9V_-BON_Q_\ \$O/"?Q3TNY?6KF\O/%MY&6G\222R^:UUD$2"R$H
MM%MUP(8[5$41VJK"DJR*LX^</^")?Q+U'Q!H>N^'KE_,LM*N+2>TW,[-']N$
M_FQ+N8HL0:W$JHBK^]EG=BQD^7]OJ\/^-_[.7AC]HZWM[/Q1:27MM:R-+%"+
MNZMXQ(R[=[);S1+(X7*HT@8QAY A42/N_GQ_X)2?LN>$/VE/^$C_ .$KT_[?
M]@_LW[-_I-S!Y?G_ &OS?^/>6+=N\J/[^[&WC&3G]7_^"C?A:S\#?!#5M*T^
M/R;*QM](MK:+<S[(8;^SCC3<Y9VVJH&YBS'&22<FOF#]@K]E2#]HWX<:-)XX
ME^W>'K;[:NCZ-;RW%M$CF]N#/?7LD,D<DUV7,L%N@8006N2%::XE*?-^O_#)
M/V"OC_X?L?"L\G]G:U)9@VLS2%8K74[N2SEM699 TZ1-'Y]NTN2KK 9!,\)D
ME_:_]L;]H7_AF#P7?^)(DMYKV+RH;*WN)?+6:XFD5%  (>7RU+W#Q1E7>*&0
M!XQF1/@#]E'3?A9J&ACQ)\1-:\+ZWXNU_9?:E-JM[I]PT&\$P6L<-P%%KY,1
M1)841=DH:$,T$-ND?P_XN^,.A_L"?%6*]^'>IV][X0U&WLI-2L+&X%_"L(=X
M9X1(UU)YEVGEO=6\CR1-$UP(2/L[2+-_3]17\L7[86HWFD?M(&YT^U^W7L.L
M>'9+:T\U8?M$R6]@T</FN"D7F, GF,"J;MQ& :_9[_AH?XO?]$P_\NG3?_C=
M>/\ P$^-7C3XG_&NZT_Q?I']@KIWA>Y:QT[S([G"W-WIQEG^V1@)<^8T03,>
M(HO)\G:)DG=_T/\ B]\-'^+6EMI::KJFCJ\B.]SI4\=O=%4.?+$SQ2M&A;:6
M,6QV"["_E-(C_P \/_!*#X17'QLM_$VDRZC)9Z)))I)U>U@1EN-0M]M_MM!=
MK*K6UN[<70C1IKB']RLT"M(7[#_@I=^Q7X<_99T[2?&'@HW&DRIJ$-HUO'//
M)B;9-<PW<,\LKS0RQF J0K%6_=NGE/&YF_0_X>_LPVO[9&C:?XP^*8CU:[U&
MSM[G3]/M)KNTT_3+6>)9%2%(YUEDN)P5DO)IGD.\1P1XAMT:3X _9(\-W'[(
M/[0=W\/]+NY+K2;V.2&7S]RL8Q8?VG;NR1NL37$)_<><4PR27!2*+SMJ?J_^
MWI\-'^(/@76)QJNJ:='INEZG=M!83QP1WC1VDA6&\)B>62WP&5X$>-) [;PS
M+$T?Y8?\$O\ ]GV7]H;P;>V'B"YW>#H=8G>32;=Y89;^^-M:8-[/&R/]DMU$
M4EO!"RF6Z8RS-MMX4?C_ -OG]DA/V&;_ $OXA?#Z[DTN#[9';):^9)));71A
MD</%)+YAEMYHXI5N(;AG&69/WL$YB@_=[]FOXO)\>O!VC^)5:-I+^SC>X$22
M1QI=)^[NHT67+A(YTEC4DL&"A@[J0[?CC_P0Q_YF[_N#_P#M_7Z/_P#!0C]I
M2\_9>\#3ZKI?&J7EQ%86,IC65(9I5>1I75F4?)%%*8\B5?/\H/$\1<5Q_P"R
MU^QCX?B\-6.K>,]-CUSQ1JEG;7&J7FMP/=W0D92\<#)?-.87MXW6U?8(C(($
M,B JJI^>'[;WP<O/^">WBC3_ (E_#QOL-E?W$EO>6.%^QI,X\TVWE!U=K2Z6
M.1_(50MK)!OBEA)M4@^O_P!LWX%Z'^WC\.H?&WAR#SM:AT\7FFRQX:>6%?WD
M^G3+;B?S95_?)' I+17X,:R(KW DX#_@C)?>%]9\+WBV6G6\'B33[AXM0O-A
M>XGM[LB2W;SF0>7$?),7V6-V0/:_:&57GR?3_P#@I!\'=&^-]_X.\.&WC.MZ
MQKD4;7$4<27G]CV4,\NH[+J1"JI"LZS+ ['?(04AE8,*^@/VA_B-I?[!OPWF
MN= L[.&/3HXK72K"20QQR3S2!1W\V=U#27<ZAO.G$<SM*K,\R_&'[*.F_"S4
M-#'B3XB:UX7UOQ=K^R^U*;5;W3[AH-X)@M8X;@*+7R8BB2PHB[)0T(9H(;=(
M_A_Q=\8=#_8$^*L5[\.]3M[WPAJ-O92:E86-P+^%80[PSPB1KJ3S+M/+>ZMY
M'DB:)K@0D?9VD6;]?_\ @HS^U=>?LJ>$DN='-O\ VUJ5Q]DM/-=2T*^6[RW:
M0,#YWE81 &'E)+/"TF]?W,OA_P (?AC\#/#/AI=.\2ZOX3UK6;V-Y=8U.[U2
MRNKJ>\N5_P!*>&\D=+B--Y;R&C,4B@"8G[2TDK_$'[-OQSM_V3?C+<^#?#FH
MQZIX(UK5(888[9UN8(Y+Y(_LKV\AN'&^WDECM+F;S',T,3L\331PK%_0=_PJ
MW1_^$A_X2O[/_P 3K^S_ .S?M/F2?\>?G?:/*\K?Y7^M^??L\S^'?MXK\D?V
M]_BQI</Q>\%>&O%Z1R^$H8TOKF"1RL#W5W)<VL$UX))D@>WMGABD;S!A87NU
M831RF(^G_MK_ +"?A+XP^!IM5\%:5I]OJEG;_;].ETJ".)+Z$JLCQ;;2)A=>
M=$";3:"QG\H)*D4LPD_5^BBOS _X*@_M*:Y\%M#TW0/"WVA==\27$MM!-;QE
MYDAC$:RI;%&\Q;N1YX(X&1'8*TI0QSB%Q] ?#3]AOP-X'TY(-0T?3]9U*3;+
MJ&IZC:K>7%Y>,BBXN6>\:YDC\YU,IB60QH[L0-S,S?D!\6=(O/\ @E!\2K+5
M/#TMP?!VO8:YLF*S9ABE NK5%:97DEMEE26RN)3$P\X0/+,HNC-]O_\ !2G]
MF+P]\;/ U]XTT>TMYM:L[>/48=0M'A3[99JL7G-/*/ENHDM$,L!W&0>4BPMM
M=XI3_@DQ9>'O&/PO,$>FV_VC[1>:=K,DEK#_ *?\[SQK,PW-<1+;WBP@3_=_
M>1A?+P6^$/\ @H]\%/#7[-GQ&\+>)8M+LX?#EY);R7VFVL*[9FTZYB:['V1P
MEL$EMY8(UC4JDKK*TBJ7:23^A[2=)T;7]&BL[.*SGT2>S2*&&)(GLY+-X@J(
MB*#"UNT1"JJ@QM&0 "IK\X/V,O@9X5^(=_K_ ,2M%TZ/2EU*\NK+PY/:I;B.
MVT^VA2Q-_9VSVX2WN+F:.X=UN86=1^Z,9BDF:Y_-#_A6&N>!OVC?^$?\-ZS<
M3:HO[N'6-:<ZA<(LVB;YII,*@GEAB>3[)&X6(O'!'(?*WFOO#]K?_@F;X(L?
M!6KZSIPO(==TZSN-2EU2>[GNY[Z2VA>:?[6LTGE%[DAF>2)8BDQ60 QAX)/3
M_P#@D9\2]1^(GPU6#4'\W^R-0GTZVD+.SFW2*">-79V;/E_:##&%V(D$<484
M;"6_3^OG#]K/]H&W_9E\':CXCE,9N8H_*L(9-I$]Y+E8$V&2)I$#?O9UC82"
MWCF=02E?)_['_P"Q_H?C30[7QSXYM;?Q%XI\16XO[JZOP+N%8;L1RVT45M+&
MMO%Y<*PK\L1:%C+#%+]E\N,> )^PUXT^$GQM@\1^!;>WTSPG<W%O+=/#<QI"
MEHRH=0LY+5R9#YKQR-!'%$]O"TMLR/;F'-O[_P#\%0?VE-<^"VAZ;H'A;[0N
MN^)+B6V@FMXR\R0QB-94MBC>8MW(\\$<#(CL%:4H8YQ"X^@/AI^PWX&\#Z<D
M&H:/I^LZE)MEU#4]1M5O+B\O&11<7+/>-<R1^<ZF4Q+(8T=V(&YF9OR ^+.D
M7G_!*#XE66J>'I;@^#M>PUS9,5FS#%*!=6J*TRO)+;+*DME<2F)AYP@>691=
M&;W#_@L;X \-:EX0TOQCIUM9OJ-YJEM&-3M@NZZM9[*=U+RQG;<(5MX##(_F
M%$7$;*CN&_4[]D[_ ))YX4_[%_2?_2*&OQ!_:X^%6A_";]H#P7!H%A;Z=;W=
MQH%S-!;((H3-_:CP%TB7$<>4AC#+&J*S R$&1W9OUO\ V]/AH_Q!\"ZQ.-5U
M33H]-TO4[MH+">.".\:.TD*PWA,3RR6^ RO CQI(';>&98FC_+#_ ()?_L^R
M_M#>#;VP\07.[P=#K$[R:3;O+#+?WQMK3!O9XV1_LENHBDMX(64RW3&69MMO
M"C^7_MX? JP_X)\>,?#?BSP*\EJL\DLT=C)),\<4ECY D3SO-$\EO=)/LGA=
M\X,RB4Q2K'%_0]\;_&MQ\-?"NMZY9K&]SINEWUY"DH8QM);V\DJ!PK*Q0LH#
M!64D9PP/(_*'_@F+X?\ AS\<_";)K&G:7JGBT7E]/JKZI%;7M_<L\JN+M?M#
M33_9]DT$3/B-#<B8E3([22?3_P"Q[^RJG[+'C'QE:Z=%(FA:C'HUUIA9I) B
M_P"GK/;&5T4,\,F<+NE=;>2V:61I)"3\H?M%_'/3OVD?B@WPWU[5]/TKP)HF
M+C5F?4DM?[5N(DB<6C3G"CRKB1(GM%='7R+J8RBXBMUM]#]L[X;? SQ]X.U*
M;0K[PG8ZW8V<]QI[Z;=64<DDD>V9H/L]K/$MP\ZQ?9X_-64PF4O&A8E6]?\
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M;7"M\F[&QE9O7_\ @BI_R3S4O^Q@N?\ TBL:/^"U?_)/--_[&"V_](KZOO\
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M(-;TN.UTC0]-UN_DN(],-OI]M#=2-%;R27!B:*(.J+"'$LF50!UB9MTT:/\
M1]%?@#^WU_R<+X"_[@'_ *>;BOW^K^;']H2YT;P3^TV+SQC91RZ%=R62L+V"
M)K62.?2X[*.X<7.V%K>&XRTLI)$1@E(S)%MK]SO^&3OAY_T*GA__ ,%-E_\
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M[OQ5\6^+UYLM$M[?PK82Q_(LKQ/]LU-9HY,RF6"Y:...51% \3'8)B#(/?\
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M#XFR?$BU\(1O))JE_?&QDU;3ROEWYF$L(F6Y4[UCG=8Y=F X61H64&,_J?\
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M5+;Q#X8N/L6L_85^UP:AIDGV9K=Y5W2Q?:P[1%;AW=HB\J^4%2"4R?)]'_\
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MEQKJZAY4;3QR/:V;-:"62&:'4I8FM?*>.63,<H24R&.,F*9'@?\ 0_\ ;/\
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M ADV0;G6;U#]O7X%_%7X_P#A[3[W5(-][-K%M#8^&](WS6]G!<0W#-<ZG<L
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M!&T23[VF(=84C+MZ!_P5*^!>N?'GP"MMX?@^UW>G:A%J#VRY\Z:&*"XB=8$
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ME_B=_P +O_X6C_PAUQ_9OVC;]D_M72OM'V?[!_9WF_\ 'WY?F[/W_D[MF_\
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M\4LHCR8E\_RB\J1!S7Q!^S%^T+\9O NG6GP^NO ]Q/J%GOT^SUB[$UIIUM#
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M\NUG#2:'[._[-VJ?$#XGZK\8/$>FR:1'<1QIHFF7,@:\539PVWVRY6%]D#M
MKQFTE\QXY)I5<(UO%+-X!^W!^SKX\^&'Q(@^+7@"RDU.01PO=0JJW,D<Z1K8
MM&+156:2WGMRBDP&6:,_:92]NJQ./I_P5\3/BE^UW;M:_P!BR> ='\PP:A>7
M4L[:Q+&RJY&E));6ZV[[087NIT<)YXEM]T]LZU\@?\$L/V??BE\(+BZO9K"S
MTG1-3DM#>_VK%/\ VA)':M=+MM+:.6)H7+.59[P( DD4\4<ZJ4?ZO_X*,_L$
M_P##5%FFNZ(VSQ-I]OY4,;R;8;VW5GD%L2QV12AG=H)?E0L[13'8R36_QA\(
M?VBOVE_"+KX7?PU)JMS#(\*7FJV$RJ%@CV[3J*3VMI,G[IF6XEDE>X=\B>8O
M&*_4_P#9*^ >N?":+5-9\87UOJGBS7;B&34;RV0QPF&TB%O9PHH2&,^6@=VD
M6"!F:4HPD$22-^<'[4WP7^)WQF^)VB^.=*\'7"V6A?V;Y4%SJNE1S7/V.Z>\
M;?Y=W,D&YI&B7!FPJB4\L8D_7[Q'\0]:T_0QJ5CX<U"ZU)_,5-):YTZ&9& D
MV-/.;Q[9(F*)EH9+F5%E5O(9ED1/RA_X)F? ;XA?LG:CJEMXA\,7'V+6?L*_
M:X-0TR3[,UN\J[I8OM8=HBMP[NT1>5?*"I!*9/D_;ZOG#]KGX(7'[1W@C5O"
M]G<1VMS>QPF&656:,26\\5PBOM^94=HA&SJ',88N(Y"NQOR0_8K^)?QF^!5F
M?AT?!MQ<;+B>+3K^]CFM;'3V9I9)GN+F.%XKNT$I:=#%*LLH+Q0S3>;;I'Q_
MC7X9_$WX*_'=?%[:'>>+))) \-S9VIL;.9;JR:Q2,RK]KBLTMBWE$W4A<QP+
M/*X6;SC]W_M>>!?BAJ?@WPTFBS?;O&UMX@6]DN-.1+:W@S;:B[1J9V$8M(DD
M6R#79'VM-JS*TMP8V[#3/VXO$$J&QNOAUXLCUWS)8!!';))IIN!(T<0.JL8X
MA;L0ADNO*,,:LSKYL:AW/^"<7['UQ^R?X:G.K^7_ &[J\D<]ZL;,RP1QJ1!:
ME@[12/$7E>26-5!>9HP\T<44K?H?11111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M17XX_P#!:_5K>'P+I5FTL8N9=<BECA+J)'CBM+I9'5,[F1&EB5V (4R1@D%U
MS]__ +'>K6^M?#GPK+:RQS1KH>G1%XW5U$D-M'%*A*D@/'(CQR+U1U9& 92!
M]'T44445\(?%[_@HWX#^!GBQO".MS7D-S#&CW5VEJTEK;-)%YT<<A0F=G9#&
M08(9D!F0,ZE9?+/V?])N/C/XUU+XHR126^DS:7!H_AT2(T,MWIZS&ZGOIX'#
M.J33X-BQ,+O:_/);+OCD;[OHHHHHHKXP\5^ -4_:5\0>'M2O;:33O"^@WDFI
MK;7@"7FHW\: :=<"&,^;:6\(D>8+<RQW,DA:WN=-C"J]?9]%%%%%%%%%%%%%
M%%%%%%%%%?GA_P %4]6M].^$FM13RQQR7,FGQ0([JK2R"^MY2D8)!=Q'')(5
M7)"1N^-JL0?\$K-6M]1^$FBQ02QR26TFH13HCJS12&^N)0D@!)1S')'(%;!*
M2(^-K*3^A]?GA_P53U:WT[X2:U%/+'')<R:?% CNJM+(+ZWE*1@D%W$<<DA5
M<D)&[XVJQ!_P2LU:WU'X2:+%!+'));2:A%.B.K-%(;ZXE"2 $E',<D<@5L$I
M(CXVLI/Z'T44444444444444444444444444444444444444444444444444
M4444444444444444444444444444444444444444444444444445\X?MB:M;
MZ+\.?%4MU+'#&VAZC$'D=44R36TD42 L0"\DCI'&O5W944%F /P!_P $4-6M
MYO NJV:RQFYBUR662$.ID2.6TM5C=DSN5':*548@!C'( 24;'['444445\H?
MM4_MD^&OV0;>QGU]+R:349)4MX+.%9)"L*J99"99(8E1#)$I!?>QD7:C*LC)
M\_ZAX\L/V]_$'AU?"KR7/A7PYJB:QJ>JM!-:AM0M4;[!8VIN$5I7W2--?+Y(
M1+=H=MS'+(J/^E]%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%<?
MXU\6/X0MUEAL;S49Y)!'%:V:1F1VVLY)DGDAMX45$9C)<30H2%B5FGEABD\0
M_9V^"FH_#Z\U_P 0^()+>;7_ !'J'VBX-LSO#;V=LODZ?9([1P";R(L[KCR(
M))6D(<2;%D;Z?HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHKQ_P 4_L]>#?'-Y)J&J^']'OKV;;YMS<Z=;33/L4(N^22-G;:JJJY)
MPJA1P *Z#P+\)_#WPO\ ._L'2M/TS[1L\_[%:0VWF^7NV>9Y*)OV[VV[L[=S
M8QDY] HHHHHKS_7_ (3^'O%>HV^KZAI6GW>I6GE_9KR>TAEN(?*<R1^5,Z&1
M-CDNFUAM<EAAB37H%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%>7^-?@AX5^)5
MPMYKFB:7J5RD8B2:\L;>XD6,,S! \L;,$#,S!0< LQQDG)X*^"'A7X:W#7FA
MZ)I>FW+QF)YK.QM[>1HRRL4+Q1JQ0LJL5)P2JG&0,>H5Y?XU^"'A7XE7"WFN
M:)I>I7*1B))KRQM[B18PS,$#RQLP0,S,%!P"S'&2<G@KX(>%?AK<->:'HFEZ
M;<O&8GFL[&WMY&C+*Q0O%&K%"RJQ4G!*J<9 QZA111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111111117G_ (Z^$_A[XH>3_;VE:?J?V??Y'VVTAN?*\S;O
M\OSD?9NV)NVXW;5SG QS_A;]GKP;X&O(]0TKP_H]C>P[O*N;;3K:&9-ZE&V2
M1QJZ[E9E;!&58J>"17L%%%%%%<?XU^'NC?$JW6SUS3[/4K9)!*D-Y;Q7$:R!
M64.$E5E#A690P&0&89P3GH-)TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ
M JJH 4    5H444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444445X_P"/_C]X7^%^HV&D:OJ=O;ZEJ=Q;V]G9Y,EQ*]R[1PMY,8>1
M(F=&3SW58%<;6D#$ ^P45\_Z_P#M3^"_"WBBW\%WFKV\6OW/EB.T(D/S2@M%
M&\H0PQ2R  QPR.DLF^+:C>=%O^@*\?\ AI\?O"_QDO-0L?#NIV^I2Z7]G^UM
M;$R0I]I5GBV3J/)ER$<-Y+R>6RE'VN-M>P45\_Z!^U/X+\4^*+CP79:O;RZ_
M;>8)+0"0?-$ TL:2E!#++&"3)#&[RQ[)=R+Y,NSZ HKR_P"+WQH\/_ 72VUG
MQ+?1V%BLB1"1P[L\DA^5(XXU>61\!F*QJQ5%>0@(CLO0> /'^E_%/2[;6M%N
M8[S3KR,203QD[67)!!! 975@4DC<*\;JT;JKJRCL*******************Y
M_P 4^+-.\#6<FH:K=V]C90[?-N;F9(84WL$7?)(51=S,JKDC+,%') H\4^+-
M.\#6<FH:K=V]C90[?-N;F9(84WL$7?)(51=S,JKDC+,%') KH***\?\ C'\?
MO"_[/]FM]XGU.WT^)\^4LA+33;61&\F",/--L,B&3RD?RU8.^U,L/8******
M************^?\ XL_M3^"_@7J-EI7B35[>PO=0P;>*02-\I<1B29D1DMXB
MQ($UP8HCLD(?$4A3Z HHHHHHKG]?\6:=X4^S_P!H7=O:?:[B.UMO/F2+SKB7
M/EP1;R-\KX.R-<NV#@'!HU_Q9IWA3[/_ &A=V]I]KN([6V\^9(O.N)<^7!%O
M(WRO@[(UR[8. <&N@HHHHHHHHHHHKG_%/BS3O UG)J&JW=O8V4.WS;FYF2&%
M-[!%WR2%47<S*JY(RS!1R0*^8/AI^WQ\,_B[J*:5I&OV[WLNT113Q7%IYK,Z
MQK'$UW%"DDK,ZA(4+2OR50A6([_X3?M3^"_CIJ-[I7AO5[>_O=/R;B*,2+\H
M<QF2%G14N(@P ,UN98AOC)?$L9?Z HHHHHHHHHHHHHHHHHHHHHHKY_\ BS^U
M/X+^!>HV6E>)-7M["]U#!MXI!(WREQ&))F1&2WB+$@37!BB.R0A\12%/H"BB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOYL?VI?@WHGP5^/O@RUT."2&.]O-%
MOKHRW-Q=2374VL2K+,\MU+-*SN(UW9;!(+8W,Q/])U%?&'C+]@WP=XZ\>6WQ
M#NUO/[6MY+:8PI<;;66XM%"V\\B;#*'C"0X6.2.%C"F^-]TWF^__ !>^#>B?
M'?2VT7Q#!)=:<\B220)<W%NLC1G*"0VTL32(&PXC<LF]4DV[XT9?Q1_X(8_\
MS=_W!_\ V_K]_J*^,/!O[!O@[P+X\N?B':+>?VM<27,PA>XW6L5Q=J5N)XTV
M"4O('FRLDDD*F9]D:;8?*^SZ^?\ X:_M"Z=\5/%'B/PUIZ;_ /A&_L$=S="5
M'22XNA.TD*!"V/(\D1R%F#^>98C&GDAI#]I3]FO0_P!JG0_[ U_[0MNMQ'<P
MS6T@CFBFC#*'0LKQG*/)&RR(Z[7) $@1U[#X+_"'2_@+X?L?#6C+(MC81E(S
M*YDD=G=I))';@%Y)'>1@H5%+%41$"HOJ%%%%%%%%%%%%%%%%%%%?D!_P6K_Y
M)YIO_8P6W_I%?5X!^WU_R;UX"_[@'_IFN*_7[]D[_DGGA3_L7])_](H:^@**
M_FQ_X+-?!O1/A]JFC:UIT$B:CK<FIR:C/)<W$[3- +,0@">618TC61DCCB"(
MB;8PH1$5?Z3J*******^?_V?_P!H73OVBXM8N]*3_0M+UBXTN*X$J2+=?9XH
M':XC,99/*=I6$)#/OB5)25,AC3Z HHHHHHHHKXP_:._8-\'?M2ZSI^N>(%O/
MM-C&L+);W'EQW-NDIE6"<%&8(&:4;K=H)B)7S(2L1C^SZ******_ '_@N=_S
M*/\ W&/_ &PH_P""YW_,H_\ <8_]L*_?ZBBBBBBBBBBBOQA^''Q"L_VJ?VA]
M2@U*V\^P\'Z?=Q:3!/NVQ7UI>6T$]YY7FO$93*\HBDVJ?*CM)"BW$",OK_[>
MW_!.:S_:HVZWH3V^G^)D\M))I=RV]["N% N3&CNLL2_ZJ=4=BBBWD5D\E[?U
M#]D3_@GYX:_9#N)=3L+B\OM6N;-+6>YN'58PNY9)O(@C51&DLB(VV5KAXQ&B
M++S(9/M_5M6M] MY;R\EC@MH(WEFFE=4CCC12SN[L0JHJ@LS,0% )) %>/\
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MR[^'WQ"TN/1_%$<DGV5+:.402"*+S9(G#R3E7\M6N(;A9&M[F$_*RD1&Y/\
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ME56=U'A_P9_;M\6_#KQS%\./BO8V\%[<?9K;3]4LHI EU-(WE13R#)22*[;
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M^+[:;2]-TN"-7GTG38XKZZLX"7D,MT]U:R+*\*E8KJ2TD\D!//6%81+*/O\
M_8L_:83]J[P=;>(&CC@ODDDM=0@B\SRXKJ+:3L,B@E)(WBG50T@C$HA,LCQN
MU>/_ +4W[:5[\.O$NE^ ?!=K9ZIXJU21$D$[SO!IJNT3))=Q6R%V1H3-,X62
M-[:&-;ET>)T#]!\8M \??!+PK<>)-.\5R:KJ.CV<EY>6NJ6%@FGWD<%N[7(1
M;"UM[NW?@S6X^TRC>BP2LR.TJ^7_ +-'[>/B_P#:@\F\TCP-_P 27^T$LKS4
M/[>MO]%_U332?9Y+>*67RHI5DVH/WGW%;=G'U!^TY\%-1^-/_",_V?);Q_V-
MXHTO6+GSV==]O9^;YB1;(WS*=XV*VQ#@YD7C)^TY\%-1^-/_  C/]GR6\?\
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M/ W@:?5?BU);PZA8_;+F>6%8W=+&%3)ON%LPT+2J%E(6U# P"$$&X\T5\_\
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M]7X _P#!#'_F;O\ N#_^W]'[?7_)PO@+_N ?^GFXK]_J_ '_ ((8_P#,W?\
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M]BU^[W[/?C_PG\2M$.H^#+F.ZTN6\O9'9#*&6ZN+B2YNA)'.!-$[2S-*(W5
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M B5T9OWL4Z,%,?S?M]11117Y ?\ !:O_ ))YIO\ V,%M_P"D5]7W_P#LG?\
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M-O7W_P#\%1_^20^(?^X=_P"G*TH_X)<?\DA\/?\ <1_].5W7W_17X _L"_\
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M$ ,8Y "2C8^?_P#@N5JUO-<>%+-98S<Q1ZI+)"'4R)'*UFL;LF=RH[12JC$
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M S#."<^7_P##)WP\_P"A4\/_ /@ILO\ XS7H'_"I_#W]C_\ "/?V5I_]B_\
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M*= N);.\UN2"Y@D>*:&72]322.1&*NCHUF&5U8%65@"I!! (KZ?^$/QH\/\
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M2UFACVA&9U=U9$P[ (RL?F#_ (>C_"'_ *&'_P IVI?_ ")7U_\ "WXI:/\
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M7=O^U]X:.HO%':ZM92"WU&U1U91(5#)/$I9I5MYAN\OS1E7CFA#R^297\O\
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M135_''^SUXIL_ WC+P_JNH2>396.L:=<W,NUGV0PW,<DC[4#.VU5)VJ&8XP
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MM$=ID6((R*\T&7>9FC&+..,^8S1A?Z3J^ /^"H__ "2'Q#_W#O\ TY6E<_\
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MU/Q[=B2..YC;3+!#N598Q)'+=3$-& Z"2.&*&2.0@/'=1NFY5(]O_P""U?\
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M5W[*.N?LE:X=*U4>=:3;WT_4$0K#=PJ0"0"3LE3*B> DM$Q4AGB>&:7][O\
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MRM(\=Q'#):6D<L7D(;+;;8D$9V<?_P %SO\ F4?^XQ_[84?\$,?^9N_[@_\
M[?U^OW[6/_)//%?_ &+^K?\ I%-7\@7[)W_)0_"G_8P:3_Z6PU_;[17Y ?\
M!:O_ ))YIO\ V,%M_P"D5]7P!_P14_Y*'J7_ &+]S_Z6V-?T_5\X?M$?M V_
MP0.A68,;ZCKVN:=IEK"VTGRY[F);N8IYD;[(X691(@D"7$ML'0HYJ_\ M8_\
MD\\5_P#8OZM_Z135_(%^R=_R4/PI_P!C!I/_ *6PU_;[7Y0?'G_A,OVA?B8N
MG^#_ .Q_*\ ?9+JXMM;^T_9KG4=4MY7@G$=MY@E^RQ*C6TC"":WN6E92Z,#6
MA\:/A#\<?CUX?OO#6LKX#:QOXPDAB?6HY$9'62.1&Y >.1$D4,&1BH5T="R-
M_-%I-[JG[/GBJ*>6&--6\/ZHCO!*1)&MU87 )C<Q. Z"2/:QC?##.U^0U?VV
M?"KXEZ=\9-#L/$.E/OLM0MTGBRR,R;A\T4GELZ++$VZ*9 S>7*CH3E37R!_P
M5'_Y)#XA_P"X=_Z<K2OO^OY\?^"K'["5P+B;XA>%[2,VQC+ZW:P(PD60,S/J
M(4$JR,I NO+5#&4^U.)!)<RQ?$'_  2]U:XF^*WANS:60VT4FJRQPEV,:22Z
M9.LCJF=JNZQ1*[  L(XP20BX_I>_:]^$+_'?P'KGAZ!9'N;JS9[6.-XXVDNK
M=EN;:,O+\BH\T4:2%BHV,WSQG#K_ !I?"?QU_P *O\0Z5KWD_:/[,U"TO?(W
M^7YOV:9)O+W[7V;MFW=M;;G.TXP?[O***^ /^"H__)(?$/\ W#O_ $Y6E?@#
M_P $N/\ DKWA[_N(_P#IMNZ_H^/P9_L3XOQ^+[:+$6H^%[RRNVCMMJBXM;VQ
M>*2:=>'EFBD,<:N XBLCM9T7;%[?\5_BA;_"JUM+B?RWDO=4TS38(GF6)I)+
M^[BMSY>0QD>*-Y+@QJ,ND+\HH9U]0HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKXP_; ^*D4/A7Q'X?L]-US4-4
MNM+NK.&&RT74;B-Y+RW,:%;I;?[(R)YH>4K,2H1T"M,OE'^9'X3_  (^(?PO
M\0Z5KW_"'>(+C^S-0M+WR/[,O8_-^S3)-Y>_[.^S=LV[MK;<YVG&#^]WQ0_;
M1\>>/;?^Q_A]X$\26^K7D<R)?ZU8K8V]HRJ&$B^:SV\C[!+L%Q+"BS"(;+G>
M83\H?L4?\$E+S1M1AU_XCQ6YB@^>WT59%GWS*[ &^9-T+1*%61((GE6?>HF9
M$22WF_;[XL?VQ_PCVJ_\(]_R&O[/N_[._P!7_P ?GDO]G_UW[K_6[/\ 6_N_
M[_RYK^4+]A;_ (3G_A;5C_9O]H?VK_:!_M_S-WF_8_M"_P!I_;_/_'?YW[S[
M5Y6S_2_)K^OVBBBOP1_;M_X)5ZIXWUF[\5>!/+GDOY'N+[2YYQ'(;J64&26U
MEE(B*2%WFEBFDC$15_*9UDCMXM#]D?\ X*)2_L_:=9>"?BOI^H:-+9V\::??
M2V$L7^@QHZ1"YM]BS?(8A!%/!%*)N!*J/%+/+]O_ /#RKP)X@_=>&%UCQ/>C
MYI++1])NY;B.$<-.ZSQVZ")6*1L0Q;?+& I!)7H/V=?AOXT\0^(;SQ[X\?[#
M>S6\VGZ7X>@FCFM]-L7FBD=I94W)-=SM!$SRQD HHW<&*VL_7_VG?V>M._:@
M\+W?AK4'\GSMDEM="))7M;B([HYD#CZQR!6C>2"26(21^86'X0_!3X=_$K_@
ME]XHDU34M&N-7\-W-NR:G-I;2W-O]GA$<SW0 ">3+;;F"-?1PI(GVJ.-U1VN
M$_2_4_\ @K9\*[#2QJ$=]>3W)CB<Z='8S"Z#.5#1EY!':;X]Q,A%P4(1O+>0
ME WYH77[(_Q*_P""BGC2\\2^)K*X\+:6^Z*,WL<K-;101J(;:VM)WAFDW%_,
MDE"V]J\K74JE9?\ 1V_H>^%7PTT[X-Z'8>'M*399:?;I!%E45GVCYI9/+5$:
M65MTLSA5\R5W<C+&ORQ_;L^.>K^-[CPS!X5\)^)-7CT?7+'7+B<Z/J5I&6LF
MD"6BB>S$I>0.S/+LV1#R]HF9W6+]/OA?\5[7XJV_GV]IJEE(D<+RP:EIEW82
M1M*I/EYN(DBF="I60V[S(AQ\Y5T9N@\?^ -+^*>EW.BZU;1WFG7D9CG@D!VL
MN00000RNK /'(A5XW59$9756'XP_L,?LJZI^RA\9]9TRZBD.ESZ'?R:3>,P=
M;BU%_8[0TBI&OVB-61;F/:A1R'53#)"\GV__ ,%,=)N-?^%.MV=G%)/<SR:7
M%##$C/))(^IV:HB(H+,[,0JJH)8D  DU\H? ?]JCQI^R!H]CX<^*WAG4+?2]
M/MX(8=?LHX[JWM[8R1VUM'>_92\*^4-RETE-RR"!?LDLLOG2^W^/_P#@I=X=
MUO2[F/X;PWGBOQ&(R8+"UTW4"L2DA3=7.8(V^SQLRAEC.^1WCB!C#M-$?\$X
MOV''_92TN?4]:,<GB/5(XQ.BB-UL8%)86L<P!9G9B&NF1O)=XXD0.(%GE\ _
MX*B^*+O]H7PKIVA^%]"\27]RFJ)>2N/#^J01Q1PV\\6&-Q:Q,7=IP4$:N,1R
M;V0[ _PA^P#9^,OV2?%LNMZKX*\475E<Z?/92BVTFY,T>^2&99$22-$D^:!4
M92\>%<R!F*"-_P!?O%/_  4#U&TLY'TKX=^.+F]&WRH;G2'M86RP#;YHS<NF
M%W,N(GW, IVABZ^ ?L0^._B=\9?B=>:_X]TG4-,M(_#]Q;6<,FGW5G8PLUU8
MLR0BX!S++Y;22,SO*X0#/E0QI'^GWQT^!>A_M%Z'/X?\00>=:3?,CKA9K>90
M0D\#D'9*F3@X*LI:-U>)Y(V_#'X0_LU_$'_@FQXU77H-'D\5:%=QO83S:5&\
MUT+::;S XM1^]BN$%M'*P82VA#_9OM8DD66/[_U/_@K9\*[#2QJ$=]>3W)CB
M<Z='8S"Z#.5#1EY!':;X]Q,A%P4(1O+>0E WP!'^Q9\0?^"@?C&3QEXUMI/#
M6B321HEI/(YO([.'S$%O:V\JLT3[H]TLEPEM&TEP]Y%;RJYA/[_> / &E_"S
M2[;1=%MH[/3K.,1P01@[57)))))9G9B7DD<L\CLTCLSLS'R#]K/]GZW_ &FO
M!VH^')1&+F6/S;":3:!!>19:!]YCE:-"W[J=HU,AMY)D4@O7\T/P/UKQ9_P3
M1\>6FI>*=(O+6VFCEM;R(+$RW5K(L4DGV6X_>02O"YMYF6&53O06\DL(D?'[
MW>'/^"E7@3QW9F3P^NL:SJ2V\=P^CZ?I-W/?(K-&CAL1BV'E&0"5_/,61A))
M&:,/ZA^S=\(=4\-7^N>,?$2QVVN^*9+.6ZTZ!Q+;V$%E"8+2V$W6>X6-B;J=
M=L+S'$,:QH'E]O\ '7Q+L?AWY/VR+4)?/W[/L6EW^H8V;<^9]AM[CRL[AM\S
M9OPVW=L?;_(E\;_@)XZ^)7BK6]<L_"7B1+;4M4OKR%)=(NQ(L=Q<22H'"QLH
M<*P#!68 YPQ')_<[]G[]LG4?AUX2T71-5\ ^.!>Z;I]M92FVT5YH7^RQK"LB
M/(\#_.J*[*4'ELQC#2!1(WB'[47[:_Q7\?V]QI/@?P3XDTFTGC:-]1N-+O/[
M0VNL9)@2)#%:N#YL?F;[ARC)+&UM,H(_3_X&WY^&'PY\/-JEO>1R6>AZ3%<6
M\=E<W%U'(+:&)D-K;Q27!=7.)%$9,8#,X558C\\/^%_ZU_PNO_A*?^$,\4?\
M(]_8_P#8'VW^R+[?L^U_:OM_V?[-YGE;_D\G_7^1^^V^=_HE?K]X6\2P>,+.
M.^MDN$BEW;5N;6XM)AM8H=\%U'%,G*DKO1=RX=<HRL?G#]L3]E72_P!J_P -
M3Z9=11C5((Y9-)O&8HUO=%?E#2*DC?9Y&5%N8]KAT =5$T<+Q_+_ /P23\ :
MI\+/"&MZ+K5M)9ZC9^)+J.>"0#<K?8K @@@E61E(>.1"R2(RR(S(RL?O_P"-
M'PATOX]>'[[PUK*R-8W\820Q.8Y$9'62.1&Y >.1$D4,&1BH5T="R-_-EK/[
M$OQ5_86\467B;PU9_P!NK9W#?9;FQMWNMZR":,Q75DH-Q%YD 83-'NBB\Y5C
MO/.VL/U>^&G_  5Q^&?C#3DN=7NKC1;WY5EM)[6XN,-L5F:*6TBE1XMS,B,X
MAE;86:",%<]!XI_; USX[V<FG?"31]0N[BZVK;^)+^T-IHL,)813W44ESMDN
M9;=V,?V?R2Q>.6017$<)BF^G_A;X+@_9?\(6^GW=WJ&J_8O,DNKS[-<7EY=7
M%W<O//-Y%LD]P^Z:=VP!*\<?S22/L>4_@C_P4T\*^(_VD_&L&I^&O#7B2YL;
M32[>S-P^AW\*RR+-<3L8TD@678HG6,F1(R71\*4V._N'_!/#XO>(?V3?#U_H
M.O>!O&$WG:@U[!/9:/-+GS88H7CD280;-OD(RLK2;_,8%8_+!D^G_C'_ ,%
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M#U%%%%%%%%%%%%%%%%%>7_&CXO:7\!?#]]XEUEI%L;",/((D,DCL[K''&B\
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MM'E[2,N*X_XW_MF67PX\06_@K0+"3Q#XPNXVDBTN"Y@MHXE1/.(NKN=MD#M
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M3;6"-$6N#*R.K?O8H'4J8_F_:[2=)M] MXK.SBC@MH(TBAAB14CCC10J(B*
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M #*/_<8_]L*_?ZOP!_YN\_S_ -"Y7W__ ,%1_P#DD/B'_N'?^G*TH_X)<?\
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MGQ2U[Q-;6,E_X>\07AF>29)H[.X6[G-X8DDBD:*.]@(N;>%Y@[K'YLXMO*F
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M]6_](IJ^ /\ @BI_R3S4O^Q@N?\ TBL:_7^BOP!_X(8_\S=_W!__ &_K[_\
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M-5O+Z\G#E2JR),;(",!00GEVL;$,6.]G.[:55?J_]JKX6_\ "Z? VO:"MO\
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M1Y:%IWBC?ZO^'MEJFG:-I\&N31W.K1V=NE_/$ (Y;I8E$\B )& C2!F4!(P
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M#)<R;KU=D"2,K2OND1=L88Y=!C+#/]%U%? '_!4?_DD/B'_N'?\ IRM*Y_\
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M/V>TGXU^&M:\/Q>*HM4LUT*:-)$U"698;<*[B,!WE*"-_,/E-')M=)LQ,JR
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M,^$6G)I6D+<)91;1%%/>75WY2JBQK'$UW-,\<2JBA(4*Q)R50%F)^8/VE/\
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MYL842^8PW5]?T5\ ?\%1_P#DD/B'_N'?^G*TKY _8;_8MT/XM_#WP[XF@O\
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M1O#]M(]]/'Y4^H74GFW4L?F-($R%2*-,E0RP1Q"01Q-()'C5Z^KZ*^,/&O\
MP3[^'7Q*N%O-<TZ\U*Y2,1)->:SJUQ(L89F"!Y;UF"!F9@H. 68XR3GU_P"$
M/[.OAWX$(L'AZ.\M;9(WCCM7U/4+BUC623S7,=M<W,L$;E\L9$17RS_-B1PW
M0?%[X+^'_CUI;:-XEL8[^Q:1)1&Y=&22,_*\<D;)+&^"REHV4LC/&24=U;XP
M\+?\$S]#\*6<>E1>)O&#:*NY9-).L".QFAD8M-!)#!!%^ZFW.)A&49@[D,&.
MZOM_X:?"K0_@WIR:5X>L+?3[)-I\J! N]E18_,E;[\LI5$#S2EY9-H+NQYKP
M#XE_L&_#WXR:B^J^(=-N-0O7W#S9]4U-MBL[2>7$OVO9%$&=RD,02*/<0B*.
M*]_^&GPQTSX1:<FE:0MPEE%M$44]Y=7?E*J+&L<37<TSQQ*J*$A0K$G)5 68
MGG_CI\"]#_:+T.?P_P"((/.M)OF1UPLUO,H(2>!R#LE3)P<%64M&ZO$\D;?.
M'P"_X)R> _V>'FNM.AO+K498YX5U"ZNF%U!%<1B.1;9[86ZV[[0VVXB5+I!)
M(HG"-M&A_P .Y/AC_:/]K_V3<?VE]H^U?;/[7U7[1]HW^9Y_G?;/,\W?\_F;
MM^_YL[N:]O\ B;^SKX=^,>EP:+KL=Y=Z=!&L8@.IZ@BS*IC*FZ,=RC7;JT2.
MLET9G5P9 P=W9N0^#G[&W@G]G^\:^\,6-QI\KX\U8]2U!H9MJNB^=!)=/#-L
M$CF/S4?RV8NFU\,/I^BOD#XE_L&_#WXR:B^J^(=-N-0O7W#S9]4U-MBL[2>7
M$OVO9%$&=RD,02*/<0B*.*]O\%?![2?AYHS:!IOVR+3C&8D1M1OI9(8S$L(2
MWN);AY[9$15$2P21B$C?&$<EC\X?\.Y/AC_:/]K_ -DW']I?:/M7VS^U]5^T
M?:-_F>?YWVSS/-W_ #^9NW[_ )L[N:]O^)O[.OAWXQZ7!HNNQWEWIT$:QB Z
MGJ"+,JF,J;HQW*-=NK1(ZR71F=7!D#!W=FY#X.?L;>"?V?[QK[PQ8W&GROCS
M5CU+4&AFVJZ+YT$ET\,VP2.8_-1_+9BZ;7PP^GZ*_-#5O^"3/PRUKQ!+KDMM
M>+!-(\CZ3%<"'3PSH5(18HTN(TWGS5CCG5$?"*JP 0CZ@^*O[)/@SXU6]K9:
MY8236-E'%':V,5[>VMG"L*ND12TM9X;=71)&C601[Q&1'NV*JB_\%/V7_"O[
M.WF+X8M;BQBFW&2W_M"^FMRS^7ND^SSW$L(E(B1?.""4(NP/L)4^0>*?^"<G
MPQ\<WDFH:KI-Q?7LVWS;FYU?59IGV*$7?))>,[;5557).%4*. !7K_CK]F+P
MU\3='AT'64U"\TV'?^XEUC5&\W?(LW^DO]K\RZV.BM%]I:7R, 1;%XK ^#G[
M&W@G]G^\:^\,6-QI\KX\U8]2U!H9MJNB^=!)=/#-L$CF/S4?RV8NFU\,-#X\
M?LG^$_VF+BPG\56LE['IL=TEO +B6"/==-;EY&,#1REU%NJH-X3#R;D9MC)\
M_P"D_P#!-SP_#;Q:9J?B#Q9J^B11I$=&O=9<Z>\<2@0HT-O' P2%E22)8W0*
M\:<%05/W_I.DV^@6\5G9Q1P6T$:10PQ(J1QQHH5$1% 5450%55 "@   "M"O
MF#XE_L=>#OC)O7Q#!J&H1/<-<_9Y]:U9K=)FW?/%;_;/)BP'=46)$6-&*(%3
MY:Y_P+^PCX"^%_G?V#::AIGVC9Y_V+7-8MO-\O=L\SR;Y-^W>VW=G;N;&,G/
MU_17QA\??V#?!W[0>J0Z_=+>:9KL,D$@U72[C[-=,;<'RMQ9)(BZDH5G\L7"
MB*%%F$<82L_PM^P)X7LKR.^\17>L>+I;?=]D7Q'?'48;7S%*2^5 R)"WFC87
M\Y)<-%$Z;'3<?L_5M,36K>6UE,BQS1O&YBEDAD"NI4E)8F26-\'Y9(V5T.&5
ME8 CXP_X=R?#'^T?[7_LFX_M+[1]J^V?VOJOVC[1O\SS_.^V>9YN_P"?S-V_
M?\V=W-?1_C7X/:3\0]&70-2^V2Z<(Q$Z+J-]%)-&(FA*7%Q%<)/<HZ,PE6>2
M03$[Y [@,/$/AI^P;\/?@WJ*:KX>TVXT^]3:/-@U34UWJKK)Y<J_:]DL19$+
MPRAXI-H#HPXKZ_K\P/B7_P $C/AK\1-1?4(%U#2/-W&2VTZ>)+<NSL[.L<\%
MQY6=P41PF.!$152),$M]O_!SX ^%_P!G^S:Q\,:9;Z?$^/-:,%IIMK.Z^=/(
M7FFV&1Q'YKOY:L43:F%'L%?G!X&\+6?QQ^-NL^*VCW6_@[3[71;*=&:2&>^N
M%GGNW$J%8UEM4N)+.>U83%&E65C%($4?H_1117Y@?$O_ ()&?#7XB:B^H0+J
M&D>;N,EMIT\26Y=G9V=8YX+CRL[@HCA,<"(BJD28);[?^#GP!\+_ +/]FUCX
M8TRWT^)\>:T8+33;6=U\Z>0O--L,CB/S7?RU8HFU,*.P\?\ @#2_BGI=SHNM
M6T=YIUY&8YX) =K+D$$$$,KJP#QR(5>-U61&5U5A\(:!_P $S]#\#?:(O#WB
M;QAHEE/<27'V+3M8$%NC/@85?(9VVJJ1AY6DE*(H>1R,U]?_  <^ /A?]G^S
M:Q\,:9;Z?$^/-:,%IIMK.Z^=/(7FFV&1Q'YKOY:L43:F%'/_ +0O[,7A?]J#
M3DT_Q+:>=Y/FFUN8W,5Q:O*A0O#(O_ 6,<@D@D>.-I(I/+4#P#]GK_@FIX!_
M9TU%]5M(;C5+W]T;>75#!<?96C<2"2W5((D27<J$3$-*FP"-XPT@?T#P!^PM
MX&\!>(;_ ,5_8?M^M7^H7%_]IOBL_P!FEGF6XQ:Q;5BB\N5=\,VQKI-S+]H*
MG%=_\:_V7_"O[1/EKXGM;B^BAVF.W_M"^AMPR>9MD^SP7$4)E E=?.*&4HVP
MOL 4'P4_9?\ "O[.WF+X8M;BQBFW&2W_ +0OIK<L_E[I/L\]Q+")2(D7S@@E
M"+L#["5)^T+^S%X7_:@TY-/\2VGG>3YIM;F-S%<6KRH4+PR+_P !8QR"2"1X
MXVDBD\M0/G#X#?\ !,+X?? /5(]9MXKS4[ZWDCEM)-1F25;:1 ^'CCAB@B9\
ML&#3+*8WCCDB,;KN/J'[.G["W@;]F+;/HUCY^I+G_B9WI6>\&?-'[M]JQP?)
M*T3?9HX?-C"B7S&&ZOK^BOF#XQ_L;>"?V@+Q;[Q/8W&H2IGREDU+4%AAW*B-
MY,$=TD,.\1H9/*1/,90[[GRQ[_X.? C0?@%9MI_AV&XMK(XVVTE]>74,>&=S
MY,=U/,D&YI':3R0GF,0S[BJD:'Q>^"_A_P"/6EMHWB6QCO[%I$E$;ET9)(S\
MKQR1LDL;X+*6C92R,\9)1W5OSP\+?\$;?AKX?O([FYEUC4(DW;K6YNXEADW*
M5&\VMO;S#:2'79*GS* VY-RM^I^DZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4
M!515 554 *    *_-#Q3_P $C/AKXIUR36BNH6T4MPL[Z9;3Q16/!!>)$$!F
MBBD(;<D4R>6'*PF%%C5/4/VCO^"=?@K]IBXT^ZOQ>:=)IMFMC --DA@C^RQL
M6AA\J2&:)$B+/Y?E+&<.58LJQA/K_P  > -+^%FEVVBZ+;1V>G6<8C@@C!VJ
MN22222S.S$O)(Y9Y'9I'9G9F/YX?$O\ X)&?#7XB:B^H0+J&D>;N,EMIT\26
MY=G9V=8YX+CRL[@HCA,<"(BJD28);U#Q-_P3;^&_B>WTC3VTZ2#2]'DOI8[&
M"XD2.YDOEB$CW4V3=RNODQ&)A.A4(D1+0JL8^S_"WA/3O UG'I^E6EO8V4.[
MRK:VA2&%-[%VV1QA47<S,S8 RS%CR2:Z"OG#]IC]E7PU^U?I<>F>(8I T$GF
M6MY;LJ75NQ*^8(I'21=DBJ%EC=71P%?:)8XGCY_]F?\ 8L\'?LHI(WA^VD>^
MGC\J?4+J3S;J6/S&D"9"I%&F2H98(XA((XFD$CQJ]=?^T+^S%X7_ &H-.33_
M !+:>=Y/FFUN8W,5Q:O*A0O#(O\ P%C'()()'CC:2*3RU ^<-)_X)N>'X;>+
M3-3\0>+-7T2*-(CHU[K+G3WCB4"%&AMXX&"0LJ21+&Z!7C3@J"I^[_"WA/3O
M UG'I^E6EO8V4.[RK:VA2&%-[%VV1QA47<S,S8 RS%CR2:Z"BOD#X^?L->"_
MVE]1DU7Q);W$]Z=/CL+>6.YDB^RK&]Q()850A&E+7!)^T">+]U&!$!Y@DX_2
M?^"??A^:XBE\1ZQXD\4VUO(DT-AKNJO>6:7$; I.8%2)9'"[X]LOF0M'+(CQ
ML&X^[Z^(/VE/^">_@;]J&\_M358+BSU0^6);ZPE6*:9(E95259$EA?AE'F&/
MS]L448E$2!*/V:_^">_@;]EZ\_M32H+B\U0>8(KZ_E66:%)5562)8TBA3A6'
MF"/S]LLL9E,3E*^WZ\/^/O[/'A_]IC2X='\1PR36D%Y!>(L<KQ-YD)(P60@E
M)(WDAD'79(S(T<RQRI[A17YX?'G_ ()A?#[X^:I)K-Q%>:9?7$DDMW)ITR1+
M<R.$R\D<T4\2OE2Q:%8C(\DDDID=MP]@_9G_ &+/!W[**2-X?MI'OIX_*GU"
MZD\VZEC\QI F0J11IDJ&6".(2".)I!(\:O6A\8_V-O!/[0%XM]XGL;C4)4SY
M2R:EJ"PP[E1&\F".Z2&'>(T,GE(GF,H=]SY8]_\ !SX$:#\ K-M/\.PW%M9'
M&VVDOKRZACPSN?)CNIYD@W-([2>2$\QB&?<54CU#5M)M]?MY;.\BCGMIXWBF
MAE17CDC=2KHZ,"K(RDJRL"&!(((-?EAXI_X(V_#7Q!>27-M+K&GQ/MVVMM=Q
M-#'M4*=ANK>XF.X@NV^5_F8A=J;57]#_ (0_!?P_\!=+71O#5C'86*R/*8T+
MNSR2'YGDDD9Y9'P%4-(S%45(P0B(J^H44444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444444444444444444444444444444444444444444444445\X
M?M2^$O%7Q%\-7V@>%XM+,FJV=S9W%QJ-S<1+!'.HB8QQ6]M,9G:-Y0"TD(B<
M1N5G7='7R_\ \$_/V:/'7[)%E<:!K T.[TFZO'O#<6MY=BZAD:!8F'E262Q3
M(QA@"CS(#$/-<M-E(U_2^BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOB#]N7X.^
M,OVB?#EQX3\.IH\-E??9FNKR_N[E)AY,XG\J*"&TE09:*$^<\K94RQ^0#LE!
M^PU\'?&7[.WARW\)^(DT>:RL?M+6MY87=R\Q\Z<S^5+!-:1(<-+,?.25<*(H
M_()WRG[?HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHK\L/$'[,7QIN?'FHZUIGCN.RT*]DE\E'
MB:Z:VMV56BBCTN:(V(>-D2$W"RQS2('N&;S)986^_P#X0_"'2_@EI:Z7I:R%
M3(\]S<SN9;J\NI3F:[NYC\TUQ*W+N<# 5$5(D1%]0HHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK\$?VAOV@OBEX
M:^+GA3POKE_9V&G7FJ:3<I9:++/Y;VTVHR6XCN[F6*">=V0-'/& EI*%C?[.
MKY _>ZBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBN?\
M6>*;/P-IUWJNH2>396-O-<W,NUGV0PH9)'VH&=MJJ3M4,QQ@ G K\T/A9I_C
M']OSPFWB:^\17GA>TO9+C^Q;+07\IH!;RW-NLNHW+J+BZ<O\KV\$EK;ND*2A
M4FEQ!XA^Q7\8_BK\+?B*?A=XY6XU:W^SSS)>REYF@AC\V5+U+PH9+BTG<BV'
MVD[HI6AA#020R6K_ +?444445GZMJUOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B
M%5%4%F9B H!)( HU:2XAMY6LXXY;D1N88Y9&BC>0*=BO(L<K1H6P&=8Y"H)8
M1N1M/X8_#[X_?$K5/V@M-\(>+M3MQ%9_:?-L-),L6FMYNCM<KD2!9KC!$<@^
MU&7RIM_E;$(K]WJ*****S]6U:WT"WEO+R6."V@C>6::5U2..-%+.[NQ"JBJ"
MS,Q 4 DD 5^0.K?M\^,?VH=9E\/_  6TN.6V@C=+[6]3CV1VYFE,,-S"ID"J
MBJ#<1I/'/<3@./L %O(LGO\ I/P-^->G6\5W+\0K.YOHXTE>PE\/V@LY9U4,
M;9[J+R[@6[./+:>...81DR+&KX4>'^%_VWO'-C\3- ^'GC33]/T25KB[^W7D
M,C&VU-'M[@:=]B-QDQ122B->)))YKE5A_P!'<36K?K_11111111111111111
M1111111111117E_Q>D\5)I;#P='I;ZLTB!6U62X2U2/.9&*VT;RR/@!%0-$
M6\PR'R_*D_+'_@DI\?O%'[0%YXMOO$^IW&H2I_9'E+(0L,.Y;Q&\F",)##O$
M:&3RD3S&4.^Y\L?V>HHK\X++XMZY^UIXT\1^$-"U3^Q?#?ASR[74;ZR4C5[N
M[GCN(I(;>6XB:*TBBE217F2-[CS+9'@GV7&^'X0^*OB#XO?\$]O&-K);ZCJG
MBWPOJUY%%:Q7LLEY)<,=X6P9V666VO<.3$]N%2[*)+Y,HBEM(?Z#J*******
M***********_+#XH_"[XRZI\9=/UC1]0D3P4DED707J):QVJ)B]@GLC\TUQ*
MWG^5+Y4Q4S6Y%Q#Y/^C?J?111117RA^V1XM\:^!?"M[J?@PZ7%)96=[=7MS?
MM,TD4$%N\G^AP1Q/%)<9!9&N&$*F-4:*5928OF__ ()0?%77/C)X-U75?$-_
M<:A>OX@NQYL[EMBM;6<GEQ+]R*(,[E(8@D4>XA$4<5^G]%%%%?@C^T-^T%\4
MO#7Q<\*>%]<O[.PTZ\U32;E++199_+>VFU&2W$=W<RQ03SNR!HYXP$M)0L;_
M &=7R!^MW[4^@>*/%/@O5[+P7<?9M?EMP+202")N)$,J1RL"(I9(A)'#(2GE
MRNC^;#M\U/,/V#?!OCSP+X.6T^(=S)<:M]LN'A$URMW<16K;-D<]PI<2/Y@F
MD4^9,5ADCCWKL\F+[/HHHHHHHK/U;5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[
M$*J*H+,S$!0"20!6A1111111117S_P#M3Z!XH\4^"]7LO!=Q]FU^6W M)!((
MFXD0RI'*P(BEDB$D<,A*>7*Z/YL.WS4\P_8-\&^// O@Y;3XAW,EQJWVRX>$
M37*W=Q%:MLV1SW"EQ(_F":13YDQ6&2./>NSR8OL^BBBBBL_5M6M] MY;R\EC
M@MH(WEFFE=4CCC12SN[L0JHJ@LS,0% )) %:%?EA\+OA=\9=+^,NH:QK&H2/
MX*>2]*(;U'M9+5TQ90060^:&XB;R/-E\J$L8;@FXF\[_ $G]3Z**********
M**_."R^+>N?M:>-/$?A#0M4_L7PWX<\NUU&^LE(U>[NYX[B*2&WEN(FBM(HI
M4D5YDC>X\RV1X)]EQOA^$/BKX@^+W_!/;QC:R6^HZIXM\+ZM>116L5[+)>27
M#'>%L&=EEEMKW#DQ/;A4NRB2^3*(I;2'^@ZBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBO@#4O^"C7A>\U&YT_P -:9X@
M\5?8L"ZN=!TTWEO"[/(@1I&DBW;O*9DDC#P2IAHY7PP7U#]F?]M/P=^U<DB^
M'[F1+Z"/S9]/NH_*NHH_,:,/@,\4B9"EF@DE$8DB60QO(J5]7U\ :E_P4:\+
MWFHW.G^&M,\0>*OL6!=7.@Z:;RWA=GD0(TC21;MWE,R21AX)4PT<KX8+^4'[
M0WQTT/\ :+^-/P[\0>'Y_.M)O[ 5T;"S6\RZQ.7@G0$[)4R,C)5E*R(SQ/'(
MW[O?&O\ :@\*_L[>6WB>ZN+&*;:([C^S[Z:W+/YFV/[1!;RPB4B)V\DN)0B[
MRFPAB?!3]J#PK^T3YC>&+JXOHH=PDN/[/OH;<,GE[H_M$]O%"90)4;R0YE*-
MO"; 6'0?&/X[Z#\ K-=0\137%M9'.ZYCL;RZACPR(/.DM8)D@W-(BQ^<4\QB
M53<58#0^$/QDT3X[Z6NM>'IY+K3GD>..=[:XMUD:,X<QBYBB:1 V4,B!DWJ\
M>[?&ZKY!\7OVQO#_ ,*-4;0(+;5->UV.-)I]*T6R>^NK>W<<3S@%(HTR8P5:
M038G@?RS'(KUS_P"_;R\'?M!ZI-H%JUYIFNPR3QG2M4M_LUTQMP/-VA7DB+J
M2X:#S!<*(IG:$1QEZ]O^,?Q^\+_L_P!FM]XGU.WT^)\^4LA+33;61&\F",/-
M-L,B&3RD?RU8.^U,L/E#7?\ @I[\/O#7AC3_ !+=2WB-JD<TMGI8A1]0>."Z
M>T=V1)6@B3?'(R--,@E2.01EY4:,>P?"K]M/P=\5O!UUXYCN9+'1[&26*]:]
MC\N2WDCV'8RQM(LCNLD1B6!I3(94B4&<F)?+_P#AXOX<M/\ 3+[1?%%CH!^9
M?$%QHLZZ6T+_ .HG65"\WE7!,:P$PAF,L>Y4RQ7ZO^#?Q>TOX[Z)!XAT5I'T
MZZDN4@DD0QM(MO<2VQD"'YE1VB+QAPK[&7>D;[D7G_C?^T/X?_9]M[>769I#
M<WTC0Z?86T3W%Y?7 7(@MH(P69V8I&&;9"LDL2/(AD3/S!I/_!3#P=#K,6A^
M(['7/"US<1I)"^NZ?]CC<22B),E996C0MO/GRK';J(I-\RE<']#Z**^?_P!H
M7]IWPO\ LOZ<FH>);OR?.\T6MM&AEN+IXD+E(8U_X"IDD,<$;R1K)+'YBD_,
M&H_\%.?"_@^\M;;Q/HGBCPW%=^;Y5UJVDF"$^4H9L".669^61#Y44FUI$+[4
M)8?H?I.K6^OV\5Y9RQSVT\:2PS1.KQR1NH9'1U)5D92&5E)# @@D&OG#XQ_M
M>>%_@W>+I$DEQJNOR9\K0])@-]J3[521LP1G$6(G^T#[0T7F0J[Q^9M(KQ_1
M?^"DG@M-172O$D&L>%+V7R#;Q:]ITEIYRSN\8D5D:9(XE9"'FN##$O)#D)(4
M^W_%/BS3O UG)J&JW=O8V4.WS;FYF2&%-[!%WR2%47<S*JY(RS!1R0*^4/AU
M^WWX#^)]OK^HV5[)'I/AR.TDO-1N(6AMY%NED*"!'Q<.X>-H?+:%'DF*)"LN
M]2?#_"W_  5S^&OBG7(]%#:A;12W#0)J=S!%%8\$A)7<SF:**0A=KRPIY8<-
M,(461D_3^OC#Q_\ MR^'_">J7.C:3IVN>)K[3Y#%J,>@Z<]\MC)@;$N)"T<0
M=B)%"QM(4>&:.01NA6N@^#/[9_A/X\:R?#VCO>#5H;.:ZOK2YM);:2Q:"6"&
M2VN1*%'VA9)]A6$S(#%+F0?N_,]_\?\ C_2_A9I=SK6M7,=GIUG&9)YY"=JK
MD    LSLQ"1QH&>1V6-%9V53\(:__P %.?"_A3[/=:AHGBBTT6[N(X;;6Y])
M,6G3)+EH[B*1Y1*\3Q SH%B,[0@D0E@4K[O\ >/]+^*>EVVM:+<QWFG7D8D@
MGC)VLN2""" RNK I)&X5XW5HW575E&?\2_BKH?P;TY]5\0W]OI]DFX>;.X7>
MRHTGEQ+]^64JCE(8@\LFTA$8\5\@?\/%_#EI_IE]HOBBQT _,OB"XT6==+:%
M_P#43K*A>;RK@F-8"80S&6/<J98K[A\$?VJO#7[0^J:WIGAV62Z70I+>.>\"
MK]EG:X$N#:R!RTJ*T,BM(51'(#Q-+$RN>/3]O+X>_P!N0>&9=2N+?6KBXM[:
M.RN=+U.VF\ZY*"%'6>TC\O?YB%6DVKM8,2%.:^G_ !3XE@\'V<E]<I</%%MW
M+;6MQ=S'<P0;(+6.69^6!;8C;5R[8168> ?!3]LSP)^T3J,FE>&-4^W7L-NU
MS)%]DNX<0H\<;/NG@B0X:5!M!+'=D# )'T?JVK6^@6\MY>2QP6T$;RS32NJ1
MQQHI9W=V(545069F("@$D@"OSP\4_P#!3GPOX?LY-7MM$\4:AH";=NN6VDE=
M-DW,(SLGNI;<C;*3;MO5/WRE%W?*6^S_ (0_&CP_\>M+76?#5]'?V+2/$9$#
MHR21GYDDCD5)8WP58+(JED9) "CHS>(>/_VZ? W@+Q#8>%/MWV_6K_4+>P^S
M6(6?[-+/,UOFZEW+%%Y<J[)H=[72;E;[.5.:\O\ CS_P4]^'WP#U231KB6\U
M.^MY)(KN/3H4E6VD0)E)))I8(F?+%2L+2F-XY(Y1&Z[3]7_ OXZ:'^T7H<'B
M#P_/YUI-\KHV%FMYE +P3H"=DJ9&1DJRE9$9XGCD;L/'_C_2_A9I=SK6M7,=
MGIUG&9)YY"=JKD    LSLQ"1QH&>1V6-%9V53\ :M_P5&\-:=82ZU%X>\67.
MA1R.B:S%I2C3Y568P"1)Y;B,!&D&Q1((W#D1LBR90?;_ ,(?C1X?^/6EKK/A
MJ^CO[%I'B,B!T9)(S\R21R*DL;X*L%D52R,D@!1T9N?^-_[0_A_]GVWMY=9F
MD-S?2-#I]A;1/<7E]<!<B"V@C!9G9BD89MD*R2Q(\B&1,_,&D_\ !3#P=#K,
M6A^(['7/"US<1I)"^NZ?]CC<22B),E996C0MO/GRK';J(I-\RE<']#Z^$-6_
MX*">'YKB6+PYH_B3Q3;6\CPS7^A:4]Y9I<1L0\ G9XED<+LDW1>9"T<L;I(P
M;CV#X#_M8>$_VF+B_@\*W4E['IL=J]Q.;>6"/==-<!(U$ZQREU%NS.=@3#Q[
M79MZI]'T5^0'_!4?]J/PA_PB'B'P'_:'_%2?\2[_ $+[-<_\_-I=_P"N\K[/
M_J?WG^L_V?O_ "UP'[!7[>OPX^"WPXT;0=>UG[)J5I]M\^#[%>R[/-O;B9/G
MAMWC.4=&^5CC.#A@0/V^KX@\4_M]^%[*\DL?#MIK'BZ6WV_:V\.6)U&&U\Q0
M\7FSJZ0MYHWA/)>7#12H^QTVGH/@=^W+X+^/.HC0[*XN+'7Q]H$FCZC;26MY
M$UL[)+&V0T+2J%,AACEDE6,,S(OERB/W_P")?Q5T/X-Z<^J^(;^WT^R3</-G
M<+O94:3RXE^_+*51RD,0>63:0B,>*^0(O^"F/PZ/AZY\327=Q%91:A=Z?:QO
M!_I%_-:PQSEK6%69_*=98@LMS]G6-Y$6?R"ZY]0_96_;)\-?M?6]]/H"7D,F
MG21)<07D*QR!9E8Q2 Q231,CF.10 ^]3&VY%5HV?ZOK^>'_@J%_P4 T/XFZ.
M?!'A&Z^VQ2W"MJE[&H^SLMM(2EK"SIF7,J1SFX@98MD<:QRSI-*(_P!?_@I^
MV9X$_:)U&32O#&J?;KV&W:YDB^R7<.(4>.-GW3P1(<-*@V@ECNR!@$C\H/\
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M^#OV9;<R^(]1CBN3'YD-A%^]O)P5D*;(%.Y4=HGC6>7R[<2 (\R$UY?\5O\
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M%K_ &ER^%=*\0FVC_M:/5(K%;L B0VLEO=3-"Q! =!)&KIO#&,F385\V7?\
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M@N?_ $BL:Y#_ (+/?#W1M.\(6FN0:?9QZM<ZY:Q3WZ6\2W4L8LKL!))PHE=
M(XP%9B (TX^5<?;_ .P7\(=+^&G@71[ZS622^UC2],N[Z\G<RW$K&TC\F$R'
MD6]M&1!:P+A(85P 7:1W_+#X;^%K/X/_ +53Z-X?C_L_39?.#VENS)"RSZ+]
MM>,H#M\K[1B9(<>5&R1[$18XPOZG_MY?LXZS^U+X.;P_H>H1V-S]LM[AUF:5
M+>YCCW@P3M$&8(&9;A<QR@S01C8I(ECY_P 0?';P'^R]H.F^ -=U"/5M1M]+
M@TL:3;6C7EU?-%:Q0K ]G'YRQ/=JZ"&&Z=$E$N!(R!W'YX?\$,?^9N_[@_\
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M<J-SJDT_EVT!8)&[M)^]WQK%+^./[?7_ "<+X"_[@'_IYN*_?ZOP!_X(8_\
M,W?]P?\ ]OZ\O_;&\:W'[)G[1%MXSN%CGMIX[*\\J,,\@LWM3I=R-K-"OVC;
M#</ -YCR86=B"\8_H^TG5K?7[>*\LY8Y[:>-)89HG5XY(W4,CHZDJR,I#*RD
MA@002#7@&A?&^X\6_$'4/"-A;QOIVBZ7#/JEX6821ZA>NCV=JJ-MRAMEFG>5
M!,A+1QEX7C99?P@_X)L?&*W_ &1/B#KW@SQ+<6=O;74DUG<7[2+';Q7FE/.$
M)GG>%4MY%-P@+(9'F:V4+&"]?TW5\P>#?VI=.\7^'O$/BM+6X&BZ%<:BD-PA
M23^T;?385>:ZLR&$3Q/*)X8&65DD\K<SQLSQQ>'_ +0/_!//X??M66YUBS2.
MPU&\C\^'5M,*>7<&99)4FFB7]Q=)(\PFDE79<3A4472I7YP?\$]O&/C']F3X
MJ/\ "C7YY)[22.X@%J+KS;6VD2%]1BNK4,K%4FCWEHE^SES<B2=/.A$8_HNH
MKX _X*C_ /)(?$/_ '#O_3E:4?\ !+C_ ))#X>_[B/\ Z<KNOD#_ (+:?#34
M?$&AZ%XAMD\RRTJXNX+O:KLT?VX0>5*VU2BQ!K<Q,[LO[V6!%#&3Y?T^_95^
M*7_"Z? V@Z\UQ]KN+O3X/M<_E^5OO(E\F\^38BC%PDJ_(HC.,QYC*D_*'_!6
MSQK;^%?A7?6<ZR-)JMY8V<!0*561)A>DR$L"$\NUD4%0QWL@V[2S*>"OA?<?
M!S]G2ZT>\\P7*>$]6N)DEA:"2&2]M[F\>!XV)97A:<PMNP28RQ1"=B^7_P#!
M%3_DGFI?]C!<_P#I%8U^O]%?@#_P7._YE'_N,?\ MA7[_5^ /_-WG^?^A<K]
M?OVL?^2>>*_^Q?U;_P!(IJ^ /^"*G_)/-2_[&"Y_](K&OB#P5\2_^&.?VCM;
M_ME[?[%JVH74%U.&^6"WU>6._MI2\K0)'Y3/;?:G?>D<0N-@D(C<_P!)VDZM
M;Z_;Q7EG+'/;3QI+#-$ZO')&ZAD='4E61E(964D,"""0:\?^'7QOM_B=X@U_
M1K&WD-MH$EI;2ZAN5K>>\E222YMHBFY=]HHA6X!82)-*T;Q1A$>7W"OQA_X+
M&?LX7GQ$T.P\7:5;>=<:+YT>H"*%3,;&4!Q,\@82-%:NC$QA9 BW,TY,4<<S
M-Z?_ ,$D/CRGQ3\!KH4\DCZCX=D^S2&2225FM9VDDLW#,@5451):QPJ[F-+5
M3\B/&@_4^O'_ (L_&.S^%WV*TV_:=7U:X%KI>GJ6WW$QP7=RB2O%:6ZGSKVZ
M\MUMH 6V22-%#)^4/_!;3X::CX@T/0O$-LGF66E7%W!=[5=FC^W"#RI6VJ46
M(-;F)G=E_>RP(H8R?+^GW[*OQ2_X73X&T'7FN/M=Q=Z?!]KG\ORM]Y$ODWGR
M;$48N$E7Y%$9QF/,94GY0_X*V>-;?PK\*[ZSG61I-5O+&S@*!2JR),+TF0E@
M0GEVLB@J&.]D&W:69?H#]AGX7W'P<^&_A_1[SS!<I9_:)DEA:"2&2]D>\>!X
MV)97A:<PMNP28RQ1"=B_EA_P0Q_YF[_N#_\ M_7O_P#P6K_Y)YIO_8P6W_I%
M?5]__LG?\D\\*?\ 8OZ3_P"D4-?D#_S=Y_G_ *%ROU^_:Q_Y)YXK_P"Q?U;_
M -(IJ^ /^"*G_)/-2_[&"Y_](K&O8/\ @K!XIL_#_P *-4MKF39+J%Q86UJN
MUF\R9;J*Z*94$+B*WF?<Y5?DVYWLJMS_ (3U_4?V#OV?[34/L_VG4M/T^&?[
M-=1O;^5<:I=A_*GCR9/]&>\VR)F-Y?)*Y@9\Q^?_ /!.#]GK3OB;IB_%CQ6_
M]N^)M;N)IDGO(D=;+[)=-"AMT(*+*&MU:.50GV>)8K>!(420S> ?\W>?Y_Z%
MROO_ /X*C_\ )(?$/_<._P#3E:4?\$N/^20^'O\ N(_^G*[KX _;Z_Y.%\!?
M]P#_ -/-Q7[_ %?SH_M4VEQ_P3\^--CX\L!)_8FO22W%W#&S$R"1E758-AN5
M:5]TB7T'FF*W6XEA14*VQQ^E_P"QY_Q>37/$OQ0;Y[+6;A-.T$R?O&32],+0
MO-"[[98(KRY$D\EFT<)CEB#MYI99*^_Z**_#']K?Q_JG[5OQ;M/@I)<R:7X<
MCDCDOWMB&GOF2Q_M+#E@%5%4"*&,B1$F_P!*D6<I#%%]'_M]_"K0_@W\$->T
MKP]86^GV2?V8?*@0+O9;^RC\R5OORRE40/-*7EDV@N['FO0/^"7'_)(?#W_<
M1_\ 3E=U\ ?\W>?Y_P"A<K]?OVL?^2>>*_\ L7]6_P#2*:O@#_@BI_R3S4O^
MQ@N?_2*QKY0_9O\ $[_ C]I?Q!IVL11P-KEYJMLCR7$:+&M],NI63@C<KO.J
M011P[D??<*I_>KY3?T75^ /_  0Q_P"9N_[@_P#[?U^_U%%?@#_P0Q_YF[_N
M#_\ M_7Z?_M\?#34?B[\,]?TC2D\V]>WBGBB"NS2_9+B*[:*-8U=WED6%DA0
M+\\K(I*@EA\?_P#!&3XI?\)7X&O-!FN/,N-&U!_+@\O;Y-G>*)HOG"!7WW O
M6Y9Y%Q@[8_*%?J?\0O&MO\-=&U#7+Q9'MM-L[B\F2(*9&CMXFE<(&95+E5(4
M,R@G&6 Y'Y _\$3_ (7W'A[PUK7B.?S$CU:\AMX(WA9%:.P63,\<A.)4>2YD
MA.U<(]NXWLQ98_+_ -@7_DX7Q[_W'_\ T\V]?O\ 445_-CX;UY/^"7?QIN["
MZ>2+P?K$>_"^9*([&X9VMI1$MP[L]G.DEL9)A)</;K<R1PE[A ?UO_82\+7D
M^AWWC+58]FI>,=0EUDH[+--;V,P TZS-T"6FBBMPKP B(0K.T0@B96!\?_X*
MY_#34?B)\-6GT]/-_LC4(-1N8PKLYMTBG@D9%16SY?V@32%MB)!'+(6&P!O0
M/^"8OQ2_X6A\+](\VX^T7>F>;IMQ^[\OROLS_P"C1<(BOMM'M?G7=NS\[F42
M8]0_;I\:V_@#X9>)[RZ61XY-+N+,",*6\R_'V*(D,RC8LDZ-(<Y"!BJLP"GY
M_P#^"3/PON/AQ\,K:XNO,636;RXU(120M$T4;B.WBQN),B2QVZ7$<F%#),NT
M,H#O\8?\$,?^9N_[@_\ [?U]W_\ !5/5K?3OA)K44\L<<ES)I\4".ZJTL@OK
M>4I&"07<1QR2%5R0D;OC:K$:'_!+C_DD/A[_ +B/_IRNZ^_Z**_ ']OK_DX7
MP%_W /\ T\W%?O\ 5^ /_!#'_F;O^X/_ .W]>_\ _!:O_DGFF_\ 8P6W_I%?
M5]8?#WP5<?$KX)Z?H=FT:7.I>"[>SA>4L(UDN-+6)"Y568(&8%BJL0,X4G@_
MF!_P18_:!M].?4_ 5V8XY+F1M3L'.U6ED$<<5U"2T@+N(XX988XXR0D=U([[
M54#][O%GBFS\#:==ZKJ$GDV5C;S7-S+M9]D,*&21]J!G;:JD[5#,<8 )P*^,
M/$'Q&U3XO_!'6?$.L6<=A<ZEX;UJZ2UCD$JQVLT%R]EF0$[G:V,#R-A"79LQ
M0G]TGS?_ ,$5/^2>:E_V,%S_ .D5C7@'_!<[_F4?^XQ_[85^_P!7\^.F:M;Z
MU^UR9;66.:-9)8B\;JZB2'P^T4J$J2 \<B/'(O5'5D8!E('8?\%Q?"UY=Z=X
M8U5(\V5M<:A;32[E&V:Z2WDA3:3O.Y;:<[E!5=F&*ED#?L=\%/BA;_&KPUI?
MB.U\M8]2LX;@QQS+.L,CJ/-@,BA0SPR;X9/E4AT8,B,"H_%']OK_ ).%\!?]
MP#_T\W%?K]^UC_R3SQ7_ -B_JW_I%-7P!_P14_Y)YJ7_ &,%S_Z16-'_  6K
M_P"2>:;_ -C!;?\ I%?5]_\ [)W_ "3SPI_V+^D_^D4-?D#_ ,W>?Y_Z%ROU
M?_;0_P"$7_X5_K?_  F?VC^POLZ?:/LN?M&_SH_LWD8^7S?M'D^7YO[C?CSO
MW'F5\G_L;? KXK_LM:6^BXT/5-$:2:XM(+W4+RTO[9IC&1&YAMM0M(D&V1Y;
M>W,R"YEED2\E7YI.P_9]_8AU'0O&ES\3?'6H6^H>*KG?Y,%A&\-C9;HVM1Y;
M-MDN,6HCAC\U$\L&0O\ :9MEPOZ/T5^ /_!<[_F4?^XQ_P"V%?M=\;_!5Q\2
MO"NMZ'9M&ESJ6EWUG"\I81K)<6\D2%RJLP0,P+%58@9PI/!_#'_@C7^TOIWA
M3^T? ^JS6]I]KN$OM.EE=(O.N)?)M);7=)*-\KXMS;0Q1EVQ<$L<(M?T':MJ
MUOH%O+>7DL<%M!&\LTTKJD<<:*6=W=B%5%4%F9B H!)( KR_X"?%G_A>GARS
M\2+97&GQ7_G26]O<C$WV=9Y$MYG& !Y\2QW"A2Z!90$DE3;(_P",/_!#'_F;
MO^X/_P"W]?O]7X _\$,?^9N_[@__ +?U[_\ \%J_^2>:;_V,%M_Z17U??_[)
MW_)//"G_ &+^D_\ I%#7Y _\W>?Y_P"A<K]?OVL?^2>>*_\ L7]6_P#2*:O@
M#_@BI_R3S4O^Q@N?_2*QH_X+5_\ )/--_P"Q@MO_ $BOJ^__ -D[_DGGA3_L
M7])_](H:_('_ )N\_P _]"Y7T_\ \%6_VKM<_9VT/3]*\/G[-=Z]]L1]05R)
MK:&V$(<0 #Y99// $^=T*JQ11*T<T/UA^RK^QWX:_90TN*UTR".?5#&RWFK2
M1*+JX9RC2*&^9HK?=&GEVRL40(K,9)B\TGY8?\$,?^9N_P"X/_[?T?\ !<[_
M )E'_N,?^V%?O]7X _\ -WG^?^A<KZ__ ."N?PTU'XB?#5I]/3S?[(U"#4;F
M,*[.;=(IX)&145L^7]H$TA;8B01RR%AL ;T#_@F+\4O^%H?"_2/-N/M%WIGF
MZ;<?N_+\K[,_^C1<(BOMM'M?G7=NS\[F428]0_;I\:V_@#X9>)[RZ61XY-+N
M+,",*6\R_'V*(D,RC8LDZ-(<Y"!BJLP"GY__ ."3/PON/AQ\,K:XNO,636;R
MXU(120M$T4;B.WBQN),B2QVZ7$<F%#),NT,H#O\ &'[ O_)POCW_ +C_ /Z>
M;>OO_P#X*C_\DA\0_P#<._\ 3E:4?\$N/^20^'O^XC_Z<KNOO^BOQ!_X+:?#
M34?$&AZ%XAMD\RRTJXNX+O:KLT?VX0>5*VU2BQ!K<Q,[LO[V6!%#&3Y?T^_9
M5^*7_"Z? V@Z\UQ]KN+O3X/M<_E^5OO(E\F\^38BC%PDJ_(HC.,QYC*D_*'_
M  5L\:V_A7X5WUG.LC2:K>6-G 4"E5D287I,A+ A/+M9%!4,=[(-NTLR_0'[
M#/PON/@Y\-_#^CWGF"Y2S^T3)+"T$D,E[(]X\#QL2RO"TYA;=@DQEBB$[%_+
M#_@AC_S-W_<'_P#;^OW^HKQ_X_?!RS_: \+ZGX8OFV1:A;F-9<,WDS*1)!-M
M1XR_E2I'+Y9=5DV;&.QF!_GA_97_ &J-<^!WASQ-\)[F.X_X226XDT_P_%'<
M%&@U*\G%A<0)=K(\4'DRN+RW*".%Y4NBUTCS1,?Z+O@I\+[?X*^&M+\.6OEM
M'IMG#;F2.%8%FD11YLYC4L%>:3?-)\S$N[%G9B6/X8_\%B/#FN?#[QEX;\>Z
M>?+B@MX;>VN%C,GV>^L;F6[C,H>-H?G$H:%&+&7R)\Q[(R6_?[PGXIL_'.G6
MFJZ?)YUE?6\-S;2[63?#,@DC?:X5UW*P.U@K#." <BOR!_X+1:__ &AX>\.^
M&+:WN+C4M3UCS[6.&/S-_P!FA: Q!5)D:5WO81$B(V_#C(8*'Y__ (*I^!?^
M%7_!OPQH/G?:/[,U#2[+S]GE^;]FTR[A\S9N?9NV;MNYMN<;CC)_3[]D[_DG
MGA3_ +%_2?\ TBAK\<?V[M6M]1_:)\$Q02QR26TGA^*=$=6:*0ZK+*$D )*.
M8Y(Y K8)21'QM92?V._:Q_Y)YXK_ .Q?U;_TBFKX _X(J?\ )/-2_P"Q@N?_
M $BL:_7^BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBO+_C
M1\(=+^/7A^^\-:RLC6-_&$D,3F.1&1UDCD1N0'CD1)%#!D8J%='0LC?DC^S[
M_P $\OBK\"KRYT:Q\86]CX3OKAS>FRWF^>$*R"2WCGMGCLKN5-B/-!.6A(1]
M]P;>)3H>-?\ @F9XJ\,?$A?&7P^UJSTJV>02M+>&XO;RVDGC:"^<"Z2Z6]>1
M7EG#7$T1:29H\QA%F/Z/ZM^RSX?U_P $2^ ;QKR?2YXW$T\MR[WDEP\YNWNW
MG;.ZX:Y)N6+*86D)4PF$^57Y@?"?_@G=\7OV<=4>#P=XSL[71)I$\UI(Y&8K
M((?/F&F30W-I]H7RPD;B97D1%4S0K(ZKV'C_ /X)4:C\0/&5AXAG\2W"^7;V
M\^IZH"_]J7>J1W+.\EN@VV]A$L)CBLS$SBS$$*"WEPTK?K=X \&I\/M+MM+C
MN;R\6VC"&YOKF2ZNIFR2TDTTA+,[,2<#:B A(TCB5$7P#]M/]F=/VKO!USX?
M62."^22.ZT^>7S/+BNHMP&\1L"4DC>6!F*R",2F812/&BUZ_\%/A?;_!7PUI
M?ARU\MH]-LX;<R1PK LTB*/-G,:E@KS2;YI/F8EW8L[,2Q]0K\0?VE/^"1LN
MMZY_PD?PXU"WT:X:XCG^PRF6"&VF4L[3V=Q;K))#AQ&T=N(@L3%VCFCC6*!>
M_P#@7_P3F\3:A>07GQ8\37'B2TLKCS[?16O+R\L7F10(9YVNRF_;OF4VXA"N
M-N^9XGFMW^P/VO/V<M<_:AT>3P[;:[;Z1I%QY#74?]F&[N)FAD,H7SVO(D2+
M<L+[4B$N^+_7F-VBH_9#_9RUS]E[1X_#MSKMOJ^D6_GM:Q_V8;2XA::02E?/
M6\E1XMS3/M>(R[Y?]>(T6*L_]N+]E:X_:^T&PT""^CTZ.'5([R>X>)IF$<=K
M=1 1Q!HP[F2:,$-)&%3>^YF58W\_TSPC\?[!#I<FM>$Y[8R2Q#6I+2[&I"!Y
M&VW(M(UCL/M$:,#' <PED5))) 7E;Z _95_9GTO]E#PU%X>TR22=C(UQ>74F
M0UQ=.J))*(]S+$FV-$CB4D(B+N:24O+)\O\ [<?_  3BTO\ :M<:UID\>E^(
MXXRKSF,M!?*D9$,=T%(975@B+=*)'2',;13A(%B^4/AI_P $T/BG<[-(\3^.
M;B#PVMNMO)9Z=J6H3^9;C;&UHL,ZP6\430[T#%9D3"J;:1"0O[7> / &E_"S
M2[;1=%MH[/3K.,1P01@[57)))))9G9B7DD<L\CLTCLSLS'L**_-#]N/_ ()Q
M:7^U:XUK3)X]+\1QQE7G,9:"^5(R(8[H*0RNK!$6Z42.D.8VBG"0+%\P?"__
M ()=>.M?M_[&\>^-+QO#D<<,2:5IM_=SQR1Q*?+3%XB00)"Z0-&H@N P4J!"
M51Z_:[PGX6L_ VG6FE:?'Y-E8V\-M;1;F?9#"@CC3<Y9VVJH&YBS'&22<FOR
MP\:_\$Z]9^%WC%?''PCU*ST>YDD'VG2+Q)5T]XWW-<1AH!(WV>1EBQ:>6!$^
MZ6"X@,5O'%ZAXI_9R^)7[3=G)HGQ%UC1]/T!]OGV?ARWE::^VL)8_-NM260V
MWD2Q0NGD(_G*TL<FWY&'U?>_":X\&>&H?#G@2XL_#T=O&88)'L6O5AC*OEXX
MS<P!KCS&$QFN&G$CAS+%,TC,/C#]D#_@G]KG['>HW%SI?BBWN[*_^SK?6D^C
M$>8L#EE:*5=0WQ2A7E1&(DB'FEG@E*IM] _;-_8XUS]L&*'39O$5OINBVUP+
MF&UCTDS3-,(O*#S7+7R;]N^;RUBC@4+*5D$K(D@]_P#V</A9KGP6T.VT#5]7
MM]7M["WAMK*:/3S93)#"&54F(NIXY=J>5'&R)"P6,F0S2.7'P!\ _P!CGXM?
MLA:='9^$->\/W]O=^9/?Z?JEI<16\%XZ6ZF2WN+;=<S\1&,&0V\>P!_LYDD_
M=?2'PI_96UG4O&,7Q'\?WUG>>([:S^QV%GID4L.GZ?'^^1RCRMY]T\B3.V9P
MHB>>90L@6W:'U#]J[]E'0_VM=#.E:J/)NX=[Z?J"(&FM)F !(!(WQ/A1/ 2%
ME4*0R2I#-%^2'@K_ ()=?%SX:W#:?H?C2/3=$>\+NUG?ZC;R-&65#<&SB183
M<&)5)C,^"56+[1M D'Z__LS_ +,^E_LTZ7):VLDE[JE[)]HU;5KC+76H73%F
M:65F9F"!F?RHMS! S,S232332_+_ .W'_P $XM+_ &K7&M:9/'I?B..,J\YC
M+07RI&1#'=!2&5U8(BW2B1TAS&T4X2!8M#]GK]G3XH1[['XG>)[?5]"BMXH8
M]-M41_MFW (O[J2SM[F6(!0)8B\GV[>R7+O 9H;GX@_X(8_\S=_W!_\ V_K[
MO_;T_8+M_P!L2WM+RSNX].UO3HYTAF>!7CN8W7<EO<.N)E190&CD4R" 27!%
MO*TOR^?_  O_ &0OB;XSM_[)^*/B^2]T*".%([#29C%)>JJF.2+4;W[);W4M
MN\1:.:,O(]R9#*TT<D2M)Q_PA_X)<R^#_&6K^)[K6[C2[*YU"\>STW0)I;#-
MC)<I/#;W%S'Y3I%M4Q2VENBA=L3QW8*@#]'_ (Z? O0_VB]#G\/^((/.M)OF
M1UPLUO,H(2>!R#LE3)P<%64M&ZO$\D;?B#IW_!*3XI_"2\ND\%^+K>ULI_*W
M31WFH:9-/L4D>=#:QSI\C/(L>99/E);Y"[(/U?\ V6OV0[/]G7[5J5]?W&O^
M)M0PM]KE[N:XDA3:L4$?F23/'$JI'N!D=I7169MD<$4/R_\ &?\ X)V^*/CA
MXMM/&E]XRM[?5-/^R_81;: %AMOLDAFBV)+J$I?]ZSRMYS2Y9RO^J"1K]_\
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MQ#X[TZ73]!U:WTC[3;W,$]R]E-<W"><FQ);62&^L_(ECRS*[";Y]C +L(?\
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M/K]GI37DETSVMS%Y,=M'/M8V\:Q6]Q!<6^\N8XI((A;B.WV^;*@E7T_XL?\
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MWB>/6M6LK.6#2H6M5EL[&=U,0NY9,6UU?W!B5$\Z1K>9(YKV'S7^U/-7A_\
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M/BSJ/QT\%Z1XDU6R_L^]O[<R2VX#A?ED=%FC$@#B*=56XA!+XBE0"248D?Z
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M/#WQ0\[^P=5T_4_L^SS_ +%=PW/E>9NV>9Y+OLW;&V[L;MK8S@X\_P#VL?\
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MG]1\6:=I%Y:Z?<W=O#>WWF_9+:29$FN/)4/+Y,;$/+Y:D-)L#;%(9L#FN/\
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M[J0%[CRA)N92I/P_X@_9>\)?'GX[W<CZ;;R:;X?T>UN-6ABBC@AFUJ\N9KF
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M^+[*TD77=2UR&*[O)+NZG:2-[6Z<H$FFDB1 88A&L:*(D18T"QC;7U_^Q_\
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M*_@79_M;V9^*OQ&@M]:U74[B==-MI=TEC8V-NTML($LG'E?ZWSV E^TC AN
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M87GG>#M"N);&/389;B.XU"952>(:A<B4/]DLUFC%G;VYB5G6,R#;:1"3YO\
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MO'ZW&IOHMQ:>;)]HN+?[7;R*YM/M,MO<1R7$L;PR^9Y@"/LMIF\VY#RCX?\
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M6KWMDT 2(JAC3RRNV,JI087:N,#L/^"7'_)(?#W_ '$?_3E=U\ ?M]?\G"^
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M9G9B7DD<L\CLTCLSLS']+_\ @J/_ ,DA\0_]P[_TY6E'_!+C_DD/A[_N(_\
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M /M_1_P7._YE'_N,?^V%?O\ 5^ /[ O_ "<+X]_[C_\ Z>;>OO\ _P""H_\
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MD@B^</\ @G?I-OH'Q]\;V=G%'!;01Z[%##$BI''&FL6RHB(H"JBJ JJH 4
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M?^G*TKXPU/P!JFD_LFBQDMI#<FSBOA'&!*WV676%OUF/EEL(+9A/)G!B0,9
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M17&LZBJ-'%;B&YA,FG6A=978SL)M[63)-+;+<B;Q_P#94_;9\?>,O$=CX?\
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M\,>)_#EQ:Q76H27L6HQWNGSPIOMXXVCFBCNC,N#;H(VB2?>TQ#K"D9=O(/\
M@IG\!OB%^UCJ.EVWA[PQ<?8M&^W+]KGU#3(_M+7#Q+NBB^UEUB"VZ.C2E)6\
MTJ\$1C^?]7M ,_QI\/7%EXGT2XTO[;;R6E]I\]S;R[TFA"SB*XL9WS$=[QI(
M3!.=I<Q193/X(^)/V9/BS_P3Q\2W&I_#E+S5]"NY(5 A@%XTT89I5MK^SC!E
M#QA'C-Y D8V2_NY[:2X>!/K#PGX;^,W[<\%I:>.[+3_#O@YKB&34K'[--!>:
MG##<"7R?*EEENK?$ELJ^9YEBWES^<@NE"H/O_P#:[.O:OX2U31/#NB7&L7NK
MZ?>62F.YL[:&W\^/R3),]U/$YPLKO&L*2[VB,;M"'62OC_\ X)C_  N\;?LW
M:3=^&/$_ARXM8KK4)+V+48[W3YX4WV\<;1S11W1F7!MT$;1)/O:8AUA2,NW(
M?\%,_P!E7Q9XVUG1?B%X'BDNM6T6,":!&B:2-;.5[RUGM[>1,3NLC2K)%NE>
M4FW2.W?]Z:[_ .%_[17QC_:.M_[+M/"T?A&YBCA%]K>K)=&,"13'(VG6$L$3
M27 ;,\*2RSV\8C$-Q(3+&[?('[)O[+OQ2^%WQ+\0ZQH=O'%IQO-1T]]6\2+/
M+)=6QOH93<QQ126\]W<2HBS).?+M)R)5\]'(V_?_ /P4=_8^N/VL/#4!TCR_
M[=TB22>R61F59XY% GM0Q=8HWE*1/'+(K /"L9>&.665?E#]G3]JCXY>"]OA
M37O VH:[=VV;>"_E>2PW>1YI=KG4)HYK*YRJHD4ZO'YVP,9+J6<.?']._9P^
M,W_"ZKKQ7;6VGW6I6OE23:I>0S6NB[KK2S$8;<*RW-S%;AFLXY(1)+OCBEN1
M&TCU^A_[?'A/QG\5?!$_@[0]$DU>^U".Q-UJ,4]E8V<;03I/*4ANKQKC>SP*
M%A.Y$CF!^U2/$R-H?\$\?"_BKX2>$+/PAXGT"XTV73OM;1WOVNQN;>=9KEIU
M7$%P\T<N9W7:8VBV0[S.'D$0^0/^"F?P&^(7[6.HZ7;>'O#%Q]BT;[<OVN?4
M-,C^TM</$NZ*+[676(+;HZ-*4E;S2KP1&/Y_U>\.?$/6M0T,ZE?>'-0M=23R
MU?25N=.FF=B(][03B\2V>)2[X::2VE=8F;R%9HT?\@?V6?@O\3O@S\3M:\<Z
MKX.N&LM=_M+S8+;5=*DFMOMETEXNSS+N%)]K1K$V3#E6,HY41/\ 7_\ P4=^
M%GBCXC:=H%QX5U*WM;_3-8CN[2QFB#/>W\:,UF;=O+E_>P[9F,<JK:>0\UU=
M2PV]HSCX@_XR\_S_ ,(W1_POC]I?]G+_ (GWB[2O[7T6+BZ@\K3W\N)?WTLV
M_2LRV^V**1?M$ZR6L6_,D;L8Q7[G?#WQK;_$K1M/URS61+;4K.WO(4E"B18[
MB)94#A690X5@&"LP!SAB.3V%?A#^U-\%_B=\9OB=HOCG2O!UPMEH7]F^5!<Z
MKI4<US]CNGO&W^7=S)!N:1HEP9L*HE/+&)/V>_X3*^_L?^T_[&U#[7_T"_,L
M/MG^LV??^V?8ON_OO^/G_5\?ZW]U7XP_LL_!?XG?!GXG:UXYU7P=<-9:[_:7
MFP6VJZ5)-;?;+I+Q=GF7<*3[6C6)LF'*L91RHB?[?_X*'>%_%7Q;\(7GA#PQ
MH%QJ4NH_9&DO?M=C;6\"PW*SLN)[A)I)<P(NT1K%LFWB<O&8B?\ !/'POXJ^
M$GA"S\(>)] N--ET[[6T=[]KL;FWG6:Y:=5Q!</-'+F=UVF-HMD.\SAY!$/B
M#]J;X+_$[XS?$[1?'.E>#KA;+0O[-\J"YU72HYKG['=/>-O\N[F2#<TC1+@S
M851*>6,2?I_^T1K,_B#X8^)[FYLKC3Y7\/ZQNM;EK=IH]MK.HWFUFN(3N #K
MLE?Y6 ;:^Y5_&#_@F/\ &?Q1\"_#-W>QZ#J'B'PS>ZQ) Z:2@GOK"\BLXY'E
M-J(P\T5RK6T8<SI' ;=R0KRQK/\ 6'Q=\'>+/^"E-_IVDW&BZIX4\$:;>/<W
MESJ:10:A>RI#$J)#9NC2PNHFN(XYM\MJR.\K[IH%M3^GWC75+KX8:,J>'-#D
MU.2",06FG6<EI9QQJD3")2]Q+#%#;J42(^4)7C#*4MW56 _)'_@F9\!OB%^R
M=J.J6WB'PQ<?8M9^PK]K@U#3)/LS6[RKNEB^UAVB*W#N[1%Y5\H*D$ID^3]G
MO%.LS^'[.2YMK*XU"5-NVUMFMUFDW,%.PW4UO"-H)=M\J?*I"[GVJWX@_LL_
M!?XG?!GXG:UXYU7P=<-9:[_:7FP6VJZ5)-;?;+I+Q=GF7<*3[6C6)LF'*L91
MRHB?]'_V\O"VN>-/A[J5AX9CN)=:EN-+-D+9BDRS)J=HZR)("OE>7M\QIBR+
M"J&5G14+#P_P-^VCXL\#64>E^-? GBR76[2."*XN=*L8M1M;IA!$6N1-;M#
MCR.7+00^8D)^3S-P9$/V&_V3]4^'&O>)/'_BBUCL=;\17EV\.GI<"X:PM9[I
M[B2.2>)O(F>5_*(*H2B0H0ZM--#'X!^UW^QWXL^%_C>+XM?#"".ZODD>XO\
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M>L\DD+16DQF:.VBN$6>2UNX8YI8C;1SF1#.+=>?_ &C_ -GOX@?LTZ'<^*_
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M$-W<7FJ:A_9P_M>Z1&TW1+>-;A)[A+1-D+7<H\H6MI$B)<S(\]PWE03%L_\
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MXCTCQ=J?VC^S-/U*W^QVI:/3HI;;4[>/=!#A-^W?(D<\ZM=-"0LDAQ@?5_\
MP43^*WQ!^#'ABXUSPC+I=GIUI' ;R[GWS:@))KJ&%%M;=X6M @W 2O.TA=)'
MV1Q/$KR?,'[).K_$W]JGX>6&FV&L7F@VT$=['>^)+R,WU_J4\MU<!8++S9E=
M+>"%U62^\Q)EN42WM]HMYG/C_P )OBI\0?V+/B]:>"?&.LWFO:3K<EO!!+/.
M]VSQW,DD%E=0B><O:N)\QW419AL$I"7.RUFK][O%GBFS\#:==ZKJ$GDV5C;S
M7-S+M9]D,*&21]J!G;:JD[5#,<8 )P*_+#]EGXE>)?\ @H!JFJ:]J-[>:9X*
MTR\>VTRPTZ5M/GO9<2LKWUU;7)O5>&WG@,L,,L=K-,T3K_Q[RK)R'[:WQ=\9
M?\$^KRRU3PQ>7&J:!J_GQ2V.M?:=2ALKR-8-K17\DXO!Y\:NT=K+.T:LEU*B
MMN @_0_]G75O'6OV\UYXQE\-SVT\=M+IDV@/=O')&ZNSO(]R2K(RF%H&B)#
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M7[]K'_DGGBO_ +%_5O\ TBFKX _X(J?\D\U+_L8+G_TBL:/^"U?_ "3S3?\
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M ?\ IYN*_?ZBOG_]K'_DGGBO_L7]6_\ 2*:O@#_@BI_R3S4O^Q@N?_2*QKZ
M_P""H_\ R2'Q#_W#O_3E:4?\$N/^20^'O^XC_P"G*[KX _X+G?\ ,H_]QC_V
MPK]_J_ ']@7_ ).%\>_]Q_\ ]/-O7/\ _!4&]_M/XR>#]/OM2N-/TU;?3':Y
MCN?L_P!A\_4YTGO(9'S';RJD4;&<CY?)C9LK&H'Z/_\ # O_ %/OQ _\'_\
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M -OSP+_PL3X7^)K+SO(\K3WO=^S?G^SW6^\O&Y<>9]G\O=D[-^_:^W8WR?\
M\$8=6N-1^'-W%/+))';:Y=10([LRQ1FVM)2D8)(1#)))(57 +R.^-S,3\X?\
M$,?^9N_[@_\ [?U[_P#\%J_^2>:;_P!C!;?^D5]7W_\ LG?\D\\*?]B_I/\
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M8T^2*(,Y2"!<K! L<(9@@8_I_P#\%1_^20^(?^X=_P"G*TH_X)<?\DA\/?\
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M_:<U2TT7Q#I\=GXM:.]2UN+> M:RP82XDBB=WDGMW9(0\L;EH9#:K)YWF-%
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M\6:8EX/ ?AF.VGM=1?SX(+ZZBD><M9PW-NN7-RJ6UWM4CR;(EKA)'MDKV_\
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M,]Q+!+M>2)[CZ \ ?\%K_"LNEVQ\0Z5JD>K>6!=K8Q6\EJ9 2"T+374<H1@
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ME?Z/J*_!'_@N5I-Q-;^%+Q8I#;12:I%),$8QI)*MFT:,^-JNZQ2LBD@L(Y"
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M$9GFD>.6X"+&VR/YP\2?!S0_VB?V@M.U/P$UO+I>F_8-6U_4;$":S%]%/+<
M>8'6%I;H1V\;&W9R9&GG9))8;O'[_4444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44445S_BGQ9IW@:SDU#5;NWL;*';YMS<S)#"F]@B[Y)"J+N9E5<D99@HY(%?
M&'[<'C]_$?@Z#PYX9N8YM6\:R0Z;I;PF.>-[6YVO>73[1(QLELS)YUU!'*81
M-%(-N5D7[/\ "?A:S\#:=::5I\?DV5C;PVUM%N9]D,*".--SEG;:J@;F+,<9
M))R:Z"N?\4^$].\<V<FGZK:6]]93;?-MKF%)H7V,'7?'(&1MK*K+D'#*&'(!
MKC_!7P0\*_#6X:\T/1-+TVY>,Q/-9V-O;R-&65BA>*-6*%E5BI."54XR!CU"
MN/\ &OP]T;XE6ZV>N:?9ZE;)()4AO+>*XC60*RAPDJLH<*S*& R S#."<FF?
M#W1M%TLZ':Z?9PZ2T<L1L([>)+4QS%C*A@51$4D+N9%VX<LVX'<<]!I.DV^@
M6\5G9Q1P6T$:10PQ(J1QQHH5$1% 5450%55 "@   "OS@_;5^'NC?&5+CPEX
M<T^SG\4:]>:=9ZUJ5K;Q/=:7IZ20WK7.HS(H(3R[6$6]K<SV[W8"_9_,,.RO
MTOHHHHHKC_$GQ"T;P=<6EGJ>H6=G<W\GE64-Q<10R7,FY%V0)(RM*^Z1%VQA
MCET&,L,_D#^U'\+[CXJ_M(>#K>#S$CLM+LM2GE2%I5CCL+Z^N!YF"HC261([
M<2,<(\R<.Q5&_:ZO+_&OP0\*_$JX6\US1-+U*Y2,1)->6-O<2+&&9@@>6-F"
M!F9@H. 68XR3GL-?\)Z=XK^S_P!H6EO=_9+B.ZMO/A27R;B+/ESQ;P=DJ9.R
M1<.N3@C)KH*****\O\%?!#PK\-;AKS0]$TO3;EXS$\UG8V]O(T996*%XHU8H
M656*DX)53C(&/4*\_P!?^$_A[Q7J-OJ^H:5I]WJ5IY?V:\GM(9;B'RG,D?E3
M.AD38Y+IM8;7)888DUZ!117A^K?LR>!=?N);R\\-:'/<SR/+--+IEH\DDCL6
M=W=HBS.S$LS,26))))->X4445GZGI-OK2"*ZBCFC62*4)(BNHDAD66)P&! >
M.1$DC;JCJKJ0R@CR_P 4_L]>#?'-Y)J&J^']'OKV;;YMS<Z=;33/L4(N^22-
MG;:JJJY)PJA1P *]@K\T/BY\/=&^+/C'0-*\(:?9JMGXD77?$NLV%O%Y<5SI
M'FF.SO)HU1)KV>:Y=7B,SW=H&:XDMFBEW5^E]%%<?XU^'NC?$JW6SUS3[/4K
M9)!*D-Y;Q7$:R!64.$E5E#A690P&0&89P3G0\+>$].\#6<>GZ5:6]C90[O*M
MK:%(84WL7;9'&%1=S,S-@#+,6/))KH***SY-)MYKB.\:*,W,4<D4<Q13(D<K
M1M(BOC<J.T43.H(#&.,D$HN-"BBBBBBBBBBBBBO'_%/[/7@WQS>2:AJOA_1[
MZ]FV^;<W.G6TTS[%"+ODDC9VVJJJN2<*H4< "O8*X_7/A[HWB>WNK._T^SNK
M:^D26\AFMXI([F2-8U1YT=2LKJL,*JSABHBC ($:XS_ OPG\/?"_SO[!TK3]
M,^T;//\ L5I#;>;Y>[9YGDHF_;O;;NSMW-C&3GT"BN/\:_#W1OB5;K9ZYI]G
MJ5LD@E2&\MXKB-9 K*'"2JRAPK,H8#(#,,X)ST&DZ3;Z!;Q6=G%'!;01I%##
M$BI''&BA41$4!515 554 *    *S_%/A/3O'-G)I^JVEO?64VWS;:YA2:%]C
M!UWQR!D;:RJRY!PRAAR :X_P5\$/"OPUN&O-#T32]-N7C,3S6=C;V\C1EE8H
M7BC5BA958J3@E5.,@8]0HHKS_P "_"?P]\+_ #O[!TK3],^T;//^Q6D-MYOE
M[MGF>2B;]N]MN[.W<V,9.?0****\?\4_L]>#?'-Y)J&J^']'OKV;;YMS<Z=;
M33/L4(N^22-G;:JJJY)PJA1P *]@HHHKY_\ ^&3OAY_T*GA__P %-E_\9KW#
M2=)M] MXK.SBC@MH(TBAAB14CCC10J(B* JHJ@*JJ %    %:%<_XI\)Z=XY
MLY-/U6TM[ZRFV^;;7,*30OL8.N^.0,C;6567(.&4,.0#7'^"O@AX5^&MPUYH
M>B:7IMR\9B>:SL;>WD:,LK%"\4:L4+*K%2<$JIQD#'J%%%%%%?SX_L-Z3;Z_
M\??B%9WD4<]M/'XBBFAE17CDC?6+=71T8%61E)5E8$,"000:_;[P5\$/"OPU
MN&O-#T32]-N7C,3S6=C;V\C1EE8H7BC5BA958J3@E5.,@8]0KR_QK\$/"OQ*
MN%O-<T32]2N4C$237EC;W$BQAF8('EC9@@9F8*#@%F.,DYZ#QK\/=&^)5NMG
MKFGV>I6R2"5(;RWBN(UD"LH<)*K*'"LRA@,@,PS@G/0:3I-OH%O%9V<4<%M!
M&D4,,2*D<<:*%1$10%5%4!550 H    K0HK/U;5K?0+>6\O)8X+:"-Y9II75
M(XXT4L[N[$*J*H+,S$!0"20!7S!^T5^T59>#O =[XA\/7L=]<WD;66AR6#07
MC7.I7#-;6R6R;F2Y=)LO)$@E;9#-^Z<H4/?_ +-?PA3X"^#M'\-*L:R6%G&E
MP8GDDC>Z?]Y=2(TN'*23O+(H(4*&"A$4!%]PHHKR_P :_!#PK\2KA;S7-$TO
M4KE(Q$DUY8V]Q(L89F"!Y8V8(&9F"@X!9CC).>@\:_#W1OB5;K9ZYI]GJ5LD
M@E2&\MXKB-9 K*'"2JRAPK,H8#(#,,X)ST&DZ3;Z!;Q6=G%'!;01I%##$BI'
M'&BA41$4!515 554 *    *T***X_P :_#W1OB5;K9ZYI]GJ5LD@E2&\MXKB
M-9 K*'"2JRAPK,H8#(#,,X)SG_\ "I_#W]C_ /"/?V5I_P#8O_0.^R0_8_\
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MG\ZTF^5T;"S6\R@%X)T!.R5,C(R592LB,\3QR-X!^T+^UK>>#-83P7X'TO\
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MV'/VX]+_ &O=+,<@CL_$=G&#?V )VLN0OVJUW$LUNS$!E)9[=V$4A8-#-/\
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M/T_^UC_R3SQ7_P!B_JW_ *135\ ?\$5/^2>:E_V,%S_Z16-'_!:O_DGFF_\
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M_M2V]SXDM;>QU2;S))K2WE,R6ZOH#M#"TI $LL<1C2>1 (GG61HQY12OT_\
M^"H__)(?$/\ W#O_ $Y6E9__  2LTFWT[X2:++!%'')<R:A+.Z(JM+(+ZXB#
MR$ %W$<<<89LD)&B9VJH'PA^WU_R<+X"_P"X!_Z>;BOV^^*OPTT[XR:'?^'M
M53?9:A;O!+A49DW#Y98_,5T66)MLL+E6\N5$<#*BOQ1_X)+>/W^$'B7Q-\+=
M8N8S<PWDTEHJ&,0275DS6U^(I'$<\CR)'!)''L($-O-*5B(??]W_ !/_ .+]
M?%71O"S?/I'A.W3Q%?F/]XK:HSM#IEM,\>U[66%3)?1HTC"ZB)5[=HU$@^_Z
M*^$/VKOA5\-]"UG2/B;XXNI+*;0I(8K=Q+)Y<\BRM-:HUO$DDTKPRF2X1;<*
M2!(TXEMXRJ?"'[:7[37BC]HOX9ZU<Z;X6N-*\(G^SI3JVK2B*YNHFN+-XUM;
M% Q^>66)TNO-EM7MHI@&$[*B?;__  2X_P"20^'O^XC_ .G*[K\\/^"B&DV^
MO_'WP19WD4<]M/'H44T,J*\<D;ZQ<JZ.C JR,I*LK A@2""#7]!U?SH_ 7PP
M_P"SY^T_>>'M*ECCL;V2_$D45O'%&MK=6)U6.U1/F$:02"!%:(H6$(X1':*N
MP_X+G?\ ,H_]QC_VPK][M)TFWT"WBL[.*."V@C2*&&)%2..-%"HB(H"JBJ J
MJH 4    5_/#^TAX8?X$?M+^']1T>6.!M<O-*N72.WC18UOIFTV]0@[E=YU2
M>62;:C[[AF'[U?-;L/\ @J5K^H^+?BGX(\,6UOI\_E?9)[6.^C=[>:XU#4!
M8KQ5)WVA^R0AT1 Y1YAE]RA?O_\ XR%_ZI__ .5FOF#]FG]@KXA_"_XH-X_U
MK4-'6WO;C4I]2MM.N;T>;]N29_*6.6W17B6X>*0)+(VWRE?+2(I/O_[0N@?"
M_P#9?\7I\6O$MQ<0Z[-;RP6MK'(\OVJ>*V,)EAME&[S?L^VU+R21V,?F1M((
MYY%F/YX?\%+?C+XQ^,_@JSO-2\,2>'?#R:XHMFU"?_B97<GDWJ0L;,(ILT6.
M.9ITF+EVEMS!))$KR-^UW[)W_)//"G_8OZ3_ .D4-?D#^P+_ ,G"^/?^X_\
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MQ5\9/VP?[._MZY\'V_\ 9GVGR/L4NIQ[OM/D[_,\Z";./)3;MVXRV<Y&/?\
M]N[0-1\*?L_W>GZO<?:]2M-/T."\N?,>7SKB*[L4FE\R0"1][AFWN [9W, Q
M(KT#_@EQ_P DA\/?]Q'_ -.5W7W_ $5^ /\ P7._YE'_ +C'_MA7[_5^ /[
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M2_B74=0BD+:#9W]MIR/<22+;M930::[Q@;%"2K+=2F$J41[EV^:4"4_N=7X
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M/'^ER^%=5\/"YC_M:/5);YK0DB0VLEO:PK,H( =!)&R/L+&,F/>%\V+?Q_\
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MQ_#GX@Z7;:I'XBTNS6YC#FVOKVVM;J%LD-'-#)*&5U8$9&Y' #QO)$R.V?\
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M"FE26\<-O=DBS@:?3H[A#*J@*4DO'B,\DV4:-52=OLL6U/N__@K!\5=#\/\
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MY\3=$^*,$$EY8W-Y87$\9=E5;S3##B R"$I"D\$,9AW&:1GCNGV;(U6OW^\
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M&W@G]H"\6^\3V-QJ$J9\I9-2U!88=RHC>3!'=)##O$:&3RD3S&4.^Y\L>_\
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M^,?P(T'X^V:Z?XBAN+FR&=UM'?7EK#)ED<>=':SPI/M:-&C\X/Y; LFTLQ/
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M]#;AD\S;)]G@N(H3*!*Z^<4,I1MA?8 H/@I^R_X5_9V\Q?#%K<6,4VXR6_\
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MDA=C&L;.T#S0RZ'A;PGIW@:SCT_2K2WL;*'=Y5M;0I#"F]B[;(XPJ+N9F9L
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M_M'VC[/O\BZ^S[]_E[OM7D?9O*SSY_F>1L_>>9Y?S5]OU\P?&/\ ;0^'_P
MKQ=/\1:W;VUZ<[K:-)KJ:/"HX\Z.UCF>#<LB-'YP3S%)9-P5B-_X*?M3^"_V
MB?,7PQJ]O?2P[C);XDAN J>7ND^SSI%,8@947S@AB+ML#[P5'N&K:M;Z!;RW
MEY+'!;01O+--*ZI''&BEG=W8A515!9F8@* 22 *\?\)_M*>#O&VEWVN66L6;
M:3IMX]E=W\DGD6L=PAC!43S>7$Z$S1".6-FAE+KL=LUP'PA_;B^'GQWU1=%\
M/:U'=:B\;R1P/;W5NTBQC+B,W,,2R.%RYC0L^Q7DV[(W9?;_ !U\6/#WPO\
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M#S3;#(AD\I'\M6#OM3+#G_C7^U/X+_9V\M?$^KV]C+-M,=OB2:X*OYFV3[/
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MXK;88D<F0>:H'DR&-6,>]IGE_H>\:_#W1OB5;K9ZYI]GJ5LD@E2&\MXKB-9
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MSM5W6*)78 %A'&"2$7'C_P#P6:^#>B?#[5-&UK3H)$U'6Y-3DU&>2YN)VF:
M68A $\LBQI&LC)''$$1$VQA0B(J_L?H'[$OA*XTZXB\46=OXDU?4/,?4]8O[
M>-KRXFE01N89 -]E$BA8[6"U:-;6-$"-Y@:5ORP_X)=63_"KXN>-/!UA-(VD
MVT=^FV41M)(VFZBEM;2/(J*=ZQSS!@FQ',A)3Y4V^X?MZ>)+S]HWXB^'/@U8
M7OV?3;K;>:YY-RH:15WW'V>15BD:.6*WMVN((Y-T4LMS;221*L44M?I]_P *
M!\+_ /"+_P#"%_V9;_\ "/?9_L_V'!V;,[MV[/F>;O\ WWG[O/\ /_?^9YWS
MU^&/_!,/P5;_  U^-GBS0[-I'MM-L]7LX7E*F1H[?5+6)"Y554N54%BJJ"<X
M4#@?L_\ M>_%Y_@1X#USQ# TB7-K9LEK)&D<C1W5PRVUM(4E^1D2:6-Y P8;
M%;Y)#A&/V0OA"_P(\!Z'X>G61+FULU>ZCD>.1H[JX9KFYC#Q?(R)-+(D94L-
MBK\\AR[?FA\6=:G_ &ROCS9>"';[3X3\*XO+^VCGMY;>:XMXP[R3QNA63%Q-
M!ILUNWG/&@N=ODF:X*?K]XI^%6A^--#D\,W]A;RZ++;K;&R"!(5A0 1I&J;?
M*\O:IA:/8T+(C1E&12/P1_9.\;W'["GQEU'X9W=Y)-X>U&\6WMT:1I%CN+I(
MI=.G8+ ";B2-X;.Y\M882\@D=VBMHB.?_P""S7P;T3X?:IHVM:=!(FHZW)J<
MFHSR7-Q.TS0"S$( GED6-(UD9(XX@B(FV,*$1%7]?[W_ ()]?#?7-+ATS4]&
MCOY(Y#--J,\D@U*[N'+M+/=W\+17$[R/(\CJS^3N*[8U6.)4^O\ 2=)M] MX
MK.SBC@MH(TBAAB14CCC10J(B* JHJ@*JJ %    %<_X_\!V'Q/TNYT;5$DDL
M;R,Q7$<<\UNTD9(W(9+=XY0C ;9%# 2(6C<,C,I_!'_@FSX6L_ WQU\9:5I\
M?DV5C;ZU;6T6YGV0PZM:QQIN<L[;54#<Q9CC)).37ZO_ +:'PG\/>*_!OB/5
M]0TK3[O4K3P_J7V:\GM(9;B'RK:>2/RIG0R)L<ETVL-KDL,,2:_/#_@D3\$/
M"OQ*\"ZA>:YHFEZE<IKEQ$DUY8V]Q(L8M+-@@>6-F"!F9@H. 68XR3GL/^"O
M_C:\\$?\(7<S6?\ :&@6^L/>:A:21*;>XFM?):WMYI6BD">;$]Z@C(*R(9&,
M4OE?+]G^*)? ?_!1+P=?:7IE_9ZC!)&3%*%8W&GW7[V.VNFMW,-Q"ZNCE%D\
MD7,(D3+02ON]O_9Z\+7G@;P;X?TK4(_)O;'1].MKF+<K[)H;:..1-R%D;:RD
M;E+*<9!(P:]@K\,?^"SWP;T2PT&T\7I!(=;GU2UL7N7N;AU%J+6[D\F.!Y6@
MB3?&LA\J-"7+N26DD+?7_P"RG^REX5U[PAH>LZ_9Q^(+Z_T/1B)-7AM[M;2W
MCLHO*M+*-H1%;VZ%G;"KYTKNTD\TSX8?E!X3^#+_  G_ &@[[P#X.U2\T/3M
M0C>VEN(?+FNH[&:PCU.>WMYIE9HGW1B*WN1NN( (Y"\KJ_F?I_\ M;_L0?#Z
M+X<ZN+'1+/3Y]'TNXO+.[M(4BNA)8VSO&)KC:9;A'"[)Q.TAD#&0L)U29./_
M ."-OBF\\0?#66VN9-\6GZQ=VUJNU5\N%HK>Z*94 MF6XF?<Y9OGVYV*JKH?
MMF?LJ^+/VA?B-X-OHHK.[\):9(DE]#<-%MB9;E9KL2Q.A>=+J&*""*-?.3?&
MPD6"-VE?C_\ @KCXL\#:OX+NM/OKO3YO%5C<6O\ 9ULLRO?6[S21/-NCC)DB
MBDM0[-YP6!R(&YF^SFOH#_@G"\OC3X.:%%?SW$OFV]_;&07$J3+"EY<P1I',
MCK+%Y<2K'"T;(T*H@C*;%Q^0'_#/MGX6_:-_X0WPG<W'AZR'R13VKM+<00RZ
M)Y]V();AI'2657F2.<EVMGE$J*3$BU^I_P"UO^Q!\/HOASJXL=$L]/GT?2[B
M\L[NTA2*Z$EC;.\8FN-IEN$<+LG$[2&0,9"PG5)DX_\ X(V^*;SQ!\-9;:YD
MWQ:?K%W;6J[57RX6BM[HIE0"V9;B9]SEF^?;G8JJNAXL_95\6>.OCY8^--3B
ML[KPKIMFALWD:(M$T=O(L< AV>8UPE[*]['*P9$3:5N!+'' ORA_P64\6>!O
M%>G:=]AN]/N_%EIJ#VLOV:99;B&SB2;[1!<^42J;+@Q;([C$BN9O* !N:_8[
M]F35KC7_  +X:O+R62>YGT/3)9II79Y))'M(F=W=B69V8EF9B2Q))))K\@?@
M=J;_ +4?[2&L7/B,1RKX4CU&/2X$BC$2KI]\+6W,@=79W5KF2[$FX.MUL=&2
M*-(E_1__ (*$?"^W^*OPRU^WG\M)+*SDU*"5X5E:.2P!N#Y>2IC>6-)+<R*<
MHDS\.I9&^$/^"0WP5\(>+?#UOXP_LGRO$FD:A>V7]H?;+EO.WPJWF?9_,%NF
M(;O[/MV/GR_-W!W^7P_X>?MD>#/BI\4M3\7_ !#UB,Z3H<DD/A*S-A>R6X5I
MVV7ZQQI(4N!'#'(YN8R[S3QNGD_8X(XN@_X*-_M)_!_]I/PG-)H^H1W/BBTD
MM6L94TZYAGEC64I);R7,]HI^SK'//.(O,C!F1&&3E'^K_P!B#5(/V\_A4FF^
M.DN-173]0>RN)&O;B)KW[,D4\$D[6S0.^Q9XT*RM-YDL"W3LTQ!3X _X)%?!
M33OC7_PD,&L27$NFVEQHUQ-IBL@L[YT^W&%;Y#&9)HHG E2#S$@DD"F:.941
M5]@_X*]?LO>$OAQX>TSQ-H6FV^EWO]H1Z?)'911V]O+#)#<SAI(8T5/-1HL+
M*NUF1V63S L/E??_ .S;^SMI/Q1\/:?XN\<QV_BK7]=T^QNYKK4K.WD2WADA
M$L-I9VQ0PVT48E8R&)5:YG:2>3[R1Q_FA\ O!5O^S/\ M-S>%?#C20Z3/'/"
M\,A65OL\VEC4O($CJ7"1SI'Y;9\[9&JO))ND+_M]^TI\7D^ O@[6/$K-&LEA
M9R/;B5))(WNG_=VL;K%ARDD[Q1L05"ABQ=%!=?QQ_82_:[^''PVL[[Q3XWU[
MSO'.NW$KZA<RZ?>R306ZL$AM4DAAEA$1$2S!8!$@5H8"FVTB"_,'[=_[0/@N
M?Q;HOC;X4:CY&M1_:6OY;6SDLU$PD$D<[K-;0^?+<>?<)=&0S+-$B1R+M+"3
M]#_^"AGA31/CM\'XOB->64B:LNEZ3<V(-Y</'9KJ-S:-,BQ!X[=W*3&-YFA#
MR!8\X\N,(?\ !-7]F31O'_@'2=>\4)'KJF.^@TRPOH(I;/3;?[?,9Q# X9'N
M)YD,LMU(#-Y8AMDV11'S?D_XY_#33OV5OVA_"O\ PB*?8(M4N--GE@54:&+^
MT+R>PNXH$92(HI(@^$&?):1O),2+$D?Z_P#[:'PG\/>*_!OB/5]0TK3[O4K3
MP_J7V:\GM(9;B'RK:>2/RIG0R)L<ETVL-KDL,,2:_/#_ ()$_!#PK\2O NH7
MFN:)I>I7*:Y<1)->6-O<2+&+2S8('EC9@@9F8*#@%F.,DY_<ZBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOB
M#_@I#X6O/&'PH\1VUC'YLJ6\%RR[E7$-I=074[Y<J/DBBD?:#N;;M4,Y53\_
M_P#!'WXQV?CGX?\ _".HNR]\/W$L<RY9M\-[--=0S9**B[F:>'RU:1AY'F,5
M$J+7Z/\ Q5^)>G?!O0[_ ,0ZJ^RRT^W>>7#(K/M'RQ1^8R(TLK;8H4++YDKH
M@.6%?AC_ ,%@XM4\>^%?!'BBXL)+&-XYQ>6\K#S+2ZO[>UN$M75Q'*746]PK
M-Y:A3$0XC9E4_M=^S]\2_P#A<GA+1?$+/;O+J&GVT]Q]F;="EPT:_:(D^9RO
ME2^9$R,S/&R%&.]6KXP_X*V:GI=A\*[Z/4!&;F>\L8].+Q%V%T)A(YC8*WE/
M]FCN@9"4!0O%N)D"-S_PA\%7'@#]FB:SNFC>23PGK-X#&6*^7?PW5[$"653O
M6.=%D&,!PP5F4!CQ_P#P14_Y)YJ7_8P7/_I%8UX!_P %SO\ F4?^XQ_[85^_
MU?@#^P+_ ,G"^/?^X_\ ^GFWK]_J_ ']@7_DX7Q[_P!Q_P#]/-O6A_P7*TFX
MFM_"EXL4AMHI-4BDF",8TDE6S:-&?&U7=8I61206$<A (1L?M]\/?&MO\2M&
MT_7+-9$MM2L[>\A24*)%CN(EE0.%9E#A6 8*S '.&(Y/X8_M]?\ )PO@+_N
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M4%5V88J60-^OWP!^,=G^T!X7TSQ/8KLBU"W$C199O)F4F.>'<Z1E_*E22+S
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M?^A<K]_J*_ ']OK_ ).%\!?]P#_T\W%?O]7X _\ !#'_ )F[_N#_ /M_7O\
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M=934)(8)%,4ALH=/\F5;U!)Y]O)(Z0@PE696=&'N'[-?[-=G^R5X2_L#0/\
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M]+K'V[[;:+>ZA;K_ *9.MTWD2&QF,>V5$QYBS9B#(?G82I[_ /\ !0?]@_\
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M0*\?_P"&L?AY_P!#7X?_ /!M9?\ QZC_ (:Q^'G_ $-?A_\ \&UE_P#'J/\
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MCB\PHRQ[][#8K$?A#^QW\-]6_P""EOBC4O%/Q'>XOM T[>MO9+-<6]FMW<A
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MX]VQRD;,I:-"OL&DZ3;Z!;Q6=G%'!;01I%##$BI''&BA41$4!515 554 *
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M\%P?&MQ8:-X;T-5C-M>7EY>2.0WF"2RBCBC"G=M"%;R4N"I)*QX90&#?5_\
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M-0U:*VN(#?1H#IT-O\T45NXL$GDLYXGDVQSQB,;F=6>*9))WC_7[]ECXU_\
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MM(X50\?'^/?"OB/PA\(/$EOXLU?^V=:;P_J\EU<K!!!"C-92_N8$AAAS%'C
MDE4RRL6D(C5DAB_,#_@E_?>-/%_@V]\,^$&_L93K$]W?>)+BVCNHK=3;6BQ6
MEE;2,$N;N1HB;@R;8K6U(;YIIX O/_$?QA\2O^":_CG2;G7O$FH>)/#=_P ,
M;B>6?S[=&B%ZBVEQ<OY%W#O1X)%E"/NC!E*/<VZ_T/>+/%-GX&TZ[U74)/)L
MK&WFN;F7:S[(84,DC[4#.VU5)VJ&8XP 3@5^8'PFU/Q1_P %$/MOB&35]8\*
M^#([@V^C6>ER"SU&[>#(DO;B],3YB.]HC;P-)!YR%"?,LS-<^ ?$OXS^-/\
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M_2*&OR!_YN\_S_T+E?K]^UC_ ,D\\5_]B_JW_I%-7P!_P14_Y)YJ7_8P7/\
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M\+[BZUG7/%3>8EM;V::;&#"WES27$J7$FV;(7? MO%OC 8XN8V)0;1)]7_\
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M20^(?^X=_P"G*TH_X)<?\DA\/?\ <1_].5W7P!_P7._YE'_N,?\ MA7[_5^
M/_!#'_F;O^X/_P"W]>__ /!:O_DGFF_]C!;?^D5]7W_^R=_R3SPI_P!B_I/_
M *10U^0/_-WG^?\ H7*Z#_@N+XIO+33O#&E))BRN;C4+F:+:IW36J6\<+[B-
MXVK<SC:I"MORP8JA7]KOA[J>EZUHVGW6AB-=)FL[>2P$41AC%J\2M $B*H8T
M\LKMC*J4&%VKC _/#_@KSX%_X2WX7W%[YWE?V1J%E>[-F[SM[M8^7G<-F/M?
MF;L/GR]FT;]Z\?\ L^:M<:U^S%<RW4LDTB^&_$40>1V=A'";^*) 6)(2.-$C
MC7HB*J* J@#/_P""*G_)/-2_[&"Y_P#2*QK]?Z_ '_@AC_S-W_<'_P#;^O?_
M /@M7_R3S3?^Q@MO_2*^K[__ &3O^2>>%/\ L7])_P#2*&OF#_@J7\"XOC!\
M.KV^B@\W4M"_XF%LZ^4K+"F!>JSR#=Y7V??,T4;(TDMO!C>R+&W/_L$_M;:=
MXE^$K:A>#_2/!^GR0:A;0!/--O86Y>WECC:8L?-MXPH>0PI)=1W"J%C3(]P_
M8$\%7'AGP'9:GJ+1RZMXBDFU[4;B,MMGN-3;STD*%42-_(,$<D<*)"KHVT-D
MN_V?17Y ?\%J_P#DGFF_]C!;?^D5]7W_ /LG?\D\\*?]B_I/_I%#7XX_LH>/
M+?Q#^TOXGEUYXYKZ236;+3'>!2RR6<R11+&43$3I86TT9E.PN@=&=GF(D_H.
MK^=']K7PW<?#C]I?P[J-K=R+)K-YH-P?+W1-%&\RZ9+ 75R9$ECMW\SA0R3-
M"R,H+/\ T745^ /[?7_)PO@+_N ?^GFXK]_J_ '_ ((8_P#,W?\ <'_]OZ]_
M_P""U?\ R3S3?^Q@MO\ TBOJ^_\ ]D[_ ))YX4_[%_2?_2*&OA"Y_:FU3XM^
M(-6\'? W2]+4K)+<ZKXGF0)IZW4R2+),BP1$7%P\BQB&ZD\\7+Q2G[--:1FY
M'PA^T?\ #[6/AW\=? \.O:W<:_J5Q<:%//>30QVR#_B;2Q)%;VL.8[>)4B0E
M%+;YVFG)#2E5_I>K^/+]F#Q)X\\&>"O&.I>![B2!8)-*_M8V\*O=)8O#J:M-
M%*S;H4B;#2O#&;A 5N%FMXK>8O\ T/?\$Z?C?X?^,/@.PAT6WL].GTN,6U[I
M5JSE;63<^V3$O[TI<@&X61VF+.\J/<3SQ3/7O_[3>K7&@>!?$MY9RR07,&AZ
MG+#-$[))'(EI*R.CJ0RNK ,K*05(!!!%?B#_ ,$NOV>;?XW^%=1E7Q7XDT>Y
MMM4=9+#1M66TC\M[> QW$L'ER-OD998Q*<!Q!L&3$U??_C7_ ()AZ-\2K=;/
M7/%GC34K9)!*D-YJ\5Q&L@5E#A);5E#A690P&0&89P3G[/\ @)\%-._9V\.6
M?AC2I+B:RL?.\J2Y9'F/G3R3MO:..)#AI6"X1<* #DY)]@KS_P"*OBG0_!>A
MW]_XFDMXM%BMW%Z;E0\+0N-C1O&0WF^9N\M80KM,SB)4=G"G\T/A3\6_B1^V
M);Q2^ 8K/P+X*LY/L]K?3VD=W>7,=NLT:K:VC*+1;=<01RQKM$$B.D-Y<>5+
M ORA_P $V= _X13XZ^,M/^T7%W]DM]:@^TW4GFW$WE:M:IYL\F!OE?&Z1\#<
MY+8&<5_0]17X0_\ !0/Q3>7?QU^'>E/)FRMKC2+F&+:HVS76K&.9]P&\[EMH
M!M8E5V94*6<M^[U?@#_S=Y_G_H7*T/\ @N5JUQ#;^%+-99!;2R:I+)"'81O)
M$MFL;LF=K.BRRJC$$J)) " [9^W])_8;M]?MXKRS^(7CR>VGC26&:+Q$KQR1
MNH9'1UMRK(RD,K*2&!!!(-<_HW_!+;PKIWB6S\676M>)-1U:SO+6\$U]?6]P
MTLEHT;1"9VM!*Z 1HF-X(0!59<#'QA_P7._YE'_N,?\ MA7[_5_,#_P2_P#A
M=_PT5J/B7[=XI\0:3J1^R73?V7JOV6XOO,>Y\^>XWI+)<>6[1YD/W'N#N):9
M:_5_Q3_P39T[QS9R:?JOC+QQ?64VWS;:YUI)H7V,'7?'):LC;6567(.&4,.0
M#7TA^R_^R_HW[)FC3Z'H<]Y/;3WCWCO>/$\@D>**(@&**%=FV%2 5)R6^8@@
M#\D/^"&/_,W?]P?_ -OZ_?ZOP!_8%_Y.%\>_]Q__ -/-O7W_ /\ !4?_ ))#
MXA_[AW_IRM*/^"7'_)(?#W_<1_\ 3E=U\ ?M]?\ )PO@+_N ?^GFXK]_J_ '
M_@AC_P S=_W!_P#V_KW_ /X+5_\ )/--_P"Q@MO_ $BOJ^__ -D[_DGGA3_L
M7])_](H:_('_ )N\_P _]"Y7[??%7Q3H?@O0[^_\326\6BQ6[B]-RH>%H7&Q
MHWC(;S?,W>6L(5VF9Q$J.SA3^:'PI^+?Q(_;$MXI? ,5GX%\%6<GV>UOI[2.
M[O+F.W6:-5M;1E%HMNN((Y8UVB"1'2&\N/*E@7Y0_P"";.@?\(I\=?&6G_:+
MB[^R6^M0?:;J3S;B;RM6M4\V>3 WROC=(^!N<EL#.*^G_P#@M7_R3S3?^Q@M
MO_2*^K[_ /V3O^2>>%/^Q?TG_P!(H:_(']OK_DX7P%_W /\ T\W%?H__ ,%(
M?%-YX/\ A1XCN;&3RI7MX+9FVJV8;NZ@M9TPX8?/%+(FX#<N[<I5PK#R_P#X
M))ZGI=_\*[&/3Q&+F"\OH]1*1%&-T9C(AD8JOFO]FDM0) 7 0)%N!C*+]W_%
MCP+_ ,+0\/:KH/G?9_[3T^[LO/V>9Y7VF%X?,V;DW[=^[;N7=C&X9R/Q1_X(
M:ZM<36_BNS:60VT4FERQPEV,:22K>+(ZIG:KNL42NP +".,$D(N,_P#8%_Y.
M%\>_]Q__ -/-O7W_ /\ !4?_ ))#XA_[AW_IRM*/^"7'_)(?#W_<1_\ 3E=U
M]_T5^<'[4O[66G?"3Q1:Z%X2T2W\0?$74+<V<:HJ*]I;N&GB6ZN OF>5OVW+
M6OF0H(%>YEFMD,4DOYX?\%+?ACX\T?P59ZUX[\11ZA<R:XL<&DZ? L&FV:S0
MWLA(<HD]VZI%"D$EP ]NK7$>Z8RM*?VN_9._Y)YX4_[%_2?_ $BAK\D?VL_V
M'_B#\+/&.H_$7X73R!;N3[7<6EG,ZWBR'-Q= Q2LR7MO+-"LQM@7,DDRVZV3
MQ1ACV'[(_P#P4U_X3O6++PC\2=.\GQ#'J$=I8WJ6FW9>-&]HPNH6/F6MV[N\
M#26Z"/\ TEXGBM84=G_;ZBOP!_X+G?\ ,H_]QC_VPK]_J_GQ_P""-7CRW\9^
M*O%UYJSQS>(]2CAO1,8%$CQM<3-?LKH@2)&FFM6>)2@<^650B'Y/Z#J_G1^$
M_ANX^%7[5=WIT%W(\=[>:G<3[-T2R1W^G2ZF()$#L)$BD>/&XX=X4FV(P55_
MHNHK\D/^"QWPA3QKX#A\0HL8N=!O(W,CO(&^RWK);2QQHN49VF-HY,@!5(GV
MN"2DGT!X _;!M[;X-6WQ(U3S)I(-+!N!(JQ-<ZA"YLF4"W218DN+Q=L;A-D:
M2+(\<:JRK^0'B'PWX@_X)^_$;PGXQUV[D\SQ%&UQXDGDV>5]HN[EFU: 6]B^
M72UCGMYH\"2&6Z19HD95%O%^M_QQ_P"+N_%7PEX0;FRT2WN/%5_%)\BRO$_V
M/3&ADCS*98+EI))(F,4#Q,-QF($8]_\ VL?^2>>*_P#L7]6_](IJ^ /^"*G_
M "3S4O\ L8+G_P!(K&O /^"YW_,H_P#<8_\ ;"OT/_X*::M<:+\)/$4MK+)#
M(T=G$7C=D8QS7UM%*A*D$I)&[QR+T=&9&!5B#\0?\$_?V6K?XP_#S3=2@\9^
M++"027D4]AI6M+!:VLB74I"" 0N87>-HYV5CEC-YN-LBU]'^.O\ @E9X>^*'
MD_V]XG\8:G]GW^1]MU2&Y\KS-N_R_.M'V;MB;MN-VU<YP,:'_!03P5;_  U^
M!&HZ'9M(]MIMGHUG"\I4R-';WME$A<JJJ7*J"Q55!.<*!P.P_P""7'_)(?#W
M_<1_].5W7P!_P7._YE'_ +C'_MA7[_5^ /[ O_)POCW_ +C_ /Z>;>N?_P""
MH-[_ &G\9/!^GWVI7&GZ:MOICM<QW/V?[#Y^ISI/>0R/F.WE5(HV,Y'R^3&S
M96-0/T?_ .&!?^I]^('_ (/_ /[GK/\ @W_P35\*_!7Q9!XSM=3UR]U:&2YE
M+WUU;S+-)=12Q2O,5M8Y7<B9WW;P2^&8MR#\(?M]?\G"^ O^X!_Z>;BOW^HH
MK\ ?V^O^3A? 7_< _P#3S<5^_P!7X _L"_\ )POCW_N/_P#IYMZ^_P#_ (*C
M_P#)(?$/_<._].5I1_P2X_Y)#X>_[B/_ *<KNOR _P""7_PN_P"&BM1\2_;O
M%/B#2=2/V2Z;^R]5^RW%]YCW/GSW&])9+CRW:/,A^X]P=Q+3+7ZO^*?^";.G
M>.;.33]5\9>.+ZRFV^;;7.M)-"^Q@Z[XY+5D;:RJRY!PRAAR :^D/V7_ -E_
M1OV3-&GT/0Y[R>VGO'O'>\>)Y!(\441 ,44*[-L*D J3DM\Q! 'T?1111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111117G_CKXL>'OA?Y/]O:KI^F?:-_D?;;N&V\WR]N_R_.=
M-^W>F[;G;N7.,C/\N7[/'QH\/Z3^T"WBJYOHX-$NM<UN6*]E#QQ^7?+>1VSO
MO4-$C--'N:4((@Q:0QJKE?ZG?!7Q"T;XE6[7FAZA9ZE;)(8GFL[B*XC60*K%
M"\3,H<*RL5)R RG&",_GA_P5@^*NA^'_ (<:IX?N;^W35]0^P&UL=X:XD5;V
M*4R>4N76(+;S?OG"Q;T\O?YC*C'_  2?^*NA^(/AQI?A^VO[=]7T_P"WFZL=
MX6XC5KV642>4V':(K<0_OD#1;W\O?YBLB_G!^W)\?O"_B#XX>%M=L=3M[O2]
M'_L7[==VQ-Q#'Y&HRW<NQX@XFV12(S>3YGS$Q?ZU71?V?_:=^$VG?ML?#^[T
MS1;W3[C[5LFTW4 4NK=+BVFZI+$7V;MDMK)+%N>-))1LDPT3?B!^R9^W-KG[
M!%Y<> _&VF7#:;9W%PTL*DM?6<TBHRK ))Q;/:.090J%%D-RUVD\BD)+]X:G
M^UB__!1U!X'\#Z=JEGI=S)%_PDNK731VK6FF^8K/#;-!+<*UQ=JLD*I*&5D$
MB-#)"TTUM^QU%>7_ !H^$.E_'KP_?>&M961K&_C"2&)S'(C(ZR1R(W(#QR(D
MBA@R,5"NCH61OP!^$5SX@_X)'^,=1C\2V5YJ/A+4XTB&H64">7-(GFR6<BF7
M"K<*HN(Y;)IXRHD>8&>.*!Y?VO\ "W[:WPU\86<=];>*-'2*7=M6YO(K28;6
M*'?!=-%,G*DKO1=RX=<HRL?/_$?Q2U']J&4:%X%N+BUT-_,&J^*HXWC41)+)
M ]IHDLB!+F[D:*16OXO,M;*+]ZCRW+PJGH'[3O[-&G?'OP-=^$8(;>VVVZ?V
M5A$CBM+BV7_1=F(I/)B&!!)Y*;Q:O+$F-U?F!_P3J_:NB_9U^U?"GXB'^Q+W
M3+B=K*>\>*&WC5_W\EK)+A47<S27-O<.\D5RDVQ)5 MEF]__ &Y?VC[/XS^'
M+CP'\.;G_A(/$.L_9HY$TB9IEMK%YP)II[J!7MDB8HMI<1S30A8KH22D0G#_
M %!\)-)T/]A+X=:7IOB+4[>TM].MV%Q<33#;)=R^;=W$=L-D<DV7,WV:%(S<
M/$BKL>0,3^0'_!%GXJZ'X(U'Q!I6J7]O9WNJ?V6+&*=Q']H:)[F-HXF;"-*6
MN(@D(/FR;B41@CE?H#_@M'\5=#O/#-AX9AO[>76HM8AN9K*-P\T,*6<X+S*N
M?)S]IA,:R[&E5RT8=4<K]W_L7?&OPUXI^'.C26FJ6;KH^AV$>I@S*C636]MY
M<INE<JT"!H)BLD@5)$0RHS18<_CA_P +^\+_ /#3W_"4_P!IV_\ 87VC[/\
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MDI^==%MX%NM4\F31/*@+6Z.H65HFCN9X"VZV!DC9F>)L_K?_ ,% _P!EV_\
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M]AOX_>%_#_QP\4Z[?:G;VFEZQ_;7V&[N2;>&3S]1BNXM[RA!#OBC=E\[R_F
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MFEO/&--A46MV_G1VZ1*QN"RMF>621]LCQ@B(1I'^IW[)W_)//"G_ &+^D_\
MI%#7T!117YP?$7_@G/IWQ"^*%K\27U:XB\FXL;N;3Q C>9<6"(L)2X+#RXCY
M,!DC:*5VQ*%E3S$\G]'Z*****\O^#?Q>TOX[Z)!XAT5I'TZZDN4@DD0QM(MO
M<2VQD"'YE1VB+QAPK[&7>D;[D7\ ?^"S7PT?P?JFC:I)JNJ7[:I)J;BVO)XW
MM;)819A8[*&.*)84*N!(3O>4QH\CO+O=_P"DZBOA#]N/]ARW_;0M]+5M4DTN
MYTN2X,<@MUN8WCN5C\Q6C\R%M^Z&(HXDPH\Q3&Y=6C^O_A[X*M_AKHVGZ'9M
M(]MIMG;V<+RE3(T=O$L2%RJJI<JH+%54$YPH' ["BBL_5M,36K>6UE,BQS1O
M&YBEDAD"NI4E)8F26-\'Y9(V5T.&5E8 C\ ?^"JQU?\ 9HN- G\*^(?$EE'J
M4=\EQ =>U*>/=:M;E)%,]Q)*'87#*XWE,)'M1&WL_P!7_"?]C;4?BAX-TK6O
M^$^\<6^I:GH]I=[O[:>2WBN+FV27/D[$D>)7?_5^<KL@V^:&.\?&'AC]OOQY
M^R)X\E\$^.[V/5]'LKRWLYKRYA5;J*QV_NKU)+7S'D=X9(;J:.X^UW#A?)WQ
MSM(]?T/:3JUOK]O%>6<L<]M/&DL,T3J\<D;J&1T=259&4AE920P(()!K0HKR
M_P"+WPT?XM:6VEIJNJ:.KR([W.E3QV]T50Y\L3/%*T:%MI8Q;'8+L+^4TB/^
M*/\ P0Q_YF[_ +@__M_7ZG_MD_LK6_[7WAI- GOI-.DAO(;R"X2)9E$D:R1$
M21%HRZ&.:0 +)&5?8^YE5HW[_P#9N^"%O^SAX3TWPK:W$EW'81R W$BJC223
M2O/*P1<A$,DC^6F7*)M5I)&!=O<********_FQ_X+-?#1_!^J:-JDFJZI?MJ
MDFIN+:\GC>ULEA%F%CLH8XHEA0JX$A.]Y3&CR.\N]W_I.HHHHHHHHHHHK/U:
MR?4;>6"*:2VDDC=$GB$9DB9E($B"5)(BZD[E$B2(2!N1ERI_G1^%O@#_ (5?
M^U+;Z1]OU#4_L_F?Z9J5Q]IO)?,T!Y/WLVU-^W?L3Y1MC5%YQD_T?4444444
M44444445\H?MD_LK6_[7WAI- GOI-.DAO(;R"X2)9E$D:R1$21%HRZ&.:0 +
M)&5?8^YE5HW[_P#9N^"%O^SAX3TWPK:W$EW'81R W$BJC2232O/*P1<A$,DC
M^6F7*)M5I)&!=O<***_+#_@K)\-'U[P#J.O'5=4ACTZ.T1=,@GCCT^X::_MT
M:2ZB$7FSNH93$'EV1/&CHBLTID]0_P""7'_)(?#W_<1_].5W7W_117E_B[XO
M:7X*UO1?#UTTAU'7I+M+*-$)7;96[7,\DCG"JBJ$0#)=GE3:A02O'ZA11117
M\V/[4OPT?X8?'WP9!+JNJ:Q)=WFBW;SZG/'-)&TNL2@PPB**&*&W4INC@C14
MC+OM 4A1_2=1111111117\V/_!9KX:/X/U31M4DU75+]M4DU-Q;7D\;VMDL(
MLPL=E#'%$L*%7 D)WO*8T>1WEWN_])U%%%?G!^QW_P $Y]._9"\0ZEKUMJUQ
M?_:[=[2U@D@2+R+=YDF(F=6;SY?W4*B1%MTXD/E'S%$7Z/U^./[-/BW2_P#@
MH)X\\5:MK1DU+PYH,EE#H6DW#&332LJW<)OY;.2*-9+B18Y)(C<(SVZW+1'<
M88'B\_\ VCO^":?B#P;XQT_Q?\()(].FDO%::V\U((].D?(>YBW JUDREA<6
M820J&:.*":WE\BW_ '.HHHHHHHHHHKR_X:?%[2_BT^JII;2.NCZI/I5R[H44
MW5O'$\PCS\S(C2^46(4,Z.4W1;)'_('_ (+/?#1[70;3Q&^JZI*LNJ6MHFEO
M/&--A46MV_G1VZ1*QN"RMF>621]LCQ@B(1I'^IW[)W_)//"G_8OZ3_Z10U]
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MPJHJAF:25HT &P,97C1_C#]@?]M[4?VS;SQ"]SI]OIUEIO\ 9WV2&.1YIO\
M25N!+YTS;$D^: -'LBAV*Q5O,(WG[O\ '_C_ $OX6:7<ZUK5S'9Z=9QF2>>0
MG:JY    +,[,0D<:!GD=EC16=E4_ 'A+X[?&/]H5!K/A#0=#T7P]-&KV,GB*
M6Z>ZO8VDEVW"QV+9@1HUB;RY5((=9(KBYB<,O/\ [(7_  44N/B_XEF\!>,=
M-CTOQ1;R74(:U=I;6>XM&F-Q!MS*8'CCC)5C-/#.8Y6$D1,,4G/_ +;?_!3"
M]_9PN&TG1O#]XUV9)8X]1U6VGMM/D:%H3(;1/W<MZ@#O&TBO B/Y4J-<0R*6
M_6^OC#XW_M4W'AWQ!;^!?!EC'K7BVZC:2:-Y6CL]*MRGRW>HR(K,$#-&_P!F
M3;-+&P >.2:T6X^7_BK^V%\4OV1+BUO_ (AZ+H=]X<NI(K<WFA3SQR17$C.Y
M4)>R%Y76&&9_+\J*%RT8^V1D,M?I?X6^*NA^--#C\36%_;RZ++;M<B]+A(5A
M0$R/(S[?*\O:PF638T+(ZR!&1@/A#P'^T!\5_P!INP3Q+X%TWPWIOAZ>2>*T
M&NSWDMY<K!,\9N2MB/*@1BOE^0Y=TDCD8221-$Y]0_93_:DUSX_:YXDT?7-"
M_P"$?N/#_P#9\3VCSFYF,UR;MG<RA(HVB9(H6@,:%64M*LTL<L>S[?HK\\/V
MCOVS-4\)^,=/^&W@>PL]1\4:A&LCS7ER%L[%>92+B.)A,[BWCEG>/="Z1M!)
M&MR91#7A_P 6?VU?B=^Q]J-E+\1-#T>_T"^Q&+W06ND\F;>"R,UXS!I5B621
M+=U@6XR"ET/)G"?J?I/CRPU_1HM?LWDGTZ>S2]A>*"9Y)+=XA,C);JAG9V0@
MK$L9F8D($+G;7Y0K_P %7$;Q];>'M1TF3PYH4$=U)J=QK221:@JI8-=0!;5#
MB!VD4(D>;M[I)(O*6.1PAS_VE/VY/C#\*K/_ (22T\%V^F^&3Y:K-J;&ZNQY
MS,89;F&TNXGLMZF-'AF1O)N#Y+3L\B)7Z/?LQ?M"Z=^U!X7M/$NGIY/G;X[F
MU,J2O:W$1VR0N4/TDC++&\D$D4ICC\P*/ /VI?VWO^%2:Q:^"_"6G_\ "0>,
M]0RL=BDFV*TWQLT4MTP_X#,T.Z'%JKSRSVT9B>7YP_:H^,WQ7^$/A754\=:7
MH=[H6JZ7J.G-=^'_ +89+"ZNK=HK22Z6\8 V\DC^4Q0 *6!,GF>3!<W_ /@B
MI_R3S4O^Q@N?_2*QK]?Z*_(#XO?\%1I?!_C+2/#%KHEQI=E<ZA9I>:EK\,MA
MFQDN7@FN+>VD\ITBVJ)8KNX=0NV5)+0%20?'3]M/XJV-G/XK\$^%;>;P3#;^
M=%J.H([7-S"K$->K9QW<%S%:,,21;X2WV8?;'9(G*1?2'[#G[<>E_M>Z68Y!
M'9^([.,&_L 3M9<A?M5KN)9K=F(#*2SV[L(I"P:&:?Y__;;_ ."F%[^SA<-I
M.C>'[QKLR2QQZCJMM/;:?(T+0F0VB?NY;U '>-I%>!$?RI4:XAD4L?&_]M3X
MI/;V^L_#[P7)>^'+B1EM=0N8)[JXOHV7,5Q'IUK+#=VMNVR5HY;A6$\+V\G[
M@R+&_P!W_$C]H73O@7X23Q3XP3^RV^SPM-8K*EQ-]LDCW&Q@92J7$H8.@==L
M95&F9HX5=T^<-)^*_P 8_C7;Q:YX3TGPWI&B74:262:[<W5Q>75O*HEANR-.
M)A@26*2,?9G9YHI$DW.RE#7'_L]?\%&/^$P\4/X#\=Z3_P (UXDB\J!=T^^W
MNKS WQIE1Y/FY62R'F7$=PCA4N'=H/M'V_\ '3XZ:'^SIH<_B#Q!/Y-I#\J(
MN&FN)F!*00(2-\KX.!D*JAI'9(DDD7XPLOB=\?\ Q]93:UIGAWPWI%L8Q)::
M3JL]W+J4B^0D@!>%X8$>1RR+'<BT>%AY<RH%\UM#]@__ (*#V?[7_GZ5>6?]
MGZ_9VZSR11LTEO<0KY<<L\+%<Q8E< V\A=E1XRLT_P"],7TA^TQ^TQI?[-.E
MQW5U')>ZI>R?9])TFWRUUJ%TQ55BB559@@9D\V7:P0,JJLDTD,,OR?\ $OXR
M?'?X7:<_B>ZT/PO/I%ONN[S38+JY.HVEC&C3S++<R21VKRQ1H8GEMTG#3$/'
M;2QY ^H/V4?VKM#_ &M=#&JZ4?)NX=B:AI[N&FM)F!(!( WQ/AC!. %E4,"J
M2I-#%Q_[6_[:6E_LMI:64=K)K'B/4I(TL-&MG(GE5Y/+\QRJ2M&A;,<($;O<
M3?NXT(6:2'P_7_CE\:_@GIUOXG\7Z+X?O-"A\N35K/1C=MJEG;NA,DV)I7MG
M^SG!F$;RH0&/F)!ONHOC#_@B/)<0V_C1K...6Y$>E&&.61HHWD"ZAL5Y%CE:
M-"V SK'(5!+"-R-I^W_ ?[?FJ:U\3T^&&L^&H].OO,G22ZBU47<86.S>\CD1
M?L<)=)8U0J&:-T$@WHKJT8^[_B7K6N>'].>Y\/:=;ZK>Q[F^R3WIL?,549ML
M4OV>X0RLP1$6411?,6>>,+\WR!^PQ^W/_P -H_VO_P 2C^RO[*^Q_P#+Y]J\
MW[5]H_Z=X-FWR/\ :W;OX=O/A_[;?_!3"]_9PN&TG1O#]XUV9)8X]1U6VGMM
M/D:%H3(;1/W<MZ@#O&TBO B/Y4J-<0R*6/C?^VI\4GM[?6?A]X+DO?#EQ(RV
MNH7,$]U<7T;+F*XCTZUEAN[6W;9*T<MPK">%[>3]P9%C?[O^)'[0NG? OPDG
MBGQ@G]EM]GA::Q65+B;[9)'N-C RE4N)0P= Z[8RJ-,S1PJ[I\H:G\3OC_XE
MTL>(-%\.^&[2&>.*2#0[Z>[?5D5BJD32%[.T5SS/Y;M"\41$+J;A&0^H?L9?
MMT:'^V'9S+!'_9VM6F6N=,DF$K"'=M2>&39'YT1RJR$(C0RD(ZA7ADF/C'^T
MMKC^+5^'G@*RT^]\0C3SJ%Y=ZA=%+'3H1(BJL\5ONN999 R@1+Y31BXM9_WL
M+2>7X_XI_:D^)WP.U;0-#\7Z%H]Q_;^L6-E%K6E3W7V&!9[B*.6WDM[A/-^U
M^5YLD3M+'$X965)?L]PA_3^BO/\ XJ_$O3O@WH=_XAU5]EEI]N\\N&16?:/E
MBC\QD1I96VQ0H67S)71 <L*^(/"?Q<^-?Q-TZT\5Z3HOA>'1;RWAO;?2+B]N
MWU26W9 XC6[1$LDEN%^>!I$"0"6-9UW)(*]@_8S_ &D]1_:?TG5=4U+3/['E
ML=8FTX6+,[S0^1;VS2+.SI$3*)9901Y<6Q0L94NC.^?\;_VJ;CP[X@M_ O@R
MQCUKQ;=1M)-&\K1V>E6Y3Y;O49$5F"!FC?[,FV:6-@ \<DUHMQ\O_%7]L+XI
M?LB7%K?_ !#T70[[PY=216YO-"GGCDBN)&=RH2]D+RNL,,S^7Y44+EHQ]LC(
M9:^P/B-\>M;UWPU9ZU\,=(C\5-J<<C6\_P!MM[6U@4*0LDPN)(II'$N$>U01
MN#'-'++;2HJO^*'_  31^-OCN+4?%NJZ+X<_X2J]U2XL[G4I?[2M-,\J:1[V
M3?MECV/YS22G;$%6+9C #*!_1]X3U&\U?3K2YU"U^PWLUO#)<VGFK-]GF= T
MD/FH DOEL2GF* K[=P&"*Z"OR _X*C_$3Q?_ ,(AXAT;_A%_^*;_ .)=_P 5
M!_:MM_S\VDO_ "#]OVC_ %W^C?>_Z;?<XK@/V"OC-\1_"GPXT:RT'P)_;.FQ
M_;?(U#^W[*S\[=>W#/\ Z/,AD38Y:/YB=VS>/E85^QWC_P ?Z7\+-+N=:UJY
MCL].LXS)//(3M5<@   %F=F(2.- SR.RQHK.RJ?A#PM^T;\2OVF[./6_AUH^
MCZ?H#[O(O/$=Q*TU]M8Q2>5:Z:TAMO(EBF1_/=_.5HI(]OSJ//\ PM_P48U'
MX8^+8_ WQ5TFWT2];<%UFVG<Z;-OD(MIDCF4O%:2*"C7#32>5,I$T=N!.+;[
M0_:;_:+3]FS1GU0Z3JFKR>7.ZQ6%K))'$L$1D:6\N IBM;<':'D?<X#,Z0RK
M%+L^ /@7_P %&_&/[1.C:B/#/A>/4_$<=Y<^5:QS?9[.PT\Q1_8Y;V[N71+F
MX>9I$%O UN]Q';SR!;8("_7_  F_:J^-OC?P]>SS_#[=JZW!BLWDF72K=5,)
M)>:UU"X%U+Y<AC(,3+%<(\D8FMY+<F7X _X)H_&WQW%J/BW5=%\.?\)5>ZI<
M6=SJ4O\ :5IIGE32/>R;]LL>Q_.:24[8@JQ;,8 90/L#_@K_ *C>:O\ "S0[
MG4+7[#>S:Q827-IYJS?9YGT^]:2'S4 27RV)3S% 5]NX#!%=?\-OVF?%FH^!
M="T?X6:!'XBOM-T/1X-0OY[F*#3[.Z^R6[-:#S)H#>7"Q[OM"0RH+-W@$C,[
M/"NA^PE_P4/U']H37+[PAXPL+?2]?@\U[=8E>W63R"$GM7@N97F6[B.^0JI;
M=$DVY(?LY:7]7Z*_)#XD?\%,+W3O'6A^#-*\/WEG'J.J6%O->:U;3VDDMK<7
M;6KR6EFWERA& 5X+B9@01)&]F&7(_1_XO?%%/A!I;:F^GZIJC"1(TL]*LI+V
MZD9SU$:85450S-)*T: #8&,KQH_Y@_L[?\%3;CXU/K*R:/&;[S+"#P[H5I,T
ME]>W$\=P9Q-</LB6WB,(FGNC###9V['S/-?RQ)Y_\1O^"D?Q-_9Q\2V<'C_P
MI9Z?HEY))(D=NYGNC:ABN(KQ+J2TEN(<HTL92(R KE;99XY%_;[2=6M]?MXK
MRSECGMIXTEAFB=7CDC=0R.CJ2K(RD,K*2&!!!(-:%?E!_P %.OC)X[\'^%]7
ML=$T/RM >WB@U#7YKJT;,-V?(E@M[+S&F^<RQPFX==R[IMD*XBNQP'_!-[XJ
M^.]+\$^'-*L?!WVS0#<3QMK?]M6D6V&74)S/-]B=#,?(+2#RP=TOE94C>M>/
M_P#!<[_F4?\ N,?^V%?9_P 8OVN/'GB.WN+SX3^&8]=TFRDD676KB56M[IK=
M7^TQZ?:)/!<7B*^U([J!I$FFCGAABEPDIT/^"?'[>'_#7]G>66JP6]GK^G[9
M)8X&VPW%O(S!9H(I)'F7RCMCN 2Z*SPN)/WXBB/VW_V^I?V4HGMK'0=0O;MM
MD:7]Q;RP:1'-+%+(B"Y*_P"E2IL1WMX2JM&9%^U1RQ2(OV?\$/&MQ\2O"NB:
MY>+&ESJ6EV-Y,D081K)<6\<KA S,P0,Q"AF8@8RQ/)^</C'^TMKC^+5^'G@*
MRT^]\0C3SJ%Y=ZA=%+'3H1(BJL\5ONN999 R@1+Y31BXM9_WL+2>7X_XI_:D
M^)WP.U;0-#\7Z%H]Q_;^L6-E%K6E3W7V&!9[B*.6WDM[A/-^U^5YLD3M+'$X
M965)?L]PA_3^BOP!_P""YW_,H_\ <8_]L*_7[]D[_DGGA3_L7])_](H:_GB_
MX+)>*;/Q!\2HK:VDWRZ?H]I;72[67RYFEN+H)E@ V8KB%]R%E^?;G>K*O]%O
MP0TQ_A1X%T2UUPQV4FE:'8QWYEEC$=NUK:1K.7E#&()&4;=(&*84MNV\U\H:
M!^UKXM_:A^T2?"?2]/.EV=Q)!+K>OS216\TT6"T%O96A:\^>.6"XBN)O*79Y
ML3PI*%KR_P 2?\% O%7[+WB"TT#XKZ)9Q6U[)NBUW1Y+AK/[.40$I;SI)-*\
M,IQ<@21S)&RNEM(#";G]7])U:WU^WBO+.6.>VGC26&:)U>.2-U#(Z.I*LC*0
MRLI(8$$$@U^"/_!#'_F;O^X/_P"W]?I?^V#^V*G[)]A]J&AZIJ\GEK(TD$$D
M>GP*TR0J+K4#&\4+N6;RHT69RZHKK$LT3MV'[&?QKU']HGP)I?B?58[>&]OO
MM?FQVRND(\F[G@78LDDKC*Q*6R[98DC P!H?M,?M,:7^S3I<=U=1R7NJ7LGV
M?2=)M\M=:A=,558HE568(&9/-EVL$#*JK)-)##+\?_$+XO\ Q_\ !GA_4/%4
MNC>$[2TLX[BZ?2Y9KNXU"&UA=B=\L4Z6<SI"OG,T<B&1 =L2S$6X]0_9L_;G
M_P"&K?"^IZIX;TC=XATK;YVBSWGE))YA<P^5?FW,9\U(Y F^--LZ&.3RH2ER
MWA_P"_X*2>)?VBO$LWA73/!D=KJ-K'/)>"^UIK=;5;=A'()E_LUI@XE9(?+6
M-W5W&Y517=/U/\4W.HVEG(^E06]S>C;Y4-S</:PME@&WS1P7+IA=S+B)]S *
M=H8NOR!^QE^U9KG[6EG-K$_AO^QM%7*6UW)J!G:[F5MKB&+[)#F*/#+).7"^
M:!$BR,LWD_;]%?@#_P %SO\ F4?^XQ_[85]G_&+]KCQYXCM[B\^$_AF/7=)L
MI)%EUJXE5K>Z:W5_M,>GVB3P7%XBOM2.Z@:1)IHYX88I<)*=#_@GQ^WA_P -
M?V=Y9:K!;V>OZ?MDEC@;;#<6\C,%F@BDD>9?*.V.X!+HK/"XD_?B*+V#]LW]
MK_3OV.]#AU2YM_M][=W @M+%;A(&DP-TLK,P=UBB7 9TCEQ+)!&P42[U^7_B
M1\<OCY\$M#3Q3K.B^%[W3[?R9M2L=/-\;ZWMR-TY9FE>%?*&4EEA^UI"3YVR
M6WCD=?L#]FO]IRS_ &J?"7_"1Z!!MNU\R":QN9&C6*^CC5S ]PL3YB.^-EN(
MXG/E.&,(E#P+\?\ _#Q+Q1_PL#_A6W_"&V_]N_:/)S_;X^S[/)^T_:/,_L_=
MY7V?_2,;//V?)Y/G_NJ_4_29+B:WB:\CCBN3&AFCBD:6-)"HWJDC1Q-(@;(5
MVCC+ !C&A.T?$'AC]J/QCKWCR7P,_A6S)LX[>?4=3MM=^T6MI;SKN0N#I\<H
MN& 80VLJPS2D>:-MIFZ'H'[1W[5-O\#[C3]#TRQDUWQ5JTBKI^BV\JQ2/'N/
MF7$\I5UMK=%5SYLBD,4?I%%<30?)_P 8_P!HWXU_LO6:^(?$^C^%]6T"#/VX
MZ3<7=O-#O9(8,O>,Q^>65,>5!<_*CA_)RLE??_P+^.FA_M%Z'!X@\/S^=:3?
M*Z-A9K>90"\$Z G9*F1D9*LI61&>)XY&]@HK^<'XI?$BS^$G[4MQK-\EQ-%!
MY:K!:PM/<3S3: D$$$$2<O+-+)'#&"57>XW,B;F'U!\<?VY/C#\(<^)Y_!=O
M:>##<6_E_:V)U$6\NW;]J\B[?[%++RO[ZV*6LTD=N_G2 >;]_P#[*/[5VA_M
M:Z&-5TH^3=P[$U#3W<--:3,"0"0!OB?#&"< +*H8%4E2:&+0_:8_:8TO]FG2
MX[JZCDO=4O9/L^DZ3;Y:ZU"Z8JJQ1*JLP0,R>;+M8(&5562:2&&7Y/\ B7\9
M/CO\+M.?Q/=:'X7GTBWW7=YIL%U<G4;2QC1IYEEN9)([5Y8HT,3RVZ3AIB'C
MMI8\@?4'[*/[5VA_M:Z&-5TH^3=P[$U#3W<--:3,"0"0!OB?#&"< +*H8%4E
M2:&+C_C?^U3<>'?$%OX%\&6,>M>+;J-I)HWE:.STJW*?+=ZC(BLP0,T;_9DV
MS2QL 'CDFM%N/E_XJ_MA?%+]D2XM;_XAZ+H=]X<NI(K<WFA3SQR17$C.Y4)>
MR%Y76&&9_+\J*%RT8^V1D,M?=^O_ +2&CV?A>W\6Z1!J'B"PN_+^RQZ-9R7M
MQ-O)!_=*%\KR]K^=]H,/E.C0MBX*Q-^>/[.W_!4VX^-3ZRLFCQF^\RP@\.Z%
M:3-)?7MQ/'<&<37#[(EMXC")I[HPPPV=NQ\SS7\L2>?_ !&_X*1_$W]G'Q+9
MP>/_  I9Z?HEY))(D=NYGNC:ABN(KQ+J2TEN(<HTL92(R KE;99XY%_;[2=6
MM]?MXKRSECGMIXTEAFB=7CDC=0R.CJ2K(RD,K*2&!!!(-:%?F!^U_P#\% =<
M_8[U&WMM4\+V]W97_P!H:QNX-9(\Q8'"LLL3:?OBE"O$[J#)$/-"I/*5?;]_
M_#36M<\0:<ESXATZWTJ]DVM]D@O3?>6K(K;99?L]N@E5BZ.L0EB^4,D\@;Y?
MF#]I/]I[Q1\"M8TS2]-\,6^N_P!M7#6^G)!K(@O'>.-))6EM9+,[(DRY>=))
M8(8T$EQ);^8BD_:K_;)E_95T>*\N_#^H:E>M;Q2W'V1)3I=JSR1Q%)]4>W5%
MW,SK !"99"J>9#;B:,GT#]C/XUZC^T3X$TOQ/JL=O#>WWVOS8[972$>3=SP+
ML6225QE8E+9=LL21@8 T/VF/VJO#7[*&EQZGXAED+3R>7:V=NJO=7# KYABC
M=XUV1JP:61V1$!5-QEDB23Y_U;Q=\?\ 6K>74].T7PGIT?EN\6D7MW=W>H!H
MU(\MKFW:&Q=Y64M$=T:(DB)*ZLKL#]DC_@H9I?[2NJ7?AS4]/D\/>([6214T
MZYF,C3+",3*CM% PN(65_.MFC#JB^8ID"3B#0_X*C_\ )(?$/_<._P#3E:4?
M\$N/^20^'O\ N(_^G*[K0_;(_;,?]G2XTKP]H=A'JWBC7I##86CW,<,<+2,(
M8);@%@Y22=U2-"84E$=Q_I,)BY^?_C?^T_\ &?\ 9/M[?7?%6C>&]7T+S&CN
MSHSW\<D#,NV$RRW.\0H\C*!)Y$R$KY+-%)-"6^[_  M\?(OBIX+C\8>$;&XU
M?[5;M)9V!>*TFDF60PM#))<.L47ERJZS2!I%VQN\(N,QK)^",WQH^(>M_M!V
ME_J?A^.?Q'I\<]O9^'X[ZUA6*U>PN)HXC?\ SPNZQ7+W,DK$F1RT:K$"D,7[
M_?"KXDZWK6C76J>,]'C\+26LDI>*74K>\C%K%$DANGN(@D4:9,@97P4$1<G:
MPQ\H:!^TG\0_VF/M&H?#+3-'M_#UO<200:IXA:]7^U-N%:6SM[5%DBBC=9%9
MYBWF[D4"*:*XACY_]GK_ (* WFJ^*'^'WQ)TZWT#Q4GE+&T,ZR6=S-.!+% ,
M23""5HI(?*!FG6>3>FZ*8Q6[_H?X_P#'^E_"S2[G6M:N8[/3K.,R3SR$[57(
M   !9G9B$CC0,\CLL:*SLJG\X/AE^T_\5_VK4GUKP'HVAZ7X<CD:&UG\0/>-
M/?,DD@:6$6>%5%4(DB8D1)O,C2YG*2+%^8/Q:^,VJ?&7XV>"7U_2Y-'UW2[S
M0].U6T;!C%U%JCRF2W;<Y:WECFBEB)+##X62>,)/+_4;117Y8:+^V9XU_:7\
M2ZOHOPLL-#_L[09&CNM6UBYFE@NF9O+A-LEBVY4=HKEXY,SI+"B2,UN[+%)G
M_#3]O[Q#X,\<I\//BAH]OI^I7=PL5AJ.G><;.?SV6.TVQ2F61HIG$BBY63]W
M(5AFMX6CN'C^T/VF_P!HM/V;-&?5#I.J:O)Y<[K%86LDD<2P1&1I;RX"F*UM
MP=H>1]S@,SI#*L4NSX?_ &>?^"DNJ?'#1KA[+0X]3\43:I=1Z=H-E<"$QZ;!
M%;RFZO[RX+10HIF:%9V2);JX\N&&!29#'YAX3_X*4>.?A;XYM/"GQ6T33])M
M[OR4::WW1>1]H8+#=-/+=SVTMHIW).R.OE8D;>9+=X'_ &NU;5K?0+>6\O)8
MX+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!7Y@>$_P!LCQU^U7JE]%\*M*TM
M-"TR1XI-:UXW:P7DF(]B6\5L$EC?!DD*OYI\EH7F%I)(D,GY0_\ !3?XS>)?
M'-QH_A[QGI<>G>(=$DU(S2VNXZ?>VMVUM]ENK-I&:78P@D1U<DJZ<E)3+;6_
M]5M%%<?X_P#&2?#[2[G5)+:\O%MHRXMK&VDNKJ9L@+'##&"S.S$#)VH@)>1X
MXE=U_/#]E;]O[4?VG?B'JGAC^Q_[)TW3M/NI?+NM_P#:)N+>]A@_?KE8X/DE
MQ);;)'BF0C[0Z\5]?_'3XB>+_ 7V/_A%/"__  DGG>=]I_XFMMIWV;9Y?E?\
M?"MYOF;I/N8V>7S]\5^ /_!*3XB>+_ 7_"1_\(IX7_X23SO[-^T_\36VT[[-
ML^U^5_Q\*WF^9ND^YC9Y?/WQ7]'WPM\1:QXKT>WO=>TO^QM2D\SS]/\ M4=Y
MY.V1U3_2(0(WWH$D^4#;OV'YE->@45^<&D_M+>/OVC[S4V^&-EX?71=(U";3
MWU/6;J>9=0FC5&9K./3\[(DSN$LCNMQ%- Z;&$T:=!\#/VI/%OC'Q]/X!\4Z
M%;Z5=Z?H\M[/=0SR3PW[+/:PQ7%EO2/R[1_,G;8YGE5ML+O'+!,C?3_QT^.F
MA_LZ:'/X@\03^3:0_*B+AIKB9@2D$"$C?*^#@9"JH:1V2)))%^4-)^*_QC^-
M=O%KGA/2?#>D:)=1I)9)KMS=7%Y=6\JB6&[(TXF&!)8I(Q]F=GFBD23<[*4-
M<?\ L]?\%&/^$P\4/X#\=Z3_ ,(UXDB\J!=T^^WNKS WQIE1Y/FY62R'F7$=
MPCA4N'=H/M'Z?T45\0?MM?&3QW\*=#O)?!>A_:_*T^XN;G69;JT2'3UB!9W2
MTED\VZE2))) I41*WDG%UF2!?S _X)?_ !5\=^!O!M[;>&/!W_"0V3:Q/))=
M_P!M6FG[)C;6BM#Y4Z,[;55'\P':?,V@90U]/_\ !:O_ ))YIO\ V,%M_P"D
M5]6A\-OVF?%FH^!="T?X6:!'XBOM-T/1X-0OY[F*#3[.Z^R6[-:#S)H#>7"Q
M[OM"0RH+-W@$C,[/"NA^PE_P4/U']H37+[PAXPL+?2]?@\U[=8E>W63R"$GM
M7@N97F6[B.^0JI;=$DVY(?LY:7[_ /CI\=-#_9TT.?Q!X@G\FTA^5$7#37$S
M E(($)&^5\' R%50TCLD222+\8:G\3OC_P")=+'B#1?#OANTAGCBD@T.^GNW
MU9%8JI$TA>SM%<\S^6[0O%$1"ZFX1D/J'[&7[=&A_MAV<RP1_P!G:U:9:YTR
M282L(=VU)X9-D?G1'*K(0B-#*0CJ%>&2;[?HKY _;-_:_P!._8[T.'5+FW^W
MWMW<""TL5N$@:3 W2RLS!W6*)<!G2.7$LD$;!1+O7Y?^)'QR^/GP2T-/%.LZ
M+X7O=/M_)FU*QT\WQOK>W(W3EF:5X5\H9266'[6D)/G;);>.1U^T/V5?VF-+
M_:O\-1>(=,CD@82-;WEK)DM;W2*CR1"3:JRIMD1XY5 #HZ[ECE#Q1\_^T=^U
M3;_ ^XT_0],L9-=\5:M(JZ?HMO*L4CQ[CYEQ/*5=;:W15<^;(I#%'Z117$T'
MQ_\ %O\ :(^.?[/'A^+Q=XCTKPG/I<,EH=0L[.2]6\@CG=4*EY)F@#AV6 O"
M;L)(ZR".:%78?2'PT_;&G^/7@9/%?@O0;C5]2^T+:7&D&[M[/[/<*JO.'N[G
M9&\2HZO')$DCR^9$K10L9Q;_ (X?LI_&CXAW/QC\3:PWA^/7?%#V=W:ZAIT5
M]:Z=';+;W5I =DTGFQ.D!@BMU4-(\@(E,LA#NW[/_$K]JW5/@QX.B\0Z_P"%
M=475I([QY=*L"-0CM%MO,(EO-0@3[/!;LBQ.\A#.@E;;#+Y$VW/_ &"OVI=1
M_:Y\/:AKVH6MO9^3K%S:6T$!=MMND-O-&)7=CYDH\XJ\BK$CX!$2<BO?_CI\
M=-#_ &=-#G\0>()_)M(?E1%PTUQ,P)2"!"1OE?!P,A54-([)$DDB_*&D_%?X
MQ_&NWBUSPGI/AO2-$NHTDLDUVYNKB\NK>51+#=D:<3# DL4D8^S.SS12))N=
ME*&N/_9Z_P""C'_"8>*'\!^.])_X1KQ)%Y4"[I]]O=7F!OC3*CR?-RLED/,N
M([A'"I<.[0?:/</VP?VQ4_9/L/M0T/5-7D\M9&D@@DCT^!6F2%1=:@8WBA=R
MS>5&BS.75%=8EFB=OF_X3_M[^*/C5X0LI/#&A6^O>,Y[>ZFO[:VF%IIVF(+F
MXM[1[F6YF.99?+21+$3+/-"LTP>",1E^0_9G_P""CGB76_'DG@#XDZ59Z1J,
MDGV>W> - L5TJLZQ3?:+B994N5V"UE@<B1VB"+,ERLD7['5GZM>OIUO+/%#)
M<R1QNZ01&,22LJDB-#*\<0=B-JF1XT!(W.JY8?S0_M<?&CXA^*?BOX13Q#X?
MCL+FPO-/NM&T)+ZUF:9IKR-3YE_'E ]Q-;"(,X1($1#Y6?,EF_>[X%_$3Q?X
M]^V?\)7X7_X1OR?)^S?\36VU'[3O\SS?^/=5\KR]L?W\[_,X^X:\0\?_ +9C
MZSXEN? ?P^L(]=\36L9:\FFN8[?3=.7<(9)+B7<9KA[:62#[1:VR%RKR1K*M
MQ$\2^'_&/]J3XO\ [)=FNN>,-"\/ZSHK9BD?1)[V!K29F01/<O=)-B*3+QJ5
MB*^:45IHV:*.;[_^!?QTT/\ :+T.#Q!X?G\ZTF^5T;"S6\R@%X)T!.R5,C(R
M592LB,\3QR-[!7P!_P %1_\ DD/B'_N'?^G*TKX@_8S_ &D?%%E\+=+\-_#G
MP[<:WK]E]K-S=7*"#2+7?J$\SPO<RS6PGN_*F@=;>)UQ'<"8R-Y,D)] ^"G_
M  5)U'1O%$G@WXK:7;Z#?K<-"U["7CMX'(C\E+B.5YL1299Q?),T!1X7V"W+
MW(_9ZOSPE_:I\5?'[5+_ $SX36.EW5CI4BQW7B'5Y;@:;-< 'S+2R2U7S9W4
M-')]I5_)"JV4V36LTWE_A;_@H#KGP?\ %L?@OXO:=I^D7%WNDL]6L)R;%H6D
M,-N\L<DDLD44KQ3'[1*\;1@Q>=:PQB2=?U?HHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK
M^?'_ ((:Z3;S7'BN\:*,W,4>EQ1S%%,B1RM>-(BOC<J.T43.H(#&.,D$HN/T
M_P#^"A'POM_BK\,M?MY_+22RLY-2@E>%96CDL ;@^7DJ8WEC22W,BG*),_#J
M61OC#_@F-\8[SP?\%-;U6Y7[7%X;N-6DM;;*Q9A@M(K\P^8J,?GEEF/F.)&7
MS,8**J _X(NZ!_:'A[Q%XGN;BXN-2U/6/(NI)I/,W_9H5G$I9@9&E=[V8RN[
MMOPAP&#%_P!?O%GA:S\<Z==Z5J$?G65];S6US%N9-\,R&.1-R%77<K$;E*L,
MY!!P:_ '_@COXCUSX?>,O$G@+4!Y<4%O-<7-NTAD^SWUC<Q6D@B*2-#\XE*S
M.H8R^1!B39& W0?\W>?Y_P"A<K]_J_ '_@AC_P S=_W!_P#V_KT#_@MI\2]1
M\/Z'H7AZV?R[+5;B[GN]K.K2?81!Y43;6"-$6N#*R.K?O8H'4J8_F_:[2=)M
M] MXK.SBC@MH(TBAAB14CCC10J(B* JHJ@*JJ %    %>'Z!^RQX+\+>*+CQ
MI9:1;Q:_<^89+L&0_-* LLB1%S#%+( 1)-&B2R;Y=SMYTN_\@?\ @N=_S*/_
M '&/_;"OW^K^:'_@G7K_ ,0_BAXA\7^)_"%OX774KVXAGOY-6CO1Y7VZ:ZG,
M5DUL7D2)G0F9)';=Y5N<LR9'W_\ 'OX*?'7]HGPY>>&-5D\#PV5]Y/FR6S:L
MDP\F>.==C21RH,M$H;*-E20,'!'H'[+/['?B'X7?#'6O 'B+4K>274O[2AM9
M[9YKF&TM[ZU2'"),EN1ME,T[1)M1FD+;P\CD?E!^S7^VKXM_X)XR_P#"$^,]
M#N&TU;B2812M)'=P+)*L<DEFSLUM/:9BN'C2()%/<.\@NPI8G]S_ -FWQ_X*
M^.-Q>^-?"ES')=ZM9Z='J=L#"EQ UJUT(#=PH#*EP1))"9)&=)8;>'R&:% [
M_5]%?G!^T+H'PO\ V7_%Z?%KQ+<7$.NS6\L%K:QR/+]JGBMC"98;91N\W[/M
MM2\DD=C'YD;2".>19C^>'_!2WXR^,?C/X*L[S4O#$GAWP\FN*+9M0G_XF5W)
MY-ZD+&S"*;-%CCF:=)BY=I;<P221*\C?M=^R=_R3SPI_V+^D_P#I%#7XXZGI
M-OK7[7(BNHHYHUDBE"2(KJ)(?#ZRQ. P(#QR(DD;=4=5=2&4$?L=^UC_ ,D\
M\5_]B_JW_I%-7P!_P14_Y)YJ7_8P7/\ Z16->8?\$I?$Z?'7QKX[\<7L4@U&
MYDM1 9+B29K>UO9KF0VH8[5=(UM;6*-B@*) JQB-"R']3OVL?^2>>*_^Q?U;
M_P!(IJ^ /^"*G_)/-2_[&"Y_](K&OU_HK^?'_@HAI-OK_P ??!%G>11SVT\>
MA130RHKQR1OK%RKHZ,"K(RDJRL"&!(((-?T'5_.C\!?##_L^?M/WGA[2I8X[
M&]DOQ)%%;QQ1K:W5B=5CM43YA&D$@@16B*%A".$1VBKL/^"YW_,H_P#<8_\
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MV^@6\5G9Q1P6T$:10PQ(J1QQHH5$1% 5450%55 "@   "OP1_8%_Y.%\>_\
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M&ZF0_OW=(_@#_@J5K7_"U/B'X(^'-RUQ#IMU<6DUT\,^/,_M&]%D"(F1HQ+
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MZBMQXDU-S9VS0I'=+<-96VTRW>^*!XX65D:&YDC%U!"B,'/^"*G_ "3S4O\
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M'_N,?^V%?O\ 5^ /[ O_ "<+X]_[C_\ Z>;>O?\ _@M7_P D\TW_ +&"V_\
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M2./\H/\ @AC_ ,S=_P!P?_V_KW__ (+5_P#)/--_[&"V_P#2*^K[_P#V3O\
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M.S?:-^42)B?L_P#8I_:ST;]ICPUIY348YO$,%G&NJ6DGE177VB%8TN+@6Z$
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M9ZE;)(8GFL[B*XC60*K%"\3,H<*RL5)R RG&",]A17X _L"_\G"^/?\ N/\
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M>()=<EMKQ8)I'D?28K@0Z>&="I"+%&EQ&F\^:L<<ZHCX156 "$?0'Q-_8@\
M_&%X&UO3)+F.TC6*TMQJ%_#:VL:QQQ!+6UAN8[>W0I%&&6".,,4#,"W-=_\
M#+]G7P[\'-+GT70H[RTTZ>-HS -3U!UA5C(6-J9+EVM'9I7=I+4PN7(D+%T1
ME\0_X=R?#'^T?[7_ +)N/[2^T?:OMG]KZK]H^T;_ #//\[[9YGF[_G\S=OW_
M #9W<U]GZ3IB:+;Q6L1D:.&-(T,LLDTA5%"@O+*SRR/@?-)(S.YRS,S$DZ%?
M$'BG_@G)\,?'-Y)J&JZ3<7U[-M\VYN=7U6:9]BA%WR27C.VU555R3A5"C@ 5
M[_XC^!>B^+=#'AR^.H3:;^\#HVK:CYTRRB0/'/="Z%S<1,)74PS221%=J[-L
M<87R#X:?L&_#WX-ZBFJ^'M-N-/O4VCS8-4U-=ZJZR>7*OVO9+$61"\,H>*3:
M Z,.*Z#XQ_L;>"?V@+Q;[Q/8W&H2IGREDU+4%AAW*B-Y,$=TD,.\1H9/*1/,
M90[[GRQ[_P"#GP(T'X!6;:?X=AN+:R.-MM)?7EU#'AG<^3'=3S)!N:1VD\D)
MYC$,^XJI'L%<?X_\ :7\4]+N=%UJVCO-.O(S'/!(#M9<@@@@AE=6 >.1"KQN
MJR(RNJL/B#X#?\$POA]\ ]4CUFWBO-3OK>2.6TDU&9)5MI$#X>..&*")GRP8
M-,LIC>..2(QNNX^H?$O]@WX>_&347U7Q#IMQJ%Z^X>;/JFIML5G:3RXE^U[(
MH@SN4AB"11[B$11Q7K_ASX%Z+X2T,^'+$ZA#IO[L(BZMJ/G0K$(PD<%T;HW-
MO$HB11##)'$%W+LVR2!O /"W_!.3X8^!KR/4-*TFXL;V'=Y5S;:OJL,R;U*-
MLDCO%==RLRM@C*L5/!(KT#XQ_L;>"?V@+Q;[Q/8W&H2IGREDU+4%AAW*B-Y,
M$=TD,.\1H9/*1/,90[[GRQ[_ .#GP(T'X!6;:?X=AN+:R.-MM)?7EU#'AG<^
M3'=3S)!N:1VD\D)YC$,^XJI'@'Q8_P""?7@OXP:Q>^([S^T+?7[NXM;B/5+2
M]D@N+-K2.WBB%J #"N!;AM\D4LH>21ED7$7E:'@#]AKP_P"$]4MM9U;4=<\3
M7VGR"73I->U%[Y;&3!WO;QA8X@[$1L6D60H\,,D9C= U?9]9^K:8FM6\MK*9
M%CFC>-S%+)#(%=2I*2Q,DL;X/RR1LKH<,K*P!'R!XU_X)]_#KXE7"WFN:=>:
ME<I&(DFO-9U:XD6,,S! \MZS! S,P4' +,<9)SZ?\+?V8O#7P6^SKH*:A:6]
MIYGD6G]L:I+9IYN_?_H<UV]L<EV?YHSB0^8,2 ,/H"BOA#XH?\$[O!WQ#\0?
M\)593:IX?UMI)I9KW1;S[))-),@C=VW1RK&Y7?O: 0F8RRM,96?([#X:?L1^
M%_ 6HIK6H2:AXDUJ':+;4M?NCJ-Q;(CK+&EOO58HO+E4RQ2+&)T>27$NURM>
M_P#Q+^&.F?%W3GTK5UN'LI=PEB@O+JT\U61HVCE:TFA>2)E=@\+EHGX+(2JD
M> ?#3]@WX>_!O44U7P]IMQI]ZFT>;!JFIKO5763RY5^U[)8BR(7AE#Q2;0'1
MAQ7?_&O]E_PK^T3Y:^)[6XOHH=ICM_[0OH;<,GF;9/L\%Q%"90)77SBAE*-L
M+[ %!\%/V7_"O[.WF+X8M;BQBFW&2W_M"^FMRS^7ND^SSW$L(E(B1?.""4(N
MP/L)4^H>/_ &E_%/2[G1=:MH[S3KR,QSP2 [67(((((975@'CD0J\;JLB,KJ
MK#\X-,_X(]?#*PU0ZA(-4GMC)*XTZ2\ M0KA@L8>.*.[V1[@8R;@N2B^8\@+
MAOTO\+>$].\#6<>GZ5:6]C90[O*MK:%(84WL7;9'&%1=S,S-@#+,6/))K0U;
M5K?0+>6\O)8X+:"-Y9II75(XXT4L[N[$*J*H+,S$!0"20!7P!_P3I\ (FB:I
MX[GMI+34?&NJ7>K202"0-!:M<3FS@!8JLJ;9)+B.X6*$S)<K\K(D;5^A]%%?
M('Q+_8-^'OQDU%]5\0Z;<:A>ON'FSZIJ;;%9VD\N)?M>R*(,[E(8@D4>XA$4
M<5Z_X<^!>B^$M#/ARQ.H0Z;^["(NK:CYT*Q",)'!=&Z-S;Q*(D40PR1Q!=R[
M-LD@;P#PM_P3D^&/@:\CU#2M)N+&]AW>5<VVKZK#,F]2C;)([Q77<K,K8(RK
M%3P2*]0_:8_95\-?M7Z7'IGB&*0-!)YEK>6[*EU;L2OF"*1TD79(JA98W5T<
M!7VB6.)X_+_@/_P3W\#? #3M5T^R@N+W^V;>6TO;F]E5KAK.5-DEK') D'E1
M-RS>6%D=RK-(WE0B+/\ V9_^"=?@K]EK5)-:TL7E[J)C\N&?4)(96ME8,)#;
MB*&%4>13L>0AG" QHR)),LGW?7A^A?L\>'_#?C'4/'5O#(-;U.SAL[F0RN8S
M'%LY6,G:KNL5NCGD8MXRBHSSM-[A7E_Q>^"_A_X]:6VC>);&._L6D241N71D
MDC/RO')&R2QO@LI:-E+(SQDE'=6_/#PM_P $;?AKX?O([FYEUC4(DW;K6YNX
MEADW*5&\VMO;S#:2'79*GS* VY-RM^I^DZ3;Z!;Q6=G%'!;01I%##$BI''&B
MA41$4!515 554 *    *T**^8/VA?V.?!?[3^R7Q)8>;>PV\MO;WL,LD-Q"L
MF2"&1@DOEL3)$EPLT2.SD1XDD#^/^$_^"<OA?1OLD&KZGX@\0Z;8>2;/2M8U
M(W&G0/!@0NEK''#&?+0-"L;[X##))&T3*1C[_KC_ !_X TOXIZ7<Z+K5M'>:
M=>1F.>"0':RY!!!!#*ZL \<B%7C=5D1E=58?FA_PYM^&O]H_;?-UC[/]H\[[
M#]KB^S[-^[[/N^S_ &GRL?N\^?Y^SGSO,^>OTO\  '@#2_A9I=MHNBVT=GIU
MG&(X((P=JKDDDDDLSLQ+R2.6>1V:1V9V9CY?^T+^S%X7_:@TY-/\2VGG>3YI
MM;F-S%<6KRH4+PR+_P !8QR"2"1XXVDBD\M0/D#X:?\ !(SX:_#O44U"==0U
M?RMICMM1GB>W#JZNKM'!!;^;C:5,<QD@='97B?(*_?\ \2_ACIGQ=TY]*U=;
MA[*7<)8H+RZM/-5D:-HY6M)H7DB978/"Y:)^"R$JI'@'PT_8-^'OP;U%-5\/
M:;<:?>IM'FP:IJ:[U5UD\N5?M>R6(LB%X90\4FT!T8<5T'QC_8V\$_M 7BWW
MB>QN-0E3/E+)J6H+##N5$;R8([I(8=XC0R>4B>8RAWW/ECW_ ,'/@1H/P"LV
MT_P[#<6UD<;;:2^O+J&/#.Y\F.ZGF2#<TCM)Y(3S&(9]Q52/8**\/^*G[/'A
M_P",NJ:%K&L0R27?AV\-Y8,DKQJ)"%.)%4@.@DC@F X.^!%+&%IHI?<*^?\
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MU/P8=+BDLK.]NKVYOVF:2*""W>3_ $.".)XI+C(+(UPPA4QJC12K*3%\W_\
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MJ5X!^/.N0>'[9=0TZ[N_EMGU"*"*&:;("0*\5Q-B63)\H.$61AY:L97CC?\
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M]H/5)M M6O-,UV&2>,Z5JEO]FNF-N!YNT*\D1=27#0>8+A1%,[0B.,O7T?\
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M;Z9=+>:CK=Y&TMGHVF6SWFH7$:-AW2%,*J*HDDW3/&'2&;RR[1,H\?\ A?\
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MB-)W+;DW(WQ__P $<?B\GC7P'-X>=HQ<Z#>2((T20-]EO6>YBDD=LHSM,;M
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MKSPM9_"O]HSPE<Z%'_9\NJ7&CW-ZUNS1^=-=:E-:W+L%( \^)=DZJ LVZ1I
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M+Q):QZC)9R?V9J*7L2W$5U):"*6&9Q.\QF=HWMY)9)<$W0E=450A/Y8?LA_
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M\/VT'VFTN?.:_>\Q<S:C-<C%S/?/(#]HEGR?.+C:5Q&JK$J1K^*/_!-33$\
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M^,8^+&I:W;IH&GZ?(P@N&=6M=MG):R1!G;R8K0!Y;UYMRXE>1#!\S7!^ /\
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MMH"P2-W:3][OC6*7\<?V^O\ DX7P%_W /_3S<5^_U?@#_P $,?\ F;O^X/\
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MBL:/^"U?_)/--_[&"V_](KZOO_\ 9._Y)YX4_P"Q?TG_ -(H:_('_F[S_/\
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M-%"HB(H"JBJ JJH 4    5^"/_-WG^?^A<K]?OVL?^2>>*_^Q?U;_P!(IJ^
M/^"*G_)/-2_[&"Y_](K&O /V^O\ DX7P%_W /_3S<5^E_P#P4/\ !5QX_P#A
M7XEL[5HTDCLUO"9"P7R[":*]E *JQWM' ZQC&"Y4,RJ2P^0/^"./[0-OXS\)
MS>#)S''?:'))+ @VJTUG=2O*7 ,C/(\4[R),RHD<:2VJY9W8G]+OC]\8[/\
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M=VK6^H_M$^"8H)8Y)+:3P_%.B.K-%(=5EE"2 $E',<D<@5L$I(CXVLI/U?\
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M_P#)/--_[&"V_P#2*^K[_P#V3O\ DGGA3_L7])_](H:_('_F[S_/_0N5]/\
M_!5O]J[7/V=M#T_2O#Y^S7>O?;$?4%<B:VAMA"'$  ^663SP!/G="JL442M'
M-#]8?LJ_L=^&OV4-+BM=,@CGU0QLMYJTD2BZN&<HTBAOF:*WW1IY=LK%$"*S
M&28O-)^6'_!#'_F;O^X/_P"W]'_!<[_F4?\ N,?^V%?O]7X _L"_\G"^/?\
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MO^Q@N?\ TBL:\ _X+G?\RC_W&/\ VPK]_J_ ']@7_DX7Q[_W'_\ T\V]??\
M_P %1_\ DD/B'_N'?^G*TH_X)<?\DA\/?]Q'_P!.5W7SA_P6>U--3\*Z#X>M
MQ)-JVHZY')9VD44DDDZPV\T+A BD%_,NK=%CSOD,@V*VUMOV?\6/ O\ PJ_X
M-ZKH/G?:/[,\'W=EY^SR_-^S:8\/F;-S[-VS=MW-MSC<<9/Q_P#\$5/^2>:E
M_P!C!<_^D5C7S!_P6(\.:Y\/O&7AOQ[IY\N*"WAM[:X6,R?9[ZQN9;N,RAXV
MA^<2AH48L9?(GS'LC);]_O"?BFS\<Z=::KI\GG65];PW-M+M9-\,R"2-]KA7
M7<K [6"L,X(!R*_('_@M%K_]H>'O#OABVM[BXU+4]8\^UCAC\S?]FA: Q!5)
MD:5WO81$B(V_#C(8*'_3[PG\'+/2/!MIX+U!OMUE#H\.DW+8:'[1"EL+60X1
MR\7F*"<*Y9-W#Y :OY\?V;?V@;C_ ()F>+/%G@SQ$9+JQCCFEM$&X++>0Q>;
M8N!').EJE_ T:3,$GDC<VJRE4@E*_N?^QS\'+SX(>"[#3=5;S-:G\V^U:=@I
MFEOKR1IYC/*KR_:)8]RVYN"[F5858$+M5?'_ /@J/_R2'Q#_ -P[_P!.5I1_
MP2X_Y)#X>_[B/_IRNZ^ /V^O^3A? 7_< _\ 3S<5^_U?@#_P0Q_YF[_N#_\
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M1WFH:9-/L4D>=#:QSI\C/(L>99/E);Y"[(/U?_9:_9#L_P!G7[5J5]?W&O\
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M>SN+=9)(<.(VCMQ$%B8NT<T<:Q0+Z_\  '_@G-JUEJ.F>(OB5XFU#Q%JFDW
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MAVYUVWU?2+?SVM8_[,-I<0M-()2OGK>2H\6YIGVO$9=\O^O$:+%7R_\ &?\
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M_;G\5?LP>*M"T/0]"CU&VU&-)'>1+AI+N1KCRC961BPJW"J%))6Z.;J#]P
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M^H^+-.TB\M=/N;NWAO;[S?LEM),B37'DJ'E\F-B'E\M2&DV!MBD,V!S7/_\
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M\F33=7T^%8KZUN+<?N)FN%*S7&" 91-(7D/[SS$N%CGC_.#_ ((8_P#,W?\
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M(M]\&_$UYYNEFXEBTN27RU$=Q)B>V9&,["&*^B;>+4&9Q>2PHJI+)<E_+_\
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M7'V"+5+C3$U2SMY$:&+^T+SR[FS,(!$44D0BN$@<'R6DCEA\I%MA'^]WQO\
M&MQ\-?"NMZY9K&]SINEWUY"DH8QM);V\DJ!PK*Q0LH#!64D9PP/(_*'_ ()B
M^'_AS\<_";)K&G:7JGBT7E]/JKZI%;7M_<L\JN+M?M#33_9]DT$3/B-#<B8E
M3([22?3_ .Q[^RJG[+'C'QE:Z=%(FA:C'HUUIA9I) B_Z>L]L9710SPR9PNZ
M5UMY+9I9&DD)/Z'U\_\ [6/_ "3SQ7_V+^K?^D4U?C#_ ,$O_P!GV7]H;P;>
MV'B"YW>#H=8G>32;=Y89;^^-M:8-[/&R/]DMU$4EO!"RF6Z8RS-MMX4?R_\
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M6/B'6$E/R-K5Q.MUJGDR:)YLX6X=%"RM$TEM!.%W6P,<BJSQ+G]7[7_@E?\
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MJW,!W, K;\*6*N%Y_P#YN\_S_P!"Y7[_ %?@#_P0Q_YF[_N#_P#M_7W_ /\
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MK"]@B:UDCGTN.RCN'%SMA:WAN,M+*21$8)2,R1;:_<[_ (9.^'G_ $*GA_\
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M.CX-N+C9<3Q:=?WL<UK8Z>S-+),]Q<QPO%=V@E+3H8I5EE!>*&:;S;=(^/\
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MZ'0=*CDOY+2.6>9XXX(;B_NGR[M\SQQ!V(6&#SI<1PI#$]P5C\RORP_X4O\
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M#OV6M9T_0_$#7GVF^C69GM[?S([:W>4Q+/.2ZL4++*=MNL\P$3YC!:(2>?\
M@/4T_:]\>:3XXTL2?\(EX9L[Z/2[YXI+9]1U*_58+LQQS+ODLK>%?*,A2V;[
M:'5&GCC<)^A]%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%?GA_P53U:WT[X2:U%/+'')<R:?% CNJM+(+ZWE*1@D%W$<<DA5<D)
M&[XVJQ!_P2LU:WU'X2:+%!+'));2:A%.B.K-%(;ZXE"2 $E',<D<@5L$I(CX
MVLI/Z'U^>'_!5/5K?3OA)K44\L<<ES)I\4".ZJTL@OK>4I&"07<1QR2%5R0D
M;OC:K$'_  2LU:WU'X2:+%!+'));2:A%.B.K-%(;ZXE"2 $E',<D<@5L$I(C
MXVLI/Z'T444445_/#_P3[\6:=>_M >,9XKNW>+4/[>^Q2+,C+=;M4AG7R&!Q
M+F)'F'E[LQ(T@^121_0]1111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111117/\ BGPGIWCFSDT_5;2WOK*;;YMM<PI-"^Q@Z[XY R-M959<
M@X90PY ->/\ _#)WP\_Z%3P__P""FR_^,U] 4444444444445Y_XZ^$_A[XH
M>3_;VE:?J?V??Y'VVTAN?*\S;O\ +\Y'V;MB;MN-VU<YP,>@444444444444
M444444444444444444444444444444444444444444445Y?XU^"'A7XE7"WF
MN:)I>I7*1B))KRQM[B18PS,$#RQLP0,S,%!P"S'&2<G@KX(>%?AK<->:'HFE
MZ;<O&8GFL[&WMY&C+*Q0O%&K%"RJQ4G!*J<9 QZA7E_C7X(>%?B5<+>:YHFE
MZE<I&(DFO+&WN)%C#,P0/+&S! S,P4' +,<9)R>"O@AX5^&MPUYH>B:7IMR\
M9B>:SL;>WD:,LK%"\4:L4+*K%2<$JIQD#'J%%%%%%<_XI\)Z=XYLY-/U6TM[
MZRFV^;;7,*30OL8.N^.0,C;6567(.&4,.0#7C_\ PR=\//\ H5/#_P#X*;+_
M .,U] 444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
%4445_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>16
<FILENAME>imnn-20241231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaKJabP9z5Z8eekhvWB7bYlaDystGnT0XybLZpmWEasA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:IMNN="http://imunon.com/20241231" elementFormDefault="qualified" targetNamespace="http://imunon.com/20241231">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://imunon.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/StatementsOfOperations" id="StatementsOfOperations">
          <link:definition>00000004 - Statement - Consolidated Statements of Operations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/StatementsOfComprehensiveLoss" id="StatementsOfComprehensiveLoss">
          <link:definition>00000005 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/StatementsOfChangesInStockholdersEquity" id="StatementsOfChangesInStockholdersEquity">
          <link:definition>00000007 - Statement - Consolidated Statements of Changes in Stockholders' Equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/FinancialConditionAndGoingConcernUncertainty" id="FinancialConditionAndGoingConcernUncertainty">
          <link:definition>999016 - Disclosure - FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/SegmentPerformanceMeasuresAndExpenses" id="SegmentPerformanceMeasuresAndExpenses">
          <link:definition>999017 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSale" id="InvestmentsInDebtSecuritiesAvailableForSale">
          <link:definition>999018 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/FairValuesOfFinancialInstruments" id="FairValuesOfFinancialInstruments">
          <link:definition>999019 - Disclosure - FAIR VALUES OF FINANCIAL INSTRUMENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
          <link:definition>999020 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/OtherAccruedLiabilities" id="OtherAccruedLiabilities">
          <link:definition>999021 - Disclosure - OTHER ACCRUED LIABILITIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/NotesPayable" id="NotesPayable">
          <link:definition>999022 - Disclosure - NOTES PAYABLE</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>999023 - Disclosure - INCOME TAXES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/StockholdersEquity" id="StockholdersEquity">
          <link:definition>999024 - Disclosure - STOCKHOLDERS&#8217; EQUITY</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/Stock-basedCompensation" id="Stock-basedCompensation">
          <link:definition>999025 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/Warrants" id="Warrants">
          <link:definition>999026 - Disclosure - WARRANTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/ImunonEmployeeBenefitPlans" id="ImunonEmployeeBenefitPlans">
          <link:definition>999027 - Disclosure - IMUNON EMPLOYEE BENEFIT PLANS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/Leases" id="Leases">
          <link:definition>999028 - Disclosure - LEASES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>999029 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/RelatedPartyTransaction" id="RelatedPartyTransaction">
          <link:definition>999030 - Disclosure - RELATED PARTY TRANSACTION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>999031 - Disclosure - SUBSEQUENT EVENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>999032 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesTables" id="SegmentPerformanceMeasuresAndExpensesTables">
          <link:definition>999033 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleTables" id="InvestmentsInDebtSecuritiesAvailableForSaleTables">
          <link:definition>999034 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/FairValuesOfFinancialInstrumentsTables" id="FairValuesOfFinancialInstrumentsTables">
          <link:definition>999035 - Disclosure - FAIR VALUES OF FINANCIAL INSTRUMENTS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
          <link:definition>999036 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/OtherAccruedLiabilitiesTables" id="OtherAccruedLiabilitiesTables">
          <link:definition>999037 - Disclosure - OTHER ACCRUED LIABILITIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/NotesPayableTables" id="NotesPayableTables">
          <link:definition>999038 - Disclosure - NOTES PAYABLE (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>999039 - Disclosure - INCOME TAXES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/Stock-basedCompensationTables" id="Stock-basedCompensationTables">
          <link:definition>999040 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/WarrantsTables" id="WarrantsTables">
          <link:definition>999041 - Disclosure - WARRANTS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/LeasesTables" id="LeasesTables">
          <link:definition>999042 - Disclosure - LEASES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>999043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/FinancialConditionAndGoingConcernUncertaintyDetailsNarrative" id="FinancialConditionAndGoingConcernUncertaintyDetailsNarrative">
          <link:definition>999044 - Disclosure - FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails" id="ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails">
          <link:definition>999045 - Disclosure - SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesDetailsNarrative" id="SegmentPerformanceMeasuresAndExpensesDetailsNarrative">
          <link:definition>999046 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails" id="ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails">
          <link:definition>999047 - Disclosure - SCHEDULE OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/ScheduleOfInvestmentSecuritiesGrossUnrealizedGainsLossesDetails" id="ScheduleOfInvestmentSecuritiesGrossUnrealizedGainsLossesDetails">
          <link:definition>999048 - Disclosure - SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES) (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails" id="ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails">
          <link:definition>999049 - Disclosure - SCHEDULE OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleDetailsNarrative" id="InvestmentsInDebtSecuritiesAvailableForSaleDetailsNarrative">
          <link:definition>999050 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" id="ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails">
          <link:definition>999051 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails" id="ScheduleOfPropertyAndEquipmentDetails">
          <link:definition>999052 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical" id="ScheduleOfPropertyAndEquipmentDetailsParenthetical">
          <link:definition>999053 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails" id="ScheduleOfOtherAccruedLiabilitiesDetails">
          <link:definition>999054 - Disclosure - SCHEDULE OF OTHER ACCRUED LIABILITIES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/ScheduleOfDebtDetails" id="ScheduleOfDebtDetails">
          <link:definition>999055 - Disclosure - SCHEDULE OF DEBT (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/NotesPayableDetailsNarrative" id="NotesPayableDetailsNarrative">
          <link:definition>999056 - Disclosure - NOTES PAYABLE (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails" id="ScheduleOfIncomeTaxProvisionBenefitDetails">
          <link:definition>999057 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (BENEFIT) (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" id="ScheduleOfEffectiveIncomeTaxRateReconciliationDetails">
          <link:definition>999058 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" id="ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
          <link:definition>999059 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>999060 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative">
          <link:definition>999061 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/SummaryOfStockOptionsDetails" id="SummaryOfStockOptionsDetails">
          <link:definition>999062 - Disclosure - SUMMARY OF STOCK OPTIONS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails" id="SummaryOfNon-vestedRestrictedStockAwardsDetails">
          <link:definition>999063 - Disclosure - SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails" id="SummaryOfStockOptionsOutstandingDetails">
          <link:definition>999064 - Disclosure - SUMMARY OF STOCK OPTIONS OUTSTANDING (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails" id="ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails">
          <link:definition>999065 - Disclosure - SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/Stock-basedCompensationDetailsNarrative" id="Stock-basedCompensationDetailsNarrative">
          <link:definition>999066 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/SummaryOfWarrantActivityDetails" id="SummaryOfWarrantActivityDetails">
          <link:definition>999067 - Disclosure - SUMMARY OF WARRANT ACTIVITY (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/ImunonEmployeeBenefitPlansDetailsNarrative" id="ImunonEmployeeBenefitPlansDetailsNarrative">
          <link:definition>999068 - Disclosure - IMUNON EMPLOYEE BENEFIT PLANS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails" id="ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails">
          <link:definition>999069 - Disclosure - SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/LeasesDetailsNarrative" id="LeasesDetailsNarrative">
          <link:definition>999070 - Disclosure - LEASES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://imunon.com/role/RelatedPartyTransactionDetailsNarrative" id="RelatedPartyTransactionDetailsNarrative">
          <link:definition>999071 - Disclosure - RELATED PARTY TRANSACTION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="imnn-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="imnn-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="imnn-20241231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="imnn-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/cyd/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" />
    <element id="IMNN_ClinicalResearchMember" name="ClinicalResearchMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_OvationMember" name="OvationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_VaccineMember" name="VaccineMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_OtherClinicalAndRegulatoryMember" name="OtherClinicalAndRegulatoryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_NonClinicalRAndDAndCMCMember" name="NonClinicalRAndDAndCMCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_PlaCCineVaccineMember" name="PlaCCineVaccineMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_ManufacturingCMCMember" name="ManufacturingCMCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_SiliconValleyBankMember" name="SiliconValleyBankMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_HorizonTechnologyFinanceCorporationMember" name="HorizonTechnologyFinanceCorporationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_FederalIncomeTaxMember" name="FederalIncomeTaxMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_NoExpirationMember" name="NoExpirationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_AtTheMarketOfferingAgreementMember" name="AtTheMarketOfferingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_JulyTwoThousandTwentyFourOfferingMember" name="JulyTwoThousandTwentyFourOfferingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_TwoThousandAndEighteenStockIncentivePlanMember" name="TwoThousandAndEighteenStockIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_InducementOptionGrantsMember" name="InducementOptionGrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_EquityStockAwardsMember" name="EquityStockAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember" name="GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_InducementAwardsMember" name="InducementAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember" name="EmployeeStockOptionAndRestrictedStockAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_ExercisePriceOneMember" name="ExercisePriceOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_ExercisePriceTwoMember" name="ExercisePriceTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_ExercisePriceThreeMember" name="ExercisePriceThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_LeaseAgreementMember" name="LeaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_ConvertibleNotePurchaseAgreementMember" name="ConvertibleNotePurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_TransomicTechnologiesIncMember" name="TransomicTechnologiesIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable" name="AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_PaymentoffOfLoanAndAccruedEndoftermFees" name="PaymentoffOfLoanAndAccruedEndoftermFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_RecognitionOfRightUseAssetAndLiability" name="RecognitionOfRightUseAssetAndLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_Rule10b51ArrModifiedFlag" name="Rule10b51ArrModifiedFlag" nillable="true" xbrli:periodType="duration" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_NonRule10b51ArrModifiedFlag" name="NonRule10b51ArrModifiedFlag" nillable="true" xbrli:periodType="duration" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_DisclosureFairValuesOfFinancialInstrumentsAbstract" name="DisclosureFairValuesOfFinancialInstrumentsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_DisclosureWarrantsAbstract" name="DisclosureWarrantsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_WarrantsTextBlock" name="WarrantsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_DisclosureLeasesAbstract" name="DisclosureLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock" name="AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_DepositsPolicyTextBlock" name="DepositsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_WarrantAccountingPolicyTextBlock" name="WarrantAccountingPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards" name="NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_IncreaseDecreaseInOperatingCostAndExpenses" name="IncreaseDecreaseInOperatingCostAndExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage" name="IncreaseDecreaseInOperatingCostsAndExpensesPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_IncreaseDecreaseInResearchAndDevelopmentExpenses" name="IncreaseDecreaseInResearchAndDevelopmentExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage" name="IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpenes" name="IncreaseDecreaseInGeneralAndAdministrativeExpenes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage" name="IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_IncreaseDecreaseInOperatingExpenses" name="IncreaseDecreaseInOperatingExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_IncreaseDecreaseInOperatingExpensesPercentage" name="IncreaseDecreaseInOperatingExpensesPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_IncreaseDecreaseInLossFromOperations" name="IncreaseDecreaseInLossFromOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_IncreaseDecreaseInLossFromOperationsPercentage" name="IncreaseDecreaseInLossFromOperationsPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost" name="DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue" name="DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost" name="DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue" name="DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" name="AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_AvailableForSaleSecuritiesUnrealizedLossFairValue" name="AvailableForSaleSecuritiesUnrealizedLossFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths" name="AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_EarlyTerminationFee" name="EarlyTerminationFee" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_EndOfTermCharges" name="EndOfTermCharges" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_FinalPaymentPercentage" name="FinalPaymentPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_EndOfTermChargePercentage" name="EndOfTermChargePercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_EffectiveIncomeTaxRateReconciliationPermanentDifferences" name="EffectiveIncomeTaxRateReconciliationPermanentDifferences" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_EffectiveIncomeTaxRateReconciliationTimeUp" name="EffectiveIncomeTaxRateReconciliationTimeUp" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate" name="EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_EffectiveIncomeTaxRateReconciliationSaleAndExpiration" name="EffectiveIncomeTaxRateReconciliationSaleAndExpiration" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_DeferredTaxAssetsLegalAct" name="DeferredTaxAssetsLegalAct" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_ProceedsFromSaleOfNetOperatingLosses" name="ProceedsFromSaleOfNetOperatingLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_OperatingLossCarryforwardsExpirationDescription" name="OperatingLossCarryforwardsExpirationDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_NetProceedsFromSaleOfNetOperatingLosses" name="NetProceedsFromSaleOfNetOperatingLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_StockOptionsStrikePriceDescription" name="StockOptionsStrikePriceDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter" name="LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="IMNN_OperatingLeasesIncrementalBorrowingRate" name="OperatingLeasesIncrementalBorrowingRate" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>17
<FILENAME>imnn-20241231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://imunon.com/role/Cover" xlink:href="imnn-20241231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/BalanceSheets" xlink:href="imnn-20241231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/BalanceSheetsParenthetical" xlink:href="imnn-20241231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StatementsOfOperations" xlink:href="imnn-20241231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StatementsOfComprehensiveLoss" xlink:href="imnn-20241231.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StatementsOfCashFlows" xlink:href="imnn-20241231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StatementsOfChangesInStockholdersEquity" xlink:href="imnn-20241231.xsd#StatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#CybersecurityRiskManagementAndStrategyDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#MaterialCybersecurityIncidentDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="imnn-20241231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/FinancialConditionAndGoingConcernUncertainty" xlink:href="imnn-20241231.xsd#FinancialConditionAndGoingConcernUncertainty" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SegmentPerformanceMeasuresAndExpenses" xlink:href="imnn-20241231.xsd#SegmentPerformanceMeasuresAndExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSale" xlink:href="imnn-20241231.xsd#InvestmentsInDebtSecuritiesAvailableForSale" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/FairValuesOfFinancialInstruments" xlink:href="imnn-20241231.xsd#FairValuesOfFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/PropertyAndEquipment" xlink:href="imnn-20241231.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/OtherAccruedLiabilities" xlink:href="imnn-20241231.xsd#OtherAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/NotesPayable" xlink:href="imnn-20241231.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/IncomeTaxes" xlink:href="imnn-20241231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StockholdersEquity" xlink:href="imnn-20241231.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/Stock-basedCompensation" xlink:href="imnn-20241231.xsd#Stock-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/Warrants" xlink:href="imnn-20241231.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ImunonEmployeeBenefitPlans" xlink:href="imnn-20241231.xsd#ImunonEmployeeBenefitPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/Leases" xlink:href="imnn-20241231.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/CommitmentsAndContingencies" xlink:href="imnn-20241231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/RelatedPartyTransaction" xlink:href="imnn-20241231.xsd#RelatedPartyTransaction" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SubsequentEvents" xlink:href="imnn-20241231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="imnn-20241231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesTables" xlink:href="imnn-20241231.xsd#SegmentPerformanceMeasuresAndExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleTables" xlink:href="imnn-20241231.xsd#InvestmentsInDebtSecuritiesAvailableForSaleTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/FairValuesOfFinancialInstrumentsTables" xlink:href="imnn-20241231.xsd#FairValuesOfFinancialInstrumentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/PropertyAndEquipmentTables" xlink:href="imnn-20241231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/OtherAccruedLiabilitiesTables" xlink:href="imnn-20241231.xsd#OtherAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/NotesPayableTables" xlink:href="imnn-20241231.xsd#NotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/IncomeTaxesTables" xlink:href="imnn-20241231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/Stock-basedCompensationTables" xlink:href="imnn-20241231.xsd#Stock-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/WarrantsTables" xlink:href="imnn-20241231.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/LeasesTables" xlink:href="imnn-20241231.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="imnn-20241231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/FinancialConditionAndGoingConcernUncertaintyDetailsNarrative" xlink:href="imnn-20241231.xsd#FinancialConditionAndGoingConcernUncertaintyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails" xlink:href="imnn-20241231.xsd#ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesDetailsNarrative" xlink:href="imnn-20241231.xsd#SegmentPerformanceMeasuresAndExpensesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails" xlink:href="imnn-20241231.xsd#ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfInvestmentSecuritiesGrossUnrealizedGainsLossesDetails" xlink:href="imnn-20241231.xsd#ScheduleOfInvestmentSecuritiesGrossUnrealizedGainsLossesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails" xlink:href="imnn-20241231.xsd#ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleDetailsNarrative" xlink:href="imnn-20241231.xsd#InvestmentsInDebtSecuritiesAvailableForSaleDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="imnn-20241231.xsd#ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="imnn-20241231.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical" xlink:href="imnn-20241231.xsd#ScheduleOfPropertyAndEquipmentDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails" xlink:href="imnn-20241231.xsd#ScheduleOfOtherAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfDebtDetails" xlink:href="imnn-20241231.xsd#ScheduleOfDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/NotesPayableDetailsNarrative" xlink:href="imnn-20241231.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails" xlink:href="imnn-20241231.xsd#ScheduleOfIncomeTaxProvisionBenefitDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="imnn-20241231.xsd#ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="imnn-20241231.xsd#ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/IncomeTaxesDetailsNarrative" xlink:href="imnn-20241231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StockholdersEquityDetailsNarrative" xlink:href="imnn-20241231.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfStockOptionsDetails" xlink:href="imnn-20241231.xsd#SummaryOfStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails" xlink:href="imnn-20241231.xsd#SummaryOfNon-vestedRestrictedStockAwardsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails" xlink:href="imnn-20241231.xsd#SummaryOfStockOptionsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails" xlink:href="imnn-20241231.xsd#ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/Stock-basedCompensationDetailsNarrative" xlink:href="imnn-20241231.xsd#Stock-basedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfWarrantActivityDetails" xlink:href="imnn-20241231.xsd#SummaryOfWarrantActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ImunonEmployeeBenefitPlansDetailsNarrative" xlink:href="imnn-20241231.xsd#ImunonEmployeeBenefitPlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails" xlink:href="imnn-20241231.xsd#ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/LeasesDetailsNarrative" xlink:href="imnn-20241231.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/RelatedPartyTransactionDetailsNarrative" xlink:href="imnn-20241231.xsd#RelatedPartyTransactionDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivableCurrent" xlink:label="loc_us-gaapGrantsReceivableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapGrantsReceivableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsNoncurrent" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsNoncurrent" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsNoncurrent" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityBeforeTreasuryStock" xlink:label="loc_us-gaapStockholdersEquityBeforeTreasuryStock" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityBeforeTreasuryStock" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityBeforeTreasuryStock" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityBeforeTreasuryStock" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityBeforeTreasuryStock" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityBeforeTreasuryStock" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityBeforeTreasuryStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="loc_us-gaapOtherNonoperatingExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/StatementsOfComprehensiveLoss" xlink:title="00000005 - Statement - Consolidated Statements of Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaapGainLossOnInvestments" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableWriteOffs" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable" xlink:label="loc_IMNNAmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IMNNAmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedInvestmentIncomeReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedInvestmentIncomeReceivable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedInvestmentIncomeReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="loc_us-gaapPaymentsToAcquireAvailableForSaleSecuritiesDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_PaymentoffOfLoanAndAccruedEndoftermFees" xlink:label="loc_IMNNPaymentoffOfLoanAndAccruedEndoftermFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_IMNNPaymentoffOfLoanAndAccruedEndoftermFees" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/StatementsOfChangesInStockholdersEquity" xlink:title="00000007 - Statement - Consolidated Statements of Changes in Stockholders&apos; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000013 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure" />
    <link:calculationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000014 - Disclosure - Material Cybersecurity Incident Disclosure" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/FinancialConditionAndGoingConcernUncertainty" xlink:title="999016 - Disclosure - FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/SegmentPerformanceMeasuresAndExpenses" xlink:title="999017 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSale" xlink:title="999018 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/FairValuesOfFinancialInstruments" xlink:title="999019 - Disclosure - FAIR VALUES OF FINANCIAL INSTRUMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/PropertyAndEquipment" xlink:title="999020 - Disclosure - PROPERTY AND EQUIPMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/OtherAccruedLiabilities" xlink:title="999021 - Disclosure - OTHER ACCRUED LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/NotesPayable" xlink:title="999022 - Disclosure - NOTES PAYABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/IncomeTaxes" xlink:title="999023 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/StockholdersEquity" xlink:title="999024 - Disclosure - STOCKHOLDERS&#8217; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/Stock-basedCompensation" xlink:title="999025 - Disclosure - STOCK-BASED COMPENSATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/Warrants" xlink:title="999026 - Disclosure - WARRANTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/ImunonEmployeeBenefitPlans" xlink:title="999027 - Disclosure - IMUNON EMPLOYEE BENEFIT PLANS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/Leases" xlink:title="999028 - Disclosure - LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/CommitmentsAndContingencies" xlink:title="999029 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/RelatedPartyTransaction" xlink:title="999030 - Disclosure - RELATED PARTY TRANSACTION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/SubsequentEvents" xlink:title="999031 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999032 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesTables" xlink:title="999033 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleTables" xlink:title="999034 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/FairValuesOfFinancialInstrumentsTables" xlink:title="999035 - Disclosure - FAIR VALUES OF FINANCIAL INSTRUMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/PropertyAndEquipmentTables" xlink:title="999036 - Disclosure - PROPERTY AND EQUIPMENT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/OtherAccruedLiabilitiesTables" xlink:title="999037 - Disclosure - OTHER ACCRUED LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/NotesPayableTables" xlink:title="999038 - Disclosure - NOTES PAYABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/IncomeTaxesTables" xlink:title="999039 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/Stock-basedCompensationTables" xlink:title="999040 - Disclosure - STOCK-BASED COMPENSATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/WarrantsTables" xlink:title="999041 - Disclosure - WARRANTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/LeasesTables" xlink:title="999042 - Disclosure - LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/FinancialConditionAndGoingConcernUncertaintyDetailsNarrative" xlink:title="999044 - Disclosure - FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails" xlink:title="999045 - Disclosure - SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesDetailsNarrative" xlink:title="999046 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails" xlink:title="999047 - Disclosure - SCHEDULE OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfInvestmentSecuritiesGrossUnrealizedGainsLossesDetails" xlink:title="999048 - Disclosure - SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails" xlink:title="999049 - Disclosure - SCHEDULE OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="loc_us-gaapInvestmentIncomeInterestAndDividend" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInvestmentIncomeNet" xlink:to="loc_us-gaapInvestmentIncomeInterestAndDividend" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:label="loc_us-gaapDebtSecuritiesAvailableForSaleRealizedGainLoss" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInvestmentIncomeNet" xlink:to="loc_us-gaapDebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleDetailsNarrative" xlink:title="999050 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:title="999051 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="999052 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical" xlink:title="999053 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails" xlink:title="999054 - Disclosure - SCHEDULE OF OTHER ACCRUED LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractualObligation" xlink:label="loc_us-gaapContractualObligation" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapContractualObligation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfDebtDetails" xlink:title="999055 - Disclosure - SCHEDULE OF DEBT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:label="loc_us-gaapLineOfCreditFacilityFairValueOfAmountOutstanding" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLineOfCredit" xlink:to="loc_us-gaapLineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EarlyTerminationFee" xlink:label="loc_IMNNEarlyTerminationFee" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLineOfCredit" xlink:to="loc_IMNNEarlyTerminationFee" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EndOfTermCharges" xlink:label="loc_IMNNEndOfTermCharges" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLineOfCredit" xlink:to="loc_IMNNEndOfTermCharges" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/NotesPayableDetailsNarrative" xlink:title="999056 - Disclosure - NOTES PAYABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails" xlink:title="999057 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (BENEFIT) (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:title="999058 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:label="loc_IMNNEffectiveIncomeTaxRateReconciliationPermanentDifferences" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_IMNNEffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EffectiveIncomeTaxRateReconciliationTimeUp" xlink:label="loc_IMNNEffectiveIncomeTaxRateReconciliationTimeUp" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_IMNNEffectiveIncomeTaxRateReconciliationTimeUp" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate" xlink:label="loc_IMNNEffectiveIncomeTaxRateReconciliationDeferredStatutoryRate" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_IMNNEffectiveIncomeTaxRateReconciliationDeferredStatutoryRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EffectiveIncomeTaxRateReconciliationSaleAndExpiration" xlink:label="loc_IMNNEffectiveIncomeTaxRateReconciliationSaleAndExpiration" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_IMNNEffectiveIncomeTaxRateReconciliationSaleAndExpiration" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="999059 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DeferredTaxAssetsLegalAct" xlink:label="loc_IMNNDeferredTaxAssetsLegalAct" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_IMNNDeferredTaxAssetsLegalAct" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/IncomeTaxesDetailsNarrative" xlink:title="999060 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/StockholdersEquityDetailsNarrative" xlink:title="999061 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfStockOptionsDetails" xlink:title="999062 - Disclosure - SUMMARY OF STOCK OPTIONS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails" xlink:title="999063 - Disclosure - SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails" xlink:title="999064 - Disclosure - SUMMARY OF STOCK OPTIONS OUTSTANDING (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails" xlink:title="999065 - Disclosure - SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/Stock-basedCompensationDetailsNarrative" xlink:title="999066 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfWarrantActivityDetails" xlink:title="999067 - Disclosure - SUMMARY OF WARRANT ACTIVITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/ImunonEmployeeBenefitPlansDetailsNarrative" xlink:title="999068 - Disclosure - IMUNON EMPLOYEE BENEFIT PLANS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails" xlink:title="999069 - Disclosure - SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter" xlink:label="loc_IMNNLesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_IMNNLesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/LeasesDetailsNarrative" xlink:title="999070 - Disclosure - LEASES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imunon.com/role/RelatedPartyTransactionDetailsNarrative" xlink:title="999071 - Disclosure - RELATED PARTY TRANSACTION (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>18
<FILENAME>imnn-20241231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://imunon.com/role/Cover" xlink:href="imnn-20241231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/BalanceSheets" xlink:href="imnn-20241231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/BalanceSheetsParenthetical" xlink:href="imnn-20241231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StatementsOfOperations" xlink:href="imnn-20241231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StatementsOfComprehensiveLoss" xlink:href="imnn-20241231.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StatementsOfCashFlows" xlink:href="imnn-20241231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StatementsOfChangesInStockholdersEquity" xlink:href="imnn-20241231.xsd#StatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#CybersecurityRiskManagementAndStrategyDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#MaterialCybersecurityIncidentDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="imnn-20241231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/FinancialConditionAndGoingConcernUncertainty" xlink:href="imnn-20241231.xsd#FinancialConditionAndGoingConcernUncertainty" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SegmentPerformanceMeasuresAndExpenses" xlink:href="imnn-20241231.xsd#SegmentPerformanceMeasuresAndExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSale" xlink:href="imnn-20241231.xsd#InvestmentsInDebtSecuritiesAvailableForSale" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/FairValuesOfFinancialInstruments" xlink:href="imnn-20241231.xsd#FairValuesOfFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/PropertyAndEquipment" xlink:href="imnn-20241231.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/OtherAccruedLiabilities" xlink:href="imnn-20241231.xsd#OtherAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/NotesPayable" xlink:href="imnn-20241231.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/IncomeTaxes" xlink:href="imnn-20241231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StockholdersEquity" xlink:href="imnn-20241231.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/Stock-basedCompensation" xlink:href="imnn-20241231.xsd#Stock-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/Warrants" xlink:href="imnn-20241231.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ImunonEmployeeBenefitPlans" xlink:href="imnn-20241231.xsd#ImunonEmployeeBenefitPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/Leases" xlink:href="imnn-20241231.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/CommitmentsAndContingencies" xlink:href="imnn-20241231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/RelatedPartyTransaction" xlink:href="imnn-20241231.xsd#RelatedPartyTransaction" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SubsequentEvents" xlink:href="imnn-20241231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="imnn-20241231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesTables" xlink:href="imnn-20241231.xsd#SegmentPerformanceMeasuresAndExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleTables" xlink:href="imnn-20241231.xsd#InvestmentsInDebtSecuritiesAvailableForSaleTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/FairValuesOfFinancialInstrumentsTables" xlink:href="imnn-20241231.xsd#FairValuesOfFinancialInstrumentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/PropertyAndEquipmentTables" xlink:href="imnn-20241231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/OtherAccruedLiabilitiesTables" xlink:href="imnn-20241231.xsd#OtherAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/NotesPayableTables" xlink:href="imnn-20241231.xsd#NotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/IncomeTaxesTables" xlink:href="imnn-20241231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/Stock-basedCompensationTables" xlink:href="imnn-20241231.xsd#Stock-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/WarrantsTables" xlink:href="imnn-20241231.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/LeasesTables" xlink:href="imnn-20241231.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="imnn-20241231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/FinancialConditionAndGoingConcernUncertaintyDetailsNarrative" xlink:href="imnn-20241231.xsd#FinancialConditionAndGoingConcernUncertaintyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails" xlink:href="imnn-20241231.xsd#ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesDetailsNarrative" xlink:href="imnn-20241231.xsd#SegmentPerformanceMeasuresAndExpensesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails" xlink:href="imnn-20241231.xsd#ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfInvestmentSecuritiesGrossUnrealizedGainsLossesDetails" xlink:href="imnn-20241231.xsd#ScheduleOfInvestmentSecuritiesGrossUnrealizedGainsLossesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails" xlink:href="imnn-20241231.xsd#ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleDetailsNarrative" xlink:href="imnn-20241231.xsd#InvestmentsInDebtSecuritiesAvailableForSaleDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="imnn-20241231.xsd#ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="imnn-20241231.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical" xlink:href="imnn-20241231.xsd#ScheduleOfPropertyAndEquipmentDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails" xlink:href="imnn-20241231.xsd#ScheduleOfOtherAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfDebtDetails" xlink:href="imnn-20241231.xsd#ScheduleOfDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/NotesPayableDetailsNarrative" xlink:href="imnn-20241231.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails" xlink:href="imnn-20241231.xsd#ScheduleOfIncomeTaxProvisionBenefitDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="imnn-20241231.xsd#ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="imnn-20241231.xsd#ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/IncomeTaxesDetailsNarrative" xlink:href="imnn-20241231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StockholdersEquityDetailsNarrative" xlink:href="imnn-20241231.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfStockOptionsDetails" xlink:href="imnn-20241231.xsd#SummaryOfStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails" xlink:href="imnn-20241231.xsd#SummaryOfNon-vestedRestrictedStockAwardsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails" xlink:href="imnn-20241231.xsd#SummaryOfStockOptionsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails" xlink:href="imnn-20241231.xsd#ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/Stock-basedCompensationDetailsNarrative" xlink:href="imnn-20241231.xsd#Stock-basedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfWarrantActivityDetails" xlink:href="imnn-20241231.xsd#SummaryOfWarrantActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ImunonEmployeeBenefitPlansDetailsNarrative" xlink:href="imnn-20241231.xsd#ImunonEmployeeBenefitPlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails" xlink:href="imnn-20241231.xsd#ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/LeasesDetailsNarrative" xlink:href="imnn-20241231.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/RelatedPartyTransactionDetailsNarrative" xlink:href="imnn-20241231.xsd#RelatedPartyTransactionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/StatementsOfComprehensiveLoss" xlink:title="00000005 - Statement - Consolidated Statements of Comprehensive Loss" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/StatementsOfChangesInStockholdersEquity" xlink:title="00000007 - Statement - Consolidated Statements of Changes in Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockCommonMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_70" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000013 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000014 - Disclosure - Material Cybersecurity Incident Disclosure" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/FinancialConditionAndGoingConcernUncertainty" xlink:title="999016 - Disclosure - FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/SegmentPerformanceMeasuresAndExpenses" xlink:title="999017 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSale" xlink:title="999018 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/FairValuesOfFinancialInstruments" xlink:title="999019 - Disclosure - FAIR VALUES OF FINANCIAL INSTRUMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/PropertyAndEquipment" xlink:title="999020 - Disclosure - PROPERTY AND EQUIPMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/OtherAccruedLiabilities" xlink:title="999021 - Disclosure - OTHER ACCRUED LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/NotesPayable" xlink:title="999022 - Disclosure - NOTES PAYABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/IncomeTaxes" xlink:title="999023 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/StockholdersEquity" xlink:title="999024 - Disclosure - STOCKHOLDERS&#8217; EQUITY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/Stock-basedCompensation" xlink:title="999025 - Disclosure - STOCK-BASED COMPENSATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/Warrants" xlink:title="999026 - Disclosure - WARRANTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/ImunonEmployeeBenefitPlans" xlink:title="999027 - Disclosure - IMUNON EMPLOYEE BENEFIT PLANS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/Leases" xlink:title="999028 - Disclosure - LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/CommitmentsAndContingencies" xlink:title="999029 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/RelatedPartyTransaction" xlink:title="999030 - Disclosure - RELATED PARTY TRANSACTION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/SubsequentEvents" xlink:title="999031 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999032 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesTables" xlink:title="999033 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleTables" xlink:title="999034 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/FairValuesOfFinancialInstrumentsTables" xlink:title="999035 - Disclosure - FAIR VALUES OF FINANCIAL INSTRUMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/PropertyAndEquipmentTables" xlink:title="999036 - Disclosure - PROPERTY AND EQUIPMENT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/OtherAccruedLiabilitiesTables" xlink:title="999037 - Disclosure - OTHER ACCRUED LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/NotesPayableTables" xlink:title="999038 - Disclosure - NOTES PAYABLE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/IncomeTaxesTables" xlink:title="999039 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/Stock-basedCompensationTables" xlink:title="999040 - Disclosure - STOCK-BASED COMPENSATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/WarrantsTables" xlink:title="999041 - Disclosure - WARRANTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/LeasesTables" xlink:title="999042 - Disclosure - LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_NJ" xlink:label="loc_stprNJ_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_stprNJ_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewJerseyDivisionOfTaxationMember" xlink:label="loc_us-gaapNewJerseyDivisionOfTaxationMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapNewJerseyDivisionOfTaxationMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccountsReceivableNet_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards" xlink:label="loc_IMNNNumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_IMNNNumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DirectFinancingLeaseSellingLoss" xlink:label="loc_us-gaapDirectFinancingLeaseSellingLoss_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDirectFinancingLeaseSellingLoss_130" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/FinancialConditionAndGoingConcernUncertaintyDetailsNarrative" xlink:title="999044 - Disclosure - FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails" xlink:title="999045 - Disclosure - SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaapSegmentReportingInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srtConsolidationItemsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_srtConsolidationItemsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srtConsolidationItemsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidationItemsAxis" xlink:to="loc_srtConsolidationItemsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srtConsolidationItemsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidationItemsAxis" xlink:to="loc_srtConsolidationItemsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaapOperatingSegmentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidationItemsDomain" xlink:to="loc_us-gaapOperatingSegmentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ClinicalResearchMember" xlink:label="loc_IMNNClinicalResearchMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_IMNNClinicalResearchMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_NonClinicalRAndDAndCMCMember" xlink:label="loc_IMNNNonClinicalRAndDAndCMCMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_IMNNNonClinicalRAndDAndCMCMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaapSubsegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapSubsegmentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaapSubsegmentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsegmentsAxis" xlink:to="loc_us-gaapSubsegmentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaapSubsegmentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsegmentsAxis" xlink:to="loc_us-gaapSubsegmentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_OvationMember" xlink:label="loc_IMNNOvationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsegmentsDomain" xlink:to="loc_IMNNOvationMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_VaccineMember" xlink:label="loc_IMNNVaccineMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsegmentsDomain" xlink:to="loc_IMNNVaccineMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_OtherClinicalAndRegulatoryMember" xlink:label="loc_IMNNOtherClinicalAndRegulatoryMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsegmentsDomain" xlink:to="loc_IMNNOtherClinicalAndRegulatoryMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_PlaCCineVaccineMember" xlink:label="loc_IMNNPlaCCineVaccineMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsegmentsDomain" xlink:to="loc_IMNNPlaCCineVaccineMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ManufacturingCMCMember" xlink:label="loc_IMNNManufacturingCMCMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsegmentsDomain" xlink:to="loc_IMNNManufacturingCMCMember_120" xlink:type="arc" order="123" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInOperatingCostAndExpenses" xlink:label="loc_IMNNIncreaseDecreaseInOperatingCostAndExpenses_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInOperatingCostAndExpenses_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage" xlink:label="loc_IMNNIncreaseDecreaseInOperatingCostsAndExpensesPercentage_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInOperatingCostsAndExpensesPercentage_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInResearchAndDevelopmentExpenses" xlink:label="loc_IMNNIncreaseDecreaseInResearchAndDevelopmentExpenses_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInResearchAndDevelopmentExpenses_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage" xlink:label="loc_IMNNIncreaseDecreaseInResearchAndDevelopmentExpensesPercentage_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInResearchAndDevelopmentExpensesPercentage_190" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_190" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpenes" xlink:label="loc_IMNNIncreaseDecreaseInGeneralAndAdministrativeExpenes_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInGeneralAndAdministrativeExpenes_190" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage" xlink:label="loc_IMNNIncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage_190" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapOperatingExpenses_190" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInOperatingExpenses" xlink:label="loc_IMNNIncreaseDecreaseInOperatingExpenses_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInOperatingExpenses_190" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInOperatingExpensesPercentage" xlink:label="loc_IMNNIncreaseDecreaseInOperatingExpensesPercentage_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInOperatingExpensesPercentage_190" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_190" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInLossFromOperations" xlink:label="loc_IMNNIncreaseDecreaseInLossFromOperations_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInLossFromOperations_190" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInLossFromOperationsPercentage" xlink:label="loc_IMNNIncreaseDecreaseInLossFromOperationsPercentage_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInLossFromOperationsPercentage_190" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesDetailsNarrative" xlink:title="999046 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails" xlink:title="999047 - Disclosure - SCHEDULE OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="loc_us-gaapMarketableSecuritiesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="loc_us-gaapMarketableSecuritiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_us-gaapMarketableSecuritiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapMarketableSecuritiesTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaapUSTreasurySecuritiesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapUSTreasurySecuritiesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_us-gaapShortTermInvestments_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost" xlink:label="loc_IMNNDebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_IMNNDebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue" xlink:label="loc_IMNNDebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_IMNNDebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost" xlink:label="loc_IMNNDebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_IMNNDebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue" xlink:label="loc_IMNNDebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_IMNNDebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" xlink:label="loc_IMNNAvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_IMNNAvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:label="loc_us-gaapAvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_50" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfInvestmentSecuritiesGrossUnrealizedGainsLossesDetails" xlink:title="999048 - Disclosure - SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails" xlink:title="999049 - Disclosure - SCHEDULE OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleDetailsNarrative" xlink:title="999050 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:title="999051 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaapUSTreasurySecuritiesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapUSTreasurySecuritiesMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="999052 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_90" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical" xlink:title="999053 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails" xlink:title="999054 - Disclosure - SCHEDULE OF OTHER ACCRUED LIABILITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfDebtDetails" xlink:title="999055 - Disclosure - SCHEDULE OF DEBT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_HorizonTechnologyFinanceCorporationMember" xlink:label="loc_IMNNHorizonTechnologyFinanceCorporationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_IMNNHorizonTechnologyFinanceCorporationMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:label="loc_us-gaapLineOfCreditFacilityFairValueOfAmountOutstanding_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityFairValueOfAmountOutstanding_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EarlyTerminationFee" xlink:label="loc_IMNNEarlyTerminationFee_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_IMNNEarlyTerminationFee_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EndOfTermCharges" xlink:label="loc_IMNNEndOfTermCharges_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_IMNNEndOfTermCharges_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCredit_20" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/NotesPayableDetailsNarrative" xlink:title="999056 - Disclosure - NOTES PAYABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_SiliconValleyBankMember" xlink:label="loc_IMNNSiliconValleyBankMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_IMNNSiliconValleyBankMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapProceedsFromLinesOfCredit_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityCurrentBorrowingCapacity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityCurrentBorrowingCapacity_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaapRepaymentsOfLinesOfCredit_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapRepaymentsOfLinesOfCredit_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaapRestrictedCash_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapRestrictedCash_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_FinalPaymentPercentage" xlink:label="loc_IMNNFinalPaymentPercentage_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_IMNNFinalPaymentPercentage_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCredit_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDebtExpense" xlink:label="loc_us-gaapInterestAndDebtExpense_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapInterestAndDebtExpense_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EndOfTermChargePercentage" xlink:label="loc_IMNNEndOfTermChargePercentage_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_IMNNEndOfTermChargePercentage_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapInterestExpense_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapInterestExpenseDebt_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnContractTermination" xlink:label="loc_us-gaapGainLossOnContractTermination_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapGainLossOnContractTermination_60" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails" xlink:title="999057 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (BENEFIT) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:title="999058 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="999059 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/IncomeTaxesDetailsNarrative" xlink:title="999060 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_NJ" xlink:label="loc_stprNJ_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_stprNJ_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_FederalIncomeTaxMember" xlink:label="loc_IMNNFederalIncomeTaxMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_IMNNFederalIncomeTaxMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaapStateAndLocalJurisdictionMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapStateAndLocalJurisdictionMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_NoExpirationMember" xlink:label="loc_IMNNNoExpirationMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_IMNNNoExpirationMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewJerseyDivisionOfTaxationMember" xlink:label="loc_us-gaapNewJerseyDivisionOfTaxationMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapNewJerseyDivisionOfTaxationMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ProceedsFromSaleOfNetOperatingLosses" xlink:label="loc_IMNNProceedsFromSaleOfNetOperatingLosses_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_IMNNProceedsFromSaleOfNetOperatingLosses_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_OperatingLossCarryforwardsExpirationDescription" xlink:label="loc_IMNNOperatingLossCarryforwardsExpirationDescription_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_IMNNOperatingLossCarryforwardsExpirationDescription_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefits_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="loc_us-gaapIncomeTaxExaminationDescription_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationDescription_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_NetProceedsFromSaleOfNetOperatingLosses" xlink:label="loc_IMNNNetProceedsFromSaleOfNetOperatingLosses_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_IMNNNetProceedsFromSaleOfNetOperatingLosses_160" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_160" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/StockholdersEquityDetailsNarrative" xlink:title="999061 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_AtTheMarketOfferingAgreementMember" xlink:label="loc_IMNNAtTheMarketOfferingAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_IMNNAtTheMarketOfferingAgreementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_SecuritiesPurchaseAgreementMember" xlink:label="loc_IMNNSecuritiesPurchaseAgreementMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_IMNNSecuritiesPurchaseAgreementMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_JulyTwoThousandTwentyFourOfferingMember" xlink:label="loc_IMNNJulyTwoThousandTwentyFourOfferingMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_IMNNJulyTwoThousandTwentyFourOfferingMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_80" xlink:type="arc" order="83" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharePrice_110" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfStockOptionsDetails" xlink:title="999062 - Disclosure - SUMMARY OF STOCK OPTIONS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails" xlink:title="999063 - Disclosure - SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails" xlink:title="999064 - Disclosure - SUMMARY OF STOCK OPTIONS OUTSTANDING (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ExercisePriceOneMember" xlink:label="loc_IMNNExercisePriceOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_IMNNExercisePriceOneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ExercisePriceTwoMember" xlink:label="loc_IMNNExercisePriceTwoMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_IMNNExercisePriceTwoMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ExercisePriceThreeMember" xlink:label="loc_IMNNExercisePriceThreeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_IMNNExercisePriceThreeMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_80" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails" xlink:title="999065 - Disclosure - SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_70" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/Stock-basedCompensationDetailsNarrative" xlink:title="999066 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_TwoThousandAndEighteenStockIncentivePlanMember" xlink:label="loc_IMNNTwoThousandAndEighteenStockIncentivePlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_IMNNTwoThousandAndEighteenStockIncentivePlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_InducementOptionGrantsMember" xlink:label="loc_IMNNInducementOptionGrantsMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_IMNNInducementOptionGrantsMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EquityStockAwardsMember" xlink:label="loc_IMNNEquityStockAwardsMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_IMNNEquityStockAwardsMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_InducementAwardsMember" xlink:label="loc_IMNNInducementAwardsMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_IMNNInducementAwardsMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember" xlink:label="loc_IMNNEmployeeStockOptionAndRestrictedStockAwardsMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_IMNNEmployeeStockOptionAndRestrictedStockAwardsMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember" xlink:label="loc_IMNNGrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_IMNNGrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember_170" xlink:type="arc" order="172" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_190" xlink:type="arc" order="192" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_240" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_240" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_StockOptionsStrikePriceDescription" xlink:label="loc_IMNNStockOptionsStrikePriceDescription_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_IMNNStockOptionsStrikePriceDescription_240" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharesIssued_240" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_240" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_240" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_240" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_240" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_240" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfWarrantActivityDetails" xlink:title="999067 - Disclosure - SUMMARY OF WARRANT ACTIVITY (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/ImunonEmployeeBenefitPlansDetailsNarrative" xlink:title="999068 - Disclosure - IMUNON EMPLOYEE BENEFIT PLANS (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails" xlink:title="999069 - Disclosure - SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/LeasesDetailsNarrative" xlink:title="999070 - Disclosure - LEASES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_LeaseAgreementMember" xlink:label="loc_IMNNLeaseAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_IMNNLeaseAgreementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaapLesseeOperatingLeaseTermOfContract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseTermOfContract_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapAreaOfLand_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsForRent_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_OperatingLeasesIncrementalBorrowingRate" xlink:label="loc_IMNNOperatingLeasesIncrementalBorrowingRate_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_IMNNOperatingLeasesIncrementalBorrowingRate_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOperatingLeaseCost_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOperatingLeasePayments_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOtherDepreciationAndAmortization_120" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://imunon.com/role/RelatedPartyTransactionDetailsNarrative" xlink:title="999071 - Disclosure - RELATED PARTY TRANSACTION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ConvertibleNotePurchaseAgreementMember" xlink:label="loc_IMNNConvertibleNotePurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_IMNNConvertibleNotePurchaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_TransomicTechnologiesIncMember" xlink:label="loc_IMNNTransomicTechnologiesIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_IMNNTransomicTechnologiesIncMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EquityStockAwardsMember" xlink:label="loc_IMNNEquityStockAwardsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_IMNNEquityStockAwardsMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_InducementAwardsMember" xlink:label="loc_IMNNInducementAwardsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_IMNNInducementAwardsMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember" xlink:label="loc_IMNNEmployeeStockOptionAndRestrictedStockAwardsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_IMNNEmployeeStockOptionAndRestrictedStockAwardsMember" xlink:type="arc" order="20" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>19
<FILENAME>imnn-20241231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="us-gaap_TreasuryStockCommonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonMember" xlink:to="us-gaap_TreasuryStockCommonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonMember_lbl" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_NJ" xlink:label="stpr_NJ" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_NJ" xlink:to="stpr_NJ_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="stpr_NJ_lbl" xml:lang="en-US">NEW JERSEY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewJerseyDivisionOfTaxationMember" xlink:label="us-gaap_NewJerseyDivisionOfTaxationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewJerseyDivisionOfTaxationMember" xlink:to="us-gaap_NewJerseyDivisionOfTaxationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewJerseyDivisionOfTaxationMember_lbl" xml:lang="en-US">New Jersey Division of Taxation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidationItemsAxis_lbl" xml:lang="en-US">Consolidation Items [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingSegmentsMember" xlink:to="us-gaap_OperatingSegmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xml:lang="en-US">Operating Segments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US">Segments [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ClinicalResearchMember" xlink:label="IMNN_ClinicalResearchMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ClinicalResearchMember" xlink:to="IMNN_ClinicalResearchMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_ClinicalResearchMember_lbl" xml:lang="en-US">Clinical Research [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsAxis" xlink:label="us-gaap_SubsegmentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsegmentsAxis" xlink:to="us-gaap_SubsegmentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsegmentsAxis_lbl" xml:lang="en-US">Subsegments [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_OvationMember" xlink:label="IMNN_OvationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_OvationMember" xlink:to="IMNN_OvationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_OvationMember_lbl" xml:lang="en-US">Ovation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_VaccineMember" xlink:label="IMNN_VaccineMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_VaccineMember" xlink:to="IMNN_VaccineMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_VaccineMember_lbl" xml:lang="en-US">Vaccine [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_OtherClinicalAndRegulatoryMember" xlink:label="IMNN_OtherClinicalAndRegulatoryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_OtherClinicalAndRegulatoryMember" xlink:to="IMNN_OtherClinicalAndRegulatoryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_OtherClinicalAndRegulatoryMember_lbl" xml:lang="en-US">Other Clinical And Regulatory [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_NonClinicalRAndDAndCMCMember" xlink:label="IMNN_NonClinicalRAndDAndCMCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_NonClinicalRAndDAndCMCMember" xlink:to="IMNN_NonClinicalRAndDAndCMCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_NonClinicalRAndDAndCMCMember_lbl" xml:lang="en-US">Non-Clinical R&amp;D and CMC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_PlaCCineVaccineMember" xlink:label="IMNN_PlaCCineVaccineMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_PlaCCineVaccineMember" xlink:to="IMNN_PlaCCineVaccineMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_PlaCCineVaccineMember_lbl" xml:lang="en-US">PlaCCine Vaccine [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ManufacturingCMCMember" xlink:label="IMNN_ManufacturingCMCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ManufacturingCMCMember" xlink:to="IMNN_ManufacturingCMCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_ManufacturingCMCMember_lbl" xml:lang="en-US">Manufacturing (CMC) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xml:lang="en-US">US Treasury Securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityAxis_lbl" xml:lang="en-US">Lender Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_SiliconValleyBankMember" xlink:label="IMNN_SiliconValleyBankMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_SiliconValleyBankMember" xlink:to="IMNN_SiliconValleyBankMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_SiliconValleyBankMember_lbl" xml:lang="en-US">Silicon Valley Bank [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_HorizonTechnologyFinanceCorporationMember" xlink:label="IMNN_HorizonTechnologyFinanceCorporationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_HorizonTechnologyFinanceCorporationMember" xlink:to="IMNN_HorizonTechnologyFinanceCorporationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_HorizonTechnologyFinanceCorporationMember_lbl" xml:lang="en-US">Horizon Technology Finance Corporation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Domestic Tax Jurisdiction [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_FederalIncomeTaxMember" xlink:label="IMNN_FederalIncomeTaxMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_FederalIncomeTaxMember" xlink:to="IMNN_FederalIncomeTaxMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_FederalIncomeTaxMember_lbl" xml:lang="en-US">Federal Income Tax [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_NoExpirationMember" xlink:label="IMNN_NoExpirationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_NoExpirationMember" xlink:to="IMNN_NoExpirationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_NoExpirationMember_lbl" xml:lang="en-US">No Expiration [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_AtTheMarketOfferingAgreementMember" xlink:label="IMNN_AtTheMarketOfferingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_AtTheMarketOfferingAgreementMember" xlink:to="IMNN_AtTheMarketOfferingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_AtTheMarketOfferingAgreementMember_lbl" xml:lang="en-US">At the Market Offering Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_SecuritiesPurchaseAgreementMember" xlink:label="IMNN_SecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_SecuritiesPurchaseAgreementMember" xlink:to="IMNN_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_JulyTwoThousandTwentyFourOfferingMember" xlink:label="IMNN_JulyTwoThousandTwentyFourOfferingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_JulyTwoThousandTwentyFourOfferingMember" xlink:to="IMNN_JulyTwoThousandTwentyFourOfferingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_JulyTwoThousandTwentyFourOfferingMember_lbl" xml:lang="en-US">July 2024 Offering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_TwoThousandAndEighteenStockIncentivePlanMember" xlink:label="IMNN_TwoThousandAndEighteenStockIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_TwoThousandAndEighteenStockIncentivePlanMember" xlink:to="IMNN_TwoThousandAndEighteenStockIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_TwoThousandAndEighteenStockIncentivePlanMember_lbl" xml:lang="en-US">2018 Stock Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_InducementOptionGrantsMember" xlink:label="IMNN_InducementOptionGrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_InducementOptionGrantsMember" xlink:to="IMNN_InducementOptionGrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_InducementOptionGrantsMember_lbl" xml:lang="en-US">Inducement Option Grants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors Chairman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EquityStockAwardsMember" xlink:label="IMNN_EquityStockAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EquityStockAwardsMember" xlink:to="IMNN_EquityStockAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_EquityStockAwardsMember_lbl" xml:lang="en-US">Equity Stock Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember" xlink:label="IMNN_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember" xlink:to="IMNN_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember_lbl" xml:lang="en-US">Granted Under 2018 Plan and 2007 Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_InducementAwardsMember" xlink:label="IMNN_InducementAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_InducementAwardsMember" xlink:to="IMNN_InducementAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_InducementAwardsMember_lbl" xml:lang="en-US">Inducement Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember" xlink:label="IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember" xlink:to="IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember_lbl" xml:lang="en-US">Stock Options and Restricted Stock Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and Development Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ExercisePriceOneMember" xlink:label="IMNN_ExercisePriceOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ExercisePriceOneMember" xlink:to="IMNN_ExercisePriceOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_ExercisePriceOneMember_lbl" xml:lang="en-US">Exercise Price One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ExercisePriceTwoMember" xlink:label="IMNN_ExercisePriceTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ExercisePriceTwoMember" xlink:to="IMNN_ExercisePriceTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_ExercisePriceTwoMember_lbl" xml:lang="en-US">Exercise Price Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ExercisePriceThreeMember" xlink:label="IMNN_ExercisePriceThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ExercisePriceThreeMember" xlink:to="IMNN_ExercisePriceThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_ExercisePriceThreeMember_lbl" xml:lang="en-US">Exercise Price Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_LeaseAgreementMember" xlink:label="IMNN_LeaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_LeaseAgreementMember" xlink:to="IMNN_LeaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_LeaseAgreementMember_lbl" xml:lang="en-US">Lease Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ConvertibleNotePurchaseAgreementMember" xlink:label="IMNN_ConvertibleNotePurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ConvertibleNotePurchaseAgreementMember" xlink:to="IMNN_ConvertibleNotePurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_ConvertibleNotePurchaseAgreementMember_lbl" xml:lang="en-US">Convertible Note Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_TransomicTechnologiesIncMember" xlink:label="IMNN_TransomicTechnologiesIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_TransomicTechnologiesIncMember" xlink:to="IMNN_TransomicTechnologiesIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_TransomicTechnologiesIncMember_lbl" xml:lang="en-US">Transomic Technologies, Inc. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorOpinionTextBlock" xlink:to="dei_AuditorOpinionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorOpinionTextBlock_lbl" xml:lang="en-US">Auditor Opinion [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xml:lang="en-US">Investment in debt securities - available for sale, at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivableCurrent" xlink:label="us-gaap_GrantsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivableCurrent" xlink:to="us-gaap_GrantsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrantsReceivableCurrent_lbl" xml:lang="en-US">Advances and deposits on clinical programs and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment (at cost, less accumulated depreciation and amortization)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsAbstract" xlink:label="us-gaap_OtherAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsAbstract_lbl" xml:lang="en-US">Other assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xml:lang="en-US">Deferred income tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right-of-use assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">Deposits and other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Total other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="us-gaap_AccountsPayableTradeCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US">Accounts payable &#8211; trade</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liabilities - current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liabilities - non-current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred Stock - $0.01 par value (100,000 shares authorized, and no shares issued or outstanding at December 31, 2024 and 2023)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock - $0.01 par value (112,500,000 shares authorized; 14,500,707 and 9,399,811 shares issued at December 31, 2024 and 2023, respectively, and 14,500,685 and 9,399,789 shares outstanding at December 31, 2024 and 2023, respectively)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityBeforeTreasuryStock" xlink:label="us-gaap_StockholdersEquityBeforeTreasuryStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityBeforeTreasuryStock" xlink:to="us-gaap_StockholdersEquityBeforeTreasuryStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityBeforeTreasuryStock_lbl" xml:lang="en-US">Total stockholders&#8217; equity before treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost (22 shares at December 31, 2024 and 2023)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonShares" xlink:to="us-gaap_TreasuryStockCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xml:lang="en-US">Treasury stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xml:lang="en-US">Other income (expense):</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Investment income, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Loss on debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="us-gaap_InterestExpenseNonoperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpenseNonoperating_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xml:lang="en-US">Other expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income (expense), net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before income tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net loss per common share - Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Net loss per common share - Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average common shares outstanding - Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average common shares outstanding - Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xml:lang="en-US">Other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Changes in:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xml:lang="en-US">Realized and unrealized gains on available for sale securities, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Total comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization of right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments" xlink:label="us-gaap_GainLossOnInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestments" xlink:to="us-gaap_GainLossOnInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnInvestments_lbl" xml:lang="en-US">Realized and unrealized (gains) and losses, net, on investment securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Realization of deferred income tax asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xml:lang="en-US">Loss on extinguishment of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_lbl" xml:lang="en-US">Write-off of note receivable (Transomic)</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable" xlink:label="IMNN_AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable" xlink:to="IMNN_AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable_lbl" xml:lang="en-US">Amortization of deferred finance charges and debt discount associated with note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Net changes in:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedInvestmentIncomeReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccruedInvestmentIncomeReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedInvestmentIncomeReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccruedInvestmentIncomeReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedInvestmentIncomeReceivable_lbl" xml:lang="en-US">Accrued interest receivable on investment securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xml:lang="en-US">Advances, deposits, and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" xml:lang="en-US">Purchases of investment securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xml:lang="en-US">Proceeds from sale and maturity of investment securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from sale of common stock equity, net of issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_PaymentoffOfLoanAndAccruedEndoftermFees" xlink:label="IMNN_PaymentoffOfLoanAndAccruedEndoftermFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_PaymentoffOfLoanAndAccruedEndoftermFees" xlink:to="IMNN_PaymentoffOfLoanAndAccruedEndoftermFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="IMNN_PaymentoffOfLoanAndAccruedEndoftermFees_lbl" xml:lang="en-US">Payoff of the SVB loan and accrued end-of-term fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net change in cash, cash equivalents and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash and cash equivalents end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non-Cash Investing and Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_RecognitionOfRightUseAssetAndLiability" xlink:label="IMNN_RecognitionOfRightUseAssetAndLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_RecognitionOfRightUseAssetAndLiability" xlink:to="IMNN_RecognitionOfRightUseAssetAndLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_RecognitionOfRightUseAssetAndLiability_lbl" xml:lang="en-US">Recognition of right of use asset and liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Sale of equity through equity financing facilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Sale of equity through equity financing facilities, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US">Issuance of stock upon vesting of restricted shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Issuance of stock upon vesting of restricted shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Realized and unrealized gains, net, on investment securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock-based compensation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis" xlink:label="ecd_MeasureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureAxis" xlink:to="ecd_MeasureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureAxis_lbl" xml:lang="en-US">Measure [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="ecd_InsiderTradingArrLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="ecd_InsiderTradingArrLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingArrLineItems_lbl" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_Rule10b51ArrModifiedFlag" xlink:label="IMNN_Rule10b51ArrModifiedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_Rule10b51ArrModifiedFlag" xlink:to="IMNN_Rule10b51ArrModifiedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_Rule10b51ArrModifiedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Modified</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_NonRule10b51ArrModifiedFlag" xlink:label="IMNN_NonRule10b51ArrModifiedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_NonRule10b51ArrModifiedFlag" xlink:to="IMNN_NonRule10b51ArrModifiedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_NonRule10b51ArrModifiedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Modified</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Third Party Engaged [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xml:lang="en-US">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Role of Management [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentAbstract" xlink:label="cyd_MaterialCybersecurityIncidentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentAbstract" xlink:to="cyd_MaterialCybersecurityIncidentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentAbstract_lbl" xml:lang="en-US">Material Cybersecurity Incident [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentNatureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentNatureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentNatureTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Nature [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentScopeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentScopeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentScopeTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Scope [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentTimingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentTimingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentTimingTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Timing [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT PERFORMANCE MEASURES AND EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xml:lang="en-US">INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DisclosureFairValuesOfFinancialInstrumentsAbstract" xlink:label="IMNN_DisclosureFairValuesOfFinancialInstrumentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DisclosureFairValuesOfFinancialInstrumentsAbstract" xlink:to="IMNN_DisclosureFairValuesOfFinancialInstrumentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_DisclosureFairValuesOfFinancialInstrumentsAbstract_lbl" xml:lang="en-US">Fair Values Of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesAndFairValueTextBlock" xlink:label="us-gaap_DerivativesAndFairValueTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesAndFairValueTextBlock" xlink:to="us-gaap_DerivativesAndFairValueTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesAndFairValueTextBlock_lbl" xml:lang="en-US">FAIR VALUES OF FINANCIAL INSTRUMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">OTHER ACCRUED LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">NOTES PAYABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DisclosureWarrantsAbstract" xlink:label="IMNN_DisclosureWarrantsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DisclosureWarrantsAbstract" xlink:to="IMNN_DisclosureWarrantsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_DisclosureWarrantsAbstract_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_WarrantsTextBlock" xlink:label="IMNN_WarrantsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_WarrantsTextBlock" xlink:to="IMNN_WarrantsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_WarrantsTextBlock_lbl" xml:lang="en-US">WARRANTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xml:lang="en-US">IMUNON EMPLOYEE BENEFIT PLANS</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DisclosureLeasesAbstract" xlink:label="IMNN_DisclosureLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DisclosureLeasesAbstract" xlink:to="IMNN_DisclosureLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_DisclosureLeasesAbstract_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Description of Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Accounting Standards Update: Improvements to Reportable Segment Disclosures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Short-Term Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock" xlink:label="IMNN_AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock" xlink:to="IMNN_AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock_lbl" xml:lang="en-US">Advances and Deposits on Clinical Programs and Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DepositsPolicyTextBlock" xlink:label="IMNN_DepositsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DepositsPolicyTextBlock" xlink:to="IMNN_DepositsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_DepositsPolicyTextBlock_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Loss per Share of Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_WarrantAccountingPolicyTextBlock" xlink:label="IMNN_WarrantAccountingPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_WarrantAccountingPolicyTextBlock" xlink:to="IMNN_WarrantAccountingPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_WarrantAccountingPolicyTextBlock_lbl" xml:lang="en-US">Warrant Accounting</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:label="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:to="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeTextBlock" xlink:label="us-gaap_InvestmentIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeTextBlock" xlink:to="us-gaap_InvestmentIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeTextBlock_lbl" xml:lang="en-US">SCHEDULE OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PROPERTY AND EQUIPMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF OTHER ACCRUED LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DEBT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INCOME TAX PROVISION (BENEFIT)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">SUMMARY OF STOCK OPTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xml:lang="en-US">SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xml:lang="en-US">SUMMARY OF STOCK OPTIONS OUTSTANDING</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">SUMMARY OF WARRANT ACTIVITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="us-gaap_AccountsReceivableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNet_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property plant and equipment useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xml:lang="en-US">Impairment of property or equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards" xlink:label="IMNN_NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards" xlink:to="IMNN_NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards_lbl" xml:lang="en-US">Number of shares of common stock issuable upon exercise of warrants and equity awards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net proceeds from sale of net operating losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DirectFinancingLeaseSellingLoss" xlink:label="us-gaap_DirectFinancingLeaseSellingLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DirectFinancingLeaseSellingLoss" xlink:to="us-gaap_DirectFinancingLeaseSellingLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DirectFinancingLeaseSellingLoss_lbl" xml:lang="en-US">Direct financing lease, selling loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLoss_4_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Fund operation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Cumulated net losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xml:lang="en-US">Cash and cash equivalents, short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInOperatingCostAndExpenses" xlink:label="IMNN_IncreaseDecreaseInOperatingCostAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInOperatingCostAndExpenses" xlink:to="IMNN_IncreaseDecreaseInOperatingCostAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_IncreaseDecreaseInOperatingCostAndExpenses_lbl" xml:lang="en-US">Change Increase (Decrease), Subtotal</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage" xlink:label="IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage" xlink:to="IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage_lbl" xml:lang="en-US">Change Increase (Decrease), Subtotal, percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xml:lang="en-US">Research and development expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInResearchAndDevelopmentExpenses" xlink:label="IMNN_IncreaseDecreaseInResearchAndDevelopmentExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInResearchAndDevelopmentExpenses" xlink:to="IMNN_IncreaseDecreaseInResearchAndDevelopmentExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_IncreaseDecreaseInResearchAndDevelopmentExpenses_lbl" xml:lang="en-US">Change Increase (Decrease), Research and development expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage" xlink:label="IMNN_IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage" xlink:to="IMNN_IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage_lbl" xml:lang="en-US">Change Increase (Decrease), Research and development expenses, percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpenes" xlink:label="IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpenes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpenes" xlink:to="IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpenes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpenes_lbl" xml:lang="en-US">Change Increase (Decrease), General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage" xlink:label="IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage" xlink:to="IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage_lbl" xml:lang="en-US">Change Increase (Decrease), General and administrative expenses, percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInOperatingExpenses" xlink:label="IMNN_IncreaseDecreaseInOperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInOperatingExpenses" xlink:to="IMNN_IncreaseDecreaseInOperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_IncreaseDecreaseInOperatingExpenses_lbl" xml:lang="en-US">Change Increase (Decrease), Operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInOperatingExpensesPercentage" xlink:label="IMNN_IncreaseDecreaseInOperatingExpensesPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInOperatingExpensesPercentage" xlink:to="IMNN_IncreaseDecreaseInOperatingExpensesPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_IncreaseDecreaseInOperatingExpensesPercentage_lbl" xml:lang="en-US">Change Increase (Decrease), Operating expenses, percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInLossFromOperations" xlink:label="IMNN_IncreaseDecreaseInLossFromOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInLossFromOperations" xlink:to="IMNN_IncreaseDecreaseInLossFromOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_IncreaseDecreaseInLossFromOperations_lbl" xml:lang="en-US">Change Increase (Decrease), Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInLossFromOperationsPercentage" xlink:label="IMNN_IncreaseDecreaseInLossFromOperationsPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInLossFromOperationsPercentage" xlink:to="IMNN_IncreaseDecreaseInLossFromOperationsPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_IncreaseDecreaseInLossFromOperationsPercentage_lbl" xml:lang="en-US">Change Increase (Decrease), Loss from operations, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US">Number of operating segment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="us-gaap_MarketableSecuritiesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_MarketableSecuritiesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesTable_lbl" xml:lang="en-US">Marketable Securities [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="us-gaap_MarketableSecuritiesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesLineItems_lbl" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short-term investments - Cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_2_lbl" xml:lang="en-US">Short-term investments - Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost" xlink:label="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost" xlink:to="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost_lbl" xml:lang="en-US">Short-term investment maturities - Within 3 months, cost</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue" xlink:label="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue" xlink:to="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue_lbl" xml:lang="en-US">Short-term investment maturities - Within 3 months, fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost" xlink:label="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost" xlink:to="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost_lbl" xml:lang="en-US">Short-term investment maturities - Between 3-12 months, cost</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue" xlink:label="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue" xlink:to="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue_lbl" xml:lang="en-US">Short-term investment maturities - Between 3-12 months, fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" xlink:label="IMNN_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" xlink:to="IMNN_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_lbl" xml:lang="en-US">Short-term investment maturities - Cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_lbl" xml:lang="en-US">Short-term investment maturities - Fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_AvailableForSaleSecuritiesUnrealizedLossFairValue" xlink:label="IMNN_AvailableForSaleSecuritiesUnrealizedLossFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_AvailableForSaleSecuritiesUnrealizedLossFairValue" xlink:to="IMNN_AvailableForSaleSecuritiesUnrealizedLossFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_AvailableForSaleSecuritiesUnrealizedLossFairValue_lbl" xml:lang="en-US">Investments in debt securities with unrealized gains - Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths" xlink:label="IMNN_AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths" xlink:to="IMNN_AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths_lbl" xml:lang="en-US">Investments in debt securities with unrealized gains - Unrealized Holding Gains (Losses)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xml:lang="en-US">Interest and dividends accrued and paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_lbl" xml:lang="en-US">Realized losses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InvestmentIncomeNet_2_lbl" xml:lang="en-US">Investment income, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3_lbl" xml:lang="en-US">Debt securities, available for sale, current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_2_lbl" xml:lang="en-US">Estimated useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractualObligation" xlink:label="us-gaap_ContractualObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractualObligation" xlink:to="us-gaap_ContractualObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractualObligation_lbl" xml:lang="en-US">Amounts due to contract research organizations and other contractual agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued payroll and related benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Accrued professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:label="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_lbl" xml:lang="en-US">Principal balance at April 21, 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EarlyTerminationFee" xlink:label="IMNN_EarlyTerminationFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EarlyTerminationFee" xlink:to="IMNN_EarlyTerminationFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_EarlyTerminationFee_lbl" xml:lang="en-US">Early termination fees</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EndOfTermCharges" xlink:label="IMNN_EndOfTermCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EndOfTermCharges" xlink:to="IMNN_EndOfTermCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_EndOfTermCharges_lbl" xml:lang="en-US">End of term charges</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US">Total payoff amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityTable_lbl" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityLineItems_lbl" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US">Line of credit facility, maximum borrowing capacity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US">Proceeds from lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xml:lang="en-US">Loan amount withdrawn</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xml:lang="en-US">Repayments of lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCash_lbl" xml:lang="en-US">Restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_FinalPaymentPercentage" xlink:label="IMNN_FinalPaymentPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_FinalPaymentPercentage" xlink:to="IMNN_FinalPaymentPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_FinalPaymentPercentage_lbl" xml:lang="en-US">Final payment percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_2_lbl" xml:lang="en-US">Long term line of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="us-gaap_DebtInstrumentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescription" xlink:to="us-gaap_DebtInstrumentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDescription_lbl" xml:lang="en-US">Debt instrument, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDebtExpense" xlink:label="us-gaap_InterestAndDebtExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndDebtExpense" xlink:to="us-gaap_InterestAndDebtExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndDebtExpense_lbl" xml:lang="en-US">Financing fees and expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EndOfTermChargePercentage" xlink:label="IMNN_EndOfTermChargePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EndOfTermChargePercentage" xlink:to="IMNN_EndOfTermChargePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_EndOfTermChargePercentage_lbl" xml:lang="en-US">End of term charge percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US">Amortization of debt issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnContractTermination" xlink:label="us-gaap_GainLossOnContractTermination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnContractTermination" xlink:to="us-gaap_GainLossOnContractTermination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnContractTermination_lbl" xml:lang="en-US">Gain (loss) on contract termination</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State and Local</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Federal statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State taxes, net of federal tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:label="IMNN_EffectiveIncomeTaxRateReconciliationPermanentDifferences" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:to="IMNN_EffectiveIncomeTaxRateReconciliationPermanentDifferences_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_EffectiveIncomeTaxRateReconciliationPermanentDifferences_lbl" xml:lang="en-US">Permanent differences</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EffectiveIncomeTaxRateReconciliationTimeUp" xlink:label="IMNN_EffectiveIncomeTaxRateReconciliationTimeUp" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EffectiveIncomeTaxRateReconciliationTimeUp" xlink:to="IMNN_EffectiveIncomeTaxRateReconciliationTimeUp_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_EffectiveIncomeTaxRateReconciliationTimeUp_lbl" xml:lang="en-US">True-Up</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl" xml:lang="en-US">Rate Change</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate" xlink:label="IMNN_EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate" xlink:to="IMNN_EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate_lbl" xml:lang="en-US">Deferred vs statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EffectiveIncomeTaxRateReconciliationSaleAndExpiration" xlink:label="IMNN_EffectiveIncomeTaxRateReconciliationSaleAndExpiration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EffectiveIncomeTaxRateReconciliationSaleAndExpiration" xlink:to="IMNN_EffectiveIncomeTaxRateReconciliationSaleAndExpiration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_EffectiveIncomeTaxRateReconciliationSaleAndExpiration_lbl" xml:lang="en-US">Expiration of NOLs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance and deferred rate change, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DeferredTaxAssetsLegalAct" xlink:label="IMNN_DeferredTaxAssetsLegalAct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DeferredTaxAssetsLegalAct" xlink:to="IMNN_DeferredTaxAssetsLegalAct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_DeferredTaxAssetsLegalAct_lbl" xml:lang="en-US">Section 174</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other deferred tax assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Total deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTable_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ProceedsFromSaleOfNetOperatingLosses" xlink:label="IMNN_ProceedsFromSaleOfNetOperatingLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ProceedsFromSaleOfNetOperatingLosses" xlink:to="IMNN_ProceedsFromSaleOfNetOperatingLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="IMNN_ProceedsFromSaleOfNetOperatingLosses_lbl" xml:lang="en-US">Deferred income tax asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLossCarryforwards_2_lbl" xml:lang="en-US">Operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_OperatingLossCarryforwardsExpirationDescription" xlink:label="IMNN_OperatingLossCarryforwardsExpirationDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_OperatingLossCarryforwardsExpirationDescription" xlink:to="IMNN_OperatingLossCarryforwardsExpirationDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_OperatingLossCarryforwardsExpirationDescription_lbl" xml:lang="en-US">Operating loss carryforwards expiration description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US">Unrecognized tax benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xml:lang="en-US">Payment of interest and penalties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationDescription" xlink:to="us-gaap_IncomeTaxExaminationDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationDescription_lbl" xml:lang="en-US">Income tax examination, description</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_NetProceedsFromSaleOfNetOperatingLosses" xlink:label="IMNN_NetProceedsFromSaleOfNetOperatingLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_NetProceedsFromSaleOfNetOperatingLosses" xlink:to="IMNN_NetProceedsFromSaleOfNetOperatingLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_NetProceedsFromSaleOfNetOperatingLosses_lbl" xml:lang="en-US">Proceeds from sale</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingIncomeLoss_3_lbl" xml:lang="en-US">Operating losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Stock issued during period, value, new issues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Number of shares sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Proceeds from sale of stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Stock issued, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number Outstanding, Outstanding, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Number Outstanding, Options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Number Outstanding, Options canceled or expired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Options canceled or expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number Outstanding, Outstanding, Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term (years), Outstanding, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Number Outstanding, Exercisable, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercisable, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term (years), Exercisable, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Number Outstanding, Non-vested stock awards, Outstanding, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Number Outstanding, Non-vested stock awards, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Non-vested stock awards, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Number Outstanding, Non-vested stock awards, Vested and issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Non-vested stock awards, Vested and issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Number Outstanding, Non-vested stock awards, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Non-vested stock awards, Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xml:lang="en-US">Number Outstanding, Non-vested stock awards, Outstanding, Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xml:lang="en-US">Range of Exercise Prices, Upper</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Options Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xml:lang="en-US">Options Outstanding, Weighted Average Remaining Contractual Term (in years)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Options Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Options Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2_lbl" xml:lang="en-US">Options Exercisable, Weighted Average Remaining Contractual Term (in years)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Options Exercisable, Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xml:lang="en-US">Range of Exercise Prices, Lower</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Risk-free interest rate, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Risk-free interest rate, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US">Expected volatility, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Expected volatility, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life (in years)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Share-based payment award, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Shares available for issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_StockOptionsStrikePriceDescription" xlink:label="IMNN_StockOptionsStrikePriceDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_StockOptionsStrikePriceDescription" xlink:to="IMNN_StockOptionsStrikePriceDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_StockOptionsStrikePriceDescription_lbl" xml:lang="en-US">Stock options, strike price description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Shares, Issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Exercise price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Common stock, reserved for future issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Share based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized compensation cost related to non-vested stock-based compensation arrangements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Cost recognized over a weighted-average period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DisclosureWarrantsAbstract" xlink:to="IMNN_DisclosureWarrantsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="IMNN_DisclosureWarrantsAbstract_2_lbl" xml:lang="en-US">Summary Of Warrant Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Number of Warrants Issued, Warrants outstanding, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:label="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Warrants outstanding, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xml:lang="en-US">Number of Warrants Issued, Warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice" xlink:label="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice" xlink:to="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xml:lang="en-US">Number of Warrants Issued, Warrants expired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Warrants expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Warrants Issued, Warrants outstanding, Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Warrants outstanding, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" xlink:label="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" xlink:to="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value of outstanding warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="IMNN_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="IMNN_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average remaining contractual terms (years)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" xml:lang="en-US">Maximum annual contributions per employee, percent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount" xlink:to="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_lbl" xml:lang="en-US">Matching contributions of employee</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DisclosureLeasesAbstract" xlink:to="IMNN_DisclosureLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="IMNN_DisclosureLeasesAbstract_2_lbl" xml:lang="en-US">Schedule Of Lease Payments And Maturity Of Operating Lease Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter" xlink:label="IMNN_LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter" xlink:to="IMNN_LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter_lbl" xml:lang="en-US">2028 and thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Subtotal future lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less imputed interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Operating lease, weighted average remaining lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Operating lease, weighted average discount rate, percent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US">Operating lease, term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfLand" xlink:to="us-gaap_AreaOfLand_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AreaOfLand_lbl" xml:lang="en-US">Area of land</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Payments for rent</link:label>
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_OperatingLeasesIncrementalBorrowingRate" xlink:label="IMNN_OperatingLeasesIncrementalBorrowingRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_OperatingLeasesIncrementalBorrowingRate" xlink:to="IMNN_OperatingLeasesIncrementalBorrowingRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_OperatingLeasesIncrementalBorrowingRate_lbl" xml:lang="en-US">Incremental borrowing rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease, cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating lease, payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="us-gaap_OtherDepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDepreciationAndAmortization" xlink:to="us-gaap_OtherDepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDepreciationAndAmortization_lbl" xml:lang="en-US">Amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xml:lang="en-US">Convertible notes and warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_SiliconValleyBankMember" xlink:to="IMNN_SiliconValleyBankMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_SiliconValleyBankMember_doc" xml:lang="en-US">Silicon Valley Bank [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_FinalPaymentPercentage" xlink:to="IMNN_FinalPaymentPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_FinalPaymentPercentage_doc" xml:lang="en-US">Final Payment Percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EndOfTermChargePercentage" xlink:to="IMNN_EndOfTermChargePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_EndOfTermChargePercentage_doc" xml:lang="en-US">End of term charge percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EarlyTerminationFee" xlink:to="IMNN_EarlyTerminationFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_EarlyTerminationFee_doc" xml:lang="en-US">Early termination fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EndOfTermCharges" xlink:to="IMNN_EndOfTermCharges_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_EndOfTermCharges_doc" xml:lang="en-US">End of term charge.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:to="IMNN_EffectiveIncomeTaxRateReconciliationPermanentDifferences_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_EffectiveIncomeTaxRateReconciliationPermanentDifferences_doc" xml:lang="en-US">Effective income tax rate reconciliation permanent differences.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EffectiveIncomeTaxRateReconciliationTimeUp" xlink:to="IMNN_EffectiveIncomeTaxRateReconciliationTimeUp_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_EffectiveIncomeTaxRateReconciliationTimeUp_doc" xml:lang="en-US">Effective income tax rate reconciliation time up.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DeferredTaxAssetsLegalAct" xlink:to="IMNN_DeferredTaxAssetsLegalAct_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_DeferredTaxAssetsLegalAct_doc" xml:lang="en-US">Deferred tax assets legal act.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ProceedsFromSaleOfNetOperatingLosses" xlink:to="IMNN_ProceedsFromSaleOfNetOperatingLosses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_ProceedsFromSaleOfNetOperatingLosses_doc" xml:lang="en-US">Proceeds From Sale Of Net Operating Losses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_NetProceedsFromSaleOfNetOperatingLosses" xlink:to="IMNN_NetProceedsFromSaleOfNetOperatingLosses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_NetProceedsFromSaleOfNetOperatingLosses_doc" xml:lang="en-US">Net proceeds from sale of net operating losses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ConvertibleNotePurchaseAgreementMember" xlink:to="IMNN_ConvertibleNotePurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_ConvertibleNotePurchaseAgreementMember_doc" xml:lang="en-US">Convertible Note Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_TransomicTechnologiesIncMember" xlink:to="IMNN_TransomicTechnologiesIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_TransomicTechnologiesIncMember_doc" xml:lang="en-US">Transomic Technologies, Inc. [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_SecuritiesPurchaseAgreementMember" xlink:to="IMNN_SecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_SecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_TwoThousandAndEighteenStockIncentivePlanMember" xlink:to="IMNN_TwoThousandAndEighteenStockIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_TwoThousandAndEighteenStockIncentivePlanMember_doc" xml:lang="en-US">2018 Stock Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_StockOptionsStrikePriceDescription" xlink:to="IMNN_StockOptionsStrikePriceDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_StockOptionsStrikePriceDescription_doc" xml:lang="en-US">Stock options, strike price description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_InducementOptionGrantsMember" xlink:to="IMNN_InducementOptionGrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_InducementOptionGrantsMember_doc" xml:lang="en-US">Inducement Option Grants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EquityStockAwardsMember" xlink:to="IMNN_EquityStockAwardsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_EquityStockAwardsMember_doc" xml:lang="en-US">Equity Stock Awards [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember" xlink:to="IMNN_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember_doc" xml:lang="en-US">Granted Under 2018 Plan and 2007 Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_InducementAwardsMember" xlink:to="IMNN_InducementAwardsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_InducementAwardsMember_doc" xml:lang="en-US">Inducement Awards [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember" xlink:to="IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember_doc" xml:lang="en-US">Stock Options and Restricted Stock Awards [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ExercisePriceOneMember" xlink:to="IMNN_ExercisePriceOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_ExercisePriceOneMember_doc" xml:lang="en-US">Exercise Price One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ExercisePriceTwoMember" xlink:to="IMNN_ExercisePriceTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_ExercisePriceTwoMember_doc" xml:lang="en-US">Exercise Price Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ExercisePriceThreeMember" xlink:to="IMNN_ExercisePriceThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_ExercisePriceThreeMember_doc" xml:lang="en-US">Exercise Price Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_WarrantsTextBlock" xlink:to="IMNN_WarrantsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_WarrantsTextBlock_doc" xml:lang="en-US">Warrants [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable" xlink:to="IMNN_AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable_doc" xml:lang="en-US">Amortization of deferred finance charges and debt discount associated with notes payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" xlink:to="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_doc" xml:lang="en-US">Sharebased compensation arrangement by sharebased payment award non options outstanding intrinsic value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="IMNN_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_doc" xml:lang="en-US">Weighted average remaining contractual term for non-option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_PaymentoffOfLoanAndAccruedEndoftermFees" xlink:to="IMNN_PaymentoffOfLoanAndAccruedEndoftermFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_PaymentoffOfLoanAndAccruedEndoftermFees_doc" xml:lang="en-US">Payoff of the SVB loan and accrued end-of-term fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_RecognitionOfRightUseAssetAndLiability" xlink:to="IMNN_RecognitionOfRightUseAssetAndLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_RecognitionOfRightUseAssetAndLiability_doc" xml:lang="en-US">Recognition of right of use asset and liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_LeaseAgreementMember" xlink:to="IMNN_LeaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_LeaseAgreementMember_doc" xml:lang="en-US">Lease Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice" xlink:to="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted Average Exercise Price, Warrants issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock" xlink:to="IMNN_AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock_doc" xml:lang="en-US">Advances And Deposits On Clinical Programs And Other Current Assets [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DepositsPolicyTextBlock" xlink:to="IMNN_DepositsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_DepositsPolicyTextBlock_doc" xml:lang="en-US">Deposits [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards" xlink:to="IMNN_NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards_doc" xml:lang="en-US">Represents the total number of Shares of common stock issuable upon exercise of warrants and equity awards.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_WarrantAccountingPolicyTextBlock" xlink:to="IMNN_WarrantAccountingPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_WarrantAccountingPolicyTextBlock_doc" xml:lang="en-US">Warrant Accounting [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost" xlink:to="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost_doc" xml:lang="en-US">Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) with single maturity date and allocated without single maturity date, maturing in next rolling three months.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost" xlink:to="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost_doc" xml:lang="en-US">Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling three to twelve months.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" xlink:to="IMNN_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_doc" xml:lang="en-US">The current amount of amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue" xlink:to="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue_doc" xml:lang="en-US">Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling three months.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue" xlink:to="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue_doc" xml:lang="en-US">Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling three to twelve months.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_AvailableForSaleSecuritiesUnrealizedLossFairValue" xlink:to="IMNN_AvailableForSaleSecuritiesUnrealizedLossFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_AvailableForSaleSecuritiesUnrealizedLossFairValue_doc" xml:lang="en-US">Available for sale securities unrealized losses fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths" xlink:to="IMNN_AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths_doc" xml:lang="en-US">Available for sale securities unrealized gain less than twelve months.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_OperatingLeasesIncrementalBorrowingRate" xlink:to="IMNN_OperatingLeasesIncrementalBorrowingRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_OperatingLeasesIncrementalBorrowingRate_doc" xml:lang="en-US">Incremental borrowing rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ClinicalResearchMember" xlink:to="IMNN_ClinicalResearchMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_ClinicalResearchMember_doc" xml:lang="en-US">Clinical Research [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_OvationMember" xlink:to="IMNN_OvationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_OvationMember_doc" xml:lang="en-US">Ovation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_VaccineMember" xlink:to="IMNN_VaccineMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_VaccineMember_doc" xml:lang="en-US">Vaccine [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_OtherClinicalAndRegulatoryMember" xlink:to="IMNN_OtherClinicalAndRegulatoryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_OtherClinicalAndRegulatoryMember_doc" xml:lang="en-US">Other Clinical And Regulatory [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_NonClinicalRAndDAndCMCMember" xlink:to="IMNN_NonClinicalRAndDAndCMCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_NonClinicalRAndDAndCMCMember_doc" xml:lang="en-US">Non-Clinical R&amp;D and CMC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_PlaCCineVaccineMember" xlink:to="IMNN_PlaCCineVaccineMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_PlaCCineVaccineMember_doc" xml:lang="en-US">PlaCCine Vaccine [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ManufacturingCMCMember" xlink:to="IMNN_ManufacturingCMCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_ManufacturingCMCMember_doc" xml:lang="en-US">Manufacturing (CMC) [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInOperatingExpenses" xlink:to="IMNN_IncreaseDecreaseInOperatingExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_IncreaseDecreaseInOperatingExpenses_doc" xml:lang="en-US">Increase decrease in operating expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInOperatingCostAndExpenses" xlink:to="IMNN_IncreaseDecreaseInOperatingCostAndExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_IncreaseDecreaseInOperatingCostAndExpenses_doc" xml:lang="en-US">Increase decrease in operating cost and expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInResearchAndDevelopmentExpenses" xlink:to="IMNN_IncreaseDecreaseInResearchAndDevelopmentExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_IncreaseDecreaseInResearchAndDevelopmentExpenses_doc" xml:lang="en-US">Increase decrease in research and development expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpenes" xlink:to="IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpenes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpenes_doc" xml:lang="en-US">Increase decrease in general and administrative expenes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInLossFromOperations" xlink:to="IMNN_IncreaseDecreaseInLossFromOperations_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_IncreaseDecreaseInLossFromOperations_doc" xml:lang="en-US">Increase decrease in loss from operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage" xlink:to="IMNN_IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage_doc" xml:lang="en-US">Increase decrease in research and development expenses percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage" xlink:to="IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage_doc" xml:lang="en-US">Increase decrease in general and administrative expenses percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInLossFromOperationsPercentage" xlink:to="IMNN_IncreaseDecreaseInLossFromOperationsPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_IncreaseDecreaseInLossFromOperationsPercentage_doc" xml:lang="en-US">Increase decrease in loss from operations percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage" xlink:to="IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage_doc" xml:lang="en-US">Increase decrease in operating costs and expenses percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_Rule10b51ArrModifiedFlag" xlink:to="IMNN_Rule10b51ArrModifiedFlag_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_Rule10b51ArrModifiedFlag_doc" xml:lang="en-US">Rule 10b51 arrmodified flag.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_NonRule10b51ArrModifiedFlag" xlink:to="IMNN_NonRule10b51ArrModifiedFlag_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_NonRule10b51ArrModifiedFlag_doc" xml:lang="en-US">Non rule 10b51 arrmodified flag.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_FederalIncomeTaxMember" xlink:to="IMNN_FederalIncomeTaxMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_FederalIncomeTaxMember_doc" xml:lang="en-US">Federal Income Tax [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_NoExpirationMember" xlink:to="IMNN_NoExpirationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_NoExpirationMember_doc" xml:lang="en-US">No Expiration [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_OperatingLossCarryforwardsExpirationDescription" xlink:to="IMNN_OperatingLossCarryforwardsExpirationDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_OperatingLossCarryforwardsExpirationDescription_doc" xml:lang="en-US">Operating loss carryforwards expiration description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_AtTheMarketOfferingAgreementMember" xlink:to="IMNN_AtTheMarketOfferingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_AtTheMarketOfferingAgreementMember_doc" xml:lang="en-US">At the Market Offering Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_JulyTwoThousandTwentyFourOfferingMember" xlink:to="IMNN_JulyTwoThousandTwentyFourOfferingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_JulyTwoThousandTwentyFourOfferingMember_doc" xml:lang="en-US">July 2024 Offering [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_IncreaseDecreaseInOperatingExpensesPercentage" xlink:to="IMNN_IncreaseDecreaseInOperatingExpensesPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_IncreaseDecreaseInOperatingExpensesPercentage_doc" xml:lang="en-US">Increase decrease in operating expenses percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_HorizonTechnologyFinanceCorporationMember" xlink:to="IMNN_HorizonTechnologyFinanceCorporationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_HorizonTechnologyFinanceCorporationMember_doc" xml:lang="en-US">Horizon Technology Finance Corporation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter" xlink:to="IMNN_LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter_doc" xml:lang="en-US">Lessee operating lease liability payments due year four and thereafter.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EffectiveIncomeTaxRateReconciliationSaleAndExpiration" xlink:to="IMNN_EffectiveIncomeTaxRateReconciliationSaleAndExpiration_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_EffectiveIncomeTaxRateReconciliationSaleAndExpiration_doc" xml:lang="en-US">Effective income tax rate reconciliation sale and expiration.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate" xlink:to="IMNN_EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="IMNN_EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate_doc" xml:lang="en-US">Effective income tax rate reconciliation deferred statutory rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_2_lbl" xml:lang="en-US">Other Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityBeforeTreasuryStock" xlink:to="us-gaap_StockholdersEquityBeforeTreasuryStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityBeforeTreasuryStock_2_lbl" xml:lang="en-US">Stockholders' Equity before Treasury Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseNonoperating_2_lbl" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingExpense_2_lbl" xml:lang="en-US">Other Nonoperating Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestments" xlink:to="us-gaap_GainLossOnInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnInvestments_2_lbl" xml:lang="en-US">Gain (Loss) on Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedInvestmentIncomeReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccruedInvestmentIncomeReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedInvestmentIncomeReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Investment Income Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_lbl" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_PaymentoffOfLoanAndAccruedEndoftermFees" xlink:to="IMNN_PaymentoffOfLoanAndAccruedEndoftermFees_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_PaymentoffOfLoanAndAccruedEndoftermFees_3_lbl" xml:lang="en-US">PaymentoffOfLoanAndAccruedEndoftermFees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ProceedsFromSaleOfNetOperatingLosses" xlink:to="IMNN_ProceedsFromSaleOfNetOperatingLosses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_ProceedsFromSaleOfNetOperatingLosses_3_lbl" xml:lang="en-US">ProceedsFromSaleOfNetOperatingLosses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>20
<FILENAME>imnn-20241231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://imunon.com/role/Cover" xlink:href="imnn-20241231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/BalanceSheets" xlink:href="imnn-20241231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/BalanceSheetsParenthetical" xlink:href="imnn-20241231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StatementsOfOperations" xlink:href="imnn-20241231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StatementsOfComprehensiveLoss" xlink:href="imnn-20241231.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StatementsOfCashFlows" xlink:href="imnn-20241231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StatementsOfChangesInStockholdersEquity" xlink:href="imnn-20241231.xsd#StatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#CybersecurityRiskManagementAndStrategyDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#MaterialCybersecurityIncidentDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="imnn-20241231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/FinancialConditionAndGoingConcernUncertainty" xlink:href="imnn-20241231.xsd#FinancialConditionAndGoingConcernUncertainty" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SegmentPerformanceMeasuresAndExpenses" xlink:href="imnn-20241231.xsd#SegmentPerformanceMeasuresAndExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSale" xlink:href="imnn-20241231.xsd#InvestmentsInDebtSecuritiesAvailableForSale" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/FairValuesOfFinancialInstruments" xlink:href="imnn-20241231.xsd#FairValuesOfFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/PropertyAndEquipment" xlink:href="imnn-20241231.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/OtherAccruedLiabilities" xlink:href="imnn-20241231.xsd#OtherAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/NotesPayable" xlink:href="imnn-20241231.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/IncomeTaxes" xlink:href="imnn-20241231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StockholdersEquity" xlink:href="imnn-20241231.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/Stock-basedCompensation" xlink:href="imnn-20241231.xsd#Stock-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/Warrants" xlink:href="imnn-20241231.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ImunonEmployeeBenefitPlans" xlink:href="imnn-20241231.xsd#ImunonEmployeeBenefitPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/Leases" xlink:href="imnn-20241231.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/CommitmentsAndContingencies" xlink:href="imnn-20241231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/RelatedPartyTransaction" xlink:href="imnn-20241231.xsd#RelatedPartyTransaction" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SubsequentEvents" xlink:href="imnn-20241231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="imnn-20241231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesTables" xlink:href="imnn-20241231.xsd#SegmentPerformanceMeasuresAndExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleTables" xlink:href="imnn-20241231.xsd#InvestmentsInDebtSecuritiesAvailableForSaleTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/FairValuesOfFinancialInstrumentsTables" xlink:href="imnn-20241231.xsd#FairValuesOfFinancialInstrumentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/PropertyAndEquipmentTables" xlink:href="imnn-20241231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/OtherAccruedLiabilitiesTables" xlink:href="imnn-20241231.xsd#OtherAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/NotesPayableTables" xlink:href="imnn-20241231.xsd#NotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/IncomeTaxesTables" xlink:href="imnn-20241231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/Stock-basedCompensationTables" xlink:href="imnn-20241231.xsd#Stock-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/WarrantsTables" xlink:href="imnn-20241231.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/LeasesTables" xlink:href="imnn-20241231.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="imnn-20241231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/FinancialConditionAndGoingConcernUncertaintyDetailsNarrative" xlink:href="imnn-20241231.xsd#FinancialConditionAndGoingConcernUncertaintyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails" xlink:href="imnn-20241231.xsd#ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesDetailsNarrative" xlink:href="imnn-20241231.xsd#SegmentPerformanceMeasuresAndExpensesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails" xlink:href="imnn-20241231.xsd#ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfInvestmentSecuritiesGrossUnrealizedGainsLossesDetails" xlink:href="imnn-20241231.xsd#ScheduleOfInvestmentSecuritiesGrossUnrealizedGainsLossesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails" xlink:href="imnn-20241231.xsd#ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleDetailsNarrative" xlink:href="imnn-20241231.xsd#InvestmentsInDebtSecuritiesAvailableForSaleDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="imnn-20241231.xsd#ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="imnn-20241231.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical" xlink:href="imnn-20241231.xsd#ScheduleOfPropertyAndEquipmentDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails" xlink:href="imnn-20241231.xsd#ScheduleOfOtherAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfDebtDetails" xlink:href="imnn-20241231.xsd#ScheduleOfDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/NotesPayableDetailsNarrative" xlink:href="imnn-20241231.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails" xlink:href="imnn-20241231.xsd#ScheduleOfIncomeTaxProvisionBenefitDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="imnn-20241231.xsd#ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="imnn-20241231.xsd#ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/IncomeTaxesDetailsNarrative" xlink:href="imnn-20241231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/StockholdersEquityDetailsNarrative" xlink:href="imnn-20241231.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfStockOptionsDetails" xlink:href="imnn-20241231.xsd#SummaryOfStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails" xlink:href="imnn-20241231.xsd#SummaryOfNon-vestedRestrictedStockAwardsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails" xlink:href="imnn-20241231.xsd#SummaryOfStockOptionsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails" xlink:href="imnn-20241231.xsd#ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/Stock-basedCompensationDetailsNarrative" xlink:href="imnn-20241231.xsd#Stock-basedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/SummaryOfWarrantActivityDetails" xlink:href="imnn-20241231.xsd#SummaryOfWarrantActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ImunonEmployeeBenefitPlansDetailsNarrative" xlink:href="imnn-20241231.xsd#ImunonEmployeeBenefitPlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails" xlink:href="imnn-20241231.xsd#ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/LeasesDetailsNarrative" xlink:href="imnn-20241231.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imunon.com/role/RelatedPartyTransactionDetailsNarrative" xlink:href="imnn-20241231.xsd#RelatedPartyTransactionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="loc_deiAuditorOpinionTextBlock" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorOpinionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivableCurrent" xlink:label="loc_us-gaapGrantsReceivableCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapGrantsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsAbstract" xlink:label="loc_us-gaapOtherAssetsAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityBeforeTreasuryStock" xlink:label="loc_us-gaapStockholdersEquityBeforeTreasuryStock" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityBeforeTreasuryStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapTreasuryStockCommonShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="loc_us-gaapOtherNonoperatingExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapOtherNonoperatingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/StatementsOfComprehensiveLoss" xlink:title="00000005 - Statement - Consolidated Statements of Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaapGainLossOnInvestments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableWriteOffs" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable" xlink:label="loc_IMNNAmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_IMNNAmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedInvestmentIncomeReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedInvestmentIncomeReceivable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedInvestmentIncomeReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="loc_us-gaapPaymentsToAcquireAvailableForSaleSecuritiesDebt" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_PaymentoffOfLoanAndAccruedEndoftermFees" xlink:label="loc_IMNNPaymentoffOfLoanAndAccruedEndoftermFees" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_IMNNPaymentoffOfLoanAndAccruedEndoftermFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_RecognitionOfRightUseAssetAndLiability" xlink:label="loc_IMNNRecognitionOfRightUseAssetAndLiability" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_IMNNRecognitionOfRightUseAssetAndLiability" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/StatementsOfChangesInStockholdersEquity" xlink:title="00000007 - Statement - Consolidated Statements of Changes in Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockCommonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis" xlink:label="loc_ecdMeasureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdMeasureAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_Rule10b51ArrModifiedFlag" xlink:label="loc_IMNNRule10b51ArrModifiedFlag" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_IMNNRule10b51ArrModifiedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_NonRule10b51ArrModifiedFlag" xlink:label="loc_IMNNNonRule10b51ArrModifiedFlag" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_IMNNNonRule10b51ArrModifiedFlag" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000013 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="loc_cydCybersecurityRiskManagementProcessesIntegratedFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementProcessesIntegratedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="loc_cydCybersecurityRiskManagementProcessesIntegratedTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="loc_cydCybersecurityRiskManagementThirdPartyEngagedFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementThirdPartyEngagedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="loc_cydCybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="loc_cydCybersecurityRiskBoardOfDirectorsOversightTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="loc_cydCybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="loc_cydCybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="loc_cydCybersecurityRiskRoleOfManagementTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskRoleOfManagementTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000014 - Disclosure - Material Cybersecurity Incident Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentAbstract" xlink:label="loc_cydMaterialCybersecurityIncidentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentNatureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentNatureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentScopeTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentScopeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentTimingTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentTimingTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/FinancialConditionAndGoingConcernUncertainty" xlink:title="999016 - Disclosure - FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/SegmentPerformanceMeasuresAndExpenses" xlink:title="999017 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSale" xlink:title="999018 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/FairValuesOfFinancialInstruments" xlink:title="999019 - Disclosure - FAIR VALUES OF FINANCIAL INSTRUMENTS">
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DisclosureFairValuesOfFinancialInstrumentsAbstract" xlink:label="loc_IMNNDisclosureFairValuesOfFinancialInstrumentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesAndFairValueTextBlock" xlink:label="loc_us-gaapDerivativesAndFairValueTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureFairValuesOfFinancialInstrumentsAbstract" xlink:to="loc_us-gaapDerivativesAndFairValueTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/PropertyAndEquipment" xlink:title="999020 - Disclosure - PROPERTY AND EQUIPMENT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/OtherAccruedLiabilities" xlink:title="999021 - Disclosure - OTHER ACCRUED LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/NotesPayable" xlink:title="999022 - Disclosure - NOTES PAYABLE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/IncomeTaxes" xlink:title="999023 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/StockholdersEquity" xlink:title="999024 - Disclosure - STOCKHOLDERS&#8217; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/Stock-basedCompensation" xlink:title="999025 - Disclosure - STOCK-BASED COMPENSATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/Warrants" xlink:title="999026 - Disclosure - WARRANTS">
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DisclosureWarrantsAbstract" xlink:label="loc_IMNNDisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_WarrantsTextBlock" xlink:label="loc_IMNNWarrantsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureWarrantsAbstract" xlink:to="loc_IMNNWarrantsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/ImunonEmployeeBenefitPlans" xlink:title="999027 - Disclosure - IMUNON EMPLOYEE BENEFIT PLANS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="loc_us-gaapCompensationAndEmployeeBenefitPlansTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapCompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/Leases" xlink:title="999028 - Disclosure - LEASES">
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DisclosureLeasesAbstract" xlink:label="loc_IMNNDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/CommitmentsAndContingencies" xlink:title="999029 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/RelatedPartyTransaction" xlink:title="999030 - Disclosure - RELATED PARTY TRANSACTION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/SubsequentEvents" xlink:title="999031 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999032 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaapInvestmentPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock" xlink:label="loc_IMNNAdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_IMNNAdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DepositsPolicyTextBlock" xlink:label="loc_IMNNDepositsPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_IMNNDepositsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_WarrantAccountingPolicyTextBlock" xlink:label="loc_IMNNWarrantAccountingPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_IMNNWarrantAccountingPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesTables" xlink:title="999033 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleTables" xlink:title="999034 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="loc_us-gaapDebtSecuritiesAvailableForSaleTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapDebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestmentsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestmentsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeTextBlock" xlink:label="loc_us-gaapInvestmentIncomeTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapInvestmentIncomeTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/FairValuesOfFinancialInstrumentsTables" xlink:title="999035 - Disclosure - FAIR VALUES OF FINANCIAL INSTRUMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DisclosureFairValuesOfFinancialInstrumentsAbstract" xlink:label="loc_IMNNDisclosureFairValuesOfFinancialInstrumentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureFairValuesOfFinancialInstrumentsAbstract" xlink:to="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/PropertyAndEquipmentTables" xlink:title="999036 - Disclosure - PROPERTY AND EQUIPMENT (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/OtherAccruedLiabilitiesTables" xlink:title="999037 - Disclosure - OTHER ACCRUED LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/NotesPayableTables" xlink:title="999038 - Disclosure - NOTES PAYABLE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/IncomeTaxesTables" xlink:title="999039 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/Stock-basedCompensationTables" xlink:title="999040 - Disclosure - STOCK-BASED COMPENSATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/WarrantsTables" xlink:title="999041 - Disclosure - WARRANTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DisclosureWarrantsAbstract" xlink:label="loc_IMNNDisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureWarrantsAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/LeasesTables" xlink:title="999042 - Disclosure - LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DisclosureLeasesAbstract" xlink:label="loc_IMNNDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtStatementGeographicalAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_NJ" xlink:label="loc_stprNJ" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_stprNJ" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewJerseyDivisionOfTaxationMember" xlink:label="loc_us-gaapNewJerseyDivisionOfTaxationMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapNewJerseyDivisionOfTaxationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccountsReceivableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards" xlink:label="loc_IMNNNumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_IMNNNumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DirectFinancingLeaseSellingLoss" xlink:label="loc_us-gaapDirectFinancingLeaseSellingLoss" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDirectFinancingLeaseSellingLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/FinancialConditionAndGoingConcernUncertaintyDetailsNarrative" xlink:title="999044 - Disclosure - FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="loc_us-gaapCashCashEquivalentsAndShortTermInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsAndShortTermInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails" xlink:title="999045 - Disclosure - SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaapSegmentReportingInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapSegmentReportingInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srtConsolidationItemsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_srtConsolidationItemsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srtConsolidationItemsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidationItemsAxis" xlink:to="loc_srtConsolidationItemsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaapOperatingSegmentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidationItemsDomain" xlink:to="loc_us-gaapOperatingSegmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ClinicalResearchMember" xlink:label="loc_IMNNClinicalResearchMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_IMNNClinicalResearchMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_NonClinicalRAndDAndCMCMember" xlink:label="loc_IMNNNonClinicalRAndDAndCMCMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_IMNNNonClinicalRAndDAndCMCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaapSubsegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapSubsegmentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaapSubsegmentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsegmentsAxis" xlink:to="loc_us-gaapSubsegmentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_OvationMember" xlink:label="loc_IMNNOvationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsegmentsDomain" xlink:to="loc_IMNNOvationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_VaccineMember" xlink:label="loc_IMNNVaccineMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsegmentsDomain" xlink:to="loc_IMNNVaccineMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_OtherClinicalAndRegulatoryMember" xlink:label="loc_IMNNOtherClinicalAndRegulatoryMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsegmentsDomain" xlink:to="loc_IMNNOtherClinicalAndRegulatoryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_PlaCCineVaccineMember" xlink:label="loc_IMNNPlaCCineVaccineMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsegmentsDomain" xlink:to="loc_IMNNPlaCCineVaccineMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ManufacturingCMCMember" xlink:label="loc_IMNNManufacturingCMCMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsegmentsDomain" xlink:to="loc_IMNNManufacturingCMCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInOperatingCostAndExpenses" xlink:label="loc_IMNNIncreaseDecreaseInOperatingCostAndExpenses" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInOperatingCostAndExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage" xlink:label="loc_IMNNIncreaseDecreaseInOperatingCostsAndExpensesPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInOperatingCostsAndExpensesPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInResearchAndDevelopmentExpenses" xlink:label="loc_IMNNIncreaseDecreaseInResearchAndDevelopmentExpenses" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInResearchAndDevelopmentExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage" xlink:label="loc_IMNNIncreaseDecreaseInResearchAndDevelopmentExpensesPercentage" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInResearchAndDevelopmentExpensesPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpenes" xlink:label="loc_IMNNIncreaseDecreaseInGeneralAndAdministrativeExpenes" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInGeneralAndAdministrativeExpenes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage" xlink:label="loc_IMNNIncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInOperatingExpenses" xlink:label="loc_IMNNIncreaseDecreaseInOperatingExpenses" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInOperatingExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInOperatingExpensesPercentage" xlink:label="loc_IMNNIncreaseDecreaseInOperatingExpensesPercentage" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInOperatingExpensesPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInLossFromOperations" xlink:label="loc_IMNNIncreaseDecreaseInLossFromOperations" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInLossFromOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_IncreaseDecreaseInLossFromOperationsPercentage" xlink:label="loc_IMNNIncreaseDecreaseInLossFromOperationsPercentage" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_IMNNIncreaseDecreaseInLossFromOperationsPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesDetailsNarrative" xlink:title="999046 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaapNumberOfOperatingSegments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapNumberOfOperatingSegments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails" xlink:title="999047 - Disclosure - SCHEDULE OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="loc_us-gaapMarketableSecuritiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="loc_us-gaapMarketableSecuritiesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesTable" xlink:to="loc_us-gaapMarketableSecuritiesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaapUSTreasurySecuritiesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapUSTreasurySecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost" xlink:label="loc_IMNNDebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_IMNNDebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue" xlink:label="loc_IMNNDebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_IMNNDebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost" xlink:label="loc_IMNNDebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_IMNNDebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue" xlink:label="loc_IMNNDebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_IMNNDebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" xlink:label="loc_IMNNAvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_IMNNAvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:label="loc_us-gaapAvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfInvestmentSecuritiesGrossUnrealizedGainsLossesDetails" xlink:title="999048 - Disclosure - SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES) (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_AvailableForSaleSecuritiesUnrealizedLossFairValue" xlink:label="loc_IMNNAvailableForSaleSecuritiesUnrealizedLossFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_IMNNAvailableForSaleSecuritiesUnrealizedLossFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths" xlink:label="loc_IMNNAvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_IMNNAvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails" xlink:title="999049 - Disclosure - SCHEDULE OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="loc_us-gaapInvestmentIncomeInterestAndDividend" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapInvestmentIncomeInterestAndDividend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:label="loc_us-gaapDebtSecuritiesAvailableForSaleRealizedGainLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapDebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleDetailsNarrative" xlink:title="999050 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:title="999051 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)">
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DisclosureFairValuesOfFinancialInstrumentsAbstract" xlink:label="loc_IMNNDisclosureFairValuesOfFinancialInstrumentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureFairValuesOfFinancialInstrumentsAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaapUSTreasurySecuritiesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapUSTreasurySecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="999052 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical" xlink:title="999053 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails" xlink:title="999054 - Disclosure - SCHEDULE OF OTHER ACCRUED LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractualObligation" xlink:label="loc_us-gaapContractualObligation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapContractualObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfDebtDetails" xlink:title="999055 - Disclosure - SCHEDULE OF DEBT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_HorizonTechnologyFinanceCorporationMember" xlink:label="loc_IMNNHorizonTechnologyFinanceCorporationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_IMNNHorizonTechnologyFinanceCorporationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:label="loc_us-gaapLineOfCreditFacilityFairValueOfAmountOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EarlyTerminationFee" xlink:label="loc_IMNNEarlyTerminationFee" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_IMNNEarlyTerminationFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EndOfTermCharges" xlink:label="loc_IMNNEndOfTermCharges" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_IMNNEndOfTermCharges" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/NotesPayableDetailsNarrative" xlink:title="999056 - Disclosure - NOTES PAYABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLineOfCreditFacilityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_SiliconValleyBankMember" xlink:label="loc_IMNNSiliconValleyBankMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_IMNNSiliconValleyBankMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityCurrentBorrowingCapacity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaapRepaymentsOfLinesOfCredit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapRepaymentsOfLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaapRestrictedCash" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapRestrictedCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_FinalPaymentPercentage" xlink:label="loc_IMNNFinalPaymentPercentage" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_IMNNFinalPaymentPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDebtExpense" xlink:label="loc_us-gaapInterestAndDebtExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapInterestAndDebtExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EndOfTermChargePercentage" xlink:label="loc_IMNNEndOfTermChargePercentage" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_IMNNEndOfTermChargePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnContractTermination" xlink:label="loc_us-gaapGainLossOnContractTermination" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapGainLossOnContractTermination" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails" xlink:title="999057 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (BENEFIT) (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:title="999058 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:label="loc_IMNNEffectiveIncomeTaxRateReconciliationPermanentDifferences" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_IMNNEffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EffectiveIncomeTaxRateReconciliationTimeUp" xlink:label="loc_IMNNEffectiveIncomeTaxRateReconciliationTimeUp" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_IMNNEffectiveIncomeTaxRateReconciliationTimeUp" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate" xlink:label="loc_IMNNEffectiveIncomeTaxRateReconciliationDeferredStatutoryRate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_IMNNEffectiveIncomeTaxRateReconciliationDeferredStatutoryRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EffectiveIncomeTaxRateReconciliationSaleAndExpiration" xlink:label="loc_IMNNEffectiveIncomeTaxRateReconciliationSaleAndExpiration" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_IMNNEffectiveIncomeTaxRateReconciliationSaleAndExpiration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="999059 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DeferredTaxAssetsLegalAct" xlink:label="loc_IMNNDeferredTaxAssetsLegalAct" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_IMNNDeferredTaxAssetsLegalAct" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/IncomeTaxesDetailsNarrative" xlink:title="999060 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_NJ" xlink:label="loc_stprNJ" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_stprNJ" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_FederalIncomeTaxMember" xlink:label="loc_IMNNFederalIncomeTaxMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_IMNNFederalIncomeTaxMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaapStateAndLocalJurisdictionMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapStateAndLocalJurisdictionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_srtStatementScenarioAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_NoExpirationMember" xlink:label="loc_IMNNNoExpirationMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_IMNNNoExpirationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewJerseyDivisionOfTaxationMember" xlink:label="loc_us-gaapNewJerseyDivisionOfTaxationMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapNewJerseyDivisionOfTaxationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ProceedsFromSaleOfNetOperatingLosses" xlink:label="loc_IMNNProceedsFromSaleOfNetOperatingLosses" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_IMNNProceedsFromSaleOfNetOperatingLosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_OperatingLossCarryforwardsExpirationDescription" xlink:label="loc_IMNNOperatingLossCarryforwardsExpirationDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_IMNNOperatingLossCarryforwardsExpirationDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="loc_us-gaapIncomeTaxExaminationDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_NetProceedsFromSaleOfNetOperatingLosses" xlink:label="loc_IMNNNetProceedsFromSaleOfNetOperatingLosses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_IMNNNetProceedsFromSaleOfNetOperatingLosses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/StockholdersEquityDetailsNarrative" xlink:title="999061 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_AtTheMarketOfferingAgreementMember" xlink:label="loc_IMNNAtTheMarketOfferingAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_IMNNAtTheMarketOfferingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_SecuritiesPurchaseAgreementMember" xlink:label="loc_IMNNSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_IMNNSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_JulyTwoThousandTwentyFourOfferingMember" xlink:label="loc_IMNNJulyTwoThousandTwentyFourOfferingMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_IMNNJulyTwoThousandTwentyFourOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfStockOptionsDetails" xlink:title="999062 - Disclosure - SUMMARY OF STOCK OPTIONS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails" xlink:title="999063 - Disclosure - SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails" xlink:title="999064 - Disclosure - SUMMARY OF STOCK OPTIONS OUTSTANDING (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ExercisePriceOneMember" xlink:label="loc_IMNNExercisePriceOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_IMNNExercisePriceOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ExercisePriceTwoMember" xlink:label="loc_IMNNExercisePriceTwoMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_IMNNExercisePriceTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ExercisePriceThreeMember" xlink:label="loc_IMNNExercisePriceThreeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_IMNNExercisePriceThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails" xlink:title="999065 - Disclosure - SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/Stock-basedCompensationDetailsNarrative" xlink:title="999066 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_TwoThousandAndEighteenStockIncentivePlanMember" xlink:label="loc_IMNNTwoThousandAndEighteenStockIncentivePlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_IMNNTwoThousandAndEighteenStockIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_InducementOptionGrantsMember" xlink:label="loc_IMNNInducementOptionGrantsMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_IMNNInducementOptionGrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EquityStockAwardsMember" xlink:label="loc_IMNNEquityStockAwardsMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_IMNNEquityStockAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_InducementAwardsMember" xlink:label="loc_IMNNInducementAwardsMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_IMNNInducementAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember" xlink:label="loc_IMNNEmployeeStockOptionAndRestrictedStockAwardsMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_IMNNEmployeeStockOptionAndRestrictedStockAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtStatementScenarioAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember" xlink:label="loc_IMNNGrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_IMNNGrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_StockOptionsStrikePriceDescription" xlink:label="loc_IMNNStockOptionsStrikePriceDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_IMNNStockOptionsStrikePriceDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/SummaryOfWarrantActivityDetails" xlink:title="999067 - Disclosure - SUMMARY OF WARRANT ACTIVITY (Details)">
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DisclosureWarrantsAbstract" xlink:label="loc_IMNNDisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureWarrantsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:label="loc_IMNNShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureWarrantsAbstract" xlink:to="loc_IMNNShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureWarrantsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice" xlink:label="loc_IMNNShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureWarrantsAbstract" xlink:to="loc_IMNNShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureWarrantsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureWarrantsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureWarrantsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:label="loc_IMNNShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureWarrantsAbstract" xlink:to="loc_IMNNShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" xlink:label="loc_IMNNShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureWarrantsAbstract" xlink:to="loc_IMNNShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_IMNNSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureWarrantsAbstract" xlink:to="loc_IMNNSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/ImunonEmployeeBenefitPlansDetailsNarrative" xlink:title="999068 - Disclosure - IMUNON EMPLOYEE BENEFIT PLANS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="loc_us-gaapDefinedContributionPlanEmployerMatchingContributionPercent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapDefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount" xlink:label="loc_us-gaapDefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapDefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails" xlink:title="999069 - Disclosure - SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DisclosureLeasesAbstract" xlink:label="loc_IMNNDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter" xlink:label="loc_IMNNLesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureLeasesAbstract" xlink:to="loc_IMNNLesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/LeasesDetailsNarrative" xlink:title="999070 - Disclosure - LEASES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_DisclosureLeasesAbstract" xlink:label="loc_IMNNDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IMNNDisclosureLeasesAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_LeaseAgreementMember" xlink:label="loc_IMNNLeaseAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_IMNNLeaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaapLesseeOperatingLeaseTermOfContract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseTermOfContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapAreaOfLand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsForRent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_OperatingLeasesIncrementalBorrowingRate" xlink:label="loc_IMNNOperatingLeasesIncrementalBorrowingRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_IMNNOperatingLeasesIncrementalBorrowingRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/RelatedPartyTransactionDetailsNarrative" xlink:title="999071 - Disclosure - RELATED PARTY TRANSACTION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_ConvertibleNotePurchaseAgreementMember" xlink:label="loc_IMNNConvertibleNotePurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_IMNNConvertibleNotePurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="imnn-20241231.xsd#IMNN_TransomicTechnologiesIncMember" xlink:label="loc_IMNNTransomicTechnologiesIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_IMNNTransomicTechnologiesIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136612896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Feb. 21, 2025</div></th>
<th class="th"><div>Jun. 28, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IMUNON,
INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000749647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-1256615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">997
                                            LENOX DRIVE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">SUITE 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">LAWRENCEVILLE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(609)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">896-9100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, Par Value $0.01 Per Share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IMNN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,620,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference [Text Block]</a></td>
<td class="text">None<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion [Text Block]</a></td>
<td class="text">We
have audited the accompanying consolidated balance sheets of Imunon Inc. as of December 31, 2024 and 2023, and the related consolidated
statements of operations, comprehensive loss, changes in stockholders&#8217; equity, and cash flows for each of the two years in the
period ended December 31, 2024, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion,
the consolidated financial statements present fairly, in all material respects, the financial position of Imunon Inc. as of December
31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024,
in conformity with accounting principles generally accepted in the United States of America.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">WithumSmith+Brown, PC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">East
Brunswick, New Jersey<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136364912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 5,872,767<span></span>
</td>
<td class="nump">$ 5,838,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Investment in debt securities - available for sale, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,857,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrantsReceivableCurrent', window );">Advances and deposits on clinical programs and other current assets</a></td>
<td class="nump">2,136,192<span></span>
</td>
<td class="nump">2,545,051<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">8,008,959<span></span>
</td>
<td class="nump">18,240,704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment (at cost, less accumulated depreciation and amortization)</a></td>
<td class="nump">541,272<span></span>
</td>
<td class="nump">751,906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income tax asset</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,280,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net</a></td>
<td class="nump">1,117,133<span></span>
</td>
<td class="nump">1,595,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits and other assets</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total other assets</a></td>
<td class="nump">1,167,133<span></span>
</td>
<td class="nump">2,925,459<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">9,717,364<span></span>
</td>
<td class="nump">21,918,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable &#8211; trade</a></td>
<td class="nump">1,300,026<span></span>
</td>
<td class="nump">3,515,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">3,033,747<span></span>
</td>
<td class="nump">3,390,521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities - current portion</a></td>
<td class="nump">452,358<span></span>
</td>
<td class="nump">485,421<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,786,131<span></span>
</td>
<td class="nump">7,391,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities - non-current portion</a></td>
<td class="nump">686,935<span></span>
</td>
<td class="nump">1,139,293<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,473,066<span></span>
</td>
<td class="nump">8,530,427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock - $0.01 par value (100,000 shares authorized, and no shares issued or outstanding at December 31, 2024 and 2023)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock - $0.01 par value (112,500,000 shares authorized; 14,500,707 and 9,399,811 shares issued at December 31, 2024 and 2023, respectively, and 14,500,685 and 9,399,789 shares outstanding at December 31, 2024 and 2023, respectively)</a></td>
<td class="nump">145,007<span></span>
</td>
<td class="nump">93,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">410,987,523<span></span>
</td>
<td class="nump">401,500,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">60,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(406,803,044)<span></span>
</td>
<td class="num">(388,182,802)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityBeforeTreasuryStock', window );">Total stockholders&#8217; equity before treasury stock</a></td>
<td class="nump">4,329,486<span></span>
</td>
<td class="nump">13,472,830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost (22 shares at December 31, 2024 and 2023)</a></td>
<td class="num">(85,188)<span></span>
</td>
<td class="num">(85,188)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">4,244,298<span></span>
</td>
<td class="nump">13,387,642<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 9,717,364<span></span>
</td>
<td class="nump">$ 21,918,069<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityBeforeTreasuryStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of stockholders' equity (deficit) items including stock value, paid in capital, retained earnings and including equity attributable to noncontrolling interests and before deducting the carrying value of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityBeforeTreasuryStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077134970560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">112,500,000<span></span>
</td>
<td class="nump">112,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">14,500,707<span></span>
</td>
<td class="nump">9,399,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">14,500,685<span></span>
</td>
<td class="nump">9,399,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077131617792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 11,639,411<span></span>
</td>
<td class="nump">$ 11,287,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">7,493,035<span></span>
</td>
<td class="nump">9,742,739<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">19,132,446<span></span>
</td>
<td class="nump">21,030,430<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(19,132,446)<span></span>
</td>
<td class="num">(21,030,430)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income, net</a></td>
<td class="nump">512,204<span></span>
</td>
<td class="nump">1,157,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(329,158)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(197,080)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other expense</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(396,319)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="nump">512,204<span></span>
</td>
<td class="nump">235,068<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax benefit</a></td>
<td class="num">(18,620,242)<span></span>
</td>
<td class="num">(20,795,362)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,280,385<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (18,620,242)<span></span>
</td>
<td class="num">$ (19,514,977)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - Basic</a></td>
<td class="num">$ (1.62)<span></span>
</td>
<td class="num">$ (2.16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - Diluted</a></td>
<td class="num">$ (1.62)<span></span>
</td>
<td class="num">$ (2.16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - Basic</a></td>
<td class="nump">11,508,159<span></span>
</td>
<td class="nump">9,045,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - Diluted</a></td>
<td class="nump">11,508,159<span></span>
</td>
<td class="nump">9,045,320<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077234659376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Changes in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Realized and unrealized gains on available for sale securities, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 34,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(18,620,242)<span></span>
</td>
<td class="num">(19,514,977)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">$ (18,620,242)<span></span>
</td>
<td class="num">$ (19,480,675)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077135715600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (18,620,242)<span></span>
</td>
<td class="num">$ (19,514,977)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">240,175<span></span>
</td>
<td class="nump">248,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use assets</a></td>
<td class="nump">477,941<span></span>
</td>
<td class="nump">471,851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Realized and unrealized (gains) and losses, net, on investment securities</a></td>
<td class="num">(61,983)<span></span>
</td>
<td class="nump">34,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">477,256<span></span>
</td>
<td class="nump">759,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Realization of deferred income tax asset</a></td>
<td class="nump">1,280,385<span></span>
</td>
<td class="nump">286,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">329,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-off of note receivable (Transomic)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">375,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable', window );">Amortization of deferred finance charges and debt discount associated with note payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">55,122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Net changes in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedInvestmentIncomeReceivable', window );">Accrued interest receivable on investment securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">68,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Advances, deposits, and other current assets</a></td>
<td class="nump">408,859<span></span>
</td>
<td class="num">(141,619)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(3,057,361)<span></span>
</td>
<td class="num">(1,992,929)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(18,854,970)<span></span>
</td>
<td class="num">(19,022,148)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of investment securities</a></td>
<td class="num">(57,174)<span></span>
</td>
<td class="num">(13,541,806)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from sale and maturity of investment securities</a></td>
<td class="nump">9,915,448<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(29,541)<span></span>
</td>
<td class="num">(451,759)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">9,828,733<span></span>
</td>
<td class="nump">11,006,435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock equity, net of issuance costs</a></td>
<td class="nump">9,060,438<span></span>
</td>
<td class="nump">2,781,438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_PaymentoffOfLoanAndAccruedEndoftermFees', window );">Payoff of the SVB loan and accrued end-of-term fees</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(6,420,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="nump">9,060,438<span></span>
</td>
<td class="num">(3,638,562)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash, cash equivalents and restricted cash</a></td>
<td class="nump">34,201<span></span>
</td>
<td class="num">(11,654,275)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash at beginning of year</a></td>
<td class="nump">5,838,566<span></span>
</td>
<td class="nump">17,492,841<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents end of year</a></td>
<td class="nump">5,872,767<span></span>
</td>
<td class="nump">5,838,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">179,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-Cash Investing and Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_RecognitionOfRightUseAssetAndLiability', window );">Recognition of right of use asset and liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,911,049<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of deferred finance charges and debt discount associated with notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_PaymentoffOfLoanAndAccruedEndoftermFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payoff of the SVB loan and accrued end-of-term fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_PaymentoffOfLoanAndAccruedEndoftermFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_RecognitionOfRightUseAssetAndLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recognition of right of use asset and liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_RecognitionOfRightUseAssetAndLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedInvestmentIncomeReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in investment income that has been earned but not yet received in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedInvestmentIncomeReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077134538992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Treasury Stock, Common [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 74,362<span></span>
</td>
<td class="nump">$ 397,980,023<span></span>
</td>
<td class="num">$ (85,188)<span></span>
</td>
<td class="nump">$ 26,494<span></span>
</td>
<td class="num">$ (368,667,825)<span></span>
</td>
<td class="nump">$ 29,327,866<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="nump">7,436,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(19,514,977)<span></span>
</td>
<td class="num">(19,514,977)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Sale of equity through equity financing facilities</a></td>
<td class="nump">$ 19,041<span></span>
</td>
<td class="nump">2,762,397<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,781,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of equity through equity financing facilities, shares</a></td>
<td class="nump">1,904,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of stock upon vesting of restricted shares</a></td>
<td class="nump">$ 595<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of stock upon vesting of restricted shares, shares</a></td>
<td class="nump">59,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Realized and unrealized gains, net, on investment securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">34,302<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">34,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">758,418<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">758,418<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 93,998<span></span>
</td>
<td class="nump">401,500,838<span></span>
</td>
<td class="num">$ (85,188)<span></span>
</td>
<td class="nump">60,796<span></span>
</td>
<td class="num">(388,182,802)<span></span>
</td>
<td class="nump">13,387,642<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="nump">9,399,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(18,620,242)<span></span>
</td>
<td class="num">(18,620,242)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Sale of equity through equity financing facilities</a></td>
<td class="nump">$ 50,888<span></span>
</td>
<td class="nump">9,009,550<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,060,438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of equity through equity financing facilities, shares</a></td>
<td class="nump">5,088,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of stock upon vesting of restricted shares</a></td>
<td class="nump">$ 121<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of stock upon vesting of restricted shares, shares</a></td>
<td class="nump">12,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Realized and unrealized gains, net, on investment securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(60,796)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(60,796)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">477,135<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">477,135<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2024</a></td>
<td class="nump">$ 145,007<span></span>
</td>
<td class="nump">$ 410,987,523<span></span>
</td>
<td class="num">$ (85,188)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (406,803,044)<span></span>
</td>
<td class="nump">$ 4,244,298<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2024</a></td>
<td class="nump">14,500,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077135430416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (18,620,242)<span></span>
</td>
<td class="num">$ (19,514,977)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077139091200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingArrLineItems', window );"><strong>Insider Trading Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_Rule10b51ArrModifiedFlag', window );">Rule 10b5-1 Arrangement Modified</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_NonRule10b51ArrModifiedFlag', window );">Non-Rule 10b5-1 Arrangement Modified</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_NonRule10b51ArrModifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non rule 10b51 arrmodified flag.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_NonRule10b51ArrModifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_Rule10b51ArrModifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rule 10b51 arrmodified flag.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_Rule10b51ArrModifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingArrLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingArrLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077139093024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CYBERSECURITY</b></span>&#160;<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_908_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20240101__20241231_zFQsrNP64Zm8">We
have <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240101__20241231_zor46tLIquik">processes for assessing, identifying and managing</span> cybersecurity risks, which are built into our information technology (&#8220;IT&#8221;)
function and are designed to help protect our information assets and operations from internal and external cyber threats, protect employee
and clinical trial information from unauthorized access or attack, as well as secure our networks and systems. Such processes include
physical, procedural and technical safeguards, response plans, and routine review of our policies and procedures to identify risks and
refine our practices.</span> We engage certain <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_906_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240101__20241231_zcaOlp1kgktk">external parties</span>, including a full-service managed IT service provider, to enhance our <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90B_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20240101__20241231_zdr41oCqFdl6">cybersecurity
oversight</span>.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text">We
have <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240101__20241231_zor46tLIquik">processes for assessing, identifying and managing</span> cybersecurity risks, which are built into our information technology (&#8220;IT&#8221;)
function and are designed to help protect our information assets and operations from internal and external cyber threats, protect employee
and clinical trial information from unauthorized access or attack, as well as secure our networks and systems. Such processes include
physical, procedural and technical safeguards, response plans, and routine review of our policies and procedures to identify risks and
refine our practices.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</a></td>
<td class="text">We do <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90B_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240101__20241231_zZqnWGI7tySf">no</span>t believe that
there are currently any known risks from cybersecurity threats that are reasonably likely to materially affect us or our business strategy,
results of operations or financial condition.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Our
Audit Committee of the Board of Directors (the &#8220;Audit Committee&#8221;) is responsible for overseeing cybersecurity risk and periodically
updates our Board of Directors on such matters.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">The Audit Committee receives periodic updates from management regarding cybersecurity
matters and is notified between such updates regarding any significant new cybersecurity threats or incidents. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90C_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20240101__20241231_zDTe4N0EHe9b">We do <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90B_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240101__20241231_zZqnWGI7tySf">no</span>t believe that
there are currently any known risks from cybersecurity threats that are reasonably likely to materially affect us or our business strategy,
results of operations or financial condition.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text">Management
is <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_901_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20240101__20241231_zYM4N2amO9C">responsible</span> for the operational oversight of company-wide cybersecurity strategy, policy, and standards across relevant departments
to assess and help prepare us to address cybersecurity risks<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136418112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_z2M204phNIQ1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
<span id="xdx_820_zrtlyvz43qR6">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zvySlgYoTayb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zh5oy2eCD6x3">Description
of Business</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon,
Inc. (&#8220;Imunon&#8221; or the &#8220;Company&#8221;) is a clinical-stage biotechnology company focused on advancing a portfolio of
innovative treatments that harness the body&#8217;s natural mechanisms with the aim to generate safe, effective and durable responses
across a broad array of human diseases, constituting a differentiating approach from conventional therapies. Imunon is developing its
non-viral DNA technology across its modalities. The first modality, TheraPlas&#174;, is developed for the coding of proteins and cytokines
in the treatment of solid tumors where an immunological approach is deemed promising. The second modality, PlaCCine&#174;, is developed
for the coding of viral antigens that can elicit a strong immunological response. This technology may represent a promising platform
for the development of vaccines in infectious diseases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer
that has completed Phase II clinical studies. IMNN-001 works by instructing the body to produce safe and durable levels of powerful cancer-fighting
molecules, such as interleukin-12 and interferon gamma, at the tumor site. Additionally, the Company has entered a first-in-human study
of its COVID-19 booster vaccine (IMNN-101). The Company will continue to leverage these modalities and to advance the technological frontier
of plasmid DNA to better serve patients with difficult-to-treat conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zae6M2qgw8N9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zaJVUmFdjmi8">Basis
of Presentation</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements (&#8220;Financial Statements&#8221;) of Imunon have been prepared in accordance with accounting
principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and include the accounts of the Company and CLSN Laboratories,
Inc. The Company dissolved Celsion GmbH in 2023. All significant intercompany balances and transactions have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zp7DGI3bhVRl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zI7u3z2jMAB2">Accounting
Standards Update: Improvements to Reportable Segment Disclosures</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU No. 2023-07, &#8220;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&#8221;.
The disclosure requirements are required on an annual and interim basis and are applicable to entities with a single reportable segment.
The amendments in the ASU require disclosures to include significant segment expenses that are regularly provided to the chief operating
decision maker (&#8220;CODM&#8221;), a description of other segment items by reportable segment, and any additional measures of a segment&#8217;s
profit or loss used by the CODM when deciding how to allocate resources. ASU 2023-07 is effective for fiscal years beginning after December
15, 2023 and interim periods for fiscal years beginning after December 31, 2024, with early adoption allowed. We adopted this guidance
as of January 1, 2024 on a retrospective basis and the adoption did not have a material impact on our consolidated financial statements.
Refer to Note 3, &#8220;<i>Segment Performance Measures and Expenses</i>,&#8221; for new disclosures resulting from the adoption of ASU
2023-07.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p id="xdx_842_eus-gaap--UseOfEstimates_z1OUXqQnRFab" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zwIEi2FD2nra">Use
of Estimates</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the
reported amounts of expenses during the reporting period. Actual results could differ significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zKfScKLf3Bjh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_z6An9PGJcFY8">Revenue
Recognition</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not generate any revenue in 2024 or 2023 and there were <span id="xdx_907_eus-gaap--AccountsReceivableNet_iI_pdp0_do_c20241231_zQ3A5TpsjlMa" title="Accounts receivable"><span id="xdx_90E_eus-gaap--AccountsReceivableNet_iI_pdp0_do_c20231231_zvwPfGfAfP2d" title="Accounts receivable">no</span></span> accounts receivable as of December 31, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zOBhxFArpyd1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zzhY1d8iGIfc">Cash
and Cash Equivalents</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents include cash on hand and investments purchased with an original maturity of three months or less. A portion of these
funds are not covered by FDIC insurance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWVTmmcisM1e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zqyQ0nKKzRvl">Fair
Value of Financial Instruments</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of financial instruments approximate their respective fair values. Management believes that the carrying amounts of the
Company&#8217;s financial instruments, including cash and cash equivalents and accounts payable approximate fair value due to the short-term
nature of those instruments. Short-term investments are recorded at their estimated fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--InvestmentPolicyTextBlock_z8yuuJU4D5Pg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zOLBFKHY8BJ8">Short-Term
Investments</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies its investments in debt securities with readily determinable fair values as investments available-for-sale in accordance
with Accounting Standards Codification (&#8220;ASC&#8221;) 320, <i>Investments - Debt and Equity Securities</i>. Available-for-sale securities
consist of debt securities not classified as trading securities or as securities to be held to maturity. The Company has classified all
of its investments as available-for-sale. Unrealized holding gains and losses on available-for-sale securities are reported as a net
amount in accumulated other comprehensive gain or loss in stockholders&#8217; equity until realized. Gains and losses on the sale of
available-for-sale securities are determined using the specific identification method. The Company&#8217;s short-term investments consist
of corporate bonds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zug1ROyI6bp2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_z7ucnlguqE76">Property
and Equipment</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is provided over the estimated useful lives
of the related assets, ranging from <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20241231__srt--RangeAxis__srt--MinimumMember_zYE3fp0mEK27" title="Property plant and equipment useful life::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl0543">three</span></span> to <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20241231__srt--RangeAxis__srt--MaximumMember_zZIUtEY11Mi8" title="Property plant and equipment useful life">seven years</span>, using the straight-line method. Amortization is recognized over the lesser
of the life of the asset or the lease term. Major renewals and improvements are capitalized at cost and ordinary repairs and maintenance
are charged against operating expenses as incurred. Depreciation expense was approximately $<span id="xdx_90C_eus-gaap--DepreciationAndAmortization_pp0p0_c20240101__20241231_zQVcdcMNWTh8" title="Depreciation expense">240,000</span> and $<span id="xdx_90D_eus-gaap--DepreciationAndAmortization_pp0p0_c20230101__20231231_z9WPieBxdnNc" title="Depreciation expense">248,000</span> for the years ended
December 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of
an asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the future net undiscounted cash flows
that the asset is expected to generate. If such asset is considered to be impaired, the impairment recognized is the amount by which
the carrying amount of the asset, if any, exceeds its fair value determined using a discounted cash flow model. There was <span id="xdx_90D_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pdp0_do_c20240101__20241231_zVfBHWUtMXA5" title="Impairment of property or equipment"><span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pdp0_do_c20230101__20231231_zm10zQPzzU8b" title="Impairment of property or equipment">no</span></span> impairment
of property or equipment during 2024 or 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_ecustom--AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock_zgxMZgM0JY94" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zcieJVfHpkp">Advances
and Deposits on Clinical Programs and Other Current Assets</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplies
are consumable items kept on hand to support the Company&#8217;s R&amp;D and manufacturing operations which includes prepaid expense,
raw materials, clinical supplies and consumable items for clinical trials with alternate uses that are capitalized. Supplies are recorded
at cost and are charged to expense as they are used in operations. The Company regularly reviews the quality and utilization of supplies
to determine if future use of these supplies is probable. Due to the generic use of these supplies, they can be used in multiple projects
other than those currently being studied.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_ecustom--DepositsPolicyTextBlock_zv4VB1vNiPXh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zejGSx6DUqp2">Deposits</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits
include real property security deposits and other deposits which are contractually required and of a long-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p id="xdx_84E_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zZQIAu9nUID1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zn5SgiHogNtg">Comprehensive
Income (Loss)</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
220, <i>Comprehensive Income</i>, establishes standards for the reporting and display of comprehensive income (loss) and its components
in the Company&#8217;s consolidated financial statements. The objective of ASC 220 is to report a measure of comprehensive income (loss)
of all changes in equity of an enterprise that result from transactions and other economic events in a period other than transactions
with owners. Comprehensive gains (losses) result from changes in unrealized gains and losses from investment in debt securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_z4pdAbEldQXh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zWZnZktlyHl1">Research
and Development</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred. Supplies are consumable and recorded at cost and are charged to expense as they are
used in operations. Equipment and facilities acquired for research and development activities that have alternative future uses are
capitalized and charged to expense over their estimated useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zPN17PhH7Lof" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zRxYNFxPrvH5">Net
Loss per Share of Common Stock</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
and diluted net loss per common share was computed by dividing net loss for the year by the weighted average number of shares of common
stock outstanding, both basic and diluted, during each period. The impact of common stock equivalents has been excluded from the computation
of diluted weighted average common shares outstanding in periods where there is a net loss, as their effect is anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2024 and 2023, the total number of shares of common stock issuable upon exercise of warrants and equity
awards was <span id="xdx_90C_ecustom--NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards_c20240101__20241231_zIdJ8NypOvke" title="Number of shares of common stock issuable upon exercise of warrants and equity awards">6,840,633</span> and <span id="xdx_903_ecustom--NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards_c20230101__20231231_z8uqJsW68Whg" title="Number of shares of common stock issuable upon exercise of warrants and equity awards">1,255,642</span>, respectively. For the years ended December 31, 2024 and 2023, diluted loss per common share is the
same as basic loss per common share as all options and all other warrants that were convertible into shares of the Company&#8217;s common
stock were excluded from the calculation of diluted earnings attributable to common stockholders per common share as their effect would
be anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zRaWOaQJvd1e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_z5YYICLMLxq5">Income
Taxes</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for
the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities
and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using
enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered
or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in results of operations in the
period that the tax rate change occurs. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount
expected to be realized. In accordance with ASC 740, <i>Income Taxes,</i> a tax position is recognized as a benefit only if it is &#8220;more
likely than not&#8221; that the tax position taken would be sustained in a tax examination, presuming that a tax examination will occur.
The Company recognizes interest and/or penalties related to income tax matters in the income tax expense category.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
more fully discussed in Note 10, on November 28, 2023, the Company received approval from the New Jersey Economic Development Authority
to sell $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231128__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_zyQUca0mGMrj" title="Net proceeds from sale of net operating losses">1.3</span> million of its New Jersey net operating losses (&#8220;NOLs&#8221;), recognizing a tax benefit for the year ended December
31, 2023 for the net proceeds (approximately $<span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_zQqFn3poljfg" title="Net proceeds from sale of net operating losses">1.3</span> million) by reducing the net operating loss valuation allowance. As more fully discussed
in Note 10, on November 28, 2023, the Company was notified by the New Jersey Economic Development Authority that its application was
approved and the Company entered into an agreement to sell this NOL. On March 22, 2024, the Company received approximately $<span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20240322__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_zVzov2i0QTOh" title="Net proceeds from sale of net operating losses">1.3</span> million
upon completion of the sale of the 2023 NOLs. During 2021, the New Jersey State Legislature increased the maximum lifetime benefit per
company from $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MinimumMember_zuvjJAWM4cA3" title="Net proceeds from sale of net operating losses">15</span> million to $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MaximumMember_zscyKEF3T4t3" title="Net proceeds from sale of net operating losses">20</span> million, which will allow the Company to participate in this innovative funding program in future years
for up to an additional $<span id="xdx_908_eus-gaap--DirectFinancingLeaseSellingLoss_pn5n6_c20210101__20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MaximumMember_znzYDjnuVgY7" title="Direct financing lease, selling loss">0.4</span> million in net operating losses under this maximum lifetime benefit (see Note 2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zAuM5jvcHRGh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zmV0V4UKH7s4">Stock-Based
Compensation</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for all share-based payment awards granted to employees and non-employees as stock-based compensation expense at
grant date fair value. The Company&#8217;s share-based payments include stock options and grants of common stock, including common
stock subject to vesting. The measurement date for employee awards is the date of grant, and stock-based compensation costs are
recognized as expense over the employees&#8217; requisite service period, which is the vesting period, on a straight-line basis.
Prior to the adoption of Accounting Standards Update (&#8220;ASU&#8221;) No. 2018-07, <i>Compensation&#8212;Stock Compensation
(Topic 718): Improvements to Nonemployee Share-Based Payment Accounting</i> (&#8220;ASU No. 2018-07&#8221;) on January 1, 2020, the
measurement date for non-employee awards was generally the date the services were completed, resulting in financial reporting period
adjustments to stock-based compensation during the vesting terms for changes in the fair value of the awards. Since the adoption of
ASU 2018-07, the measurement date for non-employee awards is the date of grant without changes in the fair value of the award. There
was no material impact as a result of adopting this new standard. Stock-based compensation costs for non-employees are recognized as
expense over the vesting period on a straight-line basis. Stock-based compensation expense is classified in the accompanying
consolidated statements of operations based on the function to which the related services are provided. Forfeitures are recorded as
they occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. Since there is
limited historical data of the Company&#8217;s share price on the public market, the Company estimates its expected stock volatility
based on the historical volatility of a publicly traded set of representative companies and expects to continue to do so until such time
as it has adequate historical data regarding the volatility of its own traded stock price. The expected term of the Company&#8217;s stock
options has been determined utilizing the &#8220;simplified&#8221; method for awards that qualify as &#8220;plain-vanilla&#8221; options.
The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for
time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has
never paid cash dividends on common stock and does not expect to pay any cash dividends in the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_ecustom--WarrantAccountingPolicyTextBlock_zknejFqvE3v9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zubzMXlIwN6g">Warrant
Accounting</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants&#8217; specific
terms and applicable authoritative guidance in ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221; (&#8220;ASC 480&#8221;),
and ASC 815 &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all
of the requirements for equity classification under ASC 815, including whether the warrants are indexed to our own ordinary shares and
whether warrant holders could potentially require &#8220;net cash settlement&#8221; in a circumstance outside of our control, among other
conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant
issuance and as of each subsequent quarterly period end-date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
issued or modified warrants that meet all the criteria for equity classification, the warrants are required to be recorded as a component
of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants
are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of warrants classified as liabilities are recognized as a non-cash gain or loss on our statements
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the warrants issued upon our financings in 2024 meet the criteria for equity classification under ASC 815, those warrants were classified
as equity as of December 31, 2024. No warrants were issued in 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zDyZDNP766sh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zqPXVdyVEl3d">Recent
Accounting Pronouncements</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements are issued by the FASB and are adopted by the Company as of the specified effective date.
Unless otherwise discussed, the Company believes that the impact of recently issued accounting pronouncements will not have a material
impact on the Company&#8217;s consolidated financial position, results of operations, and cash flows, or do not apply to its operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU No. 2023-07, &#8220;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&#8221;.
The disclosure requirements are required on an annual and interim basis and are applicable to entities with a single reportable segment.
The amendments in the ASU require disclosures to include significant segment expenses that are regularly provided to the chief operating
decision maker (&#8220;CODM&#8221;), a description of other segment items by reportable segment, and any additional measures of a segment&#8217;s
profit or loss used by the CODM when deciding how to allocate resources. ASU 2023-07 is effective for fiscal years beginning after December
15, 2023 and interim periods for fiscal years beginning after December 31, 2024, with early adoption allowed. We adopted this guidance
as of January 1, 2024 on a retrospective basis and the adoption did not have a material impact on our consolidated financial statements.
Refer to Note 3, &#8220;<i>Segment Performance Measures and Expenses</i>,&#8221; for new disclosures resulting from the adoption of ASU
2023-07.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU No. 2023-09, <i>Improvements to Income Tax Disclosures</i>, which requires disclosure of disaggregated
income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income
tax-related disclosures. ASU No. 2023-09 is effective for fiscal years beginning after December 15, 2024 and allows for adoption on a
prospective basis, with a retrospective option. Early adoption is permitted. The Company is currently evaluating the impact of the ASU
on the income tax disclosures within the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2024, the FASB issued Accounting Standards Update No. 2024-03, Income Statement &#8211; Reporting Comprehensive Income &#8211;
Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses (&#8220;ASU 2024-03&#8221;). ASU 2024-03 will require
more detailed information about the types of expenses in commonly presented income statement captions such as &#8220;Cost of sales&#8221;
and &#8220;Selling, general and administrative expenses&#8221;. The new guidance is effective for annual reporting periods beginning
after December 15, 2026, and interim reporting periods beginning after December 15, 2027 with early adoption permitted. The Company is
currently evaluating the impact that this change will have on the Company&#8217;s disclosures.</span></p>

<p id="xdx_851_zczJowsXYUid" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136415168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY</a></td>
<td class="text"><p id="xdx_808_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zCnMSkstZca9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
<span id="xdx_821_zgDVjFnPoFXc">FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
inception, the Company has incurred substantial operating losses, principally from expenses associated with the Company&#8217;s research
and development programs, clinical trials conducted in connection with the Company&#8217;s drug candidates, and applications and submissions
to the FDA. The Company has not generated significant revenue and has incurred significant net losses in each year since inception. For
the year ended December 31, 2024, the Company had a net loss of $<span id="xdx_90F_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20240101__20241231_zfpK4dOpOVm9" title="Net loss">18.6</span> million and used $<span id="xdx_901_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20240101__20241231_ztZxwtxe5gUb" title="Fund operation">18.9</span> million to fund operations. As of December
31, 2024, the Company has incurred approximately $<span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn6n6_di_c20241231_zpzS9gjb3sd" title="Cumulated net losses">407</span> million of cumulative net losses. As of December 31, 2024, the Company had $<span id="xdx_90D_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_pn5n6_c20241231_z9sVC6OiUSk8" title="Cash and cash equivalents, short-term investments">5.9</span>
million in cash and cash equivalents and short-term investments. The Company has substantial future capital requirements to continue
its research and development activities and advance its drug candidates through various development stages. The Company believes these
expenditures are essential for the commercialization of its drug candidates and technologies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expects its operating losses to continue for the foreseeable future as it continues its product development efforts, and when
it undertakes marketing and sales activities. The Company&#8217;s ability to achieve profitability is dependent upon its ability to obtain
governmental approvals, manufacture, and market and sell its new drug candidates. There can be no assurance that the Company will be
able to commercialize its technology successfully or that profitability will ever be achieved. The Company expects that its operating
results will fluctuate significantly in the future and will depend on a number of factors, many of which are outside the Company&#8217;s
control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s ability to raise additional capital may be adversely impacted by potential worsening global economic conditions and the
recent disruptions to, and volatility in, financial markets in the U.S. and worldwide resulting from the Russian invasion of Ukraine
and the unrest in the Middle East. The Company continues to monitor its operating activities in light of these events, and it is possible
that these events could result in a variety of risks to the business. The specific impact, if any, is not readily determinable as of
the date of these consolidated Financial Statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has based its estimates on assumptions that may prove to be wrong. The Company may need to obtain additional funds sooner or
in greater amounts than it currently anticipates. Potential sources of financing include strategic relationships, public or private sales
of the Company&#8217;s shares or debt, the sale of the Company&#8217;s New Jersey NOLs and other sources. If the Company raises funds
by selling additional shares of common stock or other securities convertible into common stock, the ownership interest of existing stockholders
may be diluted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
actual amount of funds the Company will need to operate is subject to many factors, some of which are beyond the Company&#8217;s control.
These factors include the progress of research activities; the number and scope of research programs; the progress of preclinical and
clinical development activities; the progress of the development efforts of parties with whom the Company has entered into research and
development agreements; the costs associated with additional clinical trials of drug candidates; the ability to maintain current research
and development licensing arrangements and to establish new research and development and licensing arrangements; the ability to achieve
milestones under licensing arrangements; the costs involved in prosecuting and enforcing patent claims and other intellectual property
rights; and the costs and timing of regulatory approvals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements have been prepared on the going concern basis. In making this assessment, management conducted a comprehensive
review of the Company&#8217;s business plan including, but not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company&#8217;s financial position for the year ended December 31, 2024;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
    events and transactions the Company has entered into since December 31, 2024;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company&#8217;s cash flow and cash usage forecasts for the period one year from the issuance date of this Annual Report on Form 10-K;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company&#8217;s capitalization structure including common stock outstanding and common stock issuable on exercise of warrants and
    equity awards, and other common stock issuable under equity plans; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">continued
    support of the Company&#8217;s stockholders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the uncertainties involved in our business, we are unable to estimate the duration and completion costs of our research and
development projects or when, if ever, and to what extent we will receive cash inflows from the commercialization and sale of a product.
Our inability to complete our research and development projects in a timely manner or our failure to enter into collaborative agreements,
when appropriate, could significantly increase our capital requirements and could adversely impact our liquidity. These uncertainties
could force us to seek additional, external sources of financing from time to time in order to continue with our business strategy. Our
inability to raise additional capital, or to do so on terms reasonably acceptable to us, would jeopardize the future success of our business.
Our estimated future capital requirements are uncertain and could change materially as a result of many factors, including the progress
of our research, development, clinical, manufacturing, and commercialization activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
has determined the Company has suffered recurring losses from operations and has an accumulated deficit that raises substantial doubt
about our ability to continue as a going concern for the next twelve months from the issuance date of this Annual Report on Form 10-K.
The report of our independent registered public accounting firm for the year ended December 31, 2024 includes an explanatory paragraph,
which expresses substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments
that might result from the outcome of the uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
fundamental component of the ability to continue as a going concern is the Company&#8217;s ability to raise capital as required, as to
which no assurances can be provided. To address the additional funding requirements of the Company, management has undertaken the following
initiatives:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    has assessed its current expenditures and will be reducing the current spending requirements where necessary;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    will pursue additional capital funding in the public and private markets through equity sales and/or debt facilities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    will pursue possible partnerships and collaborations; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    will pursue potential out licensing for its drug candidates.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to continue as a going concern may depend on our ability to raise additional capital, attain further operating efficiencies,
reduce expenditures, and, ultimately, to generate revenue. There are no assurances that these future funding and operating efforts will
be successful. If management is unsuccessful in these efforts, our current capital is not expected to be sufficient to fund our operations
for the next twelve months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136700688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT PERFORMANCE MEASURES AND EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT PERFORMANCE MEASURES AND EXPENSES</a></td>
<td class="text"><p id="xdx_803_eus-gaap--SegmentReportingDisclosureTextBlock_zzQTVrseoFp6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.
<span id="xdx_821_zukiTH0MiWai">SEGMENT PERFORMANCE MEASURES AND EXPENSES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates in <span id="xdx_901_eus-gaap--NumberOfOperatingSegments_pid_dc_uSegment_c20240101__20241231_zdHcMDCYRi69" title="Number of operating segment">one</span> segment for the research and development of our product candidates. The Company&#8217;s chief operating decision
maker (&#8220;CODM&#8221;) has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions
about allocating resources and assessing performance for the entire Company based on consolidated financial information. Consequently,
we view the entire organization as one reportable segment and the strategic purpose of all operating activities (including general &amp;
administrative expenses) is to support that one segment. As a pre-revenue research and development company, the CODM evaluates company-wide
performance and allocates resources based on non-financial research and development milestones achieved, and to a lesser extent, financial
measures of performance such as clinical development (research and development expenses) and general and administrative expenses incurred.
Our CODM does not generally evaluate our performance using asset or historical cash flow information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zlYQ79s71ut1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below provides a summary of the significant expense categories and consolidated net loss details provided to the CODM (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B1_zFMVxNtWuuRe" style="display: none">SCHEDULE
OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z9zuGKD5DL8g" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20230101__20231231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z4JR9kjY8526" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(In thousands)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Change Increase (Decrease)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating Expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Clinical Research</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OvationMember_z4e9KjHX7xFc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; width: 36%">OVATION</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,386</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,197</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zFtaV2ODW7J" style="width: 12%; text-align: right">189</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_905_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zl3kXxShCr7d">15.8</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--VaccineMember_z0OCox7LvAb2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Vaccine</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,420</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0611">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--VaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zjRKddLokjw7" style="text-align: right">1,420</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--VaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zb0C42p2TNTc">100.0</span></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OtherClinicalAndRegulatoryMember_zPYfOJ8X3dJd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Other clinical and regulatory</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,434</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,793</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OtherClinicalAndRegulatoryMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z3T2geOY6303" style="border-bottom: Black 1pt solid; text-align: right">641</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OtherClinicalAndRegulatoryMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zw5gp35Sd7Md">35.8</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember_zKd0FMmOdJp1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,240</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,990</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z452SWsVlj4g" style="text-align: right">2,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z4a7RGkHKSl3">75.3</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Non-Clinical R&amp;D and CMC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--OvationMember_zKDwOJJJJWU5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">OVATION</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,819</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,504</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z4DP2VlA9jT2" style="text-align: right">315</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zrcBUfUtWYj9">20.9</span></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--PlaCCineVaccineMember_zzqUozQSQxn1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">PlaCCine Vaccine</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,554</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,511</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--PlaCCineVaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zgHqSp0xeY9d" style="text-align: right">(1,957</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--PlaCCineVaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zTtNvCMJJ7d5">(43.4</span></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--ManufacturingCMCMember_zo4TRj9NNMz9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Manufacturing (CMC)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,026</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,283</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--ManufacturingCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zRx7aVJlZEMg" style="border-bottom: Black 1pt solid; text-align: right">(257</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--ManufacturingCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z7iaC6rBWGH3">(11.3</span></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember_z6i4WbV7mvbj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,399</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,298</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zwSNi41ErFb1" style="border-bottom: Black 1pt solid; text-align: right" title="Change Increase (Decrease), Subtotal">(1,899</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zBowl8SqcpX4" title="Change Increase (Decrease), Subtotal, percentage">(22.9</span></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr id="xdx_404_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_ztqM0GgOWf9l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Research and development expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,639</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,288</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--IncreaseDecreaseInResearchAndDevelopmentExpenses_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zYFMsCxY8myk" style="text-align: right" title="Change Increase (Decrease), Research and development expenses">351</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_ecustom--IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_ziAmP68chYk9" title="Change Increase (Decrease), Research and development expenses, percentage">3.1</span></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40D_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_zLS5FIlTy7Bi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">General and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7,493</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">9,742</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--IncreaseDecreaseInGeneralAndAdministrativeExpenes_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zECrFD39e8Qh" style="border-bottom: Black 1pt solid; text-align: right" title="Change Increase (Decrease), General and administrative expenses">(2,249</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_ecustom--IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zyxAuV2CPhYa" title="Change Increase (Decrease), General and administrative expenses, percentage">(23.1</span></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingExpenses_pn3n3_zfgajMq7vzx4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">19,132</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">21,030</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--IncreaseDecreaseInOperatingExpenses_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z3A3fIYodV3f" style="border-bottom: Black 1pt solid; text-align: right" title="Change Increase (Decrease), Operating expenses">(1,898</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_ecustom--IncreaseDecreaseInOperatingExpensesPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zkeS1CfGQgA5" title="Change Increase (Decrease), Operating expenses, percentage">(9.0</span></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingIncomeLoss_pn3n3_zEdiaCmAvLR4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Loss from operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(19,132</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(21,030</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--IncreaseDecreaseInLossFromOperations_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zWgXhZ2zDbN3" style="border-bottom: Black 2.5pt double; text-align: right" title="Change Increase (Decrease), Loss from operations">(1,898</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_ecustom--IncreaseDecreaseInLossFromOperationsPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zdAJmKiYcYVc" title="Change Increase (Decrease), Loss from operations, percentage">(9.0</span></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  </table>

<p id="xdx_8AD_z7LwPaQy3k1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077233963328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zSPdFfKASWO3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.
<span id="xdx_82C_zTpkOu60T2Wa">INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
in debt securities available for sale with a fair value of $<span id="xdx_90A_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_dxL_c20241231_zPGGVFNRdtag" title="Debt securities, available for sale, current::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0677">0</span></span> and $<span id="xdx_90E_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231_z8xrrKZwAmtd" title="Debt securities, available for sale, current">9,857,087</span> as of December 31, 2024 and 2023, respectively, consisted
of U.S. Treasury securities and corporate debt securities. These investments are valued at estimated fair value, with unrealized gains
and losses reported as a separate component of stockholders&#8217; equity in accumulated other comprehensive loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviews its debt securities classified as short-term investments on a regular basis for impairment. For debt securities in unrealized
loss positions, the Company determines whether any portion of the decline in fair value below the amortized cost basis is due to credit-related
factors if it neither intends to sell nor anticipates that it is more likely than not that it will be required to sell prior to recovery
of the amortized cost basis. The Company considers factors such as the extent to which the market value has been less than the cost,
any noted failure of the issuer to make scheduled payments, changes to the rating of the security and other relevant credit-related factors
in determining whether or not a credit loss exists. During fiscal 2024 and 2023, the Company did not recognize an allowance for credit-related
losses on any of our investments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--DebtSecuritiesAvailableForSaleTableTextBlock_zJhMhxVWqx8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the cost, fair value and maturities of the Company&#8217;s short-term investments is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zFMeTwAajRV5" style="display: none">SCHEDULE
OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Short-term investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%; text-align: left">U.S. Treasury securities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShortTermInvestments_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zop2FxWWLzPi" style="width: 12%; text-align: right" title="Short-term investments - Cost"><span style="-sec-ix-hidden: xdx2ixbrl0683">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zEml1ZLOhUY9" style="width: 12%; text-align: right" title="Short-term investments - Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0685">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShortTermInvestments_iI_pp0p0_c20231231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zDqeN0KHQiF5" style="width: 12%; text-align: right" title="Short-term investments - Cost">9,796,291</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_ziEbR6ujJHN8" style="width: 12%; text-align: right" title="Short-term investments - Fair Value">9,857,087</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Short-term investment maturities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%">Within 3 months</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost_iI_pp0p0_c20241231_zQlUqIkK3kTj" style="width: 12%; text-align: right" title="Short-term investment maturities - Within 3 months, cost"><span style="-sec-ix-hidden: xdx2ixbrl0691">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue_iI_pp0p0_c20241231_zbmS20GpWvpj" style="width: 12%; text-align: right" title="Short-term investment maturities - Within 3 months, fair value"><span style="-sec-ix-hidden: xdx2ixbrl0693">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost_iI_pp0p0_c20231231_zkz8QPcho9p5" style="width: 12%; text-align: right" title="Short-term investment maturities - Within 3 months, cost">2,467,518</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue_iI_pp0p0_c20231231_zvGVwKxRcQBc" style="width: 12%; text-align: right" title="Short-term investment maturities - Within 3 months, fair value">2,490,775</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Between 3-12 months</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost_iI_pp0p0_c20241231_ztS153aL0mij" style="border-bottom: Black 1pt solid; text-align: right" title="Short-term investment maturities - Between 3-12 months, cost"><span style="-sec-ix-hidden: xdx2ixbrl0699">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue_iI_pp0p0_c20241231_zMqhyymOuDo5" style="border-bottom: Black 1pt solid; text-align: right" title="Short-term investment maturities - Between 3-12 months, fair value"><span style="-sec-ix-hidden: xdx2ixbrl0701">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost_iI_pp0p0_c20231231_zHMVpemb6uVd" style="border-bottom: Black 1pt solid; text-align: right" title="Short-term investment maturities - Between 3-12 months, cost">7,328,773</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue_iI_pp0p0_c20231231_zB8ZhcMRk2cj" style="border-bottom: Black 1pt solid; text-align: right" title="Short-term investment maturities - Between 3-12 months, fair value">7,366,312</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_iI_pp0p0_c20241231_zqaPVn5jycGb" style="border-bottom: Black 2.5pt double; text-align: right" title="Short-term investment maturities - Cost"><span style="-sec-ix-hidden: xdx2ixbrl0707">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_iI_pp0p0_c20241231_z3BpHKtUrjA3" style="border-bottom: Black 2.5pt double; text-align: right" title="Short-term investment maturities - Fair value"><span style="-sec-ix-hidden: xdx2ixbrl0709">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_iI_pp0p0_c20231231_zFRnRRpU0xai" style="border-bottom: Black 2.5pt double; text-align: right" title="Short-term investment maturities - Cost">9,796,291</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_iI_pp0p0_c20231231_zvAMrI8mXcwd" style="border-bottom: Black 2.5pt double; text-align: right" title="Short-term investment maturities - Fair value">9,857,087</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_zfvCdnXDTW6f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89F_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_ztNRNPJJaSRi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the Company&#8217;s investment in debt securities available for sale gross unrealized gains (losses) and fair value
by investment category and length of time that individual securities have been in a continuous unrealized loss position at December 31,
2024 and 2023. The Company has reviewed individual securities to determine whether a decline in fair value below the amortizable cost
basis is other than temporary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BA_ztEDdfznwVke" style="display: none">SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES)</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Available for sale securities (all unrealized holding gains and losses are less than 12 months at date of measurement)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Unrealized Holding Gains (Losses)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Unrealized Holding Gains (Losses)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Investments in debt securities with unrealized gains</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--AvailableForSaleSecuritiesUnrealizedLossFairValue_iI_c20241231_zpqP4HgJM6Ri" style="width: 12%; text-align: right" title="Investments in debt securities with unrealized gains - Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0717">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths_iI_c20241231_zZL6gqpCzoKi" style="width: 12%; text-align: right" title="Investments in debt securities with unrealized gains - Unrealized Holding Gains"><span style="-sec-ix-hidden: xdx2ixbrl0719">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--AvailableForSaleSecuritiesUnrealizedLossFairValue_iI_c20231231_zFASLmzCc1kh" style="width: 12%; text-align: right" title="Investments in debt securities with unrealized gains - Fair Value">9,857,087</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths_iI_c20231231_ziM6wy1neKGl" style="width: 12%; text-align: right" title="Investments in debt securities with unrealized gains - Unrealized Holding Gains (Losses)">60,796</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A0_zCigmoEY1tJb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--InvestmentIncomeTextBlock_zY581MyLYWEf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
income, net, which includes net realized losses on sales of available for sale securities and investment income interest and dividends,
is summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zlVNZnw7O8D" style="display: none">SCHEDULE
OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20240101__20241231_zljdSH3y5Laj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230101__20231231_zAr7TAvXzvm1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InvestmentIncomeInterestAndDividend_maIILNzUXt_zHteq5yzEnRc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Interest and dividends accrued and paid</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">450,221</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">725,824</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DebtSecuritiesAvailableForSaleRealizedGainLoss_maIILNzUXt_zadHWzORz6Xk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Realized losses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">61,983</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">431,801</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InvestmentIncomeNet_iT_pp0p0_mtIILNzUXt_zADW9BYCXPA6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Investment income, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">512,204</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,157,625</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p id="xdx_8A5_zbSaJ1z5LZx2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 940<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/940-320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph b<br> -Publisher SEC<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/320/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/942-320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136417856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUES OF FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_DisclosureFairValuesOfFinancialInstrumentsAbstract', window );"><strong>Fair Values Of Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesAndFairValueTextBlock', window );">FAIR VALUES OF FINANCIAL INSTRUMENTS</a></td>
<td class="text"><p id="xdx_807_eus-gaap--DerivativesAndFairValueTextBlock_z90s5e0CXOkd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.
<span id="xdx_82A_z7ti2co9pHGk">FAIR VALUES OF FINANCIAL INSTRUMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FASB
ASC Section 820, <i>Fair Value Measurements and Disclosures,</i> establishes a three-level hierarchy for fair value measurements which
requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The
three levels of inputs that may be used to measure fair value are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1: Quoted prices (unadjusted) or identical assets or liabilities in active markets that the entity has the ability to access as of the
measurement date;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices
in markets that are not active; or other inputs that are observable or can be corroborated by observable market data; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3: Significant unobservable inputs that reflect a reporting entity&#8217;s own assumptions that market participants would use in pricing
an asset or liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents and accounts payable are reflected in the consolidated balance sheets at their approximate estimated fair values
primarily due to their short-term nature. The fair values of securities available for sale are determined by relying on the securities&#8217;
relationship to other benchmark quoted securities and classified its investments as Level 2 items in both 2024 and 2023. There were no
transfers of assets or liabilities between Level 1 and Level 2 and no transfers in or out of Level 3 during the years ended December
31, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_894_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zKZ4VOdG6wd6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
and liabilities measured at fair value are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zJnndAhHH5V" style="display: none">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Active Markets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for Identical</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assets/Liabilities (Level 1)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable Inputs</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 2)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs<br/> (Level 3)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Recurring items as of December 31, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%; text-align: left">U.S. treasury obligations, available for sale</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zceD1u3nzxuf" style="width: 12%; text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0740">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zXXAxtFvvFm5" style="width: 12%; text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zuTQGnUuLv9l" style="width: 12%; text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0744">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zy4foxjilXN" style="width: 12%; text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Recurring items as of December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">U.S. treasury obligations, available for sale</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zywdXOLBVdLj" style="text-align: right" title="U.S. treasury obligations, available for sale - Fair Value">9,857,087</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_z9PG169Tbm41" style="text-align: right" title="U.S. treasury obligations, available for sale - Fair Value">9,857,087</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zZmBwQPrcrK3" style="text-align: right" title="U.S. treasury obligations, available for sale - Fair Value">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0752">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zobKQnGwO3Ci" style="text-align: right" title="U.S. treasury obligations, available for sale - Fair Value">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0754">-</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A6_zKmnBLp5zFC1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_DisclosureFairValuesOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_DisclosureFairValuesOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesAndFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivatives and fair value of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/815/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/820/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesAndFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136169008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zx45VJL7crtc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.
<span id="xdx_820_zbmBu1IrWYpj">PROPERTY AND EQUIPMENT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zmOlp6UwTvgd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment at December 31, 2024 and 2023 consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B8_zj3I9xNoiaZ1" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20241231_ztMynUkEH0mc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20231231_zcW0s8XAC9u1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zc7JeGc0Hj4f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Machinery and equipment (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4kNSSdpEdah" title="Estimated useful life">5</span>-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zfrXNENf7Ye" title="Estimated useful life">7</span> year life)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">951,192</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,055,192</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z3CoxXI5hCNh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Furniture and fixtures (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zvc0pSnWHmll" title="Estimated useful life">3</span>-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zxpPcHQ1Kavj" title="Estimated useful life">5</span> year life)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">167,351</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">191,932</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zyFZFZLvQfw9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Leasehold improvements (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MinimumMember_zlSnyGFwysfj" title="Estimated useful life">5</span>-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MaximumMember_zgD8FhAwgKs3" title="Estimated useful life">7</span> year life)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">619,024</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">607,054</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzwDA_zwGd7tMJa6Qj" style="vertical-align: bottom; background-color: White">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
    and equipment gross</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,737,567</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,854,178</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzwDA_z7VL7Xxs8i8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,196,295</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,102,272</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzwDA_zvMBbyyWPvdb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">541,272</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">751,906</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AF_zs4m0rG6Ceu5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077240939088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER ACCRUED LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">OTHER ACCRUED LIABILITIES</a></td>
<td class="text"><p id="xdx_803_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zx4KChnwTsM6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
<span id="xdx_82C_zjYEatQKrdc8">OTHER ACCRUED LIABILITIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_898_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zE0zruNMp2J7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
accrued liabilities at December 31, 2024 and 2023 include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zRjvPPOH0rWa" style="display: none">SCHEDULE OF OTHER ACCRUED LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20241231_zhcb6QF9v0Zd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20231231_zLaOpZh06MUk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ContractualObligation_iI_maCz80K_zoiVYfAmyVTc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Amounts due to contract research organizations and other contractual agreements</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,048,036</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,442,659</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_maCz80K_z4q7nyKo0cN9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued payroll and related benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,945,111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,693,383</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedProfessionalFeesCurrent_iI_maCz80K_zqQm09ZloMo1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">234,479</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maCz80K_zurJLkpqUzK2" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">20,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">20,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtCz80K_zjIFJsOXJr6h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,033,747</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,390,521</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A7_zCDHdYnOP6Dj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077137171632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">NOTES PAYABLE</a></td>
<td class="text"><p id="xdx_809_eus-gaap--DebtDisclosureTextBlock_ze4EH12B2o1f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.
<span id="xdx_821_z0sB8LFTqFoi">NOTES PAYABLE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
SVB Loan Facility</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 18, 2021, the Company entered into a $<span id="xdx_908_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn6n6_c20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_z1dwh8NMbA7k" title="Line of credit facility, maximum borrowing capacity">10</span> million loan facility (the &#8220;SVB Loan Facility&#8221;) with Silicon Valley Bank (&#8220;SVB&#8221;).
Imunon immediately drew down $<span id="xdx_90C_eus-gaap--ProceedsFromLinesOfCredit_pn6n6_c20210617__20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_znGztfgxmSC2" title="Proceeds from lines of credit">6</span> million from the SVB Loan Facility and used the funds to retire all outstanding indebtedness with Horizon
Technology Finance Corporation pursuant to a loan agreement entered into on June 27, 2018, under which the Company had drawn down $<span id="xdx_904_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn6n6_c20200831__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_z5Ivv2YivX6j" title="Loan amount withdrawn">10</span>
million and repaid $<span id="xdx_900_eus-gaap--RepaymentsOfLinesOfCredit_pn6n6_c20200801__20200831__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zXatBAv4Au2c" title="Repayments of lines of credit">5</span> million in August 2020. Concurrently with this transaction, the Company used $<span id="xdx_901_eus-gaap--RestrictedCash_iI_pn5n6_c20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zsspH5qRUHAk" title="Restricted cash">6.0</span> million of other available funds
to establish a restricted cash account which served as security for the SVB Loan Facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SVB Loan Facility was in the form of money market secured indebtedness bearing interest at a calculated WSJ Prime-based variable rate.
A final payment equal to <span id="xdx_90A_ecustom--FinalPaymentPercentage_iI_pid_dp_uPure_c20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zPJ6tk3znYmi" title="Final payment percentage">3</span>% of the total $<span id="xdx_90C_eus-gaap--LineOfCredit_iI_pn6n6_c20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_z8V8IToQRU27" title="Long term line of credit">10</span> million commitment amount was due upon maturity or prepayment of the SVB Loan Facility.
There was no facility commitment fee, and no stock or warrants were issued to SVB. <span id="xdx_90C_eus-gaap--DebtInstrumentDescription_c20210617__20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zwn8kYX2YmG9" title="Debt instrument, description">Payments under the loan agreement were interest only
for the first 24 months after loan closing, followed by a 24-month amortization period of principal and interest through the scheduled
maturity date.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the SVB Loan Facility, the Company incurred financing fees and expenses totaling $<span id="xdx_90E_eus-gaap--InterestAndDebtExpense_c20210617__20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zfKBBCnACjIb" title="Financing fees and expenses">243,370</span> which was recorded and classified
as debt discount and was amortized as interest expense using the effective interest method over the life of the loan. Also, in connection
with the SVB Loan Facility, the Company was required to pay an end-of-term fee equal to <span id="xdx_90C_ecustom--EndOfTermChargePercentage_pid_dp_uPure_c20210617__20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zcXJp5mYWeYh" title="End of term charge percentage">3.0</span>% of the original loan amount at time of maturity.
Therefore, these amounts totaling $<span id="xdx_907_eus-gaap--InterestExpense_c20210617__20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zS0xSqYHWVAf" title="Interest expense">300,000</span> were amortized as interest expense using the effective interest method over the life of the
loan. During the year ended December 31, 2023, the Company incurred interest expense of $<span id="xdx_90F_eus-gaap--InterestExpenseDebt_c20230101__20231231__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zw2Nknyzc4ni" title="Interest expense">197,080</span> and amortized $<span id="xdx_901_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_pp0p0_c20230101__20231231__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zpMGmQFfQE43" title="Amortization of debt issuance costs">329,158</span>, as interest
expense for debt discounts and end-of-term fee in connection with the SVB Loan Facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zTIxlDJfvCCj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 21, 2023, the Company repaid the outstanding principal balance, an early termination fee and the end-of-term charges in full satisfaction
of the SVB Loan Facility. The following is a schedule of the amounts paid to SVB on April 21, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_ziCUQQAoOYna" style="display: none">SCHEDULE OF DEBT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td id="xdx_49C_20230421_zU6pXR4OSoea" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--LineOfCreditFacilityFairValueOfAmountOutstanding_iI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_maLOCzybh_zLiwc0vJ4Goh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Principal balance at April 21, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">6,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--EarlyTerminationFee_iI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_maLOCzybh_z5yGTfguhCj2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Early termination fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--EndOfTermCharges_iI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_maLOCzybh_zEwkqVLLB0N7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">End of term charges</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">300,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LineOfCredit_iTI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_mtLOCzybh_zeo9YYC4MpS3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total payoff amount</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,420,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A1_z90niu9X332" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2023, the Company recorded a loss of $<span id="xdx_90F_eus-gaap--GainLossOnContractTermination_c20230101__20231231__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_znYufO5KRXu3" title="Gain (loss) on contract termination">329,158</span> on the early termination of the SVB Loan Facility which represented
the early termination fee and the end of the term fees, net of previously amortized interest expense totaling $<span id="xdx_901_eus-gaap--InterestExpense_c20230101__20231231__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zqWFOwIY756i" title="Interest expense debt">334,212</span> on the date of
its payoff.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136411904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_803_eus-gaap--IncomeTaxDisclosureTextBlock_zhjIeR0tTFSa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.
<span id="xdx_823_zUua3GGe1zig">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zEtZntAdjWO7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax benefit for the years ended December 31, 2024 and 2023 consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B5_zoT2mr4aedKc" style="display: none">SCHEDULE OF INCOME TAX PROVISION (BENEFIT)</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20240101__20241231_zJ13oxA4MKr5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230101__20231231_zGCtj1PfqiO6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CurrentFederalTaxExpenseBenefit_maITEBzpPN_zZSsqGTL5El5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0855">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maITEBzpPN_zROJEDZ4oFvg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0859">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_maITEBzpPN_zsNPOZ7Uj9G9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State and Local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0861">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0862">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maITEBzpPN_zaVkmcGmtLPi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0865">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maITEBzpPN_zSQn9EcAazQ5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; padding-bottom: 1pt">Deferred</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0867">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(1,280,385</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">)</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzpPN_zGBNikyFsVOb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0870">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,280,385</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A8_zKiDMzrlEQMf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zOcjI0HUYhUc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the Company&#8217;s statutory tax rate to the effective rate for the years ended December 31, 2024 and 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BB_zRHdyxfQieWh" style="display: none">SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20240101__20241231_z4MfqOJasFKd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230101__20231231_zLOUNGZp5s54" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maEIT001_zSnQ2rFZBM8j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Federal statutory rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">21.00</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maEIT001_zuGwNqWaxq7i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State taxes, net of federal tax benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.1</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--EffectiveIncomeTaxRateReconciliationPermanentDifferences_pid_dp_uPure_maEIT001_ze1NMFbfZjhc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Permanent differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.74</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3.1</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--EffectiveIncomeTaxRateReconciliationTimeUp_pid_dp_uPure_maEIT001_zQ8X9rRHvpHf" style="vertical-align: bottom; background-color: White">
    <td>True-Up</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.07</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(105.0</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maEIT001_zCD6t8UiOWY1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.11</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.9</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_maEIT001_z6nLsLcjWhBf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Rate Change</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.57</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0891">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate_pid_dp_uPure_maEIT001_zhq7Gs2R3kN9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred vs statutory rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">(0.75</p></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0894">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--EffectiveIncomeTaxRateReconciliationSaleAndExpiration_pid_dp_uPure_maEIT001_z6em4UqgIS94" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expiration of NOLs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">(17.51</p></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0897">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maEIT001_zDh2FHlNRLOe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Change in valuation allowance and deferred rate change, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9.01</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">89.0</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_uPure_mtEIT001_zMgG0RgSABza" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0902">-</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">6.1</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  </table>

<p id="xdx_8A3_zcDlUH27oNY9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_894_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z1rYeM2k69Qk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of the Company&#8217;s deferred tax asset as of December 31, 2024 and 2023 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BA_zUDCXVSy1E43" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20241231_zS9srSO4cn8a" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20231231_zV03sdyHJfn6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzVBe_zy3iHYw1xYLd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Net operating loss carryforwards</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">66,141,490</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">67,310,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DeferredTaxAssetsLegalAct_iI_pp0p0_maDTAGzVBe_z3ljGiepV6i1" style="vertical-align: bottom; background-color: White">
    <td>Section 174</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,482,099</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,929,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGzVBe_zZxzEcf50Qek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Other deferred tax assets, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,010,744</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,016,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzVBe_maDTANzv9R_zqu8M1QiHnh6" style="vertical-align: bottom; background-color: White">
    <td>Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74,634,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74,255,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzv9R_z8M94y7oICYf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(74,634,333</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(72,974,615</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzv9R_zthyYaKwBNg6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0922">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,280,385</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A3_zKr4rlbtJGb6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
evaluation of the realizability of such deferred tax assets in future periods is made based upon a variety of factors that affect
the Company&#8217;s ability to generate future taxable income, such as intent and ability to sell assets and historical and
projected operating performance. As of December 31, 2024, based on the Company&#8217;s history of earnings and its assessment of
future earnings, management believes that it is more likely than not future taxable income will not be sufficient to realize the
deferred tax assets. Therefore, full valuation allowance has been applied to deferred tax assets. At December 31, 2023, after its
evaluation of its New Jersey NOLs as discussed more fully below, the Company reduced the valuation reserve and recognized $<span id="xdx_902_ecustom--ProceedsFromSaleOfNetOperatingLosses_pn5n6_c20230101__20231231__srt--StatementGeographicalAxis__stpr--NJ_zDUeJHDQX6b5" title="Deferred income tax asset">1.3</span>
million as a deferred income tax asset. Such tax assets are available to be recognized and benefit future periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024, the Company had federal net operating loss carry forwards of approximately $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z6F017paUaJ6">303</span> million. If unused, will <span id="xdx_90C_ecustom--OperatingLossCarryforwardsExpirationDescription_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zYskvG7Nntp2" title="Operating losses expiration description">expire
starting in 2025 through 2037</span>. The federal NOLs generated for the years ended after 2017 of approximately $<span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20181231__us-gaap--IncomeTaxAuthorityAxis__custom--FederalIncomeTaxMember__srt--StatementScenarioAxis__custom--NoExpirationMember_zDoxjcUP3DM5">101</span> million can be carried
forward indefinitely. As of December 31, 2024, the Company had state net operating loss carryforwards of approximately $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zBErChhcPG16" title="Operating loss carryforwards">40</span> million, net
of net operating losses utilized in prior years, and, if unused, will <span id="xdx_90B_ecustom--OperatingLossCarryforwardsExpirationDescription_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_ztpLCKPm7UPh" title="Operating loss carryforwards expiration description">expire starting in 2029 through 2043</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be
sustained upon examination by taxing authorities. As of December 31, 2024, and 2023, there were <span id="xdx_901_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20241231_zAm0NJzZ1Zy7" title="Unrecognized tax benefits"><span id="xdx_909_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zRJ2LbEHfSB5" title="Unrecognized tax benefits">no</span></span> unrecognized tax benefits. The Company
recognizes accrued interest and penalties as income tax expense. <span id="xdx_90E_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_do_c20240101__20241231_z11G9gloEBb" title="Payment of interest and penalties"><span id="xdx_904_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_do_c20230101__20231231_ziLxq3m14KB7" title="Payment of interest and penalties">No</span></span> amounts were accrued for the payment of interest and penalties at
December 31, 2024 and 2023. The Company is currently not aware of any issues under review that could result in significant payments,
accruals or material deviation from its position in the next year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sections
382 and 383 of the Internal Revenue Code provide for a limitation on the annual use of NOL and tax credit carryforwards following certain
ownership changes that could limit the Company&#8217;s ability to utilize these carryforwards. The Company has completed an analysis
to determine if such ownership changes have occurred and concluded it was more likely than not that there were changes in ownership.
Due to the existence of full valuation allowance, limitations under Section 382 and 383 will not impact the Company&#8217;s effective
tax rate. Further analyses will be performed prior to recognizing the benefits of any losses or credits in the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
for tax years beginning after December 31, 2021, taxpayers are required to capitalize any expenses incurred that are considered incidental
to research and experimentation (&#8220;R&amp;E&#8221;) activities under IRC Section 174. While taxpayers historically had the option
of deducting these expenses under IRC Section 174, the December 2017 Tax Cuts and Jobs Act mandates capitalization and amortization of
R&amp;E expenses for tax years beginning after December 31, 2021. <span id="xdx_908_eus-gaap--IncomeTaxExaminationDescription_c20240101__20241231_zSMGtleefBc9" title="Income tax examination, description">Expenses incurred in connection with R&amp;E activities in the US must
be amortized over a 5-year period if incurred, and R&amp;E expenses incurred outside the US must be amortized over a 15-year period.
R&amp;E activities are broader in scope than qualified research activities considered under IRC Section 41 (relating to the research
tax credit). For the year ended December 31, 2024, the Company performed an analysis based on available guidance and determined that
it will continue to be in a loss position even after the required capitalization and amortization of its R&amp;E expenses. The Company
will continue to monitor this issue for future developments, but it does not expect R&amp;E capitalization and amortization to require
it to pay cash taxes now or in the near future. The Company&#8217;s income tax returns for 2020 to 2023 are still open and subject to
audit. In addition, net operating losses arising from prior years are also subject to examination at the time they are utilized in future
years.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Sale
of New Jersey Net Operating Losses</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
2018, the Company has annually submitted applications to sell a portion of the Company&#8217;s New Jersey NOLs as part of the Technology
Business Tax Certificate Program sponsored by The New Jersey Economic Development Authority. Under the program, emerging biotechnology
companies with unused NOLs and unused research and development credits are allowed to sell these benefits to other New Jersey-based companies.
As part of the Technology Business Tax Certificate Program, the Company sold $<span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_z65s9wpCqj3b">1.3</span> million of its New Jersey NOLs in 2023. The sale of
these net operating losses resulted in net proceeds to the Company of approximately $<span id="xdx_90D_ecustom--NetProceedsFromSaleOfNetOperatingLosses_pn5n6_c20240101__20241231__srt--StatementGeographicalAxis__stpr--NJ_zM7tCMf6cXz2" title="Net operating losses">1.3</span> million in 2024. During 2021, the New Jersey
State Legislature increased the maximum lifetime benefit per company from $<span id="xdx_90F_ecustom--NetProceedsFromSaleOfNetOperatingLosses_pn6n6_c20210101__20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MinimumMember__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zr7Iqfone3x8" title="Proceeds from sale">15</span> million to $<span id="xdx_90B_ecustom--NetProceedsFromSaleOfNetOperatingLosses_pn6n6_c20210101__20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MaximumMember__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zWSsYfr7oaBh" title="Proceeds from sale">20</span> million, which will allow the Company to
participate in this funding program in future years for up to an additional $<span id="xdx_904_eus-gaap--OperatingIncomeLoss_pn5n6_c20210101__20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MaximumMember_z7TRyvVk9GJd" title="Operating losses">0.3</span> million in net operating losses under this maximum lifetime
benefit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077234583072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="text"><p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zhTTnRONoUD4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.
<span id="xdx_829_zzpPZQLH4vbb">STOCKHOLDERS&#8217; EQUITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 15, 2024, the Company filed with the SEC a shelf registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;)
for the offer and sale of up to $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20240515__20240515_zvrhV7PqeBY1" title="Stock issued during period, value, new issues">75</span> million of its securities. The 2024 Registration Statement was declared effective on May 22, 2024.
The 2024 Registration Statement is intended to provide the Company with flexibility to raise capital in the future for general corporate
purposes. However, the Company&#8217;s ability to offer and sell its securities in a primary offering on the 2024 Registration Statement
is limited by General Instruction I.B.6 of Form S-3 (the &#8220;Baby Shelf Limitation&#8221;), which limits the amount that the Company
can offer to up to one-third of its public float during any trailing 12-month period. The Company would no longer be subject to the Baby
Shelf Limitation if its public float exceeds $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20240515__20240515_zvWgFQF3PgR9" title="Stock issued during period, value, new issues">75</span> million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">At
the Market Offering Agreement</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 15, 2024, the Company amended the At the Market Offering Agreement, dated as of May 25, 2022 (the &#8220;ATM Agreement&#8221;) with
H.C. Wainwright &amp; Co., LLC (&#8220;Wainwright&#8221;) as sales agent. Pursuant to the terms of the amended ATM Agreement, the Company
may offer and sell, from time to time, through Wainwright, shares of the Company&#8217;s common stock having an aggregate offering price
of up to $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240515__20240515__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_zT8Y2tPrzHA" title="Stock issued during period, value, new issues">5,500,000</span>. The Company intends to use the net proceeds from any offering under the amended ATM Agreement for general corporate
purposes, including research and development activities, capital expenditures and working capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2024, the Company notified Wainwright that it was suspending its use of and terminating the &#8220;at the market offering&#8221;
sales agreement prospectus (the &#8220;ATM Prospectus&#8221;), related to the potential issuance from time to time of the Company&#8217;s
common stock pursuant to the ATM Agreement, by and between the Company and Wainwright. Notwithstanding the termination of the ATM Prospectus,
the ATM Agreement remains in full force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 3, 2024, the Company filed a new prospectus supplement to the 2024 Registration Statement with the SEC for an aggregate offering
price of up to $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20240903__20240903_zy68mZFebLN" title="Issuance of common stock">5,500,000</span> related to the potential issuance from time to time of the Company&#8217;s common stock pursuant to the ATM
Agreement with Wainwright as sales agent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company sold <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240101__20241231__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_z1hPCovJa3Gi" title="Number of shares sold">88,796</span>
shares of common stock under the ATM Agreement for net proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20240101__20241231__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_zl9vGpzZwyYi" title="Proceeds from sale of stock">99,506</span>
during 2024. During 2023, the Company sold <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_zXvhdIIv0hU" title="Number of shares sold">1,878,488</span>
shares of common stock under the ATM Agreement for net proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_zGyO5DiQSK6a" title="Proceeds from sale of stock">2,750,658</span>. The Company sold <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250101__20250221__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zDtCnA8pkbpg" title="Number of shares sold">120,047</span> shares of common stock under the ATM Agreement for net proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20250101__20250221__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zzuAdJhf9ef8" title="Proceeds from sale of stock">105,693</span> from January
1, 2025 through February 21, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">July
2024 Offering</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2024, the Company entered into the July 2024 Purchase Agreement with the Purchasers, pursuant to which the Company issued, in
a registered direct offering, an aggregate of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240730__20240730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--JulyTwoThousandTwentyFourOfferingMember_zZlgbMEa4p31" title="Stock issued, shares">5,000,000</span> shares of the Company&#8217;s common stock at an offering price of $<span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20240730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--JulyTwoThousandTwentyFourOfferingMember_z3qBAl2xsjBe" title="Share price">2.00</span> per
share for gross proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20240730__20240730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--JulyTwoThousandTwentyFourOfferingMember_z4vAUXEzhxoe" title="Proceeds from issuance of common stock">10.0</span> million before the deduction of placement agent fees and offering expenses. In a concurrent private
placement and also pursuant to the July 2024 Purchase Agreement, the Company issued to the Purchasers the Warrants to purchase an aggregate
of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240730__20240730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--JulyTwoThousandTwentyFourOfferingMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAPOFpmLpmj5" title="Stock issued, shares">5,000,000</span> shares of its common stock at an exercise price of $<span id="xdx_908_eus-gaap--SharePrice_iI_pid_c20240730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--JulyTwoThousandTwentyFourOfferingMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNXWFqZv9jOb" title="Share price">2.00</span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants became exercisable immediately after issuance for a term of five and one-half years following the date of issuance. The closing
of the July 2024 Offering occurred on August 1, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136410992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zKTW4wR9HPki" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.
<span id="xdx_82B_zl3f96Iow6oa">STOCK-BASED COMPENSATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has long-term compensation plans that permit the granting of equity-based awards in the form of stock options, restricted stock,
restricted stock units, stock appreciation rights, other stock awards, and performance awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the 2018 Annual Stockholders Meeting of the Company held on May 15, 2018, stockholders approved the Imunon, Inc. 2018 Stock Incentive
Plan (the &#8220;2018 Plan&#8221;). The 2018 Plan, as adopted, permits the granting of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20180515__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember_zisEblMdRbu7" title="Share-based payment award, shares authorized">180,000</span> shares of Imunon common stock as equity
awards in the form of incentive stock options, nonqualified stock options, restricted stock, restricted stock units, stock appreciation
rights, other stock awards, performance awards, or in any combination of the foregoing. At the 2019 Annual Stockholders Meeting of the
Company held on May 14, 2019, stockholders approved an amendment to the 2018 Plan whereby the Company increased the number of common
stock shares available by <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20190514__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MinimumMember_zQe6P0ftFbri" title="Share based payment award, shares granted">80,000</span> to a total of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20190514__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zcrS350VE0jc" title="Share based payment award, shares granted">260,000</span> under the 2018 Plan, as amended. At the 2020 Annual Stockholders Meeting of the
Company held on June 15, 2020, stockholders approved an amendment to the 2018 Plan, as previously amended, whereby the Company increased
the number of shares of common stock available by <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20200615__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MinimumMember_z5ervcvjoxj2" title="Share based payment award, shares granted">166,667</span> to a total of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20200615__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zl7Rrti3C4qj" title="Share based payment award, shares granted">426,667</span> under the 2018 Plan, as amended. At the 2021 Annual Stockholders
Meeting of the Company held on June 10, 2021, stockholders approved an amendment to the 2018 Plan, as previously amended, whereby the
Company increased the number of shares of common stock available by <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210610__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MinimumMember_zEKnldVWLYD7" title="Share based payment award, shares granted">513,333</span> to a total of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210610__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zBG8HOp8pJQa" title="Share based payment award, shares granted">940,000</span> under the 2018 Plan, as amended. At
the 2023 Annual Stockholders Meeting of the Company held on June 14, 2023, stockholders approved an amendment to the 2018 Plan, as previously
amended, whereby the Company increased the number of shares of common stock available by <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230614__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MinimumMember_zFh6RVbIO76h" title="Share based payment award, shares granted">1,030,000</span> to a total of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230614__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zB7Y9Ae3EAka" title="Share based payment award, shares granted">1,970,000</span> under the
2018 Plan, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has issued stock awards to employees and directors in the form of stock options and restricted stock. <span id="xdx_90B_ecustom--StockOptionsStrikePriceDescription_c20240101__20241231__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember_z5kmYKZC7jT1" title="Stock options, strike price description">Options are generally granted
with strike prices equal to the fair market value of a share of Imunon common stock on the date of grant. Incentive stock options may
be granted to purchase shares of common stock at a price not less than 100% of the fair market value of the underlying shares on the
date of grant, provided that the exercise price of any incentive stock option granted to an eligible employee owning more than 10% of
the outstanding stock of Imunon must be at least 110% of such fair market value on the date of grant. Only officers and key employees
may receive incentive stock options.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
and restricted stock awards vest upon terms determined by the Compensation Committee of the Board of Directors and are subject to accelerated
vesting in the event of a change of control or certain terminations of employment. The Company issues new shares to satisfy its obligations
from the exercise of options or the grant of restricted stock awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024, the Compensation Committee of the Board of Directors approved the grant of inducement stock options (the &#8220;Inducement
Option Grants&#8221;) to purchase a total of <span id="xdx_909_eus-gaap--SharesIssued_iI_c20241231__us-gaap--PlanNameAxis__custom--InducementOptionGrantsMember__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhH9UK2TxXmg" title="Shares, Issued">110,000</span> shares of Imunon common stock. Each award has a grant date of the date of grant.
Each Inducement Option Grant has a weighted exercise price of $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20241231__us-gaap--PlanNameAxis__custom--InducementOptionGrantsMember__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zeJsIzeu9XPk" title="Exercise price per share">1.02</span> per share. Each Inducement Option Grant vests over four years, with
one-fourth vesting on the one-year anniversary of the employee&#8217;s first day of employment with the Company and one-fourth vesting
on the second, third and fourth anniversaries thereafter, subject to the new employee&#8217;s continued service relationship with the
Company on each such date. Each Inducement Option Grant has a ten-year term and is subject to the terms and conditions of the applicable
stock option agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024, there were a total of <span id="xdx_909_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20241231__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember_zNbo5GHMqnOk" title="Common stock, reserved for future issuance">1,975,073</span> shares of Imunon common stock reserved for issuance under the 2018 Plan, which
were comprised of <span id="xdx_900_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20241231__us-gaap--AwardTypeAxis__custom--EquityStockAwardsMember__srt--StatementScenarioAxis__custom--GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember_zJHHakkPzZba" title="Common stock, reserved for future issuance">1,555,073</span> shares of Imunon common stock subject to equity awards previously granted under the 2018 Plan and 2007 Plan
and <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20241231__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember_zLrj9bSYFSMk" title="Shares available for issuance">420,000</span> shares of Imunon common stock available for future issuance under the 2018 Plan. As of December 31, 2024, there are a total
of <span id="xdx_90A_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20241231__us-gaap--AwardTypeAxis__custom--InducementAwardsMember_zrqjMOEvC972" title="Common stock, reserved for future issuance">130,500</span> shares of Imunon common stock subject to outstanding inducement awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
compensation cost related to stock options and restricted stock awards was approximately $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240101__20241231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember_zZKr7Xbk0Ly7" title="Share based compensation">0.5</span> million and $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20231231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember_zMm4JRhZcZMh" title="Share based compensation">0.8</span> million during 2024 and
2023, respectively. Of these amounts, $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240101__20241231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zvFiZ55Q4zy4" title="Share based compensation expense">0.3</span> million and $<span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20231231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zdMi7N3N3dGl" title="Share based compensation expense">0.2</span> million were charged to research and development expenses during 2024 and
2023, respectively, and $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240101__20241231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zM6kUoHiDdr4" title="Share based compensation">0.2</span> million and $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20231231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_z59MNpv4F4Uh" title="Share based compensation">0.6</span> million were charged to general and administrative expenses during 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z8l0Ay4zzcI7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of stock option awards as of December 31, 2024 and changes during the two-year period ended December 31, 2024 is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B2_zRT355IYq1Rk" style="display: none">SUMMARY OF STOCK OPTIONS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Stock Options</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average<br/>
 Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average<br/>
 Remaining<br/>
 Contractual<br/>
 Term (years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate<br/>

Intrinsic Value</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zNJMXarr63H6" style="width: 12%; text-align: right" title="Number Outstanding, Outstanding, Beginning balance">760,220</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z4eNJRRL00yl" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance">4.55</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zjlUlgrQXE1b" style="text-align: right" title="Number Outstanding, Options granted">432,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z86IZFDQBwmc" style="text-align: right" title="Weighted Average Exercise Price, Options granted">1.23</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Options canceled or expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z0qzbteOkC7h" style="border-bottom: Black 1pt solid; text-align: right" title="Number Outstanding, Options canceled or expired">(129,238</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zjMKEcOzuJij" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Options canceled or expired">9.37</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z41s54Q7FPA" style="text-align: right" title="Number Outstanding, Outstanding, Beginning balance">1,063,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zZZKG3Pnf601" style="text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance">2.61</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGnmgQ5m4mDd" style="text-align: right" title="Number Outstanding, Options granted">1,051,835</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zB9aU3mYf3Ig" style="text-align: right" title="Weighted Average Exercise Price, Options granted">1.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Options canceled or expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zdk0cT81T7Y7" style="border-bottom: Black 1pt solid; text-align: right" title="Number Outstanding, Options canceled or expired">(469,444</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zXIQ6eKuWvRd" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Options canceled or expired">1.58</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Outstanding at December 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zB9YdanU429a" style="border-bottom: Black 2.5pt double; text-align: right" title="Number Outstanding, Outstanding, Ending balance">1,645,873</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zPgcGEuAWKs6" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending balance">1.95</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z7KqOTDF2zhh" title="Weighted Average Remaining Contractual Term (years), Outstanding, Ending balance">8.8</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pp0p0_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z80FYQgd8joc" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Ending balance">13,476</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Exercisable at December 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z34A130IUop3" style="border-bottom: Black 2.5pt double; text-align: right" title="Number Outstanding, Exercisable, Ending balance">907,723</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zbos3BQsD5nd" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable, Ending balance">2.58</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_ztNEf6U3r8Ya" title="Weighted Average Remaining Contractual Term (years), Exercisable, Ending balance">8.3</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zzovtrSpQvGb" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable, Ending balance">7,299</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AB_zCZImOcaKF7l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_eus-gaap--ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_z4CQpCRPhkib" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the status of the Company&#8217;s non-vested restricted stock awards as of December 31, 2024 and changes during the two-year
period ended December 31, 2024, is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zNlHSt0omjU6" style="display: none">SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Restricted Stock</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
                                                                               Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant Date</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Non-vested stock awards outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20231231_zrAa5r7ijF47" style="width: 16%; text-align: right" title="Number Outstanding, Non-vested stock awards, Outstanding, Beginning balance">69,650</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20231231_z4GTYcL6ZXYf" style="width: 16%; text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Beginning balance">1.92</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231_z9Wjq5p9onjg" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Granted">22,100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231_zb9Og7xe4Mce" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Granted">0.92</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vested and issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20231231_zVQ1h5tySgp6" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Vested and issued">(59,450</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231_zrVzDHqAA35d" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Vested and issued">1.91</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20230101__20231231_zLm1EdDMhxu7" style="border-bottom: Black 1pt solid; text-align: right" title="Number Outstanding, Non-vested stock awards, Forfeited">(200</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20231231_z3EprKT964d5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Forfeited">4.60</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Non-vested stock awards outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20240101__20241231_zzlYQPS5wAod" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Outstanding, Beginning balance">32,100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20240101__20241231_zQvn5ShkEkNb" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Beginning balance">1.23</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240101__20241231_zqOa9UhzjXmk" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Granted">39,700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240101__20241231_zcYZqQzgWbq9" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Granted">0.99</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vested and issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20240101__20241231_zjd1ppaRNEB4" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Vested and issued">(12,100</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20240101__20241231_zAvVVdZq9Mff" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Vested and issued">1.84</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20240101__20241231_z0WgeoM8sAB4" style="border-bottom: Black 1pt solid; text-align: right" title="Number Outstanding, Non-vested stock awards, Forfeited">(20,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20240101__20241231_zrr4LewQ5dU4" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Forfeited">0.88</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Non-vested stock awards outstanding at December 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20240101__20241231_za3je5nz976l" style="border-bottom: Black 2.5pt double; text-align: right" title="Number Outstanding, Non-vested stock awards, Outstanding, Ending balance">39,700</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20240101__20241231_zT4qcQ0aRKma" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Ending balance">0.99</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AC_z68OMfuXKA23" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z4uMi7arfhc6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of stock options outstanding at December 31, 2024 by price range is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_zFWKO5JmzFB2" style="display: none">SUMMARY OF STOCK OPTIONS OUTSTANDING</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options Exercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Range of Exercise Prices</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Contractual Term (in years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
                                                                               Average Remaining Contractual Term (in years)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">Up to $<span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zC2EgXvNdui6" title="Range of Exercise Prices, Upper">1.50</span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zOABDZXKzbz1" style="width: 8%; text-align: right" title="Options Outstanding, Number">1,250,252</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zBS2gZE4ARnl" title="Options Outstanding, Weighted Average Remaining Contractual Term (in years)">9.3</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zLwlTvB5X1Nc" style="width: 8%; text-align: right" title="Options Outstanding, Weighted Average Exercise Price">1.15</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zUyBq80VkaDg" style="width: 8%; text-align: right" title="Options Exercisable, Number">513,433</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zjg2C1U2Uqoj" title="Options Exercisable, Weighted Average Remaining Contractual Term (in years)">9.1</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zZPCgkp8keJe" style="width: 8%; text-align: right" title="Options Exercisable, Weighted Average Exercise Price">1.13</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>$<span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zVWu8UBrqpA1" title="Range of Exercise Prices, Lower">1.51</span> to $<span id="xdx_905_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_z8dizvnAXnRj" title="Range of Exercise Prices, Upper">4.50</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zJYbSSVN4667" style="text-align: right" title="Options Outstanding, Number">207,345</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zCIRvRAsVSl" title="Options Outstanding, Weighted Average Remaining Contractual Term (in years)">7.5</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zz61uMkY9wL4" style="text-align: right" title="Options Outstanding, Weighted Average Exercise Price">1.93</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zTahOV2subqg" style="text-align: right" title="Options Exercisable, Number">206,289</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zaw6ZHbbKA8j" title="Options Exercisable, Weighted Average Remaining Contractual Term (in years)">7.5</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zMVRzkiZWrSf" style="text-align: right" title="Options Exercisable, Weighted Average Exercise Price">1.93</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Above $<span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_z9j5NnQlDsN2" title="Range of Exercise Prices, Upper">4.51</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zsNUpLwp6gQ7" style="border-bottom: Black 1pt solid; text-align: right" title="Options Outstanding, Number">188,276</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zNBVjGePI7t4" title="Options Outstanding, Weighted Average Remaining Contractual Term (in years)">6.9</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zyB1BcHBruH9" style="padding-bottom: 1pt; text-align: right" title="Options Outstanding, Weighted Average Exercise Price">7.28</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_ztBKsnFquL5" style="border-bottom: Black 1pt solid; text-align: right" title="Options Exercisable, Number">188,001</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zosgcMRbfIA8" title="Options Exercisable, Weighted Average Remaining Contractual Term (in years)">6.9</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zwwVWasmmWVi" style="padding-bottom: 1pt; text-align: right" title="Options Exercisable, Weighted Average Exercise Price">7.27</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231_zJSATgPb4Zs2" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, Number">1,645,873</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231_zWWsWlE1Ojlk" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Exercisable, Number">907,723</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AE_zuLCI1C6AI73" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zRn1E7vsrxu" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair values of stock options granted were estimated at the date of grant using the Black-Scholes option pricing model. The Black-Scholes
model was originally developed for use in estimating the fair value of traded options, which have different characteristics from Imunon&#8217;s
stock options. The model is also sensitive to changes in assumptions, which can materially affect the fair value estimate. The Company
used the following assumptions for determining the fair value of options granted under the Black-Scholes option pricing model:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B6_znVN2aMnFbve" style="display: none">SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Year Ended December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20241231_zGTyUNEaqw6b" title="Risk-free interest rate, minimum">3.72</span>%
to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20241231_zOkmyCvW4FMc" title="Risk-free interest rate, maximum">4.50</span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231_zrRrmc9xZQkl" title="Risk-free interest rate, minimum">3.39</span>
% to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231_zpbW6ynBzo7j" title="Risk-free interest rate, maximum">4.81</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20240101__20241231_zxlHAtQoGwc" title="Expected volatility, minimum">101.7</span>% to <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20240101__20241231_zYeGq2RjFJhi" title="Expected volatility, maximum">115.8</span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20231231_zsio7YMyPY4f" title="Expected volatility, minimum">100.0</span>%
to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20231231_zTpLuGyWtvTi" title="Expected volatility, maximum">113.6</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected life (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231__srt--RangeAxis__srt--MinimumMember_zk09D2exgTjh" title="Expected life (in years)">7.5</span> to <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231__srt--RangeAxis__srt--MaximumMember_zFbDBv8hAmL6" title="Expected life (in years)">10</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zVFdjiTdvoj9" title="Expected life (in years)">7.5</span> to <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zwtWbIOu3Ywf" title="Expected life (in years)">10</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Expected dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240101__20241231_zL7AaJc4Rar7" style="width: 16%; text-align: right" title="Expected dividend yield">0.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231_zrkO6QxHlKh5" style="width: 16%; text-align: right" title="Expected dividend yield">0.0</td><td style="width: 1%; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_8A2_zTr8D98efn3c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
volatilities utilized in the model are based on historical volatility of the Company&#8217;s stock price. As of December 31, 2024, there
was $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pn5n6_c20241231_zViXpu5K4stj" title="Unrecognized compensation cost related to non-vested stock-based compensation arrangements">0.5</span> million of total unrecognized compensation cost related to non-vested stock-based compensation arrangements. That cost is expected
to be recognized over a weighted-average period of <span id="xdx_905_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20240101__20241231_z6SnXkh9HZy9" title="Cost recognized over a weighted-average period">1.4</span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136415168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_DisclosureWarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_WarrantsTextBlock', window );">WARRANTS</a></td>
<td class="text"><p id="xdx_800_ecustom--WarrantsTextBlock_zXIZYjpljPK1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.
<span id="xdx_822_zNB7aZ50AHzj">WARRANTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s
specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity (&#8220;ASC 480&#8221;),
and ASC 815, Derivatives and Hedging (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial
instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements
for equity classification under ASC 815, including whether the warrants are indexed to the Company&#8217;s own common stock, among other
conditions for equity classification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly
period end date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component
of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification,
the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter.
The Company has analyzed the Warrants issued in the July 2024 Offering and determined they are considered to be freestanding instruments
and do not exhibit any of the characteristics in ASC 480 and therefore are not classified as liabilities under ASC 480. The Warrants
meet all of the requirements for equity classification under ASC 815 and therefore are classified as equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zJ2ZnTFgCM0c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
is a summary of all warrant activity for the two years ended December 31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_z2F2T7VOb049" style="display: none">SUMMARY OF WARRANT ACTIVITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of<br/>
 Warrants Issued</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
                                                                               Average</b></span></p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
                                                                               Price</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Warrants outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20231231_fKg_____z34bE1wU0zL8" style="width: 16%; text-align: right" title="Number of Warrants Issued, Warrants outstanding, Beginning balance">168,519</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_zcKF45NV6RBd" style="width: 16%; text-align: right" title="Weighted Average Exercise Price, Warrants outstanding, Beginning balance">19.78</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrants issued during 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20241231_zeMEUKZYq7Ba" style="text-align: right" title="Number of Warrants Issued, Warrants issued">5,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice_c20240101__20241231_zgdqQZqWLjAf" style="text-align: right" title="Weighted Average Exercise Price, Warrants issued">2.00</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Warrants expired during 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20230101__20231231_zYc1C5iqDFk7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants Issued, warrants expired">(8,459</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231_zkTJAkmi1rl8" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants expired">37.29</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants outstanding and exercisable at December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20240101__20241231_fKg_____z5lebPFRBBci" style="text-align: right" title="Number of Warrants Issued, Warrants outstanding, Beginning balance">160,060</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20240101__20241231_zCdsBv4AEEE4" style="text-align: right" title="Weighted Average Exercise Price, Warrants outstanding, Beginning balance">18.86</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrants issued during 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20241231_zoyRFWBjB1p7" style="text-align: right" title="Number of Warrants Issued, Warrants issued">5,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice_c20240101__20241231_zxLHC3wAQTI6" style="text-align: right" title="Weighted Average Exercise Price, Warrants issued">2.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Warrants expired during 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20240101__20241231_zti0AXQom2y7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants Issued, Warrants expired">(5,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20241231_zLqFJVD2qeo4" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants expired">11.85</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Warrants outstanding and exercisable at December 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20240101__20241231_ztWbPxwDd6b6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Warrants Issued, Warrants outstanding, Ending balance">5,155,060</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_c20240101__20241231_zys4QATDg5dk" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Warrants outstanding, Ending balance">2.51</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Aggregate intrinsic value of outstanding warrants at December 31, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iI_pp0p0_c20241231_zgqrkSeOdIW8" title="Aggregate intrinsic value of outstanding warrants"><span style="-sec-ix-hidden: xdx2ixbrl1228">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted average remaining contractual terms (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_fKg_____zwIguOVwLCRg" title="Weighted average remaining contractual terms (years)">5.0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A1_zf5qazZbbxV8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_DisclosureWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_DisclosureWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_WarrantsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_WarrantsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077234510560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>IMUNON EMPLOYEE BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">IMUNON EMPLOYEE BENEFIT PLANS</a></td>
<td class="text"><p id="xdx_805_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zSjUR1FgFAL" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.
<span id="xdx_821_zYk7fPUfNDhh">IMUNON EMPLOYEE BENEFIT PLANS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon
maintains a defined-contribution plan under Section 401(k) of the Code. The plan covers substantially all employees over the age of twenty-one.
Participating employees may defer a portion of their pretax earnings, up to the IRS annual contribution limit. The Company makes a matching
contribution up to a maximum of <span id="xdx_906_eus-gaap--DefinedContributionPlanEmployerMatchingContributionPercent_pid_dp_uPure_c20240101__20241231_ztJDzsccaFW3" title="Maximum annual contributions per employee, percent">3</span>% of an employee&#8217;s annual salary. The Company&#8217;s total matching contributions for the year
ended December 31, 2024 and 2023 were $<span id="xdx_909_eus-gaap--DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_pp0p0_c20240101__20241231_z41gkPYRqotl" title="Matching contributions of employee">62,000</span> and $<span id="xdx_90A_eus-gaap--DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_pp0p0_c20230101__20231231_zgsDODgfjLLk" title="Matching contributions of employee">142,000</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/710/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 712<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/712/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077234635488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text"><p id="xdx_809_eus-gaap--LesseeOperatingLeasesTextBlock_zr6s4i8EpNMk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.
<span id="xdx_823_zCqeCRmmZC83">LEASES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
New Jersey Lease</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2023, the Company renewed its Lawrenceville office lease for a <span id="xdx_903_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtM_c20230831_zcJCAZqi6Zbf" title="Operating lease, term">24</span>-month agreement for <span id="xdx_901_eus-gaap--AreaOfLand_iI_pp0p0_usqrt_c20230831__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zcbWGLq8W29c" title="Area of land">9,850</span> square feet with monthly rent payments
of approximately $<span id="xdx_909_eus-gaap--PaymentsForRent_pp0p0_c20230801__20230831__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zPClH1MhBFOd" title="Payments for rent">22,983</span> to $<span id="xdx_906_eus-gaap--PaymentsForRent_pp0p0_c20230801__20230831__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zKwimQSDSEye" title="Payments for rent">23,394</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Huntsville,
Alabama Lease</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2023, the Company renewed its Huntsville facility lease for a <span id="xdx_90D_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtM_c20230131_zKCXv94E01dk" title="Operating lease, term">60</span>-month lease agreement for <span id="xdx_90B_eus-gaap--AreaOfLand_iI_pp0p0_usqrt_c20230131__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zHJP1JD2Jaeb" title="Area of land">11,420</span> square feet with monthly rent
payments of approximately $<span id="xdx_90D_eus-gaap--PaymentsForRent_pp0p0_c20230101__20230131__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zKoMycPK3NAl" title="Payments for rent">28,550</span> to $<span id="xdx_901_eus-gaap--PaymentsForRent_pp0p0_c20230101__20230131__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember__srt--RangeAxis__srt--MaximumMember_z16RY8z5Wusg" title="Payments for rent">30,903</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zTtl57qOKdca" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a table of the lease payments and maturity of the Company&#8217;s operating lease liabilities as of December 31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zk0OYEyekFtj" style="display: none">SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20241231_zlwmB1L5fH14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ending December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzy9p_z8U9WnNpaBub" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">2025</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">543,009</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzy9p_zFGm5DMTnwre" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">362,976</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzy9p_zW6RfUsRkspe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">370,235</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter_iI_maLOLLPzy9p_z9aKaq1ytOM5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">2028 and thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">30,904</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzy9p_maOLLz45C_maOLLzlbh_zotiXEslMm4f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Subtotal future lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,307,124</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zdcmyBRBBK01" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less imputed interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(167,831</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingLeaseLiability_iI_zv06nHSZ7uk6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Total lease liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,139,293</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Weighted average remaining life</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_z9wC3KQMMn5d" title="Operating lease, weighted average remaining lease term">2.7</span> years </span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average discount rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20241231_zVcwOso1kwV3" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease, weighted average discount rate, percent">9.98</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  </table>

<p id="xdx_8A6_zLcEcZhZqQC7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discount rate used was the Company&#8217;s incremental borrowing rate, which is <span id="xdx_90B_ecustom--OperatingLeasesIncrementalBorrowingRate_iI_dp_uPure_c20241231_zQXoKyHKJ8n2" title="Incremental borrowing rate">9.98</span>%, as the Company could not determine the rate implicit
in the lease.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
2024, operating lease expense was $<span id="xdx_901_eus-gaap--OperatingLeaseCost_pp0p0_c20240101__20241231_zs0Fnfs0F3O3" title="Operating lease, cost">652,166</span> and cash paid for operating leases included in operating cash flows was $<span id="xdx_902_eus-gaap--OperatingLeasePayments_pp0p0_c20240101__20241231_z19S8IGFb7tf" title="Operating lease, payments">659,646</span>. For 2023,
operating lease expense was $<span id="xdx_907_eus-gaap--OperatingLeaseCost_pp0p0_c20230101__20231231_zqMsFXNBxCB4" title="Operating lease, cost">646,633</span> and cash paid for operating leases included in operating cash flows was $<span id="xdx_907_eus-gaap--OperatingLeasePayments_pp0p0_c20230101__20231231_zKm7azc4ONnc" title="Operating lease, payments">644,593</span>. Amortization expense
was approximately $<span id="xdx_904_eus-gaap--OtherDepreciationAndAmortization_c20240101__20241231_zPvyPlINkmCb" title="Amortization expense">478,000</span> and $<span id="xdx_907_eus-gaap--OtherDepreciationAndAmortization_c20230101__20231231_zdqTbMk9xpqc" title="Amortization expense">472,000</span> for the years ended December 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077135545568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z8zBLQlNyDX5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15.
<span id="xdx_82E_zO8Yr3F9ZSD9">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not currently a party to any material legal proceedings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077234879312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTION</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zteBUWcvnHK8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16.
<span id="xdx_82A_zbkpGyTOqKn">RELATED PARTY TRANSACTION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 16, 2022, the Company entered into a convertible note purchase agreement with Transomic Technologies, Inc. (&#8220;Transomic&#8221;)
whereby the Company purchased $<span id="xdx_908_eus-gaap--ConvertibleNotesPayable_iI_c20221116__us-gaap--TypeOfArrangementAxis__custom--ConvertibleNotePurchaseAgreementMember__dei--LegalEntityAxis__custom--TransomicTechnologiesIncMember_zRtQ0peERVej" title="Convertible notes and warrants">375,000</span> of convertible notes secured by certain assets held by Transomic and warrants. Imunon purchased
products from Transomic for research and development purposes &#8211; primarily delivery vectors for its vaccine program. As a result
of this investment in Transomic, Imunon&#8217;s executive chairman, Mr. Michael Tardugno, was appointed to the Board of Directors of
Transomic. The Company disclosed the notes receivable as a related party transaction. In December 2023, Transomic filed a formal certificate
of dissolution of the company resulting in a complete write-off of the convertible note and related warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077140727712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_zIORMTUG7grh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.
<span id="xdx_827_zj9ZS1U4Yih4">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated its subsequent events from December 31, 2024, through the date these condensed consolidated financial statements
were issued, determining all subsequent events have been disclosed.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077235214912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">Description of Business</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zvySlgYoTayb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zh5oy2eCD6x3">Description
of Business</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon,
Inc. (&#8220;Imunon&#8221; or the &#8220;Company&#8221;) is a clinical-stage biotechnology company focused on advancing a portfolio of
innovative treatments that harness the body&#8217;s natural mechanisms with the aim to generate safe, effective and durable responses
across a broad array of human diseases, constituting a differentiating approach from conventional therapies. Imunon is developing its
non-viral DNA technology across its modalities. The first modality, TheraPlas&#174;, is developed for the coding of proteins and cytokines
in the treatment of solid tumors where an immunological approach is deemed promising. The second modality, PlaCCine&#174;, is developed
for the coding of viral antigens that can elicit a strong immunological response. This technology may represent a promising platform
for the development of vaccines in infectious diseases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer
that has completed Phase II clinical studies. IMNN-001 works by instructing the body to produce safe and durable levels of powerful cancer-fighting
molecules, such as interleukin-12 and interferon gamma, at the tumor site. Additionally, the Company has entered a first-in-human study
of its COVID-19 booster vaccine (IMNN-101). The Company will continue to leverage these modalities and to advance the technological frontier
of plasmid DNA to better serve patients with difficult-to-treat conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zae6M2qgw8N9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zaJVUmFdjmi8">Basis
of Presentation</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements (&#8220;Financial Statements&#8221;) of Imunon have been prepared in accordance with accounting
principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and include the accounts of the Company and CLSN Laboratories,
Inc. The Company dissolved Celsion GmbH in 2023. All significant intercompany balances and transactions have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Accounting Standards Update: Improvements to Reportable Segment Disclosures</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zp7DGI3bhVRl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zI7u3z2jMAB2">Accounting
Standards Update: Improvements to Reportable Segment Disclosures</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU No. 2023-07, &#8220;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&#8221;.
The disclosure requirements are required on an annual and interim basis and are applicable to entities with a single reportable segment.
The amendments in the ASU require disclosures to include significant segment expenses that are regularly provided to the chief operating
decision maker (&#8220;CODM&#8221;), a description of other segment items by reportable segment, and any additional measures of a segment&#8217;s
profit or loss used by the CODM when deciding how to allocate resources. ASU 2023-07 is effective for fiscal years beginning after December
15, 2023 and interim periods for fiscal years beginning after December 31, 2024, with early adoption allowed. We adopted this guidance
as of January 1, 2024 on a retrospective basis and the adoption did not have a material impact on our consolidated financial statements.
Refer to Note 3, &#8220;<i>Segment Performance Measures and Expenses</i>,&#8221; for new disclosures resulting from the adoption of ASU
2023-07.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_842_eus-gaap--UseOfEstimates_z1OUXqQnRFab" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zwIEi2FD2nra">Use
of Estimates</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the
reported amounts of expenses during the reporting period. Actual results could differ significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_843_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zKfScKLf3Bjh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_z6An9PGJcFY8">Revenue
Recognition</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not generate any revenue in 2024 or 2023 and there were <span id="xdx_907_eus-gaap--AccountsReceivableNet_iI_pdp0_do_c20241231_zQ3A5TpsjlMa" title="Accounts receivable"><span id="xdx_90E_eus-gaap--AccountsReceivableNet_iI_pdp0_do_c20231231_zvwPfGfAfP2d" title="Accounts receivable">no</span></span> accounts receivable as of December 31, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zOBhxFArpyd1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zzhY1d8iGIfc">Cash
and Cash Equivalents</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents include cash on hand and investments purchased with an original maturity of three months or less. A portion of these
funds are not covered by FDIC insurance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWVTmmcisM1e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zqyQ0nKKzRvl">Fair
Value of Financial Instruments</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of financial instruments approximate their respective fair values. Management believes that the carrying amounts of the
Company&#8217;s financial instruments, including cash and cash equivalents and accounts payable approximate fair value due to the short-term
nature of those instruments. Short-term investments are recorded at their estimated fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Short-Term Investments</a></td>
<td class="text"><p id="xdx_849_eus-gaap--InvestmentPolicyTextBlock_z8yuuJU4D5Pg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zOLBFKHY8BJ8">Short-Term
Investments</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies its investments in debt securities with readily determinable fair values as investments available-for-sale in accordance
with Accounting Standards Codification (&#8220;ASC&#8221;) 320, <i>Investments - Debt and Equity Securities</i>. Available-for-sale securities
consist of debt securities not classified as trading securities or as securities to be held to maturity. The Company has classified all
of its investments as available-for-sale. Unrealized holding gains and losses on available-for-sale securities are reported as a net
amount in accumulated other comprehensive gain or loss in stockholders&#8217; equity until realized. Gains and losses on the sale of
available-for-sale securities are determined using the specific identification method. The Company&#8217;s short-term investments consist
of corporate bonds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zug1ROyI6bp2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_z7ucnlguqE76">Property
and Equipment</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is provided over the estimated useful lives
of the related assets, ranging from <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20241231__srt--RangeAxis__srt--MinimumMember_zYE3fp0mEK27" title="Property plant and equipment useful life::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl0543">three</span></span> to <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20241231__srt--RangeAxis__srt--MaximumMember_zZIUtEY11Mi8" title="Property plant and equipment useful life">seven years</span>, using the straight-line method. Amortization is recognized over the lesser
of the life of the asset or the lease term. Major renewals and improvements are capitalized at cost and ordinary repairs and maintenance
are charged against operating expenses as incurred. Depreciation expense was approximately $<span id="xdx_90C_eus-gaap--DepreciationAndAmortization_pp0p0_c20240101__20241231_zQVcdcMNWTh8" title="Depreciation expense">240,000</span> and $<span id="xdx_90D_eus-gaap--DepreciationAndAmortization_pp0p0_c20230101__20231231_z9WPieBxdnNc" title="Depreciation expense">248,000</span> for the years ended
December 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of
an asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the future net undiscounted cash flows
that the asset is expected to generate. If such asset is considered to be impaired, the impairment recognized is the amount by which
the carrying amount of the asset, if any, exceeds its fair value determined using a discounted cash flow model. There was <span id="xdx_90D_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pdp0_do_c20240101__20241231_zVfBHWUtMXA5" title="Impairment of property or equipment"><span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pdp0_do_c20230101__20231231_zm10zQPzzU8b" title="Impairment of property or equipment">no</span></span> impairment
of property or equipment during 2024 or 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock', window );">Advances and Deposits on Clinical Programs and Other Current Assets</a></td>
<td class="text"><p id="xdx_840_ecustom--AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock_zgxMZgM0JY94" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zcieJVfHpkp">Advances
and Deposits on Clinical Programs and Other Current Assets</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplies
are consumable items kept on hand to support the Company&#8217;s R&amp;D and manufacturing operations which includes prepaid expense,
raw materials, clinical supplies and consumable items for clinical trials with alternate uses that are capitalized. Supplies are recorded
at cost and are charged to expense as they are used in operations. The Company regularly reviews the quality and utilization of supplies
to determine if future use of these supplies is probable. Due to the generic use of these supplies, they can be used in multiple projects
other than those currently being studied.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_DepositsPolicyTextBlock', window );">Deposits</a></td>
<td class="text"><p id="xdx_84D_ecustom--DepositsPolicyTextBlock_zv4VB1vNiPXh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zejGSx6DUqp2">Deposits</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits
include real property security deposits and other deposits which are contractually required and of a long-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zZQIAu9nUID1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zn5SgiHogNtg">Comprehensive
Income (Loss)</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
220, <i>Comprehensive Income</i>, establishes standards for the reporting and display of comprehensive income (loss) and its components
in the Company&#8217;s consolidated financial statements. The objective of ASC 220 is to report a measure of comprehensive income (loss)
of all changes in equity of an enterprise that result from transactions and other economic events in a period other than transactions
with owners. Comprehensive gains (losses) result from changes in unrealized gains and losses from investment in debt securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_z4pdAbEldQXh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zWZnZktlyHl1">Research
and Development</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred. Supplies are consumable and recorded at cost and are charged to expense as they are
used in operations. Equipment and facilities acquired for research and development activities that have alternative future uses are
capitalized and charged to expense over their estimated useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss per Share of Common Stock</a></td>
<td class="text"><p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zPN17PhH7Lof" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zRxYNFxPrvH5">Net
Loss per Share of Common Stock</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
and diluted net loss per common share was computed by dividing net loss for the year by the weighted average number of shares of common
stock outstanding, both basic and diluted, during each period. The impact of common stock equivalents has been excluded from the computation
of diluted weighted average common shares outstanding in periods where there is a net loss, as their effect is anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2024 and 2023, the total number of shares of common stock issuable upon exercise of warrants and equity
awards was <span id="xdx_90C_ecustom--NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards_c20240101__20241231_zIdJ8NypOvke" title="Number of shares of common stock issuable upon exercise of warrants and equity awards">6,840,633</span> and <span id="xdx_903_ecustom--NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards_c20230101__20231231_z8uqJsW68Whg" title="Number of shares of common stock issuable upon exercise of warrants and equity awards">1,255,642</span>, respectively. For the years ended December 31, 2024 and 2023, diluted loss per common share is the
same as basic loss per common share as all options and all other warrants that were convertible into shares of the Company&#8217;s common
stock were excluded from the calculation of diluted earnings attributable to common stockholders per common share as their effect would
be anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zRaWOaQJvd1e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_z5YYICLMLxq5">Income
Taxes</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for
the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities
and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using
enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered
or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in results of operations in the
period that the tax rate change occurs. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount
expected to be realized. In accordance with ASC 740, <i>Income Taxes,</i> a tax position is recognized as a benefit only if it is &#8220;more
likely than not&#8221; that the tax position taken would be sustained in a tax examination, presuming that a tax examination will occur.
The Company recognizes interest and/or penalties related to income tax matters in the income tax expense category.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
more fully discussed in Note 10, on November 28, 2023, the Company received approval from the New Jersey Economic Development Authority
to sell $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231128__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_zyQUca0mGMrj" title="Net proceeds from sale of net operating losses">1.3</span> million of its New Jersey net operating losses (&#8220;NOLs&#8221;), recognizing a tax benefit for the year ended December
31, 2023 for the net proceeds (approximately $<span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_zQqFn3poljfg" title="Net proceeds from sale of net operating losses">1.3</span> million) by reducing the net operating loss valuation allowance. As more fully discussed
in Note 10, on November 28, 2023, the Company was notified by the New Jersey Economic Development Authority that its application was
approved and the Company entered into an agreement to sell this NOL. On March 22, 2024, the Company received approximately $<span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20240322__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_zVzov2i0QTOh" title="Net proceeds from sale of net operating losses">1.3</span> million
upon completion of the sale of the 2023 NOLs. During 2021, the New Jersey State Legislature increased the maximum lifetime benefit per
company from $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MinimumMember_zuvjJAWM4cA3" title="Net proceeds from sale of net operating losses">15</span> million to $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MaximumMember_zscyKEF3T4t3" title="Net proceeds from sale of net operating losses">20</span> million, which will allow the Company to participate in this innovative funding program in future years
for up to an additional $<span id="xdx_908_eus-gaap--DirectFinancingLeaseSellingLoss_pn5n6_c20210101__20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MaximumMember_znzYDjnuVgY7" title="Direct financing lease, selling loss">0.4</span> million in net operating losses under this maximum lifetime benefit (see Note 2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zAuM5jvcHRGh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zmV0V4UKH7s4">Stock-Based
Compensation</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for all share-based payment awards granted to employees and non-employees as stock-based compensation expense at
grant date fair value. The Company&#8217;s share-based payments include stock options and grants of common stock, including common
stock subject to vesting. The measurement date for employee awards is the date of grant, and stock-based compensation costs are
recognized as expense over the employees&#8217; requisite service period, which is the vesting period, on a straight-line basis.
Prior to the adoption of Accounting Standards Update (&#8220;ASU&#8221;) No. 2018-07, <i>Compensation&#8212;Stock Compensation
(Topic 718): Improvements to Nonemployee Share-Based Payment Accounting</i> (&#8220;ASU No. 2018-07&#8221;) on January 1, 2020, the
measurement date for non-employee awards was generally the date the services were completed, resulting in financial reporting period
adjustments to stock-based compensation during the vesting terms for changes in the fair value of the awards. Since the adoption of
ASU 2018-07, the measurement date for non-employee awards is the date of grant without changes in the fair value of the award. There
was no material impact as a result of adopting this new standard. Stock-based compensation costs for non-employees are recognized as
expense over the vesting period on a straight-line basis. Stock-based compensation expense is classified in the accompanying
consolidated statements of operations based on the function to which the related services are provided. Forfeitures are recorded as
they occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. Since there is
limited historical data of the Company&#8217;s share price on the public market, the Company estimates its expected stock volatility
based on the historical volatility of a publicly traded set of representative companies and expects to continue to do so until such time
as it has adequate historical data regarding the volatility of its own traded stock price. The expected term of the Company&#8217;s stock
options has been determined utilizing the &#8220;simplified&#8221; method for awards that qualify as &#8220;plain-vanilla&#8221; options.
The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for
time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has
never paid cash dividends on common stock and does not expect to pay any cash dividends in the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_WarrantAccountingPolicyTextBlock', window );">Warrant Accounting</a></td>
<td class="text"><p id="xdx_84D_ecustom--WarrantAccountingPolicyTextBlock_zknejFqvE3v9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zubzMXlIwN6g">Warrant
Accounting</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants&#8217; specific
terms and applicable authoritative guidance in ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221; (&#8220;ASC 480&#8221;),
and ASC 815 &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all
of the requirements for equity classification under ASC 815, including whether the warrants are indexed to our own ordinary shares and
whether warrant holders could potentially require &#8220;net cash settlement&#8221; in a circumstance outside of our control, among other
conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant
issuance and as of each subsequent quarterly period end-date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
issued or modified warrants that meet all the criteria for equity classification, the warrants are required to be recorded as a component
of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants
are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of warrants classified as liabilities are recognized as a non-cash gain or loss on our statements
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the warrants issued upon our financings in 2024 meet the criteria for equity classification under ASC 815, those warrants were classified
as equity as of December 31, 2024. No warrants were issued in 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zDyZDNP766sh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zqPXVdyVEl3d">Recent
Accounting Pronouncements</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements are issued by the FASB and are adopted by the Company as of the specified effective date.
Unless otherwise discussed, the Company believes that the impact of recently issued accounting pronouncements will not have a material
impact on the Company&#8217;s consolidated financial position, results of operations, and cash flows, or do not apply to its operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU No. 2023-07, &#8220;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&#8221;.
The disclosure requirements are required on an annual and interim basis and are applicable to entities with a single reportable segment.
The amendments in the ASU require disclosures to include significant segment expenses that are regularly provided to the chief operating
decision maker (&#8220;CODM&#8221;), a description of other segment items by reportable segment, and any additional measures of a segment&#8217;s
profit or loss used by the CODM when deciding how to allocate resources. ASU 2023-07 is effective for fiscal years beginning after December
15, 2023 and interim periods for fiscal years beginning after December 31, 2024, with early adoption allowed. We adopted this guidance
as of January 1, 2024 on a retrospective basis and the adoption did not have a material impact on our consolidated financial statements.
Refer to Note 3, &#8220;<i>Segment Performance Measures and Expenses</i>,&#8221; for new disclosures resulting from the adoption of ASU
2023-07.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU No. 2023-09, <i>Improvements to Income Tax Disclosures</i>, which requires disclosure of disaggregated
income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income
tax-related disclosures. ASU No. 2023-09 is effective for fiscal years beginning after December 15, 2024 and allows for adoption on a
prospective basis, with a retrospective option. Early adoption is permitted. The Company is currently evaluating the impact of the ASU
on the income tax disclosures within the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2024, the FASB issued Accounting Standards Update No. 2024-03, Income Statement &#8211; Reporting Comprehensive Income &#8211;
Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses (&#8220;ASU 2024-03&#8221;). ASU 2024-03 will require
more detailed information about the types of expenses in commonly presented income statement captions such as &#8220;Cost of sales&#8221;
and &#8220;Selling, general and administrative expenses&#8221;. The new guidance is effective for annual reporting periods beginning
after December 15, 2026, and interim reporting periods beginning after December 15, 2027 with early adoption permitted. The Company is
currently evaluating the impact that this change will have on the Company&#8217;s disclosures.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advances And Deposits On Clinical Programs And Other Current Assets [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_DepositsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deposits [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_DepositsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_WarrantAccountingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Accounting [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_WarrantAccountingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077240669984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT PERFORMANCE MEASURES AND EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zlYQ79s71ut1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below provides a summary of the significant expense categories and consolidated net loss details provided to the CODM (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B1_zFMVxNtWuuRe" style="display: none">SCHEDULE
OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z9zuGKD5DL8g" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20230101__20231231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z4JR9kjY8526" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(In thousands)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Change Increase (Decrease)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating Expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Clinical Research</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OvationMember_z4e9KjHX7xFc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; width: 36%">OVATION</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,386</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,197</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zFtaV2ODW7J" style="width: 12%; text-align: right">189</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_905_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zl3kXxShCr7d">15.8</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--VaccineMember_z0OCox7LvAb2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Vaccine</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,420</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0611">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--VaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zjRKddLokjw7" style="text-align: right">1,420</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--VaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zb0C42p2TNTc">100.0</span></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OtherClinicalAndRegulatoryMember_zPYfOJ8X3dJd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Other clinical and regulatory</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,434</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,793</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OtherClinicalAndRegulatoryMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z3T2geOY6303" style="border-bottom: Black 1pt solid; text-align: right">641</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OtherClinicalAndRegulatoryMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zw5gp35Sd7Md">35.8</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember_zKd0FMmOdJp1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,240</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,990</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z452SWsVlj4g" style="text-align: right">2,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z4a7RGkHKSl3">75.3</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Non-Clinical R&amp;D and CMC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--OvationMember_zKDwOJJJJWU5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">OVATION</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,819</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,504</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z4DP2VlA9jT2" style="text-align: right">315</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zrcBUfUtWYj9">20.9</span></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--PlaCCineVaccineMember_zzqUozQSQxn1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">PlaCCine Vaccine</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,554</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,511</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--PlaCCineVaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zgHqSp0xeY9d" style="text-align: right">(1,957</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--PlaCCineVaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zTtNvCMJJ7d5">(43.4</span></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--ManufacturingCMCMember_zo4TRj9NNMz9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Manufacturing (CMC)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,026</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,283</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--ManufacturingCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zRx7aVJlZEMg" style="border-bottom: Black 1pt solid; text-align: right">(257</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--ManufacturingCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z7iaC6rBWGH3">(11.3</span></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember_z6i4WbV7mvbj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,399</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,298</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zwSNi41ErFb1" style="border-bottom: Black 1pt solid; text-align: right" title="Change Increase (Decrease), Subtotal">(1,899</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zBowl8SqcpX4" title="Change Increase (Decrease), Subtotal, percentage">(22.9</span></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr id="xdx_404_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_ztqM0GgOWf9l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Research and development expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,639</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,288</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--IncreaseDecreaseInResearchAndDevelopmentExpenses_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zYFMsCxY8myk" style="text-align: right" title="Change Increase (Decrease), Research and development expenses">351</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_ecustom--IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_ziAmP68chYk9" title="Change Increase (Decrease), Research and development expenses, percentage">3.1</span></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40D_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_zLS5FIlTy7Bi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">General and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7,493</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">9,742</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--IncreaseDecreaseInGeneralAndAdministrativeExpenes_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zECrFD39e8Qh" style="border-bottom: Black 1pt solid; text-align: right" title="Change Increase (Decrease), General and administrative expenses">(2,249</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_ecustom--IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zyxAuV2CPhYa" title="Change Increase (Decrease), General and administrative expenses, percentage">(23.1</span></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingExpenses_pn3n3_zfgajMq7vzx4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">19,132</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">21,030</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--IncreaseDecreaseInOperatingExpenses_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z3A3fIYodV3f" style="border-bottom: Black 1pt solid; text-align: right" title="Change Increase (Decrease), Operating expenses">(1,898</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_ecustom--IncreaseDecreaseInOperatingExpensesPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zkeS1CfGQgA5" title="Change Increase (Decrease), Operating expenses, percentage">(9.0</span></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingIncomeLoss_pn3n3_zEdiaCmAvLR4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Loss from operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(19,132</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(21,030</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--IncreaseDecreaseInLossFromOperations_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zWgXhZ2zDbN3" style="border-bottom: Black 2.5pt double; text-align: right" title="Change Increase (Decrease), Loss from operations">(1,898</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_ecustom--IncreaseDecreaseInLossFromOperationsPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zdAJmKiYcYVc" title="Change Increase (Decrease), Loss from operations, percentage">(9.0</span></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077233962368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">SCHEDULE OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS</a></td>
<td class="text"><p id="xdx_891_eus-gaap--DebtSecuritiesAvailableForSaleTableTextBlock_zJhMhxVWqx8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the cost, fair value and maturities of the Company&#8217;s short-term investments is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zFMeTwAajRV5" style="display: none">SCHEDULE
OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Short-term investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%; text-align: left">U.S. Treasury securities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShortTermInvestments_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zop2FxWWLzPi" style="width: 12%; text-align: right" title="Short-term investments - Cost"><span style="-sec-ix-hidden: xdx2ixbrl0683">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zEml1ZLOhUY9" style="width: 12%; text-align: right" title="Short-term investments - Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0685">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShortTermInvestments_iI_pp0p0_c20231231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zDqeN0KHQiF5" style="width: 12%; text-align: right" title="Short-term investments - Cost">9,796,291</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_ziEbR6ujJHN8" style="width: 12%; text-align: right" title="Short-term investments - Fair Value">9,857,087</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Short-term investment maturities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%">Within 3 months</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost_iI_pp0p0_c20241231_zQlUqIkK3kTj" style="width: 12%; text-align: right" title="Short-term investment maturities - Within 3 months, cost"><span style="-sec-ix-hidden: xdx2ixbrl0691">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue_iI_pp0p0_c20241231_zbmS20GpWvpj" style="width: 12%; text-align: right" title="Short-term investment maturities - Within 3 months, fair value"><span style="-sec-ix-hidden: xdx2ixbrl0693">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost_iI_pp0p0_c20231231_zkz8QPcho9p5" style="width: 12%; text-align: right" title="Short-term investment maturities - Within 3 months, cost">2,467,518</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue_iI_pp0p0_c20231231_zvGVwKxRcQBc" style="width: 12%; text-align: right" title="Short-term investment maturities - Within 3 months, fair value">2,490,775</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Between 3-12 months</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost_iI_pp0p0_c20241231_ztS153aL0mij" style="border-bottom: Black 1pt solid; text-align: right" title="Short-term investment maturities - Between 3-12 months, cost"><span style="-sec-ix-hidden: xdx2ixbrl0699">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue_iI_pp0p0_c20241231_zMqhyymOuDo5" style="border-bottom: Black 1pt solid; text-align: right" title="Short-term investment maturities - Between 3-12 months, fair value"><span style="-sec-ix-hidden: xdx2ixbrl0701">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost_iI_pp0p0_c20231231_zHMVpemb6uVd" style="border-bottom: Black 1pt solid; text-align: right" title="Short-term investment maturities - Between 3-12 months, cost">7,328,773</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue_iI_pp0p0_c20231231_zB8ZhcMRk2cj" style="border-bottom: Black 1pt solid; text-align: right" title="Short-term investment maturities - Between 3-12 months, fair value">7,366,312</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_iI_pp0p0_c20241231_zqaPVn5jycGb" style="border-bottom: Black 2.5pt double; text-align: right" title="Short-term investment maturities - Cost"><span style="-sec-ix-hidden: xdx2ixbrl0707">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_iI_pp0p0_c20241231_z3BpHKtUrjA3" style="border-bottom: Black 2.5pt double; text-align: right" title="Short-term investment maturities - Fair value"><span style="-sec-ix-hidden: xdx2ixbrl0709">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_iI_pp0p0_c20231231_zFRnRRpU0xai" style="border-bottom: Black 2.5pt double; text-align: right" title="Short-term investment maturities - Cost">9,796,291</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_iI_pp0p0_c20231231_zvAMrI8mXcwd" style="border-bottom: Black 2.5pt double; text-align: right" title="Short-term investment maturities - Fair value">9,857,087</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock', window );">SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES)</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_ztNRNPJJaSRi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the Company&#8217;s investment in debt securities available for sale gross unrealized gains (losses) and fair value
by investment category and length of time that individual securities have been in a continuous unrealized loss position at December 31,
2024 and 2023. The Company has reviewed individual securities to determine whether a decline in fair value below the amortizable cost
basis is other than temporary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BA_ztEDdfznwVke" style="display: none">SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES)</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Available for sale securities (all unrealized holding gains and losses are less than 12 months at date of measurement)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Unrealized Holding Gains (Losses)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Unrealized Holding Gains (Losses)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Investments in debt securities with unrealized gains</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--AvailableForSaleSecuritiesUnrealizedLossFairValue_iI_c20241231_zpqP4HgJM6Ri" style="width: 12%; text-align: right" title="Investments in debt securities with unrealized gains - Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0717">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths_iI_c20241231_zZL6gqpCzoKi" style="width: 12%; text-align: right" title="Investments in debt securities with unrealized gains - Unrealized Holding Gains"><span style="-sec-ix-hidden: xdx2ixbrl0719">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--AvailableForSaleSecuritiesUnrealizedLossFairValue_iI_c20231231_zFASLmzCc1kh" style="width: 12%; text-align: right" title="Investments in debt securities with unrealized gains - Fair Value">9,857,087</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths_iI_c20231231_ziM6wy1neKGl" style="width: 12%; text-align: right" title="Investments in debt securities with unrealized gains - Unrealized Holding Gains (Losses)">60,796</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeTextBlock', window );">SCHEDULE OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS</a></td>
<td class="text"><p id="xdx_897_eus-gaap--InvestmentIncomeTextBlock_zY581MyLYWEf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
income, net, which includes net realized losses on sales of available for sale securities and investment income interest and dividends,
is summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zlVNZnw7O8D" style="display: none">SCHEDULE
OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20240101__20241231_zljdSH3y5Laj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230101__20231231_zAr7TAvXzvm1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InvestmentIncomeInterestAndDividend_maIILNzUXt_zHteq5yzEnRc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Interest and dividends accrued and paid</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">450,221</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">725,824</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DebtSecuritiesAvailableForSaleRealizedGainLoss_maIILNzUXt_zadHWzORz6Xk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Realized losses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">61,983</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">431,801</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InvestmentIncomeNet_iT_pp0p0_mtIILNzUXt_zADW9BYCXPA6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Investment income, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">512,204</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,157,625</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrealized gains and losses on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077135576080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUES OF FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_DisclosureFairValuesOfFinancialInstrumentsAbstract', window );"><strong>Fair Values Of Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</a></td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zKZ4VOdG6wd6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
and liabilities measured at fair value are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zJnndAhHH5V" style="display: none">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Active Markets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for Identical</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assets/Liabilities (Level 1)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable Inputs</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 2)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs<br/> (Level 3)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Recurring items as of December 31, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%; text-align: left">U.S. treasury obligations, available for sale</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zceD1u3nzxuf" style="width: 12%; text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0740">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zXXAxtFvvFm5" style="width: 12%; text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zuTQGnUuLv9l" style="width: 12%; text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0744">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zy4foxjilXN" style="width: 12%; text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Recurring items as of December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">U.S. treasury obligations, available for sale</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zywdXOLBVdLj" style="text-align: right" title="U.S. treasury obligations, available for sale - Fair Value">9,857,087</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_z9PG169Tbm41" style="text-align: right" title="U.S. treasury obligations, available for sale - Fair Value">9,857,087</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zZmBwQPrcrK3" style="text-align: right" title="U.S. treasury obligations, available for sale - Fair Value">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0752">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zobKQnGwO3Ci" style="text-align: right" title="U.S. treasury obligations, available for sale - Fair Value">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0754">-</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_DisclosureFairValuesOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_DisclosureFairValuesOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136435456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">SCHEDULE OF PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zmOlp6UwTvgd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment at December 31, 2024 and 2023 consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B8_zj3I9xNoiaZ1" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20241231_ztMynUkEH0mc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20231231_zcW0s8XAC9u1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zc7JeGc0Hj4f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Machinery and equipment (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4kNSSdpEdah" title="Estimated useful life">5</span>-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zfrXNENf7Ye" title="Estimated useful life">7</span> year life)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">951,192</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,055,192</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z3CoxXI5hCNh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Furniture and fixtures (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zvc0pSnWHmll" title="Estimated useful life">3</span>-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zxpPcHQ1Kavj" title="Estimated useful life">5</span> year life)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">167,351</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">191,932</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zyFZFZLvQfw9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Leasehold improvements (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MinimumMember_zlSnyGFwysfj" title="Estimated useful life">5</span>-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MaximumMember_zgD8FhAwgKs3" title="Estimated useful life">7</span> year life)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">619,024</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">607,054</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzwDA_zwGd7tMJa6Qj" style="vertical-align: bottom; background-color: White">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
    and equipment gross</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,737,567</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,854,178</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzwDA_z7VL7Xxs8i8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,196,295</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,102,272</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzwDA_zvMBbyyWPvdb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">541,272</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">751,906</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077135545312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER ACCRUED LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">SCHEDULE OF OTHER ACCRUED LIABILITIES</a></td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zE0zruNMp2J7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
accrued liabilities at December 31, 2024 and 2023 include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zRjvPPOH0rWa" style="display: none">SCHEDULE OF OTHER ACCRUED LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20241231_zhcb6QF9v0Zd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20231231_zLaOpZh06MUk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ContractualObligation_iI_maCz80K_zoiVYfAmyVTc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Amounts due to contract research organizations and other contractual agreements</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,048,036</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,442,659</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_maCz80K_z4q7nyKo0cN9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued payroll and related benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,945,111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,693,383</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedProfessionalFeesCurrent_iI_maCz80K_zqQm09ZloMo1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">234,479</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maCz80K_zurJLkpqUzK2" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">20,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">20,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtCz80K_zjIFJsOXJr6h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,033,747</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,390,521</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077137603792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">SCHEDULE OF DEBT</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zTIxlDJfvCCj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 21, 2023, the Company repaid the outstanding principal balance, an early termination fee and the end-of-term charges in full satisfaction
of the SVB Loan Facility. The following is a schedule of the amounts paid to SVB on April 21, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_ziCUQQAoOYna" style="display: none">SCHEDULE OF DEBT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td id="xdx_49C_20230421_zU6pXR4OSoea" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--LineOfCreditFacilityFairValueOfAmountOutstanding_iI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_maLOCzybh_zLiwc0vJ4Goh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Principal balance at April 21, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">6,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--EarlyTerminationFee_iI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_maLOCzybh_z5yGTfguhCj2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Early termination fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--EndOfTermCharges_iI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_maLOCzybh_zEwkqVLLB0N7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">End of term charges</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">300,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LineOfCredit_iTI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_mtLOCzybh_zeo9YYC4MpS3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total payoff amount</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,420,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136431360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">SCHEDULE OF INCOME TAX PROVISION (BENEFIT)</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zEtZntAdjWO7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax benefit for the years ended December 31, 2024 and 2023 consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B5_zoT2mr4aedKc" style="display: none">SCHEDULE OF INCOME TAX PROVISION (BENEFIT)</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20240101__20241231_zJ13oxA4MKr5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230101__20231231_zGCtj1PfqiO6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CurrentFederalTaxExpenseBenefit_maITEBzpPN_zZSsqGTL5El5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0855">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maITEBzpPN_zROJEDZ4oFvg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0859">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_maITEBzpPN_zsNPOZ7Uj9G9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State and Local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0861">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0862">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maITEBzpPN_zaVkmcGmtLPi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0865">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maITEBzpPN_zSQn9EcAazQ5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; padding-bottom: 1pt">Deferred</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0867">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(1,280,385</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">)</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzpPN_zGBNikyFsVOb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0870">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,280,385</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zOcjI0HUYhUc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the Company&#8217;s statutory tax rate to the effective rate for the years ended December 31, 2024 and 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BB_zRHdyxfQieWh" style="display: none">SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20240101__20241231_z4MfqOJasFKd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230101__20231231_zLOUNGZp5s54" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maEIT001_zSnQ2rFZBM8j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Federal statutory rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">21.00</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maEIT001_zuGwNqWaxq7i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State taxes, net of federal tax benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.1</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--EffectiveIncomeTaxRateReconciliationPermanentDifferences_pid_dp_uPure_maEIT001_ze1NMFbfZjhc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Permanent differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.74</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3.1</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--EffectiveIncomeTaxRateReconciliationTimeUp_pid_dp_uPure_maEIT001_zQ8X9rRHvpHf" style="vertical-align: bottom; background-color: White">
    <td>True-Up</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.07</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(105.0</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maEIT001_zCD6t8UiOWY1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.11</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.9</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_maEIT001_z6nLsLcjWhBf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Rate Change</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.57</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0891">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate_pid_dp_uPure_maEIT001_zhq7Gs2R3kN9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred vs statutory rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">(0.75</p></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0894">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--EffectiveIncomeTaxRateReconciliationSaleAndExpiration_pid_dp_uPure_maEIT001_z6em4UqgIS94" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expiration of NOLs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">(17.51</p></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0897">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maEIT001_zDh2FHlNRLOe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Change in valuation allowance and deferred rate change, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9.01</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">89.0</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_uPure_mtEIT001_zMgG0RgSABza" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0902">-</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">6.1</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</a></td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z1rYeM2k69Qk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of the Company&#8217;s deferred tax asset as of December 31, 2024 and 2023 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BA_zUDCXVSy1E43" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20241231_zS9srSO4cn8a" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20231231_zV03sdyHJfn6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzVBe_zy3iHYw1xYLd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Net operating loss carryforwards</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">66,141,490</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">67,310,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DeferredTaxAssetsLegalAct_iI_pp0p0_maDTAGzVBe_z3ljGiepV6i1" style="vertical-align: bottom; background-color: White">
    <td>Section 174</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,482,099</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,929,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGzVBe_zZxzEcf50Qek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Other deferred tax assets, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,010,744</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,016,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzVBe_maDTANzv9R_zqu8M1QiHnh6" style="vertical-align: bottom; background-color: White">
    <td>Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74,634,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74,255,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzv9R_z8M94y7oICYf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(74,634,333</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(72,974,615</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzv9R_zthyYaKwBNg6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0922">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,280,385</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136410496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">SUMMARY OF STOCK OPTIONS</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z8l0Ay4zzcI7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of stock option awards as of December 31, 2024 and changes during the two-year period ended December 31, 2024 is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B2_zRT355IYq1Rk" style="display: none">SUMMARY OF STOCK OPTIONS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Stock Options</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average<br/>
 Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average<br/>
 Remaining<br/>
 Contractual<br/>
 Term (years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate<br/>

Intrinsic Value</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zNJMXarr63H6" style="width: 12%; text-align: right" title="Number Outstanding, Outstanding, Beginning balance">760,220</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z4eNJRRL00yl" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance">4.55</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zjlUlgrQXE1b" style="text-align: right" title="Number Outstanding, Options granted">432,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z86IZFDQBwmc" style="text-align: right" title="Weighted Average Exercise Price, Options granted">1.23</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Options canceled or expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z0qzbteOkC7h" style="border-bottom: Black 1pt solid; text-align: right" title="Number Outstanding, Options canceled or expired">(129,238</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zjMKEcOzuJij" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Options canceled or expired">9.37</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z41s54Q7FPA" style="text-align: right" title="Number Outstanding, Outstanding, Beginning balance">1,063,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zZZKG3Pnf601" style="text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance">2.61</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGnmgQ5m4mDd" style="text-align: right" title="Number Outstanding, Options granted">1,051,835</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zB9aU3mYf3Ig" style="text-align: right" title="Weighted Average Exercise Price, Options granted">1.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Options canceled or expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zdk0cT81T7Y7" style="border-bottom: Black 1pt solid; text-align: right" title="Number Outstanding, Options canceled or expired">(469,444</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zXIQ6eKuWvRd" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Options canceled or expired">1.58</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Outstanding at December 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zB9YdanU429a" style="border-bottom: Black 2.5pt double; text-align: right" title="Number Outstanding, Outstanding, Ending balance">1,645,873</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zPgcGEuAWKs6" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending balance">1.95</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z7KqOTDF2zhh" title="Weighted Average Remaining Contractual Term (years), Outstanding, Ending balance">8.8</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pp0p0_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z80FYQgd8joc" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Ending balance">13,476</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Exercisable at December 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z34A130IUop3" style="border-bottom: Black 2.5pt double; text-align: right" title="Number Outstanding, Exercisable, Ending balance">907,723</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zbos3BQsD5nd" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable, Ending balance">2.58</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_ztNEf6U3r8Ya" title="Weighted Average Remaining Contractual Term (years), Exercisable, Ending balance">8.3</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zzovtrSpQvGb" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable, Ending balance">7,299</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_z4CQpCRPhkib" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the status of the Company&#8217;s non-vested restricted stock awards as of December 31, 2024 and changes during the two-year
period ended December 31, 2024, is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zNlHSt0omjU6" style="display: none">SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Restricted Stock</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
                                                                               Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant Date</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Non-vested stock awards outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20231231_zrAa5r7ijF47" style="width: 16%; text-align: right" title="Number Outstanding, Non-vested stock awards, Outstanding, Beginning balance">69,650</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20231231_z4GTYcL6ZXYf" style="width: 16%; text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Beginning balance">1.92</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231_z9Wjq5p9onjg" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Granted">22,100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231_zb9Og7xe4Mce" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Granted">0.92</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vested and issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20231231_zVQ1h5tySgp6" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Vested and issued">(59,450</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231_zrVzDHqAA35d" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Vested and issued">1.91</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20230101__20231231_zLm1EdDMhxu7" style="border-bottom: Black 1pt solid; text-align: right" title="Number Outstanding, Non-vested stock awards, Forfeited">(200</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20231231_z3EprKT964d5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Forfeited">4.60</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Non-vested stock awards outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20240101__20241231_zzlYQPS5wAod" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Outstanding, Beginning balance">32,100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20240101__20241231_zQvn5ShkEkNb" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Beginning balance">1.23</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240101__20241231_zqOa9UhzjXmk" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Granted">39,700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240101__20241231_zcYZqQzgWbq9" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Granted">0.99</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vested and issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20240101__20241231_zjd1ppaRNEB4" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Vested and issued">(12,100</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20240101__20241231_zAvVVdZq9Mff" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Vested and issued">1.84</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20240101__20241231_z0WgeoM8sAB4" style="border-bottom: Black 1pt solid; text-align: right" title="Number Outstanding, Non-vested stock awards, Forfeited">(20,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20240101__20241231_zrr4LewQ5dU4" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Forfeited">0.88</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Non-vested stock awards outstanding at December 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20240101__20241231_za3je5nz976l" style="border-bottom: Black 2.5pt double; text-align: right" title="Number Outstanding, Non-vested stock awards, Outstanding, Ending balance">39,700</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20240101__20241231_zT4qcQ0aRKma" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Ending balance">0.99</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">SUMMARY OF STOCK OPTIONS OUTSTANDING</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z4uMi7arfhc6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of stock options outstanding at December 31, 2024 by price range is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_zFWKO5JmzFB2" style="display: none">SUMMARY OF STOCK OPTIONS OUTSTANDING</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options Exercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Range of Exercise Prices</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Contractual Term (in years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
                                                                               Average Remaining Contractual Term (in years)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">Up to $<span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zC2EgXvNdui6" title="Range of Exercise Prices, Upper">1.50</span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zOABDZXKzbz1" style="width: 8%; text-align: right" title="Options Outstanding, Number">1,250,252</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zBS2gZE4ARnl" title="Options Outstanding, Weighted Average Remaining Contractual Term (in years)">9.3</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zLwlTvB5X1Nc" style="width: 8%; text-align: right" title="Options Outstanding, Weighted Average Exercise Price">1.15</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zUyBq80VkaDg" style="width: 8%; text-align: right" title="Options Exercisable, Number">513,433</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zjg2C1U2Uqoj" title="Options Exercisable, Weighted Average Remaining Contractual Term (in years)">9.1</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zZPCgkp8keJe" style="width: 8%; text-align: right" title="Options Exercisable, Weighted Average Exercise Price">1.13</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>$<span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zVWu8UBrqpA1" title="Range of Exercise Prices, Lower">1.51</span> to $<span id="xdx_905_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_z8dizvnAXnRj" title="Range of Exercise Prices, Upper">4.50</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zJYbSSVN4667" style="text-align: right" title="Options Outstanding, Number">207,345</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zCIRvRAsVSl" title="Options Outstanding, Weighted Average Remaining Contractual Term (in years)">7.5</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zz61uMkY9wL4" style="text-align: right" title="Options Outstanding, Weighted Average Exercise Price">1.93</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zTahOV2subqg" style="text-align: right" title="Options Exercisable, Number">206,289</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zaw6ZHbbKA8j" title="Options Exercisable, Weighted Average Remaining Contractual Term (in years)">7.5</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zMVRzkiZWrSf" style="text-align: right" title="Options Exercisable, Weighted Average Exercise Price">1.93</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Above $<span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_z9j5NnQlDsN2" title="Range of Exercise Prices, Upper">4.51</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zsNUpLwp6gQ7" style="border-bottom: Black 1pt solid; text-align: right" title="Options Outstanding, Number">188,276</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zNBVjGePI7t4" title="Options Outstanding, Weighted Average Remaining Contractual Term (in years)">6.9</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zyB1BcHBruH9" style="padding-bottom: 1pt; text-align: right" title="Options Outstanding, Weighted Average Exercise Price">7.28</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_ztBKsnFquL5" style="border-bottom: Black 1pt solid; text-align: right" title="Options Exercisable, Number">188,001</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zosgcMRbfIA8" title="Options Exercisable, Weighted Average Remaining Contractual Term (in years)">6.9</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zwwVWasmmWVi" style="padding-bottom: 1pt; text-align: right" title="Options Exercisable, Weighted Average Exercise Price">7.27</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231_zJSATgPb4Zs2" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, Number">1,645,873</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231_zWWsWlE1Ojlk" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Exercisable, Number">907,723</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zRn1E7vsrxu" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair values of stock options granted were estimated at the date of grant using the Black-Scholes option pricing model. The Black-Scholes
model was originally developed for use in estimating the fair value of traded options, which have different characteristics from Imunon&#8217;s
stock options. The model is also sensitive to changes in assumptions, which can materially affect the fair value estimate. The Company
used the following assumptions for determining the fair value of options granted under the Black-Scholes option pricing model:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B6_znVN2aMnFbve" style="display: none">SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Year Ended December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20241231_zGTyUNEaqw6b" title="Risk-free interest rate, minimum">3.72</span>%
to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20241231_zOkmyCvW4FMc" title="Risk-free interest rate, maximum">4.50</span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231_zrRrmc9xZQkl" title="Risk-free interest rate, minimum">3.39</span>
% to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231_zpbW6ynBzo7j" title="Risk-free interest rate, maximum">4.81</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20240101__20241231_zxlHAtQoGwc" title="Expected volatility, minimum">101.7</span>% to <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20240101__20241231_zYeGq2RjFJhi" title="Expected volatility, maximum">115.8</span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20231231_zsio7YMyPY4f" title="Expected volatility, minimum">100.0</span>%
to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20231231_zTpLuGyWtvTi" title="Expected volatility, maximum">113.6</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected life (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231__srt--RangeAxis__srt--MinimumMember_zk09D2exgTjh" title="Expected life (in years)">7.5</span> to <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231__srt--RangeAxis__srt--MaximumMember_zFbDBv8hAmL6" title="Expected life (in years)">10</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zVFdjiTdvoj9" title="Expected life (in years)">7.5</span> to <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zwtWbIOu3Ywf" title="Expected life (in years)">10</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Expected dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240101__20241231_zL7AaJc4Rar7" style="width: 16%; text-align: right" title="Expected dividend yield">0.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231_zrkO6QxHlKh5" style="width: 16%; text-align: right" title="Expected dividend yield">0.0</td><td style="width: 1%; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077234836032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_DisclosureWarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">SUMMARY OF WARRANT ACTIVITY</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zJ2ZnTFgCM0c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
is a summary of all warrant activity for the two years ended December 31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_z2F2T7VOb049" style="display: none">SUMMARY OF WARRANT ACTIVITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of<br/>
 Warrants Issued</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
                                                                               Average</b></span></p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
                                                                               Price</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Warrants outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20231231_fKg_____z34bE1wU0zL8" style="width: 16%; text-align: right" title="Number of Warrants Issued, Warrants outstanding, Beginning balance">168,519</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_zcKF45NV6RBd" style="width: 16%; text-align: right" title="Weighted Average Exercise Price, Warrants outstanding, Beginning balance">19.78</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrants issued during 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20241231_zeMEUKZYq7Ba" style="text-align: right" title="Number of Warrants Issued, Warrants issued">5,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice_c20240101__20241231_zgdqQZqWLjAf" style="text-align: right" title="Weighted Average Exercise Price, Warrants issued">2.00</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Warrants expired during 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20230101__20231231_zYc1C5iqDFk7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants Issued, warrants expired">(8,459</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231_zkTJAkmi1rl8" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants expired">37.29</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants outstanding and exercisable at December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20240101__20241231_fKg_____z5lebPFRBBci" style="text-align: right" title="Number of Warrants Issued, Warrants outstanding, Beginning balance">160,060</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20240101__20241231_zCdsBv4AEEE4" style="text-align: right" title="Weighted Average Exercise Price, Warrants outstanding, Beginning balance">18.86</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrants issued during 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20241231_zoyRFWBjB1p7" style="text-align: right" title="Number of Warrants Issued, Warrants issued">5,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice_c20240101__20241231_zxLHC3wAQTI6" style="text-align: right" title="Weighted Average Exercise Price, Warrants issued">2.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Warrants expired during 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20240101__20241231_zti0AXQom2y7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants Issued, Warrants expired">(5,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20241231_zLqFJVD2qeo4" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants expired">11.85</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Warrants outstanding and exercisable at December 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20240101__20241231_ztWbPxwDd6b6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Warrants Issued, Warrants outstanding, Ending balance">5,155,060</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_c20240101__20241231_zys4QATDg5dk" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Warrants outstanding, Ending balance">2.51</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Aggregate intrinsic value of outstanding warrants at December 31, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iI_pp0p0_c20241231_zgqrkSeOdIW8" title="Aggregate intrinsic value of outstanding warrants"><span style="-sec-ix-hidden: xdx2ixbrl1228">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted average remaining contractual terms (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_fKg_____zwIguOVwLCRg" title="Weighted average remaining contractual terms (years)">5.0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_DisclosureWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_DisclosureWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077135575024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zTtl57qOKdca" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a table of the lease payments and maturity of the Company&#8217;s operating lease liabilities as of December 31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zk0OYEyekFtj" style="display: none">SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20241231_zlwmB1L5fH14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ending December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzy9p_z8U9WnNpaBub" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">2025</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">543,009</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzy9p_zFGm5DMTnwre" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">362,976</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzy9p_zW6RfUsRkspe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">370,235</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter_iI_maLOLLPzy9p_z9aKaq1ytOM5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">2028 and thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">30,904</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzy9p_maOLLz45C_maOLLzlbh_zotiXEslMm4f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Subtotal future lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,307,124</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zdcmyBRBBK01" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less imputed interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(167,831</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingLeaseLiability_iI_zv06nHSZ7uk6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Total lease liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,139,293</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Weighted average remaining life</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_z9wC3KQMMn5d" title="Operating lease, weighted average remaining lease term">2.7</span> years </span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average discount rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20241231_zVcwOso1kwV3" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease, weighted average discount rate, percent">9.98</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136454160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 22, 2024</div></th>
<th class="th"><div>Nov. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation expense</a></td>
<td class="nump">240,000<span></span>
</td>
<td class="nump">248,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment of property or equipment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards', window );">Number of shares of common stock issuable upon exercise of warrants and equity awards</a></td>
<td class="nump">6,840,633<span></span>
</td>
<td class="nump">1,255,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NJ', window );">NEW JERSEY | New Jersey Division of Taxation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net proceeds from sale of net operating losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property plant and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | NEW JERSEY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net proceeds from sale of net operating losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property plant and equipment useful life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | NEW JERSEY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net proceeds from sale of net operating losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DirectFinancingLeaseSellingLoss', window );">Direct financing lease, selling loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the total number of Shares of common stock issuable upon exercise of warrants and equity awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479196/954-310-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectFinancingLeaseSellingLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss recognized at commencement from direct financing lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-6A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectFinancingLeaseSellingLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NJ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NJ</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewJerseyDivisionOfTaxationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewJerseyDivisionOfTaxationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077137117168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 18,620,242<span></span>
</td>
<td class="nump">$ 19,514,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Fund operation</a></td>
<td class="nump">18,854,970<span></span>
</td>
<td class="nump">19,022,148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Cumulated net losses</a></td>
<td class="nump">406,803,044<span></span>
</td>
<td class="nump">$ 388,182,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash and cash equivalents, short-term investments</a></td>
<td class="nump">$ 5,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136632448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 11,639,411<span></span>
</td>
<td class="nump">$ 11,287,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">7,493,035<span></span>
</td>
<td class="nump">9,742,739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">19,132,446<span></span>
</td>
<td class="nump">21,030,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(19,132,446)<span></span>
</td>
<td class="num">(21,030,430)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">11,639,000<span></span>
</td>
<td class="nump">11,288,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInResearchAndDevelopmentExpenses', window );">Change Increase (Decrease), Research and development expenses</a></td>
<td class="nump">$ 351,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage', window );">Change Increase (Decrease), Research and development expenses, percentage</a></td>
<td class="nump">3.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">$ 7,493,000<span></span>
</td>
<td class="nump">9,742,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpenes', window );">Change Increase (Decrease), General and administrative expenses</a></td>
<td class="num">$ (2,249,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage', window );">Change Increase (Decrease), General and administrative expenses, percentage</a></td>
<td class="num">(23.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">$ 19,132,000<span></span>
</td>
<td class="nump">21,030,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingExpenses', window );">Change Increase (Decrease), Operating expenses</a></td>
<td class="num">$ (1,898,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingExpensesPercentage', window );">Change Increase (Decrease), Operating expenses, percentage</a></td>
<td class="num">(9.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">$ (19,132,000)<span></span>
</td>
<td class="num">(21,030,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInLossFromOperations', window );">Change Increase (Decrease), Loss from operations</a></td>
<td class="num">$ (1,898,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInLossFromOperationsPercentage', window );">Change Increase (Decrease), Loss from operations, percentage</a></td>
<td class="num">(9.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Clinical Research [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Subtotal</a></td>
<td class="nump">$ 5,240,000<span></span>
</td>
<td class="nump">2,990,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingCostAndExpenses', window );">Change Increase (Decrease), Subtotal</a></td>
<td class="nump">$ 2,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage', window );">Change Increase (Decrease), Subtotal, percentage</a></td>
<td class="nump">75.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Clinical Research [Member] | Ovation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Subtotal</a></td>
<td class="nump">$ 1,386,000<span></span>
</td>
<td class="nump">1,197,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingCostAndExpenses', window );">Change Increase (Decrease), Subtotal</a></td>
<td class="nump">$ 189,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage', window );">Change Increase (Decrease), Subtotal, percentage</a></td>
<td class="nump">15.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Clinical Research [Member] | Vaccine [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Subtotal</a></td>
<td class="nump">$ 1,420,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingCostAndExpenses', window );">Change Increase (Decrease), Subtotal</a></td>
<td class="nump">$ 1,420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage', window );">Change Increase (Decrease), Subtotal, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Clinical Research [Member] | Other Clinical And Regulatory [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Subtotal</a></td>
<td class="nump">$ 2,434,000<span></span>
</td>
<td class="nump">1,793,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingCostAndExpenses', window );">Change Increase (Decrease), Subtotal</a></td>
<td class="nump">$ 641,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage', window );">Change Increase (Decrease), Subtotal, percentage</a></td>
<td class="nump">35.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Non-Clinical R&amp;D and CMC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Subtotal</a></td>
<td class="nump">$ 6,399,000<span></span>
</td>
<td class="nump">8,298,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingCostAndExpenses', window );">Change Increase (Decrease), Subtotal</a></td>
<td class="num">$ (1,899,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage', window );">Change Increase (Decrease), Subtotal, percentage</a></td>
<td class="num">(22.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Non-Clinical R&amp;D and CMC [Member] | Ovation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Subtotal</a></td>
<td class="nump">$ 1,819,000<span></span>
</td>
<td class="nump">1,504,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingCostAndExpenses', window );">Change Increase (Decrease), Subtotal</a></td>
<td class="nump">$ 315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage', window );">Change Increase (Decrease), Subtotal, percentage</a></td>
<td class="nump">20.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Non-Clinical R&amp;D and CMC [Member] | PlaCCine Vaccine [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Subtotal</a></td>
<td class="nump">$ 2,554,000<span></span>
</td>
<td class="nump">4,511,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingCostAndExpenses', window );">Change Increase (Decrease), Subtotal</a></td>
<td class="num">$ (1,957,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage', window );">Change Increase (Decrease), Subtotal, percentage</a></td>
<td class="num">(43.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Non-Clinical R&amp;D and CMC [Member] | Manufacturing (CMC) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Subtotal</a></td>
<td class="nump">$ 2,026,000<span></span>
</td>
<td class="nump">$ 2,283,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingCostAndExpenses', window );">Change Increase (Decrease), Subtotal</a></td>
<td class="num">$ (257,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage', window );">Change Increase (Decrease), Subtotal, percentage</a></td>
<td class="num">(11.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpenes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in general and administrative expenes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpenes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in general and administrative expenses percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_IncreaseDecreaseInLossFromOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in loss from operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_IncreaseDecreaseInLossFromOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_IncreaseDecreaseInLossFromOperationsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in loss from operations percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_IncreaseDecreaseInLossFromOperationsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_IncreaseDecreaseInOperatingCostAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in operating cost and expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_IncreaseDecreaseInOperatingCostAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in operating costs and expenses percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_IncreaseDecreaseInOperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in operating expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_IncreaseDecreaseInOperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_IncreaseDecreaseInOperatingExpensesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in operating expenses percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_IncreaseDecreaseInOperatingExpensesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_IncreaseDecreaseInResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in research and development expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_IncreaseDecreaseInResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in research and development expenses percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=IMNN_ClinicalResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=IMNN_ClinicalResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=IMNN_OvationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=IMNN_OvationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=IMNN_VaccineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=IMNN_VaccineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=IMNN_OtherClinicalAndRegulatoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=IMNN_OtherClinicalAndRegulatoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=IMNN_NonClinicalRAndDAndCMCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=IMNN_NonClinicalRAndDAndCMCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=IMNN_PlaCCineVaccineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=IMNN_PlaCCineVaccineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=IMNN_ManufacturingCMCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=IMNN_ManufacturingCMCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077134572896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT PERFORMANCE MEASURES AND EXPENSES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segment</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077137114432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investments - Fair Value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,857,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost', window );">Short-term investment maturities - Within 3 months, cost</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,467,518<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue', window );">Short-term investment maturities - Within 3 months, fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,490,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost', window );">Short-term investment maturities - Between 3-12 months, cost</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">7,328,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue', window );">Short-term investment maturities - Between 3-12 months, fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">7,366,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent', window );">Short-term investment maturities - Cost</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,796,291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Short-term investment maturities - Fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,857,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">US Treasury Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments - Cost</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,796,291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investments - Fair Value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,857,087<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling three to twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling three to twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) with single maturity date and allocated without single maturity date, maturing in next rolling three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077135643552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_AvailableForSaleSecuritiesUnrealizedLossFairValue', window );">Investments in debt securities with unrealized gains - Fair Value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,857,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths', window );">Investments in debt securities with unrealized gains - Unrealized Holding Gains (Losses)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 60,796<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Available for sale securities unrealized gain less than twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_AvailableForSaleSecuritiesUnrealizedLossFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Available for sale securities unrealized losses fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_AvailableForSaleSecuritiesUnrealizedLossFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077234893424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Interest and dividends accrued and paid</a></td>
<td class="nump">$ 450,221<span></span>
</td>
<td class="nump">$ 725,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss', window );">Realized losses</a></td>
<td class="nump">61,983<span></span>
</td>
<td class="nump">431,801<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income, net</a></td>
<td class="nump">$ 512,204<span></span>
</td>
<td class="nump">$ 1,157,625<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077135430416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Debt securities, available for sale, current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,857,087<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077137478032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Investment in debt securities - available for sale, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,857,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">US Treasury Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Investment in debt securities - available for sale, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,857,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | US Treasury Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Investment in debt securities - available for sale, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,857,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | US Treasury Securities [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Investment in debt securities - available for sale, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,857,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | US Treasury Securities [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Investment in debt securities - available for sale, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | US Treasury Securities [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Investment in debt securities - available for sale, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077135461824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment gross</a></td>
<td class="nump">$ 1,737,567<span></span>
</td>
<td class="nump">$ 2,854,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(1,196,295)<span></span>
</td>
<td class="num">(2,102,272)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total</a></td>
<td class="nump">541,272<span></span>
</td>
<td class="nump">751,906<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment gross</a></td>
<td class="nump">951,192<span></span>
</td>
<td class="nump">2,055,192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment gross</a></td>
<td class="nump">167,351<span></span>
</td>
<td class="nump">191,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment gross</a></td>
<td class="nump">$ 619,024<span></span>
</td>
<td class="nump">$ 607,054<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136456400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF PROPERTY AND EQUIPMENT (Details) (Parenthetical)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077131706704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF OTHER ACCRUED LIABILITIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Amounts due to contract research organizations and other contractual agreements</a></td>
<td class="nump">$ 1,048,036<span></span>
</td>
<td class="nump">$ 1,442,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and related benefits</a></td>
<td class="nump">1,945,111<span></span>
</td>
<td class="nump">1,693,383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">20,600<span></span>
</td>
<td class="nump">234,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 3,033,747<span></span>
</td>
<td class="nump">$ 3,390,521<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077130890080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF DEBT (Details) - Horizon Technology Finance Corporation [Member]<br></strong></div></th>
<th class="th">
<div>Apr. 21, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Principal balance at April 21, 2023</a></td>
<td class="nump">$ 6,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_EarlyTerminationFee', window );">Early termination fees</a></td>
<td class="nump">120,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_EndOfTermCharges', window );">End of term charges</a></td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total payoff amount</a></td>
<td class="nump">$ 6,420,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_EarlyTerminationFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Early termination fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_EarlyTerminationFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_EndOfTermCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End of term charge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_EndOfTermCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=IMNN_HorizonTechnologyFinanceCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=IMNN_HorizonTechnologyFinanceCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136622880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE (Details Narrative) - Silicon Valley Bank [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 18, 2021</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from lines of credit</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Loan amount withdrawn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments of lines of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">$ 6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_FinalPaymentPercentage', window );">Final payment percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long term line of credit</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt instrument, description</a></td>
<td class="text">Payments under the loan agreement were interest only
for the first 24 months after loan closing, followed by a 24-month amortization period of principal and interest through the scheduled
maturity date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Financing fees and expenses</a></td>
<td class="nump">$ 243,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_EndOfTermChargePercentage', window );">End of term charge percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense debt</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 334,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">329,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnContractTermination', window );">Gain (loss) on contract termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 329,158<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_EndOfTermChargePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End of term charge percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_EndOfTermChargePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_FinalPaymentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Final Payment Percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_FinalPaymentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=IMNN_SiliconValleyBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=IMNN_SiliconValleyBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136267008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF INCOME TAX PROVISION (BENEFIT) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit', window );">State and Local</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,280,385)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (1,280,385)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077137393744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal tax benefit</a></td>
<td class="nump">8.40%<span></span>
</td>
<td class="nump">7.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_EffectiveIncomeTaxRateReconciliationPermanentDifferences', window );">Permanent differences</a></td>
<td class="num">(2.74%)<span></span>
</td>
<td class="num">(3.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_EffectiveIncomeTaxRateReconciliationTimeUp', window );">True-Up</a></td>
<td class="num">(0.07%)<span></span>
</td>
<td class="num">(105.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0.11%<span></span>
</td>
<td class="num">(2.90%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Rate Change</a></td>
<td class="nump">0.57%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate', window );">Deferred vs statutory rate</a></td>
<td class="num">(0.75%)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_EffectiveIncomeTaxRateReconciliationSaleAndExpiration', window );">Expiration of NOLs</a></td>
<td class="num">(17.51%)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance and deferred rate change, net</a></td>
<td class="num">(9.01%)<span></span>
</td>
<td class="nump">89.00%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation deferred statutory rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_EffectiveIncomeTaxRateReconciliationPermanentDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation permanent differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_EffectiveIncomeTaxRateReconciliationPermanentDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_EffectiveIncomeTaxRateReconciliationSaleAndExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation sale and expiration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_EffectiveIncomeTaxRateReconciliationSaleAndExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_EffectiveIncomeTaxRateReconciliationTimeUp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation time up.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_EffectiveIncomeTaxRateReconciliationTimeUp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077137532432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 66,141,490<span></span>
</td>
<td class="nump">$ 67,310,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_DeferredTaxAssetsLegalAct', window );">Section 174</a></td>
<td class="nump">6,482,099<span></span>
</td>
<td class="nump">4,929,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other deferred tax assets, net</a></td>
<td class="nump">2,010,744<span></span>
</td>
<td class="nump">2,016,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Subtotal</a></td>
<td class="nump">74,634,333<span></span>
</td>
<td class="nump">74,255,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(74,634,333)<span></span>
</td>
<td class="num">(72,974,615)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax asset</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,280,385<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_DeferredTaxAssetsLegalAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets legal act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_DeferredTaxAssetsLegalAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077134488512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 22, 2024</div></th>
<th class="th"><div>Nov. 28, 2023</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Payment of interest and penalties</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationDescription', window );">Income tax examination, description</a></td>
<td class="text">Expenses incurred in connection with R&E activities in the US must
be amortized over a 5-year period if incurred, and R&E expenses incurred outside the US must be amortized over a 15-year period.
R&E activities are broader in scope than qualified research activities considered under IRC Section 41 (relating to the research
tax credit). For the year ended December 31, 2024, the Company performed an analysis based on available guidance and determined that
it will continue to be in a loss position even after the required capitalization and amortization of its R&E expenses. The Company
will continue to monitor this issue for future developments, but it does not expect R&E capitalization and amortization to require
it to pay cash taxes now or in the near future. The Company&#8217;s income tax returns for 2020 to 2023 are still open and subject to
audit. In addition, net operating losses arising from prior years are also subject to examination at the time they are utilized in future
years.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating losses</a></td>
<td class="num">$ (19,132,446)<span></span>
</td>
<td class="num">(21,030,430)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 303,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_OperatingLossCarryforwardsExpirationDescription', window );">Operating loss carryforwards expiration description</a></td>
<td class="text">expire
starting in 2025 through 2037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=IMNN_FederalIncomeTaxMember', window );">Federal Income Tax [Member] | No Expiration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_OperatingLossCarryforwardsExpirationDescription', window );">Operating loss carryforwards expiration description</a></td>
<td class="text">expire starting in 2029 through 2043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NJ', window );">NEW JERSEY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_ProceedsFromSaleOfNetOperatingLosses', window );">Deferred income tax asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_NetProceedsFromSaleOfNetOperatingLosses', window );">Proceeds from sale</a></td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NJ', window );">NEW JERSEY | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NJ', window );">NEW JERSEY | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NJ', window );">NEW JERSEY | New Jersey Division of Taxation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NJ', window );">NEW JERSEY | State and Local Jurisdiction [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_NetProceedsFromSaleOfNetOperatingLosses', window );">Proceeds from sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NJ', window );">NEW JERSEY | State and Local Jurisdiction [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_NetProceedsFromSaleOfNetOperatingLosses', window );">Proceeds from sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_NetProceedsFromSaleOfNetOperatingLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net proceeds from sale of net operating losses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_NetProceedsFromSaleOfNetOperatingLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_OperatingLossCarryforwardsExpirationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating loss carryforwards expiration description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_OperatingLossCarryforwardsExpirationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_ProceedsFromSaleOfNetOperatingLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Net Operating Losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_ProceedsFromSaleOfNetOperatingLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=IMNN_FederalIncomeTaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=IMNN_FederalIncomeTaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=IMNN_NoExpirationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=IMNN_NoExpirationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NJ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NJ</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewJerseyDivisionOfTaxationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewJerseyDivisionOfTaxationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077135677856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 03, 2024</div></th>
<th class="th"><div>Jul. 30, 2024</div></th>
<th class="th"><div>May 15, 2024</div></th>
<th class="th"><div>Feb. 21, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock issued during period, value, new issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,060,438<span></span>
</td>
<td class="nump">$ 2,781,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,060,438<span></span>
</td>
<td class="nump">$ 2,781,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=IMNN_AtTheMarketOfferingAgreementMember', window );">At the Market Offering Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock issued during period, value, new issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,796<span></span>
</td>
<td class="nump">1,878,488<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,506<span></span>
</td>
<td class="nump">$ 2,750,658<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=IMNN_AtTheMarketOfferingAgreementMember', window );">At the Market Offering Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=IMNN_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | July 2024 Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=IMNN_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | July 2024 Offering [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=IMNN_AtTheMarketOfferingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=IMNN_AtTheMarketOfferingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=IMNN_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=IMNN_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=IMNN_JulyTwoThousandTwentyFourOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=IMNN_JulyTwoThousandTwentyFourOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077139089856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF STOCK OPTIONS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number Outstanding, Outstanding, Ending balance</a></td>
<td class="nump">1,645,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number Outstanding, Exercisable, Ending balance</a></td>
<td class="nump">907,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number Outstanding, Outstanding, Beginning balance</a></td>
<td class="nump">1,063,482<span></span>
</td>
<td class="nump">760,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding, Beginning balance</a></td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="nump">$ 4.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Number Outstanding, Options granted</a></td>
<td class="nump">1,051,835<span></span>
</td>
<td class="nump">432,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Options granted</a></td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="nump">$ 1.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Number Outstanding, Options canceled or expired</a></td>
<td class="num">(469,444)<span></span>
</td>
<td class="num">(129,238)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Options canceled or expired</a></td>
<td class="nump">$ 1.58<span></span>
</td>
<td class="nump">$ 9.37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number Outstanding, Outstanding, Ending balance</a></td>
<td class="nump">1,645,873<span></span>
</td>
<td class="nump">1,063,482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding, Ending balance</a></td>
<td class="nump">$ 1.95<span></span>
</td>
<td class="nump">$ 2.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (years), Outstanding, Ending balance</a></td>
<td class="text">8 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding, Ending balance</a></td>
<td class="nump">$ 13,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number Outstanding, Exercisable, Ending balance</a></td>
<td class="nump">907,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable, Ending balance</a></td>
<td class="nump">$ 2.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term (years), Exercisable, Ending balance</a></td>
<td class="text">8 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable, Ending balance</a></td>
<td class="nump">$ 7,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077131776336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number Outstanding, Non-vested stock awards, Outstanding, Beginning balance</a></td>
<td class="nump">32,100<span></span>
</td>
<td class="nump">69,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Beginning balance</a></td>
<td class="nump">$ 1.23<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number Outstanding, Non-vested stock awards, Granted</a></td>
<td class="nump">39,700<span></span>
</td>
<td class="nump">22,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Non-vested stock awards, Granted</a></td>
<td class="nump">$ 0.99<span></span>
</td>
<td class="nump">$ 0.92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number Outstanding, Non-vested stock awards, Vested and issued</a></td>
<td class="num">(12,100)<span></span>
</td>
<td class="num">(59,450)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Non-vested stock awards, Vested and issued</a></td>
<td class="nump">$ 1.84<span></span>
</td>
<td class="nump">$ 1.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number Outstanding, Non-vested stock awards, Forfeited</a></td>
<td class="num">(20,000)<span></span>
</td>
<td class="num">(200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Non-vested stock awards, Forfeited</a></td>
<td class="nump">$ 0.88<span></span>
</td>
<td class="nump">$ 4.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number Outstanding, Non-vested stock awards, Outstanding, Ending balance</a></td>
<td class="nump">39,700<span></span>
</td>
<td class="nump">32,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Ending balance</a></td>
<td class="nump">$ 0.99<span></span>
</td>
<td class="nump">$ 1.23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077135683792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF STOCK OPTIONS OUTSTANDING (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Number | shares</a></td>
<td class="nump">1,645,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options Exercisable, Number | shares</a></td>
<td class="nump">907,723<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=IMNN_ExercisePriceOneMember', window );">Exercise Price One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of Exercise Prices, Upper</a></td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Number | shares</a></td>
<td class="nump">1,250,252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">9 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 1.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options Exercisable, Number | shares</a></td>
<td class="nump">513,433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options Exercisable, Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">9 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 1.13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=IMNN_ExercisePriceTwoMember', window );">Exercise Price Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of Exercise Prices, Upper</a></td>
<td class="nump">$ 4.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Number | shares</a></td>
<td class="nump">207,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">7 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 1.93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options Exercisable, Number | shares</a></td>
<td class="nump">206,289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options Exercisable, Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">7 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 1.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of Exercise Prices, Lower</a></td>
<td class="nump">1.51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=IMNN_ExercisePriceThreeMember', window );">Exercise Price Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of Exercise Prices, Upper</a></td>
<td class="nump">$ 4.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Number | shares</a></td>
<td class="nump">188,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 7.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options Exercisable, Number | shares</a></td>
<td class="nump">188,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options Exercisable, Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 7.27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=IMNN_ExercisePriceOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=IMNN_ExercisePriceOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=IMNN_ExercisePriceTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=IMNN_ExercisePriceTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=IMNN_ExercisePriceThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=IMNN_ExercisePriceThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077235206912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">3.72%<span></span>
</td>
<td class="nump">3.39%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.81%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">101.70%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">115.80%<span></span>
</td>
<td class="nump">113.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">7 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077130731856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 14, 2023</div></th>
<th class="th"><div>Jun. 10, 2021</div></th>
<th class="th"><div>Jun. 15, 2020</div></th>
<th class="th"><div>May 14, 2019</div></th>
<th class="th"><div>May 15, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to non-vested stock-based compensation arrangements</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Cost recognized over a weighted-average period</a></td>
<td class="text">1 year 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=IMNN_EquityStockAwardsMember', window );">Equity Stock Awards [Member] | Granted Under 2018 Plan and 2007 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, reserved for future issuance</a></td>
<td class="nump">1,555,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=IMNN_InducementAwardsMember', window );">Inducement Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, reserved for future issuance</a></td>
<td class="nump">130,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember', window );">Stock Options and Restricted Stock Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember', window );">Stock Options and Restricted Stock Awards [Member] | Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember', window );">Stock Options and Restricted Stock Awards [Member] | General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=IMNN_TwoThousandAndEighteenStockIncentivePlanMember', window );">2018 Stock Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based payment award, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance</a></td>
<td class="nump">420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_StockOptionsStrikePriceDescription', window );">Stock options, strike price description</a></td>
<td class="text">Options are generally granted
with strike prices equal to the fair market value of a share of Imunon common stock on the date of grant. Incentive stock options may
be granted to purchase shares of common stock at a price not less than 100% of the fair market value of the underlying shares on the
date of grant, provided that the exercise price of any incentive stock option granted to an eligible employee owning more than 10% of
the outstanding stock of Imunon must be at least 110% of such fair market value on the date of grant. Only officers and key employees
may receive incentive stock options.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, reserved for future issuance</a></td>
<td class="nump">1,975,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=IMNN_TwoThousandAndEighteenStockIncentivePlanMember', window );">2018 Stock Incentive Plan [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,030,000<span></span>
</td>
<td class="nump">513,333<span></span>
</td>
<td class="nump">166,667<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=IMNN_TwoThousandAndEighteenStockIncentivePlanMember', window );">2018 Stock Incentive Plan [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,970,000<span></span>
</td>
<td class="nump">940,000<span></span>
</td>
<td class="nump">426,667<span></span>
</td>
<td class="nump">260,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=IMNN_InducementOptionGrantsMember', window );">Inducement Option Grants [Member] | Board of Directors Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price per share</a></td>
<td class="nump">$ 1.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=IMNN_InducementOptionGrantsMember', window );">Inducement Option Grants [Member] | Board of Directors Chairman [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares, Issued</a></td>
<td class="nump">110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_StockOptionsStrikePriceDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock options, strike price description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_StockOptionsStrikePriceDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=IMNN_EquityStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=IMNN_EquityStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=IMNN_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=IMNN_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=IMNN_InducementAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=IMNN_InducementAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=IMNN_TwoThousandAndEighteenStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=IMNN_TwoThousandAndEighteenStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=IMNN_InducementOptionGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=IMNN_InducementOptionGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077140440480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF WARRANT ACTIVITY (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_DisclosureWarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Warrants Issued, Warrants outstanding, Beginning balance</a></td>
<td class="nump">160,060<span></span>
</td>
<td class="nump">168,519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Warrants outstanding, Beginning balance</a></td>
<td class="nump">$ 18.86<span></span>
</td>
<td class="nump">$ 19.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Number of Warrants Issued, Warrants issued</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Warrants issued</a></td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations', window );">Number of Warrants Issued, Warrants expired</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="num">(8,459)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Warrants expired</a></td>
<td class="nump">$ 11.85<span></span>
</td>
<td class="nump">$ 37.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Warrants Issued, Warrants outstanding, Ending balance</a></td>
<td class="nump">5,155,060<span></span>
</td>
<td class="nump">160,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Warrants outstanding, Ending balance</a></td>
<td class="nump">$ 2.51<span></span>
</td>
<td class="nump">$ 18.86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of outstanding warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual terms (years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_DisclosureWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_DisclosureWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation arrangement by sharebased payment award non options outstanding intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for non-option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077140334528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>IMUNON EMPLOYEE BENEFIT PLANS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Maximum annual contributions per employee, percent</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount', window );">Matching contributions of employee</a></td>
<td class="nump">$ 62,000<span></span>
</td>
<td class="nump">$ 142,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077135798400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 543,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">362,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">370,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter', window );">2028 and thereafter</a></td>
<td class="nump">30,904<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Subtotal future lease payments</a></td>
<td class="nump">1,307,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(167,831)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 1,139,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease, weighted average remaining lease term</a></td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease, weighted average discount rate, percent</a></td>
<td class="nump">9.98%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee operating lease liability payments due year four and thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077134335424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">60 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_IMNN_OperatingLeasesIncrementalBorrowingRate', window );">Incremental borrowing rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.98%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease, cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 652,166<span></span>
</td>
<td class="nump">$ 646,633<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease, payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">659,646<span></span>
</td>
<td class="nump">644,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 478,000<span></span>
</td>
<td class="nump">$ 472,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=IMNN_LeaseAgreementMember', window );">Lease Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of land | ft&#178;</a></td>
<td class="nump">9,850<span></span>
</td>
<td class="nump">11,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=IMNN_LeaseAgreementMember', window );">Lease Agreement [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for rent</a></td>
<td class="nump">$ 22,983<span></span>
</td>
<td class="nump">$ 28,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=IMNN_LeaseAgreementMember', window );">Lease Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for rent</a></td>
<td class="nump">$ 23,394<span></span>
</td>
<td class="nump">$ 30,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_IMNN_OperatingLeasesIncrementalBorrowingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incremental borrowing rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">IMNN_OperatingLeasesIncrementalBorrowingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>IMNN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=IMNN_LeaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=IMNN_LeaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46077136346928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTION (Details Narrative)<br></strong></div></th>
<th class="th">
<div>Nov. 16, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=IMNN_ConvertibleNotePurchaseAgreementMember', window );">Convertible Note Purchase Agreement [Member] | Transomic Technologies, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible notes and warrants</a></td>
<td class="nump">$ 375,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=IMNN_ConvertibleNotePurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=IMNN_ConvertibleNotePurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=IMNN_TransomicTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=IMNN_TransomicTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>89
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M5Y_D%1B)E=Y[\3V^JA-*ALY)OEC,]Y&\'49F\J4'N-68RFG^?(J'RUWS7(X
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MT 7Z_>X&O?OV^\N%A9]R Q9YZ_9SXY:.N+V1^7O$R!Q13*/ \.N7#V>GPQ<
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M)'2;VAG \[52]OG&O1DZO E<_@-02P,$%     @ \T%;6IC5T,<! P  >@H
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MJY6_ST0ZMJ68T?111;K9:8$NUIM+8NQ'(XK.2BI^(?:2P=CRE,!:&4:(M\C
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M9?,1H(=IODE\H=4V@VXV9QN ="8A;!]5T^8W#Y+OZDYYQ27TW?5MRFC"*F4
M_V\XEZ<'-4#WL67^/U!+ P04    " #S05M:M^KI&[$"   S!P  &    'AL
M+W=O<FMS:&5E=',O<VAE970U+GAM;*U576_3,!3]*U9 "*1M^6RZE3;2VH%
M8FA:&3R[R6UCS;&+[;2#7\^UDV;M2"L>>$ELYYYSS[FQK\=;J1YU"6#(4\6%
MGGBE,>N1[^N\A(KJ"[D&@5^64E74X%2M?+U60 L'JK@?!4'J5Y0)+QN[M3N5
MC65M.!-PIXBNJXJJ7U/@<COQ0F^W<,]6I;$+?C9>TQ7,P3RL[Q3._(ZE8!4(
MS:0@"I83[SH<S5(;[P*^,]CJO3&Q3A92/MK)YV+B!580<,B-9:#XVL ,.+=$
M*.-GR^EU*2UP?[QC_^B\HY<%U3"3_ <K3#GQ+CU2P)+6W-S+[2=H_0PL7RZY
M=D^R;6)3#,YK;635@E%!Q43SID]M'?8 87H$$+6 Z"4@.0*(6T#LC#;*G*T;
M:F@V5G)+E(U&-CMPM7%H=,.$_8MSH_ K0YS)9E)HR5E!#11D;O"%O\AH(I=D
M)BO<&*7]8QL@7Z36Y)P\S&_(V]?OQK[!Y);"S]M$TR91="11&)%;*4RIR0=1
M0'%(X*/J3GJTDSZ-3C+>0'Y!XO",1$&4] B:_3L\/B$G[BH9.[[X6"5+*E:@
M"1.CONHTX*0?;,_J2*]I#A,/:ZY!;<#+WKP*T^!]G[/_1';@,^E\)J?8LWN@
MG/W&W4)%06JA=M,5M@S<-W@R-Y1QNN! L,D037&@(:\5,PST&1%@^NIS,FF_
M)=)7FH9GZ'AL"]MD<1('T=C?]'@>=)X')SU_Q7;*\0#T"6^0Z5["\_ RM7OR
M.6DCK2_R:A F5\-AO[RTDY>>E/=-&LI)?G!>C\E-_ZK/,;E]D5?)99 .!R_D
M^GO]IP*U<FU9HZ!:F.8\=ZM=Y[]V#>_%^A1OA*:!/],TU\DM52N[OS@LD3*X
M&&(Q5=.BFXF1:]?E%M)@SW3#$F\U4#8 OR^E-+N)3=#=D]D?4$L#!!0    (
M /-!6UI"<-6640<  /<>   8    >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL
MM5EM;]LX$OXKA.]P:(&Z%JGW7&(@2:^X K=%T-SN?F8DVN95$KTD[33[ZV](
M*9)M43RG\"% K)?A:)Z9X<Q#\OI9R.]JPYA&/^JJ43>SC=;;J\5"%1M64_51
M;%D#;U9"UE3#K5POU%8R6MI!=;4@09 L:LJ;V?+:/GN0RVNQTQ5OV(-$:E?7
M5+[<L4H\W\SP[/7!-[[>:/-@L;S>TC5[9/K7[8.$NT6OI>0U:Q07#9)L=3.[
MQ5?W860&6(G?.'M6!]?(0'D2XKNY^5+>S )C$:M8H8T*"C][=L^JRF@"._[H
ME,[Z;YJ!A]>OVC];\ #FB2IV+ZK?>:DW-[-LADJVHKM*?Q//_V0=H-CH*T2E
M['_TW,D&,U3LE!9U-Q@LJ'G3_M(?G2,.!N!D8@#I!I#3 ='$@+ ;$%J@K646
MUB>JZ?):BF<DC31H,Q?6-W8TH.&-">.CEO"6PSB]O!>-$A4OJ68E>M3P S'2
M"HD5NJ=J@SY#G!6:HU\?/Z%W?WU_O=#P43-T470?N&L_0"8^@ GZ131ZH] _
MFI*5QPH68&UO,GDU^8YX-7YBQ4<4X@^(!"1R&'1__O#08T[8>S"T^L(I#QHW
MK:R;5E+4"&:8I)HWZS9%N>9,7;G\UJJ-W&K-]+U26UJPFQG,3\7DGLV6?_L+
M3H*_NS!?2-F1!Z+> Y%/^_(K5)M**.4"V8Y,[4A34O;+.<X2$SERO=@?(G!)
MYC&.\C3M)8_,BWOS8F^ ;LO_P#QJTUH+J#V%: I>,=1T=INGYKHPD=PIF B\
M.3^,\27#>"%E1WY*>C\EWC!^8J"TX-245Q?0=G1R$" 2!3B-3^+H$LMP'+F#
MF/;&I5[C;FLA-?_3&F>*DS3E>2Y6<X@7HDHQ[4R_=&1,E*9YA$]L=HGA+,9N
MF[/>YLQK\S=&*_XGI!-M2K1KY.OMNS6T5_7>/C;YQ]0'DW\?$$#CS9ZUR8H4
M*W;2YIT+638R>9[@/ M/D(W%PB@,B!M8W@/+O< >M2B^STWW+%$A:J 4:C)K
M<E<$2)R<V#D62^,\P*';4!P,[2TX(P9]VD"#9U+:&0Z&,Z3ICS9[G(TM&!F%
M21:$V6G*.P1)EB311/[@@^:,O=;_RU0GL)S],)5HQ]7&9H8%\N2VV:O074&0
MJQ)UBHXRA^0XSB8PD0$3\6+Z'7*:P<Q=&1B-T,Q49,;W] E*\KM_2PJ$I.:%
MFVIX5;\%'1FC2^,@"";0#60 >SOMJ$[U";?B#6T*AHH-E6NF[.0W040E5X78
M050A#X4IOR#\S/6F]<V6OAC'.)WQ$SW?[8QPY(PXQF2B2."!%N#(VW@-+P"X
MC8'+&V?SQ%YF\=;N>2EMQW@'GH&][7EY6Q1R9VN+9J!?'R;V6TJ[_S-O"6P\
M"FR2X3"9".Q %+"?*=R6>Y/+T+9*MA6*:[@R^2STADE8M4#"M_D\T97QF"-$
M09;%^6E='<O-<82ASTT@&-@$_A]THK!S3KW.+VL^[>)7<?K$J^GPC-G"/ SB
M-$Q.:85+$N<Y@;\)  .UP'YN\?4<ONJTWD$<,/@>>'9P:KY+- \(P=%4%Q@8
M!,[?M&IJ)\<9=!M[J<F;*\:%M!TO9 =V0OSLY&$GH4 " 32MXNSZ0,9T8QZG
M.(U.XN>2PV$<X2R8* %D8";$STP>I"@8*[OH*=I-H9IJ8_C+V_",J48.3",Z
MR+(.T%B0F*8]V;?)P$J(GY4<16(KS6P"% 82^V/'MP:%T_0QCYB3/!XM,%QR
M40R+IXE"0 ;"0?R$HR\$8/2>EU ,GEZ<L\EI_KCSYQG)TO!T&>$0Q#@(DBB,
M)P ,+('X6<)I)6B)TAF5@%R4.UQ*V[$7!NY _-S!,9\@$6&-4@-S4&:]91-1
MO]BEHIU>2NU:1BF4N\V2<?O/@R2(PM&\&@N2-,.'@L>P!J9 _$SA@;YT3!^H
M 7K\[0X6O+0YZK:L*<TZ'B@3Q)Y-Y*GW*V]@1,3!*)*(>"K(0"F(GU+T$_%=
MUY+?'TU)5UH[H8XYPT307#0D@<5I,D'<R4 NR!GDPA)WPRP,J \M-).">\A-
MPYQ,# W+E;PP2Q;SWHG'M0-!@E&!='$-G,012:<JS, UB'^[XOYL (AJ],36
MO&E,H"!K7QB53E3C_8HX,[X_W==P"$*CSDDVM3D0#N0A]),'6S@-B!$R9KCX
MM/'AF!?$64K2)#TQWBEXC/+8]H$^A-A;]!]WVVUECQIH95? E5 [V=:\UWX
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M5[I&[337712$,=#G6\[586$NZ/MR\AM02P,$%     @ \T%;6H6CLNA@ @
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M)N%K-:FSWC*8<E.,&P+_H5)NA#<8^A^5PI  %MBJB1]9QRZ1(J_V^VI'EK!
MW#\IT*N#:$5 Y;@PVQXFV1ST$J".]-IH:X3R%4%6W.Z1:)[C56!;6ET7+A@"
MQB-[$JE=\I(\:JO'P%G*=1VX0C&S>UL(3<C4ED#/[WD=KCOV\Z"M%X-W%8PO
MX="UK-P 6F^][<QUT6N+N.!=5=P+Z,V@$%*;_;W*/(=D;ZOR_(V+7 YR8:^K
M6-F*DNOJ3M?T-E?B<741;(=7]^E+*K&\4B2#!*?V=X\0D:RNJ%5#B\)>"^="
MXR73OJ9XK0=I!N#W1 B];A@'S1\%HW\!4$L#!!0    ( /-!6UJ=GU*JF14
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M2\HL),U@5I3G1E1&>6T!\8*4C=& %W.S!#)D3+6@^(=2@VVV.'C*Y<;1E@E
M=K:#3_SE95+5,A'+,*P9774B3Z+]SE0S]:N1AZ0MP@W+P7(,*S2+ZE\:UMAO
M5%B,;13\ H"X=>!LM$Z.0W&'"A$>:5TB@(:JB1&0;1$R2D\+069_'IMGQ2>#
M[$CRO@2.4T?)6Y/372%_4L%,D?=#5#/1\S;:Z(TSE";> MDV'%TI1TCLUM&\
M=B8&B52T.H"<")*B<'08MQ5J02(9M#)I&[9#Q)QF+=%0?(5M@F>*[0($ZB8%
M;XPW7J;65L]MEF&S*(*!DIF7C.D>F2.[D'!C6MB5X:+NBDB.RLA)?@[@$\%1
MG^*CF"7%;S\(!D6R)A VU%6H'?+H 0ODNL&O.I?):890BCIB,-!UV6%TRN-C
M=A)C2D4//>QE4LA1Q^2]R6\\@_<[^J?MU)EVJX(S(3ZHM]#=K:Z9]?2FI#<F
M>Q.#'[_@I,]!A5SR%I2+Y-9P^Q6C6 F_L*3>PB$IX% )1U;#DN\-X27N35"0
M0=$'H7&=&,R/(56Q&-I*L@)Q6R+;]!*)WIU?G!%(!?J$F<_4.VW[XA==#ZS9
M4:L7C&.%.!)@B4*/0= MC77;AFZSP5S6?&5]$"VVYX(B!B_L%E:8J0^Z!09D
MSYLCJ4,)P; YU,?],A/R.XJ$G41,@M 9M)'8=RJ&]1#1SEIO./3GY(_4PFA-
M3$)N!6%/$82:@JOKX!)DB!D),W6=QFUI6C(<(3SR#Q]D%$VXRC:-2WRFK2ZR
M)7*#+H&!';S"2,V;[V0IT\PITY9D0"FW4PO4PH,J0\1!?L1WIAFI+S**;[6M
M:= 4\6OJ(+UME%KPJEE':D1>9ZA%R6/9.&-Z/KT^2^CSZ' ?%5VVV12)!S1S
MU(6N8/;7(_E7/>5^ORGB:RDPMQZ;])@DS2&8Y5RB5F%_(<J'!@B#7E14SI96
M"&2#:,B5_@AP\CQ_C>24  DY%%O#J#CD>BK>:M@YUQ(2X&0;B:L3!:=;DH1"
M\")G=A1\0@X^/-Z?[._OX^\)_\T5C2!%C5TB@9E5V\Q2/J>,:'O^2CB#BBQ%
MJWN.%=0 6DH)7MH>(H!L&&M;%$*EN.MNYZ/F$P%*8H*; !13YF+&5,C!-!"$
MX@#K.!E#3%S/,$WT08K'^TN;KZ4QE>2_Q<#NU&(1A"_D*!IA@N<N@#-<D4A,
M>U%>*;U@Q!C549@O8JG\D"0N%1-A@NHST?62.JAC8(6N0"JBY]W*EJMBMXA&
MLB;$+'0V2=P1YWDT"9['5A/[8P_9I<+8U%Q>40Z"6R(%G4II[-C889^=H\5A
MGF>Q.W$EG1()<!\9[)X-/?7>U*GD]^N!H#^MT1N6#(I\"@*"A;^@FDR)"L)R
M& VGR"%*"K^?OM/-^L4Y;P7@-"P R22_!Y1.:(6E%O.@DUH7>3@@@DG1Z[L$
MZZASF-HL@4P)W_?))(M/0SW/#<FSQE)4())+9G5%J=?62R]HED2P%8^+&"=B
MB02?Z9=B,H%:"HX0Q(9?,[R'/XV\;M?"8R43O9=D^/O [3S>9/# 6'\D[!@Y
M+K!A,A*RIN :V##E^%$\$ICFXH?G8Z9B=T#5N7/61-B@?N!\Y 1QT5-_@1;\
M#7Z%2,8&!"&V(<F58DM@:FY(T=(,JV:C,<8/180^R#CU&+A"/J($%":0)&2?
M]$AL)M@GGVH,W.Q(12[/H1*L[MJEI%E)QS,6?V]6= !W:ZA#T35&??\>!=D/
MJ*O.BD-*.EN#5!CT"1+20&+!N<8>YM:+O+E)YB)&% RDDO3)4KIO9YD-TSHY
M#/@/S*[8979C-J1%X(8)NY=!8.0O?6!#W6>#SQAE0NB 4K$5'(F16S) 9J7(
MG$G<\R'),4=NP9L\2\[4I?$%Z87P/]".%C %U0#B D9TY1?NS94B=EL/M 3E
MASI.*F6LX[EWH6_+P^:$]F^ET$Y38E>8\FTLS._X )3X"%W)=N#"E_R1EG52
M)-$^A6.:NL%3\J2E)VH.R^7:M509E9-8YQAJ\<?RYG-(-:4?UU2R9HY,J1<K
MO:ZO[$!5! PFL*?C6564R0,><KFXG& RG-@$D),)*7&XF1[E- GV1JJ3*I,K
M<V^GO"&4A\JAZXLH2FH=$YD/F@8LDK%YYCO8S#?D&V1![37VDF'=D1!,7UJ)
M87=TWA3!NV& 6.@[QIJD_&>3$T"H9T='ZF!R^/3IY-GQ87#MXK/^RCT]_N+Y
M"S?!RIAVR30 .P*N$^"0%\(;U1A$0&CQ)HR"3.31A([33<_@0G]]M(H.F2:
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M85JBM1RXB%G$5 >&T$!KD;$\K,)A?5.E"Y$L*6ZDTRJPXYWVUZP%Z;OJP7F
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MS@B.:FPWF1"QYU,3F9MDVB'IJ+)O*9TK"B. 68?8/Z5:?SI3K&R_"@5BI(^
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M2Z58R%1:2?9RW]W4&?H;&]BUL/2#P(YV!VMAW-;[[, J\J!4A(FB+?E=D+U
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M"[2_2/J-586[O%%[T570+==T]T;-!O1^J4@<U883U+?YT=]02P,$%     @
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M/> -2LE 1.-GBQD>0K+CR^<G]/=>.VE9"XLW6OXH,K<=A\,0,LQ%+=U7O?N
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MKY@C5B42P.G;R58MNBRMK)D!5CS3YUBA50](>ERG@J+,*3=XNL'L&S@:@/O
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M8F-O#?[AN%,OOL%$LA+BMYG,UB/'-X*PQ$P;!D;# UYB61HBDO'O@=,YNC3
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MJ_/WOUV\GBY^Q-YJBQ?\Z:KO61R+^>('T5]/^C8O"C)Q;*8S) S:<T/.$ Q
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MUB7_N#4:6)8>P/UU#<_A?J$%PA_;>?EO4$L#!!0    ( /-!6UJNN "R1 0
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MWU*NJJO5GET[A>! BCV%61'C]8=1M=&XFG5:J@Y5,=JM94DYJ4HHK(,7-ZT
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M[P>7 :28L96P#VI]@[6?,\>7*&'\/ZRKW/@B@&1EK"IJ,"DHN*R>[*4^ASW
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M68R\@0<9SEE5F*E<?\,FGL3RI;+0[A_6M6U,QFFEC2P;,"DHN:B_[+DYARW
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MDX:ZKALNZ)E#90UH?RZEV4RL@_;A'/\!4$L#!!0    ( /-!6UH!,7N'&@,
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MNA$@@:G6P)?HDC#,"H(INM-&T+\8)=&WV:-40M?\7T,9;@5$PP),'SB3:US
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M(<NR6[XW#QK=B_38?=2]"%=\,0_8?03BE>][T<]KM@A?+QNP\7;@83Z=\>1
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M%O*ZL]<3R3:F.2Z85*W6#-?J,D2N$]3ZDC%YG.@-FNMU\ -02P,$%     @
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M"&U:S9D;,PQ1V@"SOQ)"OSJVWYKQ&O\#4$L#!!0    ( /-!6UK:U/Q[U0,
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M&SR_!^43R9+L*G''I+J89,.UNCL"UP;J^9(Q^3C1MY/R-CK^!U!+ P04
M" #S05M:QWWR.G0#  !0$P  &0   'AL+W=O<FMS:&5E=',O<VAE970T.2YX
M;6RU6&M/VS 4_2M6)DU#FDCM/GBLK31H$4C ,AB;)K0/)KDE%DX<;(>"M!\_
M.RU)-X&3=N1+:R>^YQY?G_@D'LZ%O%,Q@$:/"4_5R(NUSO9]7X4Q)%1MBPQ2
M<V<F9$*UZ<I;7V42:%0$)=PGG<[ 3RA+O?&PN!;(\5#DFK,4 HE4GB14/AT
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MB;IS@>L M1\S)E\GNJTWMWCP%U!+ P04    " #S05M:(+*A3$ "   :!0
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MP]P^7JA<@EW/B,Q[X"Y4_1PF_P!02P,$%     @ \T%;6M"/G5T.!0  F18
M !D   !X;"]W;W)K<VAE971S+W-H965T-3(N>&ULM9C;;N,V$(;O]RD(MR@2
M(&N=?$KJ&$CBI$VQV09)=XMBL1>T-+:(2**7I.*X3]\AI<AV+-,QH.8BUH'S
MC_B1',YPN.#B2<8 BKRD22;/6[%2\S/'D6$,*95M/H<,WTRY2*G"6S%SY%P
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M,5!,470#?#_E7+W>: ?5:?3H/U!+ P04    " #S05M:2S?HG]0"  #S"0
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M:V_B.!3]*U96LV*E6?+BV85(- 0-4ELJ2F=76NT'D]Q -(G-V.8Q_W[MA*:
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M;"]W;W)K<VAE971S+W-H965T-34N>&ULK59=;]HP%/TK5C9-K=0VGR2A@TA
MJ(K4M16AW:1I#R9<(*H3,]M ^^]G)VE$P: ^C =B)_><>XYCWYO.EK(7O@00
MZ#4G!>\:2R%6UZ;)TR7DF%_1%13RR9RR' LY90N3KQC@60G*B>E8EF_F."N,
MJ%/>>V11AZX%R0IX9(BO\QRSMSX0NNT:MO%^8YPMED+=,*/."B\@ ?&T>F1R
M9C8LLRR'@F>T0 SF7:-G7P]"%5\&/&>PY3MCI)Q,*7U1D]&L:UA*$!!(A6+
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M%0XB3(L!XOL%(?QIIDC0O#0R^P]02P,$%     @ \T%;6OZ(%Y*>!   AA4
M !D   !X;"]W;W)K<VAE971S+W-H965T-3@N>&ULQ5AM;^(X$/XK5FYU:J4M
MQ,X+H0=(0+NZZJY;5-I=G5;WP213B#8OG&U*^^_7<2 )2<@"[>KZH>1EYO$\
M,Q[[B7OKF'WG"P"!7L(@XGUM(<3RLMWF[@)"REOQ$B+YYBEF(17RELW;?,F
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M8>_:$+NS =CE&%<Y9J#:>"4_D@T8DPUS@5,D@&4<7?P&S'A[.]<=QD,:VKH
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MH&+3]T)ONW!/5KFV"W[<*_ *%J ?BKDT,[]A20D#KHC@2$+6]P;AU>C"QKN
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M%INBM6-Y[*5=?3/]LIHU?%Z,?#\*NC7KN9GO1([?K5DFV^C8%*W2SSXYC,B
MK<M3H (MZ"[GU;^>FZ?-2=.L/%_I/)^[EU>NXCF6)U/EX<<17QUKW1*V3O("
MI; 2GW(NAF*1L^JDJ+KA=%L>A3Q0SFE67FZ +(%) _%^12D_W,@/-.=UTW\!
M4$L#!!0    ( /-!6UIV/I[E8@(  #T%   9    >&PO=V]R:W-H965T<R]S
M:&5E=#8W+GAM;+5476O;,!3]*Q=OC Y*[#AI.SK'X"8="[1I2-*-4?:@.#>V
MJ#X\28D[V(^?)+LF'<W8RUXL7>F>HW-T?9744CWJ$M' $V="CX+2F.HR#'5>
M(B>Z)RL4=F<K%2?&AJH(=:60;#R(LS".HO.0$RJ"-/%K<Y4F<F<8%3A7H'><
M$_7S"IFL1T$_>%Y8T*(T;B%,DXH4N$1S7\V5C<*.94,Y"DVE (7;49#U+Z^&
M+M\G?*%8ZX,Y."=K*1]=,-V,@L@)0H:Y<0S$#GL<(V..R,KXT7(&W9$.>#A_
M9O_DO5LO:Z)Q+-E7NC'E*/@0P :W9,?,0M:?L?5SYOARR;3_0MWF1@'D.VTD
M;\%6 :>B&<E3>P\'@#@^ HA;0.QU-P=YE1-B2)HH68-RV9;-3;Q5C[;BJ'!%
M61IE=ZG%F71Q?9.MKB<PSQ:K;[!:9+-E-EY-[V9P,D%#*-,P(TH1=W?OD]#8
M(QTPS%OZJX8^/D(_D_L>],]/(8[B&.Z7$SAY^P=-:!5WLN-.=NQYAT=XQU+L
M41FZ9@@S:1#F.Y67MCJ0%0K1_C4&'FZ1KU%]AU^P4D1HR6D.*\Q+(9DL*.I3
MF(J\U^6]YNZO*ES#7.J*Y#@*;$=H5'L,TG=O^N?1Q[]X''0>!YY]<-0C8V0M
MF[N'S!9!%(TS(C8OXCM3H@)3$@$O00\WEA.F!KE^U=[@/]@;=O:&_UQ"84NH
MO:W:_6S"Z-?4-GP7GL\]-OMT<'$615$2[@]UA ?=X!Z66Z(**C0PW%I@U+LX
M"T US=H$1E:^0=;2V';ST]*^;ZA<@MW?2BNO#5S/=2]F^AM02P,$%     @
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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M.&^ZF(5<ZF70BR6-YWW3Q2SD4EOHV.A/U0UF"ON+IP$/,3$+N=0[^]B^$KN
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M^=])]7B^MUP??UE^G9RP<\$YW5;4Y[]02P,$%     @ \T%;6N(A,D+Q 0
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M;%!+ 0(4 Q0    ( /-!6UJ@*N[Y[P   "L"   1              "  :\
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M2P$"% ,4    " #S05M:F-70QP$#  !Z"@  &               @(&P&
M>&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ \T%;6DIE6%=U
M!   >!$  !@              ("!YQL  'AL+W=O<FMS:&5E=',O<VAE970T
M+GAM;%!+ 0(4 Q0    ( /-!6UJWZND;L0(  #,'   8              "
M@9(@  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " #S05M:
M0G#5EE$'  #W'@  &               @(%Y(P  >&PO=V]R:W-H965T<R]S
M:&5E=#8N>&UL4$L! A0#%     @ \T%;6DEC7XAH!@  6RH  !@
M     ("! "L  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    (
M /-!6UIZK) 12P(  *,%   8              " @9XQ  !X;"]W;W)K<VAE
M971S+W-H965T."YX;6Q02P$"% ,4    " #S05M:A:.RZ& "  #)!P  &
M            @($?-   >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#
M%     @ \T%;6CBYKV]I!   -!   !D              ("!M38  'AL+W=O
M<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " #S05M:G9]2JID5  "4
M/   &0              @(%5.P  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM
M;%!+ 0(4 Q0    ( /-!6UJ(EFI#,0P   T@   9              " @251
M  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ \T%;6D!1
MMIU2!   N@@  !D              ("!C5T  'AL+W=O<FMS:&5E=',O<VAE
M970Q,RYX;6Q02P$"% ,4    " #S05M:'/O?,ZT&   8$   &0
M    @($68@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    (
M /-!6UJBV&&F*04  -D+   9              " @?IH  !X;"]W;W)K<VAE
M971S+W-H965T,34N>&UL4$L! A0#%     @ \T%;6EI8"40( P  ?08  !D
M             ("!6FX  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"
M% ,4    " #S05M:(Z/T[?,"  !;!@  &0              @(&9<0  >&PO
M=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( /-!6UJ:'PCQ)00
M .<(   9              " @<-T  !X;"]W;W)K<VAE971S+W-H965T,3@N
M>&UL4$L! A0#%     @ \T%;6C%TKS!]"@  DAD  !D              ("!
M'WD  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " #S05M:
M)YV%<O<$  #%"P  &0              @('3@P  >&PO=V]R:W-H965T<R]S
M:&5E=#(P+GAM;%!+ 0(4 Q0    ( /-!6UH%130A@ D  -<7   9
M      " @0&)  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%
M  @ \T%;6AB@/E*_!0  _0T  !D              ("!N)(  'AL+W=O<FMS
M:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " #S05M:QXOG5-<"   R!@
M&0              @(&NF   >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+
M 0(4 Q0    ( /-!6UJVE>PCX ,  !D(   9              " @;R;  !X
M;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ \T%;6D\V94A4
M @  ,P4  !D              ("!TY\  'AL+W=O<FMS:&5E=',O<VAE970R
M-2YX;6Q02P$"% ,4    " #S05M:SX)U=XP"  "2!0  &0
M@(%>H@  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( /-!
M6UI@# *">@(  '$%   9              " @2&E  !X;"]W;W)K<VAE971S
M+W-H965T,C<N>&UL4$L! A0#%     @ \T%;6O/7<RPB%P  >$<  !D
M         ("!TJ<  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4
M    " #S05M:KK@ LD0$  !_"   &0              @($KOP  >&PO=V]R
M:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( /-!6UIKWTK86P4   D.
M   9              " @:;#  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL
M4$L! A0#%     @ \T%;6MHNZYTO P  ' <  !D              ("!.,D
M 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " #S05M:2)3&
M1@T#  !X!@  &0              @(&>S   >&PO=V]R:W-H965T<R]S:&5E
M=#,R+GAM;%!+ 0(4 Q0    ( /-!6UK"KZBO]@(  %,&   9
M  " @>+/  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @
M\T%;6F&1TN?7 @  -P8  !D              ("!#],  'AL+W=O<FMS:&5E
M=',O<VAE970S-"YX;6Q02P$"% ,4    " #S05M:0UZH$XX$   ""P  &0
M            @($=U@  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4
M Q0    ( /-!6UI946T;BP8  %\1   9              " @>+:  !X;"]W
M;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ \T%;6B..?MX; P
M1 <  !D              ("!I.$  'AL+W=O<FMS:&5E=',O<VAE970S-RYX
M;6Q02P$"% ,4    " #S05M: 3%[AQH#  "5!@  &0              @('V
MY   >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( /-!6UHU
MT!P5NP4  ,(K   9              " @4?H  !X;"]W;W)K<VAE971S+W-H
M965T,SDN>&UL4$L! A0#%     @ \T%;6I"AFO\@ P  (0@  !D
M     ("!.>X  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4
M" #S05M:YQ!5-K$'  !*.@  &0              @(&0\0  >&PO=V]R:W-H
M965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( /-!6UHX^]4+00(  +L$   9
M              " @7CY  !X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L!
M A0#%     @ \T%;6B2X, IL P  APX  !D              ("!\/L  'AL
M+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " #S05M:\MA5D: "
M  ".!@  &0              @(&3_P  >&PO=V]R:W-H965T<R]S:&5E=#0T
M+GAM;%!+ 0(4 Q0    ( /-!6UJX(>XQ$@,  &H'   9              "
M@6H" 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ \T%;
M6B/EI05A @  :@4  !D              ("!LP4! 'AL+W=O<FMS:&5E=',O
M<VAE970T-BYX;6Q02P$"% ,4    " #S05M:VM3\>]4#  #C%@  &0
M        @(%+" $ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0
M   ( /-!6UK ^= 2A@,  )D.   9              " @5<, 0!X;"]W;W)K
M<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ \T%;6L=]\CIT P  4!,
M !D              ("!%! ! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q0
M2P$"% ,4    " #S05M:4GQ7#N<"  #1!P  &0              @(&_$P$
M>&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( /-!6UH@LJ%,
M0 (  !H%   9              " @=T6 0!X;"]W;W)K<VAE971S+W-H965T
M-3$N>&UL4$L! A0#%     @ \T%;6M"/G5T.!0  F18  !D
M ("!5!D! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    " #S
M05M:2S?HG]0"  #S"0  &0              @(&9'@$ >&PO=V]R:W-H965T
M<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( /-!6UHWA.3]P0,  -<,   9
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M970U."YX;6Q02P$"% ,4    " #S05M:/%%I8YX#  "5#0  &0
M    @('-/0$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    (
M /-!6UK!04"(G@0  ',8   9              " @:)! 0!X;"]W;W)K<VAE
M971S+W-H965T-C N>&UL4$L! A0#%     @ \T%;6CE/*H.> P  E0X  !D
M             ("!=T8! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"
M% ,4    " #S05M:IQ"ZR (*  !^8P  &0              @(%,2@$ >&PO
M=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( /-!6UHUZ><#G0,
M (D-   9              " @854 0!X;"]W;W)K<VAE971S+W-H965T-C,N
M>&UL4$L! A0#%     @ \T%;6DMC$JR? @  H@8  !D              ("!
M65@! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4    " #S05M:
M(("93"(#  !H"   &0              @($O6P$ >&PO=V]R:W-H965T<R]S
M:&5E=#8U+GAM;%!+ 0(4 Q0    ( /-!6UK2TR<_@@0  +L;   9
M      " @8A> 0!X;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%
M  @ \T%;6G8^GN5B @  /04  !D              ("!06,! 'AL+W=O<FMS
M:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    " #S05M:;@WKU38#  #($P
M#0              @ ':90$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( /-!
M6UJ7BKL<P    !,"   +              "  3MI 0!?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( /-!6UHK5(+4S04  $XL   /              "  21J 0!X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #S05M:R%S!4B "  #0)P  &@
M            @ $>< $ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " #S05M:XB$R0O$!   9)P  $P              @ %V<@$ 6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     2P!+ (04  "8= $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>150</ContextCount>
  <ElementCount>339</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>52</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/StatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/StatementsOfComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Consolidated Statements of Changes in Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/StatementsOfChangesInStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>999016 - Disclosure - FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/FinancialConditionAndGoingConcernUncertainty</Role>
      <ShortName>FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>999017 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/SegmentPerformanceMeasuresAndExpenses</Role>
      <ShortName>SEGMENT PERFORMANCE MEASURES AND EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>999018 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSale</Role>
      <ShortName>INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>999019 - Disclosure - FAIR VALUES OF FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/FairValuesOfFinancialInstruments</Role>
      <ShortName>FAIR VALUES OF FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>999020 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/PropertyAndEquipment</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>999021 - Disclosure - OTHER ACCRUED LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/OtherAccruedLiabilities</Role>
      <ShortName>OTHER ACCRUED LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>999022 - Disclosure - NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://imunon.com/role/NotesPayable</Role>
      <ShortName>NOTES PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>999023 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>999024 - Disclosure - STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/StockholdersEquity</Role>
      <ShortName>STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>999025 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/Stock-basedCompensation</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>999026 - Disclosure - WARRANTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/Warrants</Role>
      <ShortName>WARRANTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>999027 - Disclosure - IMUNON EMPLOYEE BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/ImunonEmployeeBenefitPlans</Role>
      <ShortName>IMUNON EMPLOYEE BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>999028 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/Leases</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>999029 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>999030 - Disclosure - RELATED PARTY TRANSACTION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/RelatedPartyTransaction</Role>
      <ShortName>RELATED PARTY TRANSACTION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>999031 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>999032 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>999033 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesTables</Role>
      <ShortName>SEGMENT PERFORMANCE MEASURES AND EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imunon.com/role/SegmentPerformanceMeasuresAndExpenses</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>999034 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleTables</Role>
      <ShortName>INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSale</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>999035 - Disclosure - FAIR VALUES OF FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/FairValuesOfFinancialInstrumentsTables</Role>
      <ShortName>FAIR VALUES OF FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imunon.com/role/FairValuesOfFinancialInstruments</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>999036 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imunon.com/role/PropertyAndEquipment</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>999037 - Disclosure - OTHER ACCRUED LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/OtherAccruedLiabilitiesTables</Role>
      <ShortName>OTHER ACCRUED LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imunon.com/role/OtherAccruedLiabilities</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>999038 - Disclosure - NOTES PAYABLE (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://imunon.com/role/NotesPayableTables</Role>
      <ShortName>NOTES PAYABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imunon.com/role/NotesPayable</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>999039 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imunon.com/role/IncomeTaxes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>999040 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/Stock-basedCompensationTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imunon.com/role/Stock-basedCompensation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>999041 - Disclosure - WARRANTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/WarrantsTables</Role>
      <ShortName>WARRANTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imunon.com/role/Warrants</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>999042 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/LeasesTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imunon.com/role/Leases</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>999043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>999044 - Disclosure - FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/FinancialConditionAndGoingConcernUncertaintyDetailsNarrative</Role>
      <ShortName>FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://imunon.com/role/FinancialConditionAndGoingConcernUncertainty</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>999045 - Disclosure - SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails</Role>
      <ShortName>SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>999046 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesDetailsNarrative</Role>
      <ShortName>SEGMENT PERFORMANCE MEASURES AND EXPENSES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>999047 - Disclosure - SCHEDULE OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails</Role>
      <ShortName>SCHEDULE OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>999048 - Disclosure - SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/ScheduleOfInvestmentSecuritiesGrossUnrealizedGainsLossesDetails</Role>
      <ShortName>SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>999049 - Disclosure - SCHEDULE OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails</Role>
      <ShortName>SCHEDULE OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>999050 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleDetailsNarrative</Role>
      <ShortName>INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>999051 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails</Role>
      <ShortName>SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>999052 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>SCHEDULE OF PROPERTY AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>999053 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical</Role>
      <ShortName>SCHEDULE OF PROPERTY AND EQUIPMENT (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>999054 - Disclosure - SCHEDULE OF OTHER ACCRUED LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails</Role>
      <ShortName>SCHEDULE OF OTHER ACCRUED LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>999055 - Disclosure - SCHEDULE OF DEBT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/ScheduleOfDebtDetails</Role>
      <ShortName>SCHEDULE OF DEBT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>999056 - Disclosure - NOTES PAYABLE (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://imunon.com/role/NotesPayableDetailsNarrative</Role>
      <ShortName>NOTES PAYABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://imunon.com/role/NotesPayableTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>999057 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (BENEFIT) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails</Role>
      <ShortName>SCHEDULE OF INCOME TAX PROVISION (BENEFIT) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>999058 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>999059 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>999060 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://imunon.com/role/IncomeTaxesTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>999061 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/StockholdersEquityDetailsNarrative</Role>
      <ShortName>STOCKHOLDERS??? EQUITY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://imunon.com/role/StockholdersEquity</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>999062 - Disclosure - SUMMARY OF STOCK OPTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/SummaryOfStockOptionsDetails</Role>
      <ShortName>SUMMARY OF STOCK OPTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>999063 - Disclosure - SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails</Role>
      <ShortName>SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>999064 - Disclosure - SUMMARY OF STOCK OPTIONS OUTSTANDING (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails</Role>
      <ShortName>SUMMARY OF STOCK OPTIONS OUTSTANDING (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>999065 - Disclosure - SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails</Role>
      <ShortName>SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>999066 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/Stock-basedCompensationDetailsNarrative</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://imunon.com/role/Stock-basedCompensationTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>999067 - Disclosure - SUMMARY OF WARRANT ACTIVITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/SummaryOfWarrantActivityDetails</Role>
      <ShortName>SUMMARY OF WARRANT ACTIVITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>999068 - Disclosure - IMUNON EMPLOYEE BENEFIT PLANS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/ImunonEmployeeBenefitPlansDetailsNarrative</Role>
      <ShortName>IMUNON EMPLOYEE BENEFIT PLANS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://imunon.com/role/ImunonEmployeeBenefitPlans</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>999069 - Disclosure - SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>999070 - Disclosure - LEASES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/LeasesDetailsNarrative</Role>
      <ShortName>LEASES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://imunon.com/role/LeasesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>999071 - Disclosure - RELATED PARTY TRANSACTION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/RelatedPartyTransactionDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://imunon.com/role/RelatedPartyTransaction</ParentRole>
      <Position>67</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="form10-k.htm">form10-k.htm</File>
    <File>imnn-20241231.xsd</File>
    <File>imnn-20241231_cal.xml</File>
    <File>imnn-20241231_def.xml</File>
    <File>imnn-20241231_lab.xml</File>
    <File>imnn-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="613">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="14">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>96
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form10-k.htm": {
   "nsprefix": "IMNN",
   "nsuri": "http://imunon.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "form10-k.htm"
     ]
    },
    "schema": {
     "local": [
      "imnn-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "imnn-20241231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "imnn-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "imnn-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "imnn-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 293,
   "keyCustom": 46,
   "axisStandard": 23,
   "axisCustom": 0,
   "memberStandard": 26,
   "memberCustom": 26,
   "hidden": {
    "total": 96,
    "http://imunon.com/20241231": 13,
    "http://fasb.org/us-gaap/2024": 80,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 150,
   "entityCount": 1,
   "segmentCount": 52,
   "elementCount": 611,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 613,
    "http://xbrl.sec.gov/dei/2024": 40,
    "http://xbrl.sec.gov/cyd/2024": 14,
    "http://xbrl.sec.gov/ecd/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://imunon.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://imunon.com/role/BalanceSheets",
     "longName": "00000002 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://imunon.com/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://imunon.com/role/StatementsOfOperations",
     "longName": "00000004 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:InterestExpenseNonoperating",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://imunon.com/role/StatementsOfComprehensiveLoss",
     "longName": "00000005 - Statement - Consolidated Statements of Comprehensive Loss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://imunon.com/role/StatementsOfCashFlows",
     "longName": "00000006 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://imunon.com/role/StatementsOfChangesInStockholdersEquity",
     "longName": "00000007 - Statement - Consolidated Statements of Changes in Stockholders' Equity",
     "shortName": "Consolidated Statements of Changes in Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R9": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://imunon.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://imunon.com/role/FinancialConditionAndGoingConcernUncertainty",
     "longName": "999016 - Disclosure - FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY",
     "shortName": "FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://imunon.com/role/SegmentPerformanceMeasuresAndExpenses",
     "longName": "999017 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES",
     "shortName": "SEGMENT PERFORMANCE MEASURES AND EXPENSES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSale",
     "longName": "999018 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE",
     "shortName": "INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://imunon.com/role/FairValuesOfFinancialInstruments",
     "longName": "999019 - Disclosure - FAIR VALUES OF FINANCIAL INSTRUMENTS",
     "shortName": "FAIR VALUES OF FINANCIAL INSTRUMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://imunon.com/role/PropertyAndEquipment",
     "longName": "999020 - Disclosure - PROPERTY AND EQUIPMENT",
     "shortName": "PROPERTY AND EQUIPMENT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://imunon.com/role/OtherAccruedLiabilities",
     "longName": "999021 - Disclosure - OTHER ACCRUED LIABILITIES",
     "shortName": "OTHER ACCRUED LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://imunon.com/role/NotesPayable",
     "longName": "999022 - Disclosure - NOTES PAYABLE",
     "shortName": "NOTES PAYABLE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://imunon.com/role/IncomeTaxes",
     "longName": "999023 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://imunon.com/role/StockholdersEquity",
     "longName": "999024 - Disclosure - STOCKHOLDERS\u2019 EQUITY",
     "shortName": "STOCKHOLDERS\u2019 EQUITY",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://imunon.com/role/Stock-basedCompensation",
     "longName": "999025 - Disclosure - STOCK-BASED COMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://imunon.com/role/Warrants",
     "longName": "999026 - Disclosure - WARRANTS",
     "shortName": "WARRANTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "IMNN:WarrantsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "IMNN:WarrantsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://imunon.com/role/ImunonEmployeeBenefitPlans",
     "longName": "999027 - Disclosure - IMUNON EMPLOYEE BENEFIT PLANS",
     "shortName": "IMUNON EMPLOYEE BENEFIT PLANS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://imunon.com/role/Leases",
     "longName": "999028 - Disclosure - LEASES",
     "shortName": "LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://imunon.com/role/CommitmentsAndContingencies",
     "longName": "999029 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://imunon.com/role/RelatedPartyTransaction",
     "longName": "999030 - Disclosure - RELATED PARTY TRANSACTION",
     "shortName": "RELATED PARTY TRANSACTION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://imunon.com/role/SubsequentEvents",
     "longName": "999031 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "999032 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesTables",
     "longName": "999033 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES (Tables)",
     "shortName": "SEGMENT PERFORMANCE MEASURES AND EXPENSES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleTables",
     "longName": "999034 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Tables)",
     "shortName": "INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://imunon.com/role/FairValuesOfFinancialInstrumentsTables",
     "longName": "999035 - Disclosure - FAIR VALUES OF FINANCIAL INSTRUMENTS (Tables)",
     "shortName": "FAIR VALUES OF FINANCIAL INSTRUMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DerivativesAndFairValueTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DerivativesAndFairValueTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://imunon.com/role/PropertyAndEquipmentTables",
     "longName": "999036 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
     "shortName": "PROPERTY AND EQUIPMENT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://imunon.com/role/OtherAccruedLiabilitiesTables",
     "longName": "999037 - Disclosure - OTHER ACCRUED LIABILITIES (Tables)",
     "shortName": "OTHER ACCRUED LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://imunon.com/role/NotesPayableTables",
     "longName": "999038 - Disclosure - NOTES PAYABLE (Tables)",
     "shortName": "NOTES PAYABLE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://imunon.com/role/IncomeTaxesTables",
     "longName": "999039 - Disclosure - INCOME TAXES (Tables)",
     "shortName": "INCOME TAXES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://imunon.com/role/Stock-basedCompensationTables",
     "longName": "999040 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://imunon.com/role/WarrantsTables",
     "longName": "999041 - Disclosure - WARRANTS (Tables)",
     "shortName": "WARRANTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "IMNN:WarrantsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "IMNN:WarrantsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://imunon.com/role/LeasesTables",
     "longName": "999042 - Disclosure - LEASES (Tables)",
     "shortName": "LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "999043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:AccountsReceivableNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:AccountsReceivableNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://imunon.com/role/FinancialConditionAndGoingConcernUncertaintyDetailsNarrative",
     "longName": "999044 - Disclosure - FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY (Details Narrative)",
     "shortName": "FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails",
     "longName": "999045 - Disclosure - SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS (Details)",
     "shortName": "SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesDetailsNarrative",
     "longName": "999046 - Disclosure - SEGMENT PERFORMANCE MEASURES AND EXPENSES (Details Narrative)",
     "shortName": "SEGMENT PERFORMANCE MEASURES AND EXPENSES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "Segment",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "Segment",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails",
     "longName": "999047 - Disclosure - SCHEDULE OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS (Details)",
     "shortName": "SCHEDULE OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://imunon.com/role/ScheduleOfInvestmentSecuritiesGrossUnrealizedGainsLossesDetails",
     "longName": "999048 - Disclosure - SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES) (Details)",
     "shortName": "SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "IMNN:AvailableForSaleSecuritiesUnrealizedLossFairValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "IMNN:AvailableForSaleSecuritiesUnrealizedLossFairValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://imunon.com/role/ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails",
     "longName": "999049 - Disclosure - SCHEDULE OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS (Details)",
     "shortName": "SCHEDULE OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentIncomeTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentIncomeTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleDetailsNarrative",
     "longName": "999050 - Disclosure - INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Details Narrative)",
     "shortName": "INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R47": {
     "role": "http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
     "longName": "999051 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)",
     "shortName": "SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_USTreasurySecuritiesMember",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:DerivativesAndFairValueTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails",
     "longName": "999052 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)",
     "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical",
     "longName": "999053 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) (Parenthetical)",
     "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT (Details) (Parenthetical)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31_srt_MaximumMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails",
     "longName": "999054 - Disclosure - SCHEDULE OF OTHER ACCRUED LIABILITIES (Details)",
     "shortName": "SCHEDULE OF OTHER ACCRUED LIABILITIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:ContractualObligation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:ContractualObligation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://imunon.com/role/ScheduleOfDebtDetails",
     "longName": "999055 - Disclosure - SCHEDULE OF DEBT (Details)",
     "shortName": "SCHEDULE OF DEBT (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "AsOf2023-04-21_custom_HorizonTechnologyFinanceCorporationMember",
      "name": "us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-04-21_custom_HorizonTechnologyFinanceCorporationMember",
      "name": "us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://imunon.com/role/NotesPayableDetailsNarrative",
     "longName": "999056 - Disclosure - NOTES PAYABLE (Details Narrative)",
     "shortName": "NOTES PAYABLE (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "AsOf2021-06-18_custom_SiliconValleyBankMember",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-06-18_custom_SiliconValleyBankMember",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails",
     "longName": "999057 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (BENEFIT) (Details)",
     "shortName": "SCHEDULE OF INCOME TAX PROVISION (BENEFIT) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails",
     "longName": "999058 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)",
     "shortName": "SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails",
     "longName": "999059 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)",
     "shortName": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://imunon.com/role/IncomeTaxesDetailsNarrative",
     "longName": "999060 - Disclosure - INCOME TAXES (Details Narrative)",
     "shortName": "INCOME TAXES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://imunon.com/role/StockholdersEquityDetailsNarrative",
     "longName": "999061 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)",
     "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "From2024-05-152024-05-15",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-152024-05-15",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://imunon.com/role/SummaryOfStockOptionsDetails",
     "longName": "999062 - Disclosure - SUMMARY OF STOCK OPTIONS (Details)",
     "shortName": "SUMMARY OF STOCK OPTIONS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_us-gaap_EmployeeStockOptionMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails",
     "longName": "999063 - Disclosure - SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS (Details)",
     "shortName": "SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails",
     "longName": "999064 - Disclosure - SUMMARY OF STOCK OPTIONS OUTSTANDING (Details)",
     "shortName": "SUMMARY OF STOCK OPTIONS OUTSTANDING (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-012024-12-31_custom_ExercisePriceOneMember",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails",
     "longName": "999065 - Disclosure - SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED (Details)",
     "shortName": "SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://imunon.com/role/Stock-basedCompensationDetailsNarrative",
     "longName": "999066 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)",
     "shortName": "STOCK-BASED COMPENSATION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://imunon.com/role/SummaryOfWarrantActivityDetails",
     "longName": "999067 - Disclosure - SUMMARY OF WARRANT ACTIVITY (Details)",
     "shortName": "SUMMARY OF WARRANT ACTIVITY (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "IMNN:WarrantsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "IMNN:WarrantsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://imunon.com/role/ImunonEmployeeBenefitPlansDetailsNarrative",
     "longName": "999068 - Disclosure - IMUNON EMPLOYEE BENEFIT PLANS (Details Narrative)",
     "shortName": "IMUNON EMPLOYEE BENEFIT PLANS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails",
     "longName": "999069 - Disclosure - SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES (Details)",
     "shortName": "SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://imunon.com/role/LeasesDetailsNarrative",
     "longName": "999070 - Disclosure - LEASES (Details Narrative)",
     "shortName": "LEASES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "AsOf2023-08-31",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-08-31",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://imunon.com/role/RelatedPartyTransactionDetailsNarrative",
     "longName": "999071 - Disclosure - RELATED PARTY TRANSACTION (Details Narrative)",
     "shortName": "RELATED PARTY TRANSACTION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "AsOf2022-11-16_custom_ConvertibleNotePurchaseAgreementMember_custom_TransomicTechnologiesIncMember",
      "name": "us-gaap:ConvertibleNotesPayable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-11-16_custom_ConvertibleNotePurchaseAgreementMember_custom_TransomicTechnologiesIncMember",
      "name": "us-gaap:ConvertibleNotesPayable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://imunon.com/role/OtherAccruedLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER ACCRUED LIABILITIES",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r49",
      "r53",
      "r1018"
     ]
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableTradeCurrent",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable \u2013 trade",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r46"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r672",
      "r726",
      "r803",
      "r1058",
      "r1059"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets",
      "http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other accrued liabilities",
        "totalLabel": "Total",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued professional fees",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less accumulated depreciation and amortization",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r136",
      "r605"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityBeforeTreasuryStock",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive income",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r17",
      "r63",
      "r139",
      "r601",
      "r635",
      "r636"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r9",
      "r17",
      "r472",
      "r475",
      "r521",
      "r631",
      "r632",
      "r941",
      "r942",
      "r943",
      "r954",
      "r955",
      "r956",
      "r958"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityBeforeTreasuryStock",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r787",
      "r1092"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r649",
      "r954",
      "r955",
      "r956",
      "r958",
      "r1029",
      "r1093"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation expense",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r43",
      "r378"
     ]
    },
    "IMNN_AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advances and Deposits on Clinical Programs and Other Current Assets",
        "documentation": "Advances And Deposits On Clinical Programs And Other Current Assets [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r839",
      "r850",
      "r864",
      "r890"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r842",
      "r853",
      "r867",
      "r893"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r878"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r885"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r843",
      "r854",
      "r868",
      "r885",
      "r894",
      "r898",
      "r906"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share based compensation",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r419"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Write-off of note receivable (Transomic)",
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance."
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of deferred finance charges and debt discount associated with note payable",
        "documentation": "Amortization of deferred finance charges and debt discount associated with notes payable."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of debt issuance costs",
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r763",
      "r764",
      "r947",
      "r1039"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "us-gaap_AreaOfLand": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AreaOfLand",
     "presentation": [
      "http://imunon.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Area of land",
        "documentation": "Area of land held."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://imunon.com/role/LeasesDetailsNarrative",
      "http://imunon.com/role/RelatedPartyTransactionDetailsNarrative",
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r116",
      "r138",
      "r166",
      "r193",
      "r200",
      "r226",
      "r230",
      "r274",
      "r317",
      "r318",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r467",
      "r469",
      "r498",
      "r597",
      "r677",
      "r752",
      "r753",
      "r787",
      "r810",
      "r988",
      "r989",
      "r1043"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r140",
      "r166",
      "r274",
      "r317",
      "r318",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r467",
      "r469",
      "r498",
      "r787",
      "r988",
      "r989",
      "r1043"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_AtTheMarketOfferingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "AtTheMarketOfferingAgreementMember",
     "presentation": [
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "At the Market Offering Agreement [Member]",
        "documentation": "At the Market Offering Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r822",
      "r824",
      "r846"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r822",
      "r824",
      "r846"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r822",
      "r824",
      "r846"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "IMNN_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term investment maturities - Cost",
        "documentation": "The current amount of amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term investment maturities - Fair value",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date."
       }
      }
     },
     "auth_ref": [
      "r972",
      "r973",
      "r1055"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets",
      "http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleDetailsNarrative",
      "http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails",
      "http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in debt securities - available for sale, at fair value",
        "verboseLabel": "Short-term investments - Fair Value",
        "terseLabel": "Debt securities, available for sale, current",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r283"
     ]
    },
    "IMNN_AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfInvestmentSecuritiesGrossUnrealizedGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in debt securities with unrealized gains - Unrealized Holding Gains (Losses)",
        "documentation": "Available for sale securities unrealized gain less than twelve months."
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_AvailableForSaleSecuritiesUnrealizedLossFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "AvailableForSaleSecuritiesUnrealizedLossFairValue",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfInvestmentSecuritiesGrossUnrealizedGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in debt securities with unrealized gains - Fair Value",
        "documentation": "Available for sale securities unrealized losses fair value."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r902"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative",
      "http://imunon.com/role/SummaryOfStockOptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r381",
      "r382",
      "r383",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]"
       }
      }
     },
     "auth_ref": [
      "r965"
     ]
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Business",
        "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r81"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r134",
      "r742"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/FinancialConditionAndGoingConcernUncertaintyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents, short-term investments",
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable."
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of year",
        "periodEndLabel": "Cash and cash equivalents end of year",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r77",
      "r162"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net change in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r77"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_ClinicalResearchMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "ClinicalResearchMember",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Clinical Research [Member]",
        "documentation": "Clinical Research [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://imunon.com/role/LeasesDetailsNarrative",
      "http://imunon.com/role/RelatedPartyTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r106",
      "r598",
      "r663"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://imunon.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r309",
      "r310",
      "r727",
      "r983",
      "r985"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, reserved for future issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity",
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r800",
      "r801",
      "r802",
      "r804",
      "r805",
      "r806",
      "r807",
      "r954",
      "r955",
      "r958",
      "r1029",
      "r1091",
      "r1093"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://imunon.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://imunon.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r664"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://imunon.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://imunon.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r57",
      "r664",
      "r683",
      "r1093",
      "r1094"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityBeforeTreasuryStock",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock - $0.01 par value (112,500,000 shares authorized; 14,500,707 and 9,399,811 shares issued at December 31, 2024 and 2023, respectively, and 14,500,685 and 9,399,789 shares outstanding at December 31, 2024 and 2023, respectively)",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r600",
      "r787"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "presentation": [
      "http://imunon.com/role/ImunonEmployeeBenefitPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IMUNON EMPLOYEE BENEFIT PLANS",
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91",
      "r92",
      "r93"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/StatementsOfComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r146",
      "r148",
      "r153",
      "r593",
      "r611",
      "r612"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "presentation": [
      "http://imunon.com/role/StatementsOfComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive loss"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss)",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]"
       }
      }
     },
     "auth_ref": [
      "r114",
      "r168",
      "r193",
      "r202",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r230",
      "r231",
      "r232",
      "r317",
      "r318",
      "r319",
      "r320",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r752",
      "r753",
      "r988",
      "r989"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "auth_ref": [
      "r114",
      "r168",
      "r193",
      "r202",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r230",
      "r231",
      "r232",
      "r317",
      "r318",
      "r319",
      "r320",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r752",
      "r753",
      "r988",
      "r989"
     ]
    },
    "us-gaap_ContractualObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractualObligation",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amounts due to contract research organizations and other contractual agreements",
        "documentation": "Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments."
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "IMNN_ConvertibleNotePurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "ConvertibleNotePurchaseAgreementMember",
     "presentation": [
      "http://imunon.com/role/RelatedPartyTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Note Purchase Agreement [Member]",
        "documentation": "Convertible Note Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleNotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/RelatedPartyTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible notes and warrants",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r105",
      "r1056"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r928",
      "r951",
      "r1028"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r928",
      "r951",
      "r1028"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r832",
      "r916"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r832",
      "r916"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r834",
      "r918"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r835",
      "r919"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r834",
      "r918"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r827",
      "r911"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r912"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r912"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r826",
      "r910"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r829",
      "r913"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r831",
      "r915"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r831",
      "r915"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r832",
      "r916"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r833",
      "r917"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r830",
      "r914"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://imunon.com/role/NotesPayable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NOTES PAYABLE",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r164",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r315",
      "r316",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r339",
      "r340",
      "r342",
      "r507"
     ]
    },
    "us-gaap_DebtInstrumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentDescription",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrument, description",
        "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r35",
      "r44",
      "r48",
      "r104",
      "r105",
      "r507"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleRealizedGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails": {
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Realized losses",
        "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "presentation": [
      "http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS",
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978"
     ]
    },
    "IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term investment maturities - Between 3-12 months, cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling three to twelve months."
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term investment maturities - Between 3-12 months, fair value",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling three to twelve months."
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term investment maturities - Within 3 months, cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) with single maturity date and allocated without single maturity date, maturing in next rolling three months."
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term investment maturities - Within 3 months, fair value",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling three months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r951",
      "r1027",
      "r1028"
     ]
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local",
        "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1019"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income tax asset",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r428"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Realization of deferred income tax asset",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r125",
      "r951"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r951",
      "r1027",
      "r1028"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Subtotal",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r444"
     ]
    },
    "IMNN_DeferredTaxAssetsLegalAct": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "DeferredTaxAssetsLegalAct",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Section 174",
        "documentation": "Deferred tax assets legal act."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax asset",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1025"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other deferred tax assets, net",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1025"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r445"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "presentation": [
      "http://imunon.com/role/ImunonEmployeeBenefitPlansDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum annual contributions per employee, percent",
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/ImunonEmployeeBenefitPlansDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Matching contributions of employee",
        "documentation": "Maximum amount the employee may contribute to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepositsAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposits and other assets",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r937"
     ]
    },
    "IMNN_DepositsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "DepositsPolicyTextBlock",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposits",
        "documentation": "Deposits [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r31"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation expense",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r31"
     ]
    },
    "us-gaap_DerivativesAndFairValueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativesAndFairValueTextBlock",
     "presentation": [
      "http://imunon.com/role/FairValuesOfFinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FAIR VALUES OF FINANCIAL INSTRUMENTS",
        "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102"
     ]
    },
    "us-gaap_DirectFinancingLeaseSellingLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DirectFinancingLeaseSellingLoss",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Direct financing lease, selling loss",
        "documentation": "Amount of loss recognized at commencement from direct financing lease."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r520"
     ]
    },
    "IMNN_DisclosureFairValuesOfFinancialInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "DisclosureFairValuesOfFinancialInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Values Of Financial Instruments"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_DisclosureLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "DisclosureLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "verboseLabel": "Schedule Of Lease Payments And Maturity Of Operating Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCK-BASED COMPENSATION",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r380",
      "r411",
      "r412",
      "r414",
      "r771"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_DisclosureWarrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "DisclosureWarrantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants",
        "verboseLabel": "Summary Of Warrant Activity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r822",
      "r824",
      "r846"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r822",
      "r824",
      "r846",
      "r886"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r811"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Jurisdiction [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "IMNN_EarlyTerminationFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "EarlyTerminationFee",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfDebtDetails": {
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Early termination fees",
        "documentation": "Early termination fee."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss per common share - Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r184",
      "r186",
      "r188",
      "r189",
      "r190",
      "r192",
      "r462",
      "r465",
      "r480",
      "r481",
      "r594",
      "r613",
      "r744"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss per common share - Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r186",
      "r188",
      "r189",
      "r190",
      "r192",
      "r462",
      "r465",
      "r480",
      "r481",
      "r594",
      "r613",
      "r744"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss per Share of Common Stock",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r191"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Effective tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r774"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal statutory rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r430",
      "r453",
      "r774"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation allowance and deferred rate change, net",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r774",
      "r952",
      "r1020"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "calculation": {
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rate Change",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r774",
      "r952",
      "r1020"
     ]
    },
    "IMNN_EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate",
     "calculation": {
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred vs statutory rate",
        "documentation": "Effective income tax rate reconciliation deferred statutory rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationLineItems",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r431",
      "r774"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "calculation": {
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r774",
      "r952",
      "r1020",
      "r1021"
     ]
    },
    "IMNN_EffectiveIncomeTaxRateReconciliationPermanentDifferences": {
     "xbrltype": "percentItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifferences",
     "calculation": {
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Permanent differences",
        "documentation": "Effective income tax rate reconciliation permanent differences."
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_EffectiveIncomeTaxRateReconciliationSaleAndExpiration": {
     "xbrltype": "percentItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationSaleAndExpiration",
     "calculation": {
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration of NOLs",
        "documentation": "Effective income tax rate reconciliation sale and expiration."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State taxes, net of federal tax benefit",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r774",
      "r952",
      "r1020"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationTable",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation [Table]",
        "documentation": "Disclosure of information about income tax rate reconciliation between amount of reported income tax expense (benefit) attributable to continuing operation to amount of income tax expense(benefit) that would result from applying statutory federal (national) tax rate to pretax income (loss) from continuing operation."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r431",
      "r774"
     ]
    },
    "IMNN_EffectiveIncomeTaxRateReconciliationTimeUp": {
     "xbrltype": "percentItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationTimeUp",
     "calculation": {
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "True-Up",
        "documentation": "Effective income tax rate reconciliation time up."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued payroll and related benefits",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized compensation cost related to non-vested stock-based compensation arrangements",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost recognized over a weighted-average period",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "IMNN_EmployeeStockOptionAndRestrictedStockAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "EmployeeStockOptionAndRestrictedStockAwardsMember",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options and Restricted Stock Awards [Member]",
        "documentation": "Stock Options and Restricted Stock Awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_EndOfTermChargePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "EndOfTermChargePercentage",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "End of term charge percentage",
        "documentation": "End of term charge percentage."
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_EndOfTermCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "EndOfTermCharges",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfDebtDetails": {
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "End of term charges",
        "documentation": "End of term charge."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://imunon.com/role/RelatedPartyTransactionDetailsNarrative",
      "http://imunon.com/role/ScheduleOfDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity",
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative",
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r129",
      "r150",
      "r151",
      "r152",
      "r169",
      "r170",
      "r171",
      "r173",
      "r178",
      "r180",
      "r182",
      "r195",
      "r275",
      "r276",
      "r297",
      "r358",
      "r451",
      "r452",
      "r459",
      "r460",
      "r461",
      "r463",
      "r464",
      "r465",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r479",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r508",
      "r510",
      "r521",
      "r609",
      "r631",
      "r632",
      "r633",
      "r649",
      "r705"
     ]
    },
    "IMNN_EquityStockAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "EquityStockAwardsMember",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Stock Awards [Member]",
        "documentation": "Equity Stock Awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r839",
      "r850",
      "r864",
      "r890"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r836",
      "r847",
      "r861",
      "r887"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "IMNN_ExercisePriceOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "ExercisePriceOneMember",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price One [Member]",
        "documentation": "Exercise Price One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_ExercisePriceThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "ExercisePriceThreeMember",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Three [Member]",
        "documentation": "Exercise Price Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_ExercisePriceTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "ExercisePriceTwoMember",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Two [Member]",
        "documentation": "Exercise Price Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r484",
      "r491",
      "r775"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r484",
      "r491",
      "r775"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r335",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r482",
      "r484",
      "r485",
      "r486",
      "r487",
      "r490",
      "r491",
      "r493",
      "r533",
      "r534",
      "r535",
      "r761",
      "r762",
      "r767",
      "r768",
      "r769",
      "r775",
      "r779"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r484",
      "r485",
      "r487",
      "r775",
      "r1034",
      "r1037"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r335",
      "r368",
      "r373",
      "r484",
      "r491",
      "r533",
      "r767",
      "r768",
      "r769",
      "r775"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r335",
      "r368",
      "r373",
      "r484",
      "r485",
      "r491",
      "r534",
      "r761",
      "r762",
      "r767",
      "r768",
      "r769",
      "r775"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r335",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r484",
      "r485",
      "r486",
      "r487",
      "r491",
      "r535",
      "r761",
      "r762",
      "r767",
      "r768",
      "r769",
      "r775",
      "r779"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r484",
      "r485",
      "r487",
      "r775",
      "r1034",
      "r1037"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r335",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r482",
      "r484",
      "r485",
      "r486",
      "r487",
      "r490",
      "r491",
      "r493",
      "r533",
      "r534",
      "r535",
      "r761",
      "r762",
      "r767",
      "r768",
      "r769",
      "r775",
      "r779"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r775",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1037"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "IMNN_FederalIncomeTaxMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "FederalIncomeTaxMember",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal Income Tax [Member]",
        "documentation": "Federal Income Tax [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_FinalPaymentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "FinalPaymentPercentage",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final payment percentage",
        "documentation": "Final Payment Percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails",
      "http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r277",
      "r278",
      "r280",
      "r281",
      "r282",
      "r284",
      "r285",
      "r286",
      "r341",
      "r356",
      "r477",
      "r494",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r610",
      "r759",
      "r775",
      "r777",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r788",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r978",
      "r979",
      "r980",
      "r981",
      "r1030",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r843",
      "r854",
      "r868",
      "r894"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r843",
      "r854",
      "r868",
      "r894"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r843",
      "r854",
      "r868",
      "r894"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r843",
      "r854",
      "r868",
      "r894"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r843",
      "r854",
      "r868",
      "r894"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnContractTermination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnContractTermination",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain (loss) on contract termination",
        "documentation": "Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_GainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Realized and unrealized (gains) and losses, net, on investment securities",
        "label": "Gain (Loss) on Investments",
        "documentation": "Amount of realized and unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r73",
      "r925"
     ]
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      },
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows",
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on debt extinguishment",
        "negatedLabel": "Loss on extinguishment of debt",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r33",
      "r34"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails",
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "verboseLabel": "General and administrative expenses",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r687"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "IMNN_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted Under 2018 Plan and 2007 Plan [Member]",
        "documentation": "Granted Under 2018 Plan and 2007 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrantsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrantsReceivableCurrent",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advances and deposits on clinical programs and other current assets",
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r938"
     ]
    },
    "IMNN_HorizonTechnologyFinanceCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "HorizonTechnologyFinanceCorporationMember",
     "presentation": [
      "http://imunon.com/role/ScheduleOfDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Horizon Technology Finance Corporation [Member]",
        "documentation": "Horizon Technology Finance Corporation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r822",
      "r824",
      "r846"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of property or equipment",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r84",
      "r776"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income tax benefit",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r110",
      "r115",
      "r595",
      "r607",
      "r746",
      "r752",
      "r959",
      "r961",
      "r962",
      "r963",
      "r964"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r305",
      "r306",
      "r488",
      "r489",
      "r492",
      "r628",
      "r630",
      "r690",
      "r739",
      "r778",
      "r1062"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r306",
      "r488",
      "r489",
      "r492",
      "r628",
      "r630",
      "r690",
      "r739",
      "r778",
      "r1062"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r430",
      "r431",
      "r440",
      "r448",
      "r774",
      "r1024"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r430",
      "r431",
      "r440",
      "r448",
      "r774",
      "r1024"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityNameAxis",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative",
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority, Name [Axis]",
        "documentation": "Information by name of taxing authority."
       }
      }
     },
     "auth_ref": [
      "r440",
      "r1024"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityNameDomain",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative",
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": [
      "r440",
      "r1024"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://imunon.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INCOME TAXES",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r423",
      "r430",
      "r436",
      "r437",
      "r438",
      "r442",
      "r447",
      "r454",
      "r456",
      "r457",
      "r458",
      "r645",
      "r774"
     ]
    },
    "us-gaap_IncomeTaxExaminationDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExaminationDescription",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax examination, description",
        "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings."
       }
      }
     },
     "auth_ref": [
      "r1022"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfIncomeTaxProvisionBenefitDetails",
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax benefit",
        "totalLabel": "Total",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r126",
      "r181",
      "r182",
      "r193",
      "r208",
      "r230",
      "r429",
      "r430",
      "r455",
      "r615",
      "r774"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r425",
      "r426",
      "r442",
      "r443",
      "r446",
      "r450",
      "r642"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedInvestmentIncomeReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedInvestmentIncomeReceivable",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accrued interest receivable on investment securities",
        "label": "Increase (Decrease) in Accrued Investment Income Receivable",
        "documentation": "The increase (decrease) during the reporting period in investment income that has been earned but not yet received in cash."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpenes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "IncreaseDecreaseInGeneralAndAdministrativeExpenes",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change Increase (Decrease), General and administrative expenses",
        "documentation": "Increase decrease in general and administrative expenes"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change Increase (Decrease), General and administrative expenses, percentage",
        "documentation": "Increase decrease in general and administrative expenses percentage"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_IncreaseDecreaseInLossFromOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "IncreaseDecreaseInLossFromOperations",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change Increase (Decrease), Loss from operations",
        "documentation": "Increase decrease in loss from operations"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_IncreaseDecreaseInLossFromOperationsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "IncreaseDecreaseInLossFromOperationsPercentage",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change Increase (Decrease), Loss from operations, percentage",
        "documentation": "Increase decrease in loss from operations percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net changes in:"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_IncreaseDecreaseInOperatingCostAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "IncreaseDecreaseInOperatingCostAndExpenses",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change Increase (Decrease), Subtotal",
        "documentation": "Increase decrease in operating cost and expenses"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_IncreaseDecreaseInOperatingCostsAndExpensesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "IncreaseDecreaseInOperatingCostsAndExpensesPercentage",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change Increase (Decrease), Subtotal, percentage",
        "documentation": "Increase decrease in operating costs and expenses percentage."
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_IncreaseDecreaseInOperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "IncreaseDecreaseInOperatingExpenses",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change Increase (Decrease), Operating expenses",
        "documentation": "Increase decrease in operating expenses"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_IncreaseDecreaseInOperatingExpensesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "IncreaseDecreaseInOperatingExpensesPercentage",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change Increase (Decrease), Operating expenses, percentage",
        "documentation": "Increase decrease in operating expenses percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Advances, deposits, and other current assets",
        "label": "Increase (Decrease) in Other Current Assets",
        "documentation": "Amount of increase (decrease) in current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "IMNN_IncreaseDecreaseInResearchAndDevelopmentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "IncreaseDecreaseInResearchAndDevelopmentExpenses",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change Increase (Decrease), Research and development expenses",
        "documentation": "Increase decrease in research and development expenses"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change Increase (Decrease), Research and development expenses, percentage",
        "documentation": "Increase decrease in research and development expenses percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r843",
      "r854",
      "r868",
      "r885",
      "r894",
      "r898",
      "r906"
     ]
    },
    "IMNN_InducementAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "InducementAwardsMember",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inducement Awards [Member]",
        "documentation": "Inducement Awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_InducementOptionGrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "InducementOptionGrantsMember",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inducement Option Grants [Member]",
        "documentation": "Inducement Option Grants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r909"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r909"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r909"
     ]
    },
    "us-gaap_InterestAndDebtExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestAndDebtExpense",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing fees and expenses",
        "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense debt",
        "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r200",
      "r204",
      "r210",
      "r230",
      "r506",
      "r752",
      "r753"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r337",
      "r343",
      "r763",
      "r764"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r945"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r159",
      "r160"
     ]
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeInterestAndDividend",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails": {
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest and dividends accrued and paid",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69"
     ]
    },
    "us-gaap_InvestmentIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      },
      "http://imunon.com/role/ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfNetRealizedLossesOnSalesOfAvailableForSaleSecuritiesAndInvestmentIncomeInterestAndDividendsDetails",
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment income, net",
        "totalLabel": "Investment income, net",
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69",
      "r72"
     ]
    },
    "us-gaap_InvestmentIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeTextBlock",
     "presentation": [
      "http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS",
        "documentation": "Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69",
      "r72",
      "r74",
      "r1060"
     ]
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Investments",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r614",
      "r638",
      "r639",
      "r640",
      "r641",
      "r714",
      "r715"
     ]
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSale"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r128",
      "r240",
      "r243",
      "r495",
      "r496",
      "r1052"
     ]
    },
    "IMNN_JulyTwoThousandTwentyFourOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "JulyTwoThousandTwentyFourOfferingMember",
     "presentation": [
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "July 2024 Offering [Member]",
        "documentation": "July 2024 Offering [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_LeaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "LeaseAgreementMember",
     "presentation": [
      "http://imunon.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Agreement [Member]",
        "documentation": "Lease Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r519"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://imunon.com/role/RelatedPartyTransactionDetailsNarrative",
      "http://imunon.com/role/ScheduleOfDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://imunon.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Subtotal future lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "IMNN_LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2028 and thereafter",
        "documentation": "Lessee operating lease liability payments due year four and thereafter."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://imunon.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease, term",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://imunon.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r509"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r48",
      "r49",
      "r50",
      "r52",
      "r53",
      "r54",
      "r55",
      "r166",
      "r274",
      "r317",
      "r318",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r468",
      "r469",
      "r470",
      "r498",
      "r662",
      "r745",
      "r810",
      "r988",
      "r1043",
      "r1044"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r107",
      "r603",
      "r787",
      "r950",
      "r982",
      "r1038"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r133",
      "r166",
      "r274",
      "r317",
      "r318",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r468",
      "r469",
      "r470",
      "r498",
      "r787",
      "r988",
      "r1043",
      "r1044"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfDebtDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative",
      "http://imunon.com/role/ScheduleOfDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total payoff amount",
        "label": "Long term line of credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r105",
      "r1056"
     ]
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityAxis",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lender Name [Axis]",
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r51",
      "r949",
      "r986",
      "r987"
     ]
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan amount withdrawn",
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r51"
     ]
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfDebtDetails": {
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal balance at April 21, 2023",
        "documentation": "Fair value of the amount outstanding under the credit facility."
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityLenderDomain",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r51",
      "r949",
      "r986"
     ]
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityLineItems",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r316",
      "r949",
      "r986"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of credit facility, maximum borrowing capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r51"
     ]
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityTable",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility [Table]",
        "documentation": "Disclosure of information about short-term and long-term contractual arrangements with lender under which borrowing can occur up to maximum amount. Includes, but is not limited to, letter of credit, standby letter of credit, and revolving credit arrangement."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r51",
      "r316",
      "r949",
      "r986"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_ManufacturingCMCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "ManufacturingCMCMember",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Manufacturing (CMC) [Member]",
        "documentation": "Manufacturing (CMC) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesLineItems",
     "presentation": [
      "http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesTable",
     "presentation": [
      "http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities [Table]",
        "documentation": "Disclosure of information about investment in marketable security."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_MaterialCybersecurityIncidentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r857",
      "r858"
     ]
    },
    "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r857",
      "r859"
     ]
    },
    "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r857",
      "r860"
     ]
    },
    "cyd_MaterialCybersecurityIncidentNatureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentNatureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Nature [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r857",
      "r860"
     ]
    },
    "cyd_MaterialCybersecurityIncidentScopeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentScopeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Scope [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r857",
      "r860"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTimingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentTimingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Timing [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r857",
      "r860"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative",
      "http://imunon.com/role/LeasesDetailsNarrative",
      "http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails",
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical",
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative",
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r311",
      "r312",
      "r313",
      "r314",
      "r374",
      "r420",
      "r487",
      "r561",
      "r627",
      "r629",
      "r637",
      "r654",
      "r655",
      "r712",
      "r716",
      "r718",
      "r719",
      "r721",
      "r737",
      "r738",
      "r758",
      "r765",
      "r770",
      "r779",
      "r780",
      "r784",
      "r785",
      "r797",
      "r990",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative",
      "http://imunon.com/role/LeasesDetailsNarrative",
      "http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails",
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical",
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative",
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r311",
      "r312",
      "r313",
      "r314",
      "r374",
      "r420",
      "r487",
      "r561",
      "r627",
      "r629",
      "r637",
      "r654",
      "r655",
      "r712",
      "r716",
      "r718",
      "r719",
      "r721",
      "r737",
      "r738",
      "r758",
      "r765",
      "r770",
      "r779",
      "r780",
      "r784",
      "r797",
      "r990",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "stpr_NJ": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "NJ",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative",
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW JERSEY"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in) provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/FinancialConditionAndGoingConcernUncertaintyDetailsNarrative",
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "negatedLabel": "Fund operation",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78",
      "r79"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://imunon.com/role/StatementsOfComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      },
      "http://imunon.com/role/StatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://imunon.com/role/FinancialConditionAndGoingConcernUncertaintyDetailsNarrative",
      "http://imunon.com/role/StatementsOfCashFlows",
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity",
      "http://imunon.com/role/StatementsOfComprehensiveLoss",
      "http://imunon.com/role/StatementsOfOperations",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "label": "Net loss",
        "verboseLabel": "Net Income (Loss)",
        "negatedLabel": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r79",
      "r111",
      "r131",
      "r144",
      "r147",
      "r152",
      "r166",
      "r172",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r181",
      "r182",
      "r187",
      "r274",
      "r317",
      "r318",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r462",
      "r465",
      "r481",
      "r498",
      "r608",
      "r685",
      "r703",
      "r704",
      "r808",
      "r988"
     ]
    },
    "IMNN_NetProceedsFromSaleOfNetOperatingLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "NetProceedsFromSaleOfNetOperatingLosses",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale",
        "documentation": "Net proceeds from sale of net operating losses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewJerseyDivisionOfTaxationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewJerseyDivisionOfTaxationMember",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative",
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Jersey Division of Taxation [Member]",
        "documentation": "Designated tax department of the government of the state of New Jersey."
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_NoExpirationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "NoExpirationMember",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Expiration [Member]",
        "documentation": "No Expiration [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_NonClinicalRAndDAndCMCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "NonClinicalRAndDAndCMCMember",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Clinical R&amp;D and CMC [Member]",
        "documentation": "Non-Clinical R&amp;D and CMC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "IMNN_NonRule10b51ArrModifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "NonRule10b51ArrModifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Modified",
        "documentation": "Non rule 10b51 arrmodified flag."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Cash Investing and Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income (expense), net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of operating segment",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r753",
      "r960"
     ]
    },
    "IMNN_NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares of common stock issuable upon exercise of warrants and equity awards",
        "documentation": "Represents the total number of Shares of common stock issuable upon exercise of warrants and equity awards."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingCostsAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subtotal",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails",
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Total operating expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative",
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails",
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Loss from operations",
        "verboseLabel": "Operating losses",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r746",
      "r959",
      "r961",
      "r962",
      "r963",
      "r964"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease, cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r514",
      "r786"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities - current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities - non-current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease, payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r513",
      "r515"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease right-of-use assets, net",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r511"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of right-of-use assets",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease, weighted average discount rate, percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r786"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://imunon.com/role/ScheduleOfLeasePaymentsAndMaturityOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease, weighted average remaining lease term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r516",
      "r786"
     ]
    },
    "IMNN_OperatingLeasesIncrementalBorrowingRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "OperatingLeasesIncrementalBorrowingRate",
     "presentation": [
      "http://imunon.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental borrowing rate",
        "documentation": "Incremental borrowing rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative",
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from sale of net operating losses",
        "verboseLabel": "Operating loss carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r449"
     ]
    },
    "IMNN_OperatingLossCarryforwardsExpirationDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "OperatingLossCarryforwardsExpirationDescription",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating loss carryforwards expiration description",
        "documentation": "Operating loss carryforwards expiration description."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r231",
      "r752",
      "r753"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfOtherAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_OtherAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsAbstract",
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "IMNN_OtherClinicalAndRegulatoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "OtherClinicalAndRegulatoryMember",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Clinical And Regulatory [Member]",
        "documentation": "Other Clinical And Regulatory [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract",
     "presentation": [
      "http://imunon.com/role/StatementsOfComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/StatementsOfComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Realized and unrealized gains on available for sale securities, net",
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r142",
      "r143",
      "r609"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Realized and unrealized gains, net, on investment securities",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r9",
      "r100",
      "r145",
      "r148",
      "r178"
     ]
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherDepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization expense",
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r31",
      "r66"
     ]
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherIncomeAndExpensesAbstract",
     "presentation": [
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income (expense):"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other expense",
        "label": "Other Nonoperating Expense",
        "documentation": "Amount of expense related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r841",
      "r852",
      "r866",
      "r892"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r844",
      "r855",
      "r869",
      "r895"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r844",
      "r855",
      "r869",
      "r895"
     ]
    },
    "IMNN_OvationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "OvationMember",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ovation [Member]",
        "documentation": "Ovation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r873"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_PaymentoffOfLoanAndAccruedEndoftermFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "PaymentoffOfLoanAndAccruedEndoftermFees",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payoff of the SVB loan and accrued end-of-term fees",
        "documentation": "Payoff of the SVB loan and accrued end-of-term fees.",
        "label": "PaymentoffOfLoanAndAccruedEndoftermFees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRent",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for rent",
        "documentation": "Cash payments to lessor's for use of assets under operating leases."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of investment securities",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r155",
      "r241"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "IMNN_PlaCCineVaccineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "PlaCCineVaccineMember",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PlaCCine Vaccine [Member]",
        "documentation": "PlaCCine Vaccine [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://imunon.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r345"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://imunon.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r664"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://imunon.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r345"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://imunon.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r664",
      "r683",
      "r1093",
      "r1094"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityBeforeTreasuryStock",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock - $0.01 par value (100,000 shares authorized, and no shares issued or outstanding at December 31, 2024 and 2023)",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r599",
      "r787"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows",
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of common stock equity, net of issuance costs",
        "verboseLabel": "Proceeds from issuance of common stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of stock",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r643"
     ]
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from lines of credit",
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r949"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale and maturity of investment securities",
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r156",
      "r966"
     ]
    },
    "IMNN_ProceedsFromSaleOfNetOperatingLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "ProceedsFromSaleOfNetOperatingLosses",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred income tax asset",
        "documentation": "Proceeds From Sale Of Net Operating Losses.",
        "label": "ProceedsFromSaleOfNetOperatingLosses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r519"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://imunon.com/role/PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROPERTY AND EQUIPMENT",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r120",
      "r123",
      "r124"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r135",
      "r606"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical",
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets",
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment (at cost, less accumulated depreciation and amortization)",
        "totalLabel": "Total",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r519",
      "r596",
      "r606",
      "r787"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r120",
      "r123",
      "r604"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://imunon.com/role/PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF PROPERTY AND EQUIPMENT",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r519"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical",
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property plant and equipment useful life",
        "verboseLabel": "Estimated useful life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative",
      "http://imunon.com/role/LeasesDetailsNarrative",
      "http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails",
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical",
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative",
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r311",
      "r312",
      "r313",
      "r314",
      "r367",
      "r374",
      "r406",
      "r407",
      "r408",
      "r420",
      "r487",
      "r536",
      "r545",
      "r561",
      "r627",
      "r629",
      "r637",
      "r654",
      "r655",
      "r712",
      "r716",
      "r718",
      "r719",
      "r721",
      "r737",
      "r738",
      "r758",
      "r765",
      "r770",
      "r779",
      "r780",
      "r784",
      "r785",
      "r797",
      "r802",
      "r984",
      "r990",
      "r1034",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative",
      "http://imunon.com/role/LeasesDetailsNarrative",
      "http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails",
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical",
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative",
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "auth_ref": [
      "r311",
      "r312",
      "r313",
      "r314",
      "r367",
      "r374",
      "r406",
      "r407",
      "r408",
      "r420",
      "r487",
      "r536",
      "r545",
      "r561",
      "r627",
      "r629",
      "r637",
      "r654",
      "r655",
      "r712",
      "r716",
      "r718",
      "r719",
      "r721",
      "r737",
      "r738",
      "r758",
      "r765",
      "r770",
      "r779",
      "r780",
      "r784",
      "r785",
      "r797",
      "r802",
      "r984",
      "r990",
      "r1034",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050"
     ]
    },
    "IMNN_RecognitionOfRightUseAssetAndLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "RecognitionOfRightUseAssetAndLiability",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recognition of right of use asset and liability",
        "documentation": "Recognition of right of use asset and liability."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r836",
      "r847",
      "r861",
      "r887"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://imunon.com/role/RelatedPartyTransaction"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY TRANSACTION",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r646",
      "r647",
      "r648",
      "r688",
      "r689",
      "r690",
      "r709",
      "r711"
     ]
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfLinesOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments of lines of credit",
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r949"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails",
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "verboseLabel": "Research and development expenses",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r422",
      "r739",
      "r752",
      "r1051"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r837",
      "r848",
      "r862",
      "r888"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r838",
      "r849",
      "r863",
      "r889"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r845",
      "r856",
      "r870",
      "r896"
     ]
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r936",
      "r948",
      "r1053",
      "r1057"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityBeforeTreasuryStock",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets",
      "http://imunon.com/role/FinancialConditionAndGoingConcernUncertaintyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "negatedLabel": "Cumulated net losses",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r89",
      "r602",
      "r634",
      "r636",
      "r644",
      "r665",
      "r787"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r169",
      "r170",
      "r171",
      "r173",
      "r178",
      "r180",
      "r182",
      "r275",
      "r276",
      "r297",
      "r451",
      "r452",
      "r459",
      "r460",
      "r461",
      "r463",
      "r464",
      "r465",
      "r471",
      "r473",
      "r474",
      "r476",
      "r479",
      "r508",
      "r510",
      "r631",
      "r633",
      "r649",
      "r1093"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r740"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "IMNN_Rule10b51ArrModifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "Rule10b51ArrModifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Modified",
        "documentation": "Rule 10b51 arrmodified flag."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares sold",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative",
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "auth_ref": [
      "r183",
      "r375",
      "r926",
      "r957"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://imunon.com/role/OtherAccruedLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF OTHER ACCRUED LIABILITIES",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://imunon.com/role/LeasesDetailsNarrative",
      "http://imunon.com/role/RelatedPartyTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF INCOME TAX PROVISION (BENEFIT)",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1026"
     ]
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://imunon.com/role/NotesPayableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF DEBT",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r774",
      "r1020"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://imunon.com/role/FairValuesOfFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1031",
      "r1032"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://imunon.com/role/ScheduleOfPropertyAndEquipmentDetailsParenthetical",
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r519"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://imunon.com/role/SegmentPerformanceMeasuresAndExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails",
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative",
      "http://imunon.com/role/SummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r379",
      "r381",
      "r382",
      "r383",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement by range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF STOCK OPTIONS OUTSTANDING",
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF STOCK OPTIONS",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r94"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS",
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://imunon.com/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF WARRANT ACTIVITY",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "IMNN_SecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "SecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Purchase Agreement [Member]",
        "documentation": "Securities Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r116",
      "r193",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r230",
      "r231",
      "r232",
      "r238",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r307",
      "r308",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r749",
      "r752",
      "r753",
      "r760",
      "r799",
      "r1061",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative",
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "auth_ref": [
      "r236",
      "r237",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r651",
      "r652",
      "r653",
      "r713",
      "r717",
      "r720",
      "r722",
      "r725",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r741",
      "r766",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r798",
      "r802",
      "r991",
      "r1061",
      "r1063",
      "r1064",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://imunon.com/role/SegmentPerformanceMeasuresAndExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEGMENT PERFORMANCE MEASURES AND EXPENSES",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r193",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r213",
      "r215",
      "r216",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r234",
      "r235",
      "r238",
      "r747",
      "r750",
      "r751",
      "r752",
      "r754",
      "r756",
      "r757"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update: Improvements to Reportable Segment Disclosures",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r233",
      "r236",
      "r748",
      "r749",
      "r755"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number Outstanding, Non-vested stock awards, Forfeited",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Grant Date Fair Value, Non-vested stock awards, Forfeited",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Outstanding, Non-vested stock awards, Granted",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Grant Date Fair Value, Non-vested stock awards, Granted",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number Outstanding, Non-vested stock awards, Outstanding, Beginning balance",
        "periodEndLabel": "Number Outstanding, Non-vested stock awards, Outstanding, Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r394"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Beginning balance",
        "periodEndLabel": "Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r394"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number Outstanding, Non-vested stock awards, Vested and issued",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r397"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://imunon.com/role/SummaryOfNon-vestedRestrictedStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Grant Date Fair Value, Non-vested stock awards, Vested and issued",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r397"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility, maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility, minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate, maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate, minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails",
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative",
      "http://imunon.com/role/SummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r379",
      "r381",
      "r382",
      "r383",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations",
     "presentation": [
      "http://imunon.com/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of Warrants Issued, Warrants expired",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations",
        "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://imunon.com/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Warrants Issued, Warrants issued",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://imunon.com/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of Warrants Issued, Warrants outstanding, Beginning balance",
        "periodEndLabel": "Number of Warrants Issued, Warrants outstanding, Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96"
     ]
    },
    "IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://imunon.com/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Exercise Price, Warrants outstanding, Beginning balance",
        "periodEndLabel": "Weighted Average Exercise Price, Warrants outstanding, Ending balance",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice",
     "presentation": [
      "http://imunon.com/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Warrants issued",
        "documentation": "Weighted Average Exercise Price, Warrants issued."
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate intrinsic value of outstanding warrants",
        "documentation": "Sharebased compensation arrangement by sharebased payment award non options outstanding intrinsic value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payment award, shares authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares available for issuance",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsDetails",
      "http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Outstanding, Exercisable, Ending balance",
        "verboseLabel": "Options Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsDetails",
      "http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Exercisable, Ending balance",
        "verboseLabel": "Options Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number Outstanding, Options canceled or expired",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Options canceled or expired",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Outstanding, Options granted",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Intrinsic Value, Outstanding, Ending balance",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsDetails",
      "http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number Outstanding, Outstanding, Beginning balance",
        "periodEndLabel": "Number Outstanding, Outstanding, Ending balance",
        "label": "Options Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r386"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsDetails",
      "http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Exercise Price, Outstanding, Beginning balance",
        "periodEndLabel": "Weighted Average Exercise Price, Outstanding, Ending balance",
        "label": "Options Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r386"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative",
      "http://imunon.com/role/SummaryOfStockOptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r381",
      "r382",
      "r383",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://imunon.com/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Warrants expired",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r392"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative",
      "http://imunon.com/role/SummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Options granted",
        "verboseLabel": "Exercise price per share",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-Based Compensation",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r384",
      "r403",
      "r404",
      "r405",
      "r406",
      "r409",
      "r415",
      "r416",
      "r417",
      "r418"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range of Exercise Prices, Lower",
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range of Exercise Prices, Upper",
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://imunon.com/role/ScheduleOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected life (in years)",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "IMNN_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://imunon.com/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual terms (years)",
        "documentation": "Weighted average remaining contractual term for non-option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Intrinsic Value, Exercisable, Ending balance",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsDetails",
      "http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Term (years), Exercisable, Ending balance",
        "verboseLabel": "Options Exercisable, Weighted Average Remaining Contractual Term (in years)",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://imunon.com/role/SummaryOfStockOptionsDetails",
      "http://imunon.com/role/SummaryOfStockOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Term (years), Outstanding, Ending balance",
        "verboseLabel": "Options Outstanding, Weighted Average Remaining Contractual Term (in years)",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_SharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssued",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares, Issued",
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, shares",
        "periodEndLabel": "Balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term investments - Cost",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r109",
      "r939"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r163"
     ]
    },
    "IMNN_SiliconValleyBankMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "SiliconValleyBankMember",
     "presentation": [
      "http://imunon.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Silicon Valley Bank [Member]",
        "documentation": "Silicon Valley Bank [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r116",
      "r130",
      "r193",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r230",
      "r231",
      "r232",
      "r238",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r299",
      "r307",
      "r308",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r749",
      "r752",
      "r753",
      "r760",
      "r799",
      "r1061",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity",
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative",
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r57",
      "r60",
      "r61",
      "r129",
      "r150",
      "r151",
      "r152",
      "r169",
      "r170",
      "r171",
      "r173",
      "r178",
      "r180",
      "r182",
      "r195",
      "r275",
      "r276",
      "r297",
      "r358",
      "r451",
      "r452",
      "r459",
      "r460",
      "r461",
      "r463",
      "r464",
      "r465",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r479",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r508",
      "r510",
      "r521",
      "r609",
      "r631",
      "r632",
      "r633",
      "r649",
      "r705"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative",
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r236",
      "r237",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r651",
      "r652",
      "r653",
      "r713",
      "r717",
      "r720",
      "r722",
      "r725",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r741",
      "r766",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r798",
      "r802",
      "r991",
      "r1061",
      "r1063",
      "r1064",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://imunon.com/role/ScheduleOfDebtDetails",
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r170",
      "r171",
      "r195",
      "r510",
      "r562",
      "r638",
      "r650",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r664",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r673",
      "r674",
      "r675",
      "r676",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r684",
      "r686",
      "r687",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r705",
      "r803"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative",
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r183",
      "r375",
      "r926",
      "r927",
      "r957"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://imunon.com/role/ScheduleOfDebtDetails",
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r170",
      "r171",
      "r195",
      "r239",
      "r510",
      "r562",
      "r638",
      "r650",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r664",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r673",
      "r674",
      "r675",
      "r676",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r684",
      "r686",
      "r687",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r705",
      "r803"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r840",
      "r851",
      "r865",
      "r891"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity",
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of equity through equity financing facilities, shares",
        "verboseLabel": "Stock issued, shares",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r56",
      "r57",
      "r89",
      "r643",
      "r705",
      "r723"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of stock upon vesting of restricted shares, shares",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r89"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity",
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of equity through equity financing facilities",
        "verboseLabel": "Stock issued during period, value, new issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r56",
      "r57",
      "r89",
      "r649",
      "r705",
      "r723",
      "r809"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of stock upon vesting of restricted shares",
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r56",
      "r57",
      "r89"
     ]
    },
    "IMNN_StockOptionsStrikePriceDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "StockOptionsStrikePriceDescription",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options, strike price description",
        "documentation": "Stock options, strike price description."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets",
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r60",
      "r61",
      "r82",
      "r666",
      "r683",
      "r706",
      "r707",
      "r787",
      "r810",
      "r950",
      "r982",
      "r1038",
      "r1093"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 equity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityBeforeTreasuryStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityBeforeTreasuryStock",
     "crdr": "credit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity before treasury stock",
        "label": "Stockholders' Equity before Treasury Stock",
        "documentation": "Total amount of stockholders' equity (deficit) items including stock value, paid in capital, retained earnings and including equity attributable to noncontrolling interests and before deducting the carrying value of treasury stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://imunon.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCKHOLDERS\u2019 EQUITY",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r165",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r357",
      "r358",
      "r478",
      "r708",
      "r710",
      "r724"
     ]
    },
    "us-gaap_SubsegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsegmentsAxis",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsegments [Axis]",
        "documentation": "Information by business subsegments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsegmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsegmentsDomain",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r505",
      "r528"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r505",
      "r528"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r505",
      "r528"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://imunon.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r529"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubstantialDoubtAboutGoingConcernTextBlock",
     "presentation": [
      "http://imunon.com/role/FinancialConditionAndGoingConcernUncertainty"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY",
        "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://imunon.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r965",
      "r1042"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails",
      "http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r341",
      "r356",
      "r477",
      "r494",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r610",
      "r775",
      "r777",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r788",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r978",
      "r979",
      "r980",
      "r981",
      "r1030",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037"
     ]
    },
    "IMNN_TransomicTechnologiesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "TransomicTechnologiesIncMember",
     "presentation": [
      "http://imunon.com/role/RelatedPartyTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transomic Technologies, Inc. [Member]",
        "documentation": "Transomic Technologies, Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r907"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r908"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r908"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r907"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://imunon.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://imunon.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury stock, shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_TreasuryStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockValue",
     "crdr": "debit",
     "calculation": {
      "http://imunon.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://imunon.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost (22 shares at December 31, 2024 and 2023)",
        "label": "Treasury Stock, Value",
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r57",
      "r60"
     ]
    },
    "IMNN_TwoThousandAndEighteenStockIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "TwoThousandAndEighteenStockIncentivePlanMember",
     "presentation": [
      "http://imunon.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2018 Stock Incentive Plan [Member]",
        "documentation": "2018 Stock Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://imunon.com/role/LeasesDetailsNarrative",
      "http://imunon.com/role/RelatedPartyTransactionDetailsNarrative",
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://imunon.com/role/ScheduleOfCostFairValueAndMaturitiesOfShortTermInvestmentsDetails",
      "http://imunon.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Treasury Securities [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r743",
      "r767",
      "r769",
      "r775",
      "r1054"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock",
     "presentation": [
      "http://imunon.com/role/InvestmentsInDebtSecuritiesAvailableForSaleTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES)",
        "documentation": "Tabular disclosure of unrealized gains and losses on investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized tax benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r441",
      "r773"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://imunon.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment of interest and penalties",
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r439",
      "r773"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r118",
      "r119",
      "r121",
      "r122"
     ]
    },
    "IMNN_VaccineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "VaccineMember",
     "presentation": [
      "http://imunon.com/role/ScheduleOfSignificantExpenseCategoriesAndConsolidatedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vaccine [Member]",
        "documentation": "Vaccine [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "IMNN_WarrantAccountingPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "WarrantAccountingPolicyTextBlock",
     "presentation": [
      "http://imunon.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Accounting",
        "documentation": "Warrant Accounting [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://imunon.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r800",
      "r801",
      "r804",
      "r805",
      "r806",
      "r807"
     ]
    },
    "IMNN_WarrantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://imunon.com/20241231",
     "localname": "WarrantsTextBlock",
     "presentation": [
      "http://imunon.com/role/Warrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "WARRANTS",
        "documentation": "Warrants [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average common shares outstanding - Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r190"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://imunon.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average common shares outstanding - Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r190"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r923"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205-40/tableOfContent"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-15"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/710/tableOfContent"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "712",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/712/tableOfContent"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715/tableOfContent"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/815/tableOfContent"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/820/tableOfContent"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/942-320/tableOfContent"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "b",
   "Publisher": "SEC"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-11"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-6A"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-2"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-10"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-5"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-12"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-19"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479196/954-310-45-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 6-K",
   "Section": "General Instruction",
   "Subsection": "B"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "Instruction",
   "Paragraph": "2"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "a"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/940-320/tableOfContent"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>97
<FILENAME>0001493152-25-008460-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-008460-xbrl.zip
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MPI+UC+T28V_BV%V:1A&WG=7UI[@E_0U02P,$%     @ \T%;6HE7/[N8 @
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M$MP'6BYMJ:3+/02")T@>* %J2X'Q0,A82**8X(#[DJY1D ?I5B8QIQN6J(/
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M$*#3:O4Z]?/FU9]_[%1VS'6GWFCDU]]LZZWTDR$5K?Q691A37ZBR%X<A'VL
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M^".XH."/)9")5.&$C>'*1$5$46$XY1J+(W-S/=<_.,V7U'J)2J0A"H!@8A"
MZ5,;4![70Q:$\:W.V4>)@=2)XNB-TTT+'E!+!?[0.2(#.6>7#8^LZJI].SSR
MX97PB#L4%EQWZF_OE/Z2QE6=,446#--N'@>!Q*7QQ";C2AB?AP_+?BC(-YD
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M4K,I,T6V=5Z?Y^6)A%GQZJO"L&TK_#-[*@%RQ$1\TE&QC_54O=+]T?*4<20
M(<F2#XF%)(QCXV,\R[LRB0D3F,4Q]EZ5KW5UFP0!=AFD;@QI!]Z(,8&3>K;+
M9YQP5UU'@1[+1*MNC:O2($_W**8B.S/)4>SVZ^:G(Z65=9G!S[;YG=OF(3KD
M1?O9(<UK8"3V<E1[//.S"5E8IXR"RX"X'Z"#:B11P+S'/$D[CF*:-6@EK1QV
M3HAGS1U.W#0P6ZS!H6KK$RFC!VQNAX25>:#@-Y]PPT\7'!_69@#,T6RF0-@;
M I]&$_G6W.JT'G<X*X8,(9_>D?#E5,)U,YJ@I@%*W%7)4O:']7^<U6%K5,]"
M*%DI/L,C'-GIG4OC3(C:A^JIAPW%N.)5*XOU%^3584'!HSC:>,4CDV)+06ZR
M!RZ(-8X2FG&A'&OGU2.&G6JEF'::)^KWDPYJO5I)4#9&1B08'HQ$.7,]P_D8
M'8\!!XE$0A-N1YZ*HONH7N' NZ"X,!;1#5//[(IX+8-,!?4MPYA>J%F[8/6[
M@8A!A(O\5'"6K.XE?,UC/0$,>3R"]'U(8[RB4-)$_J_"$=7[I=& $:.!UX,I
M6=(^"D [<%=M[(,=9Q-.#\8DD=!HE W4L-Z6J![H]E+I]GE*BFK=3PW;4\+#
M*6*7X.[3_P=CPC[SO&<NGQBW=TVN_*!V;)C!ENA[ZY5]N.S!6@LM41IERY0M
M9<O<7C_DK*<^>BE4WO],I:4^\L^_ Z"^*O W4$L#!!0    ( /-!6UJ5'E,Y
M.04  #4@   *    97@S,BTR+FAT;>U:;6_:2!#^CL1_F$-JU$KF-9=>"Q3)
MP::QQ&$$[NGZ<;'78:_VKKM>-Z&__F;]0DA2M<T5VAQM%,78NSO[S.R\/.,P
MO/#^G([JM>&%;5IX!?TS]!QO:H^&[>**H^UR>'CN6F]AZ;V=VJ\:H>"J#]U.
MHL!C,4UA1J]@(6+"C>*! 4LJ6=C A;AT7JU3]%HU2<0N>1\DNURK 7RMJ '$
M1%XRWE0BZ0-.WSY8":5$?/M91$.4VFF,AA-WYNW";H8D9M&F_Z7=\KDI^T@+
M<"CI?'3"5VDR&+;/T4!:+E[F=S0\J#H#N&? /6MH7Z_9BJEZ[;37ZGU/17<5
M\RE75.Y3L^K@CD$7/*6QO?"<B3,V/<>=U6ON!+P+&\87CCV!B3,S9V/'G(([
MP2GVXGA.$36?OUDLWY@SKU[S7.B^@#<SQ[,ME&YZ]A+&KF7#24I]A-(]/>L<
ME>KFLEXS+7>N]:W, )Y[5#H69U>OO>P\A]*KE^;BW)S9RZ;[]]1^"^;8TR.]
M3N=7>CI 3?DG2Q4+-_M4SN'UFB\XQY-E@L,54VM0:PHFYQF)8$$3(16($)PX
MXP+E.=QOP5,]Y20*WF=B,!9Q0OCF1.9WSW +F4O84"*!\H &8%&?QBLJX;1K
MH'/T?C> I!"R",>J'>NU)?4SR11#_(0'8%_[:\(O*> &,4M3#4__2B KD2F8
MT)7,B-Q [X]<Z-DM5 7P"A3"-L B'U@ KPFC4A@P7C,:PH1QPGV&FKIAR'PJ
MZS745<LIU3+0H:0VN@%))M.,< 5*Y,FMM6R-6[L)+=>*!")1J-?N['*.CIM2
M^I+(%>$T;;K7$=V Z><VUG%CX#A11KV&Z^(-O./B"LUT2?L_Q@$/'TB>>3[%
M\FA/I\NY.79FKU\U.HW\?FY:5G7_8%VO6*#6>FKGR0!60@94-GT1121)$5#U
MJ9%3ZZ&W>/@&'[1?^"2J@A.MVBB)^M"S_C/@3JMWQOC!X[[;VIZ#9WT+[ /C
M]'1FT.#*3!1F4;3!XXN32">*;;Z2]'W&)(TQ^Z<ZE)9E0NN>/B7/=-+HGCT-
MGFW#[R;5;--,&8/=EZ=%>B)QGKP&.AGMV@K_+!Z/UQS8_'="]E&[RGVL/]51
M]?YO$<TX4H68Y&&*%$01QK%N,IY':!7NA$F,]T325$>VH8=)%&&10I*GRS8.
M)!CJJ9&O"K?E' 4&+!>MN03.RJ(B,8B$RGS/M$!QN]RW/NT^[;Q(C7Y5W1]<
M=?=18,\Z3_9I7@L]L5^@NL=(/QN0I74J+SB/B/\.NJA&*B(6/.35VV$4&SJC
M=MHN8.]2YV';&>TKR7[#>3[2*K=?UT*K%T@JT_\R^^%AY9UA&=%WV\/'41Z^
M-Y4ZKE<>WIIA[2_:>N1W!4GP_9P Z(Z $G]=\8_[7?Q7-?$YZ4C7FJEPH0R@
MUSY-<B%Z':J'9*9J63#"5YLOOA1840@HMC=!^=JD7%+2EORE"V)-1$ISEE-@
M[;YX0,-3KY4=3^M(S_VHG=JLUU*4C9XA),.-,67E1\^P1\:#1X>#5"%5B7<]
M3WO1C5>OL>E=49R82(&%!X=+?ZV<3#OU%4.?7NE^N^3KMQT1G0@GA9GD+%W?
M2/B:5WL2&#)T!!F&D"7X1*.DJ?JIW!'5^ZW9Q+I#HZ /<W))!R@ [<!]O7
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M. 69@+X$G#J6"YC_N$!=V \+0Z)X^V,*SH9UO8%E;2X X6MM(6F Q-I'SF2
M-&3#RI8:$-94 BL(>UZB4J?QYZ ">L-K0)O#%G(NN:*-)U5JI_33?+G7F*7=
M!)!/0-DR7&XO7AJ2:^R>,?#U<5H_='%:79Q6)['<=1;#^$:24^><\?X#'"1@
MP%-"662&@92)021DS67CS+%EU*#N [-DOM7)H=]_%BOET#I_JR2)$?E71J71
M*?(V/O[D0EC2N9ONM@*U7]I]E"1!+ZUD,](T2=Z0)G1_%'=H>0JK4HT=IILL
MG$ "[!#Y'%J4Q!6IM/Q\4)>U'N?F<YF],>XS;!%6!67H!'@BV22R =MB-0G
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M8%;#C2HT3,YT 3+(?;R'O=[+^V/GY>V\O'_1K>H0]+;XSC1/YM(YY9[O_>
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M>RYU"M5^X ^JS$KCL4XT)=XB%Z@Q643_'"QQ7D,7FS0-P'_6&I )#;DDFT%
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M%KB8_-/+M6/#)GG+:Q.V+[JTC\O1<I%H$_# 'KP64[I @VU$@^>_E?8=R_!
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M%\E]_S0YB0U-3+YR#9 2M!N#%KT.,<D8Q;LUETS;EOD4]XUL"5A#+KAY^:)
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MNLA@>S$D;_$FY(#D1Q5,B(^A;R..Z)8_UVU/9QJLP-Q3Q"_NKWN5PST%&[#
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M*"N=?W7:-W3_T;^XZ+9E;9EV?W#='[1&'87W9>>=70ME/;=<.L35VL9Q-=,
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MOP=D<UV#]%(^.CUDNQX@.V"$8&5 0U.'D&82';]<@N4'([J>KQMKR M G/I
M]+:#FS.>&S I8-Y[.OP0RV$W! 8HZM@PL9@?G*,]1J2B8>:(7?A'9#QU >#=
M K+@N5E+B?NZXT\!T8#$=*PCNV:E@H !]X!' #*4(VQ'"XL+"DRYLQTZ2OF:
MQ9@>);_@W9(!1PUSQDB"<P?7]><+3G>P"$ 0'!#/,R1[F ;(%C^?FO88/F
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M"S9(-7UNMGU'D^=4P?% 0=O+F*"<0-4%!C.0"]ZJCF'[;DEH^V6A[LLC)J4
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MRHA7=)?W+8-.NSL,;EP("$V\(YO<B*M@T=>&"#'HD(,-OQV;-R_BPMY23H[
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MOQ!G4-\M!U7=@&F;6$*.NM2!_L)0)_#""W43RS#/;=A[M FI4Z[H^LNKR'M
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MPH[Y=^6\ T;70%K2A;AEV,Q-C T%=E%/4^UAVO%F&[S5@U5W;5T:K.)C=G4
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M$6M.[S1$-U0[CYXFNBBY\Z%-C0KF"6T0M,#T,(4ET_EDEV+A-*H/LJ;<\7[
MEDH5#\8,8V8QZ.W07!-EFT9C9KY_Z15B_=I*&C8=VU1+&@$.T8#J#2)W*(L2
MV-;GL\Q93I!HOC$V^[Q4V\*WT*Z:=A'GP?QR'-@8)SM;I]D:7ZN0M&<7W]&W
MG(>DQMO@Y&HL1O9O7=0K/1M?'&_L'?5!M$,AIW),WFBM,//7[7EJP3!992>5
MUZL* (,8K7>V4V 7-']H5>7>Q%=:.4PFM7$4\7U9OO<R?UUM<;Q^A]9 0 @"
M6)B(?B:9]09(,3O_*$8'BV98U(DCZA^PP*3WYJ.4XUED=1Q@&3T>U]\$E_@3
MGW#Y]L>W%R^?O7V;O7WWYNS=L^__EI\YW__ILY^>_?#J]8MG+]\AA/?RR"5^
M-X/_:RF]M9$NL%852W'86_X2G<L6XZ9,<%:<]AM**P"GO>I43DTXKN(\/^P\
MU_6-4TX 9JV8KJAKX Z<W^!MUG;H,B\"?-S%F^6PQH>N'THV>W/7WGU^@5)G
M@&MW8KUT<5/5/4RS+REC_#?BY9:21UCOI4)HI$V(L.C^M62$A6A[[VHX=P?]
M$D(YN\]:59V"?$3>N;7#8! RL1".+=6VVI:U>J]5/ZY 9D E&T1HDF'.;;O,
MLNK?][';1*L ;S@X?^R@FQ-+AV$>2-[K@^3!2AH"@^^[MW&^#KO":F/[[-#"
M"?IX6>+9@D114,VP6& 3L:F&CUFYXSA>]VMRICBGLV-%$BM#^2N%WS$,#7W'
M5%J# /@6C.'04N[%R.TUC#6[%66)MAM1^"6,W"H01Z/TH43\K![*=%-]-URB
M^KS;+B<0NBE H6)@H3LE""^H=A5\Y>(?0Z4\Z^UJIHDQ? )>MQUN/"7N9<RO
MVC$ZE0C%P9TT:W9=2M>6#%:Z-O'M6BZ[NM969H.\BN_3L2JJFA2#J((A=HK-
M(7U7$T8SW1*(_[VK-E:Z@GUMA]U"V^9X>]EZK>$(N0/5N=FB^TV%(A3P'$I4
M%&0$BAJSL]'YL6@H,*:0B&?, $)JGJ.9BYX1YY<"[.:,#-CT._?R3(I7M2=2
M>2D(I?3H6*89)W2K-<N'#D]TN/;.T3V5^+\8V_/Y$=OS*V)['A^Q/4<3+(VM
M.]O'S(-]&TC#LD:ICV)$'Y#EH=1"_U8NQ9R,(Y".'34WI&AO";B1>>*A&Z,J
ML$QQ'9K-5>X92_Z,%+E'TS(<8L6-\9L*@=ZPX8>8-\("*<YG*MQ-C2%0I.8#
M#8'I=XOAAS#_1K/\G!#KL*'&Q:"H4<=52YH,T1ES>@$\%8\W&;*S;0MH4.;
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MK:0MI^;'I<Y^P=SNZ=F[UQ?GA3^YOBR<1K$_ +A)/#Q#8^K>;2O"A[F$ YU
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M@'4BBU\+3N2YM*-QX[T"<?OX>Z^?O_7?,R$GA3Z15!+PW7<AFT0I=!.HD)2
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M7Y>,!&62LPYH828-8YHD#1]A7'B8TH"WW:\P\)F0K=(M:IP,C!I\)"- Y"[
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M^-8L.59:T.EFV4DS])L\\50UB>],EW*6C4(DRATD)"#K0IB51A1[5NT0?4U
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MB LJ ^3Y-#X-V0BQX"D#]ZD+9T+$*91M4=G"+&%"$I48@<(5P"SP9^5B&C$
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MQT:]:@D'#?]--+)-\9ZCXH F!L?>( BT]P0]Z/+1^;<Q2#EF*!4C9^WMA@6
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MH.;D8K@- IW?&"ZS@<M#==B+#C?NPX3<TR^HE=W+HNPMJ3[/MQ&3[A#B"#)
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M'1C@D_;N4:]Y]P=G.!8D8M(1)LR*$HRO4-07M[UWH\LT@)[@?ZPA&B*)*2=
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ME&B:>_70(!8W$--7"9<&]U-#$!]Y\DH4DA,]H?H 6CY:+L0N3N6751\H.1
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M#KA/9G=D*.<4C.F2,$Y4?LV>T>L4-=OI+_&2T?R!'GF%''A%[B2U/L#AZ5S
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MY:NF5A3#I.WM33!BDR)[8_#:LR,76K6NS[@QL+F$;%DC92\*\:N&\FO]A8]
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M3V*_S.2\_A&\"/ZQ#WV1ES$Q[>.'A4K6"TR>@G(X#QOI3R$]V'#Z?T;!X[7
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MPP?D<+@_<SC,KNJ$J\J4]V^QRA1I# WG7F ,&Q>4-6-&CZ,5*TRNKB\Q;[G
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M[P2L1DT#VL$8H2O2(]+L  "SH'=)LU]=M %]DJ+ZJ=@F4+NE$#OA3UIQ$XX
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MEND)IACAJO+Q6B2QG*G+/A&ZW,A8L@HY+<-BDJP5\#?P(I%EHWH*$\M%I#;
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MCRH9#=N#!+,(+OJ3^LK(R/,9I3:UAEY3MTE2.I^1F;H>H/'M#-#X@ "-KV:
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M"<DLM_HJDC8AVS00_RP"/E,,; J5(MZ'2L_;I.,/X7\1,P/TCM)@/^8&8CY
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MNY;)+^&J'3;KABA-R8O6(RU+CK3+ ]#GE 2 L4*PD"LB>!IOF#0>/S3!<9.
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M:Q19TJ^;A6F$3M6 439!(31Y.0@#R'-+J)ADAT7'S)NK#K&EZ:CN 0;_W5'
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M[>0N.42Z.ONT!2"IT4*@F#8<^'0*(HZD;XRH[4A$"EH')N+!4W@UT4V#@C^
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MB4CC?7M%.DFA] X=UDPX:IBI&PED9'2<X[YCLG7F6!OE+MJH!5LB-]O+N''
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M]KG1M3J<UGOYPNEHDA"\%O?*N@);(/C[;R\)UDSSI93N[+W<M5N+I^?$:?\
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MJE+#T8Q;5)?.P7Z%UT!@9D#$1G<* Z79&[Y.8,R?<[BPW>.8VFK9>E1U*%
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M<_^G*@E .:6T>N2P,479+$D\!'V%^J1@EN&$5H8_21\(QA.5$D8!^](\=*:
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M]/SZZ.;LXKRX"J)-/%])GC4ED,H#31>YJ6Z@>24UKNL8*P+KBL^C=K#?3.Q
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M1T+5YFIS'I^E?8?D2M7R7J*/_&"V6AA<2K\RM#7Q2@/T#'&-,F,VD3)Q-\$
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MGP<SSPWL@>T _L"T,&!^.%&PD L]-"[V\Y.^9^^3NBA P,?@?4"[ -TK"/:
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M4#0R@)D7\ 64?9TIHBOKU?'O,ZKV1;7*TJ)?#L(V-QL-FF@@^%"F%#"6C!O
M,P$P&0++?=##AQEI(@)$%H43SX?5C1+P6"B&$76$,^%A1LR[9@#?T!;N*G';
M9&3T$[$K"9<#%@G#8D!%D$P;B*U!1NGK(^YZ4]NE(G*P^C1:S8O\0IU07\=Z
M=*4_*NY6><+9;>Y6QV)DF]-O;'<4#:G:9?R]++0Y2MG@=.9X#UR"@GVNW.QK
MPC;"*N7B0?HRJ9%^+*HZ/JXY/:(U]1L=J37)$024 A2?ZP'P9H?Y" 4PT/CW
M#!?-,ODW& BKW",Y]TAO&^Z1GP=R,'OTCW?LSZ;9?1='R9S=G'X5*9>M1BYX
MILJL!M9S?'IU<W1V3B!>G7XYNCF[.+_^]>SR6C\Z/Q'?G)[H-U='Y]='Q_2C
M0;^<G%V='M]<7.EGYR>GEZ?PK_/CT^+"WPBI51YH.,<K[J#^IEV*4L4WP P#
M-B09\48B92L/]$7D:\?>B'3[TW!B#S'RZ+^13>:"X\0Z\RAN*&G(>L&RM60B
M;5&DW6*+29!A-NG8,X>'7(=?F1,^"(F'U:R#$#V4'!7_Q$B18E?#$5% WWGV
MB*P.@0S"ND"KQ';O/ ?;S'G2Y.!W7)2X!NN""\&:/,.PFO;8 >L"YXDG+1?V
M>GX/-.8$7F8C )1'-@(S79)]N)]@:"JL7Z@/PFC*0.+K,R_$<MW,2;_%<%8?
M%0D[C'>*A:$HZJW! $$TX_Z='6!%Y:DH\8PC"2.)+OQG/E9GED6_7>[@SUA,
M/')"&HX.Q*:.,/#TD(\B7%BB/<EN*OE=$#OSR0,E"(%(FXKZ_,[F]P(#9+@!
M[8(/QMW8EICC(W$C*4_LF7@TS-!W4H8\$K_MV?NEVRS3B$3_4BW><@.>ER^0
M%<B%_<PQ8DZ&W[-D#'I8/IT/B*##L@/]FXL]7F#C(\)C_)#O]D+EMF$T4"WT
MJ>=SC9JNC1'?9=>U19;GGGTG9LZ5[=;MZ92/Z,0$X1*6B.7CSY@=<NL!0C1J
MQDYJR0-!$L6XK9V!(C[C\"^,YU0R:"M G[G:T@VKSEDP8O\UL@P\Y=,D$N!_
M#F? Z!DLXS\>4GL\2,I5 F2GV#<F%-XM % '5AO&_$[/\;L!]4.5>!%FV"*8
MAKG66P2 G"RPOV<R(^,),_)CG&=T>R=^0__DL\@UM*\\"-"(/(&7_T(6CYT9
M8"5_T5]?X9=+L)GLO_YB/C(V/P>?-";3]EF%S1,;^Q8X2RW-R;59CALU$GLE
M1F)[;4;BFD&_O#H[/SZ[//I"\!P='U_\?GYS='ZC?SX]%3;A]>G5O\Z.3Z\W
M;^S1OWN-7C&Z13%[ ?0?P-ZCJ:%]\E'-^C_Z]13Y_67:*4@\D'0(0@Z+S!/]
M;@&I6%E6)^,<R!48V"@^+,!=8G;X(AN!THSN-2D;7&Z3RBSF -W1UZ36A?<#
M0D5#?U] %@:.,&&)<CQ#H1).?% VR<=GD.@8VRZ(+=3F$PLC4::%>)(W*+$^
M'"OXR<\(D5 H$>)H9),X(-TZ75T]V?6&&ORNCW?D('LLD=Y2B?1K3*3O[U B
M_<YS?-"6M3'@JG=/5R6$\TF#MC'Z3*AA[)T'IKVX<)[YWA@T8&"6P%:)(PK]
M>4AY<:C=R@?)5K8#P&C!DG7\<;2@M5G\K2:_;8E^M 3!./&FS$\TBL@U(RYL
MP-RWO5'P4W5YVIM)V"_+V]Q@CFEWW3FFHN!#Y7)I-['.)P/_-YN-^HS2#F 9
MZ,='-Z>_7%S]NQXIRT=?T:JI($*M?:4_ZB))^N*S?G-Q<_1E%]:\0Z>[_L/=
M2D:R=5B:&GI$ZLEG4"(JD)IKMF$A[=5R6ZN5G=L]7 GX'ZNPZ9W5$XHKMNFK
M ?_CUA*@8_*2@0(Y,GMLBY;=E[+3;!K6_&$^->"&@)G+)WPE./I&KUD56.9T
MZM?,]9V?^X9]WPJ:6H;5LRIR)-V*P&&VC%ZGIK3[>N4DCAQ'OR#?1YD64Z,"
M >U.F?*S*^41+'-75]X[- X/GTR]?ZNK;ZWCW+<K)1\OB+$4&ZIV*0C+-(U^
M9TX\[UXU"/,%E2#F;+N:X4#',EI/BZ-JXL"Z2J*\_/C77P-$Q664 4V&MD:7
M81@W; <4R)9<CN6NY.;OR 8/<4Q%?"U'UW9)SB5SW0A>3(,E@A ,^BE= =HN
M/7(D'KGB,\\/ \US]<^>/P7H#OXI[NDPP%@&'LL0N_]&S ^Q&\&B@2DI;50(
MR* Z4KT/@?Y_D]?EI'IFTO_;T&E+#GR9I$!;,9-99C*&X][SO^%WF*>:WA3B
M:D3]3XP1Y_@=K3*YB<0;DX:.EN(C^\UGS!<!(_DH^1A\ &B$";LT(JU:#V%$
MGX>1[P8 /4;OBRS:19-0C+F(NF1AZ1;)<YMR'N(J#'D"(ASZ%L83(&J972=P
M9)[;%&?P:QJ\4C.@?QY\O)9TJ0$YGB89"7!6@C95//-V@#[W-*#=,-WXA)RX
M>\MNTT14\FV6D5TI.XLYZ].1#LA?]'L6:$!^OCV(Q/4_S%C@5X F(F$DD)R"
MHM *,(\CQSG  &D#'X;U(_1)OHLB[>V0MA#/@"=3&U@JUR_!'AP^H, ZH@0<
M1JE:PEM.H=Z>>R ^Q4Q!4?^6LAE"S0Y$P*@\(R&^Q6FD)XA)\#X_D/E3E#+%
MDN-#2K-!W4*Z=>$H"T%02=X64/ C(;&&!EI',;5"I%5@ -80>(,80V98Q%GK
MR3PBYXZTJ$(<EB$^Q]I1YGM40C)/N2,M'UC5T"^396/4;* /&,;H8MJ6?N_C
MYKBXP)D7,,<@\)$YV@)23*4#+8;#L8%RP44(5_P)GHA&MUQF:!0V7!.Y&@Z_
MI2<Q4Q"8ZG#";&1J4F>ELB8B73%W.,G!E!P&[2I63DN@(!#AV*,9#O2#U<'[
M02,Y-4HSR32IT(-H.,E,;J-BC0JI +,,>4!=0^A=0&54Q")2MH225KIX++2"
M0=0",<DZ,[2Q[TU%Z@O.0AP>_HBW*+,!%(67V1IQH/FH:4,//-WQ,*<F$ N*
MPZF+Z2E)R@OIJ-K22"^UZX*4 _,C5_*X;+=*J,"FVA'I C5)K)2G.(F'9$Z<
M7"1$<)J,I.3>5CJ!Y)-2#I.([<NCJQOM[%]O1*;5,H_I%<MBQ/C03R/XUXET
M:<83M2.L3UV,T__WZ]FGLYMKD09U?J)_/CL_.C\^._JB7]\<P:I.SV_TZ^-?
M3T]^_[*-7*@WP-4V4=.)[6LWE.0=Q\2/O&$DG2<^!K0[(MDI-B+#"6@$.??8
MFL//W]XY20YA-3?#(<R&5D):UV]$'%4>Z'Q&B8W%'ASIVQ2U+ERZ+B5=O-25
M @^>32/0,0W]S!TV),G)S/,BL:%6#$8%JKQI;GKLI1[/V5_"+TI>\5DT *4R
MEZ1(^=M4P0,A29PL8B:T@<Y0BT(G^S&LVO? K+_#R(QD%>+)-U(:0BD^.-RJ
MP08O&CFS.[/OVRTIN4P ^4H'W#Z<?=^"$8+)@ N5I37A3UE@Q=^.CT]//W]^
M/FJMNUS7Z>7%U<V<WE@%Z#95SW3]^+3Y<J9EJ'1?'B'X*HC$](G/Q_]X]S=4
MT-I4&5E<OH)0SLC1JU2.7@HY>B3D*,K\S[8__?D]4WCX;$@_'Y@[S<_6=U+5
MA$KQL<T+Q,0&)'@6V($*LVJ!695B3JF,G/(_FTWSW<?CK$W[B3ETDW$]X1P[
M?"LY^!(YV-IE)I9'-*N :-<YE\G%C(MP+X5R+T2YCN)N*=*U'D4Z#(WR^82[
M 59;_>(%"OE>B'Q=Q>]BU&L_CGHLF.B?'>]>H=P+4:ZG^%V*=)W'D6["W%M.
M\>+76$1:MNZ6-P6ZZ/VM\/%E^-C?81:H'!_*/%U#8%:>IW7??3R_N#F]UF\N
M]..+\^N++V<GU(2E_)H<N9=RD;S(>5ONO56A.YN-L5JZ7FQ+U8M=7[W87G.'
MZL6^/<J+@[',S01C6:7!6 OB'.O!9VK)'#&8OR3:2@^&$SZBI!-JAT0Q^2/L
MD<2B@(MN."XFI)%K$:.Y8(RT=X7(A<5BP6DBK^N%/(A3(\JCO3(9J6\A4*KR
M0!=C]2TK(?960XL#DW5%BZ\1(9F/+T[2XEF@\^\3>X"Y,$1,2>+16X@O?B.Q
MA2^I>;S2BLKR+C823B>9 2WH_&*-C4<?BW9L-LSU=LS97KCCFK?_Y/3Z^.KL
M$MNB;CJH<5V-M;?AQ'G+#HB=[LJ^?N2Q&N;?%>J\_#ID$H:SX*?W[^_O[QL!
M'S9NO;OW1_YP8M_QX#T?W3+_/6CU['VOW>^V>^^;S:;9;O7@D]F&O]J'_??\
MNW5@-B;A-!'D!S#0 <#OLR&L5JHW8)L$ 0_UR[CI_-&MSX5Q(LP&1E<OOT4N
MU[M81\-L&Y1L[HZ2/J6Y?!'\X?27TW/QT4"5RO-!<:+!)MSG8*@,L.73&/Y&
M3P6H5Z<"%AVP)S9=B@6(<O6'"F5_DO(?LNB1+ !",+>: FA]#SO]?;9![SGW
M&CKLUX'9Z9OF?J-X8;0[Q*HXO>+T+^#TEL*<UV'T_9;9L<Q^L]EN'9K Z($E
M+L?I@:V/X@I+"]E^S-6/N8,U[8#)"O9-S:.)N?_Q>\S<A8CXRF 0W3HD3MM?
MB>.;S93E'XN.L$6&?WCPSSE^3SF)5.#'MQW=E!,K%J]8O&+QZUM[JV$JS'E%
M%F^UFLU#^ =8?&L%#H]*._#I*TY^_A$P<L"Y,6!=R$4BV3##T3/IWCEFWH[[
M *["S5LO8N;YF14W5]Q<<?.U<G.EL+\J-V\W3=!2.R_DYI\>'):6>99,U-#Y
M>,R'(>8!))S4[(BZIP4>OD[F;12YMWDH:ZTJ[JVXM^+>ZUM[6^GBK^M7[S7-
M7K^+W/O/_J%UV%N&@1/7!(X)?%3$Z3#DT$EE(ZS"Z<E<AM03\P?S?>:&JVG>
M[8;U$N9],0R]M%2VV5/L6[%OQ;[7RKZ5\OW:[-MJD[>\?=!>A7=?.FPH'.-'
MM_CO1YGVBCR[_1*>_5OD/.BF8MB*82N&O0F&W5*8\YK>$OBKUS(M8MA+>4MB
MAEWJ-8GY\YX=!!%\CK Y%Y9*"T(]O1:%M_\%_XU\K*; Q'7G-1]&5-P_N2$U
M<I$Q1]$M[)^X@[2:26P,FV*]_VQDC*'_ZOGV7\C;87:,/3XS]"]?CN>_O_%Q
M1+S2/#!%%X?XB1L^G+B>X]T^R+*G/'L]:R!(QQAF&U+W*Q)8^ZL:$B_R EWS
M62BZ[@@W?E,))B68E&!:JV!J*\QY7<'4;/7-YNJ"Z?3[D I8/-?#LP[W?&LI
MKAQ$F,XI_[V#-*88M&+0+V#0'84YKQP8V;/,]O(,.C8.L+-9[-"YGC"?QU76
M4H</?BZ)BWQIS.2S1<$:PN0%)"T51*G$@1('FQ '784YKQMV8_6[_=[J^GJY
MFKY._;S@S$\:%1,/'BL>K'BPXL'KX<&]_Z-0Y^5,&%FH"'SY>$(]DF=Q#+GT
MDML\B4P4/4J0@98SK:0>FU9262I;5VK! TL4&FNK0F-K+#1FUK'0V"*,>B,5
M4-;.=0LE3];)13#5[^]_7TMU@-<L75(]KOR2H)AFO]ULKI!"FDOUMYK-GO2+
MP&? 'PP_OW28N(ADXAYV-=?&L_)!<V[N!]WLJI@8I48K-7KMR /$J:(87SN*
ML6^9(@B]W^TO[\XX<T>1#&.\& /?%3R7^T,[X(^'- 8K,_#6&IW3:3R)+.2B
MN+KBZHJKKYFKM]:DE^\H]JR!L1\VP69LHR;^IVFVN\W.,Y1Q\W"!,KZ4__HE
ME5A(ZZ9L4X!!\6?%GQ5_7BM_;@-_%N I%*H;DR[&F$L6^_J\N^@UZ:@ $,6_
M%?_>!/_N*/WZE8- X"_3ZK96\'1?\Z'GCBK.N*G$K?!WJU0;Q;D5YUXWY^XJ
MSOW*G-N$OYK6*IS[9F+[)8R[+#9[6?Z]R5O+>SN<Q-]/[8!@3%@[.;TM\^VP
M]AAY7T1+:QAD >IG1J[Z3JZ5S_44GWME/M<&5M2CZH#+\KDX3CGE7(*378BH
MO%\HIR6MZRU2WI'1;(#KK3D/11405,JL4F;7S>0/%9.O$I.W5BLA&(2^/42V
M+#CW9AF[I1B[8NSU(<T=9^Q]Q=A?G;&WVBTJ"M+O+Z^]:\ _SST7V*5CC^V$
MM4L%/BY@E6/[1:T>62Z?SASO@3[::9P?NV?^J!B]MX#E:_U^QH,AN'E2IC;.
MY"&@KI/>U;$@N#XXS#3D$=6PK'[,[)''MUJM ^O0/&RU'F'R<3J0ZJA;WWP2
M"6[/FGW? M<SF^M.)X%'ORL>N"H/;(H_3?P3:/Z]AP'&#@_AQ)=AA*<I]Q*A
MR5_H54,GG*'.]L"8$H^H"%/ 0GNRYD96 466^1L?CWW^H/_1T(\G&,R\!5]N
M\49.E/50-W)*UU6Z[KJY_KJ2"'<4?=80!]=I-MN'S=B+L50GA 5,/M.V)M-G
MV$KZ#"]@\?\$OAY,.'#<(_<>1EG5N=&+&?R1ZX+NG?#W<F_& V>Q*^.$#V4V
MBJG:"BL.KSC\1CB\I3C\*[LS,!"XUUW%3YUA\/.MA(O\^ZL]G##NZ+\V]!OF
MCZ);US-*1 'V-Q#]Q*SG.[!7U>$7AF,@-,*M82FNK[B^XOIKYOHJ";%27'\I
M)_;27+]8$!4^VRZH^E^X_HLW'C_!_;?FP%',_[7II)I0*>:_8>;?5LS_E9TZ
MW6;;[/96J055WFQ>M#BP,<[:#7W/R0B&;-N<M+"'J-;433KGK&0TO&*\XEQI
MDNZJDF$+)1 [J@3B&DL@6JH$XEN[LGX$4? :>]UR;EV9H.K*>FWQF&:W^T*+
M)]\0#I/I6R+\9?$-QG7(A@_Z%]L= 8G<&OKEI''2V$*E%IGL?ZAB,94IHTR9
MC9@R*F7T];FZU>RT5TD9O>*A[<NP2?).N4'DA-B+<X[)4ZV47I&_YZH"9*.0
M2D.0-LC9K:9B[8JU*]:^$=:NLF0KQ=J7NIA^C)<?S7S;D2&EQ,WS'J@YIO[5
M<[VI]Z ?C>[LP/,#ZM^\-&M_]I6T8NV*M2O6OEG6KG)C7Y^UM^"K57PQN4A2
M;+"<^&9B!G\Q##WTT%M/ZNO740!;<?K@8-;4=M3U&+B>8NN*K2NVOA&VKC)C
M7Y^MMUOPEV#K2U7,O>8S)D.%YC5VD5\:IY<^<65\_3]_LUJM#P,&&P,__\K^
M(N;^=25?>V>#=\:6ZO6IN+[B^NMN4M14//]U>'ZSW6MW^\U^L]EJF?WWS#+[
M)C#_O_CW [/YI[D4^S_A=]SQ9H+K7_K>*!J&H)[/9LZ#=,Y/I]BX"';@KSDI
MD8:1)JE:Y-UI'CX97_1O]BUR0OU7SPTF#'X!$?$E'!4%Q1(Q1HG >&%V65/U
MTE#"00F'=0L'4PF'5RT3(>I$@'# \%'K@;CN<F5]N6X5*[+CEVL2&+\QX-;^
M@W#'F.9SY<56BTU(D&6]B3=4)KB*Q%5-J)2\V+"\L)2\>-7$!%2$6YWN"E>^
M-WPX<3W'NWW(RH9,(D(QV0QO5P7;MYZ^!/[?"?^/S=Q;_5<[B%S]<L+\*1OR
MB+ :Y<#SS(9U5MRD*AHR*T'EJRFAH(3"NH5"2PF%5Q4*K6:ST^D>KM(5I%PH
M4)8:/)D+X2_HU:U7$PJ;JJ]OME:7"EI5*;MN+46JL(_;K=1IM57.TZNSSJS_
MQ6RB/DULIM__<RG^^86S@.<\)]_Y, I)VP2V9)D+W"9SK/*3#_]^N+=!1;V8
M<;SH!;9Y"9S*Y7XPL6>&_J5Q^0)6^:RBG;B"CG*BO $*J36HNX-1*!4Z-3VE
MRH*Z!L6ZUS3[EHDU@/[L][O]YC-;7"^6%B+F7L2R8Q[54^+B"W>][_J)C]Z:
MB_'8!L8/PN(;A=ZO74B4:M.QE#CW[L3U+)8F1>"5I*@UM=0:U-W!*"!; LWJ
MUO2H*@OJRZ,[S3Z8%9;9?F%?[3EI(9PQL1N&HCVQ_%I!5I1U='U:9 31<,B#
MP,.RT=A;  1%0%!LQC !@?(,F?.T!Z>OI$^MB:_6H.X.1E&Y^)J>4F5!78.=
M<MAL]CLMLE-,L]7K+Q5:6I S!3$C6\O,1XK.V22_1J/ <X^<V83!E[ ](9@V
MR,,_V5Z8WC,@%_>$_,&W'#;080OAD^,-:680'+]&;AC<V8[##?T(GF!35IE+
M@I7C3[=0T*ZK"MJML:!=2Q6T4P7M7B0;#S<F<-1USUKR[^ OT^JN4C'CFH>A
MPPLA4Z+(JX,"M#0R=N8PL*7L\3@61L&$^7SB.=B;&,9'VVS(J+$EYF7+YI+'
MGNN"'+IKH/$5P7YPF,D!&^N\\5L#8WBY#Q].OH4-$D!?3Z^.#V!MW<,#- ?_
M +%ILZD.C^8'! ,2-O2.88@72$.8>L GS!FC#)P3YK8+K,<>1<PI/CJQIP&'
M/_$I^%7W8%U X#:<)4,I&X#<)QD=8&M.L=:@=(X1B&YWQ$#4;Z&1A5'L1D<5
M=BW5C:[>O*#6H.X.1B')]FMZ2I4%=2URL-GJFZO4-R?VBF5%OF/V2-Y!N;GZ
M($:VZ!,:8QA^IMAW[5&XUJ#N#D8!S;::-3VERH*ZGMY$G6;77*4]14AL%9CH
M-RZ[CBXLZ"IBORQKV1NF7QO'#?T/L'CN??MV$NK_PZ:S#R+,=RXJ87/2(87;
MR J'"R4<ZD8@M09U=S *A8-9TU.J+*CK:>/0/^Q1BN!!:^G61>370E7:S-7V
M3JK! F]^6H8\>56T#DG1:"6"0H@!Z>T*0&#<VD$H)=,UMF"B5<4"Y/J@I>_A
M$ENMUH'5Z[>MSGY>@L3+57*B#K12:U!W!Z-03E@U/:47Y#+.5E]>YCI0;]9#
MU%C];K^WHAM)HXYWP\BW0QL@OL2>$*4A;YGFIW&%P$3&L*D'L@>EP#!3AH2S
MX42?R0%]?<;\\ $?\GE8Z(^G;<H2$>":<V5L'_%2S>K!$K:2%;B6I,6J[R2R
M1-'AN9)[N8CUO)QAM)J6V6ZOPC!R.B2%X5SC_2)^ALW$H-9+!^$'7L'B%IR2
M;>!M'R4G6*TM)- 93W5-1G"$?IG--Y[C"35 WRI*W!HI!TK;W*2VV?\_-3VC
M37%KX+5]XK1KA_[,#6R,:+GQV8C2 SS''CXD:U+<;)?13W&S-:S=,ANFXF>;
M,GSY=\N46NC'ZV@ S,QF/IJDA:@UY0VLP:G6&M3=P2BKI3C:1CE:*^9HV.N/
MKC_&^A]@DT;3ZRG\Y_]\\KU[&/&2[EM&?(8V,SSET]T)V,(C?18-0(_3V7#H
M12[E?8YM,'GC'!EI[RJN6 ?,J#6HNX-1+:7G;90KMA(][QC18@R(09?$P!N/
M)S:GL-9A%*8Y\C[>(@01$RGYUUSD;+2:5NSUNV;^@+D\.+CX[O '_6A(C-9J
M-BW%&.N '+4&=7<P"ABCI1CC1AFC]2AC_&R[S,5V$8HQ[@9RU!K4W<&HEM4P
M_^=OWSNG=3VJRH*:Y8[6B]1&\U#_O7&-,8\QGS1;G::XJQYYLY!L[7EFVF]V
M%3-]&[A4:U!W!Z. F5J*F6Z>F;Y$U53,5#'3&H.Z.QC55Q7BJABI;9I=$Y."
M#OJ]9>(N\9:'NX%@T5=\Z $./L@(G]6B*?N]-;4 MI[1I^7MDUN-\+C6H.X.
M1IE-LW%V?JUZ>CT;U#/7L5U.X/V_3U=?J"PF0[9XX@TCS'"I)F)5\[2J"97B
M0!OF0-?'ORKL61L'NF'?/=>;/H!6%H):1PG2PPF?,L62W@Q4BB5MF"4='WU1
MV+-)EG3,G&'D")OSB^U^&[! Z4QO!RK%H#;,H$Y./ROLV22#.N%CV[45?U(8
MIOC3,_C3EZ-/"GLVR9^^L %W%&M2R*58TXJLZ?+J5&'/)EG3I<\Q'6UIXTZK
M*MZMNUC1YNK_B(VLYCYNL ]/>STDHQKN'..E/T%'G:?.\-RP>\T=T"T+F;B(
MW\,K^M%(5CZR10,<P0\$+QA)$M\O$RX5Q<[=I?(/^H -O]WZ7N2.L+.7Y_^D
MWT_LD%=:?&,I-26\GPGJS41([K'G.-X]YGM/&1R1S9Q '_O>M+36;CZ6)P[>
M&=L!H--C,3QM Q^&"63+1V(1>U)-&#@"DD]1 .PC".3P"-(7YMY&P(7V?]+W
M['V:C$4C&T?!1'?L9TC!2)^80S?MUQ/.L<'4GOW8TTF18*KY(1L=PP,&@0'O
M+O\R;I#/)[@,X(]?O( FOUO^?19,],]P /B>>(V 6.;5"6P.'+GMBN)XLOF6
M/"O]]+^1'8KZF'MWL*!S+X2'0R\3<)N.U]BD"5!#YJ(,R\H;EC7$*B6NG@_J
M)4H$8(8$( 61VD$<MZI/&##? 1:?]Z9V6$P*8+J/75T#(;"&GCNVL?@)<L#0
MYRRD<O& 12"NKB+0;:WVX"!-;$U+%I]^'Q++Q1R"& RSWP+9)FN0&L1M\:T8
MC%BD H2! ##@,X8!M,Y#L7)H9B8<)IDMK2BJN'0>)]:2(KZC](16W(B@PT!N
M1$*%7<7#7%=JV*ZB6.2[=C!1:/:X4J"T@N>#BG8D 6>[PKY$-S,H!D*T*I1;
MA'(*YYX/ZE?FLELRFPE$T"<IBTHGW5*F3WG^ [8#=_%+YONHQ^$+Y8CX/F0#
MAW_4JM\\I'!*,[JO0> !21T'OAW:[NT_WC7?T><9&XWBS\_WPS=_?%>5^\C,
MW<7FL_]H)'OTCW?LSZ;5>I?DN0T^GMV<?J5%F%U J,''6E -P/WYXDK"W3SX
MIW[]^]>O1U?_+B[@C5!%Y8$^]T*-S68.D =L<Z-FT-=RR_/@_G\'!_IGFSNC
MG^B>[0.\]M\(LVB!P?0^Z/]B3H1OZ@<'DJA']ET,QL#S1]P_&'AAZ$U_TC\Y
MH('H)BR"?,7QNI+?NS1[RJBSC+G(N/,S@#[CL%D @,1_Y3ASV2)3/EVJ+&7W
MV.%C>B/A5H]<& M!D-VU>+\^Z#</,YC_R&<#>_A!/V=3+O;TW,/=Z[6S;[V/
M7\.?4HX3LYN?W\,VEVRXS]FW@P$')1/&GM%YR4V&5<4[G&!@!J]27)WE!L^"
M1/>L>,XU0.+-4][Z]5V0/==GOYP?W?Q^=7J=$SBU +^6S.Y2.F U604 7;"V
MG]Y>I>5<4$<V.WNC_2=<KJF[%1^*NWZZ(?E61]A_;<BB@(^$:]@75Y0P^X#K
M :R2CS2T#4/TPTZ8,\;*!3@0.7[% Z)G7.3"2S0>B\*)Y\.B1F]!/FY>40=3
M>)'8J(@.OR63%5:-W_[CG;7RAJXU/N_K[^<7Y^)6^^S\>*-N$'4FRT&8\BUU
M&J]_&M6.?Y9\.='C0<-/^&V'U.'U^>KYP(^8_T# 6CT*VNFLQ['PV"I::UW$
MIX>?'@/Y*:MI99G7[JT5_)_MC^^#]P3U=<B&#Q@O/0*@;PW]<M(X ?9M5[3:
M434]P6\?*D(3 F0.512:**B2B&XLM$F S%4N5J[7ZIG&2]K J9&;!A<),W;
M'>\^MF_3^-X9V+F>&V!?8FD"B\FTC"V-D4<RFG_(T$Q,XI$\\2U&HF+,Z0@+
MN?+13S7;^UTSC->N\[2L'[?@KD,?[OJNMA[30#>_G*=EPOH5T_8V#NG2"Z@H
M@CJH9Q^4U=S&09T IUYXSZJT0@75FX1J^^QB\S2U+@:T(;?%U[/C7X].O^B_
M-O2;HZN3WW\YOR@Z+=8J'*J*>!L&-;'B",+C";/]*7-CT^&3Q_Q1+=:QX2W?
M- -XTF?Z-F7LWE<;#%+N$"Q(Z8!NT:WK[;]=4:*@VFVQ6^\345#5':JW2%,5
M5V6O;XZ._ZU?-?0O9^<GGRZN?EEP";>KRM5:'>(^#R@EUY *;7F31?1"G]@^
M'X:>7XMU*?VVCH)W#[A >K%Z5;Q:W5\7!Z@FIFT *OOCWJ5ONT-[QISR6\@W
MOJ=O47S7^T045'6'ZBW25,55XI.C?YV=Z+\<G9U>*;?N!D!-PW3F>N+6 GZE
M[M91J.Z=L#M;E.CXA=G<5W[<I1EC0:V=[V2-%FORC'XT''J12W4-E=Y;5QE=
M[Q-14-4=JK=(4Q77>S]?G9Z<7IT=_U/_K0$?SF[^5VF_ZP=5>7:5JKMI5?>S
MSX'1V,-O! U2LV^'?RF%5T'U1B5KO4]$055WJ-XB355<6_WMZ.OIM7[:T$].
MSV_^]_1*Z:I*5U6Z:NVDZ-YO#'X7U^5 R["M?Y&_\*U*"@75;DO5>I^(@JKN
M4+U%FJJXIGIR<7[TY43_='7T^[G24I66JK34VDG0O1//98Z('OCDL\A-@V3?
MJJ!04.VV4*WWB2BHZ@[56Z2IBBNJQ[]>G5W?G)V?ZI>G7[Z<_>__'EV=*855
M*:Q*8:V=),7DKN.);P>A[8KR&4<-_9([COW77\RWWWA IH*J%G*VUO4WM0V6
M@7RZ<\ZAZIRSQLXY'=4Y9ZT*94ZZU*-@*D ='T/]8*>1XAYZ[7<)_/;'*ZJ<
MJWEC_<P=\1FV[W9#V52&^WRD7T8#QQYF<S8^V_ZTAIM0RQ+)5,,,3R<V"40-
MXNO0&WZ;> YV[-&]<<T6=3:-7,_5SMQAXRV43:X\T#\//E[,;->&/9?%JX\]
ME^0\5J[.I&M=A_ %E=_>='.PS:PR/IWZP9XPZ.^C[W_VF^T_^8C;!P='T<@&
MHI>G=P- ?'* \O\<@I':;II-\\\_\2_3:IE__M5M_O:M=7SOMB\[**Z^_P1$
M=AY-8<HA->>%MZ_X^!_O/OO>%-\Z:)KPO]"COTWKH&6^TWDP9#-4H_R(OR.
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MU@0""5G8&.NLLY\8T%!=75WSD"$W\L38UV2+>E]DZD$6I_#IB3@L8*G_7>4
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ME]/;(T1)#3OPE:DAW\N:"?*!3GZZT$T<^M09]<2GC6>O<M5MC8N_KJ_EERD
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M.7P_DT%=I)PA*O(.4EC@[Z(R>*KF_CS^_*T>]!C10Q\VF_C0WI^R:)A<4Y.
M Z0#?(_]F![PR=L+G80A9,OES[P[M$C :3C??)K*FBF;!S&%V)WF(#.P_MF*
MC=0]'KS3)5_.NPE,=GA?TZ2&/)=5?8I:%MMV](T[V>Z=YG*B//27K=NB("J/
M9CM6X<<&Q_CVJ:DVD,3C+;E@KN+BX 9W;L6NW[EX9N@3XFO."O#_EK[)[RPD
M,3U5X$OY*E\(K) .7OY;'I^Z^R[DZ2YL<O8*"<2N80]R&+^L)K@'@:?=V_+M
M7-: A:J B)HT430%F3K6!6\[[[^EVIV:?:I>5U]UTB,#G;  T0?\&TXEVDZW
M(;L5DW\D4*Y8Y@M5G/&:SN_9WT:&L:!DPH^%'%_.[QYNBCO')W#JK*UCDDB\
M$XAG[&=B=EH7R].%TE_6I.O2PZ^<.+Y+4/'8*3=,7U- CY9DUW8G)K=)H/A3
MJ/)"/L<7"N%5+"F[B;YW80PF@8FR.0&$1)8O1*AL>1Z'21.R#@:8T&$A#G6Z
M1>5]Q</W&;N?B*V+LWIG>58'UC]5Y\.O#>N[\6M\")G""#,W@F-D2P1="Q_J
M=H09HB&9\ $['4^*Y)*L\'VN.(F$];7ZAI0<(I-#B&#*Q7* ;""&YTJH78@A
ME5>'"$R@O&IXY15V0Z$D"P9<,@[QY\R?)_"P9C?<7\P0^3OUA,?99V^3V98V
METTR%9!N=ENV?/ZP=JNY+(QN^LNVD9W]46:793E.V5*<D^R"QO:=YS39VC.2
MMS/S &S%E.U)C(85<CS@]&TV((N*R3"QF(2ES0O%,E_*A?OU8IPU;ZN3<U'1
M3%0 9+.C-9]0*9@IYCTBH3-JR(,-)T\S\Y;QXV=I.JCLL]\?4>]AGR0 A)-]
MT.V;4J)U%\OEJ@?772Q$^0O=\3@TGT^T\T\.#(-BG/Y[VVID:SX)8\D&G'6F
M0[1US7$H(KVWO8T>7)JWGBYK^9OK]GSP8M*&@FD[.0^$YO.YMT;S6_8[%K4G
M4359+?/92KBQLQN1%U?59>]2/;'%8 J_%W+?K,=I3ALDZ-R)Z,FARO0*H;]%
MAW#40U3<?(C>B_,\S$VQ@8!C'=D$E-M\M<3GA<1B=%&%E1<#5#'U'&3776N?
M8I^[MB8JOZWIG=K2X_1E3JX[$0W:!=K+/@OJ#1+Q=AK>N'GQ;+1\ K&@J#;:
M>^%"26Y@&!>*U>=TQ5&:+_+94F)M99**XZ4]ZO;O)!-\)HSMND?2JP,I*MH,
M]MNMR*'M%.EU/?%)-L'8,T0X'XHF&HN6)8/FIVM(Q(:NJH2\J9;L#0*ZL@2M
M_XOE_9]>?VGEO]1RJMZL7^QG<%LD[ROQ#;#>I4RF6.(3?*/)H_6^RP?6&C/4
M7MG;YL:3.X4D0SU"A2_ELGPN0L.8A$)\Z69'EU&%6"FUFZ)ZV"Z^R.=+R6YU
M*J@.!IA 076V)JB ;)G>=$H9=%]9\4$PV:)]Z];NOA=_//P9OJ;%T@J5*&])
MPXWHDR@44I]$%%Z]1LRQ^&RLO.%-(I7/5;)\/G#,6VH6'#FW]8Z6;,M6<#:?
MPV"7/\_NE';V3_7IU882;&QP!=!S*@ >(V?K&%IDA2B*OKV-J<?'BDT?C!Z?
M;GLL21/+:;@Y:;,H%/AJ.7QZXZOFZ:6"9U^"YT!E!C>E<^C(Y%GL4,^= "RF
M,J2URHHZLV3IG7*8;=/D[<%/5[)!9@*<(L[Z4X6.HU[K6_/M5Z\P'MP.+L[=
MN>[;MH \#KB6*IHF??WT7K/Z-_GK>^G\UOIU5\RVZMGQ]UQU-LQ53?&.?/^[
M==;._OQQK0[N;F?2E\OQ(/=SW,N?JL/)65:\@VL?:_WU=56WK*M!*6#SRN['
ME^KU?-2[:=Q'6AE[X+[6%B(5 K<MGE)0W&F"1*!<N(HV[F+#GL0$.ZJC*@+8
MPL= #]76.1B)B[MWSY;.(K.EM<Y1+?'N2G]03K.MW.&QI6WK6F5+:RL;_FQF
MFYVQV*H5CXHMA2BMQ:C5\2_*E,* CIIE$@'HW$<AJ"[J95E2JH$?##"'JX'?
MD=MDB1,!(NP'Z^5()J?/+-,"'1RK]=^:2KZ#6SD) >A-^[*Q6J-(;<^PYUYG
M1-E#Q\4I%8R!&FVM=S&<G8J_)G_RCNC8:;->5$J6PQ?/6/,:#C8L__3/GZM.
MHS MBO&6OV=1NETL[;3_,37H?8ZVVW$+XZV@]+SA=X+ %[,57B@&)74^2](>
MV5B(%^:#S6?QP345NK(LS\3<UXMZ-28C>%$^6'@F'UQ=_E22WB7["]'52SNY
M#UZ!^87!OY.!M 9_E<\6BGP^%U2!\BJ<+QV <F@K20>@;!L/L7T.2CZ=@Y+D
M')1B.@<EG8/RW#DH^7<\!Z7>N;RZ;GYIMKNMVR9WT>FF\U \\U!.^TOY2VTZ
MG%XN1V</,6>AU$%0&O*]K)G*7.9HLL;."'TG,U'R@3-1+GM7US7+G KR8%6,
M'>^P!1<IA<"9*!WQ:IH?-QZ_C_: DW0D2CH2Y;!&A1SH*3W@D[>M=MPGDYRN
M1IU13WPZC$$BI"1\Z).<W@3@ XJ_'10P:5SV8( )K=0E-!YP$&MS45%1406+
MU!15N2L/9P:=@"P]S&@C,ONP7ND&NN)JEF4H@QE1;WOZE6C )>XYS@K[.<GK
MZZ_?B]H8U%@PD ]P1PX*F-"Y/YO( PT(AT3.=*,;0B*P_SFG45N]U>[TE@M]
MT%_^RN=NS?%#MOR"0X+@XQ*##)K$S33#_CC&SF/8SDVTEX4.; YIGS.=E07V
M WF-2381B^;*6[IA'</,GJ3H,TZ,HYQ HZU\@<]GPRM4XHSV>1%>>["<[:"
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M H@9?_IHU!E=Z*+FYN4T-4D?6;(Q.9.I@1/@CR&'69_6Q2^Y:4WH%5]\!!Z
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MZ$#WFO0PHP:"V=,W9%:1:,5 -&4)10/(!3(V_1IS(DW@?5W9F"M#F3K%/),
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MYOIZWHCB2WDCGB&L]D Z:QSL<#T,A7U[&-*=2<!K4'@1K\%A;=5&_IL]"*?
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M'A+U/@-;T'A0UY].L],L)4VG4;N=AG$[E(:7[;O>O4N 0>"$)1UL>7W@#.M
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M6";8HN>?&FVO8X*F!(J3;@)3ZVAUUMWHBC9:PA_I+ U4O<%Z(308ZLP:DO*
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M5#C.E@5XG')((L#('0@V+%QA+\5E$4F/Q9'1<,(B5:QD)2-K(BV[@;L,,LC
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MGD'$.5MH;:+_(,P$G0$28-9G5D2H6(/+#'7A.CVC[,1U$FUF]:08L2=@$T3
MNS5@?';Y[T=:>['YV*VN82W70S0S:P?1?Z VGZ?-+[<?J?CFGS"<( \F# ]S
M*GQUQ6XU\4K: 7T%&R ")CRU48%T[&0*MQ.]0YRX4+N=/4F=',D*&OJK4[RP
MPZJ\8('SHQ2 1R[;_6>,%(-XA20[H-@WURG#8Y3D/\)NZWABCIYTA_>ZBCDS
MY#$G4U#U\0+6H=;A*B23-J,J$P6?#"?4T@W2R@V>+F[*>*7II_A(V09F.AN
MWHT(_(W]='V1%P8X[:KKI+S05<YUS(K%-+",[YAX('$OH0E ]%7(U@U1(F>&
M\!D#>X.;</RHJXR>4KMM'7VK25-K40[1]FP2L&^=S?XA[8?12Y+!&E"+U-C
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M7 3S<V;Z'@- C>45>#TI"_!V6@@L>8ID9=.4V4I<]^,$!ZE@EVW']Q $"@F
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MC/KZ7CW>-^O6/#HMSR\@<._"8\D>K_( K8/A;2=PTV'#]D?%+MW# .6V[[A
MB\8J1LW?#\ E\E<HN]\51$J$#5:4J5N(/IO8)QON/E?9U(J/6O.M_K&GE1<4
ME%Z\5$OEI?TC$4M&$VPVFDBE_@U 4UY!-5/),:?!_]Q"X7]8S$XL9AU\7L=4
M.BT8[KFZ[I';0N <%K,3B['AL&E&.@9$FQRS@+TH\A)O,,[64&(EMM6S_'A&
M1>V97O9O&)+4T.R,5* %,$1UY#5P5S<S+4.T,6JKGG?6QL1X->U2(7?U>O&4
M^2QWCC8A4)RTF""TJ'M-V/0_($L>\LU*K>J&MWY)XA]O$>N\*OZ/%WW_C\\S
MXPG7Y?K!SX_>^9[@O.B=Y1XV#J;EYR"@Q]/R.5?]5\?9N7S,@6<3L^9$6W9F
MB'24S7H-\_:&HR?4O<EGQX^3-8^3_:KC3(=RG/&<UXSI[3I.,W:?C;<$@TL9
MQJ9A:MKFKN.)S7)0KPA^Z[NXZKK.PK+&/21JQ<?,Y=%:V%ZYJ59_!@?EMK"R
MP,.YY^%^UFLX]S9@_MP'^YZO*\TE%9A4[,SM5E#0^N1>A!8_;(UN1XJP7X33
M9]^>/AN]@I+AUZ$);YAM"WED Y('R?O1Z>,X82,0/'>@D-1)UB\!:"E*^6?W
ME. 'KM.!!QMH$ZL5Y,_,]3C?3JR@! >R0A,D;*J_=\,FS YHLHX#<.)W/!:*
MZI-,Q!8*@&\R,1UA>$S<.Q8_CWLBSPMP#=!-0OQL*WV 1/SH]-B'(K\D%IK+
M%G=7)7/2^+J2Y;5^Q?/7\MOK1V9>_';G]+!YA)CX.PC1TJH*^Z)5A8O[[5@A
MF1@FFM5F9[>UJGG(SH:D5<5B)U[X'I")[Z N5<.B1>-V6$G=G!UKX,_M<[=V
MF7UB^4O^RWR,;M#ZA$)KM V^;8"R;?;MRA' @ '4H)QKF>?LC@JX"&]<]!F&
M?S,13;+)A<+(,S@=]*S^4AS9E(=T.1P)QVF:R;%[AB.6/I_<77U^H9Q95\UA
MFXD7H?:<9C%?/VRRVF(38$DB"\,[FT[&]XS$UL 7EQ&2WA<C9.,$^Y%Z&;*I
M!I^YV75O[W(4&)(#F%W" 1R0&.>9+_%O,%^F5WRL?#.H\9?#^*8\N[0@!JA
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M]L1+8@=48__=63WVAI-&7=CN2,%%F7=.Y62S_IJK5F^FN4TZ2@/G?#O6R?R
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MO>S=]#X?'M\_LWOBG\A'U-$ WCDQA ^1;79E 64"*-F&AJ)?ILL&737V58-
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M,:HR8J,3DL>[OV#_*[ J\9-IP!O$+B .G"@M1)EE4;8"%7(?$S>PT)@ _N[
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M :IPGR-DT1.'N!C*B]N"U.DAB1C,W)4.T^D#30!M(G T>W$I42BH($G 3\*
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MSVVA+PIC08>6J!'HRG!U7WP3<%9L#_! DC5OR# ?(FP=?VX+ *1N5^R(^%0
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M&Q8=XBAFD^3.9(Y.ZBB:$H54S"F.,1M<IR/T<?P9L"5\(^G92[%7P)8?E/,
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MF2A><D+0K&A<VRD2'BB7:V>Z)E4Y:2>^F@_=7D :/XDE A20,G/1'O4:H#$
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MT@AA%CS:*AVQQ#'1XK7G\$DO<_5>:Q;+B6FOYT]ZYIKLY9>.PLOYY+C2N,@
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MH3(-2VE?#)-Z5,LNN3AX!7G"C8*.%E+(J\H(,"[(2I(2N@X/I:#!D3W45;@
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M@=_6 WJZ*K0*A:<$?G)U"&>.L=.9(J,NQ$#T&4F^8(7H@%KG:Z/<LVK6MY.
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MW4,#D5D.7@"KK,.AO62'+ V&@A0!+Y8$3C$@4P-6T#% (-E0(2N/E-9TQC%
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MZS>&WM,[JF$I:J=C3@Q+-VZ4H=G7.[HV;F$L@K'G,-#H'.+"^+!%M2JS;SC
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M 6K5F7%QT*A7;HC\F3P0DJ5-H]<V;AV+6S<A4?9 LL!S0RF4:GNV@1].%;(
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MK:S' &U7CKTXS3:1 8P^=+,BK@$!/,1)-B7)HA3]2$OQR ':I78[SC9^NTE
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M'H.$=>)0E-P:6*I? .Q>QDP&?JNF?JVTT"B_YH,G(W*)K5]#;,?^"PVD^MW
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MJ%@<.S",]IX!ZKWO1*E?@P!8P""R0;#*>#^E43RS ['<'OHY^&\/ =*<B1\
M9^G]":8/:!"%6)E >5[/:EXLIVA$C-(ND]X&/G9.D=!/_=6,)^M/#QPD5MOT
M(X#4$F\W=+TG')6?EA=+<[0TO'8H.^X%-"U62PX#$\$2AQ RKFPZ)TT'_@B3
M&2!K<^>$7GG\1?0BEN^B]45IMC@::8SJ4COWU5L4RP]A"54:"+YVQ-*.1V]I
M0@LJB5XAEIV2>.J*ML'I<A IWY.'\[;2>&X%<\O7DECZC=D,N%@\^^Y'R 5%
MDQ?RQ)'FQ2O(TJQ4:%2T/L] @*9AU'/1+%U!U<NT)S@N4=XN,ZO6LTM5>N'
MW8+8E3KN=K".DZAX-8&CKE :+>C?8.\*3$?H_X'GHD]QW_JS$_ [K=6:JTW:
M@TT4Y\PBK^@<P9.;$3N+H*&^625=3D(T^"'J#2WO/!_L?4"<D!<7>, Q+C M
M/;.<WT>-<<=* YJ_&:%ZEH89=6QW#C,)MW[1J]>[7UQZ@B_=DMAQ$<=2D9>U
MVZA-@R#;?7:J/X^+G&-QS^]#7(2Y+#[T6C7N8)<EM&0S9R=B C=-Q!P^K0_I
MD']XT4*?)H%@9[F+'7(D8>+FXB1,].&0A%FB;:$,V?FDI7)4V^=F,A%)TZ?_
MNTDC-38DI_"4(Y?9J#@6D&0V2R?H>6$4WFV-%^!NL%ZF ?1M92XXVZV%D;/U
MG-*64.41,2!K)? 4-QR,]Y?5M8+=9%V#\URR"4V)(]=$3O>3-]TXR_-H);0C
MA-!X26.CELZBL+ 5@1-!X.#EBXZ=SCDX'_RC]FI4@'L8S*$?AW*>0)#+^RI!
M,;$E<<1FUHD""*:V)H[H9$7>0>X+L&'?7WO8F3E/C4FMB9P70F\*@@*MOMNB
ML7[&/%'<;A@=M2N.D2Z8.9OE:>)E"8I/&Z"1Y@3NCKJBPJ<4%)P?W1UCQ0='
MW\?]+U 3@;OY"FZF'A94[(^E'>78QZUX?O0:%7V=EGE=V$#]=.\[NYG"E>.5
M)#I?NP&*XYYN5F#U%1^E+47N<=7Z:766RW(4QA7JI\N'D5Z6M%V=1G4R&=65
ME7)7_9AF]+7GQTO3'OKSB&[P$@%_"O8S'&Z0[\1WY$6X:'I:_U:[P4?[XYQ8
M]#$M60\9Q:>ZC\AYBVC8'W2-Z3ED/6EI?6W70 -4%F\+'Y'\$S_)V@]'[?VM
M+A88Y\&/R']'(__0D 9G6K:I^@DGGQ0_HO\]/_U'+6I)DPWPD3M3?D3_SR7H
M1RUI:5,-T,UQQOR(DP\E.$G:UCQ?R[;^5V<-P[]K:2<IASL>E] ]8FR);]>
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M_@9:!5(5UD0'KZM!EE6E(5IU(LZ=>='.. >+Q6U=&I T+I6+8^^B7#@  Y[
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M8 1<Z&-4T[NTB%Q^I'%IW-\;'=O\;&3Y'>FV@=^9'U@=LV?J=LQYDT<S9B!
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M34[@B$?R7%BI&P^J RXE;68]D"JZRX)6-P!1LD"VH8L,PA*NXRVE%SPGD?-
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M!^.L?@K8)%0?+_5D7#HE*;RV(^H(>">+#E6?%94,'"JP:P*&AQ6Z(DZO:TC
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M=CDE$03$)#4Z!7\JR9/Z#XCIL*N;0$CS<8"I'_V3YJ,M:3Z")LW',:19?,V
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M1KM3V'SAF66])?@9ISGE>7E^\BK+V=')^7(1O*K7N(>5XG@_88R)O5V&(47
MH>DHW))MKN:D?G63J%U.=6C6.Y7O<!'$*8ZF 4E9MM06[ N\C,-8-06R471)
M6'M#VAPU:X&AI354'1.C4M([[<1YWAE>9@0O" [R#=GRWZWGB%)=O_-PC3GZ
M*;E$$=;RX1#(\H7%7#EG1X^\*%14996BWMG:,4TW8Y()NN2A&FB;=**4&X;]
MN618BI^8+])Q3(E0(%2'*/QR.+LMA[[]^+&9,,&>BXO=R;K?^?9Q=@X-NO<:
MZ:J\$\=T@M2\^Z-0@W3FU["Q)M6!13A+M,8M..ZR -.QN_QZ&Y YX0G7(NZ^
M;S'AV?&MUF[5ROZ6Q$T&J5?)59I@)A:#X*K7TJL1N%F]!,;(\G&&2;-Z:O4Q
M1"5_#%09H&9>7P,HXQ0PC4P3%L1!,F[&U^ '?(A:P3?3NL!-+"NE03.L ]&6
M7>46"DAFJ=\/LM;RS3'%"T*6*J#99GY#2$6Y[$CO!^VY4SPPI+/2]+2?/"28
MLU #PT-[K+J-:$@QG/ TES& TVIXXIM-Z*81A\@ORZ"MRRMX$9M@D39<4TI[
MY94Z4%.(PN63-D23<@E(?#;@<4<[%:^,,H1EH)]U' #2BF"0HK'.MDAE($=I
MLXW2E?>V*R6#K=R<:@N#898)H6F/JB26=S*5)UF:1S$,)]Z5TBZ)9(#<II%"
M% R)]/C$/-D\P][N!1- ;Y4T=\JFKVN<YMB8[5,M[^6&H JV]&9@7Q@,GTP(
MU3<!<:7@_[[$'<XQ_7SL+80+_(*3C*? K0Q2GHK2ZK@]@68!OWOX3*, AEDV
M*/OLJG6J3.N-EG>*?<8IY7U";9E$JSB-61]AA]/U)#-J.4W?;V=")XV_7@4,
MU>QP]LE6:94IL#MZWNDF>&5;[^UY++0: V&=LU#!4Z1M%(8_.%S9'3$WF=J6
M],(7$:J4,3LQH)P1  KY]NA/B'V$FCE9"H Q[%I!"9V],6 9?AN4G*>.-1H@
MY)!5:H 9R*Q@RG-85<G4OZW\TG?^P_+=(TVE1>K<_%))MPL$2JC=Q0%!# QU
MU-BTCV<Q41B9T#\'<9HS?XGS>3I]9>YU$^?/Y9NM['$P5?!GUG,:9MN:T0FT
M34I@:&:+5#H09M5;;;BCYYUYL[3 ]#O5<].;+&W"/&5GTVBX=5Q&Z%T'IA2'
M=I7##%7T:Z5&'9I[YQ4?F-O ]:L%:G'GL94&M!!5262A<<F 4QY006%1&W<Y
MM.MII)%WR2,C[#:1E,*PYGTFF+JG'OKQ.8R@:S>!O:2M5V;DVE#KYLULM;RD
MV3SNA',ZZ),@(U&<!F0[*_"*/WE!->DW3/B'*=VP=@/K2#6ZWU0\ZJ<3-R:/
M4AVL3G9\0Z6Q:76#N/4FV2-.\1+ G??&T,K9G)6XM)]/(NV^;R@AB[P61*&%
M$'J8BGUW2"RZP85Q@;@GXS1<D,'KA AM 5@>2P:MSP@J@Q+ZLW<>U&E ZH/=
M9T$>APK#%+(N>:&%V^:'5!#,LHD.G8HJ:%TF_^%G"YD2.D5<#QR'+N)D4RA/
M/RNE??*H!UG'I$H4+)>Z^(:PJ=+TSJ>?,'N>$T>3%QKB/>&;#4NZ,5\*YV]U
MOFI@&2ZY-\J\-B,'%0"&IV-0]]E;EX&"LI .@[L)):$X1X7955^S/>4_N!0
MA#:9:$%I51'026W O1>MH7CIYA3Q?-EL44MR'!I3H \LQ6VNHE$F=A,9#2H"
M#+''X1;3JM<GS;,EZJBC:DX,Z 2ZQ+PZ.:>!Q%::CJ]BV9K2NY%E4@-#4'NL
M\OV<;AI5$'-Q59K8R4L0)^R-PV5&\B#!]SC<D#(55/1_-N79C=KVV_+!G4E1
MD/AQ4_#'%+/;P.*]5&>U.]^^=/=)A=W0XU<-ID.ZM5>X=/E,_\8N\J;^3[KI
MTCTW7^,R(_>&KS'P0P\O'D)/'/M1;+K:T++!]Z61!HGW:H*$Y4W@=QTV*:G_
M^L1.<[%C64%=!Z*=%K%>B_*F&N-6-9Q]@8]@6E2."^RV@":Z&AZ/@8E]!\:\
ML+:5S$ 5SX/""W1;D\OS('^^3+*OIOL&>A5/BP)*\(H5 $$>C'NR *F?VU,E
MQ+4@S>AI_V# ;DGV$D<X.ML^Y#B:I<U]G0E[4:@<.O7L&U.0X^WRD8;VQLZ!
MI8#A[VCHPCR"$7G)B=R^I\5>J&J*\#_#V$5Z_&@3Q<R/.2VR.\S8$B>X$V\L
MLL-T@^-7Z_9)+#<?L?NVUG'K!-,A'1DJOO;55(N*#)&Z,C9E*?>]Z;^R/S-$
M:$-K07$*M)-?8!JWA3$_Y*CXRET1EYU'!JY-]/;O8$@I =4G4%O$.P.Z[[/?
ML4W"^9)VC4F>XV*R8HME_^!(#3=)!A?CY1;X0".E5\0MRP##R)' !;?7DF3A
M.&$%G6;+4^KA4,#*\C_I8U<%F:N?I[L;IZJ3IPI9UQ<WE7#[ES4%06CGE74@
M;5<'O^7+@]_Q?T[XE4^^$GC"%@SCW27BW4*A=\K59RLQW[JF_4<WEJJ$G:XM
M: %W5A6DDF#\FA:>]/'UTT<FS5>K:G'O_+FH,JL/NW)AU'(;IUF9T W=M"I@
M.&:'4^[=FI$RJI/GMV[Z\ '3TP;'D?(%.-H(&38@V4%6I0[H9@THV_+1_\6:
M29)D7P/:SI<9N<@VC\5RDTS",-O0 9?.?7'\PO;5?J(C))XOEZH :' I3A=.
MQIG860<95@08GS,.MW#>D_U.P_,E8VV:%9@M5%2ZZ-L%"=(\6\7AWJ]*QJLT
MY0S]\/'3!\[2V?7-S:_MV0+K;*4'O(Q39M@Y';F?^"-SK!=>Q#DWCLY',C8K
MQM%/<?%\0R'?!EL&M_>=CE"^"V8?[;,PSA^\<.^]X5@6F::US6"]+&M!85E-
ME1_TL4!151,;PZNJT%=:5]G+UF5MWL<(&K&P9-[X I?_;:UTG@?KN @2<QIM
MZP(<7_0=:%CO[J^EMO<>,!JR[,1'".CLFF@0'=[(AD79W81BN]'.^M-8E.27
MK-:FZEEK+ 9:,#[>!,%CEWJ4RE7RI59@ W:92-*)^?F[#>$'3_GRJ7W_EZAZ
M=L%*8PS.5]"#SULE9G&C\(5%$/D)C1O661X7]$\LBBBS\X1E"5"6SJ7]D\\Y
MJOB)I;HN>U[KG>@AG=VB,.^NV=I@HW<VE@0XOA@ 7^*<N6H=!Y>ISBN/W7HC
MW#O?[4_S['T<".HYK?W.9\$ZN3H8MS1(-AW8@,K:,H8ZP&E#;4$ 6&QAJ 6;
M-:6 \<JCH9M.&\9U": .(M&AAN\7+[))^/=-3+#Z"HHF,?/@4IR^*CW.Q,XK
MT\.*@!9+CX,O/$9-D3W3."5GRW4P9WNTUX881SR=(+.+1E#70<'0;>=+M=&J
MSS:V-+=OIN]E<O<M]5%%@7'=^^$7WUXO2RN]-[\GQV+J554BX$[0[^W4$AI3
M%=M;:E_!'IN@_\K?VK)U%YH"O#IRHV%:'Z[4!N^^3<BUGGM=*7,VXUK3.VOM
MXZZ] S>H$?5^D?2;F!>J<2OGA>NJ"/2XE<;04)E;[I8>8&ZH+0@ DRT,M6"T
MIA0P <9HZ*:YX;(N =;<L!5/S?)\PQ;5Y\OSW:OI%G&80L]7A*PU0Q4+2Y7
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M?Q0 AQ')=5#\]%14SE*Q -83<!;N2H$UL6WG5Q!,D$(2HM:G)X*?F+]HAAT
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MS9Y80IV^KF-BYD-?S"T=Y""[;.C* "*#%)BX3U<+^:/"Q:9$H+1D)^"V^?O
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ML'4P9#&G:%/ "6)%\&BS+ 3M2H'D3UN09VEE=?G(,UMT$^Q/HW-,BB!.ZU>
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M,D!<(.;>$)W!(*['5FW8N6T:N/&,.-YIUZ0+LUVK48E[2=QFM5(CEP5#+0-
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MS[,U[&75'^B_UBE\CK63;V'0+2:K(&7'66(J36/;4''#>719[LX![&GN[IC
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MR-X!!B>K6J"&&@,^T=CXPZ(*[SWGN'8)>[:\!/8,\DNM@H):IWQ?MAX?V)#
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M3.S2TX0WY W$K8M>3BK_X=UU</"W)%:>8&X+.!VA!& ="C6_@NG: B2A_9D
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M:95)LPY?,'_TJ_B;^+'^D?C/@[ M?O(74$L#!!0    ( /-!6UK374I= ED
M &^3!0 5    :6UN;BTR,#(T,3(S,5]P<F4N>&UL[;UAD^,VDB;\_2+>_Z#S
M1FS,1ES;[FY[[)[9N0N5I&IK5B5I)%5[^[XX6!14XIDB99"J+OG7OP!(211)
M  F*9$+5-1'C[JX"0.3S)!) (I'XS__SO/$[3X1&7AC\XYNWWW[_38<$;KCT
M@L=_?',_?].=]X;#;SI1[ 1+QP\#\H]O@O";__.__[__T6'_^\__^>9-Y]8C
M_O)OG7[HOAD&J_#OG;&S(7_K?"0!H4X<TK]W/CG^CO\DO/5\0CN]<+/U24S8
M+Y(/_ZWSX[?O?GSHO'D#:/<3"98AO9\-C^VNXW@;_>V[[[Y\^?)M$#XY7T+Z
M>_2M&VY@#<YC)]Y%Q]:^?_X^_5]2_3]]+_C];_P_#TY$.@RO(/K;<^3]XQO^
MW?2S7]Y_&]+'[]Y]__W;[_[[;C1WUV3CO/$"CIM+OCG4XJV4U7O[X<.'[\1O
M#T4+)9\?J'_XQOOO#MTYMLQ^ZRG*9WH2>7^+1/=&H>O$@G;M9SK2$OQ?;P[%
MWO ?O7G[[LW[M]\^1\MO#N +!&GHDQE9=?B?C+WC5[W-+@@#3M=W_%??]4*F
MCJR?HM*:DM4_OO$V0<#:?O?#VW=)R_]V5BC>;YE:1A[7JF\ZWU7ZZHWC<WSF
M:T+B2/?UTL*U]V+J4!+$:Q)[KN,;=:FT9AW]XT.%;%C;T60UV?+AS?1'"Y>Z
M5MW]XM:%DC4)(N^)C,+(J'O2RK7WTHG6MW[XQ:QW^4JU]VKM!(\D&@;S.'1_
M7X?^DAGHP1\[+]X;]5/?3)6>"\L3$??;Q_#I.W>_3.W%_H&U3MP=9<W/O.CW
M.R=P'D57NL%R'C-U(X_[OA>Y?ACM*#D7Y#!W%-KFPO&_""D3FU/Q0_6)>L>^
M0#W'/^O),'"])>M##1(:ME^+]NTV&X?N)ZNY]QAX*V:P&)JN&^Z"F"U!IJ'O
MN1[1#Q*C5NKH]ZT7,'O+L0J#I<<-&M.!CR'[&ON!2VAPS_\;.UZ@'SI5VJH%
M>_+(E7=*Z"JD&SY]W!&'$QRQ[P^>M\P* J W::2.7@^#)Q+%PM(,@SYYB.>)
MHC*"NT^.YSL//KD-Z=SQB:[O%9JJ17<<CXK%)C.51^Z';(5&=Z(O6GT!UJ^C
MKU,:LAD[WG,RF0'?\@_H^J>J4T>?)FQI0]GPICNR''G.@^<+RG3=TE2KHV?C
M,"9L];7GBJ/K3EG9>L8'^RM9.,]Z1$J*UK.B,%\\U+E.*.W/&[Y!6?+U';-(
M8@4*ZI2\6AT]^]6AU &,^'RY6O1$_'O F@CWA-RPW?K*BZ=L%Z%7&VW-.OHW
M8M.(7H7/2]7Q7<;UQDLF!6; V S,EQ D@"Q# %7KZ.&,^&RAMF2[O'B_8'H1
M.2Y$GS75ZEG-/43DCQT#8/ $F<EDY=M;6=:[PFQBI0E:8"WX+%+/6NV\J997
M;# Y*C?8QNH-)H)9*TVMY&!]U==L<%4'ZR*H<MTK/%C7Y#5J7NU!QXZD0H,K
M+:!U@E2N<]4%ZU9YZ?I6.+!>E)5M;Y;LDYB9U6C,H8B])^W>YK)6V_;/F$I7
M1]NU<.>NR7+GDS.8TVF\QYV1(?5(NA*-&.9+OOP;DYC[M=-^:8FL[Q.MK86,
ME?621NOEL1=&\7%EP+Y^Y\3INH81L YIO"!TDUG]&+-XX0?JE?;TG=/Z[2-E
MFG,?4.+XWI]D^9$-HH@K$S&7]:+FZY64C8A9^LGD:Y. +TX9Z/GU:F8E&RQ/
M$B2S]C"("5-+?MS0]YZX5WYI#DM[?6EY[V Z[FMHNEXM.0U,1HMP(626LJE-
M6DZ"&>\F9;/-C1-YYOS7\95ZY2[;7QB+!6BDM5X;G=Q7;[%>>21;*&,B8.W4
MVW<^>HT[6E*I[AVBJ4F"U*U[#DZW@TSYGCP>C)7Z<RM,M["6ZNW_8+4B+H?G
M^/D96X(RX\56XDSSQ [26)0*C=:MSRM"F1EF7RZSTA54W:2]FOT2YO.RMFHS
MIU3&&P=P"_7NU/EG)UL11 75!$#=6OLX#H,W?'5%EC/V7^JY[&_BV]TO#H4O
M6JLUUQC:DUTL F'9JN@2X.7-U&M%V%#?;9)/WD=L\(?L:VQ[YP7DN ;D 7FB
MP$?NXR)+8\MR^3<:]#M6&M#P9FK5L]3-V.7SSLF2@/5+7;W9\V)C V_<4KWC
M0OA2V2KK<%";.D'VQ^C4X%$4N63&O?P;]7F83?E1UVKP!-NTHX;-7!R(2=PT
M$'/ZM#4*M^051;@E^\LIW+*TE?HZ.:"46[$:.BIMJ;[.BHE\X6WXG'AYAY6M
MU=?I81!Y;/''5(_/Y5UN@9-XX*ARS_5--M7]8PP##=V:NE_6I*K[6THB)JJ8
M=$?L!V=5R'-,@B59'AKB(L ND<1>S(NFMWK>=M[P*T#BF)W]-2F9=N/0$3]T
MS[[M\ZLR(07 LB1> @O[RPD6]H_?Q(>Z#VSYRJS4H27?>2"^:/\W5B97Y+L6
M>G5 8L%:+._4>8E\G[*4=:G;"2FCGV%]:,NA[AE1Q1M$:8GOML+%]<9=>_Z1
MXQ4--S)T4B1"24>S0+%/M(-FEWU_R?MPZSN/Y7#FB@#Q?(L!:*DT6(CV2>12
M;YN-6), >U82B.\[5'Q+9&L9YL/8F9%'C_>7=^5XHT=M%R15@,"_Q[042FF1
M&.@&P<[Q9V0;4@WPYR6!>/^ B7>9;$@P_VO'-@V$^GL(TH7"0+!_Q 1;(B$2
MWF)[)F)E(( 72P,1_ROJPD,B(Q+D\S7Q?;YO<P*0EI>5!\+^$R;L<CDM %[$
MM??9U +'/E,%"/_/ML!?D!:)@2FA7KAD4SH%8%\H#$3] R;J$@E1\1X$2RC:
MQZ+@_0\^V#GQD*"^]2+7\9,>W;*?16JX2XI#(4?9<VK%1(7],W$H&/1,82CD
M*-M0C8@M ][;47K6&:55D9>&0HZR =4)V3+F@R#VXCU/SC3>;1Y.CM-SK(NE
MH!BC;#IE0J%@>_ T!#'/.:7"-U\2BC'*7E,E' K./28/Y1?IEN3YO\A>!72A
M*!1IE#VF4CP4J*?4XZ$'<\_5&XUB62C8*#M+M8 H:"^<YR'/PB.NX'"0]*!+
MJT"Q1]E6@L1%H8#')=)MF'$7]_B%-KKOA4NE2==4A-*!LM\T$!V%E.YRR>"*
MTC]&7D#>JJ@H+0X^(\(C0"&F);"_,X/]'1QVE'VH5DQ+8']O!OM[..PH>U&M
MF)BP]WC\'EV$7R0GT-+"4,A1]J(:$3$!%S/-A(H+)4GR6AWJA1I0Z!&WJ&IA
M414^F>0AVGXH"<4;<;M:+APFSM,PBAW__WI;W4JRO#P4<\2-JTK0MAV,">_<
M:2$+)<H5@>*+LE<M%:=M2#G#E#AR]3TO 04490-:)DS+>(Y"?O:Q#@.E/[98
M"HHKRDY2)E3;AI>'$4?2H9_Y-3B"#<6LYL5H&<9?J1>S'O",A[L@]=%(3L4D
M1:'PHFS_E.*U#/5<1-'S&T.'_-SE.)>5@X*,LMF3"]8RPE-*.-.$+;M%'!>_
M9T GJY7,\JK*0Q%'V>OI!<5%?AA%.T)-\2^I!64!9=L'%;IM.Y,F_'_[[F'!
M;\Q(K$RA%!1KE"V?3*B6L1V'Z96H^7[S$/KRZR&E!:$(HVSP%**U#/)9/\KA
MS16! HNRLRL5!\DF#)Y=\::+/'JAO"048)2=GDHX--O["+*]CX:V%V7')Q,*
M"=LD-IR-J,F#[SV>Y?(OA[FT OB>#2;B"E';OK\GKOSPY_;H1O3CEOVE''9)
M42C@.%<D5>*U#?5NZ<5DF73IF*/V]"Z7!'5M+2@!.'<H@4*CN/=_);[_7T'X
M)9@3)PH#LDR6^BH/O[0*E 7$,T2-N"@4? K]'4.)BD!0*AD#DJ)0R!'/#B7B
MX<1>)D'-Q[DG>5=5A;BL!A1XQ$-$M;!(\6DQX7WVGDC?B9VTARK\936@^",>
M**J%18N?IVE2=.69>:X@%&W$4-A2T5! GF\<W[_915Y (J5MR16$@HP8\UHJ
M&@K(@PVAC\RH?:3AEWB=WNU4@2VI  4=,;)5*2H.^,^G>^3)_3<E\B6EP=D)
M$&&7"HF5=N/X.LE</'5/):BKRD-Q1[U8*1>T9>1%GO#L^DET9LCV;:J@!WTM
M* LHVU6HT#AS:^8FOW)J/2L'Q1MQ8UHF&,Z=J=V#[[FW?N@HU^5GQ:#X(NY"
M2\1"@??&"7ZGNVWL[GG&04+X\4ET'&V #1&P 2@EB/M3(RAPW 7A9L,O$X7N
M[_,U$SJ;%EOI-%#6@U*#>8D3(#C2*B@Z7?0BRYO]C#\;P,,4%N0YOF$?^EV]
M* )4A_*#FE$(#$/+- W=%14.[Y!VXYA$"6SR8 )5>2@1*!MBO:!H:4#8P-W$
M TI#V@N9$775#$#J09E S3>D%QSCM"NDDZT7\$="U09*6AB<5@[M;$LN(@[@
M\@B0LP)08'%.;8NBX( Y"EU%'$*A$!14O)/8HD@XP-YZ=#.4N'!R1:"@HNQ?
M2\4I@?0_OROT?<1^</AMZ2_/6C/*KG[C^/R95+:M)ID3]K,LZ^\Z;SK'4WB1
M9OWT/FPGK=])&[A8+59.]"# WT5O'AUGF^@&\>/H\).3DJ0_^.W8N<S[Z],P
M\4@JLK2GU6&U+U?X*I*E+WQI9<B7 PZ$VH>!$:3G(T0B20.6ISH1Z5X;RD>A
M.#A#8D.\2, M8T B*CH1/2=:\S>JV1_\G;8GQ^>;O&[<<RC=LUVW>*9*3@RP
M.CB-2*-$R3@(JXAD"7_RAXG/G^V5>_@.$)DV!+X#: &G%5%"9U<\"Q?-B$N8
M'K+N:UF45@#'YEK ED9J=%;.9 %.6@9'SQ8P4"IA!G?6]^35U%$BM;2'HGMQ
M&#N^*(G%V.'Y:/Z27IQ]0WI,% 2J:X'](YB+#XC@Z.,I>18;N#0O+0SDHG[/
MN0D7"C'1*3B\@GQ\8#CIIW)XJ.H ":G?@P[ .@1+80DYY\]BSKS'-=L(WD=$
M]%0Q4M35@!35[UHWI@@D/SI+?;+E6_(HU9\P<'4+!'D-\,86GQR=V.B\9$2!
MD"(I#F6D,5^#P7!1"7S%B[A$)-UZ&TY5P]X&T!+[!="2>::9+3!%[,8Z]!G$
M$5]LQGO]D@[> I3:QIP.%WAB37%"-YR9#H,=M:HZ4/(:\T$8,R ET%9O;AK!
M'$V=/7><\#0)>I^1LA*4M,;<%@#40[@X]O!$=\S"%V13LB2K N6H,5=$%8[4
M\J,S=+[G.'1TKZ5)5P_*56.N"F.N8$B@$V8REBX91(VY+(R) 8V>:UM-2K0-
MM'/35X62W)C3X\(E"!@=FX8C:!P:G!%;RDV)Q%<\#GDDOA>+B&]^&!Z*:W&$
M[7=4?"HK0?EMS(-R(;\ 1-!'797==PW[[08>Q*B'LRO894\/AD'T51-N4UH8
M2E*#3A%#6A0RH_.1N8*DBWTJE(0RT9B'HY)1*Y,6G8;N<BF<:HX_=;SE,.@Y
M6R\N3>]\V%+**D!):<R#84R*1G9\;EQWM]GY/%Y9G#7PZ\.4K'G2]2>2G*..
MPH@?H4Y6"^=9Z=,P:PC*96.>#G,NJV&%SO&,Q(X7D.7 H0&_'YN1HT]6/#>Y
MG%9(72B3C?E!C)F$(X).7E&V&[(**5E0MFW<T;WXO<F*L+0ZE,+&/"8U+ <5
MN%SQYNU,'LTJIJPLE-G&W"3&S,HE-J?Q0T)C0![YV$8ELHB#R:@UB-&VADBY
MQ%<\'G6[V.I'XW"*;76K0+&IE7[$.X%3@>F:Q)Z;6=*?71!\#[\@V/G+67O_
M\7IAL$GO#,-Z0D5WEV*.F1(JTI1 '3;R^M=[P= ,(?2E\7EWDR0SW5V\#JGW
MYVDXZX@LUL.^BE@;@S)(K&1.9-$V9.U0!_M.8LV,G4-A)5OJ+%8*V:JDL;(Q
M!! ("CIY&:^P^90'JHQ]'?$"$@W L8E(^%2GK(1]B[$>XJR=Y I]U,UPT@K8
MUQ/K),JRN<TP/:-,JBJS6H/N\/KHLG%*.W,0ICT6G05Z1L^K8%]OO( M+1#H
M*91.+Q1-5FG 6_:%X3-7R0\J5\FIH4ZXZF2:0M' Y+#OV">]7T1: 3DR<_"\
M)4%$('>UY560'1X:,F1AES+1T<W;C*''/L\3U_3)$_%#<<D_[:[JI%99#=NI
MH<<]?T0+0 &=JX\D8&+YK)/=Y<8+/"X2?ZQ'RY:V(K9+PY0O(!+HC!7D,C!Y
M^ X+4U:DTE[Q"=Q1IE/(#8##;&%LCT7%&:LH[S6SR".H$HEX+AOX.D13#]NI
M8<@M" 5THSD,GD@DXN63OBISR906QG9A ($.]9)80LE'QPLB;@O8'CT8/'/[
ML/.B=;*1Y)GP%&L/?55L%T8ENL"0H),GGG5DJI4*-@Z#\&#D5>-*40G;BU%Q
M?&EAN.J0+P%*5BKMMD!>PXH43Z8$ZP"X:G:S<B7 :.E55+$C390IP5H,KGB%
M>EINWS*LDDN".R;GR?F81!P?L\V1B$TZU&%,>8%#]_RY.Y&UB=5D(OD"HL3@
MZ1R%#7T4/?&5V>*X!0*N7CV9U.F(NR$!6:FN<D@KH"?9JJ(64L&O>TXA,<2K
MD2N&GDK+C,!2(:]X)!YN$1U"1FZ<R'/EY$F*HZ?4,B-1*33Z!BO?N[[G[V)5
M[(6T GK2K,MHR0F.3LROA*=\)<ON$YO#'TGR'/!D50@VT(PAPV;0LVJ9D5@)
M)%NI3370(+K&N"'T1%RUT*L#RJI@CK.[SV?S^%E,QX_PF(ZS%CNB2>P+,,?=
M<,E-;Z.[,+"&T"+@\ETZW&#7RPBJ;,^%&!-"BY%Q4)C0+;$L.\'QZ1RV:X[.
MGL[I+O_?+CGI. @UY4]H,W[BF'H/NUBDWPR3"VK 0[HV.H =U6*B%26NT?8X
MLE8GN:&7/^E4E-E<Z<R_@!Y[T[)NP#2S*E/HJM>H4Z6-NTD73%LZ7XMU:XY*
M:PW\D)[&%QF-^,D0]P].M+[UPR^2?<-?#?8-K*5.TA3V?N$HE-'FH*06FIWD
M?9G2\,ECG-[L[R/^EM(Q_JSKQMY38NRU\E5IRYY]@I3(HG6MB!BZ"6[VI*$I
MCBX _!KFQ=,B2IQ;,DG%&>8BG!&7_=OSR5F_%V%MX[7Y+V,OJFM3G;9(0M?&
M/F$<N9Y@2*XYYZ6P5\VMD5-X.:T %3I_RK?VNAN^0?Q3]%@?EF;<$O9Z'$D/
MJD*.KBL\=I8#,0E.0<^*98&D.';P/1+K2O"N.A[E<+1/Q&:6::QF,I"5QP[_
M1U(,-7SH@[[P7BXTE$Q;$?O^ -HR  0H.O%67!YI["X"XBQ@>OWD^F:$KN^'
M7WC6RMN0]L/=0[S:^8=G^AB^Q'OBQP._4B\FD]5*]<2K:4/8-R"0U*HBX)?:
M&&\3!(+]M^_>OQ4:,+P;CW_+KF&Y5B?:FR0N(3TVW3V*W*]<W?M>)'K)UKXA
MWQJ1Y:]>O!Z',4F?<RS1#?Z->C^!?J^B;;6I'T)+)BV&$<]W0_HD^3.#2OJJ
M!B@/"[@-]-L2M7FLS)&SD.STG='\G=R3"31A'="8#;<B3%G3T0[&\*J7*"7
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M")W(X^4#8_K*:H)):V1_7@=I<CS0J2JL4(TI4[4 IJZ137T=U.GQ:9G"$@/
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M-/0Q.B).>>C6NT(TR6C0K1J7I9TXDFZ IXU\<9Q1,N(7K,ED2_@K'L%CTBG
MN-#5LV/N*:<DI_,P"-"U/+EFG"P* [:R$P'8))!<'WA7B(1@&Z6[81I(Q8]I
M>Q-Q:6 PQKLQH!#)<#(R:09M.M)W$C8A&;6#/R694UR<E"I ASY@TSV82%NZ
M8,O;B$E8[N%X7PBHF U&W<6@WYEV>53%@FUWYMT>GHM#(@K B:&OB3,<9?TR
M&HM&C2 /1"B%N;%7 2?T@<<O)Y _=JRQP9,D4/!](8QB?G\S'_SKGL?U#SY5
MC@JLY8Y*MN^ X'UI#;Q;-MG^ "_52*I@!^IKZ"BY%J.4W8*Q ;F/JKB7^KX0
M_0"_E]KYRZ'A_WB]HEI=BIM=Y 5LT](GD4N];;I7KW1;M4)3UW9QM3):M>87
MJ,2S$WG19)7KZC[Y+X1<8'VTK#&5*34"!IW'_/4M0QJ!U=&RQE1ET0@6=!+O
M(S)9#:+8V[#U<-F3E&G!?#FTK"U5:2D7%!W_&6$KJAVY9?)Q#P 7X%<O7O=V
M41QN" 6/)M-VT!*I5.6O&E#H_/:<:,V].^P/'L#RY/A\ 0VF%5@=[7F3JFP:
MP8).XO%N4_D]J:3;<A*!U=&>":E*HA$LZ"2>+I:"1Y^B"MK['%7)THJ/3I#T
MBA.8+W@+:*]C5*7/%)Q+V90<"W>73SS%"#^PZ+,%;N3%T23HL7J>Z_BLCX_4
MV?!?BIM?O1WE4"17LO4D\@_4V#[:^Q/&%-<L>*,*<.@<C$YI:;Q''RJQHY$:
MW73R^!9*UB2(O">27# PW(W#6\![DJ'R8M,0'70Z9PQ1]OFU, 9/Q ^%I4^3
M.>E6FZ#*>&\C5-__@3%!YV_@T(!)%DT)%5'*X%&HK8CW!$%5WH!8H'-VO)9E
ML#N0U8"R9(]W12<].CVG:/]L+.?D<.[!^L]08>9=Q'+J3&2EQJ"DVN-DN0"S
MAE:/:4!\_H0#> E 40U*C@7.$YA E@R[,?F2Z20- _97EV3<.V!K:=X2E%-[
M?"Q5T<(/GX D$5V(?!EEL1.%*_/@5**=OR2M(@5.O("<HNZ:+'?\*<%\SS*9
MY6_VZ2\AQ[)5&\0.:3+,/7H9;N@CUB ?J7S<%N[O&V<E11Z_7T=Z4@"]P-PR
M\%;0TVI<F$:T"F;HJZW[@!+']_XDRX^.%XS"*)H$&22@3!LV@QTG=3'7E6!#
M)_O4PW3S;7(>6:B"'2958]Y?"1SH4ZXN7:I\GBUD^H"D[[UL:GW-XUM<(1][
MFAR<,1W-9.Y+-SS+23#C*DOYP^T\'A-J=&O^C!T732_,$-P(].AVH"R=L'SL
M%])\E"<51EY(?U79A2^))+%@B,)Q+QV4<%C01YHD?[!\L!42E4BS"&./MQ>2
M3OADX24T&<V<^C:PQYQQTF!S@-!'739/L'RH%7*0G&4+1AY>UYTV^*0SO%_F
MPZBL%G:6.),$PA#YT4=))HNP?) 4LI5D<PFC^TY?1E+AD[;P4^XPX/N2R>K8
MT?3T*DWU9#Z8*C2*[CLU34E< X3H[K23#(/5BKCQ,=2/"3!S8L*VEB';OOJ>
MH,%<#ZJTBN]9K:X)U5&T2!7Z9$4H)4O6^S+'0Y6IU:A!?*]L=06HA!WZM"S)
MORR=HG\HY"B296'&7M*^IF,N#WLH#7(3:I!$ND5=;L:\>&\^VJNWC;W<;B(I
M<WV86S1#G% XQXDAX;D,*B&42#IZ]I/[P(LO5:R:OXJ]V&A#YQHARC9M+ XL
M_M.HNXO7(>6GW/=L-J29T2;B=V_V@V="72\B4R8^F3G!8RW&KH9O8Z^"<*QA
M;:19J9\I2MTO#EUF#3\_Y$N(C:+=)OG9)1/O)=_!SE'2FMY=3@;ZNOV8*E^Z
M4"^D-CR\E]!PH 36PPEU#MO29W0._9S0F?>XAF4TK-ZD'0$-NE<;+I?3DO&4
MION6CJ9"NL,DA7S#8^G%Y)(_.$+V=T[,X]O >X!*C=DQ=BIGG0>"A3YF8$E$
M^R1V/#\:<Q/ _:-EHZMX(<8@F6CZ@<[Q"Z]916N9!>6!+]D7<563GJX%W3@M
MZ'DCRT[S>Z)@ ;-I.2P+ZF)#GPQCLE'D,(34M8-"4Z6%AGAE!#UNNNNE,J)Q
MAD;VKQ.%[!^_B1UN]]DK8XG]/O/KZR;B7):,ZZUEJ._(YH%0!=B' LAPG^-5
MCN6AJZ?53GM@WGD!6RUL5'#FBJ Y'_)P%< LE:49)Y,.5>=9B^IY$;2TI7I4
MRV1!077.X!"7SC\2GC9LN^8IQ.0V5U'\ZFVP0K:,T[E%:I+KQ-G>],.-XP42
M:N3%\>VU5LVR/,@%J=.:1\3]]C%\^BZ*MS2A@?\M0P'[UV_C?Y:!S7[#?X&6
MUE,-4@[0M+.6' \<@TS2PXYX/W8VLD5>/C"EI,YU6QV @)FIWR;&I)9(*9(E
M!@D NP%/31BGBNEW_DEH1/9][\F+>/*F%>NJP%2Z:$KK JIBYS"&J&$QPPX,
M$'2KF'IAHAEQB??$+<68Z!UG^>+8]UW WI8<3TKIT;F1BG4?D=7.'WDKA3L0
M5!D[&*<R<0;0H-/8)PQ6USN\ZMS=\ 0^?XI_*N(=596P(U4JTP:  IVNX6;K
M>)1+,UF-PN!QY#V191):O AO2-^+MF%$EI.58@D";P([^*,RE<8P-92K<;SC
M\VD:9A*)")9-&N0YC*(=M^GWVS X!#!-5L>S]4/N#Q&/4K8)X.W7USSV4S;F
M3-<KOR7#^W3F&T91CW5VOPJI3 /22JHZV&_:5![ >B#0N>I[;+:(TXP>Z2G]
MG/A^VFG%[*FKB/V(3?49% 8)>I#",0U++PR67CK??PQ9-]D/7$*#>_[?F&VA
MXCTD5*&0 _"4C*@W&?>'XNH+3U7R<<+#%-C/>H/9N'//_UATA^/%9WLB%B;T
MT0G290]#(PI];WE8$DTS#&22V1R]F(#@AIJ:QW(EI(FUU ,\5PQY_UDKH057
M0@D@F>'-1$TNP(T2D"02?4B&94 >>4RO*(M(,7]0C9G )X^9DYL]V[,MA\%Q
M/DJO07BJ=QY-VL#>Y#:L'8987K7JS+@%#\CR\%I#UW5WFYT(4^^3E>=Z"K,(
MJ8N]L6Y25>#87;6*\.&0>Z^1@3=?AS1>$+K))("4JXI)&]@;^"95QAQ+]'5G
M)B3^%!V;9H;H,;$?0^J)Q$@GK,B265$^NZ;KP[+E9R$UYKSWRZ!_/QKD0V73
MC/&=7G<Q^#B9#=-$\FP].I^,AGWVTWYG/%AT1I/Y*8;V-:U\.VGEH0&T!HW9
M<9[8;%9Y6X)J%9TM;)OUNEM>VQ(^J^NUYIGW<JEQHFS/IBO1$WGXEZSLB^%+
M(2-*7&ZQ,ZH0,'EI_ @PM9HI\;<EP.*XGTLU*-*%54@KH&V&E?BJ'=3E0J-[
MIX_+Z)M=Q$QI%!WZJ8XITU1[,08-)FXS\:WFBPI=5%FNF"4L032P?$%0DV63
M',H>7H0^O(8J-5>\M*PPMM^N5#.R9Z-J*9LZ[PZ/[VW/^".S?"M[UU,"K*Z"
M_0"Y%F:(Q/B3P>XA@IG_?$%+3$E]!C\O('H<<:9'6C-?+&H)/^7Z)<>^60,_
M>5)']_)"N3+HYERF!5E;4RI70Y;\D^.Z;-968I@K@^UL!F%8*E=#&(JG%PZS
M@TBK]LB/-$*Z5ZNFMAIV6 ],6X'2-P3^U'=Z/<8T1)$E9:%& =<J* 5M"-P[
M)]BM')=G(@D>=2L\66$HO+@&0RTJ^M+NZ(<0F= R+PT#W"_%*I:]/ZORH<O\
M,3(<&AH)P\"E/,RM3Y(_,^$-O"=J0G@+)@V@KU(J\&,J(R9;6;V9$NIR;!_+
M#N4 0LG:PH[B:(A#-73H9O+@!>%;=/)$_%#$LZ8=5H7E**NAKWBKVTL0(.:Q
M-N^30(<G0A_"B%P2:P,>P4I)X%97UPSV#8GZQBT,L-8LL+H[%<PPO$'T?51+
MG%IHD#^2@,T>?%_876[8'I&'A/"H=ZU)UE;$OCUQ@5$&@G(59EDIBX%=UK:#
M?0._OD$,A*PURZQ1QRJVV:1)(+$_7SFQ=MKGX^+>P)]@O%AJ^MCN(D<"_I:T
MNN>@@LO )BK TF$S<XF3X *3UZ#'N3FV;#9RD%M]I86AA%GESE$)U/*(XA^]
M93*E?0D#N+$KJXI_I%#;^)$C@TA.!7NG;@1*V!6X52!HX=] 2L1E/1-B!BZY
M8[W?49+UWT*NO/^U<.=H\/%N,%YTIH/9[61VUQWW!IV[07=^/TMO&:67CRQ*
MSG_]5XP."5 *T<AR$115+#O]T]TNULF./]@R3T)'\:WC4?Z8%&$C+7W$P^-)
M:\IN+"HN^_VDNNS7F\P7_ZMSVQW..I^ZH_N!&'AWW<7];+C@M_WX?<!?)K-%
M9S&8W76&XT^#^8*/6O3;?F>R/QR2CL3[.7%3H"#OJL/;P!FN=P[]G<'\X)-3
MGS3W_A15[(C],V<N-XX5$N+?ZBOK7&%= &-M9-L]/JTV H@:-7Y-SX"LXQWR
M8< T;B>>\U.&.TLK7"=!4G&:N:-GP,R".D&T(E3<T"?TR>/IH3*7_D\=CA:L
M&U'YKW3QT?5^Q0X=T.AT3@/J10#[8N']?$'%[B0SF>CN%JKJ8(=/-3$*<@J@
MAPS=Z6:6[>2BO"9-$0E:%>1O/Y@E)FDYT?836_MS>6Y#.G>R8O$UW>E?O1WE
M\,CI,FX(>TQ6H;(B6A8>VY_W]RC7*J01D^OPU&37%VV2);=;S&2=?M-G/YV%
M(L'CKUZ\]H(%^QRY"X-X':7YDY,WFB7NPA:_CQUW::1H+6/3J%^Y23F./A4$
M_<I\&SL.U"K=*G!BOU[=D/@+(8D0K-SB"_&?<*P8O"?8\:B8.F?*UU5K8(LV
M#M8+[*A92S6O+;N77WWFI,OJ_XT3>8HU.V^N<FO88;;&6G A;I;OT4XG2D7=
MK;I=4[>)'7=;_\X-@J%%AXHG1\))C(\TC*+[@!+'Y\K\T?&"B <F$-61XL^J
M(\73(6%G/N@=#A(_SGB*T/OQ;- =#?_OH-_YV!V.YYV_\,RA@_E_O!XGUF??
M3]\[\2IB333K@@KM(+O5JA\E5I2WU7FZK#^_A/Z2F1H^3'G71B2*%FLGR"XK
M+F 7U#JV ZYYT@U MLBZCTD\RV@MB28!%S":K.0R,_!.<"91G<,@)JQW'%?^
MW..2=44U%7Q0304\-?31X">6OC,9=^;=41):TOW4'8ZZ-ZSP[60F?IR=,G@H
M2F8R&8Y[D[L!^V,QF+&?B5_WAY^&_<&X_QJ.TK*44EV!B*>H?+43BHF0ENP/
M)+O<U$C,,BM"S?-4ANU<[P1246!+^,[KIO)IW-+"V$<BM0_/\O=QS0[;XC!V
M_-Q16[MK@ PLPT"MG(!([1^_ST_IV;#/X;C3']R<;>U*9G%K(K:_CGG9^M-X
M:PU"VR?S,7]''=58G#8,I_AR\<XM V_D.0^>G\8 B5L>RTDPXR#P7&;"R2G?
M"OSX5K45.(68_Z].EVT$%LGZ?C3LW@Q'B1U)+W_T^19AQLW+C+]]>-.=#R]=
MWLN.8XZ=/4(A":%2& EQ7E"A(:2(5T/.68%QR#;&6170!*#7^ GDB,JJU)9:
MFAIAP8]RKT.8@NN]&54:V19%7_L0;$#11E9%Z1\$NMFGW>?C[9:2/W8D</>:
MB'U(Y:],,510H$?^'WM9UD==0#^HLF5LZ[5:QJ-*2.Q0_+).1D?5U07EPVIC
M.Y(,5!5 H0P==+_12[LEU;B=U=RJPGL=Z/56U>NMJM=;5:^WJG*KZN-??_$(
M95U:[T<\)2AX8:VL;\GX;6]MK40#_?6@TI5'L<M5%MJ*9BQ3 I#*0Y9L<HFQ
MC?:Q9\-@NXLC(=U;\+*[K!+VX5\ES961*$?%'L.<Z>.[*LR]L^6=I::8>W<%
MS+VOPMQ[0^8:N[/3%'/O+6/NJSU ;<217_L9*_9)Z92&6T+C?7J^+%+E*PY"
MWZD.0J>SR70P6WQ.4MS]ZWXX%=&-R/&+!PFGOA/$63'UX1& JDAY(PK\%;JH
M.<J$MV#' A?,8C[5!%A._*-':0\+9LA 54>V'1*:ZFZ.4(B@^ =[TE[>[+GC
M1>U_ %5^V61F)44_MY.+QCZJ<R> *MM!IH'20GG,"HGM-[ASF/@!H6=K'=T>
M1ED)V]UKH)B%_(5:+-!W+K<[&G@Q6V:R/MYZS_QO6N>\J@ZVKZ Z6WHDT,D:
M\<3?Z]!?#C=;&CXEVVD=6\I*V*D5JM,%P *=+ZETXM9TA>DLK8>\Z8<OH:$S
MV!D>Z+1U77>WX4^'DV6?,&Q=3R#+_NX3 7&P3+,WB)]+I5*X>6K[@K6SH]:K
M4S/(YB'U'Q(W34 >>2<N27;7G*%0WK%2U\(^;ZG?2KR,VU8@M^!4(+QF(\%U
M_#(?X?M+?(2=OYRU_^HS?/49OOH,7WV&KS[#5Y_AJ\_PU6?XZC-\]1F^^@Q?
M?8:O/L.Z^(IHG.&*_>O$$_O';S,G>)0M/=CO,[^V8SZJNK@XEZ69ZRP0J*7J
M?^@@5-4;AOL<KW(L#UUM9!+7@'GG!=YFMU'!F2N"-C'GX2J 62H+BC6X<YZU
MJ)X707/UZ5$MDP5]3I1:K?N(K';^R%LI'#2@RB_NA*:(3&47;/GK,EA.V$F\
M)K3KNG1'LK&KBO#,'U2NU\GBE\&LT^WU9O>#\_0TV!&:SIY/R3Q$5TCK^(#4
M5<I*.&.W%P;B^ZPODP??>Q3*()= 4AQ[?.K)R U,I=CH!G6PV?KAGI 9$0=Z
MF7&DC7@'5$7?S1NS!<8#G;G4\C&[OR)1Q !U_%L"N:B@J8=^^FC,&0P)=,(D
M\Y66,%T]=">,,6$P)- )J\#5Y30U=J.K\K@",72]9_G\*I)BS?BC:LTH$J(B
M+P]%_X\=U*\,9>61CMT9F01RN)XK9X<[38U]_MP\)P+^Z?BQ1X7-I8* D76G
MWZ4J) -_U-29=D3<;Q_#I^^6Q$NP9W\Y0<[^\=N(/#K^((CY"V+E+F-6JE#H
M&D NZW>M9\QZ<)-/2X^.69'S$LBPEB%6P/2\QQ?ZB26I<'\)J?=G&"R(NPY"
M/WS<)REO2"^DVY *.*3^3-Z 07VTW6 !RG.D#<6P9'7*#=EDU6-++B^^=5R^
M0CLE-YFLNIMP%\2371S%3L ?M5&<&1JWA.R$D<];^6/#BAA=2JYDK T<ZN_Y
MP^Y,MSA4;)<J&56E);&]*7K8I5UO%M9@.5GQ+_;6#GTDLG>PBL6P71U 0"7B
M666!8-8%WUE1R72\@/WN.(Q)E+H ($^!_#6_[1U/%H-Y9]K]+-[[L.:9C^O>
M_9;-3YJ-L***'3L%HSVQ0AK\[7%9YP [94TU.UC2:AZ J,:VTG61I8X)E]=X
M.119$NY=JCU\\J*Z6&]]37O)4D1WZ\5J9K<_9U]RPX#M?WRROW&"WY5[>VEI
M[)T(5)^RRVB-Z%:MI@\RI4%8-R&EX1>V/^TY6_:;>&\V7N2M(._C01,L8.3H
M8$+G=DI#EY!E=,L0X )$^FV3HHJ5HT\?GJ9& )VC,JG2\\X+QY^\%6P'1%T#
M4(<3.KDSLG7VXM+ 9 4<@(HJV$Z,*K1I$;" ([95]-R8+'M.M%81<UX..["B
M&AMELC;D'^5'&?XT87]*J,O!>91YGF6%L>\.&:&L$L02;<_*4[/S]*]6< #S
MH^* SWU4IQ<]^B1RJ;=5AR,KJ@!I^<DF6K0(H',T#&+"@.1W&7AG!\];$D0*
MQZBL/)"=GVUB1RU[.\=HVIE"41Z(^0<K,-?(8MEP (\#TP$@'.WX;,BDL),&
M/CK!5"2%H718M7U7B(U.23;9W/'%+K8'#2/QK $_B^)A'HJ3 '@+4/*LVK&;
M H3.Z$?'"T9A%$V"P^6I3#R)G$9--2AW5FW;05"4$(8533\,V _)PGF>TO#)
MXY=Q;DA 5IXJQ/XG58C]<-R;W TZB^Y_\^1XGX;SX63<^<O-8#RX'2[^ SOX
M_BBN20R"LA+2W<S$@7=+V!!P?-:UU-"GY,EET59$/F( $)2_KPF# MU(]M,
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M'\S@US4FJS&)ST(YI=>+8561 ULK'>UF-P0F %WU?<4J(<XU1#0WMN:YB'F
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MOR9W5;J_=F?]UZLJDG:O;)UX2-_!NK\3DDSB-:&+M1.D8X'I5Z)>C>U8S+N
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M U!+ 0(4 Q0    ( /-!6UH:!=+[#0(  "P5   (              "  0
M  !E>#$Y+FAT;5!+ 0(4 Q0    ( /-!6UJ)5S^[F (  #<0   *
M      "  3,"  !E>#(Q+3$N:'1M4$L! A0#%     @ \T%;6D\Q(0?Z P
M&!0   H              ( !\P0  &5X,C,M,2YH=&U02P$"% ,4    " #S
M05M:; ?Z^'L(   )1@  "@              @ $5"0  97@S,2TQ+FAT;5!+
M 0(4 Q0    ( /-!6UI13^ 46@@  %)%   *              "  ;@1  !E
M>#,Q+3(N:'1M4$L! A0#%     @ \T%;6EYO)<9=!0  ,2    H
M     ( !.AH  &5X,S(M,2YH=&U02P$"% ,4    " #S05M:E1Y3.3D%   U
M(   "@              @ &_'P  97@S,BTR+FAT;5!+ 0(4 Q0    ( /-!
M6UH*I,9H8AT   (+ 0 )              "  2 E  !E>#0M-RYH=&U02P$"
M% ,4    " #S05M:;VCD#=$I P#!P!L #               @ &I0@  9F]R
M;3$P+6LN:'1M4$L! A0#%     @ \T%;6H?@0S]D$P  -\4  !$
M     ( !I&P# &EM;FXM,C R-#$R,S$N>'-D4$L! A0#%     @ \T%;6AAH
MM80;&   =!8! !4              ( !-X # &EM;FXM,C R-#$R,S%?8V%L
M+GAM;%!+ 0(4 Q0    ( /-!6UIL??\?AB\  -?< @ 5              "
M 868 P!I;6YN+3(P,C0Q,C,Q7V1E9BYX;6Q02P$"% ,4    " #S05M:]&?6
M4N1]  !$) < %0              @ $^R , :6UN;BTR,#(T,3(S,5]L86(N
M>&UL4$L! A0#%     @ \T%;6M-=2ET"60  ;Y,% !4              ( !
M548$ &EM;FXM,C R-#$R,S%?<')E+GAM;%!+!08     #@ . $(#  "*GP0
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>form10-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:IMNN="http://imunon.com/20241231"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="imnn-20241231.xsd" xlink:type="simple"/>
    <context id="From2024-01-01to2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
        </entity>
        <period>
            <instant>2024-06-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
        </entity>
        <period>
            <instant>2025-02-21</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-11-28_stpr_NJ_us-gaap_NewJerseyDivisionOfTaxationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-28</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_stpr_NJ_us-gaap_NewJerseyDivisionOfTaxationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-22_stpr_NJ_us-gaap_NewJerseyDivisionOfTaxationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-22</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_stpr_NJ_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_stpr_NJ_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_stpr_NJ_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OvationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:ClinicalResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:OvationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OvationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:ClinicalResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:OvationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_VaccineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:ClinicalResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:VaccineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_VaccineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:ClinicalResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:VaccineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OtherClinicalAndRegulatoryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:ClinicalResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:OtherClinicalAndRegulatoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OtherClinicalAndRegulatoryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:ClinicalResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:OtherClinicalAndRegulatoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:ClinicalResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:ClinicalResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_OvationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:NonClinicalRAndDAndCMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:OvationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_OvationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:NonClinicalRAndDAndCMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:OvationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_PlaCCineVaccineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:NonClinicalRAndDAndCMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:PlaCCineVaccineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_PlaCCineVaccineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:NonClinicalRAndDAndCMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:PlaCCineVaccineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_ManufacturingCMCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:NonClinicalRAndDAndCMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:ManufacturingCMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_ManufacturingCMCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:NonClinicalRAndDAndCMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">IMNN:ManufacturingCMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:NonClinicalRAndDAndCMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">IMNN:NonClinicalRAndDAndCMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_USTreasurySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_USTreasurySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_USTreasurySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member_us-gaap_USTreasurySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member_us-gaap_USTreasurySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member_us-gaap_USTreasurySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_USTreasurySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member_us-gaap_USTreasurySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member_us-gaap_USTreasurySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member_us-gaap_USTreasurySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_LeaseholdImprovementsMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_LeaseholdImprovementsMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-06-18_custom_SiliconValleyBankMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">IMNN:SiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-18</instant>
        </period>
    </context>
    <context id="From2021-06-172021-06-18_custom_SiliconValleyBankMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">IMNN:SiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-18</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_custom_SiliconValleyBankMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">IMNN:SiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2020-08-012020-08-31_custom_SiliconValleyBankMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">IMNN:SiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SiliconValleyBankMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">IMNN:SiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-21_custom_HorizonTechnologyFinanceCorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">IMNN:HorizonTechnologyFinanceCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-21</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_stpr_NJ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_FederalIncomeTaxMember_custom_NoExpirationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">IMNN:NoExpirationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">IMNN:FederalIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_stpr_NJ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_stpr_NJ_srt_MinimumMember_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_stpr_NJ_srt_MaximumMember_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2024-05-152024-05-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
        </entity>
        <period>
            <startDate>2024-05-15</startDate>
            <endDate>2024-05-15</endDate>
        </period>
    </context>
    <context id="From2024-05-152024-05-15_custom_AtTheMarketOfferingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-15</startDate>
            <endDate>2024-05-15</endDate>
        </period>
    </context>
    <context id="From2024-09-032024-09-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
        </entity>
        <period>
            <startDate>2024-09-03</startDate>
            <endDate>2024-09-03</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AtTheMarketOfferingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AtTheMarketOfferingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-02-21_custom_AtTheMarketOfferingAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-02-21</endDate>
        </period>
    </context>
    <context id="From2024-07-302024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">IMNN:JulyTwoThousandTwentyFourOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-30</startDate>
            <endDate>2024-07-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">IMNN:JulyTwoThousandTwentyFourOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-30</instant>
        </period>
    </context>
    <context id="From2024-07-302024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">IMNN:JulyTwoThousandTwentyFourOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-30</startDate>
            <endDate>2024-07-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">IMNN:JulyTwoThousandTwentyFourOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-30</instant>
        </period>
    </context>
    <context id="AsOf2018-05-15_custom_TwoThousandAndEighteenStockIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-15</instant>
        </period>
    </context>
    <context id="AsOf2019-05-14_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-14</instant>
        </period>
    </context>
    <context id="AsOf2019-05-14_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-14</instant>
        </period>
    </context>
    <context id="AsOf2020-06-15_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-15</instant>
        </period>
    </context>
    <context id="AsOf2020-06-15_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-15</instant>
        </period>
    </context>
    <context id="AsOf2021-06-10_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-10</instant>
        </period>
    </context>
    <context id="AsOf2021-06-10_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-10</instant>
        </period>
    </context>
    <context id="AsOf2023-06-14_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-14</instant>
        </period>
    </context>
    <context id="AsOf2023-06-14_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-14</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_TwoThousandAndEighteenStockIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_InducementOptionGrantsMember_srt_BoardOfDirectorsChairmanMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:InducementOptionGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_InducementOptionGrantsMember_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:InducementOptionGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_TwoThousandAndEighteenStockIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">IMNN:TwoThousandAndEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_EquityStockAwardsMember_custom_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">IMNN:GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">IMNN:EquityStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_InducementAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">IMNN:InducementAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">IMNN:EmployeeStockOptionAndRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">IMNN:EmployeeStockOptionAndRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">IMNN:EmployeeStockOptionAndRestrictedStockAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">IMNN:EmployeeStockOptionAndRestrictedStockAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">IMNN:EmployeeStockOptionAndRestrictedStockAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">IMNN:EmployeeStockOptionAndRestrictedStockAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ExercisePriceOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">IMNN:ExercisePriceOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ExercisePriceOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">IMNN:ExercisePriceOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ExercisePriceTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">IMNN:ExercisePriceTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ExercisePriceTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">IMNN:ExercisePriceTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ExercisePriceThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">IMNN:ExercisePriceThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ExercisePriceThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">IMNN:ExercisePriceThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="AsOf2023-08-31_custom_LeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:LeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="From2023-08-012023-08-31_custom_LeaseAgreementMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:LeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2023-08-012023-08-31_custom_LeaseAgreementMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:LeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="AsOf2023-01-31_custom_LeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:LeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-01-31_custom_LeaseAgreementMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:LeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-01-31_custom_LeaseAgreementMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:LeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-11-16_custom_ConvertibleNotePurchaseAgreementMember_custom_TransomicTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">IMNN:ConvertibleNotePurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">IMNN:TransomicTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-16</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="sqrt">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="Segment">
        <measure>IMNN:Segment</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-01-01to2024-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2024-01-01to2024-12-31" id="Fact000004">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2024-01-01to2024-12-31" id="Fact000005">0000749647</dei:EntityCentralIndexKey>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0085"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0100"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0139"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0140"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0145"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0146"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0186"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0229"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0232"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingExpense
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0235"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0244"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0272"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0305"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0308"
      unitRef="USD"
      xsi:nil="true"/>
    <IMNN:AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0311"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccruedInvestmentIncomeReceivable
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0317"
      unitRef="USD"
      xsi:nil="true"/>
    <IMNN:PaymentoffOfLoanAndAccruedEndoftermFees
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0350"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0368"
      unitRef="USD"
      xsi:nil="true"/>
    <IMNN:RecognitionOfRightUseAssetAndLiability
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0374"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0388"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0389"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0390"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0391"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0397"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0398"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0399"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0405"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-01-012024-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0406"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0407"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0413"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0414"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2024-01-012024-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0415"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0417"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0420"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0422"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0423"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0424"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0430"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0458"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0459"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0460"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0461"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0467"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0468"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0469"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0475"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2023-01-012023-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0476"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0477"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0478"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0483"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0484"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2023-01-012023-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0485"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0487"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0490"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0492"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0493"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-12-31_srt_MinimumMember"
      id="xdx2ixbrl0543">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_VaccineMember"
      id="xdx2ixbrl0611"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0677"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShortTermInvestments
      contextRef="AsOf2024-12-31_us-gaap_USTreasurySecuritiesMember"
      id="xdx2ixbrl0683"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="AsOf2024-12-31_us-gaap_USTreasurySecuritiesMember"
      id="xdx2ixbrl0685"
      unitRef="USD"
      xsi:nil="true"/>
    <IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0691"
      unitRef="USD"
      xsi:nil="true"/>
    <IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0693"
      unitRef="USD"
      xsi:nil="true"/>
    <IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0699"
      unitRef="USD"
      xsi:nil="true"/>
    <IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0701"
      unitRef="USD"
      xsi:nil="true"/>
    <IMNN:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0707"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0709"
      unitRef="USD"
      xsi:nil="true"/>
    <IMNN:AvailableForSaleSecuritiesUnrealizedLossFairValue
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0717"
      unitRef="USD"
      xsi:nil="true"/>
    <IMNN:AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0719"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_USTreasurySecuritiesMember"
      id="xdx2ixbrl0740"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member_us-gaap_USTreasurySecuritiesMember"
      id="xdx2ixbrl0742"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member_us-gaap_USTreasurySecuritiesMember"
      id="xdx2ixbrl0744"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member_us-gaap_USTreasurySecuritiesMember"
      id="xdx2ixbrl0746"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member_us-gaap_USTreasurySecuritiesMember"
      id="xdx2ixbrl0752"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member_us-gaap_USTreasurySecuritiesMember"
      id="xdx2ixbrl0754"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0855"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0856"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0858"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0859"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0861"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0862"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0864"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0865"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0867"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0870"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0891"
      unitRef="Pure"
      xsi:nil="true"/>
    <IMNN:EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0894"
      unitRef="Pure"
      xsi:nil="true"/>
    <IMNN:EffectiveIncomeTaxRateReconciliationSaleAndExpiration
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0897"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0902"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0922"
      unitRef="USD"
      xsi:nil="true"/>
    <IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl1228"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2024-01-01to2024-12-31" id="Fact000013">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2024-01-01to2024-12-31" id="Fact000014">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2024-01-01to2024-12-31" id="Fact000015">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2024-01-01to2024-12-31" id="Fact000016">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2024-01-01to2024-12-31" id="Fact000017">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="From2024-01-01to2024-12-31" id="Fact000018">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2024-01-01to2024-12-31" id="Fact000019">001-15911</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2024-01-01to2024-12-31" id="Fact000020">IMUNON, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-01-01to2024-12-31" id="Fact000021">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-01-01to2024-12-31" id="Fact000022">52-1256615</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-01-01to2024-12-31" id="Fact000023">997                                             LENOX DRIVE</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-01-01to2024-12-31" id="Fact000024">SUITE 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-01-01to2024-12-31" id="Fact000025">LAWRENCEVILLE</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-01-01to2024-12-31" id="Fact000026">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-01-01to2024-12-31" id="Fact000027">08648</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-01-01to2024-12-31" id="Fact000028">(609)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-01-01to2024-12-31" id="Fact000029">896-9100</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2024-01-01to2024-12-31" id="Fact000030">Common     Stock, Par Value $0.01 Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2024-01-01to2024-12-31" id="Fact000031">IMNN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2024-01-01to2024-12-31" id="Fact000032">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2024-01-01to2024-12-31" id="Fact000033">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2024-01-01to2024-12-31" id="Fact000034">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2024-01-01to2024-12-31" id="Fact000035">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2024-01-01to2024-12-31" id="Fact000036">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2024-01-01to2024-12-31" id="Fact000037">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2024-01-01to2024-12-31" id="Fact000038">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-01-01to2024-12-31" id="Fact000039">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="From2024-01-01to2024-12-31" id="Fact000040">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2024-01-01to2024-12-31" id="Fact000041">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="From2024-01-01to2024-12-31" id="Fact000042">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="AsOf2024-06-28"
      decimals="-5"
      id="Fact000043"
      unitRef="USD">10800000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-02-21"
      decimals="INF"
      id="Fact000045"
      unitRef="Shares">14620732</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000046">None</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="From2024-01-01to2024-12-31" id="Fact000047">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000050">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;CYBERSECURITY&lt;/b&gt;&lt;/span&gt;&#160;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_908_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20240101__20241231_zFQsrNP64Zm8"&gt;We
have &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240101__20241231_zor46tLIquik"&gt;processes for assessing, identifying and managing&lt;/span&gt; cybersecurity risks, which are built into our information technology (&#x201c;IT&#x201d;)
function and are designed to help protect our information assets and operations from internal and external cyber threats, protect employee
and clinical trial information from unauthorized access or attack, as well as secure our networks and systems. Such processes include
physical, procedural and technical safeguards, response plans, and routine review of our policies and procedures to identify risks and
refine our practices.&lt;/span&gt; We engage certain &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_906_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240101__20241231_zcaOlp1kgktk"&gt;external parties&lt;/span&gt;, including a full-service managed IT service provider, to enhance our &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90B_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20240101__20241231_zdr41oCqFdl6"&gt;cybersecurity
oversight&lt;/span&gt;.</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000051">We
have &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240101__20241231_zor46tLIquik"&gt;processes for assessing, identifying and managing&lt;/span&gt; cybersecurity risks, which are built into our information technology (&#x201c;IT&#x201d;)
function and are designed to help protect our information assets and operations from internal and external cyber threats, protect employee
and clinical trial information from unauthorized access or attack, as well as secure our networks and systems. Such processes include
physical, procedural and technical safeguards, response plans, and routine review of our policies and procedures to identify risks and
refine our practices.</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="From2024-01-01to2024-12-31" id="Fact000052">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="From2024-01-01to2024-12-31" id="Fact000053">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="From2024-01-01to2024-12-31" id="Fact000054">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000055">Our
Audit Committee of the Board of Directors (the &#x201c;Audit Committee&#x201d;) is responsible for overseeing cybersecurity risk and periodically
updates our Board of Directors on such matters.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000056">The Audit Committee receives periodic updates from management regarding cybersecurity
matters and is notified between such updates regarding any significant new cybersecurity threats or incidents. &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90C_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20240101__20241231_zDTe4N0EHe9b"&gt;We do &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90B_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240101__20241231_zZqnWGI7tySf"&gt;no&lt;/span&gt;t believe that
there are currently any known risks from cybersecurity threats that are reasonably likely to materially affect us or our business strategy,
results of operations or financial condition.&lt;/span&gt;</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000057">We do &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90B_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240101__20241231_zZqnWGI7tySf"&gt;no&lt;/span&gt;t believe that
there are currently any known risks from cybersecurity threats that are reasonably likely to materially affect us or our business strategy,
results of operations or financial condition.</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="From2024-01-01to2024-12-31" id="Fact000058">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000059">Management
is &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_901_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20240101__20241231_zYM4N2amO9C"&gt;responsible&lt;/span&gt; for the operational oversight of company-wide cybersecurity strategy, policy, and standards across relevant departments
to assess and help prepare us to address cybersecurity risks</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="From2024-01-01to2024-12-31" id="Fact000060">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="From2024-01-01to2024-12-31" id="Fact000061">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="From2024-01-01to2024-12-31" id="Fact000062">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="From2024-01-01to2024-12-31" id="Fact000063">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="From2024-01-01to2024-12-31" id="Fact000064">false</ecd:NonRule10b51ArrAdoptedFlag>
    <IMNN:Rule10b51ArrModifiedFlag contextRef="From2024-01-01to2024-12-31" id="Fact000066">false</IMNN:Rule10b51ArrModifiedFlag>
    <IMNN:NonRule10b51ArrModifiedFlag contextRef="From2024-01-01to2024-12-31" id="Fact000068">false</IMNN:NonRule10b51ArrModifiedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="From2024-01-01to2024-12-31" id="Fact000069">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="From2024-01-01to2024-12-31" id="Fact000070">false</ecd:NonRule10b51ArrTrmntdFlag>
    <dei:AuditorOpinionTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000071">We
have audited the accompanying consolidated balance sheets of Imunon Inc. as of December 31, 2024 and 2023, and the related consolidated
statements of operations, comprehensive loss, changes in stockholders&#x2019; equity, and cash flows for each of the two years in the
period ended December 31, 2024, and the related notes (collectively referred to as the &#x201c;financial statements&#x201d;). In our opinion,
the consolidated financial statements present fairly, in all material respects, the financial position of Imunon Inc. as of December
31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024,
in conformity with accounting principles generally accepted in the United States of America.</dei:AuditorOpinionTextBlock>
    <dei:AuditorName contextRef="From2024-01-01to2024-12-31" id="Fact000072">WithumSmith+Brown, PC</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2024-01-01to2024-12-31" id="Fact000073">East Brunswick, New Jersey</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="From2024-01-01to2024-12-31" id="Fact000074">100</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000082"
      unitRef="USD">5872767</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000083"
      unitRef="USD">5838566</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000086"
      unitRef="USD">9857087</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:GrantsReceivableCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000088"
      unitRef="USD">2136192</us-gaap:GrantsReceivableCurrent>
    <us-gaap:GrantsReceivableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000089"
      unitRef="USD">2545051</us-gaap:GrantsReceivableCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000091"
      unitRef="USD">8008959</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000092"
      unitRef="USD">18240704</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000094"
      unitRef="USD">541272</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000095"
      unitRef="USD">751906</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000101"
      unitRef="USD">1280385</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000103"
      unitRef="USD">1117133</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000104"
      unitRef="USD">1595074</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000106"
      unitRef="USD">50000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000107"
      unitRef="USD">50000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000109"
      unitRef="USD">1167133</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000110"
      unitRef="USD">2925459</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000112"
      unitRef="USD">9717364</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000113"
      unitRef="USD">21918069</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000121"
      unitRef="USD">1300026</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000122"
      unitRef="USD">3515192</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000124"
      unitRef="USD">3033747</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000125"
      unitRef="USD">3390521</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000127"
      unitRef="USD">452358</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000128"
      unitRef="USD">485421</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000130"
      unitRef="USD">4786131</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000131"
      unitRef="USD">7391134</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000133"
      unitRef="USD">686935</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000134"
      unitRef="USD">1139293</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000136"
      unitRef="USD">5473066</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000137"
      unitRef="USD">8530427</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000148"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000150"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000152"
      unitRef="Shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000154"
      unitRef="Shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000156"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000158"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000160"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000162"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000167"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000169"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000171"
      unitRef="Shares">112500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000173"
      unitRef="Shares">112500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000175"
      unitRef="Shares">14500707</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000177"
      unitRef="Shares">9399811</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000179"
      unitRef="Shares">14500685</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000181"
      unitRef="Shares">9399789</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000164"
      unitRef="USD">145007</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000165"
      unitRef="USD">93998</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000183"
      unitRef="USD">410987523</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000184"
      unitRef="USD">401500838</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000187"
      unitRef="USD">60796</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000189"
      unitRef="USD">-406803044</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000190"
      unitRef="USD">-388182802</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquityBeforeTreasuryStock
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000192"
      unitRef="USD">4329486</us-gaap:StockholdersEquityBeforeTreasuryStock>
    <us-gaap:StockholdersEquityBeforeTreasuryStock
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000193"
      unitRef="USD">13472830</us-gaap:StockholdersEquityBeforeTreasuryStock>
    <us-gaap:TreasuryStockCommonShares
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000198"
      unitRef="Shares">22</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000200"
      unitRef="Shares">22</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000195"
      unitRef="USD">85188</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000196"
      unitRef="USD">85188</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000202"
      unitRef="USD">4244298</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000203"
      unitRef="USD">13387642</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000205"
      unitRef="USD">9717364</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000206"
      unitRef="USD">21918069</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000211"
      unitRef="USD">11639411</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000212"
      unitRef="USD">11287691</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000214"
      unitRef="USD">7493035</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000215"
      unitRef="USD">9742739</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000217"
      unitRef="USD">19132446</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000218"
      unitRef="USD">21030430</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000220"
      unitRef="USD">-19132446</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000221"
      unitRef="USD">-21030430</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000226"
      unitRef="USD">512204</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000227"
      unitRef="USD">1157625</us-gaap:InvestmentIncomeNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000230"
      unitRef="USD">-329158</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000233"
      unitRef="USD">197080</us-gaap:InterestExpenseNonoperating>
    <us-gaap:OtherNonoperatingExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000236"
      unitRef="USD">396319</us-gaap:OtherNonoperatingExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000238"
      unitRef="USD">512204</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000239"
      unitRef="USD">235068</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000241"
      unitRef="USD">-18620242</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000242"
      unitRef="USD">-20795362</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000245"
      unitRef="USD">-1280385</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000247"
      unitRef="USD">-18620242</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000248"
      unitRef="USD">-19514977</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000250"
      unitRef="USDPShares">-1.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000252"
      unitRef="USDPShares">-1.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000254"
      unitRef="USDPShares">-2.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000256"
      unitRef="USDPShares">-2.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000258"
      unitRef="Shares">11508159</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000260"
      unitRef="Shares">11508159</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000262"
      unitRef="Shares">9045320</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000264"
      unitRef="Shares">9045320</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000273"
      unitRef="USD">34302</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000275"
      unitRef="USD">-18620242</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000276"
      unitRef="USD">-19514977</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000278"
      unitRef="USD">-18620242</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000279"
      unitRef="USD">-19480675</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000284"
      unitRef="USD">-18620242</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000285"
      unitRef="USD">-19514977</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000290"
      unitRef="USD">240175</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000291"
      unitRef="USD">248154</us-gaap:Depreciation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000293"
      unitRef="USD">477941</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000294"
      unitRef="USD">471851</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:GainLossOnInvestments
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000296"
      unitRef="USD">61983</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000297"
      unitRef="USD">-34302</us-gaap:GainLossOnInvestments>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000299"
      unitRef="USD">477256</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000300"
      unitRef="USD">759013</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000302"
      unitRef="USD">1280385</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000303"
      unitRef="USD">286641</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000306"
      unitRef="USD">-329158</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000309"
      unitRef="USD">375000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <IMNN:AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000312"
      unitRef="USD">55122</IMNN:AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable>
    <us-gaap:IncreaseDecreaseInAccruedInvestmentIncomeReceivable
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000318"
      unitRef="USD">-68136</us-gaap:IncreaseDecreaseInAccruedInvestmentIncomeReceivable>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000320"
      unitRef="USD">-408859</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000321"
      unitRef="USD">141619</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000323"
      unitRef="USD">-3057361</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000324"
      unitRef="USD">-1992929</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000326"
      unitRef="USD">-18854970</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000327"
      unitRef="USD">-19022148</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000332"
      unitRef="USD">57174</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000333"
      unitRef="USD">13541806</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000335"
      unitRef="USD">9915448</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000336"
      unitRef="USD">25000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000338"
      unitRef="USD">29541</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000339"
      unitRef="USD">451759</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000341"
      unitRef="USD">9828733</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000342"
      unitRef="USD">11006435</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000347"
      unitRef="USD">9060438</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000348"
      unitRef="USD">2781438</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <IMNN:PaymentoffOfLoanAndAccruedEndoftermFees
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000351"
      unitRef="USD">6420000</IMNN:PaymentoffOfLoanAndAccruedEndoftermFees>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000353"
      unitRef="USD">9060438</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000354"
      unitRef="USD">-3638562</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000356"
      unitRef="USD">34201</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000357"
      unitRef="USD">-11654275</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000359"
      unitRef="USD">5838566</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000360"
      unitRef="USD">17492841</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000362"
      unitRef="USD">5872767</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000363"
      unitRef="USD">5838566</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000369"
      unitRef="USD">179542</us-gaap:InterestPaidNet>
    <IMNN:RecognitionOfRightUseAssetAndLiability
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000375"
      unitRef="USD">1911049</IMNN:RecognitionOfRightUseAssetAndLiability>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000384"
      unitRef="Shares">9399811</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000377"
      unitRef="USD">93998</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000378"
      unitRef="USD">401500838</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact000386"
      unitRef="Shares">22</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000379"
      unitRef="USD">-85188</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000380"
      unitRef="USD">60796</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000381"
      unitRef="USD">-388182802</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000382"
      unitRef="USD">13387642</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000392"
      unitRef="USD">-18620242</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000393"
      unitRef="USD">-18620242</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000402"
      unitRef="Shares">5088796</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000395"
      unitRef="USD">50888</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000396"
      unitRef="USD">9009550</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000400"
      unitRef="USD">9060438</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000411"
      unitRef="Shares">12100</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000404"
      unitRef="USD">121</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000409"
      unitRef="USD">121</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000416"
      unitRef="USD">-60796</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000418"
      unitRef="USD">-60796</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000421"
      unitRef="USD">477135</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000425"
      unitRef="USD">477135</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000434"
      unitRef="Shares">14500707</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000427"
      unitRef="USD">145007</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000428"
      unitRef="USD">410987523</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact000436"
      unitRef="Shares">22</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000429"
      unitRef="USD">-85188</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000431"
      unitRef="USD">-406803044</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000432"
      unitRef="USD">4244298</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000444"
      unitRef="Shares">7436219</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000438"
      unitRef="USD">74362</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000439"
      unitRef="USD">397980023</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact000446"
      unitRef="Shares">22</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000440"
      unitRef="USD">-85188</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000441"
      unitRef="USD">26494</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000442"
      unitRef="USD">-368667825</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000443"
      unitRef="USD">29327866</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000454"
      unitRef="Shares">7436219</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000448"
      unitRef="USD">74362</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000449"
      unitRef="USD">397980023</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact000456"
      unitRef="Shares">22</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000450"
      unitRef="USD">-85188</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000451"
      unitRef="USD">26494</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000452"
      unitRef="USD">-368667825</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000453"
      unitRef="USD">29327866</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000462"
      unitRef="USD">-19514977</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000463"
      unitRef="USD">-19514977</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000472"
      unitRef="Shares">1904142</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000465"
      unitRef="USD">19041</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000466"
      unitRef="USD">2762397</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000470"
      unitRef="USD">2781438</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000481"
      unitRef="Shares">59450</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000474"
      unitRef="USD">595</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000479"
      unitRef="USD">595</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000486"
      unitRef="USD">34302</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000488"
      unitRef="USD">34302</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000491"
      unitRef="USD">758418</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000495"
      unitRef="USD">758418</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000504"
      unitRef="Shares">9399811</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000497"
      unitRef="USD">93998</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000498"
      unitRef="USD">401500838</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact000506"
      unitRef="Shares">22</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000499"
      unitRef="USD">-85188</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000500"
      unitRef="USD">60796</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000501"
      unitRef="USD">-388182802</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000502"
      unitRef="USD">13387642</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000515"
      unitRef="Shares">9399811</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000508"
      unitRef="USD">93998</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000509"
      unitRef="USD">401500838</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact000517"
      unitRef="Shares">22</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000510"
      unitRef="USD">-85188</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000511"
      unitRef="USD">60796</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000512"
      unitRef="USD">-388182802</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000513"
      unitRef="USD">13387642</us-gaap:StockholdersEquity>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000519">&lt;p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_z2M204phNIQ1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1.
&lt;span id="xdx_820_zrtlyvz43qR6"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zvySlgYoTayb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_865_zh5oy2eCD6x3"&gt;Description
of Business&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Imunon,
Inc. (&#x201c;Imunon&#x201d; or the &#x201c;Company&#x201d;) is a clinical-stage biotechnology company focused on advancing a portfolio of
innovative treatments that harness the body&#x2019;s natural mechanisms with the aim to generate safe, effective and durable responses
across a broad array of human diseases, constituting a differentiating approach from conventional therapies. Imunon is developing its
non-viral DNA technology across its modalities. The first modality, TheraPlas&#xae;, is developed for the coding of proteins and cytokines
in the treatment of solid tumors where an immunological approach is deemed promising. The second modality, PlaCCine&#xae;, is developed
for the coding of viral antigens that can elicit a strong immunological response. This technology may represent a promising platform
for the development of vaccines in infectious diseases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer
that has completed Phase II clinical studies. IMNN-001 works by instructing the body to produce safe and durable levels of powerful cancer-fighting
molecules, such as interleukin-12 and interferon gamma, at the tumor site. Additionally, the Company has entered a first-in-human study
of its COVID-19 booster vaccine (IMNN-101). The Company will continue to leverage these modalities and to advance the technological frontier
of plasmid DNA to better serve patients with difficult-to-treat conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zae6M2qgw8N9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86F_zaJVUmFdjmi8"&gt;Basis
of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements (&#x201c;Financial Statements&#x201d;) of Imunon have been prepared in accordance with accounting
principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and include the accounts of the Company and CLSN Laboratories,
Inc. The Company dissolved Celsion GmbH in 2023. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zp7DGI3bhVRl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_865_zI7u3z2jMAB2"&gt;Accounting
Standards Update: Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU No. 2023-07, &#x201c;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&#x201d;.
The disclosure requirements are required on an annual and interim basis and are applicable to entities with a single reportable segment.
The amendments in the ASU require disclosures to include significant segment expenses that are regularly provided to the chief operating
decision maker (&#x201c;CODM&#x201d;), a description of other segment items by reportable segment, and any additional measures of a segment&#x2019;s
profit or loss used by the CODM when deciding how to allocate resources. ASU 2023-07 is effective for fiscal years beginning after December
15, 2023 and interim periods for fiscal years beginning after December 31, 2024, with early adoption allowed. We adopted this guidance
as of January 1, 2024 on a retrospective basis and the adoption did not have a material impact on our consolidated financial statements.
Refer to Note 3, &#x201c;&lt;i&gt;Segment Performance Measures and Expenses&lt;/i&gt;,&#x201d; for new disclosures resulting from the adoption of ASU
2023-07.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--UseOfEstimates_z1OUXqQnRFab" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_863_zwIEi2FD2nra"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the
reported amounts of expenses during the reporting period. Actual results could differ significantly from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zKfScKLf3Bjh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86C_z6An9PGJcFY8"&gt;Revenue
Recognition&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company did not generate any revenue in 2024 or 2023 and there were &lt;span id="xdx_907_eus-gaap--AccountsReceivableNet_iI_pdp0_do_c20241231_zQ3A5TpsjlMa" title="Accounts receivable"&gt;&lt;span id="xdx_90E_eus-gaap--AccountsReceivableNet_iI_pdp0_do_c20231231_zvwPfGfAfP2d" title="Accounts receivable"&gt;no&lt;/span&gt;&lt;/span&gt; accounts receivable as of December 31, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zOBhxFArpyd1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_861_zzhY1d8iGIfc"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents include cash on hand and investments purchased with an original maturity of three months or less. A portion of these
funds are not covered by FDIC insurance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWVTmmcisM1e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86B_zqyQ0nKKzRvl"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying values of financial instruments approximate their respective fair values. Management believes that the carrying amounts of the
Company&#x2019;s financial instruments, including cash and cash equivalents and accounts payable approximate fair value due to the short-term
nature of those instruments. Short-term investments are recorded at their estimated fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--InvestmentPolicyTextBlock_z8yuuJU4D5Pg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86D_zOLBFKHY8BJ8"&gt;Short-Term
Investments&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company classifies its investments in debt securities with readily determinable fair values as investments available-for-sale in accordance
with Accounting Standards Codification (&#x201c;ASC&#x201d;) 320, &lt;i&gt;Investments - Debt and Equity Securities&lt;/i&gt;. Available-for-sale securities
consist of debt securities not classified as trading securities or as securities to be held to maturity. The Company has classified all
of its investments as available-for-sale. Unrealized holding gains and losses on available-for-sale securities are reported as a net
amount in accumulated other comprehensive gain or loss in stockholders&#x2019; equity until realized. Gains and losses on the sale of
available-for-sale securities are determined using the specific identification method. The Company&#x2019;s short-term investments consist
of corporate bonds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zug1ROyI6bp2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_861_z7ucnlguqE76"&gt;Property
and Equipment&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is provided over the estimated useful lives
of the related assets, ranging from &lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20241231__srt--RangeAxis__srt--MinimumMember_zYE3fp0mEK27" title="Property plant and equipment useful life::XDX::P3Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0543"&gt;three&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20241231__srt--RangeAxis__srt--MaximumMember_zZIUtEY11Mi8" title="Property plant and equipment useful life"&gt;seven years&lt;/span&gt;, using the straight-line method. Amortization is recognized over the lesser
of the life of the asset or the lease term. Major renewals and improvements are capitalized at cost and ordinary repairs and maintenance
are charged against operating expenses as incurred. Depreciation expense was approximately $&lt;span id="xdx_90C_eus-gaap--DepreciationAndAmortization_pp0p0_c20240101__20241231_zQVcdcMNWTh8" title="Depreciation expense"&gt;240,000&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--DepreciationAndAmortization_pp0p0_c20230101__20231231_z9WPieBxdnNc" title="Depreciation expense"&gt;248,000&lt;/span&gt; for the years ended
December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of
an asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the future net undiscounted cash flows
that the asset is expected to generate. If such asset is considered to be impaired, the impairment recognized is the amount by which
the carrying amount of the asset, if any, exceeds its fair value determined using a discounted cash flow model. There was &lt;span id="xdx_90D_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pdp0_do_c20240101__20241231_zVfBHWUtMXA5" title="Impairment of property or equipment"&gt;&lt;span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pdp0_do_c20230101__20231231_zm10zQPzzU8b" title="Impairment of property or equipment"&gt;no&lt;/span&gt;&lt;/span&gt; impairment
of property or equipment during 2024 or 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock_zgxMZgM0JY94" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_861_zcieJVfHpkp"&gt;Advances
and Deposits on Clinical Programs and Other Current Assets&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Supplies
are consumable items kept on hand to support the Company&#x2019;s R&amp;amp;D and manufacturing operations which includes prepaid expense,
raw materials, clinical supplies and consumable items for clinical trials with alternate uses that are capitalized. Supplies are recorded
at cost and are charged to expense as they are used in operations. The Company regularly reviews the quality and utilization of supplies
to determine if future use of these supplies is probable. Due to the generic use of these supplies, they can be used in multiple projects
other than those currently being studied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--DepositsPolicyTextBlock_zv4VB1vNiPXh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86F_zejGSx6DUqp2"&gt;Deposits&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deposits
include real property security deposits and other deposits which are contractually required and of a long-term nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zZQIAu9nUID1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86A_zn5SgiHogNtg"&gt;Comprehensive
Income (Loss)&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
220, &lt;i&gt;Comprehensive Income&lt;/i&gt;, establishes standards for the reporting and display of comprehensive income (loss) and its components
in the Company&#x2019;s consolidated financial statements. The objective of ASC 220 is to report a measure of comprehensive income (loss)
of all changes in equity of an enterprise that result from transactions and other economic events in a period other than transactions
with owners. Comprehensive gains (losses) result from changes in unrealized gains and losses from investment in debt securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_z4pdAbEldQXh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_864_zWZnZktlyHl1"&gt;Research
and Development&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
and development costs are expensed as incurred. Supplies are consumable and recorded at cost and are charged to expense as they are
used in operations. Equipment and facilities acquired for research and development activities that have alternative future uses are
capitalized and charged to expense over their estimated useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zPN17PhH7Lof" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86E_zRxYNFxPrvH5"&gt;Net
Loss per Share of Common Stock&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
and diluted net loss per common share was computed by dividing net loss for the year by the weighted average number of shares of common
stock outstanding, both basic and diluted, during each period. The impact of common stock equivalents has been excluded from the computation
of diluted weighted average common shares outstanding in periods where there is a net loss, as their effect is anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the years ended December 31, 2024 and 2023, the total number of shares of common stock issuable upon exercise of warrants and equity
awards was &lt;span id="xdx_90C_ecustom--NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards_c20240101__20241231_zIdJ8NypOvke" title="Number of shares of common stock issuable upon exercise of warrants and equity awards"&gt;6,840,633&lt;/span&gt; and &lt;span id="xdx_903_ecustom--NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards_c20230101__20231231_z8uqJsW68Whg" title="Number of shares of common stock issuable upon exercise of warrants and equity awards"&gt;1,255,642&lt;/span&gt;, respectively. For the years ended December 31, 2024 and 2023, diluted loss per common share is the
same as basic loss per common share as all options and all other warrants that were convertible into shares of the Company&#x2019;s common
stock were excluded from the calculation of diluted earnings attributable to common stockholders per common share as their effect would
be anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zRaWOaQJvd1e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_866_z5YYICLMLxq5"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for
the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities
and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using
enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered
or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in results of operations in the
period that the tax rate change occurs. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount
expected to be realized. In accordance with ASC 740, &lt;i&gt;Income Taxes,&lt;/i&gt; a tax position is recognized as a benefit only if it is &#x201c;more
likely than not&#x201d; that the tax position taken would be sustained in a tax examination, presuming that a tax examination will occur.
The Company recognizes interest and/or penalties related to income tax matters in the income tax expense category.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
more fully discussed in Note 10, on November 28, 2023, the Company received approval from the New Jersey Economic Development Authority
to sell $&lt;span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231128__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_zyQUca0mGMrj" title="Net proceeds from sale of net operating losses"&gt;1.3&lt;/span&gt; million of its New Jersey net operating losses (&#x201c;NOLs&#x201d;), recognizing a tax benefit for the year ended December
31, 2023 for the net proceeds (approximately $&lt;span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_zQqFn3poljfg" title="Net proceeds from sale of net operating losses"&gt;1.3&lt;/span&gt; million) by reducing the net operating loss valuation allowance. As more fully discussed
in Note 10, on November 28, 2023, the Company was notified by the New Jersey Economic Development Authority that its application was
approved and the Company entered into an agreement to sell this NOL. On March 22, 2024, the Company received approximately $&lt;span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20240322__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_zVzov2i0QTOh" title="Net proceeds from sale of net operating losses"&gt;1.3&lt;/span&gt; million
upon completion of the sale of the 2023 NOLs. During 2021, the New Jersey State Legislature increased the maximum lifetime benefit per
company from $&lt;span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MinimumMember_zuvjJAWM4cA3" title="Net proceeds from sale of net operating losses"&gt;15&lt;/span&gt; million to $&lt;span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MaximumMember_zscyKEF3T4t3" title="Net proceeds from sale of net operating losses"&gt;20&lt;/span&gt; million, which will allow the Company to participate in this innovative funding program in future years
for up to an additional $&lt;span id="xdx_908_eus-gaap--DirectFinancingLeaseSellingLoss_pn5n6_c20210101__20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MaximumMember_znzYDjnuVgY7" title="Direct financing lease, selling loss"&gt;0.4&lt;/span&gt; million in net operating losses under this maximum lifetime benefit (see Note 2).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zAuM5jvcHRGh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_866_zmV0V4UKH7s4"&gt;Stock-Based
Compensation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for all share-based payment awards granted to employees and non-employees as stock-based compensation expense at
grant date fair value. The Company&#x2019;s share-based payments include stock options and grants of common stock, including common
stock subject to vesting. The measurement date for employee awards is the date of grant, and stock-based compensation costs are
recognized as expense over the employees&#x2019; requisite service period, which is the vesting period, on a straight-line basis.
Prior to the adoption of Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2018-07, &lt;i&gt;Compensation&#x2014;Stock Compensation
(Topic 718): Improvements to Nonemployee Share-Based Payment Accounting&lt;/i&gt; (&#x201c;ASU No. 2018-07&#x201d;) on January 1, 2020, the
measurement date for non-employee awards was generally the date the services were completed, resulting in financial reporting period
adjustments to stock-based compensation during the vesting terms for changes in the fair value of the awards. Since the adoption of
ASU 2018-07, the measurement date for non-employee awards is the date of grant without changes in the fair value of the award. There
was no material impact as a result of adopting this new standard. Stock-based compensation costs for non-employees are recognized as
expense over the vesting period on a straight-line basis. Stock-based compensation expense is classified in the accompanying
consolidated statements of operations based on the function to which the related services are provided. Forfeitures are recorded as
they occur.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. Since there is
limited historical data of the Company&#x2019;s share price on the public market, the Company estimates its expected stock volatility
based on the historical volatility of a publicly traded set of representative companies and expects to continue to do so until such time
as it has adequate historical data regarding the volatility of its own traded stock price. The expected term of the Company&#x2019;s stock
options has been determined utilizing the &#x201c;simplified&#x201d; method for awards that qualify as &#x201c;plain-vanilla&#x201d; options.
The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for
time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has
never paid cash dividends on common stock and does not expect to pay any cash dividends in the foreseeable future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--WarrantAccountingPolicyTextBlock_zknejFqvE3v9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86A_zubzMXlIwN6g"&gt;Warrant
Accounting&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants&#x2019; specific
terms and applicable authoritative guidance in ASC 480, &#x201c;Distinguishing Liabilities from Equity&#x201d; (&#x201c;ASC 480&#x201d;),
and ASC 815 &#x201c;Derivatives and Hedging&#x201d; (&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all
of the requirements for equity classification under ASC 815, including whether the warrants are indexed to our own ordinary shares and
whether warrant holders could potentially require &#x201c;net cash settlement&#x201d; in a circumstance outside of our control, among other
conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant
issuance and as of each subsequent quarterly period end-date while the warrants are outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
issued or modified warrants that meet all the criteria for equity classification, the warrants are required to be recorded as a component
of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants
are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of warrants classified as liabilities are recognized as a non-cash gain or loss on our statements
of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
the warrants issued upon our financings in 2024 meet the criteria for equity classification under ASC 815, those warrants were classified
as equity as of December 31, 2024. No warrants were issued in 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zDyZDNP766sh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_863_zqPXVdyVEl3d"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, new accounting pronouncements are issued by the FASB and are adopted by the Company as of the specified effective date.
Unless otherwise discussed, the Company believes that the impact of recently issued accounting pronouncements will not have a material
impact on the Company&#x2019;s consolidated financial position, results of operations, and cash flows, or do not apply to its operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU No. 2023-07, &#x201c;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&#x201d;.
The disclosure requirements are required on an annual and interim basis and are applicable to entities with a single reportable segment.
The amendments in the ASU require disclosures to include significant segment expenses that are regularly provided to the chief operating
decision maker (&#x201c;CODM&#x201d;), a description of other segment items by reportable segment, and any additional measures of a segment&#x2019;s
profit or loss used by the CODM when deciding how to allocate resources. ASU 2023-07 is effective for fiscal years beginning after December
15, 2023 and interim periods for fiscal years beginning after December 31, 2024, with early adoption allowed. We adopted this guidance
as of January 1, 2024 on a retrospective basis and the adoption did not have a material impact on our consolidated financial statements.
Refer to Note 3, &#x201c;&lt;i&gt;Segment Performance Measures and Expenses&lt;/i&gt;,&#x201d; for new disclosures resulting from the adoption of ASU
2023-07.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU No. 2023-09, &lt;i&gt;Improvements to Income Tax Disclosures&lt;/i&gt;, which requires disclosure of disaggregated
income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income
tax-related disclosures. ASU No. 2023-09 is effective for fiscal years beginning after December 15, 2024 and allows for adoption on a
prospective basis, with a retrospective option. Early adoption is permitted. The Company is currently evaluating the impact of the ASU
on the income tax disclosures within the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2024, the FASB issued Accounting Standards Update No. 2024-03, Income Statement &#x2013; Reporting Comprehensive Income &#x2013;
Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses (&#x201c;ASU 2024-03&#x201d;). ASU 2024-03 will require
more detailed information about the types of expenses in commonly presented income statement captions such as &#x201c;Cost of sales&#x201d;
and &#x201c;Selling, general and administrative expenses&#x201d;. The new guidance is effective for annual reporting periods beginning
after December 15, 2026, and interim reporting periods beginning after December 15, 2027 with early adoption permitted. The Company is
currently evaluating the impact that this change will have on the Company&#x2019;s disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_851_zczJowsXYUid" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000521">&lt;p id="xdx_84D_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zvySlgYoTayb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_865_zh5oy2eCD6x3"&gt;Description
of Business&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Imunon,
Inc. (&#x201c;Imunon&#x201d; or the &#x201c;Company&#x201d;) is a clinical-stage biotechnology company focused on advancing a portfolio of
innovative treatments that harness the body&#x2019;s natural mechanisms with the aim to generate safe, effective and durable responses
across a broad array of human diseases, constituting a differentiating approach from conventional therapies. Imunon is developing its
non-viral DNA technology across its modalities. The first modality, TheraPlas&#xae;, is developed for the coding of proteins and cytokines
in the treatment of solid tumors where an immunological approach is deemed promising. The second modality, PlaCCine&#xae;, is developed
for the coding of viral antigens that can elicit a strong immunological response. This technology may represent a promising platform
for the development of vaccines in infectious diseases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer
that has completed Phase II clinical studies. IMNN-001 works by instructing the body to produce safe and durable levels of powerful cancer-fighting
molecules, such as interleukin-12 and interferon gamma, at the tumor site. Additionally, the Company has entered a first-in-human study
of its COVID-19 booster vaccine (IMNN-101). The Company will continue to leverage these modalities and to advance the technological frontier
of plasmid DNA to better serve patients with difficult-to-treat conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000523">&lt;p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zae6M2qgw8N9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86F_zaJVUmFdjmi8"&gt;Basis
of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements (&#x201c;Financial Statements&#x201d;) of Imunon have been prepared in accordance with accounting
principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and include the accounts of the Company and CLSN Laboratories,
Inc. The Company dissolved Celsion GmbH in 2023. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000525">&lt;p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zp7DGI3bhVRl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_865_zI7u3z2jMAB2"&gt;Accounting
Standards Update: Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU No. 2023-07, &#x201c;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&#x201d;.
The disclosure requirements are required on an annual and interim basis and are applicable to entities with a single reportable segment.
The amendments in the ASU require disclosures to include significant segment expenses that are regularly provided to the chief operating
decision maker (&#x201c;CODM&#x201d;), a description of other segment items by reportable segment, and any additional measures of a segment&#x2019;s
profit or loss used by the CODM when deciding how to allocate resources. ASU 2023-07 is effective for fiscal years beginning after December
15, 2023 and interim periods for fiscal years beginning after December 31, 2024, with early adoption allowed. We adopted this guidance
as of January 1, 2024 on a retrospective basis and the adoption did not have a material impact on our consolidated financial statements.
Refer to Note 3, &#x201c;&lt;i&gt;Segment Performance Measures and Expenses&lt;/i&gt;,&#x201d; for new disclosures resulting from the adoption of ASU
2023-07.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2024-01-01to2024-12-31" id="Fact000527">&lt;p id="xdx_842_eus-gaap--UseOfEstimates_z1OUXqQnRFab" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_863_zwIEi2FD2nra"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the
reported amounts of expenses during the reporting period. Actual results could differ significantly from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000529">&lt;p id="xdx_843_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zKfScKLf3Bjh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86C_z6An9PGJcFY8"&gt;Revenue
Recognition&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company did not generate any revenue in 2024 or 2023 and there were &lt;span id="xdx_907_eus-gaap--AccountsReceivableNet_iI_pdp0_do_c20241231_zQ3A5TpsjlMa" title="Accounts receivable"&gt;&lt;span id="xdx_90E_eus-gaap--AccountsReceivableNet_iI_pdp0_do_c20231231_zvwPfGfAfP2d" title="Accounts receivable"&gt;no&lt;/span&gt;&lt;/span&gt; accounts receivable as of December 31, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000531"
      unitRef="USD">0</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000533"
      unitRef="USD">0</us-gaap:AccountsReceivableNet>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000535">&lt;p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zOBhxFArpyd1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_861_zzhY1d8iGIfc"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents include cash on hand and investments purchased with an original maturity of three months or less. A portion of these
funds are not covered by FDIC insurance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2024-01-01to2024-12-31" id="Fact000537">&lt;p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWVTmmcisM1e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86B_zqyQ0nKKzRvl"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying values of financial instruments approximate their respective fair values. Management believes that the carrying amounts of the
Company&#x2019;s financial instruments, including cash and cash equivalents and accounts payable approximate fair value due to the short-term
nature of those instruments. Short-term investments are recorded at their estimated fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:InvestmentPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000539">&lt;p id="xdx_849_eus-gaap--InvestmentPolicyTextBlock_z8yuuJU4D5Pg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86D_zOLBFKHY8BJ8"&gt;Short-Term
Investments&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company classifies its investments in debt securities with readily determinable fair values as investments available-for-sale in accordance
with Accounting Standards Codification (&#x201c;ASC&#x201d;) 320, &lt;i&gt;Investments - Debt and Equity Securities&lt;/i&gt;. Available-for-sale securities
consist of debt securities not classified as trading securities or as securities to be held to maturity. The Company has classified all
of its investments as available-for-sale. Unrealized holding gains and losses on available-for-sale securities are reported as a net
amount in accumulated other comprehensive gain or loss in stockholders&#x2019; equity until realized. Gains and losses on the sale of
available-for-sale securities are determined using the specific identification method. The Company&#x2019;s short-term investments consist
of corporate bonds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000541">&lt;p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zug1ROyI6bp2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_861_z7ucnlguqE76"&gt;Property
and Equipment&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is provided over the estimated useful lives
of the related assets, ranging from &lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20241231__srt--RangeAxis__srt--MinimumMember_zYE3fp0mEK27" title="Property plant and equipment useful life::XDX::P3Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0543"&gt;three&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20241231__srt--RangeAxis__srt--MaximumMember_zZIUtEY11Mi8" title="Property plant and equipment useful life"&gt;seven years&lt;/span&gt;, using the straight-line method. Amortization is recognized over the lesser
of the life of the asset or the lease term. Major renewals and improvements are capitalized at cost and ordinary repairs and maintenance
are charged against operating expenses as incurred. Depreciation expense was approximately $&lt;span id="xdx_90C_eus-gaap--DepreciationAndAmortization_pp0p0_c20240101__20241231_zQVcdcMNWTh8" title="Depreciation expense"&gt;240,000&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--DepreciationAndAmortization_pp0p0_c20230101__20231231_z9WPieBxdnNc" title="Depreciation expense"&gt;248,000&lt;/span&gt; for the years ended
December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of
an asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the future net undiscounted cash flows
that the asset is expected to generate. If such asset is considered to be impaired, the impairment recognized is the amount by which
the carrying amount of the asset, if any, exceeds its fair value determined using a discounted cash flow model. There was &lt;span id="xdx_90D_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pdp0_do_c20240101__20241231_zVfBHWUtMXA5" title="Impairment of property or equipment"&gt;&lt;span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pdp0_do_c20230101__20231231_zm10zQPzzU8b" title="Impairment of property or equipment"&gt;no&lt;/span&gt;&lt;/span&gt; impairment
of property or equipment during 2024 or 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-12-31_srt_MaximumMember"
      id="Fact000545">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000547"
      unitRef="USD">240000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000549"
      unitRef="USD">248000</us-gaap:DepreciationAndAmortization>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000551"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000553"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <IMNN:AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000555">&lt;p id="xdx_840_ecustom--AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock_zgxMZgM0JY94" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_861_zcieJVfHpkp"&gt;Advances
and Deposits on Clinical Programs and Other Current Assets&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Supplies
are consumable items kept on hand to support the Company&#x2019;s R&amp;amp;D and manufacturing operations which includes prepaid expense,
raw materials, clinical supplies and consumable items for clinical trials with alternate uses that are capitalized. Supplies are recorded
at cost and are charged to expense as they are used in operations. The Company regularly reviews the quality and utilization of supplies
to determine if future use of these supplies is probable. Due to the generic use of these supplies, they can be used in multiple projects
other than those currently being studied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</IMNN:AdvancesAndDepositsOnClinicalProgramsAndOtherCurrentAssetsPolicyTextBlock>
    <IMNN:DepositsPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000557">&lt;p id="xdx_84D_ecustom--DepositsPolicyTextBlock_zv4VB1vNiPXh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86F_zejGSx6DUqp2"&gt;Deposits&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deposits
include real property security deposits and other deposits which are contractually required and of a long-term nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</IMNN:DepositsPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000559">&lt;p id="xdx_84E_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zZQIAu9nUID1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86A_zn5SgiHogNtg"&gt;Comprehensive
Income (Loss)&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
220, &lt;i&gt;Comprehensive Income&lt;/i&gt;, establishes standards for the reporting and display of comprehensive income (loss) and its components
in the Company&#x2019;s consolidated financial statements. The objective of ASC 220 is to report a measure of comprehensive income (loss)
of all changes in equity of an enterprise that result from transactions and other economic events in a period other than transactions
with owners. Comprehensive gains (losses) result from changes in unrealized gains and losses from investment in debt securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2024-01-01to2024-12-31" id="Fact000561">&lt;p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_z4pdAbEldQXh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_864_zWZnZktlyHl1"&gt;Research
and Development&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
and development costs are expensed as incurred. Supplies are consumable and recorded at cost and are charged to expense as they are
used in operations. Equipment and facilities acquired for research and development activities that have alternative future uses are
capitalized and charged to expense over their estimated useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000563">&lt;p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zPN17PhH7Lof" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86E_zRxYNFxPrvH5"&gt;Net
Loss per Share of Common Stock&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
and diluted net loss per common share was computed by dividing net loss for the year by the weighted average number of shares of common
stock outstanding, both basic and diluted, during each period. The impact of common stock equivalents has been excluded from the computation
of diluted weighted average common shares outstanding in periods where there is a net loss, as their effect is anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the years ended December 31, 2024 and 2023, the total number of shares of common stock issuable upon exercise of warrants and equity
awards was &lt;span id="xdx_90C_ecustom--NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards_c20240101__20241231_zIdJ8NypOvke" title="Number of shares of common stock issuable upon exercise of warrants and equity awards"&gt;6,840,633&lt;/span&gt; and &lt;span id="xdx_903_ecustom--NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards_c20230101__20231231_z8uqJsW68Whg" title="Number of shares of common stock issuable upon exercise of warrants and equity awards"&gt;1,255,642&lt;/span&gt;, respectively. For the years ended December 31, 2024 and 2023, diluted loss per common share is the
same as basic loss per common share as all options and all other warrants that were convertible into shares of the Company&#x2019;s common
stock were excluded from the calculation of diluted earnings attributable to common stockholders per common share as their effect would
be anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <IMNN:NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000565"
      unitRef="Shares">6840633</IMNN:NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards>
    <IMNN:NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000567"
      unitRef="Shares">1255642</IMNN:NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000569">&lt;p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zRaWOaQJvd1e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_866_z5YYICLMLxq5"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for
the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities
and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using
enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered
or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in results of operations in the
period that the tax rate change occurs. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount
expected to be realized. In accordance with ASC 740, &lt;i&gt;Income Taxes,&lt;/i&gt; a tax position is recognized as a benefit only if it is &#x201c;more
likely than not&#x201d; that the tax position taken would be sustained in a tax examination, presuming that a tax examination will occur.
The Company recognizes interest and/or penalties related to income tax matters in the income tax expense category.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
more fully discussed in Note 10, on November 28, 2023, the Company received approval from the New Jersey Economic Development Authority
to sell $&lt;span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231128__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_zyQUca0mGMrj" title="Net proceeds from sale of net operating losses"&gt;1.3&lt;/span&gt; million of its New Jersey net operating losses (&#x201c;NOLs&#x201d;), recognizing a tax benefit for the year ended December
31, 2023 for the net proceeds (approximately $&lt;span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_zQqFn3poljfg" title="Net proceeds from sale of net operating losses"&gt;1.3&lt;/span&gt; million) by reducing the net operating loss valuation allowance. As more fully discussed
in Note 10, on November 28, 2023, the Company was notified by the New Jersey Economic Development Authority that its application was
approved and the Company entered into an agreement to sell this NOL. On March 22, 2024, the Company received approximately $&lt;span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20240322__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_zVzov2i0QTOh" title="Net proceeds from sale of net operating losses"&gt;1.3&lt;/span&gt; million
upon completion of the sale of the 2023 NOLs. During 2021, the New Jersey State Legislature increased the maximum lifetime benefit per
company from $&lt;span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MinimumMember_zuvjJAWM4cA3" title="Net proceeds from sale of net operating losses"&gt;15&lt;/span&gt; million to $&lt;span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MaximumMember_zscyKEF3T4t3" title="Net proceeds from sale of net operating losses"&gt;20&lt;/span&gt; million, which will allow the Company to participate in this innovative funding program in future years
for up to an additional $&lt;span id="xdx_908_eus-gaap--DirectFinancingLeaseSellingLoss_pn5n6_c20210101__20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MaximumMember_znzYDjnuVgY7" title="Direct financing lease, selling loss"&gt;0.4&lt;/span&gt; million in net operating losses under this maximum lifetime benefit (see Note 2).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-11-28_stpr_NJ_us-gaap_NewJerseyDivisionOfTaxationMember"
      decimals="-5"
      id="Fact000571"
      unitRef="USD">1300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-12-31_stpr_NJ_us-gaap_NewJerseyDivisionOfTaxationMember"
      decimals="-5"
      id="Fact000573"
      unitRef="USD">1300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2024-03-22_stpr_NJ_us-gaap_NewJerseyDivisionOfTaxationMember"
      decimals="-5"
      id="Fact000575"
      unitRef="USD">1300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2021-12-31_stpr_NJ_srt_MinimumMember"
      decimals="-6"
      id="Fact000577"
      unitRef="USD">15000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2021-12-31_stpr_NJ_srt_MaximumMember"
      decimals="-6"
      id="Fact000579"
      unitRef="USD">20000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DirectFinancingLeaseSellingLoss
      contextRef="From2021-01-012021-12-31_stpr_NJ_srt_MaximumMember"
      decimals="-5"
      id="Fact000581"
      unitRef="USD">400000</us-gaap:DirectFinancingLeaseSellingLoss>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2024-01-01to2024-12-31" id="Fact000583">&lt;p id="xdx_84F_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zAuM5jvcHRGh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_866_zmV0V4UKH7s4"&gt;Stock-Based
Compensation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for all share-based payment awards granted to employees and non-employees as stock-based compensation expense at
grant date fair value. The Company&#x2019;s share-based payments include stock options and grants of common stock, including common
stock subject to vesting. The measurement date for employee awards is the date of grant, and stock-based compensation costs are
recognized as expense over the employees&#x2019; requisite service period, which is the vesting period, on a straight-line basis.
Prior to the adoption of Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2018-07, &lt;i&gt;Compensation&#x2014;Stock Compensation
(Topic 718): Improvements to Nonemployee Share-Based Payment Accounting&lt;/i&gt; (&#x201c;ASU No. 2018-07&#x201d;) on January 1, 2020, the
measurement date for non-employee awards was generally the date the services were completed, resulting in financial reporting period
adjustments to stock-based compensation during the vesting terms for changes in the fair value of the awards. Since the adoption of
ASU 2018-07, the measurement date for non-employee awards is the date of grant without changes in the fair value of the award. There
was no material impact as a result of adopting this new standard. Stock-based compensation costs for non-employees are recognized as
expense over the vesting period on a straight-line basis. Stock-based compensation expense is classified in the accompanying
consolidated statements of operations based on the function to which the related services are provided. Forfeitures are recorded as
they occur.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. Since there is
limited historical data of the Company&#x2019;s share price on the public market, the Company estimates its expected stock volatility
based on the historical volatility of a publicly traded set of representative companies and expects to continue to do so until such time
as it has adequate historical data regarding the volatility of its own traded stock price. The expected term of the Company&#x2019;s stock
options has been determined utilizing the &#x201c;simplified&#x201d; method for awards that qualify as &#x201c;plain-vanilla&#x201d; options.
The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for
time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has
never paid cash dividends on common stock and does not expect to pay any cash dividends in the foreseeable future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <IMNN:WarrantAccountingPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000585">&lt;p id="xdx_84D_ecustom--WarrantAccountingPolicyTextBlock_zknejFqvE3v9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86A_zubzMXlIwN6g"&gt;Warrant
Accounting&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants&#x2019; specific
terms and applicable authoritative guidance in ASC 480, &#x201c;Distinguishing Liabilities from Equity&#x201d; (&#x201c;ASC 480&#x201d;),
and ASC 815 &#x201c;Derivatives and Hedging&#x201d; (&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all
of the requirements for equity classification under ASC 815, including whether the warrants are indexed to our own ordinary shares and
whether warrant holders could potentially require &#x201c;net cash settlement&#x201d; in a circumstance outside of our control, among other
conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant
issuance and as of each subsequent quarterly period end-date while the warrants are outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
issued or modified warrants that meet all the criteria for equity classification, the warrants are required to be recorded as a component
of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants
are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of warrants classified as liabilities are recognized as a non-cash gain or loss on our statements
of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
the warrants issued upon our financings in 2024 meet the criteria for equity classification under ASC 815, those warrants were classified
as equity as of December 31, 2024. No warrants were issued in 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</IMNN:WarrantAccountingPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000587">&lt;p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zDyZDNP766sh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_863_zqPXVdyVEl3d"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, new accounting pronouncements are issued by the FASB and are adopted by the Company as of the specified effective date.
Unless otherwise discussed, the Company believes that the impact of recently issued accounting pronouncements will not have a material
impact on the Company&#x2019;s consolidated financial position, results of operations, and cash flows, or do not apply to its operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU No. 2023-07, &#x201c;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&#x201d;.
The disclosure requirements are required on an annual and interim basis and are applicable to entities with a single reportable segment.
The amendments in the ASU require disclosures to include significant segment expenses that are regularly provided to the chief operating
decision maker (&#x201c;CODM&#x201d;), a description of other segment items by reportable segment, and any additional measures of a segment&#x2019;s
profit or loss used by the CODM when deciding how to allocate resources. ASU 2023-07 is effective for fiscal years beginning after December
15, 2023 and interim periods for fiscal years beginning after December 31, 2024, with early adoption allowed. We adopted this guidance
as of January 1, 2024 on a retrospective basis and the adoption did not have a material impact on our consolidated financial statements.
Refer to Note 3, &#x201c;&lt;i&gt;Segment Performance Measures and Expenses&lt;/i&gt;,&#x201d; for new disclosures resulting from the adoption of ASU
2023-07.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU No. 2023-09, &lt;i&gt;Improvements to Income Tax Disclosures&lt;/i&gt;, which requires disclosure of disaggregated
income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income
tax-related disclosures. ASU No. 2023-09 is effective for fiscal years beginning after December 15, 2024 and allows for adoption on a
prospective basis, with a retrospective option. Early adoption is permitted. The Company is currently evaluating the impact of the ASU
on the income tax disclosures within the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2024, the FASB issued Accounting Standards Update No. 2024-03, Income Statement &#x2013; Reporting Comprehensive Income &#x2013;
Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses (&#x201c;ASU 2024-03&#x201d;). ASU 2024-03 will require
more detailed information about the types of expenses in commonly presented income statement captions such as &#x201c;Cost of sales&#x201d;
and &#x201c;Selling, general and administrative expenses&#x201d;. The new guidance is effective for annual reporting periods beginning
after December 15, 2026, and interim reporting periods beginning after December 15, 2027 with early adoption permitted. The Company is
currently evaluating the impact that this change will have on the Company&#x2019;s disclosures.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000589">&lt;p id="xdx_808_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zCnMSkstZca9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
&lt;span id="xdx_821_zgDVjFnPoFXc"&gt;FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Since
inception, the Company has incurred substantial operating losses, principally from expenses associated with the Company&#x2019;s research
and development programs, clinical trials conducted in connection with the Company&#x2019;s drug candidates, and applications and submissions
to the FDA. The Company has not generated significant revenue and has incurred significant net losses in each year since inception. For
the year ended December 31, 2024, the Company had a net loss of $&lt;span id="xdx_90F_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20240101__20241231_zfpK4dOpOVm9" title="Net loss"&gt;18.6&lt;/span&gt; million and used $&lt;span id="xdx_901_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20240101__20241231_ztZxwtxe5gUb" title="Fund operation"&gt;18.9&lt;/span&gt; million to fund operations. As of December
31, 2024, the Company has incurred approximately $&lt;span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn6n6_di_c20241231_zpzS9gjb3sd" title="Cumulated net losses"&gt;407&lt;/span&gt; million of cumulative net losses. As of December 31, 2024, the Company had $&lt;span id="xdx_90D_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_pn5n6_c20241231_z9sVC6OiUSk8" title="Cash and cash equivalents, short-term investments"&gt;5.9&lt;/span&gt;
million in cash and cash equivalents and short-term investments. The Company has substantial future capital requirements to continue
its research and development activities and advance its drug candidates through various development stages. The Company believes these
expenditures are essential for the commercialization of its drug candidates and technologies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company expects its operating losses to continue for the foreseeable future as it continues its product development efforts, and when
it undertakes marketing and sales activities. The Company&#x2019;s ability to achieve profitability is dependent upon its ability to obtain
governmental approvals, manufacture, and market and sell its new drug candidates. There can be no assurance that the Company will be
able to commercialize its technology successfully or that profitability will ever be achieved. The Company expects that its operating
results will fluctuate significantly in the future and will depend on a number of factors, many of which are outside the Company&#x2019;s
control.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s ability to raise additional capital may be adversely impacted by potential worsening global economic conditions and the
recent disruptions to, and volatility in, financial markets in the U.S. and worldwide resulting from the Russian invasion of Ukraine
and the unrest in the Middle East. The Company continues to monitor its operating activities in light of these events, and it is possible
that these events could result in a variety of risks to the business. The specific impact, if any, is not readily determinable as of
the date of these consolidated Financial Statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has based its estimates on assumptions that may prove to be wrong. The Company may need to obtain additional funds sooner or
in greater amounts than it currently anticipates. Potential sources of financing include strategic relationships, public or private sales
of the Company&#x2019;s shares or debt, the sale of the Company&#x2019;s New Jersey NOLs and other sources. If the Company raises funds
by selling additional shares of common stock or other securities convertible into common stock, the ownership interest of existing stockholders
may be diluted.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
actual amount of funds the Company will need to operate is subject to many factors, some of which are beyond the Company&#x2019;s control.
These factors include the progress of research activities; the number and scope of research programs; the progress of preclinical and
clinical development activities; the progress of the development efforts of parties with whom the Company has entered into research and
development agreements; the costs associated with additional clinical trials of drug candidates; the ability to maintain current research
and development licensing arrangements and to establish new research and development and licensing arrangements; the ability to achieve
milestones under licensing arrangements; the costs involved in prosecuting and enforcing patent claims and other intellectual property
rights; and the costs and timing of regulatory approvals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements have been prepared on the going concern basis. In making this assessment, management conducted a comprehensive
review of the Company&#x2019;s business plan including, but not limited to:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    Company&#x2019;s financial position for the year ended December 31, 2024;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;significant
    events and transactions the Company has entered into since December 31, 2024;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    Company&#x2019;s cash flow and cash usage forecasts for the period one year from the issuance date of this Annual Report on Form 10-K;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    Company&#x2019;s capitalization structure including common stock outstanding and common stock issuable on exercise of warrants and
    equity awards, and other common stock issuable under equity plans; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;continued
    support of the Company&#x2019;s stockholders.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
a result of the uncertainties involved in our business, we are unable to estimate the duration and completion costs of our research and
development projects or when, if ever, and to what extent we will receive cash inflows from the commercialization and sale of a product.
Our inability to complete our research and development projects in a timely manner or our failure to enter into collaborative agreements,
when appropriate, could significantly increase our capital requirements and could adversely impact our liquidity. These uncertainties
could force us to seek additional, external sources of financing from time to time in order to continue with our business strategy. Our
inability to raise additional capital, or to do so on terms reasonably acceptable to us, would jeopardize the future success of our business.
Our estimated future capital requirements are uncertain and could change materially as a result of many factors, including the progress
of our research, development, clinical, manufacturing, and commercialization activities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
has determined the Company has suffered recurring losses from operations and has an accumulated deficit that raises substantial doubt
about our ability to continue as a going concern for the next twelve months from the issuance date of this Annual Report on Form 10-K.
The report of our independent registered public accounting firm for the year ended December 31, 2024 includes an explanatory paragraph,
which expresses substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments
that might result from the outcome of the uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
fundamental component of the ability to continue as a going concern is the Company&#x2019;s ability to raise capital as required, as to
which no assurances can be provided. To address the additional funding requirements of the Company, management has undertaken the following
initiatives:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;it
    has assessed its current expenditures and will be reducing the current spending requirements where necessary;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;it
    will pursue additional capital funding in the public and private markets through equity sales and/or debt facilities;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;it
    will pursue possible partnerships and collaborations; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;it
    will pursue potential out licensing for its drug candidates.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
ability to continue as a going concern may depend on our ability to raise additional capital, attain further operating efficiencies,
reduce expenditures, and, ultimately, to generate revenue. There are no assurances that these future funding and operating efforts will
be successful. If management is unsuccessful in these efforts, our current capital is not expected to be sufficient to fund our operations
for the next twelve months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="-5"
      id="Fact000591"
      unitRef="USD">-18600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-01-01to2024-12-31"
      decimals="-5"
      id="Fact000593"
      unitRef="USD">-18900000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-12-31"
      decimals="-6"
      id="Fact000595"
      unitRef="USD">-407000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="AsOf2024-12-31"
      decimals="-5"
      id="Fact000597"
      unitRef="USD">5900000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000599">&lt;p id="xdx_803_eus-gaap--SegmentReportingDisclosureTextBlock_zzQTVrseoFp6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3.
&lt;span id="xdx_821_zukiTH0MiWai"&gt;SEGMENT PERFORMANCE MEASURES AND EXPENSES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company operates in &lt;span id="xdx_901_eus-gaap--NumberOfOperatingSegments_pid_dc_uSegment_c20240101__20241231_zdHcMDCYRi69" title="Number of operating segment"&gt;one&lt;/span&gt; segment for the research and development of our product candidates. The Company&#x2019;s chief operating decision
maker (&#x201c;CODM&#x201d;) has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions
about allocating resources and assessing performance for the entire Company based on consolidated financial information. Consequently,
we view the entire organization as one reportable segment and the strategic purpose of all operating activities (including general &amp;amp;
administrative expenses) is to support that one segment. As a pre-revenue research and development company, the CODM evaluates company-wide
performance and allocates resources based on non-financial research and development milestones achieved, and to a lesser extent, financial
measures of performance such as clinical development (research and development expenses) and general and administrative expenses incurred.
Our CODM does not generally evaluate our performance using asset or historical cash flow information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zlYQ79s71ut1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
table below provides a summary of the significant expense categories and consolidated net loss details provided to the CODM (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B1_zFMVxNtWuuRe" style="display: none"&gt;SCHEDULE
OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z9zuGKD5DL8g" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20230101__20231231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z4JR9kjY8526" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Change Increase (Decrease)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Operating Expenses:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Clinical Research&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OvationMember_z4e9KjHX7xFc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; width: 36%"&gt;OVATION&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,386&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,197&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zFtaV2ODW7J" style="width: 12%; text-align: right"&gt;189&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zl3kXxShCr7d"&gt;15.8&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--VaccineMember_z0OCox7LvAb2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt"&gt;Vaccine&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,420&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0611"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--VaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zjRKddLokjw7" style="text-align: right"&gt;1,420&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--VaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zb0C42p2TNTc"&gt;100.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OtherClinicalAndRegulatoryMember_zPYfOJ8X3dJd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Other clinical and regulatory&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,434&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,793&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OtherClinicalAndRegulatoryMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z3T2geOY6303" style="border-bottom: Black 1pt solid; text-align: right"&gt;641&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OtherClinicalAndRegulatoryMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zw5gp35Sd7Md"&gt;35.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember_zKd0FMmOdJp1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Subtotal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,240&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,990&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z452SWsVlj4g" style="text-align: right"&gt;2,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z4a7RGkHKSl3"&gt;75.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Non-Clinical R&amp;amp;D and CMC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--OvationMember_zKDwOJJJJWU5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt"&gt;OVATION&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,819&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,504&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z4DP2VlA9jT2" style="text-align: right"&gt;315&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zrcBUfUtWYj9"&gt;20.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--PlaCCineVaccineMember_zzqUozQSQxn1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;PlaCCine Vaccine&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,554&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,511&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--PlaCCineVaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zgHqSp0xeY9d" style="text-align: right"&gt;(1,957&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--PlaCCineVaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zTtNvCMJJ7d5"&gt;(43.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--ManufacturingCMCMember_zo4TRj9NNMz9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Manufacturing (CMC)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,283&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--ManufacturingCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zRx7aVJlZEMg" style="border-bottom: Black 1pt solid; text-align: right"&gt;(257&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--ManufacturingCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z7iaC6rBWGH3"&gt;(11.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember_z6i4WbV7mvbj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,399&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,298&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zwSNi41ErFb1" style="border-bottom: Black 1pt solid; text-align: right" title="Change Increase (Decrease), Subtotal"&gt;(1,899&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zBowl8SqcpX4" title="Change Increase (Decrease), Subtotal, percentage"&gt;(22.9&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_ztqM0GgOWf9l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Research and development expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,639&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,288&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IncreaseDecreaseInResearchAndDevelopmentExpenses_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zYFMsCxY8myk" style="text-align: right" title="Change Increase (Decrease), Research and development expenses"&gt;351&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_ziAmP68chYk9" title="Change Increase (Decrease), Research and development expenses, percentage"&gt;3.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_zLS5FIlTy7Bi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;General and administrative expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;7,493&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;9,742&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--IncreaseDecreaseInGeneralAndAdministrativeExpenes_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zECrFD39e8Qh" style="border-bottom: Black 1pt solid; text-align: right" title="Change Increase (Decrease), General and administrative expenses"&gt;(2,249&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zyxAuV2CPhYa" title="Change Increase (Decrease), General and administrative expenses, percentage"&gt;(23.1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OperatingExpenses_pn3n3_zfgajMq7vzx4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Total operating expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;19,132&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;21,030&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IncreaseDecreaseInOperatingExpenses_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z3A3fIYodV3f" style="border-bottom: Black 1pt solid; text-align: right" title="Change Increase (Decrease), Operating expenses"&gt;(1,898&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--IncreaseDecreaseInOperatingExpensesPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zkeS1CfGQgA5" title="Change Increase (Decrease), Operating expenses, percentage"&gt;(9.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingIncomeLoss_pn3n3_zEdiaCmAvLR4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Loss from operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(19,132&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(21,030&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--IncreaseDecreaseInLossFromOperations_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zWgXhZ2zDbN3" style="border-bottom: Black 2.5pt double; text-align: right" title="Change Increase (Decrease), Loss from operations"&gt;(1,898&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_ecustom--IncreaseDecreaseInLossFromOperationsPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zdAJmKiYcYVc" title="Change Increase (Decrease), Loss from operations, percentage"&gt;(9.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_z7LwPaQy3k1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000601"
      unitRef="Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000603">&lt;p id="xdx_89A_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zlYQ79s71ut1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
table below provides a summary of the significant expense categories and consolidated net loss details provided to the CODM (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B1_zFMVxNtWuuRe" style="display: none"&gt;SCHEDULE
OF SIGNIFICANT EXPENSE CATEGORIES AND CONSOLIDATED NET LOSS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z9zuGKD5DL8g" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20230101__20231231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z4JR9kjY8526" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Change Increase (Decrease)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Operating Expenses:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Clinical Research&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OvationMember_z4e9KjHX7xFc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; width: 36%"&gt;OVATION&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,386&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,197&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zFtaV2ODW7J" style="width: 12%; text-align: right"&gt;189&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zl3kXxShCr7d"&gt;15.8&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--VaccineMember_z0OCox7LvAb2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt"&gt;Vaccine&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,420&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0611"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--VaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zjRKddLokjw7" style="text-align: right"&gt;1,420&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--VaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zb0C42p2TNTc"&gt;100.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OtherClinicalAndRegulatoryMember_zPYfOJ8X3dJd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Other clinical and regulatory&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,434&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,793&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OtherClinicalAndRegulatoryMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z3T2geOY6303" style="border-bottom: Black 1pt solid; text-align: right"&gt;641&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__us-gaap--SubsegmentsAxis__custom--OtherClinicalAndRegulatoryMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zw5gp35Sd7Md"&gt;35.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember_zKd0FMmOdJp1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Subtotal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,240&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,990&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z452SWsVlj4g" style="text-align: right"&gt;2,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--ClinicalResearchMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z4a7RGkHKSl3"&gt;75.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Non-Clinical R&amp;amp;D and CMC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--OvationMember_zKDwOJJJJWU5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt"&gt;OVATION&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,819&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,504&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z4DP2VlA9jT2" style="text-align: right"&gt;315&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--OvationMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zrcBUfUtWYj9"&gt;20.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--PlaCCineVaccineMember_zzqUozQSQxn1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;PlaCCine Vaccine&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,554&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,511&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--PlaCCineVaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zgHqSp0xeY9d" style="text-align: right"&gt;(1,957&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--PlaCCineVaccineMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zTtNvCMJJ7d5"&gt;(43.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--ManufacturingCMCMember_zo4TRj9NNMz9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Manufacturing (CMC)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,283&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--ManufacturingCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zRx7aVJlZEMg" style="border-bottom: Black 1pt solid; text-align: right"&gt;(257&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__us-gaap--SubsegmentsAxis__custom--ManufacturingCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z7iaC6rBWGH3"&gt;(11.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OperatingCostsAndExpenses_pn3n3_hus-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember_z6i4WbV7mvbj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,399&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,298&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IncreaseDecreaseInOperatingCostAndExpenses_pn3n3_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zwSNi41ErFb1" style="border-bottom: Black 1pt solid; text-align: right" title="Change Increase (Decrease), Subtotal"&gt;(1,899&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--IncreaseDecreaseInOperatingCostsAndExpensesPercentage_dp_uPure_c20240101__20241231__us-gaap--StatementBusinessSegmentsAxis__custom--NonClinicalRAndDAndCMCMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zBowl8SqcpX4" title="Change Increase (Decrease), Subtotal, percentage"&gt;(22.9&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_ztqM0GgOWf9l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Research and development expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,639&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,288&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IncreaseDecreaseInResearchAndDevelopmentExpenses_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zYFMsCxY8myk" style="text-align: right" title="Change Increase (Decrease), Research and development expenses"&gt;351&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_ziAmP68chYk9" title="Change Increase (Decrease), Research and development expenses, percentage"&gt;3.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_zLS5FIlTy7Bi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;General and administrative expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;7,493&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;9,742&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--IncreaseDecreaseInGeneralAndAdministrativeExpenes_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zECrFD39e8Qh" style="border-bottom: Black 1pt solid; text-align: right" title="Change Increase (Decrease), General and administrative expenses"&gt;(2,249&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zyxAuV2CPhYa" title="Change Increase (Decrease), General and administrative expenses, percentage"&gt;(23.1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OperatingExpenses_pn3n3_zfgajMq7vzx4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Total operating expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;19,132&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;21,030&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IncreaseDecreaseInOperatingExpenses_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_z3A3fIYodV3f" style="border-bottom: Black 1pt solid; text-align: right" title="Change Increase (Decrease), Operating expenses"&gt;(1,898&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--IncreaseDecreaseInOperatingExpensesPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zkeS1CfGQgA5" title="Change Increase (Decrease), Operating expenses, percentage"&gt;(9.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingIncomeLoss_pn3n3_zEdiaCmAvLR4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Loss from operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(19,132&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(21,030&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--IncreaseDecreaseInLossFromOperations_pn3n3_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zWgXhZ2zDbN3" style="border-bottom: Black 2.5pt double; text-align: right" title="Change Increase (Decrease), Loss from operations"&gt;(1,898&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_ecustom--IncreaseDecreaseInLossFromOperationsPercentage_dp_uPure_c20240101__20241231__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zdAJmKiYcYVc" title="Change Increase (Decrease), Loss from operations, percentage"&gt;(9.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OvationMember"
      decimals="-3"
      id="Fact000605"
      unitRef="USD">1386000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OvationMember"
      decimals="-3"
      id="Fact000606"
      unitRef="USD">1197000</us-gaap:OperatingCostsAndExpenses>
    <IMNN:IncreaseDecreaseInOperatingCostAndExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OvationMember"
      decimals="-3"
      id="Fact000607"
      unitRef="USD">189000</IMNN:IncreaseDecreaseInOperatingCostAndExpenses>
    <IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OvationMember"
      decimals="INF"
      id="Fact000608"
      unitRef="Pure">0.158</IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_VaccineMember"
      decimals="-3"
      id="Fact000610"
      unitRef="USD">1420000</us-gaap:OperatingCostsAndExpenses>
    <IMNN:IncreaseDecreaseInOperatingCostAndExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_VaccineMember"
      decimals="-3"
      id="Fact000612"
      unitRef="USD">1420000</IMNN:IncreaseDecreaseInOperatingCostAndExpenses>
    <IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_VaccineMember"
      decimals="INF"
      id="Fact000613"
      unitRef="Pure">1.000</IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OtherClinicalAndRegulatoryMember"
      decimals="-3"
      id="Fact000615"
      unitRef="USD">2434000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OtherClinicalAndRegulatoryMember"
      decimals="-3"
      id="Fact000616"
      unitRef="USD">1793000</us-gaap:OperatingCostsAndExpenses>
    <IMNN:IncreaseDecreaseInOperatingCostAndExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OtherClinicalAndRegulatoryMember"
      decimals="-3"
      id="Fact000617"
      unitRef="USD">641000</IMNN:IncreaseDecreaseInOperatingCostAndExpenses>
    <IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember_custom_OtherClinicalAndRegulatoryMember"
      decimals="INF"
      id="Fact000618"
      unitRef="Pure">0.358</IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember"
      decimals="-3"
      id="Fact000620"
      unitRef="USD">5240000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember"
      decimals="-3"
      id="Fact000621"
      unitRef="USD">2990000</us-gaap:OperatingCostsAndExpenses>
    <IMNN:IncreaseDecreaseInOperatingCostAndExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember"
      decimals="-3"
      id="Fact000622"
      unitRef="USD">2250000</IMNN:IncreaseDecreaseInOperatingCostAndExpenses>
    <IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_ClinicalResearchMember"
      decimals="INF"
      id="Fact000623"
      unitRef="Pure">0.753</IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_OvationMember"
      decimals="-3"
      id="Fact000625"
      unitRef="USD">1819000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_OvationMember"
      decimals="-3"
      id="Fact000626"
      unitRef="USD">1504000</us-gaap:OperatingCostsAndExpenses>
    <IMNN:IncreaseDecreaseInOperatingCostAndExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_OvationMember"
      decimals="-3"
      id="Fact000627"
      unitRef="USD">315000</IMNN:IncreaseDecreaseInOperatingCostAndExpenses>
    <IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_OvationMember"
      decimals="INF"
      id="Fact000628"
      unitRef="Pure">0.209</IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_PlaCCineVaccineMember"
      decimals="-3"
      id="Fact000630"
      unitRef="USD">2554000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_PlaCCineVaccineMember"
      decimals="-3"
      id="Fact000631"
      unitRef="USD">4511000</us-gaap:OperatingCostsAndExpenses>
    <IMNN:IncreaseDecreaseInOperatingCostAndExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_PlaCCineVaccineMember"
      decimals="-3"
      id="Fact000632"
      unitRef="USD">-1957000</IMNN:IncreaseDecreaseInOperatingCostAndExpenses>
    <IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_PlaCCineVaccineMember"
      decimals="INF"
      id="Fact000633"
      unitRef="Pure">-0.434</IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_ManufacturingCMCMember"
      decimals="-3"
      id="Fact000635"
      unitRef="USD">2026000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_ManufacturingCMCMember"
      decimals="-3"
      id="Fact000636"
      unitRef="USD">2283000</us-gaap:OperatingCostsAndExpenses>
    <IMNN:IncreaseDecreaseInOperatingCostAndExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_ManufacturingCMCMember"
      decimals="-3"
      id="Fact000637"
      unitRef="USD">-257000</IMNN:IncreaseDecreaseInOperatingCostAndExpenses>
    <IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember_custom_ManufacturingCMCMember"
      decimals="INF"
      id="Fact000638"
      unitRef="Pure">-0.113</IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember"
      decimals="-3"
      id="Fact000640"
      unitRef="USD">6399000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember"
      decimals="-3"
      id="Fact000641"
      unitRef="USD">8298000</us-gaap:OperatingCostsAndExpenses>
    <IMNN:IncreaseDecreaseInOperatingCostAndExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember"
      decimals="-3"
      id="Fact000643"
      unitRef="USD">-1899000</IMNN:IncreaseDecreaseInOperatingCostAndExpenses>
    <IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember_custom_NonClinicalRAndDAndCMCMember"
      decimals="INF"
      id="Fact000645"
      unitRef="Pure">-0.229</IMNN:IncreaseDecreaseInOperatingCostsAndExpensesPercentage>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      id="Fact000647"
      unitRef="USD">11639000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      id="Fact000648"
      unitRef="USD">11288000</us-gaap:ResearchAndDevelopmentExpense>
    <IMNN:IncreaseDecreaseInResearchAndDevelopmentExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      id="Fact000650"
      unitRef="USD">351000</IMNN:IncreaseDecreaseInResearchAndDevelopmentExpenses>
    <IMNN:IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember"
      decimals="INF"
      id="Fact000652"
      unitRef="Pure">0.031</IMNN:IncreaseDecreaseInResearchAndDevelopmentExpensesPercentage>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      id="Fact000654"
      unitRef="USD">7493000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      id="Fact000655"
      unitRef="USD">9742000</us-gaap:GeneralAndAdministrativeExpense>
    <IMNN:IncreaseDecreaseInGeneralAndAdministrativeExpenes
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      id="Fact000657"
      unitRef="USD">-2249000</IMNN:IncreaseDecreaseInGeneralAndAdministrativeExpenes>
    <IMNN:IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember"
      decimals="INF"
      id="Fact000659"
      unitRef="Pure">-0.231</IMNN:IncreaseDecreaseInGeneralAndAdministrativeExpensesPercentage>
    <us-gaap:OperatingExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      id="Fact000661"
      unitRef="USD">19132000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      id="Fact000662"
      unitRef="USD">21030000</us-gaap:OperatingExpenses>
    <IMNN:IncreaseDecreaseInOperatingExpenses
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      id="Fact000664"
      unitRef="USD">-1898000</IMNN:IncreaseDecreaseInOperatingExpenses>
    <IMNN:IncreaseDecreaseInOperatingExpensesPercentage
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember"
      decimals="INF"
      id="Fact000666"
      unitRef="Pure">-0.090</IMNN:IncreaseDecreaseInOperatingExpensesPercentage>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      id="Fact000668"
      unitRef="USD">-19132000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      id="Fact000669"
      unitRef="USD">-21030000</us-gaap:OperatingIncomeLoss>
    <IMNN:IncreaseDecreaseInLossFromOperations
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      id="Fact000671"
      unitRef="USD">-1898000</IMNN:IncreaseDecreaseInLossFromOperations>
    <IMNN:IncreaseDecreaseInLossFromOperationsPercentage
      contextRef="From2024-01-012024-12-31_us-gaap_OperatingSegmentsMember"
      decimals="INF"
      id="Fact000673"
      unitRef="Pure">-0.090</IMNN:IncreaseDecreaseInLossFromOperationsPercentage>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000675">&lt;p id="xdx_80F_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zSPdFfKASWO3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;4.
&lt;span id="xdx_82C_zTpkOu60T2Wa"&gt;INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investments
in debt securities available for sale with a fair value of $&lt;span id="xdx_90A_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_dxL_c20241231_zPGGVFNRdtag" title="Debt securities, available for sale, current::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0677"&gt;0&lt;/span&gt;&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231_z8xrrKZwAmtd" title="Debt securities, available for sale, current"&gt;9,857,087&lt;/span&gt; as of December 31, 2024 and 2023, respectively, consisted
of U.S. Treasury securities and corporate debt securities. These investments are valued at estimated fair value, with unrealized gains
and losses reported as a separate component of stockholders&#x2019; equity in accumulated other comprehensive loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reviews its debt securities classified as short-term investments on a regular basis for impairment. For debt securities in unrealized
loss positions, the Company determines whether any portion of the decline in fair value below the amortized cost basis is due to credit-related
factors if it neither intends to sell nor anticipates that it is more likely than not that it will be required to sell prior to recovery
of the amortized cost basis. The Company considers factors such as the extent to which the market value has been less than the cost,
any noted failure of the issuer to make scheduled payments, changes to the rating of the security and other relevant credit-related factors
in determining whether or not a credit loss exists. During fiscal 2024 and 2023, the Company did not recognize an allowance for credit-related
losses on any of our investments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--DebtSecuritiesAvailableForSaleTableTextBlock_zJhMhxVWqx8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the cost, fair value and maturities of the Company&#x2019;s short-term investments is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zFMeTwAajRV5" style="display: none"&gt;SCHEDULE
OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Short-term investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;U.S. Treasury securities&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShortTermInvestments_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zop2FxWWLzPi" style="width: 12%; text-align: right" title="Short-term investments - Cost"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0683"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zEml1ZLOhUY9" style="width: 12%; text-align: right" title="Short-term investments - Fair Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0685"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShortTermInvestments_iI_pp0p0_c20231231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zDqeN0KHQiF5" style="width: 12%; text-align: right" title="Short-term investments - Cost"&gt;9,796,291&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_ziEbR6ujJHN8" style="width: 12%; text-align: right" title="Short-term investments - Fair Value"&gt;9,857,087&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Short-term investment maturities&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%"&gt;Within 3 months&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost_iI_pp0p0_c20241231_zQlUqIkK3kTj" style="width: 12%; text-align: right" title="Short-term investment maturities - Within 3 months, cost"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0691"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue_iI_pp0p0_c20241231_zbmS20GpWvpj" style="width: 12%; text-align: right" title="Short-term investment maturities - Within 3 months, fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0693"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost_iI_pp0p0_c20231231_zkz8QPcho9p5" style="width: 12%; text-align: right" title="Short-term investment maturities - Within 3 months, cost"&gt;2,467,518&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue_iI_pp0p0_c20231231_zvGVwKxRcQBc" style="width: 12%; text-align: right" title="Short-term investment maturities - Within 3 months, fair value"&gt;2,490,775&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Between 3-12 months&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost_iI_pp0p0_c20241231_ztS153aL0mij" style="border-bottom: Black 1pt solid; text-align: right" title="Short-term investment maturities - Between 3-12 months, cost"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0699"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue_iI_pp0p0_c20241231_zMqhyymOuDo5" style="border-bottom: Black 1pt solid; text-align: right" title="Short-term investment maturities - Between 3-12 months, fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0701"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost_iI_pp0p0_c20231231_zHMVpemb6uVd" style="border-bottom: Black 1pt solid; text-align: right" title="Short-term investment maturities - Between 3-12 months, cost"&gt;7,328,773&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue_iI_pp0p0_c20231231_zB8ZhcMRk2cj" style="border-bottom: Black 1pt solid; text-align: right" title="Short-term investment maturities - Between 3-12 months, fair value"&gt;7,366,312&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_iI_pp0p0_c20241231_zqaPVn5jycGb" style="border-bottom: Black 2.5pt double; text-align: right" title="Short-term investment maturities - Cost"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0707"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_iI_pp0p0_c20241231_z3BpHKtUrjA3" style="border-bottom: Black 2.5pt double; text-align: right" title="Short-term investment maturities - Fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0709"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_iI_pp0p0_c20231231_zFRnRRpU0xai" style="border-bottom: Black 2.5pt double; text-align: right" title="Short-term investment maturities - Cost"&gt;9,796,291&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_iI_pp0p0_c20231231_zvAMrI8mXcwd" style="border-bottom: Black 2.5pt double; text-align: right" title="Short-term investment maturities - Fair value"&gt;9,857,087&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zfvCdnXDTW6f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_ztNRNPJJaSRi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table shows the Company&#x2019;s investment in debt securities available for sale gross unrealized gains (losses) and fair value
by investment category and length of time that individual securities have been in a continuous unrealized loss position at December 31,
2024 and 2023. The Company has reviewed individual securities to determine whether a decline in fair value below the amortizable cost
basis is other than temporary.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BA_ztEDdfznwVke" style="display: none"&gt;SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES)&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Available for sale securities (all unrealized holding gains and losses are less than 12 months at date of measurement)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Unrealized Holding Gains (Losses)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Unrealized Holding Gains (Losses)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Investments in debt securities with unrealized gains&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AvailableForSaleSecuritiesUnrealizedLossFairValue_iI_c20241231_zpqP4HgJM6Ri" style="width: 12%; text-align: right" title="Investments in debt securities with unrealized gains - Fair Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0717"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths_iI_c20241231_zZL6gqpCzoKi" style="width: 12%; text-align: right" title="Investments in debt securities with unrealized gains - Unrealized Holding Gains"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0719"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--AvailableForSaleSecuritiesUnrealizedLossFairValue_iI_c20231231_zFASLmzCc1kh" style="width: 12%; text-align: right" title="Investments in debt securities with unrealized gains - Fair Value"&gt;9,857,087&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths_iI_c20231231_ziM6wy1neKGl" style="width: 12%; text-align: right" title="Investments in debt securities with unrealized gains - Unrealized Holding Gains (Losses)"&gt;60,796&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A0_zCigmoEY1tJb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--InvestmentIncomeTextBlock_zY581MyLYWEf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investment
income, net, which includes net realized losses on sales of available for sale securities and investment income interest and dividends,
is summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zlVNZnw7O8D" style="display: none"&gt;SCHEDULE
OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20240101__20241231_zljdSH3y5Laj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230101__20231231_zAr7TAvXzvm1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--InvestmentIncomeInterestAndDividend_maIILNzUXt_zHteq5yzEnRc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Interest and dividends accrued and paid&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;450,221&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;725,824&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DebtSecuritiesAvailableForSaleRealizedGainLoss_maIILNzUXt_zadHWzORz6Xk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Realized losses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;61,983&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;431,801&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InvestmentIncomeNet_iT_pp0p0_mtIILNzUXt_zADW9BYCXPA6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Investment income, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;512,204&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,157,625&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zbSaJ1z5LZx2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000679"
      unitRef="USD">9857087</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000681">&lt;p id="xdx_891_eus-gaap--DebtSecuritiesAvailableForSaleTableTextBlock_zJhMhxVWqx8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the cost, fair value and maturities of the Company&#x2019;s short-term investments is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zFMeTwAajRV5" style="display: none"&gt;SCHEDULE
OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Short-term investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;U.S. Treasury securities&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShortTermInvestments_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zop2FxWWLzPi" style="width: 12%; text-align: right" title="Short-term investments - Cost"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0683"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zEml1ZLOhUY9" style="width: 12%; text-align: right" title="Short-term investments - Fair Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0685"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShortTermInvestments_iI_pp0p0_c20231231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zDqeN0KHQiF5" style="width: 12%; text-align: right" title="Short-term investments - Cost"&gt;9,796,291&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_ziEbR6ujJHN8" style="width: 12%; text-align: right" title="Short-term investments - Fair Value"&gt;9,857,087&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Short-term investment maturities&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%"&gt;Within 3 months&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost_iI_pp0p0_c20241231_zQlUqIkK3kTj" style="width: 12%; text-align: right" title="Short-term investment maturities - Within 3 months, cost"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0691"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue_iI_pp0p0_c20241231_zbmS20GpWvpj" style="width: 12%; text-align: right" title="Short-term investment maturities - Within 3 months, fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0693"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost_iI_pp0p0_c20231231_zkz8QPcho9p5" style="width: 12%; text-align: right" title="Short-term investment maturities - Within 3 months, cost"&gt;2,467,518&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue_iI_pp0p0_c20231231_zvGVwKxRcQBc" style="width: 12%; text-align: right" title="Short-term investment maturities - Within 3 months, fair value"&gt;2,490,775&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Between 3-12 months&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost_iI_pp0p0_c20241231_ztS153aL0mij" style="border-bottom: Black 1pt solid; text-align: right" title="Short-term investment maturities - Between 3-12 months, cost"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0699"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue_iI_pp0p0_c20241231_zMqhyymOuDo5" style="border-bottom: Black 1pt solid; text-align: right" title="Short-term investment maturities - Between 3-12 months, fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0701"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost_iI_pp0p0_c20231231_zHMVpemb6uVd" style="border-bottom: Black 1pt solid; text-align: right" title="Short-term investment maturities - Between 3-12 months, cost"&gt;7,328,773&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue_iI_pp0p0_c20231231_zB8ZhcMRk2cj" style="border-bottom: Black 1pt solid; text-align: right" title="Short-term investment maturities - Between 3-12 months, fair value"&gt;7,366,312&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_iI_pp0p0_c20241231_zqaPVn5jycGb" style="border-bottom: Black 2.5pt double; text-align: right" title="Short-term investment maturities - Cost"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0707"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_iI_pp0p0_c20241231_z3BpHKtUrjA3" style="border-bottom: Black 2.5pt double; text-align: right" title="Short-term investment maturities - Fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0709"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_iI_pp0p0_c20231231_zFRnRRpU0xai" style="border-bottom: Black 2.5pt double; text-align: right" title="Short-term investment maturities - Cost"&gt;9,796,291&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_iI_pp0p0_c20231231_zvAMrI8mXcwd" style="border-bottom: Black 2.5pt double; text-align: right" title="Short-term investment maturities - Fair value"&gt;9,857,087&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:ShortTermInvestments
      contextRef="AsOf2023-12-31_us-gaap_USTreasurySecuritiesMember"
      decimals="0"
      id="Fact000687"
      unitRef="USD">9796291</us-gaap:ShortTermInvestments>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_USTreasurySecuritiesMember"
      decimals="0"
      id="Fact000689"
      unitRef="USD">9857087</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000695"
      unitRef="USD">2467518</IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost>
    <IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000697"
      unitRef="USD">2490775</IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue>
    <IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000703"
      unitRef="USD">7328773</IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost>
    <IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000705"
      unitRef="USD">7366312</IMNN:DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue>
    <IMNN:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000711"
      unitRef="USD">9796291</IMNN:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000713"
      unitRef="USD">9857087</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000715">&lt;p id="xdx_89F_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_ztNRNPJJaSRi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table shows the Company&#x2019;s investment in debt securities available for sale gross unrealized gains (losses) and fair value
by investment category and length of time that individual securities have been in a continuous unrealized loss position at December 31,
2024 and 2023. The Company has reviewed individual securities to determine whether a decline in fair value below the amortizable cost
basis is other than temporary.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BA_ztEDdfznwVke" style="display: none"&gt;SCHEDULE OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES)&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Available for sale securities (all unrealized holding gains and losses are less than 12 months at date of measurement)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Unrealized Holding Gains (Losses)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Unrealized Holding Gains (Losses)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Investments in debt securities with unrealized gains&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AvailableForSaleSecuritiesUnrealizedLossFairValue_iI_c20241231_zpqP4HgJM6Ri" style="width: 12%; text-align: right" title="Investments in debt securities with unrealized gains - Fair Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0717"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths_iI_c20241231_zZL6gqpCzoKi" style="width: 12%; text-align: right" title="Investments in debt securities with unrealized gains - Unrealized Holding Gains"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0719"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--AvailableForSaleSecuritiesUnrealizedLossFairValue_iI_c20231231_zFASLmzCc1kh" style="width: 12%; text-align: right" title="Investments in debt securities with unrealized gains - Fair Value"&gt;9,857,087&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths_iI_c20231231_ziM6wy1neKGl" style="width: 12%; text-align: right" title="Investments in debt securities with unrealized gains - Unrealized Holding Gains (Losses)"&gt;60,796&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock>
    <IMNN:AvailableForSaleSecuritiesUnrealizedLossFairValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000721"
      unitRef="USD">9857087</IMNN:AvailableForSaleSecuritiesUnrealizedLossFairValue>
    <IMNN:AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000723"
      unitRef="USD">60796</IMNN:AvailableForSaleSecuritiesUnrealizedHoldingGainLossLessThanTwelveMonths>
    <us-gaap:InvestmentIncomeTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000725">&lt;p id="xdx_897_eus-gaap--InvestmentIncomeTextBlock_zY581MyLYWEf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investment
income, net, which includes net realized losses on sales of available for sale securities and investment income interest and dividends,
is summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zlVNZnw7O8D" style="display: none"&gt;SCHEDULE
OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20240101__20241231_zljdSH3y5Laj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230101__20231231_zAr7TAvXzvm1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--InvestmentIncomeInterestAndDividend_maIILNzUXt_zHteq5yzEnRc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Interest and dividends accrued and paid&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;450,221&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;725,824&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DebtSecuritiesAvailableForSaleRealizedGainLoss_maIILNzUXt_zadHWzORz6Xk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Realized losses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;61,983&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;431,801&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InvestmentIncomeNet_iT_pp0p0_mtIILNzUXt_zADW9BYCXPA6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Investment income, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;512,204&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,157,625&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:InvestmentIncomeTextBlock>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000727"
      unitRef="USD">450221</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000728"
      unitRef="USD">725824</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000730"
      unitRef="USD">61983</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000731"
      unitRef="USD">431801</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000733"
      unitRef="USD">512204</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000734"
      unitRef="USD">1157625</us-gaap:InvestmentIncomeNet>
    <us-gaap:DerivativesAndFairValueTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000736">&lt;p id="xdx_807_eus-gaap--DerivativesAndFairValueTextBlock_z90s5e0CXOkd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;5.
&lt;span id="xdx_82A_z7ti2co9pHGk"&gt;FAIR VALUES OF FINANCIAL INSTRUMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FASB
ASC Section 820, &lt;i&gt;Fair Value Measurements and Disclosures,&lt;/i&gt; establishes a three-level hierarchy for fair value measurements which
requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The
three levels of inputs that may be used to measure fair value are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1: Quoted prices (unadjusted) or identical assets or liabilities in active markets that the entity has the ability to access as of the
measurement date;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices
in markets that are not active; or other inputs that are observable or can be corroborated by observable market data; and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3: Significant unobservable inputs that reflect a reporting entity&#x2019;s own assumptions that market participants would use in pricing
an asset or liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents and accounts payable are reflected in the consolidated balance sheets at their approximate estimated fair values
primarily due to their short-term nature. The fair values of securities available for sale are determined by relying on the securities&#x2019;
relationship to other benchmark quoted securities and classified its investments as Level 2 items in both 2024 and 2023. There were no
transfers of assets or liabilities between Level 1 and Level 2 and no transfers in or out of Level 3 during the years ended December
31, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zKZ4VOdG6wd6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
and liabilities measured at fair value are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zJnndAhHH5V" style="display: none"&gt;SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Quoted Prices&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;in Active Markets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;for Identical&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Assets/Liabilities (Level 1)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant Other&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Observable Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Level 2)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unobservable&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Inputs&lt;br/&gt; (Level 3)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Recurring items as of December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;U.S. treasury obligations, available for sale&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zceD1u3nzxuf" style="width: 12%; text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0740"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zXXAxtFvvFm5" style="width: 12%; text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0742"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zuTQGnUuLv9l" style="width: 12%; text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0744"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zy4foxjilXN" style="width: 12%; text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0746"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Recurring items as of December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;U.S. treasury obligations, available for sale&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zywdXOLBVdLj" style="text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"&gt;9,857,087&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_z9PG169Tbm41" style="text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"&gt;9,857,087&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zZmBwQPrcrK3" style="text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0752"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zobKQnGwO3Ci" style="text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0754"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zKmnBLp5zFC1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativesAndFairValueTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000738">&lt;p id="xdx_894_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zKZ4VOdG6wd6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
and liabilities measured at fair value are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zJnndAhHH5V" style="display: none"&gt;SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Quoted Prices&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;in Active Markets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;for Identical&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Assets/Liabilities (Level 1)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant Other&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Observable Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Level 2)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unobservable&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Inputs&lt;br/&gt; (Level 3)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Recurring items as of December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;U.S. treasury obligations, available for sale&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zceD1u3nzxuf" style="width: 12%; text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0740"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zXXAxtFvvFm5" style="width: 12%; text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0742"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zuTQGnUuLv9l" style="width: 12%; text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0744"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zy4foxjilXN" style="width: 12%; text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0746"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Recurring items as of December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;U.S. treasury obligations, available for sale&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zywdXOLBVdLj" style="text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"&gt;9,857,087&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_z9PG169Tbm41" style="text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"&gt;9,857,087&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zZmBwQPrcrK3" style="text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0752"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_iI_pp0p0_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zobKQnGwO3Ci" style="text-align: right" title="U.S. treasury obligations, available for sale - Fair Value"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0754"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_USTreasurySecuritiesMember"
      decimals="0"
      id="Fact000748"
      unitRef="USD">9857087</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member_us-gaap_USTreasurySecuritiesMember"
      decimals="0"
      id="Fact000750"
      unitRef="USD">9857087</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000756">&lt;p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zx45VJL7crtc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;6.
&lt;span id="xdx_820_zbmBu1IrWYpj"&gt;PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zmOlp6UwTvgd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment at December 31, 2024 and 2023 consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B8_zj3I9xNoiaZ1" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20241231_ztMynUkEH0mc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20231231_zcW0s8XAC9u1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zc7JeGc0Hj4f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Machinery and equipment (&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4kNSSdpEdah" title="Estimated useful life"&gt;5&lt;/span&gt;-&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zfrXNENf7Ye" title="Estimated useful life"&gt;7&lt;/span&gt; year life)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;951,192&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,055,192&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z3CoxXI5hCNh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Furniture and fixtures (&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zvc0pSnWHmll" title="Estimated useful life"&gt;3&lt;/span&gt;-&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zxpPcHQ1Kavj" title="Estimated useful life"&gt;5&lt;/span&gt; year life)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;167,351&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;191,932&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zyFZFZLvQfw9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Leasehold improvements (&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MinimumMember_zlSnyGFwysfj" title="Estimated useful life"&gt;5&lt;/span&gt;-&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MaximumMember_zgD8FhAwgKs3" title="Estimated useful life"&gt;7&lt;/span&gt; year life)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;619,024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;607,054&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzwDA_zwGd7tMJa6Qj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
    and equipment gross&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,737,567&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,854,178&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzwDA_z7VL7Xxs8i8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,196,295&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,102,272&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzwDA_zvMBbyyWPvdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;541,272&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;751,906&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zs4m0rG6Ceu5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000758">&lt;p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zmOlp6UwTvgd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment at December 31, 2024 and 2023 consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B8_zj3I9xNoiaZ1" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20241231_ztMynUkEH0mc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20231231_zcW0s8XAC9u1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zc7JeGc0Hj4f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Machinery and equipment (&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4kNSSdpEdah" title="Estimated useful life"&gt;5&lt;/span&gt;-&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zfrXNENf7Ye" title="Estimated useful life"&gt;7&lt;/span&gt; year life)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;951,192&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,055,192&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z3CoxXI5hCNh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Furniture and fixtures (&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zvc0pSnWHmll" title="Estimated useful life"&gt;3&lt;/span&gt;-&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zxpPcHQ1Kavj" title="Estimated useful life"&gt;5&lt;/span&gt; year life)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;167,351&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;191,932&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zyFZFZLvQfw9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Leasehold improvements (&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MinimumMember_zlSnyGFwysfj" title="Estimated useful life"&gt;5&lt;/span&gt;-&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBST1BFUlRZIEFORCBFUVVJUE1FTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MaximumMember_zgD8FhAwgKs3" title="Estimated useful life"&gt;7&lt;/span&gt; year life)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;619,024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;607,054&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzwDA_zwGd7tMJa6Qj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
    and equipment gross&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,737,567&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,854,178&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzwDA_z7VL7Xxs8i8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,196,295&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,102,272&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzwDA_zvMBbyyWPvdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;541,272&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;751,906&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-12-31_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember"
      id="Fact000763">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-12-31_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember"
      id="Fact000765">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-12-31_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      id="Fact000760"
      unitRef="USD">951192</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      id="Fact000761"
      unitRef="USD">2055192</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember"
      id="Fact000770">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember"
      id="Fact000772">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact000767"
      unitRef="USD">167351</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact000768"
      unitRef="USD">191932</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-12-31_us-gaap_LeaseholdImprovementsMember_srt_MinimumMember"
      id="Fact000777">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-12-31_us-gaap_LeaseholdImprovementsMember_srt_MaximumMember"
      id="Fact000779">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact000774"
      unitRef="USD">619024</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact000775"
      unitRef="USD">607054</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000781"
      unitRef="USD">1737567</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000782"
      unitRef="USD">2854178</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000784"
      unitRef="USD">1196295</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000785"
      unitRef="USD">2102272</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000787"
      unitRef="USD">541272</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000788"
      unitRef="USD">751906</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000790">&lt;p id="xdx_803_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zx4KChnwTsM6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;7.
&lt;span id="xdx_82C_zjYEatQKrdc8"&gt;OTHER ACCRUED LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zE0zruNMp2J7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
accrued liabilities at December 31, 2024 and 2023 include the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zRjvPPOH0rWa" style="display: none"&gt;SCHEDULE OF OTHER ACCRUED LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20241231_zhcb6QF9v0Zd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20231231_zLaOpZh06MUk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ContractualObligation_iI_maCz80K_zoiVYfAmyVTc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Amounts due to contract research organizations and other contractual agreements&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,048,036&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,442,659&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_maCz80K_z4q7nyKo0cN9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued payroll and related benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,945,111&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,693,383&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccruedProfessionalFeesCurrent_iI_maCz80K_zqQm09ZloMo1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued professional fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;234,479&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maCz80K_zurJLkpqUzK2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;20,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;20,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtCz80K_zjIFJsOXJr6h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,033,747&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,390,521&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zCDHdYnOP6Dj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000792">&lt;p id="xdx_898_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zE0zruNMp2J7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
accrued liabilities at December 31, 2024 and 2023 include the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zRjvPPOH0rWa" style="display: none"&gt;SCHEDULE OF OTHER ACCRUED LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20241231_zhcb6QF9v0Zd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20231231_zLaOpZh06MUk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ContractualObligation_iI_maCz80K_zoiVYfAmyVTc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Amounts due to contract research organizations and other contractual agreements&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,048,036&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,442,659&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_maCz80K_z4q7nyKo0cN9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued payroll and related benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,945,111&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,693,383&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccruedProfessionalFeesCurrent_iI_maCz80K_zqQm09ZloMo1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued professional fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;234,479&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maCz80K_zurJLkpqUzK2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;20,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;20,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtCz80K_zjIFJsOXJr6h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,033,747&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,390,521&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:ContractualObligation
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000794"
      unitRef="USD">1048036</us-gaap:ContractualObligation>
    <us-gaap:ContractualObligation
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000795"
      unitRef="USD">1442659</us-gaap:ContractualObligation>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000797"
      unitRef="USD">1945111</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000798"
      unitRef="USD">1693383</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000800"
      unitRef="USD">20600</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000801"
      unitRef="USD">234479</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000803"
      unitRef="USD">20000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000804"
      unitRef="USD">20000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000806"
      unitRef="USD">3033747</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000807"
      unitRef="USD">3390521</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000809">&lt;p id="xdx_809_eus-gaap--DebtDisclosureTextBlock_ze4EH12B2o1f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;8.
&lt;span id="xdx_821_z0sB8LFTqFoi"&gt;NOTES PAYABLE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;The
SVB Loan Facility&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 18, 2021, the Company entered into a $&lt;span id="xdx_908_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn6n6_c20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_z1dwh8NMbA7k" title="Line of credit facility, maximum borrowing capacity"&gt;10&lt;/span&gt; million loan facility (the &#x201c;SVB Loan Facility&#x201d;) with Silicon Valley Bank (&#x201c;SVB&#x201d;).
Imunon immediately drew down $&lt;span id="xdx_90C_eus-gaap--ProceedsFromLinesOfCredit_pn6n6_c20210617__20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_znGztfgxmSC2" title="Proceeds from lines of credit"&gt;6&lt;/span&gt; million from the SVB Loan Facility and used the funds to retire all outstanding indebtedness with Horizon
Technology Finance Corporation pursuant to a loan agreement entered into on June 27, 2018, under which the Company had drawn down $&lt;span id="xdx_904_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn6n6_c20200831__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_z5Ivv2YivX6j" title="Loan amount withdrawn"&gt;10&lt;/span&gt;
million and repaid $&lt;span id="xdx_900_eus-gaap--RepaymentsOfLinesOfCredit_pn6n6_c20200801__20200831__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zXatBAv4Au2c" title="Repayments of lines of credit"&gt;5&lt;/span&gt; million in August 2020. Concurrently with this transaction, the Company used $&lt;span id="xdx_901_eus-gaap--RestrictedCash_iI_pn5n6_c20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zsspH5qRUHAk" title="Restricted cash"&gt;6.0&lt;/span&gt; million of other available funds
to establish a restricted cash account which served as security for the SVB Loan Facility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
SVB Loan Facility was in the form of money market secured indebtedness bearing interest at a calculated WSJ Prime-based variable rate.
A final payment equal to &lt;span id="xdx_90A_ecustom--FinalPaymentPercentage_iI_pid_dp_uPure_c20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zPJ6tk3znYmi" title="Final payment percentage"&gt;3&lt;/span&gt;% of the total $&lt;span id="xdx_90C_eus-gaap--LineOfCredit_iI_pn6n6_c20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_z8V8IToQRU27" title="Long term line of credit"&gt;10&lt;/span&gt; million commitment amount was due upon maturity or prepayment of the SVB Loan Facility.
There was no facility commitment fee, and no stock or warrants were issued to SVB. &lt;span id="xdx_90C_eus-gaap--DebtInstrumentDescription_c20210617__20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zwn8kYX2YmG9" title="Debt instrument, description"&gt;Payments under the loan agreement were interest only
for the first 24 months after loan closing, followed by a 24-month amortization period of principal and interest through the scheduled
maturity date.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the SVB Loan Facility, the Company incurred financing fees and expenses totaling $&lt;span id="xdx_90E_eus-gaap--InterestAndDebtExpense_c20210617__20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zfKBBCnACjIb" title="Financing fees and expenses"&gt;243,370&lt;/span&gt; which was recorded and classified
as debt discount and was amortized as interest expense using the effective interest method over the life of the loan. Also, in connection
with the SVB Loan Facility, the Company was required to pay an end-of-term fee equal to &lt;span id="xdx_90C_ecustom--EndOfTermChargePercentage_pid_dp_uPure_c20210617__20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zcXJp5mYWeYh" title="End of term charge percentage"&gt;3.0&lt;/span&gt;% of the original loan amount at time of maturity.
Therefore, these amounts totaling $&lt;span id="xdx_907_eus-gaap--InterestExpense_c20210617__20210618__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zS0xSqYHWVAf" title="Interest expense"&gt;300,000&lt;/span&gt; were amortized as interest expense using the effective interest method over the life of the
loan. During the year ended December 31, 2023, the Company incurred interest expense of $&lt;span id="xdx_90F_eus-gaap--InterestExpenseDebt_c20230101__20231231__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zw2Nknyzc4ni" title="Interest expense"&gt;197,080&lt;/span&gt; and amortized $&lt;span id="xdx_901_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_pp0p0_c20230101__20231231__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zpMGmQFfQE43" title="Amortization of debt issuance costs"&gt;329,158&lt;/span&gt;, as interest
expense for debt discounts and end-of-term fee in connection with the SVB Loan Facility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zTIxlDJfvCCj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 21, 2023, the Company repaid the outstanding principal balance, an early termination fee and the end-of-term charges in full satisfaction
of the SVB Loan Facility. The following is a schedule of the amounts paid to SVB on April 21, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_ziCUQQAoOYna" style="display: none"&gt;SCHEDULE OF DEBT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20230421_zU6pXR4OSoea" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--LineOfCreditFacilityFairValueOfAmountOutstanding_iI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_maLOCzybh_zLiwc0vJ4Goh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Principal balance at April 21, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; text-align: right"&gt;6,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--EarlyTerminationFee_iI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_maLOCzybh_z5yGTfguhCj2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Early termination fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;120,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--EndOfTermCharges_iI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_maLOCzybh_zEwkqVLLB0N7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;End of term charges&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;300,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LineOfCredit_iTI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_mtLOCzybh_zeo9YYC4MpS3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total payoff amount&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,420,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_z90niu9X332" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2023, the Company recorded a loss of $&lt;span id="xdx_90F_eus-gaap--GainLossOnContractTermination_c20230101__20231231__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_znYufO5KRXu3" title="Gain (loss) on contract termination"&gt;329,158&lt;/span&gt; on the early termination of the SVB Loan Facility which represented
the early termination fee and the end of the term fees, net of previously amortized interest expense totaling $&lt;span id="xdx_901_eus-gaap--InterestExpense_c20230101__20231231__us-gaap--LineOfCreditFacilityAxis__custom--SiliconValleyBankMember_zqWFOwIY756i" title="Interest expense debt"&gt;334,212&lt;/span&gt; on the date of
its payoff.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2021-06-18_custom_SiliconValleyBankMember"
      decimals="-6"
      id="Fact000811"
      unitRef="USD">10000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2021-06-172021-06-18_custom_SiliconValleyBankMember"
      decimals="-6"
      id="Fact000813"
      unitRef="USD">6000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="AsOf2020-08-31_custom_SiliconValleyBankMember"
      decimals="-6"
      id="Fact000815"
      unitRef="USD">10000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="From2020-08-012020-08-31_custom_SiliconValleyBankMember"
      decimals="-6"
      id="Fact000817"
      unitRef="USD">5000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RestrictedCash
      contextRef="AsOf2021-06-18_custom_SiliconValleyBankMember"
      decimals="-5"
      id="Fact000819"
      unitRef="USD">6000000.0</us-gaap:RestrictedCash>
    <IMNN:FinalPaymentPercentage
      contextRef="AsOf2021-06-18_custom_SiliconValleyBankMember"
      decimals="INF"
      id="Fact000821"
      unitRef="Pure">0.03</IMNN:FinalPaymentPercentage>
    <us-gaap:LineOfCredit
      contextRef="AsOf2021-06-18_custom_SiliconValleyBankMember"
      decimals="-6"
      id="Fact000823"
      unitRef="USD">10000000</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentDescription
      contextRef="From2021-06-172021-06-18_custom_SiliconValleyBankMember"
      id="Fact000825">Payments under the loan agreement were interest only
for the first 24 months after loan closing, followed by a 24-month amortization period of principal and interest through the scheduled
maturity date.</us-gaap:DebtInstrumentDescription>
    <us-gaap:InterestAndDebtExpense
      contextRef="From2021-06-172021-06-18_custom_SiliconValleyBankMember"
      decimals="0"
      id="Fact000827"
      unitRef="USD">243370</us-gaap:InterestAndDebtExpense>
    <IMNN:EndOfTermChargePercentage
      contextRef="From2021-06-172021-06-18_custom_SiliconValleyBankMember"
      decimals="INF"
      id="Fact000829"
      unitRef="Pure">0.030</IMNN:EndOfTermChargePercentage>
    <us-gaap:InterestExpense
      contextRef="From2021-06-172021-06-18_custom_SiliconValleyBankMember"
      decimals="0"
      id="Fact000831"
      unitRef="USD">300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-01-012023-12-31_custom_SiliconValleyBankMember"
      decimals="0"
      id="Fact000833"
      unitRef="USD">197080</us-gaap:InterestExpenseDebt>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2023-01-012023-12-31_custom_SiliconValleyBankMember"
      decimals="0"
      id="Fact000835"
      unitRef="USD">329158</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000837">&lt;p id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zTIxlDJfvCCj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 21, 2023, the Company repaid the outstanding principal balance, an early termination fee and the end-of-term charges in full satisfaction
of the SVB Loan Facility. The following is a schedule of the amounts paid to SVB on April 21, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_ziCUQQAoOYna" style="display: none"&gt;SCHEDULE OF DEBT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20230421_zU6pXR4OSoea" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--LineOfCreditFacilityFairValueOfAmountOutstanding_iI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_maLOCzybh_zLiwc0vJ4Goh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Principal balance at April 21, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; text-align: right"&gt;6,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--EarlyTerminationFee_iI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_maLOCzybh_z5yGTfguhCj2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Early termination fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;120,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--EndOfTermCharges_iI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_maLOCzybh_zEwkqVLLB0N7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;End of term charges&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;300,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LineOfCredit_iTI_hdei--LegalEntityAxis__custom--HorizonTechnologyFinanceCorporationMember_mtLOCzybh_zeo9YYC4MpS3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total payoff amount&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,420,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="AsOf2023-04-21_custom_HorizonTechnologyFinanceCorporationMember"
      decimals="0"
      id="Fact000839"
      unitRef="USD">6000000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <IMNN:EarlyTerminationFee
      contextRef="AsOf2023-04-21_custom_HorizonTechnologyFinanceCorporationMember"
      decimals="0"
      id="Fact000841"
      unitRef="USD">120000</IMNN:EarlyTerminationFee>
    <IMNN:EndOfTermCharges
      contextRef="AsOf2023-04-21_custom_HorizonTechnologyFinanceCorporationMember"
      decimals="0"
      id="Fact000843"
      unitRef="USD">300000</IMNN:EndOfTermCharges>
    <us-gaap:LineOfCredit
      contextRef="AsOf2023-04-21_custom_HorizonTechnologyFinanceCorporationMember"
      decimals="0"
      id="Fact000845"
      unitRef="USD">6420000</us-gaap:LineOfCredit>
    <us-gaap:GainLossOnContractTermination
      contextRef="From2023-01-012023-12-31_custom_SiliconValleyBankMember"
      decimals="0"
      id="Fact000847"
      unitRef="USD">329158</us-gaap:GainLossOnContractTermination>
    <us-gaap:InterestExpense
      contextRef="From2023-01-012023-12-31_custom_SiliconValleyBankMember"
      decimals="0"
      id="Fact000849"
      unitRef="USD">334212</us-gaap:InterestExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000851">&lt;p id="xdx_803_eus-gaap--IncomeTaxDisclosureTextBlock_zhjIeR0tTFSa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;9.
&lt;span id="xdx_823_zUua3GGe1zig"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zEtZntAdjWO7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
income tax benefit for the years ended December 31, 2024 and 2023 consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B5_zoT2mr4aedKc" style="display: none"&gt;SCHEDULE OF INCOME TAX PROVISION (BENEFIT)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240101__20241231_zJ13oxA4MKr5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230101__20231231_zGCtj1PfqiO6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--CurrentFederalTaxExpenseBenefit_maITEBzpPN_zZSsqGTL5El5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0855"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0856"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maITEBzpPN_zROJEDZ4oFvg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Deferred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0858"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0859"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_maITEBzpPN_zsNPOZ7Uj9G9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;State and Local&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0861"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0862"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maITEBzpPN_zaVkmcGmtLPi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0864"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0865"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maITEBzpPN_zSQn9EcAazQ5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; padding-bottom: 1pt"&gt;Deferred&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0867"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;(1,280,385&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; width: 1%"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzpPN_zGBNikyFsVOb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0870"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1,280,385&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zKiDMzrlEQMf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zOcjI0HUYhUc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
reconciliation of the Company&#x2019;s statutory tax rate to the effective rate for the years ended December 31, 2024 and 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BB_zRHdyxfQieWh" style="display: none"&gt;SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20240101__20241231_z4MfqOJasFKd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230101__20231231_zLOUNGZp5s54" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maEIT001_zSnQ2rFZBM8j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Federal statutory rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;21.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maEIT001_zuGwNqWaxq7i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;State taxes, net of federal tax benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8.40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7.1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--EffectiveIncomeTaxRateReconciliationPermanentDifferences_pid_dp_uPure_maEIT001_ze1NMFbfZjhc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Permanent differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.74&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3.1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--EffectiveIncomeTaxRateReconciliationTimeUp_pid_dp_uPure_maEIT001_zQ8X9rRHvpHf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;True-Up&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.07&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(105.0&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maEIT001_zCD6t8UiOWY1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.11&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.9&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_maEIT001_z6nLsLcjWhBf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Rate Change&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.57&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0891"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate_pid_dp_uPure_maEIT001_zhq7Gs2R3kN9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred vs statutory rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;(0.75&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0894"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--EffectiveIncomeTaxRateReconciliationSaleAndExpiration_pid_dp_uPure_maEIT001_z6em4UqgIS94" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expiration of NOLs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;(17.51&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0897"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maEIT001_zDh2FHlNRLOe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in valuation allowance and deferred rate change, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(9.01&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;89.0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_uPure_mtEIT001_zMgG0RgSABza" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Effective tax rate&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0902"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6.1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zcDlUH27oNY9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z1rYeM2k69Qk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of the Company&#x2019;s deferred tax asset as of December 31, 2024 and 2023 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BA_zUDCXVSy1E43" style="display: none"&gt;SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20241231_zS9srSO4cn8a" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20231231_zV03sdyHJfn6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzVBe_zy3iHYw1xYLd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Net operating loss carryforwards&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;66,141,490&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;67,310,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DeferredTaxAssetsLegalAct_iI_pp0p0_maDTAGzVBe_z3ljGiepV6i1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Section 174&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,482,099&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,929,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGzVBe_zZxzEcf50Qek" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other deferred tax assets, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,010,744&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,016,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzVBe_maDTANzv9R_zqu8M1QiHnh6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Subtotal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74,634,333&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74,255,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzv9R_z8M94y7oICYf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(74,634,333&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(72,974,615&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzv9R_zthyYaKwBNg6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total deferred tax asset&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0922"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,280,385&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zKr4rlbtJGb6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
evaluation of the realizability of such deferred tax assets in future periods is made based upon a variety of factors that affect
the Company&#x2019;s ability to generate future taxable income, such as intent and ability to sell assets and historical and
projected operating performance. As of December 31, 2024, based on the Company&#x2019;s history of earnings and its assessment of
future earnings, management believes that it is more likely than not future taxable income will not be sufficient to realize the
deferred tax assets. Therefore, full valuation allowance has been applied to deferred tax assets. At December 31, 2023, after its
evaluation of its New Jersey NOLs as discussed more fully below, the Company reduced the valuation reserve and recognized $&lt;span id="xdx_902_ecustom--ProceedsFromSaleOfNetOperatingLosses_pn5n6_c20230101__20231231__srt--StatementGeographicalAxis__stpr--NJ_zDUeJHDQX6b5" title="Deferred income tax asset"&gt;1.3&lt;/span&gt;
million as a deferred income tax asset. Such tax assets are available to be recognized and benefit future periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024, the Company had federal net operating loss carry forwards of approximately $&lt;span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z6F017paUaJ6"&gt;303&lt;/span&gt; million. If unused, will &lt;span id="xdx_90C_ecustom--OperatingLossCarryforwardsExpirationDescription_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zYskvG7Nntp2" title="Operating losses expiration description"&gt;expire
starting in 2025 through 2037&lt;/span&gt;. The federal NOLs generated for the years ended after 2017 of approximately $&lt;span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20181231__us-gaap--IncomeTaxAuthorityAxis__custom--FederalIncomeTaxMember__srt--StatementScenarioAxis__custom--NoExpirationMember_zDoxjcUP3DM5"&gt;101&lt;/span&gt; million can be carried
forward indefinitely. As of December 31, 2024, the Company had state net operating loss carryforwards of approximately $&lt;span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zBErChhcPG16" title="Operating loss carryforwards"&gt;40&lt;/span&gt; million, net
of net operating losses utilized in prior years, and, if unused, will &lt;span id="xdx_90B_ecustom--OperatingLossCarryforwardsExpirationDescription_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_ztpLCKPm7UPh" title="Operating loss carryforwards expiration description"&gt;expire starting in 2029 through 2043&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be
sustained upon examination by taxing authorities. As of December 31, 2024, and 2023, there were &lt;span id="xdx_901_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20241231_zAm0NJzZ1Zy7" title="Unrecognized tax benefits"&gt;&lt;span id="xdx_909_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zRJ2LbEHfSB5" title="Unrecognized tax benefits"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized tax benefits. The Company
recognizes accrued interest and penalties as income tax expense. &lt;span id="xdx_90E_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_do_c20240101__20241231_z11G9gloEBb" title="Payment of interest and penalties"&gt;&lt;span id="xdx_904_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_do_c20230101__20231231_ziLxq3m14KB7" title="Payment of interest and penalties"&gt;No&lt;/span&gt;&lt;/span&gt; amounts were accrued for the payment of interest and penalties at
December 31, 2024 and 2023. The Company is currently not aware of any issues under review that could result in significant payments,
accruals or material deviation from its position in the next year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sections
382 and 383 of the Internal Revenue Code provide for a limitation on the annual use of NOL and tax credit carryforwards following certain
ownership changes that could limit the Company&#x2019;s ability to utilize these carryforwards. The Company has completed an analysis
to determine if such ownership changes have occurred and concluded it was more likely than not that there were changes in ownership.
Due to the existence of full valuation allowance, limitations under Section 382 and 383 will not impact the Company&#x2019;s effective
tax rate. Further analyses will be performed prior to recognizing the benefits of any losses or credits in the financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
for tax years beginning after December 31, 2021, taxpayers are required to capitalize any expenses incurred that are considered incidental
to research and experimentation (&#x201c;R&amp;amp;E&#x201d;) activities under IRC Section 174. While taxpayers historically had the option
of deducting these expenses under IRC Section 174, the December 2017 Tax Cuts and Jobs Act mandates capitalization and amortization of
R&amp;amp;E expenses for tax years beginning after December 31, 2021. &lt;span id="xdx_908_eus-gaap--IncomeTaxExaminationDescription_c20240101__20241231_zSMGtleefBc9" title="Income tax examination, description"&gt;Expenses incurred in connection with R&amp;amp;E activities in the US must
be amortized over a 5-year period if incurred, and R&amp;amp;E expenses incurred outside the US must be amortized over a 15-year period.
R&amp;amp;E activities are broader in scope than qualified research activities considered under IRC Section 41 (relating to the research
tax credit). For the year ended December 31, 2024, the Company performed an analysis based on available guidance and determined that
it will continue to be in a loss position even after the required capitalization and amortization of its R&amp;amp;E expenses. The Company
will continue to monitor this issue for future developments, but it does not expect R&amp;amp;E capitalization and amortization to require
it to pay cash taxes now or in the near future. The Company&#x2019;s income tax returns for 2020 to 2023 are still open and subject to
audit. In addition, net operating losses arising from prior years are also subject to examination at the time they are utilized in future
years.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Sale
of New Jersey Net Operating Losses&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Since
2018, the Company has annually submitted applications to sell a portion of the Company&#x2019;s New Jersey NOLs as part of the Technology
Business Tax Certificate Program sponsored by The New Jersey Economic Development Authority. Under the program, emerging biotechnology
companies with unused NOLs and unused research and development credits are allowed to sell these benefits to other New Jersey-based companies.
As part of the Technology Business Tax Certificate Program, the Company sold $&lt;span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231__srt--StatementGeographicalAxis__stpr--NJ__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--NewJerseyDivisionOfTaxationMember_z65s9wpCqj3b"&gt;1.3&lt;/span&gt; million of its New Jersey NOLs in 2023. The sale of
these net operating losses resulted in net proceeds to the Company of approximately $&lt;span id="xdx_90D_ecustom--NetProceedsFromSaleOfNetOperatingLosses_pn5n6_c20240101__20241231__srt--StatementGeographicalAxis__stpr--NJ_zM7tCMf6cXz2" title="Net operating losses"&gt;1.3&lt;/span&gt; million in 2024. During 2021, the New Jersey
State Legislature increased the maximum lifetime benefit per company from $&lt;span id="xdx_90F_ecustom--NetProceedsFromSaleOfNetOperatingLosses_pn6n6_c20210101__20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MinimumMember__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zr7Iqfone3x8" title="Proceeds from sale"&gt;15&lt;/span&gt; million to $&lt;span id="xdx_90B_ecustom--NetProceedsFromSaleOfNetOperatingLosses_pn6n6_c20210101__20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MaximumMember__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zWSsYfr7oaBh" title="Proceeds from sale"&gt;20&lt;/span&gt; million, which will allow the Company to
participate in this funding program in future years for up to an additional $&lt;span id="xdx_904_eus-gaap--OperatingIncomeLoss_pn5n6_c20210101__20211231__srt--StatementGeographicalAxis__stpr--NJ__srt--RangeAxis__srt--MaximumMember_z7TRyvVk9GJd" title="Operating losses"&gt;0.3&lt;/span&gt; million in net operating losses under this maximum lifetime
benefit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000853">&lt;p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zEtZntAdjWO7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
income tax benefit for the years ended December 31, 2024 and 2023 consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B5_zoT2mr4aedKc" style="display: none"&gt;SCHEDULE OF INCOME TAX PROVISION (BENEFIT)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240101__20241231_zJ13oxA4MKr5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230101__20231231_zGCtj1PfqiO6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--CurrentFederalTaxExpenseBenefit_maITEBzpPN_zZSsqGTL5El5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0855"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0856"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maITEBzpPN_zROJEDZ4oFvg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Deferred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0858"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0859"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_maITEBzpPN_zsNPOZ7Uj9G9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;State and Local&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0861"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0862"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maITEBzpPN_zaVkmcGmtLPi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0864"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0865"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maITEBzpPN_zSQn9EcAazQ5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; padding-bottom: 1pt"&gt;Deferred&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0867"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;(1,280,385&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; width: 1%"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzpPN_zGBNikyFsVOb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0870"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1,280,385&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000868"
      unitRef="USD">-1280385</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000871"
      unitRef="USD">-1280385</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000873">&lt;p id="xdx_893_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zOcjI0HUYhUc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
reconciliation of the Company&#x2019;s statutory tax rate to the effective rate for the years ended December 31, 2024 and 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BB_zRHdyxfQieWh" style="display: none"&gt;SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20240101__20241231_z4MfqOJasFKd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230101__20231231_zLOUNGZp5s54" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maEIT001_zSnQ2rFZBM8j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Federal statutory rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;21.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maEIT001_zuGwNqWaxq7i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;State taxes, net of federal tax benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8.40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7.1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--EffectiveIncomeTaxRateReconciliationPermanentDifferences_pid_dp_uPure_maEIT001_ze1NMFbfZjhc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Permanent differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.74&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3.1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--EffectiveIncomeTaxRateReconciliationTimeUp_pid_dp_uPure_maEIT001_zQ8X9rRHvpHf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;True-Up&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.07&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(105.0&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maEIT001_zCD6t8UiOWY1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.11&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.9&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_maEIT001_z6nLsLcjWhBf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Rate Change&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.57&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0891"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate_pid_dp_uPure_maEIT001_zhq7Gs2R3kN9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred vs statutory rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;(0.75&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0894"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--EffectiveIncomeTaxRateReconciliationSaleAndExpiration_pid_dp_uPure_maEIT001_z6em4UqgIS94" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expiration of NOLs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;(17.51&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0897"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maEIT001_zDh2FHlNRLOe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in valuation allowance and deferred rate change, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(9.01&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;89.0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_uPure_mtEIT001_zMgG0RgSABza" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Effective tax rate&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0902"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6.1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000875"
      unitRef="Pure">0.2100</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000876"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000878"
      unitRef="Pure">0.0840</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000879"
      unitRef="Pure">0.071</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <IMNN:EffectiveIncomeTaxRateReconciliationPermanentDifferences
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000881"
      unitRef="Pure">-0.0274</IMNN:EffectiveIncomeTaxRateReconciliationPermanentDifferences>
    <IMNN:EffectiveIncomeTaxRateReconciliationPermanentDifferences
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000882"
      unitRef="Pure">-0.031</IMNN:EffectiveIncomeTaxRateReconciliationPermanentDifferences>
    <IMNN:EffectiveIncomeTaxRateReconciliationTimeUp
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000884"
      unitRef="Pure">-0.0007</IMNN:EffectiveIncomeTaxRateReconciliationTimeUp>
    <IMNN:EffectiveIncomeTaxRateReconciliationTimeUp
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000885"
      unitRef="Pure">-1.050</IMNN:EffectiveIncomeTaxRateReconciliationTimeUp>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000887"
      unitRef="Pure">0.0011</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000888"
      unitRef="Pure">-0.029</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000890"
      unitRef="Pure">0.0057</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <IMNN:EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000893"
      unitRef="Pure">-0.0075</IMNN:EffectiveIncomeTaxRateReconciliationDeferredStatutoryRate>
    <IMNN:EffectiveIncomeTaxRateReconciliationSaleAndExpiration
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000896"
      unitRef="Pure">-0.1751</IMNN:EffectiveIncomeTaxRateReconciliationSaleAndExpiration>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000899"
      unitRef="Pure">-0.0901</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000900"
      unitRef="Pure">0.890</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000903"
      unitRef="Pure">0.061</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000905">&lt;p id="xdx_894_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z1rYeM2k69Qk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of the Company&#x2019;s deferred tax asset as of December 31, 2024 and 2023 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BA_zUDCXVSy1E43" style="display: none"&gt;SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20241231_zS9srSO4cn8a" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20231231_zV03sdyHJfn6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzVBe_zy3iHYw1xYLd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Net operating loss carryforwards&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;66,141,490&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;67,310,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DeferredTaxAssetsLegalAct_iI_pp0p0_maDTAGzVBe_z3ljGiepV6i1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Section 174&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,482,099&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,929,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGzVBe_zZxzEcf50Qek" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other deferred tax assets, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,010,744&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,016,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzVBe_maDTANzv9R_zqu8M1QiHnh6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Subtotal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74,634,333&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74,255,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzv9R_z8M94y7oICYf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(74,634,333&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(72,974,615&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzv9R_zthyYaKwBNg6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total deferred tax asset&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0922"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,280,385&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000907"
      unitRef="USD">66141490</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000908"
      unitRef="USD">67310000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <IMNN:DeferredTaxAssetsLegalAct
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000910"
      unitRef="USD">6482099</IMNN:DeferredTaxAssetsLegalAct>
    <IMNN:DeferredTaxAssetsLegalAct
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000911"
      unitRef="USD">4929000</IMNN:DeferredTaxAssetsLegalAct>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000913"
      unitRef="USD">2010744</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000914"
      unitRef="USD">2016000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000916"
      unitRef="USD">74634333</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000917"
      unitRef="USD">74255000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000919"
      unitRef="USD">74634333</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000920"
      unitRef="USD">72974615</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000923"
      unitRef="USD">1280385</us-gaap:DeferredTaxAssetsNet>
    <IMNN:ProceedsFromSaleOfNetOperatingLosses
      contextRef="From2023-01-012023-12-31_stpr_NJ"
      decimals="-5"
      id="Fact000925"
      unitRef="USD">1300000</IMNN:ProceedsFromSaleOfNetOperatingLosses>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2024-12-31_us-gaap_DomesticCountryMember"
      decimals="-6"
      id="Fact000926"
      unitRef="USD">303000000</us-gaap:OperatingLossCarryforwards>
    <IMNN:OperatingLossCarryforwardsExpirationDescription
      contextRef="From2024-01-012024-12-31_us-gaap_DomesticCountryMember"
      id="Fact000928">expire
starting in 2025 through 2037</IMNN:OperatingLossCarryforwardsExpirationDescription>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2018-12-31_custom_FederalIncomeTaxMember_custom_NoExpirationMember"
      decimals="-6"
      id="Fact000929"
      unitRef="USD">101000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2024-12-31_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-6"
      id="Fact000931"
      unitRef="USD">40000000</us-gaap:OperatingLossCarryforwards>
    <IMNN:OperatingLossCarryforwardsExpirationDescription
      contextRef="From2024-01-012024-12-31_us-gaap_StateAndLocalJurisdictionMember"
      id="Fact000933">expire starting in 2029 through 2043</IMNN:OperatingLossCarryforwardsExpirationDescription>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000935"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000937"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000939"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000941"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationDescription contextRef="From2024-01-01to2024-12-31" id="Fact000943">Expenses incurred in connection with R&amp;E activities in the US must
be amortized over a 5-year period if incurred, and R&amp;E expenses incurred outside the US must be amortized over a 15-year period.
R&amp;E activities are broader in scope than qualified research activities considered under IRC Section 41 (relating to the research
tax credit). For the year ended December 31, 2024, the Company performed an analysis based on available guidance and determined that
it will continue to be in a loss position even after the required capitalization and amortization of its R&amp;E expenses. The Company
will continue to monitor this issue for future developments, but it does not expect R&amp;E capitalization and amortization to require
it to pay cash taxes now or in the near future. The Company&#x2019;s income tax returns for 2020 to 2023 are still open and subject to
audit. In addition, net operating losses arising from prior years are also subject to examination at the time they are utilized in future
years.</us-gaap:IncomeTaxExaminationDescription>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-12-31_stpr_NJ_us-gaap_NewJerseyDivisionOfTaxationMember"
      decimals="-5"
      id="Fact000944"
      unitRef="USD">1300000</us-gaap:OperatingLossCarryforwards>
    <IMNN:NetProceedsFromSaleOfNetOperatingLosses
      contextRef="From2024-01-012024-12-31_stpr_NJ"
      decimals="-5"
      id="Fact000946"
      unitRef="USD">1300000</IMNN:NetProceedsFromSaleOfNetOperatingLosses>
    <IMNN:NetProceedsFromSaleOfNetOperatingLosses
      contextRef="From2021-01-012021-12-31_stpr_NJ_srt_MinimumMember_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-6"
      id="Fact000948"
      unitRef="USD">15000000</IMNN:NetProceedsFromSaleOfNetOperatingLosses>
    <IMNN:NetProceedsFromSaleOfNetOperatingLosses
      contextRef="From2021-01-012021-12-31_stpr_NJ_srt_MaximumMember_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-6"
      id="Fact000950"
      unitRef="USD">20000000</IMNN:NetProceedsFromSaleOfNetOperatingLosses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-012021-12-31_stpr_NJ_srt_MaximumMember"
      decimals="-5"
      id="Fact000952"
      unitRef="USD">300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000954">&lt;p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zhTTnRONoUD4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;10.
&lt;span id="xdx_829_zzpPZQLH4vbb"&gt;STOCKHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 15, 2024, the Company filed with the SEC a shelf registration statement on Form S-3 (the &#x201c;2024 Registration Statement&#x201d;)
for the offer and sale of up to $&lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20240515__20240515_zvrhV7PqeBY1" title="Stock issued during period, value, new issues"&gt;75&lt;/span&gt; million of its securities. The 2024 Registration Statement was declared effective on May 22, 2024.
The 2024 Registration Statement is intended to provide the Company with flexibility to raise capital in the future for general corporate
purposes. However, the Company&#x2019;s ability to offer and sell its securities in a primary offering on the 2024 Registration Statement
is limited by General Instruction I.B.6 of Form S-3 (the &#x201c;Baby Shelf Limitation&#x201d;), which limits the amount that the Company
can offer to up to one-third of its public float during any trailing 12-month period. The Company would no longer be subject to the Baby
Shelf Limitation if its public float exceeds $&lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20240515__20240515_zvWgFQF3PgR9" title="Stock issued during period, value, new issues"&gt;75&lt;/span&gt; million.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;At
the Market Offering Agreement&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 15, 2024, the Company amended the At the Market Offering Agreement, dated as of May 25, 2022 (the &#x201c;ATM Agreement&#x201d;) with
H.C. Wainwright &amp;amp; Co., LLC (&#x201c;Wainwright&#x201d;) as sales agent. Pursuant to the terms of the amended ATM Agreement, the Company
may offer and sell, from time to time, through Wainwright, shares of the Company&#x2019;s common stock having an aggregate offering price
of up to $&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240515__20240515__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_zT8Y2tPrzHA" title="Stock issued during period, value, new issues"&gt;5,500,000&lt;/span&gt;. The Company intends to use the net proceeds from any offering under the amended ATM Agreement for general corporate
purposes, including research and development activities, capital expenditures and working capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 30, 2024, the Company notified Wainwright that it was suspending its use of and terminating the &#x201c;at the market offering&#x201d;
sales agreement prospectus (the &#x201c;ATM Prospectus&#x201d;), related to the potential issuance from time to time of the Company&#x2019;s
common stock pursuant to the ATM Agreement, by and between the Company and Wainwright. Notwithstanding the termination of the ATM Prospectus,
the ATM Agreement remains in full force and effect.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 3, 2024, the Company filed a new prospectus supplement to the 2024 Registration Statement with the SEC for an aggregate offering
price of up to $&lt;span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20240903__20240903_zy68mZFebLN" title="Issuance of common stock"&gt;5,500,000&lt;/span&gt; related to the potential issuance from time to time of the Company&#x2019;s common stock pursuant to the ATM
Agreement with Wainwright as sales agent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company sold &lt;span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240101__20241231__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_z1hPCovJa3Gi" title="Number of shares sold"&gt;88,796&lt;/span&gt;
shares of common stock under the ATM Agreement for net proceeds of $&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20240101__20241231__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_zl9vGpzZwyYi" title="Proceeds from sale of stock"&gt;99,506&lt;/span&gt;
during 2024. During 2023, the Company sold &lt;span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_zXvhdIIv0hU" title="Number of shares sold"&gt;1,878,488&lt;/span&gt;
shares of common stock under the ATM Agreement for net proceeds of $&lt;span id="xdx_909_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_zGyO5DiQSK6a" title="Proceeds from sale of stock"&gt;2,750,658&lt;/span&gt;. The Company sold &lt;span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250101__20250221__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zDtCnA8pkbpg" title="Number of shares sold"&gt;120,047&lt;/span&gt; shares of common stock under the ATM Agreement for net proceeds of $&lt;span id="xdx_909_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20250101__20250221__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zzuAdJhf9ef8" title="Proceeds from sale of stock"&gt;105,693&lt;/span&gt; from January
1, 2025 through February 21, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;July
2024 Offering&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 30, 2024, the Company entered into the July 2024 Purchase Agreement with the Purchasers, pursuant to which the Company issued, in
a registered direct offering, an aggregate of &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240730__20240730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--JulyTwoThousandTwentyFourOfferingMember_zZlgbMEa4p31" title="Stock issued, shares"&gt;5,000,000&lt;/span&gt; shares of the Company&#x2019;s common stock at an offering price of $&lt;span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20240730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--JulyTwoThousandTwentyFourOfferingMember_z3qBAl2xsjBe" title="Share price"&gt;2.00&lt;/span&gt; per
share for gross proceeds of $&lt;span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20240730__20240730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--JulyTwoThousandTwentyFourOfferingMember_z4vAUXEzhxoe" title="Proceeds from issuance of common stock"&gt;10.0&lt;/span&gt; million before the deduction of placement agent fees and offering expenses. In a concurrent private
placement and also pursuant to the July 2024 Purchase Agreement, the Company issued to the Purchasers the Warrants to purchase an aggregate
of &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240730__20240730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--JulyTwoThousandTwentyFourOfferingMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAPOFpmLpmj5" title="Stock issued, shares"&gt;5,000,000&lt;/span&gt; shares of its common stock at an exercise price of $&lt;span id="xdx_908_eus-gaap--SharePrice_iI_pid_c20240730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--JulyTwoThousandTwentyFourOfferingMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNXWFqZv9jOb" title="Share price"&gt;2.00&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Warrants became exercisable immediately after issuance for a term of five and one-half years following the date of issuance. The closing
of the July 2024 Offering occurred on August 1, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-05-152024-05-15"
      decimals="-6"
      id="Fact000956"
      unitRef="USD">75000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-05-152024-05-15"
      decimals="-6"
      id="Fact000958"
      unitRef="USD">75000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-05-152024-05-15_custom_AtTheMarketOfferingAgreementMember"
      decimals="0"
      id="Fact000960"
      unitRef="USD">5500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-09-032024-09-03"
      decimals="0"
      id="Fact000962"
      unitRef="USD">5500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-01-012024-12-31_custom_AtTheMarketOfferingAgreementMember"
      decimals="INF"
      id="Fact000964"
      unitRef="Shares">88796</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2024-01-012024-12-31_custom_AtTheMarketOfferingAgreementMember"
      decimals="0"
      id="Fact000966"
      unitRef="USD">99506</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-01-012023-12-31_custom_AtTheMarketOfferingAgreementMember"
      decimals="INF"
      id="Fact000968"
      unitRef="Shares">1878488</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2023-01-012023-12-31_custom_AtTheMarketOfferingAgreementMember"
      decimals="0"
      id="Fact000970"
      unitRef="USD">2750658</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-01-012025-02-21_custom_AtTheMarketOfferingAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact000972"
      unitRef="Shares">120047</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2025-01-012025-02-21_custom_AtTheMarketOfferingAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact000974"
      unitRef="USD">105693</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-07-302024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember"
      decimals="INF"
      id="Fact000976"
      unitRef="Shares">5000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="AsOf2024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember"
      decimals="INF"
      id="Fact000978"
      unitRef="USDPShares">2.00</us-gaap:SharePrice>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-07-302024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember"
      decimals="-5"
      id="Fact000980"
      unitRef="USD">10000000.0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-07-302024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000982"
      unitRef="Shares">5000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="AsOf2024-07-30_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourOfferingMember_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000984"
      unitRef="USDPShares">2.00</us-gaap:SharePrice>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000986">&lt;p id="xdx_80F_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zKTW4wR9HPki" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;11.
&lt;span id="xdx_82B_zl3f96Iow6oa"&gt;STOCK-BASED COMPENSATION&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has long-term compensation plans that permit the granting of equity-based awards in the form of stock options, restricted stock,
restricted stock units, stock appreciation rights, other stock awards, and performance awards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
the 2018 Annual Stockholders Meeting of the Company held on May 15, 2018, stockholders approved the Imunon, Inc. 2018 Stock Incentive
Plan (the &#x201c;2018 Plan&#x201d;). The 2018 Plan, as adopted, permits the granting of &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20180515__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember_zisEblMdRbu7" title="Share-based payment award, shares authorized"&gt;180,000&lt;/span&gt; shares of Imunon common stock as equity
awards in the form of incentive stock options, nonqualified stock options, restricted stock, restricted stock units, stock appreciation
rights, other stock awards, performance awards, or in any combination of the foregoing. At the 2019 Annual Stockholders Meeting of the
Company held on May 14, 2019, stockholders approved an amendment to the 2018 Plan whereby the Company increased the number of common
stock shares available by &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20190514__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MinimumMember_zQe6P0ftFbri" title="Share based payment award, shares granted"&gt;80,000&lt;/span&gt; to a total of &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20190514__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zcrS350VE0jc" title="Share based payment award, shares granted"&gt;260,000&lt;/span&gt; under the 2018 Plan, as amended. At the 2020 Annual Stockholders Meeting of the
Company held on June 15, 2020, stockholders approved an amendment to the 2018 Plan, as previously amended, whereby the Company increased
the number of shares of common stock available by &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20200615__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MinimumMember_z5ervcvjoxj2" title="Share based payment award, shares granted"&gt;166,667&lt;/span&gt; to a total of &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20200615__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zl7Rrti3C4qj" title="Share based payment award, shares granted"&gt;426,667&lt;/span&gt; under the 2018 Plan, as amended. At the 2021 Annual Stockholders
Meeting of the Company held on June 10, 2021, stockholders approved an amendment to the 2018 Plan, as previously amended, whereby the
Company increased the number of shares of common stock available by &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210610__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MinimumMember_zEKnldVWLYD7" title="Share based payment award, shares granted"&gt;513,333&lt;/span&gt; to a total of &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210610__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zBG8HOp8pJQa" title="Share based payment award, shares granted"&gt;940,000&lt;/span&gt; under the 2018 Plan, as amended. At
the 2023 Annual Stockholders Meeting of the Company held on June 14, 2023, stockholders approved an amendment to the 2018 Plan, as previously
amended, whereby the Company increased the number of shares of common stock available by &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230614__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MinimumMember_zFh6RVbIO76h" title="Share based payment award, shares granted"&gt;1,030,000&lt;/span&gt; to a total of &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230614__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zB7Y9Ae3EAka" title="Share based payment award, shares granted"&gt;1,970,000&lt;/span&gt; under the
2018 Plan, as amended.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has issued stock awards to employees and directors in the form of stock options and restricted stock. &lt;span id="xdx_90B_ecustom--StockOptionsStrikePriceDescription_c20240101__20241231__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember_z5kmYKZC7jT1" title="Stock options, strike price description"&gt;Options are generally granted
with strike prices equal to the fair market value of a share of Imunon common stock on the date of grant. Incentive stock options may
be granted to purchase shares of common stock at a price not less than 100% of the fair market value of the underlying shares on the
date of grant, provided that the exercise price of any incentive stock option granted to an eligible employee owning more than 10% of
the outstanding stock of Imunon must be at least 110% of such fair market value on the date of grant. Only officers and key employees
may receive incentive stock options.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Option
and restricted stock awards vest upon terms determined by the Compensation Committee of the Board of Directors and are subject to accelerated
vesting in the event of a change of control or certain terminations of employment. The Company issues new shares to satisfy its obligations
from the exercise of options or the grant of restricted stock awards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024, the Compensation Committee of the Board of Directors approved the grant of inducement stock options (the &#x201c;Inducement
Option Grants&#x201d;) to purchase a total of &lt;span id="xdx_909_eus-gaap--SharesIssued_iI_c20241231__us-gaap--PlanNameAxis__custom--InducementOptionGrantsMember__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhH9UK2TxXmg" title="Shares, Issued"&gt;110,000&lt;/span&gt; shares of Imunon common stock. Each award has a grant date of the date of grant.
Each Inducement Option Grant has a weighted exercise price of $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20241231__us-gaap--PlanNameAxis__custom--InducementOptionGrantsMember__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zeJsIzeu9XPk" title="Exercise price per share"&gt;1.02&lt;/span&gt; per share. Each Inducement Option Grant vests over four years, with
one-fourth vesting on the one-year anniversary of the employee&#x2019;s first day of employment with the Company and one-fourth vesting
on the second, third and fourth anniversaries thereafter, subject to the new employee&#x2019;s continued service relationship with the
Company on each such date. Each Inducement Option Grant has a ten-year term and is subject to the terms and conditions of the applicable
stock option agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024, there were a total of &lt;span id="xdx_909_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20241231__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember_zNbo5GHMqnOk" title="Common stock, reserved for future issuance"&gt;1,975,073&lt;/span&gt; shares of Imunon common stock reserved for issuance under the 2018 Plan, which
were comprised of &lt;span id="xdx_900_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20241231__us-gaap--AwardTypeAxis__custom--EquityStockAwardsMember__srt--StatementScenarioAxis__custom--GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember_zJHHakkPzZba" title="Common stock, reserved for future issuance"&gt;1,555,073&lt;/span&gt; shares of Imunon common stock subject to equity awards previously granted under the 2018 Plan and 2007 Plan
and &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20241231__us-gaap--PlanNameAxis__custom--TwoThousandAndEighteenStockIncentivePlanMember_zLrj9bSYFSMk" title="Shares available for issuance"&gt;420,000&lt;/span&gt; shares of Imunon common stock available for future issuance under the 2018 Plan. As of December 31, 2024, there are a total
of &lt;span id="xdx_90A_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20241231__us-gaap--AwardTypeAxis__custom--InducementAwardsMember_zrqjMOEvC972" title="Common stock, reserved for future issuance"&gt;130,500&lt;/span&gt; shares of Imunon common stock subject to outstanding inducement awards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
compensation cost related to stock options and restricted stock awards was approximately $&lt;span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240101__20241231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember_zZKr7Xbk0Ly7" title="Share based compensation"&gt;0.5&lt;/span&gt; million and $&lt;span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20231231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember_zMm4JRhZcZMh" title="Share based compensation"&gt;0.8&lt;/span&gt; million during 2024 and
2023, respectively. Of these amounts, $&lt;span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240101__20241231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zvFiZ55Q4zy4" title="Share based compensation expense"&gt;0.3&lt;/span&gt; million and $&lt;span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20231231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zdMi7N3N3dGl" title="Share based compensation expense"&gt;0.2&lt;/span&gt; million were charged to research and development expenses during 2024 and
2023, respectively, and $&lt;span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240101__20241231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zM6kUoHiDdr4" title="Share based compensation"&gt;0.2&lt;/span&gt; million and $&lt;span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20231231__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionAndRestrictedStockAwardsMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_z59MNpv4F4Uh" title="Share based compensation"&gt;0.6&lt;/span&gt; million were charged to general and administrative expenses during 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z8l0Ay4zzcI7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of stock option awards as of December 31, 2024 and changes during the two-year period ended December 31, 2024 is presented below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B2_zRT355IYq1Rk" style="display: none"&gt;SUMMARY OF STOCK OPTIONS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Stock Options&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average&lt;br/&gt;
 Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average&lt;br/&gt;
 Remaining&lt;br/&gt;
 Contractual&lt;br/&gt;
 Term (years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;br/&gt;

Intrinsic Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%"&gt;Outstanding at January 1, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zNJMXarr63H6" style="width: 12%; text-align: right" title="Number Outstanding, Outstanding, Beginning balance"&gt;760,220&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z4eNJRRL00yl" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance"&gt;4.55&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zjlUlgrQXE1b" style="text-align: right" title="Number Outstanding, Options granted"&gt;432,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z86IZFDQBwmc" style="text-align: right" title="Weighted Average Exercise Price, Options granted"&gt;1.23&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Options canceled or expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z0qzbteOkC7h" style="border-bottom: Black 1pt solid; text-align: right" title="Number Outstanding, Options canceled or expired"&gt;(129,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zjMKEcOzuJij" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Options canceled or expired"&gt;9.37&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Outstanding at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z41s54Q7FPA" style="text-align: right" title="Number Outstanding, Outstanding, Beginning balance"&gt;1,063,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zZZKG3Pnf601" style="text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance"&gt;2.61&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGnmgQ5m4mDd" style="text-align: right" title="Number Outstanding, Options granted"&gt;1,051,835&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zB9aU3mYf3Ig" style="text-align: right" title="Weighted Average Exercise Price, Options granted"&gt;1.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Options canceled or expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zdk0cT81T7Y7" style="border-bottom: Black 1pt solid; text-align: right" title="Number Outstanding, Options canceled or expired"&gt;(469,444&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zXIQ6eKuWvRd" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Options canceled or expired"&gt;1.58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding at December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zB9YdanU429a" style="border-bottom: Black 2.5pt double; text-align: right" title="Number Outstanding, Outstanding, Ending balance"&gt;1,645,873&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zPgcGEuAWKs6" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending balance"&gt;1.95&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z7KqOTDF2zhh" title="Weighted Average Remaining Contractual Term (years), Outstanding, Ending balance"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pp0p0_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z80FYQgd8joc" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Ending balance"&gt;13,476&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Exercisable at December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z34A130IUop3" style="border-bottom: Black 2.5pt double; text-align: right" title="Number Outstanding, Exercisable, Ending balance"&gt;907,723&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zbos3BQsD5nd" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable, Ending balance"&gt;2.58&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_ztNEf6U3r8Ya" title="Weighted Average Remaining Contractual Term (years), Exercisable, Ending balance"&gt;8.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zzovtrSpQvGb" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable, Ending balance"&gt;7,299&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zCZImOcaKF7l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_z4CQpCRPhkib" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the status of the Company&#x2019;s non-vested restricted stock awards as of December 31, 2024 and changes during the two-year
period ended December 31, 2024, is presented below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_zNlHSt0omjU6" style="display: none"&gt;SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Restricted Stock&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
                                                                               Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Grant Date&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Non-vested stock awards outstanding at January 1, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20231231_zrAa5r7ijF47" style="width: 16%; text-align: right" title="Number Outstanding, Non-vested stock awards, Outstanding, Beginning balance"&gt;69,650&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20231231_z4GTYcL6ZXYf" style="width: 16%; text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Beginning balance"&gt;1.92&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231_z9Wjq5p9onjg" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Granted"&gt;22,100&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231_zb9Og7xe4Mce" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Granted"&gt;0.92&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Vested and issued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20231231_zVQ1h5tySgp6" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Vested and issued"&gt;(59,450&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231_zrVzDHqAA35d" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Vested and issued"&gt;1.91&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20230101__20231231_zLm1EdDMhxu7" style="border-bottom: Black 1pt solid; text-align: right" title="Number Outstanding, Non-vested stock awards, Forfeited"&gt;(200&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20231231_z3EprKT964d5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Forfeited"&gt;4.60&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Non-vested stock awards outstanding at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20240101__20241231_zzlYQPS5wAod" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Outstanding, Beginning balance"&gt;32,100&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20240101__20241231_zQvn5ShkEkNb" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Beginning balance"&gt;1.23&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240101__20241231_zqOa9UhzjXmk" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Granted"&gt;39,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240101__20241231_zcYZqQzgWbq9" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Granted"&gt;0.99&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Vested and issued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20240101__20241231_zjd1ppaRNEB4" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Vested and issued"&gt;(12,100&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20240101__20241231_zAvVVdZq9Mff" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Vested and issued"&gt;1.84&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20240101__20241231_z0WgeoM8sAB4" style="border-bottom: Black 1pt solid; text-align: right" title="Number Outstanding, Non-vested stock awards, Forfeited"&gt;(20,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20240101__20241231_zrr4LewQ5dU4" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Forfeited"&gt;0.88&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Non-vested stock awards outstanding at December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20240101__20241231_za3je5nz976l" style="border-bottom: Black 2.5pt double; text-align: right" title="Number Outstanding, Non-vested stock awards, Outstanding, Ending balance"&gt;39,700&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20240101__20241231_zT4qcQ0aRKma" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Ending balance"&gt;0.99&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_z68OMfuXKA23" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z4uMi7arfhc6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of stock options outstanding at December 31, 2024 by price range is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zFWKO5JmzFB2" style="display: none"&gt;SUMMARY OF STOCK OPTIONS OUTSTANDING&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options Exercisable&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Range of Exercise Prices&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Remaining Contractual Term (in years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
                                                                               Average Remaining Contractual Term (in years)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;Up to $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zC2EgXvNdui6" title="Range of Exercise Prices, Upper"&gt;1.50&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zOABDZXKzbz1" style="width: 8%; text-align: right" title="Options Outstanding, Number"&gt;1,250,252&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zBS2gZE4ARnl" title="Options Outstanding, Weighted Average Remaining Contractual Term (in years)"&gt;9.3&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zLwlTvB5X1Nc" style="width: 8%; text-align: right" title="Options Outstanding, Weighted Average Exercise Price"&gt;1.15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zUyBq80VkaDg" style="width: 8%; text-align: right" title="Options Exercisable, Number"&gt;513,433&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zjg2C1U2Uqoj" title="Options Exercisable, Weighted Average Remaining Contractual Term (in years)"&gt;9.1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zZPCgkp8keJe" style="width: 8%; text-align: right" title="Options Exercisable, Weighted Average Exercise Price"&gt;1.13&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;$&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zVWu8UBrqpA1" title="Range of Exercise Prices, Lower"&gt;1.51&lt;/span&gt; to $&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_z8dizvnAXnRj" title="Range of Exercise Prices, Upper"&gt;4.50&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zJYbSSVN4667" style="text-align: right" title="Options Outstanding, Number"&gt;207,345&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zCIRvRAsVSl" title="Options Outstanding, Weighted Average Remaining Contractual Term (in years)"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zz61uMkY9wL4" style="text-align: right" title="Options Outstanding, Weighted Average Exercise Price"&gt;1.93&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zTahOV2subqg" style="text-align: right" title="Options Exercisable, Number"&gt;206,289&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zaw6ZHbbKA8j" title="Options Exercisable, Weighted Average Remaining Contractual Term (in years)"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zMVRzkiZWrSf" style="text-align: right" title="Options Exercisable, Weighted Average Exercise Price"&gt;1.93&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Above $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_z9j5NnQlDsN2" title="Range of Exercise Prices, Upper"&gt;4.51&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zsNUpLwp6gQ7" style="border-bottom: Black 1pt solid; text-align: right" title="Options Outstanding, Number"&gt;188,276&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zNBVjGePI7t4" title="Options Outstanding, Weighted Average Remaining Contractual Term (in years)"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zyB1BcHBruH9" style="padding-bottom: 1pt; text-align: right" title="Options Outstanding, Weighted Average Exercise Price"&gt;7.28&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_ztBKsnFquL5" style="border-bottom: Black 1pt solid; text-align: right" title="Options Exercisable, Number"&gt;188,001&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zosgcMRbfIA8" title="Options Exercisable, Weighted Average Remaining Contractual Term (in years)"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zwwVWasmmWVi" style="padding-bottom: 1pt; text-align: right" title="Options Exercisable, Weighted Average Exercise Price"&gt;7.27&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231_zJSATgPb4Zs2" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, Number"&gt;1,645,873&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231_zWWsWlE1Ojlk" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Exercisable, Number"&gt;907,723&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zuLCI1C6AI73" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zRn1E7vsrxu" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair values of stock options granted were estimated at the date of grant using the Black-Scholes option pricing model. The Black-Scholes
model was originally developed for use in estimating the fair value of traded options, which have different characteristics from Imunon&#x2019;s
stock options. The model is also sensitive to changes in assumptions, which can materially affect the fair value estimate. The Company
used the following assumptions for determining the fair value of options granted under the Black-Scholes option pricing model:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B6_znVN2aMnFbve" style="display: none"&gt;SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20241231_zGTyUNEaqw6b" title="Risk-free interest rate, minimum"&gt;3.72&lt;/span&gt;%
to &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20241231_zOkmyCvW4FMc" title="Risk-free interest rate, maximum"&gt;4.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231_zrRrmc9xZQkl" title="Risk-free interest rate, minimum"&gt;3.39&lt;/span&gt;
% to &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231_zpbW6ynBzo7j" title="Risk-free interest rate, maximum"&gt;4.81&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20240101__20241231_zxlHAtQoGwc" title="Expected volatility, minimum"&gt;101.7&lt;/span&gt;% to &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20240101__20241231_zYeGq2RjFJhi" title="Expected volatility, maximum"&gt;115.8&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20231231_zsio7YMyPY4f" title="Expected volatility, minimum"&gt;100.0&lt;/span&gt;%
to &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20231231_zTpLuGyWtvTi" title="Expected volatility, maximum"&gt;113.6&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected life (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231__srt--RangeAxis__srt--MinimumMember_zk09D2exgTjh" title="Expected life (in years)"&gt;7.5&lt;/span&gt; to &lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231__srt--RangeAxis__srt--MaximumMember_zFbDBv8hAmL6" title="Expected life (in years)"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zVFdjiTdvoj9" title="Expected life (in years)"&gt;7.5&lt;/span&gt; to &lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zwtWbIOu3Ywf" title="Expected life (in years)"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240101__20241231_zL7AaJc4Rar7" style="width: 16%; text-align: right" title="Expected dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231_zrkO6QxHlKh5" style="width: 16%; text-align: right" title="Expected dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8A2_zTr8D98efn3c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
volatilities utilized in the model are based on historical volatility of the Company&#x2019;s stock price. As of December 31, 2024, there
was $&lt;span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pn5n6_c20241231_zViXpu5K4stj" title="Unrecognized compensation cost related to non-vested stock-based compensation arrangements"&gt;0.5&lt;/span&gt; million of total unrecognized compensation cost related to non-vested stock-based compensation arrangements. That cost is expected
to be recognized over a weighted-average period of &lt;span id="xdx_905_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20240101__20241231_z6SnXkh9HZy9" title="Cost recognized over a weighted-average period"&gt;1.4&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="AsOf2018-05-15_custom_TwoThousandAndEighteenStockIncentivePlanMember"
      decimals="INF"
      id="Fact000988"
      unitRef="Shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2019-05-14_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MinimumMember"
      decimals="INF"
      id="Fact000990"
      unitRef="Shares">80000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2019-05-14_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MaximumMember"
      decimals="INF"
      id="Fact000992"
      unitRef="Shares">260000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2020-06-15_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MinimumMember"
      decimals="INF"
      id="Fact000994"
      unitRef="Shares">166667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2020-06-15_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MaximumMember"
      decimals="INF"
      id="Fact000996"
      unitRef="Shares">426667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2021-06-10_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MinimumMember"
      decimals="INF"
      id="Fact000998"
      unitRef="Shares">513333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2021-06-10_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001000"
      unitRef="Shares">940000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2023-06-14_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MinimumMember"
      decimals="INF"
      id="Fact001002"
      unitRef="Shares">1030000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2023-06-14_custom_TwoThousandAndEighteenStockIncentivePlanMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001004"
      unitRef="Shares">1970000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <IMNN:StockOptionsStrikePriceDescription
      contextRef="From2024-01-012024-12-31_custom_TwoThousandAndEighteenStockIncentivePlanMember"
      id="Fact001006">Options are generally granted
with strike prices equal to the fair market value of a share of Imunon common stock on the date of grant. Incentive stock options may
be granted to purchase shares of common stock at a price not less than 100% of the fair market value of the underlying shares on the
date of grant, provided that the exercise price of any incentive stock option granted to an eligible employee owning more than 10% of
the outstanding stock of Imunon must be at least 110% of such fair market value on the date of grant. Only officers and key employees
may receive incentive stock options.</IMNN:StockOptionsStrikePriceDescription>
    <us-gaap:SharesIssued
      contextRef="AsOf2024-12-31_custom_InducementOptionGrantsMember_srt_BoardOfDirectorsChairmanMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001008"
      unitRef="Shares">110000</us-gaap:SharesIssued>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-01-012024-12-31_custom_InducementOptionGrantsMember_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="Fact001010"
      unitRef="USDPShares">1.02</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2024-12-31_custom_TwoThousandAndEighteenStockIncentivePlanMember"
      decimals="INF"
      id="Fact001012"
      unitRef="Shares">1975073</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2024-12-31_custom_EquityStockAwardsMember_custom_GrantedUnderTwoThousandEighteenPlanAndTwoThousandSevenPlanMember"
      decimals="INF"
      id="Fact001014"
      unitRef="Shares">1555073</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2024-12-31_custom_TwoThousandAndEighteenStockIncentivePlanMember"
      decimals="INF"
      id="Fact001016"
      unitRef="Shares">420000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2024-12-31_custom_InducementAwardsMember"
      decimals="INF"
      id="Fact001018"
      unitRef="Shares">130500</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember"
      decimals="-5"
      id="Fact001020"
      unitRef="USD">500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember"
      decimals="-5"
      id="Fact001022"
      unitRef="USD">800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="Fact001024"
      unitRef="USD">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="Fact001026"
      unitRef="USD">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-5"
      id="Fact001028"
      unitRef="USD">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-12-31_custom_EmployeeStockOptionAndRestrictedStockAwardsMember_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-5"
      id="Fact001030"
      unitRef="USD">600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001032">&lt;p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z8l0Ay4zzcI7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of stock option awards as of December 31, 2024 and changes during the two-year period ended December 31, 2024 is presented below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B2_zRT355IYq1Rk" style="display: none"&gt;SUMMARY OF STOCK OPTIONS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Stock Options&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average&lt;br/&gt;
 Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average&lt;br/&gt;
 Remaining&lt;br/&gt;
 Contractual&lt;br/&gt;
 Term (years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;br/&gt;

Intrinsic Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%"&gt;Outstanding at January 1, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zNJMXarr63H6" style="width: 12%; text-align: right" title="Number Outstanding, Outstanding, Beginning balance"&gt;760,220&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z4eNJRRL00yl" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance"&gt;4.55&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zjlUlgrQXE1b" style="text-align: right" title="Number Outstanding, Options granted"&gt;432,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z86IZFDQBwmc" style="text-align: right" title="Weighted Average Exercise Price, Options granted"&gt;1.23&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Options canceled or expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z0qzbteOkC7h" style="border-bottom: Black 1pt solid; text-align: right" title="Number Outstanding, Options canceled or expired"&gt;(129,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zjMKEcOzuJij" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Options canceled or expired"&gt;9.37&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Outstanding at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z41s54Q7FPA" style="text-align: right" title="Number Outstanding, Outstanding, Beginning balance"&gt;1,063,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zZZKG3Pnf601" style="text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance"&gt;2.61&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGnmgQ5m4mDd" style="text-align: right" title="Number Outstanding, Options granted"&gt;1,051,835&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zB9aU3mYf3Ig" style="text-align: right" title="Weighted Average Exercise Price, Options granted"&gt;1.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Options canceled or expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zdk0cT81T7Y7" style="border-bottom: Black 1pt solid; text-align: right" title="Number Outstanding, Options canceled or expired"&gt;(469,444&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zXIQ6eKuWvRd" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Options canceled or expired"&gt;1.58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding at December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zB9YdanU429a" style="border-bottom: Black 2.5pt double; text-align: right" title="Number Outstanding, Outstanding, Ending balance"&gt;1,645,873&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zPgcGEuAWKs6" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending balance"&gt;1.95&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z7KqOTDF2zhh" title="Weighted Average Remaining Contractual Term (years), Outstanding, Ending balance"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pp0p0_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z80FYQgd8joc" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Ending balance"&gt;13,476&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Exercisable at December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z34A130IUop3" style="border-bottom: Black 2.5pt double; text-align: right" title="Number Outstanding, Exercisable, Ending balance"&gt;907,723&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zbos3BQsD5nd" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable, Ending balance"&gt;2.58&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_ztNEf6U3r8Ya" title="Weighted Average Remaining Contractual Term (years), Exercisable, Ending balance"&gt;8.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_c20241231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zzovtrSpQvGb" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable, Ending balance"&gt;7,299&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001034"
      unitRef="Shares">760220</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001036"
      unitRef="USDPShares">4.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001038"
      unitRef="Shares">432500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001040"
      unitRef="USDPShares">1.23</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001042"
      unitRef="Shares">129238</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001044"
      unitRef="USDPShares">9.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001046"
      unitRef="Shares">1063482</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001048"
      unitRef="USDPShares">2.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2024-01-012024-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001050"
      unitRef="Shares">1051835</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-01-012024-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001052"
      unitRef="USDPShares">1.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2024-01-012024-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001054"
      unitRef="Shares">469444</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-01-012024-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001056"
      unitRef="USDPShares">1.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001058"
      unitRef="Shares">1645873</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001060"
      unitRef="USDPShares">1.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2024-01-012024-12-31_us-gaap_EmployeeStockOptionMember"
      id="Fact001062">P8Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2024-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="0"
      id="Fact001064"
      unitRef="USD">13476</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001066"
      unitRef="Shares">907723</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001068"
      unitRef="USDPShares">2.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="From2024-01-012024-12-31_us-gaap_EmployeeStockOptionMember"
      id="Fact001070">P8Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2024-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="0"
      id="Fact001072"
      unitRef="USD">7299</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001074">&lt;p id="xdx_89B_eus-gaap--ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_z4CQpCRPhkib" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the status of the Company&#x2019;s non-vested restricted stock awards as of December 31, 2024 and changes during the two-year
period ended December 31, 2024, is presented below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_zNlHSt0omjU6" style="display: none"&gt;SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Restricted Stock&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
                                                                               Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Grant Date&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Non-vested stock awards outstanding at January 1, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20231231_zrAa5r7ijF47" style="width: 16%; text-align: right" title="Number Outstanding, Non-vested stock awards, Outstanding, Beginning balance"&gt;69,650&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20231231_z4GTYcL6ZXYf" style="width: 16%; text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Beginning balance"&gt;1.92&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231_z9Wjq5p9onjg" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Granted"&gt;22,100&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231_zb9Og7xe4Mce" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Granted"&gt;0.92&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Vested and issued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20231231_zVQ1h5tySgp6" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Vested and issued"&gt;(59,450&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231_zrVzDHqAA35d" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Vested and issued"&gt;1.91&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20230101__20231231_zLm1EdDMhxu7" style="border-bottom: Black 1pt solid; text-align: right" title="Number Outstanding, Non-vested stock awards, Forfeited"&gt;(200&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20231231_z3EprKT964d5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Forfeited"&gt;4.60&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Non-vested stock awards outstanding at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20240101__20241231_zzlYQPS5wAod" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Outstanding, Beginning balance"&gt;32,100&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20240101__20241231_zQvn5ShkEkNb" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Beginning balance"&gt;1.23&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240101__20241231_zqOa9UhzjXmk" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Granted"&gt;39,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240101__20241231_zcYZqQzgWbq9" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Granted"&gt;0.99&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Vested and issued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20240101__20241231_zjd1ppaRNEB4" style="text-align: right" title="Number Outstanding, Non-vested stock awards, Vested and issued"&gt;(12,100&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20240101__20241231_zAvVVdZq9Mff" style="text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Vested and issued"&gt;1.84&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20240101__20241231_z0WgeoM8sAB4" style="border-bottom: Black 1pt solid; text-align: right" title="Number Outstanding, Non-vested stock awards, Forfeited"&gt;(20,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20240101__20241231_zrr4LewQ5dU4" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Forfeited"&gt;0.88&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Non-vested stock awards outstanding at December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20240101__20241231_za3je5nz976l" style="border-bottom: Black 2.5pt double; text-align: right" title="Number Outstanding, Non-vested stock awards, Outstanding, Ending balance"&gt;39,700&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20240101__20241231_zT4qcQ0aRKma" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Ending balance"&gt;0.99&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001076"
      unitRef="Shares">69650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001078"
      unitRef="USDPShares">1.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001080"
      unitRef="Shares">22100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001082"
      unitRef="USDPShares">0.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001084"
      unitRef="Shares">59450</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001086"
      unitRef="USDPShares">1.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001088"
      unitRef="Shares">200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001090"
      unitRef="USDPShares">4.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001092"
      unitRef="Shares">32100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001094"
      unitRef="USDPShares">1.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001096"
      unitRef="Shares">39700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001098"
      unitRef="USDPShares">0.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001100"
      unitRef="Shares">12100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001102"
      unitRef="USDPShares">1.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001104"
      unitRef="Shares">20000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001106"
      unitRef="USDPShares">0.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001108"
      unitRef="Shares">39700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001110"
      unitRef="USDPShares">0.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001112">&lt;p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z4uMi7arfhc6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of stock options outstanding at December 31, 2024 by price range is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zFWKO5JmzFB2" style="display: none"&gt;SUMMARY OF STOCK OPTIONS OUTSTANDING&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options Exercisable&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Range of Exercise Prices&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Remaining Contractual Term (in years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
                                                                               Average Remaining Contractual Term (in years)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;Up to $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zC2EgXvNdui6" title="Range of Exercise Prices, Upper"&gt;1.50&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zOABDZXKzbz1" style="width: 8%; text-align: right" title="Options Outstanding, Number"&gt;1,250,252&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zBS2gZE4ARnl" title="Options Outstanding, Weighted Average Remaining Contractual Term (in years)"&gt;9.3&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zLwlTvB5X1Nc" style="width: 8%; text-align: right" title="Options Outstanding, Weighted Average Exercise Price"&gt;1.15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zUyBq80VkaDg" style="width: 8%; text-align: right" title="Options Exercisable, Number"&gt;513,433&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zjg2C1U2Uqoj" title="Options Exercisable, Weighted Average Remaining Contractual Term (in years)"&gt;9.1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zZPCgkp8keJe" style="width: 8%; text-align: right" title="Options Exercisable, Weighted Average Exercise Price"&gt;1.13&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;$&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zVWu8UBrqpA1" title="Range of Exercise Prices, Lower"&gt;1.51&lt;/span&gt; to $&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_z8dizvnAXnRj" title="Range of Exercise Prices, Upper"&gt;4.50&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zJYbSSVN4667" style="text-align: right" title="Options Outstanding, Number"&gt;207,345&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zCIRvRAsVSl" title="Options Outstanding, Weighted Average Remaining Contractual Term (in years)"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zz61uMkY9wL4" style="text-align: right" title="Options Outstanding, Weighted Average Exercise Price"&gt;1.93&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zTahOV2subqg" style="text-align: right" title="Options Exercisable, Number"&gt;206,289&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zaw6ZHbbKA8j" title="Options Exercisable, Weighted Average Remaining Contractual Term (in years)"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zMVRzkiZWrSf" style="text-align: right" title="Options Exercisable, Weighted Average Exercise Price"&gt;1.93&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Above $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_z9j5NnQlDsN2" title="Range of Exercise Prices, Upper"&gt;4.51&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zsNUpLwp6gQ7" style="border-bottom: Black 1pt solid; text-align: right" title="Options Outstanding, Number"&gt;188,276&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zNBVjGePI7t4" title="Options Outstanding, Weighted Average Remaining Contractual Term (in years)"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zyB1BcHBruH9" style="padding-bottom: 1pt; text-align: right" title="Options Outstanding, Weighted Average Exercise Price"&gt;7.28&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_ztBKsnFquL5" style="border-bottom: Black 1pt solid; text-align: right" title="Options Exercisable, Number"&gt;188,001&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zosgcMRbfIA8" title="Options Exercisable, Weighted Average Remaining Contractual Term (in years)"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zwwVWasmmWVi" style="padding-bottom: 1pt; text-align: right" title="Options Exercisable, Weighted Average Exercise Price"&gt;7.27&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231_zJSATgPb4Zs2" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, Number"&gt;1,645,873&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231_zWWsWlE1Ojlk" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Exercisable, Number"&gt;907,723&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2024-01-012024-12-31_custom_ExercisePriceOneMember"
      decimals="INF"
      id="Fact001114"
      unitRef="USDPShares">1.50</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-12-31_custom_ExercisePriceOneMember"
      decimals="INF"
      id="Fact001116"
      unitRef="Shares">1250252</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2024-01-012024-12-31_custom_ExercisePriceOneMember"
      id="Fact001118">P9Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31_custom_ExercisePriceOneMember"
      decimals="INF"
      id="Fact001120"
      unitRef="USDPShares">1.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-12-31_custom_ExercisePriceOneMember"
      decimals="INF"
      id="Fact001122"
      unitRef="Shares">513433</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="From2024-01-012024-12-31_custom_ExercisePriceOneMember"
      id="Fact001124">P9Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31_custom_ExercisePriceOneMember"
      decimals="INF"
      id="Fact001126"
      unitRef="USDPShares">1.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2024-01-012024-12-31_custom_ExercisePriceTwoMember"
      decimals="INF"
      id="Fact001128"
      unitRef="USDPShares">1.51</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2024-01-012024-12-31_custom_ExercisePriceTwoMember"
      decimals="INF"
      id="Fact001130"
      unitRef="USDPShares">4.50</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-12-31_custom_ExercisePriceTwoMember"
      decimals="INF"
      id="Fact001132"
      unitRef="Shares">207345</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2024-01-012024-12-31_custom_ExercisePriceTwoMember"
      id="Fact001134">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31_custom_ExercisePriceTwoMember"
      decimals="INF"
      id="Fact001136"
      unitRef="USDPShares">1.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-12-31_custom_ExercisePriceTwoMember"
      decimals="INF"
      id="Fact001138"
      unitRef="Shares">206289</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="From2024-01-012024-12-31_custom_ExercisePriceTwoMember"
      id="Fact001140">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31_custom_ExercisePriceTwoMember"
      decimals="INF"
      id="Fact001142"
      unitRef="USDPShares">1.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2024-01-012024-12-31_custom_ExercisePriceThreeMember"
      decimals="INF"
      id="Fact001144"
      unitRef="USDPShares">4.51</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-12-31_custom_ExercisePriceThreeMember"
      decimals="INF"
      id="Fact001146"
      unitRef="Shares">188276</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2024-01-012024-12-31_custom_ExercisePriceThreeMember"
      id="Fact001148">P6Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31_custom_ExercisePriceThreeMember"
      decimals="INF"
      id="Fact001150"
      unitRef="USDPShares">7.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-12-31_custom_ExercisePriceThreeMember"
      decimals="INF"
      id="Fact001152"
      unitRef="Shares">188001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="From2024-01-012024-12-31_custom_ExercisePriceThreeMember"
      id="Fact001154">P6Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31_custom_ExercisePriceThreeMember"
      decimals="INF"
      id="Fact001156"
      unitRef="USDPShares">7.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001158"
      unitRef="Shares">1645873</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001160"
      unitRef="Shares">907723</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001162">&lt;p id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zRn1E7vsrxu" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair values of stock options granted were estimated at the date of grant using the Black-Scholes option pricing model. The Black-Scholes
model was originally developed for use in estimating the fair value of traded options, which have different characteristics from Imunon&#x2019;s
stock options. The model is also sensitive to changes in assumptions, which can materially affect the fair value estimate. The Company
used the following assumptions for determining the fair value of options granted under the Black-Scholes option pricing model:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B6_znVN2aMnFbve" style="display: none"&gt;SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20241231_zGTyUNEaqw6b" title="Risk-free interest rate, minimum"&gt;3.72&lt;/span&gt;%
to &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20241231_zOkmyCvW4FMc" title="Risk-free interest rate, maximum"&gt;4.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231_zrRrmc9xZQkl" title="Risk-free interest rate, minimum"&gt;3.39&lt;/span&gt;
% to &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231_zpbW6ynBzo7j" title="Risk-free interest rate, maximum"&gt;4.81&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20240101__20241231_zxlHAtQoGwc" title="Expected volatility, minimum"&gt;101.7&lt;/span&gt;% to &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20240101__20241231_zYeGq2RjFJhi" title="Expected volatility, maximum"&gt;115.8&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20231231_zsio7YMyPY4f" title="Expected volatility, minimum"&gt;100.0&lt;/span&gt;%
to &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20231231_zTpLuGyWtvTi" title="Expected volatility, maximum"&gt;113.6&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected life (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231__srt--RangeAxis__srt--MinimumMember_zk09D2exgTjh" title="Expected life (in years)"&gt;7.5&lt;/span&gt; to &lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231__srt--RangeAxis__srt--MaximumMember_zFbDBv8hAmL6" title="Expected life (in years)"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zVFdjiTdvoj9" title="Expected life (in years)"&gt;7.5&lt;/span&gt; to &lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zwtWbIOu3Ywf" title="Expected life (in years)"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240101__20241231_zL7AaJc4Rar7" style="width: 16%; text-align: right" title="Expected dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231_zrkO6QxHlKh5" style="width: 16%; text-align: right" title="Expected dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001164"
      unitRef="Pure">0.0372</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001166"
      unitRef="Pure">0.0450</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001168"
      unitRef="Pure">0.0339</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001170"
      unitRef="Pure">0.0481</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001172"
      unitRef="Pure">1.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001174"
      unitRef="Pure">1.158</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001176"
      unitRef="Pure">1.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001178"
      unitRef="Pure">1.136</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-01-012024-12-31_srt_MinimumMember"
      id="Fact001180">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-01-012024-12-31_srt_MaximumMember"
      id="Fact001182">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-12-31_srt_MinimumMember"
      id="Fact001184">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-12-31_srt_MaximumMember"
      id="Fact001186">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001188"
      unitRef="Pure">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001190"
      unitRef="Pure">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="AsOf2024-12-31"
      decimals="-5"
      id="Fact001192"
      unitRef="USD">500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2024-01-01to2024-12-31" id="Fact001194">P1Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <IMNN:WarrantsTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001196">&lt;p id="xdx_800_ecustom--WarrantsTextBlock_zXIZYjpljPK1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12.
&lt;span id="xdx_822_zNB7aZ50AHzj"&gt;WARRANTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#x2019;s
specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity (&#x201c;ASC 480&#x201d;),
and ASC 815, Derivatives and Hedging (&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding financial
instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements
for equity classification under ASC 815, including whether the warrants are indexed to the Company&#x2019;s own common stock, among other
conditions for equity classification.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This
assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly
period end date while the warrants are outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component
of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification,
the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter.
The Company has analyzed the Warrants issued in the July 2024 Offering and determined they are considered to be freestanding instruments
and do not exhibit any of the characteristics in ASC 480 and therefore are not classified as liabilities under ASC 480. The Warrants
meet all of the requirements for equity classification under ASC 815 and therefore are classified as equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zJ2ZnTFgCM0c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
is a summary of all warrant activity for the two years ended December 31, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_z2F2T7VOb049" style="display: none"&gt;SUMMARY OF WARRANT ACTIVITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Number of&lt;br/&gt;
 Warrants Issued&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
                                                                               Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise
                                                                               Price&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Warrants outstanding at January 1, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20231231_fKg_____z34bE1wU0zL8" style="width: 16%; text-align: right" title="Number of Warrants Issued, Warrants outstanding, Beginning balance"&gt;168,519&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_zcKF45NV6RBd" style="width: 16%; text-align: right" title="Weighted Average Exercise Price, Warrants outstanding, Beginning balance"&gt;19.78&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrants issued during 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20241231_zeMEUKZYq7Ba" style="text-align: right" title="Number of Warrants Issued, Warrants issued"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice_c20240101__20241231_zgdqQZqWLjAf" style="text-align: right" title="Weighted Average Exercise Price, Warrants issued"&gt;2.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Warrants expired during 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20230101__20231231_zYc1C5iqDFk7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants Issued, warrants expired"&gt;(8,459&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231_zkTJAkmi1rl8" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants expired"&gt;37.29&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrants outstanding and exercisable at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20240101__20241231_fKg_____z5lebPFRBBci" style="text-align: right" title="Number of Warrants Issued, Warrants outstanding, Beginning balance"&gt;160,060&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20240101__20241231_zCdsBv4AEEE4" style="text-align: right" title="Weighted Average Exercise Price, Warrants outstanding, Beginning balance"&gt;18.86&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrants issued during 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20241231_zoyRFWBjB1p7" style="text-align: right" title="Number of Warrants Issued, Warrants issued"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice_c20240101__20241231_zxLHC3wAQTI6" style="text-align: right" title="Weighted Average Exercise Price, Warrants issued"&gt;2.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Warrants expired during 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20240101__20241231_zti0AXQom2y7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants Issued, Warrants expired"&gt;(5,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20241231_zLqFJVD2qeo4" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants expired"&gt;11.85&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Warrants outstanding and exercisable at December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20240101__20241231_ztWbPxwDd6b6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Warrants Issued, Warrants outstanding, Ending balance"&gt;5,155,060&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_c20240101__20241231_zys4QATDg5dk" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Warrants outstanding, Ending balance"&gt;2.51&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Aggregate intrinsic value of outstanding warrants at December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iI_pp0p0_c20241231_zgqrkSeOdIW8" title="Aggregate intrinsic value of outstanding warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1228"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Weighted average remaining contractual terms (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_fKg_____zwIguOVwLCRg" title="Weighted average remaining contractual terms (years)"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zf5qazZbbxV8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</IMNN:WarrantsTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001198">&lt;p id="xdx_895_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zJ2ZnTFgCM0c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
is a summary of all warrant activity for the two years ended December 31, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_z2F2T7VOb049" style="display: none"&gt;SUMMARY OF WARRANT ACTIVITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Number of&lt;br/&gt;
 Warrants Issued&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
                                                                               Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise
                                                                               Price&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Warrants outstanding at January 1, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20231231_fKg_____z34bE1wU0zL8" style="width: 16%; text-align: right" title="Number of Warrants Issued, Warrants outstanding, Beginning balance"&gt;168,519&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_zcKF45NV6RBd" style="width: 16%; text-align: right" title="Weighted Average Exercise Price, Warrants outstanding, Beginning balance"&gt;19.78&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrants issued during 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20241231_zeMEUKZYq7Ba" style="text-align: right" title="Number of Warrants Issued, Warrants issued"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice_c20240101__20241231_zgdqQZqWLjAf" style="text-align: right" title="Weighted Average Exercise Price, Warrants issued"&gt;2.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Warrants expired during 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20230101__20231231_zYc1C5iqDFk7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants Issued, warrants expired"&gt;(8,459&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231_zkTJAkmi1rl8" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants expired"&gt;37.29&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrants outstanding and exercisable at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20240101__20241231_fKg_____z5lebPFRBBci" style="text-align: right" title="Number of Warrants Issued, Warrants outstanding, Beginning balance"&gt;160,060&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20240101__20241231_zCdsBv4AEEE4" style="text-align: right" title="Weighted Average Exercise Price, Warrants outstanding, Beginning balance"&gt;18.86&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrants issued during 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20241231_zoyRFWBjB1p7" style="text-align: right" title="Number of Warrants Issued, Warrants issued"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice_c20240101__20241231_zxLHC3wAQTI6" style="text-align: right" title="Weighted Average Exercise Price, Warrants issued"&gt;2.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Warrants expired during 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20240101__20241231_zti0AXQom2y7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants Issued, Warrants expired"&gt;(5,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20241231_zLqFJVD2qeo4" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants expired"&gt;11.85&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Warrants outstanding and exercisable at December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20240101__20241231_ztWbPxwDd6b6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Warrants Issued, Warrants outstanding, Ending balance"&gt;5,155,060&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_c20240101__20241231_zys4QATDg5dk" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Warrants outstanding, Ending balance"&gt;2.51&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Aggregate intrinsic value of outstanding warrants at December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iI_pp0p0_c20241231_zgqrkSeOdIW8" title="Aggregate intrinsic value of outstanding warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1228"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Weighted average remaining contractual terms (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_fKg_____zwIguOVwLCRg" title="Weighted average remaining contractual terms (years)"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001200"
      unitRef="Shares">168519</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001202"
      unitRef="USDPShares">19.78</IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001204"
      unitRef="Shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001206"
      unitRef="USDPShares">2.00</IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001208"
      unitRef="Shares">8459</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001210"
      unitRef="USDPShares">37.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001212"
      unitRef="Shares">160060</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001214"
      unitRef="USDPShares">18.86</IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001216"
      unitRef="Shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001218"
      unitRef="USDPShares">2.00</IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriosWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001220"
      unitRef="Shares">5000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001222"
      unitRef="USDPShares">11.85</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001224"
      unitRef="Shares">5155060</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001226"
      unitRef="USDPShares">2.51</IMNN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <IMNN:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2024-01-01to2024-12-31" id="Fact001230">P5Y</IMNN:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001232">&lt;p id="xdx_805_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zSjUR1FgFAL" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;13.
&lt;span id="xdx_821_zYk7fPUfNDhh"&gt;IMUNON EMPLOYEE BENEFIT PLANS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Imunon
maintains a defined-contribution plan under Section 401(k) of the Code. The plan covers substantially all employees over the age of twenty-one.
Participating employees may defer a portion of their pretax earnings, up to the IRS annual contribution limit. The Company makes a matching
contribution up to a maximum of &lt;span id="xdx_906_eus-gaap--DefinedContributionPlanEmployerMatchingContributionPercent_pid_dp_uPure_c20240101__20241231_ztJDzsccaFW3" title="Maximum annual contributions per employee, percent"&gt;3&lt;/span&gt;% of an employee&#x2019;s annual salary. The Company&#x2019;s total matching contributions for the year
ended December 31, 2024 and 2023 were $&lt;span id="xdx_909_eus-gaap--DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_pp0p0_c20240101__20241231_z41gkPYRqotl" title="Matching contributions of employee"&gt;62,000&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_pp0p0_c20230101__20231231_zgsDODgfjLLk" title="Matching contributions of employee"&gt;142,000&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001234"
      unitRef="Pure">0.03</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact001236"
      unitRef="USD">62000</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001238"
      unitRef="USD">142000</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001240">&lt;p id="xdx_809_eus-gaap--LesseeOperatingLeasesTextBlock_zr6s4i8EpNMk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;14.
&lt;span id="xdx_823_zCqeCRmmZC83"&gt;LEASES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lawrenceville,
New Jersey Lease&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2023, the Company renewed its Lawrenceville office lease for a &lt;span id="xdx_903_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtM_c20230831_zcJCAZqi6Zbf" title="Operating lease, term"&gt;24&lt;/span&gt;-month agreement for &lt;span id="xdx_901_eus-gaap--AreaOfLand_iI_pp0p0_usqrt_c20230831__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zcbWGLq8W29c" title="Area of land"&gt;9,850&lt;/span&gt; square feet with monthly rent payments
of approximately $&lt;span id="xdx_909_eus-gaap--PaymentsForRent_pp0p0_c20230801__20230831__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zPClH1MhBFOd" title="Payments for rent"&gt;22,983&lt;/span&gt; to $&lt;span id="xdx_906_eus-gaap--PaymentsForRent_pp0p0_c20230801__20230831__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zKwimQSDSEye" title="Payments for rent"&gt;23,394&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Huntsville,
Alabama Lease&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2023, the Company renewed its Huntsville facility lease for a &lt;span id="xdx_90D_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtM_c20230131_zKCXv94E01dk" title="Operating lease, term"&gt;60&lt;/span&gt;-month lease agreement for &lt;span id="xdx_90B_eus-gaap--AreaOfLand_iI_pp0p0_usqrt_c20230131__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zHJP1JD2Jaeb" title="Area of land"&gt;11,420&lt;/span&gt; square feet with monthly rent
payments of approximately $&lt;span id="xdx_90D_eus-gaap--PaymentsForRent_pp0p0_c20230101__20230131__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zKoMycPK3NAl" title="Payments for rent"&gt;28,550&lt;/span&gt; to $&lt;span id="xdx_901_eus-gaap--PaymentsForRent_pp0p0_c20230101__20230131__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember__srt--RangeAxis__srt--MaximumMember_z16RY8z5Wusg" title="Payments for rent"&gt;30,903&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zTtl57qOKdca" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a table of the lease payments and maturity of the Company&#x2019;s operating lease liabilities as of December 31, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zk0OYEyekFtj" style="display: none"&gt;SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20241231_zlwmB1L5fH14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ending December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzy9p_z8U9WnNpaBub" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; text-align: right"&gt;543,009&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzy9p_zFGm5DMTnwre" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;362,976&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzy9p_zW6RfUsRkspe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;370,235&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter_iI_maLOLLPzy9p_z9aKaq1ytOM5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;2028 and thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;30,904&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzy9p_maOLLz45C_maOLLzlbh_zotiXEslMm4f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Subtotal future lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,307,124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zdcmyBRBBK01" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(167,831&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingLeaseLiability_iI_zv06nHSZ7uk6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,139,293&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Weighted average remaining life&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_z9wC3KQMMn5d" title="Operating lease, weighted average remaining lease term"&gt;2.7&lt;/span&gt; years &lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Weighted average discount rate&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20241231_zVcwOso1kwV3" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease, weighted average discount rate, percent"&gt;9.98&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zLcEcZhZqQC7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
discount rate used was the Company&#x2019;s incremental borrowing rate, which is &lt;span id="xdx_90B_ecustom--OperatingLeasesIncrementalBorrowingRate_iI_dp_uPure_c20241231_zQXoKyHKJ8n2" title="Incremental borrowing rate"&gt;9.98&lt;/span&gt;%, as the Company could not determine the rate implicit
in the lease.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
2024, operating lease expense was $&lt;span id="xdx_901_eus-gaap--OperatingLeaseCost_pp0p0_c20240101__20241231_zs0Fnfs0F3O3" title="Operating lease, cost"&gt;652,166&lt;/span&gt; and cash paid for operating leases included in operating cash flows was $&lt;span id="xdx_902_eus-gaap--OperatingLeasePayments_pp0p0_c20240101__20241231_z19S8IGFb7tf" title="Operating lease, payments"&gt;659,646&lt;/span&gt;. For 2023,
operating lease expense was $&lt;span id="xdx_907_eus-gaap--OperatingLeaseCost_pp0p0_c20230101__20231231_zqMsFXNBxCB4" title="Operating lease, cost"&gt;646,633&lt;/span&gt; and cash paid for operating leases included in operating cash flows was $&lt;span id="xdx_907_eus-gaap--OperatingLeasePayments_pp0p0_c20230101__20231231_zKm7azc4ONnc" title="Operating lease, payments"&gt;644,593&lt;/span&gt;. Amortization expense
was approximately $&lt;span id="xdx_904_eus-gaap--OtherDepreciationAndAmortization_c20240101__20241231_zPvyPlINkmCb" title="Amortization expense"&gt;478,000&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--OtherDepreciationAndAmortization_c20230101__20231231_zdqTbMk9xpqc" title="Amortization expense"&gt;472,000&lt;/span&gt; for the years ended December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="AsOf2023-08-31" id="Fact001242">P24M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:AreaOfLand
      contextRef="AsOf2023-08-31_custom_LeaseAgreementMember"
      decimals="0"
      id="Fact001244"
      unitRef="sqrt">9850</us-gaap:AreaOfLand>
    <us-gaap:PaymentsForRent
      contextRef="From2023-08-012023-08-31_custom_LeaseAgreementMember_srt_MinimumMember"
      decimals="0"
      id="Fact001246"
      unitRef="USD">22983</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="From2023-08-012023-08-31_custom_LeaseAgreementMember_srt_MaximumMember"
      decimals="0"
      id="Fact001248"
      unitRef="USD">23394</us-gaap:PaymentsForRent>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="AsOf2023-01-31" id="Fact001250">P60M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:AreaOfLand
      contextRef="AsOf2023-01-31_custom_LeaseAgreementMember"
      decimals="0"
      id="Fact001252"
      unitRef="sqrt">11420</us-gaap:AreaOfLand>
    <us-gaap:PaymentsForRent
      contextRef="From2023-01-012023-01-31_custom_LeaseAgreementMember_srt_MinimumMember"
      decimals="0"
      id="Fact001254"
      unitRef="USD">28550</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="From2023-01-012023-01-31_custom_LeaseAgreementMember_srt_MaximumMember"
      decimals="0"
      id="Fact001256"
      unitRef="USD">30903</us-gaap:PaymentsForRent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001258">&lt;p id="xdx_89C_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zTtl57qOKdca" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a table of the lease payments and maturity of the Company&#x2019;s operating lease liabilities as of December 31, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zk0OYEyekFtj" style="display: none"&gt;SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20241231_zlwmB1L5fH14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ending December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzy9p_z8U9WnNpaBub" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; text-align: right"&gt;543,009&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzy9p_zFGm5DMTnwre" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;362,976&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzy9p_zW6RfUsRkspe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;370,235&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter_iI_maLOLLPzy9p_z9aKaq1ytOM5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;2028 and thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;30,904&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzy9p_maOLLz45C_maOLLzlbh_zotiXEslMm4f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Subtotal future lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,307,124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zdcmyBRBBK01" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(167,831&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingLeaseLiability_iI_zv06nHSZ7uk6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,139,293&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Weighted average remaining life&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_z9wC3KQMMn5d" title="Operating lease, weighted average remaining lease term"&gt;2.7&lt;/span&gt; years &lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Weighted average discount rate&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20241231_zVcwOso1kwV3" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease, weighted average discount rate, percent"&gt;9.98&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001260"
      unitRef="USD">543009</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001262"
      unitRef="USD">362976</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001264"
      unitRef="USD">370235</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <IMNN:LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001266"
      unitRef="USD">30904</IMNN:LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001268"
      unitRef="USD">1307124</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001270"
      unitRef="USD">167831</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001272"
      unitRef="USD">1139293</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2024-12-31" id="Fact001274">P2Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001276"
      unitRef="Pure">0.0998</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <IMNN:OperatingLeasesIncrementalBorrowingRate
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001278"
      unitRef="Pure">0.0998</IMNN:OperatingLeasesIncrementalBorrowingRate>
    <us-gaap:OperatingLeaseCost
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact001280"
      unitRef="USD">652166</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact001282"
      unitRef="USD">659646</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseCost
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001284"
      unitRef="USD">646633</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001286"
      unitRef="USD">644593</us-gaap:OperatingLeasePayments>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact001288"
      unitRef="USD">478000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001290"
      unitRef="USD">472000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001292">&lt;p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z8zBLQlNyDX5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;15.
&lt;span id="xdx_82E_zO8Yr3F9ZSD9"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
are not currently a party to any material legal proceedings.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001294">&lt;p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zteBUWcvnHK8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;16.
&lt;span id="xdx_82A_zbkpGyTOqKn"&gt;RELATED PARTY TRANSACTION&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 16, 2022, the Company entered into a convertible note purchase agreement with Transomic Technologies, Inc. (&#x201c;Transomic&#x201d;)
whereby the Company purchased $&lt;span id="xdx_908_eus-gaap--ConvertibleNotesPayable_iI_c20221116__us-gaap--TypeOfArrangementAxis__custom--ConvertibleNotePurchaseAgreementMember__dei--LegalEntityAxis__custom--TransomicTechnologiesIncMember_zRtQ0peERVej" title="Convertible notes and warrants"&gt;375,000&lt;/span&gt; of convertible notes secured by certain assets held by Transomic and warrants. Imunon purchased
products from Transomic for research and development purposes &#x2013; primarily delivery vectors for its vaccine program. As a result
of this investment in Transomic, Imunon&#x2019;s executive chairman, Mr. Michael Tardugno, was appointed to the Board of Directors of
Transomic. The Company disclosed the notes receivable as a related party transaction. In December 2023, Transomic filed a formal certificate
of dissolution of the company resulting in a complete write-off of the convertible note and related warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2022-11-16_custom_ConvertibleNotePurchaseAgreementMember_custom_TransomicTechnologiesIncMember"
      decimals="0"
      id="Fact001296"
      unitRef="USD">375000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001298">&lt;p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_zIORMTUG7grh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;17.
&lt;span id="xdx_827_zj9ZS1U4Yih4"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has evaluated its subsequent events from December 31, 2024, through the date these condensed consolidated financial statements
were issued, determining all subsequent events have been disclosed.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
